data_2lbh_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lbh _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.5 m . . . . . 0 CA--C 1.556 1.2 0 N-CA-C 113.201 0.815 . . . . 2.89 113.201 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.575 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -34.82 113.29 0.46 Allowed Pre-proline 0 N--CA 1.491 1.609 0 CA-C-N 119.0 0.818 . . . . 3.22 111.661 179.461 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.472 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 71.5 Cg_endo -75.48 117.92 4.97 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 122.82 2.347 . . . . 1.89 113.309 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 5.7 p -130.93 -178.29 4.75 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 121.057 0.456 . . . . 1.32 111.702 178.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.462 ' HA2' ' HB3' ' A' ' 40' ' ' GLU . . . 77.21 -162.54 51.4 Favored Glycine 0 CA--C 1.519 0.303 0 CA-C-N 116.162 -0.472 . . . . 1.23 112.121 -178.111 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.5 ' O ' ' HG2' ' A' ' 15' ' ' PRO . 44.6 Cg_endo -65.8 100.29 0.42 Allowed 'Trans proline' 0 N--CA 1.48 0.692 0 C-N-CA 124.165 3.244 . . . . 1.9 111.886 177.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.03 5.89 76.29 Favored Glycine 0 C--N 1.299 -1.473 0 CA-C-N 115.316 -0.856 . . . . 2.18 113.465 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.472 ' O ' ' CB ' ' A' ' 12' ' ' PRO . . . 71.95 45.33 42.75 Favored Glycine 0 N--CA 1.426 -2.011 0 N-CA-C 115.71 1.044 . . . . 1.48 115.71 177.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.458 ' HB2' ' CD1' ' A' ' 32' ' ' LEU . 0.5 OUTLIER -94.89 -24.02 17.19 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 112.66 0.615 . . . . 3.51 112.66 -179.828 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -79.5 171.84 54.87 Favored Glycine 0 CA--C 1.495 -1.157 0 CA-C-N 115.235 -0.893 . . . . 1.27 111.64 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.579 ' O ' ' SG ' ' A' ' 27' ' ' CYS . 0.8 OUTLIER -120.86 149.41 42.64 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 109.848 -0.427 . . . . 3.02 109.848 -178.62 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.401 ' HB2' HD22 ' A' ' 11' ' ' LEU . 57.0 m -98.64 127.02 44.42 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.988 0.899 . . . . 1.22 109.741 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -109.89 -29.94 8.05 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 113.963 -1.472 . . . . 2.99 111.315 -177.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -157.03 -174.49 26.8 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 121.089 -0.577 . . . . 1.1 112.708 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.41 -54.27 5.22 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 122.747 2.298 . . . . 1.11 113.45 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.588 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.7 OUTLIER -120.65 36.32 4.61 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 122.462 -0.149 . . . . 1.29 111.207 179.695 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.508 HG12 HG12 ' A' ' 36' ' ' VAL . 19.7 mt -140.77 111.42 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 C-N-CA 120.32 -0.552 . . . . 1.69 111.896 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.579 ' SG ' ' O ' ' A' ' 20' ' ' ARG . 0.5 OUTLIER -126.49 120.71 30.39 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 116.528 -0.305 . . . . 1.2 110.19 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.884 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -131.07 127.85 39.03 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 119.526 -0.87 . . . . 1.2 112.65 -179.579 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 33' ' ' GLY . . . -103.92 -169.51 25.24 Favored Glycine 0 N--CA 1.421 -2.325 0 C-N-CA 120.45 -0.881 . . . . 0.9 111.858 178.022 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -69.87 -51.06 36.54 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 114.694 -0.753 . . . . 2.64 112.969 -178.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -121.08 9.42 10.52 Favored 'General case' 0 CA--C 1.503 -0.836 0 CA-C-N 115.041 -0.981 . . . . 2.1 109.437 -177.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.458 ' CD1' ' HB2' ' A' ' 18' ' ' LYS . 4.7 mt -109.67 -9.83 14.84 Favored 'General case' 0 N--CA 1.408 -2.569 0 N-CA-C 108.871 -0.789 . . . . 1.5 108.871 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.884 ' O ' ' HA ' ' A' ' 28' ' ' CYS . . . 65.8 -136.0 35.64 Favored Glycine 0 N--CA 1.43 -1.751 0 C-N-CA 120.42 -0.895 . . . . 0.74 112.921 176.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.62 ' HB2' ' CD1' ' A' ' 72' ' ' ILE . 1.6 t -135.66 125.54 25.73 Favored 'General case' 0 CA--C 1.503 -0.827 0 N-CA-C 114.37 1.248 . . . . 0.94 114.37 -178.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.454 ' CD1' ' N ' ' A' ' 35' ' ' PHE . 4.2 m-85 -98.88 101.03 12.29 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 104.655 -2.35 . . . . 2.68 104.655 176.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.572 HG23 HG23 ' B' ' 136' ' ' VAL . 3.8 t -87.06 94.48 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 CA-C-O 122.937 1.351 . . . . 1.24 110.603 -178.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.588 ' N ' ' O ' ' A' ' 25' ' ' SER . . . 76.95 83.63 0.5 Allowed Glycine 0 CA--C 1.499 -0.911 0 CA-C-N 112.028 -2.351 . . . . 1.32 112.186 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 19.2 p -149.95 169.08 22.02 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-O 120.972 0.415 . . . . 1.79 111.16 -178.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -55.08 -27.73 47.09 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.867 -0.606 . . . . 1.67 110.781 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.462 ' HB3' ' HA2' ' A' ' 14' ' ' GLY . 30.1 mp0 -73.56 -29.21 62.29 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 112.665 0.617 . . . . 2.56 112.665 -179.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.405 ' O ' ' HB2' ' A' ' 44' ' ' CYS . . . -97.55 -1.35 44.13 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 120.701 0.286 . . . . 1.37 110.38 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.6 mt -57.61 -32.98 67.75 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 120.939 0.4 . . . . 2.46 110.308 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.7 ptm85 -72.13 -9.07 57.92 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.89 -0.596 . . . . 4.29 110.594 179.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.405 ' HB2' ' O ' ' A' ' 41' ' ' ALA . 94.4 m -69.36 -10.18 56.76 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 120.198 -0.601 . . . . 1.32 111.389 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -54.96 -24.76 25.46 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.109 0.48 . . . . 3.28 110.928 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -85.83 5.01 34.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.241 -0.436 . . . . 3.55 110.434 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.443 -0.791 0 N-CA-C 108.789 -0.819 . . . . 2.79 108.789 179.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.9 t . . . . . 0 N--CA 1.473 0.677 0 CA-C-O 120.456 0.169 . . . . 4.04 110.835 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.478 ' O ' ' HB2' ' A' ' 66' ' ' ARG . . . -66.12 120.44 15.93 Favored Glycine 0 N--CA 1.429 -1.782 0 C-N-CA 120.213 -0.994 . . . . 2.88 110.827 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.61 77.58 6.21 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 107.886 -1.153 . . . . 5.79 107.886 179.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.473 ' O ' ' HA ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -146.33 58.26 4.45 Favored Pre-proline 0 C--N 1.306 -1.318 0 CA-C-N 114.933 -1.03 . . . . 6.52 108.868 -179.524 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 59' ' ' LYS . 36.8 Cg_endo -64.63 85.5 0.17 Allowed 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.584 2.189 . . . . 2.54 112.235 179.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.506 ' N ' ' O ' ' A' ' 65' ' ' GLY . 0.5 OUTLIER -108.41 -179.4 3.87 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.624 -0.717 . . . . 2.8 109.083 179.44 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.08 -161.01 44.94 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 117.859 -2.115 . . . . 2.47 111.816 178.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 50.9 m -78.79 45.33 0.59 Allowed 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 120.689 0.281 . . . . 3.61 111.637 -179.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 105.28 16.07 17.53 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 120.945 -0.645 . . . . 2.33 114.674 178.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.506 ' O ' ' N ' ' A' ' 61' ' ' CYS . . . -103.7 132.85 11.22 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 119.822 -1.18 . . . . 1.92 114.738 -179.268 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.478 ' HB2' ' O ' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -93.61 159.16 15.34 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 122.49 0.316 . . . . 3.78 110.95 178.335 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 13.8 t -70.05 106.37 3.21 Favored 'General case' 0 N--CA 1.432 -1.363 0 C-N-CA 119.782 -0.767 . . . . 1.76 109.438 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -93.15 -17.57 23.59 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.906 0.384 . . . . 1.71 110.613 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.628 ' HB3' ' HA2' ' A' ' 33' ' ' GLY . . . -168.11 164.21 13.45 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 115.969 -0.56 . . . . 1.37 110.377 -178.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -45.17 121.76 3.04 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 114.218 1.192 . . . . 1.96 114.218 -177.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.649 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . 59.86 31.44 71.96 Favored Glycine 0 CA--C 1.506 -0.526 0 CA-C-N 113.479 -1.691 . . . . 1.71 115.673 176.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.62 ' CD1' ' HB2' ' A' ' 34' ' ' CYS . 1.3 pt -142.37 112.6 2.73 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-O 122.015 0.912 . . . . 2.58 111.976 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.731 ' HB2' ' HB3' ' A' ' 82' ' ' ASP . 0.0 OUTLIER -93.07 94.2 8.73 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 114.72 -1.127 . . . . 1.72 109.14 179.302 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.553 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 43.7 m -102.4 147.94 26.1 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.295 0.569 . . . . 1.89 111.469 -179.19 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.48 ' CB ' ' HD2' ' A' ' 76' ' ' PRO . 0.3 OUTLIER -122.64 -179.12 0.72 Allowed Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 114.632 -1.167 . . . . 2.53 108.813 179.615 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.48 ' HD2' ' CB ' ' A' ' 75' ' ' SER . 58.0 Cg_endo -74.26 32.6 0.34 Allowed 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 121.883 1.722 . . . . 3.07 112.954 -179.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.452 ' HB3' ' NE2' ' B' ' 180' ' ' HIS . 5.4 m-20 -147.54 -49.68 0.18 Allowed 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.876 -0.602 . . . . 2.63 111.002 178.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.563 ' HA3' ' O ' ' B' ' 179' ' ' CYS . . . -143.69 -152.2 5.61 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 120.412 -0.899 . . . . 0.9 113.727 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.554 ' O ' ' HA3' ' B' ' 178' ' ' GLY . 5.0 m -138.46 149.82 45.84 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.045 -0.578 . . . . 1.23 110.156 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.636 ' O ' ' N ' ' A' ' 73' ' ' CYS . 0.1 OUTLIER -147.41 145.46 29.24 Favored 'General case' 0 CA--C 1.513 -0.474 0 O-C-N 121.516 -0.74 . . . . 3.88 111.408 -178.404 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -67.95 144.58 55.14 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.344 -0.613 . . . . 2.9 109.344 178.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.731 ' HB3' ' HB2' ' A' ' 73' ' ' CYS . 2.2 p-10 -146.34 121.2 5.41 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 116.066 -0.515 . . . . 2.52 110.055 -177.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -61.83 -15.08 40.4 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.776 2.317 . . . . 3.27 114.385 -178.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.16 -44.84 78.74 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.908 0.385 . . . . 2.78 111.814 -179.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.649 ' O ' ' N ' ' A' ' 71' ' ' GLY . 14.0 m -106.04 26.16 10.06 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.681 0.753 . . . . 2.16 109.919 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 11.6 t0 . . . . . 0 C--N 1.309 -1.175 0 O-C-N 121.308 -0.87 . . . . 3.14 112.425 -179.063 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 110' ' ' CYS . . . . . . . . . . . . . 1.3 m . . . . . 0 CA--C 1.552 1.037 0 N-CA-C 113.097 0.777 . . . . 2.9 113.097 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 111' ' ' LEU . . . . . 0.598 ' O ' ' HA ' ' B' ' 120' ' ' ARG . 0.7 OUTLIER -33.78 112.82 0.41 Allowed Pre-proline 0 N--CA 1.483 1.214 0 CA-C-N 118.554 0.616 . . . . 3.25 112.485 179.533 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 112' ' ' PRO . . . . . 0.46 ' CB ' ' O ' ' B' ' 117' ' ' GLY . 73.3 Cg_endo -75.87 119.44 5.4 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.7 2.267 . . . . 1.94 114.171 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . . . . . . . . . 4.3 p -133.09 -178.16 4.84 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 120.502 -0.479 . . . . 1.29 112.137 178.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 114' ' ' GLY . . . . . 0.463 ' HA2' ' HB3' ' B' ' 140' ' ' GLU . . . 77.17 -162.23 51.25 Favored Glycine 0 CA--C 1.522 0.5 0 CA-C-N 116.037 -0.529 . . . . 1.2 111.999 -177.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 115' ' ' PRO . . . . . 0.496 ' O ' ' HG2' ' B' ' 115' ' ' PRO . 45.1 Cg_endo -66.19 99.32 0.41 Allowed 'Trans proline' 0 N--CA 1.478 0.588 0 C-N-CA 124.089 3.192 . . . . 1.86 112.089 177.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 89.12 5.95 72.33 Favored Glycine 0 C--N 1.298 -1.541 0 CA-C-N 115.404 -0.816 . . . . 2.16 113.436 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 117' ' ' GLY . . . . . 0.46 ' O ' ' CB ' ' B' ' 112' ' ' PRO . . . 72.24 45.03 41.52 Favored Glycine 0 N--CA 1.425 -2.064 0 C-N-CA 120.386 -0.911 . . . . 1.48 115.268 177.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 118' ' ' LYS . . . . . 0.447 ' HB2' ' CD1' ' B' ' 132' ' ' LEU . 0.4 OUTLIER -94.29 -24.67 17.34 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 121.153 0.502 . . . . 3.51 111.94 -179.601 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . -78.84 173.06 55.35 Favored Glycine 0 N--CA 1.438 -1.227 0 C-N-CA 120.589 -0.815 . . . . 1.26 111.893 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.598 ' HA ' ' O ' ' B' ' 111' ' ' LEU . 0.7 OUTLIER -120.85 149.0 43.27 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 110.024 -0.362 . . . . 3.03 110.024 -179.508 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 121' ' ' CYS . . . . . . . . . . . . . 57.3 m -98.16 127.63 44.21 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 119.639 -0.825 . . . . 1.21 110.203 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 122' ' ' PHE . . . . . 0.454 ' CE2' ' HB1' ' B' ' 168' ' ' ALA . 3.5 m-85 -110.9 -28.41 8.38 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 114.413 -1.267 . . . . 2.99 111.657 -177.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -158.12 -175.65 29.29 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 121.149 -0.548 . . . . 1.07 112.445 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -52.42 -54.09 5.78 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 122.85 2.366 . . . . 1.14 113.447 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 125' ' ' SER . . . . . 0.57 ' O ' ' N ' ' B' ' 137' ' ' GLY . 1.0 OUTLIER -121.0 36.77 4.5 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 122.413 -0.18 . . . . 1.24 110.961 179.671 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 126' ' ' ILE . . . . . 0.451 HG12 HG13 ' B' ' 136' ' ' VAL . 16.0 mt -139.72 111.02 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 C-N-CA 120.499 -0.48 . . . . 1.4 112.047 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 127' ' ' CYS . . . . . 0.559 ' SG ' ' O ' ' B' ' 120' ' ' ARG . 0.5 OUTLIER -127.55 119.74 26.66 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 110.099 -0.334 . . . . 1.19 110.099 179.677 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 128' ' ' CYS . . . . . 0.932 ' HA ' ' O ' ' B' ' 133' ' ' GLY . 0.0 OUTLIER -130.09 128.18 41.36 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 119.952 -0.699 . . . . 1.21 112.608 -178.941 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 129' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' B' ' 133' ' ' GLY . . . -105.48 -169.19 23.72 Favored Glycine 0 N--CA 1.418 -2.506 0 C-N-CA 120.065 -1.064 . . . . 0.87 111.989 178.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -70.41 -51.62 28.21 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 115.126 -0.537 . . . . 2.63 112.351 -177.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.8 30.61 5.46 Favored 'General case' 0 CA--C 1.503 -0.861 0 N-CA-C 108.861 -0.792 . . . . 2.1 108.861 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 132' ' ' LEU . . . . . 0.447 ' CD1' ' HB2' ' B' ' 118' ' ' LYS . 3.8 mt -127.06 -7.8 5.98 Favored 'General case' 0 N--CA 1.396 -3.159 0 N-CA-C 106.752 -1.573 . . . . 1.62 106.752 177.374 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 133' ' ' GLY . . . . . 0.932 ' O ' ' HA ' ' B' ' 128' ' ' CYS . . . 61.87 -136.36 46.4 Favored Glycine 0 N--CA 1.427 -1.942 0 CA-C-N 115.283 -0.871 . . . . 0.74 113.851 176.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 134' ' ' CYS . . . . . 0.618 ' HB2' ' CD1' ' B' ' 172' ' ' ILE . 1.6 t -134.36 126.24 29.23 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 114.5 1.296 . . . . 0.96 114.5 -178.044 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 135' ' ' PHE . . . . . 0.467 ' CD1' ' N ' ' B' ' 135' ' ' PHE . 4.8 m-85 -99.28 101.09 12.28 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 104.455 -2.424 . . . . 2.69 104.455 176.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 136' ' ' VAL . . . . . 0.572 HG23 HG23 ' A' ' 36' ' ' VAL . 38.3 t -85.58 93.76 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 CA-C-O 122.97 1.367 . . . . 1.2 110.072 -178.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 137' ' ' GLY . . . . . 0.57 ' N ' ' O ' ' B' ' 125' ' ' SER . . . 75.32 84.75 0.35 Allowed Glycine 0 CA--C 1.502 -0.729 0 CA-C-N 112.136 -2.302 . . . . 1.33 112.448 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 138' ' ' THR . . . . . . . . . . . . . 19.1 p -150.22 169.64 20.85 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 120.9 0.381 . . . . 1.68 111.172 -179.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -55.39 -27.65 49.0 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.038 -0.528 . . . . 1.73 110.805 179.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 140' ' ' GLU . . . . . 0.463 ' HB3' ' HA2' ' B' ' 114' ' ' GLY . 30.2 mp0 -73.52 -29.14 62.28 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 112.542 0.571 . . . . 2.53 112.542 -179.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -97.47 -0.91 45.28 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 120.713 0.292 . . . . 1.45 110.489 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 1.6 mt -58.02 -33.05 68.53 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 121.031 0.443 . . . . 2.47 110.318 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 143' ' ' ARG . . . . . . . . . . . . . 2.0 ptm85 -71.96 -9.2 58.03 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.883 -0.599 . . . . 4.3 110.606 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 144' ' ' CYS . . . . . . . . . . . . . 94.2 m -69.48 -9.89 55.71 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 120.169 -0.613 . . . . 1.37 111.414 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -55.04 -24.96 27.41 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.072 0.463 . . . . 3.26 110.802 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -85.81 5.41 32.7 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 116.351 -0.386 . . . . 3.53 110.495 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.445 -0.712 0 N-CA-C 108.879 -0.786 . . . . 2.81 108.879 178.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 1.8 t . . . . . 0 N--CA 1.471 0.625 0 CA-C-O 120.518 0.199 . . . . 4.25 111.007 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 157' ' ' GLY . . . . . 0.436 ' O ' ' HB2' ' B' ' 166' ' ' ARG . . . -62.04 120.62 22.79 Favored Glycine 0 N--CA 1.441 -0.971 0 C-N-CA 120.159 -1.02 . . . . 2.89 111.025 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.36 60.11 3.67 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.691 0.758 . . . . 5.82 110.27 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 159' ' ' LYS . . . . . 0.551 ' HB2' ' CB ' ' B' ' 167' ' ' CYS . 0.1 OUTLIER -115.42 55.41 1.01 Allowed Pre-proline 0 N--CA 1.443 -0.778 0 CA-C-N 114.766 -1.107 . . . . 6.5 111.541 176.076 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 160' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -63.09 85.57 0.12 Allowed 'Trans proline' 0 CA--C 1.531 0.336 0 CA-C-N 121.306 1.502 . . . . 2.53 113.794 -178.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 161' ' ' CYS . . . . . 0.512 ' N ' ' O ' ' B' ' 165' ' ' GLY . 0.5 OUTLIER -109.61 -179.65 3.88 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.05 -0.523 . . . . 2.76 109.705 179.504 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 66.68 -160.75 47.14 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 118.26 -1.924 . . . . 2.45 111.642 178.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 39.0 m -78.57 43.77 0.49 Allowed 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 116.802 0.301 . . . . 3.61 111.53 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 106.86 15.9 15.35 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 120.74 -0.743 . . . . 2.31 114.588 178.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 165' ' ' GLY . . . . . 0.512 ' O ' ' N ' ' B' ' 161' ' ' CYS . . . -103.61 134.08 11.74 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.044 -1.074 . . . . 1.89 114.444 -179.321 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 166' ' ' ARG . . . . . 0.496 ' HA ' ' O ' ' B' ' 159' ' ' LYS . 0.0 OUTLIER -95.27 158.64 15.37 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 115.415 -0.393 . . . . 3.77 110.875 178.254 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 167' ' ' CYS . . . . . 0.551 ' CB ' ' HB2' ' B' ' 159' ' ' LYS . 14.1 t -70.17 106.1 3.17 Favored 'General case' 0 N--CA 1.435 -1.218 0 C-N-CA 119.731 -0.788 . . . . 1.73 109.342 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 168' ' ' ALA . . . . . 0.454 ' HB1' ' CE2' ' B' ' 122' ' ' PHE . . . -93.12 -18.81 22.15 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.205 0.526 . . . . 1.59 110.782 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 169' ' ' ALA . . . . . 0.676 ' CB ' ' HA2' ' B' ' 133' ' ' GLY . . . -165.63 164.94 19.09 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 115.466 -0.788 . . . . 1.55 110.53 -178.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 170' ' ' ALA . . . . . . . . . . . . . . . -46.89 121.71 3.82 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 114.762 1.393 . . . . 1.84 114.762 -177.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 171' ' ' GLY . . . . . 0.759 ' N ' ' O ' ' B' ' 185' ' ' CYS . . . 61.83 29.66 72.94 Favored Glycine 0 C--N 1.315 -0.633 0 CA-C-N 113.974 -1.466 . . . . 1.7 115.896 177.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 172' ' ' ILE . . . . . 0.618 ' CD1' ' HB2' ' B' ' 134' ' ' CYS . 1.3 pt -142.58 113.71 2.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 118.331 1.066 . . . . 2.72 111.95 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 173' ' ' CYS . . . . . 0.774 ' HB2' ' HB3' ' B' ' 182' ' ' ASP . 0.0 OUTLIER -94.22 93.93 8.05 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 114.56 -1.2 . . . . 1.73 108.81 179.692 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 174' ' ' CYS . . . . . 0.581 ' HA ' ' HA ' ' B' ' 179' ' ' CYS . 37.2 m -102.22 148.0 25.96 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.458 0.646 . . . . 1.87 111.745 -179.013 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 175' ' ' SER . . . . . 0.486 ' CB ' ' HD2' ' B' ' 176' ' ' PRO . 0.3 OUTLIER -122.88 -179.26 0.76 Allowed Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 114.627 -1.169 . . . . 2.53 108.914 179.792 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 176' ' ' PRO . . . . . 0.486 ' HD2' ' CB ' ' B' ' 175' ' ' SER . 57.9 Cg_endo -74.02 32.61 0.34 Allowed 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 121.811 1.674 . . . . 3.04 113.044 -179.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 177' ' ' ASP . . . . . 0.433 ' HB3' ' NE2' ' A' ' 80' ' ' HIS . 5.1 m-20 -147.69 -49.53 0.17 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.915 -0.584 . . . . 2.66 110.949 178.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 178' ' ' GLY . . . . . 0.554 ' HA3' ' O ' ' A' ' 79' ' ' CYS . . . -143.49 -151.57 5.49 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 120.492 -0.861 . . . . 0.91 113.944 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 179' ' ' CYS . . . . . 0.581 ' HA ' ' HA ' ' B' ' 174' ' ' CYS . 4.8 m -139.42 149.24 43.83 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 114.879 -0.66 . . . . 1.24 110.095 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 180' ' ' HIS . . . . . 0.613 ' O ' ' N ' ' B' ' 173' ' ' CYS . 0.1 OUTLIER -146.88 145.74 29.94 Favored 'General case' 0 CA--C 1.511 -0.547 0 C-N-CA 119.807 -0.757 . . . . 3.87 111.41 -178.436 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 181' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -67.9 145.26 54.75 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 120.175 -0.61 . . . . 2.9 109.48 178.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 182' ' ' ASP . . . . . 0.774 ' HB3' ' HB2' ' B' ' 173' ' ' CYS . 1.8 p-10 -146.9 121.05 5.11 Favored Pre-proline 0 C--N 1.319 -0.753 0 CA-C-N 116.196 -0.456 . . . . 2.49 110.412 -178.005 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 183' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -61.51 -14.8 37.35 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 122.653 2.236 . . . . 3.23 114.448 -178.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -67.55 -44.98 76.97 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.846 0.355 . . . . 2.72 111.647 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 185' ' ' CYS . . . . . 0.759 ' O ' ' N ' ' B' ' 171' ' ' GLY . 11.9 m -106.91 28.87 7.56 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.629 0.728 . . . . 2.13 110.767 -179.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 186' ' ' ASP . . . . . . . . . . . . . 11.8 t0 . . . . . 0 C--N 1.319 -0.738 0 CA-C-N 115.835 -0.62 . . . . 3.11 112.52 -179.144 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.509 ' O ' ' C ' ' A' ' 11' ' ' LEU . 8.4 m . . . . . 0 CA--C 1.531 0.237 0 N-CA-C 115.944 1.831 . . . . 2.89 115.944 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.513 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -31.56 110.88 0.3 Allowed Pre-proline 0 N--CA 1.48 1.054 0 CA-C-N 119.055 0.843 . . . . 2.89 110.125 178.739 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.627 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 41.5 Cg_endo -99.98 139.49 0.28 Allowed 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.143 1.896 . . . . 1.72 116.758 -177.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.461 ' HA ' ' HD2' ' A' ' 43' ' ' ARG . 2.4 p -134.59 -165.75 1.71 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 118.674 -1.21 . . . . 1.0 109.866 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.441 ' HA2' ' HG2' ' A' ' 40' ' ' GLU . . . 64.65 -159.45 42.37 Favored Glycine 0 CA--C 1.499 -0.939 0 C-N-CA 121.365 -0.445 . . . . 1.15 113.527 176.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.435 ' C ' ' H ' ' A' ' 17' ' ' GLY . 42.7 Cg_endo -64.75 138.19 57.31 Favored 'Trans proline' 0 N--CA 1.443 -1.448 0 C-N-CA 122.25 1.967 . . . . 1.6 109.029 176.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 55.93 -6.58 0.01 OUTLIER Glycine 0 C--N 1.273 -2.965 0 CA-C-N 114.055 -1.43 . . . . 1.68 114.029 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.435 ' H ' ' C ' ' A' ' 15' ' ' PRO . . . 69.66 40.98 76.53 Favored Glycine 1 N--CA 1.387 -4.567 0 C-N-CA 116.947 -2.549 . . . . 1.37 108.871 -178.455 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.495 ' HB2' HD12 ' A' ' 32' ' ' LEU . 1.6 mttp -93.59 -10.91 33.08 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 111.677 -2.262 . . . . 2.91 113.24 179.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.627 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -122.85 179.0 16.27 Favored Glycine 0 N--CA 1.44 -1.051 0 N-CA-C 106.539 -2.624 . . . . 1.06 106.539 178.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.513 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 0.3 OUTLIER -122.55 170.23 10.21 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 119.95 1.875 . . . . 3.32 112.274 -178.98 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.438 ' SG ' ' O ' ' A' ' 23' ' ' GLY . 20.2 t -114.66 150.76 34.68 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.735 0.303 . . . . 1.19 111.796 -179.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.683 ' CE1' HG21 ' A' ' 26' ' ' ILE . 28.5 p90 -131.85 -49.56 0.96 Allowed 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 108.704 -0.85 . . . . 2.26 108.704 177.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.438 ' O ' ' SG ' ' A' ' 21' ' ' CYS . . . -99.29 -154.87 28.54 Favored Glycine 0 N--CA 1.448 -0.553 0 N-CA-C 109.007 -1.637 . . . . 1.05 109.007 176.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -94.18 -60.55 0.01 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.032 0 CA-C-N 119.829 1.814 . . . . 1.81 112.14 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.636 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.6 OUTLIER -90.92 9.82 28.95 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-O 120.615 0.245 . . . . 1.62 110.403 179.05 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.739 HG12 HG13 ' A' ' 36' ' ' VAL . 1.5 mt -120.08 118.08 55.71 Favored 'Isoleucine or valine' 0 C--O 1.245 0.854 0 CA-C-O 122.061 0.934 . . . . 1.39 112.311 -177.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.744 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 0.7 OUTLIER -134.83 130.47 36.09 Favored 'General case' 0 C--O 1.223 -0.31 0 CA-C-N 114.238 -1.346 . . . . 0.92 110.556 -179.492 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 1.106 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -132.4 172.65 12.2 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-O 123.155 1.455 . . . . 1.28 114.167 -178.086 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.519 ' O ' ' HB1' ' A' ' 69' ' ' ALA . . . -156.87 176.0 34.26 Favored Glycine 0 N--CA 1.429 -1.812 0 CA-C-N 111.664 -2.517 . . . . 0.71 108.602 178.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -62.17 -53.0 61.54 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 121.964 0.888 . . . . 2.27 110.453 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.29 11.69 14.11 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 113.79 -1.55 . . . . 1.66 109.402 179.027 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.495 HD12 ' HB2' ' A' ' 18' ' ' LYS . 0.5 OUTLIER -106.47 -4.2 20.09 Favored 'General case' 0 N--CA 1.412 -2.352 0 N-CA-C 106.897 -1.519 . . . . 1.93 106.897 179.275 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 1.106 ' O ' ' HA ' ' A' ' 28' ' ' CYS . . . 46.76 -140.59 6.77 Favored Glycine 0 N--CA 1.419 -2.441 0 CA-C-N 113.67 -1.604 . . . . 0.77 113.028 178.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.744 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 0.5 OUTLIER -138.23 122.16 17.77 Favored 'General case' 0 CA--C 1.493 -1.234 0 N-CA-C 113.168 0.803 . . . . 1.08 113.168 179.709 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.926 ' HA ' ' HA ' ' B' ' 135' ' ' PHE . 0.0 OUTLIER -88.8 106.2 18.21 Favored 'General case' 0 N--CA 1.423 -1.81 0 N-CA-C 104.22 -2.511 . . . . 1.85 104.22 175.437 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.739 HG13 HG12 ' A' ' 26' ' ' ILE . 1.4 t -96.09 83.71 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 N-CA-C 107.734 -1.21 . . . . 1.29 107.734 -179.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.699 ' O ' ' HA3' ' B' ' 133' ' ' GLY . . . 103.01 92.57 2.23 Favored Glycine 0 CA--C 1.531 1.073 0 CA-C-N 112.955 -1.929 . . . . 0.85 114.259 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.401 ' CG2' ' CB ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER 177.86 167.1 0.72 Allowed 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 108.808 -0.812 . . . . 1.3 108.808 178.455 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.767 ' CA ' HD22 ' A' ' 42' ' ' LEU . . . -61.24 -16.77 48.69 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 119.996 1.271 . . . . 1.45 111.677 179.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.65 ' HB3' ' CD2' ' A' ' 35' ' ' PHE . 5.0 mt-10 -64.19 -14.95 58.68 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.629 -0.508 . . . . 2.32 109.629 178.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.581 ' O ' ' HB3' ' A' ' 44' ' ' CYS . . . -126.1 -4.81 6.8 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 115.67 -0.696 . . . . 1.11 111.949 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.767 HD22 ' CA ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -73.95 -36.3 64.62 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 108.218 -1.03 . . . . 1.68 108.218 179.231 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.461 ' HD2' ' HA ' ' A' ' 13' ' ' CYS . 1.2 ptp180 -63.52 -5.63 4.08 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 114.31 -1.313 . . . . 3.4 109.529 178.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.581 ' HB3' ' O ' ' A' ' 41' ' ' ALA . 9.3 t -82.2 11.8 4.97 Favored 'General case' 0 N--CA 1.445 -0.701 0 O-C-N 121.572 -0.705 . . . . 1.57 109.166 177.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -73.02 -18.3 61.36 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.945 -0.571 . . . . 3.49 109.477 178.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.42 5.7 33.77 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 119.303 -0.959 . . . . 3.69 109.862 179.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 . . . . . 0 N--CA 1.448 -0.562 0 CA-C-N 115.866 -0.607 . . . . 3.99 109.583 177.53 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.542 0.653 0 N-CA-C 111.382 0.141 . . . . 3.36 111.382 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 56.45 58.57 13.66 Favored Glycine 0 N--CA 1.426 -2.033 0 C-N-CA 121.346 -0.454 . . . . 2.3 112.214 176.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 -119.46 70.46 0.85 Allowed 'General case' 0 N--CA 1.435 -1.206 0 CA-C-O 122.82 1.295 . . . . 5.06 107.684 177.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.642 ' N ' ' CD ' ' A' ' 60' ' ' PRO . 2.2 mmpp? -143.68 44.69 0.51 Allowed Pre-proline 0 C--N 1.303 -1.435 0 CA-C-N 112.428 -2.169 . . . . 3.91 108.089 177.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.642 ' CD ' ' N ' ' A' ' 59' ' ' LYS . 1.3 Cg_endo -42.96 114.75 0.47 Allowed 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 123.629 2.886 . . . . 1.74 115.247 -178.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -146.68 170.53 16.76 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 113.357 -1.747 . . . . 1.9 108.19 177.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 71.07 -168.54 50.28 Favored Glycine 0 CA--C 1.494 -1.264 0 C-N-CA 118.704 -1.713 . . . . 2.43 113.63 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 14.4 p -83.29 44.46 0.95 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.015 -0.593 . . . . 4.32 111.692 -178.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 118.26 9.61 9.43 Favored Glycine 0 C--N 1.334 0.455 0 N-CA-C 115.222 0.849 . . . . 2.4 115.222 177.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.633 ' HA3' ' HA ' ' A' ' 75' ' ' SER . . . -105.16 162.29 14.55 Favored Glycine 0 C--N 1.338 0.642 0 CA-C-N 119.202 1.501 . . . . 1.82 115.178 -178.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.1 153.67 21.19 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 108.524 -0.917 . . . . 3.51 108.524 177.068 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.51 ' HA ' ' HA ' ' A' ' 73' ' ' CYS . 50.5 t -58.7 115.57 3.15 Favored 'General case' 0 N--CA 1.426 -1.669 0 N-CA-C 109.217 -0.66 . . . . 1.52 109.217 -179.403 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.49 ' H ' ' HA ' ' A' ' 73' ' ' CYS . . . -62.88 -48.37 79.3 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 106.875 -1.528 . . . . 1.5 106.875 178.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.705 ' CB ' ' HA2' ' A' ' 33' ' ' GLY . . . -167.8 163.92 14.15 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 112.9 -1.954 . . . . 1.31 110.736 -174.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 1.029 ' HA ' ' HB3' ' A' ' 85' ' ' CYS . . . -43.96 130.61 5.85 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.428 0.632 . . . . 1.5 112.298 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.727 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . 80.23 -26.09 3.04 Favored Glycine 0 CA--C 1.522 0.481 0 CA-C-N 115.006 -0.997 . . . . 1.44 115.059 177.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.609 ' CD1' ' HB2' ' A' ' 34' ' ' CYS . 1.2 pp -129.25 116.59 40.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 122.319 1.057 . . . . 2.77 111.021 -179.149 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.51 ' HA ' ' HA ' ' A' ' 67' ' ' CYS . 1.6 t -106.13 112.45 25.48 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.175 -1.375 . . . . 1.98 110.578 -177.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.652 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 3.7 m -84.45 147.85 26.88 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 121.94 0.876 . . . . 1.43 112.752 -177.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.812 ' HB2' ' HD2' ' A' ' 76' ' ' PRO . 12.1 p -122.64 -179.9 0.88 Allowed Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 114.031 -1.44 . . . . 2.37 108.106 178.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.812 ' HD2' ' HB2' ' A' ' 75' ' ' SER . 57.0 Cg_endo -73.73 29.93 0.32 Allowed 'Trans proline' 0 N--CA 1.459 -0.516 0 CA-C-N 119.895 0.998 . . . . 2.09 111.59 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.524 ' H ' ' C ' ' A' ' 75' ' ' SER . 2.5 p30 -145.89 -48.93 0.22 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.607 -0.724 . . . . 2.65 110.63 179.053 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 1.089 ' HA3' ' O ' ' B' ' 179' ' ' CYS . . . -156.3 -140.8 3.05 Favored Glycine 0 C--N 1.336 0.547 0 C-N-CA 120.398 -0.906 . . . . 1.04 113.843 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 1.057 ' O ' ' HA3' ' B' ' 178' ' ' GLY . 0.0 OUTLIER -142.73 153.2 43.11 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.329 -0.436 . . . . 1.42 110.556 -179.826 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 4.2 p-80 -154.36 160.36 41.66 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.096 -0.642 . . . . 2.81 112.008 -178.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.58 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -60.25 140.53 56.98 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.874 -0.603 . . . . 3.05 110.32 179.867 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.466 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 3.7 p-10 -139.75 140.29 24.31 Favored Pre-proline 0 CA--C 1.541 0.598 0 CA-C-N 116.018 -0.537 . . . . 2.02 110.763 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 82' ' ' ASP . 3.2 Cg_exo -77.26 -24.97 8.93 Favored 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 123.159 2.572 . . . . 2.29 114.196 -177.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.37 -43.93 84.57 Favored 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 107.781 -1.192 . . . . 1.53 107.781 178.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 1.029 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 33.2 m -99.95 73.73 1.77 Allowed 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 114.082 -1.417 . . . . 1.88 109.033 177.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.312 -1.052 0 CA-C-N 115.558 -0.746 . . . . 3.6 112.01 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 110' ' ' CYS . . . . . 0.532 ' O ' ' C ' ' B' ' 111' ' ' LEU . 7.4 m . . . . . 0 N--CA 1.45 -0.445 0 N-CA-C 115.587 1.699 . . . . 2.87 115.587 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 111' ' ' LEU . . . . . 0.545 ' O ' ' HA ' ' B' ' 120' ' ' ARG . 0.0 OUTLIER -31.63 110.34 0.3 Allowed Pre-proline 0 N--CA 1.472 0.668 0 CA-C-N 118.614 0.643 . . . . 2.95 109.821 178.761 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 112' ' ' PRO . . . . . 0.594 ' HA ' ' O ' ' B' ' 119' ' ' GLY . 74.1 Cg_endo -82.3 158.97 17.45 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 124.482 3.455 . . . . 1.71 111.307 -179.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.444 ' HA ' ' HD2' ' B' ' 143' ' ' ARG . 3.2 p -155.93 -168.71 2.85 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 120.427 -1.421 . . . . 1.0 109.351 166.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 114' ' ' GLY . . . . . 0.444 ' CA ' ' HG2' ' B' ' 140' ' ' GLU . . . 64.71 -158.85 43.41 Favored Glycine 0 C--N 1.34 0.752 0 C-N-CA 121.007 -0.616 . . . . 1.16 113.482 176.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 115' ' ' PRO . . . . . 0.51 ' O ' ' N ' ' B' ' 117' ' ' GLY . 56.4 Cg_endo -62.01 143.73 95.47 Favored 'Trans proline' 0 CA--C 1.503 -1.031 0 C-N-CA 122.801 2.334 . . . . 1.6 106.962 176.161 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 116' ' ' GLY . . . . . 0.402 ' HA3' ' HE3' ' B' ' 118' ' ' LYS . . . 50.0 -4.64 0.01 OUTLIER Glycine 0 N--CA 1.416 -2.662 0 N-CA-C 115.209 0.843 . . . . 1.7 115.209 177.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 117' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' B' ' 115' ' ' PRO . . . 68.18 39.88 88.15 Favored Glycine 1 N--CA 1.394 -4.1 0 C-N-CA 117.102 -2.475 . . . . 1.38 109.623 -178.612 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 118' ' ' LYS . . . . . 0.462 ' HB2' HD12 ' B' ' 132' ' ' LEU . 1.6 mmtp -91.99 -13.87 30.35 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 112.318 -1.941 . . . . 2.96 112.949 -178.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 119' ' ' GLY . . . . . 0.594 ' O ' ' HA ' ' B' ' 112' ' ' PRO . . . -113.57 -171.2 17.64 Favored Glycine 0 CA--C 1.5 -0.847 0 N-CA-C 108.324 -1.91 . . . . 1.07 108.324 178.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.545 ' HA ' ' O ' ' B' ' 111' ' ' LEU . 0.4 OUTLIER -136.77 169.74 17.23 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 121.845 2.823 . . . . 3.29 108.625 178.328 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 121' ' ' CYS . . . . . 0.457 ' SG ' ' O ' ' B' ' 123' ' ' GLY . 19.5 t -114.63 151.87 32.81 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.337 0.495 . . . . 1.21 112.337 -178.306 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 122' ' ' PHE . . . . . 0.675 ' CE1' HG22 ' B' ' 126' ' ' ILE . 28.3 p90 -131.95 -49.66 0.95 Allowed 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 108.696 -0.853 . . . . 2.28 108.696 176.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 123' ' ' GLY . . . . . 0.457 ' O ' ' SG ' ' B' ' 121' ' ' CYS . . . -99.23 -154.84 28.59 Favored Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 109.115 -1.594 . . . . 1.04 109.115 176.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -94.19 -60.66 0.01 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.958 0 CA-C-N 119.816 1.808 . . . . 1.84 112.151 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 125' ' ' SER . . . . . 0.644 ' O ' ' N ' ' B' ' 137' ' ' GLY . 0.6 OUTLIER -90.65 9.89 27.94 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 110.266 -0.272 . . . . 1.49 110.266 179.031 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 126' ' ' ILE . . . . . 0.767 HG12 HG11 ' B' ' 136' ' ' VAL . 1.8 mt -119.98 117.87 55.07 Favored 'Isoleucine or valine' 0 C--O 1.244 0.802 0 CA-C-O 121.962 0.887 . . . . 1.41 112.566 -177.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 127' ' ' CYS . . . . . 0.752 ' O ' ' HA ' ' B' ' 134' ' ' CYS . 0.7 OUTLIER -134.91 130.69 36.29 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-N 114.313 -1.312 . . . . 0.89 110.643 -179.641 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 128' ' ' CYS . . . . . 1.097 ' HA ' ' O ' ' B' ' 133' ' ' GLY . 0.0 OUTLIER -130.96 173.58 10.85 Favored 'General case' 0 CA--C 1.56 1.33 0 CA-C-O 122.814 1.292 . . . . 1.23 114.327 -178.069 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 129' ' ' GLY . . . . . 0.623 ' O ' ' HB3' ' B' ' 169' ' ' ALA . . . -157.32 176.47 34.49 Favored Glycine 0 N--CA 1.427 -1.936 0 CA-C-N 111.643 -2.526 . . . . 0.69 109.045 177.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -62.01 -54.83 36.04 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 109.198 -0.667 . . . . 2.35 109.198 179.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -122.12 29.71 6.91 Favored 'General case' 0 N--CA 1.428 -1.539 0 N-CA-C 108.191 -1.04 . . . . 1.69 108.191 178.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 132' ' ' LEU . . . . . 0.642 HD23 ' CZ ' ' B' ' 135' ' ' PHE . 0.5 OUTLIER -121.09 -3.42 9.57 Favored 'General case' 0 N--CA 1.41 -2.451 0 N-CA-C 104.428 -2.434 . . . . 1.84 104.428 179.103 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 133' ' ' GLY . . . . . 1.097 ' O ' ' HA ' ' B' ' 128' ' ' CYS . . . 42.36 -141.01 1.84 Allowed Glycine 0 N--CA 1.401 -3.664 0 CA-C-N 112.531 -2.122 . . . . 0.76 112.519 176.358 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 134' ' ' CYS . . . . . 0.752 ' HA ' ' O ' ' B' ' 127' ' ' CYS . 0.5 OUTLIER -136.75 122.08 19.34 Favored 'General case' 0 CA--C 1.493 -1.23 0 CA-C-N 118.802 1.301 . . . . 1.08 113.629 -178.515 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 135' ' ' PHE . . . . . 0.926 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -88.08 106.35 18.1 Favored 'General case' 0 N--CA 1.422 -1.829 0 N-CA-C 104.326 -2.472 . . . . 1.83 104.326 175.858 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 136' ' ' VAL . . . . . 0.767 HG11 HG12 ' B' ' 126' ' ' ILE . 1.8 t -95.62 83.69 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 N-CA-C 107.725 -1.213 . . . . 1.29 107.725 -179.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 137' ' ' GLY . . . . . 0.737 ' O ' ' HA3' ' A' ' 33' ' ' GLY . . . 102.53 93.03 2.23 Favored Glycine 0 CA--C 1.531 1.055 0 CA-C-N 113.071 -1.877 . . . . 0.85 114.283 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 138' ' ' THR . . . . . 0.405 ' CG2' ' CB ' ' B' ' 135' ' ' PHE . 0.0 OUTLIER 178.44 169.19 0.82 Allowed 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 108.623 -0.88 . . . . 1.2 108.623 178.576 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 139' ' ' ALA . . . . . 0.838 ' O ' HD21 ' B' ' 142' ' ' LEU . . . -63.77 -15.33 58.4 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 119.616 1.098 . . . . 1.35 111.373 178.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 140' ' ' GLU . . . . . 0.659 ' HB3' ' CD2' ' B' ' 135' ' ' PHE . 5.0 mt-10 -65.24 -15.87 62.94 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.498 -0.556 . . . . 2.31 109.498 178.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 141' ' ' ALA . . . . . 0.637 ' O ' ' HB3' ' B' ' 144' ' ' CYS . . . -122.78 -11.0 8.23 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.995 -0.548 . . . . 1.09 111.695 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 142' ' ' LEU . . . . . 0.838 HD21 ' O ' ' B' ' 139' ' ' ALA . 0.0 OUTLIER -69.22 -37.02 77.85 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.382 -0.97 . . . . 1.61 108.382 -178.681 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 143' ' ' ARG . . . . . 0.444 ' HD2' ' HA ' ' B' ' 113' ' ' CYS . 1.1 ptp180 -64.91 -2.29 2.54 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 114.583 -1.189 . . . . 3.43 109.753 178.132 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 144' ' ' CYS . . . . . 0.637 ' HB3' ' O ' ' B' ' 141' ' ' ALA . 10.3 t -83.4 9.26 11.45 Favored 'General case' 0 N--CA 1.443 -0.786 0 O-C-N 121.556 -0.715 . . . . 1.61 109.125 176.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -71.17 -18.65 62.48 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.598 -0.728 . . . . 3.52 109.711 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.41 5.73 33.61 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 119.234 -0.986 . . . . 3.76 110.035 179.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 . . . . . 0 N--CA 1.448 -0.533 0 CA-C-N 115.781 -0.645 . . . . 4.01 109.51 177.605 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.465 0.297 0 N-CA-C 110.126 -0.324 . . . . 3.41 110.126 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 64.95 57.13 12.75 Favored Glycine 0 N--CA 1.426 -1.972 0 C-N-CA 120.245 -0.979 . . . . 2.26 112.164 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -120.29 59.83 0.89 Allowed 'General case' 0 N--CA 1.435 -1.19 0 C-N-CA 117.228 -1.789 . . . . 5.03 108.604 176.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 159' ' ' LYS . . . . . 0.564 ' HB2' ' HB3' ' B' ' 167' ' ' CYS . 2.6 mmpp? -118.2 39.23 0.29 Allowed Pre-proline 0 C--N 1.314 -0.943 0 CA-C-N 112.346 -2.206 . . . . 3.96 111.731 171.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 160' ' ' PRO . . . . . 0.454 ' CD ' ' N ' ' B' ' 159' ' ' LYS . 2.3 Cg_endo -41.17 117.21 0.53 Allowed 'Trans proline' 0 C--N 1.34 0.109 0 C-N-CA 122.306 2.004 . . . . 1.7 115.621 -173.06 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 161' ' ' CYS . . . . . 0.466 ' SG ' ' N ' ' B' ' 162' ' ' GLY . 0.1 OUTLIER -138.73 -170.58 2.88 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 113.198 -1.819 . . . . 1.93 108.715 -179.803 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 162' ' ' GLY . . . . . 0.466 ' N ' ' SG ' ' B' ' 161' ' ' CYS . . . 47.9 -166.03 0.17 Allowed Glycine 0 CA--C 1.528 0.864 0 C-N-CA 119.064 -1.541 . . . . 2.37 114.9 171.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 13.8 p -82.35 44.24 0.86 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 114.981 -0.61 . . . . 4.56 112.216 -178.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 119.33 8.93 8.97 Favored Glycine 0 C--N 1.338 0.64 0 N-CA-C 115.15 0.82 . . . . 2.39 115.15 177.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 165' ' ' GLY . . . . . 0.615 ' HA3' ' HA ' ' B' ' 175' ' ' SER . . . -103.61 160.69 16.28 Favored Glycine 0 CA--C 1.521 0.425 0 C-N-CA 119.551 -1.309 . . . . 1.79 115.684 -178.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 166' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.73 153.23 22.14 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 108.342 -0.985 . . . . 3.53 108.342 176.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 167' ' ' CYS . . . . . 0.564 ' HB3' ' HB2' ' B' ' 159' ' ' LYS . 47.5 t -58.31 115.53 3.02 Favored 'General case' 0 N--CA 1.426 -1.629 0 N-CA-C 109.345 -0.613 . . . . 1.56 109.345 -179.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 168' ' ' ALA . . . . . 0.536 ' H ' ' HA ' ' B' ' 173' ' ' CYS . . . -63.26 -47.3 82.97 Favored 'General case' 0 N--CA 1.428 -1.546 0 N-CA-C 107.263 -1.384 . . . . 1.42 107.263 178.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 169' ' ' ALA . . . . . 0.791 ' CB ' ' HA2' ' B' ' 133' ' ' GLY . . . -169.01 164.25 11.39 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.189 -1.369 . . . . 1.18 108.967 -175.034 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 170' ' ' ALA . . . . . 1.041 ' HA ' ' HB3' ' B' ' 185' ' ' CYS . . . -44.07 130.71 6.02 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.469 0.652 . . . . 1.47 112.691 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 171' ' ' GLY . . . . . 0.735 ' N ' ' O ' ' B' ' 185' ' ' CYS . . . 78.4 -21.04 3.78 Favored Glycine 0 CA--C 1.521 0.458 0 CA-C-N 114.845 -1.071 . . . . 1.45 115.511 177.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 172' ' ' ILE . . . . . 0.61 ' CD1' ' HB2' ' B' ' 134' ' ' CYS . 1.2 pp -132.43 116.24 27.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 122.408 1.099 . . . . 2.7 110.747 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 173' ' ' CYS . . . . . 0.536 ' HA ' ' H ' ' B' ' 168' ' ' ALA . 1.5 t -106.5 112.5 25.53 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.083 -1.417 . . . . 1.94 110.686 -177.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 174' ' ' CYS . . . . . 0.677 ' HA ' ' HA ' ' B' ' 179' ' ' CYS . 4.4 m -84.29 148.0 26.91 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.903 0.859 . . . . 1.43 112.838 -177.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 175' ' ' SER . . . . . 0.792 ' HB2' ' HD2' ' B' ' 176' ' ' PRO . 11.6 p -122.68 -179.89 0.88 Allowed Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 114.057 -1.429 . . . . 2.3 107.998 178.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 176' ' ' PRO . . . . . 0.792 ' HD2' ' HB2' ' B' ' 175' ' ' SER . 57.3 Cg_endo -73.71 29.92 0.32 Allowed 'Trans proline' 0 N--CA 1.46 -0.482 0 CA-C-N 119.797 0.963 . . . . 2.13 111.681 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 177' ' ' ASP . . . . . 0.53 ' H ' ' C ' ' B' ' 175' ' ' SER . 2.5 p30 -145.78 -49.41 0.22 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.63 -0.713 . . . . 2.72 110.585 179.133 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 178' ' ' GLY . . . . . 1.057 ' HA3' ' O ' ' A' ' 79' ' ' CYS . . . -155.77 -140.69 3.04 Favored Glycine 0 C--N 1.338 0.652 0 C-N-CA 120.492 -0.861 . . . . 1.05 113.886 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 179' ' ' CYS . . . . . 1.089 ' O ' ' HA3' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -142.94 153.04 42.66 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-N 115.281 -0.46 . . . . 1.39 110.511 -179.892 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 180' ' ' HIS . . . . . 0.414 ' HE2' ' HA3' ' B' ' 162' ' ' GLY . 4.2 p-80 -154.11 160.39 41.92 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.098 -0.641 . . . . 2.73 111.975 -178.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 181' ' ' GLU . . . . . 0.562 ' HA ' ' O ' ' B' ' 171' ' ' GLY . 0.0 OUTLIER -60.23 140.48 56.99 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.844 -0.616 . . . . 3.06 110.307 179.828 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 182' ' ' ASP . . . . . 0.428 ' HB3' ' HB3' ' B' ' 173' ' ' CYS . 3.7 p-10 -139.69 140.28 24.46 Favored Pre-proline 0 CA--C 1.541 0.627 0 CA-C-N 116.01 -0.541 . . . . 2.06 110.759 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 183' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' B' ' 182' ' ' ASP . 3.4 Cg_exo -77.09 -25.17 8.98 Favored 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 123.236 2.624 . . . . 2.27 114.252 -177.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -66.23 -43.88 85.37 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 107.808 -1.182 . . . . 1.56 107.808 178.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 185' ' ' CYS . . . . . 1.041 ' HB3' ' HA ' ' B' ' 170' ' ' ALA . 33.2 m -100.05 73.44 1.73 Allowed 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 114.037 -1.438 . . . . 1.94 109.067 177.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 186' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.311 -1.095 0 CA-C-N 115.666 -0.697 . . . . 3.61 111.92 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.618 ' HB3' ' HD3' ' A' ' 20' ' ' ARG . 1.0 OUTLIER . . . . . 0 N--CA 1.447 -0.592 0 N-CA-C 111.689 0.255 . . . . 2.89 111.689 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.682 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 3.4 mm? -30.68 111.08 0.28 Allowed Pre-proline 0 N--CA 1.472 0.673 0 N-CA-C 112.976 0.732 . . . . 2.89 112.976 -178.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.795 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 72.9 Cg_endo -73.96 153.44 47.31 Favored 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 123.087 2.525 . . . . 1.72 111.518 179.06 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.602 ' O ' ' HA2' ' A' ' 17' ' ' GLY . 16.1 p -160.7 -167.33 1.83 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 119.134 -1.027 . . . . 1.0 111.266 174.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 1.018 ' HA2' ' HB3' ' A' ' 40' ' ' GLU . . . 76.0 -160.38 51.39 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 120.241 -0.981 . . . . 1.15 114.761 177.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.536 ' HD2' ' CZ ' ' A' ' 35' ' ' PHE . 43.5 Cg_endo -64.94 99.07 0.32 Allowed 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 124.198 3.265 . . . . 1.6 113.328 178.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.62 -4.37 84.68 Favored Glycine 0 C--N 1.265 -3.363 0 CA-C-N 112.801 -1.999 . . . . 1.68 111.975 -176.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.602 ' HA2' ' O ' ' A' ' 13' ' ' CYS . . . 71.03 42.52 59.03 Favored Glycine 0 N--CA 1.432 -1.621 0 C-N-CA 118.31 -1.9 . . . . 1.37 113.19 174.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.98 -33.97 18.22 Favored 'General case' 0 C--N 1.359 1.021 0 CA-C-N 112.922 -1.639 . . . . 2.91 111.329 -178.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.795 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -77.55 -167.37 28.89 Favored Glycine 0 N--CA 1.468 0.795 0 C-N-CA 128.194 2.807 . . . . 1.06 111.165 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.682 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -130.74 173.76 10.6 Favored 'General case' 0 CA--C 1.553 1.089 0 N-CA-C 105.268 -2.123 . . . . 3.32 105.268 174.375 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.1 m -105.7 141.62 36.82 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 119.534 1.061 . . . . 1.19 111.395 -178.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -124.48 -48.2 1.82 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.765 -0.652 . . . . 2.26 110.549 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -128.94 -177.81 15.06 Favored Glycine 0 C--N 1.33 0.248 0 N-CA-C 111.322 -0.711 . . . . 1.05 111.322 179.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo -64.79 -71.02 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 121.969 1.779 . . . . 1.81 111.219 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.585 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.6 OUTLIER -89.8 41.53 1.05 Allowed 'General case' 0 CA--C 1.521 -0.145 0 N-CA-C 108.788 -0.819 . . . . 1.62 108.788 177.759 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.761 HG12 HG11 ' A' ' 36' ' ' VAL . 2.0 mt -144.92 111.59 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.908 0 CA-C-N 116.079 -0.51 . . . . 1.39 112.184 -177.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.673 ' SG ' ' HA ' ' A' ' 41' ' ' ALA . 0.8 OUTLIER -120.82 130.98 54.19 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 109.574 -0.528 . . . . 0.92 109.574 179.585 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.888 ' SG ' ' HB2' ' A' ' 68' ' ' ALA . 1.6 m -123.84 171.51 9.61 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 117.365 -1.734 . . . . 1.28 114.41 -177.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.521 ' HA3' ' HB2' ' A' ' 32' ' ' LEU . . . -146.85 174.86 26.53 Favored Glycine 0 N--CA 1.415 -2.714 0 N-CA-C 109.405 -1.478 . . . . 0.71 109.405 173.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -65.01 -58.51 5.92 Favored 'General case' 0 N--CA 1.422 -1.829 0 N-CA-C 104.424 -2.436 . . . . 2.27 104.424 177.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -115.07 22.11 13.66 Favored 'General case' 0 CA--C 1.478 -1.809 0 CA-C-N 114.246 -1.343 . . . . 1.66 108.689 -175.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.662 HD23 ' HE1' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -109.92 -17.8 13.54 Favored 'General case' 0 N--CA 1.408 -2.563 0 N-CA-C 105.987 -1.857 . . . . 1.93 105.987 177.793 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.874 ' HA2' ' CB ' ' A' ' 69' ' ' ALA . . . 63.6 -135.83 41.72 Favored Glycine 0 N--CA 1.403 -3.524 0 CA-C-N 113.635 -1.62 . . . . 0.77 110.797 -179.152 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.633 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 0.7 OUTLIER -143.27 122.1 12.68 Favored 'General case' 0 CA--C 1.479 -1.767 0 CA-C-N 119.13 1.465 . . . . 1.08 113.582 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 1.057 ' HA ' ' HA ' ' B' ' 135' ' ' PHE . 0.0 OUTLIER -88.84 105.34 17.67 Favored 'General case' 0 N--CA 1.411 -2.419 0 N-CA-C 103.945 -2.613 . . . . 1.85 103.945 176.13 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.761 HG11 HG12 ' A' ' 26' ' ' ILE . 1.6 t -96.7 85.67 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.863 0 N-CA-C 107.579 -1.267 . . . . 1.29 107.579 -179.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.838 ' HA3' HG12 ' B' ' 172' ' ' ILE . . . 122.03 12.99 5.11 Favored Glycine 0 C--N 1.32 -0.36 0 CA-C-N 113.738 -1.573 . . . . 0.85 115.898 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.834 HG22 ' HB3' ' A' ' 35' ' ' PHE . 47.4 p -94.89 164.47 12.9 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 118.496 1.148 . . . . 1.3 110.195 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.2 -34.82 75.7 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.184 0.516 . . . . 1.45 109.811 179.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 1.018 ' HB3' ' HA2' ' A' ' 14' ' ' GLY . 0.6 OUTLIER -59.83 -14.63 15.9 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.912 -0.586 . . . . 2.32 111.537 -179.397 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.823 ' O ' ' HB2' ' A' ' 44' ' ' CYS . . . -91.95 -26.77 18.26 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 116.285 -0.416 . . . . 1.11 109.982 179.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.1 mt -48.21 -36.58 14.03 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 112.505 0.558 . . . . 1.68 112.505 -179.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.658 ' C ' ' H ' ' A' ' 45' ' ' GLN . 0.0 OUTLIER -54.91 -28.19 48.8 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 107.502 -1.296 . . . . 3.4 107.502 177.417 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.823 ' HB2' ' O ' ' A' ' 41' ' ' ALA . 1.2 m -54.97 4.01 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 114.435 -1.257 . . . . 1.57 111.18 -176.035 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.658 ' H ' ' C ' ' A' ' 43' ' ' ARG . 17.3 tt0 -72.48 -31.92 65.78 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.212 0.53 . . . . 3.49 110.951 177.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -86.3 6.78 28.19 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.995 0.426 . . . . 3.69 110.685 -179.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 25.0 tp10 . . . . . 0 N--CA 1.444 -0.769 0 N-CA-C 109.078 -0.712 . . . . 3.99 109.078 177.521 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 12.2 t . . . . . 0 CA--C 1.534 0.333 0 N-CA-C 109.071 -0.714 . . . . 3.36 109.071 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 112.97 -107.22 1.95 Allowed Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.555 -0.831 . . . . 2.3 112.652 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.69 87.05 2.67 Favored 'General case' 0 CA--C 1.476 -1.877 0 N-CA-C 102.944 -2.984 . . . . 5.06 102.944 176.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.812 ' CA ' ' H ' ' A' ' 67' ' ' CYS . 15.4 mmtt -137.32 -57.37 0.02 OUTLIER Pre-proline 0 C--N 1.296 -1.76 0 C-N-CA 118.629 -1.228 . . . . 3.91 112.05 -173.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.613 ' HD2' ' H ' ' A' ' 59' ' ' LYS . 9.4 Cg_endo -51.94 98.08 0.04 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.121 0 CA-C-N 120.709 1.289 . . . . 1.74 113.703 -179.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.417 ' SG ' ' N ' ' A' ' 62' ' ' GLY . 0.1 OUTLIER -140.98 -173.77 3.81 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 105.832 -1.914 . . . . 1.9 105.832 178.776 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.417 ' N ' ' SG ' ' A' ' 61' ' ' CYS . . . 61.91 -165.18 20.73 Favored Glycine 0 C--N 1.316 -0.577 0 C-N-CA 117.454 -2.308 . . . . 2.43 112.548 176.144 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.4 m -84.39 42.46 0.89 Allowed 'General case' 0 N--CA 1.479 1.0 0 CA-C-O 122.204 1.002 . . . . 4.32 111.575 -176.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 115.78 5.84 17.64 Favored Glycine 0 CA--C 1.535 1.292 0 CA-C-N 113.89 -1.505 . . . . 2.4 114.937 178.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.656 ' CA ' ' HA ' ' A' ' 75' ' ' SER . . . -101.13 153.37 19.05 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 119.132 -1.508 . . . . 1.82 116.481 -174.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.771 ' CB ' ' HB3' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -85.24 152.26 23.45 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 114.354 -0.923 . . . . 3.51 109.553 179.364 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.812 ' H ' ' CA ' ' A' ' 59' ' ' LYS . 0.1 OUTLIER -70.13 107.83 3.84 Favored 'General case' 0 N--CA 1.42 -1.94 0 CA-C-N 119.643 1.11 . . . . 1.52 109.798 -178.767 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.888 ' HB2' ' SG ' ' A' ' 28' ' ' CYS . . . -67.02 -32.05 73.0 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 115.235 -0.893 . . . . 1.5 109.78 179.176 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.874 ' CB ' ' HA2' ' A' ' 33' ' ' GLY . . . -170.66 164.54 8.2 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.464 -1.244 . . . . 1.31 110.917 -177.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 1.112 ' HA ' ' HB3' ' A' ' 85' ' ' CYS . . . -66.91 70.76 0.08 Allowed 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.264 -0.574 . . . . 1.5 111.985 178.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.604 ' HA2' ' O ' ' A' ' 85' ' ' CYS . . . 164.99 -42.33 0.29 Allowed Glycine 0 CA--C 1.52 0.369 0 CA-C-N 115.818 -0.628 . . . . 1.44 114.227 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.846 HG12 ' HA3' ' B' ' 137' ' ' GLY . 1.3 pp -120.76 121.52 65.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.191 0.52 . . . . 2.77 111.037 -178.006 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.587 ' HB2' ' HB3' ' A' ' 82' ' ' ASP . 0.1 OUTLIER -95.58 111.72 23.58 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.635 -0.711 . . . . 1.98 109.825 -179.888 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.515 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 1.3 m -84.74 117.3 23.74 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.382 0.61 . . . . 1.43 112.378 -178.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.656 ' HA ' ' CA ' ' A' ' 65' ' ' GLY . 29.6 p -92.66 -179.67 1.12 Allowed Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 114.909 -1.041 . . . . 2.37 109.162 178.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.62 ' CD ' ' HB2' ' A' ' 75' ' ' SER . 4.2 Cg_exo -74.6 29.62 0.35 Allowed 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 121.7 1.6 . . . . 2.09 111.691 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.489 ' H ' ' C ' ' A' ' 75' ' ' SER . 2.4 p30 -145.65 -37.94 0.26 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.704 -0.68 . . . . 2.65 110.825 179.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.781 ' HA3' ' O ' ' B' ' 179' ' ' CYS . . . -170.0 -133.56 1.61 Allowed Glycine 0 C--N 1.339 0.702 0 C-N-CA 120.617 -0.801 . . . . 1.04 113.38 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.819 ' O ' ' HA3' ' B' ' 178' ' ' GLY . 0.0 OUTLIER -146.27 150.93 36.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.126 0.489 . . . . 1.42 110.831 -179.62 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.414 ' CE1' ' HA3' ' A' ' 62' ' ' GLY . 50.2 p-80 -154.25 160.48 41.83 Favored 'General case' 0 C--N 1.331 -0.236 0 O-C-N 122.03 -0.419 . . . . 2.81 111.56 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.55 ' OE2' ' HG2' ' B' ' 124' ' ' PRO . 1.5 mt-10 -59.7 140.75 56.21 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.281 -0.418 . . . . 3.05 110.228 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.587 ' HB3' ' HB2' ' A' ' 73' ' ' CYS . 7.9 p-10 -145.08 140.59 16.28 Favored Pre-proline 0 CA--C 1.535 0.385 0 CA-C-N 116.487 -0.324 . . . . 2.02 111.599 -179.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 82' ' ' ASP . 3.4 Cg_exo -77.58 -14.5 15.95 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 123.243 2.629 . . . . 2.29 113.665 -179.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.3 -46.58 60.4 Favored 'General case' 0 CA--C 1.504 -0.826 0 N-CA-C 107.158 -1.423 . . . . 1.53 107.158 178.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 1.112 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 97.7 m -106.84 84.76 2.04 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 113.559 -1.655 . . . . 1.88 107.493 176.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' A' ' 82' ' ' ASP . 1.2 t70 . . . . . 0 C--N 1.316 -0.856 0 CA-C-N 113.857 -1.52 . . . . 3.6 113.619 -177.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 110' ' ' CYS . . . . . 0.591 ' HB3' ' HD3' ' B' ' 120' ' ' ARG . 0.9 OUTLIER . . . . . 0 N--CA 1.446 -0.632 0 N-CA-C 111.441 0.163 . . . . 2.87 111.441 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 111' ' ' LEU . . . . . 0.647 ' O ' ' HA ' ' B' ' 120' ' ' ARG . 3.4 mm? -30.92 111.48 0.29 Allowed Pre-proline 0 N--CA 1.471 0.614 0 N-CA-C 112.923 0.712 . . . . 2.95 112.923 -178.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 112' ' ' PRO . . . . . 0.883 ' HA ' ' O ' ' B' ' 119' ' ' GLY . 89.6 Cg_endo -81.53 144.66 14.32 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.119 1.879 . . . . 1.71 114.183 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.587 ' O ' ' HA2' ' B' ' 117' ' ' GLY . 18.0 p -150.57 -165.0 2.15 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 118.633 -1.227 . . . . 1.0 111.479 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 114' ' ' GLY . . . . . 1.049 ' HA2' ' HB3' ' B' ' 140' ' ' GLU . . . 76.24 -160.81 51.42 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 120.449 -0.881 . . . . 1.16 115.192 177.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 115' ' ' PRO . . . . . 0.651 ' HG2' ' O ' ' B' ' 115' ' ' PRO . 43.4 Cg_endo -63.5 114.76 2.66 Favored 'Trans proline' 0 C--N 1.366 1.478 0 C-N-CA 123.922 3.081 . . . . 1.6 106.945 176.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 77.62 -14.99 8.19 Favored Glycine 0 C--N 1.261 -3.624 0 C-N-CA 123.98 0.8 . . . . 1.7 111.193 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 117' ' ' GLY . . . . . 0.587 ' HA2' ' O ' ' B' ' 113' ' ' CYS . . . 75.12 43.01 27.55 Favored Glycine 0 N--CA 1.413 -2.893 0 C-N-CA 117.767 -2.159 . . . . 1.38 110.909 179.223 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.38 -27.92 17.22 Favored 'General case' 0 C--N 1.355 0.833 0 CA-C-N 112.269 -1.965 . . . . 2.96 113.345 -179.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 119' ' ' GLY . . . . . 0.883 ' O ' ' HA ' ' B' ' 112' ' ' PRO . . . -102.29 -151.82 24.05 Favored Glycine 0 N--CA 1.431 -1.686 0 N-CA-C 108.507 -1.837 . . . . 1.07 108.507 178.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.647 ' HA ' ' O ' ' B' ' 111' ' ' LEU . 0.0 OUTLIER -127.32 174.51 8.91 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 118.638 1.219 . . . . 3.29 110.714 -177.872 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 121' ' ' CYS . . . . . . . . . . . . . 1.1 m -105.35 140.69 38.09 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.276 0.56 . . . . 1.21 111.092 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -124.52 -48.13 1.82 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.447 -0.797 . . . . 2.28 110.375 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -128.94 -177.8 15.05 Favored Glycine 0 C--N 1.33 0.247 0 N-CA-C 111.303 -0.719 . . . . 1.04 111.303 179.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . 0.55 ' HG2' ' OE2' ' A' ' 81' ' ' GLU . 20.2 Cg_exo -64.84 -70.97 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 121.942 1.761 . . . . 1.84 111.258 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 125' ' ' SER . . . . . 0.591 ' O ' ' N ' ' B' ' 137' ' ' GLY . 0.6 OUTLIER -89.77 41.47 1.04 Allowed 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 108.7 -0.852 . . . . 1.49 108.7 177.808 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 126' ' ' ILE . . . . . 0.923 HG12 HG13 ' B' ' 136' ' ' VAL . 2.2 mt -144.71 111.39 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 CA-C-N 116.025 -0.534 . . . . 1.41 112.374 -177.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 127' ' ' CYS . . . . . 0.67 ' SG ' ' HA ' ' B' ' 141' ' ' ALA . 0.8 OUTLIER -121.1 130.46 53.76 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 109.436 -0.579 . . . . 0.89 109.436 179.352 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 128' ' ' CYS . . . . . 0.815 ' HA ' ' O ' ' B' ' 133' ' ' GLY . 1.0 OUTLIER -125.48 169.03 12.81 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 114.22 1.193 . . . . 1.23 114.22 -177.084 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 129' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' B' ' 133' ' ' GLY . . . -147.88 176.05 26.9 Favored Glycine 0 N--CA 1.419 -2.444 0 N-CA-C 107.515 -2.234 . . . . 0.69 107.515 175.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -66.55 -55.93 13.16 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 106.681 -1.6 . . . . 2.35 106.681 178.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -117.62 31.48 6.69 Favored 'General case' 0 CA--C 1.478 -1.817 0 CA-C-N 113.337 -1.756 . . . . 1.69 109.591 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 132' ' ' LEU . . . . . 0.432 HD22 ' CE1' ' B' ' 135' ' ' PHE . 0.5 OUTLIER -120.99 -14.0 8.51 Favored 'General case' 0 N--CA 1.408 -2.562 0 N-CA-C 104.667 -2.345 . . . . 1.84 104.667 178.239 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 133' ' ' GLY . . . . . 0.866 ' HA2' ' CB ' ' B' ' 169' ' ' ALA . . . 63.08 -132.48 42.85 Favored Glycine 0 N--CA 1.404 -3.476 0 CA-C-N 114.092 -1.413 . . . . 0.76 111.821 177.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 134' ' ' CYS . . . . . 0.651 ' HA ' ' O ' ' B' ' 127' ' ' CYS . 1.0 OUTLIER -146.2 121.98 10.57 Favored 'General case' 0 CA--C 1.479 -1.768 0 CA-C-N 119.462 1.631 . . . . 1.08 112.762 178.62 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 135' ' ' PHE . . . . . 1.057 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -88.83 105.78 17.95 Favored 'General case' 0 N--CA 1.409 -2.5 0 N-CA-C 103.959 -2.608 . . . . 1.83 103.959 176.369 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 136' ' ' VAL . . . . . 0.923 HG13 HG12 ' B' ' 126' ' ' ILE . 1.9 t -96.24 85.49 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.781 0 N-CA-C 107.59 -1.263 . . . . 1.29 107.59 -179.447 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 137' ' ' GLY . . . . . 0.846 ' HA3' HG12 ' A' ' 72' ' ' ILE . . . 122.51 12.7 5.0 Favored Glycine 0 C--O 1.227 -0.296 0 CA-C-N 113.993 -1.458 . . . . 0.85 115.874 179.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 138' ' ' THR . . . . . 0.814 HG22 ' HB3' ' B' ' 135' ' ' PHE . 46.6 p -96.74 160.7 14.23 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 118.521 1.16 . . . . 1.2 110.422 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 139' ' ' ALA . . . . . 0.67 ' HA ' HD11 ' B' ' 142' ' ' LEU . . . -62.37 -23.13 66.63 Favored 'General case' 0 N--CA 1.446 -0.641 0 O-C-N 121.965 -0.459 . . . . 1.35 111.85 -179.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 140' ' ' GLU . . . . . 1.049 ' HB3' ' HA2' ' B' ' 114' ' ' GLY . 0.6 OUTLIER -67.45 -14.17 62.69 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.24 0.543 . . . . 2.31 110.781 178.56 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 141' ' ' ALA . . . . . 0.843 ' O ' ' HB2' ' B' ' 144' ' ' CYS . . . -92.74 -26.31 17.81 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 115.562 -0.744 . . . . 1.09 110.304 179.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 142' ' ' LEU . . . . . 0.67 HD11 ' HA ' ' B' ' 139' ' ' ALA . 9.8 mt -47.7 -36.64 11.55 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.146 0.424 . . . . 1.61 112.146 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 143' ' ' ARG . . . . . 0.479 ' C ' ' H ' ' B' ' 145' ' ' GLN . 0.0 OUTLIER -60.72 -17.47 48.51 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 121.965 0.888 . . . . 3.43 109.567 177.661 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 144' ' ' CYS . . . . . 0.843 ' HB2' ' O ' ' B' ' 141' ' ' ALA . 1.2 m -58.21 -3.83 0.3 Allowed 'General case' 0 CA--C 1.552 1.048 0 CA-C-N 113.178 -1.828 . . . . 1.61 110.868 178.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 145' ' ' GLN . . . . . 0.479 ' H ' ' C ' ' B' ' 143' ' ' ARG . 16.7 tt0 -67.83 -32.85 73.68 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.233 0.54 . . . . 3.52 111.769 179.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -86.35 6.89 27.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.008 0.432 . . . . 3.76 110.701 -179.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 24.9 tp10 . . . . . 0 N--CA 1.444 -0.769 0 N-CA-C 109.082 -0.71 . . . . 4.01 109.082 177.451 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 12.1 t . . . . . 0 N--CA 1.453 -0.297 0 N-CA-C 108.925 -0.768 . . . . 3.41 108.925 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 114.04 -108.81 2.1 Favored Glycine 0 C--N 1.336 0.561 0 C-N-CA 120.02 -1.086 . . . . 2.26 112.404 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 158' ' ' GLN . . . . . 0.417 ' O ' ' HB2' ' B' ' 167' ' ' CYS . 0.0 OUTLIER -124.0 71.41 1.12 Allowed 'General case' 0 CA--C 1.486 -1.502 0 N-CA-C 104.669 -2.345 . . . . 5.03 104.669 176.148 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 159' ' ' LYS . . . . . 0.831 ' HB3' ' CB ' ' B' ' 166' ' ' ARG . 18.9 mmtt -107.08 -65.77 0.04 OUTLIER Pre-proline 0 N--CA 1.421 -1.899 0 N-CA-C 116.764 2.135 . . . . 3.96 116.764 -177.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 160' ' ' PRO . . . . . 0.537 ' CD ' ' HB2' ' B' ' 159' ' ' LYS . 9.6 Cg_endo -51.96 96.61 0.04 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.267 0 C-N-CA 122.351 2.034 . . . . 1.7 114.722 -174.111 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 161' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -143.62 179.72 6.96 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 112.922 -1.944 . . . . 1.93 105.838 177.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 70.03 -166.21 50.22 Favored Glycine 0 N--CA 1.441 -0.972 0 C-N-CA 117.58 -2.248 . . . . 2.37 111.863 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 2.8 m -83.95 43.55 0.93 Allowed 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 121.869 0.842 . . . . 4.56 111.21 -177.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 112.2 8.54 21.53 Favored Glycine 0 C--N 1.346 1.108 0 CA-C-N 113.961 -1.472 . . . . 2.39 114.775 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 165' ' ' GLY . . . . . 0.654 ' CA ' ' HA ' ' B' ' 175' ' ' SER . . . -103.0 156.12 18.12 Favored Glycine 0 C--N 1.339 0.748 0 CA-C-N 119.916 1.858 . . . . 1.79 116.27 -177.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 166' ' ' ARG . . . . . 0.831 ' CB ' ' HB3' ' B' ' 159' ' ' LYS . 0.0 OUTLIER -85.64 152.19 23.3 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 114.309 -0.945 . . . . 3.53 109.324 178.765 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 167' ' ' CYS . . . . . 0.792 ' H ' ' HA ' ' B' ' 159' ' ' LYS . 0.1 OUTLIER -70.32 107.74 3.9 Favored 'General case' 0 N--CA 1.418 -2.042 0 CA-C-N 119.558 1.072 . . . . 1.56 109.656 -178.853 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 168' ' ' ALA . . . . . 0.627 ' HB3' HD12 ' B' ' 172' ' ' ILE . . . -64.39 -36.1 83.04 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 122.238 1.018 . . . . 1.42 108.718 178.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 169' ' ' ALA . . . . . 0.866 ' CB ' ' HA2' ' B' ' 133' ' ' GLY . . . -168.57 164.59 12.42 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 113.287 -1.779 . . . . 1.18 112.017 -175.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 170' ' ' ALA . . . . . 1.013 ' HA ' ' HB3' ' B' ' 185' ' ' CYS . . . -67.28 71.15 0.11 Allowed 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.127 -0.629 . . . . 1.47 111.93 178.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 171' ' ' GLY . . . . . 0.563 ' HA2' ' O ' ' B' ' 185' ' ' CYS . . . 167.19 -48.83 0.25 Allowed Glycine 0 N--CA 1.455 -0.098 0 CA-C-N 115.525 -0.761 . . . . 1.45 112.74 179.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 172' ' ' ILE . . . . . 0.838 HG12 ' HA3' ' A' ' 37' ' ' GLY . 1.3 pp -115.86 121.77 68.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 C-N-CA 123.139 0.576 . . . . 2.7 111.647 -175.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 173' ' ' CYS . . . . . 0.582 ' HB2' ' HB3' ' B' ' 182' ' ' ASP . 0.1 OUTLIER -95.96 111.65 23.59 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.739 -0.664 . . . . 1.94 109.781 -179.918 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 174' ' ' CYS . . . . . 0.533 ' HA ' ' HA ' ' B' ' 179' ' ' CYS . 1.3 m -84.8 117.48 23.88 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.363 0.601 . . . . 1.43 112.359 -178.26 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 175' ' ' SER . . . . . 0.654 ' HA ' ' CA ' ' B' ' 165' ' ' GLY . 28.6 p -92.75 -179.67 1.11 Allowed Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 114.883 -1.053 . . . . 2.3 109.141 179.019 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 176' ' ' PRO . . . . . 0.605 ' CD ' ' HB2' ' B' ' 175' ' ' SER . 4.2 Cg_exo -74.62 29.67 0.35 Allowed 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 121.718 1.612 . . . . 2.13 111.681 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 177' ' ' ASP . . . . . 0.491 ' H ' ' C ' ' B' ' 175' ' ' SER . 2.4 p30 -145.7 -38.17 0.25 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.672 -0.694 . . . . 2.72 110.753 179.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 178' ' ' GLY . . . . . 0.819 ' HA3' ' O ' ' A' ' 79' ' ' CYS . . . -169.48 -133.87 1.65 Allowed Glycine 0 C--N 1.338 0.642 0 C-N-CA 120.63 -0.795 . . . . 1.05 113.388 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 179' ' ' CYS . . . . . 0.781 ' O ' ' HA3' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -146.08 151.14 37.23 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.073 0.463 . . . . 1.39 110.808 -179.77 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 180' ' ' HIS . . . . . . . . . . . . . 50.1 p-80 -154.56 160.46 41.52 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.625 -0.43 . . . . 2.73 111.542 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 181' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -59.9 140.52 56.61 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.309 -0.405 . . . . 3.06 110.187 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 182' ' ' ASP . . . . . 0.582 ' HB3' ' HB2' ' B' ' 173' ' ' CYS . 7.9 p-10 -144.81 140.61 16.52 Favored Pre-proline 0 CA--C 1.537 0.455 0 CA-C-N 116.493 -0.321 . . . . 2.06 111.629 -179.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 183' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' B' ' 182' ' ' ASP . 3.4 Cg_exo -77.41 -14.71 16.15 Favored 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 123.156 2.57 . . . . 2.27 113.672 -179.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -71.25 -46.62 60.6 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 107.134 -1.432 . . . . 1.56 107.134 178.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 185' ' ' CYS . . . . . 1.013 ' HB3' ' HA ' ' B' ' 170' ' ' ALA . 87.0 m -106.5 84.53 2.03 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 113.566 -1.652 . . . . 1.94 107.515 176.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 186' ' ' ASP . . . . . 0.433 ' HB2' ' O ' ' B' ' 182' ' ' ASP . 1.1 t70 . . . . . 0 CA--C 1.545 0.765 0 CA-C-N 113.782 -1.554 . . . . 3.61 113.835 -177.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.578 ' HB3' ' NE ' ' A' ' 20' ' ' ARG . 82.7 m . . . . . 0 N--CA 1.456 -0.138 0 N-CA-C 112.766 0.654 . . . . 2.89 112.766 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.842 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -35.63 108.46 0.37 Allowed Pre-proline 0 N--CA 1.483 1.221 0 C-N-CA 123.555 0.742 . . . . 2.89 112.389 179.28 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.769 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 43.8 Cg_endo -90.08 138.92 2.97 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.988 2.459 . . . . 1.72 114.044 -179.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.5 ' SG ' ' HE2' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -151.43 173.05 15.01 Favored 'General case' 0 C--N 1.351 0.642 0 N-CA-C 106.475 -1.676 . . . . 1.0 106.475 179.014 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.546 ' HA2' ' OE1' ' A' ' 40' ' ' GLU . . . 71.53 -163.26 54.26 Favored Glycine 0 CA--C 1.534 1.243 0 CA-C-N 119.635 1.107 . . . . 1.15 114.445 178.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.666 ' C ' ' H ' ' A' ' 17' ' ' GLY . 10.2 Cg_endo -69.68 130.49 19.52 Favored 'Trans proline' 0 C--N 1.369 1.621 0 C-N-CA 124.414 3.409 . . . . 1.6 113.285 179.019 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 70.35 -16.51 0.92 Allowed Glycine 0 C--N 1.284 -2.315 0 CA-C-N 112.492 -2.14 . . . . 1.68 109.575 -176.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.666 ' H ' ' C ' ' A' ' 15' ' ' PRO . . . 77.51 16.75 79.95 Favored Glycine 1 N--CA 1.388 -4.532 0 CA-C-N 113.706 -1.247 . . . . 1.37 113.74 178.285 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.34 6.97 3.15 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 107.846 -1.168 . . . . 2.91 107.846 174.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.769 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -71.45 155.68 52.47 Favored Glycine 0 CA--C 1.486 -1.732 0 N-CA-C 106.441 -2.664 . . . . 1.06 106.441 178.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.842 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -148.2 132.71 17.69 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 118.68 1.24 . . . . 3.32 108.955 174.644 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -103.91 128.12 51.42 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.242 -0.89 . . . . 1.19 112.464 -175.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -101.23 -45.25 5.42 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 114.317 -1.311 . . . . 2.26 109.119 178.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -122.05 -132.22 4.06 Favored Glycine 0 CA--C 1.524 0.617 0 CA-C-N 115.415 -0.811 . . . . 1.05 111.892 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.416 ' CG ' ' H ' ' A' ' 25' ' ' SER . 84.3 Cg_endo -98.1 -72.82 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 123.061 2.507 . . . . 1.81 111.912 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.674 ' O ' HG13 ' A' ' 26' ' ' ILE . 0.9 OUTLIER -89.62 46.97 1.41 Allowed 'General case' 0 C--N 1.333 -0.124 0 N-CA-C 109.301 -0.629 . . . . 1.62 109.301 178.762 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 1.072 HG13 HG12 ' A' ' 36' ' ' VAL . 10.1 mt -151.65 116.97 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.97 0 CA-C-O 121.286 0.565 . . . . 1.39 111.598 -179.059 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.653 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 0.5 OUTLIER -138.77 108.09 6.12 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 107.086 -1.45 . . . . 0.92 107.086 178.865 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.991 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -123.92 130.41 52.55 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 115.276 1.584 . . . . 1.28 115.276 -176.704 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.845 ' O ' ' HB3' ' A' ' 69' ' ' ALA . . . -117.23 179.58 17.43 Favored Glycine 0 C--N 1.354 1.55 0 CA-C-O 122.393 0.996 . . . . 0.71 113.877 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -66.39 -35.98 81.7 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 126.873 2.069 . . . . 2.27 113.471 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.5 0.93 5.02 Favored 'General case' 0 N--CA 1.502 2.163 0 CA-C-O 121.928 0.87 . . . . 1.66 112.969 177.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.71 ' O ' ' HA ' ' B' ' 138' ' ' THR . 0.3 OUTLIER -111.37 -11.71 14.11 Favored 'General case' 0 N--CA 1.416 -2.173 0 CA-C-N 113.836 -1.529 . . . . 1.93 111.559 -175.83 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.991 ' O ' ' HA ' ' A' ' 28' ' ' CYS . . . 57.28 -154.51 19.95 Favored Glycine 0 N--CA 1.437 -1.273 0 CA-C-N 115.634 -0.712 . . . . 0.77 113.494 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.937 ' HB2' ' CD1' ' A' ' 72' ' ' ILE . 0.2 OUTLIER -107.38 123.37 48.27 Favored 'General case' 0 CA--C 1.502 -0.895 0 N-CA-C 114.137 1.162 . . . . 1.08 114.137 179.19 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.748 ' HD1' ' CG2' ' B' ' 138' ' ' THR . 0.0 OUTLIER -95.31 101.96 13.73 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 102.053 -3.314 . . . . 1.85 102.053 173.636 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 1.072 HG12 HG13 ' A' ' 26' ' ' ILE . 2.6 t -90.48 85.0 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 CA-C-O 122.859 1.314 . . . . 1.29 109.834 -177.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.476 ' O ' ' HA3' ' B' ' 133' ' ' GLY . . . 78.94 78.25 0.85 Allowed Glycine 0 N--CA 1.453 -0.181 0 CA-C-N 112.705 -2.043 . . . . 0.85 111.625 -179.031 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.766 ' CG2' ' HD1' ' B' ' 135' ' ' PHE . 0.8 OUTLIER -151.29 155.06 37.98 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 119.04 -0.505 . . . . 1.3 109.843 -178.704 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.868 ' O ' ' HB2' ' A' ' 42' ' ' LEU . . . -36.28 -43.82 0.38 Allowed 'General case' 0 N--CA 1.484 1.248 0 CA-C-O 120.92 0.39 . . . . 1.45 111.746 -177.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.716 ' O ' ' HG2' ' A' ' 43' ' ' ARG . 59.4 mm-40 -50.37 -49.59 53.78 Favored 'General case' 0 CA--C 1.545 0.774 0 O-C-N 121.996 -0.44 . . . . 2.32 110.276 178.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.848 ' O ' ' HB2' ' A' ' 44' ' ' CYS . . . -72.77 -0.8 14.29 Favored 'General case' 0 C--O 1.216 -0.693 0 CA-C-O 121.584 0.707 . . . . 1.11 111.191 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.868 ' HB2' ' O ' ' A' ' 39' ' ' ALA . 2.4 mt -55.85 -47.32 77.5 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 107.065 -1.457 . . . . 1.68 107.065 176.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.716 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -68.89 1.08 3.65 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 114.654 -1.157 . . . . 3.4 110.658 175.943 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.848 ' HB2' ' O ' ' A' ' 41' ' ' ALA . 1.2 m -63.3 -42.98 99.11 Favored 'General case' 0 C--N 1.345 0.394 0 CA-C-O 118.184 -0.912 . . . . 1.57 109.546 178.237 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -39.77 -12.76 0.01 OUTLIER 'General case' 0 C--N 1.361 1.107 0 N-CA-C 117.069 2.248 . . . . 3.49 117.069 -177.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.441 ' N ' ' O ' ' A' ' 44' ' ' CYS . 1.2 mm-40 -81.34 0.81 35.53 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 118.489 -1.284 . . . . 3.69 108.412 178.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.631 ' HG3' HD23 ' A' ' 11' ' ' LEU . 1.0 OUTLIER . . . . . 0 N--CA 1.449 -0.488 0 CA-C-N 114.991 -1.004 . . . . 3.99 109.954 176.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 N--CA 1.476 0.848 0 N-CA-C 110.879 -0.045 . . . . 3.36 110.879 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.545 ' O ' ' HB2' ' A' ' 66' ' ' ARG . . . 141.71 60.94 0.03 OUTLIER Glycine 0 N--CA 1.434 -1.436 0 N-CA-C 108.527 -1.829 . . . . 2.3 108.527 -178.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -117.22 74.0 0.9 Allowed 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 122.581 1.181 . . . . 5.06 109.672 -179.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.976 ' HB3' ' HB3' ' A' ' 67' ' ' CYS . 0.4 OUTLIER -137.62 68.34 52.26 Favored Pre-proline 0 C--N 1.3 -1.562 0 N-CA-C 105.553 -2.018 . . . . 3.91 105.553 178.521 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -62.32 119.21 6.21 Favored 'Trans proline' 0 C--N 1.361 1.188 0 C-N-CA 122.537 2.158 . . . . 1.74 115.514 -176.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -145.56 -171.71 3.74 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 112.514 -2.13 . . . . 1.9 105.647 177.195 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.432 ' HA2' ' CE1' ' A' ' 80' ' ' HIS . . . 66.62 -166.23 39.43 Favored Glycine 0 N--CA 1.454 -0.121 0 C-N-CA 118.553 -1.784 . . . . 2.43 112.982 178.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 4.6 p -88.05 37.42 0.81 Allowed 'General case' 0 N--CA 1.487 1.381 0 CA-C-O 122.538 1.161 . . . . 4.32 110.677 -176.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.406 ' H ' ' C ' ' A' ' 62' ' ' GLY . . . 121.5 5.75 9.15 Favored Glycine 0 CA--C 1.557 2.664 0 CA-C-N 112.954 -1.93 . . . . 2.4 114.47 -176.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.883 ' HA2' ' HB3' ' A' ' 75' ' ' SER . . . -100.74 134.89 11.87 Favored Glycine 0 N--CA 1.472 1.099 0 CA-C-N 121.071 2.435 . . . . 1.82 116.275 -176.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.545 ' HB2' ' O ' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -90.43 154.87 19.34 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.023 0.529 . . . . 3.51 110.47 178.405 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.976 ' HB3' ' HB3' ' A' ' 59' ' ' LYS . 43.2 t -71.02 103.12 2.6 Favored 'General case' 0 N--CA 1.409 -2.501 0 N-CA-C 108.046 -1.094 . . . . 1.52 108.046 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -76.13 -40.97 51.5 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 105.481 -2.044 . . . . 1.5 105.481 176.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.845 ' HB3' ' O ' ' A' ' 29' ' ' GLY . . . -140.83 160.85 39.17 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 111.59 -2.55 . . . . 1.31 112.12 -173.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.828 ' HA ' ' HB3' ' A' ' 85' ' ' CYS . . . -53.63 120.99 6.89 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 121.602 0.715 . . . . 1.5 112.826 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.539 ' H ' ' CB ' ' A' ' 85' ' ' CYS . . . 77.53 3.71 83.43 Favored Glycine 0 N--CA 1.444 -0.832 0 N-CA-C 116.41 1.324 . . . . 1.44 116.41 176.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.937 ' CD1' ' HB2' ' A' ' 34' ' ' CYS . 1.1 pp -132.04 106.56 11.43 Favored 'Isoleucine or valine' 0 C--O 1.244 0.79 0 CA-C-N 118.611 1.205 . . . . 2.77 110.702 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.639 ' HB2' ' O ' ' A' ' 80' ' ' HIS . 0.1 OUTLIER -84.63 90.32 7.66 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 115.154 -0.93 . . . . 1.98 109.822 -179.118 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.718 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 0.5 OUTLIER -99.52 132.79 44.62 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 113.326 0.862 . . . . 1.43 113.326 -177.962 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.923 ' HB2' ' HD2' ' A' ' 76' ' ' PRO . 45.8 p -109.3 -177.63 0.49 Allowed Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 114.411 -1.268 . . . . 2.37 108.713 178.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.923 ' HD2' ' HB2' ' A' ' 75' ' ' SER . 64.0 Cg_endo -74.45 30.92 0.34 Allowed 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 121.351 1.367 . . . . 2.09 111.765 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 1.084 ' HB3' ' HD2' ' B' ' 180' ' ' HIS . 4.8 m-20 -143.3 -50.7 0.34 Allowed 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.593 -0.731 . . . . 2.65 110.714 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.594 ' HA3' ' O ' ' B' ' 179' ' ' CYS . . . -160.64 -166.22 18.99 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 111.724 -0.55 . . . . 1.04 111.724 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.718 ' HA ' ' HA ' ' A' ' 74' ' ' CYS . 2.9 m -124.8 156.13 38.28 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 117.71 0.755 . . . . 1.42 110.391 179.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.964 ' HD2' ' HB3' ' B' ' 177' ' ' ASP . 5.8 t-80 -140.93 124.72 17.02 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.016 -0.993 . . . . 2.81 108.709 -174.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.85 132.76 14.7 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.366 0.603 . . . . 3.05 111.849 -177.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.536 ' O ' ' HA2' ' A' ' 71' ' ' GLY . 0.8 OUTLIER -141.64 119.79 7.75 Favored Pre-proline 0 CA--C 1.544 0.728 0 CA-C-N 115.138 -0.937 . . . . 2.02 110.443 -178.889 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.664 ' HA ' ' OD2' ' A' ' 86' ' ' ASP . 4.3 Cg_exo -78.28 -13.71 15.15 Favored 'Trans proline' 0 C--N 1.357 0.981 0 C-N-CA 122.822 2.348 . . . . 2.29 113.879 -178.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.38 -38.13 89.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.798 0.332 . . . . 1.53 111.699 -179.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.828 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 21.9 m -91.98 50.42 1.67 Allowed 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 116.193 -0.458 . . . . 1.88 110.569 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.664 ' OD2' ' HA ' ' A' ' 83' ' ' PRO . 78.6 m-20 . . . . . 0 CA--C 1.554 1.105 0 N-CA-C 116.015 1.857 . . . . 3.6 116.015 -177.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 110' ' ' CYS . . . . . 0.581 ' HB3' ' NE ' ' B' ' 120' ' ' ARG . 81.5 m . . . . . 0 N--CA 1.456 -0.139 0 N-CA-C 112.189 0.44 . . . . 2.87 112.189 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 111' ' ' LEU . . . . . 0.919 HD21 ' HG3' ' B' ' 147' ' ' GLU . 0.0 OUTLIER -36.29 108.58 0.39 Allowed Pre-proline 0 N--CA 1.481 1.115 0 C-N-CA 123.671 0.789 . . . . 2.95 112.417 178.876 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 112' ' ' PRO . . . . . 0.601 ' HA ' ' O ' ' B' ' 119' ' ' GLY . 39.3 Cg_endo -90.44 138.84 2.75 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 123.08 2.52 . . . . 1.71 114.055 -179.291 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.528 ' N ' ' O ' ' B' ' 119' ' ' GLY . 0.5 OUTLIER -151.79 172.38 16.25 Favored 'General case' 0 C--N 1.347 0.495 0 N-CA-C 106.822 -1.547 . . . . 1.0 106.822 179.435 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 114' ' ' GLY . . . . . 0.556 ' HA2' ' OE1' ' B' ' 140' ' ' GLU . . . 71.89 -163.38 54.41 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 119.931 -1.128 . . . . 1.16 114.379 178.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 115' ' ' PRO . . . . . 0.649 ' C ' ' H ' ' B' ' 117' ' ' GLY . 9.5 Cg_endo -69.65 130.35 19.33 Favored 'Trans proline' 0 C--N 1.367 1.549 0 C-N-CA 124.45 3.433 . . . . 1.6 113.194 178.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 70.73 -16.5 1.02 Allowed Glycine 0 C--N 1.287 -2.186 0 CA-C-N 113.041 -1.89 . . . . 1.7 109.686 -176.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 117' ' ' GLY . . . . . 0.649 ' H ' ' C ' ' B' ' 115' ' ' PRO . . . 76.87 16.44 80.77 Favored Glycine 1 N--CA 1.39 -4.42 0 CA-C-N 113.505 -1.347 . . . . 1.38 113.77 178.369 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 118' ' ' LYS . . . . . 0.43 ' H ' ' HG2' ' B' ' 118' ' ' LYS . 0.0 OUTLIER -73.85 6.95 2.86 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 122.257 1.027 . . . . 2.96 108.253 174.955 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 119' ' ' GLY . . . . . 0.601 ' O ' ' HA ' ' B' ' 112' ' ' PRO . . . -89.59 124.15 7.25 Favored Glycine 0 N--CA 1.419 -2.438 0 CA-C-N 113.933 -1.485 . . . . 1.07 115.332 -178.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.833 ' HA ' ' O ' ' B' ' 111' ' ' LEU . 0.1 OUTLIER -112.96 136.4 52.67 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 120.816 -1.402 . . . . 3.29 112.288 -171.719 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 121' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -104.45 127.83 52.23 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.597 0.713 . . . . 1.21 112.131 -177.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -101.32 -45.32 5.37 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 114.656 -1.156 . . . . 2.28 109.237 179.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -122.11 -132.33 4.07 Favored Glycine 0 CA--C 1.522 0.524 0 CA-C-N 115.321 -0.854 . . . . 1.04 111.895 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . 0.416 ' CG ' ' H ' ' B' ' 125' ' ' SER . 89.0 Cg_endo -97.77 -72.84 0.0 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 123.041 2.494 . . . . 1.84 112.02 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 125' ' ' SER . . . . . 0.688 ' O ' HG13 ' B' ' 126' ' ' ILE . 0.9 OUTLIER -89.46 46.73 1.4 Allowed 'General case' 0 C--O 1.225 -0.19 0 N-CA-C 109.288 -0.634 . . . . 1.49 109.288 178.752 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 126' ' ' ILE . . . . . 0.728 HD11 ' HA2' ' B' ' 178' ' ' GLY . 13.4 mt -150.96 116.8 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 CA-C-N 116.041 -0.527 . . . . 1.41 111.735 -178.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 127' ' ' CYS . . . . . 0.649 ' HA ' ' O ' ' B' ' 120' ' ' ARG . 0.5 OUTLIER -139.02 108.3 6.1 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 106.992 -1.484 . . . . 0.89 106.992 178.627 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 128' ' ' CYS . . . . . 1.004 ' HA ' ' O ' ' B' ' 133' ' ' GLY . 0.0 OUTLIER -124.7 129.03 49.73 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 115.357 1.614 . . . . 1.23 115.357 -176.396 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 129' ' ' GLY . . . . . 0.825 ' O ' ' HB3' ' B' ' 169' ' ' ALA . . . -116.21 -178.97 18.18 Favored Glycine 0 C--N 1.356 1.644 0 CA-C-O 122.468 1.038 . . . . 0.69 113.864 -179.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -67.28 -34.88 78.32 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 126.767 2.027 . . . . 2.35 113.42 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.57 17.57 2.91 Favored 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 118.404 -1.319 . . . . 1.69 111.892 176.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 132' ' ' LEU . . . . . 0.862 HD23 ' CE1' ' B' ' 135' ' ' PHE . 0.3 OUTLIER -124.7 -13.5 6.97 Favored 'General case' 0 N--CA 1.42 -1.937 0 CA-C-N 113.17 -1.832 . . . . 1.84 109.306 -176.838 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 133' ' ' GLY . . . . . 1.004 ' O ' ' HA ' ' B' ' 128' ' ' CYS . . . 53.24 -152.48 8.49 Favored Glycine 0 N--CA 1.41 -3.085 0 CA-C-N 114.175 -1.375 . . . . 0.76 114.303 177.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 134' ' ' CYS . . . . . 0.937 ' HB2' ' CD1' ' B' ' 172' ' ' ILE . 0.1 OUTLIER -104.32 123.58 47.64 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 115.301 1.593 . . . . 1.08 115.301 -178.927 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 135' ' ' PHE . . . . . 0.862 ' CE1' HD23 ' B' ' 132' ' ' LEU . 0.0 OUTLIER -96.59 101.75 13.42 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 102.127 -3.286 . . . . 1.83 102.127 173.238 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 136' ' ' VAL . . . . . 0.726 HG12 ' CG1' ' B' ' 126' ' ' ILE . 3.1 t -90.41 84.71 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 CA-C-O 122.471 1.129 . . . . 1.29 109.689 -176.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 137' ' ' GLY . . . . . 0.69 ' O ' ' HA3' ' A' ' 33' ' ' GLY . . . 78.87 78.05 0.86 Allowed Glycine 0 N--CA 1.453 -0.195 0 CA-C-N 113.059 -1.882 . . . . 0.85 111.631 -179.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 138' ' ' THR . . . . . 0.748 ' CG2' ' HD1' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -150.96 155.74 39.73 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 118.928 -0.558 . . . . 1.2 109.671 -178.794 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 139' ' ' ALA . . . . . 0.861 ' O ' ' HB2' ' B' ' 142' ' ' LEU . . . -36.9 -44.06 0.48 Allowed 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 118.142 0.428 . . . . 1.35 111.949 -177.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 140' ' ' GLU . . . . . 0.712 ' O ' ' HG2' ' B' ' 143' ' ' ARG . 55.4 mm-40 -50.25 -49.42 53.14 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.775 -0.578 . . . . 2.31 110.476 178.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 141' ' ' ALA . . . . . 0.856 ' O ' ' HB2' ' B' ' 144' ' ' CYS . . . -71.02 -3.94 22.25 Favored 'General case' 0 C--O 1.214 -0.787 0 CA-C-O 121.495 0.664 . . . . 1.09 110.968 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 142' ' ' LEU . . . . . 0.861 ' HB2' ' O ' ' B' ' 139' ' ' ALA . 2.4 mt -54.39 -46.94 73.19 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 107.267 -1.382 . . . . 1.61 107.267 177.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 143' ' ' ARG . . . . . 0.712 ' HG2' ' O ' ' B' ' 140' ' ' GLU . 0.0 OUTLIER -68.9 0.81 3.96 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 114.921 -1.036 . . . . 3.43 110.727 175.872 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 144' ' ' CYS . . . . . 0.856 ' HB2' ' O ' ' B' ' 141' ' ' ALA . 1.2 m -63.06 -42.79 99.78 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 118.202 -0.904 . . . . 1.61 109.66 178.204 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -40.18 -12.67 0.01 OUTLIER 'General case' 0 C--N 1.36 1.059 0 N-CA-C 117.016 2.228 . . . . 3.52 117.016 -178.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 146' ' ' GLU . . . . . 0.44 ' N ' ' O ' ' B' ' 144' ' ' CYS . 1.2 mm-40 -81.38 0.62 36.53 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 118.515 -1.274 . . . . 3.76 108.342 178.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 147' ' ' GLU . . . . . 0.919 ' HG3' HD21 ' B' ' 111' ' ' LEU . 1.0 OUTLIER . . . . . 0 N--CA 1.449 -0.498 0 CA-C-N 114.984 -1.007 . . . . 4.01 109.931 176.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 N--CA 1.472 0.66 0 N-CA-C 111.321 0.119 . . . . 3.41 111.321 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 157' ' ' GLY . . . . . 0.536 ' O ' ' HB2' ' B' ' 166' ' ' ARG . . . 142.0 61.71 0.03 OUTLIER Glycine 0 N--CA 1.44 -1.092 0 N-CA-C 109.075 -1.61 . . . . 2.26 109.075 -178.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -117.24 64.15 0.73 Allowed 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 122.508 1.147 . . . . 5.03 110.719 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 159' ' ' LYS . . . . . 1.037 ' HB3' ' HB3' ' B' ' 167' ' ' CYS . 0.5 OUTLIER -118.64 66.79 7.19 Favored Pre-proline 0 C--N 1.31 -1.113 0 CA-C-N 113.126 -1.852 . . . . 3.96 108.083 174.457 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 160' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -62.17 119.39 6.47 Favored 'Trans proline' 0 C--O 1.231 0.145 0 N-CA-C 116.259 1.6 . . . . 1.7 116.259 -174.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 161' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -146.49 -174.4 4.45 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 112.84 -1.982 . . . . 1.93 105.84 176.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 162' ' ' GLY . . . . . 0.434 ' HA2' ' CE1' ' B' ' 180' ' ' HIS . . . 69.2 -166.07 48.43 Favored Glycine 0 CA--C 1.508 -0.366 0 C-N-CA 118.5 -1.81 . . . . 2.37 112.51 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 4.6 p -88.0 37.05 0.79 Allowed 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 122.713 1.244 . . . . 4.56 110.644 -175.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 164' ' ' GLY . . . . . 0.417 ' H ' ' C ' ' B' ' 162' ' ' GLY . . . 121.57 5.62 9.16 Favored Glycine 0 CA--C 1.556 2.598 0 CA-C-N 112.833 -1.985 . . . . 2.39 114.61 -176.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 165' ' ' GLY . . . . . 0.896 ' HA2' ' HB3' ' B' ' 175' ' ' SER . . . -101.21 135.36 12.12 Favored Glycine 0 C--N 1.346 1.087 0 CA-C-N 121.319 2.56 . . . . 1.79 116.283 -177.007 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 166' ' ' ARG . . . . . 0.536 ' HB2' ' O ' ' B' ' 157' ' ' GLY . 0.0 OUTLIER -90.2 154.93 19.38 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.01 0.524 . . . . 3.53 110.497 178.391 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 167' ' ' CYS . . . . . 1.037 ' HB3' ' HB3' ' B' ' 159' ' ' LYS . 42.9 t -70.96 103.17 2.59 Favored 'General case' 0 N--CA 1.406 -2.633 0 N-CA-C 108.071 -1.085 . . . . 1.56 108.071 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 168' ' ' ALA . . . . . . . . . . . . . . . -75.95 -41.38 51.78 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 105.363 -2.088 . . . . 1.42 105.363 176.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 169' ' ' ALA . . . . . 0.825 ' HB3' ' O ' ' B' ' 129' ' ' GLY . . . -140.45 160.74 39.32 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 111.547 -2.57 . . . . 1.18 112.047 -173.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 170' ' ' ALA . . . . . 0.849 ' HA ' ' HB3' ' B' ' 185' ' ' CYS . . . -53.76 121.03 7.04 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 121.686 0.755 . . . . 1.47 112.792 -179.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 171' ' ' GLY . . . . . 0.539 ' H ' ' CB ' ' B' ' 185' ' ' CYS . . . 77.52 3.75 83.47 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 116.369 1.308 . . . . 1.45 116.369 176.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 172' ' ' ILE . . . . . 0.937 ' CD1' ' HB2' ' B' ' 134' ' ' CYS . 1.1 pp -131.97 106.41 11.26 Favored 'Isoleucine or valine' 0 C--O 1.245 0.823 0 CA-C-N 118.482 1.141 . . . . 2.7 110.781 -179.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 173' ' ' CYS . . . . . 0.672 ' HB2' ' O ' ' B' ' 180' ' ' HIS . 0.1 OUTLIER -84.52 90.51 7.65 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 115.153 -0.931 . . . . 1.94 109.755 -179.2 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 174' ' ' CYS . . . . . 0.753 ' HA ' ' HA ' ' B' ' 179' ' ' CYS . 0.5 OUTLIER -99.84 132.86 44.93 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 113.241 0.83 . . . . 1.43 113.241 -177.986 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 175' ' ' SER . . . . . 0.911 ' HB2' ' HD2' ' B' ' 176' ' ' PRO . 43.5 p -109.34 -177.58 0.48 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 114.269 -1.332 . . . . 2.3 108.686 178.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 176' ' ' PRO . . . . . 0.911 ' HD2' ' HB2' ' B' ' 175' ' ' SER . 62.8 Cg_endo -74.48 30.95 0.34 Allowed 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 121.387 1.391 . . . . 2.13 111.768 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 177' ' ' ASP . . . . . 0.964 ' HB3' ' HD2' ' A' ' 80' ' ' HIS . 4.8 m-20 -143.22 -50.79 0.34 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.523 -0.762 . . . . 2.72 110.778 179.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 178' ' ' GLY . . . . . 0.728 ' HA2' HD11 ' B' ' 126' ' ' ILE . . . -160.48 -166.05 18.52 Favored Glycine 0 CA--C 1.522 0.48 0 N-CA-C 111.752 -0.539 . . . . 1.05 111.752 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 179' ' ' CYS . . . . . 0.753 ' HA ' ' HA ' ' B' ' 174' ' ' CYS . 3.1 m -124.26 160.78 27.2 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 117.718 0.759 . . . . 1.39 110.144 179.349 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 180' ' ' HIS . . . . . 1.084 ' HD2' ' HB3' ' A' ' 77' ' ' ASP . 5.6 t-80 -148.72 123.21 9.72 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-O 121.663 0.744 . . . . 2.73 109.072 -174.098 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 181' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -46.78 132.41 11.33 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 114.572 -1.194 . . . . 3.06 111.921 -176.162 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 182' ' ' ASP . . . . . 0.525 ' O ' ' HA2' ' B' ' 171' ' ' GLY . 0.9 OUTLIER -141.54 119.84 7.84 Favored Pre-proline 0 CA--C 1.545 0.751 0 CA-C-N 114.909 -1.041 . . . . 2.06 110.341 -178.735 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 183' ' ' PRO . . . . . 0.671 ' HA ' ' OD2' ' B' ' 186' ' ' ASP . 4.4 Cg_exo -78.31 -13.81 15.06 Favored 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 122.836 2.358 . . . . 2.27 113.854 -178.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -64.26 -38.27 90.44 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.834 0.35 . . . . 1.56 111.661 -179.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 185' ' ' CYS . . . . . 0.849 ' HB3' ' HA ' ' B' ' 170' ' ' ALA . 21.8 m -91.91 50.34 1.67 Allowed 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 116.179 -0.464 . . . . 1.94 110.53 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 186' ' ' ASP . . . . . 0.671 ' OD2' ' HA ' ' B' ' 183' ' ' PRO . 78.5 m-20 . . . . . 0 CA--C 1.551 1.013 0 N-CA-C 116.042 1.867 . . . . 3.61 116.042 -177.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.426 ' SG ' ' HB3' ' A' ' 20' ' ' ARG . 12.5 p . . . . . 0 CA--C 1.542 0.668 0 N-CA-C 113.806 1.039 . . . . 2.89 113.806 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.428 HD22 ' CD ' ' A' ' 12' ' ' PRO . 26.1 mt -30.96 154.53 0.03 OUTLIER Pre-proline 0 N--CA 1.48 1.039 0 C-N-CA 123.872 0.869 . . . . 2.89 113.305 178.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.693 ' HB2' ' O ' ' A' ' 17' ' ' GLY . 33.4 Cg_endo -91.92 117.39 0.44 Allowed 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 123.312 2.675 . . . . 1.72 116.295 -178.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.647 ' SG ' ' O ' ' A' ' 20' ' ' ARG . 10.6 p -106.64 -156.41 0.58 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.693 1.197 . . . . 1.0 110.515 -176.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 79.96 -168.22 51.98 Favored Glycine 0 CA--C 1.498 -0.987 0 N-CA-C 110.373 -1.091 . . . . 1.15 110.373 -177.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.486 ' HG2' ' HG3' ' A' ' 18' ' ' LYS . 85.2 Cg_endo -63.8 89.87 0.15 Allowed 'Trans proline' 0 CA--C 1.51 -0.706 0 CA-C-N 119.793 1.796 . . . . 1.6 110.932 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.88 18.3 63.67 Favored Glycine 0 N--CA 1.418 -2.548 0 CA-C-N 114.168 -1.378 . . . . 1.68 114.199 177.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.693 ' O ' ' HB2' ' A' ' 12' ' ' PRO . . . 84.18 36.76 12.19 Favored Glycine 0 N--CA 1.404 -3.485 0 C-N-CA 118.077 -2.011 . . . . 1.37 115.947 176.035 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.486 ' HG3' ' HG2' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -92.63 -12.54 31.35 Favored 'General case' 0 CA--C 1.559 1.32 0 CA-C-N 115.0 -0.6 . . . . 2.91 110.999 175.896 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.551 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -102.21 -176.79 27.69 Favored Glycine 0 N--CA 1.478 1.467 0 C-N-CA 126.298 1.904 . . . . 1.06 109.379 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.647 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -126.18 168.97 13.32 Favored 'General case' 0 C--N 1.354 0.786 0 CA-C-N 122.707 3.253 . . . . 3.32 105.7 175.368 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.659 ' HB2' ' HG2' ' A' ' 47' ' ' GLU . 33.7 m -108.49 163.08 13.54 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 119.334 0.97 . . . . 1.19 113.331 -178.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -143.47 -57.04 0.4 Allowed 'General case' 0 C--O 1.232 0.146 0 CA-C-N 114.82 -1.082 . . . . 2.26 109.913 178.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.532 ' O ' ' HB3' ' A' ' 44' ' ' CYS . . . -120.54 176.91 16.33 Favored Glycine 0 C--N 1.332 0.319 0 CA-C-N 115.866 -0.606 . . . . 1.05 112.005 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.411 ' HB2' ' OE1' ' B' ' 181' ' ' GLU . 47.7 Cg_exo -53.67 -68.77 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.49 2.127 . . . . 1.81 112.368 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.652 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.5 OUTLIER -95.59 18.19 13.33 Favored 'General case' 0 C--O 1.224 -0.271 0 N-CA-C 109.995 -0.372 . . . . 1.62 109.995 178.878 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.894 HG12 HG13 ' A' ' 36' ' ' VAL . 1.2 mt -122.41 106.26 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 CA-C-O 121.751 0.786 . . . . 1.39 111.797 -177.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.749 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 0.6 OUTLIER -121.94 124.13 43.31 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 114.725 -1.125 . . . . 0.92 109.615 -179.011 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 1.168 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -138.52 112.82 8.72 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 114.978 1.473 . . . . 1.28 114.978 -178.607 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.495 ' O ' ' HB3' ' A' ' 69' ' ' ALA . . . -106.41 -159.17 22.03 Favored Glycine 0 N--CA 1.429 -1.832 0 N-CA-C 109.559 -1.416 . . . . 0.71 109.559 175.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -65.5 -64.86 0.76 Allowed 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 112.69 0.626 . . . . 2.27 112.69 -178.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.51 17.36 20.85 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 122.61 1.195 . . . . 1.66 109.808 -176.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -113.95 -11.72 12.74 Favored 'General case' 0 N--CA 1.404 -2.759 0 N-CA-C 105.486 -2.042 . . . . 1.93 105.486 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 1.168 ' O ' ' HA ' ' A' ' 28' ' ' CYS . . . 50.68 -135.48 29.33 Favored Glycine 0 N--CA 1.415 -2.758 0 CA-C-N 114.275 -1.33 . . . . 0.77 111.769 175.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.81 ' HB2' ' CD1' ' A' ' 72' ' ' ILE . 1.8 t -129.04 111.85 13.41 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-N 118.803 1.301 . . . . 1.08 112.678 179.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.761 ' HA ' ' HA ' ' B' ' 135' ' ' PHE . 6.2 m-30 -85.18 105.41 15.86 Favored 'General case' 0 N--CA 1.408 -2.525 0 N-CA-C 103.543 -2.762 . . . . 1.85 103.543 176.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.894 HG13 HG12 ' A' ' 26' ' ' ILE . 2.2 t -97.27 85.27 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.75 0 CA-C-O 123.129 1.443 . . . . 1.29 107.79 -178.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.657 ' O ' ' HA3' ' B' ' 133' ' ' GLY . . . 110.97 92.96 2.17 Favored Glycine 0 CA--C 1.521 0.464 0 CA-C-N 112.427 -2.169 . . . . 0.85 114.263 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.688 ' CG2' ' HB3' ' A' ' 35' ' ' PHE . 0.0 OUTLIER 178.77 169.26 0.89 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 110.096 -0.335 . . . . 1.3 110.096 178.29 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.609 ' HA ' HD11 ' A' ' 42' ' ' LEU . . . -68.42 -35.83 78.21 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.832 -0.347 . . . . 1.45 110.933 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.86 -24.18 14.94 Favored 'General case' 0 C--N 1.332 -0.181 0 O-C-N 122.093 -0.379 . . . . 2.32 111.691 -178.54 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.682 ' O ' ' N ' ' A' ' 44' ' ' CYS . . . -97.23 -23.33 16.22 Favored 'General case' 0 C--O 1.214 -0.781 0 CA-C-N 116.818 -0.174 . . . . 1.11 111.242 -179.373 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.609 HD11 ' HA ' ' A' ' 39' ' ' ALA . 1.0 OUTLIER -37.38 -46.73 0.8 Allowed 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.969 0.729 . . . . 1.68 112.969 -175.771 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.481 ' HD2' ' H ' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -53.7 -25.68 19.43 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.813 -0.81 . . . . 3.4 108.813 177.557 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.682 ' N ' ' O ' ' A' ' 41' ' ' ALA . 86.2 m -57.33 -20.57 29.67 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.427 -0.806 . . . . 1.57 110.473 -178.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -39.09 -45.04 1.22 Allowed 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.594 0.59 . . . . 3.49 112.594 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -87.74 -7.57 57.17 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 119.873 -0.731 . . . . 3.69 110.991 -179.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.659 ' HG2' ' HB2' ' A' ' 21' ' ' CYS . 0.8 OUTLIER . . . . . 0 N--CA 1.442 -0.826 0 CA-C-N 115.903 -0.589 . . . . 3.99 109.453 177.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.2 t . . . . . 0 N--CA 1.463 0.182 0 N-CA-C 112.569 0.581 . . . . 3.36 112.569 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 164.17 35.23 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 110.534 -1.026 . . . . 2.3 110.534 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.523 ' HA ' ' HB2' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -123.26 88.99 3.02 Favored 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 109.043 -0.725 . . . . 5.06 109.043 179.611 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.529 ' HB3' ' HB2' ' A' ' 67' ' ' CYS . 0.5 OUTLIER -135.52 81.39 42.42 Favored Pre-proline 0 C--N 1.296 -1.755 0 N-CA-C 106.065 -1.828 . . . . 3.91 106.065 -178.647 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.449 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 12.0 Cg_endo -55.44 107.18 0.22 Allowed 'Trans proline' 0 C--N 1.358 1.05 0 C-N-CA 123.868 3.046 . . . . 1.74 114.241 -177.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.482 ' O ' ' O ' ' A' ' 65' ' ' GLY . 0.5 OUTLIER -144.34 149.63 36.49 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-N 114.333 -1.303 . . . . 1.9 110.144 178.811 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 79.36 -167.26 51.97 Favored Glycine 0 C--N 1.339 0.73 0 C-N-CA 119.039 -1.553 . . . . 2.43 109.683 -173.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.05 66.67 0.15 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 118.668 1.234 . . . . 4.32 112.472 -175.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.22 13.73 80.24 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.984 -0.627 . . . . 2.4 114.347 177.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.482 ' O ' ' O ' ' A' ' 61' ' ' CYS . . . -101.01 122.19 7.51 Favored Glycine 0 CA--C 1.501 -0.836 0 C-N-CA 119.59 -1.29 . . . . 1.82 113.66 -175.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.523 ' HB2' ' HA ' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -86.54 152.24 22.8 Favored 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 110.067 -0.345 . . . . 3.51 110.067 -178.929 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.529 ' HB2' ' HB3' ' A' ' 59' ' ' LYS . 0.1 OUTLIER -67.03 106.54 1.98 Allowed 'General case' 0 N--CA 1.423 -1.802 0 N-CA-C 108.674 -0.862 . . . . 1.52 108.674 -179.196 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -91.88 -23.72 19.55 Favored 'General case' 0 N--CA 1.417 -2.108 0 N-CA-C 107.468 -1.308 . . . . 1.5 107.468 177.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.827 ' CB ' ' HA2' ' A' ' 33' ' ' GLY . . . -169.72 163.26 9.92 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 109.875 -0.417 . . . . 1.31 109.875 -178.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.823 ' HA ' ' HB3' ' A' ' 85' ' ' CYS . . . -37.35 127.06 1.05 Allowed 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 115.611 1.708 . . . . 1.5 115.611 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.627 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . 59.08 -6.39 0.05 OUTLIER Glycine 0 C--N 1.342 0.912 0 N-CA-C 115.97 1.148 . . . . 1.44 115.97 177.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.81 ' CD1' ' HB2' ' A' ' 34' ' ' CYS . 1.6 pp -117.58 105.82 18.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 117.662 0.731 . . . . 2.77 111.846 -178.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -91.93 106.7 18.66 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.018 -0.992 . . . . 1.98 108.844 179.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.447 ' SG ' HD11 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -129.65 170.49 13.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 122.113 0.958 . . . . 1.43 113.561 -178.436 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.735 ' HB3' ' HD2' ' A' ' 76' ' ' PRO . 10.3 m -130.42 179.62 1.28 Allowed Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 113.297 -1.774 . . . . 2.37 106.947 178.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.735 ' HD2' ' HB3' ' A' ' 75' ' ' SER . 58.1 Cg_endo -75.94 30.81 0.39 Allowed 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 120.994 1.129 . . . . 2.09 112.258 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.46 ' H ' ' C ' ' A' ' 75' ' ' SER . 2.7 m-20 -138.16 -57.15 0.66 Allowed 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.859 -0.61 . . . . 2.65 109.925 179.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.489 ' HA3' ' HD2' ' B' ' 180' ' ' HIS . . . -139.31 -178.15 16.23 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.507 -0.854 . . . . 1.04 112.842 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.503 ' SG ' ' HB ' ' A' ' 72' ' ' ILE . 13.4 t -142.48 160.68 39.8 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 110.139 -0.319 . . . . 1.42 110.139 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.481 ' HD2' ' HA3' ' B' ' 178' ' ' GLY . 0.3 OUTLIER -149.7 134.68 17.93 Favored 'General case' 0 CA--C 1.521 -0.164 0 C-N-CA 119.986 -0.686 . . . . 2.81 112.179 -178.587 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.86 119.46 10.04 Favored 'General case' 0 CA--C 1.51 -0.59 0 N-CA-C 108.363 -0.977 . . . . 3.05 108.363 177.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.509 ' OD1' ' HB1' ' A' ' 84' ' ' ALA . 0.2 OUTLIER -154.48 139.18 11.65 Favored Pre-proline 0 C--N 1.317 -0.846 0 C-N-CA 120.534 -0.466 . . . . 2.02 110.971 -179.013 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -70.17 41.84 0.36 Allowed 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.987 2.458 . . . . 2.29 113.049 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.509 ' HB1' ' OD1' ' A' ' 82' ' ' ASP . . . -75.11 -58.96 2.96 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-O 122.698 1.237 . . . . 1.53 109.363 178.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.823 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 52.5 m -105.78 80.98 1.6 Allowed 'General case' 0 N--CA 1.435 -1.222 0 CA-C-N 112.507 -2.133 . . . . 1.88 109.102 -179.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.287 0 CA-C-N 116.007 -0.542 . . . . 3.6 111.942 -178.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 110' ' ' CYS . . . . . 0.435 ' SG ' ' HB3' ' B' ' 120' ' ' ARG . 12.0 p . . . . . 0 CA--C 1.545 0.767 0 N-CA-C 114.003 1.112 . . . . 2.87 114.003 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 111' ' ' LEU . . . . . 0.421 ' O ' ' O ' ' B' ' 110' ' ' CYS . 25.5 mt -30.19 154.3 0.03 OUTLIER Pre-proline 0 N--CA 1.481 1.081 0 N-CA-C 113.314 0.857 . . . . 2.95 113.314 178.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 112' ' ' PRO . . . . . 0.717 ' HB2' ' O ' ' B' ' 117' ' ' GLY . 48.5 Cg_endo -88.14 122.32 1.53 Allowed 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.423 2.749 . . . . 1.71 113.726 -178.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.646 ' SG ' ' O ' ' B' ' 120' ' ' ARG . 8.1 p -109.26 -153.59 0.51 Allowed 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 121.267 0.556 . . . . 1.0 110.625 178.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . 78.9 -168.13 53.26 Favored Glycine 0 CA--C 1.49 -1.498 0 N-CA-C 110.361 -1.096 . . . . 1.16 110.361 -179.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 115' ' ' PRO . . . . . 0.497 ' HG2' ' HG3' ' B' ' 118' ' ' LYS . 97.2 Cg_endo -64.59 85.93 0.16 Allowed 'Trans proline' 0 N--CA 1.45 -1.044 0 CA-C-N 119.556 1.678 . . . . 1.6 113.608 -178.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 86.13 19.22 57.84 Favored Glycine 0 N--CA 1.423 -2.192 0 CA-C-N 113.154 -1.839 . . . . 1.7 115.083 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 117' ' ' GLY . . . . . 0.717 ' O ' ' HB2' ' B' ' 112' ' ' PRO . . . 87.33 34.7 10.24 Favored Glycine 0 N--CA 1.413 -2.883 0 C-N-CA 119.536 -1.316 . . . . 1.38 116.182 176.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 118' ' ' LYS . . . . . 0.497 ' HG3' ' HG2' ' B' ' 115' ' ' PRO . 0.1 OUTLIER -93.03 -7.37 45.92 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 122.252 0.221 . . . . 2.96 111.267 177.289 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 119' ' ' GLY . . . . . 0.583 ' O ' ' HA ' ' B' ' 112' ' ' PRO . . . -114.89 -169.22 16.0 Favored Glycine 0 C--N 1.344 1.008 0 N-CA-C 108.112 -1.995 . . . . 1.07 108.112 177.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.646 ' O ' ' SG ' ' B' ' 113' ' ' CYS . 0.0 OUTLIER -125.08 168.69 13.03 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 120.934 2.367 . . . . 3.29 108.838 179.589 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 121' ' ' CYS . . . . . 0.664 ' HB2' ' HG2' ' B' ' 147' ' ' GLU . 33.4 m -108.28 162.45 14.08 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.201 0.815 . . . . 1.21 113.201 -178.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -143.52 -56.98 0.4 Allowed 'General case' 0 C--O 1.231 0.107 0 CA-C-N 114.698 -1.137 . . . . 2.28 109.91 179.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 123' ' ' GLY . . . . . 0.551 ' O ' ' HB3' ' B' ' 144' ' ' CYS . . . -120.83 177.07 16.36 Favored Glycine 0 CA--C 1.52 0.36 0 CA-C-N 115.898 -0.592 . . . . 1.04 112.029 179.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . 0.408 ' O ' ' HB2' ' B' ' 144' ' ' CYS . 51.2 Cg_exo -53.58 -68.93 0.06 OUTLIER 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.515 2.143 . . . . 1.84 112.427 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 125' ' ' SER . . . . . 0.654 ' O ' ' N ' ' B' ' 137' ' ' GLY . 0.5 OUTLIER -95.47 18.33 12.88 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-O 120.88 0.372 . . . . 1.49 110.018 178.794 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 126' ' ' ILE . . . . . 0.871 HG12 HG13 ' B' ' 136' ' ' VAL . 1.5 mt -122.21 105.8 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 CA-C-O 121.546 0.688 . . . . 1.41 111.951 -177.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 127' ' ' CYS . . . . . 0.755 ' O ' ' HA ' ' B' ' 134' ' ' CYS . 0.6 OUTLIER -122.02 124.5 44.12 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 114.821 -1.081 . . . . 0.89 109.828 -179.175 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 128' ' ' CYS . . . . . 1.239 ' HA ' ' O ' ' B' ' 133' ' ' GLY . 0.0 OUTLIER -140.16 110.49 6.63 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 115.995 1.85 . . . . 1.23 115.995 -178.097 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 129' ' ' GLY . . . . . 0.492 ' O ' ' HB3' ' B' ' 169' ' ' ALA . . . -102.77 -161.05 25.78 Favored Glycine 0 N--CA 1.433 -1.53 0 N-CA-C 110.499 -1.04 . . . . 0.69 110.499 176.016 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -68.32 -56.97 6.73 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 114.766 1.395 . . . . 2.35 114.766 -177.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.34 29.27 7.56 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 122.81 1.29 . . . . 1.69 109.478 178.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.66 -12.21 7.67 Favored 'General case' 0 N--CA 1.4 -2.926 0 N-CA-C 104.16 -2.533 . . . . 1.84 104.16 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 133' ' ' GLY . . . . . 1.239 ' O ' ' HA ' ' B' ' 128' ' ' CYS . . . 51.09 -132.66 33.16 Favored Glycine 0 N--CA 1.4 -3.755 0 CA-C-N 113.424 -1.716 . . . . 0.76 112.674 176.126 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 134' ' ' CYS . . . . . 0.823 ' HB2' ' CD1' ' B' ' 172' ' ' ILE . 1.7 t -129.42 112.43 13.8 Favored 'General case' 0 CA--C 1.495 -1.152 0 CA-C-N 118.413 1.106 . . . . 1.08 112.675 178.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 135' ' ' PHE . . . . . 0.761 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 6.2 m-30 -86.72 105.27 16.83 Favored 'General case' 0 N--CA 1.407 -2.578 0 N-CA-C 103.452 -2.796 . . . . 1.83 103.452 175.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 136' ' ' VAL . . . . . 0.871 HG13 HG12 ' B' ' 126' ' ' ILE . 2.8 t -97.15 85.32 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.728 0 CA-C-O 122.913 1.34 . . . . 1.29 107.64 -178.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 137' ' ' GLY . . . . . 0.654 ' N ' ' O ' ' B' ' 125' ' ' SER . . . 110.7 92.93 2.18 Favored Glycine 0 CA--C 1.522 0.507 0 CA-C-N 112.64 -2.073 . . . . 0.85 114.193 -179.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 138' ' ' THR . . . . . 0.688 ' CG2' ' HB3' ' B' ' 135' ' ' PHE . 0.0 OUTLIER 178.84 169.97 0.88 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.761 -0.459 . . . . 1.2 109.761 178.298 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 139' ' ' ALA . . . . . 0.616 ' HA ' HD11 ' B' ' 142' ' ' LEU . . . -74.59 -22.89 58.72 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.586 0.588 . . . . 1.35 112.586 -179.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 140' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.7 -25.37 67.37 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.904 -0.318 . . . . 2.31 110.587 178.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 141' ' ' ALA . . . . . 0.682 ' O ' ' N ' ' B' ' 144' ' ' CYS . . . -97.36 -20.79 17.59 Favored 'General case' 0 C--O 1.213 -0.866 0 CA-C-N 116.265 -0.425 . . . . 1.09 111.583 -178.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 142' ' ' LEU . . . . . 0.616 HD11 ' HA ' ' B' ' 139' ' ' ALA . 0.9 OUTLIER -38.16 -47.41 1.15 Allowed 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 112.701 0.63 . . . . 1.61 112.701 -176.73 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 143' ' ' ARG . . . . . 0.481 ' HD2' ' H ' ' B' ' 143' ' ' ARG . 0.0 OUTLIER -54.0 -24.56 17.32 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.07 -0.715 . . . . 3.43 109.07 177.475 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 144' ' ' CYS . . . . . 0.682 ' N ' ' O ' ' B' ' 141' ' ' ALA . 93.6 m -56.09 -24.96 43.55 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 114.292 -1.322 . . . . 1.61 109.496 -179.154 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -36.47 -45.55 0.5 Allowed 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.929 0.714 . . . . 3.52 112.929 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -87.84 -7.39 57.3 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 119.826 -0.75 . . . . 3.76 111.017 -178.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 147' ' ' GLU . . . . . 0.664 ' HG2' ' HB2' ' B' ' 121' ' ' CYS . 0.8 OUTLIER . . . . . 0 N--CA 1.442 -0.832 0 CA-C-N 115.875 -0.602 . . . . 4.01 109.411 177.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 2.3 t . . . . . 0 CA--C 1.529 0.172 0 N-CA-C 112.782 0.66 . . . . 3.41 112.782 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 165.34 34.96 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 CA-C-N 115.015 -0.993 . . . . 2.26 111.22 179.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 158' ' ' GLN . . . . . 0.524 ' HA ' ' HB2' ' B' ' 166' ' ' ARG . 0.0 OUTLIER -122.86 73.42 1.14 Allowed 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 121.437 0.637 . . . . 5.03 111.059 179.395 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 159' ' ' LYS . . . . . 0.453 ' CB ' ' HB2' ' B' ' 167' ' ' CYS . 0.9 OUTLIER -106.18 79.37 0.58 Allowed Pre-proline 0 C--N 1.314 -0.953 0 CA-C-O 117.788 -1.101 . . . . 3.96 110.673 175.544 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 160' ' ' PRO . . . . . 0.444 ' HA ' ' HA ' ' B' ' 166' ' ' ARG . 11.9 Cg_endo -55.2 108.36 0.3 Allowed 'Trans proline' 0 CA--C 1.531 0.343 0 C-N-CA 122.074 1.849 . . . . 1.7 114.868 -177.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 161' ' ' CYS . . . . . 0.487 ' O ' ' O ' ' B' ' 165' ' ' GLY . 0.5 OUTLIER -142.08 155.33 45.37 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 114.831 -1.077 . . . . 1.93 108.847 178.652 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 74.82 -166.24 54.84 Favored Glycine 0 CA--C 1.521 0.427 0 C-N-CA 118.716 -1.707 . . . . 2.37 110.004 -176.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.79 65.11 0.12 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.729 1.264 . . . . 4.56 112.421 -176.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.91 19.6 72.48 Favored Glycine 0 CA--C 1.502 -0.77 0 C-N-CA 120.8 -0.714 . . . . 2.39 113.906 176.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 165' ' ' GLY . . . . . 0.487 ' O ' ' O ' ' B' ' 161' ' ' CYS . . . -103.42 126.44 8.81 Favored Glycine 0 N--CA 1.439 -1.105 0 C-N-CA 119.779 -1.2 . . . . 1.79 112.741 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 166' ' ' ARG . . . . . 0.524 ' HB2' ' HA ' ' B' ' 158' ' ' GLN . 0.0 OUTLIER -87.74 152.89 21.78 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.567 -0.317 . . . . 3.53 110.177 179.453 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 167' ' ' CYS . . . . . 0.453 ' HB2' ' CB ' ' B' ' 159' ' ' LYS . 0.1 OUTLIER -67.29 106.35 2.03 Favored 'General case' 0 N--CA 1.418 -2.058 0 N-CA-C 108.577 -0.898 . . . . 1.56 108.577 -179.299 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 168' ' ' ALA . . . . . . . . . . . . . . . -86.43 -33.09 20.54 Favored 'General case' 0 N--CA 1.424 -1.728 0 N-CA-C 105.637 -1.986 . . . . 1.42 105.637 177.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 169' ' ' ALA . . . . . 0.851 ' CB ' ' HA2' ' B' ' 133' ' ' GLY . . . -164.01 163.45 23.38 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 114.502 -1.226 . . . . 1.18 111.403 -174.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 170' ' ' ALA . . . . . 0.817 ' HA ' ' HB3' ' B' ' 185' ' ' CYS . . . -37.03 127.02 0.94 Allowed 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 115.288 1.588 . . . . 1.47 115.288 -179.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 171' ' ' GLY . . . . . 0.633 ' N ' ' O ' ' B' ' 185' ' ' CYS . . . 61.51 -11.94 0.06 OUTLIER Glycine 0 C--N 1.339 0.729 0 N-CA-C 115.806 1.083 . . . . 1.45 115.806 177.201 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 172' ' ' ILE . . . . . 0.823 ' CD1' ' HB2' ' B' ' 134' ' ' CYS . 1.6 pp -114.17 106.31 20.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 121.605 0.717 . . . . 2.7 112.191 -176.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 173' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -92.14 106.8 18.73 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.113 -0.949 . . . . 1.94 108.835 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 174' ' ' CYS . . . . . 0.457 ' SG ' HD11 ' B' ' 172' ' ' ILE . 0.0 OUTLIER -129.74 170.44 13.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 122.199 0.999 . . . . 1.43 113.598 -178.441 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 175' ' ' SER . . . . . 0.729 ' HB3' ' HD2' ' B' ' 176' ' ' PRO . 9.9 m -130.29 179.52 1.31 Allowed Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 113.303 -1.771 . . . . 2.3 106.993 178.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 176' ' ' PRO . . . . . 0.729 ' HD2' ' HB3' ' B' ' 175' ' ' SER . 58.1 Cg_endo -75.84 30.83 0.38 Allowed 'Trans proline' 0 N--CA 1.461 -0.422 0 CA-C-N 120.12 1.079 . . . . 2.13 112.28 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 177' ' ' ASP . . . . . 0.461 ' H ' ' C ' ' B' ' 175' ' ' SER . 2.7 m-20 -138.25 -56.96 0.65 Allowed 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.868 -0.606 . . . . 2.72 109.956 179.184 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 178' ' ' GLY . . . . . 0.481 ' HA3' ' HD2' ' A' ' 80' ' ' HIS . . . -139.33 -178.22 16.31 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.598 -0.811 . . . . 1.05 112.948 179.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 179' ' ' CYS . . . . . 0.507 ' SG ' ' HB ' ' B' ' 172' ' ' ILE . 13.4 t -142.55 160.61 39.95 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 110.148 -0.316 . . . . 1.39 110.148 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 180' ' ' HIS . . . . . 0.489 ' HD2' ' HA3' ' A' ' 78' ' ' GLY . 0.3 OUTLIER -149.69 134.74 18.0 Favored 'General case' 0 CA--C 1.521 -0.17 0 C-N-CA 119.925 -0.71 . . . . 2.73 112.187 -178.603 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 181' ' ' GLU . . . . . 0.411 ' OE1' ' HB2' ' A' ' 24' ' ' PRO . 0.2 OUTLIER -63.9 119.5 10.16 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 108.337 -0.986 . . . . 3.06 108.337 177.953 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 182' ' ' ASP . . . . . 0.502 ' OD1' ' HB1' ' B' ' 184' ' ' ALA . 0.2 OUTLIER -154.52 139.14 11.6 Favored Pre-proline 0 C--N 1.316 -0.872 0 C-N-CA 120.452 -0.499 . . . . 2.06 110.939 -178.995 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 183' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -70.09 41.69 0.35 Allowed 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.943 2.429 . . . . 2.27 113.139 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 184' ' ' ALA . . . . . 0.502 ' HB1' ' OD1' ' B' ' 182' ' ' ASP . . . -75.01 -58.94 2.97 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 122.651 1.215 . . . . 1.56 109.343 178.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 185' ' ' CYS . . . . . 0.817 ' HB3' ' HA ' ' B' ' 170' ' ' ALA . 49.0 m -105.6 80.33 1.55 Allowed 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 112.508 -2.133 . . . . 1.94 109.297 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 186' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.071 -0.513 . . . . 3.61 112.178 -177.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.808 ' HB3' ' HG2' ' A' ' 20' ' ' ARG . 0.1 OUTLIER . . . . . 0 CA--C 1.543 0.695 0 N-CA-C 114.52 1.304 . . . . 2.89 114.52 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.556 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 1.3 tt -32.21 112.31 0.35 Allowed Pre-proline 0 N--CA 1.484 1.269 0 CA-C-N 119.294 0.952 . . . . 2.89 111.589 177.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.842 ' HB2' ' O ' ' A' ' 17' ' ' GLY . 41.4 Cg_endo -94.82 125.58 0.4 Allowed 'Trans proline' 0 C--N 1.356 0.948 0 C-N-CA 123.567 2.845 . . . . 1.72 114.65 -178.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.629 ' SG ' ' N ' ' A' ' 14' ' ' GLY . 0.0 OUTLIER -140.82 -168.43 2.59 Favored 'General case' 0 C--N 1.353 0.729 0 CA-C-N 118.228 0.467 . . . . 1.0 111.183 -176.472 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.989 ' HA2' ' HB3' ' A' ' 40' ' ' GLU . . . 75.23 -163.81 54.14 Favored Glycine 0 CA--C 1.501 -0.787 0 C-N-CA 120.832 -0.699 . . . . 1.15 111.705 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -63.2 142.04 84.99 Favored 'Trans proline' 0 N--CA 1.446 -1.315 0 N-CA-C 106.867 -2.013 . . . . 1.6 106.867 175.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 62.73 -12.24 0.1 OUTLIER Glycine 0 C--N 1.269 -3.176 0 C-N-CA 124.66 1.124 . . . . 1.68 113.38 -179.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.842 ' O ' ' HB2' ' A' ' 12' ' ' PRO . . . 64.9 20.14 66.28 Favored Glycine 1 N--CA 1.391 -4.333 0 C-N-CA 116.978 -2.534 . . . . 1.37 110.58 179.411 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.18 -1.61 57.04 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 113.293 -1.454 . . . . 2.91 113.31 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.773 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -116.67 177.73 16.93 Favored Glycine 0 C--N 1.335 0.476 0 N-CA-C 108.488 -1.845 . . . . 1.06 108.488 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.808 ' HG2' ' HB3' ' A' ' 10' ' ' CYS . 0.5 OUTLIER -119.75 173.06 7.26 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 120.408 2.104 . . . . 3.32 111.193 179.89 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.435 ' CB ' ' HG3' ' A' ' 47' ' ' GLU . 4.6 m -105.86 147.43 28.71 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.027 0.441 . . . . 1.19 110.422 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.407 ' HE1' ' O ' ' A' ' 28' ' ' CYS . 44.0 m-85 -137.6 -52.07 0.64 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.807 -0.633 . . . . 2.26 110.711 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.545 ' O ' ' HB3' ' A' ' 44' ' ' CYS . . . -101.4 -166.2 27.56 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.858 -0.687 . . . . 1.05 111.714 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.431 ' O ' ' HB2' ' A' ' 44' ' ' CYS . 2.4 Cg_endo -77.31 -60.64 0.04 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.404 2.069 . . . . 1.81 111.54 179.416 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -102.86 26.34 8.21 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.794 -0.639 . . . . 1.62 109.935 179.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.889 HG22 HG13 ' A' ' 36' ' ' VAL . 0.6 OUTLIER -131.46 121.33 48.08 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 N-CA-C 113.346 0.869 . . . . 1.39 113.346 -177.402 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.443 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . 1.8 t -123.16 118.19 27.1 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 109.022 -0.732 . . . . 0.92 109.022 178.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 1.089 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -132.97 112.26 11.71 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 113.911 1.078 . . . . 1.28 113.911 -177.689 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.807 ' O ' ' HB3' ' A' ' 69' ' ' ALA . . . -105.71 -158.89 22.68 Favored Glycine 0 C--N 1.358 1.784 0 C-N-CA 120.318 -0.944 . . . . 0.71 112.738 178.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.674 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 19.0 p-10 -66.37 -57.09 8.19 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 115.498 1.666 . . . . 2.27 115.498 -176.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -120.29 17.7 12.26 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 121.891 0.853 . . . . 1.66 110.071 -176.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.502 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -112.93 -24.37 9.56 Favored 'General case' 0 N--CA 1.408 -2.567 0 CA-C-N 113.628 -1.624 . . . . 1.93 107.396 -179.315 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 1.089 ' O ' ' HA ' ' A' ' 28' ' ' CYS . . . 73.22 -128.39 11.61 Favored Glycine 0 N--CA 1.415 -2.727 0 CA-C-N 113.951 -1.477 . . . . 0.77 113.755 177.123 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.781 ' HB2' HG13 ' A' ' 72' ' ' ILE . 5.1 t -138.72 118.08 12.81 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 114.834 1.42 . . . . 1.08 114.834 -177.22 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.731 ' HB3' ' CG2' ' A' ' 38' ' ' THR . 0.2 OUTLIER -92.83 106.97 18.85 Favored 'General case' 0 N--CA 1.423 -1.789 0 N-CA-C 105.408 -2.071 . . . . 1.85 105.408 177.031 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.889 HG13 HG22 ' A' ' 26' ' ' ILE . 2.2 t -97.9 85.15 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.577 0 C-N-CA 118.718 -1.193 . . . . 1.29 108.856 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.59 ' O ' ' O ' ' A' ' 38' ' ' THR . . . 143.39 -75.78 0.3 Allowed Glycine 0 CA--C 1.524 0.607 0 CA-C-N 114.3 -1.318 . . . . 0.85 115.568 179.203 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.731 ' CG2' ' HB3' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -23.47 154.27 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 113.111 0.782 . . . . 1.3 113.111 -178.298 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.52 ' O ' ' N ' ' A' ' 42' ' ' LEU . . . -60.14 -39.09 85.09 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.971 -0.559 . . . . 1.45 111.366 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.989 ' HB3' ' HA2' ' A' ' 14' ' ' GLY . 1.2 mt-10 -40.36 -29.52 0.08 Allowed 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.794 0.665 . . . . 2.32 112.794 -178.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.692 ' O ' ' N ' ' A' ' 44' ' ' CYS . . . -89.16 -20.95 23.6 Favored 'General case' 0 N--CA 1.44 -0.954 0 O-C-N 122.328 -0.232 . . . . 1.11 110.952 -179.233 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.52 ' N ' ' O ' ' A' ' 39' ' ' ALA . 3.2 mt -39.22 -43.62 1.13 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.819 0.674 . . . . 1.68 112.819 -177.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.32 -30.44 28.4 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 107.903 -1.147 . . . . 3.4 107.903 177.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.692 ' N ' ' O ' ' A' ' 41' ' ' ALA . 70.0 m -53.04 -21.65 4.85 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 114.279 -1.328 . . . . 1.57 110.556 -177.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -49.03 -34.45 13.37 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 113.505 0.928 . . . . 3.49 113.505 -179.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -87.09 -5.0 59.18 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 119.869 -0.733 . . . . 3.69 111.157 -178.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.435 ' HG3' ' CB ' ' A' ' 21' ' ' CYS . 3.9 mm-40 . . . . . 0 N--CA 1.443 -0.787 0 N-CA-C 109.512 -0.551 . . . . 3.99 109.512 177.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.7 p . . . . . 0 CA--C 1.531 0.231 0 CA-C-O 120.889 0.376 . . . . 3.36 111.293 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 173.39 38.38 0.04 OUTLIER Glycine 0 N--CA 1.444 -0.815 0 N-CA-C 110.415 -1.074 . . . . 2.3 110.415 -179.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.4 tp60 -120.78 85.58 2.42 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 108.613 -0.884 . . . . 5.06 108.613 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.499 ' O ' ' HA ' ' A' ' 66' ' ' ARG . 0.5 OUTLIER -136.32 82.28 35.22 Favored Pre-proline 0 C--N 1.299 -1.618 0 N-CA-C 106.28 -1.748 . . . . 3.91 106.28 -178.713 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.516 ' HA ' ' O ' ' A' ' 65' ' ' GLY . 60.5 Cg_endo -72.4 73.5 2.75 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 123.197 2.598 . . . . 1.74 113.856 -177.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.406 ' N ' ' O ' ' A' ' 65' ' ' GLY . 4.5 p -99.25 157.87 16.08 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.389 -1.278 . . . . 1.9 109.084 178.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.56 -167.86 54.11 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 119.787 -1.197 . . . . 2.43 112.094 -175.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -76.47 66.09 2.44 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 122.058 0.933 . . . . 4.32 112.623 -175.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.59 19.41 58.35 Favored Glycine 0 C--N 1.339 0.72 0 CA-C-N 114.112 -1.403 . . . . 2.4 114.695 177.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.524 ' HA3' ' HA ' ' A' ' 74' ' ' CYS . . . -105.28 135.01 12.34 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 119.227 -1.463 . . . . 1.82 114.213 -179.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.516 ' HA ' ' HA ' ' A' ' 60' ' ' PRO . 0.0 OUTLIER -107.04 152.99 23.26 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 109.248 -0.649 . . . . 3.51 109.248 177.091 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.676 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 41.7 t -52.77 106.37 0.16 Allowed 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 108.967 -0.753 . . . . 1.52 108.967 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -88.96 -36.55 15.81 Favored 'General case' 0 N--CA 1.423 -1.816 0 N-CA-C 106.718 -1.586 . . . . 1.5 106.718 177.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.807 ' HB3' ' O ' ' A' ' 29' ' ' GLY . . . -165.18 165.06 20.03 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 108.985 -0.746 . . . . 1.31 108.985 -177.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.674 ' HB3' ' O ' ' A' ' 30' ' ' ASP . . . -31.24 108.66 0.05 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.25 0.548 . . . . 1.5 111.402 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.84 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . 75.68 -3.4 49.71 Favored Glycine 0 C--O 1.227 -0.336 0 CA-C-N 115.249 -0.887 . . . . 1.44 114.548 179.109 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.781 HG13 ' HB2' ' A' ' 34' ' ' CYS . 1.6 mm -96.9 119.07 44.48 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.599 0 CA-C-N 117.702 0.751 . . . . 2.77 110.399 -179.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.961 ' HB2' ' HB3' ' A' ' 82' ' ' ASP . 1.9 t -118.99 95.61 4.89 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.72 -1.127 . . . . 1.98 108.391 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 1.028 ' HB3' ' HA ' ' A' ' 79' ' ' CYS . 26.7 p -156.13 -174.32 4.9 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 116.912 2.19 . . . . 1.43 116.912 -176.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.507 ' CB ' ' HD2' ' A' ' 76' ' ' PRO . 0.3 OUTLIER -128.56 -178.29 0.77 Allowed Pre-proline 0 N--CA 1.456 -0.169 0 CA-C-N 112.808 -1.996 . . . . 2.37 109.253 -178.831 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.507 ' HD2' ' CB ' ' A' ' 75' ' ' SER . 60.3 Cg_endo -73.28 30.85 0.31 Allowed 'Trans proline' 0 CA--C 1.533 0.464 0 C-N-CA 121.882 1.721 . . . . 2.09 113.413 -179.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.405 ' H ' ' C ' ' A' ' 75' ' ' SER . 11.2 m-20 -125.88 -60.66 1.28 Allowed 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 109.536 -0.542 . . . . 2.65 109.536 178.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.87 ' O ' ' HB2' ' A' ' 74' ' ' CYS . . . -138.39 -167.29 10.94 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 110.917 -0.873 . . . . 1.04 110.917 178.373 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 1.028 ' HA ' ' HB3' ' A' ' 74' ' ' CYS . 63.8 m -146.43 161.08 41.16 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 117.534 0.667 . . . . 1.42 111.723 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 34.6 t60 -152.58 150.1 29.17 Favored 'General case' 0 C--N 1.344 0.34 0 C-N-CA 119.896 -0.722 . . . . 2.81 111.388 -178.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.453 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 0.4 OUTLIER -60.71 140.86 57.37 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.764 -0.653 . . . . 3.05 110.422 179.558 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.961 ' HB3' ' HB2' ' A' ' 73' ' ' CYS . 0.0 OUTLIER -137.21 138.24 24.76 Favored Pre-proline 0 CA--C 1.544 0.733 0 CA-C-N 115.983 -0.553 . . . . 2.02 111.89 -179.023 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.449 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 2.5 Cg_endo -84.38 -31.68 0.46 Allowed 'Trans proline' 0 C--N 1.359 1.122 0 C-N-CA 123.311 2.674 . . . . 2.29 115.301 -177.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.82 -47.62 84.99 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 108.29 -1.004 . . . . 1.53 108.29 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.84 ' O ' ' N ' ' A' ' 71' ' ' GLY . 81.5 m -96.77 71.68 2.58 Favored 'General case' 0 C--O 1.215 -0.739 0 N-CA-C 105.694 -1.965 . . . . 1.88 105.694 175.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.449 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 0.9 OUTLIER . . . . . 0 CA--C 1.497 -1.084 0 C-N-CA 119.089 -1.044 . . . . 3.6 110.582 -177.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 110' ' ' CYS . . . . . 0.79 ' HB3' ' HG2' ' B' ' 120' ' ' ARG . 0.1 OUTLIER . . . . . 0 CA--C 1.546 0.799 0 N-CA-C 114.332 1.234 . . . . 2.87 114.332 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 111' ' ' LEU . . . . . 0.534 ' O ' ' HA ' ' B' ' 120' ' ' ARG . 1.3 tt -32.09 112.06 0.34 Allowed Pre-proline 0 N--CA 1.484 1.253 0 CA-C-N 119.001 0.819 . . . . 2.95 111.626 178.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 112' ' ' PRO . . . . . 0.833 ' HB2' ' O ' ' B' ' 117' ' ' GLY . 43.4 Cg_endo -93.59 127.39 0.61 Allowed 'Trans proline' 0 C--N 1.356 0.921 0 C-N-CA 123.579 2.853 . . . . 1.71 113.937 -178.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.627 ' SG ' ' N ' ' B' ' 114' ' ' GLY . 0.0 OUTLIER -142.54 -168.84 2.84 Favored 'General case' 0 C--N 1.351 0.631 0 O-C-N 121.943 -0.473 . . . . 1.0 111.212 -177.502 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 114' ' ' GLY . . . . . 0.96 ' HA2' ' HB3' ' B' ' 140' ' ' GLU . . . 75.33 -163.74 54.02 Favored Glycine 0 CA--C 1.502 -0.728 0 C-N-CA 120.817 -0.706 . . . . 1.16 111.535 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 115' ' ' PRO . . . . . 0.406 ' C ' ' H ' ' B' ' 117' ' ' GLY . 48.3 Cg_endo -63.23 142.01 84.67 Favored 'Trans proline' 0 N--CA 1.446 -1.281 0 N-CA-C 107.002 -1.961 . . . . 1.6 107.002 175.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 62.86 -12.48 0.1 OUTLIER Glycine 0 C--N 1.27 -3.124 0 C-N-CA 124.792 1.187 . . . . 1.7 113.251 -179.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 117' ' ' GLY . . . . . 0.833 ' O ' ' HB2' ' B' ' 112' ' ' PRO . . . 64.95 20.5 66.78 Favored Glycine 1 N--CA 1.395 -4.086 0 C-N-CA 116.901 -2.571 . . . . 1.38 110.566 179.431 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.92 -2.63 56.7 Favored 'General case' 0 C--N 1.346 0.435 0 CA-C-N 113.003 -1.599 . . . . 2.96 113.241 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 119' ' ' GLY . . . . . 0.784 ' O ' ' HA ' ' B' ' 112' ' ' PRO . . . -117.65 -178.29 17.44 Favored Glycine 0 C--N 1.34 0.764 0 N-CA-C 108.607 -1.797 . . . . 1.07 108.607 178.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.79 ' HG2' ' HB3' ' B' ' 110' ' ' CYS . 0.4 OUTLIER -120.73 172.52 7.82 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 119.298 1.549 . . . . 3.29 112.364 -178.886 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 121' ' ' CYS . . . . . 0.431 ' CB ' ' HG3' ' B' ' 147' ' ' GLU . 4.4 m -105.89 147.29 28.91 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.081 0.467 . . . . 1.21 110.347 -179.223 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 122' ' ' PHE . . . . . 0.405 ' HE1' ' O ' ' B' ' 128' ' ' CYS . 43.9 m-85 -137.53 -52.02 0.64 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.905 -0.589 . . . . 2.28 110.691 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 123' ' ' GLY . . . . . 0.54 ' O ' ' HB3' ' B' ' 144' ' ' CYS . . . -101.45 -166.21 27.52 Favored Glycine 0 C--O 1.229 -0.203 0 C-N-CA 120.836 -0.697 . . . . 1.04 111.677 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . 0.421 ' O ' ' HB2' ' B' ' 144' ' ' CYS . 2.4 Cg_endo -77.31 -60.65 0.04 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 122.469 2.113 . . . . 1.84 111.564 179.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 125' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -102.89 26.44 8.11 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.839 -0.619 . . . . 1.49 109.921 179.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 126' ' ' ILE . . . . . 0.881 HG21 ' SG ' ' B' ' 134' ' ' CYS . 0.8 OUTLIER -131.37 121.37 48.43 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 N-CA-C 113.399 0.889 . . . . 1.41 113.399 -177.41 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 127' ' ' CYS . . . . . 0.535 ' HB2' ' HB2' ' B' ' 141' ' ' ALA . 1.8 t -123.28 118.05 26.68 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 109.059 -0.719 . . . . 0.89 109.059 178.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 128' ' ' CYS . . . . . 1.099 ' HA ' ' O ' ' B' ' 133' ' ' GLY . 0.0 OUTLIER -132.36 112.0 11.82 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 114.067 1.136 . . . . 1.23 114.067 -177.999 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 129' ' ' GLY . . . . . 0.825 ' O ' ' HB3' ' B' ' 169' ' ' ALA . . . -104.55 -157.96 23.7 Favored Glycine 0 C--N 1.357 1.742 0 C-N-CA 120.298 -0.954 . . . . 0.69 112.992 178.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 130' ' ' ASP . . . . . 0.42 ' O ' ' HB3' ' B' ' 170' ' ' ALA . 18.2 p-10 -68.61 -55.28 12.06 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 115.867 1.802 . . . . 2.35 115.867 -176.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -125.03 30.67 5.81 Favored 'General case' 0 CA--C 1.493 -1.218 0 C-N-CA 118.878 -1.129 . . . . 1.69 109.744 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 132' ' ' LEU . . . . . 0.499 HD22 ' CE1' ' B' ' 135' ' ' PHE . 0.4 OUTLIER -123.82 -23.82 4.59 Favored 'General case' 0 N--CA 1.404 -2.744 0 N-CA-C 105.672 -1.973 . . . . 1.84 105.672 -179.23 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 133' ' ' GLY . . . . . 1.099 ' O ' ' HA ' ' B' ' 128' ' ' CYS . . . 72.15 -126.58 11.85 Favored Glycine 0 N--CA 1.408 -3.195 0 CA-C-N 114.196 -1.366 . . . . 0.76 114.17 175.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 134' ' ' CYS . . . . . 0.881 ' SG ' HG21 ' B' ' 126' ' ' ILE . 5.4 t -140.17 118.13 11.83 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 114.948 1.462 . . . . 1.08 114.948 -177.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 135' ' ' PHE . . . . . 0.745 ' HB3' ' CG2' ' B' ' 138' ' ' THR . 0.1 OUTLIER -93.0 107.14 18.98 Favored 'General case' 0 N--CA 1.424 -1.761 0 N-CA-C 105.4 -2.074 . . . . 1.83 105.4 177.204 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 136' ' ' VAL . . . . . 0.696 HG13 HG22 ' B' ' 126' ' ' ILE . 2.5 t -97.56 85.42 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.552 0 C-N-CA 118.861 -1.136 . . . . 1.29 108.712 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 137' ' ' GLY . . . . . 0.596 ' O ' ' O ' ' B' ' 138' ' ' THR . . . 142.65 -76.04 0.31 Allowed Glycine 0 CA--C 1.522 0.524 0 C-N-CA 119.614 -1.279 . . . . 0.85 115.778 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 138' ' ' THR . . . . . 0.745 ' CG2' ' HB3' ' B' ' 135' ' ' PHE . 0.0 OUTLIER -23.27 154.62 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 113.081 0.771 . . . . 1.2 113.081 -178.242 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 139' ' ' ALA . . . . . 0.498 ' O ' ' N ' ' B' ' 142' ' ' LEU . . . -60.45 -39.38 87.35 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 116.147 -0.479 . . . . 1.35 111.144 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 140' ' ' GLU . . . . . 0.96 ' HB3' ' HA2' ' B' ' 114' ' ' GLY . 1.2 mt-10 -40.09 -29.56 0.08 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.84 0.682 . . . . 2.31 112.84 -178.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 141' ' ' ALA . . . . . 0.684 ' O ' ' N ' ' B' ' 144' ' ' CYS . . . -89.16 -20.72 23.88 Favored 'General case' 0 N--CA 1.441 -0.912 0 O-C-N 122.307 -0.246 . . . . 1.09 110.992 -179.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 142' ' ' LEU . . . . . 0.498 ' N ' ' O ' ' B' ' 139' ' ' ALA . 3.1 mt -39.32 -43.81 1.21 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.787 0.662 . . . . 1.61 112.787 -177.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.18 -30.61 27.73 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 107.947 -1.131 . . . . 3.43 107.947 177.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 144' ' ' CYS . . . . . 0.684 ' N ' ' O ' ' B' ' 141' ' ' ALA . 69.4 m -52.96 -21.39 4.32 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 114.083 -1.417 . . . . 1.61 110.538 -177.246 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -49.39 -34.34 15.95 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 113.538 0.94 . . . . 3.52 113.538 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -87.13 -4.87 59.15 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 119.846 -0.742 . . . . 3.76 111.152 -178.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 147' ' ' GLU . . . . . 0.431 ' HG3' ' CB ' ' B' ' 121' ' ' CYS . 3.9 mm-40 . . . . . 0 N--CA 1.443 -0.812 0 N-CA-C 109.482 -0.562 . . . . 4.01 109.482 177.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 50.3 p . . . . . 0 C--O 1.232 0.175 0 CA-C-O 121.218 0.532 . . . . 3.41 111.216 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 173.89 38.18 0.04 OUTLIER Glycine 0 N--CA 1.444 -0.832 0 N-CA-C 110.835 -0.906 . . . . 2.26 110.835 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 5.1 tp60 -120.85 71.54 0.94 Allowed 'General case' 0 N--CA 1.441 -0.883 0 CA-C-O 121.867 0.841 . . . . 5.03 110.275 179.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 159' ' ' LYS . . . . . 0.531 ' O ' ' HA ' ' B' ' 166' ' ' ARG . 0.7 OUTLIER -107.55 79.98 0.87 Allowed Pre-proline 0 C--N 1.316 -0.863 0 CA-C-N 114.068 -1.424 . . . . 3.96 110.643 175.117 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 160' ' ' PRO . . . . . 0.532 ' HA ' ' HA ' ' B' ' 166' ' ' ARG . 59.3 Cg_endo -72.39 74.49 2.59 Favored 'Trans proline' 0 C--N 1.333 -0.249 0 CA-C-N 121.688 1.638 . . . . 1.7 114.521 -177.416 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 161' ' ' CYS . . . . . . . . . . . . . 4.6 p -98.97 158.92 15.32 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.856 -1.065 . . . . 1.93 109.09 178.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 77.05 -167.85 54.5 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 119.726 -1.226 . . . . 2.37 112.216 -176.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -76.71 65.61 2.51 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 122.173 0.987 . . . . 4.56 112.529 -175.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 84.55 22.24 54.25 Favored Glycine 0 C--N 1.337 0.59 0 CA-C-N 113.858 -1.519 . . . . 2.39 114.626 177.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 165' ' ' GLY . . . . . 0.56 ' HA3' ' HA ' ' B' ' 174' ' ' CYS . . . -108.0 135.77 13.03 Favored Glycine 0 N--CA 1.442 -0.963 0 C-N-CA 119.279 -1.439 . . . . 1.79 113.69 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 166' ' ' ARG . . . . . 0.532 ' HA ' ' HA ' ' B' ' 160' ' ' PRO . 0.0 OUTLIER -106.79 153.27 22.71 Favored 'General case' 0 CA--C 1.521 -0.167 0 N-CA-C 109.273 -0.64 . . . . 3.53 109.273 177.681 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 167' ' ' CYS . . . . . 0.685 ' HA ' ' O ' ' B' ' 172' ' ' ILE . 41.8 t -52.88 106.34 0.16 Allowed 'General case' 0 N--CA 1.424 -1.773 0 N-CA-C 108.932 -0.766 . . . . 1.56 108.932 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 168' ' ' ALA . . . . . . . . . . . . . . . -88.16 -38.05 15.66 Favored 'General case' 0 N--CA 1.423 -1.787 0 N-CA-C 106.402 -1.703 . . . . 1.42 106.402 177.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 169' ' ' ALA . . . . . 0.825 ' HB3' ' O ' ' B' ' 129' ' ' GLY . . . -164.07 165.0 22.77 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 109.196 -0.668 . . . . 1.18 109.196 -176.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 170' ' ' ALA . . . . . 0.487 ' C ' ' O ' ' B' ' 169' ' ' ALA . . . -31.08 108.69 0.05 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.319 0.58 . . . . 1.47 111.284 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 171' ' ' GLY . . . . . 0.851 ' N ' ' O ' ' B' ' 185' ' ' CYS . . . 75.51 -3.3 49.3 Favored Glycine 0 C--O 1.228 -0.25 0 CA-C-N 115.237 -0.892 . . . . 1.45 114.58 179.157 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 172' ' ' ILE . . . . . 0.773 HG13 ' HB2' ' B' ' 134' ' ' CYS . 1.6 mm -96.9 119.1 44.51 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.578 0 CA-C-N 117.723 0.762 . . . . 2.7 110.468 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 173' ' ' CYS . . . . . 0.937 ' HB2' ' HB3' ' B' ' 182' ' ' ASP . 1.9 t -118.96 95.83 4.99 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 114.723 -1.126 . . . . 1.94 108.416 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 174' ' ' CYS . . . . . 1.115 ' HB3' ' HA ' ' B' ' 179' ' ' CYS . 26.6 p -156.26 -174.3 4.88 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 116.9 2.185 . . . . 1.43 116.9 -176.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 175' ' ' SER . . . . . 0.501 ' CB ' ' HD2' ' B' ' 176' ' ' PRO . 0.3 OUTLIER -128.53 -178.35 0.78 Allowed Pre-proline 0 N--CA 1.454 -0.239 0 CA-C-N 112.861 -1.972 . . . . 2.3 109.383 -178.877 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 176' ' ' PRO . . . . . 0.501 ' HD2' ' CB ' ' B' ' 175' ' ' SER . 60.3 Cg_endo -73.23 30.95 0.3 Allowed 'Trans proline' 0 CA--C 1.534 0.507 0 C-N-CA 121.865 1.71 . . . . 2.13 113.428 -179.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 177' ' ' ASP . . . . . 0.407 ' H ' ' C ' ' B' ' 175' ' ' SER . 11.3 m-20 -125.94 -60.68 1.28 Allowed 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 109.612 -0.514 . . . . 2.72 109.612 178.482 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 178' ' ' GLY . . . . . 0.848 ' O ' ' HB2' ' B' ' 174' ' ' CYS . . . -138.44 -167.36 10.96 Favored Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 110.832 -0.907 . . . . 1.05 110.832 178.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 179' ' ' CYS . . . . . 1.115 ' HA ' ' HB3' ' B' ' 174' ' ' CYS . 63.3 m -146.51 161.07 41.24 Favored 'General case' 0 N--CA 1.461 0.101 0 CA-C-N 117.507 0.653 . . . . 1.39 111.632 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 180' ' ' HIS . . . . . . . . . . . . . 34.9 t60 -152.37 150.31 29.56 Favored 'General case' 0 C--N 1.344 0.36 0 C-N-CA 120.014 -0.674 . . . . 2.73 111.401 -178.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 181' ' ' GLU . . . . . 0.452 ' HA ' ' O ' ' B' ' 171' ' ' GLY . 0.4 OUTLIER -60.91 140.82 57.62 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.766 -0.652 . . . . 3.06 110.359 179.557 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 182' ' ' ASP . . . . . 0.937 ' HB3' ' HB2' ' B' ' 173' ' ' CYS . 0.0 OUTLIER -137.19 138.27 24.9 Favored Pre-proline 0 CA--C 1.543 0.701 0 CA-C-N 116.005 -0.543 . . . . 2.06 111.852 -179.024 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 183' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' B' ' 182' ' ' ASP . 2.5 Cg_endo -84.41 -31.66 0.46 Allowed 'Trans proline' 0 C--N 1.358 1.068 0 C-N-CA 123.359 2.706 . . . . 2.27 115.256 -177.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -59.9 -47.6 85.12 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 108.279 -1.008 . . . . 1.56 108.279 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 185' ' ' CYS . . . . . 0.851 ' O ' ' N ' ' B' ' 171' ' ' GLY . 82.2 m -96.68 71.62 2.61 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 105.7 -1.963 . . . . 1.94 105.7 175.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 186' ' ' ASP . . . . . 0.448 ' HB2' ' O ' ' B' ' 183' ' ' PRO . 0.9 OUTLIER . . . . . 0 CA--C 1.497 -1.094 0 C-N-CA 119.055 -1.058 . . . . 3.61 110.644 -177.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.556 ' O ' ' C ' ' A' ' 11' ' ' LEU . 67.9 m . . . . . 0 N--CA 1.455 -0.191 0 CA-C-O 118.524 -0.75 . . . . 2.89 112.862 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.892 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 6.9 mp -31.76 108.76 0.28 Allowed Pre-proline 0 N--CA 1.476 0.847 0 CA-C-N 120.036 1.289 . . . . 2.89 110.228 -179.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.737 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 89.8 Cg_endo -82.94 135.69 7.74 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 121.621 1.548 . . . . 1.72 114.593 -178.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.696 ' N ' ' O ' ' A' ' 19' ' ' GLY . 29.3 p -145.15 -175.06 4.55 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 118.267 -1.373 . . . . 1.0 111.322 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.671 ' HA2' ' HB3' ' A' ' 40' ' ' GLU . . . 75.75 -164.35 53.89 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 120.499 -0.857 . . . . 1.15 114.377 178.025 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.864 ' HD2' HD12 ' A' ' 32' ' ' LEU . 38.3 Cg_endo -63.14 112.75 1.78 Allowed 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 124.861 3.707 . . . . 1.6 109.601 177.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.19 -11.86 53.03 Favored Glycine 0 C--N 1.276 -2.803 0 N-CA-C 110.59 -1.004 . . . . 1.68 110.59 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.662 ' O ' ' HB2' ' A' ' 12' ' ' PRO . . . 68.59 47.3 57.48 Favored Glycine 0 N--CA 1.418 -2.538 0 C-N-CA 117.929 -2.081 . . . . 1.37 111.648 176.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.723 ' HD3' ' O ' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -92.26 -28.91 16.7 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 111.858 -2.171 . . . . 2.91 111.907 179.959 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.737 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -103.8 -178.08 25.73 Favored Glycine 0 C--O 1.213 -1.216 0 O-C-N 121.023 -1.048 . . . . 1.06 115.181 -176.009 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.892 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -96.16 144.71 26.15 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 115.579 1.696 . . . . 3.32 115.579 -174.588 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.659 ' C ' ' CD1' ' A' ' 22' ' ' PHE . 0.1 OUTLIER -108.25 170.24 8.13 Favored 'General case' 0 C--N 1.344 0.334 0 CA-C-N 113.49 -1.686 . . . . 1.19 109.36 -179.692 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.659 ' CD1' ' C ' ' A' ' 21' ' ' CYS . 33.8 m-85 -156.8 52.54 0.51 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.966 0.412 . . . . 2.26 110.649 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.518 ' O ' ' SG ' ' A' ' 44' ' ' CYS . . . 133.08 -145.68 17.66 Favored Glycine 0 C--O 1.225 -0.433 0 N-CA-C 111.265 -0.734 . . . . 1.05 111.265 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -94.86 -70.19 0.0 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 122.779 2.319 . . . . 1.81 112.145 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.635 ' O ' ' N ' ' A' ' 37' ' ' GLY . 2.8 m -92.5 45.52 1.2 Allowed 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 109.746 -0.465 . . . . 1.62 109.746 179.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.804 ' CG2' ' HB3' ' A' ' 74' ' ' CYS . 3.6 mt -145.13 115.04 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 N-CA-C 112.015 0.376 . . . . 1.39 112.015 -177.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.58 ' SG ' ' CE2' ' A' ' 35' ' ' PHE . 1.9 t -149.15 123.75 9.78 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-O 121.346 0.593 . . . . 0.92 110.803 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.865 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 0.5 OUTLIER -126.37 152.5 46.2 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.201 1.0 . . . . 1.28 110.949 -179.852 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 33' ' ' GLY . . . -143.52 -179.83 20.41 Favored Glycine 0 N--CA 1.424 -2.144 0 C-N-CA 120.386 -0.911 . . . . 0.71 111.273 176.211 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -70.01 -44.93 68.32 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 126.351 1.861 . . . . 2.27 112.442 177.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -121.65 23.42 10.22 Favored 'General case' 0 CA--C 1.471 -2.075 0 CA-C-N 112.956 -1.929 . . . . 1.66 111.31 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.864 HD12 ' HD2' ' A' ' 15' ' ' PRO . 1.0 OUTLIER -125.62 -36.36 2.44 Favored 'General case' 0 N--CA 1.425 -1.685 0 CA-C-N 113.589 -1.641 . . . . 1.93 109.682 -174.623 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.865 ' O ' ' HA ' ' A' ' 28' ' ' CYS . . . 89.96 -138.85 14.76 Favored Glycine 0 N--CA 1.425 -2.045 0 CA-C-N 114.845 -1.071 . . . . 0.77 114.368 177.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.793 ' SG ' ' SG ' ' A' ' 74' ' ' CYS . 1.3 m -126.75 121.24 31.44 Favored 'General case' 0 CA--C 1.489 -1.384 0 CA-C-N 119.318 1.559 . . . . 1.08 110.37 177.068 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.996 ' HA ' ' HA ' ' B' ' 135' ' ' PHE . 0.0 OUTLIER -119.07 107.49 13.56 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 104.578 -2.379 . . . . 1.85 104.578 176.705 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 1.037 HG21 ' SG ' ' A' ' 79' ' ' CYS . 1.0 OUTLIER -92.07 89.71 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.552 0 CA-C-O 122.077 0.941 . . . . 1.29 109.849 -178.266 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.635 ' N ' ' O ' ' A' ' 25' ' ' SER . . . 88.37 87.3 1.19 Allowed Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 113.907 -1.497 . . . . 0.85 112.101 -179.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.597 HG23 ' O ' ' A' ' 37' ' ' GLY . 40.3 p -150.17 176.03 11.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.807 0.337 . . . . 1.3 110.589 -179.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.41 ' HA ' ' CD1' ' A' ' 42' ' ' LEU . . . -63.92 -41.68 97.6 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.343 -1.355 . . . . 1.45 107.343 177.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.671 ' HB3' ' HA2' ' A' ' 14' ' ' GLY . 3.0 mm-40 -55.82 -34.37 65.3 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 113.884 -1.507 . . . . 2.32 110.201 179.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.818 ' O ' ' HB2' ' A' ' 44' ' ' CYS . . . -82.75 -37.63 24.37 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 115.349 -0.841 . . . . 1.11 109.953 -179.264 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.41 ' CD1' ' HA ' ' A' ' 39' ' ' ALA . 0.2 OUTLIER -38.96 -32.92 0.1 Allowed 'General case' 0 C--O 1.24 0.564 0 CA-C-O 121.105 0.479 . . . . 1.68 110.685 -178.672 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.448 ' O ' ' N ' ' A' ' 45' ' ' GLN . 2.1 mmm180 -51.97 -29.02 18.82 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 108.239 -1.023 . . . . 3.4 108.239 176.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.818 ' HB2' ' O ' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -44.65 -2.66 0.01 OUTLIER 'General case' 0 C--O 1.239 0.552 0 N-CA-C 115.434 1.642 . . . . 1.57 115.434 -176.621 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.448 ' N ' ' O ' ' A' ' 43' ' ' ARG . 0.3 OUTLIER -88.99 3.37 51.86 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 122.624 2.466 . . . . 3.49 107.203 174.976 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -83.56 11.33 7.28 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 108.505 -0.924 . . . . 3.69 108.505 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.447 -0.613 0 N-CA-C 109.263 -0.644 . . . . 3.99 109.263 176.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 66.0 m . . . . . 0 CA--C 1.558 1.27 0 N-CA-C 112.189 0.44 . . . . 3.36 112.189 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' A' ' 66' ' ' ARG . . . -133.43 123.11 3.29 Favored Glycine 0 CA--C 1.49 -1.504 0 CA-C-N 114.983 -1.008 . . . . 2.3 111.995 -176.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -111.12 78.78 1.14 Allowed 'General case' 0 N--CA 1.439 -0.988 0 CA-C-O 121.951 0.881 . . . . 5.06 108.901 178.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.731 ' CB ' ' HB2' ' A' ' 67' ' ' CYS . 0.4 OUTLIER -138.15 68.88 48.73 Favored Pre-proline 0 C--N 1.305 -1.326 0 CA-C-O 122.96 1.362 . . . . 3.91 108.247 -179.799 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -55.59 86.78 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.589 2.859 . . . . 1.74 115.191 -178.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.649 ' N ' ' O ' ' A' ' 65' ' ' GLY . 1.8 m -96.64 -173.8 2.84 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 113.786 -1.552 . . . . 1.9 107.062 176.249 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 45.14 -167.03 0.04 OUTLIER Glycine 0 CA--C 1.53 0.97 0 C-N-CA 119.837 -1.173 . . . . 2.43 114.36 175.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 6.5 t -84.2 61.02 6.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 122.683 1.23 . . . . 4.32 111.256 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 109.93 3.89 29.81 Favored Glycine 0 CA--C 1.532 1.144 0 CA-C-N 112.585 -2.098 . . . . 2.4 116.209 176.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.649 ' O ' ' N ' ' A' ' 61' ' ' CYS . . . -101.4 142.8 15.86 Favored Glycine 0 C--O 1.225 -0.442 0 C-N-CA 117.227 -2.416 . . . . 1.82 115.995 -175.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.459 ' HB2' ' O ' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -98.03 154.0 18.01 Favored 'General case' 0 C--N 1.335 -0.055 0 CA-C-N 114.549 -0.826 . . . . 3.51 110.142 179.274 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.731 ' HB2' ' CB ' ' A' ' 59' ' ' LYS . 3.7 t -44.98 109.48 0.17 Allowed 'General case' 0 CA--C 1.506 -0.74 0 CA-C-O 121.257 0.551 . . . . 1.52 111.763 -178.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.699 ' HB2' ' HB3' ' A' ' 28' ' ' CYS . . . -100.39 -15.42 17.96 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 108.074 -1.084 . . . . 1.5 108.074 177.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -168.19 162.26 12.77 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 114.532 -1.213 . . . . 1.31 110.872 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.532 ' HA ' ' HB3' ' A' ' 85' ' ' CYS . . . -73.3 74.87 1.34 Allowed 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 121.446 0.641 . . . . 1.5 112.673 -179.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.709 ' O ' ' HA ' ' A' ' 81' ' ' GLU . . . 163.53 -51.57 0.3 Allowed Glycine 0 N--CA 1.437 -1.298 0 CA-C-N 114.983 -1.008 . . . . 1.44 112.952 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.686 HD11 ' SG ' ' A' ' 34' ' ' CYS . 0.6 OUTLIER -126.63 140.23 49.49 Favored 'Isoleucine or valine' 0 C--O 1.248 0.99 0 CA-C-O 122.83 1.3 . . . . 2.77 110.704 -175.936 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.539 ' HB2' ' HB2' ' A' ' 61' ' ' CYS . 47.9 m -112.15 113.19 25.3 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 114.895 -1.048 . . . . 1.98 110.258 -179.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.804 ' HB3' ' CG2' ' A' ' 26' ' ' ILE . 64.6 m -78.58 144.03 35.92 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.596 -0.729 . . . . 1.43 111.105 -178.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.681 ' HB2' ' HD2' ' A' ' 76' ' ' PRO . 92.0 p -136.76 179.95 1.23 Allowed Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 114.318 -1.31 . . . . 2.37 108.742 -178.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.681 ' HD2' ' HB2' ' A' ' 75' ' ' SER . 66.9 Cg_endo -76.32 29.88 0.4 Allowed 'Trans proline' 0 N--CA 1.452 -0.93 0 N-CA-C 109.822 -0.876 . . . . 2.09 109.822 177.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.563 ' H ' ' C ' ' A' ' 75' ' ' SER . 2.0 m-20 -144.29 -46.73 0.26 Allowed 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.17 -0.923 . . . . 2.65 111.171 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.992 ' HA2' HG12 ' A' ' 36' ' ' VAL . . . -170.5 -155.99 10.89 Favored Glycine 0 C--N 1.34 0.785 0 C-N-CA 119.745 -1.217 . . . . 1.04 115.313 179.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 1.037 ' SG ' HG21 ' A' ' 36' ' ' VAL . 10.4 m -140.98 129.29 22.32 Favored 'General case' 0 CA--C 1.555 1.171 0 CA-C-O 122.732 1.253 . . . . 1.42 107.767 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.428 ' N ' HG22 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -144.42 132.2 21.29 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-N 112.414 -2.175 . . . . 2.81 112.443 -168.392 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.709 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 0.4 OUTLIER -47.36 142.24 4.24 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 114.036 -1.438 . . . . 3.05 109.981 -179.7 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.679 ' OD1' ' HB2' ' A' ' 85' ' ' CYS . 3.1 p-10 -145.26 137.37 13.22 Favored Pre-proline 0 C--N 1.309 -1.174 0 CA-C-N 115.712 -0.676 . . . . 2.02 109.738 -178.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -57.87 -35.42 98.79 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.667 2.245 . . . . 2.29 114.373 -177.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.8 -51.69 60.82 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 108.616 -0.883 . . . . 1.53 108.616 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.679 ' HB2' ' OD1' ' A' ' 82' ' ' ASP . 3.2 m -98.74 77.09 2.23 Favored 'General case' 0 CA--C 1.499 -1.015 0 N-CA-C 106.703 -1.591 . . . . 1.88 106.703 176.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.5 -0.944 0 C-N-CA 119.301 -0.96 . . . . 3.6 110.06 -178.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 110' ' ' CYS . . . . . 0.566 ' O ' ' C ' ' B' ' 111' ' ' LEU . 67.5 m . . . . . 0 CA--C 1.527 0.095 0 CA-C-O 118.544 -0.741 . . . . 2.87 112.894 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 111' ' ' LEU . . . . . 0.881 ' O ' ' HA ' ' B' ' 120' ' ' ARG . 6.9 mp -31.29 108.67 0.27 Allowed Pre-proline 0 N--CA 1.477 0.892 0 CA-C-N 119.962 1.256 . . . . 2.95 110.332 -179.283 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 112' ' ' PRO . . . . . 0.848 ' HA ' ' O ' ' B' ' 119' ' ' GLY . 84.0 Cg_endo -81.62 138.14 10.56 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 121.926 1.751 . . . . 1.71 113.696 -179.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.564 ' N ' ' O ' ' B' ' 119' ' ' GLY . 31.2 p -149.14 -178.7 6.53 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 120.697 -0.401 . . . . 1.0 111.499 178.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 114' ' ' GLY . . . . . 0.676 ' HA2' ' HB3' ' B' ' 140' ' ' GLU . . . 76.06 -163.1 53.07 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 120.793 -0.718 . . . . 1.16 113.929 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 115' ' ' PRO . . . . . 0.837 ' HD2' HD12 ' B' ' 132' ' ' LEU . 38.8 Cg_endo -64.37 101.5 0.36 Allowed 'Trans proline' 0 N--CA 1.485 1.005 0 C-N-CA 125.234 3.956 . . . . 1.6 114.784 178.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 89.53 -8.05 80.65 Favored Glycine 0 C--N 1.28 -2.566 0 CA-C-N 114.263 -1.335 . . . . 1.7 110.992 -175.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 117' ' ' GLY . . . . . 0.61 ' O ' ' HB2' ' B' ' 112' ' ' PRO . . . 65.28 55.25 22.18 Favored Glycine 0 N--CA 1.421 -2.345 0 CA-C-O 122.451 1.028 . . . . 1.38 111.568 179.081 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 118' ' ' LYS . . . . . 0.655 ' HD3' ' O ' ' B' ' 115' ' ' PRO . 0.0 OUTLIER -94.32 -26.13 16.7 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 112.494 -1.853 . . . . 2.96 111.408 177.94 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 119' ' ' GLY . . . . . 0.848 ' O ' ' HA ' ' B' ' 112' ' ' PRO . . . -95.79 -175.61 36.73 Favored Glycine 0 C--O 1.212 -1.255 0 N-CA-C 116.728 1.451 . . . . 1.07 116.728 -176.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.881 ' HA ' ' O ' ' B' ' 111' ' ' LEU . 0.0 OUTLIER -105.12 142.44 34.89 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 112.729 -1.735 . . . . 3.29 114.71 -178.112 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 121' ' ' CYS . . . . . 0.657 ' C ' ' CD1' ' B' ' 122' ' ' PHE . 0.1 OUTLIER -108.05 169.92 8.32 Favored 'General case' 0 C--N 1.342 0.267 0 CA-C-N 113.573 -1.649 . . . . 1.21 109.3 -178.717 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 122' ' ' PHE . . . . . 0.657 ' CD1' ' C ' ' B' ' 121' ' ' CYS . 33.1 m-85 -156.81 52.55 0.51 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.032 0.444 . . . . 2.28 110.574 -179.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 123' ' ' GLY . . . . . 0.523 ' O ' ' SG ' ' B' ' 144' ' ' CYS . . . 133.09 -145.63 17.63 Favored Glycine 0 C--N 1.334 0.44 0 N-CA-C 111.322 -0.711 . . . . 1.04 111.322 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -95.02 -70.22 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 122.729 2.286 . . . . 1.84 112.064 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 125' ' ' SER . . . . . 0.651 ' O ' ' N ' ' B' ' 137' ' ' GLY . 2.8 m -92.27 45.08 1.19 Allowed 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.715 -0.476 . . . . 1.49 109.715 179.093 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 126' ' ' ILE . . . . . 0.803 ' CG2' ' HB3' ' B' ' 174' ' ' CYS . 3.4 mt -144.01 114.54 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 N-CA-C 112.317 0.488 . . . . 1.41 112.317 -177.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 127' ' ' CYS . . . . . 0.587 ' SG ' ' CE2' ' B' ' 135' ' ' PHE . 1.7 t -148.55 124.4 10.58 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 121.039 0.447 . . . . 0.89 110.887 179.368 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 128' ' ' CYS . . . . . 0.92 ' HA ' ' O ' ' B' ' 133' ' ' GLY . 0.8 OUTLIER -129.34 150.44 50.7 Favored 'General case' 0 CA--C 1.509 -0.619 0 CA-C-N 115.896 -0.593 . . . . 1.23 111.484 -178.868 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 129' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' B' ' 133' ' ' GLY . . . -141.67 -174.46 14.51 Favored Glycine 0 N--CA 1.422 -2.236 0 CA-C-N 120.089 1.313 . . . . 0.69 110.135 177.2 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -74.33 -44.55 52.01 Favored 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 126.215 1.806 . . . . 2.35 112.375 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -124.32 33.26 5.3 Favored 'General case' 0 CA--C 1.483 -1.606 0 CA-C-N 113.911 -1.495 . . . . 1.69 110.034 177.021 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 132' ' ' LEU . . . . . 0.837 HD12 ' HD2' ' B' ' 115' ' ' PRO . 0.9 OUTLIER -130.1 -37.7 1.46 Allowed 'General case' 0 N--CA 1.411 -2.38 0 CA-C-N 114.239 -1.346 . . . . 1.84 108.531 -179.418 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 133' ' ' GLY . . . . . 0.92 ' O ' ' HA ' ' B' ' 128' ' ' CYS . . . 79.25 -151.43 34.85 Favored Glycine 0 N--CA 1.435 -1.369 0 CA-C-N 113.585 -1.643 . . . . 0.76 111.195 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 134' ' ' CYS . . . . . 0.771 ' SG ' ' SG ' ' B' ' 174' ' ' CYS . 3.0 m -107.93 124.2 49.77 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-N 119.691 1.745 . . . . 1.08 112.084 -175.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 135' ' ' PHE . . . . . 0.996 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -121.09 106.97 12.05 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 104.499 -2.408 . . . . 1.83 104.499 174.263 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 136' ' ' VAL . . . . . 1.054 HG21 ' SG ' ' B' ' 179' ' ' CYS . 1.8 t -91.7 89.82 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.396 0 CA-C-O 122.091 0.948 . . . . 1.29 109.635 -178.235 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 137' ' ' GLY . . . . . 0.651 ' N ' ' O ' ' B' ' 125' ' ' SER . . . 87.56 88.59 1.09 Allowed Glycine 0 C--O 1.228 -0.231 0 CA-C-N 114.133 -1.394 . . . . 0.85 112.012 -179.115 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 138' ' ' THR . . . . . 0.47 ' H ' ' HB3' ' B' ' 141' ' ' ALA . 43.5 p -154.13 171.12 19.64 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 110.313 -0.255 . . . . 1.2 110.313 -179.252 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 139' ' ' ALA . . . . . 0.432 ' HA ' ' CD1' ' B' ' 142' ' ' LEU . . . -60.51 -39.48 87.94 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.484 -0.932 . . . . 1.35 108.484 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 140' ' ' GLU . . . . . 0.676 ' HB3' ' HA2' ' B' ' 114' ' ' GLY . 3.0 mm-40 -57.46 -33.61 68.15 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.307 -0.861 . . . . 2.31 110.094 178.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 141' ' ' ALA . . . . . 0.777 ' O ' ' HB2' ' B' ' 144' ' ' CYS . . . -82.11 -39.06 23.89 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 115.062 -0.972 . . . . 1.09 109.508 -179.067 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 142' ' ' LEU . . . . . 0.432 ' CD1' ' HA ' ' B' ' 139' ' ' ALA . 0.2 OUTLIER -38.94 -31.41 0.06 Allowed 'General case' 0 C--O 1.232 0.156 0 CA-C-N 117.871 0.305 . . . . 1.61 111.578 -178.483 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 143' ' ' ARG . . . . . 0.451 ' O ' ' N ' ' B' ' 145' ' ' GLN . 2.1 mmm180 -52.57 -28.93 23.01 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.401 -0.962 . . . . 3.43 108.401 176.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 144' ' ' CYS . . . . . 0.777 ' HB2' ' O ' ' B' ' 141' ' ' ALA . 0.1 OUTLIER -41.94 -8.11 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 113.648 -1.614 . . . . 1.61 115.002 -176.79 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 145' ' ' GLN . . . . . 0.451 ' N ' ' O ' ' B' ' 143' ' ' ARG . 0.3 OUTLIER -84.51 -0.19 52.13 Favored 'General case' 0 C--O 1.242 0.709 0 CA-C-O 122.525 1.155 . . . . 3.52 108.357 176.098 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -83.91 11.48 7.63 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 115.072 -0.967 . . . . 3.76 109.064 179.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 147' ' ' GLU . . . . . 0.401 ' HG3' HD21 ' B' ' 111' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.448 -0.546 0 N-CA-C 109.14 -0.689 . . . . 4.01 109.14 176.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 74.4 m . . . . . 0 CA--C 1.539 0.521 0 N-CA-C 113.508 0.929 . . . . 3.41 113.508 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 157' ' ' GLY . . . . . 0.43 ' O ' ' HB2' ' B' ' 166' ' ' ARG . . . -146.92 126.36 2.42 Favored Glycine 0 N--CA 1.439 -1.104 0 N-CA-C 109.794 -1.322 . . . . 2.26 109.794 178.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -112.55 68.02 0.67 Allowed 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 118.784 -1.166 . . . . 5.03 110.023 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 159' ' ' LYS . . . . . 0.826 ' CB ' ' HB2' ' B' ' 167' ' ' CYS . 0.1 OUTLIER -110.9 63.95 0.45 Allowed Pre-proline 0 C--N 1.318 -0.787 0 CA-C-N 113.875 -1.511 . . . . 3.96 112.059 174.514 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 160' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -55.37 86.78 0.04 OUTLIER 'Trans proline' 0 C--N 1.325 -0.682 0 C-N-CA 121.945 1.764 . . . . 1.7 116.391 -175.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 161' ' ' CYS . . . . . 0.649 ' N ' ' O ' ' B' ' 165' ' ' GLY . 1.4 m -98.81 -177.9 3.8 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.146 -1.427 . . . . 1.93 107.146 175.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 51.58 -167.27 0.71 Allowed Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.365 -0.921 . . . . 2.37 113.956 176.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 7.3 t -84.99 59.39 5.59 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 122.282 1.039 . . . . 4.56 111.664 -178.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 108.84 9.19 26.89 Favored Glycine 0 CA--C 1.544 1.9 0 CA-C-N 113.218 -1.81 . . . . 2.39 115.963 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 165' ' ' GLY . . . . . 0.649 ' O ' ' N ' ' B' ' 161' ' ' CYS . . . -102.59 141.76 15.34 Favored Glycine 0 C--N 1.312 -0.805 0 CA-C-N 121.631 2.716 . . . . 1.79 115.366 -176.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 166' ' ' ARG . . . . . 0.43 ' HB2' ' O ' ' B' ' 157' ' ' GLY . 0.0 OUTLIER -97.94 153.96 18.0 Favored 'General case' 0 N--CA 1.458 -0.056 0 CA-C-N 115.036 -0.582 . . . . 3.53 109.853 178.478 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 167' ' ' CYS . . . . . 0.826 ' HB2' ' CB ' ' B' ' 159' ' ' LYS . 3.6 t -45.42 109.57 0.18 Allowed 'General case' 0 CA--C 1.505 -0.75 0 CA-C-O 121.061 0.458 . . . . 1.56 111.975 -178.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 168' ' ' ALA . . . . . 0.74 ' HB2' ' HB3' ' B' ' 128' ' ' CYS . . . -99.83 -15.58 18.36 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 108.189 -1.041 . . . . 1.42 108.189 177.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -168.03 161.98 12.98 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 114.075 -1.42 . . . . 1.18 111.33 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 170' ' ' ALA . . . . . 0.548 ' HA ' ' HB3' ' B' ' 185' ' ' CYS . . . -72.98 74.94 1.19 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.375 0.607 . . . . 1.47 112.622 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 171' ' ' GLY . . . . . 0.742 ' O ' ' HA ' ' B' ' 181' ' ' GLU . . . 163.43 -52.9 0.3 Allowed Glycine 0 C--O 1.22 -0.724 0 CA-C-N 115.231 -0.895 . . . . 1.45 112.504 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 172' ' ' ILE . . . . . 0.645 HG12 ' O ' ' A' ' 36' ' ' VAL . 0.6 OUTLIER -124.17 139.72 49.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-O 122.93 1.348 . . . . 2.7 111.663 -175.998 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 173' ' ' CYS . . . . . 0.539 ' HB2' ' HB2' ' B' ' 161' ' ' CYS . 48.6 m -112.3 113.5 25.76 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.914 -1.039 . . . . 1.94 110.017 -179.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 174' ' ' CYS . . . . . 0.803 ' HB3' ' CG2' ' B' ' 126' ' ' ILE . 64.1 m -79.41 144.03 34.49 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 115.476 -0.784 . . . . 1.43 110.913 -178.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 175' ' ' SER . . . . . 0.669 ' HB2' ' HD2' ' B' ' 176' ' ' PRO . 59.8 p -136.68 179.86 1.25 Allowed Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 114.328 -1.305 . . . . 2.3 108.799 -178.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 176' ' ' PRO . . . . . 0.669 ' HD2' ' HB2' ' B' ' 175' ' ' SER . 66.9 Cg_endo -76.39 29.76 0.4 Allowed 'Trans proline' 0 N--CA 1.454 -0.835 0 N-CA-C 109.679 -0.931 . . . . 2.13 109.679 177.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 177' ' ' ASP . . . . . 0.57 ' H ' ' C ' ' B' ' 175' ' ' SER . 2.0 m-20 -144.01 -46.44 0.27 Allowed 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.237 -0.892 . . . . 2.72 111.145 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 178' ' ' GLY . . . . . 0.857 ' HA2' ' CG1' ' B' ' 136' ' ' VAL . . . -171.72 -155.42 10.88 Favored Glycine 0 C--N 1.342 0.874 0 C-N-CA 119.796 -1.192 . . . . 1.05 115.149 179.03 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 179' ' ' CYS . . . . . 1.054 ' SG ' HG21 ' B' ' 136' ' ' VAL . 10.0 m -140.32 136.18 32.95 Favored 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 107.027 -1.471 . . . . 1.39 107.027 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 180' ' ' HIS . . . . . 0.571 ' N ' HG22 ' B' ' 172' ' ' ILE . 0.2 OUTLIER -156.81 131.48 8.8 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 124.069 1.89 . . . . 2.73 111.824 -167.639 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 181' ' ' GLU . . . . . 0.742 ' HA ' ' O ' ' B' ' 171' ' ' GLY . 0.3 OUTLIER -45.87 141.23 3.16 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 110.326 -3.125 . . . . 3.06 109.851 -177.605 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 182' ' ' ASP . . . . . 0.68 ' OD1' ' HB2' ' B' ' 185' ' ' CYS . 3.1 p-10 -145.15 137.29 13.21 Favored Pre-proline 0 C--N 1.306 -1.291 0 CA-C-N 115.32 -0.854 . . . . 2.06 109.628 -178.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 183' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -57.73 -35.37 98.83 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.618 2.212 . . . . 2.27 114.425 -177.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -64.84 -51.57 61.37 Favored 'General case' 0 CA--C 1.508 -0.656 0 N-CA-C 108.701 -0.851 . . . . 1.56 108.701 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 185' ' ' CYS . . . . . 0.68 ' HB2' ' OD1' ' B' ' 182' ' ' ASP . 3.2 m -98.97 77.08 2.17 Favored 'General case' 0 CA--C 1.499 -0.998 0 N-CA-C 106.772 -1.566 . . . . 1.94 106.772 176.319 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 186' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.5 -0.943 0 C-N-CA 119.469 -0.892 . . . . 3.61 110.184 -178.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.2 m . . . . . 0 C--O 1.232 0.164 0 N-CA-C 112.628 0.603 . . . . 2.89 112.628 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.625 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 0.3 OUTLIER -36.18 112.5 0.52 Allowed Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.804 -0.634 . . . . 2.89 112.628 178.443 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.514 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 56.3 Cg_endo -91.75 145.22 3.11 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 121.696 1.597 . . . . 1.72 113.808 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.642 ' O ' ' HA2' ' A' ' 17' ' ' GLY . 20.8 p -146.12 -174.26 4.39 Favored 'General case' 0 C--N 1.347 0.487 0 C-N-CA 119.043 -1.063 . . . . 1.0 113.543 -179.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.601 ' HA2' ' HG3' ' A' ' 40' ' ' GLU . . . 73.99 -161.38 53.88 Favored Glycine 0 N--CA 1.451 -0.317 0 CA-C-N 115.3 -0.864 . . . . 1.15 113.547 177.333 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.606 ' O ' ' HG2' ' A' ' 15' ' ' PRO . 39.7 Cg_endo -63.26 101.03 0.28 Allowed 'Trans proline' 0 N--CA 1.481 0.785 0 C-N-CA 123.664 2.909 . . . . 1.6 109.211 176.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 82.85 13.21 78.33 Favored Glycine 0 C--N 1.291 -1.917 0 C-N-CA 120.847 -0.692 . . . . 1.68 111.993 178.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.642 ' HA2' ' O ' ' A' ' 13' ' ' CYS . . . 51.8 49.09 49.1 Favored Glycine 0 N--CA 1.409 -3.136 0 N-CA-C 107.897 -2.081 . . . . 1.37 107.897 174.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.518 ' HG3' ' O ' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -99.94 18.52 18.19 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 112.519 -1.841 . . . . 2.91 111.553 174.299 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.514 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -131.73 -177.7 15.05 Favored Glycine 0 N--CA 1.444 -0.789 0 N-CA-C 104.405 -3.478 . . . . 1.06 104.405 176.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.625 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -124.41 172.58 9.03 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 120.538 2.169 . . . . 3.32 109.453 178.754 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.473 ' HB2' ' HB3' ' A' ' 11' ' ' LEU . 0.8 OUTLIER -105.64 134.97 47.9 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 121.334 -0.854 . . . . 1.19 111.16 -178.367 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.5 ' HE2' ' HA ' ' A' ' 56' ' ' SER . 68.0 m-85 -128.2 13.79 6.68 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.3 -0.864 . . . . 2.26 111.253 -179.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -176.16 -167.82 35.49 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.391 -0.909 . . . . 1.05 112.525 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.494 ' O ' ' HB3' ' A' ' 44' ' ' CYS . 1.9 Cg_endo -81.76 -44.26 0.09 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.814 2.343 . . . . 1.81 112.746 -179.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.421 ' HB2' ' OE2' ' B' ' 181' ' ' GLU . 0.1 OUTLIER -124.62 16.03 8.8 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.938 0.399 . . . . 1.62 110.797 179.823 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.846 HG23 HG12 ' A' ' 36' ' ' VAL . 0.8 OUTLIER -126.23 121.76 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.09 0 CA-C-O 121.464 0.649 . . . . 1.39 111.563 -178.041 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.816 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -119.1 132.86 56.04 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-N 115.641 -0.709 . . . . 0.92 109.108 179.051 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 1.156 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -144.82 116.15 8.01 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 112.52 0.563 . . . . 1.28 112.52 -178.718 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.799 ' O ' ' HB3' ' A' ' 69' ' ' ALA . . . -107.43 -163.54 21.74 Favored Glycine 0 N--CA 1.428 -1.866 0 N-CA-C 109.806 -1.318 . . . . 0.71 109.806 177.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.656 ' O ' ' HB2' ' A' ' 70' ' ' ALA . 11.4 t70 -67.54 -60.37 2.61 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 113.885 1.069 . . . . 2.27 113.885 -179.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.51 9.33 23.2 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 115.661 -0.699 . . . . 1.66 111.122 -176.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.556 HD23 ' CZ ' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -109.71 -18.96 13.33 Favored 'General case' 0 N--CA 1.405 -2.687 0 N-CA-C 106.791 -1.559 . . . . 1.93 106.791 179.982 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 1.156 ' O ' ' HA ' ' A' ' 28' ' ' CYS . . . 68.8 -133.86 27.43 Favored Glycine 0 N--CA 1.43 -1.755 0 CA-C-N 114.919 -1.037 . . . . 0.77 115.257 173.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.845 ' HB2' HG13 ' A' ' 72' ' ' ILE . 3.1 t -136.26 117.69 14.74 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-N 118.387 1.094 . . . . 1.08 113.254 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.858 ' HA ' ' HA ' ' B' ' 135' ' ' PHE . 0.0 OUTLIER -100.03 108.67 20.91 Favored 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 106.786 -1.561 . . . . 1.85 106.786 176.984 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.846 HG12 HG23 ' A' ' 26' ' ' ILE . 1.7 t -90.92 87.07 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.304 0 CA-C-O 122.473 1.13 . . . . 1.29 110.269 -179.048 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.493 ' O ' HG21 ' A' ' 38' ' ' THR . . . 102.55 69.29 0.82 Allowed Glycine 0 C--O 1.228 -0.26 0 CA-C-N 112.99 -1.913 . . . . 0.85 113.953 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.493 HG21 ' O ' ' A' ' 37' ' ' GLY . 72.4 p -151.29 164.51 36.46 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 109.251 -0.648 . . . . 1.3 109.251 179.174 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.779 ' O ' HD11 ' A' ' 42' ' ' LEU . . . -70.62 -16.26 62.82 Favored 'General case' 0 N--CA 1.44 -0.968 0 C-N-CA 119.975 -0.69 . . . . 1.45 110.308 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.601 ' HG3' ' HA2' ' A' ' 14' ' ' GLY . 5.0 mp0 -67.57 -15.83 63.86 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.424 -0.954 . . . . 2.32 108.424 176.228 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 1.023 ' O ' ' HB2' ' A' ' 44' ' ' CYS . . . -120.91 -10.57 9.08 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-N 116.361 -0.381 . . . . 1.11 111.221 -178.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.834 HD13 ' N ' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -61.71 -20.4 63.46 Favored 'General case' 0 N--CA 1.45 -0.439 0 O-C-N 121.211 -0.93 . . . . 1.68 113.229 -177.867 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.834 ' N ' HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -71.6 -6.78 43.43 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 107.556 -1.276 . . . . 3.4 107.556 174.95 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 1.023 ' HB2' ' O ' ' A' ' 41' ' ' ALA . 0.2 OUTLIER -66.53 -1.54 3.73 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 112.361 -2.2 . . . . 1.57 110.012 176.462 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -82.84 -17.35 44.26 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.02 0.438 . . . . 3.49 111.457 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -85.51 6.42 27.08 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 120.107 -0.637 . . . . 3.69 109.892 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.434 ' HG3' HD11 ' A' ' 11' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.446 -0.634 0 N-CA-C 109.416 -0.587 . . . . 3.99 109.416 177.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.5 ' HA ' ' HE2' ' A' ' 22' ' ' PHE . 0.3 OUTLIER . . . . . 0 C--O 1.234 0.289 0 N-CA-C 111.441 0.163 . . . . 3.36 111.441 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 160.41 133.73 1.54 Allowed Glycine 0 N--CA 1.444 -0.819 0 N-CA-C 106.509 -2.637 . . . . 2.3 106.509 -179.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -109.0 76.9 1.03 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 118.991 1.396 . . . . 5.06 111.614 -177.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.477 ' N ' ' CD ' ' A' ' 60' ' ' PRO . 0.4 OUTLIER -145.79 57.19 3.88 Favored Pre-proline 0 C--N 1.309 -1.175 0 N-CA-C 106.33 -1.73 . . . . 3.91 106.33 176.799 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.477 ' CD ' ' N ' ' A' ' 59' ' ' LYS . 41.0 Cg_endo -70.3 81.76 0.92 Allowed 'Trans proline' 0 N--CA 1.448 -1.159 0 C-N-CA 122.096 1.864 . . . . 1.74 113.772 -178.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -103.08 179.31 4.31 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 106.988 -1.486 . . . . 1.9 106.988 177.127 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.16 -169.34 46.49 Favored Glycine 0 N--CA 1.437 -1.246 0 C-N-CA 118.656 -1.735 . . . . 2.43 114.607 178.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 50.2 p -85.46 47.26 1.4 Allowed 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 113.504 -1.348 . . . . 4.32 111.394 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 118.06 5.9 12.93 Favored Glycine 0 C--N 1.336 0.552 0 N-CA-C 115.828 1.091 . . . . 2.4 115.828 175.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.418 ' HA3' ' HA ' ' A' ' 74' ' ' CYS . . . -105.77 137.41 13.76 Favored Glycine 0 CA--C 1.52 0.385 0 N-CA-C 117.044 1.577 . . . . 1.82 117.044 -177.103 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.427 ' HA ' ' O ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -107.41 153.76 22.32 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 114.176 -1.012 . . . . 3.51 109.111 177.668 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.76 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 2.2 m -59.41 107.64 0.6 Allowed 'General case' 0 N--CA 1.441 -0.891 0 O-C-N 121.968 -0.457 . . . . 1.52 111.442 -177.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -84.21 -20.23 32.68 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.308 -0.627 . . . . 1.5 109.308 177.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.799 ' HB3' ' O ' ' A' ' 29' ' ' GLY . . . -166.46 164.07 17.23 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.776 -0.647 . . . . 1.31 111.62 179.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.656 ' HB2' ' O ' ' A' ' 30' ' ' ASP . . . -39.76 96.9 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.778 -0.646 . . . . 1.5 110.185 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.653 ' HA2' ' O ' ' A' ' 82' ' ' ASP . . . 73.57 50.23 12.32 Favored Glycine 0 CA--C 1.504 -0.655 0 CA-C-N 114.877 -1.056 . . . . 1.44 111.456 -179.126 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.845 HG13 ' HB2' ' A' ' 34' ' ' CYS . 0.5 OUTLIER -137.51 98.88 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.817 0 N-CA-C 108.049 -1.093 . . . . 2.77 108.049 170.969 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.452 ' O ' ' HB2' ' A' ' 80' ' ' HIS . 51.2 t -91.91 96.27 10.29 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 108.613 -0.884 . . . . 1.98 108.613 179.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 1.04 ' CB ' ' HA ' ' A' ' 79' ' ' CYS . 24.4 p -167.3 -171.57 1.75 Allowed 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 116.577 2.066 . . . . 1.43 116.577 -176.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.85 ' HB3' ' HD2' ' A' ' 76' ' ' PRO . 72.8 m -124.6 -178.9 0.74 Allowed Pre-proline 0 CA--C 1.531 0.225 0 CA-C-N 112.927 -1.942 . . . . 2.37 108.564 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.85 ' HD2' ' HB3' ' A' ' 75' ' ' SER . 58.0 Cg_endo -73.16 31.17 0.3 Allowed 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 121.717 1.611 . . . . 2.09 113.172 -179.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.424 ' H ' ' C ' ' A' ' 75' ' ' SER . 10.7 t70 -134.36 -60.94 0.79 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.85 0.357 . . . . 2.65 110.221 178.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.929 ' O ' ' HB2' ' A' ' 74' ' ' CYS . . . -118.22 -178.51 17.14 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.95 -0.643 . . . . 1.04 111.661 178.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 1.04 ' HA ' ' CB ' ' A' ' 74' ' ' CYS . 22.5 m -152.27 161.37 42.72 Favored 'General case' 0 C--O 1.226 -0.169 0 N-CA-C 112.428 0.529 . . . . 1.42 112.428 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.501 ' HA ' ' HA2' ' B' ' 178' ' ' GLY . 7.1 m80 -143.17 139.04 30.16 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-O 121.173 0.511 . . . . 2.81 111.823 -178.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.459 ' OE2' ' HB2' ' B' ' 125' ' ' SER . 37.0 tt0 -65.51 122.97 18.43 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-N 115.671 -0.695 . . . . 3.05 109.605 178.114 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.653 ' O ' ' HA2' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -138.9 106.75 7.47 Favored Pre-proline 0 C--N 1.319 -0.749 0 C-N-CA 118.963 -1.095 . . . . 2.02 111.385 179.424 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -63.85 -16.65 56.07 Favored 'Trans proline' 0 C--N 1.356 0.948 0 C-N-CA 123.004 2.47 . . . . 2.29 114.315 -178.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.08 -40.16 96.86 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.108 0.48 . . . . 1.53 110.542 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.632 ' O ' ' N ' ' A' ' 71' ' ' GLY . 68.8 m -94.18 46.74 1.17 Allowed 'General case' 0 C--O 1.219 -0.55 0 CA-C-N 115.484 -0.78 . . . . 1.88 110.351 179.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.475 0.803 0 O-C-N 121.544 -0.722 . . . . 3.6 112.027 -178.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 110' ' ' CYS . . . . . . . . . . . . . 1.2 m . . . . . 0 CA--C 1.52 -0.2 0 CA-C-O 121.247 0.546 . . . . 2.87 111.457 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 111' ' ' LEU . . . . . 0.698 ' O ' ' HA ' ' B' ' 120' ' ' ARG . 0.2 OUTLIER -37.92 112.08 0.61 Allowed Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.007 -0.997 . . . . 2.95 112.367 176.864 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 112' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -84.49 153.28 12.02 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.339 2.026 . . . . 1.71 111.018 178.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.469 ' O ' ' HA2' ' B' ' 117' ' ' GLY . 20.0 p -154.33 -174.71 5.07 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 113.638 0.977 . . . . 1.0 113.638 174.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 114' ' ' GLY . . . . . 0.579 ' HA2' ' HG3' ' B' ' 140' ' ' GLU . . . 73.54 -161.44 54.15 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.151 -0.931 . . . . 1.16 113.529 177.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 115' ' ' PRO . . . . . 0.516 ' O ' ' HG3' ' B' ' 118' ' ' LYS . 42.8 Cg_endo -64.57 95.74 0.23 Allowed 'Trans proline' 0 C--O 1.224 -0.182 0 C-N-CA 123.11 2.54 . . . . 1.6 112.5 177.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 87.65 11.41 68.5 Favored Glycine 0 C--N 1.283 -2.403 0 CA-C-N 114.767 -1.106 . . . . 1.7 113.228 -178.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 117' ' ' GLY . . . . . 0.469 ' HA2' ' O ' ' B' ' 113' ' ' CYS . . . 62.11 39.41 97.6 Favored Glycine 0 N--CA 1.414 -2.822 0 C-N-CA 118.002 -2.047 . . . . 1.38 111.438 176.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 118' ' ' LYS . . . . . 0.516 ' HG3' ' O ' ' B' ' 115' ' ' PRO . 0.0 OUTLIER -91.85 7.06 43.69 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 113.904 -1.148 . . . . 2.96 112.094 179.644 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . -115.93 -159.5 11.97 Favored Glycine 0 C--N 1.343 0.961 0 N-CA-C 108.139 -1.984 . . . . 1.07 108.139 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.698 ' HA ' ' O ' ' B' ' 111' ' ' LEU . 0.0 OUTLIER -145.37 170.46 16.29 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 121.098 2.449 . . . . 3.29 105.844 174.685 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 121' ' ' CYS . . . . . 0.47 ' HB2' ' HB3' ' B' ' 111' ' ' LEU . 0.9 OUTLIER -106.26 135.61 47.45 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 119.115 0.87 . . . . 1.21 111.942 -176.769 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 122' ' ' PHE . . . . . 0.555 ' HE2' ' HA ' ' B' ' 156' ' ' SER . 68.7 m-85 -128.12 13.71 6.72 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.038 -0.983 . . . . 2.28 111.287 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -176.16 -167.81 35.49 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.339 -0.934 . . . . 1.04 112.56 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . 0.469 ' O ' ' HB3' ' B' ' 144' ' ' CYS . 2.0 Cg_endo -81.68 -44.37 0.09 OUTLIER 'Trans proline' 0 CA--C 1.532 0.423 0 C-N-CA 122.701 2.267 . . . . 1.84 112.791 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 125' ' ' SER . . . . . 0.459 ' HB2' ' OE2' ' A' ' 81' ' ' GLU . 0.1 OUTLIER -124.73 16.54 8.73 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.983 0.421 . . . . 1.49 110.722 179.823 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 126' ' ' ILE . . . . . 0.76 HG12 HG13 ' B' ' 136' ' ' VAL . 1.0 OUTLIER -126.44 121.63 59.3 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 CA-C-O 121.454 0.645 . . . . 1.41 111.57 -178.106 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 127' ' ' CYS . . . . . 0.734 ' HB2' ' CB ' ' B' ' 141' ' ' ALA . 0.1 OUTLIER -119.28 133.59 55.67 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-N 115.578 -0.737 . . . . 0.89 109.078 178.912 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 128' ' ' CYS . . . . . 1.197 ' HA ' ' O ' ' B' ' 133' ' ' GLY . 0.0 OUTLIER -145.53 120.5 10.02 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 118.246 -0.883 . . . . 1.23 111.145 -179.171 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 129' ' ' GLY . . . . . 0.43 ' O ' ' HB2' ' B' ' 169' ' ' ALA . . . -114.69 -156.95 11.56 Favored Glycine 0 N--CA 1.417 -2.613 0 N-CA-C 107.555 -2.218 . . . . 0.69 107.555 176.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 130' ' ' ASP . . . . . 0.744 ' O ' ' HB2' ' B' ' 170' ' ' ALA . 8.0 t70 -65.85 -71.0 0.21 Allowed 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 122.168 0.187 . . . . 2.35 111.493 -178.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.47 32.25 5.52 Favored 'General case' 0 CA--C 1.498 -1.024 0 C-N-CA 120.095 -0.642 . . . . 1.69 110.027 -175.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 132' ' ' LEU . . . . . 0.521 HD23 ' CE1' ' B' ' 135' ' ' PHE . 0.8 OUTLIER -124.79 -18.88 5.46 Favored 'General case' 0 N--CA 1.403 -2.802 0 N-CA-C 104.898 -2.26 . . . . 1.84 104.898 176.127 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 133' ' ' GLY . . . . . 1.197 ' O ' ' HA ' ' B' ' 128' ' ' CYS . . . 66.86 -134.96 32.33 Favored Glycine 0 N--CA 1.407 -3.269 0 CA-C-N 115.134 -0.939 . . . . 0.76 114.769 173.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 134' ' ' CYS . . . . . 0.854 ' HB2' HG13 ' B' ' 172' ' ' ILE . 2.7 t -135.14 116.44 14.52 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 114.141 1.163 . . . . 1.08 114.141 -177.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 135' ' ' PHE . . . . . 0.858 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -98.16 107.68 20.21 Favored 'General case' 0 CA--C 1.503 -0.857 0 N-CA-C 107.068 -1.456 . . . . 1.83 107.068 177.158 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 136' ' ' VAL . . . . . 0.76 HG13 HG12 ' B' ' 126' ' ' ILE . 2.2 t -90.99 86.57 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.324 0 CA-C-O 122.611 1.196 . . . . 1.29 109.792 -179.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 137' ' ' GLY . . . . . 0.454 ' O ' ' HA3' ' A' ' 33' ' ' GLY . . . 102.47 68.92 0.81 Allowed Glycine 0 C--N 1.321 -0.285 0 CA-C-N 112.85 -1.977 . . . . 0.85 114.135 179.403 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 138' ' ' THR . . . . . 0.502 HG22 ' O ' ' A' ' 32' ' ' LEU . 81.2 p -146.45 173.15 12.55 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.824 -0.806 . . . . 1.2 108.824 178.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 139' ' ' ALA . . . . . 0.777 ' O ' HD11 ' B' ' 142' ' ' LEU . . . -78.35 -17.36 56.61 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 120.197 -0.601 . . . . 1.35 109.669 177.169 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 140' ' ' GLU . . . . . 0.579 ' HG3' ' HA2' ' B' ' 114' ' ' GLY . 5.3 mp0 -67.48 -14.33 62.83 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.86 -0.793 . . . . 2.31 108.86 176.11 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 141' ' ' ALA . . . . . 1.016 ' O ' ' HB2' ' B' ' 144' ' ' CYS . . . -120.42 -15.59 8.53 Favored 'General case' 0 C--O 1.218 -0.585 0 CA-C-N 115.198 -0.91 . . . . 1.09 111.802 -179.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 142' ' ' LEU . . . . . 0.829 HD13 ' N ' ' B' ' 143' ' ' ARG . 0.0 OUTLIER -59.91 -21.15 60.71 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 113.529 0.937 . . . . 1.61 113.529 -176.569 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 143' ' ' ARG . . . . . 0.829 ' N ' HD13 ' B' ' 142' ' ' LEU . 0.0 OUTLIER -64.32 -20.63 66.22 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 105.966 -1.865 . . . . 3.43 105.966 175.222 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 144' ' ' CYS . . . . . 1.016 ' HB2' ' O ' ' B' ' 141' ' ' ALA . 0.2 OUTLIER -59.28 2.49 0.06 Allowed 'General case' 0 N--CA 1.486 1.374 0 CA-C-N 113.521 -1.672 . . . . 1.61 110.578 -177.985 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 145' ' ' GLN . . . . . 0.572 ' H ' ' C ' ' B' ' 143' ' ' ARG . 14.4 mm100 -84.03 -17.46 40.32 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.039 0.447 . . . . 3.52 111.004 178.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -85.69 6.49 27.42 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 120.147 -0.621 . . . . 3.76 109.808 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 147' ' ' GLU . . . . . 0.426 ' HG3' HD11 ' B' ' 111' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.446 -0.633 0 C-N-CA 120.241 -0.584 . . . . 4.01 109.508 177.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 156' ' ' SER . . . . . 0.555 ' HA ' ' HE2' ' B' ' 122' ' ' PHE . 0.3 OUTLIER . . . . . 0 CA--C 1.535 0.396 0 N-CA-C 108.997 -0.742 . . . . 3.41 108.997 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 165.68 136.63 2.05 Favored Glycine 0 CA--C 1.501 -0.798 0 N-CA-C 108.291 -1.924 . . . . 2.26 108.291 -178.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -110.91 64.63 0.61 Allowed 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 117.013 -1.875 . . . . 5.03 112.682 -178.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 159' ' ' LYS . . . . . 0.458 ' HB3' ' SG ' ' B' ' 167' ' ' CYS . 0.2 OUTLIER -118.19 53.63 1.75 Allowed Pre-proline 0 C--N 1.315 -0.893 0 CA-C-N 113.686 -1.597 . . . . 3.96 110.048 170.175 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 160' ' ' PRO . . . . . 0.4 ' HA ' ' HA ' ' B' ' 166' ' ' ARG . 37.7 Cg_endo -69.79 83.9 0.68 Allowed 'Trans proline' 0 CA--C 1.519 -0.244 0 CA-C-N 122.153 1.805 . . . . 1.7 114.46 -173.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 161' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -97.13 -170.91 2.11 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 113.8 -1.545 . . . . 1.93 107.761 178.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 55.87 -167.53 3.27 Favored Glycine 0 N--CA 1.439 -1.159 0 C-N-CA 119.645 -1.264 . . . . 2.37 114.779 173.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 78.8 p -85.65 47.03 1.37 Allowed 'General case' 0 C--N 1.309 -1.168 0 C-N-CA 126.637 1.975 . . . . 4.56 111.66 -179.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 118.35 5.11 13.19 Favored Glycine 0 C--N 1.347 1.189 0 CA-C-N 112.863 -1.971 . . . . 2.39 116.004 173.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 165' ' ' GLY . . . . . 0.424 ' HA3' ' HA ' ' B' ' 174' ' ' CYS . . . -104.0 137.97 13.82 Favored Glycine 0 CA--C 1.522 0.473 0 C-N-CA 118.837 -1.649 . . . . 1.79 117.081 -176.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 166' ' ' ARG . . . . . 0.451 ' HA ' ' O ' ' B' ' 159' ' ' LYS . 0.0 OUTLIER -107.96 153.69 22.7 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 114.006 -1.097 . . . . 3.53 108.99 177.03 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 167' ' ' CYS . . . . . 0.771 ' HA ' ' O ' ' B' ' 172' ' ' ILE . 2.0 m -59.52 107.54 0.6 Allowed 'General case' 0 N--CA 1.438 -1.049 0 O-C-N 121.832 -0.542 . . . . 1.56 111.479 -177.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 168' ' ' ALA . . . . . . . . . . . . . . . -81.62 -24.65 36.26 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 108.808 -0.812 . . . . 1.42 108.808 177.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 169' ' ' ALA . . . . . 0.652 ' HB2' ' HA2' ' B' ' 133' ' ' GLY . . . -163.52 163.94 24.51 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 115.169 -0.923 . . . . 1.18 112.782 -178.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 170' ' ' ALA . . . . . 0.744 ' HB2' ' O ' ' B' ' 130' ' ' ASP . . . -40.97 97.77 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.563 -0.744 . . . . 1.47 110.115 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 171' ' ' GLY . . . . . 0.728 ' HA2' ' O ' ' B' ' 182' ' ' ASP . . . 88.19 20.73 48.18 Favored Glycine 0 N--CA 1.443 -0.876 0 N-CA-C 115.559 0.983 . . . . 1.45 115.559 179.017 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 172' ' ' ILE . . . . . 0.854 HG13 ' HB2' ' B' ' 134' ' ' CYS . 0.3 OUTLIER -120.19 99.25 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 CA-C-N 117.229 0.515 . . . . 2.7 110.908 -179.801 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 173' ' ' CYS . . . . . 0.444 ' O ' ' HB2' ' B' ' 180' ' ' HIS . 53.2 t -91.51 96.29 10.41 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 108.932 -0.766 . . . . 1.94 108.932 178.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 174' ' ' CYS . . . . . 1.053 ' CB ' ' HA ' ' B' ' 179' ' ' CYS . 21.9 p -167.67 -171.67 1.69 Allowed 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 116.53 2.048 . . . . 1.43 116.53 -176.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 175' ' ' SER . . . . . 0.864 ' HB3' ' HD2' ' B' ' 176' ' ' PRO . 72.3 m -124.48 -178.82 0.73 Allowed Pre-proline 0 CA--C 1.531 0.241 0 CA-C-N 112.981 -1.918 . . . . 2.3 108.537 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 176' ' ' PRO . . . . . 0.864 ' HD2' ' HB3' ' B' ' 175' ' ' SER . 57.9 Cg_endo -73.28 31.13 0.31 Allowed 'Trans proline' 0 CA--C 1.533 0.435 0 C-N-CA 121.725 1.617 . . . . 2.13 113.092 -179.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 177' ' ' ASP . . . . . 0.424 ' H ' ' C ' ' B' ' 175' ' ' SER . 10.8 t70 -134.32 -60.83 0.79 Allowed 'General case' 0 C--O 1.234 0.277 0 CA-C-O 120.914 0.387 . . . . 2.72 110.267 178.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 178' ' ' GLY . . . . . 0.915 ' O ' ' HB2' ' B' ' 174' ' ' CYS . . . -118.15 -178.52 17.18 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 121.006 -0.616 . . . . 1.05 111.668 178.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 179' ' ' CYS . . . . . 1.053 ' HA ' ' CB ' ' B' ' 174' ' ' CYS . 21.7 m -152.24 161.34 42.76 Favored 'General case' 0 N--CA 1.462 0.127 0 N-CA-C 112.453 0.538 . . . . 1.39 112.453 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 180' ' ' HIS . . . . . 0.497 ' HA ' ' HA2' ' A' ' 78' ' ' GLY . 7.1 m80 -143.15 139.08 30.22 Favored 'General case' 0 CA--C 1.517 -0.295 0 O-C-N 121.897 -0.502 . . . . 2.73 111.763 -178.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 181' ' ' GLU . . . . . 0.421 ' OE2' ' HB2' ' A' ' 25' ' ' SER . 37.4 tt0 -65.57 123.0 18.51 Favored 'General case' 0 CA--C 1.503 -0.858 0 CA-C-N 115.674 -0.694 . . . . 3.06 109.586 178.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 182' ' ' ASP . . . . . 0.728 ' O ' ' HA2' ' B' ' 171' ' ' GLY . 0.0 OUTLIER -138.81 106.6 7.52 Favored Pre-proline 0 C--N 1.319 -0.757 0 C-N-CA 118.957 -1.097 . . . . 2.06 111.346 179.466 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 183' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -63.6 -16.85 57.16 Favored 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 123.034 2.489 . . . . 2.27 114.391 -178.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -63.02 -40.2 97.03 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.177 0.513 . . . . 1.56 110.512 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 185' ' ' CYS . . . . . 0.601 ' O ' ' N ' ' B' ' 171' ' ' GLY . 69.5 m -94.0 46.83 1.18 Allowed 'General case' 0 C--O 1.217 -0.613 0 CA-C-N 115.576 -0.738 . . . . 1.94 110.399 179.322 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 186' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.473 0.719 0 O-C-N 121.518 -0.739 . . . . 3.61 111.861 -178.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.534 0.332 0 N-CA-C 112.329 0.492 . . . . 2.89 112.329 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.797 HD21 ' HB3' ' A' ' 21' ' ' CYS . 15.0 tp -36.93 114.41 0.64 Allowed Pre-proline 0 N--CA 1.476 0.869 0 N-CA-C 114.054 1.131 . . . . 2.89 114.054 179.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.497 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 52.0 Cg_endo -95.73 134.83 0.57 Allowed 'Trans proline' 0 CA--C 1.534 0.513 0 C-N-CA 122.167 1.911 . . . . 1.72 115.216 179.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.663 ' O ' ' HA2' ' A' ' 17' ' ' GLY . 0.5 OUTLIER -140.65 -169.06 2.71 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 113.444 0.905 . . . . 1.0 113.444 -178.389 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.561 ' HA2' ' HB3' ' A' ' 40' ' ' GLU . . . 77.09 -156.18 45.21 Favored Glycine 0 C--N 1.337 0.605 0 CA-C-N 114.932 -1.031 . . . . 1.15 111.899 178.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.721 ' O ' ' HG2' ' A' ' 15' ' ' PRO . 41.4 Cg_endo -62.8 113.44 1.98 Allowed 'Trans proline' 0 N--CA 1.479 0.667 0 C-N-CA 122.783 2.322 . . . . 1.6 106.193 176.161 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 73.3 -7.12 12.25 Favored Glycine 0 C--N 1.276 -2.776 0 CA-C-O 119.067 -0.852 . . . . 1.68 112.73 175.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.663 ' HA2' ' O ' ' A' ' 13' ' ' CYS . . . 77.61 49.69 7.06 Favored Glycine 1 N--CA 1.383 -4.858 0 C-N-CA 118.295 -1.907 . . . . 1.37 111.515 -179.42 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.426 ' CG ' ' O ' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -99.61 9.46 43.11 Favored 'General case' 0 C--N 1.342 0.278 0 CA-C-N 112.864 -1.668 . . . . 2.91 111.946 175.643 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.497 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -124.63 -167.92 12.73 Favored Glycine 0 C--N 1.333 0.404 0 N-CA-C 106.465 -2.654 . . . . 1.06 106.465 178.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.695 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 0.6 OUTLIER -135.98 158.56 44.09 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 121.056 2.428 . . . . 3.32 108.184 -179.925 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.797 ' HB3' HD21 ' A' ' 11' ' ' LEU . 1.7 t -107.65 160.49 15.66 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 112.883 0.697 . . . . 1.19 112.883 -178.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.558 ' HE1' ' O ' ' A' ' 28' ' ' CYS . 60.7 m-85 -126.38 -47.46 1.59 Allowed 'General case' 0 C--N 1.339 0.143 0 CA-C-N 115.538 -0.755 . . . . 2.26 110.184 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -117.46 -159.62 11.46 Favored Glycine 0 CA--C 1.521 0.414 0 CA-C-N 115.723 -0.671 . . . . 1.05 111.559 179.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -84.33 -68.1 0.01 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.32 2.013 . . . . 1.81 111.657 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.409 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.4 OUTLIER -89.41 26.54 1.66 Allowed 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.867 -0.42 . . . . 1.62 109.867 178.753 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 1.024 HG23 HG12 ' A' ' 36' ' ' VAL . 5.6 mt -144.82 112.81 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 CA-C-O 121.875 0.845 . . . . 1.39 111.771 -178.287 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.617 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 4.7 t -126.57 131.3 51.56 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 114.991 -1.004 . . . . 0.92 109.451 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.843 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -142.44 123.12 14.21 Favored 'General case' 0 CA--C 1.561 1.374 0 N-CA-C 115.38 1.622 . . . . 1.28 115.38 -177.358 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -109.37 -170.34 20.5 Favored Glycine 0 C--N 1.368 2.31 0 N-CA-C 109.117 -1.593 . . . . 0.71 109.117 175.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -66.07 -56.07 13.39 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 114.573 1.323 . . . . 2.27 114.573 -178.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.45 -1.11 16.03 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 122.129 0.966 . . . . 1.66 111.234 -177.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.929 HD21 ' CZ ' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -97.39 -13.0 22.1 Favored 'General case' 0 N--CA 1.407 -2.587 0 N-CA-C 106.531 -1.655 . . . . 1.93 106.531 179.937 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.883 ' HA2' ' CB ' ' A' ' 69' ' ' ALA . . . 58.78 -132.66 52.66 Favored Glycine 0 C--O 1.197 -2.168 0 CA-C-O 118.165 -1.353 . . . . 0.77 112.28 175.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.895 ' HB2' HD13 ' A' ' 72' ' ' ILE . 2.4 t -135.39 122.21 21.08 Favored 'General case' 0 CA--C 1.486 -1.517 0 CA-C-N 118.496 1.148 . . . . 1.08 113.748 -179.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.929 ' CZ ' HD21 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -97.69 100.63 12.02 Favored 'General case' 0 N--CA 1.427 -1.606 0 N-CA-C 103.296 -2.853 . . . . 1.85 103.296 175.426 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 1.024 HG12 HG23 ' A' ' 26' ' ' ILE . 2.1 t -92.12 83.66 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 CA-C-O 123.319 1.533 . . . . 1.29 107.139 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.828 ' HA3' HG23 ' B' ' 172' ' ' ILE . . . 100.43 85.71 1.87 Allowed Glycine 0 CA--C 1.525 0.689 0 CA-C-N 112.42 -2.173 . . . . 0.85 113.67 -179.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.68 HG22 ' HD1' ' B' ' 135' ' ' PHE . 67.0 p -161.56 159.49 27.82 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 109.631 -0.507 . . . . 1.3 109.631 179.298 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.615 ' HA ' HD11 ' A' ' 42' ' ' LEU . . . -62.15 -23.07 66.36 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 118.666 0.666 . . . . 1.45 111.242 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.561 ' HB3' ' HA2' ' A' ' 14' ' ' GLY . 3.2 mm-40 -68.75 -13.05 62.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.795 -0.639 . . . . 2.32 109.704 176.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.551 ' O ' ' HB2' ' A' ' 44' ' ' CYS . . . -100.3 -24.36 14.55 Favored 'General case' 0 C--O 1.205 -1.24 0 N-CA-C 109.154 -0.684 . . . . 1.11 109.154 178.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.615 HD11 ' HA ' ' A' ' 39' ' ' ALA . 26.4 mt -42.5 -38.49 1.95 Allowed 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.31 0.485 . . . . 1.68 112.31 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.643 ' HD3' ' O ' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -69.25 -6.25 28.05 Favored 'General case' 0 CA--C 1.556 1.197 0 CA-C-O 121.822 0.82 . . . . 3.4 110.733 179.348 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.551 ' HB2' ' O ' ' A' ' 41' ' ' ALA . 65.7 m -72.59 -18.21 61.62 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 113.829 -1.532 . . . . 1.57 109.715 177.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -55.48 -17.17 4.7 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.667 -0.697 . . . . 3.49 111.471 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -84.43 5.64 26.48 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 120.444 -0.502 . . . . 3.69 110.063 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 . . . . . 0 N--CA 1.452 -0.345 0 CA-C-N 115.89 -0.595 . . . . 3.99 109.833 177.755 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.754 ' OG ' ' HG3' ' A' ' 59' ' ' LYS . 0.4 OUTLIER . . . . . 0 N--CA 1.477 0.916 0 N-CA-C 108.72 -0.845 . . . . 3.36 108.72 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 103.87 -108.73 3.25 Favored Glycine 0 CA--C 1.479 -2.167 0 N-CA-C 110.806 -0.918 . . . . 2.3 110.806 -178.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.467 ' HB2' ' HB3' ' A' ' 67' ' ' CYS . 3.5 mt-30 -112.56 115.85 29.28 Favored 'General case' 0 N--CA 1.422 -1.85 0 N-CA-C 102.889 -3.004 . . . . 5.06 102.889 175.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.906 ' HB3' ' CD ' ' A' ' 60' ' ' PRO . 0.0 OUTLIER -99.22 -100.11 0.0 OUTLIER Pre-proline 0 C--N 1.305 -1.329 0 CA-C-O 114.575 -2.631 . . . . 3.91 109.558 -173.273 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.906 ' CD ' ' HB3' ' A' ' 59' ' ' LYS . 9.7 Cg_endo -49.84 127.04 17.99 Favored 'Trans proline' 0 N--CA 1.474 0.354 0 CA-C-N 127.036 3.549 . . . . 1.74 118.437 -176.024 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.477 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 5.0 t -145.3 -172.98 3.98 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 110.793 -2.912 . . . . 1.9 106.637 177.08 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 37.89 -162.49 0.01 OUTLIER Glycine 0 N--CA 1.485 1.932 0 N-CA-C 114.857 0.703 . . . . 2.43 114.857 175.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 71.2 m -82.78 51.8 1.98 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 120.438 -0.505 . . . . 4.32 109.887 178.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 112.66 2.26 25.71 Favored Glycine 0 CA--C 1.539 1.548 0 C-N-CA 120.742 -0.742 . . . . 2.4 113.467 -178.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.702 ' HA2' ' HA ' ' A' ' 75' ' ' SER . . . -98.62 129.14 9.8 Favored Glycine 0 N--CA 1.464 0.564 0 C-N-CA 120.646 -0.788 . . . . 1.82 112.461 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.685 ' HA ' ' O ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -78.62 150.36 32.71 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-O 121.039 0.447 . . . . 3.51 111.592 -177.749 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.467 ' HB3' ' HB2' ' A' ' 58' ' ' GLN . 9.1 t -70.77 109.54 5.03 Favored 'General case' 0 N--CA 1.397 -3.086 0 N-CA-C 109.24 -0.652 . . . . 1.52 109.24 -178.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.571 ' HB1' ' SG ' ' A' ' 28' ' ' CYS . . . -85.23 -21.5 29.07 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.775 0.798 . . . . 1.5 108.865 178.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.883 ' CB ' ' HA2' ' A' ' 33' ' ' GLY . . . -168.8 161.18 10.9 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.163 -1.381 . . . . 1.31 109.092 -178.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.77 ' HA ' ' HB3' ' A' ' 85' ' ' CYS . . . -55.01 140.18 38.55 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 118.176 0.444 . . . . 1.5 111.138 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.609 ' H ' ' CB ' ' A' ' 85' ' ' CYS . . . 75.14 -44.44 1.6 Allowed Glycine 0 CA--C 1.529 0.943 0 CA-C-N 116.202 -0.453 . . . . 1.44 113.779 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.897 HG23 ' HA3' ' B' ' 137' ' ' GLY . 1.6 pp -97.54 99.14 8.3 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.952 0 CA-C-O 122.142 0.973 . . . . 2.77 111.737 -177.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.477 ' HB3' ' HB3' ' A' ' 61' ' ' CYS . 34.2 m -93.21 104.26 16.46 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 115.531 -0.759 . . . . 1.98 109.302 179.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 1.02 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 33.8 m -84.7 124.63 31.73 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.439 -0.801 . . . . 1.43 112.459 -177.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.933 ' HB3' ' HD2' ' A' ' 76' ' ' PRO . 49.5 m -84.58 -178.52 1.19 Allowed Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 115.067 -0.97 . . . . 2.37 110.431 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.933 ' HD2' ' HB3' ' A' ' 75' ' ' SER . 74.1 Cg_endo -75.7 30.3 0.38 Allowed 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 121.672 1.581 . . . . 2.09 111.942 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.825 ' HB2' ' ND1' ' B' ' 180' ' ' HIS . 2.8 p30 -145.51 -28.41 0.44 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.602 -0.726 . . . . 2.65 110.536 179.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.779 ' HA3' ' O ' ' B' ' 179' ' ' CYS . . . -177.68 -133.17 1.81 Allowed Glycine 0 CA--C 1.521 0.437 0 C-N-CA 121.153 -0.546 . . . . 1.04 112.141 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 1.02 ' HA ' ' HA ' ' A' ' 74' ' ' CYS . 80.4 m -128.43 148.62 50.72 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 109.635 -0.506 . . . . 1.42 109.635 179.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.805 ' ND1' ' HB2' ' B' ' 177' ' ' ASP . 4.5 t60 -138.64 116.33 11.43 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 108.246 -1.02 . . . . 2.81 108.246 -173.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.568 ' HG3' ' O ' ' B' ' 177' ' ' ASP . 0.0 OUTLIER -57.31 117.5 4.16 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.803 0.811 . . . . 3.05 110.268 -178.701 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.843 ' OD1' ' HB1' ' A' ' 84' ' ' ALA . 0.3 OUTLIER -147.37 101.47 3.79 Favored Pre-proline 0 N--CA 1.439 -0.991 0 CA-C-N 114.285 -1.325 . . . . 2.02 108.951 -178.167 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -56.28 -2.19 0.37 Allowed 'Trans proline' 0 C--N 1.361 1.201 0 C-N-CA 123.142 2.561 . . . . 2.29 115.15 -177.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.843 ' HB1' ' OD1' ' A' ' 82' ' ' ASP . . . -65.84 -17.83 64.91 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 111.985 0.365 . . . . 1.53 111.985 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.77 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 13.2 m -99.69 7.01 45.49 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.329 0.862 . . . . 1.88 113.329 -178.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.384 0 N-CA-C 115.448 1.647 . . . . 3.6 115.448 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 110' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.53 0.197 0 CA-C-O 121.395 0.617 . . . . 2.87 111.084 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 111' ' ' LEU . . . . . 0.755 ' O ' ' HA ' ' B' ' 120' ' ' ARG . 14.8 tp -39.89 113.67 0.92 Allowed Pre-proline 0 N--CA 1.47 0.529 0 CA-C-N 114.913 -1.04 . . . . 2.95 113.771 177.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 112' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -83.85 152.61 13.0 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 122.515 2.143 . . . . 1.71 110.037 178.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.661 ' C ' ' HA2' ' B' ' 117' ' ' GLY . 0.5 OUTLIER -158.7 -170.87 3.21 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 118.88 -1.128 . . . . 1.0 113.182 172.275 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 114' ' ' GLY . . . . . 0.571 ' HA2' ' HB3' ' B' ' 140' ' ' GLU . . . 76.41 -156.15 46.35 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.482 -0.866 . . . . 1.16 111.478 178.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 115' ' ' PRO . . . . . 0.584 ' O ' ' HG2' ' B' ' 115' ' ' PRO . 41.2 Cg_endo -65.31 95.89 0.27 Allowed 'Trans proline' 0 N--CA 1.467 -0.085 0 C-N-CA 122.848 2.366 . . . . 1.6 113.12 178.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 82.9 3.24 90.58 Favored Glycine 0 C--N 1.28 -2.56 0 CA-C-N 114.963 -1.017 . . . . 1.7 112.944 -178.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 117' ' ' GLY . . . . . 0.661 ' HA2' ' C ' ' B' ' 113' ' ' CYS . . . 76.34 45.68 14.12 Favored Glycine 0 N--CA 1.402 -3.604 0 C-N-CA 120.955 -0.64 . . . . 1.38 114.131 178.145 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.39 -1.91 57.46 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 114.696 -0.752 . . . . 2.96 111.32 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . -107.46 -156.22 19.86 Favored Glycine 0 C--N 1.343 0.92 0 N-CA-C 110.209 -1.156 . . . . 1.07 110.209 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.755 ' HA ' ' O ' ' B' ' 111' ' ' LEU . 1.2 mtm180 -150.64 154.33 37.29 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 120.216 2.008 . . . . 3.29 106.302 176.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 121' ' ' CYS . . . . . 0.484 ' CB ' HD22 ' B' ' 111' ' ' LEU . 1.5 t -107.28 160.95 15.22 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 113.246 0.832 . . . . 1.21 113.246 -177.083 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 122' ' ' PHE . . . . . 0.533 ' HE1' ' O ' ' B' ' 128' ' ' CYS . 60.8 m-85 -126.43 -47.65 1.58 Allowed 'General case' 0 C--N 1.339 0.113 0 CA-C-N 115.34 -0.846 . . . . 2.28 110.107 179.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -117.29 -159.67 11.52 Favored Glycine 0 CA--C 1.52 0.381 0 CA-C-N 115.797 -0.638 . . . . 1.04 111.634 179.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -84.26 -68.15 0.01 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.344 2.029 . . . . 1.84 111.667 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 125' ' ' SER . . . . . 0.408 ' O ' ' N ' ' B' ' 137' ' ' GLY . 0.4 OUTLIER -89.49 26.65 1.65 Allowed 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 109.943 -0.391 . . . . 1.49 109.943 178.78 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 126' ' ' ILE . . . . . 1.017 HG22 HG11 ' B' ' 136' ' ' VAL . 7.0 mt -144.7 112.59 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 CA-C-O 121.751 0.786 . . . . 1.41 111.827 -178.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 127' ' ' CYS . . . . . 0.599 ' O ' ' HA ' ' B' ' 134' ' ' CYS . 4.6 t -126.45 131.38 51.69 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.112 -0.949 . . . . 0.89 109.234 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 128' ' ' CYS . . . . . 0.869 ' HA ' ' O ' ' B' ' 133' ' ' GLY . 0.0 OUTLIER -142.39 122.16 13.47 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 115.103 1.52 . . . . 1.23 115.103 -176.906 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 129' ' ' GLY . . . . . . . . . . . . . . . -111.46 -166.11 18.28 Favored Glycine 0 C--N 1.373 2.636 0 N-CA-C 108.173 -1.971 . . . . 0.69 108.173 175.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -65.4 -58.74 5.12 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 114.074 1.139 . . . . 2.35 114.074 -177.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.28 21.82 11.57 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.57 0.7 . . . . 1.69 109.921 -177.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 132' ' ' LEU . . . . . 0.777 HD23 ' CZ ' ' B' ' 135' ' ' PHE . 0.4 OUTLIER -114.6 -12.41 12.25 Favored 'General case' 0 N--CA 1.397 -3.085 0 N-CA-C 103.84 -2.652 . . . . 1.84 103.84 175.459 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 133' ' ' GLY . . . . . 0.917 ' HA2' ' CB ' ' B' ' 169' ' ' ALA . . . 57.97 -129.57 49.74 Favored Glycine 1 N--CA 1.394 -4.128 0 CA-C-O 117.249 -1.862 . . . . 0.76 112.989 174.572 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 134' ' ' CYS . . . . . 0.845 ' HB2' HD13 ' B' ' 172' ' ' ILE . 2.5 t -136.96 122.98 20.25 Favored 'General case' 0 CA--C 1.496 -1.116 0 CA-C-N 119.648 1.724 . . . . 1.08 113.696 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 135' ' ' PHE . . . . . 0.777 ' CZ ' HD23 ' B' ' 132' ' ' LEU . 0.0 OUTLIER -98.03 100.21 11.53 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 103.645 -2.724 . . . . 1.83 103.645 175.153 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 136' ' ' VAL . . . . . 1.017 HG11 HG22 ' B' ' 126' ' ' ILE . 2.2 t -92.09 83.14 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.368 0 CA-C-O 123.27 1.509 . . . . 1.29 107.093 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 137' ' ' GLY . . . . . 0.897 ' HA3' HG23 ' A' ' 72' ' ' ILE . . . 100.49 85.36 1.85 Allowed Glycine 0 CA--C 1.525 0.678 0 CA-C-N 112.43 -2.168 . . . . 0.85 113.719 -179.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 138' ' ' THR . . . . . 0.738 HG21 ' O ' ' B' ' 137' ' ' GLY . 67.8 p -157.74 166.53 32.54 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 108.895 -0.78 . . . . 1.2 108.895 179.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 139' ' ' ALA . . . . . 0.576 ' HA ' ' CD1' ' B' ' 142' ' ' LEU . . . -68.58 -24.54 64.61 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 119.294 0.952 . . . . 1.35 110.575 177.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 140' ' ' GLU . . . . . 0.571 ' HB3' ' HA2' ' B' ' 114' ' ' GLY . 3.3 mm-40 -66.81 -11.92 57.09 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.618 -1.173 . . . . 2.31 109.972 177.116 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 141' ' ' ALA . . . . . 0.506 ' O ' ' HB2' ' B' ' 144' ' ' CYS . . . -102.93 -22.57 13.81 Favored 'General case' 0 C--O 1.211 -0.944 0 C-N-CA 123.736 0.814 . . . . 1.09 109.611 178.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 142' ' ' LEU . . . . . 0.576 ' CD1' ' HA ' ' B' ' 139' ' ' ALA . 23.8 mt -44.85 -38.42 4.57 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.015 0.436 . . . . 1.61 111.855 -179.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 143' ' ' ARG . . . . . 0.701 ' HD3' ' O ' ' B' ' 143' ' ' ARG . 0.0 OUTLIER -71.43 -1.28 12.58 Favored 'General case' 0 C--O 1.247 0.963 0 CA-C-N 116.05 -0.523 . . . . 3.43 110.063 179.378 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 144' ' ' CYS . . . . . 0.506 ' HB2' ' O ' ' B' ' 141' ' ' ALA . 66.3 m -82.0 -5.5 58.39 Favored 'General case' 0 C--N 1.341 0.226 0 O-C-N 120.825 -1.172 . . . . 1.61 110.108 176.259 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -60.61 -16.7 41.05 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.619 -0.719 . . . . 3.52 110.113 178.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -84.32 5.86 25.25 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 120.13 -0.628 . . . . 3.76 110.253 178.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 . . . . . 0 N--CA 1.452 -0.357 0 CA-C-N 116.038 -0.528 . . . . 4.01 109.892 177.811 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 156' ' ' SER . . . . . 0.694 ' OG ' ' HG3' ' B' ' 159' ' ' LYS . 1.8 t . . . . . 0 N--CA 1.457 -0.104 0 N-CA-C 116.772 2.138 . . . . 3.41 116.772 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 79.99 -113.76 3.72 Favored Glycine 0 CA--C 1.49 -1.509 0 O-C-N 119.487 -2.008 . . . . 2.26 113.301 173.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 158' ' ' GLN . . . . . 0.677 ' O ' ' HB3' ' B' ' 167' ' ' CYS . 3.3 mt-30 -113.67 96.07 5.67 Favored 'General case' 0 N--CA 1.413 -2.28 0 N-CA-C 106.931 -1.507 . . . . 5.03 106.931 177.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 159' ' ' LYS . . . . . 0.923 ' HB3' ' CD ' ' B' ' 160' ' ' PRO . 0.0 OUTLIER -69.6 -107.2 0.0 OUTLIER Pre-proline 0 CA--C 1.575 1.908 0 N-CA-C 114.196 1.184 . . . . 3.96 114.196 -177.153 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 160' ' ' PRO . . . . . 0.923 ' CD ' ' HB3' ' B' ' 159' ' ' LYS . 10.4 Cg_endo -50.58 126.8 18.94 Favored 'Trans proline' 0 C--N 1.363 1.336 0 N-CA-C 119.271 2.758 . . . . 1.7 119.271 -175.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 161' ' ' CYS . . . . . 0.506 ' HB3' ' HB3' ' B' ' 173' ' ' CYS . 6.5 t -149.05 -179.71 7.23 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 110.94 -2.846 . . . . 1.93 106.667 176.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 47.02 -164.61 0.13 Allowed Glycine 0 C--N 1.345 1.081 0 C-N-CA 119.818 -1.182 . . . . 2.37 114.434 178.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 69.5 m -84.3 48.85 1.55 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.67 0.748 . . . . 4.56 109.913 178.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 117.92 -1.58 17.35 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-N 115.166 -0.925 . . . . 2.39 113.654 178.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 165' ' ' GLY . . . . . 0.709 ' CA ' ' HA ' ' B' ' 175' ' ' SER . . . -97.27 132.4 10.97 Favored Glycine 0 C--N 1.339 0.696 0 C-N-CA 119.318 -1.42 . . . . 1.79 112.257 -176.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 166' ' ' ARG . . . . . 0.648 ' HA ' ' O ' ' B' ' 159' ' ' LYS . 0.0 OUTLIER -78.57 150.48 32.78 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.168 0.509 . . . . 3.53 111.841 -177.591 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 167' ' ' CYS . . . . . 0.677 ' HB3' ' O ' ' B' ' 158' ' ' GLN . 9.1 t -70.77 109.73 5.14 Favored 'General case' 0 N--CA 1.405 -2.702 0 CA-C-N 115.548 -0.751 . . . . 1.56 109.231 -179.206 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 168' ' ' ALA . . . . . 0.574 ' HB2' ' SG ' ' B' ' 128' ' ' CYS . . . -90.09 -14.28 34.08 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 121.583 0.706 . . . . 1.42 110.047 179.302 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 169' ' ' ALA . . . . . 0.917 ' CB ' ' HA2' ' B' ' 133' ' ' GLY . . . -172.71 161.62 4.82 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.854 -1.067 . . . . 1.18 108.785 177.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 170' ' ' ALA . . . . . 0.759 ' HA ' ' HB3' ' B' ' 185' ' ' CYS . . . -55.55 139.06 45.34 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 118.33 0.514 . . . . 1.47 111.361 179.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 171' ' ' GLY . . . . . 0.643 ' H ' ' CB ' ' B' ' 185' ' ' CYS . . . 67.73 -22.98 0.24 Allowed Glycine 0 CA--C 1.534 1.244 0 N-CA-C 116.35 1.3 . . . . 1.45 116.35 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 172' ' ' ILE . . . . . 0.845 HD13 ' HB2' ' B' ' 134' ' ' CYS . 1.7 pp -111.03 98.17 6.7 Favored 'Isoleucine or valine' 0 C--O 1.244 0.793 0 CA-C-N 118.586 1.193 . . . . 2.7 110.069 177.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 173' ' ' CYS . . . . . 0.506 ' HB3' ' HB3' ' B' ' 161' ' ' CYS . 33.9 m -93.0 104.3 16.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.421 -0.809 . . . . 1.94 109.311 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 174' ' ' CYS . . . . . 1.002 ' HA ' ' HA ' ' B' ' 179' ' ' CYS . 34.0 m -84.84 124.57 31.75 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.33 -0.85 . . . . 1.43 112.265 -177.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 175' ' ' SER . . . . . 0.886 ' HB3' ' HD2' ' B' ' 176' ' ' PRO . 49.5 m -84.47 -178.56 1.2 Allowed Pre-proline 0 CA--C 1.533 0.296 0 CA-C-N 115.075 -0.966 . . . . 2.3 110.515 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 176' ' ' PRO . . . . . 0.886 ' HD2' ' HB3' ' B' ' 175' ' ' SER . 73.9 Cg_endo -75.75 30.31 0.38 Allowed 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 121.675 1.583 . . . . 2.13 111.961 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 177' ' ' ASP . . . . . 0.805 ' HB2' ' ND1' ' A' ' 80' ' ' HIS . 2.8 p30 -145.38 -28.21 0.45 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.598 -0.728 . . . . 2.72 110.545 179.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 178' ' ' GLY . . . . . 0.823 ' HA3' ' O ' ' A' ' 79' ' ' CYS . . . -178.21 -132.65 1.74 Allowed Glycine 0 C--N 1.334 0.447 0 C-N-CA 121.21 -0.519 . . . . 1.05 112.183 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 179' ' ' CYS . . . . . 1.002 ' HA ' ' HA ' ' B' ' 174' ' ' CYS . 81.6 m -128.03 154.18 45.94 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 109.441 -0.577 . . . . 1.39 109.441 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 180' ' ' HIS . . . . . 0.825 ' ND1' ' HB2' ' A' ' 77' ' ' ASP . 4.0 t60 -147.29 115.37 6.54 Favored 'General case' 0 CA--C 1.499 -0.996 0 CA-C-O 121.913 0.863 . . . . 2.73 108.811 -173.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 181' ' ' GLU . . . . . 0.587 ' HG3' ' O ' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -56.73 117.41 3.89 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-N 114.246 -1.343 . . . . 3.06 110.274 -176.746 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 182' ' ' ASP . . . . . 0.803 ' OD1' ' HB1' ' B' ' 184' ' ' ALA . 0.3 OUTLIER -147.38 101.27 3.79 Favored Pre-proline 0 N--CA 1.437 -1.087 0 CA-C-N 114.063 -1.426 . . . . 2.06 108.929 -178.007 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 183' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -56.16 -2.22 0.36 Allowed 'Trans proline' 0 C--N 1.36 1.16 0 C-N-CA 123.229 2.619 . . . . 2.27 115.207 -177.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 184' ' ' ALA . . . . . 0.803 ' HB1' ' OD1' ' B' ' 182' ' ' ASP . . . -65.96 -17.93 65.0 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 111.983 0.364 . . . . 1.56 111.983 -179.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 185' ' ' CYS . . . . . 0.759 ' HB3' ' HA ' ' B' ' 170' ' ' ALA . 12.3 m -100.18 7.82 44.26 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 113.032 0.752 . . . . 1.94 113.032 -178.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 186' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.358 0 N-CA-C 115.027 1.491 . . . . 3.61 115.027 179.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.581 ' HB3' ' HB3' ' A' ' 20' ' ' ARG . 0.1 OUTLIER . . . . . 0 CA--C 1.548 0.898 0 N-CA-C 112.856 0.687 . . . . 2.89 112.856 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.594 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 4.4 mm? 3.62 111.86 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.461 0 N-CA-C 113.202 0.816 . . . . 2.89 113.202 178.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.571 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 87.6 Cg_endo -79.32 123.98 5.74 Favored 'Trans proline' 0 C--N 1.357 1.019 0 C-N-CA 123.203 2.602 . . . . 1.72 115.866 -178.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.589 ' O ' ' HA2' ' A' ' 17' ' ' GLY . 26.8 p -129.83 -176.23 3.86 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.307 -0.86 . . . . 1.0 111.138 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.441 ' HA2' ' HG2' ' A' ' 40' ' ' GLU . . . 75.54 -161.45 52.7 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 120.312 -0.947 . . . . 1.15 112.43 -178.144 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.687 ' HD2' HD12 ' A' ' 32' ' ' LEU . 39.3 Cg_endo -64.95 95.04 0.24 Allowed 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 123.488 2.792 . . . . 1.6 113.108 178.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.51 -2.09 87.76 Favored Glycine 0 C--N 1.288 -2.129 0 CA-C-N 113.868 -1.515 . . . . 1.68 112.724 178.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.589 ' HA2' ' O ' ' A' ' 13' ' ' CYS . . . 84.28 35.69 14.2 Favored Glycine 0 N--CA 1.412 -2.934 0 C-N-CA 118.501 -1.809 . . . . 1.37 116.417 177.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.1 -31.71 61.25 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 112.941 -1.629 . . . . 2.91 107.237 175.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.571 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -79.09 175.04 55.25 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 113.099 -1.864 . . . . 1.06 112.891 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.594 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -139.8 162.99 33.82 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.955 -0.387 . . . . 3.32 109.955 179.749 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 15.6 t -108.66 143.17 38.09 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.438 0.637 . . . . 1.19 112.301 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -127.5 -54.12 1.35 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 114.78 -1.1 . . . . 2.26 108.834 178.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -95.95 149.79 19.43 Favored Glycine 0 C--N 1.331 0.298 0 N-CA-C 110.179 -1.168 . . . . 1.05 110.179 177.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -50.25 -48.21 20.92 Favored 'Trans proline' 0 CA--C 1.531 0.349 0 C-N-CA 121.849 1.699 . . . . 1.81 112.765 -179.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.16 4.06 41.67 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.603 0.24 . . . . 1.62 111.347 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.948 HG22 HG13 ' A' ' 36' ' ' VAL . 0.5 OUTLIER -119.83 122.8 69.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 113.309 0.855 . . . . 1.39 113.309 -178.016 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.444 ' HB3' ' OE1' ' A' ' 40' ' ' GLU . 0.1 OUTLIER -125.84 124.48 41.0 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.01 -0.541 . . . . 0.92 109.704 178.566 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 1.019 ' HB2' ' HB2' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -131.88 141.12 49.29 Favored 'General case' 0 CA--C 1.562 1.426 0 N-CA-C 114.296 1.221 . . . . 1.28 114.296 -177.594 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.624 ' O ' ' HB3' ' A' ' 69' ' ' ALA . . . -131.71 -174.2 13.57 Favored Glycine 0 C--N 1.369 2.396 0 CA-C-N 113.443 -1.708 . . . . 0.71 110.119 178.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.703 ' O ' ' HB2' ' A' ' 70' ' ' ALA . 18.9 p-10 -63.17 -56.36 17.37 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 113.376 0.88 . . . . 2.27 113.376 -178.017 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.21 5.54 17.03 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-O 121.435 0.636 . . . . 1.66 110.716 -175.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.687 HD12 ' HD2' ' A' ' 15' ' ' PRO . 0.3 OUTLIER -103.93 -10.24 18.3 Favored 'General case' 0 N--CA 1.419 -2.001 0 N-CA-C 106.272 -1.751 . . . . 1.93 106.272 177.638 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.858 ' O ' ' HB3' ' A' ' 28' ' ' CYS . . . 67.37 -98.09 0.43 Allowed Glycine 0 C--O 1.221 -0.717 0 N-CA-C 118.283 2.073 . . . . 0.77 118.283 172.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 1.037 ' HB2' HG13 ' A' ' 72' ' ' ILE . 6.0 t -169.25 106.64 0.4 Allowed 'General case' 0 C--N 1.354 0.789 0 CA-C-N 118.644 1.222 . . . . 1.08 109.314 176.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.552 ' HB3' ' CG2' ' A' ' 38' ' ' THR . 3.7 m-30 -89.16 105.24 17.66 Favored 'General case' 0 N--CA 1.427 -1.611 0 N-CA-C 106.036 -1.839 . . . . 1.85 106.036 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.948 HG13 HG22 ' A' ' 26' ' ' ILE . 1.5 t -94.69 88.62 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.195 0 CA-C-O 123.361 1.553 . . . . 1.29 108.72 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.78 ' O ' ' HA3' ' B' ' 133' ' ' GLY . . . 94.63 98.64 1.66 Allowed Glycine 0 C--O 1.228 -0.256 0 CA-C-N 111.633 -2.53 . . . . 0.85 115.979 179.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.552 ' CG2' ' HB3' ' A' ' 35' ' ' PHE . 0.7 OUTLIER 177.02 170.27 0.53 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.627 0.251 . . . . 1.3 111.057 177.339 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.428 ' HA ' ' CD1' ' A' ' 42' ' ' LEU . . . -58.97 -14.18 8.54 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.377 0.608 . . . . 1.45 110.547 178.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.563 ' OE2' HD23 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -73.21 -13.16 61.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.741 -1.118 . . . . 2.32 109.327 176.594 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.429 ' O ' ' HB2' ' A' ' 44' ' ' CYS . . . -105.87 -22.53 12.9 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 115.121 -0.945 . . . . 1.11 111.66 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.454 ' O ' ' HB2' ' A' ' 45' ' ' GLN . 3.4 mt -44.25 -39.3 4.36 Favored 'General case' 0 C--N 1.344 0.368 0 N-CA-C 113.177 0.806 . . . . 1.68 113.177 -178.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -58.36 -19.33 34.58 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.275 0.559 . . . . 3.4 109.768 179.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.642 ' O ' ' N ' ' A' ' 47' ' ' GLU . 97.2 m -65.13 -45.64 84.23 Favored 'General case' 0 C--O 1.223 -0.294 0 N-CA-C 108.533 -0.914 . . . . 1.57 108.533 177.279 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.454 ' HB2' ' O ' ' A' ' 42' ' ' LEU . 75.3 mm-40 -28.98 -37.75 0.01 OUTLIER 'General case' 0 CA--C 1.551 0.996 0 CA-C-N 113.721 -1.581 . . . . 3.49 113.03 -178.411 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -87.43 -3.11 59.01 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 119.593 -0.843 . . . . 3.69 111.518 -179.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.642 ' N ' ' O ' ' A' ' 44' ' ' CYS . 1.1 tt0 . . . . . 0 N--CA 1.443 -0.784 0 CA-C-N 115.441 -0.8 . . . . 3.99 109.574 178.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 119.884 -0.103 . . . . 3.36 111.259 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 113.84 -63.84 0.29 Allowed Glycine 0 CA--C 1.496 -1.102 0 C-N-CA 120.428 -0.891 . . . . 2.3 112.66 178.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -114.45 127.71 55.97 Favored 'General case' 0 N--CA 1.419 -1.983 0 N-CA-C 104.956 -2.238 . . . . 5.06 104.956 177.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.936 ' O ' ' HA ' ' A' ' 66' ' ' ARG . 2.0 mtmp? -120.22 -100.14 0.0 OUTLIER Pre-proline 0 C--N 1.285 -2.239 0 CA-C-O 114.201 -2.809 . . . . 3.91 105.47 -176.13 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.769 ' CD ' ' HB3' ' A' ' 59' ' ' LYS . 56.5 Cg_endo -71.34 138.48 33.02 Favored 'Trans proline' 0 C--N 1.318 -1.066 0 CA-C-N 128.211 3.968 . . . . 1.74 115.569 -178.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.51 ' O ' ' SG ' ' A' ' 73' ' ' CYS . 20.6 p -143.18 146.02 33.33 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 114.432 -1.258 . . . . 1.9 110.363 177.085 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.56 -164.05 51.19 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 119.165 -1.493 . . . . 2.43 112.951 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.4 m -76.82 49.62 0.65 Allowed 'General case' 0 CA--C 1.553 1.072 0 N-CA-C 113.119 0.785 . . . . 4.32 113.119 -178.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 110.03 49.81 0.71 Allowed Glycine 0 N--CA 1.475 1.275 0 N-CA-C 115.466 0.947 . . . . 2.4 115.466 174.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.467 ' O ' ' SG ' ' A' ' 61' ' ' CYS . . . -152.3 120.73 1.1 Allowed Glycine 0 N--CA 1.475 1.259 0 C-N-CA 119.415 -1.374 . . . . 1.82 114.041 -179.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.936 ' HA ' ' O ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -83.81 152.76 24.44 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 118.83 1.315 . . . . 3.51 112.697 -177.251 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 20.3 t -65.32 103.1 0.75 Allowed 'General case' 0 N--CA 1.414 -2.234 0 N-CA-C 107.188 -1.412 . . . . 1.52 107.188 -179.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.697 ' HB1' ' HB ' ' A' ' 72' ' ' ILE . . . -80.14 -35.91 35.97 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-N 114.776 -1.102 . . . . 1.5 108.953 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 1.019 ' HB2' ' HB2' ' A' ' 28' ' ' CYS . . . -169.98 165.27 9.53 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.463 -0.94 . . . . 1.31 108.463 -179.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.704 ' HA ' ' O ' ' A' ' 85' ' ' CYS . . . -40.67 96.0 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.107 0 CA-C-O 122.33 1.062 . . . . 1.5 110.648 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' A' ' 69' ' ' ALA . . . 93.75 11.51 57.86 Favored Glycine 0 N--CA 1.428 -1.855 0 CA-C-O 117.085 -1.953 . . . . 1.44 117.578 177.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 1.037 HG13 ' HB2' ' A' ' 34' ' ' CYS . 3.6 mm -109.53 104.15 16.61 Favored 'Isoleucine or valine' 0 C--N 1.361 1.084 0 CA-C-N 123.303 3.551 . . . . 2.77 108.247 178.275 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.802 ' HB2' ' HB3' ' A' ' 82' ' ' ASP . 6.3 t -89.01 92.53 9.26 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 109.21 -0.663 . . . . 1.98 109.21 -179.131 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 1.28 ' CB ' ' HA ' ' A' ' 79' ' ' CYS . 31.6 p -163.51 176.3 9.87 Favored 'General case' 0 C--O 1.225 -0.227 0 N-CA-C 115.329 1.603 . . . . 1.43 115.329 -177.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.897 ' HB2' ' HD2' ' A' ' 76' ' ' PRO . 73.2 p -109.33 -178.81 0.59 Allowed Pre-proline 0 N--CA 1.472 0.644 0 CA-C-N 114.051 -1.432 . . . . 2.37 110.414 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.897 ' HD2' ' HB2' ' A' ' 75' ' ' SER . 71.8 Cg_endo -76.23 30.56 0.39 Allowed 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 121.908 1.739 . . . . 2.09 112.606 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.561 ' HA ' ' OE1' ' B' ' 181' ' ' GLU . 4.8 t70 -140.65 -51.13 0.46 Allowed 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.053 -0.521 . . . . 2.65 109.787 179.049 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.885 ' O ' ' HB2' ' A' ' 74' ' ' CYS . . . -119.65 179.92 16.59 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-O 119.44 -0.644 . . . . 1.04 112.382 178.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 1.28 ' HA ' ' CB ' ' A' ' 74' ' ' CYS . 12.8 m -150.52 160.98 43.4 Favored 'General case' 0 C--N 1.348 0.521 0 N-CA-C 113.105 0.78 . . . . 1.42 113.105 179.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.684 ' HB2' ' O ' ' A' ' 73' ' ' CYS . 50.3 m80 -151.9 139.36 19.54 Favored 'General case' 0 C--N 1.353 0.735 0 C-N-CA 119.921 -0.712 . . . . 2.81 112.054 -178.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -65.55 120.11 12.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.043 -0.526 . . . . 3.05 109.965 178.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.802 ' HB3' ' HB2' ' A' ' 73' ' ' CYS . 0.0 OUTLIER -143.91 101.87 4.92 Favored Pre-proline 0 CA--C 1.537 0.459 0 CA-C-N 116.505 -0.316 . . . . 2.02 110.511 -179.219 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -65.79 -8.48 19.72 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 123.115 2.543 . . . . 2.29 113.831 -178.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.89 -39.04 83.71 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.784 0.661 . . . . 1.53 112.784 -178.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.704 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 0.5 OUTLIER -94.87 -4.82 46.28 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 112.613 0.597 . . . . 1.88 112.613 -178.694 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.654 ' HA ' ' C ' ' A' ' 70' ' ' ALA . 1.6 t70 . . . . . 0 N--CA 1.47 0.532 0 N-CA-C 112.636 0.606 . . . . 3.6 112.636 -177.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 110' ' ' CYS . . . . . 0.563 ' HB3' ' HB3' ' B' ' 120' ' ' ARG . 0.1 OUTLIER . . . . . 0 CA--C 1.548 0.903 0 N-CA-C 113.157 0.799 . . . . 2.87 113.157 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 111' ' ' LEU . . . . . 0.593 ' O ' ' HA ' ' B' ' 120' ' ' ARG . 4.4 mm? 6.01 111.74 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.523 0 N-CA-C 113.027 0.751 . . . . 2.95 113.027 178.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 112' ' ' PRO . . . . . 0.559 ' HA ' ' O ' ' B' ' 119' ' ' GLY . 92.8 Cg_endo -80.18 122.63 4.76 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 123.071 2.514 . . . . 1.71 116.219 -178.294 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.594 ' O ' ' HA2' ' B' ' 117' ' ' GLY . 27.0 p -127.32 -176.16 3.66 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.043 -0.981 . . . . 1.0 111.264 179.122 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 114' ' ' GLY . . . . . 0.441 ' HA2' ' HG2' ' B' ' 140' ' ' GLU . . . 75.59 -161.38 52.6 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 120.484 -0.865 . . . . 1.16 112.43 -178.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 115' ' ' PRO . . . . . 0.799 ' HD2' HD12 ' B' ' 132' ' ' LEU . 38.7 Cg_endo -64.64 95.83 0.24 Allowed 'Trans proline' 0 N--CA 1.479 0.62 0 C-N-CA 123.624 2.882 . . . . 1.6 112.676 178.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 83.17 -2.94 86.15 Favored Glycine 0 C--N 1.29 -2.012 0 CA-C-N 114.13 -1.396 . . . . 1.7 112.781 178.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 117' ' ' GLY . . . . . 0.594 ' HA2' ' O ' ' B' ' 113' ' ' CYS . . . 84.79 35.84 12.59 Favored Glycine 0 N--CA 1.415 -2.754 0 C-N-CA 118.593 -1.765 . . . . 1.38 116.185 176.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.91 -32.57 61.83 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 112.849 -1.675 . . . . 2.96 106.959 176.216 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 119' ' ' GLY . . . . . 0.559 ' O ' ' HA ' ' B' ' 112' ' ' PRO . . . -79.29 178.44 53.66 Favored Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 113.286 -1.779 . . . . 1.07 112.878 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.593 ' HA ' ' O ' ' B' ' 111' ' ' LEU . 0.0 OUTLIER -141.76 162.7 34.84 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.272 -0.27 . . . . 3.29 110.272 -179.766 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 121' ' ' CYS . . . . . . . . . . . . . 15.3 t -108.66 143.16 38.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.404 0.621 . . . . 1.21 112.305 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -127.47 -54.21 1.35 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.801 -1.09 . . . . 2.28 108.862 178.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -95.96 149.78 19.43 Favored Glycine 0 C--N 1.332 0.325 0 N-CA-C 110.194 -1.162 . . . . 1.04 110.194 177.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -50.29 -48.33 20.47 Favored 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 121.786 1.657 . . . . 1.84 112.804 -179.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 125' ' ' SER . . . . . 0.402 ' O ' ' N ' ' B' ' 137' ' ' GLY . 0.4 OUTLIER -100.7 3.79 42.62 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.563 0.22 . . . . 1.49 111.339 179.705 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 126' ' ' ILE . . . . . 0.867 HG12 HG11 ' B' ' 136' ' ' VAL . 0.6 OUTLIER -119.73 122.8 69.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 113.359 0.874 . . . . 1.41 113.359 -177.968 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 127' ' ' CYS . . . . . 0.424 ' HB3' ' OE1' ' B' ' 140' ' ' GLU . 0.1 OUTLIER -125.14 124.47 41.89 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 109.733 -0.469 . . . . 0.89 109.733 178.689 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 128' ' ' CYS . . . . . 0.985 ' HB2' ' HB2' ' B' ' 169' ' ' ALA . 0.0 OUTLIER -130.45 142.95 50.48 Favored 'General case' 0 CA--C 1.551 1.006 0 N-CA-C 114.277 1.214 . . . . 1.23 114.277 -177.627 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 129' ' ' GLY . . . . . 0.615 ' O ' ' HB3' ' B' ' 169' ' ' ALA . . . -132.05 -173.34 13.3 Favored Glycine 0 C--N 1.359 1.838 0 N-CA-C 110.066 -1.214 . . . . 0.69 110.066 178.146 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 130' ' ' ASP . . . . . 0.689 ' O ' ' HB2' ' B' ' 170' ' ' ALA . 19.5 p-10 -63.73 -56.21 17.34 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 113.231 0.826 . . . . 2.35 113.231 -178.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 131' ' ' GLU . . . . . 0.403 ' HG2' ' OD2' ' B' ' 130' ' ' ASP . 0.0 OUTLIER -120.51 27.7 8.41 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.507 -0.745 . . . . 1.69 110.41 -179.806 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 132' ' ' LEU . . . . . 0.799 HD12 ' HD2' ' B' ' 115' ' ' PRO . 0.3 OUTLIER -122.46 -8.14 8.61 Favored 'General case' 0 N--CA 1.406 -2.672 0 N-CA-C 102.68 -3.081 . . . . 1.84 102.68 177.246 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 133' ' ' GLY . . . . . 0.869 ' O ' ' HB3' ' B' ' 128' ' ' CYS . . . 62.79 -94.15 0.11 Allowed Glycine 0 N--CA 1.426 -2.028 0 N-CA-C 118.973 2.349 . . . . 0.76 118.973 170.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 134' ' ' CYS . . . . . 1.02 ' HB2' HG13 ' B' ' 172' ' ' ILE . 6.1 t -170.02 106.85 0.34 Allowed 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 119.878 1.839 . . . . 1.08 109.453 176.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 135' ' ' PHE . . . . . 0.556 ' HB3' ' CG2' ' B' ' 138' ' ' THR . 3.6 m-30 -89.72 105.36 17.75 Favored 'General case' 0 N--CA 1.425 -1.683 0 N-CA-C 106.065 -1.828 . . . . 1.83 106.065 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 136' ' ' VAL . . . . . 0.924 HG23 HG23 ' A' ' 36' ' ' VAL . 1.7 t -94.64 89.12 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.197 0 CA-C-O 123.289 1.519 . . . . 1.29 108.561 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 137' ' ' GLY . . . . . 0.627 ' O ' ' HA3' ' A' ' 33' ' ' GLY . . . 93.94 98.83 1.57 Allowed Glycine 0 C--O 1.227 -0.309 0 CA-C-N 111.597 -2.547 . . . . 0.85 115.994 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 138' ' ' THR . . . . . 0.556 ' CG2' ' HB3' ' B' ' 135' ' ' PHE . 0.7 OUTLIER 177.0 170.55 0.52 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.651 0.262 . . . . 1.2 111.102 177.349 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 139' ' ' ALA . . . . . 0.772 ' HA ' HD11 ' B' ' 142' ' ' LEU . . . -58.81 -15.18 11.13 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 121.406 0.622 . . . . 1.35 110.654 178.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 140' ' ' GLU . . . . . 0.441 ' HG2' ' HA2' ' B' ' 114' ' ' GLY . 0.0 OUTLIER -72.65 -12.9 61.23 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.702 -1.135 . . . . 2.31 109.494 176.767 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 141' ' ' ALA . . . . . 0.423 ' O ' ' HB2' ' B' ' 144' ' ' CYS . . . -105.98 -22.72 12.82 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 115.169 -0.923 . . . . 1.09 111.643 -179.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 142' ' ' LEU . . . . . 0.772 HD11 ' HA ' ' B' ' 139' ' ' ALA . 3.6 mt -44.01 -39.28 4.01 Favored 'General case' 0 C--N 1.345 0.38 0 N-CA-C 113.176 0.806 . . . . 1.61 113.176 -178.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 143' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -58.17 -19.78 35.78 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.361 0.6 . . . . 3.43 109.769 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 144' ' ' CYS . . . . . 0.629 ' O ' ' N ' ' B' ' 147' ' ' GLU . 99.3 m -64.81 -45.77 84.83 Favored 'General case' 0 C--O 1.223 -0.3 0 N-CA-C 108.535 -0.913 . . . . 1.61 108.535 177.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 145' ' ' GLN . . . . . 0.459 ' HB2' ' O ' ' B' ' 142' ' ' LEU . 75.0 mm-40 -28.85 -37.75 0.01 OUTLIER 'General case' 0 CA--C 1.551 0.981 0 CA-C-N 113.668 -1.605 . . . . 3.52 113.05 -178.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -87.45 -3.1 59.01 Favored 'General case' 0 N--CA 1.477 0.905 0 O-C-N 121.253 -0.905 . . . . 3.76 111.5 -179.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 147' ' ' GLU . . . . . 0.629 ' N ' ' O ' ' B' ' 144' ' ' CYS . 1.1 tt0 . . . . . 0 C--N 1.318 -0.8 0 CA-C-N 115.433 -0.803 . . . . 4.01 109.54 178.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.48 1.071 0 N-CA-C 111.417 0.154 . . . . 3.41 111.417 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 111.44 -63.81 0.27 Allowed Glycine 0 C--N 1.338 0.675 0 C-N-CA 120.509 -0.853 . . . . 2.26 113.202 179.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 158' ' ' GLN . . . . . 0.564 ' O ' ' HB3' ' B' ' 167' ' ' CYS . 8.5 mt-30 -115.8 108.09 15.88 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 107.887 -1.153 . . . . 5.03 107.887 178.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 159' ' ' LYS . . . . . 0.892 ' O ' ' HA ' ' B' ' 166' ' ' ARG . 3.6 mtmp? -90.72 -103.75 0.0 OUTLIER Pre-proline 0 C--N 1.3 -1.577 0 CA-C-O 118.753 -0.641 . . . . 3.96 110.341 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 160' ' ' PRO . . . . . 0.797 ' HD3' ' HB3' ' B' ' 159' ' ' LYS . 57.6 Cg_endo -71.64 138.07 31.38 Favored 'Trans proline' 0 C--N 1.353 0.803 0 CA-C-N 122.231 1.833 . . . . 1.7 115.088 -179.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 161' ' ' CYS . . . . . 0.491 ' O ' ' SG ' ' B' ' 173' ' ' CYS . 20.1 p -142.78 146.68 34.48 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 114.155 -1.384 . . . . 1.93 110.013 177.281 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 69.64 -164.99 50.7 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 119.352 -1.404 . . . . 2.37 112.666 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 1.6 m -76.74 51.31 0.75 Allowed 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 123.872 0.869 . . . . 4.56 112.493 179.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 107.92 49.19 0.85 Allowed Glycine 0 N--CA 1.466 0.648 0 N-CA-C 115.913 1.125 . . . . 2.39 115.913 172.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 165' ' ' GLY . . . . . 0.489 ' O ' ' N ' ' B' ' 161' ' ' CYS . . . -150.95 122.98 1.44 Allowed Glycine 0 N--CA 1.469 0.878 0 C-N-CA 119.525 -1.321 . . . . 1.79 113.607 179.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 166' ' ' ARG . . . . . 0.892 ' HA ' ' O ' ' B' ' 159' ' ' LYS . 0.0 OUTLIER -84.36 152.78 23.86 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 118.841 1.321 . . . . 3.53 112.528 -178.398 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 167' ' ' CYS . . . . . 0.564 ' HB3' ' O ' ' B' ' 158' ' ' GLN . 20.0 t -65.29 103.04 0.73 Allowed 'General case' 0 N--CA 1.416 -2.171 0 N-CA-C 107.175 -1.417 . . . . 1.56 107.175 -179.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 168' ' ' ALA . . . . . 0.588 ' HB3' ' HB ' ' B' ' 172' ' ' ILE . . . -80.42 -35.09 35.61 Favored 'General case' 0 N--CA 1.424 -1.771 0 CA-C-N 114.676 -1.147 . . . . 1.42 108.969 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 169' ' ' ALA . . . . . 0.985 ' HB2' ' HB2' ' B' ' 128' ' ' CYS . . . -170.57 165.26 8.39 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 108.326 -0.99 . . . . 1.18 108.326 -179.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 170' ' ' ALA . . . . . 0.703 ' HA ' ' O ' ' B' ' 185' ' ' CYS . . . -40.76 96.07 0.01 OUTLIER 'General case' 0 C--O 1.232 0.152 0 CA-C-O 122.239 1.018 . . . . 1.47 110.622 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 171' ' ' GLY . . . . . 0.569 ' N ' ' O ' ' B' ' 169' ' ' ALA . . . 93.7 11.5 57.92 Favored Glycine 0 N--CA 1.427 -1.932 0 CA-C-O 116.883 -2.065 . . . . 1.45 117.557 177.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 172' ' ' ILE . . . . . 1.02 HG13 ' HB2' ' B' ' 134' ' ' CYS . 3.2 mm -109.59 104.35 16.93 Favored 'Isoleucine or valine' 0 C--N 1.365 1.262 0 CA-C-N 123.685 3.743 . . . . 2.7 108.124 178.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 173' ' ' CYS . . . . . 0.797 ' HB2' ' CB ' ' B' ' 182' ' ' ASP . 6.3 t -88.99 92.43 9.23 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 109.156 -0.683 . . . . 1.94 109.156 -179.128 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 174' ' ' CYS . . . . . 1.278 ' CB ' ' HA ' ' B' ' 179' ' ' CYS . 31.0 p -163.34 176.17 10.13 Favored 'General case' 0 C--O 1.226 -0.162 0 N-CA-C 115.458 1.651 . . . . 1.43 115.458 -177.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 175' ' ' SER . . . . . 0.901 ' HB2' ' HD2' ' B' ' 176' ' ' PRO . 73.7 p -109.31 -178.86 0.6 Allowed Pre-proline 0 N--CA 1.47 0.557 0 CA-C-N 114.187 -1.369 . . . . 2.3 110.441 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 176' ' ' PRO . . . . . 0.901 ' HD2' ' HB2' ' B' ' 175' ' ' SER . 71.6 Cg_endo -76.11 30.47 0.39 Allowed 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 121.913 1.742 . . . . 2.13 112.675 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 177' ' ' ASP . . . . . 0.415 ' H ' ' C ' ' B' ' 175' ' ' SER . 4.9 t70 -140.68 -51.16 0.46 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.086 -0.506 . . . . 2.72 109.769 179.103 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 178' ' ' GLY . . . . . 0.899 ' O ' ' HB2' ' B' ' 174' ' ' CYS . . . -119.65 179.99 16.59 Favored Glycine 0 N--CA 1.445 -0.759 0 CA-C-O 119.412 -0.66 . . . . 1.05 112.18 178.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 179' ' ' CYS . . . . . 1.278 ' HA ' ' CB ' ' B' ' 174' ' ' CYS . 12.5 m -150.47 161.1 43.18 Favored 'General case' 0 C--N 1.346 0.447 0 N-CA-C 113.165 0.802 . . . . 1.39 113.165 179.137 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 180' ' ' HIS . . . . . 0.688 ' HB2' ' O ' ' B' ' 173' ' ' CYS . 49.2 m80 -151.98 139.18 19.28 Favored 'General case' 0 C--N 1.354 0.775 0 C-N-CA 119.786 -0.765 . . . . 2.73 111.998 -178.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 181' ' ' GLU . . . . . 0.561 ' OE1' ' HA ' ' A' ' 77' ' ' ASP . 27.8 mt-10 -65.43 120.05 12.12 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 116.028 -0.533 . . . . 3.06 110.072 178.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 182' ' ' ASP . . . . . 0.797 ' CB ' ' HB2' ' B' ' 173' ' ' CYS . 0.0 OUTLIER -143.81 101.86 4.96 Favored Pre-proline 0 CA--C 1.536 0.413 0 CA-C-N 116.612 -0.267 . . . . 2.06 110.535 -179.187 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 183' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -65.88 -8.37 19.54 Favored 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 123.214 2.609 . . . . 2.27 113.859 -178.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 184' ' ' ALA . . . . . 0.583 ' HB1' ' OD1' ' B' ' 182' ' ' ASP . . . -67.97 -39.11 83.4 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.78 0.659 . . . . 1.56 112.78 -179.079 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 185' ' ' CYS . . . . . 0.703 ' O ' ' HA ' ' B' ' 170' ' ' ALA . 0.6 OUTLIER -94.78 -4.73 46.74 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.592 0.59 . . . . 1.94 112.592 -178.744 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 186' ' ' ASP . . . . . 0.661 ' HA ' ' C ' ' B' ' 170' ' ' ALA . 1.6 t70 . . . . . 0 N--CA 1.47 0.565 0 N-CA-C 112.659 0.614 . . . . 3.61 112.659 -177.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.84 ' HB3' ' CG ' ' A' ' 20' ' ' ARG . 61.1 m . . . . . 0 CA--C 1.535 0.366 0 N-CA-C 113.682 0.993 . . . . 2.89 113.682 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.615 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 16.3 tp -35.08 111.8 0.44 Allowed Pre-proline 0 N--CA 1.489 1.516 0 C-N-CA 123.223 0.609 . . . . 2.89 112.625 177.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.833 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 44.9 Cg_endo -86.99 144.21 7.12 Favored 'Trans proline' 0 C--N 1.357 1.012 0 C-N-CA 122.971 2.447 . . . . 1.72 116.992 -177.295 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.516 ' N ' ' O ' ' A' ' 19' ' ' GLY . 27.3 p -149.1 -170.24 3.58 Favored 'General case' 0 C--N 1.355 0.81 0 CA-C-N 115.961 -0.563 . . . . 1.0 109.79 178.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.832 ' CA ' ' HG2' ' A' ' 40' ' ' GLU . . . 75.45 -161.27 52.71 Favored Glycine 0 C--N 1.335 0.51 0 N-CA-C 115.256 0.862 . . . . 1.15 115.256 176.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.566 ' O ' ' HG2' ' A' ' 15' ' ' PRO . 38.0 Cg_endo -64.5 102.54 0.41 Allowed 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 124.027 3.151 . . . . 1.6 111.502 178.533 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 86.1 -0.98 87.72 Favored Glycine 0 C--N 1.265 -3.385 0 CA-C-N 112.028 -2.351 . . . . 1.68 112.761 -179.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.794 ' O ' ' HB2' ' A' ' 12' ' ' PRO . . . 72.43 43.03 46.9 Favored Glycine 0 N--CA 1.405 -3.385 0 C-N-CA 118.988 -1.577 . . . . 1.37 114.49 173.618 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.92 -41.13 9.33 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 114.29 -0.955 . . . . 2.91 110.416 177.367 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.833 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -71.38 169.02 50.3 Favored Glycine 0 C--O 1.194 -2.351 0 N-CA-C 116.272 1.269 . . . . 1.06 116.272 -174.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.84 ' CG ' ' HB3' ' A' ' 10' ' ' CYS . 4.2 mpp_? -104.14 160.83 14.53 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 112.747 -1.727 . . . . 3.32 114.926 -172.325 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.407 ' HB3' ' OE2' ' A' ' 47' ' ' GLU . 5.1 m -106.91 136.94 45.91 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 114.794 -1.093 . . . . 1.19 111.597 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -145.69 24.43 1.37 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.32 -0.855 . . . . 2.26 110.137 179.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 152.28 161.52 10.26 Favored Glycine 0 CA--C 1.521 0.422 0 N-CA-C 111.164 -0.775 . . . . 1.05 111.164 -179.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.64 ' HD2' ' OE2' ' B' ' 181' ' ' GLU . 31.8 Cg_exo -58.7 -64.01 0.12 Allowed 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 121.703 1.602 . . . . 1.81 112.335 -179.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.456 ' O ' ' N ' ' A' ' 37' ' ' GLY . 3.3 m -90.47 39.5 0.98 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.704 0.288 . . . . 1.62 110.289 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.959 HG12 HG12 ' A' ' 36' ' ' VAL . 3.0 mt -155.28 121.19 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 O-C-N 122.114 -0.366 . . . . 1.39 111.612 -179.276 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -137.86 110.16 7.38 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 120.877 0.37 . . . . 0.92 110.714 179.282 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.866 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -116.5 155.34 28.81 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 113.46 0.911 . . . . 1.28 113.46 179.025 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -149.67 -174.61 21.19 Favored Glycine 0 C--N 1.371 2.494 0 N-CA-C 108.259 -1.936 . . . . 0.71 108.259 177.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -67.8 -41.73 82.68 Favored 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 125.892 1.677 . . . . 2.27 115.328 -179.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -122.83 13.23 9.89 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 114.209 -1.359 . . . . 1.66 111.424 178.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.734 ' O ' HG23 ' B' ' 138' ' ' THR . 0.2 OUTLIER -120.25 -7.2 9.83 Favored 'General case' 0 N--CA 1.393 -3.323 0 N-CA-C 108.541 -0.911 . . . . 1.93 108.541 -178.383 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.968 ' HA2' ' CB ' ' A' ' 69' ' ' ALA . . . 49.83 -135.71 25.02 Favored Glycine 0 C--O 1.198 -2.103 0 CA-C-O 116.504 -2.276 . . . . 0.77 109.561 179.372 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.779 ' HB2' ' CD1' ' A' ' 72' ' ' ILE . 0.7 OUTLIER -128.71 130.46 47.18 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 121.495 2.648 . . . . 1.08 111.674 -179.842 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.723 ' CE1' HD22 ' A' ' 32' ' ' LEU . 1.3 m-85 -104.12 101.76 11.5 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 102.139 -3.282 . . . . 1.85 102.139 173.469 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.959 HG12 HG12 ' A' ' 26' ' ' ILE . 2.5 t -92.72 93.97 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.312 0 CA-C-O 123.694 1.711 . . . . 1.29 110.066 -177.113 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.849 ' O ' HG21 ' A' ' 38' ' ' THR . . . 83.18 80.37 1.0 Allowed Glycine 0 C--N 1.319 -0.379 0 CA-C-N 111.826 -2.443 . . . . 0.85 113.257 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.849 HG21 ' O ' ' A' ' 37' ' ' GLY . 70.7 p -160.76 -167.31 1.82 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.11 0.481 . . . . 1.3 110.361 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.541 ' HA ' HD11 ' A' ' 42' ' ' LEU . . . -62.14 -40.5 96.15 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 108.817 -0.809 . . . . 1.45 108.817 179.365 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.832 ' HG2' ' CA ' ' A' ' 14' ' ' GLY . 0.4 OUTLIER -55.9 -26.4 47.21 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 114.986 -1.006 . . . . 2.32 112.38 179.655 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.493 ' O ' ' N ' ' A' ' 44' ' ' CYS . . . -91.63 -35.37 14.26 Favored 'General case' 0 C--O 1.213 -0.845 0 CA-C-N 116.197 -0.456 . . . . 1.11 110.268 -179.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.541 HD11 ' HA ' ' A' ' 39' ' ' ALA . 7.9 mt -39.57 -54.31 2.0 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 114.866 1.432 . . . . 1.68 114.866 -175.483 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.653 ' C ' ' H ' ' A' ' 45' ' ' GLN . 0.0 OUTLIER -54.75 -23.6 18.61 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 119.982 -0.687 . . . . 3.4 109.763 178.171 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.493 ' N ' ' O ' ' A' ' 41' ' ' ALA . 4.9 t -69.43 17.77 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 112.823 0.675 . . . . 1.57 112.823 -177.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.653 ' H ' ' C ' ' A' ' 43' ' ' ARG . 1.3 tt0 -75.22 -28.84 60.08 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 114.312 -1.313 . . . . 3.49 107.99 176.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -82.33 9.95 7.96 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.224 -0.898 . . . . 3.69 110.837 179.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.453 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . 0.9 OUTLIER . . . . . 0 N--CA 1.455 -0.208 0 N-CA-C 109.745 -0.465 . . . . 3.99 109.745 177.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.482 1.141 0 N-CA-C 110.548 -0.168 . . . . 3.36 110.548 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.638 ' O ' ' HG3' ' A' ' 66' ' ' ARG . . . 99.18 32.14 5.93 Favored Glycine 0 C--N 1.345 1.033 0 C-N-CA 120.566 -0.826 . . . . 2.3 112.348 177.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -122.04 76.09 1.27 Allowed 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 121.908 0.861 . . . . 5.06 111.173 179.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.799 ' HB2' ' HB2' ' A' ' 67' ' ' CYS . 1.6 mmtp -133.41 69.59 77.16 Favored Pre-proline 0 C--N 1.313 -1.01 0 N-CA-C 106.734 -1.58 . . . . 3.91 106.734 178.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.633 ' HA ' ' O ' ' A' ' 65' ' ' GLY . 14.4 Cg_endo -56.9 82.38 0.04 OUTLIER 'Trans proline' 0 C--N 1.368 1.582 0 C-N-CA 123.901 3.068 . . . . 1.74 117.754 -176.413 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -101.8 -178.35 3.69 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 106.181 -1.785 . . . . 1.9 106.181 173.164 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.09 -167.15 53.14 Favored Glycine 0 C--N 1.339 0.734 0 C-N-CA 119.205 -1.474 . . . . 2.43 112.372 -179.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.6 p -83.04 41.79 0.77 Allowed 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 120.818 -0.353 . . . . 4.32 110.412 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 117.12 9.68 10.41 Favored Glycine 0 CA--C 1.538 1.492 0 CA-C-O 117.124 -1.931 . . . . 2.4 116.204 179.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.633 ' O ' ' HA ' ' A' ' 60' ' ' PRO . . . -102.64 156.3 18.31 Favored Glycine 0 C--N 1.345 1.081 0 CA-C-N 121.767 2.783 . . . . 1.82 113.554 179.147 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.638 ' HG3' ' O ' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -99.21 151.86 20.54 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 111.849 0.314 . . . . 3.51 111.849 179.415 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.799 ' HB2' ' HB2' ' A' ' 59' ' ' LYS . 1.3 m -71.59 106.85 4.18 Favored 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 109.557 -0.534 . . . . 1.52 109.557 178.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.851 ' HB3' ' HB2' ' A' ' 28' ' ' CYS . . . -89.03 -22.04 23.17 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 107.935 -1.135 . . . . 1.5 107.935 177.088 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.968 ' CB ' ' HA2' ' A' ' 33' ' ' GLY . . . -161.7 162.37 29.75 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 112.342 -2.208 . . . . 1.31 113.937 -175.073 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.665 ' HA ' ' O ' ' A' ' 85' ' ' CYS . . . -58.63 122.99 14.81 Favored 'General case' 0 CA--C 1.527 0.092 0 N-CA-C 113.05 0.759 . . . . 1.5 113.05 -178.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.679 ' HA2' ' O ' ' A' ' 82' ' ' ASP . . . 71.33 15.96 75.18 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-N 115.671 -0.695 . . . . 1.44 114.189 178.637 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.933 ' CG2' ' HA3' ' B' ' 137' ' ' GLY . 1.2 pp -141.73 98.29 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-N 113.932 -1.134 . . . . 2.77 112.733 -178.489 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.536 ' HB2' ' HB3' ' A' ' 82' ' ' ASP . 5.0 t -99.57 85.41 3.13 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 114.021 -1.445 . . . . 1.98 110.224 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 1.017 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 1.8 m -93.88 146.06 24.17 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.258 -0.428 . . . . 1.43 111.169 -179.192 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.881 ' HB2' ' HD2' ' A' ' 76' ' ' PRO . 53.9 p -109.56 -179.62 0.7 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.84 -0.618 . . . . 2.37 110.029 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.881 ' HD2' ' HB2' ' A' ' 75' ' ' SER . 77.1 Cg_endo -77.67 29.42 0.44 Allowed 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 121.695 1.596 . . . . 2.09 111.436 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.472 ' H ' ' C ' ' A' ' 75' ' ' SER . 0.6 OUTLIER -144.66 -29.44 0.47 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.218 -0.901 . . . . 2.65 110.113 179.41 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.5 ' O ' ' HB3' ' A' ' 74' ' ' CYS . . . -166.91 -145.89 4.65 Favored Glycine 0 CA--C 1.524 0.615 0 CA-C-N 115.977 -0.556 . . . . 1.04 112.603 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 1.017 ' HA ' ' HA ' ' A' ' 74' ' ' CYS . 11.9 t -146.62 159.16 43.8 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 109.808 -0.441 . . . . 1.42 109.808 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 55.3 m-70 -149.67 135.16 18.37 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 120.04 -0.664 . . . . 2.81 110.358 -176.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.673 ' CD ' HD13 ' B' ' 126' ' ' ILE . 2.6 mt-10 -60.79 132.13 52.9 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 109.712 -0.477 . . . . 3.05 109.712 179.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.679 ' O ' ' HA2' ' A' ' 71' ' ' GLY . 0.1 OUTLIER -140.01 112.8 7.52 Favored Pre-proline 0 CA--C 1.545 0.788 0 CA-C-N 116.355 -0.384 . . . . 2.02 110.755 -178.557 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 82' ' ' ASP . 13.9 Cg_exo -70.87 -21.11 28.75 Favored 'Trans proline' 0 C--N 1.359 1.09 0 C-N-CA 122.831 2.354 . . . . 2.29 113.862 -178.363 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.83 -39.75 94.97 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.718 0.294 . . . . 1.53 111.485 -179.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.665 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 68.4 m -97.95 -0.54 44.64 Favored 'General case' 0 C--O 1.215 -0.739 0 N-CA-C 112.681 0.623 . . . . 1.88 112.681 -179.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.549 ' HA ' ' N ' ' A' ' 71' ' ' GLY . 0.8 OUTLIER . . . . . 0 C--N 1.319 -0.719 0 N-CA-C 112.82 0.674 . . . . 3.6 112.82 -176.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 110' ' ' CYS . . . . . 0.828 ' HB3' ' CG ' ' B' ' 120' ' ' ARG . 59.3 m . . . . . 0 CA--C 1.535 0.366 0 N-CA-C 113.806 1.039 . . . . 2.87 113.806 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 111' ' ' LEU . . . . . 0.647 ' O ' ' HA ' ' B' ' 120' ' ' ARG . 16.5 tp -34.3 111.58 0.4 Allowed Pre-proline 0 N--CA 1.491 1.579 0 C-N-CA 123.162 0.585 . . . . 2.95 112.553 178.262 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 112' ' ' PRO . . . . . 0.833 ' HA ' ' O ' ' B' ' 119' ' ' GLY . 68.5 Cg_endo -83.12 147.88 13.13 Favored 'Trans proline' 0 C--N 1.359 1.101 0 C-N-CA 122.811 2.341 . . . . 1.71 115.442 -177.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.515 ' C ' ' HA2' ' B' ' 117' ' ' GLY . 28.0 p -152.06 -170.43 3.64 Favored 'General case' 0 C--O 1.254 1.31 0 CA-C-N 115.378 -0.828 . . . . 1.0 110.081 174.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 114' ' ' GLY . . . . . 0.81 ' CA ' ' HG2' ' B' ' 140' ' ' GLU . . . 75.79 -160.34 51.62 Favored Glycine 0 C--N 1.343 0.969 0 CA-C-N 114.712 -1.131 . . . . 1.16 115.094 176.143 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 115' ' ' PRO . . . . . 0.585 ' O ' ' HG2' ' B' ' 115' ' ' PRO . 35.5 Cg_endo -64.6 106.46 0.74 Allowed 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 124.067 3.178 . . . . 1.6 110.56 178.157 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 87.03 -11.88 63.7 Favored Glycine 0 C--N 1.257 -3.848 0 CA-C-N 112.211 -2.268 . . . . 1.7 111.174 -179.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 117' ' ' GLY . . . . . 0.73 ' O ' ' HB2' ' B' ' 112' ' ' PRO . . . 72.53 52.84 9.37 Favored Glycine 0 N--CA 1.399 -3.791 0 C-N-CA 119.596 -1.288 . . . . 1.38 113.488 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.05 -53.82 3.82 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 104.722 -2.325 . . . . 2.96 104.722 173.084 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 119' ' ' GLY . . . . . 0.833 ' O ' ' HA ' ' B' ' 112' ' ' PRO . . . -58.64 176.3 2.31 Favored Glycine 0 C--O 1.206 -1.643 0 CA-C-N 114.007 -1.451 . . . . 1.07 115.111 -167.279 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.828 ' CG ' ' HB3' ' B' ' 110' ' ' CYS . 4.7 mpp_? -113.83 163.68 14.74 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 114.081 1.141 . . . . 3.29 114.081 -173.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 121' ' ' CYS . . . . . 0.452 ' HB2' HD22 ' B' ' 111' ' ' LEU . 6.8 m -106.86 137.23 45.3 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.521 -1.218 . . . . 1.21 112.034 -179.059 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -145.68 24.35 1.37 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.186 -0.915 . . . . 2.28 110.171 179.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 152.29 161.52 10.26 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 111.196 -0.762 . . . . 1.04 111.196 -179.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . 0.614 ' HD2' ' OE2' ' A' ' 81' ' ' GLU . 32.0 Cg_exo -58.59 -64.11 0.12 Allowed 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 121.749 1.633 . . . . 1.84 112.286 -179.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 125' ' ' SER . . . . . 0.507 ' O ' HG11 ' B' ' 136' ' ' VAL . 3.2 m -90.58 39.62 0.98 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.665 0.269 . . . . 1.49 110.33 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 126' ' ' ILE . . . . . 1.048 HG12 HG11 ' B' ' 136' ' ' VAL . 3.3 mt -155.07 121.11 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 O-C-N 122.242 -0.286 . . . . 1.41 111.707 -179.21 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 127' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -138.06 110.02 7.23 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.054 0.454 . . . . 0.89 110.755 179.107 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 128' ' ' CYS . . . . . 0.824 ' HA ' ' O ' ' B' ' 133' ' ' GLY . 0.0 OUTLIER -112.51 157.59 20.95 Favored 'General case' 0 CA--C 1.562 1.417 0 C-N-CA 123.836 0.854 . . . . 1.23 112.647 178.764 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 129' ' ' GLY . . . . . . . . . . . . . . . -152.56 -175.48 24.15 Favored Glycine 0 C--N 1.38 2.985 0 N-CA-C 109.512 -1.435 . . . . 0.69 109.512 176.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -68.28 -45.79 72.12 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.871 1.268 . . . . 2.35 113.068 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.15 25.22 7.9 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-N 114.286 -1.325 . . . . 1.69 110.756 179.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 132' ' ' LEU . . . . . 0.726 HD22 ' CE1' ' B' ' 135' ' ' PHE . 0.2 OUTLIER -126.74 -10.81 6.13 Favored 'General case' 0 N--CA 1.401 -2.919 0 CA-C-N 113.427 -1.715 . . . . 1.84 109.573 179.643 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 133' ' ' GLY . . . . . 0.925 ' HA2' ' CB ' ' B' ' 169' ' ' ALA . . . 53.97 -125.06 32.04 Favored Glycine 0 N--CA 1.414 -2.828 0 CA-C-O 116.212 -2.438 . . . . 0.76 112.29 177.247 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 134' ' ' CYS . . . . . 0.771 ' HB2' ' CD1' ' B' ' 172' ' ' ILE . 0.8 OUTLIER -141.09 125.9 18.06 Favored 'General case' 0 CA--C 1.496 -1.099 0 CA-C-N 121.693 2.746 . . . . 1.08 112.261 176.211 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 135' ' ' PHE . . . . . 0.726 ' CE1' HD22 ' B' ' 132' ' ' LEU . 1.2 m-85 -101.13 101.93 12.77 Favored 'General case' 0 N--CA 1.425 -1.724 0 N-CA-C 102.266 -3.235 . . . . 1.83 102.266 175.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 136' ' ' VAL . . . . . 1.048 HG11 HG12 ' B' ' 126' ' ' ILE . 3.1 t -92.53 91.92 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.345 0 CA-C-O 123.317 1.532 . . . . 1.29 110.28 -177.014 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 137' ' ' GLY . . . . . 0.933 ' HA3' ' CG2' ' A' ' 72' ' ' ILE . . . 85.48 79.88 1.14 Allowed Glycine 0 CA--C 1.507 -0.44 0 CA-C-N 111.941 -2.39 . . . . 0.85 112.998 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 138' ' ' THR . . . . . 0.734 HG23 ' O ' ' A' ' 32' ' ' LEU . 76.4 p -155.96 -159.96 0.96 Allowed 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.427 0.632 . . . . 1.2 111.582 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 139' ' ' ALA . . . . . 0.407 ' H ' ' HB ' ' B' ' 138' ' ' THR . . . -68.67 -41.39 79.35 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.459 -1.246 . . . . 1.35 108.353 176.071 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 140' ' ' GLU . . . . . 0.81 ' HG2' ' CA ' ' B' ' 114' ' ' GLY . 0.3 OUTLIER -54.1 -30.24 47.82 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.093 -1.412 . . . . 2.31 112.248 179.081 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 141' ' ' ALA . . . . . 0.479 ' O ' ' N ' ' B' ' 144' ' ' CYS . . . -88.85 -35.71 16.41 Favored 'General case' 0 C--O 1.207 -1.178 0 N-CA-C 110.3 -0.259 . . . . 1.09 110.3 -178.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 6.2 mt -39.04 -54.75 1.67 Allowed 'General case' 0 C--O 1.24 0.566 0 N-CA-C 113.832 1.049 . . . . 1.61 113.832 -173.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 143' ' ' ARG . . . . . 0.496 ' HD2' ' H ' ' B' ' 143' ' ' ARG . 0.0 OUTLIER -55.59 -22.09 20.46 Favored 'General case' 0 CA--C 1.497 -1.094 0 C-N-CA 120.037 -0.665 . . . . 3.43 109.851 177.81 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 144' ' ' CYS . . . . . 0.479 ' N ' ' O ' ' B' ' 141' ' ' ALA . 6.7 t -75.46 29.64 0.1 Allowed 'General case' 0 CA--C 1.497 -1.064 0 C-N-CA 119.763 -0.775 . . . . 1.61 111.529 -178.335 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -84.71 -22.37 29.76 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 106.516 -1.661 . . . . 3.52 106.516 175.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -82.07 9.35 8.65 Favored 'General case' 0 C--N 1.343 0.283 0 CA-C-N 115.314 -0.857 . . . . 3.76 110.106 178.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 147' ' ' GLU . . . . . 0.479 ' HB2' ' SG ' ' B' ' 144' ' ' CYS . 0.9 OUTLIER . . . . . 0 N--CA 1.454 -0.239 0 N-CA-C 109.771 -0.455 . . . . 4.01 109.771 177.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.479 0.999 0 N-CA-C 112.116 0.414 . . . . 3.41 112.116 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 157' ' ' GLY . . . . . 0.62 ' O ' ' HG3' ' B' ' 166' ' ' ARG . . . 105.13 33.0 3.84 Favored Glycine 0 CA--C 1.505 -0.593 0 C-N-CA 120.611 -0.804 . . . . 2.26 112.479 179.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -122.15 67.42 0.93 Allowed 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 121.655 0.74 . . . . 5.03 111.858 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 159' ' ' LYS . . . . . 0.924 ' HB2' ' HB2' ' B' ' 167' ' ' CYS . 2.0 mmtp -115.71 67.54 2.83 Favored Pre-proline 0 CA--C 1.539 0.529 0 CA-C-N 114.654 -1.157 . . . . 3.96 109.33 174.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 160' ' ' PRO . . . . . 0.584 ' HA ' ' O ' ' B' ' 165' ' ' GLY . 12.5 Cg_endo -56.33 82.92 0.04 OUTLIER 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 122.942 2.428 . . . . 1.7 118.14 -174.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 161' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -98.1 -171.53 2.17 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 106.347 -1.723 . . . . 1.93 106.347 173.443 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 65.35 -166.02 34.7 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 119.319 -1.42 . . . . 2.37 112.803 177.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 3.9 p -84.46 39.65 0.74 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.758 0.789 . . . . 4.56 110.313 -179.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 121.2 5.03 9.8 Favored Glycine 0 CA--C 1.535 1.284 0 CA-C-O 117.793 -1.559 . . . . 2.39 116.513 178.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 165' ' ' GLY . . . . . 0.584 ' O ' ' HA ' ' B' ' 160' ' ' PRO . . . -101.68 155.86 18.85 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-N 121.241 2.52 . . . . 1.79 114.093 -178.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 166' ' ' ARG . . . . . 0.62 ' HG3' ' O ' ' B' ' 157' ' ' GLY . 0.0 OUTLIER -98.42 151.74 20.25 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.034 0.383 . . . . 3.53 112.034 -179.084 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 167' ' ' CYS . . . . . 0.924 ' HB2' ' HB2' ' B' ' 159' ' ' LYS . 1.3 m -71.58 107.14 4.31 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 109.634 -0.506 . . . . 1.56 109.634 178.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 168' ' ' ALA . . . . . 0.805 ' HB2' ' HB2' ' B' ' 128' ' ' CYS . . . -94.18 -13.84 26.24 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.917 -0.771 . . . . 1.42 108.917 177.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 169' ' ' ALA . . . . . 0.925 ' CB ' ' HA2' ' B' ' 133' ' ' GLY . . . -168.24 163.67 13.1 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.503 -0.771 . . . . 1.18 111.036 -179.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 170' ' ' ALA . . . . . 0.646 ' HA ' ' O ' ' B' ' 185' ' ' CYS . . . -58.78 122.46 13.62 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 113.805 1.039 . . . . 1.47 113.805 -178.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 171' ' ' GLY . . . . . 0.792 ' HA2' ' O ' ' B' ' 182' ' ' ASP . . . 60.94 35.66 90.87 Favored Glycine 0 C--N 1.343 0.963 0 CA-C-N 115.221 -0.9 . . . . 1.45 111.292 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 172' ' ' ILE . . . . . 0.848 ' CG1' ' HB1' ' B' ' 169' ' ' ALA . 1.2 pp -151.6 97.91 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 113.805 -1.197 . . . . 2.7 111.629 173.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 173' ' ' CYS . . . . . 0.545 ' HB2' ' HB3' ' B' ' 182' ' ' ASP . 5.2 t -99.71 85.85 3.19 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.682 -1.144 . . . . 1.94 110.174 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 174' ' ' CYS . . . . . 1.057 ' HA ' ' HA ' ' B' ' 179' ' ' CYS . 1.8 m -93.85 146.07 24.16 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.023 0.44 . . . . 1.43 111.187 -179.11 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 175' ' ' SER . . . . . 0.902 ' HB2' ' HD2' ' B' ' 176' ' ' PRO . 54.0 p -109.65 -179.65 0.7 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.761 -0.654 . . . . 2.3 110.031 179.505 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 176' ' ' PRO . . . . . 0.902 ' HD2' ' HB2' ' B' ' 175' ' ' SER . 78.6 Cg_endo -77.61 29.38 0.43 Allowed 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 121.675 1.583 . . . . 2.13 111.483 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 177' ' ' ASP . . . . . 0.467 ' H ' ' C ' ' B' ' 175' ' ' SER . 0.6 OUTLIER -144.63 -29.42 0.47 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.178 -0.919 . . . . 2.72 110.142 179.425 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 178' ' ' GLY . . . . . 0.589 ' HA2' HD11 ' B' ' 126' ' ' ILE . . . -166.94 -145.75 4.6 Favored Glycine 0 CA--C 1.523 0.591 0 CA-C-N 115.944 -0.571 . . . . 1.05 112.571 179.73 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 179' ' ' CYS . . . . . 1.057 ' HA ' ' HA ' ' B' ' 174' ' ' CYS . 11.7 t -146.4 161.73 39.75 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 109.803 -0.443 . . . . 1.39 109.803 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 180' ' ' HIS . . . . . . . . . . . . . 54.7 m-70 -153.77 134.14 13.46 Favored 'General case' 0 CA--C 1.504 -0.8 0 C-N-CA 119.67 -0.812 . . . . 2.73 111.284 -176.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 181' ' ' GLU . . . . . 0.64 ' OE2' ' HD2' ' A' ' 24' ' ' PRO . 2.5 mt-10 -60.05 132.07 52.8 Favored 'General case' 0 CA--C 1.521 -0.147 0 N-CA-C 109.793 -0.447 . . . . 3.06 109.793 -178.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 182' ' ' ASP . . . . . 0.792 ' O ' ' HA2' ' B' ' 171' ' ' GLY . 0.1 OUTLIER -140.0 112.72 7.51 Favored Pre-proline 0 CA--C 1.545 0.783 0 CA-C-N 116.248 -0.433 . . . . 2.06 110.74 -178.514 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 183' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -70.91 -21.15 28.5 Favored 'Trans proline' 0 C--N 1.359 1.089 0 C-N-CA 122.845 2.363 . . . . 2.27 113.776 -178.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -63.8 -39.83 95.18 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.721 0.296 . . . . 1.56 111.551 -179.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 185' ' ' CYS . . . . . 0.646 ' O ' ' HA ' ' B' ' 170' ' ' ALA . 67.2 m -97.85 -0.84 44.37 Favored 'General case' 0 C--O 1.215 -0.741 0 N-CA-C 112.504 0.557 . . . . 1.94 112.504 -179.376 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 186' ' ' ASP . . . . . 0.526 ' HA ' ' N ' ' B' ' 171' ' ' GLY . 0.8 OUTLIER . . . . . 0 C--N 1.321 -0.643 0 N-CA-C 112.953 0.723 . . . . 3.61 112.953 -176.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.656 ' HB3' ' HB3' ' A' ' 20' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.617 0 N-CA-C 115.022 1.49 . . . . 2.89 115.022 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -34.36 132.95 0.41 Allowed Pre-proline 0 N--CA 1.481 1.093 0 C-N-CA 124.067 0.947 . . . . 2.89 113.312 177.592 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.839 ' HB2' ' O ' ' A' ' 17' ' ' GLY . 79.0 Cg_endo -87.89 136.46 3.66 Favored 'Trans proline' 0 C--N 1.356 0.933 0 C-N-CA 122.736 2.291 . . . . 1.72 112.784 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 1.038 ' HB2' ' HG3' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -140.97 -162.79 1.42 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 119.975 -0.69 . . . . 1.0 112.163 -179.285 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.476 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . 81.73 -156.27 36.38 Favored Glycine 0 C--N 1.339 0.741 0 CA-C-O 119.323 -0.709 . . . . 1.15 111.836 -178.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.771 ' HG2' ' HD2' ' A' ' 18' ' ' LYS . 42.5 Cg_endo -62.49 108.17 0.68 Allowed 'Trans proline' 0 N--CA 1.483 0.867 0 N-CA-C 105.466 -2.551 . . . . 1.6 105.466 176.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 76.85 -14.37 7.48 Favored Glycine 0 C--N 1.265 -3.372 0 CA-C-O 118.485 -1.175 . . . . 1.68 112.588 176.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.839 ' O ' ' HB2' ' A' ' 12' ' ' PRO . . . 75.37 49.41 9.36 Favored Glycine 0 N--CA 1.401 -3.651 0 C-N-CA 117.075 -2.488 . . . . 1.37 111.825 178.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 1.044 ' HD3' HD12 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -94.99 -12.88 25.89 Favored 'General case' 0 C--N 1.345 0.41 0 CA-C-N 110.358 -2.921 . . . . 2.91 113.142 177.636 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.833 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -115.98 -167.53 14.98 Favored Glycine 0 C--N 1.345 1.082 0 N-CA-C 106.099 -2.801 . . . . 1.06 106.099 178.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.656 ' HB3' ' HB3' ' A' ' 10' ' ' CYS . 1.5 mpt_? -115.08 173.42 6.5 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 122.0 2.9 . . . . 3.32 111.656 -178.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.64 ' HB3' ' HG3' ' A' ' 47' ' ' GLU . 1.2 m -106.25 151.25 25.04 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.882 0.372 . . . . 1.19 110.875 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -124.11 -46.82 1.93 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.117 -0.492 . . . . 2.26 110.776 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.475 ' HA2' ' OE1' ' A' ' 47' ' ' GLU . . . -137.91 -161.18 8.77 Favored Glycine 0 CA--C 1.519 0.321 0 N-CA-C 111.601 -0.6 . . . . 1.05 111.601 179.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -77.87 -63.19 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.071 1.848 . . . . 1.81 111.451 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.425 ' O ' ' N ' ' A' ' 37' ' ' GLY . 1.1 m -92.17 33.31 1.08 Allowed 'General case' 0 C--O 1.224 -0.238 0 CA-C-N 116.216 -0.447 . . . . 1.62 109.828 178.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 1.034 HG12 HG12 ' A' ' 36' ' ' VAL . 19.0 mt -149.29 121.34 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-O 121.208 0.528 . . . . 1.39 111.99 -178.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.582 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 6.9 t -140.15 124.7 18.05 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 108.472 -0.936 . . . . 0.92 108.472 179.374 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.786 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -138.05 121.72 17.46 Favored 'General case' 0 CA--C 1.551 1.016 0 N-CA-C 114.4 1.259 . . . . 1.28 114.4 -177.743 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.683 ' O ' ' HB1' ' A' ' 69' ' ' ALA . . . -102.82 -170.62 26.43 Favored Glycine 0 C--N 1.367 2.291 0 N-CA-C 110.098 -1.201 . . . . 0.71 110.098 176.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -65.85 -53.68 36.65 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 113.773 1.027 . . . . 2.27 113.773 -178.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.54 3.44 12.43 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 122.222 1.01 . . . . 1.66 110.966 -176.245 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 1.044 HD12 ' HD3' ' A' ' 18' ' ' LYS . 0.4 OUTLIER -96.94 -22.24 16.97 Favored 'General case' 0 N--CA 1.415 -2.222 0 CA-C-N 113.887 -1.506 . . . . 1.93 107.382 -178.595 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.851 ' HA2' ' CB ' ' A' ' 69' ' ' ALA . . . 76.49 -135.73 17.82 Favored Glycine 0 N--CA 1.41 -3.094 0 CA-C-O 117.727 -1.596 . . . . 0.77 112.256 176.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.867 ' HB2' ' CD1' ' A' ' 72' ' ' ILE . 3.2 t -140.34 121.76 15.04 Favored 'General case' 0 CA--C 1.498 -1.051 0 CA-C-N 119.582 1.691 . . . . 1.08 114.1 -179.064 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.74 ' CE1' HD21 ' A' ' 32' ' ' LEU . 1.8 m-85 -95.51 102.12 13.89 Favored 'General case' 0 N--CA 1.428 -1.536 0 N-CA-C 103.469 -2.789 . . . . 1.85 103.469 175.504 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 1.034 HG12 HG12 ' A' ' 26' ' ' ILE . 2.1 t -94.41 84.34 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.137 0 CA-C-O 123.344 1.545 . . . . 1.29 108.622 -178.409 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.876 ' HA3' HG21 ' B' ' 172' ' ' ILE . . . 95.13 79.62 1.47 Allowed Glycine 0 C--N 1.313 -0.699 0 CA-C-N 112.236 -2.256 . . . . 0.85 113.722 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.819 HG21 ' O ' ' A' ' 37' ' ' GLY . 58.2 p -159.96 177.9 10.28 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.743 -0.836 . . . . 1.3 108.743 179.118 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.589 ' O ' ' HB2' ' A' ' 42' ' ' LEU . . . -65.28 -25.01 67.45 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 119.023 0.829 . . . . 1.45 112.27 -178.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.457 ' CG ' ' HA2' ' A' ' 14' ' ' GLY . 0.8 OUTLIER -64.35 -24.76 67.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.854 0.359 . . . . 2.32 110.246 178.664 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.535 ' O ' ' HB2' ' A' ' 44' ' ' CYS . . . -85.46 -10.16 56.5 Favored 'General case' 0 C--O 1.219 -0.5 0 CA-C-N 115.868 -0.605 . . . . 1.11 110.347 178.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.589 ' HB2' ' O ' ' A' ' 39' ' ' ALA . 1.1 mt -53.29 -41.83 65.98 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 121.982 -0.449 . . . . 1.68 112.156 -178.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 1.038 ' HG3' ' HB2' ' A' ' 13' ' ' CYS . 5.0 ptm180 -70.78 -16.96 62.79 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 121.788 0.804 . . . . 3.4 109.299 176.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.535 ' HB2' ' O ' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -57.67 -18.83 22.77 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 114.023 -1.444 . . . . 1.57 110.107 -178.27 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -50.62 -25.82 4.66 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.769 -0.65 . . . . 3.49 111.118 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -83.09 8.33 13.28 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.159 0.504 . . . . 3.69 110.375 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.64 ' HG3' ' HB3' ' A' ' 21' ' ' CYS . 6.0 tm-20 . . . . . 0 N--CA 1.449 -0.521 0 CA-C-N 115.751 -0.659 . . . . 3.99 109.349 177.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 43.0 p . . . . . 0 CA--C 1.544 0.744 0 CA-C-O 121.385 0.612 . . . . 3.36 112.394 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 120.29 -88.26 0.43 Allowed Glycine 0 N--CA 1.464 0.54 0 CA-C-N 114.646 -1.161 . . . . 2.3 114.016 177.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.89 ' O ' ' HB3' ' A' ' 67' ' ' CYS . 41.1 mt-30 -124.16 104.49 8.87 Favored 'General case' 0 CA--C 1.489 -1.404 0 N-CA-C 102.946 -2.983 . . . . 5.06 102.946 177.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 1.051 ' HB3' ' HB3' ' A' ' 66' ' ' ARG . 6.6 mmmt -128.68 -68.12 0.02 OUTLIER Pre-proline 0 C--N 1.314 -0.949 0 C-N-CA 118.532 -1.267 . . . . 3.91 112.812 -173.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.659 ' CD ' ' HB2' ' A' ' 59' ' ' LYS . 15.0 Cg_endo -57.08 114.97 2.17 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 CA-C-N 121.534 1.584 . . . . 1.74 115.354 -177.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -144.53 -165.36 2.12 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 111.133 -2.758 . . . . 1.9 104.494 178.159 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 47.24 -165.37 0.13 Allowed Glycine 0 N--CA 1.467 0.741 0 CA-C-N 121.283 1.856 . . . . 2.43 114.611 175.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 4.4 p -87.95 39.43 0.89 Allowed 'General case' 0 N--CA 1.479 1.016 0 CA-C-O 121.997 0.903 . . . . 4.32 110.482 -177.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 121.11 15.46 4.69 Favored Glycine 0 CA--C 1.558 2.732 0 CA-C-N 113.981 -1.463 . . . . 2.4 114.696 -175.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -101.14 146.02 17.21 Favored Glycine 0 N--CA 1.474 1.184 0 CA-C-N 119.913 1.856 . . . . 1.82 114.914 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 1.051 ' HB3' ' HB3' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -89.73 152.53 21.28 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 109.375 -0.602 . . . . 3.51 109.375 177.965 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 1.05 ' H ' ' HA ' ' A' ' 59' ' ' LYS . 36.1 t -73.47 107.53 5.81 Favored 'General case' 0 N--CA 1.407 -2.588 0 N-CA-C 108.736 -0.839 . . . . 1.52 108.736 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 1.092 ' HB1' ' HB2' ' A' ' 74' ' ' CYS . . . -71.58 -28.23 63.68 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.919 -0.771 . . . . 1.5 108.919 179.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.851 ' CB ' ' HA2' ' A' ' 33' ' ' GLY . . . -168.78 163.46 11.84 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.367 -1.288 . . . . 1.31 110.498 -176.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 1.08 ' HA ' ' HB3' ' A' ' 85' ' ' CYS . . . -55.05 122.41 10.89 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 116.111 -0.495 . . . . 1.5 112.119 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.568 ' H ' ' CB ' ' A' ' 85' ' ' CYS . . . 58.38 35.77 80.66 Favored Glycine 0 C--N 1.351 1.416 0 N-CA-C 110.904 -0.878 . . . . 1.44 110.904 -178.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 1.068 HG21 ' HA3' ' B' ' 137' ' ' GLY . 1.5 pp -154.71 97.79 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.644 0 N-CA-C 107.989 -1.115 . . . . 2.77 107.989 169.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.666 ' HB2' ' HB3' ' A' ' 82' ' ' ASP . 0.1 OUTLIER -91.48 106.33 18.42 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 112.21 0.448 . . . . 1.98 112.21 -177.319 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 1.092 ' HB2' ' HB1' ' A' ' 68' ' ' ALA . 0.6 OUTLIER -93.84 123.77 37.41 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.526 0.679 . . . . 1.43 111.663 179.754 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.88 ' HB2' ' HD2' ' A' ' 76' ' ' PRO . 36.2 p -93.26 -178.7 0.89 Allowed Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.102 -0.954 . . . . 2.37 109.035 178.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.88 ' HD2' ' HB2' ' A' ' 75' ' ' SER . 74.0 Cg_endo -76.11 29.28 0.39 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 121.328 1.352 . . . . 2.09 111.517 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.697 ' HB3' ' CE1' ' B' ' 180' ' ' HIS . 1.7 m-20 -145.78 -43.9 0.21 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.418 -0.81 . . . . 2.65 110.809 179.445 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.519 ' HA3' ' HA ' ' B' ' 180' ' ' HIS . . . -158.32 -141.61 3.19 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 120.74 -0.743 . . . . 1.04 113.128 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.752 ' HA ' ' HA ' ' A' ' 74' ' ' CYS . 0.1 OUTLIER -134.82 157.76 45.94 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.55 0.215 . . . . 1.42 110.505 -179.949 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.653 ' CE1' ' HB3' ' B' ' 177' ' ' ASP . 2.8 t60 -152.28 135.11 15.52 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 109.432 -0.581 . . . . 2.81 109.432 -176.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.8 132.19 53.19 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 109.295 -0.631 . . . . 3.05 109.295 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.666 ' HB3' ' HB2' ' A' ' 73' ' ' CYS . 1.2 p-10 -140.64 133.56 14.65 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 120.911 -0.315 . . . . 2.02 111.581 -177.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.535 ' HA ' ' HB2' ' A' ' 86' ' ' ASP . 5.7 Cg_exo -79.51 -12.16 14.01 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 122.737 2.292 . . . . 2.29 113.103 -179.28 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.8 -41.74 97.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.783 0.325 . . . . 1.53 110.944 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 1.08 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 21.5 m -99.88 22.67 10.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.156 0.503 . . . . 1.88 110.919 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.535 ' HB2' ' HA ' ' A' ' 83' ' ' PRO . 0.5 OUTLIER . . . . . 0 CA--C 1.512 -0.483 0 N-CA-C 113.887 1.069 . . . . 3.6 113.887 179.085 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 110' ' ' CYS . . . . . 0.641 ' HB3' ' HB3' ' B' ' 120' ' ' ARG . 0.0 OUTLIER . . . . . 0 CA--C 1.54 0.572 0 N-CA-C 115.381 1.622 . . . . 2.87 115.381 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -33.77 133.07 0.37 Allowed Pre-proline 0 N--CA 1.485 1.307 0 C-N-CA 123.979 0.912 . . . . 2.95 113.294 177.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 112' ' ' PRO . . . . . 0.824 ' HB2' ' O ' ' B' ' 117' ' ' GLY . 54.0 Cg_endo -92.3 129.09 0.95 Allowed 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.509 2.139 . . . . 1.71 115.253 -179.141 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 1.079 ' HB2' ' HG3' ' B' ' 143' ' ' ARG . 0.0 OUTLIER -133.65 -159.78 0.99 Allowed 'General case' 0 C--N 1.359 1.017 0 C-N-CA 119.473 -0.891 . . . . 1.0 111.299 -175.525 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 114' ' ' GLY . . . . . 0.474 ' N ' ' SG ' ' B' ' 113' ' ' CYS . . . 80.71 -156.91 39.16 Favored Glycine 0 C--N 1.334 0.443 0 CA-C-N 118.613 0.642 . . . . 1.16 111.558 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 115' ' ' PRO . . . . . 0.775 ' HG2' ' HD2' ' B' ' 118' ' ' LYS . 56.6 Cg_endo -65.24 88.59 0.2 Allowed 'Trans proline' 0 N--CA 1.458 -0.58 0 CA-C-N 119.523 1.662 . . . . 1.6 114.177 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 87.51 -3.83 86.21 Favored Glycine 0 C--N 1.265 -3.372 0 CA-C-N 112.056 -2.338 . . . . 1.7 114.202 -176.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 117' ' ' GLY . . . . . 0.824 ' O ' ' HB2' ' B' ' 112' ' ' PRO . . . 75.05 47.58 13.09 Favored Glycine 0 N--CA 1.412 -2.931 0 C-N-CA 118.966 -1.588 . . . . 1.38 113.497 175.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 118' ' ' LYS . . . . . 1.098 ' HD3' HD12 ' B' ' 132' ' ' LEU . 0.0 OUTLIER -90.72 -23.27 20.75 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 112.134 -2.033 . . . . 2.96 111.237 178.96 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 119' ' ' GLY . . . . . 0.791 ' O ' ' HA ' ' B' ' 112' ' ' PRO . . . -101.36 -160.94 27.18 Favored Glycine 0 N--CA 1.478 1.477 0 CA-C-O 117.274 -1.848 . . . . 1.07 109.242 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.641 ' HB3' ' HB3' ' B' ' 110' ' ' CYS . 1.3 mpt_? -124.0 172.83 8.66 Favored 'General case' 0 C--N 1.353 0.728 0 CA-C-N 122.238 3.019 . . . . 3.29 109.329 177.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 121' ' ' CYS . . . . . 0.618 ' HB3' ' HG3' ' B' ' 147' ' ' GLU . 1.2 m -106.11 151.44 24.7 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.927 0.394 . . . . 1.21 111.139 -179.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -124.16 -46.81 1.92 Allowed 'General case' 0 C--N 1.334 -0.101 0 CA-C-N 116.04 -0.527 . . . . 2.28 110.754 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 123' ' ' GLY . . . . . 0.49 ' HA2' ' OE1' ' B' ' 147' ' ' GLU . . . -137.98 -161.19 8.76 Favored Glycine 0 CA--C 1.52 0.374 0 N-CA-C 111.637 -0.585 . . . . 1.04 111.637 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -77.77 -63.21 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.033 1.822 . . . . 1.84 111.538 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 125' ' ' SER . . . . . 0.423 ' O ' ' N ' ' B' ' 137' ' ' GLY . 1.1 m -92.05 33.27 1.07 Allowed 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.845 -0.428 . . . . 1.49 109.845 178.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 126' ' ' ILE . . . . . 1.034 HG12 HG12 ' B' ' 136' ' ' VAL . 23.0 mt -149.01 121.23 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 CA-C-O 121.082 0.468 . . . . 1.41 112.111 -178.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 127' ' ' CYS . . . . . 0.572 ' O ' ' HA ' ' B' ' 134' ' ' CYS . 6.6 t -140.34 124.33 17.48 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 108.404 -0.962 . . . . 0.89 108.404 179.217 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 128' ' ' CYS . . . . . 0.794 ' HA ' ' O ' ' B' ' 133' ' ' GLY . 0.0 OUTLIER -137.43 120.95 17.17 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 114.235 1.198 . . . . 1.23 114.235 -177.731 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 129' ' ' GLY . . . . . 0.728 ' O ' ' HB1' ' B' ' 169' ' ' ALA . . . -103.67 -167.65 25.39 Favored Glycine 0 C--N 1.369 2.395 0 CA-C-N 120.148 1.34 . . . . 0.69 109.885 176.388 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -65.72 -55.07 19.32 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 114.148 1.166 . . . . 2.35 114.148 -177.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -124.06 21.7 8.88 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 121.691 0.758 . . . . 1.69 109.955 -177.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 132' ' ' LEU . . . . . 1.098 HD12 ' HD3' ' B' ' 118' ' ' LYS . 0.4 OUTLIER -112.18 -21.19 11.59 Favored 'General case' 0 N--CA 1.411 -2.417 0 N-CA-C 104.783 -2.303 . . . . 1.84 104.783 179.24 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 133' ' ' GLY . . . . . 0.891 ' HA2' ' CB ' ' B' ' 169' ' ' ALA . . . 75.41 -134.73 17.13 Favored Glycine 1 N--CA 1.393 -4.226 0 CA-C-O 117.07 -1.961 . . . . 0.76 112.499 174.503 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 134' ' ' CYS . . . . . 0.859 ' HB2' ' CD1' ' B' ' 172' ' ' ILE . 3.1 t -140.75 121.78 14.63 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 120.262 2.031 . . . . 1.08 114.488 -178.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 135' ' ' PHE . . . . . 0.76 ' CZ ' HG22 ' A' ' 38' ' ' THR . 4.1 m-85 -95.16 101.77 13.54 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 103.707 -2.701 . . . . 1.83 103.707 175.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 136' ' ' VAL . . . . . 1.034 HG12 HG12 ' B' ' 126' ' ' ILE . 2.3 t -94.36 83.83 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.076 0 CA-C-O 123.364 1.554 . . . . 1.29 108.597 -178.415 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 137' ' ' GLY . . . . . 1.068 ' HA3' HG21 ' A' ' 72' ' ' ILE . . . 95.19 79.55 1.46 Allowed Glycine 0 C--N 1.313 -0.697 0 CA-C-N 112.145 -2.298 . . . . 0.85 113.643 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 138' ' ' THR . . . . . 0.695 HG22 ' CZ ' ' A' ' 35' ' ' PHE . 51.2 p -158.12 -179.05 7.75 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.7 -0.852 . . . . 1.2 108.7 179.074 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 139' ' ' ALA . . . . . 0.583 ' O ' ' HB2' ' B' ' 142' ' ' LEU . . . -68.37 -24.78 64.83 Favored 'General case' 0 C--N 1.338 0.109 0 CA-C-N 119.18 0.9 . . . . 1.35 111.934 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 140' ' ' GLU . . . . . 0.449 ' CG ' ' HA2' ' B' ' 114' ' ' GLY . 0.8 OUTLIER -63.98 -25.18 68.01 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.236 -0.438 . . . . 2.31 110.195 178.643 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 141' ' ' ALA . . . . . 0.527 ' O ' ' HB2' ' B' ' 144' ' ' CYS . . . -84.72 -11.22 56.29 Favored 'General case' 0 C--O 1.219 -0.538 0 CA-C-N 115.941 -0.572 . . . . 1.09 110.27 178.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 142' ' ' LEU . . . . . 0.583 ' HB2' ' O ' ' B' ' 139' ' ' ALA . 1.1 mt -52.83 -42.09 64.82 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.312 0.486 . . . . 1.61 112.312 -178.018 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 143' ' ' ARG . . . . . 1.079 ' HG3' ' HB2' ' B' ' 113' ' ' CYS . 4.4 ptm180 -68.1 -21.57 64.95 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 108.613 -0.884 . . . . 3.43 108.613 176.299 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 144' ' ' CYS . . . . . 0.527 ' HB2' ' O ' ' B' ' 141' ' ' ALA . 0.1 OUTLIER -56.81 -13.84 2.91 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 113.743 -1.571 . . . . 1.61 110.482 -175.867 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -54.61 -24.93 23.52 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-O 121.242 0.544 . . . . 3.52 111.05 178.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -82.99 8.42 12.77 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 120.473 -0.491 . . . . 3.76 110.213 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 147' ' ' GLU . . . . . 0.618 ' HG3' ' HB3' ' B' ' 121' ' ' CYS . 6.0 tm-20 . . . . . 0 N--CA 1.449 -0.501 0 CA-C-N 115.821 -0.627 . . . . 4.01 109.375 177.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 34.5 p . . . . . 0 CA--C 1.537 0.451 0 N-CA-C 112.147 0.425 . . . . 3.41 112.147 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 120.48 -92.33 0.51 Allowed Glycine 0 C--N 1.339 0.743 0 C-N-CA 120.834 -0.698 . . . . 2.26 113.286 178.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 158' ' ' GLN . . . . . 0.94 ' O ' ' HB3' ' B' ' 167' ' ' CYS . 41.1 mt-30 -124.55 89.67 3.11 Favored 'General case' 0 CA--C 1.493 -1.237 0 N-CA-C 105.246 -2.131 . . . . 5.03 105.246 178.304 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 159' ' ' LYS . . . . . 1.058 ' HB3' ' HB3' ' B' ' 166' ' ' ARG . 6.5 mmmt -105.58 -73.69 0.02 OUTLIER Pre-proline 0 C--N 1.308 -1.232 0 N-CA-C 116.28 1.956 . . . . 3.96 116.28 -175.491 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 160' ' ' PRO . . . . . 0.625 ' CD ' ' HB2' ' B' ' 159' ' ' LYS . 14.6 Cg_endo -57.21 115.05 2.22 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 N-CA-C 116.037 1.514 . . . . 1.7 116.037 -174.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 161' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -145.57 -168.75 3.05 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 110.911 -2.859 . . . . 1.93 104.374 177.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 50.01 -165.66 0.5 Allowed Glycine 0 CA--C 1.525 0.7 0 CA-C-N 120.62 1.554 . . . . 2.37 113.882 177.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 7.3 p -88.25 39.63 0.91 Allowed 'General case' 0 N--CA 1.482 1.152 0 CA-C-O 122.491 1.138 . . . . 4.56 110.962 -178.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 123.02 12.8 4.7 Favored Glycine 0 CA--C 1.557 2.663 0 CA-C-N 113.351 -1.75 . . . . 2.39 114.857 -178.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -99.92 146.08 17.66 Favored Glycine 0 N--CA 1.471 1.02 0 CA-C-N 120.795 2.297 . . . . 1.79 115.046 -177.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 166' ' ' ARG . . . . . 1.058 ' HB3' ' HB3' ' B' ' 159' ' ' LYS . 0.0 OUTLIER -89.51 152.28 21.52 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 109.302 -0.629 . . . . 3.53 109.302 178.612 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 167' ' ' CYS . . . . . 0.94 ' HB3' ' O ' ' B' ' 158' ' ' GLN . 33.6 t -73.77 107.75 6.2 Favored 'General case' 0 N--CA 1.406 -2.628 0 N-CA-C 108.683 -0.858 . . . . 1.56 108.683 -179.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 168' ' ' ALA . . . . . 1.045 ' HB3' ' HB2' ' B' ' 174' ' ' CYS . . . -73.68 -24.18 59.92 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 119.699 -0.801 . . . . 1.42 109.438 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 169' ' ' ALA . . . . . 0.891 ' CB ' ' HA2' ' B' ' 133' ' ' GLY . . . -171.47 163.48 6.81 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 108.554 -0.906 . . . . 1.18 108.554 -178.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 170' ' ' ALA . . . . . 1.054 ' HA ' ' HB3' ' B' ' 185' ' ' CYS . . . -55.43 125.56 21.42 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 120.89 0.376 . . . . 1.47 111.974 179.263 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 171' ' ' GLY . . . . . 0.531 ' H ' ' CB ' ' B' ' 185' ' ' CYS . . . 79.27 -7.45 52.64 Favored Glycine 0 C--O 1.224 -0.513 0 C-N-CA 120.376 -0.916 . . . . 1.45 114.063 178.301 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 172' ' ' ILE . . . . . 0.876 HG21 ' HA3' ' A' ' 37' ' ' GLY . 1.6 pp -132.36 100.78 4.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-O 121.89 0.852 . . . . 2.7 110.59 -175.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 173' ' ' CYS . . . . . 0.684 ' HB2' ' HB3' ' B' ' 182' ' ' ASP . 0.1 OUTLIER -91.13 105.88 18.12 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 115.498 -0.774 . . . . 1.94 112.282 -177.811 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 174' ' ' CYS . . . . . 1.045 ' HB2' ' HB3' ' B' ' 168' ' ' ALA . 0.6 OUTLIER -93.94 123.81 37.54 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.535 0.683 . . . . 1.43 111.734 179.651 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 175' ' ' SER . . . . . 0.933 ' HB2' ' HD2' ' B' ' 176' ' ' PRO . 36.1 p -93.31 -178.71 0.89 Allowed Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.114 -0.948 . . . . 2.3 109.071 178.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 176' ' ' PRO . . . . . 0.933 ' HD2' ' HB2' ' B' ' 175' ' ' SER . 73.9 Cg_endo -76.08 29.2 0.39 Allowed 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 121.388 1.392 . . . . 2.13 111.481 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 177' ' ' ASP . . . . . 0.653 ' HB3' ' CE1' ' A' ' 80' ' ' HIS . 1.6 m-20 -145.74 -43.94 0.21 Allowed 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 115.489 -0.778 . . . . 2.72 110.798 179.431 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 178' ' ' GLY . . . . . 0.5 ' HA3' ' HA ' ' A' ' 80' ' ' HIS . . . -158.27 -141.52 3.17 Favored Glycine 0 CA--C 1.522 0.512 0 C-N-CA 120.776 -0.726 . . . . 1.05 113.137 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 179' ' ' CYS . . . . . 0.739 ' HA ' ' HA ' ' B' ' 174' ' ' CYS . 0.1 OUTLIER -134.5 160.27 38.53 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 110.424 -0.213 . . . . 1.39 110.424 -179.986 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 180' ' ' HIS . . . . . 0.697 ' CE1' ' HB3' ' A' ' 77' ' ' ASP . 2.9 t60 -156.21 134.05 11.12 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 109.886 -0.412 . . . . 2.73 109.886 -176.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 181' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.02 131.88 52.37 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 109.414 -0.588 . . . . 3.06 109.414 -179.08 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 182' ' ' ASP . . . . . 0.684 ' HB3' ' HB2' ' B' ' 173' ' ' CYS . 1.2 p-10 -140.47 133.54 14.83 Favored Pre-proline 0 CA--C 1.541 0.602 0 C-N-CA 120.937 -0.305 . . . . 2.06 111.701 -177.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 183' ' ' PRO . . . . . 0.546 ' HA ' ' HB2' ' B' ' 186' ' ' ASP . 5.9 Cg_exo -79.51 -12.11 14.03 Favored 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 122.684 2.256 . . . . 2.27 113.065 -179.236 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -63.65 -41.61 98.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.836 0.35 . . . . 1.56 111.026 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 185' ' ' CYS . . . . . 1.054 ' HB3' ' HA ' ' B' ' 170' ' ' ALA . 26.7 m -99.7 22.38 11.04 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.153 -0.476 . . . . 1.94 111.293 179.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 186' ' ' ASP . . . . . 0.546 ' HB2' ' HA ' ' B' ' 183' ' ' PRO . 0.5 OUTLIER . . . . . 0 CA--C 1.504 -0.82 0 N-CA-C 113.927 1.084 . . . . 3.61 113.927 179.136 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 1.04 ' HB3' ' HG2' ' A' ' 20' ' ' ARG . 0.6 OUTLIER . . . . . 0 N--CA 1.44 -0.93 0 CA-C-O 118.743 -0.646 . . . . 2.89 112.154 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.735 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 4.3 mm? -30.68 108.48 0.26 Allowed Pre-proline 0 N--CA 1.474 0.751 0 CA-C-N 119.208 0.913 . . . . 2.89 110.408 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.725 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 49.4 Cg_endo -100.0 114.42 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 123.085 2.523 . . . . 1.72 114.58 -177.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.746 ' HB2' ' HB3' ' A' ' 43' ' ' ARG . 0.1 OUTLIER -132.97 -157.77 0.84 Allowed 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 119.759 -0.162 . . . . 1.0 110.582 -178.465 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.612 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . 80.62 -158.77 41.63 Favored Glycine 0 CA--C 1.507 -0.409 0 CA-C-O 118.564 -1.131 . . . . 1.15 111.202 -177.299 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.475 ' HD3' ' CG ' ' A' ' 40' ' ' GLU . 84.4 Cg_endo -64.77 84.02 0.17 Allowed 'Trans proline' 0 CA--C 1.515 -0.474 0 CA-C-N 121.122 2.461 . . . . 1.6 115.035 -176.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.07 1.33 84.67 Favored Glycine 0 C--N 1.283 -2.388 0 CA-C-N 111.621 -2.536 . . . . 1.68 114.474 -178.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.625 ' O ' ' HB2' ' A' ' 12' ' ' PRO . . . 85.87 42.73 6.65 Favored Glycine 0 N--CA 1.431 -1.659 0 N-CA-C 117.38 1.712 . . . . 1.37 117.38 174.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -94.63 -14.94 24.43 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-N 114.443 -0.878 . . . . 2.91 111.799 175.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.725 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -107.7 179.39 21.93 Favored Glycine 0 N--CA 1.468 0.807 0 N-CA-C 109.478 -1.449 . . . . 1.06 109.478 -179.338 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 1.04 ' HG2' ' HB3' ' A' ' 10' ' ' CYS . 0.3 OUTLIER -120.34 174.01 6.78 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 120.833 2.316 . . . . 3.32 110.982 179.021 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 12.7 m -107.3 156.37 18.95 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.028 0.442 . . . . 1.19 112.005 -179.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.516 ' HB2' HG23 ' A' ' 26' ' ' ILE . 56.9 m-85 -143.54 16.9 1.84 Allowed 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.601 -0.727 . . . . 2.26 111.231 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.512 ' O ' ' HB3' ' A' ' 44' ' ' CYS . . . 162.45 -143.91 9.17 Favored Glycine 0 C--N 1.331 0.256 0 C-N-CA 120.743 -0.741 . . . . 1.05 112.093 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.42 ' O ' ' HB2' ' A' ' 44' ' ' CYS . 12.1 Cg_endo -90.08 -72.88 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 123.054 2.503 . . . . 1.81 112.579 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.421 ' O ' ' HA ' ' A' ' 36' ' ' VAL . 0.4 OUTLIER -91.79 35.6 0.97 Allowed 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 110.265 -0.272 . . . . 1.62 110.265 179.525 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.98 ' CG1' HG11 ' A' ' 36' ' ' VAL . 13.3 mt -139.81 98.92 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 N-CA-C 113.664 0.987 . . . . 1.39 113.664 -178.228 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.818 ' HB2' ' HA ' ' A' ' 41' ' ' ALA . 3.7 t -119.71 108.71 14.76 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 107.376 -1.342 . . . . 0.92 107.376 176.114 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.741 ' CB ' ' HB3' ' A' ' 68' ' ' ALA . 4.3 m -121.94 161.67 22.45 Favored 'General case' 0 N--CA 1.429 -1.516 0 CA-C-N 114.374 -1.285 . . . . 1.28 112.703 -176.348 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -142.02 -173.42 14.08 Favored Glycine 0 N--CA 1.426 -2.027 0 CA-C-N 113.454 -1.703 . . . . 0.71 110.096 175.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.425 ' OD2' ' HG2' ' A' ' 31' ' ' GLU . 17.4 p-10 -67.3 -52.6 38.6 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 112.578 0.585 . . . . 2.27 112.578 -179.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.425 ' HG2' ' OD2' ' A' ' 30' ' ' ASP . 0.4 OUTLIER -119.17 19.12 12.96 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 122.411 1.1 . . . . 1.66 109.468 -178.703 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.753 HD22 ' CE1' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -113.73 -12.32 12.8 Favored 'General case' 0 N--CA 1.415 -2.208 0 CA-C-N 112.902 -1.954 . . . . 1.93 106.665 -178.923 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.689 ' HA2' ' CB ' ' A' ' 69' ' ' ALA . . . 52.81 -134.1 39.88 Favored Glycine 0 N--CA 1.415 -2.727 0 CA-C-N 113.952 -1.476 . . . . 0.77 113.831 177.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.579 ' O ' ' N ' ' B' ' 136' ' ' VAL . 0.9 OUTLIER -127.28 119.99 27.6 Favored 'General case' 0 N--CA 1.429 -1.519 0 N-CA-C 116.024 1.861 . . . . 1.08 116.024 -178.188 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.818 ' HB3' ' CG2' ' A' ' 38' ' ' THR . 8.4 m-85 -95.37 105.06 16.99 Favored 'General case' 0 N--CA 1.417 -2.082 1 N-CA-C 99.622 -4.214 . . . . 1.85 99.622 173.175 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.98 HG11 ' CG1' ' A' ' 26' ' ' ILE . 2.2 t -103.04 88.27 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.642 0 CA-C-O 122.794 1.283 . . . . 1.29 110.273 -176.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.452 ' O ' ' O ' ' A' ' 38' ' ' THR . . . 120.21 -46.48 1.12 Allowed Glycine 0 N--CA 1.461 0.323 0 CA-C-N 113.397 -1.729 . . . . 0.85 115.684 178.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.818 ' CG2' ' HB3' ' A' ' 35' ' ' PHE . 3.2 t -47.36 -174.66 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 117.305 0.553 . . . . 1.3 111.906 -178.529 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.427 ' N ' ' OG1' ' A' ' 38' ' ' THR . . . -70.17 -23.73 63.02 Favored 'General case' 0 CA--C 1.515 -0.393 0 O-C-N 121.817 -0.552 . . . . 1.45 112.445 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.528 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 1.3 mp0 -60.06 -28.04 67.46 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.586 -0.279 . . . . 2.32 110.769 179.256 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.818 ' HA ' ' HB2' ' A' ' 27' ' ' CYS . . . -93.14 -22.74 18.9 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 122.221 0.208 . . . . 1.11 111.313 -179.086 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.0 mt -49.7 -39.76 37.97 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 121.238 0.542 . . . . 1.68 110.716 179.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.746 ' HB3' ' HB2' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -56.6 -17.7 9.48 Favored 'General case' 0 CA--C 1.496 -1.123 0 CA-C-N 115.622 -0.717 . . . . 3.4 109.704 178.561 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.512 ' HB3' ' O ' ' A' ' 23' ' ' GLY . 68.0 m -75.31 0.45 16.68 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 120.042 1.292 . . . . 1.57 112.036 -179.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 71.4 tp60 -60.88 -21.32 63.18 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.066 0.46 . . . . 3.49 110.216 178.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -85.8 2.8 44.21 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 119.753 -0.779 . . . . 3.69 111.112 -179.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.447 -0.583 0 CA-C-N 116.147 -0.479 . . . . 3.99 109.739 177.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.584 ' HA ' ' HE3' ' A' ' 59' ' ' LYS . 8.1 t . . . . . 0 N--CA 1.445 -0.717 0 N-CA-C 109.213 -0.662 . . . . 3.36 109.213 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 178.36 -86.64 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 119.998 -1.096 . . . . 2.3 113.15 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.935 ' HB3' ' HB3' ' A' ' 67' ' ' CYS . 15.6 mt-30 -120.6 85.94 2.48 Favored 'General case' 0 N--CA 1.417 -2.081 0 N-CA-C 107.55 -1.278 . . . . 5.06 107.55 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 1.256 ' O ' ' HA ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -136.44 -52.38 0.02 OUTLIER Pre-proline 0 C--N 1.305 -1.333 0 N-CA-C 106.562 -1.644 . . . . 3.91 106.562 179.799 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.762 ' HD2' ' H ' ' A' ' 59' ' ' LYS . 43.8 Cg_endo -84.96 108.5 1.18 Allowed 'Trans proline' 0 C--N 1.298 -2.126 0 CA-C-N 120.404 1.18 . . . . 1.74 114.076 177.009 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.562 ' O ' ' O ' ' A' ' 62' ' ' GLY . 3.0 t -142.95 -176.99 5.12 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 113.979 -1.464 . . . . 1.9 108.565 178.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.562 ' O ' ' O ' ' A' ' 61' ' ' CYS . . . 33.46 -166.19 0.01 OUTLIER Glycine 0 CA--C 1.524 0.598 0 C-N-CA 120.729 -0.748 . . . . 2.43 114.468 176.337 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -83.23 50.32 1.73 Allowed 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 122.423 1.106 . . . . 4.32 111.237 179.243 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 121.5 5.18 9.46 Favored Glycine 0 N--CA 1.474 1.172 0 CA-C-N 112.995 -1.911 . . . . 2.4 115.041 171.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.474 ' O ' ' N ' ' A' ' 61' ' ' CYS . . . -103.72 158.31 17.14 Favored Glycine 0 C--N 1.336 0.535 0 C-N-CA 120.957 -0.64 . . . . 1.82 112.767 -178.521 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 1.256 ' HA ' ' O ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -88.44 152.69 21.73 Favored 'General case' 0 CA--C 1.477 -1.863 0 CA-C-O 121.367 0.603 . . . . 3.51 112.295 -178.865 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.935 ' HB3' ' HB3' ' A' ' 58' ' ' GLN . 0.1 OUTLIER -73.75 108.2 6.44 Favored 'General case' 1 N--CA 1.374 -4.243 0 N-CA-C 107.254 -1.388 . . . . 1.52 107.254 178.145 . . . . . . . . 4 4 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.741 ' HB3' ' CB ' ' A' ' 28' ' ' CYS . . . -80.66 -57.24 3.66 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 104.873 -2.269 . . . . 1.5 104.873 178.098 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.689 ' CB ' ' HA2' ' A' ' 33' ' ' GLY . . . -154.42 161.8 41.51 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 111.785 -2.461 . . . . 1.31 111.636 -173.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.874 ' HA ' ' O ' ' A' ' 85' ' ' CYS . . . -32.8 122.7 0.36 Allowed 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 114.693 1.368 . . . . 1.5 114.693 -179.058 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.741 ' O ' ' HA ' ' A' ' 81' ' ' GLU . . . 59.45 -5.5 0.09 OUTLIER Glycine 0 CA--C 1.533 1.203 0 N-CA-C 116.801 1.48 . . . . 1.44 116.801 178.322 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.405 ' CD1' ' HB2' ' A' ' 34' ' ' CYS . 1.9 pp -121.04 100.07 8.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 122.73 1.252 . . . . 2.77 109.85 177.297 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.539 ' HB3' ' HB3' ' A' ' 61' ' ' CYS . 58.5 m -110.25 111.99 23.67 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 113.481 -1.69 . . . . 1.98 110.189 -177.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.575 ' HA ' ' O ' ' A' ' 78' ' ' GLY . 5.3 m -83.46 133.83 34.89 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 113.531 0.937 . . . . 1.43 113.531 -177.037 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.817 ' HB2' ' HD2' ' A' ' 76' ' ' PRO . 28.9 p -95.62 -179.06 0.86 Allowed Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 113.869 -1.514 . . . . 2.37 107.248 177.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.817 ' HD2' ' HB2' ' A' ' 75' ' ' SER . 57.5 Cg_endo -71.61 31.11 0.24 Allowed 'Trans proline' 0 CA--C 1.532 0.376 0 CA-C-N 120.56 1.236 . . . . 2.09 112.113 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.528 ' H ' ' C ' ' A' ' 75' ' ' SER . 3.0 p30 -145.67 -46.09 0.21 Allowed 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 115.899 -0.591 . . . . 2.65 111.661 179.43 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 1.149 ' HA3' ' O ' ' B' ' 179' ' ' CYS . . . -160.76 -151.54 6.26 Favored Glycine 0 C--N 1.349 1.28 0 C-N-CA 120.314 -0.946 . . . . 1.04 115.242 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 1.19 ' O ' ' HA3' ' B' ' 178' ' ' GLY . 32.3 m -128.87 133.75 48.05 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-O 123.377 1.561 . . . . 1.42 110.703 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 28.8 p80 -146.04 135.2 22.76 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 112.27 -2.241 . . . . 2.81 112.495 -169.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.741 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 34.4 mt-10 -51.91 123.88 11.38 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 114.132 -1.395 . . . . 3.05 111.067 -179.454 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.575 ' OD1' ' HB1' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -146.78 126.04 6.52 Favored Pre-proline 0 C--N 1.317 -0.845 0 CA-C-N 115.044 -0.98 . . . . 2.02 109.293 -179.656 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -54.77 -13.53 6.19 Favored 'Trans proline' 0 N--CA 1.482 0.838 0 C-N-CA 124.038 3.158 . . . . 2.29 116.21 -177.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.575 ' HB1' ' OD1' ' A' ' 82' ' ' ASP . . . -71.42 -32.1 67.99 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 115.094 1.516 . . . . 1.53 115.094 -177.419 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.874 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 0.1 OUTLIER -91.15 -4.24 56.34 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 115.262 1.579 . . . . 1.88 115.262 -176.158 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.2 t70 . . . . . 0 C--N 1.32 -0.696 0 N-CA-C 113.215 0.82 . . . . 3.6 113.215 -178.737 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 110' ' ' CYS . . . . . 1.12 ' HB3' ' HG2' ' B' ' 120' ' ' ARG . 0.6 OUTLIER . . . . . 0 N--CA 1.438 -1.029 0 CA-C-O 119.026 -0.511 . . . . 2.87 111.854 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 111' ' ' LEU . . . . . 0.747 ' O ' ' HA ' ' B' ' 120' ' ' ARG . 4.2 mm? -30.64 108.54 0.26 Allowed Pre-proline 0 N--CA 1.474 0.743 0 CA-C-N 118.799 0.727 . . . . 2.95 110.271 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 112' ' ' PRO . . . . . 0.719 ' HA ' ' O ' ' B' ' 119' ' ' GLY . 49.9 Cg_endo -100.87 111.93 0.06 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.896 2.397 . . . . 1.71 115.3 -177.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.725 ' HB2' ' HB3' ' B' ' 143' ' ' ARG . 0.1 OUTLIER -129.79 -156.75 0.78 Allowed 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 116.849 -0.159 . . . . 1.0 110.81 -178.476 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 114' ' ' GLY . . . . . 0.613 ' N ' ' SG ' ' B' ' 113' ' ' CYS . . . 80.45 -158.82 42.03 Favored Glycine 0 CA--C 1.506 -0.479 0 CA-C-O 118.714 -1.048 . . . . 1.16 111.276 -177.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 115' ' ' PRO . . . . . 0.487 ' HD3' ' CG ' ' B' ' 140' ' ' GLU . 88.4 Cg_endo -64.97 82.82 0.18 Allowed 'Trans proline' 0 CA--C 1.508 -0.809 0 CA-C-N 120.871 2.336 . . . . 1.6 115.659 -176.259 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 88.95 0.71 80.79 Favored Glycine 0 N--CA 1.415 -2.754 0 CA-C-N 111.949 -2.387 . . . . 1.7 115.096 -178.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 117' ' ' GLY . . . . . 0.628 ' O ' ' HB2' ' B' ' 112' ' ' PRO . . . 93.07 33.27 7.39 Favored Glycine 0 N--CA 1.429 -1.823 0 CA-C-N 120.577 2.189 . . . . 1.38 117.359 174.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -94.02 -14.03 26.29 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 112.828 0.677 . . . . 2.96 112.828 177.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 119' ' ' GLY . . . . . 0.719 ' O ' ' HA ' ' B' ' 112' ' ' PRO . . . -111.98 -174.63 19.68 Favored Glycine 0 C--N 1.345 1.072 0 CA-C-O 117.37 -1.794 . . . . 1.07 108.907 179.042 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 1.12 ' HG2' ' HB3' ' B' ' 110' ' ' CYS . 0.2 OUTLIER -123.59 175.36 6.85 Favored 'General case' 0 C--N 1.349 0.584 0 CA-C-N 122.52 3.16 . . . . 3.29 110.318 -179.032 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 121' ' ' CYS . . . . . . . . . . . . . 10.9 m -106.94 156.56 18.58 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.171 0.51 . . . . 1.21 112.123 -179.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 122' ' ' PHE . . . . . 0.569 ' HE1' ' O ' ' B' ' 128' ' ' CYS . 56.2 m-85 -143.53 17.11 1.84 Allowed 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.497 -0.774 . . . . 2.28 111.163 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 123' ' ' GLY . . . . . 0.517 ' O ' ' HB3' ' B' ' 144' ' ' CYS . . . 162.28 -144.0 9.28 Favored Glycine 0 CA--C 1.519 0.289 0 C-N-CA 120.856 -0.688 . . . . 1.04 112.139 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . 0.474 ' O ' ' HB2' ' B' ' 144' ' ' CYS . 12.1 Cg_endo -89.99 -73.05 0.0 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 123.016 2.477 . . . . 1.84 112.607 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 125' ' ' SER . . . . . 0.43 ' O ' ' HA ' ' B' ' 136' ' ' VAL . 0.4 OUTLIER -91.28 35.31 0.93 Allowed 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 110.108 -0.33 . . . . 1.49 110.108 179.431 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 126' ' ' ILE . . . . . 0.58 HG23 ' SG ' ' B' ' 128' ' ' CYS . 17.9 mt -139.38 98.14 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 114.007 1.114 . . . . 1.41 114.007 -178.02 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 127' ' ' CYS . . . . . 0.779 ' HB2' ' HA ' ' B' ' 141' ' ' ALA . 3.7 t -119.83 109.31 15.43 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 107.553 -1.277 . . . . 0.89 107.553 176.345 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 128' ' ' CYS . . . . . 0.733 ' HB3' ' O ' ' B' ' 133' ' ' GLY . 3.7 m -132.31 148.13 52.42 Favored 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 115.259 1.577 . . . . 1.23 115.259 -175.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 129' ' ' GLY . . . . . . . . . . . . . . . -126.9 -168.1 12.48 Favored Glycine 0 N--CA 1.429 -1.812 0 N-CA-C 109.874 -1.291 . . . . 0.69 109.874 179.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 130' ' ' ASP . . . . . 0.408 ' OD2' ' HG2' ' B' ' 131' ' ' GLU . 17.9 p-10 -69.1 -54.01 17.28 Favored 'General case' 0 CA--C 1.491 -1.303 0 C-N-CA 123.396 0.678 . . . . 2.35 112.199 -179.091 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 131' ' ' GLU . . . . . 0.408 ' HG2' ' OD2' ' B' ' 130' ' ' ASP . 0.3 OUTLIER -119.56 28.11 8.36 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 117.495 -1.682 . . . . 1.69 109.215 179.609 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 132' ' ' LEU . . . . . 0.648 ' O ' ' HB ' ' A' ' 38' ' ' THR . 0.7 OUTLIER -121.47 -12.2 8.6 Favored 'General case' 0 N--CA 1.424 -1.741 0 N-CA-C 104.289 -2.485 . . . . 1.84 104.289 -175.709 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 133' ' ' GLY . . . . . 0.742 ' HA2' ' CB ' ' B' ' 169' ' ' ALA . . . 48.91 -136.08 20.1 Favored Glycine 0 N--CA 1.407 -3.249 0 CA-C-N 112.831 -1.986 . . . . 0.76 113.359 176.334 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 134' ' ' CYS . . . . . 0.573 ' O ' ' N ' ' A' ' 36' ' ' VAL . 1.1 m -118.88 125.7 50.1 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.273 1.212 . . . . 1.08 114.273 -176.584 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 135' ' ' PHE . . . . . 0.788 ' HB3' ' CG2' ' B' ' 138' ' ' THR . 8.8 m-85 -102.17 104.2 14.77 Favored 'General case' 0 N--CA 1.431 -1.394 1 N-CA-C 99.508 -4.256 . . . . 1.83 99.508 169.628 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 136' ' ' VAL . . . . . 0.766 HG22 ' SG ' ' B' ' 179' ' ' CYS . 2.5 t -103.43 89.3 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.629 0 CA-C-O 122.594 1.188 . . . . 1.29 110.17 -176.257 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 137' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' B' ' 125' ' ' SER . . . 119.24 -47.61 1.01 Allowed Glycine 0 CA--C 1.519 0.3 0 CA-C-N 113.688 -1.596 . . . . 0.85 115.582 179.177 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 138' ' ' THR . . . . . 0.788 ' CG2' ' HB3' ' B' ' 135' ' ' PHE . 3.5 t -50.52 179.53 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 117.418 0.609 . . . . 1.2 112.266 -178.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 139' ' ' ALA . . . . . 0.494 ' HA ' HD11 ' B' ' 142' ' ' LEU . . . -58.08 -36.3 72.65 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.938 -1.028 . . . . 1.35 111.09 -178.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 140' ' ' GLU . . . . . 0.526 ' O ' ' SG ' ' B' ' 113' ' ' CYS . 1.3 mp0 -53.82 -27.71 31.08 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.761 0.282 . . . . 2.31 111.761 -178.384 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 141' ' ' ALA . . . . . 0.779 ' HA ' ' HB2' ' B' ' 127' ' ' CYS . . . -88.46 -33.82 17.69 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 116.123 -0.49 . . . . 1.09 109.929 -179.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 142' ' ' LEU . . . . . 0.494 HD11 ' HA ' ' B' ' 139' ' ' ALA . 6.2 mt -42.31 -41.15 2.7 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.013 -0.54 . . . . 1.61 111.748 -178.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 143' ' ' ARG . . . . . 0.725 ' HB3' ' HB2' ' B' ' 113' ' ' CYS . 0.0 OUTLIER -52.55 -26.15 12.44 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 109.354 -0.61 . . . . 3.43 109.354 178.073 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 144' ' ' CYS . . . . . 0.552 ' N ' ' O ' ' B' ' 141' ' ' ALA . 56.9 m -61.2 -16.56 46.17 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.316 -1.311 . . . . 1.61 110.702 -176.147 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 68.4 tp60 -52.68 -22.38 5.08 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 111.879 0.326 . . . . 3.52 111.879 -179.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -85.79 3.02 43.33 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 119.602 -0.839 . . . . 3.76 110.968 -179.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.448 -0.561 0 CA-C-N 116.056 -0.52 . . . . 4.01 109.686 177.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 156' ' ' SER . . . . . 0.601 ' HA ' ' HE3' ' B' ' 159' ' ' LYS . 7.5 t . . . . . 0 N--CA 1.448 -0.567 0 N-CA-C 108.728 -0.842 . . . . 3.41 108.728 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 176.41 -87.6 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 119.926 -1.13 . . . . 2.26 112.967 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 158' ' ' GLN . . . . . 0.977 ' HB3' ' HB3' ' B' ' 167' ' ' CYS . 16.6 mt-30 -120.92 71.22 0.93 Allowed 'General case' 0 N--CA 1.418 -2.047 0 CA-C-O 122.151 0.976 . . . . 5.03 109.292 179.439 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 159' ' ' LYS . . . . . 1.302 ' O ' ' HA ' ' B' ' 166' ' ' ARG . 0.0 OUTLIER -107.28 -58.57 0.05 OUTLIER Pre-proline 0 C--O 1.205 -1.238 0 CA-C-O 123.72 1.724 . . . . 3.96 110.701 174.48 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 160' ' ' PRO . . . . . 0.681 ' HD2' ' H ' ' B' ' 159' ' ' LYS . 49.5 Cg_endo -85.03 108.0 1.12 Allowed 'Trans proline' 0 N--CA 1.442 -1.553 0 C-N-CA 122.466 2.11 . . . . 1.7 114.76 -176.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 161' ' ' CYS . . . . . 0.595 ' SG ' ' HB1' ' B' ' 184' ' ' ALA . 3.1 t -143.87 -177.8 5.61 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 113.452 -1.704 . . . . 1.93 108.632 178.609 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 162' ' ' GLY . . . . . 0.506 ' O ' ' O ' ' B' ' 161' ' ' CYS . . . 35.49 -166.58 0.01 OUTLIER Glycine 0 CA--C 1.519 0.309 0 C-N-CA 121.077 -0.583 . . . . 2.37 114.414 176.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.89 51.47 1.74 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 121.052 -0.259 . . . . 4.56 111.238 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 119.64 3.83 12.22 Favored Glycine 0 CA--C 1.529 0.93 0 N-CA-C 114.631 0.613 . . . . 2.39 114.631 178.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 165' ' ' GLY . . . . . 0.48 ' O ' ' N ' ' B' ' 161' ' ' CYS . . . -102.73 157.85 17.99 Favored Glycine 0 C--O 1.226 -0.385 0 C-N-CA 120.143 -1.027 . . . . 1.79 112.754 179.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 166' ' ' ARG . . . . . 1.302 ' HA ' ' O ' ' B' ' 159' ' ' LYS . 0.0 OUTLIER -88.57 152.59 21.75 Favored 'General case' 0 CA--C 1.48 -1.73 0 C-N-CA 120.325 -0.55 . . . . 3.53 111.962 -179.625 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 167' ' ' CYS . . . . . 0.977 ' HB3' ' HB3' ' B' ' 158' ' ' GLN . 0.1 OUTLIER -73.68 108.42 6.51 Favored 'General case' 1 N--CA 1.375 -4.212 0 N-CA-C 107.261 -1.385 . . . . 1.56 107.261 178.15 . . . . . . . . 4 4 . 1 . 013 nuclear orig core ' B' B ' 168' ' ' ALA . . . . . 0.521 ' HB2' ' CB ' ' B' ' 128' ' ' CYS . . . -83.5 -49.36 9.34 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 117.627 -1.629 . . . . 1.42 107.065 178.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 169' ' ' ALA . . . . . 0.742 ' CB ' ' HA2' ' B' ' 133' ' ' GLY . . . -161.08 161.54 31.3 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 112.5 -2.136 . . . . 1.18 111.03 -175.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 170' ' ' ALA . . . . . 0.886 ' HA ' ' O ' ' B' ' 185' ' ' CYS . . . -32.69 123.31 0.35 Allowed 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 114.846 1.424 . . . . 1.47 114.846 -179.143 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 171' ' ' GLY . . . . . 0.688 ' O ' ' HA ' ' B' ' 181' ' ' GLU . . . 65.16 -19.18 0.12 Allowed Glycine 0 CA--C 1.529 0.962 0 N-CA-C 116.47 1.348 . . . . 1.45 116.47 177.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 172' ' ' ILE . . . . . . . . . . . . . 2.0 pp -113.16 101.37 12.4 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 CA-C-O 122.684 1.231 . . . . 2.7 110.529 -179.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 173' ' ' CYS . . . . . 0.511 ' HB3' ' HB3' ' B' ' 161' ' ' CYS . 59.3 m -110.27 112.21 24.03 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 113.851 -1.522 . . . . 1.94 110.131 -178.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 174' ' ' CYS . . . . . 0.569 ' HA ' ' O ' ' B' ' 178' ' ' GLY . 5.5 m -83.66 133.75 34.81 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 113.56 0.948 . . . . 1.43 113.56 -176.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 175' ' ' SER . . . . . 0.796 ' HB2' ' HD2' ' B' ' 176' ' ' PRO . 28.3 p -95.66 -178.99 0.85 Allowed Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 113.893 -1.503 . . . . 2.3 107.238 177.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 176' ' ' PRO . . . . . 0.796 ' HD2' ' HB2' ' B' ' 175' ' ' SER . 57.4 Cg_endo -71.65 31.08 0.25 Allowed 'Trans proline' 0 CA--C 1.532 0.405 0 CA-C-N 120.584 1.244 . . . . 2.13 112.106 -179.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 177' ' ' ASP . . . . . 0.523 ' H ' ' C ' ' B' ' 175' ' ' SER . 3.0 p30 -145.58 -46.01 0.21 Allowed 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 115.906 -0.588 . . . . 2.72 111.743 179.422 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 178' ' ' GLY . . . . . 1.19 ' HA3' ' O ' ' A' ' 79' ' ' CYS . . . -161.07 -151.19 6.15 Favored Glycine 0 C--N 1.35 1.335 0 C-N-CA 120.295 -0.955 . . . . 1.05 115.033 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 179' ' ' CYS . . . . . 1.149 ' O ' ' HA3' ' A' ' 78' ' ' GLY . 32.7 m -128.66 139.35 52.29 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 122.649 1.214 . . . . 1.39 110.195 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 180' ' ' HIS . . . . . . . . . . . . . 33.3 p80 -156.87 133.11 9.79 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 123.619 1.676 . . . . 2.73 112.367 -168.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 181' ' ' GLU . . . . . 0.688 ' HA ' ' O ' ' B' ' 171' ' ' GLY . 33.8 mt-10 -49.55 123.14 7.19 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 110.967 -2.833 . . . . 3.06 110.733 -177.323 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 182' ' ' ASP . . . . . 0.52 ' OD1' ' HB1' ' B' ' 184' ' ' ALA . 0.1 OUTLIER -146.79 126.06 6.52 Favored Pre-proline 0 C--N 1.315 -0.916 0 CA-C-N 114.677 -1.147 . . . . 2.06 109.103 -179.725 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 183' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -54.82 -13.53 6.26 Favored 'Trans proline' 0 N--CA 1.482 0.85 0 C-N-CA 123.981 3.121 . . . . 2.27 116.241 -177.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 184' ' ' ALA . . . . . 0.595 ' HB1' ' SG ' ' B' ' 161' ' ' CYS . . . -71.77 -31.59 66.78 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 114.974 1.472 . . . . 1.56 114.974 -177.265 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 185' ' ' CYS . . . . . 0.886 ' O ' ' HA ' ' B' ' 170' ' ' ALA . 0.1 OUTLIER -91.1 -4.55 56.16 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 115.298 1.592 . . . . 1.94 115.298 -176.329 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 186' ' ' ASP . . . . . . . . . . . . . 2.2 t70 . . . . . 0 C--N 1.321 -0.664 0 N-CA-C 113.392 0.886 . . . . 3.61 113.392 -178.753 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.587 ' HB2' ' HG2' ' A' ' 20' ' ' ARG . 77.3 m . . . . . 0 N--CA 1.463 0.214 0 CA-C-O 118.766 -0.635 . . . . 2.89 112.525 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.501 ' C ' ' O ' ' A' ' 10' ' ' CYS . 17.4 mt -30.8 136.17 0.21 Allowed Pre-proline 0 N--CA 1.477 0.884 0 CA-C-N 119.033 0.833 . . . . 2.89 111.251 177.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.697 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 41.5 Cg_endo -69.55 147.88 65.18 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.763 2.308 . . . . 1.72 114.881 -178.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.734 ' N ' ' O ' ' A' ' 19' ' ' GLY . 0.0 OUTLIER -149.91 -166.39 2.53 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-O 121.659 0.742 . . . . 1.0 110.951 176.675 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.636 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . 76.16 -159.59 50.54 Favored Glycine 0 C--N 1.337 0.624 0 CA-C-N 114.683 -1.144 . . . . 1.15 114.767 175.269 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.515 ' O ' ' HG2' ' A' ' 15' ' ' PRO . 62.8 Cg_endo -62.1 101.94 0.25 Allowed 'Trans proline' 0 CA--C 1.511 -0.625 0 C-N-CA 124.301 3.334 . . . . 1.6 110.645 177.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.53 -7.74 75.04 Favored Glycine 0 C--N 1.268 -3.198 0 CA-C-N 113.901 -1.499 . . . . 1.68 112.422 179.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 79.33 49.48 6.24 Favored Glycine 0 N--CA 1.397 -3.925 0 C-N-CA 119.714 -1.231 . . . . 1.37 113.515 -179.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.73 -49.91 6.02 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 103.567 -2.753 . . . . 2.91 103.567 173.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.734 ' O ' ' N ' ' A' ' 13' ' ' CYS . . . -67.6 165.1 44.69 Favored Glycine 0 C--O 1.219 -0.816 0 C-N-CA 117.985 -2.055 . . . . 1.06 117.404 -165.523 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.587 ' HG2' ' HB2' ' A' ' 10' ' ' CYS . 0.1 OUTLIER -104.03 147.05 27.83 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 112.691 -1.755 . . . . 3.32 114.667 -172.864 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.45 ' O ' ' HB3' ' A' ' 10' ' ' CYS . 74.1 m -108.9 139.56 43.57 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 114.785 -1.098 . . . . 1.19 111.423 -179.532 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.607 ' CE1' ' HB2' ' A' ' 28' ' ' CYS . 1.4 m-85 -124.41 -9.78 7.47 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.238 -0.437 . . . . 2.26 112.065 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.474 ' HA3' ' OE2' ' B' ' 181' ' ' GLU . . . -159.05 -161.12 10.86 Favored Glycine 0 C--N 1.334 0.459 0 C-N-CA 120.677 -0.773 . . . . 1.05 112.576 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.561 ' HD2' ' HG2' ' B' ' 181' ' ' GLU . 7.6 Cg_exo -69.76 -53.02 0.29 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.967 2.445 . . . . 1.81 112.24 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.598 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.4 OUTLIER -118.78 44.25 2.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.015 -0.539 . . . . 1.62 110.841 -179.756 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 1.005 HG12 HG11 ' A' ' 36' ' ' VAL . 59.8 mt -142.52 121.21 8.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 N-CA-C 112.609 0.596 . . . . 1.39 112.609 -179.059 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.838 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 6.4 t -135.45 144.2 46.32 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-N 115.417 -0.811 . . . . 0.92 109.075 178.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.942 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 0.5 OUTLIER -136.35 157.66 46.27 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 122.361 1.076 . . . . 1.28 113.884 -177.08 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.558 ' HA3' ' HB2' ' A' ' 32' ' ' LEU . . . -151.05 169.33 30.76 Favored Glycine 0 N--CA 1.416 -2.653 0 CA-C-N 113.812 -1.54 . . . . 0.71 110.561 176.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.429 ' OD2' ' HG3' ' A' ' 31' ' ' GLU . 15.3 p-10 -64.37 -48.4 75.64 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 122.79 1.281 . . . . 2.27 108.695 178.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.429 ' HG3' ' OD2' ' A' ' 30' ' ' ASP . 1.3 mt-10 -120.38 17.15 12.21 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 113.149 -1.842 . . . . 1.66 109.157 179.543 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.728 HD21 ' CE2' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -120.2 -2.71 10.1 Favored 'General case' 0 N--CA 1.411 -2.422 0 C-N-CA 123.71 0.804 . . . . 1.93 109.334 -177.275 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.942 ' O ' ' HA ' ' A' ' 28' ' ' CYS . . . 47.63 -131.41 16.42 Favored Glycine 0 N--CA 1.433 -1.557 0 CA-C-N 114.887 -1.051 . . . . 0.77 113.616 178.041 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.838 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 0.1 OUTLIER -138.68 113.27 8.96 Favored 'General case' 0 CA--C 1.481 -1.699 0 CA-C-N 118.546 1.173 . . . . 1.08 112.119 179.365 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.728 ' CE2' HD21 ' A' ' 32' ' ' LEU . 26.5 m-85 -86.49 108.12 18.39 Favored 'General case' 0 N--CA 1.425 -1.722 0 N-CA-C 104.993 -2.225 . . . . 1.85 104.993 176.063 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 1.005 HG11 HG12 ' A' ' 26' ' ' ILE . 5.1 t -91.77 85.42 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.756 0 C-N-CA 118.341 -1.344 . . . . 1.29 108.933 -179.098 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.712 ' HA3' HG23 ' B' ' 172' ' ' ILE . . . 89.37 108.12 1.18 Allowed Glycine 0 CA--C 1.524 0.655 0 CA-C-N 112.918 -1.946 . . . . 0.85 115.159 179.179 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.44 ' CG2' ' HB3' ' A' ' 35' ' ' PHE . 0.1 OUTLIER 179.36 168.31 1.06 Allowed 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 107.904 -1.147 . . . . 1.3 107.904 178.588 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.559 ' HA ' ' CD1' ' A' ' 42' ' ' LEU . . . -55.52 -32.93 63.34 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 120.547 1.521 . . . . 1.45 114.008 -177.499 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.586 ' HG2' ' HA2' ' A' ' 14' ' ' GLY . 0.2 OUTLIER -65.27 -23.18 66.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.059 0.457 . . . . 2.32 110.561 179.712 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.584 ' O ' ' N ' ' A' ' 44' ' ' CYS . . . -95.9 -14.71 22.91 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 116.069 -0.514 . . . . 1.11 110.906 -179.042 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.593 ' O ' ' HB2' ' A' ' 45' ' ' GLN . 4.7 mt -46.25 -44.37 16.32 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-N 119.042 0.837 . . . . 1.68 112.379 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.431 ' HD2' ' O ' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -61.91 -10.88 10.59 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 120.095 -0.642 . . . . 3.4 109.68 178.101 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.584 ' N ' ' O ' ' A' ' 41' ' ' ALA . 38.5 m -76.6 4.81 8.57 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 114.171 -1.377 . . . . 1.57 110.155 174.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.593 ' HB2' ' O ' ' A' ' 42' ' ' LEU . 0.7 OUTLIER -78.79 -18.6 53.88 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.982 -0.554 . . . . 3.49 111.268 179.337 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -86.92 -0.37 56.41 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.051 -0.66 . . . . 3.69 110.539 -179.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.448 -0.559 0 N-CA-C 109.537 -0.542 . . . . 3.99 109.537 177.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 17.7 p . . . . . 0 N--CA 1.453 -0.313 0 N-CA-C 108.043 -1.095 . . . . 3.36 108.043 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.624 ' HA3' ' O ' ' A' ' 67' ' ' CYS . . . -82.46 151.72 29.89 Favored Glycine 0 N--CA 1.448 -0.539 0 N-CA-C 109.726 -1.35 . . . . 2.3 109.726 -177.232 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 19.7 mm100 -101.88 77.45 1.71 Allowed 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.976 0.893 . . . . 5.06 109.655 179.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.456 ' HB2' ' HB2' ' A' ' 67' ' ' CYS . 0.0 OUTLIER -141.77 60.47 11.36 Favored Pre-proline 0 C--N 1.31 -1.13 0 N-CA-C 105.746 -1.946 . . . . 3.91 105.746 179.22 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.505 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 30.7 Cg_endo -63.6 78.18 0.14 Allowed 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 122.605 2.203 . . . . 1.74 114.887 -177.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.493 ' O ' ' O ' ' A' ' 65' ' ' GLY . 0.5 OUTLIER -99.26 -176.83 3.42 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 106.468 -1.678 . . . . 1.9 106.468 175.868 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.79 -167.02 51.36 Favored Glycine 0 N--CA 1.442 -0.963 0 C-N-CA 117.945 -2.074 . . . . 2.43 111.809 178.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 20.2 p -86.86 39.41 0.85 Allowed 'General case' 0 N--CA 1.484 1.262 0 CA-C-O 122.223 1.011 . . . . 4.32 111.642 -176.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 120.68 10.38 7.1 Favored Glycine 0 C--N 1.35 1.341 0 CA-C-N 114.013 -1.449 . . . . 2.4 113.886 -178.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.493 ' O ' ' O ' ' A' ' 61' ' ' CYS . . . -103.48 132.99 11.26 Favored Glycine 0 C--N 1.336 0.581 0 C-N-CA 119.657 -1.259 . . . . 1.82 115.401 -178.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.576 ' HB2' ' O ' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -97.29 152.98 18.34 Favored 'General case' 0 C--N 1.333 -0.126 0 C-N-CA 122.84 0.456 . . . . 3.51 110.441 178.555 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.624 ' O ' ' HA3' ' A' ' 57' ' ' GLY . 1.8 m -65.34 108.47 1.95 Allowed 'General case' 0 C--O 1.22 -0.486 0 C-N-CA 120.002 -0.679 . . . . 1.52 110.269 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.61 -15.55 54.31 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 107.802 -1.184 . . . . 1.5 107.802 176.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.859 ' O ' ' O ' ' A' ' 70' ' ' ALA . . . -165.11 162.15 20.02 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 112.801 -2.0 . . . . 1.31 110.405 178.561 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.859 ' O ' ' O ' ' A' ' 69' ' ' ALA . . . -16.99 -138.11 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.078 0.951 . . . . 1.5 113.287 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.583 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . -64.55 61.11 0.07 OUTLIER Glycine 0 N--CA 1.47 0.936 0 N-CA-C 110.184 -1.166 . . . . 1.44 110.184 -179.589 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.822 HD11 ' HB2' ' A' ' 34' ' ' CYS . 0.7 OUTLIER -146.04 106.12 0.69 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.817 0 CA-C-N 114.731 -0.734 . . . . 2.77 109.771 174.962 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.525 ' HB2' ' HB3' ' A' ' 82' ' ' ASP . 0.0 OUTLIER -93.25 83.42 4.62 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 116.236 -0.438 . . . . 1.98 110.407 -179.556 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.83 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 0.1 OUTLIER -83.04 136.63 34.42 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.982 -0.554 . . . . 1.43 110.816 -179.914 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.638 ' HB3' ' HD2' ' A' ' 76' ' ' PRO . 5.0 m -104.76 179.4 0.94 Allowed Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.25 -0.887 . . . . 2.37 109.312 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.638 ' HD2' ' HB3' ' A' ' 75' ' ' SER . 96.4 Cg_endo -79.96 25.08 0.61 Allowed 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 121.443 1.429 . . . . 2.09 111.722 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.409 ' H ' ' C ' ' A' ' 75' ' ' SER . 11.8 m-20 -145.58 -41.42 0.22 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.609 -0.723 . . . . 2.65 110.213 179.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.796 ' HA3' ' O ' ' B' ' 179' ' ' CYS . . . -147.92 -135.29 2.59 Favored Glycine 0 C--N 1.337 0.601 0 C-N-CA 120.574 -0.822 . . . . 1.04 113.07 179.415 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.83 ' HA ' ' HA ' ' A' ' 74' ' ' CYS . 0.1 OUTLIER -146.85 156.45 43.12 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.625 0.25 . . . . 1.42 110.57 179.954 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.474 ' N ' ' O ' ' A' ' 73' ' ' CYS . 6.6 t-160 -142.42 133.76 26.32 Favored 'General case' 0 CA--C 1.519 -0.249 0 O-C-N 121.989 -0.444 . . . . 2.81 111.638 -178.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.633 ' HG3' HD12 ' B' ' 126' ' ' ILE . 2.3 mt-10 -58.56 128.03 35.12 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.901 -0.591 . . . . 3.05 109.717 178.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.525 ' HB3' ' HB2' ' A' ' 73' ' ' CYS . 0.0 OUTLIER -146.28 112.63 4.41 Favored Pre-proline 0 C--N 1.318 -0.799 0 CA-C-N 115.514 -0.766 . . . . 2.02 110.496 -178.928 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.454 ' HA ' ' OD2' ' A' ' 86' ' ' ASP . 1.6 Cg_endo -82.86 -4.4 11.34 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 122.691 2.261 . . . . 2.29 113.231 -179.26 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.99 -35.43 79.94 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.832 0.349 . . . . 1.53 111.048 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.583 ' O ' ' N ' ' A' ' 71' ' ' GLY . 84.4 m -93.64 49.71 1.39 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.107 -0.497 . . . . 1.88 110.869 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.454 ' OD2' ' HA ' ' A' ' 83' ' ' PRO . 16.5 m-20 . . . . . 0 N--CA 1.442 -0.827 0 N-CA-C 112.422 0.527 . . . . 3.6 112.422 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 110' ' ' CYS . . . . . 0.595 ' HB2' ' HG2' ' B' ' 120' ' ' ARG . 79.7 m . . . . . 0 N--CA 1.465 0.318 0 CA-C-O 118.745 -0.645 . . . . 2.87 112.653 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 111' ' ' LEU . . . . . 0.509 ' C ' ' O ' ' B' ' 110' ' ' CYS . 17.8 mt -29.82 136.07 0.18 Allowed Pre-proline 0 N--CA 1.475 0.796 0 CA-C-N 119.034 0.834 . . . . 2.95 111.369 178.412 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 112' ' ' PRO . . . . . 0.74 ' HA ' ' O ' ' B' ' 119' ' ' GLY . 33.6 Cg_endo -65.32 151.99 83.49 Favored 'Trans proline' 0 CA--C 1.536 0.587 0 C-N-CA 123.383 2.722 . . . . 1.71 113.541 -179.34 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.748 ' N ' ' O ' ' B' ' 119' ' ' GLY . 0.0 OUTLIER -156.77 -168.69 2.75 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.232 0.539 . . . . 1.0 111.222 175.471 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 114' ' ' GLY . . . . . 0.66 ' N ' ' SG ' ' B' ' 113' ' ' CYS . . . 76.14 -159.76 50.71 Favored Glycine 0 C--N 1.334 0.437 0 CA-C-N 115.479 -0.782 . . . . 1.16 114.902 176.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 115' ' ' PRO . . . . . 0.67 ' HD2' HD23 ' B' ' 132' ' ' LEU . 68.2 Cg_endo -62.28 98.31 0.18 Allowed 'Trans proline' 0 CA--C 1.511 -0.629 0 C-N-CA 124.215 3.277 . . . . 1.6 112.066 178.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 84.76 3.07 88.38 Favored Glycine 0 C--N 1.284 -2.312 0 CA-C-N 113.63 -1.623 . . . . 1.7 113.132 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 117' ' ' GLY . . . . . 0.431 ' O ' ' HB2' ' B' ' 112' ' ' PRO . . . 76.46 41.31 25.55 Favored Glycine 0 N--CA 1.411 -2.976 0 C-N-CA 119.75 -1.214 . . . . 1.38 115.615 176.36 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.99 -30.1 14.9 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-O 121.809 0.814 . . . . 2.96 110.198 177.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 119' ' ' GLY . . . . . 0.748 ' O ' ' N ' ' B' ' 113' ' ' CYS . . . -78.65 161.39 48.07 Favored Glycine 0 C--O 1.201 -1.909 0 N-CA-C 118.745 2.258 . . . . 1.07 118.745 -175.212 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.595 ' HG2' ' HB2' ' B' ' 110' ' ' CYS . 0.1 OUTLIER -104.24 142.39 34.61 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 110.214 -2.993 . . . . 3.29 113.747 -172.55 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 121' ' ' CYS . . . . . 0.459 ' O ' ' HB3' ' B' ' 110' ' ' CYS . 73.3 m -108.51 138.98 43.92 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 114.777 -1.101 . . . . 1.21 111.23 -178.435 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 122' ' ' PHE . . . . . 0.619 ' CE1' ' HB2' ' B' ' 128' ' ' CYS . 1.4 m-85 -124.42 -9.67 7.46 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.185 -0.461 . . . . 2.28 112.052 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 123' ' ' GLY . . . . . 0.502 ' HA3' ' OE2' ' A' ' 81' ' ' GLU . . . -159.22 -161.3 11.06 Favored Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.6 -0.81 . . . . 1.04 112.465 179.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . 0.562 ' HD2' ' HG2' ' A' ' 81' ' ' GLU . 7.9 Cg_exo -69.54 -52.94 0.31 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.93 2.42 . . . . 1.84 112.302 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 125' ' ' SER . . . . . 0.615 ' O ' ' N ' ' B' ' 137' ' ' GLY . 0.4 OUTLIER -118.75 44.03 2.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.054 -0.521 . . . . 1.49 110.787 -179.811 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 126' ' ' ILE . . . . . 0.633 HD12 ' HG3' ' A' ' 81' ' ' GLU . 57.7 mt -141.8 120.95 10.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 N-CA-C 112.812 0.671 . . . . 1.41 112.812 -179.065 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 127' ' ' CYS . . . . . 0.816 ' O ' ' HA ' ' B' ' 134' ' ' CYS . 7.0 t -135.08 144.79 47.38 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.72 -0.673 . . . . 0.89 109.472 178.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 128' ' ' CYS . . . . . 0.923 ' HA ' ' O ' ' B' ' 133' ' ' GLY . 0.4 OUTLIER -138.99 153.58 48.17 Favored 'General case' 0 CA--C 1.552 1.042 0 N-CA-C 115.541 1.682 . . . . 1.23 115.541 -176.959 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 129' ' ' GLY . . . . . 0.81 ' O ' ' HB3' ' B' ' 169' ' ' ALA . . . -143.25 165.96 26.89 Favored Glycine 0 N--CA 1.43 -1.72 0 CA-C-N 111.262 -2.699 . . . . 0.69 113.767 179.26 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 15.4 p-10 -68.97 -41.64 77.69 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 126.028 1.731 . . . . 2.35 110.706 177.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -129.69 33.65 4.42 Favored 'General case' 0 CA--C 1.479 -1.78 0 CA-C-N 111.436 -2.62 . . . . 1.69 108.663 170.082 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 132' ' ' LEU . . . . . 0.67 HD23 ' HD2' ' B' ' 115' ' ' PRO . 0.1 OUTLIER -131.2 -1.44 4.03 Favored 'General case' 0 N--CA 1.401 -2.89 0 N-CA-C 107.645 -1.242 . . . . 1.84 107.645 179.59 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 133' ' ' GLY . . . . . 0.923 ' O ' ' HA ' ' B' ' 128' ' ' CYS . . . 44.32 -133.98 6.64 Favored Glycine 0 N--CA 1.426 -1.992 0 CA-C-N 115.07 -0.968 . . . . 0.76 112.909 179.263 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 134' ' ' CYS . . . . . 0.816 ' HA ' ' O ' ' B' ' 127' ' ' CYS . 0.1 OUTLIER -134.9 111.58 9.97 Favored 'General case' 0 CA--C 1.486 -1.512 0 N-CA-C 113.653 0.983 . . . . 1.08 113.653 -178.721 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 135' ' ' PHE . . . . . 0.704 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 27.5 m-85 -84.43 106.82 16.31 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 104.694 -2.336 . . . . 1.83 104.694 176.035 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 136' ' ' VAL . . . . . 0.559 ' CG2' ' CG2' ' A' ' 36' ' ' VAL . 12.6 t -92.33 84.79 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.669 0 CA-C-O 122.987 1.375 . . . . 1.29 108.65 -179.178 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 137' ' ' GLY . . . . . 0.615 ' N ' ' O ' ' B' ' 125' ' ' SER . . . 88.65 107.95 1.07 Allowed Glycine 0 CA--C 1.523 0.579 0 CA-C-N 112.493 -2.139 . . . . 0.85 115.098 179.184 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 138' ' ' THR . . . . . 0.477 ' CG2' ' HB3' ' B' ' 135' ' ' PHE . 0.1 OUTLIER -174.01 -179.51 1.71 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 107.704 -1.221 . . . . 1.2 107.704 178.472 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 139' ' ' ALA . . . . . 0.513 ' HA ' ' CD1' ' B' ' 142' ' ' LEU . . . -65.07 -37.67 88.3 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 119.68 1.127 . . . . 1.35 111.393 179.309 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 140' ' ' GLU . . . . . 0.58 ' HG2' ' HA2' ' B' ' 114' ' ' GLY . 0.2 OUTLIER -62.04 -22.85 66.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.061 0.458 . . . . 2.31 111.386 -179.418 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 141' ' ' ALA . . . . . 0.608 ' O ' ' N ' ' B' ' 144' ' ' CYS . . . -93.39 -19.46 21.28 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.508 -0.769 . . . . 1.09 110.972 -179.411 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 142' ' ' LEU . . . . . 0.57 ' O ' ' HB2' ' B' ' 145' ' ' GLN . 4.8 mt -43.95 -45.56 7.78 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.448 0.536 . . . . 1.61 112.448 -178.651 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 143' ' ' ARG . . . . . 0.56 ' C ' ' H ' ' B' ' 145' ' ' GLN . 0.0 OUTLIER -55.56 -24.16 30.91 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 107.905 -1.146 . . . . 3.43 107.905 178.331 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 144' ' ' CYS . . . . . 0.608 ' N ' ' O ' ' B' ' 141' ' ' ALA . 35.0 m -69.61 8.49 0.65 Allowed 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 115.838 -0.619 . . . . 1.61 110.559 -179.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 145' ' ' GLN . . . . . 0.57 ' HB2' ' O ' ' B' ' 142' ' ' LEU . 0.7 OUTLIER -78.84 -20.11 50.42 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.015 -0.993 . . . . 3.52 110.838 178.399 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -86.73 -0.45 56.34 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 120.384 -0.526 . . . . 3.76 110.817 -179.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.448 -0.571 0 N-CA-C 109.491 -0.559 . . . . 4.01 109.491 177.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 9.8 p . . . . . 0 N--CA 1.439 -0.989 0 N-CA-C 110.611 -0.144 . . . . 3.41 110.611 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 157' ' ' GLY . . . . . 0.571 ' HA3' ' O ' ' B' ' 167' ' ' CYS . . . -101.39 152.85 18.89 Favored Glycine 0 CA--C 1.49 -1.498 0 N-CA-C 109.14 -1.584 . . . . 2.26 109.14 175.205 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 18.2 mm100 -103.79 65.81 0.83 Allowed 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 117.352 -1.739 . . . . 5.03 111.157 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 159' ' ' LYS . . . . . 0.645 ' HB2' ' HB2' ' B' ' 167' ' ' CYS . 0.0 OUTLIER -114.37 56.19 0.81 Allowed Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 113.736 -1.574 . . . . 3.96 109.815 172.343 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 160' ' ' PRO . . . . . 0.512 ' HA ' ' HA ' ' B' ' 166' ' ' ARG . 27.2 Cg_endo -62.96 79.16 0.11 Allowed 'Trans proline' 0 CA--C 1.518 -0.299 0 CA-C-N 121.584 1.602 . . . . 1.7 115.818 -173.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 161' ' ' CYS . . . . . 0.468 ' O ' ' O ' ' B' ' 165' ' ' GLY . 0.5 OUTLIER -98.89 -176.47 3.35 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 107.044 -1.465 . . . . 1.93 107.044 176.183 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 69.74 -167.03 48.58 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 118.468 -1.825 . . . . 2.37 111.826 178.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 24.4 p -85.28 41.46 0.89 Allowed 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.058 0.456 . . . . 4.56 111.717 -178.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 120.52 7.07 9.19 Favored Glycine 0 CA--C 1.536 1.346 0 CA-C-O 118.884 -0.953 . . . . 2.39 113.79 -179.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 165' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' B' ' 161' ' ' CYS . . . -102.28 134.29 11.72 Favored Glycine 0 CA--C 1.523 0.57 0 C-N-CA 118.498 -1.811 . . . . 1.79 115.388 -177.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 166' ' ' ARG . . . . . 0.568 ' HB2' ' O ' ' B' ' 157' ' ' GLY . 0.0 OUTLIER -97.3 153.17 18.21 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 114.947 -0.627 . . . . 3.53 110.352 178.603 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 167' ' ' CYS . . . . . 0.645 ' HB2' ' HB2' ' B' ' 159' ' ' LYS . 2.2 m -65.52 108.6 2.06 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 120.008 -0.677 . . . . 1.56 110.131 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 168' ' ' ALA . . . . . 0.455 ' HB1' ' HB2' ' B' ' 174' ' ' CYS . . . -78.96 -19.92 50.49 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 106.637 -1.616 . . . . 1.42 106.637 176.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 169' ' ' ALA . . . . . 0.835 ' O ' ' O ' ' B' ' 170' ' ' ALA . . . -160.89 161.37 31.76 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 111.82 -2.445 . . . . 1.18 111.036 -178.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 170' ' ' ALA . . . . . 0.835 ' O ' ' O ' ' B' ' 169' ' ' ALA . . . -18.06 -135.15 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.771 0.829 . . . . 1.47 113.217 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 171' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' B' ' 185' ' ' CYS . . . -55.85 37.49 0.01 OUTLIER Glycine 0 CA--C 1.537 1.425 0 N-CA-C 114.97 0.748 . . . . 1.45 114.97 -178.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 172' ' ' ILE . . . . . 0.804 HD11 ' HB2' ' B' ' 134' ' ' CYS . 0.7 OUTLIER -134.41 107.01 8.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-O 122.079 0.942 . . . . 2.7 111.865 -176.755 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 173' ' ' CYS . . . . . 0.533 ' HB2' ' HB3' ' B' ' 182' ' ' ASP . 0.0 OUTLIER -93.29 82.91 4.52 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.476 -0.783 . . . . 1.94 110.526 -179.623 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 174' ' ' CYS . . . . . 0.84 ' HA ' ' HA ' ' B' ' 179' ' ' CYS . 0.1 OUTLIER -83.24 136.76 34.28 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.943 -0.571 . . . . 1.43 110.797 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 175' ' ' SER . . . . . 0.627 ' HB3' ' HD2' ' B' ' 176' ' ' PRO . 5.1 m -104.79 179.41 0.94 Allowed Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.312 -0.858 . . . . 2.3 109.236 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 176' ' ' PRO . . . . . 0.627 ' HD2' ' HB3' ' B' ' 175' ' ' SER . 95.6 Cg_endo -80.01 25.13 0.61 Allowed 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 121.406 1.404 . . . . 2.13 111.674 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 177' ' ' ASP . . . . . 0.407 ' H ' ' C ' ' B' ' 175' ' ' SER . 11.7 m-20 -145.53 -41.55 0.22 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.594 -0.73 . . . . 2.72 110.298 179.226 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 178' ' ' GLY . . . . . 0.801 ' HA3' ' O ' ' A' ' 79' ' ' CYS . . . -147.84 -135.18 2.58 Favored Glycine 0 C--N 1.337 0.617 0 C-N-CA 120.646 -0.788 . . . . 1.05 113.149 179.304 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 179' ' ' CYS . . . . . 0.84 ' HA ' ' HA ' ' B' ' 174' ' ' CYS . 0.1 OUTLIER -146.96 156.3 42.95 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.554 0.216 . . . . 1.39 110.604 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 180' ' ' HIS . . . . . 0.471 ' N ' ' O ' ' B' ' 173' ' ' CYS . 6.6 t-160 -142.19 133.73 26.68 Favored 'General case' 0 CA--C 1.519 -0.23 0 O-C-N 122.034 -0.416 . . . . 2.73 111.648 -178.43 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 181' ' ' GLU . . . . . 0.561 ' HG2' ' HD2' ' A' ' 24' ' ' PRO . 2.4 mt-10 -58.59 128.08 35.39 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.846 -0.615 . . . . 3.06 109.703 178.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 182' ' ' ASP . . . . . 0.533 ' HB3' ' HB2' ' B' ' 173' ' ' CYS . 0.0 OUTLIER -146.37 112.72 4.38 Favored Pre-proline 0 C--N 1.318 -0.764 0 CA-C-N 115.537 -0.756 . . . . 2.06 110.394 -178.87 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 183' ' ' PRO . . . . . 0.455 ' HA ' ' OD2' ' B' ' 186' ' ' ASP . 1.6 Cg_endo -82.86 -4.41 11.33 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.617 2.212 . . . . 2.27 113.302 -179.344 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -66.94 -35.39 79.88 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.89 0.376 . . . . 1.56 111.032 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 185' ' ' CYS . . . . . 0.55 ' HB2' ' O ' ' B' ' 170' ' ' ALA . 83.4 m -93.86 49.5 1.35 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.07 -0.514 . . . . 1.94 111.007 179.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 186' ' ' ASP . . . . . 0.455 ' OD2' ' HA ' ' B' ' 183' ' ' PRO . 16.8 m-20 . . . . . 0 N--CA 1.443 -0.817 0 N-CA-C 112.364 0.505 . . . . 3.61 112.364 179.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.963 ' HB2' ' HG2' ' A' ' 20' ' ' ARG . 53.6 m . . . . . 0 CA--C 1.54 0.568 0 N-CA-C 112.593 0.59 . . . . 2.89 112.593 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.45 ' HG ' ' HD2' ' A' ' 12' ' ' PRO . 6.0 tp -26.76 135.0 0.11 Allowed Pre-proline 0 N--CA 1.486 1.371 0 N-CA-C 113.619 0.97 . . . . 2.89 113.619 179.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.612 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 52.0 Cg_endo -75.04 145.11 30.91 Favored 'Trans proline' 0 CA--C 1.552 1.401 0 C-N-CA 123.384 2.723 . . . . 1.72 117.264 -178.299 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.4 ' O ' ' HA2' ' A' ' 17' ' ' GLY . 0.1 OUTLIER -155.31 173.57 16.46 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-N 112.625 -2.08 . . . . 1.0 115.376 -174.709 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 79.3 -159.97 45.49 Favored Glycine 0 CA--C 1.533 1.185 0 CA-C-N 114.406 -1.27 . . . . 1.15 110.657 -172.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.524 ' O ' ' HG2' ' A' ' 15' ' ' PRO . 60.1 Cg_endo -62.25 109.26 0.8 Allowed 'Trans proline' 0 N--CA 1.488 1.185 0 C-N-CA 123.65 2.9 . . . . 1.6 110.178 178.276 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 74.96 5.63 76.12 Favored Glycine 0 C--N 1.293 -1.839 0 CA-C-N 114.649 -1.16 . . . . 1.68 112.071 176.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.4 ' HA2' ' O ' ' A' ' 13' ' ' CYS . . . 63.73 62.14 5.55 Favored Glycine 1 N--CA 1.396 -4.024 0 C-N-CA 118.824 -1.655 . . . . 1.37 110.524 -177.756 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.474 ' HG2' ' O ' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -100.29 17.95 20.09 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 105.878 -1.897 . . . . 2.91 105.878 168.892 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.612 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -109.26 -178.61 21.34 Favored Glycine 0 N--CA 1.426 -1.99 0 N-CA-C 117.205 1.642 . . . . 1.06 117.205 -173.087 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.963 ' HG2' ' HB2' ' A' ' 10' ' ' CYS . 2.9 mtp-105 -143.12 135.71 27.53 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 110.913 -2.643 . . . . 3.32 112.572 176.009 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.59 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 1.7 m -107.72 159.52 16.42 Favored 'General case' 0 C--N 1.343 0.298 0 CA-C-O 121.554 0.692 . . . . 1.19 112.701 -177.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -132.06 8.51 4.41 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 114.784 -1.098 . . . . 2.26 110.951 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -179.64 -163.9 31.14 Favored Glycine 0 C--N 1.338 0.654 0 C-N-CA 121.046 -0.597 . . . . 1.05 112.478 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.457 ' HG2' ' OE1' ' B' ' 181' ' ' GLU . 12.5 Cg_exo -69.56 -71.01 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.74 2.293 . . . . 1.81 112.305 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.596 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.5 OUTLIER -100.33 33.9 2.54 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 120.933 0.397 . . . . 1.62 110.111 179.508 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.909 HG12 HG12 ' A' ' 36' ' ' VAL . 6.3 mt -139.07 120.54 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 CA-C-N 116.173 -0.467 . . . . 1.39 111.64 -178.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.59 ' HA ' ' HA ' ' A' ' 21' ' ' CYS . 49.6 t -142.22 122.56 13.96 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.765 -0.652 . . . . 0.92 110.179 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 1.124 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -127.59 152.51 47.55 Favored 'General case' 0 CA--C 1.551 0.983 0 N-CA-C 114.521 1.304 . . . . 1.28 114.521 -177.961 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.575 ' N ' ' O ' ' A' ' 33' ' ' GLY . . . -150.26 -176.29 23.16 Favored Glycine 0 C--N 1.354 1.575 0 N-CA-C 110.927 -0.869 . . . . 0.71 110.927 178.15 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -66.03 -54.01 31.37 Favored 'General case' 0 CA--C 1.56 1.359 0 C-N-CA 124.952 1.301 . . . . 2.27 112.211 179.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.36 -18.79 19.69 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 111.514 -2.585 . . . . 1.66 110.375 172.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.656 HD22 ' CE1' ' A' ' 35' ' ' PHE . 4.1 mt -99.9 7.6 44.76 Favored 'General case' 0 N--CA 1.4 -2.935 0 CA-C-N 115.892 -0.594 . . . . 1.93 110.749 -172.334 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 1.124 ' O ' ' HA ' ' A' ' 28' ' ' CYS . . . 24.87 -136.91 0.01 OUTLIER Glycine 0 C--O 1.21 -1.394 0 CA-C-O 118.635 -1.092 . . . . 0.77 111.959 179.165 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.705 ' HB2' ' CD1' ' A' ' 72' ' ' ILE . 1.0 OUTLIER -129.97 124.05 32.09 Favored 'General case' 0 CA--C 1.498 -1.044 0 CA-C-N 119.051 1.425 . . . . 1.08 112.422 -179.047 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.656 ' CE1' HD22 ' A' ' 32' ' ' LEU . 34.7 m-85 -97.91 105.24 17.36 Favored 'General case' 0 N--CA 1.422 -1.842 0 N-CA-C 103.597 -2.742 . . . . 1.85 103.597 174.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.909 HG12 HG12 ' A' ' 26' ' ' ILE . 1.8 t -100.91 85.59 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.884 0 CA-C-O 123.152 1.453 . . . . 1.29 107.112 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.596 ' N ' ' O ' ' A' ' 25' ' ' SER . . . 125.9 -77.7 0.38 Allowed Glycine 0 CA--C 1.524 0.607 0 CA-C-N 112.925 -1.943 . . . . 0.85 115.06 -179.38 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.598 HG22 ' CE2' ' B' ' 135' ' ' PHE . 9.9 t -32.2 124.95 0.3 Allowed 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 113.347 0.869 . . . . 1.3 113.347 -177.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.821 ' HA ' ' HG ' ' A' ' 42' ' ' LEU . . . -26.92 -35.02 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 114.12 -1.4 . . . . 1.45 113.409 -179.124 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.524 ' N ' ' O ' ' A' ' 38' ' ' THR . 1.7 mt-10 -48.13 -13.77 0.05 OUTLIER 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.634 0.254 . . . . 2.32 111.05 178.309 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.662 ' O ' ' N ' ' A' ' 44' ' ' CYS . . . -114.96 -44.42 3.03 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 109.448 -0.575 . . . . 1.11 109.448 178.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.927 HD13 ' N ' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -37.88 -19.49 0.01 OUTLIER 'General case' 0 C--N 1.346 0.417 0 N-CA-C 115.481 1.659 . . . . 1.68 115.481 -173.232 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.927 ' N ' HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -68.02 -13.65 62.35 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 106.575 -1.639 . . . . 3.4 106.575 174.708 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.662 ' N ' ' O ' ' A' ' 41' ' ' ALA . 64.0 m -85.42 25.12 1.07 Allowed 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 114.151 -1.386 . . . . 1.57 109.953 177.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -92.31 -18.66 23.05 Favored 'General case' 0 CA--C 1.509 -0.63 0 N-CA-C 107.859 -1.163 . . . . 3.49 107.859 176.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -86.87 5.46 36.73 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-N 115.174 -0.921 . . . . 3.69 109.222 177.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.447 -0.577 0 C-N-CA 119.962 -0.695 . . . . 3.99 109.289 177.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 48.8 m . . . . . 0 N--CA 1.467 0.397 0 N-CA-C 117.595 2.443 . . . . 3.36 117.595 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 134.71 69.94 0.07 OUTLIER Glycine 0 N--CA 1.427 -1.948 0 N-CA-C 109.975 -1.25 . . . . 2.3 109.975 -178.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 -117.95 72.89 0.87 Allowed 'General case' 0 N--CA 1.441 -0.923 0 CA-C-O 122.634 1.207 . . . . 5.06 108.032 179.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.638 ' CB ' ' HB2' ' A' ' 67' ' ' CYS . 10.0 mtmm -144.64 58.34 5.43 Favored Pre-proline 0 C--N 1.302 -1.475 0 CA-C-N 113.132 -1.849 . . . . 3.91 107.197 179.152 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.632 ' HA ' ' O ' ' A' ' 65' ' ' GLY . 37.7 Cg_endo -66.2 86.56 0.25 Allowed 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 122.605 2.204 . . . . 1.74 116.591 -177.231 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.467 ' SG ' ' HB2' ' A' ' 82' ' ' ASP . 0.5 OUTLIER -100.11 -173.44 2.43 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.308 -1.367 . . . . 1.9 107.308 175.471 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 62.83 -166.43 23.13 Favored Glycine 0 CA--C 1.519 0.331 0 C-N-CA 118.264 -1.922 . . . . 2.43 112.296 176.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 64.5 m -77.72 42.9 0.39 Allowed 'General case' 0 C--N 1.327 -0.371 0 O-C-N 122.494 -0.415 . . . . 4.32 111.75 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 110.51 11.31 19.89 Favored Glycine 0 N--CA 1.446 -0.681 0 N-CA-C 116.846 1.498 . . . . 2.4 116.846 176.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.632 ' O ' ' HA ' ' A' ' 60' ' ' PRO . . . -104.73 154.37 17.39 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 120.893 2.347 . . . . 1.82 112.902 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.12 150.13 23.25 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 121.266 0.555 . . . . 3.51 112.442 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.638 ' HB2' ' CB ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -72.36 112.71 8.67 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 113.671 0.989 . . . . 1.52 113.671 -179.951 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.869 ' HB2' ' HB2' ' A' ' 28' ' ' CYS . . . -99.76 -16.32 18.15 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 122.514 1.15 . . . . 1.5 108.053 175.47 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.9 ' CB ' ' HA2' ' A' ' 33' ' ' GLY . . . -162.96 161.14 25.49 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 112.506 -2.134 . . . . 1.31 116.532 176.466 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.855 ' HA ' ' HB3' ' A' ' 85' ' ' CYS . . . -50.38 121.77 6.1 Favored 'General case' 0 C--N 1.345 0.4 0 CA-C-N 113.719 -1.582 . . . . 1.5 111.725 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.605 ' HA2' ' O ' ' A' ' 82' ' ' ASP . . . 59.83 36.49 90.13 Favored Glycine 0 N--CA 1.443 -0.885 0 N-CA-C 110.018 -1.233 . . . . 1.44 110.018 -178.27 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.972 HG13 ' O ' ' A' ' 72' ' ' ILE . 0.5 OUTLIER -145.0 108.17 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 O-C-N 121.957 -0.731 . . . . 2.77 109.927 176.984 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -106.04 102.4 11.82 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 108.883 -0.784 . . . . 1.98 108.883 178.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.776 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 3.4 t -92.7 122.42 35.09 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 121.702 0.763 . . . . 1.43 112.283 -178.394 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.583 ' HA ' ' HA2' ' A' ' 65' ' ' GLY . 0.3 OUTLIER -90.59 -179.25 1.12 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 114.375 -1.284 . . . . 2.37 109.733 179.532 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.457 ' HD2' ' CB ' ' A' ' 75' ' ' SER . 86.3 Cg_endo -77.6 25.22 0.49 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 121.828 1.685 . . . . 2.09 113.003 -179.309 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -145.6 -45.75 0.21 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.921 -0.77 . . . . 2.65 108.921 178.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.556 ' HA3' ' O ' ' B' ' 179' ' ' CYS . . . -149.37 -151.62 5.53 Favored Glycine 0 N--CA 1.446 -0.667 0 CA-C-N 115.39 -0.823 . . . . 1.04 111.659 178.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.776 ' HA ' ' HA ' ' A' ' 74' ' ' CYS . 0.0 OUTLIER -146.9 162.88 37.77 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.846 -0.427 . . . . 1.42 109.846 179.798 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.543 ' HB3' ' HA3' ' B' ' 178' ' ' GLY . 0.1 OUTLIER -150.52 160.82 43.52 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.016 0.436 . . . . 2.81 111.009 -179.036 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.534 ' H ' HD11 ' B' ' 126' ' ' ILE . 0.5 OUTLIER -63.76 146.07 54.58 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.383 -0.599 . . . . 3.05 109.383 179.287 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.605 ' O ' ' HA2' ' A' ' 71' ' ' GLY . 0.8 OUTLIER -145.78 140.77 16.03 Favored Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 120.423 -0.511 . . . . 2.02 111.99 -179.462 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.471 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 5.3 Cg_exo -80.61 -20.9 7.67 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.969 2.446 . . . . 2.29 113.665 -178.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.09 -40.96 87.06 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.162 0.506 . . . . 1.53 110.682 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.855 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 93.2 m -97.21 27.09 4.32 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.779 0.8 . . . . 1.88 110.192 179.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.471 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 1.0 OUTLIER . . . . . 0 C--N 1.317 -0.843 0 CA-C-N 115.198 -0.91 . . . . 3.6 110.559 179.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 110' ' ' CYS . . . . . 0.94 ' HB2' ' HG2' ' B' ' 120' ' ' ARG . 50.9 m . . . . . 0 CA--C 1.541 0.615 0 N-CA-C 112.749 0.648 . . . . 2.87 112.749 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 111' ' ' LEU . . . . . 0.446 ' HG ' ' HD2' ' B' ' 112' ' ' PRO . 6.1 tp -24.32 134.2 0.08 OUTLIER Pre-proline 0 N--CA 1.485 1.281 0 N-CA-C 113.497 0.925 . . . . 2.95 113.497 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 112' ' ' PRO . . . . . 0.56 ' HA ' ' O ' ' B' ' 119' ' ' GLY . 29.2 Cg_endo -68.34 150.77 76.38 Favored 'Trans proline' 0 CA--C 1.547 1.127 0 C-N-CA 123.235 2.624 . . . . 1.71 114.796 -178.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -158.87 177.98 10.58 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 113.395 -1.729 . . . . 1.0 115.449 176.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . 78.06 -160.27 48.06 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 110.22 -1.152 . . . . 1.16 110.22 -175.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 115' ' ' PRO . . . . . 0.463 ' O ' ' HG2' ' B' ' 115' ' ' PRO . 54.6 Cg_endo -63.5 100.03 0.27 Allowed 'Trans proline' 0 N--CA 1.482 0.814 0 C-N-CA 123.985 3.124 . . . . 1.6 114.075 178.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 82.69 5.24 89.62 Favored Glycine 0 C--N 1.29 -2.019 0 CA-C-N 114.61 -1.177 . . . . 1.7 111.876 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . 70.44 47.62 41.73 Favored Glycine 1 N--CA 1.392 -4.288 0 C-N-CA 118.922 -1.608 . . . . 1.38 114.609 179.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.83 15.84 12.14 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 106.827 -1.546 . . . . 2.96 106.827 175.465 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 119' ' ' GLY . . . . . 0.56 ' O ' ' HA ' ' B' ' 112' ' ' PRO . . . -113.52 -171.17 17.66 Favored Glycine 0 N--CA 1.444 -0.827 0 N-CA-C 115.79 1.076 . . . . 1.07 115.79 -175.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.94 ' HG2' ' HB2' ' B' ' 110' ' ' CYS . 1.7 mtp-105 -146.89 138.94 24.58 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 114.509 -0.845 . . . . 3.29 109.396 -179.309 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 121' ' ' CYS . . . . . 0.593 ' HA ' ' HA ' ' B' ' 127' ' ' CYS . 1.7 m -107.84 160.86 15.41 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.613 0.721 . . . . 1.21 112.888 -177.129 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -132.18 8.59 4.37 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 114.697 -1.138 . . . . 2.28 110.867 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -179.67 -163.99 31.32 Favored Glycine 0 C--N 1.338 0.684 0 C-N-CA 120.885 -0.674 . . . . 1.04 112.387 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . 0.451 ' HG2' ' OE1' ' A' ' 81' ' ' GLU . 12.4 Cg_exo -69.47 -71.14 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.747 2.298 . . . . 1.84 112.313 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 125' ' ' SER . . . . . 0.595 ' O ' ' N ' ' B' ' 137' ' ' GLY . 0.5 OUTLIER -100.25 34.15 2.45 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 120.973 0.416 . . . . 1.49 110.04 179.436 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 126' ' ' ILE . . . . . 0.733 HG12 HG13 ' B' ' 136' ' ' VAL . 7.8 mt -138.71 120.44 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 CA-C-N 116.083 -0.508 . . . . 1.41 111.943 -178.474 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 127' ' ' CYS . . . . . 0.593 ' HA ' ' HA ' ' B' ' 121' ' ' CYS . 49.1 t -142.01 122.05 13.72 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 116.156 -0.474 . . . . 0.89 110.133 -179.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 128' ' ' CYS . . . . . 1.088 ' HA ' ' O ' ' B' ' 133' ' ' GLY . 0.0 OUTLIER -124.57 157.34 35.63 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 114.218 1.192 . . . . 1.23 114.218 -178.707 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 129' ' ' GLY . . . . . 0.733 ' O ' ' HB1' ' B' ' 169' ' ' ALA . . . -153.78 -177.13 26.93 Favored Glycine 0 N--CA 1.434 -1.472 0 N-CA-C 111.087 -0.805 . . . . 0.69 111.087 177.214 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -65.08 -53.38 46.49 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 124.337 1.055 . . . . 2.35 111.038 179.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.96 32.65 5.87 Favored 'General case' 0 CA--C 1.483 -1.613 0 N-CA-C 106.276 -1.75 . . . . 1.69 106.276 174.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 132' ' ' LEU . . . . . 0.425 ' O ' ' C ' ' B' ' 133' ' ' GLY . 2.1 mt -135.53 9.7 3.41 Favored 'General case' 0 N--CA 1.393 -3.28 0 N-CA-C 106.413 -1.699 . . . . 1.84 106.413 175.057 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 133' ' ' GLY . . . . . 1.088 ' O ' ' HA ' ' B' ' 128' ' ' CYS . . . 25.66 -128.87 0.03 OUTLIER Glycine 0 N--CA 1.41 -3.089 0 CA-C-N 115.29 -0.868 . . . . 0.76 114.43 178.331 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 134' ' ' CYS . . . . . 0.739 ' HB2' ' CD1' ' B' ' 172' ' ' ILE . 0.8 OUTLIER -134.96 125.1 25.97 Favored 'General case' 0 CA--C 1.494 -1.192 0 CA-C-N 117.326 0.563 . . . . 1.08 111.614 177.305 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 135' ' ' PHE . . . . . 0.598 ' CE2' HG22 ' A' ' 38' ' ' THR . 34.9 m-85 -99.91 104.99 16.66 Favored 'General case' 0 N--CA 1.422 -1.848 0 N-CA-C 103.29 -2.856 . . . . 1.83 103.29 174.299 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 136' ' ' VAL . . . . . 0.733 HG13 HG12 ' B' ' 126' ' ' ILE . 2.3 t -100.88 85.01 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.792 0 N-CA-C 107.093 -1.447 . . . . 1.29 107.093 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 137' ' ' GLY . . . . . 0.595 ' N ' ' O ' ' B' ' 125' ' ' SER . . . 126.27 -77.5 0.39 Allowed Glycine 0 CA--C 1.526 0.756 0 CA-C-N 113.22 -1.809 . . . . 0.85 114.83 -179.383 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 138' ' ' THR . . . . . 0.526 HG23 ' HB3' ' B' ' 135' ' ' PHE . 9.8 t -33.11 123.2 0.39 Allowed 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 114.346 1.239 . . . . 1.2 114.346 -177.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 139' ' ' ALA . . . . . 0.836 ' HA ' ' HG ' ' B' ' 142' ' ' LEU . . . -24.27 -37.93 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 113.532 -1.667 . . . . 1.35 112.787 -178.038 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 140' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' B' ' 138' ' ' THR . 1.8 mt-10 -48.05 -8.18 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 121.19 0.519 . . . . 2.31 111.92 177.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 141' ' ' ALA . . . . . 0.673 ' H ' ' C ' ' B' ' 139' ' ' ALA . . . -119.23 -45.81 2.53 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 114.941 -1.027 . . . . 1.09 110.605 177.131 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 142' ' ' LEU . . . . . 0.926 HD13 ' N ' ' B' ' 143' ' ' ARG . 0.0 OUTLIER -38.22 -19.82 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 115.59 1.7 . . . . 1.61 115.59 -174.176 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 143' ' ' ARG . . . . . 0.926 ' N ' HD13 ' B' ' 142' ' ' LEU . 0.0 OUTLIER -69.77 -9.69 55.54 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 106.714 -1.587 . . . . 3.43 106.714 174.869 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 144' ' ' CYS . . . . . 0.664 ' N ' ' O ' ' B' ' 141' ' ' ALA . 66.7 m -89.25 26.38 1.65 Allowed 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.447 -0.797 . . . . 1.61 109.641 176.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -91.71 -19.11 22.98 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 3.52 107.708 175.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -86.9 5.46 36.87 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 114.985 -1.007 . . . . 3.76 109.229 178.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.447 -0.595 0 C-N-CA 120.128 -0.629 . . . . 4.01 109.324 177.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 40.2 m . . . . . 0 CA--C 1.542 0.658 0 CA-C-O 122.174 0.988 . . . . 3.41 112.326 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 111.57 77.7 0.89 Allowed Glycine 0 N--CA 1.434 -1.441 0 CA-C-N 112.668 -2.06 . . . . 2.26 112.161 175.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -119.48 60.81 0.83 Allowed 'General case' 0 N--CA 1.433 -1.29 0 CA-C-O 123.189 1.471 . . . . 5.03 108.383 176.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 159' ' ' LYS . . . . . 0.718 ' CB ' ' HB2' ' B' ' 167' ' ' CYS . 10.5 mtmm -116.08 53.68 1.04 Allowed Pre-proline 0 C--N 1.303 -1.427 0 CA-C-N 112.052 -2.34 . . . . 3.96 111.797 173.005 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 160' ' ' PRO . . . . . 0.615 ' HA ' ' O ' ' B' ' 165' ' ' GLY . 36.8 Cg_endo -66.2 87.83 0.25 Allowed 'Trans proline' 0 C--N 1.329 -0.466 0 N-CA-C 117.971 2.258 . . . . 1.7 117.971 -172.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 161' ' ' CYS . . . . . 0.448 ' SG ' ' HB2' ' B' ' 182' ' ' ASP . 0.6 OUTLIER -107.17 178.76 4.46 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 107.092 -1.447 . . . . 1.93 107.092 175.238 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 72.01 -167.34 52.88 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 118.464 -1.827 . . . . 2.37 111.325 -178.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 71.2 m -76.83 40.64 0.25 Allowed 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 120.604 -0.439 . . . . 4.56 111.222 -179.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 109.56 17.76 9.59 Favored Glycine 0 C--N 1.342 0.902 0 C-N-CA 119.019 -1.562 . . . . 2.39 116.199 175.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 165' ' ' GLY . . . . . 0.615 ' O ' ' HA ' ' B' ' 160' ' ' PRO . . . -107.23 154.28 16.65 Favored Glycine 0 C--N 1.346 1.136 0 C-N-CA 119.235 -1.46 . . . . 1.79 112.179 177.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 166' ' ' ARG . . . . . 0.422 ' H ' ' HG2' ' B' ' 166' ' ' ARG . 0.0 OUTLIER -101.89 150.19 23.44 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 112.211 0.449 . . . . 3.53 112.211 179.425 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 167' ' ' CYS . . . . . 0.718 ' HB2' ' CB ' ' B' ' 159' ' ' LYS . 0.0 OUTLIER -72.68 111.88 8.23 Favored 'General case' 0 N--CA 1.438 -1.033 0 C-N-CA 124.054 0.942 . . . . 1.56 113.335 -179.933 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 168' ' ' ALA . . . . . 0.583 ' CB ' ' HB2' ' B' ' 128' ' ' CYS . . . -89.34 -31.98 17.54 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 104.79 -2.3 . . . . 1.42 104.79 174.35 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 169' ' ' ALA . . . . . 0.995 ' HB3' HG12 ' B' ' 172' ' ' ILE . . . -151.02 158.9 44.71 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 111.27 -2.695 . . . . 1.18 116.527 -172.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 170' ' ' ALA . . . . . 0.838 ' HA ' ' HB3' ' B' ' 185' ' ' CYS . . . -51.32 122.74 8.28 Favored 'General case' 0 C--N 1.347 0.496 0 CA-C-N 113.955 -1.475 . . . . 1.47 111.139 -179.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 171' ' ' GLY . . . . . 0.548 ' HA2' ' O ' ' B' ' 182' ' ' ASP . . . 69.84 16.43 72.37 Favored Glycine 0 N--CA 1.428 -1.837 0 C-N-CA 120.642 -0.789 . . . . 1.45 112.611 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 172' ' ' ILE . . . . . 0.995 HG12 ' HB3' ' B' ' 169' ' ' ALA . 0.5 OUTLIER -134.86 110.0 12.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-O 122.05 0.928 . . . . 2.7 111.809 -177.07 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 173' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -106.08 102.04 11.49 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.865 -0.791 . . . . 1.94 108.865 178.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 174' ' ' CYS . . . . . 0.798 ' HA ' ' HA ' ' B' ' 179' ' ' CYS . 3.4 t -92.74 122.34 35.04 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 121.663 0.744 . . . . 1.43 112.33 -178.408 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 175' ' ' SER . . . . . 0.612 ' HA ' ' HA2' ' B' ' 165' ' ' GLY . 0.3 OUTLIER -90.48 -179.2 1.11 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 114.378 -1.283 . . . . 2.3 109.78 179.537 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 176' ' ' PRO . . . . . 0.466 ' HD2' ' CB ' ' B' ' 175' ' ' SER . 86.0 Cg_endo -77.67 25.25 0.5 Allowed 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 121.782 1.655 . . . . 2.13 112.969 -179.267 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 177' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -145.63 -45.61 0.21 Allowed 'General case' 0 C--O 1.237 0.403 0 N-CA-C 109.032 -0.729 . . . . 2.72 109.032 178.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 178' ' ' GLY . . . . . 0.543 ' HA3' ' HB3' ' A' ' 80' ' ' HIS . . . -149.39 -151.67 5.55 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.364 -0.835 . . . . 1.05 111.691 178.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 179' ' ' CYS . . . . . 0.798 ' HA ' ' HA ' ' B' ' 174' ' ' CYS . 0.0 OUTLIER -146.93 162.77 38.03 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.868 -0.419 . . . . 1.39 109.868 179.724 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 180' ' ' HIS . . . . . 0.537 ' HB3' ' HA3' ' A' ' 78' ' ' GLY . 0.1 OUTLIER -150.42 160.74 43.53 Favored 'General case' 0 N--CA 1.464 0.263 0 O-C-N 121.967 -0.458 . . . . 2.73 111.091 -179.117 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 181' ' ' GLU . . . . . 0.538 ' HA ' ' O ' ' B' ' 171' ' ' GLY . 0.5 OUTLIER -63.57 145.97 54.62 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.435 -0.58 . . . . 3.06 109.435 179.246 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 182' ' ' ASP . . . . . 0.548 ' O ' ' HA2' ' B' ' 171' ' ' GLY . 0.7 OUTLIER -145.85 140.67 15.89 Favored Pre-proline 0 CA--C 1.537 0.475 0 C-N-CA 120.523 -0.471 . . . . 2.06 111.911 -179.366 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 183' ' ' PRO . . . . . 0.479 ' O ' ' HB2' ' B' ' 186' ' ' ASP . 5.2 Cg_exo -80.5 -20.86 7.85 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.977 2.451 . . . . 2.27 113.726 -179.004 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -67.05 -40.99 87.25 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.166 0.507 . . . . 1.56 110.666 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 185' ' ' CYS . . . . . 0.838 ' HB3' ' HA ' ' B' ' 170' ' ' ALA . 85.7 m -97.06 27.06 4.26 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.778 0.799 . . . . 1.94 110.367 179.323 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 186' ' ' ASP . . . . . 0.479 ' HB2' ' O ' ' B' ' 183' ' ' PRO . 1.1 t70 . . . . . 0 C--N 1.316 -0.865 0 CA-C-N 115.048 -0.978 . . . . 3.61 110.242 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.444 -0.759 0 N-CA-C 110.175 -0.305 . . . . 2.89 110.175 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.789 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 1.6 mm? -32.44 109.92 0.31 Allowed Pre-proline 0 N--CA 1.47 0.532 0 N-CA-C 113.672 0.99 . . . . 2.89 113.672 -178.412 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -60.61 157.18 38.25 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.393 2.062 . . . . 1.72 110.267 176.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.504 ' O ' ' HA2' ' A' ' 17' ' ' GLY . 1.0 OUTLIER -159.6 169.94 22.71 Favored 'General case' 0 CA--C 1.552 1.039 0 CA-C-O 121.363 0.601 . . . . 1.0 111.642 173.468 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.778 ' HA2' ' HB3' ' A' ' 40' ' ' GLU . . . 73.49 -160.44 53.72 Favored Glycine 0 CA--C 1.502 -0.769 0 C-N-CA 120.807 -0.711 . . . . 1.15 113.725 177.493 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.49 ' O ' ' HG2' ' A' ' 15' ' ' PRO . 41.2 Cg_endo -66.68 96.94 0.37 Allowed 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 123.049 2.499 . . . . 1.6 117.145 178.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 86.01 -2.08 87.72 Favored Glycine 1 C--N 1.254 -4.006 0 C-N-CA 119.76 -1.21 . . . . 1.68 114.31 -172.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.504 ' HA2' ' O ' ' A' ' 13' ' ' CYS . . . 79.72 44.95 8.84 Favored Glycine 0 N--CA 1.419 -2.478 0 C-N-CA 118.881 -1.628 . . . . 1.37 114.897 176.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.6 -9.73 34.18 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 113.446 -1.377 . . . . 2.91 111.294 176.041 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.452 ' C ' ' HB3' ' A' ' 13' ' ' CYS . . . -106.32 -174.42 23.34 Favored Glycine 0 CA--C 1.504 -0.643 0 N-CA-C 107.693 -2.163 . . . . 1.06 107.693 178.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.789 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 3.5 ttp180 -129.59 171.59 12.45 Favored 'General case' 0 CA--C 1.552 1.04 0 CA-C-N 121.635 2.717 . . . . 3.32 108.7 -179.475 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.475 ' HB3' ' HG3' ' A' ' 47' ' ' GLU . 1.0 OUTLIER -107.33 143.69 35.26 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 121.28 -0.887 . . . . 1.19 112.739 -178.662 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.414 ' HE2' ' HB3' ' A' ' 20' ' ' ARG . 97.0 m-85 -156.27 57.79 0.58 Allowed 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 114.87 -1.059 . . . . 2.26 109.916 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.477 ' CA ' ' HA ' ' A' ' 76' ' ' PRO . . . 125.97 148.26 7.11 Favored Glycine 0 C--N 1.334 0.432 0 N-CA-C 111.05 -0.82 . . . . 1.05 111.05 -179.095 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -52.3 -75.0 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 121.932 1.755 . . . . 1.81 112.372 -179.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.509 ' HB2' ' CG ' ' B' ' 181' ' ' GLU . 2.0 m -89.37 37.87 0.88 Allowed 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 109.182 -0.673 . . . . 1.62 109.182 178.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 1.089 HG12 HG13 ' A' ' 36' ' ' VAL . 15.9 mt -147.76 102.94 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 CA-C-N 115.269 -0.878 . . . . 1.39 109.586 -179.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.742 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 0.1 OUTLIER -118.68 123.11 44.11 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.648 -0.705 . . . . 0.92 110.53 -177.785 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 1.089 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -142.25 119.4 11.42 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 117.329 2.344 . . . . 1.28 117.329 -178.423 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.862 ' O ' ' HB3' ' A' ' 69' ' ' ALA . . . -108.48 -170.53 21.21 Favored Glycine 0 C--N 1.364 2.121 0 N-CA-C 108.259 -1.936 . . . . 0.71 108.259 175.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.499 ' OD2' ' HG2' ' A' ' 31' ' ' GLU . 20.8 p-10 -64.01 -58.83 5.52 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 114.835 1.42 . . . . 2.27 114.835 -176.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.499 ' HG2' ' OD2' ' A' ' 30' ' ' ASP . 0.0 OUTLIER -108.35 6.52 26.49 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 121.466 0.651 . . . . 1.66 111.477 -177.037 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.924 HD22 ' CZ ' ' A' ' 35' ' ' PHE . 2.2 mt -108.64 -8.44 15.44 Favored 'General case' 0 N--CA 1.398 -3.048 0 N-CA-C 105.332 -2.099 . . . . 1.93 105.332 178.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 1.089 ' O ' ' HA ' ' A' ' 28' ' ' CYS . . . 49.16 -133.15 24.46 Favored Glycine 0 N--CA 1.437 -1.251 0 CA-C-N 114.237 -1.347 . . . . 0.77 112.538 177.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.955 ' HB2' ' CD1' ' A' ' 72' ' ' ILE . 1.2 t -128.42 119.12 24.34 Favored 'General case' 0 CA--C 1.492 -1.286 0 N-CA-C 114.043 1.127 . . . . 1.08 114.043 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.988 ' HA ' ' HA ' ' B' ' 135' ' ' PHE . 0.1 OUTLIER -95.51 102.65 14.47 Favored 'General case' 0 N--CA 1.419 -2.02 0 N-CA-C 102.705 -3.072 . . . . 1.85 102.705 173.906 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 1.089 HG13 HG12 ' A' ' 26' ' ' ILE . 3.0 t -87.93 93.65 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.916 0 CA-C-O 123.102 1.43 . . . . 1.29 107.979 -179.13 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.966 ' HA3' HG22 ' B' ' 172' ' ' ILE . . . 94.26 80.0 1.47 Allowed Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 112.089 -2.323 . . . . 0.85 114.178 -178.643 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.715 HG23 ' O ' ' A' ' 37' ' ' GLY . 71.5 p -159.06 163.37 36.35 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.61 -0.515 . . . . 1.3 109.61 179.034 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.18 -15.67 26.23 Favored 'General case' 0 CA--C 1.527 0.092 0 CA-C-N 118.565 0.62 . . . . 1.45 111.275 178.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.778 ' HB3' ' HA2' ' A' ' 14' ' ' GLY . 40.6 mt-10 -69.23 -13.86 62.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.944 -0.571 . . . . 2.32 109.502 177.726 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.844 ' O ' ' HB2' ' A' ' 44' ' ' CYS . . . -96.11 -24.11 16.46 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 115.328 -0.851 . . . . 1.11 111.121 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.3 mt -41.06 -32.95 0.28 Allowed 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.136 0.791 . . . . 1.68 113.136 -178.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 5.9 mmm-85 -71.04 -15.18 62.54 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 122.456 1.122 . . . . 3.4 109.561 178.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.844 ' HB2' ' O ' ' A' ' 41' ' ' ALA . 1.3 m -62.46 -27.58 69.22 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 112.663 -2.062 . . . . 1.57 110.699 -178.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -49.86 -41.23 44.87 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.968 0.413 . . . . 3.49 111.764 179.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -85.52 6.27 27.78 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.722 -0.391 . . . . 3.69 110.257 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.475 ' HG3' ' HB3' ' A' ' 21' ' ' CYS . 1.6 tm-20 . . . . . 0 N--CA 1.448 -0.53 0 N-CA-C 109.217 -0.66 . . . . 3.99 109.217 177.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.3 p . . . . . 0 N--CA 1.48 1.033 0 CA-C-O 120.535 0.207 . . . . 3.36 110.852 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.52 115.05 7.16 Favored Glycine 0 CA--C 1.491 -1.428 0 C-N-CA 121.316 -0.468 . . . . 2.3 112.369 -178.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -73.72 79.26 1.55 Allowed 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 108.251 -1.018 . . . . 5.06 108.251 179.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.568 ' O ' ' HA ' ' A' ' 66' ' ' ARG . 8.0 mmmt -135.45 73.87 61.73 Favored Pre-proline 0 C--N 1.31 -1.116 0 N-CA-C 106.079 -1.823 . . . . 3.91 106.079 -179.327 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.541 ' HA ' ' O ' ' A' ' 65' ' ' GLY . 74.2 Cg_endo -75.79 78.8 3.01 Favored 'Trans proline' 0 C--N 1.372 1.777 0 C-N-CA 123.323 2.682 . . . . 1.74 115.515 -177.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 2.3 p -100.72 -176.05 3.07 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 105.118 -2.178 . . . . 1.9 105.118 175.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.02 -168.03 52.31 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 118.203 -1.951 . . . . 2.43 114.444 -178.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.84 40.91 0.88 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 113.891 -1.155 . . . . 4.32 110.353 -177.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 115.48 9.55 12.74 Favored Glycine 0 CA--C 1.544 1.873 0 CA-C-N 113.847 -1.524 . . . . 2.4 115.216 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.83 ' CA ' ' HB3' ' A' ' 75' ' ' SER . . . -103.55 140.41 14.89 Favored Glycine 0 C--N 1.336 0.58 0 CA-C-N 120.529 2.165 . . . . 1.82 116.2 -178.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.568 ' HA ' ' O ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -101.73 156.51 17.45 Favored 'General case' 0 C--N 1.341 0.216 0 C-N-CA 124.496 1.118 . . . . 3.51 109.685 177.837 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.471 ' HB2' ' HB2' ' A' ' 59' ' ' LYS . 1.2 m -52.1 106.28 0.14 Allowed 'General case' 0 CA--C 1.504 -0.82 0 CA-C-N 119.283 0.947 . . . . 1.52 108.793 -179.012 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.423 ' HB2' ' SG ' ' A' ' 28' ' ' CYS . . . -78.53 -29.65 46.56 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 106.31 -1.737 . . . . 1.5 106.31 177.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.932 ' O ' HG13 ' A' ' 72' ' ' ILE . . . -162.08 139.04 8.21 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 113.454 -1.703 . . . . 1.31 109.925 -176.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.608 ' O ' ' O ' ' A' ' 69' ' ' ALA . . . 12.7 -143.22 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.374 1.07 . . . . 1.5 113.796 179.127 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.519 ' C ' HG22 ' A' ' 72' ' ' ILE . . . -73.44 65.12 1.71 Allowed Glycine 0 CA--C 1.491 -1.443 0 N-CA-C 107.513 -2.235 . . . . 1.44 107.513 179.064 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.955 ' CD1' ' HB2' ' A' ' 34' ' ' CYS . 1.7 pp -150.81 97.17 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.813 0 N-CA-C 106.161 -1.792 . . . . 2.77 106.161 167.191 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.431 ' O ' ' N ' ' A' ' 80' ' ' HIS . 3.9 t -95.62 103.26 15.12 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.317 -0.856 . . . . 1.98 111.48 -175.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.583 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 0.0 OUTLIER -129.75 176.15 8.26 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 113.387 0.884 . . . . 1.43 113.387 -179.029 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.857 ' HB2' ' HD2' ' A' ' 76' ' ' PRO . 36.5 p -138.32 -179.27 1.0 Allowed Pre-proline 0 N--CA 1.462 0.15 0 CA-C-N 113.689 -1.596 . . . . 2.37 108.513 178.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.857 ' HD2' ' HB2' ' A' ' 75' ' ' SER . 77.0 Cg_endo -78.02 30.31 0.44 Allowed 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 121.449 1.433 . . . . 2.09 111.511 178.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.441 ' H ' ' C ' ' A' ' 75' ' ' SER . 0.6 OUTLIER -144.96 -34.01 0.36 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.507 -0.769 . . . . 2.65 110.864 179.816 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.571 ' O ' ' HB3' ' A' ' 74' ' ' CYS . . . -158.74 -171.98 25.28 Favored Glycine 0 C--N 1.339 0.738 0 C-N-CA 120.764 -0.732 . . . . 1.04 113.118 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.583 ' HA ' ' HA ' ' A' ' 74' ' ' CYS . 13.6 t -148.27 160.22 43.19 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 122.567 0.347 . . . . 1.42 110.664 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.431 ' N ' ' O ' ' A' ' 73' ' ' CYS . 1.8 t60 -154.71 145.92 22.84 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 120.027 -0.669 . . . . 2.81 111.659 -179.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.565 ' CG ' ' HB2' ' B' ' 125' ' ' SER . 1.8 mt-10 -64.13 132.82 51.59 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.42 -0.585 . . . . 3.05 109.42 178.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.421 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 0.3 OUTLIER -141.62 122.67 8.75 Favored Pre-proline 0 CA--C 1.541 0.621 0 CA-C-N 116.495 -0.32 . . . . 2.02 110.754 -179.08 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 82' ' ' ASP . 1.8 Cg_endo -83.7 -12.79 8.56 Favored 'Trans proline' 0 C--N 1.358 1.076 0 C-N-CA 123.17 2.58 . . . . 2.29 113.97 -177.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.87 -38.65 91.86 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.808 0.337 . . . . 1.53 111.531 -179.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.475 ' HB2' ' O ' ' A' ' 70' ' ' ALA . 78.7 m -95.24 39.7 1.11 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.034 -0.53 . . . . 1.88 111.155 -179.443 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.466 0.368 0 N-CA-C 114.744 1.386 . . . . 3.6 114.744 -178.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 110' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.44 -0.944 0 N-CA-C 109.194 -0.669 . . . . 2.87 109.194 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 111' ' ' LEU . . . . . 0.802 ' O ' ' HA ' ' B' ' 120' ' ' ARG . 1.7 mm? -34.2 109.97 0.37 Allowed Pre-proline 0 N--CA 1.469 0.507 0 N-CA-C 113.436 0.902 . . . . 2.95 113.436 -179.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 112' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -66.19 152.41 81.23 Favored 'Trans proline' 0 N--CA 1.464 -0.242 0 C-N-CA 121.84 1.693 . . . . 1.71 111.607 176.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.568 ' HB3' ' N ' ' B' ' 120' ' ' ARG . 1.0 OUTLIER -154.3 170.69 20.71 Favored 'General case' 0 CA--C 1.557 1.243 0 CA-C-O 121.185 0.517 . . . . 1.0 111.632 177.659 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 114' ' ' GLY . . . . . 0.731 ' HA2' ' HB3' ' B' ' 140' ' ' GLU . . . 74.38 -159.35 52.41 Favored Glycine 0 N--CA 1.467 0.748 0 CA-C-N 116.241 -0.436 . . . . 1.16 114.029 177.505 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 115' ' ' PRO . . . . . 0.476 ' O ' ' N ' ' B' ' 117' ' ' GLY . 87.6 Cg_endo -57.7 143.53 94.98 Favored 'Trans proline' 0 C--N 1.363 1.315 0 N-CA-C 102.355 -3.748 . . . . 1.6 102.355 175.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 48.06 -3.72 0.01 OUTLIER Glycine 0 C--N 1.274 -2.898 0 O-C-N 118.251 -2.78 . . . . 1.7 116.474 172.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 117' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' B' ' 115' ' ' PRO . . . 78.5 42.93 13.21 Favored Glycine 0 N--CA 1.407 -3.267 0 C-N-CA 116.695 -2.669 . . . . 1.38 114.231 177.143 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.09 -15.97 27.04 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 113.199 -1.5 . . . . 2.96 110.852 177.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . -96.26 -161.29 32.72 Favored Glycine 0 C--N 1.343 0.967 0 N-CA-C 109.074 -1.61 . . . . 1.07 109.074 179.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.802 ' HA ' ' O ' ' B' ' 111' ' ' LEU . 3.5 ttp180 -140.84 170.54 15.56 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 121.706 2.753 . . . . 3.29 106.788 177.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 121' ' ' CYS . . . . . 0.463 ' HB3' ' HG3' ' B' ' 147' ' ' GLU . 1.1 m -107.67 143.83 35.6 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 119.005 0.82 . . . . 1.21 112.83 -178.473 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 122' ' ' PHE . . . . . 0.409 ' HE2' ' HB3' ' B' ' 120' ' ' ARG . 97.1 m-85 -156.37 57.85 0.57 Allowed 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 114.898 -1.046 . . . . 2.28 109.897 179.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 123' ' ' GLY . . . . . 0.476 ' CA ' ' HA ' ' B' ' 176' ' ' PRO . . . 125.86 148.22 7.12 Favored Glycine 0 C--N 1.334 0.45 0 N-CA-C 110.972 -0.851 . . . . 1.04 110.972 -179.135 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . 0.414 ' O ' ' HB2' ' B' ' 141' ' ' ALA . 53.0 Cg_exo -52.27 -75.15 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 121.91 1.74 . . . . 1.84 112.312 -179.276 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 125' ' ' SER . . . . . 0.634 ' O ' HG12 ' B' ' 136' ' ' VAL . 1.9 m -89.28 37.71 0.87 Allowed 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 109.242 -0.651 . . . . 1.49 109.242 178.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 126' ' ' ILE . . . . . 0.863 HG12 ' CG1' ' B' ' 136' ' ' VAL . 18.5 mt -147.36 102.93 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 CA-C-N 115.247 -0.888 . . . . 1.41 109.737 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 127' ' ' CYS . . . . . 0.755 ' O ' ' HA ' ' B' ' 134' ' ' CYS . 0.1 OUTLIER -118.65 123.05 44.02 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.65 -0.705 . . . . 0.89 110.511 -177.837 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 128' ' ' CYS . . . . . 1.082 ' HA ' ' O ' ' B' ' 133' ' ' GLY . 0.0 OUTLIER -141.43 120.84 13.17 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 116.642 2.09 . . . . 1.23 116.642 -178.641 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 129' ' ' GLY . . . . . 0.843 ' O ' ' HB3' ' B' ' 169' ' ' ALA . . . -110.49 -169.0 19.46 Favored Glycine 0 C--N 1.366 2.249 0 N-CA-C 107.924 -2.07 . . . . 0.69 107.924 175.304 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 130' ' ' ASP . . . . . 0.498 ' OD2' ' HG2' ' B' ' 131' ' ' GLU . 21.3 p-10 -63.88 -60.88 2.72 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 113.967 1.099 . . . . 2.35 113.967 -177.294 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 131' ' ' GLU . . . . . 0.498 ' HG2' ' OD2' ' B' ' 130' ' ' ASP . 0.1 OUTLIER -115.13 27.52 9.33 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 122.287 1.042 . . . . 1.69 111.132 -178.048 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 132' ' ' LEU . . . . . 0.793 HD22 ' CE1' ' B' ' 135' ' ' PHE . 1.7 mt -124.02 -8.41 7.73 Favored 'General case' 0 N--CA 1.399 -3.01 0 N-CA-C 102.91 -2.996 . . . . 1.84 102.91 178.253 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 133' ' ' GLY . . . . . 1.082 ' O ' ' HA ' ' B' ' 128' ' ' CYS . . . 46.68 -130.36 11.96 Favored Glycine 0 N--CA 1.417 -2.604 0 CA-C-N 113.312 -1.767 . . . . 0.76 112.694 175.661 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 134' ' ' CYS . . . . . 0.956 ' HB2' ' CD1' ' B' ' 172' ' ' ILE . 1.5 t -130.85 118.7 21.13 Favored 'General case' 0 CA--C 1.492 -1.254 0 CA-C-N 120.166 1.983 . . . . 1.08 114.005 -179.356 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 135' ' ' PHE . . . . . 0.988 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -94.49 102.78 14.74 Favored 'General case' 0 N--CA 1.417 -2.085 0 N-CA-C 102.899 -3.0 . . . . 1.83 102.899 174.501 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 136' ' ' VAL . . . . . 0.863 ' CG1' HG12 ' B' ' 126' ' ' ILE . 3.8 t -87.8 93.15 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.916 0 CA-C-O 123.118 1.437 . . . . 1.29 107.968 -179.213 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 137' ' ' GLY . . . . . 0.813 ' O ' HG23 ' B' ' 138' ' ' THR . . . 94.67 79.62 1.46 Allowed Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 112.129 -2.305 . . . . 0.85 114.298 -178.699 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 138' ' ' THR . . . . . 0.813 HG23 ' O ' ' B' ' 137' ' ' GLY . 72.7 p -158.18 165.08 35.81 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.535 -0.543 . . . . 1.2 109.535 179.187 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -62.56 -14.01 37.53 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 121.107 0.479 . . . . 1.35 110.977 178.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 140' ' ' GLU . . . . . 0.731 ' HB3' ' HA2' ' B' ' 114' ' ' GLY . 40.9 mt-10 -70.15 -15.13 62.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.537 -0.756 . . . . 2.31 109.446 177.394 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 141' ' ' ALA . . . . . 0.813 ' O ' ' HB2' ' B' ' 144' ' ' CYS . . . -94.51 -25.48 16.84 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.37 -0.832 . . . . 1.09 110.871 -179.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 5.2 mt -40.31 -32.83 0.2 Allowed 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 113.245 0.831 . . . . 1.61 113.245 -177.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 143' ' ' ARG . . . . . . . . . . . . . 6.0 mmm-85 -69.34 -18.5 63.81 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 122.641 1.21 . . . . 3.43 109.141 177.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 144' ' ' CYS . . . . . 0.813 ' HB2' ' O ' ' B' ' 141' ' ' ALA . 1.3 m -60.94 -25.54 66.87 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 112.617 -2.083 . . . . 1.61 111.007 -177.367 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -51.1 -40.89 59.46 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.902 0.382 . . . . 3.52 111.693 178.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -85.55 6.37 27.48 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.68 -0.408 . . . . 3.76 110.211 -179.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 147' ' ' GLU . . . . . 0.463 ' HG3' ' HB3' ' B' ' 121' ' ' CYS . 1.6 tm-20 . . . . . 0 N--CA 1.449 -0.476 0 N-CA-C 109.19 -0.67 . . . . 4.01 109.19 177.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 5.5 p . . . . . 0 N--CA 1.476 0.846 0 CA-C-O 120.971 0.415 . . . . 3.41 111.495 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -56.51 115.12 5.88 Favored Glycine 0 CA--C 1.499 -0.909 0 CA-C-N 116.131 -0.486 . . . . 2.26 112.576 -178.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -76.28 67.45 2.53 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 119.157 -1.017 . . . . 5.03 109.504 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 159' ' ' LYS . . . . . 0.602 ' O ' ' HA ' ' B' ' 166' ' ' ARG . 14.8 mmmt -108.62 70.17 0.38 Allowed Pre-proline 0 C--N 1.318 -0.79 0 CA-C-N 114.043 -1.435 . . . . 3.96 110.852 174.408 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 160' ' ' PRO . . . . . 0.503 ' HA ' ' O ' ' B' ' 165' ' ' GLY . 68.6 Cg_endo -75.38 82.97 1.96 Allowed 'Trans proline' 0 N--CA 1.463 -0.271 0 C-N-CA 121.747 1.632 . . . . 1.7 115.582 -176.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 161' ' ' CYS . . . . . 0.403 ' N ' ' O ' ' B' ' 165' ' ' GLY . 1.8 p -93.04 -157.98 0.57 Allowed 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 113.107 -1.86 . . . . 1.93 107.279 177.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 52.95 -167.11 1.17 Allowed Glycine 0 N--CA 1.453 -0.203 0 O-C-N 119.287 -2.133 . . . . 2.37 116.938 171.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.64 41.02 0.88 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 112.849 -1.675 . . . . 4.56 110.436 -178.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 115.52 9.72 12.47 Favored Glycine 0 CA--C 1.548 2.136 0 CA-C-N 114.168 -1.378 . . . . 2.39 115.222 -179.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 165' ' ' GLY . . . . . 0.827 ' CA ' ' HB3' ' B' ' 175' ' ' SER . . . -103.93 139.5 14.55 Favored Glycine 0 N--CA 1.464 0.512 0 CA-C-N 120.327 2.064 . . . . 1.79 116.306 -179.051 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 166' ' ' ARG . . . . . 0.602 ' HA ' ' O ' ' B' ' 159' ' ' LYS . 0.0 OUTLIER -101.48 156.39 17.5 Favored 'General case' 0 C--N 1.343 0.323 0 CA-C-N 113.877 -1.162 . . . . 3.53 109.754 178.11 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 167' ' ' CYS . . . . . 0.491 ' HB2' ' HB2' ' B' ' 159' ' ' LYS . 1.2 m -52.05 106.19 0.14 Allowed 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 119.456 1.025 . . . . 1.56 108.813 -179.003 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 168' ' ' ALA . . . . . . . . . . . . . . . -79.58 -27.76 41.15 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 106.602 -1.629 . . . . 1.42 106.602 177.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 169' ' ' ALA . . . . . 0.88 ' O ' HG13 ' B' ' 172' ' ' ILE . . . -163.46 139.67 6.88 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 114.81 -1.086 . . . . 1.18 108.589 -177.407 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 170' ' ' ALA . . . . . 0.559 ' O ' ' O ' ' B' ' 169' ' ' ALA . . . 11.28 -139.65 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 114.489 1.292 . . . . 1.47 114.489 179.109 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 171' ' ' GLY . . . . . 0.429 ' HA2' ' O ' ' B' ' 182' ' ' ASP . . . -57.2 19.96 0.01 OUTLIER Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 115.72 1.048 . . . . 1.45 115.72 -179.121 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 172' ' ' ILE . . . . . 0.966 HG22 ' HA3' ' A' ' 37' ' ' GLY . 1.7 pp -128.3 99.81 5.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 CA-C-N 118.811 1.305 . . . . 2.7 109.529 -176.603 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 173' ' ' CYS . . . . . 0.422 ' O ' ' N ' ' B' ' 180' ' ' HIS . 4.6 t -94.9 102.95 14.82 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.317 -1.31 . . . . 1.94 111.854 -176.492 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 174' ' ' CYS . . . . . 0.593 ' HA ' ' HA ' ' B' ' 179' ' ' CYS . 0.0 OUTLIER -130.0 176.44 8.06 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 113.372 0.878 . . . . 1.43 113.372 -179.118 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 175' ' ' SER . . . . . 0.845 ' HB2' ' HD2' ' B' ' 176' ' ' PRO . 35.9 p -138.42 -179.29 1.01 Allowed Pre-proline 0 N--CA 1.462 0.129 0 CA-C-N 113.666 -1.606 . . . . 2.3 108.493 178.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 176' ' ' PRO . . . . . 0.845 ' HD2' ' HB2' ' B' ' 175' ' ' SER . 77.0 Cg_endo -78.0 30.3 0.44 Allowed 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 121.445 1.43 . . . . 2.13 111.524 178.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 177' ' ' ASP . . . . . 0.458 ' H ' ' C ' ' B' ' 175' ' ' SER . 0.6 OUTLIER -145.06 -33.88 0.36 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 115.534 -0.757 . . . . 2.72 110.84 179.837 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 178' ' ' GLY . . . . . 0.572 ' O ' ' HB3' ' B' ' 174' ' ' CYS . . . -158.82 -172.04 25.42 Favored Glycine 0 C--N 1.339 0.702 0 C-N-CA 120.822 -0.704 . . . . 1.05 113.19 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 179' ' ' CYS . . . . . 0.593 ' HA ' ' HA ' ' B' ' 174' ' ' CYS . 13.6 t -148.23 160.3 43.08 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 122.536 0.335 . . . . 1.39 110.65 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 180' ' ' HIS . . . . . 0.422 ' N ' ' O ' ' B' ' 173' ' ' CYS . 1.8 t60 -154.86 145.89 22.67 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 119.968 -0.693 . . . . 2.73 111.665 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 181' ' ' GLU . . . . . 0.509 ' CG ' ' HB2' ' A' ' 25' ' ' SER . 1.8 mt-10 -64.12 132.91 51.87 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.421 -0.585 . . . . 3.06 109.421 178.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 182' ' ' ASP . . . . . 0.446 ' HA ' ' HD3' ' B' ' 183' ' ' PRO . 0.3 OUTLIER -141.71 122.52 8.63 Favored Pre-proline 0 CA--C 1.541 0.613 0 CA-C-N 116.499 -0.319 . . . . 2.06 110.706 -178.984 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 183' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' B' ' 182' ' ' ASP . 1.8 Cg_endo -83.64 -12.73 8.67 Favored 'Trans proline' 0 C--N 1.359 1.097 0 C-N-CA 123.141 2.561 . . . . 2.27 114.009 -178.019 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -63.87 -38.44 91.1 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.845 0.355 . . . . 1.56 111.54 -179.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 185' ' ' CYS . . . . . 0.501 ' HB2' ' O ' ' B' ' 170' ' ' ALA . 86.0 m -95.14 39.02 1.12 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.942 -0.572 . . . . 1.94 111.468 -179.419 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 186' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.535 0.371 0 N-CA-C 115.018 1.488 . . . . 3.61 115.018 -178.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.532 ' HB3' ' HD2' ' A' ' 20' ' ' ARG . 0.5 OUTLIER . . . . . 0 CA--C 1.533 0.319 0 N-CA-C 113.207 0.818 . . . . 2.89 113.207 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.514 ' O ' ' HG3' ' A' ' 20' ' ' ARG . 0.2 OUTLIER -31.13 113.94 0.34 Allowed Pre-proline 0 N--CA 1.472 0.648 0 N-CA-C 113.244 0.831 . . . . 2.89 113.244 -179.515 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.754 ' HB2' ' O ' ' A' ' 17' ' ' GLY . 21.9 Cg_endo -93.04 152.74 2.62 Favored 'Trans proline' 0 CA--C 1.535 0.571 0 C-N-CA 124.128 3.219 . . . . 1.72 115.279 -178.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.812 ' N ' ' O ' ' A' ' 19' ' ' GLY . 15.4 p -154.06 -160.36 1.08 Allowed 'General case' 0 C--O 1.243 0.741 0 CA-C-N 115.799 -0.637 . . . . 1.0 109.676 175.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.532 ' HA2' ' HG2' ' A' ' 40' ' ' GLU . . . 74.08 -162.95 54.47 Favored Glycine 0 C--N 1.338 0.65 0 N-CA-C 115.479 0.952 . . . . 1.15 115.479 174.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.674 ' O ' ' HD3' ' A' ' 18' ' ' LYS . 64.5 Cg_endo -61.74 104.31 0.31 Allowed 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 124.411 3.408 . . . . 1.6 110.237 177.459 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 86.67 -8.83 73.73 Favored Glycine 0 C--N 1.27 -3.125 0 CA-C-N 112.625 -2.08 . . . . 1.68 112.037 -178.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.754 ' O ' ' HB2' ' A' ' 12' ' ' PRO . . . 78.08 44.33 12.01 Favored Glycine 0 N--CA 1.403 -3.555 0 C-N-CA 120.258 -0.973 . . . . 1.37 114.789 179.126 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.7 ' H ' ' HZ1' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -92.8 -49.0 6.28 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 105.494 -2.039 . . . . 2.91 105.494 175.457 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.812 ' O ' ' N ' ' A' ' 13' ' ' CYS . . . -66.46 162.68 43.95 Favored Glycine 0 C--O 1.205 -1.658 0 C-N-CA 118.099 -2.001 . . . . 1.06 116.038 -165.657 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.532 ' HD2' ' HB3' ' A' ' 10' ' ' CYS . 0.0 OUTLIER -98.53 163.6 12.6 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 115.081 1.512 . . . . 3.32 115.081 -171.052 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.4 m -106.27 134.31 49.61 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 114.266 -1.334 . . . . 1.19 110.772 -177.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -134.26 36.3 3.21 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.208 -0.905 . . . . 2.26 109.857 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 144.93 164.43 10.61 Favored Glycine 0 CA--C 1.521 0.459 0 CA-C-N 115.802 -0.635 . . . . 1.05 112.39 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.426 ' HD2' ' OE2' ' B' ' 181' ' ' GLU . 50.6 Cg_exo -52.12 -73.22 0.04 OUTLIER 'Trans proline' 0 CA--C 1.532 0.396 0 C-N-CA 122.715 2.277 . . . . 1.81 112.66 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.654 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.4 OUTLIER -90.96 42.72 1.12 Allowed 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 109.312 -0.625 . . . . 1.62 109.312 178.875 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.713 HG21 ' SG ' ' A' ' 34' ' ' CYS . 4.4 mt -144.9 121.14 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 N-CA-C 113.561 0.949 . . . . 1.39 113.561 -177.037 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.701 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -138.19 112.42 8.62 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.71 0.767 . . . . 0.92 110.632 178.736 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 1.153 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -131.74 118.53 20.08 Favored 'General case' 0 CA--C 1.557 1.242 0 N-CA-C 114.996 1.48 . . . . 1.28 114.996 -179.319 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -108.22 -165.99 21.24 Favored Glycine 0 N--CA 1.428 -1.849 0 N-CA-C 107.035 -2.426 . . . . 0.71 107.035 175.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -68.51 -60.48 2.4 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 115.322 1.601 . . . . 2.27 115.322 -179.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.28 18.43 21.64 Favored 'General case' 0 CA--C 1.482 -1.639 0 CA-C-O 121.682 0.754 . . . . 1.66 111.464 -176.607 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.591 ' CD1' ' HZ3' ' A' ' 18' ' ' LYS . 1.2 mt -115.06 -24.86 8.37 Favored 'General case' 0 N--CA 1.395 -3.195 0 N-CA-C 106.396 -1.705 . . . . 1.93 106.396 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 1.153 ' O ' ' HA ' ' A' ' 28' ' ' CYS . . . 76.18 -132.63 12.97 Favored Glycine 0 N--CA 1.4 -3.713 0 CA-C-N 114.353 -1.294 . . . . 0.77 111.28 177.267 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.733 ' HB2' ' CD1' ' A' ' 72' ' ' ILE . 3.2 t -137.96 118.35 13.75 Favored 'General case' 0 CA--C 1.479 -1.758 0 CA-C-N 118.63 1.215 . . . . 1.08 111.557 178.485 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.916 ' HA ' ' HA ' ' B' ' 135' ' ' PHE . 0.0 OUTLIER -91.62 107.21 19.05 Favored 'General case' 0 N--CA 1.42 -1.953 0 N-CA-C 102.242 -3.244 . . . . 1.85 102.242 174.106 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.708 HG13 HG12 ' A' ' 26' ' ' ILE . 1.9 t -93.0 89.76 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.587 0 CA-C-O 122.793 1.282 . . . . 1.29 110.21 -177.492 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.654 ' N ' ' O ' ' A' ' 25' ' ' SER . . . 102.76 17.44 18.96 Favored Glycine 0 CA--C 1.518 0.241 0 CA-C-N 112.962 -1.926 . . . . 0.85 116.017 178.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.66 HG23 ' HB3' ' A' ' 35' ' ' PHE . 25.9 p -95.39 164.99 12.59 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 118.505 1.152 . . . . 1.3 109.002 178.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.469 ' O ' ' HD3' ' A' ' 43' ' ' ARG . . . -49.29 -29.7 6.32 Favored 'General case' 0 CA--C 1.517 -0.291 0 O-C-N 120.963 -1.086 . . . . 1.45 112.906 -177.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.532 ' HG2' ' HA2' ' A' ' 14' ' ' GLY . 1.6 mp0 -62.53 -20.65 64.86 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 120.867 -0.333 . . . . 2.32 110.125 179.217 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.739 ' O ' ' HB2' ' A' ' 44' ' ' CYS . . . -96.14 -24.07 16.45 Favored 'General case' 0 N--CA 1.428 -1.536 0 CA-C-O 119.312 -0.375 . . . . 1.11 110.468 -178.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.601 ' C ' ' H ' ' A' ' 44' ' ' CYS . 1.8 mt -57.4 -27.18 62.11 Favored 'General case' 0 C--N 1.346 0.445 0 CA-C-N 119.791 1.178 . . . . 1.68 110.095 179.223 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.476 ' HD3' ' HA ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -77.69 9.27 3.56 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 122.231 1.015 . . . . 3.4 108.901 176.816 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.739 ' HB2' ' O ' ' A' ' 41' ' ' ALA . 5.9 m -83.29 2.95 33.48 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 112.838 -1.983 . . . . 1.57 108.214 172.513 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 30.9 tp60 -86.84 -8.34 57.39 Favored 'General case' 0 C--N 1.35 0.595 0 O-C-N 121.384 -0.823 . . . . 3.49 110.988 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -85.98 5.29 33.91 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 119.094 -1.042 . . . . 3.69 108.762 179.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 . . . . . 0 N--CA 1.445 -0.716 0 CA-C-N 116.013 -0.539 . . . . 3.99 109.782 177.267 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.2 t . . . . . 0 CA--C 1.529 0.157 0 N-CA-C 109.193 -0.669 . . . . 3.36 109.193 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -76.8 146.88 32.98 Favored Glycine 0 N--CA 1.433 -1.509 0 N-CA-C 110.064 -1.214 . . . . 2.3 110.064 -177.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -113.43 74.17 0.85 Allowed 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 122.153 0.978 . . . . 5.06 108.891 178.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.525 ' HB2' ' HB3' ' A' ' 67' ' ' CYS . 5.9 mmtp -144.1 58.22 5.73 Favored Pre-proline 0 C--N 1.304 -1.393 0 N-CA-C 106.579 -1.638 . . . . 3.91 106.579 178.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.467 ' CD ' ' N ' ' A' ' 59' ' ' LYS . 19.6 Cg_endo -59.01 80.45 0.05 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 122.437 2.091 . . . . 1.74 115.048 -177.228 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.499 ' N ' ' O ' ' A' ' 65' ' ' GLY . 0.5 OUTLIER -99.58 -178.64 3.95 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 106.449 -1.686 . . . . 1.9 106.449 175.553 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.515 ' HA3' ' CE1' ' A' ' 80' ' ' HIS . . . 70.49 -166.79 50.8 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 118.103 -1.999 . . . . 2.43 112.31 179.148 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.7 m -86.13 39.68 0.83 Allowed 'General case' 0 N--CA 1.477 0.893 0 CA-C-O 121.843 0.83 . . . . 4.32 111.354 -176.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 120.15 9.99 7.7 Favored Glycine 0 CA--C 1.543 1.789 0 CA-C-N 114.462 -1.244 . . . . 2.4 114.441 -178.111 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.499 ' O ' ' N ' ' A' ' 61' ' ' CYS . . . -103.45 151.06 17.78 Favored Glycine 0 C--N 1.336 0.559 0 CA-C-N 119.772 1.786 . . . . 1.82 114.913 -179.121 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.52 152.51 19.94 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 122.157 0.183 . . . . 3.51 111.048 178.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.525 ' HB3' ' HB2' ' A' ' 59' ' ' LYS . 42.9 t -67.6 121.83 16.73 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-O 121.037 0.446 . . . . 1.52 111.606 -179.213 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.422 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . . . -99.15 -16.66 18.51 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.836 0.827 . . . . 1.5 109.021 177.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.685 ' CB ' ' HA2' ' A' ' 33' ' ' GLY . . . -170.09 160.88 8.35 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.326 -1.307 . . . . 1.31 110.756 178.578 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.409 ' HA ' ' HB3' ' A' ' 85' ' ' CYS . . . -61.5 138.01 58.26 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 122.045 -0.409 . . . . 1.5 111.226 178.31 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.74 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . 64.06 18.97 63.15 Favored Glycine 0 N--CA 1.467 0.756 0 CA-C-N 115.77 -0.65 . . . . 1.44 112.808 -179.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.733 ' CD1' ' HB2' ' A' ' 34' ' ' CYS . 1.3 pp -150.34 105.59 0.37 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.913 0 N-CA-C 112.116 0.413 . . . . 2.77 112.116 173.11 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.534 ' HB2' ' HB3' ' A' ' 82' ' ' ASP . 16.5 t -97.75 110.79 23.29 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 120.869 0.366 . . . . 1.98 110.32 178.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.744 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 72.1 m -92.44 138.84 31.17 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.494 0.664 . . . . 1.43 111.703 -179.336 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.768 ' HB2' ' HD2' ' A' ' 76' ' ' PRO . 54.1 p -113.26 179.55 0.77 Allowed Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 114.82 -1.082 . . . . 2.37 108.948 179.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.768 ' HD2' ' HB2' ' A' ' 75' ' ' SER . 74.0 Cg_endo -76.4 30.87 0.4 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 121.349 1.366 . . . . 2.09 111.997 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.468 ' H ' ' C ' ' A' ' 75' ' ' SER . 18.4 m-20 -144.86 -41.78 0.24 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.544 -0.753 . . . . 2.65 109.983 179.378 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.849 ' HA3' ' O ' ' B' ' 179' ' ' CYS . . . -163.63 -135.07 1.75 Allowed Glycine 0 C--N 1.336 0.551 0 C-N-CA 120.951 -0.642 . . . . 1.04 112.784 179.396 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.84 ' O ' ' HA3' ' B' ' 178' ' ' GLY . 62.7 m -148.1 157.11 43.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.06 0.457 . . . . 1.42 110.314 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.515 ' CE1' ' HA3' ' A' ' 62' ' ' GLY . 1.8 p80 -158.02 153.17 25.61 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.206 -0.598 . . . . 2.81 110.641 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.4 ' OE2' ' HD2' ' B' ' 124' ' ' PRO . 14.6 mp0 -63.06 140.81 58.91 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.672 -0.411 . . . . 3.05 109.983 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.61 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 2.4 p-10 -140.89 140.88 22.49 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 116.071 -0.513 . . . . 2.02 111.195 -179.328 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -72.48 -27.35 15.88 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 123.492 2.795 . . . . 2.29 114.571 -177.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.02 -47.44 71.41 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 107.86 -1.163 . . . . 1.53 107.86 179.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.74 ' O ' ' N ' ' A' ' 71' ' ' GLY . 2.0 m -99.12 77.97 2.21 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 114.181 -1.372 . . . . 1.88 107.497 176.463 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.61 ' HB2' ' O ' ' A' ' 82' ' ' ASP . 38.2 t0 . . . . . 0 C--N 1.321 -0.649 0 N-CA-C 114.23 1.196 . . . . 2.29 114.23 -179.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 110' ' ' CYS . . . . . 0.54 ' HB3' ' HD2' ' B' ' 120' ' ' ARG . 0.5 OUTLIER . . . . . 0 CA--C 1.531 0.242 0 N-CA-C 112.654 0.612 . . . . 2.87 112.654 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 111' ' ' LEU . . . . . 0.505 ' O ' ' HA ' ' B' ' 120' ' ' ARG . 0.2 OUTLIER -31.07 113.85 0.33 Allowed Pre-proline 0 N--CA 1.469 0.508 0 N-CA-C 113.107 0.78 . . . . 2.95 113.107 -179.629 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 112' ' ' PRO . . . . . 0.82 ' HB2' ' O ' ' B' ' 117' ' ' GLY . 29.0 Cg_endo -90.72 154.31 4.17 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 124.46 3.44 . . . . 1.71 114.417 -179.074 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.829 ' N ' ' O ' ' B' ' 119' ' ' GLY . 15.3 p -156.08 -159.93 0.95 Allowed 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 109.479 -0.563 . . . . 1.0 109.479 174.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 114' ' ' GLY . . . . . 0.511 ' HA2' ' HG2' ' B' ' 140' ' ' GLU . . . 73.45 -163.24 54.78 Favored Glycine 0 C--N 1.337 0.614 0 N-CA-C 115.639 1.016 . . . . 1.16 115.639 175.014 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 115' ' ' PRO . . . . . 0.674 ' O ' ' HD3' ' B' ' 118' ' ' LYS . 67.9 Cg_endo -61.78 100.77 0.2 Allowed 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 124.361 3.374 . . . . 1.6 111.37 178.081 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 86.89 -0.14 86.14 Favored Glycine 0 C--N 1.283 -2.414 0 CA-C-N 112.688 -2.051 . . . . 1.7 112.955 -178.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 117' ' ' GLY . . . . . 0.82 ' O ' ' HB2' ' B' ' 112' ' ' PRO . . . 76.46 37.12 36.67 Favored Glycine 0 N--CA 1.416 -2.659 0 N-CA-C 115.736 1.055 . . . . 1.38 115.736 175.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 118' ' ' LYS . . . . . 0.708 ' H ' ' HZ3' ' B' ' 118' ' ' LYS . 0.0 OUTLIER -95.69 -30.47 13.73 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 121.753 0.787 . . . . 2.96 111.763 179.448 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 119' ' ' GLY . . . . . 0.829 ' O ' ' N ' ' B' ' 113' ' ' CYS . . . -77.77 158.45 46.77 Favored Glycine 0 C--O 1.193 -2.412 0 N-CA-C 117.499 1.76 . . . . 1.07 117.499 -174.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.54 ' HD2' ' HB3' ' B' ' 110' ' ' CYS . 0.0 OUTLIER -99.84 160.35 14.37 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 111.774 -2.213 . . . . 3.29 113.363 -169.069 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 121' ' ' CYS . . . . . . . . . . . . . 1.4 m -105.43 134.01 49.25 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 114.304 -1.316 . . . . 1.21 110.734 -175.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -134.16 36.3 3.23 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.152 -0.931 . . . . 2.28 109.976 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 145.11 164.51 10.7 Favored Glycine 0 CA--C 1.521 0.445 0 CA-C-N 115.849 -0.614 . . . . 1.04 112.395 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . 0.4 ' HD2' ' OE2' ' A' ' 81' ' ' GLU . 51.1 Cg_exo -52.17 -73.13 0.04 OUTLIER 'Trans proline' 0 CA--C 1.532 0.411 0 C-N-CA 122.752 2.302 . . . . 1.84 112.761 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 125' ' ' SER . . . . . 0.637 ' O ' ' N ' ' B' ' 137' ' ' GLY . 0.5 OUTLIER -91.02 42.8 1.12 Allowed 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 109.251 -0.648 . . . . 1.49 109.251 178.778 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 126' ' ' ILE . . . . . 0.606 HG12 HG12 ' B' ' 136' ' ' VAL . 6.3 mt -144.51 121.06 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 N-CA-C 113.667 0.988 . . . . 1.41 113.667 -176.798 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 127' ' ' CYS . . . . . 0.661 ' O ' ' HA ' ' B' ' 134' ' ' CYS . 0.0 OUTLIER -138.73 111.47 7.7 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-O 121.57 0.7 . . . . 0.89 110.56 178.458 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 128' ' ' CYS . . . . . 1.16 ' HA ' ' O ' ' B' ' 133' ' ' GLY . 0.0 OUTLIER -127.53 129.36 47.23 Favored 'General case' 0 N--CA 1.439 -0.977 0 C-N-CA 124.243 1.017 . . . . 1.23 111.517 179.098 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 129' ' ' GLY . . . . . 0.633 ' O ' ' HB1' ' B' ' 169' ' ' ALA . . . -120.82 -160.35 11.07 Favored Glycine 0 N--CA 1.417 -2.598 0 N-CA-C 104.126 -3.59 . . . . 0.69 104.126 172.464 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -67.14 -73.23 0.14 Allowed 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 118.283 1.041 . . . . 2.35 111.702 -178.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.97 34.6 2.96 Favored 'General case' 0 CA--C 1.478 -1.792 0 CA-C-O 121.76 0.79 . . . . 1.69 110.505 -173.024 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 132' ' ' LEU . . . . . 0.49 ' O ' ' HA ' ' A' ' 38' ' ' THR . 1.1 mt -126.49 -23.62 3.75 Favored 'General case' 0 N--CA 1.391 -3.384 0 N-CA-C 104.992 -2.225 . . . . 1.84 104.992 177.181 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 133' ' ' GLY . . . . . 1.16 ' O ' ' HA ' ' B' ' 128' ' ' CYS . . . 73.71 -135.62 20.77 Favored Glycine 1 N--CA 1.39 -4.39 0 N-CA-C 110.275 -1.13 . . . . 0.76 110.275 176.664 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 134' ' ' CYS . . . . . 0.752 ' HB2' ' CD1' ' B' ' 172' ' ' ILE . 3.1 t -135.97 116.34 13.63 Favored 'General case' 0 CA--C 1.495 -1.168 0 CA-C-N 118.227 1.014 . . . . 1.08 113.519 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 135' ' ' PHE . . . . . 0.916 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -88.57 106.3 18.22 Favored 'General case' 0 N--CA 1.421 -1.879 0 N-CA-C 102.59 -3.115 . . . . 1.83 102.59 175.101 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 136' ' ' VAL . . . . . 0.68 HG21 HG21 ' A' ' 36' ' ' VAL . 2.3 t -92.85 88.02 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-O 123.161 1.458 . . . . 1.29 110.233 -177.645 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 137' ' ' GLY . . . . . 0.678 ' HA3' HG22 ' A' ' 72' ' ' ILE . . . 102.79 18.43 15.77 Favored Glycine 0 C--N 1.32 -0.328 0 CA-C-N 112.705 -2.043 . . . . 0.85 115.916 178.58 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 138' ' ' THR . . . . . 0.642 HG23 ' HB3' ' B' ' 135' ' ' PHE . 30.2 p -89.76 177.04 6.61 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 118.071 0.936 . . . . 1.2 108.747 178.614 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 139' ' ' ALA . . . . . 0.528 ' HA ' HD13 ' B' ' 142' ' ' LEU . . . -58.07 -36.36 72.69 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 118.982 0.81 . . . . 1.35 110.516 179.151 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 140' ' ' GLU . . . . . 0.511 ' HG2' ' HA2' ' B' ' 114' ' ' GLY . 1.7 mp0 -59.54 -15.14 16.15 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.439 -0.346 . . . . 2.31 111.683 -179.357 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 141' ' ' ALA . . . . . 0.676 ' O ' ' HB2' ' B' ' 144' ' ' CYS . . . -99.17 -26.74 14.1 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 116.274 -0.421 . . . . 1.09 110.567 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 142' ' ' LEU . . . . . 0.528 HD13 ' HA ' ' B' ' 139' ' ' ALA . 2.2 mt -55.58 -29.22 58.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.311 0.576 . . . . 1.61 109.681 179.179 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 143' ' ' ARG . . . . . 0.51 ' HD3' ' HA ' ' B' ' 140' ' ' GLU . 0.0 OUTLIER -78.51 11.39 2.51 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 109.051 -0.722 . . . . 3.43 109.051 177.132 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 144' ' ' CYS . . . . . 0.676 ' HB2' ' O ' ' B' ' 141' ' ' ALA . 5.8 m -89.32 13.01 14.51 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 107.232 -1.396 . . . . 1.61 107.232 172.362 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 29.8 tp60 -88.7 -11.86 43.99 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 115.278 -0.874 . . . . 3.52 110.285 177.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -85.95 5.48 32.95 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 119.11 -1.036 . . . . 3.76 109.194 179.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 . . . . . 0 N--CA 1.444 -0.764 0 C-N-CA 120.377 -0.529 . . . . 4.01 109.784 177.322 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 1.9 t . . . . . 0 N--CA 1.45 -0.47 0 N-CA-C 108.744 -0.836 . . . . 3.41 108.744 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -88.85 147.16 19.61 Favored Glycine 0 CA--C 1.494 -1.228 0 N-CA-C 109.764 -1.334 . . . . 2.26 109.764 176.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -114.91 62.49 0.68 Allowed 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 117.207 -1.797 . . . . 5.03 110.293 178.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 159' ' ' LYS . . . . . 0.637 ' HB2' ' CB ' ' B' ' 167' ' ' CYS . 7.0 mmtp -117.94 53.9 1.71 Allowed Pre-proline 0 C--N 1.313 -1.02 0 CA-C-N 113.507 -1.679 . . . . 3.96 110.48 172.448 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 160' ' ' PRO . . . . . 0.417 ' HA ' ' O ' ' B' ' 165' ' ' GLY . 15.0 Cg_endo -58.47 81.33 0.05 OUTLIER 'Trans proline' 0 C--N 1.331 -0.363 0 CA-C-N 121.626 1.616 . . . . 1.7 116.072 -173.185 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 161' ' ' CYS . . . . . 0.489 ' N ' ' O ' ' B' ' 165' ' ' GLY . 0.5 OUTLIER -99.25 -178.29 3.87 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 106.926 -1.509 . . . . 1.93 106.926 175.762 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 162' ' ' GLY . . . . . 0.509 ' HA3' ' CE1' ' B' ' 180' ' ' HIS . . . 69.78 -166.57 49.22 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 118.301 -1.904 . . . . 2.37 112.283 178.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 2.8 m -85.75 39.95 0.82 Allowed 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.634 0.73 . . . . 4.56 111.423 -177.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 121.48 6.74 8.61 Favored Glycine 0 CA--C 1.541 1.656 0 CA-C-N 114.586 -1.188 . . . . 2.39 114.663 -179.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 165' ' ' GLY . . . . . 0.5 ' CA ' ' HA ' ' B' ' 175' ' ' SER . . . -102.14 151.74 18.41 Favored Glycine 0 CA--C 1.523 0.562 0 CA-C-N 119.909 1.855 . . . . 1.79 115.172 -177.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 166' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.2 152.63 19.68 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 122.275 0.23 . . . . 3.53 111.046 179.459 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 167' ' ' CYS . . . . . 0.637 ' CB ' ' HB2' ' B' ' 159' ' ' LYS . 41.9 t -67.73 121.47 16.01 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-O 120.771 0.319 . . . . 1.56 111.611 -179.108 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 168' ' ' ALA . . . . . 0.408 ' HB2' ' SG ' ' B' ' 128' ' ' CYS . . . -96.4 -19.54 19.11 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.444 -0.947 . . . . 1.42 108.444 177.277 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 169' ' ' ALA . . . . . 0.68 ' CB ' ' HA2' ' B' ' 133' ' ' GLY . . . -168.68 160.99 11.06 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 113.739 -1.573 . . . . 1.18 111.898 -179.228 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 170' ' ' ALA . . . . . 0.413 ' HA ' ' HB3' ' B' ' 185' ' ' CYS . . . -61.76 138.95 58.37 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.004 0.43 . . . . 1.47 110.596 178.549 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 171' ' ' GLY . . . . . 0.711 ' N ' ' O ' ' B' ' 185' ' ' CYS . . . 74.43 -1.06 52.74 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 121.191 -0.528 . . . . 1.45 114.113 179.488 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 172' ' ' ILE . . . . . 0.752 ' CD1' ' HB2' ' B' ' 134' ' ' CYS . 1.3 pp -142.51 107.54 1.51 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.598 0 CA-C-O 121.736 0.779 . . . . 2.7 113.066 -179.29 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 173' ' ' CYS . . . . . 0.523 ' HB2' ' HB3' ' B' ' 182' ' ' ASP . 16.3 t -97.8 110.64 23.17 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.698 -0.683 . . . . 1.94 110.216 178.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 174' ' ' CYS . . . . . 0.726 ' HA ' ' HA ' ' B' ' 179' ' ' CYS . 72.0 m -92.67 138.91 31.09 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.439 0.638 . . . . 1.43 111.755 -179.401 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 175' ' ' SER . . . . . 0.791 ' HB2' ' HD2' ' B' ' 176' ' ' PRO . 51.7 p -113.35 179.65 0.75 Allowed Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 114.866 -1.061 . . . . 2.3 108.906 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 176' ' ' PRO . . . . . 0.791 ' HD2' ' HB2' ' B' ' 175' ' ' SER . 74.4 Cg_endo -76.39 30.78 0.4 Allowed 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 121.427 1.418 . . . . 2.13 111.918 -179.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 177' ' ' ASP . . . . . 0.468 ' H ' ' C ' ' B' ' 175' ' ' SER . 18.4 m-20 -144.71 -41.67 0.25 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.563 -0.744 . . . . 2.72 110.065 179.342 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 178' ' ' GLY . . . . . 0.84 ' HA3' ' O ' ' A' ' 79' ' ' CYS . . . -163.74 -135.11 1.76 Allowed Glycine 0 C--N 1.337 0.613 0 C-N-CA 121.041 -0.6 . . . . 1.05 112.763 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 179' ' ' CYS . . . . . 0.849 ' O ' ' HA3' ' A' ' 78' ' ' GLY . 62.3 m -148.12 157.05 43.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.949 0.404 . . . . 1.39 110.44 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 180' ' ' HIS . . . . . 0.509 ' CE1' ' HA3' ' B' ' 162' ' ' GLY . 1.8 p80 -157.89 153.2 25.9 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.285 -0.566 . . . . 2.73 110.611 -179.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 181' ' ' GLU . . . . . 0.426 ' OE2' ' HD2' ' A' ' 24' ' ' PRO . 14.6 mp0 -62.99 140.87 58.91 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.748 -0.381 . . . . 3.06 109.983 179.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 182' ' ' ASP . . . . . 0.598 ' O ' ' HB2' ' B' ' 186' ' ' ASP . 2.4 p-10 -141.02 140.92 22.18 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 116.11 -0.495 . . . . 2.06 111.089 -179.248 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 183' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_exo -72.53 -27.17 15.91 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 123.467 2.778 . . . . 2.27 114.665 -178.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -67.13 -47.35 71.37 Favored 'General case' 0 CA--C 1.507 -0.697 0 N-CA-C 107.784 -1.191 . . . . 1.56 107.784 179.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 185' ' ' CYS . . . . . 0.711 ' O ' ' N ' ' B' ' 171' ' ' GLY . 2.2 m -99.16 77.81 2.19 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 114.192 -1.367 . . . . 1.94 107.647 176.404 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 186' ' ' ASP . . . . . 0.598 ' HB2' ' O ' ' B' ' 182' ' ' ASP . 38.3 t0 . . . . . 0 C--N 1.321 -0.631 0 N-CA-C 114.3 1.222 . . . . 2.28 114.3 -179.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.848 ' O ' ' HG2' ' A' ' 20' ' ' ARG . 71.6 m . . . . . 0 N--CA 1.48 1.074 0 N-CA-C 114.191 1.182 . . . . 2.89 114.191 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.533 ' HB3' ' NH2' ' A' ' 43' ' ' ARG . 0.2 OUTLIER -29.24 119.99 0.29 Allowed Pre-proline 0 N--CA 1.485 1.303 0 C-N-CA 123.673 0.789 . . . . 2.89 113.025 179.944 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.869 ' HB2' ' O ' ' A' ' 17' ' ' GLY . 93.4 Cg_endo -72.21 155.83 55.93 Favored 'Trans proline' 0 C--N 1.358 1.054 0 C-N-CA 124.517 3.478 . . . . 1.72 116.408 -176.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.658 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 15.6 p -159.82 -173.07 3.91 Favored 'General case' 0 C--O 1.268 2.061 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.309 178.641 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.702 ' HA2' ' HB3' ' A' ' 40' ' ' GLU . . . 76.69 -158.9 49.22 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 121.134 -0.555 . . . . 1.15 114.39 177.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.587 ' HG2' ' O ' ' A' ' 15' ' ' PRO . 25.6 Cg_endo -66.51 99.09 0.42 Allowed 'Trans proline' 0 N--CA 1.49 1.305 0 C-N-CA 124.797 3.665 . . . . 1.6 112.725 178.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.43 7.51 84.62 Favored Glycine 0 C--N 1.275 -2.814 0 CA-C-N 113.622 -1.626 . . . . 1.68 111.137 -176.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.869 ' O ' ' HB2' ' A' ' 12' ' ' PRO . . . 55.71 55.78 27.09 Favored Glycine 0 N--CA 1.415 -2.709 0 CA-C-N 113.317 -1.442 . . . . 1.37 110.617 172.486 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.55 ' HE3' ' O ' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -92.53 -51.92 4.89 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 101.908 -3.367 . . . . 2.91 101.908 175.053 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.802 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -56.59 -179.08 0.46 Allowed Glycine 0 CA--C 1.533 1.173 0 CA-C-N 112.446 -2.161 . . . . 1.06 110.999 -168.342 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.848 ' HG2' ' O ' ' A' ' 10' ' ' CYS . 42.9 mtm-85 -132.33 174.22 10.46 Favored 'General case' 0 C--N 1.322 -0.587 0 O-C-N 119.999 -1.883 . . . . 3.32 112.185 -171.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 1.045 ' HB3' ' HG3' ' A' ' 47' ' ' GLU . 1.7 m -104.8 135.2 46.62 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.688 0.756 . . . . 1.19 112.496 -178.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.417 ' CD1' ' HB2' ' A' ' 28' ' ' CYS . 54.4 m-85 -144.97 39.95 1.24 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 114.525 -1.216 . . . . 2.26 109.743 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 141.95 166.35 10.86 Favored Glycine 0 CA--C 1.524 0.624 0 CA-C-N 115.6 -0.727 . . . . 1.05 111.647 -179.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.513 ' HD2' ' OE2' ' B' ' 181' ' ' GLU . 21.2 Cg_exo -65.65 -67.75 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.079 1.852 . . . . 1.81 112.147 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.776 ' C ' HG13 ' A' ' 26' ' ' ILE . 3.1 m -89.08 39.49 0.94 Allowed 'General case' 0 C--O 1.225 -0.196 0 N-CA-C 109.592 -0.522 . . . . 1.62 109.592 179.01 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 1.053 HG12 HG13 ' A' ' 36' ' ' VAL . 0.4 OUTLIER -156.0 120.73 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 N-CA-C 112.15 0.426 . . . . 1.39 112.15 -179.032 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.73 ' HB3' ' CE2' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -125.7 119.09 27.07 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 108.53 -0.915 . . . . 0.92 108.53 178.054 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.783 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 17.9 m -105.9 153.42 21.98 Favored 'General case' 0 CA--C 1.558 1.266 0 N-CA-C 112.646 0.61 . . . . 1.28 112.646 -178.289 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.504 ' O ' ' HB3' ' A' ' 69' ' ' ALA . . . -143.5 167.5 26.55 Favored Glycine 0 C--N 1.373 2.589 0 N-CA-C 109.575 -1.41 . . . . 0.71 109.575 174.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.604 ' OD2' ' HG2' ' A' ' 31' ' ' GLU . 8.4 p-10 -66.37 -39.32 89.04 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 124.906 1.282 . . . . 2.27 109.459 178.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.604 ' HG2' ' OD2' ' A' ' 30' ' ' ASP . 0.9 OUTLIER -124.54 6.46 8.26 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 113.55 -1.659 . . . . 1.66 110.964 179.692 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.978 HD22 ' CE1' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -110.03 -12.7 14.5 Favored 'General case' 0 N--CA 1.423 -1.78 0 CA-C-N 115.235 -0.893 . . . . 1.93 110.626 -177.843 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.81 ' HA2' ' HB3' ' A' ' 69' ' ' ALA . . . 60.19 -115.3 7.45 Favored Glycine 0 N--CA 1.428 -1.869 0 CA-C-O 118.139 -1.367 . . . . 0.77 111.842 179.408 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.958 ' HB2' HD13 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -147.45 127.26 13.48 Favored 'General case' 0 CA--C 1.489 -1.375 0 CA-C-N 119.893 1.847 . . . . 1.08 112.367 179.424 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.978 ' CE1' HD22 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -101.16 100.28 10.81 Favored 'General case' 0 N--CA 1.422 -1.838 0 N-CA-C 103.101 -2.925 . . . . 1.85 103.101 174.641 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 1.053 HG13 HG12 ' A' ' 26' ' ' ILE . 2.0 t -91.98 86.12 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.669 0 CA-C-O 123.364 1.554 . . . . 1.29 107.91 -178.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.713 ' HA3' HG23 ' B' ' 172' ' ' ILE . . . 89.79 82.68 1.34 Allowed Glycine 0 CA--C 1.521 0.408 0 CA-C-N 112.338 -2.21 . . . . 0.85 113.487 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.55 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 49.7 p -156.09 163.17 39.98 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 109.116 -0.698 . . . . 1.3 109.116 179.338 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.496 ' O ' ' HB2' ' A' ' 42' ' ' LEU . . . -50.35 -35.89 29.82 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 119.729 1.149 . . . . 1.45 112.766 -178.15 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.702 ' HB3' ' HA2' ' A' ' 14' ' ' GLY . 8.5 mt-10 -58.81 -24.57 62.1 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 109.906 -0.405 . . . . 2.32 109.906 178.033 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.772 ' O ' ' HB2' ' A' ' 44' ' ' CYS . . . -78.63 -23.27 45.93 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 109.514 -0.55 . . . . 1.11 109.514 -179.478 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.496 ' HB2' ' O ' ' A' ' 39' ' ' ALA . 0.5 OUTLIER -51.2 -38.72 53.95 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 121.136 -0.977 . . . . 1.68 109.821 178.804 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.782 ' HD2' ' O ' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -66.84 -5.32 11.89 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.21 -0.904 . . . . 3.4 109.986 177.348 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.772 ' HB2' ' O ' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -75.19 -1.01 21.31 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.121 -0.945 . . . . 1.57 111.726 177.122 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.97 -24.84 64.3 Favored 'General case' 0 N--CA 1.453 -0.325 0 O-C-N 121.435 -0.79 . . . . 3.49 110.581 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -84.45 3.05 38.01 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 120.165 -0.614 . . . . 3.69 110.292 179.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 1.045 ' HG3' ' HB3' ' A' ' 21' ' ' CYS . 1.7 tm-20 . . . . . 0 N--CA 1.452 -0.35 0 N-CA-C 109.58 -0.526 . . . . 3.99 109.58 177.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.408 ' HB3' ' H ' ' A' ' 57' ' ' GLY . 10.7 m . . . . . 0 CA--C 1.54 0.576 0 N-CA-C 110.772 -0.084 . . . . 3.36 110.772 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.408 ' H ' ' HB3' ' A' ' 56' ' ' SER . . . -121.41 133.23 9.43 Favored Glycine 0 N--CA 1.435 -1.411 0 N-CA-C 110.748 -0.941 . . . . 2.3 110.748 -179.146 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.84 76.78 1.03 Allowed 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 107.967 -1.123 . . . . 5.06 107.967 178.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.519 ' O ' ' HA ' ' A' ' 66' ' ' ARG . 0.1 OUTLIER -130.82 71.78 82.2 Favored Pre-proline 0 C--N 1.31 -1.128 0 CA-C-N 114.163 -1.38 . . . . 3.91 107.863 -179.355 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.486 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 36.5 Cg_endo -65.1 78.28 0.21 Allowed 'Trans proline' 0 C--N 1.363 1.296 0 C-N-CA 122.406 2.071 . . . . 1.74 113.642 -178.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -95.69 -173.08 2.77 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 106.008 -1.849 . . . . 1.9 106.008 176.126 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.39 -166.35 34.3 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 118.558 -1.782 . . . . 2.43 113.182 179.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.9 m -87.77 42.48 1.05 Allowed 'General case' 0 N--CA 1.484 1.237 0 CA-C-O 122.642 1.211 . . . . 4.32 110.695 -177.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 115.37 11.09 10.94 Favored Glycine 0 CA--C 1.558 2.728 0 CA-C-N 112.859 -1.973 . . . . 2.4 114.873 -177.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.466 ' CA ' ' HB3' ' A' ' 75' ' ' SER . . . -103.87 129.05 9.72 Favored Glycine 0 N--CA 1.469 0.894 0 CA-C-N 121.477 2.638 . . . . 1.82 116.259 -178.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.732 ' HD3' ' O ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -90.92 155.17 18.94 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 108.993 -0.743 . . . . 3.51 108.993 176.606 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.462 ' SG ' ' HB3' ' A' ' 59' ' ' LYS . 74.0 m -64.8 108.31 1.71 Allowed 'General case' 0 N--CA 1.439 -0.991 0 CA-C-O 121.44 0.638 . . . . 1.52 110.309 -178.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.574 ' HB1' ' SG ' ' A' ' 28' ' ' CYS . . . -94.57 -11.42 29.49 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.089 -0.96 . . . . 1.5 109.756 178.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.878 ' HB1' ' CG1' ' A' ' 72' ' ' ILE . . . -165.78 161.39 17.92 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.441 -1.254 . . . . 1.31 110.09 179.164 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.606 ' HA ' ' O ' ' A' ' 85' ' ' CYS . . . -58.02 117.31 4.2 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 113.837 1.051 . . . . 1.5 113.837 -178.315 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.729 ' HA2' ' O ' ' A' ' 82' ' ' ASP . . . 63.49 35.21 91.75 Favored Glycine 0 C--N 1.344 1.012 0 CA-C-N 115.532 -0.758 . . . . 1.44 112.301 179.002 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.958 HD13 ' HB2' ' A' ' 34' ' ' CYS . 1.8 pp -150.55 100.85 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.248 1.025 0 CA-C-O 121.924 0.869 . . . . 2.77 110.473 175.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.638 ' HB2' ' HB3' ' A' ' 82' ' ' ASP . 0.0 OUTLIER -85.63 92.07 8.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.696 -1.138 . . . . 1.98 110.661 -178.257 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.596 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 81.6 m -97.15 153.49 17.95 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.722 0.773 . . . . 1.43 112.513 -178.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.875 ' HB2' ' HD2' ' A' ' 76' ' ' PRO . 34.6 p -130.06 -178.97 0.9 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 114.529 -1.214 . . . . 2.37 108.8 179.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.875 ' HD2' ' HB2' ' A' ' 75' ' ' SER . 72.1 Cg_endo -78.07 26.83 0.49 Allowed 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 121.325 1.35 . . . . 2.09 111.761 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.63 ' HB2' ' CE1' ' B' ' 180' ' ' HIS . 3.0 p30 -145.95 -40.07 0.22 Allowed 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 115.786 -0.643 . . . . 2.65 111.417 179.377 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -157.08 -155.12 7.33 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 120.571 -0.823 . . . . 1.04 113.602 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.596 ' HA ' ' HA ' ' A' ' 74' ' ' CYS . 94.9 m -141.07 149.9 42.24 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 122.413 0.285 . . . . 1.42 110.394 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.609 ' CE1' ' HB2' ' B' ' 177' ' ' ASP . 79.6 t60 -140.96 126.4 18.76 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 109.453 -0.573 . . . . 2.81 109.453 -174.017 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.56 ' OE2' HD13 ' B' ' 126' ' ' ILE . 17.7 mt-10 -53.21 130.3 34.13 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.273 0.559 . . . . 3.05 111.748 -178.223 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.729 ' O ' ' HA2' ' A' ' 71' ' ' GLY . 0.1 OUTLIER -141.83 118.37 7.25 Favored Pre-proline 0 CA--C 1.547 0.839 0 CA-C-N 115.413 -0.812 . . . . 2.02 110.369 -179.056 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' A' ' 82' ' ' ASP . 3.7 Cg_exo -81.87 -18.86 7.52 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 122.848 2.365 . . . . 2.29 113.679 -178.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.67 -39.86 95.39 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.823 0.344 . . . . 1.53 111.739 -179.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.606 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 65.1 m -99.98 14.72 29.58 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.395 -0.366 . . . . 1.88 111.768 -179.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.422 ' HA ' ' CA ' ' A' ' 71' ' ' GLY . 0.8 OUTLIER . . . . . 0 C--N 1.322 -0.596 0 C-N-CA 121.063 -0.255 . . . . 3.6 111.413 -178.066 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 110' ' ' CYS . . . . . 0.898 ' O ' ' HG2' ' B' ' 120' ' ' ARG . 73.8 m . . . . . 0 N--CA 1.483 1.193 0 N-CA-C 115.085 1.513 . . . . 2.87 115.085 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 111' ' ' LEU . . . . . 0.833 HD12 ' HD2' ' B' ' 112' ' ' PRO . 0.2 OUTLIER -24.96 119.43 0.21 Allowed Pre-proline 0 N--CA 1.49 1.555 0 C-N-CA 123.684 0.794 . . . . 2.95 113.121 179.897 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 112' ' ' PRO . . . . . 0.954 ' HB2' ' O ' ' B' ' 117' ' ' GLY . 95.8 Cg_endo -71.61 156.13 58.11 Favored 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 124.576 3.517 . . . . 1.71 116.088 -176.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.56 ' C ' ' HA2' ' B' ' 117' ' ' GLY . 16.4 p -159.1 -171.34 3.33 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 115.92 -0.582 . . . . 1.0 111.057 177.436 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 114' ' ' GLY . . . . . 0.751 ' HA2' ' HB3' ' B' ' 140' ' ' GLU . . . 75.68 -159.46 51.08 Favored Glycine 0 CA--C 1.53 1.019 0 N-CA-C 115.069 0.788 . . . . 1.16 115.069 177.463 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 115' ' ' PRO . . . . . 0.649 ' HG2' ' O ' ' B' ' 115' ' ' PRO . 22.8 Cg_endo -66.37 102.59 0.59 Allowed 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 124.748 3.632 . . . . 1.6 111.611 178.426 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 87.31 -0.35 85.47 Favored Glycine 0 C--N 1.275 -2.822 0 CA-C-N 114.368 -1.287 . . . . 1.7 111.192 -177.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 117' ' ' GLY . . . . . 0.954 ' O ' ' HB2' ' B' ' 112' ' ' PRO . . . 64.34 44.4 95.47 Favored Glycine 1 N--CA 1.395 -4.061 0 CA-C-N 114.47 -0.865 . . . . 1.38 114.098 177.465 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 118' ' ' LYS . . . . . 0.495 ' HE3' ' O ' ' B' ' 115' ' ' PRO . 0.0 OUTLIER -93.31 -29.97 15.37 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.912 -0.773 . . . . 2.96 108.912 179.742 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 119' ' ' GLY . . . . . 0.76 ' O ' ' HA ' ' B' ' 112' ' ' PRO . . . -60.97 -163.29 0.18 Allowed Glycine 0 CA--C 1.496 -1.152 0 CA-C-O 118.493 -1.171 . . . . 1.07 111.604 -176.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.898 ' HG2' ' O ' ' B' ' 110' ' ' CYS . 48.8 mtm-85 -150.83 171.55 17.03 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 120.273 2.036 . . . . 3.29 108.806 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 121' ' ' CYS . . . . . 1.01 ' HB3' ' HG3' ' B' ' 147' ' ' GLU . 1.8 m -105.3 135.78 46.04 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.693 0.758 . . . . 1.21 112.875 -178.359 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 122' ' ' PHE . . . . . 0.432 ' CD1' ' HB2' ' B' ' 128' ' ' CYS . 54.7 m-85 -145.11 39.88 1.22 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 114.466 -1.243 . . . . 2.28 109.752 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 141.89 166.4 10.86 Favored Glycine 0 CA--C 1.523 0.59 0 CA-C-N 115.624 -0.716 . . . . 1.04 111.681 -179.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . 0.489 ' HD2' ' OE2' ' A' ' 81' ' ' GLU . 21.1 Cg_exo -65.69 -67.82 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.142 1.895 . . . . 1.84 112.065 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 125' ' ' SER . . . . . 0.762 ' C ' HG13 ' B' ' 126' ' ' ILE . 3.2 m -88.97 39.51 0.93 Allowed 'General case' 0 C--O 1.225 -0.205 0 N-CA-C 109.58 -0.526 . . . . 1.49 109.58 178.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 126' ' ' ILE . . . . . 0.762 HG13 ' C ' ' B' ' 125' ' ' SER . 0.5 OUTLIER -155.75 120.32 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 N-CA-C 112.188 0.44 . . . . 1.41 112.188 -178.975 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 127' ' ' CYS . . . . . 0.747 ' HB3' ' CE2' ' B' ' 135' ' ' PHE . 0.1 OUTLIER -125.15 120.76 32.28 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 108.748 -0.834 . . . . 0.89 108.748 178.085 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 128' ' ' CYS . . . . . 0.774 ' HA ' ' O ' ' B' ' 133' ' ' GLY . 8.6 m -111.57 146.37 37.48 Favored 'General case' 0 CA--C 1.571 1.77 0 N-CA-C 114.788 1.403 . . . . 1.23 114.788 -177.605 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 129' ' ' GLY . . . . . 0.574 ' O ' ' HB3' ' B' ' 169' ' ' ALA . . . -133.75 164.45 24.38 Favored Glycine 0 N--CA 1.421 -2.31 0 CA-C-N 114.973 -1.012 . . . . 0.69 112.065 178.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 130' ' ' ASP . . . . . 0.619 ' OD2' ' HG2' ' B' ' 131' ' ' GLU . 9.6 p-10 -72.28 -27.78 62.7 Favored 'General case' 0 C--N 1.292 -1.892 0 C-N-CA 126.275 1.83 . . . . 2.35 111.033 177.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 131' ' ' GLU . . . . . 0.619 ' HG2' ' OD2' ' B' ' 130' ' ' ASP . 1.1 pt-20 -140.49 23.85 2.3 Favored 'General case' 0 CA--C 1.482 -1.672 0 CA-C-N 114.006 -1.452 . . . . 1.69 108.506 172.599 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 132' ' ' LEU . . . . . 0.826 HD22 ' CE1' ' B' ' 135' ' ' PHE . 0.6 OUTLIER -123.64 -9.54 7.89 Favored 'General case' 0 N--CA 1.408 -2.544 0 N-CA-C 107.327 -1.36 . . . . 1.84 107.327 178.1 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 133' ' ' GLY . . . . . 0.774 ' O ' ' HA ' ' B' ' 128' ' ' CYS . . . 58.93 -114.47 6.1 Favored Glycine 0 N--CA 1.408 -3.217 0 CA-C-O 117.979 -1.456 . . . . 0.76 112.423 178.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 134' ' ' CYS . . . . . 0.88 ' HB2' HD13 ' B' ' 172' ' ' ILE . 0.1 OUTLIER -148.52 124.07 10.4 Favored 'General case' 0 CA--C 1.478 -1.814 0 CA-C-N 120.326 2.063 . . . . 1.08 113.638 179.98 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 135' ' ' PHE . . . . . 0.826 ' CE1' HD22 ' B' ' 132' ' ' LEU . 0.0 OUTLIER -98.35 99.88 11.11 Favored 'General case' 0 N--CA 1.42 -1.96 0 N-CA-C 102.985 -2.969 . . . . 1.83 102.985 176.054 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 136' ' ' VAL . . . . . 0.754 HG12 HG12 ' B' ' 126' ' ' ILE . 2.3 t -91.91 85.49 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.65 0 CA-C-O 123.507 1.622 . . . . 1.29 107.875 -178.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 137' ' ' GLY . . . . . 0.643 ' HA3' HG21 ' A' ' 72' ' ' ILE . . . 90.21 81.74 1.37 Allowed Glycine 0 C--N 1.317 -0.476 0 CA-C-N 112.081 -2.327 . . . . 0.85 113.416 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 138' ' ' THR . . . . . 0.541 HG21 ' HD1' ' A' ' 35' ' ' PHE . 68.7 p -148.41 176.3 10.4 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.624 -0.88 . . . . 1.2 108.624 179.158 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 139' ' ' ALA . . . . . 0.524 ' O ' ' HB2' ' B' ' 142' ' ' LEU . . . -61.1 -40.93 95.62 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 119.323 0.965 . . . . 1.35 109.932 178.301 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 140' ' ' GLU . . . . . 0.751 ' HB3' ' HA2' ' B' ' 114' ' ' GLY . 7.7 mt-10 -56.53 -19.1 13.95 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.355 0.598 . . . . 2.31 111.204 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 141' ' ' ALA . . . . . 0.742 ' O ' ' HB2' ' B' ' 144' ' ' CYS . . . -83.26 -20.82 33.78 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 114.906 -1.043 . . . . 1.09 110.054 179.287 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 142' ' ' LEU . . . . . 0.524 ' HB2' ' O ' ' B' ' 139' ' ' ALA . 0.5 OUTLIER -53.9 -39.73 66.04 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.939 0.876 . . . . 1.61 109.088 177.704 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 143' ' ' ARG . . . . . 0.784 ' HD2' ' O ' ' B' ' 112' ' ' PRO . 0.2 OUTLIER -67.4 -3.79 9.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.605 -1.179 . . . . 3.43 109.991 177.621 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 144' ' ' CYS . . . . . 0.742 ' HB2' ' O ' ' B' ' 141' ' ' ALA . 0.1 OUTLIER -84.39 18.23 2.31 Favored 'General case' 0 C--N 1.342 0.246 0 O-C-N 120.863 -1.148 . . . . 1.61 110.993 176.148 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 145' ' ' GLN . . . . . 0.407 ' H ' ' C ' ' B' ' 143' ' ' ARG . 0.0 OUTLIER -78.23 -27.12 47.61 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.563 0.696 . . . . 3.52 109.146 175.14 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -84.55 3.17 37.88 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.78 -0.645 . . . . 3.76 110.71 179.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 147' ' ' GLU . . . . . 1.01 ' HG3' ' HB3' ' B' ' 121' ' ' CYS . 1.7 tm-20 . . . . . 0 N--CA 1.453 -0.294 0 N-CA-C 109.607 -0.516 . . . . 4.01 109.607 177.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 156' ' ' SER . . . . . 0.405 ' HB3' ' H ' ' B' ' 157' ' ' GLY . 5.8 m . . . . . 0 N--CA 1.466 0.329 0 N-CA-C 110.874 -0.047 . . . . 3.41 110.874 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 157' ' ' GLY . . . . . 0.405 ' H ' ' HB3' ' B' ' 156' ' ' SER . . . -127.6 134.82 8.43 Favored Glycine 0 N--CA 1.44 -1.043 0 N-CA-C 110.082 -1.207 . . . . 2.26 110.082 178.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.55 67.7 0.66 Allowed 'General case' 0 N--CA 1.444 -0.746 0 CA-C-O 122.144 0.973 . . . . 5.03 109.28 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 159' ' ' LYS . . . . . 0.542 ' O ' ' HA ' ' B' ' 166' ' ' ARG . 0.1 OUTLIER -112.82 69.38 1.11 Allowed Pre-proline 0 C--N 1.315 -0.919 0 CA-C-N 113.929 -1.487 . . . . 3.96 110.634 177.046 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 160' ' ' PRO . . . . . 0.483 ' HA ' ' HA ' ' B' ' 166' ' ' ARG . 33.2 Cg_endo -64.86 79.19 0.19 Allowed 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 121.56 1.507 . . . . 1.7 114.011 -177.549 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 161' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -93.74 -168.95 1.99 Allowed 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 106.682 -1.599 . . . . 1.93 106.682 176.657 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 60.09 -165.38 12.33 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 118.859 -1.638 . . . . 2.37 113.407 177.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 4.1 m -87.69 42.21 1.03 Allowed 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 122.961 1.363 . . . . 4.56 110.902 -177.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 118.15 6.59 12.12 Favored Glycine 0 CA--C 1.551 2.343 0 CA-C-N 112.552 -2.113 . . . . 2.39 115.095 -179.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 165' ' ' GLY . . . . . 0.469 ' CA ' ' HB3' ' B' ' 175' ' ' SER . . . -102.36 129.59 9.94 Favored Glycine 0 N--CA 1.472 1.07 0 CA-C-N 120.835 2.317 . . . . 1.79 116.708 -177.02 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 166' ' ' ARG . . . . . 0.728 ' HD3' ' O ' ' B' ' 166' ' ' ARG . 0.0 OUTLIER -90.77 155.35 18.86 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 108.858 -0.793 . . . . 3.53 108.858 177.115 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 167' ' ' CYS . . . . . 0.471 ' SG ' ' HB3' ' B' ' 159' ' ' LYS . 69.6 m -64.87 107.86 1.6 Allowed 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 118.392 0.542 . . . . 1.56 110.136 -178.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 168' ' ' ALA . . . . . 0.497 ' HB2' ' SG ' ' B' ' 128' ' ' CYS . . . -89.32 -19.37 25.37 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 122.056 0.931 . . . . 1.42 108.626 178.242 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 169' ' ' ALA . . . . . 0.865 ' HB1' ' CG1' ' B' ' 172' ' ' ILE . . . -159.88 160.94 34.22 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 113.55 -1.659 . . . . 1.18 111.037 -176.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 170' ' ' ALA . . . . . 0.617 ' HA ' ' O ' ' B' ' 185' ' ' CYS . . . -57.91 118.09 4.99 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 113.556 0.947 . . . . 1.47 113.556 -178.326 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 171' ' ' GLY . . . . . 0.65 ' HA2' ' O ' ' B' ' 182' ' ' ASP . . . 71.81 18.79 77.72 Favored Glycine 0 CA--C 1.521 0.441 0 CA-C-N 115.689 -0.687 . . . . 1.45 114.609 177.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 172' ' ' ILE . . . . . 0.88 HD13 ' HB2' ' B' ' 134' ' ' CYS . 1.7 pp -142.32 102.07 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-O 122.458 1.123 . . . . 2.7 111.252 -178.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 173' ' ' CYS . . . . . 0.638 ' HB2' ' HB3' ' B' ' 182' ' ' ASP . 0.0 OUTLIER -85.7 92.12 8.49 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 114.126 -1.397 . . . . 1.94 110.669 -178.38 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 174' ' ' CYS . . . . . 0.633 ' HA ' ' HA ' ' B' ' 179' ' ' CYS . 81.4 m -97.51 153.52 18.1 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.655 0.741 . . . . 1.43 112.478 -178.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 175' ' ' SER . . . . . 0.884 ' HB2' ' HD2' ' B' ' 176' ' ' PRO . 35.1 p -130.02 -178.92 0.89 Allowed Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 114.494 -1.23 . . . . 2.3 108.916 179.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 176' ' ' PRO . . . . . 0.884 ' HD2' ' HB2' ' B' ' 175' ' ' SER . 72.1 Cg_endo -78.15 26.94 0.49 Allowed 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 121.339 1.359 . . . . 2.13 111.727 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 177' ' ' ASP . . . . . 0.609 ' HB2' ' CE1' ' A' ' 80' ' ' HIS . 3.0 p30 -146.07 -39.98 0.22 Allowed 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.772 -0.649 . . . . 2.72 111.357 179.374 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -157.12 -155.03 7.29 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 120.588 -0.815 . . . . 1.05 113.51 -179.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 179' ' ' CYS . . . . . 0.633 ' HA ' ' HA ' ' B' ' 174' ' ' CYS . 99.8 m -140.19 156.15 46.63 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 110.054 -0.35 . . . . 1.39 110.054 179.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 180' ' ' HIS . . . . . 0.63 ' CE1' ' HB2' ' A' ' 77' ' ' ASP . 81.3 t60 -150.27 124.13 9.26 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-O 121.387 0.613 . . . . 2.73 110.427 -173.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 181' ' ' GLU . . . . . 0.629 ' OE2' HD12 ' A' ' 26' ' ' ILE . 18.5 mt-10 -51.21 129.89 25.37 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 115.105 -0.952 . . . . 3.06 111.98 -175.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 182' ' ' ASP . . . . . 0.65 ' O ' ' HA2' ' B' ' 171' ' ' GLY . 0.1 OUTLIER -141.83 118.28 7.23 Favored Pre-proline 0 CA--C 1.546 0.807 0 CA-C-N 115.333 -0.849 . . . . 2.06 110.371 -179.066 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 183' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -81.84 -18.81 7.59 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 122.813 2.342 . . . . 2.27 113.671 -178.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -63.59 -39.81 95.34 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.781 0.324 . . . . 1.56 111.684 -179.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 185' ' ' CYS . . . . . 0.617 ' O ' ' HA ' ' B' ' 170' ' ' ALA . 68.8 m -99.85 14.76 29.27 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 116.311 -0.404 . . . . 1.94 112.052 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 186' ' ' ASP . . . . . 0.445 ' HA ' ' CA ' ' B' ' 171' ' ' GLY . 0.8 OUTLIER . . . . . 0 C--N 1.322 -0.608 0 C-N-CA 121.015 -0.274 . . . . 3.61 111.71 -178.099 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.7 m . . . . . 0 CA--C 1.536 0.42 0 N-CA-C 111.646 0.239 . . . . 2.89 111.646 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.794 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 4.4 mm? -32.71 114.43 0.4 Allowed Pre-proline 0 N--CA 1.475 0.799 0 N-CA-C 112.067 0.395 . . . . 2.89 112.067 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.668 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 95.7 Cg_endo -88.89 114.45 0.7 Allowed 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.626 2.217 . . . . 1.72 114.408 -178.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.653 ' O ' ' HA2' ' A' ' 17' ' ' GLY . 13.6 p -116.86 -155.31 0.58 Allowed 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 121.586 0.708 . . . . 1.0 110.582 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.4 ' HA2' ' HB3' ' A' ' 40' ' ' GLU . . . 79.21 -166.46 51.48 Favored Glycine 0 CA--C 1.497 -1.063 0 CA-C-O 119.284 -0.731 . . . . 1.15 111.892 179.182 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.605 ' HD2' HD13 ' A' ' 32' ' ' LEU . 84.8 Cg_endo -64.4 83.81 0.16 Allowed 'Trans proline' 0 N--CA 1.458 -0.561 0 CA-C-N 119.712 1.756 . . . . 1.6 113.374 -178.071 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.99 8.21 72.8 Favored Glycine 0 C--N 1.29 -1.979 0 CA-C-N 111.927 -2.397 . . . . 1.68 115.2 -178.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.653 ' HA2' ' O ' ' A' ' 13' ' ' CYS . . . 91.17 42.77 4.86 Favored Glycine 0 N--CA 1.435 -1.369 0 N-CA-C 118.089 1.995 . . . . 1.37 118.089 172.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.61 -15.85 26.35 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 114.372 -0.914 . . . . 2.91 113.184 177.607 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.698 ' HA3' ' O ' ' A' ' 28' ' ' CYS . . . -121.31 -179.67 16.12 Favored Glycine 0 N--CA 1.469 0.879 0 CA-C-O 117.707 -1.607 . . . . 1.06 109.084 -179.026 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.794 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 4.2 mpt_? -106.33 173.05 6.48 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 121.804 2.802 . . . . 3.32 110.476 178.218 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.45 ' HB3' ' HG3' ' A' ' 47' ' ' GLU . 0.5 OUTLIER -107.66 135.63 48.78 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 110.372 -0.233 . . . . 1.19 110.372 179.523 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.582 ' HE1' ' HB2' ' A' ' 28' ' ' CYS . 96.0 m-85 -111.51 -68.96 0.9 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.837 0.351 . . . . 2.26 110.574 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -106.63 -153.12 19.72 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 111.133 -0.787 . . . . 1.05 111.133 178.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -88.5 -51.25 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 122.444 2.096 . . . . 1.81 112.1 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.648 ' O ' ' N ' ' A' ' 37' ' ' GLY . 1.2 m -98.84 29.64 3.69 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-N 116.434 -0.348 . . . . 1.62 110.467 179.504 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.918 ' CG1' HG12 ' A' ' 36' ' ' VAL . 6.9 mt -138.69 116.0 11.57 Favored 'Isoleucine or valine' 0 C--O 1.243 0.717 0 CA-C-O 121.528 0.68 . . . . 1.39 112.771 -178.732 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.786 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 0.6 OUTLIER -130.76 125.4 33.7 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 114.973 -1.012 . . . . 0.92 110.274 178.626 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 1.032 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 94.8 m -117.2 161.94 18.66 Favored 'General case' 0 CA--C 1.55 0.972 0 CA-C-N 115.145 -0.934 . . . . 1.28 113.432 -178.293 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.824 ' O ' ' HB3' ' A' ' 69' ' ' ALA . . . -145.48 176.38 24.52 Favored Glycine 0 C--N 1.358 1.801 0 CA-C-N 112.955 -1.929 . . . . 0.71 108.597 176.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.44 ' O ' ' HB2' ' A' ' 70' ' ' ALA . 9.1 t70 -65.78 -53.27 42.62 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 122.367 1.08 . . . . 2.27 110.601 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -120.41 19.1 12.1 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 113.067 -1.878 . . . . 1.66 108.214 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.612 HD22 ' CZ ' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -111.97 -12.6 13.72 Favored 'General case' 0 N--CA 1.405 -2.69 0 CA-C-N 114.229 -1.35 . . . . 1.93 108.033 179.988 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 1.032 ' O ' ' HA ' ' A' ' 28' ' ' CYS . . . 55.95 -127.67 43.53 Favored Glycine 0 N--CA 1.419 -2.5 0 CA-C-N 114.419 -1.264 . . . . 0.77 112.107 177.399 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.786 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -143.91 121.36 11.7 Favored 'General case' 0 CA--C 1.493 -1.238 0 N-CA-C 114.527 1.306 . . . . 1.08 114.527 179.68 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.721 ' HA ' ' HA ' ' B' ' 135' ' ' PHE . 0.0 OUTLIER -85.94 105.79 16.66 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 102.605 -3.109 . . . . 1.85 102.605 173.861 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.918 HG12 ' CG1' ' A' ' 26' ' ' ILE . 2.6 t -92.8 85.53 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.702 0 C-N-CA 118.436 -1.306 . . . . 1.29 108.714 -178.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.648 ' N ' ' O ' ' A' ' 25' ' ' SER . . . 96.55 76.97 1.33 Allowed Glycine 0 CA--C 1.527 0.786 0 CA-C-N 112.464 -2.153 . . . . 0.85 114.071 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.586 HG21 ' O ' ' B' ' 132' ' ' LEU . 47.1 p -155.36 176.67 12.28 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 108.482 -0.933 . . . . 1.3 108.482 178.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 1.078 ' O ' HD11 ' A' ' 42' ' ' LEU . . . -68.9 -13.67 62.57 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-N 119.495 1.043 . . . . 1.45 109.942 178.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.444 ' HG2' ' CE2' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -64.09 -18.55 64.51 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.368 -0.975 . . . . 2.32 108.368 177.903 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.924 ' O ' ' HB2' ' A' ' 44' ' ' CYS . . . -112.14 -12.13 13.69 Favored 'General case' 0 C--O 1.217 -0.631 0 CA-C-N 115.192 -0.913 . . . . 1.11 113.034 -179.276 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 1.078 HD11 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -54.32 -19.28 5.14 Favored 'General case' 0 C--N 1.323 -0.545 0 O-C-N 120.966 -1.084 . . . . 1.68 113.29 -177.497 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.772 ' N ' HD13 ' A' ' 42' ' ' LEU . 9.2 ptm85 -79.65 -14.68 58.62 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 106.56 -1.645 . . . . 3.4 106.56 174.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.924 ' HB2' ' O ' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -58.18 -22.65 52.46 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 111.393 -2.639 . . . . 1.57 108.984 -178.383 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.76 -20.25 5.34 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.641 0.608 . . . . 3.49 112.641 179.046 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -85.83 6.75 26.71 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.102 -0.639 . . . . 3.69 110.729 -179.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.47 ' HB2' ' O ' ' A' ' 44' ' ' CYS . 3.3 mm-40 . . . . . 0 N--CA 1.445 -0.681 0 N-CA-C 109.334 -0.617 . . . . 3.99 109.334 177.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.471 0.605 0 N-CA-C 112.047 0.388 . . . . 3.36 112.047 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.553 ' O ' ' HG3' ' A' ' 66' ' ' ARG . . . 168.32 89.9 0.08 OUTLIER Glycine 0 N--CA 1.434 -1.464 0 N-CA-C 108.053 -2.019 . . . . 2.3 108.053 -179.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -110.61 77.79 1.07 Allowed 'General case' 0 CA--C 1.497 -1.081 0 CA-C-O 122.465 1.126 . . . . 5.06 109.221 -178.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.893 ' HB2' ' HB2' ' A' ' 67' ' ' CYS . 7.7 mptt -140.77 53.06 3.53 Favored Pre-proline 0 C--N 1.293 -1.85 0 CA-C-N 113.279 -1.782 . . . . 3.91 107.391 179.012 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.552 ' CD ' ' N ' ' A' ' 59' ' ' LYS . 11.1 Cg_endo -54.6 97.32 0.05 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.202 0 C-N-CA 122.576 2.184 . . . . 1.74 113.496 -179.666 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.639 ' N ' ' O ' ' A' ' 65' ' ' GLY . 1.0 OUTLIER -96.91 -166.6 1.42 Allowed 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 111.947 -2.388 . . . . 1.9 107.189 177.56 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' A' ' 61' ' ' CYS . . . 36.91 -164.81 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 119.789 -1.196 . . . . 2.43 115.623 172.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -84.75 47.64 1.41 Allowed 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 113.1 -1.55 . . . . 4.32 111.405 -178.056 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 120.62 9.9 7.42 Favored Glycine 0 C--N 1.349 1.287 0 CA-C-N 114.77 -1.105 . . . . 2.4 115.22 178.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.639 ' O ' ' N ' ' A' ' 61' ' ' CYS . . . -105.2 132.62 11.19 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 119.551 -1.309 . . . . 1.82 115.402 -178.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.553 ' HG3' ' O ' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -101.71 154.24 19.06 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 109.38 -0.6 . . . . 3.51 109.38 177.046 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.893 ' HB2' ' HB2' ' A' ' 59' ' ' LYS . 0.5 OUTLIER -59.33 115.24 3.1 Favored 'General case' 0 CA--C 1.496 -1.128 0 N-CA-C 109.183 -0.673 . . . . 1.52 109.183 -179.696 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.839 ' HB1' ' SG ' ' A' ' 28' ' ' CYS . . . -90.72 -19.21 23.82 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 107.785 -1.191 . . . . 1.5 107.785 178.089 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.824 ' HB3' ' O ' ' A' ' 29' ' ' GLY . . . -165.1 162.93 20.51 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 109.471 -0.566 . . . . 1.31 109.471 -177.51 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.696 ' HA ' ' HB3' ' A' ' 85' ' ' CYS . . . -50.43 132.81 25.03 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 112.927 0.714 . . . . 1.5 112.927 -179.49 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.561 ' H ' ' CB ' ' A' ' 85' ' ' CYS . . . 65.67 -25.6 0.14 Allowed Glycine 0 CA--C 1.526 0.77 0 CA-C-N 115.347 -0.842 . . . . 1.44 115.183 178.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.743 HD13 ' HB2' ' A' ' 34' ' ' CYS . 1.0 OUTLIER -102.37 122.56 54.82 Favored 'Isoleucine or valine' 0 C--O 1.243 0.72 0 CA-C-O 122.148 0.975 . . . . 2.77 111.614 -179.493 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.63 ' HB2' ' HB3' ' A' ' 82' ' ' ASP . 43.8 t -105.27 111.01 23.59 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.372 -0.831 . . . . 1.98 111.178 -179.516 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.653 ' HB2' ' HB2' ' A' ' 68' ' ' ALA . 0.8 OUTLIER -110.99 143.52 41.54 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.731 0.776 . . . . 1.43 112.559 -179.129 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.648 ' HB2' ' HD2' ' A' ' 76' ' ' PRO . 84.0 p -112.16 178.57 0.95 Allowed Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 114.447 -1.251 . . . . 2.37 108.76 179.482 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.648 ' HD2' ' HB2' ' A' ' 75' ' ' SER . 86.8 Cg_endo -80.54 22.95 0.73 Allowed 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 121.362 1.375 . . . . 2.09 111.649 179.31 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -145.3 -36.93 0.28 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.835 -0.62 . . . . 2.65 110.52 179.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.771 ' HA3' ' O ' ' B' ' 179' ' ' CYS . . . -155.57 -144.0 3.81 Favored Glycine 0 C--N 1.337 0.616 0 C-N-CA 120.47 -0.871 . . . . 1.04 113.385 179.513 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.656 ' O ' ' HA3' ' B' ' 178' ' ' GLY . 0.1 OUTLIER -151.5 157.97 43.0 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.987 0.422 . . . . 1.42 111.22 -179.614 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.436 ' O ' ' HB3' ' A' ' 73' ' ' CYS . 45.3 m80 -147.14 148.32 31.44 Favored 'General case' 0 N--CA 1.461 0.089 0 O-C-N 122.162 -0.336 . . . . 2.81 110.26 179.358 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -64.5 133.99 53.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.547 -0.297 . . . . 3.05 110.496 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.63 ' HB3' ' HB2' ' A' ' 73' ' ' CYS . 0.0 OUTLIER -145.02 117.56 5.36 Favored Pre-proline 0 CA--C 1.538 0.489 0 CA-C-N 116.531 -0.304 . . . . 2.02 110.684 179.864 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -83.96 -9.29 9.79 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 123.024 2.483 . . . . 2.29 113.575 -178.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.76 -22.31 66.04 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.11 0.411 . . . . 1.53 112.11 -179.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.696 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 52.2 m -101.09 20.36 15.75 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 113.515 0.931 . . . . 1.88 113.515 -178.009 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 CA--C 1.518 -0.275 0 C-N-CA 122.911 0.484 . . . . 3.6 111.525 178.578 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 110' ' ' CYS . . . . . . . . . . . . . 1.7 m . . . . . 0 N--CA 1.446 -0.659 0 N-CA-C 110.251 -0.278 . . . . 2.87 110.251 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 111' ' ' LEU . . . . . 0.806 ' O ' ' HA ' ' B' ' 120' ' ' ARG . 4.3 mm? -35.39 114.19 0.52 Allowed Pre-proline 0 N--CA 1.47 0.552 0 C-N-CA 122.655 0.382 . . . . 2.95 111.843 178.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 112' ' ' PRO . . . . . 0.731 ' HA ' ' O ' ' B' ' 119' ' ' GLY . 92.2 Cg_endo -88.13 114.98 0.89 Allowed 'Trans proline' 0 CA--C 1.531 0.368 0 C-N-CA 122.394 2.063 . . . . 1.71 113.931 -179.215 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.625 ' O ' ' HA2' ' B' ' 117' ' ' GLY . 13.8 p -117.2 -153.94 0.54 Allowed 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.642 0.734 . . . . 1.0 110.692 178.672 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . 78.6 -166.67 52.42 Favored Glycine 0 CA--C 1.5 -0.886 0 CA-C-N 115.601 -0.727 . . . . 1.16 111.864 179.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 115' ' ' PRO . . . . . 0.568 ' HD2' HD13 ' B' ' 132' ' ' LEU . 87.1 Cg_endo -64.66 82.58 0.17 Allowed 'Trans proline' 0 N--CA 1.454 -0.848 0 CA-C-N 119.503 1.652 . . . . 1.6 114.37 -177.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 89.44 6.86 70.2 Favored Glycine 0 C--N 1.29 -2.01 0 CA-C-N 111.727 -2.488 . . . . 1.7 115.638 -177.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 117' ' ' GLY . . . . . 0.625 ' HA2' ' O ' ' B' ' 113' ' ' CYS . . . 93.48 41.87 4.38 Favored Glycine 0 N--CA 1.436 -1.335 0 N-CA-C 117.794 1.877 . . . . 1.38 117.794 173.369 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.92 -15.56 26.18 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 113.18 0.807 . . . . 2.96 113.18 177.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 119' ' ' GLY . . . . . 0.731 ' O ' ' HA ' ' B' ' 112' ' ' PRO . . . -122.19 -170.66 13.77 Favored Glycine 0 C--N 1.347 1.161 0 N-CA-C 108.472 -1.851 . . . . 1.07 108.472 178.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.806 ' HA ' ' O ' ' B' ' 111' ' ' LEU . 4.1 mpt_? -110.94 172.85 6.63 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 121.307 2.554 . . . . 3.29 110.667 178.537 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 121' ' ' CYS . . . . . 0.457 ' HB3' ' HG3' ' B' ' 147' ' ' GLU . 0.5 OUTLIER -107.8 135.5 49.1 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 110.257 -0.275 . . . . 1.21 110.257 179.662 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 122' ' ' PHE . . . . . 0.597 ' HE1' ' HB2' ' B' ' 128' ' ' CYS . 96.0 m-85 -111.46 -68.94 0.9 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.873 0.368 . . . . 2.28 110.561 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -106.89 -153.22 19.42 Favored Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 111.062 -0.815 . . . . 1.04 111.062 178.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -88.32 -51.24 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 122.38 2.053 . . . . 1.84 112.161 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 125' ' ' SER . . . . . 0.648 ' O ' ' N ' ' B' ' 137' ' ' GLY . 1.4 m -98.64 29.55 3.66 Favored 'General case' 0 C--O 1.223 -0.308 0 CA-C-N 116.478 -0.328 . . . . 1.49 110.376 179.393 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 126' ' ' ILE . . . . . 0.464 ' CG1' HG13 ' B' ' 136' ' ' VAL . 8.1 mt -138.14 115.63 12.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.645 0 N-CA-C 113.122 0.786 . . . . 1.41 113.122 -178.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 127' ' ' CYS . . . . . 0.794 ' O ' ' HA ' ' B' ' 134' ' ' CYS . 0.5 OUTLIER -130.72 125.33 33.6 Favored 'General case' 0 C--O 1.225 -0.224 0 CA-C-N 115.122 -0.945 . . . . 0.89 110.232 178.689 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 128' ' ' CYS . . . . . 1.044 ' HA ' ' O ' ' B' ' 133' ' ' GLY . 98.6 m -117.09 162.49 17.73 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.19 -0.914 . . . . 1.23 113.387 -178.117 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 129' ' ' GLY . . . . . 0.526 ' O ' ' CB ' ' B' ' 169' ' ' ALA . . . -145.68 176.44 24.67 Favored Glycine 0 C--N 1.358 1.789 0 N-CA-C 108.622 -1.791 . . . . 0.69 108.622 176.364 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 130' ' ' ASP . . . . . 0.434 ' O ' ' HB3' ' B' ' 170' ' ' ALA . 9.2 t70 -66.56 -53.21 37.13 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 121.966 0.889 . . . . 2.35 110.239 179.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -122.83 30.53 6.39 Favored 'General case' 0 N--CA 1.424 -1.766 0 CA-C-N 113.676 -1.602 . . . . 1.69 108.06 177.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 132' ' ' LEU . . . . . 0.586 ' O ' HG21 ' A' ' 38' ' ' THR . 0.8 OUTLIER -122.24 -11.26 8.42 Favored 'General case' 0 N--CA 1.406 -2.636 0 N-CA-C 106.136 -1.801 . . . . 1.84 106.136 -178.839 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 133' ' ' GLY . . . . . 1.044 ' O ' ' HA ' ' B' ' 128' ' ' CYS . . . 54.51 -126.17 36.5 Favored Glycine 0 N--CA 1.408 -3.169 0 CA-C-N 113.876 -1.511 . . . . 0.76 112.351 175.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 134' ' ' CYS . . . . . 0.794 ' HA ' ' O ' ' B' ' 127' ' ' CYS . 0.1 OUTLIER -145.06 120.63 10.41 Favored 'General case' 0 CA--C 1.491 -1.296 0 N-CA-C 115.032 1.493 . . . . 1.08 115.032 -179.841 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 135' ' ' PHE . . . . . 0.721 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -85.3 106.12 16.47 Favored 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 102.72 -3.067 . . . . 1.83 102.72 174.507 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 136' ' ' VAL . . . . . 0.608 ' CG2' ' CG2' ' A' ' 36' ' ' VAL . 3.4 t -92.63 85.63 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.601 0 CA-C-O 122.85 1.31 . . . . 1.29 108.513 -178.284 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 137' ' ' GLY . . . . . 0.648 ' N ' ' O ' ' B' ' 125' ' ' SER . . . 96.12 76.5 1.31 Allowed Glycine 0 CA--C 1.526 0.73 0 CA-C-N 112.5 -2.136 . . . . 0.85 114.222 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 138' ' ' THR . . . . . 0.478 HG23 ' C ' ' B' ' 137' ' ' GLY . 49.8 p -155.19 176.31 12.72 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 108.414 -0.958 . . . . 1.2 108.414 178.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 139' ' ' ALA . . . . . 1.097 ' O ' HD11 ' B' ' 142' ' ' LEU . . . -68.64 -12.79 61.81 Favored 'General case' 0 C--O 1.22 -0.487 0 CA-C-N 119.235 0.925 . . . . 1.35 110.133 178.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 140' ' ' GLU . . . . . 0.433 ' HG2' ' CE2' ' B' ' 135' ' ' PHE . 0.9 OUTLIER -65.63 -17.45 64.6 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.483 -0.932 . . . . 2.31 108.483 177.569 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 141' ' ' ALA . . . . . 0.903 ' O ' ' HB2' ' B' ' 144' ' ' CYS . . . -112.62 -12.65 13.39 Favored 'General case' 0 C--O 1.216 -0.688 0 CA-C-N 114.98 -1.009 . . . . 1.09 113.033 -179.46 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 142' ' ' LEU . . . . . 1.097 HD11 ' O ' ' B' ' 139' ' ' ALA . 0.0 OUTLIER -54.24 -19.23 4.9 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 121.097 -1.002 . . . . 1.61 113.222 -177.236 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 143' ' ' ARG . . . . . 0.765 ' N ' HD13 ' B' ' 142' ' ' LEU . 9.3 ptm85 -80.76 -12.58 59.43 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 106.774 -1.565 . . . . 3.43 106.774 174.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 144' ' ' CYS . . . . . 0.903 ' HB2' ' O ' ' B' ' 141' ' ' ALA . 0.1 OUTLIER -58.76 -24.84 62.36 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 111.786 -2.461 . . . . 1.61 108.948 -179.488 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.84 -20.56 2.29 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 112.672 0.619 . . . . 3.52 112.672 179.495 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -85.85 6.79 26.63 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.128 -0.629 . . . . 3.76 110.754 -179.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 147' ' ' GLU . . . . . 0.481 ' HB2' ' O ' ' B' ' 144' ' ' CYS . 3.3 mm-40 . . . . . 0 N--CA 1.446 -0.67 0 N-CA-C 109.401 -0.592 . . . . 4.01 109.401 177.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.472 0.651 0 CA-C-O 120.938 0.399 . . . . 3.41 111.5 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 157' ' ' GLY . . . . . 0.528 ' O ' ' HG3' ' B' ' 166' ' ' ARG . . . 165.14 91.05 0.08 OUTLIER Glycine 0 N--CA 1.44 -1.085 0 N-CA-C 108.847 -1.701 . . . . 2.26 108.847 179.608 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -112.34 65.61 0.64 Allowed 'General case' 0 CA--C 1.501 -0.909 0 CA-C-O 122.762 1.268 . . . . 5.03 110.402 -179.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 159' ' ' LYS . . . . . 0.964 ' HB2' ' HB2' ' B' ' 167' ' ' CYS . 7.3 mptt -113.34 47.66 0.37 Allowed Pre-proline 0 C--N 1.302 -1.499 0 CA-C-N 112.542 -2.117 . . . . 3.96 111.534 173.303 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 160' ' ' PRO . . . . . 0.413 ' HA ' ' HA ' ' B' ' 166' ' ' ARG . 10.0 Cg_endo -53.76 97.52 0.05 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.402 0 CA-C-N 121.3 1.5 . . . . 1.7 114.698 -174.612 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 161' ' ' CYS . . . . . 0.599 ' N ' ' O ' ' B' ' 165' ' ' GLY . 0.9 OUTLIER -96.9 -166.69 1.44 Allowed 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 112.397 -2.183 . . . . 1.93 107.406 177.626 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 162' ' ' GLY . . . . . 0.41 ' N ' ' SG ' ' B' ' 161' ' ' CYS . . . 37.08 -164.77 0.01 OUTLIER Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 115.746 1.059 . . . . 2.37 115.746 172.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -84.54 47.31 1.34 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 113.177 -1.511 . . . . 4.56 111.465 -178.093 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 120.4 9.82 7.62 Favored Glycine 0 CA--C 1.539 1.549 0 CA-C-N 115.043 -0.981 . . . . 2.39 115.179 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 165' ' ' GLY . . . . . 0.599 ' O ' ' N ' ' B' ' 161' ' ' CYS . . . -104.82 133.38 11.52 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 118.921 -1.609 . . . . 1.79 115.16 -179.55 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 166' ' ' ARG . . . . . 0.528 ' HG3' ' O ' ' B' ' 157' ' ' GLY . 0.0 OUTLIER -102.17 154.19 19.25 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 109.313 -0.625 . . . . 3.53 109.313 176.661 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 167' ' ' CYS . . . . . 0.964 ' HB2' ' HB2' ' B' ' 159' ' ' LYS . 0.5 OUTLIER -59.2 115.54 3.27 Favored 'General case' 0 CA--C 1.499 -0.982 0 N-CA-C 109.214 -0.661 . . . . 1.56 109.214 -179.571 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 168' ' ' ALA . . . . . 0.439 ' HB2' ' SG ' ' B' ' 128' ' ' CYS . . . -89.8 -20.75 23.12 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 107.774 -1.195 . . . . 1.42 107.774 177.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 169' ' ' ALA . . . . . 0.748 ' HB2' ' HA2' ' B' ' 133' ' ' GLY . . . -164.38 162.71 22.33 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.375 -0.83 . . . . 1.18 110.682 -177.016 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 170' ' ' ALA . . . . . 0.719 ' HA ' ' HB3' ' B' ' 185' ' ' CYS . . . -49.99 133.0 23.11 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 112.711 0.634 . . . . 1.47 112.711 -179.273 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 171' ' ' GLY . . . . . 0.539 ' H ' ' CB ' ' B' ' 185' ' ' CYS . . . 67.65 -30.74 0.22 Allowed Glycine 0 CA--C 1.527 0.809 0 CA-C-N 115.614 -0.721 . . . . 1.45 114.693 178.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 172' ' ' ILE . . . . . 0.654 HD13 ' HB2' ' B' ' 134' ' ' CYS . 1.0 OUTLIER -99.5 122.78 51.71 Favored 'Isoleucine or valine' 0 C--O 1.242 0.71 0 CA-C-O 122.322 1.058 . . . . 2.7 111.931 -178.138 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 173' ' ' CYS . . . . . 0.639 ' HB2' ' HB3' ' B' ' 182' ' ' ASP . 44.1 t -105.36 110.96 23.51 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.201 -0.909 . . . . 1.94 111.19 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 174' ' ' CYS . . . . . 0.515 ' HA ' ' HA ' ' B' ' 179' ' ' CYS . 0.8 OUTLIER -110.83 143.51 41.29 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.586 0.707 . . . . 1.43 112.603 -179.097 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 175' ' ' SER . . . . . 0.655 ' HB2' ' HD2' ' B' ' 176' ' ' PRO . 83.9 p -112.17 178.53 0.96 Allowed Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 114.542 -1.208 . . . . 2.3 108.778 179.365 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 176' ' ' PRO . . . . . 0.655 ' HD2' ' HB2' ' B' ' 175' ' ' SER . 89.0 Cg_endo -80.53 23.1 0.72 Allowed 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 121.315 1.343 . . . . 2.13 111.663 179.328 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 177' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -145.38 -36.29 0.29 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.812 -0.631 . . . . 2.72 110.711 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 178' ' ' GLY . . . . . 0.656 ' HA3' ' O ' ' A' ' 79' ' ' CYS . . . -156.41 -144.18 3.86 Favored Glycine 0 C--N 1.337 0.587 0 C-N-CA 120.671 -0.776 . . . . 1.05 113.325 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 179' ' ' CYS . . . . . 0.771 ' O ' ' HA3' ' A' ' 78' ' ' GLY . 0.1 OUTLIER -151.51 157.98 43.0 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 120.895 0.378 . . . . 1.39 111.346 -179.489 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 180' ' ' HIS . . . . . 0.435 ' O ' ' HB3' ' B' ' 173' ' ' CYS . 45.4 m80 -147.05 148.36 31.57 Favored 'General case' 0 N--CA 1.46 0.069 0 O-C-N 122.199 -0.313 . . . . 2.73 110.277 179.316 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 181' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -64.5 133.93 53.42 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.645 -0.252 . . . . 3.06 110.486 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 182' ' ' ASP . . . . . 0.639 ' HB3' ' HB2' ' B' ' 173' ' ' CYS . 0.0 OUTLIER -144.99 117.52 5.37 Favored Pre-proline 0 CA--C 1.538 0.496 0 CA-C-N 116.521 -0.309 . . . . 2.06 110.673 179.864 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 183' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -83.97 -9.14 9.85 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 123.039 2.493 . . . . 2.27 113.557 -178.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -66.75 -22.49 66.04 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.05 0.389 . . . . 1.56 112.05 -179.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 185' ' ' CYS . . . . . 0.719 ' HB3' ' HA ' ' B' ' 170' ' ' ALA . 54.1 m -100.94 20.32 15.68 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 113.622 0.971 . . . . 1.94 113.622 -178.024 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 186' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 CA--C 1.518 -0.271 0 C-N-CA 122.858 0.463 . . . . 3.61 111.52 178.577 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.749 ' HB3' ' HB3' ' A' ' 20' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.225 -0.223 0 CA-C-O 120.707 0.289 . . . . 2.89 111.347 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.463 ' C ' ' O ' ' A' ' 10' ' ' CYS . 5.6 tp -29.05 129.9 0.22 Allowed Pre-proline 0 N--CA 1.468 0.45 0 CA-C-O 121.031 0.443 . . . . 2.89 111.948 -179.396 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.858 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 54.5 Cg_endo -70.14 152.28 67.3 Favored 'Trans proline' 0 N--CA 1.475 0.39 0 C-N-CA 123.377 2.718 . . . . 1.72 114.608 -179.128 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.623 ' SG ' ' N ' ' A' ' 14' ' ' GLY . 0.0 OUTLIER -160.97 -170.22 2.64 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 119.422 -0.911 . . . . 1.0 110.946 176.969 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.838 ' HA2' ' HB3' ' A' ' 40' ' ' GLU . . . 77.61 -159.72 48.4 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 115.47 0.948 . . . . 1.15 115.47 178.393 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.518 ' CG ' HD23 ' A' ' 32' ' ' LEU . 74.4 Cg_endo -61.37 104.16 0.29 Allowed 'Trans proline' 0 N--CA 1.487 1.127 0 C-N-CA 124.749 3.633 . . . . 1.6 111.021 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.64 -10.92 60.66 Favored Glycine 0 C--N 1.28 -2.566 0 CA-C-N 113.119 -1.855 . . . . 1.68 111.219 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.49 ' O ' ' HB2' ' A' ' 12' ' ' PRO . . . 76.49 37.36 35.85 Favored Glycine 0 N--CA 1.411 -3.005 0 C-N-CA 119.336 -1.411 . . . . 1.37 111.153 -179.627 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.49 ' HB2' ' CD1' ' A' ' 32' ' ' LEU . 0.5 OUTLIER -88.09 -37.47 16.21 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 112.973 -1.614 . . . . 2.91 112.29 179.196 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.858 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -89.56 -172.79 45.63 Favored Glycine 0 N--CA 1.423 -2.198 0 CA-C-N 122.055 2.207 . . . . 1.06 110.966 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.749 ' HB3' ' HB3' ' A' ' 10' ' ' CYS . 0.4 OUTLIER -113.14 172.14 7.12 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 124.395 0.703 . . . . 3.32 112.777 -179.407 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.7 m -106.85 145.55 32.01 Favored 'General case' 0 N--CA 1.475 0.809 0 O-C-N 121.826 -0.546 . . . . 1.19 110.455 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.414 ' CZ ' ' O ' ' A' ' 68' ' ' ALA . 76.3 m-85 -142.9 22.39 1.93 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.944 -0.571 . . . . 2.26 111.752 -179.335 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.808 ' O ' ' HB3' ' A' ' 44' ' ' CYS . . . 174.04 -169.45 42.48 Favored Glycine 0 C--O 1.225 -0.444 0 C-N-CA 120.724 -0.751 . . . . 1.05 111.421 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -81.3 -54.18 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.531 2.154 . . . . 1.81 112.333 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.6 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.3 OUTLIER -106.47 12.1 30.0 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.234 -0.439 . . . . 1.62 111.39 -179.963 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.741 HG21 ' SG ' ' A' ' 34' ' ' CYS . 1.2 mt -121.8 122.43 66.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 113.218 0.821 . . . . 1.39 113.218 -177.357 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.655 ' HB3' ' CD2' ' A' ' 35' ' ' PHE . 4.3 t -130.78 116.37 17.88 Favored 'General case' 0 C--O 1.226 -0.155 0 CA-C-O 122.494 1.14 . . . . 0.92 111.48 178.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 1.163 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -121.36 148.48 44.31 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 112.552 -2.113 . . . . 1.28 109.08 -179.546 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.649 ' O ' ' HB3' ' A' ' 69' ' ' ALA . . . -144.01 -167.86 12.09 Favored Glycine 0 CA--C 1.478 -2.223 0 N-CA-C 105.494 -3.042 . . . . 0.71 105.494 174.388 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.598 ' O ' ' HB2' ' A' ' 70' ' ' ALA . 12.3 p-10 -67.18 -69.01 0.34 Allowed 'General case' 0 C--N 1.282 -2.329 0 C-N-CA 118.635 -1.226 . . . . 2.27 112.82 -179.575 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.4 ' H ' ' CG ' ' A' ' 30' ' ' ASP . 0.0 OUTLIER -95.13 15.1 19.94 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 114.722 -1.127 . . . . 1.66 111.284 -176.523 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.554 ' O ' ' O ' ' B' ' 137' ' ' GLY . 1.0 OUTLIER -116.48 -17.69 10.59 Favored 'General case' 0 N--CA 1.4 -2.944 0 CA-C-N 114.568 -1.196 . . . . 1.93 108.208 179.945 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 1.163 ' O ' ' HA ' ' A' ' 28' ' ' CYS . . . 63.19 -128.25 39.12 Favored Glycine 0 N--CA 1.405 -3.428 0 CA-C-N 113.963 -1.471 . . . . 0.77 114.285 178.098 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.821 ' HB2' HG13 ' A' ' 72' ' ' ILE . 4.8 t -141.51 120.09 12.47 Favored 'General case' 0 CA--C 1.5 -0.944 0 N-CA-C 115.572 1.693 . . . . 1.08 115.572 -179.667 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 1.044 ' HA ' ' HA ' ' B' ' 135' ' ' PHE . 0.0 OUTLIER -96.34 107.58 19.97 Favored 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 106.501 -1.666 . . . . 1.85 106.501 176.219 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.671 ' N ' ' O ' ' B' ' 134' ' ' CYS . 1.8 t -94.72 84.0 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.774 0 N-CA-C 108.008 -1.108 . . . . 1.29 108.008 179.387 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.6 ' N ' ' O ' ' A' ' 25' ' ' SER . . . 105.27 102.61 2.8 Favored Glycine 0 CA--C 1.524 0.646 0 CA-C-N 113.451 -1.704 . . . . 0.85 114.007 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.565 ' HB ' ' O ' ' B' ' 132' ' ' LEU . 0.2 OUTLIER 178.66 161.95 0.69 Allowed 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 107.992 -1.114 . . . . 1.3 107.992 179.02 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.466 ' HA ' HD13 ' A' ' 42' ' ' LEU . . . -69.28 -28.24 66.12 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 120.595 1.543 . . . . 1.45 112.175 -179.331 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.838 ' HB3' ' HA2' ' A' ' 14' ' ' GLY . 0.5 OUTLIER -62.23 -12.81 22.34 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.154 0.502 . . . . 2.32 110.524 178.125 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.801 ' O ' ' HB2' ' A' ' 44' ' ' CYS . . . -103.49 -19.32 14.44 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.091 -0.959 . . . . 1.11 110.673 178.108 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.466 HD13 ' HA ' ' A' ' 39' ' ' ALA . 0.7 OUTLIER -46.8 -38.06 9.58 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 112.403 0.52 . . . . 1.68 112.403 -179.298 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.459 ' HD2' ' H ' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -57.82 -22.35 47.14 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-O 122.552 1.167 . . . . 3.4 108.771 177.127 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.808 ' HB3' ' O ' ' A' ' 23' ' ' GLY . 28.6 m -58.8 -10.7 2.55 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-N 112.193 -2.276 . . . . 1.57 109.81 178.401 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.428 ' HB2' ' O ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -77.22 -18.98 57.29 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-O 121.126 0.489 . . . . 3.49 111.73 178.981 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -85.83 10.39 13.91 Favored 'General case' 0 CA--C 1.515 -0.369 0 C-N-CA 119.861 -0.736 . . . . 3.69 110.457 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 . . . . . 0 N--CA 1.442 -0.866 0 N-CA-C 108.865 -0.791 . . . . 3.99 108.865 177.158 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.3 t . . . . . 0 N--CA 1.467 0.412 0 CA-C-O 120.822 0.344 . . . . 3.36 110.406 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 162.01 44.69 0.02 OUTLIER Glycine 0 N--CA 1.442 -0.955 0 N-CA-C 108.66 -1.776 . . . . 2.3 108.66 -179.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.421 ' O ' ' HG3' ' A' ' 58' ' ' GLN . 15.6 pt20 -118.96 86.05 2.48 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-O 122.489 1.137 . . . . 5.06 108.91 -179.255 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.486 ' HB3' ' HB2' ' A' ' 67' ' ' CYS . 0.0 OUTLIER -137.24 69.09 55.75 Favored Pre-proline 0 C--N 1.294 -1.817 0 N-CA-C 104.419 -2.437 . . . . 3.91 104.419 -178.869 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -71.71 91.56 0.7 Allowed 'Trans proline' 0 N--CA 1.446 -1.296 0 C-N-CA 122.858 2.372 . . . . 1.74 115.055 -176.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 3.2 p -104.43 -172.32 2.08 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 113.2 -1.818 . . . . 1.9 107.03 176.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 52.21 -166.07 1.14 Allowed Glycine 0 C--N 1.329 0.148 0 C-N-CA 118.52 -1.8 . . . . 2.43 112.258 177.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 8.0 t -73.23 66.51 0.89 Allowed 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 120.33 -0.548 . . . . 4.32 110.967 -179.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 84.18 8.47 83.68 Favored Glycine 0 N--CA 1.436 -1.309 0 CA-C-O 117.752 -1.582 . . . . 2.4 116.592 178.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.961 ' HA3' ' HA ' ' A' ' 74' ' ' CYS . . . -100.29 137.33 13.2 Favored Glycine 0 N--CA 1.438 -1.192 0 CA-C-N 122.553 3.177 . . . . 1.82 114.058 -177.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.468 ' O ' ' N ' ' A' ' 74' ' ' CYS . 0.0 OUTLIER -99.66 153.03 19.4 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 114.046 -1.077 . . . . 3.51 112.515 -178.4 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.637 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 44.4 t -51.75 108.62 0.29 Allowed 'General case' 0 N--CA 1.428 -1.56 0 CA-C-N 115.764 -0.653 . . . . 1.52 110.918 -179.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.414 ' O ' ' CZ ' ' A' ' 22' ' ' PHE . . . -99.55 -33.51 10.62 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.929 -0.767 . . . . 1.5 108.929 178.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.649 ' HB3' ' O ' ' A' ' 29' ' ' GLY . . . -159.93 165.32 32.35 Favored 'General case' 0 CA--C 1.495 -1.158 0 C-N-CA 119.428 -0.909 . . . . 1.31 112.432 -178.155 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.778 ' HA ' ' O ' ' A' ' 85' ' ' CYS . . . -37.29 97.4 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.1 -0.955 . . . . 1.5 110.444 -178.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.617 ' HA2' ' O ' ' A' ' 82' ' ' ASP . . . 93.56 -12.58 69.28 Favored Glycine 0 N--CA 1.437 -1.264 0 CA-C-N 114.81 -1.086 . . . . 1.44 114.43 179.293 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.821 HG13 ' HB2' ' A' ' 34' ' ' CYS . 1.7 mm -93.56 124.72 46.1 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.04 0 CA-C-N 119.391 1.596 . . . . 2.77 110.8 -175.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.592 ' HB2' ' HB3' ' A' ' 82' ' ' ASP . 20.6 t -120.79 92.45 3.77 Favored 'General case' 0 N--CA 1.426 -1.658 0 CA-C-N 113.89 -1.504 . . . . 1.98 109.274 -179.313 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 1.021 ' CB ' ' HA ' ' A' ' 79' ' ' CYS . 6.0 p -159.9 -175.89 5.38 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 116.105 1.891 . . . . 1.43 116.105 -177.001 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.818 ' HB2' ' HD2' ' A' ' 76' ' ' PRO . 5.8 p -122.61 -179.9 0.88 Allowed Pre-proline 0 N--CA 1.454 -0.253 0 CA-C-N 113.098 -1.865 . . . . 2.37 108.926 -179.668 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.818 ' HD2' ' HB2' ' A' ' 75' ' ' SER . 56.2 Cg_endo -72.45 31.38 0.28 Allowed 'Trans proline' 0 CA--C 1.534 0.523 0 C-N-CA 121.671 1.581 . . . . 2.09 113.292 -179.219 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.445 ' OD1' ' N ' ' A' ' 78' ' ' GLY . 1.1 p30 -134.49 -59.97 0.8 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 120.714 0.292 . . . . 2.65 110.397 178.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.918 ' O ' ' HB2' ' A' ' 74' ' ' CYS . . . -124.61 -175.15 14.22 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.507 -0.854 . . . . 1.04 111.74 178.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 1.021 ' HA ' ' CB ' ' A' ' 74' ' ' CYS . 14.1 m -149.44 160.34 43.53 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 117.535 0.668 . . . . 1.42 111.929 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 72.5 m80 -149.51 139.8 22.28 Favored 'General case' 0 C--N 1.349 0.585 0 O-C-N 121.714 -0.616 . . . . 2.81 111.879 -178.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -64.72 126.02 26.62 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.921 -0.582 . . . . 3.05 109.725 178.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.617 ' O ' ' HA2' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -139.94 107.51 6.91 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-O 120.864 0.364 . . . . 2.02 111.226 -179.213 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_exo -62.78 -24.09 74.52 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.04 2.493 . . . . 2.29 114.333 -178.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.36 -10.82 27.01 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.979 0.363 . . . . 1.53 111.979 -179.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.778 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 3.8 m -128.18 9.25 6.18 Favored 'General case' 0 C--O 1.215 -0.738 0 CA-C-O 119.053 -0.499 . . . . 1.88 111.321 179.585 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.478 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 0.5 OUTLIER . . . . . 0 C--N 1.322 -0.595 0 C-N-CA 119.113 -1.035 . . . . 3.6 112.692 -176.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 110' ' ' CYS . . . . . 0.713 ' HB3' ' HB3' ' B' ' 120' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.226 -0.144 0 N-CA-C 111.883 0.327 . . . . 2.87 111.883 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 111' ' ' LEU . . . . . 0.481 ' C ' ' O ' ' B' ' 110' ' ' CYS . 5.4 tp -26.74 129.49 0.18 Allowed Pre-proline 0 CA--C 1.54 0.558 0 N-CA-C 112.209 0.448 . . . . 2.95 112.209 -179.333 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 112' ' ' PRO . . . . . 0.845 ' HA ' ' O ' ' B' ' 119' ' ' GLY . 30.3 Cg_endo -61.43 158.47 35.96 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 124.672 3.581 . . . . 1.71 112.974 179.579 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.623 ' SG ' ' N ' ' B' ' 114' ' ' GLY . 0.0 OUTLIER -168.83 -171.55 1.39 Allowed 'General case' 0 N--CA 1.497 1.907 0 C-N-CA 118.977 -1.089 . . . . 1.0 111.272 170.939 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 114' ' ' GLY . . . . . 0.864 ' HA2' ' HB3' ' B' ' 140' ' ' GLU . . . 77.35 -159.34 48.55 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 120.289 -0.958 . . . . 1.16 115.249 178.201 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 115' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -62.36 96.15 0.15 Allowed 'Trans proline' 0 C--N 1.355 0.885 0 C-N-CA 124.238 3.292 . . . . 1.6 115.398 -178.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 85.76 -0.83 88.1 Favored Glycine 0 C--N 1.285 -2.296 0 CA-C-N 110.573 -3.012 . . . . 1.7 112.197 -177.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 117' ' ' GLY . . . . . 0.486 ' O ' ' HB2' ' B' ' 112' ' ' PRO . . . 73.69 35.9 54.35 Favored Glycine 0 N--CA 1.425 -2.035 0 C-N-CA 120.171 -1.014 . . . . 1.38 112.858 176.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 118' ' ' LYS . . . . . 0.459 ' HB2' ' CD1' ' B' ' 132' ' ' LEU . 0.6 OUTLIER -87.55 -33.77 18.81 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 114.207 -0.997 . . . . 2.96 112.052 -179.629 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 119' ' ' GLY . . . . . 0.845 ' O ' ' HA ' ' B' ' 112' ' ' PRO . . . -79.67 -164.58 29.21 Favored Glycine 0 CA--C 1.497 -1.063 0 CA-C-O 118.631 -1.094 . . . . 1.07 111.521 -179.494 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.713 ' HB3' ' HB3' ' B' ' 110' ' ' CYS . 2.3 mtt85 -133.09 172.91 12.01 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 119.736 1.768 . . . . 3.29 106.961 176.438 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 121' ' ' CYS . . . . . . . . . . . . . 2.6 m -106.16 146.77 29.83 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 118.548 0.613 . . . . 1.21 111.532 -178.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 122' ' ' PHE . . . . . 0.499 ' HE1' ' O ' ' B' ' 128' ' ' CYS . 75.9 m-85 -142.91 22.14 1.94 Allowed 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.687 -0.688 . . . . 2.28 111.778 -179.533 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 123' ' ' GLY . . . . . 0.836 ' O ' ' HB3' ' B' ' 144' ' ' CYS . . . 174.05 -169.53 42.57 Favored Glycine 0 C--O 1.225 -0.465 0 C-N-CA 120.783 -0.723 . . . . 1.04 111.468 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -81.1 -54.33 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.494 2.129 . . . . 1.84 112.272 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 125' ' ' SER . . . . . 0.605 ' O ' ' N ' ' B' ' 137' ' ' GLY . 0.3 OUTLIER -106.39 12.25 29.97 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.264 -0.425 . . . . 1.49 111.39 -179.878 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 126' ' ' ILE . . . . . 0.753 HD12 ' HA ' ' B' ' 176' ' ' PRO . 1.5 mt -121.73 122.38 66.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 113.088 0.773 . . . . 1.41 113.088 -177.289 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 127' ' ' CYS . . . . . 0.663 ' HB3' ' CD2' ' B' ' 135' ' ' PHE . 4.5 t -131.06 117.66 19.45 Favored 'General case' 0 CA--C 1.522 -0.107 0 CA-C-O 122.542 1.163 . . . . 0.89 111.585 178.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 128' ' ' CYS . . . . . 1.149 ' HA ' ' O ' ' B' ' 133' ' ' GLY . 0.0 OUTLIER -130.62 135.93 48.36 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 112.96 -1.927 . . . . 1.23 112.415 -178.559 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 129' ' ' GLY . . . . . 0.669 ' O ' ' HB3' ' B' ' 169' ' ' ALA . . . -130.41 -161.6 10.44 Favored Glycine 0 N--CA 1.42 -2.413 0 N-CA-C 105.119 -3.193 . . . . 0.69 105.119 177.383 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 130' ' ' ASP . . . . . 0.424 ' OD1' ' N ' ' B' ' 130' ' ' ASP . 14.5 p-10 -68.71 -70.99 0.23 Allowed 'General case' 0 C--N 1.289 -2.06 0 C-N-CA 119.199 -1.001 . . . . 2.35 112.69 -178.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.94 32.53 3.15 Favored 'General case' 0 CA--C 1.49 -1.346 0 CA-C-O 122.085 0.945 . . . . 1.69 110.1 -177.232 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 132' ' ' LEU . . . . . 0.565 ' O ' ' HB ' ' A' ' 38' ' ' THR . 0.8 OUTLIER -127.45 -16.9 4.77 Favored 'General case' 0 N--CA 1.399 -3.01 0 CA-C-N 113.788 -1.551 . . . . 1.84 106.869 177.075 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 133' ' ' GLY . . . . . 1.149 ' O ' ' HA ' ' B' ' 128' ' ' CYS . . . 58.93 -134.55 52.43 Favored Glycine 0 N--CA 1.402 -3.587 0 CA-C-N 114.372 -1.285 . . . . 0.76 112.529 177.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 134' ' ' CYS . . . . . 0.802 ' HB2' HG13 ' B' ' 172' ' ' ILE . 5.2 t -135.25 119.79 18.11 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 116.15 1.907 . . . . 1.08 116.15 -176.631 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 135' ' ' PHE . . . . . 1.044 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -94.74 107.58 19.59 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 106.524 -1.658 . . . . 1.83 106.524 176.385 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 136' ' ' VAL . . . . . 0.686 ' N ' ' O ' ' A' ' 34' ' ' CYS . 2.4 t -94.3 83.56 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.642 0 N-CA-C 107.814 -1.18 . . . . 1.29 107.814 179.595 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 137' ' ' GLY . . . . . 0.605 ' N ' ' O ' ' B' ' 125' ' ' SER . . . 105.5 102.9 2.83 Favored Glycine 0 CA--C 1.523 0.59 0 CA-C-N 113.637 -1.62 . . . . 0.85 113.944 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 138' ' ' THR . . . . . 0.517 ' HB ' ' O ' ' A' ' 32' ' ' LEU . 0.2 OUTLIER -179.96 165.7 1.24 Allowed 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 107.905 -1.146 . . . . 1.2 107.905 179.131 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 139' ' ' ALA . . . . . 0.457 ' O ' ' HB2' ' B' ' 142' ' ' LEU . . . -68.98 -36.97 78.47 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 119.075 0.852 . . . . 1.35 110.225 179.349 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 140' ' ' GLU . . . . . 0.864 ' HB3' ' HA2' ' B' ' 114' ' ' GLY . 0.5 OUTLIER -56.87 -13.7 2.85 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.009 -0.541 . . . . 2.31 111.064 179.83 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 141' ' ' ALA . . . . . 0.718 ' O ' ' HB2' ' B' ' 144' ' ' CYS . . . -101.72 -21.81 14.55 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 116.236 -0.438 . . . . 1.09 109.942 178.351 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 142' ' ' LEU . . . . . 0.457 ' HB2' ' O ' ' B' ' 139' ' ' ALA . 0.6 OUTLIER -45.04 -38.06 4.61 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.626 0.602 . . . . 1.61 112.626 -178.483 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 143' ' ' ARG . . . . . 0.536 ' C ' ' H ' ' B' ' 145' ' ' GLN . 0.0 OUTLIER -54.13 -29.46 45.28 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 107.136 -1.431 . . . . 3.43 107.136 177.148 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 144' ' ' CYS . . . . . 0.836 ' HB3' ' O ' ' B' ' 123' ' ' GLY . 39.8 m -57.15 -4.77 0.21 Allowed 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 113.776 -1.556 . . . . 1.61 110.441 -177.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 145' ' ' GLN . . . . . 0.536 ' H ' ' C ' ' B' ' 143' ' ' ARG . 0.0 OUTLIER -79.32 -19.31 50.66 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-O 121.255 0.55 . . . . 3.52 111.208 177.584 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -85.81 10.11 14.66 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 119.998 -0.681 . . . . 3.76 110.436 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 . . . . . 0 N--CA 1.441 -0.876 0 N-CA-C 108.852 -0.795 . . . . 4.01 108.852 177.244 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 1.3 t . . . . . 0 N--CA 1.464 0.275 0 CA-C-O 121.026 0.441 . . . . 3.41 111.205 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 165.12 44.52 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 109.085 -1.606 . . . . 2.26 109.085 -179.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -118.74 71.9 0.86 Allowed 'General case' 0 N--CA 1.441 -0.919 0 CA-C-O 122.398 1.094 . . . . 5.03 110.724 -179.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 159' ' ' LYS . . . . . 0.534 ' HB3' ' HB2' ' B' ' 167' ' ' CYS . 0.0 OUTLIER -107.81 66.12 0.26 Allowed Pre-proline 0 C--N 1.31 -1.123 0 CA-C-N 113.202 -1.817 . . . . 3.96 108.486 174.33 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 160' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -71.4 92.26 0.67 Allowed 'Trans proline' 0 N--CA 1.464 -0.25 0 N-CA-C 116.17 1.565 . . . . 1.7 116.17 -174.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 161' ' ' CYS . . . . . . . . . . . . . 1.9 p -99.34 -166.91 1.4 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 113.173 -1.831 . . . . 1.93 108.32 176.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 45.35 -165.03 0.06 OUTLIER Glycine 0 CA--C 1.52 0.356 0 C-N-CA 119.135 -1.507 . . . . 2.37 112.181 173.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 8.1 t -73.11 66.89 0.87 Allowed 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 117.364 0.582 . . . . 4.56 111.496 -179.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 84.46 9.12 82.22 Favored Glycine 0 CA--C 1.541 1.67 0 CA-C-O 117.94 -1.478 . . . . 2.39 116.132 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 165' ' ' GLY . . . . . 0.857 ' HA3' ' HA ' ' B' ' 174' ' ' CYS . . . -96.98 131.25 10.54 Favored Glycine 0 C--N 1.301 -1.383 0 C-N-CA 117.177 -2.439 . . . . 1.79 114.151 -176.238 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 166' ' ' ARG . . . . . 0.478 ' O ' ' N ' ' B' ' 174' ' ' CYS . 0.0 OUTLIER -100.03 152.41 20.24 Favored 'General case' 0 C--N 1.349 0.551 0 N-CA-C 112.186 0.439 . . . . 3.53 112.186 -179.151 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 167' ' ' CYS . . . . . 0.654 ' HA ' ' O ' ' B' ' 172' ' ' ILE . 46.7 t -51.84 108.77 0.3 Allowed 'General case' 0 N--CA 1.431 -1.425 0 CA-C-N 115.905 -0.589 . . . . 1.56 111.05 -179.282 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 168' ' ' ALA . . . . . 0.572 ' HB1' ' SG ' ' B' ' 128' ' ' CYS . . . -101.33 -30.16 11.64 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.771 -0.649 . . . . 1.42 109.528 178.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 169' ' ' ALA . . . . . 0.669 ' HB3' ' O ' ' B' ' 129' ' ' GLY . . . -162.31 165.1 27.05 Favored 'General case' 0 CA--C 1.492 -1.258 0 C-N-CA 119.488 -0.885 . . . . 1.18 112.42 -179.271 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 170' ' ' ALA . . . . . 0.766 ' HA ' ' O ' ' B' ' 185' ' ' CYS . . . -36.52 95.98 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.047 -0.979 . . . . 1.47 110.851 -179.106 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 171' ' ' GLY . . . . . 0.677 ' HA2' ' O ' ' B' ' 182' ' ' ASP . . . 88.52 -1.82 84.3 Favored Glycine 0 CA--C 1.525 0.677 0 CA-C-N 114.923 -1.035 . . . . 1.45 115.11 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 172' ' ' ILE . . . . . 0.802 HG13 ' HB2' ' B' ' 134' ' ' CYS . 1.8 mm -96.65 122.24 47.96 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.093 0 CA-C-N 117.865 0.832 . . . . 2.7 110.535 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 173' ' ' CYS . . . . . 0.597 ' HB2' ' HB3' ' B' ' 182' ' ' ASP . 21.6 t -120.89 92.21 3.71 Favored 'General case' 0 N--CA 1.428 -1.561 0 CA-C-N 114.561 -1.2 . . . . 1.94 109.399 -179.568 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 174' ' ' CYS . . . . . 1.047 ' HB3' ' HA ' ' B' ' 179' ' ' CYS . 5.9 p -160.08 -175.76 5.27 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 116.033 1.864 . . . . 1.43 116.033 -176.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 175' ' ' SER . . . . . 0.817 ' HB2' ' HD2' ' B' ' 176' ' ' PRO . 6.0 p -122.68 -179.89 0.88 Allowed Pre-proline 0 N--CA 1.454 -0.25 0 CA-C-N 113.087 -1.869 . . . . 2.3 108.931 -179.569 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 176' ' ' PRO . . . . . 0.817 ' HD2' ' HB2' ' B' ' 175' ' ' SER . 55.9 Cg_endo -72.38 31.31 0.27 Allowed 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 121.699 1.599 . . . . 2.13 113.292 -179.138 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 177' ' ' ASP . . . . . 0.437 ' OD1' ' N ' ' B' ' 178' ' ' GLY . 1.1 p30 -134.58 -60.02 0.8 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.643 -0.253 . . . . 2.72 110.371 178.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 178' ' ' GLY . . . . . 0.9 ' O ' ' HB2' ' B' ' 174' ' ' CYS . . . -124.51 -175.12 14.22 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.503 -0.856 . . . . 1.05 111.683 178.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 179' ' ' CYS . . . . . 1.047 ' HA ' ' HB3' ' B' ' 174' ' ' CYS . 14.0 m -149.41 160.44 43.43 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 117.526 0.663 . . . . 1.39 111.958 179.583 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 180' ' ' HIS . . . . . 0.432 ' HA ' ' HA2' ' A' ' 78' ' ' GLY . 72.5 m80 -149.56 139.77 22.2 Favored 'General case' 0 C--N 1.35 0.612 0 C-N-CA 120.232 -0.587 . . . . 2.73 111.819 -178.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 181' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -64.78 125.89 26.22 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.968 -0.56 . . . . 3.06 109.693 178.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 182' ' ' ASP . . . . . 0.677 ' O ' ' HA2' ' B' ' 171' ' ' GLY . 0.0 OUTLIER -139.74 107.59 7.03 Favored Pre-proline 0 CA--C 1.541 0.634 0 CA-C-O 120.85 0.357 . . . . 2.06 111.236 -179.267 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 183' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_exo -62.79 -24.19 74.51 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 123.061 2.507 . . . . 2.27 114.384 -178.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -64.29 -10.52 24.45 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.102 0.408 . . . . 1.56 112.102 -179.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 185' ' ' CYS . . . . . 0.766 ' O ' ' HA ' ' B' ' 170' ' ' ALA . 1.6 m -129.1 10.03 5.8 Favored 'General case' 0 C--O 1.214 -0.784 0 CA-C-O 119.243 -0.408 . . . . 1.94 111.078 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 186' ' ' ASP . . . . . 0.585 ' O ' ' HB1' ' B' ' 170' ' ' ALA . 0.5 OUTLIER . . . . . 0 CA--C 1.511 -0.534 0 C-N-CA 119.186 -1.006 . . . . 3.61 112.511 -176.588 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 62.7 m . . . . . 0 CA--C 1.542 0.664 0 N-CA-C 112.719 0.637 . . . . 2.89 112.719 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.843 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 4.2 mp -31.22 135.31 0.23 Allowed Pre-proline 0 N--CA 1.483 1.192 0 N-CA-C 113.598 0.962 . . . . 2.89 113.598 -178.679 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -97.47 114.72 0.11 Allowed 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 123.439 2.759 . . . . 1.72 116.251 -178.632 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.517 ' O ' ' HA2' ' A' ' 17' ' ' GLY . 0.5 OUTLIER -127.59 -176.32 3.72 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-O 121.823 0.82 . . . . 1.0 111.46 -178.463 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 74.17 -178.26 44.32 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 114.524 -1.217 . . . . 1.15 110.438 -178.37 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.559 ' O ' ' HG2' ' A' ' 15' ' ' PRO . 47.3 Cg_endo -63.28 130.92 30.16 Favored 'Trans proline' 0 CA--C 1.507 -0.851 0 N-CA-C 106.317 -2.224 . . . . 1.6 106.317 175.464 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 72.34 -4.16 20.49 Favored Glycine 0 N--CA 1.414 -2.832 0 CA-C-O 119.247 -0.752 . . . . 1.68 113.459 177.07 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.517 ' HA2' ' O ' ' A' ' 13' ' ' CYS . . . 76.53 38.44 32.74 Favored Glycine 1 N--CA 1.391 -4.347 0 C-N-CA 119.121 -1.514 . . . . 1.37 112.189 -178.747 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.42 ' CG ' ' O ' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -97.72 22.0 9.67 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.317 -0.442 . . . . 2.91 110.261 174.439 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -129.58 -175.46 14.05 Favored Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 104.912 -3.275 . . . . 1.06 104.912 177.846 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.694 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 2.7 mtp180 -119.3 159.73 23.58 Favored 'General case' 0 CA--C 1.552 1.045 0 CA-C-N 121.323 2.562 . . . . 3.32 108.444 176.708 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.843 ' HB2' ' HB3' ' A' ' 11' ' ' LEU . 10.7 m -109.09 148.9 30.11 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 119.881 1.219 . . . . 1.19 111.435 -179.742 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.471 ' HE2' ' HG ' ' A' ' 56' ' ' SER . 49.9 m-85 -128.38 -52.4 1.28 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.085 -0.507 . . . . 2.26 111.36 179.989 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.417 ' O ' ' HB3' ' A' ' 44' ' ' CYS . . . -119.84 -171.3 14.65 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.935 -0.65 . . . . 1.05 112.26 -179.816 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -68.79 -61.21 0.07 OUTLIER 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.635 2.223 . . . . 1.81 112.755 -179.693 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.609 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.4 OUTLIER -98.15 26.87 4.97 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.822 -0.172 . . . . 1.62 110.749 -179.999 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 1.074 HG12 HG12 ' A' ' 36' ' ' VAL . 3.3 mt -141.37 120.58 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 N-CA-C 113.542 0.941 . . . . 1.39 113.542 -178.307 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.815 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -120.43 140.25 51.65 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 107.653 -1.239 . . . . 0.92 107.653 178.188 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 1.035 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -143.96 100.1 3.51 Favored 'General case' 0 CA--C 1.552 1.05 0 N-CA-C 117.686 2.476 . . . . 1.28 117.686 -174.907 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.494 ' O ' ' HB3' ' A' ' 69' ' ' ALA . . . -101.48 -172.48 28.25 Favored Glycine 0 N--CA 1.431 -1.687 0 N-CA-C 108.423 -1.871 . . . . 0.71 108.423 176.49 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -64.98 -62.75 1.37 Allowed 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 121.338 0.59 . . . . 2.27 112.268 -179.255 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.1 14.69 28.82 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 122.196 0.998 . . . . 1.66 111.365 -177.931 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.764 HD21 ' CE2' ' A' ' 35' ' ' PHE . 4.6 mt -115.88 -5.03 12.04 Favored 'General case' 0 N--CA 1.387 -3.593 0 N-CA-C 104.895 -2.261 . . . . 1.93 104.895 179.063 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 1.035 ' O ' ' HA ' ' A' ' 28' ' ' CYS . . . 43.7 -126.73 5.77 Favored Glycine 0 N--CA 1.432 -1.609 0 CA-C-N 114.243 -1.344 . . . . 0.77 113.918 175.941 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.815 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -132.52 107.95 8.79 Favored 'General case' 0 CA--C 1.49 -1.329 0 CA-C-N 118.008 0.904 . . . . 1.08 113.362 -179.365 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.909 ' HD1' ' HD1' ' B' ' 135' ' ' PHE . 84.7 m-85 -83.06 105.98 14.49 Favored 'General case' 0 N--CA 1.42 -1.93 0 N-CA-C 102.32 -3.215 . . . . 1.85 102.32 174.686 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 1.074 HG12 HG12 ' A' ' 26' ' ' ILE . 3.0 t -97.77 85.27 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.664 0 CA-C-O 123.036 1.398 . . . . 1.29 109.374 -176.992 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.609 ' N ' ' O ' ' A' ' 25' ' ' SER . . . 97.68 89.4 1.9 Allowed Glycine 0 CA--C 1.527 0.842 0 CA-C-N 112.492 -2.14 . . . . 0.85 115.45 178.621 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.551 HG22 ' CE1' ' B' ' 135' ' ' PHE . 0.5 OUTLIER -176.62 168.17 2.64 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 108.603 -0.888 . . . . 1.3 108.603 177.964 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.577 ' HA ' HD11 ' A' ' 42' ' ' LEU . . . -53.54 -26.79 22.65 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 115.781 1.771 . . . . 1.45 115.781 -176.648 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.464 ' OE1' HG23 ' A' ' 38' ' ' THR . 0.0 OUTLIER -66.33 -15.91 63.63 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 119.226 -0.99 . . . . 2.32 109.634 178.545 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.634 ' O ' ' N ' ' A' ' 44' ' ' CYS . . . -88.42 -24.05 23.15 Favored 'General case' 0 N--CA 1.425 -1.693 0 CA-C-O 119.283 -0.389 . . . . 1.11 111.026 -178.979 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.577 HD11 ' HA ' ' A' ' 39' ' ' ALA . 0.4 OUTLIER -44.5 -40.0 5.27 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 119.229 0.922 . . . . 1.68 112.197 179.873 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.413 ' HD3' ' HA ' ' A' ' 43' ' ' ARG . 10.8 tpp85 -64.48 -11.16 30.83 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.708 0.766 . . . . 3.4 109.748 177.713 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.634 ' N ' ' O ' ' A' ' 41' ' ' ALA . 88.8 m -73.61 -8.31 55.46 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 113.763 -1.562 . . . . 1.57 110.728 176.795 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -76.38 -6.73 52.92 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.071 0.397 . . . . 3.49 112.071 179.382 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -86.44 3.87 42.0 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.254 -0.579 . . . . 3.69 111.114 -178.926 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.626 ' HG2' ' O ' ' A' ' 44' ' ' CYS . 12.6 pt-20 . . . . . 0 N--CA 1.448 -0.552 0 N-CA-C 109.592 -0.521 . . . . 3.99 109.592 177.203 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.471 ' HG ' ' HE2' ' A' ' 22' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--O 1.226 -0.173 0 CA-C-O 120.757 0.313 . . . . 3.36 110.328 . . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.56 ' O ' ' HB2' ' A' ' 66' ' ' ARG . . . -87.67 144.35 18.89 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 110.049 -1.22 . . . . 2.3 110.049 -176.868 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -101.62 74.83 1.54 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.859 0.838 . . . . 5.06 109.834 179.297 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.701 ' HB3' ' HB2' ' A' ' 67' ' ' CYS . 15.3 tppt? -144.28 57.33 4.8 Favored Pre-proline 0 C--N 1.308 -1.222 0 N-CA-C 106.686 -1.598 . . . . 3.91 106.686 178.072 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.45 ' CD ' ' N ' ' A' ' 59' ' ' LYS . 55.0 Cg_endo -69.1 84.79 0.54 Allowed 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 121.828 1.685 . . . . 1.74 114.343 -177.681 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.44 ' N ' ' O ' ' A' ' 65' ' ' GLY . 0.8 OUTLIER -104.41 -176.49 3.1 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 113.587 -1.642 . . . . 1.9 107.693 177.014 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 62.72 -165.95 23.54 Favored Glycine 0 CA--C 1.505 -0.592 0 C-N-CA 118.712 -1.709 . . . . 2.43 112.852 178.495 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -77.77 52.37 1.02 Allowed 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.635 -0.283 . . . . 4.32 111.49 -179.066 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 102.93 8.71 41.59 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-O 118.988 -0.895 . . . . 2.4 115.001 178.964 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.54 ' HA2' ' HA ' ' A' ' 75' ' ' SER . . . -102.84 138.8 14.14 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 118.575 -1.774 . . . . 1.82 115.38 -178.373 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.56 ' HB2' ' O ' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -102.38 154.34 19.17 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 114.285 -0.958 . . . . 3.51 110.534 179.014 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.701 ' HB2' ' HB3' ' A' ' 59' ' ' LYS . 5.5 t -56.31 109.22 0.57 Allowed 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 109.695 -0.483 . . . . 1.52 109.695 -179.108 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.403 ' HB1' ' SG ' ' A' ' 28' ' ' CYS . . . -91.89 -17.73 24.81 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 107.898 -1.149 . . . . 1.5 107.898 178.773 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.818 ' O ' ' O ' ' A' ' 70' ' ' ALA . . . -165.64 156.4 13.53 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 112.946 -1.934 . . . . 1.31 109.262 179.943 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.818 ' O ' ' O ' ' A' ' 69' ' ' ALA . . . -18.11 -139.12 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 114.154 1.168 . . . . 1.5 114.154 -179.705 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.617 ' HA3' ' OD1' ' A' ' 86' ' ' ASP . . . -61.38 53.29 0.03 OUTLIER Glycine 0 N--CA 1.475 1.237 0 N-CA-C 111.387 -0.685 . . . . 1.44 111.387 -177.914 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.739 ' CD1' ' HB2' ' A' ' 34' ' ' CYS . 1.8 pp -151.94 97.96 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.257 1.49 0 CA-C-O 122.204 1.002 . . . . 2.77 109.095 168.804 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.572 ' HB3' ' HB3' ' A' ' 82' ' ' ASP . 0.9 OUTLIER -93.65 95.94 9.51 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.035 -0.984 . . . . 1.98 108.745 -178.872 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.841 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 16.5 m -92.65 162.35 14.2 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 114.512 1.301 . . . . 1.43 114.512 -176.182 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.763 ' HB2' ' HD2' ' A' ' 76' ' ' PRO . 58.6 p -125.16 179.42 1.13 Allowed Pre-proline 0 CA--C 1.531 0.224 0 CA-C-N 113.465 -1.698 . . . . 2.37 108.127 178.748 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.763 ' HD2' ' HB2' ' A' ' 75' ' ' SER . 71.9 Cg_endo -77.22 30.01 0.42 Allowed 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 121.304 1.336 . . . . 2.09 111.909 179.79 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.449 ' H ' ' C ' ' A' ' 75' ' ' SER . 1.6 t70 -145.92 -41.73 0.21 Allowed 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.652 -0.704 . . . . 2.65 110.887 179.971 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 1.261 ' HA3' ' O ' ' B' ' 179' ' ' CYS . . . -151.11 -141.63 3.38 Favored Glycine 0 C--N 1.337 0.591 0 C-N-CA 120.406 -0.902 . . . . 1.04 113.621 -179.815 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 1.217 ' O ' ' HA3' ' B' ' 178' ' ' GLY . 60.2 m -148.22 146.27 28.61 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 123.123 0.569 . . . . 1.42 110.486 -179.658 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.442 ' N ' ' O ' ' A' ' 73' ' ' CYS . 14.5 m80 -133.24 134.06 43.49 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 119.859 -0.737 . . . . 2.81 111.511 179.956 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.409 ' OE1' ' HG2' ' B' ' 124' ' ' PRO . 8.7 mt-10 -59.58 135.95 57.83 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 108.682 -0.858 . . . . 3.05 108.682 178.558 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.572 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 0.7 OUTLIER -142.96 128.97 10.36 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 116.395 -0.366 . . . . 2.02 110.998 -178.706 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 82' ' ' ASP . 15.2 Cg_exo -69.15 -31.29 23.56 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 123.212 2.608 . . . . 2.29 113.07 -179.198 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.62 -3.11 2.83 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.115 -0.493 . . . . 1.53 112.03 -179.705 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.641 ' HB3' ' C ' ' A' ' 70' ' ' ALA . 73.6 m -133.22 20.3 4.04 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 112.074 0.398 . . . . 1.88 112.074 -179.965 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.617 ' OD1' ' HA3' ' A' ' 71' ' ' GLY . 16.8 m-20 . . . . . 0 N--CA 1.449 -0.509 0 N-CA-C 113.805 1.039 . . . . 3.6 113.805 179.854 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 110' ' ' CYS . . . . . . . . . . . . . 64.4 m . . . . . 0 CA--C 1.536 0.419 0 N-CA-C 111.498 0.184 . . . . 2.87 111.498 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' B' B ' 111' ' ' LEU . . . . . 0.837 ' HB3' ' HB2' ' B' ' 121' ' ' CYS . 4.6 mp -33.59 135.22 0.32 Allowed Pre-proline 0 N--CA 1.476 0.827 0 N-CA-C 113.576 0.954 . . . . 2.95 113.576 179.854 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 112' ' ' PRO . . . . . 0.426 ' HG2' ' CG ' ' B' ' 143' ' ' ARG . 41.7 Cg_endo -93.92 122.69 0.42 Allowed 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 123.557 2.838 . . . . 1.71 112.776 179.656 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.471 ' SG ' ' HA3' ' B' ' 119' ' ' GLY . 0.4 OUTLIER -135.37 -177.35 4.62 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-O 122.398 1.094 . . . . 1.0 111.248 177.409 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . 73.98 -178.41 43.48 Favored Glycine 0 N--CA 1.439 -1.109 0 CA-C-N 113.589 -1.642 . . . . 1.16 110.204 -177.863 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 115' ' ' PRO . . . . . 0.602 ' O ' ' HG2' ' B' ' 115' ' ' PRO . 41.3 Cg_endo -64.97 121.36 8.83 Favored 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 122.041 1.827 . . . . 1.6 109.676 176.13 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 74.52 7.49 79.11 Favored Glycine 0 C--N 1.281 -2.487 0 CA-C-N 115.497 -0.774 . . . . 1.7 113.176 179.61 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 117' ' ' GLY . . . . . 0.455 ' HA2' ' O ' ' B' ' 113' ' ' CYS . . . 74.85 33.45 55.29 Favored Glycine 0 N--CA 1.408 -3.192 0 C-N-CA 119.628 -1.272 . . . . 1.38 114.636 177.311 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 118' ' ' LYS . . . . . 0.411 ' CG ' ' O ' ' B' ' 115' ' ' PRO . 0.0 OUTLIER -91.91 14.34 15.94 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 122.212 0.205 . . . . 2.96 110.722 178.698 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' B' B ' 119' ' ' GLY . . . . . 0.471 ' HA3' ' SG ' ' B' ' 113' ' ' CYS . . . -115.42 -153.8 10.4 Favored Glycine 0 C--N 1.34 0.774 0 N-CA-C 108.198 -1.961 . . . . 1.07 108.198 179.193 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.781 ' HA ' ' O ' ' B' ' 111' ' ' LEU . 2.7 ttp180 -143.08 156.75 44.88 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 123.206 3.503 . . . . 3.29 103.11 172.858 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 121' ' ' CYS . . . . . 0.837 ' HB2' ' HB3' ' B' ' 111' ' ' LEU . 15.8 m -108.74 150.15 28.01 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 120.19 1.359 . . . . 1.21 111.862 -178.036 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -128.57 -52.57 1.26 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.78 -0.645 . . . . 2.28 111.169 179.89 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 123' ' ' GLY . . . . . 0.415 ' O ' ' HB3' ' B' ' 144' ' ' CYS . . . -119.83 -171.23 14.64 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.934 -0.651 . . . . 1.04 112.353 -179.889 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . 0.409 ' HG2' ' OE1' ' A' ' 81' ' ' GLU . 14.2 Cg_exo -68.81 -61.25 0.07 OUTLIER 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.674 2.249 . . . . 1.84 112.809 -179.697 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 125' ' ' SER . . . . . 0.607 ' O ' ' N ' ' B' ' 137' ' ' GLY . 0.4 OUTLIER -98.05 26.81 4.96 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.785 -0.189 . . . . 1.49 110.832 179.87 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' B' B ' 126' ' ' ILE . . . . . 0.859 HG12 HG12 ' B' ' 136' ' ' VAL . 4.1 mt -140.93 120.62 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 113.556 0.947 . . . . 1.41 113.556 -178.209 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 127' ' ' CYS . . . . . 0.797 ' O ' ' HA ' ' B' ' 134' ' ' CYS . 0.0 OUTLIER -121.02 140.17 52.29 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 107.55 -1.278 . . . . 0.89 107.55 177.854 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' B' B ' 128' ' ' CYS . . . . . 1.055 ' HA ' ' O ' ' B' ' 133' ' ' GLY . 0.0 OUTLIER -143.14 106.69 4.61 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 115.671 1.73 . . . . 1.23 115.671 -175.563 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' B' B ' 129' ' ' GLY . . . . . 0.499 ' O ' ' HB3' ' B' ' 169' ' ' ALA . . . -109.47 -168.13 20.27 Favored Glycine 0 N--CA 1.422 -2.272 0 CA-C-N 123.698 2.954 . . . . 0.69 106.751 173.983 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -62.61 -70.95 0.17 Allowed 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 117.234 0.517 . . . . 2.35 110.572 -178.952 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.28 32.54 4.73 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 122.688 1.232 . . . . 1.69 110.135 -176.323 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 132' ' ' LEU . . . . . 0.73 HD22 ' CE2' ' B' ' 135' ' ' PHE . 4.0 mt -126.48 -4.74 6.58 Favored 'General case' 0 N--CA 1.385 -3.69 0 N-CA-C 103.845 -2.65 . . . . 1.84 103.845 175.568 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 133' ' ' GLY . . . . . 1.055 ' O ' ' HA ' ' B' ' 128' ' ' CYS . . . 43.95 -123.62 4.79 Favored Glycine 0 N--CA 1.406 -3.366 0 CA-C-N 114.226 -1.352 . . . . 0.76 114.907 174.793 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 134' ' ' CYS . . . . . 0.797 ' HA ' ' O ' ' B' ' 127' ' ' CYS . 0.0 OUTLIER -136.66 105.01 5.72 Favored 'General case' 0 CA--C 1.494 -1.189 0 N-CA-C 114.322 1.23 . . . . 1.08 114.322 179.872 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' B' B ' 135' ' ' PHE . . . . . 0.909 ' HD1' ' HD1' ' A' ' 35' ' ' PHE . 82.1 m-85 -80.22 105.39 11.45 Favored 'General case' 0 N--CA 1.42 -1.928 0 N-CA-C 102.399 -3.185 . . . . 1.83 102.399 176.035 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 136' ' ' VAL . . . . . 0.859 HG12 HG12 ' B' ' 126' ' ' ILE . 5.9 t -97.9 84.64 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.671 0 CA-C-O 123.148 1.451 . . . . 1.29 109.24 -177.129 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 137' ' ' GLY . . . . . 0.607 ' N ' ' O ' ' B' ' 125' ' ' SER . . . 97.91 88.65 1.9 Allowed Glycine 0 CA--C 1.527 0.812 0 CA-C-N 112.254 -2.248 . . . . 0.85 115.475 178.442 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 138' ' ' THR . . . . . 0.719 HG22 ' OE2' ' B' ' 140' ' ' GLU . 0.5 OUTLIER -172.14 175.65 3.67 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 108.796 -0.816 . . . . 1.2 108.796 178.045 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' B' B ' 139' ' ' ALA . . . . . 0.855 ' HA ' HD11 ' B' ' 142' ' ' LEU . . . -55.82 -40.41 72.73 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 118.818 0.736 . . . . 1.35 112.562 -178.262 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 140' ' ' GLU . . . . . 0.719 ' OE2' HG22 ' B' ' 138' ' ' THR . 0.0 OUTLIER -57.6 -13.94 4.6 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.089 -0.644 . . . . 2.31 110.862 -178.032 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' B' B ' 141' ' ' ALA . . . . . 0.668 ' O ' ' N ' ' B' ' 144' ' ' CYS . . . -87.12 -30.44 21.09 Favored 'General case' 0 C--O 1.213 -0.866 0 CA-C-N 116.223 -0.444 . . . . 1.09 110.122 179.754 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 142' ' ' LEU . . . . . 0.855 HD11 ' HA ' ' B' ' 139' ' ' ALA . 0.4 OUTLIER -40.86 -41.36 1.57 Allowed 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.462 0.542 . . . . 1.61 112.462 -178.604 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' B' B ' 143' ' ' ARG . . . . . 0.441 ' HD3' ' HA ' ' B' ' 143' ' ' ARG . 8.9 tpp85 -58.17 -23.46 55.44 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 108.37 -0.974 . . . . 3.43 108.37 177.619 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 144' ' ' CYS . . . . . 0.668 ' N ' ' O ' ' B' ' 141' ' ' ALA . 90.9 m -66.61 -5.76 12.76 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 113.889 -1.505 . . . . 1.61 110.596 -177.553 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -78.03 -6.28 54.05 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.847 0.356 . . . . 3.52 111.701 178.906 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -86.33 3.51 43.14 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.355 -0.538 . . . . 3.76 111.01 -178.981 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 147' ' ' GLU . . . . . 0.608 ' HG2' ' O ' ' B' ' 144' ' ' CYS . 12.6 pt-20 . . . . . 0 N--CA 1.449 -0.517 0 N-CA-C 109.656 -0.498 . . . . 4.01 109.656 177.281 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.45 -0.444 0 CA-C-O 119.879 -0.105 . . . . 3.41 111.028 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 157' ' ' GLY . . . . . 0.537 ' O ' ' HB2' ' B' ' 166' ' ' ARG . . . -109.09 146.02 16.64 Favored Glycine 0 CA--C 1.493 -1.342 0 N-CA-C 108.821 -1.712 . . . . 2.26 108.821 175.555 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 11.6 mt-30 -103.3 63.7 0.81 Allowed 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 117.354 -1.739 . . . . 5.03 111.363 -179.165 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 159' ' ' LYS . . . . . 0.809 ' HB3' ' HB2' ' B' ' 167' ' ' CYS . 11.2 tppt? -117.46 52.06 1.21 Allowed Pre-proline 0 C--N 1.314 -0.954 0 CA-C-O 116.694 -1.622 . . . . 3.96 110.294 172.118 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 160' ' ' PRO . . . . . 0.407 ' HA ' ' HA ' ' B' ' 166' ' ' ARG . 43.6 Cg_endo -68.38 86.16 0.43 Allowed 'Trans proline' 0 C--N 1.334 -0.231 0 CA-C-N 122.502 1.929 . . . . 1.7 115.03 -173.305 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 161' ' ' CYS . . . . . 0.448 ' N ' ' O ' ' B' ' 165' ' ' GLY . 0.7 OUTLIER -96.94 -166.57 1.42 Allowed 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 113.117 -1.856 . . . . 1.93 109.302 177.944 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 49.9 -164.67 0.56 Allowed Glycine 0 CA--C 1.524 0.613 0 C-N-CA 118.813 -1.66 . . . . 2.37 113.375 172.127 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -78.13 51.44 0.99 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.233 0.54 . . . . 4.56 111.907 -178.739 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 104.95 7.55 38.24 Favored Glycine 0 CA--C 1.533 1.211 0 N-CA-C 114.965 0.746 . . . . 2.39 114.965 178.281 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 165' ' ' GLY . . . . . 0.547 ' HA2' ' HA ' ' B' ' 175' ' ' SER . . . -101.07 136.25 12.6 Favored Glycine 0 C--O 1.224 -0.494 0 C-N-CA 119.044 -1.55 . . . . 1.79 115.885 -176.854 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 166' ' ' ARG . . . . . 0.537 ' HB2' ' O ' ' B' ' 157' ' ' GLY . 0.0 OUTLIER -102.23 154.17 19.28 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 114.469 -0.865 . . . . 3.53 110.6 178.935 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' B' B ' 167' ' ' CYS . . . . . 0.809 ' HB2' ' HB3' ' B' ' 159' ' ' LYS . 5.4 t -56.52 109.24 0.58 Allowed 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 109.721 -0.474 . . . . 1.56 109.721 -179.017 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 168' ' ' ALA . . . . . 0.521 ' HB1' ' SG ' ' B' ' 128' ' ' CYS . . . -92.31 -17.31 24.89 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 107.879 -1.156 . . . . 1.42 107.879 178.878 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 169' ' ' ALA . . . . . 0.785 ' O ' ' O ' ' B' ' 170' ' ' ALA . . . -165.83 155.89 12.66 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 113.063 -1.881 . . . . 1.18 109.13 179.856 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 170' ' ' ALA . . . . . 0.785 ' O ' ' O ' ' B' ' 169' ' ' ALA . . . -19.17 -134.94 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 114.418 1.266 . . . . 1.47 114.418 -179.623 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 171' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' B' ' 185' ' ' CYS . . . -46.69 19.77 0.0 OUTLIER Glycine 0 CA--C 1.536 1.383 0 N-CA-C 116.359 1.304 . . . . 1.45 116.359 -178.217 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 172' ' ' ILE . . . . . 0.774 ' CD1' ' HB2' ' B' ' 134' ' ' CYS . 1.8 pp -138.28 99.85 1.56 Allowed 'Isoleucine or valine' 0 C--O 1.251 1.164 0 CA-C-O 123.478 1.609 . . . . 2.7 111.198 -178.818 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 173' ' ' CYS . . . . . 0.575 ' HB3' ' HB3' ' B' ' 182' ' ' ASP . 1.1 t -92.92 95.54 9.56 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 113.523 -1.671 . . . . 1.94 109.022 -179.055 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 174' ' ' CYS . . . . . 0.842 ' HA ' ' HA ' ' B' ' 179' ' ' CYS . 16.3 m -92.82 162.6 14.04 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 114.52 1.304 . . . . 1.43 114.52 -176.25 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 175' ' ' SER . . . . . 0.758 ' HB2' ' HD2' ' B' ' 176' ' ' PRO . 55.6 p -125.27 179.42 1.14 Allowed Pre-proline 0 CA--C 1.532 0.262 0 CA-C-N 113.454 -1.703 . . . . 2.3 108.033 178.842 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 176' ' ' PRO . . . . . 0.758 ' HD2' ' HB2' ' B' ' 175' ' ' SER . 72.0 Cg_endo -77.27 30.14 0.42 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 121.283 1.322 . . . . 2.13 111.9 179.829 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 177' ' ' ASP . . . . . 0.436 ' H ' ' C ' ' B' ' 175' ' ' SER . 1.6 t70 -145.94 -41.79 0.21 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.644 -0.707 . . . . 2.72 110.921 179.939 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 178' ' ' GLY . . . . . 1.217 ' HA3' ' O ' ' A' ' 79' ' ' CYS . . . -150.97 -141.56 3.37 Favored Glycine 0 C--N 1.336 0.533 0 C-N-CA 120.588 -0.815 . . . . 1.05 113.727 -179.89 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 179' ' ' CYS . . . . . 1.261 ' O ' ' HA3' ' A' ' 78' ' ' GLY . 60.3 m -148.38 146.05 28.32 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 123.154 0.582 . . . . 1.39 110.53 -179.653 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 180' ' ' HIS . . . . . 0.455 ' N ' ' O ' ' B' ' 173' ' ' CYS . 14.6 m80 -132.97 134.14 44.1 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 119.797 -0.761 . . . . 2.73 111.508 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 181' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -59.67 135.93 57.83 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.712 -0.847 . . . . 3.06 108.712 178.506 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 182' ' ' ASP . . . . . 0.575 ' HB3' ' HB3' ' B' ' 173' ' ' CYS . 0.7 OUTLIER -143.0 128.94 10.32 Favored Pre-proline 0 C--N 1.319 -0.719 0 CA-C-N 116.443 -0.344 . . . . 2.06 111.069 -178.632 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' B' B ' 183' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -69.19 -31.34 23.29 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 123.188 2.592 . . . . 2.27 113.041 -179.106 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -64.41 -3.28 2.82 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.109 -0.496 . . . . 1.56 111.963 -179.729 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 185' ' ' CYS . . . . . 0.629 ' HB3' ' C ' ' B' ' 170' ' ' ALA . 70.6 m -133.25 20.26 4.02 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 112.227 0.454 . . . . 1.94 112.227 -179.855 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 186' ' ' ASP . . . . . 0.474 ' OD1' ' HA3' ' B' ' 171' ' ' GLY . 17.3 m-20 . . . . . 0 N--CA 1.448 -0.573 0 N-CA-C 113.858 1.058 . . . . 3.61 113.858 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.409 0 CA-C-O 121.097 0.475 . . . . 8.76 111.162 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.497 ' O ' HG13 ' A' ' 2' ' ' VAL . 11.4 p -66.94 119.29 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 CA-C-O 121.996 0.903 . . . . 7.43 111.119 179.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.792 ' O ' ' N ' ' A' ' 5' ' ' LEU . 0.3 OUTLIER -155.97 77.66 0.96 Allowed 'General case' 0 C--O 1.257 1.496 0 CA-C-N 113.603 -1.635 . . . . 5.11 107.074 -179.68 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -61.78 49.61 0.01 OUTLIER 'General case' 0 N--CA 1.439 -1.003 0 C-N-CA 117.858 -1.537 . . . . 6.12 110.248 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.792 ' N ' ' O ' ' A' ' 3' ' ' LEU . 96.4 mt -153.51 -79.86 0.1 Allowed 'General case' 1 N--CA 1.377 -4.113 0 CA-C-O 122.611 1.196 . . . . 6.64 109.464 179.362 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -167.38 -63.54 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 113.28 -1.782 . . . . 6.84 113.466 -179.164 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.4 p -150.02 121.57 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.8 0 N-CA-C 109.035 -0.728 . . . . 6.69 109.035 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.708 ' HG2' ' CD2' ' A' ' 3' ' ' LEU . 0.0 OUTLIER -77.03 100.77 5.77 Favored 'General case' 0 N--CA 1.424 -1.756 0 CA-C-N 116.015 -0.539 . . . . 8.04 112.441 -179.402 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.403 HG22 ' O ' ' A' ' 9' ' ' THR . 7.1 t -103.57 95.67 6.21 Favored 'General case' 0 N--CA 1.428 -1.534 0 C-N-CA 114.962 -2.695 . . . . 4.27 104.191 172.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.5 m -74.93 79.96 2.16 Favored 'General case' 0 CA--C 1.556 1.2 0 CA-C-N 113.133 -1.849 . . . . 2.89 113.201 -177.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.575 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -34.82 113.29 0.46 Allowed Pre-proline 0 N--CA 1.491 1.609 0 CA-C-N 119.0 0.818 . . . . 3.22 111.661 179.461 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.472 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 71.5 Cg_endo -75.48 117.92 4.97 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 122.82 2.347 . . . . 1.89 113.309 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 5.7 p -130.93 -178.29 4.75 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 121.057 0.456 . . . . 1.32 111.702 178.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.462 ' HA2' ' HB3' ' A' ' 40' ' ' GLU . . . 77.21 -162.54 51.4 Favored Glycine 0 CA--C 1.519 0.303 0 CA-C-N 116.162 -0.472 . . . . 1.23 112.121 -178.111 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.5 ' O ' ' HG2' ' A' ' 15' ' ' PRO . 44.6 Cg_endo -65.8 100.29 0.42 Allowed 'Trans proline' 0 N--CA 1.48 0.692 0 C-N-CA 124.165 3.244 . . . . 1.9 111.886 177.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.03 5.89 76.29 Favored Glycine 0 C--N 1.299 -1.473 0 CA-C-N 115.316 -0.856 . . . . 2.18 113.465 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.472 ' O ' ' CB ' ' A' ' 12' ' ' PRO . . . 71.95 45.33 42.75 Favored Glycine 0 N--CA 1.426 -2.011 0 N-CA-C 115.71 1.044 . . . . 1.48 115.71 177.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.458 ' HB2' ' CD1' ' A' ' 32' ' ' LEU . 0.5 OUTLIER -94.89 -24.02 17.19 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 112.66 0.615 . . . . 3.51 112.66 -179.828 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -79.5 171.84 54.87 Favored Glycine 0 CA--C 1.495 -1.157 0 CA-C-N 115.235 -0.893 . . . . 1.27 111.64 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.579 ' O ' ' SG ' ' A' ' 27' ' ' CYS . 0.8 OUTLIER -120.86 149.41 42.64 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 109.848 -0.427 . . . . 3.02 109.848 -178.62 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.401 ' HB2' HD22 ' A' ' 11' ' ' LEU . 57.0 m -98.64 127.02 44.42 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.988 0.899 . . . . 1.22 109.741 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -109.89 -29.94 8.05 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 113.963 -1.472 . . . . 2.99 111.315 -177.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -157.03 -174.49 26.8 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 121.089 -0.577 . . . . 1.1 112.708 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.41 -54.27 5.22 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 122.747 2.298 . . . . 1.11 113.45 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.588 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.7 OUTLIER -120.65 36.32 4.61 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 122.462 -0.149 . . . . 1.29 111.207 179.695 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.508 HG12 HG12 ' A' ' 36' ' ' VAL . 19.7 mt -140.77 111.42 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 C-N-CA 120.32 -0.552 . . . . 1.69 111.896 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.579 ' SG ' ' O ' ' A' ' 20' ' ' ARG . 0.5 OUTLIER -126.49 120.71 30.39 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 116.528 -0.305 . . . . 1.2 110.19 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.884 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -131.07 127.85 39.03 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 119.526 -0.87 . . . . 1.2 112.65 -179.579 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 33' ' ' GLY . . . -103.92 -169.51 25.24 Favored Glycine 0 N--CA 1.421 -2.325 0 C-N-CA 120.45 -0.881 . . . . 0.9 111.858 178.022 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -69.87 -51.06 36.54 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 114.694 -0.753 . . . . 2.64 112.969 -178.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -121.08 9.42 10.52 Favored 'General case' 0 CA--C 1.503 -0.836 0 CA-C-N 115.041 -0.981 . . . . 2.1 109.437 -177.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.458 ' CD1' ' HB2' ' A' ' 18' ' ' LYS . 4.7 mt -109.67 -9.83 14.84 Favored 'General case' 0 N--CA 1.408 -2.569 0 N-CA-C 108.871 -0.789 . . . . 1.5 108.871 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.884 ' O ' ' HA ' ' A' ' 28' ' ' CYS . . . 65.8 -136.0 35.64 Favored Glycine 0 N--CA 1.43 -1.751 0 C-N-CA 120.42 -0.895 . . . . 0.74 112.921 176.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.62 ' HB2' ' CD1' ' A' ' 72' ' ' ILE . 1.6 t -135.66 125.54 25.73 Favored 'General case' 0 CA--C 1.503 -0.827 0 N-CA-C 114.37 1.248 . . . . 0.94 114.37 -178.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.454 ' CD1' ' N ' ' A' ' 35' ' ' PHE . 4.2 m-85 -98.88 101.03 12.29 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 104.655 -2.35 . . . . 2.68 104.655 176.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.572 HG23 HG23 ' B' ' 136' ' ' VAL . 3.8 t -87.06 94.48 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 CA-C-O 122.937 1.351 . . . . 1.24 110.603 -178.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.588 ' N ' ' O ' ' A' ' 25' ' ' SER . . . 76.95 83.63 0.5 Allowed Glycine 0 CA--C 1.499 -0.911 0 CA-C-N 112.028 -2.351 . . . . 1.32 112.186 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 19.2 p -149.95 169.08 22.02 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-O 120.972 0.415 . . . . 1.79 111.16 -178.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -55.08 -27.73 47.09 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.867 -0.606 . . . . 1.67 110.781 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.462 ' HB3' ' HA2' ' A' ' 14' ' ' GLY . 30.1 mp0 -73.56 -29.21 62.29 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 112.665 0.617 . . . . 2.56 112.665 -179.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.405 ' O ' ' HB2' ' A' ' 44' ' ' CYS . . . -97.55 -1.35 44.13 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 120.701 0.286 . . . . 1.37 110.38 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.6 mt -57.61 -32.98 67.75 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 120.939 0.4 . . . . 2.46 110.308 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.7 ptm85 -72.13 -9.07 57.92 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.89 -0.596 . . . . 4.29 110.594 179.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.405 ' HB2' ' O ' ' A' ' 41' ' ' ALA . 94.4 m -69.36 -10.18 56.76 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 120.198 -0.601 . . . . 1.32 111.389 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -54.96 -24.76 25.46 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.109 0.48 . . . . 3.28 110.928 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -85.83 5.01 34.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.241 -0.436 . . . . 3.55 110.434 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -80.31 -7.93 59.26 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 108.789 -0.819 . . . . 2.79 108.789 179.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -73.23 -28.79 62.36 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 109.011 -0.737 . . . . 3.92 109.011 177.169 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -83.91 6.2 22.55 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.948 -0.569 . . . . 6.54 111.451 179.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.426 HD21 HD12 ' A' ' 11' ' ' LEU . 3.6 mp -134.98 97.09 13.95 Favored Pre-proline 0 C--O 1.233 0.231 0 N-CA-C 109.761 -0.459 . . . . 3.98 109.761 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -85.21 29.13 0.54 Allowed 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.026 2.484 . . . . 5.66 113.029 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 30.9 p -134.6 117.96 13.35 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.324 -0.398 . . . . 5.81 110.647 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.37 -166.9 0.22 Allowed 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 121.843 1.695 . . . . 5.16 110.994 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.612 ' SG ' ' HB2' ' A' ' 8' ' ' ARG . 4.0 t -126.4 92.53 3.58 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.77 -0.826 . . . . 3.3 108.77 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.46 ' O ' ' CB ' ' A' ' 56' ' ' SER . 33.4 tt0 53.93 -97.88 0.07 Allowed 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 117.694 -1.603 . . . . 5.32 110.52 -178.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.46 ' CB ' ' O ' ' A' ' 55' ' ' GLN . 1.9 t 92.55 142.3 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.687 0.795 . . . . 4.04 110.835 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.478 ' O ' ' HB2' ' A' ' 66' ' ' ARG . . . -66.12 120.44 15.93 Favored Glycine 0 N--CA 1.429 -1.782 0 C-N-CA 120.213 -0.994 . . . . 2.88 110.827 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.61 77.58 6.21 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 107.886 -1.153 . . . . 5.79 107.886 179.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.473 ' O ' ' HA ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -146.33 58.26 4.45 Favored Pre-proline 0 C--N 1.306 -1.318 0 CA-C-N 114.933 -1.03 . . . . 6.52 108.868 -179.524 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 59' ' ' LYS . 36.8 Cg_endo -64.63 85.5 0.17 Allowed 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.584 2.189 . . . . 2.54 112.235 179.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.506 ' N ' ' O ' ' A' ' 65' ' ' GLY . 0.5 OUTLIER -108.41 -179.4 3.87 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.624 -0.717 . . . . 2.8 109.083 179.44 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.08 -161.01 44.94 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 117.859 -2.115 . . . . 2.47 111.816 178.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 50.9 m -78.79 45.33 0.59 Allowed 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 120.689 0.281 . . . . 3.61 111.637 -179.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 105.28 16.07 17.53 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 120.945 -0.645 . . . . 2.33 114.674 178.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.506 ' O ' ' N ' ' A' ' 61' ' ' CYS . . . -103.7 132.85 11.22 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 119.822 -1.18 . . . . 1.92 114.738 -179.268 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.478 ' HB2' ' O ' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -93.61 159.16 15.34 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 122.49 0.316 . . . . 3.78 110.95 178.335 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 13.8 t -70.05 106.37 3.21 Favored 'General case' 0 N--CA 1.432 -1.363 0 C-N-CA 119.782 -0.767 . . . . 1.76 109.438 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -93.15 -17.57 23.59 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.906 0.384 . . . . 1.71 110.613 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.628 ' HB3' ' HA2' ' A' ' 33' ' ' GLY . . . -168.11 164.21 13.45 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 115.969 -0.56 . . . . 1.37 110.377 -178.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 1.011 ' HB1' ' HB3' ' A' ' 89' ' ' ALA . . . -45.17 121.76 3.04 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 114.218 1.192 . . . . 1.96 114.218 -177.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.649 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . 59.86 31.44 71.96 Favored Glycine 0 CA--C 1.506 -0.526 0 CA-C-N 113.479 -1.691 . . . . 1.71 115.673 176.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.62 ' CD1' ' HB2' ' A' ' 34' ' ' CYS . 1.3 pt -142.37 112.6 2.73 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-O 122.015 0.912 . . . . 2.58 111.976 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.731 ' HB2' ' HB3' ' A' ' 82' ' ' ASP . 0.0 OUTLIER -93.07 94.2 8.73 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 114.72 -1.127 . . . . 1.72 109.14 179.302 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.553 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 43.7 m -102.4 147.94 26.1 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.295 0.569 . . . . 1.89 111.469 -179.19 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.48 ' CB ' ' HD2' ' A' ' 76' ' ' PRO . 0.3 OUTLIER -122.64 -179.12 0.72 Allowed Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 114.632 -1.167 . . . . 2.53 108.813 179.615 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.48 ' HD2' ' CB ' ' A' ' 75' ' ' SER . 58.0 Cg_endo -74.26 32.6 0.34 Allowed 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 121.883 1.722 . . . . 3.07 112.954 -179.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.452 ' HB3' ' NE2' ' B' ' 180' ' ' HIS . 5.4 m-20 -147.54 -49.68 0.18 Allowed 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.876 -0.602 . . . . 2.63 111.002 178.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.563 ' HA3' ' O ' ' B' ' 179' ' ' CYS . . . -143.69 -152.2 5.61 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 120.412 -0.899 . . . . 0.9 113.727 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.554 ' O ' ' HA3' ' B' ' 178' ' ' GLY . 5.0 m -138.46 149.82 45.84 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.045 -0.578 . . . . 1.23 110.156 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.636 ' O ' ' N ' ' A' ' 73' ' ' CYS . 0.1 OUTLIER -147.41 145.46 29.24 Favored 'General case' 0 CA--C 1.513 -0.474 0 O-C-N 121.516 -0.74 . . . . 3.88 111.408 -178.404 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -67.95 144.58 55.14 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.344 -0.613 . . . . 2.9 109.344 178.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.731 ' HB3' ' HB2' ' A' ' 73' ' ' CYS . 2.2 p-10 -146.34 121.2 5.41 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 116.066 -0.515 . . . . 2.52 110.055 -177.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -61.83 -15.08 40.4 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.776 2.317 . . . . 3.27 114.385 -178.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.16 -44.84 78.74 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.908 0.385 . . . . 2.78 111.814 -179.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 1.039 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 14.0 m -106.04 26.16 10.06 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.681 0.753 . . . . 2.16 109.919 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.627 ' N ' ' HD2' ' A' ' 87' ' ' PRO . 11.6 t0 -85.5 -45.73 0.63 Allowed Pre-proline 0 C--N 1.309 -1.175 0 O-C-N 121.308 -0.87 . . . . 3.14 112.425 -179.063 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 1.047 ' O ' ' N ' ' A' ' 89' ' ' ALA . 6.1 Cg_exo -59.39 132.5 46.68 Favored 'Trans proline' 0 CA--C 1.483 -2.054 0 N-CA-C 106.688 -2.082 . . . . 3.55 106.688 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.995 ' C ' ' O ' ' A' ' 87' ' ' PRO . 34.3 mm-40 -5.97 75.17 0.0 OUTLIER 'General case' 0 N--CA 1.409 -2.495 0 N-CA-C 101.704 -3.443 . . . . 6.0 101.704 -178.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 1.047 ' N ' ' O ' ' A' ' 87' ' ' PRO . . . -32.91 -30.99 0.01 OUTLIER 'General case' 0 CA--C 1.494 -1.199 0 CA-C-N 113.141 -1.845 . . . . 6.54 111.642 -170.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.58 ' N ' ' O ' ' A' ' 88' ' ' GLU . . . -90.44 166.72 13.1 Favored 'General case' 0 N--CA 1.423 -1.799 0 N-CA-C 103.262 -2.866 . . . . 8.02 103.262 174.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.497 ' O ' ' O ' ' A' ' 92' ' ' SER . 2.7 m-85 -85.86 78.37 9.53 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 121.943 2.156 . . . . 12.84 112.35 -179.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.497 ' O ' ' O ' ' A' ' 91' ' ' PHE . 9.4 t . . . . . 0 C--O 1.246 0.888 0 CA-C-O 118.134 -0.936 . . . . 12.79 111.268 178.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.264 0 CA-C-O 121.548 0.69 . . . . 9.09 111.11 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 6.0 t 60.82 117.42 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.523 0 CA-C-O 123.637 1.684 . . . . 7.52 112.132 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 103' ' ' LEU . . . . . 1.022 HD11 HD11 ' B' ' 105' ' ' LEU . 2.1 pt? -145.98 139.46 26.17 Favored 'General case' 0 C--N 1.282 -2.336 1 N-CA-C 99.463 -4.273 . . . . 4.98 99.463 175.486 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.93 64.23 0.02 OUTLIER 'General case' 0 N--CA 1.429 -1.518 0 C-N-CA 117.647 -1.621 . . . . 6.19 111.073 -173.104 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . 1.022 HD11 HD11 ' B' ' 103' ' ' LEU . 70.4 mt -154.3 -83.76 0.07 Allowed 'General case' 1 N--CA 1.372 -4.375 0 CA-C-O 122.825 1.297 . . . . 6.7 111.23 -179.125 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 106' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -169.15 -54.34 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 113.022 -1.899 . . . . 7.05 113.053 -177.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 107' ' ' VAL . . . . . 0.606 ' N ' HD22 ' B' ' 103' ' ' LEU . 8.3 p -147.43 119.08 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.794 0 CA-C-O 121.526 0.679 . . . . 6.71 109.439 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 108' ' ' ARG . . . . . 0.686 ' HA ' HD12 ' B' ' 103' ' ' LEU . 0.0 OUTLIER -77.33 104.12 7.66 Favored 'General case' 0 N--CA 1.401 -2.91 0 CA-C-N 114.306 -1.316 . . . . 8.05 109.749 179.457 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 4.4 t -107.05 95.25 5.59 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 103.642 -2.725 . . . . 4.37 103.642 171.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 110' ' ' CYS . . . . . . . . . . . . . 1.3 m -75.71 79.27 2.67 Favored 'General case' 0 CA--C 1.552 1.037 0 CA-C-N 112.633 -2.076 . . . . 2.9 113.097 -175.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 111' ' ' LEU . . . . . 0.598 ' O ' ' HA ' ' B' ' 120' ' ' ARG . 0.7 OUTLIER -33.78 112.82 0.41 Allowed Pre-proline 0 N--CA 1.483 1.214 0 CA-C-N 118.554 0.616 . . . . 3.25 112.485 179.533 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 112' ' ' PRO . . . . . 0.46 ' CB ' ' O ' ' B' ' 117' ' ' GLY . 73.3 Cg_endo -75.87 119.44 5.4 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.7 2.267 . . . . 1.94 114.171 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . . . . . . . . . 4.3 p -133.09 -178.16 4.84 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 120.502 -0.479 . . . . 1.29 112.137 178.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 114' ' ' GLY . . . . . 0.463 ' HA2' ' HB3' ' B' ' 140' ' ' GLU . . . 77.17 -162.23 51.25 Favored Glycine 0 CA--C 1.522 0.5 0 CA-C-N 116.037 -0.529 . . . . 1.2 111.999 -177.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 115' ' ' PRO . . . . . 0.496 ' O ' ' HG2' ' B' ' 115' ' ' PRO . 45.1 Cg_endo -66.19 99.32 0.41 Allowed 'Trans proline' 0 N--CA 1.478 0.588 0 C-N-CA 124.089 3.192 . . . . 1.86 112.089 177.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 89.12 5.95 72.33 Favored Glycine 0 C--N 1.298 -1.541 0 CA-C-N 115.404 -0.816 . . . . 2.16 113.436 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 117' ' ' GLY . . . . . 0.46 ' O ' ' CB ' ' B' ' 112' ' ' PRO . . . 72.24 45.03 41.52 Favored Glycine 0 N--CA 1.425 -2.064 0 C-N-CA 120.386 -0.911 . . . . 1.48 115.268 177.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 118' ' ' LYS . . . . . 0.447 ' HB2' ' CD1' ' B' ' 132' ' ' LEU . 0.4 OUTLIER -94.29 -24.67 17.34 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 121.153 0.502 . . . . 3.51 111.94 -179.601 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . -78.84 173.06 55.35 Favored Glycine 0 N--CA 1.438 -1.227 0 C-N-CA 120.589 -0.815 . . . . 1.26 111.893 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.598 ' HA ' ' O ' ' B' ' 111' ' ' LEU . 0.7 OUTLIER -120.85 149.0 43.27 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 110.024 -0.362 . . . . 3.03 110.024 -179.508 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 121' ' ' CYS . . . . . . . . . . . . . 57.3 m -98.16 127.63 44.21 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 119.639 -0.825 . . . . 1.21 110.203 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 122' ' ' PHE . . . . . 0.454 ' CE2' ' HB1' ' B' ' 168' ' ' ALA . 3.5 m-85 -110.9 -28.41 8.38 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 114.413 -1.267 . . . . 2.99 111.657 -177.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -158.12 -175.65 29.29 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 121.149 -0.548 . . . . 1.07 112.445 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -52.42 -54.09 5.78 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 122.85 2.366 . . . . 1.14 113.447 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 125' ' ' SER . . . . . 0.57 ' O ' ' N ' ' B' ' 137' ' ' GLY . 1.0 OUTLIER -121.0 36.77 4.5 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 122.413 -0.18 . . . . 1.24 110.961 179.671 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 126' ' ' ILE . . . . . 0.451 HG12 HG13 ' B' ' 136' ' ' VAL . 16.0 mt -139.72 111.02 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 C-N-CA 120.499 -0.48 . . . . 1.4 112.047 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 127' ' ' CYS . . . . . 0.559 ' SG ' ' O ' ' B' ' 120' ' ' ARG . 0.5 OUTLIER -127.55 119.74 26.66 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 110.099 -0.334 . . . . 1.19 110.099 179.677 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 128' ' ' CYS . . . . . 0.932 ' HA ' ' O ' ' B' ' 133' ' ' GLY . 0.0 OUTLIER -130.09 128.18 41.36 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 119.952 -0.699 . . . . 1.21 112.608 -178.941 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 129' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' B' ' 133' ' ' GLY . . . -105.48 -169.19 23.72 Favored Glycine 0 N--CA 1.418 -2.506 0 C-N-CA 120.065 -1.064 . . . . 0.87 111.989 178.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -70.41 -51.62 28.21 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 115.126 -0.537 . . . . 2.63 112.351 -177.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.8 30.61 5.46 Favored 'General case' 0 CA--C 1.503 -0.861 0 N-CA-C 108.861 -0.792 . . . . 2.1 108.861 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 132' ' ' LEU . . . . . 0.447 ' CD1' ' HB2' ' B' ' 118' ' ' LYS . 3.8 mt -127.06 -7.8 5.98 Favored 'General case' 0 N--CA 1.396 -3.159 0 N-CA-C 106.752 -1.573 . . . . 1.62 106.752 177.374 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 133' ' ' GLY . . . . . 0.932 ' O ' ' HA ' ' B' ' 128' ' ' CYS . . . 61.87 -136.36 46.4 Favored Glycine 0 N--CA 1.427 -1.942 0 CA-C-N 115.283 -0.871 . . . . 0.74 113.851 176.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 134' ' ' CYS . . . . . 0.618 ' HB2' ' CD1' ' B' ' 172' ' ' ILE . 1.6 t -134.36 126.24 29.23 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 114.5 1.296 . . . . 0.96 114.5 -178.044 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 135' ' ' PHE . . . . . 0.467 ' CD1' ' N ' ' B' ' 135' ' ' PHE . 4.8 m-85 -99.28 101.09 12.28 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 104.455 -2.424 . . . . 2.69 104.455 176.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 136' ' ' VAL . . . . . 0.572 HG23 HG23 ' A' ' 36' ' ' VAL . 38.3 t -85.58 93.76 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 CA-C-O 122.97 1.367 . . . . 1.2 110.072 -178.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 137' ' ' GLY . . . . . 0.57 ' N ' ' O ' ' B' ' 125' ' ' SER . . . 75.32 84.75 0.35 Allowed Glycine 0 CA--C 1.502 -0.729 0 CA-C-N 112.136 -2.302 . . . . 1.33 112.448 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 138' ' ' THR . . . . . . . . . . . . . 19.1 p -150.22 169.64 20.85 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 120.9 0.381 . . . . 1.68 111.172 -179.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -55.39 -27.65 49.0 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.038 -0.528 . . . . 1.73 110.805 179.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 140' ' ' GLU . . . . . 0.463 ' HB3' ' HA2' ' B' ' 114' ' ' GLY . 30.2 mp0 -73.52 -29.14 62.28 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 112.542 0.571 . . . . 2.53 112.542 -179.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -97.47 -0.91 45.28 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 120.713 0.292 . . . . 1.45 110.489 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 1.6 mt -58.02 -33.05 68.53 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 121.031 0.443 . . . . 2.47 110.318 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 143' ' ' ARG . . . . . . . . . . . . . 2.0 ptm85 -71.96 -9.2 58.03 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.883 -0.599 . . . . 4.3 110.606 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 144' ' ' CYS . . . . . . . . . . . . . 94.2 m -69.48 -9.89 55.71 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 120.169 -0.613 . . . . 1.37 111.414 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -55.04 -24.96 27.41 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.072 0.463 . . . . 3.26 110.802 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -85.81 5.41 32.7 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 116.351 -0.386 . . . . 3.53 110.495 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -80.49 -7.49 59.2 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 108.879 -0.786 . . . . 2.81 108.879 178.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 148' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -74.0 -28.62 61.54 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 108.76 -0.83 . . . . 3.92 108.76 177.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -84.0 6.71 20.96 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.914 -0.585 . . . . 6.5 111.377 179.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 2.9 mp -135.46 96.67 13.59 Favored Pre-proline 0 C--O 1.233 0.223 0 N-CA-C 109.87 -0.418 . . . . 3.82 109.87 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 151' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -85.53 29.62 0.52 Allowed 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.941 2.428 . . . . 5.67 112.97 -179.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 51.6 p -135.28 117.65 12.52 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.359 -0.382 . . . . 5.9 110.496 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 153' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.77 -167.97 0.25 Allowed 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.036 1.824 . . . . 5.17 111.194 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 154' ' ' CYS . . . . . 0.59 ' SG ' ' HB2' ' B' ' 108' ' ' ARG . 4.0 t -125.61 90.4 3.21 Favored 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 109.189 -0.671 . . . . 3.29 109.189 179.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 155' ' ' GLN . . . . . 0.715 ' H ' HD13 ' B' ' 103' ' ' LEU . 37.1 tt0 55.12 -98.23 0.08 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 118.4 -1.32 . . . . 5.33 109.783 -178.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 156' ' ' SER . . . . . 0.494 ' CB ' ' O ' ' B' ' 155' ' ' GLN . 1.8 t 92.95 137.55 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.235 0.614 . . . . 4.25 111.007 178.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 157' ' ' GLY . . . . . 0.436 ' O ' ' HB2' ' B' ' 166' ' ' ARG . . . -62.04 120.62 22.79 Favored Glycine 0 N--CA 1.441 -0.971 0 C-N-CA 120.159 -1.02 . . . . 2.89 111.025 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.36 60.11 3.67 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.691 0.758 . . . . 5.82 110.27 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 159' ' ' LYS . . . . . 0.551 ' HB2' ' CB ' ' B' ' 167' ' ' CYS . 0.1 OUTLIER -115.42 55.41 1.01 Allowed Pre-proline 0 N--CA 1.443 -0.778 0 CA-C-N 114.766 -1.107 . . . . 6.5 111.541 176.076 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 160' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -63.09 85.57 0.12 Allowed 'Trans proline' 0 CA--C 1.531 0.336 0 CA-C-N 121.306 1.502 . . . . 2.53 113.794 -178.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 161' ' ' CYS . . . . . 0.512 ' N ' ' O ' ' B' ' 165' ' ' GLY . 0.5 OUTLIER -109.61 -179.65 3.88 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.05 -0.523 . . . . 2.76 109.705 179.504 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 66.68 -160.75 47.14 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 118.26 -1.924 . . . . 2.45 111.642 178.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 39.0 m -78.57 43.77 0.49 Allowed 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 116.802 0.301 . . . . 3.61 111.53 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 106.86 15.9 15.35 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 120.74 -0.743 . . . . 2.31 114.588 178.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 165' ' ' GLY . . . . . 0.512 ' O ' ' N ' ' B' ' 161' ' ' CYS . . . -103.61 134.08 11.74 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.044 -1.074 . . . . 1.89 114.444 -179.321 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 166' ' ' ARG . . . . . 0.496 ' HA ' ' O ' ' B' ' 159' ' ' LYS . 0.0 OUTLIER -95.27 158.64 15.37 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 115.415 -0.393 . . . . 3.77 110.875 178.254 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 167' ' ' CYS . . . . . 0.551 ' CB ' ' HB2' ' B' ' 159' ' ' LYS . 14.1 t -70.17 106.1 3.17 Favored 'General case' 0 N--CA 1.435 -1.218 0 C-N-CA 119.731 -0.788 . . . . 1.73 109.342 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 168' ' ' ALA . . . . . 0.454 ' HB1' ' CE2' ' B' ' 122' ' ' PHE . . . -93.12 -18.81 22.15 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.205 0.526 . . . . 1.59 110.782 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 169' ' ' ALA . . . . . 0.676 ' CB ' ' HA2' ' B' ' 133' ' ' GLY . . . -165.63 164.94 19.09 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 115.466 -0.788 . . . . 1.55 110.53 -178.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 170' ' ' ALA . . . . . 0.943 ' CB ' ' HB3' ' B' ' 189' ' ' ALA . . . -46.89 121.71 3.82 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 114.762 1.393 . . . . 1.84 114.762 -177.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 171' ' ' GLY . . . . . 0.759 ' N ' ' O ' ' B' ' 185' ' ' CYS . . . 61.83 29.66 72.94 Favored Glycine 0 C--N 1.315 -0.633 0 CA-C-N 113.974 -1.466 . . . . 1.7 115.896 177.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 172' ' ' ILE . . . . . 0.618 ' CD1' ' HB2' ' B' ' 134' ' ' CYS . 1.3 pt -142.58 113.71 2.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 118.331 1.066 . . . . 2.72 111.95 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 173' ' ' CYS . . . . . 0.774 ' HB2' ' HB3' ' B' ' 182' ' ' ASP . 0.0 OUTLIER -94.22 93.93 8.05 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 114.56 -1.2 . . . . 1.73 108.81 179.692 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 174' ' ' CYS . . . . . 0.581 ' HA ' ' HA ' ' B' ' 179' ' ' CYS . 37.2 m -102.22 148.0 25.96 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.458 0.646 . . . . 1.87 111.745 -179.013 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 175' ' ' SER . . . . . 0.486 ' CB ' ' HD2' ' B' ' 176' ' ' PRO . 0.3 OUTLIER -122.88 -179.26 0.76 Allowed Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 114.627 -1.169 . . . . 2.53 108.914 179.792 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 176' ' ' PRO . . . . . 0.486 ' HD2' ' CB ' ' B' ' 175' ' ' SER . 57.9 Cg_endo -74.02 32.61 0.34 Allowed 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 121.811 1.674 . . . . 3.04 113.044 -179.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 177' ' ' ASP . . . . . 0.433 ' HB3' ' NE2' ' A' ' 80' ' ' HIS . 5.1 m-20 -147.69 -49.53 0.17 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.915 -0.584 . . . . 2.66 110.949 178.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 178' ' ' GLY . . . . . 0.554 ' HA3' ' O ' ' A' ' 79' ' ' CYS . . . -143.49 -151.57 5.49 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 120.492 -0.861 . . . . 0.91 113.944 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 179' ' ' CYS . . . . . 0.581 ' HA ' ' HA ' ' B' ' 174' ' ' CYS . 4.8 m -139.42 149.24 43.83 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 114.879 -0.66 . . . . 1.24 110.095 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 180' ' ' HIS . . . . . 0.613 ' O ' ' N ' ' B' ' 173' ' ' CYS . 0.1 OUTLIER -146.88 145.74 29.94 Favored 'General case' 0 CA--C 1.511 -0.547 0 C-N-CA 119.807 -0.757 . . . . 3.87 111.41 -178.436 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 181' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -67.9 145.26 54.75 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 120.175 -0.61 . . . . 2.9 109.48 178.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 182' ' ' ASP . . . . . 0.774 ' HB3' ' HB2' ' B' ' 173' ' ' CYS . 1.8 p-10 -146.9 121.05 5.11 Favored Pre-proline 0 C--N 1.319 -0.753 0 CA-C-N 116.196 -0.456 . . . . 2.49 110.412 -178.005 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 183' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -61.51 -14.8 37.35 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 122.653 2.236 . . . . 3.23 114.448 -178.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -67.55 -44.98 76.97 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.846 0.355 . . . . 2.72 111.647 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 185' ' ' CYS . . . . . 0.97 ' O ' ' HB1' ' B' ' 189' ' ' ALA . 11.9 m -106.91 28.87 7.56 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.629 0.728 . . . . 2.13 110.767 -179.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 186' ' ' ASP . . . . . 0.635 ' N ' ' HD2' ' B' ' 187' ' ' PRO . 11.8 t0 -89.05 -46.21 0.43 Allowed Pre-proline 0 C--N 1.319 -0.738 0 CA-C-N 115.835 -0.62 . . . . 3.11 112.52 -179.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 187' ' ' PRO . . . . . 1.093 ' O ' ' N ' ' B' ' 189' ' ' ALA . 3.5 Cg_exo -57.27 136.95 79.37 Favored 'Trans proline' 0 CA--C 1.484 -1.984 0 N-CA-C 105.257 -2.632 . . . . 3.51 105.257 178.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 188' ' ' GLU . . . . . 1.158 ' O ' ' O ' ' B' ' 190' ' ' ALA . 24.5 mm-40 -11.1 79.06 0.0 OUTLIER 'General case' 0 CA--C 1.471 -2.076 0 N-CA-C 101.682 -3.451 . . . . 5.97 101.682 -178.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 189' ' ' ALA . . . . . 1.093 ' N ' ' O ' ' B' ' 187' ' ' PRO . . . -36.96 -27.4 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 114.051 -1.431 . . . . 6.55 111.609 -170.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 190' ' ' ALA . . . . . 1.158 ' O ' ' O ' ' B' ' 188' ' ' GLU . . . -92.37 164.36 13.53 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 103.205 -2.887 . . . . 8.01 103.205 173.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 191' ' ' PHE . . . . . 0.535 ' O ' ' O ' ' B' ' 192' ' ' SER . 2.5 m-85 -84.73 77.95 9.97 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 121.853 2.115 . . . . 12.83 112.537 -179.178 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 192' ' ' SER . . . . . 0.535 ' O ' ' O ' ' B' ' 191' ' ' PHE . 9.1 t . . . . . 0 C--O 1.244 0.815 0 CA-C-O 118.022 -0.99 . . . . 12.79 111.375 178.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.594 ' O ' ' CG1' ' A' ' 2' ' ' VAL . . . . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.501 0.191 . . . . 10.31 111.242 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.594 ' CG1' ' O ' ' A' ' 1' ' ' ALA . 1.0 OUTLIER 88.91 57.44 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 C-N-CA 124.265 1.026 . . . . 8.37 112.915 -179.875 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.625 ' HG ' ' CB ' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -169.72 102.43 0.32 Allowed 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 108.433 -0.951 . . . . 6.25 108.433 177.684 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.452 ' HB2' ' HG2' ' A' ' 55' ' ' GLN . 0.2 OUTLIER -92.6 8.28 39.68 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 116.876 2.176 . . . . 6.22 116.876 -174.13 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.798 HD21 ' HB2' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -80.78 -70.64 0.51 Allowed 'General case' 0 N--CA 1.424 -1.742 0 CA-C-N 121.17 1.805 . . . . 7.57 110.449 -178.969 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.798 ' HB2' HD21 ' A' ' 5' ' ' LEU . 0.2 OUTLIER -156.4 -117.77 0.03 OUTLIER 'General case' 0 C--N 1.267 -3.014 0 N-CA-C 101.597 -3.483 . . . . 8.78 101.597 -178.62 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.591 ' O ' HD22 ' A' ' 5' ' ' LEU . 2.5 m -84.55 176.03 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.482 -1.664 0 N-CA-C 103.936 -2.616 . . . . 7.88 103.936 179.065 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.625 ' CB ' ' HG ' ' A' ' 3' ' ' LEU . 2.8 mtm-85 -73.65 108.5 6.53 Favored 'General case' 0 N--CA 1.426 -1.668 1 CA-C-N 126.481 4.219 . . . . 9.7 107.538 179.132 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.474 ' O ' ' HB2' ' A' ' 54' ' ' CYS . 28.8 m -107.44 97.28 7.05 Favored 'General case' 0 N--CA 1.423 -1.814 0 C-N-CA 114.557 -2.857 . . . . 6.05 103.973 171.036 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.761 ' HA ' ' HB2' ' A' ' 54' ' ' CYS . 8.4 m -83.09 77.7 9.71 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 115.944 1.831 . . . . 2.89 115.944 179.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.513 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -31.56 110.88 0.3 Allowed Pre-proline 0 N--CA 1.48 1.054 0 CA-C-N 119.055 0.843 . . . . 2.89 110.125 178.739 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.627 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 41.5 Cg_endo -99.98 139.49 0.28 Allowed 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.143 1.896 . . . . 1.72 116.758 -177.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.461 ' HA ' ' HD2' ' A' ' 43' ' ' ARG . 2.4 p -134.59 -165.75 1.71 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 118.674 -1.21 . . . . 1.0 109.866 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.441 ' HA2' ' HG2' ' A' ' 40' ' ' GLU . . . 64.65 -159.45 42.37 Favored Glycine 0 CA--C 1.499 -0.939 0 C-N-CA 121.365 -0.445 . . . . 1.15 113.527 176.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.435 ' C ' ' H ' ' A' ' 17' ' ' GLY . 42.7 Cg_endo -64.75 138.19 57.31 Favored 'Trans proline' 0 N--CA 1.443 -1.448 0 C-N-CA 122.25 1.967 . . . . 1.6 109.029 176.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 55.93 -6.58 0.01 OUTLIER Glycine 0 C--N 1.273 -2.965 0 CA-C-N 114.055 -1.43 . . . . 1.68 114.029 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.435 ' H ' ' C ' ' A' ' 15' ' ' PRO . . . 69.66 40.98 76.53 Favored Glycine 1 N--CA 1.387 -4.567 0 C-N-CA 116.947 -2.549 . . . . 1.37 108.871 -178.455 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.495 ' HB2' HD12 ' A' ' 32' ' ' LEU . 1.6 mttp -93.59 -10.91 33.08 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 111.677 -2.262 . . . . 2.91 113.24 179.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.627 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -122.85 179.0 16.27 Favored Glycine 0 N--CA 1.44 -1.051 0 N-CA-C 106.539 -2.624 . . . . 1.06 106.539 178.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.513 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 0.3 OUTLIER -122.55 170.23 10.21 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 119.95 1.875 . . . . 3.32 112.274 -178.98 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.438 ' SG ' ' O ' ' A' ' 23' ' ' GLY . 20.2 t -114.66 150.76 34.68 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.735 0.303 . . . . 1.19 111.796 -179.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.683 ' CE1' HG21 ' A' ' 26' ' ' ILE . 28.5 p90 -131.85 -49.56 0.96 Allowed 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 108.704 -0.85 . . . . 2.26 108.704 177.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.438 ' O ' ' SG ' ' A' ' 21' ' ' CYS . . . -99.29 -154.87 28.54 Favored Glycine 0 N--CA 1.448 -0.553 0 N-CA-C 109.007 -1.637 . . . . 1.05 109.007 176.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -94.18 -60.55 0.01 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.032 0 CA-C-N 119.829 1.814 . . . . 1.81 112.14 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.636 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.6 OUTLIER -90.92 9.82 28.95 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-O 120.615 0.245 . . . . 1.62 110.403 179.05 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.739 HG12 HG13 ' A' ' 36' ' ' VAL . 1.5 mt -120.08 118.08 55.71 Favored 'Isoleucine or valine' 0 C--O 1.245 0.854 0 CA-C-O 122.061 0.934 . . . . 1.39 112.311 -177.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.744 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 0.7 OUTLIER -134.83 130.47 36.09 Favored 'General case' 0 C--O 1.223 -0.31 0 CA-C-N 114.238 -1.346 . . . . 0.92 110.556 -179.492 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 1.106 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -132.4 172.65 12.2 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-O 123.155 1.455 . . . . 1.28 114.167 -178.086 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.519 ' O ' ' HB1' ' A' ' 69' ' ' ALA . . . -156.87 176.0 34.26 Favored Glycine 0 N--CA 1.429 -1.812 0 CA-C-N 111.664 -2.517 . . . . 0.71 108.602 178.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -62.17 -53.0 61.54 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 121.964 0.888 . . . . 2.27 110.453 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.29 11.69 14.11 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 113.79 -1.55 . . . . 1.66 109.402 179.027 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.495 HD12 ' HB2' ' A' ' 18' ' ' LYS . 0.5 OUTLIER -106.47 -4.2 20.09 Favored 'General case' 0 N--CA 1.412 -2.352 0 N-CA-C 106.897 -1.519 . . . . 1.93 106.897 179.275 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 1.106 ' O ' ' HA ' ' A' ' 28' ' ' CYS . . . 46.76 -140.59 6.77 Favored Glycine 0 N--CA 1.419 -2.441 0 CA-C-N 113.67 -1.604 . . . . 0.77 113.028 178.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.744 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 0.5 OUTLIER -138.23 122.16 17.77 Favored 'General case' 0 CA--C 1.493 -1.234 0 N-CA-C 113.168 0.803 . . . . 1.08 113.168 179.709 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.926 ' HA ' ' HA ' ' B' ' 135' ' ' PHE . 0.0 OUTLIER -88.8 106.2 18.21 Favored 'General case' 0 N--CA 1.423 -1.81 0 N-CA-C 104.22 -2.511 . . . . 1.85 104.22 175.437 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.739 HG13 HG12 ' A' ' 26' ' ' ILE . 1.4 t -96.09 83.71 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 N-CA-C 107.734 -1.21 . . . . 1.29 107.734 -179.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.699 ' O ' ' HA3' ' B' ' 133' ' ' GLY . . . 103.01 92.57 2.23 Favored Glycine 0 CA--C 1.531 1.073 0 CA-C-N 112.955 -1.929 . . . . 0.85 114.259 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.401 ' CG2' ' CB ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER 177.86 167.1 0.72 Allowed 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 108.808 -0.812 . . . . 1.3 108.808 178.455 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.767 ' CA ' HD22 ' A' ' 42' ' ' LEU . . . -61.24 -16.77 48.69 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 119.996 1.271 . . . . 1.45 111.677 179.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.65 ' HB3' ' CD2' ' A' ' 35' ' ' PHE . 5.0 mt-10 -64.19 -14.95 58.68 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.629 -0.508 . . . . 2.32 109.629 178.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.581 ' O ' ' HB3' ' A' ' 44' ' ' CYS . . . -126.1 -4.81 6.8 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 115.67 -0.696 . . . . 1.11 111.949 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.767 HD22 ' CA ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -73.95 -36.3 64.62 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 108.218 -1.03 . . . . 1.68 108.218 179.231 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.461 ' HD2' ' HA ' ' A' ' 13' ' ' CYS . 1.2 ptp180 -63.52 -5.63 4.08 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 114.31 -1.313 . . . . 3.4 109.529 178.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.581 ' HB3' ' O ' ' A' ' 41' ' ' ALA . 9.3 t -82.2 11.8 4.97 Favored 'General case' 0 N--CA 1.445 -0.701 0 O-C-N 121.572 -0.705 . . . . 1.57 109.166 177.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -73.02 -18.3 61.36 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.945 -0.571 . . . . 3.49 109.477 178.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.42 5.7 33.77 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 119.303 -0.959 . . . . 3.69 109.862 179.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -83.55 0.73 45.34 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.866 -0.607 . . . . 3.99 109.583 177.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -75.32 -28.73 59.78 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 109.38 -0.6 . . . . 4.2 109.38 178.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -113.71 50.24 0.93 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.005 -0.543 . . . . 5.85 110.256 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -141.24 97.0 6.97 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.423 -0.353 . . . . 5.83 111.693 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -87.22 33.92 0.43 Allowed 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.905 2.403 . . . . 5.3 113.162 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.401 ' O ' HD21 ' A' ' 11' ' ' LEU . 46.8 p -127.93 80.4 72.17 Favored Pre-proline 0 N--CA 1.463 0.21 0 CA-C-O 120.657 0.265 . . . . 5.72 110.869 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.51 ' O ' ' HB3' ' A' ' 5' ' ' LEU . 83.7 Cg_endo -87.06 113.72 1.02 Allowed 'Trans proline' 0 CA--C 1.533 0.463 0 C-N-CA 123.186 2.591 . . . . 5.82 114.291 -178.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.761 ' HB2' ' HA ' ' A' ' 10' ' ' CYS . 0.5 OUTLIER -60.14 96.76 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.375 -0.375 . . . . 2.98 109.99 178.377 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.452 ' HG2' ' HB2' ' A' ' 4' ' ' ASP . 6.7 tp-100 -44.99 125.58 5.25 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 119.557 -0.857 . . . . 6.42 111.009 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -170.29 -154.71 0.11 Allowed 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 116.527 -0.306 . . . . 3.36 111.382 -179.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 56.45 58.57 13.66 Favored Glycine 0 N--CA 1.426 -2.033 0 C-N-CA 121.346 -0.454 . . . . 2.3 112.214 176.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 -119.46 70.46 0.85 Allowed 'General case' 0 N--CA 1.435 -1.206 0 CA-C-O 122.82 1.295 . . . . 5.06 107.684 177.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.642 ' N ' ' CD ' ' A' ' 60' ' ' PRO . 2.2 mmpp? -143.68 44.69 0.51 Allowed Pre-proline 0 C--N 1.303 -1.435 0 CA-C-N 112.428 -2.169 . . . . 3.91 108.089 177.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.642 ' CD ' ' N ' ' A' ' 59' ' ' LYS . 1.3 Cg_endo -42.96 114.75 0.47 Allowed 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 123.629 2.886 . . . . 1.74 115.247 -178.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -146.68 170.53 16.76 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 113.357 -1.747 . . . . 1.9 108.19 177.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 71.07 -168.54 50.28 Favored Glycine 0 CA--C 1.494 -1.264 0 C-N-CA 118.704 -1.713 . . . . 2.43 113.63 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 14.4 p -83.29 44.46 0.95 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.015 -0.593 . . . . 4.32 111.692 -178.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 118.26 9.61 9.43 Favored Glycine 0 C--N 1.334 0.455 0 N-CA-C 115.222 0.849 . . . . 2.4 115.222 177.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.633 ' HA3' ' HA ' ' A' ' 75' ' ' SER . . . -105.16 162.29 14.55 Favored Glycine 0 C--N 1.338 0.642 0 CA-C-N 119.202 1.501 . . . . 1.82 115.178 -178.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.1 153.67 21.19 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 108.524 -0.917 . . . . 3.51 108.524 177.068 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.51 ' HA ' ' HA ' ' A' ' 73' ' ' CYS . 50.5 t -58.7 115.57 3.15 Favored 'General case' 0 N--CA 1.426 -1.669 0 N-CA-C 109.217 -0.66 . . . . 1.52 109.217 -179.403 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.49 ' H ' ' HA ' ' A' ' 73' ' ' CYS . . . -62.88 -48.37 79.3 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 106.875 -1.528 . . . . 1.5 106.875 178.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.705 ' CB ' ' HA2' ' A' ' 33' ' ' GLY . . . -167.8 163.92 14.15 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 112.9 -1.954 . . . . 1.31 110.736 -174.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 1.029 ' HA ' ' HB3' ' A' ' 85' ' ' CYS . . . -43.96 130.61 5.85 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.428 0.632 . . . . 1.5 112.298 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.727 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . 80.23 -26.09 3.04 Favored Glycine 0 CA--C 1.522 0.481 0 CA-C-N 115.006 -0.997 . . . . 1.44 115.059 177.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.609 ' CD1' ' HB2' ' A' ' 34' ' ' CYS . 1.2 pp -129.25 116.59 40.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 122.319 1.057 . . . . 2.77 111.021 -179.149 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.51 ' HA ' ' HA ' ' A' ' 67' ' ' CYS . 1.6 t -106.13 112.45 25.48 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.175 -1.375 . . . . 1.98 110.578 -177.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.652 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 3.7 m -84.45 147.85 26.88 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 121.94 0.876 . . . . 1.43 112.752 -177.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.812 ' HB2' ' HD2' ' A' ' 76' ' ' PRO . 12.1 p -122.64 -179.9 0.88 Allowed Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 114.031 -1.44 . . . . 2.37 108.106 178.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.812 ' HD2' ' HB2' ' A' ' 75' ' ' SER . 57.0 Cg_endo -73.73 29.93 0.32 Allowed 'Trans proline' 0 N--CA 1.459 -0.516 0 CA-C-N 119.895 0.998 . . . . 2.09 111.59 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.524 ' H ' ' C ' ' A' ' 75' ' ' SER . 2.5 p30 -145.89 -48.93 0.22 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.607 -0.724 . . . . 2.65 110.63 179.053 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 1.089 ' HA3' ' O ' ' B' ' 179' ' ' CYS . . . -156.3 -140.8 3.05 Favored Glycine 0 C--N 1.336 0.547 0 C-N-CA 120.398 -0.906 . . . . 1.04 113.843 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 1.057 ' O ' ' HA3' ' B' ' 178' ' ' GLY . 0.0 OUTLIER -142.73 153.2 43.11 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.329 -0.436 . . . . 1.42 110.556 -179.826 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 4.2 p-80 -154.36 160.36 41.66 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.096 -0.642 . . . . 2.81 112.008 -178.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.58 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -60.25 140.53 56.98 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.874 -0.603 . . . . 3.05 110.32 179.867 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.466 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 3.7 p-10 -139.75 140.29 24.31 Favored Pre-proline 0 CA--C 1.541 0.598 0 CA-C-N 116.018 -0.537 . . . . 2.02 110.763 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 82' ' ' ASP . 3.2 Cg_exo -77.26 -24.97 8.93 Favored 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 123.159 2.572 . . . . 2.29 114.196 -177.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.37 -43.93 84.57 Favored 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 107.781 -1.192 . . . . 1.53 107.781 178.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 1.029 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 33.2 m -99.95 73.73 1.77 Allowed 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 114.082 -1.417 . . . . 1.88 109.033 177.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 1.009 ' H ' ' HD3' ' A' ' 87' ' ' PRO . 0.2 OUTLIER -171.17 24.19 0.0 OUTLIER Pre-proline 0 C--N 1.312 -1.052 0 CA-C-N 115.558 -0.746 . . . . 3.6 112.01 -179.719 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 1.009 ' HD3' ' H ' ' A' ' 86' ' ' ASP . 15.5 Cg_exo -65.86 -177.33 0.74 Allowed 'Trans proline' 0 CA--C 1.484 -1.987 0 CA-C-N 119.882 0.993 . . . . 3.12 110.406 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.588 ' C ' ' H ' ' A' ' 90' ' ' ALA . 1.7 pt-20 -30.93 -19.88 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 113.66 -1.609 . . . . 4.72 111.075 175.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.803 ' N ' ' O ' ' A' ' 87' ' ' PRO . . . -55.91 7.95 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 113.804 1.039 . . . . 5.29 113.804 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.588 ' H ' ' C ' ' A' ' 88' ' ' GLU . . . -75.26 157.57 34.24 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.145 0.498 . . . . 7.19 111.235 177.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -100.78 99.56 10.1 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.16 -0.927 . . . . 10.7 109.974 177.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 47.1 p . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.205 -0.903 . . . . 11.77 111.021 -179.835 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.496 0 CA-C-O 120.7 0.286 . . . . 10.42 111.114 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 102' ' ' VAL . . . . . 0.439 HG13 ' H ' ' B' ' 103' ' ' LEU . 2.6 t -95.21 -130.61 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.996 0 CA-C-O 121.761 0.791 . . . . 8.81 110.607 179.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 103' ' ' LEU . . . . . 0.715 ' HG ' ' HB3' ' B' ' 108' ' ' ARG . 0.2 OUTLIER -109.28 105.71 15.24 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 106.177 -1.786 . . . . 6.28 106.177 174.992 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 104' ' ' ASP . . . . . 0.609 ' H ' ' HB3' ' B' ' 155' ' ' GLN . 0.6 OUTLIER -82.86 90.64 6.96 Favored 'General case' 0 CA--C 1.513 -0.464 0 C-N-CA 119.655 -0.818 . . . . 6.27 112.213 -175.881 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . 0.529 HD11 ' O ' ' B' ' 107' ' ' VAL . 0.3 OUTLIER -148.75 -75.76 0.17 Allowed 'General case' 0 N--CA 1.408 -2.539 0 CA-C-O 123.382 1.563 . . . . 7.61 108.95 179.033 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 106' ' ' ASP . . . . . 0.588 ' O ' HG11 ' B' ' 107' ' ' VAL . 0.3 OUTLIER 179.48 -34.67 0.01 OUTLIER 'General case' 0 C--N 1.275 -2.663 0 CA-C-N 111.048 -2.796 . . . . 8.55 107.447 -177.926 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 107' ' ' VAL . . . . . 0.588 HG11 ' O ' ' B' ' 106' ' ' ASP . 3.3 m -152.19 170.74 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.473 -2.015 0 N-CA-C 103.85 -2.648 . . . . 7.84 103.85 169.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 108' ' ' ARG . . . . . 0.715 ' HB3' ' HG ' ' B' ' 103' ' ' LEU . 5.6 mtm-85 -75.51 110.88 10.25 Favored 'General case' 0 N--CA 1.428 -1.566 0 CA-C-N 125.956 3.98 . . . . 9.75 106.353 176.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 109' ' ' THR . . . . . 0.466 ' O ' ' HB2' ' B' ' 154' ' ' CYS . 33.5 m -112.0 97.66 6.83 Favored 'General case' 0 CA--C 1.478 -1.797 0 C-N-CA 114.229 -2.989 . . . . 6.13 103.19 171.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 110' ' ' CYS . . . . . 0.763 ' HA ' ' HB2' ' B' ' 154' ' ' CYS . 7.4 m -84.29 78.25 9.83 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-N 112.48 -2.145 . . . . 2.87 115.587 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 111' ' ' LEU . . . . . 0.545 ' O ' ' HA ' ' B' ' 120' ' ' ARG . 0.0 OUTLIER -31.63 110.34 0.3 Allowed Pre-proline 0 N--CA 1.472 0.668 0 CA-C-N 118.614 0.643 . . . . 2.95 109.821 178.761 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 112' ' ' PRO . . . . . 0.594 ' HA ' ' O ' ' B' ' 119' ' ' GLY . 74.1 Cg_endo -82.3 158.97 17.45 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 124.482 3.455 . . . . 1.71 111.307 -179.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.444 ' HA ' ' HD2' ' B' ' 143' ' ' ARG . 3.2 p -155.93 -168.71 2.85 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 120.427 -1.421 . . . . 1.0 109.351 166.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 114' ' ' GLY . . . . . 0.444 ' CA ' ' HG2' ' B' ' 140' ' ' GLU . . . 64.71 -158.85 43.41 Favored Glycine 0 C--N 1.34 0.752 0 C-N-CA 121.007 -0.616 . . . . 1.16 113.482 176.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 115' ' ' PRO . . . . . 0.51 ' O ' ' N ' ' B' ' 117' ' ' GLY . 56.4 Cg_endo -62.01 143.73 95.47 Favored 'Trans proline' 0 CA--C 1.503 -1.031 0 C-N-CA 122.801 2.334 . . . . 1.6 106.962 176.161 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . 0.402 ' HA3' ' HE3' ' B' ' 118' ' ' LYS . . . 50.0 -4.64 0.01 OUTLIER Glycine 0 N--CA 1.416 -2.662 0 N-CA-C 115.209 0.843 . . . . 1.7 115.209 177.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 117' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' B' ' 115' ' ' PRO . . . 68.18 39.88 88.15 Favored Glycine 1 N--CA 1.394 -4.1 0 C-N-CA 117.102 -2.475 . . . . 1.38 109.623 -178.612 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 118' ' ' LYS . . . . . 0.462 ' HB2' HD12 ' B' ' 132' ' ' LEU . 1.6 mmtp -91.99 -13.87 30.35 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 112.318 -1.941 . . . . 2.96 112.949 -178.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 119' ' ' GLY . . . . . 0.594 ' O ' ' HA ' ' B' ' 112' ' ' PRO . . . -113.57 -171.2 17.64 Favored Glycine 0 CA--C 1.5 -0.847 0 N-CA-C 108.324 -1.91 . . . . 1.07 108.324 178.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.545 ' HA ' ' O ' ' B' ' 111' ' ' LEU . 0.4 OUTLIER -136.77 169.74 17.23 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 121.845 2.823 . . . . 3.29 108.625 178.328 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 121' ' ' CYS . . . . . 0.457 ' SG ' ' O ' ' B' ' 123' ' ' GLY . 19.5 t -114.63 151.87 32.81 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.337 0.495 . . . . 1.21 112.337 -178.306 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 122' ' ' PHE . . . . . 0.675 ' CE1' HG22 ' B' ' 126' ' ' ILE . 28.3 p90 -131.95 -49.66 0.95 Allowed 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 108.696 -0.853 . . . . 2.28 108.696 176.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 123' ' ' GLY . . . . . 0.457 ' O ' ' SG ' ' B' ' 121' ' ' CYS . . . -99.23 -154.84 28.59 Favored Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 109.115 -1.594 . . . . 1.04 109.115 176.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -94.19 -60.66 0.01 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.958 0 CA-C-N 119.816 1.808 . . . . 1.84 112.151 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 125' ' ' SER . . . . . 0.644 ' O ' ' N ' ' B' ' 137' ' ' GLY . 0.6 OUTLIER -90.65 9.89 27.94 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 110.266 -0.272 . . . . 1.49 110.266 179.031 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 126' ' ' ILE . . . . . 0.767 HG12 HG11 ' B' ' 136' ' ' VAL . 1.8 mt -119.98 117.87 55.07 Favored 'Isoleucine or valine' 0 C--O 1.244 0.802 0 CA-C-O 121.962 0.887 . . . . 1.41 112.566 -177.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 127' ' ' CYS . . . . . 0.752 ' O ' ' HA ' ' B' ' 134' ' ' CYS . 0.7 OUTLIER -134.91 130.69 36.29 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-N 114.313 -1.312 . . . . 0.89 110.643 -179.641 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 128' ' ' CYS . . . . . 1.097 ' HA ' ' O ' ' B' ' 133' ' ' GLY . 0.0 OUTLIER -130.96 173.58 10.85 Favored 'General case' 0 CA--C 1.56 1.33 0 CA-C-O 122.814 1.292 . . . . 1.23 114.327 -178.069 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 129' ' ' GLY . . . . . 0.623 ' O ' ' HB3' ' B' ' 169' ' ' ALA . . . -157.32 176.47 34.49 Favored Glycine 0 N--CA 1.427 -1.936 0 CA-C-N 111.643 -2.526 . . . . 0.69 109.045 177.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -62.01 -54.83 36.04 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 109.198 -0.667 . . . . 2.35 109.198 179.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -122.12 29.71 6.91 Favored 'General case' 0 N--CA 1.428 -1.539 0 N-CA-C 108.191 -1.04 . . . . 1.69 108.191 178.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 132' ' ' LEU . . . . . 0.642 HD23 ' CZ ' ' B' ' 135' ' ' PHE . 0.5 OUTLIER -121.09 -3.42 9.57 Favored 'General case' 0 N--CA 1.41 -2.451 0 N-CA-C 104.428 -2.434 . . . . 1.84 104.428 179.103 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 133' ' ' GLY . . . . . 1.097 ' O ' ' HA ' ' B' ' 128' ' ' CYS . . . 42.36 -141.01 1.84 Allowed Glycine 0 N--CA 1.401 -3.664 0 CA-C-N 112.531 -2.122 . . . . 0.76 112.519 176.358 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 134' ' ' CYS . . . . . 0.752 ' HA ' ' O ' ' B' ' 127' ' ' CYS . 0.5 OUTLIER -136.75 122.08 19.34 Favored 'General case' 0 CA--C 1.493 -1.23 0 CA-C-N 118.802 1.301 . . . . 1.08 113.629 -178.515 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 135' ' ' PHE . . . . . 0.926 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -88.08 106.35 18.1 Favored 'General case' 0 N--CA 1.422 -1.829 0 N-CA-C 104.326 -2.472 . . . . 1.83 104.326 175.858 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 136' ' ' VAL . . . . . 0.767 HG11 HG12 ' B' ' 126' ' ' ILE . 1.8 t -95.62 83.69 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 N-CA-C 107.725 -1.213 . . . . 1.29 107.725 -179.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 137' ' ' GLY . . . . . 0.737 ' O ' ' HA3' ' A' ' 33' ' ' GLY . . . 102.53 93.03 2.23 Favored Glycine 0 CA--C 1.531 1.055 0 CA-C-N 113.071 -1.877 . . . . 0.85 114.283 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 138' ' ' THR . . . . . 0.405 ' CG2' ' CB ' ' B' ' 135' ' ' PHE . 0.0 OUTLIER 178.44 169.19 0.82 Allowed 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 108.623 -0.88 . . . . 1.2 108.623 178.576 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 139' ' ' ALA . . . . . 0.838 ' O ' HD21 ' B' ' 142' ' ' LEU . . . -63.77 -15.33 58.4 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 119.616 1.098 . . . . 1.35 111.373 178.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 140' ' ' GLU . . . . . 0.659 ' HB3' ' CD2' ' B' ' 135' ' ' PHE . 5.0 mt-10 -65.24 -15.87 62.94 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.498 -0.556 . . . . 2.31 109.498 178.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 141' ' ' ALA . . . . . 0.637 ' O ' ' HB3' ' B' ' 144' ' ' CYS . . . -122.78 -11.0 8.23 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.995 -0.548 . . . . 1.09 111.695 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 142' ' ' LEU . . . . . 0.838 HD21 ' O ' ' B' ' 139' ' ' ALA . 0.0 OUTLIER -69.22 -37.02 77.85 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.382 -0.97 . . . . 1.61 108.382 -178.681 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 143' ' ' ARG . . . . . 0.444 ' HD2' ' HA ' ' B' ' 113' ' ' CYS . 1.1 ptp180 -64.91 -2.29 2.54 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 114.583 -1.189 . . . . 3.43 109.753 178.132 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 144' ' ' CYS . . . . . 0.637 ' HB3' ' O ' ' B' ' 141' ' ' ALA . 10.3 t -83.4 9.26 11.45 Favored 'General case' 0 N--CA 1.443 -0.786 0 O-C-N 121.556 -0.715 . . . . 1.61 109.125 176.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -71.17 -18.65 62.48 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.598 -0.728 . . . . 3.52 109.711 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.41 5.73 33.61 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 119.234 -0.986 . . . . 3.76 110.035 179.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -83.55 0.73 45.34 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.781 -0.645 . . . . 4.01 109.51 177.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 148' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -75.36 -28.65 59.65 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.35 -0.611 . . . . 4.24 109.35 178.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -113.74 50.17 0.93 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.952 -0.567 . . . . 6.07 110.342 179.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -141.24 97.08 6.95 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.303 -0.408 . . . . 5.86 111.58 -179.358 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 151' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -87.33 33.98 0.43 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.849 2.366 . . . . 5.42 113.068 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 152' ' ' SER . . . . . 0.412 ' O ' HD22 ' B' ' 111' ' ' LEU . 51.1 p -128.0 80.62 71.86 Favored Pre-proline 0 N--CA 1.463 0.207 0 CA-C-O 120.655 0.264 . . . . 6.02 110.868 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 153' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -87.15 114.07 1.03 Allowed 'Trans proline' 0 CA--C 1.533 0.469 0 C-N-CA 123.135 2.556 . . . . 5.87 114.217 -178.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 154' ' ' CYS . . . . . 0.763 ' HB2' ' HA ' ' B' ' 110' ' ' CYS . 0.4 OUTLIER -60.4 98.42 0.06 Allowed 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 109.65 -0.5 . . . . 2.96 109.65 178.207 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 155' ' ' GLN . . . . . 0.609 ' HB3' ' H ' ' B' ' 104' ' ' ASP . 6.7 tp-100 -47.08 126.72 9.48 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 119.551 -0.86 . . . . 6.3 110.721 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -175.63 -162.51 0.1 Allowed 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 110.126 -0.324 . . . . 3.41 110.126 -179.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 64.95 57.13 12.75 Favored Glycine 0 N--CA 1.426 -1.972 0 C-N-CA 120.245 -0.979 . . . . 2.26 112.164 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -120.29 59.83 0.89 Allowed 'General case' 0 N--CA 1.435 -1.19 0 C-N-CA 117.228 -1.789 . . . . 5.03 108.604 176.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 159' ' ' LYS . . . . . 0.564 ' HB2' ' HB3' ' B' ' 167' ' ' CYS . 2.6 mmpp? -118.2 39.23 0.29 Allowed Pre-proline 0 C--N 1.314 -0.943 0 CA-C-N 112.346 -2.206 . . . . 3.96 111.731 171.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 160' ' ' PRO . . . . . 0.454 ' CD ' ' N ' ' B' ' 159' ' ' LYS . 2.3 Cg_endo -41.17 117.21 0.53 Allowed 'Trans proline' 0 C--N 1.34 0.109 0 C-N-CA 122.306 2.004 . . . . 1.7 115.621 -173.06 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 161' ' ' CYS . . . . . 0.466 ' SG ' ' N ' ' B' ' 162' ' ' GLY . 0.1 OUTLIER -138.73 -170.58 2.88 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 113.198 -1.819 . . . . 1.93 108.715 -179.803 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 162' ' ' GLY . . . . . 0.466 ' N ' ' SG ' ' B' ' 161' ' ' CYS . . . 47.9 -166.03 0.17 Allowed Glycine 0 CA--C 1.528 0.864 0 C-N-CA 119.064 -1.541 . . . . 2.37 114.9 171.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 13.8 p -82.35 44.24 0.86 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 114.981 -0.61 . . . . 4.56 112.216 -178.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 119.33 8.93 8.97 Favored Glycine 0 C--N 1.338 0.64 0 N-CA-C 115.15 0.82 . . . . 2.39 115.15 177.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 165' ' ' GLY . . . . . 0.615 ' HA3' ' HA ' ' B' ' 175' ' ' SER . . . -103.61 160.69 16.28 Favored Glycine 0 CA--C 1.521 0.425 0 C-N-CA 119.551 -1.309 . . . . 1.79 115.684 -178.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 166' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.73 153.23 22.14 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 108.342 -0.985 . . . . 3.53 108.342 176.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 167' ' ' CYS . . . . . 0.564 ' HB3' ' HB2' ' B' ' 159' ' ' LYS . 47.5 t -58.31 115.53 3.02 Favored 'General case' 0 N--CA 1.426 -1.629 0 N-CA-C 109.345 -0.613 . . . . 1.56 109.345 -179.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 168' ' ' ALA . . . . . 0.536 ' H ' ' HA ' ' B' ' 173' ' ' CYS . . . -63.26 -47.3 82.97 Favored 'General case' 0 N--CA 1.428 -1.546 0 N-CA-C 107.263 -1.384 . . . . 1.42 107.263 178.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 169' ' ' ALA . . . . . 0.791 ' CB ' ' HA2' ' B' ' 133' ' ' GLY . . . -169.01 164.25 11.39 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.189 -1.369 . . . . 1.18 108.967 -175.034 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 170' ' ' ALA . . . . . 1.041 ' HA ' ' HB3' ' B' ' 185' ' ' CYS . . . -44.07 130.71 6.02 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.469 0.652 . . . . 1.47 112.691 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 171' ' ' GLY . . . . . 0.735 ' N ' ' O ' ' B' ' 185' ' ' CYS . . . 78.4 -21.04 3.78 Favored Glycine 0 CA--C 1.521 0.458 0 CA-C-N 114.845 -1.071 . . . . 1.45 115.511 177.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 172' ' ' ILE . . . . . 0.61 ' CD1' ' HB2' ' B' ' 134' ' ' CYS . 1.2 pp -132.43 116.24 27.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 122.408 1.099 . . . . 2.7 110.747 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 173' ' ' CYS . . . . . 0.536 ' HA ' ' H ' ' B' ' 168' ' ' ALA . 1.5 t -106.5 112.5 25.53 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.083 -1.417 . . . . 1.94 110.686 -177.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 174' ' ' CYS . . . . . 0.677 ' HA ' ' HA ' ' B' ' 179' ' ' CYS . 4.4 m -84.29 148.0 26.91 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.903 0.859 . . . . 1.43 112.838 -177.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 175' ' ' SER . . . . . 0.792 ' HB2' ' HD2' ' B' ' 176' ' ' PRO . 11.6 p -122.68 -179.89 0.88 Allowed Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 114.057 -1.429 . . . . 2.3 107.998 178.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 176' ' ' PRO . . . . . 0.792 ' HD2' ' HB2' ' B' ' 175' ' ' SER . 57.3 Cg_endo -73.71 29.92 0.32 Allowed 'Trans proline' 0 N--CA 1.46 -0.482 0 CA-C-N 119.797 0.963 . . . . 2.13 111.681 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 177' ' ' ASP . . . . . 0.53 ' H ' ' C ' ' B' ' 175' ' ' SER . 2.5 p30 -145.78 -49.41 0.22 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.63 -0.713 . . . . 2.72 110.585 179.133 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 178' ' ' GLY . . . . . 1.057 ' HA3' ' O ' ' A' ' 79' ' ' CYS . . . -155.77 -140.69 3.04 Favored Glycine 0 C--N 1.338 0.652 0 C-N-CA 120.492 -0.861 . . . . 1.05 113.886 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 179' ' ' CYS . . . . . 1.089 ' O ' ' HA3' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -142.94 153.04 42.66 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-N 115.281 -0.46 . . . . 1.39 110.511 -179.892 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 180' ' ' HIS . . . . . 0.414 ' HE2' ' HA3' ' B' ' 162' ' ' GLY . 4.2 p-80 -154.11 160.39 41.92 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.098 -0.641 . . . . 2.73 111.975 -178.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 181' ' ' GLU . . . . . 0.562 ' HA ' ' O ' ' B' ' 171' ' ' GLY . 0.0 OUTLIER -60.23 140.48 56.99 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.844 -0.616 . . . . 3.06 110.307 179.828 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 182' ' ' ASP . . . . . 0.428 ' HB3' ' HB3' ' B' ' 173' ' ' CYS . 3.7 p-10 -139.69 140.28 24.46 Favored Pre-proline 0 CA--C 1.541 0.627 0 CA-C-N 116.01 -0.541 . . . . 2.06 110.759 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 183' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' B' ' 182' ' ' ASP . 3.4 Cg_exo -77.09 -25.17 8.98 Favored 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 123.236 2.624 . . . . 2.27 114.252 -177.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -66.23 -43.88 85.37 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 107.808 -1.182 . . . . 1.56 107.808 178.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 185' ' ' CYS . . . . . 1.041 ' HB3' ' HA ' ' B' ' 170' ' ' ALA . 33.2 m -100.05 73.44 1.73 Allowed 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 114.037 -1.438 . . . . 1.94 109.067 177.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 186' ' ' ASP . . . . . 0.99 ' H ' ' HD3' ' B' ' 187' ' ' PRO . 0.3 OUTLIER -170.84 24.49 0.0 OUTLIER Pre-proline 0 C--N 1.311 -1.095 0 CA-C-N 115.666 -0.697 . . . . 3.61 111.92 -179.568 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 187' ' ' PRO . . . . . 0.99 ' HD3' ' H ' ' B' ' 186' ' ' ASP . 10.2 Cg_exo -70.61 177.57 6.03 Favored 'Trans proline' 0 N--CA 1.432 -2.103 0 CA-C-N 119.769 0.953 . . . . 3.14 111.011 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 188' ' ' GLU . . . . . 0.507 ' C ' ' O ' ' B' ' 187' ' ' PRO . 1.9 pt-20 -21.71 -24.81 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 113.072 -1.876 . . . . 4.7 109.739 176.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 189' ' ' ALA . . . . . 0.931 ' N ' ' O ' ' B' ' 187' ' ' PRO . . . -47.95 -5.6 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 114.15 1.167 . . . . 5.24 114.15 -179.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 190' ' ' ALA . . . . . 0.425 ' H ' ' C ' ' B' ' 188' ' ' GLU . . . -67.4 157.83 33.17 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.67 0.747 . . . . 6.93 111.952 -179.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 191' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -100.75 99.74 10.31 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 114.688 -1.142 . . . . 10.62 110.209 177.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 44.8 p . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.155 -0.926 . . . . 11.7 111.036 -179.85 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.804 0 CA-C-O 119.974 -0.06 . . . . 10.31 111.128 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.461 ' O ' HG12 ' A' ' 2' ' ' VAL . 12.7 p -177.22 48.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-O 122.804 1.288 . . . . 8.37 111.409 -178.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.732 HD13 ' HB3' ' A' ' 55' ' ' GLN . 3.8 mm? -135.18 99.69 4.33 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 113.33 -1.759 . . . . 6.25 107.096 178.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.682 ' H ' ' HA ' ' A' ' 55' ' ' GLN . 0.6 OUTLIER -77.81 22.8 0.26 Allowed 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.116 -0.698 . . . . 6.22 109.116 178.832 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.556 HD21 ' O ' ' A' ' 53' ' ' PRO . 0.2 OUTLIER -143.96 -133.65 0.09 Allowed 'General case' 0 N--CA 1.433 -1.303 0 N-CA-C 104.233 -2.506 . . . . 7.57 104.233 -175.514 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.432 ' H ' ' CD1' ' A' ' 5' ' ' LEU . 6.8 t70 -160.24 -42.92 0.05 OUTLIER 'General case' 0 C--N 1.282 -2.356 0 CA-C-O 122.407 1.099 . . . . 8.78 109.879 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.445 ' O ' HD11 ' A' ' 5' ' ' LEU . 7.1 p -127.8 123.31 60.74 Favored 'Isoleucine or valine' 0 CA--C 1.468 -2.176 1 N-CA-C 99.363 -4.31 . . . . 7.88 99.363 170.579 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.408 ' HG2' ' HG2' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -73.44 110.8 8.01 Favored 'General case' 0 N--CA 1.394 -3.27 0 C-N-CA 116.417 -2.113 . . . . 9.7 108.957 -171.955 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.441 ' O ' HD21 ' A' ' 11' ' ' LEU . 0.9 OUTLIER -103.11 96.27 6.67 Favored 'General case' 0 N--CA 1.394 -3.274 0 N-CA-C 100.538 -3.875 . . . . 6.05 100.538 170.54 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.618 ' HB3' ' HD3' ' A' ' 20' ' ' ARG . 1.0 OUTLIER -80.49 74.52 7.37 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 112.971 -1.922 . . . . 2.89 111.689 179.535 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.682 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 3.4 mm? -30.68 111.08 0.28 Allowed Pre-proline 0 N--CA 1.472 0.673 0 N-CA-C 112.976 0.732 . . . . 2.89 112.976 -178.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.795 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 72.9 Cg_endo -73.96 153.44 47.31 Favored 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 123.087 2.525 . . . . 1.72 111.518 179.06 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.602 ' O ' ' HA2' ' A' ' 17' ' ' GLY . 16.1 p -160.7 -167.33 1.83 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 119.134 -1.027 . . . . 1.0 111.266 174.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 1.018 ' HA2' ' HB3' ' A' ' 40' ' ' GLU . . . 76.0 -160.38 51.39 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 120.241 -0.981 . . . . 1.15 114.761 177.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.536 ' HD2' ' CZ ' ' A' ' 35' ' ' PHE . 43.5 Cg_endo -64.94 99.07 0.32 Allowed 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 124.198 3.265 . . . . 1.6 113.328 178.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.62 -4.37 84.68 Favored Glycine 0 C--N 1.265 -3.363 0 CA-C-N 112.801 -1.999 . . . . 1.68 111.975 -176.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.602 ' HA2' ' O ' ' A' ' 13' ' ' CYS . . . 71.03 42.52 59.03 Favored Glycine 0 N--CA 1.432 -1.621 0 C-N-CA 118.31 -1.9 . . . . 1.37 113.19 174.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.98 -33.97 18.22 Favored 'General case' 0 C--N 1.359 1.021 0 CA-C-N 112.922 -1.639 . . . . 2.91 111.329 -178.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.795 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -77.55 -167.37 28.89 Favored Glycine 0 N--CA 1.468 0.795 0 C-N-CA 128.194 2.807 . . . . 1.06 111.165 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.682 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -130.74 173.76 10.6 Favored 'General case' 0 CA--C 1.553 1.089 0 N-CA-C 105.268 -2.123 . . . . 3.32 105.268 174.375 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.1 m -105.7 141.62 36.82 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 119.534 1.061 . . . . 1.19 111.395 -178.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -124.48 -48.2 1.82 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.765 -0.652 . . . . 2.26 110.549 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -128.94 -177.81 15.06 Favored Glycine 0 C--N 1.33 0.248 0 N-CA-C 111.322 -0.711 . . . . 1.05 111.322 179.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo -64.79 -71.02 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 121.969 1.779 . . . . 1.81 111.219 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.585 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.6 OUTLIER -89.8 41.53 1.05 Allowed 'General case' 0 CA--C 1.521 -0.145 0 N-CA-C 108.788 -0.819 . . . . 1.62 108.788 177.759 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.761 HG12 HG11 ' A' ' 36' ' ' VAL . 2.0 mt -144.92 111.59 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.908 0 CA-C-N 116.079 -0.51 . . . . 1.39 112.184 -177.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.673 ' SG ' ' HA ' ' A' ' 41' ' ' ALA . 0.8 OUTLIER -120.82 130.98 54.19 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 109.574 -0.528 . . . . 0.92 109.574 179.585 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.888 ' SG ' ' HB2' ' A' ' 68' ' ' ALA . 1.6 m -123.84 171.51 9.61 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 117.365 -1.734 . . . . 1.28 114.41 -177.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.521 ' HA3' ' HB2' ' A' ' 32' ' ' LEU . . . -146.85 174.86 26.53 Favored Glycine 0 N--CA 1.415 -2.714 0 N-CA-C 109.405 -1.478 . . . . 0.71 109.405 173.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -65.01 -58.51 5.92 Favored 'General case' 0 N--CA 1.422 -1.829 0 N-CA-C 104.424 -2.436 . . . . 2.27 104.424 177.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -115.07 22.11 13.66 Favored 'General case' 0 CA--C 1.478 -1.809 0 CA-C-N 114.246 -1.343 . . . . 1.66 108.689 -175.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.662 HD23 ' HE1' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -109.92 -17.8 13.54 Favored 'General case' 0 N--CA 1.408 -2.563 0 N-CA-C 105.987 -1.857 . . . . 1.93 105.987 177.793 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.874 ' HA2' ' CB ' ' A' ' 69' ' ' ALA . . . 63.6 -135.83 41.72 Favored Glycine 0 N--CA 1.403 -3.524 0 CA-C-N 113.635 -1.62 . . . . 0.77 110.797 -179.152 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.633 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 0.7 OUTLIER -143.27 122.1 12.68 Favored 'General case' 0 CA--C 1.479 -1.767 0 CA-C-N 119.13 1.465 . . . . 1.08 113.582 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 1.057 ' HA ' ' HA ' ' B' ' 135' ' ' PHE . 0.0 OUTLIER -88.84 105.34 17.67 Favored 'General case' 0 N--CA 1.411 -2.419 0 N-CA-C 103.945 -2.613 . . . . 1.85 103.945 176.13 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.761 HG11 HG12 ' A' ' 26' ' ' ILE . 1.6 t -96.7 85.67 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.863 0 N-CA-C 107.579 -1.267 . . . . 1.29 107.579 -179.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.838 ' HA3' HG12 ' B' ' 172' ' ' ILE . . . 122.03 12.99 5.11 Favored Glycine 0 C--N 1.32 -0.36 0 CA-C-N 113.738 -1.573 . . . . 0.85 115.898 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.834 HG22 ' HB3' ' A' ' 35' ' ' PHE . 47.4 p -94.89 164.47 12.9 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 118.496 1.148 . . . . 1.3 110.195 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.2 -34.82 75.7 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.184 0.516 . . . . 1.45 109.811 179.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 1.018 ' HB3' ' HA2' ' A' ' 14' ' ' GLY . 0.6 OUTLIER -59.83 -14.63 15.9 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.912 -0.586 . . . . 2.32 111.537 -179.397 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.823 ' O ' ' HB2' ' A' ' 44' ' ' CYS . . . -91.95 -26.77 18.26 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 116.285 -0.416 . . . . 1.11 109.982 179.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.1 mt -48.21 -36.58 14.03 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 112.505 0.558 . . . . 1.68 112.505 -179.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.658 ' C ' ' H ' ' A' ' 45' ' ' GLN . 0.0 OUTLIER -54.91 -28.19 48.8 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 107.502 -1.296 . . . . 3.4 107.502 177.417 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.823 ' HB2' ' O ' ' A' ' 41' ' ' ALA . 1.2 m -54.97 4.01 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 114.435 -1.257 . . . . 1.57 111.18 -176.035 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.658 ' H ' ' C ' ' A' ' 43' ' ' ARG . 17.3 tt0 -72.48 -31.92 65.78 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.212 0.53 . . . . 3.49 110.951 177.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -86.3 6.78 28.19 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.995 0.426 . . . . 3.69 110.685 -179.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 25.0 tp10 -83.17 1.69 39.32 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 109.078 -0.712 . . . . 3.99 109.078 177.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.43 ' C ' ' H ' ' A' ' 50' ' ' LEU . 4.2 t-20 -88.7 -28.49 20.53 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.966 -0.561 . . . . 4.2 109.74 178.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -66.51 8.88 0.2 Allowed 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 112.503 0.557 . . . . 5.85 112.503 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.43 ' H ' ' C ' ' A' ' 48' ' ' ASN . 0.4 OUTLIER -137.35 107.85 8.66 Favored Pre-proline 0 CA--C 1.53 0.198 0 CA-C-O 120.452 0.168 . . . . 5.83 110.953 -179.55 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -78.07 26.21 0.5 Allowed 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.494 2.129 . . . . 5.3 113.463 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 54.0 p -159.87 121.02 1.76 Allowed Pre-proline 0 CA--C 1.532 0.277 0 CA-C-O 120.576 0.227 . . . . 5.72 111.281 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.556 ' O ' HD21 ' A' ' 5' ' ' LEU . 82.9 Cg_endo -77.44 170.95 18.48 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.722 2.282 . . . . 5.82 112.083 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.637 ' C ' ' HG3' ' A' ' 55' ' ' GLN . 30.7 p -78.51 102.68 8.0 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.264 0.554 . . . . 2.98 111.464 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.732 ' HB3' HD13 ' A' ' 3' ' ' LEU . 0.0 OUTLIER 41.14 -142.84 0.06 Allowed 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 115.342 -0.844 . . . . 6.42 112.906 179.152 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.448 ' H ' ' HB2' ' A' ' 55' ' ' GLN . 12.2 t -156.18 -98.32 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 109.071 -0.714 . . . . 3.36 109.071 -179.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 112.97 -107.22 1.95 Allowed Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.555 -0.831 . . . . 2.3 112.652 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.69 87.05 2.67 Favored 'General case' 0 CA--C 1.476 -1.877 0 N-CA-C 102.944 -2.984 . . . . 5.06 102.944 176.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.812 ' CA ' ' H ' ' A' ' 67' ' ' CYS . 15.4 mmtt -137.32 -57.37 0.02 OUTLIER Pre-proline 0 C--N 1.296 -1.76 0 C-N-CA 118.629 -1.228 . . . . 3.91 112.05 -173.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.613 ' HD2' ' H ' ' A' ' 59' ' ' LYS . 9.4 Cg_endo -51.94 98.08 0.04 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.121 0 CA-C-N 120.709 1.289 . . . . 1.74 113.703 -179.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.417 ' SG ' ' N ' ' A' ' 62' ' ' GLY . 0.1 OUTLIER -140.98 -173.77 3.81 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 105.832 -1.914 . . . . 1.9 105.832 178.776 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.417 ' N ' ' SG ' ' A' ' 61' ' ' CYS . . . 61.91 -165.18 20.73 Favored Glycine 0 C--N 1.316 -0.577 0 C-N-CA 117.454 -2.308 . . . . 2.43 112.548 176.144 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.4 m -84.39 42.46 0.89 Allowed 'General case' 0 N--CA 1.479 1.0 0 CA-C-O 122.204 1.002 . . . . 4.32 111.575 -176.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 115.78 5.84 17.64 Favored Glycine 0 CA--C 1.535 1.292 0 CA-C-N 113.89 -1.505 . . . . 2.4 114.937 178.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.656 ' CA ' ' HA ' ' A' ' 75' ' ' SER . . . -101.13 153.37 19.05 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 119.132 -1.508 . . . . 1.82 116.481 -174.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.771 ' CB ' ' HB3' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -85.24 152.26 23.45 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 114.354 -0.923 . . . . 3.51 109.553 179.364 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.812 ' H ' ' CA ' ' A' ' 59' ' ' LYS . 0.1 OUTLIER -70.13 107.83 3.84 Favored 'General case' 0 N--CA 1.42 -1.94 0 CA-C-N 119.643 1.11 . . . . 1.52 109.798 -178.767 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.888 ' HB2' ' SG ' ' A' ' 28' ' ' CYS . . . -67.02 -32.05 73.0 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 115.235 -0.893 . . . . 1.5 109.78 179.176 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.874 ' CB ' ' HA2' ' A' ' 33' ' ' GLY . . . -170.66 164.54 8.2 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.464 -1.244 . . . . 1.31 110.917 -177.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 1.112 ' HA ' ' HB3' ' A' ' 85' ' ' CYS . . . -66.91 70.76 0.08 Allowed 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.264 -0.574 . . . . 1.5 111.985 178.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.604 ' HA2' ' O ' ' A' ' 85' ' ' CYS . . . 164.99 -42.33 0.29 Allowed Glycine 0 CA--C 1.52 0.369 0 CA-C-N 115.818 -0.628 . . . . 1.44 114.227 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.846 HG12 ' HA3' ' B' ' 137' ' ' GLY . 1.3 pp -120.76 121.52 65.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.191 0.52 . . . . 2.77 111.037 -178.006 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.587 ' HB2' ' HB3' ' A' ' 82' ' ' ASP . 0.1 OUTLIER -95.58 111.72 23.58 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.635 -0.711 . . . . 1.98 109.825 -179.888 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.515 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 1.3 m -84.74 117.3 23.74 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.382 0.61 . . . . 1.43 112.378 -178.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.656 ' HA ' ' CA ' ' A' ' 65' ' ' GLY . 29.6 p -92.66 -179.67 1.12 Allowed Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 114.909 -1.041 . . . . 2.37 109.162 178.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.62 ' CD ' ' HB2' ' A' ' 75' ' ' SER . 4.2 Cg_exo -74.6 29.62 0.35 Allowed 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 121.7 1.6 . . . . 2.09 111.691 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.489 ' H ' ' C ' ' A' ' 75' ' ' SER . 2.4 p30 -145.65 -37.94 0.26 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.704 -0.68 . . . . 2.65 110.825 179.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.781 ' HA3' ' O ' ' B' ' 179' ' ' CYS . . . -170.0 -133.56 1.61 Allowed Glycine 0 C--N 1.339 0.702 0 C-N-CA 120.617 -0.801 . . . . 1.04 113.38 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.819 ' O ' ' HA3' ' B' ' 178' ' ' GLY . 0.0 OUTLIER -146.27 150.93 36.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.126 0.489 . . . . 1.42 110.831 -179.62 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.414 ' CE1' ' HA3' ' A' ' 62' ' ' GLY . 50.2 p-80 -154.25 160.48 41.83 Favored 'General case' 0 C--N 1.331 -0.236 0 O-C-N 122.03 -0.419 . . . . 2.81 111.56 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.55 ' OE2' ' HG2' ' B' ' 124' ' ' PRO . 1.5 mt-10 -59.7 140.75 56.21 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.281 -0.418 . . . . 3.05 110.228 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.587 ' HB3' ' HB2' ' A' ' 73' ' ' CYS . 7.9 p-10 -145.08 140.59 16.28 Favored Pre-proline 0 CA--C 1.535 0.385 0 CA-C-N 116.487 -0.324 . . . . 2.02 111.599 -179.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 82' ' ' ASP . 3.4 Cg_exo -77.58 -14.5 15.95 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 123.243 2.629 . . . . 2.29 113.665 -179.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.3 -46.58 60.4 Favored 'General case' 0 CA--C 1.504 -0.826 0 N-CA-C 107.158 -1.423 . . . . 1.53 107.158 178.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 1.112 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 97.7 m -106.84 84.76 2.04 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 113.559 -1.655 . . . . 1.88 107.493 176.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.827 ' H ' ' CD ' ' A' ' 87' ' ' PRO . 1.2 t70 -165.06 -19.3 0.0 OUTLIER Pre-proline 0 C--N 1.316 -0.856 0 CA-C-N 113.857 -1.52 . . . . 3.6 113.619 -177.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.827 ' CD ' ' H ' ' A' ' 86' ' ' ASP . 5.7 Cg_endo -80.84 66.36 8.84 Favored 'Trans proline' 0 CA--C 1.501 -1.153 0 CA-C-N 120.659 1.271 . . . . 3.12 113.619 -179.197 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.513 ' HG3' ' N ' ' A' ' 89' ' ' ALA . 10.4 pt-20 174.39 -43.39 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 123.172 1.463 . . . . 4.72 109.009 177.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.513 ' N ' ' HG3' ' A' ' 88' ' ' GLU . . . -74.5 -109.78 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 111.745 -2.48 . . . . 5.29 114.812 -176.075 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.431 ' H ' ' HB3' ' A' ' 89' ' ' ALA . . . -76.04 127.63 33.36 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.051 -1.432 . . . . 7.19 113.486 -175.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -90.99 129.44 36.99 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.28 -0.873 . . . . 10.7 109.762 178.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.9 t . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.218 -0.896 . . . . 11.77 110.986 -179.946 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.19 0 CA-C-O 119.401 -0.333 . . . . 10.42 111.503 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 34.8 t -122.21 141.35 42.96 Favored 'Isoleucine or valine' 0 C--N 1.342 0.278 0 C-N-CA 118.28 -1.368 . . . . 8.81 109.561 176.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 103' ' ' LEU . . . . . 0.696 ' CB ' ' HB3' ' B' ' 155' ' ' GLN . 0.9 OUTLIER -148.43 128.69 13.79 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 120.228 1.377 . . . . 6.28 110.219 177.781 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 104' ' ' ASP . . . . . 0.422 ' H ' ' HA ' ' B' ' 155' ' ' GLN . 11.9 m-20 -97.61 51.61 1.08 Allowed 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 106.529 -1.656 . . . . 6.27 106.529 176.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . 0.707 HD23 ' O ' ' B' ' 153' ' ' PRO . 0.7 OUTLIER -155.0 -123.34 0.03 OUTLIER 'General case' 0 N--CA 1.413 -2.282 0 CA-C-N 113.094 -1.866 . . . . 7.61 106.106 -177.176 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 106' ' ' ASP . . . . . 0.528 ' H ' ' CD1' ' B' ' 105' ' ' LEU . 6.7 t70 -162.85 -95.35 0.02 OUTLIER 'General case' 0 C--N 1.277 -2.573 0 N-CA-C 106.035 -1.839 . . . . 8.55 106.035 177.225 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 107' ' ' VAL . . . . . 0.598 ' O ' HD11 ' B' ' 105' ' ' LEU . 2.8 p -89.37 129.65 40.01 Favored 'Isoleucine or valine' 0 CA--C 1.475 -1.909 0 N-CA-C 100.274 -3.972 . . . . 7.84 100.274 175.029 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 108' ' ' ARG . . . . . 0.426 ' HG2' ' HG2' ' B' ' 155' ' ' GLN . 0.0 OUTLIER -71.37 111.88 7.05 Favored 'General case' 0 N--CA 1.401 -2.904 0 C-N-CA 116.624 -2.031 . . . . 9.75 109.972 -170.207 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 109' ' ' THR . . . . . 0.401 ' O ' HD23 ' B' ' 111' ' ' LEU . 0.9 OUTLIER -104.46 96.77 6.83 Favored 'General case' 0 N--CA 1.397 -3.108 0 N-CA-C 100.46 -3.904 . . . . 6.13 100.46 170.811 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 110' ' ' CYS . . . . . 0.591 ' HB3' ' HD3' ' B' ' 120' ' ' ARG . 0.9 OUTLIER -81.72 74.98 8.68 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 112.577 -2.101 . . . . 2.87 111.441 -179.881 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 111' ' ' LEU . . . . . 0.647 ' O ' ' HA ' ' B' ' 120' ' ' ARG . 3.4 mm? -30.92 111.48 0.29 Allowed Pre-proline 0 N--CA 1.471 0.614 0 N-CA-C 112.923 0.712 . . . . 2.95 112.923 -178.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 112' ' ' PRO . . . . . 0.883 ' HA ' ' O ' ' B' ' 119' ' ' GLY . 89.6 Cg_endo -81.53 144.66 14.32 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.119 1.879 . . . . 1.71 114.183 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.587 ' O ' ' HA2' ' B' ' 117' ' ' GLY . 18.0 p -150.57 -165.0 2.15 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 118.633 -1.227 . . . . 1.0 111.479 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 114' ' ' GLY . . . . . 1.049 ' HA2' ' HB3' ' B' ' 140' ' ' GLU . . . 76.24 -160.81 51.42 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 120.449 -0.881 . . . . 1.16 115.192 177.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 115' ' ' PRO . . . . . 0.651 ' HG2' ' O ' ' B' ' 115' ' ' PRO . 43.4 Cg_endo -63.5 114.76 2.66 Favored 'Trans proline' 0 C--N 1.366 1.478 0 C-N-CA 123.922 3.081 . . . . 1.6 106.945 176.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 77.62 -14.99 8.19 Favored Glycine 0 C--N 1.261 -3.624 0 C-N-CA 123.98 0.8 . . . . 1.7 111.193 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 117' ' ' GLY . . . . . 0.587 ' HA2' ' O ' ' B' ' 113' ' ' CYS . . . 75.12 43.01 27.55 Favored Glycine 0 N--CA 1.413 -2.893 0 C-N-CA 117.767 -2.159 . . . . 1.38 110.909 179.223 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.38 -27.92 17.22 Favored 'General case' 0 C--N 1.355 0.833 0 CA-C-N 112.269 -1.965 . . . . 2.96 113.345 -179.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 119' ' ' GLY . . . . . 0.883 ' O ' ' HA ' ' B' ' 112' ' ' PRO . . . -102.29 -151.82 24.05 Favored Glycine 0 N--CA 1.431 -1.686 0 N-CA-C 108.507 -1.837 . . . . 1.07 108.507 178.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.647 ' HA ' ' O ' ' B' ' 111' ' ' LEU . 0.0 OUTLIER -127.32 174.51 8.91 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 118.638 1.219 . . . . 3.29 110.714 -177.872 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 121' ' ' CYS . . . . . . . . . . . . . 1.1 m -105.35 140.69 38.09 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.276 0.56 . . . . 1.21 111.092 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -124.52 -48.13 1.82 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.447 -0.797 . . . . 2.28 110.375 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -128.94 -177.8 15.05 Favored Glycine 0 C--N 1.33 0.247 0 N-CA-C 111.303 -0.719 . . . . 1.04 111.303 179.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . 0.55 ' HG2' ' OE2' ' A' ' 81' ' ' GLU . 20.2 Cg_exo -64.84 -70.97 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 121.942 1.761 . . . . 1.84 111.258 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 125' ' ' SER . . . . . 0.591 ' O ' ' N ' ' B' ' 137' ' ' GLY . 0.6 OUTLIER -89.77 41.47 1.04 Allowed 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 108.7 -0.852 . . . . 1.49 108.7 177.808 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 126' ' ' ILE . . . . . 0.923 HG12 HG13 ' B' ' 136' ' ' VAL . 2.2 mt -144.71 111.39 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 CA-C-N 116.025 -0.534 . . . . 1.41 112.374 -177.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 127' ' ' CYS . . . . . 0.67 ' SG ' ' HA ' ' B' ' 141' ' ' ALA . 0.8 OUTLIER -121.1 130.46 53.76 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 109.436 -0.579 . . . . 0.89 109.436 179.352 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 128' ' ' CYS . . . . . 0.815 ' HA ' ' O ' ' B' ' 133' ' ' GLY . 1.0 OUTLIER -125.48 169.03 12.81 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 114.22 1.193 . . . . 1.23 114.22 -177.084 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 129' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' B' ' 133' ' ' GLY . . . -147.88 176.05 26.9 Favored Glycine 0 N--CA 1.419 -2.444 0 N-CA-C 107.515 -2.234 . . . . 0.69 107.515 175.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -66.55 -55.93 13.16 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 106.681 -1.6 . . . . 2.35 106.681 178.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -117.62 31.48 6.69 Favored 'General case' 0 CA--C 1.478 -1.817 0 CA-C-N 113.337 -1.756 . . . . 1.69 109.591 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 132' ' ' LEU . . . . . 0.432 HD22 ' CE1' ' B' ' 135' ' ' PHE . 0.5 OUTLIER -120.99 -14.0 8.51 Favored 'General case' 0 N--CA 1.408 -2.562 0 N-CA-C 104.667 -2.345 . . . . 1.84 104.667 178.239 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 133' ' ' GLY . . . . . 0.866 ' HA2' ' CB ' ' B' ' 169' ' ' ALA . . . 63.08 -132.48 42.85 Favored Glycine 0 N--CA 1.404 -3.476 0 CA-C-N 114.092 -1.413 . . . . 0.76 111.821 177.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 134' ' ' CYS . . . . . 0.651 ' HA ' ' O ' ' B' ' 127' ' ' CYS . 1.0 OUTLIER -146.2 121.98 10.57 Favored 'General case' 0 CA--C 1.479 -1.768 0 CA-C-N 119.462 1.631 . . . . 1.08 112.762 178.62 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 135' ' ' PHE . . . . . 1.057 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -88.83 105.78 17.95 Favored 'General case' 0 N--CA 1.409 -2.5 0 N-CA-C 103.959 -2.608 . . . . 1.83 103.959 176.369 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 136' ' ' VAL . . . . . 0.923 HG13 HG12 ' B' ' 126' ' ' ILE . 1.9 t -96.24 85.49 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.781 0 N-CA-C 107.59 -1.263 . . . . 1.29 107.59 -179.447 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 137' ' ' GLY . . . . . 0.846 ' HA3' HG12 ' A' ' 72' ' ' ILE . . . 122.51 12.7 5.0 Favored Glycine 0 C--O 1.227 -0.296 0 CA-C-N 113.993 -1.458 . . . . 0.85 115.874 179.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 138' ' ' THR . . . . . 0.814 HG22 ' HB3' ' B' ' 135' ' ' PHE . 46.6 p -96.74 160.7 14.23 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 118.521 1.16 . . . . 1.2 110.422 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 139' ' ' ALA . . . . . 0.67 ' HA ' HD11 ' B' ' 142' ' ' LEU . . . -62.37 -23.13 66.63 Favored 'General case' 0 N--CA 1.446 -0.641 0 O-C-N 121.965 -0.459 . . . . 1.35 111.85 -179.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 140' ' ' GLU . . . . . 1.049 ' HB3' ' HA2' ' B' ' 114' ' ' GLY . 0.6 OUTLIER -67.45 -14.17 62.69 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.24 0.543 . . . . 2.31 110.781 178.56 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 141' ' ' ALA . . . . . 0.843 ' O ' ' HB2' ' B' ' 144' ' ' CYS . . . -92.74 -26.31 17.81 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 115.562 -0.744 . . . . 1.09 110.304 179.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 142' ' ' LEU . . . . . 0.67 HD11 ' HA ' ' B' ' 139' ' ' ALA . 9.8 mt -47.7 -36.64 11.55 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.146 0.424 . . . . 1.61 112.146 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 143' ' ' ARG . . . . . 0.479 ' C ' ' H ' ' B' ' 145' ' ' GLN . 0.0 OUTLIER -60.72 -17.47 48.51 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 121.965 0.888 . . . . 3.43 109.567 177.661 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 144' ' ' CYS . . . . . 0.843 ' HB2' ' O ' ' B' ' 141' ' ' ALA . 1.2 m -58.21 -3.83 0.3 Allowed 'General case' 0 CA--C 1.552 1.048 0 CA-C-N 113.178 -1.828 . . . . 1.61 110.868 178.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 145' ' ' GLN . . . . . 0.479 ' H ' ' C ' ' B' ' 143' ' ' ARG . 16.7 tt0 -67.83 -32.85 73.68 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.233 0.54 . . . . 3.52 111.769 179.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -86.35 6.89 27.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.008 0.432 . . . . 3.76 110.701 -179.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 24.9 tp10 -83.0 1.47 39.73 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 109.082 -0.71 . . . . 4.01 109.082 177.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 148' ' ' ASN . . . . . 0.438 ' C ' ' H ' ' B' ' 150' ' ' LEU . 4.2 t-20 -88.61 -28.31 20.76 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.995 -0.548 . . . . 4.24 109.851 178.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -66.66 9.01 0.2 Allowed 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.466 0.543 . . . . 6.07 112.466 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 150' ' ' LEU . . . . . 0.438 ' H ' ' C ' ' B' ' 148' ' ' ASN . 0.4 OUTLIER -137.41 107.84 8.61 Favored Pre-proline 0 N--CA 1.462 0.125 0 CA-C-O 120.479 0.18 . . . . 5.86 110.929 -179.542 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 151' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -78.1 26.18 0.5 Allowed 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.579 2.186 . . . . 5.42 113.482 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 53.1 p -159.87 120.86 1.75 Allowed Pre-proline 0 CA--C 1.533 0.316 0 CA-C-O 120.528 0.204 . . . . 6.02 111.294 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 153' ' ' PRO . . . . . 0.707 ' O ' HD23 ' B' ' 105' ' ' LEU . 85.0 Cg_endo -77.34 170.9 18.63 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.696 2.264 . . . . 5.87 112.174 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 154' ' ' CYS . . . . . 0.638 ' C ' ' HG3' ' B' ' 155' ' ' GLN . 30.6 p -78.53 102.87 8.11 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.108 0.48 . . . . 2.96 111.65 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 155' ' ' GLN . . . . . 0.696 ' HB3' ' CB ' ' B' ' 103' ' ' LEU . 0.0 OUTLIER 41.48 -143.18 0.07 Allowed 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 115.561 -0.745 . . . . 6.3 112.552 179.065 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 12.1 t -155.88 -98.49 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.925 -0.768 . . . . 3.41 108.925 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 114.04 -108.81 2.1 Favored Glycine 0 C--N 1.336 0.561 0 C-N-CA 120.02 -1.086 . . . . 2.26 112.404 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 158' ' ' GLN . . . . . 0.417 ' O ' ' HB2' ' B' ' 167' ' ' CYS . 0.0 OUTLIER -124.0 71.41 1.12 Allowed 'General case' 0 CA--C 1.486 -1.502 0 N-CA-C 104.669 -2.345 . . . . 5.03 104.669 176.148 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 159' ' ' LYS . . . . . 0.831 ' HB3' ' CB ' ' B' ' 166' ' ' ARG . 18.9 mmtt -107.08 -65.77 0.04 OUTLIER Pre-proline 0 N--CA 1.421 -1.899 0 N-CA-C 116.764 2.135 . . . . 3.96 116.764 -177.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 160' ' ' PRO . . . . . 0.537 ' CD ' ' HB2' ' B' ' 159' ' ' LYS . 9.6 Cg_endo -51.96 96.61 0.04 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.267 0 C-N-CA 122.351 2.034 . . . . 1.7 114.722 -174.111 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 161' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -143.62 179.72 6.96 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 112.922 -1.944 . . . . 1.93 105.838 177.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 70.03 -166.21 50.22 Favored Glycine 0 N--CA 1.441 -0.972 0 C-N-CA 117.58 -2.248 . . . . 2.37 111.863 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 2.8 m -83.95 43.55 0.93 Allowed 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 121.869 0.842 . . . . 4.56 111.21 -177.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 112.2 8.54 21.53 Favored Glycine 0 C--N 1.346 1.108 0 CA-C-N 113.961 -1.472 . . . . 2.39 114.775 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 165' ' ' GLY . . . . . 0.654 ' CA ' ' HA ' ' B' ' 175' ' ' SER . . . -103.0 156.12 18.12 Favored Glycine 0 C--N 1.339 0.748 0 CA-C-N 119.916 1.858 . . . . 1.79 116.27 -177.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 166' ' ' ARG . . . . . 0.831 ' CB ' ' HB3' ' B' ' 159' ' ' LYS . 0.0 OUTLIER -85.64 152.19 23.3 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 114.309 -0.945 . . . . 3.53 109.324 178.765 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 167' ' ' CYS . . . . . 0.792 ' H ' ' HA ' ' B' ' 159' ' ' LYS . 0.1 OUTLIER -70.32 107.74 3.9 Favored 'General case' 0 N--CA 1.418 -2.042 0 CA-C-N 119.558 1.072 . . . . 1.56 109.656 -178.853 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 168' ' ' ALA . . . . . 0.627 ' HB3' HD12 ' B' ' 172' ' ' ILE . . . -64.39 -36.1 83.04 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 122.238 1.018 . . . . 1.42 108.718 178.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 169' ' ' ALA . . . . . 0.866 ' CB ' ' HA2' ' B' ' 133' ' ' GLY . . . -168.57 164.59 12.42 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 113.287 -1.779 . . . . 1.18 112.017 -175.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 170' ' ' ALA . . . . . 1.013 ' HA ' ' HB3' ' B' ' 185' ' ' CYS . . . -67.28 71.15 0.11 Allowed 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.127 -0.629 . . . . 1.47 111.93 178.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 171' ' ' GLY . . . . . 0.563 ' HA2' ' O ' ' B' ' 185' ' ' CYS . . . 167.19 -48.83 0.25 Allowed Glycine 0 N--CA 1.455 -0.098 0 CA-C-N 115.525 -0.761 . . . . 1.45 112.74 179.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 172' ' ' ILE . . . . . 0.838 HG12 ' HA3' ' A' ' 37' ' ' GLY . 1.3 pp -115.86 121.77 68.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 C-N-CA 123.139 0.576 . . . . 2.7 111.647 -175.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 173' ' ' CYS . . . . . 0.582 ' HB2' ' HB3' ' B' ' 182' ' ' ASP . 0.1 OUTLIER -95.96 111.65 23.59 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.739 -0.664 . . . . 1.94 109.781 -179.918 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 174' ' ' CYS . . . . . 0.533 ' HA ' ' HA ' ' B' ' 179' ' ' CYS . 1.3 m -84.8 117.48 23.88 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.363 0.601 . . . . 1.43 112.359 -178.26 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 175' ' ' SER . . . . . 0.654 ' HA ' ' CA ' ' B' ' 165' ' ' GLY . 28.6 p -92.75 -179.67 1.11 Allowed Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 114.883 -1.053 . . . . 2.3 109.141 179.019 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 176' ' ' PRO . . . . . 0.605 ' CD ' ' HB2' ' B' ' 175' ' ' SER . 4.2 Cg_exo -74.62 29.67 0.35 Allowed 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 121.718 1.612 . . . . 2.13 111.681 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 177' ' ' ASP . . . . . 0.491 ' H ' ' C ' ' B' ' 175' ' ' SER . 2.4 p30 -145.7 -38.17 0.25 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.672 -0.694 . . . . 2.72 110.753 179.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 178' ' ' GLY . . . . . 0.819 ' HA3' ' O ' ' A' ' 79' ' ' CYS . . . -169.48 -133.87 1.65 Allowed Glycine 0 C--N 1.338 0.642 0 C-N-CA 120.63 -0.795 . . . . 1.05 113.388 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 179' ' ' CYS . . . . . 0.781 ' O ' ' HA3' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -146.08 151.14 37.23 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.073 0.463 . . . . 1.39 110.808 -179.77 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 180' ' ' HIS . . . . . . . . . . . . . 50.1 p-80 -154.56 160.46 41.52 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.625 -0.43 . . . . 2.73 111.542 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 181' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -59.9 140.52 56.61 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.309 -0.405 . . . . 3.06 110.187 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 182' ' ' ASP . . . . . 0.582 ' HB3' ' HB2' ' B' ' 173' ' ' CYS . 7.9 p-10 -144.81 140.61 16.52 Favored Pre-proline 0 CA--C 1.537 0.455 0 CA-C-N 116.493 -0.321 . . . . 2.06 111.629 -179.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 183' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' B' ' 182' ' ' ASP . 3.4 Cg_exo -77.41 -14.71 16.15 Favored 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 123.156 2.57 . . . . 2.27 113.672 -179.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -71.25 -46.62 60.6 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 107.134 -1.432 . . . . 1.56 107.134 178.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 185' ' ' CYS . . . . . 1.013 ' HB3' ' HA ' ' B' ' 170' ' ' ALA . 87.0 m -106.5 84.53 2.03 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 113.566 -1.652 . . . . 1.94 107.515 176.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 186' ' ' ASP . . . . . 0.822 ' H ' ' CD ' ' B' ' 187' ' ' PRO . 1.1 t70 -164.71 -19.78 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.765 0 CA-C-N 113.782 -1.554 . . . . 3.61 113.835 -177.232 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 187' ' ' PRO . . . . . 0.822 ' CD ' ' H ' ' B' ' 186' ' ' ASP . 6.2 Cg_endo -80.96 72.13 6.69 Favored 'Trans proline' 0 C--N 1.361 1.203 0 C-N-CA 121.961 1.774 . . . . 3.14 110.157 179.152 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 188' ' ' GLU . . . . . 0.584 ' HB3' ' O ' ' B' ' 187' ' ' PRO . 9.8 pt-20 169.57 -40.35 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 110.714 -2.948 . . . . 4.7 111.613 171.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 189' ' ' ALA . . . . . 0.511 ' N ' ' HG3' ' B' ' 188' ' ' GLU . . . -74.31 -96.78 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 119.477 3.14 . . . . 5.24 119.477 -173.255 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 190' ' ' ALA . . . . . . . . . . . . . . . -89.02 127.74 35.69 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 114.289 -1.323 . . . . 6.93 113.229 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 191' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -90.74 129.2 36.85 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 114.918 -1.037 . . . . 10.62 109.847 178.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 5.8 t . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.24 -0.886 . . . . 11.7 111.085 179.959 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 122.177 0.989 . . . . 10.31 110.702 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -95.48 85.72 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-N 113.379 -1.737 . . . . 8.37 109.3 177.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 1.051 HD21 ' HG ' ' A' ' 56' ' ' SER . 0.4 OUTLIER -74.05 89.21 1.93 Allowed 'General case' 0 C--N 1.356 0.871 0 C-N-CA 118.839 -1.145 . . . . 6.25 108.943 -177.715 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -91.56 65.85 5.25 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 120.48 1.491 . . . . 6.22 111.63 -178.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.911 HD11 ' H ' ' A' ' 7' ' ' VAL . 1.2 tm? -114.35 -57.79 2.23 Favored 'General case' 0 CA--C 1.454 -2.723 0 CA-C-O 124.804 2.24 . . . . 7.57 109.161 -174.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.7 ' HB2' ' O ' ' A' ' 5' ' ' LEU . 0.2 OUTLIER 156.95 -35.46 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 CA-C-N 108.596 -3.911 . . . . 8.78 111.184 176.454 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.911 ' H ' HD11 ' A' ' 5' ' ' LEU . 10.8 p -158.5 127.87 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-N 112.23 -2.259 . . . . 7.88 105.202 175.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 1.014 ' HB3' ' HG ' ' A' ' 3' ' ' LEU . 3.7 ptt-85 -78.21 105.86 9.72 Favored 'General case' 0 N--CA 1.406 -2.629 0 C-N-CA 119.466 -0.894 . . . . 9.7 110.648 -178.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.685 ' O ' ' HG2' ' A' ' 53' ' ' PRO . 0.2 OUTLIER -103.86 85.64 2.45 Favored 'General case' 0 N--CA 1.409 -2.521 1 N-CA-C 98.803 -4.517 . . . . 6.05 98.803 169.057 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.692 ' HA ' ' CB ' ' A' ' 54' ' ' CYS . 82.7 m -74.75 66.92 1.54 Allowed 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 112.889 -1.96 . . . . 2.89 112.766 -176.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.868 HD22 HD23 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -35.63 108.46 0.37 Allowed Pre-proline 0 N--CA 1.483 1.221 0 C-N-CA 123.555 0.742 . . . . 2.89 112.389 179.28 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.769 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 43.8 Cg_endo -90.08 138.92 2.97 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.988 2.459 . . . . 1.72 114.044 -179.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.5 ' SG ' ' HE2' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -151.43 173.05 15.01 Favored 'General case' 0 C--N 1.351 0.642 0 N-CA-C 106.475 -1.676 . . . . 1.0 106.475 179.014 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.546 ' HA2' ' OE1' ' A' ' 40' ' ' GLU . . . 71.53 -163.26 54.26 Favored Glycine 0 CA--C 1.534 1.243 0 CA-C-N 119.635 1.107 . . . . 1.15 114.445 178.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.666 ' C ' ' H ' ' A' ' 17' ' ' GLY . 10.2 Cg_endo -69.68 130.49 19.52 Favored 'Trans proline' 0 C--N 1.369 1.621 0 C-N-CA 124.414 3.409 . . . . 1.6 113.285 179.019 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 70.35 -16.51 0.92 Allowed Glycine 0 C--N 1.284 -2.315 0 CA-C-N 112.492 -2.14 . . . . 1.68 109.575 -176.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.666 ' H ' ' C ' ' A' ' 15' ' ' PRO . . . 77.51 16.75 79.95 Favored Glycine 1 N--CA 1.388 -4.532 0 CA-C-N 113.706 -1.247 . . . . 1.37 113.74 178.285 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.34 6.97 3.15 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 107.846 -1.168 . . . . 2.91 107.846 174.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.769 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -71.45 155.68 52.47 Favored Glycine 0 CA--C 1.486 -1.732 0 N-CA-C 106.441 -2.664 . . . . 1.06 106.441 178.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.842 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -148.2 132.71 17.69 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 118.68 1.24 . . . . 3.32 108.955 174.644 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -103.91 128.12 51.42 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.242 -0.89 . . . . 1.19 112.464 -175.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -101.23 -45.25 5.42 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 114.317 -1.311 . . . . 2.26 109.119 178.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -122.05 -132.22 4.06 Favored Glycine 0 CA--C 1.524 0.617 0 CA-C-N 115.415 -0.811 . . . . 1.05 111.892 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.416 ' CG ' ' H ' ' A' ' 25' ' ' SER . 84.3 Cg_endo -98.1 -72.82 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 123.061 2.507 . . . . 1.81 111.912 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.674 ' O ' HG13 ' A' ' 26' ' ' ILE . 0.9 OUTLIER -89.62 46.97 1.41 Allowed 'General case' 0 C--N 1.333 -0.124 0 N-CA-C 109.301 -0.629 . . . . 1.62 109.301 178.762 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 1.072 HG13 HG12 ' A' ' 36' ' ' VAL . 10.1 mt -151.65 116.97 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.97 0 CA-C-O 121.286 0.565 . . . . 1.39 111.598 -179.059 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.653 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 0.5 OUTLIER -138.77 108.09 6.12 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 107.086 -1.45 . . . . 0.92 107.086 178.865 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.991 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -123.92 130.41 52.55 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 115.276 1.584 . . . . 1.28 115.276 -176.704 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.845 ' O ' ' HB3' ' A' ' 69' ' ' ALA . . . -117.23 179.58 17.43 Favored Glycine 0 C--N 1.354 1.55 0 CA-C-O 122.393 0.996 . . . . 0.71 113.877 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -66.39 -35.98 81.7 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 126.873 2.069 . . . . 2.27 113.471 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.5 0.93 5.02 Favored 'General case' 0 N--CA 1.502 2.163 0 CA-C-O 121.928 0.87 . . . . 1.66 112.969 177.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.71 ' O ' ' HA ' ' B' ' 138' ' ' THR . 0.3 OUTLIER -111.37 -11.71 14.11 Favored 'General case' 0 N--CA 1.416 -2.173 0 CA-C-N 113.836 -1.529 . . . . 1.93 111.559 -175.83 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.991 ' O ' ' HA ' ' A' ' 28' ' ' CYS . . . 57.28 -154.51 19.95 Favored Glycine 0 N--CA 1.437 -1.273 0 CA-C-N 115.634 -0.712 . . . . 0.77 113.494 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.937 ' HB2' ' CD1' ' A' ' 72' ' ' ILE . 0.2 OUTLIER -107.38 123.37 48.27 Favored 'General case' 0 CA--C 1.502 -0.895 0 N-CA-C 114.137 1.162 . . . . 1.08 114.137 179.19 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.748 ' HD1' ' CG2' ' B' ' 138' ' ' THR . 0.0 OUTLIER -95.31 101.96 13.73 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 102.053 -3.314 . . . . 1.85 102.053 173.636 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 1.072 HG12 HG13 ' A' ' 26' ' ' ILE . 2.6 t -90.48 85.0 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 CA-C-O 122.859 1.314 . . . . 1.29 109.834 -177.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.476 ' O ' ' HA3' ' B' ' 133' ' ' GLY . . . 78.94 78.25 0.85 Allowed Glycine 0 N--CA 1.453 -0.181 0 CA-C-N 112.705 -2.043 . . . . 0.85 111.625 -179.031 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.766 ' CG2' ' HD1' ' B' ' 135' ' ' PHE . 0.8 OUTLIER -151.29 155.06 37.98 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 119.04 -0.505 . . . . 1.3 109.843 -178.704 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.868 ' O ' ' HB2' ' A' ' 42' ' ' LEU . . . -36.28 -43.82 0.38 Allowed 'General case' 0 N--CA 1.484 1.248 0 CA-C-O 120.92 0.39 . . . . 1.45 111.746 -177.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.716 ' O ' ' HG2' ' A' ' 43' ' ' ARG . 59.4 mm-40 -50.37 -49.59 53.78 Favored 'General case' 0 CA--C 1.545 0.774 0 O-C-N 121.996 -0.44 . . . . 2.32 110.276 178.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.848 ' O ' ' HB2' ' A' ' 44' ' ' CYS . . . -72.77 -0.8 14.29 Favored 'General case' 0 C--O 1.216 -0.693 0 CA-C-O 121.584 0.707 . . . . 1.11 111.191 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.868 ' HB2' ' O ' ' A' ' 39' ' ' ALA . 2.4 mt -55.85 -47.32 77.5 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 107.065 -1.457 . . . . 1.68 107.065 176.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.716 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -68.89 1.08 3.65 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 114.654 -1.157 . . . . 3.4 110.658 175.943 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.848 ' HB2' ' O ' ' A' ' 41' ' ' ALA . 1.2 m -63.3 -42.98 99.11 Favored 'General case' 0 C--N 1.345 0.394 0 CA-C-O 118.184 -0.912 . . . . 1.57 109.546 178.237 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -39.77 -12.76 0.01 OUTLIER 'General case' 0 C--N 1.361 1.107 0 N-CA-C 117.069 2.248 . . . . 3.49 117.069 -177.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.441 ' N ' ' O ' ' A' ' 44' ' ' CYS . 1.2 mm-40 -81.34 0.81 35.53 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 118.489 -1.284 . . . . 3.69 108.412 178.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 1.03 ' HA ' HD12 ' A' ' 50' ' ' LEU . 1.0 OUTLIER -82.19 1.03 38.34 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 114.991 -1.004 . . . . 3.99 109.954 176.666 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 21.3 t30 -66.53 -28.6 68.68 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 108.832 -0.803 . . . . 4.2 108.832 177.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -100.35 33.8 2.57 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 109.341 -0.614 . . . . 5.85 109.341 178.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 1.03 HD12 ' HA ' ' A' ' 47' ' ' GLU . 0.9 OUTLIER -142.23 109.83 5.87 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 115.434 -0.803 . . . . 5.83 111.12 -179.186 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -82.42 50.14 3.33 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 122.156 1.904 . . . . 5.3 112.831 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 62.86 90.43 0.09 OUTLIER Pre-proline 0 N--CA 1.468 0.474 0 CA-C-N 116.129 -0.487 . . . . 5.72 112.055 179.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.737 ' C ' ' HG ' ' A' ' 5' ' ' LEU . 69.9 Cg_endo -97.82 -111.52 0.0 OUTLIER 'Trans proline' 0 CA--C 1.554 1.51 0 C-N-CA 123.186 2.59 . . . . 5.82 113.255 -179.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.692 ' CB ' ' HA ' ' A' ' 10' ' ' CYS . 27.9 t -32.45 99.58 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.669 1.188 . . . . 2.98 113.392 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -81.64 -118.43 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.123 0 N-CA-C 112.259 0.466 . . . . 6.42 112.259 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 1.051 ' HG ' HD21 ' A' ' 3' ' ' LEU . 1.4 m 70.01 115.26 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 122.695 0.398 . . . . 3.36 110.879 -179.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.545 ' O ' ' HB2' ' A' ' 66' ' ' ARG . . . 141.71 60.94 0.03 OUTLIER Glycine 0 N--CA 1.434 -1.436 0 N-CA-C 108.527 -1.829 . . . . 2.3 108.527 -178.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -117.22 74.0 0.9 Allowed 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 122.581 1.181 . . . . 5.06 109.672 -179.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.976 ' HB3' ' HB3' ' A' ' 67' ' ' CYS . 0.4 OUTLIER -137.62 68.34 52.26 Favored Pre-proline 0 C--N 1.3 -1.562 0 N-CA-C 105.553 -2.018 . . . . 3.91 105.553 178.521 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -62.32 119.21 6.21 Favored 'Trans proline' 0 C--N 1.361 1.188 0 C-N-CA 122.537 2.158 . . . . 1.74 115.514 -176.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -145.56 -171.71 3.74 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 112.514 -2.13 . . . . 1.9 105.647 177.195 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.432 ' HA2' ' CE1' ' A' ' 80' ' ' HIS . . . 66.62 -166.23 39.43 Favored Glycine 0 N--CA 1.454 -0.121 0 C-N-CA 118.553 -1.784 . . . . 2.43 112.982 178.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 4.6 p -88.05 37.42 0.81 Allowed 'General case' 0 N--CA 1.487 1.381 0 CA-C-O 122.538 1.161 . . . . 4.32 110.677 -176.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.406 ' H ' ' C ' ' A' ' 62' ' ' GLY . . . 121.5 5.75 9.15 Favored Glycine 0 CA--C 1.557 2.664 0 CA-C-N 112.954 -1.93 . . . . 2.4 114.47 -176.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.883 ' HA2' ' HB3' ' A' ' 75' ' ' SER . . . -100.74 134.89 11.87 Favored Glycine 0 N--CA 1.472 1.099 0 CA-C-N 121.071 2.435 . . . . 1.82 116.275 -176.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.545 ' HB2' ' O ' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -90.43 154.87 19.34 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.023 0.529 . . . . 3.51 110.47 178.405 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.976 ' HB3' ' HB3' ' A' ' 59' ' ' LYS . 43.2 t -71.02 103.12 2.6 Favored 'General case' 0 N--CA 1.409 -2.501 0 N-CA-C 108.046 -1.094 . . . . 1.52 108.046 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -76.13 -40.97 51.5 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 105.481 -2.044 . . . . 1.5 105.481 176.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.845 ' HB3' ' O ' ' A' ' 29' ' ' GLY . . . -140.83 160.85 39.17 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 111.59 -2.55 . . . . 1.31 112.12 -173.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.828 ' HA ' ' HB3' ' A' ' 85' ' ' CYS . . . -53.63 120.99 6.89 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 121.602 0.715 . . . . 1.5 112.826 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.539 ' H ' ' CB ' ' A' ' 85' ' ' CYS . . . 77.53 3.71 83.43 Favored Glycine 0 N--CA 1.444 -0.832 0 N-CA-C 116.41 1.324 . . . . 1.44 116.41 176.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.937 ' CD1' ' HB2' ' A' ' 34' ' ' CYS . 1.1 pp -132.04 106.56 11.43 Favored 'Isoleucine or valine' 0 C--O 1.244 0.79 0 CA-C-N 118.611 1.205 . . . . 2.77 110.702 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.639 ' HB2' ' O ' ' A' ' 80' ' ' HIS . 0.1 OUTLIER -84.63 90.32 7.66 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 115.154 -0.93 . . . . 1.98 109.822 -179.118 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.718 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 0.5 OUTLIER -99.52 132.79 44.62 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 113.326 0.862 . . . . 1.43 113.326 -177.962 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.923 ' HB2' ' HD2' ' A' ' 76' ' ' PRO . 45.8 p -109.3 -177.63 0.49 Allowed Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 114.411 -1.268 . . . . 2.37 108.713 178.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.923 ' HD2' ' HB2' ' A' ' 75' ' ' SER . 64.0 Cg_endo -74.45 30.92 0.34 Allowed 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 121.351 1.367 . . . . 2.09 111.765 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 1.084 ' HB3' ' HD2' ' B' ' 180' ' ' HIS . 4.8 m-20 -143.3 -50.7 0.34 Allowed 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.593 -0.731 . . . . 2.65 110.714 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.594 ' HA3' ' O ' ' B' ' 179' ' ' CYS . . . -160.64 -166.22 18.99 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 111.724 -0.55 . . . . 1.04 111.724 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.718 ' HA ' ' HA ' ' A' ' 74' ' ' CYS . 2.9 m -124.8 156.13 38.28 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 117.71 0.755 . . . . 1.42 110.391 179.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.964 ' HD2' ' HB3' ' B' ' 177' ' ' ASP . 5.8 t-80 -140.93 124.72 17.02 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.016 -0.993 . . . . 2.81 108.709 -174.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.85 132.76 14.7 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.366 0.603 . . . . 3.05 111.849 -177.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.536 ' O ' ' HA2' ' A' ' 71' ' ' GLY . 0.8 OUTLIER -141.64 119.79 7.75 Favored Pre-proline 0 CA--C 1.544 0.728 0 CA-C-N 115.138 -0.937 . . . . 2.02 110.443 -178.889 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.664 ' HA ' ' OD2' ' A' ' 86' ' ' ASP . 4.3 Cg_exo -78.28 -13.71 15.15 Favored 'Trans proline' 0 C--N 1.357 0.981 0 C-N-CA 122.822 2.348 . . . . 2.29 113.879 -178.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.38 -38.13 89.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.798 0.332 . . . . 1.53 111.699 -179.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.828 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 21.9 m -91.98 50.42 1.67 Allowed 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 116.193 -0.458 . . . . 1.88 110.569 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.787 ' CB ' ' HB1' ' A' ' 89' ' ' ALA . 78.6 m-20 -133.29 37.11 0.36 Allowed Pre-proline 0 CA--C 1.554 1.105 0 N-CA-C 116.015 1.857 . . . . 3.6 116.015 -177.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.705 ' HD3' ' N ' ' A' ' 86' ' ' ASP . 2.4 Cg_endo -83.64 52.5 3.83 Favored 'Trans proline' 0 N--CA 1.482 0.8 0 C-N-CA 122.685 2.257 . . . . 3.12 111.338 179.204 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.639 ' C ' ' H ' ' A' ' 90' ' ' ALA . 4.8 pt-20 173.72 -32.52 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.615 0 CA-C-N 110.833 -2.894 . . . . 4.72 108.896 -174.159 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.787 ' HB1' ' CB ' ' A' ' 86' ' ' ASP . . . -70.7 18.49 0.06 Allowed 'General case' 0 CA--C 1.565 1.557 0 CA-C-N 110.166 -3.197 . . . . 5.29 109.135 170.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.639 ' H ' ' C ' ' A' ' 88' ' ' GLU . . . -87.05 137.79 32.05 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 126.842 2.057 . . . . 7.19 111.732 176.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -95.57 114.19 25.91 Favored 'General case' 0 C--N 1.344 0.366 0 CA-C-N 112.85 -1.977 . . . . 10.7 111.278 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 2.5 t . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.28 -0.867 . . . . 11.77 111.37 179.257 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.246 0 CA-C-O 121.189 0.519 . . . . 10.42 111.225 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 7.7 p -88.49 163.69 2.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.478 -0.783 . . . . 8.81 109.727 178.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 103' ' ' LEU . . . . . 1.066 ' HG ' ' HB3' ' B' ' 108' ' ' ARG . 0.2 OUTLIER -161.42 89.03 0.74 Allowed 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 108.754 -0.832 . . . . 6.28 108.754 174.543 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -88.19 59.15 5.12 Favored 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 119.373 -0.931 . . . . 6.27 112.315 -178.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . 0.848 ' HG ' ' O ' ' B' ' 153' ' ' PRO . 0.2 OUTLIER -119.56 -58.08 1.93 Allowed 'General case' 0 CA--C 1.451 -2.842 0 CA-C-O 124.505 2.098 . . . . 7.61 109.684 -175.727 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 106' ' ' ASP . . . . . 0.616 ' HB2' ' O ' ' B' ' 105' ' ' LEU . 0.3 OUTLIER 159.34 -40.14 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 108.925 -3.762 . . . . 8.55 111.02 177.236 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 107' ' ' VAL . . . . . 0.571 ' H ' HD11 ' B' ' 105' ' ' LEU . 12.0 p -155.05 127.1 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-N 112.128 -2.305 . . . . 7.84 105.658 175.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 108' ' ' ARG . . . . . 1.066 ' HB3' ' HG ' ' B' ' 103' ' ' LEU . 2.0 ptt-85 -77.88 106.61 9.84 Favored 'General case' 0 N--CA 1.406 -2.673 0 C-N-CA 119.598 -0.841 . . . . 9.75 110.625 -177.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 109' ' ' THR . . . . . 0.725 ' HG1' ' HB2' ' B' ' 153' ' ' PRO . 0.2 OUTLIER -105.21 85.92 2.34 Favored 'General case' 0 N--CA 1.408 -2.564 1 N-CA-C 98.598 -4.594 . . . . 6.13 98.598 168.94 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' B' B ' 110' ' ' CYS . . . . . 0.681 ' HA ' ' CB ' ' B' ' 154' ' ' CYS . 81.5 m -76.06 68.72 2.56 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 112.743 -2.026 . . . . 2.87 112.189 -176.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 111' ' ' LEU . . . . . 0.919 HD21 ' HG3' ' B' ' 147' ' ' GLU . 0.0 OUTLIER -36.29 108.58 0.39 Allowed Pre-proline 0 N--CA 1.481 1.115 0 C-N-CA 123.671 0.789 . . . . 2.95 112.417 178.876 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 112' ' ' PRO . . . . . 0.601 ' HA ' ' O ' ' B' ' 119' ' ' GLY . 39.3 Cg_endo -90.44 138.84 2.75 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 123.08 2.52 . . . . 1.71 114.055 -179.291 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.528 ' N ' ' O ' ' B' ' 119' ' ' GLY . 0.5 OUTLIER -151.79 172.38 16.25 Favored 'General case' 0 C--N 1.347 0.495 0 N-CA-C 106.822 -1.547 . . . . 1.0 106.822 179.435 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 114' ' ' GLY . . . . . 0.556 ' HA2' ' OE1' ' B' ' 140' ' ' GLU . . . 71.89 -163.38 54.41 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 119.931 -1.128 . . . . 1.16 114.379 178.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 115' ' ' PRO . . . . . 0.649 ' C ' ' H ' ' B' ' 117' ' ' GLY . 9.5 Cg_endo -69.65 130.35 19.33 Favored 'Trans proline' 0 C--N 1.367 1.549 0 C-N-CA 124.45 3.433 . . . . 1.6 113.194 178.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 70.73 -16.5 1.02 Allowed Glycine 0 C--N 1.287 -2.186 0 CA-C-N 113.041 -1.89 . . . . 1.7 109.686 -176.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 117' ' ' GLY . . . . . 0.649 ' H ' ' C ' ' B' ' 115' ' ' PRO . . . 76.87 16.44 80.77 Favored Glycine 1 N--CA 1.39 -4.42 0 CA-C-N 113.505 -1.347 . . . . 1.38 113.77 178.369 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 118' ' ' LYS . . . . . 0.43 ' H ' ' HG2' ' B' ' 118' ' ' LYS . 0.0 OUTLIER -73.85 6.95 2.86 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 122.257 1.027 . . . . 2.96 108.253 174.955 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 119' ' ' GLY . . . . . 0.601 ' O ' ' HA ' ' B' ' 112' ' ' PRO . . . -89.59 124.15 7.25 Favored Glycine 0 N--CA 1.419 -2.438 0 CA-C-N 113.933 -1.485 . . . . 1.07 115.332 -178.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.833 ' HA ' ' O ' ' B' ' 111' ' ' LEU . 0.1 OUTLIER -112.96 136.4 52.67 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 120.816 -1.402 . . . . 3.29 112.288 -171.719 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 121' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -104.45 127.83 52.23 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.597 0.713 . . . . 1.21 112.131 -177.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -101.32 -45.32 5.37 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 114.656 -1.156 . . . . 2.28 109.237 179.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -122.11 -132.33 4.07 Favored Glycine 0 CA--C 1.522 0.524 0 CA-C-N 115.321 -0.854 . . . . 1.04 111.895 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . 0.416 ' CG ' ' H ' ' B' ' 125' ' ' SER . 89.0 Cg_endo -97.77 -72.84 0.0 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 123.041 2.494 . . . . 1.84 112.02 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 125' ' ' SER . . . . . 0.688 ' O ' HG13 ' B' ' 126' ' ' ILE . 0.9 OUTLIER -89.46 46.73 1.4 Allowed 'General case' 0 C--O 1.225 -0.19 0 N-CA-C 109.288 -0.634 . . . . 1.49 109.288 178.752 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 126' ' ' ILE . . . . . 0.728 HD11 ' HA2' ' B' ' 178' ' ' GLY . 13.4 mt -150.96 116.8 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 CA-C-N 116.041 -0.527 . . . . 1.41 111.735 -178.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 127' ' ' CYS . . . . . 0.649 ' HA ' ' O ' ' B' ' 120' ' ' ARG . 0.5 OUTLIER -139.02 108.3 6.1 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 106.992 -1.484 . . . . 0.89 106.992 178.627 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 128' ' ' CYS . . . . . 1.004 ' HA ' ' O ' ' B' ' 133' ' ' GLY . 0.0 OUTLIER -124.7 129.03 49.73 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 115.357 1.614 . . . . 1.23 115.357 -176.396 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 129' ' ' GLY . . . . . 0.825 ' O ' ' HB3' ' B' ' 169' ' ' ALA . . . -116.21 -178.97 18.18 Favored Glycine 0 C--N 1.356 1.644 0 CA-C-O 122.468 1.038 . . . . 0.69 113.864 -179.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -67.28 -34.88 78.32 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 126.767 2.027 . . . . 2.35 113.42 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.57 17.57 2.91 Favored 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 118.404 -1.319 . . . . 1.69 111.892 176.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 132' ' ' LEU . . . . . 0.862 HD23 ' CE1' ' B' ' 135' ' ' PHE . 0.3 OUTLIER -124.7 -13.5 6.97 Favored 'General case' 0 N--CA 1.42 -1.937 0 CA-C-N 113.17 -1.832 . . . . 1.84 109.306 -176.838 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 133' ' ' GLY . . . . . 1.004 ' O ' ' HA ' ' B' ' 128' ' ' CYS . . . 53.24 -152.48 8.49 Favored Glycine 0 N--CA 1.41 -3.085 0 CA-C-N 114.175 -1.375 . . . . 0.76 114.303 177.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 134' ' ' CYS . . . . . 0.937 ' HB2' ' CD1' ' B' ' 172' ' ' ILE . 0.1 OUTLIER -104.32 123.58 47.64 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 115.301 1.593 . . . . 1.08 115.301 -178.927 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 135' ' ' PHE . . . . . 0.862 ' CE1' HD23 ' B' ' 132' ' ' LEU . 0.0 OUTLIER -96.59 101.75 13.42 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 102.127 -3.286 . . . . 1.83 102.127 173.238 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 136' ' ' VAL . . . . . 0.726 HG12 ' CG1' ' B' ' 126' ' ' ILE . 3.1 t -90.41 84.71 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 CA-C-O 122.471 1.129 . . . . 1.29 109.689 -176.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 137' ' ' GLY . . . . . 0.69 ' O ' ' HA3' ' A' ' 33' ' ' GLY . . . 78.87 78.05 0.86 Allowed Glycine 0 N--CA 1.453 -0.195 0 CA-C-N 113.059 -1.882 . . . . 0.85 111.631 -179.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 138' ' ' THR . . . . . 0.748 ' CG2' ' HD1' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -150.96 155.74 39.73 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 118.928 -0.558 . . . . 1.2 109.671 -178.794 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 139' ' ' ALA . . . . . 0.861 ' O ' ' HB2' ' B' ' 142' ' ' LEU . . . -36.9 -44.06 0.48 Allowed 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 118.142 0.428 . . . . 1.35 111.949 -177.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 140' ' ' GLU . . . . . 0.712 ' O ' ' HG2' ' B' ' 143' ' ' ARG . 55.4 mm-40 -50.25 -49.42 53.14 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.775 -0.578 . . . . 2.31 110.476 178.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 141' ' ' ALA . . . . . 0.856 ' O ' ' HB2' ' B' ' 144' ' ' CYS . . . -71.02 -3.94 22.25 Favored 'General case' 0 C--O 1.214 -0.787 0 CA-C-O 121.495 0.664 . . . . 1.09 110.968 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 142' ' ' LEU . . . . . 0.861 ' HB2' ' O ' ' B' ' 139' ' ' ALA . 2.4 mt -54.39 -46.94 73.19 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 107.267 -1.382 . . . . 1.61 107.267 177.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 143' ' ' ARG . . . . . 0.712 ' HG2' ' O ' ' B' ' 140' ' ' GLU . 0.0 OUTLIER -68.9 0.81 3.96 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 114.921 -1.036 . . . . 3.43 110.727 175.872 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 144' ' ' CYS . . . . . 0.856 ' HB2' ' O ' ' B' ' 141' ' ' ALA . 1.2 m -63.06 -42.79 99.78 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 118.202 -0.904 . . . . 1.61 109.66 178.204 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -40.18 -12.67 0.01 OUTLIER 'General case' 0 C--N 1.36 1.059 0 N-CA-C 117.016 2.228 . . . . 3.52 117.016 -178.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 146' ' ' GLU . . . . . 0.46 ' O ' HD13 ' B' ' 150' ' ' LEU . 1.2 mm-40 -81.38 0.62 36.53 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 118.515 -1.274 . . . . 3.76 108.342 178.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . 0.919 ' HG3' HD21 ' B' ' 111' ' ' LEU . 1.0 OUTLIER -82.04 0.98 37.87 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 114.984 -1.007 . . . . 4.01 109.931 176.698 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 148' ' ' ASN . . . . . . . . . . . . . 21.3 t30 -66.48 -28.68 68.76 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.785 -0.82 . . . . 4.24 108.785 177.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -100.25 33.67 2.59 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 109.344 -0.613 . . . . 6.07 109.344 178.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 150' ' ' LEU . . . . . 0.814 ' CD1' ' HA ' ' B' ' 147' ' ' GLU . 0.9 OUTLIER -142.2 109.84 5.89 Favored Pre-proline 0 CA--C 1.534 0.33 0 CA-C-N 115.474 -0.785 . . . . 5.86 111.144 -179.169 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 151' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -82.45 50.13 3.32 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.145 1.896 . . . . 5.42 112.868 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 62.88 90.45 0.09 OUTLIER Pre-proline 0 N--CA 1.468 0.452 0 CA-C-N 116.07 -0.514 . . . . 6.02 112.046 179.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 153' ' ' PRO . . . . . 0.848 ' O ' ' HG ' ' B' ' 105' ' ' LEU . 69.7 Cg_endo -97.91 -112.05 0.0 OUTLIER 'Trans proline' 0 CA--C 1.554 1.5 0 C-N-CA 123.281 2.654 . . . . 5.87 113.208 -179.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 154' ' ' CYS . . . . . 0.725 ' HA ' HD13 ' B' ' 103' ' ' LEU . 25.9 t -31.75 100.62 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.704 1.202 . . . . 2.96 113.237 -179.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 155' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -82.92 -117.86 0.02 OUTLIER 'General case' 0 CA--C 1.551 0.989 0 N-CA-C 112.026 0.38 . . . . 6.3 112.026 -179.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 1.4 m 69.78 114.59 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 122.567 0.347 . . . . 3.41 111.321 -179.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 157' ' ' GLY . . . . . 0.536 ' O ' ' HB2' ' B' ' 166' ' ' ARG . . . 142.0 61.71 0.03 OUTLIER Glycine 0 N--CA 1.44 -1.092 0 N-CA-C 109.075 -1.61 . . . . 2.26 109.075 -178.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -117.24 64.15 0.73 Allowed 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 122.508 1.147 . . . . 5.03 110.719 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 159' ' ' LYS . . . . . 1.037 ' HB3' ' HB3' ' B' ' 167' ' ' CYS . 0.5 OUTLIER -118.64 66.79 7.19 Favored Pre-proline 0 C--N 1.31 -1.113 0 CA-C-N 113.126 -1.852 . . . . 3.96 108.083 174.457 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 160' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -62.17 119.39 6.47 Favored 'Trans proline' 0 C--O 1.231 0.145 0 N-CA-C 116.259 1.6 . . . . 1.7 116.259 -174.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 161' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -146.49 -174.4 4.45 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 112.84 -1.982 . . . . 1.93 105.84 176.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 162' ' ' GLY . . . . . 0.434 ' HA2' ' CE1' ' B' ' 180' ' ' HIS . . . 69.2 -166.07 48.43 Favored Glycine 0 CA--C 1.508 -0.366 0 C-N-CA 118.5 -1.81 . . . . 2.37 112.51 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 4.6 p -88.0 37.05 0.79 Allowed 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 122.713 1.244 . . . . 4.56 110.644 -175.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 164' ' ' GLY . . . . . 0.417 ' H ' ' C ' ' B' ' 162' ' ' GLY . . . 121.57 5.62 9.16 Favored Glycine 0 CA--C 1.556 2.598 0 CA-C-N 112.833 -1.985 . . . . 2.39 114.61 -176.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 165' ' ' GLY . . . . . 0.896 ' HA2' ' HB3' ' B' ' 175' ' ' SER . . . -101.21 135.36 12.12 Favored Glycine 0 C--N 1.346 1.087 0 CA-C-N 121.319 2.56 . . . . 1.79 116.283 -177.007 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 166' ' ' ARG . . . . . 0.536 ' HB2' ' O ' ' B' ' 157' ' ' GLY . 0.0 OUTLIER -90.2 154.93 19.38 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.01 0.524 . . . . 3.53 110.497 178.391 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 167' ' ' CYS . . . . . 1.037 ' HB3' ' HB3' ' B' ' 159' ' ' LYS . 42.9 t -70.96 103.17 2.59 Favored 'General case' 0 N--CA 1.406 -2.633 0 N-CA-C 108.071 -1.085 . . . . 1.56 108.071 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 168' ' ' ALA . . . . . . . . . . . . . . . -75.95 -41.38 51.78 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 105.363 -2.088 . . . . 1.42 105.363 176.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 169' ' ' ALA . . . . . 0.825 ' HB3' ' O ' ' B' ' 129' ' ' GLY . . . -140.45 160.74 39.32 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 111.547 -2.57 . . . . 1.18 112.047 -173.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 170' ' ' ALA . . . . . 0.849 ' HA ' ' HB3' ' B' ' 185' ' ' CYS . . . -53.76 121.03 7.04 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 121.686 0.755 . . . . 1.47 112.792 -179.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 171' ' ' GLY . . . . . 0.539 ' H ' ' CB ' ' B' ' 185' ' ' CYS . . . 77.52 3.75 83.47 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 116.369 1.308 . . . . 1.45 116.369 176.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 172' ' ' ILE . . . . . 0.937 ' CD1' ' HB2' ' B' ' 134' ' ' CYS . 1.1 pp -131.97 106.41 11.26 Favored 'Isoleucine or valine' 0 C--O 1.245 0.823 0 CA-C-N 118.482 1.141 . . . . 2.7 110.781 -179.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 173' ' ' CYS . . . . . 0.672 ' HB2' ' O ' ' B' ' 180' ' ' HIS . 0.1 OUTLIER -84.52 90.51 7.65 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 115.153 -0.931 . . . . 1.94 109.755 -179.2 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 174' ' ' CYS . . . . . 0.753 ' HA ' ' HA ' ' B' ' 179' ' ' CYS . 0.5 OUTLIER -99.84 132.86 44.93 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 113.241 0.83 . . . . 1.43 113.241 -177.986 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 175' ' ' SER . . . . . 0.911 ' HB2' ' HD2' ' B' ' 176' ' ' PRO . 43.5 p -109.34 -177.58 0.48 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 114.269 -1.332 . . . . 2.3 108.686 178.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 176' ' ' PRO . . . . . 0.911 ' HD2' ' HB2' ' B' ' 175' ' ' SER . 62.8 Cg_endo -74.48 30.95 0.34 Allowed 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 121.387 1.391 . . . . 2.13 111.768 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 177' ' ' ASP . . . . . 0.964 ' HB3' ' HD2' ' A' ' 80' ' ' HIS . 4.8 m-20 -143.22 -50.79 0.34 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.523 -0.762 . . . . 2.72 110.778 179.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 178' ' ' GLY . . . . . 0.728 ' HA2' HD11 ' B' ' 126' ' ' ILE . . . -160.48 -166.05 18.52 Favored Glycine 0 CA--C 1.522 0.48 0 N-CA-C 111.752 -0.539 . . . . 1.05 111.752 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 179' ' ' CYS . . . . . 0.753 ' HA ' ' HA ' ' B' ' 174' ' ' CYS . 3.1 m -124.26 160.78 27.2 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 117.718 0.759 . . . . 1.39 110.144 179.349 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 180' ' ' HIS . . . . . 1.084 ' HD2' ' HB3' ' A' ' 77' ' ' ASP . 5.6 t-80 -148.72 123.21 9.72 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-O 121.663 0.744 . . . . 2.73 109.072 -174.098 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 181' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -46.78 132.41 11.33 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 114.572 -1.194 . . . . 3.06 111.921 -176.162 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 182' ' ' ASP . . . . . 0.525 ' O ' ' HA2' ' B' ' 171' ' ' GLY . 0.9 OUTLIER -141.54 119.84 7.84 Favored Pre-proline 0 CA--C 1.545 0.751 0 CA-C-N 114.909 -1.041 . . . . 2.06 110.341 -178.735 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 183' ' ' PRO . . . . . 0.671 ' HA ' ' OD2' ' B' ' 186' ' ' ASP . 4.4 Cg_exo -78.31 -13.81 15.06 Favored 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 122.836 2.358 . . . . 2.27 113.854 -178.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -64.26 -38.27 90.44 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.834 0.35 . . . . 1.56 111.661 -179.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 185' ' ' CYS . . . . . 0.849 ' HB3' ' HA ' ' B' ' 170' ' ' ALA . 21.8 m -91.91 50.34 1.67 Allowed 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 116.179 -0.464 . . . . 1.94 110.53 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 186' ' ' ASP . . . . . 0.785 ' CB ' ' HB1' ' B' ' 189' ' ' ALA . 78.5 m-20 -133.09 37.16 0.36 Allowed Pre-proline 0 CA--C 1.551 1.013 0 N-CA-C 116.042 1.867 . . . . 3.61 116.042 -177.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 187' ' ' PRO . . . . . 0.706 ' HD3' ' N ' ' B' ' 186' ' ' ASP . 2.4 Cg_endo -83.46 51.26 3.49 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.539 2.159 . . . . 3.14 111.842 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 188' ' ' GLU . . . . . 0.647 ' C ' ' H ' ' B' ' 190' ' ' ALA . 5.2 pt-20 175.49 -33.67 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.527 0 CA-C-N 110.811 -2.904 . . . . 4.7 108.522 -174.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 189' ' ' ALA . . . . . 0.785 ' HB1' ' CB ' ' B' ' 186' ' ' ASP . . . -69.49 18.95 0.04 OUTLIER 'General case' 0 CA--C 1.567 1.616 0 CA-C-N 110.403 -3.09 . . . . 5.24 109.047 170.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 190' ' ' ALA . . . . . 0.647 ' H ' ' C ' ' B' ' 188' ' ' GLU . . . -87.78 138.51 31.4 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.728 2.011 . . . . 6.93 111.551 176.33 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 191' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -95.62 114.38 26.13 Favored 'General case' 0 C--N 1.343 0.289 0 CA-C-N 112.796 -2.002 . . . . 10.62 111.296 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 2.6 t . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.321 -0.847 . . . . 11.7 111.496 179.339 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.462 ' O ' HD12 ' A' ' 3' ' ' LEU . . . . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 120.818 0.342 . . . . 10.31 110.897 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.563 ' C ' HG22 ' A' ' 9' ' ' THR . 14.4 p -79.86 75.4 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-O 124.367 2.032 . . . . 8.37 110.708 178.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.633 ' HA ' ' HB ' ' A' ' 9' ' ' THR . 0.0 OUTLIER -101.83 78.62 1.83 Allowed 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 109.243 -3.617 . . . . 6.25 114.916 -179.909 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.46 60.81 4.2 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 123.109 1.433 . . . . 6.22 108.433 175.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.651 ' CD1' ' H ' ' A' ' 6' ' ' ASP . 0.4 OUTLIER -153.53 -135.67 0.06 Allowed 'General case' 0 N--CA 1.386 -3.674 0 CA-C-N 111.208 -2.724 . . . . 7.57 106.147 178.785 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.651 ' H ' ' CD1' ' A' ' 5' ' ' LEU . 6.0 t0 -158.41 25.02 0.24 Allowed 'General case' 0 C--N 1.291 -1.974 0 CA-C-O 122.388 1.089 . . . . 8.78 109.212 -176.5 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.646 HG11 HD11 ' A' ' 5' ' ' LEU . 4.7 p -151.56 172.94 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.689 0 N-CA-C 104.578 -2.379 . . . . 7.88 104.578 179.067 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.4 ptp85 -71.05 119.54 15.32 Favored 'General case' 0 CA--C 1.475 -1.909 0 N-CA-C 106.449 -1.686 . . . . 9.7 106.449 -176.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.633 ' HB ' ' HA ' ' A' ' 3' ' ' LEU . 1.4 t -55.17 111.95 0.97 Allowed 'General case' 0 N--CA 1.418 -2.056 0 C-N-CA 117.992 -1.483 . . . . 6.05 109.512 -175.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.431 ' HB3' ' HB2' ' A' ' 54' ' ' CYS . 12.5 p -29.29 111.44 0.06 Allowed 'General case' 0 C--N 1.309 -1.152 0 CA-C-N 111.801 -2.454 . . . . 2.89 113.806 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.428 HD22 ' CD ' ' A' ' 12' ' ' PRO . 26.1 mt -30.96 154.53 0.03 OUTLIER Pre-proline 0 N--CA 1.48 1.039 0 C-N-CA 123.872 0.869 . . . . 2.89 113.305 178.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.693 ' HB2' ' O ' ' A' ' 17' ' ' GLY . 33.4 Cg_endo -91.92 117.39 0.44 Allowed 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 123.312 2.675 . . . . 1.72 116.295 -178.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.647 ' SG ' ' O ' ' A' ' 20' ' ' ARG . 10.6 p -106.64 -156.41 0.58 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.693 1.197 . . . . 1.0 110.515 -176.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 79.96 -168.22 51.98 Favored Glycine 0 CA--C 1.498 -0.987 0 N-CA-C 110.373 -1.091 . . . . 1.15 110.373 -177.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.486 ' HG2' ' HG3' ' A' ' 18' ' ' LYS . 85.2 Cg_endo -63.8 89.87 0.15 Allowed 'Trans proline' 0 CA--C 1.51 -0.706 0 CA-C-N 119.793 1.796 . . . . 1.6 110.932 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.88 18.3 63.67 Favored Glycine 0 N--CA 1.418 -2.548 0 CA-C-N 114.168 -1.378 . . . . 1.68 114.199 177.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.693 ' O ' ' HB2' ' A' ' 12' ' ' PRO . . . 84.18 36.76 12.19 Favored Glycine 0 N--CA 1.404 -3.485 0 C-N-CA 118.077 -2.011 . . . . 1.37 115.947 176.035 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.486 ' HG3' ' HG2' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -92.63 -12.54 31.35 Favored 'General case' 0 CA--C 1.559 1.32 0 CA-C-N 115.0 -0.6 . . . . 2.91 110.999 175.896 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.551 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -102.21 -176.79 27.69 Favored Glycine 0 N--CA 1.478 1.467 0 C-N-CA 126.298 1.904 . . . . 1.06 109.379 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.647 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -126.18 168.97 13.32 Favored 'General case' 0 C--N 1.354 0.786 0 CA-C-N 122.707 3.253 . . . . 3.32 105.7 175.368 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.659 ' HB2' ' HG2' ' A' ' 47' ' ' GLU . 33.7 m -108.49 163.08 13.54 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 119.334 0.97 . . . . 1.19 113.331 -178.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -143.47 -57.04 0.4 Allowed 'General case' 0 C--O 1.232 0.146 0 CA-C-N 114.82 -1.082 . . . . 2.26 109.913 178.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.532 ' O ' ' HB3' ' A' ' 44' ' ' CYS . . . -120.54 176.91 16.33 Favored Glycine 0 C--N 1.332 0.319 0 CA-C-N 115.866 -0.606 . . . . 1.05 112.005 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.411 ' HB2' ' OE1' ' B' ' 181' ' ' GLU . 47.7 Cg_exo -53.67 -68.77 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.49 2.127 . . . . 1.81 112.368 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.652 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.5 OUTLIER -95.59 18.19 13.33 Favored 'General case' 0 C--O 1.224 -0.271 0 N-CA-C 109.995 -0.372 . . . . 1.62 109.995 178.878 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.894 HG12 HG13 ' A' ' 36' ' ' VAL . 1.2 mt -122.41 106.26 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 CA-C-O 121.751 0.786 . . . . 1.39 111.797 -177.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.749 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 0.6 OUTLIER -121.94 124.13 43.31 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 114.725 -1.125 . . . . 0.92 109.615 -179.011 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 1.168 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -138.52 112.82 8.72 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 114.978 1.473 . . . . 1.28 114.978 -178.607 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.495 ' O ' ' HB3' ' A' ' 69' ' ' ALA . . . -106.41 -159.17 22.03 Favored Glycine 0 N--CA 1.429 -1.832 0 N-CA-C 109.559 -1.416 . . . . 0.71 109.559 175.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -65.5 -64.86 0.76 Allowed 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 112.69 0.626 . . . . 2.27 112.69 -178.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.51 17.36 20.85 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 122.61 1.195 . . . . 1.66 109.808 -176.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -113.95 -11.72 12.74 Favored 'General case' 0 N--CA 1.404 -2.759 0 N-CA-C 105.486 -2.042 . . . . 1.93 105.486 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 1.168 ' O ' ' HA ' ' A' ' 28' ' ' CYS . . . 50.68 -135.48 29.33 Favored Glycine 0 N--CA 1.415 -2.758 0 CA-C-N 114.275 -1.33 . . . . 0.77 111.769 175.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.81 ' HB2' ' CD1' ' A' ' 72' ' ' ILE . 1.8 t -129.04 111.85 13.41 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-N 118.803 1.301 . . . . 1.08 112.678 179.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.761 ' HA ' ' HA ' ' B' ' 135' ' ' PHE . 6.2 m-30 -85.18 105.41 15.86 Favored 'General case' 0 N--CA 1.408 -2.525 0 N-CA-C 103.543 -2.762 . . . . 1.85 103.543 176.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.894 HG13 HG12 ' A' ' 26' ' ' ILE . 2.2 t -97.27 85.27 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.75 0 CA-C-O 123.129 1.443 . . . . 1.29 107.79 -178.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.657 ' O ' ' HA3' ' B' ' 133' ' ' GLY . . . 110.97 92.96 2.17 Favored Glycine 0 CA--C 1.521 0.464 0 CA-C-N 112.427 -2.169 . . . . 0.85 114.263 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.688 ' CG2' ' HB3' ' A' ' 35' ' ' PHE . 0.0 OUTLIER 178.77 169.26 0.89 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 110.096 -0.335 . . . . 1.3 110.096 178.29 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.609 ' HA ' HD11 ' A' ' 42' ' ' LEU . . . -68.42 -35.83 78.21 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.832 -0.347 . . . . 1.45 110.933 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.86 -24.18 14.94 Favored 'General case' 0 C--N 1.332 -0.181 0 O-C-N 122.093 -0.379 . . . . 2.32 111.691 -178.54 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.682 ' O ' ' N ' ' A' ' 44' ' ' CYS . . . -97.23 -23.33 16.22 Favored 'General case' 0 C--O 1.214 -0.781 0 CA-C-N 116.818 -0.174 . . . . 1.11 111.242 -179.373 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.609 HD11 ' HA ' ' A' ' 39' ' ' ALA . 1.0 OUTLIER -37.38 -46.73 0.8 Allowed 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.969 0.729 . . . . 1.68 112.969 -175.771 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.481 ' HD2' ' H ' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -53.7 -25.68 19.43 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.813 -0.81 . . . . 3.4 108.813 177.557 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.682 ' N ' ' O ' ' A' ' 41' ' ' ALA . 86.2 m -57.33 -20.57 29.67 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.427 -0.806 . . . . 1.57 110.473 -178.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -39.09 -45.04 1.22 Allowed 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.594 0.59 . . . . 3.49 112.594 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -87.74 -7.57 57.17 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 119.873 -0.731 . . . . 3.69 110.991 -179.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.659 ' HG2' ' HB2' ' A' ' 21' ' ' CYS . 0.8 OUTLIER -85.02 6.46 25.15 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.903 -0.589 . . . . 3.99 109.453 177.139 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.528 ' C ' ' H ' ' A' ' 50' ' ' LEU . 7.5 p-10 -71.9 -26.57 62.37 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.632 -0.713 . . . . 4.2 109.394 177.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 19.7 t80 -51.59 8.31 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 114.565 1.32 . . . . 5.85 114.565 -178.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.583 ' N ' HD13 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -133.16 132.41 22.22 Favored Pre-proline 0 N--CA 1.466 0.336 0 CA-C-N 118.754 0.706 . . . . 5.83 110.738 178.539 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.524 ' HA ' ' HG3' ' A' ' 76' ' ' PRO . 95.6 Cg_endo -86.74 10.64 3.54 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.846 2.364 . . . . 5.3 113.401 -178.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.647 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 0.8 OUTLIER 160.58 -52.08 0.0 OUTLIER Pre-proline 0 N--CA 1.465 0.284 0 CA-C-O 120.686 0.279 . . . . 5.72 111.326 -179.865 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.647 ' HD2' ' N ' ' A' ' 52' ' ' SER . 11.8 Cg_endo -55.71 121.63 10.31 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 123.092 2.528 . . . . 5.82 114.758 -178.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.555 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 0.1 OUTLIER -178.78 107.13 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 115.439 -0.8 . . . . 2.98 109.84 178.139 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.613 ' HA ' ' HB2' ' A' ' 5' ' ' LEU . 18.9 pt20 33.06 -156.1 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.4 0.518 . . . . 6.42 112.4 -177.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.2 t -80.13 105.81 11.68 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 112.569 0.581 . . . . 3.36 112.569 -178.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 164.17 35.23 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 110.534 -1.026 . . . . 2.3 110.534 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.523 ' HA ' ' HB2' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -123.26 88.99 3.02 Favored 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 109.043 -0.725 . . . . 5.06 109.043 179.611 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.529 ' HB3' ' HB2' ' A' ' 67' ' ' CYS . 0.5 OUTLIER -135.52 81.39 42.42 Favored Pre-proline 0 C--N 1.296 -1.755 0 N-CA-C 106.065 -1.828 . . . . 3.91 106.065 -178.647 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.449 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 12.0 Cg_endo -55.44 107.18 0.22 Allowed 'Trans proline' 0 C--N 1.358 1.05 0 C-N-CA 123.868 3.046 . . . . 1.74 114.241 -177.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.482 ' O ' ' O ' ' A' ' 65' ' ' GLY . 0.5 OUTLIER -144.34 149.63 36.49 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-N 114.333 -1.303 . . . . 1.9 110.144 178.811 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 79.36 -167.26 51.97 Favored Glycine 0 C--N 1.339 0.73 0 C-N-CA 119.039 -1.553 . . . . 2.43 109.683 -173.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.05 66.67 0.15 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 118.668 1.234 . . . . 4.32 112.472 -175.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.22 13.73 80.24 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.984 -0.627 . . . . 2.4 114.347 177.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.482 ' O ' ' O ' ' A' ' 61' ' ' CYS . . . -101.01 122.19 7.51 Favored Glycine 0 CA--C 1.501 -0.836 0 C-N-CA 119.59 -1.29 . . . . 1.82 113.66 -175.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.523 ' HB2' ' HA ' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -86.54 152.24 22.8 Favored 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 110.067 -0.345 . . . . 3.51 110.067 -178.929 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.529 ' HB2' ' HB3' ' A' ' 59' ' ' LYS . 0.1 OUTLIER -67.03 106.54 1.98 Allowed 'General case' 0 N--CA 1.423 -1.802 0 N-CA-C 108.674 -0.862 . . . . 1.52 108.674 -179.196 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -91.88 -23.72 19.55 Favored 'General case' 0 N--CA 1.417 -2.108 0 N-CA-C 107.468 -1.308 . . . . 1.5 107.468 177.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.827 ' CB ' ' HA2' ' A' ' 33' ' ' GLY . . . -169.72 163.26 9.92 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 109.875 -0.417 . . . . 1.31 109.875 -178.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.823 ' HA ' ' HB3' ' A' ' 85' ' ' CYS . . . -37.35 127.06 1.05 Allowed 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 115.611 1.708 . . . . 1.5 115.611 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.627 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . 59.08 -6.39 0.05 OUTLIER Glycine 0 C--N 1.342 0.912 0 N-CA-C 115.97 1.148 . . . . 1.44 115.97 177.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.81 ' CD1' ' HB2' ' A' ' 34' ' ' CYS . 1.6 pp -117.58 105.82 18.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 117.662 0.731 . . . . 2.77 111.846 -178.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -91.93 106.7 18.66 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.018 -0.992 . . . . 1.98 108.844 179.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.447 ' SG ' HD11 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -129.65 170.49 13.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 122.113 0.958 . . . . 1.43 113.561 -178.436 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.735 ' HB3' ' HD2' ' A' ' 76' ' ' PRO . 10.3 m -130.42 179.62 1.28 Allowed Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 113.297 -1.774 . . . . 2.37 106.947 178.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.735 ' HD2' ' HB3' ' A' ' 75' ' ' SER . 58.1 Cg_endo -75.94 30.81 0.39 Allowed 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 120.994 1.129 . . . . 2.09 112.258 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.46 ' H ' ' C ' ' A' ' 75' ' ' SER . 2.7 m-20 -138.16 -57.15 0.66 Allowed 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.859 -0.61 . . . . 2.65 109.925 179.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.489 ' HA3' ' HD2' ' B' ' 180' ' ' HIS . . . -139.31 -178.15 16.23 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.507 -0.854 . . . . 1.04 112.842 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.503 ' SG ' ' HB ' ' A' ' 72' ' ' ILE . 13.4 t -142.48 160.68 39.8 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 110.139 -0.319 . . . . 1.42 110.139 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.481 ' HD2' ' HA3' ' B' ' 178' ' ' GLY . 0.3 OUTLIER -149.7 134.68 17.93 Favored 'General case' 0 CA--C 1.521 -0.164 0 C-N-CA 119.986 -0.686 . . . . 2.81 112.179 -178.587 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.86 119.46 10.04 Favored 'General case' 0 CA--C 1.51 -0.59 0 N-CA-C 108.363 -0.977 . . . . 3.05 108.363 177.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.509 ' OD1' ' HB1' ' A' ' 84' ' ' ALA . 0.2 OUTLIER -154.48 139.18 11.65 Favored Pre-proline 0 C--N 1.317 -0.846 0 C-N-CA 120.534 -0.466 . . . . 2.02 110.971 -179.013 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -70.17 41.84 0.36 Allowed 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.987 2.458 . . . . 2.29 113.049 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.509 ' HB1' ' OD1' ' A' ' 82' ' ' ASP . . . -75.11 -58.96 2.96 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-O 122.698 1.237 . . . . 1.53 109.363 178.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.915 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 52.5 m -105.78 80.98 1.6 Allowed 'General case' 0 N--CA 1.435 -1.222 0 CA-C-N 112.507 -2.133 . . . . 1.88 109.102 -179.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.455 ' O ' ' N ' ' A' ' 88' ' ' GLU . 0.0 OUTLIER -97.93 88.87 0.68 Allowed Pre-proline 0 N--CA 1.453 -0.287 0 CA-C-N 116.007 -0.542 . . . . 3.6 111.942 -178.013 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.915 ' HD3' ' O ' ' A' ' 85' ' ' CYS . 19.5 Cg_exo -66.7 76.96 0.38 Allowed 'Trans proline' 0 CA--C 1.506 -0.88 0 C-N-CA 123.017 2.478 . . . . 3.12 108.368 178.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.455 ' N ' ' O ' ' A' ' 86' ' ' ASP . 9.3 pt-20 -170.87 -30.7 0.02 OUTLIER 'General case' 0 N--CA 1.426 -1.647 0 CA-C-N 113.108 -1.86 . . . . 4.72 110.5 177.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.09 71.22 0.16 Allowed 'General case' 0 C--N 1.314 -0.96 0 O-C-N 118.994 -2.317 . . . . 5.29 115.94 -174.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.79 179.78 3.0 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 120.56 -1.337 . . . . 7.19 110.519 -179.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -90.06 63.29 5.84 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 118.591 0.632 . . . . 10.7 110.423 177.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 15.9 p . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.231 -0.89 . . . . 11.77 111.248 -179.892 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 101' ' ' ALA . . . . . 0.532 ' O ' ' CG2' ' B' ' 109' ' ' THR . . . . . . . . 0 N--CA 1.488 1.46 0 CA-C-O 120.559 0.219 . . . . 10.42 111.233 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 102' ' ' VAL . . . . . 0.411 HG12 ' O ' ' B' ' 101' ' ' ALA . 9.4 p 43.47 48.12 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.138 0 CA-C-O 122.616 1.198 . . . . 8.81 113.68 178.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 103' ' ' LEU . . . . . 0.563 ' HB3' ' H ' ' B' ' 109' ' ' THR . 0.0 OUTLIER -69.98 95.03 0.91 Allowed 'General case' 0 N--CA 1.484 1.232 0 CA-C-N 112.717 -2.038 . . . . 6.28 108.825 177.835 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 104' ' ' ASP . . . . . 0.441 ' C ' ' HA ' ' B' ' 155' ' ' GLN . 2.4 m-20 -104.99 59.4 0.68 Allowed 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 113.928 -1.487 . . . . 6.27 111.289 178.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . 0.629 ' HG ' ' N ' ' B' ' 154' ' ' CYS . 1.9 tm? -148.71 -87.44 0.09 Allowed 'General case' 0 N--CA 1.381 -3.925 0 N-CA-C 101.787 -3.412 . . . . 7.61 101.787 172.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 106' ' ' ASP . . . . . 0.536 ' N ' HD13 ' B' ' 105' ' ' LEU . 0.5 OUTLIER -168.25 -48.82 0.02 OUTLIER 'General case' 0 C--N 1.277 -2.561 0 CA-C-N 111.99 -2.368 . . . . 8.55 107.744 -179.434 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 107' ' ' VAL . . . . . 0.534 ' H ' HD11 ' B' ' 105' ' ' LEU . 4.6 p -84.46 174.46 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.485 -1.531 0 CA-C-N 111.701 -2.499 . . . . 7.84 107.355 -175.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 2.6 ptp85 -71.41 114.1 9.13 Favored 'General case' 0 N--CA 1.418 -2.052 0 C-N-CA 117.83 -1.548 . . . . 9.75 107.192 -175.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 109' ' ' THR . . . . . 0.563 ' H ' ' HB3' ' B' ' 103' ' ' LEU . 1.6 t -47.37 111.3 0.39 Allowed 'General case' 0 N--CA 1.425 -1.718 0 CA-C-O 122.848 1.309 . . . . 6.13 109.812 -177.021 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 110' ' ' CYS . . . . . 0.435 ' SG ' ' HB3' ' B' ' 120' ' ' ARG . 12.0 p -31.1 110.93 0.07 Allowed 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 112.085 -2.325 . . . . 2.87 114.003 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 111' ' ' LEU . . . . . 0.421 ' O ' ' O ' ' B' ' 110' ' ' CYS . 25.5 mt -30.19 154.3 0.03 OUTLIER Pre-proline 0 N--CA 1.481 1.081 0 N-CA-C 113.314 0.857 . . . . 2.95 113.314 178.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 112' ' ' PRO . . . . . 0.717 ' HB2' ' O ' ' B' ' 117' ' ' GLY . 48.5 Cg_endo -88.14 122.32 1.53 Allowed 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.423 2.749 . . . . 1.71 113.726 -178.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.646 ' SG ' ' O ' ' B' ' 120' ' ' ARG . 8.1 p -109.26 -153.59 0.51 Allowed 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 121.267 0.556 . . . . 1.0 110.625 178.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . 78.9 -168.13 53.26 Favored Glycine 0 CA--C 1.49 -1.498 0 N-CA-C 110.361 -1.096 . . . . 1.16 110.361 -179.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 115' ' ' PRO . . . . . 0.497 ' HG2' ' HG3' ' B' ' 118' ' ' LYS . 97.2 Cg_endo -64.59 85.93 0.16 Allowed 'Trans proline' 0 N--CA 1.45 -1.044 0 CA-C-N 119.556 1.678 . . . . 1.6 113.608 -178.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 86.13 19.22 57.84 Favored Glycine 0 N--CA 1.423 -2.192 0 CA-C-N 113.154 -1.839 . . . . 1.7 115.083 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 117' ' ' GLY . . . . . 0.717 ' O ' ' HB2' ' B' ' 112' ' ' PRO . . . 87.33 34.7 10.24 Favored Glycine 0 N--CA 1.413 -2.883 0 C-N-CA 119.536 -1.316 . . . . 1.38 116.182 176.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 118' ' ' LYS . . . . . 0.497 ' HG3' ' HG2' ' B' ' 115' ' ' PRO . 0.1 OUTLIER -93.03 -7.37 45.92 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 122.252 0.221 . . . . 2.96 111.267 177.289 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 119' ' ' GLY . . . . . 0.583 ' O ' ' HA ' ' B' ' 112' ' ' PRO . . . -114.89 -169.22 16.0 Favored Glycine 0 C--N 1.344 1.008 0 N-CA-C 108.112 -1.995 . . . . 1.07 108.112 177.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.646 ' O ' ' SG ' ' B' ' 113' ' ' CYS . 0.0 OUTLIER -125.08 168.69 13.03 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 120.934 2.367 . . . . 3.29 108.838 179.589 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 121' ' ' CYS . . . . . 0.664 ' HB2' ' HG2' ' B' ' 147' ' ' GLU . 33.4 m -108.28 162.45 14.08 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.201 0.815 . . . . 1.21 113.201 -178.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -143.52 -56.98 0.4 Allowed 'General case' 0 C--O 1.231 0.107 0 CA-C-N 114.698 -1.137 . . . . 2.28 109.91 179.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 123' ' ' GLY . . . . . 0.551 ' O ' ' HB3' ' B' ' 144' ' ' CYS . . . -120.83 177.07 16.36 Favored Glycine 0 CA--C 1.52 0.36 0 CA-C-N 115.898 -0.592 . . . . 1.04 112.029 179.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . 0.408 ' O ' ' HB2' ' B' ' 144' ' ' CYS . 51.2 Cg_exo -53.58 -68.93 0.06 OUTLIER 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.515 2.143 . . . . 1.84 112.427 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 125' ' ' SER . . . . . 0.654 ' O ' ' N ' ' B' ' 137' ' ' GLY . 0.5 OUTLIER -95.47 18.33 12.88 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-O 120.88 0.372 . . . . 1.49 110.018 178.794 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 126' ' ' ILE . . . . . 0.871 HG12 HG13 ' B' ' 136' ' ' VAL . 1.5 mt -122.21 105.8 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 CA-C-O 121.546 0.688 . . . . 1.41 111.951 -177.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 127' ' ' CYS . . . . . 0.755 ' O ' ' HA ' ' B' ' 134' ' ' CYS . 0.6 OUTLIER -122.02 124.5 44.12 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 114.821 -1.081 . . . . 0.89 109.828 -179.175 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 128' ' ' CYS . . . . . 1.239 ' HA ' ' O ' ' B' ' 133' ' ' GLY . 0.0 OUTLIER -140.16 110.49 6.63 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 115.995 1.85 . . . . 1.23 115.995 -178.097 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 129' ' ' GLY . . . . . 0.492 ' O ' ' HB3' ' B' ' 169' ' ' ALA . . . -102.77 -161.05 25.78 Favored Glycine 0 N--CA 1.433 -1.53 0 N-CA-C 110.499 -1.04 . . . . 0.69 110.499 176.016 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -68.32 -56.97 6.73 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 114.766 1.395 . . . . 2.35 114.766 -177.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.34 29.27 7.56 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 122.81 1.29 . . . . 1.69 109.478 178.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.66 -12.21 7.67 Favored 'General case' 0 N--CA 1.4 -2.926 0 N-CA-C 104.16 -2.533 . . . . 1.84 104.16 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 133' ' ' GLY . . . . . 1.239 ' O ' ' HA ' ' B' ' 128' ' ' CYS . . . 51.09 -132.66 33.16 Favored Glycine 0 N--CA 1.4 -3.755 0 CA-C-N 113.424 -1.716 . . . . 0.76 112.674 176.126 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 134' ' ' CYS . . . . . 0.823 ' HB2' ' CD1' ' B' ' 172' ' ' ILE . 1.7 t -129.42 112.43 13.8 Favored 'General case' 0 CA--C 1.495 -1.152 0 CA-C-N 118.413 1.106 . . . . 1.08 112.675 178.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 135' ' ' PHE . . . . . 0.761 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 6.2 m-30 -86.72 105.27 16.83 Favored 'General case' 0 N--CA 1.407 -2.578 0 N-CA-C 103.452 -2.796 . . . . 1.83 103.452 175.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 136' ' ' VAL . . . . . 0.871 HG13 HG12 ' B' ' 126' ' ' ILE . 2.8 t -97.15 85.32 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.728 0 CA-C-O 122.913 1.34 . . . . 1.29 107.64 -178.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 137' ' ' GLY . . . . . 0.654 ' N ' ' O ' ' B' ' 125' ' ' SER . . . 110.7 92.93 2.18 Favored Glycine 0 CA--C 1.522 0.507 0 CA-C-N 112.64 -2.073 . . . . 0.85 114.193 -179.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 138' ' ' THR . . . . . 0.688 ' CG2' ' HB3' ' B' ' 135' ' ' PHE . 0.0 OUTLIER 178.84 169.97 0.88 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.761 -0.459 . . . . 1.2 109.761 178.298 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 139' ' ' ALA . . . . . 0.616 ' HA ' HD11 ' B' ' 142' ' ' LEU . . . -74.59 -22.89 58.72 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.586 0.588 . . . . 1.35 112.586 -179.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 140' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.7 -25.37 67.37 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.904 -0.318 . . . . 2.31 110.587 178.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 141' ' ' ALA . . . . . 0.682 ' O ' ' N ' ' B' ' 144' ' ' CYS . . . -97.36 -20.79 17.59 Favored 'General case' 0 C--O 1.213 -0.866 0 CA-C-N 116.265 -0.425 . . . . 1.09 111.583 -178.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 142' ' ' LEU . . . . . 0.616 HD11 ' HA ' ' B' ' 139' ' ' ALA . 0.9 OUTLIER -38.16 -47.41 1.15 Allowed 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 112.701 0.63 . . . . 1.61 112.701 -176.73 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 143' ' ' ARG . . . . . 0.481 ' HD2' ' H ' ' B' ' 143' ' ' ARG . 0.0 OUTLIER -54.0 -24.56 17.32 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.07 -0.715 . . . . 3.43 109.07 177.475 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 144' ' ' CYS . . . . . 0.682 ' N ' ' O ' ' B' ' 141' ' ' ALA . 93.6 m -56.09 -24.96 43.55 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 114.292 -1.322 . . . . 1.61 109.496 -179.154 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -36.47 -45.55 0.5 Allowed 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.929 0.714 . . . . 3.52 112.929 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -87.84 -7.39 57.3 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 119.826 -0.75 . . . . 3.76 111.017 -178.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . 0.664 ' HG2' ' HB2' ' B' ' 121' ' ' CYS . 0.8 OUTLIER -85.01 6.04 26.9 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 115.875 -0.602 . . . . 4.01 109.411 177.167 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 148' ' ' ASN . . . . . 0.525 ' C ' ' H ' ' B' ' 150' ' ' LEU . 7.6 p-10 -71.53 -26.64 62.73 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.63 -0.713 . . . . 4.24 109.385 177.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -51.59 8.23 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 114.614 1.338 . . . . 6.07 114.614 -178.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 150' ' ' LEU . . . . . 0.525 ' H ' ' C ' ' B' ' 148' ' ' ASN . 0.0 OUTLIER -133.03 132.56 22.43 Favored Pre-proline 0 N--CA 1.466 0.335 0 CA-C-N 118.733 0.697 . . . . 5.86 110.734 178.401 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 151' ' ' PRO . . . . . 0.52 ' HA ' ' HG3' ' B' ' 176' ' ' PRO . 93.7 Cg_endo -86.81 10.59 3.55 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.826 2.35 . . . . 5.42 113.378 -178.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 152' ' ' SER . . . . . 0.645 ' N ' ' HD2' ' B' ' 153' ' ' PRO . 0.7 OUTLIER 160.68 -52.09 0.0 OUTLIER Pre-proline 0 N--CA 1.465 0.321 0 CA-C-O 120.681 0.277 . . . . 6.02 111.255 -179.838 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 153' ' ' PRO . . . . . 0.645 ' HD2' ' N ' ' B' ' 152' ' ' SER . 12.0 Cg_endo -55.84 121.68 10.4 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 123.191 2.594 . . . . 5.87 114.761 -178.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 154' ' ' CYS . . . . . 0.629 ' N ' ' HG ' ' B' ' 105' ' ' LEU . 0.1 OUTLIER -178.37 107.91 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.524 -0.762 . . . . 2.96 109.609 177.911 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 155' ' ' GLN . . . . . 0.584 ' N ' ' HB2' ' B' ' 105' ' ' LEU . 18.8 pt20 32.48 -156.24 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 112.853 0.686 . . . . 6.3 112.853 -177.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 2.3 t -80.31 104.88 11.16 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 112.782 0.66 . . . . 3.41 112.782 -177.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 165.34 34.96 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 CA-C-N 115.015 -0.993 . . . . 2.26 111.22 179.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 158' ' ' GLN . . . . . 0.524 ' HA ' ' HB2' ' B' ' 166' ' ' ARG . 0.0 OUTLIER -122.86 73.42 1.14 Allowed 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 121.437 0.637 . . . . 5.03 111.059 179.395 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 159' ' ' LYS . . . . . 0.453 ' CB ' ' HB2' ' B' ' 167' ' ' CYS . 0.9 OUTLIER -106.18 79.37 0.58 Allowed Pre-proline 0 C--N 1.314 -0.953 0 CA-C-O 117.788 -1.101 . . . . 3.96 110.673 175.544 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 160' ' ' PRO . . . . . 0.444 ' HA ' ' HA ' ' B' ' 166' ' ' ARG . 11.9 Cg_endo -55.2 108.36 0.3 Allowed 'Trans proline' 0 CA--C 1.531 0.343 0 C-N-CA 122.074 1.849 . . . . 1.7 114.868 -177.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 161' ' ' CYS . . . . . 0.487 ' O ' ' O ' ' B' ' 165' ' ' GLY . 0.5 OUTLIER -142.08 155.33 45.37 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 114.831 -1.077 . . . . 1.93 108.847 178.652 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 74.82 -166.24 54.84 Favored Glycine 0 CA--C 1.521 0.427 0 C-N-CA 118.716 -1.707 . . . . 2.37 110.004 -176.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.79 65.11 0.12 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.729 1.264 . . . . 4.56 112.421 -176.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.91 19.6 72.48 Favored Glycine 0 CA--C 1.502 -0.77 0 C-N-CA 120.8 -0.714 . . . . 2.39 113.906 176.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 165' ' ' GLY . . . . . 0.487 ' O ' ' O ' ' B' ' 161' ' ' CYS . . . -103.42 126.44 8.81 Favored Glycine 0 N--CA 1.439 -1.105 0 C-N-CA 119.779 -1.2 . . . . 1.79 112.741 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 166' ' ' ARG . . . . . 0.524 ' HB2' ' HA ' ' B' ' 158' ' ' GLN . 0.0 OUTLIER -87.74 152.89 21.78 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.567 -0.317 . . . . 3.53 110.177 179.453 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 167' ' ' CYS . . . . . 0.453 ' HB2' ' CB ' ' B' ' 159' ' ' LYS . 0.1 OUTLIER -67.29 106.35 2.03 Favored 'General case' 0 N--CA 1.418 -2.058 0 N-CA-C 108.577 -0.898 . . . . 1.56 108.577 -179.299 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 168' ' ' ALA . . . . . . . . . . . . . . . -86.43 -33.09 20.54 Favored 'General case' 0 N--CA 1.424 -1.728 0 N-CA-C 105.637 -1.986 . . . . 1.42 105.637 177.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 169' ' ' ALA . . . . . 0.851 ' CB ' ' HA2' ' B' ' 133' ' ' GLY . . . -164.01 163.45 23.38 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 114.502 -1.226 . . . . 1.18 111.403 -174.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 170' ' ' ALA . . . . . 0.817 ' HA ' ' HB3' ' B' ' 185' ' ' CYS . . . -37.03 127.02 0.94 Allowed 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 115.288 1.588 . . . . 1.47 115.288 -179.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 171' ' ' GLY . . . . . 0.633 ' N ' ' O ' ' B' ' 185' ' ' CYS . . . 61.51 -11.94 0.06 OUTLIER Glycine 0 C--N 1.339 0.729 0 N-CA-C 115.806 1.083 . . . . 1.45 115.806 177.201 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 172' ' ' ILE . . . . . 0.823 ' CD1' ' HB2' ' B' ' 134' ' ' CYS . 1.6 pp -114.17 106.31 20.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 121.605 0.717 . . . . 2.7 112.191 -176.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 173' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -92.14 106.8 18.73 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.113 -0.949 . . . . 1.94 108.835 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 174' ' ' CYS . . . . . 0.457 ' SG ' HD11 ' B' ' 172' ' ' ILE . 0.0 OUTLIER -129.74 170.44 13.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 122.199 0.999 . . . . 1.43 113.598 -178.441 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 175' ' ' SER . . . . . 0.729 ' HB3' ' HD2' ' B' ' 176' ' ' PRO . 9.9 m -130.29 179.52 1.31 Allowed Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 113.303 -1.771 . . . . 2.3 106.993 178.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 176' ' ' PRO . . . . . 0.729 ' HD2' ' HB3' ' B' ' 175' ' ' SER . 58.1 Cg_endo -75.84 30.83 0.38 Allowed 'Trans proline' 0 N--CA 1.461 -0.422 0 CA-C-N 120.12 1.079 . . . . 2.13 112.28 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 177' ' ' ASP . . . . . 0.461 ' H ' ' C ' ' B' ' 175' ' ' SER . 2.7 m-20 -138.25 -56.96 0.65 Allowed 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.868 -0.606 . . . . 2.72 109.956 179.184 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 178' ' ' GLY . . . . . 0.481 ' HA3' ' HD2' ' A' ' 80' ' ' HIS . . . -139.33 -178.22 16.31 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.598 -0.811 . . . . 1.05 112.948 179.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 179' ' ' CYS . . . . . 0.507 ' SG ' ' HB ' ' B' ' 172' ' ' ILE . 13.4 t -142.55 160.61 39.95 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 110.148 -0.316 . . . . 1.39 110.148 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 180' ' ' HIS . . . . . 0.489 ' HD2' ' HA3' ' A' ' 78' ' ' GLY . 0.3 OUTLIER -149.69 134.74 18.0 Favored 'General case' 0 CA--C 1.521 -0.17 0 C-N-CA 119.925 -0.71 . . . . 2.73 112.187 -178.603 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 181' ' ' GLU . . . . . 0.411 ' OE1' ' HB2' ' A' ' 24' ' ' PRO . 0.2 OUTLIER -63.9 119.5 10.16 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 108.337 -0.986 . . . . 3.06 108.337 177.953 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 182' ' ' ASP . . . . . 0.502 ' OD1' ' HB1' ' B' ' 184' ' ' ALA . 0.2 OUTLIER -154.52 139.14 11.6 Favored Pre-proline 0 C--N 1.316 -0.872 0 C-N-CA 120.452 -0.499 . . . . 2.06 110.939 -178.995 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 183' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -70.09 41.69 0.35 Allowed 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.943 2.429 . . . . 2.27 113.139 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 184' ' ' ALA . . . . . 0.502 ' HB1' ' OD1' ' B' ' 182' ' ' ASP . . . -75.01 -58.94 2.97 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 122.651 1.215 . . . . 1.56 109.343 178.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 185' ' ' CYS . . . . . 0.911 ' O ' ' HD3' ' B' ' 187' ' ' PRO . 49.0 m -105.6 80.33 1.55 Allowed 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 112.508 -2.133 . . . . 1.94 109.297 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 186' ' ' ASP . . . . . 0.411 ' O ' ' N ' ' B' ' 188' ' ' GLU . 0.0 OUTLIER -97.61 88.8 0.64 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.071 -0.513 . . . . 3.61 112.178 -177.984 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 187' ' ' PRO . . . . . 0.911 ' HD3' ' O ' ' B' ' 185' ' ' CYS . 21.3 Cg_exo -66.45 76.4 0.37 Allowed 'Trans proline' 0 CA--C 1.521 -0.128 0 C-N-CA 123.294 2.663 . . . . 3.14 109.22 178.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 188' ' ' GLU . . . . . 0.44 ' HB3' ' O ' ' B' ' 187' ' ' PRO . 6.8 pt-20 174.0 12.72 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 112.896 -1.957 . . . . 4.7 112.218 177.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 189' ' ' ALA . . . . . . . . . . . . . . . -94.5 61.93 2.78 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 113.688 0.996 . . . . 5.24 113.688 175.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 190' ' ' ALA . . . . . . . . . . . . . . . -67.55 177.85 1.83 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 120.064 1.302 . . . . 6.93 111.272 -177.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 191' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -90.21 63.05 5.65 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.722 -0.391 . . . . 10.62 110.107 177.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 15.6 p . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.242 -0.885 . . . . 11.7 111.234 179.984 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.531 ' O ' ' O ' ' A' ' 2' ' ' VAL . . . . . . . . 0 N--CA 1.484 1.275 0 N-CA-C 110.313 -0.254 . . . . 10.31 110.313 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.531 ' O ' ' O ' ' A' ' 1' ' ' ALA . 3.7 p 42.47 179.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 112.885 0.698 . . . . 8.37 112.885 178.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.749 ' HG ' ' HD3' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -89.39 12.24 16.86 Favored 'General case' 0 N--CA 1.422 -1.871 0 N-CA-C 113.889 1.07 . . . . 6.25 113.889 178.124 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.502 ' O ' ' O ' ' A' ' 3' ' ' LEU . 0.5 OUTLIER -53.39 -103.38 0.0 OUTLIER 'General case' 0 C--N 1.291 -1.955 0 C-N-CA 119.022 -1.071 . . . . 6.22 110.614 -179.332 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.561 ' O ' ' HG ' ' A' ' 5' ' ' LEU . 49.5 tp -152.02 21.04 0.67 Allowed 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 118.01 -1.476 . . . . 7.57 113.619 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.83 -60.55 2.33 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 106.815 -1.55 . . . . 8.78 106.815 179.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.623 HG11 ' O ' ' A' ' 7' ' ' VAL . 3.6 p -160.2 115.97 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.466 -2.28 0 N-CA-C 104.243 -2.503 . . . . 7.88 104.243 163.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.749 ' HD3' ' HG ' ' A' ' 3' ' ' LEU . 0.0 OUTLIER -78.07 116.6 18.66 Favored 'General case' 0 CA--C 1.479 -1.787 0 C-N-CA 115.871 -2.331 . . . . 9.7 105.887 177.525 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.405 ' O ' ' NE ' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -61.97 104.8 0.5 Allowed 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 113.448 -3.301 . . . . 6.05 104.874 179.755 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.808 ' HB3' ' HG2' ' A' ' 20' ' ' ARG . 0.1 OUTLIER -80.64 101.42 9.21 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 113.63 -1.623 . . . . 2.89 114.52 -178.377 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.556 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 1.3 tt -32.21 112.31 0.35 Allowed Pre-proline 0 N--CA 1.484 1.269 0 CA-C-N 119.294 0.952 . . . . 2.89 111.589 177.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.842 ' HB2' ' O ' ' A' ' 17' ' ' GLY . 41.4 Cg_endo -94.82 125.58 0.4 Allowed 'Trans proline' 0 C--N 1.356 0.948 0 C-N-CA 123.567 2.845 . . . . 1.72 114.65 -178.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.629 ' SG ' ' N ' ' A' ' 14' ' ' GLY . 0.0 OUTLIER -140.82 -168.43 2.59 Favored 'General case' 0 C--N 1.353 0.729 0 CA-C-N 118.228 0.467 . . . . 1.0 111.183 -176.472 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.989 ' HA2' ' HB3' ' A' ' 40' ' ' GLU . . . 75.23 -163.81 54.14 Favored Glycine 0 CA--C 1.501 -0.787 0 C-N-CA 120.832 -0.699 . . . . 1.15 111.705 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -63.2 142.04 84.99 Favored 'Trans proline' 0 N--CA 1.446 -1.315 0 N-CA-C 106.867 -2.013 . . . . 1.6 106.867 175.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 62.73 -12.24 0.1 OUTLIER Glycine 0 C--N 1.269 -3.176 0 C-N-CA 124.66 1.124 . . . . 1.68 113.38 -179.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.842 ' O ' ' HB2' ' A' ' 12' ' ' PRO . . . 64.9 20.14 66.28 Favored Glycine 1 N--CA 1.391 -4.333 0 C-N-CA 116.978 -2.534 . . . . 1.37 110.58 179.411 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.18 -1.61 57.04 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 113.293 -1.454 . . . . 2.91 113.31 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.773 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -116.67 177.73 16.93 Favored Glycine 0 C--N 1.335 0.476 0 N-CA-C 108.488 -1.845 . . . . 1.06 108.488 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.808 ' HG2' ' HB3' ' A' ' 10' ' ' CYS . 0.5 OUTLIER -119.75 173.06 7.26 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 120.408 2.104 . . . . 3.32 111.193 179.89 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.435 ' CB ' ' HG3' ' A' ' 47' ' ' GLU . 4.6 m -105.86 147.43 28.71 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.027 0.441 . . . . 1.19 110.422 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.407 ' HE1' ' O ' ' A' ' 28' ' ' CYS . 44.0 m-85 -137.6 -52.07 0.64 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.807 -0.633 . . . . 2.26 110.711 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.545 ' O ' ' HB3' ' A' ' 44' ' ' CYS . . . -101.4 -166.2 27.56 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.858 -0.687 . . . . 1.05 111.714 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.431 ' O ' ' HB2' ' A' ' 44' ' ' CYS . 2.4 Cg_endo -77.31 -60.64 0.04 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.404 2.069 . . . . 1.81 111.54 179.416 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -102.86 26.34 8.21 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.794 -0.639 . . . . 1.62 109.935 179.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.889 HG22 HG13 ' A' ' 36' ' ' VAL . 0.6 OUTLIER -131.46 121.33 48.08 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 N-CA-C 113.346 0.869 . . . . 1.39 113.346 -177.402 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.443 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . 1.8 t -123.16 118.19 27.1 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 109.022 -0.732 . . . . 0.92 109.022 178.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 1.089 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -132.97 112.26 11.71 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 113.911 1.078 . . . . 1.28 113.911 -177.689 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.807 ' O ' ' HB3' ' A' ' 69' ' ' ALA . . . -105.71 -158.89 22.68 Favored Glycine 0 C--N 1.358 1.784 0 C-N-CA 120.318 -0.944 . . . . 0.71 112.738 178.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.674 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 19.0 p-10 -66.37 -57.09 8.19 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 115.498 1.666 . . . . 2.27 115.498 -176.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -120.29 17.7 12.26 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 121.891 0.853 . . . . 1.66 110.071 -176.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.502 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -112.93 -24.37 9.56 Favored 'General case' 0 N--CA 1.408 -2.567 0 CA-C-N 113.628 -1.624 . . . . 1.93 107.396 -179.315 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 1.089 ' O ' ' HA ' ' A' ' 28' ' ' CYS . . . 73.22 -128.39 11.61 Favored Glycine 0 N--CA 1.415 -2.727 0 CA-C-N 113.951 -1.477 . . . . 0.77 113.755 177.123 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.781 ' HB2' HG13 ' A' ' 72' ' ' ILE . 5.1 t -138.72 118.08 12.81 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 114.834 1.42 . . . . 1.08 114.834 -177.22 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.731 ' HB3' ' CG2' ' A' ' 38' ' ' THR . 0.2 OUTLIER -92.83 106.97 18.85 Favored 'General case' 0 N--CA 1.423 -1.789 0 N-CA-C 105.408 -2.071 . . . . 1.85 105.408 177.031 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.889 HG13 HG22 ' A' ' 26' ' ' ILE . 2.2 t -97.9 85.15 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.577 0 C-N-CA 118.718 -1.193 . . . . 1.29 108.856 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.59 ' O ' ' O ' ' A' ' 38' ' ' THR . . . 143.39 -75.78 0.3 Allowed Glycine 0 CA--C 1.524 0.607 0 CA-C-N 114.3 -1.318 . . . . 0.85 115.568 179.203 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.731 ' CG2' ' HB3' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -23.47 154.27 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 113.111 0.782 . . . . 1.3 113.111 -178.298 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.52 ' O ' ' N ' ' A' ' 42' ' ' LEU . . . -60.14 -39.09 85.09 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.971 -0.559 . . . . 1.45 111.366 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.989 ' HB3' ' HA2' ' A' ' 14' ' ' GLY . 1.2 mt-10 -40.36 -29.52 0.08 Allowed 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.794 0.665 . . . . 2.32 112.794 -178.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.692 ' O ' ' N ' ' A' ' 44' ' ' CYS . . . -89.16 -20.95 23.6 Favored 'General case' 0 N--CA 1.44 -0.954 0 O-C-N 122.328 -0.232 . . . . 1.11 110.952 -179.233 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.52 ' N ' ' O ' ' A' ' 39' ' ' ALA . 3.2 mt -39.22 -43.62 1.13 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.819 0.674 . . . . 1.68 112.819 -177.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.32 -30.44 28.4 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 107.903 -1.147 . . . . 3.4 107.903 177.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.692 ' N ' ' O ' ' A' ' 41' ' ' ALA . 70.0 m -53.04 -21.65 4.85 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 114.279 -1.328 . . . . 1.57 110.556 -177.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -49.03 -34.45 13.37 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 113.505 0.928 . . . . 3.49 113.505 -179.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -87.09 -5.0 59.18 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 119.869 -0.733 . . . . 3.69 111.157 -178.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.435 ' HG3' ' CB ' ' A' ' 21' ' ' CYS . 3.9 mm-40 -83.3 6.18 20.62 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 109.512 -0.551 . . . . 3.99 109.512 177.287 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -74.35 -29.4 61.56 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 116.026 -0.534 . . . . 4.2 109.73 178.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -95.56 26.13 4.11 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 120.724 -0.39 . . . . 5.85 111.416 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.6 mp -147.32 85.2 6.9 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-O 120.668 0.27 . . . . 5.83 111.558 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -88.47 50.08 1.59 Allowed 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 122.801 2.334 . . . . 5.3 112.673 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.413 ' HB2' HD21 ' A' ' 3' ' ' LEU . 24.4 p -73.83 159.22 84.8 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 116.416 -0.356 . . . . 5.72 111.167 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.72 -46.04 0.14 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.705 2.27 . . . . 5.82 112.602 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.731 ' HA ' ' HG2' ' A' ' 8' ' ' ARG . 0.0 OUTLIER 72.89 87.75 0.1 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.072 -0.513 . . . . 2.98 112.23 179.584 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.445 ' HG3' ' HA ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER 47.5 -87.95 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 112.29 0.478 . . . . 6.42 112.29 178.778 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.442 ' N ' ' O ' ' A' ' 54' ' ' CYS . 47.7 p -145.73 116.84 7.84 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.889 0.376 . . . . 3.36 111.293 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 173.39 38.38 0.04 OUTLIER Glycine 0 N--CA 1.444 -0.815 0 N-CA-C 110.415 -1.074 . . . . 2.3 110.415 -179.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.4 tp60 -120.78 85.58 2.42 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 108.613 -0.884 . . . . 5.06 108.613 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.499 ' O ' ' HA ' ' A' ' 66' ' ' ARG . 0.5 OUTLIER -136.32 82.28 35.22 Favored Pre-proline 0 C--N 1.299 -1.618 0 N-CA-C 106.28 -1.748 . . . . 3.91 106.28 -178.713 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.516 ' HA ' ' O ' ' A' ' 65' ' ' GLY . 60.5 Cg_endo -72.4 73.5 2.75 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 123.197 2.598 . . . . 1.74 113.856 -177.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.406 ' N ' ' O ' ' A' ' 65' ' ' GLY . 4.5 p -99.25 157.87 16.08 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.389 -1.278 . . . . 1.9 109.084 178.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.56 -167.86 54.11 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 119.787 -1.197 . . . . 2.43 112.094 -175.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -76.47 66.09 2.44 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 122.058 0.933 . . . . 4.32 112.623 -175.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.59 19.41 58.35 Favored Glycine 0 C--N 1.339 0.72 0 CA-C-N 114.112 -1.403 . . . . 2.4 114.695 177.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.524 ' HA3' ' HA ' ' A' ' 74' ' ' CYS . . . -105.28 135.01 12.34 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 119.227 -1.463 . . . . 1.82 114.213 -179.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.516 ' HA ' ' HA ' ' A' ' 60' ' ' PRO . 0.0 OUTLIER -107.04 152.99 23.26 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 109.248 -0.649 . . . . 3.51 109.248 177.091 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.676 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 41.7 t -52.77 106.37 0.16 Allowed 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 108.967 -0.753 . . . . 1.52 108.967 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -88.96 -36.55 15.81 Favored 'General case' 0 N--CA 1.423 -1.816 0 N-CA-C 106.718 -1.586 . . . . 1.5 106.718 177.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.807 ' HB3' ' O ' ' A' ' 29' ' ' GLY . . . -165.18 165.06 20.03 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 108.985 -0.746 . . . . 1.31 108.985 -177.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.674 ' HB3' ' O ' ' A' ' 30' ' ' ASP . . . -31.24 108.66 0.05 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.25 0.548 . . . . 1.5 111.402 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.84 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . 75.68 -3.4 49.71 Favored Glycine 0 C--O 1.227 -0.336 0 CA-C-N 115.249 -0.887 . . . . 1.44 114.548 179.109 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.781 HG13 ' HB2' ' A' ' 34' ' ' CYS . 1.6 mm -96.9 119.07 44.48 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.599 0 CA-C-N 117.702 0.751 . . . . 2.77 110.399 -179.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.961 ' HB2' ' HB3' ' A' ' 82' ' ' ASP . 1.9 t -118.99 95.61 4.89 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.72 -1.127 . . . . 1.98 108.391 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 1.028 ' HB3' ' HA ' ' A' ' 79' ' ' CYS . 26.7 p -156.13 -174.32 4.9 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 116.912 2.19 . . . . 1.43 116.912 -176.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.507 ' CB ' ' HD2' ' A' ' 76' ' ' PRO . 0.3 OUTLIER -128.56 -178.29 0.77 Allowed Pre-proline 0 N--CA 1.456 -0.169 0 CA-C-N 112.808 -1.996 . . . . 2.37 109.253 -178.831 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.507 ' HD2' ' CB ' ' A' ' 75' ' ' SER . 60.3 Cg_endo -73.28 30.85 0.31 Allowed 'Trans proline' 0 CA--C 1.533 0.464 0 C-N-CA 121.882 1.721 . . . . 2.09 113.413 -179.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.405 ' H ' ' C ' ' A' ' 75' ' ' SER . 11.2 m-20 -125.88 -60.66 1.28 Allowed 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 109.536 -0.542 . . . . 2.65 109.536 178.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.87 ' O ' ' HB2' ' A' ' 74' ' ' CYS . . . -138.39 -167.29 10.94 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 110.917 -0.873 . . . . 1.04 110.917 178.373 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 1.028 ' HA ' ' HB3' ' A' ' 74' ' ' CYS . 63.8 m -146.43 161.08 41.16 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 117.534 0.667 . . . . 1.42 111.723 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 34.6 t60 -152.58 150.1 29.17 Favored 'General case' 0 C--N 1.344 0.34 0 C-N-CA 119.896 -0.722 . . . . 2.81 111.388 -178.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.453 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 0.4 OUTLIER -60.71 140.86 57.37 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.764 -0.653 . . . . 3.05 110.422 179.558 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.961 ' HB3' ' HB2' ' A' ' 73' ' ' CYS . 0.0 OUTLIER -137.21 138.24 24.76 Favored Pre-proline 0 CA--C 1.544 0.733 0 CA-C-N 115.983 -0.553 . . . . 2.02 111.89 -179.023 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.449 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 2.5 Cg_endo -84.38 -31.68 0.46 Allowed 'Trans proline' 0 C--N 1.359 1.122 0 C-N-CA 123.311 2.674 . . . . 2.29 115.301 -177.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.82 -47.62 84.99 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 108.29 -1.004 . . . . 1.53 108.29 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.84 ' O ' ' N ' ' A' ' 71' ' ' GLY . 81.5 m -96.77 71.68 2.58 Favored 'General case' 0 C--O 1.215 -0.739 0 N-CA-C 105.694 -1.965 . . . . 1.88 105.694 175.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.579 ' CB ' ' HD3' ' A' ' 87' ' ' PRO . 0.9 OUTLIER -94.08 -56.97 0.22 Allowed Pre-proline 0 CA--C 1.497 -1.084 0 C-N-CA 119.089 -1.044 . . . . 3.6 110.582 -177.7 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.579 ' HD3' ' CB ' ' A' ' 86' ' ' ASP . 58.2 Cg_endo -103.79 168.16 0.21 Allowed 'Trans proline' 0 N--CA 1.422 -2.687 0 C-N-CA 122.704 2.27 . . . . 3.12 113.138 -178.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -73.22 61.23 0.62 Allowed 'General case' 0 N--CA 1.428 -1.562 0 C-N-CA 128.354 2.662 . . . . 4.72 108.394 173.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -91.44 29.17 1.52 Allowed 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 108.754 -3.839 . . . . 5.29 107.164 171.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -80.24 163.26 24.14 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 122.445 1.116 . . . . 7.19 113.838 -179.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.423 ' O ' ' CG ' ' A' ' 91' ' ' PHE . 15.3 p90 -81.46 107.92 14.62 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-N 113.039 -1.892 . . . . 10.7 111.36 -179.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.307 -0.854 . . . . 11.77 110.867 179.851 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.242 0 CA-C-O 120.869 0.366 . . . . 10.42 110.969 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 102' ' ' VAL . . . . . 0.425 HG21 ' N ' ' B' ' 103' ' ' LEU . 8.6 p -40.69 154.29 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 115.275 1.583 . . . . 8.81 115.275 -178.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 103' ' ' LEU . . . . . 0.591 HD21 ' H ' ' B' ' 103' ' ' LEU . 0.0 OUTLIER -106.25 144.27 33.19 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 113.425 -1.716 . . . . 6.28 107.888 176.822 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -157.7 -130.75 0.03 OUTLIER 'General case' 0 N--CA 1.426 -1.635 0 N-CA-C 105.119 -2.178 . . . . 6.27 105.119 176.227 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 6.4 tp -137.02 10.35 3.05 Favored 'General case' 0 CA--C 1.489 -1.395 0 C-N-CA 117.583 -1.647 . . . . 7.61 110.106 175.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 106' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -79.88 -121.04 0.02 OUTLIER 'General case' 0 CA--C 1.464 -2.335 1 N-CA-C 98.916 -4.476 . . . . 8.55 98.916 176.219 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 107' ' ' VAL . . . . . 0.637 HG11 ' O ' ' B' ' 107' ' ' VAL . 3.1 p -111.42 118.04 56.52 Favored 'Isoleucine or valine' 0 CA--C 1.466 -2.269 0 C-N-CA 112.902 -3.519 . . . . 7.84 105.428 178.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 108' ' ' ARG . . . . . 0.748 ' HG2' ' HA ' ' B' ' 154' ' ' CYS . 0.0 OUTLIER -77.5 115.06 16.96 Favored 'General case' 0 N--CA 1.423 -1.794 0 C-N-CA 116.08 -2.248 . . . . 9.75 106.119 177.935 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 109' ' ' THR . . . . . 0.412 ' O ' ' NE ' ' B' ' 108' ' ' ARG . 0.2 OUTLIER -59.73 105.16 0.35 Allowed 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 113.704 -3.199 . . . . 6.13 105.371 179.718 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 110' ' ' CYS . . . . . 0.79 ' HB3' ' HG2' ' B' ' 120' ' ' ARG . 0.1 OUTLIER -81.81 101.97 10.51 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 113.486 -1.688 . . . . 2.87 114.332 -178.11 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 111' ' ' LEU . . . . . 0.534 ' O ' ' HA ' ' B' ' 120' ' ' ARG . 1.3 tt -32.09 112.06 0.34 Allowed Pre-proline 0 N--CA 1.484 1.253 0 CA-C-N 119.001 0.819 . . . . 2.95 111.626 178.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 112' ' ' PRO . . . . . 0.833 ' HB2' ' O ' ' B' ' 117' ' ' GLY . 43.4 Cg_endo -93.59 127.39 0.61 Allowed 'Trans proline' 0 C--N 1.356 0.921 0 C-N-CA 123.579 2.853 . . . . 1.71 113.937 -178.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.627 ' SG ' ' N ' ' B' ' 114' ' ' GLY . 0.0 OUTLIER -142.54 -168.84 2.84 Favored 'General case' 0 C--N 1.351 0.631 0 O-C-N 121.943 -0.473 . . . . 1.0 111.212 -177.502 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 114' ' ' GLY . . . . . 0.96 ' HA2' ' HB3' ' B' ' 140' ' ' GLU . . . 75.33 -163.74 54.02 Favored Glycine 0 CA--C 1.502 -0.728 0 C-N-CA 120.817 -0.706 . . . . 1.16 111.535 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 115' ' ' PRO . . . . . 0.406 ' C ' ' H ' ' B' ' 117' ' ' GLY . 48.3 Cg_endo -63.23 142.01 84.67 Favored 'Trans proline' 0 N--CA 1.446 -1.281 0 N-CA-C 107.002 -1.961 . . . . 1.6 107.002 175.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 62.86 -12.48 0.1 OUTLIER Glycine 0 C--N 1.27 -3.124 0 C-N-CA 124.792 1.187 . . . . 1.7 113.251 -179.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 117' ' ' GLY . . . . . 0.833 ' O ' ' HB2' ' B' ' 112' ' ' PRO . . . 64.95 20.5 66.78 Favored Glycine 1 N--CA 1.395 -4.086 0 C-N-CA 116.901 -2.571 . . . . 1.38 110.566 179.431 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.92 -2.63 56.7 Favored 'General case' 0 C--N 1.346 0.435 0 CA-C-N 113.003 -1.599 . . . . 2.96 113.241 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 119' ' ' GLY . . . . . 0.784 ' O ' ' HA ' ' B' ' 112' ' ' PRO . . . -117.65 -178.29 17.44 Favored Glycine 0 C--N 1.34 0.764 0 N-CA-C 108.607 -1.797 . . . . 1.07 108.607 178.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.79 ' HG2' ' HB3' ' B' ' 110' ' ' CYS . 0.4 OUTLIER -120.73 172.52 7.82 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 119.298 1.549 . . . . 3.29 112.364 -178.886 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 121' ' ' CYS . . . . . 0.431 ' CB ' ' HG3' ' B' ' 147' ' ' GLU . 4.4 m -105.89 147.29 28.91 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.081 0.467 . . . . 1.21 110.347 -179.223 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 122' ' ' PHE . . . . . 0.405 ' HE1' ' O ' ' B' ' 128' ' ' CYS . 43.9 m-85 -137.53 -52.02 0.64 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.905 -0.589 . . . . 2.28 110.691 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 123' ' ' GLY . . . . . 0.54 ' O ' ' HB3' ' B' ' 144' ' ' CYS . . . -101.45 -166.21 27.52 Favored Glycine 0 C--O 1.229 -0.203 0 C-N-CA 120.836 -0.697 . . . . 1.04 111.677 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . 0.421 ' O ' ' HB2' ' B' ' 144' ' ' CYS . 2.4 Cg_endo -77.31 -60.65 0.04 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 122.469 2.113 . . . . 1.84 111.564 179.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 125' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -102.89 26.44 8.11 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.839 -0.619 . . . . 1.49 109.921 179.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 126' ' ' ILE . . . . . 0.881 HG21 ' SG ' ' B' ' 134' ' ' CYS . 0.8 OUTLIER -131.37 121.37 48.43 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 N-CA-C 113.399 0.889 . . . . 1.41 113.399 -177.41 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 127' ' ' CYS . . . . . 0.535 ' HB2' ' HB2' ' B' ' 141' ' ' ALA . 1.8 t -123.28 118.05 26.68 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 109.059 -0.719 . . . . 0.89 109.059 178.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 128' ' ' CYS . . . . . 1.099 ' HA ' ' O ' ' B' ' 133' ' ' GLY . 0.0 OUTLIER -132.36 112.0 11.82 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 114.067 1.136 . . . . 1.23 114.067 -177.999 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 129' ' ' GLY . . . . . 0.825 ' O ' ' HB3' ' B' ' 169' ' ' ALA . . . -104.55 -157.96 23.7 Favored Glycine 0 C--N 1.357 1.742 0 C-N-CA 120.298 -0.954 . . . . 0.69 112.992 178.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 130' ' ' ASP . . . . . 0.42 ' O ' ' HB3' ' B' ' 170' ' ' ALA . 18.2 p-10 -68.61 -55.28 12.06 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 115.867 1.802 . . . . 2.35 115.867 -176.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -125.03 30.67 5.81 Favored 'General case' 0 CA--C 1.493 -1.218 0 C-N-CA 118.878 -1.129 . . . . 1.69 109.744 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 132' ' ' LEU . . . . . 0.499 HD22 ' CE1' ' B' ' 135' ' ' PHE . 0.4 OUTLIER -123.82 -23.82 4.59 Favored 'General case' 0 N--CA 1.404 -2.744 0 N-CA-C 105.672 -1.973 . . . . 1.84 105.672 -179.23 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 133' ' ' GLY . . . . . 1.099 ' O ' ' HA ' ' B' ' 128' ' ' CYS . . . 72.15 -126.58 11.85 Favored Glycine 0 N--CA 1.408 -3.195 0 CA-C-N 114.196 -1.366 . . . . 0.76 114.17 175.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 134' ' ' CYS . . . . . 0.881 ' SG ' HG21 ' B' ' 126' ' ' ILE . 5.4 t -140.17 118.13 11.83 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 114.948 1.462 . . . . 1.08 114.948 -177.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 135' ' ' PHE . . . . . 0.745 ' HB3' ' CG2' ' B' ' 138' ' ' THR . 0.1 OUTLIER -93.0 107.14 18.98 Favored 'General case' 0 N--CA 1.424 -1.761 0 N-CA-C 105.4 -2.074 . . . . 1.83 105.4 177.204 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 136' ' ' VAL . . . . . 0.696 HG13 HG22 ' B' ' 126' ' ' ILE . 2.5 t -97.56 85.42 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.552 0 C-N-CA 118.861 -1.136 . . . . 1.29 108.712 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 137' ' ' GLY . . . . . 0.596 ' O ' ' O ' ' B' ' 138' ' ' THR . . . 142.65 -76.04 0.31 Allowed Glycine 0 CA--C 1.522 0.524 0 C-N-CA 119.614 -1.279 . . . . 0.85 115.778 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 138' ' ' THR . . . . . 0.745 ' CG2' ' HB3' ' B' ' 135' ' ' PHE . 0.0 OUTLIER -23.27 154.62 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 113.081 0.771 . . . . 1.2 113.081 -178.242 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 139' ' ' ALA . . . . . 0.498 ' O ' ' N ' ' B' ' 142' ' ' LEU . . . -60.45 -39.38 87.35 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 116.147 -0.479 . . . . 1.35 111.144 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 140' ' ' GLU . . . . . 0.96 ' HB3' ' HA2' ' B' ' 114' ' ' GLY . 1.2 mt-10 -40.09 -29.56 0.08 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.84 0.682 . . . . 2.31 112.84 -178.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 141' ' ' ALA . . . . . 0.684 ' O ' ' N ' ' B' ' 144' ' ' CYS . . . -89.16 -20.72 23.88 Favored 'General case' 0 N--CA 1.441 -0.912 0 O-C-N 122.307 -0.246 . . . . 1.09 110.992 -179.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 142' ' ' LEU . . . . . 0.498 ' N ' ' O ' ' B' ' 139' ' ' ALA . 3.1 mt -39.32 -43.81 1.21 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.787 0.662 . . . . 1.61 112.787 -177.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.18 -30.61 27.73 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 107.947 -1.131 . . . . 3.43 107.947 177.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 144' ' ' CYS . . . . . 0.684 ' N ' ' O ' ' B' ' 141' ' ' ALA . 69.4 m -52.96 -21.39 4.32 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 114.083 -1.417 . . . . 1.61 110.538 -177.246 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -49.39 -34.34 15.95 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 113.538 0.94 . . . . 3.52 113.538 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -87.13 -4.87 59.15 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 119.846 -0.742 . . . . 3.76 111.152 -178.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . 0.431 ' HG3' ' CB ' ' B' ' 121' ' ' CYS . 3.9 mm-40 -83.42 6.18 21.01 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 109.482 -0.562 . . . . 4.01 109.482 177.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 148' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -74.23 -29.54 61.75 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.98 -0.554 . . . . 4.24 109.724 178.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -95.53 26.16 4.08 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 120.782 -0.367 . . . . 6.07 111.445 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 4.6 mp -147.33 85.11 6.93 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-O 120.574 0.226 . . . . 5.86 111.601 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 151' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -88.41 50.11 1.62 Allowed 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 122.819 2.346 . . . . 5.42 112.624 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 29.4 p -73.82 159.23 84.78 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.471 -0.331 . . . . 6.02 111.145 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 153' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.85 -45.81 0.14 Allowed 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.746 2.297 . . . . 5.87 112.544 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 154' ' ' CYS . . . . . 0.748 ' HA ' ' HG2' ' B' ' 108' ' ' ARG . 0.0 OUTLIER 73.26 87.48 0.1 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.905 -0.589 . . . . 2.96 112.2 179.573 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 155' ' ' GLN . . . . . 0.514 ' HG3' ' HA ' ' B' ' 107' ' ' VAL . 0.0 OUTLIER 47.62 -88.84 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.546 0.573 . . . . 6.3 112.546 178.75 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 156' ' ' SER . . . . . 0.451 ' H ' ' HB3' ' B' ' 155' ' ' GLN . 50.3 p -145.09 116.81 8.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.218 0.532 . . . . 3.41 111.216 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 173.89 38.18 0.04 OUTLIER Glycine 0 N--CA 1.444 -0.832 0 N-CA-C 110.835 -0.906 . . . . 2.26 110.835 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 5.1 tp60 -120.85 71.54 0.94 Allowed 'General case' 0 N--CA 1.441 -0.883 0 CA-C-O 121.867 0.841 . . . . 5.03 110.275 179.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 159' ' ' LYS . . . . . 0.531 ' O ' ' HA ' ' B' ' 166' ' ' ARG . 0.7 OUTLIER -107.55 79.98 0.87 Allowed Pre-proline 0 C--N 1.316 -0.863 0 CA-C-N 114.068 -1.424 . . . . 3.96 110.643 175.117 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 160' ' ' PRO . . . . . 0.532 ' HA ' ' HA ' ' B' ' 166' ' ' ARG . 59.3 Cg_endo -72.39 74.49 2.59 Favored 'Trans proline' 0 C--N 1.333 -0.249 0 CA-C-N 121.688 1.638 . . . . 1.7 114.521 -177.416 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 161' ' ' CYS . . . . . . . . . . . . . 4.6 p -98.97 158.92 15.32 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.856 -1.065 . . . . 1.93 109.09 178.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 77.05 -167.85 54.5 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 119.726 -1.226 . . . . 2.37 112.216 -176.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -76.71 65.61 2.51 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 122.173 0.987 . . . . 4.56 112.529 -175.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 84.55 22.24 54.25 Favored Glycine 0 C--N 1.337 0.59 0 CA-C-N 113.858 -1.519 . . . . 2.39 114.626 177.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 165' ' ' GLY . . . . . 0.56 ' HA3' ' HA ' ' B' ' 174' ' ' CYS . . . -108.0 135.77 13.03 Favored Glycine 0 N--CA 1.442 -0.963 0 C-N-CA 119.279 -1.439 . . . . 1.79 113.69 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 166' ' ' ARG . . . . . 0.532 ' HA ' ' HA ' ' B' ' 160' ' ' PRO . 0.0 OUTLIER -106.79 153.27 22.71 Favored 'General case' 0 CA--C 1.521 -0.167 0 N-CA-C 109.273 -0.64 . . . . 3.53 109.273 177.681 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 167' ' ' CYS . . . . . 0.685 ' HA ' ' O ' ' B' ' 172' ' ' ILE . 41.8 t -52.88 106.34 0.16 Allowed 'General case' 0 N--CA 1.424 -1.773 0 N-CA-C 108.932 -0.766 . . . . 1.56 108.932 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 168' ' ' ALA . . . . . . . . . . . . . . . -88.16 -38.05 15.66 Favored 'General case' 0 N--CA 1.423 -1.787 0 N-CA-C 106.402 -1.703 . . . . 1.42 106.402 177.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 169' ' ' ALA . . . . . 0.825 ' HB3' ' O ' ' B' ' 129' ' ' GLY . . . -164.07 165.0 22.77 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 109.196 -0.668 . . . . 1.18 109.196 -176.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 170' ' ' ALA . . . . . 0.487 ' C ' ' O ' ' B' ' 169' ' ' ALA . . . -31.08 108.69 0.05 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.319 0.58 . . . . 1.47 111.284 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 171' ' ' GLY . . . . . 0.851 ' N ' ' O ' ' B' ' 185' ' ' CYS . . . 75.51 -3.3 49.3 Favored Glycine 0 C--O 1.228 -0.25 0 CA-C-N 115.237 -0.892 . . . . 1.45 114.58 179.157 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 172' ' ' ILE . . . . . 0.773 HG13 ' HB2' ' B' ' 134' ' ' CYS . 1.6 mm -96.9 119.1 44.51 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.578 0 CA-C-N 117.723 0.762 . . . . 2.7 110.468 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 173' ' ' CYS . . . . . 0.937 ' HB2' ' HB3' ' B' ' 182' ' ' ASP . 1.9 t -118.96 95.83 4.99 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 114.723 -1.126 . . . . 1.94 108.416 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 174' ' ' CYS . . . . . 1.115 ' HB3' ' HA ' ' B' ' 179' ' ' CYS . 26.6 p -156.26 -174.3 4.88 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 116.9 2.185 . . . . 1.43 116.9 -176.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 175' ' ' SER . . . . . 0.501 ' CB ' ' HD2' ' B' ' 176' ' ' PRO . 0.3 OUTLIER -128.53 -178.35 0.78 Allowed Pre-proline 0 N--CA 1.454 -0.239 0 CA-C-N 112.861 -1.972 . . . . 2.3 109.383 -178.877 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 176' ' ' PRO . . . . . 0.501 ' HD2' ' CB ' ' B' ' 175' ' ' SER . 60.3 Cg_endo -73.23 30.95 0.3 Allowed 'Trans proline' 0 CA--C 1.534 0.507 0 C-N-CA 121.865 1.71 . . . . 2.13 113.428 -179.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 177' ' ' ASP . . . . . 0.407 ' H ' ' C ' ' B' ' 175' ' ' SER . 11.3 m-20 -125.94 -60.68 1.28 Allowed 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 109.612 -0.514 . . . . 2.72 109.612 178.482 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 178' ' ' GLY . . . . . 0.848 ' O ' ' HB2' ' B' ' 174' ' ' CYS . . . -138.44 -167.36 10.96 Favored Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 110.832 -0.907 . . . . 1.05 110.832 178.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 179' ' ' CYS . . . . . 1.115 ' HA ' ' HB3' ' B' ' 174' ' ' CYS . 63.3 m -146.51 161.07 41.24 Favored 'General case' 0 N--CA 1.461 0.101 0 CA-C-N 117.507 0.653 . . . . 1.39 111.632 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 180' ' ' HIS . . . . . . . . . . . . . 34.9 t60 -152.37 150.31 29.56 Favored 'General case' 0 C--N 1.344 0.36 0 C-N-CA 120.014 -0.674 . . . . 2.73 111.401 -178.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 181' ' ' GLU . . . . . 0.452 ' HA ' ' O ' ' B' ' 171' ' ' GLY . 0.4 OUTLIER -60.91 140.82 57.62 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.766 -0.652 . . . . 3.06 110.359 179.557 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 182' ' ' ASP . . . . . 0.937 ' HB3' ' HB2' ' B' ' 173' ' ' CYS . 0.0 OUTLIER -137.19 138.27 24.9 Favored Pre-proline 0 CA--C 1.543 0.701 0 CA-C-N 116.005 -0.543 . . . . 2.06 111.852 -179.024 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 183' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' B' ' 182' ' ' ASP . 2.5 Cg_endo -84.41 -31.66 0.46 Allowed 'Trans proline' 0 C--N 1.358 1.068 0 C-N-CA 123.359 2.706 . . . . 2.27 115.256 -177.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -59.9 -47.6 85.12 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 108.279 -1.008 . . . . 1.56 108.279 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 185' ' ' CYS . . . . . 0.851 ' O ' ' N ' ' B' ' 171' ' ' GLY . 82.2 m -96.68 71.62 2.61 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 105.7 -1.963 . . . . 1.94 105.7 175.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 186' ' ' ASP . . . . . 0.591 ' CB ' ' HD3' ' B' ' 187' ' ' PRO . 0.9 OUTLIER -94.13 -56.97 0.22 Allowed Pre-proline 0 CA--C 1.497 -1.094 0 C-N-CA 119.055 -1.058 . . . . 3.61 110.644 -177.687 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 187' ' ' PRO . . . . . 0.591 ' HD3' ' CB ' ' B' ' 186' ' ' ASP . 59.0 Cg_endo -103.88 168.01 0.21 Allowed 'Trans proline' 0 N--CA 1.424 -2.616 0 C-N-CA 122.796 2.331 . . . . 3.14 113.182 -178.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -73.38 61.12 0.65 Allowed 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 127.951 2.5 . . . . 4.7 108.515 174.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 189' ' ' ALA . . . . . . . . . . . . . . . -91.36 30.01 1.36 Allowed 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 109.001 -3.727 . . . . 5.24 106.868 172.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 190' ' ' ALA . . . . . . . . . . . . . . . -80.84 163.57 23.33 Favored 'General case' 0 C--N 1.345 0.381 0 N-CA-C 113.866 1.062 . . . . 6.93 113.866 -178.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 191' ' ' PHE . . . . . 0.425 ' O ' ' CG ' ' B' ' 191' ' ' PHE . 15.3 p90 -81.5 108.05 14.77 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-N 113.469 -1.696 . . . . 10.62 111.449 -179.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.257 -0.878 . . . . 11.7 110.822 179.916 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.51 ' O ' ' CG2' ' A' ' 2' ' ' VAL . . . . . . . . 0 N--CA 1.489 1.48 0 CA-C-O 120.443 0.163 . . . . 10.31 111.434 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.51 ' CG2' ' O ' ' A' ' 1' ' ' ALA . 9.6 t -168.66 37.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 N-CA-C 108.361 -0.977 . . . . 8.37 108.361 178.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.64 ' HB2' ' HG3' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -156.63 47.24 0.44 Allowed 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 114.132 1.16 . . . . 6.25 114.132 -178.031 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -92.48 -117.39 0.08 Allowed 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 101.674 -3.454 . . . . 6.22 101.674 170.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.405 ' HA ' HD11 ' A' ' 5' ' ' LEU . 0.2 OUTLIER -89.6 19.07 4.84 Favored 'General case' 0 N--CA 1.428 -1.568 0 C-N-CA 120.591 -0.444 . . . . 7.57 110.541 172.184 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -86.8 -126.95 0.04 OUTLIER 'General case' 0 N--CA 1.434 -1.237 1 N-CA-C 98.164 -4.754 . . . . 8.78 98.164 171.796 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.726 HG13 ' CG ' ' A' ' 53' ' ' PRO . 7.5 p -108.38 118.81 56.77 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.049 0 CA-C-N 124.01 3.095 . . . . 7.88 104.696 177.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.737 ' O ' ' N ' ' A' ' 54' ' ' CYS . 8.0 ttm180 -77.34 117.33 18.73 Favored 'General case' 0 CA--C 1.48 -1.72 0 CA-C-O 117.482 -1.246 . . . . 9.7 108.433 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.681 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 4.0 t -52.39 105.89 0.13 Allowed 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 114.534 -2.866 . . . . 6.05 107.693 -178.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.988 ' H ' ' HA ' ' A' ' 53' ' ' PRO . 67.9 m -79.49 70.85 6.02 Favored 'General case' 0 C--N 1.34 0.192 0 CA-C-N 112.346 -2.207 . . . . 2.89 112.862 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.892 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 6.9 mp -31.76 108.76 0.28 Allowed Pre-proline 0 N--CA 1.476 0.847 0 CA-C-N 120.036 1.289 . . . . 2.89 110.228 -179.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.991 ' HD2' HD23 ' A' ' 50' ' ' LEU . 89.8 Cg_endo -82.94 135.69 7.74 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 121.621 1.548 . . . . 1.72 114.593 -178.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.696 ' N ' ' O ' ' A' ' 19' ' ' GLY . 29.3 p -145.15 -175.06 4.55 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 118.267 -1.373 . . . . 1.0 111.322 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.671 ' HA2' ' HB3' ' A' ' 40' ' ' GLU . . . 75.75 -164.35 53.89 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 120.499 -0.857 . . . . 1.15 114.377 178.025 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.864 ' HD2' HD12 ' A' ' 32' ' ' LEU . 38.3 Cg_endo -63.14 112.75 1.78 Allowed 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 124.861 3.707 . . . . 1.6 109.601 177.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.19 -11.86 53.03 Favored Glycine 0 C--N 1.276 -2.803 0 N-CA-C 110.59 -1.004 . . . . 1.68 110.59 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.662 ' O ' ' HB2' ' A' ' 12' ' ' PRO . . . 68.59 47.3 57.48 Favored Glycine 0 N--CA 1.418 -2.538 0 C-N-CA 117.929 -2.081 . . . . 1.37 111.648 176.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.723 ' HD3' ' O ' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -92.26 -28.91 16.7 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 111.858 -2.171 . . . . 2.91 111.907 179.959 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.737 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -103.8 -178.08 25.73 Favored Glycine 0 C--O 1.213 -1.216 0 O-C-N 121.023 -1.048 . . . . 1.06 115.181 -176.009 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.892 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -96.16 144.71 26.15 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 115.579 1.696 . . . . 3.32 115.579 -174.588 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.659 ' C ' ' CD1' ' A' ' 22' ' ' PHE . 0.1 OUTLIER -108.25 170.24 8.13 Favored 'General case' 0 C--N 1.344 0.334 0 CA-C-N 113.49 -1.686 . . . . 1.19 109.36 -179.692 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.659 ' CD1' ' C ' ' A' ' 21' ' ' CYS . 33.8 m-85 -156.8 52.54 0.51 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.966 0.412 . . . . 2.26 110.649 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.518 ' O ' ' SG ' ' A' ' 44' ' ' CYS . . . 133.08 -145.68 17.66 Favored Glycine 0 C--O 1.225 -0.433 0 N-CA-C 111.265 -0.734 . . . . 1.05 111.265 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -94.86 -70.19 0.0 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 122.779 2.319 . . . . 1.81 112.145 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.635 ' O ' ' N ' ' A' ' 37' ' ' GLY . 2.8 m -92.5 45.52 1.2 Allowed 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 109.746 -0.465 . . . . 1.62 109.746 179.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.804 ' CG2' ' HB3' ' A' ' 74' ' ' CYS . 3.6 mt -145.13 115.04 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 N-CA-C 112.015 0.376 . . . . 1.39 112.015 -177.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.58 ' SG ' ' CE2' ' A' ' 35' ' ' PHE . 1.9 t -149.15 123.75 9.78 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-O 121.346 0.593 . . . . 0.92 110.803 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.865 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 0.5 OUTLIER -126.37 152.5 46.2 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.201 1.0 . . . . 1.28 110.949 -179.852 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 33' ' ' GLY . . . -143.52 -179.83 20.41 Favored Glycine 0 N--CA 1.424 -2.144 0 C-N-CA 120.386 -0.911 . . . . 0.71 111.273 176.211 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -70.01 -44.93 68.32 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 126.351 1.861 . . . . 2.27 112.442 177.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -121.65 23.42 10.22 Favored 'General case' 0 CA--C 1.471 -2.075 0 CA-C-N 112.956 -1.929 . . . . 1.66 111.31 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.864 HD12 ' HD2' ' A' ' 15' ' ' PRO . 1.0 OUTLIER -125.62 -36.36 2.44 Favored 'General case' 0 N--CA 1.425 -1.685 0 CA-C-N 113.589 -1.641 . . . . 1.93 109.682 -174.623 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.865 ' O ' ' HA ' ' A' ' 28' ' ' CYS . . . 89.96 -138.85 14.76 Favored Glycine 0 N--CA 1.425 -2.045 0 CA-C-N 114.845 -1.071 . . . . 0.77 114.368 177.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.793 ' SG ' ' SG ' ' A' ' 74' ' ' CYS . 1.3 m -126.75 121.24 31.44 Favored 'General case' 0 CA--C 1.489 -1.384 0 CA-C-N 119.318 1.559 . . . . 1.08 110.37 177.068 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.996 ' HA ' ' HA ' ' B' ' 135' ' ' PHE . 0.0 OUTLIER -119.07 107.49 13.56 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 104.578 -2.379 . . . . 1.85 104.578 176.705 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 1.037 HG21 ' SG ' ' A' ' 79' ' ' CYS . 1.0 OUTLIER -92.07 89.71 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.552 0 CA-C-O 122.077 0.941 . . . . 1.29 109.849 -178.266 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.635 ' N ' ' O ' ' A' ' 25' ' ' SER . . . 88.37 87.3 1.19 Allowed Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 113.907 -1.497 . . . . 0.85 112.101 -179.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.597 HG23 ' O ' ' A' ' 37' ' ' GLY . 40.3 p -150.17 176.03 11.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.807 0.337 . . . . 1.3 110.589 -179.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.41 ' HA ' ' CD1' ' A' ' 42' ' ' LEU . . . -63.92 -41.68 97.6 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.343 -1.355 . . . . 1.45 107.343 177.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.671 ' HB3' ' HA2' ' A' ' 14' ' ' GLY . 3.0 mm-40 -55.82 -34.37 65.3 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 113.884 -1.507 . . . . 2.32 110.201 179.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.818 ' O ' ' HB2' ' A' ' 44' ' ' CYS . . . -82.75 -37.63 24.37 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 115.349 -0.841 . . . . 1.11 109.953 -179.264 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.41 ' CD1' ' HA ' ' A' ' 39' ' ' ALA . 0.2 OUTLIER -38.96 -32.92 0.1 Allowed 'General case' 0 C--O 1.24 0.564 0 CA-C-O 121.105 0.479 . . . . 1.68 110.685 -178.672 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.448 ' O ' ' N ' ' A' ' 45' ' ' GLN . 2.1 mmm180 -51.97 -29.02 18.82 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 108.239 -1.023 . . . . 3.4 108.239 176.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.818 ' HB2' ' O ' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -44.65 -2.66 0.01 OUTLIER 'General case' 0 C--O 1.239 0.552 0 N-CA-C 115.434 1.642 . . . . 1.57 115.434 -176.621 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.448 ' N ' ' O ' ' A' ' 43' ' ' ARG . 0.3 OUTLIER -88.99 3.37 51.86 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 122.624 2.466 . . . . 3.49 107.203 174.976 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.659 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 8.1 tt0 -83.56 11.33 7.28 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 108.505 -0.924 . . . . 3.69 108.505 179.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.958 ' HA ' HD22 ' A' ' 50' ' ' LEU . 0.5 OUTLIER -75.18 3.02 9.46 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 109.263 -0.644 . . . . 3.99 109.263 176.453 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -98.33 -27.05 14.29 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.448 -0.342 . . . . 4.2 111.194 178.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -139.69 55.75 1.66 Allowed 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 112.702 0.63 . . . . 5.85 112.702 -177.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.991 HD23 ' HD2' ' A' ' 12' ' ' PRO . 0.4 OUTLIER -120.12 103.98 44.33 Favored Pre-proline 0 N--CA 1.473 0.689 0 N-CA-C 113.224 0.824 . . . . 5.83 113.224 -177.928 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.41 ' C ' ' HD2' ' A' ' 53' ' ' PRO . 71.0 Cg_endo -101.16 50.8 0.04 OUTLIER 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 124.207 3.271 . . . . 5.3 113.975 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.722 ' O ' ' HB2' ' A' ' 10' ' ' CYS . 6.5 t -120.04 45.96 0.83 Allowed Pre-proline 0 CA--C 1.544 0.732 0 N-CA-C 111.847 0.314 . . . . 5.72 111.847 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.988 ' HA ' ' H ' ' A' ' 10' ' ' CYS . 9.5 Cg_endo -52.47 167.05 0.62 Allowed 'Trans proline' 0 N--CA 1.49 1.293 0 C-N-CA 124.12 3.213 . . . . 5.82 116.303 -178.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.737 ' N ' ' O ' ' A' ' 8' ' ' ARG . 4.8 p 154.49 72.5 0.0 OUTLIER 'General case' 0 C--N 1.372 1.557 0 N-CA-C 115.012 1.486 . . . . 2.98 115.012 178.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.701 ' H ' ' H ' ' A' ' 8' ' ' ARG . 0.7 OUTLIER 50.85 -173.89 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 120.568 1.531 . . . . 6.42 112.376 177.96 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.508 ' OG ' ' O ' ' A' ' 55' ' ' GLN . 66.0 m -171.05 -145.4 0.04 OUTLIER 'General case' 0 CA--C 1.558 1.27 0 N-CA-C 112.189 0.44 . . . . 3.36 112.189 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' A' ' 66' ' ' ARG . . . -133.43 123.11 3.29 Favored Glycine 0 CA--C 1.49 -1.504 0 CA-C-N 114.983 -1.008 . . . . 2.3 111.995 -176.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -111.12 78.78 1.14 Allowed 'General case' 0 N--CA 1.439 -0.988 0 CA-C-O 121.951 0.881 . . . . 5.06 108.901 178.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.731 ' CB ' ' HB2' ' A' ' 67' ' ' CYS . 0.4 OUTLIER -138.15 68.88 48.73 Favored Pre-proline 0 C--N 1.305 -1.326 0 CA-C-O 122.96 1.362 . . . . 3.91 108.247 -179.799 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -55.59 86.78 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.589 2.859 . . . . 1.74 115.191 -178.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.649 ' N ' ' O ' ' A' ' 65' ' ' GLY . 1.8 m -96.64 -173.8 2.84 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 113.786 -1.552 . . . . 1.9 107.062 176.249 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 45.14 -167.03 0.04 OUTLIER Glycine 0 CA--C 1.53 0.97 0 C-N-CA 119.837 -1.173 . . . . 2.43 114.36 175.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 6.5 t -84.2 61.02 6.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 122.683 1.23 . . . . 4.32 111.256 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 109.93 3.89 29.81 Favored Glycine 0 CA--C 1.532 1.144 0 CA-C-N 112.585 -2.098 . . . . 2.4 116.209 176.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.649 ' O ' ' N ' ' A' ' 61' ' ' CYS . . . -101.4 142.8 15.86 Favored Glycine 0 C--O 1.225 -0.442 0 C-N-CA 117.227 -2.416 . . . . 1.82 115.995 -175.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.459 ' HB2' ' O ' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -98.03 154.0 18.01 Favored 'General case' 0 C--N 1.335 -0.055 0 CA-C-N 114.549 -0.826 . . . . 3.51 110.142 179.274 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.731 ' HB2' ' CB ' ' A' ' 59' ' ' LYS . 3.7 t -44.98 109.48 0.17 Allowed 'General case' 0 CA--C 1.506 -0.74 0 CA-C-O 121.257 0.551 . . . . 1.52 111.763 -178.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.699 ' HB2' ' HB3' ' A' ' 28' ' ' CYS . . . -100.39 -15.42 17.96 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 108.074 -1.084 . . . . 1.5 108.074 177.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -168.19 162.26 12.77 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 114.532 -1.213 . . . . 1.31 110.872 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.532 ' HA ' ' HB3' ' A' ' 85' ' ' CYS . . . -73.3 74.87 1.34 Allowed 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 121.446 0.641 . . . . 1.5 112.673 -179.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.709 ' O ' ' HA ' ' A' ' 81' ' ' GLU . . . 163.53 -51.57 0.3 Allowed Glycine 0 N--CA 1.437 -1.298 0 CA-C-N 114.983 -1.008 . . . . 1.44 112.952 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.686 HD11 ' SG ' ' A' ' 34' ' ' CYS . 0.6 OUTLIER -126.63 140.23 49.49 Favored 'Isoleucine or valine' 0 C--O 1.248 0.99 0 CA-C-O 122.83 1.3 . . . . 2.77 110.704 -175.936 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.539 ' HB2' ' HB2' ' A' ' 61' ' ' CYS . 47.9 m -112.15 113.19 25.3 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 114.895 -1.048 . . . . 1.98 110.258 -179.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.804 ' HB3' ' CG2' ' A' ' 26' ' ' ILE . 64.6 m -78.58 144.03 35.92 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.596 -0.729 . . . . 1.43 111.105 -178.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.681 ' HB2' ' HD2' ' A' ' 76' ' ' PRO . 92.0 p -136.76 179.95 1.23 Allowed Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 114.318 -1.31 . . . . 2.37 108.742 -178.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.681 ' HD2' ' HB2' ' A' ' 75' ' ' SER . 66.9 Cg_endo -76.32 29.88 0.4 Allowed 'Trans proline' 0 N--CA 1.452 -0.93 0 N-CA-C 109.822 -0.876 . . . . 2.09 109.822 177.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.563 ' H ' ' C ' ' A' ' 75' ' ' SER . 2.0 m-20 -144.29 -46.73 0.26 Allowed 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.17 -0.923 . . . . 2.65 111.171 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.992 ' HA2' HG12 ' A' ' 36' ' ' VAL . . . -170.5 -155.99 10.89 Favored Glycine 0 C--N 1.34 0.785 0 C-N-CA 119.745 -1.217 . . . . 1.04 115.313 179.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 1.037 ' SG ' HG21 ' A' ' 36' ' ' VAL . 10.4 m -140.98 129.29 22.32 Favored 'General case' 0 CA--C 1.555 1.171 0 CA-C-O 122.732 1.253 . . . . 1.42 107.767 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.428 ' N ' HG22 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -144.42 132.2 21.29 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-N 112.414 -2.175 . . . . 2.81 112.443 -168.392 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.709 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 0.4 OUTLIER -47.36 142.24 4.24 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 114.036 -1.438 . . . . 3.05 109.981 -179.7 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.679 ' OD1' ' HB2' ' A' ' 85' ' ' CYS . 3.1 p-10 -145.26 137.37 13.22 Favored Pre-proline 0 C--N 1.309 -1.174 0 CA-C-N 115.712 -0.676 . . . . 2.02 109.738 -178.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -57.87 -35.42 98.79 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.667 2.245 . . . . 2.29 114.373 -177.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.8 -51.69 60.82 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 108.616 -0.883 . . . . 1.53 108.616 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.679 ' HB2' ' OD1' ' A' ' 82' ' ' ASP . 3.2 m -98.74 77.09 2.23 Favored 'General case' 0 CA--C 1.499 -1.015 0 N-CA-C 106.703 -1.591 . . . . 1.88 106.703 176.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.517 ' CB ' ' HD3' ' A' ' 87' ' ' PRO . 0.6 OUTLIER -131.05 -54.72 0.03 OUTLIER Pre-proline 0 CA--C 1.5 -0.944 0 C-N-CA 119.301 -0.96 . . . . 3.6 110.06 -178.944 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.517 ' HD3' ' CB ' ' A' ' 86' ' ' ASP . 9.5 Cg_endo -91.59 165.57 3.44 Favored 'Trans proline' 0 N--CA 1.426 -2.452 0 C-N-CA 122.053 1.836 . . . . 3.12 113.387 -179.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.557 ' O ' ' N ' ' A' ' 90' ' ' ALA . 7.9 pt-20 -66.19 0.32 2.08 Favored 'General case' 0 N--CA 1.432 -1.341 0 C-N-CA 128.16 2.584 . . . . 4.72 109.988 178.262 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -53.4 36.09 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 114.255 1.205 . . . . 5.29 114.255 177.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.557 ' N ' ' O ' ' A' ' 88' ' ' GLU . . . -77.48 163.78 26.03 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 119.33 0.968 . . . . 7.19 111.57 178.302 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -85.42 63.74 8.25 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.076 -0.511 . . . . 10.7 111.707 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 11.9 p . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.209 -0.9 . . . . 11.77 110.793 179.268 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 101' ' ' ALA . . . . . 0.432 ' O ' ' N ' ' B' ' 103' ' ' LEU . . . . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 119.865 -0.112 . . . . 10.42 110.901 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 8.5 p 30.48 36.66 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.112 0 N-CA-C 113.985 1.106 . . . . 8.81 113.985 177.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 103' ' ' LEU . . . . . 1.065 ' HB2' ' HG3' ' B' ' 108' ' ' ARG . 1.5 pp -160.63 62.13 0.31 Allowed 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 114.143 1.164 . . . . 6.28 114.143 176.212 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 104' ' ' ASP . . . . . 0.416 ' HB3' ' H ' ' B' ' 105' ' ' LEU . 0.1 OUTLIER -101.08 -111.06 0.21 Allowed 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 103.464 -2.791 . . . . 6.27 103.464 170.138 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . 0.416 ' H ' ' HB3' ' B' ' 104' ' ' ASP . 3.1 tp -107.86 15.48 24.44 Favored 'General case' 0 N--CA 1.42 -1.948 0 N-CA-C 108.577 -0.897 . . . . 7.61 108.577 171.482 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 106' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.59 -121.2 0.02 OUTLIER 'General case' 0 N--CA 1.427 -1.583 1 N-CA-C 98.47 -4.641 . . . . 8.55 98.47 172.364 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 107' ' ' VAL . . . . . 0.928 HG21 ' C ' ' B' ' 153' ' ' PRO . 9.9 p -114.29 118.32 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.753 0 C-N-CA 114.388 -2.925 . . . . 7.84 106.454 179.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 108' ' ' ARG . . . . . 1.065 ' HG3' ' HB2' ' B' ' 103' ' ' LEU . 10.1 ttm180 -78.2 114.87 17.49 Favored 'General case' 0 CA--C 1.482 -1.641 0 CA-C-O 117.649 -1.167 . . . . 9.75 108.32 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 109' ' ' THR . . . . . 0.647 ' HA ' ' HB3' ' B' ' 153' ' ' PRO . 5.6 t -46.94 105.5 0.07 Allowed 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 114.987 -2.685 . . . . 6.13 107.987 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 110' ' ' CYS . . . . . 0.967 ' H ' ' HA ' ' B' ' 153' ' ' PRO . 67.5 m -81.35 70.52 8.22 Favored 'General case' 0 CA--C 1.527 0.095 0 CA-C-N 113.541 -1.663 . . . . 2.87 112.894 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 111' ' ' LEU . . . . . 0.881 ' O ' ' HA ' ' B' ' 120' ' ' ARG . 6.9 mp -31.29 108.67 0.27 Allowed Pre-proline 0 N--CA 1.477 0.892 0 CA-C-N 119.962 1.256 . . . . 2.95 110.332 -179.283 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 112' ' ' PRO . . . . . 0.999 ' HD2' HD23 ' B' ' 150' ' ' LEU . 84.0 Cg_endo -81.62 138.14 10.56 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 121.926 1.751 . . . . 1.71 113.696 -179.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.564 ' N ' ' O ' ' B' ' 119' ' ' GLY . 31.2 p -149.14 -178.7 6.53 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 120.697 -0.401 . . . . 1.0 111.499 178.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 114' ' ' GLY . . . . . 0.676 ' HA2' ' HB3' ' B' ' 140' ' ' GLU . . . 76.06 -163.1 53.07 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 120.793 -0.718 . . . . 1.16 113.929 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 115' ' ' PRO . . . . . 0.837 ' HD2' HD12 ' B' ' 132' ' ' LEU . 38.8 Cg_endo -64.37 101.5 0.36 Allowed 'Trans proline' 0 N--CA 1.485 1.005 0 C-N-CA 125.234 3.956 . . . . 1.6 114.784 178.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 89.53 -8.05 80.65 Favored Glycine 0 C--N 1.28 -2.566 0 CA-C-N 114.263 -1.335 . . . . 1.7 110.992 -175.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 117' ' ' GLY . . . . . 0.61 ' O ' ' HB2' ' B' ' 112' ' ' PRO . . . 65.28 55.25 22.18 Favored Glycine 0 N--CA 1.421 -2.345 0 CA-C-O 122.451 1.028 . . . . 1.38 111.568 179.081 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 118' ' ' LYS . . . . . 0.655 ' HD3' ' O ' ' B' ' 115' ' ' PRO . 0.0 OUTLIER -94.32 -26.13 16.7 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 112.494 -1.853 . . . . 2.96 111.408 177.94 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 119' ' ' GLY . . . . . 0.848 ' O ' ' HA ' ' B' ' 112' ' ' PRO . . . -95.79 -175.61 36.73 Favored Glycine 0 C--O 1.212 -1.255 0 N-CA-C 116.728 1.451 . . . . 1.07 116.728 -176.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.881 ' HA ' ' O ' ' B' ' 111' ' ' LEU . 0.0 OUTLIER -105.12 142.44 34.89 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 112.729 -1.735 . . . . 3.29 114.71 -178.112 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 121' ' ' CYS . . . . . 0.657 ' C ' ' CD1' ' B' ' 122' ' ' PHE . 0.1 OUTLIER -108.05 169.92 8.32 Favored 'General case' 0 C--N 1.342 0.267 0 CA-C-N 113.573 -1.649 . . . . 1.21 109.3 -178.717 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 122' ' ' PHE . . . . . 0.657 ' CD1' ' C ' ' B' ' 121' ' ' CYS . 33.1 m-85 -156.81 52.55 0.51 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.032 0.444 . . . . 2.28 110.574 -179.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 123' ' ' GLY . . . . . 0.523 ' O ' ' SG ' ' B' ' 144' ' ' CYS . . . 133.09 -145.63 17.63 Favored Glycine 0 C--N 1.334 0.44 0 N-CA-C 111.322 -0.711 . . . . 1.04 111.322 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -95.02 -70.22 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 122.729 2.286 . . . . 1.84 112.064 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 125' ' ' SER . . . . . 0.651 ' O ' ' N ' ' B' ' 137' ' ' GLY . 2.8 m -92.27 45.08 1.19 Allowed 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.715 -0.476 . . . . 1.49 109.715 179.093 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 126' ' ' ILE . . . . . 0.803 ' CG2' ' HB3' ' B' ' 174' ' ' CYS . 3.4 mt -144.01 114.54 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 N-CA-C 112.317 0.488 . . . . 1.41 112.317 -177.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 127' ' ' CYS . . . . . 0.587 ' SG ' ' CE2' ' B' ' 135' ' ' PHE . 1.7 t -148.55 124.4 10.58 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 121.039 0.447 . . . . 0.89 110.887 179.368 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 128' ' ' CYS . . . . . 0.92 ' HA ' ' O ' ' B' ' 133' ' ' GLY . 0.8 OUTLIER -129.34 150.44 50.7 Favored 'General case' 0 CA--C 1.509 -0.619 0 CA-C-N 115.896 -0.593 . . . . 1.23 111.484 -178.868 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 129' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' B' ' 133' ' ' GLY . . . -141.67 -174.46 14.51 Favored Glycine 0 N--CA 1.422 -2.236 0 CA-C-N 120.089 1.313 . . . . 0.69 110.135 177.2 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -74.33 -44.55 52.01 Favored 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 126.215 1.806 . . . . 2.35 112.375 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -124.32 33.26 5.3 Favored 'General case' 0 CA--C 1.483 -1.606 0 CA-C-N 113.911 -1.495 . . . . 1.69 110.034 177.021 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 132' ' ' LEU . . . . . 0.837 HD12 ' HD2' ' B' ' 115' ' ' PRO . 0.9 OUTLIER -130.1 -37.7 1.46 Allowed 'General case' 0 N--CA 1.411 -2.38 0 CA-C-N 114.239 -1.346 . . . . 1.84 108.531 -179.418 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 133' ' ' GLY . . . . . 0.92 ' O ' ' HA ' ' B' ' 128' ' ' CYS . . . 79.25 -151.43 34.85 Favored Glycine 0 N--CA 1.435 -1.369 0 CA-C-N 113.585 -1.643 . . . . 0.76 111.195 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 134' ' ' CYS . . . . . 0.771 ' SG ' ' SG ' ' B' ' 174' ' ' CYS . 3.0 m -107.93 124.2 49.77 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-N 119.691 1.745 . . . . 1.08 112.084 -175.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 135' ' ' PHE . . . . . 0.996 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -121.09 106.97 12.05 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 104.499 -2.408 . . . . 1.83 104.499 174.263 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 136' ' ' VAL . . . . . 1.054 HG21 ' SG ' ' B' ' 179' ' ' CYS . 1.8 t -91.7 89.82 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.396 0 CA-C-O 122.091 0.948 . . . . 1.29 109.635 -178.235 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 137' ' ' GLY . . . . . 0.651 ' N ' ' O ' ' B' ' 125' ' ' SER . . . 87.56 88.59 1.09 Allowed Glycine 0 C--O 1.228 -0.231 0 CA-C-N 114.133 -1.394 . . . . 0.85 112.012 -179.115 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 138' ' ' THR . . . . . 0.47 ' H ' ' HB3' ' B' ' 141' ' ' ALA . 43.5 p -154.13 171.12 19.64 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 110.313 -0.255 . . . . 1.2 110.313 -179.252 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 139' ' ' ALA . . . . . 0.432 ' HA ' ' CD1' ' B' ' 142' ' ' LEU . . . -60.51 -39.48 87.94 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.484 -0.932 . . . . 1.35 108.484 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 140' ' ' GLU . . . . . 0.676 ' HB3' ' HA2' ' B' ' 114' ' ' GLY . 3.0 mm-40 -57.46 -33.61 68.15 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.307 -0.861 . . . . 2.31 110.094 178.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 141' ' ' ALA . . . . . 0.777 ' O ' ' HB2' ' B' ' 144' ' ' CYS . . . -82.11 -39.06 23.89 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 115.062 -0.972 . . . . 1.09 109.508 -179.067 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 142' ' ' LEU . . . . . 0.432 ' CD1' ' HA ' ' B' ' 139' ' ' ALA . 0.2 OUTLIER -38.94 -31.41 0.06 Allowed 'General case' 0 C--O 1.232 0.156 0 CA-C-N 117.871 0.305 . . . . 1.61 111.578 -178.483 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 143' ' ' ARG . . . . . 0.451 ' O ' ' N ' ' B' ' 145' ' ' GLN . 2.1 mmm180 -52.57 -28.93 23.01 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.401 -0.962 . . . . 3.43 108.401 176.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 144' ' ' CYS . . . . . 0.777 ' HB2' ' O ' ' B' ' 141' ' ' ALA . 0.1 OUTLIER -41.94 -8.11 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 113.648 -1.614 . . . . 1.61 115.002 -176.79 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 145' ' ' GLN . . . . . 0.451 ' N ' ' O ' ' B' ' 143' ' ' ARG . 0.3 OUTLIER -84.51 -0.19 52.13 Favored 'General case' 0 C--O 1.242 0.709 0 CA-C-O 122.525 1.155 . . . . 3.52 108.357 176.098 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 146' ' ' GLU . . . . . 0.658 ' O ' ' HG ' ' B' ' 150' ' ' LEU . 7.7 tt0 -83.91 11.48 7.63 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 115.072 -0.967 . . . . 3.76 109.064 179.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . 0.794 ' HA ' HD22 ' B' ' 150' ' ' LEU . 0.5 OUTLIER -75.3 2.86 10.1 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 109.14 -0.689 . . . . 4.01 109.14 176.44 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 148' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -98.33 -27.02 14.3 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.499 -0.319 . . . . 4.24 111.13 178.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -139.72 55.86 1.65 Allowed 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 112.648 0.61 . . . . 6.07 112.648 -177.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 150' ' ' LEU . . . . . 0.999 HD23 ' HD2' ' B' ' 112' ' ' PRO . 0.4 OUTLIER -120.14 104.12 44.07 Favored Pre-proline 0 N--CA 1.474 0.736 0 N-CA-C 113.212 0.819 . . . . 5.86 113.212 -178.004 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 151' ' ' PRO . . . . . 0.407 ' C ' ' HD2' ' B' ' 153' ' ' PRO . 72.6 Cg_endo -101.34 50.85 0.04 OUTLIER 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 124.17 3.247 . . . . 5.42 113.914 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 152' ' ' SER . . . . . 0.721 ' O ' ' HB2' ' B' ' 110' ' ' CYS . 6.6 t -120.25 46.03 0.87 Allowed Pre-proline 0 CA--C 1.544 0.726 0 N-CA-C 111.821 0.304 . . . . 6.02 111.821 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 153' ' ' PRO . . . . . 0.967 ' HA ' ' H ' ' B' ' 110' ' ' CYS . 10.8 Cg_endo -52.46 167.3 0.59 Allowed 'Trans proline' 0 N--CA 1.49 1.301 0 C-N-CA 124.266 3.31 . . . . 5.87 116.256 -178.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 154' ' ' CYS . . . . . 0.7 ' N ' ' O ' ' B' ' 108' ' ' ARG . 4.7 p 154.55 72.14 0.0 OUTLIER 'General case' 0 C--N 1.374 1.66 0 N-CA-C 115.058 1.503 . . . . 2.96 115.058 178.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 155' ' ' GLN . . . . . 0.687 ' H ' ' H ' ' B' ' 108' ' ' ARG . 0.6 OUTLIER 51.69 -175.65 0.02 OUTLIER 'General case' 0 C--N 1.37 1.491 0 CA-C-N 121.001 1.728 . . . . 6.3 112.394 178.0 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 156' ' ' SER . . . . . 0.462 ' OG ' ' O ' ' B' ' 155' ' ' GLN . 74.4 m -165.95 -135.88 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 113.508 0.929 . . . . 3.41 113.508 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 157' ' ' GLY . . . . . 0.43 ' O ' ' HB2' ' B' ' 166' ' ' ARG . . . -146.92 126.36 2.42 Favored Glycine 0 N--CA 1.439 -1.104 0 N-CA-C 109.794 -1.322 . . . . 2.26 109.794 178.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -112.55 68.02 0.67 Allowed 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 118.784 -1.166 . . . . 5.03 110.023 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 159' ' ' LYS . . . . . 0.826 ' CB ' ' HB2' ' B' ' 167' ' ' CYS . 0.1 OUTLIER -110.9 63.95 0.45 Allowed Pre-proline 0 C--N 1.318 -0.787 0 CA-C-N 113.875 -1.511 . . . . 3.96 112.059 174.514 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 160' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -55.37 86.78 0.04 OUTLIER 'Trans proline' 0 C--N 1.325 -0.682 0 C-N-CA 121.945 1.764 . . . . 1.7 116.391 -175.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 161' ' ' CYS . . . . . 0.649 ' N ' ' O ' ' B' ' 165' ' ' GLY . 1.4 m -98.81 -177.9 3.8 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.146 -1.427 . . . . 1.93 107.146 175.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 51.58 -167.27 0.71 Allowed Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.365 -0.921 . . . . 2.37 113.956 176.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 7.3 t -84.99 59.39 5.59 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 122.282 1.039 . . . . 4.56 111.664 -178.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 108.84 9.19 26.89 Favored Glycine 0 CA--C 1.544 1.9 0 CA-C-N 113.218 -1.81 . . . . 2.39 115.963 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 165' ' ' GLY . . . . . 0.649 ' O ' ' N ' ' B' ' 161' ' ' CYS . . . -102.59 141.76 15.34 Favored Glycine 0 C--N 1.312 -0.805 0 CA-C-N 121.631 2.716 . . . . 1.79 115.366 -176.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 166' ' ' ARG . . . . . 0.43 ' HB2' ' O ' ' B' ' 157' ' ' GLY . 0.0 OUTLIER -97.94 153.96 18.0 Favored 'General case' 0 N--CA 1.458 -0.056 0 CA-C-N 115.036 -0.582 . . . . 3.53 109.853 178.478 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 167' ' ' CYS . . . . . 0.826 ' HB2' ' CB ' ' B' ' 159' ' ' LYS . 3.6 t -45.42 109.57 0.18 Allowed 'General case' 0 CA--C 1.505 -0.75 0 CA-C-O 121.061 0.458 . . . . 1.56 111.975 -178.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 168' ' ' ALA . . . . . 0.74 ' HB2' ' HB3' ' B' ' 128' ' ' CYS . . . -99.83 -15.58 18.36 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 108.189 -1.041 . . . . 1.42 108.189 177.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -168.03 161.98 12.98 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 114.075 -1.42 . . . . 1.18 111.33 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 170' ' ' ALA . . . . . 0.548 ' HA ' ' HB3' ' B' ' 185' ' ' CYS . . . -72.98 74.94 1.19 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.375 0.607 . . . . 1.47 112.622 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 171' ' ' GLY . . . . . 0.742 ' O ' ' HA ' ' B' ' 181' ' ' GLU . . . 163.43 -52.9 0.3 Allowed Glycine 0 C--O 1.22 -0.724 0 CA-C-N 115.231 -0.895 . . . . 1.45 112.504 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 172' ' ' ILE . . . . . 0.645 HG12 ' O ' ' A' ' 36' ' ' VAL . 0.6 OUTLIER -124.17 139.72 49.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-O 122.93 1.348 . . . . 2.7 111.663 -175.998 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 173' ' ' CYS . . . . . 0.539 ' HB2' ' HB2' ' B' ' 161' ' ' CYS . 48.6 m -112.3 113.5 25.76 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.914 -1.039 . . . . 1.94 110.017 -179.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 174' ' ' CYS . . . . . 0.803 ' HB3' ' CG2' ' B' ' 126' ' ' ILE . 64.1 m -79.41 144.03 34.49 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 115.476 -0.784 . . . . 1.43 110.913 -178.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 175' ' ' SER . . . . . 0.669 ' HB2' ' HD2' ' B' ' 176' ' ' PRO . 59.8 p -136.68 179.86 1.25 Allowed Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 114.328 -1.305 . . . . 2.3 108.799 -178.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 176' ' ' PRO . . . . . 0.669 ' HD2' ' HB2' ' B' ' 175' ' ' SER . 66.9 Cg_endo -76.39 29.76 0.4 Allowed 'Trans proline' 0 N--CA 1.454 -0.835 0 N-CA-C 109.679 -0.931 . . . . 2.13 109.679 177.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 177' ' ' ASP . . . . . 0.57 ' H ' ' C ' ' B' ' 175' ' ' SER . 2.0 m-20 -144.01 -46.44 0.27 Allowed 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.237 -0.892 . . . . 2.72 111.145 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 178' ' ' GLY . . . . . 0.857 ' HA2' ' CG1' ' B' ' 136' ' ' VAL . . . -171.72 -155.42 10.88 Favored Glycine 0 C--N 1.342 0.874 0 C-N-CA 119.796 -1.192 . . . . 1.05 115.149 179.03 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 179' ' ' CYS . . . . . 1.054 ' SG ' HG21 ' B' ' 136' ' ' VAL . 10.0 m -140.32 136.18 32.95 Favored 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 107.027 -1.471 . . . . 1.39 107.027 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 180' ' ' HIS . . . . . 0.571 ' N ' HG22 ' B' ' 172' ' ' ILE . 0.2 OUTLIER -156.81 131.48 8.8 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 124.069 1.89 . . . . 2.73 111.824 -167.639 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 181' ' ' GLU . . . . . 0.742 ' HA ' ' O ' ' B' ' 171' ' ' GLY . 0.3 OUTLIER -45.87 141.23 3.16 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 110.326 -3.125 . . . . 3.06 109.851 -177.605 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 182' ' ' ASP . . . . . 0.68 ' OD1' ' HB2' ' B' ' 185' ' ' CYS . 3.1 p-10 -145.15 137.29 13.21 Favored Pre-proline 0 C--N 1.306 -1.291 0 CA-C-N 115.32 -0.854 . . . . 2.06 109.628 -178.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 183' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -57.73 -35.37 98.83 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.618 2.212 . . . . 2.27 114.425 -177.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -64.84 -51.57 61.37 Favored 'General case' 0 CA--C 1.508 -0.656 0 N-CA-C 108.701 -0.851 . . . . 1.56 108.701 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 185' ' ' CYS . . . . . 0.68 ' HB2' ' OD1' ' B' ' 182' ' ' ASP . 3.2 m -98.97 77.08 2.17 Favored 'General case' 0 CA--C 1.499 -0.998 0 N-CA-C 106.772 -1.566 . . . . 1.94 106.772 176.319 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 186' ' ' ASP . . . . . 0.532 ' CB ' ' HD3' ' B' ' 187' ' ' PRO . 0.6 OUTLIER -130.96 -54.81 0.03 OUTLIER Pre-proline 0 CA--C 1.5 -0.943 0 C-N-CA 119.469 -0.892 . . . . 3.61 110.184 -178.907 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 187' ' ' PRO . . . . . 0.537 ' C ' ' H ' ' B' ' 189' ' ' ALA . 9.4 Cg_endo -90.71 166.17 4.06 Favored 'Trans proline' 0 N--CA 1.426 -2.495 0 C-N-CA 122.092 1.861 . . . . 3.14 112.943 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 188' ' ' GLU . . . . . 0.457 ' C ' ' H ' ' B' ' 190' ' ' ALA . 7.3 pt-20 -74.02 18.24 0.15 Allowed 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 128.018 2.527 . . . . 4.7 109.918 177.434 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 189' ' ' ALA . . . . . 0.537 ' H ' ' C ' ' B' ' 187' ' ' PRO . . . -64.83 30.8 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 124.777 1.231 . . . . 5.24 113.152 174.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 190' ' ' ALA . . . . . 0.457 ' H ' ' C ' ' B' ' 188' ' ' GLU . . . -73.53 161.42 30.38 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.427 0.632 . . . . 6.93 111.817 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 191' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -85.39 63.65 8.2 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.282 -0.872 . . . . 10.62 111.402 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 11.8 p . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.159 -0.924 . . . . 11.7 110.7 179.285 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.586 ' O ' ' CG1' ' A' ' 2' ' ' VAL . . . . . . . . 0 N--CA 1.478 0.945 0 CA-C-O 121.363 0.602 . . . . 10.31 111.388 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.586 ' CG1' ' O ' ' A' ' 1' ' ' ALA . 3.4 m -179.26 108.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 CA-C-N 114.164 -1.38 . . . . 8.37 110.661 -179.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.783 ' HG ' ' HB2' ' A' ' 8' ' ' ARG . 3.4 mm? -71.14 125.58 27.28 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 121.475 0.655 . . . . 6.25 112.456 -178.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.626 ' H ' ' HG2' ' A' ' 55' ' ' GLN . 0.3 OUTLIER -93.88 84.06 4.49 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 106.43 -1.693 . . . . 6.22 106.43 173.836 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.693 ' HG ' ' O ' ' A' ' 53' ' ' PRO . 1.3 tm? -156.18 -119.76 0.03 OUTLIER 'General case' 0 N--CA 1.397 -3.079 0 CA-C-N 112.586 -2.097 . . . . 7.57 108.236 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.512 ' H ' ' CD1' ' A' ' 5' ' ' LEU . 2.4 t0 -174.26 -14.83 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.771 0 CA-C-N 113.967 -1.469 . . . . 8.78 113.946 -179.162 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.624 HG11 ' O ' ' A' ' 7' ' ' VAL . 13.8 p -163.01 122.73 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.401 -2.888 0 CA-C-N 110.861 -2.881 . . . . 7.88 104.542 168.161 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.783 ' HB2' ' HG ' ' A' ' 3' ' ' LEU . 0.0 OUTLIER -80.87 108.35 14.46 Favored 'General case' 0 N--CA 1.383 -3.788 0 C-N-CA 116.776 -1.97 . . . . 9.7 107.34 176.107 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.441 HG22 ' O ' ' A' ' 52' ' ' SER . 1.2 t -104.52 99.56 9.25 Favored 'General case' 0 N--CA 1.414 -2.226 1 N-CA-C 99.384 -4.302 . . . . 6.05 99.384 167.174 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.2 m -74.84 61.06 0.99 Allowed 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 114.963 -1.017 . . . . 2.89 112.628 -178.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.625 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 0.3 OUTLIER -36.18 112.5 0.52 Allowed Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.804 -0.634 . . . . 2.89 112.628 178.443 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.514 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 56.3 Cg_endo -91.75 145.22 3.11 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 121.696 1.597 . . . . 1.72 113.808 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.642 ' O ' ' HA2' ' A' ' 17' ' ' GLY . 20.8 p -146.12 -174.26 4.39 Favored 'General case' 0 C--N 1.347 0.487 0 C-N-CA 119.043 -1.063 . . . . 1.0 113.543 -179.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.601 ' HA2' ' HG3' ' A' ' 40' ' ' GLU . . . 73.99 -161.38 53.88 Favored Glycine 0 N--CA 1.451 -0.317 0 CA-C-N 115.3 -0.864 . . . . 1.15 113.547 177.333 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.606 ' HG2' ' O ' ' A' ' 15' ' ' PRO . 39.7 Cg_endo -63.26 101.03 0.28 Allowed 'Trans proline' 0 N--CA 1.481 0.785 0 C-N-CA 123.664 2.909 . . . . 1.6 109.211 176.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 82.85 13.21 78.33 Favored Glycine 0 C--N 1.291 -1.917 0 C-N-CA 120.847 -0.692 . . . . 1.68 111.993 178.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.642 ' HA2' ' O ' ' A' ' 13' ' ' CYS . . . 51.8 49.09 49.1 Favored Glycine 0 N--CA 1.409 -3.136 0 N-CA-C 107.897 -2.081 . . . . 1.37 107.897 174.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.518 ' HG3' ' O ' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -99.94 18.52 18.19 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 112.519 -1.841 . . . . 2.91 111.553 174.299 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.514 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -131.73 -177.7 15.05 Favored Glycine 0 N--CA 1.444 -0.789 0 N-CA-C 104.405 -3.478 . . . . 1.06 104.405 176.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.625 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -124.41 172.58 9.03 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 120.538 2.169 . . . . 3.32 109.453 178.754 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.473 ' HB2' ' HB3' ' A' ' 11' ' ' LEU . 0.8 OUTLIER -105.64 134.97 47.9 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 121.334 -0.854 . . . . 1.19 111.16 -178.367 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.5 ' HE2' ' HA ' ' A' ' 56' ' ' SER . 68.0 m-85 -128.2 13.79 6.68 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.3 -0.864 . . . . 2.26 111.253 -179.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -176.16 -167.82 35.49 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.391 -0.909 . . . . 1.05 112.525 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.494 ' O ' ' HB3' ' A' ' 44' ' ' CYS . 1.9 Cg_endo -81.76 -44.26 0.09 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.814 2.343 . . . . 1.81 112.746 -179.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.421 ' HB2' ' OE2' ' B' ' 181' ' ' GLU . 0.1 OUTLIER -124.62 16.03 8.8 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.938 0.399 . . . . 1.62 110.797 179.823 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.846 HG23 HG12 ' A' ' 36' ' ' VAL . 0.8 OUTLIER -126.23 121.76 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.09 0 CA-C-O 121.464 0.649 . . . . 1.39 111.563 -178.041 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.816 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -119.1 132.86 56.04 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-N 115.641 -0.709 . . . . 0.92 109.108 179.051 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 1.156 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -144.82 116.15 8.01 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 112.52 0.563 . . . . 1.28 112.52 -178.718 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.799 ' O ' ' HB3' ' A' ' 69' ' ' ALA . . . -107.43 -163.54 21.74 Favored Glycine 0 N--CA 1.428 -1.866 0 N-CA-C 109.806 -1.318 . . . . 0.71 109.806 177.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.656 ' O ' ' HB2' ' A' ' 70' ' ' ALA . 11.4 t70 -67.54 -60.37 2.61 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 113.885 1.069 . . . . 2.27 113.885 -179.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.51 9.33 23.2 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 115.661 -0.699 . . . . 1.66 111.122 -176.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.556 HD23 ' CZ ' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -109.71 -18.96 13.33 Favored 'General case' 0 N--CA 1.405 -2.687 0 N-CA-C 106.791 -1.559 . . . . 1.93 106.791 179.982 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 1.156 ' O ' ' HA ' ' A' ' 28' ' ' CYS . . . 68.8 -133.86 27.43 Favored Glycine 0 N--CA 1.43 -1.755 0 CA-C-N 114.919 -1.037 . . . . 0.77 115.257 173.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.845 ' HB2' HG13 ' A' ' 72' ' ' ILE . 3.1 t -136.26 117.69 14.74 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-N 118.387 1.094 . . . . 1.08 113.254 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.858 ' HA ' ' HA ' ' B' ' 135' ' ' PHE . 0.0 OUTLIER -100.03 108.67 20.91 Favored 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 106.786 -1.561 . . . . 1.85 106.786 176.984 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.846 HG12 HG23 ' A' ' 26' ' ' ILE . 1.7 t -90.92 87.07 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.304 0 CA-C-O 122.473 1.13 . . . . 1.29 110.269 -179.048 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.493 ' O ' HG21 ' A' ' 38' ' ' THR . . . 102.55 69.29 0.82 Allowed Glycine 0 C--O 1.228 -0.26 0 CA-C-N 112.99 -1.913 . . . . 0.85 113.953 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.493 HG21 ' O ' ' A' ' 37' ' ' GLY . 72.4 p -151.29 164.51 36.46 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 109.251 -0.648 . . . . 1.3 109.251 179.174 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.779 ' O ' HD11 ' A' ' 42' ' ' LEU . . . -70.62 -16.26 62.82 Favored 'General case' 0 N--CA 1.44 -0.968 0 C-N-CA 119.975 -0.69 . . . . 1.45 110.308 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.601 ' HG3' ' HA2' ' A' ' 14' ' ' GLY . 5.0 mp0 -67.57 -15.83 63.86 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.424 -0.954 . . . . 2.32 108.424 176.228 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 1.023 ' O ' ' HB2' ' A' ' 44' ' ' CYS . . . -120.91 -10.57 9.08 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-N 116.361 -0.381 . . . . 1.11 111.221 -178.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.834 HD13 ' N ' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -61.71 -20.4 63.46 Favored 'General case' 0 N--CA 1.45 -0.439 0 O-C-N 121.211 -0.93 . . . . 1.68 113.229 -177.867 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.834 ' N ' HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -71.6 -6.78 43.43 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 107.556 -1.276 . . . . 3.4 107.556 174.95 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 1.023 ' HB2' ' O ' ' A' ' 41' ' ' ALA . 0.2 OUTLIER -66.53 -1.54 3.73 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 112.361 -2.2 . . . . 1.57 110.012 176.462 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -82.84 -17.35 44.26 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.02 0.438 . . . . 3.49 111.457 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -85.51 6.42 27.08 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 120.107 -0.637 . . . . 3.69 109.892 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.434 ' HG3' HD11 ' A' ' 11' ' ' LEU . 0.2 OUTLIER -81.99 3.02 28.15 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 109.416 -0.587 . . . . 3.99 109.416 177.427 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -78.12 -29.13 48.7 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.907 -0.405 . . . . 4.2 109.907 178.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -89.47 8.93 28.46 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 116.429 -0.35 . . . . 5.85 110.911 179.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -147.38 101.21 3.79 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-N 116.429 -0.35 . . . . 5.83 110.36 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -82.59 35.47 0.58 Allowed 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.345 2.03 . . . . 5.3 113.181 -179.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.63 ' HB3' HD12 ' A' ' 5' ' ' LEU . 17.5 m -167.11 105.57 0.63 Allowed Pre-proline 0 CA--C 1.538 0.493 0 C-N-CA 121.175 -0.21 . . . . 5.72 111.55 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.693 ' O ' ' HG ' ' A' ' 5' ' ' LEU . 69.5 Cg_endo -86.04 -137.91 0.02 OUTLIER 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 123.349 2.699 . . . . 5.82 112.257 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.412 ' H ' ' HB2' ' A' ' 53' ' ' PRO . 1.8 p -132.28 116.39 16.85 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.045 0.45 . . . . 2.98 111.225 178.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.626 ' HG2' ' H ' ' A' ' 4' ' ' ASP . 0.0 OUTLIER 52.22 -176.39 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.832 -0.622 . . . . 6.42 112.368 -179.965 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.5 ' HA ' ' HE2' ' A' ' 22' ' ' PHE . 0.3 OUTLIER -144.53 -89.4 0.11 Allowed 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.104 -0.953 . . . . 3.36 111.441 179.628 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 160.41 133.73 1.54 Allowed Glycine 0 N--CA 1.444 -0.819 0 N-CA-C 106.509 -2.637 . . . . 2.3 106.509 -179.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -109.0 76.9 1.03 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 118.991 1.396 . . . . 5.06 111.614 -177.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.477 ' N ' ' CD ' ' A' ' 60' ' ' PRO . 0.4 OUTLIER -145.79 57.19 3.88 Favored Pre-proline 0 C--N 1.309 -1.175 0 N-CA-C 106.33 -1.73 . . . . 3.91 106.33 176.799 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.477 ' CD ' ' N ' ' A' ' 59' ' ' LYS . 41.0 Cg_endo -70.3 81.76 0.92 Allowed 'Trans proline' 0 N--CA 1.448 -1.159 0 C-N-CA 122.096 1.864 . . . . 1.74 113.772 -178.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -103.08 179.31 4.31 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 106.988 -1.486 . . . . 1.9 106.988 177.127 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.16 -169.34 46.49 Favored Glycine 0 N--CA 1.437 -1.246 0 C-N-CA 118.656 -1.735 . . . . 2.43 114.607 178.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 50.2 p -85.46 47.26 1.4 Allowed 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 113.504 -1.348 . . . . 4.32 111.394 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 118.06 5.9 12.93 Favored Glycine 0 C--N 1.336 0.552 0 N-CA-C 115.828 1.091 . . . . 2.4 115.828 175.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.418 ' HA3' ' HA ' ' A' ' 74' ' ' CYS . . . -105.77 137.41 13.76 Favored Glycine 0 CA--C 1.52 0.385 0 N-CA-C 117.044 1.577 . . . . 1.82 117.044 -177.103 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.427 ' HA ' ' O ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -107.41 153.76 22.32 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 114.176 -1.012 . . . . 3.51 109.111 177.668 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.76 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 2.2 m -59.41 107.64 0.6 Allowed 'General case' 0 N--CA 1.441 -0.891 0 O-C-N 121.968 -0.457 . . . . 1.52 111.442 -177.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -84.21 -20.23 32.68 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.308 -0.627 . . . . 1.5 109.308 177.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.799 ' HB3' ' O ' ' A' ' 29' ' ' GLY . . . -166.46 164.07 17.23 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.776 -0.647 . . . . 1.31 111.62 179.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.656 ' HB2' ' O ' ' A' ' 30' ' ' ASP . . . -39.76 96.9 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.778 -0.646 . . . . 1.5 110.185 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.653 ' HA2' ' O ' ' A' ' 82' ' ' ASP . . . 73.57 50.23 12.32 Favored Glycine 0 CA--C 1.504 -0.655 0 CA-C-N 114.877 -1.056 . . . . 1.44 111.456 -179.126 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.845 HG13 ' HB2' ' A' ' 34' ' ' CYS . 0.5 OUTLIER -137.51 98.88 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.817 0 N-CA-C 108.049 -1.093 . . . . 2.77 108.049 170.969 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.452 ' O ' ' HB2' ' A' ' 80' ' ' HIS . 51.2 t -91.91 96.27 10.29 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 108.613 -0.884 . . . . 1.98 108.613 179.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 1.04 ' CB ' ' HA ' ' A' ' 79' ' ' CYS . 24.4 p -167.3 -171.57 1.75 Allowed 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 116.577 2.066 . . . . 1.43 116.577 -176.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.85 ' HB3' ' HD2' ' A' ' 76' ' ' PRO . 72.8 m -124.6 -178.9 0.74 Allowed Pre-proline 0 CA--C 1.531 0.225 0 CA-C-N 112.927 -1.942 . . . . 2.37 108.564 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.85 ' HD2' ' HB3' ' A' ' 75' ' ' SER . 58.0 Cg_endo -73.16 31.17 0.3 Allowed 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 121.717 1.611 . . . . 2.09 113.172 -179.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.424 ' H ' ' C ' ' A' ' 75' ' ' SER . 10.7 t70 -134.36 -60.94 0.79 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.85 0.357 . . . . 2.65 110.221 178.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.929 ' O ' ' HB2' ' A' ' 74' ' ' CYS . . . -118.22 -178.51 17.14 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.95 -0.643 . . . . 1.04 111.661 178.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 1.04 ' HA ' ' CB ' ' A' ' 74' ' ' CYS . 22.5 m -152.27 161.37 42.72 Favored 'General case' 0 C--O 1.226 -0.169 0 N-CA-C 112.428 0.529 . . . . 1.42 112.428 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.501 ' HA ' ' HA2' ' B' ' 178' ' ' GLY . 7.1 m80 -143.17 139.04 30.16 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-O 121.173 0.511 . . . . 2.81 111.823 -178.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.459 ' OE2' ' HB2' ' B' ' 125' ' ' SER . 37.0 tt0 -65.51 122.97 18.43 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-N 115.671 -0.695 . . . . 3.05 109.605 178.114 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.653 ' O ' ' HA2' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -138.9 106.75 7.47 Favored Pre-proline 0 C--N 1.319 -0.749 0 C-N-CA 118.963 -1.095 . . . . 2.02 111.385 179.424 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -63.85 -16.65 56.07 Favored 'Trans proline' 0 C--N 1.356 0.948 0 C-N-CA 123.004 2.47 . . . . 2.29 114.315 -178.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.08 -40.16 96.86 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.108 0.48 . . . . 1.53 110.542 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.632 ' O ' ' N ' ' A' ' 71' ' ' GLY . 68.8 m -94.18 46.74 1.17 Allowed 'General case' 0 C--O 1.219 -0.55 0 CA-C-N 115.484 -0.78 . . . . 1.88 110.351 179.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.548 ' CB ' ' HD3' ' A' ' 87' ' ' PRO . 0.2 OUTLIER -77.78 -58.08 0.93 Allowed Pre-proline 0 N--CA 1.475 0.803 0 O-C-N 121.544 -0.722 . . . . 3.6 112.027 -178.735 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.651 ' O ' ' C ' ' A' ' 88' ' ' GLU . 97.1 Cg_endo -90.99 155.72 3.93 Favored 'Trans proline' 0 CA--C 1.504 -1.016 0 C-N-CA 123.996 3.131 . . . . 3.12 108.721 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.651 ' C ' ' O ' ' A' ' 87' ' ' PRO . 0.2 OUTLIER -30.19 95.26 0.01 OUTLIER 'General case' 0 N--CA 1.417 -2.116 0 C-N-CA 118.309 -1.356 . . . . 4.72 110.45 176.785 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.651 ' N ' ' O ' ' A' ' 87' ' ' PRO . . . -91.99 20.59 5.64 Favored 'General case' 0 C--N 1.285 -2.239 0 N-CA-C 107.019 -1.475 . . . . 5.29 107.019 171.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.2 156.16 39.19 Favored 'General case' 0 C--N 1.356 0.862 0 CA-C-O 122.466 1.127 . . . . 7.19 112.083 177.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -98.35 95.57 7.45 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 112.686 -2.052 . . . . 10.7 109.951 177.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 39.5 m . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.294 -0.86 . . . . 11.77 110.815 179.983 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 101' ' ' ALA . . . . . 0.59 ' O ' HD23 ' B' ' 103' ' ' LEU . . . . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 111.752 0.279 . . . . 10.42 111.752 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 3.7 t 56.25 45.3 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.289 0 C-N-CA 118.547 -1.261 . . . . 8.81 110.022 176.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 103' ' ' LEU . . . . . 0.921 ' HG ' ' HG3' ' B' ' 108' ' ' ARG . 3.3 mm? -104.23 94.23 5.25 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 113.01 -1.905 . . . . 6.28 113.938 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 104' ' ' ASP . . . . . 0.54 ' H ' ' HG2' ' B' ' 155' ' ' GLN . 0.7 OUTLIER -81.86 107.65 14.75 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 114.01 -1.45 . . . . 6.27 111.41 178.931 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . 0.767 HD11 ' H ' ' B' ' 107' ' ' VAL . 2.7 tm? -157.16 -90.8 0.03 OUTLIER 'General case' 0 N--CA 1.4 -2.971 0 N-CA-C 106.348 -1.723 . . . . 7.61 106.348 173.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 106' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -167.71 -48.91 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 111.434 -2.621 . . . . 8.55 107.649 -178.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 107' ' ' VAL . . . . . 0.767 ' H ' HD11 ' B' ' 105' ' ' LEU . 11.3 p -141.02 123.07 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.515 0 N-CA-C 102.832 -3.025 . . . . 7.84 102.832 173.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 108' ' ' ARG . . . . . 0.921 ' HG3' ' HG ' ' B' ' 103' ' ' LEU . 0.0 OUTLIER -80.15 110.44 15.56 Favored 'General case' 0 N--CA 1.385 -3.716 0 C-N-CA 117.865 -1.534 . . . . 9.75 107.721 178.355 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 109' ' ' THR . . . . . 0.417 HG22 ' O ' ' B' ' 152' ' ' SER . 1.2 t -108.04 99.8 9.2 Favored 'General case' 0 N--CA 1.407 -2.605 1 N-CA-C 98.546 -4.612 . . . . 6.13 98.546 167.784 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 110' ' ' CYS . . . . . . . . . . . . . 1.2 m -77.7 66.46 3.39 Favored 'General case' 0 C--N 1.311 -1.084 0 C-N-CA 118.297 -1.361 . . . . 2.87 111.457 -177.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 111' ' ' LEU . . . . . 0.698 ' O ' ' HA ' ' B' ' 120' ' ' ARG . 0.2 OUTLIER -37.92 112.08 0.61 Allowed Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.007 -0.997 . . . . 2.95 112.367 176.864 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 112' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -84.49 153.28 12.02 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.339 2.026 . . . . 1.71 111.018 178.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.469 ' O ' ' HA2' ' B' ' 117' ' ' GLY . 20.0 p -154.33 -174.71 5.07 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 113.638 0.977 . . . . 1.0 113.638 174.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 114' ' ' GLY . . . . . 0.579 ' HA2' ' HG3' ' B' ' 140' ' ' GLU . . . 73.54 -161.44 54.15 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.151 -0.931 . . . . 1.16 113.529 177.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 115' ' ' PRO . . . . . 0.516 ' O ' ' HG3' ' B' ' 118' ' ' LYS . 42.8 Cg_endo -64.57 95.74 0.23 Allowed 'Trans proline' 0 C--O 1.224 -0.182 0 C-N-CA 123.11 2.54 . . . . 1.6 112.5 177.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 87.65 11.41 68.5 Favored Glycine 0 C--N 1.283 -2.403 0 CA-C-N 114.767 -1.106 . . . . 1.7 113.228 -178.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 117' ' ' GLY . . . . . 0.469 ' HA2' ' O ' ' B' ' 113' ' ' CYS . . . 62.11 39.41 97.6 Favored Glycine 0 N--CA 1.414 -2.822 0 C-N-CA 118.002 -2.047 . . . . 1.38 111.438 176.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 118' ' ' LYS . . . . . 0.516 ' HG3' ' O ' ' B' ' 115' ' ' PRO . 0.0 OUTLIER -91.85 7.06 43.69 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 113.904 -1.148 . . . . 2.96 112.094 179.644 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . -115.93 -159.5 11.97 Favored Glycine 0 C--N 1.343 0.961 0 N-CA-C 108.139 -1.984 . . . . 1.07 108.139 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.698 ' HA ' ' O ' ' B' ' 111' ' ' LEU . 0.0 OUTLIER -145.37 170.46 16.29 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 121.098 2.449 . . . . 3.29 105.844 174.685 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 121' ' ' CYS . . . . . 0.47 ' HB2' ' HB3' ' B' ' 111' ' ' LEU . 0.9 OUTLIER -106.26 135.61 47.45 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 119.115 0.87 . . . . 1.21 111.942 -176.769 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 122' ' ' PHE . . . . . 0.555 ' HE2' ' HA ' ' B' ' 156' ' ' SER . 68.7 m-85 -128.12 13.71 6.72 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.038 -0.983 . . . . 2.28 111.287 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -176.16 -167.81 35.49 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.339 -0.934 . . . . 1.04 112.56 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . 0.469 ' O ' ' HB3' ' B' ' 144' ' ' CYS . 2.0 Cg_endo -81.68 -44.37 0.09 OUTLIER 'Trans proline' 0 CA--C 1.532 0.423 0 C-N-CA 122.701 2.267 . . . . 1.84 112.791 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 125' ' ' SER . . . . . 0.459 ' HB2' ' OE2' ' A' ' 81' ' ' GLU . 0.1 OUTLIER -124.73 16.54 8.73 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.983 0.421 . . . . 1.49 110.722 179.823 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 126' ' ' ILE . . . . . 0.76 HG12 HG13 ' B' ' 136' ' ' VAL . 1.0 OUTLIER -126.44 121.63 59.3 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 CA-C-O 121.454 0.645 . . . . 1.41 111.57 -178.106 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 127' ' ' CYS . . . . . 0.734 ' HB2' ' CB ' ' B' ' 141' ' ' ALA . 0.1 OUTLIER -119.28 133.59 55.67 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-N 115.578 -0.737 . . . . 0.89 109.078 178.912 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 128' ' ' CYS . . . . . 1.197 ' HA ' ' O ' ' B' ' 133' ' ' GLY . 0.0 OUTLIER -145.53 120.5 10.02 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 118.246 -0.883 . . . . 1.23 111.145 -179.171 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 129' ' ' GLY . . . . . 0.43 ' O ' ' HB2' ' B' ' 169' ' ' ALA . . . -114.69 -156.95 11.56 Favored Glycine 0 N--CA 1.417 -2.613 0 N-CA-C 107.555 -2.218 . . . . 0.69 107.555 176.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 130' ' ' ASP . . . . . 0.744 ' O ' ' HB2' ' B' ' 170' ' ' ALA . 8.0 t70 -65.85 -71.0 0.21 Allowed 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 122.168 0.187 . . . . 2.35 111.493 -178.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.47 32.25 5.52 Favored 'General case' 0 CA--C 1.498 -1.024 0 C-N-CA 120.095 -0.642 . . . . 1.69 110.027 -175.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 132' ' ' LEU . . . . . 0.521 HD23 ' CE1' ' B' ' 135' ' ' PHE . 0.8 OUTLIER -124.79 -18.88 5.46 Favored 'General case' 0 N--CA 1.403 -2.802 0 N-CA-C 104.898 -2.26 . . . . 1.84 104.898 176.127 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 133' ' ' GLY . . . . . 1.197 ' O ' ' HA ' ' B' ' 128' ' ' CYS . . . 66.86 -134.96 32.33 Favored Glycine 0 N--CA 1.407 -3.269 0 CA-C-N 115.134 -0.939 . . . . 0.76 114.769 173.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 134' ' ' CYS . . . . . 0.854 ' HB2' HG13 ' B' ' 172' ' ' ILE . 2.7 t -135.14 116.44 14.52 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 114.141 1.163 . . . . 1.08 114.141 -177.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 135' ' ' PHE . . . . . 0.858 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -98.16 107.68 20.21 Favored 'General case' 0 CA--C 1.503 -0.857 0 N-CA-C 107.068 -1.456 . . . . 1.83 107.068 177.158 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 136' ' ' VAL . . . . . 0.76 HG13 HG12 ' B' ' 126' ' ' ILE . 2.2 t -90.99 86.57 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.324 0 CA-C-O 122.611 1.196 . . . . 1.29 109.792 -179.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 137' ' ' GLY . . . . . 0.454 ' O ' ' HA3' ' A' ' 33' ' ' GLY . . . 102.47 68.92 0.81 Allowed Glycine 0 C--N 1.321 -0.285 0 CA-C-N 112.85 -1.977 . . . . 0.85 114.135 179.403 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 138' ' ' THR . . . . . 0.502 HG22 ' O ' ' A' ' 32' ' ' LEU . 81.2 p -146.45 173.15 12.55 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.824 -0.806 . . . . 1.2 108.824 178.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 139' ' ' ALA . . . . . 0.777 ' O ' HD11 ' B' ' 142' ' ' LEU . . . -78.35 -17.36 56.61 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 120.197 -0.601 . . . . 1.35 109.669 177.169 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 140' ' ' GLU . . . . . 0.579 ' HG3' ' HA2' ' B' ' 114' ' ' GLY . 5.3 mp0 -67.48 -14.33 62.83 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.86 -0.793 . . . . 2.31 108.86 176.11 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 141' ' ' ALA . . . . . 1.016 ' O ' ' HB2' ' B' ' 144' ' ' CYS . . . -120.42 -15.59 8.53 Favored 'General case' 0 C--O 1.218 -0.585 0 CA-C-N 115.198 -0.91 . . . . 1.09 111.802 -179.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 142' ' ' LEU . . . . . 0.829 HD13 ' N ' ' B' ' 143' ' ' ARG . 0.0 OUTLIER -59.91 -21.15 60.71 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 113.529 0.937 . . . . 1.61 113.529 -176.569 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 143' ' ' ARG . . . . . 0.829 ' N ' HD13 ' B' ' 142' ' ' LEU . 0.0 OUTLIER -64.32 -20.63 66.22 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 105.966 -1.865 . . . . 3.43 105.966 175.222 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 144' ' ' CYS . . . . . 1.016 ' HB2' ' O ' ' B' ' 141' ' ' ALA . 0.2 OUTLIER -59.28 2.49 0.06 Allowed 'General case' 0 N--CA 1.486 1.374 0 CA-C-N 113.521 -1.672 . . . . 1.61 110.578 -177.985 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 145' ' ' GLN . . . . . 0.572 ' H ' ' C ' ' B' ' 143' ' ' ARG . 14.4 mm100 -84.03 -17.46 40.32 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.039 0.447 . . . . 3.52 111.004 178.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -85.69 6.49 27.42 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 120.147 -0.621 . . . . 3.76 109.808 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . 0.426 ' HG3' HD11 ' B' ' 111' ' ' LEU . 0.2 OUTLIER -81.87 2.9 28.23 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 120.241 -0.584 . . . . 4.01 109.508 177.331 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 148' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -78.1 -29.09 48.84 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 116.335 -0.393 . . . . 4.24 109.95 178.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -89.44 8.9 28.5 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.459 -0.337 . . . . 6.07 110.966 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -147.33 101.2 3.8 Favored Pre-proline 0 C--N 1.333 -0.151 0 CA-C-N 116.397 -0.365 . . . . 5.86 110.302 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 151' ' ' PRO . . . . . 0.408 ' O ' ' OG ' ' B' ' 152' ' ' SER . 93.9 Cg_endo -82.59 35.34 0.57 Allowed 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.432 2.088 . . . . 5.42 113.223 -179.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 152' ' ' SER . . . . . 0.73 ' HB3' HD12 ' B' ' 105' ' ' LEU . 16.9 m -167.04 105.53 0.63 Allowed Pre-proline 0 CA--C 1.537 0.478 0 N-CA-C 111.678 0.251 . . . . 6.02 111.678 -179.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 153' ' ' PRO . . . . . 0.464 ' HB2' ' H ' ' B' ' 154' ' ' CYS . 77.4 Cg_endo -86.18 -138.34 0.02 OUTLIER 'Trans proline' 0 CA--C 1.544 1.003 0 C-N-CA 123.239 2.626 . . . . 5.87 112.257 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 154' ' ' CYS . . . . . 0.619 ' SG ' HD12 ' B' ' 103' ' ' LEU . 1.8 p -131.95 116.98 17.83 Favored 'General case' 0 C--N 1.349 0.553 0 CA-C-O 121.281 0.562 . . . . 2.96 111.052 178.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 155' ' ' GLN . . . . . 0.595 ' HB2' ' CD1' ' B' ' 103' ' ' LEU . 0.0 OUTLIER 51.1 -174.97 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 115.436 -0.802 . . . . 6.3 112.249 -179.663 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 156' ' ' SER . . . . . 0.555 ' HA ' ' HE2' ' B' ' 122' ' ' PHE . 0.3 OUTLIER -145.46 -94.89 0.1 Allowed 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.425 -0.807 . . . . 3.41 108.997 179.156 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 165.68 136.63 2.05 Favored Glycine 0 CA--C 1.501 -0.798 0 N-CA-C 108.291 -1.924 . . . . 2.26 108.291 -178.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -110.91 64.63 0.61 Allowed 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 117.013 -1.875 . . . . 5.03 112.682 -178.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 159' ' ' LYS . . . . . 0.458 ' HB3' ' SG ' ' B' ' 167' ' ' CYS . 0.2 OUTLIER -118.19 53.63 1.75 Allowed Pre-proline 0 C--N 1.315 -0.893 0 CA-C-N 113.686 -1.597 . . . . 3.96 110.048 170.175 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 160' ' ' PRO . . . . . 0.4 ' HA ' ' HA ' ' B' ' 166' ' ' ARG . 37.7 Cg_endo -69.79 83.9 0.68 Allowed 'Trans proline' 0 CA--C 1.519 -0.244 0 CA-C-N 122.153 1.805 . . . . 1.7 114.46 -173.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 161' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -97.13 -170.91 2.11 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 113.8 -1.545 . . . . 1.93 107.761 178.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 55.87 -167.53 3.27 Favored Glycine 0 N--CA 1.439 -1.159 0 C-N-CA 119.645 -1.264 . . . . 2.37 114.779 173.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 78.8 p -85.65 47.03 1.37 Allowed 'General case' 0 C--N 1.309 -1.168 0 C-N-CA 126.637 1.975 . . . . 4.56 111.66 -179.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 118.35 5.11 13.19 Favored Glycine 0 C--N 1.347 1.189 0 CA-C-N 112.863 -1.971 . . . . 2.39 116.004 173.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 165' ' ' GLY . . . . . 0.424 ' HA3' ' HA ' ' B' ' 174' ' ' CYS . . . -104.0 137.97 13.82 Favored Glycine 0 CA--C 1.522 0.473 0 C-N-CA 118.837 -1.649 . . . . 1.79 117.081 -176.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 166' ' ' ARG . . . . . 0.451 ' HA ' ' O ' ' B' ' 159' ' ' LYS . 0.0 OUTLIER -107.96 153.69 22.7 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 114.006 -1.097 . . . . 3.53 108.99 177.03 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 167' ' ' CYS . . . . . 0.771 ' HA ' ' O ' ' B' ' 172' ' ' ILE . 2.0 m -59.52 107.54 0.6 Allowed 'General case' 0 N--CA 1.438 -1.049 0 O-C-N 121.832 -0.542 . . . . 1.56 111.479 -177.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 168' ' ' ALA . . . . . . . . . . . . . . . -81.62 -24.65 36.26 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 108.808 -0.812 . . . . 1.42 108.808 177.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 169' ' ' ALA . . . . . 0.652 ' HB2' ' HA2' ' B' ' 133' ' ' GLY . . . -163.52 163.94 24.51 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 115.169 -0.923 . . . . 1.18 112.782 -178.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 170' ' ' ALA . . . . . 0.744 ' HB2' ' O ' ' B' ' 130' ' ' ASP . . . -40.97 97.77 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.563 -0.744 . . . . 1.47 110.115 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 171' ' ' GLY . . . . . 0.728 ' HA2' ' O ' ' B' ' 182' ' ' ASP . . . 88.19 20.73 48.18 Favored Glycine 0 N--CA 1.443 -0.876 0 N-CA-C 115.559 0.983 . . . . 1.45 115.559 179.017 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 172' ' ' ILE . . . . . 0.854 HG13 ' HB2' ' B' ' 134' ' ' CYS . 0.3 OUTLIER -120.19 99.25 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 CA-C-N 117.229 0.515 . . . . 2.7 110.908 -179.801 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 173' ' ' CYS . . . . . 0.444 ' O ' ' HB2' ' B' ' 180' ' ' HIS . 53.2 t -91.51 96.29 10.41 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 108.932 -0.766 . . . . 1.94 108.932 178.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 174' ' ' CYS . . . . . 1.053 ' CB ' ' HA ' ' B' ' 179' ' ' CYS . 21.9 p -167.67 -171.67 1.69 Allowed 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 116.53 2.048 . . . . 1.43 116.53 -176.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 175' ' ' SER . . . . . 0.864 ' HB3' ' HD2' ' B' ' 176' ' ' PRO . 72.3 m -124.48 -178.82 0.73 Allowed Pre-proline 0 CA--C 1.531 0.241 0 CA-C-N 112.981 -1.918 . . . . 2.3 108.537 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 176' ' ' PRO . . . . . 0.864 ' HD2' ' HB3' ' B' ' 175' ' ' SER . 57.9 Cg_endo -73.28 31.13 0.31 Allowed 'Trans proline' 0 CA--C 1.533 0.435 0 C-N-CA 121.725 1.617 . . . . 2.13 113.092 -179.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 177' ' ' ASP . . . . . 0.424 ' H ' ' C ' ' B' ' 175' ' ' SER . 10.8 t70 -134.32 -60.83 0.79 Allowed 'General case' 0 C--O 1.234 0.277 0 CA-C-O 120.914 0.387 . . . . 2.72 110.267 178.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 178' ' ' GLY . . . . . 0.915 ' O ' ' HB2' ' B' ' 174' ' ' CYS . . . -118.15 -178.52 17.18 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 121.006 -0.616 . . . . 1.05 111.668 178.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 179' ' ' CYS . . . . . 1.053 ' HA ' ' CB ' ' B' ' 174' ' ' CYS . 21.7 m -152.24 161.34 42.76 Favored 'General case' 0 N--CA 1.462 0.127 0 N-CA-C 112.453 0.538 . . . . 1.39 112.453 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 180' ' ' HIS . . . . . 0.497 ' HA ' ' HA2' ' A' ' 78' ' ' GLY . 7.1 m80 -143.15 139.08 30.22 Favored 'General case' 0 CA--C 1.517 -0.295 0 O-C-N 121.897 -0.502 . . . . 2.73 111.763 -178.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 181' ' ' GLU . . . . . 0.421 ' OE2' ' HB2' ' A' ' 25' ' ' SER . 37.4 tt0 -65.57 123.0 18.51 Favored 'General case' 0 CA--C 1.503 -0.858 0 CA-C-N 115.674 -0.694 . . . . 3.06 109.586 178.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 182' ' ' ASP . . . . . 0.728 ' O ' ' HA2' ' B' ' 171' ' ' GLY . 0.0 OUTLIER -138.81 106.6 7.52 Favored Pre-proline 0 C--N 1.319 -0.757 0 C-N-CA 118.957 -1.097 . . . . 2.06 111.346 179.466 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 183' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -63.6 -16.85 57.16 Favored 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 123.034 2.489 . . . . 2.27 114.391 -178.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -63.02 -40.2 97.03 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.177 0.513 . . . . 1.56 110.512 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 185' ' ' CYS . . . . . 0.601 ' O ' ' N ' ' B' ' 171' ' ' GLY . 69.5 m -94.0 46.83 1.18 Allowed 'General case' 0 C--O 1.217 -0.613 0 CA-C-N 115.576 -0.738 . . . . 1.94 110.399 179.322 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 186' ' ' ASP . . . . . 0.544 ' CB ' ' HD3' ' B' ' 187' ' ' PRO . 0.2 OUTLIER -77.94 -57.84 0.93 Allowed Pre-proline 0 N--CA 1.473 0.719 0 O-C-N 121.518 -0.739 . . . . 3.61 111.861 -178.637 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 187' ' ' PRO . . . . . 0.699 ' O ' ' C ' ' B' ' 188' ' ' GLU . 51.1 Cg_endo -95.89 145.3 1.2 Allowed 'Trans proline' 0 CA--C 1.504 -0.992 0 C-N-CA 123.946 3.097 . . . . 3.14 110.43 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 188' ' ' GLU . . . . . 0.699 ' C ' ' O ' ' B' ' 187' ' ' PRO . 0.1 OUTLIER -20.11 91.6 0.01 OUTLIER 'General case' 0 N--CA 1.413 -2.281 0 C-N-CA 118.822 -1.151 . . . . 4.7 111.695 -176.97 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 189' ' ' ALA . . . . . 0.603 ' N ' ' O ' ' B' ' 187' ' ' PRO . . . -88.31 18.65 4.26 Favored 'General case' 0 N--CA 1.41 -2.432 0 CA-C-N 121.148 1.794 . . . . 5.24 107.142 174.164 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 190' ' ' ALA . . . . . 0.416 ' H ' ' C ' ' B' ' 188' ' ' GLU . . . -63.44 156.18 26.91 Favored 'General case' 0 C--N 1.355 0.828 0 CA-C-O 122.461 1.125 . . . . 6.93 111.869 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 191' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -98.18 95.85 7.69 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 113.004 -1.907 . . . . 10.62 110.096 177.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 39.4 m . . . . . 0 C--O 1.248 0.994 0 CA-C-O 118.26 -0.876 . . . . 11.7 110.749 -179.969 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 110.181 -0.303 . . . . 10.31 110.181 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 6.4 p -59.47 97.49 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.319 0 C-N-CA 119.839 -0.745 . . . . 8.37 111.573 -176.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 1.049 HD11 ' HB3' ' A' ' 5' ' ' LEU . 0.2 OUTLIER -158.01 128.78 6.39 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 119.792 -0.763 . . . . 6.25 112.611 179.78 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -88.24 89.01 7.82 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 105.678 -1.971 . . . . 6.22 105.678 175.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 1.049 ' HB3' HD11 ' A' ' 3' ' ' LEU . 1.3 tm? -159.22 -120.76 0.02 OUTLIER 'General case' 1 N--CA 1.375 -4.198 0 CA-C-N 112.063 -2.335 . . . . 7.57 105.08 178.788 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.536 ' H ' HD11 ' A' ' 5' ' ' LEU . 1.4 t70 -171.19 -33.67 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 113.807 -1.542 . . . . 8.78 110.815 -179.066 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.915 ' H ' HD11 ' A' ' 5' ' ' LEU . 15.0 p -147.46 118.11 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.896 0 CA-C-N 110.946 -2.843 . . . . 7.88 105.52 172.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.732 ' HB3' ' CD1' ' A' ' 3' ' ' LEU . 0.0 OUTLIER -79.67 105.38 10.93 Favored 'General case' 0 N--CA 1.388 -3.531 0 CA-C-N 115.272 -0.877 . . . . 9.7 111.401 -177.849 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.985 HG22 ' HD2' ' A' ' 51' ' ' PRO . 1.3 t -102.34 86.01 2.74 Favored 'General case' 0 N--CA 1.412 -2.347 1 N-CA-C 98.772 -4.529 . . . . 6.05 98.772 168.411 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.555 ' HA ' ' HB2' ' A' ' 54' ' ' CYS . 0.8 OUTLIER -74.97 56.23 0.74 Allowed 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 113.155 -1.839 . . . . 2.89 112.329 -176.876 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.797 HD21 ' HB3' ' A' ' 21' ' ' CYS . 15.0 tp -36.93 114.41 0.64 Allowed Pre-proline 0 N--CA 1.476 0.869 0 N-CA-C 114.054 1.131 . . . . 2.89 114.054 179.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.497 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 52.0 Cg_endo -95.73 134.83 0.57 Allowed 'Trans proline' 0 CA--C 1.534 0.513 0 C-N-CA 122.167 1.911 . . . . 1.72 115.216 179.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.663 ' O ' ' HA2' ' A' ' 17' ' ' GLY . 0.5 OUTLIER -140.65 -169.06 2.71 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 113.444 0.905 . . . . 1.0 113.444 -178.389 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.561 ' HA2' ' HB3' ' A' ' 40' ' ' GLU . . . 77.09 -156.18 45.21 Favored Glycine 0 C--N 1.337 0.605 0 CA-C-N 114.932 -1.031 . . . . 1.15 111.899 178.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.721 ' HG2' ' O ' ' A' ' 15' ' ' PRO . 41.4 Cg_endo -62.8 113.44 1.98 Allowed 'Trans proline' 0 N--CA 1.479 0.667 0 C-N-CA 122.783 2.322 . . . . 1.6 106.193 176.161 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 73.3 -7.12 12.25 Favored Glycine 0 C--N 1.276 -2.776 0 CA-C-O 119.067 -0.852 . . . . 1.68 112.73 175.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.663 ' HA2' ' O ' ' A' ' 13' ' ' CYS . . . 77.61 49.69 7.06 Favored Glycine 1 N--CA 1.383 -4.858 0 C-N-CA 118.295 -1.907 . . . . 1.37 111.515 -179.42 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.426 ' CG ' ' O ' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -99.61 9.46 43.11 Favored 'General case' 0 C--N 1.342 0.278 0 CA-C-N 112.864 -1.668 . . . . 2.91 111.946 175.643 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.497 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -124.63 -167.92 12.73 Favored Glycine 0 C--N 1.333 0.404 0 N-CA-C 106.465 -2.654 . . . . 1.06 106.465 178.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.695 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 0.6 OUTLIER -135.98 158.56 44.09 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 121.056 2.428 . . . . 3.32 108.184 -179.925 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.797 ' HB3' HD21 ' A' ' 11' ' ' LEU . 1.7 t -107.65 160.49 15.66 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 112.883 0.697 . . . . 1.19 112.883 -178.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.558 ' HE1' ' O ' ' A' ' 28' ' ' CYS . 60.7 m-85 -126.38 -47.46 1.59 Allowed 'General case' 0 C--N 1.339 0.143 0 CA-C-N 115.538 -0.755 . . . . 2.26 110.184 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -117.46 -159.62 11.46 Favored Glycine 0 CA--C 1.521 0.414 0 CA-C-N 115.723 -0.671 . . . . 1.05 111.559 179.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -84.33 -68.1 0.01 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.32 2.013 . . . . 1.81 111.657 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.409 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.4 OUTLIER -89.41 26.54 1.66 Allowed 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.867 -0.42 . . . . 1.62 109.867 178.753 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 1.024 HG23 HG12 ' A' ' 36' ' ' VAL . 5.6 mt -144.82 112.81 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 CA-C-O 121.875 0.845 . . . . 1.39 111.771 -178.287 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.617 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 4.7 t -126.57 131.3 51.56 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 114.991 -1.004 . . . . 0.92 109.451 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.843 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -142.44 123.12 14.21 Favored 'General case' 0 CA--C 1.561 1.374 0 N-CA-C 115.38 1.622 . . . . 1.28 115.38 -177.358 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -109.37 -170.34 20.5 Favored Glycine 0 C--N 1.368 2.31 0 N-CA-C 109.117 -1.593 . . . . 0.71 109.117 175.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -66.07 -56.07 13.39 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 114.573 1.323 . . . . 2.27 114.573 -178.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.45 -1.11 16.03 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 122.129 0.966 . . . . 1.66 111.234 -177.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.929 HD21 ' CZ ' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -97.39 -13.0 22.1 Favored 'General case' 0 N--CA 1.407 -2.587 0 N-CA-C 106.531 -1.655 . . . . 1.93 106.531 179.937 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.883 ' HA2' ' CB ' ' A' ' 69' ' ' ALA . . . 58.78 -132.66 52.66 Favored Glycine 0 C--O 1.197 -2.168 0 CA-C-O 118.165 -1.353 . . . . 0.77 112.28 175.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.895 ' HB2' HD13 ' A' ' 72' ' ' ILE . 2.4 t -135.39 122.21 21.08 Favored 'General case' 0 CA--C 1.486 -1.517 0 CA-C-N 118.496 1.148 . . . . 1.08 113.748 -179.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.929 ' CZ ' HD21 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -97.69 100.63 12.02 Favored 'General case' 0 N--CA 1.427 -1.606 0 N-CA-C 103.296 -2.853 . . . . 1.85 103.296 175.426 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 1.024 HG12 HG23 ' A' ' 26' ' ' ILE . 2.1 t -92.12 83.66 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 CA-C-O 123.319 1.533 . . . . 1.29 107.139 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.828 ' HA3' HG23 ' B' ' 172' ' ' ILE . . . 100.43 85.71 1.87 Allowed Glycine 0 CA--C 1.525 0.689 0 CA-C-N 112.42 -2.173 . . . . 0.85 113.67 -179.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.68 HG22 ' HD1' ' B' ' 135' ' ' PHE . 67.0 p -161.56 159.49 27.82 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 109.631 -0.507 . . . . 1.3 109.631 179.298 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.615 ' HA ' HD11 ' A' ' 42' ' ' LEU . . . -62.15 -23.07 66.36 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 118.666 0.666 . . . . 1.45 111.242 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.561 ' HB3' ' HA2' ' A' ' 14' ' ' GLY . 3.2 mm-40 -68.75 -13.05 62.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.795 -0.639 . . . . 2.32 109.704 176.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.551 ' O ' ' HB2' ' A' ' 44' ' ' CYS . . . -100.3 -24.36 14.55 Favored 'General case' 0 C--O 1.205 -1.24 0 N-CA-C 109.154 -0.684 . . . . 1.11 109.154 178.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.644 HD22 ' CE1' ' B' ' 191' ' ' PHE . 26.4 mt -42.5 -38.49 1.95 Allowed 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.31 0.485 . . . . 1.68 112.31 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.643 ' HD3' ' O ' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -69.25 -6.25 28.05 Favored 'General case' 0 CA--C 1.556 1.197 0 CA-C-O 121.822 0.82 . . . . 3.4 110.733 179.348 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.551 ' HB2' ' O ' ' A' ' 41' ' ' ALA . 65.7 m -72.59 -18.21 61.62 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 113.829 -1.532 . . . . 1.57 109.715 177.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -55.48 -17.17 4.7 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.667 -0.697 . . . . 3.49 111.471 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -84.43 5.64 26.48 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 120.444 -0.502 . . . . 3.69 110.063 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.575 ' HA ' ' HB2' ' A' ' 50' ' ' LEU . 17.4 tt0 -82.85 -0.96 50.58 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.89 -0.595 . . . . 3.99 109.833 177.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 15.2 m-20 -73.81 -27.94 61.37 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 109.308 -0.627 . . . . 4.2 109.308 177.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -119.18 41.23 3.13 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 115.76 -0.654 . . . . 5.85 109.75 179.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.78 HD21 ' HG1' ' A' ' 9' ' ' THR . 0.8 OUTLIER -123.58 140.13 33.53 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-N 115.862 -0.608 . . . . 5.83 111.64 -179.001 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.985 ' HD2' HG22 ' A' ' 9' ' ' THR . 2.7 Cg_exo -76.36 50.86 3.04 Favored 'Trans proline' 0 C--N 1.356 0.925 0 C-N-CA 122.891 2.394 . . . . 5.3 113.057 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.761 ' HB2' ' HD2' ' A' ' 53' ' ' PRO . 5.1 p 71.65 171.15 0.11 Allowed Pre-proline 0 N--CA 1.471 0.601 0 N-CA-C 112.401 0.519 . . . . 5.72 112.401 179.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.761 ' HD2' ' HB2' ' A' ' 52' ' ' SER . 13.7 Cg_endo -56.98 -173.0 0.04 OUTLIER 'Trans proline' 0 C--N 1.361 1.205 0 C-N-CA 123.403 2.735 . . . . 5.82 115.147 -178.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.555 ' HB2' ' HA ' ' A' ' 10' ' ' CYS . 1.0 OUTLIER -119.13 116.13 25.7 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 114.313 -1.312 . . . . 2.98 110.157 -179.025 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 66.85 -168.2 0.2 Allowed 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 118.37 0.532 . . . . 6.42 111.426 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.754 ' OG ' ' HG3' ' A' ' 59' ' ' LYS . 0.4 OUTLIER -135.19 -69.59 0.5 Allowed 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 108.72 -0.845 . . . . 3.36 108.72 -179.978 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 103.87 -108.73 3.25 Favored Glycine 0 CA--C 1.479 -2.167 0 N-CA-C 110.806 -0.918 . . . . 2.3 110.806 -178.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.467 ' HB2' ' HB3' ' A' ' 67' ' ' CYS . 3.5 mt-30 -112.56 115.85 29.28 Favored 'General case' 0 N--CA 1.422 -1.85 0 N-CA-C 102.889 -3.004 . . . . 5.06 102.889 175.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.906 ' HB3' ' CD ' ' A' ' 60' ' ' PRO . 0.0 OUTLIER -99.22 -100.11 0.0 OUTLIER Pre-proline 0 C--N 1.305 -1.329 0 CA-C-O 114.575 -2.631 . . . . 3.91 109.558 -173.273 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.906 ' CD ' ' HB3' ' A' ' 59' ' ' LYS . 9.7 Cg_endo -49.84 127.04 17.99 Favored 'Trans proline' 0 N--CA 1.474 0.354 0 CA-C-N 127.036 3.549 . . . . 1.74 118.437 -176.024 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.477 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 5.0 t -145.3 -172.98 3.98 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 110.793 -2.912 . . . . 1.9 106.637 177.08 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 37.89 -162.49 0.01 OUTLIER Glycine 0 N--CA 1.485 1.932 0 N-CA-C 114.857 0.703 . . . . 2.43 114.857 175.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 71.2 m -82.78 51.8 1.98 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 120.438 -0.505 . . . . 4.32 109.887 178.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 112.66 2.26 25.71 Favored Glycine 0 CA--C 1.539 1.548 0 C-N-CA 120.742 -0.742 . . . . 2.4 113.467 -178.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.702 ' HA2' ' HA ' ' A' ' 75' ' ' SER . . . -98.62 129.14 9.8 Favored Glycine 0 N--CA 1.464 0.564 0 C-N-CA 120.646 -0.788 . . . . 1.82 112.461 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.685 ' HA ' ' O ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -78.62 150.36 32.71 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-O 121.039 0.447 . . . . 3.51 111.592 -177.749 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.467 ' HB3' ' HB2' ' A' ' 58' ' ' GLN . 9.1 t -70.77 109.54 5.03 Favored 'General case' 0 N--CA 1.397 -3.086 0 N-CA-C 109.24 -0.652 . . . . 1.52 109.24 -178.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.571 ' HB1' ' SG ' ' A' ' 28' ' ' CYS . . . -85.23 -21.5 29.07 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.775 0.798 . . . . 1.5 108.865 178.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.883 ' CB ' ' HA2' ' A' ' 33' ' ' GLY . . . -168.8 161.18 10.9 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.163 -1.381 . . . . 1.31 109.092 -178.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.77 ' HA ' ' HB3' ' A' ' 85' ' ' CYS . . . -55.01 140.18 38.55 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 118.176 0.444 . . . . 1.5 111.138 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.609 ' H ' ' CB ' ' A' ' 85' ' ' CYS . . . 75.14 -44.44 1.6 Allowed Glycine 0 CA--C 1.529 0.943 0 CA-C-N 116.202 -0.453 . . . . 1.44 113.779 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.897 HG23 ' HA3' ' B' ' 137' ' ' GLY . 1.6 pp -97.54 99.14 8.3 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.952 0 CA-C-O 122.142 0.973 . . . . 2.77 111.737 -177.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.477 ' HB3' ' HB3' ' A' ' 61' ' ' CYS . 34.2 m -93.21 104.26 16.46 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 115.531 -0.759 . . . . 1.98 109.302 179.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 1.02 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 33.8 m -84.7 124.63 31.73 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.439 -0.801 . . . . 1.43 112.459 -177.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.933 ' HB3' ' HD2' ' A' ' 76' ' ' PRO . 49.5 m -84.58 -178.52 1.19 Allowed Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 115.067 -0.97 . . . . 2.37 110.431 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.933 ' HD2' ' HB3' ' A' ' 75' ' ' SER . 74.1 Cg_endo -75.7 30.3 0.38 Allowed 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 121.672 1.581 . . . . 2.09 111.942 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.825 ' HB2' ' ND1' ' B' ' 180' ' ' HIS . 2.8 p30 -145.51 -28.41 0.44 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.602 -0.726 . . . . 2.65 110.536 179.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.779 ' HA3' ' O ' ' B' ' 179' ' ' CYS . . . -177.68 -133.17 1.81 Allowed Glycine 0 CA--C 1.521 0.437 0 C-N-CA 121.153 -0.546 . . . . 1.04 112.141 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 1.02 ' HA ' ' HA ' ' A' ' 74' ' ' CYS . 80.4 m -128.43 148.62 50.72 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 109.635 -0.506 . . . . 1.42 109.635 179.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.805 ' ND1' ' HB2' ' B' ' 177' ' ' ASP . 4.5 t60 -138.64 116.33 11.43 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 108.246 -1.02 . . . . 2.81 108.246 -173.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.568 ' HG3' ' O ' ' B' ' 177' ' ' ASP . 0.0 OUTLIER -57.31 117.5 4.16 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.803 0.811 . . . . 3.05 110.268 -178.701 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.843 ' OD1' ' HB1' ' A' ' 84' ' ' ALA . 0.3 OUTLIER -147.37 101.47 3.79 Favored Pre-proline 0 N--CA 1.439 -0.991 0 CA-C-N 114.285 -1.325 . . . . 2.02 108.951 -178.167 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -56.28 -2.19 0.37 Allowed 'Trans proline' 0 C--N 1.361 1.201 0 C-N-CA 123.142 2.561 . . . . 2.29 115.15 -177.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.843 ' HB1' ' OD1' ' A' ' 82' ' ' ASP . . . -65.84 -17.83 64.91 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 111.985 0.365 . . . . 1.53 111.985 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.77 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 13.2 m -99.69 7.01 45.49 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.329 0.862 . . . . 1.88 113.329 -178.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.513 ' N ' ' CD ' ' A' ' 87' ' ' PRO . 0.1 OUTLIER -69.39 -19.91 0.48 Allowed Pre-proline 0 C--N 1.327 -0.384 0 N-CA-C 115.448 1.647 . . . . 3.6 115.448 179.782 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.513 ' CD ' ' N ' ' A' ' 86' ' ' ASP . 5.9 Cg_endo -80.37 57.61 6.6 Favored 'Trans proline' 0 CA--C 1.483 -2.028 0 CA-C-N 121.552 1.59 . . . . 3.12 110.197 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.653 ' HG3' ' HB3' ' A' ' 70' ' ' ALA . 6.4 pt-20 174.42 -1.62 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 112.173 -2.285 . . . . 4.72 111.36 176.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.722 ' CB ' ' HB1' ' A' ' 70' ' ' ALA . . . -94.2 57.09 2.3 Favored 'General case' 0 N--CA 1.442 -0.853 0 O-C-N 121.479 -0.763 . . . . 5.29 111.83 179.358 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.48 179.84 0.07 Allowed 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 118.982 -1.087 . . . . 7.19 112.177 -172.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -98.3 95.91 7.69 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 120.636 0.255 . . . . 10.7 110.347 175.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.215 -0.898 . . . . 11.77 110.958 -179.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.302 0 CA-C-O 121.39 0.614 . . . . 10.42 111.782 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -84.13 32.83 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.101 -0.954 . . . . 8.81 111.227 179.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 103' ' ' LEU . . . . . 0.967 HD21 ' HB3' ' B' ' 108' ' ' ARG . 6.8 tp -176.4 87.95 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 109.304 -0.628 . . . . 6.28 109.304 175.087 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.18 76.76 2.32 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 105.986 -1.857 . . . . 6.27 105.986 176.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . 0.944 HD12 ' C ' ' B' ' 107' ' ' VAL . 0.2 OUTLIER -159.42 -142.48 0.09 Allowed 'General case' 0 N--CA 1.399 -2.996 0 CA-C-N 111.7 -2.5 . . . . 7.61 106.431 -176.004 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 106' ' ' ASP . . . . . 0.644 ' H ' ' CD1' ' B' ' 105' ' ' LEU . 5.9 t70 -160.33 -46.55 0.05 OUTLIER 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 116.053 -0.522 . . . . 8.55 111.482 -178.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 107' ' ' VAL . . . . . 0.944 ' C ' HD12 ' B' ' 105' ' ' LEU . 6.2 p -134.67 117.73 24.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 101.393 -3.558 . . . . 7.84 101.393 172.183 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 108' ' ' ARG . . . . . 0.967 ' HB3' HD21 ' B' ' 103' ' ' LEU . 0.0 OUTLIER -77.84 108.18 10.89 Favored 'General case' 0 N--CA 1.4 -2.961 0 C-N-CA 120.19 -0.604 . . . . 9.75 111.684 -174.493 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 109' ' ' THR . . . . . 0.888 ' HG1' ' HG ' ' B' ' 150' ' ' LEU . 1.1 t -104.59 85.82 2.39 Favored 'General case' 0 N--CA 1.403 -2.783 1 N-CA-C 98.266 -4.716 . . . . 6.13 98.266 168.799 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 110' ' ' CYS . . . . . 0.579 ' HA ' ' HB2' ' B' ' 154' ' ' CYS . 0.8 OUTLIER -77.31 63.04 2.44 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 113.137 -1.847 . . . . 2.87 111.084 -176.675 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 111' ' ' LEU . . . . . 0.755 ' O ' ' HA ' ' B' ' 120' ' ' ARG . 14.8 tp -39.89 113.67 0.92 Allowed Pre-proline 0 N--CA 1.47 0.529 0 CA-C-N 114.913 -1.04 . . . . 2.95 113.771 177.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 112' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -83.85 152.61 13.0 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 122.515 2.143 . . . . 1.71 110.037 178.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.661 ' C ' ' HA2' ' B' ' 117' ' ' GLY . 0.5 OUTLIER -158.7 -170.87 3.21 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 118.88 -1.128 . . . . 1.0 113.182 172.275 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 114' ' ' GLY . . . . . 0.571 ' HA2' ' HB3' ' B' ' 140' ' ' GLU . . . 76.41 -156.15 46.35 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.482 -0.866 . . . . 1.16 111.478 178.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 115' ' ' PRO . . . . . 0.584 ' HG2' ' O ' ' B' ' 115' ' ' PRO . 41.2 Cg_endo -65.31 95.89 0.27 Allowed 'Trans proline' 0 N--CA 1.467 -0.085 0 C-N-CA 122.848 2.366 . . . . 1.6 113.12 178.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 82.9 3.24 90.58 Favored Glycine 0 C--N 1.28 -2.56 0 CA-C-N 114.963 -1.017 . . . . 1.7 112.944 -178.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 117' ' ' GLY . . . . . 0.661 ' HA2' ' C ' ' B' ' 113' ' ' CYS . . . 76.34 45.68 14.12 Favored Glycine 0 N--CA 1.402 -3.604 0 C-N-CA 120.955 -0.64 . . . . 1.38 114.131 178.145 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.39 -1.91 57.46 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 114.696 -0.752 . . . . 2.96 111.32 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . -107.46 -156.22 19.86 Favored Glycine 0 C--N 1.343 0.92 0 N-CA-C 110.209 -1.156 . . . . 1.07 110.209 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.755 ' HA ' ' O ' ' B' ' 111' ' ' LEU . 1.2 mtm180 -150.64 154.33 37.29 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 120.216 2.008 . . . . 3.29 106.302 176.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 121' ' ' CYS . . . . . 0.484 ' CB ' HD22 ' B' ' 111' ' ' LEU . 1.5 t -107.28 160.95 15.22 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 113.246 0.832 . . . . 1.21 113.246 -177.083 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 122' ' ' PHE . . . . . 0.533 ' HE1' ' O ' ' B' ' 128' ' ' CYS . 60.8 m-85 -126.43 -47.65 1.58 Allowed 'General case' 0 C--N 1.339 0.113 0 CA-C-N 115.34 -0.846 . . . . 2.28 110.107 179.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -117.29 -159.67 11.52 Favored Glycine 0 CA--C 1.52 0.381 0 CA-C-N 115.797 -0.638 . . . . 1.04 111.634 179.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -84.26 -68.15 0.01 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.344 2.029 . . . . 1.84 111.667 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 125' ' ' SER . . . . . 0.408 ' O ' ' N ' ' B' ' 137' ' ' GLY . 0.4 OUTLIER -89.49 26.65 1.65 Allowed 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 109.943 -0.391 . . . . 1.49 109.943 178.78 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 126' ' ' ILE . . . . . 1.017 HG22 HG11 ' B' ' 136' ' ' VAL . 7.0 mt -144.7 112.59 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 CA-C-O 121.751 0.786 . . . . 1.41 111.827 -178.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 127' ' ' CYS . . . . . 0.599 ' O ' ' HA ' ' B' ' 134' ' ' CYS . 4.6 t -126.45 131.38 51.69 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.112 -0.949 . . . . 0.89 109.234 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 128' ' ' CYS . . . . . 0.869 ' HA ' ' O ' ' B' ' 133' ' ' GLY . 0.0 OUTLIER -142.39 122.16 13.47 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 115.103 1.52 . . . . 1.23 115.103 -176.906 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 129' ' ' GLY . . . . . . . . . . . . . . . -111.46 -166.11 18.28 Favored Glycine 0 C--N 1.373 2.636 0 N-CA-C 108.173 -1.971 . . . . 0.69 108.173 175.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -65.4 -58.74 5.12 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 114.074 1.139 . . . . 2.35 114.074 -177.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.28 21.82 11.57 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.57 0.7 . . . . 1.69 109.921 -177.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 132' ' ' LEU . . . . . 0.777 HD23 ' CZ ' ' B' ' 135' ' ' PHE . 0.4 OUTLIER -114.6 -12.41 12.25 Favored 'General case' 0 N--CA 1.397 -3.085 0 N-CA-C 103.84 -2.652 . . . . 1.84 103.84 175.459 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 133' ' ' GLY . . . . . 0.917 ' HA2' ' CB ' ' B' ' 169' ' ' ALA . . . 57.97 -129.57 49.74 Favored Glycine 1 N--CA 1.394 -4.128 0 CA-C-O 117.249 -1.862 . . . . 0.76 112.989 174.572 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 134' ' ' CYS . . . . . 0.845 ' HB2' HD13 ' B' ' 172' ' ' ILE . 2.5 t -136.96 122.98 20.25 Favored 'General case' 0 CA--C 1.496 -1.116 0 CA-C-N 119.648 1.724 . . . . 1.08 113.696 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 135' ' ' PHE . . . . . 0.777 ' CZ ' HD23 ' B' ' 132' ' ' LEU . 0.0 OUTLIER -98.03 100.21 11.53 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 103.645 -2.724 . . . . 1.83 103.645 175.153 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 136' ' ' VAL . . . . . 1.017 HG11 HG22 ' B' ' 126' ' ' ILE . 2.2 t -92.09 83.14 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.368 0 CA-C-O 123.27 1.509 . . . . 1.29 107.093 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 137' ' ' GLY . . . . . 0.897 ' HA3' HG23 ' A' ' 72' ' ' ILE . . . 100.49 85.36 1.85 Allowed Glycine 0 CA--C 1.525 0.678 0 CA-C-N 112.43 -2.168 . . . . 0.85 113.719 -179.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 138' ' ' THR . . . . . 0.738 HG21 ' O ' ' B' ' 137' ' ' GLY . 67.8 p -157.74 166.53 32.54 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 108.895 -0.78 . . . . 1.2 108.895 179.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 139' ' ' ALA . . . . . 0.576 ' HA ' ' CD1' ' B' ' 142' ' ' LEU . . . -68.58 -24.54 64.61 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 119.294 0.952 . . . . 1.35 110.575 177.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 140' ' ' GLU . . . . . 0.571 ' HB3' ' HA2' ' B' ' 114' ' ' GLY . 3.3 mm-40 -66.81 -11.92 57.09 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.618 -1.173 . . . . 2.31 109.972 177.116 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 141' ' ' ALA . . . . . 0.506 ' O ' ' HB2' ' B' ' 144' ' ' CYS . . . -102.93 -22.57 13.81 Favored 'General case' 0 C--O 1.211 -0.944 0 C-N-CA 123.736 0.814 . . . . 1.09 109.611 178.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 142' ' ' LEU . . . . . 0.576 ' CD1' ' HA ' ' B' ' 139' ' ' ALA . 23.8 mt -44.85 -38.42 4.57 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.015 0.436 . . . . 1.61 111.855 -179.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 143' ' ' ARG . . . . . 0.701 ' HD3' ' O ' ' B' ' 143' ' ' ARG . 0.0 OUTLIER -71.43 -1.28 12.58 Favored 'General case' 0 C--O 1.247 0.963 0 CA-C-N 116.05 -0.523 . . . . 3.43 110.063 179.378 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 144' ' ' CYS . . . . . 0.506 ' HB2' ' O ' ' B' ' 141' ' ' ALA . 66.3 m -82.0 -5.5 58.39 Favored 'General case' 0 C--N 1.341 0.226 0 O-C-N 120.825 -1.172 . . . . 1.61 110.108 176.259 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -60.61 -16.7 41.05 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.619 -0.719 . . . . 3.52 110.113 178.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -84.32 5.86 25.25 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 120.13 -0.628 . . . . 3.76 110.253 178.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . 0.57 ' HA ' ' HB2' ' B' ' 150' ' ' LEU . 17.4 tt0 -82.81 -1.06 50.72 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 116.038 -0.528 . . . . 4.01 109.892 177.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 148' ' ' ASN . . . . . . . . . . . . . 15.1 m-20 -73.86 -27.78 61.25 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 109.351 -0.611 . . . . 4.24 109.351 177.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -119.22 41.34 3.11 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.748 -0.66 . . . . 6.07 109.738 179.324 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 150' ' ' LEU . . . . . 0.888 ' HG ' ' HG1' ' B' ' 109' ' ' THR . 0.8 OUTLIER -123.63 140.04 33.4 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 115.841 -0.618 . . . . 5.86 111.663 -179.001 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 151' ' ' PRO . . . . . 0.553 ' HD2' HG23 ' B' ' 109' ' ' THR . 2.7 Cg_exo -76.35 50.82 3.03 Favored 'Trans proline' 0 C--N 1.356 0.951 0 C-N-CA 122.84 2.36 . . . . 5.42 112.979 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 152' ' ' SER . . . . . 0.776 ' HB2' ' HD2' ' B' ' 153' ' ' PRO . 5.0 p 71.73 171.12 0.11 Allowed Pre-proline 0 N--CA 1.472 0.632 0 N-CA-C 112.414 0.524 . . . . 6.02 112.414 179.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 153' ' ' PRO . . . . . 0.776 ' HD2' ' HB2' ' B' ' 152' ' ' SER . 13.9 Cg_endo -57.02 -172.98 0.04 OUTLIER 'Trans proline' 0 C--N 1.361 1.187 0 C-N-CA 123.365 2.71 . . . . 5.87 115.208 -178.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 154' ' ' CYS . . . . . 0.579 ' HB2' ' HA ' ' B' ' 110' ' ' CYS . 1.0 OUTLIER -119.62 116.39 25.91 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 114.214 -1.357 . . . . 2.96 110.217 -178.997 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 155' ' ' GLN . . . . . 0.508 ' HG3' ' HA ' ' B' ' 103' ' ' LEU . 3.5 tt0 66.54 -165.48 0.22 Allowed 'General case' 0 N--CA 1.478 0.959 0 O-C-N 122.183 -0.323 . . . . 6.3 111.572 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 156' ' ' SER . . . . . 0.694 ' OG ' ' HG3' ' B' ' 159' ' ' LYS . 1.8 t -146.71 -35.09 0.26 Allowed 'General case' 0 C--N 1.351 0.642 0 N-CA-C 116.772 2.138 . . . . 3.41 116.772 -178.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 79.99 -113.76 3.72 Favored Glycine 0 CA--C 1.49 -1.509 0 O-C-N 119.487 -2.008 . . . . 2.26 113.301 173.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 158' ' ' GLN . . . . . 0.677 ' O ' ' HB3' ' B' ' 167' ' ' CYS . 3.3 mt-30 -113.67 96.07 5.67 Favored 'General case' 0 N--CA 1.413 -2.28 0 N-CA-C 106.931 -1.507 . . . . 5.03 106.931 177.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 159' ' ' LYS . . . . . 0.923 ' HB3' ' CD ' ' B' ' 160' ' ' PRO . 0.0 OUTLIER -69.6 -107.2 0.0 OUTLIER Pre-proline 0 CA--C 1.575 1.908 0 N-CA-C 114.196 1.184 . . . . 3.96 114.196 -177.153 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 160' ' ' PRO . . . . . 0.923 ' CD ' ' HB3' ' B' ' 159' ' ' LYS . 10.4 Cg_endo -50.58 126.8 18.94 Favored 'Trans proline' 0 C--N 1.363 1.336 0 N-CA-C 119.271 2.758 . . . . 1.7 119.271 -175.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 161' ' ' CYS . . . . . 0.506 ' HB3' ' HB3' ' B' ' 173' ' ' CYS . 6.5 t -149.05 -179.71 7.23 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 110.94 -2.846 . . . . 1.93 106.667 176.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 47.02 -164.61 0.13 Allowed Glycine 0 C--N 1.345 1.081 0 C-N-CA 119.818 -1.182 . . . . 2.37 114.434 178.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 69.5 m -84.3 48.85 1.55 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.67 0.748 . . . . 4.56 109.913 178.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 117.92 -1.58 17.35 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-N 115.166 -0.925 . . . . 2.39 113.654 178.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 165' ' ' GLY . . . . . 0.709 ' CA ' ' HA ' ' B' ' 175' ' ' SER . . . -97.27 132.4 10.97 Favored Glycine 0 C--N 1.339 0.696 0 C-N-CA 119.318 -1.42 . . . . 1.79 112.257 -176.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 166' ' ' ARG . . . . . 0.648 ' HA ' ' O ' ' B' ' 159' ' ' LYS . 0.0 OUTLIER -78.57 150.48 32.78 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.168 0.509 . . . . 3.53 111.841 -177.591 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 167' ' ' CYS . . . . . 0.677 ' HB3' ' O ' ' B' ' 158' ' ' GLN . 9.1 t -70.77 109.73 5.14 Favored 'General case' 0 N--CA 1.405 -2.702 0 CA-C-N 115.548 -0.751 . . . . 1.56 109.231 -179.206 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 168' ' ' ALA . . . . . 0.574 ' HB2' ' SG ' ' B' ' 128' ' ' CYS . . . -90.09 -14.28 34.08 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 121.583 0.706 . . . . 1.42 110.047 179.302 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 169' ' ' ALA . . . . . 0.917 ' CB ' ' HA2' ' B' ' 133' ' ' GLY . . . -172.71 161.62 4.82 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.854 -1.067 . . . . 1.18 108.785 177.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 170' ' ' ALA . . . . . 0.759 ' HA ' ' HB3' ' B' ' 185' ' ' CYS . . . -55.55 139.06 45.34 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 118.33 0.514 . . . . 1.47 111.361 179.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 171' ' ' GLY . . . . . 0.643 ' H ' ' CB ' ' B' ' 185' ' ' CYS . . . 67.73 -22.98 0.24 Allowed Glycine 0 CA--C 1.534 1.244 0 N-CA-C 116.35 1.3 . . . . 1.45 116.35 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 172' ' ' ILE . . . . . 0.845 HD13 ' HB2' ' B' ' 134' ' ' CYS . 1.7 pp -111.03 98.17 6.7 Favored 'Isoleucine or valine' 0 C--O 1.244 0.793 0 CA-C-N 118.586 1.193 . . . . 2.7 110.069 177.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 173' ' ' CYS . . . . . 0.506 ' HB3' ' HB3' ' B' ' 161' ' ' CYS . 33.9 m -93.0 104.3 16.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.421 -0.809 . . . . 1.94 109.311 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 174' ' ' CYS . . . . . 1.002 ' HA ' ' HA ' ' B' ' 179' ' ' CYS . 34.0 m -84.84 124.57 31.75 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.33 -0.85 . . . . 1.43 112.265 -177.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 175' ' ' SER . . . . . 0.886 ' HB3' ' HD2' ' B' ' 176' ' ' PRO . 49.5 m -84.47 -178.56 1.2 Allowed Pre-proline 0 CA--C 1.533 0.296 0 CA-C-N 115.075 -0.966 . . . . 2.3 110.515 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 176' ' ' PRO . . . . . 0.886 ' HD2' ' HB3' ' B' ' 175' ' ' SER . 73.9 Cg_endo -75.75 30.31 0.38 Allowed 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 121.675 1.583 . . . . 2.13 111.961 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 177' ' ' ASP . . . . . 0.805 ' HB2' ' ND1' ' A' ' 80' ' ' HIS . 2.8 p30 -145.38 -28.21 0.45 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.598 -0.728 . . . . 2.72 110.545 179.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 178' ' ' GLY . . . . . 0.823 ' HA3' ' O ' ' A' ' 79' ' ' CYS . . . -178.21 -132.65 1.74 Allowed Glycine 0 C--N 1.334 0.447 0 C-N-CA 121.21 -0.519 . . . . 1.05 112.183 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 179' ' ' CYS . . . . . 1.002 ' HA ' ' HA ' ' B' ' 174' ' ' CYS . 81.6 m -128.03 154.18 45.94 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 109.441 -0.577 . . . . 1.39 109.441 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 180' ' ' HIS . . . . . 0.825 ' ND1' ' HB2' ' A' ' 77' ' ' ASP . 4.0 t60 -147.29 115.37 6.54 Favored 'General case' 0 CA--C 1.499 -0.996 0 CA-C-O 121.913 0.863 . . . . 2.73 108.811 -173.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 181' ' ' GLU . . . . . 0.587 ' HG3' ' O ' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -56.73 117.41 3.89 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-N 114.246 -1.343 . . . . 3.06 110.274 -176.746 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 182' ' ' ASP . . . . . 0.803 ' OD1' ' HB1' ' B' ' 184' ' ' ALA . 0.3 OUTLIER -147.38 101.27 3.79 Favored Pre-proline 0 N--CA 1.437 -1.087 0 CA-C-N 114.063 -1.426 . . . . 2.06 108.929 -178.007 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 183' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -56.16 -2.22 0.36 Allowed 'Trans proline' 0 C--N 1.36 1.16 0 C-N-CA 123.229 2.619 . . . . 2.27 115.207 -177.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 184' ' ' ALA . . . . . 0.803 ' HB1' ' OD1' ' B' ' 182' ' ' ASP . . . -65.96 -17.93 65.0 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 111.983 0.364 . . . . 1.56 111.983 -179.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 185' ' ' CYS . . . . . 0.759 ' HB3' ' HA ' ' B' ' 170' ' ' ALA . 12.3 m -100.18 7.82 44.26 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 113.032 0.752 . . . . 1.94 113.032 -178.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 186' ' ' ASP . . . . . 0.608 ' C ' ' H ' ' B' ' 188' ' ' GLU . 0.1 OUTLIER -69.25 -19.32 0.45 Allowed Pre-proline 0 C--N 1.328 -0.358 0 N-CA-C 115.027 1.491 . . . . 3.61 115.027 179.436 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 187' ' ' PRO . . . . . 0.525 ' CD ' ' N ' ' B' ' 186' ' ' ASP . 3.1 Cg_endo -77.0 45.97 1.82 Allowed 'Trans proline' 0 C--N 1.359 1.085 0 CA-C-N 121.45 1.554 . . . . 3.14 113.985 -179.232 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 188' ' ' GLU . . . . . 0.705 ' HG3' ' HB1' ' B' ' 170' ' ' ALA . 6.3 pt-20 -173.73 -11.68 0.01 OUTLIER 'General case' 0 C--N 1.285 -2.196 0 CA-C-N 109.913 -3.312 . . . . 4.7 113.742 -178.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 189' ' ' ALA . . . . . 0.737 ' CB ' ' HB2' ' B' ' 170' ' ' ALA . . . -87.44 64.21 8.06 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 123.351 0.661 . . . . 5.24 110.262 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 190' ' ' ALA . . . . . . . . . . . . . . . -66.74 178.68 1.25 Allowed 'General case' 0 C--N 1.353 0.739 0 O-C-N 120.549 -1.344 . . . . 6.93 112.74 -178.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 191' ' ' PHE . . . . . 0.644 ' CE1' HD22 ' A' ' 42' ' ' LEU . 0.6 OUTLIER -96.7 95.47 7.95 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.782 -0.645 . . . . 10.62 110.534 178.468 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.167 -0.92 . . . . 11.7 110.899 -179.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 120.883 0.373 . . . . 10.31 110.987 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.857 HG21 ' H ' ' A' ' 3' ' ' LEU . 4.3 m -81.64 -80.86 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 122.362 1.077 . . . . 8.37 113.158 -178.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.857 ' H ' HG21 ' A' ' 2' ' ' VAL . 0.2 OUTLIER -130.77 120.74 24.23 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 112.653 -2.067 . . . . 6.25 108.192 178.147 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.791 ' O ' ' HG3' ' A' ' 8' ' ' ARG . 10.5 m-20 -161.62 -174.25 4.14 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 111.287 -2.688 . . . . 6.22 107.915 177.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.504 ' HA ' HD11 ' A' ' 5' ' ' LEU . 1.3 tp -91.57 7.56 40.85 Favored 'General case' 0 CA--C 1.497 -1.068 0 C-N-CA 116.549 -2.06 . . . . 7.57 111.062 -175.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.782 ' O ' ' HG3' ' A' ' 55' ' ' GLN . 0.2 OUTLIER -77.28 -76.62 0.17 Allowed 'General case' 0 CA--C 1.493 -1.221 0 N-CA-C 102.809 -3.034 . . . . 8.78 102.809 -179.784 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.641 HG11 ' O ' ' A' ' 7' ' ' VAL . 7.6 p -151.43 113.78 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.154 0 N-CA-C 104.926 -2.25 . . . . 7.88 104.926 169.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.954 ' HB2' ' H ' ' A' ' 55' ' ' GLN . 18.1 mtp180 -79.58 114.79 18.78 Favored 'General case' 0 CA--C 1.483 -1.608 0 N-CA-C 105.133 -2.173 . . . . 9.7 105.133 176.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.0 t -60.12 105.47 0.41 Allowed 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 115.144 -2.623 . . . . 6.05 107.988 -178.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.581 ' HB3' ' HB3' ' A' ' 20' ' ' ARG . 0.1 OUTLIER -79.29 114.51 18.29 Favored 'General case' 0 CA--C 1.548 0.898 0 CA-C-N 113.649 -1.614 . . . . 2.89 112.856 178.42 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.594 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 4.4 mm? 3.62 111.86 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.461 0 N-CA-C 113.202 0.816 . . . . 2.89 113.202 178.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.571 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 87.6 Cg_endo -79.32 123.98 5.74 Favored 'Trans proline' 0 C--N 1.357 1.019 0 C-N-CA 123.203 2.602 . . . . 1.72 115.866 -178.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.589 ' O ' ' HA2' ' A' ' 17' ' ' GLY . 26.8 p -129.83 -176.23 3.86 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.307 -0.86 . . . . 1.0 111.138 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.441 ' HA2' ' HG2' ' A' ' 40' ' ' GLU . . . 75.54 -161.45 52.7 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 120.312 -0.947 . . . . 1.15 112.43 -178.144 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.687 ' HD2' HD12 ' A' ' 32' ' ' LEU . 39.3 Cg_endo -64.95 95.04 0.24 Allowed 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 123.488 2.792 . . . . 1.6 113.108 178.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.51 -2.09 87.76 Favored Glycine 0 C--N 1.288 -2.129 0 CA-C-N 113.868 -1.515 . . . . 1.68 112.724 178.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.589 ' HA2' ' O ' ' A' ' 13' ' ' CYS . . . 84.28 35.69 14.2 Favored Glycine 0 N--CA 1.412 -2.934 0 C-N-CA 118.501 -1.809 . . . . 1.37 116.417 177.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.1 -31.71 61.25 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 112.941 -1.629 . . . . 2.91 107.237 175.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.571 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -79.09 175.04 55.25 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 113.099 -1.864 . . . . 1.06 112.891 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.594 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -139.8 162.99 33.82 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.955 -0.387 . . . . 3.32 109.955 179.749 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 15.6 t -108.66 143.17 38.09 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.438 0.637 . . . . 1.19 112.301 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -127.5 -54.12 1.35 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 114.78 -1.1 . . . . 2.26 108.834 178.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -95.95 149.79 19.43 Favored Glycine 0 C--N 1.331 0.298 0 N-CA-C 110.179 -1.168 . . . . 1.05 110.179 177.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -50.25 -48.21 20.92 Favored 'Trans proline' 0 CA--C 1.531 0.349 0 C-N-CA 121.849 1.699 . . . . 1.81 112.765 -179.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.16 4.06 41.67 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.603 0.24 . . . . 1.62 111.347 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.948 HG22 HG13 ' A' ' 36' ' ' VAL . 0.5 OUTLIER -119.83 122.8 69.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 113.309 0.855 . . . . 1.39 113.309 -178.016 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.444 ' HB3' ' OE1' ' A' ' 40' ' ' GLU . 0.1 OUTLIER -125.84 124.48 41.0 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.01 -0.541 . . . . 0.92 109.704 178.566 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 1.019 ' HB2' ' HB2' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -131.88 141.12 49.29 Favored 'General case' 0 CA--C 1.562 1.426 0 N-CA-C 114.296 1.221 . . . . 1.28 114.296 -177.594 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.624 ' O ' ' HB3' ' A' ' 69' ' ' ALA . . . -131.71 -174.2 13.57 Favored Glycine 0 C--N 1.369 2.396 0 CA-C-N 113.443 -1.708 . . . . 0.71 110.119 178.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.703 ' O ' ' HB2' ' A' ' 70' ' ' ALA . 18.9 p-10 -63.17 -56.36 17.37 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 113.376 0.88 . . . . 2.27 113.376 -178.017 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.21 5.54 17.03 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-O 121.435 0.636 . . . . 1.66 110.716 -175.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.687 HD12 ' HD2' ' A' ' 15' ' ' PRO . 0.3 OUTLIER -103.93 -10.24 18.3 Favored 'General case' 0 N--CA 1.419 -2.001 0 N-CA-C 106.272 -1.751 . . . . 1.93 106.272 177.638 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.858 ' O ' ' HB3' ' A' ' 28' ' ' CYS . . . 67.37 -98.09 0.43 Allowed Glycine 0 C--O 1.221 -0.717 0 N-CA-C 118.283 2.073 . . . . 0.77 118.283 172.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 1.037 ' HB2' HG13 ' A' ' 72' ' ' ILE . 6.0 t -169.25 106.64 0.4 Allowed 'General case' 0 C--N 1.354 0.789 0 CA-C-N 118.644 1.222 . . . . 1.08 109.314 176.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.552 ' HB3' ' CG2' ' A' ' 38' ' ' THR . 3.7 m-30 -89.16 105.24 17.66 Favored 'General case' 0 N--CA 1.427 -1.611 0 N-CA-C 106.036 -1.839 . . . . 1.85 106.036 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.948 HG13 HG22 ' A' ' 26' ' ' ILE . 1.5 t -94.69 88.62 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.195 0 CA-C-O 123.361 1.553 . . . . 1.29 108.72 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.78 ' O ' ' HA3' ' B' ' 133' ' ' GLY . . . 94.63 98.64 1.66 Allowed Glycine 0 C--O 1.228 -0.256 0 CA-C-N 111.633 -2.53 . . . . 0.85 115.979 179.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.552 ' CG2' ' HB3' ' A' ' 35' ' ' PHE . 0.7 OUTLIER 177.02 170.27 0.53 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.627 0.251 . . . . 1.3 111.057 177.339 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.428 ' HA ' ' CD1' ' A' ' 42' ' ' LEU . . . -58.97 -14.18 8.54 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.377 0.608 . . . . 1.45 110.547 178.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.563 ' OE2' HD23 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -73.21 -13.16 61.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.741 -1.118 . . . . 2.32 109.327 176.594 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.429 ' O ' ' HB2' ' A' ' 44' ' ' CYS . . . -105.87 -22.53 12.9 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 115.121 -0.945 . . . . 1.11 111.66 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.454 ' O ' ' HB2' ' A' ' 45' ' ' GLN . 3.4 mt -44.25 -39.3 4.36 Favored 'General case' 0 C--N 1.344 0.368 0 N-CA-C 113.177 0.806 . . . . 1.68 113.177 -178.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -58.36 -19.33 34.58 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.275 0.559 . . . . 3.4 109.768 179.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.642 ' O ' ' N ' ' A' ' 47' ' ' GLU . 97.2 m -65.13 -45.64 84.23 Favored 'General case' 0 C--O 1.223 -0.294 0 N-CA-C 108.533 -0.914 . . . . 1.57 108.533 177.279 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.454 ' HB2' ' O ' ' A' ' 42' ' ' LEU . 75.3 mm-40 -28.98 -37.75 0.01 OUTLIER 'General case' 0 CA--C 1.551 0.996 0 CA-C-N 113.721 -1.581 . . . . 3.49 113.03 -178.411 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -87.43 -3.11 59.01 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 119.593 -0.843 . . . . 3.69 111.518 -179.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.642 ' N ' ' O ' ' A' ' 44' ' ' CYS . 1.1 tt0 -81.05 -0.29 39.17 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 115.441 -0.8 . . . . 3.99 109.574 178.24 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -64.27 -28.18 69.55 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.647 -0.501 . . . . 4.2 109.647 178.18 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -112.89 47.97 1.06 Allowed 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.254 -0.43 . . . . 5.85 111.091 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.8 mt -143.89 88.23 7.74 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-N 116.335 -0.393 . . . . 5.83 111.094 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -91.19 31.93 0.32 Allowed 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.637 2.225 . . . . 5.3 113.16 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -92.46 118.78 68.19 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.679 -0.237 . . . . 5.72 110.991 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -80.3 116.86 3.38 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.28 1.987 . . . . 5.82 113.062 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.75 ' HA ' ' CD ' ' A' ' 8' ' ' ARG . 28.9 p -86.13 153.46 22.06 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 115.77 -0.65 . . . . 2.98 111.113 179.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.954 ' H ' ' HB2' ' A' ' 8' ' ' ARG . 2.4 tt0 -12.46 -81.35 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 114.761 1.393 . . . . 6.42 114.761 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.576 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 0.6 OUTLIER 86.82 -101.93 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.678 0.791 . . . . 3.36 111.259 -178.478 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 113.84 -63.84 0.29 Allowed Glycine 0 CA--C 1.496 -1.102 0 C-N-CA 120.428 -0.891 . . . . 2.3 112.66 178.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -114.45 127.71 55.97 Favored 'General case' 0 N--CA 1.419 -1.983 0 N-CA-C 104.956 -2.238 . . . . 5.06 104.956 177.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.936 ' O ' ' HA ' ' A' ' 66' ' ' ARG . 2.0 mtmp? -120.22 -100.14 0.0 OUTLIER Pre-proline 0 C--N 1.285 -2.239 0 CA-C-O 114.201 -2.809 . . . . 3.91 105.47 -176.13 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.769 ' CD ' ' HB3' ' A' ' 59' ' ' LYS . 56.5 Cg_endo -71.34 138.48 33.02 Favored 'Trans proline' 0 C--N 1.318 -1.066 0 CA-C-N 128.211 3.968 . . . . 1.74 115.569 -178.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.51 ' O ' ' SG ' ' A' ' 73' ' ' CYS . 20.6 p -143.18 146.02 33.33 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 114.432 -1.258 . . . . 1.9 110.363 177.085 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.56 -164.05 51.19 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 119.165 -1.493 . . . . 2.43 112.951 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.4 m -76.82 49.62 0.65 Allowed 'General case' 0 CA--C 1.553 1.072 0 N-CA-C 113.119 0.785 . . . . 4.32 113.119 -178.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 110.03 49.81 0.71 Allowed Glycine 0 N--CA 1.475 1.275 0 N-CA-C 115.466 0.947 . . . . 2.4 115.466 174.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.467 ' O ' ' SG ' ' A' ' 61' ' ' CYS . . . -152.3 120.73 1.1 Allowed Glycine 0 N--CA 1.475 1.259 0 C-N-CA 119.415 -1.374 . . . . 1.82 114.041 -179.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.936 ' HA ' ' O ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -83.81 152.76 24.44 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 118.83 1.315 . . . . 3.51 112.697 -177.251 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 20.3 t -65.32 103.1 0.75 Allowed 'General case' 0 N--CA 1.414 -2.234 0 N-CA-C 107.188 -1.412 . . . . 1.52 107.188 -179.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.697 ' HB1' ' HB ' ' A' ' 72' ' ' ILE . . . -80.14 -35.91 35.97 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-N 114.776 -1.102 . . . . 1.5 108.953 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 1.019 ' HB2' ' HB2' ' A' ' 28' ' ' CYS . . . -169.98 165.27 9.53 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.463 -0.94 . . . . 1.31 108.463 -179.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.704 ' HA ' ' O ' ' A' ' 85' ' ' CYS . . . -40.67 96.0 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.107 0 CA-C-O 122.33 1.062 . . . . 1.5 110.648 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' A' ' 69' ' ' ALA . . . 93.75 11.51 57.86 Favored Glycine 0 N--CA 1.428 -1.855 0 CA-C-O 117.085 -1.953 . . . . 1.44 117.578 177.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 1.037 HG13 ' HB2' ' A' ' 34' ' ' CYS . 3.6 mm -109.53 104.15 16.61 Favored 'Isoleucine or valine' 0 C--N 1.361 1.084 0 CA-C-N 123.303 3.551 . . . . 2.77 108.247 178.275 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.802 ' HB2' ' HB3' ' A' ' 82' ' ' ASP . 6.3 t -89.01 92.53 9.26 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 109.21 -0.663 . . . . 1.98 109.21 -179.131 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 1.28 ' CB ' ' HA ' ' A' ' 79' ' ' CYS . 31.6 p -163.51 176.3 9.87 Favored 'General case' 0 C--O 1.225 -0.227 0 N-CA-C 115.329 1.603 . . . . 1.43 115.329 -177.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.897 ' HB2' ' HD2' ' A' ' 76' ' ' PRO . 73.2 p -109.33 -178.81 0.59 Allowed Pre-proline 0 N--CA 1.472 0.644 0 CA-C-N 114.051 -1.432 . . . . 2.37 110.414 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.897 ' HD2' ' HB2' ' A' ' 75' ' ' SER . 71.8 Cg_endo -76.23 30.56 0.39 Allowed 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 121.908 1.739 . . . . 2.09 112.606 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.561 ' HA ' ' OE1' ' B' ' 181' ' ' GLU . 4.8 t70 -140.65 -51.13 0.46 Allowed 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.053 -0.521 . . . . 2.65 109.787 179.049 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.885 ' O ' ' HB2' ' A' ' 74' ' ' CYS . . . -119.65 179.92 16.59 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-O 119.44 -0.644 . . . . 1.04 112.382 178.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 1.28 ' HA ' ' CB ' ' A' ' 74' ' ' CYS . 12.8 m -150.52 160.98 43.4 Favored 'General case' 0 C--N 1.348 0.521 0 N-CA-C 113.105 0.78 . . . . 1.42 113.105 179.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.684 ' HB2' ' O ' ' A' ' 73' ' ' CYS . 50.3 m80 -151.9 139.36 19.54 Favored 'General case' 0 C--N 1.353 0.735 0 C-N-CA 119.921 -0.712 . . . . 2.81 112.054 -178.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -65.55 120.11 12.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.043 -0.526 . . . . 3.05 109.965 178.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.802 ' HB3' ' HB2' ' A' ' 73' ' ' CYS . 0.0 OUTLIER -143.91 101.87 4.92 Favored Pre-proline 0 CA--C 1.537 0.459 0 CA-C-N 116.505 -0.316 . . . . 2.02 110.511 -179.219 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -65.79 -8.48 19.72 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 123.115 2.543 . . . . 2.29 113.831 -178.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.442 ' O ' ' HB1' ' A' ' 89' ' ' ALA . . . -67.89 -39.04 83.71 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.784 0.661 . . . . 1.53 112.784 -178.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.704 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 0.5 OUTLIER -94.87 -4.82 46.28 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 112.613 0.597 . . . . 1.88 112.613 -178.694 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.707 ' HB3' ' HD3' ' A' ' 87' ' ' PRO . 1.6 t70 -69.35 -60.69 3.84 Favored Pre-proline 0 N--CA 1.47 0.532 0 N-CA-C 112.636 0.606 . . . . 3.6 112.636 -177.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.707 ' HD3' ' HB3' ' A' ' 86' ' ' ASP . 59.0 Cg_endo -103.44 -158.38 0.03 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 123.575 2.85 . . . . 3.12 112.792 -178.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.54 ' C ' ' H ' ' A' ' 90' ' ' ALA . 10.8 pt-20 -60.85 86.61 0.01 OUTLIER 'General case' 0 N--CA 1.423 -1.81 0 CA-C-O 124.128 1.918 . . . . 4.72 110.648 178.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.442 ' HB1' ' O ' ' A' ' 84' ' ' ALA . . . -81.69 45.04 0.86 Allowed 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 109.407 -3.542 . . . . 5.29 105.308 175.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.54 ' H ' ' C ' ' A' ' 88' ' ' GLU . . . -84.14 125.79 32.49 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 113.68 -1.6 . . . . 7.19 113.163 -172.005 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -81.0 97.32 7.44 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 120.074 1.306 . . . . 10.7 111.894 -177.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 7.2 t . . . . . 0 C--O 1.25 1.108 0 CA-C-O 118.231 -0.89 . . . . 11.77 110.731 179.505 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.755 0 CA-C-O 120.467 0.175 . . . . 10.42 111.411 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 102' ' ' VAL . . . . . 0.44 ' O ' HG12 ' B' ' 102' ' ' VAL . 4.2 t 75.14 43.49 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 CA-C-O 121.863 0.839 . . . . 8.81 112.372 179.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 103' ' ' LEU . . . . . 0.758 ' HA ' ' HG2' ' B' ' 108' ' ' ARG . 0.0 OUTLIER -115.11 111.94 21.81 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 105.029 -2.211 . . . . 6.28 105.029 172.878 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 104' ' ' ASP . . . . . 0.687 ' O ' ' HG3' ' B' ' 108' ' ' ARG . 35.0 m-20 -161.92 -172.99 3.48 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 113.67 -1.605 . . . . 6.27 108.12 179.141 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . 0.411 HD11 ' HA ' ' B' ' 105' ' ' LEU . 6.8 tp -87.81 6.44 35.26 Favored 'General case' 0 CA--C 1.511 -0.551 0 C-N-CA 114.547 -2.861 . . . . 7.61 110.153 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 106' ' ' ASP . . . . . 0.753 ' O ' ' HG3' ' B' ' 155' ' ' GLN . 0.6 OUTLIER -76.93 -76.42 0.17 Allowed 'General case' 0 CA--C 1.48 -1.735 0 N-CA-C 102.728 -3.064 . . . . 8.55 102.728 -179.199 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 107' ' ' VAL . . . . . 0.639 HG11 ' O ' ' B' ' 107' ' ' VAL . 3.8 p -151.24 113.44 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.482 -1.667 0 N-CA-C 104.238 -2.504 . . . . 7.84 104.238 169.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 108' ' ' ARG . . . . . 0.932 ' HB2' ' H ' ' B' ' 155' ' ' GLN . 17.9 mtp180 -79.04 115.32 18.64 Favored 'General case' 0 CA--C 1.48 -1.746 0 N-CA-C 105.433 -2.062 . . . . 9.75 105.433 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 4.3 t -59.94 105.84 0.43 Allowed 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 115.097 -2.641 . . . . 6.13 108.006 -178.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 110' ' ' CYS . . . . . 0.563 ' HB3' ' HB3' ' B' ' 120' ' ' ARG . 0.1 OUTLIER -80.38 111.42 16.76 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 113.354 -1.748 . . . . 2.87 113.157 178.914 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 111' ' ' LEU . . . . . 0.593 ' O ' ' HA ' ' B' ' 120' ' ' ARG . 4.4 mm? 6.01 111.74 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.523 0 N-CA-C 113.027 0.751 . . . . 2.95 113.027 178.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 112' ' ' PRO . . . . . 0.559 ' HA ' ' O ' ' B' ' 119' ' ' GLY . 92.8 Cg_endo -80.18 122.63 4.76 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 123.071 2.514 . . . . 1.71 116.219 -178.294 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.594 ' O ' ' HA2' ' B' ' 117' ' ' GLY . 27.0 p -127.32 -176.16 3.66 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.043 -0.981 . . . . 1.0 111.264 179.122 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 114' ' ' GLY . . . . . 0.441 ' HA2' ' HG2' ' B' ' 140' ' ' GLU . . . 75.59 -161.38 52.6 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 120.484 -0.865 . . . . 1.16 112.43 -178.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 115' ' ' PRO . . . . . 0.799 ' HD2' HD12 ' B' ' 132' ' ' LEU . 38.7 Cg_endo -64.64 95.83 0.24 Allowed 'Trans proline' 0 N--CA 1.479 0.62 0 C-N-CA 123.624 2.882 . . . . 1.6 112.676 178.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 83.17 -2.94 86.15 Favored Glycine 0 C--N 1.29 -2.012 0 CA-C-N 114.13 -1.396 . . . . 1.7 112.781 178.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 117' ' ' GLY . . . . . 0.594 ' HA2' ' O ' ' B' ' 113' ' ' CYS . . . 84.79 35.84 12.59 Favored Glycine 0 N--CA 1.415 -2.754 0 C-N-CA 118.593 -1.765 . . . . 1.38 116.185 176.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.91 -32.57 61.83 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 112.849 -1.675 . . . . 2.96 106.959 176.216 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 119' ' ' GLY . . . . . 0.559 ' O ' ' HA ' ' B' ' 112' ' ' PRO . . . -79.29 178.44 53.66 Favored Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 113.286 -1.779 . . . . 1.07 112.878 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.593 ' HA ' ' O ' ' B' ' 111' ' ' LEU . 0.0 OUTLIER -141.76 162.7 34.84 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.272 -0.27 . . . . 3.29 110.272 -179.766 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 121' ' ' CYS . . . . . . . . . . . . . 15.3 t -108.66 143.16 38.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.404 0.621 . . . . 1.21 112.305 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -127.47 -54.21 1.35 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.801 -1.09 . . . . 2.28 108.862 178.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -95.96 149.78 19.43 Favored Glycine 0 C--N 1.332 0.325 0 N-CA-C 110.194 -1.162 . . . . 1.04 110.194 177.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -50.29 -48.33 20.47 Favored 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 121.786 1.657 . . . . 1.84 112.804 -179.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 125' ' ' SER . . . . . 0.402 ' O ' ' N ' ' B' ' 137' ' ' GLY . 0.4 OUTLIER -100.7 3.79 42.62 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.563 0.22 . . . . 1.49 111.339 179.705 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 126' ' ' ILE . . . . . 0.867 HG12 HG11 ' B' ' 136' ' ' VAL . 0.6 OUTLIER -119.73 122.8 69.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 113.359 0.874 . . . . 1.41 113.359 -177.968 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 127' ' ' CYS . . . . . 0.424 ' HB3' ' OE1' ' B' ' 140' ' ' GLU . 0.1 OUTLIER -125.14 124.47 41.89 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 109.733 -0.469 . . . . 0.89 109.733 178.689 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 128' ' ' CYS . . . . . 0.985 ' HB2' ' HB2' ' B' ' 169' ' ' ALA . 0.0 OUTLIER -130.45 142.95 50.48 Favored 'General case' 0 CA--C 1.551 1.006 0 N-CA-C 114.277 1.214 . . . . 1.23 114.277 -177.627 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 129' ' ' GLY . . . . . 0.615 ' O ' ' HB3' ' B' ' 169' ' ' ALA . . . -132.05 -173.34 13.3 Favored Glycine 0 C--N 1.359 1.838 0 N-CA-C 110.066 -1.214 . . . . 0.69 110.066 178.146 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 130' ' ' ASP . . . . . 0.689 ' O ' ' HB2' ' B' ' 170' ' ' ALA . 19.5 p-10 -63.73 -56.21 17.34 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 113.231 0.826 . . . . 2.35 113.231 -178.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 131' ' ' GLU . . . . . 0.403 ' HG2' ' OD2' ' B' ' 130' ' ' ASP . 0.0 OUTLIER -120.51 27.7 8.41 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.507 -0.745 . . . . 1.69 110.41 -179.806 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 132' ' ' LEU . . . . . 0.799 HD12 ' HD2' ' B' ' 115' ' ' PRO . 0.3 OUTLIER -122.46 -8.14 8.61 Favored 'General case' 0 N--CA 1.406 -2.672 0 N-CA-C 102.68 -3.081 . . . . 1.84 102.68 177.246 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 133' ' ' GLY . . . . . 0.869 ' O ' ' HB3' ' B' ' 128' ' ' CYS . . . 62.79 -94.15 0.11 Allowed Glycine 0 N--CA 1.426 -2.028 0 N-CA-C 118.973 2.349 . . . . 0.76 118.973 170.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 134' ' ' CYS . . . . . 1.02 ' HB2' HG13 ' B' ' 172' ' ' ILE . 6.1 t -170.02 106.85 0.34 Allowed 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 119.878 1.839 . . . . 1.08 109.453 176.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 135' ' ' PHE . . . . . 0.556 ' HB3' ' CG2' ' B' ' 138' ' ' THR . 3.6 m-30 -89.72 105.36 17.75 Favored 'General case' 0 N--CA 1.425 -1.683 0 N-CA-C 106.065 -1.828 . . . . 1.83 106.065 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 136' ' ' VAL . . . . . 0.924 HG23 HG23 ' A' ' 36' ' ' VAL . 1.7 t -94.64 89.12 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.197 0 CA-C-O 123.289 1.519 . . . . 1.29 108.561 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 137' ' ' GLY . . . . . 0.627 ' O ' ' HA3' ' A' ' 33' ' ' GLY . . . 93.94 98.83 1.57 Allowed Glycine 0 C--O 1.227 -0.309 0 CA-C-N 111.597 -2.547 . . . . 0.85 115.994 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 138' ' ' THR . . . . . 0.556 ' CG2' ' HB3' ' B' ' 135' ' ' PHE . 0.7 OUTLIER 177.0 170.55 0.52 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.651 0.262 . . . . 1.2 111.102 177.349 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 139' ' ' ALA . . . . . 0.772 ' HA ' HD11 ' B' ' 142' ' ' LEU . . . -58.81 -15.18 11.13 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 121.406 0.622 . . . . 1.35 110.654 178.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 140' ' ' GLU . . . . . 0.441 ' HG2' ' HA2' ' B' ' 114' ' ' GLY . 0.0 OUTLIER -72.65 -12.9 61.23 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.702 -1.135 . . . . 2.31 109.494 176.767 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 141' ' ' ALA . . . . . 0.423 ' O ' ' HB2' ' B' ' 144' ' ' CYS . . . -105.98 -22.72 12.82 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 115.169 -0.923 . . . . 1.09 111.643 -179.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 142' ' ' LEU . . . . . 0.772 HD11 ' HA ' ' B' ' 139' ' ' ALA . 3.6 mt -44.01 -39.28 4.01 Favored 'General case' 0 C--N 1.345 0.38 0 N-CA-C 113.176 0.806 . . . . 1.61 113.176 -178.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 143' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -58.17 -19.78 35.78 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.361 0.6 . . . . 3.43 109.769 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 144' ' ' CYS . . . . . 0.629 ' O ' ' N ' ' B' ' 147' ' ' GLU . 99.3 m -64.81 -45.77 84.83 Favored 'General case' 0 C--O 1.223 -0.3 0 N-CA-C 108.535 -0.913 . . . . 1.61 108.535 177.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 145' ' ' GLN . . . . . 0.459 ' HB2' ' O ' ' B' ' 142' ' ' LEU . 75.0 mm-40 -28.85 -37.75 0.01 OUTLIER 'General case' 0 CA--C 1.551 0.981 0 CA-C-N 113.668 -1.605 . . . . 3.52 113.05 -178.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -87.45 -3.1 59.01 Favored 'General case' 0 N--CA 1.477 0.905 0 O-C-N 121.253 -0.905 . . . . 3.76 111.5 -179.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . 0.629 ' N ' ' O ' ' B' ' 144' ' ' CYS . 1.1 tt0 -81.11 -0.26 39.28 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.433 -0.803 . . . . 4.01 109.54 178.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 148' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -64.2 -28.24 69.61 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.692 -0.484 . . . . 4.24 109.692 178.141 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -112.77 47.89 1.06 Allowed 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.151 -0.477 . . . . 6.07 111.116 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 6.0 mt -143.86 88.27 7.75 Favored Pre-proline 0 CA--C 1.533 0.311 0 CA-C-N 116.394 -0.366 . . . . 5.86 111.073 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 151' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -91.25 31.91 0.32 Allowed 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.702 2.268 . . . . 5.42 113.167 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -92.48 118.78 68.18 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.657 -0.247 . . . . 6.02 111.009 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 153' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -80.26 116.91 3.39 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.242 1.961 . . . . 5.87 113.126 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 154' ' ' CYS . . . . . 0.752 ' HA ' ' CD ' ' B' ' 108' ' ' ARG . 28.7 p -86.15 153.5 22.02 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 115.735 -0.666 . . . . 2.96 111.127 179.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 155' ' ' GLN . . . . . 0.932 ' H ' ' HB2' ' B' ' 108' ' ' ARG . 2.4 tt0 -12.45 -81.19 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 114.853 1.427 . . . . 6.3 114.853 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 156' ' ' SER . . . . . 0.584 ' HB2' ' O ' ' B' ' 155' ' ' GLN . 0.6 OUTLIER 86.79 -100.12 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.673 0.789 . . . . 3.41 111.417 -178.617 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 111.44 -63.81 0.27 Allowed Glycine 0 C--N 1.338 0.675 0 C-N-CA 120.509 -0.853 . . . . 2.26 113.202 179.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 158' ' ' GLN . . . . . 0.564 ' O ' ' HB3' ' B' ' 167' ' ' CYS . 8.5 mt-30 -115.8 108.09 15.88 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 107.887 -1.153 . . . . 5.03 107.887 178.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 159' ' ' LYS . . . . . 0.892 ' O ' ' HA ' ' B' ' 166' ' ' ARG . 3.6 mtmp? -90.72 -103.75 0.0 OUTLIER Pre-proline 0 C--N 1.3 -1.577 0 CA-C-O 118.753 -0.641 . . . . 3.96 110.341 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 160' ' ' PRO . . . . . 0.797 ' HD3' ' HB3' ' B' ' 159' ' ' LYS . 57.6 Cg_endo -71.64 138.07 31.38 Favored 'Trans proline' 0 C--N 1.353 0.803 0 CA-C-N 122.231 1.833 . . . . 1.7 115.088 -179.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 161' ' ' CYS . . . . . 0.491 ' O ' ' SG ' ' B' ' 173' ' ' CYS . 20.1 p -142.78 146.68 34.48 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 114.155 -1.384 . . . . 1.93 110.013 177.281 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 69.64 -164.99 50.7 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 119.352 -1.404 . . . . 2.37 112.666 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 1.6 m -76.74 51.31 0.75 Allowed 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 123.872 0.869 . . . . 4.56 112.493 179.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 107.92 49.19 0.85 Allowed Glycine 0 N--CA 1.466 0.648 0 N-CA-C 115.913 1.125 . . . . 2.39 115.913 172.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 165' ' ' GLY . . . . . 0.489 ' O ' ' N ' ' B' ' 161' ' ' CYS . . . -150.95 122.98 1.44 Allowed Glycine 0 N--CA 1.469 0.878 0 C-N-CA 119.525 -1.321 . . . . 1.79 113.607 179.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 166' ' ' ARG . . . . . 0.892 ' HA ' ' O ' ' B' ' 159' ' ' LYS . 0.0 OUTLIER -84.36 152.78 23.86 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 118.841 1.321 . . . . 3.53 112.528 -178.398 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 167' ' ' CYS . . . . . 0.564 ' HB3' ' O ' ' B' ' 158' ' ' GLN . 20.0 t -65.29 103.04 0.73 Allowed 'General case' 0 N--CA 1.416 -2.171 0 N-CA-C 107.175 -1.417 . . . . 1.56 107.175 -179.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 168' ' ' ALA . . . . . 0.588 ' HB3' ' HB ' ' B' ' 172' ' ' ILE . . . -80.42 -35.09 35.61 Favored 'General case' 0 N--CA 1.424 -1.771 0 CA-C-N 114.676 -1.147 . . . . 1.42 108.969 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 169' ' ' ALA . . . . . 0.985 ' HB2' ' HB2' ' B' ' 128' ' ' CYS . . . -170.57 165.26 8.39 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 108.326 -0.99 . . . . 1.18 108.326 -179.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 170' ' ' ALA . . . . . 0.703 ' HA ' ' O ' ' B' ' 185' ' ' CYS . . . -40.76 96.07 0.01 OUTLIER 'General case' 0 C--O 1.232 0.152 0 CA-C-O 122.239 1.018 . . . . 1.47 110.622 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 171' ' ' GLY . . . . . 0.569 ' N ' ' O ' ' B' ' 169' ' ' ALA . . . 93.7 11.5 57.92 Favored Glycine 0 N--CA 1.427 -1.932 0 CA-C-O 116.883 -2.065 . . . . 1.45 117.557 177.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 172' ' ' ILE . . . . . 1.02 HG13 ' HB2' ' B' ' 134' ' ' CYS . 3.2 mm -109.59 104.35 16.93 Favored 'Isoleucine or valine' 0 C--N 1.365 1.262 0 CA-C-N 123.685 3.743 . . . . 2.7 108.124 178.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 173' ' ' CYS . . . . . 0.797 ' HB2' ' CB ' ' B' ' 182' ' ' ASP . 6.3 t -88.99 92.43 9.23 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 109.156 -0.683 . . . . 1.94 109.156 -179.128 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 174' ' ' CYS . . . . . 1.278 ' CB ' ' HA ' ' B' ' 179' ' ' CYS . 31.0 p -163.34 176.17 10.13 Favored 'General case' 0 C--O 1.226 -0.162 0 N-CA-C 115.458 1.651 . . . . 1.43 115.458 -177.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 175' ' ' SER . . . . . 0.901 ' HB2' ' HD2' ' B' ' 176' ' ' PRO . 73.7 p -109.31 -178.86 0.6 Allowed Pre-proline 0 N--CA 1.47 0.557 0 CA-C-N 114.187 -1.369 . . . . 2.3 110.441 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 176' ' ' PRO . . . . . 0.901 ' HD2' ' HB2' ' B' ' 175' ' ' SER . 71.6 Cg_endo -76.11 30.47 0.39 Allowed 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 121.913 1.742 . . . . 2.13 112.675 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 177' ' ' ASP . . . . . 0.415 ' H ' ' C ' ' B' ' 175' ' ' SER . 4.9 t70 -140.68 -51.16 0.46 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.086 -0.506 . . . . 2.72 109.769 179.103 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 178' ' ' GLY . . . . . 0.899 ' O ' ' HB2' ' B' ' 174' ' ' CYS . . . -119.65 179.99 16.59 Favored Glycine 0 N--CA 1.445 -0.759 0 CA-C-O 119.412 -0.66 . . . . 1.05 112.18 178.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 179' ' ' CYS . . . . . 1.278 ' HA ' ' CB ' ' B' ' 174' ' ' CYS . 12.5 m -150.47 161.1 43.18 Favored 'General case' 0 C--N 1.346 0.447 0 N-CA-C 113.165 0.802 . . . . 1.39 113.165 179.137 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 180' ' ' HIS . . . . . 0.688 ' HB2' ' O ' ' B' ' 173' ' ' CYS . 49.2 m80 -151.98 139.18 19.28 Favored 'General case' 0 C--N 1.354 0.775 0 C-N-CA 119.786 -0.765 . . . . 2.73 111.998 -178.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 181' ' ' GLU . . . . . 0.561 ' OE1' ' HA ' ' A' ' 77' ' ' ASP . 27.8 mt-10 -65.43 120.05 12.12 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 116.028 -0.533 . . . . 3.06 110.072 178.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 182' ' ' ASP . . . . . 0.797 ' CB ' ' HB2' ' B' ' 173' ' ' CYS . 0.0 OUTLIER -143.81 101.86 4.96 Favored Pre-proline 0 CA--C 1.536 0.413 0 CA-C-N 116.612 -0.267 . . . . 2.06 110.535 -179.187 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 183' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -65.88 -8.37 19.54 Favored 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 123.214 2.609 . . . . 2.27 113.859 -178.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 184' ' ' ALA . . . . . 0.583 ' HB1' ' OD1' ' B' ' 182' ' ' ASP . . . -67.97 -39.11 83.4 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.78 0.659 . . . . 1.56 112.78 -179.079 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 185' ' ' CYS . . . . . 0.703 ' O ' ' HA ' ' B' ' 170' ' ' ALA . 0.6 OUTLIER -94.78 -4.73 46.74 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.592 0.59 . . . . 1.94 112.592 -178.744 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 186' ' ' ASP . . . . . 0.715 ' HB3' ' HD3' ' B' ' 187' ' ' PRO . 1.6 t70 -69.32 -60.69 3.86 Favored Pre-proline 0 N--CA 1.47 0.565 0 N-CA-C 112.659 0.614 . . . . 3.61 112.659 -177.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 187' ' ' PRO . . . . . 0.715 ' HD3' ' HB3' ' B' ' 186' ' ' ASP . 58.3 Cg_endo -103.34 -158.62 0.03 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.201 0 C-N-CA 123.518 2.812 . . . . 3.14 112.747 -178.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 188' ' ' GLU . . . . . 0.519 ' C ' ' H ' ' B' ' 190' ' ' ALA . 11.2 pt-20 -60.54 88.23 0.02 OUTLIER 'General case' 0 N--CA 1.422 -1.832 0 CA-C-O 124.493 2.092 . . . . 4.7 109.834 177.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 189' ' ' ALA . . . . . 0.444 ' HB1' ' O ' ' B' ' 184' ' ' ALA . . . -83.01 45.18 0.99 Allowed 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 108.751 -3.84 . . . . 5.24 105.109 174.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 190' ' ' ALA . . . . . 0.519 ' H ' ' C ' ' B' ' 188' ' ' GLU . . . -84.19 127.24 33.81 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 113.781 -1.554 . . . . 6.93 112.983 -171.05 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 191' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -81.45 97.76 7.92 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 121.222 1.828 . . . . 10.62 111.957 -178.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 7.2 t . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.353 -0.832 . . . . 11.7 110.819 179.535 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.284 0 CA-C-O 121.299 0.571 . . . . 10.31 111.616 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.1 t -134.09 55.26 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.135 0 CA-C-N 115.222 -0.899 . . . . 8.37 112.02 178.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 1.091 HD21 ' HD2' ' A' ' 53' ' ' PRO . 0.2 OUTLIER -149.05 18.59 0.98 Allowed 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 116.374 1.99 . . . . 6.25 116.374 175.576 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.662 ' O ' ' HB2' ' A' ' 55' ' ' GLN . 2.4 t70 -39.28 -99.0 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 112.731 0.641 . . . . 6.22 112.731 -177.439 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 1.026 HD13 ' HG3' ' A' ' 55' ' ' GLN . 19.8 tp -148.51 23.06 1.02 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 117.286 -1.765 . . . . 7.57 114.073 -178.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.39 -83.59 0.1 Allowed 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 104.72 -2.326 . . . . 8.78 104.72 176.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.637 HG11 ' O ' ' A' ' 7' ' ' VAL . 9.1 p -128.98 118.56 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.706 0 N-CA-C 102.778 -3.045 . . . . 7.88 102.778 174.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.851 ' HD3' ' H ' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -77.69 109.34 11.6 Favored 'General case' 0 N--CA 1.417 -2.123 0 N-CA-C 108.368 -0.975 . . . . 9.7 108.368 -177.439 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.9 m -75.53 93.33 2.99 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 116.134 -2.226 . . . . 6.05 105.564 177.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.84 ' HB3' ' CG ' ' A' ' 20' ' ' ARG . 61.1 m -81.75 112.84 19.28 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 113.094 -1.866 . . . . 2.89 113.682 -178.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.615 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 16.3 tp -35.08 111.8 0.44 Allowed Pre-proline 0 N--CA 1.489 1.516 0 C-N-CA 123.223 0.609 . . . . 2.89 112.625 177.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.833 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 44.9 Cg_endo -86.99 144.21 7.12 Favored 'Trans proline' 0 C--N 1.357 1.012 0 C-N-CA 122.971 2.447 . . . . 1.72 116.992 -177.295 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.516 ' N ' ' O ' ' A' ' 19' ' ' GLY . 27.3 p -149.1 -170.24 3.58 Favored 'General case' 0 C--N 1.355 0.81 0 CA-C-N 115.961 -0.563 . . . . 1.0 109.79 178.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.832 ' CA ' ' HG2' ' A' ' 40' ' ' GLU . . . 75.45 -161.27 52.71 Favored Glycine 0 C--N 1.335 0.51 0 N-CA-C 115.256 0.862 . . . . 1.15 115.256 176.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.566 ' HG2' ' O ' ' A' ' 15' ' ' PRO . 38.0 Cg_endo -64.5 102.54 0.41 Allowed 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 124.027 3.151 . . . . 1.6 111.502 178.533 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 86.1 -0.98 87.72 Favored Glycine 0 C--N 1.265 -3.385 0 CA-C-N 112.028 -2.351 . . . . 1.68 112.761 -179.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.794 ' O ' ' HB2' ' A' ' 12' ' ' PRO . . . 72.43 43.03 46.9 Favored Glycine 0 N--CA 1.405 -3.385 0 C-N-CA 118.988 -1.577 . . . . 1.37 114.49 173.618 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.92 -41.13 9.33 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 114.29 -0.955 . . . . 2.91 110.416 177.367 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.833 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -71.38 169.02 50.3 Favored Glycine 0 C--O 1.194 -2.351 0 N-CA-C 116.272 1.269 . . . . 1.06 116.272 -174.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.84 ' CG ' ' HB3' ' A' ' 10' ' ' CYS . 4.2 mpp_? -104.14 160.83 14.53 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 112.747 -1.727 . . . . 3.32 114.926 -172.325 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.407 ' HB3' ' OE2' ' A' ' 47' ' ' GLU . 5.1 m -106.91 136.94 45.91 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 114.794 -1.093 . . . . 1.19 111.597 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -145.69 24.43 1.37 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.32 -0.855 . . . . 2.26 110.137 179.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 152.28 161.52 10.26 Favored Glycine 0 CA--C 1.521 0.422 0 N-CA-C 111.164 -0.775 . . . . 1.05 111.164 -179.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.64 ' HD2' ' OE2' ' B' ' 181' ' ' GLU . 31.8 Cg_exo -58.7 -64.01 0.12 Allowed 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 121.703 1.602 . . . . 1.81 112.335 -179.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.456 ' O ' ' N ' ' A' ' 37' ' ' GLY . 3.3 m -90.47 39.5 0.98 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.704 0.288 . . . . 1.62 110.289 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.959 HG12 HG12 ' A' ' 36' ' ' VAL . 3.0 mt -155.28 121.19 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 O-C-N 122.114 -0.366 . . . . 1.39 111.612 -179.276 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -137.86 110.16 7.38 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 120.877 0.37 . . . . 0.92 110.714 179.282 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.866 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -116.5 155.34 28.81 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 113.46 0.911 . . . . 1.28 113.46 179.025 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -149.67 -174.61 21.19 Favored Glycine 0 C--N 1.371 2.494 0 N-CA-C 108.259 -1.936 . . . . 0.71 108.259 177.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -67.8 -41.73 82.68 Favored 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 125.892 1.677 . . . . 2.27 115.328 -179.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -122.83 13.23 9.89 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 114.209 -1.359 . . . . 1.66 111.424 178.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.734 ' O ' HG23 ' B' ' 138' ' ' THR . 0.2 OUTLIER -120.25 -7.2 9.83 Favored 'General case' 0 N--CA 1.393 -3.323 0 N-CA-C 108.541 -0.911 . . . . 1.93 108.541 -178.383 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.968 ' HA2' ' CB ' ' A' ' 69' ' ' ALA . . . 49.83 -135.71 25.02 Favored Glycine 0 C--O 1.198 -2.103 0 CA-C-O 116.504 -2.276 . . . . 0.77 109.561 179.372 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.779 ' HB2' ' CD1' ' A' ' 72' ' ' ILE . 0.7 OUTLIER -128.71 130.46 47.18 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 121.495 2.648 . . . . 1.08 111.674 -179.842 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.723 ' CE1' HD22 ' A' ' 32' ' ' LEU . 1.3 m-85 -104.12 101.76 11.5 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 102.139 -3.282 . . . . 1.85 102.139 173.469 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.959 HG12 HG12 ' A' ' 26' ' ' ILE . 2.5 t -92.72 93.97 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.312 0 CA-C-O 123.694 1.711 . . . . 1.29 110.066 -177.113 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.849 ' O ' HG21 ' A' ' 38' ' ' THR . . . 83.18 80.37 1.0 Allowed Glycine 0 C--N 1.319 -0.379 0 CA-C-N 111.826 -2.443 . . . . 0.85 113.257 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.849 HG21 ' O ' ' A' ' 37' ' ' GLY . 70.7 p -160.76 -167.31 1.82 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.11 0.481 . . . . 1.3 110.361 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.541 ' HA ' HD11 ' A' ' 42' ' ' LEU . . . -62.14 -40.5 96.15 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 108.817 -0.809 . . . . 1.45 108.817 179.365 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.832 ' HG2' ' CA ' ' A' ' 14' ' ' GLY . 0.4 OUTLIER -55.9 -26.4 47.21 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 114.986 -1.006 . . . . 2.32 112.38 179.655 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.493 ' O ' ' N ' ' A' ' 44' ' ' CYS . . . -91.63 -35.37 14.26 Favored 'General case' 0 C--O 1.213 -0.845 0 CA-C-N 116.197 -0.456 . . . . 1.11 110.268 -179.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.541 HD11 ' HA ' ' A' ' 39' ' ' ALA . 7.9 mt -39.57 -54.31 2.0 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 114.866 1.432 . . . . 1.68 114.866 -175.483 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.653 ' C ' ' H ' ' A' ' 45' ' ' GLN . 0.0 OUTLIER -54.75 -23.6 18.61 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 119.982 -0.687 . . . . 3.4 109.763 178.171 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.493 ' N ' ' O ' ' A' ' 41' ' ' ALA . 4.9 t -69.43 17.77 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 112.823 0.675 . . . . 1.57 112.823 -177.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.653 ' H ' ' C ' ' A' ' 43' ' ' ARG . 1.3 tt0 -75.22 -28.84 60.08 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 114.312 -1.313 . . . . 3.49 107.99 176.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -82.33 9.95 7.96 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.224 -0.898 . . . . 3.69 110.837 179.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.453 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . 0.9 OUTLIER -81.43 -0.91 43.68 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 109.745 -0.465 . . . . 3.99 109.745 177.584 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.786 ' H ' HD21 ' A' ' 48' ' ' ASN . 0.0 OUTLIER -76.83 -27.53 55.19 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.401 -0.363 . . . . 4.2 110.118 178.525 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -108.9 15.31 23.57 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.431 -0.349 . . . . 5.85 111.823 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.436 HD21 HD13 ' A' ' 11' ' ' LEU . 0.5 OUTLIER -143.12 90.22 7.49 Favored Pre-proline 0 CA--C 1.533 0.294 0 N-CA-C 111.584 0.216 . . . . 5.83 111.584 -179.748 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -91.67 50.47 0.67 Allowed 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 122.804 2.336 . . . . 5.3 112.493 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.56 ' HG ' HD22 ' A' ' 3' ' ' LEU . 0.1 OUTLIER -72.83 119.16 73.86 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 116.184 -0.462 . . . . 5.72 111.796 -179.443 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 1.091 ' HD2' HD21 ' A' ' 3' ' ' LEU . 84.4 Cg_endo -79.48 -48.25 0.08 OUTLIER 'Trans proline' 0 C--N 1.355 0.92 0 C-N-CA 122.248 1.965 . . . . 5.82 113.197 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.881 ' N ' HD23 ' A' ' 3' ' ' LEU . 5.3 p 55.29 125.22 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.781 0.833 . . . . 2.98 112.295 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 1.026 ' HG3' HD13 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -61.62 92.45 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 120.156 -0.617 . . . . 6.42 112.021 -179.533 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.677 ' HB2' ' HG3' ' A' ' 8' ' ' ARG . 0.1 OUTLIER 167.24 131.93 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 122.976 0.511 . . . . 3.36 110.548 179.039 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.638 ' O ' ' HG3' ' A' ' 66' ' ' ARG . . . 99.18 32.14 5.93 Favored Glycine 0 C--N 1.345 1.033 0 C-N-CA 120.566 -0.826 . . . . 2.3 112.348 177.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -122.04 76.09 1.27 Allowed 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 121.908 0.861 . . . . 5.06 111.173 179.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.799 ' HB2' ' HB2' ' A' ' 67' ' ' CYS . 1.6 mmtp -133.41 69.59 77.16 Favored Pre-proline 0 C--N 1.313 -1.01 0 N-CA-C 106.734 -1.58 . . . . 3.91 106.734 178.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.633 ' HA ' ' O ' ' A' ' 65' ' ' GLY . 14.4 Cg_endo -56.9 82.38 0.04 OUTLIER 'Trans proline' 0 C--N 1.368 1.582 0 C-N-CA 123.901 3.068 . . . . 1.74 117.754 -176.413 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -101.8 -178.35 3.69 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 106.181 -1.785 . . . . 1.9 106.181 173.164 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.09 -167.15 53.14 Favored Glycine 0 C--N 1.339 0.734 0 C-N-CA 119.205 -1.474 . . . . 2.43 112.372 -179.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.6 p -83.04 41.79 0.77 Allowed 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 120.818 -0.353 . . . . 4.32 110.412 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 117.12 9.68 10.41 Favored Glycine 0 CA--C 1.538 1.492 0 CA-C-O 117.124 -1.931 . . . . 2.4 116.204 179.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.633 ' O ' ' HA ' ' A' ' 60' ' ' PRO . . . -102.64 156.3 18.31 Favored Glycine 0 C--N 1.345 1.081 0 CA-C-N 121.767 2.783 . . . . 1.82 113.554 179.147 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.638 ' HG3' ' O ' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -99.21 151.86 20.54 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 111.849 0.314 . . . . 3.51 111.849 179.415 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.799 ' HB2' ' HB2' ' A' ' 59' ' ' LYS . 1.3 m -71.59 106.85 4.18 Favored 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 109.557 -0.534 . . . . 1.52 109.557 178.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.851 ' HB3' ' HB2' ' A' ' 28' ' ' CYS . . . -89.03 -22.04 23.17 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 107.935 -1.135 . . . . 1.5 107.935 177.088 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.968 ' CB ' ' HA2' ' A' ' 33' ' ' GLY . . . -161.7 162.37 29.75 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 112.342 -2.208 . . . . 1.31 113.937 -175.073 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.665 ' HA ' ' O ' ' A' ' 85' ' ' CYS . . . -58.63 122.99 14.81 Favored 'General case' 0 CA--C 1.527 0.092 0 N-CA-C 113.05 0.759 . . . . 1.5 113.05 -178.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.679 ' HA2' ' O ' ' A' ' 82' ' ' ASP . . . 71.33 15.96 75.18 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-N 115.671 -0.695 . . . . 1.44 114.189 178.637 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.933 ' CG2' ' HA3' ' B' ' 137' ' ' GLY . 1.2 pp -141.73 98.29 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-N 113.932 -1.134 . . . . 2.77 112.733 -178.489 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.536 ' HB2' ' HB3' ' A' ' 82' ' ' ASP . 5.0 t -99.57 85.41 3.13 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 114.021 -1.445 . . . . 1.98 110.224 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 1.017 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 1.8 m -93.88 146.06 24.17 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.258 -0.428 . . . . 1.43 111.169 -179.192 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.881 ' HB2' ' HD2' ' A' ' 76' ' ' PRO . 53.9 p -109.56 -179.62 0.7 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.84 -0.618 . . . . 2.37 110.029 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.881 ' HD2' ' HB2' ' A' ' 75' ' ' SER . 77.1 Cg_endo -77.67 29.42 0.44 Allowed 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 121.695 1.596 . . . . 2.09 111.436 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.472 ' H ' ' C ' ' A' ' 75' ' ' SER . 0.6 OUTLIER -144.66 -29.44 0.47 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.218 -0.901 . . . . 2.65 110.113 179.41 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.5 ' O ' ' HB3' ' A' ' 74' ' ' CYS . . . -166.91 -145.89 4.65 Favored Glycine 0 CA--C 1.524 0.615 0 CA-C-N 115.977 -0.556 . . . . 1.04 112.603 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 1.017 ' HA ' ' HA ' ' A' ' 74' ' ' CYS . 11.9 t -146.62 159.16 43.8 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 109.808 -0.441 . . . . 1.42 109.808 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 55.3 m-70 -149.67 135.16 18.37 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 120.04 -0.664 . . . . 2.81 110.358 -176.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.673 ' CD ' HD13 ' B' ' 126' ' ' ILE . 2.6 mt-10 -60.79 132.13 52.9 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 109.712 -0.477 . . . . 3.05 109.712 179.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.679 ' O ' ' HA2' ' A' ' 71' ' ' GLY . 0.1 OUTLIER -140.01 112.8 7.52 Favored Pre-proline 0 CA--C 1.545 0.788 0 CA-C-N 116.355 -0.384 . . . . 2.02 110.755 -178.557 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 82' ' ' ASP . 13.9 Cg_exo -70.87 -21.11 28.75 Favored 'Trans proline' 0 C--N 1.359 1.09 0 C-N-CA 122.831 2.354 . . . . 2.29 113.862 -178.363 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.83 -39.75 94.97 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.718 0.294 . . . . 1.53 111.485 -179.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.665 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 68.4 m -97.95 -0.54 44.64 Favored 'General case' 0 C--O 1.215 -0.739 0 N-CA-C 112.681 0.623 . . . . 1.88 112.681 -179.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.549 ' HA ' ' N ' ' A' ' 71' ' ' GLY . 0.8 OUTLIER -66.48 -56.3 15.95 Favored Pre-proline 0 C--N 1.319 -0.719 0 N-CA-C 112.82 0.674 . . . . 3.6 112.82 -176.58 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.517 ' HD3' ' CB ' ' A' ' 86' ' ' ASP . 10.3 Cg_endo -92.79 -162.69 0.1 Allowed 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 122.874 2.383 . . . . 3.12 113.072 -179.385 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.554 ' C ' ' H ' ' A' ' 90' ' ' ALA . 0.0 OUTLIER -83.97 50.84 1.91 Allowed 'General case' 0 C--N 1.286 -2.181 0 CA-C-N 110.882 -2.872 . . . . 4.72 107.621 172.967 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -76.19 33.15 0.12 Allowed 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.264 0.554 . . . . 5.29 109.603 176.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.554 ' H ' ' C ' ' A' ' 88' ' ' GLU . . . -53.62 111.5 0.74 Allowed 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.278 -0.874 . . . . 7.19 113.204 -176.356 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -86.99 128.06 35.08 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 115.383 -0.826 . . . . 10.7 111.406 -179.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 10.8 m . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.184 -0.912 . . . . 11.77 111.316 179.507 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.661 0.267 . . . . 10.42 111.183 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 102' ' ' VAL . . . . . 1.014 HG22 HD23 ' B' ' 103' ' ' LEU . 9.7 p 52.25 -153.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-N 115.441 -0.799 . . . . 8.81 109.911 -178.396 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 103' ' ' LEU . . . . . 1.03 HD13 ' H ' ' B' ' 109' ' ' THR . 3.1 mm? -59.73 94.74 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 O-C-N 122.111 -0.368 . . . . 6.28 110.971 -179.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 104' ' ' ASP . . . . . 0.595 ' O ' ' HB2' ' B' ' 155' ' ' GLN . 0.6 OUTLIER -73.46 -93.69 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 107.293 -1.373 . . . . 6.27 107.293 176.398 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . 0.968 HD13 HE21 ' B' ' 155' ' ' GLN . 17.2 tp -149.4 28.98 0.79 Allowed 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 116.546 -2.062 . . . . 7.61 114.691 -179.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 106' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -81.25 -108.67 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 104.046 -2.575 . . . . 8.55 104.046 177.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 107' ' ' VAL . . . . . 0.592 HG11 ' O ' ' B' ' 107' ' ' VAL . 8.2 p -106.86 120.34 57.96 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.91 0 N-CA-C 101.991 -3.337 . . . . 7.84 101.991 171.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 108' ' ' ARG . . . . . 0.859 ' HD3' ' H ' ' B' ' 108' ' ' ARG . 0.0 OUTLIER -77.75 108.66 11.14 Favored 'General case' 0 N--CA 1.411 -2.381 0 N-CA-C 108.494 -0.928 . . . . 9.75 108.494 -178.368 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 109' ' ' THR . . . . . 1.03 ' H ' HD13 ' B' ' 103' ' ' LEU . 4.8 m -74.77 93.67 2.64 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 116.163 -2.215 . . . . 6.13 105.606 177.318 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 110' ' ' CYS . . . . . 0.828 ' HB3' ' CG ' ' B' ' 120' ' ' ARG . 59.3 m -82.47 111.57 18.61 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 113.102 -1.863 . . . . 2.87 113.806 -178.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 111' ' ' LEU . . . . . 0.647 ' O ' ' HA ' ' B' ' 120' ' ' ARG . 16.5 tp -34.3 111.58 0.4 Allowed Pre-proline 0 N--CA 1.491 1.579 0 C-N-CA 123.162 0.585 . . . . 2.95 112.553 178.262 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 112' ' ' PRO . . . . . 0.833 ' HA ' ' O ' ' B' ' 119' ' ' GLY . 68.5 Cg_endo -83.12 147.88 13.13 Favored 'Trans proline' 0 C--N 1.359 1.101 0 C-N-CA 122.811 2.341 . . . . 1.71 115.442 -177.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.515 ' C ' ' HA2' ' B' ' 117' ' ' GLY . 28.0 p -152.06 -170.43 3.64 Favored 'General case' 0 C--O 1.254 1.31 0 CA-C-N 115.378 -0.828 . . . . 1.0 110.081 174.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 114' ' ' GLY . . . . . 0.81 ' CA ' ' HG2' ' B' ' 140' ' ' GLU . . . 75.79 -160.34 51.62 Favored Glycine 0 C--N 1.343 0.969 0 CA-C-N 114.712 -1.131 . . . . 1.16 115.094 176.143 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 115' ' ' PRO . . . . . 0.585 ' HG2' ' O ' ' B' ' 115' ' ' PRO . 35.5 Cg_endo -64.6 106.46 0.74 Allowed 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 124.067 3.178 . . . . 1.6 110.56 178.157 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 87.03 -11.88 63.7 Favored Glycine 0 C--N 1.257 -3.848 0 CA-C-N 112.211 -2.268 . . . . 1.7 111.174 -179.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 117' ' ' GLY . . . . . 0.73 ' O ' ' HB2' ' B' ' 112' ' ' PRO . . . 72.53 52.84 9.37 Favored Glycine 0 N--CA 1.399 -3.791 0 C-N-CA 119.596 -1.288 . . . . 1.38 113.488 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.05 -53.82 3.82 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 104.722 -2.325 . . . . 2.96 104.722 173.084 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 119' ' ' GLY . . . . . 0.833 ' O ' ' HA ' ' B' ' 112' ' ' PRO . . . -58.64 176.3 2.31 Favored Glycine 0 C--O 1.206 -1.643 0 CA-C-N 114.007 -1.451 . . . . 1.07 115.111 -167.279 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.828 ' CG ' ' HB3' ' B' ' 110' ' ' CYS . 4.7 mpp_? -113.83 163.68 14.74 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 114.081 1.141 . . . . 3.29 114.081 -173.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 121' ' ' CYS . . . . . 0.452 ' HB2' HD22 ' B' ' 111' ' ' LEU . 6.8 m -106.86 137.23 45.3 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.521 -1.218 . . . . 1.21 112.034 -179.059 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -145.68 24.35 1.37 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.186 -0.915 . . . . 2.28 110.171 179.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 152.29 161.52 10.26 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 111.196 -0.762 . . . . 1.04 111.196 -179.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . 0.614 ' HD2' ' OE2' ' A' ' 81' ' ' GLU . 32.0 Cg_exo -58.59 -64.11 0.12 Allowed 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 121.749 1.633 . . . . 1.84 112.286 -179.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 125' ' ' SER . . . . . 0.507 ' O ' HG11 ' B' ' 136' ' ' VAL . 3.2 m -90.58 39.62 0.98 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.665 0.269 . . . . 1.49 110.33 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 126' ' ' ILE . . . . . 1.048 HG12 HG11 ' B' ' 136' ' ' VAL . 3.3 mt -155.07 121.11 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 O-C-N 122.242 -0.286 . . . . 1.41 111.707 -179.21 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 127' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -138.06 110.02 7.23 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.054 0.454 . . . . 0.89 110.755 179.107 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 128' ' ' CYS . . . . . 0.824 ' HA ' ' O ' ' B' ' 133' ' ' GLY . 0.0 OUTLIER -112.51 157.59 20.95 Favored 'General case' 0 CA--C 1.562 1.417 0 C-N-CA 123.836 0.854 . . . . 1.23 112.647 178.764 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 129' ' ' GLY . . . . . . . . . . . . . . . -152.56 -175.48 24.15 Favored Glycine 0 C--N 1.38 2.985 0 N-CA-C 109.512 -1.435 . . . . 0.69 109.512 176.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -68.28 -45.79 72.12 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.871 1.268 . . . . 2.35 113.068 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.15 25.22 7.9 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-N 114.286 -1.325 . . . . 1.69 110.756 179.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 132' ' ' LEU . . . . . 0.726 HD22 ' CE1' ' B' ' 135' ' ' PHE . 0.2 OUTLIER -126.74 -10.81 6.13 Favored 'General case' 0 N--CA 1.401 -2.919 0 CA-C-N 113.427 -1.715 . . . . 1.84 109.573 179.643 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 133' ' ' GLY . . . . . 0.925 ' HA2' ' CB ' ' B' ' 169' ' ' ALA . . . 53.97 -125.06 32.04 Favored Glycine 0 N--CA 1.414 -2.828 0 CA-C-O 116.212 -2.438 . . . . 0.76 112.29 177.247 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 134' ' ' CYS . . . . . 0.771 ' HB2' ' CD1' ' B' ' 172' ' ' ILE . 0.8 OUTLIER -141.09 125.9 18.06 Favored 'General case' 0 CA--C 1.496 -1.099 0 CA-C-N 121.693 2.746 . . . . 1.08 112.261 176.211 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 135' ' ' PHE . . . . . 0.726 ' CE1' HD22 ' B' ' 132' ' ' LEU . 1.2 m-85 -101.13 101.93 12.77 Favored 'General case' 0 N--CA 1.425 -1.724 0 N-CA-C 102.266 -3.235 . . . . 1.83 102.266 175.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 136' ' ' VAL . . . . . 1.048 HG11 HG12 ' B' ' 126' ' ' ILE . 3.1 t -92.53 91.92 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.345 0 CA-C-O 123.317 1.532 . . . . 1.29 110.28 -177.014 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 137' ' ' GLY . . . . . 0.933 ' HA3' ' CG2' ' A' ' 72' ' ' ILE . . . 85.48 79.88 1.14 Allowed Glycine 0 CA--C 1.507 -0.44 0 CA-C-N 111.941 -2.39 . . . . 0.85 112.998 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 138' ' ' THR . . . . . 0.734 HG23 ' O ' ' A' ' 32' ' ' LEU . 76.4 p -155.96 -159.96 0.96 Allowed 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.427 0.632 . . . . 1.2 111.582 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 139' ' ' ALA . . . . . 0.407 ' H ' ' HB ' ' B' ' 138' ' ' THR . . . -68.67 -41.39 79.35 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.459 -1.246 . . . . 1.35 108.353 176.071 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 140' ' ' GLU . . . . . 0.81 ' HG2' ' CA ' ' B' ' 114' ' ' GLY . 0.3 OUTLIER -54.1 -30.24 47.82 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.093 -1.412 . . . . 2.31 112.248 179.081 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 141' ' ' ALA . . . . . 0.479 ' O ' ' N ' ' B' ' 144' ' ' CYS . . . -88.85 -35.71 16.41 Favored 'General case' 0 C--O 1.207 -1.178 0 N-CA-C 110.3 -0.259 . . . . 1.09 110.3 -178.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 6.2 mt -39.04 -54.75 1.67 Allowed 'General case' 0 C--O 1.24 0.566 0 N-CA-C 113.832 1.049 . . . . 1.61 113.832 -173.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 143' ' ' ARG . . . . . 0.496 ' HD2' ' H ' ' B' ' 143' ' ' ARG . 0.0 OUTLIER -55.59 -22.09 20.46 Favored 'General case' 0 CA--C 1.497 -1.094 0 C-N-CA 120.037 -0.665 . . . . 3.43 109.851 177.81 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 144' ' ' CYS . . . . . 0.479 ' N ' ' O ' ' B' ' 141' ' ' ALA . 6.7 t -75.46 29.64 0.1 Allowed 'General case' 0 CA--C 1.497 -1.064 0 C-N-CA 119.763 -0.775 . . . . 1.61 111.529 -178.335 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -84.71 -22.37 29.76 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 106.516 -1.661 . . . . 3.52 106.516 175.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -82.07 9.35 8.65 Favored 'General case' 0 C--N 1.343 0.283 0 CA-C-N 115.314 -0.857 . . . . 3.76 110.106 178.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . 0.479 ' HB2' ' SG ' ' B' ' 144' ' ' CYS . 0.9 OUTLIER -81.4 -0.71 42.68 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.771 -0.455 . . . . 4.01 109.771 177.537 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 148' ' ' ASN . . . . . 0.751 ' H ' HD21 ' B' ' 148' ' ' ASN . 0.0 OUTLIER -77.02 -27.53 54.6 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 116.389 -0.369 . . . . 4.24 110.085 178.556 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -108.94 15.25 23.58 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.403 -0.362 . . . . 6.07 111.789 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 150' ' ' LEU . . . . . 0.486 HD23 HD11 ' B' ' 111' ' ' LEU . 0.5 OUTLIER -143.1 90.19 7.51 Favored Pre-proline 0 CA--C 1.533 0.307 0 N-CA-C 111.563 0.209 . . . . 5.86 111.563 -179.743 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 151' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -91.64 50.52 0.68 Allowed 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 122.742 2.295 . . . . 5.42 112.489 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.82 119.16 73.88 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 116.145 -0.48 . . . . 6.02 111.8 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 153' ' ' PRO . . . . . 0.723 ' CG ' HG12 ' B' ' 102' ' ' VAL . 90.3 Cg_endo -79.48 -48.18 0.08 OUTLIER 'Trans proline' 0 C--N 1.356 0.925 0 C-N-CA 122.303 2.002 . . . . 5.87 113.174 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 154' ' ' CYS . . . . . 0.858 ' HA ' ' CB ' ' B' ' 103' ' ' LEU . 5.4 p 55.27 123.6 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.702 0.801 . . . . 2.96 112.596 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 155' ' ' GLN . . . . . 0.968 HE21 HD13 ' B' ' 105' ' ' LEU . 0.0 OUTLIER -59.46 92.04 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 119.623 -0.831 . . . . 6.3 112.376 -179.678 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 156' ' ' SER . . . . . 0.677 ' HB2' ' HG3' ' B' ' 108' ' ' ARG . 0.2 OUTLIER 165.36 125.77 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 112.116 0.414 . . . . 3.41 112.116 178.903 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 157' ' ' GLY . . . . . 0.62 ' O ' ' HG3' ' B' ' 166' ' ' ARG . . . 105.13 33.0 3.84 Favored Glycine 0 CA--C 1.505 -0.593 0 C-N-CA 120.611 -0.804 . . . . 2.26 112.479 179.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -122.15 67.42 0.93 Allowed 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 121.655 0.74 . . . . 5.03 111.858 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 159' ' ' LYS . . . . . 0.924 ' HB2' ' HB2' ' B' ' 167' ' ' CYS . 2.0 mmtp -115.71 67.54 2.83 Favored Pre-proline 0 CA--C 1.539 0.529 0 CA-C-N 114.654 -1.157 . . . . 3.96 109.33 174.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 160' ' ' PRO . . . . . 0.584 ' HA ' ' O ' ' B' ' 165' ' ' GLY . 12.5 Cg_endo -56.33 82.92 0.04 OUTLIER 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 122.942 2.428 . . . . 1.7 118.14 -174.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 161' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -98.1 -171.53 2.17 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 106.347 -1.723 . . . . 1.93 106.347 173.443 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 65.35 -166.02 34.7 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 119.319 -1.42 . . . . 2.37 112.803 177.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 3.9 p -84.46 39.65 0.74 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.758 0.789 . . . . 4.56 110.313 -179.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 121.2 5.03 9.8 Favored Glycine 0 CA--C 1.535 1.284 0 CA-C-O 117.793 -1.559 . . . . 2.39 116.513 178.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 165' ' ' GLY . . . . . 0.584 ' O ' ' HA ' ' B' ' 160' ' ' PRO . . . -101.68 155.86 18.85 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-N 121.241 2.52 . . . . 1.79 114.093 -178.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 166' ' ' ARG . . . . . 0.62 ' HG3' ' O ' ' B' ' 157' ' ' GLY . 0.0 OUTLIER -98.42 151.74 20.25 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.034 0.383 . . . . 3.53 112.034 -179.084 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 167' ' ' CYS . . . . . 0.924 ' HB2' ' HB2' ' B' ' 159' ' ' LYS . 1.3 m -71.58 107.14 4.31 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 109.634 -0.506 . . . . 1.56 109.634 178.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 168' ' ' ALA . . . . . 0.805 ' HB2' ' HB2' ' B' ' 128' ' ' CYS . . . -94.18 -13.84 26.24 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.917 -0.771 . . . . 1.42 108.917 177.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 169' ' ' ALA . . . . . 0.925 ' CB ' ' HA2' ' B' ' 133' ' ' GLY . . . -168.24 163.67 13.1 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.503 -0.771 . . . . 1.18 111.036 -179.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 170' ' ' ALA . . . . . 0.646 ' HA ' ' O ' ' B' ' 185' ' ' CYS . . . -58.78 122.46 13.62 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 113.805 1.039 . . . . 1.47 113.805 -178.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 171' ' ' GLY . . . . . 0.792 ' HA2' ' O ' ' B' ' 182' ' ' ASP . . . 60.94 35.66 90.87 Favored Glycine 0 C--N 1.343 0.963 0 CA-C-N 115.221 -0.9 . . . . 1.45 111.292 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 172' ' ' ILE . . . . . 0.848 ' CG1' ' HB1' ' B' ' 169' ' ' ALA . 1.2 pp -151.6 97.91 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 113.805 -1.197 . . . . 2.7 111.629 173.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 173' ' ' CYS . . . . . 0.545 ' HB2' ' HB3' ' B' ' 182' ' ' ASP . 5.2 t -99.71 85.85 3.19 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.682 -1.144 . . . . 1.94 110.174 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 174' ' ' CYS . . . . . 1.057 ' HA ' ' HA ' ' B' ' 179' ' ' CYS . 1.8 m -93.85 146.07 24.16 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.023 0.44 . . . . 1.43 111.187 -179.11 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 175' ' ' SER . . . . . 0.902 ' HB2' ' HD2' ' B' ' 176' ' ' PRO . 54.0 p -109.65 -179.65 0.7 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.761 -0.654 . . . . 2.3 110.031 179.505 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 176' ' ' PRO . . . . . 0.902 ' HD2' ' HB2' ' B' ' 175' ' ' SER . 78.6 Cg_endo -77.61 29.38 0.43 Allowed 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 121.675 1.583 . . . . 2.13 111.483 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 177' ' ' ASP . . . . . 0.467 ' H ' ' C ' ' B' ' 175' ' ' SER . 0.6 OUTLIER -144.63 -29.42 0.47 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.178 -0.919 . . . . 2.72 110.142 179.425 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 178' ' ' GLY . . . . . 0.589 ' HA2' HD11 ' B' ' 126' ' ' ILE . . . -166.94 -145.75 4.6 Favored Glycine 0 CA--C 1.523 0.591 0 CA-C-N 115.944 -0.571 . . . . 1.05 112.571 179.73 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 179' ' ' CYS . . . . . 1.057 ' HA ' ' HA ' ' B' ' 174' ' ' CYS . 11.7 t -146.4 161.73 39.75 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 109.803 -0.443 . . . . 1.39 109.803 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 180' ' ' HIS . . . . . . . . . . . . . 54.7 m-70 -153.77 134.14 13.46 Favored 'General case' 0 CA--C 1.504 -0.8 0 C-N-CA 119.67 -0.812 . . . . 2.73 111.284 -176.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 181' ' ' GLU . . . . . 0.64 ' OE2' ' HD2' ' A' ' 24' ' ' PRO . 2.5 mt-10 -60.05 132.07 52.8 Favored 'General case' 0 CA--C 1.521 -0.147 0 N-CA-C 109.793 -0.447 . . . . 3.06 109.793 -178.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 182' ' ' ASP . . . . . 0.792 ' O ' ' HA2' ' B' ' 171' ' ' GLY . 0.1 OUTLIER -140.0 112.72 7.51 Favored Pre-proline 0 CA--C 1.545 0.783 0 CA-C-N 116.248 -0.433 . . . . 2.06 110.74 -178.514 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 183' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -70.91 -21.15 28.5 Favored 'Trans proline' 0 C--N 1.359 1.089 0 C-N-CA 122.845 2.363 . . . . 2.27 113.776 -178.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -63.8 -39.83 95.18 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.721 0.296 . . . . 1.56 111.551 -179.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 185' ' ' CYS . . . . . 0.646 ' O ' ' HA ' ' B' ' 170' ' ' ALA . 67.2 m -97.85 -0.84 44.37 Favored 'General case' 0 C--O 1.215 -0.741 0 N-CA-C 112.504 0.557 . . . . 1.94 112.504 -179.376 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 186' ' ' ASP . . . . . 0.529 ' CB ' ' HD3' ' B' ' 187' ' ' PRO . 0.8 OUTLIER -66.3 -56.16 17.19 Favored Pre-proline 0 C--N 1.321 -0.643 0 N-CA-C 112.953 0.723 . . . . 3.61 112.953 -176.583 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 187' ' ' PRO . . . . . 0.529 ' HD3' ' CB ' ' B' ' 186' ' ' ASP . 6.0 Cg_endo -87.54 -158.56 0.08 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 123.392 2.728 . . . . 3.14 114.333 -179.064 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 188' ' ' GLU . . . . . 0.575 ' C ' ' H ' ' B' ' 190' ' ' ALA . 0.0 OUTLIER -88.3 50.17 1.93 Allowed 'General case' 0 N--CA 1.407 -2.576 0 CA-C-N 111.241 -2.708 . . . . 4.7 107.877 168.506 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 189' ' ' ALA . . . . . . . . . . . . . . . -72.01 26.58 0.05 OUTLIER 'General case' 0 CA--C 1.549 0.91 0 CA-C-O 121.01 0.433 . . . . 5.24 110.54 176.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 190' ' ' ALA . . . . . 0.575 ' H ' ' C ' ' B' ' 188' ' ' GLU . . . -49.02 111.79 0.53 Allowed 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 113.619 0.97 . . . . 6.93 113.619 -175.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 191' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -87.45 128.17 35.22 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 114.959 -1.018 . . . . 10.62 111.429 179.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 10.9 m . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.253 -0.88 . . . . 11.7 111.326 179.481 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.242 0 N-CA-C 112.046 0.387 . . . . 10.31 112.046 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.582 ' O ' HG13 ' A' ' 2' ' ' VAL . 13.9 p -104.8 97.56 5.74 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.208 0 N-CA-C 113.592 0.96 . . . . 8.37 113.592 177.01 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.827 ' HB2' ' CG2' ' A' ' 9' ' ' THR . 0.4 OUTLIER -87.05 87.53 7.48 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 120.84 0.352 . . . . 6.25 111.032 178.007 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.18 104.28 7.59 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 107.479 -1.304 . . . . 6.22 107.479 176.125 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 1.037 ' HG ' ' HA ' ' A' ' 54' ' ' CYS . 2.2 tm? -154.25 -100.26 0.04 OUTLIER 'General case' 0 N--CA 1.418 -2.068 0 N-CA-C 106.301 -1.741 . . . . 7.57 106.301 178.267 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.613 ' HB2' ' O ' ' A' ' 5' ' ' LEU . 2.2 t70 166.74 40.27 0.0 OUTLIER 'General case' 0 C--N 1.272 -2.789 0 CA-C-N 113.655 -1.611 . . . . 8.78 107.105 177.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.675 HG22 ' H ' ' A' ' 8' ' ' ARG . 14.8 p -150.31 -174.54 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.902 0 N-CA-C 102.647 -3.094 . . . . 7.88 102.647 -178.404 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.675 ' H ' HG22 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -77.33 135.51 38.39 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 106.122 -1.807 . . . . 9.7 106.122 178.357 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.827 ' CG2' ' HB2' ' A' ' 3' ' ' LEU . 70.0 p -48.07 105.45 0.07 Allowed 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 123.339 1.543 . . . . 6.05 112.828 -174.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.803 ' N ' ' HG ' ' A' ' 3' ' ' LEU . 0.0 OUTLIER -31.19 112.4 0.09 Allowed 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 111.298 -2.683 . . . . 2.89 115.022 -179.504 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -34.36 132.95 0.41 Allowed Pre-proline 0 N--CA 1.481 1.093 0 C-N-CA 124.067 0.947 . . . . 2.89 113.312 177.592 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.839 ' HB2' ' O ' ' A' ' 17' ' ' GLY . 79.0 Cg_endo -87.89 136.46 3.66 Favored 'Trans proline' 0 C--N 1.356 0.933 0 C-N-CA 122.736 2.291 . . . . 1.72 112.784 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 1.038 ' HB2' ' HG3' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -140.97 -162.79 1.42 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 119.975 -0.69 . . . . 1.0 112.163 -179.285 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.476 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . 81.73 -156.27 36.38 Favored Glycine 0 C--N 1.339 0.741 0 CA-C-O 119.323 -0.709 . . . . 1.15 111.836 -178.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.771 ' HG2' ' HD2' ' A' ' 18' ' ' LYS . 42.5 Cg_endo -62.49 108.17 0.68 Allowed 'Trans proline' 0 N--CA 1.483 0.867 0 N-CA-C 105.466 -2.551 . . . . 1.6 105.466 176.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 76.85 -14.37 7.48 Favored Glycine 0 C--N 1.265 -3.372 0 CA-C-O 118.485 -1.175 . . . . 1.68 112.588 176.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.839 ' O ' ' HB2' ' A' ' 12' ' ' PRO . . . 75.37 49.41 9.36 Favored Glycine 0 N--CA 1.401 -3.651 0 C-N-CA 117.075 -2.488 . . . . 1.37 111.825 178.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 1.044 ' HD3' HD12 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -94.99 -12.88 25.89 Favored 'General case' 0 C--N 1.345 0.41 0 CA-C-N 110.358 -2.921 . . . . 2.91 113.142 177.636 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.833 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -115.98 -167.53 14.98 Favored Glycine 0 C--N 1.345 1.082 0 N-CA-C 106.099 -2.801 . . . . 1.06 106.099 178.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.656 ' HB3' ' HB3' ' A' ' 10' ' ' CYS . 1.5 mpt_? -115.08 173.42 6.5 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 122.0 2.9 . . . . 3.32 111.656 -178.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.64 ' HB3' ' HG3' ' A' ' 47' ' ' GLU . 1.2 m -106.25 151.25 25.04 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.882 0.372 . . . . 1.19 110.875 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -124.11 -46.82 1.93 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.117 -0.492 . . . . 2.26 110.776 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.475 ' HA2' ' OE1' ' A' ' 47' ' ' GLU . . . -137.91 -161.18 8.77 Favored Glycine 0 CA--C 1.519 0.321 0 N-CA-C 111.601 -0.6 . . . . 1.05 111.601 179.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -77.87 -63.19 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.071 1.848 . . . . 1.81 111.451 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.425 ' O ' ' N ' ' A' ' 37' ' ' GLY . 1.1 m -92.17 33.31 1.08 Allowed 'General case' 0 C--O 1.224 -0.238 0 CA-C-N 116.216 -0.447 . . . . 1.62 109.828 178.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 1.034 HG12 HG12 ' A' ' 36' ' ' VAL . 19.0 mt -149.29 121.34 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-O 121.208 0.528 . . . . 1.39 111.99 -178.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.582 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 6.9 t -140.15 124.7 18.05 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 108.472 -0.936 . . . . 0.92 108.472 179.374 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.786 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -138.05 121.72 17.46 Favored 'General case' 0 CA--C 1.551 1.016 0 N-CA-C 114.4 1.259 . . . . 1.28 114.4 -177.743 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.683 ' O ' ' HB1' ' A' ' 69' ' ' ALA . . . -102.82 -170.62 26.43 Favored Glycine 0 C--N 1.367 2.291 0 N-CA-C 110.098 -1.201 . . . . 0.71 110.098 176.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -65.85 -53.68 36.65 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 113.773 1.027 . . . . 2.27 113.773 -178.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.54 3.44 12.43 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 122.222 1.01 . . . . 1.66 110.966 -176.245 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 1.044 HD12 ' HD3' ' A' ' 18' ' ' LYS . 0.4 OUTLIER -96.94 -22.24 16.97 Favored 'General case' 0 N--CA 1.415 -2.222 0 CA-C-N 113.887 -1.506 . . . . 1.93 107.382 -178.595 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.851 ' HA2' ' CB ' ' A' ' 69' ' ' ALA . . . 76.49 -135.73 17.82 Favored Glycine 0 N--CA 1.41 -3.094 0 CA-C-O 117.727 -1.596 . . . . 0.77 112.256 176.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.867 ' HB2' ' CD1' ' A' ' 72' ' ' ILE . 3.2 t -140.34 121.76 15.04 Favored 'General case' 0 CA--C 1.498 -1.051 0 CA-C-N 119.582 1.691 . . . . 1.08 114.1 -179.064 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.74 ' CE1' HD21 ' A' ' 32' ' ' LEU . 1.8 m-85 -95.51 102.12 13.89 Favored 'General case' 0 N--CA 1.428 -1.536 0 N-CA-C 103.469 -2.789 . . . . 1.85 103.469 175.504 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 1.034 HG12 HG12 ' A' ' 26' ' ' ILE . 2.1 t -94.41 84.34 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.137 0 CA-C-O 123.344 1.545 . . . . 1.29 108.622 -178.409 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.876 ' HA3' HG21 ' B' ' 172' ' ' ILE . . . 95.13 79.62 1.47 Allowed Glycine 0 C--N 1.313 -0.699 0 CA-C-N 112.236 -2.256 . . . . 0.85 113.722 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.819 HG21 ' O ' ' A' ' 37' ' ' GLY . 58.2 p -159.96 177.9 10.28 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.743 -0.836 . . . . 1.3 108.743 179.118 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.589 ' O ' ' HB2' ' A' ' 42' ' ' LEU . . . -65.28 -25.01 67.45 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 119.023 0.829 . . . . 1.45 112.27 -178.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.457 ' CG ' ' HA2' ' A' ' 14' ' ' GLY . 0.8 OUTLIER -64.35 -24.76 67.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.854 0.359 . . . . 2.32 110.246 178.664 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.535 ' O ' ' HB2' ' A' ' 44' ' ' CYS . . . -85.46 -10.16 56.5 Favored 'General case' 0 C--O 1.219 -0.5 0 CA-C-N 115.868 -0.605 . . . . 1.11 110.347 178.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.589 ' HB2' ' O ' ' A' ' 39' ' ' ALA . 1.1 mt -53.29 -41.83 65.98 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 121.982 -0.449 . . . . 1.68 112.156 -178.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 1.038 ' HG3' ' HB2' ' A' ' 13' ' ' CYS . 5.0 ptm180 -70.78 -16.96 62.79 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 121.788 0.804 . . . . 3.4 109.299 176.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.535 ' HB2' ' O ' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -57.67 -18.83 22.77 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 114.023 -1.444 . . . . 1.57 110.107 -178.27 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -50.62 -25.82 4.66 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.769 -0.65 . . . . 3.49 111.118 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -83.09 8.33 13.28 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.159 0.504 . . . . 3.69 110.375 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.669 ' O ' HD11 ' A' ' 50' ' ' LEU . 6.0 tm-20 -79.64 1.35 26.58 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.751 -0.659 . . . . 3.99 109.349 177.276 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 68.8 m-20 -69.86 -29.39 66.62 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 116.14 -0.482 . . . . 4.2 110.281 178.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -72.85 3.87 4.75 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 112.209 0.448 . . . . 5.85 112.209 -179.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.669 HD11 ' O ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -156.9 110.92 1.95 Allowed Pre-proline 0 CA--C 1.534 0.34 0 O-C-N 122.456 -0.152 . . . . 5.83 110.715 178.625 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -99.19 18.74 0.37 Allowed 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 122.996 2.464 . . . . 5.3 113.827 -178.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.953 ' HG ' ' HD2' ' A' ' 53' ' ' PRO . 3.8 t -126.46 151.14 72.3 Favored Pre-proline 0 C--N 1.33 -0.248 0 C-N-CA 121.177 -0.209 . . . . 5.72 111.413 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.953 ' HD2' ' HG ' ' A' ' 52' ' ' SER . 48.0 Cg_endo -68.18 158.07 59.06 Favored 'Trans proline' 0 C--N 1.356 0.959 0 C-N-CA 122.196 1.93 . . . . 5.82 111.86 179.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 1.037 ' HA ' ' HG ' ' A' ' 5' ' ' LEU . 1.7 m -132.0 -169.2 2.17 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.714 0.293 . . . . 2.98 111.278 -179.259 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.489 ' N ' ' HB2' ' A' ' 5' ' ' LEU . 0.3 OUTLIER 54.76 170.58 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.36 -0.382 . . . . 6.42 111.924 -179.961 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.434 ' H ' ' HG3' ' A' ' 55' ' ' GLN . 43.0 p -153.58 -164.66 1.95 Allowed 'General case' 0 CA--C 1.544 0.744 0 CA-C-O 121.385 0.612 . . . . 3.36 112.394 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 120.29 -88.26 0.43 Allowed Glycine 0 N--CA 1.464 0.54 0 CA-C-N 114.646 -1.161 . . . . 2.3 114.016 177.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.89 ' O ' ' HB3' ' A' ' 67' ' ' CYS . 41.1 mt-30 -124.16 104.49 8.87 Favored 'General case' 0 CA--C 1.489 -1.404 0 N-CA-C 102.946 -2.983 . . . . 5.06 102.946 177.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 1.051 ' HB3' ' HB3' ' A' ' 66' ' ' ARG . 6.6 mmmt -128.68 -68.12 0.02 OUTLIER Pre-proline 0 C--N 1.314 -0.949 0 C-N-CA 118.532 -1.267 . . . . 3.91 112.812 -173.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.659 ' CD ' ' HB2' ' A' ' 59' ' ' LYS . 15.0 Cg_endo -57.08 114.97 2.17 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 CA-C-N 121.534 1.584 . . . . 1.74 115.354 -177.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -144.53 -165.36 2.12 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 111.133 -2.758 . . . . 1.9 104.494 178.159 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 47.24 -165.37 0.13 Allowed Glycine 0 N--CA 1.467 0.741 0 CA-C-N 121.283 1.856 . . . . 2.43 114.611 175.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 4.4 p -87.95 39.43 0.89 Allowed 'General case' 0 N--CA 1.479 1.016 0 CA-C-O 121.997 0.903 . . . . 4.32 110.482 -177.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 121.11 15.46 4.69 Favored Glycine 0 CA--C 1.558 2.732 0 CA-C-N 113.981 -1.463 . . . . 2.4 114.696 -175.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -101.14 146.02 17.21 Favored Glycine 0 N--CA 1.474 1.184 0 CA-C-N 119.913 1.856 . . . . 1.82 114.914 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 1.051 ' HB3' ' HB3' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -89.73 152.53 21.28 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 109.375 -0.602 . . . . 3.51 109.375 177.965 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 1.05 ' H ' ' HA ' ' A' ' 59' ' ' LYS . 36.1 t -73.47 107.53 5.81 Favored 'General case' 0 N--CA 1.407 -2.588 0 N-CA-C 108.736 -0.839 . . . . 1.52 108.736 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 1.092 ' HB1' ' HB2' ' A' ' 74' ' ' CYS . . . -71.58 -28.23 63.68 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.919 -0.771 . . . . 1.5 108.919 179.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.851 ' CB ' ' HA2' ' A' ' 33' ' ' GLY . . . -168.78 163.46 11.84 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.367 -1.288 . . . . 1.31 110.498 -176.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 1.08 ' HA ' ' HB3' ' A' ' 85' ' ' CYS . . . -55.05 122.41 10.89 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 116.111 -0.495 . . . . 1.5 112.119 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.568 ' H ' ' CB ' ' A' ' 85' ' ' CYS . . . 58.38 35.77 80.66 Favored Glycine 0 C--N 1.351 1.416 0 N-CA-C 110.904 -0.878 . . . . 1.44 110.904 -178.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 1.068 HG21 ' HA3' ' B' ' 137' ' ' GLY . 1.5 pp -154.71 97.79 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.644 0 N-CA-C 107.989 -1.115 . . . . 2.77 107.989 169.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.666 ' HB2' ' HB3' ' A' ' 82' ' ' ASP . 0.1 OUTLIER -91.48 106.33 18.42 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 112.21 0.448 . . . . 1.98 112.21 -177.319 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 1.092 ' HB2' ' HB1' ' A' ' 68' ' ' ALA . 0.6 OUTLIER -93.84 123.77 37.41 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.526 0.679 . . . . 1.43 111.663 179.754 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.88 ' HB2' ' HD2' ' A' ' 76' ' ' PRO . 36.2 p -93.26 -178.7 0.89 Allowed Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.102 -0.954 . . . . 2.37 109.035 178.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.88 ' HD2' ' HB2' ' A' ' 75' ' ' SER . 74.0 Cg_endo -76.11 29.28 0.39 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 121.328 1.352 . . . . 2.09 111.517 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.697 ' HB3' ' CE1' ' B' ' 180' ' ' HIS . 1.7 m-20 -145.78 -43.9 0.21 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.418 -0.81 . . . . 2.65 110.809 179.445 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.519 ' HA3' ' HA ' ' B' ' 180' ' ' HIS . . . -158.32 -141.61 3.19 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 120.74 -0.743 . . . . 1.04 113.128 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.752 ' HA ' ' HA ' ' A' ' 74' ' ' CYS . 0.1 OUTLIER -134.82 157.76 45.94 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.55 0.215 . . . . 1.42 110.505 -179.949 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.653 ' CE1' ' HB3' ' B' ' 177' ' ' ASP . 2.8 t60 -152.28 135.11 15.52 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 109.432 -0.581 . . . . 2.81 109.432 -176.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.8 132.19 53.19 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 109.295 -0.631 . . . . 3.05 109.295 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.666 ' HB3' ' HB2' ' A' ' 73' ' ' CYS . 1.2 p-10 -140.64 133.56 14.65 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 120.911 -0.315 . . . . 2.02 111.581 -177.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.716 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 5.7 Cg_exo -79.51 -12.16 14.01 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 122.737 2.292 . . . . 2.29 113.103 -179.28 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.8 -41.74 97.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.783 0.325 . . . . 1.53 110.944 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 1.08 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 21.5 m -99.88 22.67 10.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.156 0.503 . . . . 1.88 110.919 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.597 ' N ' ' CD ' ' A' ' 87' ' ' PRO . 0.5 OUTLIER -103.08 -22.21 0.2 Allowed Pre-proline 0 CA--C 1.512 -0.483 0 N-CA-C 113.887 1.069 . . . . 3.6 113.887 179.085 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.716 ' HD3' ' O ' ' A' ' 83' ' ' PRO . 72.2 Cg_exo -46.12 119.97 3.33 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 121.399 1.4 . . . . 3.12 111.199 177.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 2.21 48.19 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 128.299 2.639 . . . . 4.72 113.387 -172.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.637 ' N ' ' O ' ' A' ' 87' ' ' PRO . . . -67.58 0.19 3.34 Favored 'General case' 0 CA--C 1.499 -0.994 0 CA-C-N 111.697 -2.501 . . . . 5.29 113.747 -171.591 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.88 140.22 58.79 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 118.438 -1.305 . . . . 7.19 110.813 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -102.34 67.57 1.04 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.128 -0.693 . . . . 10.7 109.128 176.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.248 0.99 0 CA-C-O 118.284 -0.865 . . . . 11.77 111.039 -178.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.182 0 CA-C-O 120.781 0.324 . . . . 10.42 111.35 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 11.5 t 60.44 55.1 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 CA-C-O 122.673 1.225 . . . . 8.81 112.671 176.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 103' ' ' LEU . . . . . 0.843 ' HB2' ' CG2' ' B' ' 109' ' ' THR . 0.4 OUTLIER -79.3 94.1 5.41 Favored 'General case' 0 C--N 1.344 0.333 0 CA-C-N 112.958 -1.928 . . . . 6.28 110.918 179.634 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 104' ' ' ASP . . . . . 0.605 ' HB3' ' OG ' ' B' ' 156' ' ' SER . 0.7 OUTLIER -82.48 101.59 10.79 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 106.714 -1.588 . . . . 6.27 106.714 177.176 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . 1.091 ' HG ' ' HA ' ' B' ' 154' ' ' CYS . 2.4 tm? -158.57 -126.11 0.02 OUTLIER 'General case' 1 N--CA 1.369 -4.485 0 C-N-CA 128.364 2.666 . . . . 7.61 104.621 -179.775 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 106' ' ' ASP . . . . . 0.758 ' H ' HD11 ' B' ' 105' ' ' LEU . 3.9 t70 -176.41 50.13 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 104.816 -2.29 . . . . 8.55 104.816 -177.205 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 107' ' ' VAL . . . . . 0.911 HG23 ' H ' ' B' ' 108' ' ' ARG . 9.9 p -154.17 -177.3 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.403 -2.793 0 CA-C-N 112.016 -2.356 . . . . 7.84 106.46 178.261 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 108' ' ' ARG . . . . . 0.911 ' H ' HG23 ' B' ' 107' ' ' VAL . 0.0 OUTLIER -79.67 129.59 34.61 Favored 'General case' 0 N--CA 1.405 -2.7 0 N-CA-C 107.086 -1.45 . . . . 9.75 107.086 176.183 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 109' ' ' THR . . . . . 0.843 ' CG2' ' HB2' ' B' ' 103' ' ' LEU . 47.0 p -39.46 103.74 0.03 OUTLIER 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 122.971 1.367 . . . . 6.13 113.35 -176.298 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 110' ' ' CYS . . . . . 0.752 ' N ' ' HG ' ' B' ' 103' ' ' LEU . 0.0 OUTLIER -32.13 111.69 0.09 Allowed 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 111.929 -2.396 . . . . 2.87 115.381 -179.797 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -33.77 133.07 0.37 Allowed Pre-proline 0 N--CA 1.485 1.307 0 C-N-CA 123.979 0.912 . . . . 2.95 113.294 177.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 112' ' ' PRO . . . . . 0.824 ' HB2' ' O ' ' B' ' 117' ' ' GLY . 54.0 Cg_endo -92.3 129.09 0.95 Allowed 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.509 2.139 . . . . 1.71 115.253 -179.141 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 1.079 ' HB2' ' HG3' ' B' ' 143' ' ' ARG . 0.0 OUTLIER -133.65 -159.78 0.99 Allowed 'General case' 0 C--N 1.359 1.017 0 C-N-CA 119.473 -0.891 . . . . 1.0 111.299 -175.525 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 114' ' ' GLY . . . . . 0.474 ' N ' ' SG ' ' B' ' 113' ' ' CYS . . . 80.71 -156.91 39.16 Favored Glycine 0 C--N 1.334 0.443 0 CA-C-N 118.613 0.642 . . . . 1.16 111.558 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 115' ' ' PRO . . . . . 0.775 ' HG2' ' HD2' ' B' ' 118' ' ' LYS . 56.6 Cg_endo -65.24 88.59 0.2 Allowed 'Trans proline' 0 N--CA 1.458 -0.58 0 CA-C-N 119.523 1.662 . . . . 1.6 114.177 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 87.51 -3.83 86.21 Favored Glycine 0 C--N 1.265 -3.372 0 CA-C-N 112.056 -2.338 . . . . 1.7 114.202 -176.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 117' ' ' GLY . . . . . 0.824 ' O ' ' HB2' ' B' ' 112' ' ' PRO . . . 75.05 47.58 13.09 Favored Glycine 0 N--CA 1.412 -2.931 0 C-N-CA 118.966 -1.588 . . . . 1.38 113.497 175.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 118' ' ' LYS . . . . . 1.098 ' HD3' HD12 ' B' ' 132' ' ' LEU . 0.0 OUTLIER -90.72 -23.27 20.75 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 112.134 -2.033 . . . . 2.96 111.237 178.96 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 119' ' ' GLY . . . . . 0.791 ' O ' ' HA ' ' B' ' 112' ' ' PRO . . . -101.36 -160.94 27.18 Favored Glycine 0 N--CA 1.478 1.477 0 CA-C-O 117.274 -1.848 . . . . 1.07 109.242 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.641 ' HB3' ' HB3' ' B' ' 110' ' ' CYS . 1.3 mpt_? -124.0 172.83 8.66 Favored 'General case' 0 C--N 1.353 0.728 0 CA-C-N 122.238 3.019 . . . . 3.29 109.329 177.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 121' ' ' CYS . . . . . 0.618 ' HB3' ' HG3' ' B' ' 147' ' ' GLU . 1.2 m -106.11 151.44 24.7 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.927 0.394 . . . . 1.21 111.139 -179.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -124.16 -46.81 1.92 Allowed 'General case' 0 C--N 1.334 -0.101 0 CA-C-N 116.04 -0.527 . . . . 2.28 110.754 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 123' ' ' GLY . . . . . 0.49 ' HA2' ' OE1' ' B' ' 147' ' ' GLU . . . -137.98 -161.19 8.76 Favored Glycine 0 CA--C 1.52 0.374 0 N-CA-C 111.637 -0.585 . . . . 1.04 111.637 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -77.77 -63.21 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.033 1.822 . . . . 1.84 111.538 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 125' ' ' SER . . . . . 0.423 ' O ' ' N ' ' B' ' 137' ' ' GLY . 1.1 m -92.05 33.27 1.07 Allowed 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.845 -0.428 . . . . 1.49 109.845 178.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 126' ' ' ILE . . . . . 1.034 HG12 HG12 ' B' ' 136' ' ' VAL . 23.0 mt -149.01 121.23 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 CA-C-O 121.082 0.468 . . . . 1.41 112.111 -178.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 127' ' ' CYS . . . . . 0.572 ' O ' ' HA ' ' B' ' 134' ' ' CYS . 6.6 t -140.34 124.33 17.48 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 108.404 -0.962 . . . . 0.89 108.404 179.217 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 128' ' ' CYS . . . . . 0.794 ' HA ' ' O ' ' B' ' 133' ' ' GLY . 0.0 OUTLIER -137.43 120.95 17.17 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 114.235 1.198 . . . . 1.23 114.235 -177.731 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 129' ' ' GLY . . . . . 0.728 ' O ' ' HB1' ' B' ' 169' ' ' ALA . . . -103.67 -167.65 25.39 Favored Glycine 0 C--N 1.369 2.395 0 CA-C-N 120.148 1.34 . . . . 0.69 109.885 176.388 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -65.72 -55.07 19.32 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 114.148 1.166 . . . . 2.35 114.148 -177.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -124.06 21.7 8.88 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 121.691 0.758 . . . . 1.69 109.955 -177.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 132' ' ' LEU . . . . . 1.098 HD12 ' HD3' ' B' ' 118' ' ' LYS . 0.4 OUTLIER -112.18 -21.19 11.59 Favored 'General case' 0 N--CA 1.411 -2.417 0 N-CA-C 104.783 -2.303 . . . . 1.84 104.783 179.24 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 133' ' ' GLY . . . . . 0.891 ' HA2' ' CB ' ' B' ' 169' ' ' ALA . . . 75.41 -134.73 17.13 Favored Glycine 1 N--CA 1.393 -4.226 0 CA-C-O 117.07 -1.961 . . . . 0.76 112.499 174.503 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 134' ' ' CYS . . . . . 0.859 ' HB2' ' CD1' ' B' ' 172' ' ' ILE . 3.1 t -140.75 121.78 14.63 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 120.262 2.031 . . . . 1.08 114.488 -178.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 135' ' ' PHE . . . . . 0.76 ' CZ ' HG22 ' A' ' 38' ' ' THR . 4.1 m-85 -95.16 101.77 13.54 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 103.707 -2.701 . . . . 1.83 103.707 175.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 136' ' ' VAL . . . . . 1.034 HG12 HG12 ' B' ' 126' ' ' ILE . 2.3 t -94.36 83.83 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.076 0 CA-C-O 123.364 1.554 . . . . 1.29 108.597 -178.415 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 137' ' ' GLY . . . . . 1.068 ' HA3' HG21 ' A' ' 72' ' ' ILE . . . 95.19 79.55 1.46 Allowed Glycine 0 C--N 1.313 -0.697 0 CA-C-N 112.145 -2.298 . . . . 0.85 113.643 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 138' ' ' THR . . . . . 0.695 HG22 ' CZ ' ' A' ' 35' ' ' PHE . 51.2 p -158.12 -179.05 7.75 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.7 -0.852 . . . . 1.2 108.7 179.074 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 139' ' ' ALA . . . . . 0.583 ' O ' ' HB2' ' B' ' 142' ' ' LEU . . . -68.37 -24.78 64.83 Favored 'General case' 0 C--N 1.338 0.109 0 CA-C-N 119.18 0.9 . . . . 1.35 111.934 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 140' ' ' GLU . . . . . 0.449 ' CG ' ' HA2' ' B' ' 114' ' ' GLY . 0.8 OUTLIER -63.98 -25.18 68.01 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.236 -0.438 . . . . 2.31 110.195 178.643 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 141' ' ' ALA . . . . . 0.527 ' O ' ' HB2' ' B' ' 144' ' ' CYS . . . -84.72 -11.22 56.29 Favored 'General case' 0 C--O 1.219 -0.538 0 CA-C-N 115.941 -0.572 . . . . 1.09 110.27 178.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 142' ' ' LEU . . . . . 0.583 ' HB2' ' O ' ' B' ' 139' ' ' ALA . 1.1 mt -52.83 -42.09 64.82 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.312 0.486 . . . . 1.61 112.312 -178.018 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 143' ' ' ARG . . . . . 1.079 ' HG3' ' HB2' ' B' ' 113' ' ' CYS . 4.4 ptm180 -68.1 -21.57 64.95 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 108.613 -0.884 . . . . 3.43 108.613 176.299 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 144' ' ' CYS . . . . . 0.527 ' HB2' ' O ' ' B' ' 141' ' ' ALA . 0.1 OUTLIER -56.81 -13.84 2.91 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 113.743 -1.571 . . . . 1.61 110.482 -175.867 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -54.61 -24.93 23.52 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-O 121.242 0.544 . . . . 3.52 111.05 178.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -82.99 8.42 12.77 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 120.473 -0.491 . . . . 3.76 110.213 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . 0.851 ' HG2' HD11 ' B' ' 150' ' ' LEU . 6.0 tm-20 -79.58 1.34 26.36 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.821 -0.627 . . . . 4.01 109.375 177.177 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 148' ' ' ASN . . . . . . . . . . . . . 68.9 m-20 -69.85 -29.47 66.73 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 116.183 -0.462 . . . . 4.24 110.259 178.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -72.79 3.92 4.65 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.237 0.458 . . . . 6.07 112.237 -179.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 150' ' ' LEU . . . . . 0.851 HD11 ' HG2' ' B' ' 147' ' ' GLU . 0.0 OUTLIER -156.95 110.96 1.94 Allowed Pre-proline 0 CA--C 1.534 0.365 0 CA-C-O 120.423 0.154 . . . . 5.86 110.602 178.652 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 151' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -99.21 18.79 0.36 Allowed 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 123.024 2.482 . . . . 5.42 113.832 -178.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 152' ' ' SER . . . . . 0.714 ' HG ' ' HD2' ' B' ' 153' ' ' PRO . 3.8 t -126.54 151.18 72.57 Favored Pre-proline 0 C--N 1.329 -0.315 0 C-N-CA 121.185 -0.206 . . . . 6.02 111.366 -179.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 153' ' ' PRO . . . . . 0.714 ' HD2' ' HG ' ' B' ' 152' ' ' SER . 47.4 Cg_endo -68.44 158.18 58.72 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 122.117 1.878 . . . . 5.87 111.798 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 154' ' ' CYS . . . . . 1.091 ' HA ' ' HG ' ' B' ' 105' ' ' LEU . 1.7 m -132.66 -170.49 2.45 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.789 0.328 . . . . 2.96 111.128 -179.255 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 155' ' ' GLN . . . . . 0.414 ' HG3' ' H ' ' B' ' 156' ' ' SER . 0.3 OUTLIER 56.37 169.17 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.307 -0.406 . . . . 6.3 111.664 179.969 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 156' ' ' SER . . . . . 0.605 ' OG ' ' HB3' ' B' ' 104' ' ' ASP . 34.5 p -151.72 -162.97 1.64 Allowed 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 112.147 0.425 . . . . 3.41 112.147 -179.046 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 120.48 -92.33 0.51 Allowed Glycine 0 C--N 1.339 0.743 0 C-N-CA 120.834 -0.698 . . . . 2.26 113.286 178.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 158' ' ' GLN . . . . . 0.94 ' O ' ' HB3' ' B' ' 167' ' ' CYS . 41.1 mt-30 -124.55 89.67 3.11 Favored 'General case' 0 CA--C 1.493 -1.237 0 N-CA-C 105.246 -2.131 . . . . 5.03 105.246 178.304 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 159' ' ' LYS . . . . . 1.058 ' HB3' ' HB3' ' B' ' 166' ' ' ARG . 6.5 mmmt -105.58 -73.69 0.02 OUTLIER Pre-proline 0 C--N 1.308 -1.232 0 N-CA-C 116.28 1.956 . . . . 3.96 116.28 -175.491 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 160' ' ' PRO . . . . . 0.625 ' CD ' ' HB2' ' B' ' 159' ' ' LYS . 14.6 Cg_endo -57.21 115.05 2.22 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 N-CA-C 116.037 1.514 . . . . 1.7 116.037 -174.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 161' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -145.57 -168.75 3.05 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 110.911 -2.859 . . . . 1.93 104.374 177.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 50.01 -165.66 0.5 Allowed Glycine 0 CA--C 1.525 0.7 0 CA-C-N 120.62 1.554 . . . . 2.37 113.882 177.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 7.3 p -88.25 39.63 0.91 Allowed 'General case' 0 N--CA 1.482 1.152 0 CA-C-O 122.491 1.138 . . . . 4.56 110.962 -178.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 123.02 12.8 4.7 Favored Glycine 0 CA--C 1.557 2.663 0 CA-C-N 113.351 -1.75 . . . . 2.39 114.857 -178.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -99.92 146.08 17.66 Favored Glycine 0 N--CA 1.471 1.02 0 CA-C-N 120.795 2.297 . . . . 1.79 115.046 -177.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 166' ' ' ARG . . . . . 1.058 ' HB3' ' HB3' ' B' ' 159' ' ' LYS . 0.0 OUTLIER -89.51 152.28 21.52 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 109.302 -0.629 . . . . 3.53 109.302 178.612 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 167' ' ' CYS . . . . . 0.94 ' HB3' ' O ' ' B' ' 158' ' ' GLN . 33.6 t -73.77 107.75 6.2 Favored 'General case' 0 N--CA 1.406 -2.628 0 N-CA-C 108.683 -0.858 . . . . 1.56 108.683 -179.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 168' ' ' ALA . . . . . 1.045 ' HB3' ' HB2' ' B' ' 174' ' ' CYS . . . -73.68 -24.18 59.92 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 119.699 -0.801 . . . . 1.42 109.438 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 169' ' ' ALA . . . . . 0.891 ' CB ' ' HA2' ' B' ' 133' ' ' GLY . . . -171.47 163.48 6.81 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 108.554 -0.906 . . . . 1.18 108.554 -178.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 170' ' ' ALA . . . . . 1.054 ' HA ' ' HB3' ' B' ' 185' ' ' CYS . . . -55.43 125.56 21.42 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 120.89 0.376 . . . . 1.47 111.974 179.263 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 171' ' ' GLY . . . . . 0.531 ' H ' ' CB ' ' B' ' 185' ' ' CYS . . . 79.27 -7.45 52.64 Favored Glycine 0 C--O 1.224 -0.513 0 C-N-CA 120.376 -0.916 . . . . 1.45 114.063 178.301 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 172' ' ' ILE . . . . . 0.876 HG21 ' HA3' ' A' ' 37' ' ' GLY . 1.6 pp -132.36 100.78 4.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-O 121.89 0.852 . . . . 2.7 110.59 -175.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 173' ' ' CYS . . . . . 0.684 ' HB2' ' HB3' ' B' ' 182' ' ' ASP . 0.1 OUTLIER -91.13 105.88 18.12 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 115.498 -0.774 . . . . 1.94 112.282 -177.811 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 174' ' ' CYS . . . . . 1.045 ' HB2' ' HB3' ' B' ' 168' ' ' ALA . 0.6 OUTLIER -93.94 123.81 37.54 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.535 0.683 . . . . 1.43 111.734 179.651 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 175' ' ' SER . . . . . 0.933 ' HB2' ' HD2' ' B' ' 176' ' ' PRO . 36.1 p -93.31 -178.71 0.89 Allowed Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.114 -0.948 . . . . 2.3 109.071 178.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 176' ' ' PRO . . . . . 0.933 ' HD2' ' HB2' ' B' ' 175' ' ' SER . 73.9 Cg_endo -76.08 29.2 0.39 Allowed 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 121.388 1.392 . . . . 2.13 111.481 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 177' ' ' ASP . . . . . 0.653 ' HB3' ' CE1' ' A' ' 80' ' ' HIS . 1.6 m-20 -145.74 -43.94 0.21 Allowed 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 115.489 -0.778 . . . . 2.72 110.798 179.431 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 178' ' ' GLY . . . . . 0.5 ' HA3' ' HA ' ' A' ' 80' ' ' HIS . . . -158.27 -141.52 3.17 Favored Glycine 0 CA--C 1.522 0.512 0 C-N-CA 120.776 -0.726 . . . . 1.05 113.137 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 179' ' ' CYS . . . . . 0.739 ' HA ' ' HA ' ' B' ' 174' ' ' CYS . 0.1 OUTLIER -134.5 160.27 38.53 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 110.424 -0.213 . . . . 1.39 110.424 -179.986 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 180' ' ' HIS . . . . . 0.697 ' CE1' ' HB3' ' A' ' 77' ' ' ASP . 2.9 t60 -156.21 134.05 11.12 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 109.886 -0.412 . . . . 2.73 109.886 -176.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 181' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.02 131.88 52.37 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 109.414 -0.588 . . . . 3.06 109.414 -179.08 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 182' ' ' ASP . . . . . 0.684 ' HB3' ' HB2' ' B' ' 173' ' ' CYS . 1.2 p-10 -140.47 133.54 14.83 Favored Pre-proline 0 CA--C 1.541 0.602 0 C-N-CA 120.937 -0.305 . . . . 2.06 111.701 -177.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 183' ' ' PRO . . . . . 0.743 ' O ' ' HD3' ' B' ' 187' ' ' PRO . 5.9 Cg_exo -79.51 -12.11 14.03 Favored 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 122.684 2.256 . . . . 2.27 113.065 -179.236 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -63.65 -41.61 98.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.836 0.35 . . . . 1.56 111.026 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 185' ' ' CYS . . . . . 1.054 ' HB3' ' HA ' ' B' ' 170' ' ' ALA . 26.7 m -99.7 22.38 11.04 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.153 -0.476 . . . . 1.94 111.293 179.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 186' ' ' ASP . . . . . 0.602 ' N ' ' CD ' ' B' ' 187' ' ' PRO . 0.5 OUTLIER -103.28 -22.32 0.2 Allowed Pre-proline 0 CA--C 1.504 -0.82 0 N-CA-C 113.927 1.084 . . . . 3.61 113.927 179.136 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 187' ' ' PRO . . . . . 0.743 ' HD3' ' O ' ' B' ' 183' ' ' PRO . 81.5 Cg_exo -46.44 117.08 1.82 Allowed 'Trans proline' 0 N--CA 1.454 -0.802 0 CA-C-N 120.531 1.225 . . . . 3.14 111.457 177.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 2.15 57.26 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.349 0 C-N-CA 128.769 2.827 . . . . 4.7 110.032 -176.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 189' ' ' ALA . . . . . 0.558 ' N ' ' O ' ' B' ' 187' ' ' PRO . . . -74.85 -1.55 22.76 Favored 'General case' 0 CA--C 1.488 -1.409 0 CA-C-N 109.338 -3.574 . . . . 5.24 112.836 -175.367 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 190' ' ' ALA . . . . . . . . . . . . . . . -61.37 143.83 55.09 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 116.748 -1.981 . . . . 6.93 110.032 -176.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 191' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -103.15 68.19 0.97 Allowed 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.077 -0.712 . . . . 10.62 109.077 174.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.17 -0.919 . . . . 11.7 111.189 -178.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.674 ' O ' ' CG2' ' A' ' 2' ' ' VAL . . . . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 118.435 -0.793 . . . . 10.31 112.76 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.674 ' CG2' ' O ' ' A' ' 1' ' ' ALA . 16.2 m 125.88 88.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 CA-C-O 121.9 0.857 . . . . 8.37 109.802 -179.409 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.854 ' HA ' ' CB ' ' A' ' 55' ' ' GLN . 0.1 OUTLIER -154.06 71.59 0.86 Allowed 'General case' 0 CA--C 1.51 -0.595 0 CA-C-N 114.507 -1.224 . . . . 6.25 110.01 179.668 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.651 ' N ' ' HA ' ' A' ' 55' ' ' GLN . 1.7 t70 -62.98 -2.75 1.32 Allowed 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 112.629 0.603 . . . . 6.22 112.629 -177.102 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.734 ' O ' ' HB2' ' A' ' 6' ' ' ASP . 2.9 tm? -96.39 -73.13 0.61 Allowed 'General case' 0 N--CA 1.418 -2.056 0 N-CA-C 107.125 -1.435 . . . . 7.57 107.125 176.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.734 ' HB2' ' O ' ' A' ' 5' ' ' LEU . 0.8 OUTLIER 155.87 -21.0 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 111.108 -2.769 . . . . 8.78 110.317 179.762 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.668 ' N ' HD13 ' A' ' 3' ' ' LEU . 14.6 p -157.04 126.94 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 N-CA-C 101.923 -3.362 . . . . 7.88 101.923 177.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 1.029 ' HB2' ' HG2' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -74.17 110.14 8.22 Favored 'General case' 0 N--CA 1.404 -2.775 0 N-CA-C 107.503 -1.295 . . . . 9.7 107.503 -175.948 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.6 m -104.4 94.85 5.56 Favored 'General case' 0 N--CA 1.396 -3.138 0 N-CA-C 101.898 -3.371 . . . . 6.05 101.898 171.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 1.04 ' HB3' ' HG2' ' A' ' 20' ' ' ARG . 0.6 OUTLIER -83.16 103.76 12.82 Favored 'General case' 0 C--N 1.288 -2.103 0 CA-C-N 112.754 -2.021 . . . . 2.89 112.154 178.275 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.735 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 4.3 mm? -30.68 108.48 0.26 Allowed Pre-proline 0 N--CA 1.474 0.751 0 CA-C-N 119.208 0.913 . . . . 2.89 110.408 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.725 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 49.4 Cg_endo -100.0 114.42 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 123.085 2.523 . . . . 1.72 114.58 -177.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.746 ' HB2' ' HB3' ' A' ' 43' ' ' ARG . 0.1 OUTLIER -132.97 -157.77 0.84 Allowed 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 119.759 -0.162 . . . . 1.0 110.582 -178.465 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.612 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . 80.62 -158.77 41.63 Favored Glycine 0 CA--C 1.507 -0.409 0 CA-C-O 118.564 -1.131 . . . . 1.15 111.202 -177.299 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.475 ' HD3' ' CG ' ' A' ' 40' ' ' GLU . 84.4 Cg_endo -64.77 84.02 0.17 Allowed 'Trans proline' 0 CA--C 1.515 -0.474 0 CA-C-N 121.122 2.461 . . . . 1.6 115.035 -176.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.07 1.33 84.67 Favored Glycine 0 C--N 1.283 -2.388 0 CA-C-N 111.621 -2.536 . . . . 1.68 114.474 -178.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.625 ' O ' ' HB2' ' A' ' 12' ' ' PRO . . . 85.87 42.73 6.65 Favored Glycine 0 N--CA 1.431 -1.659 0 N-CA-C 117.38 1.712 . . . . 1.37 117.38 174.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -94.63 -14.94 24.43 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-N 114.443 -0.878 . . . . 2.91 111.799 175.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.725 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -107.7 179.39 21.93 Favored Glycine 0 N--CA 1.468 0.807 0 N-CA-C 109.478 -1.449 . . . . 1.06 109.478 -179.338 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 1.04 ' HG2' ' HB3' ' A' ' 10' ' ' CYS . 0.3 OUTLIER -120.34 174.01 6.78 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 120.833 2.316 . . . . 3.32 110.982 179.021 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 12.7 m -107.3 156.37 18.95 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.028 0.442 . . . . 1.19 112.005 -179.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.516 ' HB2' HG23 ' A' ' 26' ' ' ILE . 56.9 m-85 -143.54 16.9 1.84 Allowed 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.601 -0.727 . . . . 2.26 111.231 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.512 ' O ' ' HB3' ' A' ' 44' ' ' CYS . . . 162.45 -143.91 9.17 Favored Glycine 0 C--N 1.331 0.256 0 C-N-CA 120.743 -0.741 . . . . 1.05 112.093 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.42 ' O ' ' HB2' ' A' ' 44' ' ' CYS . 12.1 Cg_endo -90.08 -72.88 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 123.054 2.503 . . . . 1.81 112.579 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.421 ' O ' ' HA ' ' A' ' 36' ' ' VAL . 0.4 OUTLIER -91.79 35.6 0.97 Allowed 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 110.265 -0.272 . . . . 1.62 110.265 179.525 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.98 ' CG1' HG11 ' A' ' 36' ' ' VAL . 13.3 mt -139.81 98.92 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 N-CA-C 113.664 0.987 . . . . 1.39 113.664 -178.228 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.818 ' HB2' ' HA ' ' A' ' 41' ' ' ALA . 3.7 t -119.71 108.71 14.76 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 107.376 -1.342 . . . . 0.92 107.376 176.114 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.741 ' CB ' ' HB3' ' A' ' 68' ' ' ALA . 4.3 m -121.94 161.67 22.45 Favored 'General case' 0 N--CA 1.429 -1.516 0 CA-C-N 114.374 -1.285 . . . . 1.28 112.703 -176.348 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -142.02 -173.42 14.08 Favored Glycine 0 N--CA 1.426 -2.027 0 CA-C-N 113.454 -1.703 . . . . 0.71 110.096 175.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.425 ' OD2' ' HG2' ' A' ' 31' ' ' GLU . 17.4 p-10 -67.3 -52.6 38.6 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 112.578 0.585 . . . . 2.27 112.578 -179.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.425 ' HG2' ' OD2' ' A' ' 30' ' ' ASP . 0.4 OUTLIER -119.17 19.12 12.96 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 122.411 1.1 . . . . 1.66 109.468 -178.703 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.753 HD22 ' CE1' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -113.73 -12.32 12.8 Favored 'General case' 0 N--CA 1.415 -2.208 0 CA-C-N 112.902 -1.954 . . . . 1.93 106.665 -178.923 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.689 ' HA2' ' CB ' ' A' ' 69' ' ' ALA . . . 52.81 -134.1 39.88 Favored Glycine 0 N--CA 1.415 -2.727 0 CA-C-N 113.952 -1.476 . . . . 0.77 113.831 177.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.579 ' O ' ' N ' ' B' ' 136' ' ' VAL . 0.9 OUTLIER -127.28 119.99 27.6 Favored 'General case' 0 N--CA 1.429 -1.519 0 N-CA-C 116.024 1.861 . . . . 1.08 116.024 -178.188 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.818 ' HB3' ' CG2' ' A' ' 38' ' ' THR . 8.4 m-85 -95.37 105.06 16.99 Favored 'General case' 0 N--CA 1.417 -2.082 1 N-CA-C 99.622 -4.214 . . . . 1.85 99.622 173.175 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.98 HG11 ' CG1' ' A' ' 26' ' ' ILE . 2.2 t -103.04 88.27 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.642 0 CA-C-O 122.794 1.283 . . . . 1.29 110.273 -176.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.452 ' O ' ' O ' ' A' ' 38' ' ' THR . . . 120.21 -46.48 1.12 Allowed Glycine 0 N--CA 1.461 0.323 0 CA-C-N 113.397 -1.729 . . . . 0.85 115.684 178.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.818 ' CG2' ' HB3' ' A' ' 35' ' ' PHE . 3.2 t -47.36 -174.66 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 117.305 0.553 . . . . 1.3 111.906 -178.529 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.427 ' N ' ' OG1' ' A' ' 38' ' ' THR . . . -70.17 -23.73 63.02 Favored 'General case' 0 CA--C 1.515 -0.393 0 O-C-N 121.817 -0.552 . . . . 1.45 112.445 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.528 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 1.3 mp0 -60.06 -28.04 67.46 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.586 -0.279 . . . . 2.32 110.769 179.256 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.818 ' HA ' ' HB2' ' A' ' 27' ' ' CYS . . . -93.14 -22.74 18.9 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 122.221 0.208 . . . . 1.11 111.313 -179.086 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.0 mt -49.7 -39.76 37.97 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 121.238 0.542 . . . . 1.68 110.716 179.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.746 ' HB3' ' HB2' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -56.6 -17.7 9.48 Favored 'General case' 0 CA--C 1.496 -1.123 0 CA-C-N 115.622 -0.717 . . . . 3.4 109.704 178.561 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.512 ' HB3' ' O ' ' A' ' 23' ' ' GLY . 68.0 m -75.31 0.45 16.68 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 120.042 1.292 . . . . 1.57 112.036 -179.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 71.4 tp60 -60.88 -21.32 63.18 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.066 0.46 . . . . 3.49 110.216 178.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -85.8 2.8 44.21 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 119.753 -0.779 . . . . 3.69 111.112 -179.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -82.61 3.11 30.09 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 116.147 -0.479 . . . . 3.99 109.739 177.504 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -84.92 -27.55 26.51 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 116.134 -0.485 . . . . 4.2 110.73 179.167 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -123.98 42.17 3.31 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.039 0.447 . . . . 5.85 111.677 -179.509 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.622 ' CD2' HD13 ' A' ' 11' ' ' LEU . 0.5 OUTLIER -147.05 98.4 4.06 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.76 -0.655 . . . . 5.83 110.61 178.956 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -79.6 46.77 2.31 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.59 2.193 . . . . 5.3 112.96 -179.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 49.3 m -95.56 107.57 34.16 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.488 -0.324 . . . . 5.72 111.006 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -80.19 -24.39 5.65 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.842 2.361 . . . . 5.82 112.656 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.541 ' SG ' ' HG3' ' A' ' 8' ' ' ARG . 52.8 t 65.84 99.12 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.432 -0.349 . . . . 2.98 111.075 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 1.029 ' HG2' ' HB2' ' A' ' 8' ' ' ARG . 0.4 OUTLIER 20.53 -103.88 0.01 OUTLIER 'General case' 0 C--N 1.343 0.324 0 N-CA-C 114.335 1.235 . . . . 6.42 114.335 179.036 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.6 ' HB3' ' HB ' ' A' ' 2' ' ' VAL . 8.1 t -169.5 144.78 3.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.412 -0.813 . . . . 3.36 109.213 -178.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 178.36 -86.64 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 119.998 -1.096 . . . . 2.3 113.15 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.935 ' HB3' ' HB3' ' A' ' 67' ' ' CYS . 15.6 mt-30 -120.6 85.94 2.48 Favored 'General case' 0 N--CA 1.417 -2.081 0 N-CA-C 107.55 -1.278 . . . . 5.06 107.55 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 1.256 ' O ' ' HA ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -136.44 -52.38 0.02 OUTLIER Pre-proline 0 C--N 1.305 -1.333 0 N-CA-C 106.562 -1.644 . . . . 3.91 106.562 179.799 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.762 ' HD2' ' H ' ' A' ' 59' ' ' LYS . 43.8 Cg_endo -84.96 108.5 1.18 Allowed 'Trans proline' 0 C--N 1.298 -2.126 0 CA-C-N 120.404 1.18 . . . . 1.74 114.076 177.009 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.562 ' O ' ' O ' ' A' ' 62' ' ' GLY . 3.0 t -142.95 -176.99 5.12 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 113.979 -1.464 . . . . 1.9 108.565 178.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.562 ' O ' ' O ' ' A' ' 61' ' ' CYS . . . 33.46 -166.19 0.01 OUTLIER Glycine 0 CA--C 1.524 0.598 0 C-N-CA 120.729 -0.748 . . . . 2.43 114.468 176.337 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -83.23 50.32 1.73 Allowed 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 122.423 1.106 . . . . 4.32 111.237 179.243 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 121.5 5.18 9.46 Favored Glycine 0 N--CA 1.474 1.172 0 CA-C-N 112.995 -1.911 . . . . 2.4 115.041 171.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.474 ' O ' ' N ' ' A' ' 61' ' ' CYS . . . -103.72 158.31 17.14 Favored Glycine 0 C--N 1.336 0.535 0 C-N-CA 120.957 -0.64 . . . . 1.82 112.767 -178.521 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 1.256 ' HA ' ' O ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -88.44 152.69 21.73 Favored 'General case' 0 CA--C 1.477 -1.863 0 CA-C-O 121.367 0.603 . . . . 3.51 112.295 -178.865 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.935 ' HB3' ' HB3' ' A' ' 58' ' ' GLN . 0.1 OUTLIER -73.75 108.2 6.44 Favored 'General case' 1 N--CA 1.374 -4.243 0 N-CA-C 107.254 -1.388 . . . . 1.52 107.254 178.145 . . . . . . . . 4 4 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.741 ' HB3' ' CB ' ' A' ' 28' ' ' CYS . . . -80.66 -57.24 3.66 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 104.873 -2.269 . . . . 1.5 104.873 178.098 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.689 ' CB ' ' HA2' ' A' ' 33' ' ' GLY . . . -154.42 161.8 41.51 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 111.785 -2.461 . . . . 1.31 111.636 -173.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.874 ' HA ' ' O ' ' A' ' 85' ' ' CYS . . . -32.8 122.7 0.36 Allowed 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 114.693 1.368 . . . . 1.5 114.693 -179.058 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.741 ' O ' ' HA ' ' A' ' 81' ' ' GLU . . . 59.45 -5.5 0.09 OUTLIER Glycine 0 CA--C 1.533 1.203 0 N-CA-C 116.801 1.48 . . . . 1.44 116.801 178.322 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.405 ' CD1' ' HB2' ' A' ' 34' ' ' CYS . 1.9 pp -121.04 100.07 8.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 122.73 1.252 . . . . 2.77 109.85 177.297 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.539 ' HB3' ' HB3' ' A' ' 61' ' ' CYS . 58.5 m -110.25 111.99 23.67 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 113.481 -1.69 . . . . 1.98 110.189 -177.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.575 ' HA ' ' O ' ' A' ' 78' ' ' GLY . 5.3 m -83.46 133.83 34.89 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 113.531 0.937 . . . . 1.43 113.531 -177.037 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.817 ' HB2' ' HD2' ' A' ' 76' ' ' PRO . 28.9 p -95.62 -179.06 0.86 Allowed Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 113.869 -1.514 . . . . 2.37 107.248 177.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.817 ' HD2' ' HB2' ' A' ' 75' ' ' SER . 57.5 Cg_endo -71.61 31.11 0.24 Allowed 'Trans proline' 0 CA--C 1.532 0.376 0 CA-C-N 120.56 1.236 . . . . 2.09 112.113 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.528 ' H ' ' C ' ' A' ' 75' ' ' SER . 3.0 p30 -145.67 -46.09 0.21 Allowed 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 115.899 -0.591 . . . . 2.65 111.661 179.43 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 1.149 ' HA3' ' O ' ' B' ' 179' ' ' CYS . . . -160.76 -151.54 6.26 Favored Glycine 0 C--N 1.349 1.28 0 C-N-CA 120.314 -0.946 . . . . 1.04 115.242 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 1.19 ' O ' ' HA3' ' B' ' 178' ' ' GLY . 32.3 m -128.87 133.75 48.05 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-O 123.377 1.561 . . . . 1.42 110.703 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 28.8 p80 -146.04 135.2 22.76 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 112.27 -2.241 . . . . 2.81 112.495 -169.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.741 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 34.4 mt-10 -51.91 123.88 11.38 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 114.132 -1.395 . . . . 3.05 111.067 -179.454 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.575 ' OD1' ' HB1' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -146.78 126.04 6.52 Favored Pre-proline 0 C--N 1.317 -0.845 0 CA-C-N 115.044 -0.98 . . . . 2.02 109.293 -179.656 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.68 ' HB3' ' CB ' ' A' ' 89' ' ' ALA . 71.8 Cg_exo -54.77 -13.53 6.19 Favored 'Trans proline' 0 N--CA 1.482 0.838 0 C-N-CA 124.038 3.158 . . . . 2.29 116.21 -177.12 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.575 ' HB1' ' OD1' ' A' ' 82' ' ' ASP . . . -71.42 -32.1 67.99 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 115.094 1.516 . . . . 1.53 115.094 -177.419 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.874 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 0.1 OUTLIER -91.15 -4.24 56.34 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 115.262 1.579 . . . . 1.88 115.262 -176.158 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.736 ' O ' ' N ' ' A' ' 88' ' ' GLU . 2.2 t70 -117.69 84.9 20.64 Favored Pre-proline 0 C--N 1.32 -0.696 0 N-CA-C 113.215 0.82 . . . . 3.6 113.215 -178.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -49.49 65.47 0.02 OUTLIER 'Trans proline' 0 CA--C 1.546 1.076 0 C-N-CA 123.754 2.969 . . . . 3.12 113.192 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.736 ' N ' ' O ' ' A' ' 86' ' ' ASP . 12.7 pt-20 179.48 21.99 0.0 OUTLIER 'General case' 0 CA--C 1.591 2.521 0 C-N-CA 130.935 3.694 . . . . 4.72 110.186 169.594 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.68 ' CB ' ' HB3' ' A' ' 83' ' ' PRO . . . -51.81 -3.43 0.02 OUTLIER 'General case' 0 C--N 1.313 -0.982 0 O-C-N 119.027 -2.296 . . . . 5.29 115.411 -167.239 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.444 ' N ' ' O ' ' A' ' 88' ' ' GLU . . . -24.75 135.9 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 114.248 1.203 . . . . 7.19 114.248 -176.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -88.24 136.07 33.15 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 113.545 -1.661 . . . . 10.7 111.82 -178.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 2.9 t . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.327 -0.844 . . . . 11.77 111.399 179.163 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.415 0 N-CA-C 109.739 -0.467 . . . . 10.42 109.739 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 4.2 m -85.78 168.58 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 116.613 -2.035 . . . . 8.81 110.62 -175.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 103' ' ' LEU . . . . . 0.687 ' H ' ' HD2' ' B' ' 153' ' ' PRO . 4.3 mm? -123.33 105.58 9.97 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 120.93 1.696 . . . . 6.28 109.518 175.441 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 104' ' ' ASP . . . . . 1.087 ' O ' ' HA ' ' B' ' 155' ' ' GLN . 0.5 OUTLIER -73.84 -87.97 0.03 OUTLIER 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 116.293 -2.163 . . . . 6.27 108.866 179.44 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . 0.499 ' O ' ' HG ' ' B' ' 105' ' ' LEU . 23.2 tp -156.5 41.57 0.36 Allowed 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 112.334 -2.212 . . . . 7.61 111.306 -177.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 106' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -95.55 -48.45 5.82 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 122.367 1.08 . . . . 8.55 108.705 176.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 107' ' ' VAL . . . . . 0.533 HG11 ' O ' ' B' ' 107' ' ' VAL . 8.7 p -155.61 125.67 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.948 0 CA-C-N 113.047 -1.888 . . . . 7.84 106.059 177.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 108' ' ' ARG . . . . . 1.057 ' HB2' ' HG2' ' B' ' 155' ' ' GLN . 0.0 OUTLIER -74.27 111.12 9.13 Favored 'General case' 0 N--CA 1.398 -3.039 0 N-CA-C 107.416 -1.327 . . . . 9.75 107.416 -177.374 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 3.7 m -106.94 95.42 5.71 Favored 'General case' 0 N--CA 1.399 -2.988 0 N-CA-C 101.544 -3.502 . . . . 6.13 101.544 172.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 110' ' ' CYS . . . . . 1.12 ' HB3' ' HG2' ' B' ' 120' ' ' ARG . 0.6 OUTLIER -84.32 103.86 13.85 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 111.916 -2.402 . . . . 2.87 111.854 178.875 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 111' ' ' LEU . . . . . 0.747 ' O ' ' HA ' ' B' ' 120' ' ' ARG . 4.2 mm? -30.64 108.54 0.26 Allowed Pre-proline 0 N--CA 1.474 0.743 0 CA-C-N 118.799 0.727 . . . . 2.95 110.271 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 112' ' ' PRO . . . . . 0.719 ' HA ' ' O ' ' B' ' 119' ' ' GLY . 49.9 Cg_endo -100.87 111.93 0.06 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.896 2.397 . . . . 1.71 115.3 -177.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.725 ' HB2' ' HB3' ' B' ' 143' ' ' ARG . 0.1 OUTLIER -129.79 -156.75 0.78 Allowed 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 116.849 -0.159 . . . . 1.0 110.81 -178.476 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 114' ' ' GLY . . . . . 0.613 ' N ' ' SG ' ' B' ' 113' ' ' CYS . . . 80.45 -158.82 42.03 Favored Glycine 0 CA--C 1.506 -0.479 0 CA-C-O 118.714 -1.048 . . . . 1.16 111.276 -177.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 115' ' ' PRO . . . . . 0.487 ' HD3' ' CG ' ' B' ' 140' ' ' GLU . 88.4 Cg_endo -64.97 82.82 0.18 Allowed 'Trans proline' 0 CA--C 1.508 -0.809 0 CA-C-N 120.871 2.336 . . . . 1.6 115.659 -176.259 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 88.95 0.71 80.79 Favored Glycine 0 N--CA 1.415 -2.754 0 CA-C-N 111.949 -2.387 . . . . 1.7 115.096 -178.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 117' ' ' GLY . . . . . 0.628 ' O ' ' HB2' ' B' ' 112' ' ' PRO . . . 93.07 33.27 7.39 Favored Glycine 0 N--CA 1.429 -1.823 0 CA-C-N 120.577 2.189 . . . . 1.38 117.359 174.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -94.02 -14.03 26.29 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 112.828 0.677 . . . . 2.96 112.828 177.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 119' ' ' GLY . . . . . 0.719 ' O ' ' HA ' ' B' ' 112' ' ' PRO . . . -111.98 -174.63 19.68 Favored Glycine 0 C--N 1.345 1.072 0 CA-C-O 117.37 -1.794 . . . . 1.07 108.907 179.042 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 1.12 ' HG2' ' HB3' ' B' ' 110' ' ' CYS . 0.2 OUTLIER -123.59 175.36 6.85 Favored 'General case' 0 C--N 1.349 0.584 0 CA-C-N 122.52 3.16 . . . . 3.29 110.318 -179.032 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 121' ' ' CYS . . . . . . . . . . . . . 10.9 m -106.94 156.56 18.58 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.171 0.51 . . . . 1.21 112.123 -179.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 122' ' ' PHE . . . . . 0.569 ' HE1' ' O ' ' B' ' 128' ' ' CYS . 56.2 m-85 -143.53 17.11 1.84 Allowed 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.497 -0.774 . . . . 2.28 111.163 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 123' ' ' GLY . . . . . 0.517 ' O ' ' HB3' ' B' ' 144' ' ' CYS . . . 162.28 -144.0 9.28 Favored Glycine 0 CA--C 1.519 0.289 0 C-N-CA 120.856 -0.688 . . . . 1.04 112.139 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . 0.474 ' O ' ' HB2' ' B' ' 144' ' ' CYS . 12.1 Cg_endo -89.99 -73.05 0.0 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 123.016 2.477 . . . . 1.84 112.607 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 125' ' ' SER . . . . . 0.43 ' O ' ' HA ' ' B' ' 136' ' ' VAL . 0.4 OUTLIER -91.28 35.31 0.93 Allowed 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 110.108 -0.33 . . . . 1.49 110.108 179.431 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 126' ' ' ILE . . . . . 0.58 HG23 ' SG ' ' B' ' 128' ' ' CYS . 17.9 mt -139.38 98.14 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 114.007 1.114 . . . . 1.41 114.007 -178.02 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 127' ' ' CYS . . . . . 0.779 ' HB2' ' HA ' ' B' ' 141' ' ' ALA . 3.7 t -119.83 109.31 15.43 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 107.553 -1.277 . . . . 0.89 107.553 176.345 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 128' ' ' CYS . . . . . 0.733 ' HB3' ' O ' ' B' ' 133' ' ' GLY . 3.7 m -132.31 148.13 52.42 Favored 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 115.259 1.577 . . . . 1.23 115.259 -175.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 129' ' ' GLY . . . . . . . . . . . . . . . -126.9 -168.1 12.48 Favored Glycine 0 N--CA 1.429 -1.812 0 N-CA-C 109.874 -1.291 . . . . 0.69 109.874 179.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 130' ' ' ASP . . . . . 0.408 ' OD2' ' HG2' ' B' ' 131' ' ' GLU . 17.9 p-10 -69.1 -54.01 17.28 Favored 'General case' 0 CA--C 1.491 -1.303 0 C-N-CA 123.396 0.678 . . . . 2.35 112.199 -179.091 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 131' ' ' GLU . . . . . 0.408 ' HG2' ' OD2' ' B' ' 130' ' ' ASP . 0.3 OUTLIER -119.56 28.11 8.36 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 117.495 -1.682 . . . . 1.69 109.215 179.609 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 132' ' ' LEU . . . . . 0.648 ' O ' ' HB ' ' A' ' 38' ' ' THR . 0.7 OUTLIER -121.47 -12.2 8.6 Favored 'General case' 0 N--CA 1.424 -1.741 0 N-CA-C 104.289 -2.485 . . . . 1.84 104.289 -175.709 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 133' ' ' GLY . . . . . 0.742 ' HA2' ' CB ' ' B' ' 169' ' ' ALA . . . 48.91 -136.08 20.1 Favored Glycine 0 N--CA 1.407 -3.249 0 CA-C-N 112.831 -1.986 . . . . 0.76 113.359 176.334 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 134' ' ' CYS . . . . . 0.573 ' O ' ' N ' ' A' ' 36' ' ' VAL . 1.1 m -118.88 125.7 50.1 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.273 1.212 . . . . 1.08 114.273 -176.584 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 135' ' ' PHE . . . . . 0.788 ' HB3' ' CG2' ' B' ' 138' ' ' THR . 8.8 m-85 -102.17 104.2 14.77 Favored 'General case' 0 N--CA 1.431 -1.394 1 N-CA-C 99.508 -4.256 . . . . 1.83 99.508 169.628 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 136' ' ' VAL . . . . . 0.766 HG22 ' SG ' ' B' ' 179' ' ' CYS . 2.5 t -103.43 89.3 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.629 0 CA-C-O 122.594 1.188 . . . . 1.29 110.17 -176.257 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 137' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' B' ' 125' ' ' SER . . . 119.24 -47.61 1.01 Allowed Glycine 0 CA--C 1.519 0.3 0 CA-C-N 113.688 -1.596 . . . . 0.85 115.582 179.177 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 138' ' ' THR . . . . . 0.788 ' CG2' ' HB3' ' B' ' 135' ' ' PHE . 3.5 t -50.52 179.53 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 117.418 0.609 . . . . 1.2 112.266 -178.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 139' ' ' ALA . . . . . 0.494 ' HA ' HD11 ' B' ' 142' ' ' LEU . . . -58.08 -36.3 72.65 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.938 -1.028 . . . . 1.35 111.09 -178.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 140' ' ' GLU . . . . . 0.526 ' O ' ' SG ' ' B' ' 113' ' ' CYS . 1.3 mp0 -53.82 -27.71 31.08 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.761 0.282 . . . . 2.31 111.761 -178.384 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 141' ' ' ALA . . . . . 0.779 ' HA ' ' HB2' ' B' ' 127' ' ' CYS . . . -88.46 -33.82 17.69 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 116.123 -0.49 . . . . 1.09 109.929 -179.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 142' ' ' LEU . . . . . 0.494 HD11 ' HA ' ' B' ' 139' ' ' ALA . 6.2 mt -42.31 -41.15 2.7 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.013 -0.54 . . . . 1.61 111.748 -178.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 143' ' ' ARG . . . . . 0.725 ' HB3' ' HB2' ' B' ' 113' ' ' CYS . 0.0 OUTLIER -52.55 -26.15 12.44 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 109.354 -0.61 . . . . 3.43 109.354 178.073 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 144' ' ' CYS . . . . . 0.552 ' N ' ' O ' ' B' ' 141' ' ' ALA . 56.9 m -61.2 -16.56 46.17 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.316 -1.311 . . . . 1.61 110.702 -176.147 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 68.4 tp60 -52.68 -22.38 5.08 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 111.879 0.326 . . . . 3.52 111.879 -179.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -85.79 3.02 43.33 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 119.602 -0.839 . . . . 3.76 110.968 -179.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -82.76 3.3 29.88 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 116.056 -0.52 . . . . 4.01 109.686 177.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 148' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -84.95 -27.49 26.49 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 116.092 -0.504 . . . . 4.24 110.703 179.133 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -124.06 42.23 3.29 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.936 0.398 . . . . 6.07 111.555 -179.455 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -147.09 98.36 4.05 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.815 -0.629 . . . . 5.86 110.525 178.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 151' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -79.5 46.46 2.22 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.581 2.187 . . . . 5.42 112.983 -179.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 152' ' ' SER . . . . . 0.492 ' HB2' HD23 ' B' ' 111' ' ' LEU . 50.3 m -95.48 107.11 30.93 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 116.468 -0.333 . . . . 6.02 111.214 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 153' ' ' PRO . . . . . 0.687 ' HD2' ' H ' ' B' ' 103' ' ' LEU . 92.6 Cg_endo -79.46 -24.43 6.41 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 123.046 2.498 . . . . 5.87 112.691 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 154' ' ' CYS . . . . . 0.537 ' SG ' ' HG3' ' B' ' 108' ' ' ARG . 53.5 t 66.0 98.12 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.284 -0.416 . . . . 2.96 111.421 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 155' ' ' GLN . . . . . 1.087 ' HA ' ' O ' ' B' ' 104' ' ' ASP . 0.5 OUTLIER 21.75 -104.61 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 114.366 1.247 . . . . 6.3 114.366 178.914 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 156' ' ' SER . . . . . 0.601 ' HA ' ' HE3' ' B' ' 159' ' ' LYS . 7.5 t -168.15 146.22 4.34 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 108.728 -0.842 . . . . 3.41 108.728 -178.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 176.41 -87.6 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 119.926 -1.13 . . . . 2.26 112.967 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 158' ' ' GLN . . . . . 0.977 ' HB3' ' HB3' ' B' ' 167' ' ' CYS . 16.6 mt-30 -120.92 71.22 0.93 Allowed 'General case' 0 N--CA 1.418 -2.047 0 CA-C-O 122.151 0.976 . . . . 5.03 109.292 179.439 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 159' ' ' LYS . . . . . 1.302 ' O ' ' HA ' ' B' ' 166' ' ' ARG . 0.0 OUTLIER -107.28 -58.57 0.05 OUTLIER Pre-proline 0 C--O 1.205 -1.238 0 CA-C-O 123.72 1.724 . . . . 3.96 110.701 174.48 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 160' ' ' PRO . . . . . 0.681 ' HD2' ' H ' ' B' ' 159' ' ' LYS . 49.5 Cg_endo -85.03 108.0 1.12 Allowed 'Trans proline' 0 N--CA 1.442 -1.553 0 C-N-CA 122.466 2.11 . . . . 1.7 114.76 -176.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 161' ' ' CYS . . . . . 0.595 ' SG ' ' HB1' ' B' ' 184' ' ' ALA . 3.1 t -143.87 -177.8 5.61 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 113.452 -1.704 . . . . 1.93 108.632 178.609 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 162' ' ' GLY . . . . . 0.506 ' O ' ' O ' ' B' ' 161' ' ' CYS . . . 35.49 -166.58 0.01 OUTLIER Glycine 0 CA--C 1.519 0.309 0 C-N-CA 121.077 -0.583 . . . . 2.37 114.414 176.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.89 51.47 1.74 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 121.052 -0.259 . . . . 4.56 111.238 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 119.64 3.83 12.22 Favored Glycine 0 CA--C 1.529 0.93 0 N-CA-C 114.631 0.613 . . . . 2.39 114.631 178.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 165' ' ' GLY . . . . . 0.48 ' O ' ' N ' ' B' ' 161' ' ' CYS . . . -102.73 157.85 17.99 Favored Glycine 0 C--O 1.226 -0.385 0 C-N-CA 120.143 -1.027 . . . . 1.79 112.754 179.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 166' ' ' ARG . . . . . 1.302 ' HA ' ' O ' ' B' ' 159' ' ' LYS . 0.0 OUTLIER -88.57 152.59 21.75 Favored 'General case' 0 CA--C 1.48 -1.73 0 C-N-CA 120.325 -0.55 . . . . 3.53 111.962 -179.625 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 167' ' ' CYS . . . . . 0.977 ' HB3' ' HB3' ' B' ' 158' ' ' GLN . 0.1 OUTLIER -73.68 108.42 6.51 Favored 'General case' 1 N--CA 1.375 -4.212 0 N-CA-C 107.261 -1.385 . . . . 1.56 107.261 178.15 . . . . . . . . 4 4 . 1 . 013 nuclear orig full ' B' B ' 168' ' ' ALA . . . . . 0.521 ' HB2' ' CB ' ' B' ' 128' ' ' CYS . . . -83.5 -49.36 9.34 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 117.627 -1.629 . . . . 1.42 107.065 178.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 169' ' ' ALA . . . . . 0.742 ' CB ' ' HA2' ' B' ' 133' ' ' GLY . . . -161.08 161.54 31.3 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 112.5 -2.136 . . . . 1.18 111.03 -175.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 170' ' ' ALA . . . . . 0.886 ' HA ' ' O ' ' B' ' 185' ' ' CYS . . . -32.69 123.31 0.35 Allowed 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 114.846 1.424 . . . . 1.47 114.846 -179.143 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 171' ' ' GLY . . . . . 0.688 ' O ' ' HA ' ' B' ' 181' ' ' GLU . . . 65.16 -19.18 0.12 Allowed Glycine 0 CA--C 1.529 0.962 0 N-CA-C 116.47 1.348 . . . . 1.45 116.47 177.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 172' ' ' ILE . . . . . . . . . . . . . 2.0 pp -113.16 101.37 12.4 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 CA-C-O 122.684 1.231 . . . . 2.7 110.529 -179.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 173' ' ' CYS . . . . . 0.511 ' HB3' ' HB3' ' B' ' 161' ' ' CYS . 59.3 m -110.27 112.21 24.03 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 113.851 -1.522 . . . . 1.94 110.131 -178.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 174' ' ' CYS . . . . . 0.569 ' HA ' ' O ' ' B' ' 178' ' ' GLY . 5.5 m -83.66 133.75 34.81 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 113.56 0.948 . . . . 1.43 113.56 -176.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 175' ' ' SER . . . . . 0.796 ' HB2' ' HD2' ' B' ' 176' ' ' PRO . 28.3 p -95.66 -178.99 0.85 Allowed Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 113.893 -1.503 . . . . 2.3 107.238 177.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 176' ' ' PRO . . . . . 0.796 ' HD2' ' HB2' ' B' ' 175' ' ' SER . 57.4 Cg_endo -71.65 31.08 0.25 Allowed 'Trans proline' 0 CA--C 1.532 0.405 0 CA-C-N 120.584 1.244 . . . . 2.13 112.106 -179.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 177' ' ' ASP . . . . . 0.523 ' H ' ' C ' ' B' ' 175' ' ' SER . 3.0 p30 -145.58 -46.01 0.21 Allowed 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 115.906 -0.588 . . . . 2.72 111.743 179.422 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 178' ' ' GLY . . . . . 1.19 ' HA3' ' O ' ' A' ' 79' ' ' CYS . . . -161.07 -151.19 6.15 Favored Glycine 0 C--N 1.35 1.335 0 C-N-CA 120.295 -0.955 . . . . 1.05 115.033 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 179' ' ' CYS . . . . . 1.149 ' O ' ' HA3' ' A' ' 78' ' ' GLY . 32.7 m -128.66 139.35 52.29 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 122.649 1.214 . . . . 1.39 110.195 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 180' ' ' HIS . . . . . . . . . . . . . 33.3 p80 -156.87 133.11 9.79 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 123.619 1.676 . . . . 2.73 112.367 -168.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 181' ' ' GLU . . . . . 0.688 ' HA ' ' O ' ' B' ' 171' ' ' GLY . 33.8 mt-10 -49.55 123.14 7.19 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 110.967 -2.833 . . . . 3.06 110.733 -177.323 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 182' ' ' ASP . . . . . 0.52 ' OD1' ' HB1' ' B' ' 184' ' ' ALA . 0.1 OUTLIER -146.79 126.06 6.52 Favored Pre-proline 0 C--N 1.315 -0.916 0 CA-C-N 114.677 -1.147 . . . . 2.06 109.103 -179.725 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 183' ' ' PRO . . . . . 0.673 ' HB3' ' CB ' ' B' ' 189' ' ' ALA . 72.5 Cg_exo -54.82 -13.53 6.26 Favored 'Trans proline' 0 N--CA 1.482 0.85 0 C-N-CA 123.981 3.121 . . . . 2.27 116.241 -177.178 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 184' ' ' ALA . . . . . 0.595 ' HB1' ' SG ' ' B' ' 161' ' ' CYS . . . -71.77 -31.59 66.78 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 114.974 1.472 . . . . 1.56 114.974 -177.265 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 185' ' ' CYS . . . . . 0.886 ' O ' ' HA ' ' B' ' 170' ' ' ALA . 0.1 OUTLIER -91.1 -4.55 56.16 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 115.298 1.592 . . . . 1.94 115.298 -176.329 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 186' ' ' ASP . . . . . 0.68 ' O ' ' N ' ' B' ' 188' ' ' GLU . 2.2 t70 -117.88 85.23 22.34 Favored Pre-proline 0 C--N 1.321 -0.664 0 N-CA-C 113.392 0.886 . . . . 3.61 113.392 -178.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -49.3 63.47 0.02 OUTLIER 'Trans proline' 0 CA--C 1.555 1.565 0 C-N-CA 123.955 3.103 . . . . 3.14 114.945 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 188' ' ' GLU . . . . . 0.68 ' N ' ' O ' ' B' ' 186' ' ' ASP . 13.5 pt-20 174.67 49.44 0.0 OUTLIER 'General case' 1 N--CA 1.379 -4.002 1 C-N-CA 133.246 4.618 . . . . 4.7 104.799 171.088 . . . . . . . . 4 3 . 1 . 013 nuclear orig full ' B' B ' 189' ' ' ALA . . . . . 0.673 ' CB ' ' HB3' ' B' ' 183' ' ' PRO . . . -77.22 11.75 1.76 Allowed 'General case' 0 C--N 1.303 -1.419 1 CA-C-N 129.21 5.459 . . . . 5.24 114.012 -178.245 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 190' ' ' ALA . . . . . 0.457 ' C ' ' O ' ' B' ' 189' ' ' ALA . . . -28.76 137.77 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.947 0.721 . . . . 6.93 112.947 -178.336 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 191' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -89.28 136.16 33.18 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.966 -1.015 . . . . 10.62 111.564 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 3.1 t . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.337 -0.84 . . . . 11.7 111.454 179.054 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 121.192 0.52 . . . . 10.31 111.312 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.424 HG23 ' CB ' ' A' ' 6' ' ' ASP . 1.5 m -135.43 126.82 45.47 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.122 0 CA-C-N 115.308 -0.86 . . . . 8.37 112.416 178.315 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.63 ' HA ' ' HA ' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -80.49 111.98 17.4 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 106.265 -1.754 . . . . 6.25 106.265 175.327 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -169.73 -101.36 0.01 OUTLIER 'General case' 0 N--CA 1.421 -1.922 0 CA-C-N 111.681 -2.509 . . . . 6.22 106.198 171.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 16.8 tp -142.08 12.24 2.01 Favored 'General case' 0 CA--C 1.503 -0.861 0 CA-C-N 112.249 -2.251 . . . . 7.57 109.321 178.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.424 ' CB ' HG23 ' A' ' 2' ' ' VAL . 0.9 OUTLIER -80.56 -83.54 0.11 Allowed 'General case' 0 CA--C 1.483 -1.603 0 N-CA-C 101.375 -3.565 . . . . 8.78 101.375 175.426 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.579 HG11 ' O ' ' A' ' 7' ' ' VAL . 1.8 p -139.18 117.7 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.157 1 N-CA-C 99.993 -4.077 . . . . 7.88 99.993 165.332 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.962 ' HB2' ' H ' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -79.26 119.16 21.93 Favored 'General case' 0 CA--C 1.485 -1.543 0 CA-C-N 122.736 2.516 . . . . 9.7 107.742 177.831 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.1 t -65.22 104.9 0.99 Allowed 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 114.211 -2.995 . . . . 6.05 107.593 -179.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.587 ' HB2' ' HG2' ' A' ' 20' ' ' ARG . 77.3 m -80.23 112.88 17.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 113.831 -1.532 . . . . 2.89 112.525 178.597 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.501 ' C ' ' O ' ' A' ' 10' ' ' CYS . 17.4 mt -30.8 136.17 0.21 Allowed Pre-proline 0 N--CA 1.477 0.884 0 CA-C-N 119.033 0.833 . . . . 2.89 111.251 177.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.697 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 41.5 Cg_endo -69.55 147.88 65.18 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.763 2.308 . . . . 1.72 114.881 -178.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.734 ' N ' ' O ' ' A' ' 19' ' ' GLY . 0.0 OUTLIER -149.91 -166.39 2.53 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-O 121.659 0.742 . . . . 1.0 110.951 176.675 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.636 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . 76.16 -159.59 50.54 Favored Glycine 0 C--N 1.337 0.624 0 CA-C-N 114.683 -1.144 . . . . 1.15 114.767 175.269 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.515 ' HG2' ' O ' ' A' ' 15' ' ' PRO . 62.8 Cg_endo -62.1 101.94 0.25 Allowed 'Trans proline' 0 CA--C 1.511 -0.625 0 C-N-CA 124.301 3.334 . . . . 1.6 110.645 177.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.53 -7.74 75.04 Favored Glycine 0 C--N 1.268 -3.198 0 CA-C-N 113.901 -1.499 . . . . 1.68 112.422 179.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 79.33 49.48 6.24 Favored Glycine 0 N--CA 1.397 -3.925 0 C-N-CA 119.714 -1.231 . . . . 1.37 113.515 -179.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.73 -49.91 6.02 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 103.567 -2.753 . . . . 2.91 103.567 173.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.734 ' O ' ' N ' ' A' ' 13' ' ' CYS . . . -67.6 165.1 44.69 Favored Glycine 0 C--O 1.219 -0.816 0 C-N-CA 117.985 -2.055 . . . . 1.06 117.404 -165.523 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.587 ' HG2' ' HB2' ' A' ' 10' ' ' CYS . 0.1 OUTLIER -104.03 147.05 27.83 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 112.691 -1.755 . . . . 3.32 114.667 -172.864 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.45 ' O ' ' HB3' ' A' ' 10' ' ' CYS . 74.1 m -108.9 139.56 43.57 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 114.785 -1.098 . . . . 1.19 111.423 -179.532 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.607 ' CE1' ' HB2' ' A' ' 28' ' ' CYS . 1.4 m-85 -124.41 -9.78 7.47 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.238 -0.437 . . . . 2.26 112.065 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.474 ' HA3' ' OE2' ' B' ' 181' ' ' GLU . . . -159.05 -161.12 10.86 Favored Glycine 0 C--N 1.334 0.459 0 C-N-CA 120.677 -0.773 . . . . 1.05 112.576 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.561 ' HD2' ' HG2' ' B' ' 181' ' ' GLU . 7.6 Cg_exo -69.76 -53.02 0.29 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.967 2.445 . . . . 1.81 112.24 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.598 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.4 OUTLIER -118.78 44.25 2.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.015 -0.539 . . . . 1.62 110.841 -179.756 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 1.005 HG12 HG11 ' A' ' 36' ' ' VAL . 59.8 mt -142.52 121.21 8.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 N-CA-C 112.609 0.596 . . . . 1.39 112.609 -179.059 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.838 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 6.4 t -135.45 144.2 46.32 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-N 115.417 -0.811 . . . . 0.92 109.075 178.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.942 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 0.5 OUTLIER -136.35 157.66 46.27 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 122.361 1.076 . . . . 1.28 113.884 -177.08 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.558 ' HA3' ' HB2' ' A' ' 32' ' ' LEU . . . -151.05 169.33 30.76 Favored Glycine 0 N--CA 1.416 -2.653 0 CA-C-N 113.812 -1.54 . . . . 0.71 110.561 176.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.429 ' OD2' ' HG3' ' A' ' 31' ' ' GLU . 15.3 p-10 -64.37 -48.4 75.64 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 122.79 1.281 . . . . 2.27 108.695 178.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.429 ' HG3' ' OD2' ' A' ' 30' ' ' ASP . 1.3 mt-10 -120.38 17.15 12.21 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 113.149 -1.842 . . . . 1.66 109.157 179.543 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.728 HD21 ' CE2' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -120.2 -2.71 10.1 Favored 'General case' 0 N--CA 1.411 -2.422 0 C-N-CA 123.71 0.804 . . . . 1.93 109.334 -177.275 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.942 ' O ' ' HA ' ' A' ' 28' ' ' CYS . . . 47.63 -131.41 16.42 Favored Glycine 0 N--CA 1.433 -1.557 0 CA-C-N 114.887 -1.051 . . . . 0.77 113.616 178.041 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.838 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 0.1 OUTLIER -138.68 113.27 8.96 Favored 'General case' 0 CA--C 1.481 -1.699 0 CA-C-N 118.546 1.173 . . . . 1.08 112.119 179.365 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.728 ' CE2' HD21 ' A' ' 32' ' ' LEU . 26.5 m-85 -86.49 108.12 18.39 Favored 'General case' 0 N--CA 1.425 -1.722 0 N-CA-C 104.993 -2.225 . . . . 1.85 104.993 176.063 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 1.005 HG11 HG12 ' A' ' 26' ' ' ILE . 5.1 t -91.77 85.42 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.756 0 C-N-CA 118.341 -1.344 . . . . 1.29 108.933 -179.098 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.712 ' HA3' HG23 ' B' ' 172' ' ' ILE . . . 89.37 108.12 1.18 Allowed Glycine 0 CA--C 1.524 0.655 0 CA-C-N 112.918 -1.946 . . . . 0.85 115.159 179.179 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.44 ' CG2' ' HB3' ' A' ' 35' ' ' PHE . 0.1 OUTLIER 179.36 168.31 1.06 Allowed 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 107.904 -1.147 . . . . 1.3 107.904 178.588 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.559 ' HA ' ' CD1' ' A' ' 42' ' ' LEU . . . -55.52 -32.93 63.34 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 120.547 1.521 . . . . 1.45 114.008 -177.499 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.586 ' HG2' ' HA2' ' A' ' 14' ' ' GLY . 0.2 OUTLIER -65.27 -23.18 66.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.059 0.457 . . . . 2.32 110.561 179.712 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.584 ' O ' ' N ' ' A' ' 44' ' ' CYS . . . -95.9 -14.71 22.91 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 116.069 -0.514 . . . . 1.11 110.906 -179.042 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.593 ' O ' ' HB2' ' A' ' 45' ' ' GLN . 4.7 mt -46.25 -44.37 16.32 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-N 119.042 0.837 . . . . 1.68 112.379 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.431 ' HD2' ' O ' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -61.91 -10.88 10.59 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 120.095 -0.642 . . . . 3.4 109.68 178.101 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.584 ' N ' ' O ' ' A' ' 41' ' ' ALA . 38.5 m -76.6 4.81 8.57 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 114.171 -1.377 . . . . 1.57 110.155 174.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.593 ' HB2' ' O ' ' A' ' 42' ' ' LEU . 0.7 OUTLIER -78.79 -18.6 53.88 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.982 -0.554 . . . . 3.49 111.268 179.337 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.548 ' HA ' ' CD2' ' A' ' 49' ' ' TYR . 16.8 tt0 -86.92 -0.37 56.41 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.051 -0.66 . . . . 3.69 110.539 -179.64 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.03 3.67 29.34 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 109.537 -0.542 . . . . 3.99 109.537 177.55 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.434 ' ND2' ' HG3' ' A' ' 24' ' ' PRO . 0.4 OUTLIER -97.36 -28.22 14.13 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 116.131 -0.486 . . . . 4.2 109.997 178.704 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.548 ' CD2' ' HA ' ' A' ' 46' ' ' GLU . 43.2 m-85 -69.88 8.92 0.61 Allowed 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.238 0.459 . . . . 5.85 112.238 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.7 mt -131.18 121.17 18.51 Favored Pre-proline 0 CA--C 1.529 0.146 0 O-C-N 122.348 -0.22 . . . . 5.83 111.23 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -80.73 48.93 3.06 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.353 2.035 . . . . 5.3 112.203 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 61.9 p -139.66 159.59 64.64 Favored Pre-proline 0 CA--C 1.531 0.231 0 CA-C-N 116.3 -0.409 . . . . 5.72 110.812 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.41 ' O ' ' CD ' ' A' ' 8' ' ' ARG . 2.2 Cg_endo -82.89 -163.63 0.22 Allowed 'Trans proline' 0 CA--C 1.535 0.541 0 C-N-CA 123.279 2.653 . . . . 5.82 113.524 -179.021 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.807 ' HA ' ' CB ' ' A' ' 8' ' ' ARG . 0.5 OUTLIER -160.5 126.07 3.94 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.64 -0.709 . . . . 2.98 109.398 -179.887 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.962 ' H ' ' HB2' ' A' ' 8' ' ' ARG . 0.7 OUTLIER -48.86 -169.76 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.303 0 CA-C-O 121.963 0.887 . . . . 6.42 112.901 -178.784 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 17.7 p 172.88 -162.1 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 114.345 -1.298 . . . . 3.36 108.043 178.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.624 ' HA3' ' O ' ' A' ' 67' ' ' CYS . . . -82.46 151.72 29.89 Favored Glycine 0 N--CA 1.448 -0.539 0 N-CA-C 109.726 -1.35 . . . . 2.3 109.726 -177.232 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 19.7 mm100 -101.88 77.45 1.71 Allowed 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.976 0.893 . . . . 5.06 109.655 179.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.456 ' HB2' ' HB2' ' A' ' 67' ' ' CYS . 0.0 OUTLIER -141.77 60.47 11.36 Favored Pre-proline 0 C--N 1.31 -1.13 0 N-CA-C 105.746 -1.946 . . . . 3.91 105.746 179.22 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.505 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 30.7 Cg_endo -63.6 78.18 0.14 Allowed 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 122.605 2.203 . . . . 1.74 114.887 -177.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.493 ' O ' ' O ' ' A' ' 65' ' ' GLY . 0.5 OUTLIER -99.26 -176.83 3.42 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 106.468 -1.678 . . . . 1.9 106.468 175.868 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.79 -167.02 51.36 Favored Glycine 0 N--CA 1.442 -0.963 0 C-N-CA 117.945 -2.074 . . . . 2.43 111.809 178.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 20.2 p -86.86 39.41 0.85 Allowed 'General case' 0 N--CA 1.484 1.262 0 CA-C-O 122.223 1.011 . . . . 4.32 111.642 -176.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 120.68 10.38 7.1 Favored Glycine 0 C--N 1.35 1.341 0 CA-C-N 114.013 -1.449 . . . . 2.4 113.886 -178.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.493 ' O ' ' O ' ' A' ' 61' ' ' CYS . . . -103.48 132.99 11.26 Favored Glycine 0 C--N 1.336 0.581 0 C-N-CA 119.657 -1.259 . . . . 1.82 115.401 -178.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.576 ' HB2' ' O ' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -97.29 152.98 18.34 Favored 'General case' 0 C--N 1.333 -0.126 0 C-N-CA 122.84 0.456 . . . . 3.51 110.441 178.555 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.624 ' O ' ' HA3' ' A' ' 57' ' ' GLY . 1.8 m -65.34 108.47 1.95 Allowed 'General case' 0 C--O 1.22 -0.486 0 C-N-CA 120.002 -0.679 . . . . 1.52 110.269 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.61 -15.55 54.31 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 107.802 -1.184 . . . . 1.5 107.802 176.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.859 ' O ' ' O ' ' A' ' 70' ' ' ALA . . . -165.11 162.15 20.02 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 112.801 -2.0 . . . . 1.31 110.405 178.561 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.859 ' O ' ' O ' ' A' ' 69' ' ' ALA . . . -16.99 -138.11 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.078 0.951 . . . . 1.5 113.287 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.583 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . -64.55 61.11 0.07 OUTLIER Glycine 0 N--CA 1.47 0.936 0 N-CA-C 110.184 -1.166 . . . . 1.44 110.184 -179.589 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.822 HD11 ' HB2' ' A' ' 34' ' ' CYS . 0.7 OUTLIER -146.04 106.12 0.69 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.817 0 CA-C-N 114.731 -0.734 . . . . 2.77 109.771 174.962 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.525 ' HB2' ' HB3' ' A' ' 82' ' ' ASP . 0.0 OUTLIER -93.25 83.42 4.62 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 116.236 -0.438 . . . . 1.98 110.407 -179.556 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.83 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 0.1 OUTLIER -83.04 136.63 34.42 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.982 -0.554 . . . . 1.43 110.816 -179.914 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.638 ' HB3' ' HD2' ' A' ' 76' ' ' PRO . 5.0 m -104.76 179.4 0.94 Allowed Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.25 -0.887 . . . . 2.37 109.312 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.638 ' HD2' ' HB3' ' A' ' 75' ' ' SER . 96.4 Cg_endo -79.96 25.08 0.61 Allowed 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 121.443 1.429 . . . . 2.09 111.722 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.409 ' H ' ' C ' ' A' ' 75' ' ' SER . 11.8 m-20 -145.58 -41.42 0.22 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.609 -0.723 . . . . 2.65 110.213 179.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.796 ' HA3' ' O ' ' B' ' 179' ' ' CYS . . . -147.92 -135.29 2.59 Favored Glycine 0 C--N 1.337 0.601 0 C-N-CA 120.574 -0.822 . . . . 1.04 113.07 179.415 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.83 ' HA ' ' HA ' ' A' ' 74' ' ' CYS . 0.1 OUTLIER -146.85 156.45 43.12 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.625 0.25 . . . . 1.42 110.57 179.954 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.474 ' N ' ' O ' ' A' ' 73' ' ' CYS . 6.6 t-160 -142.42 133.76 26.32 Favored 'General case' 0 CA--C 1.519 -0.249 0 O-C-N 121.989 -0.444 . . . . 2.81 111.638 -178.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.633 ' HG3' HD12 ' B' ' 126' ' ' ILE . 2.3 mt-10 -58.56 128.03 35.12 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.901 -0.591 . . . . 3.05 109.717 178.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.525 ' HB3' ' HB2' ' A' ' 73' ' ' CYS . 0.0 OUTLIER -146.28 112.63 4.41 Favored Pre-proline 0 C--N 1.318 -0.799 0 CA-C-N 115.514 -0.766 . . . . 2.02 110.496 -178.928 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.454 ' HA ' ' OD2' ' A' ' 86' ' ' ASP . 1.6 Cg_endo -82.86 -4.4 11.34 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 122.691 2.261 . . . . 2.29 113.231 -179.26 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.99 -35.43 79.94 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.832 0.349 . . . . 1.53 111.048 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.594 ' C ' ' HD3' ' A' ' 87' ' ' PRO . 84.4 m -93.64 49.71 1.39 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.107 -0.497 . . . . 1.88 110.869 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.69 ' N ' ' HD3' ' A' ' 87' ' ' PRO . 16.5 m-20 -116.68 35.19 0.2 Allowed Pre-proline 0 N--CA 1.442 -0.827 0 N-CA-C 112.422 0.527 . . . . 3.6 112.422 179.44 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.69 ' HD3' ' N ' ' A' ' 86' ' ' ASP . 1.6 Cg_endo -78.68 63.2 8.51 Favored 'Trans proline' 0 C--N 1.362 1.259 0 N-CA-C 106.697 -2.078 . . . . 3.12 106.697 176.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.47 ' HB3' ' O ' ' A' ' 87' ' ' PRO . 4.6 pt-20 178.11 -30.7 0.01 OUTLIER 'General case' 0 CA--C 1.477 -1.831 0 CA-C-N 112.239 -2.255 . . . . 4.72 110.396 179.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.456 ' N ' ' HG3' ' A' ' 88' ' ' GLU . . . -72.51 49.93 0.22 Allowed 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 110.906 -2.861 . . . . 5.29 111.798 178.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.28 119.6 15.65 Favored 'General case' 0 C--N 1.312 -1.024 0 C-N-CA 127.335 2.254 . . . . 7.19 111.641 178.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -71.17 130.44 41.47 Favored 'General case' 0 C--N 1.354 0.765 0 CA-C-N 111.252 -2.704 . . . . 10.7 113.626 -174.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 12.5 t . . . . . 0 C--O 1.248 1.022 0 CA-C-N 114.356 -1.293 . . . . 11.77 110.654 179.378 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 101' ' ' ALA . . . . . 0.432 ' HB1' ' OD2' ' B' ' 104' ' ' ASP . . . . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 121.19 0.519 . . . . 10.42 111.172 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 102' ' ' VAL . . . . . 0.408 ' O ' HG13 ' B' ' 102' ' ' VAL . 23.6 t -86.79 -13.74 10.53 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.329 0 CA-C-O 122.291 1.043 . . . . 8.81 111.361 -175.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 103' ' ' LEU . . . . . 1.036 ' HA ' ' HA ' ' B' ' 108' ' ' ARG . 0.3 OUTLIER -153.28 111.18 3.58 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 102.349 -3.204 . . . . 6.28 102.349 176.506 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 104' ' ' ASP . . . . . 0.432 ' OD2' ' HB1' ' B' ' 101' ' ' ALA . 0.4 OUTLIER -165.84 -105.91 0.01 OUTLIER 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 105.902 -1.888 . . . . 6.27 105.902 176.176 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . 0.501 ' HA ' HD11 ' B' ' 105' ' ' LEU . 10.2 tp -133.94 6.54 3.68 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 113.39 -1.732 . . . . 7.61 109.812 176.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 106' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.33 -63.83 1.27 Allowed 'General case' 0 CA--C 1.496 -1.12 0 N-CA-C 102.837 -3.023 . . . . 8.55 102.837 176.546 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 107' ' ' VAL . . . . . 0.591 ' HA ' ' CG ' ' B' ' 155' ' ' GLN . 2.7 p -154.48 114.92 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.541 0 N-CA-C 102.93 -2.989 . . . . 7.84 102.93 163.267 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 108' ' ' ARG . . . . . 1.036 ' HA ' ' HA ' ' B' ' 103' ' ' LEU . 0.0 OUTLIER -80.11 117.42 20.91 Favored 'General case' 0 CA--C 1.475 -1.913 0 CA-C-N 122.17 2.259 . . . . 9.75 107.638 178.436 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 109' ' ' THR . . . . . 0.41 ' O ' HG23 ' B' ' 109' ' ' THR . 2.5 t -63.9 105.27 0.81 Allowed 'General case' 0 C--N 1.317 -0.809 0 C-N-CA 114.256 -2.978 . . . . 6.13 107.437 -179.226 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 110' ' ' CYS . . . . . 0.595 ' HB2' ' HG2' ' B' ' 120' ' ' ARG . 79.7 m -81.63 111.21 17.7 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 113.76 -1.564 . . . . 2.87 112.653 178.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 111' ' ' LEU . . . . . 0.509 ' C ' ' O ' ' B' ' 110' ' ' CYS . 17.8 mt -29.82 136.07 0.18 Allowed Pre-proline 0 N--CA 1.475 0.796 0 CA-C-N 119.034 0.834 . . . . 2.95 111.369 178.412 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 112' ' ' PRO . . . . . 0.74 ' HA ' ' O ' ' B' ' 119' ' ' GLY . 33.6 Cg_endo -65.32 151.99 83.49 Favored 'Trans proline' 0 CA--C 1.536 0.587 0 C-N-CA 123.383 2.722 . . . . 1.71 113.541 -179.34 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.748 ' N ' ' O ' ' B' ' 119' ' ' GLY . 0.0 OUTLIER -156.77 -168.69 2.75 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.232 0.539 . . . . 1.0 111.222 175.471 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 114' ' ' GLY . . . . . 0.66 ' N ' ' SG ' ' B' ' 113' ' ' CYS . . . 76.14 -159.76 50.71 Favored Glycine 0 C--N 1.334 0.437 0 CA-C-N 115.479 -0.782 . . . . 1.16 114.902 176.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 115' ' ' PRO . . . . . 0.67 ' HD2' HD23 ' B' ' 132' ' ' LEU . 68.2 Cg_endo -62.28 98.31 0.18 Allowed 'Trans proline' 0 CA--C 1.511 -0.629 0 C-N-CA 124.215 3.277 . . . . 1.6 112.066 178.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 84.76 3.07 88.38 Favored Glycine 0 C--N 1.284 -2.312 0 CA-C-N 113.63 -1.623 . . . . 1.7 113.132 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 117' ' ' GLY . . . . . 0.431 ' O ' ' HB2' ' B' ' 112' ' ' PRO . . . 76.46 41.31 25.55 Favored Glycine 0 N--CA 1.411 -2.976 0 C-N-CA 119.75 -1.214 . . . . 1.38 115.615 176.36 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.99 -30.1 14.9 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-O 121.809 0.814 . . . . 2.96 110.198 177.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 119' ' ' GLY . . . . . 0.748 ' O ' ' N ' ' B' ' 113' ' ' CYS . . . -78.65 161.39 48.07 Favored Glycine 0 C--O 1.201 -1.909 0 N-CA-C 118.745 2.258 . . . . 1.07 118.745 -175.212 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.595 ' HG2' ' HB2' ' B' ' 110' ' ' CYS . 0.1 OUTLIER -104.24 142.39 34.61 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 110.214 -2.993 . . . . 3.29 113.747 -172.55 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 121' ' ' CYS . . . . . 0.459 ' O ' ' HB3' ' B' ' 110' ' ' CYS . 73.3 m -108.51 138.98 43.92 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 114.777 -1.101 . . . . 1.21 111.23 -178.435 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 122' ' ' PHE . . . . . 0.619 ' CE1' ' HB2' ' B' ' 128' ' ' CYS . 1.4 m-85 -124.42 -9.67 7.46 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.185 -0.461 . . . . 2.28 112.052 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 123' ' ' GLY . . . . . 0.502 ' HA3' ' OE2' ' A' ' 81' ' ' GLU . . . -159.22 -161.3 11.06 Favored Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.6 -0.81 . . . . 1.04 112.465 179.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . 0.562 ' HD2' ' HG2' ' A' ' 81' ' ' GLU . 7.9 Cg_exo -69.54 -52.94 0.31 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.93 2.42 . . . . 1.84 112.302 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 125' ' ' SER . . . . . 0.615 ' O ' ' N ' ' B' ' 137' ' ' GLY . 0.4 OUTLIER -118.75 44.03 2.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.054 -0.521 . . . . 1.49 110.787 -179.811 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 126' ' ' ILE . . . . . 0.633 HD12 ' HG3' ' A' ' 81' ' ' GLU . 57.7 mt -141.8 120.95 10.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 N-CA-C 112.812 0.671 . . . . 1.41 112.812 -179.065 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 127' ' ' CYS . . . . . 0.816 ' O ' ' HA ' ' B' ' 134' ' ' CYS . 7.0 t -135.08 144.79 47.38 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.72 -0.673 . . . . 0.89 109.472 178.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 128' ' ' CYS . . . . . 0.923 ' HA ' ' O ' ' B' ' 133' ' ' GLY . 0.4 OUTLIER -138.99 153.58 48.17 Favored 'General case' 0 CA--C 1.552 1.042 0 N-CA-C 115.541 1.682 . . . . 1.23 115.541 -176.959 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 129' ' ' GLY . . . . . 0.81 ' O ' ' HB3' ' B' ' 169' ' ' ALA . . . -143.25 165.96 26.89 Favored Glycine 0 N--CA 1.43 -1.72 0 CA-C-N 111.262 -2.699 . . . . 0.69 113.767 179.26 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 15.4 p-10 -68.97 -41.64 77.69 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 126.028 1.731 . . . . 2.35 110.706 177.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -129.69 33.65 4.42 Favored 'General case' 0 CA--C 1.479 -1.78 0 CA-C-N 111.436 -2.62 . . . . 1.69 108.663 170.082 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 132' ' ' LEU . . . . . 0.67 HD23 ' HD2' ' B' ' 115' ' ' PRO . 0.1 OUTLIER -131.2 -1.44 4.03 Favored 'General case' 0 N--CA 1.401 -2.89 0 N-CA-C 107.645 -1.242 . . . . 1.84 107.645 179.59 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 133' ' ' GLY . . . . . 0.923 ' O ' ' HA ' ' B' ' 128' ' ' CYS . . . 44.32 -133.98 6.64 Favored Glycine 0 N--CA 1.426 -1.992 0 CA-C-N 115.07 -0.968 . . . . 0.76 112.909 179.263 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 134' ' ' CYS . . . . . 0.816 ' HA ' ' O ' ' B' ' 127' ' ' CYS . 0.1 OUTLIER -134.9 111.58 9.97 Favored 'General case' 0 CA--C 1.486 -1.512 0 N-CA-C 113.653 0.983 . . . . 1.08 113.653 -178.721 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 135' ' ' PHE . . . . . 0.704 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 27.5 m-85 -84.43 106.82 16.31 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 104.694 -2.336 . . . . 1.83 104.694 176.035 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 136' ' ' VAL . . . . . 0.559 ' CG2' ' CG2' ' A' ' 36' ' ' VAL . 12.6 t -92.33 84.79 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.669 0 CA-C-O 122.987 1.375 . . . . 1.29 108.65 -179.178 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 137' ' ' GLY . . . . . 0.615 ' N ' ' O ' ' B' ' 125' ' ' SER . . . 88.65 107.95 1.07 Allowed Glycine 0 CA--C 1.523 0.579 0 CA-C-N 112.493 -2.139 . . . . 0.85 115.098 179.184 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 138' ' ' THR . . . . . 0.477 ' CG2' ' HB3' ' B' ' 135' ' ' PHE . 0.1 OUTLIER -174.01 -179.51 1.71 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 107.704 -1.221 . . . . 1.2 107.704 178.472 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 139' ' ' ALA . . . . . 0.513 ' HA ' ' CD1' ' B' ' 142' ' ' LEU . . . -65.07 -37.67 88.3 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 119.68 1.127 . . . . 1.35 111.393 179.309 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 140' ' ' GLU . . . . . 0.58 ' HG2' ' HA2' ' B' ' 114' ' ' GLY . 0.2 OUTLIER -62.04 -22.85 66.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.061 0.458 . . . . 2.31 111.386 -179.418 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 141' ' ' ALA . . . . . 0.608 ' O ' ' N ' ' B' ' 144' ' ' CYS . . . -93.39 -19.46 21.28 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.508 -0.769 . . . . 1.09 110.972 -179.411 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 142' ' ' LEU . . . . . 0.57 ' O ' ' HB2' ' B' ' 145' ' ' GLN . 4.8 mt -43.95 -45.56 7.78 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.448 0.536 . . . . 1.61 112.448 -178.651 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 143' ' ' ARG . . . . . 0.56 ' C ' ' H ' ' B' ' 145' ' ' GLN . 0.0 OUTLIER -55.56 -24.16 30.91 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 107.905 -1.146 . . . . 3.43 107.905 178.331 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 144' ' ' CYS . . . . . 0.608 ' N ' ' O ' ' B' ' 141' ' ' ALA . 35.0 m -69.61 8.49 0.65 Allowed 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 115.838 -0.619 . . . . 1.61 110.559 -179.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 145' ' ' GLN . . . . . 0.57 ' HB2' ' O ' ' B' ' 142' ' ' LEU . 0.7 OUTLIER -78.84 -20.11 50.42 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.015 -0.993 . . . . 3.52 110.838 178.399 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 146' ' ' GLU . . . . . 0.555 ' HA ' ' CD2' ' B' ' 149' ' ' TYR . 16.5 tt0 -86.73 -0.45 56.34 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 120.384 -0.526 . . . . 3.76 110.817 -179.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.94 3.52 29.64 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 109.491 -0.559 . . . . 4.01 109.491 177.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 148' ' ' ASN . . . . . 0.438 ' ND2' ' HG3' ' B' ' 124' ' ' PRO . 0.4 OUTLIER -97.21 -28.28 14.16 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 116.195 -0.457 . . . . 4.24 110.076 178.676 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 149' ' ' TYR . . . . . 0.555 ' CD2' ' HA ' ' B' ' 146' ' ' GLU . 43.1 m-85 -69.84 9.03 0.58 Allowed 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 112.305 0.483 . . . . 6.07 112.305 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 1.7 mt -131.28 121.11 18.38 Favored Pre-proline 0 CA--C 1.529 0.159 0 O-C-N 122.442 -0.161 . . . . 5.86 111.2 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 151' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -80.7 49.01 3.08 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.404 2.069 . . . . 5.42 112.255 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 61.4 p -139.76 159.57 64.49 Favored Pre-proline 0 CA--C 1.53 0.199 0 CA-C-N 116.273 -0.421 . . . . 6.02 110.767 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 153' ' ' PRO . . . . . 0.414 ' O ' ' CD ' ' B' ' 108' ' ' ARG . 2.2 Cg_endo -82.85 -163.72 0.23 Allowed 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 123.343 2.695 . . . . 5.87 113.427 -178.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 154' ' ' CYS . . . . . 0.809 ' HA ' ' CB ' ' B' ' 108' ' ' ARG . 0.5 OUTLIER -159.88 127.21 4.59 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.709 -0.678 . . . . 2.96 109.196 -179.937 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 155' ' ' GLN . . . . . 1.015 ' H ' ' HB2' ' B' ' 108' ' ' ARG . 0.7 OUTLIER -50.03 -170.44 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.235 0 CA-C-N 119.29 0.95 . . . . 6.3 112.819 -178.491 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 9.8 p -176.31 -143.91 0.02 OUTLIER 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 114.662 -1.154 . . . . 3.41 110.611 177.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 157' ' ' GLY . . . . . 0.571 ' HA3' ' O ' ' B' ' 167' ' ' CYS . . . -101.39 152.85 18.89 Favored Glycine 0 CA--C 1.49 -1.498 0 N-CA-C 109.14 -1.584 . . . . 2.26 109.14 175.205 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 18.2 mm100 -103.79 65.81 0.83 Allowed 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 117.352 -1.739 . . . . 5.03 111.157 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 159' ' ' LYS . . . . . 0.645 ' HB2' ' HB2' ' B' ' 167' ' ' CYS . 0.0 OUTLIER -114.37 56.19 0.81 Allowed Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 113.736 -1.574 . . . . 3.96 109.815 172.343 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 160' ' ' PRO . . . . . 0.512 ' HA ' ' HA ' ' B' ' 166' ' ' ARG . 27.2 Cg_endo -62.96 79.16 0.11 Allowed 'Trans proline' 0 CA--C 1.518 -0.299 0 CA-C-N 121.584 1.602 . . . . 1.7 115.818 -173.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 161' ' ' CYS . . . . . 0.468 ' O ' ' O ' ' B' ' 165' ' ' GLY . 0.5 OUTLIER -98.89 -176.47 3.35 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 107.044 -1.465 . . . . 1.93 107.044 176.183 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 69.74 -167.03 48.58 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 118.468 -1.825 . . . . 2.37 111.826 178.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 24.4 p -85.28 41.46 0.89 Allowed 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.058 0.456 . . . . 4.56 111.717 -178.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 120.52 7.07 9.19 Favored Glycine 0 CA--C 1.536 1.346 0 CA-C-O 118.884 -0.953 . . . . 2.39 113.79 -179.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 165' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' B' ' 161' ' ' CYS . . . -102.28 134.29 11.72 Favored Glycine 0 CA--C 1.523 0.57 0 C-N-CA 118.498 -1.811 . . . . 1.79 115.388 -177.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 166' ' ' ARG . . . . . 0.568 ' HB2' ' O ' ' B' ' 157' ' ' GLY . 0.0 OUTLIER -97.3 153.17 18.21 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 114.947 -0.627 . . . . 3.53 110.352 178.603 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 167' ' ' CYS . . . . . 0.645 ' HB2' ' HB2' ' B' ' 159' ' ' LYS . 2.2 m -65.52 108.6 2.06 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 120.008 -0.677 . . . . 1.56 110.131 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 168' ' ' ALA . . . . . 0.455 ' HB1' ' HB2' ' B' ' 174' ' ' CYS . . . -78.96 -19.92 50.49 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 106.637 -1.616 . . . . 1.42 106.637 176.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 169' ' ' ALA . . . . . 0.835 ' O ' ' O ' ' B' ' 170' ' ' ALA . . . -160.89 161.37 31.76 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 111.82 -2.445 . . . . 1.18 111.036 -178.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 170' ' ' ALA . . . . . 0.835 ' O ' ' O ' ' B' ' 169' ' ' ALA . . . -18.06 -135.15 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.771 0.829 . . . . 1.47 113.217 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 171' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' B' ' 185' ' ' CYS . . . -55.85 37.49 0.01 OUTLIER Glycine 0 CA--C 1.537 1.425 0 N-CA-C 114.97 0.748 . . . . 1.45 114.97 -178.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 172' ' ' ILE . . . . . 0.804 HD11 ' HB2' ' B' ' 134' ' ' CYS . 0.7 OUTLIER -134.41 107.01 8.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-O 122.079 0.942 . . . . 2.7 111.865 -176.755 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 173' ' ' CYS . . . . . 0.533 ' HB2' ' HB3' ' B' ' 182' ' ' ASP . 0.0 OUTLIER -93.29 82.91 4.52 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.476 -0.783 . . . . 1.94 110.526 -179.623 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 174' ' ' CYS . . . . . 0.84 ' HA ' ' HA ' ' B' ' 179' ' ' CYS . 0.1 OUTLIER -83.24 136.76 34.28 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.943 -0.571 . . . . 1.43 110.797 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 175' ' ' SER . . . . . 0.627 ' HB3' ' HD2' ' B' ' 176' ' ' PRO . 5.1 m -104.79 179.41 0.94 Allowed Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.312 -0.858 . . . . 2.3 109.236 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 176' ' ' PRO . . . . . 0.627 ' HD2' ' HB3' ' B' ' 175' ' ' SER . 95.6 Cg_endo -80.01 25.13 0.61 Allowed 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 121.406 1.404 . . . . 2.13 111.674 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 177' ' ' ASP . . . . . 0.407 ' H ' ' C ' ' B' ' 175' ' ' SER . 11.7 m-20 -145.53 -41.55 0.22 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.594 -0.73 . . . . 2.72 110.298 179.226 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 178' ' ' GLY . . . . . 0.801 ' HA3' ' O ' ' A' ' 79' ' ' CYS . . . -147.84 -135.18 2.58 Favored Glycine 0 C--N 1.337 0.617 0 C-N-CA 120.646 -0.788 . . . . 1.05 113.149 179.304 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 179' ' ' CYS . . . . . 0.84 ' HA ' ' HA ' ' B' ' 174' ' ' CYS . 0.1 OUTLIER -146.96 156.3 42.95 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.554 0.216 . . . . 1.39 110.604 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 180' ' ' HIS . . . . . 0.471 ' N ' ' O ' ' B' ' 173' ' ' CYS . 6.6 t-160 -142.19 133.73 26.68 Favored 'General case' 0 CA--C 1.519 -0.23 0 O-C-N 122.034 -0.416 . . . . 2.73 111.648 -178.43 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 181' ' ' GLU . . . . . 0.561 ' HG2' ' HD2' ' A' ' 24' ' ' PRO . 2.4 mt-10 -58.59 128.08 35.39 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.846 -0.615 . . . . 3.06 109.703 178.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 182' ' ' ASP . . . . . 0.533 ' HB3' ' HB2' ' B' ' 173' ' ' CYS . 0.0 OUTLIER -146.37 112.72 4.38 Favored Pre-proline 0 C--N 1.318 -0.764 0 CA-C-N 115.537 -0.756 . . . . 2.06 110.394 -178.87 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 183' ' ' PRO . . . . . 0.455 ' HA ' ' OD2' ' B' ' 186' ' ' ASP . 1.6 Cg_endo -82.86 -4.41 11.33 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.617 2.212 . . . . 2.27 113.302 -179.344 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -66.94 -35.39 79.88 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.89 0.376 . . . . 1.56 111.032 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 185' ' ' CYS . . . . . 0.595 ' C ' ' HD3' ' B' ' 187' ' ' PRO . 83.4 m -93.86 49.5 1.35 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.07 -0.514 . . . . 1.94 111.007 179.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 186' ' ' ASP . . . . . 0.695 ' N ' ' HD3' ' B' ' 187' ' ' PRO . 16.8 m-20 -116.38 35.27 0.2 Allowed Pre-proline 0 N--CA 1.443 -0.817 0 N-CA-C 112.364 0.505 . . . . 3.61 112.364 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 187' ' ' PRO . . . . . 0.695 ' HD3' ' N ' ' B' ' 186' ' ' ASP . 1.3 Cg_endo -78.19 59.3 6.97 Favored 'Trans proline' 0 CA--C 1.489 -1.753 0 N-CA-C 108.432 -1.411 . . . . 3.14 108.432 177.29 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 188' ' ' GLU . . . . . 0.483 ' HG3' ' N ' ' B' ' 189' ' ' ALA . 4.8 pt-20 -177.51 -34.02 0.01 OUTLIER 'General case' 0 CA--C 1.481 -1.711 0 CA-C-N 113.011 -1.904 . . . . 4.7 109.149 -177.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 189' ' ' ALA . . . . . 0.483 ' N ' ' HG3' ' B' ' 188' ' ' GLU . . . -68.95 47.29 0.06 Allowed 'General case' 0 C--N 1.355 0.843 0 CA-C-N 111.221 -2.718 . . . . 5.24 112.66 179.428 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 190' ' ' ALA . . . . . . . . . . . . . . . -69.11 123.46 21.15 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 125.674 1.59 . . . . 6.93 111.928 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 191' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -71.69 130.92 42.34 Favored 'General case' 0 C--N 1.34 0.154 0 CA-C-N 112.061 -2.336 . . . . 10.62 113.83 -175.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 13.9 t . . . . . 0 C--O 1.249 1.029 0 CA-C-N 114.375 -1.284 . . . . 11.7 110.525 179.202 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.44 ' C ' ' CG2' ' A' ' 2' ' ' VAL . . . . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 120.891 0.377 . . . . 10.31 111.469 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.44 ' CG2' ' C ' ' A' ' 1' ' ' ALA . 0.2 OUTLIER -167.76 49.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 108.526 -0.916 . . . . 8.37 108.526 177.605 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.574 ' HA ' ' HG2' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -98.13 -12.95 21.23 Favored 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 118.187 2.662 . . . . 6.25 118.187 -175.989 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -59.0 -80.95 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 122.891 2.587 . . . . 6.22 114.625 -176.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.437 HD11 ' HB2' ' A' ' 55' ' ' GLN . 11.9 tp -151.54 24.5 0.69 Allowed 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 114.592 1.331 . . . . 7.57 114.592 -177.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -88.73 -67.62 0.82 Allowed 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 104.499 -2.408 . . . . 8.78 104.499 174.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 1.11 ' HA ' ' HG2' ' A' ' 55' ' ' GLN . 7.1 p -156.52 114.23 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.414 -2.263 0 CA-C-N 112.422 -2.172 . . . . 7.88 105.669 166.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.703 ' HB2' ' H ' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -82.05 115.44 21.19 Favored 'General case' 0 N--CA 1.41 -2.461 0 N-CA-C 107.135 -1.432 . . . . 9.7 107.135 176.824 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 31.6 p -65.77 107.12 1.69 Allowed 'General case' 0 C--N 1.289 -2.049 0 C-N-CA 113.78 -3.168 . . . . 6.05 106.003 177.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.963 ' HB2' ' HG2' ' A' ' 20' ' ' ARG . 53.6 m -78.48 113.77 16.79 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 114.652 -1.158 . . . . 2.89 112.593 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.45 ' HG ' ' HD2' ' A' ' 12' ' ' PRO . 6.0 tp -26.76 135.0 0.11 Allowed Pre-proline 0 N--CA 1.486 1.371 0 N-CA-C 113.619 0.97 . . . . 2.89 113.619 179.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.612 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 52.0 Cg_endo -75.04 145.11 30.91 Favored 'Trans proline' 0 CA--C 1.552 1.401 0 C-N-CA 123.384 2.723 . . . . 1.72 117.264 -178.299 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.4 ' O ' ' HA2' ' A' ' 17' ' ' GLY . 0.1 OUTLIER -155.31 173.57 16.46 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-N 112.625 -2.08 . . . . 1.0 115.376 -174.709 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 79.3 -159.97 45.49 Favored Glycine 0 CA--C 1.533 1.185 0 CA-C-N 114.406 -1.27 . . . . 1.15 110.657 -172.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.524 ' HG2' ' O ' ' A' ' 15' ' ' PRO . 60.1 Cg_endo -62.25 109.26 0.8 Allowed 'Trans proline' 0 N--CA 1.488 1.185 0 C-N-CA 123.65 2.9 . . . . 1.6 110.178 178.276 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 74.96 5.63 76.12 Favored Glycine 0 C--N 1.293 -1.839 0 CA-C-N 114.649 -1.16 . . . . 1.68 112.071 176.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.4 ' HA2' ' O ' ' A' ' 13' ' ' CYS . . . 63.73 62.14 5.55 Favored Glycine 1 N--CA 1.396 -4.024 0 C-N-CA 118.824 -1.655 . . . . 1.37 110.524 -177.756 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.474 ' HG2' ' O ' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -100.29 17.95 20.09 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 105.878 -1.897 . . . . 2.91 105.878 168.892 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.612 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -109.26 -178.61 21.34 Favored Glycine 0 N--CA 1.426 -1.99 0 N-CA-C 117.205 1.642 . . . . 1.06 117.205 -173.087 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.963 ' HG2' ' HB2' ' A' ' 10' ' ' CYS . 2.9 mtp-105 -143.12 135.71 27.53 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 110.913 -2.643 . . . . 3.32 112.572 176.009 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.59 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 1.7 m -107.72 159.52 16.42 Favored 'General case' 0 C--N 1.343 0.298 0 CA-C-O 121.554 0.692 . . . . 1.19 112.701 -177.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -132.06 8.51 4.41 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 114.784 -1.098 . . . . 2.26 110.951 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -179.64 -163.9 31.14 Favored Glycine 0 C--N 1.338 0.654 0 C-N-CA 121.046 -0.597 . . . . 1.05 112.478 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.457 ' HG2' ' OE1' ' B' ' 181' ' ' GLU . 12.5 Cg_exo -69.56 -71.01 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.74 2.293 . . . . 1.81 112.305 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.596 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.5 OUTLIER -100.33 33.9 2.54 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 120.933 0.397 . . . . 1.62 110.111 179.508 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.909 HG12 HG12 ' A' ' 36' ' ' VAL . 6.3 mt -139.07 120.54 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 CA-C-N 116.173 -0.467 . . . . 1.39 111.64 -178.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.59 ' HA ' ' HA ' ' A' ' 21' ' ' CYS . 49.6 t -142.22 122.56 13.96 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.765 -0.652 . . . . 0.92 110.179 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 1.124 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -127.59 152.51 47.55 Favored 'General case' 0 CA--C 1.551 0.983 0 N-CA-C 114.521 1.304 . . . . 1.28 114.521 -177.961 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.575 ' N ' ' O ' ' A' ' 33' ' ' GLY . . . -150.26 -176.29 23.16 Favored Glycine 0 C--N 1.354 1.575 0 N-CA-C 110.927 -0.869 . . . . 0.71 110.927 178.15 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.551 ' CB ' ' HB3' ' A' ' 91' ' ' PHE . 2.5 p-10 -66.03 -54.01 31.37 Favored 'General case' 0 CA--C 1.56 1.359 0 C-N-CA 124.952 1.301 . . . . 2.27 112.211 179.546 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.36 -18.79 19.69 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 111.514 -2.585 . . . . 1.66 110.375 172.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.656 HD22 ' CE1' ' A' ' 35' ' ' PHE . 4.1 mt -99.9 7.6 44.76 Favored 'General case' 0 N--CA 1.4 -2.935 0 CA-C-N 115.892 -0.594 . . . . 1.93 110.749 -172.334 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 1.124 ' O ' ' HA ' ' A' ' 28' ' ' CYS . . . 24.87 -136.91 0.01 OUTLIER Glycine 0 C--O 1.21 -1.394 0 CA-C-O 118.635 -1.092 . . . . 0.77 111.959 179.165 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.705 ' HB2' ' CD1' ' A' ' 72' ' ' ILE . 1.0 OUTLIER -129.97 124.05 32.09 Favored 'General case' 0 CA--C 1.498 -1.044 0 CA-C-N 119.051 1.425 . . . . 1.08 112.422 -179.047 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.656 ' CE1' HD22 ' A' ' 32' ' ' LEU . 34.7 m-85 -97.91 105.24 17.36 Favored 'General case' 0 N--CA 1.422 -1.842 0 N-CA-C 103.597 -2.742 . . . . 1.85 103.597 174.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.909 HG12 HG12 ' A' ' 26' ' ' ILE . 1.8 t -100.91 85.59 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.884 0 CA-C-O 123.152 1.453 . . . . 1.29 107.112 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.596 ' N ' ' O ' ' A' ' 25' ' ' SER . . . 125.9 -77.7 0.38 Allowed Glycine 0 CA--C 1.524 0.607 0 CA-C-N 112.925 -1.943 . . . . 0.85 115.06 -179.38 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.598 HG22 ' CE2' ' B' ' 135' ' ' PHE . 9.9 t -32.2 124.95 0.3 Allowed 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 113.347 0.869 . . . . 1.3 113.347 -177.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.821 ' HA ' ' HG ' ' A' ' 42' ' ' LEU . . . -26.92 -35.02 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 114.12 -1.4 . . . . 1.45 113.409 -179.124 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.524 ' N ' ' O ' ' A' ' 38' ' ' THR . 1.7 mt-10 -48.13 -13.77 0.05 OUTLIER 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.634 0.254 . . . . 2.32 111.05 178.309 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.662 ' O ' ' N ' ' A' ' 44' ' ' CYS . . . -114.96 -44.42 3.03 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 109.448 -0.575 . . . . 1.11 109.448 178.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.927 HD13 ' N ' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -37.88 -19.49 0.01 OUTLIER 'General case' 0 C--N 1.346 0.417 0 N-CA-C 115.481 1.659 . . . . 1.68 115.481 -173.232 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.927 ' N ' HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -68.02 -13.65 62.35 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 106.575 -1.639 . . . . 3.4 106.575 174.708 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.662 ' N ' ' O ' ' A' ' 41' ' ' ALA . 64.0 m -85.42 25.12 1.07 Allowed 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 114.151 -1.386 . . . . 1.57 109.953 177.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -92.31 -18.66 23.05 Favored 'General case' 0 CA--C 1.509 -0.63 0 N-CA-C 107.859 -1.163 . . . . 3.49 107.859 176.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -86.87 5.46 36.73 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-N 115.174 -0.921 . . . . 3.69 109.222 177.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.34 3.34 31.99 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 119.962 -0.695 . . . . 3.99 109.289 177.419 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.485 ' C ' ' H ' ' A' ' 50' ' ' LEU . 2.8 t-20 -87.86 -28.0 21.87 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 116.055 -0.52 . . . . 4.2 109.966 178.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -59.72 8.22 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.324 0.861 . . . . 5.85 113.324 -179.483 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.485 ' H ' ' C ' ' A' ' 48' ' ' ASN . 0.5 OUTLIER -148.71 107.77 3.51 Favored Pre-proline 0 N--CA 1.463 0.18 0 O-C-N 122.099 -0.376 . . . . 5.83 111.245 179.82 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -78.24 50.14 3.25 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.504 2.136 . . . . 5.3 112.693 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.407 ' HB2' ' HD2' ' A' ' 53' ' ' PRO . 10.7 p -114.08 160.15 33.55 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.445 -0.343 . . . . 5.72 110.392 179.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.475 ' O ' ' HG3' ' A' ' 8' ' ' ARG . 57.3 Cg_endo -72.04 -174.25 1.31 Allowed 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.452 2.102 . . . . 5.82 113.237 -179.276 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.602 ' HA ' ' CB ' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -157.1 95.57 1.51 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.763 -0.653 . . . . 2.98 109.697 179.879 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 1.11 ' HG2' ' HA ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -56.65 178.29 0.06 Allowed 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 119.848 -0.741 . . . . 6.42 111.866 -179.121 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.508 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 48.8 m 86.68 100.46 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 117.595 2.443 . . . . 3.36 117.595 175.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 134.71 69.94 0.07 OUTLIER Glycine 0 N--CA 1.427 -1.948 0 N-CA-C 109.975 -1.25 . . . . 2.3 109.975 -178.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 -117.95 72.89 0.87 Allowed 'General case' 0 N--CA 1.441 -0.923 0 CA-C-O 122.634 1.207 . . . . 5.06 108.032 179.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.638 ' CB ' ' HB2' ' A' ' 67' ' ' CYS . 10.0 mtmm -144.64 58.34 5.43 Favored Pre-proline 0 C--N 1.302 -1.475 0 CA-C-N 113.132 -1.849 . . . . 3.91 107.197 179.152 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.632 ' HA ' ' O ' ' A' ' 65' ' ' GLY . 37.7 Cg_endo -66.2 86.56 0.25 Allowed 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 122.605 2.204 . . . . 1.74 116.591 -177.231 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.467 ' SG ' ' HB2' ' A' ' 82' ' ' ASP . 0.5 OUTLIER -100.11 -173.44 2.43 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.308 -1.367 . . . . 1.9 107.308 175.471 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 62.83 -166.43 23.13 Favored Glycine 0 CA--C 1.519 0.331 0 C-N-CA 118.264 -1.922 . . . . 2.43 112.296 176.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 64.5 m -77.72 42.9 0.39 Allowed 'General case' 0 C--N 1.327 -0.371 0 O-C-N 122.494 -0.415 . . . . 4.32 111.75 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 110.51 11.31 19.89 Favored Glycine 0 N--CA 1.446 -0.681 0 N-CA-C 116.846 1.498 . . . . 2.4 116.846 176.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.632 ' O ' ' HA ' ' A' ' 60' ' ' PRO . . . -104.73 154.37 17.39 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 120.893 2.347 . . . . 1.82 112.902 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.12 150.13 23.25 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 121.266 0.555 . . . . 3.51 112.442 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.638 ' HB2' ' CB ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -72.36 112.71 8.67 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 113.671 0.989 . . . . 1.52 113.671 -179.951 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.869 ' HB2' ' HB2' ' A' ' 28' ' ' CYS . . . -99.76 -16.32 18.15 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 122.514 1.15 . . . . 1.5 108.053 175.47 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.9 ' CB ' ' HA2' ' A' ' 33' ' ' GLY . . . -162.96 161.14 25.49 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 112.506 -2.134 . . . . 1.31 116.532 176.466 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.855 ' HA ' ' HB3' ' A' ' 85' ' ' CYS . . . -50.38 121.77 6.1 Favored 'General case' 0 C--N 1.345 0.4 0 CA-C-N 113.719 -1.582 . . . . 1.5 111.725 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.605 ' HA2' ' O ' ' A' ' 82' ' ' ASP . . . 59.83 36.49 90.13 Favored Glycine 0 N--CA 1.443 -0.885 0 N-CA-C 110.018 -1.233 . . . . 1.44 110.018 -178.27 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.972 ' O ' HG13 ' A' ' 72' ' ' ILE . 0.5 OUTLIER -145.0 108.17 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 O-C-N 121.957 -0.731 . . . . 2.77 109.927 176.984 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -106.04 102.4 11.82 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 108.883 -0.784 . . . . 1.98 108.883 178.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.776 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 3.4 t -92.7 122.42 35.09 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 121.702 0.763 . . . . 1.43 112.283 -178.394 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.583 ' HA ' ' HA2' ' A' ' 65' ' ' GLY . 0.3 OUTLIER -90.59 -179.25 1.12 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 114.375 -1.284 . . . . 2.37 109.733 179.532 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.457 ' HD2' ' CB ' ' A' ' 75' ' ' SER . 86.3 Cg_endo -77.6 25.22 0.49 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 121.828 1.685 . . . . 2.09 113.003 -179.309 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -145.6 -45.75 0.21 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.921 -0.77 . . . . 2.65 108.921 178.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.556 ' HA3' ' O ' ' B' ' 179' ' ' CYS . . . -149.37 -151.62 5.53 Favored Glycine 0 N--CA 1.446 -0.667 0 CA-C-N 115.39 -0.823 . . . . 1.04 111.659 178.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.776 ' HA ' ' HA ' ' A' ' 74' ' ' CYS . 0.0 OUTLIER -146.9 162.88 37.77 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.846 -0.427 . . . . 1.42 109.846 179.798 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.543 ' HB3' ' HA3' ' B' ' 178' ' ' GLY . 0.1 OUTLIER -150.52 160.82 43.52 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.016 0.436 . . . . 2.81 111.009 -179.036 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.534 ' H ' HD11 ' B' ' 126' ' ' ILE . 0.5 OUTLIER -63.76 146.07 54.58 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.383 -0.599 . . . . 3.05 109.383 179.287 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.605 ' O ' ' HA2' ' A' ' 71' ' ' GLY . 0.8 OUTLIER -145.78 140.77 16.03 Favored Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 120.423 -0.511 . . . . 2.02 111.99 -179.462 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.471 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 5.3 Cg_exo -80.61 -20.9 7.67 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.969 2.446 . . . . 2.29 113.665 -178.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.09 -40.96 87.06 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.162 0.506 . . . . 1.53 110.682 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.855 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 93.2 m -97.21 27.09 4.32 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.779 0.8 . . . . 1.88 110.192 179.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.67 ' N ' ' HD2' ' A' ' 87' ' ' PRO . 1.0 OUTLIER -77.29 -46.38 2.65 Favored Pre-proline 0 C--N 1.317 -0.843 0 CA-C-N 115.198 -0.91 . . . . 3.6 110.559 179.64 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.67 ' HD2' ' N ' ' A' ' 86' ' ' ASP . 17.9 Cg_endo -61.93 111.13 1.13 Allowed 'Trans proline' 0 N--CA 1.445 -1.324 0 C-N-CA 121.429 1.419 . . . . 3.12 111.396 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.592 ' C ' ' O ' ' A' ' 87' ' ' PRO . 0.2 OUTLIER -14.81 86.75 0.0 OUTLIER 'General case' 0 CA--C 1.469 -2.137 0 N-CA-C 104.299 -2.482 . . . . 4.72 104.299 -179.04 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.667 ' HB3' ' HB1' ' A' ' 70' ' ' ALA . . . -92.33 7.47 42.71 Favored 'General case' 0 CA--C 1.499 -0.985 0 CA-C-N 108.666 -3.879 . . . . 5.29 110.276 -178.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -55.39 112.78 1.19 Allowed 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 118.944 -1.102 . . . . 7.19 110.199 -177.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.551 ' HB3' ' CB ' ' A' ' 30' ' ' ASP . 8.1 t80 -87.12 133.42 33.62 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 120.312 -0.555 . . . . 10.7 109.621 178.6 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 12.5 m . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.174 -0.917 . . . . 11.77 110.621 -179.235 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 101' ' ' ALA . . . . . 0.516 ' O ' HG13 ' B' ' 102' ' ' VAL . . . . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 121.091 0.472 . . . . 10.42 111.285 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 102' ' ' VAL . . . . . 0.911 HG23 ' HB2' ' B' ' 106' ' ' ASP . 0.0 OUTLIER 177.2 155.78 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 108.106 -1.072 . . . . 8.81 108.106 -176.981 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 103' ' ' LEU . . . . . 0.735 ' HA ' ' HA ' ' B' ' 108' ' ' ARG . 0.1 OUTLIER -99.45 42.52 1.1 Allowed 'General case' 0 CA--C 1.503 -0.862 0 CA-C-O 122.394 1.092 . . . . 6.28 112.349 -175.891 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -105.84 -100.72 0.34 Allowed 'General case' 0 N--CA 1.398 -3.047 0 N-CA-C 101.566 -3.494 . . . . 6.27 101.566 168.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . 0.439 ' HA ' HD11 ' B' ' 105' ' ' LEU . 6.1 tp -125.69 16.73 8.11 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 118.501 -1.28 . . . . 7.61 113.431 -177.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 106' ' ' ASP . . . . . 0.911 ' HB2' HG23 ' B' ' 102' ' ' VAL . 0.1 OUTLIER -84.23 -92.73 0.08 Allowed 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 103.148 -2.908 . . . . 8.55 103.148 173.921 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 107' ' ' VAL . . . . . 1.088 ' HA ' ' HG2' ' B' ' 155' ' ' GLN . 5.4 p -132.2 115.43 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.177 0 N-CA-C 103.836 -2.653 . . . . 7.84 103.836 171.381 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 108' ' ' ARG . . . . . 0.735 ' HA ' ' HA ' ' B' ' 103' ' ' LEU . 0.0 OUTLIER -81.36 115.86 20.92 Favored 'General case' 0 CA--C 1.465 -2.295 0 N-CA-C 107.301 -1.37 . . . . 9.75 107.301 177.609 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 30.7 p -65.61 107.52 1.76 Allowed 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 113.975 -3.09 . . . . 6.13 105.976 177.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 110' ' ' CYS . . . . . 0.94 ' HB2' ' HG2' ' B' ' 120' ' ' ARG . 50.9 m -79.22 111.23 15.25 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 114.686 -1.143 . . . . 2.87 112.749 -179.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 111' ' ' LEU . . . . . 0.446 ' HG ' ' HD2' ' B' ' 112' ' ' PRO . 6.1 tp -24.32 134.2 0.08 OUTLIER Pre-proline 0 N--CA 1.485 1.281 0 N-CA-C 113.497 0.925 . . . . 2.95 113.497 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 112' ' ' PRO . . . . . 0.56 ' HA ' ' O ' ' B' ' 119' ' ' GLY . 29.2 Cg_endo -68.34 150.77 76.38 Favored 'Trans proline' 0 CA--C 1.547 1.127 0 C-N-CA 123.235 2.624 . . . . 1.71 114.796 -178.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -158.87 177.98 10.58 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 113.395 -1.729 . . . . 1.0 115.449 176.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . 78.06 -160.27 48.06 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 110.22 -1.152 . . . . 1.16 110.22 -175.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 115' ' ' PRO . . . . . 0.463 ' HG2' ' O ' ' B' ' 115' ' ' PRO . 54.6 Cg_endo -63.5 100.03 0.27 Allowed 'Trans proline' 0 N--CA 1.482 0.814 0 C-N-CA 123.985 3.124 . . . . 1.6 114.075 178.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 82.69 5.24 89.62 Favored Glycine 0 C--N 1.29 -2.019 0 CA-C-N 114.61 -1.177 . . . . 1.7 111.876 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . 70.44 47.62 41.73 Favored Glycine 1 N--CA 1.392 -4.288 0 C-N-CA 118.922 -1.608 . . . . 1.38 114.609 179.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.83 15.84 12.14 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 106.827 -1.546 . . . . 2.96 106.827 175.465 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 119' ' ' GLY . . . . . 0.56 ' O ' ' HA ' ' B' ' 112' ' ' PRO . . . -113.52 -171.17 17.66 Favored Glycine 0 N--CA 1.444 -0.827 0 N-CA-C 115.79 1.076 . . . . 1.07 115.79 -175.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.94 ' HG2' ' HB2' ' B' ' 110' ' ' CYS . 1.7 mtp-105 -146.89 138.94 24.58 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 114.509 -0.845 . . . . 3.29 109.396 -179.309 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 121' ' ' CYS . . . . . 0.593 ' HA ' ' HA ' ' B' ' 127' ' ' CYS . 1.7 m -107.84 160.86 15.41 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.613 0.721 . . . . 1.21 112.888 -177.129 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -132.18 8.59 4.37 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 114.697 -1.138 . . . . 2.28 110.867 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -179.67 -163.99 31.32 Favored Glycine 0 C--N 1.338 0.684 0 C-N-CA 120.885 -0.674 . . . . 1.04 112.387 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . 0.451 ' HG2' ' OE1' ' A' ' 81' ' ' GLU . 12.4 Cg_exo -69.47 -71.14 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.747 2.298 . . . . 1.84 112.313 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 125' ' ' SER . . . . . 0.595 ' O ' ' N ' ' B' ' 137' ' ' GLY . 0.5 OUTLIER -100.25 34.15 2.45 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 120.973 0.416 . . . . 1.49 110.04 179.436 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 126' ' ' ILE . . . . . 0.733 HG12 HG13 ' B' ' 136' ' ' VAL . 7.8 mt -138.71 120.44 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 CA-C-N 116.083 -0.508 . . . . 1.41 111.943 -178.474 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 127' ' ' CYS . . . . . 0.593 ' HA ' ' HA ' ' B' ' 121' ' ' CYS . 49.1 t -142.01 122.05 13.72 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 116.156 -0.474 . . . . 0.89 110.133 -179.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 128' ' ' CYS . . . . . 1.088 ' HA ' ' O ' ' B' ' 133' ' ' GLY . 0.0 OUTLIER -124.57 157.34 35.63 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 114.218 1.192 . . . . 1.23 114.218 -178.707 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 129' ' ' GLY . . . . . 0.733 ' O ' ' HB1' ' B' ' 169' ' ' ALA . . . -153.78 -177.13 26.93 Favored Glycine 0 N--CA 1.434 -1.472 0 N-CA-C 111.087 -0.805 . . . . 0.69 111.087 177.214 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 130' ' ' ASP . . . . . 0.537 ' CB ' ' HB3' ' B' ' 191' ' ' PHE . 2.4 p-10 -65.08 -53.38 46.49 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 124.337 1.055 . . . . 2.35 111.038 179.518 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.96 32.65 5.87 Favored 'General case' 0 CA--C 1.483 -1.613 0 N-CA-C 106.276 -1.75 . . . . 1.69 106.276 174.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 132' ' ' LEU . . . . . 0.425 ' O ' ' C ' ' B' ' 133' ' ' GLY . 2.1 mt -135.53 9.7 3.41 Favored 'General case' 0 N--CA 1.393 -3.28 0 N-CA-C 106.413 -1.699 . . . . 1.84 106.413 175.057 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 133' ' ' GLY . . . . . 1.088 ' O ' ' HA ' ' B' ' 128' ' ' CYS . . . 25.66 -128.87 0.03 OUTLIER Glycine 0 N--CA 1.41 -3.089 0 CA-C-N 115.29 -0.868 . . . . 0.76 114.43 178.331 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 134' ' ' CYS . . . . . 0.739 ' HB2' ' CD1' ' B' ' 172' ' ' ILE . 0.8 OUTLIER -134.96 125.1 25.97 Favored 'General case' 0 CA--C 1.494 -1.192 0 CA-C-N 117.326 0.563 . . . . 1.08 111.614 177.305 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 135' ' ' PHE . . . . . 0.598 ' CE2' HG22 ' A' ' 38' ' ' THR . 34.9 m-85 -99.91 104.99 16.66 Favored 'General case' 0 N--CA 1.422 -1.848 0 N-CA-C 103.29 -2.856 . . . . 1.83 103.29 174.299 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 136' ' ' VAL . . . . . 0.733 HG13 HG12 ' B' ' 126' ' ' ILE . 2.3 t -100.88 85.01 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.792 0 N-CA-C 107.093 -1.447 . . . . 1.29 107.093 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 137' ' ' GLY . . . . . 0.595 ' N ' ' O ' ' B' ' 125' ' ' SER . . . 126.27 -77.5 0.39 Allowed Glycine 0 CA--C 1.526 0.756 0 CA-C-N 113.22 -1.809 . . . . 0.85 114.83 -179.383 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 138' ' ' THR . . . . . 0.526 HG23 ' HB3' ' B' ' 135' ' ' PHE . 9.8 t -33.11 123.2 0.39 Allowed 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 114.346 1.239 . . . . 1.2 114.346 -177.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 139' ' ' ALA . . . . . 0.836 ' HA ' ' HG ' ' B' ' 142' ' ' LEU . . . -24.27 -37.93 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 113.532 -1.667 . . . . 1.35 112.787 -178.038 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 140' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' B' ' 138' ' ' THR . 1.8 mt-10 -48.05 -8.18 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 121.19 0.519 . . . . 2.31 111.92 177.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 141' ' ' ALA . . . . . 0.673 ' H ' ' C ' ' B' ' 139' ' ' ALA . . . -119.23 -45.81 2.53 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 114.941 -1.027 . . . . 1.09 110.605 177.131 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 142' ' ' LEU . . . . . 0.926 HD13 ' N ' ' B' ' 143' ' ' ARG . 0.0 OUTLIER -38.22 -19.82 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 115.59 1.7 . . . . 1.61 115.59 -174.176 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 143' ' ' ARG . . . . . 0.926 ' N ' HD13 ' B' ' 142' ' ' LEU . 0.0 OUTLIER -69.77 -9.69 55.54 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 106.714 -1.587 . . . . 3.43 106.714 174.869 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 144' ' ' CYS . . . . . 0.664 ' N ' ' O ' ' B' ' 141' ' ' ALA . 66.7 m -89.25 26.38 1.65 Allowed 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.447 -0.797 . . . . 1.61 109.641 176.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -91.71 -19.11 22.98 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 3.52 107.708 175.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -86.9 5.46 36.87 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 114.985 -1.007 . . . . 3.76 109.229 178.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.27 3.38 31.55 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 120.128 -0.629 . . . . 4.01 109.324 177.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 148' ' ' ASN . . . . . 0.485 ' C ' ' H ' ' B' ' 150' ' ' LEU . 2.8 t-20 -87.97 -27.98 21.74 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 116.064 -0.517 . . . . 4.24 109.929 178.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -59.69 8.2 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 113.174 0.805 . . . . 6.07 113.174 -179.413 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 150' ' ' LEU . . . . . 0.538 HD13 ' O ' ' B' ' 150' ' ' LEU . 0.4 OUTLIER -148.6 107.82 3.54 Favored Pre-proline 0 N--CA 1.462 0.173 0 CA-C-N 117.948 0.34 . . . . 5.86 111.321 179.79 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 151' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -78.34 50.14 3.26 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.386 2.057 . . . . 5.42 112.722 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 152' ' ' SER . . . . . 0.407 ' HB2' ' HD2' ' B' ' 153' ' ' PRO . 10.8 p -114.06 160.12 33.6 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.356 -0.384 . . . . 6.02 110.39 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 153' ' ' PRO . . . . . 0.515 ' O ' ' HG3' ' B' ' 108' ' ' ARG . 57.3 Cg_endo -72.07 -174.02 1.25 Allowed 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.356 2.037 . . . . 5.87 113.19 -179.257 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 154' ' ' CYS . . . . . 0.598 ' HA ' ' CB ' ' B' ' 108' ' ' ARG . 0.1 OUTLIER -157.08 95.73 1.52 Allowed 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.761 -0.654 . . . . 2.96 109.739 179.858 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 155' ' ' GLN . . . . . 1.088 ' HG2' ' HA ' ' B' ' 107' ' ' VAL . 0.0 OUTLIER -56.7 179.3 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 119.6 -0.84 . . . . 6.3 111.861 -179.252 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 156' ' ' SER . . . . . 0.503 ' HB2' ' O ' ' B' ' 155' ' ' GLN . 40.2 m 87.87 117.37 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 122.174 0.988 . . . . 3.41 112.326 177.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 111.57 77.7 0.89 Allowed Glycine 0 N--CA 1.434 -1.441 0 CA-C-N 112.668 -2.06 . . . . 2.26 112.161 175.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -119.48 60.81 0.83 Allowed 'General case' 0 N--CA 1.433 -1.29 0 CA-C-O 123.189 1.471 . . . . 5.03 108.383 176.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 159' ' ' LYS . . . . . 0.718 ' CB ' ' HB2' ' B' ' 167' ' ' CYS . 10.5 mtmm -116.08 53.68 1.04 Allowed Pre-proline 0 C--N 1.303 -1.427 0 CA-C-N 112.052 -2.34 . . . . 3.96 111.797 173.005 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 160' ' ' PRO . . . . . 0.615 ' HA ' ' O ' ' B' ' 165' ' ' GLY . 36.8 Cg_endo -66.2 87.83 0.25 Allowed 'Trans proline' 0 C--N 1.329 -0.466 0 N-CA-C 117.971 2.258 . . . . 1.7 117.971 -172.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 161' ' ' CYS . . . . . 0.448 ' SG ' ' HB2' ' B' ' 182' ' ' ASP . 0.6 OUTLIER -107.17 178.76 4.46 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 107.092 -1.447 . . . . 1.93 107.092 175.238 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 72.01 -167.34 52.88 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 118.464 -1.827 . . . . 2.37 111.325 -178.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 71.2 m -76.83 40.64 0.25 Allowed 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 120.604 -0.439 . . . . 4.56 111.222 -179.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 109.56 17.76 9.59 Favored Glycine 0 C--N 1.342 0.902 0 C-N-CA 119.019 -1.562 . . . . 2.39 116.199 175.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 165' ' ' GLY . . . . . 0.615 ' O ' ' HA ' ' B' ' 160' ' ' PRO . . . -107.23 154.28 16.65 Favored Glycine 0 C--N 1.346 1.136 0 C-N-CA 119.235 -1.46 . . . . 1.79 112.179 177.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 166' ' ' ARG . . . . . 0.422 ' H ' ' HG2' ' B' ' 166' ' ' ARG . 0.0 OUTLIER -101.89 150.19 23.44 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 112.211 0.449 . . . . 3.53 112.211 179.425 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 167' ' ' CYS . . . . . 0.718 ' HB2' ' CB ' ' B' ' 159' ' ' LYS . 0.0 OUTLIER -72.68 111.88 8.23 Favored 'General case' 0 N--CA 1.438 -1.033 0 C-N-CA 124.054 0.942 . . . . 1.56 113.335 -179.933 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 168' ' ' ALA . . . . . 0.583 ' CB ' ' HB2' ' B' ' 128' ' ' CYS . . . -89.34 -31.98 17.54 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 104.79 -2.3 . . . . 1.42 104.79 174.35 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 169' ' ' ALA . . . . . 0.995 ' HB3' HG12 ' B' ' 172' ' ' ILE . . . -151.02 158.9 44.71 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 111.27 -2.695 . . . . 1.18 116.527 -172.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 170' ' ' ALA . . . . . 0.838 ' HA ' ' HB3' ' B' ' 185' ' ' CYS . . . -51.32 122.74 8.28 Favored 'General case' 0 C--N 1.347 0.496 0 CA-C-N 113.955 -1.475 . . . . 1.47 111.139 -179.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 171' ' ' GLY . . . . . 0.548 ' HA2' ' O ' ' B' ' 182' ' ' ASP . . . 69.84 16.43 72.37 Favored Glycine 0 N--CA 1.428 -1.837 0 C-N-CA 120.642 -0.789 . . . . 1.45 112.611 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 172' ' ' ILE . . . . . 0.995 HG12 ' HB3' ' B' ' 169' ' ' ALA . 0.5 OUTLIER -134.86 110.0 12.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-O 122.05 0.928 . . . . 2.7 111.809 -177.07 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 173' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -106.08 102.04 11.49 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.865 -0.791 . . . . 1.94 108.865 178.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 174' ' ' CYS . . . . . 0.798 ' HA ' ' HA ' ' B' ' 179' ' ' CYS . 3.4 t -92.74 122.34 35.04 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 121.663 0.744 . . . . 1.43 112.33 -178.408 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 175' ' ' SER . . . . . 0.612 ' HA ' ' HA2' ' B' ' 165' ' ' GLY . 0.3 OUTLIER -90.48 -179.2 1.11 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 114.378 -1.283 . . . . 2.3 109.78 179.537 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 176' ' ' PRO . . . . . 0.466 ' HD2' ' CB ' ' B' ' 175' ' ' SER . 86.0 Cg_endo -77.67 25.25 0.5 Allowed 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 121.782 1.655 . . . . 2.13 112.969 -179.267 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 177' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -145.63 -45.61 0.21 Allowed 'General case' 0 C--O 1.237 0.403 0 N-CA-C 109.032 -0.729 . . . . 2.72 109.032 178.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 178' ' ' GLY . . . . . 0.543 ' HA3' ' HB3' ' A' ' 80' ' ' HIS . . . -149.39 -151.67 5.55 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.364 -0.835 . . . . 1.05 111.691 178.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 179' ' ' CYS . . . . . 0.798 ' HA ' ' HA ' ' B' ' 174' ' ' CYS . 0.0 OUTLIER -146.93 162.77 38.03 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.868 -0.419 . . . . 1.39 109.868 179.724 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 180' ' ' HIS . . . . . 0.537 ' HB3' ' HA3' ' A' ' 78' ' ' GLY . 0.1 OUTLIER -150.42 160.74 43.53 Favored 'General case' 0 N--CA 1.464 0.263 0 O-C-N 121.967 -0.458 . . . . 2.73 111.091 -179.117 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 181' ' ' GLU . . . . . 0.538 ' HA ' ' O ' ' B' ' 171' ' ' GLY . 0.5 OUTLIER -63.57 145.97 54.62 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.435 -0.58 . . . . 3.06 109.435 179.246 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 182' ' ' ASP . . . . . 0.548 ' O ' ' HA2' ' B' ' 171' ' ' GLY . 0.7 OUTLIER -145.85 140.67 15.89 Favored Pre-proline 0 CA--C 1.537 0.475 0 C-N-CA 120.523 -0.471 . . . . 2.06 111.911 -179.366 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 183' ' ' PRO . . . . . 0.479 ' O ' ' HB2' ' B' ' 186' ' ' ASP . 5.2 Cg_exo -80.5 -20.86 7.85 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.977 2.451 . . . . 2.27 113.726 -179.004 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -67.05 -40.99 87.25 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.166 0.507 . . . . 1.56 110.666 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 185' ' ' CYS . . . . . 0.838 ' HB3' ' HA ' ' B' ' 170' ' ' ALA . 85.7 m -97.06 27.06 4.26 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.778 0.799 . . . . 1.94 110.367 179.323 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 186' ' ' ASP . . . . . 0.671 ' N ' ' HD2' ' B' ' 187' ' ' PRO . 1.1 t70 -77.25 -46.35 2.67 Favored Pre-proline 0 C--N 1.316 -0.865 0 CA-C-N 115.048 -0.978 . . . . 3.61 110.242 179.618 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 187' ' ' PRO . . . . . 0.671 ' HD2' ' N ' ' B' ' 186' ' ' ASP . 22.5 Cg_endo -62.71 107.79 0.65 Allowed 'Trans proline' 0 N--CA 1.439 -1.682 0 C-N-CA 121.28 1.32 . . . . 3.14 112.292 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 188' ' ' GLU . . . . . 0.532 ' C ' ' O ' ' B' ' 187' ' ' PRO . 0.3 OUTLIER -12.59 81.15 0.0 OUTLIER 'General case' 0 CA--C 1.468 -2.197 0 CA-C-O 125.274 2.464 . . . . 4.7 106.261 -179.539 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 189' ' ' ALA . . . . . 0.569 ' N ' ' O ' ' B' ' 187' ' ' PRO . . . -86.76 4.61 40.18 Favored 'General case' 0 N--CA 1.439 -0.998 1 CA-C-N 108.289 -4.05 . . . . 5.24 109.789 -176.901 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 190' ' ' ALA . . . . . . . . . . . . . . . -51.18 116.98 2.28 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 116.894 -1.923 . . . . 6.93 109.502 -174.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 191' ' ' PHE . . . . . 0.537 ' HB3' ' CB ' ' B' ' 130' ' ' ASP . 8.2 t80 -88.54 134.13 33.96 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 119.591 1.087 . . . . 10.62 109.826 176.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 13.1 m . . . . . 0 C--O 1.247 0.969 0 CA-C-O 118.142 -0.932 . . . . 11.7 110.727 -179.396 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.694 0 CA-C-O 120.673 0.273 . . . . 10.31 111.697 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 8.0 m -143.72 40.49 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-O 121.094 0.473 . . . . 8.37 112.256 -179.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 1.109 HD22 ' HB2' ' A' ' 8' ' ' ARG . 3.7 tp -162.0 114.96 1.79 Allowed 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.116 -1.068 . . . . 6.25 108.116 178.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.421 ' O ' ' O ' ' A' ' 5' ' ' LEU . 0.3 OUTLIER -76.59 -58.48 3.26 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 113.227 -1.806 . . . . 6.22 112.291 -177.584 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 1.026 HD23 ' HG ' ' A' ' 3' ' ' LEU . 0.1 OUTLIER -22.36 -116.09 0.0 OUTLIER 'General case' 0 CA--C 1.478 -1.818 0 CA-C-N 111.06 -2.791 . . . . 7.57 113.411 -173.4 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.713 ' H ' ' HG ' ' A' ' 5' ' ' LEU 0.287 5.8 t70 -174.61 -40.34 0.01 OUTLIER 'General case' 0 C--N 1.278 -2.512 0 CA-C-O 123.509 1.623 . . . . 8.78 109.499 -175.291 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.544 HG11 ' O ' ' A' ' 7' ' ' VAL . 7.4 p -137.28 122.47 25.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 N-CA-C 102.633 -3.099 . . . . 7.88 102.633 171.545 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 1.109 ' HB2' HD22 ' A' ' 3' ' ' LEU . 12.0 ttp180 -76.72 105.64 7.91 Favored 'General case' 0 N--CA 1.385 -3.697 0 C-N-CA 118.076 -1.45 . . . . 9.7 108.347 -178.178 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.806 HG21 HD23 ' A' ' 50' ' ' LEU . 22.4 m -105.77 94.19 5.05 Favored 'General case' 0 N--CA 1.384 -3.755 1 N-CA-C 98.364 -4.68 . . . . 6.05 98.364 168.507 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.45 62.42 1.86 Allowed 'General case' 0 C--N 1.288 -2.07 0 CA-C-N 114.032 -1.44 . . . . 2.89 110.175 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.789 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 1.6 mm? -32.44 109.92 0.31 Allowed Pre-proline 0 N--CA 1.47 0.532 0 N-CA-C 113.672 0.99 . . . . 2.89 113.672 -178.412 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -60.61 157.18 38.25 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.393 2.062 . . . . 1.72 110.267 176.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.504 ' O ' ' HA2' ' A' ' 17' ' ' GLY . 1.0 OUTLIER -159.6 169.94 22.71 Favored 'General case' 0 CA--C 1.552 1.039 0 CA-C-O 121.363 0.601 . . . . 1.0 111.642 173.468 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.778 ' HA2' ' HB3' ' A' ' 40' ' ' GLU . . . 73.49 -160.44 53.72 Favored Glycine 0 CA--C 1.502 -0.769 0 C-N-CA 120.807 -0.711 . . . . 1.15 113.725 177.493 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.49 ' HG2' ' O ' ' A' ' 15' ' ' PRO . 41.2 Cg_endo -66.68 96.94 0.37 Allowed 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 123.049 2.499 . . . . 1.6 117.145 178.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 86.01 -2.08 87.72 Favored Glycine 1 C--N 1.254 -4.006 0 C-N-CA 119.76 -1.21 . . . . 1.68 114.31 -172.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.504 ' HA2' ' O ' ' A' ' 13' ' ' CYS . . . 79.72 44.95 8.84 Favored Glycine 0 N--CA 1.419 -2.478 0 C-N-CA 118.881 -1.628 . . . . 1.37 114.897 176.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.6 -9.73 34.18 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 113.446 -1.377 . . . . 2.91 111.294 176.041 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.452 ' C ' ' HB3' ' A' ' 13' ' ' CYS . . . -106.32 -174.42 23.34 Favored Glycine 0 CA--C 1.504 -0.643 0 N-CA-C 107.693 -2.163 . . . . 1.06 107.693 178.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.789 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 3.5 ttp180 -129.59 171.59 12.45 Favored 'General case' 0 CA--C 1.552 1.04 0 CA-C-N 121.635 2.717 . . . . 3.32 108.7 -179.475 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.475 ' HB3' ' HG3' ' A' ' 47' ' ' GLU . 1.0 OUTLIER -107.33 143.69 35.26 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 121.28 -0.887 . . . . 1.19 112.739 -178.662 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.414 ' HE2' ' HB3' ' A' ' 20' ' ' ARG . 97.0 m-85 -156.27 57.79 0.58 Allowed 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 114.87 -1.059 . . . . 2.26 109.916 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.477 ' CA ' ' HA ' ' A' ' 76' ' ' PRO . . . 125.97 148.26 7.11 Favored Glycine 0 C--N 1.334 0.432 0 N-CA-C 111.05 -0.82 . . . . 1.05 111.05 -179.095 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -52.3 -75.0 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 121.932 1.755 . . . . 1.81 112.372 -179.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.509 ' HB2' ' CG ' ' B' ' 181' ' ' GLU . 2.0 m -89.37 37.87 0.88 Allowed 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 109.182 -0.673 . . . . 1.62 109.182 178.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 1.089 HG12 HG13 ' A' ' 36' ' ' VAL . 15.9 mt -147.76 102.94 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 CA-C-N 115.269 -0.878 . . . . 1.39 109.586 -179.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.742 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 0.1 OUTLIER -118.68 123.11 44.11 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.648 -0.705 . . . . 0.92 110.53 -177.785 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 1.089 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -142.25 119.4 11.42 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 117.329 2.344 . . . . 1.28 117.329 -178.423 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.862 ' O ' ' HB3' ' A' ' 69' ' ' ALA . . . -108.48 -170.53 21.21 Favored Glycine 0 C--N 1.364 2.121 0 N-CA-C 108.259 -1.936 . . . . 0.71 108.259 175.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.499 ' OD2' ' HG2' ' A' ' 31' ' ' GLU . 20.8 p-10 -64.01 -58.83 5.52 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 114.835 1.42 . . . . 2.27 114.835 -176.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.499 ' HG2' ' OD2' ' A' ' 30' ' ' ASP . 0.0 OUTLIER -108.35 6.52 26.49 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 121.466 0.651 . . . . 1.66 111.477 -177.037 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.924 HD22 ' CZ ' ' A' ' 35' ' ' PHE . 2.2 mt -108.64 -8.44 15.44 Favored 'General case' 0 N--CA 1.398 -3.048 0 N-CA-C 105.332 -2.099 . . . . 1.93 105.332 178.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 1.089 ' O ' ' HA ' ' A' ' 28' ' ' CYS . . . 49.16 -133.15 24.46 Favored Glycine 0 N--CA 1.437 -1.251 0 CA-C-N 114.237 -1.347 . . . . 0.77 112.538 177.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.955 ' HB2' ' CD1' ' A' ' 72' ' ' ILE . 1.2 t -128.42 119.12 24.34 Favored 'General case' 0 CA--C 1.492 -1.286 0 N-CA-C 114.043 1.127 . . . . 1.08 114.043 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.988 ' HA ' ' HA ' ' B' ' 135' ' ' PHE . 0.1 OUTLIER -95.51 102.65 14.47 Favored 'General case' 0 N--CA 1.419 -2.02 0 N-CA-C 102.705 -3.072 . . . . 1.85 102.705 173.906 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 1.089 HG13 HG12 ' A' ' 26' ' ' ILE . 3.0 t -87.93 93.65 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.916 0 CA-C-O 123.102 1.43 . . . . 1.29 107.979 -179.13 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.966 ' HA3' HG22 ' B' ' 172' ' ' ILE . . . 94.26 80.0 1.47 Allowed Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 112.089 -2.323 . . . . 0.85 114.178 -178.643 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.715 HG23 ' O ' ' A' ' 37' ' ' GLY . 71.5 p -159.06 163.37 36.35 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.61 -0.515 . . . . 1.3 109.61 179.034 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.18 -15.67 26.23 Favored 'General case' 0 CA--C 1.527 0.092 0 CA-C-N 118.565 0.62 . . . . 1.45 111.275 178.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.778 ' HB3' ' HA2' ' A' ' 14' ' ' GLY . 40.6 mt-10 -69.23 -13.86 62.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.944 -0.571 . . . . 2.32 109.502 177.726 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.844 ' O ' ' HB2' ' A' ' 44' ' ' CYS . . . -96.11 -24.11 16.46 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 115.328 -0.851 . . . . 1.11 111.121 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.604 HD23 ' HB2' ' B' ' 191' ' ' PHE . 5.3 mt -41.06 -32.95 0.28 Allowed 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.136 0.791 . . . . 1.68 113.136 -178.309 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 5.9 mmm-85 -71.04 -15.18 62.54 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 122.456 1.122 . . . . 3.4 109.561 178.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.844 ' HB2' ' O ' ' A' ' 41' ' ' ALA . 1.3 m -62.46 -27.58 69.22 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 112.663 -2.062 . . . . 1.57 110.699 -178.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -49.86 -41.23 44.87 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.968 0.413 . . . . 3.49 111.764 179.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.401 ' O ' HD12 ' A' ' 50' ' ' LEU . 0.8 OUTLIER -85.52 6.27 27.78 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.722 -0.391 . . . . 3.69 110.257 -179.717 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.475 ' HG3' ' HB3' ' A' ' 21' ' ' CYS . 1.6 tm-20 -82.04 1.36 36.14 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.217 -0.66 . . . . 3.99 109.217 177.478 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -91.92 -28.27 17.37 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.984 -0.553 . . . . 4.2 109.795 178.417 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -91.9 11.64 24.29 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 115.971 -0.559 . . . . 5.85 111.387 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.806 HD23 HG21 ' A' ' 9' ' ' THR . 4.4 mp -141.02 93.19 8.28 Favored Pre-proline 0 CA--C 1.53 0.187 0 CA-C-N 116.792 -0.186 . . . . 5.83 110.884 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -85.19 45.74 1.67 Allowed 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 122.452 2.101 . . . . 5.3 113.041 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.563 ' O ' ' HB ' ' A' ' 9' ' ' THR . 1.4 p -133.43 91.74 25.98 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 116.454 -0.339 . . . . 5.72 110.806 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.451 ' O ' HD12 ' A' ' 5' ' ' LEU . 97.8 Cg_endo -90.11 138.07 2.77 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.537 2.158 . . . . 5.82 112.99 -179.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.809 ' SG ' ' HG3' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -63.53 92.26 0.06 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.985 -0.552 . . . . 2.98 111.344 179.711 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.668 ' HB2' HD13 ' A' ' 3' ' ' LEU . 8.8 tt0 44.1 -106.43 0.1 Allowed 'General case' 0 CA--C 1.552 1.044 0 N-CA-C 112.688 0.625 . . . . 6.42 112.688 179.446 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.3 p 89.95 143.25 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.791 0.837 . . . . 3.36 110.852 -178.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.52 115.05 7.16 Favored Glycine 0 CA--C 1.491 -1.428 0 C-N-CA 121.316 -0.468 . . . . 2.3 112.369 -178.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -73.72 79.26 1.55 Allowed 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 108.251 -1.018 . . . . 5.06 108.251 179.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.568 ' O ' ' HA ' ' A' ' 66' ' ' ARG . 8.0 mmmt -135.45 73.87 61.73 Favored Pre-proline 0 C--N 1.31 -1.116 0 N-CA-C 106.079 -1.823 . . . . 3.91 106.079 -179.327 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.541 ' HA ' ' O ' ' A' ' 65' ' ' GLY . 74.2 Cg_endo -75.79 78.8 3.01 Favored 'Trans proline' 0 C--N 1.372 1.777 0 C-N-CA 123.323 2.682 . . . . 1.74 115.515 -177.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 2.3 p -100.72 -176.05 3.07 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 105.118 -2.178 . . . . 1.9 105.118 175.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.02 -168.03 52.31 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 118.203 -1.951 . . . . 2.43 114.444 -178.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.84 40.91 0.88 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 113.891 -1.155 . . . . 4.32 110.353 -177.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 115.48 9.55 12.74 Favored Glycine 0 CA--C 1.544 1.873 0 CA-C-N 113.847 -1.524 . . . . 2.4 115.216 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.83 ' CA ' ' HB3' ' A' ' 75' ' ' SER . . . -103.55 140.41 14.89 Favored Glycine 0 C--N 1.336 0.58 0 CA-C-N 120.529 2.165 . . . . 1.82 116.2 -178.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.568 ' HA ' ' O ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -101.73 156.51 17.45 Favored 'General case' 0 C--N 1.341 0.216 0 C-N-CA 124.496 1.118 . . . . 3.51 109.685 177.837 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.471 ' HB2' ' HB2' ' A' ' 59' ' ' LYS . 1.2 m -52.1 106.28 0.14 Allowed 'General case' 0 CA--C 1.504 -0.82 0 CA-C-N 119.283 0.947 . . . . 1.52 108.793 -179.012 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.423 ' HB2' ' SG ' ' A' ' 28' ' ' CYS . . . -78.53 -29.65 46.56 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 106.31 -1.737 . . . . 1.5 106.31 177.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.932 ' O ' HG13 ' A' ' 72' ' ' ILE . . . -162.08 139.04 8.21 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 113.454 -1.703 . . . . 1.31 109.925 -176.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.608 ' O ' ' O ' ' A' ' 69' ' ' ALA . . . 12.7 -143.22 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.374 1.07 . . . . 1.5 113.796 179.127 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.519 ' C ' HG22 ' A' ' 72' ' ' ILE . . . -73.44 65.12 1.71 Allowed Glycine 0 CA--C 1.491 -1.443 0 N-CA-C 107.513 -2.235 . . . . 1.44 107.513 179.064 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.955 ' CD1' ' HB2' ' A' ' 34' ' ' CYS . 1.7 pp -150.81 97.17 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.813 0 N-CA-C 106.161 -1.792 . . . . 2.77 106.161 167.191 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.431 ' O ' ' N ' ' A' ' 80' ' ' HIS . 3.9 t -95.62 103.26 15.12 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.317 -0.856 . . . . 1.98 111.48 -175.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.583 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 0.0 OUTLIER -129.75 176.15 8.26 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 113.387 0.884 . . . . 1.43 113.387 -179.029 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.857 ' HB2' ' HD2' ' A' ' 76' ' ' PRO . 36.5 p -138.32 -179.27 1.0 Allowed Pre-proline 0 N--CA 1.462 0.15 0 CA-C-N 113.689 -1.596 . . . . 2.37 108.513 178.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.857 ' HD2' ' HB2' ' A' ' 75' ' ' SER . 77.0 Cg_endo -78.02 30.31 0.44 Allowed 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 121.449 1.433 . . . . 2.09 111.511 178.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.441 ' H ' ' C ' ' A' ' 75' ' ' SER . 0.6 OUTLIER -144.96 -34.01 0.36 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.507 -0.769 . . . . 2.65 110.864 179.816 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.571 ' O ' ' HB3' ' A' ' 74' ' ' CYS . . . -158.74 -171.98 25.28 Favored Glycine 0 C--N 1.339 0.738 0 C-N-CA 120.764 -0.732 . . . . 1.04 113.118 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.583 ' HA ' ' HA ' ' A' ' 74' ' ' CYS . 13.6 t -148.27 160.22 43.19 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 122.567 0.347 . . . . 1.42 110.664 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.431 ' N ' ' O ' ' A' ' 73' ' ' CYS . 1.8 t60 -154.71 145.92 22.84 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 120.027 -0.669 . . . . 2.81 111.659 -179.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.565 ' CG ' ' HB2' ' B' ' 125' ' ' SER . 1.8 mt-10 -64.13 132.82 51.59 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.42 -0.585 . . . . 3.05 109.42 178.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.421 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 0.3 OUTLIER -141.62 122.67 8.75 Favored Pre-proline 0 CA--C 1.541 0.621 0 CA-C-N 116.495 -0.32 . . . . 2.02 110.754 -179.08 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 82' ' ' ASP . 1.8 Cg_endo -83.7 -12.79 8.56 Favored 'Trans proline' 0 C--N 1.358 1.076 0 C-N-CA 123.17 2.58 . . . . 2.29 113.97 -177.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.87 -38.65 91.86 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.808 0.337 . . . . 1.53 111.531 -179.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.475 ' HB2' ' O ' ' A' ' 70' ' ' ALA . 78.7 m -95.24 39.7 1.11 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.034 -0.53 . . . . 1.88 111.155 -179.443 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.804 ' N ' ' HD2' ' A' ' 87' ' ' PRO . 0.1 OUTLIER -70.62 -31.27 2.08 Favored Pre-proline 0 N--CA 1.466 0.368 0 N-CA-C 114.744 1.386 . . . . 3.6 114.744 -178.769 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.804 ' HD2' ' N ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER -10.68 -115.35 0.0 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.252 0 C-N-CA 123.543 2.829 . . . . 3.12 115.696 177.708 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.97 35.62 0.13 Allowed 'General case' 0 C--N 1.272 -2.773 0 CA-C-N 110.087 -3.233 . . . . 4.72 109.749 179.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.673 ' HB1' ' O ' ' A' ' 86' ' ' ASP . . . -97.11 39.23 1.19 Allowed 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 113.006 -1.906 . . . . 5.29 106.003 172.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.83 161.49 29.52 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 114.078 1.14 . . . . 7.19 114.078 -177.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.557 ' HB3' HD22 ' B' ' 142' ' ' LEU . 15.7 p90 -85.25 100.32 11.7 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 114.531 -1.213 . . . . 10.7 110.507 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 19.0 t . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.206 -0.902 . . . . 11.77 110.746 -179.795 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 101' ' ' ALA . . . . . 0.462 ' C ' HG21 ' B' ' 102' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.336 0 N-CA-C 110.369 -0.234 . . . . 10.42 110.369 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 102' ' ' VAL . . . . . 0.462 HG21 ' C ' ' B' ' 101' ' ' ALA . 28.0 t -144.2 125.73 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 CA-C-O 121.769 0.795 . . . . 8.81 110.18 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 103' ' ' LEU . . . . . 0.755 HD13 ' HB2' ' B' ' 155' ' ' GLN . 4.1 mm? -85.38 114.15 22.22 Favored 'General case' 0 C--O 1.225 -0.207 0 CA-C-N 114.338 -1.301 . . . . 6.28 111.16 179.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 104' ' ' ASP . . . . . 0.469 ' H ' ' HG3' ' B' ' 155' ' ' GLN . 3.6 t70 -77.58 76.43 4.11 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 105.541 -2.022 . . . . 6.27 105.541 175.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . 1.026 HD23 ' HA ' ' B' ' 108' ' ' ARG . 0.3 OUTLIER -151.3 -128.85 0.04 OUTLIER 'General case' 0 N--CA 1.412 -2.364 0 CA-C-N 112.905 -1.952 . . . . 7.61 106.708 -174.117 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 106' ' ' ASP . . . . . 0.698 ' H ' ' CG ' ' B' ' 105' ' ' LEU . 4.2 t70 -168.65 -41.83 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 107.813 -1.18 . . . . 8.55 107.813 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 107' ' ' VAL . . . . . 0.535 HG11 ' O ' ' B' ' 107' ' ' VAL . 7.2 p -139.89 123.84 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 N-CA-C 103.422 -2.807 . . . . 7.84 103.422 174.44 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 108' ' ' ARG . . . . . 1.026 ' HA ' HD23 ' B' ' 105' ' ' LEU . 11.4 ttp180 -76.03 106.96 7.91 Favored 'General case' 0 N--CA 1.388 -3.556 0 C-N-CA 118.655 -1.218 . . . . 9.75 108.101 -178.475 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 109' ' ' THR . . . . . 0.64 HG23 HD11 ' B' ' 111' ' ' LEU . 24.4 m -108.45 94.3 4.99 Favored 'General case' 0 N--CA 1.385 -3.696 1 N-CA-C 97.718 -4.919 . . . . 6.13 97.718 168.929 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 110' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -78.49 66.88 4.14 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 113.239 -1.8 . . . . 2.87 109.194 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 111' ' ' LEU . . . . . 0.802 ' O ' ' HA ' ' B' ' 120' ' ' ARG . 1.7 mm? -34.2 109.97 0.37 Allowed Pre-proline 0 N--CA 1.469 0.507 0 N-CA-C 113.436 0.902 . . . . 2.95 113.436 -179.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 112' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -66.19 152.41 81.23 Favored 'Trans proline' 0 N--CA 1.464 -0.242 0 C-N-CA 121.84 1.693 . . . . 1.71 111.607 176.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.568 ' HB3' ' N ' ' B' ' 120' ' ' ARG . 1.0 OUTLIER -154.3 170.69 20.71 Favored 'General case' 0 CA--C 1.557 1.243 0 CA-C-O 121.185 0.517 . . . . 1.0 111.632 177.659 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 114' ' ' GLY . . . . . 0.731 ' HA2' ' HB3' ' B' ' 140' ' ' GLU . . . 74.38 -159.35 52.41 Favored Glycine 0 N--CA 1.467 0.748 0 CA-C-N 116.241 -0.436 . . . . 1.16 114.029 177.505 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 115' ' ' PRO . . . . . 0.476 ' O ' ' N ' ' B' ' 117' ' ' GLY . 87.6 Cg_endo -57.7 143.53 94.98 Favored 'Trans proline' 0 C--N 1.363 1.315 0 N-CA-C 102.355 -3.748 . . . . 1.6 102.355 175.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 48.06 -3.72 0.01 OUTLIER Glycine 0 C--N 1.274 -2.898 0 O-C-N 118.251 -2.78 . . . . 1.7 116.474 172.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 117' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' B' ' 115' ' ' PRO . . . 78.5 42.93 13.21 Favored Glycine 0 N--CA 1.407 -3.267 0 C-N-CA 116.695 -2.669 . . . . 1.38 114.231 177.143 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.09 -15.97 27.04 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 113.199 -1.5 . . . . 2.96 110.852 177.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . -96.26 -161.29 32.72 Favored Glycine 0 C--N 1.343 0.967 0 N-CA-C 109.074 -1.61 . . . . 1.07 109.074 179.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.802 ' HA ' ' O ' ' B' ' 111' ' ' LEU . 3.5 ttp180 -140.84 170.54 15.56 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 121.706 2.753 . . . . 3.29 106.788 177.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 121' ' ' CYS . . . . . 0.463 ' HB3' ' HG3' ' B' ' 147' ' ' GLU . 1.1 m -107.67 143.83 35.6 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 119.005 0.82 . . . . 1.21 112.83 -178.473 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 122' ' ' PHE . . . . . 0.409 ' HE2' ' HB3' ' B' ' 120' ' ' ARG . 97.1 m-85 -156.37 57.85 0.57 Allowed 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 114.898 -1.046 . . . . 2.28 109.897 179.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 123' ' ' GLY . . . . . 0.476 ' CA ' ' HA ' ' B' ' 176' ' ' PRO . . . 125.86 148.22 7.12 Favored Glycine 0 C--N 1.334 0.45 0 N-CA-C 110.972 -0.851 . . . . 1.04 110.972 -179.135 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . 0.414 ' O ' ' HB2' ' B' ' 141' ' ' ALA . 53.0 Cg_exo -52.27 -75.15 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 121.91 1.74 . . . . 1.84 112.312 -179.276 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 125' ' ' SER . . . . . 0.634 ' O ' HG12 ' B' ' 136' ' ' VAL . 1.9 m -89.28 37.71 0.87 Allowed 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 109.242 -0.651 . . . . 1.49 109.242 178.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 126' ' ' ILE . . . . . 0.863 HG12 ' CG1' ' B' ' 136' ' ' VAL . 18.5 mt -147.36 102.93 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 CA-C-N 115.247 -0.888 . . . . 1.41 109.737 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 127' ' ' CYS . . . . . 0.755 ' O ' ' HA ' ' B' ' 134' ' ' CYS . 0.1 OUTLIER -118.65 123.05 44.02 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.65 -0.705 . . . . 0.89 110.511 -177.837 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 128' ' ' CYS . . . . . 1.082 ' HA ' ' O ' ' B' ' 133' ' ' GLY . 0.0 OUTLIER -141.43 120.84 13.17 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 116.642 2.09 . . . . 1.23 116.642 -178.641 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 129' ' ' GLY . . . . . 0.843 ' O ' ' HB3' ' B' ' 169' ' ' ALA . . . -110.49 -169.0 19.46 Favored Glycine 0 C--N 1.366 2.249 0 N-CA-C 107.924 -2.07 . . . . 0.69 107.924 175.304 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 130' ' ' ASP . . . . . 0.498 ' OD2' ' HG2' ' B' ' 131' ' ' GLU . 21.3 p-10 -63.88 -60.88 2.72 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 113.967 1.099 . . . . 2.35 113.967 -177.294 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 131' ' ' GLU . . . . . 0.498 ' HG2' ' OD2' ' B' ' 130' ' ' ASP . 0.1 OUTLIER -115.13 27.52 9.33 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 122.287 1.042 . . . . 1.69 111.132 -178.048 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 132' ' ' LEU . . . . . 0.793 HD22 ' CE1' ' B' ' 135' ' ' PHE . 1.7 mt -124.02 -8.41 7.73 Favored 'General case' 0 N--CA 1.399 -3.01 0 N-CA-C 102.91 -2.996 . . . . 1.84 102.91 178.253 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 133' ' ' GLY . . . . . 1.082 ' O ' ' HA ' ' B' ' 128' ' ' CYS . . . 46.68 -130.36 11.96 Favored Glycine 0 N--CA 1.417 -2.604 0 CA-C-N 113.312 -1.767 . . . . 0.76 112.694 175.661 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 134' ' ' CYS . . . . . 0.956 ' HB2' ' CD1' ' B' ' 172' ' ' ILE . 1.5 t -130.85 118.7 21.13 Favored 'General case' 0 CA--C 1.492 -1.254 0 CA-C-N 120.166 1.983 . . . . 1.08 114.005 -179.356 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 135' ' ' PHE . . . . . 0.988 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -94.49 102.78 14.74 Favored 'General case' 0 N--CA 1.417 -2.085 0 N-CA-C 102.899 -3.0 . . . . 1.83 102.899 174.501 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 136' ' ' VAL . . . . . 0.863 ' CG1' HG12 ' B' ' 126' ' ' ILE . 3.8 t -87.8 93.15 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.916 0 CA-C-O 123.118 1.437 . . . . 1.29 107.968 -179.213 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 137' ' ' GLY . . . . . 0.813 ' O ' HG23 ' B' ' 138' ' ' THR . . . 94.67 79.62 1.46 Allowed Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 112.129 -2.305 . . . . 0.85 114.298 -178.699 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 138' ' ' THR . . . . . 0.813 HG23 ' O ' ' B' ' 137' ' ' GLY . 72.7 p -158.18 165.08 35.81 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.535 -0.543 . . . . 1.2 109.535 179.187 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -62.56 -14.01 37.53 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 121.107 0.479 . . . . 1.35 110.977 178.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 140' ' ' GLU . . . . . 0.731 ' HB3' ' HA2' ' B' ' 114' ' ' GLY . 40.9 mt-10 -70.15 -15.13 62.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.537 -0.756 . . . . 2.31 109.446 177.394 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 141' ' ' ALA . . . . . 0.813 ' O ' ' HB2' ' B' ' 144' ' ' CYS . . . -94.51 -25.48 16.84 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.37 -0.832 . . . . 1.09 110.871 -179.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 142' ' ' LEU . . . . . 0.557 HD22 ' HB3' ' A' ' 91' ' ' PHE . 5.2 mt -40.31 -32.83 0.2 Allowed 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 113.245 0.831 . . . . 1.61 113.245 -177.327 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 143' ' ' ARG . . . . . . . . . . . . . 6.0 mmm-85 -69.34 -18.5 63.81 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 122.641 1.21 . . . . 3.43 109.141 177.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 144' ' ' CYS . . . . . 0.813 ' HB2' ' O ' ' B' ' 141' ' ' ALA . 1.3 m -60.94 -25.54 66.87 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 112.617 -2.083 . . . . 1.61 111.007 -177.367 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -51.1 -40.89 59.46 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.902 0.382 . . . . 3.52 111.693 178.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -85.55 6.37 27.48 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.68 -0.408 . . . . 3.76 110.211 -179.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . 0.463 ' HG3' ' HB3' ' B' ' 121' ' ' CYS . 1.6 tm-20 -82.1 1.36 36.34 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.19 -0.67 . . . . 4.01 109.19 177.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 148' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -91.98 -28.19 17.37 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.931 -0.577 . . . . 4.24 109.724 178.491 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -91.95 11.66 24.35 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.0 -0.545 . . . . 6.07 111.335 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 150' ' ' LEU . . . . . 0.583 HD22 HG21 ' B' ' 109' ' ' THR . 4.4 mp -141.03 93.21 8.27 Favored Pre-proline 0 CA--C 1.53 0.187 0 CA-C-N 116.817 -0.174 . . . . 5.86 110.837 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 151' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -85.15 45.66 1.66 Allowed 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.415 2.077 . . . . 5.42 113.027 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 152' ' ' SER . . . . . 0.558 ' O ' ' HB ' ' B' ' 109' ' ' THR . 1.4 p -133.43 91.84 25.72 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.506 -0.315 . . . . 6.02 110.891 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 153' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -90.2 138.07 2.73 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.427 2.085 . . . . 5.87 112.976 -179.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 154' ' ' CYS . . . . . 0.797 ' SG ' ' HG3' ' B' ' 108' ' ' ARG . 0.0 OUTLIER -63.78 93.96 0.09 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.934 -0.575 . . . . 2.96 111.011 179.714 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 155' ' ' GLN . . . . . 0.755 ' HB2' HD13 ' B' ' 103' ' ' LEU . 8.9 tt0 42.57 -106.52 0.08 Allowed 'General case' 0 CA--C 1.553 1.082 0 N-CA-C 112.837 0.68 . . . . 6.3 112.837 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 156' ' ' SER . . . . . 0.408 ' CB ' ' O ' ' B' ' 155' ' ' GLN . 5.5 p 89.29 139.7 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.894 0.878 . . . . 3.41 111.495 -179.165 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -56.51 115.12 5.88 Favored Glycine 0 CA--C 1.499 -0.909 0 CA-C-N 116.131 -0.486 . . . . 2.26 112.576 -178.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -76.28 67.45 2.53 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 119.157 -1.017 . . . . 5.03 109.504 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 159' ' ' LYS . . . . . 0.602 ' O ' ' HA ' ' B' ' 166' ' ' ARG . 14.8 mmmt -108.62 70.17 0.38 Allowed Pre-proline 0 C--N 1.318 -0.79 0 CA-C-N 114.043 -1.435 . . . . 3.96 110.852 174.408 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 160' ' ' PRO . . . . . 0.503 ' HA ' ' O ' ' B' ' 165' ' ' GLY . 68.6 Cg_endo -75.38 82.97 1.96 Allowed 'Trans proline' 0 N--CA 1.463 -0.271 0 C-N-CA 121.747 1.632 . . . . 1.7 115.582 -176.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 161' ' ' CYS . . . . . 0.403 ' N ' ' O ' ' B' ' 165' ' ' GLY . 1.8 p -93.04 -157.98 0.57 Allowed 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 113.107 -1.86 . . . . 1.93 107.279 177.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 52.95 -167.11 1.17 Allowed Glycine 0 N--CA 1.453 -0.203 0 O-C-N 119.287 -2.133 . . . . 2.37 116.938 171.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.64 41.02 0.88 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 112.849 -1.675 . . . . 4.56 110.436 -178.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 115.52 9.72 12.47 Favored Glycine 0 CA--C 1.548 2.136 0 CA-C-N 114.168 -1.378 . . . . 2.39 115.222 -179.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 165' ' ' GLY . . . . . 0.827 ' CA ' ' HB3' ' B' ' 175' ' ' SER . . . -103.93 139.5 14.55 Favored Glycine 0 N--CA 1.464 0.512 0 CA-C-N 120.327 2.064 . . . . 1.79 116.306 -179.051 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 166' ' ' ARG . . . . . 0.602 ' HA ' ' O ' ' B' ' 159' ' ' LYS . 0.0 OUTLIER -101.48 156.39 17.5 Favored 'General case' 0 C--N 1.343 0.323 0 CA-C-N 113.877 -1.162 . . . . 3.53 109.754 178.11 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 167' ' ' CYS . . . . . 0.491 ' HB2' ' HB2' ' B' ' 159' ' ' LYS . 1.2 m -52.05 106.19 0.14 Allowed 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 119.456 1.025 . . . . 1.56 108.813 -179.003 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 168' ' ' ALA . . . . . . . . . . . . . . . -79.58 -27.76 41.15 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 106.602 -1.629 . . . . 1.42 106.602 177.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 169' ' ' ALA . . . . . 0.88 ' O ' HG13 ' B' ' 172' ' ' ILE . . . -163.46 139.67 6.88 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 114.81 -1.086 . . . . 1.18 108.589 -177.407 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 170' ' ' ALA . . . . . 0.559 ' O ' ' O ' ' B' ' 169' ' ' ALA . . . 11.28 -139.65 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 114.489 1.292 . . . . 1.47 114.489 179.109 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 171' ' ' GLY . . . . . 0.429 ' HA2' ' O ' ' B' ' 182' ' ' ASP . . . -57.2 19.96 0.01 OUTLIER Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 115.72 1.048 . . . . 1.45 115.72 -179.121 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 172' ' ' ILE . . . . . 0.966 HG22 ' HA3' ' A' ' 37' ' ' GLY . 1.7 pp -128.3 99.81 5.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 CA-C-N 118.811 1.305 . . . . 2.7 109.529 -176.603 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 173' ' ' CYS . . . . . 0.422 ' O ' ' N ' ' B' ' 180' ' ' HIS . 4.6 t -94.9 102.95 14.82 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.317 -1.31 . . . . 1.94 111.854 -176.492 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 174' ' ' CYS . . . . . 0.593 ' HA ' ' HA ' ' B' ' 179' ' ' CYS . 0.0 OUTLIER -130.0 176.44 8.06 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 113.372 0.878 . . . . 1.43 113.372 -179.118 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 175' ' ' SER . . . . . 0.845 ' HB2' ' HD2' ' B' ' 176' ' ' PRO . 35.9 p -138.42 -179.29 1.01 Allowed Pre-proline 0 N--CA 1.462 0.129 0 CA-C-N 113.666 -1.606 . . . . 2.3 108.493 178.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 176' ' ' PRO . . . . . 0.845 ' HD2' ' HB2' ' B' ' 175' ' ' SER . 77.0 Cg_endo -78.0 30.3 0.44 Allowed 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 121.445 1.43 . . . . 2.13 111.524 178.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 177' ' ' ASP . . . . . 0.458 ' H ' ' C ' ' B' ' 175' ' ' SER . 0.6 OUTLIER -145.06 -33.88 0.36 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 115.534 -0.757 . . . . 2.72 110.84 179.837 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 178' ' ' GLY . . . . . 0.572 ' O ' ' HB3' ' B' ' 174' ' ' CYS . . . -158.82 -172.04 25.42 Favored Glycine 0 C--N 1.339 0.702 0 C-N-CA 120.822 -0.704 . . . . 1.05 113.19 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 179' ' ' CYS . . . . . 0.593 ' HA ' ' HA ' ' B' ' 174' ' ' CYS . 13.6 t -148.23 160.3 43.08 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 122.536 0.335 . . . . 1.39 110.65 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 180' ' ' HIS . . . . . 0.422 ' N ' ' O ' ' B' ' 173' ' ' CYS . 1.8 t60 -154.86 145.89 22.67 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 119.968 -0.693 . . . . 2.73 111.665 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 181' ' ' GLU . . . . . 0.509 ' CG ' ' HB2' ' A' ' 25' ' ' SER . 1.8 mt-10 -64.12 132.91 51.87 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.421 -0.585 . . . . 3.06 109.421 178.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 182' ' ' ASP . . . . . 0.446 ' HA ' ' HD3' ' B' ' 183' ' ' PRO . 0.3 OUTLIER -141.71 122.52 8.63 Favored Pre-proline 0 CA--C 1.541 0.613 0 CA-C-N 116.499 -0.319 . . . . 2.06 110.706 -178.984 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 183' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' B' ' 182' ' ' ASP . 1.8 Cg_endo -83.64 -12.73 8.67 Favored 'Trans proline' 0 C--N 1.359 1.097 0 C-N-CA 123.141 2.561 . . . . 2.27 114.009 -178.019 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -63.87 -38.44 91.1 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.845 0.355 . . . . 1.56 111.54 -179.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 185' ' ' CYS . . . . . 0.501 ' HB2' ' O ' ' B' ' 170' ' ' ALA . 86.0 m -95.14 39.02 1.12 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.942 -0.572 . . . . 1.94 111.468 -179.419 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 186' ' ' ASP . . . . . 0.805 ' N ' ' HD2' ' B' ' 187' ' ' PRO . 0.1 OUTLIER -70.36 -31.36 2.22 Favored Pre-proline 0 CA--C 1.535 0.371 0 N-CA-C 115.018 1.488 . . . . 3.61 115.018 -178.848 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 187' ' ' PRO . . . . . 0.805 ' HD2' ' N ' ' B' ' 186' ' ' ASP . 0.1 OUTLIER -10.08 -116.13 0.0 OUTLIER 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 123.665 2.91 . . . . 3.14 115.547 177.497 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.95 60.41 5.41 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 101.47 -3.53 . . . . 4.7 101.47 175.607 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 189' ' ' ALA . . . . . 0.761 ' HB1' ' O ' ' B' ' 186' ' ' ASP . . . -112.27 31.33 6.36 Favored 'General case' 0 CA--C 1.509 -0.6 1 CA-C-N 106.737 -4.756 . . . . 5.24 108.234 163.147 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 190' ' ' ALA . . . . . . . . . . . . . . . -72.6 161.77 30.35 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 114.755 1.391 . . . . 6.93 114.755 -173.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 191' ' ' PHE . . . . . 0.604 ' HB2' HD23 ' A' ' 42' ' ' LEU . 15.6 p90 -85.26 100.42 11.77 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 114.076 -1.42 . . . . 10.62 110.271 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 18.5 t . . . . . 0 C--O 1.248 0.981 0 CA-C-O 118.251 -0.88 . . . . 11.7 110.735 -179.858 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.46 ' O ' ' CG2' ' A' ' 2' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.637 0.256 . . . . 10.31 111.581 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.649 ' O ' ' HG3' ' A' ' 55' ' ' GLN . 24.0 m 50.27 47.45 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-O 122.149 0.976 . . . . 8.37 109.76 -176.343 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.629 ' HA ' ' HG3' ' A' ' 55' ' ' GLN . 0.5 OUTLIER -109.89 77.44 1.05 Allowed 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 112.914 -1.948 . . . . 6.25 109.775 179.725 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -68.48 64.17 0.11 Allowed 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 118.538 -1.265 . . . . 6.22 109.479 -177.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.727 HD23 ' HA ' ' A' ' 52' ' ' SER . 0.2 OUTLIER -148.74 -102.21 0.08 Allowed 'General case' 0 N--CA 1.41 -2.454 0 N-CA-C 105.757 -1.942 . . . . 7.57 105.757 -179.141 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.525 ' H ' HD11 ' A' ' 5' ' ' LEU . 9.7 t70 -171.49 -106.16 0.01 OUTLIER 'General case' 0 C--N 1.274 -2.688 0 CA-C-N 113.631 -1.622 . . . . 8.78 107.242 178.135 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.503 HG11 ' O ' ' A' ' 7' ' ' VAL . 5.1 p -89.76 132.09 35.35 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.997 0 N-CA-C 103.152 -2.907 . . . . 7.88 103.152 175.35 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.01 109.29 7.39 Favored 'General case' 0 N--CA 1.4 -2.936 0 C-N-CA 116.946 -1.902 . . . . 9.7 112.373 -174.51 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.457 ' O ' ' HB2' ' A' ' 54' ' ' CYS . 0.1 OUTLIER -105.63 100.23 9.8 Favored 'General case' 0 N--CA 1.407 -2.622 0 N-CA-C 100.217 -3.994 . . . . 6.05 100.217 167.265 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.577 ' HA ' ' CB ' ' A' ' 54' ' ' CYS . 0.5 OUTLIER -77.21 75.58 3.77 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 115.295 -0.866 . . . . 2.89 113.207 -178.717 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.514 ' O ' ' HG3' ' A' ' 20' ' ' ARG . 0.2 OUTLIER -31.13 113.94 0.34 Allowed Pre-proline 0 N--CA 1.472 0.648 0 N-CA-C 113.244 0.831 . . . . 2.89 113.244 -179.515 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.754 ' HB2' ' O ' ' A' ' 17' ' ' GLY . 21.9 Cg_endo -93.04 152.74 2.62 Favored 'Trans proline' 0 CA--C 1.535 0.571 0 C-N-CA 124.128 3.219 . . . . 1.72 115.279 -178.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.812 ' N ' ' O ' ' A' ' 19' ' ' GLY . 15.4 p -154.06 -160.36 1.08 Allowed 'General case' 0 C--O 1.243 0.741 0 CA-C-N 115.799 -0.637 . . . . 1.0 109.676 175.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.532 ' HA2' ' HG2' ' A' ' 40' ' ' GLU . . . 74.08 -162.95 54.47 Favored Glycine 0 C--N 1.338 0.65 0 N-CA-C 115.479 0.952 . . . . 1.15 115.479 174.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.674 ' O ' ' HD3' ' A' ' 18' ' ' LYS . 64.5 Cg_endo -61.74 104.31 0.31 Allowed 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 124.411 3.408 . . . . 1.6 110.237 177.459 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 86.67 -8.83 73.73 Favored Glycine 0 C--N 1.27 -3.125 0 CA-C-N 112.625 -2.08 . . . . 1.68 112.037 -178.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.754 ' O ' ' HB2' ' A' ' 12' ' ' PRO . . . 78.08 44.33 12.01 Favored Glycine 0 N--CA 1.403 -3.555 0 C-N-CA 120.258 -0.973 . . . . 1.37 114.789 179.126 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.7 ' H ' ' HZ1' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -92.8 -49.0 6.28 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 105.494 -2.039 . . . . 2.91 105.494 175.457 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.812 ' O ' ' N ' ' A' ' 13' ' ' CYS . . . -66.46 162.68 43.95 Favored Glycine 0 C--O 1.205 -1.658 0 C-N-CA 118.099 -2.001 . . . . 1.06 116.038 -165.657 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.532 ' HD2' ' HB3' ' A' ' 10' ' ' CYS . 0.0 OUTLIER -98.53 163.6 12.6 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 115.081 1.512 . . . . 3.32 115.081 -171.052 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.4 m -106.27 134.31 49.61 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 114.266 -1.334 . . . . 1.19 110.772 -177.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -134.26 36.3 3.21 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.208 -0.905 . . . . 2.26 109.857 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 144.93 164.43 10.61 Favored Glycine 0 CA--C 1.521 0.459 0 CA-C-N 115.802 -0.635 . . . . 1.05 112.39 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.426 ' HD2' ' OE2' ' B' ' 181' ' ' GLU . 50.6 Cg_exo -52.12 -73.22 0.04 OUTLIER 'Trans proline' 0 CA--C 1.532 0.396 0 C-N-CA 122.715 2.277 . . . . 1.81 112.66 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.654 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.4 OUTLIER -90.96 42.72 1.12 Allowed 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 109.312 -0.625 . . . . 1.62 109.312 178.875 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.713 HG21 ' SG ' ' A' ' 34' ' ' CYS . 4.4 mt -144.9 121.14 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 N-CA-C 113.561 0.949 . . . . 1.39 113.561 -177.037 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.701 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -138.19 112.42 8.62 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.71 0.767 . . . . 0.92 110.632 178.736 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 1.153 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -131.74 118.53 20.08 Favored 'General case' 0 CA--C 1.557 1.242 0 N-CA-C 114.996 1.48 . . . . 1.28 114.996 -179.319 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -108.22 -165.99 21.24 Favored Glycine 0 N--CA 1.428 -1.849 0 N-CA-C 107.035 -2.426 . . . . 0.71 107.035 175.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -68.51 -60.48 2.4 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 115.322 1.601 . . . . 2.27 115.322 -179.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.28 18.43 21.64 Favored 'General case' 0 CA--C 1.482 -1.639 0 CA-C-O 121.682 0.754 . . . . 1.66 111.464 -176.607 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.591 ' CD1' ' HZ3' ' A' ' 18' ' ' LYS . 1.2 mt -115.06 -24.86 8.37 Favored 'General case' 0 N--CA 1.395 -3.195 0 N-CA-C 106.396 -1.705 . . . . 1.93 106.396 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 1.153 ' O ' ' HA ' ' A' ' 28' ' ' CYS . . . 76.18 -132.63 12.97 Favored Glycine 0 N--CA 1.4 -3.713 0 CA-C-N 114.353 -1.294 . . . . 0.77 111.28 177.267 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.733 ' HB2' ' CD1' ' A' ' 72' ' ' ILE . 3.2 t -137.96 118.35 13.75 Favored 'General case' 0 CA--C 1.479 -1.758 0 CA-C-N 118.63 1.215 . . . . 1.08 111.557 178.485 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.916 ' HA ' ' HA ' ' B' ' 135' ' ' PHE . 0.0 OUTLIER -91.62 107.21 19.05 Favored 'General case' 0 N--CA 1.42 -1.953 0 N-CA-C 102.242 -3.244 . . . . 1.85 102.242 174.106 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.708 HG13 HG12 ' A' ' 26' ' ' ILE . 1.9 t -93.0 89.76 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.587 0 CA-C-O 122.793 1.282 . . . . 1.29 110.21 -177.492 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.654 ' N ' ' O ' ' A' ' 25' ' ' SER . . . 102.76 17.44 18.96 Favored Glycine 0 CA--C 1.518 0.241 0 CA-C-N 112.962 -1.926 . . . . 0.85 116.017 178.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.66 HG23 ' HB3' ' A' ' 35' ' ' PHE . 25.9 p -95.39 164.99 12.59 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 118.505 1.152 . . . . 1.3 109.002 178.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.469 ' O ' ' HD3' ' A' ' 43' ' ' ARG . . . -49.29 -29.7 6.32 Favored 'General case' 0 CA--C 1.517 -0.291 0 O-C-N 120.963 -1.086 . . . . 1.45 112.906 -177.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.532 ' HG2' ' HA2' ' A' ' 14' ' ' GLY . 1.6 mp0 -62.53 -20.65 64.86 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 120.867 -0.333 . . . . 2.32 110.125 179.217 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.739 ' O ' ' HB2' ' A' ' 44' ' ' CYS . . . -96.14 -24.07 16.45 Favored 'General case' 0 N--CA 1.428 -1.536 0 CA-C-O 119.312 -0.375 . . . . 1.11 110.468 -178.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.601 ' C ' ' H ' ' A' ' 44' ' ' CYS . 1.8 mt -57.4 -27.18 62.11 Favored 'General case' 0 C--N 1.346 0.445 0 CA-C-N 119.791 1.178 . . . . 1.68 110.095 179.223 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.476 ' HD3' ' HA ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -77.69 9.27 3.56 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 122.231 1.015 . . . . 3.4 108.901 176.816 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.739 ' HB2' ' O ' ' A' ' 41' ' ' ALA . 5.9 m -83.29 2.95 33.48 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 112.838 -1.983 . . . . 1.57 108.214 172.513 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 30.9 tp60 -86.84 -8.34 57.39 Favored 'General case' 0 C--N 1.35 0.595 0 O-C-N 121.384 -0.823 . . . . 3.49 110.988 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.468 ' HA ' ' CD2' ' A' ' 49' ' ' TYR . 7.2 mt-10 -85.98 5.29 33.91 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 119.094 -1.042 . . . . 3.69 108.762 179.1 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -79.3 2.87 19.87 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 116.013 -0.539 . . . . 3.99 109.782 177.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 40.9 p30 -99.19 -28.86 13.15 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 120.911 -0.316 . . . . 4.2 110.488 178.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.468 ' CD2' ' HA ' ' A' ' 46' ' ' GLU . 4.7 m-85 -87.09 9.32 20.17 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 120.951 -0.3 . . . . 5.85 111.305 179.65 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.459 HD11 HD22 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -143.21 117.67 6.25 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.838 -0.164 . . . . 5.83 111.092 -179.539 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -79.74 45.45 1.95 Allowed 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 122.315 2.01 . . . . 5.3 112.321 179.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.727 ' HA ' HD23 ' A' ' 5' ' ' LEU . 3.4 p -156.36 104.23 2.03 Favored Pre-proline 0 C--O 1.232 0.168 0 CA-C-O 120.604 0.24 . . . . 5.72 111.642 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.701 ' HD2' ' HG ' ' A' ' 5' ' ' LEU . 94.3 Cg_endo -95.52 -4.97 1.92 Allowed 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 123.342 2.695 . . . . 5.82 114.724 -178.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.577 ' CB ' ' HA ' ' A' ' 10' ' ' CYS . 10.2 t 69.18 80.67 0.19 Allowed 'General case' 0 N--CA 1.473 0.692 0 O-C-N 122.279 -0.263 . . . . 2.98 111.343 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.649 ' HG3' ' O ' ' A' ' 2' ' ' VAL . 0.0 OUTLIER 27.43 -144.29 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 112.865 0.691 . . . . 6.42 112.865 179.793 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.509 ' H ' ' CD ' ' A' ' 55' ' ' GLN . 3.2 t -167.8 172.88 8.76 Favored 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 109.193 -0.669 . . . . 3.36 109.193 -179.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -76.8 146.88 32.98 Favored Glycine 0 N--CA 1.433 -1.509 0 N-CA-C 110.064 -1.214 . . . . 2.3 110.064 -177.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -113.43 74.17 0.85 Allowed 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 122.153 0.978 . . . . 5.06 108.891 178.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.525 ' HB2' ' HB3' ' A' ' 67' ' ' CYS . 5.9 mmtp -144.1 58.22 5.73 Favored Pre-proline 0 C--N 1.304 -1.393 0 N-CA-C 106.579 -1.638 . . . . 3.91 106.579 178.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.467 ' CD ' ' N ' ' A' ' 59' ' ' LYS . 19.6 Cg_endo -59.01 80.45 0.05 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 122.437 2.091 . . . . 1.74 115.048 -177.228 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.499 ' N ' ' O ' ' A' ' 65' ' ' GLY . 0.5 OUTLIER -99.58 -178.64 3.95 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 106.449 -1.686 . . . . 1.9 106.449 175.553 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.515 ' HA3' ' CE1' ' A' ' 80' ' ' HIS . . . 70.49 -166.79 50.8 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 118.103 -1.999 . . . . 2.43 112.31 179.148 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.7 m -86.13 39.68 0.83 Allowed 'General case' 0 N--CA 1.477 0.893 0 CA-C-O 121.843 0.83 . . . . 4.32 111.354 -176.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 120.15 9.99 7.7 Favored Glycine 0 CA--C 1.543 1.789 0 CA-C-N 114.462 -1.244 . . . . 2.4 114.441 -178.111 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.499 ' O ' ' N ' ' A' ' 61' ' ' CYS . . . -103.45 151.06 17.78 Favored Glycine 0 C--N 1.336 0.559 0 CA-C-N 119.772 1.786 . . . . 1.82 114.913 -179.121 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.52 152.51 19.94 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 122.157 0.183 . . . . 3.51 111.048 178.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.525 ' HB3' ' HB2' ' A' ' 59' ' ' LYS . 42.9 t -67.6 121.83 16.73 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-O 121.037 0.446 . . . . 1.52 111.606 -179.213 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.422 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . . . -99.15 -16.66 18.51 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.836 0.827 . . . . 1.5 109.021 177.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.685 ' CB ' ' HA2' ' A' ' 33' ' ' GLY . . . -170.09 160.88 8.35 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.326 -1.307 . . . . 1.31 110.756 178.578 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.409 ' HA ' ' HB3' ' A' ' 85' ' ' CYS . . . -61.5 138.01 58.26 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 122.045 -0.409 . . . . 1.5 111.226 178.31 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.74 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . 64.06 18.97 63.15 Favored Glycine 0 N--CA 1.467 0.756 0 CA-C-N 115.77 -0.65 . . . . 1.44 112.808 -179.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.733 ' CD1' ' HB2' ' A' ' 34' ' ' CYS . 1.3 pp -150.34 105.59 0.37 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.913 0 N-CA-C 112.116 0.413 . . . . 2.77 112.116 173.11 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.534 ' HB2' ' HB3' ' A' ' 82' ' ' ASP . 16.5 t -97.75 110.79 23.29 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 120.869 0.366 . . . . 1.98 110.32 178.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.744 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 72.1 m -92.44 138.84 31.17 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.494 0.664 . . . . 1.43 111.703 -179.336 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.768 ' HB2' ' HD2' ' A' ' 76' ' ' PRO . 54.1 p -113.26 179.55 0.77 Allowed Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 114.82 -1.082 . . . . 2.37 108.948 179.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.768 ' HD2' ' HB2' ' A' ' 75' ' ' SER . 74.0 Cg_endo -76.4 30.87 0.4 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 121.349 1.366 . . . . 2.09 111.997 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.468 ' H ' ' C ' ' A' ' 75' ' ' SER . 18.4 m-20 -144.86 -41.78 0.24 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.544 -0.753 . . . . 2.65 109.983 179.378 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.849 ' HA3' ' O ' ' B' ' 179' ' ' CYS . . . -163.63 -135.07 1.75 Allowed Glycine 0 C--N 1.336 0.551 0 C-N-CA 120.951 -0.642 . . . . 1.04 112.784 179.396 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.84 ' O ' ' HA3' ' B' ' 178' ' ' GLY . 62.7 m -148.1 157.11 43.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.06 0.457 . . . . 1.42 110.314 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.515 ' CE1' ' HA3' ' A' ' 62' ' ' GLY . 1.8 p80 -158.02 153.17 25.61 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.206 -0.598 . . . . 2.81 110.641 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.4 ' OE2' ' HD2' ' B' ' 124' ' ' PRO . 14.6 mp0 -63.06 140.81 58.91 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.672 -0.411 . . . . 3.05 109.983 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.61 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 2.4 p-10 -140.89 140.88 22.49 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 116.071 -0.513 . . . . 2.02 111.195 -179.328 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -72.48 -27.35 15.88 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 123.492 2.795 . . . . 2.29 114.571 -177.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.02 -47.44 71.41 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 107.86 -1.163 . . . . 1.53 107.86 179.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.74 ' O ' ' N ' ' A' ' 71' ' ' GLY . 2.0 m -99.12 77.97 2.21 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 114.181 -1.372 . . . . 1.88 107.497 176.463 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.969 ' H ' ' CD ' ' A' ' 87' ' ' PRO . 38.2 t0 -164.89 3.09 0.0 OUTLIER Pre-proline 0 C--N 1.321 -0.649 0 N-CA-C 114.23 1.196 . . . . 2.29 114.23 -179.136 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.969 ' CD ' ' H ' ' A' ' 86' ' ' ASP . 59.5 Cg_endo -83.46 132.31 5.85 Favored 'Trans proline' 0 C--N 1.357 1.01 0 C-N-CA 121.475 1.45 . . . . 0.0 111.541 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -8.09 36.81 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 117.036 2.236 . . . . 4.72 117.036 -173.668 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.961 ' N ' ' O ' ' A' ' 87' ' ' PRO . . . -61.16 -38.08 85.18 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 113.635 -1.62 . . . . 5.29 108.888 -176.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -88.85 111.04 21.58 Favored 'General case' 0 C--N 1.299 -1.611 0 C-N-CA 128.396 2.678 . . . . 7.19 112.76 178.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -88.56 88.46 7.62 Favored 'General case' 0 C--N 1.359 1.001 0 CA-C-N 110.156 -3.202 . . . . 10.7 110.957 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 2.4 m . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.219 -0.896 . . . . 11.77 110.801 -179.964 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.779 0 N-CA-C 110.578 -0.156 . . . . 10.42 110.578 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 102' ' ' VAL . . . . . 0.734 ' O ' HD23 ' B' ' 103' ' ' LEU . 5.9 m -92.97 -173.44 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 120.787 -0.365 . . . . 8.81 111.625 -177.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 103' ' ' LEU . . . . . 0.738 ' HA ' ' HG3' ' B' ' 155' ' ' GLN . 0.3 OUTLIER -161.14 93.04 0.94 Allowed 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 108.873 -0.788 . . . . 6.28 108.873 177.127 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -81.7 70.77 8.66 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 107.155 -1.424 . . . . 6.27 107.155 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . 0.994 ' HG ' ' H ' ' B' ' 106' ' ' ASP . 2.2 tp -153.62 -119.32 0.03 OUTLIER 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 108.882 -0.785 . . . . 7.61 108.882 -172.214 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 106' ' ' ASP . . . . . 0.994 ' H ' ' HG ' ' B' ' 105' ' ' LEU . 5.0 t70 -170.42 -44.43 0.02 OUTLIER 'General case' 0 C--N 1.289 -2.06 0 CA-C-O 121.396 0.617 . . . . 8.55 109.589 179.084 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 107' ' ' VAL . . . . . 0.477 HG11 ' O ' ' B' ' 107' ' ' VAL . 7.5 p -149.71 127.84 2.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 101.948 -3.353 . . . . 7.84 101.948 173.334 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 108' ' ' ARG . . . . . 0.991 ' HA ' HD22 ' B' ' 105' ' ' LEU . 0.0 OUTLIER -73.45 111.69 8.82 Favored 'General case' 0 N--CA 1.401 -2.919 0 C-N-CA 117.903 -1.519 . . . . 9.75 112.201 -175.26 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 109' ' ' THR . . . . . 0.452 ' O ' ' HB2' ' B' ' 154' ' ' CYS . 0.1 OUTLIER -111.06 100.28 8.99 Favored 'General case' 0 N--CA 1.402 -2.833 1 N-CA-C 99.134 -4.395 . . . . 6.13 99.134 167.733 . . . . . . . . 4 4 . 1 . 017 nuclear orig full ' B' B ' 110' ' ' CYS . . . . . 0.576 ' HA ' ' CB ' ' B' ' 154' ' ' CYS . 0.5 OUTLIER -78.56 75.96 5.06 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 113.978 -1.465 . . . . 2.87 112.654 -177.928 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 111' ' ' LEU . . . . . 0.505 ' O ' ' HA ' ' B' ' 120' ' ' ARG . 0.2 OUTLIER -31.07 113.85 0.33 Allowed Pre-proline 0 N--CA 1.469 0.508 0 N-CA-C 113.107 0.78 . . . . 2.95 113.107 -179.629 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 112' ' ' PRO . . . . . 0.82 ' HB2' ' O ' ' B' ' 117' ' ' GLY . 29.0 Cg_endo -90.72 154.31 4.17 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 124.46 3.44 . . . . 1.71 114.417 -179.074 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.829 ' N ' ' O ' ' B' ' 119' ' ' GLY . 15.3 p -156.08 -159.93 0.95 Allowed 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 109.479 -0.563 . . . . 1.0 109.479 174.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 114' ' ' GLY . . . . . 0.511 ' HA2' ' HG2' ' B' ' 140' ' ' GLU . . . 73.45 -163.24 54.78 Favored Glycine 0 C--N 1.337 0.614 0 N-CA-C 115.639 1.016 . . . . 1.16 115.639 175.014 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 115' ' ' PRO . . . . . 0.674 ' O ' ' HD3' ' B' ' 118' ' ' LYS . 67.9 Cg_endo -61.78 100.77 0.2 Allowed 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 124.361 3.374 . . . . 1.6 111.37 178.081 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 86.89 -0.14 86.14 Favored Glycine 0 C--N 1.283 -2.414 0 CA-C-N 112.688 -2.051 . . . . 1.7 112.955 -178.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 117' ' ' GLY . . . . . 0.82 ' O ' ' HB2' ' B' ' 112' ' ' PRO . . . 76.46 37.12 36.67 Favored Glycine 0 N--CA 1.416 -2.659 0 N-CA-C 115.736 1.055 . . . . 1.38 115.736 175.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 118' ' ' LYS . . . . . 0.708 ' HZ3' ' H ' ' B' ' 118' ' ' LYS . 0.0 OUTLIER -95.69 -30.47 13.73 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 121.753 0.787 . . . . 2.96 111.763 179.448 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 119' ' ' GLY . . . . . 0.829 ' O ' ' N ' ' B' ' 113' ' ' CYS . . . -77.77 158.45 46.77 Favored Glycine 0 C--O 1.193 -2.412 0 N-CA-C 117.499 1.76 . . . . 1.07 117.499 -174.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.54 ' HD2' ' HB3' ' B' ' 110' ' ' CYS . 0.0 OUTLIER -99.84 160.35 14.37 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 111.774 -2.213 . . . . 3.29 113.363 -169.069 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 121' ' ' CYS . . . . . . . . . . . . . 1.4 m -105.43 134.01 49.25 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 114.304 -1.316 . . . . 1.21 110.734 -175.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -134.16 36.3 3.23 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.152 -0.931 . . . . 2.28 109.976 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 145.11 164.51 10.7 Favored Glycine 0 CA--C 1.521 0.445 0 CA-C-N 115.849 -0.614 . . . . 1.04 112.395 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . 0.4 ' HD2' ' OE2' ' A' ' 81' ' ' GLU . 51.1 Cg_exo -52.17 -73.13 0.04 OUTLIER 'Trans proline' 0 CA--C 1.532 0.411 0 C-N-CA 122.752 2.302 . . . . 1.84 112.761 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 125' ' ' SER . . . . . 0.637 ' O ' ' N ' ' B' ' 137' ' ' GLY . 0.5 OUTLIER -91.02 42.8 1.12 Allowed 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 109.251 -0.648 . . . . 1.49 109.251 178.778 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 126' ' ' ILE . . . . . 0.606 HG12 HG12 ' B' ' 136' ' ' VAL . 6.3 mt -144.51 121.06 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 N-CA-C 113.667 0.988 . . . . 1.41 113.667 -176.798 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 127' ' ' CYS . . . . . 0.661 ' O ' ' HA ' ' B' ' 134' ' ' CYS . 0.0 OUTLIER -138.73 111.47 7.7 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-O 121.57 0.7 . . . . 0.89 110.56 178.458 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 128' ' ' CYS . . . . . 1.16 ' HA ' ' O ' ' B' ' 133' ' ' GLY . 0.0 OUTLIER -127.53 129.36 47.23 Favored 'General case' 0 N--CA 1.439 -0.977 0 C-N-CA 124.243 1.017 . . . . 1.23 111.517 179.098 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 129' ' ' GLY . . . . . 0.633 ' O ' ' HB1' ' B' ' 169' ' ' ALA . . . -120.82 -160.35 11.07 Favored Glycine 0 N--CA 1.417 -2.598 0 N-CA-C 104.126 -3.59 . . . . 0.69 104.126 172.464 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -67.14 -73.23 0.14 Allowed 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 118.283 1.041 . . . . 2.35 111.702 -178.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.97 34.6 2.96 Favored 'General case' 0 CA--C 1.478 -1.792 0 CA-C-O 121.76 0.79 . . . . 1.69 110.505 -173.024 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 132' ' ' LEU . . . . . 0.49 ' O ' ' HA ' ' A' ' 38' ' ' THR . 1.1 mt -126.49 -23.62 3.75 Favored 'General case' 0 N--CA 1.391 -3.384 0 N-CA-C 104.992 -2.225 . . . . 1.84 104.992 177.181 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 133' ' ' GLY . . . . . 1.16 ' O ' ' HA ' ' B' ' 128' ' ' CYS . . . 73.71 -135.62 20.77 Favored Glycine 1 N--CA 1.39 -4.39 0 N-CA-C 110.275 -1.13 . . . . 0.76 110.275 176.664 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 134' ' ' CYS . . . . . 0.752 ' HB2' ' CD1' ' B' ' 172' ' ' ILE . 3.1 t -135.97 116.34 13.63 Favored 'General case' 0 CA--C 1.495 -1.168 0 CA-C-N 118.227 1.014 . . . . 1.08 113.519 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 135' ' ' PHE . . . . . 0.916 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -88.57 106.3 18.22 Favored 'General case' 0 N--CA 1.421 -1.879 0 N-CA-C 102.59 -3.115 . . . . 1.83 102.59 175.101 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 136' ' ' VAL . . . . . 0.68 HG21 HG21 ' A' ' 36' ' ' VAL . 2.3 t -92.85 88.02 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-O 123.161 1.458 . . . . 1.29 110.233 -177.645 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 137' ' ' GLY . . . . . 0.678 ' HA3' HG22 ' A' ' 72' ' ' ILE . . . 102.79 18.43 15.77 Favored Glycine 0 C--N 1.32 -0.328 0 CA-C-N 112.705 -2.043 . . . . 0.85 115.916 178.58 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 138' ' ' THR . . . . . 0.642 HG23 ' HB3' ' B' ' 135' ' ' PHE . 30.2 p -89.76 177.04 6.61 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 118.071 0.936 . . . . 1.2 108.747 178.614 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 139' ' ' ALA . . . . . 0.528 ' HA ' HD13 ' B' ' 142' ' ' LEU . . . -58.07 -36.36 72.69 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 118.982 0.81 . . . . 1.35 110.516 179.151 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 140' ' ' GLU . . . . . 0.511 ' HG2' ' HA2' ' B' ' 114' ' ' GLY . 1.7 mp0 -59.54 -15.14 16.15 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.439 -0.346 . . . . 2.31 111.683 -179.357 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 141' ' ' ALA . . . . . 0.676 ' O ' ' HB2' ' B' ' 144' ' ' CYS . . . -99.17 -26.74 14.1 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 116.274 -0.421 . . . . 1.09 110.567 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 142' ' ' LEU . . . . . 0.528 HD13 ' HA ' ' B' ' 139' ' ' ALA . 2.2 mt -55.58 -29.22 58.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.311 0.576 . . . . 1.61 109.681 179.179 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 143' ' ' ARG . . . . . 0.51 ' HD3' ' HA ' ' B' ' 140' ' ' GLU . 0.0 OUTLIER -78.51 11.39 2.51 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 109.051 -0.722 . . . . 3.43 109.051 177.132 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 144' ' ' CYS . . . . . 0.676 ' HB2' ' O ' ' B' ' 141' ' ' ALA . 5.8 m -89.32 13.01 14.51 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 107.232 -1.396 . . . . 1.61 107.232 172.362 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 29.8 tp60 -88.7 -11.86 43.99 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 115.278 -0.874 . . . . 3.52 110.285 177.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 146' ' ' GLU . . . . . 0.47 ' HA ' ' CD2' ' B' ' 149' ' ' TYR . 7.2 mt-10 -85.95 5.48 32.95 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 119.11 -1.036 . . . . 3.76 109.194 179.205 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -79.47 3.15 19.46 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 120.377 -0.529 . . . . 4.01 109.784 177.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 148' ' ' ASN . . . . . . . . . . . . . 40.5 p30 -99.3 -28.85 13.12 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 120.778 -0.369 . . . . 4.24 110.463 178.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 149' ' ' TYR . . . . . 0.47 ' CD2' ' HA ' ' B' ' 146' ' ' GLU . 4.7 m-85 -87.08 9.47 19.67 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 121.005 -0.278 . . . . 6.07 111.339 179.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 150' ' ' LEU . . . . . 0.427 ' CD1' HD21 ' B' ' 111' ' ' LEU . 0.1 OUTLIER -143.39 117.72 6.17 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-O 120.504 0.193 . . . . 5.86 111.018 -179.539 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 151' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -80.0 45.63 2.01 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.353 2.036 . . . . 5.42 112.354 179.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 3.7 p -156.49 104.32 2.01 Favored Pre-proline 0 CA--C 1.531 0.235 0 CA-C-O 120.645 0.26 . . . . 6.02 111.37 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 153' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -95.64 -5.2 1.84 Allowed 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 123.4 2.733 . . . . 5.87 114.649 -178.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 154' ' ' CYS . . . . . 0.779 ' HA ' HD23 ' B' ' 105' ' ' LEU . 9.1 t 69.64 81.37 0.17 Allowed 'General case' 0 N--CA 1.473 0.707 0 O-C-N 122.225 -0.297 . . . . 2.96 111.204 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 155' ' ' GLN . . . . . 0.738 ' HG3' ' HA ' ' B' ' 103' ' ' LEU . 0.0 OUTLIER 26.41 -145.08 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 112.785 0.661 . . . . 6.3 112.785 -179.916 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 156' ' ' SER . . . . . 0.519 ' H ' ' CD ' ' B' ' 155' ' ' GLN . 1.9 t -159.14 -175.27 5.16 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 108.744 -0.836 . . . . 3.41 108.744 179.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -88.85 147.16 19.61 Favored Glycine 0 CA--C 1.494 -1.228 0 N-CA-C 109.764 -1.334 . . . . 2.26 109.764 176.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -114.91 62.49 0.68 Allowed 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 117.207 -1.797 . . . . 5.03 110.293 178.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 159' ' ' LYS . . . . . 0.637 ' HB2' ' CB ' ' B' ' 167' ' ' CYS . 7.0 mmtp -117.94 53.9 1.71 Allowed Pre-proline 0 C--N 1.313 -1.02 0 CA-C-N 113.507 -1.679 . . . . 3.96 110.48 172.448 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 160' ' ' PRO . . . . . 0.417 ' HA ' ' O ' ' B' ' 165' ' ' GLY . 15.0 Cg_endo -58.47 81.33 0.05 OUTLIER 'Trans proline' 0 C--N 1.331 -0.363 0 CA-C-N 121.626 1.616 . . . . 1.7 116.072 -173.185 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 161' ' ' CYS . . . . . 0.489 ' N ' ' O ' ' B' ' 165' ' ' GLY . 0.5 OUTLIER -99.25 -178.29 3.87 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 106.926 -1.509 . . . . 1.93 106.926 175.762 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 162' ' ' GLY . . . . . 0.509 ' HA3' ' CE1' ' B' ' 180' ' ' HIS . . . 69.78 -166.57 49.22 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 118.301 -1.904 . . . . 2.37 112.283 178.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 2.8 m -85.75 39.95 0.82 Allowed 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.634 0.73 . . . . 4.56 111.423 -177.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 121.48 6.74 8.61 Favored Glycine 0 CA--C 1.541 1.656 0 CA-C-N 114.586 -1.188 . . . . 2.39 114.663 -179.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 165' ' ' GLY . . . . . 0.5 ' CA ' ' HA ' ' B' ' 175' ' ' SER . . . -102.14 151.74 18.41 Favored Glycine 0 CA--C 1.523 0.562 0 CA-C-N 119.909 1.855 . . . . 1.79 115.172 -177.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 166' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.2 152.63 19.68 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 122.275 0.23 . . . . 3.53 111.046 179.459 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 167' ' ' CYS . . . . . 0.637 ' CB ' ' HB2' ' B' ' 159' ' ' LYS . 41.9 t -67.73 121.47 16.01 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-O 120.771 0.319 . . . . 1.56 111.611 -179.108 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 168' ' ' ALA . . . . . 0.408 ' HB2' ' SG ' ' B' ' 128' ' ' CYS . . . -96.4 -19.54 19.11 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.444 -0.947 . . . . 1.42 108.444 177.277 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 169' ' ' ALA . . . . . 0.68 ' CB ' ' HA2' ' B' ' 133' ' ' GLY . . . -168.68 160.99 11.06 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 113.739 -1.573 . . . . 1.18 111.898 -179.228 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 170' ' ' ALA . . . . . 0.413 ' HA ' ' HB3' ' B' ' 185' ' ' CYS . . . -61.76 138.95 58.37 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.004 0.43 . . . . 1.47 110.596 178.549 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 171' ' ' GLY . . . . . 0.711 ' N ' ' O ' ' B' ' 185' ' ' CYS . . . 74.43 -1.06 52.74 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 121.191 -0.528 . . . . 1.45 114.113 179.488 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 172' ' ' ILE . . . . . 0.752 ' CD1' ' HB2' ' B' ' 134' ' ' CYS . 1.3 pp -142.51 107.54 1.51 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.598 0 CA-C-O 121.736 0.779 . . . . 2.7 113.066 -179.29 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 173' ' ' CYS . . . . . 0.523 ' HB2' ' HB3' ' B' ' 182' ' ' ASP . 16.3 t -97.8 110.64 23.17 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.698 -0.683 . . . . 1.94 110.216 178.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 174' ' ' CYS . . . . . 0.726 ' HA ' ' HA ' ' B' ' 179' ' ' CYS . 72.0 m -92.67 138.91 31.09 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.439 0.638 . . . . 1.43 111.755 -179.401 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 175' ' ' SER . . . . . 0.791 ' HB2' ' HD2' ' B' ' 176' ' ' PRO . 51.7 p -113.35 179.65 0.75 Allowed Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 114.866 -1.061 . . . . 2.3 108.906 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 176' ' ' PRO . . . . . 0.791 ' HD2' ' HB2' ' B' ' 175' ' ' SER . 74.4 Cg_endo -76.39 30.78 0.4 Allowed 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 121.427 1.418 . . . . 2.13 111.918 -179.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 177' ' ' ASP . . . . . 0.468 ' H ' ' C ' ' B' ' 175' ' ' SER . 18.4 m-20 -144.71 -41.67 0.25 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.563 -0.744 . . . . 2.72 110.065 179.342 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 178' ' ' GLY . . . . . 0.84 ' HA3' ' O ' ' A' ' 79' ' ' CYS . . . -163.74 -135.11 1.76 Allowed Glycine 0 C--N 1.337 0.613 0 C-N-CA 121.041 -0.6 . . . . 1.05 112.763 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 179' ' ' CYS . . . . . 0.849 ' O ' ' HA3' ' A' ' 78' ' ' GLY . 62.3 m -148.12 157.05 43.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.949 0.404 . . . . 1.39 110.44 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 180' ' ' HIS . . . . . 0.509 ' CE1' ' HA3' ' B' ' 162' ' ' GLY . 1.8 p80 -157.89 153.2 25.9 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.285 -0.566 . . . . 2.73 110.611 -179.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 181' ' ' GLU . . . . . 0.426 ' OE2' ' HD2' ' A' ' 24' ' ' PRO . 14.6 mp0 -62.99 140.87 58.91 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.748 -0.381 . . . . 3.06 109.983 179.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 182' ' ' ASP . . . . . 0.598 ' O ' ' HB2' ' B' ' 186' ' ' ASP . 2.4 p-10 -141.02 140.92 22.18 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 116.11 -0.495 . . . . 2.06 111.089 -179.248 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 183' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_exo -72.53 -27.17 15.91 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 123.467 2.778 . . . . 2.27 114.665 -178.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -67.13 -47.35 71.37 Favored 'General case' 0 CA--C 1.507 -0.697 0 N-CA-C 107.784 -1.191 . . . . 1.56 107.784 179.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 185' ' ' CYS . . . . . 0.711 ' O ' ' N ' ' B' ' 171' ' ' GLY . 2.2 m -99.16 77.81 2.19 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 114.192 -1.367 . . . . 1.94 107.647 176.404 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 186' ' ' ASP . . . . . 0.941 ' H ' ' CD ' ' B' ' 187' ' ' PRO . 38.3 t0 -164.65 3.32 0.0 OUTLIER Pre-proline 0 C--N 1.321 -0.631 0 N-CA-C 114.3 1.222 . . . . 2.28 114.3 -179.298 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 187' ' ' PRO . . . . . 0.941 ' CD ' ' H ' ' B' ' 186' ' ' ASP . 74.4 Cg_endo -86.19 124.17 2.42 Favored 'Trans proline' 0 N--CA 1.45 -1.07 0 CA-C-N 120.916 1.363 . . . . 2.31 114.254 -179.182 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 188' ' ' GLU . . . . . 0.505 ' C ' ' O ' ' B' ' 187' ' ' PRO . 0.7 OUTLIER -8.91 64.95 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.137 0 CA-C-O 123.808 1.766 . . . . 4.7 109.011 -173.486 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 189' ' ' ALA . . . . . 0.811 ' N ' ' O ' ' B' ' 187' ' ' PRO . . . -83.18 -36.85 24.37 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 110.727 -2.942 . . . . 5.24 109.226 173.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 190' ' ' ALA . . . . . . . . . . . . . . . -90.11 109.82 20.86 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 110.002 -3.272 . . . . 6.93 112.463 178.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 191' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -88.28 88.72 7.72 Favored 'General case' 0 C--N 1.353 0.748 0 CA-C-N 110.766 -2.924 . . . . 10.62 110.561 -179.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 2.4 m . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.24 -0.886 . . . . 11.7 110.708 -179.757 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.531 ' O ' HG23 ' A' ' 2' ' ' VAL . . . . . . . . 0 N--CA 1.488 1.451 0 N-CA-C 111.62 0.23 . . . . 10.31 111.62 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.661 HG22 ' O ' ' A' ' 2' ' ' VAL . 1.4 m 80.25 43.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 O-C-N 124.678 1.236 . . . . 8.37 111.545 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 1.059 HD11 ' HB3' ' A' ' 5' ' ' LEU . 2.0 tm? -82.99 101.88 11.37 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 114.395 -1.275 . . . . 6.25 112.23 178.151 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.738 ' O ' ' HB3' ' A' ' 55' ' ' GLN . 1.6 m-20 -81.94 82.0 7.72 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 106.126 -1.805 . . . . 6.22 106.126 177.47 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 1.102 ' HG ' ' HA ' ' A' ' 54' ' ' CYS . 1.4 tm? -153.71 -68.91 0.14 Allowed 'General case' 0 CA--C 1.48 -1.741 0 CA-C-O 123.437 1.589 . . . . 7.57 109.398 -177.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.701 ' HB2' ' O ' ' A' ' 5' ' ' LEU . 0.6 OUTLIER 155.36 -23.67 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 CA-C-N 110.452 -3.067 . . . . 8.78 111.71 174.926 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.807 HG12 ' O ' ' A' ' 53' ' ' PRO . 3.6 p -89.61 178.5 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.409 -2.522 0 CA-C-N 112.835 -1.984 . . . . 7.88 109.675 -178.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.453 ' H ' ' CG2' ' A' ' 7' ' ' VAL . 4.3 ttp85 -80.21 114.32 19.03 Favored 'General case' 0 N--CA 1.406 -2.67 0 N-CA-C 104.391 -2.448 . . . . 9.7 104.391 177.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 1.006 ' HB ' ' HB2' ' A' ' 3' ' ' LEU . 14.7 t -40.04 111.92 0.23 Allowed 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 123.113 1.435 . . . . 6.05 112.213 -174.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.848 ' O ' ' HG2' ' A' ' 20' ' ' ARG . 71.6 m -19.02 123.67 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 111.021 -2.809 . . . . 2.89 114.191 -175.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.978 HD23 HD21 ' A' ' 50' ' ' LEU . 0.2 OUTLIER -29.24 119.99 0.29 Allowed Pre-proline 0 N--CA 1.485 1.303 0 C-N-CA 123.673 0.789 . . . . 2.89 113.025 179.944 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.869 ' HB2' ' O ' ' A' ' 17' ' ' GLY . 93.4 Cg_endo -72.21 155.83 55.93 Favored 'Trans proline' 0 C--N 1.358 1.054 0 C-N-CA 124.517 3.478 . . . . 1.72 116.408 -176.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.658 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 15.6 p -159.82 -173.07 3.91 Favored 'General case' 0 C--O 1.268 2.061 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.309 178.641 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.702 ' HA2' ' HB3' ' A' ' 40' ' ' GLU . . . 76.69 -158.9 49.22 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 121.134 -0.555 . . . . 1.15 114.39 177.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.587 ' HG2' ' O ' ' A' ' 15' ' ' PRO . 25.6 Cg_endo -66.51 99.09 0.42 Allowed 'Trans proline' 0 N--CA 1.49 1.305 0 C-N-CA 124.797 3.665 . . . . 1.6 112.725 178.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.43 7.51 84.62 Favored Glycine 0 C--N 1.275 -2.814 0 CA-C-N 113.622 -1.626 . . . . 1.68 111.137 -176.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.869 ' O ' ' HB2' ' A' ' 12' ' ' PRO . . . 55.71 55.78 27.09 Favored Glycine 0 N--CA 1.415 -2.709 0 CA-C-N 113.317 -1.442 . . . . 1.37 110.617 172.486 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.55 ' HE3' ' O ' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -92.53 -51.92 4.89 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 101.908 -3.367 . . . . 2.91 101.908 175.053 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.802 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -56.59 -179.08 0.46 Allowed Glycine 0 CA--C 1.533 1.173 0 CA-C-N 112.446 -2.161 . . . . 1.06 110.999 -168.342 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.848 ' HG2' ' O ' ' A' ' 10' ' ' CYS . 42.9 mtm-85 -132.33 174.22 10.46 Favored 'General case' 0 C--N 1.322 -0.587 0 O-C-N 119.999 -1.883 . . . . 3.32 112.185 -171.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 1.045 ' HB3' ' HG3' ' A' ' 47' ' ' GLU . 1.7 m -104.8 135.2 46.62 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.688 0.756 . . . . 1.19 112.496 -178.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.417 ' CD1' ' HB2' ' A' ' 28' ' ' CYS . 54.4 m-85 -144.97 39.95 1.24 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 114.525 -1.216 . . . . 2.26 109.743 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 141.95 166.35 10.86 Favored Glycine 0 CA--C 1.524 0.624 0 CA-C-N 115.6 -0.727 . . . . 1.05 111.647 -179.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.513 ' HD2' ' OE2' ' B' ' 181' ' ' GLU . 21.2 Cg_exo -65.65 -67.75 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.079 1.852 . . . . 1.81 112.147 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.776 ' C ' HG13 ' A' ' 26' ' ' ILE . 3.1 m -89.08 39.49 0.94 Allowed 'General case' 0 C--O 1.225 -0.196 0 N-CA-C 109.592 -0.522 . . . . 1.62 109.592 179.01 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 1.053 HG12 HG13 ' A' ' 36' ' ' VAL . 0.4 OUTLIER -156.0 120.73 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 N-CA-C 112.15 0.426 . . . . 1.39 112.15 -179.032 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.73 ' HB3' ' CE2' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -125.7 119.09 27.07 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 108.53 -0.915 . . . . 0.92 108.53 178.054 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.783 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 17.9 m -105.9 153.42 21.98 Favored 'General case' 0 CA--C 1.558 1.266 0 N-CA-C 112.646 0.61 . . . . 1.28 112.646 -178.289 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.504 ' O ' ' HB3' ' A' ' 69' ' ' ALA . . . -143.5 167.5 26.55 Favored Glycine 0 C--N 1.373 2.589 0 N-CA-C 109.575 -1.41 . . . . 0.71 109.575 174.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.604 ' OD2' ' HG2' ' A' ' 31' ' ' GLU . 8.4 p-10 -66.37 -39.32 89.04 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 124.906 1.282 . . . . 2.27 109.459 178.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.604 ' HG2' ' OD2' ' A' ' 30' ' ' ASP . 0.9 OUTLIER -124.54 6.46 8.26 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 113.55 -1.659 . . . . 1.66 110.964 179.692 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.978 HD22 ' CE1' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -110.03 -12.7 14.5 Favored 'General case' 0 N--CA 1.423 -1.78 0 CA-C-N 115.235 -0.893 . . . . 1.93 110.626 -177.843 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.81 ' HA2' ' HB3' ' A' ' 69' ' ' ALA . . . 60.19 -115.3 7.45 Favored Glycine 0 N--CA 1.428 -1.869 0 CA-C-O 118.139 -1.367 . . . . 0.77 111.842 179.408 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.958 ' HB2' HD13 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -147.45 127.26 13.48 Favored 'General case' 0 CA--C 1.489 -1.375 0 CA-C-N 119.893 1.847 . . . . 1.08 112.367 179.424 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.978 ' CE1' HD22 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -101.16 100.28 10.81 Favored 'General case' 0 N--CA 1.422 -1.838 0 N-CA-C 103.101 -2.925 . . . . 1.85 103.101 174.641 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 1.053 HG13 HG12 ' A' ' 26' ' ' ILE . 2.0 t -91.98 86.12 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.669 0 CA-C-O 123.364 1.554 . . . . 1.29 107.91 -178.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.713 ' HA3' HG23 ' B' ' 172' ' ' ILE . . . 89.79 82.68 1.34 Allowed Glycine 0 CA--C 1.521 0.408 0 CA-C-N 112.338 -2.21 . . . . 0.85 113.487 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.55 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 49.7 p -156.09 163.17 39.98 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 109.116 -0.698 . . . . 1.3 109.116 179.338 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.496 ' O ' ' HB2' ' A' ' 42' ' ' LEU . . . -50.35 -35.89 29.82 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 119.729 1.149 . . . . 1.45 112.766 -178.15 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.702 ' HB3' ' HA2' ' A' ' 14' ' ' GLY . 8.5 mt-10 -58.81 -24.57 62.1 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 109.906 -0.405 . . . . 2.32 109.906 178.033 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.772 ' O ' ' HB2' ' A' ' 44' ' ' CYS . . . -78.63 -23.27 45.93 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 109.514 -0.55 . . . . 1.11 109.514 -179.478 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.496 ' HB2' ' O ' ' A' ' 39' ' ' ALA . 0.5 OUTLIER -51.2 -38.72 53.95 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 121.136 -0.977 . . . . 1.68 109.821 178.804 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.782 ' HD2' ' O ' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -66.84 -5.32 11.89 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.21 -0.904 . . . . 3.4 109.986 177.348 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.772 ' HB2' ' O ' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -75.19 -1.01 21.31 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.121 -0.945 . . . . 1.57 111.726 177.122 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.97 -24.84 64.3 Favored 'General case' 0 N--CA 1.453 -0.325 0 O-C-N 121.435 -0.79 . . . . 3.49 110.581 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -84.45 3.05 38.01 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 120.165 -0.614 . . . . 3.69 110.292 179.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 1.045 ' HG3' ' HB3' ' A' ' 21' ' ' CYS . 1.7 tm-20 -81.88 2.96 28.01 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.58 -0.526 . . . . 3.99 109.58 177.26 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 24.5 t30 -94.99 -26.99 15.86 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.045 -0.525 . . . . 4.2 109.948 178.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -110.38 9.99 23.44 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.388 -0.369 . . . . 5.85 111.951 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.978 HD21 HD23 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -145.16 80.25 11.22 Favored Pre-proline 0 CA--C 1.536 0.411 0 CA-C-O 120.359 0.123 . . . . 5.83 111.279 179.995 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -95.37 50.82 0.19 Allowed 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 123.056 2.504 . . . . 5.3 112.829 -179.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.626 ' HB3' HG23 ' A' ' 7' ' ' VAL . 59.7 m -83.99 118.25 70.82 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-N 116.399 -0.364 . . . . 5.72 111.913 -179.335 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.807 ' O ' HG12 ' A' ' 7' ' ' VAL . 90.9 Cg_endo -81.8 121.41 3.67 Favored 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 122.51 2.14 . . . . 5.82 111.661 179.056 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 1.102 ' HA ' ' HG ' ' A' ' 5' ' ' LEU . 10.2 p -120.69 -160.18 0.83 Allowed 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.864 0.364 . . . . 2.98 111.882 -178.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.822 ' H ' HD23 ' A' ' 3' ' ' LEU . 0.4 OUTLIER -61.38 126.06 26.01 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.08 -0.509 . . . . 6.42 110.867 178.575 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.408 ' HB3' ' H ' ' A' ' 57' ' ' GLY . 10.7 m -155.06 -160.32 1.04 Allowed 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 116.9 -0.137 . . . . 3.36 110.772 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.408 ' H ' ' HB3' ' A' ' 56' ' ' SER . . . -121.41 133.23 9.43 Favored Glycine 0 N--CA 1.435 -1.411 0 N-CA-C 110.748 -0.941 . . . . 2.3 110.748 -179.146 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.84 76.78 1.03 Allowed 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 107.967 -1.123 . . . . 5.06 107.967 178.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.519 ' O ' ' HA ' ' A' ' 66' ' ' ARG . 0.1 OUTLIER -130.82 71.78 82.2 Favored Pre-proline 0 C--N 1.31 -1.128 0 CA-C-N 114.163 -1.38 . . . . 3.91 107.863 -179.355 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.486 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 36.5 Cg_endo -65.1 78.28 0.21 Allowed 'Trans proline' 0 C--N 1.363 1.296 0 C-N-CA 122.406 2.071 . . . . 1.74 113.642 -178.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -95.69 -173.08 2.77 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 106.008 -1.849 . . . . 1.9 106.008 176.126 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.39 -166.35 34.3 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 118.558 -1.782 . . . . 2.43 113.182 179.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.9 m -87.77 42.48 1.05 Allowed 'General case' 0 N--CA 1.484 1.237 0 CA-C-O 122.642 1.211 . . . . 4.32 110.695 -177.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 115.37 11.09 10.94 Favored Glycine 0 CA--C 1.558 2.728 0 CA-C-N 112.859 -1.973 . . . . 2.4 114.873 -177.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.466 ' CA ' ' HB3' ' A' ' 75' ' ' SER . . . -103.87 129.05 9.72 Favored Glycine 0 N--CA 1.469 0.894 0 CA-C-N 121.477 2.638 . . . . 1.82 116.259 -178.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.732 ' HD3' ' O ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -90.92 155.17 18.94 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 108.993 -0.743 . . . . 3.51 108.993 176.606 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.462 ' SG ' ' HB3' ' A' ' 59' ' ' LYS . 74.0 m -64.8 108.31 1.71 Allowed 'General case' 0 N--CA 1.439 -0.991 0 CA-C-O 121.44 0.638 . . . . 1.52 110.309 -178.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.574 ' HB1' ' SG ' ' A' ' 28' ' ' CYS . . . -94.57 -11.42 29.49 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.089 -0.96 . . . . 1.5 109.756 178.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.878 ' HB1' ' CG1' ' A' ' 72' ' ' ILE . . . -165.78 161.39 17.92 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.441 -1.254 . . . . 1.31 110.09 179.164 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.606 ' HA ' ' O ' ' A' ' 85' ' ' CYS . . . -58.02 117.31 4.2 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 113.837 1.051 . . . . 1.5 113.837 -178.315 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.729 ' HA2' ' O ' ' A' ' 82' ' ' ASP . . . 63.49 35.21 91.75 Favored Glycine 0 C--N 1.344 1.012 0 CA-C-N 115.532 -0.758 . . . . 1.44 112.301 179.002 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.958 HD13 ' HB2' ' A' ' 34' ' ' CYS . 1.8 pp -150.55 100.85 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.248 1.025 0 CA-C-O 121.924 0.869 . . . . 2.77 110.473 175.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.638 ' HB2' ' HB3' ' A' ' 82' ' ' ASP . 0.0 OUTLIER -85.63 92.07 8.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.696 -1.138 . . . . 1.98 110.661 -178.257 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.596 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 81.6 m -97.15 153.49 17.95 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.722 0.773 . . . . 1.43 112.513 -178.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.875 ' HB2' ' HD2' ' A' ' 76' ' ' PRO . 34.6 p -130.06 -178.97 0.9 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 114.529 -1.214 . . . . 2.37 108.8 179.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.875 ' HD2' ' HB2' ' A' ' 75' ' ' SER . 72.1 Cg_endo -78.07 26.83 0.49 Allowed 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 121.325 1.35 . . . . 2.09 111.761 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.63 ' HB2' ' CE1' ' B' ' 180' ' ' HIS . 3.0 p30 -145.95 -40.07 0.22 Allowed 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 115.786 -0.643 . . . . 2.65 111.417 179.377 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -157.08 -155.12 7.33 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 120.571 -0.823 . . . . 1.04 113.602 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.596 ' HA ' ' HA ' ' A' ' 74' ' ' CYS . 94.9 m -141.07 149.9 42.24 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 122.413 0.285 . . . . 1.42 110.394 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.609 ' CE1' ' HB2' ' B' ' 177' ' ' ASP . 79.6 t60 -140.96 126.4 18.76 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 109.453 -0.573 . . . . 2.81 109.453 -174.017 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.56 ' OE2' HD13 ' B' ' 126' ' ' ILE . 17.7 mt-10 -53.21 130.3 34.13 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.273 0.559 . . . . 3.05 111.748 -178.223 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.729 ' O ' ' HA2' ' A' ' 71' ' ' GLY . 0.1 OUTLIER -141.83 118.37 7.25 Favored Pre-proline 0 CA--C 1.547 0.839 0 CA-C-N 115.413 -0.812 . . . . 2.02 110.369 -179.056 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' A' ' 82' ' ' ASP . 3.7 Cg_exo -81.87 -18.86 7.52 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 122.848 2.365 . . . . 2.29 113.679 -178.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.67 -39.86 95.39 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.823 0.344 . . . . 1.53 111.739 -179.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.606 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 65.1 m -99.98 14.72 29.58 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.395 -0.366 . . . . 1.88 111.768 -179.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.514 ' CB ' ' HD3' ' A' ' 87' ' ' PRO . 0.8 OUTLIER -66.15 -55.5 20.65 Favored Pre-proline 0 C--N 1.322 -0.596 0 C-N-CA 121.063 -0.255 . . . . 3.6 111.413 -178.066 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.62 ' C ' ' H ' ' A' ' 89' ' ' ALA . 73.4 Cg_endo -104.19 -170.97 0.06 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.687 0 C-N-CA 122.639 2.226 . . . . 3.12 113.901 -178.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.498 ' C ' ' H ' ' A' ' 90' ' ' ALA . 5.5 pt-20 -56.6 26.93 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.045 0 CA-C-N 110.809 -2.905 . . . . 4.72 112.019 179.272 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.62 ' H ' ' C ' ' A' ' 87' ' ' PRO . . . -79.62 13.56 2.01 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 108.136 -1.061 . . . . 5.29 108.136 171.251 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.498 ' H ' ' C ' ' A' ' 88' ' ' GLU . . . -76.41 141.25 41.5 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-O 122.083 0.944 . . . . 7.19 111.511 177.302 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -100.47 101.53 12.5 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 113.447 -1.706 . . . . 10.7 110.241 176.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 16.6 m . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.354 -0.832 . . . . 11.77 110.941 179.927 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 101' ' ' ALA . . . . . 0.646 ' C ' HG23 ' B' ' 102' ' ' VAL . . . . . . . . 0 N--CA 1.485 1.283 0 CA-C-O 120.5 0.191 . . . . 10.42 110.608 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 102' ' ' VAL . . . . . 0.646 HG23 ' C ' ' B' ' 101' ' ' ALA . 0.0 OUTLIER 173.05 -176.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 N-CA-C 113.042 0.756 . . . . 8.81 113.042 -179.788 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 103' ' ' LEU . . . . . 1.057 HD11 ' HA ' ' B' ' 109' ' ' THR . 23.1 tp -107.07 115.26 29.86 Favored 'General case' 0 CA--C 1.5 -0.975 0 N-CA-C 106.138 -1.801 . . . . 6.28 106.138 174.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.32 69.06 8.11 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 106.543 -1.651 . . . . 6.27 106.543 177.169 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . 0.986 HD11 HG11 ' B' ' 107' ' ' VAL . 1.2 tm? -139.2 -80.86 0.31 Allowed 'General case' 0 CA--C 1.47 -2.118 0 C-N-CA 117.62 -1.632 . . . . 7.61 109.608 -176.459 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 106' ' ' ASP . . . . . 0.822 ' N ' HD13 ' B' ' 105' ' ' LEU . 0.5 OUTLIER 150.57 40.17 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 111.94 -2.391 . . . . 8.55 108.722 175.395 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 107' ' ' VAL . . . . . 0.986 HG11 HD11 ' B' ' 105' ' ' LEU . 3.6 p -155.95 177.46 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.562 0 C-N-CA 125.542 1.537 . . . . 7.84 108.752 -176.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 108' ' ' ARG . . . . . 0.449 ' H ' HG21 ' B' ' 107' ' ' VAL . 4.4 ttp85 -80.91 116.78 21.06 Favored 'General case' 0 N--CA 1.413 -2.298 0 N-CA-C 104.32 -2.474 . . . . 9.75 104.32 179.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 109' ' ' THR . . . . . 1.057 ' HA ' HD11 ' B' ' 103' ' ' LEU . 5.6 t -38.28 111.17 0.16 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.927 0.87 . . . . 6.13 112.73 -176.147 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 110' ' ' CYS . . . . . 0.898 ' O ' ' HG2' ' B' ' 120' ' ' ARG . 73.8 m -18.7 118.05 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.193 0 CA-C-N 112.454 -2.157 . . . . 2.87 115.085 -177.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 111' ' ' LEU . . . . . 0.833 HD12 ' HD2' ' B' ' 112' ' ' PRO . 0.2 OUTLIER -24.96 119.43 0.21 Allowed Pre-proline 0 N--CA 1.49 1.555 0 C-N-CA 123.684 0.794 . . . . 2.95 113.121 179.897 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 112' ' ' PRO . . . . . 0.954 ' HB2' ' O ' ' B' ' 117' ' ' GLY . 95.8 Cg_endo -71.61 156.13 58.11 Favored 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 124.576 3.517 . . . . 1.71 116.088 -176.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.56 ' C ' ' HA2' ' B' ' 117' ' ' GLY . 16.4 p -159.1 -171.34 3.33 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 115.92 -0.582 . . . . 1.0 111.057 177.436 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 114' ' ' GLY . . . . . 0.751 ' HA2' ' HB3' ' B' ' 140' ' ' GLU . . . 75.68 -159.46 51.08 Favored Glycine 0 CA--C 1.53 1.019 0 N-CA-C 115.069 0.788 . . . . 1.16 115.069 177.463 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 115' ' ' PRO . . . . . 0.649 ' HG2' ' O ' ' B' ' 115' ' ' PRO . 22.8 Cg_endo -66.37 102.59 0.59 Allowed 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 124.748 3.632 . . . . 1.6 111.611 178.426 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 87.31 -0.35 85.47 Favored Glycine 0 C--N 1.275 -2.822 0 CA-C-N 114.368 -1.287 . . . . 1.7 111.192 -177.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 117' ' ' GLY . . . . . 0.954 ' O ' ' HB2' ' B' ' 112' ' ' PRO . . . 64.34 44.4 95.47 Favored Glycine 1 N--CA 1.395 -4.061 0 CA-C-N 114.47 -0.865 . . . . 1.38 114.098 177.465 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 118' ' ' LYS . . . . . 0.495 ' HE3' ' O ' ' B' ' 115' ' ' PRO . 0.0 OUTLIER -93.31 -29.97 15.37 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.912 -0.773 . . . . 2.96 108.912 179.742 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 119' ' ' GLY . . . . . 0.76 ' O ' ' HA ' ' B' ' 112' ' ' PRO . . . -60.97 -163.29 0.18 Allowed Glycine 0 CA--C 1.496 -1.152 0 CA-C-O 118.493 -1.171 . . . . 1.07 111.604 -176.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.898 ' HG2' ' O ' ' B' ' 110' ' ' CYS . 48.8 mtm-85 -150.83 171.55 17.03 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 120.273 2.036 . . . . 3.29 108.806 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 121' ' ' CYS . . . . . 1.01 ' HB3' ' HG3' ' B' ' 147' ' ' GLU . 1.8 m -105.3 135.78 46.04 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.693 0.758 . . . . 1.21 112.875 -178.359 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 122' ' ' PHE . . . . . 0.432 ' CD1' ' HB2' ' B' ' 128' ' ' CYS . 54.7 m-85 -145.11 39.88 1.22 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 114.466 -1.243 . . . . 2.28 109.752 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 141.89 166.4 10.86 Favored Glycine 0 CA--C 1.523 0.59 0 CA-C-N 115.624 -0.716 . . . . 1.04 111.681 -179.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . 0.489 ' HD2' ' OE2' ' A' ' 81' ' ' GLU . 21.1 Cg_exo -65.69 -67.82 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.142 1.895 . . . . 1.84 112.065 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 125' ' ' SER . . . . . 0.762 ' C ' HG13 ' B' ' 126' ' ' ILE . 3.2 m -88.97 39.51 0.93 Allowed 'General case' 0 C--O 1.225 -0.205 0 N-CA-C 109.58 -0.526 . . . . 1.49 109.58 178.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 126' ' ' ILE . . . . . 0.762 HG13 ' C ' ' B' ' 125' ' ' SER . 0.5 OUTLIER -155.75 120.32 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 N-CA-C 112.188 0.44 . . . . 1.41 112.188 -178.975 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 127' ' ' CYS . . . . . 0.747 ' HB3' ' CE2' ' B' ' 135' ' ' PHE . 0.1 OUTLIER -125.15 120.76 32.28 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 108.748 -0.834 . . . . 0.89 108.748 178.085 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 128' ' ' CYS . . . . . 0.774 ' HA ' ' O ' ' B' ' 133' ' ' GLY . 8.6 m -111.57 146.37 37.48 Favored 'General case' 0 CA--C 1.571 1.77 0 N-CA-C 114.788 1.403 . . . . 1.23 114.788 -177.605 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 129' ' ' GLY . . . . . 0.574 ' O ' ' HB3' ' B' ' 169' ' ' ALA . . . -133.75 164.45 24.38 Favored Glycine 0 N--CA 1.421 -2.31 0 CA-C-N 114.973 -1.012 . . . . 0.69 112.065 178.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 130' ' ' ASP . . . . . 0.619 ' OD2' ' HG2' ' B' ' 131' ' ' GLU . 9.6 p-10 -72.28 -27.78 62.7 Favored 'General case' 0 C--N 1.292 -1.892 0 C-N-CA 126.275 1.83 . . . . 2.35 111.033 177.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 131' ' ' GLU . . . . . 0.619 ' HG2' ' OD2' ' B' ' 130' ' ' ASP . 1.1 pt-20 -140.49 23.85 2.3 Favored 'General case' 0 CA--C 1.482 -1.672 0 CA-C-N 114.006 -1.452 . . . . 1.69 108.506 172.599 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 132' ' ' LEU . . . . . 0.826 HD22 ' CE1' ' B' ' 135' ' ' PHE . 0.6 OUTLIER -123.64 -9.54 7.89 Favored 'General case' 0 N--CA 1.408 -2.544 0 N-CA-C 107.327 -1.36 . . . . 1.84 107.327 178.1 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 133' ' ' GLY . . . . . 0.774 ' O ' ' HA ' ' B' ' 128' ' ' CYS . . . 58.93 -114.47 6.1 Favored Glycine 0 N--CA 1.408 -3.217 0 CA-C-O 117.979 -1.456 . . . . 0.76 112.423 178.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 134' ' ' CYS . . . . . 0.88 ' HB2' HD13 ' B' ' 172' ' ' ILE . 0.1 OUTLIER -148.52 124.07 10.4 Favored 'General case' 0 CA--C 1.478 -1.814 0 CA-C-N 120.326 2.063 . . . . 1.08 113.638 179.98 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 135' ' ' PHE . . . . . 0.826 ' CE1' HD22 ' B' ' 132' ' ' LEU . 0.0 OUTLIER -98.35 99.88 11.11 Favored 'General case' 0 N--CA 1.42 -1.96 0 N-CA-C 102.985 -2.969 . . . . 1.83 102.985 176.054 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 136' ' ' VAL . . . . . 0.754 HG12 HG12 ' B' ' 126' ' ' ILE . 2.3 t -91.91 85.49 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.65 0 CA-C-O 123.507 1.622 . . . . 1.29 107.875 -178.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 137' ' ' GLY . . . . . 0.643 ' HA3' HG21 ' A' ' 72' ' ' ILE . . . 90.21 81.74 1.37 Allowed Glycine 0 C--N 1.317 -0.476 0 CA-C-N 112.081 -2.327 . . . . 0.85 113.416 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 138' ' ' THR . . . . . 0.541 HG21 ' HD1' ' A' ' 35' ' ' PHE . 68.7 p -148.41 176.3 10.4 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.624 -0.88 . . . . 1.2 108.624 179.158 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 139' ' ' ALA . . . . . 0.524 ' O ' ' HB2' ' B' ' 142' ' ' LEU . . . -61.1 -40.93 95.62 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 119.323 0.965 . . . . 1.35 109.932 178.301 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 140' ' ' GLU . . . . . 0.751 ' HB3' ' HA2' ' B' ' 114' ' ' GLY . 7.7 mt-10 -56.53 -19.1 13.95 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.355 0.598 . . . . 2.31 111.204 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 141' ' ' ALA . . . . . 0.742 ' O ' ' HB2' ' B' ' 144' ' ' CYS . . . -83.26 -20.82 33.78 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 114.906 -1.043 . . . . 1.09 110.054 179.287 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 142' ' ' LEU . . . . . 0.524 ' HB2' ' O ' ' B' ' 139' ' ' ALA . 0.5 OUTLIER -53.9 -39.73 66.04 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.939 0.876 . . . . 1.61 109.088 177.704 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 143' ' ' ARG . . . . . 0.784 ' HD2' ' O ' ' B' ' 112' ' ' PRO . 0.2 OUTLIER -67.4 -3.79 9.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.605 -1.179 . . . . 3.43 109.991 177.621 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 144' ' ' CYS . . . . . 0.742 ' HB2' ' O ' ' B' ' 141' ' ' ALA . 0.1 OUTLIER -84.39 18.23 2.31 Favored 'General case' 0 C--N 1.342 0.246 0 O-C-N 120.863 -1.148 . . . . 1.61 110.993 176.148 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 145' ' ' GLN . . . . . 0.407 ' H ' ' C ' ' B' ' 143' ' ' ARG . 0.0 OUTLIER -78.23 -27.12 47.61 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.563 0.696 . . . . 3.52 109.146 175.14 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -84.55 3.17 37.88 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.78 -0.645 . . . . 3.76 110.71 179.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . 1.01 ' HG3' ' HB3' ' B' ' 121' ' ' CYS . 1.7 tm-20 -81.7 2.76 28.23 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.607 -0.516 . . . . 4.01 109.607 177.32 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 148' ' ' ASN . . . . . . . . . . . . . 24.7 t30 -94.94 -26.87 15.95 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.019 -0.537 . . . . 4.24 109.943 178.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -110.38 9.97 23.44 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.418 -0.355 . . . . 6.07 111.891 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 150' ' ' LEU . . . . . 0.524 HD21 ' CD2' ' B' ' 111' ' ' LEU . 0.1 OUTLIER -145.15 80.33 11.19 Favored Pre-proline 0 CA--C 1.535 0.39 0 C-N-CA 121.31 -0.156 . . . . 5.86 111.243 -179.998 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 151' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -95.43 50.83 0.19 Allowed 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 123.065 2.51 . . . . 5.42 112.814 -179.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 59.8 m -83.94 118.23 70.77 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 116.342 -0.39 . . . . 6.02 111.965 -179.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 153' ' ' PRO . . . . . 0.567 ' O ' HG12 ' B' ' 107' ' ' VAL . 91.9 Cg_endo -81.6 121.69 3.82 Favored 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 122.434 2.089 . . . . 5.87 111.563 179.077 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 154' ' ' CYS . . . . . 1.045 ' HB2' HD21 ' B' ' 103' ' ' LEU . 8.9 p -120.96 -160.87 0.87 Allowed 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 112.076 0.399 . . . . 2.96 112.076 -178.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 155' ' ' GLN . . . . . 0.744 ' N ' ' HB2' ' B' ' 105' ' ' LEU . 0.4 OUTLIER -60.92 125.58 24.24 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 120.636 -0.426 . . . . 6.3 110.707 178.561 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 156' ' ' SER . . . . . 0.405 ' HB3' ' H ' ' B' ' 157' ' ' GLY . 5.8 m -152.0 -155.85 0.65 Allowed 'General case' 0 N--CA 1.466 0.329 0 O-C-N 122.517 -0.114 . . . . 3.41 110.874 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 157' ' ' GLY . . . . . 0.405 ' H ' ' HB3' ' B' ' 156' ' ' SER . . . -127.6 134.82 8.43 Favored Glycine 0 N--CA 1.44 -1.043 0 N-CA-C 110.082 -1.207 . . . . 2.26 110.082 178.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.55 67.7 0.66 Allowed 'General case' 0 N--CA 1.444 -0.746 0 CA-C-O 122.144 0.973 . . . . 5.03 109.28 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 159' ' ' LYS . . . . . 0.542 ' O ' ' HA ' ' B' ' 166' ' ' ARG . 0.1 OUTLIER -112.82 69.38 1.11 Allowed Pre-proline 0 C--N 1.315 -0.919 0 CA-C-N 113.929 -1.487 . . . . 3.96 110.634 177.046 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 160' ' ' PRO . . . . . 0.483 ' HA ' ' HA ' ' B' ' 166' ' ' ARG . 33.2 Cg_endo -64.86 79.19 0.19 Allowed 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 121.56 1.507 . . . . 1.7 114.011 -177.549 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 161' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -93.74 -168.95 1.99 Allowed 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 106.682 -1.599 . . . . 1.93 106.682 176.657 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 60.09 -165.38 12.33 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 118.859 -1.638 . . . . 2.37 113.407 177.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 4.1 m -87.69 42.21 1.03 Allowed 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 122.961 1.363 . . . . 4.56 110.902 -177.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 118.15 6.59 12.12 Favored Glycine 0 CA--C 1.551 2.343 0 CA-C-N 112.552 -2.113 . . . . 2.39 115.095 -179.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 165' ' ' GLY . . . . . 0.469 ' CA ' ' HB3' ' B' ' 175' ' ' SER . . . -102.36 129.59 9.94 Favored Glycine 0 N--CA 1.472 1.07 0 CA-C-N 120.835 2.317 . . . . 1.79 116.708 -177.02 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 166' ' ' ARG . . . . . 0.728 ' HD3' ' O ' ' B' ' 166' ' ' ARG . 0.0 OUTLIER -90.77 155.35 18.86 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 108.858 -0.793 . . . . 3.53 108.858 177.115 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 167' ' ' CYS . . . . . 0.471 ' SG ' ' HB3' ' B' ' 159' ' ' LYS . 69.6 m -64.87 107.86 1.6 Allowed 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 118.392 0.542 . . . . 1.56 110.136 -178.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 168' ' ' ALA . . . . . 0.497 ' HB2' ' SG ' ' B' ' 128' ' ' CYS . . . -89.32 -19.37 25.37 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 122.056 0.931 . . . . 1.42 108.626 178.242 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 169' ' ' ALA . . . . . 0.865 ' HB1' ' CG1' ' B' ' 172' ' ' ILE . . . -159.88 160.94 34.22 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 113.55 -1.659 . . . . 1.18 111.037 -176.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 170' ' ' ALA . . . . . 0.617 ' HA ' ' O ' ' B' ' 185' ' ' CYS . . . -57.91 118.09 4.99 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 113.556 0.947 . . . . 1.47 113.556 -178.326 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 171' ' ' GLY . . . . . 0.65 ' HA2' ' O ' ' B' ' 182' ' ' ASP . . . 71.81 18.79 77.72 Favored Glycine 0 CA--C 1.521 0.441 0 CA-C-N 115.689 -0.687 . . . . 1.45 114.609 177.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 172' ' ' ILE . . . . . 0.88 HD13 ' HB2' ' B' ' 134' ' ' CYS . 1.7 pp -142.32 102.07 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-O 122.458 1.123 . . . . 2.7 111.252 -178.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 173' ' ' CYS . . . . . 0.638 ' HB2' ' HB3' ' B' ' 182' ' ' ASP . 0.0 OUTLIER -85.7 92.12 8.49 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 114.126 -1.397 . . . . 1.94 110.669 -178.38 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 174' ' ' CYS . . . . . 0.633 ' HA ' ' HA ' ' B' ' 179' ' ' CYS . 81.4 m -97.51 153.52 18.1 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.655 0.741 . . . . 1.43 112.478 -178.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 175' ' ' SER . . . . . 0.884 ' HB2' ' HD2' ' B' ' 176' ' ' PRO . 35.1 p -130.02 -178.92 0.89 Allowed Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 114.494 -1.23 . . . . 2.3 108.916 179.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 176' ' ' PRO . . . . . 0.884 ' HD2' ' HB2' ' B' ' 175' ' ' SER . 72.1 Cg_endo -78.15 26.94 0.49 Allowed 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 121.339 1.359 . . . . 2.13 111.727 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 177' ' ' ASP . . . . . 0.609 ' HB2' ' CE1' ' A' ' 80' ' ' HIS . 3.0 p30 -146.07 -39.98 0.22 Allowed 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.772 -0.649 . . . . 2.72 111.357 179.374 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -157.12 -155.03 7.29 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 120.588 -0.815 . . . . 1.05 113.51 -179.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 179' ' ' CYS . . . . . 0.633 ' HA ' ' HA ' ' B' ' 174' ' ' CYS . 99.8 m -140.19 156.15 46.63 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 110.054 -0.35 . . . . 1.39 110.054 179.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 180' ' ' HIS . . . . . 0.63 ' CE1' ' HB2' ' A' ' 77' ' ' ASP . 81.3 t60 -150.27 124.13 9.26 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-O 121.387 0.613 . . . . 2.73 110.427 -173.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 181' ' ' GLU . . . . . 0.629 ' OE2' HD12 ' A' ' 26' ' ' ILE . 18.5 mt-10 -51.21 129.89 25.37 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 115.105 -0.952 . . . . 3.06 111.98 -175.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 182' ' ' ASP . . . . . 0.65 ' O ' ' HA2' ' B' ' 171' ' ' GLY . 0.1 OUTLIER -141.83 118.28 7.23 Favored Pre-proline 0 CA--C 1.546 0.807 0 CA-C-N 115.333 -0.849 . . . . 2.06 110.371 -179.066 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 183' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -81.84 -18.81 7.59 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 122.813 2.342 . . . . 2.27 113.671 -178.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -63.59 -39.81 95.34 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.781 0.324 . . . . 1.56 111.684 -179.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 185' ' ' CYS . . . . . 0.617 ' O ' ' HA ' ' B' ' 170' ' ' ALA . 68.8 m -99.85 14.76 29.27 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 116.311 -0.404 . . . . 1.94 112.052 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 186' ' ' ASP . . . . . 0.515 ' CB ' ' HD3' ' B' ' 187' ' ' PRO . 0.8 OUTLIER -66.78 -55.6 16.95 Favored Pre-proline 0 C--N 1.322 -0.608 0 C-N-CA 121.015 -0.274 . . . . 3.61 111.71 -178.099 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 187' ' ' PRO . . . . . 0.542 ' C ' ' H ' ' B' ' 189' ' ' ALA . 57.1 Cg_endo -99.66 -169.36 0.1 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.17 0 C-N-CA 123.284 2.656 . . . . 3.14 113.883 -179.049 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 188' ' ' GLU . . . . . 0.463 ' C ' ' H ' ' B' ' 190' ' ' ALA . 5.9 pt-20 -61.64 30.47 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 111.586 -2.552 . . . . 4.7 112.189 175.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 189' ' ' ALA . . . . . 0.542 ' H ' ' C ' ' B' ' 187' ' ' PRO . . . -82.24 16.02 2.18 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 107.895 -1.15 . . . . 5.24 107.895 169.464 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 190' ' ' ALA . . . . . 0.463 ' H ' ' C ' ' B' ' 188' ' ' GLU . . . -78.4 140.89 38.67 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-O 122.3 1.048 . . . . 6.93 111.547 176.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 191' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -100.18 101.56 12.62 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 113.145 -1.843 . . . . 10.62 110.194 177.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 16.6 m . . . . . 0 C--O 1.248 0.975 0 CA-C-O 118.279 -0.867 . . . . 11.7 110.898 -179.989 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.441 0 CA-C-O 121.515 0.674 . . . . 10.31 112.009 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.1 p -138.01 135.76 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.262 0 CA-C-O 123.046 1.403 . . . . 8.37 113.025 179.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.882 ' HG ' ' HG3' ' A' ' 8' ' ' ARG . 1.1 mm? -69.95 118.39 12.74 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 111.976 -2.375 . . . . 6.25 110.611 178.152 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.415 ' H ' ' HG3' ' A' ' 55' ' ' GLN . 1.1 m-20 -98.85 53.56 1.0 Allowed 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 113.005 -1.907 . . . . 6.22 109.994 178.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.693 ' CD1' ' H ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -141.67 -66.92 0.4 Allowed 'General case' 0 N--CA 1.383 -3.806 0 CA-C-N 111.71 -2.496 . . . . 7.57 107.974 175.905 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.693 ' H ' ' CD1' ' A' ' 5' ' ' LEU . 0.2 OUTLIER 165.7 -42.18 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.965 0 CA-C-O 125.132 2.396 . . . . 8.78 111.554 -178.597 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.667 ' H ' HD23 ' A' ' 5' ' ' LEU . 8.2 p -156.72 129.27 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.05 1 CA-C-N 107.232 -4.531 . . . . 7.88 108.486 172.902 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.882 ' HG3' ' HG ' ' A' ' 3' ' ' LEU . 0.0 OUTLIER -74.94 103.55 5.19 Favored 'General case' 0 N--CA 1.385 -3.71 0 C-N-CA 116.362 -2.135 . . . . 9.7 108.811 -179.841 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -112.06 98.36 7.29 Favored 'General case' 0 N--CA 1.395 -3.205 1 N-CA-C 99.941 -4.096 . . . . 6.05 99.941 166.426 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.7 m -77.01 59.68 1.7 Allowed 'General case' 0 C--N 1.282 -2.363 0 C-N-CA 118.437 -1.305 . . . . 2.89 111.646 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.794 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 4.4 mm? -32.71 114.43 0.4 Allowed Pre-proline 0 N--CA 1.475 0.799 0 N-CA-C 112.067 0.395 . . . . 2.89 112.067 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.668 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 95.7 Cg_endo -88.89 114.45 0.7 Allowed 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.626 2.217 . . . . 1.72 114.408 -178.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.653 ' O ' ' HA2' ' A' ' 17' ' ' GLY . 13.6 p -116.86 -155.31 0.58 Allowed 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 121.586 0.708 . . . . 1.0 110.582 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.4 ' HA2' ' HB3' ' A' ' 40' ' ' GLU . . . 79.21 -166.46 51.48 Favored Glycine 0 CA--C 1.497 -1.063 0 CA-C-O 119.284 -0.731 . . . . 1.15 111.892 179.182 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.605 ' HD2' HD13 ' A' ' 32' ' ' LEU . 84.8 Cg_endo -64.4 83.81 0.16 Allowed 'Trans proline' 0 N--CA 1.458 -0.561 0 CA-C-N 119.712 1.756 . . . . 1.6 113.374 -178.071 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.99 8.21 72.8 Favored Glycine 0 C--N 1.29 -1.979 0 CA-C-N 111.927 -2.397 . . . . 1.68 115.2 -178.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.653 ' HA2' ' O ' ' A' ' 13' ' ' CYS . . . 91.17 42.77 4.86 Favored Glycine 0 N--CA 1.435 -1.369 0 N-CA-C 118.089 1.995 . . . . 1.37 118.089 172.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.61 -15.85 26.35 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 114.372 -0.914 . . . . 2.91 113.184 177.607 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.698 ' HA3' ' O ' ' A' ' 28' ' ' CYS . . . -121.31 -179.67 16.12 Favored Glycine 0 N--CA 1.469 0.879 0 CA-C-O 117.707 -1.607 . . . . 1.06 109.084 -179.026 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.794 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 4.2 mpt_? -106.33 173.05 6.48 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 121.804 2.802 . . . . 3.32 110.476 178.218 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.45 ' HB3' ' HG3' ' A' ' 47' ' ' GLU . 0.5 OUTLIER -107.66 135.63 48.78 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 110.372 -0.233 . . . . 1.19 110.372 179.523 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.582 ' HE1' ' HB2' ' A' ' 28' ' ' CYS . 96.0 m-85 -111.51 -68.96 0.9 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.837 0.351 . . . . 2.26 110.574 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -106.63 -153.12 19.72 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 111.133 -0.787 . . . . 1.05 111.133 178.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -88.5 -51.25 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 122.444 2.096 . . . . 1.81 112.1 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.648 ' O ' ' N ' ' A' ' 37' ' ' GLY . 1.2 m -98.84 29.64 3.69 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-N 116.434 -0.348 . . . . 1.62 110.467 179.504 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.918 ' CG1' HG12 ' A' ' 36' ' ' VAL . 6.9 mt -138.69 116.0 11.57 Favored 'Isoleucine or valine' 0 C--O 1.243 0.717 0 CA-C-O 121.528 0.68 . . . . 1.39 112.771 -178.732 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.786 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 0.6 OUTLIER -130.76 125.4 33.7 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 114.973 -1.012 . . . . 0.92 110.274 178.626 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 1.032 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 94.8 m -117.2 161.94 18.66 Favored 'General case' 0 CA--C 1.55 0.972 0 CA-C-N 115.145 -0.934 . . . . 1.28 113.432 -178.293 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.824 ' O ' ' HB3' ' A' ' 69' ' ' ALA . . . -145.48 176.38 24.52 Favored Glycine 0 C--N 1.358 1.801 0 CA-C-N 112.955 -1.929 . . . . 0.71 108.597 176.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.44 ' O ' ' HB2' ' A' ' 70' ' ' ALA . 9.1 t70 -65.78 -53.27 42.62 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 122.367 1.08 . . . . 2.27 110.601 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.56 ' OE2' ' HA ' ' A' ' 91' ' ' PHE . 1.1 pt-20 -120.41 19.1 12.1 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 113.067 -1.878 . . . . 1.66 108.214 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.612 HD22 ' CZ ' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -111.97 -12.6 13.72 Favored 'General case' 0 N--CA 1.405 -2.69 0 CA-C-N 114.229 -1.35 . . . . 1.93 108.033 179.988 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 1.032 ' O ' ' HA ' ' A' ' 28' ' ' CYS . . . 55.95 -127.67 43.53 Favored Glycine 0 N--CA 1.419 -2.5 0 CA-C-N 114.419 -1.264 . . . . 0.77 112.107 177.399 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.786 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -143.91 121.36 11.7 Favored 'General case' 0 CA--C 1.493 -1.238 0 N-CA-C 114.527 1.306 . . . . 1.08 114.527 179.68 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.721 ' HA ' ' HA ' ' B' ' 135' ' ' PHE . 0.0 OUTLIER -85.94 105.79 16.66 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 102.605 -3.109 . . . . 1.85 102.605 173.861 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.918 HG12 ' CG1' ' A' ' 26' ' ' ILE . 2.6 t -92.8 85.53 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.702 0 C-N-CA 118.436 -1.306 . . . . 1.29 108.714 -178.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.648 ' N ' ' O ' ' A' ' 25' ' ' SER . . . 96.55 76.97 1.33 Allowed Glycine 0 CA--C 1.527 0.786 0 CA-C-N 112.464 -2.153 . . . . 0.85 114.071 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.586 HG21 ' O ' ' B' ' 132' ' ' LEU . 47.1 p -155.36 176.67 12.28 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 108.482 -0.933 . . . . 1.3 108.482 178.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 1.078 ' O ' HD11 ' A' ' 42' ' ' LEU . . . -68.9 -13.67 62.57 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-N 119.495 1.043 . . . . 1.45 109.942 178.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.444 ' HG2' ' CE2' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -64.09 -18.55 64.51 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.368 -0.975 . . . . 2.32 108.368 177.903 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.924 ' O ' ' HB2' ' A' ' 44' ' ' CYS . . . -112.14 -12.13 13.69 Favored 'General case' 0 C--O 1.217 -0.631 0 CA-C-N 115.192 -0.913 . . . . 1.11 113.034 -179.276 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 1.078 HD11 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -54.32 -19.28 5.14 Favored 'General case' 0 C--N 1.323 -0.545 0 O-C-N 120.966 -1.084 . . . . 1.68 113.29 -177.497 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.772 ' N ' HD13 ' A' ' 42' ' ' LEU . 9.2 ptm85 -79.65 -14.68 58.62 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 106.56 -1.645 . . . . 3.4 106.56 174.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.924 ' HB2' ' O ' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -58.18 -22.65 52.46 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 111.393 -2.639 . . . . 1.57 108.984 -178.383 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.76 -20.25 5.34 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.641 0.608 . . . . 3.49 112.641 179.046 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -85.83 6.75 26.71 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.102 -0.639 . . . . 3.69 110.729 -179.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.47 ' HB2' ' O ' ' A' ' 44' ' ' CYS . 3.3 mm-40 -82.49 0.88 40.35 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 109.334 -0.617 . . . . 3.99 109.334 177.473 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 23.3 p-10 -75.26 -29.36 60.14 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.713 -0.477 . . . . 4.2 109.713 178.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -80.78 9.08 6.78 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.473 -0.331 . . . . 5.85 111.605 179.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.5 mt -134.51 130.48 19.97 Favored Pre-proline 0 C--N 1.333 -0.139 0 CA-C-O 120.507 0.194 . . . . 5.83 111.028 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -80.86 9.8 3.63 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.493 2.129 . . . . 5.3 112.532 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 178.42 150.26 0.42 Allowed Pre-proline 0 CA--C 1.529 0.15 0 CA-C-O 120.657 0.265 . . . . 5.72 110.799 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -79.27 -104.21 0.01 OUTLIER 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 122.661 2.24 . . . . 5.82 112.283 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 9.0 p -158.5 117.02 3.01 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 109.892 -0.41 . . . . 2.98 109.892 179.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.596 ' CD ' ' HA ' ' A' ' 3' ' ' LEU . 1.2 pm0 -56.47 134.78 54.26 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 119.916 -0.714 . . . . 6.42 112.18 -178.569 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.547 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 0.3 OUTLIER 168.76 67.71 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 112.047 0.388 . . . . 3.36 112.047 178.734 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.553 ' O ' ' HG3' ' A' ' 66' ' ' ARG . . . 168.32 89.9 0.08 OUTLIER Glycine 0 N--CA 1.434 -1.464 0 N-CA-C 108.053 -2.019 . . . . 2.3 108.053 -179.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -110.61 77.79 1.07 Allowed 'General case' 0 CA--C 1.497 -1.081 0 CA-C-O 122.465 1.126 . . . . 5.06 109.221 -178.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.893 ' HB2' ' HB2' ' A' ' 67' ' ' CYS . 7.7 mptt -140.77 53.06 3.53 Favored Pre-proline 0 C--N 1.293 -1.85 0 CA-C-N 113.279 -1.782 . . . . 3.91 107.391 179.012 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.552 ' CD ' ' N ' ' A' ' 59' ' ' LYS . 11.1 Cg_endo -54.6 97.32 0.05 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.202 0 C-N-CA 122.576 2.184 . . . . 1.74 113.496 -179.666 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.639 ' N ' ' O ' ' A' ' 65' ' ' GLY . 1.0 OUTLIER -96.91 -166.6 1.42 Allowed 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 111.947 -2.388 . . . . 1.9 107.189 177.56 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' A' ' 61' ' ' CYS . . . 36.91 -164.81 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 119.789 -1.196 . . . . 2.43 115.623 172.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -84.75 47.64 1.41 Allowed 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 113.1 -1.55 . . . . 4.32 111.405 -178.056 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 120.62 9.9 7.42 Favored Glycine 0 C--N 1.349 1.287 0 CA-C-N 114.77 -1.105 . . . . 2.4 115.22 178.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.639 ' O ' ' N ' ' A' ' 61' ' ' CYS . . . -105.2 132.62 11.19 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 119.551 -1.309 . . . . 1.82 115.402 -178.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.553 ' HG3' ' O ' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -101.71 154.24 19.06 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 109.38 -0.6 . . . . 3.51 109.38 177.046 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.893 ' HB2' ' HB2' ' A' ' 59' ' ' LYS . 0.5 OUTLIER -59.33 115.24 3.1 Favored 'General case' 0 CA--C 1.496 -1.128 0 N-CA-C 109.183 -0.673 . . . . 1.52 109.183 -179.696 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.839 ' HB1' ' SG ' ' A' ' 28' ' ' CYS . . . -90.72 -19.21 23.82 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 107.785 -1.191 . . . . 1.5 107.785 178.089 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.824 ' HB3' ' O ' ' A' ' 29' ' ' GLY . . . -165.1 162.93 20.51 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 109.471 -0.566 . . . . 1.31 109.471 -177.51 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.834 ' CB ' ' HG3' ' A' ' 88' ' ' GLU . . . -50.43 132.81 25.03 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 112.927 0.714 . . . . 1.5 112.927 -179.49 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.561 ' H ' ' CB ' ' A' ' 85' ' ' CYS . . . 65.67 -25.6 0.14 Allowed Glycine 0 CA--C 1.526 0.77 0 CA-C-N 115.347 -0.842 . . . . 1.44 115.183 178.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.743 HD13 ' HB2' ' A' ' 34' ' ' CYS . 1.0 OUTLIER -102.37 122.56 54.82 Favored 'Isoleucine or valine' 0 C--O 1.243 0.72 0 CA-C-O 122.148 0.975 . . . . 2.77 111.614 -179.493 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.63 ' HB2' ' HB3' ' A' ' 82' ' ' ASP . 43.8 t -105.27 111.01 23.59 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.372 -0.831 . . . . 1.98 111.178 -179.516 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.653 ' HB2' ' HB2' ' A' ' 68' ' ' ALA . 0.8 OUTLIER -110.99 143.52 41.54 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.731 0.776 . . . . 1.43 112.559 -179.129 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.648 ' HB2' ' HD2' ' A' ' 76' ' ' PRO . 84.0 p -112.16 178.57 0.95 Allowed Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 114.447 -1.251 . . . . 2.37 108.76 179.482 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.648 ' HD2' ' HB2' ' A' ' 75' ' ' SER . 86.8 Cg_endo -80.54 22.95 0.73 Allowed 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 121.362 1.375 . . . . 2.09 111.649 179.31 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -145.3 -36.93 0.28 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.835 -0.62 . . . . 2.65 110.52 179.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.771 ' HA3' ' O ' ' B' ' 179' ' ' CYS . . . -155.57 -144.0 3.81 Favored Glycine 0 C--N 1.337 0.616 0 C-N-CA 120.47 -0.871 . . . . 1.04 113.385 179.513 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.656 ' O ' ' HA3' ' B' ' 178' ' ' GLY . 0.1 OUTLIER -151.5 157.97 43.0 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.987 0.422 . . . . 1.42 111.22 -179.614 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.436 ' O ' ' HB3' ' A' ' 73' ' ' CYS . 45.3 m80 -147.14 148.32 31.44 Favored 'General case' 0 N--CA 1.461 0.089 0 O-C-N 122.162 -0.336 . . . . 2.81 110.26 179.358 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -64.5 133.99 53.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.547 -0.297 . . . . 3.05 110.496 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.63 ' HB3' ' HB2' ' A' ' 73' ' ' CYS . 0.0 OUTLIER -145.02 117.56 5.36 Favored Pre-proline 0 CA--C 1.538 0.489 0 CA-C-N 116.531 -0.304 . . . . 2.02 110.684 179.864 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -83.96 -9.29 9.79 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 123.024 2.483 . . . . 2.29 113.575 -178.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.76 -22.31 66.04 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.11 0.411 . . . . 1.53 112.11 -179.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.696 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 52.2 m -101.09 20.36 15.75 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 113.515 0.931 . . . . 1.88 113.515 -178.009 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.617 ' N ' ' CD ' ' A' ' 87' ' ' PRO . 1.2 m-20 -69.43 -36.54 7.19 Favored Pre-proline 0 CA--C 1.518 -0.275 0 C-N-CA 122.911 0.484 . . . . 3.6 111.525 178.578 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.617 ' CD ' ' N ' ' A' ' 86' ' ' ASP . 1.3 Cg_endo -76.46 71.72 5.79 Favored 'Trans proline' 0 CA--C 1.497 -1.362 0 N-CA-C 107.595 -1.733 . . . . 3.12 107.595 177.321 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.834 ' HG3' ' CB ' ' A' ' 70' ' ' ALA . 8.1 pt-20 169.45 -15.33 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 113.032 -1.895 . . . . 4.72 108.805 176.103 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.55 -11.6 61.04 Favored 'General case' 0 C--N 1.366 1.315 0 C-N-CA 124.538 1.135 . . . . 5.29 113.892 -177.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.49 128.38 35.43 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-O 124.22 1.962 . . . . 7.19 111.019 173.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.56 ' HA ' ' OE2' ' A' ' 31' ' ' GLU . 35.4 p90 -96.8 91.62 5.76 Favored 'General case' 0 C--N 1.356 0.878 0 CA-C-N 109.562 -3.472 . . . . 10.7 109.643 178.516 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 52.2 p . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.198 -0.906 . . . . 11.77 111.235 -179.333 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.452 0 CA-C-O 120.795 0.331 . . . . 10.42 111.481 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 102' ' ' VAL . . . . . 0.62 HG11 ' O ' ' B' ' 102' ' ' VAL . 12.0 p 46.85 89.5 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 C-N-CA 124.056 0.942 . . . . 8.81 113.447 -178.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 103' ' ' LEU . . . . . 0.549 HD21 ' N ' ' B' ' 103' ' ' LEU . 2.6 mm? -112.2 105.07 13.31 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.387 0.613 . . . . 6.28 110.654 179.254 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -105.91 62.54 0.66 Allowed 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 122.61 1.195 . . . . 6.27 110.488 179.287 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . 0.859 ' HG ' ' HA ' ' B' ' 154' ' ' CYS . 0.0 OUTLIER -153.04 -74.39 0.13 Allowed 'General case' 0 N--CA 1.384 -3.759 0 C-N-CA 128.308 2.643 . . . . 7.61 107.346 177.658 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 106' ' ' ASP . . . . . 0.778 ' H ' HD12 ' B' ' 105' ' ' LEU . 0.2 OUTLIER -173.32 -71.66 0.01 OUTLIER 'General case' 0 C--N 1.267 -2.999 0 N-CA-C 109.716 -0.476 . . . . 8.55 109.716 -177.931 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 107' ' ' VAL . . . . . 0.555 ' C ' HD11 ' B' ' 105' ' ' LEU . 2.7 p -138.89 141.86 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.684 1 N-CA-C 96.057 -5.534 . . . . 7.84 96.057 173.878 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 108' ' ' ARG . . . . . 0.777 ' O ' ' HD2' ' B' ' 108' ' ' ARG . 0.0 OUTLIER -73.96 108.55 6.85 Favored 'General case' 0 N--CA 1.4 -2.93 0 C-N-CA 116.621 -2.031 . . . . 9.75 110.076 -177.678 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.49 98.13 5.99 Favored 'General case' 0 N--CA 1.4 -2.95 1 N-CA-C 99.136 -4.394 . . . . 6.13 99.136 167.496 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 110' ' ' CYS . . . . . . . . . . . . . 1.7 m -79.39 66.0 4.72 Favored 'General case' 0 C--N 1.294 -1.817 0 C-N-CA 117.657 -1.617 . . . . 2.87 110.251 -178.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 111' ' ' LEU . . . . . 0.806 ' O ' ' HA ' ' B' ' 120' ' ' ARG . 4.3 mm? -35.39 114.19 0.52 Allowed Pre-proline 0 N--CA 1.47 0.552 0 C-N-CA 122.655 0.382 . . . . 2.95 111.843 178.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 112' ' ' PRO . . . . . 0.731 ' HA ' ' O ' ' B' ' 119' ' ' GLY . 92.2 Cg_endo -88.13 114.98 0.89 Allowed 'Trans proline' 0 CA--C 1.531 0.368 0 C-N-CA 122.394 2.063 . . . . 1.71 113.931 -179.215 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.625 ' O ' ' HA2' ' B' ' 117' ' ' GLY . 13.8 p -117.2 -153.94 0.54 Allowed 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.642 0.734 . . . . 1.0 110.692 178.672 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . 78.6 -166.67 52.42 Favored Glycine 0 CA--C 1.5 -0.886 0 CA-C-N 115.601 -0.727 . . . . 1.16 111.864 179.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 115' ' ' PRO . . . . . 0.568 ' HD2' HD13 ' B' ' 132' ' ' LEU . 87.1 Cg_endo -64.66 82.58 0.17 Allowed 'Trans proline' 0 N--CA 1.454 -0.848 0 CA-C-N 119.503 1.652 . . . . 1.6 114.37 -177.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 89.44 6.86 70.2 Favored Glycine 0 C--N 1.29 -2.01 0 CA-C-N 111.727 -2.488 . . . . 1.7 115.638 -177.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 117' ' ' GLY . . . . . 0.625 ' HA2' ' O ' ' B' ' 113' ' ' CYS . . . 93.48 41.87 4.38 Favored Glycine 0 N--CA 1.436 -1.335 0 N-CA-C 117.794 1.877 . . . . 1.38 117.794 173.369 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.92 -15.56 26.18 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 113.18 0.807 . . . . 2.96 113.18 177.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 119' ' ' GLY . . . . . 0.731 ' O ' ' HA ' ' B' ' 112' ' ' PRO . . . -122.19 -170.66 13.77 Favored Glycine 0 C--N 1.347 1.161 0 N-CA-C 108.472 -1.851 . . . . 1.07 108.472 178.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.806 ' HA ' ' O ' ' B' ' 111' ' ' LEU . 4.1 mpt_? -110.94 172.85 6.63 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 121.307 2.554 . . . . 3.29 110.667 178.537 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 121' ' ' CYS . . . . . 0.457 ' HB3' ' HG3' ' B' ' 147' ' ' GLU . 0.5 OUTLIER -107.8 135.5 49.1 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 110.257 -0.275 . . . . 1.21 110.257 179.662 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 122' ' ' PHE . . . . . 0.597 ' HE1' ' HB2' ' B' ' 128' ' ' CYS . 96.0 m-85 -111.46 -68.94 0.9 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.873 0.368 . . . . 2.28 110.561 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -106.89 -153.22 19.42 Favored Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 111.062 -0.815 . . . . 1.04 111.062 178.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -88.32 -51.24 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 122.38 2.053 . . . . 1.84 112.161 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 125' ' ' SER . . . . . 0.648 ' O ' ' N ' ' B' ' 137' ' ' GLY . 1.4 m -98.64 29.55 3.66 Favored 'General case' 0 C--O 1.223 -0.308 0 CA-C-N 116.478 -0.328 . . . . 1.49 110.376 179.393 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 126' ' ' ILE . . . . . 0.464 ' CG1' HG13 ' B' ' 136' ' ' VAL . 8.1 mt -138.14 115.63 12.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.645 0 N-CA-C 113.122 0.786 . . . . 1.41 113.122 -178.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 127' ' ' CYS . . . . . 0.794 ' O ' ' HA ' ' B' ' 134' ' ' CYS . 0.5 OUTLIER -130.72 125.33 33.6 Favored 'General case' 0 C--O 1.225 -0.224 0 CA-C-N 115.122 -0.945 . . . . 0.89 110.232 178.689 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 128' ' ' CYS . . . . . 1.044 ' HA ' ' O ' ' B' ' 133' ' ' GLY . 98.6 m -117.09 162.49 17.73 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.19 -0.914 . . . . 1.23 113.387 -178.117 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 129' ' ' GLY . . . . . 0.526 ' O ' ' CB ' ' B' ' 169' ' ' ALA . . . -145.68 176.44 24.67 Favored Glycine 0 C--N 1.358 1.789 0 N-CA-C 108.622 -1.791 . . . . 0.69 108.622 176.364 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 130' ' ' ASP . . . . . 0.434 ' O ' ' HB3' ' B' ' 170' ' ' ALA . 9.2 t70 -66.56 -53.21 37.13 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 121.966 0.889 . . . . 2.35 110.239 179.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 131' ' ' GLU . . . . . 0.55 ' OE2' ' HA ' ' B' ' 191' ' ' PHE . 1.2 pt-20 -122.83 30.53 6.39 Favored 'General case' 0 N--CA 1.424 -1.766 0 CA-C-N 113.676 -1.602 . . . . 1.69 108.06 177.58 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 132' ' ' LEU . . . . . 0.586 ' O ' HG21 ' A' ' 38' ' ' THR . 0.8 OUTLIER -122.24 -11.26 8.42 Favored 'General case' 0 N--CA 1.406 -2.636 0 N-CA-C 106.136 -1.801 . . . . 1.84 106.136 -178.839 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 133' ' ' GLY . . . . . 1.044 ' O ' ' HA ' ' B' ' 128' ' ' CYS . . . 54.51 -126.17 36.5 Favored Glycine 0 N--CA 1.408 -3.169 0 CA-C-N 113.876 -1.511 . . . . 0.76 112.351 175.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 134' ' ' CYS . . . . . 0.794 ' HA ' ' O ' ' B' ' 127' ' ' CYS . 0.1 OUTLIER -145.06 120.63 10.41 Favored 'General case' 0 CA--C 1.491 -1.296 0 N-CA-C 115.032 1.493 . . . . 1.08 115.032 -179.841 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 135' ' ' PHE . . . . . 0.721 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -85.3 106.12 16.47 Favored 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 102.72 -3.067 . . . . 1.83 102.72 174.507 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 136' ' ' VAL . . . . . 0.608 ' CG2' ' CG2' ' A' ' 36' ' ' VAL . 3.4 t -92.63 85.63 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.601 0 CA-C-O 122.85 1.31 . . . . 1.29 108.513 -178.284 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 137' ' ' GLY . . . . . 0.648 ' N ' ' O ' ' B' ' 125' ' ' SER . . . 96.12 76.5 1.31 Allowed Glycine 0 CA--C 1.526 0.73 0 CA-C-N 112.5 -2.136 . . . . 0.85 114.222 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 138' ' ' THR . . . . . 0.478 HG23 ' C ' ' B' ' 137' ' ' GLY . 49.8 p -155.19 176.31 12.72 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 108.414 -0.958 . . . . 1.2 108.414 178.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 139' ' ' ALA . . . . . 1.097 ' O ' HD11 ' B' ' 142' ' ' LEU . . . -68.64 -12.79 61.81 Favored 'General case' 0 C--O 1.22 -0.487 0 CA-C-N 119.235 0.925 . . . . 1.35 110.133 178.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 140' ' ' GLU . . . . . 0.433 ' HG2' ' CE2' ' B' ' 135' ' ' PHE . 0.9 OUTLIER -65.63 -17.45 64.6 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.483 -0.932 . . . . 2.31 108.483 177.569 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 141' ' ' ALA . . . . . 0.903 ' O ' ' HB2' ' B' ' 144' ' ' CYS . . . -112.62 -12.65 13.39 Favored 'General case' 0 C--O 1.216 -0.688 0 CA-C-N 114.98 -1.009 . . . . 1.09 113.033 -179.46 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 142' ' ' LEU . . . . . 1.097 HD11 ' O ' ' B' ' 139' ' ' ALA . 0.0 OUTLIER -54.24 -19.23 4.9 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 121.097 -1.002 . . . . 1.61 113.222 -177.236 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 143' ' ' ARG . . . . . 0.765 ' N ' HD13 ' B' ' 142' ' ' LEU . 9.3 ptm85 -80.76 -12.58 59.43 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 106.774 -1.565 . . . . 3.43 106.774 174.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 144' ' ' CYS . . . . . 0.903 ' HB2' ' O ' ' B' ' 141' ' ' ALA . 0.1 OUTLIER -58.76 -24.84 62.36 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 111.786 -2.461 . . . . 1.61 108.948 -179.488 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.84 -20.56 2.29 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 112.672 0.619 . . . . 3.52 112.672 179.495 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -85.85 6.79 26.63 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.128 -0.629 . . . . 3.76 110.754 -179.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . 0.481 ' HB2' ' O ' ' B' ' 144' ' ' CYS . 3.3 mm-40 -82.62 1.16 39.6 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 109.401 -0.592 . . . . 4.01 109.401 177.406 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 148' ' ' ASN . . . . . . . . . . . . . 23.3 p-10 -75.36 -29.35 59.87 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.719 -0.474 . . . . 4.24 109.719 178.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -80.72 9.03 6.78 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.432 -0.349 . . . . 6.07 111.585 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 150' ' ' LEU . . . . . 0.584 HD12 HD21 ' B' ' 111' ' ' LEU . 10.5 mt -134.57 130.48 19.91 Favored Pre-proline 0 C--N 1.332 -0.161 0 CA-C-O 120.495 0.188 . . . . 5.86 111.054 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 151' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -80.89 9.83 3.63 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.466 2.111 . . . . 5.42 112.578 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 178.42 150.22 0.42 Allowed Pre-proline 0 CA--C 1.529 0.169 0 CA-C-N 116.611 -0.268 . . . . 6.02 110.795 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 153' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -79.38 -104.24 0.01 OUTLIER 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 122.662 2.241 . . . . 5.87 112.32 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 154' ' ' CYS . . . . . 0.859 ' HA ' ' HG ' ' B' ' 105' ' ' LEU . 8.1 p -158.48 118.09 3.18 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 109.883 -0.414 . . . . 2.96 109.883 179.124 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 155' ' ' GLN . . . . . 0.548 ' O ' ' HB2' ' B' ' 156' ' ' SER . 1.3 pm0 -57.97 134.42 56.36 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 120.322 -0.551 . . . . 6.3 111.839 -178.401 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 156' ' ' SER . . . . . 0.548 ' HB2' ' O ' ' B' ' 155' ' ' GLN . 0.3 OUTLIER 168.47 70.75 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 120.938 0.399 . . . . 3.41 111.5 179.043 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 157' ' ' GLY . . . . . 0.528 ' O ' ' HG3' ' B' ' 166' ' ' ARG . . . 165.14 91.05 0.08 OUTLIER Glycine 0 N--CA 1.44 -1.085 0 N-CA-C 108.847 -1.701 . . . . 2.26 108.847 179.608 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -112.34 65.61 0.64 Allowed 'General case' 0 CA--C 1.501 -0.909 0 CA-C-O 122.762 1.268 . . . . 5.03 110.402 -179.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 159' ' ' LYS . . . . . 0.964 ' HB2' ' HB2' ' B' ' 167' ' ' CYS . 7.3 mptt -113.34 47.66 0.37 Allowed Pre-proline 0 C--N 1.302 -1.499 0 CA-C-N 112.542 -2.117 . . . . 3.96 111.534 173.303 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 160' ' ' PRO . . . . . 0.413 ' HA ' ' HA ' ' B' ' 166' ' ' ARG . 10.0 Cg_endo -53.76 97.52 0.05 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.402 0 CA-C-N 121.3 1.5 . . . . 1.7 114.698 -174.612 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 161' ' ' CYS . . . . . 0.599 ' N ' ' O ' ' B' ' 165' ' ' GLY . 0.9 OUTLIER -96.9 -166.69 1.44 Allowed 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 112.397 -2.183 . . . . 1.93 107.406 177.626 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 162' ' ' GLY . . . . . 0.41 ' N ' ' SG ' ' B' ' 161' ' ' CYS . . . 37.08 -164.77 0.01 OUTLIER Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 115.746 1.059 . . . . 2.37 115.746 172.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -84.54 47.31 1.34 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 113.177 -1.511 . . . . 4.56 111.465 -178.093 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 120.4 9.82 7.62 Favored Glycine 0 CA--C 1.539 1.549 0 CA-C-N 115.043 -0.981 . . . . 2.39 115.179 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 165' ' ' GLY . . . . . 0.599 ' O ' ' N ' ' B' ' 161' ' ' CYS . . . -104.82 133.38 11.52 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 118.921 -1.609 . . . . 1.79 115.16 -179.55 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 166' ' ' ARG . . . . . 0.528 ' HG3' ' O ' ' B' ' 157' ' ' GLY . 0.0 OUTLIER -102.17 154.19 19.25 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 109.313 -0.625 . . . . 3.53 109.313 176.661 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 167' ' ' CYS . . . . . 0.964 ' HB2' ' HB2' ' B' ' 159' ' ' LYS . 0.5 OUTLIER -59.2 115.54 3.27 Favored 'General case' 0 CA--C 1.499 -0.982 0 N-CA-C 109.214 -0.661 . . . . 1.56 109.214 -179.571 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 168' ' ' ALA . . . . . 0.439 ' HB2' ' SG ' ' B' ' 128' ' ' CYS . . . -89.8 -20.75 23.12 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 107.774 -1.195 . . . . 1.42 107.774 177.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 169' ' ' ALA . . . . . 0.748 ' HB2' ' HA2' ' B' ' 133' ' ' GLY . . . -164.38 162.71 22.33 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.375 -0.83 . . . . 1.18 110.682 -177.016 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 170' ' ' ALA . . . . . 0.832 ' CB ' ' HG3' ' B' ' 188' ' ' GLU . . . -49.99 133.0 23.11 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 112.711 0.634 . . . . 1.47 112.711 -179.273 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 171' ' ' GLY . . . . . 0.539 ' H ' ' CB ' ' B' ' 185' ' ' CYS . . . 67.65 -30.74 0.22 Allowed Glycine 0 CA--C 1.527 0.809 0 CA-C-N 115.614 -0.721 . . . . 1.45 114.693 178.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 172' ' ' ILE . . . . . 0.654 HD13 ' HB2' ' B' ' 134' ' ' CYS . 1.0 OUTLIER -99.5 122.78 51.71 Favored 'Isoleucine or valine' 0 C--O 1.242 0.71 0 CA-C-O 122.322 1.058 . . . . 2.7 111.931 -178.138 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 173' ' ' CYS . . . . . 0.639 ' HB2' ' HB3' ' B' ' 182' ' ' ASP . 44.1 t -105.36 110.96 23.51 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.201 -0.909 . . . . 1.94 111.19 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 174' ' ' CYS . . . . . 0.515 ' HA ' ' HA ' ' B' ' 179' ' ' CYS . 0.8 OUTLIER -110.83 143.51 41.29 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.586 0.707 . . . . 1.43 112.603 -179.097 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 175' ' ' SER . . . . . 0.655 ' HB2' ' HD2' ' B' ' 176' ' ' PRO . 83.9 p -112.17 178.53 0.96 Allowed Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 114.542 -1.208 . . . . 2.3 108.778 179.365 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 176' ' ' PRO . . . . . 0.655 ' HD2' ' HB2' ' B' ' 175' ' ' SER . 89.0 Cg_endo -80.53 23.1 0.72 Allowed 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 121.315 1.343 . . . . 2.13 111.663 179.328 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 177' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -145.38 -36.29 0.29 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.812 -0.631 . . . . 2.72 110.711 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 178' ' ' GLY . . . . . 0.656 ' HA3' ' O ' ' A' ' 79' ' ' CYS . . . -156.41 -144.18 3.86 Favored Glycine 0 C--N 1.337 0.587 0 C-N-CA 120.671 -0.776 . . . . 1.05 113.325 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 179' ' ' CYS . . . . . 0.771 ' O ' ' HA3' ' A' ' 78' ' ' GLY . 0.1 OUTLIER -151.51 157.98 43.0 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 120.895 0.378 . . . . 1.39 111.346 -179.489 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 180' ' ' HIS . . . . . 0.435 ' O ' ' HB3' ' B' ' 173' ' ' CYS . 45.4 m80 -147.05 148.36 31.57 Favored 'General case' 0 N--CA 1.46 0.069 0 O-C-N 122.199 -0.313 . . . . 2.73 110.277 179.316 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 181' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -64.5 133.93 53.42 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.645 -0.252 . . . . 3.06 110.486 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 182' ' ' ASP . . . . . 0.639 ' HB3' ' HB2' ' B' ' 173' ' ' CYS . 0.0 OUTLIER -144.99 117.52 5.37 Favored Pre-proline 0 CA--C 1.538 0.496 0 CA-C-N 116.521 -0.309 . . . . 2.06 110.673 179.864 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 183' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -83.97 -9.14 9.85 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 123.039 2.493 . . . . 2.27 113.557 -178.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -66.75 -22.49 66.04 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.05 0.389 . . . . 1.56 112.05 -179.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 185' ' ' CYS . . . . . 0.719 ' HB3' ' HA ' ' B' ' 170' ' ' ALA . 54.1 m -100.94 20.32 15.68 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 113.622 0.971 . . . . 1.94 113.622 -178.024 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 186' ' ' ASP . . . . . 0.622 ' N ' ' CD ' ' B' ' 187' ' ' PRO . 1.2 m-20 -69.45 -36.46 7.05 Favored Pre-proline 0 CA--C 1.518 -0.271 0 C-N-CA 122.858 0.463 . . . . 3.61 111.52 178.577 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 187' ' ' PRO . . . . . 0.622 ' CD ' ' N ' ' B' ' 186' ' ' ASP . 1.2 Cg_endo -76.32 70.19 6.26 Favored 'Trans proline' 0 CA--C 1.497 -1.345 0 C-N-CA 121.554 1.503 . . . . 3.14 108.28 177.586 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 188' ' ' GLU . . . . . 0.832 ' HG3' ' CB ' ' B' ' 170' ' ' ALA . 8.2 pt-20 170.1 -14.21 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 112.821 -1.991 . . . . 4.7 109.064 176.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 189' ' ' ALA . . . . . . . . . . . . . . . -71.79 -11.13 60.66 Favored 'General case' 0 C--N 1.363 1.184 0 C-N-CA 124.401 1.08 . . . . 5.24 113.831 -177.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 190' ' ' ALA . . . . . . . . . . . . . . . -72.68 131.87 42.95 Favored 'General case' 0 N--CA 1.418 -2.043 0 CA-C-O 124.173 1.939 . . . . 6.93 111.026 172.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 191' ' ' PHE . . . . . 0.55 ' HA ' ' OE2' ' B' ' 131' ' ' GLU . 35.8 p90 -97.55 91.77 5.6 Favored 'General case' 0 C--N 1.35 0.599 0 CA-C-N 109.24 -3.618 . . . . 10.62 109.923 177.26 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 53.0 p . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.179 -0.915 . . . . 11.7 111.125 -179.343 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.308 0 CA-C-O 121.053 0.454 . . . . 10.31 111.879 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 18.6 t 53.46 51.12 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 N-CA-C 112.874 0.694 . . . . 8.37 112.874 176.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.812 ' CB ' ' HD3' ' A' ' 8' ' ' ARG . 0.6 OUTLIER -129.17 112.98 14.51 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 115.822 -0.626 . . . . 6.25 109.331 -179.554 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.703 ' O ' ' HB2' ' A' ' 55' ' ' GLN . 0.1 OUTLIER -154.29 -153.3 0.45 Allowed 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 103.208 -2.886 . . . . 6.22 103.208 178.174 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.634 ' HA ' ' CB ' ' A' ' 55' ' ' GLN . 0.1 OUTLIER -86.23 9.78 16.64 Favored 'General case' 0 C--N 1.347 0.486 0 C-N-CA 114.967 -2.693 . . . . 7.57 109.852 175.539 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.54 -85.67 0.06 Allowed 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 104.919 -2.252 . . . . 8.78 104.919 -179.577 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.882 ' HA ' ' HB2' ' A' ' 56' ' ' SER . 2.4 p -149.76 115.33 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.455 -2.705 0 C-N-CA 115.72 -2.392 . . . . 7.88 105.014 172.741 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.823 ' CG ' ' HA ' ' A' ' 54' ' ' CYS . 9.2 tpt180 -77.59 116.55 18.23 Favored 'General case' 0 CA--C 1.462 -2.431 0 C-N-CA 118.818 -1.153 . . . . 9.7 108.688 -177.348 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.546 ' O ' ' HD2' ' A' ' 8' ' ' ARG . 2.5 t -64.54 108.21 1.6 Allowed 'General case' 0 N--CA 1.426 -1.628 0 C-N-CA 114.023 -3.071 . . . . 6.05 103.079 176.096 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.749 ' HB3' ' HB3' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -69.71 114.93 8.38 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.845 -1.071 . . . . 2.89 111.347 -176.96 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.463 ' C ' ' O ' ' A' ' 10' ' ' CYS . 5.6 tp -29.05 129.9 0.22 Allowed Pre-proline 0 N--CA 1.468 0.45 0 CA-C-O 121.031 0.443 . . . . 2.89 111.948 -179.396 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.858 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 54.5 Cg_endo -70.14 152.28 67.3 Favored 'Trans proline' 0 N--CA 1.475 0.39 0 C-N-CA 123.377 2.718 . . . . 1.72 114.608 -179.128 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.623 ' SG ' ' N ' ' A' ' 14' ' ' GLY . 0.0 OUTLIER -160.97 -170.22 2.64 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 119.422 -0.911 . . . . 1.0 110.946 176.969 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.838 ' HA2' ' HB3' ' A' ' 40' ' ' GLU . . . 77.61 -159.72 48.4 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 115.47 0.948 . . . . 1.15 115.47 178.393 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.518 ' CG ' HD23 ' A' ' 32' ' ' LEU . 74.4 Cg_endo -61.37 104.16 0.29 Allowed 'Trans proline' 0 N--CA 1.487 1.127 0 C-N-CA 124.749 3.633 . . . . 1.6 111.021 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.64 -10.92 60.66 Favored Glycine 0 C--N 1.28 -2.566 0 CA-C-N 113.119 -1.855 . . . . 1.68 111.219 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.49 ' O ' ' HB2' ' A' ' 12' ' ' PRO . . . 76.49 37.36 35.85 Favored Glycine 0 N--CA 1.411 -3.005 0 C-N-CA 119.336 -1.411 . . . . 1.37 111.153 -179.627 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.49 ' HB2' ' CD1' ' A' ' 32' ' ' LEU . 0.5 OUTLIER -88.09 -37.47 16.21 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 112.973 -1.614 . . . . 2.91 112.29 179.196 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.858 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -89.56 -172.79 45.63 Favored Glycine 0 N--CA 1.423 -2.198 0 CA-C-N 122.055 2.207 . . . . 1.06 110.966 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.749 ' HB3' ' HB3' ' A' ' 10' ' ' CYS . 0.4 OUTLIER -113.14 172.14 7.12 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 124.395 0.703 . . . . 3.32 112.777 -179.407 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.7 m -106.85 145.55 32.01 Favored 'General case' 0 N--CA 1.475 0.809 0 O-C-N 121.826 -0.546 . . . . 1.19 110.455 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.414 ' CZ ' ' O ' ' A' ' 68' ' ' ALA . 76.3 m-85 -142.9 22.39 1.93 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.944 -0.571 . . . . 2.26 111.752 -179.335 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.808 ' O ' ' HB3' ' A' ' 44' ' ' CYS . . . 174.04 -169.45 42.48 Favored Glycine 0 C--O 1.225 -0.444 0 C-N-CA 120.724 -0.751 . . . . 1.05 111.421 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -81.3 -54.18 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.531 2.154 . . . . 1.81 112.333 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.6 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.3 OUTLIER -106.47 12.1 30.0 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.234 -0.439 . . . . 1.62 111.39 -179.963 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.741 HG21 ' SG ' ' A' ' 34' ' ' CYS . 1.2 mt -121.8 122.43 66.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 113.218 0.821 . . . . 1.39 113.218 -177.357 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.655 ' HB3' ' CD2' ' A' ' 35' ' ' PHE . 4.3 t -130.78 116.37 17.88 Favored 'General case' 0 C--O 1.226 -0.155 0 CA-C-O 122.494 1.14 . . . . 0.92 111.48 178.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 1.163 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -121.36 148.48 44.31 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 112.552 -2.113 . . . . 1.28 109.08 -179.546 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.649 ' O ' ' HB3' ' A' ' 69' ' ' ALA . . . -144.01 -167.86 12.09 Favored Glycine 0 CA--C 1.478 -2.223 0 N-CA-C 105.494 -3.042 . . . . 0.71 105.494 174.388 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.598 ' O ' ' HB2' ' A' ' 70' ' ' ALA . 12.3 p-10 -67.18 -69.01 0.34 Allowed 'General case' 0 C--N 1.282 -2.329 0 C-N-CA 118.635 -1.226 . . . . 2.27 112.82 -179.575 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.4 ' H ' ' CG ' ' A' ' 30' ' ' ASP . 0.0 OUTLIER -95.13 15.1 19.94 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 114.722 -1.127 . . . . 1.66 111.284 -176.523 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.554 ' O ' ' O ' ' B' ' 137' ' ' GLY . 1.0 OUTLIER -116.48 -17.69 10.59 Favored 'General case' 0 N--CA 1.4 -2.944 0 CA-C-N 114.568 -1.196 . . . . 1.93 108.208 179.945 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 1.163 ' O ' ' HA ' ' A' ' 28' ' ' CYS . . . 63.19 -128.25 39.12 Favored Glycine 0 N--CA 1.405 -3.428 0 CA-C-N 113.963 -1.471 . . . . 0.77 114.285 178.098 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.821 ' HB2' HG13 ' A' ' 72' ' ' ILE . 4.8 t -141.51 120.09 12.47 Favored 'General case' 0 CA--C 1.5 -0.944 0 N-CA-C 115.572 1.693 . . . . 1.08 115.572 -179.667 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 1.044 ' HA ' ' HA ' ' B' ' 135' ' ' PHE . 0.0 OUTLIER -96.34 107.58 19.97 Favored 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 106.501 -1.666 . . . . 1.85 106.501 176.219 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.671 ' N ' ' O ' ' B' ' 134' ' ' CYS . 1.8 t -94.72 84.0 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.774 0 N-CA-C 108.008 -1.108 . . . . 1.29 108.008 179.387 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.6 ' N ' ' O ' ' A' ' 25' ' ' SER . . . 105.27 102.61 2.8 Favored Glycine 0 CA--C 1.524 0.646 0 CA-C-N 113.451 -1.704 . . . . 0.85 114.007 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.565 ' HB ' ' O ' ' B' ' 132' ' ' LEU . 0.2 OUTLIER 178.66 161.95 0.69 Allowed 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 107.992 -1.114 . . . . 1.3 107.992 179.02 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.466 ' HA ' HD13 ' A' ' 42' ' ' LEU . . . -69.28 -28.24 66.12 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 120.595 1.543 . . . . 1.45 112.175 -179.331 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.838 ' HB3' ' HA2' ' A' ' 14' ' ' GLY . 0.5 OUTLIER -62.23 -12.81 22.34 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.154 0.502 . . . . 2.32 110.524 178.125 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.801 ' O ' ' HB2' ' A' ' 44' ' ' CYS . . . -103.49 -19.32 14.44 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.091 -0.959 . . . . 1.11 110.673 178.108 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.466 HD13 ' HA ' ' A' ' 39' ' ' ALA . 0.7 OUTLIER -46.8 -38.06 9.58 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 112.403 0.52 . . . . 1.68 112.403 -179.298 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.459 ' HD2' ' H ' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -57.82 -22.35 47.14 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-O 122.552 1.167 . . . . 3.4 108.771 177.127 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.808 ' HB3' ' O ' ' A' ' 23' ' ' GLY . 28.6 m -58.8 -10.7 2.55 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-N 112.193 -2.276 . . . . 1.57 109.81 178.401 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.428 ' HB2' ' O ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -77.22 -18.98 57.29 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-O 121.126 0.489 . . . . 3.49 111.73 178.981 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -85.83 10.39 13.91 Favored 'General case' 0 CA--C 1.515 -0.369 0 C-N-CA 119.861 -0.736 . . . . 3.69 110.457 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -81.03 2.5 26.81 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 108.865 -0.791 . . . . 3.99 108.865 177.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -94.64 -28.94 15.1 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 116.303 -0.408 . . . . 4.2 110.134 178.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -105.08 30.26 5.71 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.308 -0.405 . . . . 5.85 110.981 179.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -124.37 131.87 24.23 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 120.633 0.254 . . . . 5.83 111.454 -179.485 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -77.05 12.92 1.62 Allowed 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.739 2.293 . . . . 5.3 113.045 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 35.0 p -103.69 105.94 50.0 Favored Pre-proline 0 CA--C 1.531 0.22 0 CA-C-O 120.438 0.161 . . . . 5.72 110.653 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -88.16 -4.66 6.82 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.924 2.416 . . . . 5.82 112.937 -179.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.823 ' HA ' ' CG ' ' A' ' 8' ' ' ARG . 1.8 t 63.68 97.2 0.04 OUTLIER 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 116.602 -0.272 . . . . 2.98 111.352 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.703 ' HB2' ' O ' ' A' ' 4' ' ' ASP . 19.1 mm100 -103.36 72.34 1.15 Allowed 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 118.706 -1.198 . . . . 6.42 111.776 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.882 ' HB2' ' HA ' ' A' ' 7' ' ' VAL . 1.3 t 173.2 79.66 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.679 -0.691 . . . . 3.36 110.406 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 162.01 44.69 0.02 OUTLIER Glycine 0 N--CA 1.442 -0.955 0 N-CA-C 108.66 -1.776 . . . . 2.3 108.66 -179.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.421 ' O ' ' HG3' ' A' ' 58' ' ' GLN . 15.6 pt20 -118.96 86.05 2.48 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-O 122.489 1.137 . . . . 5.06 108.91 -179.255 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.486 ' HB3' ' HB2' ' A' ' 67' ' ' CYS . 0.0 OUTLIER -137.24 69.09 55.75 Favored Pre-proline 0 C--N 1.294 -1.817 0 N-CA-C 104.419 -2.437 . . . . 3.91 104.419 -178.869 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -71.71 91.56 0.7 Allowed 'Trans proline' 0 N--CA 1.446 -1.296 0 C-N-CA 122.858 2.372 . . . . 1.74 115.055 -176.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 3.2 p -104.43 -172.32 2.08 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 113.2 -1.818 . . . . 1.9 107.03 176.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 52.21 -166.07 1.14 Allowed Glycine 0 C--N 1.329 0.148 0 C-N-CA 118.52 -1.8 . . . . 2.43 112.258 177.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 8.0 t -73.23 66.51 0.89 Allowed 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 120.33 -0.548 . . . . 4.32 110.967 -179.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 84.18 8.47 83.68 Favored Glycine 0 N--CA 1.436 -1.309 0 CA-C-O 117.752 -1.582 . . . . 2.4 116.592 178.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.961 ' HA3' ' HA ' ' A' ' 74' ' ' CYS . . . -100.29 137.33 13.2 Favored Glycine 0 N--CA 1.438 -1.192 0 CA-C-N 122.553 3.177 . . . . 1.82 114.058 -177.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.468 ' O ' ' N ' ' A' ' 74' ' ' CYS . 0.0 OUTLIER -99.66 153.03 19.4 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 114.046 -1.077 . . . . 3.51 112.515 -178.4 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.637 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 44.4 t -51.75 108.62 0.29 Allowed 'General case' 0 N--CA 1.428 -1.56 0 CA-C-N 115.764 -0.653 . . . . 1.52 110.918 -179.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.414 ' O ' ' CZ ' ' A' ' 22' ' ' PHE . . . -99.55 -33.51 10.62 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.929 -0.767 . . . . 1.5 108.929 178.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.649 ' HB3' ' O ' ' A' ' 29' ' ' GLY . . . -159.93 165.32 32.35 Favored 'General case' 0 CA--C 1.495 -1.158 0 C-N-CA 119.428 -0.909 . . . . 1.31 112.432 -178.155 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.778 ' HA ' ' O ' ' A' ' 85' ' ' CYS . . . -37.29 97.4 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.1 -0.955 . . . . 1.5 110.444 -178.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.617 ' HA2' ' O ' ' A' ' 82' ' ' ASP . . . 93.56 -12.58 69.28 Favored Glycine 0 N--CA 1.437 -1.264 0 CA-C-N 114.81 -1.086 . . . . 1.44 114.43 179.293 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.821 HG13 ' HB2' ' A' ' 34' ' ' CYS . 1.7 mm -93.56 124.72 46.1 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.04 0 CA-C-N 119.391 1.596 . . . . 2.77 110.8 -175.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.592 ' HB2' ' HB3' ' A' ' 82' ' ' ASP . 20.6 t -120.79 92.45 3.77 Favored 'General case' 0 N--CA 1.426 -1.658 0 CA-C-N 113.89 -1.504 . . . . 1.98 109.274 -179.313 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 1.021 ' CB ' ' HA ' ' A' ' 79' ' ' CYS . 6.0 p -159.9 -175.89 5.38 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 116.105 1.891 . . . . 1.43 116.105 -177.001 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.818 ' HB2' ' HD2' ' A' ' 76' ' ' PRO . 5.8 p -122.61 -179.9 0.88 Allowed Pre-proline 0 N--CA 1.454 -0.253 0 CA-C-N 113.098 -1.865 . . . . 2.37 108.926 -179.668 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.818 ' HD2' ' HB2' ' A' ' 75' ' ' SER . 56.2 Cg_endo -72.45 31.38 0.28 Allowed 'Trans proline' 0 CA--C 1.534 0.523 0 C-N-CA 121.671 1.581 . . . . 2.09 113.292 -179.219 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.445 ' OD1' ' N ' ' A' ' 78' ' ' GLY . 1.1 p30 -134.49 -59.97 0.8 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 120.714 0.292 . . . . 2.65 110.397 178.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.918 ' O ' ' HB2' ' A' ' 74' ' ' CYS . . . -124.61 -175.15 14.22 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.507 -0.854 . . . . 1.04 111.74 178.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 1.021 ' HA ' ' CB ' ' A' ' 74' ' ' CYS . 14.1 m -149.44 160.34 43.53 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 117.535 0.668 . . . . 1.42 111.929 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 72.5 m80 -149.51 139.8 22.28 Favored 'General case' 0 C--N 1.349 0.585 0 O-C-N 121.714 -0.616 . . . . 2.81 111.879 -178.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -64.72 126.02 26.62 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.921 -0.582 . . . . 3.05 109.725 178.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.617 ' O ' ' HA2' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -139.94 107.51 6.91 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-O 120.864 0.364 . . . . 2.02 111.226 -179.213 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_exo -62.78 -24.09 74.52 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.04 2.493 . . . . 2.29 114.333 -178.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.36 -10.82 27.01 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.979 0.363 . . . . 1.53 111.979 -179.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.778 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 3.8 m -128.18 9.25 6.18 Favored 'General case' 0 C--O 1.215 -0.738 0 CA-C-O 119.053 -0.499 . . . . 1.88 111.321 179.585 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.51 ' CB ' ' HD3' ' A' ' 87' ' ' PRO . 0.5 OUTLIER -72.35 -58.05 3.27 Favored Pre-proline 0 C--N 1.322 -0.595 0 C-N-CA 119.113 -1.035 . . . . 3.6 112.692 -176.512 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.51 ' HD3' ' CB ' ' A' ' 86' ' ' ASP . 44.6 Cg_endo -114.69 -171.53 0.02 OUTLIER 'Trans proline' 0 N--CA 1.436 -1.876 0 C-N-CA 123.196 2.597 . . . . 3.12 113.487 -176.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.543 ' C ' ' H ' ' A' ' 90' ' ' ALA . 5.9 pt-20 -69.79 75.15 0.44 Allowed 'General case' 0 N--CA 1.426 -1.63 0 CA-C-N 112.783 -2.008 . . . . 4.72 108.824 177.246 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -76.03 48.57 0.5 Allowed 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 104.546 -2.391 . . . . 5.29 104.546 174.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.543 ' H ' ' C ' ' A' ' 88' ' ' GLU . . . -64.84 134.33 53.83 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 115.138 1.533 . . . . 7.19 115.138 -172.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -89.73 96.25 10.61 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.532 -0.467 . . . . 10.7 110.962 178.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.2 t . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.241 -0.885 . . . . 11.77 110.918 179.782 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 120.783 0.325 . . . . 10.42 111.137 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 102' ' ' VAL . . . . . 0.543 ' O ' HG13 ' B' ' 102' ' ' VAL . 13.8 p -102.24 88.04 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.311 0 CA-C-O 123.204 1.478 . . . . 8.81 114.531 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -100.55 83.41 2.6 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 111.21 -2.723 . . . . 6.28 112.418 175.371 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 104' ' ' ASP . . . . . 0.592 ' O ' ' HB2' ' B' ' 155' ' ' GLN . 2.9 m-20 -139.61 -178.3 5.34 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 105.911 -1.885 . . . . 6.27 105.911 173.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . 0.732 ' HA ' ' CB ' ' B' ' 155' ' ' GLN . 0.1 OUTLIER -80.37 12.21 3.12 Favored 'General case' 0 CA--C 1.504 -0.805 0 CA-C-O 121.754 0.788 . . . . 7.61 111.42 -179.694 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 106' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.0 -91.42 0.04 OUTLIER 'General case' 0 CA--C 1.492 -1.279 0 N-CA-C 101.029 -3.693 . . . . 8.55 101.029 175.485 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 107' ' ' VAL . . . . . 0.899 ' HA ' ' HB2' ' B' ' 156' ' ' SER . 2.3 p -147.11 116.19 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.468 -2.176 0 N-CA-C 104.736 -2.32 . . . . 7.84 104.736 173.415 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 108' ' ' ARG . . . . . 0.821 ' HG2' ' HA ' ' B' ' 154' ' ' CYS . 9.9 tpt180 -77.05 116.5 17.76 Favored 'General case' 0 CA--C 1.464 -2.33 0 C-N-CA 119.232 -0.987 . . . . 9.75 108.852 -177.363 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 109' ' ' THR . . . . . 0.539 ' O ' ' HD2' ' B' ' 108' ' ' ARG . 2.8 t -64.4 108.52 1.65 Allowed 'General case' 0 N--CA 1.423 -1.782 0 C-N-CA 114.097 -3.041 . . . . 6.13 103.145 175.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 110' ' ' CYS . . . . . 0.713 ' HB3' ' HB3' ' B' ' 120' ' ' ARG . 0.0 OUTLIER -69.28 111.71 5.38 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 114.479 -1.237 . . . . 2.87 111.883 -177.243 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 111' ' ' LEU . . . . . 0.481 ' C ' ' O ' ' B' ' 110' ' ' CYS . 5.4 tp -26.74 129.49 0.18 Allowed Pre-proline 0 CA--C 1.54 0.558 0 N-CA-C 112.209 0.448 . . . . 2.95 112.209 -179.333 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 112' ' ' PRO . . . . . 0.845 ' HA ' ' O ' ' B' ' 119' ' ' GLY . 30.3 Cg_endo -61.43 158.47 35.96 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 124.672 3.581 . . . . 1.71 112.974 179.579 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.623 ' SG ' ' N ' ' B' ' 114' ' ' GLY . 0.0 OUTLIER -168.83 -171.55 1.39 Allowed 'General case' 0 N--CA 1.497 1.907 0 C-N-CA 118.977 -1.089 . . . . 1.0 111.272 170.939 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 114' ' ' GLY . . . . . 0.864 ' HA2' ' HB3' ' B' ' 140' ' ' GLU . . . 77.35 -159.34 48.55 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 120.289 -0.958 . . . . 1.16 115.249 178.201 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 115' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -62.36 96.15 0.15 Allowed 'Trans proline' 0 C--N 1.355 0.885 0 C-N-CA 124.238 3.292 . . . . 1.6 115.398 -178.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 85.76 -0.83 88.1 Favored Glycine 0 C--N 1.285 -2.296 0 CA-C-N 110.573 -3.012 . . . . 1.7 112.197 -177.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 117' ' ' GLY . . . . . 0.486 ' O ' ' HB2' ' B' ' 112' ' ' PRO . . . 73.69 35.9 54.35 Favored Glycine 0 N--CA 1.425 -2.035 0 C-N-CA 120.171 -1.014 . . . . 1.38 112.858 176.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 118' ' ' LYS . . . . . 0.459 ' HB2' ' CD1' ' B' ' 132' ' ' LEU . 0.6 OUTLIER -87.55 -33.77 18.81 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 114.207 -0.997 . . . . 2.96 112.052 -179.629 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 119' ' ' GLY . . . . . 0.845 ' O ' ' HA ' ' B' ' 112' ' ' PRO . . . -79.67 -164.58 29.21 Favored Glycine 0 CA--C 1.497 -1.063 0 CA-C-O 118.631 -1.094 . . . . 1.07 111.521 -179.494 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.713 ' HB3' ' HB3' ' B' ' 110' ' ' CYS . 2.3 mtt85 -133.09 172.91 12.01 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 119.736 1.768 . . . . 3.29 106.961 176.438 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 121' ' ' CYS . . . . . . . . . . . . . 2.6 m -106.16 146.77 29.83 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 118.548 0.613 . . . . 1.21 111.532 -178.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 122' ' ' PHE . . . . . 0.499 ' HE1' ' O ' ' B' ' 128' ' ' CYS . 75.9 m-85 -142.91 22.14 1.94 Allowed 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.687 -0.688 . . . . 2.28 111.778 -179.533 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 123' ' ' GLY . . . . . 0.836 ' O ' ' HB3' ' B' ' 144' ' ' CYS . . . 174.05 -169.53 42.57 Favored Glycine 0 C--O 1.225 -0.465 0 C-N-CA 120.783 -0.723 . . . . 1.04 111.468 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -81.1 -54.33 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.494 2.129 . . . . 1.84 112.272 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 125' ' ' SER . . . . . 0.605 ' O ' ' N ' ' B' ' 137' ' ' GLY . 0.3 OUTLIER -106.39 12.25 29.97 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.264 -0.425 . . . . 1.49 111.39 -179.878 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 126' ' ' ILE . . . . . 0.753 HD12 ' HA ' ' B' ' 176' ' ' PRO . 1.5 mt -121.73 122.38 66.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 113.088 0.773 . . . . 1.41 113.088 -177.289 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 127' ' ' CYS . . . . . 0.663 ' HB3' ' CD2' ' B' ' 135' ' ' PHE . 4.5 t -131.06 117.66 19.45 Favored 'General case' 0 CA--C 1.522 -0.107 0 CA-C-O 122.542 1.163 . . . . 0.89 111.585 178.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 128' ' ' CYS . . . . . 1.149 ' HA ' ' O ' ' B' ' 133' ' ' GLY . 0.0 OUTLIER -130.62 135.93 48.36 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 112.96 -1.927 . . . . 1.23 112.415 -178.559 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 129' ' ' GLY . . . . . 0.669 ' O ' ' HB3' ' B' ' 169' ' ' ALA . . . -130.41 -161.6 10.44 Favored Glycine 0 N--CA 1.42 -2.413 0 N-CA-C 105.119 -3.193 . . . . 0.69 105.119 177.383 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 130' ' ' ASP . . . . . 0.424 ' OD1' ' N ' ' B' ' 130' ' ' ASP . 14.5 p-10 -68.71 -70.99 0.23 Allowed 'General case' 0 C--N 1.289 -2.06 0 C-N-CA 119.199 -1.001 . . . . 2.35 112.69 -178.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.94 32.53 3.15 Favored 'General case' 0 CA--C 1.49 -1.346 0 CA-C-O 122.085 0.945 . . . . 1.69 110.1 -177.232 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 132' ' ' LEU . . . . . 0.565 ' O ' ' HB ' ' A' ' 38' ' ' THR . 0.8 OUTLIER -127.45 -16.9 4.77 Favored 'General case' 0 N--CA 1.399 -3.01 0 CA-C-N 113.788 -1.551 . . . . 1.84 106.869 177.075 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 133' ' ' GLY . . . . . 1.149 ' O ' ' HA ' ' B' ' 128' ' ' CYS . . . 58.93 -134.55 52.43 Favored Glycine 0 N--CA 1.402 -3.587 0 CA-C-N 114.372 -1.285 . . . . 0.76 112.529 177.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 134' ' ' CYS . . . . . 0.802 ' HB2' HG13 ' B' ' 172' ' ' ILE . 5.2 t -135.25 119.79 18.11 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 116.15 1.907 . . . . 1.08 116.15 -176.631 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 135' ' ' PHE . . . . . 1.044 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -94.74 107.58 19.59 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 106.524 -1.658 . . . . 1.83 106.524 176.385 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 136' ' ' VAL . . . . . 0.686 ' N ' ' O ' ' A' ' 34' ' ' CYS . 2.4 t -94.3 83.56 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.642 0 N-CA-C 107.814 -1.18 . . . . 1.29 107.814 179.595 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 137' ' ' GLY . . . . . 0.605 ' N ' ' O ' ' B' ' 125' ' ' SER . . . 105.5 102.9 2.83 Favored Glycine 0 CA--C 1.523 0.59 0 CA-C-N 113.637 -1.62 . . . . 0.85 113.944 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 138' ' ' THR . . . . . 0.517 ' HB ' ' O ' ' A' ' 32' ' ' LEU . 0.2 OUTLIER -179.96 165.7 1.24 Allowed 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 107.905 -1.146 . . . . 1.2 107.905 179.131 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 139' ' ' ALA . . . . . 0.457 ' O ' ' HB2' ' B' ' 142' ' ' LEU . . . -68.98 -36.97 78.47 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 119.075 0.852 . . . . 1.35 110.225 179.349 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 140' ' ' GLU . . . . . 0.864 ' HB3' ' HA2' ' B' ' 114' ' ' GLY . 0.5 OUTLIER -56.87 -13.7 2.85 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.009 -0.541 . . . . 2.31 111.064 179.83 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 141' ' ' ALA . . . . . 0.718 ' O ' ' HB2' ' B' ' 144' ' ' CYS . . . -101.72 -21.81 14.55 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 116.236 -0.438 . . . . 1.09 109.942 178.351 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 142' ' ' LEU . . . . . 0.457 ' HB2' ' O ' ' B' ' 139' ' ' ALA . 0.6 OUTLIER -45.04 -38.06 4.61 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.626 0.602 . . . . 1.61 112.626 -178.483 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 143' ' ' ARG . . . . . 0.536 ' C ' ' H ' ' B' ' 145' ' ' GLN . 0.0 OUTLIER -54.13 -29.46 45.28 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 107.136 -1.431 . . . . 3.43 107.136 177.148 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 144' ' ' CYS . . . . . 0.836 ' HB3' ' O ' ' B' ' 123' ' ' GLY . 39.8 m -57.15 -4.77 0.21 Allowed 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 113.776 -1.556 . . . . 1.61 110.441 -177.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 145' ' ' GLN . . . . . 0.536 ' H ' ' C ' ' B' ' 143' ' ' ARG . 0.0 OUTLIER -79.32 -19.31 50.66 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-O 121.255 0.55 . . . . 3.52 111.208 177.584 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -85.81 10.11 14.66 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 119.998 -0.681 . . . . 3.76 110.436 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -81.01 2.75 25.65 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 108.852 -0.795 . . . . 4.01 108.852 177.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 148' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -94.83 -28.83 15.04 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 116.354 -0.384 . . . . 4.24 110.098 178.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -105.09 30.21 5.76 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.379 -0.373 . . . . 6.07 111.052 179.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -124.3 131.78 24.23 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.623 -0.262 . . . . 5.86 111.47 -179.469 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 151' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.01 13.04 1.58 Allowed 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.72 2.28 . . . . 5.42 113.094 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 35.6 p -103.77 105.87 49.9 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-O 120.531 0.205 . . . . 6.02 110.655 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 153' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -88.18 -4.51 6.82 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.924 2.416 . . . . 5.87 112.963 -179.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 154' ' ' CYS . . . . . 0.821 ' HA ' ' HG2' ' B' ' 108' ' ' ARG . 1.8 t 63.33 96.32 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.758 -0.201 . . . . 2.96 111.454 179.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 155' ' ' GLN . . . . . 0.732 ' CB ' ' HA ' ' B' ' 105' ' ' LEU . 19.0 mm100 -102.23 71.37 1.24 Allowed 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 119.286 -0.966 . . . . 6.3 111.952 -179.604 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 156' ' ' SER . . . . . 0.899 ' HB2' ' HA ' ' B' ' 107' ' ' VAL . 1.3 t 174.05 76.57 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.773 -0.649 . . . . 3.41 111.205 179.61 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 165.12 44.52 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 109.085 -1.606 . . . . 2.26 109.085 -179.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -118.74 71.9 0.86 Allowed 'General case' 0 N--CA 1.441 -0.919 0 CA-C-O 122.398 1.094 . . . . 5.03 110.724 -179.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 159' ' ' LYS . . . . . 0.534 ' HB3' ' HB2' ' B' ' 167' ' ' CYS . 0.0 OUTLIER -107.81 66.12 0.26 Allowed Pre-proline 0 C--N 1.31 -1.123 0 CA-C-N 113.202 -1.817 . . . . 3.96 108.486 174.33 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 160' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -71.4 92.26 0.67 Allowed 'Trans proline' 0 N--CA 1.464 -0.25 0 N-CA-C 116.17 1.565 . . . . 1.7 116.17 -174.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 161' ' ' CYS . . . . . . . . . . . . . 1.9 p -99.34 -166.91 1.4 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 113.173 -1.831 . . . . 1.93 108.32 176.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 45.35 -165.03 0.06 OUTLIER Glycine 0 CA--C 1.52 0.356 0 C-N-CA 119.135 -1.507 . . . . 2.37 112.181 173.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 8.1 t -73.11 66.89 0.87 Allowed 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 117.364 0.582 . . . . 4.56 111.496 -179.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 84.46 9.12 82.22 Favored Glycine 0 CA--C 1.541 1.67 0 CA-C-O 117.94 -1.478 . . . . 2.39 116.132 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 165' ' ' GLY . . . . . 0.857 ' HA3' ' HA ' ' B' ' 174' ' ' CYS . . . -96.98 131.25 10.54 Favored Glycine 0 C--N 1.301 -1.383 0 C-N-CA 117.177 -2.439 . . . . 1.79 114.151 -176.238 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 166' ' ' ARG . . . . . 0.478 ' O ' ' N ' ' B' ' 174' ' ' CYS . 0.0 OUTLIER -100.03 152.41 20.24 Favored 'General case' 0 C--N 1.349 0.551 0 N-CA-C 112.186 0.439 . . . . 3.53 112.186 -179.151 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 167' ' ' CYS . . . . . 0.654 ' HA ' ' O ' ' B' ' 172' ' ' ILE . 46.7 t -51.84 108.77 0.3 Allowed 'General case' 0 N--CA 1.431 -1.425 0 CA-C-N 115.905 -0.589 . . . . 1.56 111.05 -179.282 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 168' ' ' ALA . . . . . 0.572 ' HB1' ' SG ' ' B' ' 128' ' ' CYS . . . -101.33 -30.16 11.64 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.771 -0.649 . . . . 1.42 109.528 178.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 169' ' ' ALA . . . . . 0.669 ' HB3' ' O ' ' B' ' 129' ' ' GLY . . . -162.31 165.1 27.05 Favored 'General case' 0 CA--C 1.492 -1.258 0 C-N-CA 119.488 -0.885 . . . . 1.18 112.42 -179.271 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 170' ' ' ALA . . . . . 0.766 ' HA ' ' O ' ' B' ' 185' ' ' CYS . . . -36.52 95.98 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.047 -0.979 . . . . 1.47 110.851 -179.106 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 171' ' ' GLY . . . . . 0.677 ' HA2' ' O ' ' B' ' 182' ' ' ASP . . . 88.52 -1.82 84.3 Favored Glycine 0 CA--C 1.525 0.677 0 CA-C-N 114.923 -1.035 . . . . 1.45 115.11 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 172' ' ' ILE . . . . . 0.802 HG13 ' HB2' ' B' ' 134' ' ' CYS . 1.8 mm -96.65 122.24 47.96 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.093 0 CA-C-N 117.865 0.832 . . . . 2.7 110.535 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 173' ' ' CYS . . . . . 0.597 ' HB2' ' HB3' ' B' ' 182' ' ' ASP . 21.6 t -120.89 92.21 3.71 Favored 'General case' 0 N--CA 1.428 -1.561 0 CA-C-N 114.561 -1.2 . . . . 1.94 109.399 -179.568 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 174' ' ' CYS . . . . . 1.047 ' HB3' ' HA ' ' B' ' 179' ' ' CYS . 5.9 p -160.08 -175.76 5.27 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 116.033 1.864 . . . . 1.43 116.033 -176.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 175' ' ' SER . . . . . 0.817 ' HB2' ' HD2' ' B' ' 176' ' ' PRO . 6.0 p -122.68 -179.89 0.88 Allowed Pre-proline 0 N--CA 1.454 -0.25 0 CA-C-N 113.087 -1.869 . . . . 2.3 108.931 -179.569 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 176' ' ' PRO . . . . . 0.817 ' HD2' ' HB2' ' B' ' 175' ' ' SER . 55.9 Cg_endo -72.38 31.31 0.27 Allowed 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 121.699 1.599 . . . . 2.13 113.292 -179.138 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 177' ' ' ASP . . . . . 0.437 ' OD1' ' N ' ' B' ' 178' ' ' GLY . 1.1 p30 -134.58 -60.02 0.8 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.643 -0.253 . . . . 2.72 110.371 178.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 178' ' ' GLY . . . . . 0.9 ' O ' ' HB2' ' B' ' 174' ' ' CYS . . . -124.51 -175.12 14.22 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.503 -0.856 . . . . 1.05 111.683 178.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 179' ' ' CYS . . . . . 1.047 ' HA ' ' HB3' ' B' ' 174' ' ' CYS . 14.0 m -149.41 160.44 43.43 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 117.526 0.663 . . . . 1.39 111.958 179.583 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 180' ' ' HIS . . . . . 0.432 ' HA ' ' HA2' ' A' ' 78' ' ' GLY . 72.5 m80 -149.56 139.77 22.2 Favored 'General case' 0 C--N 1.35 0.612 0 C-N-CA 120.232 -0.587 . . . . 2.73 111.819 -178.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 181' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -64.78 125.89 26.22 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.968 -0.56 . . . . 3.06 109.693 178.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 182' ' ' ASP . . . . . 0.677 ' O ' ' HA2' ' B' ' 171' ' ' GLY . 0.0 OUTLIER -139.74 107.59 7.03 Favored Pre-proline 0 CA--C 1.541 0.634 0 CA-C-O 120.85 0.357 . . . . 2.06 111.236 -179.267 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 183' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_exo -62.79 -24.19 74.51 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 123.061 2.507 . . . . 2.27 114.384 -178.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -64.29 -10.52 24.45 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.102 0.408 . . . . 1.56 112.102 -179.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 185' ' ' CYS . . . . . 0.766 ' O ' ' HA ' ' B' ' 170' ' ' ALA . 1.6 m -129.1 10.03 5.8 Favored 'General case' 0 C--O 1.214 -0.784 0 CA-C-O 119.243 -0.408 . . . . 1.94 111.078 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 186' ' ' ASP . . . . . 0.585 ' O ' ' HB1' ' B' ' 170' ' ' ALA . 0.5 OUTLIER -73.48 -57.74 2.57 Favored Pre-proline 0 CA--C 1.511 -0.534 0 C-N-CA 119.186 -1.006 . . . . 3.61 112.511 -176.588 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 187' ' ' PRO . . . . . 0.505 ' HD3' ' CB ' ' B' ' 186' ' ' ASP . 95.9 Cg_endo -108.38 -166.63 0.03 OUTLIER 'Trans proline' 0 N--CA 1.428 -2.341 0 C-N-CA 122.967 2.445 . . . . 3.14 113.824 -177.033 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 188' ' ' GLU . . . . . 0.642 ' C ' ' H ' ' B' ' 190' ' ' ALA . 6.1 pt-20 -74.77 72.38 2.02 Favored 'General case' 0 N--CA 1.414 -2.266 0 CA-C-N 111.359 -2.655 . . . . 4.7 109.255 173.187 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 189' ' ' ALA . . . . . . . . . . . . . . . -75.31 47.71 0.39 Allowed 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 107.279 -1.378 . . . . 5.24 107.279 175.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 190' ' ' ALA . . . . . 0.642 ' H ' ' C ' ' B' ' 188' ' ' GLU . . . -58.47 134.78 56.97 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 113.096 -1.866 . . . . 6.93 113.94 -172.051 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 191' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -89.93 96.45 10.68 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 120.707 -0.397 . . . . 10.62 110.707 178.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 1.2 t . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.252 -0.88 . . . . 11.7 111.01 179.798 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.855 0 N-CA-C 112.236 0.458 . . . . 10.31 112.236 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -172.97 171.75 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-O 121.606 0.717 . . . . 8.37 110.521 179.358 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.975 ' HG ' ' HG3' ' A' ' 8' ' ' ARG . 3.6 mm? -79.65 144.85 33.38 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 114.962 -1.017 . . . . 6.25 110.225 179.127 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.6 69.42 1.22 Allowed 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 105.269 -2.123 . . . . 6.22 105.269 175.906 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.72 HD22 ' H ' ' A' ' 6' ' ' ASP . 0.8 OUTLIER -155.93 -146.98 0.19 Allowed 'General case' 0 N--CA 1.389 -3.5 0 CA-C-N 109.941 -3.3 . . . . 7.57 104.873 177.478 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.72 ' H ' HD22 ' A' ' 5' ' ' LEU . 6.3 t70 -153.23 -8.76 0.17 Allowed 'General case' 0 CA--C 1.587 2.388 0 CA-C-O 123.179 1.466 . . . . 8.78 112.61 178.954 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.477 HG11 ' O ' ' A' ' 6' ' ' ASP . 8.1 m -154.66 126.3 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.402 -2.866 0 C-N-CA 130.603 3.561 . . . . 7.88 103.833 173.634 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.975 ' HG3' ' HG ' ' A' ' 3' ' ' LEU . 0.7 OUTLIER -76.1 109.21 9.57 Favored 'General case' 0 N--CA 1.391 -3.417 0 N-CA-C 105.928 -1.878 . . . . 9.7 105.928 179.121 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.78 ' HB ' HD12 ' A' ' 50' ' ' LEU . 0.7 OUTLIER -106.9 98.06 7.77 Favored 'General case' 0 N--CA 1.392 -3.362 0 N-CA-C 101.882 -3.377 . . . . 6.05 101.882 171.491 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 62.7 m -79.79 60.97 3.59 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 114.278 -1.328 . . . . 2.89 112.719 -179.721 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.843 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 4.2 mp -31.22 135.31 0.23 Allowed Pre-proline 0 N--CA 1.483 1.192 0 N-CA-C 113.598 0.962 . . . . 2.89 113.598 -178.679 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -97.47 114.72 0.11 Allowed 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 123.439 2.759 . . . . 1.72 116.251 -178.632 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.517 ' O ' ' HA2' ' A' ' 17' ' ' GLY . 0.5 OUTLIER -127.59 -176.32 3.72 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-O 121.823 0.82 . . . . 1.0 111.46 -178.463 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 74.17 -178.26 44.32 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 114.524 -1.217 . . . . 1.15 110.438 -178.37 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.559 ' HG2' ' O ' ' A' ' 15' ' ' PRO . 47.3 Cg_endo -63.28 130.92 30.16 Favored 'Trans proline' 0 CA--C 1.507 -0.851 0 N-CA-C 106.317 -2.224 . . . . 1.6 106.317 175.464 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 72.34 -4.16 20.49 Favored Glycine 0 N--CA 1.414 -2.832 0 CA-C-O 119.247 -0.752 . . . . 1.68 113.459 177.07 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.517 ' HA2' ' O ' ' A' ' 13' ' ' CYS . . . 76.53 38.44 32.74 Favored Glycine 1 N--CA 1.391 -4.347 0 C-N-CA 119.121 -1.514 . . . . 1.37 112.189 -178.747 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.42 ' CG ' ' O ' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -97.72 22.0 9.67 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.317 -0.442 . . . . 2.91 110.261 174.439 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -129.58 -175.46 14.05 Favored Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 104.912 -3.275 . . . . 1.06 104.912 177.846 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.694 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 2.7 mtp180 -119.3 159.73 23.58 Favored 'General case' 0 CA--C 1.552 1.045 0 CA-C-N 121.323 2.562 . . . . 3.32 108.444 176.708 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.843 ' HB2' ' HB3' ' A' ' 11' ' ' LEU . 10.7 m -109.09 148.9 30.11 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 119.881 1.219 . . . . 1.19 111.435 -179.742 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.471 ' HE2' ' HG ' ' A' ' 56' ' ' SER . 49.9 m-85 -128.38 -52.4 1.28 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.085 -0.507 . . . . 2.26 111.36 179.989 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.417 ' O ' ' HB3' ' A' ' 44' ' ' CYS . . . -119.84 -171.3 14.65 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.935 -0.65 . . . . 1.05 112.26 -179.816 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -68.79 -61.21 0.07 OUTLIER 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.635 2.223 . . . . 1.81 112.755 -179.693 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.609 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.4 OUTLIER -98.15 26.87 4.97 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.822 -0.172 . . . . 1.62 110.749 -179.999 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 1.074 HG12 HG12 ' A' ' 36' ' ' VAL . 3.3 mt -141.37 120.58 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 N-CA-C 113.542 0.941 . . . . 1.39 113.542 -178.307 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.815 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -120.43 140.25 51.65 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 107.653 -1.239 . . . . 0.92 107.653 178.188 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 1.035 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -143.96 100.1 3.51 Favored 'General case' 0 CA--C 1.552 1.05 0 N-CA-C 117.686 2.476 . . . . 1.28 117.686 -174.907 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.494 ' O ' ' HB3' ' A' ' 69' ' ' ALA . . . -101.48 -172.48 28.25 Favored Glycine 0 N--CA 1.431 -1.687 0 N-CA-C 108.423 -1.871 . . . . 0.71 108.423 176.49 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -64.98 -62.75 1.37 Allowed 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 121.338 0.59 . . . . 2.27 112.268 -179.255 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.1 14.69 28.82 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 122.196 0.998 . . . . 1.66 111.365 -177.931 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.764 HD21 ' CE2' ' A' ' 35' ' ' PHE . 4.6 mt -115.88 -5.03 12.04 Favored 'General case' 0 N--CA 1.387 -3.593 0 N-CA-C 104.895 -2.261 . . . . 1.93 104.895 179.063 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 1.035 ' O ' ' HA ' ' A' ' 28' ' ' CYS . . . 43.7 -126.73 5.77 Favored Glycine 0 N--CA 1.432 -1.609 0 CA-C-N 114.243 -1.344 . . . . 0.77 113.918 175.941 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.815 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -132.52 107.95 8.79 Favored 'General case' 0 CA--C 1.49 -1.329 0 CA-C-N 118.008 0.904 . . . . 1.08 113.362 -179.365 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.909 ' HD1' ' HD1' ' B' ' 135' ' ' PHE . 84.7 m-85 -83.06 105.98 14.49 Favored 'General case' 0 N--CA 1.42 -1.93 0 N-CA-C 102.32 -3.215 . . . . 1.85 102.32 174.686 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 1.074 HG12 HG12 ' A' ' 26' ' ' ILE . 3.0 t -97.77 85.27 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.664 0 CA-C-O 123.036 1.398 . . . . 1.29 109.374 -176.992 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.609 ' N ' ' O ' ' A' ' 25' ' ' SER . . . 97.68 89.4 1.9 Allowed Glycine 0 CA--C 1.527 0.842 0 CA-C-N 112.492 -2.14 . . . . 0.85 115.45 178.621 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.551 HG22 ' CE1' ' B' ' 135' ' ' PHE . 0.5 OUTLIER -176.62 168.17 2.64 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 108.603 -0.888 . . . . 1.3 108.603 177.964 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.577 ' HA ' HD11 ' A' ' 42' ' ' LEU . . . -53.54 -26.79 22.65 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 115.781 1.771 . . . . 1.45 115.781 -176.648 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.464 ' OE1' HG23 ' A' ' 38' ' ' THR . 0.0 OUTLIER -66.33 -15.91 63.63 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 119.226 -0.99 . . . . 2.32 109.634 178.545 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.634 ' O ' ' N ' ' A' ' 44' ' ' CYS . . . -88.42 -24.05 23.15 Favored 'General case' 0 N--CA 1.425 -1.693 0 CA-C-O 119.283 -0.389 . . . . 1.11 111.026 -178.979 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.577 HD11 ' HA ' ' A' ' 39' ' ' ALA . 0.4 OUTLIER -44.5 -40.0 5.27 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 119.229 0.922 . . . . 1.68 112.197 179.873 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.413 ' HD3' ' HA ' ' A' ' 43' ' ' ARG . 10.8 tpp85 -64.48 -11.16 30.83 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.708 0.766 . . . . 3.4 109.748 177.713 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.634 ' N ' ' O ' ' A' ' 41' ' ' ALA . 88.8 m -73.61 -8.31 55.46 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 113.763 -1.562 . . . . 1.57 110.728 176.795 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -76.38 -6.73 52.92 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.071 0.397 . . . . 3.49 112.071 179.382 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.549 ' HG3' ' HE1' ' A' ' 49' ' ' TYR . 0.4 OUTLIER -86.44 3.87 42.0 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.254 -0.579 . . . . 3.69 111.114 -178.926 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.626 ' HG2' ' O ' ' A' ' 44' ' ' CYS . 12.6 pt-20 -83.79 1.81 41.14 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 109.592 -0.521 . . . . 3.99 109.592 177.203 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -71.79 -28.94 63.95 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 109.393 -0.595 . . . . 4.2 109.393 178.135 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.549 ' HE1' ' HG3' ' A' ' 46' ' ' GLU . 6.0 p90 -117.21 25.01 10.77 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.975 0.417 . . . . 5.85 110.997 179.603 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.78 HD12 ' HB ' ' A' ' 9' ' ' THR . 3.9 tt -127.05 142.59 44.16 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.906 -0.588 . . . . 5.83 111.512 -179.19 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.599 ' HD2' ' HG ' ' A' ' 50' ' ' LEU . 85.4 Cg_endo -84.8 50.82 3.02 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.71 2.273 . . . . 5.3 113.054 -179.98 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.563 ' HB2' ' O ' ' A' ' 51' ' ' PRO . 4.0 m 75.47 151.35 0.14 Allowed Pre-proline 0 N--CA 1.468 0.447 0 CA-C-N 116.231 -0.44 . . . . 5.72 111.716 179.737 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.713 ' O ' HD12 ' A' ' 5' ' ' LEU . 43.9 Cg_endo -66.67 165.05 26.77 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.214 2.609 . . . . 5.82 113.306 -179.312 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.778 ' HB2' HD12 ' A' ' 3' ' ' LEU . 25.2 p -60.79 116.29 4.31 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.632 -0.713 . . . . 2.98 111.666 -179.631 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.669 ' OE1' HD13 ' A' ' 3' ' ' LEU . 12.8 pt20 42.43 -169.47 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 115.025 -0.989 . . . . 6.42 112.816 -179.67 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.471 ' HG ' ' HE2' ' A' ' 22' ' ' PHE . 0.4 OUTLIER -169.77 178.88 3.9 Favored 'General case' 0 C--N 1.345 0.395 0 CA-C-O 120.757 0.313 . . . . 3.36 110.328 -179.458 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.56 ' O ' ' HB2' ' A' ' 66' ' ' ARG . . . -87.67 144.35 18.89 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 110.049 -1.22 . . . . 2.3 110.049 -176.868 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -101.62 74.83 1.54 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.859 0.838 . . . . 5.06 109.834 179.297 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.701 ' HB3' ' HB2' ' A' ' 67' ' ' CYS . 15.3 tppt? -144.28 57.33 4.8 Favored Pre-proline 0 C--N 1.308 -1.222 0 N-CA-C 106.686 -1.598 . . . . 3.91 106.686 178.072 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.45 ' CD ' ' N ' ' A' ' 59' ' ' LYS . 55.0 Cg_endo -69.1 84.79 0.54 Allowed 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 121.828 1.685 . . . . 1.74 114.343 -177.681 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.44 ' N ' ' O ' ' A' ' 65' ' ' GLY . 0.8 OUTLIER -104.41 -176.49 3.1 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 113.587 -1.642 . . . . 1.9 107.693 177.014 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 62.72 -165.95 23.54 Favored Glycine 0 CA--C 1.505 -0.592 0 C-N-CA 118.712 -1.709 . . . . 2.43 112.852 178.495 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -77.77 52.37 1.02 Allowed 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.635 -0.283 . . . . 4.32 111.49 -179.066 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 102.93 8.71 41.59 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-O 118.988 -0.895 . . . . 2.4 115.001 178.964 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.54 ' HA2' ' HA ' ' A' ' 75' ' ' SER . . . -102.84 138.8 14.14 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 118.575 -1.774 . . . . 1.82 115.38 -178.373 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.56 ' HB2' ' O ' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -102.38 154.34 19.17 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 114.285 -0.958 . . . . 3.51 110.534 179.014 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.701 ' HB2' ' HB3' ' A' ' 59' ' ' LYS . 5.5 t -56.31 109.22 0.57 Allowed 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 109.695 -0.483 . . . . 1.52 109.695 -179.108 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.403 ' HB1' ' SG ' ' A' ' 28' ' ' CYS . . . -91.89 -17.73 24.81 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 107.898 -1.149 . . . . 1.5 107.898 178.773 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.818 ' O ' ' O ' ' A' ' 70' ' ' ALA . . . -165.64 156.4 13.53 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 112.946 -1.934 . . . . 1.31 109.262 179.943 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.818 ' O ' ' O ' ' A' ' 69' ' ' ALA . . . -18.11 -139.12 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 114.154 1.168 . . . . 1.5 114.154 -179.705 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.617 ' HA3' ' OD1' ' A' ' 86' ' ' ASP . . . -61.38 53.29 0.03 OUTLIER Glycine 0 N--CA 1.475 1.237 0 N-CA-C 111.387 -0.685 . . . . 1.44 111.387 -177.914 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.739 ' CD1' ' HB2' ' A' ' 34' ' ' CYS . 1.8 pp -151.94 97.96 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.257 1.49 0 CA-C-O 122.204 1.002 . . . . 2.77 109.095 168.804 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.572 ' HB3' ' HB3' ' A' ' 82' ' ' ASP . 0.9 OUTLIER -93.65 95.94 9.51 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.035 -0.984 . . . . 1.98 108.745 -178.872 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.841 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 16.5 m -92.65 162.35 14.2 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 114.512 1.301 . . . . 1.43 114.512 -176.182 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.763 ' HB2' ' HD2' ' A' ' 76' ' ' PRO . 58.6 p -125.16 179.42 1.13 Allowed Pre-proline 0 CA--C 1.531 0.224 0 CA-C-N 113.465 -1.698 . . . . 2.37 108.127 178.748 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.763 ' HD2' ' HB2' ' A' ' 75' ' ' SER . 71.9 Cg_endo -77.22 30.01 0.42 Allowed 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 121.304 1.336 . . . . 2.09 111.909 179.79 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.449 ' H ' ' C ' ' A' ' 75' ' ' SER . 1.6 t70 -145.92 -41.73 0.21 Allowed 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.652 -0.704 . . . . 2.65 110.887 179.971 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 1.261 ' HA3' ' O ' ' B' ' 179' ' ' CYS . . . -151.11 -141.63 3.38 Favored Glycine 0 C--N 1.337 0.591 0 C-N-CA 120.406 -0.902 . . . . 1.04 113.621 -179.815 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 1.217 ' O ' ' HA3' ' B' ' 178' ' ' GLY . 60.2 m -148.22 146.27 28.61 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 123.123 0.569 . . . . 1.42 110.486 -179.658 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.442 ' N ' ' O ' ' A' ' 73' ' ' CYS . 14.5 m80 -133.24 134.06 43.49 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 119.859 -0.737 . . . . 2.81 111.511 179.956 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.409 ' OE1' ' HG2' ' B' ' 124' ' ' PRO . 8.7 mt-10 -59.58 135.95 57.83 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 108.682 -0.858 . . . . 3.05 108.682 178.558 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.572 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 0.7 OUTLIER -142.96 128.97 10.36 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 116.395 -0.366 . . . . 2.02 110.998 -178.706 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 82' ' ' ASP . 15.2 Cg_exo -69.15 -31.29 23.56 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 123.212 2.608 . . . . 2.29 113.07 -179.198 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.62 -3.11 2.83 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.115 -0.493 . . . . 1.53 112.03 -179.705 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.641 ' HB3' ' C ' ' A' ' 70' ' ' ALA . 73.6 m -133.22 20.3 4.04 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 112.074 0.398 . . . . 1.88 112.074 -179.965 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.757 ' N ' ' HD3' ' A' ' 87' ' ' PRO . 16.8 m-20 -107.37 20.66 0.06 OUTLIER Pre-proline 0 N--CA 1.449 -0.509 0 N-CA-C 113.805 1.039 . . . . 3.6 113.805 179.854 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.757 ' HD3' ' N ' ' A' ' 86' ' ' ASP . 1.9 Cg_endo -77.78 65.7 8.18 Favored 'Trans proline' 0 CA--C 1.5 -1.218 0 N-CA-C 106.64 -2.1 . . . . 3.12 106.64 176.138 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.533 ' HB3' ' O ' ' A' ' 87' ' ' PRO . 4.7 pt-20 177.25 -35.37 0.01 OUTLIER 'General case' 0 CA--C 1.473 -1.997 0 CA-C-N 113.283 -1.78 . . . . 4.72 108.842 -179.709 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.475 ' N ' ' HG3' ' A' ' 88' ' ' GLU . . . -77.36 38.43 0.23 Allowed 'General case' 0 C--N 1.354 0.769 0 CA-C-N 110.542 -3.026 . . . . 5.29 109.01 176.541 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.475 ' H ' ' C ' ' A' ' 88' ' ' GLU . . . -79.2 147.08 32.75 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 113.846 -1.525 . . . . 7.19 111.367 -179.092 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -63.05 127.66 32.27 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.422 0.63 . . . . 10.7 112.288 -175.418 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 6.2 t . . . . . 0 C--O 1.248 0.98 0 CA-C-N 114.898 -1.046 . . . . 11.77 110.554 179.863 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.465 0 N-CA-C 111.786 0.291 . . . . 10.42 111.786 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 1.2 t -163.47 153.85 2.7 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.283 0 CA-C-O 122.311 1.053 . . . . 8.81 111.265 -179.913 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 103' ' ' LEU . . . . . 0.69 ' HA ' ' HB3' ' B' ' 155' ' ' GLN . 0.7 OUTLIER -76.48 110.89 11.39 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 113.066 -1.879 . . . . 6.28 114.275 -178.241 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.59 76.02 5.1 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 122.813 1.292 . . . . 6.27 108.428 175.991 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . 0.623 HD11 ' H ' ' B' ' 106' ' ' ASP . 0.3 OUTLIER -156.18 -130.28 0.03 OUTLIER 'General case' 0 N--CA 1.391 -3.379 0 C-N-CA 128.181 2.592 . . . . 7.61 105.455 177.193 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 106' ' ' ASP . . . . . 0.623 ' H ' HD11 ' B' ' 105' ' ' LEU . 4.1 t70 -163.11 -44.35 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.052 -1.092 . . . . 8.55 108.052 -178.718 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 107' ' ' VAL . . . . . 0.567 ' H ' HD11 ' B' ' 105' ' ' LEU . 5.9 m -121.85 127.32 75.4 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.374 0 N-CA-C 102.731 -3.062 . . . . 7.84 102.731 171.439 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 108' ' ' ARG . . . . . 0.651 ' CD ' HD13 ' B' ' 103' ' ' LEU . 0.7 OUTLIER -75.07 111.64 10.5 Favored 'General case' 0 N--CA 1.391 -3.385 0 N-CA-C 106.029 -1.841 . . . . 9.75 106.029 179.148 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 109' ' ' THR . . . . . 0.789 ' OG1' HD22 ' B' ' 150' ' ' LEU . 0.7 OUTLIER -111.05 98.06 7.27 Favored 'General case' 0 N--CA 1.39 -3.449 0 N-CA-C 101.134 -3.654 . . . . 6.13 101.134 171.77 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 110' ' ' CYS . . . . . . . . . . . . . 64.4 m -81.9 66.86 7.66 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 113.599 -1.637 . . . . 2.87 111.498 -179.079 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 111' ' ' LEU . . . . . 0.837 ' HB3' ' HB2' ' B' ' 121' ' ' CYS . 4.6 mp -33.59 135.22 0.32 Allowed Pre-proline 0 N--CA 1.476 0.827 0 N-CA-C 113.576 0.954 . . . . 2.95 113.576 179.854 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 112' ' ' PRO . . . . . 0.426 ' HG2' ' CG ' ' B' ' 143' ' ' ARG . 41.7 Cg_endo -93.92 122.69 0.42 Allowed 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 123.557 2.838 . . . . 1.71 112.776 179.656 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.471 ' SG ' ' HA3' ' B' ' 119' ' ' GLY . 0.4 OUTLIER -135.37 -177.35 4.62 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-O 122.398 1.094 . . . . 1.0 111.248 177.409 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . 73.98 -178.41 43.48 Favored Glycine 0 N--CA 1.439 -1.109 0 CA-C-N 113.589 -1.642 . . . . 1.16 110.204 -177.863 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 115' ' ' PRO . . . . . 0.602 ' HG2' ' O ' ' B' ' 115' ' ' PRO . 41.3 Cg_endo -64.97 121.36 8.83 Favored 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 122.041 1.827 . . . . 1.6 109.676 176.13 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 74.52 7.49 79.11 Favored Glycine 0 C--N 1.281 -2.487 0 CA-C-N 115.497 -0.774 . . . . 1.7 113.176 179.61 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 117' ' ' GLY . . . . . 0.455 ' HA2' ' O ' ' B' ' 113' ' ' CYS . . . 74.85 33.45 55.29 Favored Glycine 0 N--CA 1.408 -3.192 0 C-N-CA 119.628 -1.272 . . . . 1.38 114.636 177.311 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 118' ' ' LYS . . . . . 0.411 ' CG ' ' O ' ' B' ' 115' ' ' PRO . 0.0 OUTLIER -91.91 14.34 15.94 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 122.212 0.205 . . . . 2.96 110.722 178.698 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 119' ' ' GLY . . . . . 0.471 ' HA3' ' SG ' ' B' ' 113' ' ' CYS . . . -115.42 -153.8 10.4 Favored Glycine 0 C--N 1.34 0.774 0 N-CA-C 108.198 -1.961 . . . . 1.07 108.198 179.193 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.781 ' HA ' ' O ' ' B' ' 111' ' ' LEU . 2.7 ttp180 -143.08 156.75 44.88 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 123.206 3.503 . . . . 3.29 103.11 172.858 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 121' ' ' CYS . . . . . 0.837 ' HB2' ' HB3' ' B' ' 111' ' ' LEU . 15.8 m -108.74 150.15 28.01 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 120.19 1.359 . . . . 1.21 111.862 -178.036 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -128.57 -52.57 1.26 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.78 -0.645 . . . . 2.28 111.169 179.89 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 123' ' ' GLY . . . . . 0.415 ' O ' ' HB3' ' B' ' 144' ' ' CYS . . . -119.83 -171.23 14.64 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.934 -0.651 . . . . 1.04 112.353 -179.889 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . 0.409 ' HG2' ' OE1' ' A' ' 81' ' ' GLU . 14.2 Cg_exo -68.81 -61.25 0.07 OUTLIER 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.674 2.249 . . . . 1.84 112.809 -179.697 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 125' ' ' SER . . . . . 0.607 ' O ' ' N ' ' B' ' 137' ' ' GLY . 0.4 OUTLIER -98.05 26.81 4.96 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.785 -0.189 . . . . 1.49 110.832 179.87 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 126' ' ' ILE . . . . . 0.859 HG12 HG12 ' B' ' 136' ' ' VAL . 4.1 mt -140.93 120.62 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 113.556 0.947 . . . . 1.41 113.556 -178.209 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 127' ' ' CYS . . . . . 0.797 ' O ' ' HA ' ' B' ' 134' ' ' CYS . 0.0 OUTLIER -121.02 140.17 52.29 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 107.55 -1.278 . . . . 0.89 107.55 177.854 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 128' ' ' CYS . . . . . 1.055 ' HA ' ' O ' ' B' ' 133' ' ' GLY . 0.0 OUTLIER -143.14 106.69 4.61 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 115.671 1.73 . . . . 1.23 115.671 -175.563 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 129' ' ' GLY . . . . . 0.499 ' O ' ' HB3' ' B' ' 169' ' ' ALA . . . -109.47 -168.13 20.27 Favored Glycine 0 N--CA 1.422 -2.272 0 CA-C-N 123.698 2.954 . . . . 0.69 106.751 173.983 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -62.61 -70.95 0.17 Allowed 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 117.234 0.517 . . . . 2.35 110.572 -178.952 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.28 32.54 4.73 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 122.688 1.232 . . . . 1.69 110.135 -176.323 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 132' ' ' LEU . . . . . 0.73 HD22 ' CE2' ' B' ' 135' ' ' PHE . 4.0 mt -126.48 -4.74 6.58 Favored 'General case' 0 N--CA 1.385 -3.69 0 N-CA-C 103.845 -2.65 . . . . 1.84 103.845 175.568 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 133' ' ' GLY . . . . . 1.055 ' O ' ' HA ' ' B' ' 128' ' ' CYS . . . 43.95 -123.62 4.79 Favored Glycine 0 N--CA 1.406 -3.366 0 CA-C-N 114.226 -1.352 . . . . 0.76 114.907 174.793 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 134' ' ' CYS . . . . . 0.797 ' HA ' ' O ' ' B' ' 127' ' ' CYS . 0.0 OUTLIER -136.66 105.01 5.72 Favored 'General case' 0 CA--C 1.494 -1.189 0 N-CA-C 114.322 1.23 . . . . 1.08 114.322 179.872 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 135' ' ' PHE . . . . . 0.909 ' HD1' ' HD1' ' A' ' 35' ' ' PHE . 82.1 m-85 -80.22 105.39 11.45 Favored 'General case' 0 N--CA 1.42 -1.928 0 N-CA-C 102.399 -3.185 . . . . 1.83 102.399 176.035 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 136' ' ' VAL . . . . . 0.859 HG12 HG12 ' B' ' 126' ' ' ILE . 5.9 t -97.9 84.64 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.671 0 CA-C-O 123.148 1.451 . . . . 1.29 109.24 -177.129 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 137' ' ' GLY . . . . . 0.607 ' N ' ' O ' ' B' ' 125' ' ' SER . . . 97.91 88.65 1.9 Allowed Glycine 0 CA--C 1.527 0.812 0 CA-C-N 112.254 -2.248 . . . . 0.85 115.475 178.442 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 138' ' ' THR . . . . . 0.719 HG22 ' OE2' ' B' ' 140' ' ' GLU . 0.5 OUTLIER -172.14 175.65 3.67 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 108.796 -0.816 . . . . 1.2 108.796 178.045 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 139' ' ' ALA . . . . . 0.855 ' HA ' HD11 ' B' ' 142' ' ' LEU . . . -55.82 -40.41 72.73 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 118.818 0.736 . . . . 1.35 112.562 -178.262 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 140' ' ' GLU . . . . . 0.719 ' OE2' HG22 ' B' ' 138' ' ' THR . 0.0 OUTLIER -57.6 -13.94 4.6 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.089 -0.644 . . . . 2.31 110.862 -178.032 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 141' ' ' ALA . . . . . 0.668 ' O ' ' N ' ' B' ' 144' ' ' CYS . . . -87.12 -30.44 21.09 Favored 'General case' 0 C--O 1.213 -0.866 0 CA-C-N 116.223 -0.444 . . . . 1.09 110.122 179.754 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 142' ' ' LEU . . . . . 0.855 HD11 ' HA ' ' B' ' 139' ' ' ALA . 0.4 OUTLIER -40.86 -41.36 1.57 Allowed 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.462 0.542 . . . . 1.61 112.462 -178.604 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 143' ' ' ARG . . . . . 0.441 ' HD3' ' HA ' ' B' ' 143' ' ' ARG . 8.9 tpp85 -58.17 -23.46 55.44 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 108.37 -0.974 . . . . 3.43 108.37 177.619 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 144' ' ' CYS . . . . . 0.668 ' N ' ' O ' ' B' ' 141' ' ' ALA . 90.9 m -66.61 -5.76 12.76 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 113.889 -1.505 . . . . 1.61 110.596 -177.553 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -78.03 -6.28 54.05 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.847 0.356 . . . . 3.52 111.701 178.906 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 146' ' ' GLU . . . . . 0.565 ' HG3' ' HE1' ' B' ' 149' ' ' TYR . 0.4 OUTLIER -86.33 3.51 43.14 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.355 -0.538 . . . . 3.76 111.01 -178.981 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . 0.608 ' HG2' ' O ' ' B' ' 144' ' ' CYS . 12.6 pt-20 -83.51 1.59 41.1 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.656 -0.498 . . . . 4.01 109.656 177.281 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 148' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -71.53 -28.95 64.23 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 109.47 -0.567 . . . . 4.24 109.47 178.11 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 149' ' ' TYR . . . . . 0.565 ' HE1' ' HG3' ' B' ' 146' ' ' GLU . 6.0 p90 -117.32 25.21 10.61 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.35 -0.386 . . . . 6.07 110.887 179.682 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 150' ' ' LEU . . . . . 0.789 HD22 ' OG1' ' B' ' 109' ' ' THR . 5.0 tt -127.49 142.5 44.25 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.91 -0.587 . . . . 5.86 111.502 -179.125 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 151' ' ' PRO . . . . . 0.607 ' HD2' ' HG ' ' B' ' 150' ' ' LEU . 85.1 Cg_endo -84.72 50.73 3.01 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.76 2.307 . . . . 5.42 113.053 -179.634 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 152' ' ' SER . . . . . 0.548 ' HB2' ' O ' ' B' ' 151' ' ' PRO . 3.9 m 75.53 151.38 0.14 Allowed Pre-proline 0 N--CA 1.467 0.387 0 CA-C-O 121.017 0.437 . . . . 6.02 111.639 179.739 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 153' ' ' PRO . . . . . 0.582 ' HA ' ' O ' ' B' ' 109' ' ' THR . 43.8 Cg_endo -66.5 165.75 24.08 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.138 2.559 . . . . 5.87 113.29 -179.306 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 154' ' ' CYS . . . . . . . . . . . . . 21.5 p -61.88 115.98 4.48 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.57 -0.741 . . . . 2.96 111.747 -179.679 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 155' ' ' GLN . . . . . 0.69 ' HB3' ' HA ' ' B' ' 103' ' ' LEU . 12.5 pt20 43.74 -171.29 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 114.736 -1.12 . . . . 6.3 112.672 179.891 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -157.19 -162.44 1.21 Allowed 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 120.901 -0.319 . . . . 3.41 111.028 -179.876 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 157' ' ' GLY . . . . . 0.537 ' O ' ' HB2' ' B' ' 166' ' ' ARG . . . -109.09 146.02 16.64 Favored Glycine 0 CA--C 1.493 -1.342 0 N-CA-C 108.821 -1.712 . . . . 2.26 108.821 175.555 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 11.6 mt-30 -103.3 63.7 0.81 Allowed 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 117.354 -1.739 . . . . 5.03 111.363 -179.165 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 159' ' ' LYS . . . . . 0.809 ' HB3' ' HB2' ' B' ' 167' ' ' CYS . 11.2 tppt? -117.46 52.06 1.21 Allowed Pre-proline 0 C--N 1.314 -0.954 0 CA-C-O 116.694 -1.622 . . . . 3.96 110.294 172.118 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 160' ' ' PRO . . . . . 0.407 ' HA ' ' HA ' ' B' ' 166' ' ' ARG . 43.6 Cg_endo -68.38 86.16 0.43 Allowed 'Trans proline' 0 C--N 1.334 -0.231 0 CA-C-N 122.502 1.929 . . . . 1.7 115.03 -173.305 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 161' ' ' CYS . . . . . 0.448 ' N ' ' O ' ' B' ' 165' ' ' GLY . 0.7 OUTLIER -96.94 -166.57 1.42 Allowed 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 113.117 -1.856 . . . . 1.93 109.302 177.944 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 49.9 -164.67 0.56 Allowed Glycine 0 CA--C 1.524 0.613 0 C-N-CA 118.813 -1.66 . . . . 2.37 113.375 172.127 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -78.13 51.44 0.99 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.233 0.54 . . . . 4.56 111.907 -178.739 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 104.95 7.55 38.24 Favored Glycine 0 CA--C 1.533 1.211 0 N-CA-C 114.965 0.746 . . . . 2.39 114.965 178.281 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 165' ' ' GLY . . . . . 0.547 ' HA2' ' HA ' ' B' ' 175' ' ' SER . . . -101.07 136.25 12.6 Favored Glycine 0 C--O 1.224 -0.494 0 C-N-CA 119.044 -1.55 . . . . 1.79 115.885 -176.854 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 166' ' ' ARG . . . . . 0.537 ' HB2' ' O ' ' B' ' 157' ' ' GLY . 0.0 OUTLIER -102.23 154.17 19.28 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 114.469 -0.865 . . . . 3.53 110.6 178.935 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 167' ' ' CYS . . . . . 0.809 ' HB2' ' HB3' ' B' ' 159' ' ' LYS . 5.4 t -56.52 109.24 0.58 Allowed 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 109.721 -0.474 . . . . 1.56 109.721 -179.017 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 168' ' ' ALA . . . . . 0.521 ' HB1' ' SG ' ' B' ' 128' ' ' CYS . . . -92.31 -17.31 24.89 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 107.879 -1.156 . . . . 1.42 107.879 178.878 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 169' ' ' ALA . . . . . 0.785 ' O ' ' O ' ' B' ' 170' ' ' ALA . . . -165.83 155.89 12.66 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 113.063 -1.881 . . . . 1.18 109.13 179.856 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 170' ' ' ALA . . . . . 0.785 ' O ' ' O ' ' B' ' 169' ' ' ALA . . . -19.17 -134.94 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 114.418 1.266 . . . . 1.47 114.418 -179.623 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 171' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' B' ' 185' ' ' CYS . . . -46.69 19.77 0.0 OUTLIER Glycine 0 CA--C 1.536 1.383 0 N-CA-C 116.359 1.304 . . . . 1.45 116.359 -178.217 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 172' ' ' ILE . . . . . 0.774 ' CD1' ' HB2' ' B' ' 134' ' ' CYS . 1.8 pp -138.28 99.85 1.56 Allowed 'Isoleucine or valine' 0 C--O 1.251 1.164 0 CA-C-O 123.478 1.609 . . . . 2.7 111.198 -178.818 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 173' ' ' CYS . . . . . 0.575 ' HB3' ' HB3' ' B' ' 182' ' ' ASP . 1.1 t -92.92 95.54 9.56 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 113.523 -1.671 . . . . 1.94 109.022 -179.055 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 174' ' ' CYS . . . . . 0.842 ' HA ' ' HA ' ' B' ' 179' ' ' CYS . 16.3 m -92.82 162.6 14.04 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 114.52 1.304 . . . . 1.43 114.52 -176.25 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 175' ' ' SER . . . . . 0.758 ' HB2' ' HD2' ' B' ' 176' ' ' PRO . 55.6 p -125.27 179.42 1.14 Allowed Pre-proline 0 CA--C 1.532 0.262 0 CA-C-N 113.454 -1.703 . . . . 2.3 108.033 178.842 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 176' ' ' PRO . . . . . 0.758 ' HD2' ' HB2' ' B' ' 175' ' ' SER . 72.0 Cg_endo -77.27 30.14 0.42 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 121.283 1.322 . . . . 2.13 111.9 179.829 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 177' ' ' ASP . . . . . 0.436 ' H ' ' C ' ' B' ' 175' ' ' SER . 1.6 t70 -145.94 -41.79 0.21 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.644 -0.707 . . . . 2.72 110.921 179.939 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 178' ' ' GLY . . . . . 1.217 ' HA3' ' O ' ' A' ' 79' ' ' CYS . . . -150.97 -141.56 3.37 Favored Glycine 0 C--N 1.336 0.533 0 C-N-CA 120.588 -0.815 . . . . 1.05 113.727 -179.89 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 179' ' ' CYS . . . . . 1.261 ' O ' ' HA3' ' A' ' 78' ' ' GLY . 60.3 m -148.38 146.05 28.32 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 123.154 0.582 . . . . 1.39 110.53 -179.653 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 180' ' ' HIS . . . . . 0.455 ' N ' ' O ' ' B' ' 173' ' ' CYS . 14.6 m80 -132.97 134.14 44.1 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 119.797 -0.761 . . . . 2.73 111.508 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 181' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -59.67 135.93 57.83 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.712 -0.847 . . . . 3.06 108.712 178.506 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 182' ' ' ASP . . . . . 0.575 ' HB3' ' HB3' ' B' ' 173' ' ' CYS . 0.7 OUTLIER -143.0 128.94 10.32 Favored Pre-proline 0 C--N 1.319 -0.719 0 CA-C-N 116.443 -0.344 . . . . 2.06 111.069 -178.632 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 183' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -69.19 -31.34 23.29 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 123.188 2.592 . . . . 2.27 113.041 -179.106 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -64.41 -3.28 2.82 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.109 -0.496 . . . . 1.56 111.963 -179.729 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 185' ' ' CYS . . . . . 0.629 ' HB3' ' C ' ' B' ' 170' ' ' ALA . 70.6 m -133.25 20.26 4.02 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 112.227 0.454 . . . . 1.94 112.227 -179.855 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 186' ' ' ASP . . . . . 0.758 ' N ' ' HD3' ' B' ' 187' ' ' PRO . 17.3 m-20 -107.65 20.65 0.06 OUTLIER Pre-proline 0 N--CA 1.448 -0.573 0 N-CA-C 113.858 1.058 . . . . 3.61 113.858 179.761 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 187' ' ' PRO . . . . . 0.758 ' HD3' ' N ' ' B' ' 186' ' ' ASP . 1.9 Cg_endo -77.79 66.15 8.14 Favored 'Trans proline' 0 CA--C 1.485 -1.974 0 N-CA-C 106.424 -2.183 . . . . 3.14 106.424 176.371 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 188' ' ' GLU . . . . . 0.536 ' HB3' ' O ' ' B' ' 187' ' ' PRO . 4.5 pt-20 176.55 -34.01 0.01 OUTLIER 'General case' 0 CA--C 1.475 -1.911 0 CA-C-O 123.838 1.78 . . . . 4.7 108.213 -179.261 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 189' ' ' ALA . . . . . 0.466 ' N ' ' HG3' ' B' ' 188' ' ' GLU . . . -77.13 34.09 0.15 Allowed 'General case' 0 C--N 1.366 1.284 0 CA-C-N 110.504 -3.044 . . . . 5.24 110.407 176.111 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 190' ' ' ALA . . . . . 0.523 ' H ' ' C ' ' B' ' 188' ' ' GLU . . . -76.5 145.31 39.23 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 112.999 -1.909 . . . . 6.93 111.37 -176.256 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 191' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -62.62 128.18 34.75 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.45 0.643 . . . . 10.62 112.356 -174.189 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 6.0 t . . . . . 0 C--O 1.25 1.096 0 CA-C-N 114.989 -1.005 . . . . 11.7 110.573 179.833 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.5 m . . . . . 0 CA--C 1.556 1.2 0 N-CA-C 113.201 0.815 . . . . 2.64 113.201 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.596 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -34.82 113.29 0.46 Allowed Pre-proline 0 N--CA 1.491 1.609 0 CA-C-N 119.0 0.818 . . . . 2.75 111.661 179.461 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.472 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 71.5 Cg_endo -75.48 117.92 4.97 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 122.82 2.347 . . . . 1.66 113.309 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 5.7 p -130.93 -178.29 4.75 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 121.057 0.456 . . . . 1.3 111.702 178.439 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.465 ' HA2' ' HB3' ' A' ' 40' ' ' GLU . . . 77.21 -162.54 51.4 Favored Glycine 0 CA--C 1.519 0.303 0 CA-C-N 116.162 -0.472 . . . . 1.23 112.121 -178.111 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.407 ' O ' ' HG2' ' A' ' 15' ' ' PRO . 44.6 Cg_endo -65.8 100.29 0.42 Allowed 'Trans proline' 0 N--CA 1.48 0.692 0 C-N-CA 124.165 3.244 . . . . 1.78 111.886 177.729 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.03 5.89 76.29 Favored Glycine 0 C--N 1.299 -1.473 0 CA-C-N 115.316 -0.856 . . . . 1.96 113.465 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.472 ' O ' ' CB ' ' A' ' 12' ' ' PRO . . . 71.95 45.33 42.75 Favored Glycine 0 N--CA 1.426 -2.011 0 N-CA-C 115.71 1.044 . . . . 1.48 115.71 177.713 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.467 ' HB2' ' CD1' ' A' ' 32' ' ' LEU . 0.5 OUTLIER -94.89 -24.02 17.19 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 112.66 0.615 . . . . 3.06 112.66 -179.828 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -79.5 171.84 54.87 Favored Glycine 0 CA--C 1.495 -1.157 0 CA-C-N 115.235 -0.893 . . . . 1.16 111.64 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.596 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 0.8 OUTLIER -120.86 149.41 42.64 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 109.848 -0.427 . . . . 2.62 109.848 -178.62 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 57.0 m -98.64 127.02 44.42 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.988 0.899 . . . . 1.22 109.741 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.418 ' CE2' ' HB1' ' A' ' 68' ' ' ALA . 3.7 m-85 -109.89 -29.94 8.05 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 113.963 -1.472 . . . . 2.15 111.315 -177.646 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -157.03 -174.49 26.8 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 121.089 -0.577 . . . . 0.98 112.708 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.41 -54.27 5.22 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 122.747 2.298 . . . . 0.93 113.45 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.588 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.7 OUTLIER -120.65 36.32 4.61 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 122.462 -0.149 . . . . 0.96 111.207 179.695 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.892 HG12 HG13 ' A' ' 36' ' ' VAL . 19.7 mt -140.77 111.42 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 C-N-CA 120.32 -0.552 . . . . 0.99 111.896 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.579 ' SG ' ' O ' ' A' ' 20' ' ' ARG . 0.5 OUTLIER -126.49 120.71 30.39 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 116.528 -0.305 . . . . 1.2 110.19 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.887 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -131.07 127.85 39.03 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 119.526 -0.87 . . . . 1.13 112.65 -179.579 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 33' ' ' GLY . . . -103.92 -169.51 25.24 Favored Glycine 0 N--CA 1.421 -2.325 0 C-N-CA 120.45 -0.881 . . . . 0.79 111.858 178.022 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -69.87 -51.06 36.54 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 114.694 -0.753 . . . . 2.64 112.969 -178.059 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -121.08 9.42 10.52 Favored 'General case' 0 CA--C 1.503 -0.836 0 CA-C-N 115.041 -0.981 . . . . 2.1 109.437 -177.445 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.467 ' CD1' ' HB2' ' A' ' 18' ' ' LYS . 4.7 mt -109.67 -9.83 14.84 Favored 'General case' 0 N--CA 1.408 -2.569 0 N-CA-C 108.871 -0.789 . . . . 1.0 108.871 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.954 ' HA2' ' HB1' ' A' ' 69' ' ' ALA . . . 65.8 -136.0 35.64 Favored Glycine 0 N--CA 1.43 -1.751 0 C-N-CA 120.42 -0.895 . . . . 0.7 112.921 176.555 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.719 ' HB2' HD13 ' A' ' 72' ' ' ILE . 1.6 t -135.66 125.54 25.73 Favored 'General case' 0 CA--C 1.503 -0.827 0 N-CA-C 114.37 1.248 . . . . 0.94 114.37 -178.583 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.48 ' HA ' ' HA ' ' B' ' 135' ' ' PHE . 4.2 m-85 -98.88 101.03 12.29 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 104.655 -2.35 . . . . 1.84 104.655 176.067 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.892 HG13 HG12 ' A' ' 26' ' ' ILE . 3.8 t -87.06 94.48 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 CA-C-O 122.937 1.351 . . . . 0.59 110.603 -178.244 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.588 ' N ' ' O ' ' A' ' 25' ' ' SER . . . 76.95 83.63 0.5 Allowed Glycine 0 CA--C 1.499 -0.911 0 CA-C-N 112.028 -2.351 . . . . 1.32 112.186 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 19.2 p -149.95 169.08 22.02 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-O 120.972 0.415 . . . . 1.48 111.16 -178.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.683 ' HA ' HD12 ' A' ' 42' ' ' LEU . . . -55.08 -27.73 47.09 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.867 -0.606 . . . . 1.28 110.781 179.164 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.465 ' HB3' ' HA2' ' A' ' 14' ' ' GLY . 30.1 mp0 -73.56 -29.21 62.29 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 112.665 0.617 . . . . 2.56 112.665 -179.194 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.422 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . . . -97.55 -1.35 44.13 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 120.701 0.286 . . . . 0.95 110.38 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.683 HD12 ' HA ' ' A' ' 39' ' ' ALA . 1.6 mt -57.61 -32.98 67.75 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 120.939 0.4 . . . . 1.99 110.308 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.7 ptm85 -72.13 -9.07 57.92 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.89 -0.596 . . . . 3.75 110.594 179.002 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 94.4 m -69.36 -10.18 56.76 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 120.198 -0.601 . . . . 1.32 111.389 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -54.96 -24.76 25.46 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.109 0.48 . . . . 2.8 110.928 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -85.83 5.01 34.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.241 -0.436 . . . . 3.55 110.434 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.443 -0.791 0 N-CA-C 108.789 -0.819 . . . . 2.79 108.789 179.118 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.9 t . . . . . 0 N--CA 1.473 0.677 0 CA-C-O 120.456 0.169 . . . . 3.86 110.835 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.492 ' O ' ' HB2' ' A' ' 66' ' ' ARG . . . -66.12 120.44 15.93 Favored Glycine 0 N--CA 1.429 -1.782 0 C-N-CA 120.213 -0.994 . . . . 2.88 110.827 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.61 77.58 6.21 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 107.886 -1.153 . . . . 5.45 107.886 179.312 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.482 ' O ' ' HA ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -146.33 58.26 4.45 Favored Pre-proline 0 C--N 1.306 -1.318 0 CA-C-N 114.933 -1.03 . . . . 6.09 108.868 -179.524 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 59' ' ' LYS . 36.8 Cg_endo -64.63 85.5 0.17 Allowed 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.584 2.189 . . . . 2.54 112.235 179.183 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.506 ' N ' ' O ' ' A' ' 65' ' ' GLY . 0.5 OUTLIER -108.41 -179.4 3.87 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.624 -0.717 . . . . 2.27 109.083 179.44 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.08 -161.01 44.94 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 117.859 -2.115 . . . . 2.47 111.816 178.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 50.9 m -78.79 45.33 0.59 Allowed 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 120.689 0.281 . . . . 3.28 111.637 -179.421 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 105.28 16.07 17.53 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 120.945 -0.645 . . . . 2.3 114.674 178.48 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.506 ' O ' ' N ' ' A' ' 61' ' ' CYS . . . -103.7 132.85 11.22 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 119.822 -1.18 . . . . 1.86 114.738 -179.268 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.492 ' HB2' ' O ' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -93.61 159.16 15.34 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 122.49 0.316 . . . . 3.36 110.95 178.335 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 13.8 t -70.05 106.37 3.21 Favored 'General case' 0 N--CA 1.432 -1.363 0 C-N-CA 119.782 -0.767 . . . . 1.64 109.438 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.418 ' HB1' ' CE2' ' A' ' 22' ' ' PHE . . . -93.15 -17.57 23.59 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.906 0.384 . . . . 1.21 110.613 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.954 ' HB1' ' HA2' ' A' ' 33' ' ' GLY . . . -168.11 164.21 13.45 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 115.969 -0.56 . . . . 1.05 110.377 -178.543 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -45.17 121.76 3.04 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 114.218 1.192 . . . . 1.63 114.218 -177.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.649 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . 59.86 31.44 71.96 Favored Glycine 0 CA--C 1.506 -0.526 0 CA-C-N 113.479 -1.691 . . . . 1.58 115.673 176.264 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.779 HD12 ' SG ' ' A' ' 74' ' ' CYS . 1.3 pt -142.37 112.6 2.73 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-O 122.015 0.912 . . . . 2.04 111.976 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.71 ' HB2' ' HB3' ' A' ' 82' ' ' ASP . 0.0 OUTLIER -93.07 94.2 8.73 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 114.72 -1.127 . . . . 1.72 109.14 179.302 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.779 ' SG ' HD12 ' A' ' 72' ' ' ILE . 43.7 m -102.4 147.94 26.1 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.295 0.569 . . . . 1.37 111.469 -179.19 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.494 ' CB ' ' HD2' ' A' ' 76' ' ' PRO . 0.3 OUTLIER -122.64 -179.12 0.72 Allowed Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 114.632 -1.167 . . . . 2.25 108.813 179.615 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.494 ' HD2' ' CB ' ' A' ' 75' ' ' SER . 58.0 Cg_endo -74.26 32.6 0.34 Allowed 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 121.883 1.722 . . . . 2.7 112.954 -179.396 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.475 ' HB3' ' NE2' ' B' ' 180' ' ' HIS . 5.4 m-20 -147.54 -49.68 0.18 Allowed 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.876 -0.602 . . . . 2.63 111.002 178.43 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.564 ' HA3' ' O ' ' B' ' 179' ' ' CYS . . . -143.69 -152.2 5.61 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 120.412 -0.899 . . . . 0.75 113.727 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.573 ' HA ' ' HA ' ' A' ' 74' ' ' CYS . 5.0 m -138.46 149.82 45.84 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.045 -0.578 . . . . 1.23 110.156 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.636 ' O ' ' N ' ' A' ' 73' ' ' CYS . 0.1 OUTLIER -147.41 145.46 29.24 Favored 'General case' 0 CA--C 1.513 -0.474 0 O-C-N 121.516 -0.74 . . . . 3.01 111.408 -178.404 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -67.95 144.58 55.14 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.344 -0.613 . . . . 2.9 109.344 178.03 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.71 ' HB3' ' HB2' ' A' ' 73' ' ' CYS . 2.2 p-10 -146.34 121.2 5.41 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 116.066 -0.515 . . . . 2.52 110.055 -177.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 82' ' ' ASP . 38.4 Cg_exo -61.83 -15.08 40.4 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.776 2.317 . . . . 2.98 114.385 -178.247 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.16 -44.84 78.74 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.908 0.385 . . . . 2.42 111.814 -179.348 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.649 ' O ' ' N ' ' A' ' 71' ' ' GLY . 14.0 m -106.04 26.16 10.06 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.681 0.753 . . . . 2.16 109.919 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 11.6 t0 . . . . . 0 C--N 1.309 -1.175 0 O-C-N 121.308 -0.87 . . . . 3.14 112.425 -179.063 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 110' ' ' CYS . . . . . . . . . . . . . 1.3 m . . . . . 0 CA--C 1.552 1.037 0 N-CA-C 113.097 0.777 . . . . 2.64 113.097 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 111' ' ' LEU . . . . . 0.617 ' O ' ' HA ' ' B' ' 120' ' ' ARG . 0.7 OUTLIER -33.78 112.82 0.41 Allowed Pre-proline 0 N--CA 1.483 1.214 0 CA-C-N 118.554 0.616 . . . . 2.77 112.485 179.533 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 112' ' ' PRO . . . . . 0.46 ' CB ' ' O ' ' B' ' 117' ' ' GLY . 73.3 Cg_endo -75.87 119.44 5.4 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.7 2.267 . . . . 1.7 114.171 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 113' ' ' CYS . . . . . . . . . . . . . 4.3 p -133.09 -178.16 4.84 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 120.502 -0.479 . . . . 1.26 112.137 178.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 114' ' ' GLY . . . . . 0.467 ' HA2' ' HB3' ' B' ' 140' ' ' GLU . . . 77.17 -162.23 51.25 Favored Glycine 0 CA--C 1.522 0.5 0 CA-C-N 116.037 -0.529 . . . . 1.2 111.999 -177.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 115' ' ' PRO . . . . . 0.406 ' O ' ' HG2' ' B' ' 115' ' ' PRO . 45.1 Cg_endo -66.19 99.32 0.41 Allowed 'Trans proline' 0 N--CA 1.478 0.588 0 C-N-CA 124.089 3.192 . . . . 1.78 112.089 177.698 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 89.12 5.95 72.33 Favored Glycine 0 C--N 1.298 -1.541 0 CA-C-N 115.404 -0.816 . . . . 1.94 113.436 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 117' ' ' GLY . . . . . 0.46 ' O ' ' CB ' ' B' ' 112' ' ' PRO . . . 72.24 45.03 41.52 Favored Glycine 0 N--CA 1.425 -2.064 0 C-N-CA 120.386 -0.911 . . . . 1.48 115.268 177.488 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 118' ' ' LYS . . . . . 0.457 ' HB2' ' CD1' ' B' ' 132' ' ' LEU . 0.4 OUTLIER -94.29 -24.67 17.34 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 121.153 0.502 . . . . 3.07 111.94 -179.601 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . -78.84 173.06 55.35 Favored Glycine 0 N--CA 1.438 -1.227 0 C-N-CA 120.589 -0.815 . . . . 1.16 111.893 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.617 ' HA ' ' O ' ' B' ' 111' ' ' LEU . 0.7 OUTLIER -120.85 149.0 43.27 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 110.024 -0.362 . . . . 2.63 110.024 -179.508 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 121' ' ' CYS . . . . . . . . . . . . . 57.3 m -98.16 127.63 44.21 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 119.639 -0.825 . . . . 1.21 110.203 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 122' ' ' PHE . . . . . 0.404 ' CE2' ' HB1' ' B' ' 168' ' ' ALA . 3.5 m-85 -110.9 -28.41 8.38 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 114.413 -1.267 . . . . 2.14 111.657 -177.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -158.12 -175.65 29.29 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 121.149 -0.548 . . . . 0.99 112.445 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -52.42 -54.09 5.78 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 122.85 2.366 . . . . 0.96 113.447 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 125' ' ' SER . . . . . 0.57 ' O ' ' N ' ' B' ' 137' ' ' GLY . 1.0 OUTLIER -121.0 36.77 4.5 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 122.413 -0.18 . . . . 1.0 110.961 179.671 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 126' ' ' ILE . . . . . 0.478 HG12 HG13 ' B' ' 136' ' ' VAL . 16.0 mt -139.72 111.02 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 C-N-CA 120.499 -0.48 . . . . 0.97 112.047 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 127' ' ' CYS . . . . . 0.559 ' SG ' ' O ' ' B' ' 120' ' ' ARG . 0.5 OUTLIER -127.55 119.74 26.66 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 110.099 -0.334 . . . . 1.19 110.099 179.677 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 128' ' ' CYS . . . . . 0.926 ' HA ' ' O ' ' B' ' 133' ' ' GLY . 0.0 OUTLIER -130.09 128.18 41.36 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 119.952 -0.699 . . . . 1.12 112.608 -178.941 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 129' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' B' ' 133' ' ' GLY . . . -105.48 -169.19 23.72 Favored Glycine 0 N--CA 1.418 -2.506 0 C-N-CA 120.065 -1.064 . . . . 0.78 111.989 178.428 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -70.41 -51.62 28.21 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 115.126 -0.537 . . . . 2.63 112.351 -177.304 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.8 30.61 5.46 Favored 'General case' 0 CA--C 1.503 -0.861 0 N-CA-C 108.861 -0.792 . . . . 2.1 108.861 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 132' ' ' LEU . . . . . 0.457 ' CD1' ' HB2' ' B' ' 118' ' ' LYS . 3.8 mt -127.06 -7.8 5.98 Favored 'General case' 0 N--CA 1.396 -3.159 0 N-CA-C 106.752 -1.573 . . . . 0.98 106.752 177.374 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 133' ' ' GLY . . . . . 0.996 ' HA2' ' HB1' ' B' ' 169' ' ' ALA . . . 61.87 -136.36 46.4 Favored Glycine 0 N--CA 1.427 -1.942 0 CA-C-N 115.283 -0.871 . . . . 0.68 113.851 176.728 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 134' ' ' CYS . . . . . 0.749 ' HB2' HD13 ' B' ' 172' ' ' ILE . 1.6 t -134.36 126.24 29.23 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 114.5 1.296 . . . . 0.96 114.5 -178.044 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 135' ' ' PHE . . . . . 0.48 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 4.8 m-85 -99.28 101.09 12.28 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 104.455 -2.424 . . . . 1.84 104.455 176.009 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 136' ' ' VAL . . . . . 0.478 HG13 HG12 ' B' ' 126' ' ' ILE . 38.3 t -85.58 93.76 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 CA-C-O 122.97 1.367 . . . . 0.6 110.072 -178.069 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 137' ' ' GLY . . . . . 0.57 ' N ' ' O ' ' B' ' 125' ' ' SER . . . 75.32 84.75 0.35 Allowed Glycine 0 CA--C 1.502 -0.729 0 CA-C-N 112.136 -2.302 . . . . 1.33 112.448 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 138' ' ' THR . . . . . . . . . . . . . 19.1 p -150.22 169.64 20.85 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 120.9 0.381 . . . . 1.48 111.172 -179.088 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 139' ' ' ALA . . . . . 0.685 ' HA ' HD12 ' B' ' 142' ' ' LEU . . . -55.39 -27.65 49.0 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.038 -0.528 . . . . 1.3 110.805 179.02 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 140' ' ' GLU . . . . . 0.467 ' HB3' ' HA2' ' B' ' 114' ' ' GLY . 30.2 mp0 -73.52 -29.14 62.28 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 112.542 0.571 . . . . 2.53 112.542 -179.241 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 141' ' ' ALA . . . . . 0.443 ' HB2' ' HB2' ' B' ' 127' ' ' CYS . . . -97.47 -0.91 45.28 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 120.713 0.292 . . . . 0.98 110.489 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 142' ' ' LEU . . . . . 0.685 HD12 ' HA ' ' B' ' 139' ' ' ALA . 1.6 mt -58.02 -33.05 68.53 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 121.031 0.443 . . . . 2.02 110.318 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 143' ' ' ARG . . . . . . . . . . . . . 2.0 ptm85 -71.96 -9.2 58.03 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.883 -0.599 . . . . 3.76 110.606 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 144' ' ' CYS . . . . . . . . . . . . . 94.2 m -69.48 -9.89 55.71 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 120.169 -0.613 . . . . 1.37 111.414 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -55.04 -24.96 27.41 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.072 0.463 . . . . 2.78 110.802 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -85.81 5.41 32.7 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 116.351 -0.386 . . . . 3.53 110.495 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.445 -0.712 0 N-CA-C 108.879 -0.786 . . . . 2.81 108.879 178.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 1.8 t . . . . . 0 N--CA 1.471 0.625 0 CA-C-O 120.518 0.199 . . . . 3.9 111.007 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 157' ' ' GLY . . . . . 0.44 ' O ' ' HB2' ' B' ' 166' ' ' ARG . . . -62.04 120.62 22.79 Favored Glycine 0 N--CA 1.441 -0.971 0 C-N-CA 120.159 -1.02 . . . . 2.89 111.025 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.36 60.11 3.67 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.691 0.758 . . . . 5.47 110.27 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 159' ' ' LYS . . . . . 0.576 ' HB2' ' CB ' ' B' ' 167' ' ' CYS . 0.1 OUTLIER -115.42 55.41 1.01 Allowed Pre-proline 0 N--CA 1.443 -0.778 0 CA-C-N 114.766 -1.107 . . . . 6.05 111.541 176.076 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 160' ' ' PRO . . . . . 0.437 ' HA ' ' HA ' ' B' ' 166' ' ' ARG . 30.1 Cg_endo -63.09 85.57 0.12 Allowed 'Trans proline' 0 CA--C 1.531 0.336 0 CA-C-N 121.306 1.502 . . . . 2.53 113.794 -178.492 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 161' ' ' CYS . . . . . 0.512 ' N ' ' O ' ' B' ' 165' ' ' GLY . 0.5 OUTLIER -109.61 -179.65 3.88 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.05 -0.523 . . . . 2.24 109.705 179.504 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 66.68 -160.75 47.14 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 118.26 -1.924 . . . . 2.45 111.642 178.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 39.0 m -78.57 43.77 0.49 Allowed 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 116.802 0.301 . . . . 3.26 111.53 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 106.86 15.9 15.35 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 120.74 -0.743 . . . . 2.3 114.588 178.46 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 165' ' ' GLY . . . . . 0.512 ' O ' ' N ' ' B' ' 161' ' ' CYS . . . -103.61 134.08 11.74 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.044 -1.074 . . . . 1.83 114.444 -179.321 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 166' ' ' ARG . . . . . 0.502 ' HA ' ' O ' ' B' ' 159' ' ' LYS . 0.0 OUTLIER -95.27 158.64 15.37 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 115.415 -0.393 . . . . 3.34 110.875 178.254 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 167' ' ' CYS . . . . . 0.576 ' CB ' ' HB2' ' B' ' 159' ' ' LYS . 14.1 t -70.17 106.1 3.17 Favored 'General case' 0 N--CA 1.435 -1.218 0 C-N-CA 119.731 -0.788 . . . . 1.61 109.342 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 168' ' ' ALA . . . . . 0.404 ' HB1' ' CE2' ' B' ' 122' ' ' PHE . . . -93.12 -18.81 22.15 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.205 0.526 . . . . 1.22 110.782 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 169' ' ' ALA . . . . . 0.996 ' HB1' ' HA2' ' B' ' 133' ' ' GLY . . . -165.63 164.94 19.09 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 115.466 -0.788 . . . . 1.04 110.53 -178.788 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 170' ' ' ALA . . . . . . . . . . . . . . . -46.89 121.71 3.82 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 114.762 1.393 . . . . 1.63 114.762 -177.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 171' ' ' GLY . . . . . 0.759 ' N ' ' O ' ' B' ' 185' ' ' CYS . . . 61.83 29.66 72.94 Favored Glycine 0 C--N 1.315 -0.633 0 CA-C-N 113.974 -1.466 . . . . 1.49 115.896 177.02 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 172' ' ' ILE . . . . . 0.77 HD12 ' SG ' ' B' ' 174' ' ' CYS . 1.3 pt -142.58 113.71 2.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 118.331 1.066 . . . . 2.05 111.95 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 173' ' ' CYS . . . . . 0.764 ' HB2' ' HB3' ' B' ' 182' ' ' ASP . 0.0 OUTLIER -94.22 93.93 8.05 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 114.56 -1.2 . . . . 1.73 108.81 179.692 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 174' ' ' CYS . . . . . 0.77 ' SG ' HD12 ' B' ' 172' ' ' ILE . 37.2 m -102.22 148.0 25.96 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.458 0.646 . . . . 1.35 111.745 -179.013 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 175' ' ' SER . . . . . 0.505 ' CB ' ' HD2' ' B' ' 176' ' ' PRO . 0.3 OUTLIER -122.88 -179.26 0.76 Allowed Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 114.627 -1.169 . . . . 2.25 108.914 179.792 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 176' ' ' PRO . . . . . 0.505 ' HD2' ' CB ' ' B' ' 175' ' ' SER . 57.9 Cg_endo -74.02 32.61 0.34 Allowed 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 121.811 1.674 . . . . 2.68 113.044 -179.407 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 177' ' ' ASP . . . . . 0.457 ' HB3' ' NE2' ' A' ' 80' ' ' HIS . 5.1 m-20 -147.69 -49.53 0.17 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.915 -0.584 . . . . 2.66 110.949 178.614 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 178' ' ' GLY . . . . . 0.555 ' HA3' ' O ' ' A' ' 79' ' ' CYS . . . -143.49 -151.57 5.49 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 120.492 -0.861 . . . . 0.75 113.944 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 179' ' ' CYS . . . . . 0.602 ' HA ' ' HA ' ' B' ' 174' ' ' CYS . 4.8 m -139.42 149.24 43.83 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 114.879 -0.66 . . . . 1.24 110.095 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 180' ' ' HIS . . . . . 0.613 ' O ' ' N ' ' B' ' 173' ' ' CYS . 0.1 OUTLIER -146.88 145.74 29.94 Favored 'General case' 0 CA--C 1.511 -0.547 0 C-N-CA 119.807 -0.757 . . . . 3.0 111.41 -178.436 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 181' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -67.9 145.26 54.75 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 120.175 -0.61 . . . . 2.9 109.48 178.167 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 182' ' ' ASP . . . . . 0.764 ' HB3' ' HB2' ' B' ' 173' ' ' CYS . 1.8 p-10 -146.9 121.05 5.11 Favored Pre-proline 0 C--N 1.319 -0.753 0 CA-C-N 116.196 -0.456 . . . . 2.49 110.412 -178.005 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 183' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -61.51 -14.8 37.35 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 122.653 2.236 . . . . 2.94 114.448 -178.285 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -67.55 -44.98 76.97 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.846 0.355 . . . . 2.37 111.647 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 185' ' ' CYS . . . . . 0.759 ' O ' ' N ' ' B' ' 171' ' ' GLY . 11.9 m -106.91 28.87 7.56 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.629 0.728 . . . . 2.13 110.767 -179.507 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 186' ' ' ASP . . . . . . . . . . . . . 11.8 t0 . . . . . 0 C--N 1.319 -0.738 0 CA-C-N 115.835 -0.62 . . . . 3.11 112.52 -179.144 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.509 ' O ' ' C ' ' A' ' 11' ' ' LEU . 8.4 m . . . . . 0 CA--C 1.531 0.237 0 N-CA-C 115.944 1.831 . . . . 2.68 115.944 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.513 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -31.56 110.88 0.3 Allowed Pre-proline 0 N--CA 1.48 1.054 0 CA-C-N 119.055 0.843 . . . . 2.48 110.125 178.739 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.632 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 41.5 Cg_endo -99.98 139.49 0.28 Allowed 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.143 1.896 . . . . 1.49 116.758 -177.409 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.544 ' HA ' ' HD2' ' A' ' 43' ' ' ARG . 2.4 p -134.59 -165.75 1.71 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 118.674 -1.21 . . . . 1.0 109.866 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.483 ' HA2' ' HG2' ' A' ' 40' ' ' GLU . . . 64.65 -159.45 42.37 Favored Glycine 0 CA--C 1.499 -0.939 0 C-N-CA 121.365 -0.445 . . . . 1.15 113.527 176.312 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.435 ' C ' ' H ' ' A' ' 17' ' ' GLY . 42.7 Cg_endo -64.75 138.19 57.31 Favored 'Trans proline' 0 N--CA 1.443 -1.448 0 C-N-CA 122.25 1.967 . . . . 1.57 109.029 176.401 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 55.93 -6.58 0.01 OUTLIER Glycine 0 C--N 1.273 -2.965 0 CA-C-N 114.055 -1.43 . . . . 1.68 114.029 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.435 ' H ' ' C ' ' A' ' 15' ' ' PRO . . . 69.66 40.98 76.53 Favored Glycine 1 N--CA 1.387 -4.567 0 C-N-CA 116.947 -2.549 . . . . 1.36 108.871 -178.455 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.433 ' HB2' HD11 ' A' ' 32' ' ' LEU . 1.6 mttp -93.59 -10.91 33.08 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 111.677 -2.262 . . . . 2.5 113.24 179.442 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.632 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -122.85 179.0 16.27 Favored Glycine 0 N--CA 1.44 -1.051 0 N-CA-C 106.539 -2.624 . . . . 1.02 106.539 178.628 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.513 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 0.3 OUTLIER -122.55 170.23 10.21 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 119.95 1.875 . . . . 2.92 112.274 -178.98 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.465 ' O ' HD12 ' A' ' 11' ' ' LEU . 20.2 t -114.66 150.76 34.68 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.735 0.303 . . . . 1.1 111.796 -179.437 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -131.85 -49.56 0.96 Allowed 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 108.704 -0.85 . . . . 1.51 108.704 177.096 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.438 ' O ' ' SG ' ' A' ' 21' ' ' CYS . . . -99.29 -154.87 28.54 Favored Glycine 0 N--CA 1.448 -0.553 0 N-CA-C 109.007 -1.637 . . . . 0.9 109.007 176.423 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -94.18 -60.55 0.01 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.032 0 CA-C-N 119.829 1.814 . . . . 1.5 112.14 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.636 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.6 OUTLIER -90.92 9.82 28.95 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-O 120.615 0.245 . . . . 1.26 110.403 179.05 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.826 HG23 HG13 ' A' ' 36' ' ' VAL . 1.5 mt -120.08 118.08 55.71 Favored 'Isoleucine or valine' 0 C--O 1.245 0.854 0 CA-C-O 122.061 0.934 . . . . 0.83 112.311 -177.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.737 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 0.7 OUTLIER -134.83 130.47 36.09 Favored 'General case' 0 C--O 1.223 -0.31 0 CA-C-N 114.238 -1.346 . . . . 0.92 110.556 -179.492 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 1.086 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -132.4 172.65 12.2 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-O 123.155 1.455 . . . . 1.28 114.167 -178.086 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.481 ' O ' ' HB1' ' A' ' 69' ' ' ALA . . . -156.87 176.0 34.26 Favored Glycine 0 N--CA 1.429 -1.812 0 CA-C-N 111.664 -2.517 . . . . 0.67 108.602 178.674 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -62.17 -53.0 61.54 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 121.964 0.888 . . . . 2.27 110.453 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.29 11.69 14.11 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 113.79 -1.55 . . . . 1.66 109.402 179.027 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.697 HD22 ' CZ ' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -106.47 -4.2 20.09 Favored 'General case' 0 N--CA 1.412 -2.352 0 N-CA-C 106.897 -1.519 . . . . 1.37 106.897 179.275 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 1.086 ' O ' ' HA ' ' A' ' 28' ' ' CYS . . . 46.76 -140.59 6.77 Favored Glycine 0 N--CA 1.419 -2.441 0 CA-C-N 113.67 -1.604 . . . . 0.73 113.028 178.051 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.8 ' SG ' HG22 ' A' ' 26' ' ' ILE . 0.5 OUTLIER -138.23 122.16 17.77 Favored 'General case' 0 CA--C 1.493 -1.234 0 N-CA-C 113.168 0.803 . . . . 1.08 113.168 179.709 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.978 ' HA ' ' HA ' ' B' ' 135' ' ' PHE . 0.0 OUTLIER -88.8 106.2 18.21 Favored 'General case' 0 N--CA 1.423 -1.81 0 N-CA-C 104.22 -2.511 . . . . 1.38 104.22 175.437 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.912 HG23 HG23 ' B' ' 136' ' ' VAL . 1.4 t -96.09 83.71 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 N-CA-C 107.734 -1.21 . . . . 0.76 107.734 -179.303 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.727 ' O ' ' HA3' ' B' ' 133' ' ' GLY . . . 103.01 92.57 2.23 Favored Glycine 0 CA--C 1.531 1.073 0 CA-C-N 112.955 -1.929 . . . . 0.81 114.259 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.475 HG21 ' HB3' ' A' ' 35' ' ' PHE . 0.0 OUTLIER 177.86 167.1 0.72 Allowed 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 108.808 -0.812 . . . . 0.77 108.808 178.455 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.772 ' CB ' HD22 ' A' ' 42' ' ' LEU . . . -61.24 -16.77 48.69 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 119.996 1.271 . . . . 1.02 111.677 179.435 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.669 ' HB3' ' CD2' ' A' ' 35' ' ' PHE . 5.0 mt-10 -64.19 -14.95 58.68 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.629 -0.508 . . . . 2.32 109.629 178.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.645 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . . . -126.1 -4.81 6.8 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 115.67 -0.696 . . . . 0.87 111.949 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.772 HD22 ' CB ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -73.95 -36.3 64.62 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 108.218 -1.03 . . . . 1.23 108.218 179.231 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.544 ' HD2' ' HA ' ' A' ' 13' ' ' CYS . 1.2 ptp180 -63.52 -5.63 4.08 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 114.31 -1.313 . . . . 2.92 109.529 178.246 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.599 ' HB3' ' O ' ' A' ' 41' ' ' ALA . 9.3 t -82.2 11.8 4.97 Favored 'General case' 0 N--CA 1.445 -0.701 0 O-C-N 121.572 -0.705 . . . . 1.57 109.166 177.467 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -73.02 -18.3 61.36 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.945 -0.571 . . . . 3.31 109.477 178.602 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.42 5.7 33.77 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 119.303 -0.959 . . . . 3.69 109.862 179.28 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 . . . . . 0 N--CA 1.448 -0.562 0 CA-C-N 115.866 -0.607 . . . . 3.99 109.583 177.53 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.542 0.653 0 N-CA-C 111.382 0.141 . . . . 3.12 111.382 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 56.45 58.57 13.66 Favored Glycine 0 N--CA 1.426 -2.033 0 C-N-CA 121.346 -0.454 . . . . 2.1 112.214 176.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 -119.46 70.46 0.85 Allowed 'General case' 0 N--CA 1.435 -1.206 0 CA-C-O 122.82 1.295 . . . . 4.36 107.684 177.033 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.642 ' N ' ' CD ' ' A' ' 60' ' ' PRO . 2.2 mmpp? -143.68 44.69 0.51 Allowed Pre-proline 0 C--N 1.303 -1.435 0 CA-C-N 112.428 -2.169 . . . . 3.55 108.089 177.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.642 ' CD ' ' N ' ' A' ' 59' ' ' LYS . 1.3 Cg_endo -42.96 114.75 0.47 Allowed 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 123.629 2.886 . . . . 1.54 115.247 -178.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -146.68 170.53 16.76 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 113.357 -1.747 . . . . 1.59 108.19 177.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 71.07 -168.54 50.28 Favored Glycine 0 CA--C 1.494 -1.264 0 C-N-CA 118.704 -1.713 . . . . 2.43 113.63 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 14.4 p -83.29 44.46 0.95 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.015 -0.593 . . . . 4.11 111.692 -178.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 118.26 9.61 9.43 Favored Glycine 0 C--N 1.334 0.455 0 N-CA-C 115.222 0.849 . . . . 2.21 115.222 177.087 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.673 ' HA3' ' HA ' ' A' ' 75' ' ' SER . . . -105.16 162.29 14.55 Favored Glycine 0 C--N 1.338 0.642 0 CA-C-N 119.202 1.501 . . . . 1.62 115.178 -178.628 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.1 153.67 21.19 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 108.524 -0.917 . . . . 3.02 108.524 177.068 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.543 ' HA ' ' HA ' ' A' ' 73' ' ' CYS . 50.5 t -58.7 115.57 3.15 Favored 'General case' 0 N--CA 1.426 -1.669 0 N-CA-C 109.217 -0.66 . . . . 1.52 109.217 -179.403 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 1.011 ' HB1' ' SG ' ' A' ' 28' ' ' CYS . . . -62.88 -48.37 79.3 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 106.875 -1.528 . . . . 1.07 106.875 178.844 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.719 ' CB ' ' HA2' ' A' ' 33' ' ' GLY . . . -167.8 163.92 14.15 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 112.9 -1.954 . . . . 1.0 110.736 -174.586 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 1.073 ' HA ' ' HB3' ' A' ' 85' ' ' CYS . . . -43.96 130.61 5.85 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.428 0.632 . . . . 1.24 112.298 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.727 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . 80.23 -26.09 3.04 Favored Glycine 0 CA--C 1.522 0.481 0 CA-C-N 115.006 -0.997 . . . . 1.28 115.059 177.736 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.629 ' CD1' ' HB2' ' A' ' 34' ' ' CYS . 1.2 pp -129.25 116.59 40.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 122.319 1.057 . . . . 2.27 111.021 -179.149 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.543 ' HA ' ' HA ' ' A' ' 67' ' ' CYS . 1.6 t -106.13 112.45 25.48 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.175 -1.375 . . . . 1.98 110.578 -177.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.715 ' HB2' ' HB2' ' A' ' 68' ' ' ALA . 3.7 m -84.45 147.85 26.88 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 121.94 0.876 . . . . 1.33 112.752 -177.718 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.847 ' HB2' ' HD2' ' A' ' 76' ' ' PRO . 12.1 p -122.64 -179.9 0.88 Allowed Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 114.031 -1.44 . . . . 1.99 108.106 178.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.847 ' HD2' ' HB2' ' A' ' 75' ' ' SER . 57.0 Cg_endo -73.73 29.93 0.32 Allowed 'Trans proline' 0 N--CA 1.459 -0.516 0 CA-C-N 119.895 0.998 . . . . 1.86 111.59 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.504 ' H ' ' C ' ' A' ' 75' ' ' SER . 2.5 p30 -145.89 -48.93 0.22 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.607 -0.724 . . . . 2.65 110.63 179.053 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 1.083 ' HA3' ' O ' ' B' ' 179' ' ' CYS . . . -156.3 -140.8 3.05 Favored Glycine 0 C--N 1.336 0.547 0 C-N-CA 120.398 -0.906 . . . . 0.99 113.843 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 1.061 ' O ' ' HA3' ' B' ' 178' ' ' GLY . 0.0 OUTLIER -142.73 153.2 43.11 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.329 -0.436 . . . . 1.34 110.556 -179.826 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 4.2 p-80 -154.36 160.36 41.66 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.096 -0.642 . . . . 2.17 112.008 -178.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.601 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -60.25 140.53 56.98 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.874 -0.603 . . . . 3.05 110.32 179.867 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.492 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 3.7 p-10 -139.75 140.29 24.31 Favored Pre-proline 0 CA--C 1.541 0.598 0 CA-C-N 116.018 -0.537 . . . . 2.02 110.763 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.492 ' HD3' ' HA ' ' A' ' 82' ' ' ASP . 3.2 Cg_exo -77.26 -24.97 8.93 Favored 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 123.159 2.572 . . . . 1.93 114.196 -177.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.37 -43.93 84.57 Favored 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 107.781 -1.192 . . . . 1.53 107.781 178.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 1.073 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 33.2 m -99.95 73.73 1.77 Allowed 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 114.082 -1.417 . . . . 1.88 109.033 177.533 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.312 -1.052 0 CA-C-N 115.558 -0.746 . . . . 3.6 112.01 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 110' ' ' CYS . . . . . 0.532 ' O ' ' C ' ' B' ' 111' ' ' LEU . 7.4 m . . . . . 0 N--CA 1.45 -0.445 0 N-CA-C 115.587 1.699 . . . . 2.61 115.587 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 111' ' ' LEU . . . . . 0.575 ' O ' ' HA ' ' B' ' 120' ' ' ARG . 0.0 OUTLIER -31.63 110.34 0.3 Allowed Pre-proline 0 N--CA 1.472 0.668 0 CA-C-N 118.614 0.643 . . . . 2.47 109.821 178.761 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 112' ' ' PRO . . . . . 0.646 ' HA ' ' O ' ' B' ' 119' ' ' GLY . 74.1 Cg_endo -82.3 158.97 17.45 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 124.482 3.455 . . . . 1.47 111.307 -179.56 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.499 ' HA ' ' HD2' ' B' ' 143' ' ' ARG . 3.2 p -155.93 -168.71 2.85 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 120.427 -1.421 . . . . 1.0 109.351 166.383 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 114' ' ' GLY . . . . . 0.465 ' HA2' ' HG2' ' B' ' 140' ' ' GLU . . . 64.71 -158.85 43.41 Favored Glycine 0 C--N 1.34 0.752 0 C-N-CA 121.007 -0.616 . . . . 1.16 113.482 176.264 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 115' ' ' PRO . . . . . 0.51 ' O ' ' N ' ' B' ' 117' ' ' GLY . 56.4 Cg_endo -62.01 143.73 95.47 Favored 'Trans proline' 0 CA--C 1.503 -1.031 0 C-N-CA 122.801 2.334 . . . . 1.57 106.962 176.161 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 116' ' ' GLY . . . . . 0.425 ' HA3' ' HE3' ' B' ' 118' ' ' LYS . . . 50.0 -4.64 0.01 OUTLIER Glycine 0 N--CA 1.416 -2.662 0 N-CA-C 115.209 0.843 . . . . 1.7 115.209 177.556 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 117' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' B' ' 115' ' ' PRO . . . 68.18 39.88 88.15 Favored Glycine 1 N--CA 1.394 -4.1 0 C-N-CA 117.102 -2.475 . . . . 1.38 109.623 -178.612 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 118' ' ' LYS . . . . . 0.425 ' HE3' ' HA3' ' B' ' 116' ' ' GLY . 1.6 mmtp -91.99 -13.87 30.35 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 112.318 -1.941 . . . . 2.54 112.949 -178.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 119' ' ' GLY . . . . . 0.646 ' O ' ' HA ' ' B' ' 112' ' ' PRO . . . -113.57 -171.2 17.64 Favored Glycine 0 CA--C 1.5 -0.847 0 N-CA-C 108.324 -1.91 . . . . 1.04 108.324 178.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.575 ' HA ' ' O ' ' B' ' 111' ' ' LEU . 0.4 OUTLIER -136.77 169.74 17.23 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 121.845 2.823 . . . . 2.89 108.625 178.328 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 121' ' ' CYS . . . . . 0.457 ' SG ' ' O ' ' B' ' 123' ' ' GLY . 19.5 t -114.63 151.87 32.81 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.337 0.495 . . . . 1.07 112.337 -178.306 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -131.95 -49.66 0.95 Allowed 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 108.696 -0.853 . . . . 1.53 108.696 176.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 123' ' ' GLY . . . . . 0.457 ' O ' ' SG ' ' B' ' 121' ' ' CYS . . . -99.23 -154.84 28.59 Favored Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 109.115 -1.594 . . . . 0.9 109.115 176.327 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -94.19 -60.66 0.01 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.958 0 CA-C-N 119.816 1.808 . . . . 1.51 112.151 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 125' ' ' SER . . . . . 0.644 ' O ' ' N ' ' B' ' 137' ' ' GLY . 0.6 OUTLIER -90.65 9.89 27.94 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 110.266 -0.272 . . . . 1.25 110.266 179.031 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 126' ' ' ILE . . . . . 0.804 HG22 ' SG ' ' B' ' 134' ' ' CYS . 1.8 mt -119.98 117.87 55.07 Favored 'Isoleucine or valine' 0 C--O 1.244 0.802 0 CA-C-O 121.962 0.887 . . . . 0.85 112.566 -177.641 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 127' ' ' CYS . . . . . 0.747 ' O ' ' HA ' ' B' ' 134' ' ' CYS . 0.7 OUTLIER -134.91 130.69 36.29 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-N 114.313 -1.312 . . . . 0.89 110.643 -179.641 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 128' ' ' CYS . . . . . 1.084 ' HA ' ' O ' ' B' ' 133' ' ' GLY . 0.0 OUTLIER -130.96 173.58 10.85 Favored 'General case' 0 CA--C 1.56 1.33 0 CA-C-O 122.814 1.292 . . . . 1.23 114.327 -178.069 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 129' ' ' GLY . . . . . 0.518 ' O ' ' HB1' ' B' ' 169' ' ' ALA . . . -157.32 176.47 34.49 Favored Glycine 0 N--CA 1.427 -1.936 0 CA-C-N 111.643 -2.526 . . . . 0.66 109.045 177.422 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -62.01 -54.83 36.04 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 109.198 -0.667 . . . . 2.35 109.198 179.166 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -122.12 29.71 6.91 Favored 'General case' 0 N--CA 1.428 -1.539 0 N-CA-C 108.191 -1.04 . . . . 1.69 108.191 178.421 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 132' ' ' LEU . . . . . 0.662 HD22 ' CZ ' ' B' ' 135' ' ' PHE . 0.5 OUTLIER -121.09 -3.42 9.57 Favored 'General case' 0 N--CA 1.41 -2.451 0 N-CA-C 104.428 -2.434 . . . . 1.38 104.428 179.103 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 133' ' ' GLY . . . . . 1.084 ' O ' ' HA ' ' B' ' 128' ' ' CYS . . . 42.36 -141.01 1.84 Allowed Glycine 0 N--CA 1.401 -3.664 0 CA-C-N 112.531 -2.122 . . . . 0.72 112.519 176.358 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 134' ' ' CYS . . . . . 0.804 ' SG ' HG22 ' B' ' 126' ' ' ILE . 0.5 OUTLIER -136.75 122.08 19.34 Favored 'General case' 0 CA--C 1.493 -1.23 0 CA-C-N 118.802 1.301 . . . . 1.08 113.629 -178.515 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 135' ' ' PHE . . . . . 0.978 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -88.08 106.35 18.1 Favored 'General case' 0 N--CA 1.422 -1.829 0 N-CA-C 104.326 -2.472 . . . . 1.36 104.326 175.858 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 136' ' ' VAL . . . . . 0.912 HG23 HG23 ' A' ' 36' ' ' VAL . 1.8 t -95.62 83.69 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 N-CA-C 107.725 -1.213 . . . . 0.75 107.725 -179.278 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 137' ' ' GLY . . . . . 0.756 ' O ' ' HA3' ' A' ' 33' ' ' GLY . . . 102.53 93.03 2.23 Favored Glycine 0 CA--C 1.531 1.055 0 CA-C-N 113.071 -1.877 . . . . 0.83 114.283 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 138' ' ' THR . . . . . 0.466 HG21 ' HB3' ' B' ' 135' ' ' PHE . 0.0 OUTLIER 178.44 169.19 0.82 Allowed 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 108.623 -0.88 . . . . 0.78 108.623 178.576 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 139' ' ' ALA . . . . . 0.775 ' CB ' HD22 ' B' ' 142' ' ' LEU . . . -63.77 -15.33 58.4 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 119.616 1.098 . . . . 1.04 111.373 178.623 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 140' ' ' GLU . . . . . 0.677 ' HB3' ' CD2' ' B' ' 135' ' ' PHE . 5.0 mt-10 -65.24 -15.87 62.94 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.498 -0.556 . . . . 2.31 109.498 178.343 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 141' ' ' ALA . . . . . 0.659 ' O ' ' HB3' ' B' ' 144' ' ' CYS . . . -122.78 -11.0 8.23 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.995 -0.548 . . . . 0.87 111.695 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 142' ' ' LEU . . . . . 0.775 HD22 ' CB ' ' B' ' 139' ' ' ALA . 0.0 OUTLIER -69.22 -37.02 77.85 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.382 -0.97 . . . . 1.24 108.382 -178.681 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 143' ' ' ARG . . . . . 0.499 ' HD2' ' HA ' ' B' ' 113' ' ' CYS . 1.1 ptp180 -64.91 -2.29 2.54 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 114.583 -1.189 . . . . 2.93 109.753 178.132 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 144' ' ' CYS . . . . . 0.659 ' HB3' ' O ' ' B' ' 141' ' ' ALA . 10.3 t -83.4 9.26 11.45 Favored 'General case' 0 N--CA 1.443 -0.786 0 O-C-N 121.556 -0.715 . . . . 1.61 109.125 176.604 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -71.17 -18.65 62.48 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.598 -0.728 . . . . 3.35 109.711 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.41 5.73 33.61 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 119.234 -0.986 . . . . 3.76 110.035 179.24 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 . . . . . 0 N--CA 1.448 -0.533 0 CA-C-N 115.781 -0.645 . . . . 4.01 109.51 177.605 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.465 0.297 0 N-CA-C 110.126 -0.324 . . . . 3.11 110.126 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 64.95 57.13 12.75 Favored Glycine 0 N--CA 1.426 -1.972 0 C-N-CA 120.245 -0.979 . . . . 2.07 112.164 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 158' ' ' GLN . . . . . 0.418 ' C ' ' HD2' ' B' ' 160' ' ' PRO . 12.8 tt0 -120.29 59.83 0.89 Allowed 'General case' 0 N--CA 1.435 -1.19 0 C-N-CA 117.228 -1.789 . . . . 4.34 108.604 176.511 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 159' ' ' LYS . . . . . 0.615 ' HB2' ' HB3' ' B' ' 167' ' ' CYS . 2.6 mmpp? -118.2 39.23 0.29 Allowed Pre-proline 0 C--N 1.314 -0.943 0 CA-C-N 112.346 -2.206 . . . . 3.54 111.731 171.802 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 160' ' ' PRO . . . . . 0.454 ' CD ' ' N ' ' B' ' 159' ' ' LYS . 2.3 Cg_endo -41.17 117.21 0.53 Allowed 'Trans proline' 0 C--N 1.34 0.109 0 C-N-CA 122.306 2.004 . . . . 1.51 115.621 -173.06 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 161' ' ' CYS . . . . . 0.466 ' SG ' ' N ' ' B' ' 162' ' ' GLY . 0.1 OUTLIER -138.73 -170.58 2.88 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 113.198 -1.819 . . . . 1.58 108.715 -179.803 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 162' ' ' GLY . . . . . 0.466 ' N ' ' SG ' ' B' ' 161' ' ' CYS . . . 47.9 -166.03 0.17 Allowed Glycine 0 CA--C 1.528 0.864 0 C-N-CA 119.064 -1.541 . . . . 2.37 114.9 171.612 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 13.8 p -82.35 44.24 0.86 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 114.981 -0.61 . . . . 4.07 112.216 -178.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 119.33 8.93 8.97 Favored Glycine 0 C--N 1.338 0.64 0 N-CA-C 115.15 0.82 . . . . 2.2 115.15 177.248 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 165' ' ' GLY . . . . . 0.651 ' HA3' ' HA ' ' B' ' 175' ' ' SER . . . -103.61 160.69 16.28 Favored Glycine 0 CA--C 1.521 0.425 0 C-N-CA 119.551 -1.309 . . . . 1.62 115.684 -178.072 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 166' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.73 153.23 22.14 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 108.342 -0.985 . . . . 3.05 108.342 176.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 167' ' ' CYS . . . . . 0.615 ' HB3' ' HB2' ' B' ' 159' ' ' LYS . 47.5 t -58.31 115.53 3.02 Favored 'General case' 0 N--CA 1.426 -1.629 0 N-CA-C 109.345 -0.613 . . . . 1.56 109.345 -179.293 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 168' ' ' ALA . . . . . 0.978 ' HB1' ' SG ' ' B' ' 128' ' ' CYS . . . -63.26 -47.3 82.97 Favored 'General case' 0 N--CA 1.428 -1.546 0 N-CA-C 107.263 -1.384 . . . . 1.04 107.263 178.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 169' ' ' ALA . . . . . 0.811 ' CB ' ' HA2' ' B' ' 133' ' ' GLY . . . -169.01 164.25 11.39 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.189 -1.369 . . . . 0.98 108.967 -175.034 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 170' ' ' ALA . . . . . 1.003 ' HA ' ' HB3' ' B' ' 185' ' ' CYS . . . -44.07 130.71 6.02 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.469 0.652 . . . . 1.25 112.691 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 171' ' ' GLY . . . . . 0.735 ' N ' ' O ' ' B' ' 185' ' ' CYS . . . 78.4 -21.04 3.78 Favored Glycine 0 CA--C 1.521 0.458 0 CA-C-N 114.845 -1.071 . . . . 1.29 115.511 177.546 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 172' ' ' ILE . . . . . 0.631 ' CD1' ' HB2' ' B' ' 134' ' ' CYS . 1.2 pp -132.43 116.24 27.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 122.408 1.099 . . . . 2.27 110.747 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 173' ' ' CYS . . . . . 0.553 ' HA ' ' H ' ' B' ' 168' ' ' ALA . 1.5 t -106.5 112.5 25.53 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.083 -1.417 . . . . 1.94 110.686 -177.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 174' ' ' CYS . . . . . 0.702 ' HA ' ' HA ' ' B' ' 179' ' ' CYS . 4.4 m -84.29 148.0 26.91 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.903 0.859 . . . . 1.35 112.838 -177.731 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 175' ' ' SER . . . . . 0.832 ' HB2' ' HD2' ' B' ' 176' ' ' PRO . 11.6 p -122.68 -179.89 0.88 Allowed Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 114.057 -1.429 . . . . 2.0 107.998 178.807 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 176' ' ' PRO . . . . . 0.832 ' HD2' ' HB2' ' B' ' 175' ' ' SER . 57.3 Cg_endo -73.71 29.92 0.32 Allowed 'Trans proline' 0 N--CA 1.46 -0.482 0 CA-C-N 119.797 0.963 . . . . 1.9 111.681 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 177' ' ' ASP . . . . . 0.505 ' H ' ' C ' ' B' ' 175' ' ' SER . 2.5 p30 -145.78 -49.41 0.22 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.63 -0.713 . . . . 2.72 110.585 179.133 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 178' ' ' GLY . . . . . 1.061 ' HA3' ' O ' ' A' ' 79' ' ' CYS . . . -155.77 -140.69 3.04 Favored Glycine 0 C--N 1.338 0.652 0 C-N-CA 120.492 -0.861 . . . . 0.99 113.886 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 179' ' ' CYS . . . . . 1.083 ' O ' ' HA3' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -142.94 153.04 42.66 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-N 115.281 -0.46 . . . . 1.34 110.511 -179.892 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 180' ' ' HIS . . . . . . . . . . . . . 4.2 p-80 -154.11 160.39 41.92 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.098 -0.641 . . . . 2.1 111.975 -178.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 181' ' ' GLU . . . . . 0.586 ' HA ' ' O ' ' B' ' 171' ' ' GLY . 0.0 OUTLIER -60.23 140.48 56.99 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.844 -0.616 . . . . 3.06 110.307 179.828 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 182' ' ' ASP . . . . . 0.457 ' HB3' ' HB3' ' B' ' 173' ' ' CYS . 3.7 p-10 -139.69 140.28 24.46 Favored Pre-proline 0 CA--C 1.541 0.627 0 CA-C-N 116.01 -0.541 . . . . 2.06 110.759 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 183' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' B' ' 182' ' ' ASP . 3.4 Cg_exo -77.09 -25.17 8.98 Favored 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 123.236 2.624 . . . . 1.91 114.252 -177.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -66.23 -43.88 85.37 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 107.808 -1.182 . . . . 1.56 107.808 178.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 185' ' ' CYS . . . . . 1.003 ' HB3' ' HA ' ' B' ' 170' ' ' ALA . 33.2 m -100.05 73.44 1.73 Allowed 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 114.037 -1.438 . . . . 1.94 109.067 177.579 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 186' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.311 -1.095 0 CA-C-N 115.666 -0.697 . . . . 3.61 111.92 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.606 ' HB3' ' HD3' ' A' ' 20' ' ' ARG . 1.0 OUTLIER . . . . . 0 N--CA 1.447 -0.592 0 N-CA-C 111.689 0.255 . . . . 2.68 111.689 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.742 ' H ' HD22 ' A' ' 11' ' ' LEU . 3.4 mm? -30.68 111.08 0.28 Allowed Pre-proline 0 N--CA 1.472 0.673 0 N-CA-C 112.976 0.732 . . . . 2.48 112.976 -178.602 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.842 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 72.9 Cg_endo -73.96 153.44 47.31 Favored 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 123.087 2.525 . . . . 1.49 111.518 179.06 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.626 ' O ' ' HA2' ' A' ' 17' ' ' GLY . 16.1 p -160.7 -167.33 1.83 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 119.134 -1.027 . . . . 1.0 111.266 174.503 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 1.033 ' HA2' ' HB3' ' A' ' 40' ' ' GLU . . . 76.0 -160.38 51.39 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 120.241 -0.981 . . . . 1.15 114.761 177.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.573 ' HD2' ' CZ ' ' A' ' 35' ' ' PHE . 43.5 Cg_endo -64.94 99.07 0.32 Allowed 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 124.198 3.265 . . . . 1.57 113.328 178.498 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.62 -4.37 84.68 Favored Glycine 0 C--N 1.265 -3.363 0 CA-C-N 112.801 -1.999 . . . . 1.68 111.975 -176.37 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.626 ' HA2' ' O ' ' A' ' 13' ' ' CYS . . . 71.03 42.52 59.03 Favored Glycine 0 N--CA 1.432 -1.621 0 C-N-CA 118.31 -1.9 . . . . 1.36 113.19 174.685 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.98 -33.97 18.22 Favored 'General case' 0 C--N 1.359 1.021 0 CA-C-N 112.922 -1.639 . . . . 2.5 111.329 -178.697 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.842 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -77.55 -167.37 28.89 Favored Glycine 0 N--CA 1.468 0.795 0 C-N-CA 128.194 2.807 . . . . 1.02 111.165 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.729 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -130.74 173.76 10.6 Favored 'General case' 0 CA--C 1.553 1.089 0 N-CA-C 105.268 -2.123 . . . . 2.92 105.268 174.375 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.1 m -105.7 141.62 36.82 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 119.534 1.061 . . . . 1.1 111.395 -178.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -124.48 -48.2 1.82 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.765 -0.652 . . . . 1.51 110.549 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.533 ' HA3' HD12 ' A' ' 26' ' ' ILE . . . -128.94 -177.81 15.06 Favored Glycine 0 C--N 1.33 0.248 0 N-CA-C 111.322 -0.711 . . . . 0.9 111.322 179.313 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo -64.79 -71.02 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 121.969 1.779 . . . . 1.5 111.219 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.585 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.6 OUTLIER -89.8 41.53 1.05 Allowed 'General case' 0 CA--C 1.521 -0.145 0 N-CA-C 108.788 -0.819 . . . . 1.26 108.788 177.759 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.858 HG23 HG13 ' A' ' 36' ' ' VAL . 2.0 mt -144.92 111.59 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.908 0 CA-C-N 116.079 -0.51 . . . . 0.83 112.184 -177.556 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.692 ' SG ' ' HA ' ' A' ' 41' ' ' ALA . 0.8 OUTLIER -120.82 130.98 54.19 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 109.574 -0.528 . . . . 0.92 109.574 179.585 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.794 ' SG ' ' HB1' ' A' ' 68' ' ' ALA . 1.6 m -123.84 171.51 9.61 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 117.365 -1.734 . . . . 1.28 114.41 -177.673 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.571 ' HA3' ' HB2' ' A' ' 32' ' ' LEU . . . -146.85 174.86 26.53 Favored Glycine 0 N--CA 1.415 -2.714 0 N-CA-C 109.405 -1.478 . . . . 0.67 109.405 173.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -65.01 -58.51 5.92 Favored 'General case' 0 N--CA 1.422 -1.829 0 N-CA-C 104.424 -2.436 . . . . 2.27 104.424 177.14 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -115.07 22.11 13.66 Favored 'General case' 0 CA--C 1.478 -1.809 0 CA-C-N 114.246 -1.343 . . . . 1.66 108.689 -175.225 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.773 HD22 ' CE1' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -109.92 -17.8 13.54 Favored 'General case' 0 N--CA 1.408 -2.563 0 N-CA-C 105.987 -1.857 . . . . 1.37 105.987 177.793 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.892 ' HA2' ' CB ' ' A' ' 69' ' ' ALA . . . 63.6 -135.83 41.72 Favored Glycine 0 N--CA 1.403 -3.524 0 CA-C-N 113.635 -1.62 . . . . 0.73 110.797 -179.152 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.832 ' SG ' HG22 ' A' ' 26' ' ' ILE . 0.7 OUTLIER -143.27 122.1 12.68 Favored 'General case' 0 CA--C 1.479 -1.767 0 CA-C-N 119.13 1.465 . . . . 1.08 113.582 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 1.133 ' HA ' ' HA ' ' B' ' 135' ' ' PHE . 0.0 OUTLIER -88.84 105.34 17.67 Favored 'General case' 0 N--CA 1.411 -2.419 0 N-CA-C 103.945 -2.613 . . . . 1.38 103.945 176.13 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.858 HG13 HG23 ' A' ' 26' ' ' ILE . 1.6 t -96.7 85.67 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.863 0 N-CA-C 107.579 -1.267 . . . . 0.76 107.579 -179.496 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.878 ' HA3' HG12 ' B' ' 172' ' ' ILE . . . 122.03 12.99 5.11 Favored Glycine 0 C--N 1.32 -0.36 0 CA-C-N 113.738 -1.573 . . . . 0.81 115.898 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.697 HG22 ' O ' ' B' ' 132' ' ' LEU . 47.4 p -94.89 164.47 12.9 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 118.496 1.148 . . . . 0.77 110.195 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.641 ' HA ' HD12 ' A' ' 42' ' ' LEU . . . -61.2 -34.82 75.7 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.184 0.516 . . . . 1.02 109.811 179.206 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 1.033 ' HB3' ' HA2' ' A' ' 14' ' ' GLY . 0.6 OUTLIER -59.83 -14.63 15.9 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.912 -0.586 . . . . 2.32 111.537 -179.397 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.831 ' O ' ' HB2' ' A' ' 44' ' ' CYS . . . -91.95 -26.77 18.26 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 116.285 -0.416 . . . . 0.87 109.982 179.241 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.641 HD12 ' HA ' ' A' ' 39' ' ' ALA . 9.1 mt -48.21 -36.58 14.03 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 112.505 0.558 . . . . 1.23 112.505 -179.111 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.586 ' C ' ' H ' ' A' ' 45' ' ' GLN . 0.0 OUTLIER -54.91 -28.19 48.8 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 107.502 -1.296 . . . . 2.92 107.502 177.417 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.831 ' HB2' ' O ' ' A' ' 41' ' ' ALA . 1.2 m -54.97 4.01 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 114.435 -1.257 . . . . 1.57 111.18 -176.035 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.586 ' H ' ' C ' ' A' ' 43' ' ' ARG . 17.3 tt0 -72.48 -31.92 65.78 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.212 0.53 . . . . 3.31 110.951 177.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -86.3 6.78 28.19 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.995 0.426 . . . . 3.69 110.685 -179.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 25.0 tp10 . . . . . 0 N--CA 1.444 -0.769 0 N-CA-C 109.078 -0.712 . . . . 3.99 109.078 177.521 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 12.2 t . . . . . 0 CA--C 1.534 0.333 0 N-CA-C 109.071 -0.714 . . . . 3.12 109.071 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 112.97 -107.22 1.95 Allowed Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.555 -0.831 . . . . 2.1 112.652 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.69 87.05 2.67 Favored 'General case' 0 CA--C 1.476 -1.877 0 N-CA-C 102.944 -2.984 . . . . 4.36 102.944 176.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.863 ' CA ' ' H ' ' A' ' 67' ' ' CYS . 15.4 mmtt -137.32 -57.37 0.02 OUTLIER Pre-proline 0 C--N 1.296 -1.76 0 C-N-CA 118.629 -1.228 . . . . 3.55 112.05 -173.673 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.674 ' HD2' ' H ' ' A' ' 59' ' ' LYS . 9.4 Cg_endo -51.94 98.08 0.04 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.121 0 CA-C-N 120.709 1.289 . . . . 1.54 113.703 -179.521 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.417 ' SG ' ' N ' ' A' ' 62' ' ' GLY . 0.1 OUTLIER -140.98 -173.77 3.81 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 105.832 -1.914 . . . . 1.59 105.832 178.776 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.434 ' HA3' ' CE1' ' A' ' 80' ' ' HIS . . . 61.91 -165.18 20.73 Favored Glycine 0 C--N 1.316 -0.577 0 C-N-CA 117.454 -2.308 . . . . 2.43 112.548 176.144 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.4 m -84.39 42.46 0.89 Allowed 'General case' 0 N--CA 1.479 1.0 0 CA-C-O 122.204 1.002 . . . . 4.11 111.575 -176.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 115.78 5.84 17.64 Favored Glycine 0 CA--C 1.535 1.292 0 CA-C-N 113.89 -1.505 . . . . 2.21 114.937 178.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.666 ' CA ' ' HA ' ' A' ' 75' ' ' SER . . . -101.13 153.37 19.05 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 119.132 -1.508 . . . . 1.62 116.481 -174.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.804 ' CB ' ' HB3' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -85.24 152.26 23.45 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 114.354 -0.923 . . . . 3.02 109.553 179.364 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.863 ' H ' ' CA ' ' A' ' 59' ' ' LYS . 0.1 OUTLIER -70.13 107.83 3.84 Favored 'General case' 0 N--CA 1.42 -1.94 0 CA-C-N 119.643 1.11 . . . . 1.52 109.798 -178.767 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.846 ' HB3' HD12 ' A' ' 72' ' ' ILE . . . -67.02 -32.05 73.0 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 115.235 -0.893 . . . . 1.07 109.78 179.176 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.892 ' CB ' ' HA2' ' A' ' 33' ' ' GLY . . . -170.66 164.54 8.2 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.464 -1.244 . . . . 1.0 110.917 -177.423 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 1.044 ' HA ' ' HB3' ' A' ' 85' ' ' CYS . . . -66.91 70.76 0.08 Allowed 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.264 -0.574 . . . . 1.24 111.985 178.554 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.608 ' HA2' ' O ' ' A' ' 85' ' ' CYS . . . 164.99 -42.33 0.29 Allowed Glycine 0 CA--C 1.52 0.369 0 CA-C-N 115.818 -0.628 . . . . 1.28 114.227 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.885 HG12 ' HA3' ' B' ' 137' ' ' GLY . 1.3 pp -120.76 121.52 65.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.191 0.52 . . . . 2.27 111.037 -178.006 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.596 ' HB2' ' HB3' ' A' ' 82' ' ' ASP . 0.1 OUTLIER -95.58 111.72 23.58 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.635 -0.711 . . . . 1.98 109.825 -179.888 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.622 ' HB2' ' HB2' ' A' ' 68' ' ' ALA . 1.3 m -84.74 117.3 23.74 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.382 0.61 . . . . 1.33 112.378 -178.313 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.666 ' HA ' ' CA ' ' A' ' 65' ' ' GLY . 29.6 p -92.66 -179.67 1.12 Allowed Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 114.909 -1.041 . . . . 1.99 109.162 178.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.626 ' CD ' ' HB2' ' A' ' 75' ' ' SER . 4.2 Cg_exo -74.6 29.62 0.35 Allowed 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 121.7 1.6 . . . . 1.86 111.691 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.461 ' H ' ' C ' ' A' ' 75' ' ' SER . 2.4 p30 -145.65 -37.94 0.26 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.704 -0.68 . . . . 2.65 110.825 179.24 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.791 ' HA3' ' O ' ' B' ' 179' ' ' CYS . . . -170.0 -133.56 1.61 Allowed Glycine 0 C--N 1.339 0.702 0 C-N-CA 120.617 -0.801 . . . . 0.99 113.38 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.825 ' O ' ' HA3' ' B' ' 178' ' ' GLY . 0.0 OUTLIER -146.27 150.93 36.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.126 0.489 . . . . 1.34 110.831 -179.62 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.434 ' CE1' ' HA3' ' A' ' 62' ' ' GLY . 50.2 p-80 -154.25 160.48 41.83 Favored 'General case' 0 C--N 1.331 -0.236 0 O-C-N 122.03 -0.419 . . . . 2.17 111.56 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.556 ' OE2' ' HG2' ' B' ' 124' ' ' PRO . 1.5 mt-10 -59.7 140.75 56.21 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.281 -0.418 . . . . 3.05 110.228 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.596 ' HB3' ' HB2' ' A' ' 73' ' ' CYS . 7.9 p-10 -145.08 140.59 16.28 Favored Pre-proline 0 CA--C 1.535 0.385 0 CA-C-N 116.487 -0.324 . . . . 2.02 111.599 -179.097 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 82' ' ' ASP . 3.4 Cg_exo -77.58 -14.5 15.95 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 123.243 2.629 . . . . 1.93 113.665 -179.08 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.3 -46.58 60.4 Favored 'General case' 0 CA--C 1.504 -0.826 0 N-CA-C 107.158 -1.423 . . . . 1.53 107.158 178.204 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 1.044 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 97.7 m -106.84 84.76 2.04 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 113.559 -1.655 . . . . 1.88 107.493 176.716 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.445 ' HB2' ' O ' ' A' ' 82' ' ' ASP . 1.2 t70 . . . . . 0 C--N 1.316 -0.856 0 CA-C-N 113.857 -1.52 . . . . 3.6 113.619 -177.179 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 110' ' ' CYS . . . . . 0.583 ' HB3' ' HD3' ' B' ' 120' ' ' ARG . 0.9 OUTLIER . . . . . 0 N--CA 1.446 -0.632 0 N-CA-C 111.441 0.163 . . . . 2.61 111.441 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 111' ' ' LEU . . . . . 0.738 ' H ' HD22 ' B' ' 111' ' ' LEU . 3.4 mm? -30.92 111.48 0.29 Allowed Pre-proline 0 N--CA 1.471 0.614 0 N-CA-C 112.923 0.712 . . . . 2.47 112.923 -178.758 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 112' ' ' PRO . . . . . 0.89 ' HA ' ' O ' ' B' ' 119' ' ' GLY . 89.6 Cg_endo -81.53 144.66 14.32 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.119 1.879 . . . . 1.47 114.183 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.593 ' O ' ' HA2' ' B' ' 117' ' ' GLY . 18.0 p -150.57 -165.0 2.15 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 118.633 -1.227 . . . . 1.0 111.479 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 114' ' ' GLY . . . . . 1.073 ' HA2' ' HB3' ' B' ' 140' ' ' GLU . . . 76.24 -160.81 51.42 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 120.449 -0.881 . . . . 1.16 115.192 177.354 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 115' ' ' PRO . . . . . 0.548 ' HD2' ' CZ ' ' B' ' 135' ' ' PHE . 43.4 Cg_endo -63.5 114.76 2.66 Favored 'Trans proline' 0 C--N 1.366 1.478 0 C-N-CA 123.922 3.081 . . . . 1.57 106.945 176.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 77.62 -14.99 8.19 Favored Glycine 0 C--N 1.261 -3.624 0 C-N-CA 123.98 0.8 . . . . 1.7 111.193 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 117' ' ' GLY . . . . . 0.593 ' HA2' ' O ' ' B' ' 113' ' ' CYS . . . 75.12 43.01 27.55 Favored Glycine 0 N--CA 1.413 -2.893 0 C-N-CA 117.767 -2.159 . . . . 1.38 110.909 179.223 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.38 -27.92 17.22 Favored 'General case' 0 C--N 1.355 0.833 0 CA-C-N 112.269 -1.965 . . . . 2.54 113.345 -179.13 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 119' ' ' GLY . . . . . 0.89 ' O ' ' HA ' ' B' ' 112' ' ' PRO . . . -102.29 -151.82 24.05 Favored Glycine 0 N--CA 1.431 -1.686 0 N-CA-C 108.507 -1.837 . . . . 1.04 108.507 178.673 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.669 ' HA ' ' O ' ' B' ' 111' ' ' LEU . 0.0 OUTLIER -127.32 174.51 8.91 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 118.638 1.219 . . . . 2.89 110.714 -177.872 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 121' ' ' CYS . . . . . . . . . . . . . 1.1 m -105.35 140.69 38.09 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.276 0.56 . . . . 1.07 111.092 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -124.52 -48.13 1.82 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.447 -0.797 . . . . 1.53 110.375 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 123' ' ' GLY . . . . . 0.537 ' HA3' HD12 ' B' ' 126' ' ' ILE . . . -128.94 -177.8 15.05 Favored Glycine 0 C--N 1.33 0.247 0 N-CA-C 111.303 -0.719 . . . . 0.9 111.303 179.321 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 124' ' ' PRO . . . . . 0.556 ' HG2' ' OE2' ' A' ' 81' ' ' GLU . 20.2 Cg_exo -64.84 -70.97 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 121.942 1.761 . . . . 1.51 111.258 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 125' ' ' SER . . . . . 0.591 ' O ' ' N ' ' B' ' 137' ' ' GLY . 0.6 OUTLIER -89.77 41.47 1.04 Allowed 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 108.7 -0.852 . . . . 1.25 108.7 177.808 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 126' ' ' ILE . . . . . 0.841 HG22 ' SG ' ' B' ' 134' ' ' CYS . 2.2 mt -144.71 111.39 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 CA-C-N 116.025 -0.534 . . . . 0.85 112.374 -177.501 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 127' ' ' CYS . . . . . 0.686 ' SG ' ' HA ' ' B' ' 141' ' ' ALA . 0.8 OUTLIER -121.1 130.46 53.76 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 109.436 -0.579 . . . . 0.89 109.436 179.352 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 128' ' ' CYS . . . . . 0.793 ' HA ' ' O ' ' B' ' 133' ' ' GLY . 1.0 OUTLIER -125.48 169.03 12.81 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 114.22 1.193 . . . . 1.23 114.22 -177.084 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 129' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' B' ' 133' ' ' GLY . . . -147.88 176.05 26.9 Favored Glycine 0 N--CA 1.419 -2.444 0 N-CA-C 107.515 -2.234 . . . . 0.66 107.515 175.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -66.55 -55.93 13.16 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 106.681 -1.6 . . . . 2.35 106.681 178.426 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -117.62 31.48 6.69 Favored 'General case' 0 CA--C 1.478 -1.817 0 CA-C-N 113.337 -1.756 . . . . 1.69 109.591 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 132' ' ' LEU . . . . . 0.775 HD22 ' CE1' ' B' ' 135' ' ' PHE . 0.5 OUTLIER -120.99 -14.0 8.51 Favored 'General case' 0 N--CA 1.408 -2.562 0 N-CA-C 104.667 -2.345 . . . . 1.38 104.667 178.239 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 133' ' ' GLY . . . . . 0.876 ' HA2' ' CB ' ' B' ' 169' ' ' ALA . . . 63.08 -132.48 42.85 Favored Glycine 0 N--CA 1.404 -3.476 0 CA-C-N 114.092 -1.413 . . . . 0.72 111.821 177.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 134' ' ' CYS . . . . . 0.841 ' SG ' HG22 ' B' ' 126' ' ' ILE . 1.0 OUTLIER -146.2 121.98 10.57 Favored 'General case' 0 CA--C 1.479 -1.768 0 CA-C-N 119.462 1.631 . . . . 1.08 112.762 178.62 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 135' ' ' PHE . . . . . 1.133 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -88.83 105.78 17.95 Favored 'General case' 0 N--CA 1.409 -2.5 0 N-CA-C 103.959 -2.608 . . . . 1.36 103.959 176.369 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 136' ' ' VAL . . . . . 0.799 HG23 HG23 ' A' ' 36' ' ' VAL . 1.9 t -96.24 85.49 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.781 0 N-CA-C 107.59 -1.263 . . . . 0.75 107.59 -179.447 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 137' ' ' GLY . . . . . 0.885 ' HA3' HG12 ' A' ' 72' ' ' ILE . . . 122.51 12.7 5.0 Favored Glycine 0 C--O 1.227 -0.296 0 CA-C-N 113.993 -1.458 . . . . 0.83 115.874 179.432 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 138' ' ' THR . . . . . 0.713 HG22 ' O ' ' A' ' 32' ' ' LEU . 46.6 p -96.74 160.7 14.23 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 118.521 1.16 . . . . 0.78 110.422 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 139' ' ' ALA . . . . . 0.596 ' HA ' HD12 ' B' ' 142' ' ' LEU . . . -62.37 -23.13 66.63 Favored 'General case' 0 N--CA 1.446 -0.641 0 O-C-N 121.965 -0.459 . . . . 1.04 111.85 -179.338 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 140' ' ' GLU . . . . . 1.073 ' HB3' ' HA2' ' B' ' 114' ' ' GLY . 0.6 OUTLIER -67.45 -14.17 62.69 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.24 0.543 . . . . 2.31 110.781 178.56 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 141' ' ' ALA . . . . . 0.858 ' O ' ' HB2' ' B' ' 144' ' ' CYS . . . -92.74 -26.31 17.81 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 115.562 -0.744 . . . . 0.87 110.304 179.443 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 142' ' ' LEU . . . . . 0.596 HD12 ' HA ' ' B' ' 139' ' ' ALA . 9.8 mt -47.7 -36.64 11.55 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.146 0.424 . . . . 1.24 112.146 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 143' ' ' ARG . . . . . 0.454 ' HD3' ' O ' ' B' ' 140' ' ' GLU . 0.0 OUTLIER -60.72 -17.47 48.51 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 121.965 0.888 . . . . 2.93 109.567 177.661 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 144' ' ' CYS . . . . . 0.858 ' HB2' ' O ' ' B' ' 141' ' ' ALA . 1.2 m -58.21 -3.83 0.3 Allowed 'General case' 0 CA--C 1.552 1.048 0 CA-C-N 113.178 -1.828 . . . . 1.61 110.868 178.345 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 145' ' ' GLN . . . . . 0.425 ' H ' ' C ' ' B' ' 143' ' ' ARG . 16.7 tt0 -67.83 -32.85 73.68 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.233 0.54 . . . . 3.35 111.769 179.341 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -86.35 6.89 27.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.008 0.432 . . . . 3.76 110.701 -179.33 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 24.9 tp10 . . . . . 0 N--CA 1.444 -0.769 0 N-CA-C 109.082 -0.71 . . . . 4.01 109.082 177.451 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 12.1 t . . . . . 0 N--CA 1.453 -0.297 0 N-CA-C 108.925 -0.768 . . . . 3.11 108.925 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 114.04 -108.81 2.1 Favored Glycine 0 C--N 1.336 0.561 0 C-N-CA 120.02 -1.086 . . . . 2.07 112.404 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 158' ' ' GLN . . . . . 0.435 ' O ' ' HB2' ' B' ' 167' ' ' CYS . 0.0 OUTLIER -124.0 71.41 1.12 Allowed 'General case' 0 CA--C 1.486 -1.502 0 N-CA-C 104.669 -2.345 . . . . 4.34 104.669 176.148 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 159' ' ' LYS . . . . . 0.892 ' HA ' ' H ' ' B' ' 167' ' ' CYS . 18.9 mmtt -107.08 -65.77 0.04 OUTLIER Pre-proline 0 N--CA 1.421 -1.899 0 N-CA-C 116.764 2.135 . . . . 3.54 116.764 -177.32 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 160' ' ' PRO . . . . . 0.587 ' HD2' ' H ' ' B' ' 159' ' ' LYS . 9.6 Cg_endo -51.96 96.61 0.04 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.267 0 C-N-CA 122.351 2.034 . . . . 1.51 114.722 -174.111 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 161' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -143.62 179.72 6.96 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 112.922 -1.944 . . . . 1.58 105.838 177.554 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 70.03 -166.21 50.22 Favored Glycine 0 N--CA 1.441 -0.972 0 C-N-CA 117.58 -2.248 . . . . 2.37 111.863 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 2.8 m -83.95 43.55 0.93 Allowed 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 121.869 0.842 . . . . 4.07 111.21 -177.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 112.2 8.54 21.53 Favored Glycine 0 C--N 1.346 1.108 0 CA-C-N 113.961 -1.472 . . . . 2.2 114.775 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 165' ' ' GLY . . . . . 0.667 ' CA ' ' HA ' ' B' ' 175' ' ' SER . . . -103.0 156.12 18.12 Favored Glycine 0 C--N 1.339 0.748 0 CA-C-N 119.916 1.858 . . . . 1.62 116.27 -177.54 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 166' ' ' ARG . . . . . 0.871 ' CB ' ' HB3' ' B' ' 159' ' ' LYS . 0.0 OUTLIER -85.64 152.19 23.3 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 114.309 -0.945 . . . . 3.05 109.324 178.765 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 167' ' ' CYS . . . . . 0.892 ' H ' ' HA ' ' B' ' 159' ' ' LYS . 0.1 OUTLIER -70.32 107.74 3.9 Favored 'General case' 0 N--CA 1.418 -2.042 0 CA-C-N 119.558 1.072 . . . . 1.56 109.656 -178.853 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 168' ' ' ALA . . . . . 0.884 ' HB3' HD12 ' B' ' 172' ' ' ILE . . . -64.39 -36.1 83.04 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 122.238 1.018 . . . . 1.04 108.718 178.678 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 169' ' ' ALA . . . . . 0.876 ' CB ' ' HA2' ' B' ' 133' ' ' GLY . . . -168.57 164.59 12.42 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 113.287 -1.779 . . . . 0.98 112.017 -175.55 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 170' ' ' ALA . . . . . 1.067 ' HA ' ' HB3' ' B' ' 185' ' ' CYS . . . -67.28 71.15 0.11 Allowed 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.127 -0.629 . . . . 1.25 111.93 178.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 171' ' ' GLY . . . . . 0.552 ' HA2' ' O ' ' B' ' 185' ' ' CYS . . . 167.19 -48.83 0.25 Allowed Glycine 0 N--CA 1.455 -0.098 0 CA-C-N 115.525 -0.761 . . . . 1.29 112.74 179.464 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 172' ' ' ILE . . . . . 0.884 HD12 ' HB3' ' B' ' 168' ' ' ALA . 1.3 pp -115.86 121.77 68.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 C-N-CA 123.139 0.576 . . . . 2.27 111.647 -175.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 173' ' ' CYS . . . . . 0.6 ' HB2' ' HB3' ' B' ' 182' ' ' ASP . 0.1 OUTLIER -95.96 111.65 23.59 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.739 -0.664 . . . . 1.94 109.781 -179.918 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 174' ' ' CYS . . . . . 0.576 ' HB2' ' HB2' ' B' ' 168' ' ' ALA . 1.3 m -84.8 117.48 23.88 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.363 0.601 . . . . 1.35 112.359 -178.26 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 175' ' ' SER . . . . . 0.667 ' HA ' ' CA ' ' B' ' 165' ' ' GLY . 28.6 p -92.75 -179.67 1.11 Allowed Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 114.883 -1.053 . . . . 2.0 109.141 179.019 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 176' ' ' PRO . . . . . 0.612 ' CD ' ' HB2' ' B' ' 175' ' ' SER . 4.2 Cg_exo -74.62 29.67 0.35 Allowed 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 121.718 1.612 . . . . 1.9 111.681 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 177' ' ' ASP . . . . . 0.471 ' H ' ' C ' ' B' ' 175' ' ' SER . 2.4 p30 -145.7 -38.17 0.25 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.672 -0.694 . . . . 2.72 110.753 179.289 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 178' ' ' GLY . . . . . 0.825 ' HA3' ' O ' ' A' ' 79' ' ' CYS . . . -169.48 -133.87 1.65 Allowed Glycine 0 C--N 1.338 0.642 0 C-N-CA 120.63 -0.795 . . . . 0.99 113.388 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 179' ' ' CYS . . . . . 0.791 ' O ' ' HA3' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -146.08 151.14 37.23 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.073 0.463 . . . . 1.34 110.808 -179.77 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 180' ' ' HIS . . . . . . . . . . . . . 50.1 p-80 -154.56 160.46 41.52 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.625 -0.43 . . . . 2.1 111.542 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 181' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -59.9 140.52 56.61 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.309 -0.405 . . . . 3.06 110.187 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 182' ' ' ASP . . . . . 0.6 ' HB3' ' HB2' ' B' ' 173' ' ' CYS . 7.9 p-10 -144.81 140.61 16.52 Favored Pre-proline 0 CA--C 1.537 0.455 0 CA-C-N 116.493 -0.321 . . . . 2.06 111.629 -179.126 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 183' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' B' ' 182' ' ' ASP . 3.4 Cg_exo -77.41 -14.71 16.15 Favored 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 123.156 2.57 . . . . 1.91 113.672 -179.095 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -71.25 -46.62 60.6 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 107.134 -1.432 . . . . 1.56 107.134 178.308 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 185' ' ' CYS . . . . . 1.067 ' HB3' ' HA ' ' B' ' 170' ' ' ALA . 87.0 m -106.5 84.53 2.03 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 113.566 -1.652 . . . . 1.94 107.515 176.49 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 186' ' ' ASP . . . . . 0.437 ' HB2' ' O ' ' B' ' 182' ' ' ASP . 1.1 t70 . . . . . 0 CA--C 1.545 0.765 0 CA-C-N 113.782 -1.554 . . . . 3.61 113.835 -177.232 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.59 ' HB3' ' NE ' ' A' ' 20' ' ' ARG . 82.7 m . . . . . 0 N--CA 1.456 -0.138 0 N-CA-C 112.766 0.654 . . . . 2.68 112.766 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.941 HD22 ' HG3' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -35.63 108.46 0.37 Allowed Pre-proline 0 N--CA 1.483 1.221 0 C-N-CA 123.555 0.742 . . . . 2.48 112.389 179.28 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.852 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 43.8 Cg_endo -90.08 138.92 2.97 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.988 2.459 . . . . 1.49 114.044 -179.219 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.502 ' SG ' ' HE2' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -151.43 173.05 15.01 Favored 'General case' 0 C--N 1.351 0.642 0 N-CA-C 106.475 -1.676 . . . . 1.0 106.475 179.014 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.557 ' HA2' ' OE1' ' A' ' 40' ' ' GLU . . . 71.53 -163.26 54.26 Favored Glycine 0 CA--C 1.534 1.243 0 CA-C-N 119.635 1.107 . . . . 1.15 114.445 178.193 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.808 ' HG2' HD11 ' A' ' 32' ' ' LEU . 10.2 Cg_endo -69.68 130.49 19.52 Favored 'Trans proline' 0 C--N 1.369 1.621 0 C-N-CA 124.414 3.409 . . . . 1.57 113.285 179.019 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 70.35 -16.51 0.92 Allowed Glycine 0 C--N 1.284 -2.315 0 CA-C-N 112.492 -2.14 . . . . 1.68 109.575 -176.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.643 ' H ' ' C ' ' A' ' 15' ' ' PRO . . . 77.51 16.75 79.95 Favored Glycine 1 N--CA 1.388 -4.532 0 CA-C-N 113.706 -1.247 . . . . 1.36 113.74 178.285 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.447 ' H ' ' HG2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -74.34 6.97 3.15 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 107.846 -1.168 . . . . 2.5 107.846 174.033 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.852 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -71.45 155.68 52.47 Favored Glycine 0 CA--C 1.486 -1.732 0 N-CA-C 106.441 -2.664 . . . . 1.02 106.441 178.814 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.876 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -148.2 132.71 17.69 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 118.68 1.24 . . . . 2.92 108.955 174.644 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.447 ' O ' HD13 ' A' ' 11' ' ' LEU . 0.5 OUTLIER -103.91 128.12 51.42 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.242 -0.89 . . . . 1.1 112.464 -175.864 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -101.23 -45.25 5.42 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 114.317 -1.311 . . . . 1.51 109.119 178.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -122.05 -132.22 4.06 Favored Glycine 0 CA--C 1.524 0.617 0 CA-C-N 115.415 -0.811 . . . . 0.9 111.892 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -98.1 -72.82 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 123.061 2.507 . . . . 1.5 111.912 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.687 ' O ' HG13 ' A' ' 26' ' ' ILE . 0.9 OUTLIER -89.62 46.97 1.41 Allowed 'General case' 0 C--N 1.333 -0.124 0 N-CA-C 109.301 -0.629 . . . . 1.26 109.301 178.762 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 1.033 HG13 HG13 ' A' ' 36' ' ' VAL . 10.1 mt -151.65 116.97 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.97 0 CA-C-O 121.286 0.565 . . . . 0.83 111.598 -179.059 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.679 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 0.5 OUTLIER -138.77 108.09 6.12 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 107.086 -1.45 . . . . 0.92 107.086 178.865 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.967 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -123.92 130.41 52.55 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 115.276 1.584 . . . . 1.28 115.276 -176.704 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.472 ' O ' ' HB1' ' A' ' 69' ' ' ALA . . . -117.23 179.58 17.43 Favored Glycine 0 C--N 1.354 1.55 0 CA-C-O 122.393 0.996 . . . . 0.67 113.877 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -66.39 -35.98 81.7 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 126.873 2.069 . . . . 2.27 113.471 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.5 0.93 5.02 Favored 'General case' 0 N--CA 1.502 2.163 0 CA-C-O 121.928 0.87 . . . . 1.66 112.969 177.729 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.84 HD22 ' CE1' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -111.37 -11.71 14.11 Favored 'General case' 0 N--CA 1.416 -2.173 0 CA-C-N 113.836 -1.529 . . . . 1.37 111.559 -175.83 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.967 ' O ' ' HA ' ' A' ' 28' ' ' CYS . . . 57.28 -154.51 19.95 Favored Glycine 0 N--CA 1.437 -1.273 0 CA-C-N 115.634 -0.712 . . . . 0.73 113.494 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.998 ' HB2' HD13 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -107.38 123.37 48.27 Favored 'General case' 0 CA--C 1.502 -0.895 0 N-CA-C 114.137 1.162 . . . . 1.08 114.137 179.19 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.84 ' CE1' HD22 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -95.31 101.96 13.73 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 102.053 -3.314 . . . . 1.38 102.053 173.636 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 1.033 HG13 HG13 ' A' ' 26' ' ' ILE . 2.6 t -90.48 85.0 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 CA-C-O 122.859 1.314 . . . . 0.76 109.834 -177.005 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.526 ' O ' ' HA3' ' B' ' 133' ' ' GLY . . . 78.94 78.25 0.85 Allowed Glycine 0 N--CA 1.453 -0.181 0 CA-C-N 112.705 -2.043 . . . . 0.81 111.625 -179.031 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.768 ' CG2' ' HD1' ' B' ' 135' ' ' PHE . 0.8 OUTLIER -151.29 155.06 37.98 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 119.04 -0.505 . . . . 0.77 109.843 -178.704 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.868 ' O ' ' HB2' ' A' ' 42' ' ' LEU . . . -36.28 -43.82 0.38 Allowed 'General case' 0 N--CA 1.484 1.248 0 CA-C-O 120.92 0.39 . . . . 1.02 111.746 -177.454 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.729 ' O ' ' HG2' ' A' ' 43' ' ' ARG . 59.4 mm-40 -50.37 -49.59 53.78 Favored 'General case' 0 CA--C 1.545 0.774 0 O-C-N 121.996 -0.44 . . . . 2.32 110.276 178.793 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.85 ' O ' ' HB2' ' A' ' 44' ' ' CYS . . . -72.77 -0.8 14.29 Favored 'General case' 0 C--O 1.216 -0.693 0 CA-C-O 121.584 0.707 . . . . 0.87 111.191 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.868 ' HB2' ' O ' ' A' ' 39' ' ' ALA . 2.4 mt -55.85 -47.32 77.5 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 107.065 -1.457 . . . . 1.23 107.065 176.456 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.729 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -68.89 1.08 3.65 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 114.654 -1.157 . . . . 2.92 110.658 175.943 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.85 ' HB2' ' O ' ' A' ' 41' ' ' ALA . 1.2 m -63.3 -42.98 99.11 Favored 'General case' 0 C--N 1.345 0.394 0 CA-C-O 118.184 -0.912 . . . . 1.57 109.546 178.237 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -39.77 -12.76 0.01 OUTLIER 'General case' 0 C--N 1.361 1.107 0 N-CA-C 117.069 2.248 . . . . 3.31 117.069 -177.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.441 ' N ' ' O ' ' A' ' 44' ' ' CYS . 1.2 mm-40 -81.34 0.81 35.53 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 118.489 -1.284 . . . . 3.69 108.412 178.481 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.941 ' HG3' HD22 ' A' ' 11' ' ' LEU . 1.0 OUTLIER . . . . . 0 N--CA 1.449 -0.488 0 CA-C-N 114.991 -1.004 . . . . 3.99 109.954 176.666 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 N--CA 1.476 0.848 0 N-CA-C 110.879 -0.045 . . . . 3.12 110.879 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.544 ' O ' ' HB2' ' A' ' 66' ' ' ARG . . . 141.71 60.94 0.03 OUTLIER Glycine 0 N--CA 1.434 -1.436 0 N-CA-C 108.527 -1.829 . . . . 2.1 108.527 -178.492 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -117.22 74.0 0.9 Allowed 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 122.581 1.181 . . . . 4.36 109.672 -179.166 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 1.0 ' HB3' ' HB3' ' A' ' 67' ' ' CYS . 0.4 OUTLIER -137.62 68.34 52.26 Favored Pre-proline 0 C--N 1.3 -1.562 0 N-CA-C 105.553 -2.018 . . . . 3.55 105.553 178.521 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.443 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 26.4 Cg_endo -62.32 119.21 6.21 Favored 'Trans proline' 0 C--N 1.361 1.188 0 C-N-CA 122.537 2.158 . . . . 1.54 115.514 -176.41 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -145.56 -171.71 3.74 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 112.514 -2.13 . . . . 1.59 105.647 177.195 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.588 ' HA2' ' CD2' ' A' ' 80' ' ' HIS . . . 66.62 -166.23 39.43 Favored Glycine 0 N--CA 1.454 -0.121 0 C-N-CA 118.553 -1.784 . . . . 2.43 112.982 178.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 4.6 p -88.05 37.42 0.81 Allowed 'General case' 0 N--CA 1.487 1.381 0 CA-C-O 122.538 1.161 . . . . 4.11 110.677 -176.469 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 121.5 5.75 9.15 Favored Glycine 0 CA--C 1.557 2.664 0 CA-C-N 112.954 -1.93 . . . . 2.21 114.47 -176.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.893 ' HA2' ' HB3' ' A' ' 75' ' ' SER . . . -100.74 134.89 11.87 Favored Glycine 0 N--CA 1.472 1.099 0 CA-C-N 121.071 2.435 . . . . 1.62 116.275 -176.778 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.544 ' HB2' ' O ' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -90.43 154.87 19.34 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.023 0.529 . . . . 3.02 110.47 178.405 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 1.0 ' HB3' ' HB3' ' A' ' 59' ' ' LYS . 43.2 t -71.02 103.12 2.6 Favored 'General case' 0 N--CA 1.409 -2.501 0 N-CA-C 108.046 -1.094 . . . . 1.52 108.046 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -76.13 -40.97 51.5 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 105.481 -2.044 . . . . 1.07 105.481 176.392 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.472 ' HB1' ' O ' ' A' ' 29' ' ' GLY . . . -140.83 160.85 39.17 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 111.59 -2.55 . . . . 1.0 112.12 -173.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.856 ' HA ' ' HB3' ' A' ' 85' ' ' CYS . . . -53.63 120.99 6.89 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 121.602 0.715 . . . . 1.24 112.826 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.584 ' H ' ' CB ' ' A' ' 85' ' ' CYS . . . 77.53 3.71 83.43 Favored Glycine 0 N--CA 1.444 -0.832 0 N-CA-C 116.41 1.324 . . . . 1.28 116.41 176.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.998 HD13 ' HB2' ' A' ' 34' ' ' CYS . 1.1 pp -132.04 106.56 11.43 Favored 'Isoleucine or valine' 0 C--O 1.244 0.79 0 CA-C-N 118.611 1.205 . . . . 2.27 110.702 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.664 ' HB2' ' O ' ' A' ' 80' ' ' HIS . 0.1 OUTLIER -84.63 90.32 7.66 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 115.154 -0.93 . . . . 1.98 109.822 -179.118 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.74 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 0.5 OUTLIER -99.52 132.79 44.62 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 113.326 0.862 . . . . 1.33 113.326 -177.962 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.935 ' HB2' ' HD2' ' A' ' 76' ' ' PRO . 45.8 p -109.3 -177.63 0.49 Allowed Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 114.411 -1.268 . . . . 1.99 108.713 178.661 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.935 ' HD2' ' HB2' ' A' ' 75' ' ' SER . 64.0 Cg_endo -74.45 30.92 0.34 Allowed 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 121.351 1.367 . . . . 1.86 111.765 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.687 ' HB3' ' ND1' ' B' ' 180' ' ' HIS . 4.8 m-20 -143.3 -50.7 0.34 Allowed 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.593 -0.731 . . . . 2.65 110.714 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.774 ' HA2' HD11 ' A' ' 26' ' ' ILE . . . -160.64 -166.22 18.99 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 111.724 -0.55 . . . . 0.99 111.724 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.74 ' HA ' ' HA ' ' A' ' 74' ' ' CYS . 2.9 m -124.8 156.13 38.28 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 117.71 0.755 . . . . 1.34 110.391 179.412 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.664 ' O ' ' HB2' ' A' ' 73' ' ' CYS . 18.4 t60 -140.93 124.72 17.02 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.016 -0.993 . . . . 2.17 108.709 -174.686 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.85 132.76 14.7 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.366 0.603 . . . . 3.05 111.849 -177.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.542 ' O ' ' HA2' ' A' ' 71' ' ' GLY . 0.8 OUTLIER -141.64 119.79 7.75 Favored Pre-proline 0 CA--C 1.544 0.728 0 CA-C-N 115.138 -0.937 . . . . 2.02 110.443 -178.889 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.698 ' HA ' ' OD2' ' A' ' 86' ' ' ASP . 4.3 Cg_exo -78.28 -13.71 15.15 Favored 'Trans proline' 0 C--N 1.357 0.981 0 C-N-CA 122.822 2.348 . . . . 1.93 113.879 -178.385 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.38 -38.13 89.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.798 0.332 . . . . 1.53 111.699 -179.334 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.856 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 21.9 m -91.98 50.42 1.67 Allowed 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 116.193 -0.458 . . . . 1.88 110.569 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.698 ' OD2' ' HA ' ' A' ' 83' ' ' PRO . 78.6 m-20 . . . . . 0 CA--C 1.554 1.105 0 N-CA-C 116.015 1.857 . . . . 3.6 116.015 -177.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 110' ' ' CYS . . . . . 0.588 ' HB3' ' NE ' ' B' ' 120' ' ' ARG . 81.5 m . . . . . 0 N--CA 1.456 -0.139 0 N-CA-C 112.189 0.44 . . . . 2.61 112.189 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 111' ' ' LEU . . . . . 0.936 HD22 ' HG3' ' B' ' 147' ' ' GLU . 0.0 OUTLIER -36.29 108.58 0.39 Allowed Pre-proline 0 N--CA 1.481 1.115 0 C-N-CA 123.671 0.789 . . . . 2.47 112.417 178.876 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 112' ' ' PRO . . . . . 0.708 ' HA ' ' O ' ' B' ' 119' ' ' GLY . 39.3 Cg_endo -90.44 138.84 2.75 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 123.08 2.52 . . . . 1.47 114.055 -179.291 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.528 ' N ' ' O ' ' B' ' 119' ' ' GLY . 0.5 OUTLIER -151.79 172.38 16.25 Favored 'General case' 0 C--N 1.347 0.495 0 N-CA-C 106.822 -1.547 . . . . 1.0 106.822 179.435 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 114' ' ' GLY . . . . . 0.568 ' HA2' ' OE1' ' B' ' 140' ' ' GLU . . . 71.89 -163.38 54.41 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 119.931 -1.128 . . . . 1.16 114.379 178.431 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 115' ' ' PRO . . . . . 0.815 ' HG2' HD11 ' B' ' 132' ' ' LEU . 9.5 Cg_endo -69.65 130.35 19.33 Favored 'Trans proline' 0 C--N 1.367 1.549 0 C-N-CA 124.45 3.433 . . . . 1.57 113.194 178.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 70.73 -16.5 1.02 Allowed Glycine 0 C--N 1.287 -2.186 0 CA-C-N 113.041 -1.89 . . . . 1.7 109.686 -176.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 117' ' ' GLY . . . . . 0.621 ' H ' ' C ' ' B' ' 115' ' ' PRO . . . 76.87 16.44 80.77 Favored Glycine 1 N--CA 1.39 -4.42 0 CA-C-N 113.505 -1.347 . . . . 1.38 113.77 178.369 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 118' ' ' LYS . . . . . 0.474 ' H ' ' HG2' ' B' ' 118' ' ' LYS . 0.0 OUTLIER -73.85 6.95 2.86 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 122.257 1.027 . . . . 2.54 108.253 174.955 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 119' ' ' GLY . . . . . 0.708 ' O ' ' HA ' ' B' ' 112' ' ' PRO . . . -89.59 124.15 7.25 Favored Glycine 0 N--CA 1.419 -2.438 0 CA-C-N 113.933 -1.485 . . . . 1.04 115.332 -178.406 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.849 ' HA ' ' O ' ' B' ' 111' ' ' LEU . 0.1 OUTLIER -112.96 136.4 52.67 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 120.816 -1.402 . . . . 2.89 112.288 -171.719 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 121' ' ' CYS . . . . . 0.437 ' O ' HD13 ' B' ' 111' ' ' LEU . 0.6 OUTLIER -104.45 127.83 52.23 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.597 0.713 . . . . 1.07 112.131 -177.68 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -101.32 -45.32 5.37 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 114.656 -1.156 . . . . 1.53 109.237 179.306 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -122.11 -132.33 4.07 Favored Glycine 0 CA--C 1.522 0.524 0 CA-C-N 115.321 -0.854 . . . . 0.9 111.895 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -97.77 -72.84 0.0 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 123.041 2.494 . . . . 1.51 112.02 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 125' ' ' SER . . . . . 0.698 ' O ' HG13 ' B' ' 126' ' ' ILE . 0.9 OUTLIER -89.46 46.73 1.4 Allowed 'General case' 0 C--O 1.225 -0.19 0 N-CA-C 109.288 -0.634 . . . . 1.25 109.288 178.752 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 126' ' ' ILE . . . . . 0.939 ' CG1' HG13 ' B' ' 136' ' ' VAL . 13.4 mt -150.96 116.8 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 CA-C-N 116.041 -0.527 . . . . 0.85 111.735 -178.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 127' ' ' CYS . . . . . 0.675 ' HA ' ' O ' ' B' ' 120' ' ' ARG . 0.5 OUTLIER -139.02 108.3 6.1 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 106.992 -1.484 . . . . 0.89 106.992 178.627 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 128' ' ' CYS . . . . . 0.982 ' HA ' ' O ' ' B' ' 133' ' ' GLY . 0.0 OUTLIER -124.7 129.03 49.73 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 115.357 1.614 . . . . 1.23 115.357 -176.396 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 129' ' ' GLY . . . . . 0.469 ' O ' ' HB1' ' B' ' 169' ' ' ALA . . . -116.21 -178.97 18.18 Favored Glycine 0 C--N 1.356 1.644 0 CA-C-O 122.468 1.038 . . . . 0.66 113.864 -179.498 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -67.28 -34.88 78.32 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 126.767 2.027 . . . . 2.35 113.42 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.57 17.57 2.91 Favored 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 118.404 -1.319 . . . . 1.69 111.892 176.371 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 132' ' ' LEU . . . . . 0.862 HD22 ' CE1' ' B' ' 135' ' ' PHE . 0.3 OUTLIER -124.7 -13.5 6.97 Favored 'General case' 0 N--CA 1.42 -1.937 0 CA-C-N 113.17 -1.832 . . . . 1.38 109.306 -176.838 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 133' ' ' GLY . . . . . 0.982 ' O ' ' HA ' ' B' ' 128' ' ' CYS . . . 53.24 -152.48 8.49 Favored Glycine 0 N--CA 1.41 -3.085 0 CA-C-N 114.175 -1.375 . . . . 0.72 114.303 177.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 134' ' ' CYS . . . . . 0.982 ' HB2' HD13 ' B' ' 172' ' ' ILE . 0.1 OUTLIER -104.32 123.58 47.64 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 115.301 1.593 . . . . 1.08 115.301 -178.927 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 135' ' ' PHE . . . . . 0.862 ' CE1' HD22 ' B' ' 132' ' ' LEU . 0.0 OUTLIER -96.59 101.75 13.42 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 102.127 -3.286 . . . . 1.36 102.127 173.238 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 136' ' ' VAL . . . . . 0.939 HG13 ' CG1' ' B' ' 126' ' ' ILE . 3.1 t -90.41 84.71 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 CA-C-O 122.471 1.129 . . . . 0.75 109.689 -176.791 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 137' ' ' GLY . . . . . 0.703 ' O ' ' HA3' ' A' ' 33' ' ' GLY . . . 78.87 78.05 0.86 Allowed Glycine 0 N--CA 1.453 -0.195 0 CA-C-N 113.059 -1.882 . . . . 0.83 111.631 -179.03 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 138' ' ' THR . . . . . 0.748 ' CG2' ' HD1' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -150.96 155.74 39.73 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 118.928 -0.558 . . . . 0.78 109.671 -178.794 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 139' ' ' ALA . . . . . 0.865 ' O ' ' HB2' ' B' ' 142' ' ' LEU . . . -36.9 -44.06 0.48 Allowed 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 118.142 0.428 . . . . 1.04 111.949 -177.552 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 140' ' ' GLU . . . . . 0.724 ' O ' ' HG2' ' B' ' 143' ' ' ARG . 55.4 mm-40 -50.25 -49.42 53.14 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.775 -0.578 . . . . 2.31 110.476 178.796 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 141' ' ' ALA . . . . . 0.857 ' O ' ' HB2' ' B' ' 144' ' ' CYS . . . -71.02 -3.94 22.25 Favored 'General case' 0 C--O 1.214 -0.787 0 CA-C-O 121.495 0.664 . . . . 0.87 110.968 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 142' ' ' LEU . . . . . 0.865 ' HB2' ' O ' ' B' ' 139' ' ' ALA . 2.4 mt -54.39 -46.94 73.19 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 107.267 -1.382 . . . . 1.24 107.267 177.412 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 143' ' ' ARG . . . . . 0.724 ' HG2' ' O ' ' B' ' 140' ' ' GLU . 0.0 OUTLIER -68.9 0.81 3.96 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 114.921 -1.036 . . . . 2.93 110.727 175.872 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 144' ' ' CYS . . . . . 0.857 ' HB2' ' O ' ' B' ' 141' ' ' ALA . 1.2 m -63.06 -42.79 99.78 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 118.202 -0.904 . . . . 1.61 109.66 178.204 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -40.18 -12.67 0.01 OUTLIER 'General case' 0 C--N 1.36 1.059 0 N-CA-C 117.016 2.228 . . . . 3.35 117.016 -178.119 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 146' ' ' GLU . . . . . 0.44 ' N ' ' O ' ' B' ' 144' ' ' CYS . 1.2 mm-40 -81.38 0.62 36.53 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 118.515 -1.274 . . . . 3.76 108.342 178.534 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 147' ' ' GLU . . . . . 0.936 ' HG3' HD22 ' B' ' 111' ' ' LEU . 1.0 OUTLIER . . . . . 0 N--CA 1.449 -0.498 0 CA-C-N 114.984 -1.007 . . . . 4.01 109.931 176.698 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 N--CA 1.472 0.66 0 N-CA-C 111.321 0.119 . . . . 3.11 111.321 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 157' ' ' GLY . . . . . 0.536 ' O ' ' HB2' ' B' ' 166' ' ' ARG . . . 142.0 61.71 0.03 OUTLIER Glycine 0 N--CA 1.44 -1.092 0 N-CA-C 109.075 -1.61 . . . . 2.07 109.075 -178.28 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -117.24 64.15 0.73 Allowed 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 122.508 1.147 . . . . 4.34 110.719 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 159' ' ' LYS . . . . . 1.067 ' HB3' ' HB3' ' B' ' 167' ' ' CYS . 0.5 OUTLIER -118.64 66.79 7.19 Favored Pre-proline 0 C--N 1.31 -1.113 0 CA-C-N 113.126 -1.852 . . . . 3.54 108.083 174.457 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 160' ' ' PRO . . . . . 0.441 ' HA ' ' HA ' ' B' ' 166' ' ' ARG . 23.1 Cg_endo -62.17 119.39 6.47 Favored 'Trans proline' 0 C--O 1.231 0.145 0 N-CA-C 116.259 1.6 . . . . 1.51 116.259 -174.716 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 161' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -146.49 -174.4 4.45 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 112.84 -1.982 . . . . 1.58 105.84 176.781 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 162' ' ' GLY . . . . . 0.558 ' HA2' ' CD2' ' B' ' 180' ' ' HIS . . . 69.2 -166.07 48.43 Favored Glycine 0 CA--C 1.508 -0.366 0 C-N-CA 118.5 -1.81 . . . . 2.37 112.51 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 4.6 p -88.0 37.05 0.79 Allowed 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 122.713 1.244 . . . . 4.07 110.644 -175.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 121.57 5.62 9.16 Favored Glycine 0 CA--C 1.556 2.598 0 CA-C-N 112.833 -1.985 . . . . 2.2 114.61 -176.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 165' ' ' GLY . . . . . 0.914 ' HA2' ' HB3' ' B' ' 175' ' ' SER . . . -101.21 135.36 12.12 Favored Glycine 0 C--N 1.346 1.087 0 CA-C-N 121.319 2.56 . . . . 1.62 116.283 -177.007 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 166' ' ' ARG . . . . . 0.536 ' HB2' ' O ' ' B' ' 157' ' ' GLY . 0.0 OUTLIER -90.2 154.93 19.38 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.01 0.524 . . . . 3.05 110.497 178.391 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 167' ' ' CYS . . . . . 1.067 ' HB3' ' HB3' ' B' ' 159' ' ' LYS . 42.9 t -70.96 103.17 2.59 Favored 'General case' 0 N--CA 1.406 -2.633 0 N-CA-C 108.071 -1.085 . . . . 1.56 108.071 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 168' ' ' ALA . . . . . . . . . . . . . . . -75.95 -41.38 51.78 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 105.363 -2.088 . . . . 1.04 105.363 176.375 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 169' ' ' ALA . . . . . 0.518 ' CB ' ' HA2' ' B' ' 133' ' ' GLY . . . -140.45 160.74 39.32 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 111.547 -2.57 . . . . 0.98 112.047 -173.578 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 170' ' ' ALA . . . . . 0.866 ' HA ' ' HB3' ' B' ' 185' ' ' CYS . . . -53.76 121.03 7.04 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 121.686 0.755 . . . . 1.25 112.792 -179.405 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 171' ' ' GLY . . . . . 0.579 ' H ' ' CB ' ' B' ' 185' ' ' CYS . . . 77.52 3.75 83.47 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 116.369 1.308 . . . . 1.29 116.369 176.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 172' ' ' ILE . . . . . 0.982 HD13 ' HB2' ' B' ' 134' ' ' CYS . 1.1 pp -131.97 106.41 11.26 Favored 'Isoleucine or valine' 0 C--O 1.245 0.823 0 CA-C-N 118.482 1.141 . . . . 2.27 110.781 -179.489 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 173' ' ' CYS . . . . . 0.697 ' HB2' ' O ' ' B' ' 180' ' ' HIS . 0.1 OUTLIER -84.52 90.51 7.65 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 115.153 -0.931 . . . . 1.94 109.755 -179.2 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 174' ' ' CYS . . . . . 0.775 ' HA ' ' HA ' ' B' ' 179' ' ' CYS . 0.5 OUTLIER -99.84 132.86 44.93 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 113.241 0.83 . . . . 1.35 113.241 -177.986 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 175' ' ' SER . . . . . 0.929 ' HB2' ' HD2' ' B' ' 176' ' ' PRO . 43.5 p -109.34 -177.58 0.48 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 114.269 -1.332 . . . . 2.0 108.686 178.685 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 176' ' ' PRO . . . . . 0.929 ' HD2' ' HB2' ' B' ' 175' ' ' SER . 62.8 Cg_endo -74.48 30.95 0.34 Allowed 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 121.387 1.391 . . . . 1.9 111.768 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 177' ' ' ASP . . . . . 0.614 ' HB3' ' ND1' ' A' ' 80' ' ' HIS . 4.8 m-20 -143.22 -50.79 0.34 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.523 -0.762 . . . . 2.72 110.778 179.437 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 178' ' ' GLY . . . . . 0.76 ' HA2' HD11 ' B' ' 126' ' ' ILE . . . -160.48 -166.05 18.52 Favored Glycine 0 CA--C 1.522 0.48 0 N-CA-C 111.752 -0.539 . . . . 0.99 111.752 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 179' ' ' CYS . . . . . 0.775 ' HA ' ' HA ' ' B' ' 174' ' ' CYS . 3.1 m -124.26 160.78 27.2 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 117.718 0.759 . . . . 1.34 110.144 179.349 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 180' ' ' HIS . . . . . 0.697 ' O ' ' HB2' ' B' ' 173' ' ' CYS . 17.9 t60 -148.72 123.21 9.72 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-O 121.663 0.744 . . . . 2.1 109.072 -174.098 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 181' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -46.78 132.41 11.33 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 114.572 -1.194 . . . . 3.06 111.921 -176.162 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 182' ' ' ASP . . . . . 0.532 ' O ' ' HA2' ' B' ' 171' ' ' GLY . 0.9 OUTLIER -141.54 119.84 7.84 Favored Pre-proline 0 CA--C 1.545 0.751 0 CA-C-N 114.909 -1.041 . . . . 2.06 110.341 -178.735 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 183' ' ' PRO . . . . . 0.704 ' HA ' ' OD2' ' B' ' 186' ' ' ASP . 4.4 Cg_exo -78.31 -13.81 15.06 Favored 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 122.836 2.358 . . . . 1.91 113.854 -178.431 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -64.26 -38.27 90.44 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.834 0.35 . . . . 1.56 111.661 -179.285 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 185' ' ' CYS . . . . . 0.866 ' HB3' ' HA ' ' B' ' 170' ' ' ALA . 21.8 m -91.91 50.34 1.67 Allowed 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 116.179 -0.464 . . . . 1.94 110.53 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 186' ' ' ASP . . . . . 0.704 ' OD2' ' HA ' ' B' ' 183' ' ' PRO . 78.5 m-20 . . . . . 0 CA--C 1.551 1.013 0 N-CA-C 116.042 1.867 . . . . 3.61 116.042 -177.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.439 ' SG ' ' HB3' ' A' ' 20' ' ' ARG . 12.5 p . . . . . 0 CA--C 1.542 0.668 0 N-CA-C 113.806 1.039 . . . . 2.68 113.806 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.415 ' O ' ' O ' ' A' ' 10' ' ' CYS . 26.1 mt -30.96 154.53 0.03 OUTLIER Pre-proline 0 N--CA 1.48 1.039 0 C-N-CA 123.872 0.869 . . . . 2.48 113.305 178.459 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.719 ' HB2' ' O ' ' A' ' 17' ' ' GLY . 33.4 Cg_endo -91.92 117.39 0.44 Allowed 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 123.312 2.675 . . . . 1.49 116.295 -178.36 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.647 ' SG ' ' O ' ' A' ' 20' ' ' ARG . 10.6 p -106.64 -156.41 0.58 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.693 1.197 . . . . 1.0 110.515 -176.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 79.96 -168.22 51.98 Favored Glycine 0 CA--C 1.498 -0.987 0 N-CA-C 110.373 -1.091 . . . . 1.15 110.373 -177.042 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.595 ' HD2' HD11 ' A' ' 32' ' ' LEU . 85.2 Cg_endo -63.8 89.87 0.15 Allowed 'Trans proline' 0 CA--C 1.51 -0.706 0 CA-C-N 119.793 1.796 . . . . 1.57 110.932 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.88 18.3 63.67 Favored Glycine 0 N--CA 1.418 -2.548 0 CA-C-N 114.168 -1.378 . . . . 1.68 114.199 177.401 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.719 ' O ' ' HB2' ' A' ' 12' ' ' PRO . . . 84.18 36.76 12.19 Favored Glycine 0 N--CA 1.404 -3.485 0 C-N-CA 118.077 -2.011 . . . . 1.36 115.947 176.035 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.543 ' HG3' ' HG2' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -92.63 -12.54 31.35 Favored 'General case' 0 CA--C 1.559 1.32 0 CA-C-N 115.0 -0.6 . . . . 2.5 110.999 175.896 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.531 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -102.21 -176.79 27.69 Favored Glycine 0 N--CA 1.478 1.467 0 C-N-CA 126.298 1.904 . . . . 1.02 109.379 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.647 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -126.18 168.97 13.32 Favored 'General case' 0 C--N 1.354 0.786 0 CA-C-N 122.707 3.253 . . . . 2.92 105.7 175.368 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.673 ' HB2' ' HG2' ' A' ' 47' ' ' GLU . 33.7 m -108.49 163.08 13.54 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 119.334 0.97 . . . . 1.1 113.331 -178.517 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -143.47 -57.04 0.4 Allowed 'General case' 0 C--O 1.232 0.146 0 CA-C-N 114.82 -1.082 . . . . 1.51 109.913 178.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.556 ' O ' ' HB3' ' A' ' 44' ' ' CYS . . . -120.54 176.91 16.33 Favored Glycine 0 C--N 1.332 0.319 0 CA-C-N 115.866 -0.606 . . . . 0.9 112.005 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.437 ' HB2' ' OE1' ' B' ' 181' ' ' GLU . 47.7 Cg_exo -53.67 -68.77 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.49 2.127 . . . . 1.5 112.368 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.65 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.5 OUTLIER -95.59 18.19 13.33 Favored 'General case' 0 C--O 1.224 -0.271 0 N-CA-C 109.995 -0.372 . . . . 1.26 109.995 178.878 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.931 HG12 HG13 ' A' ' 36' ' ' VAL . 1.2 mt -122.41 106.26 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 CA-C-O 121.751 0.786 . . . . 0.83 111.797 -177.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.748 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 0.6 OUTLIER -121.94 124.13 43.31 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 114.725 -1.125 . . . . 0.92 109.615 -179.011 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 1.178 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -138.52 112.82 8.72 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 114.978 1.473 . . . . 1.28 114.978 -178.607 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.419 ' O ' ' CB ' ' A' ' 69' ' ' ALA . . . -106.41 -159.17 22.03 Favored Glycine 0 N--CA 1.429 -1.832 0 N-CA-C 109.559 -1.416 . . . . 0.67 109.559 175.723 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -65.5 -64.86 0.76 Allowed 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 112.69 0.626 . . . . 2.27 112.69 -178.148 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.51 17.36 20.85 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 122.61 1.195 . . . . 1.66 109.808 -176.094 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.595 HD11 ' HD2' ' A' ' 15' ' ' PRO . 0.3 OUTLIER -113.95 -11.72 12.74 Favored 'General case' 0 N--CA 1.404 -2.759 0 N-CA-C 105.486 -2.042 . . . . 1.37 105.486 -179.642 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 1.178 ' O ' ' HA ' ' A' ' 28' ' ' CYS . . . 50.68 -135.48 29.33 Favored Glycine 0 N--CA 1.415 -2.758 0 CA-C-N 114.275 -1.33 . . . . 0.73 111.769 175.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.981 ' HB2' HD13 ' A' ' 72' ' ' ILE . 1.8 t -129.04 111.85 13.41 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-N 118.803 1.301 . . . . 1.08 112.678 179.379 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.827 ' HA ' ' HA ' ' B' ' 135' ' ' PHE . 6.2 m-30 -85.18 105.41 15.86 Favored 'General case' 0 N--CA 1.408 -2.525 0 N-CA-C 103.543 -2.762 . . . . 1.38 103.543 176.376 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.931 HG13 HG12 ' A' ' 26' ' ' ILE . 2.2 t -97.27 85.27 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.75 0 CA-C-O 123.129 1.443 . . . . 0.76 107.79 -178.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.779 ' HA3' HG21 ' B' ' 172' ' ' ILE . . . 110.97 92.96 2.17 Favored Glycine 0 CA--C 1.521 0.464 0 CA-C-N 112.427 -2.169 . . . . 0.81 114.263 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.715 ' CG2' ' HB3' ' A' ' 35' ' ' PHE . 0.0 OUTLIER 178.77 169.26 0.89 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 110.096 -0.335 . . . . 0.77 110.096 178.29 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.784 ' HA ' HD12 ' A' ' 42' ' ' LEU . . . -68.42 -35.83 78.21 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.832 -0.347 . . . . 1.02 110.933 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.86 -24.18 14.94 Favored 'General case' 0 C--N 1.332 -0.181 0 O-C-N 122.093 -0.379 . . . . 2.32 111.691 -178.54 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.675 ' O ' ' N ' ' A' ' 44' ' ' CYS . . . -97.23 -23.33 16.22 Favored 'General case' 0 C--O 1.214 -0.781 0 CA-C-N 116.818 -0.174 . . . . 0.87 111.242 -179.373 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.784 HD12 ' HA ' ' A' ' 39' ' ' ALA . 1.0 OUTLIER -37.38 -46.73 0.8 Allowed 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.969 0.729 . . . . 1.23 112.969 -175.771 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.531 ' HD2' ' H ' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -53.7 -25.68 19.43 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.813 -0.81 . . . . 2.92 108.813 177.557 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.675 ' N ' ' O ' ' A' ' 41' ' ' ALA . 86.2 m -57.33 -20.57 29.67 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.427 -0.806 . . . . 1.57 110.473 -178.817 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -39.09 -45.04 1.22 Allowed 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.594 0.59 . . . . 3.31 112.594 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -87.74 -7.57 57.17 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 119.873 -0.731 . . . . 3.69 110.991 -179.036 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.673 ' HG2' ' HB2' ' A' ' 21' ' ' CYS . 0.8 OUTLIER . . . . . 0 N--CA 1.442 -0.826 0 CA-C-N 115.903 -0.589 . . . . 3.99 109.453 177.139 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.2 t . . . . . 0 N--CA 1.463 0.182 0 N-CA-C 112.569 0.581 . . . . 3.12 112.569 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 164.17 35.23 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 110.534 -1.026 . . . . 2.1 110.534 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.535 ' HA ' ' HB2' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -123.26 88.99 3.02 Favored 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 109.043 -0.725 . . . . 4.36 109.043 179.611 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.554 ' HB3' ' HB2' ' A' ' 67' ' ' CYS . 0.5 OUTLIER -135.52 81.39 42.42 Favored Pre-proline 0 C--N 1.296 -1.755 0 N-CA-C 106.065 -1.828 . . . . 3.55 106.065 -178.647 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.501 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 12.0 Cg_endo -55.44 107.18 0.22 Allowed 'Trans proline' 0 C--N 1.358 1.05 0 C-N-CA 123.868 3.046 . . . . 1.54 114.241 -177.512 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.59 ' SG ' ' HB2' ' A' ' 84' ' ' ALA . 0.5 OUTLIER -144.34 149.63 36.49 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-N 114.333 -1.303 . . . . 1.59 110.144 178.811 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 79.36 -167.26 51.97 Favored Glycine 0 C--N 1.339 0.73 0 C-N-CA 119.039 -1.553 . . . . 2.43 109.683 -173.005 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.05 66.67 0.15 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 118.668 1.234 . . . . 4.11 112.472 -175.289 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.22 13.73 80.24 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.984 -0.627 . . . . 2.21 114.347 177.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.482 ' O ' ' O ' ' A' ' 61' ' ' CYS . . . -101.01 122.19 7.51 Favored Glycine 0 CA--C 1.501 -0.836 0 C-N-CA 119.59 -1.29 . . . . 1.62 113.66 -175.299 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.535 ' HB2' ' HA ' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -86.54 152.24 22.8 Favored 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 110.067 -0.345 . . . . 3.02 110.067 -178.929 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.554 ' HB2' ' HB3' ' A' ' 59' ' ' LYS . 0.1 OUTLIER -67.03 106.54 1.98 Allowed 'General case' 0 N--CA 1.423 -1.802 0 N-CA-C 108.674 -0.862 . . . . 1.52 108.674 -179.196 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -91.88 -23.72 19.55 Favored 'General case' 0 N--CA 1.417 -2.108 0 N-CA-C 107.468 -1.308 . . . . 1.07 107.468 177.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.906 ' HB1' ' HA2' ' A' ' 33' ' ' GLY . . . -169.72 163.26 9.92 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 109.875 -0.417 . . . . 1.0 109.875 -178.056 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.851 ' HA ' ' HB3' ' A' ' 85' ' ' CYS . . . -37.35 127.06 1.05 Allowed 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 115.611 1.708 . . . . 1.24 115.611 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.627 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . 59.08 -6.39 0.05 OUTLIER Glycine 0 C--N 1.342 0.912 0 N-CA-C 115.97 1.148 . . . . 1.28 115.97 177.32 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.981 HD13 ' HB2' ' A' ' 34' ' ' CYS . 1.6 pp -117.58 105.82 18.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 117.662 0.731 . . . . 2.27 111.846 -178.307 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -91.93 106.7 18.66 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.018 -0.992 . . . . 1.98 108.844 179.589 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.671 ' SG ' HD12 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -129.65 170.49 13.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 122.113 0.958 . . . . 1.33 113.561 -178.436 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.763 ' HB3' ' HD2' ' A' ' 76' ' ' PRO . 10.3 m -130.42 179.62 1.28 Allowed Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 113.297 -1.774 . . . . 1.99 106.947 178.258 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.763 ' HD2' ' HB3' ' A' ' 75' ' ' SER . 58.1 Cg_endo -75.94 30.81 0.39 Allowed 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 120.994 1.129 . . . . 1.86 112.258 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.469 ' HB3' ' CE1' ' B' ' 180' ' ' HIS . 2.7 m-20 -138.16 -57.15 0.66 Allowed 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.859 -0.61 . . . . 2.65 109.925 179.17 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.431 ' O ' ' HB3' ' A' ' 74' ' ' CYS . . . -139.31 -178.15 16.23 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.507 -0.854 . . . . 0.99 112.842 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.515 ' SG ' ' HB ' ' A' ' 72' ' ' ILE . 13.4 t -142.48 160.68 39.8 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 110.139 -0.319 . . . . 1.34 110.139 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.43 ' CE1' ' HB3' ' B' ' 177' ' ' ASP . 1.6 t60 -149.7 134.68 17.93 Favored 'General case' 0 CA--C 1.521 -0.164 0 C-N-CA 119.986 -0.686 . . . . 2.17 112.179 -178.587 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.86 119.46 10.04 Favored 'General case' 0 CA--C 1.51 -0.59 0 N-CA-C 108.363 -0.977 . . . . 3.05 108.363 177.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.423 ' OD1' ' HB2' ' A' ' 84' ' ' ALA . 0.2 OUTLIER -154.48 139.18 11.65 Favored Pre-proline 0 C--N 1.317 -0.846 0 C-N-CA 120.534 -0.466 . . . . 2.02 110.971 -179.013 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 82' ' ' ASP . 12.7 Cg_exo -70.17 41.84 0.36 Allowed 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.987 2.458 . . . . 1.93 113.049 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.59 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . . . -75.11 -58.96 2.96 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-O 122.698 1.237 . . . . 1.53 109.363 178.532 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.851 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 52.5 m -105.78 80.98 1.6 Allowed 'General case' 0 N--CA 1.435 -1.222 0 CA-C-N 112.507 -2.133 . . . . 1.88 109.102 -179.513 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.287 0 CA-C-N 116.007 -0.542 . . . . 3.6 111.942 -178.013 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 110' ' ' CYS . . . . . 0.45 ' SG ' ' HB3' ' B' ' 120' ' ' ARG . 12.0 p . . . . . 0 CA--C 1.545 0.767 0 N-CA-C 114.003 1.112 . . . . 2.61 114.003 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 111' ' ' LEU . . . . . 0.421 ' O ' ' O ' ' B' ' 110' ' ' CYS . 25.5 mt -30.19 154.3 0.03 OUTLIER Pre-proline 0 N--CA 1.481 1.081 0 N-CA-C 113.314 0.857 . . . . 2.47 113.314 178.64 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 112' ' ' PRO . . . . . 0.744 ' HB2' ' O ' ' B' ' 117' ' ' GLY . 48.5 Cg_endo -88.14 122.32 1.53 Allowed 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.423 2.749 . . . . 1.47 113.726 -178.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.646 ' SG ' ' O ' ' B' ' 120' ' ' ARG . 8.1 p -109.26 -153.59 0.51 Allowed 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 121.267 0.556 . . . . 1.0 110.625 178.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . 78.9 -168.13 53.26 Favored Glycine 0 CA--C 1.49 -1.498 0 N-CA-C 110.361 -1.096 . . . . 1.16 110.361 -179.06 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 115' ' ' PRO . . . . . 0.637 ' HD2' HD11 ' B' ' 132' ' ' LEU . 97.2 Cg_endo -64.59 85.93 0.16 Allowed 'Trans proline' 0 N--CA 1.45 -1.044 0 CA-C-N 119.556 1.678 . . . . 1.57 113.608 -178.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 86.13 19.22 57.84 Favored Glycine 0 N--CA 1.423 -2.192 0 CA-C-N 113.154 -1.839 . . . . 1.7 115.083 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 117' ' ' GLY . . . . . 0.744 ' O ' ' HB2' ' B' ' 112' ' ' PRO . . . 87.33 34.7 10.24 Favored Glycine 0 N--CA 1.413 -2.883 0 C-N-CA 119.536 -1.316 . . . . 1.38 116.182 176.762 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 118' ' ' LYS . . . . . 0.553 ' HG3' ' HG2' ' B' ' 115' ' ' PRO . 0.1 OUTLIER -93.03 -7.37 45.92 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 122.252 0.221 . . . . 2.54 111.267 177.289 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 119' ' ' GLY . . . . . 0.609 ' O ' ' HA ' ' B' ' 112' ' ' PRO . . . -114.89 -169.22 16.0 Favored Glycine 0 C--N 1.344 1.008 0 N-CA-C 108.112 -1.995 . . . . 1.04 108.112 177.303 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.646 ' O ' ' SG ' ' B' ' 113' ' ' CYS . 0.0 OUTLIER -125.08 168.69 13.03 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 120.934 2.367 . . . . 2.89 108.838 179.589 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 121' ' ' CYS . . . . . 0.681 ' HB2' ' HG2' ' B' ' 147' ' ' GLU . 33.4 m -108.28 162.45 14.08 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.201 0.815 . . . . 1.07 113.201 -178.524 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -143.52 -56.98 0.4 Allowed 'General case' 0 C--O 1.231 0.107 0 CA-C-N 114.698 -1.137 . . . . 1.53 109.91 179.06 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 123' ' ' GLY . . . . . 0.58 ' O ' ' HB3' ' B' ' 144' ' ' CYS . . . -120.83 177.07 16.36 Favored Glycine 0 CA--C 1.52 0.36 0 CA-C-N 115.898 -0.592 . . . . 0.9 112.029 179.319 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 124' ' ' PRO . . . . . 0.423 ' O ' ' HB2' ' B' ' 144' ' ' CYS . 51.2 Cg_exo -53.58 -68.93 0.06 OUTLIER 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.515 2.143 . . . . 1.51 112.427 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 125' ' ' SER . . . . . 0.654 ' O ' ' N ' ' B' ' 137' ' ' GLY . 0.5 OUTLIER -95.47 18.33 12.88 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-O 120.88 0.372 . . . . 1.25 110.018 178.794 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 126' ' ' ILE . . . . . 0.924 HG12 HG13 ' B' ' 136' ' ' VAL . 1.5 mt -122.21 105.8 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 CA-C-O 121.546 0.688 . . . . 0.85 111.951 -177.791 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 127' ' ' CYS . . . . . 0.751 ' O ' ' HA ' ' B' ' 134' ' ' CYS . 0.6 OUTLIER -122.02 124.5 44.12 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 114.821 -1.081 . . . . 0.89 109.828 -179.175 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 128' ' ' CYS . . . . . 1.17 ' HA ' ' O ' ' B' ' 133' ' ' GLY . 0.0 OUTLIER -140.16 110.49 6.63 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 115.995 1.85 . . . . 1.23 115.995 -178.097 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 129' ' ' GLY . . . . . 0.433 ' HA2' ' HE ' ' B' ' 120' ' ' ARG . . . -102.77 -161.05 25.78 Favored Glycine 0 N--CA 1.433 -1.53 0 N-CA-C 110.499 -1.04 . . . . 0.66 110.499 176.016 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -68.32 -56.97 6.73 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 114.766 1.395 . . . . 2.35 114.766 -177.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.34 29.27 7.56 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 122.81 1.29 . . . . 1.69 109.478 178.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 132' ' ' LEU . . . . . 0.637 HD11 ' HD2' ' B' ' 115' ' ' PRO . 0.3 OUTLIER -123.66 -12.21 7.67 Favored 'General case' 0 N--CA 1.4 -2.926 0 N-CA-C 104.16 -2.533 . . . . 1.38 104.16 179.425 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 133' ' ' GLY . . . . . 1.17 ' O ' ' HA ' ' B' ' 128' ' ' CYS . . . 51.09 -132.66 33.16 Favored Glycine 0 N--CA 1.4 -3.755 0 CA-C-N 113.424 -1.716 . . . . 0.72 112.674 176.126 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 134' ' ' CYS . . . . . 0.997 ' HB2' HD13 ' B' ' 172' ' ' ILE . 1.7 t -129.42 112.43 13.8 Favored 'General case' 0 CA--C 1.495 -1.152 0 CA-C-N 118.413 1.106 . . . . 1.08 112.675 178.761 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 135' ' ' PHE . . . . . 0.827 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 6.2 m-30 -86.72 105.27 16.83 Favored 'General case' 0 N--CA 1.407 -2.578 0 N-CA-C 103.452 -2.796 . . . . 1.36 103.452 175.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 136' ' ' VAL . . . . . 0.924 HG13 HG12 ' B' ' 126' ' ' ILE . 2.8 t -97.15 85.32 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.728 0 CA-C-O 122.913 1.34 . . . . 0.75 107.64 -178.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 137' ' ' GLY . . . . . 0.801 ' HA3' HG21 ' A' ' 72' ' ' ILE . . . 110.7 92.93 2.18 Favored Glycine 0 CA--C 1.522 0.507 0 CA-C-N 112.64 -2.073 . . . . 0.83 114.193 -179.592 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 138' ' ' THR . . . . . 0.714 ' CG2' ' HB3' ' B' ' 135' ' ' PHE . 0.0 OUTLIER 178.84 169.97 0.88 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.761 -0.459 . . . . 0.78 109.761 178.298 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 139' ' ' ALA . . . . . 0.711 ' HA ' HD12 ' B' ' 142' ' ' LEU . . . -74.59 -22.89 58.72 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.586 0.588 . . . . 1.04 112.586 -179.578 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 140' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.7 -25.37 67.37 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.904 -0.318 . . . . 2.31 110.587 178.69 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 141' ' ' ALA . . . . . 0.682 ' O ' ' N ' ' B' ' 144' ' ' CYS . . . -97.36 -20.79 17.59 Favored 'General case' 0 C--O 1.213 -0.866 0 CA-C-N 116.265 -0.425 . . . . 0.87 111.583 -178.777 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 142' ' ' LEU . . . . . 0.711 HD12 ' HA ' ' B' ' 139' ' ' ALA . 0.9 OUTLIER -38.16 -47.41 1.15 Allowed 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 112.701 0.63 . . . . 1.24 112.701 -176.73 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 143' ' ' ARG . . . . . 0.508 ' HD2' ' H ' ' B' ' 143' ' ' ARG . 0.0 OUTLIER -54.0 -24.56 17.32 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.07 -0.715 . . . . 2.93 109.07 177.475 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 144' ' ' CYS . . . . . 0.682 ' N ' ' O ' ' B' ' 141' ' ' ALA . 93.6 m -56.09 -24.96 43.55 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 114.292 -1.322 . . . . 1.61 109.496 -179.154 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -36.47 -45.55 0.5 Allowed 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.929 0.714 . . . . 3.35 112.929 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -87.84 -7.39 57.3 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 119.826 -0.75 . . . . 3.76 111.017 -178.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 147' ' ' GLU . . . . . 0.681 ' HG2' ' HB2' ' B' ' 121' ' ' CYS . 0.8 OUTLIER . . . . . 0 N--CA 1.442 -0.832 0 CA-C-N 115.875 -0.602 . . . . 4.01 109.411 177.167 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 2.3 t . . . . . 0 CA--C 1.529 0.172 0 N-CA-C 112.782 0.66 . . . . 3.11 112.782 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 165.34 34.96 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 CA-C-N 115.015 -0.993 . . . . 2.07 111.22 179.428 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 158' ' ' GLN . . . . . 0.557 ' HA ' ' HB2' ' B' ' 166' ' ' ARG . 0.0 OUTLIER -122.86 73.42 1.14 Allowed 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 121.437 0.637 . . . . 4.34 111.059 179.395 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 159' ' ' LYS . . . . . 0.476 ' CB ' ' HB2' ' B' ' 167' ' ' CYS . 0.9 OUTLIER -106.18 79.37 0.58 Allowed Pre-proline 0 C--N 1.314 -0.953 0 CA-C-O 117.788 -1.101 . . . . 3.54 110.673 175.544 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 160' ' ' PRO . . . . . 0.497 ' HA ' ' HA ' ' B' ' 166' ' ' ARG . 11.9 Cg_endo -55.2 108.36 0.3 Allowed 'Trans proline' 0 CA--C 1.531 0.343 0 C-N-CA 122.074 1.849 . . . . 1.51 114.868 -177.348 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 161' ' ' CYS . . . . . 0.596 ' SG ' ' HB2' ' B' ' 184' ' ' ALA . 0.5 OUTLIER -142.08 155.33 45.37 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 114.831 -1.077 . . . . 1.58 108.847 178.652 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 162' ' ' GLY . . . . . 0.44 ' O ' ' N ' ' B' ' 164' ' ' GLY . . . 74.82 -166.24 54.84 Favored Glycine 0 CA--C 1.521 0.427 0 C-N-CA 118.716 -1.707 . . . . 2.37 110.004 -176.238 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.79 65.11 0.12 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.729 1.264 . . . . 4.07 112.421 -176.617 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 164' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' B' ' 162' ' ' GLY . . . 78.91 19.6 72.48 Favored Glycine 0 CA--C 1.502 -0.77 0 C-N-CA 120.8 -0.714 . . . . 2.2 113.906 176.518 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 165' ' ' GLY . . . . . 0.487 ' O ' ' O ' ' B' ' 161' ' ' CYS . . . -103.42 126.44 8.81 Favored Glycine 0 N--CA 1.439 -1.105 0 C-N-CA 119.779 -1.2 . . . . 1.62 112.741 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 166' ' ' ARG . . . . . 0.557 ' HB2' ' HA ' ' B' ' 158' ' ' GLN . 0.0 OUTLIER -87.74 152.89 21.78 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.567 -0.317 . . . . 3.05 110.177 179.453 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 167' ' ' CYS . . . . . 0.476 ' HB2' ' CB ' ' B' ' 159' ' ' LYS . 0.1 OUTLIER -67.29 106.35 2.03 Favored 'General case' 0 N--CA 1.418 -2.058 0 N-CA-C 108.577 -0.898 . . . . 1.56 108.577 -179.299 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 168' ' ' ALA . . . . . 0.404 ' HB1' ' SG ' ' B' ' 128' ' ' CYS . . . -86.43 -33.09 20.54 Favored 'General case' 0 N--CA 1.424 -1.728 0 N-CA-C 105.637 -1.986 . . . . 1.04 105.637 177.336 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 169' ' ' ALA . . . . . 0.889 ' HB1' ' HA2' ' B' ' 133' ' ' GLY . . . -164.01 163.45 23.38 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 114.502 -1.226 . . . . 0.98 111.403 -174.318 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 170' ' ' ALA . . . . . 0.861 ' HA ' ' HB3' ' B' ' 185' ' ' CYS . . . -37.03 127.02 0.94 Allowed 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 115.288 1.588 . . . . 1.25 115.288 -179.17 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 171' ' ' GLY . . . . . 0.633 ' N ' ' O ' ' B' ' 185' ' ' CYS . . . 61.51 -11.94 0.06 OUTLIER Glycine 0 C--N 1.339 0.729 0 N-CA-C 115.806 1.083 . . . . 1.29 115.806 177.201 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 172' ' ' ILE . . . . . 0.997 HD13 ' HB2' ' B' ' 134' ' ' CYS . 1.6 pp -114.17 106.31 20.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 121.605 0.717 . . . . 2.27 112.191 -176.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 173' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -92.14 106.8 18.73 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.113 -0.949 . . . . 1.94 108.835 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 174' ' ' CYS . . . . . 0.677 ' SG ' HD12 ' B' ' 172' ' ' ILE . 0.0 OUTLIER -129.74 170.44 13.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 122.199 0.999 . . . . 1.35 113.598 -178.441 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 175' ' ' SER . . . . . 0.77 ' HB3' ' HD2' ' B' ' 176' ' ' PRO . 9.9 m -130.29 179.52 1.31 Allowed Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 113.303 -1.771 . . . . 2.0 106.993 178.302 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 176' ' ' PRO . . . . . 0.77 ' HD2' ' HB3' ' B' ' 175' ' ' SER . 58.1 Cg_endo -75.84 30.83 0.38 Allowed 'Trans proline' 0 N--CA 1.461 -0.422 0 CA-C-N 120.12 1.079 . . . . 1.9 112.28 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 177' ' ' ASP . . . . . 0.43 ' HB3' ' CE1' ' A' ' 80' ' ' HIS . 2.7 m-20 -138.25 -56.96 0.65 Allowed 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.868 -0.606 . . . . 2.72 109.956 179.184 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 178' ' ' GLY . . . . . 0.442 ' O ' ' HB3' ' B' ' 174' ' ' CYS . . . -139.33 -178.22 16.31 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.598 -0.811 . . . . 0.99 112.948 179.438 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 179' ' ' CYS . . . . . 0.52 ' SG ' ' HB ' ' B' ' 172' ' ' ILE . 13.4 t -142.55 160.61 39.95 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 110.148 -0.316 . . . . 1.34 110.148 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 180' ' ' HIS . . . . . 0.469 ' CE1' ' HB3' ' A' ' 77' ' ' ASP . 1.6 t60 -149.69 134.74 18.0 Favored 'General case' 0 CA--C 1.521 -0.17 0 C-N-CA 119.925 -0.71 . . . . 2.1 112.187 -178.603 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 181' ' ' GLU . . . . . 0.437 ' OE1' ' HB2' ' A' ' 24' ' ' PRO . 0.2 OUTLIER -63.9 119.5 10.16 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 108.337 -0.986 . . . . 3.06 108.337 177.953 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 182' ' ' ASP . . . . . 0.433 ' HA ' ' HD3' ' B' ' 183' ' ' PRO . 0.2 OUTLIER -154.52 139.14 11.6 Favored Pre-proline 0 C--N 1.316 -0.872 0 C-N-CA 120.452 -0.499 . . . . 2.06 110.939 -178.995 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 183' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' B' ' 182' ' ' ASP . 12.7 Cg_exo -70.09 41.69 0.35 Allowed 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.943 2.429 . . . . 1.91 113.139 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 184' ' ' ALA . . . . . 0.596 ' HB2' ' SG ' ' B' ' 161' ' ' CYS . . . -75.01 -58.94 2.97 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 122.651 1.215 . . . . 1.56 109.343 178.567 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 185' ' ' CYS . . . . . 0.861 ' HB3' ' HA ' ' B' ' 170' ' ' ALA . 49.0 m -105.6 80.33 1.55 Allowed 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 112.508 -2.133 . . . . 1.94 109.297 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 186' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.071 -0.513 . . . . 3.61 112.178 -177.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.844 ' HB3' ' HG2' ' A' ' 20' ' ' ARG . 0.1 OUTLIER . . . . . 0 CA--C 1.543 0.695 0 N-CA-C 114.52 1.304 . . . . 2.68 114.52 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.569 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 1.3 tt -32.21 112.31 0.35 Allowed Pre-proline 0 N--CA 1.484 1.269 0 CA-C-N 119.294 0.952 . . . . 2.48 111.589 177.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.858 ' HB2' ' O ' ' A' ' 17' ' ' GLY . 41.4 Cg_endo -94.82 125.58 0.4 Allowed 'Trans proline' 0 C--N 1.356 0.948 0 C-N-CA 123.567 2.845 . . . . 1.49 114.65 -178.512 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.629 ' SG ' ' N ' ' A' ' 14' ' ' GLY . 0.0 OUTLIER -140.82 -168.43 2.59 Favored 'General case' 0 C--N 1.353 0.729 0 CA-C-N 118.228 0.467 . . . . 1.0 111.183 -176.472 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 1.022 ' HA2' ' HB3' ' A' ' 40' ' ' GLU . . . 75.23 -163.81 54.14 Favored Glycine 0 CA--C 1.501 -0.787 0 C-N-CA 120.832 -0.699 . . . . 1.15 111.705 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.409 ' HD3' ' OE1' ' A' ' 40' ' ' GLU . 49.5 Cg_endo -63.2 142.04 84.99 Favored 'Trans proline' 0 N--CA 1.446 -1.315 0 N-CA-C 106.867 -2.013 . . . . 1.57 106.867 175.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 62.73 -12.24 0.1 OUTLIER Glycine 0 C--N 1.269 -3.176 0 C-N-CA 124.66 1.124 . . . . 1.68 113.38 -179.205 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.858 ' O ' ' HB2' ' A' ' 12' ' ' PRO . . . 64.9 20.14 66.28 Favored Glycine 1 N--CA 1.391 -4.333 0 C-N-CA 116.978 -2.534 . . . . 1.36 110.58 179.411 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.464 ' HB2' HD12 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -92.18 -1.61 57.04 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 113.293 -1.454 . . . . 2.5 113.31 179.879 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.811 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -116.67 177.73 16.93 Favored Glycine 0 C--N 1.335 0.476 0 N-CA-C 108.488 -1.845 . . . . 1.02 108.488 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.844 ' HG2' ' HB3' ' A' ' 10' ' ' CYS . 0.5 OUTLIER -119.75 173.06 7.26 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 120.408 2.104 . . . . 2.92 111.193 179.89 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.436 ' CB ' ' HG3' ' A' ' 47' ' ' GLU . 4.6 m -105.86 147.43 28.71 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.027 0.441 . . . . 1.1 110.422 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.412 ' HE1' ' O ' ' A' ' 28' ' ' CYS . 44.0 m-85 -137.6 -52.07 0.64 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.807 -0.633 . . . . 1.51 110.711 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.565 ' O ' ' HB3' ' A' ' 44' ' ' CYS . . . -101.4 -166.2 27.56 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.858 -0.687 . . . . 0.9 111.714 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.454 ' O ' ' HB2' ' A' ' 44' ' ' CYS . 2.4 Cg_endo -77.31 -60.64 0.04 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.404 2.069 . . . . 1.5 111.54 179.416 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -102.86 26.34 8.21 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.794 -0.639 . . . . 1.26 109.935 179.291 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.831 HG22 ' SG ' ' A' ' 34' ' ' CYS . 0.6 OUTLIER -131.46 121.33 48.08 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 N-CA-C 113.346 0.869 . . . . 0.83 113.346 -177.402 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.8 t -123.16 118.19 27.1 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 109.022 -0.732 . . . . 0.92 109.022 178.409 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 1.053 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -132.97 112.26 11.71 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 113.911 1.078 . . . . 1.28 113.911 -177.689 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.835 ' O ' ' HB1' ' A' ' 69' ' ' ALA . . . -105.71 -158.89 22.68 Favored Glycine 0 C--N 1.358 1.784 0 C-N-CA 120.318 -0.944 . . . . 0.67 112.738 178.579 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.542 ' O ' ' HB2' ' A' ' 70' ' ' ALA . 19.0 p-10 -66.37 -57.09 8.19 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 115.498 1.666 . . . . 2.27 115.498 -176.744 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -120.29 17.7 12.26 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 121.891 0.853 . . . . 1.66 110.071 -176.795 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.521 HD22 ' CE1' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -112.93 -24.37 9.56 Favored 'General case' 0 N--CA 1.408 -2.567 0 CA-C-N 113.628 -1.624 . . . . 1.37 107.396 -179.315 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 1.053 ' O ' ' HA ' ' A' ' 28' ' ' CYS . . . 73.22 -128.39 11.61 Favored Glycine 0 N--CA 1.415 -2.727 0 CA-C-N 113.951 -1.477 . . . . 0.73 113.755 177.123 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.831 ' SG ' HG22 ' A' ' 26' ' ' ILE . 5.1 t -138.72 118.08 12.81 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 114.834 1.42 . . . . 1.08 114.834 -177.22 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.752 ' HB3' ' CG2' ' A' ' 38' ' ' THR . 0.2 OUTLIER -92.83 106.97 18.85 Favored 'General case' 0 N--CA 1.423 -1.789 0 N-CA-C 105.408 -2.071 . . . . 1.38 105.408 177.031 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.829 ' HA ' HG23 ' A' ' 26' ' ' ILE . 2.2 t -97.9 85.15 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.577 0 C-N-CA 118.718 -1.193 . . . . 0.76 108.856 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.59 ' O ' ' O ' ' A' ' 38' ' ' THR . . . 143.39 -75.78 0.3 Allowed Glycine 0 CA--C 1.524 0.607 0 CA-C-N 114.3 -1.318 . . . . 0.81 115.568 179.203 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.752 ' CG2' ' HB3' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -23.47 154.27 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 113.111 0.782 . . . . 0.77 113.111 -178.298 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.52 ' O ' ' N ' ' A' ' 42' ' ' LEU . . . -60.14 -39.09 85.09 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.971 -0.559 . . . . 1.02 111.366 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 1.022 ' HB3' ' HA2' ' A' ' 14' ' ' GLY . 1.2 mt-10 -40.36 -29.52 0.08 Allowed 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.794 0.665 . . . . 2.32 112.794 -178.769 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.692 ' O ' ' N ' ' A' ' 44' ' ' CYS . . . -89.16 -20.95 23.6 Favored 'General case' 0 N--CA 1.44 -0.954 0 O-C-N 122.328 -0.232 . . . . 0.87 110.952 -179.233 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.52 ' N ' ' O ' ' A' ' 39' ' ' ALA . 3.2 mt -39.22 -43.62 1.13 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.819 0.674 . . . . 1.23 112.819 -177.394 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.406 ' HD3' ' O ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -52.32 -30.44 28.4 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 107.903 -1.147 . . . . 2.92 107.903 177.469 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.692 ' N ' ' O ' ' A' ' 41' ' ' ALA . 70.0 m -53.04 -21.65 4.85 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 114.279 -1.328 . . . . 1.57 110.556 -177.34 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -49.03 -34.45 13.37 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 113.505 0.928 . . . . 3.31 113.505 -179.511 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -87.09 -5.0 59.18 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 119.869 -0.733 . . . . 3.69 111.157 -178.346 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.436 ' HG3' ' CB ' ' A' ' 21' ' ' CYS . 3.9 mm-40 . . . . . 0 N--CA 1.443 -0.787 0 N-CA-C 109.512 -0.551 . . . . 3.99 109.512 177.287 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.7 p . . . . . 0 CA--C 1.531 0.231 0 CA-C-O 120.889 0.376 . . . . 3.12 111.293 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 173.39 38.38 0.04 OUTLIER Glycine 0 N--CA 1.444 -0.815 0 N-CA-C 110.415 -1.074 . . . . 2.1 110.415 -179.23 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.4 tp60 -120.78 85.58 2.42 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 108.613 -0.884 . . . . 4.36 108.613 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.5 ' O ' ' HA ' ' A' ' 66' ' ' ARG . 0.5 OUTLIER -136.32 82.28 35.22 Favored Pre-proline 0 C--N 1.299 -1.618 0 N-CA-C 106.28 -1.748 . . . . 3.55 106.28 -178.713 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.599 ' HA ' ' O ' ' A' ' 65' ' ' GLY . 60.5 Cg_endo -72.4 73.5 2.75 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 123.197 2.598 . . . . 1.54 113.856 -177.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.406 ' N ' ' O ' ' A' ' 65' ' ' GLY . 4.5 p -99.25 157.87 16.08 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.389 -1.278 . . . . 1.59 109.084 178.199 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.56 -167.86 54.11 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 119.787 -1.197 . . . . 2.43 112.094 -175.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -76.47 66.09 2.44 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 122.058 0.933 . . . . 4.11 112.623 -175.429 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.59 19.41 58.35 Favored Glycine 0 C--N 1.339 0.72 0 CA-C-N 114.112 -1.403 . . . . 2.21 114.695 177.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.638 ' HA3' ' HA ' ' A' ' 74' ' ' CYS . . . -105.28 135.01 12.34 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 119.227 -1.463 . . . . 1.62 114.213 -179.39 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.598 ' HA ' ' HA ' ' A' ' 60' ' ' PRO . 0.0 OUTLIER -107.04 152.99 23.26 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 109.248 -0.649 . . . . 3.02 109.248 177.091 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.7 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 41.7 t -52.77 106.37 0.16 Allowed 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 108.967 -0.753 . . . . 1.52 108.967 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.41 ' N ' ' O ' ' A' ' 72' ' ' ILE . . . -88.96 -36.55 15.81 Favored 'General case' 0 N--CA 1.423 -1.816 0 N-CA-C 106.718 -1.586 . . . . 1.07 106.718 177.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.835 ' HB1' ' O ' ' A' ' 29' ' ' GLY . . . -165.18 165.06 20.03 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 108.985 -0.746 . . . . 1.0 108.985 -177.339 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.542 ' HB2' ' O ' ' A' ' 30' ' ' ASP . . . -31.24 108.66 0.05 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.25 0.548 . . . . 1.24 111.402 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.84 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . 75.68 -3.4 49.71 Favored Glycine 0 C--O 1.227 -0.336 0 CA-C-N 115.249 -0.887 . . . . 1.28 114.548 179.109 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.825 HG13 ' HB2' ' A' ' 34' ' ' CYS . 1.6 mm -96.9 119.07 44.48 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.599 0 CA-C-N 117.702 0.751 . . . . 2.27 110.399 -179.645 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 1.009 ' HB2' ' HB3' ' A' ' 82' ' ' ASP . 1.9 t -118.99 95.61 4.89 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.72 -1.127 . . . . 1.98 108.391 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 1.05 ' HB3' ' HA ' ' A' ' 79' ' ' CYS . 26.7 p -156.13 -174.32 4.9 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 116.912 2.19 . . . . 1.33 116.912 -176.619 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.528 ' CB ' ' HD2' ' A' ' 76' ' ' PRO . 0.3 OUTLIER -128.56 -178.29 0.77 Allowed Pre-proline 0 N--CA 1.456 -0.169 0 CA-C-N 112.808 -1.996 . . . . 1.99 109.253 -178.831 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.528 ' HD2' ' CB ' ' A' ' 75' ' ' SER . 60.3 Cg_endo -73.28 30.85 0.31 Allowed 'Trans proline' 0 CA--C 1.533 0.464 0 C-N-CA 121.882 1.721 . . . . 1.86 113.413 -179.091 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -125.88 -60.66 1.28 Allowed 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 109.536 -0.542 . . . . 2.65 109.536 178.452 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.883 ' O ' ' HB2' ' A' ' 74' ' ' CYS . . . -138.39 -167.29 10.94 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 110.917 -0.873 . . . . 0.99 110.917 178.373 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 1.05 ' HA ' ' HB3' ' A' ' 74' ' ' CYS . 63.8 m -146.43 161.08 41.16 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 117.534 0.667 . . . . 1.34 111.723 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 34.6 t60 -152.58 150.1 29.17 Favored 'General case' 0 C--N 1.344 0.34 0 C-N-CA 119.896 -0.722 . . . . 2.17 111.388 -178.03 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.461 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 0.4 OUTLIER -60.71 140.86 57.37 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.764 -0.653 . . . . 3.05 110.422 179.558 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 1.009 ' HB3' ' HB2' ' A' ' 73' ' ' CYS . 0.0 OUTLIER -137.21 138.24 24.76 Favored Pre-proline 0 CA--C 1.544 0.733 0 CA-C-N 115.983 -0.553 . . . . 2.02 111.89 -179.023 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.458 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 2.5 Cg_endo -84.38 -31.68 0.46 Allowed 'Trans proline' 0 C--N 1.359 1.122 0 C-N-CA 123.311 2.674 . . . . 1.93 115.301 -177.263 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.82 -47.62 84.99 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 108.29 -1.004 . . . . 1.53 108.29 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.84 ' O ' ' N ' ' A' ' 71' ' ' GLY . 81.5 m -96.77 71.68 2.58 Favored 'General case' 0 C--O 1.215 -0.739 0 N-CA-C 105.694 -1.965 . . . . 1.88 105.694 175.266 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.458 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 0.9 OUTLIER . . . . . 0 CA--C 1.497 -1.084 0 C-N-CA 119.089 -1.044 . . . . 3.6 110.582 -177.7 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 110' ' ' CYS . . . . . 0.829 ' HB3' ' HG2' ' B' ' 120' ' ' ARG . 0.1 OUTLIER . . . . . 0 CA--C 1.546 0.799 0 N-CA-C 114.332 1.234 . . . . 2.61 114.332 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 111' ' ' LEU . . . . . 0.546 ' O ' ' HA ' ' B' ' 120' ' ' ARG . 1.3 tt -32.09 112.06 0.34 Allowed Pre-proline 0 N--CA 1.484 1.253 0 CA-C-N 119.001 0.819 . . . . 2.47 111.626 178.04 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 112' ' ' PRO . . . . . 0.847 ' HB2' ' O ' ' B' ' 117' ' ' GLY . 43.4 Cg_endo -93.59 127.39 0.61 Allowed 'Trans proline' 0 C--N 1.356 0.921 0 C-N-CA 123.579 2.853 . . . . 1.47 113.937 -178.745 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.627 ' SG ' ' N ' ' B' ' 114' ' ' GLY . 0.0 OUTLIER -142.54 -168.84 2.84 Favored 'General case' 0 C--N 1.351 0.631 0 O-C-N 121.943 -0.473 . . . . 1.0 111.212 -177.502 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 114' ' ' GLY . . . . . 0.985 ' HA2' ' HB3' ' B' ' 140' ' ' GLU . . . 75.33 -163.74 54.02 Favored Glycine 0 CA--C 1.502 -0.728 0 C-N-CA 120.817 -0.706 . . . . 1.16 111.535 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 115' ' ' PRO . . . . . 0.418 ' C ' ' H ' ' B' ' 117' ' ' GLY . 48.3 Cg_endo -63.23 142.01 84.67 Favored 'Trans proline' 0 N--CA 1.446 -1.281 0 N-CA-C 107.002 -1.961 . . . . 1.57 107.002 175.763 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 62.86 -12.48 0.1 OUTLIER Glycine 0 C--N 1.27 -3.124 0 C-N-CA 124.792 1.187 . . . . 1.7 113.251 -179.102 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 117' ' ' GLY . . . . . 0.847 ' O ' ' HB2' ' B' ' 112' ' ' PRO . . . 64.95 20.5 66.78 Favored Glycine 1 N--CA 1.395 -4.086 0 C-N-CA 116.901 -2.571 . . . . 1.38 110.566 179.431 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 118' ' ' LYS . . . . . 0.477 ' HB2' HD12 ' B' ' 132' ' ' LEU . 0.0 OUTLIER -91.92 -2.63 56.7 Favored 'General case' 0 C--N 1.346 0.435 0 CA-C-N 113.003 -1.599 . . . . 2.54 113.241 -179.894 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 119' ' ' GLY . . . . . 0.845 ' O ' ' HA ' ' B' ' 112' ' ' PRO . . . -117.65 -178.29 17.44 Favored Glycine 0 C--N 1.34 0.764 0 N-CA-C 108.607 -1.797 . . . . 1.04 108.607 178.476 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.829 ' HG2' ' HB3' ' B' ' 110' ' ' CYS . 0.4 OUTLIER -120.73 172.52 7.82 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 119.298 1.549 . . . . 2.89 112.364 -178.886 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 121' ' ' CYS . . . . . 0.431 ' CB ' ' HG3' ' B' ' 147' ' ' GLU . 4.4 m -105.89 147.29 28.91 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.081 0.467 . . . . 1.07 110.347 -179.223 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 122' ' ' PHE . . . . . 0.411 ' HE1' ' O ' ' B' ' 128' ' ' CYS . 43.9 m-85 -137.53 -52.02 0.64 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.905 -0.589 . . . . 1.53 110.691 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 123' ' ' GLY . . . . . 0.556 ' O ' ' HB3' ' B' ' 144' ' ' CYS . . . -101.45 -166.21 27.52 Favored Glycine 0 C--O 1.229 -0.203 0 C-N-CA 120.836 -0.697 . . . . 0.9 111.677 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 124' ' ' PRO . . . . . 0.441 ' O ' ' HB2' ' B' ' 144' ' ' CYS . 2.4 Cg_endo -77.31 -60.65 0.04 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 122.469 2.113 . . . . 1.51 111.564 179.405 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 125' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -102.89 26.44 8.11 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.839 -0.619 . . . . 1.25 109.921 179.295 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 126' ' ' ILE . . . . . 0.837 HG22 ' SG ' ' B' ' 134' ' ' CYS . 0.8 OUTLIER -131.37 121.37 48.43 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 N-CA-C 113.399 0.889 . . . . 0.85 113.399 -177.41 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 127' ' ' CYS . . . . . . . . . . . . . 1.8 t -123.28 118.05 26.68 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 109.059 -0.719 . . . . 0.89 109.059 178.258 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 128' ' ' CYS . . . . . 1.059 ' HA ' ' O ' ' B' ' 133' ' ' GLY . 0.0 OUTLIER -132.36 112.0 11.82 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 114.067 1.136 . . . . 1.23 114.067 -177.999 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 129' ' ' GLY . . . . . 0.852 ' O ' ' HB1' ' B' ' 169' ' ' ALA . . . -104.55 -157.96 23.7 Favored Glycine 0 C--N 1.357 1.742 0 C-N-CA 120.298 -0.954 . . . . 0.66 112.992 178.21 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 130' ' ' ASP . . . . . 0.515 ' O ' ' HB2' ' B' ' 170' ' ' ALA . 18.2 p-10 -68.61 -55.28 12.06 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 115.867 1.802 . . . . 2.35 115.867 -176.773 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -125.03 30.67 5.81 Favored 'General case' 0 CA--C 1.493 -1.218 0 C-N-CA 118.878 -1.129 . . . . 1.69 109.744 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 132' ' ' LEU . . . . . 0.523 HD22 ' CE1' ' B' ' 135' ' ' PHE . 0.4 OUTLIER -123.82 -23.82 4.59 Favored 'General case' 0 N--CA 1.404 -2.744 0 N-CA-C 105.672 -1.973 . . . . 1.38 105.672 -179.23 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 133' ' ' GLY . . . . . 1.059 ' O ' ' HA ' ' B' ' 128' ' ' CYS . . . 72.15 -126.58 11.85 Favored Glycine 0 N--CA 1.408 -3.195 0 CA-C-N 114.196 -1.366 . . . . 0.72 114.17 175.3 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 134' ' ' CYS . . . . . 0.837 ' SG ' HG22 ' B' ' 126' ' ' ILE . 5.4 t -140.17 118.13 11.83 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 114.948 1.462 . . . . 1.08 114.948 -177.035 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 135' ' ' PHE . . . . . 0.766 ' HB3' ' CG2' ' B' ' 138' ' ' THR . 0.1 OUTLIER -93.0 107.14 18.98 Favored 'General case' 0 N--CA 1.424 -1.761 0 N-CA-C 105.4 -2.074 . . . . 1.36 105.4 177.204 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 136' ' ' VAL . . . . . 0.781 ' HA ' HG23 ' B' ' 126' ' ' ILE . 2.5 t -97.56 85.42 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.552 0 C-N-CA 118.861 -1.136 . . . . 0.75 108.712 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 137' ' ' GLY . . . . . 0.596 ' O ' ' O ' ' B' ' 138' ' ' THR . . . 142.65 -76.04 0.31 Allowed Glycine 0 CA--C 1.522 0.524 0 C-N-CA 119.614 -1.279 . . . . 0.83 115.778 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 138' ' ' THR . . . . . 0.766 ' CG2' ' HB3' ' B' ' 135' ' ' PHE . 0.0 OUTLIER -23.27 154.62 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 113.081 0.771 . . . . 0.78 113.081 -178.242 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 139' ' ' ALA . . . . . 0.498 ' O ' ' N ' ' B' ' 142' ' ' LEU . . . -60.45 -39.38 87.35 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 116.147 -0.479 . . . . 1.04 111.144 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 140' ' ' GLU . . . . . 0.985 ' HB3' ' HA2' ' B' ' 114' ' ' GLY . 1.2 mt-10 -40.09 -29.56 0.08 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.84 0.682 . . . . 2.31 112.84 -178.722 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 141' ' ' ALA . . . . . 0.684 ' O ' ' N ' ' B' ' 144' ' ' CYS . . . -89.16 -20.72 23.88 Favored 'General case' 0 N--CA 1.441 -0.912 0 O-C-N 122.307 -0.246 . . . . 0.87 110.992 -179.24 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 142' ' ' LEU . . . . . 0.498 ' N ' ' O ' ' B' ' 139' ' ' ALA . 3.1 mt -39.32 -43.81 1.21 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.787 0.662 . . . . 1.24 112.787 -177.435 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 143' ' ' ARG . . . . . 0.412 ' HD3' ' O ' ' B' ' 140' ' ' GLU . 0.0 OUTLIER -52.18 -30.61 27.73 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 107.947 -1.131 . . . . 2.93 107.947 177.457 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 144' ' ' CYS . . . . . 0.684 ' N ' ' O ' ' B' ' 141' ' ' ALA . 69.4 m -52.96 -21.39 4.32 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 114.083 -1.417 . . . . 1.61 110.538 -177.246 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -49.39 -34.34 15.95 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 113.538 0.94 . . . . 3.35 113.538 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -87.13 -4.87 59.15 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 119.846 -0.742 . . . . 3.76 111.152 -178.401 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 147' ' ' GLU . . . . . 0.431 ' HG3' ' CB ' ' B' ' 121' ' ' CYS . 3.9 mm-40 . . . . . 0 N--CA 1.443 -0.812 0 N-CA-C 109.482 -0.562 . . . . 4.01 109.482 177.359 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 50.3 p . . . . . 0 C--O 1.232 0.175 0 CA-C-O 121.218 0.532 . . . . 3.11 111.216 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 173.89 38.18 0.04 OUTLIER Glycine 0 N--CA 1.444 -0.832 0 N-CA-C 110.835 -0.906 . . . . 2.07 110.835 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 5.1 tp60 -120.85 71.54 0.94 Allowed 'General case' 0 N--CA 1.441 -0.883 0 CA-C-O 121.867 0.841 . . . . 4.34 110.275 179.051 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 159' ' ' LYS . . . . . 0.536 ' O ' ' HA ' ' B' ' 166' ' ' ARG . 0.7 OUTLIER -107.55 79.98 0.87 Allowed Pre-proline 0 C--N 1.316 -0.863 0 CA-C-N 114.068 -1.424 . . . . 3.54 110.643 175.117 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 160' ' ' PRO . . . . . 0.605 ' HA ' ' HA ' ' B' ' 166' ' ' ARG . 59.3 Cg_endo -72.39 74.49 2.59 Favored 'Trans proline' 0 C--N 1.333 -0.249 0 CA-C-N 121.688 1.638 . . . . 1.51 114.521 -177.416 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 161' ' ' CYS . . . . . . . . . . . . . 4.6 p -98.97 158.92 15.32 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.856 -1.065 . . . . 1.58 109.09 178.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 77.05 -167.85 54.5 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 119.726 -1.226 . . . . 2.37 112.216 -176.325 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -76.71 65.61 2.51 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 122.173 0.987 . . . . 4.07 112.529 -175.344 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 84.55 22.24 54.25 Favored Glycine 0 C--N 1.337 0.59 0 CA-C-N 113.858 -1.519 . . . . 2.2 114.626 177.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 165' ' ' GLY . . . . . 0.681 ' HA3' ' HA ' ' B' ' 174' ' ' CYS . . . -108.0 135.77 13.03 Favored Glycine 0 N--CA 1.442 -0.963 0 C-N-CA 119.279 -1.439 . . . . 1.62 113.69 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 166' ' ' ARG . . . . . 0.605 ' HA ' ' HA ' ' B' ' 160' ' ' PRO . 0.0 OUTLIER -106.79 153.27 22.71 Favored 'General case' 0 CA--C 1.521 -0.167 0 N-CA-C 109.273 -0.64 . . . . 3.05 109.273 177.681 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 167' ' ' CYS . . . . . 0.706 ' HA ' ' O ' ' B' ' 172' ' ' ILE . 41.8 t -52.88 106.34 0.16 Allowed 'General case' 0 N--CA 1.424 -1.773 0 N-CA-C 108.932 -0.766 . . . . 1.56 108.932 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 168' ' ' ALA . . . . . 0.432 ' N ' ' O ' ' B' ' 172' ' ' ILE . . . -88.16 -38.05 15.66 Favored 'General case' 0 N--CA 1.423 -1.787 0 N-CA-C 106.402 -1.703 . . . . 1.04 106.402 177.708 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 169' ' ' ALA . . . . . 0.852 ' HB1' ' O ' ' B' ' 129' ' ' GLY . . . -164.07 165.0 22.77 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 109.196 -0.668 . . . . 0.98 109.196 -176.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 170' ' ' ALA . . . . . 0.515 ' HB2' ' O ' ' B' ' 130' ' ' ASP . . . -31.08 108.69 0.05 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.319 0.58 . . . . 1.25 111.284 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 171' ' ' GLY . . . . . 0.85 ' N ' ' O ' ' B' ' 185' ' ' CYS . . . 75.51 -3.3 49.3 Favored Glycine 0 C--O 1.228 -0.25 0 CA-C-N 115.237 -0.892 . . . . 1.29 114.58 179.157 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 172' ' ' ILE . . . . . 0.822 HG13 ' HB2' ' B' ' 134' ' ' CYS . 1.6 mm -96.9 119.1 44.51 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.578 0 CA-C-N 117.723 0.762 . . . . 2.27 110.468 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 173' ' ' CYS . . . . . 0.987 ' HB2' ' HB3' ' B' ' 182' ' ' ASP . 1.9 t -118.96 95.83 4.99 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 114.723 -1.126 . . . . 1.94 108.416 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 174' ' ' CYS . . . . . 1.105 ' HB3' ' HA ' ' B' ' 179' ' ' CYS . 26.6 p -156.26 -174.3 4.88 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 116.9 2.185 . . . . 1.35 116.9 -176.622 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 175' ' ' SER . . . . . 0.517 ' CB ' ' HD2' ' B' ' 176' ' ' PRO . 0.3 OUTLIER -128.53 -178.35 0.78 Allowed Pre-proline 0 N--CA 1.454 -0.239 0 CA-C-N 112.861 -1.972 . . . . 2.0 109.383 -178.877 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 176' ' ' PRO . . . . . 0.517 ' HD2' ' CB ' ' B' ' 175' ' ' SER . 60.3 Cg_endo -73.23 30.95 0.3 Allowed 'Trans proline' 0 CA--C 1.534 0.507 0 C-N-CA 121.865 1.71 . . . . 1.9 113.428 -179.133 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 177' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -125.94 -60.68 1.28 Allowed 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 109.612 -0.514 . . . . 2.72 109.612 178.482 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 178' ' ' GLY . . . . . 0.858 ' O ' ' HB2' ' B' ' 174' ' ' CYS . . . -138.44 -167.36 10.96 Favored Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 110.832 -0.907 . . . . 0.99 110.832 178.393 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 179' ' ' CYS . . . . . 1.105 ' HA ' ' HB3' ' B' ' 174' ' ' CYS . 63.3 m -146.51 161.07 41.24 Favored 'General case' 0 N--CA 1.461 0.101 0 CA-C-N 117.507 0.653 . . . . 1.34 111.632 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 180' ' ' HIS . . . . . . . . . . . . . 34.9 t60 -152.37 150.31 29.56 Favored 'General case' 0 C--N 1.344 0.36 0 C-N-CA 120.014 -0.674 . . . . 2.1 111.401 -178.08 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 181' ' ' GLU . . . . . 0.458 ' HA ' ' O ' ' B' ' 171' ' ' GLY . 0.4 OUTLIER -60.91 140.82 57.62 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.766 -0.652 . . . . 3.06 110.359 179.557 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 182' ' ' ASP . . . . . 0.987 ' HB3' ' HB2' ' B' ' 173' ' ' CYS . 0.0 OUTLIER -137.19 138.27 24.9 Favored Pre-proline 0 CA--C 1.543 0.701 0 CA-C-N 116.005 -0.543 . . . . 2.06 111.852 -179.024 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 183' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' B' ' 182' ' ' ASP . 2.5 Cg_endo -84.41 -31.66 0.46 Allowed 'Trans proline' 0 C--N 1.358 1.068 0 C-N-CA 123.359 2.706 . . . . 1.91 115.256 -177.288 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -59.9 -47.6 85.12 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 108.279 -1.008 . . . . 1.56 108.279 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 185' ' ' CYS . . . . . 0.85 ' O ' ' N ' ' B' ' 171' ' ' GLY . 82.2 m -96.68 71.62 2.61 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 105.7 -1.963 . . . . 1.94 105.7 175.229 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 186' ' ' ASP . . . . . 0.456 ' HB2' ' O ' ' B' ' 183' ' ' PRO . 0.9 OUTLIER . . . . . 0 CA--C 1.497 -1.094 0 C-N-CA 119.055 -1.058 . . . . 3.61 110.644 -177.687 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.556 ' O ' ' C ' ' A' ' 11' ' ' LEU . 67.9 m . . . . . 0 N--CA 1.455 -0.191 0 CA-C-O 118.524 -0.75 . . . . 2.68 112.862 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.922 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 6.9 mp -31.76 108.76 0.28 Allowed Pre-proline 0 N--CA 1.476 0.847 0 CA-C-N 120.036 1.289 . . . . 2.48 110.228 -179.557 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.86 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 89.8 Cg_endo -82.94 135.69 7.74 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 121.621 1.548 . . . . 1.49 114.593 -178.606 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.696 ' N ' ' O ' ' A' ' 19' ' ' GLY . 29.3 p -145.15 -175.06 4.55 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 118.267 -1.373 . . . . 1.0 111.322 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.704 ' HA2' ' HB3' ' A' ' 40' ' ' GLU . . . 75.75 -164.35 53.89 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 120.499 -0.857 . . . . 1.15 114.377 178.025 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.793 ' HD2' HD11 ' A' ' 32' ' ' LEU . 38.3 Cg_endo -63.14 112.75 1.78 Allowed 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 124.861 3.707 . . . . 1.57 109.601 177.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.19 -11.86 53.03 Favored Glycine 0 C--N 1.276 -2.803 0 N-CA-C 110.59 -1.004 . . . . 1.68 110.59 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.692 ' O ' ' HB2' ' A' ' 12' ' ' PRO . . . 68.59 47.3 57.48 Favored Glycine 0 N--CA 1.418 -2.538 0 C-N-CA 117.929 -2.081 . . . . 1.36 111.648 176.629 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.716 ' HD3' ' O ' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -92.26 -28.91 16.7 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 111.858 -2.171 . . . . 2.5 111.907 179.959 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.86 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -103.8 -178.08 25.73 Favored Glycine 0 C--O 1.213 -1.216 0 O-C-N 121.023 -1.048 . . . . 1.02 115.181 -176.009 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.922 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -96.16 144.71 26.15 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 115.579 1.696 . . . . 2.92 115.579 -174.588 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.659 ' C ' ' CD1' ' A' ' 22' ' ' PHE . 0.1 OUTLIER -108.25 170.24 8.13 Favored 'General case' 0 C--N 1.344 0.334 0 CA-C-N 113.49 -1.686 . . . . 1.1 109.36 -179.692 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.659 ' CD1' ' C ' ' A' ' 21' ' ' CYS . 33.8 m-85 -156.8 52.54 0.51 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.966 0.412 . . . . 1.51 110.649 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.518 ' O ' ' SG ' ' A' ' 44' ' ' CYS . . . 133.08 -145.68 17.66 Favored Glycine 0 C--O 1.225 -0.433 0 N-CA-C 111.265 -0.734 . . . . 0.9 111.265 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.741 ' HD2' HD12 ' A' ' 26' ' ' ILE . 37.9 Cg_endo -94.86 -70.19 0.0 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 122.779 2.319 . . . . 1.5 112.145 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.635 ' O ' ' N ' ' A' ' 37' ' ' GLY . 2.8 m -92.5 45.52 1.2 Allowed 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 109.746 -0.465 . . . . 1.26 109.746 179.167 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.811 ' CG2' ' HB3' ' A' ' 74' ' ' CYS . 3.6 mt -145.13 115.04 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 N-CA-C 112.015 0.376 . . . . 0.83 112.015 -177.728 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.58 ' SG ' ' CE2' ' A' ' 35' ' ' PHE . 1.9 t -149.15 123.75 9.78 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-O 121.346 0.593 . . . . 0.92 110.803 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.94 ' HB3' ' HB1' ' A' ' 68' ' ' ALA . 0.5 OUTLIER -126.37 152.5 46.2 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.201 1.0 . . . . 1.28 110.949 -179.852 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 33' ' ' GLY . . . -143.52 -179.83 20.41 Favored Glycine 0 N--CA 1.424 -2.144 0 C-N-CA 120.386 -0.911 . . . . 0.67 111.273 176.211 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -70.01 -44.93 68.32 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 126.351 1.861 . . . . 2.27 112.442 177.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -121.65 23.42 10.22 Favored 'General case' 0 CA--C 1.471 -2.075 0 CA-C-N 112.956 -1.929 . . . . 1.66 111.31 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.812 HD13 ' HZ ' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -125.62 -36.36 2.44 Favored 'General case' 0 N--CA 1.425 -1.685 0 CA-C-N 113.589 -1.641 . . . . 1.37 109.682 -174.623 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.871 ' O ' ' HA ' ' A' ' 28' ' ' CYS . . . 89.96 -138.85 14.76 Favored Glycine 0 N--CA 1.425 -2.045 0 CA-C-N 114.845 -1.071 . . . . 0.73 114.368 177.371 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 1.057 ' SG ' HD13 ' A' ' 72' ' ' ILE . 1.3 m -126.75 121.24 31.44 Favored 'General case' 0 CA--C 1.489 -1.384 0 CA-C-N 119.318 1.559 . . . . 1.08 110.37 177.068 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 1.014 ' HA ' ' HA ' ' B' ' 135' ' ' PHE . 0.0 OUTLIER -119.07 107.49 13.56 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 104.578 -2.379 . . . . 1.38 104.578 176.705 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 1.034 HG23 HG23 ' B' ' 136' ' ' VAL . 1.0 OUTLIER -92.07 89.71 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.552 0 CA-C-O 122.077 0.941 . . . . 0.76 109.849 -178.266 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.635 ' N ' ' O ' ' A' ' 25' ' ' SER . . . 88.37 87.3 1.19 Allowed Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 113.907 -1.497 . . . . 0.81 112.101 -179.141 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.509 HG22 ' O ' ' B' ' 132' ' ' LEU . 40.3 p -150.17 176.03 11.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.807 0.337 . . . . 0.77 110.589 -179.569 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.665 ' HA ' HD12 ' A' ' 42' ' ' LEU . . . -63.92 -41.68 97.6 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.343 -1.355 . . . . 1.02 107.343 177.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.704 ' HB3' ' HA2' ' A' ' 14' ' ' GLY . 3.0 mm-40 -55.82 -34.37 65.3 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 113.884 -1.507 . . . . 2.32 110.201 179.205 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.842 ' O ' ' HB2' ' A' ' 44' ' ' CYS . . . -82.75 -37.63 24.37 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 115.349 -0.841 . . . . 0.87 109.953 -179.264 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.665 HD12 ' HA ' ' A' ' 39' ' ' ALA . 0.2 OUTLIER -38.96 -32.92 0.1 Allowed 'General case' 0 C--O 1.24 0.564 0 CA-C-O 121.105 0.479 . . . . 1.23 110.685 -178.672 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.448 ' O ' ' N ' ' A' ' 45' ' ' GLN . 2.1 mmm180 -51.97 -29.02 18.82 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 108.239 -1.023 . . . . 2.92 108.239 176.361 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.842 ' HB2' ' O ' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -44.65 -2.66 0.01 OUTLIER 'General case' 0 C--O 1.239 0.552 0 N-CA-C 115.434 1.642 . . . . 1.57 115.434 -176.621 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.448 ' N ' ' O ' ' A' ' 43' ' ' ARG . 0.3 OUTLIER -88.99 3.37 51.86 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 122.624 2.466 . . . . 3.31 107.203 174.976 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -83.56 11.33 7.28 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 108.505 -0.924 . . . . 3.69 108.505 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.447 -0.613 0 N-CA-C 109.263 -0.644 . . . . 3.99 109.263 176.453 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 66.0 m . . . . . 0 CA--C 1.558 1.27 0 N-CA-C 112.189 0.44 . . . . 3.12 112.189 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 66' ' ' ARG . . . -133.43 123.11 3.29 Favored Glycine 0 CA--C 1.49 -1.504 0 CA-C-N 114.983 -1.008 . . . . 2.1 111.995 -176.765 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -111.12 78.78 1.14 Allowed 'General case' 0 N--CA 1.439 -0.988 0 CA-C-O 121.951 0.881 . . . . 4.36 108.901 178.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.753 ' CB ' ' HB2' ' A' ' 67' ' ' CYS . 0.4 OUTLIER -138.15 68.88 48.73 Favored Pre-proline 0 C--N 1.305 -1.326 0 CA-C-O 122.96 1.362 . . . . 3.55 108.247 -179.799 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.442 ' HA ' ' O ' ' A' ' 65' ' ' GLY . 14.6 Cg_endo -55.59 86.78 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.589 2.859 . . . . 1.54 115.191 -178.512 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.649 ' N ' ' O ' ' A' ' 65' ' ' GLY . 1.8 m -96.64 -173.8 2.84 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 113.786 -1.552 . . . . 1.59 107.062 176.249 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 45.14 -167.03 0.04 OUTLIER Glycine 0 CA--C 1.53 0.97 0 C-N-CA 119.837 -1.173 . . . . 2.43 114.36 175.411 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 6.5 t -84.2 61.02 6.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 122.683 1.23 . . . . 4.11 111.256 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 109.93 3.89 29.81 Favored Glycine 0 CA--C 1.532 1.144 0 CA-C-N 112.585 -2.098 . . . . 2.21 116.209 176.496 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.649 ' O ' ' N ' ' A' ' 61' ' ' CYS . . . -101.4 142.8 15.86 Favored Glycine 0 C--O 1.225 -0.442 0 C-N-CA 117.227 -2.416 . . . . 1.62 115.995 -175.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.468 ' HB2' ' O ' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -98.03 154.0 18.01 Favored 'General case' 0 C--N 1.335 -0.055 0 CA-C-N 114.549 -0.826 . . . . 3.02 110.142 179.274 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.753 ' HB2' ' CB ' ' A' ' 59' ' ' LYS . 3.7 t -44.98 109.48 0.17 Allowed 'General case' 0 CA--C 1.506 -0.74 0 CA-C-O 121.257 0.551 . . . . 1.52 111.763 -178.437 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.94 ' HB1' ' HB3' ' A' ' 28' ' ' CYS . . . -100.39 -15.42 17.96 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 108.074 -1.084 . . . . 1.07 108.074 177.671 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -168.19 162.26 12.77 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 114.532 -1.213 . . . . 1.0 110.872 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.562 ' HA ' ' HB3' ' A' ' 85' ' ' CYS . . . -73.3 74.87 1.34 Allowed 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 121.446 0.641 . . . . 1.24 112.673 -179.422 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.73 ' O ' ' HA ' ' A' ' 81' ' ' GLU . . . 163.53 -51.57 0.3 Allowed Glycine 0 N--CA 1.437 -1.298 0 CA-C-N 114.983 -1.008 . . . . 1.28 112.952 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 1.057 HD13 ' SG ' ' A' ' 34' ' ' CYS . 0.6 OUTLIER -126.63 140.23 49.49 Favored 'Isoleucine or valine' 0 C--O 1.248 0.99 0 CA-C-O 122.83 1.3 . . . . 2.27 110.704 -175.936 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.549 ' HB2' ' HB2' ' A' ' 61' ' ' CYS . 47.9 m -112.15 113.19 25.3 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 114.895 -1.048 . . . . 1.98 110.258 -179.224 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.811 ' HB3' ' CG2' ' A' ' 26' ' ' ILE . 64.6 m -78.58 144.03 35.92 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.596 -0.729 . . . . 1.33 111.105 -178.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.715 ' HB2' ' HD2' ' A' ' 76' ' ' PRO . 92.0 p -136.76 179.95 1.23 Allowed Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 114.318 -1.31 . . . . 1.99 108.742 -178.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.715 ' HD2' ' HB2' ' A' ' 75' ' ' SER . 66.9 Cg_endo -76.32 29.88 0.4 Allowed 'Trans proline' 0 N--CA 1.452 -0.93 0 N-CA-C 109.822 -0.876 . . . . 1.86 109.822 177.705 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.545 ' H ' ' C ' ' A' ' 75' ' ' SER . 2.0 m-20 -144.29 -46.73 0.26 Allowed 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.17 -0.923 . . . . 2.65 111.171 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 1.013 ' HA2' HG11 ' A' ' 36' ' ' VAL . . . -170.5 -155.99 10.89 Favored Glycine 0 C--N 1.34 0.785 0 C-N-CA 119.745 -1.217 . . . . 0.99 115.313 179.516 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 1.011 ' SG ' HG22 ' A' ' 36' ' ' VAL . 10.4 m -140.98 129.29 22.32 Favored 'General case' 0 CA--C 1.555 1.171 0 CA-C-O 122.732 1.253 . . . . 1.34 107.767 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.472 ' CA ' HG22 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -144.42 132.2 21.29 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-N 112.414 -2.175 . . . . 2.17 112.443 -168.392 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.73 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 0.4 OUTLIER -47.36 142.24 4.24 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 114.036 -1.438 . . . . 3.05 109.981 -179.7 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.682 ' OD1' ' HB2' ' A' ' 85' ' ' CYS . 3.1 p-10 -145.26 137.37 13.22 Favored Pre-proline 0 C--N 1.309 -1.174 0 CA-C-N 115.712 -0.676 . . . . 2.02 109.738 -178.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 82' ' ' ASP . 52.7 Cg_exo -57.87 -35.42 98.79 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.667 2.245 . . . . 1.93 114.373 -177.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.8 -51.69 60.82 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 108.616 -0.883 . . . . 1.53 108.616 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.682 ' HB2' ' OD1' ' A' ' 82' ' ' ASP . 3.2 m -98.74 77.09 2.23 Favored 'General case' 0 CA--C 1.499 -1.015 0 N-CA-C 106.703 -1.591 . . . . 1.88 106.703 176.401 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.5 -0.944 0 C-N-CA 119.301 -0.96 . . . . 3.6 110.06 -178.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 110' ' ' CYS . . . . . 0.566 ' O ' ' C ' ' B' ' 111' ' ' LEU . 67.5 m . . . . . 0 CA--C 1.527 0.095 0 CA-C-O 118.544 -0.741 . . . . 2.61 112.894 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 111' ' ' LEU . . . . . 0.891 ' O ' ' HA ' ' B' ' 120' ' ' ARG . 6.9 mp -31.29 108.67 0.27 Allowed Pre-proline 0 N--CA 1.477 0.892 0 CA-C-N 119.962 1.256 . . . . 2.47 110.332 -179.283 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 112' ' ' PRO . . . . . 0.918 ' HA ' ' O ' ' B' ' 119' ' ' GLY . 84.0 Cg_endo -81.62 138.14 10.56 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 121.926 1.751 . . . . 1.47 113.696 -179.208 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.564 ' N ' ' O ' ' B' ' 119' ' ' GLY . 31.2 p -149.14 -178.7 6.53 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 120.697 -0.401 . . . . 1.0 111.499 178.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 114' ' ' GLY . . . . . 0.716 ' HA2' ' HB3' ' B' ' 140' ' ' GLU . . . 76.06 -163.1 53.07 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 120.793 -0.718 . . . . 1.16 113.929 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 115' ' ' PRO . . . . . 0.825 ' HD2' HD11 ' B' ' 132' ' ' LEU . 38.8 Cg_endo -64.37 101.5 0.36 Allowed 'Trans proline' 0 N--CA 1.485 1.005 0 C-N-CA 125.234 3.956 . . . . 1.57 114.784 178.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 89.53 -8.05 80.65 Favored Glycine 0 C--N 1.28 -2.566 0 CA-C-N 114.263 -1.335 . . . . 1.7 110.992 -175.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 117' ' ' GLY . . . . . 0.641 ' O ' ' HB2' ' B' ' 112' ' ' PRO . . . 65.28 55.25 22.18 Favored Glycine 0 N--CA 1.421 -2.345 0 CA-C-O 122.451 1.028 . . . . 1.38 111.568 179.081 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 118' ' ' LYS . . . . . 0.654 ' HD3' ' O ' ' B' ' 115' ' ' PRO . 0.0 OUTLIER -94.32 -26.13 16.7 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 112.494 -1.853 . . . . 2.54 111.408 177.94 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 119' ' ' GLY . . . . . 0.918 ' O ' ' HA ' ' B' ' 112' ' ' PRO . . . -95.79 -175.61 36.73 Favored Glycine 0 C--O 1.212 -1.255 0 N-CA-C 116.728 1.451 . . . . 1.04 116.728 -176.533 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.891 ' HA ' ' O ' ' B' ' 111' ' ' LEU . 0.0 OUTLIER -105.12 142.44 34.89 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 112.729 -1.735 . . . . 2.89 114.71 -178.112 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 121' ' ' CYS . . . . . 0.657 ' C ' ' CD1' ' B' ' 122' ' ' PHE . 0.1 OUTLIER -108.05 169.92 8.32 Favored 'General case' 0 C--N 1.342 0.267 0 CA-C-N 113.573 -1.649 . . . . 1.07 109.3 -178.717 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 122' ' ' PHE . . . . . 0.657 ' CD1' ' C ' ' B' ' 121' ' ' CYS . 33.1 m-85 -156.81 52.55 0.51 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.032 0.444 . . . . 1.53 110.574 -179.62 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 123' ' ' GLY . . . . . 0.523 ' O ' ' SG ' ' B' ' 144' ' ' CYS . . . 133.09 -145.63 17.63 Favored Glycine 0 C--N 1.334 0.44 0 N-CA-C 111.322 -0.711 . . . . 0.9 111.322 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 124' ' ' PRO . . . . . 0.769 ' HD2' HD12 ' B' ' 126' ' ' ILE . 37.7 Cg_endo -95.02 -70.22 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 122.729 2.286 . . . . 1.51 112.064 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 125' ' ' SER . . . . . 0.651 ' O ' ' N ' ' B' ' 137' ' ' GLY . 2.8 m -92.27 45.08 1.19 Allowed 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.715 -0.476 . . . . 1.25 109.715 179.093 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 126' ' ' ILE . . . . . 0.81 ' CG2' ' HB3' ' B' ' 174' ' ' CYS . 3.4 mt -144.01 114.54 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 N-CA-C 112.317 0.488 . . . . 0.85 112.317 -177.77 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 127' ' ' CYS . . . . . 0.587 ' SG ' ' CE2' ' B' ' 135' ' ' PHE . 1.7 t -148.55 124.4 10.58 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 121.039 0.447 . . . . 0.89 110.887 179.368 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 128' ' ' CYS . . . . . 0.951 ' HB3' ' HB1' ' B' ' 168' ' ' ALA . 0.8 OUTLIER -129.34 150.44 50.7 Favored 'General case' 0 CA--C 1.509 -0.619 0 CA-C-N 115.896 -0.593 . . . . 1.23 111.484 -178.868 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 129' ' ' GLY . . . . . 0.418 ' O ' ' HB2' ' B' ' 169' ' ' ALA . . . -141.67 -174.46 14.51 Favored Glycine 0 N--CA 1.422 -2.236 0 CA-C-N 120.089 1.313 . . . . 0.66 110.135 177.2 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -74.33 -44.55 52.01 Favored 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 126.215 1.806 . . . . 2.35 112.375 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -124.32 33.26 5.3 Favored 'General case' 0 CA--C 1.483 -1.606 0 CA-C-N 113.911 -1.495 . . . . 1.69 110.034 177.021 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 132' ' ' LEU . . . . . 0.829 HD13 ' HZ ' ' B' ' 135' ' ' PHE . 0.9 OUTLIER -130.1 -37.7 1.46 Allowed 'General case' 0 N--CA 1.411 -2.38 0 CA-C-N 114.239 -1.346 . . . . 1.38 108.531 -179.418 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 133' ' ' GLY . . . . . 0.915 ' O ' ' HA ' ' B' ' 128' ' ' CYS . . . 79.25 -151.43 34.85 Favored Glycine 0 N--CA 1.435 -1.369 0 CA-C-N 113.585 -1.643 . . . . 0.72 111.195 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 134' ' ' CYS . . . . . 1.056 ' SG ' HD13 ' B' ' 172' ' ' ILE . 3.0 m -107.93 124.2 49.77 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-N 119.691 1.745 . . . . 1.08 112.084 -175.475 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 135' ' ' PHE . . . . . 1.014 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -121.09 106.97 12.05 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 104.499 -2.408 . . . . 1.36 104.499 174.263 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 136' ' ' VAL . . . . . 1.073 HG22 ' SG ' ' B' ' 179' ' ' CYS . 1.8 t -91.7 89.82 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.396 0 CA-C-O 122.091 0.948 . . . . 0.75 109.635 -178.235 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 137' ' ' GLY . . . . . 0.651 ' N ' ' O ' ' B' ' 125' ' ' SER . . . 87.56 88.59 1.09 Allowed Glycine 0 C--O 1.228 -0.231 0 CA-C-N 114.133 -1.394 . . . . 0.83 112.012 -179.115 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 138' ' ' THR . . . . . 0.505 HG22 ' O ' ' A' ' 32' ' ' LEU . 43.5 p -154.13 171.12 19.64 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 110.313 -0.255 . . . . 0.78 110.313 -179.252 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 139' ' ' ALA . . . . . 0.722 ' HA ' HD12 ' B' ' 142' ' ' LEU . . . -60.51 -39.48 87.94 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.484 -0.932 . . . . 1.04 108.484 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 140' ' ' GLU . . . . . 0.716 ' HB3' ' HA2' ' B' ' 114' ' ' GLY . 3.0 mm-40 -57.46 -33.61 68.15 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.307 -0.861 . . . . 2.31 110.094 178.281 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 141' ' ' ALA . . . . . 0.8 ' O ' ' HB2' ' B' ' 144' ' ' CYS . . . -82.11 -39.06 23.89 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 115.062 -0.972 . . . . 0.87 109.508 -179.067 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 142' ' ' LEU . . . . . 0.722 HD12 ' HA ' ' B' ' 139' ' ' ALA . 0.2 OUTLIER -38.94 -31.41 0.06 Allowed 'General case' 0 C--O 1.232 0.156 0 CA-C-N 117.871 0.305 . . . . 1.24 111.578 -178.483 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 143' ' ' ARG . . . . . 0.451 ' O ' ' N ' ' B' ' 145' ' ' GLN . 2.1 mmm180 -52.57 -28.93 23.01 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.401 -0.962 . . . . 2.93 108.401 176.243 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 144' ' ' CYS . . . . . 0.8 ' HB2' ' O ' ' B' ' 141' ' ' ALA . 0.1 OUTLIER -41.94 -8.11 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 113.648 -1.614 . . . . 1.61 115.002 -176.79 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 145' ' ' GLN . . . . . 0.451 ' N ' ' O ' ' B' ' 143' ' ' ARG . 0.3 OUTLIER -84.51 -0.19 52.13 Favored 'General case' 0 C--O 1.242 0.709 0 CA-C-O 122.525 1.155 . . . . 3.35 108.357 176.098 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -83.91 11.48 7.63 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 115.072 -0.967 . . . . 3.76 109.064 179.418 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.448 -0.546 0 N-CA-C 109.14 -0.689 . . . . 4.01 109.14 176.44 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 74.4 m . . . . . 0 CA--C 1.539 0.521 0 N-CA-C 113.508 0.929 . . . . 3.11 113.508 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 157' ' ' GLY . . . . . 0.436 ' O ' ' HB2' ' B' ' 166' ' ' ARG . . . -146.92 126.36 2.42 Favored Glycine 0 N--CA 1.439 -1.104 0 N-CA-C 109.794 -1.322 . . . . 2.07 109.794 178.61 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -112.55 68.02 0.67 Allowed 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 118.784 -1.166 . . . . 4.34 110.023 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 159' ' ' LYS . . . . . 0.848 ' CB ' ' HB2' ' B' ' 167' ' ' CYS . 0.1 OUTLIER -110.9 63.95 0.45 Allowed Pre-proline 0 C--N 1.318 -0.787 0 CA-C-N 113.875 -1.511 . . . . 3.54 112.059 174.514 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 160' ' ' PRO . . . . . 0.441 ' HA ' ' O ' ' B' ' 165' ' ' GLY . 12.8 Cg_endo -55.37 86.78 0.04 OUTLIER 'Trans proline' 0 C--N 1.325 -0.682 0 C-N-CA 121.945 1.764 . . . . 1.51 116.391 -175.552 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 161' ' ' CYS . . . . . 0.649 ' N ' ' O ' ' B' ' 165' ' ' GLY . 1.4 m -98.81 -177.9 3.8 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.146 -1.427 . . . . 1.58 107.146 175.773 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 51.58 -167.27 0.71 Allowed Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.365 -0.921 . . . . 2.37 113.956 176.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 7.3 t -84.99 59.39 5.59 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 122.282 1.039 . . . . 4.07 111.664 -178.486 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 108.84 9.19 26.89 Favored Glycine 0 CA--C 1.544 1.9 0 CA-C-N 113.218 -1.81 . . . . 2.2 115.963 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 165' ' ' GLY . . . . . 0.649 ' O ' ' N ' ' B' ' 161' ' ' CYS . . . -102.59 141.76 15.34 Favored Glycine 0 C--N 1.312 -0.805 0 CA-C-N 121.631 2.716 . . . . 1.62 115.366 -176.503 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 166' ' ' ARG . . . . . 0.436 ' HB2' ' O ' ' B' ' 157' ' ' GLY . 0.0 OUTLIER -97.94 153.96 18.0 Favored 'General case' 0 N--CA 1.458 -0.056 0 CA-C-N 115.036 -0.582 . . . . 3.05 109.853 178.478 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 167' ' ' CYS . . . . . 0.848 ' HB2' ' CB ' ' B' ' 159' ' ' LYS . 3.6 t -45.42 109.57 0.18 Allowed 'General case' 0 CA--C 1.505 -0.75 0 CA-C-O 121.061 0.458 . . . . 1.56 111.975 -178.403 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 168' ' ' ALA . . . . . 0.951 ' HB1' ' HB3' ' B' ' 128' ' ' CYS . . . -99.83 -15.58 18.36 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 108.189 -1.041 . . . . 1.04 108.189 177.413 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 169' ' ' ALA . . . . . 0.418 ' HB2' ' O ' ' B' ' 129' ' ' GLY . . . -168.03 161.98 12.98 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 114.075 -1.42 . . . . 0.98 111.33 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 170' ' ' ALA . . . . . 0.586 ' HA ' ' HB3' ' B' ' 185' ' ' CYS . . . -72.98 74.94 1.19 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.375 0.607 . . . . 1.25 112.622 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 171' ' ' GLY . . . . . 0.763 ' O ' ' HA ' ' B' ' 181' ' ' GLU . . . 163.43 -52.9 0.3 Allowed Glycine 0 C--O 1.22 -0.724 0 CA-C-N 115.231 -0.895 . . . . 1.29 112.504 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 172' ' ' ILE . . . . . 1.056 HD13 ' SG ' ' B' ' 134' ' ' CYS . 0.6 OUTLIER -124.17 139.72 49.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-O 122.93 1.348 . . . . 2.27 111.663 -175.998 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 173' ' ' CYS . . . . . 0.547 ' HB2' ' HB2' ' B' ' 161' ' ' CYS . 48.6 m -112.3 113.5 25.76 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.914 -1.039 . . . . 1.94 110.017 -179.402 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 174' ' ' CYS . . . . . 0.81 ' HB3' ' CG2' ' B' ' 126' ' ' ILE . 64.1 m -79.41 144.03 34.49 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 115.476 -0.784 . . . . 1.35 110.913 -178.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 175' ' ' SER . . . . . 0.704 ' HB2' ' HD2' ' B' ' 176' ' ' PRO . 59.8 p -136.68 179.86 1.25 Allowed Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 114.328 -1.305 . . . . 2.0 108.799 -178.69 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 176' ' ' PRO . . . . . 0.704 ' HD2' ' HB2' ' B' ' 175' ' ' SER . 66.9 Cg_endo -76.39 29.76 0.4 Allowed 'Trans proline' 0 N--CA 1.454 -0.835 0 N-CA-C 109.679 -0.931 . . . . 1.9 109.679 177.614 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 177' ' ' ASP . . . . . 0.541 ' H ' ' C ' ' B' ' 175' ' ' SER . 2.0 m-20 -144.01 -46.44 0.27 Allowed 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.237 -0.892 . . . . 2.72 111.145 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 178' ' ' GLY . . . . . 1.006 ' HA2' HG11 ' B' ' 136' ' ' VAL . . . -171.72 -155.42 10.88 Favored Glycine 0 C--N 1.342 0.874 0 C-N-CA 119.796 -1.192 . . . . 0.99 115.149 179.03 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 179' ' ' CYS . . . . . 1.073 ' SG ' HG22 ' B' ' 136' ' ' VAL . 10.0 m -140.32 136.18 32.95 Favored 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 107.027 -1.471 . . . . 1.34 107.027 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 180' ' ' HIS . . . . . 0.52 ' CA ' HG22 ' B' ' 172' ' ' ILE . 0.2 OUTLIER -156.81 131.48 8.8 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 124.069 1.89 . . . . 2.1 111.824 -167.639 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 181' ' ' GLU . . . . . 0.763 ' HA ' ' O ' ' B' ' 171' ' ' GLY . 0.3 OUTLIER -45.87 141.23 3.16 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 110.326 -3.125 . . . . 3.06 109.851 -177.605 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 182' ' ' ASP . . . . . 0.684 ' OD1' ' HB2' ' B' ' 185' ' ' CYS . 3.1 p-10 -145.15 137.29 13.21 Favored Pre-proline 0 C--N 1.306 -1.291 0 CA-C-N 115.32 -0.854 . . . . 2.06 109.628 -178.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 183' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' B' ' 182' ' ' ASP . 52.1 Cg_exo -57.73 -35.37 98.83 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.618 2.212 . . . . 1.91 114.425 -177.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -64.84 -51.57 61.37 Favored 'General case' 0 CA--C 1.508 -0.656 0 N-CA-C 108.701 -0.851 . . . . 1.56 108.701 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 185' ' ' CYS . . . . . 0.684 ' HB2' ' OD1' ' B' ' 182' ' ' ASP . 3.2 m -98.97 77.08 2.17 Favored 'General case' 0 CA--C 1.499 -0.998 0 N-CA-C 106.772 -1.566 . . . . 1.94 106.772 176.319 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 186' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.5 -0.943 0 C-N-CA 119.469 -0.892 . . . . 3.61 110.184 -178.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.2 m . . . . . 0 C--O 1.232 0.164 0 N-CA-C 112.628 0.603 . . . . 2.68 112.628 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.662 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 0.3 OUTLIER -36.18 112.5 0.52 Allowed Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.804 -0.634 . . . . 2.48 112.628 178.443 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.563 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 56.3 Cg_endo -91.75 145.22 3.11 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 121.696 1.597 . . . . 1.49 113.808 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.682 ' O ' ' HA2' ' A' ' 17' ' ' GLY . 20.8 p -146.12 -174.26 4.39 Favored 'General case' 0 C--N 1.347 0.487 0 C-N-CA 119.043 -1.063 . . . . 1.0 113.543 -179.022 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.625 ' HA2' ' HG3' ' A' ' 40' ' ' GLU . . . 73.99 -161.38 53.88 Favored Glycine 0 N--CA 1.451 -0.317 0 CA-C-N 115.3 -0.864 . . . . 1.15 113.547 177.333 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.541 ' O ' ' HG3' ' A' ' 18' ' ' LYS . 39.7 Cg_endo -63.26 101.03 0.28 Allowed 'Trans proline' 0 N--CA 1.481 0.785 0 C-N-CA 123.664 2.909 . . . . 1.57 109.211 176.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 82.85 13.21 78.33 Favored Glycine 0 C--N 1.291 -1.917 0 C-N-CA 120.847 -0.692 . . . . 1.68 111.993 178.258 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.682 ' HA2' ' O ' ' A' ' 13' ' ' CYS . . . 51.8 49.09 49.1 Favored Glycine 0 N--CA 1.409 -3.136 0 N-CA-C 107.897 -2.081 . . . . 1.36 107.897 174.61 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.541 ' HG3' ' O ' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -99.94 18.52 18.19 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 112.519 -1.841 . . . . 2.5 111.553 174.299 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.563 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -131.73 -177.7 15.05 Favored Glycine 0 N--CA 1.444 -0.789 0 N-CA-C 104.405 -3.478 . . . . 1.02 104.405 176.636 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.662 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -124.41 172.58 9.03 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 120.538 2.169 . . . . 2.92 109.453 178.754 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.501 ' HB2' ' HB3' ' A' ' 11' ' ' LEU . 0.8 OUTLIER -105.64 134.97 47.9 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 121.334 -0.854 . . . . 1.1 111.16 -178.367 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.516 ' HE2' ' HA ' ' A' ' 56' ' ' SER . 68.0 m-85 -128.2 13.79 6.68 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.3 -0.864 . . . . 1.51 111.253 -179.472 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -176.16 -167.82 35.49 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.391 -0.909 . . . . 0.9 112.525 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.523 ' O ' ' HB3' ' A' ' 44' ' ' CYS . 1.9 Cg_endo -81.76 -44.26 0.09 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.814 2.343 . . . . 1.5 112.746 -179.43 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.438 ' HB2' ' OE2' ' B' ' 181' ' ' GLU . 0.1 OUTLIER -124.62 16.03 8.8 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.938 0.399 . . . . 1.26 110.797 179.823 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.755 HG23 ' HA ' ' A' ' 36' ' ' VAL . 0.8 OUTLIER -126.23 121.76 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.09 0 CA-C-O 121.464 0.649 . . . . 0.83 111.563 -178.041 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.884 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -119.1 132.86 56.04 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-N 115.641 -0.709 . . . . 0.92 109.108 179.051 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 1.133 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -144.82 116.15 8.01 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 112.52 0.563 . . . . 1.28 112.52 -178.718 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.676 ' O ' ' HB1' ' A' ' 69' ' ' ALA . . . -107.43 -163.54 21.74 Favored Glycine 0 N--CA 1.428 -1.866 0 N-CA-C 109.806 -1.318 . . . . 0.67 109.806 177.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.407 ' O ' ' HB2' ' A' ' 70' ' ' ALA . 11.4 t70 -67.54 -60.37 2.61 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 113.885 1.069 . . . . 2.27 113.885 -179.304 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.51 9.33 23.2 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 115.661 -0.699 . . . . 1.66 111.122 -176.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.825 ' O ' HG22 ' B' ' 138' ' ' THR . 1.0 OUTLIER -109.71 -18.96 13.33 Favored 'General case' 0 N--CA 1.405 -2.687 0 N-CA-C 106.791 -1.559 . . . . 1.37 106.791 179.982 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 1.133 ' O ' ' HA ' ' A' ' 28' ' ' CYS . . . 68.8 -133.86 27.43 Favored Glycine 0 N--CA 1.43 -1.755 0 CA-C-N 114.919 -1.037 . . . . 0.73 115.257 173.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.876 ' HB2' HG13 ' A' ' 72' ' ' ILE . 3.1 t -136.26 117.69 14.74 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-N 118.387 1.094 . . . . 1.08 113.254 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.885 ' HA ' ' HA ' ' B' ' 135' ' ' PHE . 0.0 OUTLIER -100.03 108.67 20.91 Favored 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 106.786 -1.561 . . . . 1.38 106.786 176.984 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.755 ' HA ' HG23 ' A' ' 26' ' ' ILE . 1.7 t -90.92 87.07 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.304 0 CA-C-O 122.473 1.13 . . . . 0.76 110.269 -179.048 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.441 ' O ' ' HA3' ' B' ' 133' ' ' GLY . . . 102.55 69.29 0.82 Allowed Glycine 0 C--O 1.228 -0.26 0 CA-C-N 112.99 -1.913 . . . . 0.81 113.953 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.881 HG22 ' O ' ' B' ' 132' ' ' LEU . 72.4 p -151.29 164.51 36.46 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 109.251 -0.648 . . . . 0.77 109.251 179.174 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.756 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -70.62 -16.26 62.82 Favored 'General case' 0 N--CA 1.44 -0.968 0 C-N-CA 119.975 -0.69 . . . . 1.02 110.308 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.625 ' HG3' ' HA2' ' A' ' 14' ' ' GLY . 5.0 mp0 -67.57 -15.83 63.86 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.424 -0.954 . . . . 2.32 108.424 176.228 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 1.051 ' O ' ' HB2' ' A' ' 44' ' ' CYS . . . -120.91 -10.57 9.08 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-N 116.361 -0.381 . . . . 0.87 111.221 -178.568 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.756 HD12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -61.71 -20.4 63.46 Favored 'General case' 0 N--CA 1.45 -0.439 0 O-C-N 121.211 -0.93 . . . . 1.23 113.229 -177.867 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.69 ' N ' HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -71.6 -6.78 43.43 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 107.556 -1.276 . . . . 2.92 107.556 174.95 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 1.051 ' HB2' ' O ' ' A' ' 41' ' ' ALA . 0.2 OUTLIER -66.53 -1.54 3.73 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 112.361 -2.2 . . . . 1.57 110.012 176.462 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -82.84 -17.35 44.26 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.02 0.438 . . . . 3.31 111.457 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -85.51 6.42 27.08 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 120.107 -0.637 . . . . 3.69 109.892 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.404 ' HG3' HD13 ' A' ' 11' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.446 -0.634 0 N-CA-C 109.416 -0.587 . . . . 3.99 109.416 177.427 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.516 ' HA ' ' HE2' ' A' ' 22' ' ' PHE . 0.3 OUTLIER . . . . . 0 C--O 1.234 0.289 0 N-CA-C 111.441 0.163 . . . . 3.12 111.441 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 160.41 133.73 1.54 Allowed Glycine 0 N--CA 1.444 -0.819 0 N-CA-C 106.509 -2.637 . . . . 2.1 106.509 -179.369 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -109.0 76.9 1.03 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 118.991 1.396 . . . . 4.36 111.614 -177.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.477 ' N ' ' CD ' ' A' ' 60' ' ' PRO . 0.4 OUTLIER -145.79 57.19 3.88 Favored Pre-proline 0 C--N 1.309 -1.175 0 N-CA-C 106.33 -1.73 . . . . 3.55 106.33 176.799 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.477 ' CD ' ' N ' ' A' ' 59' ' ' LYS . 41.0 Cg_endo -70.3 81.76 0.92 Allowed 'Trans proline' 0 N--CA 1.448 -1.159 0 C-N-CA 122.096 1.864 . . . . 1.54 113.772 -178.123 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -103.08 179.31 4.31 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 106.988 -1.486 . . . . 1.59 106.988 177.127 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.16 -169.34 46.49 Favored Glycine 0 N--CA 1.437 -1.246 0 C-N-CA 118.656 -1.735 . . . . 2.43 114.607 178.661 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 50.2 p -85.46 47.26 1.4 Allowed 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 113.504 -1.348 . . . . 4.11 111.394 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 118.06 5.9 12.93 Favored Glycine 0 C--N 1.336 0.552 0 N-CA-C 115.828 1.091 . . . . 2.21 115.828 175.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.551 ' HA3' ' HA ' ' A' ' 74' ' ' CYS . . . -105.77 137.41 13.76 Favored Glycine 0 CA--C 1.52 0.385 0 N-CA-C 117.044 1.577 . . . . 1.62 117.044 -177.103 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.436 ' HA ' ' O ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -107.41 153.76 22.32 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 114.176 -1.012 . . . . 3.02 109.111 177.668 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.792 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 2.2 m -59.41 107.64 0.6 Allowed 'General case' 0 N--CA 1.441 -0.891 0 O-C-N 121.968 -0.457 . . . . 1.52 111.442 -177.767 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -84.21 -20.23 32.68 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.308 -0.627 . . . . 1.07 109.308 177.496 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.703 ' HB3' ' CG1' ' A' ' 72' ' ' ILE . . . -166.46 164.07 17.23 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.776 -0.647 . . . . 1.0 111.62 179.123 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.623 ' HA ' ' O ' ' A' ' 85' ' ' CYS . . . -39.76 96.9 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.778 -0.646 . . . . 1.24 110.185 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 1.044 ' C ' HD13 ' A' ' 72' ' ' ILE . . . 73.57 50.23 12.32 Favored Glycine 0 CA--C 1.504 -0.655 0 CA-C-N 114.877 -1.056 . . . . 1.28 111.456 -179.126 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 1.044 HD13 ' C ' ' A' ' 71' ' ' GLY . 0.5 OUTLIER -137.51 98.88 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.817 0 N-CA-C 108.049 -1.093 . . . . 2.27 108.049 170.969 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.461 ' O ' ' HB2' ' A' ' 80' ' ' HIS . 51.2 t -91.91 96.27 10.29 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 108.613 -0.884 . . . . 1.98 108.613 179.383 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 1.066 ' CB ' ' HA ' ' A' ' 79' ' ' CYS . 24.4 p -167.3 -171.57 1.75 Allowed 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 116.577 2.066 . . . . 1.33 116.577 -176.765 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.883 ' HB3' ' HD2' ' A' ' 76' ' ' PRO . 72.8 m -124.6 -178.9 0.74 Allowed Pre-proline 0 CA--C 1.531 0.225 0 CA-C-N 112.927 -1.942 . . . . 1.99 108.564 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.883 ' HD2' ' HB3' ' A' ' 75' ' ' SER . 58.0 Cg_endo -73.16 31.17 0.3 Allowed 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 121.717 1.611 . . . . 1.86 113.172 -179.271 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -134.36 -60.94 0.79 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.85 0.357 . . . . 2.65 110.221 178.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.935 ' O ' ' HB2' ' A' ' 74' ' ' CYS . . . -118.22 -178.51 17.14 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.95 -0.643 . . . . 0.99 111.661 178.727 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 1.066 ' HA ' ' CB ' ' A' ' 74' ' ' CYS . 22.5 m -152.27 161.37 42.72 Favored 'General case' 0 C--O 1.226 -0.169 0 N-CA-C 112.428 0.529 . . . . 1.34 112.428 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.541 ' HA ' ' HA2' ' B' ' 178' ' ' GLY . 7.1 m80 -143.17 139.04 30.16 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-O 121.173 0.511 . . . . 2.17 111.823 -178.509 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.477 ' OE2' ' HB2' ' B' ' 125' ' ' SER . 37.0 tt0 -65.51 122.97 18.43 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-N 115.671 -0.695 . . . . 3.05 109.605 178.114 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.698 ' O ' ' HA2' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -138.9 106.75 7.47 Favored Pre-proline 0 C--N 1.319 -0.749 0 C-N-CA 118.963 -1.095 . . . . 2.02 111.385 179.424 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -63.85 -16.65 56.07 Favored 'Trans proline' 0 C--N 1.356 0.948 0 C-N-CA 123.004 2.47 . . . . 1.93 114.315 -178.301 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.08 -40.16 96.86 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.108 0.48 . . . . 1.53 110.542 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.632 ' O ' ' N ' ' A' ' 71' ' ' GLY . 68.8 m -94.18 46.74 1.17 Allowed 'General case' 0 C--O 1.219 -0.55 0 CA-C-N 115.484 -0.78 . . . . 1.88 110.351 179.457 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.475 0.803 0 O-C-N 121.544 -0.722 . . . . 3.6 112.027 -178.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 110' ' ' CYS . . . . . . . . . . . . . 1.2 m . . . . . 0 CA--C 1.52 -0.2 0 CA-C-O 121.247 0.546 . . . . 2.61 111.457 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 111' ' ' LEU . . . . . 0.748 ' O ' ' HA ' ' B' ' 120' ' ' ARG . 0.2 OUTLIER -37.92 112.08 0.61 Allowed Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.007 -0.997 . . . . 2.47 112.367 176.864 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 112' ' ' PRO . . . . . 0.433 ' HA ' ' O ' ' B' ' 119' ' ' GLY . 88.6 Cg_endo -84.49 153.28 12.02 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.339 2.026 . . . . 1.47 111.018 178.399 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.508 ' O ' ' HA2' ' B' ' 117' ' ' GLY . 20.0 p -154.33 -174.71 5.07 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 113.638 0.977 . . . . 1.0 113.638 174.588 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 114' ' ' GLY . . . . . 0.606 ' HA2' ' HG3' ' B' ' 140' ' ' GLU . . . 73.54 -161.44 54.15 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.151 -0.931 . . . . 1.16 113.529 177.366 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 115' ' ' PRO . . . . . 0.547 ' O ' ' HG3' ' B' ' 118' ' ' LYS . 42.8 Cg_endo -64.57 95.74 0.23 Allowed 'Trans proline' 0 C--O 1.224 -0.182 0 C-N-CA 123.11 2.54 . . . . 1.57 112.5 177.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 87.65 11.41 68.5 Favored Glycine 0 C--N 1.283 -2.403 0 CA-C-N 114.767 -1.106 . . . . 1.7 113.228 -178.424 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 117' ' ' GLY . . . . . 0.508 ' HA2' ' O ' ' B' ' 113' ' ' CYS . . . 62.11 39.41 97.6 Favored Glycine 0 N--CA 1.414 -2.822 0 C-N-CA 118.002 -2.047 . . . . 1.38 111.438 176.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 118' ' ' LYS . . . . . 0.547 ' HG3' ' O ' ' B' ' 115' ' ' PRO . 0.0 OUTLIER -91.85 7.06 43.69 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 113.904 -1.148 . . . . 2.54 112.094 179.644 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 119' ' ' GLY . . . . . 0.433 ' O ' ' HA ' ' B' ' 112' ' ' PRO . . . -115.93 -159.5 11.97 Favored Glycine 0 C--N 1.343 0.961 0 N-CA-C 108.139 -1.984 . . . . 1.04 108.139 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.748 ' HA ' ' O ' ' B' ' 111' ' ' LEU . 0.0 OUTLIER -145.37 170.46 16.29 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 121.098 2.449 . . . . 2.89 105.844 174.685 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 121' ' ' CYS . . . . . 0.493 ' HB2' ' HB3' ' B' ' 111' ' ' LEU . 0.9 OUTLIER -106.26 135.61 47.45 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 119.115 0.87 . . . . 1.07 111.942 -176.769 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 122' ' ' PHE . . . . . 0.549 ' HE2' ' HA ' ' B' ' 156' ' ' SER . 68.7 m-85 -128.12 13.71 6.72 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.038 -0.983 . . . . 1.53 111.287 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -176.16 -167.81 35.49 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.339 -0.934 . . . . 0.9 112.56 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 124' ' ' PRO . . . . . 0.494 ' O ' ' HB3' ' B' ' 144' ' ' CYS . 2.0 Cg_endo -81.68 -44.37 0.09 OUTLIER 'Trans proline' 0 CA--C 1.532 0.423 0 C-N-CA 122.701 2.267 . . . . 1.51 112.791 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 125' ' ' SER . . . . . 0.477 ' HB2' ' OE2' ' A' ' 81' ' ' GLU . 0.1 OUTLIER -124.73 16.54 8.73 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.983 0.421 . . . . 1.25 110.722 179.823 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 126' ' ' ILE . . . . . 0.739 HG23 ' HA ' ' B' ' 136' ' ' VAL . 1.0 OUTLIER -126.44 121.63 59.3 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 CA-C-O 121.454 0.645 . . . . 0.85 111.57 -178.106 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 127' ' ' CYS . . . . . 0.833 ' HB2' ' HB2' ' B' ' 141' ' ' ALA . 0.1 OUTLIER -119.28 133.59 55.67 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-N 115.578 -0.737 . . . . 0.89 109.078 178.912 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 128' ' ' CYS . . . . . 1.205 ' HA ' ' O ' ' B' ' 133' ' ' GLY . 0.0 OUTLIER -145.53 120.5 10.02 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 118.246 -0.883 . . . . 1.23 111.145 -179.171 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 129' ' ' GLY . . . . . 0.631 ' O ' ' HB1' ' B' ' 169' ' ' ALA . . . -114.69 -156.95 11.56 Favored Glycine 0 N--CA 1.417 -2.613 0 N-CA-C 107.555 -2.218 . . . . 0.66 107.555 176.498 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -65.85 -71.0 0.21 Allowed 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 122.168 0.187 . . . . 2.35 111.493 -178.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.47 32.25 5.52 Favored 'General case' 0 CA--C 1.498 -1.024 0 C-N-CA 120.095 -0.642 . . . . 1.69 110.027 -175.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 132' ' ' LEU . . . . . 0.881 ' O ' HG22 ' A' ' 38' ' ' THR . 0.8 OUTLIER -124.79 -18.88 5.46 Favored 'General case' 0 N--CA 1.403 -2.802 0 N-CA-C 104.898 -2.26 . . . . 1.38 104.898 176.127 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 133' ' ' GLY . . . . . 1.205 ' O ' ' HA ' ' B' ' 128' ' ' CYS . . . 66.86 -134.96 32.33 Favored Glycine 0 N--CA 1.407 -3.269 0 CA-C-N 115.134 -0.939 . . . . 0.72 114.769 173.671 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 134' ' ' CYS . . . . . 0.894 ' HB2' HG13 ' B' ' 172' ' ' ILE . 2.7 t -135.14 116.44 14.52 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 114.141 1.163 . . . . 1.08 114.141 -177.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 135' ' ' PHE . . . . . 0.885 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -98.16 107.68 20.21 Favored 'General case' 0 CA--C 1.503 -0.857 0 N-CA-C 107.068 -1.456 . . . . 1.36 107.068 177.158 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 136' ' ' VAL . . . . . 0.739 ' HA ' HG23 ' B' ' 126' ' ' ILE . 2.2 t -90.99 86.57 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.324 0 CA-C-O 122.611 1.196 . . . . 0.75 109.792 -179.281 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 137' ' ' GLY . . . . . 0.475 ' O ' ' HA3' ' A' ' 33' ' ' GLY . . . 102.47 68.92 0.81 Allowed Glycine 0 C--N 1.321 -0.285 0 CA-C-N 112.85 -1.977 . . . . 0.83 114.135 179.403 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 138' ' ' THR . . . . . 0.825 HG22 ' O ' ' A' ' 32' ' ' LEU . 81.2 p -146.45 173.15 12.55 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.824 -0.806 . . . . 0.78 108.824 178.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 139' ' ' ALA . . . . . 0.79 ' O ' HD12 ' B' ' 142' ' ' LEU . . . -78.35 -17.36 56.61 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 120.197 -0.601 . . . . 1.04 109.669 177.169 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 140' ' ' GLU . . . . . 0.606 ' HG3' ' HA2' ' B' ' 114' ' ' GLY . 5.3 mp0 -67.48 -14.33 62.83 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.86 -0.793 . . . . 2.31 108.86 176.11 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 141' ' ' ALA . . . . . 1.034 ' O ' ' HB2' ' B' ' 144' ' ' CYS . . . -120.42 -15.59 8.53 Favored 'General case' 0 C--O 1.218 -0.585 0 CA-C-N 115.198 -0.91 . . . . 0.87 111.802 -179.375 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 142' ' ' LEU . . . . . 0.79 HD12 ' O ' ' B' ' 139' ' ' ALA . 0.0 OUTLIER -59.91 -21.15 60.71 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 113.529 0.937 . . . . 1.24 113.529 -176.569 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 143' ' ' ARG . . . . . 0.698 ' N ' HD13 ' B' ' 142' ' ' LEU . 0.0 OUTLIER -64.32 -20.63 66.22 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 105.966 -1.865 . . . . 2.93 105.966 175.222 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 144' ' ' CYS . . . . . 1.034 ' HB2' ' O ' ' B' ' 141' ' ' ALA . 0.2 OUTLIER -59.28 2.49 0.06 Allowed 'General case' 0 N--CA 1.486 1.374 0 CA-C-N 113.521 -1.672 . . . . 1.61 110.578 -177.985 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 145' ' ' GLN . . . . . 0.499 ' H ' ' C ' ' B' ' 143' ' ' ARG . 14.4 mm100 -84.03 -17.46 40.32 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.039 0.447 . . . . 3.35 111.004 178.607 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -85.69 6.49 27.42 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 120.147 -0.621 . . . . 3.76 109.808 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 147' ' ' GLU . . . . . 0.406 ' HG3' HD13 ' B' ' 111' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.446 -0.633 0 C-N-CA 120.241 -0.584 . . . . 4.01 109.508 177.331 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 156' ' ' SER . . . . . 0.549 ' HA ' ' HE2' ' B' ' 122' ' ' PHE . 0.3 OUTLIER . . . . . 0 CA--C 1.535 0.396 0 N-CA-C 108.997 -0.742 . . . . 3.11 108.997 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 165.68 136.63 2.05 Favored Glycine 0 CA--C 1.501 -0.798 0 N-CA-C 108.291 -1.924 . . . . 2.07 108.291 -178.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -110.91 64.63 0.61 Allowed 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 117.013 -1.875 . . . . 4.34 112.682 -178.316 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 159' ' ' LYS . . . . . 0.471 ' HB3' ' SG ' ' B' ' 167' ' ' CYS . 0.2 OUTLIER -118.19 53.63 1.75 Allowed Pre-proline 0 C--N 1.315 -0.893 0 CA-C-N 113.686 -1.597 . . . . 3.54 110.048 170.175 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 160' ' ' PRO . . . . . 0.421 ' HA ' ' HA ' ' B' ' 166' ' ' ARG . 37.7 Cg_endo -69.79 83.9 0.68 Allowed 'Trans proline' 0 CA--C 1.519 -0.244 0 CA-C-N 122.153 1.805 . . . . 1.51 114.46 -173.764 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 161' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -97.13 -170.91 2.11 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 113.8 -1.545 . . . . 1.58 107.761 178.038 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 55.87 -167.53 3.27 Favored Glycine 0 N--CA 1.439 -1.159 0 C-N-CA 119.645 -1.264 . . . . 2.37 114.779 173.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 78.8 p -85.65 47.03 1.37 Allowed 'General case' 0 C--N 1.309 -1.168 0 C-N-CA 126.637 1.975 . . . . 4.07 111.66 -179.362 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 118.35 5.11 13.19 Favored Glycine 0 C--N 1.347 1.189 0 CA-C-N 112.863 -1.971 . . . . 2.2 116.004 173.32 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 165' ' ' GLY . . . . . 0.546 ' HA3' ' HA ' ' B' ' 174' ' ' CYS . . . -104.0 137.97 13.82 Favored Glycine 0 CA--C 1.522 0.473 0 C-N-CA 118.837 -1.649 . . . . 1.62 117.081 -176.46 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 166' ' ' ARG . . . . . 0.464 ' HA ' ' O ' ' B' ' 159' ' ' LYS . 0.0 OUTLIER -107.96 153.69 22.7 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 114.006 -1.097 . . . . 3.05 108.99 177.03 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 167' ' ' CYS . . . . . 0.801 ' HA ' ' O ' ' B' ' 172' ' ' ILE . 2.0 m -59.52 107.54 0.6 Allowed 'General case' 0 N--CA 1.438 -1.049 0 O-C-N 121.832 -0.542 . . . . 1.56 111.479 -177.686 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 168' ' ' ALA . . . . . . . . . . . . . . . -81.62 -24.65 36.26 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 108.808 -0.812 . . . . 1.04 108.808 177.364 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 169' ' ' ALA . . . . . 0.713 ' HB3' ' CG1' ' B' ' 172' ' ' ILE . . . -163.52 163.94 24.51 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 115.169 -0.923 . . . . 0.98 112.782 -178.619 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 170' ' ' ALA . . . . . 0.596 ' HA ' ' O ' ' B' ' 185' ' ' CYS . . . -40.97 97.77 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.563 -0.744 . . . . 1.25 110.115 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 171' ' ' GLY . . . . . 0.891 ' C ' HD13 ' B' ' 172' ' ' ILE . . . 88.19 20.73 48.18 Favored Glycine 0 N--CA 1.443 -0.876 0 N-CA-C 115.559 0.983 . . . . 1.29 115.559 179.017 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 172' ' ' ILE . . . . . 0.894 HG13 ' HB2' ' B' ' 134' ' ' CYS . 0.3 OUTLIER -120.19 99.25 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 CA-C-N 117.229 0.515 . . . . 2.27 110.908 -179.801 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 173' ' ' CYS . . . . . 0.455 ' O ' ' HB2' ' B' ' 180' ' ' HIS . 53.2 t -91.51 96.29 10.41 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 108.932 -0.766 . . . . 1.94 108.932 178.604 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 174' ' ' CYS . . . . . 1.077 ' CB ' ' HA ' ' B' ' 179' ' ' CYS . 21.9 p -167.67 -171.67 1.69 Allowed 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 116.53 2.048 . . . . 1.35 116.53 -176.755 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 175' ' ' SER . . . . . 0.915 ' HB3' ' HD2' ' B' ' 176' ' ' PRO . 72.3 m -124.48 -178.82 0.73 Allowed Pre-proline 0 CA--C 1.531 0.241 0 CA-C-N 112.981 -1.918 . . . . 2.0 108.537 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 176' ' ' PRO . . . . . 0.915 ' HD2' ' HB3' ' B' ' 175' ' ' SER . 57.9 Cg_endo -73.28 31.13 0.31 Allowed 'Trans proline' 0 CA--C 1.533 0.435 0 C-N-CA 121.725 1.617 . . . . 1.9 113.092 -179.25 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 177' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -134.32 -60.83 0.79 Allowed 'General case' 0 C--O 1.234 0.277 0 CA-C-O 120.914 0.387 . . . . 2.72 110.267 178.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 178' ' ' GLY . . . . . 0.918 ' O ' ' HB2' ' B' ' 174' ' ' CYS . . . -118.15 -178.52 17.18 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 121.006 -0.616 . . . . 0.99 111.668 178.675 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 179' ' ' CYS . . . . . 1.077 ' HA ' ' CB ' ' B' ' 174' ' ' CYS . 21.7 m -152.24 161.34 42.76 Favored 'General case' 0 N--CA 1.462 0.127 0 N-CA-C 112.453 0.538 . . . . 1.34 112.453 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 180' ' ' HIS . . . . . 0.529 ' HA ' ' HA2' ' A' ' 78' ' ' GLY . 7.1 m80 -143.15 139.08 30.22 Favored 'General case' 0 CA--C 1.517 -0.295 0 O-C-N 121.897 -0.502 . . . . 2.1 111.763 -178.509 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 181' ' ' GLU . . . . . 0.438 ' OE2' ' HB2' ' A' ' 25' ' ' SER . 37.4 tt0 -65.57 123.0 18.51 Favored 'General case' 0 CA--C 1.503 -0.858 0 CA-C-N 115.674 -0.694 . . . . 3.06 109.586 178.069 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 182' ' ' ASP . . . . . 0.766 ' O ' ' HA2' ' B' ' 171' ' ' GLY . 0.0 OUTLIER -138.81 106.6 7.52 Favored Pre-proline 0 C--N 1.319 -0.757 0 C-N-CA 118.957 -1.097 . . . . 2.06 111.346 179.466 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 183' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -63.6 -16.85 57.16 Favored 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 123.034 2.489 . . . . 1.91 114.391 -178.524 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -63.02 -40.2 97.03 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.177 0.513 . . . . 1.56 110.512 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 185' ' ' CYS . . . . . 0.601 ' O ' ' N ' ' B' ' 171' ' ' GLY . 69.5 m -94.0 46.83 1.18 Allowed 'General case' 0 C--O 1.217 -0.613 0 CA-C-N 115.576 -0.738 . . . . 1.94 110.399 179.322 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 186' ' ' ASP . . . . . 0.402 ' O ' ' HB1' ' B' ' 170' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.473 0.719 0 O-C-N 121.518 -0.739 . . . . 3.61 111.861 -178.637 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.534 0.332 0 N-CA-C 112.329 0.492 . . . . 2.68 112.329 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.898 HD23 ' HB3' ' A' ' 21' ' ' CYS . 15.0 tp -36.93 114.41 0.64 Allowed Pre-proline 0 N--CA 1.476 0.869 0 N-CA-C 114.054 1.131 . . . . 2.48 114.054 179.207 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.528 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 52.0 Cg_endo -95.73 134.83 0.57 Allowed 'Trans proline' 0 CA--C 1.534 0.513 0 C-N-CA 122.167 1.911 . . . . 1.49 115.216 179.518 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.661 ' O ' ' HA2' ' A' ' 17' ' ' GLY . 0.5 OUTLIER -140.65 -169.06 2.71 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 113.444 0.905 . . . . 1.0 113.444 -178.389 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.566 ' HA2' ' HB3' ' A' ' 40' ' ' GLU . . . 77.09 -156.18 45.21 Favored Glycine 0 C--N 1.337 0.605 0 CA-C-N 114.932 -1.031 . . . . 1.15 111.899 178.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.612 ' O ' ' HG2' ' A' ' 15' ' ' PRO . 41.4 Cg_endo -62.8 113.44 1.98 Allowed 'Trans proline' 0 N--CA 1.479 0.667 0 C-N-CA 122.783 2.322 . . . . 1.57 106.193 176.161 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 73.3 -7.12 12.25 Favored Glycine 0 C--N 1.276 -2.776 0 CA-C-O 119.067 -0.852 . . . . 1.68 112.73 175.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.661 ' HA2' ' O ' ' A' ' 13' ' ' CYS . . . 77.61 49.69 7.06 Favored Glycine 1 N--CA 1.383 -4.858 0 C-N-CA 118.295 -1.907 . . . . 1.36 111.515 -179.42 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.426 ' CG ' ' O ' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -99.61 9.46 43.11 Favored 'General case' 0 C--N 1.342 0.278 0 CA-C-N 112.864 -1.668 . . . . 2.5 111.946 175.643 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.528 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -124.63 -167.92 12.73 Favored Glycine 0 C--N 1.333 0.404 0 N-CA-C 106.465 -2.654 . . . . 1.02 106.465 178.56 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.721 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 0.6 OUTLIER -135.98 158.56 44.09 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 121.056 2.428 . . . . 2.92 108.184 -179.925 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.898 ' HB3' HD23 ' A' ' 11' ' ' LEU . 1.7 t -107.65 160.49 15.66 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 112.883 0.697 . . . . 1.1 112.883 -178.243 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.559 ' HE1' ' O ' ' A' ' 28' ' ' CYS . 60.7 m-85 -126.38 -47.46 1.59 Allowed 'General case' 0 C--N 1.339 0.143 0 CA-C-N 115.538 -0.755 . . . . 1.51 110.184 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -117.46 -159.62 11.46 Favored Glycine 0 CA--C 1.521 0.414 0 CA-C-N 115.723 -0.671 . . . . 0.9 111.559 179.188 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -84.33 -68.1 0.01 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.32 2.013 . . . . 1.5 111.657 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.409 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.4 OUTLIER -89.41 26.54 1.66 Allowed 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.867 -0.42 . . . . 1.26 109.867 178.753 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.937 HG12 HG13 ' A' ' 36' ' ' VAL . 5.6 mt -144.82 112.81 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 CA-C-O 121.875 0.845 . . . . 0.83 111.771 -178.287 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.587 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 4.7 t -126.57 131.3 51.56 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 114.991 -1.004 . . . . 0.92 109.451 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.792 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -142.44 123.12 14.21 Favored 'General case' 0 CA--C 1.561 1.374 0 N-CA-C 115.38 1.622 . . . . 1.28 115.38 -177.358 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -109.37 -170.34 20.5 Favored Glycine 0 C--N 1.368 2.31 0 N-CA-C 109.117 -1.593 . . . . 0.67 109.117 175.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -66.07 -56.07 13.39 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 114.573 1.323 . . . . 2.27 114.573 -178.09 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.45 -1.11 16.03 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 122.129 0.966 . . . . 1.66 111.234 -177.137 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.94 HD22 ' CZ ' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -97.39 -13.0 22.1 Favored 'General case' 0 N--CA 1.407 -2.587 0 N-CA-C 106.531 -1.655 . . . . 1.37 106.531 179.937 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.886 ' HA2' ' CB ' ' A' ' 69' ' ' ALA . . . 58.78 -132.66 52.66 Favored Glycine 0 C--O 1.197 -2.168 0 CA-C-O 118.165 -1.353 . . . . 0.73 112.28 175.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.872 ' HB2' HD13 ' A' ' 72' ' ' ILE . 2.4 t -135.39 122.21 21.08 Favored 'General case' 0 CA--C 1.486 -1.517 0 CA-C-N 118.496 1.148 . . . . 1.08 113.748 -179.499 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.94 ' CZ ' HD22 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -97.69 100.63 12.02 Favored 'General case' 0 N--CA 1.427 -1.606 0 N-CA-C 103.296 -2.853 . . . . 1.38 103.296 175.426 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.937 HG13 HG12 ' A' ' 26' ' ' ILE . 2.1 t -92.12 83.66 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 CA-C-O 123.319 1.533 . . . . 0.76 107.139 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.798 ' HA3' HG21 ' B' ' 172' ' ' ILE . . . 100.43 85.71 1.87 Allowed Glycine 0 CA--C 1.525 0.689 0 CA-C-N 112.42 -2.173 . . . . 0.81 113.67 -179.431 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.708 HG22 ' O ' ' B' ' 132' ' ' LEU . 67.0 p -161.56 159.49 27.82 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 109.631 -0.507 . . . . 0.77 109.631 179.298 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.594 ' HA ' ' CD1' ' A' ' 42' ' ' LEU . . . -62.15 -23.07 66.36 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 118.666 0.666 . . . . 1.02 111.242 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.566 ' HB3' ' HA2' ' A' ' 14' ' ' GLY . 3.2 mm-40 -68.75 -13.05 62.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.795 -0.639 . . . . 2.32 109.704 176.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.536 ' O ' ' HB2' ' A' ' 44' ' ' CYS . . . -100.3 -24.36 14.55 Favored 'General case' 0 C--O 1.205 -1.24 0 N-CA-C 109.154 -0.684 . . . . 0.87 109.154 178.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.594 ' CD1' ' HA ' ' A' ' 39' ' ' ALA . 26.4 mt -42.5 -38.49 1.95 Allowed 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.31 0.485 . . . . 1.23 112.31 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.648 ' HD3' ' O ' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -69.25 -6.25 28.05 Favored 'General case' 0 CA--C 1.556 1.197 0 CA-C-O 121.822 0.82 . . . . 2.92 110.733 179.348 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.536 ' HB2' ' O ' ' A' ' 41' ' ' ALA . 65.7 m -72.59 -18.21 61.62 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 113.829 -1.532 . . . . 1.57 109.715 177.664 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -55.48 -17.17 4.7 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.667 -0.697 . . . . 3.31 111.471 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -84.43 5.64 26.48 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 120.444 -0.502 . . . . 3.69 110.063 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 . . . . . 0 N--CA 1.452 -0.345 0 CA-C-N 115.89 -0.595 . . . . 3.99 109.833 177.755 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.775 ' OG ' ' HG3' ' A' ' 59' ' ' LYS . 0.4 OUTLIER . . . . . 0 N--CA 1.477 0.916 0 N-CA-C 108.72 -0.845 . . . . 3.12 108.72 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 103.87 -108.73 3.25 Favored Glycine 0 CA--C 1.479 -2.167 0 N-CA-C 110.806 -0.918 . . . . 2.1 110.806 -178.134 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.486 ' O ' ' HB3' ' A' ' 67' ' ' CYS . 3.5 mt-30 -112.56 115.85 29.28 Favored 'General case' 0 N--CA 1.422 -1.85 0 N-CA-C 102.889 -3.004 . . . . 4.36 102.889 175.401 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.918 ' HB3' ' CD ' ' A' ' 60' ' ' PRO . 0.0 OUTLIER -99.22 -100.11 0.0 OUTLIER Pre-proline 0 C--N 1.305 -1.329 0 CA-C-O 114.575 -2.631 . . . . 3.55 109.558 -173.273 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.918 ' CD ' ' HB3' ' A' ' 59' ' ' LYS . 9.7 Cg_endo -49.84 127.04 17.99 Favored 'Trans proline' 0 N--CA 1.474 0.354 0 CA-C-N 127.036 3.549 . . . . 1.54 118.437 -176.024 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.47 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 5.0 t -145.3 -172.98 3.98 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 110.793 -2.912 . . . . 1.59 106.637 177.08 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 37.89 -162.49 0.01 OUTLIER Glycine 0 N--CA 1.485 1.932 0 N-CA-C 114.857 0.703 . . . . 2.43 114.857 175.293 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 71.2 m -82.78 51.8 1.98 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 120.438 -0.505 . . . . 4.11 109.887 178.459 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 112.66 2.26 25.71 Favored Glycine 0 CA--C 1.539 1.548 0 C-N-CA 120.742 -0.742 . . . . 2.21 113.467 -178.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.734 ' HA2' ' HA ' ' A' ' 75' ' ' SER . . . -98.62 129.14 9.8 Favored Glycine 0 N--CA 1.464 0.564 0 C-N-CA 120.646 -0.788 . . . . 1.62 112.461 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.677 ' HA ' ' O ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -78.62 150.36 32.71 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-O 121.039 0.447 . . . . 3.02 111.592 -177.749 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.486 ' HB3' ' O ' ' A' ' 58' ' ' GLN . 9.1 t -70.77 109.54 5.03 Favored 'General case' 0 N--CA 1.397 -3.086 0 N-CA-C 109.24 -0.652 . . . . 1.52 109.24 -178.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.605 ' HB1' ' SG ' ' A' ' 28' ' ' CYS . . . -85.23 -21.5 29.07 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.775 0.798 . . . . 1.07 108.865 178.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.886 ' CB ' ' HA2' ' A' ' 33' ' ' GLY . . . -168.8 161.18 10.9 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.163 -1.381 . . . . 1.0 109.092 -178.248 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.802 ' HA ' ' HB3' ' A' ' 85' ' ' CYS . . . -55.01 140.18 38.55 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 118.176 0.444 . . . . 1.24 111.138 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.632 ' H ' ' CB ' ' A' ' 85' ' ' CYS . . . 75.14 -44.44 1.6 Allowed Glycine 0 CA--C 1.529 0.943 0 CA-C-N 116.202 -0.453 . . . . 1.28 113.779 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.876 HG21 ' HA3' ' B' ' 137' ' ' GLY . 1.6 pp -97.54 99.14 8.3 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.952 0 CA-C-O 122.142 0.973 . . . . 2.27 111.737 -177.391 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.487 ' SG ' ' HB3' ' A' ' 82' ' ' ASP . 34.2 m -93.21 104.26 16.46 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 115.531 -0.759 . . . . 1.98 109.302 179.536 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 1.027 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 33.8 m -84.7 124.63 31.73 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.439 -0.801 . . . . 1.33 112.459 -177.723 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.968 ' HB3' ' HD2' ' A' ' 76' ' ' PRO . 49.5 m -84.58 -178.52 1.19 Allowed Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 115.067 -0.97 . . . . 1.99 110.431 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.968 ' HD2' ' HB3' ' A' ' 75' ' ' SER . 74.1 Cg_endo -75.7 30.3 0.38 Allowed 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 121.672 1.581 . . . . 1.86 111.942 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.832 ' HB2' ' ND1' ' B' ' 180' ' ' HIS . 2.8 p30 -145.51 -28.41 0.44 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.602 -0.726 . . . . 2.65 110.536 179.362 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.781 ' HA3' ' O ' ' B' ' 179' ' ' CYS . . . -177.68 -133.17 1.81 Allowed Glycine 0 CA--C 1.521 0.437 0 C-N-CA 121.153 -0.546 . . . . 0.99 112.141 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 1.027 ' HA ' ' HA ' ' A' ' 74' ' ' CYS . 80.4 m -128.43 148.62 50.72 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 109.635 -0.506 . . . . 1.34 109.635 179.301 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.819 ' ND1' ' HB2' ' B' ' 177' ' ' ASP . 4.5 t60 -138.64 116.33 11.43 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 108.246 -1.02 . . . . 2.17 108.246 -173.708 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.593 ' HG3' ' O ' ' B' ' 177' ' ' ASP . 0.0 OUTLIER -57.31 117.5 4.16 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.803 0.811 . . . . 3.05 110.268 -178.701 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.63 ' OD1' ' HB3' ' A' ' 84' ' ' ALA . 0.3 OUTLIER -147.37 101.47 3.79 Favored Pre-proline 0 N--CA 1.439 -0.991 0 CA-C-N 114.285 -1.325 . . . . 2.02 108.951 -178.167 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -56.28 -2.19 0.37 Allowed 'Trans proline' 0 C--N 1.361 1.201 0 C-N-CA 123.142 2.561 . . . . 1.93 115.15 -177.165 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.63 ' HB3' ' OD1' ' A' ' 82' ' ' ASP . . . -65.84 -17.83 64.91 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 111.985 0.365 . . . . 1.53 111.985 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.802 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 13.2 m -99.69 7.01 45.49 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.329 0.862 . . . . 1.88 113.329 -178.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.384 0 N-CA-C 115.448 1.647 . . . . 3.6 115.448 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 110' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.53 0.197 0 CA-C-O 121.395 0.617 . . . . 2.61 111.084 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 111' ' ' LEU . . . . . 0.919 HD23 ' HB3' ' B' ' 121' ' ' CYS . 14.8 tp -39.89 113.67 0.92 Allowed Pre-proline 0 N--CA 1.47 0.529 0 CA-C-N 114.913 -1.04 . . . . 2.47 113.771 177.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 112' ' ' PRO . . . . . 0.402 ' HA ' ' O ' ' B' ' 119' ' ' GLY . 73.6 Cg_endo -83.85 152.61 13.0 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 122.515 2.143 . . . . 1.47 110.037 178.055 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.663 ' C ' ' HA2' ' B' ' 117' ' ' GLY . 0.5 OUTLIER -158.7 -170.87 3.21 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 118.88 -1.128 . . . . 1.0 113.182 172.275 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 114' ' ' GLY . . . . . 0.572 ' HA2' ' HB3' ' B' ' 140' ' ' GLU . . . 76.41 -156.15 46.35 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.482 -0.866 . . . . 1.16 111.478 178.77 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 115' ' ' PRO . . . . . 0.479 ' O ' ' HG2' ' B' ' 115' ' ' PRO . 41.2 Cg_endo -65.31 95.89 0.27 Allowed 'Trans proline' 0 N--CA 1.467 -0.085 0 C-N-CA 122.848 2.366 . . . . 1.57 113.12 178.22 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 82.9 3.24 90.58 Favored Glycine 0 C--N 1.28 -2.56 0 CA-C-N 114.963 -1.017 . . . . 1.7 112.944 -178.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 117' ' ' GLY . . . . . 0.663 ' HA2' ' C ' ' B' ' 113' ' ' CYS . . . 76.34 45.68 14.12 Favored Glycine 0 N--CA 1.402 -3.604 0 C-N-CA 120.955 -0.64 . . . . 1.38 114.131 178.145 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.39 -1.91 57.46 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 114.696 -0.752 . . . . 2.54 111.32 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 119' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' B' ' 112' ' ' PRO . . . -107.46 -156.22 19.86 Favored Glycine 0 C--N 1.343 0.92 0 N-CA-C 110.209 -1.156 . . . . 1.04 110.209 -179.591 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.8 ' HA ' ' O ' ' B' ' 111' ' ' LEU . 1.2 mtm180 -150.64 154.33 37.29 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 120.216 2.008 . . . . 2.89 106.302 176.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 121' ' ' CYS . . . . . 0.919 ' HB3' HD23 ' B' ' 111' ' ' LEU . 1.5 t -107.28 160.95 15.22 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 113.246 0.832 . . . . 1.07 113.246 -177.083 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 122' ' ' PHE . . . . . 0.533 ' HE1' ' O ' ' B' ' 128' ' ' CYS . 60.8 m-85 -126.43 -47.65 1.58 Allowed 'General case' 0 C--N 1.339 0.113 0 CA-C-N 115.34 -0.846 . . . . 1.53 110.107 179.52 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -117.29 -159.67 11.52 Favored Glycine 0 CA--C 1.52 0.381 0 CA-C-N 115.797 -0.638 . . . . 0.9 111.634 179.213 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -84.26 -68.15 0.01 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.344 2.029 . . . . 1.51 111.667 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 125' ' ' SER . . . . . 0.408 ' O ' ' N ' ' B' ' 137' ' ' GLY . 0.4 OUTLIER -89.49 26.65 1.65 Allowed 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 109.943 -0.391 . . . . 1.25 109.943 178.78 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 126' ' ' ILE . . . . . 0.945 HG12 HG13 ' B' ' 136' ' ' VAL . 7.0 mt -144.7 112.59 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 CA-C-O 121.751 0.786 . . . . 0.85 111.827 -178.231 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 127' ' ' CYS . . . . . 0.576 ' O ' ' HA ' ' B' ' 134' ' ' CYS . 4.6 t -126.45 131.38 51.69 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.112 -0.949 . . . . 0.89 109.234 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 128' ' ' CYS . . . . . 0.817 ' HA ' ' O ' ' B' ' 133' ' ' GLY . 0.0 OUTLIER -142.39 122.16 13.47 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 115.103 1.52 . . . . 1.23 115.103 -176.906 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 129' ' ' GLY . . . . . . . . . . . . . . . -111.46 -166.11 18.28 Favored Glycine 0 C--N 1.373 2.636 0 N-CA-C 108.173 -1.971 . . . . 0.66 108.173 175.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -65.4 -58.74 5.12 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 114.074 1.139 . . . . 2.35 114.074 -177.031 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.28 21.82 11.57 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.57 0.7 . . . . 1.69 109.921 -177.019 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 132' ' ' LEU . . . . . 0.929 HD22 ' CZ ' ' B' ' 135' ' ' PHE . 0.4 OUTLIER -114.6 -12.41 12.25 Favored 'General case' 0 N--CA 1.397 -3.085 0 N-CA-C 103.84 -2.652 . . . . 1.38 103.84 175.459 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 133' ' ' GLY . . . . . 0.917 ' HA2' ' CB ' ' B' ' 169' ' ' ALA . . . 57.97 -129.57 49.74 Favored Glycine 1 N--CA 1.394 -4.128 0 CA-C-O 117.249 -1.862 . . . . 0.72 112.989 174.572 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 134' ' ' CYS . . . . . 0.874 ' HB2' HD13 ' B' ' 172' ' ' ILE . 2.5 t -136.96 122.98 20.25 Favored 'General case' 0 CA--C 1.496 -1.116 0 CA-C-N 119.648 1.724 . . . . 1.08 113.696 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 135' ' ' PHE . . . . . 0.929 ' CZ ' HD22 ' B' ' 132' ' ' LEU . 0.0 OUTLIER -98.03 100.21 11.53 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 103.645 -2.724 . . . . 1.36 103.645 175.153 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 136' ' ' VAL . . . . . 0.945 HG13 HG12 ' B' ' 126' ' ' ILE . 2.2 t -92.09 83.14 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.368 0 CA-C-O 123.27 1.509 . . . . 0.75 107.093 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 137' ' ' GLY . . . . . 0.876 ' HA3' HG21 ' A' ' 72' ' ' ILE . . . 100.49 85.36 1.85 Allowed Glycine 0 CA--C 1.525 0.678 0 CA-C-N 112.43 -2.168 . . . . 0.83 113.719 -179.329 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 138' ' ' THR . . . . . 0.7 HG22 ' O ' ' A' ' 32' ' ' LEU . 67.8 p -157.74 166.53 32.54 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 108.895 -0.78 . . . . 0.78 108.895 179.124 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 139' ' ' ALA . . . . . 0.576 ' HA ' ' CD1' ' B' ' 142' ' ' LEU . . . -68.58 -24.54 64.61 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 119.294 0.952 . . . . 1.04 110.575 177.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 140' ' ' GLU . . . . . 0.572 ' HB3' ' HA2' ' B' ' 114' ' ' GLY . 3.3 mm-40 -66.81 -11.92 57.09 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.618 -1.173 . . . . 2.31 109.972 177.116 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 141' ' ' ALA . . . . . 0.491 ' O ' ' HB2' ' B' ' 144' ' ' CYS . . . -102.93 -22.57 13.81 Favored 'General case' 0 C--O 1.211 -0.944 0 C-N-CA 123.736 0.814 . . . . 0.87 109.611 178.72 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 142' ' ' LEU . . . . . 0.576 ' CD1' ' HA ' ' B' ' 139' ' ' ALA . 23.8 mt -44.85 -38.42 4.57 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.015 0.436 . . . . 1.24 111.855 -179.673 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 143' ' ' ARG . . . . . 0.705 ' HD3' ' O ' ' B' ' 143' ' ' ARG . 0.0 OUTLIER -71.43 -1.28 12.58 Favored 'General case' 0 C--O 1.247 0.963 0 CA-C-N 116.05 -0.523 . . . . 2.93 110.063 179.378 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 144' ' ' CYS . . . . . 0.491 ' HB2' ' O ' ' B' ' 141' ' ' ALA . 66.3 m -82.0 -5.5 58.39 Favored 'General case' 0 C--N 1.341 0.226 0 O-C-N 120.825 -1.172 . . . . 1.61 110.108 176.259 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -60.61 -16.7 41.05 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.619 -0.719 . . . . 3.35 110.113 178.469 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -84.32 5.86 25.25 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 120.13 -0.628 . . . . 3.76 110.253 178.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 . . . . . 0 N--CA 1.452 -0.357 0 CA-C-N 116.038 -0.528 . . . . 4.01 109.892 177.811 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 156' ' ' SER . . . . . 0.714 ' OG ' ' HG3' ' B' ' 159' ' ' LYS . 1.8 t . . . . . 0 N--CA 1.457 -0.104 0 N-CA-C 116.772 2.138 . . . . 3.11 116.772 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 79.99 -113.76 3.72 Favored Glycine 0 CA--C 1.49 -1.509 0 O-C-N 119.487 -2.008 . . . . 2.07 113.301 173.406 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 158' ' ' GLN . . . . . 0.699 ' O ' ' HB3' ' B' ' 167' ' ' CYS . 3.3 mt-30 -113.67 96.07 5.67 Favored 'General case' 0 N--CA 1.413 -2.28 0 N-CA-C 106.931 -1.507 . . . . 4.34 106.931 177.732 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 159' ' ' LYS . . . . . 0.94 ' HB3' ' CD ' ' B' ' 160' ' ' PRO . 0.0 OUTLIER -69.6 -107.2 0.0 OUTLIER Pre-proline 0 CA--C 1.575 1.908 0 N-CA-C 114.196 1.184 . . . . 3.54 114.196 -177.153 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 160' ' ' PRO . . . . . 0.94 ' CD ' ' HB3' ' B' ' 159' ' ' LYS . 10.4 Cg_endo -50.58 126.8 18.94 Favored 'Trans proline' 0 C--N 1.363 1.336 0 N-CA-C 119.271 2.758 . . . . 1.51 119.271 -175.251 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 161' ' ' CYS . . . . . 0.491 ' HB3' ' HB3' ' B' ' 173' ' ' CYS . 6.5 t -149.05 -179.71 7.23 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 110.94 -2.846 . . . . 1.58 106.667 176.556 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 47.02 -164.61 0.13 Allowed Glycine 0 C--N 1.345 1.081 0 C-N-CA 119.818 -1.182 . . . . 2.37 114.434 178.436 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 69.5 m -84.3 48.85 1.55 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.67 0.748 . . . . 4.07 109.913 178.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 117.92 -1.58 17.35 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-N 115.166 -0.925 . . . . 2.2 113.654 178.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 165' ' ' GLY . . . . . 0.712 ' CA ' ' HA ' ' B' ' 175' ' ' SER . . . -97.27 132.4 10.97 Favored Glycine 0 C--N 1.339 0.696 0 C-N-CA 119.318 -1.42 . . . . 1.62 112.257 -176.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 166' ' ' ARG . . . . . 0.644 ' HA ' ' O ' ' B' ' 159' ' ' LYS . 0.0 OUTLIER -78.57 150.48 32.78 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.168 0.509 . . . . 3.05 111.841 -177.591 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 167' ' ' CYS . . . . . 0.699 ' HB3' ' O ' ' B' ' 158' ' ' GLN . 9.1 t -70.77 109.73 5.14 Favored 'General case' 0 N--CA 1.405 -2.702 0 CA-C-N 115.548 -0.751 . . . . 1.56 109.231 -179.206 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 168' ' ' ALA . . . . . 0.59 ' HB1' ' SG ' ' B' ' 128' ' ' CYS . . . -90.09 -14.28 34.08 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 121.583 0.706 . . . . 1.04 110.047 179.302 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 169' ' ' ALA . . . . . 0.917 ' CB ' ' HA2' ' B' ' 133' ' ' GLY . . . -172.71 161.62 4.82 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.854 -1.067 . . . . 0.98 108.785 177.634 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 170' ' ' ALA . . . . . 0.79 ' HA ' ' HB3' ' B' ' 185' ' ' CYS . . . -55.55 139.06 45.34 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 118.33 0.514 . . . . 1.25 111.361 179.397 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 171' ' ' GLY . . . . . 0.687 ' H ' ' CB ' ' B' ' 185' ' ' CYS . . . 67.73 -22.98 0.24 Allowed Glycine 0 CA--C 1.534 1.244 0 N-CA-C 116.35 1.3 . . . . 1.29 116.35 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 172' ' ' ILE . . . . . 0.874 HD13 ' HB2' ' B' ' 134' ' ' CYS . 1.7 pp -111.03 98.17 6.7 Favored 'Isoleucine or valine' 0 C--O 1.244 0.793 0 CA-C-N 118.586 1.193 . . . . 2.27 110.069 177.574 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 173' ' ' CYS . . . . . 0.491 ' HB3' ' HB3' ' B' ' 161' ' ' CYS . 33.9 m -93.0 104.3 16.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.421 -0.809 . . . . 1.94 109.311 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 174' ' ' CYS . . . . . 1.009 ' HA ' ' HA ' ' B' ' 179' ' ' CYS . 34.0 m -84.84 124.57 31.75 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.33 -0.85 . . . . 1.35 112.265 -177.681 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 175' ' ' SER . . . . . 0.923 ' HB3' ' HD2' ' B' ' 176' ' ' PRO . 49.5 m -84.47 -178.56 1.2 Allowed Pre-proline 0 CA--C 1.533 0.296 0 CA-C-N 115.075 -0.966 . . . . 2.0 110.515 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 176' ' ' PRO . . . . . 0.923 ' HD2' ' HB3' ' B' ' 175' ' ' SER . 73.9 Cg_endo -75.75 30.31 0.38 Allowed 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 121.675 1.583 . . . . 1.9 111.961 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 177' ' ' ASP . . . . . 0.819 ' HB2' ' ND1' ' A' ' 80' ' ' HIS . 2.8 p30 -145.38 -28.21 0.45 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.598 -0.728 . . . . 2.72 110.545 179.303 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 178' ' ' GLY . . . . . 0.826 ' HA3' ' O ' ' A' ' 79' ' ' CYS . . . -178.21 -132.65 1.74 Allowed Glycine 0 C--N 1.334 0.447 0 C-N-CA 121.21 -0.519 . . . . 0.99 112.183 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 179' ' ' CYS . . . . . 1.009 ' HA ' ' HA ' ' B' ' 174' ' ' CYS . 81.6 m -128.03 154.18 45.94 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 109.441 -0.577 . . . . 1.34 109.441 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 180' ' ' HIS . . . . . 0.832 ' ND1' ' HB2' ' A' ' 77' ' ' ASP . 4.0 t60 -147.29 115.37 6.54 Favored 'General case' 0 CA--C 1.499 -0.996 0 CA-C-O 121.913 0.863 . . . . 2.1 108.811 -173.365 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 181' ' ' GLU . . . . . 0.615 ' HG3' ' O ' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -56.73 117.41 3.89 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-N 114.246 -1.343 . . . . 3.06 110.274 -176.746 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 182' ' ' ASP . . . . . 0.615 ' OD1' ' HB3' ' B' ' 184' ' ' ALA . 0.3 OUTLIER -147.38 101.27 3.79 Favored Pre-proline 0 N--CA 1.437 -1.087 0 CA-C-N 114.063 -1.426 . . . . 2.06 108.929 -178.007 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 183' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -56.16 -2.22 0.36 Allowed 'Trans proline' 0 C--N 1.36 1.16 0 C-N-CA 123.229 2.619 . . . . 1.91 115.207 -177.247 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 184' ' ' ALA . . . . . 0.615 ' HB3' ' OD1' ' B' ' 182' ' ' ASP . . . -65.96 -17.93 65.0 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 111.983 0.364 . . . . 1.56 111.983 -179.489 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 185' ' ' CYS . . . . . 0.79 ' HB3' ' HA ' ' B' ' 170' ' ' ALA . 12.3 m -100.18 7.82 44.26 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 113.032 0.752 . . . . 1.94 113.032 -178.788 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 186' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.358 0 N-CA-C 115.027 1.491 . . . . 3.61 115.027 179.436 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.609 ' HB3' ' HB3' ' A' ' 20' ' ' ARG . 0.1 OUTLIER . . . . . 0 CA--C 1.548 0.898 0 N-CA-C 112.856 0.687 . . . . 2.68 112.856 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.609 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 4.4 mm? 3.62 111.86 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.461 0 N-CA-C 113.202 0.816 . . . . 2.48 113.202 178.718 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.615 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 87.6 Cg_endo -79.32 123.98 5.74 Favored 'Trans proline' 0 C--N 1.357 1.019 0 C-N-CA 123.203 2.602 . . . . 1.49 115.866 -178.283 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.585 ' O ' ' HA2' ' A' ' 17' ' ' GLY . 26.8 p -129.83 -176.23 3.86 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.307 -0.86 . . . . 1.0 111.138 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.463 ' HA2' ' HG2' ' A' ' 40' ' ' GLU . . . 75.54 -161.45 52.7 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 120.312 -0.947 . . . . 1.15 112.43 -178.144 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 1.078 ' HD2' HD11 ' A' ' 32' ' ' LEU . 39.3 Cg_endo -64.95 95.04 0.24 Allowed 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 123.488 2.792 . . . . 1.57 113.108 178.698 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.51 -2.09 87.76 Favored Glycine 0 C--N 1.288 -2.129 0 CA-C-N 113.868 -1.515 . . . . 1.68 112.724 178.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.585 ' HA2' ' O ' ' A' ' 13' ' ' CYS . . . 84.28 35.69 14.2 Favored Glycine 0 N--CA 1.412 -2.934 0 C-N-CA 118.501 -1.809 . . . . 1.36 116.417 177.111 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.1 -31.71 61.25 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 112.941 -1.629 . . . . 2.5 107.237 175.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.615 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -79.09 175.04 55.25 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 113.099 -1.864 . . . . 1.02 112.891 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.609 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -139.8 162.99 33.82 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.955 -0.387 . . . . 2.92 109.955 179.749 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 15.6 t -108.66 143.17 38.09 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.438 0.637 . . . . 1.1 112.301 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -127.5 -54.12 1.35 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 114.78 -1.1 . . . . 1.51 108.834 178.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -95.95 149.79 19.43 Favored Glycine 0 C--N 1.331 0.298 0 N-CA-C 110.179 -1.168 . . . . 0.9 110.179 177.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -50.25 -48.21 20.92 Favored 'Trans proline' 0 CA--C 1.531 0.349 0 C-N-CA 121.849 1.699 . . . . 1.5 112.765 -179.056 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.16 4.06 41.67 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.603 0.24 . . . . 1.26 111.347 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.926 HG12 HG13 ' A' ' 36' ' ' VAL . 0.5 OUTLIER -119.83 122.8 69.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 113.309 0.855 . . . . 0.83 113.309 -178.016 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.463 ' HB3' ' OE1' ' A' ' 40' ' ' GLU . 0.1 OUTLIER -125.84 124.48 41.0 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.01 -0.541 . . . . 0.92 109.704 178.566 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.913 ' HB2' ' HB2' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -131.88 141.12 49.29 Favored 'General case' 0 CA--C 1.562 1.426 0 N-CA-C 114.296 1.221 . . . . 1.28 114.296 -177.594 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.743 ' O ' ' HB1' ' A' ' 69' ' ' ALA . . . -131.71 -174.2 13.57 Favored Glycine 0 C--N 1.369 2.396 0 CA-C-N 113.443 -1.708 . . . . 0.67 110.119 178.658 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.747 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 18.9 p-10 -63.17 -56.36 17.37 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 113.376 0.88 . . . . 2.27 113.376 -178.017 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.415 ' HG2' ' OD2' ' A' ' 30' ' ' ASP . 0.0 OUTLIER -113.21 5.54 17.03 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-O 121.435 0.636 . . . . 1.66 110.716 -175.798 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 1.078 HD11 ' HD2' ' A' ' 15' ' ' PRO . 0.3 OUTLIER -103.93 -10.24 18.3 Favored 'General case' 0 N--CA 1.419 -2.001 0 N-CA-C 106.272 -1.751 . . . . 1.37 106.272 177.638 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.875 ' O ' ' HB3' ' A' ' 28' ' ' CYS . . . 67.37 -98.09 0.43 Allowed Glycine 0 C--O 1.221 -0.717 0 N-CA-C 118.283 2.073 . . . . 0.73 118.283 172.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.97 ' HB2' HG13 ' A' ' 72' ' ' ILE . 6.0 t -169.25 106.64 0.4 Allowed 'General case' 0 C--N 1.354 0.789 0 CA-C-N 118.644 1.222 . . . . 1.08 109.314 176.577 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.564 ' HB3' ' CG2' ' A' ' 38' ' ' THR . 3.7 m-30 -89.16 105.24 17.66 Favored 'General case' 0 N--CA 1.427 -1.611 0 N-CA-C 106.036 -1.839 . . . . 1.38 106.036 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.926 HG13 HG12 ' A' ' 26' ' ' ILE . 1.5 t -94.69 88.62 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.195 0 CA-C-O 123.361 1.553 . . . . 0.76 108.72 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.822 ' O ' ' HA3' ' B' ' 133' ' ' GLY . . . 94.63 98.64 1.66 Allowed Glycine 0 C--O 1.228 -0.256 0 CA-C-N 111.633 -2.53 . . . . 0.81 115.979 179.307 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.565 HG21 ' CE1' ' B' ' 135' ' ' PHE . 0.7 OUTLIER 177.02 170.27 0.53 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.627 0.251 . . . . 0.77 111.057 177.339 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.805 ' HA ' HD12 ' A' ' 42' ' ' LEU . . . -58.97 -14.18 8.54 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.377 0.608 . . . . 1.02 110.547 178.231 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.587 ' OE2' HD22 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -73.21 -13.16 61.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.741 -1.118 . . . . 2.32 109.327 176.594 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.413 ' O ' ' HB2' ' A' ' 44' ' ' CYS . . . -105.87 -22.53 12.9 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 115.121 -0.945 . . . . 0.87 111.66 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.805 HD12 ' HA ' ' A' ' 39' ' ' ALA . 3.4 mt -44.25 -39.3 4.36 Favored 'General case' 0 C--N 1.344 0.368 0 N-CA-C 113.177 0.806 . . . . 1.23 113.177 -178.669 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' A' ' 43' ' ' ARG . 3.6 mmp_? -58.36 -19.33 34.58 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.275 0.559 . . . . 2.92 109.768 179.203 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.642 ' O ' ' N ' ' A' ' 47' ' ' GLU . 97.2 m -65.13 -45.64 84.23 Favored 'General case' 0 C--O 1.223 -0.294 0 N-CA-C 108.533 -0.914 . . . . 1.57 108.533 177.279 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.449 ' HB2' ' O ' ' A' ' 42' ' ' LEU . 75.3 mm-40 -28.98 -37.75 0.01 OUTLIER 'General case' 0 CA--C 1.551 0.996 0 CA-C-N 113.721 -1.581 . . . . 3.31 113.03 -178.411 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -87.43 -3.11 59.01 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 119.593 -0.843 . . . . 3.69 111.518 -179.142 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.642 ' N ' ' O ' ' A' ' 44' ' ' CYS . 1.1 tt0 . . . . . 0 N--CA 1.443 -0.784 0 CA-C-N 115.441 -0.8 . . . . 3.99 109.574 178.24 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 119.884 -0.103 . . . . 3.12 111.259 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 113.84 -63.84 0.29 Allowed Glycine 0 CA--C 1.496 -1.102 0 C-N-CA 120.428 -0.891 . . . . 2.1 112.66 178.185 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -114.45 127.71 55.97 Favored 'General case' 0 N--CA 1.419 -1.983 0 N-CA-C 104.956 -2.238 . . . . 4.36 104.956 177.355 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.94 ' O ' ' HA ' ' A' ' 66' ' ' ARG . 2.0 mtmp? -120.22 -100.14 0.0 OUTLIER Pre-proline 0 C--N 1.285 -2.239 0 CA-C-O 114.201 -2.809 . . . . 3.55 105.47 -176.13 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.797 ' CD ' ' HB3' ' A' ' 59' ' ' LYS . 56.5 Cg_endo -71.34 138.48 33.02 Favored 'Trans proline' 0 C--N 1.318 -1.066 0 CA-C-N 128.211 3.968 . . . . 1.54 115.569 -178.705 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.51 ' O ' ' SG ' ' A' ' 73' ' ' CYS . 20.6 p -143.18 146.02 33.33 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 114.432 -1.258 . . . . 1.59 110.363 177.085 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.56 -164.05 51.19 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 119.165 -1.493 . . . . 2.43 112.951 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.4 m -76.82 49.62 0.65 Allowed 'General case' 0 CA--C 1.553 1.072 0 N-CA-C 113.119 0.785 . . . . 4.11 113.119 -178.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 110.03 49.81 0.71 Allowed Glycine 0 N--CA 1.475 1.275 0 N-CA-C 115.466 0.947 . . . . 2.21 115.466 174.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.467 ' O ' ' SG ' ' A' ' 61' ' ' CYS . . . -152.3 120.73 1.1 Allowed Glycine 0 N--CA 1.475 1.259 0 C-N-CA 119.415 -1.374 . . . . 1.62 114.041 -179.351 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.94 ' HA ' ' O ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -83.81 152.76 24.44 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 118.83 1.315 . . . . 3.02 112.697 -177.251 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 20.3 t -65.32 103.1 0.75 Allowed 'General case' 0 N--CA 1.414 -2.234 0 N-CA-C 107.188 -1.412 . . . . 1.52 107.188 -179.472 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.769 ' HB3' ' HB ' ' A' ' 72' ' ' ILE . . . -80.14 -35.91 35.97 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-N 114.776 -1.102 . . . . 1.07 108.953 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.913 ' HB2' ' HB2' ' A' ' 28' ' ' CYS . . . -169.98 165.27 9.53 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.463 -0.94 . . . . 1.0 108.463 -179.509 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.747 ' HB3' ' O ' ' A' ' 30' ' ' ASP . . . -40.67 96.0 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.107 0 CA-C-O 122.33 1.062 . . . . 1.24 110.648 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.639 ' C ' HD13 ' A' ' 72' ' ' ILE . . . 93.75 11.51 57.86 Favored Glycine 0 N--CA 1.428 -1.855 0 CA-C-O 117.085 -1.953 . . . . 1.28 117.578 177.184 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.97 HG13 ' HB2' ' A' ' 34' ' ' CYS . 3.6 mm -109.53 104.15 16.61 Favored 'Isoleucine or valine' 0 C--N 1.361 1.084 0 CA-C-N 123.303 3.551 . . . . 2.27 108.247 178.275 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.853 ' HB2' ' HB3' ' A' ' 82' ' ' ASP . 6.3 t -89.01 92.53 9.26 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 109.21 -0.663 . . . . 1.98 109.21 -179.131 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 1.314 ' CB ' ' HA ' ' A' ' 79' ' ' CYS . 31.6 p -163.51 176.3 9.87 Favored 'General case' 0 C--O 1.225 -0.227 0 N-CA-C 115.329 1.603 . . . . 1.33 115.329 -177.496 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.941 ' HB2' ' HD2' ' A' ' 76' ' ' PRO . 73.2 p -109.33 -178.81 0.59 Allowed Pre-proline 0 N--CA 1.472 0.644 0 CA-C-N 114.051 -1.432 . . . . 1.99 110.414 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.941 ' HD2' ' HB2' ' A' ' 75' ' ' SER . 71.8 Cg_endo -76.23 30.56 0.39 Allowed 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 121.908 1.739 . . . . 1.86 112.606 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.564 ' HA ' ' OE1' ' B' ' 181' ' ' GLU . 4.8 t70 -140.65 -51.13 0.46 Allowed 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.053 -0.521 . . . . 2.65 109.787 179.049 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.894 ' O ' ' HB2' ' A' ' 74' ' ' CYS . . . -119.65 179.92 16.59 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-O 119.44 -0.644 . . . . 0.99 112.382 178.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 1.314 ' HA ' ' CB ' ' A' ' 74' ' ' CYS . 12.8 m -150.52 160.98 43.4 Favored 'General case' 0 C--N 1.348 0.521 0 N-CA-C 113.105 0.78 . . . . 1.34 113.105 179.096 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.692 ' HB2' ' O ' ' A' ' 73' ' ' CYS . 50.3 m80 -151.9 139.36 19.54 Favored 'General case' 0 C--N 1.353 0.735 0 C-N-CA 119.921 -0.712 . . . . 2.17 112.054 -178.487 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -65.55 120.11 12.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.043 -0.526 . . . . 3.05 109.965 178.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.853 ' HB3' ' HB2' ' A' ' 73' ' ' CYS . 0.0 OUTLIER -143.91 101.87 4.92 Favored Pre-proline 0 CA--C 1.537 0.459 0 CA-C-N 116.505 -0.316 . . . . 2.02 110.511 -179.219 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -65.79 -8.48 19.72 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 123.115 2.543 . . . . 1.93 113.831 -178.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.495 ' HB3' ' OD1' ' A' ' 82' ' ' ASP . . . -67.89 -39.04 83.71 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.784 0.661 . . . . 1.53 112.784 -178.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.699 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 0.5 OUTLIER -94.87 -4.82 46.28 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 112.613 0.597 . . . . 1.88 112.613 -178.694 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.669 ' HA ' ' C ' ' A' ' 70' ' ' ALA . 1.6 t70 . . . . . 0 N--CA 1.47 0.532 0 N-CA-C 112.636 0.606 . . . . 3.6 112.636 -177.231 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 110' ' ' CYS . . . . . 0.588 ' HB3' ' HB3' ' B' ' 120' ' ' ARG . 0.1 OUTLIER . . . . . 0 CA--C 1.548 0.903 0 N-CA-C 113.157 0.799 . . . . 2.61 113.157 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 111' ' ' LEU . . . . . 0.604 ' O ' ' HA ' ' B' ' 120' ' ' ARG . 4.4 mm? 6.01 111.74 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.523 0 N-CA-C 113.027 0.751 . . . . 2.47 113.027 178.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 112' ' ' PRO . . . . . 0.599 ' HA ' ' O ' ' B' ' 119' ' ' GLY . 92.8 Cg_endo -80.18 122.63 4.76 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 123.071 2.514 . . . . 1.47 116.219 -178.294 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.59 ' O ' ' HA2' ' B' ' 117' ' ' GLY . 27.0 p -127.32 -176.16 3.66 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.043 -0.981 . . . . 1.0 111.264 179.122 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 114' ' ' GLY . . . . . 0.462 ' HA2' ' HG2' ' B' ' 140' ' ' GLU . . . 75.59 -161.38 52.6 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 120.484 -0.865 . . . . 1.16 112.43 -178.246 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 115' ' ' PRO . . . . . 1.045 ' HD2' HD11 ' B' ' 132' ' ' LEU . 38.7 Cg_endo -64.64 95.83 0.24 Allowed 'Trans proline' 0 N--CA 1.479 0.62 0 C-N-CA 123.624 2.882 . . . . 1.57 112.676 178.338 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 83.17 -2.94 86.15 Favored Glycine 0 C--N 1.29 -2.012 0 CA-C-N 114.13 -1.396 . . . . 1.7 112.781 178.068 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 117' ' ' GLY . . . . . 0.59 ' HA2' ' O ' ' B' ' 113' ' ' CYS . . . 84.79 35.84 12.59 Favored Glycine 0 N--CA 1.415 -2.754 0 C-N-CA 118.593 -1.765 . . . . 1.38 116.185 176.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 118' ' ' LYS . . . . . 0.423 ' HG2' ' H ' ' B' ' 118' ' ' LYS . 0.1 OUTLIER -74.91 -32.57 61.83 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 112.849 -1.675 . . . . 2.54 106.959 176.216 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 119' ' ' GLY . . . . . 0.599 ' O ' ' HA ' ' B' ' 112' ' ' PRO . . . -79.29 178.44 53.66 Favored Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 113.286 -1.779 . . . . 1.04 112.878 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.604 ' HA ' ' O ' ' B' ' 111' ' ' LEU . 0.0 OUTLIER -141.76 162.7 34.84 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.272 -0.27 . . . . 2.89 110.272 -179.766 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 121' ' ' CYS . . . . . . . . . . . . . 15.3 t -108.66 143.16 38.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.404 0.621 . . . . 1.07 112.305 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -127.47 -54.21 1.35 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.801 -1.09 . . . . 1.53 108.862 178.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -95.96 149.78 19.43 Favored Glycine 0 C--N 1.332 0.325 0 N-CA-C 110.194 -1.162 . . . . 0.9 110.194 177.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -50.29 -48.33 20.47 Favored 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 121.786 1.657 . . . . 1.51 112.804 -179.12 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 125' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -100.7 3.79 42.62 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.563 0.22 . . . . 1.25 111.339 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 126' ' ' ILE . . . . . 0.903 HG12 HG13 ' B' ' 136' ' ' VAL . 0.6 OUTLIER -119.73 122.8 69.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 113.359 0.874 . . . . 0.85 113.359 -177.968 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 127' ' ' CYS . . . . . 0.437 ' HB3' ' OE1' ' B' ' 140' ' ' GLU . 0.1 OUTLIER -125.14 124.47 41.89 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 109.733 -0.469 . . . . 0.89 109.733 178.689 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 128' ' ' CYS . . . . . 0.937 ' HB2' ' HB2' ' B' ' 169' ' ' ALA . 0.0 OUTLIER -130.45 142.95 50.48 Favored 'General case' 0 CA--C 1.551 1.006 0 N-CA-C 114.277 1.214 . . . . 1.23 114.277 -177.627 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 129' ' ' GLY . . . . . 0.741 ' O ' ' HB1' ' B' ' 169' ' ' ALA . . . -132.05 -173.34 13.3 Favored Glycine 0 C--N 1.359 1.838 0 N-CA-C 110.066 -1.214 . . . . 0.66 110.066 178.146 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 130' ' ' ASP . . . . . 0.75 ' O ' ' HB3' ' B' ' 170' ' ' ALA . 19.5 p-10 -63.73 -56.21 17.34 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 113.231 0.826 . . . . 2.35 113.231 -178.538 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 131' ' ' GLU . . . . . 0.42 ' HG2' ' OD2' ' B' ' 130' ' ' ASP . 0.0 OUTLIER -120.51 27.7 8.41 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.507 -0.745 . . . . 1.69 110.41 -179.806 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 132' ' ' LEU . . . . . 1.045 HD11 ' HD2' ' B' ' 115' ' ' PRO . 0.3 OUTLIER -122.46 -8.14 8.61 Favored 'General case' 0 N--CA 1.406 -2.672 0 N-CA-C 102.68 -3.081 . . . . 1.38 102.68 177.246 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 133' ' ' GLY . . . . . 0.888 ' O ' ' HB3' ' B' ' 128' ' ' CYS . . . 62.79 -94.15 0.11 Allowed Glycine 0 N--CA 1.426 -2.028 0 N-CA-C 118.973 2.349 . . . . 0.72 118.973 170.738 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 134' ' ' CYS . . . . . 0.988 ' HB2' HG13 ' B' ' 172' ' ' ILE . 6.1 t -170.02 106.85 0.34 Allowed 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 119.878 1.839 . . . . 1.08 109.453 176.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 135' ' ' PHE . . . . . 0.572 ' HB3' ' CG2' ' B' ' 138' ' ' THR . 3.6 m-30 -89.72 105.36 17.75 Favored 'General case' 0 N--CA 1.425 -1.683 0 N-CA-C 106.065 -1.828 . . . . 1.36 106.065 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 136' ' ' VAL . . . . . 0.903 HG13 HG12 ' B' ' 126' ' ' ILE . 1.7 t -94.64 89.12 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.197 0 CA-C-O 123.289 1.519 . . . . 0.75 108.561 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 137' ' ' GLY . . . . . 0.651 ' O ' ' HA3' ' A' ' 33' ' ' GLY . . . 93.94 98.83 1.57 Allowed Glycine 0 C--O 1.227 -0.309 0 CA-C-N 111.597 -2.547 . . . . 0.83 115.994 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 138' ' ' THR . . . . . 0.572 ' CG2' ' HB3' ' B' ' 135' ' ' PHE . 0.7 OUTLIER 177.0 170.55 0.52 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.651 0.262 . . . . 0.78 111.102 177.349 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 139' ' ' ALA . . . . . 0.8 ' HA ' HD12 ' B' ' 142' ' ' LEU . . . -58.81 -15.18 11.13 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 121.406 0.622 . . . . 1.04 110.654 178.119 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 140' ' ' GLU . . . . . 0.594 ' OE2' HD22 ' B' ' 132' ' ' LEU . 0.0 OUTLIER -72.65 -12.9 61.23 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.702 -1.135 . . . . 2.31 109.494 176.767 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 141' ' ' ALA . . . . . 0.406 ' O ' ' HB2' ' B' ' 144' ' ' CYS . . . -105.98 -22.72 12.82 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 115.169 -0.923 . . . . 0.87 111.643 -179.499 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 142' ' ' LEU . . . . . 0.8 HD12 ' HA ' ' B' ' 139' ' ' ALA . 3.6 mt -44.01 -39.28 4.01 Favored 'General case' 0 C--N 1.345 0.38 0 N-CA-C 113.176 0.806 . . . . 1.24 113.176 -178.718 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 143' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -58.17 -19.78 35.78 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.361 0.6 . . . . 2.93 109.769 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 144' ' ' CYS . . . . . 0.629 ' O ' ' N ' ' B' ' 147' ' ' GLU . 99.3 m -64.81 -45.77 84.83 Favored 'General case' 0 C--O 1.223 -0.3 0 N-CA-C 108.535 -0.913 . . . . 1.61 108.535 177.408 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 145' ' ' GLN . . . . . 0.451 ' HB2' ' O ' ' B' ' 142' ' ' LEU . 75.0 mm-40 -28.85 -37.75 0.01 OUTLIER 'General case' 0 CA--C 1.551 0.981 0 CA-C-N 113.668 -1.605 . . . . 3.35 113.05 -178.381 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -87.45 -3.1 59.01 Favored 'General case' 0 N--CA 1.477 0.905 0 O-C-N 121.253 -0.905 . . . . 3.76 111.5 -179.152 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 147' ' ' GLU . . . . . 0.629 ' N ' ' O ' ' B' ' 144' ' ' CYS . 1.1 tt0 . . . . . 0 C--N 1.318 -0.8 0 CA-C-N 115.433 -0.803 . . . . 4.01 109.54 178.243 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.48 1.071 0 N-CA-C 111.417 0.154 . . . . 3.11 111.417 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 111.44 -63.81 0.27 Allowed Glycine 0 C--N 1.338 0.675 0 C-N-CA 120.509 -0.853 . . . . 2.07 113.202 179.006 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 158' ' ' GLN . . . . . 0.584 ' O ' ' HB3' ' B' ' 167' ' ' CYS . 8.5 mt-30 -115.8 108.09 15.88 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 107.887 -1.153 . . . . 4.34 107.887 178.497 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 159' ' ' LYS . . . . . 0.889 ' O ' ' HA ' ' B' ' 166' ' ' ARG . 3.6 mtmp? -90.72 -103.75 0.0 OUTLIER Pre-proline 0 C--N 1.3 -1.577 0 CA-C-O 118.753 -0.641 . . . . 3.54 110.341 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 160' ' ' PRO . . . . . 0.854 ' HD3' ' HB3' ' B' ' 159' ' ' LYS . 57.6 Cg_endo -71.64 138.07 31.38 Favored 'Trans proline' 0 C--N 1.353 0.803 0 CA-C-N 122.231 1.833 . . . . 1.51 115.088 -179.051 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 161' ' ' CYS . . . . . 0.491 ' O ' ' SG ' ' B' ' 173' ' ' CYS . 20.1 p -142.78 146.68 34.48 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 114.155 -1.384 . . . . 1.58 110.013 177.281 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 69.64 -164.99 50.7 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 119.352 -1.404 . . . . 2.37 112.666 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 1.6 m -76.74 51.31 0.75 Allowed 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 123.872 0.869 . . . . 4.07 112.493 179.071 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 107.92 49.19 0.85 Allowed Glycine 0 N--CA 1.466 0.648 0 N-CA-C 115.913 1.125 . . . . 2.2 115.913 172.324 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 165' ' ' GLY . . . . . 0.489 ' O ' ' N ' ' B' ' 161' ' ' CYS . . . -150.95 122.98 1.44 Allowed Glycine 0 N--CA 1.469 0.878 0 C-N-CA 119.525 -1.321 . . . . 1.62 113.607 179.271 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 166' ' ' ARG . . . . . 0.889 ' HA ' ' O ' ' B' ' 159' ' ' LYS . 0.0 OUTLIER -84.36 152.78 23.86 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 118.841 1.321 . . . . 3.05 112.528 -178.398 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 167' ' ' CYS . . . . . 0.584 ' HB3' ' O ' ' B' ' 158' ' ' GLN . 20.0 t -65.29 103.04 0.73 Allowed 'General case' 0 N--CA 1.416 -2.171 0 N-CA-C 107.175 -1.417 . . . . 1.56 107.175 -179.608 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 168' ' ' ALA . . . . . 0.762 ' HB3' ' HB ' ' B' ' 172' ' ' ILE . . . -80.42 -35.09 35.61 Favored 'General case' 0 N--CA 1.424 -1.771 0 CA-C-N 114.676 -1.147 . . . . 1.04 108.969 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 169' ' ' ALA . . . . . 0.937 ' HB2' ' HB2' ' B' ' 128' ' ' CYS . . . -170.57 165.26 8.39 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 108.326 -0.99 . . . . 0.98 108.326 -179.509 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 170' ' ' ALA . . . . . 0.75 ' HB3' ' O ' ' B' ' 130' ' ' ASP . . . -40.76 96.07 0.01 OUTLIER 'General case' 0 C--O 1.232 0.152 0 CA-C-O 122.239 1.018 . . . . 1.25 110.622 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 171' ' ' GLY . . . . . 0.66 ' C ' HD13 ' B' ' 172' ' ' ILE . . . 93.7 11.5 57.92 Favored Glycine 0 N--CA 1.427 -1.932 0 CA-C-O 116.883 -2.065 . . . . 1.29 117.557 177.227 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 172' ' ' ILE . . . . . 0.988 HG13 ' HB2' ' B' ' 134' ' ' CYS . 3.2 mm -109.59 104.35 16.93 Favored 'Isoleucine or valine' 0 C--N 1.365 1.262 0 CA-C-N 123.685 3.743 . . . . 2.27 108.124 178.298 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 173' ' ' CYS . . . . . 0.829 ' HB2' ' HB3' ' B' ' 182' ' ' ASP . 6.3 t -88.99 92.43 9.23 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 109.156 -0.683 . . . . 1.94 109.156 -179.128 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 174' ' ' CYS . . . . . 1.308 ' CB ' ' HA ' ' B' ' 179' ' ' CYS . 31.0 p -163.34 176.17 10.13 Favored 'General case' 0 C--O 1.226 -0.162 0 N-CA-C 115.458 1.651 . . . . 1.35 115.458 -177.381 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 175' ' ' SER . . . . . 0.944 ' HB2' ' HD2' ' B' ' 176' ' ' PRO . 73.7 p -109.31 -178.86 0.6 Allowed Pre-proline 0 N--CA 1.47 0.557 0 CA-C-N 114.187 -1.369 . . . . 2.0 110.441 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 176' ' ' PRO . . . . . 0.944 ' HD2' ' HB2' ' B' ' 175' ' ' SER . 71.6 Cg_endo -76.11 30.47 0.39 Allowed 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 121.913 1.742 . . . . 1.9 112.675 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 177' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -140.68 -51.16 0.46 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.086 -0.506 . . . . 2.72 109.769 179.103 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 178' ' ' GLY . . . . . 0.904 ' O ' ' HB2' ' B' ' 174' ' ' CYS . . . -119.65 179.99 16.59 Favored Glycine 0 N--CA 1.445 -0.759 0 CA-C-O 119.412 -0.66 . . . . 0.99 112.18 178.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 179' ' ' CYS . . . . . 1.308 ' HA ' ' CB ' ' B' ' 174' ' ' CYS . 12.5 m -150.47 161.1 43.18 Favored 'General case' 0 C--N 1.346 0.447 0 N-CA-C 113.165 0.802 . . . . 1.34 113.165 179.137 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 180' ' ' HIS . . . . . 0.698 ' HB2' ' O ' ' B' ' 173' ' ' CYS . 49.2 m80 -151.98 139.18 19.28 Favored 'General case' 0 C--N 1.354 0.775 0 C-N-CA 119.786 -0.765 . . . . 2.1 111.998 -178.322 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 181' ' ' GLU . . . . . 0.564 ' OE1' ' HA ' ' A' ' 77' ' ' ASP . 27.8 mt-10 -65.43 120.05 12.12 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 116.028 -0.533 . . . . 3.06 110.072 178.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 182' ' ' ASP . . . . . 0.829 ' HB3' ' HB2' ' B' ' 173' ' ' CYS . 0.0 OUTLIER -143.81 101.86 4.96 Favored Pre-proline 0 CA--C 1.536 0.413 0 CA-C-N 116.612 -0.267 . . . . 2.06 110.535 -179.187 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 183' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -65.88 -8.37 19.54 Favored 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 123.214 2.609 . . . . 1.91 113.859 -178.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 184' ' ' ALA . . . . . 0.482 ' HB3' ' OD1' ' B' ' 182' ' ' ASP . . . -67.97 -39.11 83.4 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.78 0.659 . . . . 1.56 112.78 -179.079 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 185' ' ' CYS . . . . . 0.704 ' O ' ' HA ' ' B' ' 170' ' ' ALA . 0.6 OUTLIER -94.78 -4.73 46.74 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.592 0.59 . . . . 1.94 112.592 -178.744 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 186' ' ' ASP . . . . . 0.669 ' HA ' ' C ' ' B' ' 170' ' ' ALA . 1.6 t70 . . . . . 0 N--CA 1.47 0.565 0 N-CA-C 112.659 0.614 . . . . 3.61 112.659 -177.268 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.858 ' HB3' ' CG ' ' A' ' 20' ' ' ARG . 61.1 m . . . . . 0 CA--C 1.535 0.366 0 N-CA-C 113.682 0.993 . . . . 2.68 113.682 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.662 HD23 ' HB2' ' A' ' 21' ' ' CYS . 16.3 tp -35.08 111.8 0.44 Allowed Pre-proline 0 N--CA 1.489 1.516 0 C-N-CA 123.223 0.609 . . . . 2.48 112.625 177.845 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.908 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 44.9 Cg_endo -86.99 144.21 7.12 Favored 'Trans proline' 0 C--N 1.357 1.012 0 C-N-CA 122.971 2.447 . . . . 1.49 116.992 -177.295 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.555 ' N ' ' O ' ' A' ' 19' ' ' GLY . 27.3 p -149.1 -170.24 3.58 Favored 'General case' 0 C--N 1.355 0.81 0 CA-C-N 115.961 -0.563 . . . . 1.0 109.79 178.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.832 ' CA ' ' HG2' ' A' ' 40' ' ' GLU . . . 75.45 -161.27 52.71 Favored Glycine 0 C--N 1.335 0.51 0 N-CA-C 115.256 0.862 . . . . 1.15 115.256 176.697 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.46 ' O ' ' HG2' ' A' ' 15' ' ' PRO . 38.0 Cg_endo -64.5 102.54 0.41 Allowed 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 124.027 3.151 . . . . 1.57 111.502 178.533 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 86.1 -0.98 87.72 Favored Glycine 0 C--N 1.265 -3.385 0 CA-C-N 112.028 -2.351 . . . . 1.68 112.761 -179.179 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.817 ' O ' ' HB2' ' A' ' 12' ' ' PRO . . . 72.43 43.03 46.9 Favored Glycine 0 N--CA 1.405 -3.385 0 C-N-CA 118.988 -1.577 . . . . 1.36 114.49 173.618 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.92 -41.13 9.33 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 114.29 -0.955 . . . . 2.5 110.416 177.367 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.908 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -71.38 169.02 50.3 Favored Glycine 0 C--O 1.194 -2.351 0 N-CA-C 116.272 1.269 . . . . 1.02 116.272 -174.692 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.858 ' CG ' ' HB3' ' A' ' 10' ' ' CYS . 4.2 mpp_? -104.14 160.83 14.53 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 112.747 -1.727 . . . . 2.92 114.926 -172.325 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.662 ' HB2' HD23 ' A' ' 11' ' ' LEU . 5.1 m -106.91 136.94 45.91 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 114.794 -1.093 . . . . 1.1 111.597 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -145.69 24.43 1.37 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.32 -0.855 . . . . 1.51 110.137 179.206 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 152.28 161.52 10.26 Favored Glycine 0 CA--C 1.521 0.422 0 N-CA-C 111.164 -0.775 . . . . 0.9 111.164 -179.353 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.661 ' HD2' ' OE2' ' B' ' 181' ' ' GLU . 31.8 Cg_exo -58.7 -64.01 0.12 Allowed 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 121.703 1.602 . . . . 1.5 112.335 -179.532 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.456 ' O ' ' N ' ' A' ' 37' ' ' GLY . 3.3 m -90.47 39.5 0.98 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.704 0.288 . . . . 1.26 110.289 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.971 HG12 HG13 ' A' ' 36' ' ' VAL . 3.0 mt -155.28 121.19 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 O-C-N 122.114 -0.366 . . . . 0.83 111.612 -179.276 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -137.86 110.16 7.38 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 120.877 0.37 . . . . 0.92 110.714 179.282 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.811 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -116.5 155.34 28.81 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 113.46 0.911 . . . . 1.28 113.46 179.025 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.516 ' O ' ' HB2' ' A' ' 69' ' ' ALA . . . -149.67 -174.61 21.19 Favored Glycine 0 C--N 1.371 2.494 0 N-CA-C 108.259 -1.936 . . . . 0.67 108.259 177.033 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -67.8 -41.73 82.68 Favored 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 125.892 1.677 . . . . 2.27 115.328 -179.028 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -122.83 13.23 9.89 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 114.209 -1.359 . . . . 1.66 111.424 178.785 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.688 HD23 ' CE1' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -120.25 -7.2 9.83 Favored 'General case' 0 N--CA 1.393 -3.323 0 N-CA-C 108.541 -0.911 . . . . 1.37 108.541 -178.383 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.972 ' HA2' ' CB ' ' A' ' 69' ' ' ALA . . . 49.83 -135.71 25.02 Favored Glycine 0 C--O 1.198 -2.103 0 CA-C-O 116.504 -2.276 . . . . 0.73 109.561 179.372 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 1.082 ' HB2' HD13 ' A' ' 72' ' ' ILE . 0.7 OUTLIER -128.71 130.46 47.18 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 121.495 2.648 . . . . 1.08 111.674 -179.842 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.688 ' CE1' HD23 ' A' ' 32' ' ' LEU . 1.3 m-85 -104.12 101.76 11.5 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 102.139 -3.282 . . . . 1.38 102.139 173.469 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.971 HG13 HG12 ' A' ' 26' ' ' ILE . 2.5 t -92.72 93.97 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.312 0 CA-C-O 123.694 1.711 . . . . 0.76 110.066 -177.113 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.779 ' HA3' ' CG2' ' B' ' 172' ' ' ILE . . . 83.18 80.37 1.0 Allowed Glycine 0 C--N 1.319 -0.379 0 CA-C-N 111.826 -2.443 . . . . 0.81 113.257 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.616 HG21 ' CE1' ' B' ' 135' ' ' PHE . 70.7 p -160.76 -167.31 1.82 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.11 0.481 . . . . 0.77 110.361 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.762 ' HA ' HD12 ' A' ' 42' ' ' LEU . . . -62.14 -40.5 96.15 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 108.817 -0.809 . . . . 1.02 108.817 179.365 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.832 ' HG2' ' CA ' ' A' ' 14' ' ' GLY . 0.4 OUTLIER -55.9 -26.4 47.21 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 114.986 -1.006 . . . . 2.32 112.38 179.655 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.493 ' O ' ' N ' ' A' ' 44' ' ' CYS . . . -91.63 -35.37 14.26 Favored 'General case' 0 C--O 1.213 -0.845 0 CA-C-N 116.197 -0.456 . . . . 0.87 110.268 -179.675 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.762 HD12 ' HA ' ' A' ' 39' ' ' ALA . 7.9 mt -39.57 -54.31 2.0 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 114.866 1.432 . . . . 1.23 114.866 -175.483 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.564 ' HD2' ' H ' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -54.75 -23.6 18.61 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 119.982 -0.687 . . . . 2.92 109.763 178.171 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.493 ' N ' ' O ' ' A' ' 41' ' ' ALA . 4.9 t -69.43 17.77 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 112.823 0.675 . . . . 1.57 112.823 -177.586 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.515 ' H ' ' C ' ' A' ' 43' ' ' ARG . 1.3 tt0 -75.22 -28.84 60.08 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 114.312 -1.313 . . . . 3.31 107.99 176.726 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -82.33 9.95 7.96 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.224 -0.898 . . . . 3.69 110.837 179.255 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.464 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . 0.9 OUTLIER . . . . . 0 N--CA 1.455 -0.208 0 N-CA-C 109.745 -0.465 . . . . 3.99 109.745 177.584 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.482 1.141 0 N-CA-C 110.548 -0.168 . . . . 3.12 110.548 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.632 ' O ' ' HG3' ' A' ' 66' ' ' ARG . . . 99.18 32.14 5.93 Favored Glycine 0 C--N 1.345 1.033 0 C-N-CA 120.566 -0.826 . . . . 2.1 112.348 177.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -122.04 76.09 1.27 Allowed 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 121.908 0.861 . . . . 4.36 111.173 179.384 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.836 ' HB2' ' HB2' ' A' ' 67' ' ' CYS . 1.6 mmtp -133.41 69.59 77.16 Favored Pre-proline 0 C--N 1.313 -1.01 0 N-CA-C 106.734 -1.58 . . . . 3.55 106.734 178.517 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.704 ' HA ' ' O ' ' A' ' 65' ' ' GLY . 14.4 Cg_endo -56.9 82.38 0.04 OUTLIER 'Trans proline' 0 C--N 1.368 1.582 0 C-N-CA 123.901 3.068 . . . . 1.54 117.754 -176.413 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -101.8 -178.35 3.69 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 106.181 -1.785 . . . . 1.59 106.181 173.164 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.09 -167.15 53.14 Favored Glycine 0 C--N 1.339 0.734 0 C-N-CA 119.205 -1.474 . . . . 2.43 112.372 -179.13 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.6 p -83.04 41.79 0.77 Allowed 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 120.818 -0.353 . . . . 4.11 110.412 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 117.12 9.68 10.41 Favored Glycine 0 CA--C 1.538 1.492 0 CA-C-O 117.124 -1.931 . . . . 2.21 116.204 179.503 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.704 ' O ' ' HA ' ' A' ' 60' ' ' PRO . . . -102.64 156.3 18.31 Favored Glycine 0 C--N 1.345 1.081 0 CA-C-N 121.767 2.783 . . . . 1.62 113.554 179.147 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.632 ' HG3' ' O ' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -99.21 151.86 20.54 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 111.849 0.314 . . . . 3.02 111.849 179.415 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.836 ' HB2' ' HB2' ' A' ' 59' ' ' LYS . 1.3 m -71.59 106.85 4.18 Favored 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 109.557 -0.534 . . . . 1.52 109.557 178.729 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.557 ' HB1' ' HB2' ' A' ' 28' ' ' CYS . . . -89.03 -22.04 23.17 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 107.935 -1.135 . . . . 1.07 107.935 177.088 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.972 ' CB ' ' HA2' ' A' ' 33' ' ' GLY . . . -161.7 162.37 29.75 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 112.342 -2.208 . . . . 1.0 113.937 -175.073 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.648 ' HA ' ' O ' ' A' ' 85' ' ' CYS . . . -58.63 122.99 14.81 Favored 'General case' 0 CA--C 1.527 0.092 0 N-CA-C 113.05 0.759 . . . . 1.24 113.05 -178.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.686 ' HA2' ' O ' ' A' ' 82' ' ' ASP . . . 71.33 15.96 75.18 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-N 115.671 -0.695 . . . . 1.28 114.189 178.637 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 1.082 HD13 ' HB2' ' A' ' 34' ' ' CYS . 1.2 pp -141.73 98.29 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-N 113.932 -1.134 . . . . 2.27 112.733 -178.489 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.562 ' HB2' ' HB3' ' A' ' 82' ' ' ASP . 5.0 t -99.57 85.41 3.13 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 114.021 -1.445 . . . . 1.98 110.224 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 1.049 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 1.8 m -93.88 146.06 24.17 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.258 -0.428 . . . . 1.33 111.169 -179.192 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.906 ' HB2' ' HD2' ' A' ' 76' ' ' PRO . 53.9 p -109.56 -179.62 0.7 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.84 -0.618 . . . . 1.99 110.029 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.906 ' HD2' ' HB2' ' A' ' 75' ' ' SER . 77.1 Cg_endo -77.67 29.42 0.44 Allowed 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 121.695 1.596 . . . . 1.86 111.436 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.447 ' H ' ' C ' ' A' ' 75' ' ' SER . 0.6 OUTLIER -144.66 -29.44 0.47 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.218 -0.901 . . . . 2.65 110.113 179.41 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.515 ' O ' ' HB3' ' A' ' 74' ' ' CYS . . . -166.91 -145.89 4.65 Favored Glycine 0 CA--C 1.524 0.615 0 CA-C-N 115.977 -0.556 . . . . 0.99 112.603 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 1.049 ' HA ' ' HA ' ' A' ' 74' ' ' CYS . 11.9 t -146.62 159.16 43.8 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 109.808 -0.441 . . . . 1.34 109.808 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 55.3 m-70 -149.67 135.16 18.37 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 120.04 -0.664 . . . . 2.17 110.358 -176.545 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.701 ' HG3' HD11 ' B' ' 126' ' ' ILE . 2.6 mt-10 -60.79 132.13 52.9 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 109.712 -0.477 . . . . 3.05 109.712 179.5 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.686 ' O ' ' HA2' ' A' ' 71' ' ' GLY . 0.1 OUTLIER -140.01 112.8 7.52 Favored Pre-proline 0 CA--C 1.545 0.788 0 CA-C-N 116.355 -0.384 . . . . 2.02 110.755 -178.557 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 82' ' ' ASP . 13.9 Cg_exo -70.87 -21.11 28.75 Favored 'Trans proline' 0 C--N 1.359 1.09 0 C-N-CA 122.831 2.354 . . . . 1.93 113.862 -178.363 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.83 -39.75 94.97 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.718 0.294 . . . . 1.53 111.485 -179.42 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.648 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 68.4 m -97.95 -0.54 44.64 Favored 'General case' 0 C--O 1.215 -0.739 0 N-CA-C 112.681 0.623 . . . . 1.88 112.681 -179.486 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.554 ' HA ' ' N ' ' A' ' 71' ' ' GLY . 0.8 OUTLIER . . . . . 0 C--N 1.319 -0.719 0 N-CA-C 112.82 0.674 . . . . 3.6 112.82 -176.58 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 110' ' ' CYS . . . . . 0.842 ' HB3' ' CG ' ' B' ' 120' ' ' ARG . 59.3 m . . . . . 0 CA--C 1.535 0.366 0 N-CA-C 113.806 1.039 . . . . 2.61 113.806 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 111' ' ' LEU . . . . . 0.668 ' O ' ' HA ' ' B' ' 120' ' ' ARG . 16.5 tp -34.3 111.58 0.4 Allowed Pre-proline 0 N--CA 1.491 1.579 0 C-N-CA 123.162 0.585 . . . . 2.47 112.553 178.262 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 112' ' ' PRO . . . . . 0.922 ' HA ' ' O ' ' B' ' 119' ' ' GLY . 68.5 Cg_endo -83.12 147.88 13.13 Favored 'Trans proline' 0 C--N 1.359 1.101 0 C-N-CA 122.811 2.341 . . . . 1.47 115.442 -177.551 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.513 ' C ' ' HA2' ' B' ' 117' ' ' GLY . 28.0 p -152.06 -170.43 3.64 Favored 'General case' 0 C--O 1.254 1.31 0 CA-C-N 115.378 -0.828 . . . . 1.0 110.081 174.745 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 114' ' ' GLY . . . . . 0.81 ' CA ' ' HG2' ' B' ' 140' ' ' GLU . . . 75.79 -160.34 51.62 Favored Glycine 0 C--N 1.343 0.969 0 CA-C-N 114.712 -1.131 . . . . 1.16 115.094 176.143 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 115' ' ' PRO . . . . . 0.48 ' O ' ' HG2' ' B' ' 115' ' ' PRO . 35.5 Cg_endo -64.6 106.46 0.74 Allowed 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 124.067 3.178 . . . . 1.57 110.56 178.157 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 87.03 -11.88 63.7 Favored Glycine 0 C--N 1.257 -3.848 0 CA-C-N 112.211 -2.268 . . . . 1.7 111.174 -179.057 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 117' ' ' GLY . . . . . 0.755 ' O ' ' HB2' ' B' ' 112' ' ' PRO . . . 72.53 52.84 9.37 Favored Glycine 0 N--CA 1.399 -3.791 0 C-N-CA 119.596 -1.288 . . . . 1.38 113.488 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.05 -53.82 3.82 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 104.722 -2.325 . . . . 2.54 104.722 173.084 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 119' ' ' GLY . . . . . 0.922 ' O ' ' HA ' ' B' ' 112' ' ' PRO . . . -58.64 176.3 2.31 Favored Glycine 0 C--O 1.206 -1.643 0 CA-C-N 114.007 -1.451 . . . . 1.04 115.111 -167.279 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.842 ' CG ' ' HB3' ' B' ' 110' ' ' CYS . 4.7 mpp_? -113.83 163.68 14.74 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 114.081 1.141 . . . . 2.89 114.081 -173.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 121' ' ' CYS . . . . . 0.658 ' HB2' HD23 ' B' ' 111' ' ' LEU . 6.8 m -106.86 137.23 45.3 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.521 -1.218 . . . . 1.07 112.034 -179.059 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -145.68 24.35 1.37 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.186 -0.915 . . . . 1.53 110.171 179.017 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 152.29 161.52 10.26 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 111.196 -0.762 . . . . 0.9 111.196 -179.362 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 124' ' ' PRO . . . . . 0.635 ' HD2' ' OE2' ' A' ' 81' ' ' GLU . 32.0 Cg_exo -58.59 -64.11 0.12 Allowed 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 121.749 1.633 . . . . 1.51 112.286 -179.495 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 125' ' ' SER . . . . . 0.455 ' O ' ' N ' ' B' ' 137' ' ' GLY . 3.2 m -90.58 39.62 0.98 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.665 0.269 . . . . 1.25 110.33 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 126' ' ' ILE . . . . . 1.006 HG12 HG13 ' B' ' 136' ' ' VAL . 3.3 mt -155.07 121.11 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 O-C-N 122.242 -0.286 . . . . 0.85 111.707 -179.21 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 127' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -138.06 110.02 7.23 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.054 0.454 . . . . 0.89 110.755 179.107 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 128' ' ' CYS . . . . . 0.806 ' HA ' ' O ' ' B' ' 133' ' ' GLY . 0.0 OUTLIER -112.51 157.59 20.95 Favored 'General case' 0 CA--C 1.562 1.417 0 C-N-CA 123.836 0.854 . . . . 1.23 112.647 178.764 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 129' ' ' GLY . . . . . 0.502 ' O ' ' HB2' ' B' ' 169' ' ' ALA . . . -152.56 -175.48 24.15 Favored Glycine 0 C--N 1.38 2.985 0 N-CA-C 109.512 -1.435 . . . . 0.66 109.512 176.047 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -68.28 -45.79 72.12 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.871 1.268 . . . . 2.35 113.068 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.15 25.22 7.9 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-N 114.286 -1.325 . . . . 1.69 110.756 179.34 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 132' ' ' LEU . . . . . 0.688 HD23 ' CE1' ' B' ' 135' ' ' PHE . 0.2 OUTLIER -126.74 -10.81 6.13 Favored 'General case' 0 N--CA 1.401 -2.919 0 CA-C-N 113.427 -1.715 . . . . 1.38 109.573 179.643 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 133' ' ' GLY . . . . . 0.93 ' HA2' ' CB ' ' B' ' 169' ' ' ALA . . . 53.97 -125.06 32.04 Favored Glycine 0 N--CA 1.414 -2.828 0 CA-C-O 116.212 -2.438 . . . . 0.72 112.29 177.247 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 134' ' ' CYS . . . . . 1.091 ' HB2' HD13 ' B' ' 172' ' ' ILE . 0.8 OUTLIER -141.09 125.9 18.06 Favored 'General case' 0 CA--C 1.496 -1.099 0 CA-C-N 121.693 2.746 . . . . 1.08 112.261 176.211 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 135' ' ' PHE . . . . . 0.688 ' CE1' HD23 ' B' ' 132' ' ' LEU . 1.2 m-85 -101.13 101.93 12.77 Favored 'General case' 0 N--CA 1.425 -1.724 0 N-CA-C 102.266 -3.235 . . . . 1.36 102.266 175.782 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 136' ' ' VAL . . . . . 1.006 HG13 HG12 ' B' ' 126' ' ' ILE . 3.1 t -92.53 91.92 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.345 0 CA-C-O 123.317 1.532 . . . . 0.75 110.28 -177.014 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 137' ' ' GLY . . . . . 0.95 ' HA3' HG21 ' A' ' 72' ' ' ILE . . . 85.48 79.88 1.14 Allowed Glycine 0 CA--C 1.507 -0.44 0 CA-C-N 111.941 -2.39 . . . . 0.83 112.998 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 138' ' ' THR . . . . . 0.639 HG22 ' O ' ' A' ' 32' ' ' LEU . 76.4 p -155.96 -159.96 0.96 Allowed 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.427 0.632 . . . . 0.78 111.582 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 139' ' ' ALA . . . . . 0.725 ' HA ' HD12 ' B' ' 142' ' ' LEU . . . -68.67 -41.39 79.35 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.459 -1.246 . . . . 1.04 108.353 176.071 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 140' ' ' GLU . . . . . 0.81 ' HG2' ' CA ' ' B' ' 114' ' ' GLY . 0.3 OUTLIER -54.1 -30.24 47.82 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.093 -1.412 . . . . 2.31 112.248 179.081 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 141' ' ' ALA . . . . . 0.479 ' O ' ' N ' ' B' ' 144' ' ' CYS . . . -88.85 -35.71 16.41 Favored 'General case' 0 C--O 1.207 -1.178 0 N-CA-C 110.3 -0.259 . . . . 0.87 110.3 -178.851 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 142' ' ' LEU . . . . . 0.725 HD12 ' HA ' ' B' ' 139' ' ' ALA . 6.2 mt -39.04 -54.75 1.67 Allowed 'General case' 0 C--O 1.24 0.566 0 N-CA-C 113.832 1.049 . . . . 1.24 113.832 -173.861 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 143' ' ' ARG . . . . . 0.562 ' HD2' ' H ' ' B' ' 143' ' ' ARG . 0.0 OUTLIER -55.59 -22.09 20.46 Favored 'General case' 0 CA--C 1.497 -1.094 0 C-N-CA 120.037 -0.665 . . . . 2.93 109.851 177.81 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 144' ' ' CYS . . . . . 0.49 ' SG ' ' HB2' ' B' ' 147' ' ' GLU . 6.7 t -75.46 29.64 0.1 Allowed 'General case' 0 CA--C 1.497 -1.064 0 C-N-CA 119.763 -0.775 . . . . 1.61 111.529 -178.335 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -84.71 -22.37 29.76 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 106.516 -1.661 . . . . 3.35 106.516 175.009 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -82.07 9.35 8.65 Favored 'General case' 0 C--N 1.343 0.283 0 CA-C-N 115.314 -0.857 . . . . 3.76 110.106 178.582 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 147' ' ' GLU . . . . . 0.49 ' HB2' ' SG ' ' B' ' 144' ' ' CYS . 0.9 OUTLIER . . . . . 0 N--CA 1.454 -0.239 0 N-CA-C 109.771 -0.455 . . . . 4.01 109.771 177.537 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.479 0.999 0 N-CA-C 112.116 0.414 . . . . 3.11 112.116 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 157' ' ' GLY . . . . . 0.614 ' O ' ' HG3' ' B' ' 166' ' ' ARG . . . 105.13 33.0 3.84 Favored Glycine 0 CA--C 1.505 -0.593 0 C-N-CA 120.611 -0.804 . . . . 2.07 112.479 179.603 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -122.15 67.42 0.93 Allowed 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 121.655 0.74 . . . . 4.34 111.858 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 159' ' ' LYS . . . . . 0.965 ' HB2' ' HB2' ' B' ' 167' ' ' CYS . 2.0 mmtp -115.71 67.54 2.83 Favored Pre-proline 0 CA--C 1.539 0.529 0 CA-C-N 114.654 -1.157 . . . . 3.54 109.33 174.713 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 160' ' ' PRO . . . . . 0.658 ' HA ' ' O ' ' B' ' 165' ' ' GLY . 12.5 Cg_endo -56.33 82.92 0.04 OUTLIER 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 122.942 2.428 . . . . 1.51 118.14 -174.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 161' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -98.1 -171.53 2.17 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 106.347 -1.723 . . . . 1.58 106.347 173.443 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 65.35 -166.02 34.7 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 119.319 -1.42 . . . . 2.37 112.803 177.595 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 3.9 p -84.46 39.65 0.74 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.758 0.789 . . . . 4.07 110.313 -179.046 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 121.2 5.03 9.8 Favored Glycine 0 CA--C 1.535 1.284 0 CA-C-O 117.793 -1.559 . . . . 2.2 116.513 178.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 165' ' ' GLY . . . . . 0.658 ' O ' ' HA ' ' B' ' 160' ' ' PRO . . . -101.68 155.86 18.85 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-N 121.241 2.52 . . . . 1.62 114.093 -178.848 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 166' ' ' ARG . . . . . 0.614 ' HG3' ' O ' ' B' ' 157' ' ' GLY . 0.0 OUTLIER -98.42 151.74 20.25 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.034 0.383 . . . . 3.05 112.034 -179.084 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 167' ' ' CYS . . . . . 0.965 ' HB2' ' HB2' ' B' ' 159' ' ' LYS . 1.3 m -71.58 107.14 4.31 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 109.634 -0.506 . . . . 1.56 109.634 178.731 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 168' ' ' ALA . . . . . 0.551 ' HB1' ' HB2' ' B' ' 128' ' ' CYS . . . -94.18 -13.84 26.24 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.917 -0.771 . . . . 1.04 108.917 177.648 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 169' ' ' ALA . . . . . 0.93 ' CB ' ' HA2' ' B' ' 133' ' ' GLY . . . -168.24 163.67 13.1 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.503 -0.771 . . . . 0.98 111.036 -179.465 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 170' ' ' ALA . . . . . 0.623 ' HA ' ' O ' ' B' ' 185' ' ' CYS . . . -58.78 122.46 13.62 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 113.805 1.039 . . . . 1.25 113.805 -178.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 171' ' ' GLY . . . . . 0.802 ' HA2' ' O ' ' B' ' 182' ' ' ASP . . . 60.94 35.66 90.87 Favored Glycine 0 C--N 1.343 0.963 0 CA-C-N 115.221 -0.9 . . . . 1.29 111.292 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 172' ' ' ILE . . . . . 1.091 HD13 ' HB2' ' B' ' 134' ' ' CYS . 1.2 pp -151.6 97.91 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 113.805 -1.197 . . . . 2.27 111.629 173.719 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 173' ' ' CYS . . . . . 0.563 ' HB2' ' HB3' ' B' ' 182' ' ' ASP . 5.2 t -99.71 85.85 3.19 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.682 -1.144 . . . . 1.94 110.174 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 174' ' ' CYS . . . . . 1.047 ' HA ' ' HA ' ' B' ' 179' ' ' CYS . 1.8 m -93.85 146.07 24.16 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.023 0.44 . . . . 1.35 111.187 -179.11 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 175' ' ' SER . . . . . 0.92 ' HB2' ' HD2' ' B' ' 176' ' ' PRO . 54.0 p -109.65 -179.65 0.7 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.761 -0.654 . . . . 2.0 110.031 179.505 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 176' ' ' PRO . . . . . 0.92 ' HD2' ' HB2' ' B' ' 175' ' ' SER . 78.6 Cg_endo -77.61 29.38 0.43 Allowed 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 121.675 1.583 . . . . 1.9 111.483 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 177' ' ' ASP . . . . . 0.449 ' H ' ' C ' ' B' ' 175' ' ' SER . 0.6 OUTLIER -144.63 -29.42 0.47 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.178 -0.919 . . . . 2.72 110.142 179.425 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 178' ' ' GLY . . . . . 0.523 ' O ' ' HB3' ' B' ' 174' ' ' CYS . . . -166.94 -145.75 4.6 Favored Glycine 0 CA--C 1.523 0.591 0 CA-C-N 115.944 -0.571 . . . . 0.99 112.571 179.73 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 179' ' ' CYS . . . . . 1.047 ' HA ' ' HA ' ' B' ' 174' ' ' CYS . 11.7 t -146.4 161.73 39.75 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 109.803 -0.443 . . . . 1.34 109.803 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 180' ' ' HIS . . . . . . . . . . . . . 54.7 m-70 -153.77 134.14 13.46 Favored 'General case' 0 CA--C 1.504 -0.8 0 C-N-CA 119.67 -0.812 . . . . 2.1 111.284 -176.717 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 181' ' ' GLU . . . . . 0.661 ' OE2' ' HD2' ' A' ' 24' ' ' PRO . 2.5 mt-10 -60.05 132.07 52.8 Favored 'General case' 0 CA--C 1.521 -0.147 0 N-CA-C 109.793 -0.447 . . . . 3.06 109.793 -178.785 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 182' ' ' ASP . . . . . 0.802 ' O ' ' HA2' ' B' ' 171' ' ' GLY . 0.1 OUTLIER -140.0 112.72 7.51 Favored Pre-proline 0 CA--C 1.545 0.783 0 CA-C-N 116.248 -0.433 . . . . 2.06 110.74 -178.514 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 183' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -70.91 -21.15 28.5 Favored 'Trans proline' 0 C--N 1.359 1.089 0 C-N-CA 122.845 2.363 . . . . 1.91 113.776 -178.286 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -63.8 -39.83 95.18 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.721 0.296 . . . . 1.56 111.551 -179.401 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 185' ' ' CYS . . . . . 0.623 ' O ' ' HA ' ' B' ' 170' ' ' ALA . 67.2 m -97.85 -0.84 44.37 Favored 'General case' 0 C--O 1.215 -0.741 0 N-CA-C 112.504 0.557 . . . . 1.94 112.504 -179.376 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 186' ' ' ASP . . . . . 0.543 ' HA ' ' N ' ' B' ' 171' ' ' GLY . 0.8 OUTLIER . . . . . 0 C--N 1.321 -0.643 0 N-CA-C 112.953 0.723 . . . . 3.61 112.953 -176.583 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.66 ' HB3' ' HB3' ' A' ' 20' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.617 0 N-CA-C 115.022 1.49 . . . . 2.68 115.022 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.516 HD23 ' HD2' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -34.36 132.95 0.41 Allowed Pre-proline 0 N--CA 1.481 1.093 0 C-N-CA 124.067 0.947 . . . . 2.48 113.312 177.592 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.86 ' HB2' ' O ' ' A' ' 17' ' ' GLY . 79.0 Cg_endo -87.89 136.46 3.66 Favored 'Trans proline' 0 C--N 1.356 0.933 0 C-N-CA 122.736 2.291 . . . . 1.49 112.784 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 1.054 ' HB2' ' HG3' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -140.97 -162.79 1.42 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 119.975 -0.69 . . . . 1.0 112.163 -179.285 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.476 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . 81.73 -156.27 36.38 Favored Glycine 0 C--N 1.339 0.741 0 CA-C-O 119.323 -0.709 . . . . 1.15 111.836 -178.844 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.856 ' HG2' ' HD2' ' A' ' 18' ' ' LYS . 42.5 Cg_endo -62.49 108.17 0.68 Allowed 'Trans proline' 0 N--CA 1.483 0.867 0 N-CA-C 105.466 -2.551 . . . . 1.57 105.466 176.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 76.85 -14.37 7.48 Favored Glycine 0 C--N 1.265 -3.372 0 CA-C-O 118.485 -1.175 . . . . 1.68 112.588 176.189 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.86 ' O ' ' HB2' ' A' ' 12' ' ' PRO . . . 75.37 49.41 9.36 Favored Glycine 0 N--CA 1.401 -3.651 0 C-N-CA 117.075 -2.488 . . . . 1.36 111.825 178.561 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 1.052 ' HD3' HD11 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -94.99 -12.88 25.89 Favored 'General case' 0 C--N 1.345 0.41 0 CA-C-N 110.358 -2.921 . . . . 2.5 113.142 177.636 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.821 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -115.98 -167.53 14.98 Favored Glycine 0 C--N 1.345 1.082 0 N-CA-C 106.099 -2.801 . . . . 1.02 106.099 178.615 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.66 ' HB3' ' HB3' ' A' ' 10' ' ' CYS . 1.5 mpt_? -115.08 173.42 6.5 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 122.0 2.9 . . . . 2.92 111.656 -178.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.666 ' HB3' ' HG3' ' A' ' 47' ' ' GLU . 1.2 m -106.25 151.25 25.04 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.882 0.372 . . . . 1.1 110.875 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -124.11 -46.82 1.93 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.117 -0.492 . . . . 1.51 110.776 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.464 ' HA2' ' OE1' ' A' ' 47' ' ' GLU . . . -137.91 -161.18 8.77 Favored Glycine 0 CA--C 1.519 0.321 0 N-CA-C 111.601 -0.6 . . . . 0.9 111.601 179.58 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -77.87 -63.19 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.071 1.848 . . . . 1.5 111.451 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.442 ' C ' HG13 ' A' ' 26' ' ' ILE . 1.1 m -92.17 33.31 1.08 Allowed 'General case' 0 C--O 1.224 -0.238 0 CA-C-N 116.216 -0.447 . . . . 1.26 109.828 178.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 1.071 HG12 HG13 ' A' ' 36' ' ' VAL . 19.0 mt -149.29 121.34 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-O 121.208 0.528 . . . . 0.83 111.99 -178.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.557 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 6.9 t -140.15 124.7 18.05 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 108.472 -0.936 . . . . 0.92 108.472 179.374 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.73 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -138.05 121.72 17.46 Favored 'General case' 0 CA--C 1.551 1.016 0 N-CA-C 114.4 1.259 . . . . 1.28 114.4 -177.743 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.516 ' O ' ' HB2' ' A' ' 69' ' ' ALA . . . -102.82 -170.62 26.43 Favored Glycine 0 C--N 1.367 2.291 0 N-CA-C 110.098 -1.201 . . . . 0.67 110.098 176.653 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -65.85 -53.68 36.65 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 113.773 1.027 . . . . 2.27 113.773 -178.265 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.54 3.44 12.43 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 122.222 1.01 . . . . 1.66 110.966 -176.245 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 1.052 HD11 ' HD3' ' A' ' 18' ' ' LYS . 0.4 OUTLIER -96.94 -22.24 16.97 Favored 'General case' 0 N--CA 1.415 -2.222 0 CA-C-N 113.887 -1.506 . . . . 1.37 107.382 -178.595 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.857 ' HA2' ' CB ' ' A' ' 69' ' ' ALA . . . 76.49 -135.73 17.82 Favored Glycine 0 N--CA 1.41 -3.094 0 CA-C-O 117.727 -1.596 . . . . 0.73 112.256 176.84 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 1.03 ' HB2' HD13 ' A' ' 72' ' ' ILE . 3.2 t -140.34 121.76 15.04 Favored 'General case' 0 CA--C 1.498 -1.051 0 CA-C-N 119.582 1.691 . . . . 1.08 114.1 -179.064 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.721 ' CE1' HD22 ' A' ' 32' ' ' LEU . 1.8 m-85 -95.51 102.12 13.89 Favored 'General case' 0 N--CA 1.428 -1.536 0 N-CA-C 103.469 -2.789 . . . . 1.38 103.469 175.504 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 1.071 HG13 HG12 ' A' ' 26' ' ' ILE . 2.1 t -94.41 84.34 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.137 0 CA-C-O 123.344 1.545 . . . . 0.76 108.622 -178.409 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 1.084 ' HA3' HG21 ' B' ' 172' ' ' ILE . . . 95.13 79.62 1.47 Allowed Glycine 0 C--N 1.313 -0.699 0 CA-C-N 112.236 -2.256 . . . . 0.81 113.722 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.724 HG21 ' CD2' ' B' ' 135' ' ' PHE . 58.2 p -159.96 177.9 10.28 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.743 -0.836 . . . . 0.77 108.743 179.118 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.73 ' HA ' HD12 ' A' ' 42' ' ' LEU . . . -65.28 -25.01 67.45 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 119.023 0.829 . . . . 1.02 112.27 -178.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.463 ' CG ' ' HA2' ' A' ' 14' ' ' GLY . 0.8 OUTLIER -64.35 -24.76 67.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.854 0.359 . . . . 2.32 110.246 178.664 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.564 ' O ' ' HB2' ' A' ' 44' ' ' CYS . . . -85.46 -10.16 56.5 Favored 'General case' 0 C--O 1.219 -0.5 0 CA-C-N 115.868 -0.605 . . . . 0.87 110.347 178.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.73 HD12 ' HA ' ' A' ' 39' ' ' ALA . 1.1 mt -53.29 -41.83 65.98 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 121.982 -0.449 . . . . 1.23 112.156 -178.731 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 1.054 ' HG3' ' HB2' ' A' ' 13' ' ' CYS . 5.0 ptm180 -70.78 -16.96 62.79 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 121.788 0.804 . . . . 2.92 109.299 176.633 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.564 ' HB2' ' O ' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -57.67 -18.83 22.77 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 114.023 -1.444 . . . . 1.57 110.107 -178.27 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -50.62 -25.82 4.66 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.769 -0.65 . . . . 3.31 111.118 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -83.09 8.33 13.28 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.159 0.504 . . . . 3.69 110.375 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.666 ' HG3' ' HB3' ' A' ' 21' ' ' CYS . 6.0 tm-20 . . . . . 0 N--CA 1.449 -0.521 0 CA-C-N 115.751 -0.659 . . . . 3.99 109.349 177.276 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 43.0 p . . . . . 0 CA--C 1.544 0.744 0 CA-C-O 121.385 0.612 . . . . 3.12 112.394 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 120.29 -88.26 0.43 Allowed Glycine 0 N--CA 1.464 0.54 0 CA-C-N 114.646 -1.161 . . . . 2.1 114.016 177.62 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.904 ' O ' ' HB3' ' A' ' 67' ' ' CYS . 41.1 mt-30 -124.16 104.49 8.87 Favored 'General case' 0 CA--C 1.489 -1.404 0 N-CA-C 102.946 -2.983 . . . . 4.36 102.946 177.64 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 1.088 ' HA ' ' H ' ' A' ' 67' ' ' CYS . 6.6 mmmt -128.68 -68.12 0.02 OUTLIER Pre-proline 0 C--N 1.314 -0.949 0 C-N-CA 118.532 -1.267 . . . . 3.55 112.812 -173.821 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.672 ' CD ' ' HB2' ' A' ' 59' ' ' LYS . 15.0 Cg_endo -57.08 114.97 2.17 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 CA-C-N 121.534 1.584 . . . . 1.54 115.354 -177.817 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -144.53 -165.36 2.12 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 111.133 -2.758 . . . . 1.59 104.494 178.159 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 47.24 -165.37 0.13 Allowed Glycine 0 N--CA 1.467 0.741 0 CA-C-N 121.283 1.856 . . . . 2.43 114.611 175.601 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 4.4 p -87.95 39.43 0.89 Allowed 'General case' 0 N--CA 1.479 1.016 0 CA-C-O 121.997 0.903 . . . . 4.11 110.482 -177.416 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 121.11 15.46 4.69 Favored Glycine 0 CA--C 1.558 2.732 0 CA-C-N 113.981 -1.463 . . . . 2.21 114.696 -175.709 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -101.14 146.02 17.21 Favored Glycine 0 N--CA 1.474 1.184 0 CA-C-N 119.913 1.856 . . . . 1.62 114.914 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 1.057 ' HB3' ' HB3' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -89.73 152.53 21.28 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 109.375 -0.602 . . . . 3.02 109.375 177.965 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 1.088 ' H ' ' HA ' ' A' ' 59' ' ' LYS . 36.1 t -73.47 107.53 5.81 Favored 'General case' 0 N--CA 1.407 -2.588 0 N-CA-C 108.736 -0.839 . . . . 1.52 108.736 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 1.011 ' HB2' ' HB2' ' A' ' 74' ' ' CYS . . . -71.58 -28.23 63.68 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.919 -0.771 . . . . 1.07 108.919 179.527 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.874 ' HB3' ' CG1' ' A' ' 72' ' ' ILE . . . -168.78 163.46 11.84 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.367 -1.288 . . . . 1.0 110.498 -176.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 1.087 ' HA ' ' HB3' ' A' ' 85' ' ' CYS . . . -55.05 122.41 10.89 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 116.111 -0.495 . . . . 1.24 112.119 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.585 ' H ' ' CB ' ' A' ' 85' ' ' CYS . . . 58.38 35.77 80.66 Favored Glycine 0 C--N 1.351 1.416 0 N-CA-C 110.904 -0.878 . . . . 1.28 110.904 -178.807 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 1.071 HG21 ' HA3' ' B' ' 137' ' ' GLY . 1.5 pp -154.71 97.79 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.644 0 N-CA-C 107.989 -1.115 . . . . 2.27 107.989 169.767 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.665 ' HB2' ' HB3' ' A' ' 82' ' ' ASP . 0.1 OUTLIER -91.48 106.33 18.42 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 112.21 0.448 . . . . 1.98 112.21 -177.319 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 1.011 ' HB2' ' HB2' ' A' ' 68' ' ' ALA . 0.6 OUTLIER -93.84 123.77 37.41 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.526 0.679 . . . . 1.33 111.663 179.754 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.901 ' HB2' ' HD2' ' A' ' 76' ' ' PRO . 36.2 p -93.26 -178.7 0.89 Allowed Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.102 -0.954 . . . . 1.99 109.035 178.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.901 ' HD2' ' HB2' ' A' ' 75' ' ' SER . 74.0 Cg_endo -76.11 29.28 0.39 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 121.328 1.352 . . . . 1.86 111.517 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.692 ' HB3' ' CE1' ' B' ' 180' ' ' HIS . 1.7 m-20 -145.78 -43.9 0.21 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.418 -0.81 . . . . 2.65 110.809 179.445 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.537 ' HA3' ' HA ' ' B' ' 180' ' ' HIS . . . -158.32 -141.61 3.19 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 120.74 -0.743 . . . . 0.99 113.128 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.766 ' HA ' ' HA ' ' A' ' 74' ' ' CYS . 0.1 OUTLIER -134.82 157.76 45.94 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.55 0.215 . . . . 1.34 110.505 -179.949 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.642 ' CE1' ' HB3' ' B' ' 177' ' ' ASP . 2.8 t60 -152.28 135.11 15.52 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 109.432 -0.581 . . . . 2.17 109.432 -176.837 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.8 132.19 53.19 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 109.295 -0.631 . . . . 3.05 109.295 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.665 ' HB3' ' HB2' ' A' ' 73' ' ' CYS . 1.2 p-10 -140.64 133.56 14.65 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 120.911 -0.315 . . . . 2.02 111.581 -177.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.606 ' HA ' ' HB2' ' A' ' 86' ' ' ASP . 5.7 Cg_exo -79.51 -12.16 14.01 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 122.737 2.292 . . . . 1.93 113.103 -179.28 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.8 -41.74 97.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.783 0.325 . . . . 1.53 110.944 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 1.087 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 21.5 m -99.88 22.67 10.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.156 0.503 . . . . 1.88 110.919 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.606 ' HB2' ' HA ' ' A' ' 83' ' ' PRO . 0.5 OUTLIER . . . . . 0 CA--C 1.512 -0.483 0 N-CA-C 113.887 1.069 . . . . 3.6 113.887 179.085 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 110' ' ' CYS . . . . . 0.64 ' HB3' ' HB3' ' B' ' 120' ' ' ARG . 0.0 OUTLIER . . . . . 0 CA--C 1.54 0.572 0 N-CA-C 115.381 1.622 . . . . 2.61 115.381 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 111' ' ' LEU . . . . . 0.509 HD23 ' HD2' ' B' ' 112' ' ' PRO . 0.2 OUTLIER -33.77 133.07 0.37 Allowed Pre-proline 0 N--CA 1.485 1.307 0 C-N-CA 123.979 0.912 . . . . 2.47 113.294 177.603 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 112' ' ' PRO . . . . . 0.845 ' HB2' ' O ' ' B' ' 117' ' ' GLY . 54.0 Cg_endo -92.3 129.09 0.95 Allowed 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.509 2.139 . . . . 1.47 115.253 -179.141 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 1.091 ' HB2' ' HG3' ' B' ' 143' ' ' ARG . 0.0 OUTLIER -133.65 -159.78 0.99 Allowed 'General case' 0 C--N 1.359 1.017 0 C-N-CA 119.473 -0.891 . . . . 1.0 111.299 -175.525 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 114' ' ' GLY . . . . . 0.474 ' N ' ' SG ' ' B' ' 113' ' ' CYS . . . 80.71 -156.91 39.16 Favored Glycine 0 C--N 1.334 0.443 0 CA-C-N 118.613 0.642 . . . . 1.16 111.558 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 115' ' ' PRO . . . . . 0.821 ' HG2' ' HD2' ' B' ' 118' ' ' LYS . 56.6 Cg_endo -65.24 88.59 0.2 Allowed 'Trans proline' 0 N--CA 1.458 -0.58 0 CA-C-N 119.523 1.662 . . . . 1.57 114.177 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 87.51 -3.83 86.21 Favored Glycine 0 C--N 1.265 -3.372 0 CA-C-N 112.056 -2.338 . . . . 1.7 114.202 -176.358 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 117' ' ' GLY . . . . . 0.845 ' O ' ' HB2' ' B' ' 112' ' ' PRO . . . 75.05 47.58 13.09 Favored Glycine 0 N--CA 1.412 -2.931 0 C-N-CA 118.966 -1.588 . . . . 1.38 113.497 175.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 118' ' ' LYS . . . . . 1.009 ' HD3' HD11 ' B' ' 132' ' ' LEU . 0.0 OUTLIER -90.72 -23.27 20.75 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 112.134 -2.033 . . . . 2.54 111.237 178.96 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 119' ' ' GLY . . . . . 0.728 ' O ' ' HA ' ' B' ' 112' ' ' PRO . . . -101.36 -160.94 27.18 Favored Glycine 0 N--CA 1.478 1.477 0 CA-C-O 117.274 -1.848 . . . . 1.04 109.242 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.64 ' HB3' ' HB3' ' B' ' 110' ' ' CYS . 1.3 mpt_? -124.0 172.83 8.66 Favored 'General case' 0 C--N 1.353 0.728 0 CA-C-N 122.238 3.019 . . . . 2.89 109.329 177.721 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 121' ' ' CYS . . . . . 0.645 ' HB3' ' HG3' ' B' ' 147' ' ' GLU . 1.2 m -106.11 151.44 24.7 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.927 0.394 . . . . 1.07 111.139 -179.575 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -124.16 -46.81 1.92 Allowed 'General case' 0 C--N 1.334 -0.101 0 CA-C-N 116.04 -0.527 . . . . 1.53 110.754 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 123' ' ' GLY . . . . . 0.484 ' HA2' ' OE1' ' B' ' 147' ' ' GLU . . . -137.98 -161.19 8.76 Favored Glycine 0 CA--C 1.52 0.374 0 N-CA-C 111.637 -0.585 . . . . 0.9 111.637 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -77.77 -63.21 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.033 1.822 . . . . 1.51 111.538 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 125' ' ' SER . . . . . 0.432 ' C ' HG13 ' B' ' 126' ' ' ILE . 1.1 m -92.05 33.27 1.07 Allowed 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.845 -0.428 . . . . 1.25 109.845 178.84 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 126' ' ' ILE . . . . . 1.067 HG12 HG13 ' B' ' 136' ' ' VAL . 23.0 mt -149.01 121.23 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 CA-C-O 121.082 0.468 . . . . 0.85 112.111 -178.74 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 127' ' ' CYS . . . . . 0.549 ' O ' ' HA ' ' B' ' 134' ' ' CYS . 6.6 t -140.34 124.33 17.48 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 108.404 -0.962 . . . . 0.89 108.404 179.217 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 128' ' ' CYS . . . . . 0.729 ' HA ' ' O ' ' B' ' 133' ' ' GLY . 0.0 OUTLIER -137.43 120.95 17.17 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 114.235 1.198 . . . . 1.23 114.235 -177.731 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 129' ' ' GLY . . . . . 0.501 ' O ' ' HB2' ' B' ' 169' ' ' ALA . . . -103.67 -167.65 25.39 Favored Glycine 0 C--N 1.369 2.395 0 CA-C-N 120.148 1.34 . . . . 0.66 109.885 176.388 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -65.72 -55.07 19.32 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 114.148 1.166 . . . . 2.35 114.148 -177.488 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -124.06 21.7 8.88 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 121.691 0.758 . . . . 1.69 109.955 -177.787 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 132' ' ' LEU . . . . . 1.009 HD11 ' HD3' ' B' ' 118' ' ' LYS . 0.4 OUTLIER -112.18 -21.19 11.59 Favored 'General case' 0 N--CA 1.411 -2.417 0 N-CA-C 104.783 -2.303 . . . . 1.38 104.783 179.24 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 133' ' ' GLY . . . . . 0.897 ' HA2' ' CB ' ' B' ' 169' ' ' ALA . . . 75.41 -134.73 17.13 Favored Glycine 1 N--CA 1.393 -4.226 0 CA-C-O 117.07 -1.961 . . . . 0.72 112.499 174.503 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 134' ' ' CYS . . . . . 1.031 ' HB2' HD13 ' B' ' 172' ' ' ILE . 3.1 t -140.75 121.78 14.63 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 120.262 2.031 . . . . 1.08 114.488 -178.858 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 135' ' ' PHE . . . . . 0.729 ' CE1' HD22 ' B' ' 132' ' ' LEU . 4.1 m-85 -95.16 101.77 13.54 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 103.707 -2.701 . . . . 1.36 103.707 175.557 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 136' ' ' VAL . . . . . 1.067 HG13 HG12 ' B' ' 126' ' ' ILE . 2.3 t -94.36 83.83 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.076 0 CA-C-O 123.364 1.554 . . . . 0.75 108.597 -178.415 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 137' ' ' GLY . . . . . 1.071 ' HA3' HG21 ' A' ' 72' ' ' ILE . . . 95.19 79.55 1.46 Allowed Glycine 0 C--N 1.313 -0.697 0 CA-C-N 112.145 -2.298 . . . . 0.83 113.643 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 138' ' ' THR . . . . . 0.604 ' OG1' ' HB3' ' B' ' 135' ' ' PHE . 51.2 p -158.12 -179.05 7.75 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.7 -0.852 . . . . 0.78 108.7 179.074 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 139' ' ' ALA . . . . . 0.733 ' HA ' HD12 ' B' ' 142' ' ' LEU . . . -68.37 -24.78 64.83 Favored 'General case' 0 C--N 1.338 0.109 0 CA-C-N 119.18 0.9 . . . . 1.04 111.934 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 140' ' ' GLU . . . . . 0.457 ' CG ' ' HA2' ' B' ' 114' ' ' GLY . 0.8 OUTLIER -63.98 -25.18 68.01 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.236 -0.438 . . . . 2.31 110.195 178.643 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 141' ' ' ALA . . . . . 0.556 ' O ' ' HB2' ' B' ' 144' ' ' CYS . . . -84.72 -11.22 56.29 Favored 'General case' 0 C--O 1.219 -0.538 0 CA-C-N 115.941 -0.572 . . . . 0.87 110.27 178.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 142' ' ' LEU . . . . . 0.733 HD12 ' HA ' ' B' ' 139' ' ' ALA . 1.1 mt -52.83 -42.09 64.82 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.312 0.486 . . . . 1.24 112.312 -178.018 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 143' ' ' ARG . . . . . 1.091 ' HG3' ' HB2' ' B' ' 113' ' ' CYS . 4.4 ptm180 -68.1 -21.57 64.95 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 108.613 -0.884 . . . . 2.93 108.613 176.299 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 144' ' ' CYS . . . . . 0.556 ' HB2' ' O ' ' B' ' 141' ' ' ALA . 0.1 OUTLIER -56.81 -13.84 2.91 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 113.743 -1.571 . . . . 1.61 110.482 -175.867 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -54.61 -24.93 23.52 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-O 121.242 0.544 . . . . 3.35 111.05 178.584 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -82.99 8.42 12.77 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 120.473 -0.491 . . . . 3.76 110.213 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 147' ' ' GLU . . . . . 0.645 ' HG3' ' HB3' ' B' ' 121' ' ' CYS . 6.0 tm-20 . . . . . 0 N--CA 1.449 -0.501 0 CA-C-N 115.821 -0.627 . . . . 4.01 109.375 177.177 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 34.5 p . . . . . 0 CA--C 1.537 0.451 0 N-CA-C 112.147 0.425 . . . . 3.11 112.147 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 120.48 -92.33 0.51 Allowed Glycine 0 C--N 1.339 0.743 0 C-N-CA 120.834 -0.698 . . . . 2.07 113.286 178.432 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 158' ' ' GLN . . . . . 0.953 ' O ' ' HB3' ' B' ' 167' ' ' CYS . 41.1 mt-30 -124.55 89.67 3.11 Favored 'General case' 0 CA--C 1.493 -1.237 0 N-CA-C 105.246 -2.131 . . . . 4.34 105.246 178.304 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 159' ' ' LYS . . . . . 1.075 ' HB3' ' HB3' ' B' ' 166' ' ' ARG . 6.5 mmmt -105.58 -73.69 0.02 OUTLIER Pre-proline 0 C--N 1.308 -1.232 0 N-CA-C 116.28 1.956 . . . . 3.54 116.28 -175.491 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 160' ' ' PRO . . . . . 0.64 ' CD ' ' HB2' ' B' ' 159' ' ' LYS . 14.6 Cg_endo -57.21 115.05 2.22 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 N-CA-C 116.037 1.514 . . . . 1.51 116.037 -174.645 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 161' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -145.57 -168.75 3.05 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 110.911 -2.859 . . . . 1.58 104.374 177.776 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 50.01 -165.66 0.5 Allowed Glycine 0 CA--C 1.525 0.7 0 CA-C-N 120.62 1.554 . . . . 2.37 113.882 177.24 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 7.3 p -88.25 39.63 0.91 Allowed 'General case' 0 N--CA 1.482 1.152 0 CA-C-O 122.491 1.138 . . . . 4.07 110.962 -178.14 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 123.02 12.8 4.7 Favored Glycine 0 CA--C 1.557 2.663 0 CA-C-N 113.351 -1.75 . . . . 2.2 114.857 -178.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -99.92 146.08 17.66 Favored Glycine 0 N--CA 1.471 1.02 0 CA-C-N 120.795 2.297 . . . . 1.62 115.046 -177.293 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 166' ' ' ARG . . . . . 1.075 ' HB3' ' HB3' ' B' ' 159' ' ' LYS . 0.0 OUTLIER -89.51 152.28 21.52 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 109.302 -0.629 . . . . 3.05 109.302 178.612 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 167' ' ' CYS . . . . . 0.996 ' H ' ' HA ' ' B' ' 159' ' ' LYS . 33.6 t -73.77 107.75 6.2 Favored 'General case' 0 N--CA 1.406 -2.628 0 N-CA-C 108.683 -0.858 . . . . 1.56 108.683 -179.557 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 168' ' ' ALA . . . . . 1.009 ' HB2' ' HB2' ' B' ' 174' ' ' CYS . . . -73.68 -24.18 59.92 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 119.699 -0.801 . . . . 1.04 109.438 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 169' ' ' ALA . . . . . 0.897 ' CB ' ' HA2' ' B' ' 133' ' ' GLY . . . -171.47 163.48 6.81 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 108.554 -0.906 . . . . 0.98 108.554 -178.805 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 170' ' ' ALA . . . . . 1.053 ' HA ' ' HB3' ' B' ' 185' ' ' CYS . . . -55.43 125.56 21.42 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 120.89 0.376 . . . . 1.25 111.974 179.263 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 171' ' ' GLY . . . . . 0.541 ' H ' ' CB ' ' B' ' 185' ' ' CYS . . . 79.27 -7.45 52.64 Favored Glycine 0 C--O 1.224 -0.513 0 C-N-CA 120.376 -0.916 . . . . 1.29 114.063 178.301 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 172' ' ' ILE . . . . . 1.084 HG21 ' HA3' ' A' ' 37' ' ' GLY . 1.6 pp -132.36 100.78 4.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-O 121.89 0.852 . . . . 2.27 110.59 -175.79 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 173' ' ' CYS . . . . . 0.674 ' HB2' ' HB3' ' B' ' 182' ' ' ASP . 0.1 OUTLIER -91.13 105.88 18.12 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 115.498 -0.774 . . . . 1.94 112.282 -177.811 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 174' ' ' CYS . . . . . 1.009 ' HB2' ' HB2' ' B' ' 168' ' ' ALA . 0.6 OUTLIER -93.94 123.81 37.54 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.535 0.683 . . . . 1.35 111.734 179.651 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 175' ' ' SER . . . . . 0.955 ' HB2' ' HD2' ' B' ' 176' ' ' PRO . 36.1 p -93.31 -178.71 0.89 Allowed Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.114 -0.948 . . . . 2.0 109.071 178.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 176' ' ' PRO . . . . . 0.955 ' HD2' ' HB2' ' B' ' 175' ' ' SER . 73.9 Cg_endo -76.08 29.2 0.39 Allowed 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 121.388 1.392 . . . . 1.9 111.481 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 177' ' ' ASP . . . . . 0.642 ' HB3' ' CE1' ' A' ' 80' ' ' HIS . 1.6 m-20 -145.74 -43.94 0.21 Allowed 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 115.489 -0.778 . . . . 2.72 110.798 179.431 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 178' ' ' GLY . . . . . 0.517 ' HA3' ' HA ' ' A' ' 80' ' ' HIS . . . -158.27 -141.52 3.17 Favored Glycine 0 CA--C 1.522 0.512 0 C-N-CA 120.776 -0.726 . . . . 0.99 113.137 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 179' ' ' CYS . . . . . 0.759 ' HA ' ' HA ' ' B' ' 174' ' ' CYS . 0.1 OUTLIER -134.5 160.27 38.53 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 110.424 -0.213 . . . . 1.34 110.424 -179.986 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 180' ' ' HIS . . . . . 0.692 ' CE1' ' HB3' ' A' ' 77' ' ' ASP . 2.9 t60 -156.21 134.05 11.12 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 109.886 -0.412 . . . . 2.1 109.886 -176.837 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 181' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.02 131.88 52.37 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 109.414 -0.588 . . . . 3.06 109.414 -179.08 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 182' ' ' ASP . . . . . 0.674 ' HB3' ' HB2' ' B' ' 173' ' ' CYS . 1.2 p-10 -140.47 133.54 14.83 Favored Pre-proline 0 CA--C 1.541 0.602 0 C-N-CA 120.937 -0.305 . . . . 2.06 111.701 -177.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 183' ' ' PRO . . . . . 0.615 ' HA ' ' HB2' ' B' ' 186' ' ' ASP . 5.9 Cg_exo -79.51 -12.11 14.03 Favored 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 122.684 2.256 . . . . 1.91 113.065 -179.236 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -63.65 -41.61 98.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.836 0.35 . . . . 1.56 111.026 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 185' ' ' CYS . . . . . 1.053 ' HB3' ' HA ' ' B' ' 170' ' ' ALA . 26.7 m -99.7 22.38 11.04 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.153 -0.476 . . . . 1.94 111.293 179.327 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 186' ' ' ASP . . . . . 0.615 ' HB2' ' HA ' ' B' ' 183' ' ' PRO . 0.5 OUTLIER . . . . . 0 CA--C 1.504 -0.82 0 N-CA-C 113.927 1.084 . . . . 3.61 113.927 179.136 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 1.051 ' HB3' ' HG2' ' A' ' 20' ' ' ARG . 0.6 OUTLIER . . . . . 0 N--CA 1.44 -0.93 0 CA-C-O 118.743 -0.646 . . . . 2.68 112.154 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.75 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 4.3 mm? -30.68 108.48 0.26 Allowed Pre-proline 0 N--CA 1.474 0.751 0 CA-C-N 119.208 0.913 . . . . 2.48 110.408 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.78 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 49.4 Cg_endo -100.0 114.42 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 123.085 2.523 . . . . 1.49 114.58 -177.828 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.764 ' HB2' ' HB3' ' A' ' 43' ' ' ARG . 0.1 OUTLIER -132.97 -157.77 0.84 Allowed 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 119.759 -0.162 . . . . 1.0 110.582 -178.465 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.612 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . 80.62 -158.77 41.63 Favored Glycine 0 CA--C 1.507 -0.409 0 CA-C-O 118.564 -1.131 . . . . 1.15 111.202 -177.299 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.527 ' HD3' ' HG2' ' A' ' 40' ' ' GLU . 84.4 Cg_endo -64.77 84.02 0.17 Allowed 'Trans proline' 0 CA--C 1.515 -0.474 0 CA-C-N 121.122 2.461 . . . . 1.57 115.035 -176.643 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.07 1.33 84.67 Favored Glycine 0 C--N 1.283 -2.388 0 CA-C-N 111.621 -2.536 . . . . 1.68 114.474 -178.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.64 ' O ' ' HB2' ' A' ' 12' ' ' PRO . . . 85.87 42.73 6.65 Favored Glycine 0 N--CA 1.431 -1.659 0 N-CA-C 117.38 1.712 . . . . 1.36 117.38 174.362 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -94.63 -14.94 24.43 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-N 114.443 -0.878 . . . . 2.5 111.799 175.523 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.78 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -107.7 179.39 21.93 Favored Glycine 0 N--CA 1.468 0.807 0 N-CA-C 109.478 -1.449 . . . . 1.02 109.478 -179.338 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 1.051 ' HG2' ' HB3' ' A' ' 10' ' ' CYS . 0.3 OUTLIER -120.34 174.01 6.78 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 120.833 2.316 . . . . 2.92 110.982 179.021 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 12.7 m -107.3 156.37 18.95 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.028 0.442 . . . . 1.1 112.005 -179.458 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.507 ' CE1' ' HB2' ' A' ' 28' ' ' CYS . 56.9 m-85 -143.54 16.9 1.84 Allowed 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.601 -0.727 . . . . 1.51 111.231 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.522 ' O ' ' HB3' ' A' ' 44' ' ' CYS . . . 162.45 -143.91 9.17 Favored Glycine 0 C--N 1.331 0.256 0 C-N-CA 120.743 -0.741 . . . . 0.9 112.093 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.44 ' O ' ' HB2' ' A' ' 44' ' ' CYS . 12.1 Cg_endo -90.08 -72.88 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 123.054 2.503 . . . . 1.5 112.579 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.418 ' O ' ' HA ' ' A' ' 36' ' ' VAL . 0.4 OUTLIER -91.79 35.6 0.97 Allowed 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 110.265 -0.272 . . . . 1.26 110.265 179.525 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.999 ' CG1' HG13 ' A' ' 36' ' ' VAL . 13.3 mt -139.81 98.92 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 N-CA-C 113.664 0.987 . . . . 0.83 113.664 -178.228 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.864 ' HB2' ' HA ' ' A' ' 41' ' ' ALA . 3.7 t -119.71 108.71 14.76 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 107.376 -1.342 . . . . 0.92 107.376 176.114 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.803 ' CB ' ' HB1' ' A' ' 68' ' ' ALA . 4.3 m -121.94 161.67 22.45 Favored 'General case' 0 N--CA 1.429 -1.516 0 CA-C-N 114.374 -1.285 . . . . 1.28 112.703 -176.348 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.503 ' O ' ' HB2' ' A' ' 69' ' ' ALA . . . -142.02 -173.42 14.08 Favored Glycine 0 N--CA 1.426 -2.027 0 CA-C-N 113.454 -1.703 . . . . 0.67 110.096 175.193 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.445 ' OD2' ' HG2' ' A' ' 31' ' ' GLU . 17.4 p-10 -67.3 -52.6 38.6 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 112.578 0.585 . . . . 2.27 112.578 -179.688 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.445 ' HG2' ' OD2' ' A' ' 30' ' ' ASP . 0.4 OUTLIER -119.17 19.12 12.96 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 122.411 1.1 . . . . 1.66 109.468 -178.703 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.712 HD22 ' CE1' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -113.73 -12.32 12.8 Favored 'General case' 0 N--CA 1.415 -2.208 0 CA-C-N 112.902 -1.954 . . . . 1.37 106.665 -178.923 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.701 ' HA2' ' CB ' ' A' ' 69' ' ' ALA . . . 52.81 -134.1 39.88 Favored Glycine 0 N--CA 1.415 -2.727 0 CA-C-N 113.952 -1.476 . . . . 0.73 113.831 177.719 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.793 ' HB2' HD13 ' A' ' 72' ' ' ILE . 0.9 OUTLIER -127.28 119.99 27.6 Favored 'General case' 0 N--CA 1.429 -1.519 0 N-CA-C 116.024 1.861 . . . . 1.08 116.024 -178.188 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.833 ' HB3' ' CG2' ' A' ' 38' ' ' THR . 8.4 m-85 -95.37 105.06 16.99 Favored 'General case' 0 N--CA 1.417 -2.082 1 N-CA-C 99.622 -4.214 . . . . 1.38 99.622 173.175 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.999 HG13 ' CG1' ' A' ' 26' ' ' ILE . 2.2 t -103.04 88.27 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.642 0 CA-C-O 122.794 1.283 . . . . 0.76 110.273 -176.57 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.452 ' O ' ' O ' ' A' ' 38' ' ' THR . . . 120.21 -46.48 1.12 Allowed Glycine 0 N--CA 1.461 0.323 0 CA-C-N 113.397 -1.729 . . . . 0.81 115.684 178.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.833 ' CG2' ' HB3' ' A' ' 35' ' ' PHE . 3.2 t -47.36 -174.66 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 117.305 0.553 . . . . 0.77 111.906 -178.529 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.808 ' HA ' HD12 ' A' ' 42' ' ' LEU . . . -70.17 -23.73 63.02 Favored 'General case' 0 CA--C 1.515 -0.393 0 O-C-N 121.817 -0.552 . . . . 1.02 112.445 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.528 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 1.3 mp0 -60.06 -28.04 67.46 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.586 -0.279 . . . . 2.32 110.769 179.256 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.864 ' HA ' ' HB2' ' A' ' 27' ' ' CYS . . . -93.14 -22.74 18.9 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 122.221 0.208 . . . . 0.87 111.313 -179.086 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.808 HD12 ' HA ' ' A' ' 39' ' ' ALA . 5.0 mt -49.7 -39.76 37.97 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 121.238 0.542 . . . . 1.23 110.716 179.183 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.764 ' HB3' ' HB2' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -56.6 -17.7 9.48 Favored 'General case' 0 CA--C 1.496 -1.123 0 CA-C-N 115.622 -0.717 . . . . 2.92 109.704 178.561 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.522 ' HB3' ' O ' ' A' ' 23' ' ' GLY . 68.0 m -75.31 0.45 16.68 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 120.042 1.292 . . . . 1.57 112.036 -179.45 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 71.4 tp60 -60.88 -21.32 63.18 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.066 0.46 . . . . 3.31 110.216 178.459 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -85.8 2.8 44.21 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 119.753 -0.779 . . . . 3.69 111.112 -179.409 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.447 -0.583 0 CA-C-N 116.147 -0.479 . . . . 3.99 109.739 177.504 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.63 ' HA ' ' HE3' ' A' ' 59' ' ' LYS . 8.1 t . . . . . 0 N--CA 1.445 -0.717 0 N-CA-C 109.213 -0.662 . . . . 3.12 109.213 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 178.36 -86.64 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 119.998 -1.096 . . . . 2.1 113.15 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.965 ' HB3' ' HB3' ' A' ' 67' ' ' CYS . 15.6 mt-30 -120.6 85.94 2.48 Favored 'General case' 0 N--CA 1.417 -2.081 0 N-CA-C 107.55 -1.278 . . . . 4.36 107.55 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 1.298 ' O ' ' HA ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -136.44 -52.38 0.02 OUTLIER Pre-proline 0 C--N 1.305 -1.333 0 N-CA-C 106.562 -1.644 . . . . 3.55 106.562 179.799 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.83 ' HD2' ' H ' ' A' ' 59' ' ' LYS . 43.8 Cg_endo -84.96 108.5 1.18 Allowed 'Trans proline' 0 C--N 1.298 -2.126 0 CA-C-N 120.404 1.18 . . . . 1.54 114.076 177.009 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.737 ' SG ' ' HB3' ' A' ' 84' ' ' ALA . 3.0 t -142.95 -176.99 5.12 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 113.979 -1.464 . . . . 1.59 108.565 178.45 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.562 ' O ' ' O ' ' A' ' 61' ' ' CYS . . . 33.46 -166.19 0.01 OUTLIER Glycine 0 CA--C 1.524 0.598 0 C-N-CA 120.729 -0.748 . . . . 2.43 114.468 176.337 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -83.23 50.32 1.73 Allowed 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 122.423 1.106 . . . . 4.11 111.237 179.243 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 121.5 5.18 9.46 Favored Glycine 0 N--CA 1.474 1.172 0 CA-C-N 112.995 -1.911 . . . . 2.21 115.041 171.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.466 ' O ' ' N ' ' A' ' 61' ' ' CYS . . . -103.72 158.31 17.14 Favored Glycine 0 C--N 1.336 0.535 0 C-N-CA 120.957 -0.64 . . . . 1.62 112.767 -178.521 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 1.298 ' HA ' ' O ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -88.44 152.69 21.73 Favored 'General case' 0 CA--C 1.477 -1.863 0 CA-C-O 121.367 0.603 . . . . 3.02 112.295 -178.865 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.965 ' HB3' ' HB3' ' A' ' 58' ' ' GLN . 0.1 OUTLIER -73.75 108.2 6.44 Favored 'General case' 1 N--CA 1.374 -4.243 0 N-CA-C 107.254 -1.388 . . . . 1.52 107.254 178.145 . . . . . . . . 4 4 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.803 ' HB1' ' CB ' ' A' ' 28' ' ' CYS . . . -80.66 -57.24 3.66 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 104.873 -2.269 . . . . 1.07 104.873 178.098 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.856 ' HB3' HD11 ' A' ' 72' ' ' ILE . . . -154.42 161.8 41.51 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 111.785 -2.461 . . . . 1.0 111.636 -173.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.858 ' HA ' ' O ' ' A' ' 85' ' ' CYS . . . -32.8 122.7 0.36 Allowed 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 114.693 1.368 . . . . 1.24 114.693 -179.058 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.764 ' O ' ' HA ' ' A' ' 81' ' ' GLU . . . 59.45 -5.5 0.09 OUTLIER Glycine 0 CA--C 1.533 1.203 0 N-CA-C 116.801 1.48 . . . . 1.28 116.801 178.322 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.856 HD11 ' HB3' ' A' ' 69' ' ' ALA . 1.9 pp -121.04 100.07 8.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 122.73 1.252 . . . . 2.27 109.85 177.297 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.539 ' HB3' ' HB3' ' A' ' 61' ' ' CYS . 58.5 m -110.25 111.99 23.67 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 113.481 -1.69 . . . . 1.98 110.189 -177.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.583 ' HA ' ' O ' ' A' ' 78' ' ' GLY . 5.3 m -83.46 133.83 34.89 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 113.531 0.937 . . . . 1.33 113.531 -177.037 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.854 ' HB2' ' HD2' ' A' ' 76' ' ' PRO . 28.9 p -95.62 -179.06 0.86 Allowed Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 113.869 -1.514 . . . . 1.99 107.248 177.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.854 ' HD2' ' HB2' ' A' ' 75' ' ' SER . 57.5 Cg_endo -71.61 31.11 0.24 Allowed 'Trans proline' 0 CA--C 1.532 0.376 0 CA-C-N 120.56 1.236 . . . . 1.86 112.113 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.503 ' H ' ' C ' ' A' ' 75' ' ' SER . 3.0 p30 -145.67 -46.09 0.21 Allowed 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 115.899 -0.591 . . . . 2.65 111.661 179.43 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 1.142 ' HA3' ' O ' ' B' ' 179' ' ' CYS . . . -160.76 -151.54 6.26 Favored Glycine 0 C--N 1.349 1.28 0 C-N-CA 120.314 -0.946 . . . . 0.99 115.242 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 1.175 ' O ' ' HA3' ' B' ' 178' ' ' GLY . 32.3 m -128.87 133.75 48.05 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-O 123.377 1.561 . . . . 1.34 110.703 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 28.8 p80 -146.04 135.2 22.76 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 112.27 -2.241 . . . . 2.17 112.495 -169.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.764 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 34.4 mt-10 -51.91 123.88 11.38 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 114.132 -1.395 . . . . 3.05 111.067 -179.454 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.401 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 0.0 OUTLIER -146.78 126.04 6.52 Favored Pre-proline 0 C--N 1.317 -0.845 0 CA-C-N 115.044 -0.98 . . . . 2.02 109.293 -179.656 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 82' ' ' ASP . 71.8 Cg_exo -54.77 -13.53 6.19 Favored 'Trans proline' 0 N--CA 1.482 0.838 0 C-N-CA 124.038 3.158 . . . . 1.93 116.21 -177.12 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.737 ' HB3' ' SG ' ' A' ' 61' ' ' CYS . . . -71.42 -32.1 67.99 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 115.094 1.516 . . . . 1.53 115.094 -177.419 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.858 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 0.1 OUTLIER -91.15 -4.24 56.34 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 115.262 1.579 . . . . 1.88 115.262 -176.158 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.2 t70 . . . . . 0 C--N 1.32 -0.696 0 N-CA-C 113.215 0.82 . . . . 3.6 113.215 -178.737 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 110' ' ' CYS . . . . . 1.095 ' HB3' ' HG2' ' B' ' 120' ' ' ARG . 0.6 OUTLIER . . . . . 0 N--CA 1.438 -1.029 0 CA-C-O 119.026 -0.511 . . . . 2.61 111.854 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 111' ' ' LEU . . . . . 0.76 ' O ' ' HA ' ' B' ' 120' ' ' ARG . 4.2 mm? -30.64 108.54 0.26 Allowed Pre-proline 0 N--CA 1.474 0.743 0 CA-C-N 118.799 0.727 . . . . 2.47 110.271 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 112' ' ' PRO . . . . . 0.734 ' HA ' ' O ' ' B' ' 119' ' ' GLY . 49.9 Cg_endo -100.87 111.93 0.06 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.896 2.397 . . . . 1.47 115.3 -177.565 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.757 ' HB2' ' HB3' ' B' ' 143' ' ' ARG . 0.1 OUTLIER -129.79 -156.75 0.78 Allowed 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 116.849 -0.159 . . . . 1.0 110.81 -178.476 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 114' ' ' GLY . . . . . 0.613 ' N ' ' SG ' ' B' ' 113' ' ' CYS . . . 80.45 -158.82 42.03 Favored Glycine 0 CA--C 1.506 -0.479 0 CA-C-O 118.714 -1.048 . . . . 1.16 111.276 -177.427 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 115' ' ' PRO . . . . . 0.529 ' HD3' ' HG2' ' B' ' 140' ' ' GLU . 88.4 Cg_endo -64.97 82.82 0.18 Allowed 'Trans proline' 0 CA--C 1.508 -0.809 0 CA-C-N 120.871 2.336 . . . . 1.57 115.659 -176.259 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 116' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' B' ' 114' ' ' GLY . . . 88.95 0.71 80.79 Favored Glycine 0 N--CA 1.415 -2.754 0 CA-C-N 111.949 -2.387 . . . . 1.7 115.096 -178.172 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 117' ' ' GLY . . . . . 0.645 ' O ' ' HB2' ' B' ' 112' ' ' PRO . . . 93.07 33.27 7.39 Favored Glycine 0 N--CA 1.429 -1.823 0 CA-C-N 120.577 2.189 . . . . 1.38 117.359 174.701 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -94.02 -14.03 26.29 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 112.828 0.677 . . . . 2.54 112.828 177.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 119' ' ' GLY . . . . . 0.734 ' O ' ' HA ' ' B' ' 112' ' ' PRO . . . -111.98 -174.63 19.68 Favored Glycine 0 C--N 1.345 1.072 0 CA-C-O 117.37 -1.794 . . . . 1.04 108.907 179.042 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 1.095 ' HG2' ' HB3' ' B' ' 110' ' ' CYS . 0.2 OUTLIER -123.59 175.36 6.85 Favored 'General case' 0 C--N 1.349 0.584 0 CA-C-N 122.52 3.16 . . . . 2.89 110.318 -179.032 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 121' ' ' CYS . . . . . . . . . . . . . 10.9 m -106.94 156.56 18.58 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.171 0.51 . . . . 1.07 112.123 -179.118 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 122' ' ' PHE . . . . . 0.576 ' HE1' ' O ' ' B' ' 128' ' ' CYS . 56.2 m-85 -143.53 17.11 1.84 Allowed 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.497 -0.774 . . . . 1.53 111.163 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 123' ' ' GLY . . . . . 0.532 ' O ' ' HB3' ' B' ' 144' ' ' CYS . . . 162.28 -144.0 9.28 Favored Glycine 0 CA--C 1.519 0.289 0 C-N-CA 120.856 -0.688 . . . . 0.9 112.139 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 124' ' ' PRO . . . . . 0.493 ' O ' ' HB2' ' B' ' 144' ' ' CYS . 12.1 Cg_endo -89.99 -73.05 0.0 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 123.016 2.477 . . . . 1.51 112.607 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 125' ' ' SER . . . . . 0.438 ' O ' ' HA ' ' B' ' 136' ' ' VAL . 0.4 OUTLIER -91.28 35.31 0.93 Allowed 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 110.108 -0.33 . . . . 1.25 110.108 179.431 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 126' ' ' ILE . . . . . 0.914 ' CG1' HG13 ' B' ' 136' ' ' VAL . 17.9 mt -139.38 98.14 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 114.007 1.114 . . . . 0.85 114.007 -178.02 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 127' ' ' CYS . . . . . 0.834 ' HB2' ' HA ' ' B' ' 141' ' ' ALA . 3.7 t -119.83 109.31 15.43 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 107.553 -1.277 . . . . 0.89 107.553 176.345 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 128' ' ' CYS . . . . . 0.751 ' HB2' ' HB1' ' B' ' 168' ' ' ALA . 3.7 m -132.31 148.13 52.42 Favored 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 115.259 1.577 . . . . 1.23 115.259 -175.579 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 129' ' ' GLY . . . . . 0.47 ' O ' ' HB2' ' B' ' 169' ' ' ALA . . . -126.9 -168.1 12.48 Favored Glycine 0 N--CA 1.429 -1.812 0 N-CA-C 109.874 -1.291 . . . . 0.66 109.874 179.156 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 130' ' ' ASP . . . . . 0.427 ' OD2' ' HG2' ' B' ' 131' ' ' GLU . 17.9 p-10 -69.1 -54.01 17.28 Favored 'General case' 0 CA--C 1.491 -1.303 0 C-N-CA 123.396 0.678 . . . . 2.35 112.199 -179.091 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 131' ' ' GLU . . . . . 0.427 ' HG2' ' OD2' ' B' ' 130' ' ' ASP . 0.3 OUTLIER -119.56 28.11 8.36 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 117.495 -1.682 . . . . 1.69 109.215 179.609 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 132' ' ' LEU . . . . . 0.737 HD22 ' CE1' ' B' ' 135' ' ' PHE . 0.7 OUTLIER -121.47 -12.2 8.6 Favored 'General case' 0 N--CA 1.424 -1.741 0 N-CA-C 104.289 -2.485 . . . . 1.38 104.289 -175.709 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 133' ' ' GLY . . . . . 0.756 ' HA2' ' CB ' ' B' ' 169' ' ' ALA . . . 48.91 -136.08 20.1 Favored Glycine 0 N--CA 1.407 -3.249 0 CA-C-N 112.831 -1.986 . . . . 0.72 113.359 176.334 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 134' ' ' CYS . . . . . 0.802 ' HB2' HD13 ' B' ' 172' ' ' ILE . 1.1 m -118.88 125.7 50.1 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.273 1.212 . . . . 1.08 114.273 -176.584 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 135' ' ' PHE . . . . . 0.804 ' HB3' ' CG2' ' B' ' 138' ' ' THR . 8.8 m-85 -102.17 104.2 14.77 Favored 'General case' 0 N--CA 1.431 -1.394 1 N-CA-C 99.508 -4.256 . . . . 1.36 99.508 169.628 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 136' ' ' VAL . . . . . 0.914 HG13 ' CG1' ' B' ' 126' ' ' ILE . 2.5 t -103.43 89.3 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.629 0 CA-C-O 122.594 1.188 . . . . 0.75 110.17 -176.257 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 137' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' B' ' 125' ' ' SER . . . 119.24 -47.61 1.01 Allowed Glycine 0 CA--C 1.519 0.3 0 CA-C-N 113.688 -1.596 . . . . 0.83 115.582 179.177 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 138' ' ' THR . . . . . 0.804 ' CG2' ' HB3' ' B' ' 135' ' ' PHE . 3.5 t -50.52 179.53 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 117.418 0.609 . . . . 0.78 112.266 -178.47 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 139' ' ' ALA . . . . . 0.847 ' HA ' HD12 ' B' ' 142' ' ' LEU . . . -58.08 -36.3 72.65 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.938 -1.028 . . . . 1.04 111.09 -178.712 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 140' ' ' GLU . . . . . 0.529 ' HG2' ' HD3' ' B' ' 115' ' ' PRO . 1.3 mp0 -53.82 -27.71 31.08 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.761 0.282 . . . . 2.31 111.761 -178.384 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 141' ' ' ALA . . . . . 0.834 ' HA ' ' HB2' ' B' ' 127' ' ' CYS . . . -88.46 -33.82 17.69 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 116.123 -0.49 . . . . 0.87 109.929 -179.548 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 142' ' ' LEU . . . . . 0.847 HD12 ' HA ' ' B' ' 139' ' ' ALA . 6.2 mt -42.31 -41.15 2.7 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.013 -0.54 . . . . 1.24 111.748 -178.692 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 143' ' ' ARG . . . . . 0.757 ' HB3' ' HB2' ' B' ' 113' ' ' CYS . 0.0 OUTLIER -52.55 -26.15 12.44 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 109.354 -0.61 . . . . 2.93 109.354 178.073 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 144' ' ' CYS . . . . . 0.532 ' HB3' ' O ' ' B' ' 123' ' ' GLY . 56.9 m -61.2 -16.56 46.17 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.316 -1.311 . . . . 1.61 110.702 -176.147 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 68.4 tp60 -52.68 -22.38 5.08 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 111.879 0.326 . . . . 3.35 111.879 -179.137 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -85.79 3.02 43.33 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 119.602 -0.839 . . . . 3.76 110.968 -179.29 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.448 -0.561 0 CA-C-N 116.056 -0.52 . . . . 4.01 109.686 177.623 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 156' ' ' SER . . . . . 0.652 ' HA ' ' HE3' ' B' ' 159' ' ' LYS . 7.5 t . . . . . 0 N--CA 1.448 -0.567 0 N-CA-C 108.728 -0.842 . . . . 3.11 108.728 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 176.41 -87.6 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 119.926 -1.13 . . . . 2.07 112.967 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 158' ' ' GLN . . . . . 0.986 ' HB3' ' HB3' ' B' ' 167' ' ' CYS . 16.6 mt-30 -120.92 71.22 0.93 Allowed 'General case' 0 N--CA 1.418 -2.047 0 CA-C-O 122.151 0.976 . . . . 4.34 109.292 179.439 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 159' ' ' LYS . . . . . 1.252 ' O ' ' HA ' ' B' ' 166' ' ' ARG . 0.0 OUTLIER -107.28 -58.57 0.05 OUTLIER Pre-proline 0 C--O 1.205 -1.238 0 CA-C-O 123.72 1.724 . . . . 3.54 110.701 174.48 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 160' ' ' PRO . . . . . 0.697 ' HD2' ' H ' ' B' ' 159' ' ' LYS . 49.5 Cg_endo -85.03 108.0 1.12 Allowed 'Trans proline' 0 N--CA 1.442 -1.553 0 C-N-CA 122.466 2.11 . . . . 1.51 114.76 -176.542 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 161' ' ' CYS . . . . . 0.708 ' SG ' ' HB3' ' B' ' 184' ' ' ALA . 3.1 t -143.87 -177.8 5.61 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 113.452 -1.704 . . . . 1.58 108.632 178.609 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 162' ' ' GLY . . . . . 0.506 ' O ' ' O ' ' B' ' 161' ' ' CYS . . . 35.49 -166.58 0.01 OUTLIER Glycine 0 CA--C 1.519 0.309 0 C-N-CA 121.077 -0.583 . . . . 2.37 114.414 176.481 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.89 51.47 1.74 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 121.052 -0.259 . . . . 4.07 111.238 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 119.64 3.83 12.22 Favored Glycine 0 CA--C 1.529 0.93 0 N-CA-C 114.631 0.613 . . . . 2.2 114.631 178.106 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 165' ' ' GLY . . . . . 0.48 ' O ' ' N ' ' B' ' 161' ' ' CYS . . . -102.73 157.85 17.99 Favored Glycine 0 C--O 1.226 -0.385 0 C-N-CA 120.143 -1.027 . . . . 1.62 112.754 179.665 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 166' ' ' ARG . . . . . 1.252 ' HA ' ' O ' ' B' ' 159' ' ' LYS . 0.0 OUTLIER -88.57 152.59 21.75 Favored 'General case' 0 CA--C 1.48 -1.73 0 C-N-CA 120.325 -0.55 . . . . 3.05 111.962 -179.625 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 167' ' ' CYS . . . . . 0.986 ' HB3' ' HB3' ' B' ' 158' ' ' GLN . 0.1 OUTLIER -73.68 108.42 6.51 Favored 'General case' 1 N--CA 1.375 -4.212 0 N-CA-C 107.261 -1.385 . . . . 1.56 107.261 178.15 . . . . . . . . 4 4 . 1 . 013 nuclear build core ' B' B ' 168' ' ' ALA . . . . . 0.751 ' HB1' ' HB2' ' B' ' 128' ' ' CYS . . . -83.5 -49.36 9.34 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 117.627 -1.629 . . . . 1.04 107.065 178.815 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 169' ' ' ALA . . . . . 0.866 ' HB3' HD11 ' B' ' 172' ' ' ILE . . . -161.08 161.54 31.3 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 112.5 -2.136 . . . . 0.98 111.03 -175.763 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 170' ' ' ALA . . . . . 0.871 ' HA ' ' O ' ' B' ' 185' ' ' CYS . . . -32.69 123.31 0.35 Allowed 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 114.846 1.424 . . . . 1.25 114.846 -179.143 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 171' ' ' GLY . . . . . 0.711 ' O ' ' HA ' ' B' ' 181' ' ' GLU . . . 65.16 -19.18 0.12 Allowed Glycine 0 CA--C 1.529 0.962 0 N-CA-C 116.47 1.348 . . . . 1.29 116.47 177.806 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 172' ' ' ILE . . . . . 0.866 HD11 ' HB3' ' B' ' 169' ' ' ALA . 2.0 pp -113.16 101.37 12.4 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 CA-C-O 122.684 1.231 . . . . 2.27 110.529 -179.33 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 173' ' ' CYS . . . . . 0.506 ' HB3' ' HB3' ' B' ' 161' ' ' CYS . 59.3 m -110.27 112.21 24.03 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 113.851 -1.522 . . . . 1.94 110.131 -178.484 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 174' ' ' CYS . . . . . 0.569 ' HA ' ' O ' ' B' ' 178' ' ' GLY . 5.5 m -83.66 133.75 34.81 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 113.56 0.948 . . . . 1.35 113.56 -176.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 175' ' ' SER . . . . . 0.828 ' HB2' ' HD2' ' B' ' 176' ' ' PRO . 28.3 p -95.66 -178.99 0.85 Allowed Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 113.893 -1.503 . . . . 2.0 107.238 177.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 176' ' ' PRO . . . . . 0.828 ' HD2' ' HB2' ' B' ' 175' ' ' SER . 57.4 Cg_endo -71.65 31.08 0.25 Allowed 'Trans proline' 0 CA--C 1.532 0.405 0 CA-C-N 120.584 1.244 . . . . 1.9 112.106 -179.669 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 177' ' ' ASP . . . . . 0.498 ' H ' ' C ' ' B' ' 175' ' ' SER . 3.0 p30 -145.58 -46.01 0.21 Allowed 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 115.906 -0.588 . . . . 2.72 111.743 179.422 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 178' ' ' GLY . . . . . 1.175 ' HA3' ' O ' ' A' ' 79' ' ' CYS . . . -161.07 -151.19 6.15 Favored Glycine 0 C--N 1.35 1.335 0 C-N-CA 120.295 -0.955 . . . . 0.99 115.033 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 179' ' ' CYS . . . . . 1.142 ' O ' ' HA3' ' A' ' 78' ' ' GLY . 32.7 m -128.66 139.35 52.29 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 122.649 1.214 . . . . 1.34 110.195 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 180' ' ' HIS . . . . . . . . . . . . . 33.3 p80 -156.87 133.11 9.79 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 123.619 1.676 . . . . 2.1 112.367 -168.407 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 181' ' ' GLU . . . . . 0.711 ' HA ' ' O ' ' B' ' 171' ' ' GLY . 33.8 mt-10 -49.55 123.14 7.19 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 110.967 -2.833 . . . . 3.06 110.733 -177.323 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 182' ' ' ASP . . . . . 0.403 ' HA ' ' HD3' ' B' ' 183' ' ' PRO . 0.1 OUTLIER -146.79 126.06 6.52 Favored Pre-proline 0 C--N 1.315 -0.916 0 CA-C-N 114.677 -1.147 . . . . 2.06 109.103 -179.725 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 183' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' B' ' 182' ' ' ASP . 72.5 Cg_exo -54.82 -13.53 6.26 Favored 'Trans proline' 0 N--CA 1.482 0.85 0 C-N-CA 123.981 3.121 . . . . 1.91 116.241 -177.178 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 184' ' ' ALA . . . . . 0.708 ' HB3' ' SG ' ' B' ' 161' ' ' CYS . . . -71.77 -31.59 66.78 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 114.974 1.472 . . . . 1.56 114.974 -177.265 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 185' ' ' CYS . . . . . 0.871 ' O ' ' HA ' ' B' ' 170' ' ' ALA . 0.1 OUTLIER -91.1 -4.55 56.16 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 115.298 1.592 . . . . 1.94 115.298 -176.329 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 186' ' ' ASP . . . . . . . . . . . . . 2.2 t70 . . . . . 0 C--N 1.321 -0.664 0 N-CA-C 113.392 0.886 . . . . 3.61 113.392 -178.753 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.608 ' HB2' ' HG2' ' A' ' 20' ' ' ARG . 77.3 m . . . . . 0 N--CA 1.463 0.214 0 CA-C-O 118.766 -0.635 . . . . 2.68 112.525 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.501 ' C ' ' O ' ' A' ' 10' ' ' CYS . 17.4 mt -30.8 136.17 0.21 Allowed Pre-proline 0 N--CA 1.477 0.884 0 CA-C-N 119.033 0.833 . . . . 2.48 111.251 177.834 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.776 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 41.5 Cg_endo -69.55 147.88 65.18 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.763 2.308 . . . . 1.49 114.881 -178.83 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.734 ' N ' ' O ' ' A' ' 19' ' ' GLY . 0.0 OUTLIER -149.91 -166.39 2.53 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-O 121.659 0.742 . . . . 1.0 110.951 176.675 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.636 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . 76.16 -159.59 50.54 Favored Glycine 0 C--N 1.337 0.624 0 CA-C-N 114.683 -1.144 . . . . 1.15 114.767 175.269 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.619 ' HD2' HD21 ' A' ' 32' ' ' LEU . 62.8 Cg_endo -62.1 101.94 0.25 Allowed 'Trans proline' 0 CA--C 1.511 -0.625 0 C-N-CA 124.301 3.334 . . . . 1.57 110.645 177.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.53 -7.74 75.04 Favored Glycine 0 C--N 1.268 -3.198 0 CA-C-N 113.901 -1.499 . . . . 1.68 112.422 179.124 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.412 ' O ' ' HB2' ' A' ' 12' ' ' PRO . . . 79.33 49.48 6.24 Favored Glycine 0 N--CA 1.397 -3.925 0 C-N-CA 119.714 -1.231 . . . . 1.36 113.515 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.73 -49.91 6.02 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 103.567 -2.753 . . . . 2.5 103.567 173.858 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.776 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -67.6 165.1 44.69 Favored Glycine 0 C--O 1.219 -0.816 0 C-N-CA 117.985 -2.055 . . . . 1.02 117.404 -165.523 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.608 ' HG2' ' HB2' ' A' ' 10' ' ' CYS . 0.1 OUTLIER -104.03 147.05 27.83 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 112.691 -1.755 . . . . 2.92 114.667 -172.864 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.448 ' O ' ' HB3' ' A' ' 10' ' ' CYS . 74.1 m -108.9 139.56 43.57 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 114.785 -1.098 . . . . 1.1 111.423 -179.532 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.631 ' CE1' ' HB2' ' A' ' 28' ' ' CYS . 1.4 m-85 -124.41 -9.78 7.47 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.238 -0.437 . . . . 1.51 112.065 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.491 ' HA3' ' OE2' ' B' ' 181' ' ' GLU . . . -159.05 -161.12 10.86 Favored Glycine 0 C--N 1.334 0.459 0 C-N-CA 120.677 -0.773 . . . . 0.9 112.576 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.559 ' HD2' ' HG2' ' B' ' 181' ' ' GLU . 7.6 Cg_exo -69.76 -53.02 0.29 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.967 2.445 . . . . 1.5 112.24 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.598 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.4 OUTLIER -118.78 44.25 2.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.015 -0.539 . . . . 1.26 110.841 -179.756 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 1.118 HG12 HG13 ' A' ' 36' ' ' VAL . 59.8 mt -142.52 121.21 8.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 N-CA-C 112.609 0.596 . . . . 0.83 112.609 -179.059 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.83 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 6.4 t -135.45 144.2 46.32 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-N 115.417 -0.811 . . . . 0.92 109.075 178.603 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.933 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 0.5 OUTLIER -136.35 157.66 46.27 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 122.361 1.076 . . . . 1.28 113.884 -177.08 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.609 ' O ' ' HB1' ' A' ' 69' ' ' ALA . . . -151.05 169.33 30.76 Favored Glycine 0 N--CA 1.416 -2.653 0 CA-C-N 113.812 -1.54 . . . . 0.67 110.561 176.57 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.457 ' OD2' ' HG3' ' A' ' 31' ' ' GLU . 15.3 p-10 -64.37 -48.4 75.64 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 122.79 1.281 . . . . 2.27 108.695 178.623 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.457 ' HG3' ' OD2' ' A' ' 30' ' ' ASP . 1.3 mt-10 -120.38 17.15 12.21 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 113.149 -1.842 . . . . 1.66 109.157 179.543 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.756 HD23 ' CZ ' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -120.2 -2.71 10.1 Favored 'General case' 0 N--CA 1.411 -2.422 0 C-N-CA 123.71 0.804 . . . . 1.37 109.334 -177.275 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.933 ' O ' ' HA ' ' A' ' 28' ' ' CYS . . . 47.63 -131.41 16.42 Favored Glycine 0 N--CA 1.433 -1.557 0 CA-C-N 114.887 -1.051 . . . . 0.73 113.616 178.041 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.893 ' HB2' HD13 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -138.68 113.27 8.96 Favored 'General case' 0 CA--C 1.481 -1.699 0 CA-C-N 118.546 1.173 . . . . 1.08 112.119 179.365 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.756 ' CZ ' HD23 ' A' ' 32' ' ' LEU . 26.5 m-85 -86.49 108.12 18.39 Favored 'General case' 0 N--CA 1.425 -1.722 0 N-CA-C 104.993 -2.225 . . . . 1.38 104.993 176.063 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 1.118 HG13 HG12 ' A' ' 26' ' ' ILE . 5.1 t -91.77 85.42 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.756 0 C-N-CA 118.341 -1.344 . . . . 0.76 108.933 -179.098 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.736 ' HA3' HG22 ' B' ' 172' ' ' ILE . . . 89.37 108.12 1.18 Allowed Glycine 0 CA--C 1.524 0.655 0 CA-C-N 112.918 -1.946 . . . . 0.81 115.159 179.179 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.511 HG21 ' HB3' ' A' ' 35' ' ' PHE . 0.1 OUTLIER 179.36 168.31 1.06 Allowed 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 107.904 -1.147 . . . . 0.77 107.904 178.588 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.887 ' HA ' HD12 ' A' ' 42' ' ' LEU . . . -55.52 -32.93 63.34 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 120.547 1.521 . . . . 1.02 114.008 -177.499 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.598 ' HG2' ' HA2' ' A' ' 14' ' ' GLY . 0.2 OUTLIER -65.27 -23.18 66.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.059 0.457 . . . . 2.32 110.561 179.712 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.584 ' O ' ' N ' ' A' ' 44' ' ' CYS . . . -95.9 -14.71 22.91 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 116.069 -0.514 . . . . 0.87 110.906 -179.042 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.887 HD12 ' HA ' ' A' ' 39' ' ' ALA . 4.7 mt -46.25 -44.37 16.32 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-N 119.042 0.837 . . . . 1.23 112.379 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.43 ' HD2' ' O ' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -61.91 -10.88 10.59 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 120.095 -0.642 . . . . 2.92 109.68 178.101 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.584 ' N ' ' O ' ' A' ' 41' ' ' ALA . 38.5 m -76.6 4.81 8.57 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 114.171 -1.377 . . . . 1.57 110.155 174.752 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.607 ' HB2' ' O ' ' A' ' 42' ' ' LEU . 0.7 OUTLIER -78.79 -18.6 53.88 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.982 -0.554 . . . . 3.31 111.268 179.337 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -86.92 -0.37 56.41 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.051 -0.66 . . . . 3.69 110.539 -179.64 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.448 -0.559 0 N-CA-C 109.537 -0.542 . . . . 3.99 109.537 177.55 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.434 ' HB2' ' HA ' ' A' ' 68' ' ' ALA . 17.7 p . . . . . 0 N--CA 1.453 -0.313 0 N-CA-C 108.043 -1.095 . . . . 3.12 108.043 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.633 ' HA3' ' O ' ' A' ' 67' ' ' CYS . . . -82.46 151.72 29.89 Favored Glycine 0 N--CA 1.448 -0.539 0 N-CA-C 109.726 -1.35 . . . . 2.1 109.726 -177.232 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 19.7 mm100 -101.88 77.45 1.71 Allowed 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.976 0.893 . . . . 4.36 109.655 179.438 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.497 ' HB2' ' HB2' ' A' ' 67' ' ' CYS . 0.0 OUTLIER -141.77 60.47 11.36 Favored Pre-proline 0 C--N 1.31 -1.13 0 N-CA-C 105.746 -1.946 . . . . 3.55 105.746 179.22 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.546 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 30.7 Cg_endo -63.6 78.18 0.14 Allowed 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 122.605 2.203 . . . . 1.54 114.887 -177.554 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.493 ' O ' ' O ' ' A' ' 65' ' ' GLY . 0.5 OUTLIER -99.26 -176.83 3.42 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 106.468 -1.678 . . . . 1.59 106.468 175.868 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.79 -167.02 51.36 Favored Glycine 0 N--CA 1.442 -0.963 0 C-N-CA 117.945 -2.074 . . . . 2.43 111.809 178.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 20.2 p -86.86 39.41 0.85 Allowed 'General case' 0 N--CA 1.484 1.262 0 CA-C-O 122.223 1.011 . . . . 4.11 111.642 -176.107 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 120.68 10.38 7.1 Favored Glycine 0 C--N 1.35 1.341 0 CA-C-N 114.013 -1.449 . . . . 2.21 113.886 -178.679 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.493 ' O ' ' O ' ' A' ' 61' ' ' CYS . . . -103.48 132.99 11.26 Favored Glycine 0 C--N 1.336 0.581 0 C-N-CA 119.657 -1.259 . . . . 1.62 115.401 -178.537 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.58 ' HB2' ' O ' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -97.29 152.98 18.34 Favored 'General case' 0 C--N 1.333 -0.126 0 C-N-CA 122.84 0.456 . . . . 3.02 110.441 178.555 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.633 ' O ' ' HA3' ' A' ' 57' ' ' GLY . 1.8 m -65.34 108.47 1.95 Allowed 'General case' 0 C--O 1.22 -0.486 0 C-N-CA 120.002 -0.679 . . . . 1.52 110.269 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.483 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . . . -81.61 -15.55 54.31 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 107.802 -1.184 . . . . 1.07 107.802 176.706 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.859 ' O ' ' O ' ' A' ' 70' ' ' ALA . . . -165.11 162.15 20.02 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 112.801 -2.0 . . . . 1.0 110.405 178.561 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.859 ' O ' ' O ' ' A' ' 69' ' ' ALA . . . -16.99 -138.11 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.078 0.951 . . . . 1.24 113.287 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.583 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . -64.55 61.11 0.07 OUTLIER Glycine 0 N--CA 1.47 0.936 0 N-CA-C 110.184 -1.166 . . . . 1.28 110.184 -179.589 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.893 HD13 ' HB2' ' A' ' 34' ' ' CYS . 0.7 OUTLIER -146.04 106.12 0.69 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.817 0 CA-C-N 114.731 -0.734 . . . . 2.27 109.771 174.962 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.521 ' HB2' ' HB3' ' A' ' 82' ' ' ASP . 0.0 OUTLIER -93.25 83.42 4.62 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 116.236 -0.438 . . . . 1.98 110.407 -179.556 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.861 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 0.1 OUTLIER -83.04 136.63 34.42 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.982 -0.554 . . . . 1.33 110.816 -179.914 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.699 ' HB3' ' HD2' ' A' ' 76' ' ' PRO . 5.0 m -104.76 179.4 0.94 Allowed Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.25 -0.887 . . . . 1.99 109.312 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.699 ' HD2' ' HB3' ' A' ' 75' ' ' SER . 96.4 Cg_endo -79.96 25.08 0.61 Allowed 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 121.443 1.429 . . . . 1.86 111.722 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -145.58 -41.42 0.22 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.609 -0.723 . . . . 2.65 110.213 179.337 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.792 ' HA3' ' O ' ' B' ' 179' ' ' CYS . . . -147.92 -135.29 2.59 Favored Glycine 0 C--N 1.337 0.601 0 C-N-CA 120.574 -0.822 . . . . 0.99 113.07 179.415 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.861 ' HA ' ' HA ' ' A' ' 74' ' ' CYS . 0.1 OUTLIER -146.85 156.45 43.12 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.625 0.25 . . . . 1.34 110.57 179.954 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.474 ' N ' ' O ' ' A' ' 73' ' ' CYS . 1.2 t-80 -142.42 133.76 26.32 Favored 'General case' 0 CA--C 1.519 -0.249 0 O-C-N 121.989 -0.444 . . . . 2.17 111.638 -178.479 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.571 ' CG ' ' HD2' ' B' ' 124' ' ' PRO . 2.3 mt-10 -58.56 128.03 35.12 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.901 -0.591 . . . . 3.05 109.717 178.71 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.521 ' HB3' ' HB2' ' A' ' 73' ' ' CYS . 0.0 OUTLIER -146.28 112.63 4.41 Favored Pre-proline 0 C--N 1.318 -0.799 0 CA-C-N 115.514 -0.766 . . . . 2.02 110.496 -178.928 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.458 ' HA ' ' OD2' ' A' ' 86' ' ' ASP . 1.6 Cg_endo -82.86 -4.4 11.34 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 122.691 2.261 . . . . 1.93 113.231 -179.26 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.99 -35.43 79.94 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.832 0.349 . . . . 1.53 111.048 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.583 ' O ' ' N ' ' A' ' 71' ' ' GLY . 84.4 m -93.64 49.71 1.39 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.107 -0.497 . . . . 1.88 110.869 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.458 ' OD2' ' HA ' ' A' ' 83' ' ' PRO . 16.5 m-20 . . . . . 0 N--CA 1.442 -0.827 0 N-CA-C 112.422 0.527 . . . . 3.6 112.422 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 110' ' ' CYS . . . . . 0.62 ' HB2' ' HG2' ' B' ' 120' ' ' ARG . 79.7 m . . . . . 0 N--CA 1.465 0.318 0 CA-C-O 118.745 -0.645 . . . . 2.61 112.653 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 111' ' ' LEU . . . . . 0.509 ' C ' ' O ' ' B' ' 110' ' ' CYS . 17.8 mt -29.82 136.07 0.18 Allowed Pre-proline 0 N--CA 1.475 0.796 0 CA-C-N 119.034 0.834 . . . . 2.47 111.369 178.412 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 112' ' ' PRO . . . . . 0.819 ' HA ' ' O ' ' B' ' 119' ' ' GLY . 33.6 Cg_endo -65.32 151.99 83.49 Favored 'Trans proline' 0 CA--C 1.536 0.587 0 C-N-CA 123.383 2.722 . . . . 1.47 113.541 -179.34 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.748 ' N ' ' O ' ' B' ' 119' ' ' GLY . 0.0 OUTLIER -156.77 -168.69 2.75 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.232 0.539 . . . . 1.0 111.222 175.471 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 114' ' ' GLY . . . . . 0.66 ' N ' ' SG ' ' B' ' 113' ' ' CYS . . . 76.14 -159.76 50.71 Favored Glycine 0 C--N 1.334 0.437 0 CA-C-N 115.479 -0.782 . . . . 1.16 114.902 176.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 115' ' ' PRO . . . . . 0.618 ' HD2' HD21 ' B' ' 132' ' ' LEU . 68.2 Cg_endo -62.28 98.31 0.18 Allowed 'Trans proline' 0 CA--C 1.511 -0.629 0 C-N-CA 124.215 3.277 . . . . 1.57 112.066 178.684 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 84.76 3.07 88.38 Favored Glycine 0 C--N 1.284 -2.312 0 CA-C-N 113.63 -1.623 . . . . 1.7 113.132 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 117' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' B' ' 112' ' ' PRO . . . 76.46 41.31 25.55 Favored Glycine 0 N--CA 1.411 -2.976 0 C-N-CA 119.75 -1.214 . . . . 1.38 115.615 176.36 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.99 -30.1 14.9 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-O 121.809 0.814 . . . . 2.54 110.198 177.556 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 119' ' ' GLY . . . . . 0.819 ' O ' ' HA ' ' B' ' 112' ' ' PRO . . . -78.65 161.39 48.07 Favored Glycine 0 C--O 1.201 -1.909 0 N-CA-C 118.745 2.258 . . . . 1.04 118.745 -175.212 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.62 ' HG2' ' HB2' ' B' ' 110' ' ' CYS . 0.1 OUTLIER -104.24 142.39 34.61 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 110.214 -2.993 . . . . 2.89 113.747 -172.55 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 121' ' ' CYS . . . . . 0.459 ' O ' ' HB3' ' B' ' 110' ' ' CYS . 73.3 m -108.51 138.98 43.92 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 114.777 -1.101 . . . . 1.07 111.23 -178.435 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 122' ' ' PHE . . . . . 0.65 ' CE1' ' HB2' ' B' ' 128' ' ' CYS . 1.4 m-85 -124.42 -9.67 7.46 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.185 -0.461 . . . . 1.53 112.052 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 123' ' ' GLY . . . . . 0.517 ' HA3' ' OE2' ' A' ' 81' ' ' GLU . . . -159.22 -161.3 11.06 Favored Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.6 -0.81 . . . . 0.9 112.465 179.716 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 124' ' ' PRO . . . . . 0.571 ' HD2' ' CG ' ' A' ' 81' ' ' GLU . 7.9 Cg_exo -69.54 -52.94 0.31 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.93 2.42 . . . . 1.51 112.302 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 125' ' ' SER . . . . . 0.615 ' O ' ' N ' ' B' ' 137' ' ' GLY . 0.4 OUTLIER -118.75 44.03 2.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.054 -0.521 . . . . 1.25 110.787 -179.811 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 126' ' ' ILE . . . . . 0.983 HG12 HG13 ' B' ' 136' ' ' VAL . 57.7 mt -141.8 120.95 10.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 N-CA-C 112.812 0.671 . . . . 0.85 112.812 -179.065 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 127' ' ' CYS . . . . . 0.806 ' O ' ' HA ' ' B' ' 134' ' ' CYS . 7.0 t -135.08 144.79 47.38 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.72 -0.673 . . . . 0.89 109.472 178.672 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 128' ' ' CYS . . . . . 0.906 ' HA ' ' O ' ' B' ' 133' ' ' GLY . 0.4 OUTLIER -138.99 153.58 48.17 Favored 'General case' 0 CA--C 1.552 1.042 0 N-CA-C 115.541 1.682 . . . . 1.23 115.541 -176.959 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 129' ' ' GLY . . . . . 0.684 ' HA3' ' HB2' ' B' ' 132' ' ' LEU . . . -143.25 165.96 26.89 Favored Glycine 0 N--CA 1.43 -1.72 0 CA-C-N 111.262 -2.699 . . . . 0.66 113.767 179.26 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 130' ' ' ASP . . . . . 0.413 ' OD2' ' HG3' ' B' ' 131' ' ' GLU . 15.4 p-10 -68.97 -41.64 77.69 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 126.028 1.731 . . . . 2.35 110.706 177.146 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 131' ' ' GLU . . . . . 0.413 ' HG3' ' OD2' ' B' ' 130' ' ' ASP . 0.5 OUTLIER -129.69 33.65 4.42 Favored 'General case' 0 CA--C 1.479 -1.78 0 CA-C-N 111.436 -2.62 . . . . 1.69 108.663 170.082 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 132' ' ' LEU . . . . . 0.73 HD23 ' CZ ' ' B' ' 135' ' ' PHE . 0.1 OUTLIER -131.2 -1.44 4.03 Favored 'General case' 0 N--CA 1.401 -2.89 0 N-CA-C 107.645 -1.242 . . . . 1.38 107.645 179.59 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 133' ' ' GLY . . . . . 0.906 ' O ' ' HA ' ' B' ' 128' ' ' CYS . . . 44.32 -133.98 6.64 Favored Glycine 0 N--CA 1.426 -1.992 0 CA-C-N 115.07 -0.968 . . . . 0.72 112.909 179.263 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 134' ' ' CYS . . . . . 0.898 ' HB2' HD13 ' B' ' 172' ' ' ILE . 0.1 OUTLIER -134.9 111.58 9.97 Favored 'General case' 0 CA--C 1.486 -1.512 0 N-CA-C 113.653 0.983 . . . . 1.08 113.653 -178.721 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 135' ' ' PHE . . . . . 0.74 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 27.5 m-85 -84.43 106.82 16.31 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 104.694 -2.336 . . . . 1.36 104.694 176.035 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 136' ' ' VAL . . . . . 0.983 HG13 HG12 ' B' ' 126' ' ' ILE . 12.6 t -92.33 84.79 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.669 0 CA-C-O 122.987 1.375 . . . . 0.75 108.65 -179.178 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 137' ' ' GLY . . . . . 0.749 ' HA3' HG22 ' A' ' 72' ' ' ILE . . . 88.65 107.95 1.07 Allowed Glycine 0 CA--C 1.523 0.579 0 CA-C-N 112.493 -2.139 . . . . 0.83 115.098 179.184 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 138' ' ' THR . . . . . 0.514 HG21 ' HB3' ' B' ' 135' ' ' PHE . 0.1 OUTLIER -174.01 -179.51 1.71 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 107.704 -1.221 . . . . 0.78 107.704 178.472 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 139' ' ' ALA . . . . . 0.857 ' HA ' HD12 ' B' ' 142' ' ' LEU . . . -65.07 -37.67 88.3 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 119.68 1.127 . . . . 1.04 111.393 179.309 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 140' ' ' GLU . . . . . 0.593 ' HG2' ' HA2' ' B' ' 114' ' ' GLY . 0.2 OUTLIER -62.04 -22.85 66.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.061 0.458 . . . . 2.31 111.386 -179.418 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 141' ' ' ALA . . . . . 0.608 ' O ' ' N ' ' B' ' 144' ' ' CYS . . . -93.39 -19.46 21.28 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.508 -0.769 . . . . 0.87 110.972 -179.411 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 142' ' ' LEU . . . . . 0.857 HD12 ' HA ' ' B' ' 139' ' ' ALA . 4.8 mt -43.95 -45.56 7.78 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.448 0.536 . . . . 1.24 112.448 -178.651 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 143' ' ' ARG . . . . . 0.503 ' HD2' ' O ' ' B' ' 112' ' ' PRO . 0.0 OUTLIER -55.56 -24.16 30.91 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 107.905 -1.146 . . . . 2.93 107.905 178.331 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 144' ' ' CYS . . . . . 0.608 ' N ' ' O ' ' B' ' 141' ' ' ALA . 35.0 m -69.61 8.49 0.65 Allowed 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 115.838 -0.619 . . . . 1.61 110.559 -179.625 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 145' ' ' GLN . . . . . 0.582 ' HB2' ' O ' ' B' ' 142' ' ' LEU . 0.7 OUTLIER -78.84 -20.11 50.42 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.015 -0.993 . . . . 3.35 110.838 178.399 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -86.73 -0.45 56.34 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 120.384 -0.526 . . . . 3.76 110.817 -179.579 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.448 -0.571 0 N-CA-C 109.491 -0.559 . . . . 4.01 109.491 177.628 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 156' ' ' SER . . . . . 0.439 ' HB2' ' HA ' ' B' ' 168' ' ' ALA . 9.8 p . . . . . 0 N--CA 1.439 -0.989 0 N-CA-C 110.611 -0.144 . . . . 3.11 110.611 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 157' ' ' GLY . . . . . 0.575 ' O ' ' HB2' ' B' ' 166' ' ' ARG . . . -101.39 152.85 18.89 Favored Glycine 0 CA--C 1.49 -1.498 0 N-CA-C 109.14 -1.584 . . . . 2.07 109.14 175.205 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 18.2 mm100 -103.79 65.81 0.83 Allowed 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 117.352 -1.739 . . . . 4.34 111.157 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 159' ' ' LYS . . . . . 0.689 ' HB2' ' HB2' ' B' ' 167' ' ' CYS . 0.0 OUTLIER -114.37 56.19 0.81 Allowed Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 113.736 -1.574 . . . . 3.54 109.815 172.343 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 160' ' ' PRO . . . . . 0.542 ' HA ' ' HA ' ' B' ' 166' ' ' ARG . 27.2 Cg_endo -62.96 79.16 0.11 Allowed 'Trans proline' 0 CA--C 1.518 -0.299 0 CA-C-N 121.584 1.602 . . . . 1.51 115.818 -173.798 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 161' ' ' CYS . . . . . 0.468 ' O ' ' O ' ' B' ' 165' ' ' GLY . 0.5 OUTLIER -98.89 -176.47 3.35 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 107.044 -1.465 . . . . 1.58 107.044 176.183 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 69.74 -167.03 48.58 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 118.468 -1.825 . . . . 2.37 111.826 178.578 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 24.4 p -85.28 41.46 0.89 Allowed 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.058 0.456 . . . . 4.07 111.717 -178.328 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 120.52 7.07 9.19 Favored Glycine 0 CA--C 1.536 1.346 0 CA-C-O 118.884 -0.953 . . . . 2.2 113.79 -179.142 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 165' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' B' ' 161' ' ' CYS . . . -102.28 134.29 11.72 Favored Glycine 0 CA--C 1.523 0.57 0 C-N-CA 118.498 -1.811 . . . . 1.62 115.388 -177.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 166' ' ' ARG . . . . . 0.575 ' HB2' ' O ' ' B' ' 157' ' ' GLY . 0.0 OUTLIER -97.3 153.17 18.21 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 114.947 -0.627 . . . . 3.05 110.352 178.603 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 167' ' ' CYS . . . . . 0.689 ' HB2' ' HB2' ' B' ' 159' ' ' LYS . 2.2 m -65.52 108.6 2.06 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 120.008 -0.677 . . . . 1.56 110.131 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 168' ' ' ALA . . . . . 0.488 ' HB3' ' SG ' ' B' ' 128' ' ' CYS . . . -78.96 -19.92 50.49 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 106.637 -1.616 . . . . 1.04 106.637 176.662 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 169' ' ' ALA . . . . . 0.835 ' O ' ' O ' ' B' ' 170' ' ' ALA . . . -160.89 161.37 31.76 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 111.82 -2.445 . . . . 0.98 111.036 -178.684 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 170' ' ' ALA . . . . . 0.835 ' O ' ' O ' ' B' ' 169' ' ' ALA . . . -18.06 -135.15 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.771 0.829 . . . . 1.25 113.217 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 171' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' B' ' 185' ' ' CYS . . . -55.85 37.49 0.01 OUTLIER Glycine 0 CA--C 1.537 1.425 0 N-CA-C 114.97 0.748 . . . . 1.29 114.97 -178.823 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 172' ' ' ILE . . . . . 0.898 HD13 ' HB2' ' B' ' 134' ' ' CYS . 0.7 OUTLIER -134.41 107.01 8.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-O 122.079 0.942 . . . . 2.27 111.865 -176.755 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 173' ' ' CYS . . . . . 0.528 ' HB2' ' HB3' ' B' ' 182' ' ' ASP . 0.0 OUTLIER -93.29 82.91 4.52 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.476 -0.783 . . . . 1.94 110.526 -179.623 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 174' ' ' CYS . . . . . 0.879 ' HA ' ' HA ' ' B' ' 179' ' ' CYS . 0.1 OUTLIER -83.24 136.76 34.28 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.943 -0.571 . . . . 1.35 110.797 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 175' ' ' SER . . . . . 0.685 ' HB3' ' HD2' ' B' ' 176' ' ' PRO . 5.1 m -104.79 179.41 0.94 Allowed Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.312 -0.858 . . . . 2.0 109.236 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 176' ' ' PRO . . . . . 0.685 ' HD2' ' HB3' ' B' ' 175' ' ' SER . 95.6 Cg_endo -80.01 25.13 0.61 Allowed 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 121.406 1.404 . . . . 1.9 111.674 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 177' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -145.53 -41.55 0.22 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.594 -0.73 . . . . 2.72 110.298 179.226 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 178' ' ' GLY . . . . . 0.799 ' HA3' ' O ' ' A' ' 79' ' ' CYS . . . -147.84 -135.18 2.58 Favored Glycine 0 C--N 1.337 0.617 0 C-N-CA 120.646 -0.788 . . . . 0.99 113.149 179.304 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 179' ' ' CYS . . . . . 0.879 ' HA ' ' HA ' ' B' ' 174' ' ' CYS . 0.1 OUTLIER -146.96 156.3 42.95 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.554 0.216 . . . . 1.34 110.604 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 180' ' ' HIS . . . . . 0.471 ' N ' ' O ' ' B' ' 173' ' ' CYS . 1.2 t-80 -142.19 133.73 26.68 Favored 'General case' 0 CA--C 1.519 -0.23 0 O-C-N 122.034 -0.416 . . . . 2.1 111.648 -178.43 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 181' ' ' GLU . . . . . 0.559 ' HG2' ' HD2' ' A' ' 24' ' ' PRO . 2.4 mt-10 -58.59 128.08 35.39 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.846 -0.615 . . . . 3.06 109.703 178.716 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 182' ' ' ASP . . . . . 0.528 ' HB3' ' HB2' ' B' ' 173' ' ' CYS . 0.0 OUTLIER -146.37 112.72 4.38 Favored Pre-proline 0 C--N 1.318 -0.764 0 CA-C-N 115.537 -0.756 . . . . 2.06 110.394 -178.87 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 183' ' ' PRO . . . . . 0.458 ' HA ' ' OD2' ' B' ' 186' ' ' ASP . 1.6 Cg_endo -82.86 -4.41 11.33 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.617 2.212 . . . . 1.91 113.302 -179.344 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -66.94 -35.39 79.88 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.89 0.376 . . . . 1.56 111.032 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 185' ' ' CYS . . . . . 0.572 ' HB2' ' O ' ' B' ' 170' ' ' ALA . 83.4 m -93.86 49.5 1.35 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.07 -0.514 . . . . 1.94 111.007 179.75 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 186' ' ' ASP . . . . . 0.458 ' OD2' ' HA ' ' B' ' 183' ' ' PRO . 16.8 m-20 . . . . . 0 N--CA 1.443 -0.817 0 N-CA-C 112.364 0.505 . . . . 3.61 112.364 179.35 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 1.009 ' HB2' ' HG2' ' A' ' 20' ' ' ARG . 53.6 m . . . . . 0 CA--C 1.54 0.568 0 N-CA-C 112.593 0.59 . . . . 2.68 112.593 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.467 ' HG ' ' HD2' ' A' ' 12' ' ' PRO . 6.0 tp -26.76 135.0 0.11 Allowed Pre-proline 0 N--CA 1.486 1.371 0 N-CA-C 113.619 0.97 . . . . 2.48 113.619 179.641 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.62 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 52.0 Cg_endo -75.04 145.11 30.91 Favored 'Trans proline' 0 CA--C 1.552 1.401 0 C-N-CA 123.384 2.723 . . . . 1.49 117.264 -178.299 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.433 ' O ' ' HA2' ' A' ' 17' ' ' GLY . 0.1 OUTLIER -155.31 173.57 16.46 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-N 112.625 -2.08 . . . . 1.0 115.376 -174.709 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 79.3 -159.97 45.49 Favored Glycine 0 CA--C 1.533 1.185 0 CA-C-N 114.406 -1.27 . . . . 1.15 110.657 -172.806 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.498 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 60.1 Cg_endo -62.25 109.26 0.8 Allowed 'Trans proline' 0 N--CA 1.488 1.185 0 C-N-CA 123.65 2.9 . . . . 1.57 110.178 178.276 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 74.96 5.63 76.12 Favored Glycine 0 C--N 1.293 -1.839 0 CA-C-N 114.649 -1.16 . . . . 1.68 112.071 176.721 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.433 ' HA2' ' O ' ' A' ' 13' ' ' CYS . . . 63.73 62.14 5.55 Favored Glycine 1 N--CA 1.396 -4.024 0 C-N-CA 118.824 -1.655 . . . . 1.36 110.524 -177.756 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.498 ' HG2' ' O ' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -100.29 17.95 20.09 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 105.878 -1.897 . . . . 2.5 105.878 168.892 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.62 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -109.26 -178.61 21.34 Favored Glycine 0 N--CA 1.426 -1.99 0 N-CA-C 117.205 1.642 . . . . 1.02 117.205 -173.087 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 1.009 ' HG2' ' HB2' ' A' ' 10' ' ' CYS . 2.9 mtp-105 -143.12 135.71 27.53 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 110.913 -2.643 . . . . 2.92 112.572 176.009 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.609 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 1.7 m -107.72 159.52 16.42 Favored 'General case' 0 C--N 1.343 0.298 0 CA-C-O 121.554 0.692 . . . . 1.1 112.701 -177.741 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -132.06 8.51 4.41 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 114.784 -1.098 . . . . 1.51 110.951 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -179.64 -163.9 31.14 Favored Glycine 0 C--N 1.338 0.654 0 C-N-CA 121.046 -0.597 . . . . 0.9 112.478 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.474 ' HG2' ' OE1' ' B' ' 181' ' ' GLU . 12.5 Cg_exo -69.56 -71.01 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.74 2.293 . . . . 1.5 112.305 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.596 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.5 OUTLIER -100.33 33.9 2.54 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 120.933 0.397 . . . . 1.26 110.111 179.508 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.937 HG12 HG13 ' A' ' 36' ' ' VAL . 6.3 mt -139.07 120.54 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 CA-C-N 116.173 -0.467 . . . . 0.83 111.64 -178.417 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.609 ' HA ' ' HA ' ' A' ' 21' ' ' CYS . 49.6 t -142.22 122.56 13.96 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.765 -0.652 . . . . 0.92 110.179 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 1.104 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -127.59 152.51 47.55 Favored 'General case' 0 CA--C 1.551 0.983 0 N-CA-C 114.521 1.304 . . . . 1.28 114.521 -177.961 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.624 ' O ' ' HB2' ' A' ' 69' ' ' ALA . . . -150.26 -176.29 23.16 Favored Glycine 0 C--N 1.354 1.575 0 N-CA-C 110.927 -0.869 . . . . 0.67 110.927 178.15 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -66.03 -54.01 31.37 Favored 'General case' 0 CA--C 1.56 1.359 0 C-N-CA 124.952 1.301 . . . . 2.27 112.211 179.546 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.36 -18.79 19.69 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 111.514 -2.585 . . . . 1.66 110.375 172.811 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.517 ' O ' ' C ' ' A' ' 33' ' ' GLY . 4.1 mt -99.9 7.6 44.76 Favored 'General case' 0 N--CA 1.4 -2.935 0 CA-C-N 115.892 -0.594 . . . . 1.37 110.749 -172.334 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 1.104 ' O ' ' HA ' ' A' ' 28' ' ' CYS . . . 24.87 -136.91 0.01 OUTLIER Glycine 0 C--O 1.21 -1.394 0 CA-C-O 118.635 -1.092 . . . . 0.73 111.959 179.165 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 1.048 ' HB2' HD13 ' A' ' 72' ' ' ILE . 1.0 OUTLIER -129.97 124.05 32.09 Favored 'General case' 0 CA--C 1.498 -1.044 0 CA-C-N 119.051 1.425 . . . . 1.08 112.422 -179.047 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.714 ' CE2' HG21 ' B' ' 138' ' ' THR . 34.7 m-85 -97.91 105.24 17.36 Favored 'General case' 0 N--CA 1.422 -1.842 0 N-CA-C 103.597 -2.742 . . . . 1.38 103.597 174.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.937 HG13 HG12 ' A' ' 26' ' ' ILE . 1.8 t -100.91 85.59 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.884 0 CA-C-O 123.152 1.453 . . . . 0.76 107.112 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.606 ' HA3' HG21 ' B' ' 172' ' ' ILE . . . 125.9 -77.7 0.38 Allowed Glycine 0 CA--C 1.524 0.607 0 CA-C-N 112.925 -1.943 . . . . 0.81 115.06 -179.38 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.718 HG21 ' CE2' ' B' ' 135' ' ' PHE . 9.9 t -32.2 124.95 0.3 Allowed 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 113.347 0.869 . . . . 0.77 113.347 -177.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.868 ' HA ' ' HG ' ' A' ' 42' ' ' LEU . . . -26.92 -35.02 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 114.12 -1.4 . . . . 1.02 113.409 -179.124 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.524 ' N ' ' O ' ' A' ' 38' ' ' THR . 1.7 mt-10 -48.13 -13.77 0.05 OUTLIER 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.634 0.254 . . . . 2.32 111.05 178.309 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.662 ' O ' ' N ' ' A' ' 44' ' ' CYS . . . -114.96 -44.42 3.03 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 109.448 -0.575 . . . . 0.87 109.448 178.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.868 ' HG ' ' HA ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -37.88 -19.49 0.01 OUTLIER 'General case' 0 C--N 1.346 0.417 0 N-CA-C 115.481 1.659 . . . . 1.23 115.481 -173.232 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.545 ' N ' HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -68.02 -13.65 62.35 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 106.575 -1.639 . . . . 2.92 106.575 174.708 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.662 ' N ' ' O ' ' A' ' 41' ' ' ALA . 64.0 m -85.42 25.12 1.07 Allowed 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 114.151 -1.386 . . . . 1.57 109.953 177.721 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -92.31 -18.66 23.05 Favored 'General case' 0 CA--C 1.509 -0.63 0 N-CA-C 107.859 -1.163 . . . . 3.31 107.859 176.032 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -86.87 5.46 36.73 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-N 115.174 -0.921 . . . . 3.69 109.222 177.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.447 -0.577 0 C-N-CA 119.962 -0.695 . . . . 3.99 109.289 177.419 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 48.8 m . . . . . 0 N--CA 1.467 0.397 0 N-CA-C 117.595 2.443 . . . . 3.12 117.595 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 134.71 69.94 0.07 OUTLIER Glycine 0 N--CA 1.427 -1.948 0 N-CA-C 109.975 -1.25 . . . . 2.1 109.975 -178.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 -117.95 72.89 0.87 Allowed 'General case' 0 N--CA 1.441 -0.923 0 CA-C-O 122.634 1.207 . . . . 4.36 108.032 179.328 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.671 ' CB ' ' HB2' ' A' ' 67' ' ' CYS . 10.0 mtmm -144.64 58.34 5.43 Favored Pre-proline 0 C--N 1.302 -1.475 0 CA-C-N 113.132 -1.849 . . . . 3.55 107.197 179.152 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.7 ' HA ' ' O ' ' A' ' 65' ' ' GLY . 37.7 Cg_endo -66.2 86.56 0.25 Allowed 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 122.605 2.204 . . . . 1.54 116.591 -177.231 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.491 ' SG ' ' HB2' ' A' ' 82' ' ' ASP . 0.5 OUTLIER -100.11 -173.44 2.43 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.308 -1.367 . . . . 1.59 107.308 175.471 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 62.83 -166.43 23.13 Favored Glycine 0 CA--C 1.519 0.331 0 C-N-CA 118.264 -1.922 . . . . 2.43 112.296 176.175 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 64.5 m -77.72 42.9 0.39 Allowed 'General case' 0 C--N 1.327 -0.371 0 O-C-N 122.494 -0.415 . . . . 4.11 111.75 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 110.51 11.31 19.89 Favored Glycine 0 N--CA 1.446 -0.681 0 N-CA-C 116.846 1.498 . . . . 2.21 116.846 176.702 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.7 ' O ' ' HA ' ' A' ' 60' ' ' PRO . . . -104.73 154.37 17.39 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 120.893 2.347 . . . . 1.62 112.902 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.479 ' HG2' ' H ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -101.12 150.13 23.25 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 121.266 0.555 . . . . 3.02 112.442 -179.763 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.671 ' HB2' ' CB ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -72.36 112.71 8.67 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 113.671 0.989 . . . . 1.52 113.671 -179.951 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.67 ' HB1' ' HB2' ' A' ' 28' ' ' CYS . . . -99.76 -16.32 18.15 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 122.514 1.15 . . . . 1.07 108.053 175.47 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 1.026 ' HB3' HG12 ' A' ' 72' ' ' ILE . . . -162.96 161.14 25.49 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 112.506 -2.134 . . . . 1.0 116.532 176.466 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.896 ' HA ' ' HB3' ' A' ' 85' ' ' CYS . . . -50.38 121.77 6.1 Favored 'General case' 0 C--N 1.345 0.4 0 CA-C-N 113.719 -1.582 . . . . 1.24 111.725 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.622 ' HA2' ' O ' ' A' ' 82' ' ' ASP . . . 59.83 36.49 90.13 Favored Glycine 0 N--CA 1.443 -0.885 0 N-CA-C 110.018 -1.233 . . . . 1.28 110.018 -178.27 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 1.048 HD13 ' HB2' ' A' ' 34' ' ' CYS . 0.5 OUTLIER -145.0 108.17 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 O-C-N 121.957 -0.731 . . . . 2.27 109.927 176.984 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -106.04 102.4 11.82 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 108.883 -0.784 . . . . 1.98 108.883 178.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.838 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 3.4 t -92.7 122.42 35.09 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 121.702 0.763 . . . . 1.33 112.283 -178.394 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.615 ' HA ' ' HA2' ' A' ' 65' ' ' GLY . 0.3 OUTLIER -90.59 -179.25 1.12 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 114.375 -1.284 . . . . 1.99 109.733 179.532 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.479 ' HD2' ' CB ' ' A' ' 75' ' ' SER . 86.3 Cg_endo -77.6 25.22 0.49 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 121.828 1.685 . . . . 1.86 113.003 -179.309 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -145.6 -45.75 0.21 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.921 -0.77 . . . . 2.65 108.921 178.548 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.561 ' HA3' ' O ' ' B' ' 179' ' ' CYS . . . -149.37 -151.62 5.53 Favored Glycine 0 N--CA 1.446 -0.667 0 CA-C-N 115.39 -0.823 . . . . 0.99 111.659 178.571 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.838 ' HA ' ' HA ' ' A' ' 74' ' ' CYS . 0.0 OUTLIER -146.9 162.88 37.77 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.846 -0.427 . . . . 1.34 109.846 179.798 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.57 ' HB3' ' HA3' ' B' ' 178' ' ' GLY . 0.1 OUTLIER -150.52 160.82 43.52 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.016 0.436 . . . . 2.17 111.009 -179.036 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.593 ' H ' HD11 ' B' ' 126' ' ' ILE . 0.5 OUTLIER -63.76 146.07 54.58 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.383 -0.599 . . . . 3.05 109.383 179.287 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.622 ' O ' ' HA2' ' A' ' 71' ' ' GLY . 0.8 OUTLIER -145.78 140.77 16.03 Favored Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 120.423 -0.511 . . . . 2.02 111.99 -179.462 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.493 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 5.3 Cg_exo -80.61 -20.9 7.67 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.969 2.446 . . . . 1.93 113.665 -178.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.09 -40.96 87.06 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.162 0.506 . . . . 1.53 110.682 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.896 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 93.2 m -97.21 27.09 4.32 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.779 0.8 . . . . 1.88 110.192 179.491 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.493 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 1.0 OUTLIER . . . . . 0 C--N 1.317 -0.843 0 CA-C-N 115.198 -0.91 . . . . 3.6 110.559 179.64 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 110' ' ' CYS . . . . . 0.983 ' HB2' ' HG2' ' B' ' 120' ' ' ARG . 50.9 m . . . . . 0 CA--C 1.541 0.615 0 N-CA-C 112.749 0.648 . . . . 2.61 112.749 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 111' ' ' LEU . . . . . 0.449 ' HG ' ' HD2' ' B' ' 112' ' ' PRO . 6.1 tp -24.32 134.2 0.08 OUTLIER Pre-proline 0 N--CA 1.485 1.281 0 N-CA-C 113.497 0.925 . . . . 2.47 113.497 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 112' ' ' PRO . . . . . 0.598 ' HA ' ' O ' ' B' ' 119' ' ' GLY . 29.2 Cg_endo -68.34 150.77 76.38 Favored 'Trans proline' 0 CA--C 1.547 1.127 0 C-N-CA 123.235 2.624 . . . . 1.47 114.796 -178.684 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 113' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -158.87 177.98 10.58 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 113.395 -1.729 . . . . 1.0 115.449 176.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . 78.06 -160.27 48.06 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 110.22 -1.152 . . . . 1.16 110.22 -175.501 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 115' ' ' PRO . . . . . 0.402 ' O ' ' HG2' ' B' ' 118' ' ' LYS . 54.6 Cg_endo -63.5 100.03 0.27 Allowed 'Trans proline' 0 N--CA 1.482 0.814 0 C-N-CA 123.985 3.124 . . . . 1.57 114.075 178.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 82.69 5.24 89.62 Favored Glycine 0 C--N 1.29 -2.019 0 CA-C-N 114.61 -1.177 . . . . 1.7 111.876 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . 70.44 47.62 41.73 Favored Glycine 1 N--CA 1.392 -4.288 0 C-N-CA 118.922 -1.608 . . . . 1.38 114.609 179.736 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 118' ' ' LYS . . . . . 0.402 ' HG2' ' O ' ' B' ' 115' ' ' PRO . 0.0 OUTLIER -91.83 15.84 12.14 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 106.827 -1.546 . . . . 2.54 106.827 175.465 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 119' ' ' GLY . . . . . 0.598 ' O ' ' HA ' ' B' ' 112' ' ' PRO . . . -113.52 -171.17 17.66 Favored Glycine 0 N--CA 1.444 -0.827 0 N-CA-C 115.79 1.076 . . . . 1.04 115.79 -175.764 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.983 ' HG2' ' HB2' ' B' ' 110' ' ' CYS . 1.7 mtp-105 -146.89 138.94 24.58 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 114.509 -0.845 . . . . 2.89 109.396 -179.309 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 121' ' ' CYS . . . . . 0.607 ' HA ' ' HA ' ' B' ' 127' ' ' CYS . 1.7 m -107.84 160.86 15.41 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.613 0.721 . . . . 1.07 112.888 -177.129 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -132.18 8.59 4.37 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 114.697 -1.138 . . . . 1.53 110.867 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -179.67 -163.99 31.32 Favored Glycine 0 C--N 1.338 0.684 0 C-N-CA 120.885 -0.674 . . . . 0.9 112.387 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 124' ' ' PRO . . . . . 0.468 ' HG2' ' OE1' ' A' ' 81' ' ' GLU . 12.4 Cg_exo -69.47 -71.14 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.747 2.298 . . . . 1.51 112.313 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 125' ' ' SER . . . . . 0.595 ' O ' ' N ' ' B' ' 137' ' ' GLY . 0.5 OUTLIER -100.25 34.15 2.45 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 120.973 0.416 . . . . 1.25 110.04 179.436 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 126' ' ' ILE . . . . . 0.889 HG12 HG13 ' B' ' 136' ' ' VAL . 7.8 mt -138.71 120.44 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 CA-C-N 116.083 -0.508 . . . . 0.85 111.943 -178.474 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 127' ' ' CYS . . . . . 0.607 ' HA ' ' HA ' ' B' ' 121' ' ' CYS . 49.1 t -142.01 122.05 13.72 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 116.156 -0.474 . . . . 0.89 110.133 -179.773 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 128' ' ' CYS . . . . . 1.076 ' HA ' ' O ' ' B' ' 133' ' ' GLY . 0.0 OUTLIER -124.57 157.34 35.63 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 114.218 1.192 . . . . 1.23 114.218 -178.707 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 129' ' ' GLY . . . . . 0.623 ' N ' ' O ' ' B' ' 133' ' ' GLY . . . -153.78 -177.13 26.93 Favored Glycine 0 N--CA 1.434 -1.472 0 N-CA-C 111.087 -0.805 . . . . 0.66 111.087 177.214 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 130' ' ' ASP . . . . . 0.426 ' OD2' ' HG2' ' B' ' 131' ' ' GLU . 2.4 p-10 -65.08 -53.38 46.49 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 124.337 1.055 . . . . 2.35 111.038 179.518 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 131' ' ' GLU . . . . . 0.426 ' HG2' ' OD2' ' B' ' 130' ' ' ASP . 0.0 OUTLIER -120.96 32.65 5.87 Favored 'General case' 0 CA--C 1.483 -1.613 0 N-CA-C 106.276 -1.75 . . . . 1.69 106.276 174.921 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 132' ' ' LEU . . . . . 0.571 HD22 ' HE1' ' B' ' 135' ' ' PHE . 2.1 mt -135.53 9.7 3.41 Favored 'General case' 0 N--CA 1.393 -3.28 0 N-CA-C 106.413 -1.699 . . . . 1.38 106.413 175.057 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 133' ' ' GLY . . . . . 1.076 ' O ' ' HA ' ' B' ' 128' ' ' CYS . . . 25.66 -128.87 0.03 OUTLIER Glycine 0 N--CA 1.41 -3.089 0 CA-C-N 115.29 -0.868 . . . . 0.72 114.43 178.331 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 134' ' ' CYS . . . . . 1.024 ' HB2' HD13 ' B' ' 172' ' ' ILE . 0.8 OUTLIER -134.96 125.1 25.97 Favored 'General case' 0 CA--C 1.494 -1.192 0 CA-C-N 117.326 0.563 . . . . 1.08 111.614 177.305 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 135' ' ' PHE . . . . . 0.718 ' CE2' HG21 ' A' ' 38' ' ' THR . 34.9 m-85 -99.91 104.99 16.66 Favored 'General case' 0 N--CA 1.422 -1.848 0 N-CA-C 103.29 -2.856 . . . . 1.36 103.29 174.299 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 136' ' ' VAL . . . . . 0.889 HG13 HG12 ' B' ' 126' ' ' ILE . 2.3 t -100.88 85.01 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.792 0 N-CA-C 107.093 -1.447 . . . . 0.75 107.093 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 137' ' ' GLY . . . . . 0.595 ' N ' ' O ' ' B' ' 125' ' ' SER . . . 126.27 -77.5 0.39 Allowed Glycine 0 CA--C 1.526 0.756 0 CA-C-N 113.22 -1.809 . . . . 0.83 114.83 -179.383 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 138' ' ' THR . . . . . 0.714 HG21 ' CE2' ' A' ' 35' ' ' PHE . 9.8 t -33.11 123.2 0.39 Allowed 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 114.346 1.239 . . . . 0.78 114.346 -177.858 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 139' ' ' ALA . . . . . 0.891 ' HA ' ' HG ' ' B' ' 142' ' ' LEU . . . -24.27 -37.93 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 113.532 -1.667 . . . . 1.04 112.787 -178.038 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 140' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' B' ' 138' ' ' THR . 1.8 mt-10 -48.05 -8.18 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 121.19 0.519 . . . . 2.31 111.92 177.851 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 141' ' ' ALA . . . . . 0.634 ' O ' ' N ' ' B' ' 144' ' ' CYS . . . -119.23 -45.81 2.53 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 114.941 -1.027 . . . . 0.87 110.605 177.131 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 142' ' ' LEU . . . . . 0.891 ' HG ' ' HA ' ' B' ' 139' ' ' ALA . 0.0 OUTLIER -38.22 -19.82 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 115.59 1.7 . . . . 1.24 115.59 -174.176 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 143' ' ' ARG . . . . . 0.545 ' N ' HD13 ' B' ' 142' ' ' LEU . 0.0 OUTLIER -69.77 -9.69 55.54 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 106.714 -1.587 . . . . 2.93 106.714 174.869 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 144' ' ' CYS . . . . . 0.634 ' N ' ' O ' ' B' ' 141' ' ' ALA . 66.7 m -89.25 26.38 1.65 Allowed 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.447 -0.797 . . . . 1.61 109.641 176.599 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -91.71 -19.11 22.98 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 3.35 107.708 175.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -86.9 5.46 36.87 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 114.985 -1.007 . . . . 3.76 109.229 178.017 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.447 -0.595 0 C-N-CA 120.128 -0.629 . . . . 4.01 109.324 177.43 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 40.2 m . . . . . 0 CA--C 1.542 0.658 0 CA-C-O 122.174 0.988 . . . . 3.11 112.326 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 111.57 77.7 0.89 Allowed Glycine 0 N--CA 1.434 -1.441 0 CA-C-N 112.668 -2.06 . . . . 2.07 112.161 175.08 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -119.48 60.81 0.83 Allowed 'General case' 0 N--CA 1.433 -1.29 0 CA-C-O 123.189 1.471 . . . . 4.34 108.383 176.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 159' ' ' LYS . . . . . 0.758 ' CB ' ' HB2' ' B' ' 167' ' ' CYS . 10.5 mtmm -116.08 53.68 1.04 Allowed Pre-proline 0 C--N 1.303 -1.427 0 CA-C-N 112.052 -2.34 . . . . 3.54 111.797 173.005 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 160' ' ' PRO . . . . . 0.679 ' HA ' ' O ' ' B' ' 165' ' ' GLY . 36.8 Cg_endo -66.2 87.83 0.25 Allowed 'Trans proline' 0 C--N 1.329 -0.466 0 N-CA-C 117.971 2.258 . . . . 1.51 117.971 -172.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 161' ' ' CYS . . . . . 0.471 ' SG ' ' HB2' ' B' ' 182' ' ' ASP . 0.6 OUTLIER -107.17 178.76 4.46 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 107.092 -1.447 . . . . 1.58 107.092 175.238 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 72.01 -167.34 52.88 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 118.464 -1.827 . . . . 2.37 111.325 -178.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 71.2 m -76.83 40.64 0.25 Allowed 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 120.604 -0.439 . . . . 4.07 111.222 -179.387 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 109.56 17.76 9.59 Favored Glycine 0 C--N 1.342 0.902 0 C-N-CA 119.019 -1.562 . . . . 2.2 116.199 175.813 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 165' ' ' GLY . . . . . 0.679 ' O ' ' HA ' ' B' ' 160' ' ' PRO . . . -107.23 154.28 16.65 Favored Glycine 0 C--N 1.346 1.136 0 C-N-CA 119.235 -1.46 . . . . 1.62 112.179 177.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 166' ' ' ARG . . . . . 0.41 ' HG2' ' H ' ' B' ' 166' ' ' ARG . 0.0 OUTLIER -101.89 150.19 23.44 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 112.211 0.449 . . . . 3.05 112.211 179.425 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 167' ' ' CYS . . . . . 0.758 ' HB2' ' CB ' ' B' ' 159' ' ' LYS . 0.0 OUTLIER -72.68 111.88 8.23 Favored 'General case' 0 N--CA 1.438 -1.033 0 C-N-CA 124.054 0.942 . . . . 1.56 113.335 -179.933 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 168' ' ' ALA . . . . . 0.751 ' HB1' ' HB2' ' B' ' 128' ' ' CYS . . . -89.34 -31.98 17.54 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 104.79 -2.3 . . . . 1.04 104.79 174.35 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 169' ' ' ALA . . . . . 1.054 ' HB3' HG12 ' B' ' 172' ' ' ILE . . . -151.02 158.9 44.71 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 111.27 -2.695 . . . . 0.98 116.527 -172.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 170' ' ' ALA . . . . . 0.875 ' HA ' ' HB3' ' B' ' 185' ' ' CYS . . . -51.32 122.74 8.28 Favored 'General case' 0 C--N 1.347 0.496 0 CA-C-N 113.955 -1.475 . . . . 1.25 111.139 -179.571 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 171' ' ' GLY . . . . . 0.561 ' HA2' ' O ' ' B' ' 182' ' ' ASP . . . 69.84 16.43 72.37 Favored Glycine 0 N--CA 1.428 -1.837 0 C-N-CA 120.642 -0.789 . . . . 1.29 112.611 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 172' ' ' ILE . . . . . 1.054 HG12 ' HB3' ' B' ' 169' ' ' ALA . 0.5 OUTLIER -134.86 110.0 12.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-O 122.05 0.928 . . . . 2.27 111.809 -177.07 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 173' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -106.08 102.04 11.49 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.865 -0.791 . . . . 1.94 108.865 178.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 174' ' ' CYS . . . . . 0.85 ' HA ' ' HA ' ' B' ' 179' ' ' CYS . 3.4 t -92.74 122.34 35.04 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 121.663 0.744 . . . . 1.35 112.33 -178.408 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 175' ' ' SER . . . . . 0.63 ' HA ' ' HA2' ' B' ' 165' ' ' GLY . 0.3 OUTLIER -90.48 -179.2 1.11 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 114.378 -1.283 . . . . 2.0 109.78 179.537 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 176' ' ' PRO . . . . . 0.484 ' HD2' ' CB ' ' B' ' 175' ' ' SER . 86.0 Cg_endo -77.67 25.25 0.5 Allowed 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 121.782 1.655 . . . . 1.9 112.969 -179.267 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 177' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -145.63 -45.61 0.21 Allowed 'General case' 0 C--O 1.237 0.403 0 N-CA-C 109.032 -0.729 . . . . 2.72 109.032 178.514 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 178' ' ' GLY . . . . . 0.57 ' HA3' ' HB3' ' A' ' 80' ' ' HIS . . . -149.39 -151.67 5.55 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.364 -0.835 . . . . 0.99 111.691 178.533 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 179' ' ' CYS . . . . . 0.85 ' HA ' ' HA ' ' B' ' 174' ' ' CYS . 0.0 OUTLIER -146.93 162.77 38.03 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.868 -0.419 . . . . 1.34 109.868 179.724 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 180' ' ' HIS . . . . . 0.56 ' HB3' ' HA3' ' A' ' 78' ' ' GLY . 0.1 OUTLIER -150.42 160.74 43.53 Favored 'General case' 0 N--CA 1.464 0.263 0 O-C-N 121.967 -0.458 . . . . 2.1 111.091 -179.117 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 181' ' ' GLU . . . . . 0.618 ' H ' HD11 ' A' ' 26' ' ' ILE . 0.5 OUTLIER -63.57 145.97 54.62 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.435 -0.58 . . . . 3.06 109.435 179.246 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 182' ' ' ASP . . . . . 0.561 ' O ' ' HA2' ' B' ' 171' ' ' GLY . 0.7 OUTLIER -145.85 140.67 15.89 Favored Pre-proline 0 CA--C 1.537 0.475 0 C-N-CA 120.523 -0.471 . . . . 2.06 111.911 -179.366 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 183' ' ' PRO . . . . . 0.504 ' O ' ' HB2' ' B' ' 186' ' ' ASP . 5.2 Cg_exo -80.5 -20.86 7.85 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.977 2.451 . . . . 1.91 113.726 -179.004 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -67.05 -40.99 87.25 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.166 0.507 . . . . 1.56 110.666 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 185' ' ' CYS . . . . . 0.875 ' HB3' ' HA ' ' B' ' 170' ' ' ALA . 85.7 m -97.06 27.06 4.26 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.778 0.799 . . . . 1.94 110.367 179.323 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 186' ' ' ASP . . . . . 0.504 ' HB2' ' O ' ' B' ' 183' ' ' PRO . 1.1 t70 . . . . . 0 C--N 1.316 -0.865 0 CA-C-N 115.048 -0.978 . . . . 3.61 110.242 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.444 -0.759 0 N-CA-C 110.175 -0.305 . . . . 2.68 110.175 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.833 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 1.6 mm? -32.44 109.92 0.31 Allowed Pre-proline 0 N--CA 1.47 0.532 0 N-CA-C 113.672 0.99 . . . . 2.48 113.672 -178.412 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -60.61 157.18 38.25 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.393 2.062 . . . . 1.49 110.267 176.041 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.516 ' HB3' ' N ' ' A' ' 20' ' ' ARG . 1.0 OUTLIER -159.6 169.94 22.71 Favored 'General case' 0 CA--C 1.552 1.039 0 CA-C-O 121.363 0.601 . . . . 1.0 111.642 173.468 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.778 ' HA2' ' HB3' ' A' ' 40' ' ' GLU . . . 73.49 -160.44 53.72 Favored Glycine 0 CA--C 1.502 -0.769 0 C-N-CA 120.807 -0.711 . . . . 1.15 113.725 177.493 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.413 ' O ' ' HG2' ' A' ' 15' ' ' PRO . 41.2 Cg_endo -66.68 96.94 0.37 Allowed 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 123.049 2.499 . . . . 1.57 117.145 178.846 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 86.01 -2.08 87.72 Favored Glycine 1 C--N 1.254 -4.006 0 C-N-CA 119.76 -1.21 . . . . 1.68 114.31 -172.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.46 ' HA2' ' O ' ' A' ' 13' ' ' CYS . . . 79.72 44.95 8.84 Favored Glycine 0 N--CA 1.419 -2.478 0 C-N-CA 118.881 -1.628 . . . . 1.36 114.897 176.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.6 -9.73 34.18 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 113.446 -1.377 . . . . 2.5 111.294 176.041 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.474 ' C ' ' HB3' ' A' ' 13' ' ' CYS . . . -106.32 -174.42 23.34 Favored Glycine 0 CA--C 1.504 -0.643 0 N-CA-C 107.693 -2.163 . . . . 1.02 107.693 178.886 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.833 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 3.5 ttp180 -129.59 171.59 12.45 Favored 'General case' 0 CA--C 1.552 1.04 0 CA-C-N 121.635 2.717 . . . . 2.92 108.7 -179.475 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.499 ' HB3' ' HG3' ' A' ' 47' ' ' GLU . 1.0 OUTLIER -107.33 143.69 35.26 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 121.28 -0.887 . . . . 1.1 112.739 -178.662 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.424 ' HE2' ' HB3' ' A' ' 20' ' ' ARG . 97.0 m-85 -156.27 57.79 0.58 Allowed 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 114.87 -1.059 . . . . 1.51 109.916 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.505 ' HA3' ' HA ' ' A' ' 76' ' ' PRO . . . 125.97 148.26 7.11 Favored Glycine 0 C--N 1.334 0.432 0 N-CA-C 111.05 -0.82 . . . . 0.9 111.05 -179.095 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.478 ' O ' ' HB1' ' A' ' 41' ' ' ALA . 53.1 Cg_exo -52.3 -75.0 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 121.932 1.755 . . . . 1.5 112.372 -179.262 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.528 ' HB2' ' CG ' ' B' ' 181' ' ' GLU . 2.0 m -89.37 37.87 0.88 Allowed 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 109.182 -0.673 . . . . 1.26 109.182 178.455 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 1.082 HG12 HG13 ' A' ' 36' ' ' VAL . 15.9 mt -147.76 102.94 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 CA-C-N 115.269 -0.878 . . . . 0.83 109.586 -179.679 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.707 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 0.1 OUTLIER -118.68 123.11 44.11 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.648 -0.705 . . . . 0.92 110.53 -177.785 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 1.004 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -142.25 119.4 11.42 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 117.329 2.344 . . . . 1.28 117.329 -178.423 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.465 ' O ' ' CB ' ' A' ' 69' ' ' ALA . . . -108.48 -170.53 21.21 Favored Glycine 0 C--N 1.364 2.121 0 N-CA-C 108.259 -1.936 . . . . 0.67 108.259 175.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.519 ' OD2' ' HG2' ' A' ' 31' ' ' GLU . 20.8 p-10 -64.01 -58.83 5.52 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 114.835 1.42 . . . . 2.27 114.835 -176.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.519 ' HG2' ' OD2' ' A' ' 30' ' ' ASP . 0.0 OUTLIER -108.35 6.52 26.49 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 121.466 0.651 . . . . 1.66 111.477 -177.037 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.949 HD22 ' CZ ' ' A' ' 35' ' ' PHE . 2.2 mt -108.64 -8.44 15.44 Favored 'General case' 0 N--CA 1.398 -3.048 0 N-CA-C 105.332 -2.099 . . . . 1.37 105.332 178.776 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 1.004 ' O ' ' HA ' ' A' ' 28' ' ' CYS . . . 49.16 -133.15 24.46 Favored Glycine 0 N--CA 1.437 -1.251 0 CA-C-N 114.237 -1.347 . . . . 0.73 112.538 177.894 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 1.014 ' HB2' HD13 ' A' ' 72' ' ' ILE . 1.2 t -128.42 119.12 24.34 Favored 'General case' 0 CA--C 1.492 -1.286 0 N-CA-C 114.043 1.127 . . . . 1.08 114.043 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 1.076 ' HA ' ' HA ' ' B' ' 135' ' ' PHE . 0.1 OUTLIER -95.51 102.65 14.47 Favored 'General case' 0 N--CA 1.419 -2.02 0 N-CA-C 102.705 -3.072 . . . . 1.38 102.705 173.906 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 1.082 HG13 HG12 ' A' ' 26' ' ' ILE . 3.0 t -87.93 93.65 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.916 0 CA-C-O 123.102 1.43 . . . . 0.76 107.979 -179.13 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.947 ' HA3' HG21 ' B' ' 172' ' ' ILE . . . 94.26 80.0 1.47 Allowed Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 112.089 -2.323 . . . . 0.81 114.178 -178.643 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.578 HG22 ' O ' ' B' ' 132' ' ' LEU . 71.5 p -159.06 163.37 36.35 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.61 -0.515 . . . . 0.77 109.61 179.034 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.18 -15.67 26.23 Favored 'General case' 0 CA--C 1.527 0.092 0 CA-C-N 118.565 0.62 . . . . 1.02 111.275 178.625 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.778 ' HB3' ' HA2' ' A' ' 14' ' ' GLY . 40.6 mt-10 -69.23 -13.86 62.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.944 -0.571 . . . . 2.32 109.502 177.726 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.851 ' O ' ' HB2' ' A' ' 44' ' ' CYS . . . -96.11 -24.11 16.46 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 115.328 -0.851 . . . . 0.87 111.121 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.3 mt -41.06 -32.95 0.28 Allowed 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.136 0.791 . . . . 1.23 113.136 -178.309 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 5.9 mmm-85 -71.04 -15.18 62.54 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 122.456 1.122 . . . . 2.92 109.561 178.091 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.851 ' HB2' ' O ' ' A' ' 41' ' ' ALA . 1.3 m -62.46 -27.58 69.22 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 112.663 -2.062 . . . . 1.57 110.699 -178.87 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -49.86 -41.23 44.87 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.968 0.413 . . . . 3.31 111.764 179.212 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -85.52 6.27 27.78 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.722 -0.391 . . . . 3.69 110.257 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.499 ' HG3' ' HB3' ' A' ' 21' ' ' CYS . 1.6 tm-20 . . . . . 0 N--CA 1.448 -0.53 0 N-CA-C 109.217 -0.66 . . . . 3.99 109.217 177.478 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.3 p . . . . . 0 N--CA 1.48 1.033 0 CA-C-O 120.535 0.207 . . . . 3.12 110.852 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.52 115.05 7.16 Favored Glycine 0 CA--C 1.491 -1.428 0 C-N-CA 121.316 -0.468 . . . . 2.1 112.369 -178.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -73.72 79.26 1.55 Allowed 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 108.251 -1.018 . . . . 4.36 108.251 179.12 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.576 ' O ' ' HA ' ' A' ' 66' ' ' ARG . 8.0 mmmt -135.45 73.87 61.73 Favored Pre-proline 0 C--N 1.31 -1.116 0 N-CA-C 106.079 -1.823 . . . . 3.55 106.079 -179.327 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.623 ' HA ' ' O ' ' A' ' 65' ' ' GLY . 74.2 Cg_endo -75.79 78.8 3.01 Favored 'Trans proline' 0 C--N 1.372 1.777 0 C-N-CA 123.323 2.682 . . . . 1.54 115.515 -177.775 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 2.3 p -100.72 -176.05 3.07 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 105.118 -2.178 . . . . 1.59 105.118 175.49 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.02 -168.03 52.31 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 118.203 -1.951 . . . . 2.43 114.444 -178.131 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.84 40.91 0.88 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 113.891 -1.155 . . . . 4.11 110.353 -177.49 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 115.48 9.55 12.74 Favored Glycine 0 CA--C 1.544 1.873 0 CA-C-N 113.847 -1.524 . . . . 2.21 115.216 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.844 ' CA ' ' HB3' ' A' ' 75' ' ' SER . . . -103.55 140.41 14.89 Favored Glycine 0 C--N 1.336 0.58 0 CA-C-N 120.529 2.165 . . . . 1.62 116.2 -178.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.576 ' HA ' ' O ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -101.73 156.51 17.45 Favored 'General case' 0 C--N 1.341 0.216 0 C-N-CA 124.496 1.118 . . . . 3.02 109.685 177.837 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.466 ' HB2' ' HB2' ' A' ' 59' ' ' LYS . 1.2 m -52.1 106.28 0.14 Allowed 'General case' 0 CA--C 1.504 -0.82 0 CA-C-N 119.283 0.947 . . . . 1.52 108.793 -179.012 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -78.53 -29.65 46.56 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 106.31 -1.737 . . . . 1.07 106.31 177.588 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.957 ' O ' HG13 ' A' ' 72' ' ' ILE . . . -162.08 139.04 8.21 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 113.454 -1.703 . . . . 1.0 109.925 -176.504 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.608 ' O ' ' O ' ' A' ' 69' ' ' ALA . . . 12.7 -143.22 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.374 1.07 . . . . 1.24 113.796 179.127 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.421 ' HA2' ' O ' ' A' ' 82' ' ' ASP . . . -73.44 65.12 1.71 Allowed Glycine 0 CA--C 1.491 -1.443 0 N-CA-C 107.513 -2.235 . . . . 1.28 107.513 179.064 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 1.035 HG21 ' HA3' ' B' ' 137' ' ' GLY . 1.7 pp -150.81 97.17 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.813 0 N-CA-C 106.161 -1.792 . . . . 2.27 106.161 167.191 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.431 ' O ' ' N ' ' A' ' 80' ' ' HIS . 3.9 t -95.62 103.26 15.12 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.317 -0.856 . . . . 1.98 111.48 -175.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.595 ' HB3' ' O ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -129.75 176.15 8.26 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 113.387 0.884 . . . . 1.33 113.387 -179.029 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.902 ' HB2' ' HD2' ' A' ' 76' ' ' PRO . 36.5 p -138.32 -179.27 1.0 Allowed Pre-proline 0 N--CA 1.462 0.15 0 CA-C-N 113.689 -1.596 . . . . 1.99 108.513 178.752 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.902 ' HD2' ' HB2' ' A' ' 75' ' ' SER . 77.0 Cg_endo -78.02 30.31 0.44 Allowed 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 121.449 1.433 . . . . 1.86 111.511 178.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.425 ' H ' ' C ' ' A' ' 75' ' ' SER . 0.6 OUTLIER -144.96 -34.01 0.36 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.507 -0.769 . . . . 2.65 110.864 179.816 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.595 ' O ' ' HB3' ' A' ' 74' ' ' CYS . . . -158.74 -171.98 25.28 Favored Glycine 0 C--N 1.339 0.738 0 C-N-CA 120.764 -0.732 . . . . 0.99 113.118 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.59 ' HA ' ' HA ' ' A' ' 74' ' ' CYS . 13.6 t -148.27 160.22 43.19 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 122.567 0.347 . . . . 1.34 110.664 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.431 ' N ' ' O ' ' A' ' 73' ' ' CYS . 10.7 t-80 -154.71 145.92 22.84 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 120.027 -0.669 . . . . 2.17 111.659 -179.734 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.585 ' CG ' ' HB2' ' B' ' 125' ' ' SER . 1.8 mt-10 -64.13 132.82 51.59 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.42 -0.585 . . . . 3.05 109.42 178.793 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.453 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 0.3 OUTLIER -141.62 122.67 8.75 Favored Pre-proline 0 CA--C 1.541 0.621 0 CA-C-N 116.495 -0.32 . . . . 2.02 110.754 -179.08 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 82' ' ' ASP . 1.8 Cg_endo -83.7 -12.79 8.56 Favored 'Trans proline' 0 C--N 1.358 1.076 0 C-N-CA 123.17 2.58 . . . . 1.93 113.97 -177.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.87 -38.65 91.86 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.808 0.337 . . . . 1.53 111.531 -179.479 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.507 ' HB2' ' O ' ' A' ' 70' ' ' ALA . 78.7 m -95.24 39.7 1.11 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.034 -0.53 . . . . 1.88 111.155 -179.443 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.466 0.368 0 N-CA-C 114.744 1.386 . . . . 3.6 114.744 -178.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 110' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.44 -0.944 0 N-CA-C 109.194 -0.669 . . . . 2.61 109.194 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 111' ' ' LEU . . . . . 0.845 ' O ' ' HA ' ' B' ' 120' ' ' ARG . 1.7 mm? -34.2 109.97 0.37 Allowed Pre-proline 0 N--CA 1.469 0.507 0 N-CA-C 113.436 0.902 . . . . 2.47 113.436 -179.638 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 112' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -66.19 152.41 81.23 Favored 'Trans proline' 0 N--CA 1.464 -0.242 0 C-N-CA 121.84 1.693 . . . . 1.47 111.607 176.806 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.584 ' HB3' ' N ' ' B' ' 120' ' ' ARG . 1.0 OUTLIER -154.3 170.69 20.71 Favored 'General case' 0 CA--C 1.557 1.243 0 CA-C-O 121.185 0.517 . . . . 1.0 111.632 177.659 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 114' ' ' GLY . . . . . 0.748 ' HA2' ' HB3' ' B' ' 140' ' ' GLU . . . 74.38 -159.35 52.41 Favored Glycine 0 N--CA 1.467 0.748 0 CA-C-N 116.241 -0.436 . . . . 1.16 114.029 177.505 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 115' ' ' PRO . . . . . 0.476 ' O ' ' N ' ' B' ' 117' ' ' GLY . 87.6 Cg_endo -57.7 143.53 94.98 Favored 'Trans proline' 0 C--N 1.363 1.315 0 N-CA-C 102.355 -3.748 . . . . 1.57 102.355 175.635 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 48.06 -3.72 0.01 OUTLIER Glycine 0 C--N 1.274 -2.898 0 O-C-N 118.251 -2.78 . . . . 1.7 116.474 172.794 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 117' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' B' ' 115' ' ' PRO . . . 78.5 42.93 13.21 Favored Glycine 0 N--CA 1.407 -3.267 0 C-N-CA 116.695 -2.669 . . . . 1.38 114.231 177.143 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.09 -15.97 27.04 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 113.199 -1.5 . . . . 2.54 110.852 177.539 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . -96.26 -161.29 32.72 Favored Glycine 0 C--N 1.343 0.967 0 N-CA-C 109.074 -1.61 . . . . 1.04 109.074 179.448 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.845 ' HA ' ' O ' ' B' ' 111' ' ' LEU . 3.5 ttp180 -140.84 170.54 15.56 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 121.706 2.753 . . . . 2.89 106.788 177.882 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 121' ' ' CYS . . . . . 0.48 ' HB3' ' HG3' ' B' ' 147' ' ' GLU . 1.1 m -107.67 143.83 35.6 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 119.005 0.82 . . . . 1.07 112.83 -178.473 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 122' ' ' PHE . . . . . 0.434 ' HE2' ' HB3' ' B' ' 120' ' ' ARG . 97.1 m-85 -156.37 57.85 0.57 Allowed 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 114.898 -1.046 . . . . 1.53 109.897 179.612 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 123' ' ' GLY . . . . . 0.503 ' HA3' ' HA ' ' B' ' 176' ' ' PRO . . . 125.86 148.22 7.12 Favored Glycine 0 C--N 1.334 0.45 0 N-CA-C 110.972 -0.851 . . . . 0.9 110.972 -179.135 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 124' ' ' PRO . . . . . 0.471 ' O ' ' HB1' ' B' ' 141' ' ' ALA . 53.0 Cg_exo -52.27 -75.15 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 121.91 1.74 . . . . 1.51 112.312 -179.276 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 125' ' ' SER . . . . . 0.585 ' HB2' ' CG ' ' A' ' 81' ' ' GLU . 1.9 m -89.28 37.71 0.87 Allowed 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 109.242 -0.651 . . . . 1.25 109.242 178.501 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 126' ' ' ILE . . . . . 1.04 HG12 HG13 ' B' ' 136' ' ' VAL . 18.5 mt -147.36 102.93 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 CA-C-N 115.247 -0.888 . . . . 0.85 109.737 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 127' ' ' CYS . . . . . 0.719 ' O ' ' HA ' ' B' ' 134' ' ' CYS . 0.1 OUTLIER -118.65 123.05 44.02 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.65 -0.705 . . . . 0.89 110.511 -177.837 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 128' ' ' CYS . . . . . 0.996 ' HA ' ' O ' ' B' ' 133' ' ' GLY . 0.0 OUTLIER -141.43 120.84 13.17 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 116.642 2.09 . . . . 1.23 116.642 -178.641 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 129' ' ' GLY . . . . . 0.49 ' O ' ' HB1' ' B' ' 169' ' ' ALA . . . -110.49 -169.0 19.46 Favored Glycine 0 C--N 1.366 2.249 0 N-CA-C 107.924 -2.07 . . . . 0.66 107.924 175.304 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 130' ' ' ASP . . . . . 0.514 ' OD2' ' HG2' ' B' ' 131' ' ' GLU . 21.3 p-10 -63.88 -60.88 2.72 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 113.967 1.099 . . . . 2.35 113.967 -177.294 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 131' ' ' GLU . . . . . 0.514 ' HG2' ' OD2' ' B' ' 130' ' ' ASP . 0.1 OUTLIER -115.13 27.52 9.33 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 122.287 1.042 . . . . 1.69 111.132 -178.048 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 132' ' ' LEU . . . . . 0.968 HD22 ' CZ ' ' B' ' 135' ' ' PHE . 1.7 mt -124.02 -8.41 7.73 Favored 'General case' 0 N--CA 1.399 -3.01 0 N-CA-C 102.91 -2.996 . . . . 1.38 102.91 178.253 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 133' ' ' GLY . . . . . 0.996 ' O ' ' HA ' ' B' ' 128' ' ' CYS . . . 46.68 -130.36 11.96 Favored Glycine 0 N--CA 1.417 -2.604 0 CA-C-N 113.312 -1.767 . . . . 0.72 112.694 175.661 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 134' ' ' CYS . . . . . 1.011 ' HB2' HD13 ' B' ' 172' ' ' ILE . 1.5 t -130.85 118.7 21.13 Favored 'General case' 0 CA--C 1.492 -1.254 0 CA-C-N 120.166 1.983 . . . . 1.08 114.005 -179.356 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 135' ' ' PHE . . . . . 1.076 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -94.49 102.78 14.74 Favored 'General case' 0 N--CA 1.417 -2.085 0 N-CA-C 102.899 -3.0 . . . . 1.36 102.899 174.501 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 136' ' ' VAL . . . . . 1.04 HG13 HG12 ' B' ' 126' ' ' ILE . 3.8 t -87.8 93.15 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.916 0 CA-C-O 123.118 1.437 . . . . 0.75 107.968 -179.213 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 137' ' ' GLY . . . . . 1.035 ' HA3' HG21 ' A' ' 72' ' ' ILE . . . 94.67 79.62 1.46 Allowed Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 112.129 -2.305 . . . . 0.83 114.298 -178.699 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 138' ' ' THR . . . . . 0.654 HG22 ' O ' ' A' ' 32' ' ' LEU . 72.7 p -158.18 165.08 35.81 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.535 -0.543 . . . . 0.78 109.535 179.187 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -62.56 -14.01 37.53 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 121.107 0.479 . . . . 1.04 110.977 178.548 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 140' ' ' GLU . . . . . 0.748 ' HB3' ' HA2' ' B' ' 114' ' ' GLY . 40.9 mt-10 -70.15 -15.13 62.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.537 -0.756 . . . . 2.31 109.446 177.394 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 141' ' ' ALA . . . . . 0.815 ' O ' ' HB2' ' B' ' 144' ' ' CYS . . . -94.51 -25.48 16.84 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.37 -0.832 . . . . 0.87 110.871 -179.722 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 5.2 mt -40.31 -32.83 0.2 Allowed 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 113.245 0.831 . . . . 1.24 113.245 -177.327 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 143' ' ' ARG . . . . . . . . . . . . . 6.0 mmm-85 -69.34 -18.5 63.81 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 122.641 1.21 . . . . 2.93 109.141 177.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 144' ' ' CYS . . . . . 0.815 ' HB2' ' O ' ' B' ' 141' ' ' ALA . 1.3 m -60.94 -25.54 66.87 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 112.617 -2.083 . . . . 1.61 111.007 -177.367 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -51.1 -40.89 59.46 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.902 0.382 . . . . 3.35 111.693 178.762 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -85.55 6.37 27.48 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.68 -0.408 . . . . 3.76 110.211 -179.681 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 147' ' ' GLU . . . . . 0.48 ' HG3' ' HB3' ' B' ' 121' ' ' CYS . 1.6 tm-20 . . . . . 0 N--CA 1.449 -0.476 0 N-CA-C 109.19 -0.67 . . . . 4.01 109.19 177.494 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 5.5 p . . . . . 0 N--CA 1.476 0.846 0 CA-C-O 120.971 0.415 . . . . 3.11 111.495 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -56.51 115.12 5.88 Favored Glycine 0 CA--C 1.499 -0.909 0 CA-C-N 116.131 -0.486 . . . . 2.07 112.576 -178.161 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -76.28 67.45 2.53 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 119.157 -1.017 . . . . 4.34 109.504 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 159' ' ' LYS . . . . . 0.623 ' O ' ' HA ' ' B' ' 166' ' ' ARG . 14.8 mmmt -108.62 70.17 0.38 Allowed Pre-proline 0 C--N 1.318 -0.79 0 CA-C-N 114.043 -1.435 . . . . 3.54 110.852 174.408 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 160' ' ' PRO . . . . . 0.59 ' HA ' ' O ' ' B' ' 165' ' ' GLY . 68.6 Cg_endo -75.38 82.97 1.96 Allowed 'Trans proline' 0 N--CA 1.463 -0.271 0 C-N-CA 121.747 1.632 . . . . 1.51 115.582 -176.382 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 161' ' ' CYS . . . . . 0.403 ' N ' ' O ' ' B' ' 165' ' ' GLY . 1.8 p -93.04 -157.98 0.57 Allowed 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 113.107 -1.86 . . . . 1.58 107.279 177.782 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 52.95 -167.11 1.17 Allowed Glycine 0 N--CA 1.453 -0.203 0 O-C-N 119.287 -2.133 . . . . 2.37 116.938 171.746 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.64 41.02 0.88 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 112.849 -1.675 . . . . 4.07 110.436 -178.271 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 115.52 9.72 12.47 Favored Glycine 0 CA--C 1.548 2.136 0 CA-C-N 114.168 -1.378 . . . . 2.2 115.222 -179.436 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 165' ' ' GLY . . . . . 0.836 ' CA ' ' HB3' ' B' ' 175' ' ' SER . . . -103.93 139.5 14.55 Favored Glycine 0 N--CA 1.464 0.512 0 CA-C-N 120.327 2.064 . . . . 1.62 116.306 -179.051 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 166' ' ' ARG . . . . . 0.623 ' HA ' ' O ' ' B' ' 159' ' ' LYS . 0.0 OUTLIER -101.48 156.39 17.5 Favored 'General case' 0 C--N 1.343 0.323 0 CA-C-N 113.877 -1.162 . . . . 3.05 109.754 178.11 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 167' ' ' CYS . . . . . 0.477 ' HB2' ' HB2' ' B' ' 159' ' ' LYS . 1.2 m -52.05 106.19 0.14 Allowed 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 119.456 1.025 . . . . 1.56 108.813 -179.003 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 168' ' ' ALA . . . . . . . . . . . . . . . -79.58 -27.76 41.15 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 106.602 -1.629 . . . . 1.04 106.602 177.699 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 169' ' ' ALA . . . . . 0.903 ' O ' HG13 ' B' ' 172' ' ' ILE . . . -163.46 139.67 6.88 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 114.81 -1.086 . . . . 0.98 108.589 -177.407 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 170' ' ' ALA . . . . . 0.559 ' O ' ' O ' ' B' ' 169' ' ' ALA . . . 11.28 -139.65 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 114.489 1.292 . . . . 1.25 114.489 179.109 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 171' ' ' GLY . . . . . 0.471 ' HA2' ' O ' ' B' ' 182' ' ' ASP . . . -57.2 19.96 0.01 OUTLIER Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 115.72 1.048 . . . . 1.29 115.72 -179.121 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 172' ' ' ILE . . . . . 1.011 HD13 ' HB2' ' B' ' 134' ' ' CYS . 1.7 pp -128.3 99.81 5.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 CA-C-N 118.811 1.305 . . . . 2.27 109.529 -176.603 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 173' ' ' CYS . . . . . 0.427 ' HB3' ' HB3' ' B' ' 182' ' ' ASP . 4.6 t -94.9 102.95 14.82 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.317 -1.31 . . . . 1.94 111.854 -176.492 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 174' ' ' CYS . . . . . 0.595 ' HB3' ' O ' ' B' ' 178' ' ' GLY . 0.0 OUTLIER -130.0 176.44 8.06 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 113.372 0.878 . . . . 1.35 113.372 -179.118 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 175' ' ' SER . . . . . 0.882 ' HB2' ' HD2' ' B' ' 176' ' ' PRO . 35.9 p -138.42 -179.29 1.01 Allowed Pre-proline 0 N--CA 1.462 0.129 0 CA-C-N 113.666 -1.606 . . . . 2.0 108.493 178.766 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 176' ' ' PRO . . . . . 0.882 ' HD2' ' HB2' ' B' ' 175' ' ' SER . 77.0 Cg_endo -78.0 30.3 0.44 Allowed 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 121.445 1.43 . . . . 1.9 111.524 178.866 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 177' ' ' ASP . . . . . 0.426 ' H ' ' C ' ' B' ' 175' ' ' SER . 0.6 OUTLIER -145.06 -33.88 0.36 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 115.534 -0.757 . . . . 2.72 110.84 179.837 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 178' ' ' GLY . . . . . 0.595 ' O ' ' HB3' ' B' ' 174' ' ' CYS . . . -158.82 -172.04 25.42 Favored Glycine 0 C--N 1.339 0.702 0 C-N-CA 120.822 -0.704 . . . . 0.99 113.19 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 179' ' ' CYS . . . . . 0.593 ' HA ' ' HA ' ' B' ' 174' ' ' CYS . 13.6 t -148.23 160.3 43.08 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 122.536 0.335 . . . . 1.34 110.65 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 180' ' ' HIS . . . . . 0.422 ' N ' ' O ' ' B' ' 173' ' ' CYS . 1.8 t60 -154.86 145.89 22.67 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 119.968 -0.693 . . . . 2.1 111.665 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 181' ' ' GLU . . . . . 0.528 ' CG ' ' HB2' ' A' ' 25' ' ' SER . 1.8 mt-10 -64.12 132.91 51.87 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.421 -0.585 . . . . 3.06 109.421 178.852 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 182' ' ' ASP . . . . . 0.471 ' O ' ' HA2' ' B' ' 171' ' ' GLY . 0.3 OUTLIER -141.71 122.52 8.63 Favored Pre-proline 0 CA--C 1.541 0.613 0 CA-C-N 116.499 -0.319 . . . . 2.06 110.706 -178.984 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 183' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' B' ' 182' ' ' ASP . 1.8 Cg_endo -83.64 -12.73 8.67 Favored 'Trans proline' 0 C--N 1.359 1.097 0 C-N-CA 123.141 2.561 . . . . 1.91 114.009 -178.019 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -63.87 -38.44 91.1 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.845 0.355 . . . . 1.56 111.54 -179.544 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 185' ' ' CYS . . . . . 0.533 ' HB2' ' O ' ' B' ' 170' ' ' ALA . 86.0 m -95.14 39.02 1.12 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.942 -0.572 . . . . 1.94 111.468 -179.419 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 186' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.535 0.371 0 N-CA-C 115.018 1.488 . . . . 3.61 115.018 -178.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.536 ' HB3' ' HD2' ' A' ' 20' ' ' ARG . 0.5 OUTLIER . . . . . 0 CA--C 1.533 0.319 0 N-CA-C 113.207 0.818 . . . . 2.68 113.207 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.601 HD13 ' HD2' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -31.13 113.94 0.34 Allowed Pre-proline 0 N--CA 1.472 0.648 0 N-CA-C 113.244 0.831 . . . . 2.48 113.244 -179.515 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.791 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 21.9 Cg_endo -93.04 152.74 2.62 Favored 'Trans proline' 0 CA--C 1.535 0.571 0 C-N-CA 124.128 3.219 . . . . 1.49 115.279 -178.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.812 ' N ' ' O ' ' A' ' 19' ' ' GLY . 15.4 p -154.06 -160.36 1.08 Allowed 'General case' 0 C--O 1.243 0.741 0 CA-C-N 115.799 -0.637 . . . . 1.0 109.676 175.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.558 ' HA2' ' HG2' ' A' ' 40' ' ' GLU . . . 74.08 -162.95 54.47 Favored Glycine 0 C--N 1.338 0.65 0 N-CA-C 115.479 0.952 . . . . 1.15 115.479 174.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.655 ' O ' ' HD3' ' A' ' 18' ' ' LYS . 64.5 Cg_endo -61.74 104.31 0.31 Allowed 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 124.411 3.408 . . . . 1.57 110.237 177.459 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 86.67 -8.83 73.73 Favored Glycine 0 C--N 1.27 -3.125 0 CA-C-N 112.625 -2.08 . . . . 1.68 112.037 -178.745 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.782 ' O ' ' HB2' ' A' ' 12' ' ' PRO . . . 78.08 44.33 12.01 Favored Glycine 0 N--CA 1.403 -3.555 0 C-N-CA 120.258 -0.973 . . . . 1.36 114.789 179.126 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.657 ' HZ3' ' H ' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -92.8 -49.0 6.28 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 105.494 -2.039 . . . . 2.5 105.494 175.457 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.812 ' O ' ' N ' ' A' ' 13' ' ' CYS . . . -66.46 162.68 43.95 Favored Glycine 0 C--O 1.205 -1.658 0 C-N-CA 118.099 -2.001 . . . . 1.02 116.038 -165.657 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.536 ' HD2' ' HB3' ' A' ' 10' ' ' CYS . 0.0 OUTLIER -98.53 163.6 12.6 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 115.081 1.512 . . . . 2.92 115.081 -171.052 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.4 m -106.27 134.31 49.61 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 114.266 -1.334 . . . . 1.1 110.772 -177.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -134.26 36.3 3.21 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.208 -0.905 . . . . 1.51 109.857 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 144.93 164.43 10.61 Favored Glycine 0 CA--C 1.521 0.459 0 CA-C-N 115.802 -0.635 . . . . 0.9 112.39 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.436 ' O ' ' HB2' ' A' ' 44' ' ' CYS . 50.6 Cg_exo -52.12 -73.22 0.04 OUTLIER 'Trans proline' 0 CA--C 1.532 0.396 0 C-N-CA 122.715 2.277 . . . . 1.5 112.66 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.654 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.4 OUTLIER -90.96 42.72 1.12 Allowed 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 109.312 -0.625 . . . . 1.26 109.312 178.875 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.678 HG12 HG13 ' A' ' 36' ' ' VAL . 4.4 mt -144.9 121.14 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 N-CA-C 113.561 0.949 . . . . 0.83 113.561 -177.037 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.706 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -138.19 112.42 8.62 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.71 0.767 . . . . 0.92 110.632 178.736 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 1.091 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -131.74 118.53 20.08 Favored 'General case' 0 CA--C 1.557 1.242 0 N-CA-C 114.996 1.48 . . . . 1.28 114.996 -179.319 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.482 ' O ' ' HB2' ' A' ' 69' ' ' ALA . . . -108.22 -165.99 21.24 Favored Glycine 0 N--CA 1.428 -1.849 0 N-CA-C 107.035 -2.426 . . . . 0.67 107.035 175.705 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -68.51 -60.48 2.4 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 115.322 1.601 . . . . 2.27 115.322 -179.535 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.28 18.43 21.64 Favored 'General case' 0 CA--C 1.482 -1.639 0 CA-C-O 121.682 0.754 . . . . 1.66 111.464 -176.607 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.787 HD22 ' CZ ' ' A' ' 35' ' ' PHE . 1.2 mt -115.06 -24.86 8.37 Favored 'General case' 0 N--CA 1.395 -3.195 0 N-CA-C 106.396 -1.705 . . . . 1.37 106.396 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 1.091 ' O ' ' HA ' ' A' ' 28' ' ' CYS . . . 76.18 -132.63 12.97 Favored Glycine 0 N--CA 1.4 -3.713 0 CA-C-N 114.353 -1.294 . . . . 0.73 111.28 177.267 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 1.066 ' HB2' HD13 ' A' ' 72' ' ' ILE . 3.2 t -137.96 118.35 13.75 Favored 'General case' 0 CA--C 1.479 -1.758 0 CA-C-N 118.63 1.215 . . . . 1.08 111.557 178.485 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.982 ' HA ' ' HA ' ' B' ' 135' ' ' PHE . 0.0 OUTLIER -91.62 107.21 19.05 Favored 'General case' 0 N--CA 1.42 -1.953 0 N-CA-C 102.242 -3.244 . . . . 1.38 102.242 174.106 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.728 HG23 HG23 ' B' ' 136' ' ' VAL . 1.9 t -93.0 89.76 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.587 0 CA-C-O 122.793 1.282 . . . . 0.76 110.21 -177.492 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.848 ' HA3' HG21 ' B' ' 172' ' ' ILE . . . 102.76 17.44 18.96 Favored Glycine 0 CA--C 1.518 0.241 0 CA-C-N 112.962 -1.926 . . . . 0.81 116.017 178.633 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.826 HG21 ' CD2' ' B' ' 135' ' ' PHE . 25.9 p -95.39 164.99 12.59 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 118.505 1.152 . . . . 0.77 109.002 178.821 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.884 ' HA ' HD12 ' A' ' 42' ' ' LEU . . . -49.29 -29.7 6.32 Favored 'General case' 0 CA--C 1.517 -0.291 0 O-C-N 120.963 -1.086 . . . . 1.02 112.906 -177.635 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.558 ' HG2' ' HA2' ' A' ' 14' ' ' GLY . 1.6 mp0 -62.53 -20.65 64.86 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 120.867 -0.333 . . . . 2.32 110.125 179.217 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.747 ' O ' ' HB2' ' A' ' 44' ' ' CYS . . . -96.14 -24.07 16.45 Favored 'General case' 0 N--CA 1.428 -1.536 0 CA-C-O 119.312 -0.375 . . . . 0.87 110.468 -178.632 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.884 HD12 ' HA ' ' A' ' 39' ' ' ALA . 1.8 mt -57.4 -27.18 62.11 Favored 'General case' 0 C--N 1.346 0.445 0 CA-C-N 119.791 1.178 . . . . 1.23 110.095 179.223 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.498 ' HD3' ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -77.69 9.27 3.56 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 122.231 1.015 . . . . 2.92 108.901 176.816 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.747 ' HB2' ' O ' ' A' ' 41' ' ' ALA . 5.9 m -83.29 2.95 33.48 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 112.838 -1.983 . . . . 1.57 108.214 172.513 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 30.9 tp60 -86.84 -8.34 57.39 Favored 'General case' 0 C--N 1.35 0.595 0 O-C-N 121.384 -0.823 . . . . 3.31 110.988 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -85.98 5.29 33.91 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 119.094 -1.042 . . . . 3.69 108.762 179.1 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 . . . . . 0 N--CA 1.445 -0.716 0 CA-C-N 116.013 -0.539 . . . . 3.99 109.782 177.267 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.2 t . . . . . 0 CA--C 1.529 0.157 0 N-CA-C 109.193 -0.669 . . . . 3.12 109.193 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.405 ' O ' ' HB2' ' A' ' 66' ' ' ARG . . . -76.8 146.88 32.98 Favored Glycine 0 N--CA 1.433 -1.509 0 N-CA-C 110.064 -1.214 . . . . 2.1 110.064 -177.772 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -113.43 74.17 0.85 Allowed 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 122.153 0.978 . . . . 4.36 108.891 178.672 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.57 ' HB2' ' HB3' ' A' ' 67' ' ' CYS . 5.9 mmtp -144.1 58.22 5.73 Favored Pre-proline 0 C--N 1.304 -1.393 0 N-CA-C 106.579 -1.638 . . . . 3.55 106.579 178.503 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.538 ' HA ' ' O ' ' A' ' 65' ' ' GLY . 19.6 Cg_endo -59.01 80.45 0.05 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 122.437 2.091 . . . . 1.54 115.048 -177.228 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.499 ' N ' ' O ' ' A' ' 65' ' ' GLY . 0.5 OUTLIER -99.58 -178.64 3.95 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 106.449 -1.686 . . . . 1.59 106.449 175.553 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.533 ' HA3' ' CE1' ' A' ' 80' ' ' HIS . . . 70.49 -166.79 50.8 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 118.103 -1.999 . . . . 2.43 112.31 179.148 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.7 m -86.13 39.68 0.83 Allowed 'General case' 0 N--CA 1.477 0.893 0 CA-C-O 121.843 0.83 . . . . 4.11 111.354 -176.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 120.15 9.99 7.7 Favored Glycine 0 CA--C 1.543 1.789 0 CA-C-N 114.462 -1.244 . . . . 2.21 114.441 -178.111 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.538 ' O ' ' HA ' ' A' ' 60' ' ' PRO . . . -103.45 151.06 17.78 Favored Glycine 0 C--N 1.336 0.559 0 CA-C-N 119.772 1.786 . . . . 1.62 114.913 -179.121 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.405 ' HB2' ' O ' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -99.52 152.51 19.94 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 122.157 0.183 . . . . 3.02 111.048 178.731 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.57 ' HB3' ' HB2' ' A' ' 59' ' ' LYS . 42.9 t -67.6 121.83 16.73 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-O 121.037 0.446 . . . . 1.52 111.606 -179.213 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.15 -16.66 18.51 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.836 0.827 . . . . 1.07 109.021 177.64 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.698 ' CB ' ' HA2' ' A' ' 33' ' ' GLY . . . -170.09 160.88 8.35 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.326 -1.307 . . . . 1.0 110.756 178.578 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.417 ' HA ' ' HB3' ' A' ' 85' ' ' CYS . . . -61.5 138.01 58.26 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 122.045 -0.409 . . . . 1.24 111.226 178.31 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.74 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . 64.06 18.97 63.15 Favored Glycine 0 N--CA 1.467 0.756 0 CA-C-N 115.77 -0.65 . . . . 1.28 112.808 -179.409 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 1.066 HD13 ' HB2' ' A' ' 34' ' ' CYS . 1.3 pp -150.34 105.59 0.37 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.913 0 N-CA-C 112.116 0.413 . . . . 2.27 112.116 173.11 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.567 ' HB2' ' HB3' ' A' ' 82' ' ' ASP . 16.5 t -97.75 110.79 23.29 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 120.869 0.366 . . . . 1.98 110.32 178.778 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.783 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 72.1 m -92.44 138.84 31.17 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.494 0.664 . . . . 1.33 111.703 -179.336 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.809 ' HB2' ' HD2' ' A' ' 76' ' ' PRO . 54.1 p -113.26 179.55 0.77 Allowed Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 114.82 -1.082 . . . . 1.99 108.948 179.729 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.809 ' HD2' ' HB2' ' A' ' 75' ' ' SER . 74.0 Cg_endo -76.4 30.87 0.4 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 121.349 1.366 . . . . 1.86 111.997 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.441 ' H ' ' C ' ' A' ' 75' ' ' SER . 18.4 m-20 -144.86 -41.78 0.24 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.544 -0.753 . . . . 2.65 109.983 179.378 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.852 ' HA3' ' O ' ' B' ' 179' ' ' CYS . . . -163.63 -135.07 1.75 Allowed Glycine 0 C--N 1.336 0.551 0 C-N-CA 120.951 -0.642 . . . . 0.99 112.784 179.396 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.841 ' O ' ' HA3' ' B' ' 178' ' ' GLY . 62.7 m -148.1 157.11 43.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.06 0.457 . . . . 1.34 110.314 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.533 ' CE1' ' HA3' ' A' ' 62' ' ' GLY . 1.8 p80 -158.02 153.17 25.61 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.206 -0.598 . . . . 2.17 110.641 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.451 ' OE1' HD11 ' B' ' 126' ' ' ILE . 14.6 mp0 -63.06 140.81 58.91 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.672 -0.411 . . . . 3.05 109.983 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.599 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 2.4 p-10 -140.89 140.88 22.49 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 116.071 -0.513 . . . . 2.02 111.195 -179.328 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 82' ' ' ASP . 10.6 Cg_exo -72.48 -27.35 15.88 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 123.492 2.795 . . . . 1.93 114.571 -177.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.02 -47.44 71.41 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 107.86 -1.163 . . . . 1.53 107.86 179.074 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.74 ' O ' ' N ' ' A' ' 71' ' ' GLY . 2.0 m -99.12 77.97 2.21 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 114.181 -1.372 . . . . 1.88 107.497 176.463 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.599 ' HB2' ' O ' ' A' ' 82' ' ' ASP . 38.2 t0 . . . . . 0 C--N 1.321 -0.649 0 N-CA-C 114.23 1.196 . . . . 2.29 114.23 -179.136 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 110' ' ' CYS . . . . . 0.545 ' HB3' ' HD2' ' B' ' 120' ' ' ARG . 0.5 OUTLIER . . . . . 0 CA--C 1.531 0.242 0 N-CA-C 112.654 0.612 . . . . 2.61 112.654 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 111' ' ' LEU . . . . . 0.616 HD13 ' HD2' ' B' ' 112' ' ' PRO . 0.2 OUTLIER -31.07 113.85 0.33 Allowed Pre-proline 0 N--CA 1.469 0.508 0 N-CA-C 113.107 0.78 . . . . 2.47 113.107 -179.629 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 112' ' ' PRO . . . . . 0.853 ' HB2' ' O ' ' B' ' 117' ' ' GLY . 29.0 Cg_endo -90.72 154.31 4.17 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 124.46 3.44 . . . . 1.47 114.417 -179.074 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.829 ' N ' ' O ' ' B' ' 119' ' ' GLY . 15.3 p -156.08 -159.93 0.95 Allowed 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 109.479 -0.563 . . . . 1.0 109.479 174.579 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 114' ' ' GLY . . . . . 0.543 ' HA2' ' HG2' ' B' ' 140' ' ' GLU . . . 73.45 -163.24 54.78 Favored Glycine 0 C--N 1.337 0.614 0 N-CA-C 115.639 1.016 . . . . 1.16 115.639 175.014 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 115' ' ' PRO . . . . . 0.657 ' O ' ' HD3' ' B' ' 118' ' ' LYS . 67.9 Cg_endo -61.78 100.77 0.2 Allowed 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 124.361 3.374 . . . . 1.57 111.37 178.081 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 86.89 -0.14 86.14 Favored Glycine 0 C--N 1.283 -2.414 0 CA-C-N 112.688 -2.051 . . . . 1.7 112.955 -178.549 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 117' ' ' GLY . . . . . 0.853 ' O ' ' HB2' ' B' ' 112' ' ' PRO . . . 76.46 37.12 36.67 Favored Glycine 0 N--CA 1.416 -2.659 0 N-CA-C 115.736 1.055 . . . . 1.38 115.736 175.605 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 118' ' ' LYS . . . . . 0.667 ' HZ1' ' CD1' ' B' ' 132' ' ' LEU . 0.0 OUTLIER -95.69 -30.47 13.73 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 121.753 0.787 . . . . 2.54 111.763 179.448 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 119' ' ' GLY . . . . . 0.829 ' O ' ' N ' ' B' ' 113' ' ' CYS . . . -77.77 158.45 46.77 Favored Glycine 0 C--O 1.193 -2.412 0 N-CA-C 117.499 1.76 . . . . 1.04 117.499 -174.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.545 ' HD2' ' HB3' ' B' ' 110' ' ' CYS . 0.0 OUTLIER -99.84 160.35 14.37 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 111.774 -2.213 . . . . 2.89 113.363 -169.069 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 121' ' ' CYS . . . . . . . . . . . . . 1.4 m -105.43 134.01 49.25 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 114.304 -1.316 . . . . 1.07 110.734 -175.788 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -134.16 36.3 3.23 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.152 -0.931 . . . . 1.53 109.976 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 145.11 164.51 10.7 Favored Glycine 0 CA--C 1.521 0.445 0 CA-C-N 115.849 -0.614 . . . . 0.9 112.395 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -52.17 -73.13 0.04 OUTLIER 'Trans proline' 0 CA--C 1.532 0.411 0 C-N-CA 122.752 2.302 . . . . 1.51 112.761 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 125' ' ' SER . . . . . 0.637 ' O ' ' N ' ' B' ' 137' ' ' GLY . 0.5 OUTLIER -91.02 42.8 1.12 Allowed 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 109.251 -0.648 . . . . 1.25 109.251 178.778 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 126' ' ' ILE . . . . . 0.698 HG12 HG13 ' B' ' 136' ' ' VAL . 6.3 mt -144.51 121.06 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 N-CA-C 113.667 0.988 . . . . 0.85 113.667 -176.798 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 127' ' ' CYS . . . . . 0.67 ' O ' ' HA ' ' B' ' 134' ' ' CYS . 0.0 OUTLIER -138.73 111.47 7.7 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-O 121.57 0.7 . . . . 0.89 110.56 178.458 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 128' ' ' CYS . . . . . 1.146 ' HA ' ' O ' ' B' ' 133' ' ' GLY . 0.0 OUTLIER -127.53 129.36 47.23 Favored 'General case' 0 N--CA 1.439 -0.977 0 C-N-CA 124.243 1.017 . . . . 1.23 111.517 179.098 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 129' ' ' GLY . . . . . 0.481 ' O ' ' HB2' ' B' ' 169' ' ' ALA . . . -120.82 -160.35 11.07 Favored Glycine 0 N--CA 1.417 -2.598 0 N-CA-C 104.126 -3.59 . . . . 0.66 104.126 172.464 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -67.14 -73.23 0.14 Allowed 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 118.283 1.041 . . . . 2.35 111.702 -178.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.97 34.6 2.96 Favored 'General case' 0 CA--C 1.478 -1.792 0 CA-C-O 121.76 0.79 . . . . 1.69 110.505 -173.024 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 132' ' ' LEU . . . . . 0.805 HD22 ' CZ ' ' B' ' 135' ' ' PHE . 1.1 mt -126.49 -23.62 3.75 Favored 'General case' 0 N--CA 1.391 -3.384 0 N-CA-C 104.992 -2.225 . . . . 1.38 104.992 177.181 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 133' ' ' GLY . . . . . 1.146 ' O ' ' HA ' ' B' ' 128' ' ' CYS . . . 73.71 -135.62 20.77 Favored Glycine 1 N--CA 1.39 -4.39 0 N-CA-C 110.275 -1.13 . . . . 0.72 110.275 176.664 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 134' ' ' CYS . . . . . 1.025 ' HB2' HD13 ' B' ' 172' ' ' ILE . 3.1 t -135.97 116.34 13.63 Favored 'General case' 0 CA--C 1.495 -1.168 0 CA-C-N 118.227 1.014 . . . . 1.08 113.519 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 135' ' ' PHE . . . . . 0.982 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -88.57 106.3 18.22 Favored 'General case' 0 N--CA 1.421 -1.879 0 N-CA-C 102.59 -3.115 . . . . 1.36 102.59 175.101 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 136' ' ' VAL . . . . . 0.728 HG23 HG23 ' A' ' 36' ' ' VAL . 2.3 t -92.85 88.02 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-O 123.161 1.458 . . . . 0.75 110.233 -177.645 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 137' ' ' GLY . . . . . 0.827 ' HA3' HG21 ' A' ' 72' ' ' ILE . . . 102.79 18.43 15.77 Favored Glycine 0 C--N 1.32 -0.328 0 CA-C-N 112.705 -2.043 . . . . 0.83 115.916 178.58 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 138' ' ' THR . . . . . 0.837 HG21 ' CD2' ' A' ' 35' ' ' PHE . 30.2 p -89.76 177.04 6.61 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 118.071 0.936 . . . . 0.78 108.747 178.614 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 139' ' ' ALA . . . . . 0.875 ' HA ' HD12 ' B' ' 142' ' ' LEU . . . -58.07 -36.36 72.69 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 118.982 0.81 . . . . 1.04 110.516 179.151 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 140' ' ' GLU . . . . . 0.543 ' HG2' ' HA2' ' B' ' 114' ' ' GLY . 1.7 mp0 -59.54 -15.14 16.15 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.439 -0.346 . . . . 2.31 111.683 -179.357 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 141' ' ' ALA . . . . . 0.674 ' O ' ' HB2' ' B' ' 144' ' ' CYS . . . -99.17 -26.74 14.1 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 116.274 -0.421 . . . . 0.87 110.567 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 142' ' ' LEU . . . . . 0.875 HD12 ' HA ' ' B' ' 139' ' ' ALA . 2.2 mt -55.58 -29.22 58.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.311 0.576 . . . . 1.24 109.681 179.179 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 143' ' ' ARG . . . . . 0.534 ' HD3' ' HA ' ' B' ' 140' ' ' GLU . 0.0 OUTLIER -78.51 11.39 2.51 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 109.051 -0.722 . . . . 2.93 109.051 177.132 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 144' ' ' CYS . . . . . 0.674 ' HB2' ' O ' ' B' ' 141' ' ' ALA . 5.8 m -89.32 13.01 14.51 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 107.232 -1.396 . . . . 1.61 107.232 172.362 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 29.8 tp60 -88.7 -11.86 43.99 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 115.278 -0.874 . . . . 3.35 110.285 177.525 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -85.95 5.48 32.95 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 119.11 -1.036 . . . . 3.76 109.194 179.205 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 . . . . . 0 N--CA 1.444 -0.764 0 C-N-CA 120.377 -0.529 . . . . 4.01 109.784 177.322 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 1.9 t . . . . . 0 N--CA 1.45 -0.47 0 N-CA-C 108.744 -0.836 . . . . 3.11 108.744 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 157' ' ' GLY . . . . . 0.407 ' O ' ' HB2' ' B' ' 166' ' ' ARG . . . -88.85 147.16 19.61 Favored Glycine 0 CA--C 1.494 -1.228 0 N-CA-C 109.764 -1.334 . . . . 2.07 109.764 176.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -114.91 62.49 0.68 Allowed 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 117.207 -1.797 . . . . 4.34 110.293 178.672 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 159' ' ' LYS . . . . . 0.677 ' HB2' ' HB3' ' B' ' 167' ' ' CYS . 7.0 mmtp -117.94 53.9 1.71 Allowed Pre-proline 0 C--N 1.313 -1.02 0 CA-C-N 113.507 -1.679 . . . . 3.54 110.48 172.448 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 160' ' ' PRO . . . . . 0.495 ' HA ' ' O ' ' B' ' 165' ' ' GLY . 15.0 Cg_endo -58.47 81.33 0.05 OUTLIER 'Trans proline' 0 C--N 1.331 -0.363 0 CA-C-N 121.626 1.616 . . . . 1.51 116.072 -173.185 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 161' ' ' CYS . . . . . 0.489 ' N ' ' O ' ' B' ' 165' ' ' GLY . 0.5 OUTLIER -99.25 -178.29 3.87 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 106.926 -1.509 . . . . 1.58 106.926 175.762 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 162' ' ' GLY . . . . . 0.528 ' HA3' ' CE1' ' B' ' 180' ' ' HIS . . . 69.78 -166.57 49.22 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 118.301 -1.904 . . . . 2.37 112.283 178.866 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 2.8 m -85.75 39.95 0.82 Allowed 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.634 0.73 . . . . 4.07 111.423 -177.806 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 121.48 6.74 8.61 Favored Glycine 0 CA--C 1.541 1.656 0 CA-C-N 114.586 -1.188 . . . . 2.2 114.663 -179.13 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 165' ' ' GLY . . . . . 0.515 ' CA ' ' HA ' ' B' ' 175' ' ' SER . . . -102.14 151.74 18.41 Favored Glycine 0 CA--C 1.523 0.562 0 CA-C-N 119.909 1.855 . . . . 1.62 115.172 -177.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 166' ' ' ARG . . . . . 0.407 ' HB2' ' O ' ' B' ' 157' ' ' GLY . 0.0 OUTLIER -99.2 152.63 19.68 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 122.275 0.23 . . . . 3.05 111.046 179.459 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 167' ' ' CYS . . . . . 0.677 ' HB3' ' HB2' ' B' ' 159' ' ' LYS . 41.9 t -67.73 121.47 16.01 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-O 120.771 0.319 . . . . 1.56 111.611 -179.108 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 168' ' ' ALA . . . . . . . . . . . . . . . -96.4 -19.54 19.11 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.444 -0.947 . . . . 1.04 108.444 177.277 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 169' ' ' ALA . . . . . 0.69 ' CB ' ' HA2' ' B' ' 133' ' ' GLY . . . -168.68 160.99 11.06 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 113.739 -1.573 . . . . 0.98 111.898 -179.228 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 170' ' ' ALA . . . . . 0.411 ' HA ' ' HB3' ' B' ' 185' ' ' CYS . . . -61.76 138.95 58.37 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.004 0.43 . . . . 1.25 110.596 178.549 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 171' ' ' GLY . . . . . 0.711 ' N ' ' O ' ' B' ' 185' ' ' CYS . . . 74.43 -1.06 52.74 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 121.191 -0.528 . . . . 1.29 114.113 179.488 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 172' ' ' ILE . . . . . 1.025 HD13 ' HB2' ' B' ' 134' ' ' CYS . 1.3 pp -142.51 107.54 1.51 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.598 0 CA-C-O 121.736 0.779 . . . . 2.27 113.066 -179.29 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 173' ' ' CYS . . . . . 0.562 ' HB2' ' HB3' ' B' ' 182' ' ' ASP . 16.3 t -97.8 110.64 23.17 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.698 -0.683 . . . . 1.94 110.216 178.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 174' ' ' CYS . . . . . 0.756 ' HA ' ' HA ' ' B' ' 179' ' ' CYS . 72.0 m -92.67 138.91 31.09 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.439 0.638 . . . . 1.35 111.755 -179.401 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 175' ' ' SER . . . . . 0.83 ' HB2' ' HD2' ' B' ' 176' ' ' PRO . 51.7 p -113.35 179.65 0.75 Allowed Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 114.866 -1.061 . . . . 2.0 108.906 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 176' ' ' PRO . . . . . 0.83 ' HD2' ' HB2' ' B' ' 175' ' ' SER . 74.4 Cg_endo -76.39 30.78 0.4 Allowed 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 121.427 1.418 . . . . 1.9 111.918 -179.566 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 177' ' ' ASP . . . . . 0.439 ' H ' ' C ' ' B' ' 175' ' ' SER . 18.4 m-20 -144.71 -41.67 0.25 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.563 -0.744 . . . . 2.72 110.065 179.342 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 178' ' ' GLY . . . . . 0.841 ' HA3' ' O ' ' A' ' 79' ' ' CYS . . . -163.74 -135.11 1.76 Allowed Glycine 0 C--N 1.337 0.613 0 C-N-CA 121.041 -0.6 . . . . 0.99 112.763 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 179' ' ' CYS . . . . . 0.852 ' O ' ' HA3' ' A' ' 78' ' ' GLY . 62.3 m -148.12 157.05 43.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.949 0.404 . . . . 1.34 110.44 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 180' ' ' HIS . . . . . 0.528 ' CE1' ' HA3' ' B' ' 162' ' ' GLY . 1.8 p80 -157.89 153.2 25.9 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.285 -0.566 . . . . 2.1 110.611 -179.63 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 181' ' ' GLU . . . . . 0.499 ' OE1' HD11 ' A' ' 26' ' ' ILE . 14.6 mp0 -62.99 140.87 58.91 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.748 -0.381 . . . . 3.06 109.983 179.709 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 182' ' ' ASP . . . . . 0.588 ' O ' ' HB2' ' B' ' 186' ' ' ASP . 2.4 p-10 -141.02 140.92 22.18 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 116.11 -0.495 . . . . 2.06 111.089 -179.248 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 183' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' B' ' 182' ' ' ASP . 10.4 Cg_exo -72.53 -27.17 15.91 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 123.467 2.778 . . . . 1.91 114.665 -178.057 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -67.13 -47.35 71.37 Favored 'General case' 0 CA--C 1.507 -0.697 0 N-CA-C 107.784 -1.191 . . . . 1.56 107.784 179.055 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 185' ' ' CYS . . . . . 0.711 ' O ' ' N ' ' B' ' 171' ' ' GLY . 2.2 m -99.16 77.81 2.19 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 114.192 -1.367 . . . . 1.94 107.647 176.404 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 186' ' ' ASP . . . . . 0.588 ' HB2' ' O ' ' B' ' 182' ' ' ASP . 38.3 t0 . . . . . 0 C--N 1.321 -0.631 0 N-CA-C 114.3 1.222 . . . . 2.28 114.3 -179.298 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.851 ' O ' ' HG2' ' A' ' 20' ' ' ARG . 71.6 m . . . . . 0 N--CA 1.48 1.074 0 N-CA-C 114.191 1.182 . . . . 2.68 114.191 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.916 HD13 ' HD2' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -29.24 119.99 0.29 Allowed Pre-proline 0 N--CA 1.485 1.303 0 C-N-CA 123.673 0.789 . . . . 2.48 113.025 179.944 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.916 ' HD2' HD13 ' A' ' 11' ' ' LEU . 93.4 Cg_endo -72.21 155.83 55.93 Favored 'Trans proline' 0 C--N 1.358 1.054 0 C-N-CA 124.517 3.478 . . . . 1.49 116.408 -176.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.671 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 15.6 p -159.82 -173.07 3.91 Favored 'General case' 0 C--O 1.268 2.061 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.309 178.641 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.697 ' HA2' ' HB3' ' A' ' 40' ' ' GLU . . . 76.69 -158.9 49.22 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 121.134 -0.555 . . . . 1.15 114.39 177.694 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.614 ' HD2' HD11 ' A' ' 32' ' ' LEU . 25.6 Cg_endo -66.51 99.09 0.42 Allowed 'Trans proline' 0 N--CA 1.49 1.305 0 C-N-CA 124.797 3.665 . . . . 1.57 112.725 178.882 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.43 7.51 84.62 Favored Glycine 0 C--N 1.275 -2.814 0 CA-C-N 113.622 -1.626 . . . . 1.68 111.137 -176.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.893 ' O ' ' HB2' ' A' ' 12' ' ' PRO . . . 55.71 55.78 27.09 Favored Glycine 0 N--CA 1.415 -2.709 0 CA-C-N 113.317 -1.442 . . . . 1.36 110.617 172.486 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.55 ' HE3' ' O ' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -92.53 -51.92 4.89 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 101.908 -3.367 . . . . 2.5 101.908 175.053 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.836 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -56.59 -179.08 0.46 Allowed Glycine 0 CA--C 1.533 1.173 0 CA-C-N 112.446 -2.161 . . . . 1.02 110.999 -168.342 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.851 ' HG2' ' O ' ' A' ' 10' ' ' CYS . 42.9 mtm-85 -132.33 174.22 10.46 Favored 'General case' 0 C--N 1.322 -0.587 0 O-C-N 119.999 -1.883 . . . . 2.92 112.185 -171.742 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 1.059 ' HB3' ' HG3' ' A' ' 47' ' ' GLU . 1.7 m -104.8 135.2 46.62 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.688 0.756 . . . . 1.1 112.496 -178.867 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.433 ' CD1' ' HB2' ' A' ' 28' ' ' CYS . 54.4 m-85 -144.97 39.95 1.24 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 114.525 -1.216 . . . . 1.51 109.743 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 141.95 166.35 10.86 Favored Glycine 0 CA--C 1.524 0.624 0 CA-C-N 115.6 -0.727 . . . . 0.9 111.647 -179.267 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.526 ' HD2' ' OE2' ' B' ' 181' ' ' GLU . 21.2 Cg_exo -65.65 -67.75 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.079 1.852 . . . . 1.5 112.147 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.782 ' C ' HG13 ' A' ' 26' ' ' ILE . 3.1 m -89.08 39.49 0.94 Allowed 'General case' 0 C--O 1.225 -0.196 0 N-CA-C 109.592 -0.522 . . . . 1.26 109.592 179.01 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 1.089 HG12 HG13 ' A' ' 36' ' ' VAL . 0.4 OUTLIER -156.0 120.73 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 N-CA-C 112.15 0.426 . . . . 0.83 112.15 -179.032 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.742 ' HB3' ' CE2' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -125.7 119.09 27.07 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 108.53 -0.915 . . . . 0.92 108.53 178.054 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.785 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 17.9 m -105.9 153.42 21.98 Favored 'General case' 0 CA--C 1.558 1.266 0 N-CA-C 112.646 0.61 . . . . 1.28 112.646 -178.289 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -143.5 167.5 26.55 Favored Glycine 0 C--N 1.373 2.589 0 N-CA-C 109.575 -1.41 . . . . 0.67 109.575 174.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.622 ' OD2' ' HG2' ' A' ' 31' ' ' GLU . 8.4 p-10 -66.37 -39.32 89.04 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 124.906 1.282 . . . . 2.27 109.459 178.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.622 ' HG2' ' OD2' ' A' ' 30' ' ' ASP . 0.9 OUTLIER -124.54 6.46 8.26 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 113.55 -1.659 . . . . 1.66 110.964 179.692 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.982 HD22 ' CE1' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -110.03 -12.7 14.5 Favored 'General case' 0 N--CA 1.423 -1.78 0 CA-C-N 115.235 -0.893 . . . . 1.37 110.626 -177.843 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 1.014 ' HA2' ' HB1' ' A' ' 69' ' ' ALA . . . 60.19 -115.3 7.45 Favored Glycine 0 N--CA 1.428 -1.869 0 CA-C-O 118.139 -1.367 . . . . 0.73 111.842 179.408 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 1.034 ' HB2' HD13 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -147.45 127.26 13.48 Favored 'General case' 0 CA--C 1.489 -1.375 0 CA-C-N 119.893 1.847 . . . . 1.08 112.367 179.424 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.982 ' CE1' HD22 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -101.16 100.28 10.81 Favored 'General case' 0 N--CA 1.422 -1.838 0 N-CA-C 103.101 -2.925 . . . . 1.38 103.101 174.641 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 1.089 HG13 HG12 ' A' ' 26' ' ' ILE . 2.0 t -91.98 86.12 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.669 0 CA-C-O 123.364 1.554 . . . . 0.76 107.91 -178.742 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.794 ' HA3' HG21 ' B' ' 172' ' ' ILE . . . 89.79 82.68 1.34 Allowed Glycine 0 CA--C 1.521 0.408 0 CA-C-N 112.338 -2.21 . . . . 0.81 113.487 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.766 HG22 ' O ' ' B' ' 132' ' ' LEU . 49.7 p -156.09 163.17 39.98 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 109.116 -0.698 . . . . 0.77 109.116 179.338 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.869 ' HA ' HD12 ' A' ' 42' ' ' LEU . . . -50.35 -35.89 29.82 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 119.729 1.149 . . . . 1.02 112.766 -178.15 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.697 ' HB3' ' HA2' ' A' ' 14' ' ' GLY . 8.5 mt-10 -58.81 -24.57 62.1 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 109.906 -0.405 . . . . 2.32 109.906 178.033 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.794 ' O ' ' HB2' ' A' ' 44' ' ' CYS . . . -78.63 -23.27 45.93 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 109.514 -0.55 . . . . 0.87 109.514 -179.478 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.869 HD12 ' HA ' ' A' ' 39' ' ' ALA . 0.5 OUTLIER -51.2 -38.72 53.95 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 121.136 -0.977 . . . . 1.23 109.821 178.804 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.795 ' HD2' ' O ' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -66.84 -5.32 11.89 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.21 -0.904 . . . . 2.92 109.986 177.348 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.794 ' HB2' ' O ' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -75.19 -1.01 21.31 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.121 -0.945 . . . . 1.57 111.726 177.122 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.97 -24.84 64.3 Favored 'General case' 0 N--CA 1.453 -0.325 0 O-C-N 121.435 -0.79 . . . . 3.31 110.581 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -84.45 3.05 38.01 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 120.165 -0.614 . . . . 3.69 110.292 179.46 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 1.059 ' HG3' ' HB3' ' A' ' 21' ' ' CYS . 1.7 tm-20 . . . . . 0 N--CA 1.452 -0.35 0 N-CA-C 109.58 -0.526 . . . . 3.99 109.58 177.26 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 10.7 m . . . . . 0 CA--C 1.54 0.576 0 N-CA-C 110.772 -0.084 . . . . 3.12 110.772 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -121.41 133.23 9.43 Favored Glycine 0 N--CA 1.435 -1.411 0 N-CA-C 110.748 -0.941 . . . . 2.1 110.748 -179.146 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.84 76.78 1.03 Allowed 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 107.967 -1.123 . . . . 4.36 107.967 178.874 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.505 ' O ' ' HA ' ' A' ' 66' ' ' ARG . 0.1 OUTLIER -130.82 71.78 82.2 Favored Pre-proline 0 C--N 1.31 -1.128 0 CA-C-N 114.163 -1.38 . . . . 3.55 107.863 -179.355 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.521 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 36.5 Cg_endo -65.1 78.28 0.21 Allowed 'Trans proline' 0 C--N 1.363 1.296 0 C-N-CA 122.406 2.071 . . . . 1.54 113.642 -178.679 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -95.69 -173.08 2.77 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 106.008 -1.849 . . . . 1.59 106.008 176.126 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.39 -166.35 34.3 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 118.558 -1.782 . . . . 2.43 113.182 179.474 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.9 m -87.77 42.48 1.05 Allowed 'General case' 0 N--CA 1.484 1.237 0 CA-C-O 122.642 1.211 . . . . 4.11 110.695 -177.394 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 115.37 11.09 10.94 Favored Glycine 0 CA--C 1.558 2.728 0 CA-C-N 112.859 -1.973 . . . . 2.21 114.873 -177.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.475 ' CA ' ' HB3' ' A' ' 75' ' ' SER . . . -103.87 129.05 9.72 Favored Glycine 0 N--CA 1.469 0.894 0 CA-C-N 121.477 2.638 . . . . 1.62 116.259 -178.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.749 ' HD3' ' O ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -90.92 155.17 18.94 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 108.993 -0.743 . . . . 3.02 108.993 176.606 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.479 ' SG ' ' HB3' ' A' ' 59' ' ' LYS . 74.0 m -64.8 108.31 1.71 Allowed 'General case' 0 N--CA 1.439 -0.991 0 CA-C-O 121.44 0.638 . . . . 1.52 110.309 -178.884 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.414 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . . . -94.57 -11.42 29.49 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.089 -0.96 . . . . 1.07 109.756 178.779 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 1.014 ' HB1' ' HA2' ' A' ' 33' ' ' GLY . . . -165.78 161.39 17.92 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.441 -1.254 . . . . 1.0 110.09 179.164 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.61 ' HA ' ' O ' ' A' ' 85' ' ' CYS . . . -58.02 117.31 4.2 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 113.837 1.051 . . . . 1.24 113.837 -178.315 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.741 ' HA2' ' O ' ' A' ' 82' ' ' ASP . . . 63.49 35.21 91.75 Favored Glycine 0 C--N 1.344 1.012 0 CA-C-N 115.532 -0.758 . . . . 1.28 112.301 179.002 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 1.034 HD13 ' HB2' ' A' ' 34' ' ' CYS . 1.8 pp -150.55 100.85 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.248 1.025 0 CA-C-O 121.924 0.869 . . . . 2.27 110.473 175.367 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.633 ' HB2' ' HB3' ' A' ' 82' ' ' ASP . 0.0 OUTLIER -85.63 92.07 8.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.696 -1.138 . . . . 1.98 110.661 -178.257 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.624 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 81.6 m -97.15 153.49 17.95 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.722 0.773 . . . . 1.33 112.513 -178.882 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.892 ' HB2' ' HD2' ' A' ' 76' ' ' PRO . 34.6 p -130.06 -178.97 0.9 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 114.529 -1.214 . . . . 1.99 108.8 179.584 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.892 ' HD2' ' HB2' ' A' ' 75' ' ' SER . 72.1 Cg_endo -78.07 26.83 0.49 Allowed 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 121.325 1.35 . . . . 1.86 111.761 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.435 ' HB2' ' NE2' ' B' ' 180' ' ' HIS . 3.0 p30 -145.95 -40.07 0.22 Allowed 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 115.786 -0.643 . . . . 2.65 111.417 179.377 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -157.08 -155.12 7.33 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 120.571 -0.823 . . . . 0.99 113.602 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.624 ' HA ' ' HA ' ' A' ' 74' ' ' CYS . 94.9 m -141.07 149.9 42.24 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 122.413 0.285 . . . . 1.34 110.394 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.415 ' O ' ' HB2' ' A' ' 73' ' ' CYS . 28.4 t-80 -140.96 126.4 18.76 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 109.453 -0.573 . . . . 2.17 109.453 -174.017 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.506 ' OE2' ' HD2' ' B' ' 124' ' ' PRO . 17.7 mt-10 -53.21 130.3 34.13 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.273 0.559 . . . . 3.05 111.748 -178.223 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.741 ' O ' ' HA2' ' A' ' 71' ' ' GLY . 0.1 OUTLIER -141.83 118.37 7.25 Favored Pre-proline 0 CA--C 1.547 0.839 0 CA-C-N 115.413 -0.812 . . . . 2.02 110.369 -179.056 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.49 ' HD3' ' HA ' ' A' ' 82' ' ' ASP . 3.7 Cg_exo -81.87 -18.86 7.52 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 122.848 2.365 . . . . 1.93 113.679 -178.551 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.67 -39.86 95.39 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.823 0.344 . . . . 1.53 111.739 -179.259 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.61 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 65.1 m -99.98 14.72 29.58 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.395 -0.366 . . . . 1.88 111.768 -179.689 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.426 ' HA ' ' CA ' ' A' ' 71' ' ' GLY . 0.8 OUTLIER . . . . . 0 C--N 1.322 -0.596 0 C-N-CA 121.063 -0.255 . . . . 3.6 111.413 -178.066 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 110' ' ' CYS . . . . . 0.906 ' O ' ' HG2' ' B' ' 120' ' ' ARG . 73.8 m . . . . . 0 N--CA 1.483 1.193 0 N-CA-C 115.085 1.513 . . . . 2.61 115.085 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 111' ' ' LEU . . . . . 0.93 HD13 ' HD2' ' B' ' 112' ' ' PRO . 0.2 OUTLIER -24.96 119.43 0.21 Allowed Pre-proline 0 N--CA 1.49 1.555 0 C-N-CA 123.684 0.794 . . . . 2.47 113.121 179.897 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 112' ' ' PRO . . . . . 0.972 ' HB2' ' O ' ' B' ' 117' ' ' GLY . 95.8 Cg_endo -71.61 156.13 58.11 Favored 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 124.576 3.517 . . . . 1.47 116.088 -176.747 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.572 ' C ' ' HA2' ' B' ' 117' ' ' GLY . 16.4 p -159.1 -171.34 3.33 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 115.92 -0.582 . . . . 1.0 111.057 177.436 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 114' ' ' GLY . . . . . 0.749 ' HA2' ' HB3' ' B' ' 140' ' ' GLU . . . 75.68 -159.46 51.08 Favored Glycine 0 CA--C 1.53 1.019 0 N-CA-C 115.069 0.788 . . . . 1.16 115.069 177.463 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 115' ' ' PRO . . . . . 0.596 ' HD2' HD11 ' B' ' 132' ' ' LEU . 22.8 Cg_endo -66.37 102.59 0.59 Allowed 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 124.748 3.632 . . . . 1.57 111.611 178.426 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 87.31 -0.35 85.47 Favored Glycine 0 C--N 1.275 -2.822 0 CA-C-N 114.368 -1.287 . . . . 1.7 111.192 -177.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 117' ' ' GLY . . . . . 0.972 ' O ' ' HB2' ' B' ' 112' ' ' PRO . . . 64.34 44.4 95.47 Favored Glycine 1 N--CA 1.395 -4.061 0 CA-C-N 114.47 -0.865 . . . . 1.38 114.098 177.465 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 118' ' ' LYS . . . . . 0.497 ' HE3' ' O ' ' B' ' 115' ' ' PRO . 0.0 OUTLIER -93.31 -29.97 15.37 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.912 -0.773 . . . . 2.54 108.912 179.742 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 119' ' ' GLY . . . . . 0.807 ' O ' ' HA ' ' B' ' 112' ' ' PRO . . . -60.97 -163.29 0.18 Allowed Glycine 0 CA--C 1.496 -1.152 0 CA-C-O 118.493 -1.171 . . . . 1.04 111.604 -176.778 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.906 ' HG2' ' O ' ' B' ' 110' ' ' CYS . 48.8 mtm-85 -150.83 171.55 17.03 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 120.273 2.036 . . . . 2.89 108.806 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 121' ' ' CYS . . . . . 1.032 ' HB3' ' HG3' ' B' ' 147' ' ' GLU . 1.8 m -105.3 135.78 46.04 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.693 0.758 . . . . 1.07 112.875 -178.359 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 122' ' ' PHE . . . . . 0.451 ' CD1' ' HB2' ' B' ' 128' ' ' CYS . 54.7 m-85 -145.11 39.88 1.22 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 114.466 -1.243 . . . . 1.53 109.752 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 141.89 166.4 10.86 Favored Glycine 0 CA--C 1.523 0.59 0 CA-C-N 115.624 -0.716 . . . . 0.9 111.681 -179.321 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 124' ' ' PRO . . . . . 0.506 ' HD2' ' OE2' ' A' ' 81' ' ' GLU . 21.1 Cg_exo -65.69 -67.82 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.142 1.895 . . . . 1.51 112.065 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 125' ' ' SER . . . . . 0.76 ' C ' HG13 ' B' ' 126' ' ' ILE . 3.2 m -88.97 39.51 0.93 Allowed 'General case' 0 C--O 1.225 -0.205 0 N-CA-C 109.58 -0.526 . . . . 1.25 109.58 178.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 126' ' ' ILE . . . . . 1.044 HG12 HG13 ' B' ' 136' ' ' VAL . 0.5 OUTLIER -155.75 120.32 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 N-CA-C 112.188 0.44 . . . . 0.85 112.188 -178.975 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 127' ' ' CYS . . . . . 0.762 ' HB3' ' CE2' ' B' ' 135' ' ' PHE . 0.1 OUTLIER -125.15 120.76 32.28 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 108.748 -0.834 . . . . 0.89 108.748 178.085 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 128' ' ' CYS . . . . . 0.746 ' HA ' ' O ' ' B' ' 133' ' ' GLY . 8.6 m -111.57 146.37 37.48 Favored 'General case' 0 CA--C 1.571 1.77 0 N-CA-C 114.788 1.403 . . . . 1.23 114.788 -177.605 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 129' ' ' GLY . . . . . . . . . . . . . . . -133.75 164.45 24.38 Favored Glycine 0 N--CA 1.421 -2.31 0 CA-C-N 114.973 -1.012 . . . . 0.66 112.065 178.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 130' ' ' ASP . . . . . 0.638 ' OD2' ' HG2' ' B' ' 131' ' ' GLU . 9.6 p-10 -72.28 -27.78 62.7 Favored 'General case' 0 C--N 1.292 -1.892 0 C-N-CA 126.275 1.83 . . . . 2.35 111.033 177.796 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 131' ' ' GLU . . . . . 0.638 ' HG2' ' OD2' ' B' ' 130' ' ' ASP . 1.1 pt-20 -140.49 23.85 2.3 Favored 'General case' 0 CA--C 1.482 -1.672 0 CA-C-N 114.006 -1.452 . . . . 1.69 108.506 172.599 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 132' ' ' LEU . . . . . 0.973 HD22 ' CE1' ' B' ' 135' ' ' PHE . 0.6 OUTLIER -123.64 -9.54 7.89 Favored 'General case' 0 N--CA 1.408 -2.544 0 N-CA-C 107.327 -1.36 . . . . 1.38 107.327 178.1 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 133' ' ' GLY . . . . . 1.015 ' HA2' ' HB1' ' B' ' 169' ' ' ALA . . . 58.93 -114.47 6.1 Favored Glycine 0 N--CA 1.408 -3.217 0 CA-C-O 117.979 -1.456 . . . . 0.72 112.423 178.769 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 134' ' ' CYS . . . . . 0.98 ' HB2' HD13 ' B' ' 172' ' ' ILE . 0.1 OUTLIER -148.52 124.07 10.4 Favored 'General case' 0 CA--C 1.478 -1.814 0 CA-C-N 120.326 2.063 . . . . 1.08 113.638 179.98 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 135' ' ' PHE . . . . . 0.973 ' CE1' HD22 ' B' ' 132' ' ' LEU . 0.0 OUTLIER -98.35 99.88 11.11 Favored 'General case' 0 N--CA 1.42 -1.96 0 N-CA-C 102.985 -2.969 . . . . 1.36 102.985 176.054 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 136' ' ' VAL . . . . . 1.044 HG13 HG12 ' B' ' 126' ' ' ILE . 2.3 t -91.91 85.49 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.65 0 CA-C-O 123.507 1.622 . . . . 0.75 107.875 -178.767 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 137' ' ' GLY . . . . . 0.739 ' HA3' HG21 ' A' ' 72' ' ' ILE . . . 90.21 81.74 1.37 Allowed Glycine 0 C--N 1.317 -0.476 0 CA-C-N 112.081 -2.327 . . . . 0.83 113.416 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 138' ' ' THR . . . . . 0.707 HG22 ' O ' ' A' ' 32' ' ' LEU . 68.7 p -148.41 176.3 10.4 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.624 -0.88 . . . . 0.78 108.624 179.158 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 139' ' ' ALA . . . . . 0.812 ' HA ' HD12 ' B' ' 142' ' ' LEU . . . -61.1 -40.93 95.62 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 119.323 0.965 . . . . 1.04 109.932 178.301 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 140' ' ' GLU . . . . . 0.749 ' HB3' ' HA2' ' B' ' 114' ' ' GLY . 7.7 mt-10 -56.53 -19.1 13.95 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.355 0.598 . . . . 2.31 111.204 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 141' ' ' ALA . . . . . 0.765 ' O ' ' HB2' ' B' ' 144' ' ' CYS . . . -83.26 -20.82 33.78 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 114.906 -1.043 . . . . 0.87 110.054 179.287 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 142' ' ' LEU . . . . . 0.812 HD12 ' HA ' ' B' ' 139' ' ' ALA . 0.5 OUTLIER -53.9 -39.73 66.04 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.939 0.876 . . . . 1.24 109.088 177.704 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 143' ' ' ARG . . . . . 0.793 ' HD2' ' O ' ' B' ' 112' ' ' PRO . 0.2 OUTLIER -67.4 -3.79 9.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.605 -1.179 . . . . 2.93 109.991 177.621 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 144' ' ' CYS . . . . . 0.765 ' HB2' ' O ' ' B' ' 141' ' ' ALA . 0.1 OUTLIER -84.39 18.23 2.31 Favored 'General case' 0 C--N 1.342 0.246 0 O-C-N 120.863 -1.148 . . . . 1.61 110.993 176.148 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.23 -27.12 47.61 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.563 0.696 . . . . 3.35 109.146 175.14 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -84.55 3.17 37.88 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.78 -0.645 . . . . 3.76 110.71 179.315 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 147' ' ' GLU . . . . . 1.032 ' HG3' ' HB3' ' B' ' 121' ' ' CYS . 1.7 tm-20 . . . . . 0 N--CA 1.453 -0.294 0 N-CA-C 109.607 -0.516 . . . . 4.01 109.607 177.32 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 156' ' ' SER . . . . . 0.414 ' HB3' ' H ' ' B' ' 157' ' ' GLY . 5.8 m . . . . . 0 N--CA 1.466 0.329 0 N-CA-C 110.874 -0.047 . . . . 3.11 110.874 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 157' ' ' GLY . . . . . 0.414 ' H ' ' HB3' ' B' ' 156' ' ' SER . . . -127.6 134.82 8.43 Favored Glycine 0 N--CA 1.44 -1.043 0 N-CA-C 110.082 -1.207 . . . . 2.07 110.082 178.516 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.55 67.7 0.66 Allowed 'General case' 0 N--CA 1.444 -0.746 0 CA-C-O 122.144 0.973 . . . . 4.34 109.28 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 159' ' ' LYS . . . . . 0.542 ' O ' ' HA ' ' B' ' 166' ' ' ARG . 0.1 OUTLIER -112.82 69.38 1.11 Allowed Pre-proline 0 C--N 1.315 -0.919 0 CA-C-N 113.929 -1.487 . . . . 3.54 110.634 177.046 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 160' ' ' PRO . . . . . 0.533 ' HA ' ' HA ' ' B' ' 166' ' ' ARG . 33.2 Cg_endo -64.86 79.19 0.19 Allowed 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 121.56 1.507 . . . . 1.51 114.011 -177.549 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 161' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -93.74 -168.95 1.99 Allowed 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 106.682 -1.599 . . . . 1.58 106.682 176.657 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 60.09 -165.38 12.33 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 118.859 -1.638 . . . . 2.37 113.407 177.491 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 4.1 m -87.69 42.21 1.03 Allowed 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 122.961 1.363 . . . . 4.07 110.902 -177.393 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 118.15 6.59 12.12 Favored Glycine 0 CA--C 1.551 2.343 0 CA-C-N 112.552 -2.113 . . . . 2.2 115.095 -179.294 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 165' ' ' GLY . . . . . 0.48 ' CA ' ' HB3' ' B' ' 175' ' ' SER . . . -102.36 129.59 9.94 Favored Glycine 0 N--CA 1.472 1.07 0 CA-C-N 120.835 2.317 . . . . 1.62 116.708 -177.02 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 166' ' ' ARG . . . . . 0.758 ' H ' ' HD2' ' B' ' 166' ' ' ARG . 0.0 OUTLIER -90.77 155.35 18.86 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 108.858 -0.793 . . . . 3.05 108.858 177.115 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 167' ' ' CYS . . . . . 0.49 ' SG ' ' HB3' ' B' ' 159' ' ' LYS . 69.6 m -64.87 107.86 1.6 Allowed 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 118.392 0.542 . . . . 1.56 110.136 -178.736 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 168' ' ' ALA . . . . . 0.459 ' HB3' ' SG ' ' B' ' 128' ' ' CYS . . . -89.32 -19.37 25.37 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 122.056 0.931 . . . . 1.04 108.626 178.242 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 169' ' ' ALA . . . . . 1.015 ' HB1' ' HA2' ' B' ' 133' ' ' GLY . . . -159.88 160.94 34.22 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 113.55 -1.659 . . . . 0.98 111.037 -176.835 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 170' ' ' ALA . . . . . 0.616 ' HA ' ' O ' ' B' ' 185' ' ' CYS . . . -57.91 118.09 4.99 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 113.556 0.947 . . . . 1.25 113.556 -178.326 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 171' ' ' GLY . . . . . 0.657 ' HA2' ' O ' ' B' ' 182' ' ' ASP . . . 71.81 18.79 77.72 Favored Glycine 0 CA--C 1.521 0.441 0 CA-C-N 115.689 -0.687 . . . . 1.29 114.609 177.633 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 172' ' ' ILE . . . . . 0.98 HD13 ' HB2' ' B' ' 134' ' ' CYS . 1.7 pp -142.32 102.07 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-O 122.458 1.123 . . . . 2.27 111.252 -178.858 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 173' ' ' CYS . . . . . 0.623 ' HB2' ' HB3' ' B' ' 182' ' ' ASP . 0.0 OUTLIER -85.7 92.12 8.49 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 114.126 -1.397 . . . . 1.94 110.669 -178.38 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 174' ' ' CYS . . . . . 0.646 ' HA ' ' HA ' ' B' ' 179' ' ' CYS . 81.4 m -97.51 153.52 18.1 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.655 0.741 . . . . 1.35 112.478 -178.877 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 175' ' ' SER . . . . . 0.906 ' HB2' ' HD2' ' B' ' 176' ' ' PRO . 35.1 p -130.02 -178.92 0.89 Allowed Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 114.494 -1.23 . . . . 2.0 108.916 179.516 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 176' ' ' PRO . . . . . 0.906 ' HD2' ' HB2' ' B' ' 175' ' ' SER . 72.1 Cg_endo -78.15 26.94 0.49 Allowed 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 121.339 1.359 . . . . 1.9 111.727 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 177' ' ' ASP . . . . . 0.409 ' H ' ' C ' ' B' ' 175' ' ' SER . 3.0 p30 -146.07 -39.98 0.22 Allowed 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.772 -0.649 . . . . 2.72 111.357 179.374 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 178' ' ' GLY . . . . . 0.407 ' HA3' ' O ' ' A' ' 79' ' ' CYS . . . -157.12 -155.03 7.29 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 120.588 -0.815 . . . . 0.99 113.51 -179.728 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 179' ' ' CYS . . . . . 0.646 ' HA ' ' HA ' ' B' ' 174' ' ' CYS . 99.8 m -140.19 156.15 46.63 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 110.054 -0.35 . . . . 1.34 110.054 179.678 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 180' ' ' HIS . . . . . 0.449 ' O ' ' HB2' ' B' ' 173' ' ' CYS . 33.6 t-80 -150.27 124.13 9.26 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-O 121.387 0.613 . . . . 2.1 110.427 -173.827 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 181' ' ' GLU . . . . . 0.526 ' OE2' ' HD2' ' A' ' 24' ' ' PRO . 18.5 mt-10 -51.21 129.89 25.37 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 115.105 -0.952 . . . . 3.06 111.98 -175.892 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 182' ' ' ASP . . . . . 0.657 ' O ' ' HA2' ' B' ' 171' ' ' GLY . 0.1 OUTLIER -141.83 118.28 7.23 Favored Pre-proline 0 CA--C 1.546 0.807 0 CA-C-N 115.333 -0.849 . . . . 2.06 110.371 -179.066 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 183' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' B' ' 182' ' ' ASP . 3.8 Cg_exo -81.84 -18.81 7.59 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 122.813 2.342 . . . . 1.91 113.671 -178.524 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -63.59 -39.81 95.34 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.781 0.324 . . . . 1.56 111.684 -179.316 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 185' ' ' CYS . . . . . 0.616 ' O ' ' HA ' ' B' ' 170' ' ' ALA . 68.8 m -99.85 14.76 29.27 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 116.311 -0.404 . . . . 1.94 112.052 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 186' ' ' ASP . . . . . 0.448 ' HA ' ' CA ' ' B' ' 171' ' ' GLY . 0.8 OUTLIER . . . . . 0 C--N 1.322 -0.608 0 C-N-CA 121.015 -0.274 . . . . 3.61 111.71 -178.099 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.7 m . . . . . 0 CA--C 1.536 0.42 0 N-CA-C 111.646 0.239 . . . . 2.68 111.646 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.809 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 4.4 mm? -32.71 114.43 0.4 Allowed Pre-proline 0 N--CA 1.475 0.799 0 N-CA-C 112.067 0.395 . . . . 2.48 112.067 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.729 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 95.7 Cg_endo -88.89 114.45 0.7 Allowed 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.626 2.217 . . . . 1.49 114.408 -178.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.666 ' O ' ' HA2' ' A' ' 17' ' ' GLY . 13.6 p -116.86 -155.31 0.58 Allowed 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 121.586 0.708 . . . . 1.0 110.582 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.417 ' O ' ' N ' ' A' ' 16' ' ' GLY . . . 79.21 -166.46 51.48 Favored Glycine 0 CA--C 1.497 -1.063 0 CA-C-O 119.284 -0.731 . . . . 1.15 111.892 179.182 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.551 ' CG ' HD11 ' A' ' 32' ' ' LEU . 84.8 Cg_endo -64.4 83.81 0.16 Allowed 'Trans proline' 0 N--CA 1.458 -0.561 0 CA-C-N 119.712 1.756 . . . . 1.57 113.374 -178.071 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 14' ' ' GLY . . . 87.99 8.21 72.8 Favored Glycine 0 C--N 1.29 -1.979 0 CA-C-N 111.927 -2.397 . . . . 1.68 115.2 -178.313 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.666 ' HA2' ' O ' ' A' ' 13' ' ' CYS . . . 91.17 42.77 4.86 Favored Glycine 0 N--CA 1.435 -1.369 0 N-CA-C 118.089 1.995 . . . . 1.36 118.089 172.777 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.61 -15.85 26.35 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 114.372 -0.914 . . . . 2.5 113.184 177.607 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.729 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -121.31 -179.67 16.12 Favored Glycine 0 N--CA 1.469 0.879 0 CA-C-O 117.707 -1.607 . . . . 1.02 109.084 -179.026 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.809 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 4.2 mpt_? -106.33 173.05 6.48 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 121.804 2.802 . . . . 2.92 110.476 178.218 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.474 ' HB3' ' HG3' ' A' ' 47' ' ' GLU . 0.5 OUTLIER -107.66 135.63 48.78 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 110.372 -0.233 . . . . 1.1 110.372 179.523 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.6 ' HE1' ' HB2' ' A' ' 28' ' ' CYS . 96.0 m-85 -111.51 -68.96 0.9 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.837 0.351 . . . . 1.51 110.574 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -106.63 -153.12 19.72 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 111.133 -0.787 . . . . 0.9 111.133 178.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -88.5 -51.25 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 122.444 2.096 . . . . 1.5 112.1 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.648 ' O ' ' N ' ' A' ' 37' ' ' GLY . 1.2 m -98.84 29.64 3.69 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-N 116.434 -0.348 . . . . 1.26 110.467 179.504 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.987 HG12 HG13 ' A' ' 36' ' ' VAL . 6.9 mt -138.69 116.0 11.57 Favored 'Isoleucine or valine' 0 C--O 1.243 0.717 0 CA-C-O 121.528 0.68 . . . . 0.83 112.771 -178.732 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.765 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 0.6 OUTLIER -130.76 125.4 33.7 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 114.973 -1.012 . . . . 0.92 110.274 178.626 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.994 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 94.8 m -117.2 161.94 18.66 Favored 'General case' 0 CA--C 1.55 0.972 0 CA-C-N 115.145 -0.934 . . . . 1.28 113.432 -178.293 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.734 ' O ' ' HB1' ' A' ' 69' ' ' ALA . . . -145.48 176.38 24.52 Favored Glycine 0 C--N 1.358 1.801 0 CA-C-N 112.955 -1.929 . . . . 0.67 108.597 176.65 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -65.78 -53.27 42.62 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 122.367 1.08 . . . . 2.27 110.601 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -120.41 19.1 12.1 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 113.067 -1.878 . . . . 1.66 108.214 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.613 HD22 ' CZ ' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -111.97 -12.6 13.72 Favored 'General case' 0 N--CA 1.405 -2.69 0 CA-C-N 114.229 -1.35 . . . . 1.37 108.033 179.988 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.994 ' O ' ' HA ' ' A' ' 28' ' ' CYS . . . 55.95 -127.67 43.53 Favored Glycine 0 N--CA 1.419 -2.5 0 CA-C-N 114.419 -1.264 . . . . 0.73 112.107 177.399 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.889 ' HB2' HD13 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -143.91 121.36 11.7 Favored 'General case' 0 CA--C 1.493 -1.238 0 N-CA-C 114.527 1.306 . . . . 1.08 114.527 179.68 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.75 ' HA ' ' HA ' ' B' ' 135' ' ' PHE . 0.0 OUTLIER -85.94 105.79 16.66 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 102.605 -3.109 . . . . 1.38 102.605 173.861 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.987 HG13 HG12 ' A' ' 26' ' ' ILE . 2.6 t -92.8 85.53 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.702 0 C-N-CA 118.436 -1.306 . . . . 0.76 108.714 -178.5 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.655 ' HA3' ' CG2' ' B' ' 172' ' ' ILE . . . 96.55 76.97 1.33 Allowed Glycine 0 CA--C 1.527 0.786 0 CA-C-N 112.464 -2.153 . . . . 0.81 114.071 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.603 HG22 ' O ' ' B' ' 132' ' ' LEU . 47.1 p -155.36 176.67 12.28 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 108.482 -0.933 . . . . 0.77 108.482 178.707 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 1.1 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -68.9 -13.67 62.57 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-N 119.495 1.043 . . . . 1.02 109.942 178.663 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.432 ' HG2' ' CE2' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -64.09 -18.55 64.51 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.368 -0.975 . . . . 2.32 108.368 177.903 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.954 ' O ' ' HB2' ' A' ' 44' ' ' CYS . . . -112.14 -12.13 13.69 Favored 'General case' 0 C--O 1.217 -0.631 0 CA-C-N 115.192 -0.913 . . . . 0.87 113.034 -179.276 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 1.1 HD12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -54.32 -19.28 5.14 Favored 'General case' 0 C--N 1.323 -0.545 0 O-C-N 120.966 -1.084 . . . . 1.23 113.29 -177.497 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.769 ' N ' HD13 ' A' ' 42' ' ' LEU . 9.2 ptm85 -79.65 -14.68 58.62 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 106.56 -1.645 . . . . 2.92 106.56 174.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.954 ' HB2' ' O ' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -58.18 -22.65 52.46 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 111.393 -2.639 . . . . 1.57 108.984 -178.383 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.76 -20.25 5.34 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.641 0.608 . . . . 3.31 112.641 179.046 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -85.83 6.75 26.71 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.102 -0.639 . . . . 3.69 110.729 -179.037 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.474 ' HG3' ' HB3' ' A' ' 21' ' ' CYS . 3.3 mm-40 . . . . . 0 N--CA 1.445 -0.681 0 N-CA-C 109.334 -0.617 . . . . 3.99 109.334 177.473 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.471 0.605 0 N-CA-C 112.047 0.388 . . . . 3.12 112.047 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.561 ' O ' ' HG3' ' A' ' 66' ' ' ARG . . . 168.32 89.9 0.08 OUTLIER Glycine 0 N--CA 1.434 -1.464 0 N-CA-C 108.053 -2.019 . . . . 2.1 108.053 -179.477 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -110.61 77.79 1.07 Allowed 'General case' 0 CA--C 1.497 -1.081 0 CA-C-O 122.465 1.126 . . . . 4.36 109.221 -178.658 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.9 ' HB2' ' HB2' ' A' ' 67' ' ' CYS . 7.7 mptt -140.77 53.06 3.53 Favored Pre-proline 0 C--N 1.293 -1.85 0 CA-C-N 113.279 -1.782 . . . . 3.55 107.391 179.012 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.552 ' CD ' ' N ' ' A' ' 59' ' ' LYS . 11.1 Cg_endo -54.6 97.32 0.05 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.202 0 C-N-CA 122.576 2.184 . . . . 1.54 113.496 -179.666 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.639 ' N ' ' O ' ' A' ' 65' ' ' GLY . 1.0 OUTLIER -96.91 -166.6 1.42 Allowed 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 111.947 -2.388 . . . . 1.59 107.189 177.56 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' A' ' 61' ' ' CYS . . . 36.91 -164.81 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 119.789 -1.196 . . . . 2.43 115.623 172.812 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -84.75 47.64 1.41 Allowed 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 113.1 -1.55 . . . . 4.11 111.405 -178.056 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 120.62 9.9 7.42 Favored Glycine 0 C--N 1.349 1.287 0 CA-C-N 114.77 -1.105 . . . . 2.21 115.22 178.04 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.639 ' O ' ' N ' ' A' ' 61' ' ' CYS . . . -105.2 132.62 11.19 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 119.551 -1.309 . . . . 1.62 115.402 -178.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.561 ' HG3' ' O ' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -101.71 154.24 19.06 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 109.38 -0.6 . . . . 3.02 109.38 177.046 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.9 ' HB2' ' HB2' ' A' ' 59' ' ' LYS . 0.5 OUTLIER -59.33 115.24 3.1 Favored 'General case' 0 CA--C 1.496 -1.128 0 N-CA-C 109.183 -0.673 . . . . 1.52 109.183 -179.696 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.404 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . . . -90.72 -19.21 23.82 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 107.785 -1.191 . . . . 1.07 107.785 178.089 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.734 ' HB1' ' O ' ' A' ' 29' ' ' GLY . . . -165.1 162.93 20.51 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 109.471 -0.566 . . . . 1.0 109.471 -177.51 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.738 ' HA ' ' HB3' ' A' ' 85' ' ' CYS . . . -50.43 132.81 25.03 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 112.927 0.714 . . . . 1.24 112.927 -179.49 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.598 ' H ' ' CB ' ' A' ' 85' ' ' CYS . . . 65.67 -25.6 0.14 Allowed Glycine 0 CA--C 1.526 0.77 0 CA-C-N 115.347 -0.842 . . . . 1.28 115.183 178.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.889 HD13 ' HB2' ' A' ' 34' ' ' CYS . 1.0 OUTLIER -102.37 122.56 54.82 Favored 'Isoleucine or valine' 0 C--O 1.243 0.72 0 CA-C-O 122.148 0.975 . . . . 2.27 111.614 -179.493 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.662 ' HB2' ' HB3' ' A' ' 82' ' ' ASP . 43.8 t -105.27 111.01 23.59 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.372 -0.831 . . . . 1.98 111.178 -179.516 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.529 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 0.8 OUTLIER -110.99 143.52 41.54 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.731 0.776 . . . . 1.33 112.559 -179.129 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.677 ' HB2' ' HD2' ' A' ' 76' ' ' PRO . 84.0 p -112.16 178.57 0.95 Allowed Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 114.447 -1.251 . . . . 1.99 108.76 179.482 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.677 ' HD2' ' HB2' ' A' ' 75' ' ' SER . 86.8 Cg_endo -80.54 22.95 0.73 Allowed 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 121.362 1.375 . . . . 1.86 111.649 179.31 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -145.3 -36.93 0.28 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.835 -0.62 . . . . 2.65 110.52 179.693 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.771 ' HA3' ' O ' ' B' ' 179' ' ' CYS . . . -155.57 -144.0 3.81 Favored Glycine 0 C--N 1.337 0.616 0 C-N-CA 120.47 -0.871 . . . . 0.99 113.385 179.513 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.659 ' O ' ' HA3' ' B' ' 178' ' ' GLY . 0.1 OUTLIER -151.5 157.97 43.0 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.987 0.422 . . . . 1.34 111.22 -179.614 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.459 ' O ' ' HB3' ' A' ' 73' ' ' CYS . 97.2 m-70 -147.14 148.32 31.44 Favored 'General case' 0 N--CA 1.461 0.089 0 O-C-N 122.162 -0.336 . . . . 2.17 110.26 179.358 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -64.5 133.99 53.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.547 -0.297 . . . . 3.05 110.496 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.662 ' HB3' ' HB2' ' A' ' 73' ' ' CYS . 0.0 OUTLIER -145.02 117.56 5.36 Favored Pre-proline 0 CA--C 1.538 0.489 0 CA-C-N 116.531 -0.304 . . . . 2.02 110.684 179.864 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -83.96 -9.29 9.79 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 123.024 2.483 . . . . 1.93 113.575 -178.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.76 -22.31 66.04 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.11 0.411 . . . . 1.53 112.11 -179.258 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.738 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 52.2 m -101.09 20.36 15.75 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 113.515 0.931 . . . . 1.88 113.515 -178.009 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 CA--C 1.518 -0.275 0 C-N-CA 122.911 0.484 . . . . 3.6 111.525 178.578 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 110' ' ' CYS . . . . . . . . . . . . . 1.7 m . . . . . 0 N--CA 1.446 -0.659 0 N-CA-C 110.251 -0.278 . . . . 2.61 110.251 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 111' ' ' LEU . . . . . 0.821 ' O ' ' HA ' ' B' ' 120' ' ' ARG . 4.3 mm? -35.39 114.19 0.52 Allowed Pre-proline 0 N--CA 1.47 0.552 0 C-N-CA 122.655 0.382 . . . . 2.47 111.843 178.631 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 112' ' ' PRO . . . . . 0.782 ' HA ' ' O ' ' B' ' 119' ' ' GLY . 92.2 Cg_endo -88.13 114.98 0.89 Allowed 'Trans proline' 0 CA--C 1.531 0.368 0 C-N-CA 122.394 2.063 . . . . 1.47 113.931 -179.215 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.618 ' O ' ' HA2' ' B' ' 117' ' ' GLY . 13.8 p -117.2 -153.94 0.54 Allowed 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.642 0.734 . . . . 1.0 110.692 178.672 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 114' ' ' GLY . . . . . 0.414 ' O ' ' N ' ' B' ' 116' ' ' GLY . . . 78.6 -166.67 52.42 Favored Glycine 0 CA--C 1.5 -0.886 0 CA-C-N 115.601 -0.727 . . . . 1.16 111.864 179.389 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 115' ' ' PRO . . . . . 0.554 ' CG ' HD11 ' B' ' 132' ' ' LEU . 87.1 Cg_endo -64.66 82.58 0.17 Allowed 'Trans proline' 0 N--CA 1.454 -0.848 0 CA-C-N 119.503 1.652 . . . . 1.57 114.37 -177.828 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 116' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' B' ' 114' ' ' GLY . . . 89.44 6.86 70.2 Favored Glycine 0 C--N 1.29 -2.01 0 CA-C-N 111.727 -2.488 . . . . 1.7 115.638 -177.028 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 117' ' ' GLY . . . . . 0.618 ' HA2' ' O ' ' B' ' 113' ' ' CYS . . . 93.48 41.87 4.38 Favored Glycine 0 N--CA 1.436 -1.335 0 N-CA-C 117.794 1.877 . . . . 1.38 117.794 173.369 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.92 -15.56 26.18 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 113.18 0.807 . . . . 2.54 113.18 177.663 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 119' ' ' GLY . . . . . 0.782 ' O ' ' HA ' ' B' ' 112' ' ' PRO . . . -122.19 -170.66 13.77 Favored Glycine 0 C--N 1.347 1.161 0 N-CA-C 108.472 -1.851 . . . . 1.04 108.472 178.706 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.821 ' HA ' ' O ' ' B' ' 111' ' ' LEU . 4.1 mpt_? -110.94 172.85 6.63 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 121.307 2.554 . . . . 2.89 110.667 178.537 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 121' ' ' CYS . . . . . 0.484 ' HB3' ' HG3' ' B' ' 147' ' ' GLU . 0.5 OUTLIER -107.8 135.5 49.1 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 110.257 -0.275 . . . . 1.07 110.257 179.662 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 122' ' ' PHE . . . . . 0.611 ' HE1' ' HB2' ' B' ' 128' ' ' CYS . 96.0 m-85 -111.46 -68.94 0.9 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.873 0.368 . . . . 1.53 110.561 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -106.89 -153.22 19.42 Favored Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 111.062 -0.815 . . . . 0.9 111.062 178.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -88.32 -51.24 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 122.38 2.053 . . . . 1.51 112.161 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 125' ' ' SER . . . . . 0.648 ' O ' ' N ' ' B' ' 137' ' ' GLY . 1.4 m -98.64 29.55 3.66 Favored 'General case' 0 C--O 1.223 -0.308 0 CA-C-N 116.478 -0.328 . . . . 1.25 110.376 179.393 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 126' ' ' ILE . . . . . 0.957 HG12 HG13 ' B' ' 136' ' ' VAL . 8.1 mt -138.14 115.63 12.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.645 0 N-CA-C 113.122 0.786 . . . . 0.85 113.122 -178.754 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 127' ' ' CYS . . . . . 0.787 ' O ' ' HA ' ' B' ' 134' ' ' CYS . 0.5 OUTLIER -130.72 125.33 33.6 Favored 'General case' 0 C--O 1.225 -0.224 0 CA-C-N 115.122 -0.945 . . . . 0.89 110.232 178.689 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 128' ' ' CYS . . . . . 1.016 ' HA ' ' O ' ' B' ' 133' ' ' GLY . 98.6 m -117.09 162.49 17.73 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.19 -0.914 . . . . 1.23 113.387 -178.117 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 129' ' ' GLY . . . . . 0.742 ' O ' ' HB1' ' B' ' 169' ' ' ALA . . . -145.68 176.44 24.67 Favored Glycine 0 C--N 1.358 1.789 0 N-CA-C 108.622 -1.791 . . . . 0.66 108.622 176.364 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -66.56 -53.21 37.13 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 121.966 0.889 . . . . 2.35 110.239 179.69 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 131' ' ' GLU . . . . . 0.402 ' H ' ' HG2' ' B' ' 131' ' ' GLU . 1.2 pt-20 -122.83 30.53 6.39 Favored 'General case' 0 N--CA 1.424 -1.766 0 CA-C-N 113.676 -1.602 . . . . 1.69 108.06 177.58 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 132' ' ' LEU . . . . . 0.62 HD22 ' CZ ' ' B' ' 135' ' ' PHE . 0.8 OUTLIER -122.24 -11.26 8.42 Favored 'General case' 0 N--CA 1.406 -2.636 0 N-CA-C 106.136 -1.801 . . . . 1.38 106.136 -178.839 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 133' ' ' GLY . . . . . 1.016 ' O ' ' HA ' ' B' ' 128' ' ' CYS . . . 54.51 -126.17 36.5 Favored Glycine 0 N--CA 1.408 -3.169 0 CA-C-N 113.876 -1.511 . . . . 0.72 112.351 175.926 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 134' ' ' CYS . . . . . 0.897 ' HB2' HD13 ' B' ' 172' ' ' ILE . 0.1 OUTLIER -145.06 120.63 10.41 Favored 'General case' 0 CA--C 1.491 -1.296 0 N-CA-C 115.032 1.493 . . . . 1.08 115.032 -179.841 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 135' ' ' PHE . . . . . 0.75 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -85.3 106.12 16.47 Favored 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 102.72 -3.067 . . . . 1.36 102.72 174.507 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 136' ' ' VAL . . . . . 0.957 HG13 HG12 ' B' ' 126' ' ' ILE . 3.4 t -92.63 85.63 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.601 0 CA-C-O 122.85 1.31 . . . . 0.75 108.513 -178.284 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 137' ' ' GLY . . . . . 0.648 ' N ' ' O ' ' B' ' 125' ' ' SER . . . 96.12 76.5 1.31 Allowed Glycine 0 CA--C 1.526 0.73 0 CA-C-N 112.5 -2.136 . . . . 0.83 114.222 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 138' ' ' THR . . . . . 0.513 HG22 ' O ' ' A' ' 32' ' ' LEU . 49.8 p -155.19 176.31 12.72 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 108.414 -0.958 . . . . 0.78 108.414 178.781 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 139' ' ' ALA . . . . . 1.103 ' O ' HD12 ' B' ' 142' ' ' LEU . . . -68.64 -12.79 61.81 Favored 'General case' 0 C--O 1.22 -0.487 0 CA-C-N 119.235 0.925 . . . . 1.04 110.133 178.78 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 140' ' ' GLU . . . . . 0.427 ' HG2' ' HD3' ' B' ' 115' ' ' PRO . 0.9 OUTLIER -65.63 -17.45 64.6 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.483 -0.932 . . . . 2.31 108.483 177.569 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 141' ' ' ALA . . . . . 0.938 ' O ' ' HB2' ' B' ' 144' ' ' CYS . . . -112.62 -12.65 13.39 Favored 'General case' 0 C--O 1.216 -0.688 0 CA-C-N 114.98 -1.009 . . . . 0.87 113.033 -179.46 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 142' ' ' LEU . . . . . 1.103 HD12 ' O ' ' B' ' 139' ' ' ALA . 0.0 OUTLIER -54.24 -19.23 4.9 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 121.097 -1.002 . . . . 1.24 113.222 -177.236 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 143' ' ' ARG . . . . . 0.772 ' N ' HD13 ' B' ' 142' ' ' LEU . 9.3 ptm85 -80.76 -12.58 59.43 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 106.774 -1.565 . . . . 2.93 106.774 174.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 144' ' ' CYS . . . . . 0.938 ' HB2' ' O ' ' B' ' 141' ' ' ALA . 0.1 OUTLIER -58.76 -24.84 62.36 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 111.786 -2.461 . . . . 1.61 108.948 -179.488 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.84 -20.56 2.29 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 112.672 0.619 . . . . 3.35 112.672 179.495 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -85.85 6.79 26.63 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.128 -0.629 . . . . 3.76 110.754 -179.086 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 147' ' ' GLU . . . . . 0.484 ' HG3' ' HB3' ' B' ' 121' ' ' CYS . 3.3 mm-40 . . . . . 0 N--CA 1.446 -0.67 0 N-CA-C 109.401 -0.592 . . . . 4.01 109.401 177.406 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.472 0.651 0 CA-C-O 120.938 0.399 . . . . 3.11 111.5 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 157' ' ' GLY . . . . . 0.539 ' O ' ' HG3' ' B' ' 166' ' ' ARG . . . 165.14 91.05 0.08 OUTLIER Glycine 0 N--CA 1.44 -1.085 0 N-CA-C 108.847 -1.701 . . . . 2.07 108.847 179.608 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -112.34 65.61 0.64 Allowed 'General case' 0 CA--C 1.501 -0.909 0 CA-C-O 122.762 1.268 . . . . 4.34 110.402 -179.246 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 159' ' ' LYS . . . . . 0.963 ' HB2' ' HB2' ' B' ' 167' ' ' CYS . 7.3 mptt -113.34 47.66 0.37 Allowed Pre-proline 0 C--N 1.302 -1.499 0 CA-C-N 112.542 -2.117 . . . . 3.54 111.534 173.303 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 160' ' ' PRO . . . . . 0.451 ' HA ' ' HA ' ' B' ' 166' ' ' ARG . 10.0 Cg_endo -53.76 97.52 0.05 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.402 0 CA-C-N 121.3 1.5 . . . . 1.51 114.698 -174.612 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 161' ' ' CYS . . . . . 0.625 ' N ' ' O ' ' B' ' 165' ' ' GLY . 0.9 OUTLIER -96.9 -166.69 1.44 Allowed 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 112.397 -2.183 . . . . 1.58 107.406 177.626 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 162' ' ' GLY . . . . . 0.41 ' N ' ' SG ' ' B' ' 161' ' ' CYS . . . 37.08 -164.77 0.01 OUTLIER Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 115.746 1.059 . . . . 2.37 115.746 172.848 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -84.54 47.31 1.34 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 113.177 -1.511 . . . . 4.07 111.465 -178.093 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 120.4 9.82 7.62 Favored Glycine 0 CA--C 1.539 1.549 0 CA-C-N 115.043 -0.981 . . . . 2.2 115.179 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 165' ' ' GLY . . . . . 0.625 ' O ' ' N ' ' B' ' 161' ' ' CYS . . . -104.82 133.38 11.52 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 118.921 -1.609 . . . . 1.62 115.16 -179.55 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 166' ' ' ARG . . . . . 0.539 ' HG3' ' O ' ' B' ' 157' ' ' GLY . 0.0 OUTLIER -102.17 154.19 19.25 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 109.313 -0.625 . . . . 3.05 109.313 176.661 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 167' ' ' CYS . . . . . 0.963 ' HB2' ' HB2' ' B' ' 159' ' ' LYS . 0.5 OUTLIER -59.2 115.54 3.27 Favored 'General case' 0 CA--C 1.499 -0.982 0 N-CA-C 109.214 -0.661 . . . . 1.56 109.214 -179.571 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 168' ' ' ALA . . . . . 0.43 ' HB3' ' SG ' ' B' ' 128' ' ' CYS . . . -89.8 -20.75 23.12 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 107.774 -1.195 . . . . 1.04 107.774 177.882 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 169' ' ' ALA . . . . . 0.742 ' HB1' ' O ' ' B' ' 129' ' ' GLY . . . -164.38 162.71 22.33 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.375 -0.83 . . . . 0.98 110.682 -177.016 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 170' ' ' ALA . . . . . 0.749 ' HA ' ' HB3' ' B' ' 185' ' ' CYS . . . -49.99 133.0 23.11 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 112.711 0.634 . . . . 1.25 112.711 -179.273 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 171' ' ' GLY . . . . . 0.576 ' H ' ' CB ' ' B' ' 185' ' ' CYS . . . 67.65 -30.74 0.22 Allowed Glycine 0 CA--C 1.527 0.809 0 CA-C-N 115.614 -0.721 . . . . 1.29 114.693 178.881 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 172' ' ' ILE . . . . . 0.897 HD13 ' HB2' ' B' ' 134' ' ' CYS . 1.0 OUTLIER -99.5 122.78 51.71 Favored 'Isoleucine or valine' 0 C--O 1.242 0.71 0 CA-C-O 122.322 1.058 . . . . 2.27 111.931 -178.138 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 173' ' ' CYS . . . . . 0.656 ' HB2' ' HB3' ' B' ' 182' ' ' ASP . 44.1 t -105.36 110.96 23.51 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.201 -0.909 . . . . 1.94 111.19 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 174' ' ' CYS . . . . . 0.534 ' HA ' ' HA ' ' B' ' 179' ' ' CYS . 0.8 OUTLIER -110.83 143.51 41.29 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.586 0.707 . . . . 1.35 112.603 -179.097 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 175' ' ' SER . . . . . 0.687 ' HB2' ' HD2' ' B' ' 176' ' ' PRO . 83.9 p -112.17 178.53 0.96 Allowed Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 114.542 -1.208 . . . . 2.0 108.778 179.365 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 176' ' ' PRO . . . . . 0.687 ' HD2' ' HB2' ' B' ' 175' ' ' SER . 89.0 Cg_endo -80.53 23.1 0.72 Allowed 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 121.315 1.343 . . . . 1.9 111.663 179.328 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 177' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -145.38 -36.29 0.29 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.812 -0.631 . . . . 2.72 110.711 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 178' ' ' GLY . . . . . 0.659 ' HA3' ' O ' ' A' ' 79' ' ' CYS . . . -156.41 -144.18 3.86 Favored Glycine 0 C--N 1.337 0.587 0 C-N-CA 120.671 -0.776 . . . . 0.99 113.325 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 179' ' ' CYS . . . . . 0.771 ' O ' ' HA3' ' A' ' 78' ' ' GLY . 0.1 OUTLIER -151.51 157.98 43.0 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 120.895 0.378 . . . . 1.34 111.346 -179.489 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 180' ' ' HIS . . . . . 0.459 ' O ' ' HB3' ' B' ' 173' ' ' CYS . 97.1 m-70 -147.05 148.36 31.57 Favored 'General case' 0 N--CA 1.46 0.069 0 O-C-N 122.199 -0.313 . . . . 2.1 110.277 179.316 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 181' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -64.5 133.93 53.42 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.645 -0.252 . . . . 3.06 110.486 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 182' ' ' ASP . . . . . 0.656 ' HB3' ' HB2' ' B' ' 173' ' ' CYS . 0.0 OUTLIER -144.99 117.52 5.37 Favored Pre-proline 0 CA--C 1.538 0.496 0 CA-C-N 116.521 -0.309 . . . . 2.06 110.673 179.864 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 183' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' B' ' 182' ' ' ASP . 1.2 Cg_endo -83.97 -9.14 9.85 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 123.039 2.493 . . . . 1.91 113.557 -178.863 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -66.75 -22.49 66.04 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.05 0.389 . . . . 1.56 112.05 -179.344 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 185' ' ' CYS . . . . . 0.749 ' HB3' ' HA ' ' B' ' 170' ' ' ALA . 54.1 m -100.94 20.32 15.68 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 113.622 0.971 . . . . 1.94 113.622 -178.024 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 186' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 CA--C 1.518 -0.271 0 C-N-CA 122.858 0.463 . . . . 3.61 111.52 178.577 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.779 ' HB3' ' HB3' ' A' ' 20' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.225 -0.223 0 CA-C-O 120.707 0.289 . . . . 2.68 111.347 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.463 ' C ' ' O ' ' A' ' 10' ' ' CYS . 5.6 tp -29.05 129.9 0.22 Allowed Pre-proline 0 N--CA 1.468 0.45 0 CA-C-O 121.031 0.443 . . . . 2.48 111.948 -179.396 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.871 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 54.5 Cg_endo -70.14 152.28 67.3 Favored 'Trans proline' 0 N--CA 1.475 0.39 0 C-N-CA 123.377 2.718 . . . . 1.49 114.608 -179.128 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.623 ' SG ' ' N ' ' A' ' 14' ' ' GLY . 0.0 OUTLIER -160.97 -170.22 2.64 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 119.422 -0.911 . . . . 1.0 110.946 176.969 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.856 ' HA2' ' HB3' ' A' ' 40' ' ' GLU . . . 77.61 -159.72 48.4 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 115.47 0.948 . . . . 1.15 115.47 178.393 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.597 ' CG ' HD21 ' A' ' 32' ' ' LEU . 74.4 Cg_endo -61.37 104.16 0.29 Allowed 'Trans proline' 0 N--CA 1.487 1.127 0 C-N-CA 124.749 3.633 . . . . 1.57 111.021 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.64 -10.92 60.66 Favored Glycine 0 C--N 1.28 -2.566 0 CA-C-N 113.119 -1.855 . . . . 1.68 111.219 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.518 ' O ' ' HB2' ' A' ' 12' ' ' PRO . . . 76.49 37.36 35.85 Favored Glycine 0 N--CA 1.411 -3.005 0 C-N-CA 119.336 -1.411 . . . . 1.36 111.153 -179.627 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.539 ' HB2' HD12 ' A' ' 32' ' ' LEU . 0.5 OUTLIER -88.09 -37.47 16.21 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 112.973 -1.614 . . . . 2.5 112.29 179.196 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.871 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -89.56 -172.79 45.63 Favored Glycine 0 N--CA 1.423 -2.198 0 CA-C-N 122.055 2.207 . . . . 1.02 110.966 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.779 ' HB3' ' HB3' ' A' ' 10' ' ' CYS . 0.4 OUTLIER -113.14 172.14 7.12 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 124.395 0.703 . . . . 2.92 112.777 -179.407 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.7 m -106.85 145.55 32.01 Favored 'General case' 0 N--CA 1.475 0.809 0 O-C-N 121.826 -0.546 . . . . 1.1 110.455 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.414 ' CZ ' ' O ' ' A' ' 68' ' ' ALA . 76.3 m-85 -142.9 22.39 1.93 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.944 -0.571 . . . . 1.51 111.752 -179.335 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.811 ' O ' ' HB3' ' A' ' 44' ' ' CYS . . . 174.04 -169.45 42.48 Favored Glycine 0 C--O 1.225 -0.444 0 C-N-CA 120.724 -0.751 . . . . 0.9 111.421 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -81.3 -54.18 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.531 2.154 . . . . 1.5 112.333 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.591 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.3 OUTLIER -106.47 12.1 30.0 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.234 -0.439 . . . . 1.26 111.39 -179.963 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.786 HG22 ' SG ' ' A' ' 34' ' ' CYS . 1.2 mt -121.8 122.43 66.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 113.218 0.821 . . . . 0.83 113.218 -177.357 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.682 ' HB3' ' CD2' ' A' ' 35' ' ' PHE . 4.3 t -130.78 116.37 17.88 Favored 'General case' 0 C--O 1.226 -0.155 0 CA-C-O 122.494 1.14 . . . . 0.92 111.48 178.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 1.214 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -121.36 148.48 44.31 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 112.552 -2.113 . . . . 1.28 109.08 -179.546 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.786 ' O ' ' HB1' ' A' ' 69' ' ' ALA . . . -144.01 -167.86 12.09 Favored Glycine 0 CA--C 1.478 -2.223 0 N-CA-C 105.494 -3.042 . . . . 0.67 105.494 174.388 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.462 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 12.3 p-10 -67.18 -69.01 0.34 Allowed 'General case' 0 C--N 1.282 -2.329 0 C-N-CA 118.635 -1.226 . . . . 2.27 112.82 -179.575 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.13 15.1 19.94 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 114.722 -1.127 . . . . 1.66 111.284 -176.523 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.734 HD22 ' CZ ' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -116.48 -17.69 10.59 Favored 'General case' 0 N--CA 1.4 -2.944 0 CA-C-N 114.568 -1.196 . . . . 1.37 108.208 179.945 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 1.214 ' O ' ' HA ' ' A' ' 28' ' ' CYS . . . 63.19 -128.25 39.12 Favored Glycine 0 N--CA 1.405 -3.428 0 CA-C-N 113.963 -1.471 . . . . 0.73 114.285 178.098 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.87 ' HB2' HG13 ' A' ' 72' ' ' ILE . 4.8 t -141.51 120.09 12.47 Favored 'General case' 0 CA--C 1.5 -0.944 0 N-CA-C 115.572 1.693 . . . . 1.08 115.572 -179.667 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 1.026 ' HA ' ' HA ' ' B' ' 135' ' ' PHE . 0.0 OUTLIER -96.34 107.58 19.97 Favored 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 106.501 -1.666 . . . . 1.38 106.501 176.219 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.833 HG23 HG23 ' B' ' 136' ' ' VAL . 1.8 t -94.72 84.0 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.774 0 N-CA-C 108.008 -1.108 . . . . 0.76 108.008 179.387 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 25' ' ' SER . . . 105.27 102.61 2.8 Favored Glycine 0 CA--C 1.524 0.646 0 CA-C-N 113.451 -1.704 . . . . 0.81 114.007 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.615 ' HB ' ' O ' ' B' ' 132' ' ' LEU . 0.2 OUTLIER 178.66 161.95 0.69 Allowed 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 107.992 -1.114 . . . . 0.77 107.992 179.02 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.818 ' HA ' HD12 ' A' ' 42' ' ' LEU . . . -69.28 -28.24 66.12 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 120.595 1.543 . . . . 1.02 112.175 -179.331 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.856 ' HB3' ' HA2' ' A' ' 14' ' ' GLY . 0.5 OUTLIER -62.23 -12.81 22.34 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.154 0.502 . . . . 2.32 110.524 178.125 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.808 ' O ' ' HB2' ' A' ' 44' ' ' CYS . . . -103.49 -19.32 14.44 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.091 -0.959 . . . . 0.87 110.673 178.108 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.818 HD12 ' HA ' ' A' ' 39' ' ' ALA . 0.7 OUTLIER -46.8 -38.06 9.58 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 112.403 0.52 . . . . 1.23 112.403 -179.298 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.555 ' HD2' ' H ' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -57.82 -22.35 47.14 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-O 122.552 1.167 . . . . 2.92 108.771 177.127 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.811 ' HB3' ' O ' ' A' ' 23' ' ' GLY . 28.6 m -58.8 -10.7 2.55 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-N 112.193 -2.276 . . . . 1.57 109.81 178.401 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.444 ' HB2' ' O ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -77.22 -18.98 57.29 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-O 121.126 0.489 . . . . 3.31 111.73 178.981 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -85.83 10.39 13.91 Favored 'General case' 0 CA--C 1.515 -0.369 0 C-N-CA 119.861 -0.736 . . . . 3.69 110.457 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 . . . . . 0 N--CA 1.442 -0.866 0 N-CA-C 108.865 -0.791 . . . . 3.99 108.865 177.158 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.3 t . . . . . 0 N--CA 1.467 0.412 0 CA-C-O 120.822 0.344 . . . . 3.12 110.406 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 162.01 44.69 0.02 OUTLIER Glycine 0 N--CA 1.442 -0.955 0 N-CA-C 108.66 -1.776 . . . . 2.1 108.66 -179.556 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.421 ' O ' ' HG3' ' A' ' 58' ' ' GLN . 15.6 pt20 -118.96 86.05 2.48 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-O 122.489 1.137 . . . . 4.36 108.91 -179.255 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.524 ' HB3' ' HB2' ' A' ' 67' ' ' CYS . 0.0 OUTLIER -137.24 69.09 55.75 Favored Pre-proline 0 C--N 1.294 -1.817 0 N-CA-C 104.419 -2.437 . . . . 3.55 104.419 -178.869 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.435 ' HA ' ' O ' ' A' ' 65' ' ' GLY . 55.7 Cg_endo -71.71 91.56 0.7 Allowed 'Trans proline' 0 N--CA 1.446 -1.296 0 C-N-CA 122.858 2.372 . . . . 1.54 115.055 -176.354 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 3.2 p -104.43 -172.32 2.08 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 113.2 -1.818 . . . . 1.59 107.03 176.681 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 52.21 -166.07 1.14 Allowed Glycine 0 C--N 1.329 0.148 0 C-N-CA 118.52 -1.8 . . . . 2.43 112.258 177.208 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 8.0 t -73.23 66.51 0.89 Allowed 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 120.33 -0.548 . . . . 4.11 110.967 -179.239 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 84.18 8.47 83.68 Favored Glycine 0 N--CA 1.436 -1.309 0 CA-C-O 117.752 -1.582 . . . . 2.21 116.592 178.525 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 1.039 ' HA3' ' HA ' ' A' ' 74' ' ' CYS . . . -100.29 137.33 13.2 Favored Glycine 0 N--CA 1.438 -1.192 0 CA-C-N 122.553 3.177 . . . . 1.62 114.058 -177.857 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.468 ' O ' ' N ' ' A' ' 74' ' ' CYS . 0.0 OUTLIER -99.66 153.03 19.4 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 114.046 -1.077 . . . . 3.02 112.515 -178.4 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.682 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 44.4 t -51.75 108.62 0.29 Allowed 'General case' 0 N--CA 1.428 -1.56 0 CA-C-N 115.764 -0.653 . . . . 1.52 110.918 -179.529 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.414 ' O ' ' CZ ' ' A' ' 22' ' ' PHE . . . -99.55 -33.51 10.62 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.929 -0.767 . . . . 1.07 108.929 178.682 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.786 ' HB1' ' O ' ' A' ' 29' ' ' GLY . . . -159.93 165.32 32.35 Favored 'General case' 0 CA--C 1.495 -1.158 0 C-N-CA 119.428 -0.909 . . . . 1.0 112.432 -178.155 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.798 ' HA ' ' O ' ' A' ' 85' ' ' CYS . . . -37.29 97.4 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.1 -0.955 . . . . 1.24 110.444 -178.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.633 ' HA2' ' O ' ' A' ' 82' ' ' ASP . . . 93.56 -12.58 69.28 Favored Glycine 0 N--CA 1.437 -1.264 0 CA-C-N 114.81 -1.086 . . . . 1.28 114.43 179.293 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.87 HG13 ' HB2' ' A' ' 34' ' ' CYS . 1.7 mm -93.56 124.72 46.1 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.04 0 CA-C-N 119.391 1.596 . . . . 2.27 110.8 -175.865 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.615 ' HB2' ' HB3' ' A' ' 82' ' ' ASP . 20.6 t -120.79 92.45 3.77 Favored 'General case' 0 N--CA 1.426 -1.658 0 CA-C-N 113.89 -1.504 . . . . 1.98 109.274 -179.313 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 1.044 ' CB ' ' HA ' ' A' ' 79' ' ' CYS . 6.0 p -159.9 -175.89 5.38 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 116.105 1.891 . . . . 1.33 116.105 -177.001 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.852 ' HB2' ' HD2' ' A' ' 76' ' ' PRO . 5.8 p -122.61 -179.9 0.88 Allowed Pre-proline 0 N--CA 1.454 -0.253 0 CA-C-N 113.098 -1.865 . . . . 1.99 108.926 -179.668 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.852 ' HD2' ' HB2' ' A' ' 75' ' ' SER . 56.2 Cg_endo -72.45 31.38 0.28 Allowed 'Trans proline' 0 CA--C 1.534 0.523 0 C-N-CA 121.671 1.581 . . . . 1.86 113.292 -179.219 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.445 ' OD1' ' N ' ' A' ' 78' ' ' GLY . 1.1 p30 -134.49 -59.97 0.8 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 120.714 0.292 . . . . 2.65 110.397 178.816 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.932 ' O ' ' HB2' ' A' ' 74' ' ' CYS . . . -124.61 -175.15 14.22 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.507 -0.854 . . . . 0.99 111.74 178.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 1.044 ' HA ' ' CB ' ' A' ' 74' ' ' CYS . 14.1 m -149.44 160.34 43.53 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 117.535 0.668 . . . . 1.34 111.929 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.429 ' HA ' ' HA2' ' B' ' 178' ' ' GLY . 72.5 m80 -149.51 139.8 22.28 Favored 'General case' 0 C--N 1.349 0.585 0 O-C-N 121.714 -0.616 . . . . 2.17 111.879 -178.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -64.72 126.02 26.62 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.921 -0.582 . . . . 3.05 109.725 178.41 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.633 ' O ' ' HA2' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -139.94 107.51 6.91 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-O 120.864 0.364 . . . . 2.02 111.226 -179.213 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_exo -62.78 -24.09 74.52 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.04 2.493 . . . . 1.93 114.333 -178.67 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.36 -10.82 27.01 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.979 0.363 . . . . 1.53 111.979 -179.475 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.798 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 3.8 m -128.18 9.25 6.18 Favored 'General case' 0 C--O 1.215 -0.738 0 CA-C-O 119.053 -0.499 . . . . 1.88 111.321 179.585 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.597 ' O ' ' HB1' ' A' ' 70' ' ' ALA . 0.5 OUTLIER . . . . . 0 C--N 1.322 -0.595 0 C-N-CA 119.113 -1.035 . . . . 3.6 112.692 -176.512 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 110' ' ' CYS . . . . . 0.737 ' HB3' ' HB3' ' B' ' 120' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.226 -0.144 0 N-CA-C 111.883 0.327 . . . . 2.61 111.883 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 111' ' ' LEU . . . . . 0.481 ' C ' ' O ' ' B' ' 110' ' ' CYS . 5.4 tp -26.74 129.49 0.18 Allowed Pre-proline 0 CA--C 1.54 0.558 0 N-CA-C 112.209 0.448 . . . . 2.47 112.209 -179.333 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 112' ' ' PRO . . . . . 0.873 ' HA ' ' O ' ' B' ' 119' ' ' GLY . 30.3 Cg_endo -61.43 158.47 35.96 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 124.672 3.581 . . . . 1.47 112.974 179.579 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.623 ' SG ' ' N ' ' B' ' 114' ' ' GLY . 0.0 OUTLIER -168.83 -171.55 1.39 Allowed 'General case' 0 N--CA 1.497 1.907 0 C-N-CA 118.977 -1.089 . . . . 1.0 111.272 170.939 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 114' ' ' GLY . . . . . 0.885 ' HA2' ' HB3' ' B' ' 140' ' ' GLU . . . 77.35 -159.34 48.55 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 120.289 -0.958 . . . . 1.16 115.249 178.201 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 115' ' ' PRO . . . . . 0.627 ' CG ' HD21 ' B' ' 132' ' ' LEU . 96.4 Cg_endo -62.36 96.15 0.15 Allowed 'Trans proline' 0 C--N 1.355 0.885 0 C-N-CA 124.238 3.292 . . . . 1.57 115.398 -178.658 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 85.76 -0.83 88.1 Favored Glycine 0 C--N 1.285 -2.296 0 CA-C-N 110.573 -3.012 . . . . 1.7 112.197 -177.029 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 117' ' ' GLY . . . . . 0.519 ' O ' ' HB2' ' B' ' 112' ' ' PRO . . . 73.69 35.9 54.35 Favored Glycine 0 N--CA 1.425 -2.035 0 C-N-CA 120.171 -1.014 . . . . 1.38 112.858 176.877 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 118' ' ' LYS . . . . . 0.548 ' HB2' HD12 ' B' ' 132' ' ' LEU . 0.6 OUTLIER -87.55 -33.77 18.81 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 114.207 -0.997 . . . . 2.54 112.052 -179.629 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 119' ' ' GLY . . . . . 0.873 ' O ' ' HA ' ' B' ' 112' ' ' PRO . . . -79.67 -164.58 29.21 Favored Glycine 0 CA--C 1.497 -1.063 0 CA-C-O 118.631 -1.094 . . . . 1.04 111.521 -179.494 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.737 ' HB3' ' HB3' ' B' ' 110' ' ' CYS . 2.3 mtt85 -133.09 172.91 12.01 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 119.736 1.768 . . . . 2.89 106.961 176.438 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 121' ' ' CYS . . . . . . . . . . . . . 2.6 m -106.16 146.77 29.83 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 118.548 0.613 . . . . 1.07 111.532 -178.62 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 122' ' ' PHE . . . . . 0.507 ' HE1' ' O ' ' B' ' 128' ' ' CYS . 75.9 m-85 -142.91 22.14 1.94 Allowed 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.687 -0.688 . . . . 1.53 111.778 -179.533 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 123' ' ' GLY . . . . . 0.851 ' O ' ' HB3' ' B' ' 144' ' ' CYS . . . 174.05 -169.53 42.57 Favored Glycine 0 C--O 1.225 -0.465 0 C-N-CA 120.783 -0.723 . . . . 0.9 111.468 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -81.1 -54.33 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.494 2.129 . . . . 1.51 112.272 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 125' ' ' SER . . . . . 0.605 ' O ' ' N ' ' B' ' 137' ' ' GLY . 0.3 OUTLIER -106.39 12.25 29.97 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.264 -0.425 . . . . 1.25 111.39 -179.878 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 126' ' ' ILE . . . . . 0.814 HG22 ' SG ' ' B' ' 134' ' ' CYS . 1.5 mt -121.73 122.38 66.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 113.088 0.773 . . . . 0.85 113.088 -177.289 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 127' ' ' CYS . . . . . 0.687 ' HB3' ' CD2' ' B' ' 135' ' ' PHE . 4.5 t -131.06 117.66 19.45 Favored 'General case' 0 CA--C 1.522 -0.107 0 CA-C-O 122.542 1.163 . . . . 0.89 111.585 178.86 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 128' ' ' CYS . . . . . 1.104 ' HA ' ' O ' ' B' ' 133' ' ' GLY . 0.0 OUTLIER -130.62 135.93 48.36 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 112.96 -1.927 . . . . 1.23 112.415 -178.559 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 129' ' ' GLY . . . . . 0.798 ' O ' ' HB1' ' B' ' 169' ' ' ALA . . . -130.41 -161.6 10.44 Favored Glycine 0 N--CA 1.42 -2.413 0 N-CA-C 105.119 -3.193 . . . . 0.66 105.119 177.383 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 130' ' ' ASP . . . . . 0.437 ' O ' ' HB3' ' B' ' 170' ' ' ALA . 14.5 p-10 -68.71 -70.99 0.23 Allowed 'General case' 0 C--N 1.289 -2.06 0 C-N-CA 119.199 -1.001 . . . . 2.35 112.69 -178.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.94 32.53 3.15 Favored 'General case' 0 CA--C 1.49 -1.346 0 CA-C-O 122.085 0.945 . . . . 1.69 110.1 -177.232 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 132' ' ' LEU . . . . . 0.739 HD22 ' CZ ' ' B' ' 135' ' ' PHE . 0.8 OUTLIER -127.45 -16.9 4.77 Favored 'General case' 0 N--CA 1.399 -3.01 0 CA-C-N 113.788 -1.551 . . . . 1.38 106.869 177.075 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 133' ' ' GLY . . . . . 1.104 ' O ' ' HA ' ' B' ' 128' ' ' CYS . . . 58.93 -134.55 52.43 Favored Glycine 0 N--CA 1.402 -3.587 0 CA-C-N 114.372 -1.285 . . . . 0.72 112.529 177.839 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 134' ' ' CYS . . . . . 0.845 ' HB2' HG13 ' B' ' 172' ' ' ILE . 5.2 t -135.25 119.79 18.11 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 116.15 1.907 . . . . 1.08 116.15 -176.631 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 135' ' ' PHE . . . . . 1.026 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -94.74 107.58 19.59 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 106.524 -1.658 . . . . 1.36 106.524 176.385 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 136' ' ' VAL . . . . . 0.833 HG23 HG23 ' A' ' 36' ' ' VAL . 2.4 t -94.3 83.56 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.642 0 N-CA-C 107.814 -1.18 . . . . 0.75 107.814 179.595 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 137' ' ' GLY . . . . . 0.605 ' N ' ' O ' ' B' ' 125' ' ' SER . . . 105.5 102.9 2.83 Favored Glycine 0 CA--C 1.523 0.59 0 CA-C-N 113.637 -1.62 . . . . 0.83 113.944 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 138' ' ' THR . . . . . 0.567 ' HB ' ' O ' ' A' ' 32' ' ' LEU . 0.2 OUTLIER -179.96 165.7 1.24 Allowed 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 107.905 -1.146 . . . . 0.78 107.905 179.131 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 139' ' ' ALA . . . . . 0.856 ' HA ' HD12 ' B' ' 142' ' ' LEU . . . -68.98 -36.97 78.47 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 119.075 0.852 . . . . 1.04 110.225 179.349 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 140' ' ' GLU . . . . . 0.885 ' HB3' ' HA2' ' B' ' 114' ' ' GLY . 0.5 OUTLIER -56.87 -13.7 2.85 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.009 -0.541 . . . . 2.31 111.064 179.83 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 141' ' ' ALA . . . . . 0.723 ' O ' ' HB2' ' B' ' 144' ' ' CYS . . . -101.72 -21.81 14.55 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 116.236 -0.438 . . . . 0.87 109.942 178.351 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 142' ' ' LEU . . . . . 0.856 HD12 ' HA ' ' B' ' 139' ' ' ALA . 0.6 OUTLIER -45.04 -38.06 4.61 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.626 0.602 . . . . 1.24 112.626 -178.483 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 143' ' ' ARG . . . . . 0.578 ' HD2' ' H ' ' B' ' 143' ' ' ARG . 0.0 OUTLIER -54.13 -29.46 45.28 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 107.136 -1.431 . . . . 2.93 107.136 177.148 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 144' ' ' CYS . . . . . 0.851 ' HB3' ' O ' ' B' ' 123' ' ' GLY . 39.8 m -57.15 -4.77 0.21 Allowed 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 113.776 -1.556 . . . . 1.61 110.441 -177.86 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 145' ' ' GLN . . . . . 0.43 ' HB2' ' O ' ' B' ' 142' ' ' LEU . 0.0 OUTLIER -79.32 -19.31 50.66 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-O 121.255 0.55 . . . . 3.35 111.208 177.584 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -85.81 10.11 14.66 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 119.998 -0.681 . . . . 3.76 110.436 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 . . . . . 0 N--CA 1.441 -0.876 0 N-CA-C 108.852 -0.795 . . . . 4.01 108.852 177.244 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 1.3 t . . . . . 0 N--CA 1.464 0.275 0 CA-C-O 121.026 0.441 . . . . 3.11 111.205 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 165.12 44.52 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 109.085 -1.606 . . . . 2.07 109.085 -179.001 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -118.74 71.9 0.86 Allowed 'General case' 0 N--CA 1.441 -0.919 0 CA-C-O 122.398 1.094 . . . . 4.34 110.724 -179.525 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 159' ' ' LYS . . . . . 0.579 ' HB3' ' HB2' ' B' ' 167' ' ' CYS . 0.0 OUTLIER -107.81 66.12 0.26 Allowed Pre-proline 0 C--N 1.31 -1.123 0 CA-C-N 113.202 -1.817 . . . . 3.54 108.486 174.33 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 160' ' ' PRO . . . . . 0.404 ' HA ' ' O ' ' B' ' 165' ' ' GLY . 54.0 Cg_endo -71.4 92.26 0.67 Allowed 'Trans proline' 0 N--CA 1.464 -0.25 0 N-CA-C 116.17 1.565 . . . . 1.51 116.17 -174.077 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 161' ' ' CYS . . . . . . . . . . . . . 1.9 p -99.34 -166.91 1.4 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 113.173 -1.831 . . . . 1.58 108.32 176.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 45.35 -165.03 0.06 OUTLIER Glycine 0 CA--C 1.52 0.356 0 C-N-CA 119.135 -1.507 . . . . 2.37 112.181 173.111 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 8.1 t -73.11 66.89 0.87 Allowed 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 117.364 0.582 . . . . 4.07 111.496 -179.429 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 84.46 9.12 82.22 Favored Glycine 0 CA--C 1.541 1.67 0 CA-C-O 117.94 -1.478 . . . . 2.2 116.132 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 165' ' ' GLY . . . . . 0.943 ' HA3' ' HA ' ' B' ' 174' ' ' CYS . . . -96.98 131.25 10.54 Favored Glycine 0 C--N 1.301 -1.383 0 C-N-CA 117.177 -2.439 . . . . 1.62 114.151 -176.238 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 166' ' ' ARG . . . . . 0.428 ' HA ' ' O ' ' B' ' 159' ' ' LYS . 0.0 OUTLIER -100.03 152.41 20.24 Favored 'General case' 0 C--N 1.349 0.551 0 N-CA-C 112.186 0.439 . . . . 3.05 112.186 -179.151 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 167' ' ' CYS . . . . . 0.691 ' HA ' ' O ' ' B' ' 172' ' ' ILE . 46.7 t -51.84 108.77 0.3 Allowed 'General case' 0 N--CA 1.431 -1.425 0 CA-C-N 115.905 -0.589 . . . . 1.56 111.05 -179.282 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 168' ' ' ALA . . . . . 0.401 ' O ' ' CZ ' ' B' ' 122' ' ' PHE . . . -101.33 -30.16 11.64 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.771 -0.649 . . . . 1.04 109.528 178.865 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 169' ' ' ALA . . . . . 0.812 ' HB2' ' HB2' ' B' ' 128' ' ' CYS . . . -162.31 165.1 27.05 Favored 'General case' 0 CA--C 1.492 -1.258 0 C-N-CA 119.488 -0.885 . . . . 0.98 112.42 -179.271 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 170' ' ' ALA . . . . . 0.788 ' HA ' ' O ' ' B' ' 185' ' ' CYS . . . -36.52 95.98 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.047 -0.979 . . . . 1.25 110.851 -179.106 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 171' ' ' GLY . . . . . 0.692 ' HA2' ' O ' ' B' ' 182' ' ' ASP . . . 88.52 -1.82 84.3 Favored Glycine 0 CA--C 1.525 0.677 0 CA-C-N 114.923 -1.035 . . . . 1.29 115.11 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 172' ' ' ILE . . . . . 0.845 HG13 ' HB2' ' B' ' 134' ' ' CYS . 1.8 mm -96.65 122.24 47.96 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.093 0 CA-C-N 117.865 0.832 . . . . 2.27 110.535 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 173' ' ' CYS . . . . . 0.631 ' HB2' ' HB3' ' B' ' 182' ' ' ASP . 21.6 t -120.89 92.21 3.71 Favored 'General case' 0 N--CA 1.428 -1.561 0 CA-C-N 114.561 -1.2 . . . . 1.94 109.399 -179.568 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 174' ' ' CYS . . . . . 1.031 ' CB ' ' HA ' ' B' ' 179' ' ' CYS . 5.9 p -160.08 -175.76 5.27 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 116.033 1.864 . . . . 1.35 116.033 -176.833 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 175' ' ' SER . . . . . 0.851 ' HB2' ' HD2' ' B' ' 176' ' ' PRO . 6.0 p -122.68 -179.89 0.88 Allowed Pre-proline 0 N--CA 1.454 -0.25 0 CA-C-N 113.087 -1.869 . . . . 2.0 108.931 -179.569 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 176' ' ' PRO . . . . . 0.851 ' HD2' ' HB2' ' B' ' 175' ' ' SER . 55.9 Cg_endo -72.38 31.31 0.27 Allowed 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 121.699 1.599 . . . . 1.9 113.292 -179.138 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 177' ' ' ASP . . . . . 0.437 ' OD1' ' N ' ' B' ' 178' ' ' GLY . 1.1 p30 -134.58 -60.02 0.8 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.643 -0.253 . . . . 2.72 110.371 178.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 178' ' ' GLY . . . . . 0.916 ' O ' ' HB2' ' B' ' 174' ' ' CYS . . . -124.51 -175.12 14.22 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.503 -0.856 . . . . 0.99 111.683 178.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 179' ' ' CYS . . . . . 1.031 ' HA ' ' CB ' ' B' ' 174' ' ' CYS . 14.0 m -149.41 160.44 43.43 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 117.526 0.663 . . . . 1.34 111.958 179.583 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 180' ' ' HIS . . . . . 0.48 ' HA ' ' HA2' ' A' ' 78' ' ' GLY . 72.5 m80 -149.56 139.77 22.2 Favored 'General case' 0 C--N 1.35 0.612 0 C-N-CA 120.232 -0.587 . . . . 2.1 111.819 -178.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 181' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -64.78 125.89 26.22 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.968 -0.56 . . . . 3.06 109.693 178.476 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 182' ' ' ASP . . . . . 0.692 ' O ' ' HA2' ' B' ' 171' ' ' GLY . 0.0 OUTLIER -139.74 107.59 7.03 Favored Pre-proline 0 CA--C 1.541 0.634 0 CA-C-O 120.85 0.357 . . . . 2.06 111.236 -179.267 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 183' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_exo -62.79 -24.19 74.51 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 123.061 2.507 . . . . 1.91 114.384 -178.626 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -64.29 -10.52 24.45 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.102 0.408 . . . . 1.56 112.102 -179.449 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 185' ' ' CYS . . . . . 0.788 ' O ' ' HA ' ' B' ' 170' ' ' ALA . 1.6 m -129.1 10.03 5.8 Favored 'General case' 0 C--O 1.214 -0.784 0 CA-C-O 119.243 -0.408 . . . . 1.94 111.078 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 186' ' ' ASP . . . . . 0.549 ' O ' ' HB1' ' B' ' 170' ' ' ALA . 0.5 OUTLIER . . . . . 0 CA--C 1.511 -0.534 0 C-N-CA 119.186 -1.006 . . . . 3.61 112.511 -176.588 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 62.7 m . . . . . 0 CA--C 1.542 0.664 0 N-CA-C 112.719 0.637 . . . . 2.68 112.719 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.888 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 4.2 mp -31.22 135.31 0.23 Allowed Pre-proline 0 N--CA 1.483 1.192 0 N-CA-C 113.598 0.962 . . . . 2.48 113.598 -178.679 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.402 ' HG2' ' CG ' ' A' ' 43' ' ' ARG . 30.8 Cg_endo -97.47 114.72 0.11 Allowed 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 123.439 2.759 . . . . 1.49 116.251 -178.632 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.528 ' O ' ' HA2' ' A' ' 17' ' ' GLY . 0.5 OUTLIER -127.59 -176.32 3.72 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-O 121.823 0.82 . . . . 1.0 111.46 -178.463 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.404 ' CA ' ' HB2' ' A' ' 40' ' ' GLU . . . 74.17 -178.26 44.32 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 114.524 -1.217 . . . . 1.15 110.438 -178.37 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.473 ' O ' ' HG2' ' A' ' 15' ' ' PRO . 47.3 Cg_endo -63.28 130.92 30.16 Favored 'Trans proline' 0 CA--C 1.507 -0.851 0 N-CA-C 106.317 -2.224 . . . . 1.57 106.317 175.464 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 72.34 -4.16 20.49 Favored Glycine 0 N--CA 1.414 -2.832 0 CA-C-O 119.247 -0.752 . . . . 1.68 113.459 177.07 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.528 ' HA2' ' O ' ' A' ' 13' ' ' CYS . . . 76.53 38.44 32.74 Favored Glycine 1 N--CA 1.391 -4.347 0 C-N-CA 119.121 -1.514 . . . . 1.36 112.189 -178.747 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.42 ' CG ' ' O ' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -97.72 22.0 9.67 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.317 -0.442 . . . . 2.5 110.261 174.439 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -129.58 -175.46 14.05 Favored Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 104.912 -3.275 . . . . 1.02 104.912 177.846 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.724 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 2.7 mtp180 -119.3 159.73 23.58 Favored 'General case' 0 CA--C 1.552 1.045 0 CA-C-N 121.323 2.562 . . . . 2.92 108.444 176.708 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.888 ' HB2' ' HB3' ' A' ' 11' ' ' LEU . 10.7 m -109.09 148.9 30.11 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 119.881 1.219 . . . . 1.1 111.435 -179.742 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -128.38 -52.4 1.28 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.085 -0.507 . . . . 1.51 111.36 179.989 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.431 ' O ' ' HB3' ' A' ' 44' ' ' CYS . . . -119.84 -171.3 14.65 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.935 -0.65 . . . . 0.9 112.26 -179.816 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -68.79 -61.21 0.07 OUTLIER 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.635 2.223 . . . . 1.5 112.755 -179.693 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.609 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.4 OUTLIER -98.15 26.87 4.97 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.822 -0.172 . . . . 1.26 110.749 -179.999 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 1.033 HG12 HG13 ' A' ' 36' ' ' VAL . 3.3 mt -141.37 120.58 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 N-CA-C 113.542 0.941 . . . . 0.83 113.542 -178.307 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.789 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -120.43 140.25 51.65 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 107.653 -1.239 . . . . 0.92 107.653 178.188 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 1.016 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -143.96 100.1 3.51 Favored 'General case' 0 CA--C 1.552 1.05 0 N-CA-C 117.686 2.476 . . . . 1.28 117.686 -174.907 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -101.48 -172.48 28.25 Favored Glycine 0 N--CA 1.431 -1.687 0 N-CA-C 108.423 -1.871 . . . . 0.67 108.423 176.49 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -64.98 -62.75 1.37 Allowed 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 121.338 0.59 . . . . 2.27 112.268 -179.255 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.1 14.69 28.82 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 122.196 0.998 . . . . 1.66 111.365 -177.931 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.735 HD22 ' CE2' ' A' ' 35' ' ' PHE . 4.6 mt -115.88 -5.03 12.04 Favored 'General case' 0 N--CA 1.387 -3.593 0 N-CA-C 104.895 -2.261 . . . . 1.37 104.895 179.063 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 1.016 ' O ' ' HA ' ' A' ' 28' ' ' CYS . . . 43.7 -126.73 5.77 Favored Glycine 0 N--CA 1.432 -1.609 0 CA-C-N 114.243 -1.344 . . . . 0.73 113.918 175.941 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 1.023 ' HB2' HD13 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -132.52 107.95 8.79 Favored 'General case' 0 CA--C 1.49 -1.329 0 CA-C-N 118.008 0.904 . . . . 1.08 113.362 -179.365 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.922 ' HD1' ' HD1' ' B' ' 135' ' ' PHE . 84.7 m-85 -83.06 105.98 14.49 Favored 'General case' 0 N--CA 1.42 -1.93 0 N-CA-C 102.32 -3.215 . . . . 1.38 102.32 174.686 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 1.033 HG13 HG12 ' A' ' 26' ' ' ILE . 3.0 t -97.77 85.27 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.664 0 CA-C-O 123.036 1.398 . . . . 0.76 109.374 -176.992 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.609 ' N ' ' O ' ' A' ' 25' ' ' SER . . . 97.68 89.4 1.9 Allowed Glycine 0 CA--C 1.527 0.842 0 CA-C-N 112.492 -2.14 . . . . 0.81 115.45 178.621 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.684 HG21 ' CE1' ' B' ' 135' ' ' PHE . 0.5 OUTLIER -176.62 168.17 2.64 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 108.603 -0.888 . . . . 0.77 108.603 177.964 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.837 ' HA ' HD12 ' A' ' 42' ' ' LEU . . . -53.54 -26.79 22.65 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 115.781 1.771 . . . . 1.02 115.781 -176.648 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.646 ' OE1' HG23 ' A' ' 38' ' ' THR . 0.0 OUTLIER -66.33 -15.91 63.63 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 119.226 -0.99 . . . . 2.32 109.634 178.545 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.634 ' O ' ' N ' ' A' ' 44' ' ' CYS . . . -88.42 -24.05 23.15 Favored 'General case' 0 N--CA 1.425 -1.693 0 CA-C-O 119.283 -0.389 . . . . 0.87 111.026 -178.979 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.837 HD12 ' HA ' ' A' ' 39' ' ' ALA . 0.4 OUTLIER -44.5 -40.0 5.27 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 119.229 0.922 . . . . 1.23 112.197 179.873 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.412 ' HD3' ' HA ' ' A' ' 43' ' ' ARG . 10.8 tpp85 -64.48 -11.16 30.83 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.708 0.766 . . . . 2.92 109.748 177.713 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.634 ' N ' ' O ' ' A' ' 41' ' ' ALA . 88.8 m -73.61 -8.31 55.46 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 113.763 -1.562 . . . . 1.57 110.728 176.795 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -76.38 -6.73 52.92 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.071 0.397 . . . . 3.31 112.071 179.382 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -86.44 3.87 42.0 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.254 -0.579 . . . . 3.69 111.114 -178.926 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.624 ' HG2' ' O ' ' A' ' 44' ' ' CYS . 12.6 pt-20 . . . . . 0 N--CA 1.448 -0.552 0 N-CA-C 109.592 -0.521 . . . . 3.99 109.592 177.203 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.226 -0.173 0 CA-C-O 120.757 0.313 . . . . 3.12 110.328 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.573 ' O ' ' HB2' ' A' ' 66' ' ' ARG . . . -87.67 144.35 18.89 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 110.049 -1.22 . . . . 2.1 110.049 -176.868 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -101.62 74.83 1.54 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.859 0.838 . . . . 4.36 109.834 179.297 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.748 ' HB3' ' HB2' ' A' ' 67' ' ' CYS . 15.3 tppt? -144.28 57.33 4.8 Favored Pre-proline 0 C--N 1.308 -1.222 0 N-CA-C 106.686 -1.598 . . . . 3.55 106.686 178.072 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.45 ' CD ' ' N ' ' A' ' 59' ' ' LYS . 55.0 Cg_endo -69.1 84.79 0.54 Allowed 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 121.828 1.685 . . . . 1.54 114.343 -177.681 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.444 ' N ' ' O ' ' A' ' 65' ' ' GLY . 0.8 OUTLIER -104.41 -176.49 3.1 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 113.587 -1.642 . . . . 1.59 107.693 177.014 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 62.72 -165.95 23.54 Favored Glycine 0 CA--C 1.505 -0.592 0 C-N-CA 118.712 -1.709 . . . . 2.43 112.852 178.495 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -77.77 52.37 1.02 Allowed 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.635 -0.283 . . . . 4.11 111.49 -179.066 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 102.93 8.71 41.59 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-O 118.988 -0.895 . . . . 2.21 115.001 178.964 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.578 ' HA2' ' HA ' ' A' ' 75' ' ' SER . . . -102.84 138.8 14.14 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 118.575 -1.774 . . . . 1.62 115.38 -178.373 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.573 ' HB2' ' O ' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -102.38 154.34 19.17 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 114.285 -0.958 . . . . 3.02 110.534 179.014 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.748 ' HB2' ' HB3' ' A' ' 59' ' ' LYS . 5.5 t -56.31 109.22 0.57 Allowed 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 109.695 -0.483 . . . . 1.52 109.695 -179.108 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.576 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . . . -91.89 -17.73 24.81 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 107.898 -1.149 . . . . 1.07 107.898 178.773 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 1.06 ' HB3' HD11 ' A' ' 72' ' ' ILE . . . -165.64 156.4 13.53 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 112.946 -1.934 . . . . 1.0 109.262 179.943 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.818 ' O ' ' O ' ' A' ' 69' ' ' ALA . . . -18.11 -139.12 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 114.154 1.168 . . . . 1.24 114.154 -179.705 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.636 ' HA3' ' OD1' ' A' ' 86' ' ' ASP . . . -61.38 53.29 0.03 OUTLIER Glycine 0 N--CA 1.475 1.237 0 N-CA-C 111.387 -0.685 . . . . 1.28 111.387 -177.914 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 1.06 HD11 ' HB3' ' A' ' 69' ' ' ALA . 1.8 pp -151.94 97.96 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.257 1.49 0 CA-C-O 122.204 1.002 . . . . 2.27 109.095 168.804 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.6 ' HB3' ' HB3' ' A' ' 82' ' ' ASP . 0.9 OUTLIER -93.65 95.94 9.51 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.035 -0.984 . . . . 1.98 108.745 -178.872 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.81 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 16.5 m -92.65 162.35 14.2 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 114.512 1.301 . . . . 1.33 114.512 -176.182 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.796 ' HB2' ' HD2' ' A' ' 76' ' ' PRO . 58.6 p -125.16 179.42 1.13 Allowed Pre-proline 0 CA--C 1.531 0.224 0 CA-C-N 113.465 -1.698 . . . . 1.99 108.127 178.748 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.796 ' HD2' ' HB2' ' A' ' 75' ' ' SER . 71.9 Cg_endo -77.22 30.01 0.42 Allowed 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 121.304 1.336 . . . . 1.86 111.909 179.79 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.407 ' H ' ' C ' ' A' ' 75' ' ' SER . 1.6 t70 -145.92 -41.73 0.21 Allowed 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.652 -0.704 . . . . 2.65 110.887 179.971 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 1.247 ' HA3' ' O ' ' B' ' 179' ' ' CYS . . . -151.11 -141.63 3.38 Favored Glycine 0 C--N 1.337 0.591 0 C-N-CA 120.406 -0.902 . . . . 0.99 113.621 -179.815 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 1.214 ' O ' ' HA3' ' B' ' 178' ' ' GLY . 60.2 m -148.22 146.27 28.61 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 123.123 0.569 . . . . 1.34 110.486 -179.658 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.442 ' N ' ' O ' ' A' ' 73' ' ' CYS . 14.5 m80 -133.24 134.06 43.49 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 119.859 -0.737 . . . . 2.17 111.511 179.956 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.404 ' OE1' ' HG2' ' B' ' 124' ' ' PRO . 8.7 mt-10 -59.58 135.95 57.83 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 108.682 -0.858 . . . . 3.05 108.682 178.558 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.6 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 0.7 OUTLIER -142.96 128.97 10.36 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 116.395 -0.366 . . . . 2.02 110.998 -178.706 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 82' ' ' ASP . 15.2 Cg_exo -69.15 -31.29 23.56 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 123.212 2.608 . . . . 1.93 113.07 -179.198 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.62 -3.11 2.83 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.115 -0.493 . . . . 1.53 112.03 -179.705 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.672 ' HB3' ' C ' ' A' ' 70' ' ' ALA . 73.6 m -133.22 20.3 4.04 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 112.074 0.398 . . . . 1.88 112.074 -179.965 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.636 ' OD1' ' HA3' ' A' ' 71' ' ' GLY . 16.8 m-20 . . . . . 0 N--CA 1.449 -0.509 0 N-CA-C 113.805 1.039 . . . . 3.6 113.805 179.854 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 110' ' ' CYS . . . . . . . . . . . . . 64.4 m . . . . . 0 CA--C 1.536 0.419 0 N-CA-C 111.498 0.184 . . . . 2.61 111.498 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' B' B ' 111' ' ' LEU . . . . . 0.865 ' HB3' ' HB2' ' B' ' 121' ' ' CYS . 4.6 mp -33.59 135.22 0.32 Allowed Pre-proline 0 N--CA 1.476 0.827 0 N-CA-C 113.576 0.954 . . . . 2.47 113.576 179.854 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 112' ' ' PRO . . . . . 0.439 ' HG2' ' CG ' ' B' ' 143' ' ' ARG . 41.7 Cg_endo -93.92 122.69 0.42 Allowed 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 123.557 2.838 . . . . 1.47 112.776 179.656 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.473 ' O ' ' HA2' ' B' ' 117' ' ' GLY . 0.4 OUTLIER -135.37 -177.35 4.62 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-O 122.398 1.094 . . . . 1.0 111.248 177.409 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 114' ' ' GLY . . . . . 0.403 ' CA ' ' HB2' ' B' ' 140' ' ' GLU . . . 73.98 -178.41 43.48 Favored Glycine 0 N--CA 1.439 -1.109 0 CA-C-N 113.589 -1.642 . . . . 1.16 110.204 -177.863 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 115' ' ' PRO . . . . . 0.493 ' O ' ' HG2' ' B' ' 115' ' ' PRO . 41.3 Cg_endo -64.97 121.36 8.83 Favored 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 122.041 1.827 . . . . 1.57 109.676 176.13 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 74.52 7.49 79.11 Favored Glycine 0 C--N 1.281 -2.487 0 CA-C-N 115.497 -0.774 . . . . 1.7 113.176 179.61 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 117' ' ' GLY . . . . . 0.473 ' HA2' ' O ' ' B' ' 113' ' ' CYS . . . 74.85 33.45 55.29 Favored Glycine 0 N--CA 1.408 -3.192 0 C-N-CA 119.628 -1.272 . . . . 1.38 114.636 177.311 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 118' ' ' LYS . . . . . 0.411 ' CG ' ' O ' ' B' ' 115' ' ' PRO . 0.0 OUTLIER -91.91 14.34 15.94 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 122.212 0.205 . . . . 2.54 110.722 178.698 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 119' ' ' GLY . . . . . 0.472 ' HA3' ' SG ' ' B' ' 113' ' ' CYS . . . -115.42 -153.8 10.4 Favored Glycine 0 C--N 1.34 0.774 0 N-CA-C 108.198 -1.961 . . . . 1.04 108.198 179.193 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.828 ' HA ' ' O ' ' B' ' 111' ' ' LEU . 2.7 ttp180 -143.08 156.75 44.88 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 123.206 3.503 . . . . 2.89 103.11 172.858 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 121' ' ' CYS . . . . . 0.865 ' HB2' ' HB3' ' B' ' 111' ' ' LEU . 15.8 m -108.74 150.15 28.01 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 120.19 1.359 . . . . 1.07 111.862 -178.036 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -128.57 -52.57 1.26 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.78 -0.645 . . . . 1.53 111.169 179.89 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 123' ' ' GLY . . . . . 0.424 ' O ' ' HB3' ' B' ' 144' ' ' CYS . . . -119.83 -171.23 14.64 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.934 -0.651 . . . . 0.9 112.353 -179.889 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 124' ' ' PRO . . . . . 0.404 ' HG2' ' OE1' ' A' ' 81' ' ' GLU . 14.2 Cg_exo -68.81 -61.25 0.07 OUTLIER 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.674 2.249 . . . . 1.51 112.809 -179.697 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 125' ' ' SER . . . . . 0.607 ' O ' ' N ' ' B' ' 137' ' ' GLY . 0.4 OUTLIER -98.05 26.81 4.96 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.785 -0.189 . . . . 1.25 110.832 179.87 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 126' ' ' ILE . . . . . 1.081 HG12 HG13 ' B' ' 136' ' ' VAL . 4.1 mt -140.93 120.62 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 113.556 0.947 . . . . 0.85 113.556 -178.209 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 127' ' ' CYS . . . . . 0.778 ' O ' ' HA ' ' B' ' 134' ' ' CYS . 0.0 OUTLIER -121.02 140.17 52.29 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 107.55 -1.278 . . . . 0.89 107.55 177.854 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 128' ' ' CYS . . . . . 1.047 ' HA ' ' O ' ' B' ' 133' ' ' GLY . 0.0 OUTLIER -143.14 106.69 4.61 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 115.671 1.73 . . . . 1.23 115.671 -175.563 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 129' ' ' GLY . . . . . . . . . . . . . . . -109.47 -168.13 20.27 Favored Glycine 0 N--CA 1.422 -2.272 0 CA-C-N 123.698 2.954 . . . . 0.66 106.751 173.983 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -62.61 -70.95 0.17 Allowed 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 117.234 0.517 . . . . 2.35 110.572 -178.952 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.28 32.54 4.73 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 122.688 1.232 . . . . 1.69 110.135 -176.323 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 132' ' ' LEU . . . . . 0.749 HD22 ' CE2' ' B' ' 135' ' ' PHE . 4.0 mt -126.48 -4.74 6.58 Favored 'General case' 0 N--CA 1.385 -3.69 0 N-CA-C 103.845 -2.65 . . . . 1.38 103.845 175.568 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 133' ' ' GLY . . . . . 1.047 ' O ' ' HA ' ' B' ' 128' ' ' CYS . . . 43.95 -123.62 4.79 Favored Glycine 0 N--CA 1.406 -3.366 0 CA-C-N 114.226 -1.352 . . . . 0.72 114.907 174.793 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 134' ' ' CYS . . . . . 1.018 ' HB2' HD13 ' B' ' 172' ' ' ILE . 0.0 OUTLIER -136.66 105.01 5.72 Favored 'General case' 0 CA--C 1.494 -1.189 0 N-CA-C 114.322 1.23 . . . . 1.08 114.322 179.872 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 135' ' ' PHE . . . . . 0.922 ' HD1' ' HD1' ' A' ' 35' ' ' PHE . 82.1 m-85 -80.22 105.39 11.45 Favored 'General case' 0 N--CA 1.42 -1.928 0 N-CA-C 102.399 -3.185 . . . . 1.36 102.399 176.035 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 136' ' ' VAL . . . . . 1.081 HG13 HG12 ' B' ' 126' ' ' ILE . 5.9 t -97.9 84.64 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.671 0 CA-C-O 123.148 1.451 . . . . 0.75 109.24 -177.129 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 137' ' ' GLY . . . . . 0.607 ' N ' ' O ' ' B' ' 125' ' ' SER . . . 97.91 88.65 1.9 Allowed Glycine 0 CA--C 1.527 0.812 0 CA-C-N 112.254 -2.248 . . . . 0.83 115.475 178.442 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 138' ' ' THR . . . . . 0.713 HG21 ' CE1' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -172.14 175.65 3.67 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 108.796 -0.816 . . . . 0.78 108.796 178.045 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 139' ' ' ALA . . . . . 0.836 ' HA ' HD12 ' B' ' 142' ' ' LEU . . . -55.82 -40.41 72.73 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 118.818 0.736 . . . . 1.04 112.562 -178.262 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 140' ' ' GLU . . . . . 0.603 ' OE1' HG23 ' B' ' 138' ' ' THR . 0.0 OUTLIER -57.6 -13.94 4.6 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.089 -0.644 . . . . 2.31 110.862 -178.032 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 141' ' ' ALA . . . . . 0.668 ' O ' ' N ' ' B' ' 144' ' ' CYS . . . -87.12 -30.44 21.09 Favored 'General case' 0 C--O 1.213 -0.866 0 CA-C-N 116.223 -0.444 . . . . 0.87 110.122 179.754 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 142' ' ' LEU . . . . . 0.836 HD12 ' HA ' ' B' ' 139' ' ' ALA . 0.4 OUTLIER -40.86 -41.36 1.57 Allowed 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.462 0.542 . . . . 1.24 112.462 -178.604 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 143' ' ' ARG . . . . . 0.467 ' HA ' ' HD3' ' B' ' 143' ' ' ARG . 8.9 tpp85 -58.17 -23.46 55.44 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 108.37 -0.974 . . . . 2.93 108.37 177.619 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 144' ' ' CYS . . . . . 0.668 ' N ' ' O ' ' B' ' 141' ' ' ALA . 90.9 m -66.61 -5.76 12.76 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 113.889 -1.505 . . . . 1.61 110.596 -177.553 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -78.03 -6.28 54.05 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.847 0.356 . . . . 3.35 111.701 178.906 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -86.33 3.51 43.14 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.355 -0.538 . . . . 3.76 111.01 -178.981 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 147' ' ' GLU . . . . . 0.608 ' HG2' ' O ' ' B' ' 144' ' ' CYS . 12.6 pt-20 . . . . . 0 N--CA 1.449 -0.517 0 N-CA-C 109.656 -0.498 . . . . 4.01 109.656 177.281 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.45 -0.444 0 CA-C-O 119.879 -0.105 . . . . 3.11 111.028 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 157' ' ' GLY . . . . . 0.551 ' O ' ' HB2' ' B' ' 166' ' ' ARG . . . -109.09 146.02 16.64 Favored Glycine 0 CA--C 1.493 -1.342 0 N-CA-C 108.821 -1.712 . . . . 2.07 108.821 175.555 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 11.6 mt-30 -103.3 63.7 0.81 Allowed 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 117.354 -1.739 . . . . 4.34 111.363 -179.165 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 159' ' ' LYS . . . . . 0.876 ' HB3' ' HB2' ' B' ' 167' ' ' CYS . 11.2 tppt? -117.46 52.06 1.21 Allowed Pre-proline 0 C--N 1.314 -0.954 0 CA-C-O 116.694 -1.622 . . . . 3.54 110.294 172.118 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 160' ' ' PRO . . . . . 0.435 ' HA ' ' HA ' ' B' ' 166' ' ' ARG . 43.6 Cg_endo -68.38 86.16 0.43 Allowed 'Trans proline' 0 C--N 1.334 -0.231 0 CA-C-N 122.502 1.929 . . . . 1.51 115.03 -173.305 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 161' ' ' CYS . . . . . 0.448 ' N ' ' O ' ' B' ' 165' ' ' GLY . 0.7 OUTLIER -96.94 -166.57 1.42 Allowed 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 113.117 -1.856 . . . . 1.58 109.302 177.944 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 49.9 -164.67 0.56 Allowed Glycine 0 CA--C 1.524 0.613 0 C-N-CA 118.813 -1.66 . . . . 2.37 113.375 172.127 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -78.13 51.44 0.99 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.233 0.54 . . . . 4.07 111.907 -178.739 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 104.95 7.55 38.24 Favored Glycine 0 CA--C 1.533 1.211 0 N-CA-C 114.965 0.746 . . . . 2.2 114.965 178.281 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 165' ' ' GLY . . . . . 0.598 ' HA2' ' HA ' ' B' ' 175' ' ' SER . . . -101.07 136.25 12.6 Favored Glycine 0 C--O 1.224 -0.494 0 C-N-CA 119.044 -1.55 . . . . 1.62 115.885 -176.854 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 166' ' ' ARG . . . . . 0.551 ' HB2' ' O ' ' B' ' 157' ' ' GLY . 0.0 OUTLIER -102.23 154.17 19.28 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 114.469 -0.865 . . . . 3.05 110.6 178.935 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 167' ' ' CYS . . . . . 0.876 ' HB2' ' HB3' ' B' ' 159' ' ' LYS . 5.4 t -56.52 109.24 0.58 Allowed 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 109.721 -0.474 . . . . 1.56 109.721 -179.017 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 168' ' ' ALA . . . . . 0.579 ' HB3' ' SG ' ' B' ' 128' ' ' CYS . . . -92.31 -17.31 24.89 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 107.879 -1.156 . . . . 1.04 107.879 178.878 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 169' ' ' ALA . . . . . 1.021 ' HB3' HD11 ' B' ' 172' ' ' ILE . . . -165.83 155.89 12.66 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 113.063 -1.881 . . . . 0.98 109.13 179.856 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 170' ' ' ALA . . . . . 0.785 ' O ' ' O ' ' B' ' 169' ' ' ALA . . . -19.17 -134.94 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 114.418 1.266 . . . . 1.25 114.418 -179.623 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 171' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' B' ' 185' ' ' CYS . . . -46.69 19.77 0.0 OUTLIER Glycine 0 CA--C 1.536 1.383 0 N-CA-C 116.359 1.304 . . . . 1.29 116.359 -178.217 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 172' ' ' ILE . . . . . 1.021 HD11 ' HB3' ' B' ' 169' ' ' ALA . 1.8 pp -138.28 99.85 1.56 Allowed 'Isoleucine or valine' 0 C--O 1.251 1.164 0 CA-C-O 123.478 1.609 . . . . 2.27 111.198 -178.818 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 173' ' ' CYS . . . . . 0.593 ' HA ' ' HA ' ' B' ' 167' ' ' CYS . 1.1 t -92.92 95.54 9.56 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 113.523 -1.671 . . . . 1.94 109.022 -179.055 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 174' ' ' CYS . . . . . 0.848 ' HA ' ' HA ' ' B' ' 179' ' ' CYS . 16.3 m -92.82 162.6 14.04 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 114.52 1.304 . . . . 1.35 114.52 -176.25 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 175' ' ' SER . . . . . 0.789 ' HB2' ' HD2' ' B' ' 176' ' ' PRO . 55.6 p -125.27 179.42 1.14 Allowed Pre-proline 0 CA--C 1.532 0.262 0 CA-C-N 113.454 -1.703 . . . . 2.0 108.033 178.842 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 176' ' ' PRO . . . . . 0.789 ' HD2' ' HB2' ' B' ' 175' ' ' SER . 72.0 Cg_endo -77.27 30.14 0.42 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 121.283 1.322 . . . . 1.9 111.9 179.829 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 177' ' ' ASP . . . . . 0.416 ' H ' ' C ' ' B' ' 175' ' ' SER . 1.6 t70 -145.94 -41.79 0.21 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.644 -0.707 . . . . 2.72 110.921 179.939 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 178' ' ' GLY . . . . . 1.214 ' HA3' ' O ' ' A' ' 79' ' ' CYS . . . -150.97 -141.56 3.37 Favored Glycine 0 C--N 1.336 0.533 0 C-N-CA 120.588 -0.815 . . . . 0.99 113.727 -179.89 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 179' ' ' CYS . . . . . 1.247 ' O ' ' HA3' ' A' ' 78' ' ' GLY . 60.3 m -148.38 146.05 28.32 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 123.154 0.582 . . . . 1.34 110.53 -179.653 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 180' ' ' HIS . . . . . 0.455 ' N ' ' O ' ' B' ' 173' ' ' CYS . 14.6 m80 -132.97 134.14 44.1 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 119.797 -0.761 . . . . 2.1 111.508 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 181' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -59.67 135.93 57.83 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.712 -0.847 . . . . 3.06 108.712 178.506 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 182' ' ' ASP . . . . . 0.592 ' HB3' ' HB3' ' B' ' 173' ' ' CYS . 0.7 OUTLIER -143.0 128.94 10.32 Favored Pre-proline 0 C--N 1.319 -0.719 0 CA-C-N 116.443 -0.344 . . . . 2.06 111.069 -178.632 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 183' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -69.19 -31.34 23.29 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 123.188 2.592 . . . . 1.91 113.041 -179.106 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -64.41 -3.28 2.82 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.109 -0.496 . . . . 1.56 111.963 -179.729 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 185' ' ' CYS . . . . . 0.661 ' HB3' ' C ' ' B' ' 170' ' ' ALA . 70.6 m -133.25 20.26 4.02 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 112.227 0.454 . . . . 1.94 112.227 -179.855 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 186' ' ' ASP . . . . . 0.477 ' OD1' ' HA3' ' B' ' 171' ' ' GLY . 17.3 m-20 . . . . . 0 N--CA 1.448 -0.573 0 N-CA-C 113.858 1.058 . . . . 3.61 113.858 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.409 0 CA-C-O 121.097 0.475 . . . . 8.2 111.162 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.776 ' O ' HD22 ' A' ' 3' ' ' LEU . 11.4 p -66.94 119.29 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 CA-C-O 121.996 0.903 . . . . 7.12 111.119 179.25 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 1.205 HD21 ' CG ' ' A' ' 8' ' ' ARG . 0.3 OUTLIER -155.97 77.66 0.96 Allowed 'General case' 0 C--O 1.257 1.496 0 CA-C-N 113.603 -1.635 . . . . 4.54 107.074 -179.68 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.451 ' O ' HD23 ' A' ' 5' ' ' LEU . 0.8 OUTLIER -61.78 49.61 0.01 OUTLIER 'General case' 0 N--CA 1.439 -1.003 0 C-N-CA 117.858 -1.537 . . . . 6.12 110.248 -179.864 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.792 ' N ' ' O ' ' A' ' 3' ' ' LEU . 96.4 mt -153.51 -79.86 0.1 Allowed 'General case' 1 N--CA 1.377 -4.113 0 CA-C-O 122.611 1.196 . . . . 6.29 109.464 179.362 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -167.38 -63.54 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 113.28 -1.782 . . . . 6.84 113.466 -179.164 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.5 ' O ' HG13 ' A' ' 7' ' ' VAL . 7.4 p -150.02 121.57 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.8 0 N-CA-C 109.035 -0.728 . . . . 6.15 109.035 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 1.205 ' CG ' HD21 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -77.03 100.77 5.77 Favored 'General case' 0 N--CA 1.424 -1.756 0 CA-C-N 116.015 -0.539 . . . . 7.3 112.441 -179.402 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.473 HG23 ' O ' ' A' ' 9' ' ' THR . 7.1 t -103.57 95.67 6.21 Favored 'General case' 0 N--CA 1.428 -1.534 0 C-N-CA 114.962 -2.695 . . . . 4.01 104.191 172.239 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.5 m -74.93 79.96 2.16 Favored 'General case' 0 CA--C 1.556 1.2 0 CA-C-N 113.133 -1.849 . . . . 2.64 113.201 -177.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.596 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -34.82 113.29 0.46 Allowed Pre-proline 0 N--CA 1.491 1.609 0 CA-C-N 119.0 0.818 . . . . 2.75 111.661 179.461 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.472 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 71.5 Cg_endo -75.48 117.92 4.97 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 122.82 2.347 . . . . 1.66 113.309 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 5.7 p -130.93 -178.29 4.75 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 121.057 0.456 . . . . 1.3 111.702 178.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.465 ' HA2' ' HB3' ' A' ' 40' ' ' GLU . . . 77.21 -162.54 51.4 Favored Glycine 0 CA--C 1.519 0.303 0 CA-C-N 116.162 -0.472 . . . . 1.23 112.121 -178.111 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.407 ' O ' ' HG2' ' A' ' 15' ' ' PRO . 44.6 Cg_endo -65.8 100.29 0.42 Allowed 'Trans proline' 0 N--CA 1.48 0.692 0 C-N-CA 124.165 3.244 . . . . 1.78 111.886 177.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.03 5.89 76.29 Favored Glycine 0 C--N 1.299 -1.473 0 CA-C-N 115.316 -0.856 . . . . 1.96 113.465 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.472 ' O ' ' CB ' ' A' ' 12' ' ' PRO . . . 71.95 45.33 42.75 Favored Glycine 0 N--CA 1.426 -2.011 0 N-CA-C 115.71 1.044 . . . . 1.48 115.71 177.713 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.467 ' HB2' ' CD1' ' A' ' 32' ' ' LEU . 0.5 OUTLIER -94.89 -24.02 17.19 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 112.66 0.615 . . . . 3.06 112.66 -179.828 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -79.5 171.84 54.87 Favored Glycine 0 CA--C 1.495 -1.157 0 CA-C-N 115.235 -0.893 . . . . 1.16 111.64 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.596 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 0.8 OUTLIER -120.86 149.41 42.64 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 109.848 -0.427 . . . . 2.62 109.848 -178.62 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 57.0 m -98.64 127.02 44.42 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.988 0.899 . . . . 1.22 109.741 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.418 ' CE2' ' HB1' ' A' ' 68' ' ' ALA . 3.7 m-85 -109.89 -29.94 8.05 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 113.963 -1.472 . . . . 2.15 111.315 -177.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -157.03 -174.49 26.8 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 121.089 -0.577 . . . . 0.98 112.708 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.41 -54.27 5.22 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 122.747 2.298 . . . . 0.93 113.45 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.588 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.7 OUTLIER -120.65 36.32 4.61 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 122.462 -0.149 . . . . 0.96 111.207 179.695 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.892 HG12 HG13 ' A' ' 36' ' ' VAL . 19.7 mt -140.77 111.42 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 C-N-CA 120.32 -0.552 . . . . 0.99 111.896 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.579 ' SG ' ' O ' ' A' ' 20' ' ' ARG . 0.5 OUTLIER -126.49 120.71 30.39 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 116.528 -0.305 . . . . 1.2 110.19 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.887 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -131.07 127.85 39.03 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 119.526 -0.87 . . . . 1.13 112.65 -179.579 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 33' ' ' GLY . . . -103.92 -169.51 25.24 Favored Glycine 0 N--CA 1.421 -2.325 0 C-N-CA 120.45 -0.881 . . . . 0.79 111.858 178.022 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -69.87 -51.06 36.54 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 114.694 -0.753 . . . . 2.64 112.969 -178.059 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -121.08 9.42 10.52 Favored 'General case' 0 CA--C 1.503 -0.836 0 CA-C-N 115.041 -0.981 . . . . 2.1 109.437 -177.445 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.467 ' CD1' ' HB2' ' A' ' 18' ' ' LYS . 4.7 mt -109.67 -9.83 14.84 Favored 'General case' 0 N--CA 1.408 -2.569 0 N-CA-C 108.871 -0.789 . . . . 1.0 108.871 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.954 ' HA2' ' HB1' ' A' ' 69' ' ' ALA . . . 65.8 -136.0 35.64 Favored Glycine 0 N--CA 1.43 -1.751 0 C-N-CA 120.42 -0.895 . . . . 0.7 112.921 176.555 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.719 ' HB2' HD13 ' A' ' 72' ' ' ILE . 1.6 t -135.66 125.54 25.73 Favored 'General case' 0 CA--C 1.503 -0.827 0 N-CA-C 114.37 1.248 . . . . 0.94 114.37 -178.583 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.48 ' HA ' ' HA ' ' B' ' 135' ' ' PHE . 4.2 m-85 -98.88 101.03 12.29 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 104.655 -2.35 . . . . 1.84 104.655 176.067 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.892 HG13 HG12 ' A' ' 26' ' ' ILE . 3.8 t -87.06 94.48 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 CA-C-O 122.937 1.351 . . . . 0.59 110.603 -178.244 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.588 ' N ' ' O ' ' A' ' 25' ' ' SER . . . 76.95 83.63 0.5 Allowed Glycine 0 CA--C 1.499 -0.911 0 CA-C-N 112.028 -2.351 . . . . 1.32 112.186 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 19.2 p -149.95 169.08 22.02 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-O 120.972 0.415 . . . . 1.48 111.16 -178.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.683 ' HA ' HD12 ' A' ' 42' ' ' LEU . . . -55.08 -27.73 47.09 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.867 -0.606 . . . . 1.28 110.781 179.164 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.465 ' HB3' ' HA2' ' A' ' 14' ' ' GLY . 30.1 mp0 -73.56 -29.21 62.29 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 112.665 0.617 . . . . 2.56 112.665 -179.194 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.422 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . . . -97.55 -1.35 44.13 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 120.701 0.286 . . . . 0.95 110.38 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.683 HD12 ' HA ' ' A' ' 39' ' ' ALA . 1.6 mt -57.61 -32.98 67.75 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 120.939 0.4 . . . . 1.99 110.308 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.7 ptm85 -72.13 -9.07 57.92 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.89 -0.596 . . . . 3.75 110.594 179.002 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 94.4 m -69.36 -10.18 56.76 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 120.198 -0.601 . . . . 1.32 111.389 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -54.96 -24.76 25.46 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.109 0.48 . . . . 2.8 110.928 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -85.83 5.01 34.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.241 -0.436 . . . . 3.55 110.434 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -80.31 -7.93 59.26 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 108.789 -0.819 . . . . 2.79 108.789 179.118 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -73.23 -28.79 62.36 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 109.011 -0.737 . . . . 3.48 109.011 177.169 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -83.91 6.2 22.55 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.948 -0.569 . . . . 6.08 111.451 179.245 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.6 mp -134.98 97.09 13.95 Favored Pre-proline 0 C--O 1.233 0.231 0 N-CA-C 109.761 -0.459 . . . . 3.65 109.761 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -85.21 29.13 0.54 Allowed 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.026 2.484 . . . . 5.28 113.029 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 30.9 p -134.6 117.96 13.35 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.324 -0.398 . . . . 5.56 110.647 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.37 -166.9 0.22 Allowed 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 121.843 1.695 . . . . 4.53 110.994 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.65 ' SG ' ' HB2' ' A' ' 8' ' ' ARG . 4.0 t -126.4 92.53 3.58 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.77 -0.826 . . . . 2.92 108.77 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.46 ' O ' ' CB ' ' A' ' 56' ' ' SER . 33.4 tt0 53.93 -97.88 0.07 Allowed 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 117.694 -1.603 . . . . 4.75 110.52 -178.48 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.46 ' CB ' ' O ' ' A' ' 55' ' ' GLN . 1.9 t 92.55 142.3 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.687 0.795 . . . . 3.86 110.835 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.492 ' O ' ' HB2' ' A' ' 66' ' ' ARG . . . -66.12 120.44 15.93 Favored Glycine 0 N--CA 1.429 -1.782 0 C-N-CA 120.213 -0.994 . . . . 2.88 110.827 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.61 77.58 6.21 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 107.886 -1.153 . . . . 5.45 107.886 179.312 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.482 ' O ' ' HA ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -146.33 58.26 4.45 Favored Pre-proline 0 C--N 1.306 -1.318 0 CA-C-N 114.933 -1.03 . . . . 6.09 108.868 -179.524 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 59' ' ' LYS . 36.8 Cg_endo -64.63 85.5 0.17 Allowed 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.584 2.189 . . . . 2.54 112.235 179.183 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.506 ' N ' ' O ' ' A' ' 65' ' ' GLY . 0.5 OUTLIER -108.41 -179.4 3.87 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.624 -0.717 . . . . 2.27 109.083 179.44 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.08 -161.01 44.94 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 117.859 -2.115 . . . . 2.47 111.816 178.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 50.9 m -78.79 45.33 0.59 Allowed 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 120.689 0.281 . . . . 3.28 111.637 -179.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 105.28 16.07 17.53 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 120.945 -0.645 . . . . 2.3 114.674 178.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.506 ' O ' ' N ' ' A' ' 61' ' ' CYS . . . -103.7 132.85 11.22 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 119.822 -1.18 . . . . 1.86 114.738 -179.268 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.492 ' HB2' ' O ' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -93.61 159.16 15.34 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 122.49 0.316 . . . . 3.36 110.95 178.335 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 13.8 t -70.05 106.37 3.21 Favored 'General case' 0 N--CA 1.432 -1.363 0 C-N-CA 119.782 -0.767 . . . . 1.64 109.438 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.418 ' HB1' ' CE2' ' A' ' 22' ' ' PHE . . . -93.15 -17.57 23.59 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.906 0.384 . . . . 1.21 110.613 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.954 ' HB1' ' HA2' ' A' ' 33' ' ' GLY . . . -168.11 164.21 13.45 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 115.969 -0.56 . . . . 1.05 110.377 -178.543 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.97 ' CB ' ' HB3' ' A' ' 89' ' ' ALA . . . -45.17 121.76 3.04 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 114.218 1.192 . . . . 1.63 114.218 -177.515 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.649 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . 59.86 31.44 71.96 Favored Glycine 0 CA--C 1.506 -0.526 0 CA-C-N 113.479 -1.691 . . . . 1.58 115.673 176.264 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.779 HD12 ' SG ' ' A' ' 74' ' ' CYS . 1.3 pt -142.37 112.6 2.73 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-O 122.015 0.912 . . . . 2.04 111.976 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.71 ' HB2' ' HB3' ' A' ' 82' ' ' ASP . 0.0 OUTLIER -93.07 94.2 8.73 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 114.72 -1.127 . . . . 1.72 109.14 179.302 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.779 ' SG ' HD12 ' A' ' 72' ' ' ILE . 43.7 m -102.4 147.94 26.1 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.295 0.569 . . . . 1.37 111.469 -179.19 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.494 ' CB ' ' HD2' ' A' ' 76' ' ' PRO . 0.3 OUTLIER -122.64 -179.12 0.72 Allowed Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 114.632 -1.167 . . . . 2.25 108.813 179.615 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.494 ' HD2' ' CB ' ' A' ' 75' ' ' SER . 58.0 Cg_endo -74.26 32.6 0.34 Allowed 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 121.883 1.722 . . . . 2.7 112.954 -179.396 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.475 ' HB3' ' NE2' ' B' ' 180' ' ' HIS . 5.4 m-20 -147.54 -49.68 0.18 Allowed 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.876 -0.602 . . . . 2.63 111.002 178.43 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.564 ' HA3' ' O ' ' B' ' 179' ' ' CYS . . . -143.69 -152.2 5.61 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 120.412 -0.899 . . . . 0.75 113.727 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.573 ' HA ' ' HA ' ' A' ' 74' ' ' CYS . 5.0 m -138.46 149.82 45.84 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.045 -0.578 . . . . 1.23 110.156 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.636 ' O ' ' N ' ' A' ' 73' ' ' CYS . 0.1 OUTLIER -147.41 145.46 29.24 Favored 'General case' 0 CA--C 1.513 -0.474 0 O-C-N 121.516 -0.74 . . . . 3.01 111.408 -178.404 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -67.95 144.58 55.14 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.344 -0.613 . . . . 2.9 109.344 178.03 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.71 ' HB3' ' HB2' ' A' ' 73' ' ' CYS . 2.2 p-10 -146.34 121.2 5.41 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 116.066 -0.515 . . . . 2.52 110.055 -177.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 82' ' ' ASP . 38.4 Cg_exo -61.83 -15.08 40.4 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.776 2.317 . . . . 2.98 114.385 -178.247 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.16 -44.84 78.74 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.908 0.385 . . . . 2.42 111.814 -179.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.962 ' O ' ' HB2' ' A' ' 89' ' ' ALA . 14.0 m -106.04 26.16 10.06 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.681 0.753 . . . . 2.16 109.919 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.653 ' N ' ' HD2' ' A' ' 87' ' ' PRO . 11.6 t0 -85.5 -45.73 0.63 Allowed Pre-proline 0 C--N 1.309 -1.175 0 O-C-N 121.308 -0.87 . . . . 3.14 112.425 -179.063 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 1.047 ' O ' ' N ' ' A' ' 89' ' ' ALA . 6.1 Cg_exo -59.39 132.5 46.68 Favored 'Trans proline' 0 CA--C 1.483 -2.054 0 N-CA-C 106.688 -2.082 . . . . 2.96 106.688 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.995 ' C ' ' O ' ' A' ' 87' ' ' PRO . 34.3 mm-40 -5.97 75.17 0.0 OUTLIER 'General case' 0 N--CA 1.409 -2.495 0 N-CA-C 101.704 -3.443 . . . . 6.0 101.704 -178.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 1.047 ' N ' ' O ' ' A' ' 87' ' ' PRO . . . -32.91 -30.99 0.01 OUTLIER 'General case' 0 CA--C 1.494 -1.199 0 CA-C-N 113.141 -1.845 . . . . 6.54 111.642 -170.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.58 ' N ' ' O ' ' A' ' 88' ' ' GLU . . . -90.44 166.72 13.1 Favored 'General case' 0 N--CA 1.423 -1.799 0 N-CA-C 103.262 -2.866 . . . . 8.02 103.262 174.485 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.497 ' O ' ' O ' ' A' ' 92' ' ' SER . 2.7 m-85 -85.86 78.37 9.53 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 121.943 2.156 . . . . 12.31 112.35 -179.221 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.497 ' O ' ' O ' ' A' ' 91' ' ' PHE . 9.4 t . . . . . 0 C--O 1.246 0.888 0 CA-C-O 118.134 -0.936 . . . . 12.79 111.268 178.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.264 0 CA-C-O 121.548 0.69 . . . . 8.8 111.11 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 6.0 t 60.82 117.42 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.523 0 CA-C-O 123.637 1.684 . . . . 7.16 112.132 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 103' ' ' LEU . . . . . 0.759 HD22 ' N ' ' B' ' 108' ' ' ARG . 2.1 pt? -145.98 139.46 26.17 Favored 'General case' 0 C--N 1.282 -2.336 1 N-CA-C 99.463 -4.273 . . . . 4.51 99.463 175.486 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 104' ' ' ASP . . . . . 0.515 ' O ' HD23 ' B' ' 105' ' ' LEU . 0.4 OUTLIER -64.93 64.23 0.02 OUTLIER 'General case' 0 N--CA 1.429 -1.518 0 C-N-CA 117.647 -1.621 . . . . 6.19 111.073 -173.104 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 105' ' ' LEU . . . . . 0.694 ' N ' ' O ' ' B' ' 103' ' ' LEU . 70.4 mt -154.3 -83.76 0.07 Allowed 'General case' 1 N--CA 1.372 -4.375 0 CA-C-O 122.825 1.297 . . . . 6.29 111.23 -179.125 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 106' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -169.15 -54.34 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 113.022 -1.899 . . . . 7.05 113.053 -177.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 107' ' ' VAL . . . . . 0.65 ' N ' HD21 ' B' ' 103' ' ' LEU . 8.3 p -147.43 119.08 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.794 0 CA-C-O 121.526 0.679 . . . . 6.18 109.439 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 108' ' ' ARG . . . . . 0.759 ' N ' HD22 ' B' ' 103' ' ' LEU . 0.0 OUTLIER -77.33 104.12 7.66 Favored 'General case' 0 N--CA 1.401 -2.91 0 CA-C-N 114.306 -1.316 . . . . 7.3 109.749 179.457 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 109' ' ' THR . . . . . 0.456 ' O ' HG23 ' B' ' 109' ' ' THR . 4.4 t -107.05 95.25 5.59 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 103.642 -2.725 . . . . 4.05 103.642 171.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 110' ' ' CYS . . . . . . . . . . . . . 1.3 m -75.71 79.27 2.67 Favored 'General case' 0 CA--C 1.552 1.037 0 CA-C-N 112.633 -2.076 . . . . 2.64 113.097 -175.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 111' ' ' LEU . . . . . 0.617 ' O ' ' HA ' ' B' ' 120' ' ' ARG . 0.7 OUTLIER -33.78 112.82 0.41 Allowed Pre-proline 0 N--CA 1.483 1.214 0 CA-C-N 118.554 0.616 . . . . 2.77 112.485 179.533 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 112' ' ' PRO . . . . . 0.46 ' CB ' ' O ' ' B' ' 117' ' ' GLY . 73.3 Cg_endo -75.87 119.44 5.4 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.7 2.267 . . . . 1.7 114.171 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 113' ' ' CYS . . . . . . . . . . . . . 4.3 p -133.09 -178.16 4.84 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 120.502 -0.479 . . . . 1.26 112.137 178.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 114' ' ' GLY . . . . . 0.467 ' HA2' ' HB3' ' B' ' 140' ' ' GLU . . . 77.17 -162.23 51.25 Favored Glycine 0 CA--C 1.522 0.5 0 CA-C-N 116.037 -0.529 . . . . 1.2 111.999 -177.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 115' ' ' PRO . . . . . 0.406 ' O ' ' HG2' ' B' ' 115' ' ' PRO . 45.1 Cg_endo -66.19 99.32 0.41 Allowed 'Trans proline' 0 N--CA 1.478 0.588 0 C-N-CA 124.089 3.192 . . . . 1.78 112.089 177.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 89.12 5.95 72.33 Favored Glycine 0 C--N 1.298 -1.541 0 CA-C-N 115.404 -0.816 . . . . 1.94 113.436 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 117' ' ' GLY . . . . . 0.46 ' O ' ' CB ' ' B' ' 112' ' ' PRO . . . 72.24 45.03 41.52 Favored Glycine 0 N--CA 1.425 -2.064 0 C-N-CA 120.386 -0.911 . . . . 1.48 115.268 177.488 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 118' ' ' LYS . . . . . 0.457 ' HB2' ' CD1' ' B' ' 132' ' ' LEU . 0.4 OUTLIER -94.29 -24.67 17.34 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 121.153 0.502 . . . . 3.07 111.94 -179.601 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . -78.84 173.06 55.35 Favored Glycine 0 N--CA 1.438 -1.227 0 C-N-CA 120.589 -0.815 . . . . 1.16 111.893 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.617 ' HA ' ' O ' ' B' ' 111' ' ' LEU . 0.7 OUTLIER -120.85 149.0 43.27 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 110.024 -0.362 . . . . 2.63 110.024 -179.508 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 121' ' ' CYS . . . . . . . . . . . . . 57.3 m -98.16 127.63 44.21 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 119.639 -0.825 . . . . 1.21 110.203 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 122' ' ' PHE . . . . . 0.404 ' CE2' ' HB1' ' B' ' 168' ' ' ALA . 3.5 m-85 -110.9 -28.41 8.38 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 114.413 -1.267 . . . . 2.14 111.657 -177.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -158.12 -175.65 29.29 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 121.149 -0.548 . . . . 0.99 112.445 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -52.42 -54.09 5.78 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 122.85 2.366 . . . . 0.96 113.447 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 125' ' ' SER . . . . . 0.57 ' O ' ' N ' ' B' ' 137' ' ' GLY . 1.0 OUTLIER -121.0 36.77 4.5 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 122.413 -0.18 . . . . 1.0 110.961 179.671 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 126' ' ' ILE . . . . . 0.478 HG12 HG13 ' B' ' 136' ' ' VAL . 16.0 mt -139.72 111.02 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 C-N-CA 120.499 -0.48 . . . . 0.97 112.047 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 127' ' ' CYS . . . . . 0.559 ' SG ' ' O ' ' B' ' 120' ' ' ARG . 0.5 OUTLIER -127.55 119.74 26.66 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 110.099 -0.334 . . . . 1.19 110.099 179.677 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 128' ' ' CYS . . . . . 0.926 ' HA ' ' O ' ' B' ' 133' ' ' GLY . 0.0 OUTLIER -130.09 128.18 41.36 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 119.952 -0.699 . . . . 1.12 112.608 -178.941 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 129' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' B' ' 133' ' ' GLY . . . -105.48 -169.19 23.72 Favored Glycine 0 N--CA 1.418 -2.506 0 C-N-CA 120.065 -1.064 . . . . 0.78 111.989 178.428 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -70.41 -51.62 28.21 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 115.126 -0.537 . . . . 2.63 112.351 -177.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.8 30.61 5.46 Favored 'General case' 0 CA--C 1.503 -0.861 0 N-CA-C 108.861 -0.792 . . . . 2.1 108.861 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 132' ' ' LEU . . . . . 0.457 ' CD1' ' HB2' ' B' ' 118' ' ' LYS . 3.8 mt -127.06 -7.8 5.98 Favored 'General case' 0 N--CA 1.396 -3.159 0 N-CA-C 106.752 -1.573 . . . . 0.98 106.752 177.374 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 133' ' ' GLY . . . . . 0.996 ' HA2' ' HB1' ' B' ' 169' ' ' ALA . . . 61.87 -136.36 46.4 Favored Glycine 0 N--CA 1.427 -1.942 0 CA-C-N 115.283 -0.871 . . . . 0.68 113.851 176.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 134' ' ' CYS . . . . . 0.749 ' HB2' HD13 ' B' ' 172' ' ' ILE . 1.6 t -134.36 126.24 29.23 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 114.5 1.296 . . . . 0.96 114.5 -178.044 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 135' ' ' PHE . . . . . 0.48 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 4.8 m-85 -99.28 101.09 12.28 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 104.455 -2.424 . . . . 1.84 104.455 176.009 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 136' ' ' VAL . . . . . 0.478 HG13 HG12 ' B' ' 126' ' ' ILE . 38.3 t -85.58 93.76 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 CA-C-O 122.97 1.367 . . . . 0.6 110.072 -178.069 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 137' ' ' GLY . . . . . 0.57 ' N ' ' O ' ' B' ' 125' ' ' SER . . . 75.32 84.75 0.35 Allowed Glycine 0 CA--C 1.502 -0.729 0 CA-C-N 112.136 -2.302 . . . . 1.33 112.448 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 138' ' ' THR . . . . . . . . . . . . . 19.1 p -150.22 169.64 20.85 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 120.9 0.381 . . . . 1.48 111.172 -179.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 139' ' ' ALA . . . . . 0.685 ' HA ' HD12 ' B' ' 142' ' ' LEU . . . -55.39 -27.65 49.0 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.038 -0.528 . . . . 1.3 110.805 179.02 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 140' ' ' GLU . . . . . 0.467 ' HB3' ' HA2' ' B' ' 114' ' ' GLY . 30.2 mp0 -73.52 -29.14 62.28 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 112.542 0.571 . . . . 2.53 112.542 -179.241 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 141' ' ' ALA . . . . . 0.443 ' HB2' ' HB2' ' B' ' 127' ' ' CYS . . . -97.47 -0.91 45.28 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 120.713 0.292 . . . . 0.98 110.489 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 142' ' ' LEU . . . . . 0.685 HD12 ' HA ' ' B' ' 139' ' ' ALA . 1.6 mt -58.02 -33.05 68.53 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 121.031 0.443 . . . . 2.02 110.318 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 143' ' ' ARG . . . . . . . . . . . . . 2.0 ptm85 -71.96 -9.2 58.03 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.883 -0.599 . . . . 3.76 110.606 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 144' ' ' CYS . . . . . . . . . . . . . 94.2 m -69.48 -9.89 55.71 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 120.169 -0.613 . . . . 1.37 111.414 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -55.04 -24.96 27.41 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.072 0.463 . . . . 2.78 110.802 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -85.81 5.41 32.7 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 116.351 -0.386 . . . . 3.53 110.495 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -80.49 -7.49 59.2 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 108.879 -0.786 . . . . 2.81 108.879 178.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 148' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -74.0 -28.62 61.54 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 108.76 -0.83 . . . . 3.48 108.76 177.54 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -84.0 6.71 20.96 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.914 -0.585 . . . . 6.08 111.377 179.195 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 2.9 mp -135.46 96.67 13.59 Favored Pre-proline 0 C--O 1.233 0.223 0 N-CA-C 109.87 -0.418 . . . . 3.66 109.87 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 151' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -85.53 29.62 0.52 Allowed 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.941 2.428 . . . . 5.29 112.97 -179.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 51.6 p -135.28 117.65 12.52 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.359 -0.382 . . . . 5.57 110.496 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 153' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.77 -167.97 0.25 Allowed 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.036 1.824 . . . . 4.53 111.194 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 154' ' ' CYS . . . . . 0.622 ' SG ' ' HB2' ' B' ' 108' ' ' ARG . 4.0 t -125.61 90.4 3.21 Favored 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 109.189 -0.671 . . . . 2.92 109.189 179.172 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 155' ' ' GLN . . . . . 0.494 ' O ' ' CB ' ' B' ' 156' ' ' SER . 37.1 tt0 55.12 -98.23 0.08 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 118.4 -1.32 . . . . 4.77 109.783 -178.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 156' ' ' SER . . . . . 0.494 ' CB ' ' O ' ' B' ' 155' ' ' GLN . 1.8 t 92.95 137.55 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.235 0.614 . . . . 3.9 111.007 178.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 157' ' ' GLY . . . . . 0.44 ' O ' ' HB2' ' B' ' 166' ' ' ARG . . . -62.04 120.62 22.79 Favored Glycine 0 N--CA 1.441 -0.971 0 C-N-CA 120.159 -1.02 . . . . 2.89 111.025 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.36 60.11 3.67 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.691 0.758 . . . . 5.47 110.27 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 159' ' ' LYS . . . . . 0.576 ' HB2' ' CB ' ' B' ' 167' ' ' CYS . 0.1 OUTLIER -115.42 55.41 1.01 Allowed Pre-proline 0 N--CA 1.443 -0.778 0 CA-C-N 114.766 -1.107 . . . . 6.05 111.541 176.076 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 160' ' ' PRO . . . . . 0.437 ' HA ' ' HA ' ' B' ' 166' ' ' ARG . 30.1 Cg_endo -63.09 85.57 0.12 Allowed 'Trans proline' 0 CA--C 1.531 0.336 0 CA-C-N 121.306 1.502 . . . . 2.53 113.794 -178.492 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 161' ' ' CYS . . . . . 0.512 ' N ' ' O ' ' B' ' 165' ' ' GLY . 0.5 OUTLIER -109.61 -179.65 3.88 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.05 -0.523 . . . . 2.24 109.705 179.504 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 66.68 -160.75 47.14 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 118.26 -1.924 . . . . 2.45 111.642 178.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 39.0 m -78.57 43.77 0.49 Allowed 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 116.802 0.301 . . . . 3.26 111.53 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 106.86 15.9 15.35 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 120.74 -0.743 . . . . 2.3 114.588 178.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 165' ' ' GLY . . . . . 0.512 ' O ' ' N ' ' B' ' 161' ' ' CYS . . . -103.61 134.08 11.74 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.044 -1.074 . . . . 1.83 114.444 -179.321 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 166' ' ' ARG . . . . . 0.502 ' HA ' ' O ' ' B' ' 159' ' ' LYS . 0.0 OUTLIER -95.27 158.64 15.37 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 115.415 -0.393 . . . . 3.34 110.875 178.254 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 167' ' ' CYS . . . . . 0.576 ' CB ' ' HB2' ' B' ' 159' ' ' LYS . 14.1 t -70.17 106.1 3.17 Favored 'General case' 0 N--CA 1.435 -1.218 0 C-N-CA 119.731 -0.788 . . . . 1.61 109.342 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 168' ' ' ALA . . . . . 0.404 ' HB1' ' CE2' ' B' ' 122' ' ' PHE . . . -93.12 -18.81 22.15 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.205 0.526 . . . . 1.22 110.782 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 169' ' ' ALA . . . . . 0.996 ' HB1' ' HA2' ' B' ' 133' ' ' GLY . . . -165.63 164.94 19.09 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 115.466 -0.788 . . . . 1.04 110.53 -178.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 170' ' ' ALA . . . . . 0.994 ' CB ' ' HB3' ' B' ' 189' ' ' ALA . . . -46.89 121.71 3.82 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 114.762 1.393 . . . . 1.63 114.762 -177.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 171' ' ' GLY . . . . . 0.759 ' N ' ' O ' ' B' ' 185' ' ' CYS . . . 61.83 29.66 72.94 Favored Glycine 0 C--N 1.315 -0.633 0 CA-C-N 113.974 -1.466 . . . . 1.49 115.896 177.02 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 172' ' ' ILE . . . . . 0.77 HD12 ' SG ' ' B' ' 174' ' ' CYS . 1.3 pt -142.58 113.71 2.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 118.331 1.066 . . . . 2.05 111.95 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 173' ' ' CYS . . . . . 0.764 ' HB2' ' HB3' ' B' ' 182' ' ' ASP . 0.0 OUTLIER -94.22 93.93 8.05 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 114.56 -1.2 . . . . 1.73 108.81 179.692 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 174' ' ' CYS . . . . . 0.77 ' SG ' HD12 ' B' ' 172' ' ' ILE . 37.2 m -102.22 148.0 25.96 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.458 0.646 . . . . 1.35 111.745 -179.013 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 175' ' ' SER . . . . . 0.505 ' CB ' ' HD2' ' B' ' 176' ' ' PRO . 0.3 OUTLIER -122.88 -179.26 0.76 Allowed Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 114.627 -1.169 . . . . 2.25 108.914 179.792 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 176' ' ' PRO . . . . . 0.505 ' HD2' ' CB ' ' B' ' 175' ' ' SER . 57.9 Cg_endo -74.02 32.61 0.34 Allowed 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 121.811 1.674 . . . . 2.68 113.044 -179.407 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 177' ' ' ASP . . . . . 0.457 ' HB3' ' NE2' ' A' ' 80' ' ' HIS . 5.1 m-20 -147.69 -49.53 0.17 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.915 -0.584 . . . . 2.66 110.949 178.614 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 178' ' ' GLY . . . . . 0.555 ' HA3' ' O ' ' A' ' 79' ' ' CYS . . . -143.49 -151.57 5.49 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 120.492 -0.861 . . . . 0.75 113.944 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 179' ' ' CYS . . . . . 0.602 ' HA ' ' HA ' ' B' ' 174' ' ' CYS . 4.8 m -139.42 149.24 43.83 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 114.879 -0.66 . . . . 1.24 110.095 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 180' ' ' HIS . . . . . 0.613 ' O ' ' N ' ' B' ' 173' ' ' CYS . 0.1 OUTLIER -146.88 145.74 29.94 Favored 'General case' 0 CA--C 1.511 -0.547 0 C-N-CA 119.807 -0.757 . . . . 3.0 111.41 -178.436 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 181' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -67.9 145.26 54.75 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 120.175 -0.61 . . . . 2.9 109.48 178.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 182' ' ' ASP . . . . . 0.764 ' HB3' ' HB2' ' B' ' 173' ' ' CYS . 1.8 p-10 -146.9 121.05 5.11 Favored Pre-proline 0 C--N 1.319 -0.753 0 CA-C-N 116.196 -0.456 . . . . 2.49 110.412 -178.005 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 183' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -61.51 -14.8 37.35 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 122.653 2.236 . . . . 2.94 114.448 -178.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -67.55 -44.98 76.97 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.846 0.355 . . . . 2.37 111.647 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 185' ' ' CYS . . . . . 0.951 ' O ' ' HB2' ' B' ' 189' ' ' ALA . 11.9 m -106.91 28.87 7.56 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.629 0.728 . . . . 2.13 110.767 -179.507 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 186' ' ' ASP . . . . . 0.664 ' N ' ' HD2' ' B' ' 187' ' ' PRO . 11.8 t0 -89.05 -46.21 0.43 Allowed Pre-proline 0 C--N 1.319 -0.738 0 CA-C-N 115.835 -0.62 . . . . 3.11 112.52 -179.144 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 187' ' ' PRO . . . . . 1.093 ' O ' ' N ' ' B' ' 189' ' ' ALA . 3.5 Cg_exo -57.27 136.95 79.37 Favored 'Trans proline' 0 CA--C 1.484 -1.984 0 N-CA-C 105.257 -2.632 . . . . 2.91 105.257 178.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 188' ' ' GLU . . . . . 1.158 ' O ' ' O ' ' B' ' 190' ' ' ALA . 24.5 mm-40 -11.1 79.06 0.0 OUTLIER 'General case' 0 CA--C 1.471 -2.076 0 N-CA-C 101.682 -3.451 . . . . 5.97 101.682 -178.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 189' ' ' ALA . . . . . 1.093 ' N ' ' O ' ' B' ' 187' ' ' PRO . . . -36.96 -27.4 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 114.051 -1.431 . . . . 6.55 111.609 -170.586 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 190' ' ' ALA . . . . . 1.158 ' O ' ' O ' ' B' ' 188' ' ' GLU . . . -92.37 164.36 13.53 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 103.205 -2.887 . . . . 8.01 103.205 173.396 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 191' ' ' PHE . . . . . 0.535 ' O ' ' O ' ' B' ' 192' ' ' SER . 2.5 m-85 -84.73 77.95 9.97 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 121.853 2.115 . . . . 12.3 112.537 -179.178 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 192' ' ' SER . . . . . 0.535 ' O ' ' O ' ' B' ' 191' ' ' PHE . 9.1 t . . . . . 0 C--O 1.244 0.815 0 CA-C-O 118.022 -0.99 . . . . 12.79 111.375 178.03 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.923 ' O ' HG12 ' A' ' 2' ' ' VAL . . . . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.501 0.191 . . . . 9.95 111.242 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.923 HG12 ' O ' ' A' ' 1' ' ' ALA . 1.0 OUTLIER 88.91 57.44 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 C-N-CA 124.265 1.026 . . . . 8.02 112.915 -179.875 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.899 HD22 ' O ' ' A' ' 2' ' ' VAL . 0.2 OUTLIER -169.72 102.43 0.32 Allowed 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 108.433 -0.951 . . . . 5.86 108.433 177.684 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.482 ' HB2' ' HG2' ' A' ' 55' ' ' GLN . 0.2 OUTLIER -92.6 8.28 39.68 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 116.876 2.176 . . . . 6.22 116.876 -174.13 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.772 HD12 HD12 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -80.78 -70.64 0.51 Allowed 'General case' 0 N--CA 1.424 -1.742 0 CA-C-N 121.17 1.805 . . . . 7.09 110.449 -178.969 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.761 ' H ' HD13 ' A' ' 5' ' ' LEU . 0.2 OUTLIER -156.4 -117.77 0.03 OUTLIER 'General case' 0 C--N 1.267 -3.014 0 N-CA-C 101.597 -3.483 . . . . 8.78 101.597 -178.62 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.428 ' O ' HD11 ' A' ' 5' ' ' LEU . 2.5 m -84.55 176.03 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.482 -1.664 0 N-CA-C 103.936 -2.616 . . . . 7.51 103.936 179.065 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.629 ' CB ' ' HG ' ' A' ' 3' ' ' LEU . 2.8 mtm-85 -73.65 108.5 6.53 Favored 'General case' 0 N--CA 1.426 -1.668 1 CA-C-N 126.481 4.219 . . . . 9.08 107.538 179.132 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.462 ' O ' ' HB2' ' A' ' 54' ' ' CYS . 28.8 m -107.44 97.28 7.05 Favored 'General case' 0 N--CA 1.423 -1.814 0 C-N-CA 114.557 -2.857 . . . . 5.66 103.973 171.036 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.749 ' HA ' ' HB2' ' A' ' 54' ' ' CYS . 8.4 m -83.09 77.7 9.71 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 115.944 1.831 . . . . 2.68 115.944 179.257 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.513 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -31.56 110.88 0.3 Allowed Pre-proline 0 N--CA 1.48 1.054 0 CA-C-N 119.055 0.843 . . . . 2.48 110.125 178.739 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.632 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 41.5 Cg_endo -99.98 139.49 0.28 Allowed 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.143 1.896 . . . . 1.49 116.758 -177.409 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.544 ' HA ' ' HD2' ' A' ' 43' ' ' ARG . 2.4 p -134.59 -165.75 1.71 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 118.674 -1.21 . . . . 1.0 109.866 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.483 ' HA2' ' HG2' ' A' ' 40' ' ' GLU . . . 64.65 -159.45 42.37 Favored Glycine 0 CA--C 1.499 -0.939 0 C-N-CA 121.365 -0.445 . . . . 1.15 113.527 176.312 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.435 ' C ' ' H ' ' A' ' 17' ' ' GLY . 42.7 Cg_endo -64.75 138.19 57.31 Favored 'Trans proline' 0 N--CA 1.443 -1.448 0 C-N-CA 122.25 1.967 . . . . 1.57 109.029 176.401 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 55.93 -6.58 0.01 OUTLIER Glycine 0 C--N 1.273 -2.965 0 CA-C-N 114.055 -1.43 . . . . 1.68 114.029 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.435 ' H ' ' C ' ' A' ' 15' ' ' PRO . . . 69.66 40.98 76.53 Favored Glycine 1 N--CA 1.387 -4.567 0 C-N-CA 116.947 -2.549 . . . . 1.36 108.871 -178.455 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.433 ' HB2' HD11 ' A' ' 32' ' ' LEU . 1.6 mttp -93.59 -10.91 33.08 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 111.677 -2.262 . . . . 2.5 113.24 179.442 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.632 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -122.85 179.0 16.27 Favored Glycine 0 N--CA 1.44 -1.051 0 N-CA-C 106.539 -2.624 . . . . 1.02 106.539 178.628 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.513 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 0.3 OUTLIER -122.55 170.23 10.21 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 119.95 1.875 . . . . 2.92 112.274 -178.98 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.465 ' O ' HD12 ' A' ' 11' ' ' LEU . 20.2 t -114.66 150.76 34.68 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.735 0.303 . . . . 1.1 111.796 -179.437 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -131.85 -49.56 0.96 Allowed 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 108.704 -0.85 . . . . 1.51 108.704 177.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.438 ' O ' ' SG ' ' A' ' 21' ' ' CYS . . . -99.29 -154.87 28.54 Favored Glycine 0 N--CA 1.448 -0.553 0 N-CA-C 109.007 -1.637 . . . . 0.9 109.007 176.423 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -94.18 -60.55 0.01 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.032 0 CA-C-N 119.829 1.814 . . . . 1.5 112.14 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.636 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.6 OUTLIER -90.92 9.82 28.95 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-O 120.615 0.245 . . . . 1.26 110.403 179.05 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.826 HG23 HG13 ' A' ' 36' ' ' VAL . 1.5 mt -120.08 118.08 55.71 Favored 'Isoleucine or valine' 0 C--O 1.245 0.854 0 CA-C-O 122.061 0.934 . . . . 0.83 112.311 -177.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.737 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 0.7 OUTLIER -134.83 130.47 36.09 Favored 'General case' 0 C--O 1.223 -0.31 0 CA-C-N 114.238 -1.346 . . . . 0.92 110.556 -179.492 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 1.086 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -132.4 172.65 12.2 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-O 123.155 1.455 . . . . 1.28 114.167 -178.086 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.481 ' O ' ' HB1' ' A' ' 69' ' ' ALA . . . -156.87 176.0 34.26 Favored Glycine 0 N--CA 1.429 -1.812 0 CA-C-N 111.664 -2.517 . . . . 0.67 108.602 178.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -62.17 -53.0 61.54 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 121.964 0.888 . . . . 2.27 110.453 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.29 11.69 14.11 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 113.79 -1.55 . . . . 1.66 109.402 179.027 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.697 HD22 ' CZ ' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -106.47 -4.2 20.09 Favored 'General case' 0 N--CA 1.412 -2.352 0 N-CA-C 106.897 -1.519 . . . . 1.37 106.897 179.275 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 1.086 ' O ' ' HA ' ' A' ' 28' ' ' CYS . . . 46.76 -140.59 6.77 Favored Glycine 0 N--CA 1.419 -2.441 0 CA-C-N 113.67 -1.604 . . . . 0.73 113.028 178.051 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.8 ' SG ' HG22 ' A' ' 26' ' ' ILE . 0.5 OUTLIER -138.23 122.16 17.77 Favored 'General case' 0 CA--C 1.493 -1.234 0 N-CA-C 113.168 0.803 . . . . 1.08 113.168 179.709 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.978 ' HA ' ' HA ' ' B' ' 135' ' ' PHE . 0.0 OUTLIER -88.8 106.2 18.21 Favored 'General case' 0 N--CA 1.423 -1.81 0 N-CA-C 104.22 -2.511 . . . . 1.38 104.22 175.437 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.912 HG23 HG23 ' B' ' 136' ' ' VAL . 1.4 t -96.09 83.71 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 N-CA-C 107.734 -1.21 . . . . 0.76 107.734 -179.303 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.727 ' O ' ' HA3' ' B' ' 133' ' ' GLY . . . 103.01 92.57 2.23 Favored Glycine 0 CA--C 1.531 1.073 0 CA-C-N 112.955 -1.929 . . . . 0.81 114.259 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.475 HG21 ' HB3' ' A' ' 35' ' ' PHE . 0.0 OUTLIER 177.86 167.1 0.72 Allowed 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 108.808 -0.812 . . . . 0.77 108.808 178.455 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.772 ' CB ' HD22 ' A' ' 42' ' ' LEU . . . -61.24 -16.77 48.69 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 119.996 1.271 . . . . 1.02 111.677 179.435 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.669 ' HB3' ' CD2' ' A' ' 35' ' ' PHE . 5.0 mt-10 -64.19 -14.95 58.68 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.629 -0.508 . . . . 2.32 109.629 178.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.645 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . . . -126.1 -4.81 6.8 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 115.67 -0.696 . . . . 0.87 111.949 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.772 HD22 ' CB ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -73.95 -36.3 64.62 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 108.218 -1.03 . . . . 1.23 108.218 179.231 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.544 ' HD2' ' HA ' ' A' ' 13' ' ' CYS . 1.2 ptp180 -63.52 -5.63 4.08 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 114.31 -1.313 . . . . 2.92 109.529 178.246 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.599 ' HB3' ' O ' ' A' ' 41' ' ' ALA . 9.3 t -82.2 11.8 4.97 Favored 'General case' 0 N--CA 1.445 -0.701 0 O-C-N 121.572 -0.705 . . . . 1.57 109.166 177.467 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -73.02 -18.3 61.36 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.945 -0.571 . . . . 3.31 109.477 178.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.42 5.7 33.77 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 119.303 -0.959 . . . . 3.69 109.862 179.28 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -83.55 0.73 45.34 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.866 -0.607 . . . . 3.99 109.583 177.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -75.32 -28.73 59.78 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 109.38 -0.6 . . . . 3.86 109.38 178.143 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -113.71 50.24 0.93 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.005 -0.543 . . . . 5.68 110.256 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -141.24 97.0 6.97 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.423 -0.353 . . . . 5.4 111.693 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -87.22 33.92 0.43 Allowed 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.905 2.403 . . . . 4.92 113.162 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 46.8 p -127.93 80.4 72.17 Favored Pre-proline 0 N--CA 1.463 0.21 0 CA-C-O 120.657 0.265 . . . . 5.64 110.869 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.525 ' O ' ' HB3' ' A' ' 5' ' ' LEU . 83.7 Cg_endo -87.06 113.72 1.02 Allowed 'Trans proline' 0 CA--C 1.533 0.463 0 C-N-CA 123.186 2.591 . . . . 5.04 114.291 -178.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.749 ' HB2' ' HA ' ' A' ' 10' ' ' CYS . 0.5 OUTLIER -60.14 96.76 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.375 -0.375 . . . . 2.74 109.99 178.377 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.482 ' HG2' ' HB2' ' A' ' 4' ' ' ASP . 6.7 tp-100 -44.99 125.58 5.25 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 119.557 -0.857 . . . . 5.75 111.009 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -170.29 -154.71 0.11 Allowed 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 116.527 -0.306 . . . . 3.12 111.382 -179.398 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 56.45 58.57 13.66 Favored Glycine 0 N--CA 1.426 -2.033 0 C-N-CA 121.346 -0.454 . . . . 2.1 112.214 176.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 -119.46 70.46 0.85 Allowed 'General case' 0 N--CA 1.435 -1.206 0 CA-C-O 122.82 1.295 . . . . 4.36 107.684 177.033 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.642 ' N ' ' CD ' ' A' ' 60' ' ' PRO . 2.2 mmpp? -143.68 44.69 0.51 Allowed Pre-proline 0 C--N 1.303 -1.435 0 CA-C-N 112.428 -2.169 . . . . 3.55 108.089 177.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.642 ' CD ' ' N ' ' A' ' 59' ' ' LYS . 1.3 Cg_endo -42.96 114.75 0.47 Allowed 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 123.629 2.886 . . . . 1.54 115.247 -178.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -146.68 170.53 16.76 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 113.357 -1.747 . . . . 1.59 108.19 177.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 71.07 -168.54 50.28 Favored Glycine 0 CA--C 1.494 -1.264 0 C-N-CA 118.704 -1.713 . . . . 2.43 113.63 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 14.4 p -83.29 44.46 0.95 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.015 -0.593 . . . . 4.11 111.692 -178.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 118.26 9.61 9.43 Favored Glycine 0 C--N 1.334 0.455 0 N-CA-C 115.222 0.849 . . . . 2.21 115.222 177.087 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.673 ' HA3' ' HA ' ' A' ' 75' ' ' SER . . . -105.16 162.29 14.55 Favored Glycine 0 C--N 1.338 0.642 0 CA-C-N 119.202 1.501 . . . . 1.62 115.178 -178.628 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.1 153.67 21.19 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 108.524 -0.917 . . . . 3.02 108.524 177.068 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.543 ' HA ' ' HA ' ' A' ' 73' ' ' CYS . 50.5 t -58.7 115.57 3.15 Favored 'General case' 0 N--CA 1.426 -1.669 0 N-CA-C 109.217 -0.66 . . . . 1.52 109.217 -179.403 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 1.011 ' HB1' ' SG ' ' A' ' 28' ' ' CYS . . . -62.88 -48.37 79.3 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 106.875 -1.528 . . . . 1.07 106.875 178.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.719 ' CB ' ' HA2' ' A' ' 33' ' ' GLY . . . -167.8 163.92 14.15 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 112.9 -1.954 . . . . 1.0 110.736 -174.586 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 1.073 ' HA ' ' HB3' ' A' ' 85' ' ' CYS . . . -43.96 130.61 5.85 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.428 0.632 . . . . 1.24 112.298 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.727 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . 80.23 -26.09 3.04 Favored Glycine 0 CA--C 1.522 0.481 0 CA-C-N 115.006 -0.997 . . . . 1.28 115.059 177.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.629 ' CD1' ' HB2' ' A' ' 34' ' ' CYS . 1.2 pp -129.25 116.59 40.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 122.319 1.057 . . . . 2.27 111.021 -179.149 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.543 ' HA ' ' HA ' ' A' ' 67' ' ' CYS . 1.6 t -106.13 112.45 25.48 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.175 -1.375 . . . . 1.98 110.578 -177.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.715 ' HB2' ' HB2' ' A' ' 68' ' ' ALA . 3.7 m -84.45 147.85 26.88 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 121.94 0.876 . . . . 1.33 112.752 -177.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.847 ' HB2' ' HD2' ' A' ' 76' ' ' PRO . 12.1 p -122.64 -179.9 0.88 Allowed Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 114.031 -1.44 . . . . 1.99 108.106 178.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.847 ' HD2' ' HB2' ' A' ' 75' ' ' SER . 57.0 Cg_endo -73.73 29.93 0.32 Allowed 'Trans proline' 0 N--CA 1.459 -0.516 0 CA-C-N 119.895 0.998 . . . . 1.86 111.59 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.504 ' H ' ' C ' ' A' ' 75' ' ' SER . 2.5 p30 -145.89 -48.93 0.22 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.607 -0.724 . . . . 2.65 110.63 179.053 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 1.083 ' HA3' ' O ' ' B' ' 179' ' ' CYS . . . -156.3 -140.8 3.05 Favored Glycine 0 C--N 1.336 0.547 0 C-N-CA 120.398 -0.906 . . . . 0.99 113.843 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 1.061 ' O ' ' HA3' ' B' ' 178' ' ' GLY . 0.0 OUTLIER -142.73 153.2 43.11 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.329 -0.436 . . . . 1.34 110.556 -179.826 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 4.2 p-80 -154.36 160.36 41.66 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.096 -0.642 . . . . 2.17 112.008 -178.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.601 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -60.25 140.53 56.98 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.874 -0.603 . . . . 3.05 110.32 179.867 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.492 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 3.7 p-10 -139.75 140.29 24.31 Favored Pre-proline 0 CA--C 1.541 0.598 0 CA-C-N 116.018 -0.537 . . . . 2.02 110.763 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.492 ' HD3' ' HA ' ' A' ' 82' ' ' ASP . 3.2 Cg_exo -77.26 -24.97 8.93 Favored 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 123.159 2.572 . . . . 1.93 114.196 -177.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.37 -43.93 84.57 Favored 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 107.781 -1.192 . . . . 1.53 107.781 178.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 1.073 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 33.2 m -99.95 73.73 1.77 Allowed 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 114.082 -1.417 . . . . 1.88 109.033 177.533 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 1.051 ' H ' ' HD3' ' A' ' 87' ' ' PRO . 0.2 OUTLIER -171.17 24.19 0.0 OUTLIER Pre-proline 0 C--N 1.312 -1.052 0 CA-C-N 115.558 -0.746 . . . . 3.6 112.01 -179.719 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 1.051 ' HD3' ' H ' ' A' ' 86' ' ' ASP . 15.5 Cg_exo -65.86 -177.33 0.74 Allowed 'Trans proline' 0 CA--C 1.484 -1.987 0 CA-C-N 119.882 0.993 . . . . 2.56 110.406 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.499 ' C ' ' H ' ' A' ' 90' ' ' ALA . 1.7 pt-20 -30.93 -19.88 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 113.66 -1.609 . . . . 4.72 111.075 175.549 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.803 ' N ' ' O ' ' A' ' 87' ' ' PRO . . . -55.91 7.95 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 113.804 1.039 . . . . 5.29 113.804 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.499 ' H ' ' C ' ' A' ' 88' ' ' GLU . . . -75.26 157.57 34.24 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.145 0.498 . . . . 6.98 111.235 177.218 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -100.78 99.56 10.1 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.16 -0.927 . . . . 10.21 109.974 177.44 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 47.1 p . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.205 -0.903 . . . . 11.77 111.021 -179.835 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.496 0 CA-C-O 120.7 0.286 . . . . 10.07 111.114 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 102' ' ' VAL . . . . . 0.51 HG12 ' H ' ' B' ' 103' ' ' LEU . 2.6 t -95.21 -130.61 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.996 0 CA-C-O 121.761 0.791 . . . . 8.41 110.607 179.527 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 103' ' ' LEU . . . . . 0.739 ' HG ' ' HB3' ' B' ' 108' ' ' ARG . 0.2 OUTLIER -109.28 105.71 15.24 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 106.177 -1.786 . . . . 5.87 106.177 174.992 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 104' ' ' ASP . . . . . 0.721 ' H ' ' HB3' ' B' ' 155' ' ' GLN . 0.6 OUTLIER -82.86 90.64 6.96 Favored 'General case' 0 CA--C 1.513 -0.464 0 C-N-CA 119.655 -0.818 . . . . 6.27 112.213 -175.881 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -148.75 -75.76 0.17 Allowed 'General case' 0 N--CA 1.408 -2.539 0 CA-C-O 123.382 1.563 . . . . 7.2 108.95 179.033 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 106' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 179.48 -34.67 0.01 OUTLIER 'General case' 0 C--N 1.275 -2.663 0 CA-C-N 111.048 -2.796 . . . . 8.55 107.447 -177.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 3.3 m -152.19 170.74 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.473 -2.015 0 N-CA-C 103.85 -2.648 . . . . 7.48 103.85 169.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 108' ' ' ARG . . . . . 0.739 ' HB3' ' HG ' ' B' ' 103' ' ' LEU . 5.6 mtm-85 -75.51 110.88 10.25 Favored 'General case' 0 N--CA 1.428 -1.566 0 CA-C-N 125.956 3.98 . . . . 9.12 106.353 176.451 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 109' ' ' THR . . . . . 0.455 ' O ' ' HB2' ' B' ' 154' ' ' CYS . 33.5 m -112.0 97.66 6.83 Favored 'General case' 0 CA--C 1.478 -1.797 0 C-N-CA 114.229 -2.989 . . . . 5.69 103.19 171.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 110' ' ' CYS . . . . . 0.76 ' HA ' ' HB2' ' B' ' 154' ' ' CYS . 7.4 m -84.29 78.25 9.83 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-N 112.48 -2.145 . . . . 2.61 115.587 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 111' ' ' LEU . . . . . 0.575 ' O ' ' HA ' ' B' ' 120' ' ' ARG . 0.0 OUTLIER -31.63 110.34 0.3 Allowed Pre-proline 0 N--CA 1.472 0.668 0 CA-C-N 118.614 0.643 . . . . 2.47 109.821 178.761 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 112' ' ' PRO . . . . . 0.646 ' HA ' ' O ' ' B' ' 119' ' ' GLY . 74.1 Cg_endo -82.3 158.97 17.45 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 124.482 3.455 . . . . 1.47 111.307 -179.56 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.499 ' HA ' ' HD2' ' B' ' 143' ' ' ARG . 3.2 p -155.93 -168.71 2.85 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 120.427 -1.421 . . . . 1.0 109.351 166.383 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 114' ' ' GLY . . . . . 0.465 ' HA2' ' HG2' ' B' ' 140' ' ' GLU . . . 64.71 -158.85 43.41 Favored Glycine 0 C--N 1.34 0.752 0 C-N-CA 121.007 -0.616 . . . . 1.16 113.482 176.264 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 115' ' ' PRO . . . . . 0.51 ' O ' ' N ' ' B' ' 117' ' ' GLY . 56.4 Cg_endo -62.01 143.73 95.47 Favored 'Trans proline' 0 CA--C 1.503 -1.031 0 C-N-CA 122.801 2.334 . . . . 1.57 106.962 176.161 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 116' ' ' GLY . . . . . 0.425 ' HA3' ' HE3' ' B' ' 118' ' ' LYS . . . 50.0 -4.64 0.01 OUTLIER Glycine 0 N--CA 1.416 -2.662 0 N-CA-C 115.209 0.843 . . . . 1.7 115.209 177.556 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 117' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' B' ' 115' ' ' PRO . . . 68.18 39.88 88.15 Favored Glycine 1 N--CA 1.394 -4.1 0 C-N-CA 117.102 -2.475 . . . . 1.38 109.623 -178.612 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 118' ' ' LYS . . . . . 0.425 ' HE3' ' HA3' ' B' ' 116' ' ' GLY . 1.6 mmtp -91.99 -13.87 30.35 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 112.318 -1.941 . . . . 2.54 112.949 -178.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 119' ' ' GLY . . . . . 0.646 ' O ' ' HA ' ' B' ' 112' ' ' PRO . . . -113.57 -171.2 17.64 Favored Glycine 0 CA--C 1.5 -0.847 0 N-CA-C 108.324 -1.91 . . . . 1.04 108.324 178.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.575 ' HA ' ' O ' ' B' ' 111' ' ' LEU . 0.4 OUTLIER -136.77 169.74 17.23 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 121.845 2.823 . . . . 2.89 108.625 178.328 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 121' ' ' CYS . . . . . 0.457 ' SG ' ' O ' ' B' ' 123' ' ' GLY . 19.5 t -114.63 151.87 32.81 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.337 0.495 . . . . 1.07 112.337 -178.306 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -131.95 -49.66 0.95 Allowed 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 108.696 -0.853 . . . . 1.53 108.696 176.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 123' ' ' GLY . . . . . 0.457 ' O ' ' SG ' ' B' ' 121' ' ' CYS . . . -99.23 -154.84 28.59 Favored Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 109.115 -1.594 . . . . 0.9 109.115 176.327 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -94.19 -60.66 0.01 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.958 0 CA-C-N 119.816 1.808 . . . . 1.51 112.151 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 125' ' ' SER . . . . . 0.644 ' O ' ' N ' ' B' ' 137' ' ' GLY . 0.6 OUTLIER -90.65 9.89 27.94 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 110.266 -0.272 . . . . 1.25 110.266 179.031 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 126' ' ' ILE . . . . . 0.804 HG22 ' SG ' ' B' ' 134' ' ' CYS . 1.8 mt -119.98 117.87 55.07 Favored 'Isoleucine or valine' 0 C--O 1.244 0.802 0 CA-C-O 121.962 0.887 . . . . 0.85 112.566 -177.641 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 127' ' ' CYS . . . . . 0.747 ' O ' ' HA ' ' B' ' 134' ' ' CYS . 0.7 OUTLIER -134.91 130.69 36.29 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-N 114.313 -1.312 . . . . 0.89 110.643 -179.641 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 128' ' ' CYS . . . . . 1.084 ' HA ' ' O ' ' B' ' 133' ' ' GLY . 0.0 OUTLIER -130.96 173.58 10.85 Favored 'General case' 0 CA--C 1.56 1.33 0 CA-C-O 122.814 1.292 . . . . 1.23 114.327 -178.069 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 129' ' ' GLY . . . . . 0.518 ' O ' ' HB1' ' B' ' 169' ' ' ALA . . . -157.32 176.47 34.49 Favored Glycine 0 N--CA 1.427 -1.936 0 CA-C-N 111.643 -2.526 . . . . 0.66 109.045 177.422 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -62.01 -54.83 36.04 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 109.198 -0.667 . . . . 2.35 109.198 179.166 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -122.12 29.71 6.91 Favored 'General case' 0 N--CA 1.428 -1.539 0 N-CA-C 108.191 -1.04 . . . . 1.69 108.191 178.421 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 132' ' ' LEU . . . . . 0.662 HD22 ' CZ ' ' B' ' 135' ' ' PHE . 0.5 OUTLIER -121.09 -3.42 9.57 Favored 'General case' 0 N--CA 1.41 -2.451 0 N-CA-C 104.428 -2.434 . . . . 1.38 104.428 179.103 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 133' ' ' GLY . . . . . 1.084 ' O ' ' HA ' ' B' ' 128' ' ' CYS . . . 42.36 -141.01 1.84 Allowed Glycine 0 N--CA 1.401 -3.664 0 CA-C-N 112.531 -2.122 . . . . 0.72 112.519 176.358 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 134' ' ' CYS . . . . . 0.804 ' SG ' HG22 ' B' ' 126' ' ' ILE . 0.5 OUTLIER -136.75 122.08 19.34 Favored 'General case' 0 CA--C 1.493 -1.23 0 CA-C-N 118.802 1.301 . . . . 1.08 113.629 -178.515 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 135' ' ' PHE . . . . . 0.978 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -88.08 106.35 18.1 Favored 'General case' 0 N--CA 1.422 -1.829 0 N-CA-C 104.326 -2.472 . . . . 1.36 104.326 175.858 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 136' ' ' VAL . . . . . 0.912 HG23 HG23 ' A' ' 36' ' ' VAL . 1.8 t -95.62 83.69 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 N-CA-C 107.725 -1.213 . . . . 0.75 107.725 -179.278 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 137' ' ' GLY . . . . . 0.756 ' O ' ' HA3' ' A' ' 33' ' ' GLY . . . 102.53 93.03 2.23 Favored Glycine 0 CA--C 1.531 1.055 0 CA-C-N 113.071 -1.877 . . . . 0.83 114.283 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 138' ' ' THR . . . . . 0.466 HG21 ' HB3' ' B' ' 135' ' ' PHE . 0.0 OUTLIER 178.44 169.19 0.82 Allowed 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 108.623 -0.88 . . . . 0.78 108.623 178.576 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 139' ' ' ALA . . . . . 0.775 ' CB ' HD22 ' B' ' 142' ' ' LEU . . . -63.77 -15.33 58.4 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 119.616 1.098 . . . . 1.04 111.373 178.623 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 140' ' ' GLU . . . . . 0.677 ' HB3' ' CD2' ' B' ' 135' ' ' PHE . 5.0 mt-10 -65.24 -15.87 62.94 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.498 -0.556 . . . . 2.31 109.498 178.343 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 141' ' ' ALA . . . . . 0.659 ' O ' ' HB3' ' B' ' 144' ' ' CYS . . . -122.78 -11.0 8.23 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.995 -0.548 . . . . 0.87 111.695 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 142' ' ' LEU . . . . . 0.775 HD22 ' CB ' ' B' ' 139' ' ' ALA . 0.0 OUTLIER -69.22 -37.02 77.85 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.382 -0.97 . . . . 1.24 108.382 -178.681 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 143' ' ' ARG . . . . . 0.499 ' HD2' ' HA ' ' B' ' 113' ' ' CYS . 1.1 ptp180 -64.91 -2.29 2.54 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 114.583 -1.189 . . . . 2.93 109.753 178.132 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 144' ' ' CYS . . . . . 0.659 ' HB3' ' O ' ' B' ' 141' ' ' ALA . 10.3 t -83.4 9.26 11.45 Favored 'General case' 0 N--CA 1.443 -0.786 0 O-C-N 121.556 -0.715 . . . . 1.61 109.125 176.604 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -71.17 -18.65 62.48 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.598 -0.728 . . . . 3.35 109.711 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.41 5.73 33.61 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 119.234 -0.986 . . . . 3.76 110.035 179.24 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -83.55 0.73 45.34 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.781 -0.645 . . . . 4.01 109.51 177.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 148' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -75.36 -28.65 59.65 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.35 -0.611 . . . . 3.92 109.35 178.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -113.74 50.17 0.93 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.952 -0.567 . . . . 5.73 110.342 179.518 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -141.24 97.08 6.95 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.303 -0.408 . . . . 5.46 111.58 -179.358 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 151' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -87.33 33.98 0.43 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.849 2.366 . . . . 5.02 113.068 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 51.1 p -128.0 80.62 71.86 Favored Pre-proline 0 N--CA 1.463 0.207 0 CA-C-O 120.655 0.264 . . . . 5.73 110.868 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 153' ' ' PRO . . . . . 0.504 ' HA ' HD21 ' B' ' 111' ' ' LEU . 90.0 Cg_endo -87.15 114.07 1.03 Allowed 'Trans proline' 0 CA--C 1.533 0.469 0 C-N-CA 123.135 2.556 . . . . 5.1 114.217 -178.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 154' ' ' CYS . . . . . 0.76 ' HB2' ' HA ' ' B' ' 110' ' ' CYS . 0.4 OUTLIER -60.4 98.42 0.06 Allowed 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 109.65 -0.5 . . . . 2.68 109.65 178.207 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 155' ' ' GLN . . . . . 0.721 ' HB3' ' H ' ' B' ' 104' ' ' ASP . 38.2 tp60 -47.08 126.72 9.48 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 119.551 -0.86 . . . . 5.63 110.721 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -175.63 -162.51 0.1 Allowed 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 110.126 -0.324 . . . . 3.11 110.126 -179.055 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 64.95 57.13 12.75 Favored Glycine 0 N--CA 1.426 -1.972 0 C-N-CA 120.245 -0.979 . . . . 2.07 112.164 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 158' ' ' GLN . . . . . 0.418 ' C ' ' HD2' ' B' ' 160' ' ' PRO . 12.8 tt0 -120.29 59.83 0.89 Allowed 'General case' 0 N--CA 1.435 -1.19 0 C-N-CA 117.228 -1.789 . . . . 4.34 108.604 176.511 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 159' ' ' LYS . . . . . 0.615 ' HB2' ' HB3' ' B' ' 167' ' ' CYS . 2.6 mmpp? -118.2 39.23 0.29 Allowed Pre-proline 0 C--N 1.314 -0.943 0 CA-C-N 112.346 -2.206 . . . . 3.54 111.731 171.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 160' ' ' PRO . . . . . 0.454 ' CD ' ' N ' ' B' ' 159' ' ' LYS . 2.3 Cg_endo -41.17 117.21 0.53 Allowed 'Trans proline' 0 C--N 1.34 0.109 0 C-N-CA 122.306 2.004 . . . . 1.51 115.621 -173.06 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 161' ' ' CYS . . . . . 0.466 ' SG ' ' N ' ' B' ' 162' ' ' GLY . 0.1 OUTLIER -138.73 -170.58 2.88 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 113.198 -1.819 . . . . 1.58 108.715 -179.803 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 162' ' ' GLY . . . . . 0.466 ' N ' ' SG ' ' B' ' 161' ' ' CYS . . . 47.9 -166.03 0.17 Allowed Glycine 0 CA--C 1.528 0.864 0 C-N-CA 119.064 -1.541 . . . . 2.37 114.9 171.612 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 13.8 p -82.35 44.24 0.86 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 114.981 -0.61 . . . . 4.07 112.216 -178.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 119.33 8.93 8.97 Favored Glycine 0 C--N 1.338 0.64 0 N-CA-C 115.15 0.82 . . . . 2.2 115.15 177.248 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 165' ' ' GLY . . . . . 0.651 ' HA3' ' HA ' ' B' ' 175' ' ' SER . . . -103.61 160.69 16.28 Favored Glycine 0 CA--C 1.521 0.425 0 C-N-CA 119.551 -1.309 . . . . 1.62 115.684 -178.072 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 166' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.73 153.23 22.14 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 108.342 -0.985 . . . . 3.05 108.342 176.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 167' ' ' CYS . . . . . 0.615 ' HB3' ' HB2' ' B' ' 159' ' ' LYS . 47.5 t -58.31 115.53 3.02 Favored 'General case' 0 N--CA 1.426 -1.629 0 N-CA-C 109.345 -0.613 . . . . 1.56 109.345 -179.293 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 168' ' ' ALA . . . . . 0.978 ' HB1' ' SG ' ' B' ' 128' ' ' CYS . . . -63.26 -47.3 82.97 Favored 'General case' 0 N--CA 1.428 -1.546 0 N-CA-C 107.263 -1.384 . . . . 1.04 107.263 178.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 169' ' ' ALA . . . . . 0.811 ' CB ' ' HA2' ' B' ' 133' ' ' GLY . . . -169.01 164.25 11.39 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.189 -1.369 . . . . 0.98 108.967 -175.034 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 170' ' ' ALA . . . . . 1.003 ' HA ' ' HB3' ' B' ' 185' ' ' CYS . . . -44.07 130.71 6.02 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.469 0.652 . . . . 1.25 112.691 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 171' ' ' GLY . . . . . 0.735 ' N ' ' O ' ' B' ' 185' ' ' CYS . . . 78.4 -21.04 3.78 Favored Glycine 0 CA--C 1.521 0.458 0 CA-C-N 114.845 -1.071 . . . . 1.29 115.511 177.546 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 172' ' ' ILE . . . . . 0.631 ' CD1' ' HB2' ' B' ' 134' ' ' CYS . 1.2 pp -132.43 116.24 27.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 122.408 1.099 . . . . 2.27 110.747 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 173' ' ' CYS . . . . . 0.553 ' HA ' ' H ' ' B' ' 168' ' ' ALA . 1.5 t -106.5 112.5 25.53 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.083 -1.417 . . . . 1.94 110.686 -177.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 174' ' ' CYS . . . . . 0.702 ' HA ' ' HA ' ' B' ' 179' ' ' CYS . 4.4 m -84.29 148.0 26.91 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.903 0.859 . . . . 1.35 112.838 -177.731 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 175' ' ' SER . . . . . 0.832 ' HB2' ' HD2' ' B' ' 176' ' ' PRO . 11.6 p -122.68 -179.89 0.88 Allowed Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 114.057 -1.429 . . . . 2.0 107.998 178.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 176' ' ' PRO . . . . . 0.832 ' HD2' ' HB2' ' B' ' 175' ' ' SER . 57.3 Cg_endo -73.71 29.92 0.32 Allowed 'Trans proline' 0 N--CA 1.46 -0.482 0 CA-C-N 119.797 0.963 . . . . 1.9 111.681 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 177' ' ' ASP . . . . . 0.505 ' H ' ' C ' ' B' ' 175' ' ' SER . 2.5 p30 -145.78 -49.41 0.22 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.63 -0.713 . . . . 2.72 110.585 179.133 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 178' ' ' GLY . . . . . 1.061 ' HA3' ' O ' ' A' ' 79' ' ' CYS . . . -155.77 -140.69 3.04 Favored Glycine 0 C--N 1.338 0.652 0 C-N-CA 120.492 -0.861 . . . . 0.99 113.886 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 179' ' ' CYS . . . . . 1.083 ' O ' ' HA3' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -142.94 153.04 42.66 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-N 115.281 -0.46 . . . . 1.34 110.511 -179.892 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 180' ' ' HIS . . . . . . . . . . . . . 4.2 p-80 -154.11 160.39 41.92 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.098 -0.641 . . . . 2.1 111.975 -178.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 181' ' ' GLU . . . . . 0.586 ' HA ' ' O ' ' B' ' 171' ' ' GLY . 0.0 OUTLIER -60.23 140.48 56.99 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.844 -0.616 . . . . 3.06 110.307 179.828 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 182' ' ' ASP . . . . . 0.457 ' HB3' ' HB3' ' B' ' 173' ' ' CYS . 3.7 p-10 -139.69 140.28 24.46 Favored Pre-proline 0 CA--C 1.541 0.627 0 CA-C-N 116.01 -0.541 . . . . 2.06 110.759 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 183' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' B' ' 182' ' ' ASP . 3.4 Cg_exo -77.09 -25.17 8.98 Favored 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 123.236 2.624 . . . . 1.91 114.252 -177.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -66.23 -43.88 85.37 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 107.808 -1.182 . . . . 1.56 107.808 178.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 185' ' ' CYS . . . . . 1.003 ' HB3' ' HA ' ' B' ' 170' ' ' ALA . 33.2 m -100.05 73.44 1.73 Allowed 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 114.037 -1.438 . . . . 1.94 109.067 177.579 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 186' ' ' ASP . . . . . 1.074 ' H ' ' HD3' ' B' ' 187' ' ' PRO . 0.3 OUTLIER -170.84 24.49 0.0 OUTLIER Pre-proline 0 C--N 1.311 -1.095 0 CA-C-N 115.666 -0.697 . . . . 3.61 111.92 -179.568 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 187' ' ' PRO . . . . . 1.074 ' HD3' ' H ' ' B' ' 186' ' ' ASP . 10.2 Cg_exo -70.61 177.57 6.03 Favored 'Trans proline' 0 N--CA 1.432 -2.103 0 CA-C-N 119.769 0.953 . . . . 2.58 111.011 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 188' ' ' GLU . . . . . 0.507 ' C ' ' O ' ' B' ' 187' ' ' PRO . 1.9 pt-20 -21.71 -24.81 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 113.072 -1.876 . . . . 4.7 109.739 176.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 189' ' ' ALA . . . . . 0.931 ' N ' ' O ' ' B' ' 187' ' ' PRO . . . -47.95 -5.6 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 114.15 1.167 . . . . 5.24 114.15 -179.54 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 190' ' ' ALA . . . . . 0.446 ' H ' ' C ' ' B' ' 188' ' ' GLU . . . -67.4 157.83 33.17 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.67 0.747 . . . . 6.93 111.952 -179.399 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 191' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -100.75 99.74 10.31 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 114.688 -1.142 . . . . 10.14 110.209 177.461 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 44.8 p . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.155 -0.926 . . . . 11.7 111.036 -179.85 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.804 0 CA-C-O 119.974 -0.06 . . . . 9.95 111.128 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.618 ' C ' HD22 ' A' ' 3' ' ' LEU . 12.7 p -177.22 48.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-O 122.804 1.288 . . . . 8.02 111.409 -178.465 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.979 HD13 ' HB3' ' A' ' 55' ' ' GLN . 3.8 mm? -135.18 99.69 4.33 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 113.33 -1.759 . . . . 5.86 107.096 178.573 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.694 ' H ' ' HA ' ' A' ' 55' ' ' GLN . 0.6 OUTLIER -77.81 22.8 0.26 Allowed 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.116 -0.698 . . . . 6.22 109.116 178.832 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.588 HD12 ' H ' ' A' ' 6' ' ' ASP . 0.2 OUTLIER -143.96 -133.65 0.09 Allowed 'General case' 0 N--CA 1.433 -1.303 0 N-CA-C 104.233 -2.506 . . . . 7.09 104.233 -175.514 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.588 ' H ' HD12 ' A' ' 5' ' ' LEU . 6.8 t70 -160.24 -42.92 0.05 OUTLIER 'General case' 0 C--N 1.282 -2.356 0 CA-C-O 122.407 1.099 . . . . 8.78 109.879 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.41 ' H ' HD12 ' A' ' 5' ' ' LEU . 7.1 p -127.8 123.31 60.74 Favored 'Isoleucine or valine' 0 CA--C 1.468 -2.176 1 N-CA-C 99.363 -4.31 . . . . 7.51 99.363 170.579 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.428 ' HG2' ' HG2' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -73.44 110.8 8.01 Favored 'General case' 0 N--CA 1.394 -3.27 0 C-N-CA 116.417 -2.113 . . . . 9.08 108.957 -171.955 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.469 ' O ' HD22 ' A' ' 11' ' ' LEU . 0.9 OUTLIER -103.11 96.27 6.67 Favored 'General case' 0 N--CA 1.394 -3.274 0 N-CA-C 100.538 -3.875 . . . . 5.66 100.538 170.54 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.606 ' HB3' ' HD3' ' A' ' 20' ' ' ARG . 1.0 OUTLIER -80.49 74.52 7.37 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 112.971 -1.922 . . . . 2.68 111.689 179.535 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.742 ' H ' HD22 ' A' ' 11' ' ' LEU . 3.4 mm? -30.68 111.08 0.28 Allowed Pre-proline 0 N--CA 1.472 0.673 0 N-CA-C 112.976 0.732 . . . . 2.48 112.976 -178.602 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.842 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 72.9 Cg_endo -73.96 153.44 47.31 Favored 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 123.087 2.525 . . . . 1.49 111.518 179.06 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.626 ' O ' ' HA2' ' A' ' 17' ' ' GLY . 16.1 p -160.7 -167.33 1.83 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 119.134 -1.027 . . . . 1.0 111.266 174.503 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 1.033 ' HA2' ' HB3' ' A' ' 40' ' ' GLU . . . 76.0 -160.38 51.39 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 120.241 -0.981 . . . . 1.15 114.761 177.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.573 ' HD2' ' CZ ' ' A' ' 35' ' ' PHE . 43.5 Cg_endo -64.94 99.07 0.32 Allowed 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 124.198 3.265 . . . . 1.57 113.328 178.498 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.62 -4.37 84.68 Favored Glycine 0 C--N 1.265 -3.363 0 CA-C-N 112.801 -1.999 . . . . 1.68 111.975 -176.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.626 ' HA2' ' O ' ' A' ' 13' ' ' CYS . . . 71.03 42.52 59.03 Favored Glycine 0 N--CA 1.432 -1.621 0 C-N-CA 118.31 -1.9 . . . . 1.36 113.19 174.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.98 -33.97 18.22 Favored 'General case' 0 C--N 1.359 1.021 0 CA-C-N 112.922 -1.639 . . . . 2.5 111.329 -178.697 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.842 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -77.55 -167.37 28.89 Favored Glycine 0 N--CA 1.468 0.795 0 C-N-CA 128.194 2.807 . . . . 1.02 111.165 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.729 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -130.74 173.76 10.6 Favored 'General case' 0 CA--C 1.553 1.089 0 N-CA-C 105.268 -2.123 . . . . 2.92 105.268 174.375 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.1 m -105.7 141.62 36.82 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 119.534 1.061 . . . . 1.1 111.395 -178.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -124.48 -48.2 1.82 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.765 -0.652 . . . . 1.51 110.549 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.533 ' HA3' HD12 ' A' ' 26' ' ' ILE . . . -128.94 -177.81 15.06 Favored Glycine 0 C--N 1.33 0.248 0 N-CA-C 111.322 -0.711 . . . . 0.9 111.322 179.313 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo -64.79 -71.02 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 121.969 1.779 . . . . 1.5 111.219 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.585 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.6 OUTLIER -89.8 41.53 1.05 Allowed 'General case' 0 CA--C 1.521 -0.145 0 N-CA-C 108.788 -0.819 . . . . 1.26 108.788 177.759 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.858 HG23 HG13 ' A' ' 36' ' ' VAL . 2.0 mt -144.92 111.59 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.908 0 CA-C-N 116.079 -0.51 . . . . 0.83 112.184 -177.556 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.692 ' SG ' ' HA ' ' A' ' 41' ' ' ALA . 0.8 OUTLIER -120.82 130.98 54.19 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 109.574 -0.528 . . . . 0.92 109.574 179.585 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.794 ' SG ' ' HB1' ' A' ' 68' ' ' ALA . 1.6 m -123.84 171.51 9.61 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 117.365 -1.734 . . . . 1.28 114.41 -177.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.571 ' HA3' ' HB2' ' A' ' 32' ' ' LEU . . . -146.85 174.86 26.53 Favored Glycine 0 N--CA 1.415 -2.714 0 N-CA-C 109.405 -1.478 . . . . 0.67 109.405 173.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -65.01 -58.51 5.92 Favored 'General case' 0 N--CA 1.422 -1.829 0 N-CA-C 104.424 -2.436 . . . . 2.27 104.424 177.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -115.07 22.11 13.66 Favored 'General case' 0 CA--C 1.478 -1.809 0 CA-C-N 114.246 -1.343 . . . . 1.66 108.689 -175.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.773 HD22 ' CE1' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -109.92 -17.8 13.54 Favored 'General case' 0 N--CA 1.408 -2.563 0 N-CA-C 105.987 -1.857 . . . . 1.37 105.987 177.793 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.892 ' HA2' ' CB ' ' A' ' 69' ' ' ALA . . . 63.6 -135.83 41.72 Favored Glycine 0 N--CA 1.403 -3.524 0 CA-C-N 113.635 -1.62 . . . . 0.73 110.797 -179.152 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.832 ' SG ' HG22 ' A' ' 26' ' ' ILE . 0.7 OUTLIER -143.27 122.1 12.68 Favored 'General case' 0 CA--C 1.479 -1.767 0 CA-C-N 119.13 1.465 . . . . 1.08 113.582 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 1.133 ' HA ' ' HA ' ' B' ' 135' ' ' PHE . 0.0 OUTLIER -88.84 105.34 17.67 Favored 'General case' 0 N--CA 1.411 -2.419 0 N-CA-C 103.945 -2.613 . . . . 1.38 103.945 176.13 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.858 HG13 HG23 ' A' ' 26' ' ' ILE . 1.6 t -96.7 85.67 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.863 0 N-CA-C 107.579 -1.267 . . . . 0.76 107.579 -179.496 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.878 ' HA3' HG12 ' B' ' 172' ' ' ILE . . . 122.03 12.99 5.11 Favored Glycine 0 C--N 1.32 -0.36 0 CA-C-N 113.738 -1.573 . . . . 0.81 115.898 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.697 HG22 ' O ' ' B' ' 132' ' ' LEU . 47.4 p -94.89 164.47 12.9 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 118.496 1.148 . . . . 0.77 110.195 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.641 ' HA ' HD12 ' A' ' 42' ' ' LEU . . . -61.2 -34.82 75.7 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.184 0.516 . . . . 1.02 109.811 179.206 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 1.033 ' HB3' ' HA2' ' A' ' 14' ' ' GLY . 0.6 OUTLIER -59.83 -14.63 15.9 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.912 -0.586 . . . . 2.32 111.537 -179.397 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.831 ' O ' ' HB2' ' A' ' 44' ' ' CYS . . . -91.95 -26.77 18.26 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 116.285 -0.416 . . . . 0.87 109.982 179.241 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.641 HD12 ' HA ' ' A' ' 39' ' ' ALA . 9.1 mt -48.21 -36.58 14.03 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 112.505 0.558 . . . . 1.23 112.505 -179.111 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.586 ' C ' ' H ' ' A' ' 45' ' ' GLN . 0.0 OUTLIER -54.91 -28.19 48.8 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 107.502 -1.296 . . . . 2.92 107.502 177.417 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.831 ' HB2' ' O ' ' A' ' 41' ' ' ALA . 1.2 m -54.97 4.01 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 114.435 -1.257 . . . . 1.57 111.18 -176.035 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.586 ' H ' ' C ' ' A' ' 43' ' ' ARG . 17.3 tt0 -72.48 -31.92 65.78 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.212 0.53 . . . . 3.31 110.951 177.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -86.3 6.78 28.19 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.995 0.426 . . . . 3.69 110.685 -179.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 25.0 tp10 -83.17 1.69 39.32 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 109.078 -0.712 . . . . 3.99 109.078 177.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.407 ' C ' ' H ' ' A' ' 50' ' ' LEU . 4.2 t-20 -88.7 -28.49 20.53 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.966 -0.561 . . . . 3.86 109.74 178.598 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -66.51 8.88 0.2 Allowed 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 112.503 0.557 . . . . 5.68 112.503 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.407 ' H ' ' C ' ' A' ' 48' ' ' ASN . 0.4 OUTLIER -137.35 107.85 8.66 Favored Pre-proline 0 CA--C 1.53 0.198 0 CA-C-O 120.452 0.168 . . . . 5.4 110.953 -179.55 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -78.07 26.21 0.5 Allowed 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.494 2.129 . . . . 4.92 113.463 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 54.0 p -159.87 121.02 1.76 Allowed Pre-proline 0 CA--C 1.532 0.277 0 CA-C-O 120.576 0.227 . . . . 5.64 111.281 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.587 ' O ' HD23 ' A' ' 5' ' ' LEU . 82.9 Cg_endo -77.44 170.95 18.48 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.722 2.282 . . . . 5.04 112.083 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.646 ' C ' ' HG3' ' A' ' 55' ' ' GLN . 30.7 p -78.51 102.68 8.0 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.264 0.554 . . . . 2.74 111.464 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.979 ' HB3' HD13 ' A' ' 3' ' ' LEU . 0.0 OUTLIER 41.14 -142.84 0.06 Allowed 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 115.342 -0.844 . . . . 5.75 112.906 179.152 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.422 ' H ' ' HB2' ' A' ' 55' ' ' GLN . 12.2 t -156.18 -98.32 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 109.071 -0.714 . . . . 3.12 109.071 -179.346 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 112.97 -107.22 1.95 Allowed Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.555 -0.831 . . . . 2.1 112.652 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.69 87.05 2.67 Favored 'General case' 0 CA--C 1.476 -1.877 0 N-CA-C 102.944 -2.984 . . . . 4.36 102.944 176.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.863 ' CA ' ' H ' ' A' ' 67' ' ' CYS . 15.4 mmtt -137.32 -57.37 0.02 OUTLIER Pre-proline 0 C--N 1.296 -1.76 0 C-N-CA 118.629 -1.228 . . . . 3.55 112.05 -173.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.674 ' HD2' ' H ' ' A' ' 59' ' ' LYS . 9.4 Cg_endo -51.94 98.08 0.04 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.121 0 CA-C-N 120.709 1.289 . . . . 1.54 113.703 -179.521 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.417 ' SG ' ' N ' ' A' ' 62' ' ' GLY . 0.1 OUTLIER -140.98 -173.77 3.81 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 105.832 -1.914 . . . . 1.59 105.832 178.776 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.434 ' HA3' ' CE1' ' A' ' 80' ' ' HIS . . . 61.91 -165.18 20.73 Favored Glycine 0 C--N 1.316 -0.577 0 C-N-CA 117.454 -2.308 . . . . 2.43 112.548 176.144 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.4 m -84.39 42.46 0.89 Allowed 'General case' 0 N--CA 1.479 1.0 0 CA-C-O 122.204 1.002 . . . . 4.11 111.575 -176.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 115.78 5.84 17.64 Favored Glycine 0 CA--C 1.535 1.292 0 CA-C-N 113.89 -1.505 . . . . 2.21 114.937 178.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.666 ' CA ' ' HA ' ' A' ' 75' ' ' SER . . . -101.13 153.37 19.05 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 119.132 -1.508 . . . . 1.62 116.481 -174.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.804 ' CB ' ' HB3' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -85.24 152.26 23.45 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 114.354 -0.923 . . . . 3.02 109.553 179.364 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.863 ' H ' ' CA ' ' A' ' 59' ' ' LYS . 0.1 OUTLIER -70.13 107.83 3.84 Favored 'General case' 0 N--CA 1.42 -1.94 0 CA-C-N 119.643 1.11 . . . . 1.52 109.798 -178.767 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.846 ' HB3' HD12 ' A' ' 72' ' ' ILE . . . -67.02 -32.05 73.0 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 115.235 -0.893 . . . . 1.07 109.78 179.176 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.892 ' CB ' ' HA2' ' A' ' 33' ' ' GLY . . . -170.66 164.54 8.2 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.464 -1.244 . . . . 1.0 110.917 -177.423 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 1.044 ' HA ' ' HB3' ' A' ' 85' ' ' CYS . . . -66.91 70.76 0.08 Allowed 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.264 -0.574 . . . . 1.24 111.985 178.554 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.608 ' HA2' ' O ' ' A' ' 85' ' ' CYS . . . 164.99 -42.33 0.29 Allowed Glycine 0 CA--C 1.52 0.369 0 CA-C-N 115.818 -0.628 . . . . 1.28 114.227 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.885 HG12 ' HA3' ' B' ' 137' ' ' GLY . 1.3 pp -120.76 121.52 65.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.191 0.52 . . . . 2.27 111.037 -178.006 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.596 ' HB2' ' HB3' ' A' ' 82' ' ' ASP . 0.1 OUTLIER -95.58 111.72 23.58 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.635 -0.711 . . . . 1.98 109.825 -179.888 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.622 ' HB2' ' HB2' ' A' ' 68' ' ' ALA . 1.3 m -84.74 117.3 23.74 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.382 0.61 . . . . 1.33 112.378 -178.313 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.666 ' HA ' ' CA ' ' A' ' 65' ' ' GLY . 29.6 p -92.66 -179.67 1.12 Allowed Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 114.909 -1.041 . . . . 1.99 109.162 178.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.626 ' CD ' ' HB2' ' A' ' 75' ' ' SER . 4.2 Cg_exo -74.6 29.62 0.35 Allowed 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 121.7 1.6 . . . . 1.86 111.691 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.461 ' H ' ' C ' ' A' ' 75' ' ' SER . 2.4 p30 -145.65 -37.94 0.26 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.704 -0.68 . . . . 2.65 110.825 179.24 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.791 ' HA3' ' O ' ' B' ' 179' ' ' CYS . . . -170.0 -133.56 1.61 Allowed Glycine 0 C--N 1.339 0.702 0 C-N-CA 120.617 -0.801 . . . . 0.99 113.38 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.825 ' O ' ' HA3' ' B' ' 178' ' ' GLY . 0.0 OUTLIER -146.27 150.93 36.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.126 0.489 . . . . 1.34 110.831 -179.62 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.434 ' CE1' ' HA3' ' A' ' 62' ' ' GLY . 50.2 p-80 -154.25 160.48 41.83 Favored 'General case' 0 C--N 1.331 -0.236 0 O-C-N 122.03 -0.419 . . . . 2.17 111.56 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.556 ' OE2' ' HG2' ' B' ' 124' ' ' PRO . 1.5 mt-10 -59.7 140.75 56.21 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.281 -0.418 . . . . 3.05 110.228 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.596 ' HB3' ' HB2' ' A' ' 73' ' ' CYS . 7.9 p-10 -145.08 140.59 16.28 Favored Pre-proline 0 CA--C 1.535 0.385 0 CA-C-N 116.487 -0.324 . . . . 2.02 111.599 -179.097 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 82' ' ' ASP . 3.4 Cg_exo -77.58 -14.5 15.95 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 123.243 2.629 . . . . 1.93 113.665 -179.08 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.3 -46.58 60.4 Favored 'General case' 0 CA--C 1.504 -0.826 0 N-CA-C 107.158 -1.423 . . . . 1.53 107.158 178.204 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 1.044 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 97.7 m -106.84 84.76 2.04 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 113.559 -1.655 . . . . 1.88 107.493 176.716 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.937 ' H ' ' CD ' ' A' ' 87' ' ' PRO . 1.2 t70 -165.06 -19.3 0.0 OUTLIER Pre-proline 0 C--N 1.316 -0.856 0 CA-C-N 113.857 -1.52 . . . . 3.6 113.619 -177.179 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.937 ' CD ' ' H ' ' A' ' 86' ' ' ASP . 5.7 Cg_endo -80.84 66.36 8.84 Favored 'Trans proline' 0 CA--C 1.501 -1.153 0 CA-C-N 120.659 1.271 . . . . 2.56 113.619 -179.197 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.532 ' HG3' ' N ' ' A' ' 89' ' ' ALA . 10.4 pt-20 174.39 -43.39 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 123.172 1.463 . . . . 4.72 109.009 177.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.532 ' N ' ' HG3' ' A' ' 88' ' ' GLU . . . -74.5 -109.78 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 111.745 -2.48 . . . . 5.29 114.812 -176.075 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -76.04 127.63 33.36 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.051 -1.432 . . . . 6.98 113.486 -175.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -90.99 129.44 36.99 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.28 -0.873 . . . . 10.21 109.762 178.002 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.9 t . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.218 -0.896 . . . . 11.77 110.986 -179.946 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.19 0 CA-C-O 119.401 -0.333 . . . . 10.07 111.503 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 34.8 t -122.21 141.35 42.96 Favored 'Isoleucine or valine' 0 C--N 1.342 0.278 0 C-N-CA 118.28 -1.368 . . . . 8.41 109.561 176.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 103' ' ' LEU . . . . . 0.736 HD13 ' O ' ' B' ' 106' ' ' ASP . 0.9 OUTLIER -148.43 128.69 13.79 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 120.228 1.377 . . . . 5.87 110.219 177.781 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -97.61 51.61 1.08 Allowed 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 106.529 -1.656 . . . . 6.27 106.529 176.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 105' ' ' LEU . . . . . 0.715 HD23 ' O ' ' B' ' 153' ' ' PRO . 0.7 OUTLIER -155.0 -123.34 0.03 OUTLIER 'General case' 0 N--CA 1.413 -2.282 0 CA-C-N 113.094 -1.866 . . . . 7.2 106.106 -177.176 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 106' ' ' ASP . . . . . 0.736 ' O ' HD13 ' B' ' 103' ' ' LEU . 6.7 t70 -162.85 -95.35 0.02 OUTLIER 'General case' 0 C--N 1.277 -2.573 0 N-CA-C 106.035 -1.839 . . . . 8.55 106.035 177.225 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 107' ' ' VAL . . . . . 0.473 ' O ' HD12 ' B' ' 105' ' ' LEU . 2.8 p -89.37 129.65 40.01 Favored 'Isoleucine or valine' 0 CA--C 1.475 -1.909 0 N-CA-C 100.274 -3.972 . . . . 7.48 100.274 175.029 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 108' ' ' ARG . . . . . 0.44 ' HG2' ' HG2' ' B' ' 155' ' ' GLN . 0.0 OUTLIER -71.37 111.88 7.05 Favored 'General case' 0 N--CA 1.401 -2.904 0 C-N-CA 116.624 -2.031 . . . . 9.12 109.972 -170.207 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 109' ' ' THR . . . . . 0.464 ' O ' HD22 ' B' ' 111' ' ' LEU . 0.9 OUTLIER -104.46 96.77 6.83 Favored 'General case' 0 N--CA 1.397 -3.108 0 N-CA-C 100.46 -3.904 . . . . 5.69 100.46 170.811 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 110' ' ' CYS . . . . . 0.583 ' HB3' ' HD3' ' B' ' 120' ' ' ARG . 0.9 OUTLIER -81.72 74.98 8.68 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 112.577 -2.101 . . . . 2.61 111.441 -179.881 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 111' ' ' LEU . . . . . 0.738 ' H ' HD22 ' B' ' 111' ' ' LEU . 3.4 mm? -30.92 111.48 0.29 Allowed Pre-proline 0 N--CA 1.471 0.614 0 N-CA-C 112.923 0.712 . . . . 2.47 112.923 -178.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 112' ' ' PRO . . . . . 0.89 ' HA ' ' O ' ' B' ' 119' ' ' GLY . 89.6 Cg_endo -81.53 144.66 14.32 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.119 1.879 . . . . 1.47 114.183 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.593 ' O ' ' HA2' ' B' ' 117' ' ' GLY . 18.0 p -150.57 -165.0 2.15 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 118.633 -1.227 . . . . 1.0 111.479 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 114' ' ' GLY . . . . . 1.073 ' HA2' ' HB3' ' B' ' 140' ' ' GLU . . . 76.24 -160.81 51.42 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 120.449 -0.881 . . . . 1.16 115.192 177.354 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 115' ' ' PRO . . . . . 0.548 ' HD2' ' CZ ' ' B' ' 135' ' ' PHE . 43.4 Cg_endo -63.5 114.76 2.66 Favored 'Trans proline' 0 C--N 1.366 1.478 0 C-N-CA 123.922 3.081 . . . . 1.57 106.945 176.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 77.62 -14.99 8.19 Favored Glycine 0 C--N 1.261 -3.624 0 C-N-CA 123.98 0.8 . . . . 1.7 111.193 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 117' ' ' GLY . . . . . 0.593 ' HA2' ' O ' ' B' ' 113' ' ' CYS . . . 75.12 43.01 27.55 Favored Glycine 0 N--CA 1.413 -2.893 0 C-N-CA 117.767 -2.159 . . . . 1.38 110.909 179.223 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.38 -27.92 17.22 Favored 'General case' 0 C--N 1.355 0.833 0 CA-C-N 112.269 -1.965 . . . . 2.54 113.345 -179.13 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 119' ' ' GLY . . . . . 0.89 ' O ' ' HA ' ' B' ' 112' ' ' PRO . . . -102.29 -151.82 24.05 Favored Glycine 0 N--CA 1.431 -1.686 0 N-CA-C 108.507 -1.837 . . . . 1.04 108.507 178.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.669 ' HA ' ' O ' ' B' ' 111' ' ' LEU . 0.0 OUTLIER -127.32 174.51 8.91 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 118.638 1.219 . . . . 2.89 110.714 -177.872 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 121' ' ' CYS . . . . . . . . . . . . . 1.1 m -105.35 140.69 38.09 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.276 0.56 . . . . 1.07 111.092 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -124.52 -48.13 1.82 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.447 -0.797 . . . . 1.53 110.375 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 123' ' ' GLY . . . . . 0.537 ' HA3' HD12 ' B' ' 126' ' ' ILE . . . -128.94 -177.8 15.05 Favored Glycine 0 C--N 1.33 0.247 0 N-CA-C 111.303 -0.719 . . . . 0.9 111.303 179.321 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 124' ' ' PRO . . . . . 0.556 ' HG2' ' OE2' ' A' ' 81' ' ' GLU . 20.2 Cg_exo -64.84 -70.97 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 121.942 1.761 . . . . 1.51 111.258 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 125' ' ' SER . . . . . 0.591 ' O ' ' N ' ' B' ' 137' ' ' GLY . 0.6 OUTLIER -89.77 41.47 1.04 Allowed 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 108.7 -0.852 . . . . 1.25 108.7 177.808 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 126' ' ' ILE . . . . . 0.841 HG22 ' SG ' ' B' ' 134' ' ' CYS . 2.2 mt -144.71 111.39 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 CA-C-N 116.025 -0.534 . . . . 0.85 112.374 -177.501 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 127' ' ' CYS . . . . . 0.686 ' SG ' ' HA ' ' B' ' 141' ' ' ALA . 0.8 OUTLIER -121.1 130.46 53.76 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 109.436 -0.579 . . . . 0.89 109.436 179.352 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 128' ' ' CYS . . . . . 0.793 ' HA ' ' O ' ' B' ' 133' ' ' GLY . 1.0 OUTLIER -125.48 169.03 12.81 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 114.22 1.193 . . . . 1.23 114.22 -177.084 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 129' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' B' ' 133' ' ' GLY . . . -147.88 176.05 26.9 Favored Glycine 0 N--CA 1.419 -2.444 0 N-CA-C 107.515 -2.234 . . . . 0.66 107.515 175.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -66.55 -55.93 13.16 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 106.681 -1.6 . . . . 2.35 106.681 178.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -117.62 31.48 6.69 Favored 'General case' 0 CA--C 1.478 -1.817 0 CA-C-N 113.337 -1.756 . . . . 1.69 109.591 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 132' ' ' LEU . . . . . 0.775 HD22 ' CE1' ' B' ' 135' ' ' PHE . 0.5 OUTLIER -120.99 -14.0 8.51 Favored 'General case' 0 N--CA 1.408 -2.562 0 N-CA-C 104.667 -2.345 . . . . 1.38 104.667 178.239 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 133' ' ' GLY . . . . . 0.876 ' HA2' ' CB ' ' B' ' 169' ' ' ALA . . . 63.08 -132.48 42.85 Favored Glycine 0 N--CA 1.404 -3.476 0 CA-C-N 114.092 -1.413 . . . . 0.72 111.821 177.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 134' ' ' CYS . . . . . 0.841 ' SG ' HG22 ' B' ' 126' ' ' ILE . 1.0 OUTLIER -146.2 121.98 10.57 Favored 'General case' 0 CA--C 1.479 -1.768 0 CA-C-N 119.462 1.631 . . . . 1.08 112.762 178.62 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 135' ' ' PHE . . . . . 1.133 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -88.83 105.78 17.95 Favored 'General case' 0 N--CA 1.409 -2.5 0 N-CA-C 103.959 -2.608 . . . . 1.36 103.959 176.369 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 136' ' ' VAL . . . . . 0.799 HG23 HG23 ' A' ' 36' ' ' VAL . 1.9 t -96.24 85.49 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.781 0 N-CA-C 107.59 -1.263 . . . . 0.75 107.59 -179.447 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 137' ' ' GLY . . . . . 0.885 ' HA3' HG12 ' A' ' 72' ' ' ILE . . . 122.51 12.7 5.0 Favored Glycine 0 C--O 1.227 -0.296 0 CA-C-N 113.993 -1.458 . . . . 0.83 115.874 179.432 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 138' ' ' THR . . . . . 0.713 HG22 ' O ' ' A' ' 32' ' ' LEU . 46.6 p -96.74 160.7 14.23 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 118.521 1.16 . . . . 0.78 110.422 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 139' ' ' ALA . . . . . 0.596 ' HA ' HD12 ' B' ' 142' ' ' LEU . . . -62.37 -23.13 66.63 Favored 'General case' 0 N--CA 1.446 -0.641 0 O-C-N 121.965 -0.459 . . . . 1.04 111.85 -179.338 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 140' ' ' GLU . . . . . 1.073 ' HB3' ' HA2' ' B' ' 114' ' ' GLY . 0.6 OUTLIER -67.45 -14.17 62.69 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.24 0.543 . . . . 2.31 110.781 178.56 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 141' ' ' ALA . . . . . 0.858 ' O ' ' HB2' ' B' ' 144' ' ' CYS . . . -92.74 -26.31 17.81 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 115.562 -0.744 . . . . 0.87 110.304 179.443 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 142' ' ' LEU . . . . . 0.596 HD12 ' HA ' ' B' ' 139' ' ' ALA . 9.8 mt -47.7 -36.64 11.55 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.146 0.424 . . . . 1.24 112.146 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 143' ' ' ARG . . . . . 0.454 ' HD3' ' O ' ' B' ' 140' ' ' GLU . 0.0 OUTLIER -60.72 -17.47 48.51 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 121.965 0.888 . . . . 2.93 109.567 177.661 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 144' ' ' CYS . . . . . 0.858 ' HB2' ' O ' ' B' ' 141' ' ' ALA . 1.2 m -58.21 -3.83 0.3 Allowed 'General case' 0 CA--C 1.552 1.048 0 CA-C-N 113.178 -1.828 . . . . 1.61 110.868 178.345 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 145' ' ' GLN . . . . . 0.425 ' H ' ' C ' ' B' ' 143' ' ' ARG . 16.7 tt0 -67.83 -32.85 73.68 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.233 0.54 . . . . 3.35 111.769 179.341 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -86.35 6.89 27.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.008 0.432 . . . . 3.76 110.701 -179.33 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 24.9 tp10 -83.0 1.47 39.73 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 109.082 -0.71 . . . . 4.01 109.082 177.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 148' ' ' ASN . . . . . 0.408 ' C ' ' H ' ' B' ' 150' ' ' LEU . 4.2 t-20 -88.61 -28.31 20.76 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.995 -0.548 . . . . 3.92 109.851 178.636 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -66.66 9.01 0.2 Allowed 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.466 0.543 . . . . 5.73 112.466 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 150' ' ' LEU . . . . . 0.408 ' H ' ' C ' ' B' ' 148' ' ' ASN . 0.4 OUTLIER -137.41 107.84 8.61 Favored Pre-proline 0 N--CA 1.462 0.125 0 CA-C-O 120.479 0.18 . . . . 5.46 110.929 -179.542 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 151' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -78.1 26.18 0.5 Allowed 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.579 2.186 . . . . 5.02 113.482 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 53.1 p -159.87 120.86 1.75 Allowed Pre-proline 0 CA--C 1.533 0.316 0 CA-C-O 120.528 0.204 . . . . 5.73 111.294 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 153' ' ' PRO . . . . . 0.715 ' O ' HD23 ' B' ' 105' ' ' LEU . 85.0 Cg_endo -77.34 170.9 18.63 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.696 2.264 . . . . 5.1 112.174 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 154' ' ' CYS . . . . . 0.65 ' C ' ' HG3' ' B' ' 155' ' ' GLN . 30.6 p -78.53 102.87 8.11 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.108 0.48 . . . . 2.68 111.65 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 155' ' ' GLN . . . . . 0.724 ' HB3' ' CB ' ' B' ' 103' ' ' LEU . 0.0 OUTLIER 41.48 -143.18 0.07 Allowed 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 115.561 -0.745 . . . . 5.63 112.552 179.065 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 156' ' ' SER . . . . . 0.46 ' H ' ' HB2' ' B' ' 155' ' ' GLN . 12.1 t -155.88 -98.49 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.925 -0.768 . . . . 3.11 108.925 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 114.04 -108.81 2.1 Favored Glycine 0 C--N 1.336 0.561 0 C-N-CA 120.02 -1.086 . . . . 2.07 112.404 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 158' ' ' GLN . . . . . 0.435 ' O ' ' HB2' ' B' ' 167' ' ' CYS . 0.0 OUTLIER -124.0 71.41 1.12 Allowed 'General case' 0 CA--C 1.486 -1.502 0 N-CA-C 104.669 -2.345 . . . . 4.34 104.669 176.148 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 159' ' ' LYS . . . . . 0.892 ' HA ' ' H ' ' B' ' 167' ' ' CYS . 18.9 mmtt -107.08 -65.77 0.04 OUTLIER Pre-proline 0 N--CA 1.421 -1.899 0 N-CA-C 116.764 2.135 . . . . 3.54 116.764 -177.32 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 160' ' ' PRO . . . . . 0.587 ' HD2' ' H ' ' B' ' 159' ' ' LYS . 9.6 Cg_endo -51.96 96.61 0.04 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.267 0 C-N-CA 122.351 2.034 . . . . 1.51 114.722 -174.111 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 161' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -143.62 179.72 6.96 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 112.922 -1.944 . . . . 1.58 105.838 177.554 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 70.03 -166.21 50.22 Favored Glycine 0 N--CA 1.441 -0.972 0 C-N-CA 117.58 -2.248 . . . . 2.37 111.863 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 2.8 m -83.95 43.55 0.93 Allowed 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 121.869 0.842 . . . . 4.07 111.21 -177.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 112.2 8.54 21.53 Favored Glycine 0 C--N 1.346 1.108 0 CA-C-N 113.961 -1.472 . . . . 2.2 114.775 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 165' ' ' GLY . . . . . 0.667 ' CA ' ' HA ' ' B' ' 175' ' ' SER . . . -103.0 156.12 18.12 Favored Glycine 0 C--N 1.339 0.748 0 CA-C-N 119.916 1.858 . . . . 1.62 116.27 -177.54 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 166' ' ' ARG . . . . . 0.871 ' CB ' ' HB3' ' B' ' 159' ' ' LYS . 0.0 OUTLIER -85.64 152.19 23.3 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 114.309 -0.945 . . . . 3.05 109.324 178.765 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 167' ' ' CYS . . . . . 0.892 ' H ' ' HA ' ' B' ' 159' ' ' LYS . 0.1 OUTLIER -70.32 107.74 3.9 Favored 'General case' 0 N--CA 1.418 -2.042 0 CA-C-N 119.558 1.072 . . . . 1.56 109.656 -178.853 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 168' ' ' ALA . . . . . 0.884 ' HB3' HD12 ' B' ' 172' ' ' ILE . . . -64.39 -36.1 83.04 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 122.238 1.018 . . . . 1.04 108.718 178.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 169' ' ' ALA . . . . . 0.876 ' CB ' ' HA2' ' B' ' 133' ' ' GLY . . . -168.57 164.59 12.42 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 113.287 -1.779 . . . . 0.98 112.017 -175.55 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 170' ' ' ALA . . . . . 1.067 ' HA ' ' HB3' ' B' ' 185' ' ' CYS . . . -67.28 71.15 0.11 Allowed 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.127 -0.629 . . . . 1.25 111.93 178.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 171' ' ' GLY . . . . . 0.552 ' HA2' ' O ' ' B' ' 185' ' ' CYS . . . 167.19 -48.83 0.25 Allowed Glycine 0 N--CA 1.455 -0.098 0 CA-C-N 115.525 -0.761 . . . . 1.29 112.74 179.464 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 172' ' ' ILE . . . . . 0.884 HD12 ' HB3' ' B' ' 168' ' ' ALA . 1.3 pp -115.86 121.77 68.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 C-N-CA 123.139 0.576 . . . . 2.27 111.647 -175.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 173' ' ' CYS . . . . . 0.6 ' HB2' ' HB3' ' B' ' 182' ' ' ASP . 0.1 OUTLIER -95.96 111.65 23.59 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.739 -0.664 . . . . 1.94 109.781 -179.918 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 174' ' ' CYS . . . . . 0.576 ' HB2' ' HB2' ' B' ' 168' ' ' ALA . 1.3 m -84.8 117.48 23.88 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.363 0.601 . . . . 1.35 112.359 -178.26 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 175' ' ' SER . . . . . 0.667 ' HA ' ' CA ' ' B' ' 165' ' ' GLY . 28.6 p -92.75 -179.67 1.11 Allowed Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 114.883 -1.053 . . . . 2.0 109.141 179.019 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 176' ' ' PRO . . . . . 0.612 ' CD ' ' HB2' ' B' ' 175' ' ' SER . 4.2 Cg_exo -74.62 29.67 0.35 Allowed 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 121.718 1.612 . . . . 1.9 111.681 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 177' ' ' ASP . . . . . 0.471 ' H ' ' C ' ' B' ' 175' ' ' SER . 2.4 p30 -145.7 -38.17 0.25 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.672 -0.694 . . . . 2.72 110.753 179.289 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 178' ' ' GLY . . . . . 0.825 ' HA3' ' O ' ' A' ' 79' ' ' CYS . . . -169.48 -133.87 1.65 Allowed Glycine 0 C--N 1.338 0.642 0 C-N-CA 120.63 -0.795 . . . . 0.99 113.388 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 179' ' ' CYS . . . . . 0.791 ' O ' ' HA3' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -146.08 151.14 37.23 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.073 0.463 . . . . 1.34 110.808 -179.77 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 180' ' ' HIS . . . . . . . . . . . . . 50.1 p-80 -154.56 160.46 41.52 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.625 -0.43 . . . . 2.1 111.542 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 181' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -59.9 140.52 56.61 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.309 -0.405 . . . . 3.06 110.187 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 182' ' ' ASP . . . . . 0.6 ' HB3' ' HB2' ' B' ' 173' ' ' CYS . 7.9 p-10 -144.81 140.61 16.52 Favored Pre-proline 0 CA--C 1.537 0.455 0 CA-C-N 116.493 -0.321 . . . . 2.06 111.629 -179.126 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 183' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' B' ' 182' ' ' ASP . 3.4 Cg_exo -77.41 -14.71 16.15 Favored 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 123.156 2.57 . . . . 1.91 113.672 -179.095 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -71.25 -46.62 60.6 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 107.134 -1.432 . . . . 1.56 107.134 178.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 185' ' ' CYS . . . . . 1.067 ' HB3' ' HA ' ' B' ' 170' ' ' ALA . 87.0 m -106.5 84.53 2.03 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 113.566 -1.652 . . . . 1.94 107.515 176.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 186' ' ' ASP . . . . . 0.934 ' H ' ' CD ' ' B' ' 187' ' ' PRO . 1.1 t70 -164.71 -19.78 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.765 0 CA-C-N 113.782 -1.554 . . . . 3.61 113.835 -177.232 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 187' ' ' PRO . . . . . 0.934 ' CD ' ' H ' ' B' ' 186' ' ' ASP . 6.2 Cg_endo -80.96 72.13 6.69 Favored 'Trans proline' 0 C--N 1.361 1.203 0 C-N-CA 121.961 1.774 . . . . 2.58 110.157 179.152 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 188' ' ' GLU . . . . . 0.548 ' HB3' ' O ' ' B' ' 187' ' ' PRO . 9.8 pt-20 169.57 -40.35 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 110.714 -2.948 . . . . 4.7 111.613 171.252 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 189' ' ' ALA . . . . . 0.507 ' N ' ' HG3' ' B' ' 188' ' ' GLU . . . -74.31 -96.78 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 119.477 3.14 . . . . 5.24 119.477 -173.255 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 190' ' ' ALA . . . . . . . . . . . . . . . -89.02 127.74 35.69 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 114.289 -1.323 . . . . 6.93 113.229 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 191' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -90.74 129.2 36.85 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 114.918 -1.037 . . . . 10.14 109.847 178.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 5.8 t . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.24 -0.886 . . . . 11.7 111.085 179.959 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 122.177 0.989 . . . . 9.95 110.702 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -95.48 85.72 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-N 113.379 -1.737 . . . . 8.02 109.3 177.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.999 ' HG ' ' HB3' ' A' ' 8' ' ' ARG . 0.4 OUTLIER -74.05 89.21 1.93 Allowed 'General case' 0 C--N 1.356 0.871 0 C-N-CA 118.839 -1.145 . . . . 5.86 108.943 -177.715 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -91.56 65.85 5.25 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 120.48 1.491 . . . . 6.22 111.63 -178.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.781 HD12 ' O ' ' A' ' 7' ' ' VAL . 1.2 tm? -114.35 -57.79 2.23 Favored 'General case' 0 CA--C 1.454 -2.723 0 CA-C-O 124.804 2.24 . . . . 7.09 109.161 -174.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.653 ' HB2' ' O ' ' A' ' 5' ' ' LEU . 0.2 OUTLIER 156.95 -35.46 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 CA-C-N 108.596 -3.911 . . . . 8.78 111.184 176.454 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.781 ' O ' HD12 ' A' ' 5' ' ' LEU . 10.8 p -158.5 127.87 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-N 112.23 -2.259 . . . . 7.51 105.202 175.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.999 ' HB3' ' HG ' ' A' ' 3' ' ' LEU . 3.7 ptt-85 -78.21 105.86 9.72 Favored 'General case' 0 N--CA 1.406 -2.629 0 C-N-CA 119.466 -0.894 . . . . 9.08 110.648 -178.179 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.699 ' O ' ' HG2' ' A' ' 53' ' ' PRO . 0.2 OUTLIER -103.86 85.64 2.45 Favored 'General case' 0 N--CA 1.409 -2.521 1 N-CA-C 98.803 -4.517 . . . . 5.66 98.803 169.057 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.673 ' HA ' ' CB ' ' A' ' 54' ' ' CYS . 82.7 m -74.75 66.92 1.54 Allowed 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 112.889 -1.96 . . . . 2.68 112.766 -176.69 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.941 HD22 ' HG3' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -35.63 108.46 0.37 Allowed Pre-proline 0 N--CA 1.483 1.221 0 C-N-CA 123.555 0.742 . . . . 2.48 112.389 179.28 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.852 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 43.8 Cg_endo -90.08 138.92 2.97 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.988 2.459 . . . . 1.49 114.044 -179.219 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.502 ' SG ' ' HE2' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -151.43 173.05 15.01 Favored 'General case' 0 C--N 1.351 0.642 0 N-CA-C 106.475 -1.676 . . . . 1.0 106.475 179.014 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.557 ' HA2' ' OE1' ' A' ' 40' ' ' GLU . . . 71.53 -163.26 54.26 Favored Glycine 0 CA--C 1.534 1.243 0 CA-C-N 119.635 1.107 . . . . 1.15 114.445 178.193 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.808 ' HG2' HD11 ' A' ' 32' ' ' LEU . 10.2 Cg_endo -69.68 130.49 19.52 Favored 'Trans proline' 0 C--N 1.369 1.621 0 C-N-CA 124.414 3.409 . . . . 1.57 113.285 179.019 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 70.35 -16.51 0.92 Allowed Glycine 0 C--N 1.284 -2.315 0 CA-C-N 112.492 -2.14 . . . . 1.68 109.575 -176.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.643 ' H ' ' C ' ' A' ' 15' ' ' PRO . . . 77.51 16.75 79.95 Favored Glycine 1 N--CA 1.388 -4.532 0 CA-C-N 113.706 -1.247 . . . . 1.36 113.74 178.285 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.447 ' H ' ' HG2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -74.34 6.97 3.15 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 107.846 -1.168 . . . . 2.5 107.846 174.033 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.852 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -71.45 155.68 52.47 Favored Glycine 0 CA--C 1.486 -1.732 0 N-CA-C 106.441 -2.664 . . . . 1.02 106.441 178.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.876 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -148.2 132.71 17.69 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 118.68 1.24 . . . . 2.92 108.955 174.644 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.447 ' O ' HD13 ' A' ' 11' ' ' LEU . 0.5 OUTLIER -103.91 128.12 51.42 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.242 -0.89 . . . . 1.1 112.464 -175.864 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -101.23 -45.25 5.42 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 114.317 -1.311 . . . . 1.51 109.119 178.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -122.05 -132.22 4.06 Favored Glycine 0 CA--C 1.524 0.617 0 CA-C-N 115.415 -0.811 . . . . 0.9 111.892 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -98.1 -72.82 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 123.061 2.507 . . . . 1.5 111.912 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.687 ' O ' HG13 ' A' ' 26' ' ' ILE . 0.9 OUTLIER -89.62 46.97 1.41 Allowed 'General case' 0 C--N 1.333 -0.124 0 N-CA-C 109.301 -0.629 . . . . 1.26 109.301 178.762 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 1.033 HG13 HG13 ' A' ' 36' ' ' VAL . 10.1 mt -151.65 116.97 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.97 0 CA-C-O 121.286 0.565 . . . . 0.83 111.598 -179.059 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.679 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 0.5 OUTLIER -138.77 108.09 6.12 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 107.086 -1.45 . . . . 0.92 107.086 178.865 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.967 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -123.92 130.41 52.55 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 115.276 1.584 . . . . 1.28 115.276 -176.704 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.472 ' O ' ' HB1' ' A' ' 69' ' ' ALA . . . -117.23 179.58 17.43 Favored Glycine 0 C--N 1.354 1.55 0 CA-C-O 122.393 0.996 . . . . 0.67 113.877 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -66.39 -35.98 81.7 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 126.873 2.069 . . . . 2.27 113.471 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.5 0.93 5.02 Favored 'General case' 0 N--CA 1.502 2.163 0 CA-C-O 121.928 0.87 . . . . 1.66 112.969 177.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.84 HD22 ' CE1' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -111.37 -11.71 14.11 Favored 'General case' 0 N--CA 1.416 -2.173 0 CA-C-N 113.836 -1.529 . . . . 1.37 111.559 -175.83 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.967 ' O ' ' HA ' ' A' ' 28' ' ' CYS . . . 57.28 -154.51 19.95 Favored Glycine 0 N--CA 1.437 -1.273 0 CA-C-N 115.634 -0.712 . . . . 0.73 113.494 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.998 ' HB2' HD13 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -107.38 123.37 48.27 Favored 'General case' 0 CA--C 1.502 -0.895 0 N-CA-C 114.137 1.162 . . . . 1.08 114.137 179.19 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.84 ' CE1' HD22 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -95.31 101.96 13.73 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 102.053 -3.314 . . . . 1.38 102.053 173.636 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 1.033 HG13 HG13 ' A' ' 26' ' ' ILE . 2.6 t -90.48 85.0 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 CA-C-O 122.859 1.314 . . . . 0.76 109.834 -177.005 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.526 ' O ' ' HA3' ' B' ' 133' ' ' GLY . . . 78.94 78.25 0.85 Allowed Glycine 0 N--CA 1.453 -0.181 0 CA-C-N 112.705 -2.043 . . . . 0.81 111.625 -179.031 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.768 ' CG2' ' HD1' ' B' ' 135' ' ' PHE . 0.8 OUTLIER -151.29 155.06 37.98 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 119.04 -0.505 . . . . 0.77 109.843 -178.704 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.868 ' O ' ' HB2' ' A' ' 42' ' ' LEU . . . -36.28 -43.82 0.38 Allowed 'General case' 0 N--CA 1.484 1.248 0 CA-C-O 120.92 0.39 . . . . 1.02 111.746 -177.454 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.729 ' O ' ' HG2' ' A' ' 43' ' ' ARG . 59.4 mm-40 -50.37 -49.59 53.78 Favored 'General case' 0 CA--C 1.545 0.774 0 O-C-N 121.996 -0.44 . . . . 2.32 110.276 178.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.85 ' O ' ' HB2' ' A' ' 44' ' ' CYS . . . -72.77 -0.8 14.29 Favored 'General case' 0 C--O 1.216 -0.693 0 CA-C-O 121.584 0.707 . . . . 0.87 111.191 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.868 ' HB2' ' O ' ' A' ' 39' ' ' ALA . 2.4 mt -55.85 -47.32 77.5 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 107.065 -1.457 . . . . 1.23 107.065 176.456 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.729 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -68.89 1.08 3.65 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 114.654 -1.157 . . . . 2.92 110.658 175.943 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.85 ' HB2' ' O ' ' A' ' 41' ' ' ALA . 1.2 m -63.3 -42.98 99.11 Favored 'General case' 0 C--N 1.345 0.394 0 CA-C-O 118.184 -0.912 . . . . 1.57 109.546 178.237 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -39.77 -12.76 0.01 OUTLIER 'General case' 0 C--N 1.361 1.107 0 N-CA-C 117.069 2.248 . . . . 3.31 117.069 -177.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.513 ' O ' HD12 ' A' ' 50' ' ' LEU . 1.2 mm-40 -81.34 0.81 35.53 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 118.489 -1.284 . . . . 3.69 108.412 178.481 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.941 ' HG3' HD22 ' A' ' 11' ' ' LEU . 1.0 OUTLIER -82.19 1.03 38.34 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 114.991 -1.004 . . . . 3.99 109.954 176.666 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 21.3 t30 -66.53 -28.6 68.68 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 108.832 -0.803 . . . . 3.86 108.832 177.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -100.35 33.8 2.57 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 109.341 -0.614 . . . . 5.68 109.341 178.368 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.824 ' CD1' ' HA ' ' A' ' 47' ' ' GLU . 0.9 OUTLIER -142.23 109.83 5.87 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 115.434 -0.803 . . . . 5.4 111.12 -179.186 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -82.42 50.14 3.33 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 122.156 1.904 . . . . 4.92 112.831 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 62.86 90.43 0.09 OUTLIER Pre-proline 0 N--CA 1.468 0.474 0 CA-C-N 116.129 -0.487 . . . . 5.64 112.055 179.356 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.752 ' C ' ' HG ' ' A' ' 5' ' ' LEU . 69.9 Cg_endo -97.82 -111.52 0.0 OUTLIER 'Trans proline' 0 CA--C 1.554 1.51 0 C-N-CA 123.186 2.59 . . . . 5.04 113.255 -179.46 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.768 ' SG ' HD11 ' A' ' 3' ' ' LEU . 27.9 t -32.45 99.58 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.669 1.188 . . . . 2.74 113.392 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -81.64 -118.43 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.123 0 N-CA-C 112.259 0.466 . . . . 5.75 112.259 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.875 ' OG ' HD22 ' A' ' 3' ' ' LEU . 1.4 m 70.01 115.26 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 122.695 0.398 . . . . 3.12 110.879 -179.124 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.544 ' O ' ' HB2' ' A' ' 66' ' ' ARG . . . 141.71 60.94 0.03 OUTLIER Glycine 0 N--CA 1.434 -1.436 0 N-CA-C 108.527 -1.829 . . . . 2.1 108.527 -178.492 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -117.22 74.0 0.9 Allowed 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 122.581 1.181 . . . . 4.36 109.672 -179.166 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 1.0 ' HB3' ' HB3' ' A' ' 67' ' ' CYS . 0.4 OUTLIER -137.62 68.34 52.26 Favored Pre-proline 0 C--N 1.3 -1.562 0 N-CA-C 105.553 -2.018 . . . . 3.55 105.553 178.521 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.443 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 26.4 Cg_endo -62.32 119.21 6.21 Favored 'Trans proline' 0 C--N 1.361 1.188 0 C-N-CA 122.537 2.158 . . . . 1.54 115.514 -176.41 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -145.56 -171.71 3.74 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 112.514 -2.13 . . . . 1.59 105.647 177.195 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.588 ' HA2' ' CD2' ' A' ' 80' ' ' HIS . . . 66.62 -166.23 39.43 Favored Glycine 0 N--CA 1.454 -0.121 0 C-N-CA 118.553 -1.784 . . . . 2.43 112.982 178.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 4.6 p -88.05 37.42 0.81 Allowed 'General case' 0 N--CA 1.487 1.381 0 CA-C-O 122.538 1.161 . . . . 4.11 110.677 -176.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 121.5 5.75 9.15 Favored Glycine 0 CA--C 1.557 2.664 0 CA-C-N 112.954 -1.93 . . . . 2.21 114.47 -176.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.893 ' HA2' ' HB3' ' A' ' 75' ' ' SER . . . -100.74 134.89 11.87 Favored Glycine 0 N--CA 1.472 1.099 0 CA-C-N 121.071 2.435 . . . . 1.62 116.275 -176.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.544 ' HB2' ' O ' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -90.43 154.87 19.34 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.023 0.529 . . . . 3.02 110.47 178.405 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 1.0 ' HB3' ' HB3' ' A' ' 59' ' ' LYS . 43.2 t -71.02 103.12 2.6 Favored 'General case' 0 N--CA 1.409 -2.501 0 N-CA-C 108.046 -1.094 . . . . 1.52 108.046 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -76.13 -40.97 51.5 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 105.481 -2.044 . . . . 1.07 105.481 176.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.472 ' HB1' ' O ' ' A' ' 29' ' ' GLY . . . -140.83 160.85 39.17 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 111.59 -2.55 . . . . 1.0 112.12 -173.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.856 ' HA ' ' HB3' ' A' ' 85' ' ' CYS . . . -53.63 120.99 6.89 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 121.602 0.715 . . . . 1.24 112.826 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.584 ' H ' ' CB ' ' A' ' 85' ' ' CYS . . . 77.53 3.71 83.43 Favored Glycine 0 N--CA 1.444 -0.832 0 N-CA-C 116.41 1.324 . . . . 1.28 116.41 176.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.998 HD13 ' HB2' ' A' ' 34' ' ' CYS . 1.1 pp -132.04 106.56 11.43 Favored 'Isoleucine or valine' 0 C--O 1.244 0.79 0 CA-C-N 118.611 1.205 . . . . 2.27 110.702 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.664 ' HB2' ' O ' ' A' ' 80' ' ' HIS . 0.1 OUTLIER -84.63 90.32 7.66 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 115.154 -0.93 . . . . 1.98 109.822 -179.118 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.74 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 0.5 OUTLIER -99.52 132.79 44.62 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 113.326 0.862 . . . . 1.33 113.326 -177.962 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.935 ' HB2' ' HD2' ' A' ' 76' ' ' PRO . 45.8 p -109.3 -177.63 0.49 Allowed Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 114.411 -1.268 . . . . 1.99 108.713 178.661 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.935 ' HD2' ' HB2' ' A' ' 75' ' ' SER . 64.0 Cg_endo -74.45 30.92 0.34 Allowed 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 121.351 1.367 . . . . 1.86 111.765 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.687 ' HB3' ' ND1' ' B' ' 180' ' ' HIS . 4.8 m-20 -143.3 -50.7 0.34 Allowed 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.593 -0.731 . . . . 2.65 110.714 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.774 ' HA2' HD11 ' A' ' 26' ' ' ILE . . . -160.64 -166.22 18.99 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 111.724 -0.55 . . . . 0.99 111.724 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.74 ' HA ' ' HA ' ' A' ' 74' ' ' CYS . 2.9 m -124.8 156.13 38.28 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 117.71 0.755 . . . . 1.34 110.391 179.412 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.664 ' O ' ' HB2' ' A' ' 73' ' ' CYS . 18.4 t60 -140.93 124.72 17.02 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.016 -0.993 . . . . 2.17 108.709 -174.686 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.85 132.76 14.7 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.366 0.603 . . . . 3.05 111.849 -177.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.542 ' O ' ' HA2' ' A' ' 71' ' ' GLY . 0.8 OUTLIER -141.64 119.79 7.75 Favored Pre-proline 0 CA--C 1.544 0.728 0 CA-C-N 115.138 -0.937 . . . . 2.02 110.443 -178.889 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.698 ' HA ' ' OD2' ' A' ' 86' ' ' ASP . 4.3 Cg_exo -78.28 -13.71 15.15 Favored 'Trans proline' 0 C--N 1.357 0.981 0 C-N-CA 122.822 2.348 . . . . 1.93 113.879 -178.385 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.38 -38.13 89.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.798 0.332 . . . . 1.53 111.699 -179.334 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.856 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 21.9 m -91.98 50.42 1.67 Allowed 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 116.193 -0.458 . . . . 1.88 110.569 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.907 ' CB ' ' HB3' ' A' ' 89' ' ' ALA . 78.6 m-20 -133.29 37.11 0.36 Allowed Pre-proline 0 CA--C 1.554 1.105 0 N-CA-C 116.015 1.857 . . . . 3.6 116.015 -177.649 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.699 ' HD3' ' N ' ' A' ' 86' ' ' ASP . 2.4 Cg_endo -83.64 52.5 3.83 Favored 'Trans proline' 0 N--CA 1.482 0.8 0 C-N-CA 122.685 2.257 . . . . 2.56 111.338 179.204 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.594 ' C ' ' H ' ' A' ' 90' ' ' ALA . 4.8 pt-20 173.72 -32.52 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.615 0 CA-C-N 110.833 -2.894 . . . . 4.72 108.896 -174.159 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.907 ' HB3' ' CB ' ' A' ' 86' ' ' ASP . . . -70.7 18.49 0.06 Allowed 'General case' 0 CA--C 1.565 1.557 0 CA-C-N 110.166 -3.197 . . . . 5.29 109.135 170.55 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.594 ' H ' ' C ' ' A' ' 88' ' ' GLU . . . -87.05 137.79 32.05 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 126.842 2.057 . . . . 6.98 111.732 176.2 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -95.57 114.19 25.91 Favored 'General case' 0 C--N 1.344 0.366 0 CA-C-N 112.85 -1.977 . . . . 10.21 111.278 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 2.5 t . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.28 -0.867 . . . . 11.77 111.37 179.257 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.246 0 CA-C-O 121.189 0.519 . . . . 10.07 111.225 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 102' ' ' VAL . . . . . 0.443 HG22 ' N ' ' B' ' 103' ' ' LEU . 7.7 p -88.49 163.69 2.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.478 -0.783 . . . . 8.41 109.727 178.4 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 103' ' ' LEU . . . . . 1.065 ' HG ' ' HB3' ' B' ' 108' ' ' ARG . 0.2 OUTLIER -161.42 89.03 0.74 Allowed 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 108.754 -0.832 . . . . 5.87 108.754 174.543 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -88.19 59.15 5.12 Favored 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 119.373 -0.931 . . . . 6.27 112.315 -178.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 105' ' ' LEU . . . . . 0.872 ' HG ' ' O ' ' B' ' 153' ' ' PRO . 0.2 OUTLIER -119.56 -58.08 1.93 Allowed 'General case' 0 CA--C 1.451 -2.842 0 CA-C-O 124.505 2.098 . . . . 7.2 109.684 -175.727 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 106' ' ' ASP . . . . . 0.569 ' HB2' ' O ' ' B' ' 105' ' ' LEU . 0.3 OUTLIER 159.34 -40.14 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 108.925 -3.762 . . . . 8.55 111.02 177.236 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 107' ' ' VAL . . . . . 0.667 ' O ' HD12 ' B' ' 105' ' ' LEU . 12.0 p -155.05 127.1 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-N 112.128 -2.305 . . . . 7.48 105.658 175.525 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 108' ' ' ARG . . . . . 1.065 ' HB3' ' HG ' ' B' ' 103' ' ' LEU . 2.0 ptt-85 -77.88 106.61 9.84 Favored 'General case' 0 N--CA 1.406 -2.673 0 C-N-CA 119.598 -0.841 . . . . 9.12 110.625 -177.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 109' ' ' THR . . . . . 0.698 ' O ' ' HG2' ' B' ' 153' ' ' PRO . 0.2 OUTLIER -105.21 85.92 2.34 Favored 'General case' 0 N--CA 1.408 -2.564 1 N-CA-C 98.598 -4.594 . . . . 5.69 98.598 168.94 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' B' B ' 110' ' ' CYS . . . . . 0.667 ' HA ' ' CB ' ' B' ' 154' ' ' CYS . 81.5 m -76.06 68.72 2.56 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 112.743 -2.026 . . . . 2.61 112.189 -176.292 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 111' ' ' LEU . . . . . 0.936 HD22 ' HG3' ' B' ' 147' ' ' GLU . 0.0 OUTLIER -36.29 108.58 0.39 Allowed Pre-proline 0 N--CA 1.481 1.115 0 C-N-CA 123.671 0.789 . . . . 2.47 112.417 178.876 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 112' ' ' PRO . . . . . 0.708 ' HA ' ' O ' ' B' ' 119' ' ' GLY . 39.3 Cg_endo -90.44 138.84 2.75 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 123.08 2.52 . . . . 1.47 114.055 -179.291 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.528 ' N ' ' O ' ' B' ' 119' ' ' GLY . 0.5 OUTLIER -151.79 172.38 16.25 Favored 'General case' 0 C--N 1.347 0.495 0 N-CA-C 106.822 -1.547 . . . . 1.0 106.822 179.435 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 114' ' ' GLY . . . . . 0.568 ' HA2' ' OE1' ' B' ' 140' ' ' GLU . . . 71.89 -163.38 54.41 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 119.931 -1.128 . . . . 1.16 114.379 178.431 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 115' ' ' PRO . . . . . 0.815 ' HG2' HD11 ' B' ' 132' ' ' LEU . 9.5 Cg_endo -69.65 130.35 19.33 Favored 'Trans proline' 0 C--N 1.367 1.549 0 C-N-CA 124.45 3.433 . . . . 1.57 113.194 178.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 70.73 -16.5 1.02 Allowed Glycine 0 C--N 1.287 -2.186 0 CA-C-N 113.041 -1.89 . . . . 1.7 109.686 -176.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 117' ' ' GLY . . . . . 0.621 ' H ' ' C ' ' B' ' 115' ' ' PRO . . . 76.87 16.44 80.77 Favored Glycine 1 N--CA 1.39 -4.42 0 CA-C-N 113.505 -1.347 . . . . 1.38 113.77 178.369 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 118' ' ' LYS . . . . . 0.474 ' H ' ' HG2' ' B' ' 118' ' ' LYS . 0.0 OUTLIER -73.85 6.95 2.86 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 122.257 1.027 . . . . 2.54 108.253 174.955 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 119' ' ' GLY . . . . . 0.708 ' O ' ' HA ' ' B' ' 112' ' ' PRO . . . -89.59 124.15 7.25 Favored Glycine 0 N--CA 1.419 -2.438 0 CA-C-N 113.933 -1.485 . . . . 1.04 115.332 -178.406 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.849 ' HA ' ' O ' ' B' ' 111' ' ' LEU . 0.1 OUTLIER -112.96 136.4 52.67 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 120.816 -1.402 . . . . 2.89 112.288 -171.719 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 121' ' ' CYS . . . . . 0.437 ' O ' HD13 ' B' ' 111' ' ' LEU . 0.6 OUTLIER -104.45 127.83 52.23 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.597 0.713 . . . . 1.07 112.131 -177.68 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -101.32 -45.32 5.37 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 114.656 -1.156 . . . . 1.53 109.237 179.306 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -122.11 -132.33 4.07 Favored Glycine 0 CA--C 1.522 0.524 0 CA-C-N 115.321 -0.854 . . . . 0.9 111.895 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -97.77 -72.84 0.0 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 123.041 2.494 . . . . 1.51 112.02 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 125' ' ' SER . . . . . 0.698 ' O ' HG13 ' B' ' 126' ' ' ILE . 0.9 OUTLIER -89.46 46.73 1.4 Allowed 'General case' 0 C--O 1.225 -0.19 0 N-CA-C 109.288 -0.634 . . . . 1.25 109.288 178.752 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 126' ' ' ILE . . . . . 0.939 ' CG1' HG13 ' B' ' 136' ' ' VAL . 13.4 mt -150.96 116.8 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 CA-C-N 116.041 -0.527 . . . . 0.85 111.735 -178.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 127' ' ' CYS . . . . . 0.675 ' HA ' ' O ' ' B' ' 120' ' ' ARG . 0.5 OUTLIER -139.02 108.3 6.1 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 106.992 -1.484 . . . . 0.89 106.992 178.627 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 128' ' ' CYS . . . . . 0.982 ' HA ' ' O ' ' B' ' 133' ' ' GLY . 0.0 OUTLIER -124.7 129.03 49.73 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 115.357 1.614 . . . . 1.23 115.357 -176.396 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 129' ' ' GLY . . . . . 0.469 ' O ' ' HB1' ' B' ' 169' ' ' ALA . . . -116.21 -178.97 18.18 Favored Glycine 0 C--N 1.356 1.644 0 CA-C-O 122.468 1.038 . . . . 0.66 113.864 -179.498 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -67.28 -34.88 78.32 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 126.767 2.027 . . . . 2.35 113.42 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.57 17.57 2.91 Favored 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 118.404 -1.319 . . . . 1.69 111.892 176.371 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 132' ' ' LEU . . . . . 0.862 HD22 ' CE1' ' B' ' 135' ' ' PHE . 0.3 OUTLIER -124.7 -13.5 6.97 Favored 'General case' 0 N--CA 1.42 -1.937 0 CA-C-N 113.17 -1.832 . . . . 1.38 109.306 -176.838 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 133' ' ' GLY . . . . . 0.982 ' O ' ' HA ' ' B' ' 128' ' ' CYS . . . 53.24 -152.48 8.49 Favored Glycine 0 N--CA 1.41 -3.085 0 CA-C-N 114.175 -1.375 . . . . 0.72 114.303 177.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 134' ' ' CYS . . . . . 0.982 ' HB2' HD13 ' B' ' 172' ' ' ILE . 0.1 OUTLIER -104.32 123.58 47.64 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 115.301 1.593 . . . . 1.08 115.301 -178.927 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 135' ' ' PHE . . . . . 0.862 ' CE1' HD22 ' B' ' 132' ' ' LEU . 0.0 OUTLIER -96.59 101.75 13.42 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 102.127 -3.286 . . . . 1.36 102.127 173.238 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 136' ' ' VAL . . . . . 0.939 HG13 ' CG1' ' B' ' 126' ' ' ILE . 3.1 t -90.41 84.71 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 CA-C-O 122.471 1.129 . . . . 0.75 109.689 -176.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 137' ' ' GLY . . . . . 0.703 ' O ' ' HA3' ' A' ' 33' ' ' GLY . . . 78.87 78.05 0.86 Allowed Glycine 0 N--CA 1.453 -0.195 0 CA-C-N 113.059 -1.882 . . . . 0.83 111.631 -179.03 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 138' ' ' THR . . . . . 0.748 ' CG2' ' HD1' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -150.96 155.74 39.73 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 118.928 -0.558 . . . . 0.78 109.671 -178.794 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 139' ' ' ALA . . . . . 0.865 ' O ' ' HB2' ' B' ' 142' ' ' LEU . . . -36.9 -44.06 0.48 Allowed 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 118.142 0.428 . . . . 1.04 111.949 -177.552 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 140' ' ' GLU . . . . . 0.724 ' O ' ' HG2' ' B' ' 143' ' ' ARG . 55.4 mm-40 -50.25 -49.42 53.14 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.775 -0.578 . . . . 2.31 110.476 178.796 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 141' ' ' ALA . . . . . 0.857 ' O ' ' HB2' ' B' ' 144' ' ' CYS . . . -71.02 -3.94 22.25 Favored 'General case' 0 C--O 1.214 -0.787 0 CA-C-O 121.495 0.664 . . . . 0.87 110.968 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 142' ' ' LEU . . . . . 0.865 ' HB2' ' O ' ' B' ' 139' ' ' ALA . 2.4 mt -54.39 -46.94 73.19 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 107.267 -1.382 . . . . 1.24 107.267 177.412 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 143' ' ' ARG . . . . . 0.724 ' HG2' ' O ' ' B' ' 140' ' ' GLU . 0.0 OUTLIER -68.9 0.81 3.96 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 114.921 -1.036 . . . . 2.93 110.727 175.872 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 144' ' ' CYS . . . . . 0.857 ' HB2' ' O ' ' B' ' 141' ' ' ALA . 1.2 m -63.06 -42.79 99.78 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 118.202 -0.904 . . . . 1.61 109.66 178.204 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -40.18 -12.67 0.01 OUTLIER 'General case' 0 C--N 1.36 1.059 0 N-CA-C 117.016 2.228 . . . . 3.35 117.016 -178.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 146' ' ' GLU . . . . . 0.527 ' O ' HD12 ' B' ' 150' ' ' LEU . 1.2 mm-40 -81.38 0.62 36.53 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 118.515 -1.274 . . . . 3.76 108.342 178.534 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 147' ' ' GLU . . . . . 0.936 ' HG3' HD22 ' B' ' 111' ' ' LEU . 1.0 OUTLIER -82.04 0.98 37.87 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 114.984 -1.007 . . . . 4.01 109.931 176.698 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 148' ' ' ASN . . . . . . . . . . . . . 21.3 t30 -66.48 -28.68 68.76 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.785 -0.82 . . . . 3.92 108.785 177.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -100.25 33.67 2.59 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 109.344 -0.613 . . . . 5.73 109.344 178.347 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 150' ' ' LEU . . . . . 0.825 ' CD1' ' HA ' ' B' ' 147' ' ' GLU . 0.9 OUTLIER -142.2 109.84 5.89 Favored Pre-proline 0 CA--C 1.534 0.33 0 CA-C-N 115.474 -0.785 . . . . 5.46 111.144 -179.169 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 151' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -82.45 50.13 3.32 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.145 1.896 . . . . 5.02 112.868 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 62.88 90.45 0.09 OUTLIER Pre-proline 0 N--CA 1.468 0.452 0 CA-C-N 116.07 -0.514 . . . . 5.73 112.046 179.319 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 153' ' ' PRO . . . . . 0.872 ' O ' ' HG ' ' B' ' 105' ' ' LEU . 69.7 Cg_endo -97.91 -112.05 0.0 OUTLIER 'Trans proline' 0 CA--C 1.554 1.5 0 C-N-CA 123.281 2.654 . . . . 5.1 113.208 -179.49 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 154' ' ' CYS . . . . . 0.725 ' SG ' HD21 ' B' ' 103' ' ' LEU . 25.9 t -31.75 100.62 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.704 1.202 . . . . 2.68 113.237 -179.536 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 155' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -82.92 -117.86 0.02 OUTLIER 'General case' 0 CA--C 1.551 0.989 0 N-CA-C 112.026 0.38 . . . . 5.63 112.026 -179.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 1.4 m 69.78 114.59 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 122.567 0.347 . . . . 3.11 111.321 -179.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 157' ' ' GLY . . . . . 0.536 ' O ' ' HB2' ' B' ' 166' ' ' ARG . . . 142.0 61.71 0.03 OUTLIER Glycine 0 N--CA 1.44 -1.092 0 N-CA-C 109.075 -1.61 . . . . 2.07 109.075 -178.28 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -117.24 64.15 0.73 Allowed 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 122.508 1.147 . . . . 4.34 110.719 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 159' ' ' LYS . . . . . 1.067 ' HB3' ' HB3' ' B' ' 167' ' ' CYS . 0.5 OUTLIER -118.64 66.79 7.19 Favored Pre-proline 0 C--N 1.31 -1.113 0 CA-C-N 113.126 -1.852 . . . . 3.54 108.083 174.457 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 160' ' ' PRO . . . . . 0.441 ' HA ' ' HA ' ' B' ' 166' ' ' ARG . 23.1 Cg_endo -62.17 119.39 6.47 Favored 'Trans proline' 0 C--O 1.231 0.145 0 N-CA-C 116.259 1.6 . . . . 1.51 116.259 -174.716 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 161' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -146.49 -174.4 4.45 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 112.84 -1.982 . . . . 1.58 105.84 176.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 162' ' ' GLY . . . . . 0.558 ' HA2' ' CD2' ' B' ' 180' ' ' HIS . . . 69.2 -166.07 48.43 Favored Glycine 0 CA--C 1.508 -0.366 0 C-N-CA 118.5 -1.81 . . . . 2.37 112.51 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 4.6 p -88.0 37.05 0.79 Allowed 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 122.713 1.244 . . . . 4.07 110.644 -175.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 121.57 5.62 9.16 Favored Glycine 0 CA--C 1.556 2.598 0 CA-C-N 112.833 -1.985 . . . . 2.2 114.61 -176.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 165' ' ' GLY . . . . . 0.914 ' HA2' ' HB3' ' B' ' 175' ' ' SER . . . -101.21 135.36 12.12 Favored Glycine 0 C--N 1.346 1.087 0 CA-C-N 121.319 2.56 . . . . 1.62 116.283 -177.007 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 166' ' ' ARG . . . . . 0.536 ' HB2' ' O ' ' B' ' 157' ' ' GLY . 0.0 OUTLIER -90.2 154.93 19.38 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.01 0.524 . . . . 3.05 110.497 178.391 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 167' ' ' CYS . . . . . 1.067 ' HB3' ' HB3' ' B' ' 159' ' ' LYS . 42.9 t -70.96 103.17 2.59 Favored 'General case' 0 N--CA 1.406 -2.633 0 N-CA-C 108.071 -1.085 . . . . 1.56 108.071 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 168' ' ' ALA . . . . . . . . . . . . . . . -75.95 -41.38 51.78 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 105.363 -2.088 . . . . 1.04 105.363 176.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 169' ' ' ALA . . . . . 0.518 ' CB ' ' HA2' ' B' ' 133' ' ' GLY . . . -140.45 160.74 39.32 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 111.547 -2.57 . . . . 0.98 112.047 -173.578 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 170' ' ' ALA . . . . . 0.866 ' HA ' ' HB3' ' B' ' 185' ' ' CYS . . . -53.76 121.03 7.04 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 121.686 0.755 . . . . 1.25 112.792 -179.405 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 171' ' ' GLY . . . . . 0.579 ' H ' ' CB ' ' B' ' 185' ' ' CYS . . . 77.52 3.75 83.47 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 116.369 1.308 . . . . 1.29 116.369 176.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 172' ' ' ILE . . . . . 0.982 HD13 ' HB2' ' B' ' 134' ' ' CYS . 1.1 pp -131.97 106.41 11.26 Favored 'Isoleucine or valine' 0 C--O 1.245 0.823 0 CA-C-N 118.482 1.141 . . . . 2.27 110.781 -179.489 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 173' ' ' CYS . . . . . 0.697 ' HB2' ' O ' ' B' ' 180' ' ' HIS . 0.1 OUTLIER -84.52 90.51 7.65 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 115.153 -0.931 . . . . 1.94 109.755 -179.2 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 174' ' ' CYS . . . . . 0.775 ' HA ' ' HA ' ' B' ' 179' ' ' CYS . 0.5 OUTLIER -99.84 132.86 44.93 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 113.241 0.83 . . . . 1.35 113.241 -177.986 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 175' ' ' SER . . . . . 0.929 ' HB2' ' HD2' ' B' ' 176' ' ' PRO . 43.5 p -109.34 -177.58 0.48 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 114.269 -1.332 . . . . 2.0 108.686 178.685 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 176' ' ' PRO . . . . . 0.929 ' HD2' ' HB2' ' B' ' 175' ' ' SER . 62.8 Cg_endo -74.48 30.95 0.34 Allowed 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 121.387 1.391 . . . . 1.9 111.768 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 177' ' ' ASP . . . . . 0.614 ' HB3' ' ND1' ' A' ' 80' ' ' HIS . 4.8 m-20 -143.22 -50.79 0.34 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.523 -0.762 . . . . 2.72 110.778 179.437 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 178' ' ' GLY . . . . . 0.76 ' HA2' HD11 ' B' ' 126' ' ' ILE . . . -160.48 -166.05 18.52 Favored Glycine 0 CA--C 1.522 0.48 0 N-CA-C 111.752 -0.539 . . . . 0.99 111.752 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 179' ' ' CYS . . . . . 0.775 ' HA ' ' HA ' ' B' ' 174' ' ' CYS . 3.1 m -124.26 160.78 27.2 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 117.718 0.759 . . . . 1.34 110.144 179.349 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 180' ' ' HIS . . . . . 0.697 ' O ' ' HB2' ' B' ' 173' ' ' CYS . 17.9 t60 -148.72 123.21 9.72 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-O 121.663 0.744 . . . . 2.1 109.072 -174.098 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 181' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -46.78 132.41 11.33 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 114.572 -1.194 . . . . 3.06 111.921 -176.162 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 182' ' ' ASP . . . . . 0.532 ' O ' ' HA2' ' B' ' 171' ' ' GLY . 0.9 OUTLIER -141.54 119.84 7.84 Favored Pre-proline 0 CA--C 1.545 0.751 0 CA-C-N 114.909 -1.041 . . . . 2.06 110.341 -178.735 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 183' ' ' PRO . . . . . 0.704 ' HA ' ' OD2' ' B' ' 186' ' ' ASP . 4.4 Cg_exo -78.31 -13.81 15.06 Favored 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 122.836 2.358 . . . . 1.91 113.854 -178.431 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -64.26 -38.27 90.44 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.834 0.35 . . . . 1.56 111.661 -179.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 185' ' ' CYS . . . . . 0.866 ' HB3' ' HA ' ' B' ' 170' ' ' ALA . 21.8 m -91.91 50.34 1.67 Allowed 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 116.179 -0.464 . . . . 1.94 110.53 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 186' ' ' ASP . . . . . 0.911 ' CB ' ' HB3' ' B' ' 189' ' ' ALA . 78.5 m-20 -133.09 37.16 0.36 Allowed Pre-proline 0 CA--C 1.551 1.013 0 N-CA-C 116.042 1.867 . . . . 3.61 116.042 -177.779 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 187' ' ' PRO . . . . . 0.713 ' HD3' ' N ' ' B' ' 186' ' ' ASP . 2.4 Cg_endo -83.46 51.26 3.49 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.539 2.159 . . . . 2.58 111.842 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 188' ' ' GLU . . . . . 0.605 ' C ' ' H ' ' B' ' 190' ' ' ALA . 5.2 pt-20 175.49 -33.67 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.527 0 CA-C-N 110.811 -2.904 . . . . 4.7 108.522 -174.365 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 189' ' ' ALA . . . . . 0.911 ' HB3' ' CB ' ' B' ' 186' ' ' ASP . . . -69.49 18.95 0.04 OUTLIER 'General case' 0 CA--C 1.567 1.616 0 CA-C-N 110.403 -3.09 . . . . 5.24 109.047 170.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 190' ' ' ALA . . . . . 0.605 ' H ' ' C ' ' B' ' 188' ' ' GLU . . . -87.78 138.51 31.4 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.728 2.011 . . . . 6.93 111.551 176.33 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 191' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -95.62 114.38 26.13 Favored 'General case' 0 C--N 1.343 0.289 0 CA-C-N 112.796 -2.002 . . . . 10.14 111.296 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 2.6 t . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.321 -0.847 . . . . 11.7 111.496 179.339 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.546 ' O ' HD12 ' A' ' 3' ' ' LEU . . . . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 120.818 0.342 . . . . 9.95 110.897 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.548 ' O ' HG13 ' A' ' 2' ' ' VAL . 14.4 p -79.86 75.4 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-O 124.367 2.032 . . . . 8.02 110.708 178.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.753 ' O ' HD22 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -101.83 78.62 1.83 Allowed 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 109.243 -3.617 . . . . 5.86 114.916 -179.909 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.46 60.81 4.2 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 123.109 1.433 . . . . 6.22 108.433 175.089 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 1.04 HD12 HG12 ' A' ' 7' ' ' VAL . 0.4 OUTLIER -153.53 -135.67 0.06 Allowed 'General case' 0 N--CA 1.386 -3.674 0 CA-C-N 111.208 -2.724 . . . . 7.09 106.147 178.785 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.719 ' H ' HD13 ' A' ' 5' ' ' LEU . 6.0 t0 -158.41 25.02 0.24 Allowed 'General case' 0 C--N 1.291 -1.974 0 CA-C-O 122.388 1.089 . . . . 8.78 109.212 -176.5 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 1.04 HG12 HD12 ' A' ' 5' ' ' LEU . 4.7 p -151.56 172.94 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.689 0 N-CA-C 104.578 -2.379 . . . . 7.51 104.578 179.067 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.547 ' H ' HG22 ' A' ' 7' ' ' VAL . 2.4 ptp85 -71.05 119.54 15.32 Favored 'General case' 0 CA--C 1.475 -1.909 0 N-CA-C 106.449 -1.686 . . . . 9.08 106.449 -176.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.632 ' HB ' ' HA ' ' A' ' 3' ' ' LEU . 1.4 t -55.17 111.95 0.97 Allowed 'General case' 0 N--CA 1.418 -2.056 0 C-N-CA 117.992 -1.483 . . . . 5.66 109.512 -175.247 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.439 ' SG ' ' HB3' ' A' ' 20' ' ' ARG . 12.5 p -29.29 111.44 0.06 Allowed 'General case' 0 C--N 1.309 -1.152 0 CA-C-N 111.801 -2.454 . . . . 2.68 113.806 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.415 ' O ' ' O ' ' A' ' 10' ' ' CYS . 26.1 mt -30.96 154.53 0.03 OUTLIER Pre-proline 0 N--CA 1.48 1.039 0 C-N-CA 123.872 0.869 . . . . 2.48 113.305 178.459 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.719 ' HB2' ' O ' ' A' ' 17' ' ' GLY . 33.4 Cg_endo -91.92 117.39 0.44 Allowed 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 123.312 2.675 . . . . 1.49 116.295 -178.36 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.647 ' SG ' ' O ' ' A' ' 20' ' ' ARG . 10.6 p -106.64 -156.41 0.58 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.693 1.197 . . . . 1.0 110.515 -176.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 79.96 -168.22 51.98 Favored Glycine 0 CA--C 1.498 -0.987 0 N-CA-C 110.373 -1.091 . . . . 1.15 110.373 -177.042 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.595 ' HD2' HD11 ' A' ' 32' ' ' LEU . 85.2 Cg_endo -63.8 89.87 0.15 Allowed 'Trans proline' 0 CA--C 1.51 -0.706 0 CA-C-N 119.793 1.796 . . . . 1.57 110.932 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.88 18.3 63.67 Favored Glycine 0 N--CA 1.418 -2.548 0 CA-C-N 114.168 -1.378 . . . . 1.68 114.199 177.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.719 ' O ' ' HB2' ' A' ' 12' ' ' PRO . . . 84.18 36.76 12.19 Favored Glycine 0 N--CA 1.404 -3.485 0 C-N-CA 118.077 -2.011 . . . . 1.36 115.947 176.035 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.543 ' HG3' ' HG2' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -92.63 -12.54 31.35 Favored 'General case' 0 CA--C 1.559 1.32 0 CA-C-N 115.0 -0.6 . . . . 2.5 110.999 175.896 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.531 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -102.21 -176.79 27.69 Favored Glycine 0 N--CA 1.478 1.467 0 C-N-CA 126.298 1.904 . . . . 1.02 109.379 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.647 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -126.18 168.97 13.32 Favored 'General case' 0 C--N 1.354 0.786 0 CA-C-N 122.707 3.253 . . . . 2.92 105.7 175.368 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.673 ' HB2' ' HG2' ' A' ' 47' ' ' GLU . 33.7 m -108.49 163.08 13.54 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 119.334 0.97 . . . . 1.1 113.331 -178.517 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -143.47 -57.04 0.4 Allowed 'General case' 0 C--O 1.232 0.146 0 CA-C-N 114.82 -1.082 . . . . 1.51 109.913 178.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.556 ' O ' ' HB3' ' A' ' 44' ' ' CYS . . . -120.54 176.91 16.33 Favored Glycine 0 C--N 1.332 0.319 0 CA-C-N 115.866 -0.606 . . . . 0.9 112.005 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.437 ' HB2' ' OE1' ' B' ' 181' ' ' GLU . 47.7 Cg_exo -53.67 -68.77 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.49 2.127 . . . . 1.5 112.368 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.65 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.5 OUTLIER -95.59 18.19 13.33 Favored 'General case' 0 C--O 1.224 -0.271 0 N-CA-C 109.995 -0.372 . . . . 1.26 109.995 178.878 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.931 HG12 HG13 ' A' ' 36' ' ' VAL . 1.2 mt -122.41 106.26 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 CA-C-O 121.751 0.786 . . . . 0.83 111.797 -177.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.748 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 0.6 OUTLIER -121.94 124.13 43.31 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 114.725 -1.125 . . . . 0.92 109.615 -179.011 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 1.178 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -138.52 112.82 8.72 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 114.978 1.473 . . . . 1.28 114.978 -178.607 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 33' ' ' GLY . . . -106.41 -159.17 22.03 Favored Glycine 0 N--CA 1.429 -1.832 0 N-CA-C 109.559 -1.416 . . . . 0.67 109.559 175.723 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -65.5 -64.86 0.76 Allowed 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 112.69 0.626 . . . . 2.27 112.69 -178.148 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.51 17.36 20.85 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 122.61 1.195 . . . . 1.66 109.808 -176.094 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.595 HD11 ' HD2' ' A' ' 15' ' ' PRO . 0.3 OUTLIER -113.95 -11.72 12.74 Favored 'General case' 0 N--CA 1.404 -2.759 0 N-CA-C 105.486 -2.042 . . . . 1.37 105.486 -179.642 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 1.178 ' O ' ' HA ' ' A' ' 28' ' ' CYS . . . 50.68 -135.48 29.33 Favored Glycine 0 N--CA 1.415 -2.758 0 CA-C-N 114.275 -1.33 . . . . 0.73 111.769 175.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.981 ' HB2' HD13 ' A' ' 72' ' ' ILE . 1.8 t -129.04 111.85 13.41 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-N 118.803 1.301 . . . . 1.08 112.678 179.379 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.827 ' HA ' ' HA ' ' B' ' 135' ' ' PHE . 6.2 m-30 -85.18 105.41 15.86 Favored 'General case' 0 N--CA 1.408 -2.525 0 N-CA-C 103.543 -2.762 . . . . 1.38 103.543 176.376 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.931 HG13 HG12 ' A' ' 26' ' ' ILE . 2.2 t -97.27 85.27 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.75 0 CA-C-O 123.129 1.443 . . . . 0.76 107.79 -178.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.779 ' HA3' HG21 ' B' ' 172' ' ' ILE . . . 110.97 92.96 2.17 Favored Glycine 0 CA--C 1.521 0.464 0 CA-C-N 112.427 -2.169 . . . . 0.81 114.263 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.715 ' CG2' ' HB3' ' A' ' 35' ' ' PHE . 0.0 OUTLIER 178.77 169.26 0.89 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 110.096 -0.335 . . . . 0.77 110.096 178.29 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.784 ' HA ' HD12 ' A' ' 42' ' ' LEU . . . -68.42 -35.83 78.21 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.832 -0.347 . . . . 1.02 110.933 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.86 -24.18 14.94 Favored 'General case' 0 C--N 1.332 -0.181 0 O-C-N 122.093 -0.379 . . . . 2.32 111.691 -178.54 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.675 ' O ' ' N ' ' A' ' 44' ' ' CYS . . . -97.23 -23.33 16.22 Favored 'General case' 0 C--O 1.214 -0.781 0 CA-C-N 116.818 -0.174 . . . . 0.87 111.242 -179.373 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.784 HD12 ' HA ' ' A' ' 39' ' ' ALA . 1.0 OUTLIER -37.38 -46.73 0.8 Allowed 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.969 0.729 . . . . 1.23 112.969 -175.771 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.531 ' HD2' ' H ' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -53.7 -25.68 19.43 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.813 -0.81 . . . . 2.92 108.813 177.557 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.675 ' N ' ' O ' ' A' ' 41' ' ' ALA . 86.2 m -57.33 -20.57 29.67 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.427 -0.806 . . . . 1.57 110.473 -178.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -39.09 -45.04 1.22 Allowed 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.594 0.59 . . . . 3.31 112.594 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -87.74 -7.57 57.17 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 119.873 -0.731 . . . . 3.69 110.991 -179.036 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.673 ' HG2' ' HB2' ' A' ' 21' ' ' CYS . 0.8 OUTLIER -85.02 6.46 25.15 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.903 -0.589 . . . . 3.99 109.453 177.139 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.503 ' C ' ' H ' ' A' ' 50' ' ' LEU . 7.5 p-10 -71.9 -26.57 62.37 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.632 -0.713 . . . . 3.86 109.394 177.559 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 19.7 t80 -51.59 8.31 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 114.565 1.32 . . . . 5.68 114.565 -178.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.575 ' N ' HD13 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -133.16 132.41 22.22 Favored Pre-proline 0 N--CA 1.466 0.336 0 CA-C-N 118.754 0.706 . . . . 5.4 110.738 178.539 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.671 ' HA ' ' HG3' ' A' ' 76' ' ' PRO . 95.6 Cg_endo -86.74 10.64 3.54 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.846 2.364 . . . . 4.92 113.401 -178.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.661 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 0.8 OUTLIER 160.58 -52.08 0.0 OUTLIER Pre-proline 0 N--CA 1.465 0.284 0 CA-C-O 120.686 0.279 . . . . 5.64 111.326 -179.865 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.661 ' HD2' ' N ' ' A' ' 52' ' ' SER . 11.8 Cg_endo -55.71 121.63 10.31 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 123.092 2.528 . . . . 5.04 114.758 -178.579 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.531 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 0.1 OUTLIER -178.78 107.13 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 115.439 -0.8 . . . . 2.74 109.84 178.139 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.631 ' N ' ' HB2' ' A' ' 5' ' ' LEU . 18.9 pt20 33.06 -156.1 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.4 0.518 . . . . 5.75 112.4 -177.526 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.2 t -80.13 105.81 11.68 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 112.569 0.581 . . . . 3.12 112.569 -178.086 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 164.17 35.23 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 110.534 -1.026 . . . . 2.1 110.534 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.535 ' HA ' ' HB2' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -123.26 88.99 3.02 Favored 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 109.043 -0.725 . . . . 4.36 109.043 179.611 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.554 ' HB3' ' HB2' ' A' ' 67' ' ' CYS . 0.5 OUTLIER -135.52 81.39 42.42 Favored Pre-proline 0 C--N 1.296 -1.755 0 N-CA-C 106.065 -1.828 . . . . 3.55 106.065 -178.647 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.501 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 12.0 Cg_endo -55.44 107.18 0.22 Allowed 'Trans proline' 0 C--N 1.358 1.05 0 C-N-CA 123.868 3.046 . . . . 1.54 114.241 -177.512 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.59 ' SG ' ' HB2' ' A' ' 84' ' ' ALA . 0.5 OUTLIER -144.34 149.63 36.49 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-N 114.333 -1.303 . . . . 1.59 110.144 178.811 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 79.36 -167.26 51.97 Favored Glycine 0 C--N 1.339 0.73 0 C-N-CA 119.039 -1.553 . . . . 2.43 109.683 -173.005 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.05 66.67 0.15 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 118.668 1.234 . . . . 4.11 112.472 -175.289 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.22 13.73 80.24 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.984 -0.627 . . . . 2.21 114.347 177.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.482 ' O ' ' O ' ' A' ' 61' ' ' CYS . . . -101.01 122.19 7.51 Favored Glycine 0 CA--C 1.501 -0.836 0 C-N-CA 119.59 -1.29 . . . . 1.62 113.66 -175.299 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.535 ' HB2' ' HA ' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -86.54 152.24 22.8 Favored 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 110.067 -0.345 . . . . 3.02 110.067 -178.929 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.554 ' HB2' ' HB3' ' A' ' 59' ' ' LYS . 0.1 OUTLIER -67.03 106.54 1.98 Allowed 'General case' 0 N--CA 1.423 -1.802 0 N-CA-C 108.674 -0.862 . . . . 1.52 108.674 -179.196 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -91.88 -23.72 19.55 Favored 'General case' 0 N--CA 1.417 -2.108 0 N-CA-C 107.468 -1.308 . . . . 1.07 107.468 177.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.906 ' HB1' ' HA2' ' A' ' 33' ' ' GLY . . . -169.72 163.26 9.92 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 109.875 -0.417 . . . . 1.0 109.875 -178.056 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.851 ' HA ' ' HB3' ' A' ' 85' ' ' CYS . . . -37.35 127.06 1.05 Allowed 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 115.611 1.708 . . . . 1.24 115.611 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.627 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . 59.08 -6.39 0.05 OUTLIER Glycine 0 C--N 1.342 0.912 0 N-CA-C 115.97 1.148 . . . . 1.28 115.97 177.32 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.981 HD13 ' HB2' ' A' ' 34' ' ' CYS . 1.6 pp -117.58 105.82 18.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 117.662 0.731 . . . . 2.27 111.846 -178.307 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -91.93 106.7 18.66 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.018 -0.992 . . . . 1.98 108.844 179.589 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.671 ' SG ' HD12 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -129.65 170.49 13.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 122.113 0.958 . . . . 1.33 113.561 -178.436 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.763 ' HB3' ' HD2' ' A' ' 76' ' ' PRO . 10.3 m -130.42 179.62 1.28 Allowed Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 113.297 -1.774 . . . . 1.99 106.947 178.258 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.763 ' HD2' ' HB3' ' A' ' 75' ' ' SER . 58.1 Cg_endo -75.94 30.81 0.39 Allowed 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 120.994 1.129 . . . . 1.86 112.258 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.469 ' HB3' ' CE1' ' B' ' 180' ' ' HIS . 2.7 m-20 -138.16 -57.15 0.66 Allowed 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.859 -0.61 . . . . 2.65 109.925 179.17 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.431 ' O ' ' HB3' ' A' ' 74' ' ' CYS . . . -139.31 -178.15 16.23 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.507 -0.854 . . . . 0.99 112.842 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.515 ' SG ' ' HB ' ' A' ' 72' ' ' ILE . 13.4 t -142.48 160.68 39.8 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 110.139 -0.319 . . . . 1.34 110.139 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.43 ' CE1' ' HB3' ' B' ' 177' ' ' ASP . 1.6 t60 -149.7 134.68 17.93 Favored 'General case' 0 CA--C 1.521 -0.164 0 C-N-CA 119.986 -0.686 . . . . 2.17 112.179 -178.587 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.86 119.46 10.04 Favored 'General case' 0 CA--C 1.51 -0.59 0 N-CA-C 108.363 -0.977 . . . . 3.05 108.363 177.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.423 ' OD1' ' HB2' ' A' ' 84' ' ' ALA . 0.2 OUTLIER -154.48 139.18 11.65 Favored Pre-proline 0 C--N 1.317 -0.846 0 C-N-CA 120.534 -0.466 . . . . 2.02 110.971 -179.013 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 82' ' ' ASP . 12.7 Cg_exo -70.17 41.84 0.36 Allowed 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.987 2.458 . . . . 1.93 113.049 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.59 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . . . -75.11 -58.96 2.96 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-O 122.698 1.237 . . . . 1.53 109.363 178.532 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.917 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 52.5 m -105.78 80.98 1.6 Allowed 'General case' 0 N--CA 1.435 -1.222 0 CA-C-N 112.507 -2.133 . . . . 1.88 109.102 -179.513 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.455 ' O ' ' N ' ' A' ' 88' ' ' GLU . 0.0 OUTLIER -97.93 88.87 0.68 Allowed Pre-proline 0 N--CA 1.453 -0.287 0 CA-C-N 116.007 -0.542 . . . . 3.6 111.942 -178.013 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.917 ' HD3' ' O ' ' A' ' 85' ' ' CYS . 19.5 Cg_exo -66.7 76.96 0.38 Allowed 'Trans proline' 0 CA--C 1.506 -0.88 0 C-N-CA 123.017 2.478 . . . . 2.56 108.368 178.432 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.455 ' N ' ' O ' ' A' ' 86' ' ' ASP . 9.3 pt-20 -170.87 -30.7 0.02 OUTLIER 'General case' 0 N--CA 1.426 -1.647 0 CA-C-N 113.108 -1.86 . . . . 4.72 110.5 177.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.09 71.22 0.16 Allowed 'General case' 0 C--N 1.314 -0.96 0 O-C-N 118.994 -2.317 . . . . 5.29 115.94 -174.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.79 179.78 3.0 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 120.56 -1.337 . . . . 6.98 110.519 -179.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -90.06 63.29 5.84 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 118.591 0.632 . . . . 10.21 110.423 177.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 15.9 p . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.231 -0.89 . . . . 11.77 111.248 -179.892 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 101' ' ' ALA . . . . . 0.532 ' O ' ' CG2' ' B' ' 109' ' ' THR . . . . . . . . 0 N--CA 1.488 1.46 0 CA-C-O 120.559 0.219 . . . . 10.07 111.233 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 102' ' ' VAL . . . . . 0.539 HG22 ' OD1' ' B' ' 104' ' ' ASP . 9.4 p 43.47 48.12 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.138 0 CA-C-O 122.616 1.198 . . . . 8.41 113.68 178.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 103' ' ' LEU . . . . . 0.731 HD13 ' H ' ' B' ' 103' ' ' LEU . 0.0 OUTLIER -69.98 95.03 0.91 Allowed 'General case' 0 N--CA 1.484 1.232 0 CA-C-N 112.717 -2.038 . . . . 5.87 108.825 177.835 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 104' ' ' ASP . . . . . 0.539 ' OD1' HG22 ' B' ' 102' ' ' VAL . 2.4 m-20 -104.99 59.4 0.68 Allowed 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 113.928 -1.487 . . . . 6.27 111.289 178.28 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 105' ' ' LEU . . . . . 0.904 HD12 HG12 ' B' ' 107' ' ' VAL . 1.9 tm? -148.71 -87.44 0.09 Allowed 'General case' 0 N--CA 1.381 -3.925 0 N-CA-C 101.787 -3.412 . . . . 7.2 101.787 172.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 106' ' ' ASP . . . . . 0.653 ' N ' HD13 ' B' ' 105' ' ' LEU . 0.5 OUTLIER -168.25 -48.82 0.02 OUTLIER 'General case' 0 C--N 1.277 -2.561 0 CA-C-N 111.99 -2.368 . . . . 8.55 107.744 -179.434 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 107' ' ' VAL . . . . . 0.904 HG12 HD12 ' B' ' 105' ' ' LEU . 4.6 p -84.46 174.46 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.485 -1.531 0 CA-C-N 111.701 -2.499 . . . . 7.48 107.355 -175.066 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 108' ' ' ARG . . . . . 0.542 ' H ' HG22 ' B' ' 107' ' ' VAL . 2.6 ptp85 -71.41 114.1 9.13 Favored 'General case' 0 N--CA 1.418 -2.052 0 C-N-CA 117.83 -1.548 . . . . 9.12 107.192 -175.463 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 109' ' ' THR . . . . . 0.537 ' H ' ' HB3' ' B' ' 103' ' ' LEU . 1.6 t -47.37 111.3 0.39 Allowed 'General case' 0 N--CA 1.425 -1.718 0 CA-C-O 122.848 1.309 . . . . 5.69 109.812 -177.021 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 110' ' ' CYS . . . . . 0.45 ' SG ' ' HB3' ' B' ' 120' ' ' ARG . 12.0 p -31.1 110.93 0.07 Allowed 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 112.085 -2.325 . . . . 2.61 114.003 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 111' ' ' LEU . . . . . 0.421 ' O ' ' O ' ' B' ' 110' ' ' CYS . 25.5 mt -30.19 154.3 0.03 OUTLIER Pre-proline 0 N--CA 1.481 1.081 0 N-CA-C 113.314 0.857 . . . . 2.47 113.314 178.64 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 112' ' ' PRO . . . . . 0.744 ' HB2' ' O ' ' B' ' 117' ' ' GLY . 48.5 Cg_endo -88.14 122.32 1.53 Allowed 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.423 2.749 . . . . 1.47 113.726 -178.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.646 ' SG ' ' O ' ' B' ' 120' ' ' ARG . 8.1 p -109.26 -153.59 0.51 Allowed 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 121.267 0.556 . . . . 1.0 110.625 178.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . 78.9 -168.13 53.26 Favored Glycine 0 CA--C 1.49 -1.498 0 N-CA-C 110.361 -1.096 . . . . 1.16 110.361 -179.06 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 115' ' ' PRO . . . . . 0.637 ' HD2' HD11 ' B' ' 132' ' ' LEU . 97.2 Cg_endo -64.59 85.93 0.16 Allowed 'Trans proline' 0 N--CA 1.45 -1.044 0 CA-C-N 119.556 1.678 . . . . 1.57 113.608 -178.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 86.13 19.22 57.84 Favored Glycine 0 N--CA 1.423 -2.192 0 CA-C-N 113.154 -1.839 . . . . 1.7 115.083 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 117' ' ' GLY . . . . . 0.744 ' O ' ' HB2' ' B' ' 112' ' ' PRO . . . 87.33 34.7 10.24 Favored Glycine 0 N--CA 1.413 -2.883 0 C-N-CA 119.536 -1.316 . . . . 1.38 116.182 176.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 118' ' ' LYS . . . . . 0.553 ' HG3' ' HG2' ' B' ' 115' ' ' PRO . 0.1 OUTLIER -93.03 -7.37 45.92 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 122.252 0.221 . . . . 2.54 111.267 177.289 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 119' ' ' GLY . . . . . 0.609 ' O ' ' HA ' ' B' ' 112' ' ' PRO . . . -114.89 -169.22 16.0 Favored Glycine 0 C--N 1.344 1.008 0 N-CA-C 108.112 -1.995 . . . . 1.04 108.112 177.303 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.646 ' O ' ' SG ' ' B' ' 113' ' ' CYS . 0.0 OUTLIER -125.08 168.69 13.03 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 120.934 2.367 . . . . 2.89 108.838 179.589 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 121' ' ' CYS . . . . . 0.681 ' HB2' ' HG2' ' B' ' 147' ' ' GLU . 33.4 m -108.28 162.45 14.08 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.201 0.815 . . . . 1.07 113.201 -178.524 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -143.52 -56.98 0.4 Allowed 'General case' 0 C--O 1.231 0.107 0 CA-C-N 114.698 -1.137 . . . . 1.53 109.91 179.06 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 123' ' ' GLY . . . . . 0.58 ' O ' ' HB3' ' B' ' 144' ' ' CYS . . . -120.83 177.07 16.36 Favored Glycine 0 CA--C 1.52 0.36 0 CA-C-N 115.898 -0.592 . . . . 0.9 112.029 179.319 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 124' ' ' PRO . . . . . 0.423 ' O ' ' HB2' ' B' ' 144' ' ' CYS . 51.2 Cg_exo -53.58 -68.93 0.06 OUTLIER 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.515 2.143 . . . . 1.51 112.427 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 125' ' ' SER . . . . . 0.654 ' O ' ' N ' ' B' ' 137' ' ' GLY . 0.5 OUTLIER -95.47 18.33 12.88 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-O 120.88 0.372 . . . . 1.25 110.018 178.794 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 126' ' ' ILE . . . . . 0.924 HG12 HG13 ' B' ' 136' ' ' VAL . 1.5 mt -122.21 105.8 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 CA-C-O 121.546 0.688 . . . . 0.85 111.951 -177.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 127' ' ' CYS . . . . . 0.751 ' O ' ' HA ' ' B' ' 134' ' ' CYS . 0.6 OUTLIER -122.02 124.5 44.12 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 114.821 -1.081 . . . . 0.89 109.828 -179.175 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 128' ' ' CYS . . . . . 1.17 ' HA ' ' O ' ' B' ' 133' ' ' GLY . 0.0 OUTLIER -140.16 110.49 6.63 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 115.995 1.85 . . . . 1.23 115.995 -178.097 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 129' ' ' GLY . . . . . 0.433 ' HA2' ' HE ' ' B' ' 120' ' ' ARG . . . -102.77 -161.05 25.78 Favored Glycine 0 N--CA 1.433 -1.53 0 N-CA-C 110.499 -1.04 . . . . 0.66 110.499 176.016 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -68.32 -56.97 6.73 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 114.766 1.395 . . . . 2.35 114.766 -177.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.34 29.27 7.56 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 122.81 1.29 . . . . 1.69 109.478 178.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 132' ' ' LEU . . . . . 0.637 HD11 ' HD2' ' B' ' 115' ' ' PRO . 0.3 OUTLIER -123.66 -12.21 7.67 Favored 'General case' 0 N--CA 1.4 -2.926 0 N-CA-C 104.16 -2.533 . . . . 1.38 104.16 179.425 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 133' ' ' GLY . . . . . 1.17 ' O ' ' HA ' ' B' ' 128' ' ' CYS . . . 51.09 -132.66 33.16 Favored Glycine 0 N--CA 1.4 -3.755 0 CA-C-N 113.424 -1.716 . . . . 0.72 112.674 176.126 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 134' ' ' CYS . . . . . 0.997 ' HB2' HD13 ' B' ' 172' ' ' ILE . 1.7 t -129.42 112.43 13.8 Favored 'General case' 0 CA--C 1.495 -1.152 0 CA-C-N 118.413 1.106 . . . . 1.08 112.675 178.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 135' ' ' PHE . . . . . 0.827 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 6.2 m-30 -86.72 105.27 16.83 Favored 'General case' 0 N--CA 1.407 -2.578 0 N-CA-C 103.452 -2.796 . . . . 1.36 103.452 175.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 136' ' ' VAL . . . . . 0.924 HG13 HG12 ' B' ' 126' ' ' ILE . 2.8 t -97.15 85.32 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.728 0 CA-C-O 122.913 1.34 . . . . 0.75 107.64 -178.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 137' ' ' GLY . . . . . 0.801 ' HA3' HG21 ' A' ' 72' ' ' ILE . . . 110.7 92.93 2.18 Favored Glycine 0 CA--C 1.522 0.507 0 CA-C-N 112.64 -2.073 . . . . 0.83 114.193 -179.592 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 138' ' ' THR . . . . . 0.714 ' CG2' ' HB3' ' B' ' 135' ' ' PHE . 0.0 OUTLIER 178.84 169.97 0.88 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.761 -0.459 . . . . 0.78 109.761 178.298 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 139' ' ' ALA . . . . . 0.711 ' HA ' HD12 ' B' ' 142' ' ' LEU . . . -74.59 -22.89 58.72 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.586 0.588 . . . . 1.04 112.586 -179.578 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 140' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.7 -25.37 67.37 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.904 -0.318 . . . . 2.31 110.587 178.69 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 141' ' ' ALA . . . . . 0.682 ' O ' ' N ' ' B' ' 144' ' ' CYS . . . -97.36 -20.79 17.59 Favored 'General case' 0 C--O 1.213 -0.866 0 CA-C-N 116.265 -0.425 . . . . 0.87 111.583 -178.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 142' ' ' LEU . . . . . 0.711 HD12 ' HA ' ' B' ' 139' ' ' ALA . 0.9 OUTLIER -38.16 -47.41 1.15 Allowed 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 112.701 0.63 . . . . 1.24 112.701 -176.73 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 143' ' ' ARG . . . . . 0.508 ' HD2' ' H ' ' B' ' 143' ' ' ARG . 0.0 OUTLIER -54.0 -24.56 17.32 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.07 -0.715 . . . . 2.93 109.07 177.475 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 144' ' ' CYS . . . . . 0.682 ' N ' ' O ' ' B' ' 141' ' ' ALA . 93.6 m -56.09 -24.96 43.55 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 114.292 -1.322 . . . . 1.61 109.496 -179.154 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -36.47 -45.55 0.5 Allowed 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.929 0.714 . . . . 3.35 112.929 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -87.84 -7.39 57.3 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 119.826 -0.75 . . . . 3.76 111.017 -178.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 147' ' ' GLU . . . . . 0.681 ' HG2' ' HB2' ' B' ' 121' ' ' CYS . 0.8 OUTLIER -85.01 6.04 26.9 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 115.875 -0.602 . . . . 4.01 109.411 177.167 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 148' ' ' ASN . . . . . 0.493 ' C ' ' H ' ' B' ' 150' ' ' LEU . 7.6 p-10 -71.53 -26.64 62.73 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.63 -0.713 . . . . 3.92 109.385 177.621 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -51.59 8.23 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 114.614 1.338 . . . . 5.73 114.614 -178.216 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 150' ' ' LEU . . . . . 0.594 ' N ' HD13 ' B' ' 150' ' ' LEU . 0.0 OUTLIER -133.03 132.56 22.43 Favored Pre-proline 0 N--CA 1.466 0.335 0 CA-C-N 118.733 0.697 . . . . 5.46 110.734 178.401 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 151' ' ' PRO . . . . . 0.671 ' HA ' ' HG3' ' B' ' 176' ' ' PRO . 93.7 Cg_endo -86.81 10.59 3.55 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.826 2.35 . . . . 5.02 113.378 -178.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 152' ' ' SER . . . . . 0.661 ' N ' ' HD2' ' B' ' 153' ' ' PRO . 0.7 OUTLIER 160.68 -52.09 0.0 OUTLIER Pre-proline 0 N--CA 1.465 0.321 0 CA-C-O 120.681 0.277 . . . . 5.73 111.255 -179.838 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 153' ' ' PRO . . . . . 0.661 ' HD2' ' N ' ' B' ' 152' ' ' SER . 12.0 Cg_endo -55.84 121.68 10.4 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 123.191 2.594 . . . . 5.1 114.761 -178.474 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 154' ' ' CYS . . . . . 0.642 ' N ' ' HG ' ' B' ' 105' ' ' LEU . 0.1 OUTLIER -178.37 107.91 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.524 -0.762 . . . . 2.68 109.609 177.911 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 155' ' ' GLN . . . . . 0.624 ' N ' ' HB2' ' B' ' 105' ' ' LEU . 18.8 pt20 32.48 -156.24 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 112.853 0.686 . . . . 5.63 112.853 -177.499 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 2.3 t -80.31 104.88 11.16 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 112.782 0.66 . . . . 3.11 112.782 -177.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 165.34 34.96 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 CA-C-N 115.015 -0.993 . . . . 2.07 111.22 179.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 158' ' ' GLN . . . . . 0.557 ' HA ' ' HB2' ' B' ' 166' ' ' ARG . 0.0 OUTLIER -122.86 73.42 1.14 Allowed 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 121.437 0.637 . . . . 4.34 111.059 179.395 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 159' ' ' LYS . . . . . 0.476 ' CB ' ' HB2' ' B' ' 167' ' ' CYS . 0.9 OUTLIER -106.18 79.37 0.58 Allowed Pre-proline 0 C--N 1.314 -0.953 0 CA-C-O 117.788 -1.101 . . . . 3.54 110.673 175.544 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 160' ' ' PRO . . . . . 0.497 ' HA ' ' HA ' ' B' ' 166' ' ' ARG . 11.9 Cg_endo -55.2 108.36 0.3 Allowed 'Trans proline' 0 CA--C 1.531 0.343 0 C-N-CA 122.074 1.849 . . . . 1.51 114.868 -177.348 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 161' ' ' CYS . . . . . 0.596 ' SG ' ' HB2' ' B' ' 184' ' ' ALA . 0.5 OUTLIER -142.08 155.33 45.37 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 114.831 -1.077 . . . . 1.58 108.847 178.652 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 162' ' ' GLY . . . . . 0.44 ' O ' ' N ' ' B' ' 164' ' ' GLY . . . 74.82 -166.24 54.84 Favored Glycine 0 CA--C 1.521 0.427 0 C-N-CA 118.716 -1.707 . . . . 2.37 110.004 -176.238 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.79 65.11 0.12 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.729 1.264 . . . . 4.07 112.421 -176.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 164' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' B' ' 162' ' ' GLY . . . 78.91 19.6 72.48 Favored Glycine 0 CA--C 1.502 -0.77 0 C-N-CA 120.8 -0.714 . . . . 2.2 113.906 176.518 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 165' ' ' GLY . . . . . 0.487 ' O ' ' O ' ' B' ' 161' ' ' CYS . . . -103.42 126.44 8.81 Favored Glycine 0 N--CA 1.439 -1.105 0 C-N-CA 119.779 -1.2 . . . . 1.62 112.741 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 166' ' ' ARG . . . . . 0.557 ' HB2' ' HA ' ' B' ' 158' ' ' GLN . 0.0 OUTLIER -87.74 152.89 21.78 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.567 -0.317 . . . . 3.05 110.177 179.453 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 167' ' ' CYS . . . . . 0.476 ' HB2' ' CB ' ' B' ' 159' ' ' LYS . 0.1 OUTLIER -67.29 106.35 2.03 Favored 'General case' 0 N--CA 1.418 -2.058 0 N-CA-C 108.577 -0.898 . . . . 1.56 108.577 -179.299 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 168' ' ' ALA . . . . . 0.404 ' HB1' ' SG ' ' B' ' 128' ' ' CYS . . . -86.43 -33.09 20.54 Favored 'General case' 0 N--CA 1.424 -1.728 0 N-CA-C 105.637 -1.986 . . . . 1.04 105.637 177.336 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 169' ' ' ALA . . . . . 0.889 ' HB1' ' HA2' ' B' ' 133' ' ' GLY . . . -164.01 163.45 23.38 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 114.502 -1.226 . . . . 0.98 111.403 -174.318 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 170' ' ' ALA . . . . . 0.861 ' HA ' ' HB3' ' B' ' 185' ' ' CYS . . . -37.03 127.02 0.94 Allowed 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 115.288 1.588 . . . . 1.25 115.288 -179.17 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 171' ' ' GLY . . . . . 0.633 ' N ' ' O ' ' B' ' 185' ' ' CYS . . . 61.51 -11.94 0.06 OUTLIER Glycine 0 C--N 1.339 0.729 0 N-CA-C 115.806 1.083 . . . . 1.29 115.806 177.201 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 172' ' ' ILE . . . . . 0.997 HD13 ' HB2' ' B' ' 134' ' ' CYS . 1.6 pp -114.17 106.31 20.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 121.605 0.717 . . . . 2.27 112.191 -176.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 173' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -92.14 106.8 18.73 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.113 -0.949 . . . . 1.94 108.835 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 174' ' ' CYS . . . . . 0.677 ' SG ' HD12 ' B' ' 172' ' ' ILE . 0.0 OUTLIER -129.74 170.44 13.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 122.199 0.999 . . . . 1.35 113.598 -178.441 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 175' ' ' SER . . . . . 0.77 ' HB3' ' HD2' ' B' ' 176' ' ' PRO . 9.9 m -130.29 179.52 1.31 Allowed Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 113.303 -1.771 . . . . 2.0 106.993 178.302 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 176' ' ' PRO . . . . . 0.77 ' HD2' ' HB3' ' B' ' 175' ' ' SER . 58.1 Cg_endo -75.84 30.83 0.38 Allowed 'Trans proline' 0 N--CA 1.461 -0.422 0 CA-C-N 120.12 1.079 . . . . 1.9 112.28 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 177' ' ' ASP . . . . . 0.43 ' HB3' ' CE1' ' A' ' 80' ' ' HIS . 2.7 m-20 -138.25 -56.96 0.65 Allowed 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.868 -0.606 . . . . 2.72 109.956 179.184 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 178' ' ' GLY . . . . . 0.442 ' O ' ' HB3' ' B' ' 174' ' ' CYS . . . -139.33 -178.22 16.31 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.598 -0.811 . . . . 0.99 112.948 179.438 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 179' ' ' CYS . . . . . 0.52 ' SG ' ' HB ' ' B' ' 172' ' ' ILE . 13.4 t -142.55 160.61 39.95 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 110.148 -0.316 . . . . 1.34 110.148 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 180' ' ' HIS . . . . . 0.469 ' CE1' ' HB3' ' A' ' 77' ' ' ASP . 1.6 t60 -149.69 134.74 18.0 Favored 'General case' 0 CA--C 1.521 -0.17 0 C-N-CA 119.925 -0.71 . . . . 2.1 112.187 -178.603 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 181' ' ' GLU . . . . . 0.437 ' OE1' ' HB2' ' A' ' 24' ' ' PRO . 0.2 OUTLIER -63.9 119.5 10.16 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 108.337 -0.986 . . . . 3.06 108.337 177.953 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 182' ' ' ASP . . . . . 0.433 ' HA ' ' HD3' ' B' ' 183' ' ' PRO . 0.2 OUTLIER -154.52 139.14 11.6 Favored Pre-proline 0 C--N 1.316 -0.872 0 C-N-CA 120.452 -0.499 . . . . 2.06 110.939 -178.995 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 183' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' B' ' 182' ' ' ASP . 12.7 Cg_exo -70.09 41.69 0.35 Allowed 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.943 2.429 . . . . 1.91 113.139 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 184' ' ' ALA . . . . . 0.596 ' HB2' ' SG ' ' B' ' 161' ' ' CYS . . . -75.01 -58.94 2.97 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 122.651 1.215 . . . . 1.56 109.343 178.567 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 185' ' ' CYS . . . . . 0.915 ' O ' ' HD3' ' B' ' 187' ' ' PRO . 49.0 m -105.6 80.33 1.55 Allowed 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 112.508 -2.133 . . . . 1.94 109.297 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 186' ' ' ASP . . . . . 0.411 ' O ' ' N ' ' B' ' 188' ' ' GLU . 0.0 OUTLIER -97.61 88.8 0.64 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.071 -0.513 . . . . 3.61 112.178 -177.984 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 187' ' ' PRO . . . . . 0.915 ' HD3' ' O ' ' B' ' 185' ' ' CYS . 21.3 Cg_exo -66.45 76.4 0.37 Allowed 'Trans proline' 0 CA--C 1.521 -0.128 0 C-N-CA 123.294 2.663 . . . . 2.58 109.22 178.521 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 188' ' ' GLU . . . . . 0.424 ' HB3' ' O ' ' B' ' 187' ' ' PRO . 6.8 pt-20 174.0 12.72 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 112.896 -1.957 . . . . 4.7 112.218 177.46 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 189' ' ' ALA . . . . . . . . . . . . . . . -94.5 61.93 2.78 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 113.688 0.996 . . . . 5.24 113.688 175.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 190' ' ' ALA . . . . . . . . . . . . . . . -67.55 177.85 1.83 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 120.064 1.302 . . . . 6.93 111.272 -177.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 191' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -90.21 63.05 5.65 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.722 -0.391 . . . . 10.14 110.107 177.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 15.6 p . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.242 -0.885 . . . . 11.7 111.234 179.984 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.531 ' O ' ' O ' ' A' ' 2' ' ' VAL . . . . . . . . 0 N--CA 1.484 1.275 0 N-CA-C 110.313 -0.254 . . . . 9.95 110.313 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.929 HG13 ' H ' ' A' ' 4' ' ' ASP . 3.7 p 42.47 179.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 112.885 0.698 . . . . 8.02 112.885 178.078 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.791 ' HG ' ' HD3' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -89.39 12.24 16.86 Favored 'General case' 0 N--CA 1.422 -1.871 0 N-CA-C 113.889 1.07 . . . . 5.86 113.889 178.124 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.929 ' H ' HG13 ' A' ' 2' ' ' VAL . 0.5 OUTLIER -53.39 -103.38 0.0 OUTLIER 'General case' 0 C--N 1.291 -1.955 0 C-N-CA 119.022 -1.071 . . . . 6.22 110.614 -179.332 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.58 ' O ' ' HG ' ' A' ' 5' ' ' LEU . 49.5 tp -152.02 21.04 0.67 Allowed 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 118.01 -1.476 . . . . 7.09 113.619 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.83 -60.55 2.33 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 106.815 -1.55 . . . . 8.78 106.815 179.309 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.492 ' O ' HG13 ' A' ' 7' ' ' VAL . 3.6 p -160.2 115.97 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.466 -2.28 0 N-CA-C 104.243 -2.503 . . . . 7.51 104.243 163.309 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.791 ' HD3' ' HG ' ' A' ' 3' ' ' LEU . 0.0 OUTLIER -78.07 116.6 18.66 Favored 'General case' 0 CA--C 1.479 -1.787 0 C-N-CA 115.871 -2.331 . . . . 9.08 105.887 177.525 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.405 ' O ' ' NE ' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -61.97 104.8 0.5 Allowed 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 113.448 -3.301 . . . . 5.66 104.874 179.755 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.844 ' HB3' ' HG2' ' A' ' 20' ' ' ARG . 0.1 OUTLIER -80.64 101.42 9.21 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 113.63 -1.623 . . . . 2.68 114.52 -178.377 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.569 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 1.3 tt -32.21 112.31 0.35 Allowed Pre-proline 0 N--CA 1.484 1.269 0 CA-C-N 119.294 0.952 . . . . 2.48 111.589 177.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.858 ' HB2' ' O ' ' A' ' 17' ' ' GLY . 41.4 Cg_endo -94.82 125.58 0.4 Allowed 'Trans proline' 0 C--N 1.356 0.948 0 C-N-CA 123.567 2.845 . . . . 1.49 114.65 -178.512 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.629 ' SG ' ' N ' ' A' ' 14' ' ' GLY . 0.0 OUTLIER -140.82 -168.43 2.59 Favored 'General case' 0 C--N 1.353 0.729 0 CA-C-N 118.228 0.467 . . . . 1.0 111.183 -176.472 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 1.022 ' HA2' ' HB3' ' A' ' 40' ' ' GLU . . . 75.23 -163.81 54.14 Favored Glycine 0 CA--C 1.501 -0.787 0 C-N-CA 120.832 -0.699 . . . . 1.15 111.705 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.409 ' HD3' ' OE1' ' A' ' 40' ' ' GLU . 49.5 Cg_endo -63.2 142.04 84.99 Favored 'Trans proline' 0 N--CA 1.446 -1.315 0 N-CA-C 106.867 -2.013 . . . . 1.57 106.867 175.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 62.73 -12.24 0.1 OUTLIER Glycine 0 C--N 1.269 -3.176 0 C-N-CA 124.66 1.124 . . . . 1.68 113.38 -179.205 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.858 ' O ' ' HB2' ' A' ' 12' ' ' PRO . . . 64.9 20.14 66.28 Favored Glycine 1 N--CA 1.391 -4.333 0 C-N-CA 116.978 -2.534 . . . . 1.36 110.58 179.411 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.464 ' HB2' HD12 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -92.18 -1.61 57.04 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 113.293 -1.454 . . . . 2.5 113.31 179.879 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.811 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -116.67 177.73 16.93 Favored Glycine 0 C--N 1.335 0.476 0 N-CA-C 108.488 -1.845 . . . . 1.02 108.488 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.844 ' HG2' ' HB3' ' A' ' 10' ' ' CYS . 0.5 OUTLIER -119.75 173.06 7.26 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 120.408 2.104 . . . . 2.92 111.193 179.89 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.436 ' CB ' ' HG3' ' A' ' 47' ' ' GLU . 4.6 m -105.86 147.43 28.71 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.027 0.441 . . . . 1.1 110.422 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.412 ' HE1' ' O ' ' A' ' 28' ' ' CYS . 44.0 m-85 -137.6 -52.07 0.64 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.807 -0.633 . . . . 1.51 110.711 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.565 ' O ' ' HB3' ' A' ' 44' ' ' CYS . . . -101.4 -166.2 27.56 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.858 -0.687 . . . . 0.9 111.714 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.454 ' O ' ' HB2' ' A' ' 44' ' ' CYS . 2.4 Cg_endo -77.31 -60.64 0.04 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.404 2.069 . . . . 1.5 111.54 179.416 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -102.86 26.34 8.21 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.794 -0.639 . . . . 1.26 109.935 179.291 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.831 HG22 ' SG ' ' A' ' 34' ' ' CYS . 0.6 OUTLIER -131.46 121.33 48.08 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 N-CA-C 113.346 0.869 . . . . 0.83 113.346 -177.402 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.8 t -123.16 118.19 27.1 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 109.022 -0.732 . . . . 0.92 109.022 178.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 1.053 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -132.97 112.26 11.71 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 113.911 1.078 . . . . 1.28 113.911 -177.689 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.835 ' O ' ' HB1' ' A' ' 69' ' ' ALA . . . -105.71 -158.89 22.68 Favored Glycine 0 C--N 1.358 1.784 0 C-N-CA 120.318 -0.944 . . . . 0.67 112.738 178.579 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.542 ' O ' ' HB2' ' A' ' 70' ' ' ALA . 19.0 p-10 -66.37 -57.09 8.19 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 115.498 1.666 . . . . 2.27 115.498 -176.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -120.29 17.7 12.26 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 121.891 0.853 . . . . 1.66 110.071 -176.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.521 HD22 ' CE1' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -112.93 -24.37 9.56 Favored 'General case' 0 N--CA 1.408 -2.567 0 CA-C-N 113.628 -1.624 . . . . 1.37 107.396 -179.315 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 1.053 ' O ' ' HA ' ' A' ' 28' ' ' CYS . . . 73.22 -128.39 11.61 Favored Glycine 0 N--CA 1.415 -2.727 0 CA-C-N 113.951 -1.477 . . . . 0.73 113.755 177.123 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.831 ' SG ' HG22 ' A' ' 26' ' ' ILE . 5.1 t -138.72 118.08 12.81 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 114.834 1.42 . . . . 1.08 114.834 -177.22 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.752 ' HB3' ' CG2' ' A' ' 38' ' ' THR . 0.2 OUTLIER -92.83 106.97 18.85 Favored 'General case' 0 N--CA 1.423 -1.789 0 N-CA-C 105.408 -2.071 . . . . 1.38 105.408 177.031 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.829 ' HA ' HG23 ' A' ' 26' ' ' ILE . 2.2 t -97.9 85.15 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.577 0 C-N-CA 118.718 -1.193 . . . . 0.76 108.856 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.59 ' O ' ' O ' ' A' ' 38' ' ' THR . . . 143.39 -75.78 0.3 Allowed Glycine 0 CA--C 1.524 0.607 0 CA-C-N 114.3 -1.318 . . . . 0.81 115.568 179.203 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.752 ' CG2' ' HB3' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -23.47 154.27 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 113.111 0.782 . . . . 0.77 113.111 -178.298 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.52 ' O ' ' N ' ' A' ' 42' ' ' LEU . . . -60.14 -39.09 85.09 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.971 -0.559 . . . . 1.02 111.366 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 1.022 ' HB3' ' HA2' ' A' ' 14' ' ' GLY . 1.2 mt-10 -40.36 -29.52 0.08 Allowed 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.794 0.665 . . . . 2.32 112.794 -178.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.692 ' O ' ' N ' ' A' ' 44' ' ' CYS . . . -89.16 -20.95 23.6 Favored 'General case' 0 N--CA 1.44 -0.954 0 O-C-N 122.328 -0.232 . . . . 0.87 110.952 -179.233 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.52 ' N ' ' O ' ' A' ' 39' ' ' ALA . 3.2 mt -39.22 -43.62 1.13 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.819 0.674 . . . . 1.23 112.819 -177.394 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.406 ' HD3' ' O ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -52.32 -30.44 28.4 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 107.903 -1.147 . . . . 2.92 107.903 177.469 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.692 ' N ' ' O ' ' A' ' 41' ' ' ALA . 70.0 m -53.04 -21.65 4.85 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 114.279 -1.328 . . . . 1.57 110.556 -177.34 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -49.03 -34.45 13.37 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 113.505 0.928 . . . . 3.31 113.505 -179.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -87.09 -5.0 59.18 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 119.869 -0.733 . . . . 3.69 111.157 -178.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.436 ' HG3' ' CB ' ' A' ' 21' ' ' CYS . 3.9 mm-40 -83.3 6.18 20.62 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 109.512 -0.551 . . . . 3.99 109.512 177.287 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -74.35 -29.4 61.56 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 116.026 -0.534 . . . . 3.86 109.73 178.293 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.464 ' C ' HD12 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -95.56 26.13 4.11 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 120.724 -0.39 . . . . 5.68 111.416 -179.753 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.464 HD12 ' C ' ' A' ' 49' ' ' TYR . 4.6 mp -147.32 85.2 6.9 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-O 120.668 0.27 . . . . 5.4 111.558 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -88.47 50.08 1.59 Allowed 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 122.801 2.334 . . . . 4.92 112.673 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.418 ' HB2' ' HD2' ' A' ' 53' ' ' PRO . 24.4 p -73.83 159.22 84.8 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 116.416 -0.356 . . . . 5.64 111.167 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.418 ' HD2' ' HB2' ' A' ' 52' ' ' SER . 72.8 Cg_endo -77.72 -46.04 0.14 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.705 2.27 . . . . 5.04 112.602 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.765 ' HA ' ' HG2' ' A' ' 8' ' ' ARG . 0.0 OUTLIER 72.89 87.75 0.1 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.072 -0.513 . . . . 2.74 112.23 179.584 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.463 ' N ' ' HB3' ' A' ' 8' ' ' ARG . 0.0 OUTLIER 47.5 -87.95 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 112.29 0.478 . . . . 5.75 112.29 178.778 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.442 ' N ' ' O ' ' A' ' 54' ' ' CYS . 47.7 p -145.73 116.84 7.84 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.889 0.376 . . . . 3.12 111.293 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 173.39 38.38 0.04 OUTLIER Glycine 0 N--CA 1.444 -0.815 0 N-CA-C 110.415 -1.074 . . . . 2.1 110.415 -179.23 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.4 tp60 -120.78 85.58 2.42 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 108.613 -0.884 . . . . 4.36 108.613 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.5 ' O ' ' HA ' ' A' ' 66' ' ' ARG . 0.5 OUTLIER -136.32 82.28 35.22 Favored Pre-proline 0 C--N 1.299 -1.618 0 N-CA-C 106.28 -1.748 . . . . 3.55 106.28 -178.713 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.599 ' HA ' ' O ' ' A' ' 65' ' ' GLY . 60.5 Cg_endo -72.4 73.5 2.75 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 123.197 2.598 . . . . 1.54 113.856 -177.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.406 ' N ' ' O ' ' A' ' 65' ' ' GLY . 4.5 p -99.25 157.87 16.08 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.389 -1.278 . . . . 1.59 109.084 178.199 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.56 -167.86 54.11 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 119.787 -1.197 . . . . 2.43 112.094 -175.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -76.47 66.09 2.44 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 122.058 0.933 . . . . 4.11 112.623 -175.429 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.59 19.41 58.35 Favored Glycine 0 C--N 1.339 0.72 0 CA-C-N 114.112 -1.403 . . . . 2.21 114.695 177.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.638 ' HA3' ' HA ' ' A' ' 74' ' ' CYS . . . -105.28 135.01 12.34 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 119.227 -1.463 . . . . 1.62 114.213 -179.39 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.598 ' HA ' ' HA ' ' A' ' 60' ' ' PRO . 0.0 OUTLIER -107.04 152.99 23.26 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 109.248 -0.649 . . . . 3.02 109.248 177.091 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.7 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 41.7 t -52.77 106.37 0.16 Allowed 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 108.967 -0.753 . . . . 1.52 108.967 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.41 ' N ' ' O ' ' A' ' 72' ' ' ILE . . . -88.96 -36.55 15.81 Favored 'General case' 0 N--CA 1.423 -1.816 0 N-CA-C 106.718 -1.586 . . . . 1.07 106.718 177.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.835 ' HB1' ' O ' ' A' ' 29' ' ' GLY . . . -165.18 165.06 20.03 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 108.985 -0.746 . . . . 1.0 108.985 -177.339 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.542 ' HB2' ' O ' ' A' ' 30' ' ' ASP . . . -31.24 108.66 0.05 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.25 0.548 . . . . 1.24 111.402 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.84 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . 75.68 -3.4 49.71 Favored Glycine 0 C--O 1.227 -0.336 0 CA-C-N 115.249 -0.887 . . . . 1.28 114.548 179.109 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.825 HG13 ' HB2' ' A' ' 34' ' ' CYS . 1.6 mm -96.9 119.07 44.48 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.599 0 CA-C-N 117.702 0.751 . . . . 2.27 110.399 -179.645 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 1.009 ' HB2' ' HB3' ' A' ' 82' ' ' ASP . 1.9 t -118.99 95.61 4.89 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.72 -1.127 . . . . 1.98 108.391 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 1.05 ' HB3' ' HA ' ' A' ' 79' ' ' CYS . 26.7 p -156.13 -174.32 4.9 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 116.912 2.19 . . . . 1.33 116.912 -176.619 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.528 ' CB ' ' HD2' ' A' ' 76' ' ' PRO . 0.3 OUTLIER -128.56 -178.29 0.77 Allowed Pre-proline 0 N--CA 1.456 -0.169 0 CA-C-N 112.808 -1.996 . . . . 1.99 109.253 -178.831 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.528 ' HD2' ' CB ' ' A' ' 75' ' ' SER . 60.3 Cg_endo -73.28 30.85 0.31 Allowed 'Trans proline' 0 CA--C 1.533 0.464 0 C-N-CA 121.882 1.721 . . . . 1.86 113.413 -179.091 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -125.88 -60.66 1.28 Allowed 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 109.536 -0.542 . . . . 2.65 109.536 178.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.883 ' O ' ' HB2' ' A' ' 74' ' ' CYS . . . -138.39 -167.29 10.94 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 110.917 -0.873 . . . . 0.99 110.917 178.373 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 1.05 ' HA ' ' HB3' ' A' ' 74' ' ' CYS . 63.8 m -146.43 161.08 41.16 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 117.534 0.667 . . . . 1.34 111.723 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 34.6 t60 -152.58 150.1 29.17 Favored 'General case' 0 C--N 1.344 0.34 0 C-N-CA 119.896 -0.722 . . . . 2.17 111.388 -178.03 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.461 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 0.4 OUTLIER -60.71 140.86 57.37 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.764 -0.653 . . . . 3.05 110.422 179.558 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 1.009 ' HB3' ' HB2' ' A' ' 73' ' ' CYS . 0.0 OUTLIER -137.21 138.24 24.76 Favored Pre-proline 0 CA--C 1.544 0.733 0 CA-C-N 115.983 -0.553 . . . . 2.02 111.89 -179.023 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.458 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 2.5 Cg_endo -84.38 -31.68 0.46 Allowed 'Trans proline' 0 C--N 1.359 1.122 0 C-N-CA 123.311 2.674 . . . . 1.93 115.301 -177.263 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.82 -47.62 84.99 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 108.29 -1.004 . . . . 1.53 108.29 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.84 ' O ' ' N ' ' A' ' 71' ' ' GLY . 81.5 m -96.77 71.68 2.58 Favored 'General case' 0 C--O 1.215 -0.739 0 N-CA-C 105.694 -1.965 . . . . 1.88 105.694 175.266 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.58 ' CB ' ' HD3' ' A' ' 87' ' ' PRO . 0.9 OUTLIER -94.08 -56.97 0.22 Allowed Pre-proline 0 CA--C 1.497 -1.084 0 C-N-CA 119.089 -1.044 . . . . 3.6 110.582 -177.7 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.58 ' HD3' ' CB ' ' A' ' 86' ' ' ASP . 58.2 Cg_endo -103.79 168.16 0.21 Allowed 'Trans proline' 0 N--CA 1.422 -2.687 0 C-N-CA 122.704 2.27 . . . . 2.56 113.138 -178.512 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -73.22 61.23 0.62 Allowed 'General case' 0 N--CA 1.428 -1.562 0 C-N-CA 128.354 2.662 . . . . 4.72 108.394 173.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -91.44 29.17 1.52 Allowed 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 108.754 -3.839 . . . . 5.29 107.164 171.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -80.24 163.26 24.14 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 122.445 1.116 . . . . 6.98 113.838 -179.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.423 ' O ' ' CG ' ' A' ' 91' ' ' PHE . 15.3 p90 -81.46 107.92 14.62 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-N 113.039 -1.892 . . . . 10.21 111.36 -179.228 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.307 -0.854 . . . . 11.77 110.867 179.851 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.242 0 CA-C-O 120.869 0.366 . . . . 10.07 110.969 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 102' ' ' VAL . . . . . 0.461 HG22 ' N ' ' B' ' 103' ' ' LEU . 8.6 p -40.69 154.29 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 115.275 1.583 . . . . 8.41 115.275 -178.511 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 103' ' ' LEU . . . . . 0.725 ' H ' HD22 ' B' ' 103' ' ' LEU . 0.0 OUTLIER -106.25 144.27 33.19 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 113.425 -1.716 . . . . 5.87 107.888 176.822 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 104' ' ' ASP . . . . . 0.449 ' HB3' ' H ' ' B' ' 105' ' ' LEU . 0.2 OUTLIER -157.7 -130.75 0.03 OUTLIER 'General case' 0 N--CA 1.426 -1.635 0 N-CA-C 105.119 -2.178 . . . . 6.27 105.119 176.227 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 105' ' ' LEU . . . . . 0.474 HD13 ' O ' ' B' ' 155' ' ' GLN . 6.4 tp -137.02 10.35 3.05 Favored 'General case' 0 CA--C 1.489 -1.395 0 C-N-CA 117.583 -1.647 . . . . 7.2 110.106 175.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 106' ' ' ASP . . . . . 0.404 ' O ' ' HG2' ' B' ' 155' ' ' GLN . 0.8 OUTLIER -79.88 -121.04 0.02 OUTLIER 'General case' 0 CA--C 1.464 -2.335 1 N-CA-C 98.916 -4.476 . . . . 8.55 98.916 176.219 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' B' B ' 107' ' ' VAL . . . . . 0.548 ' O ' HG13 ' B' ' 107' ' ' VAL . 3.1 p -111.42 118.04 56.52 Favored 'Isoleucine or valine' 0 CA--C 1.466 -2.269 0 C-N-CA 112.902 -3.519 . . . . 7.48 105.428 178.688 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 108' ' ' ARG . . . . . 0.787 ' HG2' ' HA ' ' B' ' 154' ' ' CYS . 0.0 OUTLIER -77.5 115.06 16.96 Favored 'General case' 0 N--CA 1.423 -1.794 0 C-N-CA 116.08 -2.248 . . . . 9.12 106.119 177.935 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 109' ' ' THR . . . . . 0.412 ' O ' ' NE ' ' B' ' 108' ' ' ARG . 0.2 OUTLIER -59.73 105.16 0.35 Allowed 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 113.704 -3.199 . . . . 5.69 105.371 179.718 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 110' ' ' CYS . . . . . 0.829 ' HB3' ' HG2' ' B' ' 120' ' ' ARG . 0.1 OUTLIER -81.81 101.97 10.51 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 113.486 -1.688 . . . . 2.61 114.332 -178.11 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 111' ' ' LEU . . . . . 0.546 ' O ' ' HA ' ' B' ' 120' ' ' ARG . 1.3 tt -32.09 112.06 0.34 Allowed Pre-proline 0 N--CA 1.484 1.253 0 CA-C-N 119.001 0.819 . . . . 2.47 111.626 178.04 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 112' ' ' PRO . . . . . 0.847 ' HB2' ' O ' ' B' ' 117' ' ' GLY . 43.4 Cg_endo -93.59 127.39 0.61 Allowed 'Trans proline' 0 C--N 1.356 0.921 0 C-N-CA 123.579 2.853 . . . . 1.47 113.937 -178.745 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.627 ' SG ' ' N ' ' B' ' 114' ' ' GLY . 0.0 OUTLIER -142.54 -168.84 2.84 Favored 'General case' 0 C--N 1.351 0.631 0 O-C-N 121.943 -0.473 . . . . 1.0 111.212 -177.502 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 114' ' ' GLY . . . . . 0.985 ' HA2' ' HB3' ' B' ' 140' ' ' GLU . . . 75.33 -163.74 54.02 Favored Glycine 0 CA--C 1.502 -0.728 0 C-N-CA 120.817 -0.706 . . . . 1.16 111.535 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 115' ' ' PRO . . . . . 0.418 ' C ' ' H ' ' B' ' 117' ' ' GLY . 48.3 Cg_endo -63.23 142.01 84.67 Favored 'Trans proline' 0 N--CA 1.446 -1.281 0 N-CA-C 107.002 -1.961 . . . . 1.57 107.002 175.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 62.86 -12.48 0.1 OUTLIER Glycine 0 C--N 1.27 -3.124 0 C-N-CA 124.792 1.187 . . . . 1.7 113.251 -179.102 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 117' ' ' GLY . . . . . 0.847 ' O ' ' HB2' ' B' ' 112' ' ' PRO . . . 64.95 20.5 66.78 Favored Glycine 1 N--CA 1.395 -4.086 0 C-N-CA 116.901 -2.571 . . . . 1.38 110.566 179.431 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 118' ' ' LYS . . . . . 0.477 ' HB2' HD12 ' B' ' 132' ' ' LEU . 0.0 OUTLIER -91.92 -2.63 56.7 Favored 'General case' 0 C--N 1.346 0.435 0 CA-C-N 113.003 -1.599 . . . . 2.54 113.241 -179.894 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 119' ' ' GLY . . . . . 0.845 ' O ' ' HA ' ' B' ' 112' ' ' PRO . . . -117.65 -178.29 17.44 Favored Glycine 0 C--N 1.34 0.764 0 N-CA-C 108.607 -1.797 . . . . 1.04 108.607 178.476 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.829 ' HG2' ' HB3' ' B' ' 110' ' ' CYS . 0.4 OUTLIER -120.73 172.52 7.82 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 119.298 1.549 . . . . 2.89 112.364 -178.886 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 121' ' ' CYS . . . . . 0.431 ' CB ' ' HG3' ' B' ' 147' ' ' GLU . 4.4 m -105.89 147.29 28.91 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.081 0.467 . . . . 1.07 110.347 -179.223 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 122' ' ' PHE . . . . . 0.411 ' HE1' ' O ' ' B' ' 128' ' ' CYS . 43.9 m-85 -137.53 -52.02 0.64 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.905 -0.589 . . . . 1.53 110.691 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 123' ' ' GLY . . . . . 0.556 ' O ' ' HB3' ' B' ' 144' ' ' CYS . . . -101.45 -166.21 27.52 Favored Glycine 0 C--O 1.229 -0.203 0 C-N-CA 120.836 -0.697 . . . . 0.9 111.677 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 124' ' ' PRO . . . . . 0.441 ' O ' ' HB2' ' B' ' 144' ' ' CYS . 2.4 Cg_endo -77.31 -60.65 0.04 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 122.469 2.113 . . . . 1.51 111.564 179.405 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 125' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -102.89 26.44 8.11 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.839 -0.619 . . . . 1.25 109.921 179.295 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 126' ' ' ILE . . . . . 0.837 HG22 ' SG ' ' B' ' 134' ' ' CYS . 0.8 OUTLIER -131.37 121.37 48.43 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 N-CA-C 113.399 0.889 . . . . 0.85 113.399 -177.41 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 127' ' ' CYS . . . . . . . . . . . . . 1.8 t -123.28 118.05 26.68 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 109.059 -0.719 . . . . 0.89 109.059 178.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 128' ' ' CYS . . . . . 1.059 ' HA ' ' O ' ' B' ' 133' ' ' GLY . 0.0 OUTLIER -132.36 112.0 11.82 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 114.067 1.136 . . . . 1.23 114.067 -177.999 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 129' ' ' GLY . . . . . 0.852 ' O ' ' HB1' ' B' ' 169' ' ' ALA . . . -104.55 -157.96 23.7 Favored Glycine 0 C--N 1.357 1.742 0 C-N-CA 120.298 -0.954 . . . . 0.66 112.992 178.21 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 130' ' ' ASP . . . . . 0.515 ' O ' ' HB2' ' B' ' 170' ' ' ALA . 18.2 p-10 -68.61 -55.28 12.06 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 115.867 1.802 . . . . 2.35 115.867 -176.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -125.03 30.67 5.81 Favored 'General case' 0 CA--C 1.493 -1.218 0 C-N-CA 118.878 -1.129 . . . . 1.69 109.744 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 132' ' ' LEU . . . . . 0.523 HD22 ' CE1' ' B' ' 135' ' ' PHE . 0.4 OUTLIER -123.82 -23.82 4.59 Favored 'General case' 0 N--CA 1.404 -2.744 0 N-CA-C 105.672 -1.973 . . . . 1.38 105.672 -179.23 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 133' ' ' GLY . . . . . 1.059 ' O ' ' HA ' ' B' ' 128' ' ' CYS . . . 72.15 -126.58 11.85 Favored Glycine 0 N--CA 1.408 -3.195 0 CA-C-N 114.196 -1.366 . . . . 0.72 114.17 175.3 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 134' ' ' CYS . . . . . 0.837 ' SG ' HG22 ' B' ' 126' ' ' ILE . 5.4 t -140.17 118.13 11.83 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 114.948 1.462 . . . . 1.08 114.948 -177.035 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 135' ' ' PHE . . . . . 0.766 ' HB3' ' CG2' ' B' ' 138' ' ' THR . 0.1 OUTLIER -93.0 107.14 18.98 Favored 'General case' 0 N--CA 1.424 -1.761 0 N-CA-C 105.4 -2.074 . . . . 1.36 105.4 177.204 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 136' ' ' VAL . . . . . 0.781 ' HA ' HG23 ' B' ' 126' ' ' ILE . 2.5 t -97.56 85.42 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.552 0 C-N-CA 118.861 -1.136 . . . . 0.75 108.712 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 137' ' ' GLY . . . . . 0.596 ' O ' ' O ' ' B' ' 138' ' ' THR . . . 142.65 -76.04 0.31 Allowed Glycine 0 CA--C 1.522 0.524 0 C-N-CA 119.614 -1.279 . . . . 0.83 115.778 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 138' ' ' THR . . . . . 0.766 ' CG2' ' HB3' ' B' ' 135' ' ' PHE . 0.0 OUTLIER -23.27 154.62 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 113.081 0.771 . . . . 0.78 113.081 -178.242 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 139' ' ' ALA . . . . . 0.498 ' O ' ' N ' ' B' ' 142' ' ' LEU . . . -60.45 -39.38 87.35 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 116.147 -0.479 . . . . 1.04 111.144 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 140' ' ' GLU . . . . . 0.985 ' HB3' ' HA2' ' B' ' 114' ' ' GLY . 1.2 mt-10 -40.09 -29.56 0.08 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.84 0.682 . . . . 2.31 112.84 -178.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 141' ' ' ALA . . . . . 0.684 ' O ' ' N ' ' B' ' 144' ' ' CYS . . . -89.16 -20.72 23.88 Favored 'General case' 0 N--CA 1.441 -0.912 0 O-C-N 122.307 -0.246 . . . . 0.87 110.992 -179.24 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 142' ' ' LEU . . . . . 0.498 ' N ' ' O ' ' B' ' 139' ' ' ALA . 3.1 mt -39.32 -43.81 1.21 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.787 0.662 . . . . 1.24 112.787 -177.435 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 143' ' ' ARG . . . . . 0.412 ' HD3' ' O ' ' B' ' 140' ' ' GLU . 0.0 OUTLIER -52.18 -30.61 27.73 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 107.947 -1.131 . . . . 2.93 107.947 177.457 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 144' ' ' CYS . . . . . 0.684 ' N ' ' O ' ' B' ' 141' ' ' ALA . 69.4 m -52.96 -21.39 4.32 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 114.083 -1.417 . . . . 1.61 110.538 -177.246 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -49.39 -34.34 15.95 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 113.538 0.94 . . . . 3.35 113.538 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -87.13 -4.87 59.15 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 119.846 -0.742 . . . . 3.76 111.152 -178.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 147' ' ' GLU . . . . . 0.431 ' HG3' ' CB ' ' B' ' 121' ' ' CYS . 3.9 mm-40 -83.42 6.18 21.01 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 109.482 -0.562 . . . . 4.01 109.482 177.359 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 148' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -74.23 -29.54 61.75 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.98 -0.554 . . . . 3.92 109.724 178.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 149' ' ' TYR . . . . . 0.471 ' C ' HD12 ' B' ' 150' ' ' LEU . 0.1 OUTLIER -95.53 26.16 4.08 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 120.782 -0.367 . . . . 5.73 111.445 -179.697 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 150' ' ' LEU . . . . . 0.471 HD12 ' C ' ' B' ' 149' ' ' TYR . 4.6 mp -147.33 85.11 6.93 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-O 120.574 0.226 . . . . 5.46 111.601 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 151' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -88.41 50.11 1.62 Allowed 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 122.819 2.346 . . . . 5.02 112.624 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 152' ' ' SER . . . . . 0.414 ' HB2' ' HD2' ' B' ' 153' ' ' PRO . 29.4 p -73.82 159.23 84.78 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.471 -0.331 . . . . 5.73 111.145 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 153' ' ' PRO . . . . . 0.414 ' HD2' ' HB2' ' B' ' 152' ' ' SER . 72.8 Cg_endo -77.85 -45.81 0.14 Allowed 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.746 2.297 . . . . 5.1 112.544 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 154' ' ' CYS . . . . . 0.787 ' HA ' ' HG2' ' B' ' 108' ' ' ARG . 0.0 OUTLIER 73.26 87.48 0.1 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.905 -0.589 . . . . 2.68 112.2 179.573 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 155' ' ' GLN . . . . . 0.538 ' HG3' ' HA ' ' B' ' 107' ' ' VAL . 0.0 OUTLIER 47.62 -88.84 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.546 0.573 . . . . 5.63 112.546 178.75 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 156' ' ' SER . . . . . 0.435 ' N ' ' O ' ' B' ' 154' ' ' CYS . 50.3 p -145.09 116.81 8.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.218 0.532 . . . . 3.11 111.216 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 173.89 38.18 0.04 OUTLIER Glycine 0 N--CA 1.444 -0.832 0 N-CA-C 110.835 -0.906 . . . . 2.07 110.835 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 5.1 tp60 -120.85 71.54 0.94 Allowed 'General case' 0 N--CA 1.441 -0.883 0 CA-C-O 121.867 0.841 . . . . 4.34 110.275 179.051 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 159' ' ' LYS . . . . . 0.536 ' O ' ' HA ' ' B' ' 166' ' ' ARG . 0.7 OUTLIER -107.55 79.98 0.87 Allowed Pre-proline 0 C--N 1.316 -0.863 0 CA-C-N 114.068 -1.424 . . . . 3.54 110.643 175.117 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 160' ' ' PRO . . . . . 0.605 ' HA ' ' HA ' ' B' ' 166' ' ' ARG . 59.3 Cg_endo -72.39 74.49 2.59 Favored 'Trans proline' 0 C--N 1.333 -0.249 0 CA-C-N 121.688 1.638 . . . . 1.51 114.521 -177.416 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 161' ' ' CYS . . . . . . . . . . . . . 4.6 p -98.97 158.92 15.32 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.856 -1.065 . . . . 1.58 109.09 178.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 77.05 -167.85 54.5 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 119.726 -1.226 . . . . 2.37 112.216 -176.325 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -76.71 65.61 2.51 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 122.173 0.987 . . . . 4.07 112.529 -175.344 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 84.55 22.24 54.25 Favored Glycine 0 C--N 1.337 0.59 0 CA-C-N 113.858 -1.519 . . . . 2.2 114.626 177.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 165' ' ' GLY . . . . . 0.681 ' HA3' ' HA ' ' B' ' 174' ' ' CYS . . . -108.0 135.77 13.03 Favored Glycine 0 N--CA 1.442 -0.963 0 C-N-CA 119.279 -1.439 . . . . 1.62 113.69 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 166' ' ' ARG . . . . . 0.605 ' HA ' ' HA ' ' B' ' 160' ' ' PRO . 0.0 OUTLIER -106.79 153.27 22.71 Favored 'General case' 0 CA--C 1.521 -0.167 0 N-CA-C 109.273 -0.64 . . . . 3.05 109.273 177.681 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 167' ' ' CYS . . . . . 0.706 ' HA ' ' O ' ' B' ' 172' ' ' ILE . 41.8 t -52.88 106.34 0.16 Allowed 'General case' 0 N--CA 1.424 -1.773 0 N-CA-C 108.932 -0.766 . . . . 1.56 108.932 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 168' ' ' ALA . . . . . 0.432 ' N ' ' O ' ' B' ' 172' ' ' ILE . . . -88.16 -38.05 15.66 Favored 'General case' 0 N--CA 1.423 -1.787 0 N-CA-C 106.402 -1.703 . . . . 1.04 106.402 177.708 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 169' ' ' ALA . . . . . 0.852 ' HB1' ' O ' ' B' ' 129' ' ' GLY . . . -164.07 165.0 22.77 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 109.196 -0.668 . . . . 0.98 109.196 -176.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 170' ' ' ALA . . . . . 0.515 ' HB2' ' O ' ' B' ' 130' ' ' ASP . . . -31.08 108.69 0.05 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.319 0.58 . . . . 1.25 111.284 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 171' ' ' GLY . . . . . 0.85 ' N ' ' O ' ' B' ' 185' ' ' CYS . . . 75.51 -3.3 49.3 Favored Glycine 0 C--O 1.228 -0.25 0 CA-C-N 115.237 -0.892 . . . . 1.29 114.58 179.157 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 172' ' ' ILE . . . . . 0.822 HG13 ' HB2' ' B' ' 134' ' ' CYS . 1.6 mm -96.9 119.1 44.51 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.578 0 CA-C-N 117.723 0.762 . . . . 2.27 110.468 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 173' ' ' CYS . . . . . 0.987 ' HB2' ' HB3' ' B' ' 182' ' ' ASP . 1.9 t -118.96 95.83 4.99 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 114.723 -1.126 . . . . 1.94 108.416 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 174' ' ' CYS . . . . . 1.105 ' HB3' ' HA ' ' B' ' 179' ' ' CYS . 26.6 p -156.26 -174.3 4.88 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 116.9 2.185 . . . . 1.35 116.9 -176.622 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 175' ' ' SER . . . . . 0.517 ' CB ' ' HD2' ' B' ' 176' ' ' PRO . 0.3 OUTLIER -128.53 -178.35 0.78 Allowed Pre-proline 0 N--CA 1.454 -0.239 0 CA-C-N 112.861 -1.972 . . . . 2.0 109.383 -178.877 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 176' ' ' PRO . . . . . 0.517 ' HD2' ' CB ' ' B' ' 175' ' ' SER . 60.3 Cg_endo -73.23 30.95 0.3 Allowed 'Trans proline' 0 CA--C 1.534 0.507 0 C-N-CA 121.865 1.71 . . . . 1.9 113.428 -179.133 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 177' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -125.94 -60.68 1.28 Allowed 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 109.612 -0.514 . . . . 2.72 109.612 178.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 178' ' ' GLY . . . . . 0.858 ' O ' ' HB2' ' B' ' 174' ' ' CYS . . . -138.44 -167.36 10.96 Favored Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 110.832 -0.907 . . . . 0.99 110.832 178.393 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 179' ' ' CYS . . . . . 1.105 ' HA ' ' HB3' ' B' ' 174' ' ' CYS . 63.3 m -146.51 161.07 41.24 Favored 'General case' 0 N--CA 1.461 0.101 0 CA-C-N 117.507 0.653 . . . . 1.34 111.632 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 180' ' ' HIS . . . . . . . . . . . . . 34.9 t60 -152.37 150.31 29.56 Favored 'General case' 0 C--N 1.344 0.36 0 C-N-CA 120.014 -0.674 . . . . 2.1 111.401 -178.08 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 181' ' ' GLU . . . . . 0.458 ' HA ' ' O ' ' B' ' 171' ' ' GLY . 0.4 OUTLIER -60.91 140.82 57.62 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.766 -0.652 . . . . 3.06 110.359 179.557 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 182' ' ' ASP . . . . . 0.987 ' HB3' ' HB2' ' B' ' 173' ' ' CYS . 0.0 OUTLIER -137.19 138.27 24.9 Favored Pre-proline 0 CA--C 1.543 0.701 0 CA-C-N 116.005 -0.543 . . . . 2.06 111.852 -179.024 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 183' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' B' ' 182' ' ' ASP . 2.5 Cg_endo -84.41 -31.66 0.46 Allowed 'Trans proline' 0 C--N 1.358 1.068 0 C-N-CA 123.359 2.706 . . . . 1.91 115.256 -177.288 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -59.9 -47.6 85.12 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 108.279 -1.008 . . . . 1.56 108.279 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 185' ' ' CYS . . . . . 0.85 ' O ' ' N ' ' B' ' 171' ' ' GLY . 82.2 m -96.68 71.62 2.61 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 105.7 -1.963 . . . . 1.94 105.7 175.229 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 186' ' ' ASP . . . . . 0.591 ' CB ' ' HD3' ' B' ' 187' ' ' PRO . 0.9 OUTLIER -94.13 -56.97 0.22 Allowed Pre-proline 0 CA--C 1.497 -1.094 0 C-N-CA 119.055 -1.058 . . . . 3.61 110.644 -177.687 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 187' ' ' PRO . . . . . 0.591 ' HD3' ' CB ' ' B' ' 186' ' ' ASP . 59.0 Cg_endo -103.88 168.01 0.21 Allowed 'Trans proline' 0 N--CA 1.424 -2.616 0 C-N-CA 122.796 2.331 . . . . 2.58 113.182 -178.39 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -73.38 61.12 0.65 Allowed 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 127.951 2.5 . . . . 4.7 108.515 174.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 189' ' ' ALA . . . . . . . . . . . . . . . -91.36 30.01 1.36 Allowed 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 109.001 -3.727 . . . . 5.24 106.868 172.417 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 190' ' ' ALA . . . . . . . . . . . . . . . -80.84 163.57 23.33 Favored 'General case' 0 C--N 1.345 0.381 0 N-CA-C 113.866 1.062 . . . . 6.93 113.866 -178.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 191' ' ' PHE . . . . . 0.425 ' O ' ' CG ' ' B' ' 191' ' ' PHE . 15.3 p90 -81.5 108.05 14.77 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-N 113.469 -1.696 . . . . 10.14 111.449 -179.392 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.257 -0.878 . . . . 11.7 110.822 179.916 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.51 ' O ' ' CG2' ' A' ' 2' ' ' VAL . . . . . . . . 0 N--CA 1.489 1.48 0 CA-C-O 120.443 0.163 . . . . 9.95 111.434 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.51 ' CG2' ' O ' ' A' ' 1' ' ' ALA . 9.6 t -168.66 37.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 N-CA-C 108.361 -0.977 . . . . 8.02 108.361 178.523 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.805 HD23 HG22 ' A' ' 9' ' ' THR . 0.2 OUTLIER -156.63 47.24 0.44 Allowed 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 114.132 1.16 . . . . 5.86 114.132 -178.031 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -92.48 -117.39 0.08 Allowed 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 101.674 -3.454 . . . . 6.22 101.674 170.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.6 19.07 4.84 Favored 'General case' 0 N--CA 1.428 -1.568 0 C-N-CA 120.591 -0.444 . . . . 7.09 110.541 172.184 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -86.8 -126.95 0.04 OUTLIER 'General case' 0 N--CA 1.434 -1.237 1 N-CA-C 98.164 -4.754 . . . . 8.78 98.164 171.796 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.93 HG22 ' C ' ' A' ' 53' ' ' PRO . 7.5 p -108.38 118.81 56.77 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.049 0 CA-C-N 124.01 3.095 . . . . 7.51 104.696 177.548 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.784 ' H ' ' H ' ' A' ' 55' ' ' GLN . 8.0 ttm180 -77.34 117.33 18.73 Favored 'General case' 0 CA--C 1.48 -1.72 0 CA-C-O 117.482 -1.246 . . . . 9.08 108.433 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.805 HG22 HD23 ' A' ' 3' ' ' LEU . 4.0 t -52.39 105.89 0.13 Allowed 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 114.534 -2.866 . . . . 5.66 107.693 -178.714 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 1.013 ' H ' ' HA ' ' A' ' 53' ' ' PRO . 67.9 m -79.49 70.85 6.02 Favored 'General case' 0 C--N 1.34 0.192 0 CA-C-N 112.346 -2.207 . . . . 2.68 112.862 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.922 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 6.9 mp -31.76 108.76 0.28 Allowed Pre-proline 0 N--CA 1.476 0.847 0 CA-C-N 120.036 1.289 . . . . 2.48 110.228 -179.557 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.86 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 89.8 Cg_endo -82.94 135.69 7.74 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 121.621 1.548 . . . . 1.49 114.593 -178.606 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.696 ' N ' ' O ' ' A' ' 19' ' ' GLY . 29.3 p -145.15 -175.06 4.55 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 118.267 -1.373 . . . . 1.0 111.322 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.704 ' HA2' ' HB3' ' A' ' 40' ' ' GLU . . . 75.75 -164.35 53.89 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 120.499 -0.857 . . . . 1.15 114.377 178.025 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.793 ' HD2' HD11 ' A' ' 32' ' ' LEU . 38.3 Cg_endo -63.14 112.75 1.78 Allowed 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 124.861 3.707 . . . . 1.57 109.601 177.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.19 -11.86 53.03 Favored Glycine 0 C--N 1.276 -2.803 0 N-CA-C 110.59 -1.004 . . . . 1.68 110.59 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.692 ' O ' ' HB2' ' A' ' 12' ' ' PRO . . . 68.59 47.3 57.48 Favored Glycine 0 N--CA 1.418 -2.538 0 C-N-CA 117.929 -2.081 . . . . 1.36 111.648 176.629 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.716 ' HD3' ' O ' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -92.26 -28.91 16.7 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 111.858 -2.171 . . . . 2.5 111.907 179.959 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.86 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -103.8 -178.08 25.73 Favored Glycine 0 C--O 1.213 -1.216 0 O-C-N 121.023 -1.048 . . . . 1.02 115.181 -176.009 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.922 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -96.16 144.71 26.15 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 115.579 1.696 . . . . 2.92 115.579 -174.588 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.659 ' C ' ' CD1' ' A' ' 22' ' ' PHE . 0.1 OUTLIER -108.25 170.24 8.13 Favored 'General case' 0 C--N 1.344 0.334 0 CA-C-N 113.49 -1.686 . . . . 1.1 109.36 -179.692 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.659 ' CD1' ' C ' ' A' ' 21' ' ' CYS . 33.8 m-85 -156.8 52.54 0.51 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.966 0.412 . . . . 1.51 110.649 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.518 ' O ' ' SG ' ' A' ' 44' ' ' CYS . . . 133.08 -145.68 17.66 Favored Glycine 0 C--O 1.225 -0.433 0 N-CA-C 111.265 -0.734 . . . . 0.9 111.265 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.741 ' HD2' HD12 ' A' ' 26' ' ' ILE . 37.9 Cg_endo -94.86 -70.19 0.0 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 122.779 2.319 . . . . 1.5 112.145 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.635 ' O ' ' N ' ' A' ' 37' ' ' GLY . 2.8 m -92.5 45.52 1.2 Allowed 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 109.746 -0.465 . . . . 1.26 109.746 179.167 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.811 ' CG2' ' HB3' ' A' ' 74' ' ' CYS . 3.6 mt -145.13 115.04 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 N-CA-C 112.015 0.376 . . . . 0.83 112.015 -177.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.58 ' SG ' ' CE2' ' A' ' 35' ' ' PHE . 1.9 t -149.15 123.75 9.78 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-O 121.346 0.593 . . . . 0.92 110.803 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.94 ' HB3' ' HB1' ' A' ' 68' ' ' ALA . 0.5 OUTLIER -126.37 152.5 46.2 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.201 1.0 . . . . 1.28 110.949 -179.852 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 33' ' ' GLY . . . -143.52 -179.83 20.41 Favored Glycine 0 N--CA 1.424 -2.144 0 C-N-CA 120.386 -0.911 . . . . 0.67 111.273 176.211 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -70.01 -44.93 68.32 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 126.351 1.861 . . . . 2.27 112.442 177.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -121.65 23.42 10.22 Favored 'General case' 0 CA--C 1.471 -2.075 0 CA-C-N 112.956 -1.929 . . . . 1.66 111.31 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.812 HD13 ' HZ ' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -125.62 -36.36 2.44 Favored 'General case' 0 N--CA 1.425 -1.685 0 CA-C-N 113.589 -1.641 . . . . 1.37 109.682 -174.623 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.871 ' O ' ' HA ' ' A' ' 28' ' ' CYS . . . 89.96 -138.85 14.76 Favored Glycine 0 N--CA 1.425 -2.045 0 CA-C-N 114.845 -1.071 . . . . 0.73 114.368 177.371 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 1.057 ' SG ' HD13 ' A' ' 72' ' ' ILE . 1.3 m -126.75 121.24 31.44 Favored 'General case' 0 CA--C 1.489 -1.384 0 CA-C-N 119.318 1.559 . . . . 1.08 110.37 177.068 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 1.014 ' HA ' ' HA ' ' B' ' 135' ' ' PHE . 0.0 OUTLIER -119.07 107.49 13.56 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 104.578 -2.379 . . . . 1.38 104.578 176.705 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 1.034 HG23 HG23 ' B' ' 136' ' ' VAL . 1.0 OUTLIER -92.07 89.71 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.552 0 CA-C-O 122.077 0.941 . . . . 0.76 109.849 -178.266 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.635 ' N ' ' O ' ' A' ' 25' ' ' SER . . . 88.37 87.3 1.19 Allowed Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 113.907 -1.497 . . . . 0.81 112.101 -179.141 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.509 HG22 ' O ' ' B' ' 132' ' ' LEU . 40.3 p -150.17 176.03 11.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.807 0.337 . . . . 0.77 110.589 -179.569 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.665 ' HA ' HD12 ' A' ' 42' ' ' LEU . . . -63.92 -41.68 97.6 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.343 -1.355 . . . . 1.02 107.343 177.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.704 ' HB3' ' HA2' ' A' ' 14' ' ' GLY . 3.0 mm-40 -55.82 -34.37 65.3 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 113.884 -1.507 . . . . 2.32 110.201 179.205 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.842 ' O ' ' HB2' ' A' ' 44' ' ' CYS . . . -82.75 -37.63 24.37 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 115.349 -0.841 . . . . 0.87 109.953 -179.264 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.665 HD12 ' HA ' ' A' ' 39' ' ' ALA . 0.2 OUTLIER -38.96 -32.92 0.1 Allowed 'General case' 0 C--O 1.24 0.564 0 CA-C-O 121.105 0.479 . . . . 1.23 110.685 -178.672 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.448 ' O ' ' N ' ' A' ' 45' ' ' GLN . 2.1 mmm180 -51.97 -29.02 18.82 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 108.239 -1.023 . . . . 2.92 108.239 176.361 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.842 ' HB2' ' O ' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -44.65 -2.66 0.01 OUTLIER 'General case' 0 C--O 1.239 0.552 0 N-CA-C 115.434 1.642 . . . . 1.57 115.434 -176.621 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.448 ' N ' ' O ' ' A' ' 43' ' ' ARG . 0.3 OUTLIER -88.99 3.37 51.86 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 122.624 2.466 . . . . 3.31 107.203 174.976 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.67 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 8.1 tt0 -83.56 11.33 7.28 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 108.505 -0.924 . . . . 3.69 108.505 179.282 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.794 ' HA ' HD21 ' A' ' 50' ' ' LEU . 0.5 OUTLIER -75.18 3.02 9.46 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 109.263 -0.644 . . . . 3.99 109.263 176.453 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -98.33 -27.05 14.29 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.448 -0.342 . . . . 3.86 111.194 178.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -139.69 55.75 1.66 Allowed 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 112.702 0.63 . . . . 5.68 112.702 -177.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.888 HD22 ' HA ' ' A' ' 11' ' ' LEU . 0.4 OUTLIER -120.12 103.98 44.33 Favored Pre-proline 0 N--CA 1.473 0.689 0 N-CA-C 113.224 0.824 . . . . 5.4 113.224 -177.928 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.448 ' C ' ' HD2' ' A' ' 53' ' ' PRO . 71.0 Cg_endo -101.16 50.8 0.04 OUTLIER 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 124.207 3.271 . . . . 4.92 113.975 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.735 ' O ' ' HB2' ' A' ' 10' ' ' CYS . 6.5 t -120.04 45.96 0.83 Allowed Pre-proline 0 CA--C 1.544 0.732 0 N-CA-C 111.847 0.314 . . . . 5.64 111.847 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 1.013 ' HA ' ' H ' ' A' ' 10' ' ' CYS . 9.5 Cg_endo -52.47 167.05 0.62 Allowed 'Trans proline' 0 N--CA 1.49 1.293 0 C-N-CA 124.12 3.213 . . . . 5.04 116.303 -178.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.737 ' N ' ' O ' ' A' ' 8' ' ' ARG . 4.8 p 154.49 72.5 0.0 OUTLIER 'General case' 0 C--N 1.372 1.557 0 N-CA-C 115.012 1.486 . . . . 2.74 115.012 178.527 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.784 ' H ' ' H ' ' A' ' 8' ' ' ARG . 0.7 OUTLIER 50.85 -173.89 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 120.568 1.531 . . . . 5.75 112.376 177.96 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.496 ' OG ' ' O ' ' A' ' 55' ' ' GLN . 66.0 m -171.05 -145.4 0.04 OUTLIER 'General case' 0 CA--C 1.558 1.27 0 N-CA-C 112.189 0.44 . . . . 3.12 112.189 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 66' ' ' ARG . . . -133.43 123.11 3.29 Favored Glycine 0 CA--C 1.49 -1.504 0 CA-C-N 114.983 -1.008 . . . . 2.1 111.995 -176.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -111.12 78.78 1.14 Allowed 'General case' 0 N--CA 1.439 -0.988 0 CA-C-O 121.951 0.881 . . . . 4.36 108.901 178.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.753 ' CB ' ' HB2' ' A' ' 67' ' ' CYS . 0.4 OUTLIER -138.15 68.88 48.73 Favored Pre-proline 0 C--N 1.305 -1.326 0 CA-C-O 122.96 1.362 . . . . 3.55 108.247 -179.799 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.442 ' HA ' ' O ' ' A' ' 65' ' ' GLY . 14.6 Cg_endo -55.59 86.78 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.589 2.859 . . . . 1.54 115.191 -178.512 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.649 ' N ' ' O ' ' A' ' 65' ' ' GLY . 1.8 m -96.64 -173.8 2.84 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 113.786 -1.552 . . . . 1.59 107.062 176.249 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 45.14 -167.03 0.04 OUTLIER Glycine 0 CA--C 1.53 0.97 0 C-N-CA 119.837 -1.173 . . . . 2.43 114.36 175.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 6.5 t -84.2 61.02 6.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 122.683 1.23 . . . . 4.11 111.256 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 109.93 3.89 29.81 Favored Glycine 0 CA--C 1.532 1.144 0 CA-C-N 112.585 -2.098 . . . . 2.21 116.209 176.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.649 ' O ' ' N ' ' A' ' 61' ' ' CYS . . . -101.4 142.8 15.86 Favored Glycine 0 C--O 1.225 -0.442 0 C-N-CA 117.227 -2.416 . . . . 1.62 115.995 -175.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.468 ' HB2' ' O ' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -98.03 154.0 18.01 Favored 'General case' 0 C--N 1.335 -0.055 0 CA-C-N 114.549 -0.826 . . . . 3.02 110.142 179.274 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.753 ' HB2' ' CB ' ' A' ' 59' ' ' LYS . 3.7 t -44.98 109.48 0.17 Allowed 'General case' 0 CA--C 1.506 -0.74 0 CA-C-O 121.257 0.551 . . . . 1.52 111.763 -178.437 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.94 ' HB1' ' HB3' ' A' ' 28' ' ' CYS . . . -100.39 -15.42 17.96 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 108.074 -1.084 . . . . 1.07 108.074 177.671 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -168.19 162.26 12.77 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 114.532 -1.213 . . . . 1.0 110.872 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.562 ' HA ' ' HB3' ' A' ' 85' ' ' CYS . . . -73.3 74.87 1.34 Allowed 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 121.446 0.641 . . . . 1.24 112.673 -179.422 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.73 ' O ' ' HA ' ' A' ' 81' ' ' GLU . . . 163.53 -51.57 0.3 Allowed Glycine 0 N--CA 1.437 -1.298 0 CA-C-N 114.983 -1.008 . . . . 1.28 112.952 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 1.057 HD13 ' SG ' ' A' ' 34' ' ' CYS . 0.6 OUTLIER -126.63 140.23 49.49 Favored 'Isoleucine or valine' 0 C--O 1.248 0.99 0 CA-C-O 122.83 1.3 . . . . 2.27 110.704 -175.936 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.549 ' HB2' ' HB2' ' A' ' 61' ' ' CYS . 47.9 m -112.15 113.19 25.3 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 114.895 -1.048 . . . . 1.98 110.258 -179.224 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.811 ' HB3' ' CG2' ' A' ' 26' ' ' ILE . 64.6 m -78.58 144.03 35.92 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.596 -0.729 . . . . 1.33 111.105 -178.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.715 ' HB2' ' HD2' ' A' ' 76' ' ' PRO . 92.0 p -136.76 179.95 1.23 Allowed Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 114.318 -1.31 . . . . 1.99 108.742 -178.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.715 ' HD2' ' HB2' ' A' ' 75' ' ' SER . 66.9 Cg_endo -76.32 29.88 0.4 Allowed 'Trans proline' 0 N--CA 1.452 -0.93 0 N-CA-C 109.822 -0.876 . . . . 1.86 109.822 177.705 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.545 ' H ' ' C ' ' A' ' 75' ' ' SER . 2.0 m-20 -144.29 -46.73 0.26 Allowed 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.17 -0.923 . . . . 2.65 111.171 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 1.013 ' HA2' HG11 ' A' ' 36' ' ' VAL . . . -170.5 -155.99 10.89 Favored Glycine 0 C--N 1.34 0.785 0 C-N-CA 119.745 -1.217 . . . . 0.99 115.313 179.516 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 1.011 ' SG ' HG22 ' A' ' 36' ' ' VAL . 10.4 m -140.98 129.29 22.32 Favored 'General case' 0 CA--C 1.555 1.171 0 CA-C-O 122.732 1.253 . . . . 1.34 107.767 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.472 ' CA ' HG22 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -144.42 132.2 21.29 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-N 112.414 -2.175 . . . . 2.17 112.443 -168.392 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.73 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 0.4 OUTLIER -47.36 142.24 4.24 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 114.036 -1.438 . . . . 3.05 109.981 -179.7 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.682 ' OD1' ' HB2' ' A' ' 85' ' ' CYS . 3.1 p-10 -145.26 137.37 13.22 Favored Pre-proline 0 C--N 1.309 -1.174 0 CA-C-N 115.712 -0.676 . . . . 2.02 109.738 -178.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 82' ' ' ASP . 52.7 Cg_exo -57.87 -35.42 98.79 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.667 2.245 . . . . 1.93 114.373 -177.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.8 -51.69 60.82 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 108.616 -0.883 . . . . 1.53 108.616 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.682 ' HB2' ' OD1' ' A' ' 82' ' ' ASP . 3.2 m -98.74 77.09 2.23 Favored 'General case' 0 CA--C 1.499 -1.015 0 N-CA-C 106.703 -1.591 . . . . 1.88 106.703 176.401 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.58 ' H ' ' CD ' ' A' ' 87' ' ' PRO . 0.6 OUTLIER -131.05 -54.72 0.03 OUTLIER Pre-proline 0 CA--C 1.5 -0.944 0 C-N-CA 119.301 -0.96 . . . . 3.6 110.06 -178.944 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.58 ' CD ' ' H ' ' A' ' 86' ' ' ASP . 9.5 Cg_endo -91.59 165.57 3.44 Favored 'Trans proline' 0 N--CA 1.426 -2.452 0 C-N-CA 122.053 1.836 . . . . 2.56 113.387 -179.263 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.557 ' O ' ' N ' ' A' ' 90' ' ' ALA . 7.9 pt-20 -66.19 0.32 2.08 Favored 'General case' 0 N--CA 1.432 -1.341 0 C-N-CA 128.16 2.584 . . . . 4.72 109.988 178.262 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -53.4 36.09 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 114.255 1.205 . . . . 5.29 114.255 177.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.557 ' N ' ' O ' ' A' ' 88' ' ' GLU . . . -77.48 163.78 26.03 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 119.33 0.968 . . . . 6.98 111.57 178.302 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -85.42 63.74 8.25 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.076 -0.511 . . . . 10.21 111.707 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 11.9 p . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.209 -0.9 . . . . 11.77 110.793 179.268 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 101' ' ' ALA . . . . . 0.517 ' O ' HD23 ' B' ' 103' ' ' LEU . . . . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 119.865 -0.112 . . . . 10.07 110.901 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 102' ' ' VAL . . . . . 0.516 HG22 ' O ' ' B' ' 102' ' ' VAL . 8.5 p 30.48 36.66 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.112 0 N-CA-C 113.985 1.106 . . . . 8.41 113.985 177.442 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 103' ' ' LEU . . . . . 1.08 ' HB2' ' HG3' ' B' ' 108' ' ' ARG . 1.5 pp -160.63 62.13 0.31 Allowed 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 114.143 1.164 . . . . 5.87 114.143 176.212 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 104' ' ' ASP . . . . . 0.435 ' HB3' ' H ' ' B' ' 105' ' ' LEU . 0.1 OUTLIER -101.08 -111.06 0.21 Allowed 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 103.464 -2.791 . . . . 6.27 103.464 170.138 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 105' ' ' LEU . . . . . 0.435 ' H ' ' HB3' ' B' ' 104' ' ' ASP . 3.1 tp -107.86 15.48 24.44 Favored 'General case' 0 N--CA 1.42 -1.948 0 N-CA-C 108.577 -0.897 . . . . 7.2 108.577 171.482 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 106' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.59 -121.2 0.02 OUTLIER 'General case' 0 N--CA 1.427 -1.583 1 N-CA-C 98.47 -4.641 . . . . 8.55 98.47 172.364 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 107' ' ' VAL . . . . . 0.933 HG22 ' C ' ' B' ' 153' ' ' PRO . 9.9 p -114.29 118.32 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.753 0 C-N-CA 114.388 -2.925 . . . . 7.48 106.454 179.484 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 108' ' ' ARG . . . . . 1.08 ' HG3' ' HB2' ' B' ' 103' ' ' LEU . 10.1 ttm180 -78.2 114.87 17.49 Favored 'General case' 0 CA--C 1.482 -1.641 0 CA-C-O 117.649 -1.167 . . . . 9.12 108.32 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 109' ' ' THR . . . . . 0.635 ' HA ' ' HB3' ' B' ' 153' ' ' PRO . 5.6 t -46.94 105.5 0.07 Allowed 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 114.987 -2.685 . . . . 5.69 107.987 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 110' ' ' CYS . . . . . 1.033 ' H ' ' HA ' ' B' ' 153' ' ' PRO . 67.5 m -81.35 70.52 8.22 Favored 'General case' 0 CA--C 1.527 0.095 0 CA-C-N 113.541 -1.663 . . . . 2.61 112.894 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 111' ' ' LEU . . . . . 0.905 ' HA ' HD22 ' B' ' 150' ' ' LEU . 6.9 mp -31.29 108.67 0.27 Allowed Pre-proline 0 N--CA 1.477 0.892 0 CA-C-N 119.962 1.256 . . . . 2.47 110.332 -179.283 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 112' ' ' PRO . . . . . 0.918 ' HA ' ' O ' ' B' ' 119' ' ' GLY . 84.0 Cg_endo -81.62 138.14 10.56 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 121.926 1.751 . . . . 1.47 113.696 -179.208 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.564 ' N ' ' O ' ' B' ' 119' ' ' GLY . 31.2 p -149.14 -178.7 6.53 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 120.697 -0.401 . . . . 1.0 111.499 178.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 114' ' ' GLY . . . . . 0.716 ' HA2' ' HB3' ' B' ' 140' ' ' GLU . . . 76.06 -163.1 53.07 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 120.793 -0.718 . . . . 1.16 113.929 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 115' ' ' PRO . . . . . 0.825 ' HD2' HD11 ' B' ' 132' ' ' LEU . 38.8 Cg_endo -64.37 101.5 0.36 Allowed 'Trans proline' 0 N--CA 1.485 1.005 0 C-N-CA 125.234 3.956 . . . . 1.57 114.784 178.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 89.53 -8.05 80.65 Favored Glycine 0 C--N 1.28 -2.566 0 CA-C-N 114.263 -1.335 . . . . 1.7 110.992 -175.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 117' ' ' GLY . . . . . 0.641 ' O ' ' HB2' ' B' ' 112' ' ' PRO . . . 65.28 55.25 22.18 Favored Glycine 0 N--CA 1.421 -2.345 0 CA-C-O 122.451 1.028 . . . . 1.38 111.568 179.081 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 118' ' ' LYS . . . . . 0.654 ' HD3' ' O ' ' B' ' 115' ' ' PRO . 0.0 OUTLIER -94.32 -26.13 16.7 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 112.494 -1.853 . . . . 2.54 111.408 177.94 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 119' ' ' GLY . . . . . 0.918 ' O ' ' HA ' ' B' ' 112' ' ' PRO . . . -95.79 -175.61 36.73 Favored Glycine 0 C--O 1.212 -1.255 0 N-CA-C 116.728 1.451 . . . . 1.04 116.728 -176.533 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.891 ' HA ' ' O ' ' B' ' 111' ' ' LEU . 0.0 OUTLIER -105.12 142.44 34.89 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 112.729 -1.735 . . . . 2.89 114.71 -178.112 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 121' ' ' CYS . . . . . 0.657 ' C ' ' CD1' ' B' ' 122' ' ' PHE . 0.1 OUTLIER -108.05 169.92 8.32 Favored 'General case' 0 C--N 1.342 0.267 0 CA-C-N 113.573 -1.649 . . . . 1.07 109.3 -178.717 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 122' ' ' PHE . . . . . 0.657 ' CD1' ' C ' ' B' ' 121' ' ' CYS . 33.1 m-85 -156.81 52.55 0.51 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.032 0.444 . . . . 1.53 110.574 -179.62 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 123' ' ' GLY . . . . . 0.523 ' O ' ' SG ' ' B' ' 144' ' ' CYS . . . 133.09 -145.63 17.63 Favored Glycine 0 C--N 1.334 0.44 0 N-CA-C 111.322 -0.711 . . . . 0.9 111.322 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 124' ' ' PRO . . . . . 0.769 ' HD2' HD12 ' B' ' 126' ' ' ILE . 37.7 Cg_endo -95.02 -70.22 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 122.729 2.286 . . . . 1.51 112.064 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 125' ' ' SER . . . . . 0.651 ' O ' ' N ' ' B' ' 137' ' ' GLY . 2.8 m -92.27 45.08 1.19 Allowed 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.715 -0.476 . . . . 1.25 109.715 179.093 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 126' ' ' ILE . . . . . 0.81 ' CG2' ' HB3' ' B' ' 174' ' ' CYS . 3.4 mt -144.01 114.54 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 N-CA-C 112.317 0.488 . . . . 0.85 112.317 -177.77 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 127' ' ' CYS . . . . . 0.587 ' SG ' ' CE2' ' B' ' 135' ' ' PHE . 1.7 t -148.55 124.4 10.58 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 121.039 0.447 . . . . 0.89 110.887 179.368 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 128' ' ' CYS . . . . . 0.951 ' HB3' ' HB1' ' B' ' 168' ' ' ALA . 0.8 OUTLIER -129.34 150.44 50.7 Favored 'General case' 0 CA--C 1.509 -0.619 0 CA-C-N 115.896 -0.593 . . . . 1.23 111.484 -178.868 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 129' ' ' GLY . . . . . 0.418 ' O ' ' HB2' ' B' ' 169' ' ' ALA . . . -141.67 -174.46 14.51 Favored Glycine 0 N--CA 1.422 -2.236 0 CA-C-N 120.089 1.313 . . . . 0.66 110.135 177.2 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -74.33 -44.55 52.01 Favored 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 126.215 1.806 . . . . 2.35 112.375 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -124.32 33.26 5.3 Favored 'General case' 0 CA--C 1.483 -1.606 0 CA-C-N 113.911 -1.495 . . . . 1.69 110.034 177.021 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 132' ' ' LEU . . . . . 0.829 HD13 ' HZ ' ' B' ' 135' ' ' PHE . 0.9 OUTLIER -130.1 -37.7 1.46 Allowed 'General case' 0 N--CA 1.411 -2.38 0 CA-C-N 114.239 -1.346 . . . . 1.38 108.531 -179.418 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 133' ' ' GLY . . . . . 0.915 ' O ' ' HA ' ' B' ' 128' ' ' CYS . . . 79.25 -151.43 34.85 Favored Glycine 0 N--CA 1.435 -1.369 0 CA-C-N 113.585 -1.643 . . . . 0.72 111.195 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 134' ' ' CYS . . . . . 1.056 ' SG ' HD13 ' B' ' 172' ' ' ILE . 3.0 m -107.93 124.2 49.77 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-N 119.691 1.745 . . . . 1.08 112.084 -175.475 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 135' ' ' PHE . . . . . 1.014 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -121.09 106.97 12.05 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 104.499 -2.408 . . . . 1.36 104.499 174.263 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 136' ' ' VAL . . . . . 1.073 HG22 ' SG ' ' B' ' 179' ' ' CYS . 1.8 t -91.7 89.82 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.396 0 CA-C-O 122.091 0.948 . . . . 0.75 109.635 -178.235 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 137' ' ' GLY . . . . . 0.651 ' N ' ' O ' ' B' ' 125' ' ' SER . . . 87.56 88.59 1.09 Allowed Glycine 0 C--O 1.228 -0.231 0 CA-C-N 114.133 -1.394 . . . . 0.83 112.012 -179.115 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 138' ' ' THR . . . . . 0.505 HG22 ' O ' ' A' ' 32' ' ' LEU . 43.5 p -154.13 171.12 19.64 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 110.313 -0.255 . . . . 0.78 110.313 -179.252 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 139' ' ' ALA . . . . . 0.722 ' HA ' HD12 ' B' ' 142' ' ' LEU . . . -60.51 -39.48 87.94 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.484 -0.932 . . . . 1.04 108.484 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 140' ' ' GLU . . . . . 0.716 ' HB3' ' HA2' ' B' ' 114' ' ' GLY . 3.0 mm-40 -57.46 -33.61 68.15 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.307 -0.861 . . . . 2.31 110.094 178.281 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 141' ' ' ALA . . . . . 0.8 ' O ' ' HB2' ' B' ' 144' ' ' CYS . . . -82.11 -39.06 23.89 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 115.062 -0.972 . . . . 0.87 109.508 -179.067 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 142' ' ' LEU . . . . . 0.722 HD12 ' HA ' ' B' ' 139' ' ' ALA . 0.2 OUTLIER -38.94 -31.41 0.06 Allowed 'General case' 0 C--O 1.232 0.156 0 CA-C-N 117.871 0.305 . . . . 1.24 111.578 -178.483 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 143' ' ' ARG . . . . . 0.451 ' O ' ' N ' ' B' ' 145' ' ' GLN . 2.1 mmm180 -52.57 -28.93 23.01 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.401 -0.962 . . . . 2.93 108.401 176.243 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 144' ' ' CYS . . . . . 0.8 ' HB2' ' O ' ' B' ' 141' ' ' ALA . 0.1 OUTLIER -41.94 -8.11 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 113.648 -1.614 . . . . 1.61 115.002 -176.79 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 145' ' ' GLN . . . . . 0.451 ' N ' ' O ' ' B' ' 143' ' ' ARG . 0.3 OUTLIER -84.51 -0.19 52.13 Favored 'General case' 0 C--O 1.242 0.709 0 CA-C-O 122.525 1.155 . . . . 3.35 108.357 176.098 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 146' ' ' GLU . . . . . 0.67 ' O ' ' HG ' ' B' ' 150' ' ' LEU . 7.7 tt0 -83.91 11.48 7.63 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 115.072 -0.967 . . . . 3.76 109.064 179.418 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 147' ' ' GLU . . . . . 0.803 ' HA ' HD21 ' B' ' 150' ' ' LEU . 0.5 OUTLIER -75.3 2.86 10.1 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 109.14 -0.689 . . . . 4.01 109.14 176.44 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 148' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -98.33 -27.02 14.3 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.499 -0.319 . . . . 3.92 111.13 178.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -139.72 55.86 1.65 Allowed 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 112.648 0.61 . . . . 5.73 112.648 -177.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 150' ' ' LEU . . . . . 0.905 HD22 ' HA ' ' B' ' 111' ' ' LEU . 0.4 OUTLIER -120.14 104.12 44.07 Favored Pre-proline 0 N--CA 1.474 0.736 0 N-CA-C 113.212 0.819 . . . . 5.46 113.212 -178.004 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 151' ' ' PRO . . . . . 0.443 ' C ' ' HD2' ' B' ' 153' ' ' PRO . 72.6 Cg_endo -101.34 50.85 0.04 OUTLIER 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 124.17 3.247 . . . . 5.02 113.914 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 152' ' ' SER . . . . . 0.733 ' O ' ' HB2' ' B' ' 110' ' ' CYS . 6.6 t -120.25 46.03 0.87 Allowed Pre-proline 0 CA--C 1.544 0.726 0 N-CA-C 111.821 0.304 . . . . 5.73 111.821 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 153' ' ' PRO . . . . . 1.033 ' HA ' ' H ' ' B' ' 110' ' ' CYS . 10.8 Cg_endo -52.46 167.3 0.59 Allowed 'Trans proline' 0 N--CA 1.49 1.301 0 C-N-CA 124.266 3.31 . . . . 5.1 116.256 -178.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 154' ' ' CYS . . . . . 0.7 ' N ' ' O ' ' B' ' 108' ' ' ARG . 4.7 p 154.55 72.14 0.0 OUTLIER 'General case' 0 C--N 1.374 1.66 0 N-CA-C 115.058 1.503 . . . . 2.68 115.058 178.271 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 155' ' ' GLN . . . . . 0.751 ' H ' ' H ' ' B' ' 108' ' ' ARG . 0.6 OUTLIER 51.69 -175.65 0.02 OUTLIER 'General case' 0 C--N 1.37 1.491 0 CA-C-N 121.001 1.728 . . . . 5.63 112.394 178.0 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 156' ' ' SER . . . . . 0.402 ' OG ' ' O ' ' B' ' 155' ' ' GLN . 74.4 m -165.95 -135.88 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 113.508 0.929 . . . . 3.11 113.508 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 157' ' ' GLY . . . . . 0.436 ' O ' ' HB2' ' B' ' 166' ' ' ARG . . . -146.92 126.36 2.42 Favored Glycine 0 N--CA 1.439 -1.104 0 N-CA-C 109.794 -1.322 . . . . 2.07 109.794 178.61 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -112.55 68.02 0.67 Allowed 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 118.784 -1.166 . . . . 4.34 110.023 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 159' ' ' LYS . . . . . 0.848 ' CB ' ' HB2' ' B' ' 167' ' ' CYS . 0.1 OUTLIER -110.9 63.95 0.45 Allowed Pre-proline 0 C--N 1.318 -0.787 0 CA-C-N 113.875 -1.511 . . . . 3.54 112.059 174.514 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 160' ' ' PRO . . . . . 0.441 ' HA ' ' O ' ' B' ' 165' ' ' GLY . 12.8 Cg_endo -55.37 86.78 0.04 OUTLIER 'Trans proline' 0 C--N 1.325 -0.682 0 C-N-CA 121.945 1.764 . . . . 1.51 116.391 -175.552 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 161' ' ' CYS . . . . . 0.649 ' N ' ' O ' ' B' ' 165' ' ' GLY . 1.4 m -98.81 -177.9 3.8 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.146 -1.427 . . . . 1.58 107.146 175.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 51.58 -167.27 0.71 Allowed Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.365 -0.921 . . . . 2.37 113.956 176.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 7.3 t -84.99 59.39 5.59 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 122.282 1.039 . . . . 4.07 111.664 -178.486 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 108.84 9.19 26.89 Favored Glycine 0 CA--C 1.544 1.9 0 CA-C-N 113.218 -1.81 . . . . 2.2 115.963 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 165' ' ' GLY . . . . . 0.649 ' O ' ' N ' ' B' ' 161' ' ' CYS . . . -102.59 141.76 15.34 Favored Glycine 0 C--N 1.312 -0.805 0 CA-C-N 121.631 2.716 . . . . 1.62 115.366 -176.503 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 166' ' ' ARG . . . . . 0.436 ' HB2' ' O ' ' B' ' 157' ' ' GLY . 0.0 OUTLIER -97.94 153.96 18.0 Favored 'General case' 0 N--CA 1.458 -0.056 0 CA-C-N 115.036 -0.582 . . . . 3.05 109.853 178.478 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 167' ' ' CYS . . . . . 0.848 ' HB2' ' CB ' ' B' ' 159' ' ' LYS . 3.6 t -45.42 109.57 0.18 Allowed 'General case' 0 CA--C 1.505 -0.75 0 CA-C-O 121.061 0.458 . . . . 1.56 111.975 -178.403 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 168' ' ' ALA . . . . . 0.951 ' HB1' ' HB3' ' B' ' 128' ' ' CYS . . . -99.83 -15.58 18.36 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 108.189 -1.041 . . . . 1.04 108.189 177.413 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 169' ' ' ALA . . . . . 0.418 ' HB2' ' O ' ' B' ' 129' ' ' GLY . . . -168.03 161.98 12.98 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 114.075 -1.42 . . . . 0.98 111.33 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 170' ' ' ALA . . . . . 0.586 ' HA ' ' HB3' ' B' ' 185' ' ' CYS . . . -72.98 74.94 1.19 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.375 0.607 . . . . 1.25 112.622 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 171' ' ' GLY . . . . . 0.763 ' O ' ' HA ' ' B' ' 181' ' ' GLU . . . 163.43 -52.9 0.3 Allowed Glycine 0 C--O 1.22 -0.724 0 CA-C-N 115.231 -0.895 . . . . 1.29 112.504 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 172' ' ' ILE . . . . . 1.056 HD13 ' SG ' ' B' ' 134' ' ' CYS . 0.6 OUTLIER -124.17 139.72 49.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-O 122.93 1.348 . . . . 2.27 111.663 -175.998 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 173' ' ' CYS . . . . . 0.547 ' HB2' ' HB2' ' B' ' 161' ' ' CYS . 48.6 m -112.3 113.5 25.76 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.914 -1.039 . . . . 1.94 110.017 -179.402 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 174' ' ' CYS . . . . . 0.81 ' HB3' ' CG2' ' B' ' 126' ' ' ILE . 64.1 m -79.41 144.03 34.49 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 115.476 -0.784 . . . . 1.35 110.913 -178.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 175' ' ' SER . . . . . 0.704 ' HB2' ' HD2' ' B' ' 176' ' ' PRO . 59.8 p -136.68 179.86 1.25 Allowed Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 114.328 -1.305 . . . . 2.0 108.799 -178.69 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 176' ' ' PRO . . . . . 0.704 ' HD2' ' HB2' ' B' ' 175' ' ' SER . 66.9 Cg_endo -76.39 29.76 0.4 Allowed 'Trans proline' 0 N--CA 1.454 -0.835 0 N-CA-C 109.679 -0.931 . . . . 1.9 109.679 177.614 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 177' ' ' ASP . . . . . 0.541 ' H ' ' C ' ' B' ' 175' ' ' SER . 2.0 m-20 -144.01 -46.44 0.27 Allowed 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.237 -0.892 . . . . 2.72 111.145 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 178' ' ' GLY . . . . . 1.006 ' HA2' HG11 ' B' ' 136' ' ' VAL . . . -171.72 -155.42 10.88 Favored Glycine 0 C--N 1.342 0.874 0 C-N-CA 119.796 -1.192 . . . . 0.99 115.149 179.03 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 179' ' ' CYS . . . . . 1.073 ' SG ' HG22 ' B' ' 136' ' ' VAL . 10.0 m -140.32 136.18 32.95 Favored 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 107.027 -1.471 . . . . 1.34 107.027 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 180' ' ' HIS . . . . . 0.52 ' CA ' HG22 ' B' ' 172' ' ' ILE . 0.2 OUTLIER -156.81 131.48 8.8 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 124.069 1.89 . . . . 2.1 111.824 -167.639 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 181' ' ' GLU . . . . . 0.763 ' HA ' ' O ' ' B' ' 171' ' ' GLY . 0.3 OUTLIER -45.87 141.23 3.16 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 110.326 -3.125 . . . . 3.06 109.851 -177.605 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 182' ' ' ASP . . . . . 0.684 ' OD1' ' HB2' ' B' ' 185' ' ' CYS . 3.1 p-10 -145.15 137.29 13.21 Favored Pre-proline 0 C--N 1.306 -1.291 0 CA-C-N 115.32 -0.854 . . . . 2.06 109.628 -178.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 183' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' B' ' 182' ' ' ASP . 52.1 Cg_exo -57.73 -35.37 98.83 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.618 2.212 . . . . 1.91 114.425 -177.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -64.84 -51.57 61.37 Favored 'General case' 0 CA--C 1.508 -0.656 0 N-CA-C 108.701 -0.851 . . . . 1.56 108.701 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 185' ' ' CYS . . . . . 0.684 ' HB2' ' OD1' ' B' ' 182' ' ' ASP . 3.2 m -98.97 77.08 2.17 Favored 'General case' 0 CA--C 1.499 -0.998 0 N-CA-C 106.772 -1.566 . . . . 1.94 106.772 176.319 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 186' ' ' ASP . . . . . 0.57 ' H ' ' CD ' ' B' ' 187' ' ' PRO . 0.6 OUTLIER -130.96 -54.81 0.03 OUTLIER Pre-proline 0 CA--C 1.5 -0.943 0 C-N-CA 119.469 -0.892 . . . . 3.61 110.184 -178.907 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 187' ' ' PRO . . . . . 0.57 ' CD ' ' H ' ' B' ' 186' ' ' ASP . 9.4 Cg_endo -90.71 166.17 4.06 Favored 'Trans proline' 0 N--CA 1.426 -2.495 0 C-N-CA 122.092 1.861 . . . . 2.58 112.943 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 188' ' ' GLU . . . . . 0.423 ' C ' ' H ' ' B' ' 190' ' ' ALA . 7.3 pt-20 -74.02 18.24 0.15 Allowed 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 128.018 2.527 . . . . 4.7 109.918 177.434 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 189' ' ' ALA . . . . . 0.524 ' H ' ' C ' ' B' ' 187' ' ' PRO . . . -64.83 30.8 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 124.777 1.231 . . . . 5.24 113.152 174.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 190' ' ' ALA . . . . . 0.423 ' H ' ' C ' ' B' ' 188' ' ' GLU . . . -73.53 161.42 30.38 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.427 0.632 . . . . 6.93 111.817 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 191' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -85.39 63.65 8.2 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.282 -0.872 . . . . 10.14 111.402 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 11.8 p . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.159 -0.924 . . . . 11.7 110.7 179.285 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.95 ' O ' HG13 ' A' ' 2' ' ' VAL . . . . . . . . 0 N--CA 1.478 0.945 0 CA-C-O 121.363 0.602 . . . . 9.95 111.388 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.95 HG13 ' O ' ' A' ' 1' ' ' ALA . 3.4 m -179.26 108.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 CA-C-N 114.164 -1.38 . . . . 8.02 110.661 -179.285 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.818 ' HG ' ' HB2' ' A' ' 8' ' ' ARG . 3.4 mm? -71.14 125.58 27.28 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 121.475 0.655 . . . . 5.86 112.456 -178.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.662 ' H ' ' HG2' ' A' ' 55' ' ' GLN . 0.3 OUTLIER -93.88 84.06 4.49 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 106.43 -1.693 . . . . 6.22 106.43 173.836 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.909 HD12 ' H ' ' A' ' 7' ' ' VAL . 1.3 tm? -156.18 -119.76 0.03 OUTLIER 'General case' 0 N--CA 1.397 -3.079 0 CA-C-N 112.586 -2.097 . . . . 7.09 108.236 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.504 ' H ' ' CD1' ' A' ' 5' ' ' LEU . 2.4 t0 -174.26 -14.83 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.771 0 CA-C-N 113.967 -1.469 . . . . 8.78 113.946 -179.162 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.909 ' H ' HD12 ' A' ' 5' ' ' LEU . 13.8 p -163.01 122.73 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.401 -2.888 0 CA-C-N 110.861 -2.881 . . . . 7.51 104.542 168.161 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.818 ' HB2' ' HG ' ' A' ' 3' ' ' LEU . 0.0 OUTLIER -80.87 108.35 14.46 Favored 'General case' 0 N--CA 1.383 -3.788 0 C-N-CA 116.776 -1.97 . . . . 9.08 107.34 176.107 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.528 HG23 ' HA ' ' A' ' 53' ' ' PRO . 1.2 t -104.52 99.56 9.25 Favored 'General case' 0 N--CA 1.414 -2.226 1 N-CA-C 99.384 -4.302 . . . . 5.66 99.384 167.174 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.2 m -74.84 61.06 0.99 Allowed 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 114.963 -1.017 . . . . 2.68 112.628 -178.234 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.662 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 0.3 OUTLIER -36.18 112.5 0.52 Allowed Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.804 -0.634 . . . . 2.48 112.628 178.443 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.563 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 56.3 Cg_endo -91.75 145.22 3.11 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 121.696 1.597 . . . . 1.49 113.808 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.682 ' O ' ' HA2' ' A' ' 17' ' ' GLY . 20.8 p -146.12 -174.26 4.39 Favored 'General case' 0 C--N 1.347 0.487 0 C-N-CA 119.043 -1.063 . . . . 1.0 113.543 -179.022 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.625 ' HA2' ' HG3' ' A' ' 40' ' ' GLU . . . 73.99 -161.38 53.88 Favored Glycine 0 N--CA 1.451 -0.317 0 CA-C-N 115.3 -0.864 . . . . 1.15 113.547 177.333 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.541 ' O ' ' HG3' ' A' ' 18' ' ' LYS . 39.7 Cg_endo -63.26 101.03 0.28 Allowed 'Trans proline' 0 N--CA 1.481 0.785 0 C-N-CA 123.664 2.909 . . . . 1.57 109.211 176.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 82.85 13.21 78.33 Favored Glycine 0 C--N 1.291 -1.917 0 C-N-CA 120.847 -0.692 . . . . 1.68 111.993 178.258 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.682 ' HA2' ' O ' ' A' ' 13' ' ' CYS . . . 51.8 49.09 49.1 Favored Glycine 0 N--CA 1.409 -3.136 0 N-CA-C 107.897 -2.081 . . . . 1.36 107.897 174.61 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.541 ' HG3' ' O ' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -99.94 18.52 18.19 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 112.519 -1.841 . . . . 2.5 111.553 174.299 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.563 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -131.73 -177.7 15.05 Favored Glycine 0 N--CA 1.444 -0.789 0 N-CA-C 104.405 -3.478 . . . . 1.02 104.405 176.636 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.662 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -124.41 172.58 9.03 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 120.538 2.169 . . . . 2.92 109.453 178.754 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.501 ' HB2' ' HB3' ' A' ' 11' ' ' LEU . 0.8 OUTLIER -105.64 134.97 47.9 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 121.334 -0.854 . . . . 1.1 111.16 -178.367 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.516 ' HE2' ' HA ' ' A' ' 56' ' ' SER . 68.0 m-85 -128.2 13.79 6.68 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.3 -0.864 . . . . 1.51 111.253 -179.472 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -176.16 -167.82 35.49 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.391 -0.909 . . . . 0.9 112.525 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.523 ' O ' ' HB3' ' A' ' 44' ' ' CYS . 1.9 Cg_endo -81.76 -44.26 0.09 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.814 2.343 . . . . 1.5 112.746 -179.43 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.438 ' HB2' ' OE2' ' B' ' 181' ' ' GLU . 0.1 OUTLIER -124.62 16.03 8.8 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.938 0.399 . . . . 1.26 110.797 179.823 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.755 HG23 ' HA ' ' A' ' 36' ' ' VAL . 0.8 OUTLIER -126.23 121.76 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.09 0 CA-C-O 121.464 0.649 . . . . 0.83 111.563 -178.041 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.884 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -119.1 132.86 56.04 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-N 115.641 -0.709 . . . . 0.92 109.108 179.051 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 1.133 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -144.82 116.15 8.01 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 112.52 0.563 . . . . 1.28 112.52 -178.718 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.676 ' O ' ' HB1' ' A' ' 69' ' ' ALA . . . -107.43 -163.54 21.74 Favored Glycine 0 N--CA 1.428 -1.866 0 N-CA-C 109.806 -1.318 . . . . 0.67 109.806 177.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.407 ' O ' ' HB2' ' A' ' 70' ' ' ALA . 11.4 t70 -67.54 -60.37 2.61 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 113.885 1.069 . . . . 2.27 113.885 -179.304 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.51 9.33 23.2 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 115.661 -0.699 . . . . 1.66 111.122 -176.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.825 ' O ' HG22 ' B' ' 138' ' ' THR . 1.0 OUTLIER -109.71 -18.96 13.33 Favored 'General case' 0 N--CA 1.405 -2.687 0 N-CA-C 106.791 -1.559 . . . . 1.37 106.791 179.982 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 1.133 ' O ' ' HA ' ' A' ' 28' ' ' CYS . . . 68.8 -133.86 27.43 Favored Glycine 0 N--CA 1.43 -1.755 0 CA-C-N 114.919 -1.037 . . . . 0.73 115.257 173.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.876 ' HB2' HG13 ' A' ' 72' ' ' ILE . 3.1 t -136.26 117.69 14.74 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-N 118.387 1.094 . . . . 1.08 113.254 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.885 ' HA ' ' HA ' ' B' ' 135' ' ' PHE . 0.0 OUTLIER -100.03 108.67 20.91 Favored 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 106.786 -1.561 . . . . 1.38 106.786 176.984 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.755 ' HA ' HG23 ' A' ' 26' ' ' ILE . 1.7 t -90.92 87.07 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.304 0 CA-C-O 122.473 1.13 . . . . 0.76 110.269 -179.048 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.441 ' O ' ' HA3' ' B' ' 133' ' ' GLY . . . 102.55 69.29 0.82 Allowed Glycine 0 C--O 1.228 -0.26 0 CA-C-N 112.99 -1.913 . . . . 0.81 113.953 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.881 HG22 ' O ' ' B' ' 132' ' ' LEU . 72.4 p -151.29 164.51 36.46 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 109.251 -0.648 . . . . 0.77 109.251 179.174 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.756 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -70.62 -16.26 62.82 Favored 'General case' 0 N--CA 1.44 -0.968 0 C-N-CA 119.975 -0.69 . . . . 1.02 110.308 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.625 ' HG3' ' HA2' ' A' ' 14' ' ' GLY . 5.0 mp0 -67.57 -15.83 63.86 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.424 -0.954 . . . . 2.32 108.424 176.228 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 1.051 ' O ' ' HB2' ' A' ' 44' ' ' CYS . . . -120.91 -10.57 9.08 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-N 116.361 -0.381 . . . . 0.87 111.221 -178.568 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.756 HD12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -61.71 -20.4 63.46 Favored 'General case' 0 N--CA 1.45 -0.439 0 O-C-N 121.211 -0.93 . . . . 1.23 113.229 -177.867 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.69 ' N ' HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -71.6 -6.78 43.43 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 107.556 -1.276 . . . . 2.92 107.556 174.95 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 1.051 ' HB2' ' O ' ' A' ' 41' ' ' ALA . 0.2 OUTLIER -66.53 -1.54 3.73 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 112.361 -2.2 . . . . 1.57 110.012 176.462 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -82.84 -17.35 44.26 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.02 0.438 . . . . 3.31 111.457 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -85.51 6.42 27.08 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 120.107 -0.637 . . . . 3.69 109.892 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.404 ' HG3' HD13 ' A' ' 11' ' ' LEU . 0.2 OUTLIER -81.99 3.02 28.15 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 109.416 -0.587 . . . . 3.99 109.416 177.427 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -78.12 -29.13 48.7 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.907 -0.405 . . . . 3.86 109.907 178.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -89.47 8.93 28.46 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 116.429 -0.35 . . . . 5.68 110.911 179.495 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -147.38 101.21 3.79 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-N 116.429 -0.35 . . . . 5.4 110.36 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -82.59 35.47 0.58 Allowed 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.345 2.03 . . . . 4.92 113.181 -179.267 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.736 ' HB3' HD11 ' A' ' 5' ' ' LEU . 17.5 m -167.11 105.57 0.63 Allowed Pre-proline 0 CA--C 1.538 0.493 0 C-N-CA 121.175 -0.21 . . . . 5.64 111.55 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.692 ' O ' ' HG ' ' A' ' 5' ' ' LEU . 69.5 Cg_endo -86.04 -137.91 0.02 OUTLIER 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 123.349 2.699 . . . . 5.04 112.257 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.439 ' H ' ' HB2' ' A' ' 53' ' ' PRO . 1.8 p -132.28 116.39 16.85 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.045 0.45 . . . . 2.74 111.225 178.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.662 ' HG2' ' H ' ' A' ' 4' ' ' ASP . 0.0 OUTLIER 52.22 -176.39 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.832 -0.622 . . . . 5.75 112.368 -179.965 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.516 ' HA ' ' HE2' ' A' ' 22' ' ' PHE . 0.3 OUTLIER -144.53 -89.4 0.11 Allowed 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.104 -0.953 . . . . 3.12 111.441 179.628 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 160.41 133.73 1.54 Allowed Glycine 0 N--CA 1.444 -0.819 0 N-CA-C 106.509 -2.637 . . . . 2.1 106.509 -179.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -109.0 76.9 1.03 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 118.991 1.396 . . . . 4.36 111.614 -177.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.477 ' N ' ' CD ' ' A' ' 60' ' ' PRO . 0.4 OUTLIER -145.79 57.19 3.88 Favored Pre-proline 0 C--N 1.309 -1.175 0 N-CA-C 106.33 -1.73 . . . . 3.55 106.33 176.799 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.477 ' CD ' ' N ' ' A' ' 59' ' ' LYS . 41.0 Cg_endo -70.3 81.76 0.92 Allowed 'Trans proline' 0 N--CA 1.448 -1.159 0 C-N-CA 122.096 1.864 . . . . 1.54 113.772 -178.123 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -103.08 179.31 4.31 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 106.988 -1.486 . . . . 1.59 106.988 177.127 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.16 -169.34 46.49 Favored Glycine 0 N--CA 1.437 -1.246 0 C-N-CA 118.656 -1.735 . . . . 2.43 114.607 178.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 50.2 p -85.46 47.26 1.4 Allowed 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 113.504 -1.348 . . . . 4.11 111.394 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 118.06 5.9 12.93 Favored Glycine 0 C--N 1.336 0.552 0 N-CA-C 115.828 1.091 . . . . 2.21 115.828 175.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.551 ' HA3' ' HA ' ' A' ' 74' ' ' CYS . . . -105.77 137.41 13.76 Favored Glycine 0 CA--C 1.52 0.385 0 N-CA-C 117.044 1.577 . . . . 1.62 117.044 -177.103 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.436 ' HA ' ' O ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -107.41 153.76 22.32 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 114.176 -1.012 . . . . 3.02 109.111 177.668 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.792 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 2.2 m -59.41 107.64 0.6 Allowed 'General case' 0 N--CA 1.441 -0.891 0 O-C-N 121.968 -0.457 . . . . 1.52 111.442 -177.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -84.21 -20.23 32.68 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.308 -0.627 . . . . 1.07 109.308 177.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.703 ' HB3' ' CG1' ' A' ' 72' ' ' ILE . . . -166.46 164.07 17.23 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.776 -0.647 . . . . 1.0 111.62 179.123 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.623 ' HA ' ' O ' ' A' ' 85' ' ' CYS . . . -39.76 96.9 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.778 -0.646 . . . . 1.24 110.185 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 1.044 ' C ' HD13 ' A' ' 72' ' ' ILE . . . 73.57 50.23 12.32 Favored Glycine 0 CA--C 1.504 -0.655 0 CA-C-N 114.877 -1.056 . . . . 1.28 111.456 -179.126 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 1.044 HD13 ' C ' ' A' ' 71' ' ' GLY . 0.5 OUTLIER -137.51 98.88 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.817 0 N-CA-C 108.049 -1.093 . . . . 2.27 108.049 170.969 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.461 ' O ' ' HB2' ' A' ' 80' ' ' HIS . 51.2 t -91.91 96.27 10.29 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 108.613 -0.884 . . . . 1.98 108.613 179.383 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 1.066 ' CB ' ' HA ' ' A' ' 79' ' ' CYS . 24.4 p -167.3 -171.57 1.75 Allowed 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 116.577 2.066 . . . . 1.33 116.577 -176.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.883 ' HB3' ' HD2' ' A' ' 76' ' ' PRO . 72.8 m -124.6 -178.9 0.74 Allowed Pre-proline 0 CA--C 1.531 0.225 0 CA-C-N 112.927 -1.942 . . . . 1.99 108.564 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.883 ' HD2' ' HB3' ' A' ' 75' ' ' SER . 58.0 Cg_endo -73.16 31.17 0.3 Allowed 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 121.717 1.611 . . . . 1.86 113.172 -179.271 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -134.36 -60.94 0.79 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.85 0.357 . . . . 2.65 110.221 178.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.935 ' O ' ' HB2' ' A' ' 74' ' ' CYS . . . -118.22 -178.51 17.14 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.95 -0.643 . . . . 0.99 111.661 178.727 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 1.066 ' HA ' ' CB ' ' A' ' 74' ' ' CYS . 22.5 m -152.27 161.37 42.72 Favored 'General case' 0 C--O 1.226 -0.169 0 N-CA-C 112.428 0.529 . . . . 1.34 112.428 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.541 ' HA ' ' HA2' ' B' ' 178' ' ' GLY . 7.1 m80 -143.17 139.04 30.16 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-O 121.173 0.511 . . . . 2.17 111.823 -178.509 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.477 ' OE2' ' HB2' ' B' ' 125' ' ' SER . 37.0 tt0 -65.51 122.97 18.43 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-N 115.671 -0.695 . . . . 3.05 109.605 178.114 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.698 ' O ' ' HA2' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -138.9 106.75 7.47 Favored Pre-proline 0 C--N 1.319 -0.749 0 C-N-CA 118.963 -1.095 . . . . 2.02 111.385 179.424 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -63.85 -16.65 56.07 Favored 'Trans proline' 0 C--N 1.356 0.948 0 C-N-CA 123.004 2.47 . . . . 1.93 114.315 -178.301 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.08 -40.16 96.86 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.108 0.48 . . . . 1.53 110.542 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.632 ' O ' ' N ' ' A' ' 71' ' ' GLY . 68.8 m -94.18 46.74 1.17 Allowed 'General case' 0 C--O 1.219 -0.55 0 CA-C-N 115.484 -0.78 . . . . 1.88 110.351 179.457 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.563 ' CB ' ' HD3' ' A' ' 87' ' ' PRO . 0.2 OUTLIER -77.78 -58.08 0.93 Allowed Pre-proline 0 N--CA 1.475 0.803 0 O-C-N 121.544 -0.722 . . . . 3.6 112.027 -178.735 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.651 ' O ' ' C ' ' A' ' 88' ' ' GLU . 97.1 Cg_endo -90.99 155.72 3.93 Favored 'Trans proline' 0 CA--C 1.504 -1.016 0 C-N-CA 123.996 3.131 . . . . 2.56 108.721 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.651 ' C ' ' O ' ' A' ' 87' ' ' PRO . 0.2 OUTLIER -30.19 95.26 0.01 OUTLIER 'General case' 0 N--CA 1.417 -2.116 0 C-N-CA 118.309 -1.356 . . . . 4.72 110.45 176.785 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.651 ' N ' ' O ' ' A' ' 87' ' ' PRO . . . -91.99 20.59 5.64 Favored 'General case' 0 C--N 1.285 -2.239 0 N-CA-C 107.019 -1.475 . . . . 5.29 107.019 171.442 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.2 156.16 39.19 Favored 'General case' 0 C--N 1.356 0.862 0 CA-C-O 122.466 1.127 . . . . 6.98 112.083 177.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -98.35 95.57 7.45 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 112.686 -2.052 . . . . 10.21 109.951 177.564 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 39.5 m . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.294 -0.86 . . . . 11.77 110.815 179.983 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 101' ' ' ALA . . . . . 0.566 ' N ' HD23 ' B' ' 103' ' ' LEU . . . . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 111.752 0.279 . . . . 10.07 111.752 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 3.7 t 56.25 45.3 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.289 0 C-N-CA 118.547 -1.261 . . . . 8.41 110.022 176.083 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 103' ' ' LEU . . . . . 0.897 ' HG ' ' HG3' ' B' ' 108' ' ' ARG . 3.3 mm? -104.23 94.23 5.25 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 113.01 -1.905 . . . . 5.87 113.938 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 104' ' ' ASP . . . . . 0.674 ' H ' ' HG2' ' B' ' 155' ' ' GLN . 0.7 OUTLIER -81.86 107.65 14.75 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 114.01 -1.45 . . . . 6.27 111.41 178.931 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 105' ' ' LEU . . . . . 1.051 HD11 ' HB3' ' B' ' 152' ' ' SER . 2.7 tm? -157.16 -90.8 0.03 OUTLIER 'General case' 0 N--CA 1.4 -2.971 0 N-CA-C 106.348 -1.723 . . . . 7.2 106.348 173.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 106' ' ' ASP . . . . . 0.598 ' HB2' HD13 ' B' ' 105' ' ' LEU . 0.2 OUTLIER -167.71 -48.91 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 111.434 -2.621 . . . . 8.55 107.649 -178.438 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 107' ' ' VAL . . . . . 0.632 ' O ' HD12 ' B' ' 105' ' ' LEU . 11.3 p -141.02 123.07 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.515 0 N-CA-C 102.832 -3.025 . . . . 7.48 102.832 173.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 108' ' ' ARG . . . . . 0.897 ' HG3' ' HG ' ' B' ' 103' ' ' LEU . 0.0 OUTLIER -80.15 110.44 15.56 Favored 'General case' 0 N--CA 1.385 -3.716 0 C-N-CA 117.865 -1.534 . . . . 9.12 107.721 178.355 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 109' ' ' THR . . . . . 0.51 HG23 ' HA ' ' B' ' 153' ' ' PRO . 1.2 t -108.04 99.8 9.2 Favored 'General case' 0 N--CA 1.407 -2.605 1 N-CA-C 98.546 -4.612 . . . . 5.69 98.546 167.784 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 110' ' ' CYS . . . . . . . . . . . . . 1.2 m -77.7 66.46 3.39 Favored 'General case' 0 C--N 1.311 -1.084 0 C-N-CA 118.297 -1.361 . . . . 2.61 111.457 -177.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 111' ' ' LEU . . . . . 0.748 ' O ' ' HA ' ' B' ' 120' ' ' ARG . 0.2 OUTLIER -37.92 112.08 0.61 Allowed Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.007 -0.997 . . . . 2.47 112.367 176.864 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 112' ' ' PRO . . . . . 0.433 ' HA ' ' O ' ' B' ' 119' ' ' GLY . 88.6 Cg_endo -84.49 153.28 12.02 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.339 2.026 . . . . 1.47 111.018 178.399 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.508 ' O ' ' HA2' ' B' ' 117' ' ' GLY . 20.0 p -154.33 -174.71 5.07 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 113.638 0.977 . . . . 1.0 113.638 174.588 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 114' ' ' GLY . . . . . 0.606 ' HA2' ' HG3' ' B' ' 140' ' ' GLU . . . 73.54 -161.44 54.15 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.151 -0.931 . . . . 1.16 113.529 177.366 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 115' ' ' PRO . . . . . 0.547 ' O ' ' HG3' ' B' ' 118' ' ' LYS . 42.8 Cg_endo -64.57 95.74 0.23 Allowed 'Trans proline' 0 C--O 1.224 -0.182 0 C-N-CA 123.11 2.54 . . . . 1.57 112.5 177.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 87.65 11.41 68.5 Favored Glycine 0 C--N 1.283 -2.403 0 CA-C-N 114.767 -1.106 . . . . 1.7 113.228 -178.424 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 117' ' ' GLY . . . . . 0.508 ' HA2' ' O ' ' B' ' 113' ' ' CYS . . . 62.11 39.41 97.6 Favored Glycine 0 N--CA 1.414 -2.822 0 C-N-CA 118.002 -2.047 . . . . 1.38 111.438 176.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 118' ' ' LYS . . . . . 0.547 ' HG3' ' O ' ' B' ' 115' ' ' PRO . 0.0 OUTLIER -91.85 7.06 43.69 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 113.904 -1.148 . . . . 2.54 112.094 179.644 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 119' ' ' GLY . . . . . 0.433 ' O ' ' HA ' ' B' ' 112' ' ' PRO . . . -115.93 -159.5 11.97 Favored Glycine 0 C--N 1.343 0.961 0 N-CA-C 108.139 -1.984 . . . . 1.04 108.139 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.748 ' HA ' ' O ' ' B' ' 111' ' ' LEU . 0.0 OUTLIER -145.37 170.46 16.29 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 121.098 2.449 . . . . 2.89 105.844 174.685 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 121' ' ' CYS . . . . . 0.493 ' HB2' ' HB3' ' B' ' 111' ' ' LEU . 0.9 OUTLIER -106.26 135.61 47.45 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 119.115 0.87 . . . . 1.07 111.942 -176.769 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 122' ' ' PHE . . . . . 0.549 ' HE2' ' HA ' ' B' ' 156' ' ' SER . 68.7 m-85 -128.12 13.71 6.72 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.038 -0.983 . . . . 1.53 111.287 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -176.16 -167.81 35.49 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.339 -0.934 . . . . 0.9 112.56 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 124' ' ' PRO . . . . . 0.494 ' O ' ' HB3' ' B' ' 144' ' ' CYS . 2.0 Cg_endo -81.68 -44.37 0.09 OUTLIER 'Trans proline' 0 CA--C 1.532 0.423 0 C-N-CA 122.701 2.267 . . . . 1.51 112.791 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 125' ' ' SER . . . . . 0.477 ' HB2' ' OE2' ' A' ' 81' ' ' GLU . 0.1 OUTLIER -124.73 16.54 8.73 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.983 0.421 . . . . 1.25 110.722 179.823 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 126' ' ' ILE . . . . . 0.739 HG23 ' HA ' ' B' ' 136' ' ' VAL . 1.0 OUTLIER -126.44 121.63 59.3 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 CA-C-O 121.454 0.645 . . . . 0.85 111.57 -178.106 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 127' ' ' CYS . . . . . 0.833 ' HB2' ' HB2' ' B' ' 141' ' ' ALA . 0.1 OUTLIER -119.28 133.59 55.67 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-N 115.578 -0.737 . . . . 0.89 109.078 178.912 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 128' ' ' CYS . . . . . 1.205 ' HA ' ' O ' ' B' ' 133' ' ' GLY . 0.0 OUTLIER -145.53 120.5 10.02 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 118.246 -0.883 . . . . 1.23 111.145 -179.171 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 129' ' ' GLY . . . . . 0.631 ' O ' ' HB1' ' B' ' 169' ' ' ALA . . . -114.69 -156.95 11.56 Favored Glycine 0 N--CA 1.417 -2.613 0 N-CA-C 107.555 -2.218 . . . . 0.66 107.555 176.498 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -65.85 -71.0 0.21 Allowed 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 122.168 0.187 . . . . 2.35 111.493 -178.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.47 32.25 5.52 Favored 'General case' 0 CA--C 1.498 -1.024 0 C-N-CA 120.095 -0.642 . . . . 1.69 110.027 -175.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 132' ' ' LEU . . . . . 0.881 ' O ' HG22 ' A' ' 38' ' ' THR . 0.8 OUTLIER -124.79 -18.88 5.46 Favored 'General case' 0 N--CA 1.403 -2.802 0 N-CA-C 104.898 -2.26 . . . . 1.38 104.898 176.127 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 133' ' ' GLY . . . . . 1.205 ' O ' ' HA ' ' B' ' 128' ' ' CYS . . . 66.86 -134.96 32.33 Favored Glycine 0 N--CA 1.407 -3.269 0 CA-C-N 115.134 -0.939 . . . . 0.72 114.769 173.671 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 134' ' ' CYS . . . . . 0.894 ' HB2' HG13 ' B' ' 172' ' ' ILE . 2.7 t -135.14 116.44 14.52 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 114.141 1.163 . . . . 1.08 114.141 -177.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 135' ' ' PHE . . . . . 0.885 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -98.16 107.68 20.21 Favored 'General case' 0 CA--C 1.503 -0.857 0 N-CA-C 107.068 -1.456 . . . . 1.36 107.068 177.158 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 136' ' ' VAL . . . . . 0.739 ' HA ' HG23 ' B' ' 126' ' ' ILE . 2.2 t -90.99 86.57 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.324 0 CA-C-O 122.611 1.196 . . . . 0.75 109.792 -179.281 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 137' ' ' GLY . . . . . 0.475 ' O ' ' HA3' ' A' ' 33' ' ' GLY . . . 102.47 68.92 0.81 Allowed Glycine 0 C--N 1.321 -0.285 0 CA-C-N 112.85 -1.977 . . . . 0.83 114.135 179.403 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 138' ' ' THR . . . . . 0.825 HG22 ' O ' ' A' ' 32' ' ' LEU . 81.2 p -146.45 173.15 12.55 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.824 -0.806 . . . . 0.78 108.824 178.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 139' ' ' ALA . . . . . 0.79 ' O ' HD12 ' B' ' 142' ' ' LEU . . . -78.35 -17.36 56.61 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 120.197 -0.601 . . . . 1.04 109.669 177.169 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 140' ' ' GLU . . . . . 0.606 ' HG3' ' HA2' ' B' ' 114' ' ' GLY . 5.3 mp0 -67.48 -14.33 62.83 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.86 -0.793 . . . . 2.31 108.86 176.11 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 141' ' ' ALA . . . . . 1.034 ' O ' ' HB2' ' B' ' 144' ' ' CYS . . . -120.42 -15.59 8.53 Favored 'General case' 0 C--O 1.218 -0.585 0 CA-C-N 115.198 -0.91 . . . . 0.87 111.802 -179.375 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 142' ' ' LEU . . . . . 0.79 HD12 ' O ' ' B' ' 139' ' ' ALA . 0.0 OUTLIER -59.91 -21.15 60.71 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 113.529 0.937 . . . . 1.24 113.529 -176.569 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 143' ' ' ARG . . . . . 0.698 ' N ' HD13 ' B' ' 142' ' ' LEU . 0.0 OUTLIER -64.32 -20.63 66.22 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 105.966 -1.865 . . . . 2.93 105.966 175.222 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 144' ' ' CYS . . . . . 1.034 ' HB2' ' O ' ' B' ' 141' ' ' ALA . 0.2 OUTLIER -59.28 2.49 0.06 Allowed 'General case' 0 N--CA 1.486 1.374 0 CA-C-N 113.521 -1.672 . . . . 1.61 110.578 -177.985 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 145' ' ' GLN . . . . . 0.499 ' H ' ' C ' ' B' ' 143' ' ' ARG . 14.4 mm100 -84.03 -17.46 40.32 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.039 0.447 . . . . 3.35 111.004 178.607 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -85.69 6.49 27.42 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 120.147 -0.621 . . . . 3.76 109.808 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 147' ' ' GLU . . . . . 0.406 ' HG3' HD13 ' B' ' 111' ' ' LEU . 0.2 OUTLIER -81.87 2.9 28.23 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 120.241 -0.584 . . . . 4.01 109.508 177.331 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 148' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -78.1 -29.09 48.84 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 116.335 -0.393 . . . . 3.92 109.95 178.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -89.44 8.9 28.5 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.459 -0.337 . . . . 5.73 110.966 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -147.33 101.2 3.8 Favored Pre-proline 0 C--N 1.333 -0.151 0 CA-C-N 116.397 -0.365 . . . . 5.46 110.302 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 151' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -82.59 35.34 0.57 Allowed 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.432 2.088 . . . . 5.02 113.223 -179.321 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 152' ' ' SER . . . . . 1.051 ' HB3' HD11 ' B' ' 105' ' ' LEU . 16.9 m -167.04 105.53 0.63 Allowed Pre-proline 0 CA--C 1.537 0.478 0 N-CA-C 111.678 0.251 . . . . 5.73 111.678 -179.653 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 153' ' ' PRO . . . . . 0.51 ' HA ' HG23 ' B' ' 109' ' ' THR . 77.4 Cg_endo -86.18 -138.34 0.02 OUTLIER 'Trans proline' 0 CA--C 1.544 1.003 0 C-N-CA 123.239 2.626 . . . . 5.1 112.257 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 154' ' ' CYS . . . . . 0.456 ' HB2' HD12 ' B' ' 103' ' ' LEU . 1.8 p -131.95 116.98 17.83 Favored 'General case' 0 C--N 1.349 0.553 0 CA-C-O 121.281 0.562 . . . . 2.68 111.052 178.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 155' ' ' GLN . . . . . 0.674 ' HG2' ' H ' ' B' ' 104' ' ' ASP . 0.0 OUTLIER 51.1 -174.97 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 115.436 -0.802 . . . . 5.63 112.249 -179.663 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 156' ' ' SER . . . . . 0.549 ' HA ' ' HE2' ' B' ' 122' ' ' PHE . 0.3 OUTLIER -145.46 -94.89 0.1 Allowed 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.425 -0.807 . . . . 3.11 108.997 179.156 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 165.68 136.63 2.05 Favored Glycine 0 CA--C 1.501 -0.798 0 N-CA-C 108.291 -1.924 . . . . 2.07 108.291 -178.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -110.91 64.63 0.61 Allowed 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 117.013 -1.875 . . . . 4.34 112.682 -178.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 159' ' ' LYS . . . . . 0.471 ' HB3' ' SG ' ' B' ' 167' ' ' CYS . 0.2 OUTLIER -118.19 53.63 1.75 Allowed Pre-proline 0 C--N 1.315 -0.893 0 CA-C-N 113.686 -1.597 . . . . 3.54 110.048 170.175 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 160' ' ' PRO . . . . . 0.421 ' HA ' ' HA ' ' B' ' 166' ' ' ARG . 37.7 Cg_endo -69.79 83.9 0.68 Allowed 'Trans proline' 0 CA--C 1.519 -0.244 0 CA-C-N 122.153 1.805 . . . . 1.51 114.46 -173.764 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 161' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -97.13 -170.91 2.11 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 113.8 -1.545 . . . . 1.58 107.761 178.038 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 55.87 -167.53 3.27 Favored Glycine 0 N--CA 1.439 -1.159 0 C-N-CA 119.645 -1.264 . . . . 2.37 114.779 173.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 78.8 p -85.65 47.03 1.37 Allowed 'General case' 0 C--N 1.309 -1.168 0 C-N-CA 126.637 1.975 . . . . 4.07 111.66 -179.362 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 118.35 5.11 13.19 Favored Glycine 0 C--N 1.347 1.189 0 CA-C-N 112.863 -1.971 . . . . 2.2 116.004 173.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 165' ' ' GLY . . . . . 0.546 ' HA3' ' HA ' ' B' ' 174' ' ' CYS . . . -104.0 137.97 13.82 Favored Glycine 0 CA--C 1.522 0.473 0 C-N-CA 118.837 -1.649 . . . . 1.62 117.081 -176.46 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 166' ' ' ARG . . . . . 0.464 ' HA ' ' O ' ' B' ' 159' ' ' LYS . 0.0 OUTLIER -107.96 153.69 22.7 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 114.006 -1.097 . . . . 3.05 108.99 177.03 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 167' ' ' CYS . . . . . 0.801 ' HA ' ' O ' ' B' ' 172' ' ' ILE . 2.0 m -59.52 107.54 0.6 Allowed 'General case' 0 N--CA 1.438 -1.049 0 O-C-N 121.832 -0.542 . . . . 1.56 111.479 -177.686 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 168' ' ' ALA . . . . . . . . . . . . . . . -81.62 -24.65 36.26 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 108.808 -0.812 . . . . 1.04 108.808 177.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 169' ' ' ALA . . . . . 0.713 ' HB3' ' CG1' ' B' ' 172' ' ' ILE . . . -163.52 163.94 24.51 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 115.169 -0.923 . . . . 0.98 112.782 -178.619 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 170' ' ' ALA . . . . . 0.596 ' HA ' ' O ' ' B' ' 185' ' ' CYS . . . -40.97 97.77 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.563 -0.744 . . . . 1.25 110.115 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 171' ' ' GLY . . . . . 0.891 ' C ' HD13 ' B' ' 172' ' ' ILE . . . 88.19 20.73 48.18 Favored Glycine 0 N--CA 1.443 -0.876 0 N-CA-C 115.559 0.983 . . . . 1.29 115.559 179.017 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 172' ' ' ILE . . . . . 0.894 HG13 ' HB2' ' B' ' 134' ' ' CYS . 0.3 OUTLIER -120.19 99.25 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 CA-C-N 117.229 0.515 . . . . 2.27 110.908 -179.801 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 173' ' ' CYS . . . . . 0.455 ' O ' ' HB2' ' B' ' 180' ' ' HIS . 53.2 t -91.51 96.29 10.41 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 108.932 -0.766 . . . . 1.94 108.932 178.604 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 174' ' ' CYS . . . . . 1.077 ' CB ' ' HA ' ' B' ' 179' ' ' CYS . 21.9 p -167.67 -171.67 1.69 Allowed 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 116.53 2.048 . . . . 1.35 116.53 -176.755 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 175' ' ' SER . . . . . 0.915 ' HB3' ' HD2' ' B' ' 176' ' ' PRO . 72.3 m -124.48 -178.82 0.73 Allowed Pre-proline 0 CA--C 1.531 0.241 0 CA-C-N 112.981 -1.918 . . . . 2.0 108.537 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 176' ' ' PRO . . . . . 0.915 ' HD2' ' HB3' ' B' ' 175' ' ' SER . 57.9 Cg_endo -73.28 31.13 0.31 Allowed 'Trans proline' 0 CA--C 1.533 0.435 0 C-N-CA 121.725 1.617 . . . . 1.9 113.092 -179.25 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 177' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -134.32 -60.83 0.79 Allowed 'General case' 0 C--O 1.234 0.277 0 CA-C-O 120.914 0.387 . . . . 2.72 110.267 178.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 178' ' ' GLY . . . . . 0.918 ' O ' ' HB2' ' B' ' 174' ' ' CYS . . . -118.15 -178.52 17.18 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 121.006 -0.616 . . . . 0.99 111.668 178.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 179' ' ' CYS . . . . . 1.077 ' HA ' ' CB ' ' B' ' 174' ' ' CYS . 21.7 m -152.24 161.34 42.76 Favored 'General case' 0 N--CA 1.462 0.127 0 N-CA-C 112.453 0.538 . . . . 1.34 112.453 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 180' ' ' HIS . . . . . 0.529 ' HA ' ' HA2' ' A' ' 78' ' ' GLY . 7.1 m80 -143.15 139.08 30.22 Favored 'General case' 0 CA--C 1.517 -0.295 0 O-C-N 121.897 -0.502 . . . . 2.1 111.763 -178.509 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 181' ' ' GLU . . . . . 0.438 ' OE2' ' HB2' ' A' ' 25' ' ' SER . 37.4 tt0 -65.57 123.0 18.51 Favored 'General case' 0 CA--C 1.503 -0.858 0 CA-C-N 115.674 -0.694 . . . . 3.06 109.586 178.069 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 182' ' ' ASP . . . . . 0.766 ' O ' ' HA2' ' B' ' 171' ' ' GLY . 0.0 OUTLIER -138.81 106.6 7.52 Favored Pre-proline 0 C--N 1.319 -0.757 0 C-N-CA 118.957 -1.097 . . . . 2.06 111.346 179.466 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 183' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -63.6 -16.85 57.16 Favored 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 123.034 2.489 . . . . 1.91 114.391 -178.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -63.02 -40.2 97.03 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.177 0.513 . . . . 1.56 110.512 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 185' ' ' CYS . . . . . 0.601 ' O ' ' N ' ' B' ' 171' ' ' GLY . 69.5 m -94.0 46.83 1.18 Allowed 'General case' 0 C--O 1.217 -0.613 0 CA-C-N 115.576 -0.738 . . . . 1.94 110.399 179.322 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 186' ' ' ASP . . . . . 0.557 ' CB ' ' HD3' ' B' ' 187' ' ' PRO . 0.2 OUTLIER -77.94 -57.84 0.93 Allowed Pre-proline 0 N--CA 1.473 0.719 0 O-C-N 121.518 -0.739 . . . . 3.61 111.861 -178.637 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 187' ' ' PRO . . . . . 0.699 ' O ' ' C ' ' B' ' 188' ' ' GLU . 51.1 Cg_endo -95.89 145.3 1.2 Allowed 'Trans proline' 0 CA--C 1.504 -0.992 0 C-N-CA 123.946 3.097 . . . . 2.58 110.43 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 188' ' ' GLU . . . . . 0.699 ' C ' ' O ' ' B' ' 187' ' ' PRO . 0.1 OUTLIER -20.11 91.6 0.01 OUTLIER 'General case' 0 N--CA 1.413 -2.281 0 C-N-CA 118.822 -1.151 . . . . 4.7 111.695 -176.97 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 189' ' ' ALA . . . . . 0.603 ' N ' ' O ' ' B' ' 187' ' ' PRO . . . -88.31 18.65 4.26 Favored 'General case' 0 N--CA 1.41 -2.432 0 CA-C-N 121.148 1.794 . . . . 5.24 107.142 174.164 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 190' ' ' ALA . . . . . . . . . . . . . . . -63.44 156.18 26.91 Favored 'General case' 0 C--N 1.355 0.828 0 CA-C-O 122.461 1.125 . . . . 6.93 111.869 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 191' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -98.18 95.85 7.69 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 113.004 -1.907 . . . . 10.14 110.096 177.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 39.4 m . . . . . 0 C--O 1.248 0.994 0 CA-C-O 118.26 -0.876 . . . . 11.7 110.749 -179.969 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.432 ' O ' HD23 ' A' ' 3' ' ' LEU . . . . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 110.181 -0.303 . . . . 9.95 110.181 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.517 ' O ' HG13 ' A' ' 2' ' ' VAL . 6.4 p -59.47 97.49 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.319 0 C-N-CA 119.839 -0.745 . . . . 8.02 111.573 -176.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 1.022 HD13 ' HB3' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -158.01 128.78 6.39 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 119.792 -0.763 . . . . 5.86 112.611 179.78 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -88.24 89.01 7.82 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 105.678 -1.971 . . . . 6.22 105.678 175.138 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.961 HD12 ' H ' ' A' ' 7' ' ' VAL . 1.3 tm? -159.22 -120.76 0.02 OUTLIER 'General case' 1 N--CA 1.375 -4.198 0 CA-C-N 112.063 -2.335 . . . . 7.09 105.08 178.788 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.475 ' H ' ' CD1' ' A' ' 5' ' ' LEU . 1.4 t70 -171.19 -33.67 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 113.807 -1.542 . . . . 8.78 110.815 -179.066 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.961 ' H ' HD12 ' A' ' 5' ' ' LEU . 15.0 p -147.46 118.11 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.896 0 CA-C-N 110.946 -2.843 . . . . 7.51 105.52 172.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 1.022 ' HB3' HD13 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -79.67 105.38 10.93 Favored 'General case' 0 N--CA 1.388 -3.531 0 CA-C-N 115.272 -0.877 . . . . 9.08 111.401 -177.849 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.685 HG21 ' HD2' ' A' ' 51' ' ' PRO . 1.3 t -102.34 86.01 2.74 Favored 'General case' 0 N--CA 1.412 -2.347 1 N-CA-C 98.772 -4.529 . . . . 5.66 98.772 168.411 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.54 ' HA ' ' HB2' ' A' ' 54' ' ' CYS . 0.8 OUTLIER -74.97 56.23 0.74 Allowed 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 113.155 -1.839 . . . . 2.68 112.329 -176.876 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.898 HD23 ' HB3' ' A' ' 21' ' ' CYS . 15.0 tp -36.93 114.41 0.64 Allowed Pre-proline 0 N--CA 1.476 0.869 0 N-CA-C 114.054 1.131 . . . . 2.48 114.054 179.207 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.528 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 52.0 Cg_endo -95.73 134.83 0.57 Allowed 'Trans proline' 0 CA--C 1.534 0.513 0 C-N-CA 122.167 1.911 . . . . 1.49 115.216 179.518 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.661 ' O ' ' HA2' ' A' ' 17' ' ' GLY . 0.5 OUTLIER -140.65 -169.06 2.71 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 113.444 0.905 . . . . 1.0 113.444 -178.389 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.566 ' HA2' ' HB3' ' A' ' 40' ' ' GLU . . . 77.09 -156.18 45.21 Favored Glycine 0 C--N 1.337 0.605 0 CA-C-N 114.932 -1.031 . . . . 1.15 111.899 178.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.612 ' HG2' ' O ' ' A' ' 15' ' ' PRO . 41.4 Cg_endo -62.8 113.44 1.98 Allowed 'Trans proline' 0 N--CA 1.479 0.667 0 C-N-CA 122.783 2.322 . . . . 1.57 106.193 176.161 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 73.3 -7.12 12.25 Favored Glycine 0 C--N 1.276 -2.776 0 CA-C-O 119.067 -0.852 . . . . 1.68 112.73 175.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.661 ' HA2' ' O ' ' A' ' 13' ' ' CYS . . . 77.61 49.69 7.06 Favored Glycine 1 N--CA 1.383 -4.858 0 C-N-CA 118.295 -1.907 . . . . 1.36 111.515 -179.42 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.426 ' CG ' ' O ' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -99.61 9.46 43.11 Favored 'General case' 0 C--N 1.342 0.278 0 CA-C-N 112.864 -1.668 . . . . 2.5 111.946 175.643 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.528 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -124.63 -167.92 12.73 Favored Glycine 0 C--N 1.333 0.404 0 N-CA-C 106.465 -2.654 . . . . 1.02 106.465 178.56 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.721 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 0.6 OUTLIER -135.98 158.56 44.09 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 121.056 2.428 . . . . 2.92 108.184 -179.925 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.898 ' HB3' HD23 ' A' ' 11' ' ' LEU . 1.7 t -107.65 160.49 15.66 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 112.883 0.697 . . . . 1.1 112.883 -178.243 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.559 ' HE1' ' O ' ' A' ' 28' ' ' CYS . 60.7 m-85 -126.38 -47.46 1.59 Allowed 'General case' 0 C--N 1.339 0.143 0 CA-C-N 115.538 -0.755 . . . . 1.51 110.184 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -117.46 -159.62 11.46 Favored Glycine 0 CA--C 1.521 0.414 0 CA-C-N 115.723 -0.671 . . . . 0.9 111.559 179.188 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -84.33 -68.1 0.01 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.32 2.013 . . . . 1.5 111.657 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.409 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.4 OUTLIER -89.41 26.54 1.66 Allowed 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.867 -0.42 . . . . 1.26 109.867 178.753 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.937 HG12 HG13 ' A' ' 36' ' ' VAL . 5.6 mt -144.82 112.81 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 CA-C-O 121.875 0.845 . . . . 0.83 111.771 -178.287 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.587 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 4.7 t -126.57 131.3 51.56 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 114.991 -1.004 . . . . 0.92 109.451 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.792 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -142.44 123.12 14.21 Favored 'General case' 0 CA--C 1.561 1.374 0 N-CA-C 115.38 1.622 . . . . 1.28 115.38 -177.358 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -109.37 -170.34 20.5 Favored Glycine 0 C--N 1.368 2.31 0 N-CA-C 109.117 -1.593 . . . . 0.67 109.117 175.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -66.07 -56.07 13.39 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 114.573 1.323 . . . . 2.27 114.573 -178.09 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.45 -1.11 16.03 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 122.129 0.966 . . . . 1.66 111.234 -177.137 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.94 HD22 ' CZ ' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -97.39 -13.0 22.1 Favored 'General case' 0 N--CA 1.407 -2.587 0 N-CA-C 106.531 -1.655 . . . . 1.37 106.531 179.937 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.886 ' HA2' ' CB ' ' A' ' 69' ' ' ALA . . . 58.78 -132.66 52.66 Favored Glycine 0 C--O 1.197 -2.168 0 CA-C-O 118.165 -1.353 . . . . 0.73 112.28 175.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.872 ' HB2' HD13 ' A' ' 72' ' ' ILE . 2.4 t -135.39 122.21 21.08 Favored 'General case' 0 CA--C 1.486 -1.517 0 CA-C-N 118.496 1.148 . . . . 1.08 113.748 -179.499 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.94 ' CZ ' HD22 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -97.69 100.63 12.02 Favored 'General case' 0 N--CA 1.427 -1.606 0 N-CA-C 103.296 -2.853 . . . . 1.38 103.296 175.426 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.937 HG13 HG12 ' A' ' 26' ' ' ILE . 2.1 t -92.12 83.66 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 CA-C-O 123.319 1.533 . . . . 0.76 107.139 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.798 ' HA3' HG21 ' B' ' 172' ' ' ILE . . . 100.43 85.71 1.87 Allowed Glycine 0 CA--C 1.525 0.689 0 CA-C-N 112.42 -2.173 . . . . 0.81 113.67 -179.431 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.708 HG22 ' O ' ' B' ' 132' ' ' LEU . 67.0 p -161.56 159.49 27.82 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 109.631 -0.507 . . . . 0.77 109.631 179.298 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.594 ' HA ' ' CD1' ' A' ' 42' ' ' LEU . . . -62.15 -23.07 66.36 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 118.666 0.666 . . . . 1.02 111.242 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.566 ' HB3' ' HA2' ' A' ' 14' ' ' GLY . 3.2 mm-40 -68.75 -13.05 62.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.795 -0.639 . . . . 2.32 109.704 176.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.536 ' O ' ' HB2' ' A' ' 44' ' ' CYS . . . -100.3 -24.36 14.55 Favored 'General case' 0 C--O 1.205 -1.24 0 N-CA-C 109.154 -0.684 . . . . 0.87 109.154 178.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.66 HD22 ' CE1' ' B' ' 191' ' ' PHE . 26.4 mt -42.5 -38.49 1.95 Allowed 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.31 0.485 . . . . 1.23 112.31 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.648 ' HD3' ' O ' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -69.25 -6.25 28.05 Favored 'General case' 0 CA--C 1.556 1.197 0 CA-C-O 121.822 0.82 . . . . 2.92 110.733 179.348 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.536 ' HB2' ' O ' ' A' ' 41' ' ' ALA . 65.7 m -72.59 -18.21 61.62 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 113.829 -1.532 . . . . 1.57 109.715 177.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -55.48 -17.17 4.7 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.667 -0.697 . . . . 3.31 111.471 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.572 ' O ' HD13 ' A' ' 50' ' ' LEU . 14.2 tt0 -84.43 5.64 26.48 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 120.444 -0.502 . . . . 3.69 110.063 179.177 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.597 ' HA ' ' HB2' ' A' ' 50' ' ' LEU . 17.4 tt0 -82.85 -0.96 50.58 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.89 -0.595 . . . . 3.99 109.833 177.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 15.2 m-20 -73.81 -27.94 61.37 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 109.308 -0.627 . . . . 3.86 109.308 177.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -119.18 41.23 3.13 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 115.76 -0.654 . . . . 5.68 109.75 179.406 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.597 ' HB2' ' HA ' ' A' ' 47' ' ' GLU . 0.8 OUTLIER -123.58 140.13 33.53 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-N 115.862 -0.608 . . . . 5.4 111.64 -179.001 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.685 ' HD2' HG21 ' A' ' 9' ' ' THR . 2.7 Cg_exo -76.36 50.86 3.04 Favored 'Trans proline' 0 C--N 1.356 0.925 0 C-N-CA 122.891 2.394 . . . . 4.92 113.057 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.754 ' HB2' ' HD2' ' A' ' 53' ' ' PRO . 5.1 p 71.65 171.15 0.11 Allowed Pre-proline 0 N--CA 1.471 0.601 0 N-CA-C 112.401 0.519 . . . . 5.64 112.401 179.268 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.754 ' HD2' ' HB2' ' A' ' 52' ' ' SER . 13.7 Cg_endo -56.98 -173.0 0.04 OUTLIER 'Trans proline' 0 C--N 1.361 1.205 0 C-N-CA 123.403 2.735 . . . . 5.04 115.147 -178.246 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.54 ' HB2' ' HA ' ' A' ' 10' ' ' CYS . 1.0 OUTLIER -119.13 116.13 25.7 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 114.313 -1.312 . . . . 2.74 110.157 -179.025 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 66.85 -168.2 0.2 Allowed 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 118.37 0.532 . . . . 5.75 111.426 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.775 ' OG ' ' HG3' ' A' ' 59' ' ' LYS . 0.4 OUTLIER -135.19 -69.59 0.5 Allowed 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 108.72 -0.845 . . . . 3.12 108.72 -179.978 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 103.87 -108.73 3.25 Favored Glycine 0 CA--C 1.479 -2.167 0 N-CA-C 110.806 -0.918 . . . . 2.1 110.806 -178.134 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.486 ' HB2' ' HB3' ' A' ' 67' ' ' CYS . 3.5 mt-30 -112.56 115.85 29.28 Favored 'General case' 0 N--CA 1.422 -1.85 0 N-CA-C 102.889 -3.004 . . . . 4.36 102.889 175.401 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.918 ' HB3' ' CD ' ' A' ' 60' ' ' PRO . 0.0 OUTLIER -99.22 -100.11 0.0 OUTLIER Pre-proline 0 C--N 1.305 -1.329 0 CA-C-O 114.575 -2.631 . . . . 3.55 109.558 -173.273 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.918 ' CD ' ' HB3' ' A' ' 59' ' ' LYS . 9.7 Cg_endo -49.84 127.04 17.99 Favored 'Trans proline' 0 N--CA 1.474 0.354 0 CA-C-N 127.036 3.549 . . . . 1.54 118.437 -176.024 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.47 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 5.0 t -145.3 -172.98 3.98 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 110.793 -2.912 . . . . 1.59 106.637 177.08 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 37.89 -162.49 0.01 OUTLIER Glycine 0 N--CA 1.485 1.932 0 N-CA-C 114.857 0.703 . . . . 2.43 114.857 175.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 71.2 m -82.78 51.8 1.98 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 120.438 -0.505 . . . . 4.11 109.887 178.459 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 112.66 2.26 25.71 Favored Glycine 0 CA--C 1.539 1.548 0 C-N-CA 120.742 -0.742 . . . . 2.21 113.467 -178.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.734 ' HA2' ' HA ' ' A' ' 75' ' ' SER . . . -98.62 129.14 9.8 Favored Glycine 0 N--CA 1.464 0.564 0 C-N-CA 120.646 -0.788 . . . . 1.62 112.461 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.677 ' HA ' ' O ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -78.62 150.36 32.71 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-O 121.039 0.447 . . . . 3.02 111.592 -177.749 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.486 ' HB3' ' HB2' ' A' ' 58' ' ' GLN . 9.1 t -70.77 109.54 5.03 Favored 'General case' 0 N--CA 1.397 -3.086 0 N-CA-C 109.24 -0.652 . . . . 1.52 109.24 -178.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.605 ' HB1' ' SG ' ' A' ' 28' ' ' CYS . . . -85.23 -21.5 29.07 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.775 0.798 . . . . 1.07 108.865 178.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.886 ' CB ' ' HA2' ' A' ' 33' ' ' GLY . . . -168.8 161.18 10.9 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.163 -1.381 . . . . 1.0 109.092 -178.248 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 1.007 ' HB2' ' HG3' ' A' ' 88' ' ' GLU . . . -55.01 140.18 38.55 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 118.176 0.444 . . . . 1.24 111.138 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.632 ' H ' ' CB ' ' A' ' 85' ' ' CYS . . . 75.14 -44.44 1.6 Allowed Glycine 0 CA--C 1.529 0.943 0 CA-C-N 116.202 -0.453 . . . . 1.28 113.779 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.876 HG21 ' HA3' ' B' ' 137' ' ' GLY . 1.6 pp -97.54 99.14 8.3 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.952 0 CA-C-O 122.142 0.973 . . . . 2.27 111.737 -177.391 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.487 ' SG ' ' HB3' ' A' ' 82' ' ' ASP . 34.2 m -93.21 104.26 16.46 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 115.531 -0.759 . . . . 1.98 109.302 179.536 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 1.027 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 33.8 m -84.7 124.63 31.73 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.439 -0.801 . . . . 1.33 112.459 -177.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.968 ' HB3' ' HD2' ' A' ' 76' ' ' PRO . 49.5 m -84.58 -178.52 1.19 Allowed Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 115.067 -0.97 . . . . 1.99 110.431 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.968 ' HD2' ' HB3' ' A' ' 75' ' ' SER . 74.1 Cg_endo -75.7 30.3 0.38 Allowed 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 121.672 1.581 . . . . 1.86 111.942 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.832 ' HB2' ' ND1' ' B' ' 180' ' ' HIS . 2.8 p30 -145.51 -28.41 0.44 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.602 -0.726 . . . . 2.65 110.536 179.362 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.781 ' HA3' ' O ' ' B' ' 179' ' ' CYS . . . -177.68 -133.17 1.81 Allowed Glycine 0 CA--C 1.521 0.437 0 C-N-CA 121.153 -0.546 . . . . 0.99 112.141 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 1.027 ' HA ' ' HA ' ' A' ' 74' ' ' CYS . 80.4 m -128.43 148.62 50.72 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 109.635 -0.506 . . . . 1.34 109.635 179.301 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.819 ' ND1' ' HB2' ' B' ' 177' ' ' ASP . 4.5 t60 -138.64 116.33 11.43 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 108.246 -1.02 . . . . 2.17 108.246 -173.708 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.593 ' HG3' ' O ' ' B' ' 177' ' ' ASP . 0.0 OUTLIER -57.31 117.5 4.16 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.803 0.811 . . . . 3.05 110.268 -178.701 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.63 ' OD1' ' HB3' ' A' ' 84' ' ' ALA . 0.3 OUTLIER -147.37 101.47 3.79 Favored Pre-proline 0 N--CA 1.439 -0.991 0 CA-C-N 114.285 -1.325 . . . . 2.02 108.951 -178.167 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -56.28 -2.19 0.37 Allowed 'Trans proline' 0 C--N 1.361 1.201 0 C-N-CA 123.142 2.561 . . . . 1.93 115.15 -177.165 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.63 ' HB3' ' OD1' ' A' ' 82' ' ' ASP . . . -65.84 -17.83 64.91 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 111.985 0.365 . . . . 1.53 111.985 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.802 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 13.2 m -99.69 7.01 45.49 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.329 0.862 . . . . 1.88 113.329 -178.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.513 ' N ' ' CD ' ' A' ' 87' ' ' PRO . 0.1 OUTLIER -69.39 -19.91 0.48 Allowed Pre-proline 0 C--N 1.327 -0.384 0 N-CA-C 115.448 1.647 . . . . 3.6 115.448 179.782 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.513 ' CD ' ' N ' ' A' ' 86' ' ' ASP . 5.9 Cg_endo -80.37 57.61 6.6 Favored 'Trans proline' 0 CA--C 1.483 -2.028 0 CA-C-N 121.552 1.59 . . . . 2.56 110.197 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 1.007 ' HG3' ' HB2' ' A' ' 70' ' ' ALA . 6.4 pt-20 174.42 -1.62 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 112.173 -2.285 . . . . 4.72 111.36 176.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.776 ' HB2' ' CB ' ' A' ' 70' ' ' ALA . . . -94.2 57.09 2.3 Favored 'General case' 0 N--CA 1.442 -0.853 0 O-C-N 121.479 -0.763 . . . . 5.29 111.83 179.358 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.48 179.84 0.07 Allowed 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 118.982 -1.087 . . . . 6.98 112.177 -172.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.637 ' CE1' HD22 ' B' ' 142' ' ' LEU . 0.6 OUTLIER -98.3 95.91 7.69 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 120.636 0.255 . . . . 10.21 110.347 175.988 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.215 -0.898 . . . . 11.77 110.958 -179.448 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.302 0 CA-C-O 121.39 0.614 . . . . 10.07 111.782 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -84.13 32.83 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.101 -0.954 . . . . 8.41 111.227 179.27 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 103' ' ' LEU . . . . . 1.017 HD21 ' HB3' ' B' ' 108' ' ' ARG . 6.8 tp -176.4 87.95 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 109.304 -0.628 . . . . 5.87 109.304 175.087 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.18 76.76 2.32 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 105.986 -1.857 . . . . 6.27 105.986 176.676 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 105' ' ' LEU . . . . . 0.878 HD11 ' C ' ' B' ' 107' ' ' VAL . 0.2 OUTLIER -159.42 -142.48 0.09 Allowed 'General case' 0 N--CA 1.399 -2.996 0 CA-C-N 111.7 -2.5 . . . . 7.2 106.431 -176.004 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 106' ' ' ASP . . . . . 0.804 ' H ' HD13 ' B' ' 105' ' ' LEU . 5.9 t70 -160.33 -46.55 0.05 OUTLIER 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 116.053 -0.522 . . . . 8.55 111.482 -178.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 107' ' ' VAL . . . . . 0.878 ' C ' HD11 ' B' ' 105' ' ' LEU . 6.2 p -134.67 117.73 24.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 101.393 -3.558 . . . . 7.48 101.393 172.183 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 108' ' ' ARG . . . . . 1.017 ' HB3' HD21 ' B' ' 103' ' ' LEU . 0.0 OUTLIER -77.84 108.18 10.89 Favored 'General case' 0 N--CA 1.4 -2.961 0 C-N-CA 120.19 -0.604 . . . . 9.12 111.684 -174.493 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 109' ' ' THR . . . . . 0.684 HG21 ' HD2' ' B' ' 151' ' ' PRO . 1.1 t -104.59 85.82 2.39 Favored 'General case' 0 N--CA 1.403 -2.783 1 N-CA-C 98.266 -4.716 . . . . 5.69 98.266 168.799 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 110' ' ' CYS . . . . . 0.569 ' HA ' ' HB2' ' B' ' 154' ' ' CYS . 0.8 OUTLIER -77.31 63.04 2.44 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 113.137 -1.847 . . . . 2.61 111.084 -176.675 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 111' ' ' LEU . . . . . 0.919 HD23 ' HB3' ' B' ' 121' ' ' CYS . 14.8 tp -39.89 113.67 0.92 Allowed Pre-proline 0 N--CA 1.47 0.529 0 CA-C-N 114.913 -1.04 . . . . 2.47 113.771 177.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 112' ' ' PRO . . . . . 0.402 ' HA ' ' O ' ' B' ' 119' ' ' GLY . 73.6 Cg_endo -83.85 152.61 13.0 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 122.515 2.143 . . . . 1.47 110.037 178.055 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.663 ' C ' ' HA2' ' B' ' 117' ' ' GLY . 0.5 OUTLIER -158.7 -170.87 3.21 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 118.88 -1.128 . . . . 1.0 113.182 172.275 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 114' ' ' GLY . . . . . 0.572 ' HA2' ' HB3' ' B' ' 140' ' ' GLU . . . 76.41 -156.15 46.35 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.482 -0.866 . . . . 1.16 111.478 178.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 115' ' ' PRO . . . . . 0.479 ' HG2' ' O ' ' B' ' 115' ' ' PRO . 41.2 Cg_endo -65.31 95.89 0.27 Allowed 'Trans proline' 0 N--CA 1.467 -0.085 0 C-N-CA 122.848 2.366 . . . . 1.57 113.12 178.22 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 82.9 3.24 90.58 Favored Glycine 0 C--N 1.28 -2.56 0 CA-C-N 114.963 -1.017 . . . . 1.7 112.944 -178.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 117' ' ' GLY . . . . . 0.663 ' HA2' ' C ' ' B' ' 113' ' ' CYS . . . 76.34 45.68 14.12 Favored Glycine 0 N--CA 1.402 -3.604 0 C-N-CA 120.955 -0.64 . . . . 1.38 114.131 178.145 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.39 -1.91 57.46 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 114.696 -0.752 . . . . 2.54 111.32 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 119' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' B' ' 112' ' ' PRO . . . -107.46 -156.22 19.86 Favored Glycine 0 C--N 1.343 0.92 0 N-CA-C 110.209 -1.156 . . . . 1.04 110.209 -179.591 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.8 ' HA ' ' O ' ' B' ' 111' ' ' LEU . 1.2 mtm180 -150.64 154.33 37.29 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 120.216 2.008 . . . . 2.89 106.302 176.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 121' ' ' CYS . . . . . 0.919 ' HB3' HD23 ' B' ' 111' ' ' LEU . 1.5 t -107.28 160.95 15.22 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 113.246 0.832 . . . . 1.07 113.246 -177.083 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 122' ' ' PHE . . . . . 0.533 ' HE1' ' O ' ' B' ' 128' ' ' CYS . 60.8 m-85 -126.43 -47.65 1.58 Allowed 'General case' 0 C--N 1.339 0.113 0 CA-C-N 115.34 -0.846 . . . . 1.53 110.107 179.52 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -117.29 -159.67 11.52 Favored Glycine 0 CA--C 1.52 0.381 0 CA-C-N 115.797 -0.638 . . . . 0.9 111.634 179.213 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -84.26 -68.15 0.01 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.344 2.029 . . . . 1.51 111.667 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 125' ' ' SER . . . . . 0.408 ' O ' ' N ' ' B' ' 137' ' ' GLY . 0.4 OUTLIER -89.49 26.65 1.65 Allowed 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 109.943 -0.391 . . . . 1.25 109.943 178.78 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 126' ' ' ILE . . . . . 0.945 HG12 HG13 ' B' ' 136' ' ' VAL . 7.0 mt -144.7 112.59 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 CA-C-O 121.751 0.786 . . . . 0.85 111.827 -178.231 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 127' ' ' CYS . . . . . 0.576 ' O ' ' HA ' ' B' ' 134' ' ' CYS . 4.6 t -126.45 131.38 51.69 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.112 -0.949 . . . . 0.89 109.234 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 128' ' ' CYS . . . . . 0.817 ' HA ' ' O ' ' B' ' 133' ' ' GLY . 0.0 OUTLIER -142.39 122.16 13.47 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 115.103 1.52 . . . . 1.23 115.103 -176.906 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 129' ' ' GLY . . . . . . . . . . . . . . . -111.46 -166.11 18.28 Favored Glycine 0 C--N 1.373 2.636 0 N-CA-C 108.173 -1.971 . . . . 0.66 108.173 175.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -65.4 -58.74 5.12 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 114.074 1.139 . . . . 2.35 114.074 -177.031 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.28 21.82 11.57 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.57 0.7 . . . . 1.69 109.921 -177.019 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 132' ' ' LEU . . . . . 0.929 HD22 ' CZ ' ' B' ' 135' ' ' PHE . 0.4 OUTLIER -114.6 -12.41 12.25 Favored 'General case' 0 N--CA 1.397 -3.085 0 N-CA-C 103.84 -2.652 . . . . 1.38 103.84 175.459 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 133' ' ' GLY . . . . . 0.917 ' HA2' ' CB ' ' B' ' 169' ' ' ALA . . . 57.97 -129.57 49.74 Favored Glycine 1 N--CA 1.394 -4.128 0 CA-C-O 117.249 -1.862 . . . . 0.72 112.989 174.572 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 134' ' ' CYS . . . . . 0.874 ' HB2' HD13 ' B' ' 172' ' ' ILE . 2.5 t -136.96 122.98 20.25 Favored 'General case' 0 CA--C 1.496 -1.116 0 CA-C-N 119.648 1.724 . . . . 1.08 113.696 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 135' ' ' PHE . . . . . 0.929 ' CZ ' HD22 ' B' ' 132' ' ' LEU . 0.0 OUTLIER -98.03 100.21 11.53 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 103.645 -2.724 . . . . 1.36 103.645 175.153 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 136' ' ' VAL . . . . . 0.945 HG13 HG12 ' B' ' 126' ' ' ILE . 2.2 t -92.09 83.14 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.368 0 CA-C-O 123.27 1.509 . . . . 0.75 107.093 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 137' ' ' GLY . . . . . 0.876 ' HA3' HG21 ' A' ' 72' ' ' ILE . . . 100.49 85.36 1.85 Allowed Glycine 0 CA--C 1.525 0.678 0 CA-C-N 112.43 -2.168 . . . . 0.83 113.719 -179.329 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 138' ' ' THR . . . . . 0.7 HG22 ' O ' ' A' ' 32' ' ' LEU . 67.8 p -157.74 166.53 32.54 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 108.895 -0.78 . . . . 0.78 108.895 179.124 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 139' ' ' ALA . . . . . 0.576 ' HA ' ' CD1' ' B' ' 142' ' ' LEU . . . -68.58 -24.54 64.61 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 119.294 0.952 . . . . 1.04 110.575 177.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 140' ' ' GLU . . . . . 0.572 ' HB3' ' HA2' ' B' ' 114' ' ' GLY . 3.3 mm-40 -66.81 -11.92 57.09 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.618 -1.173 . . . . 2.31 109.972 177.116 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 141' ' ' ALA . . . . . 0.491 ' O ' ' HB2' ' B' ' 144' ' ' CYS . . . -102.93 -22.57 13.81 Favored 'General case' 0 C--O 1.211 -0.944 0 C-N-CA 123.736 0.814 . . . . 0.87 109.611 178.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 142' ' ' LEU . . . . . 0.637 HD22 ' CE1' ' A' ' 91' ' ' PHE . 23.8 mt -44.85 -38.42 4.57 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.015 0.436 . . . . 1.24 111.855 -179.673 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 143' ' ' ARG . . . . . 0.705 ' HD3' ' O ' ' B' ' 143' ' ' ARG . 0.0 OUTLIER -71.43 -1.28 12.58 Favored 'General case' 0 C--O 1.247 0.963 0 CA-C-N 116.05 -0.523 . . . . 2.93 110.063 179.378 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 144' ' ' CYS . . . . . 0.491 ' HB2' ' O ' ' B' ' 141' ' ' ALA . 66.3 m -82.0 -5.5 58.39 Favored 'General case' 0 C--N 1.341 0.226 0 O-C-N 120.825 -1.172 . . . . 1.61 110.108 176.259 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -60.61 -16.7 41.05 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.619 -0.719 . . . . 3.35 110.113 178.469 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 146' ' ' GLU . . . . . 0.58 ' O ' HD13 ' B' ' 150' ' ' LEU . 14.0 tt0 -84.32 5.86 25.25 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 120.13 -0.628 . . . . 3.76 110.253 178.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 147' ' ' GLU . . . . . 0.59 ' HA ' ' HB2' ' B' ' 150' ' ' LEU . 17.4 tt0 -82.81 -1.06 50.72 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 116.038 -0.528 . . . . 4.01 109.892 177.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 148' ' ' ASN . . . . . . . . . . . . . 15.1 m-20 -73.86 -27.78 61.25 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 109.351 -0.611 . . . . 3.92 109.351 177.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -119.22 41.34 3.11 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.748 -0.66 . . . . 5.73 109.738 179.324 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 150' ' ' LEU . . . . . 0.59 ' HB2' ' HA ' ' B' ' 147' ' ' GLU . 0.8 OUTLIER -123.63 140.04 33.4 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 115.841 -0.618 . . . . 5.46 111.663 -179.001 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 151' ' ' PRO . . . . . 0.684 ' HD2' HG21 ' B' ' 109' ' ' THR . 2.7 Cg_exo -76.35 50.82 3.03 Favored 'Trans proline' 0 C--N 1.356 0.951 0 C-N-CA 122.84 2.36 . . . . 5.02 112.979 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 152' ' ' SER . . . . . 0.775 ' HB2' ' HD2' ' B' ' 153' ' ' PRO . 5.0 p 71.73 171.12 0.11 Allowed Pre-proline 0 N--CA 1.472 0.632 0 N-CA-C 112.414 0.524 . . . . 5.73 112.414 179.255 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 153' ' ' PRO . . . . . 0.775 ' HD2' ' HB2' ' B' ' 152' ' ' SER . 13.9 Cg_endo -57.02 -172.98 0.04 OUTLIER 'Trans proline' 0 C--N 1.361 1.187 0 C-N-CA 123.365 2.71 . . . . 5.1 115.208 -178.247 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 154' ' ' CYS . . . . . 0.569 ' HB2' ' HA ' ' B' ' 110' ' ' CYS . 1.0 OUTLIER -119.62 116.39 25.91 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 114.214 -1.357 . . . . 2.68 110.217 -178.997 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 155' ' ' GLN . . . . . 0.523 ' HG3' ' HA ' ' B' ' 103' ' ' LEU . 3.5 tt0 66.54 -165.48 0.22 Allowed 'General case' 0 N--CA 1.478 0.959 0 O-C-N 122.183 -0.323 . . . . 5.63 111.572 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 156' ' ' SER . . . . . 0.714 ' OG ' ' HG3' ' B' ' 159' ' ' LYS . 1.8 t -146.71 -35.09 0.26 Allowed 'General case' 0 C--N 1.351 0.642 0 N-CA-C 116.772 2.138 . . . . 3.11 116.772 -178.361 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 79.99 -113.76 3.72 Favored Glycine 0 CA--C 1.49 -1.509 0 O-C-N 119.487 -2.008 . . . . 2.07 113.301 173.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 158' ' ' GLN . . . . . 0.699 ' O ' ' HB3' ' B' ' 167' ' ' CYS . 3.3 mt-30 -113.67 96.07 5.67 Favored 'General case' 0 N--CA 1.413 -2.28 0 N-CA-C 106.931 -1.507 . . . . 4.34 106.931 177.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 159' ' ' LYS . . . . . 0.94 ' HB3' ' CD ' ' B' ' 160' ' ' PRO . 0.0 OUTLIER -69.6 -107.2 0.0 OUTLIER Pre-proline 0 CA--C 1.575 1.908 0 N-CA-C 114.196 1.184 . . . . 3.54 114.196 -177.153 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 160' ' ' PRO . . . . . 0.94 ' CD ' ' HB3' ' B' ' 159' ' ' LYS . 10.4 Cg_endo -50.58 126.8 18.94 Favored 'Trans proline' 0 C--N 1.363 1.336 0 N-CA-C 119.271 2.758 . . . . 1.51 119.271 -175.251 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 161' ' ' CYS . . . . . 0.491 ' HB3' ' HB3' ' B' ' 173' ' ' CYS . 6.5 t -149.05 -179.71 7.23 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 110.94 -2.846 . . . . 1.58 106.667 176.556 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 47.02 -164.61 0.13 Allowed Glycine 0 C--N 1.345 1.081 0 C-N-CA 119.818 -1.182 . . . . 2.37 114.434 178.436 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 69.5 m -84.3 48.85 1.55 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.67 0.748 . . . . 4.07 109.913 178.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 117.92 -1.58 17.35 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-N 115.166 -0.925 . . . . 2.2 113.654 178.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 165' ' ' GLY . . . . . 0.712 ' CA ' ' HA ' ' B' ' 175' ' ' SER . . . -97.27 132.4 10.97 Favored Glycine 0 C--N 1.339 0.696 0 C-N-CA 119.318 -1.42 . . . . 1.62 112.257 -176.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 166' ' ' ARG . . . . . 0.644 ' HA ' ' O ' ' B' ' 159' ' ' LYS . 0.0 OUTLIER -78.57 150.48 32.78 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.168 0.509 . . . . 3.05 111.841 -177.591 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 167' ' ' CYS . . . . . 0.699 ' HB3' ' O ' ' B' ' 158' ' ' GLN . 9.1 t -70.77 109.73 5.14 Favored 'General case' 0 N--CA 1.405 -2.702 0 CA-C-N 115.548 -0.751 . . . . 1.56 109.231 -179.206 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 168' ' ' ALA . . . . . 0.59 ' HB1' ' SG ' ' B' ' 128' ' ' CYS . . . -90.09 -14.28 34.08 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 121.583 0.706 . . . . 1.04 110.047 179.302 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 169' ' ' ALA . . . . . 0.917 ' CB ' ' HA2' ' B' ' 133' ' ' GLY . . . -172.71 161.62 4.82 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.854 -1.067 . . . . 0.98 108.785 177.634 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 170' ' ' ALA . . . . . 1.011 ' HB2' ' HG3' ' B' ' 188' ' ' GLU . . . -55.55 139.06 45.34 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 118.33 0.514 . . . . 1.25 111.361 179.397 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 171' ' ' GLY . . . . . 0.687 ' H ' ' CB ' ' B' ' 185' ' ' CYS . . . 67.73 -22.98 0.24 Allowed Glycine 0 CA--C 1.534 1.244 0 N-CA-C 116.35 1.3 . . . . 1.29 116.35 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 172' ' ' ILE . . . . . 0.874 HD13 ' HB2' ' B' ' 134' ' ' CYS . 1.7 pp -111.03 98.17 6.7 Favored 'Isoleucine or valine' 0 C--O 1.244 0.793 0 CA-C-N 118.586 1.193 . . . . 2.27 110.069 177.574 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 173' ' ' CYS . . . . . 0.491 ' HB3' ' HB3' ' B' ' 161' ' ' CYS . 33.9 m -93.0 104.3 16.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.421 -0.809 . . . . 1.94 109.311 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 174' ' ' CYS . . . . . 1.009 ' HA ' ' HA ' ' B' ' 179' ' ' CYS . 34.0 m -84.84 124.57 31.75 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.33 -0.85 . . . . 1.35 112.265 -177.681 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 175' ' ' SER . . . . . 0.923 ' HB3' ' HD2' ' B' ' 176' ' ' PRO . 49.5 m -84.47 -178.56 1.2 Allowed Pre-proline 0 CA--C 1.533 0.296 0 CA-C-N 115.075 -0.966 . . . . 2.0 110.515 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 176' ' ' PRO . . . . . 0.923 ' HD2' ' HB3' ' B' ' 175' ' ' SER . 73.9 Cg_endo -75.75 30.31 0.38 Allowed 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 121.675 1.583 . . . . 1.9 111.961 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 177' ' ' ASP . . . . . 0.819 ' HB2' ' ND1' ' A' ' 80' ' ' HIS . 2.8 p30 -145.38 -28.21 0.45 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.598 -0.728 . . . . 2.72 110.545 179.303 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 178' ' ' GLY . . . . . 0.826 ' HA3' ' O ' ' A' ' 79' ' ' CYS . . . -178.21 -132.65 1.74 Allowed Glycine 0 C--N 1.334 0.447 0 C-N-CA 121.21 -0.519 . . . . 0.99 112.183 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 179' ' ' CYS . . . . . 1.009 ' HA ' ' HA ' ' B' ' 174' ' ' CYS . 81.6 m -128.03 154.18 45.94 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 109.441 -0.577 . . . . 1.34 109.441 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 180' ' ' HIS . . . . . 0.832 ' ND1' ' HB2' ' A' ' 77' ' ' ASP . 4.0 t60 -147.29 115.37 6.54 Favored 'General case' 0 CA--C 1.499 -0.996 0 CA-C-O 121.913 0.863 . . . . 2.1 108.811 -173.365 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 181' ' ' GLU . . . . . 0.615 ' HG3' ' O ' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -56.73 117.41 3.89 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-N 114.246 -1.343 . . . . 3.06 110.274 -176.746 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 182' ' ' ASP . . . . . 0.615 ' OD1' ' HB3' ' B' ' 184' ' ' ALA . 0.3 OUTLIER -147.38 101.27 3.79 Favored Pre-proline 0 N--CA 1.437 -1.087 0 CA-C-N 114.063 -1.426 . . . . 2.06 108.929 -178.007 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 183' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -56.16 -2.22 0.36 Allowed 'Trans proline' 0 C--N 1.36 1.16 0 C-N-CA 123.229 2.619 . . . . 1.91 115.207 -177.247 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 184' ' ' ALA . . . . . 0.615 ' HB3' ' OD1' ' B' ' 182' ' ' ASP . . . -65.96 -17.93 65.0 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 111.983 0.364 . . . . 1.56 111.983 -179.489 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 185' ' ' CYS . . . . . 0.79 ' HB3' ' HA ' ' B' ' 170' ' ' ALA . 12.3 m -100.18 7.82 44.26 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 113.032 0.752 . . . . 1.94 113.032 -178.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 186' ' ' ASP . . . . . 0.525 ' N ' ' CD ' ' B' ' 187' ' ' PRO . 0.1 OUTLIER -69.25 -19.32 0.45 Allowed Pre-proline 0 C--N 1.328 -0.358 0 N-CA-C 115.027 1.491 . . . . 3.61 115.027 179.436 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 187' ' ' PRO . . . . . 0.525 ' CD ' ' N ' ' B' ' 186' ' ' ASP . 3.1 Cg_endo -77.0 45.97 1.82 Allowed 'Trans proline' 0 C--N 1.359 1.085 0 CA-C-N 121.45 1.554 . . . . 2.58 113.985 -179.232 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 188' ' ' GLU . . . . . 1.011 ' HG3' ' HB2' ' B' ' 170' ' ' ALA . 6.3 pt-20 -173.73 -11.68 0.01 OUTLIER 'General case' 0 C--N 1.285 -2.196 0 CA-C-N 109.913 -3.312 . . . . 4.7 113.742 -178.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 189' ' ' ALA . . . . . 0.782 ' HB2' ' CB ' ' B' ' 170' ' ' ALA . . . -87.44 64.21 8.06 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 123.351 0.661 . . . . 5.24 110.262 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 190' ' ' ALA . . . . . . . . . . . . . . . -66.74 178.68 1.25 Allowed 'General case' 0 C--N 1.353 0.739 0 O-C-N 120.549 -1.344 . . . . 6.93 112.74 -178.153 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 191' ' ' PHE . . . . . 0.66 ' CE1' HD22 ' A' ' 42' ' ' LEU . 0.6 OUTLIER -96.7 95.47 7.95 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.782 -0.645 . . . . 10.14 110.534 178.468 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.167 -0.92 . . . . 11.7 110.899 -179.547 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 120.883 0.373 . . . . 9.95 110.987 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.966 HG23 ' H ' ' A' ' 3' ' ' LEU . 4.3 m -81.64 -80.86 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 122.362 1.077 . . . . 8.02 113.158 -178.511 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.966 ' H ' HG23 ' A' ' 2' ' ' VAL . 0.2 OUTLIER -130.77 120.74 24.23 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 112.653 -2.067 . . . . 5.86 108.192 178.147 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.809 ' O ' ' HG3' ' A' ' 8' ' ' ARG . 10.5 m-20 -161.62 -174.25 4.14 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 111.287 -2.688 . . . . 6.22 107.915 177.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.3 tp -91.57 7.56 40.85 Favored 'General case' 0 CA--C 1.497 -1.068 0 C-N-CA 116.549 -2.06 . . . . 7.09 111.062 -175.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.776 ' O ' ' HG3' ' A' ' 55' ' ' GLN . 0.2 OUTLIER -77.28 -76.62 0.17 Allowed 'General case' 0 CA--C 1.493 -1.221 0 N-CA-C 102.809 -3.034 . . . . 8.78 102.809 -179.784 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.577 ' HA ' ' CB ' ' A' ' 55' ' ' GLN . 7.6 p -151.43 113.78 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.154 0 N-CA-C 104.926 -2.25 . . . . 7.51 104.926 169.558 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.872 ' HB2' ' H ' ' A' ' 55' ' ' GLN . 18.1 mtp180 -79.58 114.79 18.78 Favored 'General case' 0 CA--C 1.483 -1.608 0 N-CA-C 105.133 -2.173 . . . . 9.08 105.133 176.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.439 HG23 ' O ' ' A' ' 9' ' ' THR . 4.0 t -60.12 105.47 0.41 Allowed 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 115.144 -2.623 . . . . 5.66 107.988 -178.628 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.609 ' HB3' ' HB3' ' A' ' 20' ' ' ARG . 0.1 OUTLIER -79.29 114.51 18.29 Favored 'General case' 0 CA--C 1.548 0.898 0 CA-C-N 113.649 -1.614 . . . . 2.68 112.856 178.42 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.609 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 4.4 mm? 3.62 111.86 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.461 0 N-CA-C 113.202 0.816 . . . . 2.48 113.202 178.718 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.615 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 87.6 Cg_endo -79.32 123.98 5.74 Favored 'Trans proline' 0 C--N 1.357 1.019 0 C-N-CA 123.203 2.602 . . . . 1.49 115.866 -178.283 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.585 ' O ' ' HA2' ' A' ' 17' ' ' GLY . 26.8 p -129.83 -176.23 3.86 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.307 -0.86 . . . . 1.0 111.138 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.463 ' HA2' ' HG2' ' A' ' 40' ' ' GLU . . . 75.54 -161.45 52.7 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 120.312 -0.947 . . . . 1.15 112.43 -178.144 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 1.078 ' HD2' HD11 ' A' ' 32' ' ' LEU . 39.3 Cg_endo -64.95 95.04 0.24 Allowed 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 123.488 2.792 . . . . 1.57 113.108 178.698 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.51 -2.09 87.76 Favored Glycine 0 C--N 1.288 -2.129 0 CA-C-N 113.868 -1.515 . . . . 1.68 112.724 178.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.585 ' HA2' ' O ' ' A' ' 13' ' ' CYS . . . 84.28 35.69 14.2 Favored Glycine 0 N--CA 1.412 -2.934 0 C-N-CA 118.501 -1.809 . . . . 1.36 116.417 177.111 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.1 -31.71 61.25 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 112.941 -1.629 . . . . 2.5 107.237 175.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.615 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -79.09 175.04 55.25 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 113.099 -1.864 . . . . 1.02 112.891 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.609 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -139.8 162.99 33.82 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.955 -0.387 . . . . 2.92 109.955 179.749 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 15.6 t -108.66 143.17 38.09 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.438 0.637 . . . . 1.1 112.301 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -127.5 -54.12 1.35 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 114.78 -1.1 . . . . 1.51 108.834 178.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -95.95 149.79 19.43 Favored Glycine 0 C--N 1.331 0.298 0 N-CA-C 110.179 -1.168 . . . . 0.9 110.179 177.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -50.25 -48.21 20.92 Favored 'Trans proline' 0 CA--C 1.531 0.349 0 C-N-CA 121.849 1.699 . . . . 1.5 112.765 -179.056 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.16 4.06 41.67 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.603 0.24 . . . . 1.26 111.347 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.926 HG12 HG13 ' A' ' 36' ' ' VAL . 0.5 OUTLIER -119.83 122.8 69.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 113.309 0.855 . . . . 0.83 113.309 -178.016 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.463 ' HB3' ' OE1' ' A' ' 40' ' ' GLU . 0.1 OUTLIER -125.84 124.48 41.0 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.01 -0.541 . . . . 0.92 109.704 178.566 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.913 ' HB2' ' HB2' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -131.88 141.12 49.29 Favored 'General case' 0 CA--C 1.562 1.426 0 N-CA-C 114.296 1.221 . . . . 1.28 114.296 -177.594 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.743 ' O ' ' HB1' ' A' ' 69' ' ' ALA . . . -131.71 -174.2 13.57 Favored Glycine 0 C--N 1.369 2.396 0 CA-C-N 113.443 -1.708 . . . . 0.67 110.119 178.658 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.747 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 18.9 p-10 -63.17 -56.36 17.37 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 113.376 0.88 . . . . 2.27 113.376 -178.017 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.415 ' HG2' ' OD2' ' A' ' 30' ' ' ASP . 0.0 OUTLIER -113.21 5.54 17.03 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-O 121.435 0.636 . . . . 1.66 110.716 -175.798 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 1.078 HD11 ' HD2' ' A' ' 15' ' ' PRO . 0.3 OUTLIER -103.93 -10.24 18.3 Favored 'General case' 0 N--CA 1.419 -2.001 0 N-CA-C 106.272 -1.751 . . . . 1.37 106.272 177.638 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.875 ' O ' ' HB3' ' A' ' 28' ' ' CYS . . . 67.37 -98.09 0.43 Allowed Glycine 0 C--O 1.221 -0.717 0 N-CA-C 118.283 2.073 . . . . 0.73 118.283 172.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.97 ' HB2' HG13 ' A' ' 72' ' ' ILE . 6.0 t -169.25 106.64 0.4 Allowed 'General case' 0 C--N 1.354 0.789 0 CA-C-N 118.644 1.222 . . . . 1.08 109.314 176.577 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.564 ' HB3' ' CG2' ' A' ' 38' ' ' THR . 3.7 m-30 -89.16 105.24 17.66 Favored 'General case' 0 N--CA 1.427 -1.611 0 N-CA-C 106.036 -1.839 . . . . 1.38 106.036 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.926 HG13 HG12 ' A' ' 26' ' ' ILE . 1.5 t -94.69 88.62 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.195 0 CA-C-O 123.361 1.553 . . . . 0.76 108.72 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.822 ' O ' ' HA3' ' B' ' 133' ' ' GLY . . . 94.63 98.64 1.66 Allowed Glycine 0 C--O 1.228 -0.256 0 CA-C-N 111.633 -2.53 . . . . 0.81 115.979 179.307 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.565 HG21 ' CE1' ' B' ' 135' ' ' PHE . 0.7 OUTLIER 177.02 170.27 0.53 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.627 0.251 . . . . 0.77 111.057 177.339 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.805 ' HA ' HD12 ' A' ' 42' ' ' LEU . . . -58.97 -14.18 8.54 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.377 0.608 . . . . 1.02 110.547 178.231 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.587 ' OE2' HD22 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -73.21 -13.16 61.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.741 -1.118 . . . . 2.32 109.327 176.594 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.413 ' O ' ' HB2' ' A' ' 44' ' ' CYS . . . -105.87 -22.53 12.9 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 115.121 -0.945 . . . . 0.87 111.66 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.805 HD12 ' HA ' ' A' ' 39' ' ' ALA . 3.4 mt -44.25 -39.3 4.36 Favored 'General case' 0 C--N 1.344 0.368 0 N-CA-C 113.177 0.806 . . . . 1.23 113.177 -178.669 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' A' ' 43' ' ' ARG . 3.6 mmp_? -58.36 -19.33 34.58 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.275 0.559 . . . . 2.92 109.768 179.203 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.642 ' O ' ' N ' ' A' ' 47' ' ' GLU . 97.2 m -65.13 -45.64 84.23 Favored 'General case' 0 C--O 1.223 -0.294 0 N-CA-C 108.533 -0.914 . . . . 1.57 108.533 177.279 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.449 ' HB2' ' O ' ' A' ' 42' ' ' LEU . 75.3 mm-40 -28.98 -37.75 0.01 OUTLIER 'General case' 0 CA--C 1.551 0.996 0 CA-C-N 113.721 -1.581 . . . . 3.31 113.03 -178.411 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -87.43 -3.11 59.01 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 119.593 -0.843 . . . . 3.69 111.518 -179.142 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.642 ' N ' ' O ' ' A' ' 44' ' ' CYS . 1.1 tt0 -81.05 -0.29 39.17 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 115.441 -0.8 . . . . 3.99 109.574 178.24 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -64.27 -28.18 69.55 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.647 -0.501 . . . . 3.86 109.647 178.18 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -112.89 47.97 1.06 Allowed 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.254 -0.43 . . . . 5.68 111.091 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.8 mt -143.89 88.23 7.74 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-N 116.335 -0.393 . . . . 5.4 111.094 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -91.19 31.93 0.32 Allowed 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.637 2.225 . . . . 4.92 113.16 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -92.46 118.78 68.19 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.679 -0.237 . . . . 5.64 110.991 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -80.3 116.86 3.38 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.28 1.987 . . . . 5.04 113.062 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.777 ' HA ' ' CD ' ' A' ' 8' ' ' ARG . 28.9 p -86.13 153.46 22.06 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 115.77 -0.65 . . . . 2.74 111.113 179.34 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.872 ' H ' ' HB2' ' A' ' 8' ' ' ARG . 2.4 tt0 -12.46 -81.35 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 114.761 1.393 . . . . 5.75 114.761 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.601 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 0.6 OUTLIER 86.82 -101.93 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.678 0.791 . . . . 3.12 111.259 -178.478 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 113.84 -63.84 0.29 Allowed Glycine 0 CA--C 1.496 -1.102 0 C-N-CA 120.428 -0.891 . . . . 2.1 112.66 178.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -114.45 127.71 55.97 Favored 'General case' 0 N--CA 1.419 -1.983 0 N-CA-C 104.956 -2.238 . . . . 4.36 104.956 177.355 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.94 ' O ' ' HA ' ' A' ' 66' ' ' ARG . 2.0 mtmp? -120.22 -100.14 0.0 OUTLIER Pre-proline 0 C--N 1.285 -2.239 0 CA-C-O 114.201 -2.809 . . . . 3.55 105.47 -176.13 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.797 ' CD ' ' HB3' ' A' ' 59' ' ' LYS . 56.5 Cg_endo -71.34 138.48 33.02 Favored 'Trans proline' 0 C--N 1.318 -1.066 0 CA-C-N 128.211 3.968 . . . . 1.54 115.569 -178.705 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.51 ' O ' ' SG ' ' A' ' 73' ' ' CYS . 20.6 p -143.18 146.02 33.33 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 114.432 -1.258 . . . . 1.59 110.363 177.085 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.56 -164.05 51.19 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 119.165 -1.493 . . . . 2.43 112.951 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.4 m -76.82 49.62 0.65 Allowed 'General case' 0 CA--C 1.553 1.072 0 N-CA-C 113.119 0.785 . . . . 4.11 113.119 -178.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 110.03 49.81 0.71 Allowed Glycine 0 N--CA 1.475 1.275 0 N-CA-C 115.466 0.947 . . . . 2.21 115.466 174.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.467 ' O ' ' SG ' ' A' ' 61' ' ' CYS . . . -152.3 120.73 1.1 Allowed Glycine 0 N--CA 1.475 1.259 0 C-N-CA 119.415 -1.374 . . . . 1.62 114.041 -179.351 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.94 ' HA ' ' O ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -83.81 152.76 24.44 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 118.83 1.315 . . . . 3.02 112.697 -177.251 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 20.3 t -65.32 103.1 0.75 Allowed 'General case' 0 N--CA 1.414 -2.234 0 N-CA-C 107.188 -1.412 . . . . 1.52 107.188 -179.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.769 ' HB3' ' HB ' ' A' ' 72' ' ' ILE . . . -80.14 -35.91 35.97 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-N 114.776 -1.102 . . . . 1.07 108.953 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.913 ' HB2' ' HB2' ' A' ' 28' ' ' CYS . . . -169.98 165.27 9.53 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.463 -0.94 . . . . 1.0 108.463 -179.509 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.747 ' HB3' ' O ' ' A' ' 30' ' ' ASP . . . -40.67 96.0 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.107 0 CA-C-O 122.33 1.062 . . . . 1.24 110.648 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.639 ' C ' HD13 ' A' ' 72' ' ' ILE . . . 93.75 11.51 57.86 Favored Glycine 0 N--CA 1.428 -1.855 0 CA-C-O 117.085 -1.953 . . . . 1.28 117.578 177.184 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.97 HG13 ' HB2' ' A' ' 34' ' ' CYS . 3.6 mm -109.53 104.15 16.61 Favored 'Isoleucine or valine' 0 C--N 1.361 1.084 0 CA-C-N 123.303 3.551 . . . . 2.27 108.247 178.275 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.853 ' HB2' ' HB3' ' A' ' 82' ' ' ASP . 6.3 t -89.01 92.53 9.26 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 109.21 -0.663 . . . . 1.98 109.21 -179.131 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 1.314 ' CB ' ' HA ' ' A' ' 79' ' ' CYS . 31.6 p -163.51 176.3 9.87 Favored 'General case' 0 C--O 1.225 -0.227 0 N-CA-C 115.329 1.603 . . . . 1.33 115.329 -177.496 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.941 ' HB2' ' HD2' ' A' ' 76' ' ' PRO . 73.2 p -109.33 -178.81 0.59 Allowed Pre-proline 0 N--CA 1.472 0.644 0 CA-C-N 114.051 -1.432 . . . . 1.99 110.414 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.941 ' HD2' ' HB2' ' A' ' 75' ' ' SER . 71.8 Cg_endo -76.23 30.56 0.39 Allowed 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 121.908 1.739 . . . . 1.86 112.606 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.564 ' HA ' ' OE1' ' B' ' 181' ' ' GLU . 4.8 t70 -140.65 -51.13 0.46 Allowed 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.053 -0.521 . . . . 2.65 109.787 179.049 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.894 ' O ' ' HB2' ' A' ' 74' ' ' CYS . . . -119.65 179.92 16.59 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-O 119.44 -0.644 . . . . 0.99 112.382 178.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 1.314 ' HA ' ' CB ' ' A' ' 74' ' ' CYS . 12.8 m -150.52 160.98 43.4 Favored 'General case' 0 C--N 1.348 0.521 0 N-CA-C 113.105 0.78 . . . . 1.34 113.105 179.096 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.692 ' HB2' ' O ' ' A' ' 73' ' ' CYS . 50.3 m80 -151.9 139.36 19.54 Favored 'General case' 0 C--N 1.353 0.735 0 C-N-CA 119.921 -0.712 . . . . 2.17 112.054 -178.487 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -65.55 120.11 12.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.043 -0.526 . . . . 3.05 109.965 178.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.853 ' HB3' ' HB2' ' A' ' 73' ' ' CYS . 0.0 OUTLIER -143.91 101.87 4.92 Favored Pre-proline 0 CA--C 1.537 0.459 0 CA-C-N 116.505 -0.316 . . . . 2.02 110.511 -179.219 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -65.79 -8.48 19.72 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 123.115 2.543 . . . . 1.93 113.831 -178.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.616 ' O ' ' HB2' ' A' ' 89' ' ' ALA . . . -67.89 -39.04 83.71 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.784 0.661 . . . . 1.53 112.784 -178.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.699 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 0.5 OUTLIER -94.87 -4.82 46.28 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 112.613 0.597 . . . . 1.88 112.613 -178.694 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.716 ' HB3' ' HD3' ' A' ' 87' ' ' PRO . 1.6 t70 -69.35 -60.69 3.84 Favored Pre-proline 0 N--CA 1.47 0.532 0 N-CA-C 112.636 0.606 . . . . 3.6 112.636 -177.231 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.716 ' HD3' ' HB3' ' A' ' 86' ' ' ASP . 59.0 Cg_endo -103.44 -158.38 0.03 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 123.575 2.85 . . . . 2.56 112.792 -178.609 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.452 ' C ' ' H ' ' A' ' 90' ' ' ALA . 10.8 pt-20 -60.85 86.61 0.01 OUTLIER 'General case' 0 N--CA 1.423 -1.81 0 CA-C-O 124.128 1.918 . . . . 4.72 110.648 178.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.616 ' HB2' ' O ' ' A' ' 84' ' ' ALA . . . -81.69 45.04 0.86 Allowed 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 109.407 -3.542 . . . . 5.29 105.308 175.552 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.452 ' H ' ' C ' ' A' ' 88' ' ' GLU . . . -84.14 125.79 32.49 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 113.68 -1.6 . . . . 6.98 113.163 -172.005 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -81.0 97.32 7.44 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 120.074 1.306 . . . . 10.21 111.894 -177.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 7.2 t . . . . . 0 C--O 1.25 1.108 0 CA-C-O 118.231 -0.89 . . . . 11.77 110.731 179.505 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 101' ' ' ALA . . . . . 0.415 ' C ' HD13 ' B' ' 103' ' ' LEU . . . . . . . . 0 N--CA 1.494 1.755 0 CA-C-O 120.467 0.175 . . . . 10.07 111.411 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 102' ' ' VAL . . . . . 0.479 ' O ' HG12 ' B' ' 102' ' ' VAL . 4.2 t 75.14 43.49 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 CA-C-O 121.863 0.839 . . . . 8.41 112.372 179.15 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 103' ' ' LEU . . . . . 0.841 ' H ' HD22 ' B' ' 103' ' ' LEU . 0.0 OUTLIER -115.11 111.94 21.81 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 105.029 -2.211 . . . . 5.87 105.029 172.878 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 104' ' ' ASP . . . . . 0.702 ' O ' ' HG3' ' B' ' 108' ' ' ARG . 35.0 m-20 -161.92 -172.99 3.48 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 113.67 -1.605 . . . . 6.27 108.12 179.141 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 105' ' ' LEU . . . . . 0.469 HD12 ' HA ' ' B' ' 105' ' ' LEU . 6.8 tp -87.81 6.44 35.26 Favored 'General case' 0 CA--C 1.511 -0.551 0 C-N-CA 114.547 -2.861 . . . . 7.2 110.153 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 106' ' ' ASP . . . . . 0.744 ' O ' ' HG3' ' B' ' 155' ' ' GLN . 0.6 OUTLIER -76.93 -76.42 0.17 Allowed 'General case' 0 CA--C 1.48 -1.735 0 N-CA-C 102.728 -3.064 . . . . 8.55 102.728 -179.199 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 107' ' ' VAL . . . . . 0.552 ' HA ' ' CB ' ' B' ' 155' ' ' GLN . 3.8 p -151.24 113.44 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.482 -1.667 0 N-CA-C 104.238 -2.504 . . . . 7.48 104.238 169.558 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 108' ' ' ARG . . . . . 0.898 ' HB2' ' H ' ' B' ' 155' ' ' GLN . 17.9 mtp180 -79.04 115.32 18.64 Favored 'General case' 0 CA--C 1.48 -1.746 0 N-CA-C 105.433 -2.062 . . . . 9.12 105.433 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 109' ' ' THR . . . . . 0.427 ' O ' HG23 ' B' ' 109' ' ' THR . 4.3 t -59.94 105.84 0.43 Allowed 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 115.097 -2.641 . . . . 5.69 108.006 -178.448 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 110' ' ' CYS . . . . . 0.588 ' HB3' ' HB3' ' B' ' 120' ' ' ARG . 0.1 OUTLIER -80.38 111.42 16.76 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 113.354 -1.748 . . . . 2.61 113.157 178.914 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 111' ' ' LEU . . . . . 0.604 ' O ' ' HA ' ' B' ' 120' ' ' ARG . 4.4 mm? 6.01 111.74 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.523 0 N-CA-C 113.027 0.751 . . . . 2.47 113.027 178.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 112' ' ' PRO . . . . . 0.599 ' HA ' ' O ' ' B' ' 119' ' ' GLY . 92.8 Cg_endo -80.18 122.63 4.76 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 123.071 2.514 . . . . 1.47 116.219 -178.294 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.59 ' O ' ' HA2' ' B' ' 117' ' ' GLY . 27.0 p -127.32 -176.16 3.66 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.043 -0.981 . . . . 1.0 111.264 179.122 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 114' ' ' GLY . . . . . 0.462 ' HA2' ' HG2' ' B' ' 140' ' ' GLU . . . 75.59 -161.38 52.6 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 120.484 -0.865 . . . . 1.16 112.43 -178.246 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 115' ' ' PRO . . . . . 1.045 ' HD2' HD11 ' B' ' 132' ' ' LEU . 38.7 Cg_endo -64.64 95.83 0.24 Allowed 'Trans proline' 0 N--CA 1.479 0.62 0 C-N-CA 123.624 2.882 . . . . 1.57 112.676 178.338 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 83.17 -2.94 86.15 Favored Glycine 0 C--N 1.29 -2.012 0 CA-C-N 114.13 -1.396 . . . . 1.7 112.781 178.068 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 117' ' ' GLY . . . . . 0.59 ' HA2' ' O ' ' B' ' 113' ' ' CYS . . . 84.79 35.84 12.59 Favored Glycine 0 N--CA 1.415 -2.754 0 C-N-CA 118.593 -1.765 . . . . 1.38 116.185 176.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 118' ' ' LYS . . . . . 0.423 ' H ' ' HG2' ' B' ' 118' ' ' LYS . 0.1 OUTLIER -74.91 -32.57 61.83 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 112.849 -1.675 . . . . 2.54 106.959 176.216 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 119' ' ' GLY . . . . . 0.599 ' O ' ' HA ' ' B' ' 112' ' ' PRO . . . -79.29 178.44 53.66 Favored Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 113.286 -1.779 . . . . 1.04 112.878 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.604 ' HA ' ' O ' ' B' ' 111' ' ' LEU . 0.0 OUTLIER -141.76 162.7 34.84 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.272 -0.27 . . . . 2.89 110.272 -179.766 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 121' ' ' CYS . . . . . . . . . . . . . 15.3 t -108.66 143.16 38.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.404 0.621 . . . . 1.07 112.305 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -127.47 -54.21 1.35 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.801 -1.09 . . . . 1.53 108.862 178.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -95.96 149.78 19.43 Favored Glycine 0 C--N 1.332 0.325 0 N-CA-C 110.194 -1.162 . . . . 0.9 110.194 177.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -50.29 -48.33 20.47 Favored 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 121.786 1.657 . . . . 1.51 112.804 -179.12 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 125' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -100.7 3.79 42.62 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.563 0.22 . . . . 1.25 111.339 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 126' ' ' ILE . . . . . 0.903 HG12 HG13 ' B' ' 136' ' ' VAL . 0.6 OUTLIER -119.73 122.8 69.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 113.359 0.874 . . . . 0.85 113.359 -177.968 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 127' ' ' CYS . . . . . 0.437 ' HB3' ' OE1' ' B' ' 140' ' ' GLU . 0.1 OUTLIER -125.14 124.47 41.89 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 109.733 -0.469 . . . . 0.89 109.733 178.689 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 128' ' ' CYS . . . . . 0.937 ' HB2' ' HB2' ' B' ' 169' ' ' ALA . 0.0 OUTLIER -130.45 142.95 50.48 Favored 'General case' 0 CA--C 1.551 1.006 0 N-CA-C 114.277 1.214 . . . . 1.23 114.277 -177.627 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 129' ' ' GLY . . . . . 0.741 ' O ' ' HB1' ' B' ' 169' ' ' ALA . . . -132.05 -173.34 13.3 Favored Glycine 0 C--N 1.359 1.838 0 N-CA-C 110.066 -1.214 . . . . 0.66 110.066 178.146 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 130' ' ' ASP . . . . . 0.75 ' O ' ' HB3' ' B' ' 170' ' ' ALA . 19.5 p-10 -63.73 -56.21 17.34 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 113.231 0.826 . . . . 2.35 113.231 -178.538 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 131' ' ' GLU . . . . . 0.42 ' HG2' ' OD2' ' B' ' 130' ' ' ASP . 0.0 OUTLIER -120.51 27.7 8.41 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.507 -0.745 . . . . 1.69 110.41 -179.806 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 132' ' ' LEU . . . . . 1.045 HD11 ' HD2' ' B' ' 115' ' ' PRO . 0.3 OUTLIER -122.46 -8.14 8.61 Favored 'General case' 0 N--CA 1.406 -2.672 0 N-CA-C 102.68 -3.081 . . . . 1.38 102.68 177.246 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 133' ' ' GLY . . . . . 0.888 ' O ' ' HB3' ' B' ' 128' ' ' CYS . . . 62.79 -94.15 0.11 Allowed Glycine 0 N--CA 1.426 -2.028 0 N-CA-C 118.973 2.349 . . . . 0.72 118.973 170.738 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 134' ' ' CYS . . . . . 0.988 ' HB2' HG13 ' B' ' 172' ' ' ILE . 6.1 t -170.02 106.85 0.34 Allowed 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 119.878 1.839 . . . . 1.08 109.453 176.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 135' ' ' PHE . . . . . 0.572 ' HB3' ' CG2' ' B' ' 138' ' ' THR . 3.6 m-30 -89.72 105.36 17.75 Favored 'General case' 0 N--CA 1.425 -1.683 0 N-CA-C 106.065 -1.828 . . . . 1.36 106.065 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 136' ' ' VAL . . . . . 0.903 HG13 HG12 ' B' ' 126' ' ' ILE . 1.7 t -94.64 89.12 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.197 0 CA-C-O 123.289 1.519 . . . . 0.75 108.561 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 137' ' ' GLY . . . . . 0.651 ' O ' ' HA3' ' A' ' 33' ' ' GLY . . . 93.94 98.83 1.57 Allowed Glycine 0 C--O 1.227 -0.309 0 CA-C-N 111.597 -2.547 . . . . 0.83 115.994 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 138' ' ' THR . . . . . 0.572 ' CG2' ' HB3' ' B' ' 135' ' ' PHE . 0.7 OUTLIER 177.0 170.55 0.52 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.651 0.262 . . . . 0.78 111.102 177.349 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 139' ' ' ALA . . . . . 0.8 ' HA ' HD12 ' B' ' 142' ' ' LEU . . . -58.81 -15.18 11.13 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 121.406 0.622 . . . . 1.04 110.654 178.119 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 140' ' ' GLU . . . . . 0.594 ' OE2' HD22 ' B' ' 132' ' ' LEU . 0.0 OUTLIER -72.65 -12.9 61.23 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.702 -1.135 . . . . 2.31 109.494 176.767 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 141' ' ' ALA . . . . . 0.406 ' O ' ' HB2' ' B' ' 144' ' ' CYS . . . -105.98 -22.72 12.82 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 115.169 -0.923 . . . . 0.87 111.643 -179.499 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 142' ' ' LEU . . . . . 0.8 HD12 ' HA ' ' B' ' 139' ' ' ALA . 3.6 mt -44.01 -39.28 4.01 Favored 'General case' 0 C--N 1.345 0.38 0 N-CA-C 113.176 0.806 . . . . 1.24 113.176 -178.718 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 143' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -58.17 -19.78 35.78 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.361 0.6 . . . . 2.93 109.769 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 144' ' ' CYS . . . . . 0.629 ' O ' ' N ' ' B' ' 147' ' ' GLU . 99.3 m -64.81 -45.77 84.83 Favored 'General case' 0 C--O 1.223 -0.3 0 N-CA-C 108.535 -0.913 . . . . 1.61 108.535 177.408 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 145' ' ' GLN . . . . . 0.451 ' HB2' ' O ' ' B' ' 142' ' ' LEU . 75.0 mm-40 -28.85 -37.75 0.01 OUTLIER 'General case' 0 CA--C 1.551 0.981 0 CA-C-N 113.668 -1.605 . . . . 3.35 113.05 -178.381 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -87.45 -3.1 59.01 Favored 'General case' 0 N--CA 1.477 0.905 0 O-C-N 121.253 -0.905 . . . . 3.76 111.5 -179.152 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 147' ' ' GLU . . . . . 0.629 ' N ' ' O ' ' B' ' 144' ' ' CYS . 1.1 tt0 -81.11 -0.26 39.28 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.433 -0.803 . . . . 4.01 109.54 178.243 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 148' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -64.2 -28.24 69.61 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.692 -0.484 . . . . 3.92 109.692 178.141 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -112.77 47.89 1.06 Allowed 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.151 -0.477 . . . . 5.73 111.116 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 6.0 mt -143.86 88.27 7.75 Favored Pre-proline 0 CA--C 1.533 0.311 0 CA-C-N 116.394 -0.366 . . . . 5.46 111.073 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 151' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -91.25 31.91 0.32 Allowed 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.702 2.268 . . . . 5.02 113.167 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -92.48 118.78 68.18 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.657 -0.247 . . . . 5.73 111.009 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 153' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -80.26 116.91 3.39 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.242 1.961 . . . . 5.1 113.126 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 154' ' ' CYS . . . . . 0.78 ' HA ' ' CD ' ' B' ' 108' ' ' ARG . 28.7 p -86.15 153.5 22.02 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 115.735 -0.666 . . . . 2.68 111.127 179.388 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 155' ' ' GLN . . . . . 0.898 ' H ' ' HB2' ' B' ' 108' ' ' ARG . 2.4 tt0 -12.45 -81.19 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 114.853 1.427 . . . . 5.63 114.853 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 156' ' ' SER . . . . . 0.6 ' HB2' ' O ' ' B' ' 155' ' ' GLN . 0.6 OUTLIER 86.79 -100.12 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.673 0.789 . . . . 3.11 111.417 -178.617 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 111.44 -63.81 0.27 Allowed Glycine 0 C--N 1.338 0.675 0 C-N-CA 120.509 -0.853 . . . . 2.07 113.202 179.006 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 158' ' ' GLN . . . . . 0.584 ' O ' ' HB3' ' B' ' 167' ' ' CYS . 8.5 mt-30 -115.8 108.09 15.88 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 107.887 -1.153 . . . . 4.34 107.887 178.497 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 159' ' ' LYS . . . . . 0.889 ' O ' ' HA ' ' B' ' 166' ' ' ARG . 3.6 mtmp? -90.72 -103.75 0.0 OUTLIER Pre-proline 0 C--N 1.3 -1.577 0 CA-C-O 118.753 -0.641 . . . . 3.54 110.341 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 160' ' ' PRO . . . . . 0.854 ' HD3' ' HB3' ' B' ' 159' ' ' LYS . 57.6 Cg_endo -71.64 138.07 31.38 Favored 'Trans proline' 0 C--N 1.353 0.803 0 CA-C-N 122.231 1.833 . . . . 1.51 115.088 -179.051 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 161' ' ' CYS . . . . . 0.491 ' O ' ' SG ' ' B' ' 173' ' ' CYS . 20.1 p -142.78 146.68 34.48 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 114.155 -1.384 . . . . 1.58 110.013 177.281 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 69.64 -164.99 50.7 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 119.352 -1.404 . . . . 2.37 112.666 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 1.6 m -76.74 51.31 0.75 Allowed 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 123.872 0.869 . . . . 4.07 112.493 179.071 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 107.92 49.19 0.85 Allowed Glycine 0 N--CA 1.466 0.648 0 N-CA-C 115.913 1.125 . . . . 2.2 115.913 172.324 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 165' ' ' GLY . . . . . 0.489 ' O ' ' N ' ' B' ' 161' ' ' CYS . . . -150.95 122.98 1.44 Allowed Glycine 0 N--CA 1.469 0.878 0 C-N-CA 119.525 -1.321 . . . . 1.62 113.607 179.271 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 166' ' ' ARG . . . . . 0.889 ' HA ' ' O ' ' B' ' 159' ' ' LYS . 0.0 OUTLIER -84.36 152.78 23.86 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 118.841 1.321 . . . . 3.05 112.528 -178.398 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 167' ' ' CYS . . . . . 0.584 ' HB3' ' O ' ' B' ' 158' ' ' GLN . 20.0 t -65.29 103.04 0.73 Allowed 'General case' 0 N--CA 1.416 -2.171 0 N-CA-C 107.175 -1.417 . . . . 1.56 107.175 -179.608 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 168' ' ' ALA . . . . . 0.762 ' HB3' ' HB ' ' B' ' 172' ' ' ILE . . . -80.42 -35.09 35.61 Favored 'General case' 0 N--CA 1.424 -1.771 0 CA-C-N 114.676 -1.147 . . . . 1.04 108.969 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 169' ' ' ALA . . . . . 0.937 ' HB2' ' HB2' ' B' ' 128' ' ' CYS . . . -170.57 165.26 8.39 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 108.326 -0.99 . . . . 0.98 108.326 -179.509 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 170' ' ' ALA . . . . . 0.75 ' HB3' ' O ' ' B' ' 130' ' ' ASP . . . -40.76 96.07 0.01 OUTLIER 'General case' 0 C--O 1.232 0.152 0 CA-C-O 122.239 1.018 . . . . 1.25 110.622 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 171' ' ' GLY . . . . . 0.66 ' C ' HD13 ' B' ' 172' ' ' ILE . . . 93.7 11.5 57.92 Favored Glycine 0 N--CA 1.427 -1.932 0 CA-C-O 116.883 -2.065 . . . . 1.29 117.557 177.227 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 172' ' ' ILE . . . . . 0.988 HG13 ' HB2' ' B' ' 134' ' ' CYS . 3.2 mm -109.59 104.35 16.93 Favored 'Isoleucine or valine' 0 C--N 1.365 1.262 0 CA-C-N 123.685 3.743 . . . . 2.27 108.124 178.298 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 173' ' ' CYS . . . . . 0.829 ' HB2' ' HB3' ' B' ' 182' ' ' ASP . 6.3 t -88.99 92.43 9.23 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 109.156 -0.683 . . . . 1.94 109.156 -179.128 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 174' ' ' CYS . . . . . 1.308 ' CB ' ' HA ' ' B' ' 179' ' ' CYS . 31.0 p -163.34 176.17 10.13 Favored 'General case' 0 C--O 1.226 -0.162 0 N-CA-C 115.458 1.651 . . . . 1.35 115.458 -177.381 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 175' ' ' SER . . . . . 0.944 ' HB2' ' HD2' ' B' ' 176' ' ' PRO . 73.7 p -109.31 -178.86 0.6 Allowed Pre-proline 0 N--CA 1.47 0.557 0 CA-C-N 114.187 -1.369 . . . . 2.0 110.441 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 176' ' ' PRO . . . . . 0.944 ' HD2' ' HB2' ' B' ' 175' ' ' SER . 71.6 Cg_endo -76.11 30.47 0.39 Allowed 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 121.913 1.742 . . . . 1.9 112.675 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 177' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -140.68 -51.16 0.46 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.086 -0.506 . . . . 2.72 109.769 179.103 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 178' ' ' GLY . . . . . 0.904 ' O ' ' HB2' ' B' ' 174' ' ' CYS . . . -119.65 179.99 16.59 Favored Glycine 0 N--CA 1.445 -0.759 0 CA-C-O 119.412 -0.66 . . . . 0.99 112.18 178.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 179' ' ' CYS . . . . . 1.308 ' HA ' ' CB ' ' B' ' 174' ' ' CYS . 12.5 m -150.47 161.1 43.18 Favored 'General case' 0 C--N 1.346 0.447 0 N-CA-C 113.165 0.802 . . . . 1.34 113.165 179.137 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 180' ' ' HIS . . . . . 0.698 ' HB2' ' O ' ' B' ' 173' ' ' CYS . 49.2 m80 -151.98 139.18 19.28 Favored 'General case' 0 C--N 1.354 0.775 0 C-N-CA 119.786 -0.765 . . . . 2.1 111.998 -178.322 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 181' ' ' GLU . . . . . 0.564 ' OE1' ' HA ' ' A' ' 77' ' ' ASP . 27.8 mt-10 -65.43 120.05 12.12 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 116.028 -0.533 . . . . 3.06 110.072 178.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 182' ' ' ASP . . . . . 0.829 ' HB3' ' HB2' ' B' ' 173' ' ' CYS . 0.0 OUTLIER -143.81 101.86 4.96 Favored Pre-proline 0 CA--C 1.536 0.413 0 CA-C-N 116.612 -0.267 . . . . 2.06 110.535 -179.187 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 183' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -65.88 -8.37 19.54 Favored 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 123.214 2.609 . . . . 1.91 113.859 -178.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 184' ' ' ALA . . . . . 0.615 ' O ' ' HB2' ' B' ' 189' ' ' ALA . . . -67.97 -39.11 83.4 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.78 0.659 . . . . 1.56 112.78 -179.079 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 185' ' ' CYS . . . . . 0.704 ' O ' ' HA ' ' B' ' 170' ' ' ALA . 0.6 OUTLIER -94.78 -4.73 46.74 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.592 0.59 . . . . 1.94 112.592 -178.744 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 186' ' ' ASP . . . . . 0.715 ' HB3' ' HD3' ' B' ' 187' ' ' PRO . 1.6 t70 -69.32 -60.69 3.86 Favored Pre-proline 0 N--CA 1.47 0.565 0 N-CA-C 112.659 0.614 . . . . 3.61 112.659 -177.268 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 187' ' ' PRO . . . . . 0.715 ' HD3' ' HB3' ' B' ' 186' ' ' ASP . 58.3 Cg_endo -103.34 -158.62 0.03 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.201 0 C-N-CA 123.518 2.812 . . . . 2.58 112.747 -178.672 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 188' ' ' GLU . . . . . 0.427 ' C ' ' H ' ' B' ' 190' ' ' ALA . 11.2 pt-20 -60.54 88.23 0.02 OUTLIER 'General case' 0 N--CA 1.422 -1.832 0 CA-C-O 124.493 2.092 . . . . 4.7 109.834 177.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 189' ' ' ALA . . . . . 0.615 ' HB2' ' O ' ' B' ' 184' ' ' ALA . . . -83.01 45.18 0.99 Allowed 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 108.751 -3.84 . . . . 5.24 105.109 174.733 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 190' ' ' ALA . . . . . 0.427 ' H ' ' C ' ' B' ' 188' ' ' GLU . . . -84.19 127.24 33.81 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 113.781 -1.554 . . . . 6.93 112.983 -171.05 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 191' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -81.45 97.76 7.92 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 121.222 1.828 . . . . 10.14 111.957 -178.152 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 7.2 t . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.353 -0.832 . . . . 11.7 110.819 179.535 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.284 0 CA-C-O 121.299 0.571 . . . . 9.95 111.616 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.1 t -134.09 55.26 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.135 0 CA-C-N 115.222 -0.899 . . . . 8.02 112.02 178.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.999 HD22 ' H ' ' A' ' 54' ' ' CYS . 0.2 OUTLIER -149.05 18.59 0.98 Allowed 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 116.374 1.99 . . . . 5.86 116.374 175.576 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.66 ' O ' ' HB2' ' A' ' 55' ' ' GLN . 2.4 t70 -39.28 -99.0 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 112.731 0.641 . . . . 6.22 112.731 -177.439 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 1.105 HD13 ' HG3' ' A' ' 55' ' ' GLN . 19.8 tp -148.51 23.06 1.02 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 117.286 -1.765 . . . . 7.09 114.073 -178.783 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.39 -83.59 0.1 Allowed 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 104.72 -2.326 . . . . 8.78 104.72 176.703 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.423 ' O ' HG13 ' A' ' 7' ' ' VAL . 9.1 p -128.98 118.56 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.706 0 N-CA-C 102.778 -3.045 . . . . 7.51 102.778 174.461 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.937 ' HD3' ' H ' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -77.69 109.34 11.6 Favored 'General case' 0 N--CA 1.417 -2.123 0 N-CA-C 108.368 -0.975 . . . . 9.08 108.368 -177.439 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.9 m -75.53 93.33 2.99 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 116.134 -2.226 . . . . 5.66 105.564 177.459 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.858 ' HB3' ' CG ' ' A' ' 20' ' ' ARG . 61.1 m -81.75 112.84 19.28 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 113.094 -1.866 . . . . 2.68 113.682 -178.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.662 HD23 ' HB2' ' A' ' 21' ' ' CYS . 16.3 tp -35.08 111.8 0.44 Allowed Pre-proline 0 N--CA 1.489 1.516 0 C-N-CA 123.223 0.609 . . . . 2.48 112.625 177.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.908 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 44.9 Cg_endo -86.99 144.21 7.12 Favored 'Trans proline' 0 C--N 1.357 1.012 0 C-N-CA 122.971 2.447 . . . . 1.49 116.992 -177.295 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.555 ' N ' ' O ' ' A' ' 19' ' ' GLY . 27.3 p -149.1 -170.24 3.58 Favored 'General case' 0 C--N 1.355 0.81 0 CA-C-N 115.961 -0.563 . . . . 1.0 109.79 178.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.832 ' CA ' ' HG2' ' A' ' 40' ' ' GLU . . . 75.45 -161.27 52.71 Favored Glycine 0 C--N 1.335 0.51 0 N-CA-C 115.256 0.862 . . . . 1.15 115.256 176.697 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.46 ' HG2' ' O ' ' A' ' 15' ' ' PRO . 38.0 Cg_endo -64.5 102.54 0.41 Allowed 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 124.027 3.151 . . . . 1.57 111.502 178.533 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 86.1 -0.98 87.72 Favored Glycine 0 C--N 1.265 -3.385 0 CA-C-N 112.028 -2.351 . . . . 1.68 112.761 -179.179 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.817 ' O ' ' HB2' ' A' ' 12' ' ' PRO . . . 72.43 43.03 46.9 Favored Glycine 0 N--CA 1.405 -3.385 0 C-N-CA 118.988 -1.577 . . . . 1.36 114.49 173.618 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.92 -41.13 9.33 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 114.29 -0.955 . . . . 2.5 110.416 177.367 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.908 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -71.38 169.02 50.3 Favored Glycine 0 C--O 1.194 -2.351 0 N-CA-C 116.272 1.269 . . . . 1.02 116.272 -174.692 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.858 ' CG ' ' HB3' ' A' ' 10' ' ' CYS . 4.2 mpp_? -104.14 160.83 14.53 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 112.747 -1.727 . . . . 2.92 114.926 -172.325 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.662 ' HB2' HD23 ' A' ' 11' ' ' LEU . 5.1 m -106.91 136.94 45.91 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 114.794 -1.093 . . . . 1.1 111.597 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -145.69 24.43 1.37 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.32 -0.855 . . . . 1.51 110.137 179.206 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 152.28 161.52 10.26 Favored Glycine 0 CA--C 1.521 0.422 0 N-CA-C 111.164 -0.775 . . . . 0.9 111.164 -179.353 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.661 ' HD2' ' OE2' ' B' ' 181' ' ' GLU . 31.8 Cg_exo -58.7 -64.01 0.12 Allowed 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 121.703 1.602 . . . . 1.5 112.335 -179.532 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.456 ' O ' ' N ' ' A' ' 37' ' ' GLY . 3.3 m -90.47 39.5 0.98 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.704 0.288 . . . . 1.26 110.289 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.971 HG12 HG13 ' A' ' 36' ' ' VAL . 3.0 mt -155.28 121.19 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 O-C-N 122.114 -0.366 . . . . 0.83 111.612 -179.276 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -137.86 110.16 7.38 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 120.877 0.37 . . . . 0.92 110.714 179.282 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.811 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -116.5 155.34 28.81 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 113.46 0.911 . . . . 1.28 113.46 179.025 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.516 ' O ' ' HB2' ' A' ' 69' ' ' ALA . . . -149.67 -174.61 21.19 Favored Glycine 0 C--N 1.371 2.494 0 N-CA-C 108.259 -1.936 . . . . 0.67 108.259 177.033 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -67.8 -41.73 82.68 Favored 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 125.892 1.677 . . . . 2.27 115.328 -179.028 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -122.83 13.23 9.89 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 114.209 -1.359 . . . . 1.66 111.424 178.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.688 HD23 ' CE1' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -120.25 -7.2 9.83 Favored 'General case' 0 N--CA 1.393 -3.323 0 N-CA-C 108.541 -0.911 . . . . 1.37 108.541 -178.383 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.972 ' HA2' ' CB ' ' A' ' 69' ' ' ALA . . . 49.83 -135.71 25.02 Favored Glycine 0 C--O 1.198 -2.103 0 CA-C-O 116.504 -2.276 . . . . 0.73 109.561 179.372 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 1.082 ' HB2' HD13 ' A' ' 72' ' ' ILE . 0.7 OUTLIER -128.71 130.46 47.18 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 121.495 2.648 . . . . 1.08 111.674 -179.842 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.688 ' CE1' HD23 ' A' ' 32' ' ' LEU . 1.3 m-85 -104.12 101.76 11.5 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 102.139 -3.282 . . . . 1.38 102.139 173.469 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.971 HG13 HG12 ' A' ' 26' ' ' ILE . 2.5 t -92.72 93.97 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.312 0 CA-C-O 123.694 1.711 . . . . 0.76 110.066 -177.113 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.779 ' HA3' ' CG2' ' B' ' 172' ' ' ILE . . . 83.18 80.37 1.0 Allowed Glycine 0 C--N 1.319 -0.379 0 CA-C-N 111.826 -2.443 . . . . 0.81 113.257 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.616 HG21 ' CE1' ' B' ' 135' ' ' PHE . 70.7 p -160.76 -167.31 1.82 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.11 0.481 . . . . 0.77 110.361 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.762 ' HA ' HD12 ' A' ' 42' ' ' LEU . . . -62.14 -40.5 96.15 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 108.817 -0.809 . . . . 1.02 108.817 179.365 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.832 ' HG2' ' CA ' ' A' ' 14' ' ' GLY . 0.4 OUTLIER -55.9 -26.4 47.21 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 114.986 -1.006 . . . . 2.32 112.38 179.655 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.493 ' O ' ' N ' ' A' ' 44' ' ' CYS . . . -91.63 -35.37 14.26 Favored 'General case' 0 C--O 1.213 -0.845 0 CA-C-N 116.197 -0.456 . . . . 0.87 110.268 -179.675 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.762 HD12 ' HA ' ' A' ' 39' ' ' ALA . 7.9 mt -39.57 -54.31 2.0 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 114.866 1.432 . . . . 1.23 114.866 -175.483 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.564 ' HD2' ' H ' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -54.75 -23.6 18.61 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 119.982 -0.687 . . . . 2.92 109.763 178.171 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.493 ' N ' ' O ' ' A' ' 41' ' ' ALA . 4.9 t -69.43 17.77 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 112.823 0.675 . . . . 1.57 112.823 -177.586 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.515 ' H ' ' C ' ' A' ' 43' ' ' ARG . 1.3 tt0 -75.22 -28.84 60.08 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 114.312 -1.313 . . . . 3.31 107.99 176.726 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -82.33 9.95 7.96 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.224 -0.898 . . . . 3.69 110.837 179.255 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.464 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . 0.9 OUTLIER -81.43 -0.91 43.68 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 109.745 -0.465 . . . . 3.99 109.745 177.584 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 20.6 p-10 -76.83 -27.53 55.19 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.401 -0.363 . . . . 3.86 110.118 178.525 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -108.9 15.31 23.57 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.431 -0.349 . . . . 5.68 111.823 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.12 90.22 7.49 Favored Pre-proline 0 CA--C 1.533 0.294 0 N-CA-C 111.584 0.216 . . . . 5.4 111.584 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -91.67 50.47 0.67 Allowed 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 122.804 2.336 . . . . 4.92 112.493 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.83 119.16 73.86 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 116.184 -0.462 . . . . 5.64 111.796 -179.443 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.965 ' HG2' HD13 ' A' ' 3' ' ' LEU . 84.4 Cg_endo -79.48 -48.25 0.08 OUTLIER 'Trans proline' 0 C--N 1.355 0.92 0 C-N-CA 122.248 1.965 . . . . 5.04 113.197 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.999 ' H ' HD22 ' A' ' 3' ' ' LEU . 5.3 p 55.29 125.22 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.781 0.833 . . . . 2.74 112.295 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 1.105 ' HG3' HD13 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -61.62 92.45 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 120.156 -0.617 . . . . 5.75 112.021 -179.533 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.689 ' HB2' ' HG3' ' A' ' 8' ' ' ARG . 0.1 OUTLIER 167.24 131.93 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 122.976 0.511 . . . . 3.12 110.548 179.039 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.632 ' O ' ' HG3' ' A' ' 66' ' ' ARG . . . 99.18 32.14 5.93 Favored Glycine 0 C--N 1.345 1.033 0 C-N-CA 120.566 -0.826 . . . . 2.1 112.348 177.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -122.04 76.09 1.27 Allowed 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 121.908 0.861 . . . . 4.36 111.173 179.384 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.836 ' HB2' ' HB2' ' A' ' 67' ' ' CYS . 1.6 mmtp -133.41 69.59 77.16 Favored Pre-proline 0 C--N 1.313 -1.01 0 N-CA-C 106.734 -1.58 . . . . 3.55 106.734 178.517 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.704 ' HA ' ' O ' ' A' ' 65' ' ' GLY . 14.4 Cg_endo -56.9 82.38 0.04 OUTLIER 'Trans proline' 0 C--N 1.368 1.582 0 C-N-CA 123.901 3.068 . . . . 1.54 117.754 -176.413 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -101.8 -178.35 3.69 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 106.181 -1.785 . . . . 1.59 106.181 173.164 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.09 -167.15 53.14 Favored Glycine 0 C--N 1.339 0.734 0 C-N-CA 119.205 -1.474 . . . . 2.43 112.372 -179.13 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.6 p -83.04 41.79 0.77 Allowed 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 120.818 -0.353 . . . . 4.11 110.412 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 117.12 9.68 10.41 Favored Glycine 0 CA--C 1.538 1.492 0 CA-C-O 117.124 -1.931 . . . . 2.21 116.204 179.503 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.704 ' O ' ' HA ' ' A' ' 60' ' ' PRO . . . -102.64 156.3 18.31 Favored Glycine 0 C--N 1.345 1.081 0 CA-C-N 121.767 2.783 . . . . 1.62 113.554 179.147 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.632 ' HG3' ' O ' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -99.21 151.86 20.54 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 111.849 0.314 . . . . 3.02 111.849 179.415 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.836 ' HB2' ' HB2' ' A' ' 59' ' ' LYS . 1.3 m -71.59 106.85 4.18 Favored 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 109.557 -0.534 . . . . 1.52 109.557 178.729 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.557 ' HB1' ' HB2' ' A' ' 28' ' ' CYS . . . -89.03 -22.04 23.17 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 107.935 -1.135 . . . . 1.07 107.935 177.088 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.972 ' CB ' ' HA2' ' A' ' 33' ' ' GLY . . . -161.7 162.37 29.75 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 112.342 -2.208 . . . . 1.0 113.937 -175.073 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.648 ' HA ' ' O ' ' A' ' 85' ' ' CYS . . . -58.63 122.99 14.81 Favored 'General case' 0 CA--C 1.527 0.092 0 N-CA-C 113.05 0.759 . . . . 1.24 113.05 -178.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.686 ' HA2' ' O ' ' A' ' 82' ' ' ASP . . . 71.33 15.96 75.18 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-N 115.671 -0.695 . . . . 1.28 114.189 178.637 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 1.082 HD13 ' HB2' ' A' ' 34' ' ' CYS . 1.2 pp -141.73 98.29 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-N 113.932 -1.134 . . . . 2.27 112.733 -178.489 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.562 ' HB2' ' HB3' ' A' ' 82' ' ' ASP . 5.0 t -99.57 85.41 3.13 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 114.021 -1.445 . . . . 1.98 110.224 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 1.049 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 1.8 m -93.88 146.06 24.17 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.258 -0.428 . . . . 1.33 111.169 -179.192 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.906 ' HB2' ' HD2' ' A' ' 76' ' ' PRO . 53.9 p -109.56 -179.62 0.7 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.84 -0.618 . . . . 1.99 110.029 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.906 ' HD2' ' HB2' ' A' ' 75' ' ' SER . 77.1 Cg_endo -77.67 29.42 0.44 Allowed 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 121.695 1.596 . . . . 1.86 111.436 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.447 ' H ' ' C ' ' A' ' 75' ' ' SER . 0.6 OUTLIER -144.66 -29.44 0.47 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.218 -0.901 . . . . 2.65 110.113 179.41 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.515 ' O ' ' HB3' ' A' ' 74' ' ' CYS . . . -166.91 -145.89 4.65 Favored Glycine 0 CA--C 1.524 0.615 0 CA-C-N 115.977 -0.556 . . . . 0.99 112.603 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 1.049 ' HA ' ' HA ' ' A' ' 74' ' ' CYS . 11.9 t -146.62 159.16 43.8 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 109.808 -0.441 . . . . 1.34 109.808 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 55.3 m-70 -149.67 135.16 18.37 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 120.04 -0.664 . . . . 2.17 110.358 -176.545 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.701 ' HG3' HD11 ' B' ' 126' ' ' ILE . 2.6 mt-10 -60.79 132.13 52.9 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 109.712 -0.477 . . . . 3.05 109.712 179.5 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.686 ' O ' ' HA2' ' A' ' 71' ' ' GLY . 0.1 OUTLIER -140.01 112.8 7.52 Favored Pre-proline 0 CA--C 1.545 0.788 0 CA-C-N 116.355 -0.384 . . . . 2.02 110.755 -178.557 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 82' ' ' ASP . 13.9 Cg_exo -70.87 -21.11 28.75 Favored 'Trans proline' 0 C--N 1.359 1.09 0 C-N-CA 122.831 2.354 . . . . 1.93 113.862 -178.363 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.83 -39.75 94.97 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.718 0.294 . . . . 1.53 111.485 -179.42 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.648 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 68.4 m -97.95 -0.54 44.64 Favored 'General case' 0 C--O 1.215 -0.739 0 N-CA-C 112.681 0.623 . . . . 1.88 112.681 -179.486 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.554 ' HA ' ' N ' ' A' ' 71' ' ' GLY . 0.8 OUTLIER -66.48 -56.3 15.95 Favored Pre-proline 0 C--N 1.319 -0.719 0 N-CA-C 112.82 0.674 . . . . 3.6 112.82 -176.58 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.515 ' HD3' ' CB ' ' A' ' 86' ' ' ASP . 10.3 Cg_endo -92.79 -162.69 0.1 Allowed 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 122.874 2.383 . . . . 2.56 113.072 -179.385 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.505 ' C ' ' H ' ' A' ' 90' ' ' ALA . 0.0 OUTLIER -83.97 50.84 1.91 Allowed 'General case' 0 C--N 1.286 -2.181 0 CA-C-N 110.882 -2.872 . . . . 4.72 107.621 172.967 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -76.19 33.15 0.12 Allowed 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.264 0.554 . . . . 5.29 109.603 176.046 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.505 ' H ' ' C ' ' A' ' 88' ' ' GLU . . . -53.62 111.5 0.74 Allowed 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.278 -0.874 . . . . 6.98 113.204 -176.356 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -86.99 128.06 35.08 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 115.383 -0.826 . . . . 10.21 111.406 -179.689 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 10.8 m . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.184 -0.912 . . . . 11.77 111.316 179.507 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 101' ' ' ALA . . . . . 0.616 ' O ' HG12 ' B' ' 102' ' ' VAL . . . . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.661 0.267 . . . . 10.07 111.183 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 102' ' ' VAL . . . . . 0.924 HG22 ' H ' ' B' ' 103' ' ' LEU . 9.7 p 52.25 -153.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-N 115.441 -0.799 . . . . 8.41 109.911 -178.396 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 103' ' ' LEU . . . . . 0.924 ' H ' HG22 ' B' ' 102' ' ' VAL . 3.1 mm? -59.73 94.74 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 O-C-N 122.111 -0.368 . . . . 5.87 110.971 -179.665 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 104' ' ' ASP . . . . . 0.592 ' O ' ' HB2' ' B' ' 155' ' ' GLN . 0.6 OUTLIER -73.46 -93.69 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 107.293 -1.373 . . . . 6.27 107.293 176.398 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 105' ' ' LEU . . . . . 0.814 HD13 ' HG3' ' B' ' 155' ' ' GLN . 17.2 tp -149.4 28.98 0.79 Allowed 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 116.546 -2.062 . . . . 7.2 114.691 -179.617 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 106' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -81.25 -108.67 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 104.046 -2.575 . . . . 8.55 104.046 177.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 107' ' ' VAL . . . . . 0.417 ' O ' HG13 ' B' ' 107' ' ' VAL . 8.2 p -106.86 120.34 57.96 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.91 0 N-CA-C 101.991 -3.337 . . . . 7.48 101.991 171.774 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 108' ' ' ARG . . . . . 0.92 ' HD3' ' H ' ' B' ' 108' ' ' ARG . 0.0 OUTLIER -77.75 108.66 11.14 Favored 'General case' 0 N--CA 1.411 -2.381 0 N-CA-C 108.494 -0.928 . . . . 9.12 108.494 -178.368 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 109' ' ' THR . . . . . 0.644 ' H ' ' CD1' ' B' ' 103' ' ' LEU . 4.8 m -74.77 93.67 2.64 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 116.163 -2.215 . . . . 5.69 105.606 177.318 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 110' ' ' CYS . . . . . 0.842 ' HB3' ' CG ' ' B' ' 120' ' ' ARG . 59.3 m -82.47 111.57 18.61 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 113.102 -1.863 . . . . 2.61 113.806 -178.644 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 111' ' ' LEU . . . . . 0.668 ' O ' ' HA ' ' B' ' 120' ' ' ARG . 16.5 tp -34.3 111.58 0.4 Allowed Pre-proline 0 N--CA 1.491 1.579 0 C-N-CA 123.162 0.585 . . . . 2.47 112.553 178.262 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 112' ' ' PRO . . . . . 0.922 ' HA ' ' O ' ' B' ' 119' ' ' GLY . 68.5 Cg_endo -83.12 147.88 13.13 Favored 'Trans proline' 0 C--N 1.359 1.101 0 C-N-CA 122.811 2.341 . . . . 1.47 115.442 -177.551 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.513 ' C ' ' HA2' ' B' ' 117' ' ' GLY . 28.0 p -152.06 -170.43 3.64 Favored 'General case' 0 C--O 1.254 1.31 0 CA-C-N 115.378 -0.828 . . . . 1.0 110.081 174.745 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 114' ' ' GLY . . . . . 0.81 ' CA ' ' HG2' ' B' ' 140' ' ' GLU . . . 75.79 -160.34 51.62 Favored Glycine 0 C--N 1.343 0.969 0 CA-C-N 114.712 -1.131 . . . . 1.16 115.094 176.143 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 115' ' ' PRO . . . . . 0.48 ' HG2' ' O ' ' B' ' 115' ' ' PRO . 35.5 Cg_endo -64.6 106.46 0.74 Allowed 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 124.067 3.178 . . . . 1.57 110.56 178.157 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 87.03 -11.88 63.7 Favored Glycine 0 C--N 1.257 -3.848 0 CA-C-N 112.211 -2.268 . . . . 1.7 111.174 -179.057 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 117' ' ' GLY . . . . . 0.755 ' O ' ' HB2' ' B' ' 112' ' ' PRO . . . 72.53 52.84 9.37 Favored Glycine 0 N--CA 1.399 -3.791 0 C-N-CA 119.596 -1.288 . . . . 1.38 113.488 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.05 -53.82 3.82 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 104.722 -2.325 . . . . 2.54 104.722 173.084 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 119' ' ' GLY . . . . . 0.922 ' O ' ' HA ' ' B' ' 112' ' ' PRO . . . -58.64 176.3 2.31 Favored Glycine 0 C--O 1.206 -1.643 0 CA-C-N 114.007 -1.451 . . . . 1.04 115.111 -167.279 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.842 ' CG ' ' HB3' ' B' ' 110' ' ' CYS . 4.7 mpp_? -113.83 163.68 14.74 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 114.081 1.141 . . . . 2.89 114.081 -173.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 121' ' ' CYS . . . . . 0.658 ' HB2' HD23 ' B' ' 111' ' ' LEU . 6.8 m -106.86 137.23 45.3 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.521 -1.218 . . . . 1.07 112.034 -179.059 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -145.68 24.35 1.37 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.186 -0.915 . . . . 1.53 110.171 179.017 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 152.29 161.52 10.26 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 111.196 -0.762 . . . . 0.9 111.196 -179.362 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 124' ' ' PRO . . . . . 0.635 ' HD2' ' OE2' ' A' ' 81' ' ' GLU . 32.0 Cg_exo -58.59 -64.11 0.12 Allowed 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 121.749 1.633 . . . . 1.51 112.286 -179.495 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 125' ' ' SER . . . . . 0.455 ' O ' ' N ' ' B' ' 137' ' ' GLY . 3.2 m -90.58 39.62 0.98 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.665 0.269 . . . . 1.25 110.33 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 126' ' ' ILE . . . . . 1.006 HG12 HG13 ' B' ' 136' ' ' VAL . 3.3 mt -155.07 121.11 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 O-C-N 122.242 -0.286 . . . . 0.85 111.707 -179.21 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 127' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -138.06 110.02 7.23 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.054 0.454 . . . . 0.89 110.755 179.107 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 128' ' ' CYS . . . . . 0.806 ' HA ' ' O ' ' B' ' 133' ' ' GLY . 0.0 OUTLIER -112.51 157.59 20.95 Favored 'General case' 0 CA--C 1.562 1.417 0 C-N-CA 123.836 0.854 . . . . 1.23 112.647 178.764 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 129' ' ' GLY . . . . . 0.502 ' O ' ' HB2' ' B' ' 169' ' ' ALA . . . -152.56 -175.48 24.15 Favored Glycine 0 C--N 1.38 2.985 0 N-CA-C 109.512 -1.435 . . . . 0.66 109.512 176.047 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -68.28 -45.79 72.12 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.871 1.268 . . . . 2.35 113.068 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.15 25.22 7.9 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-N 114.286 -1.325 . . . . 1.69 110.756 179.34 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 132' ' ' LEU . . . . . 0.688 HD23 ' CE1' ' B' ' 135' ' ' PHE . 0.2 OUTLIER -126.74 -10.81 6.13 Favored 'General case' 0 N--CA 1.401 -2.919 0 CA-C-N 113.427 -1.715 . . . . 1.38 109.573 179.643 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 133' ' ' GLY . . . . . 0.93 ' HA2' ' CB ' ' B' ' 169' ' ' ALA . . . 53.97 -125.06 32.04 Favored Glycine 0 N--CA 1.414 -2.828 0 CA-C-O 116.212 -2.438 . . . . 0.72 112.29 177.247 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 134' ' ' CYS . . . . . 1.091 ' HB2' HD13 ' B' ' 172' ' ' ILE . 0.8 OUTLIER -141.09 125.9 18.06 Favored 'General case' 0 CA--C 1.496 -1.099 0 CA-C-N 121.693 2.746 . . . . 1.08 112.261 176.211 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 135' ' ' PHE . . . . . 0.688 ' CE1' HD23 ' B' ' 132' ' ' LEU . 1.2 m-85 -101.13 101.93 12.77 Favored 'General case' 0 N--CA 1.425 -1.724 0 N-CA-C 102.266 -3.235 . . . . 1.36 102.266 175.782 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 136' ' ' VAL . . . . . 1.006 HG13 HG12 ' B' ' 126' ' ' ILE . 3.1 t -92.53 91.92 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.345 0 CA-C-O 123.317 1.532 . . . . 0.75 110.28 -177.014 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 137' ' ' GLY . . . . . 0.95 ' HA3' HG21 ' A' ' 72' ' ' ILE . . . 85.48 79.88 1.14 Allowed Glycine 0 CA--C 1.507 -0.44 0 CA-C-N 111.941 -2.39 . . . . 0.83 112.998 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 138' ' ' THR . . . . . 0.639 HG22 ' O ' ' A' ' 32' ' ' LEU . 76.4 p -155.96 -159.96 0.96 Allowed 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.427 0.632 . . . . 0.78 111.582 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 139' ' ' ALA . . . . . 0.725 ' HA ' HD12 ' B' ' 142' ' ' LEU . . . -68.67 -41.39 79.35 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.459 -1.246 . . . . 1.04 108.353 176.071 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 140' ' ' GLU . . . . . 0.81 ' HG2' ' CA ' ' B' ' 114' ' ' GLY . 0.3 OUTLIER -54.1 -30.24 47.82 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.093 -1.412 . . . . 2.31 112.248 179.081 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 141' ' ' ALA . . . . . 0.479 ' O ' ' N ' ' B' ' 144' ' ' CYS . . . -88.85 -35.71 16.41 Favored 'General case' 0 C--O 1.207 -1.178 0 N-CA-C 110.3 -0.259 . . . . 0.87 110.3 -178.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 142' ' ' LEU . . . . . 0.725 HD12 ' HA ' ' B' ' 139' ' ' ALA . 6.2 mt -39.04 -54.75 1.67 Allowed 'General case' 0 C--O 1.24 0.566 0 N-CA-C 113.832 1.049 . . . . 1.24 113.832 -173.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 143' ' ' ARG . . . . . 0.562 ' HD2' ' H ' ' B' ' 143' ' ' ARG . 0.0 OUTLIER -55.59 -22.09 20.46 Favored 'General case' 0 CA--C 1.497 -1.094 0 C-N-CA 120.037 -0.665 . . . . 2.93 109.851 177.81 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 144' ' ' CYS . . . . . 0.49 ' SG ' ' HB2' ' B' ' 147' ' ' GLU . 6.7 t -75.46 29.64 0.1 Allowed 'General case' 0 CA--C 1.497 -1.064 0 C-N-CA 119.763 -0.775 . . . . 1.61 111.529 -178.335 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -84.71 -22.37 29.76 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 106.516 -1.661 . . . . 3.35 106.516 175.009 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -82.07 9.35 8.65 Favored 'General case' 0 C--N 1.343 0.283 0 CA-C-N 115.314 -0.857 . . . . 3.76 110.106 178.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 147' ' ' GLU . . . . . 0.49 ' HB2' ' SG ' ' B' ' 144' ' ' CYS . 0.9 OUTLIER -81.4 -0.71 42.68 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.771 -0.455 . . . . 4.01 109.771 177.537 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 148' ' ' ASN . . . . . . . . . . . . . 20.6 p-10 -77.02 -27.53 54.6 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 116.389 -0.369 . . . . 3.92 110.085 178.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -108.94 15.25 23.58 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.403 -0.362 . . . . 5.73 111.789 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.1 90.19 7.51 Favored Pre-proline 0 CA--C 1.533 0.307 0 N-CA-C 111.563 0.209 . . . . 5.46 111.563 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 151' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -91.64 50.52 0.68 Allowed 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 122.742 2.295 . . . . 5.02 112.489 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.82 119.16 73.88 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 116.145 -0.48 . . . . 5.73 111.8 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 153' ' ' PRO . . . . . 0.64 ' HG3' HG11 ' B' ' 102' ' ' VAL . 90.3 Cg_endo -79.48 -48.18 0.08 OUTLIER 'Trans proline' 0 C--N 1.356 0.925 0 C-N-CA 122.303 2.002 . . . . 5.1 113.174 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 154' ' ' CYS . . . . . 0.867 ' HA ' ' CB ' ' B' ' 103' ' ' LEU . 5.4 p 55.27 123.6 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.702 0.801 . . . . 2.68 112.596 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 155' ' ' GLN . . . . . 0.814 ' HG3' HD13 ' B' ' 105' ' ' LEU . 0.0 OUTLIER -59.46 92.04 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 119.623 -0.831 . . . . 5.63 112.376 -179.678 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 156' ' ' SER . . . . . 0.699 ' HB2' ' HG3' ' B' ' 108' ' ' ARG . 0.2 OUTLIER 165.36 125.77 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 112.116 0.414 . . . . 3.11 112.116 178.903 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 157' ' ' GLY . . . . . 0.614 ' O ' ' HG3' ' B' ' 166' ' ' ARG . . . 105.13 33.0 3.84 Favored Glycine 0 CA--C 1.505 -0.593 0 C-N-CA 120.611 -0.804 . . . . 2.07 112.479 179.603 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -122.15 67.42 0.93 Allowed 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 121.655 0.74 . . . . 4.34 111.858 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 159' ' ' LYS . . . . . 0.965 ' HB2' ' HB2' ' B' ' 167' ' ' CYS . 2.0 mmtp -115.71 67.54 2.83 Favored Pre-proline 0 CA--C 1.539 0.529 0 CA-C-N 114.654 -1.157 . . . . 3.54 109.33 174.713 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 160' ' ' PRO . . . . . 0.658 ' HA ' ' O ' ' B' ' 165' ' ' GLY . 12.5 Cg_endo -56.33 82.92 0.04 OUTLIER 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 122.942 2.428 . . . . 1.51 118.14 -174.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 161' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -98.1 -171.53 2.17 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 106.347 -1.723 . . . . 1.58 106.347 173.443 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 65.35 -166.02 34.7 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 119.319 -1.42 . . . . 2.37 112.803 177.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 3.9 p -84.46 39.65 0.74 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.758 0.789 . . . . 4.07 110.313 -179.046 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 121.2 5.03 9.8 Favored Glycine 0 CA--C 1.535 1.284 0 CA-C-O 117.793 -1.559 . . . . 2.2 116.513 178.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 165' ' ' GLY . . . . . 0.658 ' O ' ' HA ' ' B' ' 160' ' ' PRO . . . -101.68 155.86 18.85 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-N 121.241 2.52 . . . . 1.62 114.093 -178.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 166' ' ' ARG . . . . . 0.614 ' HG3' ' O ' ' B' ' 157' ' ' GLY . 0.0 OUTLIER -98.42 151.74 20.25 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.034 0.383 . . . . 3.05 112.034 -179.084 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 167' ' ' CYS . . . . . 0.965 ' HB2' ' HB2' ' B' ' 159' ' ' LYS . 1.3 m -71.58 107.14 4.31 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 109.634 -0.506 . . . . 1.56 109.634 178.731 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 168' ' ' ALA . . . . . 0.551 ' HB1' ' HB2' ' B' ' 128' ' ' CYS . . . -94.18 -13.84 26.24 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.917 -0.771 . . . . 1.04 108.917 177.648 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 169' ' ' ALA . . . . . 0.93 ' CB ' ' HA2' ' B' ' 133' ' ' GLY . . . -168.24 163.67 13.1 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.503 -0.771 . . . . 0.98 111.036 -179.465 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 170' ' ' ALA . . . . . 0.623 ' HA ' ' O ' ' B' ' 185' ' ' CYS . . . -58.78 122.46 13.62 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 113.805 1.039 . . . . 1.25 113.805 -178.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 171' ' ' GLY . . . . . 0.802 ' HA2' ' O ' ' B' ' 182' ' ' ASP . . . 60.94 35.66 90.87 Favored Glycine 0 C--N 1.343 0.963 0 CA-C-N 115.221 -0.9 . . . . 1.29 111.292 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 172' ' ' ILE . . . . . 1.091 HD13 ' HB2' ' B' ' 134' ' ' CYS . 1.2 pp -151.6 97.91 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 113.805 -1.197 . . . . 2.27 111.629 173.719 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 173' ' ' CYS . . . . . 0.563 ' HB2' ' HB3' ' B' ' 182' ' ' ASP . 5.2 t -99.71 85.85 3.19 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.682 -1.144 . . . . 1.94 110.174 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 174' ' ' CYS . . . . . 1.047 ' HA ' ' HA ' ' B' ' 179' ' ' CYS . 1.8 m -93.85 146.07 24.16 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.023 0.44 . . . . 1.35 111.187 -179.11 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 175' ' ' SER . . . . . 0.92 ' HB2' ' HD2' ' B' ' 176' ' ' PRO . 54.0 p -109.65 -179.65 0.7 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.761 -0.654 . . . . 2.0 110.031 179.505 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 176' ' ' PRO . . . . . 0.92 ' HD2' ' HB2' ' B' ' 175' ' ' SER . 78.6 Cg_endo -77.61 29.38 0.43 Allowed 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 121.675 1.583 . . . . 1.9 111.483 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 177' ' ' ASP . . . . . 0.449 ' H ' ' C ' ' B' ' 175' ' ' SER . 0.6 OUTLIER -144.63 -29.42 0.47 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.178 -0.919 . . . . 2.72 110.142 179.425 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 178' ' ' GLY . . . . . 0.523 ' O ' ' HB3' ' B' ' 174' ' ' CYS . . . -166.94 -145.75 4.6 Favored Glycine 0 CA--C 1.523 0.591 0 CA-C-N 115.944 -0.571 . . . . 0.99 112.571 179.73 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 179' ' ' CYS . . . . . 1.047 ' HA ' ' HA ' ' B' ' 174' ' ' CYS . 11.7 t -146.4 161.73 39.75 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 109.803 -0.443 . . . . 1.34 109.803 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 180' ' ' HIS . . . . . . . . . . . . . 54.7 m-70 -153.77 134.14 13.46 Favored 'General case' 0 CA--C 1.504 -0.8 0 C-N-CA 119.67 -0.812 . . . . 2.1 111.284 -176.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 181' ' ' GLU . . . . . 0.661 ' OE2' ' HD2' ' A' ' 24' ' ' PRO . 2.5 mt-10 -60.05 132.07 52.8 Favored 'General case' 0 CA--C 1.521 -0.147 0 N-CA-C 109.793 -0.447 . . . . 3.06 109.793 -178.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 182' ' ' ASP . . . . . 0.802 ' O ' ' HA2' ' B' ' 171' ' ' GLY . 0.1 OUTLIER -140.0 112.72 7.51 Favored Pre-proline 0 CA--C 1.545 0.783 0 CA-C-N 116.248 -0.433 . . . . 2.06 110.74 -178.514 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 183' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -70.91 -21.15 28.5 Favored 'Trans proline' 0 C--N 1.359 1.089 0 C-N-CA 122.845 2.363 . . . . 1.91 113.776 -178.286 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -63.8 -39.83 95.18 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.721 0.296 . . . . 1.56 111.551 -179.401 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 185' ' ' CYS . . . . . 0.623 ' O ' ' HA ' ' B' ' 170' ' ' ALA . 67.2 m -97.85 -0.84 44.37 Favored 'General case' 0 C--O 1.215 -0.741 0 N-CA-C 112.504 0.557 . . . . 1.94 112.504 -179.376 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 186' ' ' ASP . . . . . 0.543 ' HA ' ' N ' ' B' ' 171' ' ' GLY . 0.8 OUTLIER -66.3 -56.16 17.19 Favored Pre-proline 0 C--N 1.321 -0.643 0 N-CA-C 112.953 0.723 . . . . 3.61 112.953 -176.583 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 187' ' ' PRO . . . . . 0.524 ' HD3' ' CB ' ' B' ' 186' ' ' ASP . 6.0 Cg_endo -87.54 -158.56 0.08 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 123.392 2.728 . . . . 2.58 114.333 -179.064 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 188' ' ' GLU . . . . . 0.54 ' C ' ' H ' ' B' ' 190' ' ' ALA . 0.0 OUTLIER -88.3 50.17 1.93 Allowed 'General case' 0 N--CA 1.407 -2.576 0 CA-C-N 111.241 -2.708 . . . . 4.7 107.877 168.506 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 189' ' ' ALA . . . . . . . . . . . . . . . -72.01 26.58 0.05 OUTLIER 'General case' 0 CA--C 1.549 0.91 0 CA-C-O 121.01 0.433 . . . . 5.24 110.54 176.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 190' ' ' ALA . . . . . 0.54 ' H ' ' C ' ' B' ' 188' ' ' GLU . . . -49.02 111.79 0.53 Allowed 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 113.619 0.97 . . . . 6.93 113.619 -175.57 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 191' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -87.45 128.17 35.22 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 114.959 -1.018 . . . . 10.14 111.429 179.592 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 10.9 m . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.253 -0.88 . . . . 11.7 111.326 179.481 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.242 0 N-CA-C 112.046 0.387 . . . . 9.95 112.046 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.54 ' O ' HG13 ' A' ' 2' ' ' VAL . 13.9 p -104.8 97.56 5.74 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.208 0 N-CA-C 113.592 0.96 . . . . 8.02 113.592 177.01 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.877 ' HB2' HG22 ' A' ' 9' ' ' THR . 0.4 OUTLIER -87.05 87.53 7.48 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 120.84 0.352 . . . . 5.86 111.032 178.007 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.18 104.28 7.59 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 107.479 -1.304 . . . . 6.22 107.479 176.125 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 1.044 ' HG ' ' HA ' ' A' ' 54' ' ' CYS . 2.2 tm? -154.25 -100.26 0.04 OUTLIER 'General case' 0 N--CA 1.418 -2.068 0 N-CA-C 106.301 -1.741 . . . . 7.09 106.301 178.267 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.592 ' HB2' ' O ' ' A' ' 5' ' ' LEU . 2.2 t70 166.74 40.27 0.0 OUTLIER 'General case' 0 C--N 1.272 -2.789 0 CA-C-N 113.655 -1.611 . . . . 8.78 107.105 177.594 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.829 HG22 ' H ' ' A' ' 8' ' ' ARG . 14.8 p -150.31 -174.54 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.902 0 N-CA-C 102.647 -3.094 . . . . 7.51 102.647 -178.404 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.829 ' H ' HG22 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -77.33 135.51 38.39 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 106.122 -1.807 . . . . 9.08 106.122 178.357 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.877 HG22 ' HB2' ' A' ' 3' ' ' LEU . 70.0 p -48.07 105.45 0.07 Allowed 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 123.339 1.543 . . . . 5.66 112.828 -174.615 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.812 ' N ' ' HG ' ' A' ' 3' ' ' LEU . 0.0 OUTLIER -31.19 112.4 0.09 Allowed 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 111.298 -2.683 . . . . 2.68 115.022 -179.504 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.516 HD23 ' HD2' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -34.36 132.95 0.41 Allowed Pre-proline 0 N--CA 1.481 1.093 0 C-N-CA 124.067 0.947 . . . . 2.48 113.312 177.592 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.86 ' HB2' ' O ' ' A' ' 17' ' ' GLY . 79.0 Cg_endo -87.89 136.46 3.66 Favored 'Trans proline' 0 C--N 1.356 0.933 0 C-N-CA 122.736 2.291 . . . . 1.49 112.784 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 1.054 ' HB2' ' HG3' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -140.97 -162.79 1.42 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 119.975 -0.69 . . . . 1.0 112.163 -179.285 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.476 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . 81.73 -156.27 36.38 Favored Glycine 0 C--N 1.339 0.741 0 CA-C-O 119.323 -0.709 . . . . 1.15 111.836 -178.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.856 ' HG2' ' HD2' ' A' ' 18' ' ' LYS . 42.5 Cg_endo -62.49 108.17 0.68 Allowed 'Trans proline' 0 N--CA 1.483 0.867 0 N-CA-C 105.466 -2.551 . . . . 1.57 105.466 176.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 76.85 -14.37 7.48 Favored Glycine 0 C--N 1.265 -3.372 0 CA-C-O 118.485 -1.175 . . . . 1.68 112.588 176.189 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.86 ' O ' ' HB2' ' A' ' 12' ' ' PRO . . . 75.37 49.41 9.36 Favored Glycine 0 N--CA 1.401 -3.651 0 C-N-CA 117.075 -2.488 . . . . 1.36 111.825 178.561 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 1.052 ' HD3' HD11 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -94.99 -12.88 25.89 Favored 'General case' 0 C--N 1.345 0.41 0 CA-C-N 110.358 -2.921 . . . . 2.5 113.142 177.636 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.821 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -115.98 -167.53 14.98 Favored Glycine 0 C--N 1.345 1.082 0 N-CA-C 106.099 -2.801 . . . . 1.02 106.099 178.615 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.66 ' HB3' ' HB3' ' A' ' 10' ' ' CYS . 1.5 mpt_? -115.08 173.42 6.5 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 122.0 2.9 . . . . 2.92 111.656 -178.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.666 ' HB3' ' HG3' ' A' ' 47' ' ' GLU . 1.2 m -106.25 151.25 25.04 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.882 0.372 . . . . 1.1 110.875 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -124.11 -46.82 1.93 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.117 -0.492 . . . . 1.51 110.776 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.464 ' HA2' ' OE1' ' A' ' 47' ' ' GLU . . . -137.91 -161.18 8.77 Favored Glycine 0 CA--C 1.519 0.321 0 N-CA-C 111.601 -0.6 . . . . 0.9 111.601 179.58 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -77.87 -63.19 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.071 1.848 . . . . 1.5 111.451 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.442 ' C ' HG13 ' A' ' 26' ' ' ILE . 1.1 m -92.17 33.31 1.08 Allowed 'General case' 0 C--O 1.224 -0.238 0 CA-C-N 116.216 -0.447 . . . . 1.26 109.828 178.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 1.071 HG12 HG13 ' A' ' 36' ' ' VAL . 19.0 mt -149.29 121.34 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-O 121.208 0.528 . . . . 0.83 111.99 -178.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.557 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 6.9 t -140.15 124.7 18.05 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 108.472 -0.936 . . . . 0.92 108.472 179.374 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.73 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -138.05 121.72 17.46 Favored 'General case' 0 CA--C 1.551 1.016 0 N-CA-C 114.4 1.259 . . . . 1.28 114.4 -177.743 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.516 ' O ' ' HB2' ' A' ' 69' ' ' ALA . . . -102.82 -170.62 26.43 Favored Glycine 0 C--N 1.367 2.291 0 N-CA-C 110.098 -1.201 . . . . 0.67 110.098 176.653 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -65.85 -53.68 36.65 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 113.773 1.027 . . . . 2.27 113.773 -178.265 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.54 3.44 12.43 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 122.222 1.01 . . . . 1.66 110.966 -176.245 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 1.052 HD11 ' HD3' ' A' ' 18' ' ' LYS . 0.4 OUTLIER -96.94 -22.24 16.97 Favored 'General case' 0 N--CA 1.415 -2.222 0 CA-C-N 113.887 -1.506 . . . . 1.37 107.382 -178.595 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.857 ' HA2' ' CB ' ' A' ' 69' ' ' ALA . . . 76.49 -135.73 17.82 Favored Glycine 0 N--CA 1.41 -3.094 0 CA-C-O 117.727 -1.596 . . . . 0.73 112.256 176.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 1.03 ' HB2' HD13 ' A' ' 72' ' ' ILE . 3.2 t -140.34 121.76 15.04 Favored 'General case' 0 CA--C 1.498 -1.051 0 CA-C-N 119.582 1.691 . . . . 1.08 114.1 -179.064 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.721 ' CE1' HD22 ' A' ' 32' ' ' LEU . 1.8 m-85 -95.51 102.12 13.89 Favored 'General case' 0 N--CA 1.428 -1.536 0 N-CA-C 103.469 -2.789 . . . . 1.38 103.469 175.504 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 1.071 HG13 HG12 ' A' ' 26' ' ' ILE . 2.1 t -94.41 84.34 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.137 0 CA-C-O 123.344 1.545 . . . . 0.76 108.622 -178.409 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 1.084 ' HA3' HG21 ' B' ' 172' ' ' ILE . . . 95.13 79.62 1.47 Allowed Glycine 0 C--N 1.313 -0.699 0 CA-C-N 112.236 -2.256 . . . . 0.81 113.722 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.724 HG21 ' CD2' ' B' ' 135' ' ' PHE . 58.2 p -159.96 177.9 10.28 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.743 -0.836 . . . . 0.77 108.743 179.118 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.73 ' HA ' HD12 ' A' ' 42' ' ' LEU . . . -65.28 -25.01 67.45 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 119.023 0.829 . . . . 1.02 112.27 -178.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.463 ' CG ' ' HA2' ' A' ' 14' ' ' GLY . 0.8 OUTLIER -64.35 -24.76 67.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.854 0.359 . . . . 2.32 110.246 178.664 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.564 ' O ' ' HB2' ' A' ' 44' ' ' CYS . . . -85.46 -10.16 56.5 Favored 'General case' 0 C--O 1.219 -0.5 0 CA-C-N 115.868 -0.605 . . . . 0.87 110.347 178.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.73 HD12 ' HA ' ' A' ' 39' ' ' ALA . 1.1 mt -53.29 -41.83 65.98 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 121.982 -0.449 . . . . 1.23 112.156 -178.731 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 1.054 ' HG3' ' HB2' ' A' ' 13' ' ' CYS . 5.0 ptm180 -70.78 -16.96 62.79 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 121.788 0.804 . . . . 2.92 109.299 176.633 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.564 ' HB2' ' O ' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -57.67 -18.83 22.77 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 114.023 -1.444 . . . . 1.57 110.107 -178.27 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -50.62 -25.82 4.66 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.769 -0.65 . . . . 3.31 111.118 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -83.09 8.33 13.28 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.159 0.504 . . . . 3.69 110.375 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.718 ' O ' HD13 ' A' ' 50' ' ' LEU . 6.0 tm-20 -79.64 1.35 26.58 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.751 -0.659 . . . . 3.99 109.349 177.276 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 68.8 m-20 -69.86 -29.39 66.62 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 116.14 -0.482 . . . . 3.86 110.281 178.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -72.85 3.87 4.75 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 112.209 0.448 . . . . 5.68 112.209 -179.429 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.718 HD13 ' O ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -156.9 110.92 1.95 Allowed Pre-proline 0 CA--C 1.534 0.34 0 O-C-N 122.456 -0.152 . . . . 5.4 110.715 178.625 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -99.19 18.74 0.37 Allowed 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 122.996 2.464 . . . . 4.92 113.827 -178.223 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.517 ' OG ' ' HD2' ' A' ' 53' ' ' PRO . 3.8 t -126.46 151.14 72.3 Favored Pre-proline 0 C--N 1.33 -0.248 0 C-N-CA 121.177 -0.209 . . . . 5.64 111.413 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.517 ' HD2' ' OG ' ' A' ' 52' ' ' SER . 48.0 Cg_endo -68.18 158.07 59.06 Favored 'Trans proline' 0 C--N 1.356 0.959 0 C-N-CA 122.196 1.93 . . . . 5.04 111.86 179.628 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 1.044 ' HA ' ' HG ' ' A' ' 5' ' ' LEU . 1.7 m -132.0 -169.2 2.17 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.714 0.293 . . . . 2.74 111.278 -179.259 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.505 ' H ' HD12 ' A' ' 3' ' ' LEU . 0.3 OUTLIER 54.76 170.58 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.36 -0.382 . . . . 5.75 111.924 -179.961 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.427 ' H ' ' HG3' ' A' ' 55' ' ' GLN . 43.0 p -153.58 -164.66 1.95 Allowed 'General case' 0 CA--C 1.544 0.744 0 CA-C-O 121.385 0.612 . . . . 3.12 112.394 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 120.29 -88.26 0.43 Allowed Glycine 0 N--CA 1.464 0.54 0 CA-C-N 114.646 -1.161 . . . . 2.1 114.016 177.62 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.904 ' O ' ' HB3' ' A' ' 67' ' ' CYS . 41.1 mt-30 -124.16 104.49 8.87 Favored 'General case' 0 CA--C 1.489 -1.404 0 N-CA-C 102.946 -2.983 . . . . 4.36 102.946 177.64 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 1.088 ' HA ' ' H ' ' A' ' 67' ' ' CYS . 6.6 mmmt -128.68 -68.12 0.02 OUTLIER Pre-proline 0 C--N 1.314 -0.949 0 C-N-CA 118.532 -1.267 . . . . 3.55 112.812 -173.821 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.672 ' CD ' ' HB2' ' A' ' 59' ' ' LYS . 15.0 Cg_endo -57.08 114.97 2.17 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 CA-C-N 121.534 1.584 . . . . 1.54 115.354 -177.817 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -144.53 -165.36 2.12 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 111.133 -2.758 . . . . 1.59 104.494 178.159 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 47.24 -165.37 0.13 Allowed Glycine 0 N--CA 1.467 0.741 0 CA-C-N 121.283 1.856 . . . . 2.43 114.611 175.601 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 4.4 p -87.95 39.43 0.89 Allowed 'General case' 0 N--CA 1.479 1.016 0 CA-C-O 121.997 0.903 . . . . 4.11 110.482 -177.416 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 121.11 15.46 4.69 Favored Glycine 0 CA--C 1.558 2.732 0 CA-C-N 113.981 -1.463 . . . . 2.21 114.696 -175.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -101.14 146.02 17.21 Favored Glycine 0 N--CA 1.474 1.184 0 CA-C-N 119.913 1.856 . . . . 1.62 114.914 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 1.057 ' HB3' ' HB3' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -89.73 152.53 21.28 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 109.375 -0.602 . . . . 3.02 109.375 177.965 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 1.088 ' H ' ' HA ' ' A' ' 59' ' ' LYS . 36.1 t -73.47 107.53 5.81 Favored 'General case' 0 N--CA 1.407 -2.588 0 N-CA-C 108.736 -0.839 . . . . 1.52 108.736 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 1.011 ' HB2' ' HB2' ' A' ' 74' ' ' CYS . . . -71.58 -28.23 63.68 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.919 -0.771 . . . . 1.07 108.919 179.527 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.874 ' HB3' ' CG1' ' A' ' 72' ' ' ILE . . . -168.78 163.46 11.84 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.367 -1.288 . . . . 1.0 110.498 -176.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 1.087 ' HA ' ' HB3' ' A' ' 85' ' ' CYS . . . -55.05 122.41 10.89 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 116.111 -0.495 . . . . 1.24 112.119 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.585 ' H ' ' CB ' ' A' ' 85' ' ' CYS . . . 58.38 35.77 80.66 Favored Glycine 0 C--N 1.351 1.416 0 N-CA-C 110.904 -0.878 . . . . 1.28 110.904 -178.807 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 1.071 HG21 ' HA3' ' B' ' 137' ' ' GLY . 1.5 pp -154.71 97.79 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.644 0 N-CA-C 107.989 -1.115 . . . . 2.27 107.989 169.767 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.665 ' HB2' ' HB3' ' A' ' 82' ' ' ASP . 0.1 OUTLIER -91.48 106.33 18.42 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 112.21 0.448 . . . . 1.98 112.21 -177.319 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 1.011 ' HB2' ' HB2' ' A' ' 68' ' ' ALA . 0.6 OUTLIER -93.84 123.77 37.41 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.526 0.679 . . . . 1.33 111.663 179.754 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.901 ' HB2' ' HD2' ' A' ' 76' ' ' PRO . 36.2 p -93.26 -178.7 0.89 Allowed Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.102 -0.954 . . . . 1.99 109.035 178.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.901 ' HD2' ' HB2' ' A' ' 75' ' ' SER . 74.0 Cg_endo -76.11 29.28 0.39 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 121.328 1.352 . . . . 1.86 111.517 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.692 ' HB3' ' CE1' ' B' ' 180' ' ' HIS . 1.7 m-20 -145.78 -43.9 0.21 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.418 -0.81 . . . . 2.65 110.809 179.445 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.537 ' HA3' ' HA ' ' B' ' 180' ' ' HIS . . . -158.32 -141.61 3.19 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 120.74 -0.743 . . . . 0.99 113.128 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.766 ' HA ' ' HA ' ' A' ' 74' ' ' CYS . 0.1 OUTLIER -134.82 157.76 45.94 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.55 0.215 . . . . 1.34 110.505 -179.949 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.642 ' CE1' ' HB3' ' B' ' 177' ' ' ASP . 2.8 t60 -152.28 135.11 15.52 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 109.432 -0.581 . . . . 2.17 109.432 -176.837 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.8 132.19 53.19 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 109.295 -0.631 . . . . 3.05 109.295 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.665 ' HB3' ' HB2' ' A' ' 73' ' ' CYS . 1.2 p-10 -140.64 133.56 14.65 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 120.911 -0.315 . . . . 2.02 111.581 -177.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.736 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 5.7 Cg_exo -79.51 -12.16 14.01 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 122.737 2.292 . . . . 1.93 113.103 -179.28 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.8 -41.74 97.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.783 0.325 . . . . 1.53 110.944 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 1.087 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 21.5 m -99.88 22.67 10.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.156 0.503 . . . . 1.88 110.919 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.606 ' HB2' ' HA ' ' A' ' 83' ' ' PRO . 0.5 OUTLIER -103.08 -22.21 0.2 Allowed Pre-proline 0 CA--C 1.512 -0.483 0 N-CA-C 113.887 1.069 . . . . 3.6 113.887 179.085 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.736 ' HD3' ' O ' ' A' ' 83' ' ' PRO . 72.2 Cg_exo -46.12 119.97 3.33 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 121.399 1.4 . . . . 2.56 111.199 177.558 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 2.21 48.19 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 128.299 2.639 . . . . 4.72 113.387 -172.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.637 ' N ' ' O ' ' A' ' 87' ' ' PRO . . . -67.58 0.19 3.34 Favored 'General case' 0 CA--C 1.499 -0.994 0 CA-C-N 111.697 -2.501 . . . . 5.29 113.747 -171.591 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.88 140.22 58.79 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 118.438 -1.305 . . . . 6.98 110.813 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -102.34 67.57 1.04 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.128 -0.693 . . . . 10.21 109.128 176.372 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.248 0.99 0 CA-C-O 118.284 -0.865 . . . . 11.77 111.039 -178.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.182 0 CA-C-O 120.781 0.324 . . . . 10.07 111.35 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 11.5 t 60.44 55.1 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 CA-C-O 122.673 1.225 . . . . 8.41 112.671 176.21 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 103' ' ' LEU . . . . . 1.032 ' HB2' HG22 ' B' ' 109' ' ' THR . 0.4 OUTLIER -79.3 94.1 5.41 Favored 'General case' 0 C--N 1.344 0.333 0 CA-C-N 112.958 -1.928 . . . . 5.87 110.918 179.634 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 104' ' ' ASP . . . . . 0.608 ' HB3' ' OG ' ' B' ' 156' ' ' SER . 0.7 OUTLIER -82.48 101.59 10.79 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 106.714 -1.588 . . . . 6.27 106.714 177.176 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 105' ' ' LEU . . . . . 1.096 ' HG ' ' HA ' ' B' ' 154' ' ' CYS . 2.4 tm? -158.57 -126.11 0.02 OUTLIER 'General case' 1 N--CA 1.369 -4.485 0 C-N-CA 128.364 2.666 . . . . 7.2 104.621 -179.775 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 106' ' ' ASP . . . . . 0.757 ' H ' ' CD1' ' B' ' 105' ' ' LEU . 3.9 t70 -176.41 50.13 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 104.816 -2.29 . . . . 8.55 104.816 -177.205 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 107' ' ' VAL . . . . . 0.835 HG22 ' H ' ' B' ' 108' ' ' ARG . 9.9 p -154.17 -177.3 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.403 -2.793 0 CA-C-N 112.016 -2.356 . . . . 7.48 106.46 178.261 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 108' ' ' ARG . . . . . 0.835 ' H ' HG22 ' B' ' 107' ' ' VAL . 0.0 OUTLIER -79.67 129.59 34.61 Favored 'General case' 0 N--CA 1.405 -2.7 0 N-CA-C 107.086 -1.45 . . . . 9.12 107.086 176.183 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 109' ' ' THR . . . . . 1.032 HG22 ' HB2' ' B' ' 103' ' ' LEU . 47.0 p -39.46 103.74 0.03 OUTLIER 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 122.971 1.367 . . . . 5.69 113.35 -176.298 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 110' ' ' CYS . . . . . 0.757 ' N ' ' HG ' ' B' ' 103' ' ' LEU . 0.0 OUTLIER -32.13 111.69 0.09 Allowed 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 111.929 -2.396 . . . . 2.61 115.381 -179.797 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 111' ' ' LEU . . . . . 0.509 HD23 ' HD2' ' B' ' 112' ' ' PRO . 0.2 OUTLIER -33.77 133.07 0.37 Allowed Pre-proline 0 N--CA 1.485 1.307 0 C-N-CA 123.979 0.912 . . . . 2.47 113.294 177.603 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 112' ' ' PRO . . . . . 0.845 ' HB2' ' O ' ' B' ' 117' ' ' GLY . 54.0 Cg_endo -92.3 129.09 0.95 Allowed 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.509 2.139 . . . . 1.47 115.253 -179.141 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 1.091 ' HB2' ' HG3' ' B' ' 143' ' ' ARG . 0.0 OUTLIER -133.65 -159.78 0.99 Allowed 'General case' 0 C--N 1.359 1.017 0 C-N-CA 119.473 -0.891 . . . . 1.0 111.299 -175.525 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 114' ' ' GLY . . . . . 0.474 ' N ' ' SG ' ' B' ' 113' ' ' CYS . . . 80.71 -156.91 39.16 Favored Glycine 0 C--N 1.334 0.443 0 CA-C-N 118.613 0.642 . . . . 1.16 111.558 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 115' ' ' PRO . . . . . 0.821 ' HG2' ' HD2' ' B' ' 118' ' ' LYS . 56.6 Cg_endo -65.24 88.59 0.2 Allowed 'Trans proline' 0 N--CA 1.458 -0.58 0 CA-C-N 119.523 1.662 . . . . 1.57 114.177 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 87.51 -3.83 86.21 Favored Glycine 0 C--N 1.265 -3.372 0 CA-C-N 112.056 -2.338 . . . . 1.7 114.202 -176.358 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 117' ' ' GLY . . . . . 0.845 ' O ' ' HB2' ' B' ' 112' ' ' PRO . . . 75.05 47.58 13.09 Favored Glycine 0 N--CA 1.412 -2.931 0 C-N-CA 118.966 -1.588 . . . . 1.38 113.497 175.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 118' ' ' LYS . . . . . 1.009 ' HD3' HD11 ' B' ' 132' ' ' LEU . 0.0 OUTLIER -90.72 -23.27 20.75 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 112.134 -2.033 . . . . 2.54 111.237 178.96 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 119' ' ' GLY . . . . . 0.728 ' O ' ' HA ' ' B' ' 112' ' ' PRO . . . -101.36 -160.94 27.18 Favored Glycine 0 N--CA 1.478 1.477 0 CA-C-O 117.274 -1.848 . . . . 1.04 109.242 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.64 ' HB3' ' HB3' ' B' ' 110' ' ' CYS . 1.3 mpt_? -124.0 172.83 8.66 Favored 'General case' 0 C--N 1.353 0.728 0 CA-C-N 122.238 3.019 . . . . 2.89 109.329 177.721 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 121' ' ' CYS . . . . . 0.645 ' HB3' ' HG3' ' B' ' 147' ' ' GLU . 1.2 m -106.11 151.44 24.7 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.927 0.394 . . . . 1.07 111.139 -179.575 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -124.16 -46.81 1.92 Allowed 'General case' 0 C--N 1.334 -0.101 0 CA-C-N 116.04 -0.527 . . . . 1.53 110.754 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 123' ' ' GLY . . . . . 0.484 ' HA2' ' OE1' ' B' ' 147' ' ' GLU . . . -137.98 -161.19 8.76 Favored Glycine 0 CA--C 1.52 0.374 0 N-CA-C 111.637 -0.585 . . . . 0.9 111.637 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -77.77 -63.21 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.033 1.822 . . . . 1.51 111.538 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 125' ' ' SER . . . . . 0.432 ' C ' HG13 ' B' ' 126' ' ' ILE . 1.1 m -92.05 33.27 1.07 Allowed 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.845 -0.428 . . . . 1.25 109.845 178.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 126' ' ' ILE . . . . . 1.067 HG12 HG13 ' B' ' 136' ' ' VAL . 23.0 mt -149.01 121.23 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 CA-C-O 121.082 0.468 . . . . 0.85 112.111 -178.74 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 127' ' ' CYS . . . . . 0.549 ' O ' ' HA ' ' B' ' 134' ' ' CYS . 6.6 t -140.34 124.33 17.48 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 108.404 -0.962 . . . . 0.89 108.404 179.217 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 128' ' ' CYS . . . . . 0.729 ' HA ' ' O ' ' B' ' 133' ' ' GLY . 0.0 OUTLIER -137.43 120.95 17.17 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 114.235 1.198 . . . . 1.23 114.235 -177.731 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 129' ' ' GLY . . . . . 0.501 ' O ' ' HB2' ' B' ' 169' ' ' ALA . . . -103.67 -167.65 25.39 Favored Glycine 0 C--N 1.369 2.395 0 CA-C-N 120.148 1.34 . . . . 0.66 109.885 176.388 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -65.72 -55.07 19.32 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 114.148 1.166 . . . . 2.35 114.148 -177.488 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -124.06 21.7 8.88 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 121.691 0.758 . . . . 1.69 109.955 -177.787 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 132' ' ' LEU . . . . . 1.009 HD11 ' HD3' ' B' ' 118' ' ' LYS . 0.4 OUTLIER -112.18 -21.19 11.59 Favored 'General case' 0 N--CA 1.411 -2.417 0 N-CA-C 104.783 -2.303 . . . . 1.38 104.783 179.24 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 133' ' ' GLY . . . . . 0.897 ' HA2' ' CB ' ' B' ' 169' ' ' ALA . . . 75.41 -134.73 17.13 Favored Glycine 1 N--CA 1.393 -4.226 0 CA-C-O 117.07 -1.961 . . . . 0.72 112.499 174.503 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 134' ' ' CYS . . . . . 1.031 ' HB2' HD13 ' B' ' 172' ' ' ILE . 3.1 t -140.75 121.78 14.63 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 120.262 2.031 . . . . 1.08 114.488 -178.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 135' ' ' PHE . . . . . 0.729 ' CE1' HD22 ' B' ' 132' ' ' LEU . 4.1 m-85 -95.16 101.77 13.54 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 103.707 -2.701 . . . . 1.36 103.707 175.557 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 136' ' ' VAL . . . . . 1.067 HG13 HG12 ' B' ' 126' ' ' ILE . 2.3 t -94.36 83.83 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.076 0 CA-C-O 123.364 1.554 . . . . 0.75 108.597 -178.415 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 137' ' ' GLY . . . . . 1.071 ' HA3' HG21 ' A' ' 72' ' ' ILE . . . 95.19 79.55 1.46 Allowed Glycine 0 C--N 1.313 -0.697 0 CA-C-N 112.145 -2.298 . . . . 0.83 113.643 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 138' ' ' THR . . . . . 0.604 ' OG1' ' HB3' ' B' ' 135' ' ' PHE . 51.2 p -158.12 -179.05 7.75 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.7 -0.852 . . . . 0.78 108.7 179.074 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 139' ' ' ALA . . . . . 0.733 ' HA ' HD12 ' B' ' 142' ' ' LEU . . . -68.37 -24.78 64.83 Favored 'General case' 0 C--N 1.338 0.109 0 CA-C-N 119.18 0.9 . . . . 1.04 111.934 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 140' ' ' GLU . . . . . 0.457 ' CG ' ' HA2' ' B' ' 114' ' ' GLY . 0.8 OUTLIER -63.98 -25.18 68.01 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.236 -0.438 . . . . 2.31 110.195 178.643 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 141' ' ' ALA . . . . . 0.556 ' O ' ' HB2' ' B' ' 144' ' ' CYS . . . -84.72 -11.22 56.29 Favored 'General case' 0 C--O 1.219 -0.538 0 CA-C-N 115.941 -0.572 . . . . 0.87 110.27 178.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 142' ' ' LEU . . . . . 0.733 HD12 ' HA ' ' B' ' 139' ' ' ALA . 1.1 mt -52.83 -42.09 64.82 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.312 0.486 . . . . 1.24 112.312 -178.018 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 143' ' ' ARG . . . . . 1.091 ' HG3' ' HB2' ' B' ' 113' ' ' CYS . 4.4 ptm180 -68.1 -21.57 64.95 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 108.613 -0.884 . . . . 2.93 108.613 176.299 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 144' ' ' CYS . . . . . 0.556 ' HB2' ' O ' ' B' ' 141' ' ' ALA . 0.1 OUTLIER -56.81 -13.84 2.91 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 113.743 -1.571 . . . . 1.61 110.482 -175.867 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -54.61 -24.93 23.52 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-O 121.242 0.544 . . . . 3.35 111.05 178.584 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -82.99 8.42 12.77 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 120.473 -0.491 . . . . 3.76 110.213 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 147' ' ' GLU . . . . . 0.728 ' O ' HD13 ' B' ' 150' ' ' LEU . 6.0 tm-20 -79.58 1.34 26.36 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.821 -0.627 . . . . 4.01 109.375 177.177 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 148' ' ' ASN . . . . . . . . . . . . . 68.9 m-20 -69.85 -29.47 66.73 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 116.183 -0.462 . . . . 3.92 110.259 178.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -72.79 3.92 4.65 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.237 0.458 . . . . 5.73 112.237 -179.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 150' ' ' LEU . . . . . 0.728 HD13 ' O ' ' B' ' 147' ' ' GLU . 0.0 OUTLIER -156.95 110.96 1.94 Allowed Pre-proline 0 CA--C 1.534 0.365 0 CA-C-O 120.423 0.154 . . . . 5.46 110.602 178.652 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 151' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -99.21 18.79 0.36 Allowed 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 123.024 2.482 . . . . 5.02 113.832 -178.29 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 152' ' ' SER . . . . . 0.519 ' OG ' ' HD2' ' B' ' 153' ' ' PRO . 3.8 t -126.54 151.18 72.57 Favored Pre-proline 0 C--N 1.329 -0.315 0 C-N-CA 121.185 -0.206 . . . . 5.73 111.366 -179.758 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 153' ' ' PRO . . . . . 0.519 ' HD2' ' OG ' ' B' ' 152' ' ' SER . 47.4 Cg_endo -68.44 158.18 58.72 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 122.117 1.878 . . . . 5.1 111.798 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 154' ' ' CYS . . . . . 1.096 ' HA ' ' HG ' ' B' ' 105' ' ' LEU . 1.7 m -132.66 -170.49 2.45 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.789 0.328 . . . . 2.68 111.128 -179.255 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 155' ' ' GLN . . . . . 0.5 ' H ' HD12 ' B' ' 103' ' ' LEU . 0.3 OUTLIER 56.37 169.17 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.307 -0.406 . . . . 5.63 111.664 179.969 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 156' ' ' SER . . . . . 0.608 ' OG ' ' HB3' ' B' ' 104' ' ' ASP . 34.5 p -151.72 -162.97 1.64 Allowed 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 112.147 0.425 . . . . 3.11 112.147 -179.046 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 120.48 -92.33 0.51 Allowed Glycine 0 C--N 1.339 0.743 0 C-N-CA 120.834 -0.698 . . . . 2.07 113.286 178.432 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 158' ' ' GLN . . . . . 0.953 ' O ' ' HB3' ' B' ' 167' ' ' CYS . 41.1 mt-30 -124.55 89.67 3.11 Favored 'General case' 0 CA--C 1.493 -1.237 0 N-CA-C 105.246 -2.131 . . . . 4.34 105.246 178.304 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 159' ' ' LYS . . . . . 1.075 ' HB3' ' HB3' ' B' ' 166' ' ' ARG . 6.5 mmmt -105.58 -73.69 0.02 OUTLIER Pre-proline 0 C--N 1.308 -1.232 0 N-CA-C 116.28 1.956 . . . . 3.54 116.28 -175.491 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 160' ' ' PRO . . . . . 0.64 ' CD ' ' HB2' ' B' ' 159' ' ' LYS . 14.6 Cg_endo -57.21 115.05 2.22 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 N-CA-C 116.037 1.514 . . . . 1.51 116.037 -174.645 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 161' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -145.57 -168.75 3.05 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 110.911 -2.859 . . . . 1.58 104.374 177.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 50.01 -165.66 0.5 Allowed Glycine 0 CA--C 1.525 0.7 0 CA-C-N 120.62 1.554 . . . . 2.37 113.882 177.24 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 7.3 p -88.25 39.63 0.91 Allowed 'General case' 0 N--CA 1.482 1.152 0 CA-C-O 122.491 1.138 . . . . 4.07 110.962 -178.14 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 123.02 12.8 4.7 Favored Glycine 0 CA--C 1.557 2.663 0 CA-C-N 113.351 -1.75 . . . . 2.2 114.857 -178.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -99.92 146.08 17.66 Favored Glycine 0 N--CA 1.471 1.02 0 CA-C-N 120.795 2.297 . . . . 1.62 115.046 -177.293 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 166' ' ' ARG . . . . . 1.075 ' HB3' ' HB3' ' B' ' 159' ' ' LYS . 0.0 OUTLIER -89.51 152.28 21.52 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 109.302 -0.629 . . . . 3.05 109.302 178.612 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 167' ' ' CYS . . . . . 0.996 ' H ' ' HA ' ' B' ' 159' ' ' LYS . 33.6 t -73.77 107.75 6.2 Favored 'General case' 0 N--CA 1.406 -2.628 0 N-CA-C 108.683 -0.858 . . . . 1.56 108.683 -179.557 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 168' ' ' ALA . . . . . 1.009 ' HB2' ' HB2' ' B' ' 174' ' ' CYS . . . -73.68 -24.18 59.92 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 119.699 -0.801 . . . . 1.04 109.438 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 169' ' ' ALA . . . . . 0.897 ' CB ' ' HA2' ' B' ' 133' ' ' GLY . . . -171.47 163.48 6.81 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 108.554 -0.906 . . . . 0.98 108.554 -178.805 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 170' ' ' ALA . . . . . 1.053 ' HA ' ' HB3' ' B' ' 185' ' ' CYS . . . -55.43 125.56 21.42 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 120.89 0.376 . . . . 1.25 111.974 179.263 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 171' ' ' GLY . . . . . 0.541 ' H ' ' CB ' ' B' ' 185' ' ' CYS . . . 79.27 -7.45 52.64 Favored Glycine 0 C--O 1.224 -0.513 0 C-N-CA 120.376 -0.916 . . . . 1.29 114.063 178.301 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 172' ' ' ILE . . . . . 1.084 HG21 ' HA3' ' A' ' 37' ' ' GLY . 1.6 pp -132.36 100.78 4.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-O 121.89 0.852 . . . . 2.27 110.59 -175.79 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 173' ' ' CYS . . . . . 0.674 ' HB2' ' HB3' ' B' ' 182' ' ' ASP . 0.1 OUTLIER -91.13 105.88 18.12 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 115.498 -0.774 . . . . 1.94 112.282 -177.811 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 174' ' ' CYS . . . . . 1.009 ' HB2' ' HB2' ' B' ' 168' ' ' ALA . 0.6 OUTLIER -93.94 123.81 37.54 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.535 0.683 . . . . 1.35 111.734 179.651 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 175' ' ' SER . . . . . 0.955 ' HB2' ' HD2' ' B' ' 176' ' ' PRO . 36.1 p -93.31 -178.71 0.89 Allowed Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.114 -0.948 . . . . 2.0 109.071 178.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 176' ' ' PRO . . . . . 0.955 ' HD2' ' HB2' ' B' ' 175' ' ' SER . 73.9 Cg_endo -76.08 29.2 0.39 Allowed 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 121.388 1.392 . . . . 1.9 111.481 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 177' ' ' ASP . . . . . 0.642 ' HB3' ' CE1' ' A' ' 80' ' ' HIS . 1.6 m-20 -145.74 -43.94 0.21 Allowed 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 115.489 -0.778 . . . . 2.72 110.798 179.431 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 178' ' ' GLY . . . . . 0.517 ' HA3' ' HA ' ' A' ' 80' ' ' HIS . . . -158.27 -141.52 3.17 Favored Glycine 0 CA--C 1.522 0.512 0 C-N-CA 120.776 -0.726 . . . . 0.99 113.137 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 179' ' ' CYS . . . . . 0.759 ' HA ' ' HA ' ' B' ' 174' ' ' CYS . 0.1 OUTLIER -134.5 160.27 38.53 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 110.424 -0.213 . . . . 1.34 110.424 -179.986 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 180' ' ' HIS . . . . . 0.692 ' CE1' ' HB3' ' A' ' 77' ' ' ASP . 2.9 t60 -156.21 134.05 11.12 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 109.886 -0.412 . . . . 2.1 109.886 -176.837 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 181' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.02 131.88 52.37 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 109.414 -0.588 . . . . 3.06 109.414 -179.08 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 182' ' ' ASP . . . . . 0.674 ' HB3' ' HB2' ' B' ' 173' ' ' CYS . 1.2 p-10 -140.47 133.54 14.83 Favored Pre-proline 0 CA--C 1.541 0.602 0 C-N-CA 120.937 -0.305 . . . . 2.06 111.701 -177.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 183' ' ' PRO . . . . . 0.758 ' O ' ' HD3' ' B' ' 187' ' ' PRO . 5.9 Cg_exo -79.51 -12.11 14.03 Favored 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 122.684 2.256 . . . . 1.91 113.065 -179.236 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -63.65 -41.61 98.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.836 0.35 . . . . 1.56 111.026 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 185' ' ' CYS . . . . . 1.053 ' HB3' ' HA ' ' B' ' 170' ' ' ALA . 26.7 m -99.7 22.38 11.04 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.153 -0.476 . . . . 1.94 111.293 179.327 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 186' ' ' ASP . . . . . 0.615 ' HB2' ' HA ' ' B' ' 183' ' ' PRO . 0.5 OUTLIER -103.28 -22.32 0.2 Allowed Pre-proline 0 CA--C 1.504 -0.82 0 N-CA-C 113.927 1.084 . . . . 3.61 113.927 179.136 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 187' ' ' PRO . . . . . 0.758 ' HD3' ' O ' ' B' ' 183' ' ' PRO . 81.5 Cg_exo -46.44 117.08 1.82 Allowed 'Trans proline' 0 N--CA 1.454 -0.802 0 CA-C-N 120.531 1.225 . . . . 2.58 111.457 177.732 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 2.15 57.26 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.349 0 C-N-CA 128.769 2.827 . . . . 4.7 110.032 -176.531 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 189' ' ' ALA . . . . . 0.558 ' N ' ' O ' ' B' ' 187' ' ' PRO . . . -74.85 -1.55 22.76 Favored 'General case' 0 CA--C 1.488 -1.409 0 CA-C-N 109.338 -3.574 . . . . 5.24 112.836 -175.367 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 190' ' ' ALA . . . . . . . . . . . . . . . -61.37 143.83 55.09 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 116.748 -1.981 . . . . 6.93 110.032 -176.279 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 191' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -103.15 68.19 0.97 Allowed 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.077 -0.712 . . . . 10.14 109.077 174.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.17 -0.919 . . . . 11.7 111.189 -178.594 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.92 ' O ' HG22 ' A' ' 2' ' ' VAL . . . . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 118.435 -0.793 . . . . 9.95 112.76 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.92 HG22 ' O ' ' A' ' 1' ' ' ALA . 16.2 m 125.88 88.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 CA-C-O 121.9 0.857 . . . . 8.02 109.802 -179.409 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 1.044 HD13 ' HB3' ' A' ' 55' ' ' GLN . 0.1 OUTLIER -154.06 71.59 0.86 Allowed 'General case' 0 CA--C 1.51 -0.595 0 CA-C-N 114.507 -1.224 . . . . 5.86 110.01 179.668 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.634 ' N ' ' HA ' ' A' ' 55' ' ' GLN . 1.7 t70 -62.98 -2.75 1.32 Allowed 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 112.629 0.603 . . . . 6.22 112.629 -177.102 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.708 ' O ' ' HB2' ' A' ' 6' ' ' ASP . 2.9 tm? -96.39 -73.13 0.61 Allowed 'General case' 0 N--CA 1.418 -2.056 0 N-CA-C 107.125 -1.435 . . . . 7.09 107.125 176.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.768 ' H ' HD12 ' A' ' 3' ' ' LEU . 0.8 OUTLIER 155.87 -21.0 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 111.108 -2.769 . . . . 8.78 110.317 179.762 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.442 ' C ' HD11 ' A' ' 3' ' ' LEU . 14.6 p -157.04 126.94 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 N-CA-C 101.923 -3.362 . . . . 7.51 101.923 177.402 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 1.086 ' HB2' ' HG2' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -74.17 110.14 8.22 Favored 'General case' 0 N--CA 1.404 -2.775 0 N-CA-C 107.503 -1.295 . . . . 9.08 107.503 -175.948 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.6 m -104.4 94.85 5.56 Favored 'General case' 0 N--CA 1.396 -3.138 0 N-CA-C 101.898 -3.371 . . . . 5.66 101.898 171.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 1.051 ' HB3' ' HG2' ' A' ' 20' ' ' ARG . 0.6 OUTLIER -83.16 103.76 12.82 Favored 'General case' 0 C--N 1.288 -2.103 0 CA-C-N 112.754 -2.021 . . . . 2.68 112.154 178.275 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.75 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 4.3 mm? -30.68 108.48 0.26 Allowed Pre-proline 0 N--CA 1.474 0.751 0 CA-C-N 119.208 0.913 . . . . 2.48 110.408 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.78 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 49.4 Cg_endo -100.0 114.42 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 123.085 2.523 . . . . 1.49 114.58 -177.828 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.764 ' HB2' ' HB3' ' A' ' 43' ' ' ARG . 0.1 OUTLIER -132.97 -157.77 0.84 Allowed 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 119.759 -0.162 . . . . 1.0 110.582 -178.465 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.612 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . 80.62 -158.77 41.63 Favored Glycine 0 CA--C 1.507 -0.409 0 CA-C-O 118.564 -1.131 . . . . 1.15 111.202 -177.299 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.527 ' HD3' ' HG2' ' A' ' 40' ' ' GLU . 84.4 Cg_endo -64.77 84.02 0.17 Allowed 'Trans proline' 0 CA--C 1.515 -0.474 0 CA-C-N 121.122 2.461 . . . . 1.57 115.035 -176.643 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.07 1.33 84.67 Favored Glycine 0 C--N 1.283 -2.388 0 CA-C-N 111.621 -2.536 . . . . 1.68 114.474 -178.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.64 ' O ' ' HB2' ' A' ' 12' ' ' PRO . . . 85.87 42.73 6.65 Favored Glycine 0 N--CA 1.431 -1.659 0 N-CA-C 117.38 1.712 . . . . 1.36 117.38 174.362 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -94.63 -14.94 24.43 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-N 114.443 -0.878 . . . . 2.5 111.799 175.523 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.78 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -107.7 179.39 21.93 Favored Glycine 0 N--CA 1.468 0.807 0 N-CA-C 109.478 -1.449 . . . . 1.02 109.478 -179.338 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 1.051 ' HG2' ' HB3' ' A' ' 10' ' ' CYS . 0.3 OUTLIER -120.34 174.01 6.78 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 120.833 2.316 . . . . 2.92 110.982 179.021 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 12.7 m -107.3 156.37 18.95 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.028 0.442 . . . . 1.1 112.005 -179.458 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.507 ' CE1' ' HB2' ' A' ' 28' ' ' CYS . 56.9 m-85 -143.54 16.9 1.84 Allowed 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.601 -0.727 . . . . 1.51 111.231 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.522 ' O ' ' HB3' ' A' ' 44' ' ' CYS . . . 162.45 -143.91 9.17 Favored Glycine 0 C--N 1.331 0.256 0 C-N-CA 120.743 -0.741 . . . . 0.9 112.093 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.44 ' O ' ' HB2' ' A' ' 44' ' ' CYS . 12.1 Cg_endo -90.08 -72.88 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 123.054 2.503 . . . . 1.5 112.579 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.418 ' O ' ' HA ' ' A' ' 36' ' ' VAL . 0.4 OUTLIER -91.79 35.6 0.97 Allowed 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 110.265 -0.272 . . . . 1.26 110.265 179.525 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.999 ' CG1' HG13 ' A' ' 36' ' ' VAL . 13.3 mt -139.81 98.92 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 N-CA-C 113.664 0.987 . . . . 0.83 113.664 -178.228 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.864 ' HB2' ' HA ' ' A' ' 41' ' ' ALA . 3.7 t -119.71 108.71 14.76 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 107.376 -1.342 . . . . 0.92 107.376 176.114 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.803 ' CB ' ' HB1' ' A' ' 68' ' ' ALA . 4.3 m -121.94 161.67 22.45 Favored 'General case' 0 N--CA 1.429 -1.516 0 CA-C-N 114.374 -1.285 . . . . 1.28 112.703 -176.348 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.503 ' O ' ' HB2' ' A' ' 69' ' ' ALA . . . -142.02 -173.42 14.08 Favored Glycine 0 N--CA 1.426 -2.027 0 CA-C-N 113.454 -1.703 . . . . 0.67 110.096 175.193 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.445 ' OD2' ' HG2' ' A' ' 31' ' ' GLU . 17.4 p-10 -67.3 -52.6 38.6 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 112.578 0.585 . . . . 2.27 112.578 -179.688 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.445 ' HG2' ' OD2' ' A' ' 30' ' ' ASP . 0.4 OUTLIER -119.17 19.12 12.96 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 122.411 1.1 . . . . 1.66 109.468 -178.703 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.712 HD22 ' CE1' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -113.73 -12.32 12.8 Favored 'General case' 0 N--CA 1.415 -2.208 0 CA-C-N 112.902 -1.954 . . . . 1.37 106.665 -178.923 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.701 ' HA2' ' CB ' ' A' ' 69' ' ' ALA . . . 52.81 -134.1 39.88 Favored Glycine 0 N--CA 1.415 -2.727 0 CA-C-N 113.952 -1.476 . . . . 0.73 113.831 177.719 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.793 ' HB2' HD13 ' A' ' 72' ' ' ILE . 0.9 OUTLIER -127.28 119.99 27.6 Favored 'General case' 0 N--CA 1.429 -1.519 0 N-CA-C 116.024 1.861 . . . . 1.08 116.024 -178.188 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.833 ' HB3' ' CG2' ' A' ' 38' ' ' THR . 8.4 m-85 -95.37 105.06 16.99 Favored 'General case' 0 N--CA 1.417 -2.082 1 N-CA-C 99.622 -4.214 . . . . 1.38 99.622 173.175 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.999 HG13 ' CG1' ' A' ' 26' ' ' ILE . 2.2 t -103.04 88.27 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.642 0 CA-C-O 122.794 1.283 . . . . 0.76 110.273 -176.57 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.452 ' O ' ' O ' ' A' ' 38' ' ' THR . . . 120.21 -46.48 1.12 Allowed Glycine 0 N--CA 1.461 0.323 0 CA-C-N 113.397 -1.729 . . . . 0.81 115.684 178.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.833 ' CG2' ' HB3' ' A' ' 35' ' ' PHE . 3.2 t -47.36 -174.66 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 117.305 0.553 . . . . 0.77 111.906 -178.529 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.808 ' HA ' HD12 ' A' ' 42' ' ' LEU . . . -70.17 -23.73 63.02 Favored 'General case' 0 CA--C 1.515 -0.393 0 O-C-N 121.817 -0.552 . . . . 1.02 112.445 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.528 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 1.3 mp0 -60.06 -28.04 67.46 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.586 -0.279 . . . . 2.32 110.769 179.256 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.864 ' HA ' ' HB2' ' A' ' 27' ' ' CYS . . . -93.14 -22.74 18.9 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 122.221 0.208 . . . . 0.87 111.313 -179.086 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.808 HD12 ' HA ' ' A' ' 39' ' ' ALA . 5.0 mt -49.7 -39.76 37.97 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 121.238 0.542 . . . . 1.23 110.716 179.183 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.764 ' HB3' ' HB2' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -56.6 -17.7 9.48 Favored 'General case' 0 CA--C 1.496 -1.123 0 CA-C-N 115.622 -0.717 . . . . 2.92 109.704 178.561 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.522 ' HB3' ' O ' ' A' ' 23' ' ' GLY . 68.0 m -75.31 0.45 16.68 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 120.042 1.292 . . . . 1.57 112.036 -179.45 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 71.4 tp60 -60.88 -21.32 63.18 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.066 0.46 . . . . 3.31 110.216 178.459 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -85.8 2.8 44.21 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 119.753 -0.779 . . . . 3.69 111.112 -179.409 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -82.61 3.11 30.09 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 116.147 -0.479 . . . . 3.99 109.739 177.504 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -84.92 -27.55 26.51 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 116.134 -0.485 . . . . 3.86 110.73 179.167 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.426 ' H ' ' HD1' ' A' ' 49' ' ' TYR . 0.4 OUTLIER -123.98 42.17 3.31 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.039 0.447 . . . . 5.68 111.677 -179.509 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.671 ' CD2' HD11 ' A' ' 11' ' ' LEU . 0.5 OUTLIER -147.05 98.4 4.06 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.76 -0.655 . . . . 5.4 110.61 178.956 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -79.6 46.77 2.31 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.59 2.193 . . . . 4.92 112.96 -179.567 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 49.3 m -95.56 107.57 34.16 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.488 -0.324 . . . . 5.64 111.006 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -80.19 -24.39 5.65 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.842 2.361 . . . . 5.04 112.656 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.58 ' SG ' ' HG3' ' A' ' 8' ' ' ARG . 52.8 t 65.84 99.12 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.432 -0.349 . . . . 2.74 111.075 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 1.086 ' HG2' ' HB2' ' A' ' 8' ' ' ARG . 0.4 OUTLIER 20.53 -103.88 0.01 OUTLIER 'General case' 0 C--N 1.343 0.324 0 N-CA-C 114.335 1.235 . . . . 5.75 114.335 179.036 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.631 ' HB3' ' HB ' ' A' ' 2' ' ' VAL . 8.1 t -169.5 144.78 3.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.412 -0.813 . . . . 3.12 109.213 -178.709 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 178.36 -86.64 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 119.998 -1.096 . . . . 2.1 113.15 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.965 ' HB3' ' HB3' ' A' ' 67' ' ' CYS . 15.6 mt-30 -120.6 85.94 2.48 Favored 'General case' 0 N--CA 1.417 -2.081 0 N-CA-C 107.55 -1.278 . . . . 4.36 107.55 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 1.298 ' O ' ' HA ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -136.44 -52.38 0.02 OUTLIER Pre-proline 0 C--N 1.305 -1.333 0 N-CA-C 106.562 -1.644 . . . . 3.55 106.562 179.799 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.83 ' HD2' ' H ' ' A' ' 59' ' ' LYS . 43.8 Cg_endo -84.96 108.5 1.18 Allowed 'Trans proline' 0 C--N 1.298 -2.126 0 CA-C-N 120.404 1.18 . . . . 1.54 114.076 177.009 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.737 ' SG ' ' HB3' ' A' ' 84' ' ' ALA . 3.0 t -142.95 -176.99 5.12 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 113.979 -1.464 . . . . 1.59 108.565 178.45 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.562 ' O ' ' O ' ' A' ' 61' ' ' CYS . . . 33.46 -166.19 0.01 OUTLIER Glycine 0 CA--C 1.524 0.598 0 C-N-CA 120.729 -0.748 . . . . 2.43 114.468 176.337 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -83.23 50.32 1.73 Allowed 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 122.423 1.106 . . . . 4.11 111.237 179.243 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 121.5 5.18 9.46 Favored Glycine 0 N--CA 1.474 1.172 0 CA-C-N 112.995 -1.911 . . . . 2.21 115.041 171.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.466 ' O ' ' N ' ' A' ' 61' ' ' CYS . . . -103.72 158.31 17.14 Favored Glycine 0 C--N 1.336 0.535 0 C-N-CA 120.957 -0.64 . . . . 1.62 112.767 -178.521 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 1.298 ' HA ' ' O ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -88.44 152.69 21.73 Favored 'General case' 0 CA--C 1.477 -1.863 0 CA-C-O 121.367 0.603 . . . . 3.02 112.295 -178.865 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.965 ' HB3' ' HB3' ' A' ' 58' ' ' GLN . 0.1 OUTLIER -73.75 108.2 6.44 Favored 'General case' 1 N--CA 1.374 -4.243 0 N-CA-C 107.254 -1.388 . . . . 1.52 107.254 178.145 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.803 ' HB1' ' CB ' ' A' ' 28' ' ' CYS . . . -80.66 -57.24 3.66 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 104.873 -2.269 . . . . 1.07 104.873 178.098 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.856 ' HB3' HD11 ' A' ' 72' ' ' ILE . . . -154.42 161.8 41.51 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 111.785 -2.461 . . . . 1.0 111.636 -173.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.858 ' HA ' ' O ' ' A' ' 85' ' ' CYS . . . -32.8 122.7 0.36 Allowed 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 114.693 1.368 . . . . 1.24 114.693 -179.058 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.764 ' O ' ' HA ' ' A' ' 81' ' ' GLU . . . 59.45 -5.5 0.09 OUTLIER Glycine 0 CA--C 1.533 1.203 0 N-CA-C 116.801 1.48 . . . . 1.28 116.801 178.322 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.856 HD11 ' HB3' ' A' ' 69' ' ' ALA . 1.9 pp -121.04 100.07 8.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 122.73 1.252 . . . . 2.27 109.85 177.297 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.539 ' HB3' ' HB3' ' A' ' 61' ' ' CYS . 58.5 m -110.25 111.99 23.67 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 113.481 -1.69 . . . . 1.98 110.189 -177.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.583 ' HA ' ' O ' ' A' ' 78' ' ' GLY . 5.3 m -83.46 133.83 34.89 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 113.531 0.937 . . . . 1.33 113.531 -177.037 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.854 ' HB2' ' HD2' ' A' ' 76' ' ' PRO . 28.9 p -95.62 -179.06 0.86 Allowed Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 113.869 -1.514 . . . . 1.99 107.248 177.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.854 ' HD2' ' HB2' ' A' ' 75' ' ' SER . 57.5 Cg_endo -71.61 31.11 0.24 Allowed 'Trans proline' 0 CA--C 1.532 0.376 0 CA-C-N 120.56 1.236 . . . . 1.86 112.113 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.503 ' H ' ' C ' ' A' ' 75' ' ' SER . 3.0 p30 -145.67 -46.09 0.21 Allowed 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 115.899 -0.591 . . . . 2.65 111.661 179.43 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 1.142 ' HA3' ' O ' ' B' ' 179' ' ' CYS . . . -160.76 -151.54 6.26 Favored Glycine 0 C--N 1.349 1.28 0 C-N-CA 120.314 -0.946 . . . . 0.99 115.242 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 1.175 ' O ' ' HA3' ' B' ' 178' ' ' GLY . 32.3 m -128.87 133.75 48.05 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-O 123.377 1.561 . . . . 1.34 110.703 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 28.8 p80 -146.04 135.2 22.76 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 112.27 -2.241 . . . . 2.17 112.495 -169.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.764 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 34.4 mt-10 -51.91 123.88 11.38 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 114.132 -1.395 . . . . 3.05 111.067 -179.454 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.401 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 0.0 OUTLIER -146.78 126.04 6.52 Favored Pre-proline 0 C--N 1.317 -0.845 0 CA-C-N 115.044 -0.98 . . . . 2.02 109.293 -179.656 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.745 ' HB3' ' HB1' ' A' ' 89' ' ' ALA . 71.8 Cg_exo -54.77 -13.53 6.19 Favored 'Trans proline' 0 N--CA 1.482 0.838 0 C-N-CA 124.038 3.158 . . . . 1.93 116.21 -177.12 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.737 ' HB3' ' SG ' ' A' ' 61' ' ' CYS . . . -71.42 -32.1 67.99 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 115.094 1.516 . . . . 1.53 115.094 -177.419 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.858 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 0.1 OUTLIER -91.15 -4.24 56.34 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 115.262 1.579 . . . . 1.88 115.262 -176.158 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.736 ' O ' ' N ' ' A' ' 88' ' ' GLU . 2.2 t70 -117.69 84.9 20.64 Favored Pre-proline 0 C--N 1.32 -0.696 0 N-CA-C 113.215 0.82 . . . . 3.6 113.215 -178.737 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -49.49 65.47 0.02 OUTLIER 'Trans proline' 0 CA--C 1.546 1.076 0 C-N-CA 123.754 2.969 . . . . 2.56 113.192 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.736 ' N ' ' O ' ' A' ' 86' ' ' ASP . 12.7 pt-20 179.48 21.99 0.0 OUTLIER 'General case' 0 CA--C 1.591 2.521 0 C-N-CA 130.935 3.694 . . . . 4.72 110.186 169.594 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.745 ' HB1' ' HB3' ' A' ' 83' ' ' PRO . . . -51.81 -3.43 0.02 OUTLIER 'General case' 0 C--N 1.313 -0.982 0 O-C-N 119.027 -2.296 . . . . 5.29 115.411 -167.239 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.446 ' H ' ' C ' ' A' ' 88' ' ' GLU . . . -24.75 135.9 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 114.248 1.203 . . . . 6.98 114.248 -176.644 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -88.24 136.07 33.15 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 113.545 -1.661 . . . . 10.21 111.82 -178.626 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 2.9 t . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.327 -0.844 . . . . 11.77 111.399 179.163 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.415 0 N-CA-C 109.739 -0.467 . . . . 10.07 109.739 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 102' ' ' VAL . . . . . 0.616 ' C ' HD22 ' B' ' 103' ' ' LEU . 4.2 m -85.78 168.58 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 116.613 -2.035 . . . . 8.41 110.62 -175.132 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 103' ' ' LEU . . . . . 0.709 ' H ' ' HD2' ' B' ' 153' ' ' PRO . 4.3 mm? -123.33 105.58 9.97 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 120.93 1.696 . . . . 5.87 109.518 175.441 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 104' ' ' ASP . . . . . 1.088 ' O ' ' HA ' ' B' ' 155' ' ' GLN . 0.5 OUTLIER -73.84 -87.97 0.03 OUTLIER 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 116.293 -2.163 . . . . 6.27 108.866 179.44 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 105' ' ' LEU . . . . . 0.509 ' O ' ' HG ' ' B' ' 105' ' ' LEU . 23.2 tp -156.5 41.57 0.36 Allowed 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 112.334 -2.212 . . . . 7.2 111.306 -177.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 106' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -95.55 -48.45 5.82 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 122.367 1.08 . . . . 8.55 108.705 176.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 107' ' ' VAL . . . . . 0.413 ' O ' HD12 ' B' ' 103' ' ' LEU . 8.7 p -155.61 125.67 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.948 0 CA-C-N 113.047 -1.888 . . . . 7.48 106.059 177.63 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 108' ' ' ARG . . . . . 1.097 ' HB2' ' HG2' ' B' ' 155' ' ' GLN . 0.0 OUTLIER -74.27 111.12 9.13 Favored 'General case' 0 N--CA 1.398 -3.039 0 N-CA-C 107.416 -1.327 . . . . 9.12 107.416 -177.374 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 3.7 m -106.94 95.42 5.71 Favored 'General case' 0 N--CA 1.399 -2.988 0 N-CA-C 101.544 -3.502 . . . . 5.69 101.544 172.017 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 110' ' ' CYS . . . . . 1.095 ' HB3' ' HG2' ' B' ' 120' ' ' ARG . 0.6 OUTLIER -84.32 103.86 13.85 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 111.916 -2.402 . . . . 2.61 111.854 178.875 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 111' ' ' LEU . . . . . 0.76 ' O ' ' HA ' ' B' ' 120' ' ' ARG . 4.2 mm? -30.64 108.54 0.26 Allowed Pre-proline 0 N--CA 1.474 0.743 0 CA-C-N 118.799 0.727 . . . . 2.47 110.271 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 112' ' ' PRO . . . . . 0.734 ' HA ' ' O ' ' B' ' 119' ' ' GLY . 49.9 Cg_endo -100.87 111.93 0.06 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.896 2.397 . . . . 1.47 115.3 -177.565 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.757 ' HB2' ' HB3' ' B' ' 143' ' ' ARG . 0.1 OUTLIER -129.79 -156.75 0.78 Allowed 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 116.849 -0.159 . . . . 1.0 110.81 -178.476 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 114' ' ' GLY . . . . . 0.613 ' N ' ' SG ' ' B' ' 113' ' ' CYS . . . 80.45 -158.82 42.03 Favored Glycine 0 CA--C 1.506 -0.479 0 CA-C-O 118.714 -1.048 . . . . 1.16 111.276 -177.427 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 115' ' ' PRO . . . . . 0.529 ' HD3' ' HG2' ' B' ' 140' ' ' GLU . 88.4 Cg_endo -64.97 82.82 0.18 Allowed 'Trans proline' 0 CA--C 1.508 -0.809 0 CA-C-N 120.871 2.336 . . . . 1.57 115.659 -176.259 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 116' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' B' ' 114' ' ' GLY . . . 88.95 0.71 80.79 Favored Glycine 0 N--CA 1.415 -2.754 0 CA-C-N 111.949 -2.387 . . . . 1.7 115.096 -178.172 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 117' ' ' GLY . . . . . 0.645 ' O ' ' HB2' ' B' ' 112' ' ' PRO . . . 93.07 33.27 7.39 Favored Glycine 0 N--CA 1.429 -1.823 0 CA-C-N 120.577 2.189 . . . . 1.38 117.359 174.701 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -94.02 -14.03 26.29 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 112.828 0.677 . . . . 2.54 112.828 177.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 119' ' ' GLY . . . . . 0.734 ' O ' ' HA ' ' B' ' 112' ' ' PRO . . . -111.98 -174.63 19.68 Favored Glycine 0 C--N 1.345 1.072 0 CA-C-O 117.37 -1.794 . . . . 1.04 108.907 179.042 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 1.095 ' HG2' ' HB3' ' B' ' 110' ' ' CYS . 0.2 OUTLIER -123.59 175.36 6.85 Favored 'General case' 0 C--N 1.349 0.584 0 CA-C-N 122.52 3.16 . . . . 2.89 110.318 -179.032 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 121' ' ' CYS . . . . . . . . . . . . . 10.9 m -106.94 156.56 18.58 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.171 0.51 . . . . 1.07 112.123 -179.118 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 122' ' ' PHE . . . . . 0.576 ' HE1' ' O ' ' B' ' 128' ' ' CYS . 56.2 m-85 -143.53 17.11 1.84 Allowed 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.497 -0.774 . . . . 1.53 111.163 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 123' ' ' GLY . . . . . 0.532 ' O ' ' HB3' ' B' ' 144' ' ' CYS . . . 162.28 -144.0 9.28 Favored Glycine 0 CA--C 1.519 0.289 0 C-N-CA 120.856 -0.688 . . . . 0.9 112.139 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 124' ' ' PRO . . . . . 0.493 ' O ' ' HB2' ' B' ' 144' ' ' CYS . 12.1 Cg_endo -89.99 -73.05 0.0 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 123.016 2.477 . . . . 1.51 112.607 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 125' ' ' SER . . . . . 0.438 ' O ' ' HA ' ' B' ' 136' ' ' VAL . 0.4 OUTLIER -91.28 35.31 0.93 Allowed 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 110.108 -0.33 . . . . 1.25 110.108 179.431 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 126' ' ' ILE . . . . . 0.914 ' CG1' HG13 ' B' ' 136' ' ' VAL . 17.9 mt -139.38 98.14 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 114.007 1.114 . . . . 0.85 114.007 -178.02 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 127' ' ' CYS . . . . . 0.834 ' HB2' ' HA ' ' B' ' 141' ' ' ALA . 3.7 t -119.83 109.31 15.43 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 107.553 -1.277 . . . . 0.89 107.553 176.345 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 128' ' ' CYS . . . . . 0.751 ' HB3' ' O ' ' B' ' 133' ' ' GLY . 3.7 m -132.31 148.13 52.42 Favored 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 115.259 1.577 . . . . 1.23 115.259 -175.579 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 129' ' ' GLY . . . . . 0.47 ' O ' ' HB2' ' B' ' 169' ' ' ALA . . . -126.9 -168.1 12.48 Favored Glycine 0 N--CA 1.429 -1.812 0 N-CA-C 109.874 -1.291 . . . . 0.66 109.874 179.156 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 130' ' ' ASP . . . . . 0.427 ' OD2' ' HG2' ' B' ' 131' ' ' GLU . 17.9 p-10 -69.1 -54.01 17.28 Favored 'General case' 0 CA--C 1.491 -1.303 0 C-N-CA 123.396 0.678 . . . . 2.35 112.199 -179.091 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 131' ' ' GLU . . . . . 0.427 ' HG2' ' OD2' ' B' ' 130' ' ' ASP . 0.3 OUTLIER -119.56 28.11 8.36 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 117.495 -1.682 . . . . 1.69 109.215 179.609 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 132' ' ' LEU . . . . . 0.737 HD22 ' CE1' ' B' ' 135' ' ' PHE . 0.7 OUTLIER -121.47 -12.2 8.6 Favored 'General case' 0 N--CA 1.424 -1.741 0 N-CA-C 104.289 -2.485 . . . . 1.38 104.289 -175.709 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 133' ' ' GLY . . . . . 0.756 ' HA2' ' CB ' ' B' ' 169' ' ' ALA . . . 48.91 -136.08 20.1 Favored Glycine 0 N--CA 1.407 -3.249 0 CA-C-N 112.831 -1.986 . . . . 0.72 113.359 176.334 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 134' ' ' CYS . . . . . 0.802 ' HB2' HD13 ' B' ' 172' ' ' ILE . 1.1 m -118.88 125.7 50.1 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.273 1.212 . . . . 1.08 114.273 -176.584 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 135' ' ' PHE . . . . . 0.804 ' HB3' ' CG2' ' B' ' 138' ' ' THR . 8.8 m-85 -102.17 104.2 14.77 Favored 'General case' 0 N--CA 1.431 -1.394 1 N-CA-C 99.508 -4.256 . . . . 1.36 99.508 169.628 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 136' ' ' VAL . . . . . 0.914 HG13 ' CG1' ' B' ' 126' ' ' ILE . 2.5 t -103.43 89.3 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.629 0 CA-C-O 122.594 1.188 . . . . 0.75 110.17 -176.257 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 137' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' B' ' 125' ' ' SER . . . 119.24 -47.61 1.01 Allowed Glycine 0 CA--C 1.519 0.3 0 CA-C-N 113.688 -1.596 . . . . 0.83 115.582 179.177 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 138' ' ' THR . . . . . 0.804 ' CG2' ' HB3' ' B' ' 135' ' ' PHE . 3.5 t -50.52 179.53 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 117.418 0.609 . . . . 0.78 112.266 -178.47 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 139' ' ' ALA . . . . . 0.847 ' HA ' HD12 ' B' ' 142' ' ' LEU . . . -58.08 -36.3 72.65 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.938 -1.028 . . . . 1.04 111.09 -178.712 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 140' ' ' GLU . . . . . 0.529 ' HG2' ' HD3' ' B' ' 115' ' ' PRO . 1.3 mp0 -53.82 -27.71 31.08 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.761 0.282 . . . . 2.31 111.761 -178.384 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 141' ' ' ALA . . . . . 0.834 ' HA ' ' HB2' ' B' ' 127' ' ' CYS . . . -88.46 -33.82 17.69 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 116.123 -0.49 . . . . 0.87 109.929 -179.548 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 142' ' ' LEU . . . . . 0.847 HD12 ' HA ' ' B' ' 139' ' ' ALA . 6.2 mt -42.31 -41.15 2.7 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.013 -0.54 . . . . 1.24 111.748 -178.692 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 143' ' ' ARG . . . . . 0.757 ' HB3' ' HB2' ' B' ' 113' ' ' CYS . 0.0 OUTLIER -52.55 -26.15 12.44 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 109.354 -0.61 . . . . 2.93 109.354 178.073 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 144' ' ' CYS . . . . . 0.532 ' HB3' ' O ' ' B' ' 123' ' ' GLY . 56.9 m -61.2 -16.56 46.17 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.316 -1.311 . . . . 1.61 110.702 -176.147 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 68.4 tp60 -52.68 -22.38 5.08 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 111.879 0.326 . . . . 3.35 111.879 -179.137 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -85.79 3.02 43.33 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 119.602 -0.839 . . . . 3.76 110.968 -179.29 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -82.76 3.3 29.88 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 116.056 -0.52 . . . . 4.01 109.686 177.623 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 148' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -84.95 -27.49 26.49 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 116.092 -0.504 . . . . 3.92 110.703 179.133 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 149' ' ' TYR . . . . . 0.421 ' HD1' ' H ' ' B' ' 149' ' ' TYR . 0.4 OUTLIER -124.06 42.23 3.29 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.936 0.398 . . . . 5.73 111.555 -179.455 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 150' ' ' LEU . . . . . 0.69 ' CD2' HD11 ' B' ' 111' ' ' LEU . 0.5 OUTLIER -147.09 98.36 4.05 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.815 -0.629 . . . . 5.46 110.525 178.939 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 151' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -79.5 46.46 2.22 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.581 2.187 . . . . 5.02 112.983 -179.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 152' ' ' SER . . . . . 0.467 ' HB3' HD23 ' B' ' 103' ' ' LEU . 50.3 m -95.48 107.11 30.93 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 116.468 -0.333 . . . . 5.73 111.214 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 153' ' ' PRO . . . . . 0.709 ' HD2' ' H ' ' B' ' 103' ' ' LEU . 92.6 Cg_endo -79.46 -24.43 6.41 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 123.046 2.498 . . . . 5.1 112.691 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 154' ' ' CYS . . . . . 0.577 ' SG ' ' HG3' ' B' ' 108' ' ' ARG . 53.5 t 66.0 98.12 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.284 -0.416 . . . . 2.68 111.421 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 155' ' ' GLN . . . . . 1.097 ' HG2' ' HB2' ' B' ' 108' ' ' ARG . 0.5 OUTLIER 21.75 -104.61 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 114.366 1.247 . . . . 5.63 114.366 178.914 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 156' ' ' SER . . . . . 0.652 ' HA ' ' HE3' ' B' ' 159' ' ' LYS . 7.5 t -168.15 146.22 4.34 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 108.728 -0.842 . . . . 3.11 108.728 -178.764 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 176.41 -87.6 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 119.926 -1.13 . . . . 2.07 112.967 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 158' ' ' GLN . . . . . 0.986 ' HB3' ' HB3' ' B' ' 167' ' ' CYS . 16.6 mt-30 -120.92 71.22 0.93 Allowed 'General case' 0 N--CA 1.418 -2.047 0 CA-C-O 122.151 0.976 . . . . 4.34 109.292 179.439 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 159' ' ' LYS . . . . . 1.252 ' O ' ' HA ' ' B' ' 166' ' ' ARG . 0.0 OUTLIER -107.28 -58.57 0.05 OUTLIER Pre-proline 0 C--O 1.205 -1.238 0 CA-C-O 123.72 1.724 . . . . 3.54 110.701 174.48 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 160' ' ' PRO . . . . . 0.697 ' HD2' ' H ' ' B' ' 159' ' ' LYS . 49.5 Cg_endo -85.03 108.0 1.12 Allowed 'Trans proline' 0 N--CA 1.442 -1.553 0 C-N-CA 122.466 2.11 . . . . 1.51 114.76 -176.542 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 161' ' ' CYS . . . . . 0.708 ' SG ' ' HB3' ' B' ' 184' ' ' ALA . 3.1 t -143.87 -177.8 5.61 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 113.452 -1.704 . . . . 1.58 108.632 178.609 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 162' ' ' GLY . . . . . 0.506 ' O ' ' O ' ' B' ' 161' ' ' CYS . . . 35.49 -166.58 0.01 OUTLIER Glycine 0 CA--C 1.519 0.309 0 C-N-CA 121.077 -0.583 . . . . 2.37 114.414 176.481 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.89 51.47 1.74 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 121.052 -0.259 . . . . 4.07 111.238 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 119.64 3.83 12.22 Favored Glycine 0 CA--C 1.529 0.93 0 N-CA-C 114.631 0.613 . . . . 2.2 114.631 178.106 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 165' ' ' GLY . . . . . 0.48 ' O ' ' N ' ' B' ' 161' ' ' CYS . . . -102.73 157.85 17.99 Favored Glycine 0 C--O 1.226 -0.385 0 C-N-CA 120.143 -1.027 . . . . 1.62 112.754 179.665 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 166' ' ' ARG . . . . . 1.252 ' HA ' ' O ' ' B' ' 159' ' ' LYS . 0.0 OUTLIER -88.57 152.59 21.75 Favored 'General case' 0 CA--C 1.48 -1.73 0 C-N-CA 120.325 -0.55 . . . . 3.05 111.962 -179.625 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 167' ' ' CYS . . . . . 0.986 ' HB3' ' HB3' ' B' ' 158' ' ' GLN . 0.1 OUTLIER -73.68 108.42 6.51 Favored 'General case' 1 N--CA 1.375 -4.212 0 N-CA-C 107.261 -1.385 . . . . 1.56 107.261 178.15 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' B' B ' 168' ' ' ALA . . . . . 0.751 ' HB1' ' HB2' ' B' ' 128' ' ' CYS . . . -83.5 -49.36 9.34 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 117.627 -1.629 . . . . 1.04 107.065 178.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 169' ' ' ALA . . . . . 0.866 ' HB3' HD11 ' B' ' 172' ' ' ILE . . . -161.08 161.54 31.3 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 112.5 -2.136 . . . . 0.98 111.03 -175.763 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 170' ' ' ALA . . . . . 0.871 ' HA ' ' O ' ' B' ' 185' ' ' CYS . . . -32.69 123.31 0.35 Allowed 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 114.846 1.424 . . . . 1.25 114.846 -179.143 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 171' ' ' GLY . . . . . 0.711 ' O ' ' HA ' ' B' ' 181' ' ' GLU . . . 65.16 -19.18 0.12 Allowed Glycine 0 CA--C 1.529 0.962 0 N-CA-C 116.47 1.348 . . . . 1.29 116.47 177.806 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 172' ' ' ILE . . . . . 0.866 HD11 ' HB3' ' B' ' 169' ' ' ALA . 2.0 pp -113.16 101.37 12.4 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 CA-C-O 122.684 1.231 . . . . 2.27 110.529 -179.33 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 173' ' ' CYS . . . . . 0.506 ' HB3' ' HB3' ' B' ' 161' ' ' CYS . 59.3 m -110.27 112.21 24.03 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 113.851 -1.522 . . . . 1.94 110.131 -178.484 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 174' ' ' CYS . . . . . 0.569 ' HA ' ' O ' ' B' ' 178' ' ' GLY . 5.5 m -83.66 133.75 34.81 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 113.56 0.948 . . . . 1.35 113.56 -176.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 175' ' ' SER . . . . . 0.828 ' HB2' ' HD2' ' B' ' 176' ' ' PRO . 28.3 p -95.66 -178.99 0.85 Allowed Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 113.893 -1.503 . . . . 2.0 107.238 177.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 176' ' ' PRO . . . . . 0.828 ' HD2' ' HB2' ' B' ' 175' ' ' SER . 57.4 Cg_endo -71.65 31.08 0.25 Allowed 'Trans proline' 0 CA--C 1.532 0.405 0 CA-C-N 120.584 1.244 . . . . 1.9 112.106 -179.669 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 177' ' ' ASP . . . . . 0.498 ' H ' ' C ' ' B' ' 175' ' ' SER . 3.0 p30 -145.58 -46.01 0.21 Allowed 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 115.906 -0.588 . . . . 2.72 111.743 179.422 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 178' ' ' GLY . . . . . 1.175 ' HA3' ' O ' ' A' ' 79' ' ' CYS . . . -161.07 -151.19 6.15 Favored Glycine 0 C--N 1.35 1.335 0 C-N-CA 120.295 -0.955 . . . . 0.99 115.033 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 179' ' ' CYS . . . . . 1.142 ' O ' ' HA3' ' A' ' 78' ' ' GLY . 32.7 m -128.66 139.35 52.29 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 122.649 1.214 . . . . 1.34 110.195 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 180' ' ' HIS . . . . . . . . . . . . . 33.3 p80 -156.87 133.11 9.79 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 123.619 1.676 . . . . 2.1 112.367 -168.407 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 181' ' ' GLU . . . . . 0.711 ' HA ' ' O ' ' B' ' 171' ' ' GLY . 33.8 mt-10 -49.55 123.14 7.19 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 110.967 -2.833 . . . . 3.06 110.733 -177.323 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 182' ' ' ASP . . . . . 0.403 ' HA ' ' HD3' ' B' ' 183' ' ' PRO . 0.1 OUTLIER -146.79 126.06 6.52 Favored Pre-proline 0 C--N 1.315 -0.916 0 CA-C-N 114.677 -1.147 . . . . 2.06 109.103 -179.725 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 183' ' ' PRO . . . . . 0.669 ' HB3' ' CB ' ' B' ' 189' ' ' ALA . 72.5 Cg_exo -54.82 -13.53 6.26 Favored 'Trans proline' 0 N--CA 1.482 0.85 0 C-N-CA 123.981 3.121 . . . . 1.91 116.241 -177.178 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 184' ' ' ALA . . . . . 0.708 ' HB3' ' SG ' ' B' ' 161' ' ' CYS . . . -71.77 -31.59 66.78 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 114.974 1.472 . . . . 1.56 114.974 -177.265 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 185' ' ' CYS . . . . . 0.871 ' O ' ' HA ' ' B' ' 170' ' ' ALA . 0.1 OUTLIER -91.1 -4.55 56.16 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 115.298 1.592 . . . . 1.94 115.298 -176.329 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 186' ' ' ASP . . . . . 0.669 ' O ' ' N ' ' B' ' 188' ' ' GLU . 2.2 t70 -117.88 85.23 22.34 Favored Pre-proline 0 C--N 1.321 -0.664 0 N-CA-C 113.392 0.886 . . . . 3.61 113.392 -178.753 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -49.3 63.47 0.02 OUTLIER 'Trans proline' 0 CA--C 1.555 1.565 0 C-N-CA 123.955 3.103 . . . . 2.58 114.945 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 188' ' ' GLU . . . . . 0.669 ' N ' ' O ' ' B' ' 186' ' ' ASP . 13.5 pt-20 174.67 49.44 0.0 OUTLIER 'General case' 1 N--CA 1.379 -4.002 1 C-N-CA 133.246 4.618 . . . . 4.7 104.799 171.088 . . . . . . . . 4 3 . 1 . 013 nuclear build full ' B' B ' 189' ' ' ALA . . . . . 0.669 ' CB ' ' HB3' ' B' ' 183' ' ' PRO . . . -77.22 11.75 1.76 Allowed 'General case' 0 C--N 1.303 -1.419 1 CA-C-N 129.21 5.459 . . . . 5.24 114.012 -178.245 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 190' ' ' ALA . . . . . 0.457 ' C ' ' O ' ' B' ' 189' ' ' ALA . . . -28.76 137.77 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.947 0.721 . . . . 6.93 112.947 -178.336 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 191' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -89.28 136.16 33.18 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.966 -1.015 . . . . 10.14 111.564 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 3.1 t . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.337 -0.84 . . . . 11.7 111.454 179.054 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 121.192 0.52 . . . . 9.95 111.312 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.817 HG23 ' HB3' ' A' ' 6' ' ' ASP . 1.5 m -135.43 126.82 45.47 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.122 0 CA-C-N 115.308 -0.86 . . . . 8.02 112.416 178.315 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.678 ' HA ' ' HA ' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -80.49 111.98 17.4 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 106.265 -1.754 . . . . 5.86 106.265 175.327 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -169.73 -101.36 0.01 OUTLIER 'General case' 0 N--CA 1.421 -1.922 0 CA-C-N 111.681 -2.509 . . . . 6.22 106.198 171.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 16.8 tp -142.08 12.24 2.01 Favored 'General case' 0 CA--C 1.503 -0.861 0 CA-C-N 112.249 -2.251 . . . . 7.09 109.321 178.289 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.817 ' HB3' HG23 ' A' ' 2' ' ' VAL . 0.9 OUTLIER -80.56 -83.54 0.11 Allowed 'General case' 0 CA--C 1.483 -1.603 0 N-CA-C 101.375 -3.565 . . . . 8.78 101.375 175.426 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.618 ' HA ' ' CG ' ' A' ' 55' ' ' GLN . 1.8 p -139.18 117.7 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.157 1 N-CA-C 99.993 -4.077 . . . . 7.51 99.993 165.332 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.978 ' HB2' ' H ' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -79.26 119.16 21.93 Favored 'General case' 0 CA--C 1.485 -1.543 0 CA-C-N 122.736 2.516 . . . . 9.08 107.742 177.831 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.1 t -65.22 104.9 0.99 Allowed 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 114.211 -2.995 . . . . 5.66 107.593 -179.085 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.608 ' HB2' ' HG2' ' A' ' 20' ' ' ARG . 77.3 m -80.23 112.88 17.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 113.831 -1.532 . . . . 2.68 112.525 178.597 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.501 ' C ' ' O ' ' A' ' 10' ' ' CYS . 17.4 mt -30.8 136.17 0.21 Allowed Pre-proline 0 N--CA 1.477 0.884 0 CA-C-N 119.033 0.833 . . . . 2.48 111.251 177.834 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.776 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 41.5 Cg_endo -69.55 147.88 65.18 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.763 2.308 . . . . 1.49 114.881 -178.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.734 ' N ' ' O ' ' A' ' 19' ' ' GLY . 0.0 OUTLIER -149.91 -166.39 2.53 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-O 121.659 0.742 . . . . 1.0 110.951 176.675 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.636 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . 76.16 -159.59 50.54 Favored Glycine 0 C--N 1.337 0.624 0 CA-C-N 114.683 -1.144 . . . . 1.15 114.767 175.269 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.619 ' HD2' HD21 ' A' ' 32' ' ' LEU . 62.8 Cg_endo -62.1 101.94 0.25 Allowed 'Trans proline' 0 CA--C 1.511 -0.625 0 C-N-CA 124.301 3.334 . . . . 1.57 110.645 177.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.53 -7.74 75.04 Favored Glycine 0 C--N 1.268 -3.198 0 CA-C-N 113.901 -1.499 . . . . 1.68 112.422 179.124 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.412 ' O ' ' HB2' ' A' ' 12' ' ' PRO . . . 79.33 49.48 6.24 Favored Glycine 0 N--CA 1.397 -3.925 0 C-N-CA 119.714 -1.231 . . . . 1.36 113.515 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.73 -49.91 6.02 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 103.567 -2.753 . . . . 2.5 103.567 173.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.776 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -67.6 165.1 44.69 Favored Glycine 0 C--O 1.219 -0.816 0 C-N-CA 117.985 -2.055 . . . . 1.02 117.404 -165.523 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.608 ' HG2' ' HB2' ' A' ' 10' ' ' CYS . 0.1 OUTLIER -104.03 147.05 27.83 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 112.691 -1.755 . . . . 2.92 114.667 -172.864 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.448 ' O ' ' HB3' ' A' ' 10' ' ' CYS . 74.1 m -108.9 139.56 43.57 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 114.785 -1.098 . . . . 1.1 111.423 -179.532 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.631 ' CE1' ' HB2' ' A' ' 28' ' ' CYS . 1.4 m-85 -124.41 -9.78 7.47 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.238 -0.437 . . . . 1.51 112.065 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.491 ' HA3' ' OE2' ' B' ' 181' ' ' GLU . . . -159.05 -161.12 10.86 Favored Glycine 0 C--N 1.334 0.459 0 C-N-CA 120.677 -0.773 . . . . 0.9 112.576 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.559 ' HD2' ' HG2' ' B' ' 181' ' ' GLU . 7.6 Cg_exo -69.76 -53.02 0.29 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.967 2.445 . . . . 1.5 112.24 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.598 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.4 OUTLIER -118.78 44.25 2.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.015 -0.539 . . . . 1.26 110.841 -179.756 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 1.118 HG12 HG13 ' A' ' 36' ' ' VAL . 59.8 mt -142.52 121.21 8.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 N-CA-C 112.609 0.596 . . . . 0.83 112.609 -179.059 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.83 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 6.4 t -135.45 144.2 46.32 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-N 115.417 -0.811 . . . . 0.92 109.075 178.603 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.933 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 0.5 OUTLIER -136.35 157.66 46.27 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 122.361 1.076 . . . . 1.28 113.884 -177.08 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.609 ' O ' ' HB1' ' A' ' 69' ' ' ALA . . . -151.05 169.33 30.76 Favored Glycine 0 N--CA 1.416 -2.653 0 CA-C-N 113.812 -1.54 . . . . 0.67 110.561 176.57 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.457 ' OD2' ' HG3' ' A' ' 31' ' ' GLU . 15.3 p-10 -64.37 -48.4 75.64 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 122.79 1.281 . . . . 2.27 108.695 178.623 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.457 ' HG3' ' OD2' ' A' ' 30' ' ' ASP . 1.3 mt-10 -120.38 17.15 12.21 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 113.149 -1.842 . . . . 1.66 109.157 179.543 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.756 HD23 ' CZ ' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -120.2 -2.71 10.1 Favored 'General case' 0 N--CA 1.411 -2.422 0 C-N-CA 123.71 0.804 . . . . 1.37 109.334 -177.275 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.933 ' O ' ' HA ' ' A' ' 28' ' ' CYS . . . 47.63 -131.41 16.42 Favored Glycine 0 N--CA 1.433 -1.557 0 CA-C-N 114.887 -1.051 . . . . 0.73 113.616 178.041 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.893 ' HB2' HD13 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -138.68 113.27 8.96 Favored 'General case' 0 CA--C 1.481 -1.699 0 CA-C-N 118.546 1.173 . . . . 1.08 112.119 179.365 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.756 ' CZ ' HD23 ' A' ' 32' ' ' LEU . 26.5 m-85 -86.49 108.12 18.39 Favored 'General case' 0 N--CA 1.425 -1.722 0 N-CA-C 104.993 -2.225 . . . . 1.38 104.993 176.063 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 1.118 HG13 HG12 ' A' ' 26' ' ' ILE . 5.1 t -91.77 85.42 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.756 0 C-N-CA 118.341 -1.344 . . . . 0.76 108.933 -179.098 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.736 ' HA3' HG22 ' B' ' 172' ' ' ILE . . . 89.37 108.12 1.18 Allowed Glycine 0 CA--C 1.524 0.655 0 CA-C-N 112.918 -1.946 . . . . 0.81 115.159 179.179 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.511 HG21 ' HB3' ' A' ' 35' ' ' PHE . 0.1 OUTLIER 179.36 168.31 1.06 Allowed 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 107.904 -1.147 . . . . 0.77 107.904 178.588 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.887 ' HA ' HD12 ' A' ' 42' ' ' LEU . . . -55.52 -32.93 63.34 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 120.547 1.521 . . . . 1.02 114.008 -177.499 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.598 ' HG2' ' HA2' ' A' ' 14' ' ' GLY . 0.2 OUTLIER -65.27 -23.18 66.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.059 0.457 . . . . 2.32 110.561 179.712 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.584 ' O ' ' N ' ' A' ' 44' ' ' CYS . . . -95.9 -14.71 22.91 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 116.069 -0.514 . . . . 0.87 110.906 -179.042 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.887 HD12 ' HA ' ' A' ' 39' ' ' ALA . 4.7 mt -46.25 -44.37 16.32 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-N 119.042 0.837 . . . . 1.23 112.379 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.43 ' HD2' ' O ' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -61.91 -10.88 10.59 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 120.095 -0.642 . . . . 2.92 109.68 178.101 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.584 ' N ' ' O ' ' A' ' 41' ' ' ALA . 38.5 m -76.6 4.81 8.57 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 114.171 -1.377 . . . . 1.57 110.155 174.752 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.607 ' HB2' ' O ' ' A' ' 42' ' ' LEU . 0.7 OUTLIER -78.79 -18.6 53.88 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.982 -0.554 . . . . 3.31 111.268 179.337 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.567 ' HA ' ' CD2' ' A' ' 49' ' ' TYR . 16.8 tt0 -86.92 -0.37 56.41 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.051 -0.66 . . . . 3.69 110.539 -179.64 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.03 3.67 29.34 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 109.537 -0.542 . . . . 3.99 109.537 177.55 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -97.36 -28.22 14.13 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 116.131 -0.486 . . . . 3.86 109.997 178.704 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.567 ' CD2' ' HA ' ' A' ' 46' ' ' GLU . 43.2 m-85 -69.88 8.92 0.61 Allowed 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.238 0.459 . . . . 5.68 112.238 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.7 mt -131.18 121.17 18.51 Favored Pre-proline 0 CA--C 1.529 0.146 0 O-C-N 122.348 -0.22 . . . . 5.4 111.23 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -80.73 48.93 3.06 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.353 2.035 . . . . 4.92 112.203 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 61.9 p -139.66 159.59 64.64 Favored Pre-proline 0 CA--C 1.531 0.231 0 CA-C-N 116.3 -0.409 . . . . 5.64 110.812 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.41 ' O ' ' CD ' ' A' ' 8' ' ' ARG . 2.2 Cg_endo -82.89 -163.63 0.22 Allowed 'Trans proline' 0 CA--C 1.535 0.541 0 C-N-CA 123.279 2.653 . . . . 5.04 113.524 -179.021 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.836 ' HA ' ' CB ' ' A' ' 8' ' ' ARG . 0.5 OUTLIER -160.5 126.07 3.94 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.64 -0.709 . . . . 2.74 109.398 -179.887 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.978 ' H ' ' HB2' ' A' ' 8' ' ' ARG . 0.7 OUTLIER -48.86 -169.76 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.303 0 CA-C-O 121.963 0.887 . . . . 5.75 112.901 -178.784 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.434 ' HB2' ' HA ' ' A' ' 68' ' ' ALA . 17.7 p 172.88 -162.1 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 114.345 -1.298 . . . . 3.12 108.043 178.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.633 ' HA3' ' O ' ' A' ' 67' ' ' CYS . . . -82.46 151.72 29.89 Favored Glycine 0 N--CA 1.448 -0.539 0 N-CA-C 109.726 -1.35 . . . . 2.1 109.726 -177.232 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 19.7 mm100 -101.88 77.45 1.71 Allowed 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.976 0.893 . . . . 4.36 109.655 179.438 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.497 ' HB2' ' HB2' ' A' ' 67' ' ' CYS . 0.0 OUTLIER -141.77 60.47 11.36 Favored Pre-proline 0 C--N 1.31 -1.13 0 N-CA-C 105.746 -1.946 . . . . 3.55 105.746 179.22 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.546 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 30.7 Cg_endo -63.6 78.18 0.14 Allowed 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 122.605 2.203 . . . . 1.54 114.887 -177.554 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.493 ' O ' ' O ' ' A' ' 65' ' ' GLY . 0.5 OUTLIER -99.26 -176.83 3.42 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 106.468 -1.678 . . . . 1.59 106.468 175.868 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.79 -167.02 51.36 Favored Glycine 0 N--CA 1.442 -0.963 0 C-N-CA 117.945 -2.074 . . . . 2.43 111.809 178.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 20.2 p -86.86 39.41 0.85 Allowed 'General case' 0 N--CA 1.484 1.262 0 CA-C-O 122.223 1.011 . . . . 4.11 111.642 -176.107 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 120.68 10.38 7.1 Favored Glycine 0 C--N 1.35 1.341 0 CA-C-N 114.013 -1.449 . . . . 2.21 113.886 -178.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.493 ' O ' ' O ' ' A' ' 61' ' ' CYS . . . -103.48 132.99 11.26 Favored Glycine 0 C--N 1.336 0.581 0 C-N-CA 119.657 -1.259 . . . . 1.62 115.401 -178.537 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.58 ' HB2' ' O ' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -97.29 152.98 18.34 Favored 'General case' 0 C--N 1.333 -0.126 0 C-N-CA 122.84 0.456 . . . . 3.02 110.441 178.555 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.633 ' O ' ' HA3' ' A' ' 57' ' ' GLY . 1.8 m -65.34 108.47 1.95 Allowed 'General case' 0 C--O 1.22 -0.486 0 C-N-CA 120.002 -0.679 . . . . 1.52 110.269 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.483 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . . . -81.61 -15.55 54.31 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 107.802 -1.184 . . . . 1.07 107.802 176.706 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.859 ' O ' ' O ' ' A' ' 70' ' ' ALA . . . -165.11 162.15 20.02 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 112.801 -2.0 . . . . 1.0 110.405 178.561 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.859 ' O ' ' O ' ' A' ' 69' ' ' ALA . . . -16.99 -138.11 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.078 0.951 . . . . 1.24 113.287 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.583 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . -64.55 61.11 0.07 OUTLIER Glycine 0 N--CA 1.47 0.936 0 N-CA-C 110.184 -1.166 . . . . 1.28 110.184 -179.589 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.893 HD13 ' HB2' ' A' ' 34' ' ' CYS . 0.7 OUTLIER -146.04 106.12 0.69 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.817 0 CA-C-N 114.731 -0.734 . . . . 2.27 109.771 174.962 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.521 ' HB2' ' HB3' ' A' ' 82' ' ' ASP . 0.0 OUTLIER -93.25 83.42 4.62 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 116.236 -0.438 . . . . 1.98 110.407 -179.556 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.861 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 0.1 OUTLIER -83.04 136.63 34.42 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.982 -0.554 . . . . 1.33 110.816 -179.914 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.699 ' HB3' ' HD2' ' A' ' 76' ' ' PRO . 5.0 m -104.76 179.4 0.94 Allowed Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.25 -0.887 . . . . 1.99 109.312 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.699 ' HD2' ' HB3' ' A' ' 75' ' ' SER . 96.4 Cg_endo -79.96 25.08 0.61 Allowed 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 121.443 1.429 . . . . 1.86 111.722 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -145.58 -41.42 0.22 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.609 -0.723 . . . . 2.65 110.213 179.337 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.792 ' HA3' ' O ' ' B' ' 179' ' ' CYS . . . -147.92 -135.29 2.59 Favored Glycine 0 C--N 1.337 0.601 0 C-N-CA 120.574 -0.822 . . . . 0.99 113.07 179.415 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.861 ' HA ' ' HA ' ' A' ' 74' ' ' CYS . 0.1 OUTLIER -146.85 156.45 43.12 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.625 0.25 . . . . 1.34 110.57 179.954 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.474 ' N ' ' O ' ' A' ' 73' ' ' CYS . 1.2 t-80 -142.42 133.76 26.32 Favored 'General case' 0 CA--C 1.519 -0.249 0 O-C-N 121.989 -0.444 . . . . 2.17 111.638 -178.479 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.571 ' CG ' ' HD2' ' B' ' 124' ' ' PRO . 2.3 mt-10 -58.56 128.03 35.12 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.901 -0.591 . . . . 3.05 109.717 178.71 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.521 ' HB3' ' HB2' ' A' ' 73' ' ' CYS . 0.0 OUTLIER -146.28 112.63 4.41 Favored Pre-proline 0 C--N 1.318 -0.799 0 CA-C-N 115.514 -0.766 . . . . 2.02 110.496 -178.928 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.458 ' HA ' ' OD2' ' A' ' 86' ' ' ASP . 1.6 Cg_endo -82.86 -4.4 11.34 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 122.691 2.261 . . . . 1.93 113.231 -179.26 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.99 -35.43 79.94 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.832 0.349 . . . . 1.53 111.048 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.635 ' C ' ' HD3' ' A' ' 87' ' ' PRO . 84.4 m -93.64 49.71 1.39 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.107 -0.497 . . . . 1.88 110.869 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.755 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 16.5 m-20 -116.68 35.19 0.2 Allowed Pre-proline 0 N--CA 1.442 -0.827 0 N-CA-C 112.422 0.527 . . . . 3.6 112.422 179.44 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.71 ' HD3' ' N ' ' A' ' 86' ' ' ASP . 1.6 Cg_endo -78.68 63.2 8.51 Favored 'Trans proline' 0 C--N 1.362 1.259 0 N-CA-C 106.697 -2.078 . . . . 2.56 106.697 176.508 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.471 ' HG3' ' N ' ' A' ' 89' ' ' ALA . 4.6 pt-20 178.11 -30.7 0.01 OUTLIER 'General case' 0 CA--C 1.477 -1.831 0 CA-C-N 112.239 -2.255 . . . . 4.72 110.396 179.652 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.755 ' HB3' ' HB3' ' A' ' 86' ' ' ASP . . . -72.51 49.93 0.22 Allowed 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 110.906 -2.861 . . . . 5.29 111.798 178.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.28 119.6 15.65 Favored 'General case' 0 C--N 1.312 -1.024 0 C-N-CA 127.335 2.254 . . . . 6.98 111.641 178.565 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -71.17 130.44 41.47 Favored 'General case' 0 C--N 1.354 0.765 0 CA-C-N 111.252 -2.704 . . . . 10.21 113.626 -174.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 12.5 t . . . . . 0 C--O 1.248 1.022 0 CA-C-N 114.356 -1.293 . . . . 11.77 110.654 179.378 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 101' ' ' ALA . . . . . 0.603 ' HB3' ' OD2' ' B' ' 104' ' ' ASP . . . . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 121.19 0.519 . . . . 10.07 111.172 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 102' ' ' VAL . . . . . 0.474 ' O ' HG12 ' B' ' 102' ' ' VAL . 23.6 t -86.79 -13.74 10.53 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.329 0 CA-C-O 122.291 1.043 . . . . 8.41 111.361 -175.747 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 103' ' ' LEU . . . . . 1.093 ' HA ' ' HA ' ' B' ' 108' ' ' ARG . 0.3 OUTLIER -153.28 111.18 3.58 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 102.349 -3.204 . . . . 5.87 102.349 176.506 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 104' ' ' ASP . . . . . 0.603 ' OD2' ' HB3' ' B' ' 101' ' ' ALA . 0.4 OUTLIER -165.84 -105.91 0.01 OUTLIER 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 105.902 -1.888 . . . . 6.27 105.902 176.176 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 105' ' ' LEU . . . . . 0.409 ' H ' ' HB3' ' B' ' 104' ' ' ASP . 10.2 tp -133.94 6.54 3.68 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 113.39 -1.732 . . . . 7.2 109.812 176.198 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 106' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.33 -63.83 1.27 Allowed 'General case' 0 CA--C 1.496 -1.12 0 N-CA-C 102.837 -3.023 . . . . 8.55 102.837 176.546 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 107' ' ' VAL . . . . . 0.631 ' HA ' ' CG ' ' B' ' 155' ' ' GLN . 2.7 p -154.48 114.92 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.541 0 N-CA-C 102.93 -2.989 . . . . 7.48 102.93 163.267 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 108' ' ' ARG . . . . . 1.093 ' HA ' ' HA ' ' B' ' 103' ' ' LEU . 0.0 OUTLIER -80.11 117.42 20.91 Favored 'General case' 0 CA--C 1.475 -1.913 0 CA-C-N 122.17 2.259 . . . . 9.12 107.638 178.436 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 109' ' ' THR . . . . . 0.412 ' CG2' HD23 ' B' ' 103' ' ' LEU . 2.5 t -63.9 105.27 0.81 Allowed 'General case' 0 C--N 1.317 -0.809 0 C-N-CA 114.256 -2.978 . . . . 5.69 107.437 -179.226 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 110' ' ' CYS . . . . . 0.62 ' HB2' ' HG2' ' B' ' 120' ' ' ARG . 79.7 m -81.63 111.21 17.7 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 113.76 -1.564 . . . . 2.61 112.653 178.793 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 111' ' ' LEU . . . . . 0.509 ' C ' ' O ' ' B' ' 110' ' ' CYS . 17.8 mt -29.82 136.07 0.18 Allowed Pre-proline 0 N--CA 1.475 0.796 0 CA-C-N 119.034 0.834 . . . . 2.47 111.369 178.412 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 112' ' ' PRO . . . . . 0.819 ' HA ' ' O ' ' B' ' 119' ' ' GLY . 33.6 Cg_endo -65.32 151.99 83.49 Favored 'Trans proline' 0 CA--C 1.536 0.587 0 C-N-CA 123.383 2.722 . . . . 1.47 113.541 -179.34 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.748 ' N ' ' O ' ' B' ' 119' ' ' GLY . 0.0 OUTLIER -156.77 -168.69 2.75 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.232 0.539 . . . . 1.0 111.222 175.471 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 114' ' ' GLY . . . . . 0.66 ' N ' ' SG ' ' B' ' 113' ' ' CYS . . . 76.14 -159.76 50.71 Favored Glycine 0 C--N 1.334 0.437 0 CA-C-N 115.479 -0.782 . . . . 1.16 114.902 176.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 115' ' ' PRO . . . . . 0.618 ' HD2' HD21 ' B' ' 132' ' ' LEU . 68.2 Cg_endo -62.28 98.31 0.18 Allowed 'Trans proline' 0 CA--C 1.511 -0.629 0 C-N-CA 124.215 3.277 . . . . 1.57 112.066 178.684 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 84.76 3.07 88.38 Favored Glycine 0 C--N 1.284 -2.312 0 CA-C-N 113.63 -1.623 . . . . 1.7 113.132 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 117' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' B' ' 112' ' ' PRO . . . 76.46 41.31 25.55 Favored Glycine 0 N--CA 1.411 -2.976 0 C-N-CA 119.75 -1.214 . . . . 1.38 115.615 176.36 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.99 -30.1 14.9 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-O 121.809 0.814 . . . . 2.54 110.198 177.556 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 119' ' ' GLY . . . . . 0.819 ' O ' ' HA ' ' B' ' 112' ' ' PRO . . . -78.65 161.39 48.07 Favored Glycine 0 C--O 1.201 -1.909 0 N-CA-C 118.745 2.258 . . . . 1.04 118.745 -175.212 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.62 ' HG2' ' HB2' ' B' ' 110' ' ' CYS . 0.1 OUTLIER -104.24 142.39 34.61 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 110.214 -2.993 . . . . 2.89 113.747 -172.55 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 121' ' ' CYS . . . . . 0.459 ' O ' ' HB3' ' B' ' 110' ' ' CYS . 73.3 m -108.51 138.98 43.92 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 114.777 -1.101 . . . . 1.07 111.23 -178.435 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 122' ' ' PHE . . . . . 0.65 ' CE1' ' HB2' ' B' ' 128' ' ' CYS . 1.4 m-85 -124.42 -9.67 7.46 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.185 -0.461 . . . . 1.53 112.052 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 123' ' ' GLY . . . . . 0.517 ' HA3' ' OE2' ' A' ' 81' ' ' GLU . . . -159.22 -161.3 11.06 Favored Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.6 -0.81 . . . . 0.9 112.465 179.716 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 124' ' ' PRO . . . . . 0.571 ' HD2' ' CG ' ' A' ' 81' ' ' GLU . 7.9 Cg_exo -69.54 -52.94 0.31 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.93 2.42 . . . . 1.51 112.302 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 125' ' ' SER . . . . . 0.615 ' O ' ' N ' ' B' ' 137' ' ' GLY . 0.4 OUTLIER -118.75 44.03 2.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.054 -0.521 . . . . 1.25 110.787 -179.811 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 126' ' ' ILE . . . . . 0.983 HG12 HG13 ' B' ' 136' ' ' VAL . 57.7 mt -141.8 120.95 10.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 N-CA-C 112.812 0.671 . . . . 0.85 112.812 -179.065 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 127' ' ' CYS . . . . . 0.806 ' O ' ' HA ' ' B' ' 134' ' ' CYS . 7.0 t -135.08 144.79 47.38 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.72 -0.673 . . . . 0.89 109.472 178.672 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 128' ' ' CYS . . . . . 0.906 ' HA ' ' O ' ' B' ' 133' ' ' GLY . 0.4 OUTLIER -138.99 153.58 48.17 Favored 'General case' 0 CA--C 1.552 1.042 0 N-CA-C 115.541 1.682 . . . . 1.23 115.541 -176.959 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 129' ' ' GLY . . . . . 0.684 ' HA3' ' HB2' ' B' ' 132' ' ' LEU . . . -143.25 165.96 26.89 Favored Glycine 0 N--CA 1.43 -1.72 0 CA-C-N 111.262 -2.699 . . . . 0.66 113.767 179.26 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 130' ' ' ASP . . . . . 0.413 ' OD2' ' HG3' ' B' ' 131' ' ' GLU . 15.4 p-10 -68.97 -41.64 77.69 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 126.028 1.731 . . . . 2.35 110.706 177.146 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 131' ' ' GLU . . . . . 0.413 ' HG3' ' OD2' ' B' ' 130' ' ' ASP . 0.5 OUTLIER -129.69 33.65 4.42 Favored 'General case' 0 CA--C 1.479 -1.78 0 CA-C-N 111.436 -2.62 . . . . 1.69 108.663 170.082 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 132' ' ' LEU . . . . . 0.73 HD23 ' CZ ' ' B' ' 135' ' ' PHE . 0.1 OUTLIER -131.2 -1.44 4.03 Favored 'General case' 0 N--CA 1.401 -2.89 0 N-CA-C 107.645 -1.242 . . . . 1.38 107.645 179.59 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 133' ' ' GLY . . . . . 0.906 ' O ' ' HA ' ' B' ' 128' ' ' CYS . . . 44.32 -133.98 6.64 Favored Glycine 0 N--CA 1.426 -1.992 0 CA-C-N 115.07 -0.968 . . . . 0.72 112.909 179.263 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 134' ' ' CYS . . . . . 0.898 ' HB2' HD13 ' B' ' 172' ' ' ILE . 0.1 OUTLIER -134.9 111.58 9.97 Favored 'General case' 0 CA--C 1.486 -1.512 0 N-CA-C 113.653 0.983 . . . . 1.08 113.653 -178.721 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 135' ' ' PHE . . . . . 0.74 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 27.5 m-85 -84.43 106.82 16.31 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 104.694 -2.336 . . . . 1.36 104.694 176.035 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 136' ' ' VAL . . . . . 0.983 HG13 HG12 ' B' ' 126' ' ' ILE . 12.6 t -92.33 84.79 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.669 0 CA-C-O 122.987 1.375 . . . . 0.75 108.65 -179.178 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 137' ' ' GLY . . . . . 0.749 ' HA3' HG22 ' A' ' 72' ' ' ILE . . . 88.65 107.95 1.07 Allowed Glycine 0 CA--C 1.523 0.579 0 CA-C-N 112.493 -2.139 . . . . 0.83 115.098 179.184 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 138' ' ' THR . . . . . 0.514 HG21 ' HB3' ' B' ' 135' ' ' PHE . 0.1 OUTLIER -174.01 -179.51 1.71 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 107.704 -1.221 . . . . 0.78 107.704 178.472 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 139' ' ' ALA . . . . . 0.857 ' HA ' HD12 ' B' ' 142' ' ' LEU . . . -65.07 -37.67 88.3 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 119.68 1.127 . . . . 1.04 111.393 179.309 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 140' ' ' GLU . . . . . 0.593 ' HG2' ' HA2' ' B' ' 114' ' ' GLY . 0.2 OUTLIER -62.04 -22.85 66.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.061 0.458 . . . . 2.31 111.386 -179.418 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 141' ' ' ALA . . . . . 0.608 ' O ' ' N ' ' B' ' 144' ' ' CYS . . . -93.39 -19.46 21.28 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.508 -0.769 . . . . 0.87 110.972 -179.411 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 142' ' ' LEU . . . . . 0.857 HD12 ' HA ' ' B' ' 139' ' ' ALA . 4.8 mt -43.95 -45.56 7.78 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.448 0.536 . . . . 1.24 112.448 -178.651 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 143' ' ' ARG . . . . . 0.503 ' HD2' ' O ' ' B' ' 112' ' ' PRO . 0.0 OUTLIER -55.56 -24.16 30.91 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 107.905 -1.146 . . . . 2.93 107.905 178.331 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 144' ' ' CYS . . . . . 0.608 ' N ' ' O ' ' B' ' 141' ' ' ALA . 35.0 m -69.61 8.49 0.65 Allowed 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 115.838 -0.619 . . . . 1.61 110.559 -179.625 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 145' ' ' GLN . . . . . 0.582 ' HB2' ' O ' ' B' ' 142' ' ' LEU . 0.7 OUTLIER -78.84 -20.11 50.42 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.015 -0.993 . . . . 3.35 110.838 178.399 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 146' ' ' GLU . . . . . 0.573 ' HA ' ' CD2' ' B' ' 149' ' ' TYR . 16.5 tt0 -86.73 -0.45 56.34 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 120.384 -0.526 . . . . 3.76 110.817 -179.579 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.94 3.52 29.64 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 109.491 -0.559 . . . . 4.01 109.491 177.628 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 148' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -97.21 -28.28 14.16 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 116.195 -0.457 . . . . 3.92 110.076 178.676 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 149' ' ' TYR . . . . . 0.573 ' CD2' ' HA ' ' B' ' 146' ' ' GLU . 43.1 m-85 -69.84 9.03 0.58 Allowed 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 112.305 0.483 . . . . 5.73 112.305 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 1.7 mt -131.28 121.11 18.38 Favored Pre-proline 0 CA--C 1.529 0.159 0 O-C-N 122.442 -0.161 . . . . 5.46 111.2 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 151' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -80.7 49.01 3.08 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.404 2.069 . . . . 5.02 112.255 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 61.4 p -139.76 159.57 64.49 Favored Pre-proline 0 CA--C 1.53 0.199 0 CA-C-N 116.273 -0.421 . . . . 5.73 110.767 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 153' ' ' PRO . . . . . 0.414 ' O ' ' CD ' ' B' ' 108' ' ' ARG . 2.2 Cg_endo -82.85 -163.72 0.23 Allowed 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 123.343 2.695 . . . . 5.1 113.427 -178.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 154' ' ' CYS . . . . . 0.835 ' HA ' ' CB ' ' B' ' 108' ' ' ARG . 0.5 OUTLIER -159.88 127.21 4.59 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.709 -0.678 . . . . 2.68 109.196 -179.937 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 155' ' ' GLN . . . . . 0.964 ' H ' ' HB2' ' B' ' 108' ' ' ARG . 0.7 OUTLIER -50.03 -170.44 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.235 0 CA-C-N 119.29 0.95 . . . . 5.63 112.819 -178.491 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 156' ' ' SER . . . . . 0.439 ' HB2' ' HA ' ' B' ' 168' ' ' ALA . 9.8 p -176.31 -143.91 0.02 OUTLIER 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 114.662 -1.154 . . . . 3.11 110.611 177.82 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 157' ' ' GLY . . . . . 0.575 ' O ' ' HB2' ' B' ' 166' ' ' ARG . . . -101.39 152.85 18.89 Favored Glycine 0 CA--C 1.49 -1.498 0 N-CA-C 109.14 -1.584 . . . . 2.07 109.14 175.205 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 18.2 mm100 -103.79 65.81 0.83 Allowed 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 117.352 -1.739 . . . . 4.34 111.157 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 159' ' ' LYS . . . . . 0.689 ' HB2' ' HB2' ' B' ' 167' ' ' CYS . 0.0 OUTLIER -114.37 56.19 0.81 Allowed Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 113.736 -1.574 . . . . 3.54 109.815 172.343 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 160' ' ' PRO . . . . . 0.542 ' HA ' ' HA ' ' B' ' 166' ' ' ARG . 27.2 Cg_endo -62.96 79.16 0.11 Allowed 'Trans proline' 0 CA--C 1.518 -0.299 0 CA-C-N 121.584 1.602 . . . . 1.51 115.818 -173.798 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 161' ' ' CYS . . . . . 0.468 ' O ' ' O ' ' B' ' 165' ' ' GLY . 0.5 OUTLIER -98.89 -176.47 3.35 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 107.044 -1.465 . . . . 1.58 107.044 176.183 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 69.74 -167.03 48.58 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 118.468 -1.825 . . . . 2.37 111.826 178.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 24.4 p -85.28 41.46 0.89 Allowed 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.058 0.456 . . . . 4.07 111.717 -178.328 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 120.52 7.07 9.19 Favored Glycine 0 CA--C 1.536 1.346 0 CA-C-O 118.884 -0.953 . . . . 2.2 113.79 -179.142 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 165' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' B' ' 161' ' ' CYS . . . -102.28 134.29 11.72 Favored Glycine 0 CA--C 1.523 0.57 0 C-N-CA 118.498 -1.811 . . . . 1.62 115.388 -177.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 166' ' ' ARG . . . . . 0.575 ' HB2' ' O ' ' B' ' 157' ' ' GLY . 0.0 OUTLIER -97.3 153.17 18.21 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 114.947 -0.627 . . . . 3.05 110.352 178.603 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 167' ' ' CYS . . . . . 0.689 ' HB2' ' HB2' ' B' ' 159' ' ' LYS . 2.2 m -65.52 108.6 2.06 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 120.008 -0.677 . . . . 1.56 110.131 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 168' ' ' ALA . . . . . 0.488 ' HB3' ' SG ' ' B' ' 128' ' ' CYS . . . -78.96 -19.92 50.49 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 106.637 -1.616 . . . . 1.04 106.637 176.662 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 169' ' ' ALA . . . . . 0.835 ' O ' ' O ' ' B' ' 170' ' ' ALA . . . -160.89 161.37 31.76 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 111.82 -2.445 . . . . 0.98 111.036 -178.684 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 170' ' ' ALA . . . . . 0.835 ' O ' ' O ' ' B' ' 169' ' ' ALA . . . -18.06 -135.15 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.771 0.829 . . . . 1.25 113.217 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 171' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' B' ' 185' ' ' CYS . . . -55.85 37.49 0.01 OUTLIER Glycine 0 CA--C 1.537 1.425 0 N-CA-C 114.97 0.748 . . . . 1.29 114.97 -178.823 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 172' ' ' ILE . . . . . 0.898 HD13 ' HB2' ' B' ' 134' ' ' CYS . 0.7 OUTLIER -134.41 107.01 8.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-O 122.079 0.942 . . . . 2.27 111.865 -176.755 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 173' ' ' CYS . . . . . 0.528 ' HB2' ' HB3' ' B' ' 182' ' ' ASP . 0.0 OUTLIER -93.29 82.91 4.52 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.476 -0.783 . . . . 1.94 110.526 -179.623 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 174' ' ' CYS . . . . . 0.879 ' HA ' ' HA ' ' B' ' 179' ' ' CYS . 0.1 OUTLIER -83.24 136.76 34.28 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.943 -0.571 . . . . 1.35 110.797 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 175' ' ' SER . . . . . 0.685 ' HB3' ' HD2' ' B' ' 176' ' ' PRO . 5.1 m -104.79 179.41 0.94 Allowed Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.312 -0.858 . . . . 2.0 109.236 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 176' ' ' PRO . . . . . 0.685 ' HD2' ' HB3' ' B' ' 175' ' ' SER . 95.6 Cg_endo -80.01 25.13 0.61 Allowed 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 121.406 1.404 . . . . 1.9 111.674 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 177' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -145.53 -41.55 0.22 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.594 -0.73 . . . . 2.72 110.298 179.226 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 178' ' ' GLY . . . . . 0.799 ' HA3' ' O ' ' A' ' 79' ' ' CYS . . . -147.84 -135.18 2.58 Favored Glycine 0 C--N 1.337 0.617 0 C-N-CA 120.646 -0.788 . . . . 0.99 113.149 179.304 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 179' ' ' CYS . . . . . 0.879 ' HA ' ' HA ' ' B' ' 174' ' ' CYS . 0.1 OUTLIER -146.96 156.3 42.95 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.554 0.216 . . . . 1.34 110.604 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 180' ' ' HIS . . . . . 0.471 ' N ' ' O ' ' B' ' 173' ' ' CYS . 1.2 t-80 -142.19 133.73 26.68 Favored 'General case' 0 CA--C 1.519 -0.23 0 O-C-N 122.034 -0.416 . . . . 2.1 111.648 -178.43 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 181' ' ' GLU . . . . . 0.559 ' HG2' ' HD2' ' A' ' 24' ' ' PRO . 2.4 mt-10 -58.59 128.08 35.39 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.846 -0.615 . . . . 3.06 109.703 178.716 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 182' ' ' ASP . . . . . 0.528 ' HB3' ' HB2' ' B' ' 173' ' ' CYS . 0.0 OUTLIER -146.37 112.72 4.38 Favored Pre-proline 0 C--N 1.318 -0.764 0 CA-C-N 115.537 -0.756 . . . . 2.06 110.394 -178.87 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 183' ' ' PRO . . . . . 0.458 ' HA ' ' OD2' ' B' ' 186' ' ' ASP . 1.6 Cg_endo -82.86 -4.41 11.33 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.617 2.212 . . . . 1.91 113.302 -179.344 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -66.94 -35.39 79.88 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.89 0.376 . . . . 1.56 111.032 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 185' ' ' CYS . . . . . 0.639 ' C ' ' HD3' ' B' ' 187' ' ' PRO . 83.4 m -93.86 49.5 1.35 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.07 -0.514 . . . . 1.94 111.007 179.75 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 186' ' ' ASP . . . . . 0.729 ' HB3' ' HB3' ' B' ' 189' ' ' ALA . 16.8 m-20 -116.38 35.27 0.2 Allowed Pre-proline 0 N--CA 1.443 -0.817 0 N-CA-C 112.364 0.505 . . . . 3.61 112.364 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 187' ' ' PRO . . . . . 0.721 ' HD3' ' N ' ' B' ' 186' ' ' ASP . 1.3 Cg_endo -78.19 59.3 6.97 Favored 'Trans proline' 0 CA--C 1.489 -1.753 0 N-CA-C 108.432 -1.411 . . . . 2.58 108.432 177.29 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 188' ' ' GLU . . . . . 0.502 ' HG3' ' N ' ' B' ' 189' ' ' ALA . 4.8 pt-20 -177.51 -34.02 0.01 OUTLIER 'General case' 0 CA--C 1.481 -1.711 0 CA-C-N 113.011 -1.904 . . . . 4.7 109.149 -177.696 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 189' ' ' ALA . . . . . 0.729 ' HB3' ' HB3' ' B' ' 186' ' ' ASP . . . -68.95 47.29 0.06 Allowed 'General case' 0 C--N 1.355 0.843 0 CA-C-N 111.221 -2.718 . . . . 5.24 112.66 179.428 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 190' ' ' ALA . . . . . . . . . . . . . . . -69.11 123.46 21.15 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 125.674 1.59 . . . . 6.93 111.928 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 191' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -71.69 130.92 42.34 Favored 'General case' 0 C--N 1.34 0.154 0 CA-C-N 112.061 -2.336 . . . . 10.14 113.83 -175.399 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 13.9 t . . . . . 0 C--O 1.249 1.029 0 CA-C-N 114.375 -1.284 . . . . 11.7 110.525 179.202 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.615 ' O ' HG22 ' A' ' 2' ' ' VAL . . . . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 120.891 0.377 . . . . 9.95 111.469 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.615 HG22 ' O ' ' A' ' 1' ' ' ALA . 0.2 OUTLIER -167.76 49.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 108.526 -0.916 . . . . 8.02 108.526 177.605 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.622 HD12 ' HE ' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -98.13 -12.95 21.23 Favored 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 118.187 2.662 . . . . 5.86 118.187 -175.989 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -59.0 -80.95 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 122.891 2.587 . . . . 6.22 114.625 -176.75 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.501 HD12 ' HB2' ' A' ' 55' ' ' GLN . 11.9 tp -151.54 24.5 0.69 Allowed 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 114.592 1.331 . . . . 7.09 114.592 -177.373 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -88.73 -67.62 0.82 Allowed 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 104.499 -2.408 . . . . 8.78 104.499 174.549 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 1.066 ' HA ' ' HG2' ' A' ' 55' ' ' GLN . 7.1 p -156.52 114.23 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.414 -2.263 0 CA-C-N 112.422 -2.172 . . . . 7.51 105.669 166.841 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.756 ' HB2' ' H ' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -82.05 115.44 21.19 Favored 'General case' 0 N--CA 1.41 -2.461 0 N-CA-C 107.135 -1.432 . . . . 9.08 107.135 176.824 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 31.6 p -65.77 107.12 1.69 Allowed 'General case' 0 C--N 1.289 -2.049 0 C-N-CA 113.78 -3.168 . . . . 5.66 106.003 177.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 1.009 ' HB2' ' HG2' ' A' ' 20' ' ' ARG . 53.6 m -78.48 113.77 16.79 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 114.652 -1.158 . . . . 2.68 112.593 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.467 ' HG ' ' HD2' ' A' ' 12' ' ' PRO . 6.0 tp -26.76 135.0 0.11 Allowed Pre-proline 0 N--CA 1.486 1.371 0 N-CA-C 113.619 0.97 . . . . 2.48 113.619 179.641 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.62 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 52.0 Cg_endo -75.04 145.11 30.91 Favored 'Trans proline' 0 CA--C 1.552 1.401 0 C-N-CA 123.384 2.723 . . . . 1.49 117.264 -178.299 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.433 ' O ' ' HA2' ' A' ' 17' ' ' GLY . 0.1 OUTLIER -155.31 173.57 16.46 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-N 112.625 -2.08 . . . . 1.0 115.376 -174.709 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 79.3 -159.97 45.49 Favored Glycine 0 CA--C 1.533 1.185 0 CA-C-N 114.406 -1.27 . . . . 1.15 110.657 -172.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.498 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 60.1 Cg_endo -62.25 109.26 0.8 Allowed 'Trans proline' 0 N--CA 1.488 1.185 0 C-N-CA 123.65 2.9 . . . . 1.57 110.178 178.276 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 74.96 5.63 76.12 Favored Glycine 0 C--N 1.293 -1.839 0 CA-C-N 114.649 -1.16 . . . . 1.68 112.071 176.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.433 ' HA2' ' O ' ' A' ' 13' ' ' CYS . . . 63.73 62.14 5.55 Favored Glycine 1 N--CA 1.396 -4.024 0 C-N-CA 118.824 -1.655 . . . . 1.36 110.524 -177.756 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.498 ' HG2' ' O ' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -100.29 17.95 20.09 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 105.878 -1.897 . . . . 2.5 105.878 168.892 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.62 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -109.26 -178.61 21.34 Favored Glycine 0 N--CA 1.426 -1.99 0 N-CA-C 117.205 1.642 . . . . 1.02 117.205 -173.087 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 1.009 ' HG2' ' HB2' ' A' ' 10' ' ' CYS . 2.9 mtp-105 -143.12 135.71 27.53 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 110.913 -2.643 . . . . 2.92 112.572 176.009 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.609 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 1.7 m -107.72 159.52 16.42 Favored 'General case' 0 C--N 1.343 0.298 0 CA-C-O 121.554 0.692 . . . . 1.1 112.701 -177.741 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -132.06 8.51 4.41 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 114.784 -1.098 . . . . 1.51 110.951 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -179.64 -163.9 31.14 Favored Glycine 0 C--N 1.338 0.654 0 C-N-CA 121.046 -0.597 . . . . 0.9 112.478 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.474 ' HG2' ' OE1' ' B' ' 181' ' ' GLU . 12.5 Cg_exo -69.56 -71.01 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.74 2.293 . . . . 1.5 112.305 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.596 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.5 OUTLIER -100.33 33.9 2.54 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 120.933 0.397 . . . . 1.26 110.111 179.508 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.937 HG12 HG13 ' A' ' 36' ' ' VAL . 6.3 mt -139.07 120.54 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 CA-C-N 116.173 -0.467 . . . . 0.83 111.64 -178.417 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.609 ' HA ' ' HA ' ' A' ' 21' ' ' CYS . 49.6 t -142.22 122.56 13.96 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.765 -0.652 . . . . 0.92 110.179 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 1.104 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -127.59 152.51 47.55 Favored 'General case' 0 CA--C 1.551 0.983 0 N-CA-C 114.521 1.304 . . . . 1.28 114.521 -177.961 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.624 ' O ' ' HB2' ' A' ' 69' ' ' ALA . . . -150.26 -176.29 23.16 Favored Glycine 0 C--N 1.354 1.575 0 N-CA-C 110.927 -0.869 . . . . 0.67 110.927 178.15 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.579 ' CB ' ' HB3' ' A' ' 91' ' ' PHE . 2.5 p-10 -66.03 -54.01 31.37 Favored 'General case' 0 CA--C 1.56 1.359 0 C-N-CA 124.952 1.301 . . . . 2.27 112.211 179.546 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.36 -18.79 19.69 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 111.514 -2.585 . . . . 1.66 110.375 172.811 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.517 ' O ' ' C ' ' A' ' 33' ' ' GLY . 4.1 mt -99.9 7.6 44.76 Favored 'General case' 0 N--CA 1.4 -2.935 0 CA-C-N 115.892 -0.594 . . . . 1.37 110.749 -172.334 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 1.104 ' O ' ' HA ' ' A' ' 28' ' ' CYS . . . 24.87 -136.91 0.01 OUTLIER Glycine 0 C--O 1.21 -1.394 0 CA-C-O 118.635 -1.092 . . . . 0.73 111.959 179.165 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 1.048 ' HB2' HD13 ' A' ' 72' ' ' ILE . 1.0 OUTLIER -129.97 124.05 32.09 Favored 'General case' 0 CA--C 1.498 -1.044 0 CA-C-N 119.051 1.425 . . . . 1.08 112.422 -179.047 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.714 ' CE2' HG21 ' B' ' 138' ' ' THR . 34.7 m-85 -97.91 105.24 17.36 Favored 'General case' 0 N--CA 1.422 -1.842 0 N-CA-C 103.597 -2.742 . . . . 1.38 103.597 174.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.937 HG13 HG12 ' A' ' 26' ' ' ILE . 1.8 t -100.91 85.59 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.884 0 CA-C-O 123.152 1.453 . . . . 0.76 107.112 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.606 ' HA3' HG21 ' B' ' 172' ' ' ILE . . . 125.9 -77.7 0.38 Allowed Glycine 0 CA--C 1.524 0.607 0 CA-C-N 112.925 -1.943 . . . . 0.81 115.06 -179.38 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.718 HG21 ' CE2' ' B' ' 135' ' ' PHE . 9.9 t -32.2 124.95 0.3 Allowed 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 113.347 0.869 . . . . 0.77 113.347 -177.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.868 ' HA ' ' HG ' ' A' ' 42' ' ' LEU . . . -26.92 -35.02 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 114.12 -1.4 . . . . 1.02 113.409 -179.124 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.524 ' N ' ' O ' ' A' ' 38' ' ' THR . 1.7 mt-10 -48.13 -13.77 0.05 OUTLIER 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.634 0.254 . . . . 2.32 111.05 178.309 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.662 ' O ' ' N ' ' A' ' 44' ' ' CYS . . . -114.96 -44.42 3.03 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 109.448 -0.575 . . . . 0.87 109.448 178.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.868 ' HG ' ' HA ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -37.88 -19.49 0.01 OUTLIER 'General case' 0 C--N 1.346 0.417 0 N-CA-C 115.481 1.659 . . . . 1.23 115.481 -173.232 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.545 ' N ' HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -68.02 -13.65 62.35 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 106.575 -1.639 . . . . 2.92 106.575 174.708 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.662 ' N ' ' O ' ' A' ' 41' ' ' ALA . 64.0 m -85.42 25.12 1.07 Allowed 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 114.151 -1.386 . . . . 1.57 109.953 177.721 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -92.31 -18.66 23.05 Favored 'General case' 0 CA--C 1.509 -0.63 0 N-CA-C 107.859 -1.163 . . . . 3.31 107.859 176.032 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -86.87 5.46 36.73 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-N 115.174 -0.921 . . . . 3.69 109.222 177.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.34 3.34 31.99 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 119.962 -0.695 . . . . 3.99 109.289 177.419 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.448 ' C ' ' H ' ' A' ' 50' ' ' LEU . 2.8 t-20 -87.86 -28.0 21.87 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 116.055 -0.52 . . . . 3.86 109.966 178.596 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -59.72 8.22 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.324 0.861 . . . . 5.68 113.324 -179.483 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.647 ' O ' HD12 ' A' ' 50' ' ' LEU . 0.5 OUTLIER -148.71 107.77 3.51 Favored Pre-proline 0 N--CA 1.463 0.18 0 O-C-N 122.099 -0.376 . . . . 5.4 111.245 179.82 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -78.24 50.14 3.25 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.504 2.136 . . . . 4.92 112.693 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.426 ' HB2' ' HD2' ' A' ' 53' ' ' PRO . 10.7 p -114.08 160.15 33.55 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.445 -0.343 . . . . 5.64 110.392 179.643 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.481 ' O ' ' HG3' ' A' ' 8' ' ' ARG . 57.3 Cg_endo -72.04 -174.25 1.31 Allowed 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.452 2.102 . . . . 5.04 113.237 -179.276 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.609 ' HA ' ' CB ' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -157.1 95.57 1.51 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.763 -0.653 . . . . 2.74 109.697 179.879 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 1.066 ' HG2' ' HA ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -56.65 178.29 0.06 Allowed 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 119.848 -0.741 . . . . 5.75 111.866 -179.121 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.506 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 48.8 m 86.68 100.46 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 117.595 2.443 . . . . 3.12 117.595 175.633 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 134.71 69.94 0.07 OUTLIER Glycine 0 N--CA 1.427 -1.948 0 N-CA-C 109.975 -1.25 . . . . 2.1 109.975 -178.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 -117.95 72.89 0.87 Allowed 'General case' 0 N--CA 1.441 -0.923 0 CA-C-O 122.634 1.207 . . . . 4.36 108.032 179.328 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.671 ' CB ' ' HB2' ' A' ' 67' ' ' CYS . 10.0 mtmm -144.64 58.34 5.43 Favored Pre-proline 0 C--N 1.302 -1.475 0 CA-C-N 113.132 -1.849 . . . . 3.55 107.197 179.152 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.7 ' HA ' ' O ' ' A' ' 65' ' ' GLY . 37.7 Cg_endo -66.2 86.56 0.25 Allowed 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 122.605 2.204 . . . . 1.54 116.591 -177.231 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.491 ' SG ' ' HB2' ' A' ' 82' ' ' ASP . 0.5 OUTLIER -100.11 -173.44 2.43 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.308 -1.367 . . . . 1.59 107.308 175.471 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 62.83 -166.43 23.13 Favored Glycine 0 CA--C 1.519 0.331 0 C-N-CA 118.264 -1.922 . . . . 2.43 112.296 176.175 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 64.5 m -77.72 42.9 0.39 Allowed 'General case' 0 C--N 1.327 -0.371 0 O-C-N 122.494 -0.415 . . . . 4.11 111.75 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 110.51 11.31 19.89 Favored Glycine 0 N--CA 1.446 -0.681 0 N-CA-C 116.846 1.498 . . . . 2.21 116.846 176.702 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.7 ' O ' ' HA ' ' A' ' 60' ' ' PRO . . . -104.73 154.37 17.39 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 120.893 2.347 . . . . 1.62 112.902 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.479 ' H ' ' HG2' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -101.12 150.13 23.25 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 121.266 0.555 . . . . 3.02 112.442 -179.763 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.671 ' HB2' ' CB ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -72.36 112.71 8.67 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 113.671 0.989 . . . . 1.52 113.671 -179.951 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.67 ' HB1' ' HB2' ' A' ' 28' ' ' CYS . . . -99.76 -16.32 18.15 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 122.514 1.15 . . . . 1.07 108.053 175.47 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 1.026 ' HB3' HG12 ' A' ' 72' ' ' ILE . . . -162.96 161.14 25.49 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 112.506 -2.134 . . . . 1.0 116.532 176.466 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.96 ' HB2' ' HB3' ' A' ' 89' ' ' ALA . . . -50.38 121.77 6.1 Favored 'General case' 0 C--N 1.345 0.4 0 CA-C-N 113.719 -1.582 . . . . 1.24 111.725 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.622 ' HA2' ' O ' ' A' ' 82' ' ' ASP . . . 59.83 36.49 90.13 Favored Glycine 0 N--CA 1.443 -0.885 0 N-CA-C 110.018 -1.233 . . . . 1.28 110.018 -178.27 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 1.048 HD13 ' HB2' ' A' ' 34' ' ' CYS . 0.5 OUTLIER -145.0 108.17 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 O-C-N 121.957 -0.731 . . . . 2.27 109.927 176.984 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -106.04 102.4 11.82 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 108.883 -0.784 . . . . 1.98 108.883 178.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.838 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 3.4 t -92.7 122.42 35.09 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 121.702 0.763 . . . . 1.33 112.283 -178.394 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.615 ' HA ' ' HA2' ' A' ' 65' ' ' GLY . 0.3 OUTLIER -90.59 -179.25 1.12 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 114.375 -1.284 . . . . 1.99 109.733 179.532 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.479 ' HD2' ' CB ' ' A' ' 75' ' ' SER . 86.3 Cg_endo -77.6 25.22 0.49 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 121.828 1.685 . . . . 1.86 113.003 -179.309 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -145.6 -45.75 0.21 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.921 -0.77 . . . . 2.65 108.921 178.548 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.561 ' HA3' ' O ' ' B' ' 179' ' ' CYS . . . -149.37 -151.62 5.53 Favored Glycine 0 N--CA 1.446 -0.667 0 CA-C-N 115.39 -0.823 . . . . 0.99 111.659 178.571 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.838 ' HA ' ' HA ' ' A' ' 74' ' ' CYS . 0.0 OUTLIER -146.9 162.88 37.77 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.846 -0.427 . . . . 1.34 109.846 179.798 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.57 ' HB3' ' HA3' ' B' ' 178' ' ' GLY . 0.1 OUTLIER -150.52 160.82 43.52 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.016 0.436 . . . . 2.17 111.009 -179.036 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.593 ' H ' HD11 ' B' ' 126' ' ' ILE . 0.5 OUTLIER -63.76 146.07 54.58 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.383 -0.599 . . . . 3.05 109.383 179.287 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.622 ' O ' ' HA2' ' A' ' 71' ' ' GLY . 0.8 OUTLIER -145.78 140.77 16.03 Favored Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 120.423 -0.511 . . . . 2.02 111.99 -179.462 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.493 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 5.3 Cg_exo -80.61 -20.9 7.67 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.969 2.446 . . . . 1.93 113.665 -178.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.09 -40.96 87.06 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.162 0.506 . . . . 1.53 110.682 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.896 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 93.2 m -97.21 27.09 4.32 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.779 0.8 . . . . 1.88 110.192 179.491 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.7 ' N ' ' HD2' ' A' ' 87' ' ' PRO . 1.0 OUTLIER -77.29 -46.38 2.65 Favored Pre-proline 0 C--N 1.317 -0.843 0 CA-C-N 115.198 -0.91 . . . . 3.6 110.559 179.64 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.7 ' HD2' ' N ' ' A' ' 86' ' ' ASP . 17.9 Cg_endo -61.93 111.13 1.13 Allowed 'Trans proline' 0 N--CA 1.445 -1.324 0 C-N-CA 121.429 1.419 . . . . 2.56 111.396 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.592 ' C ' ' O ' ' A' ' 87' ' ' PRO . 0.2 OUTLIER -14.81 86.75 0.0 OUTLIER 'General case' 0 CA--C 1.469 -2.137 0 N-CA-C 104.299 -2.482 . . . . 4.72 104.299 -179.04 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.96 ' HB3' ' HB2' ' A' ' 70' ' ' ALA . . . -92.33 7.47 42.71 Favored 'General case' 0 CA--C 1.499 -0.985 0 CA-C-N 108.666 -3.879 . . . . 5.29 110.276 -178.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -55.39 112.78 1.19 Allowed 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 118.944 -1.102 . . . . 6.98 110.199 -177.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.579 ' HB3' ' CB ' ' A' ' 30' ' ' ASP . 8.1 t80 -87.12 133.42 33.62 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 120.312 -0.555 . . . . 10.21 109.621 178.6 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 12.5 m . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.174 -0.917 . . . . 11.77 110.621 -179.235 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 101' ' ' ALA . . . . . 0.613 ' O ' HG13 ' B' ' 102' ' ' VAL . . . . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 121.091 0.472 . . . . 10.07 111.285 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 102' ' ' VAL . . . . . 0.927 HG23 ' HB2' ' B' ' 106' ' ' ASP . 0.0 OUTLIER 177.2 155.78 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 108.106 -1.072 . . . . 8.41 108.106 -176.981 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 103' ' ' LEU . . . . . 0.772 ' HA ' ' HA ' ' B' ' 108' ' ' ARG . 0.1 OUTLIER -99.45 42.52 1.1 Allowed 'General case' 0 CA--C 1.503 -0.862 0 CA-C-O 122.394 1.092 . . . . 5.87 112.349 -175.891 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -105.84 -100.72 0.34 Allowed 'General case' 0 N--CA 1.398 -3.047 0 N-CA-C 101.566 -3.494 . . . . 6.27 101.566 168.27 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 6.1 tp -125.69 16.73 8.11 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 118.501 -1.28 . . . . 7.2 113.431 -177.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 106' ' ' ASP . . . . . 0.927 ' HB2' HG23 ' B' ' 102' ' ' VAL . 0.1 OUTLIER -84.23 -92.73 0.08 Allowed 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 103.148 -2.908 . . . . 8.55 103.148 173.921 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 107' ' ' VAL . . . . . 1.032 ' HA ' ' HG2' ' B' ' 155' ' ' GLN . 5.4 p -132.2 115.43 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.177 0 N-CA-C 103.836 -2.653 . . . . 7.48 103.836 171.381 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 108' ' ' ARG . . . . . 0.772 ' HA ' ' HA ' ' B' ' 103' ' ' LEU . 0.0 OUTLIER -81.36 115.86 20.92 Favored 'General case' 0 CA--C 1.465 -2.295 0 N-CA-C 107.301 -1.37 . . . . 9.12 107.301 177.609 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 30.7 p -65.61 107.52 1.76 Allowed 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 113.975 -3.09 . . . . 5.69 105.976 177.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 110' ' ' CYS . . . . . 0.983 ' HB2' ' HG2' ' B' ' 120' ' ' ARG . 50.9 m -79.22 111.23 15.25 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 114.686 -1.143 . . . . 2.61 112.749 -179.511 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 111' ' ' LEU . . . . . 0.449 ' HG ' ' HD2' ' B' ' 112' ' ' PRO . 6.1 tp -24.32 134.2 0.08 OUTLIER Pre-proline 0 N--CA 1.485 1.281 0 N-CA-C 113.497 0.925 . . . . 2.47 113.497 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 112' ' ' PRO . . . . . 0.598 ' HA ' ' O ' ' B' ' 119' ' ' GLY . 29.2 Cg_endo -68.34 150.77 76.38 Favored 'Trans proline' 0 CA--C 1.547 1.127 0 C-N-CA 123.235 2.624 . . . . 1.47 114.796 -178.684 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 113' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -158.87 177.98 10.58 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 113.395 -1.729 . . . . 1.0 115.449 176.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . 78.06 -160.27 48.06 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 110.22 -1.152 . . . . 1.16 110.22 -175.501 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 115' ' ' PRO . . . . . 0.402 ' O ' ' HG2' ' B' ' 118' ' ' LYS . 54.6 Cg_endo -63.5 100.03 0.27 Allowed 'Trans proline' 0 N--CA 1.482 0.814 0 C-N-CA 123.985 3.124 . . . . 1.57 114.075 178.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 82.69 5.24 89.62 Favored Glycine 0 C--N 1.29 -2.019 0 CA-C-N 114.61 -1.177 . . . . 1.7 111.876 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . 70.44 47.62 41.73 Favored Glycine 1 N--CA 1.392 -4.288 0 C-N-CA 118.922 -1.608 . . . . 1.38 114.609 179.736 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 118' ' ' LYS . . . . . 0.402 ' HG2' ' O ' ' B' ' 115' ' ' PRO . 0.0 OUTLIER -91.83 15.84 12.14 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 106.827 -1.546 . . . . 2.54 106.827 175.465 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 119' ' ' GLY . . . . . 0.598 ' O ' ' HA ' ' B' ' 112' ' ' PRO . . . -113.52 -171.17 17.66 Favored Glycine 0 N--CA 1.444 -0.827 0 N-CA-C 115.79 1.076 . . . . 1.04 115.79 -175.764 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.983 ' HG2' ' HB2' ' B' ' 110' ' ' CYS . 1.7 mtp-105 -146.89 138.94 24.58 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 114.509 -0.845 . . . . 2.89 109.396 -179.309 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 121' ' ' CYS . . . . . 0.607 ' HA ' ' HA ' ' B' ' 127' ' ' CYS . 1.7 m -107.84 160.86 15.41 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.613 0.721 . . . . 1.07 112.888 -177.129 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -132.18 8.59 4.37 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 114.697 -1.138 . . . . 1.53 110.867 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -179.67 -163.99 31.32 Favored Glycine 0 C--N 1.338 0.684 0 C-N-CA 120.885 -0.674 . . . . 0.9 112.387 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 124' ' ' PRO . . . . . 0.468 ' HG2' ' OE1' ' A' ' 81' ' ' GLU . 12.4 Cg_exo -69.47 -71.14 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.747 2.298 . . . . 1.51 112.313 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 125' ' ' SER . . . . . 0.595 ' O ' ' N ' ' B' ' 137' ' ' GLY . 0.5 OUTLIER -100.25 34.15 2.45 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 120.973 0.416 . . . . 1.25 110.04 179.436 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 126' ' ' ILE . . . . . 0.889 HG12 HG13 ' B' ' 136' ' ' VAL . 7.8 mt -138.71 120.44 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 CA-C-N 116.083 -0.508 . . . . 0.85 111.943 -178.474 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 127' ' ' CYS . . . . . 0.607 ' HA ' ' HA ' ' B' ' 121' ' ' CYS . 49.1 t -142.01 122.05 13.72 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 116.156 -0.474 . . . . 0.89 110.133 -179.773 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 128' ' ' CYS . . . . . 1.076 ' HA ' ' O ' ' B' ' 133' ' ' GLY . 0.0 OUTLIER -124.57 157.34 35.63 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 114.218 1.192 . . . . 1.23 114.218 -178.707 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 129' ' ' GLY . . . . . 0.623 ' N ' ' O ' ' B' ' 133' ' ' GLY . . . -153.78 -177.13 26.93 Favored Glycine 0 N--CA 1.434 -1.472 0 N-CA-C 111.087 -0.805 . . . . 0.66 111.087 177.214 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 130' ' ' ASP . . . . . 0.56 ' CB ' ' HB3' ' B' ' 191' ' ' PHE . 2.4 p-10 -65.08 -53.38 46.49 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 124.337 1.055 . . . . 2.35 111.038 179.518 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 131' ' ' GLU . . . . . 0.426 ' HG2' ' OD2' ' B' ' 130' ' ' ASP . 0.0 OUTLIER -120.96 32.65 5.87 Favored 'General case' 0 CA--C 1.483 -1.613 0 N-CA-C 106.276 -1.75 . . . . 1.69 106.276 174.921 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 132' ' ' LEU . . . . . 0.571 HD22 ' HE1' ' B' ' 135' ' ' PHE . 2.1 mt -135.53 9.7 3.41 Favored 'General case' 0 N--CA 1.393 -3.28 0 N-CA-C 106.413 -1.699 . . . . 1.38 106.413 175.057 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 133' ' ' GLY . . . . . 1.076 ' O ' ' HA ' ' B' ' 128' ' ' CYS . . . 25.66 -128.87 0.03 OUTLIER Glycine 0 N--CA 1.41 -3.089 0 CA-C-N 115.29 -0.868 . . . . 0.72 114.43 178.331 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 134' ' ' CYS . . . . . 1.024 ' HB2' HD13 ' B' ' 172' ' ' ILE . 0.8 OUTLIER -134.96 125.1 25.97 Favored 'General case' 0 CA--C 1.494 -1.192 0 CA-C-N 117.326 0.563 . . . . 1.08 111.614 177.305 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 135' ' ' PHE . . . . . 0.718 ' CE2' HG21 ' A' ' 38' ' ' THR . 34.9 m-85 -99.91 104.99 16.66 Favored 'General case' 0 N--CA 1.422 -1.848 0 N-CA-C 103.29 -2.856 . . . . 1.36 103.29 174.299 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 136' ' ' VAL . . . . . 0.889 HG13 HG12 ' B' ' 126' ' ' ILE . 2.3 t -100.88 85.01 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.792 0 N-CA-C 107.093 -1.447 . . . . 0.75 107.093 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 137' ' ' GLY . . . . . 0.595 ' N ' ' O ' ' B' ' 125' ' ' SER . . . 126.27 -77.5 0.39 Allowed Glycine 0 CA--C 1.526 0.756 0 CA-C-N 113.22 -1.809 . . . . 0.83 114.83 -179.383 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 138' ' ' THR . . . . . 0.714 HG21 ' CE2' ' A' ' 35' ' ' PHE . 9.8 t -33.11 123.2 0.39 Allowed 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 114.346 1.239 . . . . 0.78 114.346 -177.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 139' ' ' ALA . . . . . 0.891 ' HA ' ' HG ' ' B' ' 142' ' ' LEU . . . -24.27 -37.93 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 113.532 -1.667 . . . . 1.04 112.787 -178.038 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 140' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' B' ' 138' ' ' THR . 1.8 mt-10 -48.05 -8.18 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 121.19 0.519 . . . . 2.31 111.92 177.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 141' ' ' ALA . . . . . 0.634 ' O ' ' N ' ' B' ' 144' ' ' CYS . . . -119.23 -45.81 2.53 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 114.941 -1.027 . . . . 0.87 110.605 177.131 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 142' ' ' LEU . . . . . 0.891 ' HG ' ' HA ' ' B' ' 139' ' ' ALA . 0.0 OUTLIER -38.22 -19.82 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 115.59 1.7 . . . . 1.24 115.59 -174.176 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 143' ' ' ARG . . . . . 0.545 ' N ' HD13 ' B' ' 142' ' ' LEU . 0.0 OUTLIER -69.77 -9.69 55.54 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 106.714 -1.587 . . . . 2.93 106.714 174.869 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 144' ' ' CYS . . . . . 0.634 ' N ' ' O ' ' B' ' 141' ' ' ALA . 66.7 m -89.25 26.38 1.65 Allowed 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.447 -0.797 . . . . 1.61 109.641 176.599 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -91.71 -19.11 22.98 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 3.35 107.708 175.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -86.9 5.46 36.87 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 114.985 -1.007 . . . . 3.76 109.229 178.017 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.27 3.38 31.55 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 120.128 -0.629 . . . . 4.01 109.324 177.43 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 148' ' ' ASN . . . . . 0.463 ' C ' ' H ' ' B' ' 150' ' ' LEU . 2.8 t-20 -87.97 -27.98 21.74 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 116.064 -0.517 . . . . 3.92 109.929 178.638 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -59.69 8.2 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 113.174 0.805 . . . . 5.73 113.174 -179.413 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 150' ' ' LEU . . . . . 0.636 ' O ' HD12 ' B' ' 150' ' ' LEU . 0.4 OUTLIER -148.6 107.82 3.54 Favored Pre-proline 0 N--CA 1.462 0.173 0 CA-C-N 117.948 0.34 . . . . 5.46 111.321 179.79 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 151' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -78.34 50.14 3.26 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.386 2.057 . . . . 5.02 112.722 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 152' ' ' SER . . . . . 0.425 ' HB2' ' HD2' ' B' ' 153' ' ' PRO . 10.8 p -114.06 160.12 33.6 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.356 -0.384 . . . . 5.73 110.39 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 153' ' ' PRO . . . . . 0.517 ' O ' ' HG3' ' B' ' 108' ' ' ARG . 57.3 Cg_endo -72.07 -174.02 1.25 Allowed 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.356 2.037 . . . . 5.1 113.19 -179.257 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 154' ' ' CYS . . . . . 0.61 ' HA ' ' CB ' ' B' ' 108' ' ' ARG . 0.1 OUTLIER -157.08 95.73 1.52 Allowed 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.761 -0.654 . . . . 2.68 109.739 179.858 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 155' ' ' GLN . . . . . 1.032 ' HG2' ' HA ' ' B' ' 107' ' ' VAL . 0.0 OUTLIER -56.7 179.3 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 119.6 -0.84 . . . . 5.63 111.861 -179.252 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 156' ' ' SER . . . . . 0.496 ' HB2' ' O ' ' B' ' 155' ' ' GLN . 40.2 m 87.87 117.37 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 122.174 0.988 . . . . 3.11 112.326 177.827 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 111.57 77.7 0.89 Allowed Glycine 0 N--CA 1.434 -1.441 0 CA-C-N 112.668 -2.06 . . . . 2.07 112.161 175.08 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -119.48 60.81 0.83 Allowed 'General case' 0 N--CA 1.433 -1.29 0 CA-C-O 123.189 1.471 . . . . 4.34 108.383 176.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 159' ' ' LYS . . . . . 0.758 ' CB ' ' HB2' ' B' ' 167' ' ' CYS . 10.5 mtmm -116.08 53.68 1.04 Allowed Pre-proline 0 C--N 1.303 -1.427 0 CA-C-N 112.052 -2.34 . . . . 3.54 111.797 173.005 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 160' ' ' PRO . . . . . 0.679 ' HA ' ' O ' ' B' ' 165' ' ' GLY . 36.8 Cg_endo -66.2 87.83 0.25 Allowed 'Trans proline' 0 C--N 1.329 -0.466 0 N-CA-C 117.971 2.258 . . . . 1.51 117.971 -172.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 161' ' ' CYS . . . . . 0.471 ' SG ' ' HB2' ' B' ' 182' ' ' ASP . 0.6 OUTLIER -107.17 178.76 4.46 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 107.092 -1.447 . . . . 1.58 107.092 175.238 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 72.01 -167.34 52.88 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 118.464 -1.827 . . . . 2.37 111.325 -178.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 71.2 m -76.83 40.64 0.25 Allowed 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 120.604 -0.439 . . . . 4.07 111.222 -179.387 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 109.56 17.76 9.59 Favored Glycine 0 C--N 1.342 0.902 0 C-N-CA 119.019 -1.562 . . . . 2.2 116.199 175.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 165' ' ' GLY . . . . . 0.679 ' O ' ' HA ' ' B' ' 160' ' ' PRO . . . -107.23 154.28 16.65 Favored Glycine 0 C--N 1.346 1.136 0 C-N-CA 119.235 -1.46 . . . . 1.62 112.179 177.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 166' ' ' ARG . . . . . 0.41 ' HG2' ' H ' ' B' ' 166' ' ' ARG . 0.0 OUTLIER -101.89 150.19 23.44 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 112.211 0.449 . . . . 3.05 112.211 179.425 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 167' ' ' CYS . . . . . 0.758 ' HB2' ' CB ' ' B' ' 159' ' ' LYS . 0.0 OUTLIER -72.68 111.88 8.23 Favored 'General case' 0 N--CA 1.438 -1.033 0 C-N-CA 124.054 0.942 . . . . 1.56 113.335 -179.933 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 168' ' ' ALA . . . . . 0.751 ' HB1' ' HB2' ' B' ' 128' ' ' CYS . . . -89.34 -31.98 17.54 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 104.79 -2.3 . . . . 1.04 104.79 174.35 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 169' ' ' ALA . . . . . 1.054 ' HB3' HG12 ' B' ' 172' ' ' ILE . . . -151.02 158.9 44.71 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 111.27 -2.695 . . . . 0.98 116.527 -172.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 170' ' ' ALA . . . . . 0.941 ' HB2' ' HB3' ' B' ' 189' ' ' ALA . . . -51.32 122.74 8.28 Favored 'General case' 0 C--N 1.347 0.496 0 CA-C-N 113.955 -1.475 . . . . 1.25 111.139 -179.571 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 171' ' ' GLY . . . . . 0.561 ' HA2' ' O ' ' B' ' 182' ' ' ASP . . . 69.84 16.43 72.37 Favored Glycine 0 N--CA 1.428 -1.837 0 C-N-CA 120.642 -0.789 . . . . 1.29 112.611 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 172' ' ' ILE . . . . . 1.054 HG12 ' HB3' ' B' ' 169' ' ' ALA . 0.5 OUTLIER -134.86 110.0 12.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-O 122.05 0.928 . . . . 2.27 111.809 -177.07 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 173' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -106.08 102.04 11.49 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.865 -0.791 . . . . 1.94 108.865 178.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 174' ' ' CYS . . . . . 0.85 ' HA ' ' HA ' ' B' ' 179' ' ' CYS . 3.4 t -92.74 122.34 35.04 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 121.663 0.744 . . . . 1.35 112.33 -178.408 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 175' ' ' SER . . . . . 0.63 ' HA ' ' HA2' ' B' ' 165' ' ' GLY . 0.3 OUTLIER -90.48 -179.2 1.11 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 114.378 -1.283 . . . . 2.0 109.78 179.537 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 176' ' ' PRO . . . . . 0.484 ' HD2' ' CB ' ' B' ' 175' ' ' SER . 86.0 Cg_endo -77.67 25.25 0.5 Allowed 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 121.782 1.655 . . . . 1.9 112.969 -179.267 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 177' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -145.63 -45.61 0.21 Allowed 'General case' 0 C--O 1.237 0.403 0 N-CA-C 109.032 -0.729 . . . . 2.72 109.032 178.514 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 178' ' ' GLY . . . . . 0.57 ' HA3' ' HB3' ' A' ' 80' ' ' HIS . . . -149.39 -151.67 5.55 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.364 -0.835 . . . . 0.99 111.691 178.533 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 179' ' ' CYS . . . . . 0.85 ' HA ' ' HA ' ' B' ' 174' ' ' CYS . 0.0 OUTLIER -146.93 162.77 38.03 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.868 -0.419 . . . . 1.34 109.868 179.724 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 180' ' ' HIS . . . . . 0.56 ' HB3' ' HA3' ' A' ' 78' ' ' GLY . 0.1 OUTLIER -150.42 160.74 43.53 Favored 'General case' 0 N--CA 1.464 0.263 0 O-C-N 121.967 -0.458 . . . . 2.1 111.091 -179.117 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 181' ' ' GLU . . . . . 0.618 ' H ' HD11 ' A' ' 26' ' ' ILE . 0.5 OUTLIER -63.57 145.97 54.62 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.435 -0.58 . . . . 3.06 109.435 179.246 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 182' ' ' ASP . . . . . 0.561 ' O ' ' HA2' ' B' ' 171' ' ' GLY . 0.7 OUTLIER -145.85 140.67 15.89 Favored Pre-proline 0 CA--C 1.537 0.475 0 C-N-CA 120.523 -0.471 . . . . 2.06 111.911 -179.366 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 183' ' ' PRO . . . . . 0.504 ' O ' ' HB2' ' B' ' 186' ' ' ASP . 5.2 Cg_exo -80.5 -20.86 7.85 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.977 2.451 . . . . 1.91 113.726 -179.004 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -67.05 -40.99 87.25 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.166 0.507 . . . . 1.56 110.666 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 185' ' ' CYS . . . . . 0.875 ' HB3' ' HA ' ' B' ' 170' ' ' ALA . 85.7 m -97.06 27.06 4.26 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.778 0.799 . . . . 1.94 110.367 179.323 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 186' ' ' ASP . . . . . 0.7 ' N ' ' HD2' ' B' ' 187' ' ' PRO . 1.1 t70 -77.25 -46.35 2.67 Favored Pre-proline 0 C--N 1.316 -0.865 0 CA-C-N 115.048 -0.978 . . . . 3.61 110.242 179.618 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 187' ' ' PRO . . . . . 0.7 ' HD2' ' N ' ' B' ' 186' ' ' ASP . 22.5 Cg_endo -62.71 107.79 0.65 Allowed 'Trans proline' 0 N--CA 1.439 -1.682 0 C-N-CA 121.28 1.32 . . . . 2.58 112.292 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 188' ' ' GLU . . . . . 0.532 ' C ' ' O ' ' B' ' 187' ' ' PRO . 0.3 OUTLIER -12.59 81.15 0.0 OUTLIER 'General case' 0 CA--C 1.468 -2.197 0 CA-C-O 125.274 2.464 . . . . 4.7 106.261 -179.539 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 189' ' ' ALA . . . . . 0.941 ' HB3' ' HB2' ' B' ' 170' ' ' ALA . . . -86.76 4.61 40.18 Favored 'General case' 0 N--CA 1.439 -0.998 1 CA-C-N 108.289 -4.05 . . . . 5.24 109.789 -176.901 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 190' ' ' ALA . . . . . . . . . . . . . . . -51.18 116.98 2.28 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 116.894 -1.923 . . . . 6.93 109.502 -174.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 191' ' ' PHE . . . . . 0.56 ' HB3' ' CB ' ' B' ' 130' ' ' ASP . 8.2 t80 -88.54 134.13 33.96 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 119.591 1.087 . . . . 10.14 109.826 176.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 13.1 m . . . . . 0 C--O 1.247 0.969 0 CA-C-O 118.142 -0.932 . . . . 11.7 110.727 -179.396 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.694 0 CA-C-O 120.673 0.273 . . . . 9.95 111.697 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 8.0 m -143.72 40.49 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-O 121.094 0.473 . . . . 8.02 112.256 -179.337 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.811 ' HG ' ' CD2' ' A' ' 5' ' ' LEU . 3.7 tp -162.0 114.96 1.79 Allowed 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.116 -1.068 . . . . 5.86 108.116 178.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.421 ' O ' ' O ' ' A' ' 5' ' ' LEU . 0.3 OUTLIER -76.59 -58.48 3.26 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 113.227 -1.806 . . . . 6.22 112.291 -177.584 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.871 HD11 ' HA ' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -22.36 -116.09 0.0 OUTLIER 'General case' 0 CA--C 1.478 -1.818 0 CA-C-N 111.06 -2.791 . . . . 7.09 113.411 -173.4 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.833 ' H ' ' HG ' ' A' ' 5' ' ' LEU 0.287 5.8 t70 -174.61 -40.34 0.01 OUTLIER 'General case' 0 C--N 1.278 -2.512 0 CA-C-O 123.509 1.623 . . . . 8.78 109.499 -175.291 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.4 p -137.28 122.47 25.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 N-CA-C 102.633 -3.099 . . . . 7.51 102.633 171.545 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.871 ' HA ' HD11 ' A' ' 5' ' ' LEU . 12.0 ttp180 -76.72 105.64 7.91 Favored 'General case' 0 N--CA 1.385 -3.697 0 C-N-CA 118.076 -1.45 . . . . 9.08 108.347 -178.178 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.771 ' O ' HD22 ' A' ' 11' ' ' LEU . 22.4 m -105.77 94.19 5.05 Favored 'General case' 0 N--CA 1.384 -3.755 1 N-CA-C 98.364 -4.68 . . . . 5.66 98.364 168.507 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.45 62.42 1.86 Allowed 'General case' 0 C--N 1.288 -2.07 0 CA-C-N 114.032 -1.44 . . . . 2.68 110.175 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.833 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 1.6 mm? -32.44 109.92 0.31 Allowed Pre-proline 0 N--CA 1.47 0.532 0 N-CA-C 113.672 0.99 . . . . 2.48 113.672 -178.412 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -60.61 157.18 38.25 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.393 2.062 . . . . 1.49 110.267 176.041 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.516 ' HB3' ' N ' ' A' ' 20' ' ' ARG . 1.0 OUTLIER -159.6 169.94 22.71 Favored 'General case' 0 CA--C 1.552 1.039 0 CA-C-O 121.363 0.601 . . . . 1.0 111.642 173.468 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.778 ' HA2' ' HB3' ' A' ' 40' ' ' GLU . . . 73.49 -160.44 53.72 Favored Glycine 0 CA--C 1.502 -0.769 0 C-N-CA 120.807 -0.711 . . . . 1.15 113.725 177.493 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.413 ' HG2' ' O ' ' A' ' 15' ' ' PRO . 41.2 Cg_endo -66.68 96.94 0.37 Allowed 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 123.049 2.499 . . . . 1.57 117.145 178.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 86.01 -2.08 87.72 Favored Glycine 1 C--N 1.254 -4.006 0 C-N-CA 119.76 -1.21 . . . . 1.68 114.31 -172.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.46 ' HA2' ' O ' ' A' ' 13' ' ' CYS . . . 79.72 44.95 8.84 Favored Glycine 0 N--CA 1.419 -2.478 0 C-N-CA 118.881 -1.628 . . . . 1.36 114.897 176.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.6 -9.73 34.18 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 113.446 -1.377 . . . . 2.5 111.294 176.041 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.474 ' C ' ' HB3' ' A' ' 13' ' ' CYS . . . -106.32 -174.42 23.34 Favored Glycine 0 CA--C 1.504 -0.643 0 N-CA-C 107.693 -2.163 . . . . 1.02 107.693 178.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.833 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 3.5 ttp180 -129.59 171.59 12.45 Favored 'General case' 0 CA--C 1.552 1.04 0 CA-C-N 121.635 2.717 . . . . 2.92 108.7 -179.475 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.499 ' HB3' ' HG3' ' A' ' 47' ' ' GLU . 1.0 OUTLIER -107.33 143.69 35.26 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 121.28 -0.887 . . . . 1.1 112.739 -178.662 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.424 ' HE2' ' HB3' ' A' ' 20' ' ' ARG . 97.0 m-85 -156.27 57.79 0.58 Allowed 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 114.87 -1.059 . . . . 1.51 109.916 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.505 ' HA3' ' HA ' ' A' ' 76' ' ' PRO . . . 125.97 148.26 7.11 Favored Glycine 0 C--N 1.334 0.432 0 N-CA-C 111.05 -0.82 . . . . 0.9 111.05 -179.095 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.478 ' O ' ' HB1' ' A' ' 41' ' ' ALA . 53.1 Cg_exo -52.3 -75.0 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 121.932 1.755 . . . . 1.5 112.372 -179.262 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.528 ' HB2' ' CG ' ' B' ' 181' ' ' GLU . 2.0 m -89.37 37.87 0.88 Allowed 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 109.182 -0.673 . . . . 1.26 109.182 178.455 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 1.082 HG12 HG13 ' A' ' 36' ' ' VAL . 15.9 mt -147.76 102.94 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 CA-C-N 115.269 -0.878 . . . . 0.83 109.586 -179.679 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.707 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 0.1 OUTLIER -118.68 123.11 44.11 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.648 -0.705 . . . . 0.92 110.53 -177.785 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 1.004 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -142.25 119.4 11.42 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 117.329 2.344 . . . . 1.28 117.329 -178.423 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.465 ' O ' ' CB ' ' A' ' 69' ' ' ALA . . . -108.48 -170.53 21.21 Favored Glycine 0 C--N 1.364 2.121 0 N-CA-C 108.259 -1.936 . . . . 0.67 108.259 175.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.519 ' OD2' ' HG2' ' A' ' 31' ' ' GLU . 20.8 p-10 -64.01 -58.83 5.52 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 114.835 1.42 . . . . 2.27 114.835 -176.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.519 ' HG2' ' OD2' ' A' ' 30' ' ' ASP . 0.0 OUTLIER -108.35 6.52 26.49 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 121.466 0.651 . . . . 1.66 111.477 -177.037 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.949 HD22 ' CZ ' ' A' ' 35' ' ' PHE . 2.2 mt -108.64 -8.44 15.44 Favored 'General case' 0 N--CA 1.398 -3.048 0 N-CA-C 105.332 -2.099 . . . . 1.37 105.332 178.776 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 1.004 ' O ' ' HA ' ' A' ' 28' ' ' CYS . . . 49.16 -133.15 24.46 Favored Glycine 0 N--CA 1.437 -1.251 0 CA-C-N 114.237 -1.347 . . . . 0.73 112.538 177.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 1.014 ' HB2' HD13 ' A' ' 72' ' ' ILE . 1.2 t -128.42 119.12 24.34 Favored 'General case' 0 CA--C 1.492 -1.286 0 N-CA-C 114.043 1.127 . . . . 1.08 114.043 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 1.076 ' HA ' ' HA ' ' B' ' 135' ' ' PHE . 0.1 OUTLIER -95.51 102.65 14.47 Favored 'General case' 0 N--CA 1.419 -2.02 0 N-CA-C 102.705 -3.072 . . . . 1.38 102.705 173.906 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 1.082 HG13 HG12 ' A' ' 26' ' ' ILE . 3.0 t -87.93 93.65 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.916 0 CA-C-O 123.102 1.43 . . . . 0.76 107.979 -179.13 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.947 ' HA3' HG21 ' B' ' 172' ' ' ILE . . . 94.26 80.0 1.47 Allowed Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 112.089 -2.323 . . . . 0.81 114.178 -178.643 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.578 HG22 ' O ' ' B' ' 132' ' ' LEU . 71.5 p -159.06 163.37 36.35 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.61 -0.515 . . . . 0.77 109.61 179.034 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.18 -15.67 26.23 Favored 'General case' 0 CA--C 1.527 0.092 0 CA-C-N 118.565 0.62 . . . . 1.02 111.275 178.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.778 ' HB3' ' HA2' ' A' ' 14' ' ' GLY . 40.6 mt-10 -69.23 -13.86 62.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.944 -0.571 . . . . 2.32 109.502 177.726 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.851 ' O ' ' HB2' ' A' ' 44' ' ' CYS . . . -96.11 -24.11 16.46 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 115.328 -0.851 . . . . 0.87 111.121 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.544 HD21 ' HB3' ' B' ' 191' ' ' PHE . 5.3 mt -41.06 -32.95 0.28 Allowed 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.136 0.791 . . . . 1.23 113.136 -178.309 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 5.9 mmm-85 -71.04 -15.18 62.54 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 122.456 1.122 . . . . 2.92 109.561 178.091 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.851 ' HB2' ' O ' ' A' ' 41' ' ' ALA . 1.3 m -62.46 -27.58 69.22 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 112.663 -2.062 . . . . 1.57 110.699 -178.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -49.86 -41.23 44.87 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.968 0.413 . . . . 3.31 111.764 179.212 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -85.52 6.27 27.78 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.722 -0.391 . . . . 3.69 110.257 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.499 ' HG3' ' HB3' ' A' ' 21' ' ' CYS . 1.6 tm-20 -82.04 1.36 36.14 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.217 -0.66 . . . . 3.99 109.217 177.478 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -91.92 -28.27 17.37 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.984 -0.553 . . . . 3.86 109.795 178.417 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -91.9 11.64 24.29 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 115.971 -0.559 . . . . 5.68 111.387 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.697 HD23 HG21 ' A' ' 9' ' ' THR . 4.4 mp -141.02 93.19 8.28 Favored Pre-proline 0 CA--C 1.53 0.187 0 CA-C-N 116.792 -0.186 . . . . 5.4 110.884 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -85.19 45.74 1.67 Allowed 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 122.452 2.101 . . . . 4.92 113.041 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.562 ' O ' ' HB ' ' A' ' 9' ' ' THR . 1.4 p -133.43 91.74 25.98 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 116.454 -0.339 . . . . 5.64 110.806 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -90.11 138.07 2.77 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.537 2.158 . . . . 5.04 112.99 -179.609 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.864 ' HA ' HD13 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -63.53 92.26 0.06 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.985 -0.552 . . . . 2.74 111.344 179.711 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.778 ' HB2' HD12 ' A' ' 3' ' ' LEU . 8.8 tt0 44.1 -106.43 0.1 Allowed 'General case' 0 CA--C 1.552 1.044 0 N-CA-C 112.688 0.625 . . . . 5.75 112.688 179.446 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.3 p 89.95 143.25 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.791 0.837 . . . . 3.12 110.852 -178.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.52 115.05 7.16 Favored Glycine 0 CA--C 1.491 -1.428 0 C-N-CA 121.316 -0.468 . . . . 2.1 112.369 -178.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -73.72 79.26 1.55 Allowed 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 108.251 -1.018 . . . . 4.36 108.251 179.12 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.576 ' O ' ' HA ' ' A' ' 66' ' ' ARG . 8.0 mmmt -135.45 73.87 61.73 Favored Pre-proline 0 C--N 1.31 -1.116 0 N-CA-C 106.079 -1.823 . . . . 3.55 106.079 -179.327 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.623 ' HA ' ' O ' ' A' ' 65' ' ' GLY . 74.2 Cg_endo -75.79 78.8 3.01 Favored 'Trans proline' 0 C--N 1.372 1.777 0 C-N-CA 123.323 2.682 . . . . 1.54 115.515 -177.775 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 2.3 p -100.72 -176.05 3.07 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 105.118 -2.178 . . . . 1.59 105.118 175.49 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.02 -168.03 52.31 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 118.203 -1.951 . . . . 2.43 114.444 -178.131 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.84 40.91 0.88 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 113.891 -1.155 . . . . 4.11 110.353 -177.49 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 115.48 9.55 12.74 Favored Glycine 0 CA--C 1.544 1.873 0 CA-C-N 113.847 -1.524 . . . . 2.21 115.216 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.844 ' CA ' ' HB3' ' A' ' 75' ' ' SER . . . -103.55 140.41 14.89 Favored Glycine 0 C--N 1.336 0.58 0 CA-C-N 120.529 2.165 . . . . 1.62 116.2 -178.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.576 ' HA ' ' O ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -101.73 156.51 17.45 Favored 'General case' 0 C--N 1.341 0.216 0 C-N-CA 124.496 1.118 . . . . 3.02 109.685 177.837 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.466 ' HB2' ' HB2' ' A' ' 59' ' ' LYS . 1.2 m -52.1 106.28 0.14 Allowed 'General case' 0 CA--C 1.504 -0.82 0 CA-C-N 119.283 0.947 . . . . 1.52 108.793 -179.012 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -78.53 -29.65 46.56 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 106.31 -1.737 . . . . 1.07 106.31 177.588 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.957 ' O ' HG13 ' A' ' 72' ' ' ILE . . . -162.08 139.04 8.21 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 113.454 -1.703 . . . . 1.0 109.925 -176.504 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.775 ' HB1' ' HB2' ' A' ' 89' ' ' ALA . . . 12.7 -143.22 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.374 1.07 . . . . 1.24 113.796 179.127 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.421 ' HA2' ' O ' ' A' ' 82' ' ' ASP . . . -73.44 65.12 1.71 Allowed Glycine 0 CA--C 1.491 -1.443 0 N-CA-C 107.513 -2.235 . . . . 1.28 107.513 179.064 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 1.035 HG21 ' HA3' ' B' ' 137' ' ' GLY . 1.7 pp -150.81 97.17 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.813 0 N-CA-C 106.161 -1.792 . . . . 2.27 106.161 167.191 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.431 ' O ' ' N ' ' A' ' 80' ' ' HIS . 3.9 t -95.62 103.26 15.12 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.317 -0.856 . . . . 1.98 111.48 -175.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.595 ' HB3' ' O ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -129.75 176.15 8.26 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 113.387 0.884 . . . . 1.33 113.387 -179.029 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.902 ' HB2' ' HD2' ' A' ' 76' ' ' PRO . 36.5 p -138.32 -179.27 1.0 Allowed Pre-proline 0 N--CA 1.462 0.15 0 CA-C-N 113.689 -1.596 . . . . 1.99 108.513 178.752 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.902 ' HD2' ' HB2' ' A' ' 75' ' ' SER . 77.0 Cg_endo -78.02 30.31 0.44 Allowed 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 121.449 1.433 . . . . 1.86 111.511 178.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.425 ' H ' ' C ' ' A' ' 75' ' ' SER . 0.6 OUTLIER -144.96 -34.01 0.36 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.507 -0.769 . . . . 2.65 110.864 179.816 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.595 ' O ' ' HB3' ' A' ' 74' ' ' CYS . . . -158.74 -171.98 25.28 Favored Glycine 0 C--N 1.339 0.738 0 C-N-CA 120.764 -0.732 . . . . 0.99 113.118 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.59 ' HA ' ' HA ' ' A' ' 74' ' ' CYS . 13.6 t -148.27 160.22 43.19 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 122.567 0.347 . . . . 1.34 110.664 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.431 ' N ' ' O ' ' A' ' 73' ' ' CYS . 10.7 t-80 -154.71 145.92 22.84 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 120.027 -0.669 . . . . 2.17 111.659 -179.734 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.585 ' CG ' ' HB2' ' B' ' 125' ' ' SER . 1.8 mt-10 -64.13 132.82 51.59 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.42 -0.585 . . . . 3.05 109.42 178.793 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.453 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 0.3 OUTLIER -141.62 122.67 8.75 Favored Pre-proline 0 CA--C 1.541 0.621 0 CA-C-N 116.495 -0.32 . . . . 2.02 110.754 -179.08 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 82' ' ' ASP . 1.8 Cg_endo -83.7 -12.79 8.56 Favored 'Trans proline' 0 C--N 1.358 1.076 0 C-N-CA 123.17 2.58 . . . . 1.93 113.97 -177.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.87 -38.65 91.86 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.808 0.337 . . . . 1.53 111.531 -179.479 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.507 ' HB2' ' O ' ' A' ' 70' ' ' ALA . 78.7 m -95.24 39.7 1.11 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.034 -0.53 . . . . 1.88 111.155 -179.443 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.821 ' N ' ' HD2' ' A' ' 87' ' ' PRO . 0.1 OUTLIER -70.62 -31.27 2.08 Favored Pre-proline 0 N--CA 1.466 0.368 0 N-CA-C 114.744 1.386 . . . . 3.6 114.744 -178.769 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.821 ' HD2' ' N ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER -10.68 -115.35 0.0 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.252 0 C-N-CA 123.543 2.829 . . . . 2.56 115.696 177.708 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.97 35.62 0.13 Allowed 'General case' 0 C--N 1.272 -2.773 0 CA-C-N 110.087 -3.233 . . . . 4.72 109.749 179.396 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.775 ' HB2' ' HB1' ' A' ' 70' ' ' ALA . . . -97.11 39.23 1.19 Allowed 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 113.006 -1.906 . . . . 5.29 106.003 172.762 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.83 161.49 29.52 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 114.078 1.14 . . . . 6.98 114.078 -177.601 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.714 ' HB3' HD21 ' B' ' 142' ' ' LEU . 15.7 p90 -85.25 100.32 11.7 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 114.531 -1.213 . . . . 10.21 110.507 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 19.0 t . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.206 -0.902 . . . . 11.77 110.746 -179.795 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.336 0 N-CA-C 110.369 -0.234 . . . . 10.07 110.369 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 28.0 t -144.2 125.73 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 CA-C-O 121.769 0.795 . . . . 8.41 110.18 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -85.38 114.15 22.22 Favored 'General case' 0 C--O 1.225 -0.207 0 CA-C-N 114.338 -1.301 . . . . 5.87 111.16 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 104' ' ' ASP . . . . . 0.567 ' H ' ' HG3' ' B' ' 155' ' ' GLN . 3.6 t70 -77.58 76.43 4.11 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 105.541 -2.022 . . . . 6.27 105.541 175.696 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 105' ' ' LEU . . . . . 0.895 HD22 ' O ' ' B' ' 153' ' ' PRO . 0.3 OUTLIER -151.3 -128.85 0.04 OUTLIER 'General case' 0 N--CA 1.412 -2.364 0 CA-C-N 112.905 -1.952 . . . . 7.2 106.708 -174.117 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 106' ' ' ASP . . . . . 0.739 ' H ' ' HG ' ' B' ' 105' ' ' LEU . 4.2 t70 -168.65 -41.83 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 107.813 -1.18 . . . . 8.55 107.813 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 107' ' ' VAL . . . . . 0.542 ' O ' HD21 ' B' ' 105' ' ' LEU . 7.2 p -139.89 123.84 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 N-CA-C 103.422 -2.807 . . . . 7.48 103.422 174.44 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 108' ' ' ARG . . . . . 0.821 ' HG3' ' SG ' ' B' ' 154' ' ' CYS . 11.4 ttp180 -76.03 106.96 7.91 Favored 'General case' 0 N--CA 1.388 -3.556 0 C-N-CA 118.655 -1.218 . . . . 9.12 108.101 -178.475 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 109' ' ' THR . . . . . 0.768 ' O ' HD22 ' B' ' 111' ' ' LEU . 24.4 m -108.45 94.3 4.99 Favored 'General case' 0 N--CA 1.385 -3.696 1 N-CA-C 97.718 -4.919 . . . . 5.69 97.718 168.929 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 110' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -78.49 66.88 4.14 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 113.239 -1.8 . . . . 2.61 109.194 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 111' ' ' LEU . . . . . 0.845 ' O ' ' HA ' ' B' ' 120' ' ' ARG . 1.7 mm? -34.2 109.97 0.37 Allowed Pre-proline 0 N--CA 1.469 0.507 0 N-CA-C 113.436 0.902 . . . . 2.47 113.436 -179.638 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 112' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -66.19 152.41 81.23 Favored 'Trans proline' 0 N--CA 1.464 -0.242 0 C-N-CA 121.84 1.693 . . . . 1.47 111.607 176.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.584 ' HB3' ' N ' ' B' ' 120' ' ' ARG . 1.0 OUTLIER -154.3 170.69 20.71 Favored 'General case' 0 CA--C 1.557 1.243 0 CA-C-O 121.185 0.517 . . . . 1.0 111.632 177.659 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 114' ' ' GLY . . . . . 0.748 ' HA2' ' HB3' ' B' ' 140' ' ' GLU . . . 74.38 -159.35 52.41 Favored Glycine 0 N--CA 1.467 0.748 0 CA-C-N 116.241 -0.436 . . . . 1.16 114.029 177.505 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 115' ' ' PRO . . . . . 0.476 ' O ' ' N ' ' B' ' 117' ' ' GLY . 87.6 Cg_endo -57.7 143.53 94.98 Favored 'Trans proline' 0 C--N 1.363 1.315 0 N-CA-C 102.355 -3.748 . . . . 1.57 102.355 175.635 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 48.06 -3.72 0.01 OUTLIER Glycine 0 C--N 1.274 -2.898 0 O-C-N 118.251 -2.78 . . . . 1.7 116.474 172.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 117' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' B' ' 115' ' ' PRO . . . 78.5 42.93 13.21 Favored Glycine 0 N--CA 1.407 -3.267 0 C-N-CA 116.695 -2.669 . . . . 1.38 114.231 177.143 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.09 -15.97 27.04 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 113.199 -1.5 . . . . 2.54 110.852 177.539 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . -96.26 -161.29 32.72 Favored Glycine 0 C--N 1.343 0.967 0 N-CA-C 109.074 -1.61 . . . . 1.04 109.074 179.448 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.845 ' HA ' ' O ' ' B' ' 111' ' ' LEU . 3.5 ttp180 -140.84 170.54 15.56 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 121.706 2.753 . . . . 2.89 106.788 177.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 121' ' ' CYS . . . . . 0.48 ' HB3' ' HG3' ' B' ' 147' ' ' GLU . 1.1 m -107.67 143.83 35.6 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 119.005 0.82 . . . . 1.07 112.83 -178.473 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 122' ' ' PHE . . . . . 0.434 ' HE2' ' HB3' ' B' ' 120' ' ' ARG . 97.1 m-85 -156.37 57.85 0.57 Allowed 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 114.898 -1.046 . . . . 1.53 109.897 179.612 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 123' ' ' GLY . . . . . 0.503 ' HA3' ' HA ' ' B' ' 176' ' ' PRO . . . 125.86 148.22 7.12 Favored Glycine 0 C--N 1.334 0.45 0 N-CA-C 110.972 -0.851 . . . . 0.9 110.972 -179.135 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 124' ' ' PRO . . . . . 0.471 ' O ' ' HB1' ' B' ' 141' ' ' ALA . 53.0 Cg_exo -52.27 -75.15 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 121.91 1.74 . . . . 1.51 112.312 -179.276 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 125' ' ' SER . . . . . 0.585 ' HB2' ' CG ' ' A' ' 81' ' ' GLU . 1.9 m -89.28 37.71 0.87 Allowed 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 109.242 -0.651 . . . . 1.25 109.242 178.501 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 126' ' ' ILE . . . . . 1.04 HG12 HG13 ' B' ' 136' ' ' VAL . 18.5 mt -147.36 102.93 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 CA-C-N 115.247 -0.888 . . . . 0.85 109.737 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 127' ' ' CYS . . . . . 0.719 ' O ' ' HA ' ' B' ' 134' ' ' CYS . 0.1 OUTLIER -118.65 123.05 44.02 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.65 -0.705 . . . . 0.89 110.511 -177.837 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 128' ' ' CYS . . . . . 0.996 ' HA ' ' O ' ' B' ' 133' ' ' GLY . 0.0 OUTLIER -141.43 120.84 13.17 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 116.642 2.09 . . . . 1.23 116.642 -178.641 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 129' ' ' GLY . . . . . 0.49 ' O ' ' HB1' ' B' ' 169' ' ' ALA . . . -110.49 -169.0 19.46 Favored Glycine 0 C--N 1.366 2.249 0 N-CA-C 107.924 -2.07 . . . . 0.66 107.924 175.304 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 130' ' ' ASP . . . . . 0.514 ' OD2' ' HG2' ' B' ' 131' ' ' GLU . 21.3 p-10 -63.88 -60.88 2.72 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 113.967 1.099 . . . . 2.35 113.967 -177.294 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 131' ' ' GLU . . . . . 0.514 ' HG2' ' OD2' ' B' ' 130' ' ' ASP . 0.1 OUTLIER -115.13 27.52 9.33 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 122.287 1.042 . . . . 1.69 111.132 -178.048 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 132' ' ' LEU . . . . . 0.968 HD22 ' CZ ' ' B' ' 135' ' ' PHE . 1.7 mt -124.02 -8.41 7.73 Favored 'General case' 0 N--CA 1.399 -3.01 0 N-CA-C 102.91 -2.996 . . . . 1.38 102.91 178.253 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 133' ' ' GLY . . . . . 0.996 ' O ' ' HA ' ' B' ' 128' ' ' CYS . . . 46.68 -130.36 11.96 Favored Glycine 0 N--CA 1.417 -2.604 0 CA-C-N 113.312 -1.767 . . . . 0.72 112.694 175.661 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 134' ' ' CYS . . . . . 1.011 ' HB2' HD13 ' B' ' 172' ' ' ILE . 1.5 t -130.85 118.7 21.13 Favored 'General case' 0 CA--C 1.492 -1.254 0 CA-C-N 120.166 1.983 . . . . 1.08 114.005 -179.356 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 135' ' ' PHE . . . . . 1.076 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -94.49 102.78 14.74 Favored 'General case' 0 N--CA 1.417 -2.085 0 N-CA-C 102.899 -3.0 . . . . 1.36 102.899 174.501 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 136' ' ' VAL . . . . . 1.04 HG13 HG12 ' B' ' 126' ' ' ILE . 3.8 t -87.8 93.15 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.916 0 CA-C-O 123.118 1.437 . . . . 0.75 107.968 -179.213 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 137' ' ' GLY . . . . . 1.035 ' HA3' HG21 ' A' ' 72' ' ' ILE . . . 94.67 79.62 1.46 Allowed Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 112.129 -2.305 . . . . 0.83 114.298 -178.699 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 138' ' ' THR . . . . . 0.654 HG22 ' O ' ' A' ' 32' ' ' LEU . 72.7 p -158.18 165.08 35.81 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.535 -0.543 . . . . 0.78 109.535 179.187 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -62.56 -14.01 37.53 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 121.107 0.479 . . . . 1.04 110.977 178.548 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 140' ' ' GLU . . . . . 0.748 ' HB3' ' HA2' ' B' ' 114' ' ' GLY . 40.9 mt-10 -70.15 -15.13 62.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.537 -0.756 . . . . 2.31 109.446 177.394 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 141' ' ' ALA . . . . . 0.815 ' O ' ' HB2' ' B' ' 144' ' ' CYS . . . -94.51 -25.48 16.84 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.37 -0.832 . . . . 0.87 110.871 -179.722 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 142' ' ' LEU . . . . . 0.714 HD21 ' HB3' ' A' ' 91' ' ' PHE . 5.2 mt -40.31 -32.83 0.2 Allowed 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 113.245 0.831 . . . . 1.24 113.245 -177.327 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 143' ' ' ARG . . . . . . . . . . . . . 6.0 mmm-85 -69.34 -18.5 63.81 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 122.641 1.21 . . . . 2.93 109.141 177.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 144' ' ' CYS . . . . . 0.815 ' HB2' ' O ' ' B' ' 141' ' ' ALA . 1.3 m -60.94 -25.54 66.87 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 112.617 -2.083 . . . . 1.61 111.007 -177.367 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -51.1 -40.89 59.46 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.902 0.382 . . . . 3.35 111.693 178.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -85.55 6.37 27.48 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.68 -0.408 . . . . 3.76 110.211 -179.681 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 147' ' ' GLU . . . . . 0.48 ' HG3' ' HB3' ' B' ' 121' ' ' CYS . 1.6 tm-20 -82.1 1.36 36.34 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.19 -0.67 . . . . 4.01 109.19 177.494 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 148' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -91.98 -28.19 17.37 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.931 -0.577 . . . . 3.92 109.724 178.491 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -91.95 11.66 24.35 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.0 -0.545 . . . . 5.73 111.335 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 150' ' ' LEU . . . . . 0.671 HD23 HG21 ' B' ' 109' ' ' THR . 4.4 mp -141.03 93.21 8.27 Favored Pre-proline 0 CA--C 1.53 0.187 0 CA-C-N 116.817 -0.174 . . . . 5.46 110.837 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 151' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -85.15 45.66 1.66 Allowed 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.415 2.077 . . . . 5.02 113.027 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 152' ' ' SER . . . . . 0.554 ' O ' ' HB ' ' B' ' 109' ' ' THR . 1.4 p -133.43 91.84 25.72 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.506 -0.315 . . . . 5.73 110.891 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 153' ' ' PRO . . . . . 0.895 ' O ' HD22 ' B' ' 105' ' ' LEU . 97.4 Cg_endo -90.2 138.07 2.73 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.427 2.085 . . . . 5.1 112.976 -179.596 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 154' ' ' CYS . . . . . 0.821 ' SG ' ' HG3' ' B' ' 108' ' ' ARG . 0.0 OUTLIER -63.78 93.96 0.09 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.934 -0.575 . . . . 2.68 111.011 179.714 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 155' ' ' GLN . . . . . 0.567 ' HG3' ' H ' ' B' ' 104' ' ' ASP . 8.9 tt0 42.57 -106.52 0.08 Allowed 'General case' 0 CA--C 1.553 1.082 0 N-CA-C 112.837 0.68 . . . . 5.63 112.837 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 156' ' ' SER . . . . . 0.408 ' CB ' ' O ' ' B' ' 155' ' ' GLN . 5.5 p 89.29 139.7 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.894 0.878 . . . . 3.11 111.495 -179.165 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -56.51 115.12 5.88 Favored Glycine 0 CA--C 1.499 -0.909 0 CA-C-N 116.131 -0.486 . . . . 2.07 112.576 -178.161 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -76.28 67.45 2.53 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 119.157 -1.017 . . . . 4.34 109.504 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 159' ' ' LYS . . . . . 0.623 ' O ' ' HA ' ' B' ' 166' ' ' ARG . 14.8 mmmt -108.62 70.17 0.38 Allowed Pre-proline 0 C--N 1.318 -0.79 0 CA-C-N 114.043 -1.435 . . . . 3.54 110.852 174.408 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 160' ' ' PRO . . . . . 0.59 ' HA ' ' O ' ' B' ' 165' ' ' GLY . 68.6 Cg_endo -75.38 82.97 1.96 Allowed 'Trans proline' 0 N--CA 1.463 -0.271 0 C-N-CA 121.747 1.632 . . . . 1.51 115.582 -176.382 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 161' ' ' CYS . . . . . 0.403 ' N ' ' O ' ' B' ' 165' ' ' GLY . 1.8 p -93.04 -157.98 0.57 Allowed 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 113.107 -1.86 . . . . 1.58 107.279 177.782 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 52.95 -167.11 1.17 Allowed Glycine 0 N--CA 1.453 -0.203 0 O-C-N 119.287 -2.133 . . . . 2.37 116.938 171.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.64 41.02 0.88 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 112.849 -1.675 . . . . 4.07 110.436 -178.271 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 115.52 9.72 12.47 Favored Glycine 0 CA--C 1.548 2.136 0 CA-C-N 114.168 -1.378 . . . . 2.2 115.222 -179.436 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 165' ' ' GLY . . . . . 0.836 ' CA ' ' HB3' ' B' ' 175' ' ' SER . . . -103.93 139.5 14.55 Favored Glycine 0 N--CA 1.464 0.512 0 CA-C-N 120.327 2.064 . . . . 1.62 116.306 -179.051 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 166' ' ' ARG . . . . . 0.623 ' HA ' ' O ' ' B' ' 159' ' ' LYS . 0.0 OUTLIER -101.48 156.39 17.5 Favored 'General case' 0 C--N 1.343 0.323 0 CA-C-N 113.877 -1.162 . . . . 3.05 109.754 178.11 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 167' ' ' CYS . . . . . 0.477 ' HB2' ' HB2' ' B' ' 159' ' ' LYS . 1.2 m -52.05 106.19 0.14 Allowed 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 119.456 1.025 . . . . 1.56 108.813 -179.003 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 168' ' ' ALA . . . . . . . . . . . . . . . -79.58 -27.76 41.15 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 106.602 -1.629 . . . . 1.04 106.602 177.699 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 169' ' ' ALA . . . . . 0.903 ' O ' HG13 ' B' ' 172' ' ' ILE . . . -163.46 139.67 6.88 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 114.81 -1.086 . . . . 0.98 108.589 -177.407 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 170' ' ' ALA . . . . . 0.675 ' HB1' ' HB2' ' B' ' 189' ' ' ALA . . . 11.28 -139.65 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 114.489 1.292 . . . . 1.25 114.489 179.109 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 171' ' ' GLY . . . . . 0.471 ' HA2' ' O ' ' B' ' 182' ' ' ASP . . . -57.2 19.96 0.01 OUTLIER Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 115.72 1.048 . . . . 1.29 115.72 -179.121 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 172' ' ' ILE . . . . . 1.011 HD13 ' HB2' ' B' ' 134' ' ' CYS . 1.7 pp -128.3 99.81 5.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 CA-C-N 118.811 1.305 . . . . 2.27 109.529 -176.603 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 173' ' ' CYS . . . . . 0.427 ' HB3' ' HB3' ' B' ' 182' ' ' ASP . 4.6 t -94.9 102.95 14.82 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.317 -1.31 . . . . 1.94 111.854 -176.492 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 174' ' ' CYS . . . . . 0.595 ' HB3' ' O ' ' B' ' 178' ' ' GLY . 0.0 OUTLIER -130.0 176.44 8.06 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 113.372 0.878 . . . . 1.35 113.372 -179.118 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 175' ' ' SER . . . . . 0.882 ' HB2' ' HD2' ' B' ' 176' ' ' PRO . 35.9 p -138.42 -179.29 1.01 Allowed Pre-proline 0 N--CA 1.462 0.129 0 CA-C-N 113.666 -1.606 . . . . 2.0 108.493 178.766 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 176' ' ' PRO . . . . . 0.882 ' HD2' ' HB2' ' B' ' 175' ' ' SER . 77.0 Cg_endo -78.0 30.3 0.44 Allowed 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 121.445 1.43 . . . . 1.9 111.524 178.866 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 177' ' ' ASP . . . . . 0.426 ' H ' ' C ' ' B' ' 175' ' ' SER . 0.6 OUTLIER -145.06 -33.88 0.36 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 115.534 -0.757 . . . . 2.72 110.84 179.837 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 178' ' ' GLY . . . . . 0.595 ' O ' ' HB3' ' B' ' 174' ' ' CYS . . . -158.82 -172.04 25.42 Favored Glycine 0 C--N 1.339 0.702 0 C-N-CA 120.822 -0.704 . . . . 0.99 113.19 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 179' ' ' CYS . . . . . 0.593 ' HA ' ' HA ' ' B' ' 174' ' ' CYS . 13.6 t -148.23 160.3 43.08 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 122.536 0.335 . . . . 1.34 110.65 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 180' ' ' HIS . . . . . 0.422 ' N ' ' O ' ' B' ' 173' ' ' CYS . 1.8 t60 -154.86 145.89 22.67 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 119.968 -0.693 . . . . 2.1 111.665 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 181' ' ' GLU . . . . . 0.528 ' CG ' ' HB2' ' A' ' 25' ' ' SER . 1.8 mt-10 -64.12 132.91 51.87 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.421 -0.585 . . . . 3.06 109.421 178.852 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 182' ' ' ASP . . . . . 0.471 ' O ' ' HA2' ' B' ' 171' ' ' GLY . 0.3 OUTLIER -141.71 122.52 8.63 Favored Pre-proline 0 CA--C 1.541 0.613 0 CA-C-N 116.499 -0.319 . . . . 2.06 110.706 -178.984 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 183' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' B' ' 182' ' ' ASP . 1.8 Cg_endo -83.64 -12.73 8.67 Favored 'Trans proline' 0 C--N 1.359 1.097 0 C-N-CA 123.141 2.561 . . . . 1.91 114.009 -178.019 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -63.87 -38.44 91.1 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.845 0.355 . . . . 1.56 111.54 -179.544 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 185' ' ' CYS . . . . . 0.533 ' HB2' ' O ' ' B' ' 170' ' ' ALA . 86.0 m -95.14 39.02 1.12 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.942 -0.572 . . . . 1.94 111.468 -179.419 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 186' ' ' ASP . . . . . 0.826 ' N ' ' HD2' ' B' ' 187' ' ' PRO . 0.1 OUTLIER -70.36 -31.36 2.22 Favored Pre-proline 0 CA--C 1.535 0.371 0 N-CA-C 115.018 1.488 . . . . 3.61 115.018 -178.848 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 187' ' ' PRO . . . . . 0.826 ' HD2' ' N ' ' B' ' 186' ' ' ASP . 0.1 OUTLIER -10.08 -116.13 0.0 OUTLIER 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 123.665 2.91 . . . . 2.58 115.547 177.497 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.95 60.41 5.41 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 101.47 -3.53 . . . . 4.7 101.47 175.607 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 189' ' ' ALA . . . . . 0.715 ' HB3' ' O ' ' B' ' 186' ' ' ASP . . . -112.27 31.33 6.36 Favored 'General case' 0 CA--C 1.509 -0.6 1 CA-C-N 106.737 -4.756 . . . . 5.24 108.234 163.147 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 190' ' ' ALA . . . . . . . . . . . . . . . -72.6 161.77 30.35 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 114.755 1.391 . . . . 6.93 114.755 -173.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 191' ' ' PHE . . . . . 0.544 ' HB3' HD21 ' A' ' 42' ' ' LEU . 15.6 p90 -85.26 100.42 11.77 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 114.076 -1.42 . . . . 10.14 110.271 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 18.5 t . . . . . 0 C--O 1.248 0.981 0 CA-C-O 118.251 -0.88 . . . . 11.7 110.735 -179.858 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.56 ' O ' HG22 ' A' ' 2' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.637 0.256 . . . . 9.95 111.581 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.654 ' O ' ' HG3' ' A' ' 55' ' ' GLN . 24.0 m 50.27 47.45 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-O 122.149 0.976 . . . . 8.02 109.76 -176.343 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.836 HD13 ' HB2' ' A' ' 55' ' ' GLN . 0.5 OUTLIER -109.89 77.44 1.05 Allowed 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 112.914 -1.948 . . . . 5.86 109.775 179.725 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -68.48 64.17 0.11 Allowed 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 118.538 -1.265 . . . . 6.22 109.479 -177.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.737 ' HG ' ' HD2' ' A' ' 53' ' ' PRO . 0.2 OUTLIER -148.74 -102.21 0.08 Allowed 'General case' 0 N--CA 1.41 -2.454 0 N-CA-C 105.757 -1.942 . . . . 7.09 105.757 -179.141 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.537 ' H ' HD13 ' A' ' 5' ' ' LEU . 9.7 t70 -171.49 -106.16 0.01 OUTLIER 'General case' 0 C--N 1.274 -2.688 0 CA-C-N 113.631 -1.622 . . . . 8.78 107.242 178.135 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.461 ' O ' ' CD1' ' A' ' 5' ' ' LEU . 5.1 p -89.76 132.09 35.35 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.997 0 N-CA-C 103.152 -2.907 . . . . 7.51 103.152 175.35 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.01 109.29 7.39 Favored 'General case' 0 N--CA 1.4 -2.936 0 C-N-CA 116.946 -1.902 . . . . 9.08 112.373 -174.51 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.472 ' O ' ' HB2' ' A' ' 54' ' ' CYS . 0.1 OUTLIER -105.63 100.23 9.8 Favored 'General case' 0 N--CA 1.407 -2.622 0 N-CA-C 100.217 -3.994 . . . . 5.66 100.217 167.265 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.553 ' HA ' ' CB ' ' A' ' 54' ' ' CYS . 0.5 OUTLIER -77.21 75.58 3.77 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 115.295 -0.866 . . . . 2.68 113.207 -178.717 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.601 HD13 ' HD2' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -31.13 113.94 0.34 Allowed Pre-proline 0 N--CA 1.472 0.648 0 N-CA-C 113.244 0.831 . . . . 2.48 113.244 -179.515 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.791 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 21.9 Cg_endo -93.04 152.74 2.62 Favored 'Trans proline' 0 CA--C 1.535 0.571 0 C-N-CA 124.128 3.219 . . . . 1.49 115.279 -178.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.812 ' N ' ' O ' ' A' ' 19' ' ' GLY . 15.4 p -154.06 -160.36 1.08 Allowed 'General case' 0 C--O 1.243 0.741 0 CA-C-N 115.799 -0.637 . . . . 1.0 109.676 175.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.558 ' HA2' ' HG2' ' A' ' 40' ' ' GLU . . . 74.08 -162.95 54.47 Favored Glycine 0 C--N 1.338 0.65 0 N-CA-C 115.479 0.952 . . . . 1.15 115.479 174.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.655 ' O ' ' HD3' ' A' ' 18' ' ' LYS . 64.5 Cg_endo -61.74 104.31 0.31 Allowed 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 124.411 3.408 . . . . 1.57 110.237 177.459 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 86.67 -8.83 73.73 Favored Glycine 0 C--N 1.27 -3.125 0 CA-C-N 112.625 -2.08 . . . . 1.68 112.037 -178.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.782 ' O ' ' HB2' ' A' ' 12' ' ' PRO . . . 78.08 44.33 12.01 Favored Glycine 0 N--CA 1.403 -3.555 0 C-N-CA 120.258 -0.973 . . . . 1.36 114.789 179.126 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.657 ' HZ3' ' H ' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -92.8 -49.0 6.28 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 105.494 -2.039 . . . . 2.5 105.494 175.457 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.812 ' O ' ' N ' ' A' ' 13' ' ' CYS . . . -66.46 162.68 43.95 Favored Glycine 0 C--O 1.205 -1.658 0 C-N-CA 118.099 -2.001 . . . . 1.02 116.038 -165.657 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.536 ' HD2' ' HB3' ' A' ' 10' ' ' CYS . 0.0 OUTLIER -98.53 163.6 12.6 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 115.081 1.512 . . . . 2.92 115.081 -171.052 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.4 m -106.27 134.31 49.61 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 114.266 -1.334 . . . . 1.1 110.772 -177.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -134.26 36.3 3.21 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.208 -0.905 . . . . 1.51 109.857 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 144.93 164.43 10.61 Favored Glycine 0 CA--C 1.521 0.459 0 CA-C-N 115.802 -0.635 . . . . 0.9 112.39 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.436 ' O ' ' HB2' ' A' ' 44' ' ' CYS . 50.6 Cg_exo -52.12 -73.22 0.04 OUTLIER 'Trans proline' 0 CA--C 1.532 0.396 0 C-N-CA 122.715 2.277 . . . . 1.5 112.66 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.654 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.4 OUTLIER -90.96 42.72 1.12 Allowed 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 109.312 -0.625 . . . . 1.26 109.312 178.875 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.678 HG12 HG13 ' A' ' 36' ' ' VAL . 4.4 mt -144.9 121.14 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 N-CA-C 113.561 0.949 . . . . 0.83 113.561 -177.037 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.706 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -138.19 112.42 8.62 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.71 0.767 . . . . 0.92 110.632 178.736 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 1.091 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -131.74 118.53 20.08 Favored 'General case' 0 CA--C 1.557 1.242 0 N-CA-C 114.996 1.48 . . . . 1.28 114.996 -179.319 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.482 ' O ' ' HB2' ' A' ' 69' ' ' ALA . . . -108.22 -165.99 21.24 Favored Glycine 0 N--CA 1.428 -1.849 0 N-CA-C 107.035 -2.426 . . . . 0.67 107.035 175.705 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -68.51 -60.48 2.4 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 115.322 1.601 . . . . 2.27 115.322 -179.535 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.28 18.43 21.64 Favored 'General case' 0 CA--C 1.482 -1.639 0 CA-C-O 121.682 0.754 . . . . 1.66 111.464 -176.607 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.787 HD22 ' CZ ' ' A' ' 35' ' ' PHE . 1.2 mt -115.06 -24.86 8.37 Favored 'General case' 0 N--CA 1.395 -3.195 0 N-CA-C 106.396 -1.705 . . . . 1.37 106.396 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 1.091 ' O ' ' HA ' ' A' ' 28' ' ' CYS . . . 76.18 -132.63 12.97 Favored Glycine 0 N--CA 1.4 -3.713 0 CA-C-N 114.353 -1.294 . . . . 0.73 111.28 177.267 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 1.066 ' HB2' HD13 ' A' ' 72' ' ' ILE . 3.2 t -137.96 118.35 13.75 Favored 'General case' 0 CA--C 1.479 -1.758 0 CA-C-N 118.63 1.215 . . . . 1.08 111.557 178.485 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.982 ' HA ' ' HA ' ' B' ' 135' ' ' PHE . 0.0 OUTLIER -91.62 107.21 19.05 Favored 'General case' 0 N--CA 1.42 -1.953 0 N-CA-C 102.242 -3.244 . . . . 1.38 102.242 174.106 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.728 HG23 HG23 ' B' ' 136' ' ' VAL . 1.9 t -93.0 89.76 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.587 0 CA-C-O 122.793 1.282 . . . . 0.76 110.21 -177.492 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.848 ' HA3' HG21 ' B' ' 172' ' ' ILE . . . 102.76 17.44 18.96 Favored Glycine 0 CA--C 1.518 0.241 0 CA-C-N 112.962 -1.926 . . . . 0.81 116.017 178.633 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.826 HG21 ' CD2' ' B' ' 135' ' ' PHE . 25.9 p -95.39 164.99 12.59 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 118.505 1.152 . . . . 0.77 109.002 178.821 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.884 ' HA ' HD12 ' A' ' 42' ' ' LEU . . . -49.29 -29.7 6.32 Favored 'General case' 0 CA--C 1.517 -0.291 0 O-C-N 120.963 -1.086 . . . . 1.02 112.906 -177.635 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.558 ' HG2' ' HA2' ' A' ' 14' ' ' GLY . 1.6 mp0 -62.53 -20.65 64.86 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 120.867 -0.333 . . . . 2.32 110.125 179.217 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.747 ' O ' ' HB2' ' A' ' 44' ' ' CYS . . . -96.14 -24.07 16.45 Favored 'General case' 0 N--CA 1.428 -1.536 0 CA-C-O 119.312 -0.375 . . . . 0.87 110.468 -178.632 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.884 HD12 ' HA ' ' A' ' 39' ' ' ALA . 1.8 mt -57.4 -27.18 62.11 Favored 'General case' 0 C--N 1.346 0.445 0 CA-C-N 119.791 1.178 . . . . 1.23 110.095 179.223 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.498 ' HD3' ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -77.69 9.27 3.56 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 122.231 1.015 . . . . 2.92 108.901 176.816 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.747 ' HB2' ' O ' ' A' ' 41' ' ' ALA . 5.9 m -83.29 2.95 33.48 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 112.838 -1.983 . . . . 1.57 108.214 172.513 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 30.9 tp60 -86.84 -8.34 57.39 Favored 'General case' 0 C--N 1.35 0.595 0 O-C-N 121.384 -0.823 . . . . 3.31 110.988 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.49 ' HA ' ' CD2' ' A' ' 49' ' ' TYR . 7.2 mt-10 -85.98 5.29 33.91 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 119.094 -1.042 . . . . 3.69 108.762 179.1 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -79.3 2.87 19.87 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 116.013 -0.539 . . . . 3.99 109.782 177.267 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 40.9 p30 -99.19 -28.86 13.15 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 120.911 -0.316 . . . . 3.86 110.488 178.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.49 ' CD2' ' HA ' ' A' ' 46' ' ' GLU . 4.7 m-85 -87.09 9.32 20.17 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 120.951 -0.3 . . . . 5.68 111.305 179.65 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.415 ' CD1' HD21 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -143.21 117.67 6.25 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.838 -0.164 . . . . 5.4 111.092 -179.539 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -79.74 45.45 1.95 Allowed 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 122.315 2.01 . . . . 4.92 112.321 179.562 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.669 ' HA ' HD21 ' A' ' 5' ' ' LEU . 3.4 p -156.36 104.23 2.03 Favored Pre-proline 0 C--O 1.232 0.168 0 CA-C-O 120.604 0.24 . . . . 5.64 111.642 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.737 ' HD2' ' HG ' ' A' ' 5' ' ' LEU . 94.3 Cg_endo -95.52 -4.97 1.92 Allowed 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 123.342 2.695 . . . . 5.04 114.724 -178.695 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.553 ' CB ' ' HA ' ' A' ' 10' ' ' CYS . 10.2 t 69.18 80.67 0.19 Allowed 'General case' 0 N--CA 1.473 0.692 0 O-C-N 122.279 -0.263 . . . . 2.74 111.343 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.836 ' HB2' HD13 ' A' ' 3' ' ' LEU . 0.0 OUTLIER 27.43 -144.29 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 112.865 0.691 . . . . 5.75 112.865 179.793 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.548 ' H ' ' CD ' ' A' ' 55' ' ' GLN . 3.2 t -167.8 172.88 8.76 Favored 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 109.193 -0.669 . . . . 3.12 109.193 -179.699 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.405 ' O ' ' HB2' ' A' ' 66' ' ' ARG . . . -76.8 146.88 32.98 Favored Glycine 0 N--CA 1.433 -1.509 0 N-CA-C 110.064 -1.214 . . . . 2.1 110.064 -177.772 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -113.43 74.17 0.85 Allowed 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 122.153 0.978 . . . . 4.36 108.891 178.672 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.57 ' HB2' ' HB3' ' A' ' 67' ' ' CYS . 5.9 mmtp -144.1 58.22 5.73 Favored Pre-proline 0 C--N 1.304 -1.393 0 N-CA-C 106.579 -1.638 . . . . 3.55 106.579 178.503 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.538 ' HA ' ' O ' ' A' ' 65' ' ' GLY . 19.6 Cg_endo -59.01 80.45 0.05 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 122.437 2.091 . . . . 1.54 115.048 -177.228 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.499 ' N ' ' O ' ' A' ' 65' ' ' GLY . 0.5 OUTLIER -99.58 -178.64 3.95 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 106.449 -1.686 . . . . 1.59 106.449 175.553 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.533 ' HA3' ' CE1' ' A' ' 80' ' ' HIS . . . 70.49 -166.79 50.8 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 118.103 -1.999 . . . . 2.43 112.31 179.148 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.7 m -86.13 39.68 0.83 Allowed 'General case' 0 N--CA 1.477 0.893 0 CA-C-O 121.843 0.83 . . . . 4.11 111.354 -176.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 120.15 9.99 7.7 Favored Glycine 0 CA--C 1.543 1.789 0 CA-C-N 114.462 -1.244 . . . . 2.21 114.441 -178.111 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.538 ' O ' ' HA ' ' A' ' 60' ' ' PRO . . . -103.45 151.06 17.78 Favored Glycine 0 C--N 1.336 0.559 0 CA-C-N 119.772 1.786 . . . . 1.62 114.913 -179.121 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.405 ' HB2' ' O ' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -99.52 152.51 19.94 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 122.157 0.183 . . . . 3.02 111.048 178.731 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.57 ' HB3' ' HB2' ' A' ' 59' ' ' LYS . 42.9 t -67.6 121.83 16.73 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-O 121.037 0.446 . . . . 1.52 111.606 -179.213 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.15 -16.66 18.51 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.836 0.827 . . . . 1.07 109.021 177.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.698 ' CB ' ' HA2' ' A' ' 33' ' ' GLY . . . -170.09 160.88 8.35 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.326 -1.307 . . . . 1.0 110.756 178.578 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.417 ' HA ' ' HB3' ' A' ' 85' ' ' CYS . . . -61.5 138.01 58.26 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 122.045 -0.409 . . . . 1.24 111.226 178.31 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.74 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . 64.06 18.97 63.15 Favored Glycine 0 N--CA 1.467 0.756 0 CA-C-N 115.77 -0.65 . . . . 1.28 112.808 -179.409 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 1.066 HD13 ' HB2' ' A' ' 34' ' ' CYS . 1.3 pp -150.34 105.59 0.37 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.913 0 N-CA-C 112.116 0.413 . . . . 2.27 112.116 173.11 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.567 ' HB2' ' HB3' ' A' ' 82' ' ' ASP . 16.5 t -97.75 110.79 23.29 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 120.869 0.366 . . . . 1.98 110.32 178.778 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.783 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 72.1 m -92.44 138.84 31.17 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.494 0.664 . . . . 1.33 111.703 -179.336 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.809 ' HB2' ' HD2' ' A' ' 76' ' ' PRO . 54.1 p -113.26 179.55 0.77 Allowed Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 114.82 -1.082 . . . . 1.99 108.948 179.729 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.809 ' HD2' ' HB2' ' A' ' 75' ' ' SER . 74.0 Cg_endo -76.4 30.87 0.4 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 121.349 1.366 . . . . 1.86 111.997 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.441 ' H ' ' C ' ' A' ' 75' ' ' SER . 18.4 m-20 -144.86 -41.78 0.24 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.544 -0.753 . . . . 2.65 109.983 179.378 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.852 ' HA3' ' O ' ' B' ' 179' ' ' CYS . . . -163.63 -135.07 1.75 Allowed Glycine 0 C--N 1.336 0.551 0 C-N-CA 120.951 -0.642 . . . . 0.99 112.784 179.396 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.841 ' O ' ' HA3' ' B' ' 178' ' ' GLY . 62.7 m -148.1 157.11 43.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.06 0.457 . . . . 1.34 110.314 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.533 ' CE1' ' HA3' ' A' ' 62' ' ' GLY . 1.8 p80 -158.02 153.17 25.61 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.206 -0.598 . . . . 2.17 110.641 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.451 ' OE1' HD11 ' B' ' 126' ' ' ILE . 14.6 mp0 -63.06 140.81 58.91 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.672 -0.411 . . . . 3.05 109.983 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.599 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 2.4 p-10 -140.89 140.88 22.49 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 116.071 -0.513 . . . . 2.02 111.195 -179.328 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 82' ' ' ASP . 10.6 Cg_exo -72.48 -27.35 15.88 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 123.492 2.795 . . . . 1.93 114.571 -177.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.02 -47.44 71.41 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 107.86 -1.163 . . . . 1.53 107.86 179.074 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.74 ' O ' ' N ' ' A' ' 71' ' ' GLY . 2.0 m -99.12 77.97 2.21 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 114.181 -1.372 . . . . 1.88 107.497 176.463 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.985 ' H ' ' CD ' ' A' ' 87' ' ' PRO . 38.2 t0 -164.89 3.09 0.0 OUTLIER Pre-proline 0 C--N 1.321 -0.649 0 N-CA-C 114.23 1.196 . . . . 2.29 114.23 -179.136 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.985 ' CD ' ' H ' ' A' ' 86' ' ' ASP . 59.5 Cg_endo -83.46 132.31 5.85 Favored 'Trans proline' 0 C--N 1.357 1.01 0 C-N-CA 121.475 1.45 . . . . 0.0 111.541 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.408 ' H ' ' HG2' ' A' ' 88' ' ' GLU . 0.5 OUTLIER -8.09 36.81 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 117.036 2.236 . . . . 4.72 117.036 -173.668 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.961 ' N ' ' O ' ' A' ' 87' ' ' PRO . . . -61.16 -38.08 85.18 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 113.635 -1.62 . . . . 5.29 108.888 -176.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -88.85 111.04 21.58 Favored 'General case' 0 C--N 1.299 -1.611 0 C-N-CA 128.396 2.678 . . . . 6.98 112.76 178.324 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -88.56 88.46 7.62 Favored 'General case' 0 C--N 1.359 1.001 0 CA-C-N 110.156 -3.202 . . . . 10.21 110.957 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 2.4 m . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.219 -0.896 . . . . 11.77 110.801 -179.964 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.779 0 N-CA-C 110.578 -0.156 . . . . 10.07 110.578 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 102' ' ' VAL . . . . . 0.416 ' O ' ' CD2' ' B' ' 103' ' ' LEU . 5.9 m -92.97 -173.44 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 120.787 -0.365 . . . . 8.41 111.625 -177.694 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 103' ' ' LEU . . . . . 0.706 ' HA ' ' HG3' ' B' ' 155' ' ' GLN . 0.3 OUTLIER -161.14 93.04 0.94 Allowed 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 108.873 -0.788 . . . . 5.87 108.873 177.127 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -81.7 70.77 8.66 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 107.155 -1.424 . . . . 6.27 107.155 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 105' ' ' LEU . . . . . 1.066 HD21 ' HA ' ' B' ' 108' ' ' ARG . 2.2 tp -153.62 -119.32 0.03 OUTLIER 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 108.882 -0.785 . . . . 7.2 108.882 -172.214 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 106' ' ' ASP . . . . . 1.065 ' H ' ' HG ' ' B' ' 105' ' ' LEU . 5.0 t70 -170.42 -44.43 0.02 OUTLIER 'General case' 0 C--N 1.289 -2.06 0 CA-C-O 121.396 0.617 . . . . 8.55 109.589 179.084 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 107' ' ' VAL . . . . . 0.516 ' O ' HD21 ' B' ' 105' ' ' LEU . 7.5 p -149.71 127.84 2.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 101.948 -3.353 . . . . 7.48 101.948 173.334 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 108' ' ' ARG . . . . . 1.066 ' HA ' HD21 ' B' ' 105' ' ' LEU . 0.0 OUTLIER -73.45 111.69 8.82 Favored 'General case' 0 N--CA 1.401 -2.919 0 C-N-CA 117.903 -1.519 . . . . 9.12 112.201 -175.26 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 109' ' ' THR . . . . . 0.465 ' O ' ' HB2' ' B' ' 154' ' ' CYS . 0.1 OUTLIER -111.06 100.28 8.99 Favored 'General case' 0 N--CA 1.402 -2.833 1 N-CA-C 99.134 -4.395 . . . . 5.69 99.134 167.733 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' B' B ' 110' ' ' CYS . . . . . 0.559 ' HA ' ' CB ' ' B' ' 154' ' ' CYS . 0.5 OUTLIER -78.56 75.96 5.06 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 113.978 -1.465 . . . . 2.61 112.654 -177.928 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 111' ' ' LEU . . . . . 0.616 HD13 ' HD2' ' B' ' 112' ' ' PRO . 0.2 OUTLIER -31.07 113.85 0.33 Allowed Pre-proline 0 N--CA 1.469 0.508 0 N-CA-C 113.107 0.78 . . . . 2.47 113.107 -179.629 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 112' ' ' PRO . . . . . 0.853 ' HB2' ' O ' ' B' ' 117' ' ' GLY . 29.0 Cg_endo -90.72 154.31 4.17 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 124.46 3.44 . . . . 1.47 114.417 -179.074 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.829 ' N ' ' O ' ' B' ' 119' ' ' GLY . 15.3 p -156.08 -159.93 0.95 Allowed 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 109.479 -0.563 . . . . 1.0 109.479 174.579 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 114' ' ' GLY . . . . . 0.543 ' HA2' ' HG2' ' B' ' 140' ' ' GLU . . . 73.45 -163.24 54.78 Favored Glycine 0 C--N 1.337 0.614 0 N-CA-C 115.639 1.016 . . . . 1.16 115.639 175.014 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 115' ' ' PRO . . . . . 0.657 ' O ' ' HD3' ' B' ' 118' ' ' LYS . 67.9 Cg_endo -61.78 100.77 0.2 Allowed 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 124.361 3.374 . . . . 1.57 111.37 178.081 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 86.89 -0.14 86.14 Favored Glycine 0 C--N 1.283 -2.414 0 CA-C-N 112.688 -2.051 . . . . 1.7 112.955 -178.549 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 117' ' ' GLY . . . . . 0.853 ' O ' ' HB2' ' B' ' 112' ' ' PRO . . . 76.46 37.12 36.67 Favored Glycine 0 N--CA 1.416 -2.659 0 N-CA-C 115.736 1.055 . . . . 1.38 115.736 175.605 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 118' ' ' LYS . . . . . 0.667 ' HZ1' ' CD1' ' B' ' 132' ' ' LEU . 0.0 OUTLIER -95.69 -30.47 13.73 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 121.753 0.787 . . . . 2.54 111.763 179.448 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 119' ' ' GLY . . . . . 0.829 ' O ' ' N ' ' B' ' 113' ' ' CYS . . . -77.77 158.45 46.77 Favored Glycine 0 C--O 1.193 -2.412 0 N-CA-C 117.499 1.76 . . . . 1.04 117.499 -174.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.545 ' HD2' ' HB3' ' B' ' 110' ' ' CYS . 0.0 OUTLIER -99.84 160.35 14.37 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 111.774 -2.213 . . . . 2.89 113.363 -169.069 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 121' ' ' CYS . . . . . . . . . . . . . 1.4 m -105.43 134.01 49.25 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 114.304 -1.316 . . . . 1.07 110.734 -175.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -134.16 36.3 3.23 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.152 -0.931 . . . . 1.53 109.976 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 145.11 164.51 10.7 Favored Glycine 0 CA--C 1.521 0.445 0 CA-C-N 115.849 -0.614 . . . . 0.9 112.395 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -52.17 -73.13 0.04 OUTLIER 'Trans proline' 0 CA--C 1.532 0.411 0 C-N-CA 122.752 2.302 . . . . 1.51 112.761 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 125' ' ' SER . . . . . 0.637 ' O ' ' N ' ' B' ' 137' ' ' GLY . 0.5 OUTLIER -91.02 42.8 1.12 Allowed 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 109.251 -0.648 . . . . 1.25 109.251 178.778 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 126' ' ' ILE . . . . . 0.698 HG12 HG13 ' B' ' 136' ' ' VAL . 6.3 mt -144.51 121.06 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 N-CA-C 113.667 0.988 . . . . 0.85 113.667 -176.798 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 127' ' ' CYS . . . . . 0.67 ' O ' ' HA ' ' B' ' 134' ' ' CYS . 0.0 OUTLIER -138.73 111.47 7.7 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-O 121.57 0.7 . . . . 0.89 110.56 178.458 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 128' ' ' CYS . . . . . 1.146 ' HA ' ' O ' ' B' ' 133' ' ' GLY . 0.0 OUTLIER -127.53 129.36 47.23 Favored 'General case' 0 N--CA 1.439 -0.977 0 C-N-CA 124.243 1.017 . . . . 1.23 111.517 179.098 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 129' ' ' GLY . . . . . 0.481 ' O ' ' HB2' ' B' ' 169' ' ' ALA . . . -120.82 -160.35 11.07 Favored Glycine 0 N--CA 1.417 -2.598 0 N-CA-C 104.126 -3.59 . . . . 0.66 104.126 172.464 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -67.14 -73.23 0.14 Allowed 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 118.283 1.041 . . . . 2.35 111.702 -178.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.97 34.6 2.96 Favored 'General case' 0 CA--C 1.478 -1.792 0 CA-C-O 121.76 0.79 . . . . 1.69 110.505 -173.024 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 132' ' ' LEU . . . . . 0.805 HD22 ' CZ ' ' B' ' 135' ' ' PHE . 1.1 mt -126.49 -23.62 3.75 Favored 'General case' 0 N--CA 1.391 -3.384 0 N-CA-C 104.992 -2.225 . . . . 1.38 104.992 177.181 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 133' ' ' GLY . . . . . 1.146 ' O ' ' HA ' ' B' ' 128' ' ' CYS . . . 73.71 -135.62 20.77 Favored Glycine 1 N--CA 1.39 -4.39 0 N-CA-C 110.275 -1.13 . . . . 0.72 110.275 176.664 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 134' ' ' CYS . . . . . 1.025 ' HB2' HD13 ' B' ' 172' ' ' ILE . 3.1 t -135.97 116.34 13.63 Favored 'General case' 0 CA--C 1.495 -1.168 0 CA-C-N 118.227 1.014 . . . . 1.08 113.519 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 135' ' ' PHE . . . . . 0.982 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -88.57 106.3 18.22 Favored 'General case' 0 N--CA 1.421 -1.879 0 N-CA-C 102.59 -3.115 . . . . 1.36 102.59 175.101 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 136' ' ' VAL . . . . . 0.728 HG23 HG23 ' A' ' 36' ' ' VAL . 2.3 t -92.85 88.02 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-O 123.161 1.458 . . . . 0.75 110.233 -177.645 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 137' ' ' GLY . . . . . 0.827 ' HA3' HG21 ' A' ' 72' ' ' ILE . . . 102.79 18.43 15.77 Favored Glycine 0 C--N 1.32 -0.328 0 CA-C-N 112.705 -2.043 . . . . 0.83 115.916 178.58 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 138' ' ' THR . . . . . 0.837 HG21 ' CD2' ' A' ' 35' ' ' PHE . 30.2 p -89.76 177.04 6.61 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 118.071 0.936 . . . . 0.78 108.747 178.614 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 139' ' ' ALA . . . . . 0.875 ' HA ' HD12 ' B' ' 142' ' ' LEU . . . -58.07 -36.36 72.69 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 118.982 0.81 . . . . 1.04 110.516 179.151 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 140' ' ' GLU . . . . . 0.543 ' HG2' ' HA2' ' B' ' 114' ' ' GLY . 1.7 mp0 -59.54 -15.14 16.15 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.439 -0.346 . . . . 2.31 111.683 -179.357 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 141' ' ' ALA . . . . . 0.674 ' O ' ' HB2' ' B' ' 144' ' ' CYS . . . -99.17 -26.74 14.1 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 116.274 -0.421 . . . . 0.87 110.567 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 142' ' ' LEU . . . . . 0.875 HD12 ' HA ' ' B' ' 139' ' ' ALA . 2.2 mt -55.58 -29.22 58.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.311 0.576 . . . . 1.24 109.681 179.179 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 143' ' ' ARG . . . . . 0.534 ' HD3' ' HA ' ' B' ' 140' ' ' GLU . 0.0 OUTLIER -78.51 11.39 2.51 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 109.051 -0.722 . . . . 2.93 109.051 177.132 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 144' ' ' CYS . . . . . 0.674 ' HB2' ' O ' ' B' ' 141' ' ' ALA . 5.8 m -89.32 13.01 14.51 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 107.232 -1.396 . . . . 1.61 107.232 172.362 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 29.8 tp60 -88.7 -11.86 43.99 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 115.278 -0.874 . . . . 3.35 110.285 177.525 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 146' ' ' GLU . . . . . 0.491 ' HA ' ' CD2' ' B' ' 149' ' ' TYR . 7.2 mt-10 -85.95 5.48 32.95 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 119.11 -1.036 . . . . 3.76 109.194 179.205 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -79.47 3.15 19.46 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 120.377 -0.529 . . . . 4.01 109.784 177.322 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 148' ' ' ASN . . . . . . . . . . . . . 40.5 p30 -99.3 -28.85 13.12 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 120.778 -0.369 . . . . 3.92 110.463 178.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 149' ' ' TYR . . . . . 0.491 ' CD2' ' HA ' ' B' ' 146' ' ' GLU . 4.7 m-85 -87.08 9.47 19.67 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 121.005 -0.278 . . . . 5.73 111.339 179.642 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 150' ' ' LEU . . . . . 0.411 ' CD1' HD21 ' B' ' 111' ' ' LEU . 0.1 OUTLIER -143.39 117.72 6.17 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-O 120.504 0.193 . . . . 5.46 111.018 -179.539 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 151' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -80.0 45.63 2.01 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.353 2.036 . . . . 5.02 112.354 179.654 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 3.7 p -156.49 104.32 2.01 Favored Pre-proline 0 CA--C 1.531 0.235 0 CA-C-O 120.645 0.26 . . . . 5.73 111.37 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 153' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -95.64 -5.2 1.84 Allowed 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 123.4 2.733 . . . . 5.1 114.649 -178.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 154' ' ' CYS . . . . . 0.978 ' HA ' HD22 ' B' ' 105' ' ' LEU . 9.1 t 69.64 81.37 0.17 Allowed 'General case' 0 N--CA 1.473 0.707 0 O-C-N 122.225 -0.297 . . . . 2.68 111.204 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 155' ' ' GLN . . . . . 0.706 ' HG3' ' HA ' ' B' ' 103' ' ' LEU . 0.0 OUTLIER 26.41 -145.08 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 112.785 0.661 . . . . 5.63 112.785 -179.916 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 156' ' ' SER . . . . . 0.563 ' H ' ' CD ' ' B' ' 155' ' ' GLN . 1.9 t -159.14 -175.27 5.16 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 108.744 -0.836 . . . . 3.11 108.744 179.757 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 157' ' ' GLY . . . . . 0.407 ' O ' ' HB2' ' B' ' 166' ' ' ARG . . . -88.85 147.16 19.61 Favored Glycine 0 CA--C 1.494 -1.228 0 N-CA-C 109.764 -1.334 . . . . 2.07 109.764 176.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -114.91 62.49 0.68 Allowed 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 117.207 -1.797 . . . . 4.34 110.293 178.672 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 159' ' ' LYS . . . . . 0.677 ' HB2' ' HB3' ' B' ' 167' ' ' CYS . 7.0 mmtp -117.94 53.9 1.71 Allowed Pre-proline 0 C--N 1.313 -1.02 0 CA-C-N 113.507 -1.679 . . . . 3.54 110.48 172.448 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 160' ' ' PRO . . . . . 0.495 ' HA ' ' O ' ' B' ' 165' ' ' GLY . 15.0 Cg_endo -58.47 81.33 0.05 OUTLIER 'Trans proline' 0 C--N 1.331 -0.363 0 CA-C-N 121.626 1.616 . . . . 1.51 116.072 -173.185 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 161' ' ' CYS . . . . . 0.489 ' N ' ' O ' ' B' ' 165' ' ' GLY . 0.5 OUTLIER -99.25 -178.29 3.87 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 106.926 -1.509 . . . . 1.58 106.926 175.762 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 162' ' ' GLY . . . . . 0.528 ' HA3' ' CE1' ' B' ' 180' ' ' HIS . . . 69.78 -166.57 49.22 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 118.301 -1.904 . . . . 2.37 112.283 178.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 2.8 m -85.75 39.95 0.82 Allowed 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.634 0.73 . . . . 4.07 111.423 -177.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 121.48 6.74 8.61 Favored Glycine 0 CA--C 1.541 1.656 0 CA-C-N 114.586 -1.188 . . . . 2.2 114.663 -179.13 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 165' ' ' GLY . . . . . 0.515 ' CA ' ' HA ' ' B' ' 175' ' ' SER . . . -102.14 151.74 18.41 Favored Glycine 0 CA--C 1.523 0.562 0 CA-C-N 119.909 1.855 . . . . 1.62 115.172 -177.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 166' ' ' ARG . . . . . 0.407 ' HB2' ' O ' ' B' ' 157' ' ' GLY . 0.0 OUTLIER -99.2 152.63 19.68 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 122.275 0.23 . . . . 3.05 111.046 179.459 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 167' ' ' CYS . . . . . 0.677 ' HB3' ' HB2' ' B' ' 159' ' ' LYS . 41.9 t -67.73 121.47 16.01 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-O 120.771 0.319 . . . . 1.56 111.611 -179.108 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 168' ' ' ALA . . . . . . . . . . . . . . . -96.4 -19.54 19.11 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.444 -0.947 . . . . 1.04 108.444 177.277 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 169' ' ' ALA . . . . . 0.69 ' CB ' ' HA2' ' B' ' 133' ' ' GLY . . . -168.68 160.99 11.06 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 113.739 -1.573 . . . . 0.98 111.898 -179.228 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 170' ' ' ALA . . . . . 0.411 ' HA ' ' HB3' ' B' ' 185' ' ' CYS . . . -61.76 138.95 58.37 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.004 0.43 . . . . 1.25 110.596 178.549 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 171' ' ' GLY . . . . . 0.711 ' N ' ' O ' ' B' ' 185' ' ' CYS . . . 74.43 -1.06 52.74 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 121.191 -0.528 . . . . 1.29 114.113 179.488 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 172' ' ' ILE . . . . . 1.025 HD13 ' HB2' ' B' ' 134' ' ' CYS . 1.3 pp -142.51 107.54 1.51 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.598 0 CA-C-O 121.736 0.779 . . . . 2.27 113.066 -179.29 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 173' ' ' CYS . . . . . 0.562 ' HB2' ' HB3' ' B' ' 182' ' ' ASP . 16.3 t -97.8 110.64 23.17 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.698 -0.683 . . . . 1.94 110.216 178.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 174' ' ' CYS . . . . . 0.756 ' HA ' ' HA ' ' B' ' 179' ' ' CYS . 72.0 m -92.67 138.91 31.09 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.439 0.638 . . . . 1.35 111.755 -179.401 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 175' ' ' SER . . . . . 0.83 ' HB2' ' HD2' ' B' ' 176' ' ' PRO . 51.7 p -113.35 179.65 0.75 Allowed Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 114.866 -1.061 . . . . 2.0 108.906 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 176' ' ' PRO . . . . . 0.83 ' HD2' ' HB2' ' B' ' 175' ' ' SER . 74.4 Cg_endo -76.39 30.78 0.4 Allowed 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 121.427 1.418 . . . . 1.9 111.918 -179.566 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 177' ' ' ASP . . . . . 0.439 ' H ' ' C ' ' B' ' 175' ' ' SER . 18.4 m-20 -144.71 -41.67 0.25 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.563 -0.744 . . . . 2.72 110.065 179.342 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 178' ' ' GLY . . . . . 0.841 ' HA3' ' O ' ' A' ' 79' ' ' CYS . . . -163.74 -135.11 1.76 Allowed Glycine 0 C--N 1.337 0.613 0 C-N-CA 121.041 -0.6 . . . . 0.99 112.763 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 179' ' ' CYS . . . . . 0.852 ' O ' ' HA3' ' A' ' 78' ' ' GLY . 62.3 m -148.12 157.05 43.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.949 0.404 . . . . 1.34 110.44 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 180' ' ' HIS . . . . . 0.528 ' CE1' ' HA3' ' B' ' 162' ' ' GLY . 1.8 p80 -157.89 153.2 25.9 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.285 -0.566 . . . . 2.1 110.611 -179.63 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 181' ' ' GLU . . . . . 0.499 ' OE1' HD11 ' A' ' 26' ' ' ILE . 14.6 mp0 -62.99 140.87 58.91 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.748 -0.381 . . . . 3.06 109.983 179.709 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 182' ' ' ASP . . . . . 0.588 ' O ' ' HB2' ' B' ' 186' ' ' ASP . 2.4 p-10 -141.02 140.92 22.18 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 116.11 -0.495 . . . . 2.06 111.089 -179.248 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 183' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' B' ' 182' ' ' ASP . 10.4 Cg_exo -72.53 -27.17 15.91 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 123.467 2.778 . . . . 1.91 114.665 -178.057 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -67.13 -47.35 71.37 Favored 'General case' 0 CA--C 1.507 -0.697 0 N-CA-C 107.784 -1.191 . . . . 1.56 107.784 179.055 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 185' ' ' CYS . . . . . 0.711 ' O ' ' N ' ' B' ' 171' ' ' GLY . 2.2 m -99.16 77.81 2.19 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 114.192 -1.367 . . . . 1.94 107.647 176.404 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 186' ' ' ASP . . . . . 0.955 ' H ' ' CD ' ' B' ' 187' ' ' PRO . 38.3 t0 -164.65 3.32 0.0 OUTLIER Pre-proline 0 C--N 1.321 -0.631 0 N-CA-C 114.3 1.222 . . . . 2.28 114.3 -179.298 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 187' ' ' PRO . . . . . 0.955 ' CD ' ' H ' ' B' ' 186' ' ' ASP . 74.4 Cg_endo -86.19 124.17 2.42 Favored 'Trans proline' 0 N--CA 1.45 -1.07 0 CA-C-N 120.916 1.363 . . . . 2.31 114.254 -179.182 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 188' ' ' GLU . . . . . 0.505 ' C ' ' O ' ' B' ' 187' ' ' PRO . 0.7 OUTLIER -8.91 64.95 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.137 0 CA-C-O 123.808 1.766 . . . . 4.7 109.011 -173.486 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 189' ' ' ALA . . . . . 0.811 ' N ' ' O ' ' B' ' 187' ' ' PRO . . . -83.18 -36.85 24.37 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 110.727 -2.942 . . . . 5.24 109.226 173.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 190' ' ' ALA . . . . . . . . . . . . . . . -90.11 109.82 20.86 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 110.002 -3.272 . . . . 6.93 112.463 178.319 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 191' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -88.28 88.72 7.72 Favored 'General case' 0 C--N 1.353 0.748 0 CA-C-N 110.766 -2.924 . . . . 10.14 110.561 -179.477 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 2.4 m . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.24 -0.886 . . . . 11.7 110.708 -179.757 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.816 ' O ' HG22 ' A' ' 2' ' ' VAL . . . . . . . . 0 N--CA 1.488 1.451 0 N-CA-C 111.62 0.23 . . . . 9.95 111.62 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.816 HG22 ' O ' ' A' ' 1' ' ' ALA . 1.4 m 80.25 43.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 O-C-N 124.678 1.236 . . . . 8.02 111.545 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 1.125 HD11 ' HB3' ' A' ' 5' ' ' LEU . 2.0 tm? -82.99 101.88 11.37 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 114.395 -1.275 . . . . 5.86 112.23 178.151 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.756 ' O ' ' HB3' ' A' ' 55' ' ' GLN . 1.6 m-20 -81.94 82.0 7.72 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 106.126 -1.805 . . . . 6.22 106.126 177.47 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 1.125 ' HB3' HD11 ' A' ' 3' ' ' LEU . 1.4 tm? -153.71 -68.91 0.14 Allowed 'General case' 0 CA--C 1.48 -1.741 0 CA-C-O 123.437 1.589 . . . . 7.09 109.398 -177.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.772 ' H ' HD11 ' A' ' 3' ' ' LEU . 0.6 OUTLIER 155.36 -23.67 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 CA-C-N 110.452 -3.067 . . . . 8.78 111.71 174.926 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.744 HG22 ' H ' ' A' ' 8' ' ' ARG . 3.6 p -89.61 178.5 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.409 -2.522 0 CA-C-N 112.835 -1.984 . . . . 7.51 109.675 -178.722 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.744 ' H ' HG22 ' A' ' 7' ' ' VAL . 4.3 ttp85 -80.21 114.32 19.03 Favored 'General case' 0 N--CA 1.406 -2.67 0 N-CA-C 104.391 -2.448 . . . . 9.08 104.391 177.827 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' THR . . . . . 1.013 ' CB ' ' HB2' ' A' ' 3' ' ' LEU . 14.7 t -40.04 111.92 0.23 Allowed 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 123.113 1.435 . . . . 5.66 112.213 -174.792 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.851 ' O ' ' HG2' ' A' ' 20' ' ' ARG . 71.6 m -19.02 123.67 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 111.021 -2.809 . . . . 2.68 114.191 -175.681 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 1.085 HD23 HD22 ' A' ' 50' ' ' LEU . 0.2 OUTLIER -29.24 119.99 0.29 Allowed Pre-proline 0 N--CA 1.485 1.303 0 C-N-CA 123.673 0.789 . . . . 2.48 113.025 179.944 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.916 ' HD2' HD13 ' A' ' 11' ' ' LEU . 93.4 Cg_endo -72.21 155.83 55.93 Favored 'Trans proline' 0 C--N 1.358 1.054 0 C-N-CA 124.517 3.478 . . . . 1.49 116.408 -176.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.671 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 15.6 p -159.82 -173.07 3.91 Favored 'General case' 0 C--O 1.268 2.061 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.309 178.641 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.697 ' HA2' ' HB3' ' A' ' 40' ' ' GLU . . . 76.69 -158.9 49.22 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 121.134 -0.555 . . . . 1.15 114.39 177.694 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.614 ' HD2' HD11 ' A' ' 32' ' ' LEU . 25.6 Cg_endo -66.51 99.09 0.42 Allowed 'Trans proline' 0 N--CA 1.49 1.305 0 C-N-CA 124.797 3.665 . . . . 1.57 112.725 178.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.43 7.51 84.62 Favored Glycine 0 C--N 1.275 -2.814 0 CA-C-N 113.622 -1.626 . . . . 1.68 111.137 -176.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.893 ' O ' ' HB2' ' A' ' 12' ' ' PRO . . . 55.71 55.78 27.09 Favored Glycine 0 N--CA 1.415 -2.709 0 CA-C-N 113.317 -1.442 . . . . 1.36 110.617 172.486 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.55 ' HE3' ' O ' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -92.53 -51.92 4.89 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 101.908 -3.367 . . . . 2.5 101.908 175.053 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.836 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -56.59 -179.08 0.46 Allowed Glycine 0 CA--C 1.533 1.173 0 CA-C-N 112.446 -2.161 . . . . 1.02 110.999 -168.342 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.851 ' HG2' ' O ' ' A' ' 10' ' ' CYS . 42.9 mtm-85 -132.33 174.22 10.46 Favored 'General case' 0 C--N 1.322 -0.587 0 O-C-N 119.999 -1.883 . . . . 2.92 112.185 -171.742 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 1.059 ' HB3' ' HG3' ' A' ' 47' ' ' GLU . 1.7 m -104.8 135.2 46.62 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.688 0.756 . . . . 1.1 112.496 -178.867 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.433 ' CD1' ' HB2' ' A' ' 28' ' ' CYS . 54.4 m-85 -144.97 39.95 1.24 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 114.525 -1.216 . . . . 1.51 109.743 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 141.95 166.35 10.86 Favored Glycine 0 CA--C 1.524 0.624 0 CA-C-N 115.6 -0.727 . . . . 0.9 111.647 -179.267 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.526 ' HD2' ' OE2' ' B' ' 181' ' ' GLU . 21.2 Cg_exo -65.65 -67.75 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.079 1.852 . . . . 1.5 112.147 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.782 ' C ' HG13 ' A' ' 26' ' ' ILE . 3.1 m -89.08 39.49 0.94 Allowed 'General case' 0 C--O 1.225 -0.196 0 N-CA-C 109.592 -0.522 . . . . 1.26 109.592 179.01 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 1.089 HG12 HG13 ' A' ' 36' ' ' VAL . 0.4 OUTLIER -156.0 120.73 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 N-CA-C 112.15 0.426 . . . . 0.83 112.15 -179.032 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.742 ' HB3' ' CE2' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -125.7 119.09 27.07 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 108.53 -0.915 . . . . 0.92 108.53 178.054 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.785 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 17.9 m -105.9 153.42 21.98 Favored 'General case' 0 CA--C 1.558 1.266 0 N-CA-C 112.646 0.61 . . . . 1.28 112.646 -178.289 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -143.5 167.5 26.55 Favored Glycine 0 C--N 1.373 2.589 0 N-CA-C 109.575 -1.41 . . . . 0.67 109.575 174.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.622 ' OD2' ' HG2' ' A' ' 31' ' ' GLU . 8.4 p-10 -66.37 -39.32 89.04 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 124.906 1.282 . . . . 2.27 109.459 178.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.622 ' HG2' ' OD2' ' A' ' 30' ' ' ASP . 0.9 OUTLIER -124.54 6.46 8.26 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 113.55 -1.659 . . . . 1.66 110.964 179.692 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.982 HD22 ' CE1' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -110.03 -12.7 14.5 Favored 'General case' 0 N--CA 1.423 -1.78 0 CA-C-N 115.235 -0.893 . . . . 1.37 110.626 -177.843 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 1.014 ' HA2' ' HB1' ' A' ' 69' ' ' ALA . . . 60.19 -115.3 7.45 Favored Glycine 0 N--CA 1.428 -1.869 0 CA-C-O 118.139 -1.367 . . . . 0.73 111.842 179.408 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 1.034 ' HB2' HD13 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -147.45 127.26 13.48 Favored 'General case' 0 CA--C 1.489 -1.375 0 CA-C-N 119.893 1.847 . . . . 1.08 112.367 179.424 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.982 ' CE1' HD22 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -101.16 100.28 10.81 Favored 'General case' 0 N--CA 1.422 -1.838 0 N-CA-C 103.101 -2.925 . . . . 1.38 103.101 174.641 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 1.089 HG13 HG12 ' A' ' 26' ' ' ILE . 2.0 t -91.98 86.12 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.669 0 CA-C-O 123.364 1.554 . . . . 0.76 107.91 -178.742 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.794 ' HA3' HG21 ' B' ' 172' ' ' ILE . . . 89.79 82.68 1.34 Allowed Glycine 0 CA--C 1.521 0.408 0 CA-C-N 112.338 -2.21 . . . . 0.81 113.487 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.766 HG22 ' O ' ' B' ' 132' ' ' LEU . 49.7 p -156.09 163.17 39.98 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 109.116 -0.698 . . . . 0.77 109.116 179.338 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.869 ' HA ' HD12 ' A' ' 42' ' ' LEU . . . -50.35 -35.89 29.82 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 119.729 1.149 . . . . 1.02 112.766 -178.15 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.697 ' HB3' ' HA2' ' A' ' 14' ' ' GLY . 8.5 mt-10 -58.81 -24.57 62.1 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 109.906 -0.405 . . . . 2.32 109.906 178.033 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.794 ' O ' ' HB2' ' A' ' 44' ' ' CYS . . . -78.63 -23.27 45.93 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 109.514 -0.55 . . . . 0.87 109.514 -179.478 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.869 HD12 ' HA ' ' A' ' 39' ' ' ALA . 0.5 OUTLIER -51.2 -38.72 53.95 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 121.136 -0.977 . . . . 1.23 109.821 178.804 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.795 ' HD2' ' O ' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -66.84 -5.32 11.89 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.21 -0.904 . . . . 2.92 109.986 177.348 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.794 ' HB2' ' O ' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -75.19 -1.01 21.31 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.121 -0.945 . . . . 1.57 111.726 177.122 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.97 -24.84 64.3 Favored 'General case' 0 N--CA 1.453 -0.325 0 O-C-N 121.435 -0.79 . . . . 3.31 110.581 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -84.45 3.05 38.01 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 120.165 -0.614 . . . . 3.69 110.292 179.46 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 1.059 ' HG3' ' HB3' ' A' ' 21' ' ' CYS . 1.7 tm-20 -81.88 2.96 28.01 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.58 -0.526 . . . . 3.99 109.58 177.26 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 24.5 t30 -94.99 -26.99 15.86 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.045 -0.525 . . . . 3.86 109.948 178.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -110.38 9.99 23.44 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.388 -0.369 . . . . 5.68 111.951 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 1.085 HD22 HD23 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -145.16 80.25 11.22 Favored Pre-proline 0 CA--C 1.536 0.411 0 CA-C-O 120.359 0.123 . . . . 5.4 111.279 179.995 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -95.37 50.82 0.19 Allowed 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 123.056 2.504 . . . . 4.92 112.829 -179.554 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.562 ' HB3' HG21 ' A' ' 7' ' ' VAL . 59.7 m -83.99 118.25 70.82 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-N 116.399 -0.364 . . . . 5.64 111.913 -179.335 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.546 ' O ' HG11 ' A' ' 7' ' ' VAL . 90.9 Cg_endo -81.8 121.41 3.67 Favored 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 122.51 2.14 . . . . 5.04 111.661 179.056 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 1.121 ' HA ' ' HG ' ' A' ' 5' ' ' LEU . 10.2 p -120.69 -160.18 0.83 Allowed 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.864 0.364 . . . . 2.74 111.882 -178.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.84 ' H ' HD21 ' A' ' 3' ' ' LEU . 0.4 OUTLIER -61.38 126.06 26.01 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.08 -0.509 . . . . 5.75 110.867 178.575 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 10.7 m -155.06 -160.32 1.04 Allowed 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 116.9 -0.137 . . . . 3.12 110.772 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -121.41 133.23 9.43 Favored Glycine 0 N--CA 1.435 -1.411 0 N-CA-C 110.748 -0.941 . . . . 2.1 110.748 -179.146 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.84 76.78 1.03 Allowed 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 107.967 -1.123 . . . . 4.36 107.967 178.874 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.505 ' O ' ' HA ' ' A' ' 66' ' ' ARG . 0.1 OUTLIER -130.82 71.78 82.2 Favored Pre-proline 0 C--N 1.31 -1.128 0 CA-C-N 114.163 -1.38 . . . . 3.55 107.863 -179.355 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.521 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 36.5 Cg_endo -65.1 78.28 0.21 Allowed 'Trans proline' 0 C--N 1.363 1.296 0 C-N-CA 122.406 2.071 . . . . 1.54 113.642 -178.679 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -95.69 -173.08 2.77 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 106.008 -1.849 . . . . 1.59 106.008 176.126 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.39 -166.35 34.3 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 118.558 -1.782 . . . . 2.43 113.182 179.474 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.9 m -87.77 42.48 1.05 Allowed 'General case' 0 N--CA 1.484 1.237 0 CA-C-O 122.642 1.211 . . . . 4.11 110.695 -177.394 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 115.37 11.09 10.94 Favored Glycine 0 CA--C 1.558 2.728 0 CA-C-N 112.859 -1.973 . . . . 2.21 114.873 -177.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.475 ' CA ' ' HB3' ' A' ' 75' ' ' SER . . . -103.87 129.05 9.72 Favored Glycine 0 N--CA 1.469 0.894 0 CA-C-N 121.477 2.638 . . . . 1.62 116.259 -178.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.749 ' HD3' ' O ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -90.92 155.17 18.94 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 108.993 -0.743 . . . . 3.02 108.993 176.606 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.479 ' SG ' ' HB3' ' A' ' 59' ' ' LYS . 74.0 m -64.8 108.31 1.71 Allowed 'General case' 0 N--CA 1.439 -0.991 0 CA-C-O 121.44 0.638 . . . . 1.52 110.309 -178.884 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.414 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . . . -94.57 -11.42 29.49 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.089 -0.96 . . . . 1.07 109.756 178.779 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 1.014 ' HB1' ' HA2' ' A' ' 33' ' ' GLY . . . -165.78 161.39 17.92 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.441 -1.254 . . . . 1.0 110.09 179.164 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.61 ' HA ' ' O ' ' A' ' 85' ' ' CYS . . . -58.02 117.31 4.2 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 113.837 1.051 . . . . 1.24 113.837 -178.315 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.741 ' HA2' ' O ' ' A' ' 82' ' ' ASP . . . 63.49 35.21 91.75 Favored Glycine 0 C--N 1.344 1.012 0 CA-C-N 115.532 -0.758 . . . . 1.28 112.301 179.002 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 1.034 HD13 ' HB2' ' A' ' 34' ' ' CYS . 1.8 pp -150.55 100.85 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.248 1.025 0 CA-C-O 121.924 0.869 . . . . 2.27 110.473 175.367 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.633 ' HB2' ' HB3' ' A' ' 82' ' ' ASP . 0.0 OUTLIER -85.63 92.07 8.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.696 -1.138 . . . . 1.98 110.661 -178.257 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.624 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 81.6 m -97.15 153.49 17.95 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.722 0.773 . . . . 1.33 112.513 -178.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.892 ' HB2' ' HD2' ' A' ' 76' ' ' PRO . 34.6 p -130.06 -178.97 0.9 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 114.529 -1.214 . . . . 1.99 108.8 179.584 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.892 ' HD2' ' HB2' ' A' ' 75' ' ' SER . 72.1 Cg_endo -78.07 26.83 0.49 Allowed 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 121.325 1.35 . . . . 1.86 111.761 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.435 ' HB2' ' NE2' ' B' ' 180' ' ' HIS . 3.0 p30 -145.95 -40.07 0.22 Allowed 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 115.786 -0.643 . . . . 2.65 111.417 179.377 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -157.08 -155.12 7.33 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 120.571 -0.823 . . . . 0.99 113.602 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.624 ' HA ' ' HA ' ' A' ' 74' ' ' CYS . 94.9 m -141.07 149.9 42.24 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 122.413 0.285 . . . . 1.34 110.394 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.415 ' O ' ' HB2' ' A' ' 73' ' ' CYS . 28.4 t-80 -140.96 126.4 18.76 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 109.453 -0.573 . . . . 2.17 109.453 -174.017 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.506 ' OE2' ' HD2' ' B' ' 124' ' ' PRO . 17.7 mt-10 -53.21 130.3 34.13 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.273 0.559 . . . . 3.05 111.748 -178.223 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.741 ' O ' ' HA2' ' A' ' 71' ' ' GLY . 0.1 OUTLIER -141.83 118.37 7.25 Favored Pre-proline 0 CA--C 1.547 0.839 0 CA-C-N 115.413 -0.812 . . . . 2.02 110.369 -179.056 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.49 ' HD3' ' HA ' ' A' ' 82' ' ' ASP . 3.7 Cg_exo -81.87 -18.86 7.52 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 122.848 2.365 . . . . 1.93 113.679 -178.551 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.67 -39.86 95.39 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.823 0.344 . . . . 1.53 111.739 -179.259 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.61 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 65.1 m -99.98 14.72 29.58 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.395 -0.366 . . . . 1.88 111.768 -179.689 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.51 ' CB ' ' HD3' ' A' ' 87' ' ' PRO . 0.8 OUTLIER -66.15 -55.5 20.65 Favored Pre-proline 0 C--N 1.322 -0.596 0 C-N-CA 121.063 -0.255 . . . . 3.6 111.413 -178.066 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.605 ' C ' ' H ' ' A' ' 89' ' ' ALA . 73.4 Cg_endo -104.19 -170.97 0.06 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.687 0 C-N-CA 122.639 2.226 . . . . 2.56 113.901 -178.747 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.421 ' C ' ' H ' ' A' ' 90' ' ' ALA . 5.5 pt-20 -56.6 26.93 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.045 0 CA-C-N 110.809 -2.905 . . . . 4.72 112.019 179.272 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.605 ' H ' ' C ' ' A' ' 87' ' ' PRO . . . -79.62 13.56 2.01 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 108.136 -1.061 . . . . 5.29 108.136 171.251 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.421 ' H ' ' C ' ' A' ' 88' ' ' GLU . . . -76.41 141.25 41.5 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-O 122.083 0.944 . . . . 6.98 111.511 177.302 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -100.47 101.53 12.5 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 113.447 -1.706 . . . . 10.21 110.241 176.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 16.6 m . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.354 -0.832 . . . . 11.77 110.941 179.927 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 101' ' ' ALA . . . . . 0.648 ' O ' HG13 ' B' ' 102' ' ' VAL . . . . . . . . 0 N--CA 1.485 1.283 0 CA-C-O 120.5 0.191 . . . . 10.07 110.608 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 102' ' ' VAL . . . . . 0.648 HG13 ' O ' ' B' ' 101' ' ' ALA . 0.0 OUTLIER 173.05 -176.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 N-CA-C 113.042 0.756 . . . . 8.41 113.042 -179.788 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 103' ' ' LEU . . . . . 1.02 HD21 ' HB2' ' B' ' 154' ' ' CYS . 23.1 tp -107.07 115.26 29.86 Favored 'General case' 0 CA--C 1.5 -0.975 0 N-CA-C 106.138 -1.801 . . . . 5.87 106.138 174.819 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.32 69.06 8.11 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 106.543 -1.651 . . . . 6.27 106.543 177.169 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 105' ' ' LEU . . . . . 1.0 HD12 HG12 ' B' ' 107' ' ' VAL . 1.2 tm? -139.2 -80.86 0.31 Allowed 'General case' 0 CA--C 1.47 -2.118 0 C-N-CA 117.62 -1.632 . . . . 7.2 109.608 -176.459 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 106' ' ' ASP . . . . . 0.803 ' N ' HD13 ' B' ' 105' ' ' LEU . 0.5 OUTLIER 150.57 40.17 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 111.94 -2.391 . . . . 8.55 108.722 175.395 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 107' ' ' VAL . . . . . 1.0 HG12 HD12 ' B' ' 105' ' ' LEU . 3.6 p -155.95 177.46 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.562 0 C-N-CA 125.542 1.537 . . . . 7.48 108.752 -176.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 108' ' ' ARG . . . . . 0.761 ' H ' HG22 ' B' ' 107' ' ' VAL . 4.4 ttp85 -80.91 116.78 21.06 Favored 'General case' 0 N--CA 1.413 -2.298 0 N-CA-C 104.32 -2.474 . . . . 9.12 104.32 179.401 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 109' ' ' THR . . . . . 0.917 ' HB ' ' HB2' ' B' ' 103' ' ' LEU . 5.6 t -38.28 111.17 0.16 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.927 0.87 . . . . 5.69 112.73 -176.147 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 110' ' ' CYS . . . . . 0.906 ' O ' ' HG2' ' B' ' 120' ' ' ARG . 73.8 m -18.7 118.05 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.193 0 CA-C-N 112.454 -2.157 . . . . 2.61 115.085 -177.74 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 111' ' ' LEU . . . . . 1.064 HD23 HD22 ' B' ' 150' ' ' LEU . 0.2 OUTLIER -24.96 119.43 0.21 Allowed Pre-proline 0 N--CA 1.49 1.555 0 C-N-CA 123.684 0.794 . . . . 2.47 113.121 179.897 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 112' ' ' PRO . . . . . 0.972 ' HB2' ' O ' ' B' ' 117' ' ' GLY . 95.8 Cg_endo -71.61 156.13 58.11 Favored 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 124.576 3.517 . . . . 1.47 116.088 -176.747 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.572 ' C ' ' HA2' ' B' ' 117' ' ' GLY . 16.4 p -159.1 -171.34 3.33 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 115.92 -0.582 . . . . 1.0 111.057 177.436 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 114' ' ' GLY . . . . . 0.749 ' HA2' ' HB3' ' B' ' 140' ' ' GLU . . . 75.68 -159.46 51.08 Favored Glycine 0 CA--C 1.53 1.019 0 N-CA-C 115.069 0.788 . . . . 1.16 115.069 177.463 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 115' ' ' PRO . . . . . 0.596 ' HD2' HD11 ' B' ' 132' ' ' LEU . 22.8 Cg_endo -66.37 102.59 0.59 Allowed 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 124.748 3.632 . . . . 1.57 111.611 178.426 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 87.31 -0.35 85.47 Favored Glycine 0 C--N 1.275 -2.822 0 CA-C-N 114.368 -1.287 . . . . 1.7 111.192 -177.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 117' ' ' GLY . . . . . 0.972 ' O ' ' HB2' ' B' ' 112' ' ' PRO . . . 64.34 44.4 95.47 Favored Glycine 1 N--CA 1.395 -4.061 0 CA-C-N 114.47 -0.865 . . . . 1.38 114.098 177.465 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 118' ' ' LYS . . . . . 0.497 ' HE3' ' O ' ' B' ' 115' ' ' PRO . 0.0 OUTLIER -93.31 -29.97 15.37 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.912 -0.773 . . . . 2.54 108.912 179.742 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 119' ' ' GLY . . . . . 0.807 ' O ' ' HA ' ' B' ' 112' ' ' PRO . . . -60.97 -163.29 0.18 Allowed Glycine 0 CA--C 1.496 -1.152 0 CA-C-O 118.493 -1.171 . . . . 1.04 111.604 -176.778 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.906 ' HG2' ' O ' ' B' ' 110' ' ' CYS . 48.8 mtm-85 -150.83 171.55 17.03 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 120.273 2.036 . . . . 2.89 108.806 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 121' ' ' CYS . . . . . 1.032 ' HB3' ' HG3' ' B' ' 147' ' ' GLU . 1.8 m -105.3 135.78 46.04 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.693 0.758 . . . . 1.07 112.875 -178.359 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 122' ' ' PHE . . . . . 0.451 ' CD1' ' HB2' ' B' ' 128' ' ' CYS . 54.7 m-85 -145.11 39.88 1.22 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 114.466 -1.243 . . . . 1.53 109.752 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 141.89 166.4 10.86 Favored Glycine 0 CA--C 1.523 0.59 0 CA-C-N 115.624 -0.716 . . . . 0.9 111.681 -179.321 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 124' ' ' PRO . . . . . 0.506 ' HD2' ' OE2' ' A' ' 81' ' ' GLU . 21.1 Cg_exo -65.69 -67.82 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.142 1.895 . . . . 1.51 112.065 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 125' ' ' SER . . . . . 0.76 ' C ' HG13 ' B' ' 126' ' ' ILE . 3.2 m -88.97 39.51 0.93 Allowed 'General case' 0 C--O 1.225 -0.205 0 N-CA-C 109.58 -0.526 . . . . 1.25 109.58 178.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 126' ' ' ILE . . . . . 1.044 HG12 HG13 ' B' ' 136' ' ' VAL . 0.5 OUTLIER -155.75 120.32 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 N-CA-C 112.188 0.44 . . . . 0.85 112.188 -178.975 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 127' ' ' CYS . . . . . 0.762 ' HB3' ' CE2' ' B' ' 135' ' ' PHE . 0.1 OUTLIER -125.15 120.76 32.28 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 108.748 -0.834 . . . . 0.89 108.748 178.085 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 128' ' ' CYS . . . . . 0.746 ' HA ' ' O ' ' B' ' 133' ' ' GLY . 8.6 m -111.57 146.37 37.48 Favored 'General case' 0 CA--C 1.571 1.77 0 N-CA-C 114.788 1.403 . . . . 1.23 114.788 -177.605 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 129' ' ' GLY . . . . . . . . . . . . . . . -133.75 164.45 24.38 Favored Glycine 0 N--CA 1.421 -2.31 0 CA-C-N 114.973 -1.012 . . . . 0.66 112.065 178.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 130' ' ' ASP . . . . . 0.638 ' OD2' ' HG2' ' B' ' 131' ' ' GLU . 9.6 p-10 -72.28 -27.78 62.7 Favored 'General case' 0 C--N 1.292 -1.892 0 C-N-CA 126.275 1.83 . . . . 2.35 111.033 177.796 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 131' ' ' GLU . . . . . 0.638 ' HG2' ' OD2' ' B' ' 130' ' ' ASP . 1.1 pt-20 -140.49 23.85 2.3 Favored 'General case' 0 CA--C 1.482 -1.672 0 CA-C-N 114.006 -1.452 . . . . 1.69 108.506 172.599 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 132' ' ' LEU . . . . . 0.973 HD22 ' CE1' ' B' ' 135' ' ' PHE . 0.6 OUTLIER -123.64 -9.54 7.89 Favored 'General case' 0 N--CA 1.408 -2.544 0 N-CA-C 107.327 -1.36 . . . . 1.38 107.327 178.1 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 133' ' ' GLY . . . . . 1.015 ' HA2' ' HB1' ' B' ' 169' ' ' ALA . . . 58.93 -114.47 6.1 Favored Glycine 0 N--CA 1.408 -3.217 0 CA-C-O 117.979 -1.456 . . . . 0.72 112.423 178.769 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 134' ' ' CYS . . . . . 0.98 ' HB2' HD13 ' B' ' 172' ' ' ILE . 0.1 OUTLIER -148.52 124.07 10.4 Favored 'General case' 0 CA--C 1.478 -1.814 0 CA-C-N 120.326 2.063 . . . . 1.08 113.638 179.98 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 135' ' ' PHE . . . . . 0.973 ' CE1' HD22 ' B' ' 132' ' ' LEU . 0.0 OUTLIER -98.35 99.88 11.11 Favored 'General case' 0 N--CA 1.42 -1.96 0 N-CA-C 102.985 -2.969 . . . . 1.36 102.985 176.054 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 136' ' ' VAL . . . . . 1.044 HG13 HG12 ' B' ' 126' ' ' ILE . 2.3 t -91.91 85.49 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.65 0 CA-C-O 123.507 1.622 . . . . 0.75 107.875 -178.767 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 137' ' ' GLY . . . . . 0.739 ' HA3' HG21 ' A' ' 72' ' ' ILE . . . 90.21 81.74 1.37 Allowed Glycine 0 C--N 1.317 -0.476 0 CA-C-N 112.081 -2.327 . . . . 0.83 113.416 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 138' ' ' THR . . . . . 0.707 HG22 ' O ' ' A' ' 32' ' ' LEU . 68.7 p -148.41 176.3 10.4 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.624 -0.88 . . . . 0.78 108.624 179.158 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 139' ' ' ALA . . . . . 0.812 ' HA ' HD12 ' B' ' 142' ' ' LEU . . . -61.1 -40.93 95.62 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 119.323 0.965 . . . . 1.04 109.932 178.301 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 140' ' ' GLU . . . . . 0.749 ' HB3' ' HA2' ' B' ' 114' ' ' GLY . 7.7 mt-10 -56.53 -19.1 13.95 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.355 0.598 . . . . 2.31 111.204 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 141' ' ' ALA . . . . . 0.765 ' O ' ' HB2' ' B' ' 144' ' ' CYS . . . -83.26 -20.82 33.78 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 114.906 -1.043 . . . . 0.87 110.054 179.287 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 142' ' ' LEU . . . . . 0.812 HD12 ' HA ' ' B' ' 139' ' ' ALA . 0.5 OUTLIER -53.9 -39.73 66.04 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.939 0.876 . . . . 1.24 109.088 177.704 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 143' ' ' ARG . . . . . 0.793 ' HD2' ' O ' ' B' ' 112' ' ' PRO . 0.2 OUTLIER -67.4 -3.79 9.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.605 -1.179 . . . . 2.93 109.991 177.621 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 144' ' ' CYS . . . . . 0.765 ' HB2' ' O ' ' B' ' 141' ' ' ALA . 0.1 OUTLIER -84.39 18.23 2.31 Favored 'General case' 0 C--N 1.342 0.246 0 O-C-N 120.863 -1.148 . . . . 1.61 110.993 176.148 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.23 -27.12 47.61 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.563 0.696 . . . . 3.35 109.146 175.14 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -84.55 3.17 37.88 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.78 -0.645 . . . . 3.76 110.71 179.315 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 147' ' ' GLU . . . . . 1.032 ' HG3' ' HB3' ' B' ' 121' ' ' CYS . 1.7 tm-20 -81.7 2.76 28.23 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.607 -0.516 . . . . 4.01 109.607 177.32 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 148' ' ' ASN . . . . . . . . . . . . . 24.7 t30 -94.94 -26.87 15.95 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.019 -0.537 . . . . 3.92 109.943 178.721 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -110.38 9.97 23.44 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.418 -0.355 . . . . 5.73 111.891 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 150' ' ' LEU . . . . . 1.064 HD22 HD23 ' B' ' 111' ' ' LEU . 0.1 OUTLIER -145.15 80.33 11.19 Favored Pre-proline 0 CA--C 1.535 0.39 0 C-N-CA 121.31 -0.156 . . . . 5.46 111.243 -179.998 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 151' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -95.43 50.83 0.19 Allowed 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 123.065 2.51 . . . . 5.02 112.814 -179.57 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 152' ' ' SER . . . . . 0.533 ' HB3' HG21 ' B' ' 107' ' ' VAL . 59.8 m -83.94 118.23 70.77 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 116.342 -0.39 . . . . 5.73 111.965 -179.459 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 153' ' ' PRO . . . . . 0.568 ' O ' HG11 ' B' ' 107' ' ' VAL . 91.9 Cg_endo -81.6 121.69 3.82 Favored 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 122.434 2.089 . . . . 5.1 111.563 179.077 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 154' ' ' CYS . . . . . 1.02 ' HB2' HD21 ' B' ' 103' ' ' LEU . 8.9 p -120.96 -160.87 0.87 Allowed 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 112.076 0.399 . . . . 2.68 112.076 -178.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 155' ' ' GLN . . . . . 0.761 ' N ' ' HB2' ' B' ' 105' ' ' LEU . 0.4 OUTLIER -60.92 125.58 24.24 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 120.636 -0.426 . . . . 5.63 110.707 178.561 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 156' ' ' SER . . . . . 0.414 ' HB3' ' H ' ' B' ' 157' ' ' GLY . 5.8 m -152.0 -155.85 0.65 Allowed 'General case' 0 N--CA 1.466 0.329 0 O-C-N 122.517 -0.114 . . . . 3.11 110.874 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 157' ' ' GLY . . . . . 0.414 ' H ' ' HB3' ' B' ' 156' ' ' SER . . . -127.6 134.82 8.43 Favored Glycine 0 N--CA 1.44 -1.043 0 N-CA-C 110.082 -1.207 . . . . 2.07 110.082 178.516 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.55 67.7 0.66 Allowed 'General case' 0 N--CA 1.444 -0.746 0 CA-C-O 122.144 0.973 . . . . 4.34 109.28 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 159' ' ' LYS . . . . . 0.542 ' O ' ' HA ' ' B' ' 166' ' ' ARG . 0.1 OUTLIER -112.82 69.38 1.11 Allowed Pre-proline 0 C--N 1.315 -0.919 0 CA-C-N 113.929 -1.487 . . . . 3.54 110.634 177.046 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 160' ' ' PRO . . . . . 0.533 ' HA ' ' HA ' ' B' ' 166' ' ' ARG . 33.2 Cg_endo -64.86 79.19 0.19 Allowed 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 121.56 1.507 . . . . 1.51 114.011 -177.549 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 161' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -93.74 -168.95 1.99 Allowed 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 106.682 -1.599 . . . . 1.58 106.682 176.657 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 60.09 -165.38 12.33 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 118.859 -1.638 . . . . 2.37 113.407 177.491 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 4.1 m -87.69 42.21 1.03 Allowed 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 122.961 1.363 . . . . 4.07 110.902 -177.393 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 118.15 6.59 12.12 Favored Glycine 0 CA--C 1.551 2.343 0 CA-C-N 112.552 -2.113 . . . . 2.2 115.095 -179.294 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 165' ' ' GLY . . . . . 0.48 ' CA ' ' HB3' ' B' ' 175' ' ' SER . . . -102.36 129.59 9.94 Favored Glycine 0 N--CA 1.472 1.07 0 CA-C-N 120.835 2.317 . . . . 1.62 116.708 -177.02 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 166' ' ' ARG . . . . . 0.758 ' H ' ' HD2' ' B' ' 166' ' ' ARG . 0.0 OUTLIER -90.77 155.35 18.86 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 108.858 -0.793 . . . . 3.05 108.858 177.115 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 167' ' ' CYS . . . . . 0.49 ' SG ' ' HB3' ' B' ' 159' ' ' LYS . 69.6 m -64.87 107.86 1.6 Allowed 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 118.392 0.542 . . . . 1.56 110.136 -178.736 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 168' ' ' ALA . . . . . 0.459 ' HB3' ' SG ' ' B' ' 128' ' ' CYS . . . -89.32 -19.37 25.37 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 122.056 0.931 . . . . 1.04 108.626 178.242 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 169' ' ' ALA . . . . . 1.015 ' HB1' ' HA2' ' B' ' 133' ' ' GLY . . . -159.88 160.94 34.22 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 113.55 -1.659 . . . . 0.98 111.037 -176.835 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 170' ' ' ALA . . . . . 0.616 ' HA ' ' O ' ' B' ' 185' ' ' CYS . . . -57.91 118.09 4.99 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 113.556 0.947 . . . . 1.25 113.556 -178.326 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 171' ' ' GLY . . . . . 0.657 ' HA2' ' O ' ' B' ' 182' ' ' ASP . . . 71.81 18.79 77.72 Favored Glycine 0 CA--C 1.521 0.441 0 CA-C-N 115.689 -0.687 . . . . 1.29 114.609 177.633 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 172' ' ' ILE . . . . . 0.98 HD13 ' HB2' ' B' ' 134' ' ' CYS . 1.7 pp -142.32 102.07 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-O 122.458 1.123 . . . . 2.27 111.252 -178.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 173' ' ' CYS . . . . . 0.623 ' HB2' ' HB3' ' B' ' 182' ' ' ASP . 0.0 OUTLIER -85.7 92.12 8.49 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 114.126 -1.397 . . . . 1.94 110.669 -178.38 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 174' ' ' CYS . . . . . 0.646 ' HA ' ' HA ' ' B' ' 179' ' ' CYS . 81.4 m -97.51 153.52 18.1 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.655 0.741 . . . . 1.35 112.478 -178.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 175' ' ' SER . . . . . 0.906 ' HB2' ' HD2' ' B' ' 176' ' ' PRO . 35.1 p -130.02 -178.92 0.89 Allowed Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 114.494 -1.23 . . . . 2.0 108.916 179.516 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 176' ' ' PRO . . . . . 0.906 ' HD2' ' HB2' ' B' ' 175' ' ' SER . 72.1 Cg_endo -78.15 26.94 0.49 Allowed 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 121.339 1.359 . . . . 1.9 111.727 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 177' ' ' ASP . . . . . 0.409 ' H ' ' C ' ' B' ' 175' ' ' SER . 3.0 p30 -146.07 -39.98 0.22 Allowed 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.772 -0.649 . . . . 2.72 111.357 179.374 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 178' ' ' GLY . . . . . 0.407 ' HA3' ' O ' ' A' ' 79' ' ' CYS . . . -157.12 -155.03 7.29 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 120.588 -0.815 . . . . 0.99 113.51 -179.728 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 179' ' ' CYS . . . . . 0.646 ' HA ' ' HA ' ' B' ' 174' ' ' CYS . 99.8 m -140.19 156.15 46.63 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 110.054 -0.35 . . . . 1.34 110.054 179.678 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 180' ' ' HIS . . . . . 0.449 ' O ' ' HB2' ' B' ' 173' ' ' CYS . 33.6 t-80 -150.27 124.13 9.26 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-O 121.387 0.613 . . . . 2.1 110.427 -173.827 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 181' ' ' GLU . . . . . 0.526 ' OE2' ' HD2' ' A' ' 24' ' ' PRO . 18.5 mt-10 -51.21 129.89 25.37 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 115.105 -0.952 . . . . 3.06 111.98 -175.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 182' ' ' ASP . . . . . 0.657 ' O ' ' HA2' ' B' ' 171' ' ' GLY . 0.1 OUTLIER -141.83 118.28 7.23 Favored Pre-proline 0 CA--C 1.546 0.807 0 CA-C-N 115.333 -0.849 . . . . 2.06 110.371 -179.066 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 183' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' B' ' 182' ' ' ASP . 3.8 Cg_exo -81.84 -18.81 7.59 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 122.813 2.342 . . . . 1.91 113.671 -178.524 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -63.59 -39.81 95.34 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.781 0.324 . . . . 1.56 111.684 -179.316 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 185' ' ' CYS . . . . . 0.616 ' O ' ' HA ' ' B' ' 170' ' ' ALA . 68.8 m -99.85 14.76 29.27 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 116.311 -0.404 . . . . 1.94 112.052 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 186' ' ' ASP . . . . . 0.517 ' CB ' ' HD3' ' B' ' 187' ' ' PRO . 0.8 OUTLIER -66.78 -55.6 16.95 Favored Pre-proline 0 C--N 1.322 -0.608 0 C-N-CA 121.015 -0.274 . . . . 3.61 111.71 -178.099 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 187' ' ' PRO . . . . . 0.546 ' C ' ' H ' ' B' ' 189' ' ' ALA . 57.1 Cg_endo -99.66 -169.36 0.1 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.17 0 C-N-CA 123.284 2.656 . . . . 2.58 113.883 -179.049 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 188' ' ' GLU . . . . . 0.406 ' C ' ' H ' ' B' ' 190' ' ' ALA . 5.9 pt-20 -61.64 30.47 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 111.586 -2.552 . . . . 4.7 112.189 175.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 189' ' ' ALA . . . . . 0.546 ' H ' ' C ' ' B' ' 187' ' ' PRO . . . -82.24 16.02 2.18 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 107.895 -1.15 . . . . 5.24 107.895 169.464 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 190' ' ' ALA . . . . . 0.406 ' H ' ' C ' ' B' ' 188' ' ' GLU . . . -78.4 140.89 38.67 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-O 122.3 1.048 . . . . 6.93 111.547 176.624 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 191' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -100.18 101.56 12.62 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 113.145 -1.843 . . . . 10.14 110.194 177.383 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 16.6 m . . . . . 0 C--O 1.248 0.975 0 CA-C-O 118.279 -0.867 . . . . 11.7 110.898 -179.989 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.441 0 CA-C-O 121.515 0.674 . . . . 9.95 112.009 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.1 p -138.01 135.76 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.262 0 CA-C-O 123.046 1.403 . . . . 8.02 113.025 179.177 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.907 ' HG ' ' HG3' ' A' ' 8' ' ' ARG . 1.1 mm? -69.95 118.39 12.74 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 111.976 -2.375 . . . . 5.86 110.611 178.152 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.479 ' H ' ' HG3' ' A' ' 55' ' ' GLN . 1.1 m-20 -98.85 53.56 1.0 Allowed 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 113.005 -1.907 . . . . 6.22 109.994 178.67 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 1.1 HD13 ' H ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -141.67 -66.92 0.4 Allowed 'General case' 0 N--CA 1.383 -3.806 0 CA-C-N 111.71 -2.496 . . . . 7.09 107.974 175.905 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 1.1 ' H ' HD13 ' A' ' 5' ' ' LEU . 0.2 OUTLIER 165.7 -42.18 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.965 0 CA-C-O 125.132 2.396 . . . . 8.78 111.554 -178.597 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.887 ' C ' HD11 ' A' ' 5' ' ' LEU . 8.2 p -156.72 129.27 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.05 1 CA-C-N 107.232 -4.531 . . . . 7.51 108.486 172.902 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.907 ' HG3' ' HG ' ' A' ' 3' ' ' LEU . 0.0 OUTLIER -74.94 103.55 5.19 Favored 'General case' 0 N--CA 1.385 -3.71 0 C-N-CA 116.362 -2.135 . . . . 9.08 108.811 -179.841 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -112.06 98.36 7.29 Favored 'General case' 0 N--CA 1.395 -3.205 1 N-CA-C 99.941 -4.096 . . . . 5.66 99.941 166.426 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.7 m -77.01 59.68 1.7 Allowed 'General case' 0 C--N 1.282 -2.363 0 C-N-CA 118.437 -1.305 . . . . 2.68 111.646 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.809 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 4.4 mm? -32.71 114.43 0.4 Allowed Pre-proline 0 N--CA 1.475 0.799 0 N-CA-C 112.067 0.395 . . . . 2.48 112.067 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.729 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 95.7 Cg_endo -88.89 114.45 0.7 Allowed 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.626 2.217 . . . . 1.49 114.408 -178.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.666 ' O ' ' HA2' ' A' ' 17' ' ' GLY . 13.6 p -116.86 -155.31 0.58 Allowed 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 121.586 0.708 . . . . 1.0 110.582 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.417 ' O ' ' N ' ' A' ' 16' ' ' GLY . . . 79.21 -166.46 51.48 Favored Glycine 0 CA--C 1.497 -1.063 0 CA-C-O 119.284 -0.731 . . . . 1.15 111.892 179.182 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.551 ' CG ' HD11 ' A' ' 32' ' ' LEU . 84.8 Cg_endo -64.4 83.81 0.16 Allowed 'Trans proline' 0 N--CA 1.458 -0.561 0 CA-C-N 119.712 1.756 . . . . 1.57 113.374 -178.071 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 14' ' ' GLY . . . 87.99 8.21 72.8 Favored Glycine 0 C--N 1.29 -1.979 0 CA-C-N 111.927 -2.397 . . . . 1.68 115.2 -178.313 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.666 ' HA2' ' O ' ' A' ' 13' ' ' CYS . . . 91.17 42.77 4.86 Favored Glycine 0 N--CA 1.435 -1.369 0 N-CA-C 118.089 1.995 . . . . 1.36 118.089 172.777 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.61 -15.85 26.35 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 114.372 -0.914 . . . . 2.5 113.184 177.607 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.729 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -121.31 -179.67 16.12 Favored Glycine 0 N--CA 1.469 0.879 0 CA-C-O 117.707 -1.607 . . . . 1.02 109.084 -179.026 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.809 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 4.2 mpt_? -106.33 173.05 6.48 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 121.804 2.802 . . . . 2.92 110.476 178.218 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.474 ' HB3' ' HG3' ' A' ' 47' ' ' GLU . 0.5 OUTLIER -107.66 135.63 48.78 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 110.372 -0.233 . . . . 1.1 110.372 179.523 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.6 ' HE1' ' HB2' ' A' ' 28' ' ' CYS . 96.0 m-85 -111.51 -68.96 0.9 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.837 0.351 . . . . 1.51 110.574 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -106.63 -153.12 19.72 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 111.133 -0.787 . . . . 0.9 111.133 178.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -88.5 -51.25 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 122.444 2.096 . . . . 1.5 112.1 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.648 ' O ' ' N ' ' A' ' 37' ' ' GLY . 1.2 m -98.84 29.64 3.69 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-N 116.434 -0.348 . . . . 1.26 110.467 179.504 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.987 HG12 HG13 ' A' ' 36' ' ' VAL . 6.9 mt -138.69 116.0 11.57 Favored 'Isoleucine or valine' 0 C--O 1.243 0.717 0 CA-C-O 121.528 0.68 . . . . 0.83 112.771 -178.732 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.765 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 0.6 OUTLIER -130.76 125.4 33.7 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 114.973 -1.012 . . . . 0.92 110.274 178.626 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.994 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 94.8 m -117.2 161.94 18.66 Favored 'General case' 0 CA--C 1.55 0.972 0 CA-C-N 115.145 -0.934 . . . . 1.28 113.432 -178.293 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.734 ' O ' ' HB1' ' A' ' 69' ' ' ALA . . . -145.48 176.38 24.52 Favored Glycine 0 C--N 1.358 1.801 0 CA-C-N 112.955 -1.929 . . . . 0.67 108.597 176.65 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -65.78 -53.27 42.62 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 122.367 1.08 . . . . 2.27 110.601 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.577 ' OE2' ' HA ' ' A' ' 91' ' ' PHE . 1.1 pt-20 -120.41 19.1 12.1 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 113.067 -1.878 . . . . 1.66 108.214 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.613 HD22 ' CZ ' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -111.97 -12.6 13.72 Favored 'General case' 0 N--CA 1.405 -2.69 0 CA-C-N 114.229 -1.35 . . . . 1.37 108.033 179.988 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.994 ' O ' ' HA ' ' A' ' 28' ' ' CYS . . . 55.95 -127.67 43.53 Favored Glycine 0 N--CA 1.419 -2.5 0 CA-C-N 114.419 -1.264 . . . . 0.73 112.107 177.399 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.889 ' HB2' HD13 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -143.91 121.36 11.7 Favored 'General case' 0 CA--C 1.493 -1.238 0 N-CA-C 114.527 1.306 . . . . 1.08 114.527 179.68 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.75 ' HA ' ' HA ' ' B' ' 135' ' ' PHE . 0.0 OUTLIER -85.94 105.79 16.66 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 102.605 -3.109 . . . . 1.38 102.605 173.861 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.987 HG13 HG12 ' A' ' 26' ' ' ILE . 2.6 t -92.8 85.53 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.702 0 C-N-CA 118.436 -1.306 . . . . 0.76 108.714 -178.5 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.655 ' HA3' ' CG2' ' B' ' 172' ' ' ILE . . . 96.55 76.97 1.33 Allowed Glycine 0 CA--C 1.527 0.786 0 CA-C-N 112.464 -2.153 . . . . 0.81 114.071 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.603 HG22 ' O ' ' B' ' 132' ' ' LEU . 47.1 p -155.36 176.67 12.28 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 108.482 -0.933 . . . . 0.77 108.482 178.707 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 1.1 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -68.9 -13.67 62.57 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-N 119.495 1.043 . . . . 1.02 109.942 178.663 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.432 ' HG2' ' CE2' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -64.09 -18.55 64.51 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.368 -0.975 . . . . 2.32 108.368 177.903 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.954 ' O ' ' HB2' ' A' ' 44' ' ' CYS . . . -112.14 -12.13 13.69 Favored 'General case' 0 C--O 1.217 -0.631 0 CA-C-N 115.192 -0.913 . . . . 0.87 113.034 -179.276 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 1.1 HD12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -54.32 -19.28 5.14 Favored 'General case' 0 C--N 1.323 -0.545 0 O-C-N 120.966 -1.084 . . . . 1.23 113.29 -177.497 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.769 ' N ' HD13 ' A' ' 42' ' ' LEU . 9.2 ptm85 -79.65 -14.68 58.62 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 106.56 -1.645 . . . . 2.92 106.56 174.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.954 ' HB2' ' O ' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -58.18 -22.65 52.46 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 111.393 -2.639 . . . . 1.57 108.984 -178.383 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.76 -20.25 5.34 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.641 0.608 . . . . 3.31 112.641 179.046 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -85.83 6.75 26.71 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.102 -0.639 . . . . 3.69 110.729 -179.037 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.474 ' HG3' ' HB3' ' A' ' 21' ' ' CYS . 3.3 mm-40 -82.49 0.88 40.35 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 109.334 -0.617 . . . . 3.99 109.334 177.473 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 23.3 p-10 -75.26 -29.36 60.14 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.713 -0.477 . . . . 3.86 109.713 178.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -80.78 9.08 6.78 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.473 -0.331 . . . . 5.68 111.605 179.703 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.5 mt -134.51 130.48 19.97 Favored Pre-proline 0 C--N 1.333 -0.139 0 CA-C-O 120.507 0.194 . . . . 5.4 111.028 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -80.86 9.8 3.63 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.493 2.129 . . . . 4.92 112.532 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 178.42 150.26 0.42 Allowed Pre-proline 0 CA--C 1.529 0.15 0 CA-C-O 120.657 0.265 . . . . 5.64 110.799 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -79.27 -104.21 0.01 OUTLIER 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 122.661 2.24 . . . . 5.04 112.283 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 9.0 p -158.5 117.02 3.01 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 109.892 -0.41 . . . . 2.74 109.892 179.024 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.592 ' CD ' ' HA ' ' A' ' 3' ' ' LEU . 1.2 pm0 -56.47 134.78 54.26 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 119.916 -0.714 . . . . 5.75 112.18 -178.569 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.544 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 0.3 OUTLIER 168.76 67.71 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 112.047 0.388 . . . . 3.12 112.047 178.734 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.561 ' O ' ' HG3' ' A' ' 66' ' ' ARG . . . 168.32 89.9 0.08 OUTLIER Glycine 0 N--CA 1.434 -1.464 0 N-CA-C 108.053 -2.019 . . . . 2.1 108.053 -179.477 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -110.61 77.79 1.07 Allowed 'General case' 0 CA--C 1.497 -1.081 0 CA-C-O 122.465 1.126 . . . . 4.36 109.221 -178.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.9 ' HB2' ' HB2' ' A' ' 67' ' ' CYS . 7.7 mptt -140.77 53.06 3.53 Favored Pre-proline 0 C--N 1.293 -1.85 0 CA-C-N 113.279 -1.782 . . . . 3.55 107.391 179.012 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.552 ' CD ' ' N ' ' A' ' 59' ' ' LYS . 11.1 Cg_endo -54.6 97.32 0.05 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.202 0 C-N-CA 122.576 2.184 . . . . 1.54 113.496 -179.666 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.639 ' N ' ' O ' ' A' ' 65' ' ' GLY . 1.0 OUTLIER -96.91 -166.6 1.42 Allowed 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 111.947 -2.388 . . . . 1.59 107.189 177.56 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' A' ' 61' ' ' CYS . . . 36.91 -164.81 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 119.789 -1.196 . . . . 2.43 115.623 172.812 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -84.75 47.64 1.41 Allowed 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 113.1 -1.55 . . . . 4.11 111.405 -178.056 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 120.62 9.9 7.42 Favored Glycine 0 C--N 1.349 1.287 0 CA-C-N 114.77 -1.105 . . . . 2.21 115.22 178.04 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.639 ' O ' ' N ' ' A' ' 61' ' ' CYS . . . -105.2 132.62 11.19 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 119.551 -1.309 . . . . 1.62 115.402 -178.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.561 ' HG3' ' O ' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -101.71 154.24 19.06 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 109.38 -0.6 . . . . 3.02 109.38 177.046 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.9 ' HB2' ' HB2' ' A' ' 59' ' ' LYS . 0.5 OUTLIER -59.33 115.24 3.1 Favored 'General case' 0 CA--C 1.496 -1.128 0 N-CA-C 109.183 -0.673 . . . . 1.52 109.183 -179.696 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.404 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . . . -90.72 -19.21 23.82 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 107.785 -1.191 . . . . 1.07 107.785 178.089 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.734 ' HB1' ' O ' ' A' ' 29' ' ' GLY . . . -165.1 162.93 20.51 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 109.471 -0.566 . . . . 1.0 109.471 -177.51 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.916 ' HB2' ' HG3' ' A' ' 88' ' ' GLU . . . -50.43 132.81 25.03 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 112.927 0.714 . . . . 1.24 112.927 -179.49 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.598 ' H ' ' CB ' ' A' ' 85' ' ' CYS . . . 65.67 -25.6 0.14 Allowed Glycine 0 CA--C 1.526 0.77 0 CA-C-N 115.347 -0.842 . . . . 1.28 115.183 178.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.889 HD13 ' HB2' ' A' ' 34' ' ' CYS . 1.0 OUTLIER -102.37 122.56 54.82 Favored 'Isoleucine or valine' 0 C--O 1.243 0.72 0 CA-C-O 122.148 0.975 . . . . 2.27 111.614 -179.493 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.662 ' HB2' ' HB3' ' A' ' 82' ' ' ASP . 43.8 t -105.27 111.01 23.59 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.372 -0.831 . . . . 1.98 111.178 -179.516 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.529 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 0.8 OUTLIER -110.99 143.52 41.54 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.731 0.776 . . . . 1.33 112.559 -179.129 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.677 ' HB2' ' HD2' ' A' ' 76' ' ' PRO . 84.0 p -112.16 178.57 0.95 Allowed Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 114.447 -1.251 . . . . 1.99 108.76 179.482 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.677 ' HD2' ' HB2' ' A' ' 75' ' ' SER . 86.8 Cg_endo -80.54 22.95 0.73 Allowed 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 121.362 1.375 . . . . 1.86 111.649 179.31 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -145.3 -36.93 0.28 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.835 -0.62 . . . . 2.65 110.52 179.693 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.771 ' HA3' ' O ' ' B' ' 179' ' ' CYS . . . -155.57 -144.0 3.81 Favored Glycine 0 C--N 1.337 0.616 0 C-N-CA 120.47 -0.871 . . . . 0.99 113.385 179.513 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.659 ' O ' ' HA3' ' B' ' 178' ' ' GLY . 0.1 OUTLIER -151.5 157.97 43.0 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.987 0.422 . . . . 1.34 111.22 -179.614 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.459 ' O ' ' HB3' ' A' ' 73' ' ' CYS . 97.2 m-70 -147.14 148.32 31.44 Favored 'General case' 0 N--CA 1.461 0.089 0 O-C-N 122.162 -0.336 . . . . 2.17 110.26 179.358 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -64.5 133.99 53.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.547 -0.297 . . . . 3.05 110.496 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.662 ' HB3' ' HB2' ' A' ' 73' ' ' CYS . 0.0 OUTLIER -145.02 117.56 5.36 Favored Pre-proline 0 CA--C 1.538 0.489 0 CA-C-N 116.531 -0.304 . . . . 2.02 110.684 179.864 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -83.96 -9.29 9.79 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 123.024 2.483 . . . . 1.93 113.575 -178.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.76 -22.31 66.04 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.11 0.411 . . . . 1.53 112.11 -179.258 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.738 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 52.2 m -101.09 20.36 15.75 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 113.515 0.931 . . . . 1.88 113.515 -178.009 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.617 ' N ' ' CD ' ' A' ' 87' ' ' PRO . 1.2 m-20 -69.43 -36.54 7.19 Favored Pre-proline 0 CA--C 1.518 -0.275 0 C-N-CA 122.911 0.484 . . . . 3.6 111.525 178.578 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.617 ' CD ' ' N ' ' A' ' 86' ' ' ASP . 1.3 Cg_endo -76.46 71.72 5.79 Favored 'Trans proline' 0 CA--C 1.497 -1.362 0 N-CA-C 107.595 -1.733 . . . . 2.56 107.595 177.321 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.916 ' HG3' ' HB2' ' A' ' 70' ' ' ALA . 8.1 pt-20 169.45 -15.33 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 113.032 -1.895 . . . . 4.72 108.805 176.103 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.55 -11.6 61.04 Favored 'General case' 0 C--N 1.366 1.315 0 C-N-CA 124.538 1.135 . . . . 5.29 113.892 -177.454 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.49 128.38 35.43 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-O 124.22 1.962 . . . . 6.98 111.019 173.29 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.577 ' HA ' ' OE2' ' A' ' 31' ' ' GLU . 35.4 p90 -96.8 91.62 5.76 Favored 'General case' 0 C--N 1.356 0.878 0 CA-C-N 109.562 -3.472 . . . . 10.21 109.643 178.516 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 52.2 p . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.198 -0.906 . . . . 11.77 111.235 -179.333 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 101' ' ' ALA . . . . . 0.44 ' O ' HG12 ' B' ' 102' ' ' VAL . . . . . . . . 0 N--CA 1.488 1.452 0 CA-C-O 120.795 0.331 . . . . 10.07 111.481 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 102' ' ' VAL . . . . . 0.604 ' O ' HG13 ' B' ' 102' ' ' VAL . 12.0 p 46.85 89.5 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 C-N-CA 124.056 0.942 . . . . 8.41 113.447 -178.755 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 103' ' ' LEU . . . . . 0.492 ' N ' HD22 ' B' ' 103' ' ' LEU . 2.6 mm? -112.2 105.07 13.31 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.387 0.613 . . . . 5.87 110.654 179.254 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 104' ' ' ASP . . . . . 0.424 ' H ' ' CG ' ' B' ' 155' ' ' GLN . 0.6 OUTLIER -105.91 62.54 0.66 Allowed 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 122.61 1.195 . . . . 6.27 110.488 179.287 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 105' ' ' LEU . . . . . 1.016 HD13 ' H ' ' B' ' 106' ' ' ASP . 0.0 OUTLIER -153.04 -74.39 0.13 Allowed 'General case' 0 N--CA 1.384 -3.759 0 C-N-CA 128.308 2.643 . . . . 7.2 107.346 177.658 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 106' ' ' ASP . . . . . 1.016 ' H ' HD13 ' B' ' 105' ' ' LEU . 0.2 OUTLIER -173.32 -71.66 0.01 OUTLIER 'General case' 0 C--N 1.267 -2.999 0 N-CA-C 109.716 -0.476 . . . . 8.55 109.716 -177.931 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 107' ' ' VAL . . . . . 0.954 ' O ' HD21 ' B' ' 105' ' ' LEU . 2.7 p -138.89 141.86 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.684 1 N-CA-C 96.057 -5.534 . . . . 7.48 96.057 173.878 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 108' ' ' ARG . . . . . 0.789 ' O ' ' HD2' ' B' ' 108' ' ' ARG . 0.0 OUTLIER -73.96 108.55 6.85 Favored 'General case' 0 N--CA 1.4 -2.93 0 C-N-CA 116.621 -2.031 . . . . 9.12 110.076 -177.678 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.49 98.13 5.99 Favored 'General case' 0 N--CA 1.4 -2.95 1 N-CA-C 99.136 -4.394 . . . . 5.69 99.136 167.496 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 110' ' ' CYS . . . . . . . . . . . . . 1.7 m -79.39 66.0 4.72 Favored 'General case' 0 C--N 1.294 -1.817 0 C-N-CA 117.657 -1.617 . . . . 2.61 110.251 -178.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 111' ' ' LEU . . . . . 0.821 ' O ' ' HA ' ' B' ' 120' ' ' ARG . 4.3 mm? -35.39 114.19 0.52 Allowed Pre-proline 0 N--CA 1.47 0.552 0 C-N-CA 122.655 0.382 . . . . 2.47 111.843 178.631 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 112' ' ' PRO . . . . . 0.782 ' HA ' ' O ' ' B' ' 119' ' ' GLY . 92.2 Cg_endo -88.13 114.98 0.89 Allowed 'Trans proline' 0 CA--C 1.531 0.368 0 C-N-CA 122.394 2.063 . . . . 1.47 113.931 -179.215 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.618 ' O ' ' HA2' ' B' ' 117' ' ' GLY . 13.8 p -117.2 -153.94 0.54 Allowed 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.642 0.734 . . . . 1.0 110.692 178.672 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 114' ' ' GLY . . . . . 0.414 ' O ' ' N ' ' B' ' 116' ' ' GLY . . . 78.6 -166.67 52.42 Favored Glycine 0 CA--C 1.5 -0.886 0 CA-C-N 115.601 -0.727 . . . . 1.16 111.864 179.389 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 115' ' ' PRO . . . . . 0.554 ' CG ' HD11 ' B' ' 132' ' ' LEU . 87.1 Cg_endo -64.66 82.58 0.17 Allowed 'Trans proline' 0 N--CA 1.454 -0.848 0 CA-C-N 119.503 1.652 . . . . 1.57 114.37 -177.828 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 116' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' B' ' 114' ' ' GLY . . . 89.44 6.86 70.2 Favored Glycine 0 C--N 1.29 -2.01 0 CA-C-N 111.727 -2.488 . . . . 1.7 115.638 -177.028 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 117' ' ' GLY . . . . . 0.618 ' HA2' ' O ' ' B' ' 113' ' ' CYS . . . 93.48 41.87 4.38 Favored Glycine 0 N--CA 1.436 -1.335 0 N-CA-C 117.794 1.877 . . . . 1.38 117.794 173.369 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.92 -15.56 26.18 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 113.18 0.807 . . . . 2.54 113.18 177.663 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 119' ' ' GLY . . . . . 0.782 ' O ' ' HA ' ' B' ' 112' ' ' PRO . . . -122.19 -170.66 13.77 Favored Glycine 0 C--N 1.347 1.161 0 N-CA-C 108.472 -1.851 . . . . 1.04 108.472 178.706 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.821 ' HA ' ' O ' ' B' ' 111' ' ' LEU . 4.1 mpt_? -110.94 172.85 6.63 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 121.307 2.554 . . . . 2.89 110.667 178.537 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 121' ' ' CYS . . . . . 0.484 ' HB3' ' HG3' ' B' ' 147' ' ' GLU . 0.5 OUTLIER -107.8 135.5 49.1 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 110.257 -0.275 . . . . 1.07 110.257 179.662 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 122' ' ' PHE . . . . . 0.611 ' HE1' ' HB2' ' B' ' 128' ' ' CYS . 96.0 m-85 -111.46 -68.94 0.9 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.873 0.368 . . . . 1.53 110.561 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -106.89 -153.22 19.42 Favored Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 111.062 -0.815 . . . . 0.9 111.062 178.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -88.32 -51.24 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 122.38 2.053 . . . . 1.51 112.161 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 125' ' ' SER . . . . . 0.648 ' O ' ' N ' ' B' ' 137' ' ' GLY . 1.4 m -98.64 29.55 3.66 Favored 'General case' 0 C--O 1.223 -0.308 0 CA-C-N 116.478 -0.328 . . . . 1.25 110.376 179.393 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 126' ' ' ILE . . . . . 0.957 HG12 HG13 ' B' ' 136' ' ' VAL . 8.1 mt -138.14 115.63 12.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.645 0 N-CA-C 113.122 0.786 . . . . 0.85 113.122 -178.754 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 127' ' ' CYS . . . . . 0.787 ' O ' ' HA ' ' B' ' 134' ' ' CYS . 0.5 OUTLIER -130.72 125.33 33.6 Favored 'General case' 0 C--O 1.225 -0.224 0 CA-C-N 115.122 -0.945 . . . . 0.89 110.232 178.689 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 128' ' ' CYS . . . . . 1.016 ' HA ' ' O ' ' B' ' 133' ' ' GLY . 98.6 m -117.09 162.49 17.73 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.19 -0.914 . . . . 1.23 113.387 -178.117 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 129' ' ' GLY . . . . . 0.742 ' O ' ' HB1' ' B' ' 169' ' ' ALA . . . -145.68 176.44 24.67 Favored Glycine 0 C--N 1.358 1.789 0 N-CA-C 108.622 -1.791 . . . . 0.66 108.622 176.364 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -66.56 -53.21 37.13 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 121.966 0.889 . . . . 2.35 110.239 179.69 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 131' ' ' GLU . . . . . 0.567 ' OE2' ' HA ' ' B' ' 191' ' ' PHE . 1.2 pt-20 -122.83 30.53 6.39 Favored 'General case' 0 N--CA 1.424 -1.766 0 CA-C-N 113.676 -1.602 . . . . 1.69 108.06 177.58 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 132' ' ' LEU . . . . . 0.62 HD22 ' CZ ' ' B' ' 135' ' ' PHE . 0.8 OUTLIER -122.24 -11.26 8.42 Favored 'General case' 0 N--CA 1.406 -2.636 0 N-CA-C 106.136 -1.801 . . . . 1.38 106.136 -178.839 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 133' ' ' GLY . . . . . 1.016 ' O ' ' HA ' ' B' ' 128' ' ' CYS . . . 54.51 -126.17 36.5 Favored Glycine 0 N--CA 1.408 -3.169 0 CA-C-N 113.876 -1.511 . . . . 0.72 112.351 175.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 134' ' ' CYS . . . . . 0.897 ' HB2' HD13 ' B' ' 172' ' ' ILE . 0.1 OUTLIER -145.06 120.63 10.41 Favored 'General case' 0 CA--C 1.491 -1.296 0 N-CA-C 115.032 1.493 . . . . 1.08 115.032 -179.841 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 135' ' ' PHE . . . . . 0.75 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -85.3 106.12 16.47 Favored 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 102.72 -3.067 . . . . 1.36 102.72 174.507 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 136' ' ' VAL . . . . . 0.957 HG13 HG12 ' B' ' 126' ' ' ILE . 3.4 t -92.63 85.63 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.601 0 CA-C-O 122.85 1.31 . . . . 0.75 108.513 -178.284 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 137' ' ' GLY . . . . . 0.648 ' N ' ' O ' ' B' ' 125' ' ' SER . . . 96.12 76.5 1.31 Allowed Glycine 0 CA--C 1.526 0.73 0 CA-C-N 112.5 -2.136 . . . . 0.83 114.222 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 138' ' ' THR . . . . . 0.513 HG22 ' O ' ' A' ' 32' ' ' LEU . 49.8 p -155.19 176.31 12.72 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 108.414 -0.958 . . . . 0.78 108.414 178.781 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 139' ' ' ALA . . . . . 1.103 ' O ' HD12 ' B' ' 142' ' ' LEU . . . -68.64 -12.79 61.81 Favored 'General case' 0 C--O 1.22 -0.487 0 CA-C-N 119.235 0.925 . . . . 1.04 110.133 178.78 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 140' ' ' GLU . . . . . 0.427 ' HG2' ' HD3' ' B' ' 115' ' ' PRO . 0.9 OUTLIER -65.63 -17.45 64.6 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.483 -0.932 . . . . 2.31 108.483 177.569 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 141' ' ' ALA . . . . . 0.938 ' O ' ' HB2' ' B' ' 144' ' ' CYS . . . -112.62 -12.65 13.39 Favored 'General case' 0 C--O 1.216 -0.688 0 CA-C-N 114.98 -1.009 . . . . 0.87 113.033 -179.46 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 142' ' ' LEU . . . . . 1.103 HD12 ' O ' ' B' ' 139' ' ' ALA . 0.0 OUTLIER -54.24 -19.23 4.9 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 121.097 -1.002 . . . . 1.24 113.222 -177.236 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 143' ' ' ARG . . . . . 0.772 ' N ' HD13 ' B' ' 142' ' ' LEU . 9.3 ptm85 -80.76 -12.58 59.43 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 106.774 -1.565 . . . . 2.93 106.774 174.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 144' ' ' CYS . . . . . 0.938 ' HB2' ' O ' ' B' ' 141' ' ' ALA . 0.1 OUTLIER -58.76 -24.84 62.36 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 111.786 -2.461 . . . . 1.61 108.948 -179.488 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.84 -20.56 2.29 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 112.672 0.619 . . . . 3.35 112.672 179.495 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -85.85 6.79 26.63 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.128 -0.629 . . . . 3.76 110.754 -179.086 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 147' ' ' GLU . . . . . 0.484 ' HG3' ' HB3' ' B' ' 121' ' ' CYS . 3.3 mm-40 -82.62 1.16 39.6 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 109.401 -0.592 . . . . 4.01 109.401 177.406 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 148' ' ' ASN . . . . . . . . . . . . . 23.3 p-10 -75.36 -29.35 59.87 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.719 -0.474 . . . . 3.92 109.719 178.575 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -80.72 9.03 6.78 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.432 -0.349 . . . . 5.73 111.585 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 10.5 mt -134.57 130.48 19.91 Favored Pre-proline 0 C--N 1.332 -0.161 0 CA-C-O 120.495 0.188 . . . . 5.46 111.054 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 151' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -80.89 9.83 3.63 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.466 2.111 . . . . 5.02 112.578 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 178.42 150.22 0.42 Allowed Pre-proline 0 CA--C 1.529 0.169 0 CA-C-N 116.611 -0.268 . . . . 5.73 110.795 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 153' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -79.38 -104.24 0.01 OUTLIER 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 122.662 2.241 . . . . 5.1 112.32 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 154' ' ' CYS . . . . . 0.87 ' HA ' ' HG ' ' B' ' 105' ' ' LEU . 8.1 p -158.48 118.09 3.18 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 109.883 -0.414 . . . . 2.68 109.883 179.124 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 155' ' ' GLN . . . . . 0.549 ' O ' ' HB2' ' B' ' 156' ' ' SER . 1.3 pm0 -57.97 134.42 56.36 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 120.322 -0.551 . . . . 5.63 111.839 -178.401 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 156' ' ' SER . . . . . 0.549 ' HB2' ' O ' ' B' ' 155' ' ' GLN . 0.3 OUTLIER 168.47 70.75 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 120.938 0.399 . . . . 3.11 111.5 179.043 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 157' ' ' GLY . . . . . 0.539 ' O ' ' HG3' ' B' ' 166' ' ' ARG . . . 165.14 91.05 0.08 OUTLIER Glycine 0 N--CA 1.44 -1.085 0 N-CA-C 108.847 -1.701 . . . . 2.07 108.847 179.608 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -112.34 65.61 0.64 Allowed 'General case' 0 CA--C 1.501 -0.909 0 CA-C-O 122.762 1.268 . . . . 4.34 110.402 -179.246 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 159' ' ' LYS . . . . . 0.963 ' HB2' ' HB2' ' B' ' 167' ' ' CYS . 7.3 mptt -113.34 47.66 0.37 Allowed Pre-proline 0 C--N 1.302 -1.499 0 CA-C-N 112.542 -2.117 . . . . 3.54 111.534 173.303 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 160' ' ' PRO . . . . . 0.451 ' HA ' ' HA ' ' B' ' 166' ' ' ARG . 10.0 Cg_endo -53.76 97.52 0.05 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.402 0 CA-C-N 121.3 1.5 . . . . 1.51 114.698 -174.612 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 161' ' ' CYS . . . . . 0.625 ' N ' ' O ' ' B' ' 165' ' ' GLY . 0.9 OUTLIER -96.9 -166.69 1.44 Allowed 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 112.397 -2.183 . . . . 1.58 107.406 177.626 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 162' ' ' GLY . . . . . 0.41 ' N ' ' SG ' ' B' ' 161' ' ' CYS . . . 37.08 -164.77 0.01 OUTLIER Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 115.746 1.059 . . . . 2.37 115.746 172.848 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -84.54 47.31 1.34 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 113.177 -1.511 . . . . 4.07 111.465 -178.093 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 120.4 9.82 7.62 Favored Glycine 0 CA--C 1.539 1.549 0 CA-C-N 115.043 -0.981 . . . . 2.2 115.179 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 165' ' ' GLY . . . . . 0.625 ' O ' ' N ' ' B' ' 161' ' ' CYS . . . -104.82 133.38 11.52 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 118.921 -1.609 . . . . 1.62 115.16 -179.55 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 166' ' ' ARG . . . . . 0.539 ' HG3' ' O ' ' B' ' 157' ' ' GLY . 0.0 OUTLIER -102.17 154.19 19.25 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 109.313 -0.625 . . . . 3.05 109.313 176.661 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 167' ' ' CYS . . . . . 0.963 ' HB2' ' HB2' ' B' ' 159' ' ' LYS . 0.5 OUTLIER -59.2 115.54 3.27 Favored 'General case' 0 CA--C 1.499 -0.982 0 N-CA-C 109.214 -0.661 . . . . 1.56 109.214 -179.571 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 168' ' ' ALA . . . . . 0.43 ' HB3' ' SG ' ' B' ' 128' ' ' CYS . . . -89.8 -20.75 23.12 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 107.774 -1.195 . . . . 1.04 107.774 177.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 169' ' ' ALA . . . . . 0.742 ' HB1' ' O ' ' B' ' 129' ' ' GLY . . . -164.38 162.71 22.33 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.375 -0.83 . . . . 0.98 110.682 -177.016 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 170' ' ' ALA . . . . . 0.892 ' HB2' ' HG3' ' B' ' 188' ' ' GLU . . . -49.99 133.0 23.11 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 112.711 0.634 . . . . 1.25 112.711 -179.273 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 171' ' ' GLY . . . . . 0.576 ' H ' ' CB ' ' B' ' 185' ' ' CYS . . . 67.65 -30.74 0.22 Allowed Glycine 0 CA--C 1.527 0.809 0 CA-C-N 115.614 -0.721 . . . . 1.29 114.693 178.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 172' ' ' ILE . . . . . 0.897 HD13 ' HB2' ' B' ' 134' ' ' CYS . 1.0 OUTLIER -99.5 122.78 51.71 Favored 'Isoleucine or valine' 0 C--O 1.242 0.71 0 CA-C-O 122.322 1.058 . . . . 2.27 111.931 -178.138 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 173' ' ' CYS . . . . . 0.656 ' HB2' ' HB3' ' B' ' 182' ' ' ASP . 44.1 t -105.36 110.96 23.51 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.201 -0.909 . . . . 1.94 111.19 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 174' ' ' CYS . . . . . 0.534 ' HA ' ' HA ' ' B' ' 179' ' ' CYS . 0.8 OUTLIER -110.83 143.51 41.29 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.586 0.707 . . . . 1.35 112.603 -179.097 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 175' ' ' SER . . . . . 0.687 ' HB2' ' HD2' ' B' ' 176' ' ' PRO . 83.9 p -112.17 178.53 0.96 Allowed Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 114.542 -1.208 . . . . 2.0 108.778 179.365 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 176' ' ' PRO . . . . . 0.687 ' HD2' ' HB2' ' B' ' 175' ' ' SER . 89.0 Cg_endo -80.53 23.1 0.72 Allowed 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 121.315 1.343 . . . . 1.9 111.663 179.328 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 177' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -145.38 -36.29 0.29 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.812 -0.631 . . . . 2.72 110.711 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 178' ' ' GLY . . . . . 0.659 ' HA3' ' O ' ' A' ' 79' ' ' CYS . . . -156.41 -144.18 3.86 Favored Glycine 0 C--N 1.337 0.587 0 C-N-CA 120.671 -0.776 . . . . 0.99 113.325 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 179' ' ' CYS . . . . . 0.771 ' O ' ' HA3' ' A' ' 78' ' ' GLY . 0.1 OUTLIER -151.51 157.98 43.0 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 120.895 0.378 . . . . 1.34 111.346 -179.489 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 180' ' ' HIS . . . . . 0.459 ' O ' ' HB3' ' B' ' 173' ' ' CYS . 97.1 m-70 -147.05 148.36 31.57 Favored 'General case' 0 N--CA 1.46 0.069 0 O-C-N 122.199 -0.313 . . . . 2.1 110.277 179.316 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 181' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -64.5 133.93 53.42 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.645 -0.252 . . . . 3.06 110.486 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 182' ' ' ASP . . . . . 0.656 ' HB3' ' HB2' ' B' ' 173' ' ' CYS . 0.0 OUTLIER -144.99 117.52 5.37 Favored Pre-proline 0 CA--C 1.538 0.496 0 CA-C-N 116.521 -0.309 . . . . 2.06 110.673 179.864 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 183' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' B' ' 182' ' ' ASP . 1.2 Cg_endo -83.97 -9.14 9.85 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 123.039 2.493 . . . . 1.91 113.557 -178.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -66.75 -22.49 66.04 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.05 0.389 . . . . 1.56 112.05 -179.344 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 185' ' ' CYS . . . . . 0.749 ' HB3' ' HA ' ' B' ' 170' ' ' ALA . 54.1 m -100.94 20.32 15.68 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 113.622 0.971 . . . . 1.94 113.622 -178.024 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 186' ' ' ASP . . . . . 0.622 ' N ' ' CD ' ' B' ' 187' ' ' PRO . 1.2 m-20 -69.45 -36.46 7.05 Favored Pre-proline 0 CA--C 1.518 -0.271 0 C-N-CA 122.858 0.463 . . . . 3.61 111.52 178.577 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 187' ' ' PRO . . . . . 0.622 ' CD ' ' N ' ' B' ' 186' ' ' ASP . 1.2 Cg_endo -76.32 70.19 6.26 Favored 'Trans proline' 0 CA--C 1.497 -1.345 0 C-N-CA 121.554 1.503 . . . . 2.58 108.28 177.586 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 188' ' ' GLU . . . . . 0.892 ' HG3' ' HB2' ' B' ' 170' ' ' ALA . 8.2 pt-20 170.1 -14.21 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 112.821 -1.991 . . . . 4.7 109.064 176.802 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 189' ' ' ALA . . . . . . . . . . . . . . . -71.79 -11.13 60.66 Favored 'General case' 0 C--N 1.363 1.184 0 C-N-CA 124.401 1.08 . . . . 5.24 113.831 -177.631 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 190' ' ' ALA . . . . . . . . . . . . . . . -72.68 131.87 42.95 Favored 'General case' 0 N--CA 1.418 -2.043 0 CA-C-O 124.173 1.939 . . . . 6.93 111.026 172.425 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 191' ' ' PHE . . . . . 0.567 ' HA ' ' OE2' ' B' ' 131' ' ' GLU . 35.8 p90 -97.55 91.77 5.6 Favored 'General case' 0 C--N 1.35 0.599 0 CA-C-N 109.24 -3.618 . . . . 10.14 109.923 177.26 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 53.0 p . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.179 -0.915 . . . . 11.7 111.125 -179.343 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.452 ' O ' HG22 ' A' ' 9' ' ' THR . . . . . . . . 0 N--CA 1.485 1.308 0 CA-C-O 121.053 0.454 . . . . 9.95 111.879 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.487 ' O ' HG12 ' A' ' 2' ' ' VAL . 18.6 t 53.46 51.12 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 N-CA-C 112.874 0.694 . . . . 8.02 112.874 176.779 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.846 ' CB ' ' HD3' ' A' ' 8' ' ' ARG . 0.6 OUTLIER -129.17 112.98 14.51 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 115.822 -0.626 . . . . 5.86 109.331 -179.554 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.71 ' O ' ' HB2' ' A' ' 55' ' ' GLN . 0.1 OUTLIER -154.29 -153.3 0.45 Allowed 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 103.208 -2.886 . . . . 6.22 103.208 178.174 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 1.068 HD13 ' HB3' ' A' ' 55' ' ' GLN . 0.1 OUTLIER -86.23 9.78 16.64 Favored 'General case' 0 C--N 1.347 0.486 0 C-N-CA 114.967 -2.693 . . . . 7.09 109.852 175.539 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.54 -85.67 0.06 Allowed 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 104.919 -2.252 . . . . 8.78 104.919 -179.577 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.892 ' HA ' ' HB2' ' A' ' 56' ' ' SER . 2.4 p -149.76 115.33 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.455 -2.705 0 C-N-CA 115.72 -2.392 . . . . 7.51 105.014 172.741 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.869 ' HG2' ' HA ' ' A' ' 54' ' ' CYS . 9.2 tpt180 -77.59 116.55 18.23 Favored 'General case' 0 CA--C 1.462 -2.431 0 C-N-CA 118.818 -1.153 . . . . 9.08 108.688 -177.348 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.548 ' O ' ' HD2' ' A' ' 8' ' ' ARG . 2.5 t -64.54 108.21 1.6 Allowed 'General case' 0 N--CA 1.426 -1.628 0 C-N-CA 114.023 -3.071 . . . . 5.66 103.079 176.096 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.779 ' HB3' ' HB3' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -69.71 114.93 8.38 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.845 -1.071 . . . . 2.68 111.347 -176.96 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.463 ' C ' ' O ' ' A' ' 10' ' ' CYS . 5.6 tp -29.05 129.9 0.22 Allowed Pre-proline 0 N--CA 1.468 0.45 0 CA-C-O 121.031 0.443 . . . . 2.48 111.948 -179.396 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.871 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 54.5 Cg_endo -70.14 152.28 67.3 Favored 'Trans proline' 0 N--CA 1.475 0.39 0 C-N-CA 123.377 2.718 . . . . 1.49 114.608 -179.128 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.623 ' SG ' ' N ' ' A' ' 14' ' ' GLY . 0.0 OUTLIER -160.97 -170.22 2.64 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 119.422 -0.911 . . . . 1.0 110.946 176.969 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.856 ' HA2' ' HB3' ' A' ' 40' ' ' GLU . . . 77.61 -159.72 48.4 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 115.47 0.948 . . . . 1.15 115.47 178.393 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.597 ' CG ' HD21 ' A' ' 32' ' ' LEU . 74.4 Cg_endo -61.37 104.16 0.29 Allowed 'Trans proline' 0 N--CA 1.487 1.127 0 C-N-CA 124.749 3.633 . . . . 1.57 111.021 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.64 -10.92 60.66 Favored Glycine 0 C--N 1.28 -2.566 0 CA-C-N 113.119 -1.855 . . . . 1.68 111.219 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.518 ' O ' ' HB2' ' A' ' 12' ' ' PRO . . . 76.49 37.36 35.85 Favored Glycine 0 N--CA 1.411 -3.005 0 C-N-CA 119.336 -1.411 . . . . 1.36 111.153 -179.627 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.539 ' HB2' HD12 ' A' ' 32' ' ' LEU . 0.5 OUTLIER -88.09 -37.47 16.21 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 112.973 -1.614 . . . . 2.5 112.29 179.196 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.871 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -89.56 -172.79 45.63 Favored Glycine 0 N--CA 1.423 -2.198 0 CA-C-N 122.055 2.207 . . . . 1.02 110.966 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.779 ' HB3' ' HB3' ' A' ' 10' ' ' CYS . 0.4 OUTLIER -113.14 172.14 7.12 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 124.395 0.703 . . . . 2.92 112.777 -179.407 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.7 m -106.85 145.55 32.01 Favored 'General case' 0 N--CA 1.475 0.809 0 O-C-N 121.826 -0.546 . . . . 1.1 110.455 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.414 ' CZ ' ' O ' ' A' ' 68' ' ' ALA . 76.3 m-85 -142.9 22.39 1.93 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.944 -0.571 . . . . 1.51 111.752 -179.335 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.811 ' O ' ' HB3' ' A' ' 44' ' ' CYS . . . 174.04 -169.45 42.48 Favored Glycine 0 C--O 1.225 -0.444 0 C-N-CA 120.724 -0.751 . . . . 0.9 111.421 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -81.3 -54.18 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.531 2.154 . . . . 1.5 112.333 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.591 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.3 OUTLIER -106.47 12.1 30.0 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.234 -0.439 . . . . 1.26 111.39 -179.963 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.786 HG22 ' SG ' ' A' ' 34' ' ' CYS . 1.2 mt -121.8 122.43 66.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 113.218 0.821 . . . . 0.83 113.218 -177.357 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.682 ' HB3' ' CD2' ' A' ' 35' ' ' PHE . 4.3 t -130.78 116.37 17.88 Favored 'General case' 0 C--O 1.226 -0.155 0 CA-C-O 122.494 1.14 . . . . 0.92 111.48 178.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 1.214 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -121.36 148.48 44.31 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 112.552 -2.113 . . . . 1.28 109.08 -179.546 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.786 ' O ' ' HB1' ' A' ' 69' ' ' ALA . . . -144.01 -167.86 12.09 Favored Glycine 0 CA--C 1.478 -2.223 0 N-CA-C 105.494 -3.042 . . . . 0.67 105.494 174.388 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.462 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 12.3 p-10 -67.18 -69.01 0.34 Allowed 'General case' 0 C--N 1.282 -2.329 0 C-N-CA 118.635 -1.226 . . . . 2.27 112.82 -179.575 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.13 15.1 19.94 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 114.722 -1.127 . . . . 1.66 111.284 -176.523 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.734 HD22 ' CZ ' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -116.48 -17.69 10.59 Favored 'General case' 0 N--CA 1.4 -2.944 0 CA-C-N 114.568 -1.196 . . . . 1.37 108.208 179.945 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 1.214 ' O ' ' HA ' ' A' ' 28' ' ' CYS . . . 63.19 -128.25 39.12 Favored Glycine 0 N--CA 1.405 -3.428 0 CA-C-N 113.963 -1.471 . . . . 0.73 114.285 178.098 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.87 ' HB2' HG13 ' A' ' 72' ' ' ILE . 4.8 t -141.51 120.09 12.47 Favored 'General case' 0 CA--C 1.5 -0.944 0 N-CA-C 115.572 1.693 . . . . 1.08 115.572 -179.667 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 1.026 ' HA ' ' HA ' ' B' ' 135' ' ' PHE . 0.0 OUTLIER -96.34 107.58 19.97 Favored 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 106.501 -1.666 . . . . 1.38 106.501 176.219 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.833 HG23 HG23 ' B' ' 136' ' ' VAL . 1.8 t -94.72 84.0 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.774 0 N-CA-C 108.008 -1.108 . . . . 0.76 108.008 179.387 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 25' ' ' SER . . . 105.27 102.61 2.8 Favored Glycine 0 CA--C 1.524 0.646 0 CA-C-N 113.451 -1.704 . . . . 0.81 114.007 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.615 ' HB ' ' O ' ' B' ' 132' ' ' LEU . 0.2 OUTLIER 178.66 161.95 0.69 Allowed 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 107.992 -1.114 . . . . 0.77 107.992 179.02 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.818 ' HA ' HD12 ' A' ' 42' ' ' LEU . . . -69.28 -28.24 66.12 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 120.595 1.543 . . . . 1.02 112.175 -179.331 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.856 ' HB3' ' HA2' ' A' ' 14' ' ' GLY . 0.5 OUTLIER -62.23 -12.81 22.34 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.154 0.502 . . . . 2.32 110.524 178.125 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.808 ' O ' ' HB2' ' A' ' 44' ' ' CYS . . . -103.49 -19.32 14.44 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.091 -0.959 . . . . 0.87 110.673 178.108 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.818 HD12 ' HA ' ' A' ' 39' ' ' ALA . 0.7 OUTLIER -46.8 -38.06 9.58 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 112.403 0.52 . . . . 1.23 112.403 -179.298 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.555 ' HD2' ' H ' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -57.82 -22.35 47.14 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-O 122.552 1.167 . . . . 2.92 108.771 177.127 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.811 ' HB3' ' O ' ' A' ' 23' ' ' GLY . 28.6 m -58.8 -10.7 2.55 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-N 112.193 -2.276 . . . . 1.57 109.81 178.401 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.444 ' HB2' ' O ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -77.22 -18.98 57.29 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-O 121.126 0.489 . . . . 3.31 111.73 178.981 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -85.83 10.39 13.91 Favored 'General case' 0 CA--C 1.515 -0.369 0 C-N-CA 119.861 -0.736 . . . . 3.69 110.457 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -81.03 2.5 26.81 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 108.865 -0.791 . . . . 3.99 108.865 177.158 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -94.64 -28.94 15.1 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 116.303 -0.408 . . . . 3.86 110.134 178.572 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -105.08 30.26 5.71 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.308 -0.405 . . . . 5.68 110.981 179.679 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -124.37 131.87 24.23 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 120.633 0.254 . . . . 5.4 111.454 -179.485 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -77.05 12.92 1.62 Allowed 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.739 2.293 . . . . 4.92 113.045 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 35.0 p -103.69 105.94 50.0 Favored Pre-proline 0 CA--C 1.531 0.22 0 CA-C-O 120.438 0.161 . . . . 5.64 110.653 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -88.16 -4.66 6.82 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.924 2.416 . . . . 5.04 112.937 -179.604 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.869 ' HA ' ' HG2' ' A' ' 8' ' ' ARG . 1.8 t 63.68 97.2 0.04 OUTLIER 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 116.602 -0.272 . . . . 2.74 111.352 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 1.068 ' HB3' HD13 ' A' ' 5' ' ' LEU . 19.1 mm100 -103.36 72.34 1.15 Allowed 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 118.706 -1.198 . . . . 5.75 111.776 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.892 ' HB2' ' HA ' ' A' ' 7' ' ' VAL . 1.3 t 173.2 79.66 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.679 -0.691 . . . . 3.12 110.406 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 162.01 44.69 0.02 OUTLIER Glycine 0 N--CA 1.442 -0.955 0 N-CA-C 108.66 -1.776 . . . . 2.1 108.66 -179.556 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.421 ' O ' ' HG3' ' A' ' 58' ' ' GLN . 15.6 pt20 -118.96 86.05 2.48 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-O 122.489 1.137 . . . . 4.36 108.91 -179.255 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.524 ' HB3' ' HB2' ' A' ' 67' ' ' CYS . 0.0 OUTLIER -137.24 69.09 55.75 Favored Pre-proline 0 C--N 1.294 -1.817 0 N-CA-C 104.419 -2.437 . . . . 3.55 104.419 -178.869 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.435 ' HA ' ' O ' ' A' ' 65' ' ' GLY . 55.7 Cg_endo -71.71 91.56 0.7 Allowed 'Trans proline' 0 N--CA 1.446 -1.296 0 C-N-CA 122.858 2.372 . . . . 1.54 115.055 -176.354 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 3.2 p -104.43 -172.32 2.08 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 113.2 -1.818 . . . . 1.59 107.03 176.681 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 52.21 -166.07 1.14 Allowed Glycine 0 C--N 1.329 0.148 0 C-N-CA 118.52 -1.8 . . . . 2.43 112.258 177.208 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 8.0 t -73.23 66.51 0.89 Allowed 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 120.33 -0.548 . . . . 4.11 110.967 -179.239 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 84.18 8.47 83.68 Favored Glycine 0 N--CA 1.436 -1.309 0 CA-C-O 117.752 -1.582 . . . . 2.21 116.592 178.525 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 1.039 ' HA3' ' HA ' ' A' ' 74' ' ' CYS . . . -100.29 137.33 13.2 Favored Glycine 0 N--CA 1.438 -1.192 0 CA-C-N 122.553 3.177 . . . . 1.62 114.058 -177.857 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.468 ' O ' ' N ' ' A' ' 74' ' ' CYS . 0.0 OUTLIER -99.66 153.03 19.4 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 114.046 -1.077 . . . . 3.02 112.515 -178.4 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.682 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 44.4 t -51.75 108.62 0.29 Allowed 'General case' 0 N--CA 1.428 -1.56 0 CA-C-N 115.764 -0.653 . . . . 1.52 110.918 -179.529 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.414 ' O ' ' CZ ' ' A' ' 22' ' ' PHE . . . -99.55 -33.51 10.62 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.929 -0.767 . . . . 1.07 108.929 178.682 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.786 ' HB1' ' O ' ' A' ' 29' ' ' GLY . . . -159.93 165.32 32.35 Favored 'General case' 0 CA--C 1.495 -1.158 0 C-N-CA 119.428 -0.909 . . . . 1.0 112.432 -178.155 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.798 ' HA ' ' O ' ' A' ' 85' ' ' CYS . . . -37.29 97.4 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.1 -0.955 . . . . 1.24 110.444 -178.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.633 ' HA2' ' O ' ' A' ' 82' ' ' ASP . . . 93.56 -12.58 69.28 Favored Glycine 0 N--CA 1.437 -1.264 0 CA-C-N 114.81 -1.086 . . . . 1.28 114.43 179.293 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.87 HG13 ' HB2' ' A' ' 34' ' ' CYS . 1.7 mm -93.56 124.72 46.1 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.04 0 CA-C-N 119.391 1.596 . . . . 2.27 110.8 -175.865 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.615 ' HB2' ' HB3' ' A' ' 82' ' ' ASP . 20.6 t -120.79 92.45 3.77 Favored 'General case' 0 N--CA 1.426 -1.658 0 CA-C-N 113.89 -1.504 . . . . 1.98 109.274 -179.313 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 1.044 ' CB ' ' HA ' ' A' ' 79' ' ' CYS . 6.0 p -159.9 -175.89 5.38 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 116.105 1.891 . . . . 1.33 116.105 -177.001 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.852 ' HB2' ' HD2' ' A' ' 76' ' ' PRO . 5.8 p -122.61 -179.9 0.88 Allowed Pre-proline 0 N--CA 1.454 -0.253 0 CA-C-N 113.098 -1.865 . . . . 1.99 108.926 -179.668 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.852 ' HD2' ' HB2' ' A' ' 75' ' ' SER . 56.2 Cg_endo -72.45 31.38 0.28 Allowed 'Trans proline' 0 CA--C 1.534 0.523 0 C-N-CA 121.671 1.581 . . . . 1.86 113.292 -179.219 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.445 ' OD1' ' N ' ' A' ' 78' ' ' GLY . 1.1 p30 -134.49 -59.97 0.8 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 120.714 0.292 . . . . 2.65 110.397 178.816 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.932 ' O ' ' HB2' ' A' ' 74' ' ' CYS . . . -124.61 -175.15 14.22 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.507 -0.854 . . . . 0.99 111.74 178.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 1.044 ' HA ' ' CB ' ' A' ' 74' ' ' CYS . 14.1 m -149.44 160.34 43.53 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 117.535 0.668 . . . . 1.34 111.929 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.429 ' HA ' ' HA2' ' B' ' 178' ' ' GLY . 72.5 m80 -149.51 139.8 22.28 Favored 'General case' 0 C--N 1.349 0.585 0 O-C-N 121.714 -0.616 . . . . 2.17 111.879 -178.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -64.72 126.02 26.62 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.921 -0.582 . . . . 3.05 109.725 178.41 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.633 ' O ' ' HA2' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -139.94 107.51 6.91 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-O 120.864 0.364 . . . . 2.02 111.226 -179.213 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_exo -62.78 -24.09 74.52 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.04 2.493 . . . . 1.93 114.333 -178.67 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.36 -10.82 27.01 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.979 0.363 . . . . 1.53 111.979 -179.475 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.798 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 3.8 m -128.18 9.25 6.18 Favored 'General case' 0 C--O 1.215 -0.738 0 CA-C-O 119.053 -0.499 . . . . 1.88 111.321 179.585 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.597 ' O ' ' HB1' ' A' ' 70' ' ' ALA . 0.5 OUTLIER -72.35 -58.05 3.27 Favored Pre-proline 0 C--N 1.322 -0.595 0 C-N-CA 119.113 -1.035 . . . . 3.6 112.692 -176.512 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.506 ' HD3' ' CB ' ' A' ' 86' ' ' ASP . 44.6 Cg_endo -114.69 -171.53 0.02 OUTLIER 'Trans proline' 0 N--CA 1.436 -1.876 0 C-N-CA 123.196 2.597 . . . . 2.56 113.487 -176.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.474 ' C ' ' H ' ' A' ' 90' ' ' ALA . 5.9 pt-20 -69.79 75.15 0.44 Allowed 'General case' 0 N--CA 1.426 -1.63 0 CA-C-N 112.783 -2.008 . . . . 4.72 108.824 177.246 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -76.03 48.57 0.5 Allowed 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 104.546 -2.391 . . . . 5.29 104.546 174.017 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.474 ' H ' ' C ' ' A' ' 88' ' ' GLU . . . -64.84 134.33 53.83 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 115.138 1.533 . . . . 6.98 115.138 -172.655 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -89.73 96.25 10.61 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.532 -0.467 . . . . 10.21 110.962 178.65 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.2 t . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.241 -0.885 . . . . 11.77 110.918 179.782 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 120.783 0.325 . . . . 10.07 111.137 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 102' ' ' VAL . . . . . 0.507 ' O ' HG13 ' B' ' 102' ' ' VAL . 13.8 p -102.24 88.04 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.311 0 CA-C-O 123.204 1.478 . . . . 8.41 114.531 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 103' ' ' LEU . . . . . 0.846 ' H ' HD22 ' B' ' 103' ' ' LEU . 0.0 OUTLIER -100.55 83.41 2.6 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 111.21 -2.723 . . . . 5.87 112.418 175.371 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 104' ' ' ASP . . . . . 0.602 ' O ' ' HB2' ' B' ' 155' ' ' GLN . 2.9 m-20 -139.61 -178.3 5.34 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 105.911 -1.885 . . . . 6.27 105.911 173.638 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 105' ' ' LEU . . . . . 1.082 HD13 ' HB3' ' B' ' 155' ' ' GLN . 0.1 OUTLIER -80.37 12.21 3.12 Favored 'General case' 0 CA--C 1.504 -0.805 0 CA-C-O 121.754 0.788 . . . . 7.2 111.42 -179.694 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 106' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.0 -91.42 0.04 OUTLIER 'General case' 0 CA--C 1.492 -1.279 0 N-CA-C 101.029 -3.693 . . . . 8.55 101.029 175.485 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 107' ' ' VAL . . . . . 0.93 ' HA ' ' HB2' ' B' ' 156' ' ' SER . 2.3 p -147.11 116.19 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.468 -2.176 0 N-CA-C 104.736 -2.32 . . . . 7.48 104.736 173.415 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 108' ' ' ARG . . . . . 0.858 ' HG2' ' HA ' ' B' ' 154' ' ' CYS . 9.9 tpt180 -77.05 116.5 17.76 Favored 'General case' 0 CA--C 1.464 -2.33 0 C-N-CA 119.232 -0.987 . . . . 9.12 108.852 -177.363 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 109' ' ' THR . . . . . 0.531 ' O ' ' HD2' ' B' ' 108' ' ' ARG . 2.8 t -64.4 108.52 1.65 Allowed 'General case' 0 N--CA 1.423 -1.782 0 C-N-CA 114.097 -3.041 . . . . 5.69 103.145 175.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 110' ' ' CYS . . . . . 0.737 ' HB3' ' HB3' ' B' ' 120' ' ' ARG . 0.0 OUTLIER -69.28 111.71 5.38 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 114.479 -1.237 . . . . 2.61 111.883 -177.243 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 111' ' ' LEU . . . . . 0.481 ' C ' ' O ' ' B' ' 110' ' ' CYS . 5.4 tp -26.74 129.49 0.18 Allowed Pre-proline 0 CA--C 1.54 0.558 0 N-CA-C 112.209 0.448 . . . . 2.47 112.209 -179.333 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 112' ' ' PRO . . . . . 0.873 ' HA ' ' O ' ' B' ' 119' ' ' GLY . 30.3 Cg_endo -61.43 158.47 35.96 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 124.672 3.581 . . . . 1.47 112.974 179.579 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.623 ' SG ' ' N ' ' B' ' 114' ' ' GLY . 0.0 OUTLIER -168.83 -171.55 1.39 Allowed 'General case' 0 N--CA 1.497 1.907 0 C-N-CA 118.977 -1.089 . . . . 1.0 111.272 170.939 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 114' ' ' GLY . . . . . 0.885 ' HA2' ' HB3' ' B' ' 140' ' ' GLU . . . 77.35 -159.34 48.55 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 120.289 -0.958 . . . . 1.16 115.249 178.201 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 115' ' ' PRO . . . . . 0.627 ' CG ' HD21 ' B' ' 132' ' ' LEU . 96.4 Cg_endo -62.36 96.15 0.15 Allowed 'Trans proline' 0 C--N 1.355 0.885 0 C-N-CA 124.238 3.292 . . . . 1.57 115.398 -178.658 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 85.76 -0.83 88.1 Favored Glycine 0 C--N 1.285 -2.296 0 CA-C-N 110.573 -3.012 . . . . 1.7 112.197 -177.029 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 117' ' ' GLY . . . . . 0.519 ' O ' ' HB2' ' B' ' 112' ' ' PRO . . . 73.69 35.9 54.35 Favored Glycine 0 N--CA 1.425 -2.035 0 C-N-CA 120.171 -1.014 . . . . 1.38 112.858 176.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 118' ' ' LYS . . . . . 0.548 ' HB2' HD12 ' B' ' 132' ' ' LEU . 0.6 OUTLIER -87.55 -33.77 18.81 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 114.207 -0.997 . . . . 2.54 112.052 -179.629 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 119' ' ' GLY . . . . . 0.873 ' O ' ' HA ' ' B' ' 112' ' ' PRO . . . -79.67 -164.58 29.21 Favored Glycine 0 CA--C 1.497 -1.063 0 CA-C-O 118.631 -1.094 . . . . 1.04 111.521 -179.494 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.737 ' HB3' ' HB3' ' B' ' 110' ' ' CYS . 2.3 mtt85 -133.09 172.91 12.01 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 119.736 1.768 . . . . 2.89 106.961 176.438 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 121' ' ' CYS . . . . . . . . . . . . . 2.6 m -106.16 146.77 29.83 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 118.548 0.613 . . . . 1.07 111.532 -178.62 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 122' ' ' PHE . . . . . 0.507 ' HE1' ' O ' ' B' ' 128' ' ' CYS . 75.9 m-85 -142.91 22.14 1.94 Allowed 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.687 -0.688 . . . . 1.53 111.778 -179.533 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 123' ' ' GLY . . . . . 0.851 ' O ' ' HB3' ' B' ' 144' ' ' CYS . . . 174.05 -169.53 42.57 Favored Glycine 0 C--O 1.225 -0.465 0 C-N-CA 120.783 -0.723 . . . . 0.9 111.468 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -81.1 -54.33 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.494 2.129 . . . . 1.51 112.272 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 125' ' ' SER . . . . . 0.605 ' O ' ' N ' ' B' ' 137' ' ' GLY . 0.3 OUTLIER -106.39 12.25 29.97 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.264 -0.425 . . . . 1.25 111.39 -179.878 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 126' ' ' ILE . . . . . 0.814 HG22 ' SG ' ' B' ' 134' ' ' CYS . 1.5 mt -121.73 122.38 66.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 113.088 0.773 . . . . 0.85 113.088 -177.289 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 127' ' ' CYS . . . . . 0.687 ' HB3' ' CD2' ' B' ' 135' ' ' PHE . 4.5 t -131.06 117.66 19.45 Favored 'General case' 0 CA--C 1.522 -0.107 0 CA-C-O 122.542 1.163 . . . . 0.89 111.585 178.86 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 128' ' ' CYS . . . . . 1.104 ' HA ' ' O ' ' B' ' 133' ' ' GLY . 0.0 OUTLIER -130.62 135.93 48.36 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 112.96 -1.927 . . . . 1.23 112.415 -178.559 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 129' ' ' GLY . . . . . 0.798 ' O ' ' HB1' ' B' ' 169' ' ' ALA . . . -130.41 -161.6 10.44 Favored Glycine 0 N--CA 1.42 -2.413 0 N-CA-C 105.119 -3.193 . . . . 0.66 105.119 177.383 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 130' ' ' ASP . . . . . 0.437 ' O ' ' HB3' ' B' ' 170' ' ' ALA . 14.5 p-10 -68.71 -70.99 0.23 Allowed 'General case' 0 C--N 1.289 -2.06 0 C-N-CA 119.199 -1.001 . . . . 2.35 112.69 -178.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.94 32.53 3.15 Favored 'General case' 0 CA--C 1.49 -1.346 0 CA-C-O 122.085 0.945 . . . . 1.69 110.1 -177.232 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 132' ' ' LEU . . . . . 0.739 HD22 ' CZ ' ' B' ' 135' ' ' PHE . 0.8 OUTLIER -127.45 -16.9 4.77 Favored 'General case' 0 N--CA 1.399 -3.01 0 CA-C-N 113.788 -1.551 . . . . 1.38 106.869 177.075 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 133' ' ' GLY . . . . . 1.104 ' O ' ' HA ' ' B' ' 128' ' ' CYS . . . 58.93 -134.55 52.43 Favored Glycine 0 N--CA 1.402 -3.587 0 CA-C-N 114.372 -1.285 . . . . 0.72 112.529 177.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 134' ' ' CYS . . . . . 0.845 ' HB2' HG13 ' B' ' 172' ' ' ILE . 5.2 t -135.25 119.79 18.11 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 116.15 1.907 . . . . 1.08 116.15 -176.631 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 135' ' ' PHE . . . . . 1.026 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -94.74 107.58 19.59 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 106.524 -1.658 . . . . 1.36 106.524 176.385 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 136' ' ' VAL . . . . . 0.833 HG23 HG23 ' A' ' 36' ' ' VAL . 2.4 t -94.3 83.56 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.642 0 N-CA-C 107.814 -1.18 . . . . 0.75 107.814 179.595 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 137' ' ' GLY . . . . . 0.605 ' N ' ' O ' ' B' ' 125' ' ' SER . . . 105.5 102.9 2.83 Favored Glycine 0 CA--C 1.523 0.59 0 CA-C-N 113.637 -1.62 . . . . 0.83 113.944 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 138' ' ' THR . . . . . 0.567 ' HB ' ' O ' ' A' ' 32' ' ' LEU . 0.2 OUTLIER -179.96 165.7 1.24 Allowed 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 107.905 -1.146 . . . . 0.78 107.905 179.131 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 139' ' ' ALA . . . . . 0.856 ' HA ' HD12 ' B' ' 142' ' ' LEU . . . -68.98 -36.97 78.47 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 119.075 0.852 . . . . 1.04 110.225 179.349 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 140' ' ' GLU . . . . . 0.885 ' HB3' ' HA2' ' B' ' 114' ' ' GLY . 0.5 OUTLIER -56.87 -13.7 2.85 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.009 -0.541 . . . . 2.31 111.064 179.83 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 141' ' ' ALA . . . . . 0.723 ' O ' ' HB2' ' B' ' 144' ' ' CYS . . . -101.72 -21.81 14.55 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 116.236 -0.438 . . . . 0.87 109.942 178.351 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 142' ' ' LEU . . . . . 0.856 HD12 ' HA ' ' B' ' 139' ' ' ALA . 0.6 OUTLIER -45.04 -38.06 4.61 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.626 0.602 . . . . 1.24 112.626 -178.483 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 143' ' ' ARG . . . . . 0.578 ' HD2' ' H ' ' B' ' 143' ' ' ARG . 0.0 OUTLIER -54.13 -29.46 45.28 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 107.136 -1.431 . . . . 2.93 107.136 177.148 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 144' ' ' CYS . . . . . 0.851 ' HB3' ' O ' ' B' ' 123' ' ' GLY . 39.8 m -57.15 -4.77 0.21 Allowed 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 113.776 -1.556 . . . . 1.61 110.441 -177.86 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 145' ' ' GLN . . . . . 0.43 ' HB2' ' O ' ' B' ' 142' ' ' LEU . 0.0 OUTLIER -79.32 -19.31 50.66 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-O 121.255 0.55 . . . . 3.35 111.208 177.584 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -85.81 10.11 14.66 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 119.998 -0.681 . . . . 3.76 110.436 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -81.01 2.75 25.65 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 108.852 -0.795 . . . . 4.01 108.852 177.244 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 148' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -94.83 -28.83 15.04 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 116.354 -0.384 . . . . 3.92 110.098 178.604 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -105.09 30.21 5.76 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.379 -0.373 . . . . 5.73 111.052 179.609 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -124.3 131.78 24.23 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.623 -0.262 . . . . 5.46 111.47 -179.469 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 151' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.01 13.04 1.58 Allowed 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.72 2.28 . . . . 5.02 113.094 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 35.6 p -103.77 105.87 49.9 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-O 120.531 0.205 . . . . 5.73 110.655 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 153' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -88.18 -4.51 6.82 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.924 2.416 . . . . 5.1 112.963 -179.593 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 154' ' ' CYS . . . . . 0.858 ' HA ' ' HG2' ' B' ' 108' ' ' ARG . 1.8 t 63.33 96.32 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.758 -0.201 . . . . 2.68 111.454 179.768 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 155' ' ' GLN . . . . . 1.082 ' HB3' HD13 ' B' ' 105' ' ' LEU . 19.0 mm100 -102.23 71.37 1.24 Allowed 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 119.286 -0.966 . . . . 5.63 111.952 -179.604 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 156' ' ' SER . . . . . 0.93 ' HB2' ' HA ' ' B' ' 107' ' ' VAL . 1.3 t 174.05 76.57 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.773 -0.649 . . . . 3.11 111.205 179.61 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 165.12 44.52 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 109.085 -1.606 . . . . 2.07 109.085 -179.001 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -118.74 71.9 0.86 Allowed 'General case' 0 N--CA 1.441 -0.919 0 CA-C-O 122.398 1.094 . . . . 4.34 110.724 -179.525 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 159' ' ' LYS . . . . . 0.579 ' HB3' ' HB2' ' B' ' 167' ' ' CYS . 0.0 OUTLIER -107.81 66.12 0.26 Allowed Pre-proline 0 C--N 1.31 -1.123 0 CA-C-N 113.202 -1.817 . . . . 3.54 108.486 174.33 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 160' ' ' PRO . . . . . 0.404 ' HA ' ' O ' ' B' ' 165' ' ' GLY . 54.0 Cg_endo -71.4 92.26 0.67 Allowed 'Trans proline' 0 N--CA 1.464 -0.25 0 N-CA-C 116.17 1.565 . . . . 1.51 116.17 -174.077 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 161' ' ' CYS . . . . . . . . . . . . . 1.9 p -99.34 -166.91 1.4 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 113.173 -1.831 . . . . 1.58 108.32 176.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 45.35 -165.03 0.06 OUTLIER Glycine 0 CA--C 1.52 0.356 0 C-N-CA 119.135 -1.507 . . . . 2.37 112.181 173.111 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 8.1 t -73.11 66.89 0.87 Allowed 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 117.364 0.582 . . . . 4.07 111.496 -179.429 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 84.46 9.12 82.22 Favored Glycine 0 CA--C 1.541 1.67 0 CA-C-O 117.94 -1.478 . . . . 2.2 116.132 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 165' ' ' GLY . . . . . 0.943 ' HA3' ' HA ' ' B' ' 174' ' ' CYS . . . -96.98 131.25 10.54 Favored Glycine 0 C--N 1.301 -1.383 0 C-N-CA 117.177 -2.439 . . . . 1.62 114.151 -176.238 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 166' ' ' ARG . . . . . 0.428 ' HA ' ' O ' ' B' ' 159' ' ' LYS . 0.0 OUTLIER -100.03 152.41 20.24 Favored 'General case' 0 C--N 1.349 0.551 0 N-CA-C 112.186 0.439 . . . . 3.05 112.186 -179.151 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 167' ' ' CYS . . . . . 0.691 ' HA ' ' O ' ' B' ' 172' ' ' ILE . 46.7 t -51.84 108.77 0.3 Allowed 'General case' 0 N--CA 1.431 -1.425 0 CA-C-N 115.905 -0.589 . . . . 1.56 111.05 -179.282 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 168' ' ' ALA . . . . . 0.401 ' O ' ' CZ ' ' B' ' 122' ' ' PHE . . . -101.33 -30.16 11.64 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.771 -0.649 . . . . 1.04 109.528 178.865 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 169' ' ' ALA . . . . . 0.812 ' HB2' ' HB2' ' B' ' 128' ' ' CYS . . . -162.31 165.1 27.05 Favored 'General case' 0 CA--C 1.492 -1.258 0 C-N-CA 119.488 -0.885 . . . . 0.98 112.42 -179.271 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 170' ' ' ALA . . . . . 0.788 ' HA ' ' O ' ' B' ' 185' ' ' CYS . . . -36.52 95.98 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.047 -0.979 . . . . 1.25 110.851 -179.106 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 171' ' ' GLY . . . . . 0.692 ' HA2' ' O ' ' B' ' 182' ' ' ASP . . . 88.52 -1.82 84.3 Favored Glycine 0 CA--C 1.525 0.677 0 CA-C-N 114.923 -1.035 . . . . 1.29 115.11 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 172' ' ' ILE . . . . . 0.845 HG13 ' HB2' ' B' ' 134' ' ' CYS . 1.8 mm -96.65 122.24 47.96 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.093 0 CA-C-N 117.865 0.832 . . . . 2.27 110.535 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 173' ' ' CYS . . . . . 0.631 ' HB2' ' HB3' ' B' ' 182' ' ' ASP . 21.6 t -120.89 92.21 3.71 Favored 'General case' 0 N--CA 1.428 -1.561 0 CA-C-N 114.561 -1.2 . . . . 1.94 109.399 -179.568 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 174' ' ' CYS . . . . . 1.031 ' CB ' ' HA ' ' B' ' 179' ' ' CYS . 5.9 p -160.08 -175.76 5.27 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 116.033 1.864 . . . . 1.35 116.033 -176.833 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 175' ' ' SER . . . . . 0.851 ' HB2' ' HD2' ' B' ' 176' ' ' PRO . 6.0 p -122.68 -179.89 0.88 Allowed Pre-proline 0 N--CA 1.454 -0.25 0 CA-C-N 113.087 -1.869 . . . . 2.0 108.931 -179.569 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 176' ' ' PRO . . . . . 0.851 ' HD2' ' HB2' ' B' ' 175' ' ' SER . 55.9 Cg_endo -72.38 31.31 0.27 Allowed 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 121.699 1.599 . . . . 1.9 113.292 -179.138 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 177' ' ' ASP . . . . . 0.437 ' OD1' ' N ' ' B' ' 178' ' ' GLY . 1.1 p30 -134.58 -60.02 0.8 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.643 -0.253 . . . . 2.72 110.371 178.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 178' ' ' GLY . . . . . 0.916 ' O ' ' HB2' ' B' ' 174' ' ' CYS . . . -124.51 -175.12 14.22 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.503 -0.856 . . . . 0.99 111.683 178.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 179' ' ' CYS . . . . . 1.031 ' HA ' ' CB ' ' B' ' 174' ' ' CYS . 14.0 m -149.41 160.44 43.43 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 117.526 0.663 . . . . 1.34 111.958 179.583 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 180' ' ' HIS . . . . . 0.48 ' HA ' ' HA2' ' A' ' 78' ' ' GLY . 72.5 m80 -149.56 139.77 22.2 Favored 'General case' 0 C--N 1.35 0.612 0 C-N-CA 120.232 -0.587 . . . . 2.1 111.819 -178.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 181' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -64.78 125.89 26.22 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.968 -0.56 . . . . 3.06 109.693 178.476 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 182' ' ' ASP . . . . . 0.692 ' O ' ' HA2' ' B' ' 171' ' ' GLY . 0.0 OUTLIER -139.74 107.59 7.03 Favored Pre-proline 0 CA--C 1.541 0.634 0 CA-C-O 120.85 0.357 . . . . 2.06 111.236 -179.267 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 183' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_exo -62.79 -24.19 74.51 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 123.061 2.507 . . . . 1.91 114.384 -178.626 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -64.29 -10.52 24.45 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.102 0.408 . . . . 1.56 112.102 -179.449 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 185' ' ' CYS . . . . . 0.788 ' O ' ' HA ' ' B' ' 170' ' ' ALA . 1.6 m -129.1 10.03 5.8 Favored 'General case' 0 C--O 1.214 -0.784 0 CA-C-O 119.243 -0.408 . . . . 1.94 111.078 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 186' ' ' ASP . . . . . 0.549 ' O ' ' HB1' ' B' ' 170' ' ' ALA . 0.5 OUTLIER -73.48 -57.74 2.57 Favored Pre-proline 0 CA--C 1.511 -0.534 0 C-N-CA 119.186 -1.006 . . . . 3.61 112.511 -176.588 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 187' ' ' PRO . . . . . 0.498 ' HD3' ' CB ' ' B' ' 186' ' ' ASP . 95.9 Cg_endo -108.38 -166.63 0.03 OUTLIER 'Trans proline' 0 N--CA 1.428 -2.341 0 C-N-CA 122.967 2.445 . . . . 2.58 113.824 -177.033 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 188' ' ' GLU . . . . . 0.496 ' C ' ' H ' ' B' ' 190' ' ' ALA . 6.1 pt-20 -74.77 72.38 2.02 Favored 'General case' 0 N--CA 1.414 -2.266 0 CA-C-N 111.359 -2.655 . . . . 4.7 109.255 173.187 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 189' ' ' ALA . . . . . . . . . . . . . . . -75.31 47.71 0.39 Allowed 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 107.279 -1.378 . . . . 5.24 107.279 175.543 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 190' ' ' ALA . . . . . 0.496 ' H ' ' C ' ' B' ' 188' ' ' GLU . . . -58.47 134.78 56.97 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 113.096 -1.866 . . . . 6.93 113.94 -172.051 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 191' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -89.93 96.45 10.68 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 120.707 -0.397 . . . . 10.14 110.707 178.502 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 1.2 t . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.252 -0.88 . . . . 11.7 111.01 179.798 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.709 ' O ' HG13 ' A' ' 2' ' ' VAL . . . . . . . . 0 N--CA 1.496 1.855 0 N-CA-C 112.236 0.458 . . . . 9.95 112.236 . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.709 HG13 ' O ' ' A' ' 1' ' ' ALA . 0.0 OUTLIER -172.97 171.75 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-O 121.606 0.717 . . . . 8.02 110.521 179.358 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 1.043 ' HG ' ' HG3' ' A' ' 8' ' ' ARG . 3.6 mm? -79.65 144.85 33.38 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 114.962 -1.017 . . . . 5.86 110.225 179.127 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.6 69.42 1.22 Allowed 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 105.269 -2.123 . . . . 6.22 105.269 175.906 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.922 HD12 ' HA ' ' A' ' 54' ' ' CYS . 0.8 OUTLIER -155.93 -146.98 0.19 Allowed 'General case' 0 N--CA 1.389 -3.5 0 CA-C-N 109.941 -3.3 . . . . 7.09 104.873 177.478 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.495 ' H ' ' CD2' ' A' ' 5' ' ' LEU . 6.3 t70 -153.23 -8.76 0.17 Allowed 'General case' 0 CA--C 1.587 2.388 0 CA-C-O 123.179 1.466 . . . . 8.78 112.61 178.954 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.746 ' O ' HD13 ' A' ' 5' ' ' LEU . 8.1 m -154.66 126.3 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.402 -2.866 0 C-N-CA 130.603 3.561 . . . . 7.51 103.833 173.634 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 1.043 ' HG3' ' HG ' ' A' ' 3' ' ' LEU . 0.7 OUTLIER -76.1 109.21 9.57 Favored 'General case' 0 N--CA 1.391 -3.417 0 N-CA-C 105.928 -1.878 . . . . 9.08 105.928 179.121 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.877 ' OG1' HD21 ' A' ' 50' ' ' LEU . 0.7 OUTLIER -106.9 98.06 7.77 Favored 'General case' 0 N--CA 1.392 -3.362 0 N-CA-C 101.882 -3.377 . . . . 5.66 101.882 171.491 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 62.7 m -79.79 60.97 3.59 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 114.278 -1.328 . . . . 2.68 112.719 -179.721 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.888 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 4.2 mp -31.22 135.31 0.23 Allowed Pre-proline 0 N--CA 1.483 1.192 0 N-CA-C 113.598 0.962 . . . . 2.48 113.598 -178.679 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.402 ' HG2' ' CG ' ' A' ' 43' ' ' ARG . 30.8 Cg_endo -97.47 114.72 0.11 Allowed 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 123.439 2.759 . . . . 1.49 116.251 -178.632 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.528 ' O ' ' HA2' ' A' ' 17' ' ' GLY . 0.5 OUTLIER -127.59 -176.32 3.72 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-O 121.823 0.82 . . . . 1.0 111.46 -178.463 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.404 ' CA ' ' HB2' ' A' ' 40' ' ' GLU . . . 74.17 -178.26 44.32 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 114.524 -1.217 . . . . 1.15 110.438 -178.37 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.473 ' HG2' ' O ' ' A' ' 15' ' ' PRO . 47.3 Cg_endo -63.28 130.92 30.16 Favored 'Trans proline' 0 CA--C 1.507 -0.851 0 N-CA-C 106.317 -2.224 . . . . 1.57 106.317 175.464 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 72.34 -4.16 20.49 Favored Glycine 0 N--CA 1.414 -2.832 0 CA-C-O 119.247 -0.752 . . . . 1.68 113.459 177.07 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.528 ' HA2' ' O ' ' A' ' 13' ' ' CYS . . . 76.53 38.44 32.74 Favored Glycine 1 N--CA 1.391 -4.347 0 C-N-CA 119.121 -1.514 . . . . 1.36 112.189 -178.747 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.42 ' CG ' ' O ' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -97.72 22.0 9.67 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.317 -0.442 . . . . 2.5 110.261 174.439 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -129.58 -175.46 14.05 Favored Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 104.912 -3.275 . . . . 1.02 104.912 177.846 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.724 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 2.7 mtp180 -119.3 159.73 23.58 Favored 'General case' 0 CA--C 1.552 1.045 0 CA-C-N 121.323 2.562 . . . . 2.92 108.444 176.708 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.888 ' HB2' ' HB3' ' A' ' 11' ' ' LEU . 10.7 m -109.09 148.9 30.11 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 119.881 1.219 . . . . 1.1 111.435 -179.742 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -128.38 -52.4 1.28 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.085 -0.507 . . . . 1.51 111.36 179.989 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.431 ' O ' ' HB3' ' A' ' 44' ' ' CYS . . . -119.84 -171.3 14.65 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.935 -0.65 . . . . 0.9 112.26 -179.816 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -68.79 -61.21 0.07 OUTLIER 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.635 2.223 . . . . 1.5 112.755 -179.693 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.609 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.4 OUTLIER -98.15 26.87 4.97 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.822 -0.172 . . . . 1.26 110.749 -179.999 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 1.033 HG12 HG13 ' A' ' 36' ' ' VAL . 3.3 mt -141.37 120.58 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 N-CA-C 113.542 0.941 . . . . 0.83 113.542 -178.307 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.789 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -120.43 140.25 51.65 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 107.653 -1.239 . . . . 0.92 107.653 178.188 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 1.016 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -143.96 100.1 3.51 Favored 'General case' 0 CA--C 1.552 1.05 0 N-CA-C 117.686 2.476 . . . . 1.28 117.686 -174.907 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -101.48 -172.48 28.25 Favored Glycine 0 N--CA 1.431 -1.687 0 N-CA-C 108.423 -1.871 . . . . 0.67 108.423 176.49 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -64.98 -62.75 1.37 Allowed 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 121.338 0.59 . . . . 2.27 112.268 -179.255 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.1 14.69 28.82 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 122.196 0.998 . . . . 1.66 111.365 -177.931 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.735 HD22 ' CE2' ' A' ' 35' ' ' PHE . 4.6 mt -115.88 -5.03 12.04 Favored 'General case' 0 N--CA 1.387 -3.593 0 N-CA-C 104.895 -2.261 . . . . 1.37 104.895 179.063 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 1.016 ' O ' ' HA ' ' A' ' 28' ' ' CYS . . . 43.7 -126.73 5.77 Favored Glycine 0 N--CA 1.432 -1.609 0 CA-C-N 114.243 -1.344 . . . . 0.73 113.918 175.941 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 1.023 ' HB2' HD13 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -132.52 107.95 8.79 Favored 'General case' 0 CA--C 1.49 -1.329 0 CA-C-N 118.008 0.904 . . . . 1.08 113.362 -179.365 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.922 ' HD1' ' HD1' ' B' ' 135' ' ' PHE . 84.7 m-85 -83.06 105.98 14.49 Favored 'General case' 0 N--CA 1.42 -1.93 0 N-CA-C 102.32 -3.215 . . . . 1.38 102.32 174.686 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 1.033 HG13 HG12 ' A' ' 26' ' ' ILE . 3.0 t -97.77 85.27 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.664 0 CA-C-O 123.036 1.398 . . . . 0.76 109.374 -176.992 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.609 ' N ' ' O ' ' A' ' 25' ' ' SER . . . 97.68 89.4 1.9 Allowed Glycine 0 CA--C 1.527 0.842 0 CA-C-N 112.492 -2.14 . . . . 0.81 115.45 178.621 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.684 HG21 ' CE1' ' B' ' 135' ' ' PHE . 0.5 OUTLIER -176.62 168.17 2.64 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 108.603 -0.888 . . . . 0.77 108.603 177.964 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.837 ' HA ' HD12 ' A' ' 42' ' ' LEU . . . -53.54 -26.79 22.65 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 115.781 1.771 . . . . 1.02 115.781 -176.648 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.646 ' OE1' HG23 ' A' ' 38' ' ' THR . 0.0 OUTLIER -66.33 -15.91 63.63 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 119.226 -0.99 . . . . 2.32 109.634 178.545 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.634 ' O ' ' N ' ' A' ' 44' ' ' CYS . . . -88.42 -24.05 23.15 Favored 'General case' 0 N--CA 1.425 -1.693 0 CA-C-O 119.283 -0.389 . . . . 0.87 111.026 -178.979 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.837 HD12 ' HA ' ' A' ' 39' ' ' ALA . 0.4 OUTLIER -44.5 -40.0 5.27 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 119.229 0.922 . . . . 1.23 112.197 179.873 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.412 ' HD3' ' HA ' ' A' ' 43' ' ' ARG . 10.8 tpp85 -64.48 -11.16 30.83 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.708 0.766 . . . . 2.92 109.748 177.713 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.634 ' N ' ' O ' ' A' ' 41' ' ' ALA . 88.8 m -73.61 -8.31 55.46 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 113.763 -1.562 . . . . 1.57 110.728 176.795 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -76.38 -6.73 52.92 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.071 0.397 . . . . 3.31 112.071 179.382 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.579 ' HG3' ' HE1' ' A' ' 49' ' ' TYR . 0.4 OUTLIER -86.44 3.87 42.0 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.254 -0.579 . . . . 3.69 111.114 -178.926 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.624 ' HG2' ' O ' ' A' ' 44' ' ' CYS . 12.6 pt-20 -83.79 1.81 41.14 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 109.592 -0.521 . . . . 3.99 109.592 177.203 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -71.79 -28.94 63.95 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 109.393 -0.595 . . . . 3.86 109.393 178.135 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.579 ' HE1' ' HG3' ' A' ' 46' ' ' GLU . 6.0 p90 -117.21 25.01 10.77 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.975 0.417 . . . . 5.68 110.997 179.603 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.877 HD21 ' OG1' ' A' ' 9' ' ' THR . 3.9 tt -127.05 142.59 44.16 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.906 -0.588 . . . . 5.4 111.512 -179.19 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.633 ' HD2' ' HG ' ' A' ' 50' ' ' LEU . 85.4 Cg_endo -84.8 50.82 3.02 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.71 2.273 . . . . 4.92 113.054 -179.98 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.573 ' HB2' ' O ' ' A' ' 51' ' ' PRO . 4.0 m 75.47 151.35 0.14 Allowed Pre-proline 0 N--CA 1.468 0.447 0 CA-C-N 116.231 -0.44 . . . . 5.64 111.716 179.737 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.614 ' HA ' ' O ' ' A' ' 9' ' ' THR . 43.9 Cg_endo -66.67 165.05 26.77 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.214 2.609 . . . . 5.04 113.306 -179.312 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.922 ' HA ' HD12 ' A' ' 5' ' ' LEU . 25.2 p -60.79 116.29 4.31 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.632 -0.713 . . . . 2.74 111.666 -179.631 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.479 ' CG ' HD13 ' A' ' 3' ' ' LEU . 12.8 pt20 42.43 -169.47 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 115.025 -0.989 . . . . 5.75 112.816 -179.67 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -169.77 178.88 3.9 Favored 'General case' 0 C--N 1.345 0.395 0 CA-C-O 120.757 0.313 . . . . 3.12 110.328 -179.458 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.573 ' O ' ' HB2' ' A' ' 66' ' ' ARG . . . -87.67 144.35 18.89 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 110.049 -1.22 . . . . 2.1 110.049 -176.868 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -101.62 74.83 1.54 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.859 0.838 . . . . 4.36 109.834 179.297 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.748 ' HB3' ' HB2' ' A' ' 67' ' ' CYS . 15.3 tppt? -144.28 57.33 4.8 Favored Pre-proline 0 C--N 1.308 -1.222 0 N-CA-C 106.686 -1.598 . . . . 3.55 106.686 178.072 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.45 ' CD ' ' N ' ' A' ' 59' ' ' LYS . 55.0 Cg_endo -69.1 84.79 0.54 Allowed 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 121.828 1.685 . . . . 1.54 114.343 -177.681 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.444 ' N ' ' O ' ' A' ' 65' ' ' GLY . 0.8 OUTLIER -104.41 -176.49 3.1 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 113.587 -1.642 . . . . 1.59 107.693 177.014 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 62.72 -165.95 23.54 Favored Glycine 0 CA--C 1.505 -0.592 0 C-N-CA 118.712 -1.709 . . . . 2.43 112.852 178.495 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -77.77 52.37 1.02 Allowed 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.635 -0.283 . . . . 4.11 111.49 -179.066 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 102.93 8.71 41.59 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-O 118.988 -0.895 . . . . 2.21 115.001 178.964 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.578 ' HA2' ' HA ' ' A' ' 75' ' ' SER . . . -102.84 138.8 14.14 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 118.575 -1.774 . . . . 1.62 115.38 -178.373 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.573 ' HB2' ' O ' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -102.38 154.34 19.17 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 114.285 -0.958 . . . . 3.02 110.534 179.014 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.748 ' HB2' ' HB3' ' A' ' 59' ' ' LYS . 5.5 t -56.31 109.22 0.57 Allowed 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 109.695 -0.483 . . . . 1.52 109.695 -179.108 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.576 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . . . -91.89 -17.73 24.81 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 107.898 -1.149 . . . . 1.07 107.898 178.773 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 1.06 ' HB3' HD11 ' A' ' 72' ' ' ILE . . . -165.64 156.4 13.53 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 112.946 -1.934 . . . . 1.0 109.262 179.943 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.818 ' O ' ' O ' ' A' ' 69' ' ' ALA . . . -18.11 -139.12 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 114.154 1.168 . . . . 1.24 114.154 -179.705 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.636 ' HA3' ' OD1' ' A' ' 86' ' ' ASP . . . -61.38 53.29 0.03 OUTLIER Glycine 0 N--CA 1.475 1.237 0 N-CA-C 111.387 -0.685 . . . . 1.28 111.387 -177.914 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 1.06 HD11 ' HB3' ' A' ' 69' ' ' ALA . 1.8 pp -151.94 97.96 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.257 1.49 0 CA-C-O 122.204 1.002 . . . . 2.27 109.095 168.804 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.6 ' HB3' ' HB3' ' A' ' 82' ' ' ASP . 0.9 OUTLIER -93.65 95.94 9.51 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.035 -0.984 . . . . 1.98 108.745 -178.872 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.81 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 16.5 m -92.65 162.35 14.2 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 114.512 1.301 . . . . 1.33 114.512 -176.182 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.796 ' HB2' ' HD2' ' A' ' 76' ' ' PRO . 58.6 p -125.16 179.42 1.13 Allowed Pre-proline 0 CA--C 1.531 0.224 0 CA-C-N 113.465 -1.698 . . . . 1.99 108.127 178.748 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.796 ' HD2' ' HB2' ' A' ' 75' ' ' SER . 71.9 Cg_endo -77.22 30.01 0.42 Allowed 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 121.304 1.336 . . . . 1.86 111.909 179.79 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.407 ' H ' ' C ' ' A' ' 75' ' ' SER . 1.6 t70 -145.92 -41.73 0.21 Allowed 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.652 -0.704 . . . . 2.65 110.887 179.971 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 1.247 ' HA3' ' O ' ' B' ' 179' ' ' CYS . . . -151.11 -141.63 3.38 Favored Glycine 0 C--N 1.337 0.591 0 C-N-CA 120.406 -0.902 . . . . 0.99 113.621 -179.815 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 1.214 ' O ' ' HA3' ' B' ' 178' ' ' GLY . 60.2 m -148.22 146.27 28.61 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 123.123 0.569 . . . . 1.34 110.486 -179.658 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.442 ' N ' ' O ' ' A' ' 73' ' ' CYS . 14.5 m80 -133.24 134.06 43.49 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 119.859 -0.737 . . . . 2.17 111.511 179.956 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.404 ' OE1' ' HG2' ' B' ' 124' ' ' PRO . 8.7 mt-10 -59.58 135.95 57.83 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 108.682 -0.858 . . . . 3.05 108.682 178.558 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.6 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 0.7 OUTLIER -142.96 128.97 10.36 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 116.395 -0.366 . . . . 2.02 110.998 -178.706 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 82' ' ' ASP . 15.2 Cg_exo -69.15 -31.29 23.56 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 123.212 2.608 . . . . 1.93 113.07 -179.198 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.62 -3.11 2.83 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.115 -0.493 . . . . 1.53 112.03 -179.705 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.672 ' HB3' ' C ' ' A' ' 70' ' ' ALA . 73.6 m -133.22 20.3 4.04 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 112.074 0.398 . . . . 1.88 112.074 -179.965 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.788 ' N ' ' HD3' ' A' ' 87' ' ' PRO . 16.8 m-20 -107.37 20.66 0.06 OUTLIER Pre-proline 0 N--CA 1.449 -0.509 0 N-CA-C 113.805 1.039 . . . . 3.6 113.805 179.854 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.788 ' HD3' ' N ' ' A' ' 86' ' ' ASP . 1.9 Cg_endo -77.78 65.7 8.18 Favored 'Trans proline' 0 CA--C 1.5 -1.218 0 N-CA-C 106.64 -2.1 . . . . 2.56 106.64 176.138 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.52 ' OE2' ' HB2' ' A' ' 70' ' ' ALA . 4.7 pt-20 177.25 -35.37 0.01 OUTLIER 'General case' 0 CA--C 1.473 -1.997 0 CA-C-N 113.283 -1.78 . . . . 4.72 108.842 -179.709 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.487 ' N ' ' HG3' ' A' ' 88' ' ' GLU . . . -77.36 38.43 0.23 Allowed 'General case' 0 C--N 1.354 0.769 0 CA-C-N 110.542 -3.026 . . . . 5.29 109.01 176.541 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.465 ' H ' ' C ' ' A' ' 88' ' ' GLU . . . -79.2 147.08 32.75 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 113.846 -1.525 . . . . 6.98 111.367 -179.092 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -63.05 127.66 32.27 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.422 0.63 . . . . 10.21 112.288 -175.418 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 6.2 t . . . . . 0 C--O 1.248 0.98 0 CA-C-N 114.898 -1.046 . . . . 11.77 110.554 179.863 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.465 0 N-CA-C 111.786 0.291 . . . . 10.07 111.786 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 1.2 t -163.47 153.85 2.7 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.283 0 CA-C-O 122.311 1.053 . . . . 8.41 111.265 -179.913 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 103' ' ' LEU . . . . . 0.681 ' HA ' ' HB3' ' B' ' 155' ' ' GLN . 0.7 OUTLIER -76.48 110.89 11.39 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 113.066 -1.879 . . . . 5.87 114.275 -178.241 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.59 76.02 5.1 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 122.813 1.292 . . . . 6.27 108.428 175.991 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 105' ' ' LEU . . . . . 0.924 HD12 ' O ' ' B' ' 107' ' ' VAL . 0.3 OUTLIER -156.18 -130.28 0.03 OUTLIER 'General case' 0 N--CA 1.391 -3.379 0 C-N-CA 128.181 2.592 . . . . 7.2 105.455 177.193 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 106' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -163.11 -44.35 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.052 -1.092 . . . . 8.55 108.052 -178.718 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 107' ' ' VAL . . . . . 0.924 ' O ' HD12 ' B' ' 105' ' ' LEU . 5.9 m -121.85 127.32 75.4 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.374 0 N-CA-C 102.731 -3.062 . . . . 7.48 102.731 171.439 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 108' ' ' ARG . . . . . 0.616 ' HG3' HD13 ' B' ' 103' ' ' LEU . 0.7 OUTLIER -75.07 111.64 10.5 Favored 'General case' 0 N--CA 1.391 -3.385 0 N-CA-C 106.029 -1.841 . . . . 9.12 106.029 179.148 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 109' ' ' THR . . . . . 0.792 ' HB ' HD11 ' B' ' 150' ' ' LEU . 0.7 OUTLIER -111.05 98.06 7.27 Favored 'General case' 0 N--CA 1.39 -3.449 0 N-CA-C 101.134 -3.654 . . . . 5.69 101.134 171.77 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 110' ' ' CYS . . . . . . . . . . . . . 64.4 m -81.9 66.86 7.66 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 113.599 -1.637 . . . . 2.61 111.498 -179.079 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 111' ' ' LEU . . . . . 0.865 ' HB3' ' HB2' ' B' ' 121' ' ' CYS . 4.6 mp -33.59 135.22 0.32 Allowed Pre-proline 0 N--CA 1.476 0.827 0 N-CA-C 113.576 0.954 . . . . 2.47 113.576 179.854 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 112' ' ' PRO . . . . . 0.439 ' HG2' ' CG ' ' B' ' 143' ' ' ARG . 41.7 Cg_endo -93.92 122.69 0.42 Allowed 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 123.557 2.838 . . . . 1.47 112.776 179.656 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.473 ' O ' ' HA2' ' B' ' 117' ' ' GLY . 0.4 OUTLIER -135.37 -177.35 4.62 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-O 122.398 1.094 . . . . 1.0 111.248 177.409 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 114' ' ' GLY . . . . . 0.403 ' CA ' ' HB2' ' B' ' 140' ' ' GLU . . . 73.98 -178.41 43.48 Favored Glycine 0 N--CA 1.439 -1.109 0 CA-C-N 113.589 -1.642 . . . . 1.16 110.204 -177.863 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 115' ' ' PRO . . . . . 0.493 ' HG2' ' O ' ' B' ' 115' ' ' PRO . 41.3 Cg_endo -64.97 121.36 8.83 Favored 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 122.041 1.827 . . . . 1.57 109.676 176.13 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 74.52 7.49 79.11 Favored Glycine 0 C--N 1.281 -2.487 0 CA-C-N 115.497 -0.774 . . . . 1.7 113.176 179.61 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 117' ' ' GLY . . . . . 0.473 ' HA2' ' O ' ' B' ' 113' ' ' CYS . . . 74.85 33.45 55.29 Favored Glycine 0 N--CA 1.408 -3.192 0 C-N-CA 119.628 -1.272 . . . . 1.38 114.636 177.311 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 118' ' ' LYS . . . . . 0.411 ' CG ' ' O ' ' B' ' 115' ' ' PRO . 0.0 OUTLIER -91.91 14.34 15.94 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 122.212 0.205 . . . . 2.54 110.722 178.698 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 119' ' ' GLY . . . . . 0.472 ' HA3' ' SG ' ' B' ' 113' ' ' CYS . . . -115.42 -153.8 10.4 Favored Glycine 0 C--N 1.34 0.774 0 N-CA-C 108.198 -1.961 . . . . 1.04 108.198 179.193 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.828 ' HA ' ' O ' ' B' ' 111' ' ' LEU . 2.7 ttp180 -143.08 156.75 44.88 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 123.206 3.503 . . . . 2.89 103.11 172.858 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 121' ' ' CYS . . . . . 0.865 ' HB2' ' HB3' ' B' ' 111' ' ' LEU . 15.8 m -108.74 150.15 28.01 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 120.19 1.359 . . . . 1.07 111.862 -178.036 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -128.57 -52.57 1.26 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.78 -0.645 . . . . 1.53 111.169 179.89 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 123' ' ' GLY . . . . . 0.424 ' O ' ' HB3' ' B' ' 144' ' ' CYS . . . -119.83 -171.23 14.64 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.934 -0.651 . . . . 0.9 112.353 -179.889 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 124' ' ' PRO . . . . . 0.404 ' HG2' ' OE1' ' A' ' 81' ' ' GLU . 14.2 Cg_exo -68.81 -61.25 0.07 OUTLIER 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.674 2.249 . . . . 1.51 112.809 -179.697 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 125' ' ' SER . . . . . 0.607 ' O ' ' N ' ' B' ' 137' ' ' GLY . 0.4 OUTLIER -98.05 26.81 4.96 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.785 -0.189 . . . . 1.25 110.832 179.87 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 126' ' ' ILE . . . . . 1.081 HG12 HG13 ' B' ' 136' ' ' VAL . 4.1 mt -140.93 120.62 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 113.556 0.947 . . . . 0.85 113.556 -178.209 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 127' ' ' CYS . . . . . 0.778 ' O ' ' HA ' ' B' ' 134' ' ' CYS . 0.0 OUTLIER -121.02 140.17 52.29 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 107.55 -1.278 . . . . 0.89 107.55 177.854 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 128' ' ' CYS . . . . . 1.047 ' HA ' ' O ' ' B' ' 133' ' ' GLY . 0.0 OUTLIER -143.14 106.69 4.61 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 115.671 1.73 . . . . 1.23 115.671 -175.563 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 129' ' ' GLY . . . . . . . . . . . . . . . -109.47 -168.13 20.27 Favored Glycine 0 N--CA 1.422 -2.272 0 CA-C-N 123.698 2.954 . . . . 0.66 106.751 173.983 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -62.61 -70.95 0.17 Allowed 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 117.234 0.517 . . . . 2.35 110.572 -178.952 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.28 32.54 4.73 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 122.688 1.232 . . . . 1.69 110.135 -176.323 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 132' ' ' LEU . . . . . 0.749 HD22 ' CE2' ' B' ' 135' ' ' PHE . 4.0 mt -126.48 -4.74 6.58 Favored 'General case' 0 N--CA 1.385 -3.69 0 N-CA-C 103.845 -2.65 . . . . 1.38 103.845 175.568 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 133' ' ' GLY . . . . . 1.047 ' O ' ' HA ' ' B' ' 128' ' ' CYS . . . 43.95 -123.62 4.79 Favored Glycine 0 N--CA 1.406 -3.366 0 CA-C-N 114.226 -1.352 . . . . 0.72 114.907 174.793 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 134' ' ' CYS . . . . . 1.018 ' HB2' HD13 ' B' ' 172' ' ' ILE . 0.0 OUTLIER -136.66 105.01 5.72 Favored 'General case' 0 CA--C 1.494 -1.189 0 N-CA-C 114.322 1.23 . . . . 1.08 114.322 179.872 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 135' ' ' PHE . . . . . 0.922 ' HD1' ' HD1' ' A' ' 35' ' ' PHE . 82.1 m-85 -80.22 105.39 11.45 Favored 'General case' 0 N--CA 1.42 -1.928 0 N-CA-C 102.399 -3.185 . . . . 1.36 102.399 176.035 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 136' ' ' VAL . . . . . 1.081 HG13 HG12 ' B' ' 126' ' ' ILE . 5.9 t -97.9 84.64 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.671 0 CA-C-O 123.148 1.451 . . . . 0.75 109.24 -177.129 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 137' ' ' GLY . . . . . 0.607 ' N ' ' O ' ' B' ' 125' ' ' SER . . . 97.91 88.65 1.9 Allowed Glycine 0 CA--C 1.527 0.812 0 CA-C-N 112.254 -2.248 . . . . 0.83 115.475 178.442 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 138' ' ' THR . . . . . 0.713 HG21 ' CE1' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -172.14 175.65 3.67 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 108.796 -0.816 . . . . 0.78 108.796 178.045 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 139' ' ' ALA . . . . . 0.836 ' HA ' HD12 ' B' ' 142' ' ' LEU . . . -55.82 -40.41 72.73 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 118.818 0.736 . . . . 1.04 112.562 -178.262 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 140' ' ' GLU . . . . . 0.603 ' OE1' HG23 ' B' ' 138' ' ' THR . 0.0 OUTLIER -57.6 -13.94 4.6 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.089 -0.644 . . . . 2.31 110.862 -178.032 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 141' ' ' ALA . . . . . 0.668 ' O ' ' N ' ' B' ' 144' ' ' CYS . . . -87.12 -30.44 21.09 Favored 'General case' 0 C--O 1.213 -0.866 0 CA-C-N 116.223 -0.444 . . . . 0.87 110.122 179.754 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 142' ' ' LEU . . . . . 0.836 HD12 ' HA ' ' B' ' 139' ' ' ALA . 0.4 OUTLIER -40.86 -41.36 1.57 Allowed 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.462 0.542 . . . . 1.24 112.462 -178.604 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 143' ' ' ARG . . . . . 0.467 ' HA ' ' HD3' ' B' ' 143' ' ' ARG . 8.9 tpp85 -58.17 -23.46 55.44 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 108.37 -0.974 . . . . 2.93 108.37 177.619 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 144' ' ' CYS . . . . . 0.668 ' N ' ' O ' ' B' ' 141' ' ' ALA . 90.9 m -66.61 -5.76 12.76 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 113.889 -1.505 . . . . 1.61 110.596 -177.553 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -78.03 -6.28 54.05 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.847 0.356 . . . . 3.35 111.701 178.906 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 146' ' ' GLU . . . . . 0.596 ' HG3' ' HE1' ' B' ' 149' ' ' TYR . 0.4 OUTLIER -86.33 3.51 43.14 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.355 -0.538 . . . . 3.76 111.01 -178.981 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 147' ' ' GLU . . . . . 0.608 ' HG2' ' O ' ' B' ' 144' ' ' CYS . 12.6 pt-20 -83.51 1.59 41.1 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.656 -0.498 . . . . 4.01 109.656 177.281 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 148' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -71.53 -28.95 64.23 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 109.47 -0.567 . . . . 3.92 109.47 178.11 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 149' ' ' TYR . . . . . 0.596 ' HE1' ' HG3' ' B' ' 146' ' ' GLU . 6.0 p90 -117.32 25.21 10.61 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.35 -0.386 . . . . 5.73 110.887 179.682 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 150' ' ' LEU . . . . . 0.85 HD22 HD11 ' B' ' 111' ' ' LEU . 5.0 tt -127.49 142.5 44.25 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.91 -0.587 . . . . 5.46 111.502 -179.125 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 151' ' ' PRO . . . . . 0.637 ' HD2' ' HG ' ' B' ' 150' ' ' LEU . 85.1 Cg_endo -84.72 50.73 3.01 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.76 2.307 . . . . 5.02 113.053 -179.634 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 152' ' ' SER . . . . . 0.561 ' HB2' ' O ' ' B' ' 151' ' ' PRO . 3.9 m 75.53 151.38 0.14 Allowed Pre-proline 0 N--CA 1.467 0.387 0 CA-C-O 121.017 0.437 . . . . 5.73 111.639 179.739 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 153' ' ' PRO . . . . . 0.623 ' HA ' ' O ' ' B' ' 109' ' ' THR . 43.8 Cg_endo -66.5 165.75 24.08 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.138 2.559 . . . . 5.1 113.29 -179.306 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 154' ' ' CYS . . . . . . . . . . . . . 21.5 p -61.88 115.98 4.48 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.57 -0.741 . . . . 2.68 111.747 -179.679 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 155' ' ' GLN . . . . . 0.681 ' HB3' ' HA ' ' B' ' 103' ' ' LEU . 12.5 pt20 43.74 -171.29 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 114.736 -1.12 . . . . 5.63 112.672 179.891 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -157.19 -162.44 1.21 Allowed 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 120.901 -0.319 . . . . 3.11 111.028 -179.876 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 157' ' ' GLY . . . . . 0.551 ' O ' ' HB2' ' B' ' 166' ' ' ARG . . . -109.09 146.02 16.64 Favored Glycine 0 CA--C 1.493 -1.342 0 N-CA-C 108.821 -1.712 . . . . 2.07 108.821 175.555 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 11.6 mt-30 -103.3 63.7 0.81 Allowed 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 117.354 -1.739 . . . . 4.34 111.363 -179.165 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 159' ' ' LYS . . . . . 0.876 ' HB3' ' HB2' ' B' ' 167' ' ' CYS . 11.2 tppt? -117.46 52.06 1.21 Allowed Pre-proline 0 C--N 1.314 -0.954 0 CA-C-O 116.694 -1.622 . . . . 3.54 110.294 172.118 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 160' ' ' PRO . . . . . 0.435 ' HA ' ' HA ' ' B' ' 166' ' ' ARG . 43.6 Cg_endo -68.38 86.16 0.43 Allowed 'Trans proline' 0 C--N 1.334 -0.231 0 CA-C-N 122.502 1.929 . . . . 1.51 115.03 -173.305 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 161' ' ' CYS . . . . . 0.448 ' N ' ' O ' ' B' ' 165' ' ' GLY . 0.7 OUTLIER -96.94 -166.57 1.42 Allowed 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 113.117 -1.856 . . . . 1.58 109.302 177.944 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 49.9 -164.67 0.56 Allowed Glycine 0 CA--C 1.524 0.613 0 C-N-CA 118.813 -1.66 . . . . 2.37 113.375 172.127 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -78.13 51.44 0.99 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.233 0.54 . . . . 4.07 111.907 -178.739 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 104.95 7.55 38.24 Favored Glycine 0 CA--C 1.533 1.211 0 N-CA-C 114.965 0.746 . . . . 2.2 114.965 178.281 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 165' ' ' GLY . . . . . 0.598 ' HA2' ' HA ' ' B' ' 175' ' ' SER . . . -101.07 136.25 12.6 Favored Glycine 0 C--O 1.224 -0.494 0 C-N-CA 119.044 -1.55 . . . . 1.62 115.885 -176.854 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 166' ' ' ARG . . . . . 0.551 ' HB2' ' O ' ' B' ' 157' ' ' GLY . 0.0 OUTLIER -102.23 154.17 19.28 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 114.469 -0.865 . . . . 3.05 110.6 178.935 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 167' ' ' CYS . . . . . 0.876 ' HB2' ' HB3' ' B' ' 159' ' ' LYS . 5.4 t -56.52 109.24 0.58 Allowed 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 109.721 -0.474 . . . . 1.56 109.721 -179.017 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 168' ' ' ALA . . . . . 0.579 ' HB3' ' SG ' ' B' ' 128' ' ' CYS . . . -92.31 -17.31 24.89 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 107.879 -1.156 . . . . 1.04 107.879 178.878 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 169' ' ' ALA . . . . . 1.021 ' HB3' HD11 ' B' ' 172' ' ' ILE . . . -165.83 155.89 12.66 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 113.063 -1.881 . . . . 0.98 109.13 179.856 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 170' ' ' ALA . . . . . 0.785 ' O ' ' O ' ' B' ' 169' ' ' ALA . . . -19.17 -134.94 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 114.418 1.266 . . . . 1.25 114.418 -179.623 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 171' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' B' ' 185' ' ' CYS . . . -46.69 19.77 0.0 OUTLIER Glycine 0 CA--C 1.536 1.383 0 N-CA-C 116.359 1.304 . . . . 1.29 116.359 -178.217 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 172' ' ' ILE . . . . . 1.021 HD11 ' HB3' ' B' ' 169' ' ' ALA . 1.8 pp -138.28 99.85 1.56 Allowed 'Isoleucine or valine' 0 C--O 1.251 1.164 0 CA-C-O 123.478 1.609 . . . . 2.27 111.198 -178.818 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 173' ' ' CYS . . . . . 0.593 ' HA ' ' HA ' ' B' ' 167' ' ' CYS . 1.1 t -92.92 95.54 9.56 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 113.523 -1.671 . . . . 1.94 109.022 -179.055 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 174' ' ' CYS . . . . . 0.848 ' HA ' ' HA ' ' B' ' 179' ' ' CYS . 16.3 m -92.82 162.6 14.04 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 114.52 1.304 . . . . 1.35 114.52 -176.25 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 175' ' ' SER . . . . . 0.789 ' HB2' ' HD2' ' B' ' 176' ' ' PRO . 55.6 p -125.27 179.42 1.14 Allowed Pre-proline 0 CA--C 1.532 0.262 0 CA-C-N 113.454 -1.703 . . . . 2.0 108.033 178.842 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 176' ' ' PRO . . . . . 0.789 ' HD2' ' HB2' ' B' ' 175' ' ' SER . 72.0 Cg_endo -77.27 30.14 0.42 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 121.283 1.322 . . . . 1.9 111.9 179.829 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 177' ' ' ASP . . . . . 0.416 ' H ' ' C ' ' B' ' 175' ' ' SER . 1.6 t70 -145.94 -41.79 0.21 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.644 -0.707 . . . . 2.72 110.921 179.939 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 178' ' ' GLY . . . . . 1.214 ' HA3' ' O ' ' A' ' 79' ' ' CYS . . . -150.97 -141.56 3.37 Favored Glycine 0 C--N 1.336 0.533 0 C-N-CA 120.588 -0.815 . . . . 0.99 113.727 -179.89 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 179' ' ' CYS . . . . . 1.247 ' O ' ' HA3' ' A' ' 78' ' ' GLY . 60.3 m -148.38 146.05 28.32 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 123.154 0.582 . . . . 1.34 110.53 -179.653 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 180' ' ' HIS . . . . . 0.455 ' N ' ' O ' ' B' ' 173' ' ' CYS . 14.6 m80 -132.97 134.14 44.1 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 119.797 -0.761 . . . . 2.1 111.508 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 181' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -59.67 135.93 57.83 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.712 -0.847 . . . . 3.06 108.712 178.506 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 182' ' ' ASP . . . . . 0.592 ' HB3' ' HB3' ' B' ' 173' ' ' CYS . 0.7 OUTLIER -143.0 128.94 10.32 Favored Pre-proline 0 C--N 1.319 -0.719 0 CA-C-N 116.443 -0.344 . . . . 2.06 111.069 -178.632 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 183' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -69.19 -31.34 23.29 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 123.188 2.592 . . . . 1.91 113.041 -179.106 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -64.41 -3.28 2.82 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.109 -0.496 . . . . 1.56 111.963 -179.729 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 185' ' ' CYS . . . . . 0.661 ' HB3' ' C ' ' B' ' 170' ' ' ALA . 70.6 m -133.25 20.26 4.02 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 112.227 0.454 . . . . 1.94 112.227 -179.855 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 186' ' ' ASP . . . . . 0.79 ' N ' ' HD3' ' B' ' 187' ' ' PRO . 17.3 m-20 -107.65 20.65 0.06 OUTLIER Pre-proline 0 N--CA 1.448 -0.573 0 N-CA-C 113.858 1.058 . . . . 3.61 113.858 179.761 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 187' ' ' PRO . . . . . 0.79 ' HD3' ' N ' ' B' ' 186' ' ' ASP . 1.9 Cg_endo -77.79 66.15 8.14 Favored 'Trans proline' 0 CA--C 1.485 -1.974 0 N-CA-C 106.424 -2.183 . . . . 2.58 106.424 176.371 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 188' ' ' GLU . . . . . 0.531 ' HB3' ' O ' ' B' ' 187' ' ' PRO . 4.5 pt-20 176.55 -34.01 0.01 OUTLIER 'General case' 0 CA--C 1.475 -1.911 0 CA-C-O 123.838 1.78 . . . . 4.7 108.213 -179.261 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 189' ' ' ALA . . . . . 0.481 ' N ' ' HG3' ' B' ' 188' ' ' GLU . . . -77.13 34.09 0.15 Allowed 'General case' 0 C--N 1.366 1.284 0 CA-C-N 110.504 -3.044 . . . . 5.24 110.407 176.111 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 190' ' ' ALA . . . . . 0.464 ' H ' ' C ' ' B' ' 188' ' ' GLU . . . -76.5 145.31 39.23 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 112.999 -1.909 . . . . 6.93 111.37 -176.256 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 191' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -62.62 128.18 34.75 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.45 0.643 . . . . 10.14 112.356 -174.189 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 6.0 t . . . . . 0 C--O 1.25 1.096 0 CA-C-N 114.989 -1.005 . . . . 11.7 110.573 179.833 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.5 m . . . . . 0 CA--C 1.556 1.2 0 N-CA-C 113.201 0.815 . . . . 2.64 113.201 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.596 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -34.82 113.29 0.46 Allowed Pre-proline 0 N--CA 1.491 1.609 0 CA-C-N 119.0 0.818 . . . . 2.75 111.661 179.461 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.472 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 71.5 Cg_endo -75.48 117.92 4.97 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 122.82 2.347 . . . . 1.66 113.309 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 5.7 p -130.93 -178.29 4.75 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 121.057 0.456 . . . . 1.3 111.702 178.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.465 ' HA2' ' HB3' ' A' ' 40' ' ' GLU . . . 77.21 -162.54 51.4 Favored Glycine 0 CA--C 1.519 0.303 0 CA-C-N 116.162 -0.472 . . . . 1.23 112.121 -178.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.407 ' O ' ' HG2' ' A' ' 15' ' ' PRO . 44.6 Cg_endo -65.8 100.29 0.42 Allowed 'Trans proline' 0 N--CA 1.48 0.692 0 C-N-CA 124.165 3.244 . . . . 1.78 111.886 177.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.03 5.89 76.29 Favored Glycine 0 C--N 1.299 -1.473 0 CA-C-N 115.316 -0.856 . . . . 1.96 113.465 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.472 ' O ' ' CB ' ' A' ' 12' ' ' PRO . . . 71.95 45.33 42.75 Favored Glycine 0 N--CA 1.426 -2.011 0 N-CA-C 115.71 1.044 . . . . 1.48 115.71 177.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.467 ' HB2' ' CD1' ' A' ' 32' ' ' LEU . 0.5 OUTLIER -94.89 -24.02 17.19 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 112.66 0.615 . . . . 3.06 112.66 -179.828 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -79.5 171.84 54.87 Favored Glycine 0 CA--C 1.495 -1.157 0 CA-C-N 115.235 -0.893 . . . . 1.16 111.64 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.596 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 0.8 OUTLIER -120.86 149.41 42.64 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 109.848 -0.427 . . . . 2.62 109.848 -178.62 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 57.0 m -98.64 127.02 44.42 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.988 0.899 . . . . 1.22 109.741 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.418 ' CE2' ' HB1' ' A' ' 68' ' ' ALA . 3.7 m-85 -109.89 -29.94 8.05 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 113.963 -1.472 . . . . 2.15 111.315 -177.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -157.03 -174.49 26.8 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 121.089 -0.577 . . . . 0.98 112.708 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.41 -54.27 5.22 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 122.747 2.298 . . . . 0.93 113.45 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.588 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.7 OUTLIER -120.65 36.32 4.61 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 122.462 -0.149 . . . . 0.96 111.207 179.695 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.892 HG12 HG13 ' A' ' 36' ' ' VAL . 19.7 mt -140.77 111.42 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 C-N-CA 120.32 -0.552 . . . . 0.99 111.896 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.579 ' SG ' ' O ' ' A' ' 20' ' ' ARG . 0.5 OUTLIER -126.49 120.71 30.39 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 116.528 -0.305 . . . . 1.2 110.19 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.887 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -131.07 127.85 39.03 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 119.526 -0.87 . . . . 1.13 112.65 -179.579 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 33' ' ' GLY . . . -103.92 -169.51 25.24 Favored Glycine 0 N--CA 1.421 -2.325 0 C-N-CA 120.45 -0.881 . . . . 0.79 111.858 178.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -69.87 -51.06 36.54 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 114.694 -0.753 . . . . 2.64 112.969 -178.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -121.08 9.42 10.52 Favored 'General case' 0 CA--C 1.503 -0.836 0 CA-C-N 115.041 -0.981 . . . . 2.1 109.437 -177.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.467 ' CD1' ' HB2' ' A' ' 18' ' ' LYS . 4.7 mt -109.67 -9.83 14.84 Favored 'General case' 0 N--CA 1.408 -2.569 0 N-CA-C 108.871 -0.789 . . . . 1.0 108.871 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.954 ' HA2' ' HB1' ' A' ' 69' ' ' ALA . . . 65.8 -136.0 35.64 Favored Glycine 0 N--CA 1.43 -1.751 0 C-N-CA 120.42 -0.895 . . . . 0.7 112.921 176.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.719 ' HB2' HD13 ' A' ' 72' ' ' ILE . 1.6 t -135.66 125.54 25.73 Favored 'General case' 0 CA--C 1.503 -0.827 0 N-CA-C 114.37 1.248 . . . . 0.94 114.37 -178.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.48 ' HA ' ' HA ' ' B' ' 135' ' ' PHE . 4.2 m-85 -98.88 101.03 12.29 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 104.655 -2.35 . . . . 1.84 104.655 176.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.892 HG13 HG12 ' A' ' 26' ' ' ILE . 3.8 t -87.06 94.48 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 CA-C-O 122.937 1.351 . . . . 0.59 110.603 -178.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.588 ' N ' ' O ' ' A' ' 25' ' ' SER . . . 76.95 83.63 0.5 Allowed Glycine 0 CA--C 1.499 -0.911 0 CA-C-N 112.028 -2.351 . . . . 1.32 112.186 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 19.2 p -149.95 169.08 22.02 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-O 120.972 0.415 . . . . 1.48 111.16 -178.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.683 ' HA ' HD12 ' A' ' 42' ' ' LEU . . . -55.08 -27.73 47.09 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.867 -0.606 . . . . 1.28 110.781 179.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.465 ' HB3' ' HA2' ' A' ' 14' ' ' GLY . 30.1 mp0 -73.56 -29.21 62.29 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 112.665 0.617 . . . . 2.56 112.665 -179.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.422 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . . . -97.55 -1.35 44.13 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 120.701 0.286 . . . . 0.95 110.38 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.683 HD12 ' HA ' ' A' ' 39' ' ' ALA . 1.6 mt -57.61 -32.98 67.75 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 120.939 0.4 . . . . 1.99 110.308 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.7 ptm85 -72.13 -9.07 57.92 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.89 -0.596 . . . . 3.75 110.594 179.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 94.4 m -69.36 -10.18 56.76 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 120.198 -0.601 . . . . 1.32 111.389 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -54.96 -24.76 25.46 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.109 0.48 . . . . 2.8 110.928 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -85.83 5.01 34.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.241 -0.436 . . . . 3.55 110.434 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.443 -0.791 0 N-CA-C 108.789 -0.819 . . . . 2.79 108.789 179.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.9 t . . . . . 0 N--CA 1.473 0.677 0 CA-C-O 120.456 0.169 . . . . 3.86 110.835 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.492 ' O ' ' HB2' ' A' ' 66' ' ' ARG . . . -66.12 120.44 15.93 Favored Glycine 0 N--CA 1.429 -1.782 0 C-N-CA 120.213 -0.994 . . . . 2.88 110.827 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.61 77.58 6.21 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 107.886 -1.153 . . . . 5.45 107.886 179.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.482 ' O ' ' HA ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -146.33 58.26 4.45 Favored Pre-proline 0 C--N 1.306 -1.318 0 CA-C-N 114.933 -1.03 . . . . 6.09 108.868 -179.524 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 59' ' ' LYS . 36.8 Cg_endo -64.63 85.5 0.17 Allowed 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.584 2.189 . . . . 2.54 112.235 179.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.506 ' N ' ' O ' ' A' ' 65' ' ' GLY . 0.5 OUTLIER -108.41 -179.4 3.87 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.624 -0.717 . . . . 2.27 109.083 179.44 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.08 -161.01 44.94 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 117.859 -2.115 . . . . 2.47 111.816 178.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 50.9 m -78.79 45.33 0.59 Allowed 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 120.689 0.281 . . . . 3.28 111.637 -179.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 105.28 16.07 17.53 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 120.945 -0.645 . . . . 2.3 114.674 178.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.506 ' O ' ' N ' ' A' ' 61' ' ' CYS . . . -103.7 132.85 11.22 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 119.822 -1.18 . . . . 1.86 114.738 -179.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.492 ' HB2' ' O ' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -93.61 159.16 15.34 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 122.49 0.316 . . . . 3.36 110.95 178.335 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 13.8 t -70.05 106.37 3.21 Favored 'General case' 0 N--CA 1.432 -1.363 0 C-N-CA 119.782 -0.767 . . . . 1.64 109.438 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.418 ' HB1' ' CE2' ' A' ' 22' ' ' PHE . . . -93.15 -17.57 23.59 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.906 0.384 . . . . 1.21 110.613 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.954 ' HB1' ' HA2' ' A' ' 33' ' ' GLY . . . -168.11 164.21 13.45 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 115.969 -0.56 . . . . 1.05 110.377 -178.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -45.17 121.76 3.04 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 114.218 1.192 . . . . 1.63 114.218 -177.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.649 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . 59.86 31.44 71.96 Favored Glycine 0 CA--C 1.506 -0.526 0 CA-C-N 113.479 -1.691 . . . . 1.58 115.673 176.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.779 HD12 ' SG ' ' A' ' 74' ' ' CYS . 1.3 pt -142.37 112.6 2.73 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-O 122.015 0.912 . . . . 2.04 111.976 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.71 ' HB2' ' HB3' ' A' ' 82' ' ' ASP . 0.0 OUTLIER -93.07 94.2 8.73 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 114.72 -1.127 . . . . 1.72 109.14 179.302 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.779 ' SG ' HD12 ' A' ' 72' ' ' ILE . 43.7 m -102.4 147.94 26.1 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.295 0.569 . . . . 1.37 111.469 -179.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.494 ' CB ' ' HD2' ' A' ' 76' ' ' PRO . 0.3 OUTLIER -122.64 -179.12 0.72 Allowed Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 114.632 -1.167 . . . . 2.25 108.813 179.615 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.494 ' HD2' ' CB ' ' A' ' 75' ' ' SER . 58.0 Cg_endo -74.26 32.6 0.34 Allowed 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 121.883 1.722 . . . . 2.7 112.954 -179.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.475 ' HB3' ' NE2' ' B' ' 180' ' ' HIS . 5.4 m-20 -147.54 -49.68 0.18 Allowed 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.876 -0.602 . . . . 2.63 111.002 178.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.564 ' HA3' ' O ' ' B' ' 179' ' ' CYS . . . -143.69 -152.2 5.61 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 120.412 -0.899 . . . . 0.75 113.727 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.573 ' HA ' ' HA ' ' A' ' 74' ' ' CYS . 5.0 m -138.46 149.82 45.84 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.045 -0.578 . . . . 1.23 110.156 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.636 ' O ' ' N ' ' A' ' 73' ' ' CYS . 0.1 OUTLIER -147.41 145.46 29.24 Favored 'General case' 0 CA--C 1.513 -0.474 0 O-C-N 121.516 -0.74 . . . . 3.01 111.408 -178.404 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -67.95 144.58 55.14 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.344 -0.613 . . . . 2.9 109.344 178.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.71 ' HB3' ' HB2' ' A' ' 73' ' ' CYS . 2.2 p-10 -146.34 121.2 5.41 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 116.066 -0.515 . . . . 2.52 110.055 -177.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 82' ' ' ASP . 38.4 Cg_exo -61.83 -15.08 40.4 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.776 2.317 . . . . 2.98 114.385 -178.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.16 -44.84 78.74 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.908 0.385 . . . . 2.42 111.814 -179.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.649 ' O ' ' N ' ' A' ' 71' ' ' GLY . 14.0 m -106.04 26.16 10.06 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.681 0.753 . . . . 2.16 109.919 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 11.6 t0 . . . . . 0 C--N 1.309 -1.175 0 O-C-N 121.308 -0.87 . . . . 3.14 112.425 -179.063 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 110' ' ' CYS . . . . . . . . . . . . . 1.3 m . . . . . 0 CA--C 1.552 1.037 0 N-CA-C 113.097 0.777 . . . . 2.64 113.097 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 111' ' ' LEU . . . . . 0.617 ' O ' ' HA ' ' B' ' 120' ' ' ARG . 0.7 OUTLIER -33.78 112.82 0.41 Allowed Pre-proline 0 N--CA 1.483 1.214 0 CA-C-N 118.554 0.616 . . . . 2.77 112.485 179.533 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 112' ' ' PRO . . . . . 0.46 ' CB ' ' O ' ' B' ' 117' ' ' GLY . 73.3 Cg_endo -75.87 119.44 5.4 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.7 2.267 . . . . 1.7 114.171 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . . . . . . . . . 4.3 p -133.09 -178.16 4.84 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 120.502 -0.479 . . . . 1.26 112.137 178.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 114' ' ' GLY . . . . . 0.467 ' HA2' ' HB3' ' B' ' 140' ' ' GLU . . . 77.17 -162.23 51.25 Favored Glycine 0 CA--C 1.522 0.5 0 CA-C-N 116.037 -0.529 . . . . 1.2 111.999 -177.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 115' ' ' PRO . . . . . 0.406 ' O ' ' HG2' ' B' ' 115' ' ' PRO . 45.1 Cg_endo -66.19 99.32 0.41 Allowed 'Trans proline' 0 N--CA 1.478 0.588 0 C-N-CA 124.089 3.192 . . . . 1.78 112.089 177.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 89.12 5.95 72.33 Favored Glycine 0 C--N 1.298 -1.541 0 CA-C-N 115.404 -0.816 . . . . 1.94 113.436 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 117' ' ' GLY . . . . . 0.46 ' O ' ' CB ' ' B' ' 112' ' ' PRO . . . 72.24 45.03 41.52 Favored Glycine 0 N--CA 1.425 -2.064 0 C-N-CA 120.386 -0.911 . . . . 1.48 115.268 177.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 118' ' ' LYS . . . . . 0.457 ' HB2' ' CD1' ' B' ' 132' ' ' LEU . 0.4 OUTLIER -94.29 -24.67 17.34 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 121.153 0.502 . . . . 3.07 111.94 -179.601 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . -78.84 173.06 55.35 Favored Glycine 0 N--CA 1.438 -1.227 0 C-N-CA 120.589 -0.815 . . . . 1.16 111.893 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.617 ' HA ' ' O ' ' B' ' 111' ' ' LEU . 0.7 OUTLIER -120.85 149.0 43.27 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 110.024 -0.362 . . . . 2.63 110.024 -179.508 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 121' ' ' CYS . . . . . . . . . . . . . 57.3 m -98.16 127.63 44.21 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 119.639 -0.825 . . . . 1.21 110.203 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 122' ' ' PHE . . . . . 0.404 ' CE2' ' HB1' ' B' ' 168' ' ' ALA . 3.5 m-85 -110.9 -28.41 8.38 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 114.413 -1.267 . . . . 2.14 111.657 -177.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -158.12 -175.65 29.29 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 121.149 -0.548 . . . . 0.99 112.445 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -52.42 -54.09 5.78 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 122.85 2.366 . . . . 0.96 113.447 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 125' ' ' SER . . . . . 0.57 ' O ' ' N ' ' B' ' 137' ' ' GLY . 1.0 OUTLIER -121.0 36.77 4.5 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 122.413 -0.18 . . . . 1.0 110.961 179.671 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 126' ' ' ILE . . . . . 0.478 HG12 HG13 ' B' ' 136' ' ' VAL . 16.0 mt -139.72 111.02 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 C-N-CA 120.499 -0.48 . . . . 0.97 112.047 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 127' ' ' CYS . . . . . 0.559 ' SG ' ' O ' ' B' ' 120' ' ' ARG . 0.5 OUTLIER -127.55 119.74 26.66 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 110.099 -0.334 . . . . 1.19 110.099 179.677 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 128' ' ' CYS . . . . . 0.926 ' HA ' ' O ' ' B' ' 133' ' ' GLY . 0.0 OUTLIER -130.09 128.18 41.36 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 119.952 -0.699 . . . . 1.12 112.608 -178.941 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 129' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' B' ' 133' ' ' GLY . . . -105.48 -169.19 23.72 Favored Glycine 0 N--CA 1.418 -2.506 0 C-N-CA 120.065 -1.064 . . . . 0.78 111.989 178.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -70.41 -51.62 28.21 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 115.126 -0.537 . . . . 2.63 112.351 -177.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.8 30.61 5.46 Favored 'General case' 0 CA--C 1.503 -0.861 0 N-CA-C 108.861 -0.792 . . . . 2.1 108.861 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 132' ' ' LEU . . . . . 0.457 ' CD1' ' HB2' ' B' ' 118' ' ' LYS . 3.8 mt -127.06 -7.8 5.98 Favored 'General case' 0 N--CA 1.396 -3.159 0 N-CA-C 106.752 -1.573 . . . . 0.98 106.752 177.374 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 133' ' ' GLY . . . . . 0.996 ' HA2' ' HB1' ' B' ' 169' ' ' ALA . . . 61.87 -136.36 46.4 Favored Glycine 0 N--CA 1.427 -1.942 0 CA-C-N 115.283 -0.871 . . . . 0.68 113.851 176.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 134' ' ' CYS . . . . . 0.749 ' HB2' HD13 ' B' ' 172' ' ' ILE . 1.6 t -134.36 126.24 29.23 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 114.5 1.296 . . . . 0.96 114.5 -178.044 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 135' ' ' PHE . . . . . 0.48 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 4.8 m-85 -99.28 101.09 12.28 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 104.455 -2.424 . . . . 1.84 104.455 176.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 136' ' ' VAL . . . . . 0.478 HG13 HG12 ' B' ' 126' ' ' ILE . 38.3 t -85.58 93.76 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 CA-C-O 122.97 1.367 . . . . 0.6 110.072 -178.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 137' ' ' GLY . . . . . 0.57 ' N ' ' O ' ' B' ' 125' ' ' SER . . . 75.32 84.75 0.35 Allowed Glycine 0 CA--C 1.502 -0.729 0 CA-C-N 112.136 -2.302 . . . . 1.33 112.448 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 138' ' ' THR . . . . . . . . . . . . . 19.1 p -150.22 169.64 20.85 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 120.9 0.381 . . . . 1.48 111.172 -179.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 139' ' ' ALA . . . . . 0.685 ' HA ' HD12 ' B' ' 142' ' ' LEU . . . -55.39 -27.65 49.0 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.038 -0.528 . . . . 1.3 110.805 179.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 140' ' ' GLU . . . . . 0.467 ' HB3' ' HA2' ' B' ' 114' ' ' GLY . 30.2 mp0 -73.52 -29.14 62.28 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 112.542 0.571 . . . . 2.53 112.542 -179.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 141' ' ' ALA . . . . . 0.443 ' HB2' ' HB2' ' B' ' 127' ' ' CYS . . . -97.47 -0.91 45.28 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 120.713 0.292 . . . . 0.98 110.489 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 142' ' ' LEU . . . . . 0.685 HD12 ' HA ' ' B' ' 139' ' ' ALA . 1.6 mt -58.02 -33.05 68.53 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 121.031 0.443 . . . . 2.02 110.318 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 143' ' ' ARG . . . . . . . . . . . . . 2.0 ptm85 -71.96 -9.2 58.03 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.883 -0.599 . . . . 3.76 110.606 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 144' ' ' CYS . . . . . . . . . . . . . 94.2 m -69.48 -9.89 55.71 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 120.169 -0.613 . . . . 1.37 111.414 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -55.04 -24.96 27.41 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.072 0.463 . . . . 2.78 110.802 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -85.81 5.41 32.7 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 116.351 -0.386 . . . . 3.53 110.495 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.445 -0.712 0 N-CA-C 108.879 -0.786 . . . . 2.81 108.879 178.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 1.8 t . . . . . 0 N--CA 1.471 0.625 0 CA-C-O 120.518 0.199 . . . . 3.9 111.007 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 157' ' ' GLY . . . . . 0.44 ' O ' ' HB2' ' B' ' 166' ' ' ARG . . . -62.04 120.62 22.79 Favored Glycine 0 N--CA 1.441 -0.971 0 C-N-CA 120.159 -1.02 . . . . 2.89 111.025 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.36 60.11 3.67 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.691 0.758 . . . . 5.47 110.27 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 159' ' ' LYS . . . . . 0.576 ' HB2' ' CB ' ' B' ' 167' ' ' CYS . 0.1 OUTLIER -115.42 55.41 1.01 Allowed Pre-proline 0 N--CA 1.443 -0.778 0 CA-C-N 114.766 -1.107 . . . . 6.05 111.541 176.076 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 160' ' ' PRO . . . . . 0.437 ' HA ' ' HA ' ' B' ' 166' ' ' ARG . 30.1 Cg_endo -63.09 85.57 0.12 Allowed 'Trans proline' 0 CA--C 1.531 0.336 0 CA-C-N 121.306 1.502 . . . . 2.53 113.794 -178.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 161' ' ' CYS . . . . . 0.512 ' N ' ' O ' ' B' ' 165' ' ' GLY . 0.5 OUTLIER -109.61 -179.65 3.88 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.05 -0.523 . . . . 2.24 109.705 179.504 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 66.68 -160.75 47.14 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 118.26 -1.924 . . . . 2.45 111.642 178.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 39.0 m -78.57 43.77 0.49 Allowed 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 116.802 0.301 . . . . 3.26 111.53 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 106.86 15.9 15.35 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 120.74 -0.743 . . . . 2.3 114.588 178.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 165' ' ' GLY . . . . . 0.512 ' O ' ' N ' ' B' ' 161' ' ' CYS . . . -103.61 134.08 11.74 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.044 -1.074 . . . . 1.83 114.444 -179.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 166' ' ' ARG . . . . . 0.502 ' HA ' ' O ' ' B' ' 159' ' ' LYS . 0.0 OUTLIER -95.27 158.64 15.37 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 115.415 -0.393 . . . . 3.34 110.875 178.254 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 167' ' ' CYS . . . . . 0.576 ' CB ' ' HB2' ' B' ' 159' ' ' LYS . 14.1 t -70.17 106.1 3.17 Favored 'General case' 0 N--CA 1.435 -1.218 0 C-N-CA 119.731 -0.788 . . . . 1.61 109.342 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 168' ' ' ALA . . . . . 0.404 ' HB1' ' CE2' ' B' ' 122' ' ' PHE . . . -93.12 -18.81 22.15 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.205 0.526 . . . . 1.22 110.782 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 169' ' ' ALA . . . . . 0.996 ' HB1' ' HA2' ' B' ' 133' ' ' GLY . . . -165.63 164.94 19.09 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 115.466 -0.788 . . . . 1.04 110.53 -178.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 170' ' ' ALA . . . . . . . . . . . . . . . -46.89 121.71 3.82 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 114.762 1.393 . . . . 1.63 114.762 -177.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 171' ' ' GLY . . . . . 0.759 ' N ' ' O ' ' B' ' 185' ' ' CYS . . . 61.83 29.66 72.94 Favored Glycine 0 C--N 1.315 -0.633 0 CA-C-N 113.974 -1.466 . . . . 1.49 115.896 177.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 172' ' ' ILE . . . . . 0.77 HD12 ' SG ' ' B' ' 174' ' ' CYS . 1.3 pt -142.58 113.71 2.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 118.331 1.066 . . . . 2.05 111.95 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 173' ' ' CYS . . . . . 0.764 ' HB2' ' HB3' ' B' ' 182' ' ' ASP . 0.0 OUTLIER -94.22 93.93 8.05 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 114.56 -1.2 . . . . 1.73 108.81 179.692 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 174' ' ' CYS . . . . . 0.77 ' SG ' HD12 ' B' ' 172' ' ' ILE . 37.2 m -102.22 148.0 25.96 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.458 0.646 . . . . 1.35 111.745 -179.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 175' ' ' SER . . . . . 0.505 ' CB ' ' HD2' ' B' ' 176' ' ' PRO . 0.3 OUTLIER -122.88 -179.26 0.76 Allowed Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 114.627 -1.169 . . . . 2.25 108.914 179.792 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 176' ' ' PRO . . . . . 0.505 ' HD2' ' CB ' ' B' ' 175' ' ' SER . 57.9 Cg_endo -74.02 32.61 0.34 Allowed 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 121.811 1.674 . . . . 2.68 113.044 -179.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 177' ' ' ASP . . . . . 0.457 ' HB3' ' NE2' ' A' ' 80' ' ' HIS . 5.1 m-20 -147.69 -49.53 0.17 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.915 -0.584 . . . . 2.66 110.949 178.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 178' ' ' GLY . . . . . 0.555 ' HA3' ' O ' ' A' ' 79' ' ' CYS . . . -143.49 -151.57 5.49 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 120.492 -0.861 . . . . 0.75 113.944 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 179' ' ' CYS . . . . . 0.602 ' HA ' ' HA ' ' B' ' 174' ' ' CYS . 4.8 m -139.42 149.24 43.83 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 114.879 -0.66 . . . . 1.24 110.095 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 180' ' ' HIS . . . . . 0.613 ' O ' ' N ' ' B' ' 173' ' ' CYS . 0.1 OUTLIER -146.88 145.74 29.94 Favored 'General case' 0 CA--C 1.511 -0.547 0 C-N-CA 119.807 -0.757 . . . . 3.0 111.41 -178.436 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 181' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -67.9 145.26 54.75 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 120.175 -0.61 . . . . 2.9 109.48 178.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 182' ' ' ASP . . . . . 0.764 ' HB3' ' HB2' ' B' ' 173' ' ' CYS . 1.8 p-10 -146.9 121.05 5.11 Favored Pre-proline 0 C--N 1.319 -0.753 0 CA-C-N 116.196 -0.456 . . . . 2.49 110.412 -178.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 183' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -61.51 -14.8 37.35 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 122.653 2.236 . . . . 2.94 114.448 -178.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -67.55 -44.98 76.97 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.846 0.355 . . . . 2.37 111.647 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 185' ' ' CYS . . . . . 0.759 ' O ' ' N ' ' B' ' 171' ' ' GLY . 11.9 m -106.91 28.87 7.56 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.629 0.728 . . . . 2.13 110.767 -179.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 186' ' ' ASP . . . . . . . . . . . . . 11.8 t0 . . . . . 0 C--N 1.319 -0.738 0 CA-C-N 115.835 -0.62 . . . . 3.11 112.52 -179.144 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.509 ' O ' ' C ' ' A' ' 11' ' ' LEU . 8.4 m . . . . . 0 CA--C 1.531 0.237 0 N-CA-C 115.944 1.831 . . . . 2.68 115.944 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.513 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -31.56 110.88 0.3 Allowed Pre-proline 0 N--CA 1.48 1.054 0 CA-C-N 119.055 0.843 . . . . 2.48 110.125 178.739 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.632 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 41.5 Cg_endo -99.98 139.49 0.28 Allowed 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.143 1.896 . . . . 1.49 116.758 -177.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.544 ' HA ' ' HD2' ' A' ' 43' ' ' ARG . 2.4 p -134.59 -165.75 1.71 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 118.674 -1.21 . . . . 1.0 109.866 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.483 ' HA2' ' HG2' ' A' ' 40' ' ' GLU . . . 64.65 -159.45 42.37 Favored Glycine 0 CA--C 1.499 -0.939 0 C-N-CA 121.365 -0.445 . . . . 1.15 113.527 176.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.435 ' C ' ' H ' ' A' ' 17' ' ' GLY . 42.7 Cg_endo -64.75 138.19 57.31 Favored 'Trans proline' 0 N--CA 1.443 -1.448 0 C-N-CA 122.25 1.967 . . . . 1.57 109.029 176.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 55.93 -6.58 0.01 OUTLIER Glycine 0 C--N 1.273 -2.965 0 CA-C-N 114.055 -1.43 . . . . 1.68 114.029 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.435 ' H ' ' C ' ' A' ' 15' ' ' PRO . . . 69.66 40.98 76.53 Favored Glycine 1 N--CA 1.387 -4.567 0 C-N-CA 116.947 -2.549 . . . . 1.36 108.871 -178.455 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.433 ' HB2' HD11 ' A' ' 32' ' ' LEU . 1.6 mttp -93.59 -10.91 33.08 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 111.677 -2.262 . . . . 2.5 113.24 179.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.632 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -122.85 179.0 16.27 Favored Glycine 0 N--CA 1.44 -1.051 0 N-CA-C 106.539 -2.624 . . . . 1.02 106.539 178.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.513 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 0.3 OUTLIER -122.55 170.23 10.21 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 119.95 1.875 . . . . 2.92 112.274 -178.98 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.465 ' O ' HD12 ' A' ' 11' ' ' LEU . 20.2 t -114.66 150.76 34.68 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.735 0.303 . . . . 1.1 111.796 -179.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -131.85 -49.56 0.96 Allowed 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 108.704 -0.85 . . . . 1.51 108.704 177.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.438 ' O ' ' SG ' ' A' ' 21' ' ' CYS . . . -99.29 -154.87 28.54 Favored Glycine 0 N--CA 1.448 -0.553 0 N-CA-C 109.007 -1.637 . . . . 0.9 109.007 176.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -94.18 -60.55 0.01 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.032 0 CA-C-N 119.829 1.814 . . . . 1.5 112.14 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.636 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.6 OUTLIER -90.92 9.82 28.95 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-O 120.615 0.245 . . . . 1.26 110.403 179.05 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.826 HG23 HG13 ' A' ' 36' ' ' VAL . 1.5 mt -120.08 118.08 55.71 Favored 'Isoleucine or valine' 0 C--O 1.245 0.854 0 CA-C-O 122.061 0.934 . . . . 0.83 112.311 -177.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.737 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 0.7 OUTLIER -134.83 130.47 36.09 Favored 'General case' 0 C--O 1.223 -0.31 0 CA-C-N 114.238 -1.346 . . . . 0.92 110.556 -179.492 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 1.086 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -132.4 172.65 12.2 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-O 123.155 1.455 . . . . 1.28 114.167 -178.086 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.481 ' O ' ' HB1' ' A' ' 69' ' ' ALA . . . -156.87 176.0 34.26 Favored Glycine 0 N--CA 1.429 -1.812 0 CA-C-N 111.664 -2.517 . . . . 0.67 108.602 178.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -62.17 -53.0 61.54 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 121.964 0.888 . . . . 2.27 110.453 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.29 11.69 14.11 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 113.79 -1.55 . . . . 1.66 109.402 179.027 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.697 HD22 ' CZ ' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -106.47 -4.2 20.09 Favored 'General case' 0 N--CA 1.412 -2.352 0 N-CA-C 106.897 -1.519 . . . . 1.37 106.897 179.275 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 1.086 ' O ' ' HA ' ' A' ' 28' ' ' CYS . . . 46.76 -140.59 6.77 Favored Glycine 0 N--CA 1.419 -2.441 0 CA-C-N 113.67 -1.604 . . . . 0.73 113.028 178.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.8 ' SG ' HG22 ' A' ' 26' ' ' ILE . 0.5 OUTLIER -138.23 122.16 17.77 Favored 'General case' 0 CA--C 1.493 -1.234 0 N-CA-C 113.168 0.803 . . . . 1.08 113.168 179.709 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.978 ' HA ' ' HA ' ' B' ' 135' ' ' PHE . 0.0 OUTLIER -88.8 106.2 18.21 Favored 'General case' 0 N--CA 1.423 -1.81 0 N-CA-C 104.22 -2.511 . . . . 1.38 104.22 175.437 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.912 HG23 HG23 ' B' ' 136' ' ' VAL . 1.4 t -96.09 83.71 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 N-CA-C 107.734 -1.21 . . . . 0.76 107.734 -179.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.727 ' O ' ' HA3' ' B' ' 133' ' ' GLY . . . 103.01 92.57 2.23 Favored Glycine 0 CA--C 1.531 1.073 0 CA-C-N 112.955 -1.929 . . . . 0.81 114.259 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.475 HG21 ' HB3' ' A' ' 35' ' ' PHE . 0.0 OUTLIER 177.86 167.1 0.72 Allowed 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 108.808 -0.812 . . . . 0.77 108.808 178.455 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.772 ' CB ' HD22 ' A' ' 42' ' ' LEU . . . -61.24 -16.77 48.69 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 119.996 1.271 . . . . 1.02 111.677 179.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.669 ' HB3' ' CD2' ' A' ' 35' ' ' PHE . 5.0 mt-10 -64.19 -14.95 58.68 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.629 -0.508 . . . . 2.32 109.629 178.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.645 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . . . -126.1 -4.81 6.8 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 115.67 -0.696 . . . . 0.87 111.949 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.772 HD22 ' CB ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -73.95 -36.3 64.62 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 108.218 -1.03 . . . . 1.23 108.218 179.231 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.544 ' HD2' ' HA ' ' A' ' 13' ' ' CYS . 1.2 ptp180 -63.52 -5.63 4.08 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 114.31 -1.313 . . . . 2.92 109.529 178.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.599 ' HB3' ' O ' ' A' ' 41' ' ' ALA . 9.3 t -82.2 11.8 4.97 Favored 'General case' 0 N--CA 1.445 -0.701 0 O-C-N 121.572 -0.705 . . . . 1.57 109.166 177.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -73.02 -18.3 61.36 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.945 -0.571 . . . . 3.31 109.477 178.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.42 5.7 33.77 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 119.303 -0.959 . . . . 3.69 109.862 179.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 . . . . . 0 N--CA 1.448 -0.562 0 CA-C-N 115.866 -0.607 . . . . 3.99 109.583 177.53 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.542 0.653 0 N-CA-C 111.382 0.141 . . . . 3.12 111.382 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 56.45 58.57 13.66 Favored Glycine 0 N--CA 1.426 -2.033 0 C-N-CA 121.346 -0.454 . . . . 2.1 112.214 176.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 -119.46 70.46 0.85 Allowed 'General case' 0 N--CA 1.435 -1.206 0 CA-C-O 122.82 1.295 . . . . 4.36 107.684 177.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.642 ' N ' ' CD ' ' A' ' 60' ' ' PRO . 2.2 mmpp? -143.68 44.69 0.51 Allowed Pre-proline 0 C--N 1.303 -1.435 0 CA-C-N 112.428 -2.169 . . . . 3.55 108.089 177.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.642 ' CD ' ' N ' ' A' ' 59' ' ' LYS . 1.3 Cg_endo -42.96 114.75 0.47 Allowed 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 123.629 2.886 . . . . 1.54 115.247 -178.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -146.68 170.53 16.76 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 113.357 -1.747 . . . . 1.59 108.19 177.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 71.07 -168.54 50.28 Favored Glycine 0 CA--C 1.494 -1.264 0 C-N-CA 118.704 -1.713 . . . . 2.43 113.63 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 14.4 p -83.29 44.46 0.95 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.015 -0.593 . . . . 4.11 111.692 -178.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 118.26 9.61 9.43 Favored Glycine 0 C--N 1.334 0.455 0 N-CA-C 115.222 0.849 . . . . 2.21 115.222 177.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.673 ' HA3' ' HA ' ' A' ' 75' ' ' SER . . . -105.16 162.29 14.55 Favored Glycine 0 C--N 1.338 0.642 0 CA-C-N 119.202 1.501 . . . . 1.62 115.178 -178.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.1 153.67 21.19 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 108.524 -0.917 . . . . 3.02 108.524 177.068 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.543 ' HA ' ' HA ' ' A' ' 73' ' ' CYS . 50.5 t -58.7 115.57 3.15 Favored 'General case' 0 N--CA 1.426 -1.669 0 N-CA-C 109.217 -0.66 . . . . 1.52 109.217 -179.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 1.011 ' HB1' ' SG ' ' A' ' 28' ' ' CYS . . . -62.88 -48.37 79.3 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 106.875 -1.528 . . . . 1.07 106.875 178.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.719 ' CB ' ' HA2' ' A' ' 33' ' ' GLY . . . -167.8 163.92 14.15 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 112.9 -1.954 . . . . 1.0 110.736 -174.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 1.073 ' HA ' ' HB3' ' A' ' 85' ' ' CYS . . . -43.96 130.61 5.85 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.428 0.632 . . . . 1.24 112.298 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.727 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . 80.23 -26.09 3.04 Favored Glycine 0 CA--C 1.522 0.481 0 CA-C-N 115.006 -0.997 . . . . 1.28 115.059 177.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.629 ' CD1' ' HB2' ' A' ' 34' ' ' CYS . 1.2 pp -129.25 116.59 40.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 122.319 1.057 . . . . 2.27 111.021 -179.149 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.543 ' HA ' ' HA ' ' A' ' 67' ' ' CYS . 1.6 t -106.13 112.45 25.48 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.175 -1.375 . . . . 1.98 110.578 -177.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.715 ' HB2' ' HB2' ' A' ' 68' ' ' ALA . 3.7 m -84.45 147.85 26.88 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 121.94 0.876 . . . . 1.33 112.752 -177.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.847 ' HB2' ' HD2' ' A' ' 76' ' ' PRO . 12.1 p -122.64 -179.9 0.88 Allowed Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 114.031 -1.44 . . . . 1.99 108.106 178.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.847 ' HD2' ' HB2' ' A' ' 75' ' ' SER . 57.0 Cg_endo -73.73 29.93 0.32 Allowed 'Trans proline' 0 N--CA 1.459 -0.516 0 CA-C-N 119.895 0.998 . . . . 1.86 111.59 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.504 ' H ' ' C ' ' A' ' 75' ' ' SER . 2.5 p30 -145.89 -48.93 0.22 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.607 -0.724 . . . . 2.65 110.63 179.053 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 1.083 ' HA3' ' O ' ' B' ' 179' ' ' CYS . . . -156.3 -140.8 3.05 Favored Glycine 0 C--N 1.336 0.547 0 C-N-CA 120.398 -0.906 . . . . 0.99 113.843 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 1.061 ' O ' ' HA3' ' B' ' 178' ' ' GLY . 0.0 OUTLIER -142.73 153.2 43.11 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.329 -0.436 . . . . 1.34 110.556 -179.826 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 4.2 p-80 -154.36 160.36 41.66 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.096 -0.642 . . . . 2.17 112.008 -178.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.601 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -60.25 140.53 56.98 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.874 -0.603 . . . . 3.05 110.32 179.867 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.492 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 3.7 p-10 -139.75 140.29 24.31 Favored Pre-proline 0 CA--C 1.541 0.598 0 CA-C-N 116.018 -0.537 . . . . 2.02 110.763 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.492 ' HD3' ' HA ' ' A' ' 82' ' ' ASP . 3.2 Cg_exo -77.26 -24.97 8.93 Favored 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 123.159 2.572 . . . . 1.93 114.196 -177.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.37 -43.93 84.57 Favored 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 107.781 -1.192 . . . . 1.53 107.781 178.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 1.073 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 33.2 m -99.95 73.73 1.77 Allowed 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 114.082 -1.417 . . . . 1.88 109.033 177.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.312 -1.052 0 CA-C-N 115.558 -0.746 . . . . 3.6 112.01 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 110' ' ' CYS . . . . . 0.532 ' O ' ' C ' ' B' ' 111' ' ' LEU . 7.4 m . . . . . 0 N--CA 1.45 -0.445 0 N-CA-C 115.587 1.699 . . . . 2.61 115.587 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 111' ' ' LEU . . . . . 0.575 ' O ' ' HA ' ' B' ' 120' ' ' ARG . 0.0 OUTLIER -31.63 110.34 0.3 Allowed Pre-proline 0 N--CA 1.472 0.668 0 CA-C-N 118.614 0.643 . . . . 2.47 109.821 178.761 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 112' ' ' PRO . . . . . 0.646 ' HA ' ' O ' ' B' ' 119' ' ' GLY . 74.1 Cg_endo -82.3 158.97 17.45 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 124.482 3.455 . . . . 1.47 111.307 -179.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.499 ' HA ' ' HD2' ' B' ' 143' ' ' ARG . 3.2 p -155.93 -168.71 2.85 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 120.427 -1.421 . . . . 1.0 109.351 166.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 114' ' ' GLY . . . . . 0.465 ' HA2' ' HG2' ' B' ' 140' ' ' GLU . . . 64.71 -158.85 43.41 Favored Glycine 0 C--N 1.34 0.752 0 C-N-CA 121.007 -0.616 . . . . 1.16 113.482 176.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 115' ' ' PRO . . . . . 0.51 ' O ' ' N ' ' B' ' 117' ' ' GLY . 56.4 Cg_endo -62.01 143.73 95.47 Favored 'Trans proline' 0 CA--C 1.503 -1.031 0 C-N-CA 122.801 2.334 . . . . 1.57 106.962 176.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 116' ' ' GLY . . . . . 0.425 ' HA3' ' HE3' ' B' ' 118' ' ' LYS . . . 50.0 -4.64 0.01 OUTLIER Glycine 0 N--CA 1.416 -2.662 0 N-CA-C 115.209 0.843 . . . . 1.7 115.209 177.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 117' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' B' ' 115' ' ' PRO . . . 68.18 39.88 88.15 Favored Glycine 1 N--CA 1.394 -4.1 0 C-N-CA 117.102 -2.475 . . . . 1.38 109.623 -178.612 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 118' ' ' LYS . . . . . 0.425 ' HE3' ' HA3' ' B' ' 116' ' ' GLY . 1.6 mmtp -91.99 -13.87 30.35 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 112.318 -1.941 . . . . 2.54 112.949 -178.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 119' ' ' GLY . . . . . 0.646 ' O ' ' HA ' ' B' ' 112' ' ' PRO . . . -113.57 -171.2 17.64 Favored Glycine 0 CA--C 1.5 -0.847 0 N-CA-C 108.324 -1.91 . . . . 1.04 108.324 178.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.575 ' HA ' ' O ' ' B' ' 111' ' ' LEU . 0.4 OUTLIER -136.77 169.74 17.23 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 121.845 2.823 . . . . 2.89 108.625 178.328 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 121' ' ' CYS . . . . . 0.457 ' SG ' ' O ' ' B' ' 123' ' ' GLY . 19.5 t -114.63 151.87 32.81 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.337 0.495 . . . . 1.07 112.337 -178.306 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -131.95 -49.66 0.95 Allowed 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 108.696 -0.853 . . . . 1.53 108.696 176.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 123' ' ' GLY . . . . . 0.457 ' O ' ' SG ' ' B' ' 121' ' ' CYS . . . -99.23 -154.84 28.59 Favored Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 109.115 -1.594 . . . . 0.9 109.115 176.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -94.19 -60.66 0.01 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.958 0 CA-C-N 119.816 1.808 . . . . 1.51 112.151 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 125' ' ' SER . . . . . 0.644 ' O ' ' N ' ' B' ' 137' ' ' GLY . 0.6 OUTLIER -90.65 9.89 27.94 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 110.266 -0.272 . . . . 1.25 110.266 179.031 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 126' ' ' ILE . . . . . 0.804 HG22 ' SG ' ' B' ' 134' ' ' CYS . 1.8 mt -119.98 117.87 55.07 Favored 'Isoleucine or valine' 0 C--O 1.244 0.802 0 CA-C-O 121.962 0.887 . . . . 0.85 112.566 -177.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 127' ' ' CYS . . . . . 0.747 ' O ' ' HA ' ' B' ' 134' ' ' CYS . 0.7 OUTLIER -134.91 130.69 36.29 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-N 114.313 -1.312 . . . . 0.89 110.643 -179.641 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 128' ' ' CYS . . . . . 1.084 ' HA ' ' O ' ' B' ' 133' ' ' GLY . 0.0 OUTLIER -130.96 173.58 10.85 Favored 'General case' 0 CA--C 1.56 1.33 0 CA-C-O 122.814 1.292 . . . . 1.23 114.327 -178.069 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 129' ' ' GLY . . . . . 0.518 ' O ' ' HB1' ' B' ' 169' ' ' ALA . . . -157.32 176.47 34.49 Favored Glycine 0 N--CA 1.427 -1.936 0 CA-C-N 111.643 -2.526 . . . . 0.66 109.045 177.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -62.01 -54.83 36.04 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 109.198 -0.667 . . . . 2.35 109.198 179.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -122.12 29.71 6.91 Favored 'General case' 0 N--CA 1.428 -1.539 0 N-CA-C 108.191 -1.04 . . . . 1.69 108.191 178.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 132' ' ' LEU . . . . . 0.662 HD22 ' CZ ' ' B' ' 135' ' ' PHE . 0.5 OUTLIER -121.09 -3.42 9.57 Favored 'General case' 0 N--CA 1.41 -2.451 0 N-CA-C 104.428 -2.434 . . . . 1.38 104.428 179.103 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 133' ' ' GLY . . . . . 1.084 ' O ' ' HA ' ' B' ' 128' ' ' CYS . . . 42.36 -141.01 1.84 Allowed Glycine 0 N--CA 1.401 -3.664 0 CA-C-N 112.531 -2.122 . . . . 0.72 112.519 176.358 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 134' ' ' CYS . . . . . 0.804 ' SG ' HG22 ' B' ' 126' ' ' ILE . 0.5 OUTLIER -136.75 122.08 19.34 Favored 'General case' 0 CA--C 1.493 -1.23 0 CA-C-N 118.802 1.301 . . . . 1.08 113.629 -178.515 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 135' ' ' PHE . . . . . 0.978 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -88.08 106.35 18.1 Favored 'General case' 0 N--CA 1.422 -1.829 0 N-CA-C 104.326 -2.472 . . . . 1.36 104.326 175.858 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 136' ' ' VAL . . . . . 0.912 HG23 HG23 ' A' ' 36' ' ' VAL . 1.8 t -95.62 83.69 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 N-CA-C 107.725 -1.213 . . . . 0.75 107.725 -179.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 137' ' ' GLY . . . . . 0.756 ' O ' ' HA3' ' A' ' 33' ' ' GLY . . . 102.53 93.03 2.23 Favored Glycine 0 CA--C 1.531 1.055 0 CA-C-N 113.071 -1.877 . . . . 0.83 114.283 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 138' ' ' THR . . . . . 0.466 HG21 ' HB3' ' B' ' 135' ' ' PHE . 0.0 OUTLIER 178.44 169.19 0.82 Allowed 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 108.623 -0.88 . . . . 0.78 108.623 178.576 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 139' ' ' ALA . . . . . 0.775 ' CB ' HD22 ' B' ' 142' ' ' LEU . . . -63.77 -15.33 58.4 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 119.616 1.098 . . . . 1.04 111.373 178.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 140' ' ' GLU . . . . . 0.677 ' HB3' ' CD2' ' B' ' 135' ' ' PHE . 5.0 mt-10 -65.24 -15.87 62.94 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.498 -0.556 . . . . 2.31 109.498 178.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 141' ' ' ALA . . . . . 0.659 ' O ' ' HB3' ' B' ' 144' ' ' CYS . . . -122.78 -11.0 8.23 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.995 -0.548 . . . . 0.87 111.695 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 142' ' ' LEU . . . . . 0.775 HD22 ' CB ' ' B' ' 139' ' ' ALA . 0.0 OUTLIER -69.22 -37.02 77.85 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.382 -0.97 . . . . 1.24 108.382 -178.681 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 143' ' ' ARG . . . . . 0.499 ' HD2' ' HA ' ' B' ' 113' ' ' CYS . 1.1 ptp180 -64.91 -2.29 2.54 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 114.583 -1.189 . . . . 2.93 109.753 178.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 144' ' ' CYS . . . . . 0.659 ' HB3' ' O ' ' B' ' 141' ' ' ALA . 10.3 t -83.4 9.26 11.45 Favored 'General case' 0 N--CA 1.443 -0.786 0 O-C-N 121.556 -0.715 . . . . 1.61 109.125 176.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -71.17 -18.65 62.48 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.598 -0.728 . . . . 3.35 109.711 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.41 5.73 33.61 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 119.234 -0.986 . . . . 3.76 110.035 179.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 . . . . . 0 N--CA 1.448 -0.533 0 CA-C-N 115.781 -0.645 . . . . 4.01 109.51 177.605 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.465 0.297 0 N-CA-C 110.126 -0.324 . . . . 3.11 110.126 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 64.95 57.13 12.75 Favored Glycine 0 N--CA 1.426 -1.972 0 C-N-CA 120.245 -0.979 . . . . 2.07 112.164 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 158' ' ' GLN . . . . . 0.418 ' C ' ' HD2' ' B' ' 160' ' ' PRO . 12.8 tt0 -120.29 59.83 0.89 Allowed 'General case' 0 N--CA 1.435 -1.19 0 C-N-CA 117.228 -1.789 . . . . 4.34 108.604 176.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 159' ' ' LYS . . . . . 0.615 ' HB2' ' HB3' ' B' ' 167' ' ' CYS . 2.6 mmpp? -118.2 39.23 0.29 Allowed Pre-proline 0 C--N 1.314 -0.943 0 CA-C-N 112.346 -2.206 . . . . 3.54 111.731 171.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 160' ' ' PRO . . . . . 0.454 ' CD ' ' N ' ' B' ' 159' ' ' LYS . 2.3 Cg_endo -41.17 117.21 0.53 Allowed 'Trans proline' 0 C--N 1.34 0.109 0 C-N-CA 122.306 2.004 . . . . 1.51 115.621 -173.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 161' ' ' CYS . . . . . 0.466 ' SG ' ' N ' ' B' ' 162' ' ' GLY . 0.1 OUTLIER -138.73 -170.58 2.88 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 113.198 -1.819 . . . . 1.58 108.715 -179.803 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 162' ' ' GLY . . . . . 0.466 ' N ' ' SG ' ' B' ' 161' ' ' CYS . . . 47.9 -166.03 0.17 Allowed Glycine 0 CA--C 1.528 0.864 0 C-N-CA 119.064 -1.541 . . . . 2.37 114.9 171.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 13.8 p -82.35 44.24 0.86 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 114.981 -0.61 . . . . 4.07 112.216 -178.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 119.33 8.93 8.97 Favored Glycine 0 C--N 1.338 0.64 0 N-CA-C 115.15 0.82 . . . . 2.2 115.15 177.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 165' ' ' GLY . . . . . 0.651 ' HA3' ' HA ' ' B' ' 175' ' ' SER . . . -103.61 160.69 16.28 Favored Glycine 0 CA--C 1.521 0.425 0 C-N-CA 119.551 -1.309 . . . . 1.62 115.684 -178.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 166' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.73 153.23 22.14 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 108.342 -0.985 . . . . 3.05 108.342 176.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 167' ' ' CYS . . . . . 0.615 ' HB3' ' HB2' ' B' ' 159' ' ' LYS . 47.5 t -58.31 115.53 3.02 Favored 'General case' 0 N--CA 1.426 -1.629 0 N-CA-C 109.345 -0.613 . . . . 1.56 109.345 -179.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 168' ' ' ALA . . . . . 0.978 ' HB1' ' SG ' ' B' ' 128' ' ' CYS . . . -63.26 -47.3 82.97 Favored 'General case' 0 N--CA 1.428 -1.546 0 N-CA-C 107.263 -1.384 . . . . 1.04 107.263 178.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 169' ' ' ALA . . . . . 0.811 ' CB ' ' HA2' ' B' ' 133' ' ' GLY . . . -169.01 164.25 11.39 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.189 -1.369 . . . . 0.98 108.967 -175.034 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 170' ' ' ALA . . . . . 1.003 ' HA ' ' HB3' ' B' ' 185' ' ' CYS . . . -44.07 130.71 6.02 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.469 0.652 . . . . 1.25 112.691 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 171' ' ' GLY . . . . . 0.735 ' N ' ' O ' ' B' ' 185' ' ' CYS . . . 78.4 -21.04 3.78 Favored Glycine 0 CA--C 1.521 0.458 0 CA-C-N 114.845 -1.071 . . . . 1.29 115.511 177.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 172' ' ' ILE . . . . . 0.631 ' CD1' ' HB2' ' B' ' 134' ' ' CYS . 1.2 pp -132.43 116.24 27.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 122.408 1.099 . . . . 2.27 110.747 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 173' ' ' CYS . . . . . 0.553 ' HA ' ' H ' ' B' ' 168' ' ' ALA . 1.5 t -106.5 112.5 25.53 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.083 -1.417 . . . . 1.94 110.686 -177.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 174' ' ' CYS . . . . . 0.702 ' HA ' ' HA ' ' B' ' 179' ' ' CYS . 4.4 m -84.29 148.0 26.91 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.903 0.859 . . . . 1.35 112.838 -177.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 175' ' ' SER . . . . . 0.832 ' HB2' ' HD2' ' B' ' 176' ' ' PRO . 11.6 p -122.68 -179.89 0.88 Allowed Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 114.057 -1.429 . . . . 2.0 107.998 178.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 176' ' ' PRO . . . . . 0.832 ' HD2' ' HB2' ' B' ' 175' ' ' SER . 57.3 Cg_endo -73.71 29.92 0.32 Allowed 'Trans proline' 0 N--CA 1.46 -0.482 0 CA-C-N 119.797 0.963 . . . . 1.9 111.681 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 177' ' ' ASP . . . . . 0.505 ' H ' ' C ' ' B' ' 175' ' ' SER . 2.5 p30 -145.78 -49.41 0.22 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.63 -0.713 . . . . 2.72 110.585 179.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 178' ' ' GLY . . . . . 1.061 ' HA3' ' O ' ' A' ' 79' ' ' CYS . . . -155.77 -140.69 3.04 Favored Glycine 0 C--N 1.338 0.652 0 C-N-CA 120.492 -0.861 . . . . 0.99 113.886 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 179' ' ' CYS . . . . . 1.083 ' O ' ' HA3' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -142.94 153.04 42.66 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-N 115.281 -0.46 . . . . 1.34 110.511 -179.892 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 180' ' ' HIS . . . . . . . . . . . . . 4.2 p-80 -154.11 160.39 41.92 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.098 -0.641 . . . . 2.1 111.975 -178.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 181' ' ' GLU . . . . . 0.586 ' HA ' ' O ' ' B' ' 171' ' ' GLY . 0.0 OUTLIER -60.23 140.48 56.99 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.844 -0.616 . . . . 3.06 110.307 179.828 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 182' ' ' ASP . . . . . 0.457 ' HB3' ' HB3' ' B' ' 173' ' ' CYS . 3.7 p-10 -139.69 140.28 24.46 Favored Pre-proline 0 CA--C 1.541 0.627 0 CA-C-N 116.01 -0.541 . . . . 2.06 110.759 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 183' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' B' ' 182' ' ' ASP . 3.4 Cg_exo -77.09 -25.17 8.98 Favored 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 123.236 2.624 . . . . 1.91 114.252 -177.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -66.23 -43.88 85.37 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 107.808 -1.182 . . . . 1.56 107.808 178.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 185' ' ' CYS . . . . . 1.003 ' HB3' ' HA ' ' B' ' 170' ' ' ALA . 33.2 m -100.05 73.44 1.73 Allowed 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 114.037 -1.438 . . . . 1.94 109.067 177.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 186' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.311 -1.095 0 CA-C-N 115.666 -0.697 . . . . 3.61 111.92 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.606 ' HB3' ' HD3' ' A' ' 20' ' ' ARG . 1.0 OUTLIER . . . . . 0 N--CA 1.447 -0.592 0 N-CA-C 111.689 0.255 . . . . 2.68 111.689 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.742 ' H ' HD22 ' A' ' 11' ' ' LEU . 3.4 mm? -30.68 111.08 0.28 Allowed Pre-proline 0 N--CA 1.472 0.673 0 N-CA-C 112.976 0.732 . . . . 2.48 112.976 -178.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.842 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 72.9 Cg_endo -73.96 153.44 47.31 Favored 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 123.087 2.525 . . . . 1.49 111.518 179.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.626 ' O ' ' HA2' ' A' ' 17' ' ' GLY . 16.1 p -160.7 -167.33 1.83 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 119.134 -1.027 . . . . 1.0 111.266 174.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 1.033 ' HA2' ' HB3' ' A' ' 40' ' ' GLU . . . 76.0 -160.38 51.39 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 120.241 -0.981 . . . . 1.15 114.761 177.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.573 ' HD2' ' CZ ' ' A' ' 35' ' ' PHE . 43.5 Cg_endo -64.94 99.07 0.32 Allowed 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 124.198 3.265 . . . . 1.57 113.328 178.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.62 -4.37 84.68 Favored Glycine 0 C--N 1.265 -3.363 0 CA-C-N 112.801 -1.999 . . . . 1.68 111.975 -176.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.626 ' HA2' ' O ' ' A' ' 13' ' ' CYS . . . 71.03 42.52 59.03 Favored Glycine 0 N--CA 1.432 -1.621 0 C-N-CA 118.31 -1.9 . . . . 1.36 113.19 174.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.98 -33.97 18.22 Favored 'General case' 0 C--N 1.359 1.021 0 CA-C-N 112.922 -1.639 . . . . 2.5 111.329 -178.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.842 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -77.55 -167.37 28.89 Favored Glycine 0 N--CA 1.468 0.795 0 C-N-CA 128.194 2.807 . . . . 1.02 111.165 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.729 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -130.74 173.76 10.6 Favored 'General case' 0 CA--C 1.553 1.089 0 N-CA-C 105.268 -2.123 . . . . 2.92 105.268 174.375 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.1 m -105.7 141.62 36.82 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 119.534 1.061 . . . . 1.1 111.395 -178.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -124.48 -48.2 1.82 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.765 -0.652 . . . . 1.51 110.549 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.533 ' HA3' HD12 ' A' ' 26' ' ' ILE . . . -128.94 -177.81 15.06 Favored Glycine 0 C--N 1.33 0.248 0 N-CA-C 111.322 -0.711 . . . . 0.9 111.322 179.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo -64.79 -71.02 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 121.969 1.779 . . . . 1.5 111.219 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.585 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.6 OUTLIER -89.8 41.53 1.05 Allowed 'General case' 0 CA--C 1.521 -0.145 0 N-CA-C 108.788 -0.819 . . . . 1.26 108.788 177.759 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.858 HG23 HG13 ' A' ' 36' ' ' VAL . 2.0 mt -144.92 111.59 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.908 0 CA-C-N 116.079 -0.51 . . . . 0.83 112.184 -177.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.692 ' SG ' ' HA ' ' A' ' 41' ' ' ALA . 0.8 OUTLIER -120.82 130.98 54.19 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 109.574 -0.528 . . . . 0.92 109.574 179.585 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.794 ' SG ' ' HB1' ' A' ' 68' ' ' ALA . 1.6 m -123.84 171.51 9.61 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 117.365 -1.734 . . . . 1.28 114.41 -177.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.571 ' HA3' ' HB2' ' A' ' 32' ' ' LEU . . . -146.85 174.86 26.53 Favored Glycine 0 N--CA 1.415 -2.714 0 N-CA-C 109.405 -1.478 . . . . 0.67 109.405 173.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -65.01 -58.51 5.92 Favored 'General case' 0 N--CA 1.422 -1.829 0 N-CA-C 104.424 -2.436 . . . . 2.27 104.424 177.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -115.07 22.11 13.66 Favored 'General case' 0 CA--C 1.478 -1.809 0 CA-C-N 114.246 -1.343 . . . . 1.66 108.689 -175.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.773 HD22 ' CE1' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -109.92 -17.8 13.54 Favored 'General case' 0 N--CA 1.408 -2.563 0 N-CA-C 105.987 -1.857 . . . . 1.37 105.987 177.793 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.892 ' HA2' ' CB ' ' A' ' 69' ' ' ALA . . . 63.6 -135.83 41.72 Favored Glycine 0 N--CA 1.403 -3.524 0 CA-C-N 113.635 -1.62 . . . . 0.73 110.797 -179.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.832 ' SG ' HG22 ' A' ' 26' ' ' ILE . 0.7 OUTLIER -143.27 122.1 12.68 Favored 'General case' 0 CA--C 1.479 -1.767 0 CA-C-N 119.13 1.465 . . . . 1.08 113.582 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 1.133 ' HA ' ' HA ' ' B' ' 135' ' ' PHE . 0.0 OUTLIER -88.84 105.34 17.67 Favored 'General case' 0 N--CA 1.411 -2.419 0 N-CA-C 103.945 -2.613 . . . . 1.38 103.945 176.13 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.858 HG13 HG23 ' A' ' 26' ' ' ILE . 1.6 t -96.7 85.67 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.863 0 N-CA-C 107.579 -1.267 . . . . 0.76 107.579 -179.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.878 ' HA3' HG12 ' B' ' 172' ' ' ILE . . . 122.03 12.99 5.11 Favored Glycine 0 C--N 1.32 -0.36 0 CA-C-N 113.738 -1.573 . . . . 0.81 115.898 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.697 HG22 ' O ' ' B' ' 132' ' ' LEU . 47.4 p -94.89 164.47 12.9 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 118.496 1.148 . . . . 0.77 110.195 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.641 ' HA ' HD12 ' A' ' 42' ' ' LEU . . . -61.2 -34.82 75.7 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.184 0.516 . . . . 1.02 109.811 179.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 1.033 ' HB3' ' HA2' ' A' ' 14' ' ' GLY . 0.6 OUTLIER -59.83 -14.63 15.9 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.912 -0.586 . . . . 2.32 111.537 -179.397 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.831 ' O ' ' HB2' ' A' ' 44' ' ' CYS . . . -91.95 -26.77 18.26 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 116.285 -0.416 . . . . 0.87 109.982 179.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.641 HD12 ' HA ' ' A' ' 39' ' ' ALA . 9.1 mt -48.21 -36.58 14.03 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 112.505 0.558 . . . . 1.23 112.505 -179.111 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.586 ' C ' ' H ' ' A' ' 45' ' ' GLN . 0.0 OUTLIER -54.91 -28.19 48.8 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 107.502 -1.296 . . . . 2.92 107.502 177.417 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.831 ' HB2' ' O ' ' A' ' 41' ' ' ALA . 1.2 m -54.97 4.01 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 114.435 -1.257 . . . . 1.57 111.18 -176.035 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.586 ' H ' ' C ' ' A' ' 43' ' ' ARG . 17.3 tt0 -72.48 -31.92 65.78 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.212 0.53 . . . . 3.31 110.951 177.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -86.3 6.78 28.19 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.995 0.426 . . . . 3.69 110.685 -179.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 25.0 tp10 . . . . . 0 N--CA 1.444 -0.769 0 N-CA-C 109.078 -0.712 . . . . 3.99 109.078 177.521 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 12.2 t . . . . . 0 CA--C 1.534 0.333 0 N-CA-C 109.071 -0.714 . . . . 3.12 109.071 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 112.97 -107.22 1.95 Allowed Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.555 -0.831 . . . . 2.1 112.652 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.69 87.05 2.67 Favored 'General case' 0 CA--C 1.476 -1.877 0 N-CA-C 102.944 -2.984 . . . . 4.36 102.944 176.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.863 ' CA ' ' H ' ' A' ' 67' ' ' CYS . 15.4 mmtt -137.32 -57.37 0.02 OUTLIER Pre-proline 0 C--N 1.296 -1.76 0 C-N-CA 118.629 -1.228 . . . . 3.55 112.05 -173.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.674 ' HD2' ' H ' ' A' ' 59' ' ' LYS . 9.4 Cg_endo -51.94 98.08 0.04 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.121 0 CA-C-N 120.709 1.289 . . . . 1.54 113.703 -179.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.417 ' SG ' ' N ' ' A' ' 62' ' ' GLY . 0.1 OUTLIER -140.98 -173.77 3.81 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 105.832 -1.914 . . . . 1.59 105.832 178.776 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.434 ' HA3' ' CE1' ' A' ' 80' ' ' HIS . . . 61.91 -165.18 20.73 Favored Glycine 0 C--N 1.316 -0.577 0 C-N-CA 117.454 -2.308 . . . . 2.43 112.548 176.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.4 m -84.39 42.46 0.89 Allowed 'General case' 0 N--CA 1.479 1.0 0 CA-C-O 122.204 1.002 . . . . 4.11 111.575 -176.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 115.78 5.84 17.64 Favored Glycine 0 CA--C 1.535 1.292 0 CA-C-N 113.89 -1.505 . . . . 2.21 114.937 178.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.666 ' CA ' ' HA ' ' A' ' 75' ' ' SER . . . -101.13 153.37 19.05 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 119.132 -1.508 . . . . 1.62 116.481 -174.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.804 ' CB ' ' HB3' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -85.24 152.26 23.45 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 114.354 -0.923 . . . . 3.02 109.553 179.364 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.863 ' H ' ' CA ' ' A' ' 59' ' ' LYS . 0.1 OUTLIER -70.13 107.83 3.84 Favored 'General case' 0 N--CA 1.42 -1.94 0 CA-C-N 119.643 1.11 . . . . 1.52 109.798 -178.767 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.846 ' HB3' HD12 ' A' ' 72' ' ' ILE . . . -67.02 -32.05 73.0 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 115.235 -0.893 . . . . 1.07 109.78 179.176 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.892 ' CB ' ' HA2' ' A' ' 33' ' ' GLY . . . -170.66 164.54 8.2 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.464 -1.244 . . . . 1.0 110.917 -177.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 1.044 ' HA ' ' HB3' ' A' ' 85' ' ' CYS . . . -66.91 70.76 0.08 Allowed 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.264 -0.574 . . . . 1.24 111.985 178.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.608 ' HA2' ' O ' ' A' ' 85' ' ' CYS . . . 164.99 -42.33 0.29 Allowed Glycine 0 CA--C 1.52 0.369 0 CA-C-N 115.818 -0.628 . . . . 1.28 114.227 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.885 HG12 ' HA3' ' B' ' 137' ' ' GLY . 1.3 pp -120.76 121.52 65.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.191 0.52 . . . . 2.27 111.037 -178.006 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.596 ' HB2' ' HB3' ' A' ' 82' ' ' ASP . 0.1 OUTLIER -95.58 111.72 23.58 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.635 -0.711 . . . . 1.98 109.825 -179.888 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.622 ' HB2' ' HB2' ' A' ' 68' ' ' ALA . 1.3 m -84.74 117.3 23.74 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.382 0.61 . . . . 1.33 112.378 -178.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.666 ' HA ' ' CA ' ' A' ' 65' ' ' GLY . 29.6 p -92.66 -179.67 1.12 Allowed Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 114.909 -1.041 . . . . 1.99 109.162 178.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.626 ' CD ' ' HB2' ' A' ' 75' ' ' SER . 4.2 Cg_exo -74.6 29.62 0.35 Allowed 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 121.7 1.6 . . . . 1.86 111.691 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.461 ' H ' ' C ' ' A' ' 75' ' ' SER . 2.4 p30 -145.65 -37.94 0.26 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.704 -0.68 . . . . 2.65 110.825 179.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.791 ' HA3' ' O ' ' B' ' 179' ' ' CYS . . . -170.0 -133.56 1.61 Allowed Glycine 0 C--N 1.339 0.702 0 C-N-CA 120.617 -0.801 . . . . 0.99 113.38 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.825 ' O ' ' HA3' ' B' ' 178' ' ' GLY . 0.0 OUTLIER -146.27 150.93 36.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.126 0.489 . . . . 1.34 110.831 -179.62 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.434 ' CE1' ' HA3' ' A' ' 62' ' ' GLY . 50.2 p-80 -154.25 160.48 41.83 Favored 'General case' 0 C--N 1.331 -0.236 0 O-C-N 122.03 -0.419 . . . . 2.17 111.56 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.556 ' OE2' ' HG2' ' B' ' 124' ' ' PRO . 1.5 mt-10 -59.7 140.75 56.21 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.281 -0.418 . . . . 3.05 110.228 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.596 ' HB3' ' HB2' ' A' ' 73' ' ' CYS . 7.9 p-10 -145.08 140.59 16.28 Favored Pre-proline 0 CA--C 1.535 0.385 0 CA-C-N 116.487 -0.324 . . . . 2.02 111.599 -179.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 82' ' ' ASP . 3.4 Cg_exo -77.58 -14.5 15.95 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 123.243 2.629 . . . . 1.93 113.665 -179.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.3 -46.58 60.4 Favored 'General case' 0 CA--C 1.504 -0.826 0 N-CA-C 107.158 -1.423 . . . . 1.53 107.158 178.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 1.044 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 97.7 m -106.84 84.76 2.04 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 113.559 -1.655 . . . . 1.88 107.493 176.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.445 ' HB2' ' O ' ' A' ' 82' ' ' ASP . 1.2 t70 . . . . . 0 C--N 1.316 -0.856 0 CA-C-N 113.857 -1.52 . . . . 3.6 113.619 -177.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 110' ' ' CYS . . . . . 0.583 ' HB3' ' HD3' ' B' ' 120' ' ' ARG . 0.9 OUTLIER . . . . . 0 N--CA 1.446 -0.632 0 N-CA-C 111.441 0.163 . . . . 2.61 111.441 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 111' ' ' LEU . . . . . 0.738 ' H ' HD22 ' B' ' 111' ' ' LEU . 3.4 mm? -30.92 111.48 0.29 Allowed Pre-proline 0 N--CA 1.471 0.614 0 N-CA-C 112.923 0.712 . . . . 2.47 112.923 -178.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 112' ' ' PRO . . . . . 0.89 ' HA ' ' O ' ' B' ' 119' ' ' GLY . 89.6 Cg_endo -81.53 144.66 14.32 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.119 1.879 . . . . 1.47 114.183 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.593 ' O ' ' HA2' ' B' ' 117' ' ' GLY . 18.0 p -150.57 -165.0 2.15 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 118.633 -1.227 . . . . 1.0 111.479 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 114' ' ' GLY . . . . . 1.073 ' HA2' ' HB3' ' B' ' 140' ' ' GLU . . . 76.24 -160.81 51.42 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 120.449 -0.881 . . . . 1.16 115.192 177.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 115' ' ' PRO . . . . . 0.548 ' HD2' ' CZ ' ' B' ' 135' ' ' PHE . 43.4 Cg_endo -63.5 114.76 2.66 Favored 'Trans proline' 0 C--N 1.366 1.478 0 C-N-CA 123.922 3.081 . . . . 1.57 106.945 176.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 77.62 -14.99 8.19 Favored Glycine 0 C--N 1.261 -3.624 0 C-N-CA 123.98 0.8 . . . . 1.7 111.193 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 117' ' ' GLY . . . . . 0.593 ' HA2' ' O ' ' B' ' 113' ' ' CYS . . . 75.12 43.01 27.55 Favored Glycine 0 N--CA 1.413 -2.893 0 C-N-CA 117.767 -2.159 . . . . 1.38 110.909 179.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.38 -27.92 17.22 Favored 'General case' 0 C--N 1.355 0.833 0 CA-C-N 112.269 -1.965 . . . . 2.54 113.345 -179.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 119' ' ' GLY . . . . . 0.89 ' O ' ' HA ' ' B' ' 112' ' ' PRO . . . -102.29 -151.82 24.05 Favored Glycine 0 N--CA 1.431 -1.686 0 N-CA-C 108.507 -1.837 . . . . 1.04 108.507 178.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.669 ' HA ' ' O ' ' B' ' 111' ' ' LEU . 0.0 OUTLIER -127.32 174.51 8.91 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 118.638 1.219 . . . . 2.89 110.714 -177.872 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 121' ' ' CYS . . . . . . . . . . . . . 1.1 m -105.35 140.69 38.09 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.276 0.56 . . . . 1.07 111.092 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -124.52 -48.13 1.82 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.447 -0.797 . . . . 1.53 110.375 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 123' ' ' GLY . . . . . 0.537 ' HA3' HD12 ' B' ' 126' ' ' ILE . . . -128.94 -177.8 15.05 Favored Glycine 0 C--N 1.33 0.247 0 N-CA-C 111.303 -0.719 . . . . 0.9 111.303 179.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . 0.556 ' HG2' ' OE2' ' A' ' 81' ' ' GLU . 20.2 Cg_exo -64.84 -70.97 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 121.942 1.761 . . . . 1.51 111.258 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 125' ' ' SER . . . . . 0.591 ' O ' ' N ' ' B' ' 137' ' ' GLY . 0.6 OUTLIER -89.77 41.47 1.04 Allowed 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 108.7 -0.852 . . . . 1.25 108.7 177.808 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 126' ' ' ILE . . . . . 0.841 HG22 ' SG ' ' B' ' 134' ' ' CYS . 2.2 mt -144.71 111.39 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 CA-C-N 116.025 -0.534 . . . . 0.85 112.374 -177.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 127' ' ' CYS . . . . . 0.686 ' SG ' ' HA ' ' B' ' 141' ' ' ALA . 0.8 OUTLIER -121.1 130.46 53.76 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 109.436 -0.579 . . . . 0.89 109.436 179.352 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 128' ' ' CYS . . . . . 0.793 ' HA ' ' O ' ' B' ' 133' ' ' GLY . 1.0 OUTLIER -125.48 169.03 12.81 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 114.22 1.193 . . . . 1.23 114.22 -177.084 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 129' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' B' ' 133' ' ' GLY . . . -147.88 176.05 26.9 Favored Glycine 0 N--CA 1.419 -2.444 0 N-CA-C 107.515 -2.234 . . . . 0.66 107.515 175.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -66.55 -55.93 13.16 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 106.681 -1.6 . . . . 2.35 106.681 178.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -117.62 31.48 6.69 Favored 'General case' 0 CA--C 1.478 -1.817 0 CA-C-N 113.337 -1.756 . . . . 1.69 109.591 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 132' ' ' LEU . . . . . 0.775 HD22 ' CE1' ' B' ' 135' ' ' PHE . 0.5 OUTLIER -120.99 -14.0 8.51 Favored 'General case' 0 N--CA 1.408 -2.562 0 N-CA-C 104.667 -2.345 . . . . 1.38 104.667 178.239 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 133' ' ' GLY . . . . . 0.876 ' HA2' ' CB ' ' B' ' 169' ' ' ALA . . . 63.08 -132.48 42.85 Favored Glycine 0 N--CA 1.404 -3.476 0 CA-C-N 114.092 -1.413 . . . . 0.72 111.821 177.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 134' ' ' CYS . . . . . 0.841 ' SG ' HG22 ' B' ' 126' ' ' ILE . 1.0 OUTLIER -146.2 121.98 10.57 Favored 'General case' 0 CA--C 1.479 -1.768 0 CA-C-N 119.462 1.631 . . . . 1.08 112.762 178.62 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 135' ' ' PHE . . . . . 1.133 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -88.83 105.78 17.95 Favored 'General case' 0 N--CA 1.409 -2.5 0 N-CA-C 103.959 -2.608 . . . . 1.36 103.959 176.369 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 136' ' ' VAL . . . . . 0.799 HG23 HG23 ' A' ' 36' ' ' VAL . 1.9 t -96.24 85.49 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.781 0 N-CA-C 107.59 -1.263 . . . . 0.75 107.59 -179.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 137' ' ' GLY . . . . . 0.885 ' HA3' HG12 ' A' ' 72' ' ' ILE . . . 122.51 12.7 5.0 Favored Glycine 0 C--O 1.227 -0.296 0 CA-C-N 113.993 -1.458 . . . . 0.83 115.874 179.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 138' ' ' THR . . . . . 0.713 HG22 ' O ' ' A' ' 32' ' ' LEU . 46.6 p -96.74 160.7 14.23 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 118.521 1.16 . . . . 0.78 110.422 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 139' ' ' ALA . . . . . 0.596 ' HA ' HD12 ' B' ' 142' ' ' LEU . . . -62.37 -23.13 66.63 Favored 'General case' 0 N--CA 1.446 -0.641 0 O-C-N 121.965 -0.459 . . . . 1.04 111.85 -179.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 140' ' ' GLU . . . . . 1.073 ' HB3' ' HA2' ' B' ' 114' ' ' GLY . 0.6 OUTLIER -67.45 -14.17 62.69 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.24 0.543 . . . . 2.31 110.781 178.56 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 141' ' ' ALA . . . . . 0.858 ' O ' ' HB2' ' B' ' 144' ' ' CYS . . . -92.74 -26.31 17.81 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 115.562 -0.744 . . . . 0.87 110.304 179.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 142' ' ' LEU . . . . . 0.596 HD12 ' HA ' ' B' ' 139' ' ' ALA . 9.8 mt -47.7 -36.64 11.55 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.146 0.424 . . . . 1.24 112.146 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 143' ' ' ARG . . . . . 0.454 ' HD3' ' O ' ' B' ' 140' ' ' GLU . 0.0 OUTLIER -60.72 -17.47 48.51 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 121.965 0.888 . . . . 2.93 109.567 177.661 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 144' ' ' CYS . . . . . 0.858 ' HB2' ' O ' ' B' ' 141' ' ' ALA . 1.2 m -58.21 -3.83 0.3 Allowed 'General case' 0 CA--C 1.552 1.048 0 CA-C-N 113.178 -1.828 . . . . 1.61 110.868 178.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 145' ' ' GLN . . . . . 0.425 ' H ' ' C ' ' B' ' 143' ' ' ARG . 16.7 tt0 -67.83 -32.85 73.68 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.233 0.54 . . . . 3.35 111.769 179.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -86.35 6.89 27.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.008 0.432 . . . . 3.76 110.701 -179.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 24.9 tp10 . . . . . 0 N--CA 1.444 -0.769 0 N-CA-C 109.082 -0.71 . . . . 4.01 109.082 177.451 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 12.1 t . . . . . 0 N--CA 1.453 -0.297 0 N-CA-C 108.925 -0.768 . . . . 3.11 108.925 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 114.04 -108.81 2.1 Favored Glycine 0 C--N 1.336 0.561 0 C-N-CA 120.02 -1.086 . . . . 2.07 112.404 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 158' ' ' GLN . . . . . 0.435 ' O ' ' HB2' ' B' ' 167' ' ' CYS . 0.0 OUTLIER -124.0 71.41 1.12 Allowed 'General case' 0 CA--C 1.486 -1.502 0 N-CA-C 104.669 -2.345 . . . . 4.34 104.669 176.148 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 159' ' ' LYS . . . . . 0.892 ' HA ' ' H ' ' B' ' 167' ' ' CYS . 18.9 mmtt -107.08 -65.77 0.04 OUTLIER Pre-proline 0 N--CA 1.421 -1.899 0 N-CA-C 116.764 2.135 . . . . 3.54 116.764 -177.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 160' ' ' PRO . . . . . 0.587 ' HD2' ' H ' ' B' ' 159' ' ' LYS . 9.6 Cg_endo -51.96 96.61 0.04 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.267 0 C-N-CA 122.351 2.034 . . . . 1.51 114.722 -174.111 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 161' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -143.62 179.72 6.96 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 112.922 -1.944 . . . . 1.58 105.838 177.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 70.03 -166.21 50.22 Favored Glycine 0 N--CA 1.441 -0.972 0 C-N-CA 117.58 -2.248 . . . . 2.37 111.863 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 2.8 m -83.95 43.55 0.93 Allowed 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 121.869 0.842 . . . . 4.07 111.21 -177.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 112.2 8.54 21.53 Favored Glycine 0 C--N 1.346 1.108 0 CA-C-N 113.961 -1.472 . . . . 2.2 114.775 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 165' ' ' GLY . . . . . 0.667 ' CA ' ' HA ' ' B' ' 175' ' ' SER . . . -103.0 156.12 18.12 Favored Glycine 0 C--N 1.339 0.748 0 CA-C-N 119.916 1.858 . . . . 1.62 116.27 -177.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 166' ' ' ARG . . . . . 0.871 ' CB ' ' HB3' ' B' ' 159' ' ' LYS . 0.0 OUTLIER -85.64 152.19 23.3 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 114.309 -0.945 . . . . 3.05 109.324 178.765 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 167' ' ' CYS . . . . . 0.892 ' H ' ' HA ' ' B' ' 159' ' ' LYS . 0.1 OUTLIER -70.32 107.74 3.9 Favored 'General case' 0 N--CA 1.418 -2.042 0 CA-C-N 119.558 1.072 . . . . 1.56 109.656 -178.853 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 168' ' ' ALA . . . . . 0.884 ' HB3' HD12 ' B' ' 172' ' ' ILE . . . -64.39 -36.1 83.04 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 122.238 1.018 . . . . 1.04 108.718 178.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 169' ' ' ALA . . . . . 0.876 ' CB ' ' HA2' ' B' ' 133' ' ' GLY . . . -168.57 164.59 12.42 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 113.287 -1.779 . . . . 0.98 112.017 -175.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 170' ' ' ALA . . . . . 1.067 ' HA ' ' HB3' ' B' ' 185' ' ' CYS . . . -67.28 71.15 0.11 Allowed 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.127 -0.629 . . . . 1.25 111.93 178.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 171' ' ' GLY . . . . . 0.552 ' HA2' ' O ' ' B' ' 185' ' ' CYS . . . 167.19 -48.83 0.25 Allowed Glycine 0 N--CA 1.455 -0.098 0 CA-C-N 115.525 -0.761 . . . . 1.29 112.74 179.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 172' ' ' ILE . . . . . 0.884 HD12 ' HB3' ' B' ' 168' ' ' ALA . 1.3 pp -115.86 121.77 68.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 C-N-CA 123.139 0.576 . . . . 2.27 111.647 -175.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 173' ' ' CYS . . . . . 0.6 ' HB2' ' HB3' ' B' ' 182' ' ' ASP . 0.1 OUTLIER -95.96 111.65 23.59 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.739 -0.664 . . . . 1.94 109.781 -179.918 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 174' ' ' CYS . . . . . 0.576 ' HB2' ' HB2' ' B' ' 168' ' ' ALA . 1.3 m -84.8 117.48 23.88 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.363 0.601 . . . . 1.35 112.359 -178.26 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 175' ' ' SER . . . . . 0.667 ' HA ' ' CA ' ' B' ' 165' ' ' GLY . 28.6 p -92.75 -179.67 1.11 Allowed Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 114.883 -1.053 . . . . 2.0 109.141 179.019 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 176' ' ' PRO . . . . . 0.612 ' CD ' ' HB2' ' B' ' 175' ' ' SER . 4.2 Cg_exo -74.62 29.67 0.35 Allowed 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 121.718 1.612 . . . . 1.9 111.681 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 177' ' ' ASP . . . . . 0.471 ' H ' ' C ' ' B' ' 175' ' ' SER . 2.4 p30 -145.7 -38.17 0.25 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.672 -0.694 . . . . 2.72 110.753 179.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 178' ' ' GLY . . . . . 0.825 ' HA3' ' O ' ' A' ' 79' ' ' CYS . . . -169.48 -133.87 1.65 Allowed Glycine 0 C--N 1.338 0.642 0 C-N-CA 120.63 -0.795 . . . . 0.99 113.388 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 179' ' ' CYS . . . . . 0.791 ' O ' ' HA3' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -146.08 151.14 37.23 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.073 0.463 . . . . 1.34 110.808 -179.77 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 180' ' ' HIS . . . . . . . . . . . . . 50.1 p-80 -154.56 160.46 41.52 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.625 -0.43 . . . . 2.1 111.542 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 181' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -59.9 140.52 56.61 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.309 -0.405 . . . . 3.06 110.187 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 182' ' ' ASP . . . . . 0.6 ' HB3' ' HB2' ' B' ' 173' ' ' CYS . 7.9 p-10 -144.81 140.61 16.52 Favored Pre-proline 0 CA--C 1.537 0.455 0 CA-C-N 116.493 -0.321 . . . . 2.06 111.629 -179.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 183' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' B' ' 182' ' ' ASP . 3.4 Cg_exo -77.41 -14.71 16.15 Favored 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 123.156 2.57 . . . . 1.91 113.672 -179.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -71.25 -46.62 60.6 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 107.134 -1.432 . . . . 1.56 107.134 178.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 185' ' ' CYS . . . . . 1.067 ' HB3' ' HA ' ' B' ' 170' ' ' ALA . 87.0 m -106.5 84.53 2.03 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 113.566 -1.652 . . . . 1.94 107.515 176.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 186' ' ' ASP . . . . . 0.437 ' HB2' ' O ' ' B' ' 182' ' ' ASP . 1.1 t70 . . . . . 0 CA--C 1.545 0.765 0 CA-C-N 113.782 -1.554 . . . . 3.61 113.835 -177.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.59 ' HB3' ' NE ' ' A' ' 20' ' ' ARG . 82.7 m . . . . . 0 N--CA 1.456 -0.138 0 N-CA-C 112.766 0.654 . . . . 2.68 112.766 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.941 HD22 ' HG3' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -35.63 108.46 0.37 Allowed Pre-proline 0 N--CA 1.483 1.221 0 C-N-CA 123.555 0.742 . . . . 2.48 112.389 179.28 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.852 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 43.8 Cg_endo -90.08 138.92 2.97 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.988 2.459 . . . . 1.49 114.044 -179.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.502 ' SG ' ' HE2' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -151.43 173.05 15.01 Favored 'General case' 0 C--N 1.351 0.642 0 N-CA-C 106.475 -1.676 . . . . 1.0 106.475 179.014 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.557 ' HA2' ' OE1' ' A' ' 40' ' ' GLU . . . 71.53 -163.26 54.26 Favored Glycine 0 CA--C 1.534 1.243 0 CA-C-N 119.635 1.107 . . . . 1.15 114.445 178.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.808 ' HG2' HD11 ' A' ' 32' ' ' LEU . 10.2 Cg_endo -69.68 130.49 19.52 Favored 'Trans proline' 0 C--N 1.369 1.621 0 C-N-CA 124.414 3.409 . . . . 1.57 113.285 179.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 70.35 -16.51 0.92 Allowed Glycine 0 C--N 1.284 -2.315 0 CA-C-N 112.492 -2.14 . . . . 1.68 109.575 -176.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.643 ' H ' ' C ' ' A' ' 15' ' ' PRO . . . 77.51 16.75 79.95 Favored Glycine 1 N--CA 1.388 -4.532 0 CA-C-N 113.706 -1.247 . . . . 1.36 113.74 178.285 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.447 ' H ' ' HG2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -74.34 6.97 3.15 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 107.846 -1.168 . . . . 2.5 107.846 174.033 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.852 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -71.45 155.68 52.47 Favored Glycine 0 CA--C 1.486 -1.732 0 N-CA-C 106.441 -2.664 . . . . 1.02 106.441 178.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.876 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -148.2 132.71 17.69 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 118.68 1.24 . . . . 2.92 108.955 174.644 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.447 ' O ' HD13 ' A' ' 11' ' ' LEU . 0.5 OUTLIER -103.91 128.12 51.42 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.242 -0.89 . . . . 1.1 112.464 -175.864 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -101.23 -45.25 5.42 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 114.317 -1.311 . . . . 1.51 109.119 178.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -122.05 -132.22 4.06 Favored Glycine 0 CA--C 1.524 0.617 0 CA-C-N 115.415 -0.811 . . . . 0.9 111.892 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -98.1 -72.82 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 123.061 2.507 . . . . 1.5 111.912 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.687 ' O ' HG13 ' A' ' 26' ' ' ILE . 0.9 OUTLIER -89.62 46.97 1.41 Allowed 'General case' 0 C--N 1.333 -0.124 0 N-CA-C 109.301 -0.629 . . . . 1.26 109.301 178.762 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 1.033 HG13 HG13 ' A' ' 36' ' ' VAL . 10.1 mt -151.65 116.97 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.97 0 CA-C-O 121.286 0.565 . . . . 0.83 111.598 -179.059 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.679 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 0.5 OUTLIER -138.77 108.09 6.12 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 107.086 -1.45 . . . . 0.92 107.086 178.865 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.967 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -123.92 130.41 52.55 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 115.276 1.584 . . . . 1.28 115.276 -176.704 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.472 ' O ' ' HB1' ' A' ' 69' ' ' ALA . . . -117.23 179.58 17.43 Favored Glycine 0 C--N 1.354 1.55 0 CA-C-O 122.393 0.996 . . . . 0.67 113.877 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -66.39 -35.98 81.7 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 126.873 2.069 . . . . 2.27 113.471 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.5 0.93 5.02 Favored 'General case' 0 N--CA 1.502 2.163 0 CA-C-O 121.928 0.87 . . . . 1.66 112.969 177.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.84 HD22 ' CE1' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -111.37 -11.71 14.11 Favored 'General case' 0 N--CA 1.416 -2.173 0 CA-C-N 113.836 -1.529 . . . . 1.37 111.559 -175.83 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.967 ' O ' ' HA ' ' A' ' 28' ' ' CYS . . . 57.28 -154.51 19.95 Favored Glycine 0 N--CA 1.437 -1.273 0 CA-C-N 115.634 -0.712 . . . . 0.73 113.494 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.998 ' HB2' HD13 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -107.38 123.37 48.27 Favored 'General case' 0 CA--C 1.502 -0.895 0 N-CA-C 114.137 1.162 . . . . 1.08 114.137 179.19 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.84 ' CE1' HD22 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -95.31 101.96 13.73 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 102.053 -3.314 . . . . 1.38 102.053 173.636 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 1.033 HG13 HG13 ' A' ' 26' ' ' ILE . 2.6 t -90.48 85.0 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 CA-C-O 122.859 1.314 . . . . 0.76 109.834 -177.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.526 ' O ' ' HA3' ' B' ' 133' ' ' GLY . . . 78.94 78.25 0.85 Allowed Glycine 0 N--CA 1.453 -0.181 0 CA-C-N 112.705 -2.043 . . . . 0.81 111.625 -179.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.768 ' CG2' ' HD1' ' B' ' 135' ' ' PHE . 0.8 OUTLIER -151.29 155.06 37.98 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 119.04 -0.505 . . . . 0.77 109.843 -178.704 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.868 ' O ' ' HB2' ' A' ' 42' ' ' LEU . . . -36.28 -43.82 0.38 Allowed 'General case' 0 N--CA 1.484 1.248 0 CA-C-O 120.92 0.39 . . . . 1.02 111.746 -177.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.729 ' O ' ' HG2' ' A' ' 43' ' ' ARG . 59.4 mm-40 -50.37 -49.59 53.78 Favored 'General case' 0 CA--C 1.545 0.774 0 O-C-N 121.996 -0.44 . . . . 2.32 110.276 178.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.85 ' O ' ' HB2' ' A' ' 44' ' ' CYS . . . -72.77 -0.8 14.29 Favored 'General case' 0 C--O 1.216 -0.693 0 CA-C-O 121.584 0.707 . . . . 0.87 111.191 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.868 ' HB2' ' O ' ' A' ' 39' ' ' ALA . 2.4 mt -55.85 -47.32 77.5 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 107.065 -1.457 . . . . 1.23 107.065 176.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.729 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -68.89 1.08 3.65 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 114.654 -1.157 . . . . 2.92 110.658 175.943 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.85 ' HB2' ' O ' ' A' ' 41' ' ' ALA . 1.2 m -63.3 -42.98 99.11 Favored 'General case' 0 C--N 1.345 0.394 0 CA-C-O 118.184 -0.912 . . . . 1.57 109.546 178.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -39.77 -12.76 0.01 OUTLIER 'General case' 0 C--N 1.361 1.107 0 N-CA-C 117.069 2.248 . . . . 3.31 117.069 -177.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.441 ' N ' ' O ' ' A' ' 44' ' ' CYS . 1.2 mm-40 -81.34 0.81 35.53 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 118.489 -1.284 . . . . 3.69 108.412 178.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.941 ' HG3' HD22 ' A' ' 11' ' ' LEU . 1.0 OUTLIER . . . . . 0 N--CA 1.449 -0.488 0 CA-C-N 114.991 -1.004 . . . . 3.99 109.954 176.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 N--CA 1.476 0.848 0 N-CA-C 110.879 -0.045 . . . . 3.12 110.879 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.544 ' O ' ' HB2' ' A' ' 66' ' ' ARG . . . 141.71 60.94 0.03 OUTLIER Glycine 0 N--CA 1.434 -1.436 0 N-CA-C 108.527 -1.829 . . . . 2.1 108.527 -178.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -117.22 74.0 0.9 Allowed 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 122.581 1.181 . . . . 4.36 109.672 -179.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 1.0 ' HB3' ' HB3' ' A' ' 67' ' ' CYS . 0.4 OUTLIER -137.62 68.34 52.26 Favored Pre-proline 0 C--N 1.3 -1.562 0 N-CA-C 105.553 -2.018 . . . . 3.55 105.553 178.521 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.443 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 26.4 Cg_endo -62.32 119.21 6.21 Favored 'Trans proline' 0 C--N 1.361 1.188 0 C-N-CA 122.537 2.158 . . . . 1.54 115.514 -176.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -145.56 -171.71 3.74 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 112.514 -2.13 . . . . 1.59 105.647 177.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.449 ' HA2' ' CE1' ' A' ' 80' ' ' HIS . . . 66.62 -166.23 39.43 Favored Glycine 0 N--CA 1.454 -0.121 0 C-N-CA 118.553 -1.784 . . . . 2.43 112.982 178.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 4.6 p -88.05 37.42 0.81 Allowed 'General case' 0 N--CA 1.487 1.381 0 CA-C-O 122.538 1.161 . . . . 4.11 110.677 -176.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 121.5 5.75 9.15 Favored Glycine 0 CA--C 1.557 2.664 0 CA-C-N 112.954 -1.93 . . . . 2.21 114.47 -176.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.893 ' HA2' ' HB3' ' A' ' 75' ' ' SER . . . -100.74 134.89 11.87 Favored Glycine 0 N--CA 1.472 1.099 0 CA-C-N 121.071 2.435 . . . . 1.62 116.275 -176.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.544 ' HB2' ' O ' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -90.43 154.87 19.34 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.023 0.529 . . . . 3.02 110.47 178.405 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 1.0 ' HB3' ' HB3' ' A' ' 59' ' ' LYS . 43.2 t -71.02 103.12 2.6 Favored 'General case' 0 N--CA 1.409 -2.501 0 N-CA-C 108.046 -1.094 . . . . 1.52 108.046 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -76.13 -40.97 51.5 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 105.481 -2.044 . . . . 1.07 105.481 176.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.472 ' HB1' ' O ' ' A' ' 29' ' ' GLY . . . -140.83 160.85 39.17 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 111.59 -2.55 . . . . 1.0 112.12 -173.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.856 ' HA ' ' HB3' ' A' ' 85' ' ' CYS . . . -53.63 120.99 6.89 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 121.602 0.715 . . . . 1.24 112.826 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.584 ' H ' ' CB ' ' A' ' 85' ' ' CYS . . . 77.53 3.71 83.43 Favored Glycine 0 N--CA 1.444 -0.832 0 N-CA-C 116.41 1.324 . . . . 1.28 116.41 176.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.998 HD13 ' HB2' ' A' ' 34' ' ' CYS . 1.1 pp -132.04 106.56 11.43 Favored 'Isoleucine or valine' 0 C--O 1.244 0.79 0 CA-C-N 118.611 1.205 . . . . 2.27 110.702 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.664 ' HB2' ' O ' ' A' ' 80' ' ' HIS . 0.1 OUTLIER -84.63 90.32 7.66 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 115.154 -0.93 . . . . 1.98 109.822 -179.118 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.74 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 0.5 OUTLIER -99.52 132.79 44.62 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 113.326 0.862 . . . . 1.33 113.326 -177.962 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.935 ' HB2' ' HD2' ' A' ' 76' ' ' PRO . 45.8 p -109.3 -177.63 0.49 Allowed Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 114.411 -1.268 . . . . 1.99 108.713 178.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.935 ' HD2' ' HB2' ' A' ' 75' ' ' SER . 64.0 Cg_endo -74.45 30.92 0.34 Allowed 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 121.351 1.367 . . . . 1.86 111.765 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 1.091 ' HB3' ' HD2' ' B' ' 180' ' ' HIS . 4.8 m-20 -143.3 -50.7 0.34 Allowed 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.593 -0.731 . . . . 2.65 110.714 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.774 ' HA2' HD11 ' A' ' 26' ' ' ILE . . . -160.64 -166.22 18.99 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 111.724 -0.55 . . . . 0.99 111.724 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.74 ' HA ' ' HA ' ' A' ' 74' ' ' CYS . 2.9 m -124.8 156.13 38.28 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 117.71 0.755 . . . . 1.34 110.391 179.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.978 ' HD2' ' HB3' ' B' ' 177' ' ' ASP . 5.8 t-80 -140.93 124.72 17.02 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.016 -0.993 . . . . 2.17 108.709 -174.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.85 132.76 14.7 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.366 0.603 . . . . 3.05 111.849 -177.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.542 ' O ' ' HA2' ' A' ' 71' ' ' GLY . 0.8 OUTLIER -141.64 119.79 7.75 Favored Pre-proline 0 CA--C 1.544 0.728 0 CA-C-N 115.138 -0.937 . . . . 2.02 110.443 -178.889 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.698 ' HA ' ' OD2' ' A' ' 86' ' ' ASP . 4.3 Cg_exo -78.28 -13.71 15.15 Favored 'Trans proline' 0 C--N 1.357 0.981 0 C-N-CA 122.822 2.348 . . . . 1.93 113.879 -178.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.38 -38.13 89.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.798 0.332 . . . . 1.53 111.699 -179.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.856 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 21.9 m -91.98 50.42 1.67 Allowed 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 116.193 -0.458 . . . . 1.88 110.569 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.698 ' OD2' ' HA ' ' A' ' 83' ' ' PRO . 78.6 m-20 . . . . . 0 CA--C 1.554 1.105 0 N-CA-C 116.015 1.857 . . . . 3.6 116.015 -177.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 110' ' ' CYS . . . . . 0.588 ' HB3' ' NE ' ' B' ' 120' ' ' ARG . 81.5 m . . . . . 0 N--CA 1.456 -0.139 0 N-CA-C 112.189 0.44 . . . . 2.61 112.189 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 111' ' ' LEU . . . . . 0.936 HD22 ' HG3' ' B' ' 147' ' ' GLU . 0.0 OUTLIER -36.29 108.58 0.39 Allowed Pre-proline 0 N--CA 1.481 1.115 0 C-N-CA 123.671 0.789 . . . . 2.47 112.417 178.876 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 112' ' ' PRO . . . . . 0.708 ' HA ' ' O ' ' B' ' 119' ' ' GLY . 39.3 Cg_endo -90.44 138.84 2.75 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 123.08 2.52 . . . . 1.47 114.055 -179.291 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.528 ' N ' ' O ' ' B' ' 119' ' ' GLY . 0.5 OUTLIER -151.79 172.38 16.25 Favored 'General case' 0 C--N 1.347 0.495 0 N-CA-C 106.822 -1.547 . . . . 1.0 106.822 179.435 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 114' ' ' GLY . . . . . 0.568 ' HA2' ' OE1' ' B' ' 140' ' ' GLU . . . 71.89 -163.38 54.41 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 119.931 -1.128 . . . . 1.16 114.379 178.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 115' ' ' PRO . . . . . 0.815 ' HG2' HD11 ' B' ' 132' ' ' LEU . 9.5 Cg_endo -69.65 130.35 19.33 Favored 'Trans proline' 0 C--N 1.367 1.549 0 C-N-CA 124.45 3.433 . . . . 1.57 113.194 178.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 70.73 -16.5 1.02 Allowed Glycine 0 C--N 1.287 -2.186 0 CA-C-N 113.041 -1.89 . . . . 1.7 109.686 -176.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 117' ' ' GLY . . . . . 0.621 ' H ' ' C ' ' B' ' 115' ' ' PRO . . . 76.87 16.44 80.77 Favored Glycine 1 N--CA 1.39 -4.42 0 CA-C-N 113.505 -1.347 . . . . 1.38 113.77 178.369 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 118' ' ' LYS . . . . . 0.474 ' H ' ' HG2' ' B' ' 118' ' ' LYS . 0.0 OUTLIER -73.85 6.95 2.86 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 122.257 1.027 . . . . 2.54 108.253 174.955 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 119' ' ' GLY . . . . . 0.708 ' O ' ' HA ' ' B' ' 112' ' ' PRO . . . -89.59 124.15 7.25 Favored Glycine 0 N--CA 1.419 -2.438 0 CA-C-N 113.933 -1.485 . . . . 1.04 115.332 -178.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.849 ' HA ' ' O ' ' B' ' 111' ' ' LEU . 0.1 OUTLIER -112.96 136.4 52.67 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 120.816 -1.402 . . . . 2.89 112.288 -171.719 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 121' ' ' CYS . . . . . 0.437 ' O ' HD13 ' B' ' 111' ' ' LEU . 0.6 OUTLIER -104.45 127.83 52.23 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.597 0.713 . . . . 1.07 112.131 -177.68 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -101.32 -45.32 5.37 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 114.656 -1.156 . . . . 1.53 109.237 179.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -122.11 -132.33 4.07 Favored Glycine 0 CA--C 1.522 0.524 0 CA-C-N 115.321 -0.854 . . . . 0.9 111.895 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -97.77 -72.84 0.0 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 123.041 2.494 . . . . 1.51 112.02 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 125' ' ' SER . . . . . 0.698 ' O ' HG13 ' B' ' 126' ' ' ILE . 0.9 OUTLIER -89.46 46.73 1.4 Allowed 'General case' 0 C--O 1.225 -0.19 0 N-CA-C 109.288 -0.634 . . . . 1.25 109.288 178.752 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 126' ' ' ILE . . . . . 0.939 ' CG1' HG13 ' B' ' 136' ' ' VAL . 13.4 mt -150.96 116.8 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 CA-C-N 116.041 -0.527 . . . . 0.85 111.735 -178.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 127' ' ' CYS . . . . . 0.675 ' HA ' ' O ' ' B' ' 120' ' ' ARG . 0.5 OUTLIER -139.02 108.3 6.1 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 106.992 -1.484 . . . . 0.89 106.992 178.627 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 128' ' ' CYS . . . . . 0.982 ' HA ' ' O ' ' B' ' 133' ' ' GLY . 0.0 OUTLIER -124.7 129.03 49.73 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 115.357 1.614 . . . . 1.23 115.357 -176.396 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 129' ' ' GLY . . . . . 0.469 ' O ' ' HB1' ' B' ' 169' ' ' ALA . . . -116.21 -178.97 18.18 Favored Glycine 0 C--N 1.356 1.644 0 CA-C-O 122.468 1.038 . . . . 0.66 113.864 -179.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -67.28 -34.88 78.32 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 126.767 2.027 . . . . 2.35 113.42 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.57 17.57 2.91 Favored 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 118.404 -1.319 . . . . 1.69 111.892 176.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 132' ' ' LEU . . . . . 0.862 HD22 ' CE1' ' B' ' 135' ' ' PHE . 0.3 OUTLIER -124.7 -13.5 6.97 Favored 'General case' 0 N--CA 1.42 -1.937 0 CA-C-N 113.17 -1.832 . . . . 1.38 109.306 -176.838 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 133' ' ' GLY . . . . . 0.982 ' O ' ' HA ' ' B' ' 128' ' ' CYS . . . 53.24 -152.48 8.49 Favored Glycine 0 N--CA 1.41 -3.085 0 CA-C-N 114.175 -1.375 . . . . 0.72 114.303 177.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 134' ' ' CYS . . . . . 0.982 ' HB2' HD13 ' B' ' 172' ' ' ILE . 0.1 OUTLIER -104.32 123.58 47.64 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 115.301 1.593 . . . . 1.08 115.301 -178.927 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 135' ' ' PHE . . . . . 0.862 ' CE1' HD22 ' B' ' 132' ' ' LEU . 0.0 OUTLIER -96.59 101.75 13.42 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 102.127 -3.286 . . . . 1.36 102.127 173.238 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 136' ' ' VAL . . . . . 0.939 HG13 ' CG1' ' B' ' 126' ' ' ILE . 3.1 t -90.41 84.71 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 CA-C-O 122.471 1.129 . . . . 0.75 109.689 -176.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 137' ' ' GLY . . . . . 0.703 ' O ' ' HA3' ' A' ' 33' ' ' GLY . . . 78.87 78.05 0.86 Allowed Glycine 0 N--CA 1.453 -0.195 0 CA-C-N 113.059 -1.882 . . . . 0.83 111.631 -179.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 138' ' ' THR . . . . . 0.748 ' CG2' ' HD1' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -150.96 155.74 39.73 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 118.928 -0.558 . . . . 0.78 109.671 -178.794 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 139' ' ' ALA . . . . . 0.865 ' O ' ' HB2' ' B' ' 142' ' ' LEU . . . -36.9 -44.06 0.48 Allowed 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 118.142 0.428 . . . . 1.04 111.949 -177.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 140' ' ' GLU . . . . . 0.724 ' O ' ' HG2' ' B' ' 143' ' ' ARG . 55.4 mm-40 -50.25 -49.42 53.14 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.775 -0.578 . . . . 2.31 110.476 178.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 141' ' ' ALA . . . . . 0.857 ' O ' ' HB2' ' B' ' 144' ' ' CYS . . . -71.02 -3.94 22.25 Favored 'General case' 0 C--O 1.214 -0.787 0 CA-C-O 121.495 0.664 . . . . 0.87 110.968 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 142' ' ' LEU . . . . . 0.865 ' HB2' ' O ' ' B' ' 139' ' ' ALA . 2.4 mt -54.39 -46.94 73.19 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 107.267 -1.382 . . . . 1.24 107.267 177.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 143' ' ' ARG . . . . . 0.724 ' HG2' ' O ' ' B' ' 140' ' ' GLU . 0.0 OUTLIER -68.9 0.81 3.96 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 114.921 -1.036 . . . . 2.93 110.727 175.872 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 144' ' ' CYS . . . . . 0.857 ' HB2' ' O ' ' B' ' 141' ' ' ALA . 1.2 m -63.06 -42.79 99.78 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 118.202 -0.904 . . . . 1.61 109.66 178.204 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -40.18 -12.67 0.01 OUTLIER 'General case' 0 C--N 1.36 1.059 0 N-CA-C 117.016 2.228 . . . . 3.35 117.016 -178.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 146' ' ' GLU . . . . . 0.44 ' N ' ' O ' ' B' ' 144' ' ' CYS . 1.2 mm-40 -81.38 0.62 36.53 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 118.515 -1.274 . . . . 3.76 108.342 178.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 147' ' ' GLU . . . . . 0.936 ' HG3' HD22 ' B' ' 111' ' ' LEU . 1.0 OUTLIER . . . . . 0 N--CA 1.449 -0.498 0 CA-C-N 114.984 -1.007 . . . . 4.01 109.931 176.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 N--CA 1.472 0.66 0 N-CA-C 111.321 0.119 . . . . 3.11 111.321 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 157' ' ' GLY . . . . . 0.536 ' O ' ' HB2' ' B' ' 166' ' ' ARG . . . 142.0 61.71 0.03 OUTLIER Glycine 0 N--CA 1.44 -1.092 0 N-CA-C 109.075 -1.61 . . . . 2.07 109.075 -178.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -117.24 64.15 0.73 Allowed 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 122.508 1.147 . . . . 4.34 110.719 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 159' ' ' LYS . . . . . 1.067 ' HB3' ' HB3' ' B' ' 167' ' ' CYS . 0.5 OUTLIER -118.64 66.79 7.19 Favored Pre-proline 0 C--N 1.31 -1.113 0 CA-C-N 113.126 -1.852 . . . . 3.54 108.083 174.457 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 160' ' ' PRO . . . . . 0.441 ' HA ' ' HA ' ' B' ' 166' ' ' ARG . 23.1 Cg_endo -62.17 119.39 6.47 Favored 'Trans proline' 0 C--O 1.231 0.145 0 N-CA-C 116.259 1.6 . . . . 1.51 116.259 -174.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 161' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -146.49 -174.4 4.45 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 112.84 -1.982 . . . . 1.58 105.84 176.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 162' ' ' GLY . . . . . 0.451 ' HA2' ' CE1' ' B' ' 180' ' ' HIS . . . 69.2 -166.07 48.43 Favored Glycine 0 CA--C 1.508 -0.366 0 C-N-CA 118.5 -1.81 . . . . 2.37 112.51 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 4.6 p -88.0 37.05 0.79 Allowed 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 122.713 1.244 . . . . 4.07 110.644 -175.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 121.57 5.62 9.16 Favored Glycine 0 CA--C 1.556 2.598 0 CA-C-N 112.833 -1.985 . . . . 2.2 114.61 -176.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 165' ' ' GLY . . . . . 0.914 ' HA2' ' HB3' ' B' ' 175' ' ' SER . . . -101.21 135.36 12.12 Favored Glycine 0 C--N 1.346 1.087 0 CA-C-N 121.319 2.56 . . . . 1.62 116.283 -177.007 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 166' ' ' ARG . . . . . 0.536 ' HB2' ' O ' ' B' ' 157' ' ' GLY . 0.0 OUTLIER -90.2 154.93 19.38 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.01 0.524 . . . . 3.05 110.497 178.391 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 167' ' ' CYS . . . . . 1.067 ' HB3' ' HB3' ' B' ' 159' ' ' LYS . 42.9 t -70.96 103.17 2.59 Favored 'General case' 0 N--CA 1.406 -2.633 0 N-CA-C 108.071 -1.085 . . . . 1.56 108.071 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 168' ' ' ALA . . . . . . . . . . . . . . . -75.95 -41.38 51.78 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 105.363 -2.088 . . . . 1.04 105.363 176.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 169' ' ' ALA . . . . . 0.518 ' CB ' ' HA2' ' B' ' 133' ' ' GLY . . . -140.45 160.74 39.32 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 111.547 -2.57 . . . . 0.98 112.047 -173.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 170' ' ' ALA . . . . . 0.866 ' HA ' ' HB3' ' B' ' 185' ' ' CYS . . . -53.76 121.03 7.04 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 121.686 0.755 . . . . 1.25 112.792 -179.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 171' ' ' GLY . . . . . 0.579 ' H ' ' CB ' ' B' ' 185' ' ' CYS . . . 77.52 3.75 83.47 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 116.369 1.308 . . . . 1.29 116.369 176.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 172' ' ' ILE . . . . . 0.982 HD13 ' HB2' ' B' ' 134' ' ' CYS . 1.1 pp -131.97 106.41 11.26 Favored 'Isoleucine or valine' 0 C--O 1.245 0.823 0 CA-C-N 118.482 1.141 . . . . 2.27 110.781 -179.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 173' ' ' CYS . . . . . 0.697 ' HB2' ' O ' ' B' ' 180' ' ' HIS . 0.1 OUTLIER -84.52 90.51 7.65 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 115.153 -0.931 . . . . 1.94 109.755 -179.2 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 174' ' ' CYS . . . . . 0.775 ' HA ' ' HA ' ' B' ' 179' ' ' CYS . 0.5 OUTLIER -99.84 132.86 44.93 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 113.241 0.83 . . . . 1.35 113.241 -177.986 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 175' ' ' SER . . . . . 0.929 ' HB2' ' HD2' ' B' ' 176' ' ' PRO . 43.5 p -109.34 -177.58 0.48 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 114.269 -1.332 . . . . 2.0 108.686 178.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 176' ' ' PRO . . . . . 0.929 ' HD2' ' HB2' ' B' ' 175' ' ' SER . 62.8 Cg_endo -74.48 30.95 0.34 Allowed 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 121.387 1.391 . . . . 1.9 111.768 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 177' ' ' ASP . . . . . 0.978 ' HB3' ' HD2' ' A' ' 80' ' ' HIS . 4.8 m-20 -143.22 -50.79 0.34 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.523 -0.762 . . . . 2.72 110.778 179.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 178' ' ' GLY . . . . . 0.76 ' HA2' HD11 ' B' ' 126' ' ' ILE . . . -160.48 -166.05 18.52 Favored Glycine 0 CA--C 1.522 0.48 0 N-CA-C 111.752 -0.539 . . . . 0.99 111.752 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 179' ' ' CYS . . . . . 0.775 ' HA ' ' HA ' ' B' ' 174' ' ' CYS . 3.1 m -124.26 160.78 27.2 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 117.718 0.759 . . . . 1.34 110.144 179.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 180' ' ' HIS . . . . . 1.091 ' HD2' ' HB3' ' A' ' 77' ' ' ASP . 5.6 t-80 -148.72 123.21 9.72 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-O 121.663 0.744 . . . . 2.1 109.072 -174.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 181' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -46.78 132.41 11.33 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 114.572 -1.194 . . . . 3.06 111.921 -176.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 182' ' ' ASP . . . . . 0.532 ' O ' ' HA2' ' B' ' 171' ' ' GLY . 0.9 OUTLIER -141.54 119.84 7.84 Favored Pre-proline 0 CA--C 1.545 0.751 0 CA-C-N 114.909 -1.041 . . . . 2.06 110.341 -178.735 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 183' ' ' PRO . . . . . 0.704 ' HA ' ' OD2' ' B' ' 186' ' ' ASP . 4.4 Cg_exo -78.31 -13.81 15.06 Favored 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 122.836 2.358 . . . . 1.91 113.854 -178.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -64.26 -38.27 90.44 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.834 0.35 . . . . 1.56 111.661 -179.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 185' ' ' CYS . . . . . 0.866 ' HB3' ' HA ' ' B' ' 170' ' ' ALA . 21.8 m -91.91 50.34 1.67 Allowed 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 116.179 -0.464 . . . . 1.94 110.53 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 186' ' ' ASP . . . . . 0.704 ' OD2' ' HA ' ' B' ' 183' ' ' PRO . 78.5 m-20 . . . . . 0 CA--C 1.551 1.013 0 N-CA-C 116.042 1.867 . . . . 3.61 116.042 -177.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.439 ' SG ' ' HB3' ' A' ' 20' ' ' ARG . 12.5 p . . . . . 0 CA--C 1.542 0.668 0 N-CA-C 113.806 1.039 . . . . 2.68 113.806 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.415 ' O ' ' O ' ' A' ' 10' ' ' CYS . 26.1 mt -30.96 154.53 0.03 OUTLIER Pre-proline 0 N--CA 1.48 1.039 0 C-N-CA 123.872 0.869 . . . . 2.48 113.305 178.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.719 ' HB2' ' O ' ' A' ' 17' ' ' GLY . 33.4 Cg_endo -91.92 117.39 0.44 Allowed 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 123.312 2.675 . . . . 1.49 116.295 -178.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.647 ' SG ' ' O ' ' A' ' 20' ' ' ARG . 10.6 p -106.64 -156.41 0.58 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.693 1.197 . . . . 1.0 110.515 -176.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 79.96 -168.22 51.98 Favored Glycine 0 CA--C 1.498 -0.987 0 N-CA-C 110.373 -1.091 . . . . 1.15 110.373 -177.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.595 ' HD2' HD11 ' A' ' 32' ' ' LEU . 85.2 Cg_endo -63.8 89.87 0.15 Allowed 'Trans proline' 0 CA--C 1.51 -0.706 0 CA-C-N 119.793 1.796 . . . . 1.57 110.932 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.88 18.3 63.67 Favored Glycine 0 N--CA 1.418 -2.548 0 CA-C-N 114.168 -1.378 . . . . 1.68 114.199 177.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.719 ' O ' ' HB2' ' A' ' 12' ' ' PRO . . . 84.18 36.76 12.19 Favored Glycine 0 N--CA 1.404 -3.485 0 C-N-CA 118.077 -2.011 . . . . 1.36 115.947 176.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.543 ' HG3' ' HG2' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -92.63 -12.54 31.35 Favored 'General case' 0 CA--C 1.559 1.32 0 CA-C-N 115.0 -0.6 . . . . 2.5 110.999 175.896 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.531 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -102.21 -176.79 27.69 Favored Glycine 0 N--CA 1.478 1.467 0 C-N-CA 126.298 1.904 . . . . 1.02 109.379 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.647 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -126.18 168.97 13.32 Favored 'General case' 0 C--N 1.354 0.786 0 CA-C-N 122.707 3.253 . . . . 2.92 105.7 175.368 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.673 ' HB2' ' HG2' ' A' ' 47' ' ' GLU . 33.7 m -108.49 163.08 13.54 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 119.334 0.97 . . . . 1.1 113.331 -178.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -143.47 -57.04 0.4 Allowed 'General case' 0 C--O 1.232 0.146 0 CA-C-N 114.82 -1.082 . . . . 1.51 109.913 178.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.556 ' O ' ' HB3' ' A' ' 44' ' ' CYS . . . -120.54 176.91 16.33 Favored Glycine 0 C--N 1.332 0.319 0 CA-C-N 115.866 -0.606 . . . . 0.9 112.005 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.437 ' HB2' ' OE1' ' B' ' 181' ' ' GLU . 47.7 Cg_exo -53.67 -68.77 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.49 2.127 . . . . 1.5 112.368 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.65 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.5 OUTLIER -95.59 18.19 13.33 Favored 'General case' 0 C--O 1.224 -0.271 0 N-CA-C 109.995 -0.372 . . . . 1.26 109.995 178.878 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.931 HG12 HG13 ' A' ' 36' ' ' VAL . 1.2 mt -122.41 106.26 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 CA-C-O 121.751 0.786 . . . . 0.83 111.797 -177.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.748 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 0.6 OUTLIER -121.94 124.13 43.31 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 114.725 -1.125 . . . . 0.92 109.615 -179.011 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 1.178 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -138.52 112.82 8.72 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 114.978 1.473 . . . . 1.28 114.978 -178.607 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.419 ' O ' ' CB ' ' A' ' 69' ' ' ALA . . . -106.41 -159.17 22.03 Favored Glycine 0 N--CA 1.429 -1.832 0 N-CA-C 109.559 -1.416 . . . . 0.67 109.559 175.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -65.5 -64.86 0.76 Allowed 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 112.69 0.626 . . . . 2.27 112.69 -178.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.51 17.36 20.85 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 122.61 1.195 . . . . 1.66 109.808 -176.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.595 HD11 ' HD2' ' A' ' 15' ' ' PRO . 0.3 OUTLIER -113.95 -11.72 12.74 Favored 'General case' 0 N--CA 1.404 -2.759 0 N-CA-C 105.486 -2.042 . . . . 1.37 105.486 -179.642 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 1.178 ' O ' ' HA ' ' A' ' 28' ' ' CYS . . . 50.68 -135.48 29.33 Favored Glycine 0 N--CA 1.415 -2.758 0 CA-C-N 114.275 -1.33 . . . . 0.73 111.769 175.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.981 ' HB2' HD13 ' A' ' 72' ' ' ILE . 1.8 t -129.04 111.85 13.41 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-N 118.803 1.301 . . . . 1.08 112.678 179.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.827 ' HA ' ' HA ' ' B' ' 135' ' ' PHE . 6.2 m-30 -85.18 105.41 15.86 Favored 'General case' 0 N--CA 1.408 -2.525 0 N-CA-C 103.543 -2.762 . . . . 1.38 103.543 176.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.931 HG13 HG12 ' A' ' 26' ' ' ILE . 2.2 t -97.27 85.27 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.75 0 CA-C-O 123.129 1.443 . . . . 0.76 107.79 -178.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.779 ' HA3' HG21 ' B' ' 172' ' ' ILE . . . 110.97 92.96 2.17 Favored Glycine 0 CA--C 1.521 0.464 0 CA-C-N 112.427 -2.169 . . . . 0.81 114.263 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.715 ' CG2' ' HB3' ' A' ' 35' ' ' PHE . 0.0 OUTLIER 178.77 169.26 0.89 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 110.096 -0.335 . . . . 0.77 110.096 178.29 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.784 ' HA ' HD12 ' A' ' 42' ' ' LEU . . . -68.42 -35.83 78.21 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.832 -0.347 . . . . 1.02 110.933 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.86 -24.18 14.94 Favored 'General case' 0 C--N 1.332 -0.181 0 O-C-N 122.093 -0.379 . . . . 2.32 111.691 -178.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.675 ' O ' ' N ' ' A' ' 44' ' ' CYS . . . -97.23 -23.33 16.22 Favored 'General case' 0 C--O 1.214 -0.781 0 CA-C-N 116.818 -0.174 . . . . 0.87 111.242 -179.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.784 HD12 ' HA ' ' A' ' 39' ' ' ALA . 1.0 OUTLIER -37.38 -46.73 0.8 Allowed 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.969 0.729 . . . . 1.23 112.969 -175.771 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.531 ' HD2' ' H ' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -53.7 -25.68 19.43 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.813 -0.81 . . . . 2.92 108.813 177.557 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.675 ' N ' ' O ' ' A' ' 41' ' ' ALA . 86.2 m -57.33 -20.57 29.67 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.427 -0.806 . . . . 1.57 110.473 -178.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -39.09 -45.04 1.22 Allowed 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.594 0.59 . . . . 3.31 112.594 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -87.74 -7.57 57.17 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 119.873 -0.731 . . . . 3.69 110.991 -179.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.673 ' HG2' ' HB2' ' A' ' 21' ' ' CYS . 0.8 OUTLIER . . . . . 0 N--CA 1.442 -0.826 0 CA-C-N 115.903 -0.589 . . . . 3.99 109.453 177.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.2 t . . . . . 0 N--CA 1.463 0.182 0 N-CA-C 112.569 0.581 . . . . 3.12 112.569 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 164.17 35.23 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 110.534 -1.026 . . . . 2.1 110.534 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.535 ' HA ' ' HB2' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -123.26 88.99 3.02 Favored 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 109.043 -0.725 . . . . 4.36 109.043 179.611 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.554 ' HB3' ' HB2' ' A' ' 67' ' ' CYS . 0.5 OUTLIER -135.52 81.39 42.42 Favored Pre-proline 0 C--N 1.296 -1.755 0 N-CA-C 106.065 -1.828 . . . . 3.55 106.065 -178.647 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.501 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 12.0 Cg_endo -55.44 107.18 0.22 Allowed 'Trans proline' 0 C--N 1.358 1.05 0 C-N-CA 123.868 3.046 . . . . 1.54 114.241 -177.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.59 ' SG ' ' HB2' ' A' ' 84' ' ' ALA . 0.5 OUTLIER -144.34 149.63 36.49 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-N 114.333 -1.303 . . . . 1.59 110.144 178.811 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 79.36 -167.26 51.97 Favored Glycine 0 C--N 1.339 0.73 0 C-N-CA 119.039 -1.553 . . . . 2.43 109.683 -173.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.05 66.67 0.15 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 118.668 1.234 . . . . 4.11 112.472 -175.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.22 13.73 80.24 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.984 -0.627 . . . . 2.21 114.347 177.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.482 ' O ' ' O ' ' A' ' 61' ' ' CYS . . . -101.01 122.19 7.51 Favored Glycine 0 CA--C 1.501 -0.836 0 C-N-CA 119.59 -1.29 . . . . 1.62 113.66 -175.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.535 ' HB2' ' HA ' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -86.54 152.24 22.8 Favored 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 110.067 -0.345 . . . . 3.02 110.067 -178.929 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.554 ' HB2' ' HB3' ' A' ' 59' ' ' LYS . 0.1 OUTLIER -67.03 106.54 1.98 Allowed 'General case' 0 N--CA 1.423 -1.802 0 N-CA-C 108.674 -0.862 . . . . 1.52 108.674 -179.196 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -91.88 -23.72 19.55 Favored 'General case' 0 N--CA 1.417 -2.108 0 N-CA-C 107.468 -1.308 . . . . 1.07 107.468 177.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.906 ' HB1' ' HA2' ' A' ' 33' ' ' GLY . . . -169.72 163.26 9.92 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 109.875 -0.417 . . . . 1.0 109.875 -178.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.851 ' HA ' ' HB3' ' A' ' 85' ' ' CYS . . . -37.35 127.06 1.05 Allowed 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 115.611 1.708 . . . . 1.24 115.611 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.627 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . 59.08 -6.39 0.05 OUTLIER Glycine 0 C--N 1.342 0.912 0 N-CA-C 115.97 1.148 . . . . 1.28 115.97 177.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.981 HD13 ' HB2' ' A' ' 34' ' ' CYS . 1.6 pp -117.58 105.82 18.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 117.662 0.731 . . . . 2.27 111.846 -178.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -91.93 106.7 18.66 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.018 -0.992 . . . . 1.98 108.844 179.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.671 ' SG ' HD12 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -129.65 170.49 13.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 122.113 0.958 . . . . 1.33 113.561 -178.436 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.763 ' HB3' ' HD2' ' A' ' 76' ' ' PRO . 10.3 m -130.42 179.62 1.28 Allowed Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 113.297 -1.774 . . . . 1.99 106.947 178.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.763 ' HD2' ' HB3' ' A' ' 75' ' ' SER . 58.1 Cg_endo -75.94 30.81 0.39 Allowed 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 120.994 1.129 . . . . 1.86 112.258 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.433 ' H ' ' C ' ' A' ' 75' ' ' SER . 2.7 m-20 -138.16 -57.15 0.66 Allowed 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.859 -0.61 . . . . 2.65 109.925 179.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.532 ' HA3' ' HD2' ' B' ' 180' ' ' HIS . . . -139.31 -178.15 16.23 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.507 -0.854 . . . . 0.99 112.842 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.515 ' SG ' ' HB ' ' A' ' 72' ' ' ILE . 13.4 t -142.48 160.68 39.8 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 110.139 -0.319 . . . . 1.34 110.139 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.521 ' HD2' ' HA3' ' B' ' 178' ' ' GLY . 0.3 OUTLIER -149.7 134.68 17.93 Favored 'General case' 0 CA--C 1.521 -0.164 0 C-N-CA 119.986 -0.686 . . . . 2.17 112.179 -178.587 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.86 119.46 10.04 Favored 'General case' 0 CA--C 1.51 -0.59 0 N-CA-C 108.363 -0.977 . . . . 3.05 108.363 177.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.423 ' OD1' ' HB2' ' A' ' 84' ' ' ALA . 0.2 OUTLIER -154.48 139.18 11.65 Favored Pre-proline 0 C--N 1.317 -0.846 0 C-N-CA 120.534 -0.466 . . . . 2.02 110.971 -179.013 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 82' ' ' ASP . 12.7 Cg_exo -70.17 41.84 0.36 Allowed 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.987 2.458 . . . . 1.93 113.049 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.59 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . . . -75.11 -58.96 2.96 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-O 122.698 1.237 . . . . 1.53 109.363 178.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.851 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 52.5 m -105.78 80.98 1.6 Allowed 'General case' 0 N--CA 1.435 -1.222 0 CA-C-N 112.507 -2.133 . . . . 1.88 109.102 -179.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.287 0 CA-C-N 116.007 -0.542 . . . . 3.6 111.942 -178.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 110' ' ' CYS . . . . . 0.45 ' SG ' ' HB3' ' B' ' 120' ' ' ARG . 12.0 p . . . . . 0 CA--C 1.545 0.767 0 N-CA-C 114.003 1.112 . . . . 2.61 114.003 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 111' ' ' LEU . . . . . 0.421 ' O ' ' O ' ' B' ' 110' ' ' CYS . 25.5 mt -30.19 154.3 0.03 OUTLIER Pre-proline 0 N--CA 1.481 1.081 0 N-CA-C 113.314 0.857 . . . . 2.47 113.314 178.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 112' ' ' PRO . . . . . 0.744 ' HB2' ' O ' ' B' ' 117' ' ' GLY . 48.5 Cg_endo -88.14 122.32 1.53 Allowed 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.423 2.749 . . . . 1.47 113.726 -178.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.646 ' SG ' ' O ' ' B' ' 120' ' ' ARG . 8.1 p -109.26 -153.59 0.51 Allowed 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 121.267 0.556 . . . . 1.0 110.625 178.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . 78.9 -168.13 53.26 Favored Glycine 0 CA--C 1.49 -1.498 0 N-CA-C 110.361 -1.096 . . . . 1.16 110.361 -179.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 115' ' ' PRO . . . . . 0.637 ' HD2' HD11 ' B' ' 132' ' ' LEU . 97.2 Cg_endo -64.59 85.93 0.16 Allowed 'Trans proline' 0 N--CA 1.45 -1.044 0 CA-C-N 119.556 1.678 . . . . 1.57 113.608 -178.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 86.13 19.22 57.84 Favored Glycine 0 N--CA 1.423 -2.192 0 CA-C-N 113.154 -1.839 . . . . 1.7 115.083 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 117' ' ' GLY . . . . . 0.744 ' O ' ' HB2' ' B' ' 112' ' ' PRO . . . 87.33 34.7 10.24 Favored Glycine 0 N--CA 1.413 -2.883 0 C-N-CA 119.536 -1.316 . . . . 1.38 116.182 176.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 118' ' ' LYS . . . . . 0.553 ' HG3' ' HG2' ' B' ' 115' ' ' PRO . 0.1 OUTLIER -93.03 -7.37 45.92 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 122.252 0.221 . . . . 2.54 111.267 177.289 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 119' ' ' GLY . . . . . 0.609 ' O ' ' HA ' ' B' ' 112' ' ' PRO . . . -114.89 -169.22 16.0 Favored Glycine 0 C--N 1.344 1.008 0 N-CA-C 108.112 -1.995 . . . . 1.04 108.112 177.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.646 ' O ' ' SG ' ' B' ' 113' ' ' CYS . 0.0 OUTLIER -125.08 168.69 13.03 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 120.934 2.367 . . . . 2.89 108.838 179.589 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 121' ' ' CYS . . . . . 0.681 ' HB2' ' HG2' ' B' ' 147' ' ' GLU . 33.4 m -108.28 162.45 14.08 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.201 0.815 . . . . 1.07 113.201 -178.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -143.52 -56.98 0.4 Allowed 'General case' 0 C--O 1.231 0.107 0 CA-C-N 114.698 -1.137 . . . . 1.53 109.91 179.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 123' ' ' GLY . . . . . 0.58 ' O ' ' HB3' ' B' ' 144' ' ' CYS . . . -120.83 177.07 16.36 Favored Glycine 0 CA--C 1.52 0.36 0 CA-C-N 115.898 -0.592 . . . . 0.9 112.029 179.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . 0.423 ' O ' ' HB2' ' B' ' 144' ' ' CYS . 51.2 Cg_exo -53.58 -68.93 0.06 OUTLIER 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.515 2.143 . . . . 1.51 112.427 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 125' ' ' SER . . . . . 0.654 ' O ' ' N ' ' B' ' 137' ' ' GLY . 0.5 OUTLIER -95.47 18.33 12.88 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-O 120.88 0.372 . . . . 1.25 110.018 178.794 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 126' ' ' ILE . . . . . 0.924 HG12 HG13 ' B' ' 136' ' ' VAL . 1.5 mt -122.21 105.8 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 CA-C-O 121.546 0.688 . . . . 0.85 111.951 -177.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 127' ' ' CYS . . . . . 0.751 ' O ' ' HA ' ' B' ' 134' ' ' CYS . 0.6 OUTLIER -122.02 124.5 44.12 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 114.821 -1.081 . . . . 0.89 109.828 -179.175 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 128' ' ' CYS . . . . . 1.17 ' HA ' ' O ' ' B' ' 133' ' ' GLY . 0.0 OUTLIER -140.16 110.49 6.63 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 115.995 1.85 . . . . 1.23 115.995 -178.097 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 129' ' ' GLY . . . . . 0.433 ' HA2' ' HE ' ' B' ' 120' ' ' ARG . . . -102.77 -161.05 25.78 Favored Glycine 0 N--CA 1.433 -1.53 0 N-CA-C 110.499 -1.04 . . . . 0.66 110.499 176.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -68.32 -56.97 6.73 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 114.766 1.395 . . . . 2.35 114.766 -177.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.34 29.27 7.56 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 122.81 1.29 . . . . 1.69 109.478 178.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 132' ' ' LEU . . . . . 0.637 HD11 ' HD2' ' B' ' 115' ' ' PRO . 0.3 OUTLIER -123.66 -12.21 7.67 Favored 'General case' 0 N--CA 1.4 -2.926 0 N-CA-C 104.16 -2.533 . . . . 1.38 104.16 179.425 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 133' ' ' GLY . . . . . 1.17 ' O ' ' HA ' ' B' ' 128' ' ' CYS . . . 51.09 -132.66 33.16 Favored Glycine 0 N--CA 1.4 -3.755 0 CA-C-N 113.424 -1.716 . . . . 0.72 112.674 176.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 134' ' ' CYS . . . . . 0.997 ' HB2' HD13 ' B' ' 172' ' ' ILE . 1.7 t -129.42 112.43 13.8 Favored 'General case' 0 CA--C 1.495 -1.152 0 CA-C-N 118.413 1.106 . . . . 1.08 112.675 178.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 135' ' ' PHE . . . . . 0.827 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 6.2 m-30 -86.72 105.27 16.83 Favored 'General case' 0 N--CA 1.407 -2.578 0 N-CA-C 103.452 -2.796 . . . . 1.36 103.452 175.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 136' ' ' VAL . . . . . 0.924 HG13 HG12 ' B' ' 126' ' ' ILE . 2.8 t -97.15 85.32 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.728 0 CA-C-O 122.913 1.34 . . . . 0.75 107.64 -178.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 137' ' ' GLY . . . . . 0.801 ' HA3' HG21 ' A' ' 72' ' ' ILE . . . 110.7 92.93 2.18 Favored Glycine 0 CA--C 1.522 0.507 0 CA-C-N 112.64 -2.073 . . . . 0.83 114.193 -179.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 138' ' ' THR . . . . . 0.714 ' CG2' ' HB3' ' B' ' 135' ' ' PHE . 0.0 OUTLIER 178.84 169.97 0.88 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.761 -0.459 . . . . 0.78 109.761 178.298 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 139' ' ' ALA . . . . . 0.711 ' HA ' HD12 ' B' ' 142' ' ' LEU . . . -74.59 -22.89 58.72 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.586 0.588 . . . . 1.04 112.586 -179.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 140' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.7 -25.37 67.37 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.904 -0.318 . . . . 2.31 110.587 178.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 141' ' ' ALA . . . . . 0.682 ' O ' ' N ' ' B' ' 144' ' ' CYS . . . -97.36 -20.79 17.59 Favored 'General case' 0 C--O 1.213 -0.866 0 CA-C-N 116.265 -0.425 . . . . 0.87 111.583 -178.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 142' ' ' LEU . . . . . 0.711 HD12 ' HA ' ' B' ' 139' ' ' ALA . 0.9 OUTLIER -38.16 -47.41 1.15 Allowed 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 112.701 0.63 . . . . 1.24 112.701 -176.73 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 143' ' ' ARG . . . . . 0.508 ' HD2' ' H ' ' B' ' 143' ' ' ARG . 0.0 OUTLIER -54.0 -24.56 17.32 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.07 -0.715 . . . . 2.93 109.07 177.475 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 144' ' ' CYS . . . . . 0.682 ' N ' ' O ' ' B' ' 141' ' ' ALA . 93.6 m -56.09 -24.96 43.55 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 114.292 -1.322 . . . . 1.61 109.496 -179.154 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -36.47 -45.55 0.5 Allowed 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.929 0.714 . . . . 3.35 112.929 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -87.84 -7.39 57.3 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 119.826 -0.75 . . . . 3.76 111.017 -178.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 147' ' ' GLU . . . . . 0.681 ' HG2' ' HB2' ' B' ' 121' ' ' CYS . 0.8 OUTLIER . . . . . 0 N--CA 1.442 -0.832 0 CA-C-N 115.875 -0.602 . . . . 4.01 109.411 177.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 2.3 t . . . . . 0 CA--C 1.529 0.172 0 N-CA-C 112.782 0.66 . . . . 3.11 112.782 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 165.34 34.96 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 CA-C-N 115.015 -0.993 . . . . 2.07 111.22 179.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 158' ' ' GLN . . . . . 0.557 ' HA ' ' HB2' ' B' ' 166' ' ' ARG . 0.0 OUTLIER -122.86 73.42 1.14 Allowed 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 121.437 0.637 . . . . 4.34 111.059 179.395 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 159' ' ' LYS . . . . . 0.476 ' CB ' ' HB2' ' B' ' 167' ' ' CYS . 0.9 OUTLIER -106.18 79.37 0.58 Allowed Pre-proline 0 C--N 1.314 -0.953 0 CA-C-O 117.788 -1.101 . . . . 3.54 110.673 175.544 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 160' ' ' PRO . . . . . 0.497 ' HA ' ' HA ' ' B' ' 166' ' ' ARG . 11.9 Cg_endo -55.2 108.36 0.3 Allowed 'Trans proline' 0 CA--C 1.531 0.343 0 C-N-CA 122.074 1.849 . . . . 1.51 114.868 -177.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 161' ' ' CYS . . . . . 0.596 ' SG ' ' HB2' ' B' ' 184' ' ' ALA . 0.5 OUTLIER -142.08 155.33 45.37 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 114.831 -1.077 . . . . 1.58 108.847 178.652 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 162' ' ' GLY . . . . . 0.44 ' O ' ' N ' ' B' ' 164' ' ' GLY . . . 74.82 -166.24 54.84 Favored Glycine 0 CA--C 1.521 0.427 0 C-N-CA 118.716 -1.707 . . . . 2.37 110.004 -176.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.79 65.11 0.12 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.729 1.264 . . . . 4.07 112.421 -176.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 164' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' B' ' 162' ' ' GLY . . . 78.91 19.6 72.48 Favored Glycine 0 CA--C 1.502 -0.77 0 C-N-CA 120.8 -0.714 . . . . 2.2 113.906 176.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 165' ' ' GLY . . . . . 0.487 ' O ' ' O ' ' B' ' 161' ' ' CYS . . . -103.42 126.44 8.81 Favored Glycine 0 N--CA 1.439 -1.105 0 C-N-CA 119.779 -1.2 . . . . 1.62 112.741 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 166' ' ' ARG . . . . . 0.557 ' HB2' ' HA ' ' B' ' 158' ' ' GLN . 0.0 OUTLIER -87.74 152.89 21.78 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.567 -0.317 . . . . 3.05 110.177 179.453 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 167' ' ' CYS . . . . . 0.476 ' HB2' ' CB ' ' B' ' 159' ' ' LYS . 0.1 OUTLIER -67.29 106.35 2.03 Favored 'General case' 0 N--CA 1.418 -2.058 0 N-CA-C 108.577 -0.898 . . . . 1.56 108.577 -179.299 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 168' ' ' ALA . . . . . 0.404 ' HB1' ' SG ' ' B' ' 128' ' ' CYS . . . -86.43 -33.09 20.54 Favored 'General case' 0 N--CA 1.424 -1.728 0 N-CA-C 105.637 -1.986 . . . . 1.04 105.637 177.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 169' ' ' ALA . . . . . 0.889 ' HB1' ' HA2' ' B' ' 133' ' ' GLY . . . -164.01 163.45 23.38 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 114.502 -1.226 . . . . 0.98 111.403 -174.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 170' ' ' ALA . . . . . 0.861 ' HA ' ' HB3' ' B' ' 185' ' ' CYS . . . -37.03 127.02 0.94 Allowed 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 115.288 1.588 . . . . 1.25 115.288 -179.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 171' ' ' GLY . . . . . 0.633 ' N ' ' O ' ' B' ' 185' ' ' CYS . . . 61.51 -11.94 0.06 OUTLIER Glycine 0 C--N 1.339 0.729 0 N-CA-C 115.806 1.083 . . . . 1.29 115.806 177.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 172' ' ' ILE . . . . . 0.997 HD13 ' HB2' ' B' ' 134' ' ' CYS . 1.6 pp -114.17 106.31 20.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 121.605 0.717 . . . . 2.27 112.191 -176.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 173' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -92.14 106.8 18.73 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.113 -0.949 . . . . 1.94 108.835 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 174' ' ' CYS . . . . . 0.677 ' SG ' HD12 ' B' ' 172' ' ' ILE . 0.0 OUTLIER -129.74 170.44 13.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 122.199 0.999 . . . . 1.35 113.598 -178.441 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 175' ' ' SER . . . . . 0.77 ' HB3' ' HD2' ' B' ' 176' ' ' PRO . 9.9 m -130.29 179.52 1.31 Allowed Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 113.303 -1.771 . . . . 2.0 106.993 178.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 176' ' ' PRO . . . . . 0.77 ' HD2' ' HB3' ' B' ' 175' ' ' SER . 58.1 Cg_endo -75.84 30.83 0.38 Allowed 'Trans proline' 0 N--CA 1.461 -0.422 0 CA-C-N 120.12 1.079 . . . . 1.9 112.28 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 177' ' ' ASP . . . . . 0.428 ' H ' ' C ' ' B' ' 175' ' ' SER . 2.7 m-20 -138.25 -56.96 0.65 Allowed 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.868 -0.606 . . . . 2.72 109.956 179.184 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 178' ' ' GLY . . . . . 0.521 ' HA3' ' HD2' ' A' ' 80' ' ' HIS . . . -139.33 -178.22 16.31 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.598 -0.811 . . . . 0.99 112.948 179.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 179' ' ' CYS . . . . . 0.52 ' SG ' ' HB ' ' B' ' 172' ' ' ILE . 13.4 t -142.55 160.61 39.95 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 110.148 -0.316 . . . . 1.34 110.148 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 180' ' ' HIS . . . . . 0.532 ' HD2' ' HA3' ' A' ' 78' ' ' GLY . 0.3 OUTLIER -149.69 134.74 18.0 Favored 'General case' 0 CA--C 1.521 -0.17 0 C-N-CA 119.925 -0.71 . . . . 2.1 112.187 -178.603 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 181' ' ' GLU . . . . . 0.437 ' OE1' ' HB2' ' A' ' 24' ' ' PRO . 0.2 OUTLIER -63.9 119.5 10.16 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 108.337 -0.986 . . . . 3.06 108.337 177.953 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 182' ' ' ASP . . . . . 0.433 ' HA ' ' HD3' ' B' ' 183' ' ' PRO . 0.2 OUTLIER -154.52 139.14 11.6 Favored Pre-proline 0 C--N 1.316 -0.872 0 C-N-CA 120.452 -0.499 . . . . 2.06 110.939 -178.995 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 183' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' B' ' 182' ' ' ASP . 12.7 Cg_exo -70.09 41.69 0.35 Allowed 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.943 2.429 . . . . 1.91 113.139 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 184' ' ' ALA . . . . . 0.596 ' HB2' ' SG ' ' B' ' 161' ' ' CYS . . . -75.01 -58.94 2.97 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 122.651 1.215 . . . . 1.56 109.343 178.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 185' ' ' CYS . . . . . 0.861 ' HB3' ' HA ' ' B' ' 170' ' ' ALA . 49.0 m -105.6 80.33 1.55 Allowed 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 112.508 -2.133 . . . . 1.94 109.297 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 186' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.071 -0.513 . . . . 3.61 112.178 -177.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.844 ' HB3' ' HG2' ' A' ' 20' ' ' ARG . 0.1 OUTLIER . . . . . 0 CA--C 1.543 0.695 0 N-CA-C 114.52 1.304 . . . . 2.68 114.52 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.569 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 1.3 tt -32.21 112.31 0.35 Allowed Pre-proline 0 N--CA 1.484 1.269 0 CA-C-N 119.294 0.952 . . . . 2.48 111.589 177.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.858 ' HB2' ' O ' ' A' ' 17' ' ' GLY . 41.4 Cg_endo -94.82 125.58 0.4 Allowed 'Trans proline' 0 C--N 1.356 0.948 0 C-N-CA 123.567 2.845 . . . . 1.49 114.65 -178.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.629 ' SG ' ' N ' ' A' ' 14' ' ' GLY . 0.0 OUTLIER -140.82 -168.43 2.59 Favored 'General case' 0 C--N 1.353 0.729 0 CA-C-N 118.228 0.467 . . . . 1.0 111.183 -176.472 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 1.022 ' HA2' ' HB3' ' A' ' 40' ' ' GLU . . . 75.23 -163.81 54.14 Favored Glycine 0 CA--C 1.501 -0.787 0 C-N-CA 120.832 -0.699 . . . . 1.15 111.705 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.409 ' HD3' ' OE1' ' A' ' 40' ' ' GLU . 49.5 Cg_endo -63.2 142.04 84.99 Favored 'Trans proline' 0 N--CA 1.446 -1.315 0 N-CA-C 106.867 -2.013 . . . . 1.57 106.867 175.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 62.73 -12.24 0.1 OUTLIER Glycine 0 C--N 1.269 -3.176 0 C-N-CA 124.66 1.124 . . . . 1.68 113.38 -179.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.858 ' O ' ' HB2' ' A' ' 12' ' ' PRO . . . 64.9 20.14 66.28 Favored Glycine 1 N--CA 1.391 -4.333 0 C-N-CA 116.978 -2.534 . . . . 1.36 110.58 179.411 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.464 ' HB2' HD12 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -92.18 -1.61 57.04 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 113.293 -1.454 . . . . 2.5 113.31 179.879 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.811 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -116.67 177.73 16.93 Favored Glycine 0 C--N 1.335 0.476 0 N-CA-C 108.488 -1.845 . . . . 1.02 108.488 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.844 ' HG2' ' HB3' ' A' ' 10' ' ' CYS . 0.5 OUTLIER -119.75 173.06 7.26 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 120.408 2.104 . . . . 2.92 111.193 179.89 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.436 ' CB ' ' HG3' ' A' ' 47' ' ' GLU . 4.6 m -105.86 147.43 28.71 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.027 0.441 . . . . 1.1 110.422 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.412 ' HE1' ' O ' ' A' ' 28' ' ' CYS . 44.0 m-85 -137.6 -52.07 0.64 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.807 -0.633 . . . . 1.51 110.711 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.565 ' O ' ' HB3' ' A' ' 44' ' ' CYS . . . -101.4 -166.2 27.56 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.858 -0.687 . . . . 0.9 111.714 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.454 ' O ' ' HB2' ' A' ' 44' ' ' CYS . 2.4 Cg_endo -77.31 -60.64 0.04 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.404 2.069 . . . . 1.5 111.54 179.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -102.86 26.34 8.21 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.794 -0.639 . . . . 1.26 109.935 179.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.831 HG22 ' SG ' ' A' ' 34' ' ' CYS . 0.6 OUTLIER -131.46 121.33 48.08 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 N-CA-C 113.346 0.869 . . . . 0.83 113.346 -177.402 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.8 t -123.16 118.19 27.1 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 109.022 -0.732 . . . . 0.92 109.022 178.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 1.053 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -132.97 112.26 11.71 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 113.911 1.078 . . . . 1.28 113.911 -177.689 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.835 ' O ' ' HB1' ' A' ' 69' ' ' ALA . . . -105.71 -158.89 22.68 Favored Glycine 0 C--N 1.358 1.784 0 C-N-CA 120.318 -0.944 . . . . 0.67 112.738 178.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.542 ' O ' ' HB2' ' A' ' 70' ' ' ALA . 19.0 p-10 -66.37 -57.09 8.19 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 115.498 1.666 . . . . 2.27 115.498 -176.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -120.29 17.7 12.26 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 121.891 0.853 . . . . 1.66 110.071 -176.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.521 HD22 ' CE1' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -112.93 -24.37 9.56 Favored 'General case' 0 N--CA 1.408 -2.567 0 CA-C-N 113.628 -1.624 . . . . 1.37 107.396 -179.315 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 1.053 ' O ' ' HA ' ' A' ' 28' ' ' CYS . . . 73.22 -128.39 11.61 Favored Glycine 0 N--CA 1.415 -2.727 0 CA-C-N 113.951 -1.477 . . . . 0.73 113.755 177.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.831 ' SG ' HG22 ' A' ' 26' ' ' ILE . 5.1 t -138.72 118.08 12.81 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 114.834 1.42 . . . . 1.08 114.834 -177.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.752 ' HB3' ' CG2' ' A' ' 38' ' ' THR . 0.2 OUTLIER -92.83 106.97 18.85 Favored 'General case' 0 N--CA 1.423 -1.789 0 N-CA-C 105.408 -2.071 . . . . 1.38 105.408 177.031 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.829 ' HA ' HG23 ' A' ' 26' ' ' ILE . 2.2 t -97.9 85.15 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.577 0 C-N-CA 118.718 -1.193 . . . . 0.76 108.856 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.59 ' O ' ' O ' ' A' ' 38' ' ' THR . . . 143.39 -75.78 0.3 Allowed Glycine 0 CA--C 1.524 0.607 0 CA-C-N 114.3 -1.318 . . . . 0.81 115.568 179.203 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.752 ' CG2' ' HB3' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -23.47 154.27 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 113.111 0.782 . . . . 0.77 113.111 -178.298 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.52 ' O ' ' N ' ' A' ' 42' ' ' LEU . . . -60.14 -39.09 85.09 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.971 -0.559 . . . . 1.02 111.366 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 1.022 ' HB3' ' HA2' ' A' ' 14' ' ' GLY . 1.2 mt-10 -40.36 -29.52 0.08 Allowed 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.794 0.665 . . . . 2.32 112.794 -178.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.692 ' O ' ' N ' ' A' ' 44' ' ' CYS . . . -89.16 -20.95 23.6 Favored 'General case' 0 N--CA 1.44 -0.954 0 O-C-N 122.328 -0.232 . . . . 0.87 110.952 -179.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.52 ' N ' ' O ' ' A' ' 39' ' ' ALA . 3.2 mt -39.22 -43.62 1.13 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.819 0.674 . . . . 1.23 112.819 -177.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.406 ' HD3' ' O ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -52.32 -30.44 28.4 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 107.903 -1.147 . . . . 2.92 107.903 177.469 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.692 ' N ' ' O ' ' A' ' 41' ' ' ALA . 70.0 m -53.04 -21.65 4.85 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 114.279 -1.328 . . . . 1.57 110.556 -177.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -49.03 -34.45 13.37 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 113.505 0.928 . . . . 3.31 113.505 -179.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -87.09 -5.0 59.18 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 119.869 -0.733 . . . . 3.69 111.157 -178.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.436 ' HG3' ' CB ' ' A' ' 21' ' ' CYS . 3.9 mm-40 . . . . . 0 N--CA 1.443 -0.787 0 N-CA-C 109.512 -0.551 . . . . 3.99 109.512 177.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.7 p . . . . . 0 CA--C 1.531 0.231 0 CA-C-O 120.889 0.376 . . . . 3.12 111.293 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 173.39 38.38 0.04 OUTLIER Glycine 0 N--CA 1.444 -0.815 0 N-CA-C 110.415 -1.074 . . . . 2.1 110.415 -179.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.4 tp60 -120.78 85.58 2.42 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 108.613 -0.884 . . . . 4.36 108.613 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.5 ' O ' ' HA ' ' A' ' 66' ' ' ARG . 0.5 OUTLIER -136.32 82.28 35.22 Favored Pre-proline 0 C--N 1.299 -1.618 0 N-CA-C 106.28 -1.748 . . . . 3.55 106.28 -178.713 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.599 ' HA ' ' O ' ' A' ' 65' ' ' GLY . 60.5 Cg_endo -72.4 73.5 2.75 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 123.197 2.598 . . . . 1.54 113.856 -177.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.406 ' N ' ' O ' ' A' ' 65' ' ' GLY . 4.5 p -99.25 157.87 16.08 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.389 -1.278 . . . . 1.59 109.084 178.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.56 -167.86 54.11 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 119.787 -1.197 . . . . 2.43 112.094 -175.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -76.47 66.09 2.44 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 122.058 0.933 . . . . 4.11 112.623 -175.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.59 19.41 58.35 Favored Glycine 0 C--N 1.339 0.72 0 CA-C-N 114.112 -1.403 . . . . 2.21 114.695 177.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.638 ' HA3' ' HA ' ' A' ' 74' ' ' CYS . . . -105.28 135.01 12.34 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 119.227 -1.463 . . . . 1.62 114.213 -179.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.598 ' HA ' ' HA ' ' A' ' 60' ' ' PRO . 0.0 OUTLIER -107.04 152.99 23.26 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 109.248 -0.649 . . . . 3.02 109.248 177.091 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.7 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 41.7 t -52.77 106.37 0.16 Allowed 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 108.967 -0.753 . . . . 1.52 108.967 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.41 ' N ' ' O ' ' A' ' 72' ' ' ILE . . . -88.96 -36.55 15.81 Favored 'General case' 0 N--CA 1.423 -1.816 0 N-CA-C 106.718 -1.586 . . . . 1.07 106.718 177.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.835 ' HB1' ' O ' ' A' ' 29' ' ' GLY . . . -165.18 165.06 20.03 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 108.985 -0.746 . . . . 1.0 108.985 -177.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.542 ' HB2' ' O ' ' A' ' 30' ' ' ASP . . . -31.24 108.66 0.05 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.25 0.548 . . . . 1.24 111.402 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.84 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . 75.68 -3.4 49.71 Favored Glycine 0 C--O 1.227 -0.336 0 CA-C-N 115.249 -0.887 . . . . 1.28 114.548 179.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.825 HG13 ' HB2' ' A' ' 34' ' ' CYS . 1.6 mm -96.9 119.07 44.48 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.599 0 CA-C-N 117.702 0.751 . . . . 2.27 110.399 -179.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 1.009 ' HB2' ' HB3' ' A' ' 82' ' ' ASP . 1.9 t -118.99 95.61 4.89 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.72 -1.127 . . . . 1.98 108.391 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 1.05 ' HB3' ' HA ' ' A' ' 79' ' ' CYS . 26.7 p -156.13 -174.32 4.9 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 116.912 2.19 . . . . 1.33 116.912 -176.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.528 ' CB ' ' HD2' ' A' ' 76' ' ' PRO . 0.3 OUTLIER -128.56 -178.29 0.77 Allowed Pre-proline 0 N--CA 1.456 -0.169 0 CA-C-N 112.808 -1.996 . . . . 1.99 109.253 -178.831 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.528 ' HD2' ' CB ' ' A' ' 75' ' ' SER . 60.3 Cg_endo -73.28 30.85 0.31 Allowed 'Trans proline' 0 CA--C 1.533 0.464 0 C-N-CA 121.882 1.721 . . . . 1.86 113.413 -179.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -125.88 -60.66 1.28 Allowed 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 109.536 -0.542 . . . . 2.65 109.536 178.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.883 ' O ' ' HB2' ' A' ' 74' ' ' CYS . . . -138.39 -167.29 10.94 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 110.917 -0.873 . . . . 0.99 110.917 178.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 1.05 ' HA ' ' HB3' ' A' ' 74' ' ' CYS . 63.8 m -146.43 161.08 41.16 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 117.534 0.667 . . . . 1.34 111.723 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 34.6 t60 -152.58 150.1 29.17 Favored 'General case' 0 C--N 1.344 0.34 0 C-N-CA 119.896 -0.722 . . . . 2.17 111.388 -178.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.461 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 0.4 OUTLIER -60.71 140.86 57.37 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.764 -0.653 . . . . 3.05 110.422 179.558 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 1.009 ' HB3' ' HB2' ' A' ' 73' ' ' CYS . 0.0 OUTLIER -137.21 138.24 24.76 Favored Pre-proline 0 CA--C 1.544 0.733 0 CA-C-N 115.983 -0.553 . . . . 2.02 111.89 -179.023 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.458 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 2.5 Cg_endo -84.38 -31.68 0.46 Allowed 'Trans proline' 0 C--N 1.359 1.122 0 C-N-CA 123.311 2.674 . . . . 1.93 115.301 -177.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.82 -47.62 84.99 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 108.29 -1.004 . . . . 1.53 108.29 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.84 ' O ' ' N ' ' A' ' 71' ' ' GLY . 81.5 m -96.77 71.68 2.58 Favored 'General case' 0 C--O 1.215 -0.739 0 N-CA-C 105.694 -1.965 . . . . 1.88 105.694 175.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.458 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 0.9 OUTLIER . . . . . 0 CA--C 1.497 -1.084 0 C-N-CA 119.089 -1.044 . . . . 3.6 110.582 -177.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 110' ' ' CYS . . . . . 0.829 ' HB3' ' HG2' ' B' ' 120' ' ' ARG . 0.1 OUTLIER . . . . . 0 CA--C 1.546 0.799 0 N-CA-C 114.332 1.234 . . . . 2.61 114.332 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 111' ' ' LEU . . . . . 0.546 ' O ' ' HA ' ' B' ' 120' ' ' ARG . 1.3 tt -32.09 112.06 0.34 Allowed Pre-proline 0 N--CA 1.484 1.253 0 CA-C-N 119.001 0.819 . . . . 2.47 111.626 178.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 112' ' ' PRO . . . . . 0.847 ' HB2' ' O ' ' B' ' 117' ' ' GLY . 43.4 Cg_endo -93.59 127.39 0.61 Allowed 'Trans proline' 0 C--N 1.356 0.921 0 C-N-CA 123.579 2.853 . . . . 1.47 113.937 -178.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.627 ' SG ' ' N ' ' B' ' 114' ' ' GLY . 0.0 OUTLIER -142.54 -168.84 2.84 Favored 'General case' 0 C--N 1.351 0.631 0 O-C-N 121.943 -0.473 . . . . 1.0 111.212 -177.502 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 114' ' ' GLY . . . . . 0.985 ' HA2' ' HB3' ' B' ' 140' ' ' GLU . . . 75.33 -163.74 54.02 Favored Glycine 0 CA--C 1.502 -0.728 0 C-N-CA 120.817 -0.706 . . . . 1.16 111.535 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 115' ' ' PRO . . . . . 0.418 ' C ' ' H ' ' B' ' 117' ' ' GLY . 48.3 Cg_endo -63.23 142.01 84.67 Favored 'Trans proline' 0 N--CA 1.446 -1.281 0 N-CA-C 107.002 -1.961 . . . . 1.57 107.002 175.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 62.86 -12.48 0.1 OUTLIER Glycine 0 C--N 1.27 -3.124 0 C-N-CA 124.792 1.187 . . . . 1.7 113.251 -179.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 117' ' ' GLY . . . . . 0.847 ' O ' ' HB2' ' B' ' 112' ' ' PRO . . . 64.95 20.5 66.78 Favored Glycine 1 N--CA 1.395 -4.086 0 C-N-CA 116.901 -2.571 . . . . 1.38 110.566 179.431 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 118' ' ' LYS . . . . . 0.477 ' HB2' HD12 ' B' ' 132' ' ' LEU . 0.0 OUTLIER -91.92 -2.63 56.7 Favored 'General case' 0 C--N 1.346 0.435 0 CA-C-N 113.003 -1.599 . . . . 2.54 113.241 -179.894 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 119' ' ' GLY . . . . . 0.845 ' O ' ' HA ' ' B' ' 112' ' ' PRO . . . -117.65 -178.29 17.44 Favored Glycine 0 C--N 1.34 0.764 0 N-CA-C 108.607 -1.797 . . . . 1.04 108.607 178.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.829 ' HG2' ' HB3' ' B' ' 110' ' ' CYS . 0.4 OUTLIER -120.73 172.52 7.82 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 119.298 1.549 . . . . 2.89 112.364 -178.886 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 121' ' ' CYS . . . . . 0.431 ' CB ' ' HG3' ' B' ' 147' ' ' GLU . 4.4 m -105.89 147.29 28.91 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.081 0.467 . . . . 1.07 110.347 -179.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 122' ' ' PHE . . . . . 0.411 ' HE1' ' O ' ' B' ' 128' ' ' CYS . 43.9 m-85 -137.53 -52.02 0.64 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.905 -0.589 . . . . 1.53 110.691 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 123' ' ' GLY . . . . . 0.556 ' O ' ' HB3' ' B' ' 144' ' ' CYS . . . -101.45 -166.21 27.52 Favored Glycine 0 C--O 1.229 -0.203 0 C-N-CA 120.836 -0.697 . . . . 0.9 111.677 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . 0.441 ' O ' ' HB2' ' B' ' 144' ' ' CYS . 2.4 Cg_endo -77.31 -60.65 0.04 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 122.469 2.113 . . . . 1.51 111.564 179.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 125' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -102.89 26.44 8.11 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.839 -0.619 . . . . 1.25 109.921 179.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 126' ' ' ILE . . . . . 0.837 HG22 ' SG ' ' B' ' 134' ' ' CYS . 0.8 OUTLIER -131.37 121.37 48.43 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 N-CA-C 113.399 0.889 . . . . 0.85 113.399 -177.41 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 127' ' ' CYS . . . . . . . . . . . . . 1.8 t -123.28 118.05 26.68 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 109.059 -0.719 . . . . 0.89 109.059 178.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 128' ' ' CYS . . . . . 1.059 ' HA ' ' O ' ' B' ' 133' ' ' GLY . 0.0 OUTLIER -132.36 112.0 11.82 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 114.067 1.136 . . . . 1.23 114.067 -177.999 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 129' ' ' GLY . . . . . 0.852 ' O ' ' HB1' ' B' ' 169' ' ' ALA . . . -104.55 -157.96 23.7 Favored Glycine 0 C--N 1.357 1.742 0 C-N-CA 120.298 -0.954 . . . . 0.66 112.992 178.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 130' ' ' ASP . . . . . 0.515 ' O ' ' HB2' ' B' ' 170' ' ' ALA . 18.2 p-10 -68.61 -55.28 12.06 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 115.867 1.802 . . . . 2.35 115.867 -176.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -125.03 30.67 5.81 Favored 'General case' 0 CA--C 1.493 -1.218 0 C-N-CA 118.878 -1.129 . . . . 1.69 109.744 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 132' ' ' LEU . . . . . 0.523 HD22 ' CE1' ' B' ' 135' ' ' PHE . 0.4 OUTLIER -123.82 -23.82 4.59 Favored 'General case' 0 N--CA 1.404 -2.744 0 N-CA-C 105.672 -1.973 . . . . 1.38 105.672 -179.23 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 133' ' ' GLY . . . . . 1.059 ' O ' ' HA ' ' B' ' 128' ' ' CYS . . . 72.15 -126.58 11.85 Favored Glycine 0 N--CA 1.408 -3.195 0 CA-C-N 114.196 -1.366 . . . . 0.72 114.17 175.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 134' ' ' CYS . . . . . 0.837 ' SG ' HG22 ' B' ' 126' ' ' ILE . 5.4 t -140.17 118.13 11.83 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 114.948 1.462 . . . . 1.08 114.948 -177.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 135' ' ' PHE . . . . . 0.766 ' HB3' ' CG2' ' B' ' 138' ' ' THR . 0.1 OUTLIER -93.0 107.14 18.98 Favored 'General case' 0 N--CA 1.424 -1.761 0 N-CA-C 105.4 -2.074 . . . . 1.36 105.4 177.204 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 136' ' ' VAL . . . . . 0.781 ' HA ' HG23 ' B' ' 126' ' ' ILE . 2.5 t -97.56 85.42 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.552 0 C-N-CA 118.861 -1.136 . . . . 0.75 108.712 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 137' ' ' GLY . . . . . 0.596 ' O ' ' O ' ' B' ' 138' ' ' THR . . . 142.65 -76.04 0.31 Allowed Glycine 0 CA--C 1.522 0.524 0 C-N-CA 119.614 -1.279 . . . . 0.83 115.778 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 138' ' ' THR . . . . . 0.766 ' CG2' ' HB3' ' B' ' 135' ' ' PHE . 0.0 OUTLIER -23.27 154.62 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 113.081 0.771 . . . . 0.78 113.081 -178.242 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 139' ' ' ALA . . . . . 0.498 ' O ' ' N ' ' B' ' 142' ' ' LEU . . . -60.45 -39.38 87.35 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 116.147 -0.479 . . . . 1.04 111.144 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 140' ' ' GLU . . . . . 0.985 ' HB3' ' HA2' ' B' ' 114' ' ' GLY . 1.2 mt-10 -40.09 -29.56 0.08 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.84 0.682 . . . . 2.31 112.84 -178.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 141' ' ' ALA . . . . . 0.684 ' O ' ' N ' ' B' ' 144' ' ' CYS . . . -89.16 -20.72 23.88 Favored 'General case' 0 N--CA 1.441 -0.912 0 O-C-N 122.307 -0.246 . . . . 0.87 110.992 -179.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 142' ' ' LEU . . . . . 0.498 ' N ' ' O ' ' B' ' 139' ' ' ALA . 3.1 mt -39.32 -43.81 1.21 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.787 0.662 . . . . 1.24 112.787 -177.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 143' ' ' ARG . . . . . 0.412 ' HD3' ' O ' ' B' ' 140' ' ' GLU . 0.0 OUTLIER -52.18 -30.61 27.73 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 107.947 -1.131 . . . . 2.93 107.947 177.457 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 144' ' ' CYS . . . . . 0.684 ' N ' ' O ' ' B' ' 141' ' ' ALA . 69.4 m -52.96 -21.39 4.32 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 114.083 -1.417 . . . . 1.61 110.538 -177.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -49.39 -34.34 15.95 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 113.538 0.94 . . . . 3.35 113.538 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -87.13 -4.87 59.15 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 119.846 -0.742 . . . . 3.76 111.152 -178.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 147' ' ' GLU . . . . . 0.431 ' HG3' ' CB ' ' B' ' 121' ' ' CYS . 3.9 mm-40 . . . . . 0 N--CA 1.443 -0.812 0 N-CA-C 109.482 -0.562 . . . . 4.01 109.482 177.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 50.3 p . . . . . 0 C--O 1.232 0.175 0 CA-C-O 121.218 0.532 . . . . 3.11 111.216 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 173.89 38.18 0.04 OUTLIER Glycine 0 N--CA 1.444 -0.832 0 N-CA-C 110.835 -0.906 . . . . 2.07 110.835 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 5.1 tp60 -120.85 71.54 0.94 Allowed 'General case' 0 N--CA 1.441 -0.883 0 CA-C-O 121.867 0.841 . . . . 4.34 110.275 179.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 159' ' ' LYS . . . . . 0.536 ' O ' ' HA ' ' B' ' 166' ' ' ARG . 0.7 OUTLIER -107.55 79.98 0.87 Allowed Pre-proline 0 C--N 1.316 -0.863 0 CA-C-N 114.068 -1.424 . . . . 3.54 110.643 175.117 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 160' ' ' PRO . . . . . 0.605 ' HA ' ' HA ' ' B' ' 166' ' ' ARG . 59.3 Cg_endo -72.39 74.49 2.59 Favored 'Trans proline' 0 C--N 1.333 -0.249 0 CA-C-N 121.688 1.638 . . . . 1.51 114.521 -177.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 161' ' ' CYS . . . . . . . . . . . . . 4.6 p -98.97 158.92 15.32 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.856 -1.065 . . . . 1.58 109.09 178.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 77.05 -167.85 54.5 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 119.726 -1.226 . . . . 2.37 112.216 -176.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -76.71 65.61 2.51 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 122.173 0.987 . . . . 4.07 112.529 -175.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 84.55 22.24 54.25 Favored Glycine 0 C--N 1.337 0.59 0 CA-C-N 113.858 -1.519 . . . . 2.2 114.626 177.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 165' ' ' GLY . . . . . 0.681 ' HA3' ' HA ' ' B' ' 174' ' ' CYS . . . -108.0 135.77 13.03 Favored Glycine 0 N--CA 1.442 -0.963 0 C-N-CA 119.279 -1.439 . . . . 1.62 113.69 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 166' ' ' ARG . . . . . 0.605 ' HA ' ' HA ' ' B' ' 160' ' ' PRO . 0.0 OUTLIER -106.79 153.27 22.71 Favored 'General case' 0 CA--C 1.521 -0.167 0 N-CA-C 109.273 -0.64 . . . . 3.05 109.273 177.681 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 167' ' ' CYS . . . . . 0.706 ' HA ' ' O ' ' B' ' 172' ' ' ILE . 41.8 t -52.88 106.34 0.16 Allowed 'General case' 0 N--CA 1.424 -1.773 0 N-CA-C 108.932 -0.766 . . . . 1.56 108.932 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 168' ' ' ALA . . . . . 0.432 ' N ' ' O ' ' B' ' 172' ' ' ILE . . . -88.16 -38.05 15.66 Favored 'General case' 0 N--CA 1.423 -1.787 0 N-CA-C 106.402 -1.703 . . . . 1.04 106.402 177.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 169' ' ' ALA . . . . . 0.852 ' HB1' ' O ' ' B' ' 129' ' ' GLY . . . -164.07 165.0 22.77 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 109.196 -0.668 . . . . 0.98 109.196 -176.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 170' ' ' ALA . . . . . 0.515 ' HB2' ' O ' ' B' ' 130' ' ' ASP . . . -31.08 108.69 0.05 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.319 0.58 . . . . 1.25 111.284 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 171' ' ' GLY . . . . . 0.85 ' N ' ' O ' ' B' ' 185' ' ' CYS . . . 75.51 -3.3 49.3 Favored Glycine 0 C--O 1.228 -0.25 0 CA-C-N 115.237 -0.892 . . . . 1.29 114.58 179.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 172' ' ' ILE . . . . . 0.822 HG13 ' HB2' ' B' ' 134' ' ' CYS . 1.6 mm -96.9 119.1 44.51 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.578 0 CA-C-N 117.723 0.762 . . . . 2.27 110.468 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 173' ' ' CYS . . . . . 0.987 ' HB2' ' HB3' ' B' ' 182' ' ' ASP . 1.9 t -118.96 95.83 4.99 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 114.723 -1.126 . . . . 1.94 108.416 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 174' ' ' CYS . . . . . 1.105 ' HB3' ' HA ' ' B' ' 179' ' ' CYS . 26.6 p -156.26 -174.3 4.88 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 116.9 2.185 . . . . 1.35 116.9 -176.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 175' ' ' SER . . . . . 0.517 ' CB ' ' HD2' ' B' ' 176' ' ' PRO . 0.3 OUTLIER -128.53 -178.35 0.78 Allowed Pre-proline 0 N--CA 1.454 -0.239 0 CA-C-N 112.861 -1.972 . . . . 2.0 109.383 -178.877 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 176' ' ' PRO . . . . . 0.517 ' HD2' ' CB ' ' B' ' 175' ' ' SER . 60.3 Cg_endo -73.23 30.95 0.3 Allowed 'Trans proline' 0 CA--C 1.534 0.507 0 C-N-CA 121.865 1.71 . . . . 1.9 113.428 -179.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 177' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -125.94 -60.68 1.28 Allowed 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 109.612 -0.514 . . . . 2.72 109.612 178.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 178' ' ' GLY . . . . . 0.858 ' O ' ' HB2' ' B' ' 174' ' ' CYS . . . -138.44 -167.36 10.96 Favored Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 110.832 -0.907 . . . . 0.99 110.832 178.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 179' ' ' CYS . . . . . 1.105 ' HA ' ' HB3' ' B' ' 174' ' ' CYS . 63.3 m -146.51 161.07 41.24 Favored 'General case' 0 N--CA 1.461 0.101 0 CA-C-N 117.507 0.653 . . . . 1.34 111.632 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 180' ' ' HIS . . . . . . . . . . . . . 34.9 t60 -152.37 150.31 29.56 Favored 'General case' 0 C--N 1.344 0.36 0 C-N-CA 120.014 -0.674 . . . . 2.1 111.401 -178.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 181' ' ' GLU . . . . . 0.458 ' HA ' ' O ' ' B' ' 171' ' ' GLY . 0.4 OUTLIER -60.91 140.82 57.62 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.766 -0.652 . . . . 3.06 110.359 179.557 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 182' ' ' ASP . . . . . 0.987 ' HB3' ' HB2' ' B' ' 173' ' ' CYS . 0.0 OUTLIER -137.19 138.27 24.9 Favored Pre-proline 0 CA--C 1.543 0.701 0 CA-C-N 116.005 -0.543 . . . . 2.06 111.852 -179.024 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 183' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' B' ' 182' ' ' ASP . 2.5 Cg_endo -84.41 -31.66 0.46 Allowed 'Trans proline' 0 C--N 1.358 1.068 0 C-N-CA 123.359 2.706 . . . . 1.91 115.256 -177.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -59.9 -47.6 85.12 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 108.279 -1.008 . . . . 1.56 108.279 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 185' ' ' CYS . . . . . 0.85 ' O ' ' N ' ' B' ' 171' ' ' GLY . 82.2 m -96.68 71.62 2.61 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 105.7 -1.963 . . . . 1.94 105.7 175.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 186' ' ' ASP . . . . . 0.456 ' HB2' ' O ' ' B' ' 183' ' ' PRO . 0.9 OUTLIER . . . . . 0 CA--C 1.497 -1.094 0 C-N-CA 119.055 -1.058 . . . . 3.61 110.644 -177.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.556 ' O ' ' C ' ' A' ' 11' ' ' LEU . 67.9 m . . . . . 0 N--CA 1.455 -0.191 0 CA-C-O 118.524 -0.75 . . . . 2.68 112.862 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.922 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 6.9 mp -31.76 108.76 0.28 Allowed Pre-proline 0 N--CA 1.476 0.847 0 CA-C-N 120.036 1.289 . . . . 2.48 110.228 -179.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.86 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 89.8 Cg_endo -82.94 135.69 7.74 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 121.621 1.548 . . . . 1.49 114.593 -178.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.696 ' N ' ' O ' ' A' ' 19' ' ' GLY . 29.3 p -145.15 -175.06 4.55 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 118.267 -1.373 . . . . 1.0 111.322 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.704 ' HA2' ' HB3' ' A' ' 40' ' ' GLU . . . 75.75 -164.35 53.89 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 120.499 -0.857 . . . . 1.15 114.377 178.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.793 ' HD2' HD11 ' A' ' 32' ' ' LEU . 38.3 Cg_endo -63.14 112.75 1.78 Allowed 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 124.861 3.707 . . . . 1.57 109.601 177.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.19 -11.86 53.03 Favored Glycine 0 C--N 1.276 -2.803 0 N-CA-C 110.59 -1.004 . . . . 1.68 110.59 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.692 ' O ' ' HB2' ' A' ' 12' ' ' PRO . . . 68.59 47.3 57.48 Favored Glycine 0 N--CA 1.418 -2.538 0 C-N-CA 117.929 -2.081 . . . . 1.36 111.648 176.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.716 ' HD3' ' O ' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -92.26 -28.91 16.7 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 111.858 -2.171 . . . . 2.5 111.907 179.959 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.86 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -103.8 -178.08 25.73 Favored Glycine 0 C--O 1.213 -1.216 0 O-C-N 121.023 -1.048 . . . . 1.02 115.181 -176.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.922 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -96.16 144.71 26.15 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 115.579 1.696 . . . . 2.92 115.579 -174.588 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.659 ' C ' ' CD1' ' A' ' 22' ' ' PHE . 0.1 OUTLIER -108.25 170.24 8.13 Favored 'General case' 0 C--N 1.344 0.334 0 CA-C-N 113.49 -1.686 . . . . 1.1 109.36 -179.692 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.659 ' CD1' ' C ' ' A' ' 21' ' ' CYS . 33.8 m-85 -156.8 52.54 0.51 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.966 0.412 . . . . 1.51 110.649 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.518 ' O ' ' SG ' ' A' ' 44' ' ' CYS . . . 133.08 -145.68 17.66 Favored Glycine 0 C--O 1.225 -0.433 0 N-CA-C 111.265 -0.734 . . . . 0.9 111.265 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.741 ' HD2' HD12 ' A' ' 26' ' ' ILE . 37.9 Cg_endo -94.86 -70.19 0.0 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 122.779 2.319 . . . . 1.5 112.145 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.635 ' O ' ' N ' ' A' ' 37' ' ' GLY . 2.8 m -92.5 45.52 1.2 Allowed 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 109.746 -0.465 . . . . 1.26 109.746 179.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.811 ' CG2' ' HB3' ' A' ' 74' ' ' CYS . 3.6 mt -145.13 115.04 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 N-CA-C 112.015 0.376 . . . . 0.83 112.015 -177.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.58 ' SG ' ' CE2' ' A' ' 35' ' ' PHE . 1.9 t -149.15 123.75 9.78 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-O 121.346 0.593 . . . . 0.92 110.803 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.94 ' HB3' ' HB1' ' A' ' 68' ' ' ALA . 0.5 OUTLIER -126.37 152.5 46.2 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.201 1.0 . . . . 1.28 110.949 -179.852 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 33' ' ' GLY . . . -143.52 -179.83 20.41 Favored Glycine 0 N--CA 1.424 -2.144 0 C-N-CA 120.386 -0.911 . . . . 0.67 111.273 176.211 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -70.01 -44.93 68.32 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 126.351 1.861 . . . . 2.27 112.442 177.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -121.65 23.42 10.22 Favored 'General case' 0 CA--C 1.471 -2.075 0 CA-C-N 112.956 -1.929 . . . . 1.66 111.31 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.812 HD13 ' HZ ' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -125.62 -36.36 2.44 Favored 'General case' 0 N--CA 1.425 -1.685 0 CA-C-N 113.589 -1.641 . . . . 1.37 109.682 -174.623 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.871 ' O ' ' HA ' ' A' ' 28' ' ' CYS . . . 89.96 -138.85 14.76 Favored Glycine 0 N--CA 1.425 -2.045 0 CA-C-N 114.845 -1.071 . . . . 0.73 114.368 177.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 1.057 ' SG ' HD13 ' A' ' 72' ' ' ILE . 1.3 m -126.75 121.24 31.44 Favored 'General case' 0 CA--C 1.489 -1.384 0 CA-C-N 119.318 1.559 . . . . 1.08 110.37 177.068 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 1.014 ' HA ' ' HA ' ' B' ' 135' ' ' PHE . 0.0 OUTLIER -119.07 107.49 13.56 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 104.578 -2.379 . . . . 1.38 104.578 176.705 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 1.034 HG23 HG23 ' B' ' 136' ' ' VAL . 1.0 OUTLIER -92.07 89.71 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.552 0 CA-C-O 122.077 0.941 . . . . 0.76 109.849 -178.266 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.635 ' N ' ' O ' ' A' ' 25' ' ' SER . . . 88.37 87.3 1.19 Allowed Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 113.907 -1.497 . . . . 0.81 112.101 -179.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.509 HG22 ' O ' ' B' ' 132' ' ' LEU . 40.3 p -150.17 176.03 11.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.807 0.337 . . . . 0.77 110.589 -179.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.665 ' HA ' HD12 ' A' ' 42' ' ' LEU . . . -63.92 -41.68 97.6 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.343 -1.355 . . . . 1.02 107.343 177.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.704 ' HB3' ' HA2' ' A' ' 14' ' ' GLY . 3.0 mm-40 -55.82 -34.37 65.3 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 113.884 -1.507 . . . . 2.32 110.201 179.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.842 ' O ' ' HB2' ' A' ' 44' ' ' CYS . . . -82.75 -37.63 24.37 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 115.349 -0.841 . . . . 0.87 109.953 -179.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.665 HD12 ' HA ' ' A' ' 39' ' ' ALA . 0.2 OUTLIER -38.96 -32.92 0.1 Allowed 'General case' 0 C--O 1.24 0.564 0 CA-C-O 121.105 0.479 . . . . 1.23 110.685 -178.672 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.448 ' O ' ' N ' ' A' ' 45' ' ' GLN . 2.1 mmm180 -51.97 -29.02 18.82 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 108.239 -1.023 . . . . 2.92 108.239 176.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.842 ' HB2' ' O ' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -44.65 -2.66 0.01 OUTLIER 'General case' 0 C--O 1.239 0.552 0 N-CA-C 115.434 1.642 . . . . 1.57 115.434 -176.621 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.448 ' N ' ' O ' ' A' ' 43' ' ' ARG . 0.3 OUTLIER -88.99 3.37 51.86 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 122.624 2.466 . . . . 3.31 107.203 174.976 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -83.56 11.33 7.28 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 108.505 -0.924 . . . . 3.69 108.505 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.447 -0.613 0 N-CA-C 109.263 -0.644 . . . . 3.99 109.263 176.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 66.0 m . . . . . 0 CA--C 1.558 1.27 0 N-CA-C 112.189 0.44 . . . . 3.12 112.189 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 66' ' ' ARG . . . -133.43 123.11 3.29 Favored Glycine 0 CA--C 1.49 -1.504 0 CA-C-N 114.983 -1.008 . . . . 2.1 111.995 -176.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -111.12 78.78 1.14 Allowed 'General case' 0 N--CA 1.439 -0.988 0 CA-C-O 121.951 0.881 . . . . 4.36 108.901 178.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.753 ' CB ' ' HB2' ' A' ' 67' ' ' CYS . 0.4 OUTLIER -138.15 68.88 48.73 Favored Pre-proline 0 C--N 1.305 -1.326 0 CA-C-O 122.96 1.362 . . . . 3.55 108.247 -179.799 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.442 ' HA ' ' O ' ' A' ' 65' ' ' GLY . 14.6 Cg_endo -55.59 86.78 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.589 2.859 . . . . 1.54 115.191 -178.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.649 ' N ' ' O ' ' A' ' 65' ' ' GLY . 1.8 m -96.64 -173.8 2.84 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 113.786 -1.552 . . . . 1.59 107.062 176.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 45.14 -167.03 0.04 OUTLIER Glycine 0 CA--C 1.53 0.97 0 C-N-CA 119.837 -1.173 . . . . 2.43 114.36 175.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 6.5 t -84.2 61.02 6.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 122.683 1.23 . . . . 4.11 111.256 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 109.93 3.89 29.81 Favored Glycine 0 CA--C 1.532 1.144 0 CA-C-N 112.585 -2.098 . . . . 2.21 116.209 176.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.649 ' O ' ' N ' ' A' ' 61' ' ' CYS . . . -101.4 142.8 15.86 Favored Glycine 0 C--O 1.225 -0.442 0 C-N-CA 117.227 -2.416 . . . . 1.62 115.995 -175.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.468 ' HB2' ' O ' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -98.03 154.0 18.01 Favored 'General case' 0 C--N 1.335 -0.055 0 CA-C-N 114.549 -0.826 . . . . 3.02 110.142 179.274 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.753 ' HB2' ' CB ' ' A' ' 59' ' ' LYS . 3.7 t -44.98 109.48 0.17 Allowed 'General case' 0 CA--C 1.506 -0.74 0 CA-C-O 121.257 0.551 . . . . 1.52 111.763 -178.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.94 ' HB1' ' HB3' ' A' ' 28' ' ' CYS . . . -100.39 -15.42 17.96 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 108.074 -1.084 . . . . 1.07 108.074 177.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -168.19 162.26 12.77 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 114.532 -1.213 . . . . 1.0 110.872 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.562 ' HA ' ' HB3' ' A' ' 85' ' ' CYS . . . -73.3 74.87 1.34 Allowed 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 121.446 0.641 . . . . 1.24 112.673 -179.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.73 ' O ' ' HA ' ' A' ' 81' ' ' GLU . . . 163.53 -51.57 0.3 Allowed Glycine 0 N--CA 1.437 -1.298 0 CA-C-N 114.983 -1.008 . . . . 1.28 112.952 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 1.057 HD13 ' SG ' ' A' ' 34' ' ' CYS . 0.6 OUTLIER -126.63 140.23 49.49 Favored 'Isoleucine or valine' 0 C--O 1.248 0.99 0 CA-C-O 122.83 1.3 . . . . 2.27 110.704 -175.936 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.549 ' HB2' ' HB2' ' A' ' 61' ' ' CYS . 47.9 m -112.15 113.19 25.3 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 114.895 -1.048 . . . . 1.98 110.258 -179.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.811 ' HB3' ' CG2' ' A' ' 26' ' ' ILE . 64.6 m -78.58 144.03 35.92 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.596 -0.729 . . . . 1.33 111.105 -178.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.715 ' HB2' ' HD2' ' A' ' 76' ' ' PRO . 92.0 p -136.76 179.95 1.23 Allowed Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 114.318 -1.31 . . . . 1.99 108.742 -178.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.715 ' HD2' ' HB2' ' A' ' 75' ' ' SER . 66.9 Cg_endo -76.32 29.88 0.4 Allowed 'Trans proline' 0 N--CA 1.452 -0.93 0 N-CA-C 109.822 -0.876 . . . . 1.86 109.822 177.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.545 ' H ' ' C ' ' A' ' 75' ' ' SER . 2.0 m-20 -144.29 -46.73 0.26 Allowed 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.17 -0.923 . . . . 2.65 111.171 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 1.013 ' HA2' HG11 ' A' ' 36' ' ' VAL . . . -170.5 -155.99 10.89 Favored Glycine 0 C--N 1.34 0.785 0 C-N-CA 119.745 -1.217 . . . . 0.99 115.313 179.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 1.011 ' SG ' HG22 ' A' ' 36' ' ' VAL . 10.4 m -140.98 129.29 22.32 Favored 'General case' 0 CA--C 1.555 1.171 0 CA-C-O 122.732 1.253 . . . . 1.34 107.767 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.472 ' CA ' HG22 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -144.42 132.2 21.29 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-N 112.414 -2.175 . . . . 2.17 112.443 -168.392 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.73 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 0.4 OUTLIER -47.36 142.24 4.24 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 114.036 -1.438 . . . . 3.05 109.981 -179.7 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.682 ' OD1' ' HB2' ' A' ' 85' ' ' CYS . 3.1 p-10 -145.26 137.37 13.22 Favored Pre-proline 0 C--N 1.309 -1.174 0 CA-C-N 115.712 -0.676 . . . . 2.02 109.738 -178.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 82' ' ' ASP . 52.7 Cg_exo -57.87 -35.42 98.79 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.667 2.245 . . . . 1.93 114.373 -177.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.8 -51.69 60.82 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 108.616 -0.883 . . . . 1.53 108.616 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.682 ' HB2' ' OD1' ' A' ' 82' ' ' ASP . 3.2 m -98.74 77.09 2.23 Favored 'General case' 0 CA--C 1.499 -1.015 0 N-CA-C 106.703 -1.591 . . . . 1.88 106.703 176.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.5 -0.944 0 C-N-CA 119.301 -0.96 . . . . 3.6 110.06 -178.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 110' ' ' CYS . . . . . 0.566 ' O ' ' C ' ' B' ' 111' ' ' LEU . 67.5 m . . . . . 0 CA--C 1.527 0.095 0 CA-C-O 118.544 -0.741 . . . . 2.61 112.894 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 111' ' ' LEU . . . . . 0.891 ' O ' ' HA ' ' B' ' 120' ' ' ARG . 6.9 mp -31.29 108.67 0.27 Allowed Pre-proline 0 N--CA 1.477 0.892 0 CA-C-N 119.962 1.256 . . . . 2.47 110.332 -179.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 112' ' ' PRO . . . . . 0.918 ' HA ' ' O ' ' B' ' 119' ' ' GLY . 84.0 Cg_endo -81.62 138.14 10.56 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 121.926 1.751 . . . . 1.47 113.696 -179.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.564 ' N ' ' O ' ' B' ' 119' ' ' GLY . 31.2 p -149.14 -178.7 6.53 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 120.697 -0.401 . . . . 1.0 111.499 178.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 114' ' ' GLY . . . . . 0.716 ' HA2' ' HB3' ' B' ' 140' ' ' GLU . . . 76.06 -163.1 53.07 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 120.793 -0.718 . . . . 1.16 113.929 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 115' ' ' PRO . . . . . 0.825 ' HD2' HD11 ' B' ' 132' ' ' LEU . 38.8 Cg_endo -64.37 101.5 0.36 Allowed 'Trans proline' 0 N--CA 1.485 1.005 0 C-N-CA 125.234 3.956 . . . . 1.57 114.784 178.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 89.53 -8.05 80.65 Favored Glycine 0 C--N 1.28 -2.566 0 CA-C-N 114.263 -1.335 . . . . 1.7 110.992 -175.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 117' ' ' GLY . . . . . 0.641 ' O ' ' HB2' ' B' ' 112' ' ' PRO . . . 65.28 55.25 22.18 Favored Glycine 0 N--CA 1.421 -2.345 0 CA-C-O 122.451 1.028 . . . . 1.38 111.568 179.081 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 118' ' ' LYS . . . . . 0.654 ' HD3' ' O ' ' B' ' 115' ' ' PRO . 0.0 OUTLIER -94.32 -26.13 16.7 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 112.494 -1.853 . . . . 2.54 111.408 177.94 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 119' ' ' GLY . . . . . 0.918 ' O ' ' HA ' ' B' ' 112' ' ' PRO . . . -95.79 -175.61 36.73 Favored Glycine 0 C--O 1.212 -1.255 0 N-CA-C 116.728 1.451 . . . . 1.04 116.728 -176.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.891 ' HA ' ' O ' ' B' ' 111' ' ' LEU . 0.0 OUTLIER -105.12 142.44 34.89 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 112.729 -1.735 . . . . 2.89 114.71 -178.112 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 121' ' ' CYS . . . . . 0.657 ' C ' ' CD1' ' B' ' 122' ' ' PHE . 0.1 OUTLIER -108.05 169.92 8.32 Favored 'General case' 0 C--N 1.342 0.267 0 CA-C-N 113.573 -1.649 . . . . 1.07 109.3 -178.717 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 122' ' ' PHE . . . . . 0.657 ' CD1' ' C ' ' B' ' 121' ' ' CYS . 33.1 m-85 -156.81 52.55 0.51 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.032 0.444 . . . . 1.53 110.574 -179.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 123' ' ' GLY . . . . . 0.523 ' O ' ' SG ' ' B' ' 144' ' ' CYS . . . 133.09 -145.63 17.63 Favored Glycine 0 C--N 1.334 0.44 0 N-CA-C 111.322 -0.711 . . . . 0.9 111.322 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . 0.769 ' HD2' HD12 ' B' ' 126' ' ' ILE . 37.7 Cg_endo -95.02 -70.22 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 122.729 2.286 . . . . 1.51 112.064 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 125' ' ' SER . . . . . 0.651 ' O ' ' N ' ' B' ' 137' ' ' GLY . 2.8 m -92.27 45.08 1.19 Allowed 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.715 -0.476 . . . . 1.25 109.715 179.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 126' ' ' ILE . . . . . 0.81 ' CG2' ' HB3' ' B' ' 174' ' ' CYS . 3.4 mt -144.01 114.54 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 N-CA-C 112.317 0.488 . . . . 0.85 112.317 -177.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 127' ' ' CYS . . . . . 0.587 ' SG ' ' CE2' ' B' ' 135' ' ' PHE . 1.7 t -148.55 124.4 10.58 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 121.039 0.447 . . . . 0.89 110.887 179.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 128' ' ' CYS . . . . . 0.951 ' HB3' ' HB1' ' B' ' 168' ' ' ALA . 0.8 OUTLIER -129.34 150.44 50.7 Favored 'General case' 0 CA--C 1.509 -0.619 0 CA-C-N 115.896 -0.593 . . . . 1.23 111.484 -178.868 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 129' ' ' GLY . . . . . 0.418 ' O ' ' HB2' ' B' ' 169' ' ' ALA . . . -141.67 -174.46 14.51 Favored Glycine 0 N--CA 1.422 -2.236 0 CA-C-N 120.089 1.313 . . . . 0.66 110.135 177.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -74.33 -44.55 52.01 Favored 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 126.215 1.806 . . . . 2.35 112.375 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -124.32 33.26 5.3 Favored 'General case' 0 CA--C 1.483 -1.606 0 CA-C-N 113.911 -1.495 . . . . 1.69 110.034 177.021 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 132' ' ' LEU . . . . . 0.829 HD13 ' HZ ' ' B' ' 135' ' ' PHE . 0.9 OUTLIER -130.1 -37.7 1.46 Allowed 'General case' 0 N--CA 1.411 -2.38 0 CA-C-N 114.239 -1.346 . . . . 1.38 108.531 -179.418 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 133' ' ' GLY . . . . . 0.915 ' O ' ' HA ' ' B' ' 128' ' ' CYS . . . 79.25 -151.43 34.85 Favored Glycine 0 N--CA 1.435 -1.369 0 CA-C-N 113.585 -1.643 . . . . 0.72 111.195 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 134' ' ' CYS . . . . . 1.056 ' SG ' HD13 ' B' ' 172' ' ' ILE . 3.0 m -107.93 124.2 49.77 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-N 119.691 1.745 . . . . 1.08 112.084 -175.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 135' ' ' PHE . . . . . 1.014 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -121.09 106.97 12.05 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 104.499 -2.408 . . . . 1.36 104.499 174.263 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 136' ' ' VAL . . . . . 1.073 HG22 ' SG ' ' B' ' 179' ' ' CYS . 1.8 t -91.7 89.82 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.396 0 CA-C-O 122.091 0.948 . . . . 0.75 109.635 -178.235 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 137' ' ' GLY . . . . . 0.651 ' N ' ' O ' ' B' ' 125' ' ' SER . . . 87.56 88.59 1.09 Allowed Glycine 0 C--O 1.228 -0.231 0 CA-C-N 114.133 -1.394 . . . . 0.83 112.012 -179.115 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 138' ' ' THR . . . . . 0.505 HG22 ' O ' ' A' ' 32' ' ' LEU . 43.5 p -154.13 171.12 19.64 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 110.313 -0.255 . . . . 0.78 110.313 -179.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 139' ' ' ALA . . . . . 0.722 ' HA ' HD12 ' B' ' 142' ' ' LEU . . . -60.51 -39.48 87.94 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.484 -0.932 . . . . 1.04 108.484 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 140' ' ' GLU . . . . . 0.716 ' HB3' ' HA2' ' B' ' 114' ' ' GLY . 3.0 mm-40 -57.46 -33.61 68.15 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.307 -0.861 . . . . 2.31 110.094 178.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 141' ' ' ALA . . . . . 0.8 ' O ' ' HB2' ' B' ' 144' ' ' CYS . . . -82.11 -39.06 23.89 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 115.062 -0.972 . . . . 0.87 109.508 -179.067 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 142' ' ' LEU . . . . . 0.722 HD12 ' HA ' ' B' ' 139' ' ' ALA . 0.2 OUTLIER -38.94 -31.41 0.06 Allowed 'General case' 0 C--O 1.232 0.156 0 CA-C-N 117.871 0.305 . . . . 1.24 111.578 -178.483 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 143' ' ' ARG . . . . . 0.451 ' O ' ' N ' ' B' ' 145' ' ' GLN . 2.1 mmm180 -52.57 -28.93 23.01 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.401 -0.962 . . . . 2.93 108.401 176.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 144' ' ' CYS . . . . . 0.8 ' HB2' ' O ' ' B' ' 141' ' ' ALA . 0.1 OUTLIER -41.94 -8.11 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 113.648 -1.614 . . . . 1.61 115.002 -176.79 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 145' ' ' GLN . . . . . 0.451 ' N ' ' O ' ' B' ' 143' ' ' ARG . 0.3 OUTLIER -84.51 -0.19 52.13 Favored 'General case' 0 C--O 1.242 0.709 0 CA-C-O 122.525 1.155 . . . . 3.35 108.357 176.098 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -83.91 11.48 7.63 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 115.072 -0.967 . . . . 3.76 109.064 179.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.448 -0.546 0 N-CA-C 109.14 -0.689 . . . . 4.01 109.14 176.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 74.4 m . . . . . 0 CA--C 1.539 0.521 0 N-CA-C 113.508 0.929 . . . . 3.11 113.508 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 157' ' ' GLY . . . . . 0.436 ' O ' ' HB2' ' B' ' 166' ' ' ARG . . . -146.92 126.36 2.42 Favored Glycine 0 N--CA 1.439 -1.104 0 N-CA-C 109.794 -1.322 . . . . 2.07 109.794 178.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -112.55 68.02 0.67 Allowed 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 118.784 -1.166 . . . . 4.34 110.023 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 159' ' ' LYS . . . . . 0.848 ' CB ' ' HB2' ' B' ' 167' ' ' CYS . 0.1 OUTLIER -110.9 63.95 0.45 Allowed Pre-proline 0 C--N 1.318 -0.787 0 CA-C-N 113.875 -1.511 . . . . 3.54 112.059 174.514 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 160' ' ' PRO . . . . . 0.441 ' HA ' ' O ' ' B' ' 165' ' ' GLY . 12.8 Cg_endo -55.37 86.78 0.04 OUTLIER 'Trans proline' 0 C--N 1.325 -0.682 0 C-N-CA 121.945 1.764 . . . . 1.51 116.391 -175.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 161' ' ' CYS . . . . . 0.649 ' N ' ' O ' ' B' ' 165' ' ' GLY . 1.4 m -98.81 -177.9 3.8 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.146 -1.427 . . . . 1.58 107.146 175.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 51.58 -167.27 0.71 Allowed Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.365 -0.921 . . . . 2.37 113.956 176.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 7.3 t -84.99 59.39 5.59 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 122.282 1.039 . . . . 4.07 111.664 -178.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 108.84 9.19 26.89 Favored Glycine 0 CA--C 1.544 1.9 0 CA-C-N 113.218 -1.81 . . . . 2.2 115.963 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 165' ' ' GLY . . . . . 0.649 ' O ' ' N ' ' B' ' 161' ' ' CYS . . . -102.59 141.76 15.34 Favored Glycine 0 C--N 1.312 -0.805 0 CA-C-N 121.631 2.716 . . . . 1.62 115.366 -176.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 166' ' ' ARG . . . . . 0.436 ' HB2' ' O ' ' B' ' 157' ' ' GLY . 0.0 OUTLIER -97.94 153.96 18.0 Favored 'General case' 0 N--CA 1.458 -0.056 0 CA-C-N 115.036 -0.582 . . . . 3.05 109.853 178.478 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 167' ' ' CYS . . . . . 0.848 ' HB2' ' CB ' ' B' ' 159' ' ' LYS . 3.6 t -45.42 109.57 0.18 Allowed 'General case' 0 CA--C 1.505 -0.75 0 CA-C-O 121.061 0.458 . . . . 1.56 111.975 -178.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 168' ' ' ALA . . . . . 0.951 ' HB1' ' HB3' ' B' ' 128' ' ' CYS . . . -99.83 -15.58 18.36 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 108.189 -1.041 . . . . 1.04 108.189 177.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 169' ' ' ALA . . . . . 0.418 ' HB2' ' O ' ' B' ' 129' ' ' GLY . . . -168.03 161.98 12.98 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 114.075 -1.42 . . . . 0.98 111.33 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 170' ' ' ALA . . . . . 0.586 ' HA ' ' HB3' ' B' ' 185' ' ' CYS . . . -72.98 74.94 1.19 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.375 0.607 . . . . 1.25 112.622 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 171' ' ' GLY . . . . . 0.763 ' O ' ' HA ' ' B' ' 181' ' ' GLU . . . 163.43 -52.9 0.3 Allowed Glycine 0 C--O 1.22 -0.724 0 CA-C-N 115.231 -0.895 . . . . 1.29 112.504 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 172' ' ' ILE . . . . . 1.056 HD13 ' SG ' ' B' ' 134' ' ' CYS . 0.6 OUTLIER -124.17 139.72 49.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-O 122.93 1.348 . . . . 2.27 111.663 -175.998 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 173' ' ' CYS . . . . . 0.547 ' HB2' ' HB2' ' B' ' 161' ' ' CYS . 48.6 m -112.3 113.5 25.76 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.914 -1.039 . . . . 1.94 110.017 -179.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 174' ' ' CYS . . . . . 0.81 ' HB3' ' CG2' ' B' ' 126' ' ' ILE . 64.1 m -79.41 144.03 34.49 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 115.476 -0.784 . . . . 1.35 110.913 -178.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 175' ' ' SER . . . . . 0.704 ' HB2' ' HD2' ' B' ' 176' ' ' PRO . 59.8 p -136.68 179.86 1.25 Allowed Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 114.328 -1.305 . . . . 2.0 108.799 -178.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 176' ' ' PRO . . . . . 0.704 ' HD2' ' HB2' ' B' ' 175' ' ' SER . 66.9 Cg_endo -76.39 29.76 0.4 Allowed 'Trans proline' 0 N--CA 1.454 -0.835 0 N-CA-C 109.679 -0.931 . . . . 1.9 109.679 177.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 177' ' ' ASP . . . . . 0.541 ' H ' ' C ' ' B' ' 175' ' ' SER . 2.0 m-20 -144.01 -46.44 0.27 Allowed 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.237 -0.892 . . . . 2.72 111.145 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 178' ' ' GLY . . . . . 1.006 ' HA2' HG11 ' B' ' 136' ' ' VAL . . . -171.72 -155.42 10.88 Favored Glycine 0 C--N 1.342 0.874 0 C-N-CA 119.796 -1.192 . . . . 0.99 115.149 179.03 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 179' ' ' CYS . . . . . 1.073 ' SG ' HG22 ' B' ' 136' ' ' VAL . 10.0 m -140.32 136.18 32.95 Favored 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 107.027 -1.471 . . . . 1.34 107.027 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 180' ' ' HIS . . . . . 0.52 ' CA ' HG22 ' B' ' 172' ' ' ILE . 0.2 OUTLIER -156.81 131.48 8.8 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 124.069 1.89 . . . . 2.1 111.824 -167.639 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 181' ' ' GLU . . . . . 0.763 ' HA ' ' O ' ' B' ' 171' ' ' GLY . 0.3 OUTLIER -45.87 141.23 3.16 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 110.326 -3.125 . . . . 3.06 109.851 -177.605 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 182' ' ' ASP . . . . . 0.684 ' OD1' ' HB2' ' B' ' 185' ' ' CYS . 3.1 p-10 -145.15 137.29 13.21 Favored Pre-proline 0 C--N 1.306 -1.291 0 CA-C-N 115.32 -0.854 . . . . 2.06 109.628 -178.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 183' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' B' ' 182' ' ' ASP . 52.1 Cg_exo -57.73 -35.37 98.83 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.618 2.212 . . . . 1.91 114.425 -177.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -64.84 -51.57 61.37 Favored 'General case' 0 CA--C 1.508 -0.656 0 N-CA-C 108.701 -0.851 . . . . 1.56 108.701 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 185' ' ' CYS . . . . . 0.684 ' HB2' ' OD1' ' B' ' 182' ' ' ASP . 3.2 m -98.97 77.08 2.17 Favored 'General case' 0 CA--C 1.499 -0.998 0 N-CA-C 106.772 -1.566 . . . . 1.94 106.772 176.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 186' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.5 -0.943 0 C-N-CA 119.469 -0.892 . . . . 3.61 110.184 -178.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.2 m . . . . . 0 C--O 1.232 0.164 0 N-CA-C 112.628 0.603 . . . . 2.68 112.628 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.662 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 0.3 OUTLIER -36.18 112.5 0.52 Allowed Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.804 -0.634 . . . . 2.48 112.628 178.443 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.563 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 56.3 Cg_endo -91.75 145.22 3.11 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 121.696 1.597 . . . . 1.49 113.808 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.682 ' O ' ' HA2' ' A' ' 17' ' ' GLY . 20.8 p -146.12 -174.26 4.39 Favored 'General case' 0 C--N 1.347 0.487 0 C-N-CA 119.043 -1.063 . . . . 1.0 113.543 -179.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.625 ' HA2' ' HG3' ' A' ' 40' ' ' GLU . . . 73.99 -161.38 53.88 Favored Glycine 0 N--CA 1.451 -0.317 0 CA-C-N 115.3 -0.864 . . . . 1.15 113.547 177.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.541 ' O ' ' HG3' ' A' ' 18' ' ' LYS . 39.7 Cg_endo -63.26 101.03 0.28 Allowed 'Trans proline' 0 N--CA 1.481 0.785 0 C-N-CA 123.664 2.909 . . . . 1.57 109.211 176.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 82.85 13.21 78.33 Favored Glycine 0 C--N 1.291 -1.917 0 C-N-CA 120.847 -0.692 . . . . 1.68 111.993 178.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.682 ' HA2' ' O ' ' A' ' 13' ' ' CYS . . . 51.8 49.09 49.1 Favored Glycine 0 N--CA 1.409 -3.136 0 N-CA-C 107.897 -2.081 . . . . 1.36 107.897 174.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.541 ' HG3' ' O ' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -99.94 18.52 18.19 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 112.519 -1.841 . . . . 2.5 111.553 174.299 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.563 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -131.73 -177.7 15.05 Favored Glycine 0 N--CA 1.444 -0.789 0 N-CA-C 104.405 -3.478 . . . . 1.02 104.405 176.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.662 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -124.41 172.58 9.03 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 120.538 2.169 . . . . 2.92 109.453 178.754 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.501 ' HB2' ' HB3' ' A' ' 11' ' ' LEU . 0.8 OUTLIER -105.64 134.97 47.9 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 121.334 -0.854 . . . . 1.1 111.16 -178.367 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.516 ' HE2' ' HA ' ' A' ' 56' ' ' SER . 68.0 m-85 -128.2 13.79 6.68 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.3 -0.864 . . . . 1.51 111.253 -179.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -176.16 -167.82 35.49 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.391 -0.909 . . . . 0.9 112.525 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.523 ' O ' ' HB3' ' A' ' 44' ' ' CYS . 1.9 Cg_endo -81.76 -44.26 0.09 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.814 2.343 . . . . 1.5 112.746 -179.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.438 ' HB2' ' OE2' ' B' ' 181' ' ' GLU . 0.1 OUTLIER -124.62 16.03 8.8 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.938 0.399 . . . . 1.26 110.797 179.823 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.755 HG23 ' HA ' ' A' ' 36' ' ' VAL . 0.8 OUTLIER -126.23 121.76 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.09 0 CA-C-O 121.464 0.649 . . . . 0.83 111.563 -178.041 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.884 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -119.1 132.86 56.04 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-N 115.641 -0.709 . . . . 0.92 109.108 179.051 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 1.133 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -144.82 116.15 8.01 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 112.52 0.563 . . . . 1.28 112.52 -178.718 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.676 ' O ' ' HB1' ' A' ' 69' ' ' ALA . . . -107.43 -163.54 21.74 Favored Glycine 0 N--CA 1.428 -1.866 0 N-CA-C 109.806 -1.318 . . . . 0.67 109.806 177.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.407 ' O ' ' HB2' ' A' ' 70' ' ' ALA . 11.4 t70 -67.54 -60.37 2.61 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 113.885 1.069 . . . . 2.27 113.885 -179.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.51 9.33 23.2 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 115.661 -0.699 . . . . 1.66 111.122 -176.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.825 ' O ' HG22 ' B' ' 138' ' ' THR . 1.0 OUTLIER -109.71 -18.96 13.33 Favored 'General case' 0 N--CA 1.405 -2.687 0 N-CA-C 106.791 -1.559 . . . . 1.37 106.791 179.982 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 1.133 ' O ' ' HA ' ' A' ' 28' ' ' CYS . . . 68.8 -133.86 27.43 Favored Glycine 0 N--CA 1.43 -1.755 0 CA-C-N 114.919 -1.037 . . . . 0.73 115.257 173.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.876 ' HB2' HG13 ' A' ' 72' ' ' ILE . 3.1 t -136.26 117.69 14.74 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-N 118.387 1.094 . . . . 1.08 113.254 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.885 ' HA ' ' HA ' ' B' ' 135' ' ' PHE . 0.0 OUTLIER -100.03 108.67 20.91 Favored 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 106.786 -1.561 . . . . 1.38 106.786 176.984 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.755 ' HA ' HG23 ' A' ' 26' ' ' ILE . 1.7 t -90.92 87.07 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.304 0 CA-C-O 122.473 1.13 . . . . 0.76 110.269 -179.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.441 ' O ' ' HA3' ' B' ' 133' ' ' GLY . . . 102.55 69.29 0.82 Allowed Glycine 0 C--O 1.228 -0.26 0 CA-C-N 112.99 -1.913 . . . . 0.81 113.953 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.881 HG22 ' O ' ' B' ' 132' ' ' LEU . 72.4 p -151.29 164.51 36.46 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 109.251 -0.648 . . . . 0.77 109.251 179.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.756 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -70.62 -16.26 62.82 Favored 'General case' 0 N--CA 1.44 -0.968 0 C-N-CA 119.975 -0.69 . . . . 1.02 110.308 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.625 ' HG3' ' HA2' ' A' ' 14' ' ' GLY . 5.0 mp0 -67.57 -15.83 63.86 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.424 -0.954 . . . . 2.32 108.424 176.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 1.051 ' O ' ' HB2' ' A' ' 44' ' ' CYS . . . -120.91 -10.57 9.08 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-N 116.361 -0.381 . . . . 0.87 111.221 -178.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.756 HD12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -61.71 -20.4 63.46 Favored 'General case' 0 N--CA 1.45 -0.439 0 O-C-N 121.211 -0.93 . . . . 1.23 113.229 -177.867 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.69 ' N ' HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -71.6 -6.78 43.43 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 107.556 -1.276 . . . . 2.92 107.556 174.95 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 1.051 ' HB2' ' O ' ' A' ' 41' ' ' ALA . 0.2 OUTLIER -66.53 -1.54 3.73 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 112.361 -2.2 . . . . 1.57 110.012 176.462 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -82.84 -17.35 44.26 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.02 0.438 . . . . 3.31 111.457 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -85.51 6.42 27.08 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 120.107 -0.637 . . . . 3.69 109.892 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.404 ' HG3' HD13 ' A' ' 11' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.446 -0.634 0 N-CA-C 109.416 -0.587 . . . . 3.99 109.416 177.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.516 ' HA ' ' HE2' ' A' ' 22' ' ' PHE . 0.3 OUTLIER . . . . . 0 C--O 1.234 0.289 0 N-CA-C 111.441 0.163 . . . . 3.12 111.441 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 160.41 133.73 1.54 Allowed Glycine 0 N--CA 1.444 -0.819 0 N-CA-C 106.509 -2.637 . . . . 2.1 106.509 -179.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -109.0 76.9 1.03 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 118.991 1.396 . . . . 4.36 111.614 -177.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.477 ' N ' ' CD ' ' A' ' 60' ' ' PRO . 0.4 OUTLIER -145.79 57.19 3.88 Favored Pre-proline 0 C--N 1.309 -1.175 0 N-CA-C 106.33 -1.73 . . . . 3.55 106.33 176.799 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.477 ' CD ' ' N ' ' A' ' 59' ' ' LYS . 41.0 Cg_endo -70.3 81.76 0.92 Allowed 'Trans proline' 0 N--CA 1.448 -1.159 0 C-N-CA 122.096 1.864 . . . . 1.54 113.772 -178.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -103.08 179.31 4.31 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 106.988 -1.486 . . . . 1.59 106.988 177.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.16 -169.34 46.49 Favored Glycine 0 N--CA 1.437 -1.246 0 C-N-CA 118.656 -1.735 . . . . 2.43 114.607 178.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 50.2 p -85.46 47.26 1.4 Allowed 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 113.504 -1.348 . . . . 4.11 111.394 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 118.06 5.9 12.93 Favored Glycine 0 C--N 1.336 0.552 0 N-CA-C 115.828 1.091 . . . . 2.21 115.828 175.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.551 ' HA3' ' HA ' ' A' ' 74' ' ' CYS . . . -105.77 137.41 13.76 Favored Glycine 0 CA--C 1.52 0.385 0 N-CA-C 117.044 1.577 . . . . 1.62 117.044 -177.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.436 ' HA ' ' O ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -107.41 153.76 22.32 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 114.176 -1.012 . . . . 3.02 109.111 177.668 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.792 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 2.2 m -59.41 107.64 0.6 Allowed 'General case' 0 N--CA 1.441 -0.891 0 O-C-N 121.968 -0.457 . . . . 1.52 111.442 -177.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -84.21 -20.23 32.68 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.308 -0.627 . . . . 1.07 109.308 177.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.703 ' HB3' ' CG1' ' A' ' 72' ' ' ILE . . . -166.46 164.07 17.23 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.776 -0.647 . . . . 1.0 111.62 179.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.623 ' HA ' ' O ' ' A' ' 85' ' ' CYS . . . -39.76 96.9 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.778 -0.646 . . . . 1.24 110.185 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 1.044 ' C ' HD13 ' A' ' 72' ' ' ILE . . . 73.57 50.23 12.32 Favored Glycine 0 CA--C 1.504 -0.655 0 CA-C-N 114.877 -1.056 . . . . 1.28 111.456 -179.126 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 1.044 HD13 ' C ' ' A' ' 71' ' ' GLY . 0.5 OUTLIER -137.51 98.88 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.817 0 N-CA-C 108.049 -1.093 . . . . 2.27 108.049 170.969 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.461 ' O ' ' HB2' ' A' ' 80' ' ' HIS . 51.2 t -91.91 96.27 10.29 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 108.613 -0.884 . . . . 1.98 108.613 179.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 1.066 ' CB ' ' HA ' ' A' ' 79' ' ' CYS . 24.4 p -167.3 -171.57 1.75 Allowed 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 116.577 2.066 . . . . 1.33 116.577 -176.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.883 ' HB3' ' HD2' ' A' ' 76' ' ' PRO . 72.8 m -124.6 -178.9 0.74 Allowed Pre-proline 0 CA--C 1.531 0.225 0 CA-C-N 112.927 -1.942 . . . . 1.99 108.564 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.883 ' HD2' ' HB3' ' A' ' 75' ' ' SER . 58.0 Cg_endo -73.16 31.17 0.3 Allowed 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 121.717 1.611 . . . . 1.86 113.172 -179.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -134.36 -60.94 0.79 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.85 0.357 . . . . 2.65 110.221 178.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.935 ' O ' ' HB2' ' A' ' 74' ' ' CYS . . . -118.22 -178.51 17.14 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.95 -0.643 . . . . 0.99 111.661 178.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 1.066 ' HA ' ' CB ' ' A' ' 74' ' ' CYS . 22.5 m -152.27 161.37 42.72 Favored 'General case' 0 C--O 1.226 -0.169 0 N-CA-C 112.428 0.529 . . . . 1.34 112.428 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.541 ' HA ' ' HA2' ' B' ' 178' ' ' GLY . 7.1 m80 -143.17 139.04 30.16 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-O 121.173 0.511 . . . . 2.17 111.823 -178.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.477 ' OE2' ' HB2' ' B' ' 125' ' ' SER . 37.0 tt0 -65.51 122.97 18.43 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-N 115.671 -0.695 . . . . 3.05 109.605 178.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.698 ' O ' ' HA2' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -138.9 106.75 7.47 Favored Pre-proline 0 C--N 1.319 -0.749 0 C-N-CA 118.963 -1.095 . . . . 2.02 111.385 179.424 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -63.85 -16.65 56.07 Favored 'Trans proline' 0 C--N 1.356 0.948 0 C-N-CA 123.004 2.47 . . . . 1.93 114.315 -178.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.08 -40.16 96.86 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.108 0.48 . . . . 1.53 110.542 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.632 ' O ' ' N ' ' A' ' 71' ' ' GLY . 68.8 m -94.18 46.74 1.17 Allowed 'General case' 0 C--O 1.219 -0.55 0 CA-C-N 115.484 -0.78 . . . . 1.88 110.351 179.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.475 0.803 0 O-C-N 121.544 -0.722 . . . . 3.6 112.027 -178.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 110' ' ' CYS . . . . . . . . . . . . . 1.2 m . . . . . 0 CA--C 1.52 -0.2 0 CA-C-O 121.247 0.546 . . . . 2.61 111.457 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 111' ' ' LEU . . . . . 0.748 ' O ' ' HA ' ' B' ' 120' ' ' ARG . 0.2 OUTLIER -37.92 112.08 0.61 Allowed Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.007 -0.997 . . . . 2.47 112.367 176.864 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 112' ' ' PRO . . . . . 0.433 ' HA ' ' O ' ' B' ' 119' ' ' GLY . 88.6 Cg_endo -84.49 153.28 12.02 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.339 2.026 . . . . 1.47 111.018 178.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.508 ' O ' ' HA2' ' B' ' 117' ' ' GLY . 20.0 p -154.33 -174.71 5.07 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 113.638 0.977 . . . . 1.0 113.638 174.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 114' ' ' GLY . . . . . 0.606 ' HA2' ' HG3' ' B' ' 140' ' ' GLU . . . 73.54 -161.44 54.15 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.151 -0.931 . . . . 1.16 113.529 177.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 115' ' ' PRO . . . . . 0.547 ' O ' ' HG3' ' B' ' 118' ' ' LYS . 42.8 Cg_endo -64.57 95.74 0.23 Allowed 'Trans proline' 0 C--O 1.224 -0.182 0 C-N-CA 123.11 2.54 . . . . 1.57 112.5 177.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 87.65 11.41 68.5 Favored Glycine 0 C--N 1.283 -2.403 0 CA-C-N 114.767 -1.106 . . . . 1.7 113.228 -178.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 117' ' ' GLY . . . . . 0.508 ' HA2' ' O ' ' B' ' 113' ' ' CYS . . . 62.11 39.41 97.6 Favored Glycine 0 N--CA 1.414 -2.822 0 C-N-CA 118.002 -2.047 . . . . 1.38 111.438 176.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 118' ' ' LYS . . . . . 0.547 ' HG3' ' O ' ' B' ' 115' ' ' PRO . 0.0 OUTLIER -91.85 7.06 43.69 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 113.904 -1.148 . . . . 2.54 112.094 179.644 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 119' ' ' GLY . . . . . 0.433 ' O ' ' HA ' ' B' ' 112' ' ' PRO . . . -115.93 -159.5 11.97 Favored Glycine 0 C--N 1.343 0.961 0 N-CA-C 108.139 -1.984 . . . . 1.04 108.139 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.748 ' HA ' ' O ' ' B' ' 111' ' ' LEU . 0.0 OUTLIER -145.37 170.46 16.29 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 121.098 2.449 . . . . 2.89 105.844 174.685 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 121' ' ' CYS . . . . . 0.493 ' HB2' ' HB3' ' B' ' 111' ' ' LEU . 0.9 OUTLIER -106.26 135.61 47.45 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 119.115 0.87 . . . . 1.07 111.942 -176.769 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 122' ' ' PHE . . . . . 0.549 ' HE2' ' HA ' ' B' ' 156' ' ' SER . 68.7 m-85 -128.12 13.71 6.72 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.038 -0.983 . . . . 1.53 111.287 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -176.16 -167.81 35.49 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.339 -0.934 . . . . 0.9 112.56 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . 0.494 ' O ' ' HB3' ' B' ' 144' ' ' CYS . 2.0 Cg_endo -81.68 -44.37 0.09 OUTLIER 'Trans proline' 0 CA--C 1.532 0.423 0 C-N-CA 122.701 2.267 . . . . 1.51 112.791 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 125' ' ' SER . . . . . 0.477 ' HB2' ' OE2' ' A' ' 81' ' ' GLU . 0.1 OUTLIER -124.73 16.54 8.73 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.983 0.421 . . . . 1.25 110.722 179.823 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 126' ' ' ILE . . . . . 0.739 HG23 ' HA ' ' B' ' 136' ' ' VAL . 1.0 OUTLIER -126.44 121.63 59.3 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 CA-C-O 121.454 0.645 . . . . 0.85 111.57 -178.106 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 127' ' ' CYS . . . . . 0.833 ' HB2' ' HB2' ' B' ' 141' ' ' ALA . 0.1 OUTLIER -119.28 133.59 55.67 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-N 115.578 -0.737 . . . . 0.89 109.078 178.912 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 128' ' ' CYS . . . . . 1.205 ' HA ' ' O ' ' B' ' 133' ' ' GLY . 0.0 OUTLIER -145.53 120.5 10.02 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 118.246 -0.883 . . . . 1.23 111.145 -179.171 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 129' ' ' GLY . . . . . 0.631 ' O ' ' HB1' ' B' ' 169' ' ' ALA . . . -114.69 -156.95 11.56 Favored Glycine 0 N--CA 1.417 -2.613 0 N-CA-C 107.555 -2.218 . . . . 0.66 107.555 176.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -65.85 -71.0 0.21 Allowed 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 122.168 0.187 . . . . 2.35 111.493 -178.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.47 32.25 5.52 Favored 'General case' 0 CA--C 1.498 -1.024 0 C-N-CA 120.095 -0.642 . . . . 1.69 110.027 -175.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 132' ' ' LEU . . . . . 0.881 ' O ' HG22 ' A' ' 38' ' ' THR . 0.8 OUTLIER -124.79 -18.88 5.46 Favored 'General case' 0 N--CA 1.403 -2.802 0 N-CA-C 104.898 -2.26 . . . . 1.38 104.898 176.127 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 133' ' ' GLY . . . . . 1.205 ' O ' ' HA ' ' B' ' 128' ' ' CYS . . . 66.86 -134.96 32.33 Favored Glycine 0 N--CA 1.407 -3.269 0 CA-C-N 115.134 -0.939 . . . . 0.72 114.769 173.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 134' ' ' CYS . . . . . 0.894 ' HB2' HG13 ' B' ' 172' ' ' ILE . 2.7 t -135.14 116.44 14.52 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 114.141 1.163 . . . . 1.08 114.141 -177.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 135' ' ' PHE . . . . . 0.885 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -98.16 107.68 20.21 Favored 'General case' 0 CA--C 1.503 -0.857 0 N-CA-C 107.068 -1.456 . . . . 1.36 107.068 177.158 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 136' ' ' VAL . . . . . 0.739 ' HA ' HG23 ' B' ' 126' ' ' ILE . 2.2 t -90.99 86.57 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.324 0 CA-C-O 122.611 1.196 . . . . 0.75 109.792 -179.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 137' ' ' GLY . . . . . 0.475 ' O ' ' HA3' ' A' ' 33' ' ' GLY . . . 102.47 68.92 0.81 Allowed Glycine 0 C--N 1.321 -0.285 0 CA-C-N 112.85 -1.977 . . . . 0.83 114.135 179.403 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 138' ' ' THR . . . . . 0.825 HG22 ' O ' ' A' ' 32' ' ' LEU . 81.2 p -146.45 173.15 12.55 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.824 -0.806 . . . . 0.78 108.824 178.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 139' ' ' ALA . . . . . 0.79 ' O ' HD12 ' B' ' 142' ' ' LEU . . . -78.35 -17.36 56.61 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 120.197 -0.601 . . . . 1.04 109.669 177.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 140' ' ' GLU . . . . . 0.606 ' HG3' ' HA2' ' B' ' 114' ' ' GLY . 5.3 mp0 -67.48 -14.33 62.83 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.86 -0.793 . . . . 2.31 108.86 176.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 141' ' ' ALA . . . . . 1.034 ' O ' ' HB2' ' B' ' 144' ' ' CYS . . . -120.42 -15.59 8.53 Favored 'General case' 0 C--O 1.218 -0.585 0 CA-C-N 115.198 -0.91 . . . . 0.87 111.802 -179.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 142' ' ' LEU . . . . . 0.79 HD12 ' O ' ' B' ' 139' ' ' ALA . 0.0 OUTLIER -59.91 -21.15 60.71 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 113.529 0.937 . . . . 1.24 113.529 -176.569 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 143' ' ' ARG . . . . . 0.698 ' N ' HD13 ' B' ' 142' ' ' LEU . 0.0 OUTLIER -64.32 -20.63 66.22 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 105.966 -1.865 . . . . 2.93 105.966 175.222 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 144' ' ' CYS . . . . . 1.034 ' HB2' ' O ' ' B' ' 141' ' ' ALA . 0.2 OUTLIER -59.28 2.49 0.06 Allowed 'General case' 0 N--CA 1.486 1.374 0 CA-C-N 113.521 -1.672 . . . . 1.61 110.578 -177.985 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 145' ' ' GLN . . . . . 0.499 ' H ' ' C ' ' B' ' 143' ' ' ARG . 14.4 mm100 -84.03 -17.46 40.32 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.039 0.447 . . . . 3.35 111.004 178.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -85.69 6.49 27.42 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 120.147 -0.621 . . . . 3.76 109.808 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 147' ' ' GLU . . . . . 0.406 ' HG3' HD13 ' B' ' 111' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.446 -0.633 0 C-N-CA 120.241 -0.584 . . . . 4.01 109.508 177.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 156' ' ' SER . . . . . 0.549 ' HA ' ' HE2' ' B' ' 122' ' ' PHE . 0.3 OUTLIER . . . . . 0 CA--C 1.535 0.396 0 N-CA-C 108.997 -0.742 . . . . 3.11 108.997 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 165.68 136.63 2.05 Favored Glycine 0 CA--C 1.501 -0.798 0 N-CA-C 108.291 -1.924 . . . . 2.07 108.291 -178.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -110.91 64.63 0.61 Allowed 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 117.013 -1.875 . . . . 4.34 112.682 -178.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 159' ' ' LYS . . . . . 0.471 ' HB3' ' SG ' ' B' ' 167' ' ' CYS . 0.2 OUTLIER -118.19 53.63 1.75 Allowed Pre-proline 0 C--N 1.315 -0.893 0 CA-C-N 113.686 -1.597 . . . . 3.54 110.048 170.175 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 160' ' ' PRO . . . . . 0.421 ' HA ' ' HA ' ' B' ' 166' ' ' ARG . 37.7 Cg_endo -69.79 83.9 0.68 Allowed 'Trans proline' 0 CA--C 1.519 -0.244 0 CA-C-N 122.153 1.805 . . . . 1.51 114.46 -173.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 161' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -97.13 -170.91 2.11 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 113.8 -1.545 . . . . 1.58 107.761 178.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 55.87 -167.53 3.27 Favored Glycine 0 N--CA 1.439 -1.159 0 C-N-CA 119.645 -1.264 . . . . 2.37 114.779 173.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 78.8 p -85.65 47.03 1.37 Allowed 'General case' 0 C--N 1.309 -1.168 0 C-N-CA 126.637 1.975 . . . . 4.07 111.66 -179.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 118.35 5.11 13.19 Favored Glycine 0 C--N 1.347 1.189 0 CA-C-N 112.863 -1.971 . . . . 2.2 116.004 173.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 165' ' ' GLY . . . . . 0.546 ' HA3' ' HA ' ' B' ' 174' ' ' CYS . . . -104.0 137.97 13.82 Favored Glycine 0 CA--C 1.522 0.473 0 C-N-CA 118.837 -1.649 . . . . 1.62 117.081 -176.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 166' ' ' ARG . . . . . 0.464 ' HA ' ' O ' ' B' ' 159' ' ' LYS . 0.0 OUTLIER -107.96 153.69 22.7 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 114.006 -1.097 . . . . 3.05 108.99 177.03 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 167' ' ' CYS . . . . . 0.801 ' HA ' ' O ' ' B' ' 172' ' ' ILE . 2.0 m -59.52 107.54 0.6 Allowed 'General case' 0 N--CA 1.438 -1.049 0 O-C-N 121.832 -0.542 . . . . 1.56 111.479 -177.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 168' ' ' ALA . . . . . . . . . . . . . . . -81.62 -24.65 36.26 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 108.808 -0.812 . . . . 1.04 108.808 177.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 169' ' ' ALA . . . . . 0.713 ' HB3' ' CG1' ' B' ' 172' ' ' ILE . . . -163.52 163.94 24.51 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 115.169 -0.923 . . . . 0.98 112.782 -178.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 170' ' ' ALA . . . . . 0.596 ' HA ' ' O ' ' B' ' 185' ' ' CYS . . . -40.97 97.77 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.563 -0.744 . . . . 1.25 110.115 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 171' ' ' GLY . . . . . 0.891 ' C ' HD13 ' B' ' 172' ' ' ILE . . . 88.19 20.73 48.18 Favored Glycine 0 N--CA 1.443 -0.876 0 N-CA-C 115.559 0.983 . . . . 1.29 115.559 179.017 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 172' ' ' ILE . . . . . 0.894 HG13 ' HB2' ' B' ' 134' ' ' CYS . 0.3 OUTLIER -120.19 99.25 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 CA-C-N 117.229 0.515 . . . . 2.27 110.908 -179.801 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 173' ' ' CYS . . . . . 0.455 ' O ' ' HB2' ' B' ' 180' ' ' HIS . 53.2 t -91.51 96.29 10.41 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 108.932 -0.766 . . . . 1.94 108.932 178.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 174' ' ' CYS . . . . . 1.077 ' CB ' ' HA ' ' B' ' 179' ' ' CYS . 21.9 p -167.67 -171.67 1.69 Allowed 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 116.53 2.048 . . . . 1.35 116.53 -176.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 175' ' ' SER . . . . . 0.915 ' HB3' ' HD2' ' B' ' 176' ' ' PRO . 72.3 m -124.48 -178.82 0.73 Allowed Pre-proline 0 CA--C 1.531 0.241 0 CA-C-N 112.981 -1.918 . . . . 2.0 108.537 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 176' ' ' PRO . . . . . 0.915 ' HD2' ' HB3' ' B' ' 175' ' ' SER . 57.9 Cg_endo -73.28 31.13 0.31 Allowed 'Trans proline' 0 CA--C 1.533 0.435 0 C-N-CA 121.725 1.617 . . . . 1.9 113.092 -179.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 177' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -134.32 -60.83 0.79 Allowed 'General case' 0 C--O 1.234 0.277 0 CA-C-O 120.914 0.387 . . . . 2.72 110.267 178.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 178' ' ' GLY . . . . . 0.918 ' O ' ' HB2' ' B' ' 174' ' ' CYS . . . -118.15 -178.52 17.18 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 121.006 -0.616 . . . . 0.99 111.668 178.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 179' ' ' CYS . . . . . 1.077 ' HA ' ' CB ' ' B' ' 174' ' ' CYS . 21.7 m -152.24 161.34 42.76 Favored 'General case' 0 N--CA 1.462 0.127 0 N-CA-C 112.453 0.538 . . . . 1.34 112.453 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 180' ' ' HIS . . . . . 0.529 ' HA ' ' HA2' ' A' ' 78' ' ' GLY . 7.1 m80 -143.15 139.08 30.22 Favored 'General case' 0 CA--C 1.517 -0.295 0 O-C-N 121.897 -0.502 . . . . 2.1 111.763 -178.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 181' ' ' GLU . . . . . 0.438 ' OE2' ' HB2' ' A' ' 25' ' ' SER . 37.4 tt0 -65.57 123.0 18.51 Favored 'General case' 0 CA--C 1.503 -0.858 0 CA-C-N 115.674 -0.694 . . . . 3.06 109.586 178.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 182' ' ' ASP . . . . . 0.766 ' O ' ' HA2' ' B' ' 171' ' ' GLY . 0.0 OUTLIER -138.81 106.6 7.52 Favored Pre-proline 0 C--N 1.319 -0.757 0 C-N-CA 118.957 -1.097 . . . . 2.06 111.346 179.466 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 183' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -63.6 -16.85 57.16 Favored 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 123.034 2.489 . . . . 1.91 114.391 -178.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -63.02 -40.2 97.03 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.177 0.513 . . . . 1.56 110.512 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 185' ' ' CYS . . . . . 0.601 ' O ' ' N ' ' B' ' 171' ' ' GLY . 69.5 m -94.0 46.83 1.18 Allowed 'General case' 0 C--O 1.217 -0.613 0 CA-C-N 115.576 -0.738 . . . . 1.94 110.399 179.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 186' ' ' ASP . . . . . 0.402 ' O ' ' HB1' ' B' ' 170' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.473 0.719 0 O-C-N 121.518 -0.739 . . . . 3.61 111.861 -178.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.534 0.332 0 N-CA-C 112.329 0.492 . . . . 2.68 112.329 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.898 HD23 ' HB3' ' A' ' 21' ' ' CYS . 15.0 tp -36.93 114.41 0.64 Allowed Pre-proline 0 N--CA 1.476 0.869 0 N-CA-C 114.054 1.131 . . . . 2.48 114.054 179.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.528 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 52.0 Cg_endo -95.73 134.83 0.57 Allowed 'Trans proline' 0 CA--C 1.534 0.513 0 C-N-CA 122.167 1.911 . . . . 1.49 115.216 179.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.661 ' O ' ' HA2' ' A' ' 17' ' ' GLY . 0.5 OUTLIER -140.65 -169.06 2.71 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 113.444 0.905 . . . . 1.0 113.444 -178.389 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.566 ' HA2' ' HB3' ' A' ' 40' ' ' GLU . . . 77.09 -156.18 45.21 Favored Glycine 0 C--N 1.337 0.605 0 CA-C-N 114.932 -1.031 . . . . 1.15 111.899 178.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.612 ' O ' ' HG2' ' A' ' 15' ' ' PRO . 41.4 Cg_endo -62.8 113.44 1.98 Allowed 'Trans proline' 0 N--CA 1.479 0.667 0 C-N-CA 122.783 2.322 . . . . 1.57 106.193 176.161 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 73.3 -7.12 12.25 Favored Glycine 0 C--N 1.276 -2.776 0 CA-C-O 119.067 -0.852 . . . . 1.68 112.73 175.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.661 ' HA2' ' O ' ' A' ' 13' ' ' CYS . . . 77.61 49.69 7.06 Favored Glycine 1 N--CA 1.383 -4.858 0 C-N-CA 118.295 -1.907 . . . . 1.36 111.515 -179.42 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.426 ' CG ' ' O ' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -99.61 9.46 43.11 Favored 'General case' 0 C--N 1.342 0.278 0 CA-C-N 112.864 -1.668 . . . . 2.5 111.946 175.643 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.528 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -124.63 -167.92 12.73 Favored Glycine 0 C--N 1.333 0.404 0 N-CA-C 106.465 -2.654 . . . . 1.02 106.465 178.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.721 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 0.6 OUTLIER -135.98 158.56 44.09 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 121.056 2.428 . . . . 2.92 108.184 -179.925 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.898 ' HB3' HD23 ' A' ' 11' ' ' LEU . 1.7 t -107.65 160.49 15.66 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 112.883 0.697 . . . . 1.1 112.883 -178.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.559 ' HE1' ' O ' ' A' ' 28' ' ' CYS . 60.7 m-85 -126.38 -47.46 1.59 Allowed 'General case' 0 C--N 1.339 0.143 0 CA-C-N 115.538 -0.755 . . . . 1.51 110.184 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -117.46 -159.62 11.46 Favored Glycine 0 CA--C 1.521 0.414 0 CA-C-N 115.723 -0.671 . . . . 0.9 111.559 179.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -84.33 -68.1 0.01 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.32 2.013 . . . . 1.5 111.657 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.409 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.4 OUTLIER -89.41 26.54 1.66 Allowed 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.867 -0.42 . . . . 1.26 109.867 178.753 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.937 HG12 HG13 ' A' ' 36' ' ' VAL . 5.6 mt -144.82 112.81 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 CA-C-O 121.875 0.845 . . . . 0.83 111.771 -178.287 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.587 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 4.7 t -126.57 131.3 51.56 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 114.991 -1.004 . . . . 0.92 109.451 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.792 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -142.44 123.12 14.21 Favored 'General case' 0 CA--C 1.561 1.374 0 N-CA-C 115.38 1.622 . . . . 1.28 115.38 -177.358 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -109.37 -170.34 20.5 Favored Glycine 0 C--N 1.368 2.31 0 N-CA-C 109.117 -1.593 . . . . 0.67 109.117 175.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -66.07 -56.07 13.39 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 114.573 1.323 . . . . 2.27 114.573 -178.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.45 -1.11 16.03 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 122.129 0.966 . . . . 1.66 111.234 -177.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.94 HD22 ' CZ ' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -97.39 -13.0 22.1 Favored 'General case' 0 N--CA 1.407 -2.587 0 N-CA-C 106.531 -1.655 . . . . 1.37 106.531 179.937 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.886 ' HA2' ' CB ' ' A' ' 69' ' ' ALA . . . 58.78 -132.66 52.66 Favored Glycine 0 C--O 1.197 -2.168 0 CA-C-O 118.165 -1.353 . . . . 0.73 112.28 175.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.872 ' HB2' HD13 ' A' ' 72' ' ' ILE . 2.4 t -135.39 122.21 21.08 Favored 'General case' 0 CA--C 1.486 -1.517 0 CA-C-N 118.496 1.148 . . . . 1.08 113.748 -179.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.94 ' CZ ' HD22 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -97.69 100.63 12.02 Favored 'General case' 0 N--CA 1.427 -1.606 0 N-CA-C 103.296 -2.853 . . . . 1.38 103.296 175.426 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.937 HG13 HG12 ' A' ' 26' ' ' ILE . 2.1 t -92.12 83.66 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 CA-C-O 123.319 1.533 . . . . 0.76 107.139 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.798 ' HA3' HG21 ' B' ' 172' ' ' ILE . . . 100.43 85.71 1.87 Allowed Glycine 0 CA--C 1.525 0.689 0 CA-C-N 112.42 -2.173 . . . . 0.81 113.67 -179.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.708 HG22 ' O ' ' B' ' 132' ' ' LEU . 67.0 p -161.56 159.49 27.82 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 109.631 -0.507 . . . . 0.77 109.631 179.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.594 ' HA ' ' CD1' ' A' ' 42' ' ' LEU . . . -62.15 -23.07 66.36 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 118.666 0.666 . . . . 1.02 111.242 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.566 ' HB3' ' HA2' ' A' ' 14' ' ' GLY . 3.2 mm-40 -68.75 -13.05 62.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.795 -0.639 . . . . 2.32 109.704 176.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.536 ' O ' ' HB2' ' A' ' 44' ' ' CYS . . . -100.3 -24.36 14.55 Favored 'General case' 0 C--O 1.205 -1.24 0 N-CA-C 109.154 -0.684 . . . . 0.87 109.154 178.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.594 ' CD1' ' HA ' ' A' ' 39' ' ' ALA . 26.4 mt -42.5 -38.49 1.95 Allowed 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.31 0.485 . . . . 1.23 112.31 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.648 ' HD3' ' O ' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -69.25 -6.25 28.05 Favored 'General case' 0 CA--C 1.556 1.197 0 CA-C-O 121.822 0.82 . . . . 2.92 110.733 179.348 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.536 ' HB2' ' O ' ' A' ' 41' ' ' ALA . 65.7 m -72.59 -18.21 61.62 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 113.829 -1.532 . . . . 1.57 109.715 177.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -55.48 -17.17 4.7 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.667 -0.697 . . . . 3.31 111.471 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -84.43 5.64 26.48 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 120.444 -0.502 . . . . 3.69 110.063 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 . . . . . 0 N--CA 1.452 -0.345 0 CA-C-N 115.89 -0.595 . . . . 3.99 109.833 177.755 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.775 ' OG ' ' HG3' ' A' ' 59' ' ' LYS . 0.4 OUTLIER . . . . . 0 N--CA 1.477 0.916 0 N-CA-C 108.72 -0.845 . . . . 3.12 108.72 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 103.87 -108.73 3.25 Favored Glycine 0 CA--C 1.479 -2.167 0 N-CA-C 110.806 -0.918 . . . . 2.1 110.806 -178.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.486 ' O ' ' HB3' ' A' ' 67' ' ' CYS . 3.5 mt-30 -112.56 115.85 29.28 Favored 'General case' 0 N--CA 1.422 -1.85 0 N-CA-C 102.889 -3.004 . . . . 4.36 102.889 175.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.918 ' HB3' ' CD ' ' A' ' 60' ' ' PRO . 0.0 OUTLIER -99.22 -100.11 0.0 OUTLIER Pre-proline 0 C--N 1.305 -1.329 0 CA-C-O 114.575 -2.631 . . . . 3.55 109.558 -173.273 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.918 ' CD ' ' HB3' ' A' ' 59' ' ' LYS . 9.7 Cg_endo -49.84 127.04 17.99 Favored 'Trans proline' 0 N--CA 1.474 0.354 0 CA-C-N 127.036 3.549 . . . . 1.54 118.437 -176.024 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.47 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 5.0 t -145.3 -172.98 3.98 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 110.793 -2.912 . . . . 1.59 106.637 177.08 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 37.89 -162.49 0.01 OUTLIER Glycine 0 N--CA 1.485 1.932 0 N-CA-C 114.857 0.703 . . . . 2.43 114.857 175.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 71.2 m -82.78 51.8 1.98 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 120.438 -0.505 . . . . 4.11 109.887 178.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 112.66 2.26 25.71 Favored Glycine 0 CA--C 1.539 1.548 0 C-N-CA 120.742 -0.742 . . . . 2.21 113.467 -178.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.734 ' HA2' ' HA ' ' A' ' 75' ' ' SER . . . -98.62 129.14 9.8 Favored Glycine 0 N--CA 1.464 0.564 0 C-N-CA 120.646 -0.788 . . . . 1.62 112.461 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.677 ' HA ' ' O ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -78.62 150.36 32.71 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-O 121.039 0.447 . . . . 3.02 111.592 -177.749 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.486 ' HB3' ' O ' ' A' ' 58' ' ' GLN . 9.1 t -70.77 109.54 5.03 Favored 'General case' 0 N--CA 1.397 -3.086 0 N-CA-C 109.24 -0.652 . . . . 1.52 109.24 -178.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.605 ' HB1' ' SG ' ' A' ' 28' ' ' CYS . . . -85.23 -21.5 29.07 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.775 0.798 . . . . 1.07 108.865 178.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.886 ' CB ' ' HA2' ' A' ' 33' ' ' GLY . . . -168.8 161.18 10.9 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.163 -1.381 . . . . 1.0 109.092 -178.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.802 ' HA ' ' HB3' ' A' ' 85' ' ' CYS . . . -55.01 140.18 38.55 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 118.176 0.444 . . . . 1.24 111.138 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.632 ' H ' ' CB ' ' A' ' 85' ' ' CYS . . . 75.14 -44.44 1.6 Allowed Glycine 0 CA--C 1.529 0.943 0 CA-C-N 116.202 -0.453 . . . . 1.28 113.779 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.876 HG21 ' HA3' ' B' ' 137' ' ' GLY . 1.6 pp -97.54 99.14 8.3 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.952 0 CA-C-O 122.142 0.973 . . . . 2.27 111.737 -177.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.487 ' SG ' ' HB3' ' A' ' 82' ' ' ASP . 34.2 m -93.21 104.26 16.46 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 115.531 -0.759 . . . . 1.98 109.302 179.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 1.027 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 33.8 m -84.7 124.63 31.73 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.439 -0.801 . . . . 1.33 112.459 -177.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.968 ' HB3' ' HD2' ' A' ' 76' ' ' PRO . 49.5 m -84.58 -178.52 1.19 Allowed Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 115.067 -0.97 . . . . 1.99 110.431 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.968 ' HD2' ' HB3' ' A' ' 75' ' ' SER . 74.1 Cg_endo -75.7 30.3 0.38 Allowed 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 121.672 1.581 . . . . 1.86 111.942 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.832 ' HB2' ' ND1' ' B' ' 180' ' ' HIS . 2.8 p30 -145.51 -28.41 0.44 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.602 -0.726 . . . . 2.65 110.536 179.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.781 ' HA3' ' O ' ' B' ' 179' ' ' CYS . . . -177.68 -133.17 1.81 Allowed Glycine 0 CA--C 1.521 0.437 0 C-N-CA 121.153 -0.546 . . . . 0.99 112.141 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 1.027 ' HA ' ' HA ' ' A' ' 74' ' ' CYS . 80.4 m -128.43 148.62 50.72 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 109.635 -0.506 . . . . 1.34 109.635 179.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.819 ' ND1' ' HB2' ' B' ' 177' ' ' ASP . 4.5 t60 -138.64 116.33 11.43 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 108.246 -1.02 . . . . 2.17 108.246 -173.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.593 ' HG3' ' O ' ' B' ' 177' ' ' ASP . 0.0 OUTLIER -57.31 117.5 4.16 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.803 0.811 . . . . 3.05 110.268 -178.701 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.63 ' OD1' ' HB3' ' A' ' 84' ' ' ALA . 0.3 OUTLIER -147.37 101.47 3.79 Favored Pre-proline 0 N--CA 1.439 -0.991 0 CA-C-N 114.285 -1.325 . . . . 2.02 108.951 -178.167 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -56.28 -2.19 0.37 Allowed 'Trans proline' 0 C--N 1.361 1.201 0 C-N-CA 123.142 2.561 . . . . 1.93 115.15 -177.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.63 ' HB3' ' OD1' ' A' ' 82' ' ' ASP . . . -65.84 -17.83 64.91 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 111.985 0.365 . . . . 1.53 111.985 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.802 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 13.2 m -99.69 7.01 45.49 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.329 0.862 . . . . 1.88 113.329 -178.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.384 0 N-CA-C 115.448 1.647 . . . . 3.6 115.448 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 110' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.53 0.197 0 CA-C-O 121.395 0.617 . . . . 2.61 111.084 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 111' ' ' LEU . . . . . 0.919 HD23 ' HB3' ' B' ' 121' ' ' CYS . 14.8 tp -39.89 113.67 0.92 Allowed Pre-proline 0 N--CA 1.47 0.529 0 CA-C-N 114.913 -1.04 . . . . 2.47 113.771 177.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 112' ' ' PRO . . . . . 0.402 ' HA ' ' O ' ' B' ' 119' ' ' GLY . 73.6 Cg_endo -83.85 152.61 13.0 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 122.515 2.143 . . . . 1.47 110.037 178.055 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.663 ' C ' ' HA2' ' B' ' 117' ' ' GLY . 0.5 OUTLIER -158.7 -170.87 3.21 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 118.88 -1.128 . . . . 1.0 113.182 172.275 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 114' ' ' GLY . . . . . 0.572 ' HA2' ' HB3' ' B' ' 140' ' ' GLU . . . 76.41 -156.15 46.35 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.482 -0.866 . . . . 1.16 111.478 178.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 115' ' ' PRO . . . . . 0.479 ' O ' ' HG2' ' B' ' 115' ' ' PRO . 41.2 Cg_endo -65.31 95.89 0.27 Allowed 'Trans proline' 0 N--CA 1.467 -0.085 0 C-N-CA 122.848 2.366 . . . . 1.57 113.12 178.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 82.9 3.24 90.58 Favored Glycine 0 C--N 1.28 -2.56 0 CA-C-N 114.963 -1.017 . . . . 1.7 112.944 -178.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 117' ' ' GLY . . . . . 0.663 ' HA2' ' C ' ' B' ' 113' ' ' CYS . . . 76.34 45.68 14.12 Favored Glycine 0 N--CA 1.402 -3.604 0 C-N-CA 120.955 -0.64 . . . . 1.38 114.131 178.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.39 -1.91 57.46 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 114.696 -0.752 . . . . 2.54 111.32 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 119' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' B' ' 112' ' ' PRO . . . -107.46 -156.22 19.86 Favored Glycine 0 C--N 1.343 0.92 0 N-CA-C 110.209 -1.156 . . . . 1.04 110.209 -179.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.8 ' HA ' ' O ' ' B' ' 111' ' ' LEU . 1.2 mtm180 -150.64 154.33 37.29 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 120.216 2.008 . . . . 2.89 106.302 176.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 121' ' ' CYS . . . . . 0.919 ' HB3' HD23 ' B' ' 111' ' ' LEU . 1.5 t -107.28 160.95 15.22 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 113.246 0.832 . . . . 1.07 113.246 -177.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 122' ' ' PHE . . . . . 0.533 ' HE1' ' O ' ' B' ' 128' ' ' CYS . 60.8 m-85 -126.43 -47.65 1.58 Allowed 'General case' 0 C--N 1.339 0.113 0 CA-C-N 115.34 -0.846 . . . . 1.53 110.107 179.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -117.29 -159.67 11.52 Favored Glycine 0 CA--C 1.52 0.381 0 CA-C-N 115.797 -0.638 . . . . 0.9 111.634 179.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -84.26 -68.15 0.01 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.344 2.029 . . . . 1.51 111.667 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 125' ' ' SER . . . . . 0.408 ' O ' ' N ' ' B' ' 137' ' ' GLY . 0.4 OUTLIER -89.49 26.65 1.65 Allowed 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 109.943 -0.391 . . . . 1.25 109.943 178.78 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 126' ' ' ILE . . . . . 0.945 HG12 HG13 ' B' ' 136' ' ' VAL . 7.0 mt -144.7 112.59 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 CA-C-O 121.751 0.786 . . . . 0.85 111.827 -178.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 127' ' ' CYS . . . . . 0.576 ' O ' ' HA ' ' B' ' 134' ' ' CYS . 4.6 t -126.45 131.38 51.69 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.112 -0.949 . . . . 0.89 109.234 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 128' ' ' CYS . . . . . 0.817 ' HA ' ' O ' ' B' ' 133' ' ' GLY . 0.0 OUTLIER -142.39 122.16 13.47 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 115.103 1.52 . . . . 1.23 115.103 -176.906 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 129' ' ' GLY . . . . . . . . . . . . . . . -111.46 -166.11 18.28 Favored Glycine 0 C--N 1.373 2.636 0 N-CA-C 108.173 -1.971 . . . . 0.66 108.173 175.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -65.4 -58.74 5.12 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 114.074 1.139 . . . . 2.35 114.074 -177.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.28 21.82 11.57 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.57 0.7 . . . . 1.69 109.921 -177.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 132' ' ' LEU . . . . . 0.929 HD22 ' CZ ' ' B' ' 135' ' ' PHE . 0.4 OUTLIER -114.6 -12.41 12.25 Favored 'General case' 0 N--CA 1.397 -3.085 0 N-CA-C 103.84 -2.652 . . . . 1.38 103.84 175.459 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 133' ' ' GLY . . . . . 0.917 ' HA2' ' CB ' ' B' ' 169' ' ' ALA . . . 57.97 -129.57 49.74 Favored Glycine 1 N--CA 1.394 -4.128 0 CA-C-O 117.249 -1.862 . . . . 0.72 112.989 174.572 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 134' ' ' CYS . . . . . 0.874 ' HB2' HD13 ' B' ' 172' ' ' ILE . 2.5 t -136.96 122.98 20.25 Favored 'General case' 0 CA--C 1.496 -1.116 0 CA-C-N 119.648 1.724 . . . . 1.08 113.696 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 135' ' ' PHE . . . . . 0.929 ' CZ ' HD22 ' B' ' 132' ' ' LEU . 0.0 OUTLIER -98.03 100.21 11.53 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 103.645 -2.724 . . . . 1.36 103.645 175.153 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 136' ' ' VAL . . . . . 0.945 HG13 HG12 ' B' ' 126' ' ' ILE . 2.2 t -92.09 83.14 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.368 0 CA-C-O 123.27 1.509 . . . . 0.75 107.093 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 137' ' ' GLY . . . . . 0.876 ' HA3' HG21 ' A' ' 72' ' ' ILE . . . 100.49 85.36 1.85 Allowed Glycine 0 CA--C 1.525 0.678 0 CA-C-N 112.43 -2.168 . . . . 0.83 113.719 -179.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 138' ' ' THR . . . . . 0.7 HG22 ' O ' ' A' ' 32' ' ' LEU . 67.8 p -157.74 166.53 32.54 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 108.895 -0.78 . . . . 0.78 108.895 179.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 139' ' ' ALA . . . . . 0.576 ' HA ' ' CD1' ' B' ' 142' ' ' LEU . . . -68.58 -24.54 64.61 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 119.294 0.952 . . . . 1.04 110.575 177.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 140' ' ' GLU . . . . . 0.572 ' HB3' ' HA2' ' B' ' 114' ' ' GLY . 3.3 mm-40 -66.81 -11.92 57.09 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.618 -1.173 . . . . 2.31 109.972 177.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 141' ' ' ALA . . . . . 0.491 ' O ' ' HB2' ' B' ' 144' ' ' CYS . . . -102.93 -22.57 13.81 Favored 'General case' 0 C--O 1.211 -0.944 0 C-N-CA 123.736 0.814 . . . . 0.87 109.611 178.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 142' ' ' LEU . . . . . 0.576 ' CD1' ' HA ' ' B' ' 139' ' ' ALA . 23.8 mt -44.85 -38.42 4.57 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.015 0.436 . . . . 1.24 111.855 -179.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 143' ' ' ARG . . . . . 0.705 ' HD3' ' O ' ' B' ' 143' ' ' ARG . 0.0 OUTLIER -71.43 -1.28 12.58 Favored 'General case' 0 C--O 1.247 0.963 0 CA-C-N 116.05 -0.523 . . . . 2.93 110.063 179.378 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 144' ' ' CYS . . . . . 0.491 ' HB2' ' O ' ' B' ' 141' ' ' ALA . 66.3 m -82.0 -5.5 58.39 Favored 'General case' 0 C--N 1.341 0.226 0 O-C-N 120.825 -1.172 . . . . 1.61 110.108 176.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -60.61 -16.7 41.05 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.619 -0.719 . . . . 3.35 110.113 178.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -84.32 5.86 25.25 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 120.13 -0.628 . . . . 3.76 110.253 178.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 . . . . . 0 N--CA 1.452 -0.357 0 CA-C-N 116.038 -0.528 . . . . 4.01 109.892 177.811 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 156' ' ' SER . . . . . 0.714 ' OG ' ' HG3' ' B' ' 159' ' ' LYS . 1.8 t . . . . . 0 N--CA 1.457 -0.104 0 N-CA-C 116.772 2.138 . . . . 3.11 116.772 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 79.99 -113.76 3.72 Favored Glycine 0 CA--C 1.49 -1.509 0 O-C-N 119.487 -2.008 . . . . 2.07 113.301 173.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 158' ' ' GLN . . . . . 0.699 ' O ' ' HB3' ' B' ' 167' ' ' CYS . 3.3 mt-30 -113.67 96.07 5.67 Favored 'General case' 0 N--CA 1.413 -2.28 0 N-CA-C 106.931 -1.507 . . . . 4.34 106.931 177.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 159' ' ' LYS . . . . . 0.94 ' HB3' ' CD ' ' B' ' 160' ' ' PRO . 0.0 OUTLIER -69.6 -107.2 0.0 OUTLIER Pre-proline 0 CA--C 1.575 1.908 0 N-CA-C 114.196 1.184 . . . . 3.54 114.196 -177.153 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 160' ' ' PRO . . . . . 0.94 ' CD ' ' HB3' ' B' ' 159' ' ' LYS . 10.4 Cg_endo -50.58 126.8 18.94 Favored 'Trans proline' 0 C--N 1.363 1.336 0 N-CA-C 119.271 2.758 . . . . 1.51 119.271 -175.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 161' ' ' CYS . . . . . 0.491 ' HB3' ' HB3' ' B' ' 173' ' ' CYS . 6.5 t -149.05 -179.71 7.23 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 110.94 -2.846 . . . . 1.58 106.667 176.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 47.02 -164.61 0.13 Allowed Glycine 0 C--N 1.345 1.081 0 C-N-CA 119.818 -1.182 . . . . 2.37 114.434 178.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 69.5 m -84.3 48.85 1.55 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.67 0.748 . . . . 4.07 109.913 178.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 117.92 -1.58 17.35 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-N 115.166 -0.925 . . . . 2.2 113.654 178.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 165' ' ' GLY . . . . . 0.712 ' CA ' ' HA ' ' B' ' 175' ' ' SER . . . -97.27 132.4 10.97 Favored Glycine 0 C--N 1.339 0.696 0 C-N-CA 119.318 -1.42 . . . . 1.62 112.257 -176.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 166' ' ' ARG . . . . . 0.644 ' HA ' ' O ' ' B' ' 159' ' ' LYS . 0.0 OUTLIER -78.57 150.48 32.78 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.168 0.509 . . . . 3.05 111.841 -177.591 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 167' ' ' CYS . . . . . 0.699 ' HB3' ' O ' ' B' ' 158' ' ' GLN . 9.1 t -70.77 109.73 5.14 Favored 'General case' 0 N--CA 1.405 -2.702 0 CA-C-N 115.548 -0.751 . . . . 1.56 109.231 -179.206 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 168' ' ' ALA . . . . . 0.59 ' HB1' ' SG ' ' B' ' 128' ' ' CYS . . . -90.09 -14.28 34.08 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 121.583 0.706 . . . . 1.04 110.047 179.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 169' ' ' ALA . . . . . 0.917 ' CB ' ' HA2' ' B' ' 133' ' ' GLY . . . -172.71 161.62 4.82 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.854 -1.067 . . . . 0.98 108.785 177.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 170' ' ' ALA . . . . . 0.79 ' HA ' ' HB3' ' B' ' 185' ' ' CYS . . . -55.55 139.06 45.34 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 118.33 0.514 . . . . 1.25 111.361 179.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 171' ' ' GLY . . . . . 0.687 ' H ' ' CB ' ' B' ' 185' ' ' CYS . . . 67.73 -22.98 0.24 Allowed Glycine 0 CA--C 1.534 1.244 0 N-CA-C 116.35 1.3 . . . . 1.29 116.35 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 172' ' ' ILE . . . . . 0.874 HD13 ' HB2' ' B' ' 134' ' ' CYS . 1.7 pp -111.03 98.17 6.7 Favored 'Isoleucine or valine' 0 C--O 1.244 0.793 0 CA-C-N 118.586 1.193 . . . . 2.27 110.069 177.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 173' ' ' CYS . . . . . 0.491 ' HB3' ' HB3' ' B' ' 161' ' ' CYS . 33.9 m -93.0 104.3 16.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.421 -0.809 . . . . 1.94 109.311 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 174' ' ' CYS . . . . . 1.009 ' HA ' ' HA ' ' B' ' 179' ' ' CYS . 34.0 m -84.84 124.57 31.75 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.33 -0.85 . . . . 1.35 112.265 -177.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 175' ' ' SER . . . . . 0.923 ' HB3' ' HD2' ' B' ' 176' ' ' PRO . 49.5 m -84.47 -178.56 1.2 Allowed Pre-proline 0 CA--C 1.533 0.296 0 CA-C-N 115.075 -0.966 . . . . 2.0 110.515 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 176' ' ' PRO . . . . . 0.923 ' HD2' ' HB3' ' B' ' 175' ' ' SER . 73.9 Cg_endo -75.75 30.31 0.38 Allowed 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 121.675 1.583 . . . . 1.9 111.961 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 177' ' ' ASP . . . . . 0.819 ' HB2' ' ND1' ' A' ' 80' ' ' HIS . 2.8 p30 -145.38 -28.21 0.45 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.598 -0.728 . . . . 2.72 110.545 179.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 178' ' ' GLY . . . . . 0.826 ' HA3' ' O ' ' A' ' 79' ' ' CYS . . . -178.21 -132.65 1.74 Allowed Glycine 0 C--N 1.334 0.447 0 C-N-CA 121.21 -0.519 . . . . 0.99 112.183 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 179' ' ' CYS . . . . . 1.009 ' HA ' ' HA ' ' B' ' 174' ' ' CYS . 81.6 m -128.03 154.18 45.94 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 109.441 -0.577 . . . . 1.34 109.441 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 180' ' ' HIS . . . . . 0.832 ' ND1' ' HB2' ' A' ' 77' ' ' ASP . 4.0 t60 -147.29 115.37 6.54 Favored 'General case' 0 CA--C 1.499 -0.996 0 CA-C-O 121.913 0.863 . . . . 2.1 108.811 -173.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 181' ' ' GLU . . . . . 0.615 ' HG3' ' O ' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -56.73 117.41 3.89 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-N 114.246 -1.343 . . . . 3.06 110.274 -176.746 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 182' ' ' ASP . . . . . 0.615 ' OD1' ' HB3' ' B' ' 184' ' ' ALA . 0.3 OUTLIER -147.38 101.27 3.79 Favored Pre-proline 0 N--CA 1.437 -1.087 0 CA-C-N 114.063 -1.426 . . . . 2.06 108.929 -178.007 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 183' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -56.16 -2.22 0.36 Allowed 'Trans proline' 0 C--N 1.36 1.16 0 C-N-CA 123.229 2.619 . . . . 1.91 115.207 -177.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 184' ' ' ALA . . . . . 0.615 ' HB3' ' OD1' ' B' ' 182' ' ' ASP . . . -65.96 -17.93 65.0 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 111.983 0.364 . . . . 1.56 111.983 -179.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 185' ' ' CYS . . . . . 0.79 ' HB3' ' HA ' ' B' ' 170' ' ' ALA . 12.3 m -100.18 7.82 44.26 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 113.032 0.752 . . . . 1.94 113.032 -178.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 186' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.358 0 N-CA-C 115.027 1.491 . . . . 3.61 115.027 179.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.609 ' HB3' ' HB3' ' A' ' 20' ' ' ARG . 0.1 OUTLIER . . . . . 0 CA--C 1.548 0.898 0 N-CA-C 112.856 0.687 . . . . 2.68 112.856 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.609 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 4.4 mm? 3.62 111.86 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.461 0 N-CA-C 113.202 0.816 . . . . 2.48 113.202 178.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.615 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 87.6 Cg_endo -79.32 123.98 5.74 Favored 'Trans proline' 0 C--N 1.357 1.019 0 C-N-CA 123.203 2.602 . . . . 1.49 115.866 -178.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.585 ' O ' ' HA2' ' A' ' 17' ' ' GLY . 26.8 p -129.83 -176.23 3.86 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.307 -0.86 . . . . 1.0 111.138 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.463 ' HA2' ' HG2' ' A' ' 40' ' ' GLU . . . 75.54 -161.45 52.7 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 120.312 -0.947 . . . . 1.15 112.43 -178.144 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 1.078 ' HD2' HD11 ' A' ' 32' ' ' LEU . 39.3 Cg_endo -64.95 95.04 0.24 Allowed 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 123.488 2.792 . . . . 1.57 113.108 178.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.51 -2.09 87.76 Favored Glycine 0 C--N 1.288 -2.129 0 CA-C-N 113.868 -1.515 . . . . 1.68 112.724 178.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.585 ' HA2' ' O ' ' A' ' 13' ' ' CYS . . . 84.28 35.69 14.2 Favored Glycine 0 N--CA 1.412 -2.934 0 C-N-CA 118.501 -1.809 . . . . 1.36 116.417 177.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.1 -31.71 61.25 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 112.941 -1.629 . . . . 2.5 107.237 175.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.615 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -79.09 175.04 55.25 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 113.099 -1.864 . . . . 1.02 112.891 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.609 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -139.8 162.99 33.82 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.955 -0.387 . . . . 2.92 109.955 179.749 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 15.6 t -108.66 143.17 38.09 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.438 0.637 . . . . 1.1 112.301 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -127.5 -54.12 1.35 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 114.78 -1.1 . . . . 1.51 108.834 178.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -95.95 149.79 19.43 Favored Glycine 0 C--N 1.331 0.298 0 N-CA-C 110.179 -1.168 . . . . 0.9 110.179 177.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -50.25 -48.21 20.92 Favored 'Trans proline' 0 CA--C 1.531 0.349 0 C-N-CA 121.849 1.699 . . . . 1.5 112.765 -179.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.16 4.06 41.67 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.603 0.24 . . . . 1.26 111.347 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.926 HG12 HG13 ' A' ' 36' ' ' VAL . 0.5 OUTLIER -119.83 122.8 69.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 113.309 0.855 . . . . 0.83 113.309 -178.016 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.463 ' HB3' ' OE1' ' A' ' 40' ' ' GLU . 0.1 OUTLIER -125.84 124.48 41.0 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.01 -0.541 . . . . 0.92 109.704 178.566 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.913 ' HB2' ' HB2' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -131.88 141.12 49.29 Favored 'General case' 0 CA--C 1.562 1.426 0 N-CA-C 114.296 1.221 . . . . 1.28 114.296 -177.594 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.743 ' O ' ' HB1' ' A' ' 69' ' ' ALA . . . -131.71 -174.2 13.57 Favored Glycine 0 C--N 1.369 2.396 0 CA-C-N 113.443 -1.708 . . . . 0.67 110.119 178.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.747 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 18.9 p-10 -63.17 -56.36 17.37 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 113.376 0.88 . . . . 2.27 113.376 -178.017 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.415 ' HG2' ' OD2' ' A' ' 30' ' ' ASP . 0.0 OUTLIER -113.21 5.54 17.03 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-O 121.435 0.636 . . . . 1.66 110.716 -175.798 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 1.078 HD11 ' HD2' ' A' ' 15' ' ' PRO . 0.3 OUTLIER -103.93 -10.24 18.3 Favored 'General case' 0 N--CA 1.419 -2.001 0 N-CA-C 106.272 -1.751 . . . . 1.37 106.272 177.638 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.875 ' O ' ' HB3' ' A' ' 28' ' ' CYS . . . 67.37 -98.09 0.43 Allowed Glycine 0 C--O 1.221 -0.717 0 N-CA-C 118.283 2.073 . . . . 0.73 118.283 172.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.97 ' HB2' HG13 ' A' ' 72' ' ' ILE . 6.0 t -169.25 106.64 0.4 Allowed 'General case' 0 C--N 1.354 0.789 0 CA-C-N 118.644 1.222 . . . . 1.08 109.314 176.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.564 ' HB3' ' CG2' ' A' ' 38' ' ' THR . 3.7 m-30 -89.16 105.24 17.66 Favored 'General case' 0 N--CA 1.427 -1.611 0 N-CA-C 106.036 -1.839 . . . . 1.38 106.036 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.926 HG13 HG12 ' A' ' 26' ' ' ILE . 1.5 t -94.69 88.62 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.195 0 CA-C-O 123.361 1.553 . . . . 0.76 108.72 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.822 ' O ' ' HA3' ' B' ' 133' ' ' GLY . . . 94.63 98.64 1.66 Allowed Glycine 0 C--O 1.228 -0.256 0 CA-C-N 111.633 -2.53 . . . . 0.81 115.979 179.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.565 HG21 ' CE1' ' B' ' 135' ' ' PHE . 0.7 OUTLIER 177.02 170.27 0.53 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.627 0.251 . . . . 0.77 111.057 177.339 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.805 ' HA ' HD12 ' A' ' 42' ' ' LEU . . . -58.97 -14.18 8.54 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.377 0.608 . . . . 1.02 110.547 178.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.587 ' OE2' HD22 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -73.21 -13.16 61.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.741 -1.118 . . . . 2.32 109.327 176.594 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.413 ' O ' ' HB2' ' A' ' 44' ' ' CYS . . . -105.87 -22.53 12.9 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 115.121 -0.945 . . . . 0.87 111.66 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.805 HD12 ' HA ' ' A' ' 39' ' ' ALA . 3.4 mt -44.25 -39.3 4.36 Favored 'General case' 0 C--N 1.344 0.368 0 N-CA-C 113.177 0.806 . . . . 1.23 113.177 -178.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' A' ' 43' ' ' ARG . 3.6 mmp_? -58.36 -19.33 34.58 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.275 0.559 . . . . 2.92 109.768 179.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.642 ' O ' ' N ' ' A' ' 47' ' ' GLU . 97.2 m -65.13 -45.64 84.23 Favored 'General case' 0 C--O 1.223 -0.294 0 N-CA-C 108.533 -0.914 . . . . 1.57 108.533 177.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.449 ' HB2' ' O ' ' A' ' 42' ' ' LEU . 75.3 mm-40 -28.98 -37.75 0.01 OUTLIER 'General case' 0 CA--C 1.551 0.996 0 CA-C-N 113.721 -1.581 . . . . 3.31 113.03 -178.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -87.43 -3.11 59.01 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 119.593 -0.843 . . . . 3.69 111.518 -179.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.642 ' N ' ' O ' ' A' ' 44' ' ' CYS . 1.1 tt0 . . . . . 0 N--CA 1.443 -0.784 0 CA-C-N 115.441 -0.8 . . . . 3.99 109.574 178.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 119.884 -0.103 . . . . 3.12 111.259 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 113.84 -63.84 0.29 Allowed Glycine 0 CA--C 1.496 -1.102 0 C-N-CA 120.428 -0.891 . . . . 2.1 112.66 178.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -114.45 127.71 55.97 Favored 'General case' 0 N--CA 1.419 -1.983 0 N-CA-C 104.956 -2.238 . . . . 4.36 104.956 177.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.94 ' O ' ' HA ' ' A' ' 66' ' ' ARG . 2.0 mtmp? -120.22 -100.14 0.0 OUTLIER Pre-proline 0 C--N 1.285 -2.239 0 CA-C-O 114.201 -2.809 . . . . 3.55 105.47 -176.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.797 ' CD ' ' HB3' ' A' ' 59' ' ' LYS . 56.5 Cg_endo -71.34 138.48 33.02 Favored 'Trans proline' 0 C--N 1.318 -1.066 0 CA-C-N 128.211 3.968 . . . . 1.54 115.569 -178.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.51 ' O ' ' SG ' ' A' ' 73' ' ' CYS . 20.6 p -143.18 146.02 33.33 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 114.432 -1.258 . . . . 1.59 110.363 177.085 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.56 -164.05 51.19 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 119.165 -1.493 . . . . 2.43 112.951 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.4 m -76.82 49.62 0.65 Allowed 'General case' 0 CA--C 1.553 1.072 0 N-CA-C 113.119 0.785 . . . . 4.11 113.119 -178.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 110.03 49.81 0.71 Allowed Glycine 0 N--CA 1.475 1.275 0 N-CA-C 115.466 0.947 . . . . 2.21 115.466 174.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.467 ' O ' ' SG ' ' A' ' 61' ' ' CYS . . . -152.3 120.73 1.1 Allowed Glycine 0 N--CA 1.475 1.259 0 C-N-CA 119.415 -1.374 . . . . 1.62 114.041 -179.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.94 ' HA ' ' O ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -83.81 152.76 24.44 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 118.83 1.315 . . . . 3.02 112.697 -177.251 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 20.3 t -65.32 103.1 0.75 Allowed 'General case' 0 N--CA 1.414 -2.234 0 N-CA-C 107.188 -1.412 . . . . 1.52 107.188 -179.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.769 ' HB3' ' HB ' ' A' ' 72' ' ' ILE . . . -80.14 -35.91 35.97 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-N 114.776 -1.102 . . . . 1.07 108.953 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.913 ' HB2' ' HB2' ' A' ' 28' ' ' CYS . . . -169.98 165.27 9.53 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.463 -0.94 . . . . 1.0 108.463 -179.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.747 ' HB3' ' O ' ' A' ' 30' ' ' ASP . . . -40.67 96.0 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.107 0 CA-C-O 122.33 1.062 . . . . 1.24 110.648 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.639 ' C ' HD13 ' A' ' 72' ' ' ILE . . . 93.75 11.51 57.86 Favored Glycine 0 N--CA 1.428 -1.855 0 CA-C-O 117.085 -1.953 . . . . 1.28 117.578 177.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.97 HG13 ' HB2' ' A' ' 34' ' ' CYS . 3.6 mm -109.53 104.15 16.61 Favored 'Isoleucine or valine' 0 C--N 1.361 1.084 0 CA-C-N 123.303 3.551 . . . . 2.27 108.247 178.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.853 ' HB2' ' HB3' ' A' ' 82' ' ' ASP . 6.3 t -89.01 92.53 9.26 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 109.21 -0.663 . . . . 1.98 109.21 -179.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 1.314 ' CB ' ' HA ' ' A' ' 79' ' ' CYS . 31.6 p -163.51 176.3 9.87 Favored 'General case' 0 C--O 1.225 -0.227 0 N-CA-C 115.329 1.603 . . . . 1.33 115.329 -177.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.941 ' HB2' ' HD2' ' A' ' 76' ' ' PRO . 73.2 p -109.33 -178.81 0.59 Allowed Pre-proline 0 N--CA 1.472 0.644 0 CA-C-N 114.051 -1.432 . . . . 1.99 110.414 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.941 ' HD2' ' HB2' ' A' ' 75' ' ' SER . 71.8 Cg_endo -76.23 30.56 0.39 Allowed 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 121.908 1.739 . . . . 1.86 112.606 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.564 ' HA ' ' OE1' ' B' ' 181' ' ' GLU . 4.8 t70 -140.65 -51.13 0.46 Allowed 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.053 -0.521 . . . . 2.65 109.787 179.049 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.894 ' O ' ' HB2' ' A' ' 74' ' ' CYS . . . -119.65 179.92 16.59 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-O 119.44 -0.644 . . . . 0.99 112.382 178.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 1.314 ' HA ' ' CB ' ' A' ' 74' ' ' CYS . 12.8 m -150.52 160.98 43.4 Favored 'General case' 0 C--N 1.348 0.521 0 N-CA-C 113.105 0.78 . . . . 1.34 113.105 179.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.692 ' HB2' ' O ' ' A' ' 73' ' ' CYS . 50.3 m80 -151.9 139.36 19.54 Favored 'General case' 0 C--N 1.353 0.735 0 C-N-CA 119.921 -0.712 . . . . 2.17 112.054 -178.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -65.55 120.11 12.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.043 -0.526 . . . . 3.05 109.965 178.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.853 ' HB3' ' HB2' ' A' ' 73' ' ' CYS . 0.0 OUTLIER -143.91 101.87 4.92 Favored Pre-proline 0 CA--C 1.537 0.459 0 CA-C-N 116.505 -0.316 . . . . 2.02 110.511 -179.219 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -65.79 -8.48 19.72 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 123.115 2.543 . . . . 1.93 113.831 -178.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.495 ' HB3' ' OD1' ' A' ' 82' ' ' ASP . . . -67.89 -39.04 83.71 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.784 0.661 . . . . 1.53 112.784 -178.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.699 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 0.5 OUTLIER -94.87 -4.82 46.28 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 112.613 0.597 . . . . 1.88 112.613 -178.694 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.669 ' HA ' ' C ' ' A' ' 70' ' ' ALA . 1.6 t70 . . . . . 0 N--CA 1.47 0.532 0 N-CA-C 112.636 0.606 . . . . 3.6 112.636 -177.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 110' ' ' CYS . . . . . 0.588 ' HB3' ' HB3' ' B' ' 120' ' ' ARG . 0.1 OUTLIER . . . . . 0 CA--C 1.548 0.903 0 N-CA-C 113.157 0.799 . . . . 2.61 113.157 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 111' ' ' LEU . . . . . 0.604 ' O ' ' HA ' ' B' ' 120' ' ' ARG . 4.4 mm? 6.01 111.74 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.523 0 N-CA-C 113.027 0.751 . . . . 2.47 113.027 178.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 112' ' ' PRO . . . . . 0.599 ' HA ' ' O ' ' B' ' 119' ' ' GLY . 92.8 Cg_endo -80.18 122.63 4.76 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 123.071 2.514 . . . . 1.47 116.219 -178.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.59 ' O ' ' HA2' ' B' ' 117' ' ' GLY . 27.0 p -127.32 -176.16 3.66 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.043 -0.981 . . . . 1.0 111.264 179.122 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 114' ' ' GLY . . . . . 0.462 ' HA2' ' HG2' ' B' ' 140' ' ' GLU . . . 75.59 -161.38 52.6 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 120.484 -0.865 . . . . 1.16 112.43 -178.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 115' ' ' PRO . . . . . 1.045 ' HD2' HD11 ' B' ' 132' ' ' LEU . 38.7 Cg_endo -64.64 95.83 0.24 Allowed 'Trans proline' 0 N--CA 1.479 0.62 0 C-N-CA 123.624 2.882 . . . . 1.57 112.676 178.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 83.17 -2.94 86.15 Favored Glycine 0 C--N 1.29 -2.012 0 CA-C-N 114.13 -1.396 . . . . 1.7 112.781 178.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 117' ' ' GLY . . . . . 0.59 ' HA2' ' O ' ' B' ' 113' ' ' CYS . . . 84.79 35.84 12.59 Favored Glycine 0 N--CA 1.415 -2.754 0 C-N-CA 118.593 -1.765 . . . . 1.38 116.185 176.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 118' ' ' LYS . . . . . 0.423 ' HG2' ' H ' ' B' ' 118' ' ' LYS . 0.1 OUTLIER -74.91 -32.57 61.83 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 112.849 -1.675 . . . . 2.54 106.959 176.216 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 119' ' ' GLY . . . . . 0.599 ' O ' ' HA ' ' B' ' 112' ' ' PRO . . . -79.29 178.44 53.66 Favored Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 113.286 -1.779 . . . . 1.04 112.878 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.604 ' HA ' ' O ' ' B' ' 111' ' ' LEU . 0.0 OUTLIER -141.76 162.7 34.84 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.272 -0.27 . . . . 2.89 110.272 -179.766 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 121' ' ' CYS . . . . . . . . . . . . . 15.3 t -108.66 143.16 38.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.404 0.621 . . . . 1.07 112.305 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -127.47 -54.21 1.35 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.801 -1.09 . . . . 1.53 108.862 178.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -95.96 149.78 19.43 Favored Glycine 0 C--N 1.332 0.325 0 N-CA-C 110.194 -1.162 . . . . 0.9 110.194 177.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -50.29 -48.33 20.47 Favored 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 121.786 1.657 . . . . 1.51 112.804 -179.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 125' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -100.7 3.79 42.62 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.563 0.22 . . . . 1.25 111.339 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 126' ' ' ILE . . . . . 0.903 HG12 HG13 ' B' ' 136' ' ' VAL . 0.6 OUTLIER -119.73 122.8 69.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 113.359 0.874 . . . . 0.85 113.359 -177.968 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 127' ' ' CYS . . . . . 0.437 ' HB3' ' OE1' ' B' ' 140' ' ' GLU . 0.1 OUTLIER -125.14 124.47 41.89 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 109.733 -0.469 . . . . 0.89 109.733 178.689 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 128' ' ' CYS . . . . . 0.937 ' HB2' ' HB2' ' B' ' 169' ' ' ALA . 0.0 OUTLIER -130.45 142.95 50.48 Favored 'General case' 0 CA--C 1.551 1.006 0 N-CA-C 114.277 1.214 . . . . 1.23 114.277 -177.627 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 129' ' ' GLY . . . . . 0.741 ' O ' ' HB1' ' B' ' 169' ' ' ALA . . . -132.05 -173.34 13.3 Favored Glycine 0 C--N 1.359 1.838 0 N-CA-C 110.066 -1.214 . . . . 0.66 110.066 178.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 130' ' ' ASP . . . . . 0.75 ' O ' ' HB3' ' B' ' 170' ' ' ALA . 19.5 p-10 -63.73 -56.21 17.34 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 113.231 0.826 . . . . 2.35 113.231 -178.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 131' ' ' GLU . . . . . 0.42 ' HG2' ' OD2' ' B' ' 130' ' ' ASP . 0.0 OUTLIER -120.51 27.7 8.41 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.507 -0.745 . . . . 1.69 110.41 -179.806 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 132' ' ' LEU . . . . . 1.045 HD11 ' HD2' ' B' ' 115' ' ' PRO . 0.3 OUTLIER -122.46 -8.14 8.61 Favored 'General case' 0 N--CA 1.406 -2.672 0 N-CA-C 102.68 -3.081 . . . . 1.38 102.68 177.246 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 133' ' ' GLY . . . . . 0.888 ' O ' ' HB3' ' B' ' 128' ' ' CYS . . . 62.79 -94.15 0.11 Allowed Glycine 0 N--CA 1.426 -2.028 0 N-CA-C 118.973 2.349 . . . . 0.72 118.973 170.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 134' ' ' CYS . . . . . 0.988 ' HB2' HG13 ' B' ' 172' ' ' ILE . 6.1 t -170.02 106.85 0.34 Allowed 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 119.878 1.839 . . . . 1.08 109.453 176.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 135' ' ' PHE . . . . . 0.572 ' HB3' ' CG2' ' B' ' 138' ' ' THR . 3.6 m-30 -89.72 105.36 17.75 Favored 'General case' 0 N--CA 1.425 -1.683 0 N-CA-C 106.065 -1.828 . . . . 1.36 106.065 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 136' ' ' VAL . . . . . 0.903 HG13 HG12 ' B' ' 126' ' ' ILE . 1.7 t -94.64 89.12 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.197 0 CA-C-O 123.289 1.519 . . . . 0.75 108.561 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 137' ' ' GLY . . . . . 0.651 ' O ' ' HA3' ' A' ' 33' ' ' GLY . . . 93.94 98.83 1.57 Allowed Glycine 0 C--O 1.227 -0.309 0 CA-C-N 111.597 -2.547 . . . . 0.83 115.994 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 138' ' ' THR . . . . . 0.572 ' CG2' ' HB3' ' B' ' 135' ' ' PHE . 0.7 OUTLIER 177.0 170.55 0.52 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.651 0.262 . . . . 0.78 111.102 177.349 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 139' ' ' ALA . . . . . 0.8 ' HA ' HD12 ' B' ' 142' ' ' LEU . . . -58.81 -15.18 11.13 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 121.406 0.622 . . . . 1.04 110.654 178.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 140' ' ' GLU . . . . . 0.594 ' OE2' HD22 ' B' ' 132' ' ' LEU . 0.0 OUTLIER -72.65 -12.9 61.23 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.702 -1.135 . . . . 2.31 109.494 176.767 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 141' ' ' ALA . . . . . 0.406 ' O ' ' HB2' ' B' ' 144' ' ' CYS . . . -105.98 -22.72 12.82 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 115.169 -0.923 . . . . 0.87 111.643 -179.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 142' ' ' LEU . . . . . 0.8 HD12 ' HA ' ' B' ' 139' ' ' ALA . 3.6 mt -44.01 -39.28 4.01 Favored 'General case' 0 C--N 1.345 0.38 0 N-CA-C 113.176 0.806 . . . . 1.24 113.176 -178.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 143' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -58.17 -19.78 35.78 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.361 0.6 . . . . 2.93 109.769 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 144' ' ' CYS . . . . . 0.629 ' O ' ' N ' ' B' ' 147' ' ' GLU . 99.3 m -64.81 -45.77 84.83 Favored 'General case' 0 C--O 1.223 -0.3 0 N-CA-C 108.535 -0.913 . . . . 1.61 108.535 177.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 145' ' ' GLN . . . . . 0.451 ' HB2' ' O ' ' B' ' 142' ' ' LEU . 75.0 mm-40 -28.85 -37.75 0.01 OUTLIER 'General case' 0 CA--C 1.551 0.981 0 CA-C-N 113.668 -1.605 . . . . 3.35 113.05 -178.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -87.45 -3.1 59.01 Favored 'General case' 0 N--CA 1.477 0.905 0 O-C-N 121.253 -0.905 . . . . 3.76 111.5 -179.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 147' ' ' GLU . . . . . 0.629 ' N ' ' O ' ' B' ' 144' ' ' CYS . 1.1 tt0 . . . . . 0 C--N 1.318 -0.8 0 CA-C-N 115.433 -0.803 . . . . 4.01 109.54 178.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.48 1.071 0 N-CA-C 111.417 0.154 . . . . 3.11 111.417 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 111.44 -63.81 0.27 Allowed Glycine 0 C--N 1.338 0.675 0 C-N-CA 120.509 -0.853 . . . . 2.07 113.202 179.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 158' ' ' GLN . . . . . 0.584 ' O ' ' HB3' ' B' ' 167' ' ' CYS . 8.5 mt-30 -115.8 108.09 15.88 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 107.887 -1.153 . . . . 4.34 107.887 178.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 159' ' ' LYS . . . . . 0.889 ' O ' ' HA ' ' B' ' 166' ' ' ARG . 3.6 mtmp? -90.72 -103.75 0.0 OUTLIER Pre-proline 0 C--N 1.3 -1.577 0 CA-C-O 118.753 -0.641 . . . . 3.54 110.341 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 160' ' ' PRO . . . . . 0.854 ' HD3' ' HB3' ' B' ' 159' ' ' LYS . 57.6 Cg_endo -71.64 138.07 31.38 Favored 'Trans proline' 0 C--N 1.353 0.803 0 CA-C-N 122.231 1.833 . . . . 1.51 115.088 -179.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 161' ' ' CYS . . . . . 0.491 ' O ' ' SG ' ' B' ' 173' ' ' CYS . 20.1 p -142.78 146.68 34.48 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 114.155 -1.384 . . . . 1.58 110.013 177.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 69.64 -164.99 50.7 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 119.352 -1.404 . . . . 2.37 112.666 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 1.6 m -76.74 51.31 0.75 Allowed 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 123.872 0.869 . . . . 4.07 112.493 179.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 107.92 49.19 0.85 Allowed Glycine 0 N--CA 1.466 0.648 0 N-CA-C 115.913 1.125 . . . . 2.2 115.913 172.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 165' ' ' GLY . . . . . 0.489 ' O ' ' N ' ' B' ' 161' ' ' CYS . . . -150.95 122.98 1.44 Allowed Glycine 0 N--CA 1.469 0.878 0 C-N-CA 119.525 -1.321 . . . . 1.62 113.607 179.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 166' ' ' ARG . . . . . 0.889 ' HA ' ' O ' ' B' ' 159' ' ' LYS . 0.0 OUTLIER -84.36 152.78 23.86 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 118.841 1.321 . . . . 3.05 112.528 -178.398 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 167' ' ' CYS . . . . . 0.584 ' HB3' ' O ' ' B' ' 158' ' ' GLN . 20.0 t -65.29 103.04 0.73 Allowed 'General case' 0 N--CA 1.416 -2.171 0 N-CA-C 107.175 -1.417 . . . . 1.56 107.175 -179.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 168' ' ' ALA . . . . . 0.762 ' HB3' ' HB ' ' B' ' 172' ' ' ILE . . . -80.42 -35.09 35.61 Favored 'General case' 0 N--CA 1.424 -1.771 0 CA-C-N 114.676 -1.147 . . . . 1.04 108.969 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 169' ' ' ALA . . . . . 0.937 ' HB2' ' HB2' ' B' ' 128' ' ' CYS . . . -170.57 165.26 8.39 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 108.326 -0.99 . . . . 0.98 108.326 -179.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 170' ' ' ALA . . . . . 0.75 ' HB3' ' O ' ' B' ' 130' ' ' ASP . . . -40.76 96.07 0.01 OUTLIER 'General case' 0 C--O 1.232 0.152 0 CA-C-O 122.239 1.018 . . . . 1.25 110.622 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 171' ' ' GLY . . . . . 0.66 ' C ' HD13 ' B' ' 172' ' ' ILE . . . 93.7 11.5 57.92 Favored Glycine 0 N--CA 1.427 -1.932 0 CA-C-O 116.883 -2.065 . . . . 1.29 117.557 177.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 172' ' ' ILE . . . . . 0.988 HG13 ' HB2' ' B' ' 134' ' ' CYS . 3.2 mm -109.59 104.35 16.93 Favored 'Isoleucine or valine' 0 C--N 1.365 1.262 0 CA-C-N 123.685 3.743 . . . . 2.27 108.124 178.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 173' ' ' CYS . . . . . 0.829 ' HB2' ' HB3' ' B' ' 182' ' ' ASP . 6.3 t -88.99 92.43 9.23 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 109.156 -0.683 . . . . 1.94 109.156 -179.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 174' ' ' CYS . . . . . 1.308 ' CB ' ' HA ' ' B' ' 179' ' ' CYS . 31.0 p -163.34 176.17 10.13 Favored 'General case' 0 C--O 1.226 -0.162 0 N-CA-C 115.458 1.651 . . . . 1.35 115.458 -177.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 175' ' ' SER . . . . . 0.944 ' HB2' ' HD2' ' B' ' 176' ' ' PRO . 73.7 p -109.31 -178.86 0.6 Allowed Pre-proline 0 N--CA 1.47 0.557 0 CA-C-N 114.187 -1.369 . . . . 2.0 110.441 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 176' ' ' PRO . . . . . 0.944 ' HD2' ' HB2' ' B' ' 175' ' ' SER . 71.6 Cg_endo -76.11 30.47 0.39 Allowed 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 121.913 1.742 . . . . 1.9 112.675 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 177' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -140.68 -51.16 0.46 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.086 -0.506 . . . . 2.72 109.769 179.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 178' ' ' GLY . . . . . 0.904 ' O ' ' HB2' ' B' ' 174' ' ' CYS . . . -119.65 179.99 16.59 Favored Glycine 0 N--CA 1.445 -0.759 0 CA-C-O 119.412 -0.66 . . . . 0.99 112.18 178.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 179' ' ' CYS . . . . . 1.308 ' HA ' ' CB ' ' B' ' 174' ' ' CYS . 12.5 m -150.47 161.1 43.18 Favored 'General case' 0 C--N 1.346 0.447 0 N-CA-C 113.165 0.802 . . . . 1.34 113.165 179.137 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 180' ' ' HIS . . . . . 0.698 ' HB2' ' O ' ' B' ' 173' ' ' CYS . 49.2 m80 -151.98 139.18 19.28 Favored 'General case' 0 C--N 1.354 0.775 0 C-N-CA 119.786 -0.765 . . . . 2.1 111.998 -178.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 181' ' ' GLU . . . . . 0.564 ' OE1' ' HA ' ' A' ' 77' ' ' ASP . 27.8 mt-10 -65.43 120.05 12.12 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 116.028 -0.533 . . . . 3.06 110.072 178.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 182' ' ' ASP . . . . . 0.829 ' HB3' ' HB2' ' B' ' 173' ' ' CYS . 0.0 OUTLIER -143.81 101.86 4.96 Favored Pre-proline 0 CA--C 1.536 0.413 0 CA-C-N 116.612 -0.267 . . . . 2.06 110.535 -179.187 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 183' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -65.88 -8.37 19.54 Favored 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 123.214 2.609 . . . . 1.91 113.859 -178.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 184' ' ' ALA . . . . . 0.482 ' HB3' ' OD1' ' B' ' 182' ' ' ASP . . . -67.97 -39.11 83.4 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.78 0.659 . . . . 1.56 112.78 -179.079 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 185' ' ' CYS . . . . . 0.704 ' O ' ' HA ' ' B' ' 170' ' ' ALA . 0.6 OUTLIER -94.78 -4.73 46.74 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.592 0.59 . . . . 1.94 112.592 -178.744 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 186' ' ' ASP . . . . . 0.669 ' HA ' ' C ' ' B' ' 170' ' ' ALA . 1.6 t70 . . . . . 0 N--CA 1.47 0.565 0 N-CA-C 112.659 0.614 . . . . 3.61 112.659 -177.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.858 ' HB3' ' CG ' ' A' ' 20' ' ' ARG . 61.1 m . . . . . 0 CA--C 1.535 0.366 0 N-CA-C 113.682 0.993 . . . . 2.68 113.682 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.662 HD23 ' HB2' ' A' ' 21' ' ' CYS . 16.3 tp -35.08 111.8 0.44 Allowed Pre-proline 0 N--CA 1.489 1.516 0 C-N-CA 123.223 0.609 . . . . 2.48 112.625 177.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.908 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 44.9 Cg_endo -86.99 144.21 7.12 Favored 'Trans proline' 0 C--N 1.357 1.012 0 C-N-CA 122.971 2.447 . . . . 1.49 116.992 -177.295 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.555 ' N ' ' O ' ' A' ' 19' ' ' GLY . 27.3 p -149.1 -170.24 3.58 Favored 'General case' 0 C--N 1.355 0.81 0 CA-C-N 115.961 -0.563 . . . . 1.0 109.79 178.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.832 ' CA ' ' HG2' ' A' ' 40' ' ' GLU . . . 75.45 -161.27 52.71 Favored Glycine 0 C--N 1.335 0.51 0 N-CA-C 115.256 0.862 . . . . 1.15 115.256 176.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.46 ' O ' ' HG2' ' A' ' 15' ' ' PRO . 38.0 Cg_endo -64.5 102.54 0.41 Allowed 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 124.027 3.151 . . . . 1.57 111.502 178.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 86.1 -0.98 87.72 Favored Glycine 0 C--N 1.265 -3.385 0 CA-C-N 112.028 -2.351 . . . . 1.68 112.761 -179.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.817 ' O ' ' HB2' ' A' ' 12' ' ' PRO . . . 72.43 43.03 46.9 Favored Glycine 0 N--CA 1.405 -3.385 0 C-N-CA 118.988 -1.577 . . . . 1.36 114.49 173.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.92 -41.13 9.33 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 114.29 -0.955 . . . . 2.5 110.416 177.367 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.908 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -71.38 169.02 50.3 Favored Glycine 0 C--O 1.194 -2.351 0 N-CA-C 116.272 1.269 . . . . 1.02 116.272 -174.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.858 ' CG ' ' HB3' ' A' ' 10' ' ' CYS . 4.2 mpp_? -104.14 160.83 14.53 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 112.747 -1.727 . . . . 2.92 114.926 -172.325 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.662 ' HB2' HD23 ' A' ' 11' ' ' LEU . 5.1 m -106.91 136.94 45.91 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 114.794 -1.093 . . . . 1.1 111.597 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -145.69 24.43 1.37 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.32 -0.855 . . . . 1.51 110.137 179.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 152.28 161.52 10.26 Favored Glycine 0 CA--C 1.521 0.422 0 N-CA-C 111.164 -0.775 . . . . 0.9 111.164 -179.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.661 ' HD2' ' OE2' ' B' ' 181' ' ' GLU . 31.8 Cg_exo -58.7 -64.01 0.12 Allowed 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 121.703 1.602 . . . . 1.5 112.335 -179.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.456 ' O ' ' N ' ' A' ' 37' ' ' GLY . 3.3 m -90.47 39.5 0.98 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.704 0.288 . . . . 1.26 110.289 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.971 HG12 HG13 ' A' ' 36' ' ' VAL . 3.0 mt -155.28 121.19 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 O-C-N 122.114 -0.366 . . . . 0.83 111.612 -179.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -137.86 110.16 7.38 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 120.877 0.37 . . . . 0.92 110.714 179.282 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.811 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -116.5 155.34 28.81 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 113.46 0.911 . . . . 1.28 113.46 179.025 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.516 ' O ' ' HB2' ' A' ' 69' ' ' ALA . . . -149.67 -174.61 21.19 Favored Glycine 0 C--N 1.371 2.494 0 N-CA-C 108.259 -1.936 . . . . 0.67 108.259 177.033 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -67.8 -41.73 82.68 Favored 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 125.892 1.677 . . . . 2.27 115.328 -179.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -122.83 13.23 9.89 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 114.209 -1.359 . . . . 1.66 111.424 178.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.688 HD23 ' CE1' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -120.25 -7.2 9.83 Favored 'General case' 0 N--CA 1.393 -3.323 0 N-CA-C 108.541 -0.911 . . . . 1.37 108.541 -178.383 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.972 ' HA2' ' CB ' ' A' ' 69' ' ' ALA . . . 49.83 -135.71 25.02 Favored Glycine 0 C--O 1.198 -2.103 0 CA-C-O 116.504 -2.276 . . . . 0.73 109.561 179.372 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 1.082 ' HB2' HD13 ' A' ' 72' ' ' ILE . 0.7 OUTLIER -128.71 130.46 47.18 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 121.495 2.648 . . . . 1.08 111.674 -179.842 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.688 ' CE1' HD23 ' A' ' 32' ' ' LEU . 1.3 m-85 -104.12 101.76 11.5 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 102.139 -3.282 . . . . 1.38 102.139 173.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.971 HG13 HG12 ' A' ' 26' ' ' ILE . 2.5 t -92.72 93.97 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.312 0 CA-C-O 123.694 1.711 . . . . 0.76 110.066 -177.113 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.779 ' HA3' ' CG2' ' B' ' 172' ' ' ILE . . . 83.18 80.37 1.0 Allowed Glycine 0 C--N 1.319 -0.379 0 CA-C-N 111.826 -2.443 . . . . 0.81 113.257 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.616 HG21 ' CE1' ' B' ' 135' ' ' PHE . 70.7 p -160.76 -167.31 1.82 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.11 0.481 . . . . 0.77 110.361 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.762 ' HA ' HD12 ' A' ' 42' ' ' LEU . . . -62.14 -40.5 96.15 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 108.817 -0.809 . . . . 1.02 108.817 179.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.832 ' HG2' ' CA ' ' A' ' 14' ' ' GLY . 0.4 OUTLIER -55.9 -26.4 47.21 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 114.986 -1.006 . . . . 2.32 112.38 179.655 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.493 ' O ' ' N ' ' A' ' 44' ' ' CYS . . . -91.63 -35.37 14.26 Favored 'General case' 0 C--O 1.213 -0.845 0 CA-C-N 116.197 -0.456 . . . . 0.87 110.268 -179.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.762 HD12 ' HA ' ' A' ' 39' ' ' ALA . 7.9 mt -39.57 -54.31 2.0 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 114.866 1.432 . . . . 1.23 114.866 -175.483 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.564 ' HD2' ' H ' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -54.75 -23.6 18.61 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 119.982 -0.687 . . . . 2.92 109.763 178.171 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.493 ' N ' ' O ' ' A' ' 41' ' ' ALA . 4.9 t -69.43 17.77 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 112.823 0.675 . . . . 1.57 112.823 -177.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.515 ' H ' ' C ' ' A' ' 43' ' ' ARG . 1.3 tt0 -75.22 -28.84 60.08 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 114.312 -1.313 . . . . 3.31 107.99 176.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -82.33 9.95 7.96 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.224 -0.898 . . . . 3.69 110.837 179.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.464 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . 0.9 OUTLIER . . . . . 0 N--CA 1.455 -0.208 0 N-CA-C 109.745 -0.465 . . . . 3.99 109.745 177.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.482 1.141 0 N-CA-C 110.548 -0.168 . . . . 3.12 110.548 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.632 ' O ' ' HG3' ' A' ' 66' ' ' ARG . . . 99.18 32.14 5.93 Favored Glycine 0 C--N 1.345 1.033 0 C-N-CA 120.566 -0.826 . . . . 2.1 112.348 177.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -122.04 76.09 1.27 Allowed 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 121.908 0.861 . . . . 4.36 111.173 179.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.836 ' HB2' ' HB2' ' A' ' 67' ' ' CYS . 1.6 mmtp -133.41 69.59 77.16 Favored Pre-proline 0 C--N 1.313 -1.01 0 N-CA-C 106.734 -1.58 . . . . 3.55 106.734 178.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.704 ' HA ' ' O ' ' A' ' 65' ' ' GLY . 14.4 Cg_endo -56.9 82.38 0.04 OUTLIER 'Trans proline' 0 C--N 1.368 1.582 0 C-N-CA 123.901 3.068 . . . . 1.54 117.754 -176.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -101.8 -178.35 3.69 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 106.181 -1.785 . . . . 1.59 106.181 173.164 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.09 -167.15 53.14 Favored Glycine 0 C--N 1.339 0.734 0 C-N-CA 119.205 -1.474 . . . . 2.43 112.372 -179.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.6 p -83.04 41.79 0.77 Allowed 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 120.818 -0.353 . . . . 4.11 110.412 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 117.12 9.68 10.41 Favored Glycine 0 CA--C 1.538 1.492 0 CA-C-O 117.124 -1.931 . . . . 2.21 116.204 179.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.704 ' O ' ' HA ' ' A' ' 60' ' ' PRO . . . -102.64 156.3 18.31 Favored Glycine 0 C--N 1.345 1.081 0 CA-C-N 121.767 2.783 . . . . 1.62 113.554 179.147 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.632 ' HG3' ' O ' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -99.21 151.86 20.54 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 111.849 0.314 . . . . 3.02 111.849 179.415 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.836 ' HB2' ' HB2' ' A' ' 59' ' ' LYS . 1.3 m -71.59 106.85 4.18 Favored 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 109.557 -0.534 . . . . 1.52 109.557 178.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.557 ' HB1' ' HB2' ' A' ' 28' ' ' CYS . . . -89.03 -22.04 23.17 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 107.935 -1.135 . . . . 1.07 107.935 177.088 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.972 ' CB ' ' HA2' ' A' ' 33' ' ' GLY . . . -161.7 162.37 29.75 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 112.342 -2.208 . . . . 1.0 113.937 -175.073 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.648 ' HA ' ' O ' ' A' ' 85' ' ' CYS . . . -58.63 122.99 14.81 Favored 'General case' 0 CA--C 1.527 0.092 0 N-CA-C 113.05 0.759 . . . . 1.24 113.05 -178.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.686 ' HA2' ' O ' ' A' ' 82' ' ' ASP . . . 71.33 15.96 75.18 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-N 115.671 -0.695 . . . . 1.28 114.189 178.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 1.082 HD13 ' HB2' ' A' ' 34' ' ' CYS . 1.2 pp -141.73 98.29 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-N 113.932 -1.134 . . . . 2.27 112.733 -178.489 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.562 ' HB2' ' HB3' ' A' ' 82' ' ' ASP . 5.0 t -99.57 85.41 3.13 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 114.021 -1.445 . . . . 1.98 110.224 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 1.049 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 1.8 m -93.88 146.06 24.17 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.258 -0.428 . . . . 1.33 111.169 -179.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.906 ' HB2' ' HD2' ' A' ' 76' ' ' PRO . 53.9 p -109.56 -179.62 0.7 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.84 -0.618 . . . . 1.99 110.029 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.906 ' HD2' ' HB2' ' A' ' 75' ' ' SER . 77.1 Cg_endo -77.67 29.42 0.44 Allowed 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 121.695 1.596 . . . . 1.86 111.436 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.447 ' H ' ' C ' ' A' ' 75' ' ' SER . 0.6 OUTLIER -144.66 -29.44 0.47 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.218 -0.901 . . . . 2.65 110.113 179.41 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.515 ' O ' ' HB3' ' A' ' 74' ' ' CYS . . . -166.91 -145.89 4.65 Favored Glycine 0 CA--C 1.524 0.615 0 CA-C-N 115.977 -0.556 . . . . 0.99 112.603 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 1.049 ' HA ' ' HA ' ' A' ' 74' ' ' CYS . 11.9 t -146.62 159.16 43.8 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 109.808 -0.441 . . . . 1.34 109.808 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 55.3 m-70 -149.67 135.16 18.37 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 120.04 -0.664 . . . . 2.17 110.358 -176.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.701 ' HG3' HD11 ' B' ' 126' ' ' ILE . 2.6 mt-10 -60.79 132.13 52.9 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 109.712 -0.477 . . . . 3.05 109.712 179.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.686 ' O ' ' HA2' ' A' ' 71' ' ' GLY . 0.1 OUTLIER -140.01 112.8 7.52 Favored Pre-proline 0 CA--C 1.545 0.788 0 CA-C-N 116.355 -0.384 . . . . 2.02 110.755 -178.557 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 82' ' ' ASP . 13.9 Cg_exo -70.87 -21.11 28.75 Favored 'Trans proline' 0 C--N 1.359 1.09 0 C-N-CA 122.831 2.354 . . . . 1.93 113.862 -178.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.83 -39.75 94.97 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.718 0.294 . . . . 1.53 111.485 -179.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.648 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 68.4 m -97.95 -0.54 44.64 Favored 'General case' 0 C--O 1.215 -0.739 0 N-CA-C 112.681 0.623 . . . . 1.88 112.681 -179.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.554 ' HA ' ' N ' ' A' ' 71' ' ' GLY . 0.8 OUTLIER . . . . . 0 C--N 1.319 -0.719 0 N-CA-C 112.82 0.674 . . . . 3.6 112.82 -176.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 110' ' ' CYS . . . . . 0.842 ' HB3' ' CG ' ' B' ' 120' ' ' ARG . 59.3 m . . . . . 0 CA--C 1.535 0.366 0 N-CA-C 113.806 1.039 . . . . 2.61 113.806 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 111' ' ' LEU . . . . . 0.668 ' O ' ' HA ' ' B' ' 120' ' ' ARG . 16.5 tp -34.3 111.58 0.4 Allowed Pre-proline 0 N--CA 1.491 1.579 0 C-N-CA 123.162 0.585 . . . . 2.47 112.553 178.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 112' ' ' PRO . . . . . 0.922 ' HA ' ' O ' ' B' ' 119' ' ' GLY . 68.5 Cg_endo -83.12 147.88 13.13 Favored 'Trans proline' 0 C--N 1.359 1.101 0 C-N-CA 122.811 2.341 . . . . 1.47 115.442 -177.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.513 ' C ' ' HA2' ' B' ' 117' ' ' GLY . 28.0 p -152.06 -170.43 3.64 Favored 'General case' 0 C--O 1.254 1.31 0 CA-C-N 115.378 -0.828 . . . . 1.0 110.081 174.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 114' ' ' GLY . . . . . 0.81 ' CA ' ' HG2' ' B' ' 140' ' ' GLU . . . 75.79 -160.34 51.62 Favored Glycine 0 C--N 1.343 0.969 0 CA-C-N 114.712 -1.131 . . . . 1.16 115.094 176.143 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 115' ' ' PRO . . . . . 0.48 ' O ' ' HG2' ' B' ' 115' ' ' PRO . 35.5 Cg_endo -64.6 106.46 0.74 Allowed 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 124.067 3.178 . . . . 1.57 110.56 178.157 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 87.03 -11.88 63.7 Favored Glycine 0 C--N 1.257 -3.848 0 CA-C-N 112.211 -2.268 . . . . 1.7 111.174 -179.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 117' ' ' GLY . . . . . 0.755 ' O ' ' HB2' ' B' ' 112' ' ' PRO . . . 72.53 52.84 9.37 Favored Glycine 0 N--CA 1.399 -3.791 0 C-N-CA 119.596 -1.288 . . . . 1.38 113.488 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.05 -53.82 3.82 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 104.722 -2.325 . . . . 2.54 104.722 173.084 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 119' ' ' GLY . . . . . 0.922 ' O ' ' HA ' ' B' ' 112' ' ' PRO . . . -58.64 176.3 2.31 Favored Glycine 0 C--O 1.206 -1.643 0 CA-C-N 114.007 -1.451 . . . . 1.04 115.111 -167.279 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.842 ' CG ' ' HB3' ' B' ' 110' ' ' CYS . 4.7 mpp_? -113.83 163.68 14.74 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 114.081 1.141 . . . . 2.89 114.081 -173.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 121' ' ' CYS . . . . . 0.658 ' HB2' HD23 ' B' ' 111' ' ' LEU . 6.8 m -106.86 137.23 45.3 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.521 -1.218 . . . . 1.07 112.034 -179.059 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -145.68 24.35 1.37 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.186 -0.915 . . . . 1.53 110.171 179.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 152.29 161.52 10.26 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 111.196 -0.762 . . . . 0.9 111.196 -179.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . 0.635 ' HD2' ' OE2' ' A' ' 81' ' ' GLU . 32.0 Cg_exo -58.59 -64.11 0.12 Allowed 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 121.749 1.633 . . . . 1.51 112.286 -179.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 125' ' ' SER . . . . . 0.455 ' O ' ' N ' ' B' ' 137' ' ' GLY . 3.2 m -90.58 39.62 0.98 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.665 0.269 . . . . 1.25 110.33 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 126' ' ' ILE . . . . . 1.006 HG12 HG13 ' B' ' 136' ' ' VAL . 3.3 mt -155.07 121.11 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 O-C-N 122.242 -0.286 . . . . 0.85 111.707 -179.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 127' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -138.06 110.02 7.23 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.054 0.454 . . . . 0.89 110.755 179.107 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 128' ' ' CYS . . . . . 0.806 ' HA ' ' O ' ' B' ' 133' ' ' GLY . 0.0 OUTLIER -112.51 157.59 20.95 Favored 'General case' 0 CA--C 1.562 1.417 0 C-N-CA 123.836 0.854 . . . . 1.23 112.647 178.764 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 129' ' ' GLY . . . . . 0.502 ' O ' ' HB2' ' B' ' 169' ' ' ALA . . . -152.56 -175.48 24.15 Favored Glycine 0 C--N 1.38 2.985 0 N-CA-C 109.512 -1.435 . . . . 0.66 109.512 176.047 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -68.28 -45.79 72.12 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.871 1.268 . . . . 2.35 113.068 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.15 25.22 7.9 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-N 114.286 -1.325 . . . . 1.69 110.756 179.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 132' ' ' LEU . . . . . 0.688 HD23 ' CE1' ' B' ' 135' ' ' PHE . 0.2 OUTLIER -126.74 -10.81 6.13 Favored 'General case' 0 N--CA 1.401 -2.919 0 CA-C-N 113.427 -1.715 . . . . 1.38 109.573 179.643 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 133' ' ' GLY . . . . . 0.93 ' HA2' ' CB ' ' B' ' 169' ' ' ALA . . . 53.97 -125.06 32.04 Favored Glycine 0 N--CA 1.414 -2.828 0 CA-C-O 116.212 -2.438 . . . . 0.72 112.29 177.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 134' ' ' CYS . . . . . 1.091 ' HB2' HD13 ' B' ' 172' ' ' ILE . 0.8 OUTLIER -141.09 125.9 18.06 Favored 'General case' 0 CA--C 1.496 -1.099 0 CA-C-N 121.693 2.746 . . . . 1.08 112.261 176.211 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 135' ' ' PHE . . . . . 0.688 ' CE1' HD23 ' B' ' 132' ' ' LEU . 1.2 m-85 -101.13 101.93 12.77 Favored 'General case' 0 N--CA 1.425 -1.724 0 N-CA-C 102.266 -3.235 . . . . 1.36 102.266 175.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 136' ' ' VAL . . . . . 1.006 HG13 HG12 ' B' ' 126' ' ' ILE . 3.1 t -92.53 91.92 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.345 0 CA-C-O 123.317 1.532 . . . . 0.75 110.28 -177.014 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 137' ' ' GLY . . . . . 0.95 ' HA3' HG21 ' A' ' 72' ' ' ILE . . . 85.48 79.88 1.14 Allowed Glycine 0 CA--C 1.507 -0.44 0 CA-C-N 111.941 -2.39 . . . . 0.83 112.998 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 138' ' ' THR . . . . . 0.639 HG22 ' O ' ' A' ' 32' ' ' LEU . 76.4 p -155.96 -159.96 0.96 Allowed 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.427 0.632 . . . . 0.78 111.582 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 139' ' ' ALA . . . . . 0.725 ' HA ' HD12 ' B' ' 142' ' ' LEU . . . -68.67 -41.39 79.35 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.459 -1.246 . . . . 1.04 108.353 176.071 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 140' ' ' GLU . . . . . 0.81 ' HG2' ' CA ' ' B' ' 114' ' ' GLY . 0.3 OUTLIER -54.1 -30.24 47.82 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.093 -1.412 . . . . 2.31 112.248 179.081 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 141' ' ' ALA . . . . . 0.479 ' O ' ' N ' ' B' ' 144' ' ' CYS . . . -88.85 -35.71 16.41 Favored 'General case' 0 C--O 1.207 -1.178 0 N-CA-C 110.3 -0.259 . . . . 0.87 110.3 -178.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 142' ' ' LEU . . . . . 0.725 HD12 ' HA ' ' B' ' 139' ' ' ALA . 6.2 mt -39.04 -54.75 1.67 Allowed 'General case' 0 C--O 1.24 0.566 0 N-CA-C 113.832 1.049 . . . . 1.24 113.832 -173.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 143' ' ' ARG . . . . . 0.562 ' HD2' ' H ' ' B' ' 143' ' ' ARG . 0.0 OUTLIER -55.59 -22.09 20.46 Favored 'General case' 0 CA--C 1.497 -1.094 0 C-N-CA 120.037 -0.665 . . . . 2.93 109.851 177.81 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 144' ' ' CYS . . . . . 0.49 ' SG ' ' HB2' ' B' ' 147' ' ' GLU . 6.7 t -75.46 29.64 0.1 Allowed 'General case' 0 CA--C 1.497 -1.064 0 C-N-CA 119.763 -0.775 . . . . 1.61 111.529 -178.335 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -84.71 -22.37 29.76 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 106.516 -1.661 . . . . 3.35 106.516 175.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -82.07 9.35 8.65 Favored 'General case' 0 C--N 1.343 0.283 0 CA-C-N 115.314 -0.857 . . . . 3.76 110.106 178.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 147' ' ' GLU . . . . . 0.49 ' HB2' ' SG ' ' B' ' 144' ' ' CYS . 0.9 OUTLIER . . . . . 0 N--CA 1.454 -0.239 0 N-CA-C 109.771 -0.455 . . . . 4.01 109.771 177.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.479 0.999 0 N-CA-C 112.116 0.414 . . . . 3.11 112.116 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 157' ' ' GLY . . . . . 0.614 ' O ' ' HG3' ' B' ' 166' ' ' ARG . . . 105.13 33.0 3.84 Favored Glycine 0 CA--C 1.505 -0.593 0 C-N-CA 120.611 -0.804 . . . . 2.07 112.479 179.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -122.15 67.42 0.93 Allowed 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 121.655 0.74 . . . . 4.34 111.858 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 159' ' ' LYS . . . . . 0.965 ' HB2' ' HB2' ' B' ' 167' ' ' CYS . 2.0 mmtp -115.71 67.54 2.83 Favored Pre-proline 0 CA--C 1.539 0.529 0 CA-C-N 114.654 -1.157 . . . . 3.54 109.33 174.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 160' ' ' PRO . . . . . 0.658 ' HA ' ' O ' ' B' ' 165' ' ' GLY . 12.5 Cg_endo -56.33 82.92 0.04 OUTLIER 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 122.942 2.428 . . . . 1.51 118.14 -174.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 161' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -98.1 -171.53 2.17 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 106.347 -1.723 . . . . 1.58 106.347 173.443 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 65.35 -166.02 34.7 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 119.319 -1.42 . . . . 2.37 112.803 177.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 3.9 p -84.46 39.65 0.74 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.758 0.789 . . . . 4.07 110.313 -179.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 121.2 5.03 9.8 Favored Glycine 0 CA--C 1.535 1.284 0 CA-C-O 117.793 -1.559 . . . . 2.2 116.513 178.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 165' ' ' GLY . . . . . 0.658 ' O ' ' HA ' ' B' ' 160' ' ' PRO . . . -101.68 155.86 18.85 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-N 121.241 2.52 . . . . 1.62 114.093 -178.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 166' ' ' ARG . . . . . 0.614 ' HG3' ' O ' ' B' ' 157' ' ' GLY . 0.0 OUTLIER -98.42 151.74 20.25 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.034 0.383 . . . . 3.05 112.034 -179.084 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 167' ' ' CYS . . . . . 0.965 ' HB2' ' HB2' ' B' ' 159' ' ' LYS . 1.3 m -71.58 107.14 4.31 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 109.634 -0.506 . . . . 1.56 109.634 178.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 168' ' ' ALA . . . . . 0.551 ' HB1' ' HB2' ' B' ' 128' ' ' CYS . . . -94.18 -13.84 26.24 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.917 -0.771 . . . . 1.04 108.917 177.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 169' ' ' ALA . . . . . 0.93 ' CB ' ' HA2' ' B' ' 133' ' ' GLY . . . -168.24 163.67 13.1 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.503 -0.771 . . . . 0.98 111.036 -179.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 170' ' ' ALA . . . . . 0.623 ' HA ' ' O ' ' B' ' 185' ' ' CYS . . . -58.78 122.46 13.62 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 113.805 1.039 . . . . 1.25 113.805 -178.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 171' ' ' GLY . . . . . 0.802 ' HA2' ' O ' ' B' ' 182' ' ' ASP . . . 60.94 35.66 90.87 Favored Glycine 0 C--N 1.343 0.963 0 CA-C-N 115.221 -0.9 . . . . 1.29 111.292 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 172' ' ' ILE . . . . . 1.091 HD13 ' HB2' ' B' ' 134' ' ' CYS . 1.2 pp -151.6 97.91 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 113.805 -1.197 . . . . 2.27 111.629 173.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 173' ' ' CYS . . . . . 0.563 ' HB2' ' HB3' ' B' ' 182' ' ' ASP . 5.2 t -99.71 85.85 3.19 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.682 -1.144 . . . . 1.94 110.174 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 174' ' ' CYS . . . . . 1.047 ' HA ' ' HA ' ' B' ' 179' ' ' CYS . 1.8 m -93.85 146.07 24.16 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.023 0.44 . . . . 1.35 111.187 -179.11 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 175' ' ' SER . . . . . 0.92 ' HB2' ' HD2' ' B' ' 176' ' ' PRO . 54.0 p -109.65 -179.65 0.7 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.761 -0.654 . . . . 2.0 110.031 179.505 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 176' ' ' PRO . . . . . 0.92 ' HD2' ' HB2' ' B' ' 175' ' ' SER . 78.6 Cg_endo -77.61 29.38 0.43 Allowed 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 121.675 1.583 . . . . 1.9 111.483 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 177' ' ' ASP . . . . . 0.449 ' H ' ' C ' ' B' ' 175' ' ' SER . 0.6 OUTLIER -144.63 -29.42 0.47 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.178 -0.919 . . . . 2.72 110.142 179.425 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 178' ' ' GLY . . . . . 0.523 ' O ' ' HB3' ' B' ' 174' ' ' CYS . . . -166.94 -145.75 4.6 Favored Glycine 0 CA--C 1.523 0.591 0 CA-C-N 115.944 -0.571 . . . . 0.99 112.571 179.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 179' ' ' CYS . . . . . 1.047 ' HA ' ' HA ' ' B' ' 174' ' ' CYS . 11.7 t -146.4 161.73 39.75 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 109.803 -0.443 . . . . 1.34 109.803 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 180' ' ' HIS . . . . . . . . . . . . . 54.7 m-70 -153.77 134.14 13.46 Favored 'General case' 0 CA--C 1.504 -0.8 0 C-N-CA 119.67 -0.812 . . . . 2.1 111.284 -176.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 181' ' ' GLU . . . . . 0.661 ' OE2' ' HD2' ' A' ' 24' ' ' PRO . 2.5 mt-10 -60.05 132.07 52.8 Favored 'General case' 0 CA--C 1.521 -0.147 0 N-CA-C 109.793 -0.447 . . . . 3.06 109.793 -178.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 182' ' ' ASP . . . . . 0.802 ' O ' ' HA2' ' B' ' 171' ' ' GLY . 0.1 OUTLIER -140.0 112.72 7.51 Favored Pre-proline 0 CA--C 1.545 0.783 0 CA-C-N 116.248 -0.433 . . . . 2.06 110.74 -178.514 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 183' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -70.91 -21.15 28.5 Favored 'Trans proline' 0 C--N 1.359 1.089 0 C-N-CA 122.845 2.363 . . . . 1.91 113.776 -178.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -63.8 -39.83 95.18 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.721 0.296 . . . . 1.56 111.551 -179.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 185' ' ' CYS . . . . . 0.623 ' O ' ' HA ' ' B' ' 170' ' ' ALA . 67.2 m -97.85 -0.84 44.37 Favored 'General case' 0 C--O 1.215 -0.741 0 N-CA-C 112.504 0.557 . . . . 1.94 112.504 -179.376 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 186' ' ' ASP . . . . . 0.543 ' HA ' ' N ' ' B' ' 171' ' ' GLY . 0.8 OUTLIER . . . . . 0 C--N 1.321 -0.643 0 N-CA-C 112.953 0.723 . . . . 3.61 112.953 -176.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.66 ' HB3' ' HB3' ' A' ' 20' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.617 0 N-CA-C 115.022 1.49 . . . . 2.68 115.022 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.516 HD23 ' HD2' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -34.36 132.95 0.41 Allowed Pre-proline 0 N--CA 1.481 1.093 0 C-N-CA 124.067 0.947 . . . . 2.48 113.312 177.592 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.86 ' HB2' ' O ' ' A' ' 17' ' ' GLY . 79.0 Cg_endo -87.89 136.46 3.66 Favored 'Trans proline' 0 C--N 1.356 0.933 0 C-N-CA 122.736 2.291 . . . . 1.49 112.784 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 1.054 ' HB2' ' HG3' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -140.97 -162.79 1.42 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 119.975 -0.69 . . . . 1.0 112.163 -179.285 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.476 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . 81.73 -156.27 36.38 Favored Glycine 0 C--N 1.339 0.741 0 CA-C-O 119.323 -0.709 . . . . 1.15 111.836 -178.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.856 ' HG2' ' HD2' ' A' ' 18' ' ' LYS . 42.5 Cg_endo -62.49 108.17 0.68 Allowed 'Trans proline' 0 N--CA 1.483 0.867 0 N-CA-C 105.466 -2.551 . . . . 1.57 105.466 176.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 76.85 -14.37 7.48 Favored Glycine 0 C--N 1.265 -3.372 0 CA-C-O 118.485 -1.175 . . . . 1.68 112.588 176.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.86 ' O ' ' HB2' ' A' ' 12' ' ' PRO . . . 75.37 49.41 9.36 Favored Glycine 0 N--CA 1.401 -3.651 0 C-N-CA 117.075 -2.488 . . . . 1.36 111.825 178.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 1.052 ' HD3' HD11 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -94.99 -12.88 25.89 Favored 'General case' 0 C--N 1.345 0.41 0 CA-C-N 110.358 -2.921 . . . . 2.5 113.142 177.636 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.821 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -115.98 -167.53 14.98 Favored Glycine 0 C--N 1.345 1.082 0 N-CA-C 106.099 -2.801 . . . . 1.02 106.099 178.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.66 ' HB3' ' HB3' ' A' ' 10' ' ' CYS . 1.5 mpt_? -115.08 173.42 6.5 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 122.0 2.9 . . . . 2.92 111.656 -178.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.666 ' HB3' ' HG3' ' A' ' 47' ' ' GLU . 1.2 m -106.25 151.25 25.04 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.882 0.372 . . . . 1.1 110.875 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -124.11 -46.82 1.93 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.117 -0.492 . . . . 1.51 110.776 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.464 ' HA2' ' OE1' ' A' ' 47' ' ' GLU . . . -137.91 -161.18 8.77 Favored Glycine 0 CA--C 1.519 0.321 0 N-CA-C 111.601 -0.6 . . . . 0.9 111.601 179.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -77.87 -63.19 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.071 1.848 . . . . 1.5 111.451 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.442 ' C ' HG13 ' A' ' 26' ' ' ILE . 1.1 m -92.17 33.31 1.08 Allowed 'General case' 0 C--O 1.224 -0.238 0 CA-C-N 116.216 -0.447 . . . . 1.26 109.828 178.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 1.071 HG12 HG13 ' A' ' 36' ' ' VAL . 19.0 mt -149.29 121.34 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-O 121.208 0.528 . . . . 0.83 111.99 -178.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.557 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 6.9 t -140.15 124.7 18.05 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 108.472 -0.936 . . . . 0.92 108.472 179.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.73 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -138.05 121.72 17.46 Favored 'General case' 0 CA--C 1.551 1.016 0 N-CA-C 114.4 1.259 . . . . 1.28 114.4 -177.743 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.516 ' O ' ' HB2' ' A' ' 69' ' ' ALA . . . -102.82 -170.62 26.43 Favored Glycine 0 C--N 1.367 2.291 0 N-CA-C 110.098 -1.201 . . . . 0.67 110.098 176.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -65.85 -53.68 36.65 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 113.773 1.027 . . . . 2.27 113.773 -178.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.54 3.44 12.43 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 122.222 1.01 . . . . 1.66 110.966 -176.245 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 1.052 HD11 ' HD3' ' A' ' 18' ' ' LYS . 0.4 OUTLIER -96.94 -22.24 16.97 Favored 'General case' 0 N--CA 1.415 -2.222 0 CA-C-N 113.887 -1.506 . . . . 1.37 107.382 -178.595 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.857 ' HA2' ' CB ' ' A' ' 69' ' ' ALA . . . 76.49 -135.73 17.82 Favored Glycine 0 N--CA 1.41 -3.094 0 CA-C-O 117.727 -1.596 . . . . 0.73 112.256 176.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 1.03 ' HB2' HD13 ' A' ' 72' ' ' ILE . 3.2 t -140.34 121.76 15.04 Favored 'General case' 0 CA--C 1.498 -1.051 0 CA-C-N 119.582 1.691 . . . . 1.08 114.1 -179.064 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.721 ' CE1' HD22 ' A' ' 32' ' ' LEU . 1.8 m-85 -95.51 102.12 13.89 Favored 'General case' 0 N--CA 1.428 -1.536 0 N-CA-C 103.469 -2.789 . . . . 1.38 103.469 175.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 1.071 HG13 HG12 ' A' ' 26' ' ' ILE . 2.1 t -94.41 84.34 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.137 0 CA-C-O 123.344 1.545 . . . . 0.76 108.622 -178.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 1.084 ' HA3' HG21 ' B' ' 172' ' ' ILE . . . 95.13 79.62 1.47 Allowed Glycine 0 C--N 1.313 -0.699 0 CA-C-N 112.236 -2.256 . . . . 0.81 113.722 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.724 HG21 ' CD2' ' B' ' 135' ' ' PHE . 58.2 p -159.96 177.9 10.28 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.743 -0.836 . . . . 0.77 108.743 179.118 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.73 ' HA ' HD12 ' A' ' 42' ' ' LEU . . . -65.28 -25.01 67.45 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 119.023 0.829 . . . . 1.02 112.27 -178.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.463 ' CG ' ' HA2' ' A' ' 14' ' ' GLY . 0.8 OUTLIER -64.35 -24.76 67.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.854 0.359 . . . . 2.32 110.246 178.664 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.564 ' O ' ' HB2' ' A' ' 44' ' ' CYS . . . -85.46 -10.16 56.5 Favored 'General case' 0 C--O 1.219 -0.5 0 CA-C-N 115.868 -0.605 . . . . 0.87 110.347 178.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.73 HD12 ' HA ' ' A' ' 39' ' ' ALA . 1.1 mt -53.29 -41.83 65.98 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 121.982 -0.449 . . . . 1.23 112.156 -178.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 1.054 ' HG3' ' HB2' ' A' ' 13' ' ' CYS . 5.0 ptm180 -70.78 -16.96 62.79 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 121.788 0.804 . . . . 2.92 109.299 176.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.564 ' HB2' ' O ' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -57.67 -18.83 22.77 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 114.023 -1.444 . . . . 1.57 110.107 -178.27 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -50.62 -25.82 4.66 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.769 -0.65 . . . . 3.31 111.118 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -83.09 8.33 13.28 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.159 0.504 . . . . 3.69 110.375 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.666 ' HG3' ' HB3' ' A' ' 21' ' ' CYS . 6.0 tm-20 . . . . . 0 N--CA 1.449 -0.521 0 CA-C-N 115.751 -0.659 . . . . 3.99 109.349 177.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 43.0 p . . . . . 0 CA--C 1.544 0.744 0 CA-C-O 121.385 0.612 . . . . 3.12 112.394 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 120.29 -88.26 0.43 Allowed Glycine 0 N--CA 1.464 0.54 0 CA-C-N 114.646 -1.161 . . . . 2.1 114.016 177.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.904 ' O ' ' HB3' ' A' ' 67' ' ' CYS . 41.1 mt-30 -124.16 104.49 8.87 Favored 'General case' 0 CA--C 1.489 -1.404 0 N-CA-C 102.946 -2.983 . . . . 4.36 102.946 177.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 1.088 ' HA ' ' H ' ' A' ' 67' ' ' CYS . 6.6 mmmt -128.68 -68.12 0.02 OUTLIER Pre-proline 0 C--N 1.314 -0.949 0 C-N-CA 118.532 -1.267 . . . . 3.55 112.812 -173.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.672 ' CD ' ' HB2' ' A' ' 59' ' ' LYS . 15.0 Cg_endo -57.08 114.97 2.17 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 CA-C-N 121.534 1.584 . . . . 1.54 115.354 -177.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -144.53 -165.36 2.12 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 111.133 -2.758 . . . . 1.59 104.494 178.159 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 47.24 -165.37 0.13 Allowed Glycine 0 N--CA 1.467 0.741 0 CA-C-N 121.283 1.856 . . . . 2.43 114.611 175.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 4.4 p -87.95 39.43 0.89 Allowed 'General case' 0 N--CA 1.479 1.016 0 CA-C-O 121.997 0.903 . . . . 4.11 110.482 -177.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 121.11 15.46 4.69 Favored Glycine 0 CA--C 1.558 2.732 0 CA-C-N 113.981 -1.463 . . . . 2.21 114.696 -175.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -101.14 146.02 17.21 Favored Glycine 0 N--CA 1.474 1.184 0 CA-C-N 119.913 1.856 . . . . 1.62 114.914 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 1.057 ' HB3' ' HB3' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -89.73 152.53 21.28 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 109.375 -0.602 . . . . 3.02 109.375 177.965 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 1.088 ' H ' ' HA ' ' A' ' 59' ' ' LYS . 36.1 t -73.47 107.53 5.81 Favored 'General case' 0 N--CA 1.407 -2.588 0 N-CA-C 108.736 -0.839 . . . . 1.52 108.736 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 1.011 ' HB2' ' HB2' ' A' ' 74' ' ' CYS . . . -71.58 -28.23 63.68 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.919 -0.771 . . . . 1.07 108.919 179.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.874 ' HB3' ' CG1' ' A' ' 72' ' ' ILE . . . -168.78 163.46 11.84 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.367 -1.288 . . . . 1.0 110.498 -176.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 1.087 ' HA ' ' HB3' ' A' ' 85' ' ' CYS . . . -55.05 122.41 10.89 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 116.111 -0.495 . . . . 1.24 112.119 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.585 ' H ' ' CB ' ' A' ' 85' ' ' CYS . . . 58.38 35.77 80.66 Favored Glycine 0 C--N 1.351 1.416 0 N-CA-C 110.904 -0.878 . . . . 1.28 110.904 -178.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 1.071 HG21 ' HA3' ' B' ' 137' ' ' GLY . 1.5 pp -154.71 97.79 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.644 0 N-CA-C 107.989 -1.115 . . . . 2.27 107.989 169.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.665 ' HB2' ' HB3' ' A' ' 82' ' ' ASP . 0.1 OUTLIER -91.48 106.33 18.42 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 112.21 0.448 . . . . 1.98 112.21 -177.319 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 1.011 ' HB2' ' HB2' ' A' ' 68' ' ' ALA . 0.6 OUTLIER -93.84 123.77 37.41 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.526 0.679 . . . . 1.33 111.663 179.754 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.901 ' HB2' ' HD2' ' A' ' 76' ' ' PRO . 36.2 p -93.26 -178.7 0.89 Allowed Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.102 -0.954 . . . . 1.99 109.035 178.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.901 ' HD2' ' HB2' ' A' ' 75' ' ' SER . 74.0 Cg_endo -76.11 29.28 0.39 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 121.328 1.352 . . . . 1.86 111.517 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.692 ' HB3' ' CE1' ' B' ' 180' ' ' HIS . 1.7 m-20 -145.78 -43.9 0.21 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.418 -0.81 . . . . 2.65 110.809 179.445 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.537 ' HA3' ' HA ' ' B' ' 180' ' ' HIS . . . -158.32 -141.61 3.19 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 120.74 -0.743 . . . . 0.99 113.128 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.766 ' HA ' ' HA ' ' A' ' 74' ' ' CYS . 0.1 OUTLIER -134.82 157.76 45.94 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.55 0.215 . . . . 1.34 110.505 -179.949 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.642 ' CE1' ' HB3' ' B' ' 177' ' ' ASP . 2.8 t60 -152.28 135.11 15.52 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 109.432 -0.581 . . . . 2.17 109.432 -176.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.8 132.19 53.19 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 109.295 -0.631 . . . . 3.05 109.295 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.665 ' HB3' ' HB2' ' A' ' 73' ' ' CYS . 1.2 p-10 -140.64 133.56 14.65 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 120.911 -0.315 . . . . 2.02 111.581 -177.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.606 ' HA ' ' HB2' ' A' ' 86' ' ' ASP . 5.7 Cg_exo -79.51 -12.16 14.01 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 122.737 2.292 . . . . 1.93 113.103 -179.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.8 -41.74 97.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.783 0.325 . . . . 1.53 110.944 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 1.087 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 21.5 m -99.88 22.67 10.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.156 0.503 . . . . 1.88 110.919 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.606 ' HB2' ' HA ' ' A' ' 83' ' ' PRO . 0.5 OUTLIER . . . . . 0 CA--C 1.512 -0.483 0 N-CA-C 113.887 1.069 . . . . 3.6 113.887 179.085 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 110' ' ' CYS . . . . . 0.64 ' HB3' ' HB3' ' B' ' 120' ' ' ARG . 0.0 OUTLIER . . . . . 0 CA--C 1.54 0.572 0 N-CA-C 115.381 1.622 . . . . 2.61 115.381 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 111' ' ' LEU . . . . . 0.509 HD23 ' HD2' ' B' ' 112' ' ' PRO . 0.2 OUTLIER -33.77 133.07 0.37 Allowed Pre-proline 0 N--CA 1.485 1.307 0 C-N-CA 123.979 0.912 . . . . 2.47 113.294 177.603 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 112' ' ' PRO . . . . . 0.845 ' HB2' ' O ' ' B' ' 117' ' ' GLY . 54.0 Cg_endo -92.3 129.09 0.95 Allowed 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.509 2.139 . . . . 1.47 115.253 -179.141 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 1.091 ' HB2' ' HG3' ' B' ' 143' ' ' ARG . 0.0 OUTLIER -133.65 -159.78 0.99 Allowed 'General case' 0 C--N 1.359 1.017 0 C-N-CA 119.473 -0.891 . . . . 1.0 111.299 -175.525 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 114' ' ' GLY . . . . . 0.474 ' N ' ' SG ' ' B' ' 113' ' ' CYS . . . 80.71 -156.91 39.16 Favored Glycine 0 C--N 1.334 0.443 0 CA-C-N 118.613 0.642 . . . . 1.16 111.558 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 115' ' ' PRO . . . . . 0.821 ' HG2' ' HD2' ' B' ' 118' ' ' LYS . 56.6 Cg_endo -65.24 88.59 0.2 Allowed 'Trans proline' 0 N--CA 1.458 -0.58 0 CA-C-N 119.523 1.662 . . . . 1.57 114.177 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 87.51 -3.83 86.21 Favored Glycine 0 C--N 1.265 -3.372 0 CA-C-N 112.056 -2.338 . . . . 1.7 114.202 -176.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 117' ' ' GLY . . . . . 0.845 ' O ' ' HB2' ' B' ' 112' ' ' PRO . . . 75.05 47.58 13.09 Favored Glycine 0 N--CA 1.412 -2.931 0 C-N-CA 118.966 -1.588 . . . . 1.38 113.497 175.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 118' ' ' LYS . . . . . 1.009 ' HD3' HD11 ' B' ' 132' ' ' LEU . 0.0 OUTLIER -90.72 -23.27 20.75 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 112.134 -2.033 . . . . 2.54 111.237 178.96 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 119' ' ' GLY . . . . . 0.728 ' O ' ' HA ' ' B' ' 112' ' ' PRO . . . -101.36 -160.94 27.18 Favored Glycine 0 N--CA 1.478 1.477 0 CA-C-O 117.274 -1.848 . . . . 1.04 109.242 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.64 ' HB3' ' HB3' ' B' ' 110' ' ' CYS . 1.3 mpt_? -124.0 172.83 8.66 Favored 'General case' 0 C--N 1.353 0.728 0 CA-C-N 122.238 3.019 . . . . 2.89 109.329 177.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 121' ' ' CYS . . . . . 0.645 ' HB3' ' HG3' ' B' ' 147' ' ' GLU . 1.2 m -106.11 151.44 24.7 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.927 0.394 . . . . 1.07 111.139 -179.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -124.16 -46.81 1.92 Allowed 'General case' 0 C--N 1.334 -0.101 0 CA-C-N 116.04 -0.527 . . . . 1.53 110.754 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 123' ' ' GLY . . . . . 0.484 ' HA2' ' OE1' ' B' ' 147' ' ' GLU . . . -137.98 -161.19 8.76 Favored Glycine 0 CA--C 1.52 0.374 0 N-CA-C 111.637 -0.585 . . . . 0.9 111.637 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -77.77 -63.21 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.033 1.822 . . . . 1.51 111.538 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 125' ' ' SER . . . . . 0.432 ' C ' HG13 ' B' ' 126' ' ' ILE . 1.1 m -92.05 33.27 1.07 Allowed 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.845 -0.428 . . . . 1.25 109.845 178.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 126' ' ' ILE . . . . . 1.067 HG12 HG13 ' B' ' 136' ' ' VAL . 23.0 mt -149.01 121.23 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 CA-C-O 121.082 0.468 . . . . 0.85 112.111 -178.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 127' ' ' CYS . . . . . 0.549 ' O ' ' HA ' ' B' ' 134' ' ' CYS . 6.6 t -140.34 124.33 17.48 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 108.404 -0.962 . . . . 0.89 108.404 179.217 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 128' ' ' CYS . . . . . 0.729 ' HA ' ' O ' ' B' ' 133' ' ' GLY . 0.0 OUTLIER -137.43 120.95 17.17 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 114.235 1.198 . . . . 1.23 114.235 -177.731 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 129' ' ' GLY . . . . . 0.501 ' O ' ' HB2' ' B' ' 169' ' ' ALA . . . -103.67 -167.65 25.39 Favored Glycine 0 C--N 1.369 2.395 0 CA-C-N 120.148 1.34 . . . . 0.66 109.885 176.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -65.72 -55.07 19.32 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 114.148 1.166 . . . . 2.35 114.148 -177.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -124.06 21.7 8.88 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 121.691 0.758 . . . . 1.69 109.955 -177.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 132' ' ' LEU . . . . . 1.009 HD11 ' HD3' ' B' ' 118' ' ' LYS . 0.4 OUTLIER -112.18 -21.19 11.59 Favored 'General case' 0 N--CA 1.411 -2.417 0 N-CA-C 104.783 -2.303 . . . . 1.38 104.783 179.24 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 133' ' ' GLY . . . . . 0.897 ' HA2' ' CB ' ' B' ' 169' ' ' ALA . . . 75.41 -134.73 17.13 Favored Glycine 1 N--CA 1.393 -4.226 0 CA-C-O 117.07 -1.961 . . . . 0.72 112.499 174.503 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 134' ' ' CYS . . . . . 1.031 ' HB2' HD13 ' B' ' 172' ' ' ILE . 3.1 t -140.75 121.78 14.63 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 120.262 2.031 . . . . 1.08 114.488 -178.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 135' ' ' PHE . . . . . 0.729 ' CE1' HD22 ' B' ' 132' ' ' LEU . 4.1 m-85 -95.16 101.77 13.54 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 103.707 -2.701 . . . . 1.36 103.707 175.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 136' ' ' VAL . . . . . 1.067 HG13 HG12 ' B' ' 126' ' ' ILE . 2.3 t -94.36 83.83 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.076 0 CA-C-O 123.364 1.554 . . . . 0.75 108.597 -178.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 137' ' ' GLY . . . . . 1.071 ' HA3' HG21 ' A' ' 72' ' ' ILE . . . 95.19 79.55 1.46 Allowed Glycine 0 C--N 1.313 -0.697 0 CA-C-N 112.145 -2.298 . . . . 0.83 113.643 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 138' ' ' THR . . . . . 0.604 ' OG1' ' HB3' ' B' ' 135' ' ' PHE . 51.2 p -158.12 -179.05 7.75 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.7 -0.852 . . . . 0.78 108.7 179.074 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 139' ' ' ALA . . . . . 0.733 ' HA ' HD12 ' B' ' 142' ' ' LEU . . . -68.37 -24.78 64.83 Favored 'General case' 0 C--N 1.338 0.109 0 CA-C-N 119.18 0.9 . . . . 1.04 111.934 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 140' ' ' GLU . . . . . 0.457 ' CG ' ' HA2' ' B' ' 114' ' ' GLY . 0.8 OUTLIER -63.98 -25.18 68.01 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.236 -0.438 . . . . 2.31 110.195 178.643 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 141' ' ' ALA . . . . . 0.556 ' O ' ' HB2' ' B' ' 144' ' ' CYS . . . -84.72 -11.22 56.29 Favored 'General case' 0 C--O 1.219 -0.538 0 CA-C-N 115.941 -0.572 . . . . 0.87 110.27 178.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 142' ' ' LEU . . . . . 0.733 HD12 ' HA ' ' B' ' 139' ' ' ALA . 1.1 mt -52.83 -42.09 64.82 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.312 0.486 . . . . 1.24 112.312 -178.018 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 143' ' ' ARG . . . . . 1.091 ' HG3' ' HB2' ' B' ' 113' ' ' CYS . 4.4 ptm180 -68.1 -21.57 64.95 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 108.613 -0.884 . . . . 2.93 108.613 176.299 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 144' ' ' CYS . . . . . 0.556 ' HB2' ' O ' ' B' ' 141' ' ' ALA . 0.1 OUTLIER -56.81 -13.84 2.91 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 113.743 -1.571 . . . . 1.61 110.482 -175.867 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -54.61 -24.93 23.52 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-O 121.242 0.544 . . . . 3.35 111.05 178.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -82.99 8.42 12.77 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 120.473 -0.491 . . . . 3.76 110.213 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 147' ' ' GLU . . . . . 0.645 ' HG3' ' HB3' ' B' ' 121' ' ' CYS . 6.0 tm-20 . . . . . 0 N--CA 1.449 -0.501 0 CA-C-N 115.821 -0.627 . . . . 4.01 109.375 177.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 34.5 p . . . . . 0 CA--C 1.537 0.451 0 N-CA-C 112.147 0.425 . . . . 3.11 112.147 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 120.48 -92.33 0.51 Allowed Glycine 0 C--N 1.339 0.743 0 C-N-CA 120.834 -0.698 . . . . 2.07 113.286 178.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 158' ' ' GLN . . . . . 0.953 ' O ' ' HB3' ' B' ' 167' ' ' CYS . 41.1 mt-30 -124.55 89.67 3.11 Favored 'General case' 0 CA--C 1.493 -1.237 0 N-CA-C 105.246 -2.131 . . . . 4.34 105.246 178.304 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 159' ' ' LYS . . . . . 1.075 ' HB3' ' HB3' ' B' ' 166' ' ' ARG . 6.5 mmmt -105.58 -73.69 0.02 OUTLIER Pre-proline 0 C--N 1.308 -1.232 0 N-CA-C 116.28 1.956 . . . . 3.54 116.28 -175.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 160' ' ' PRO . . . . . 0.64 ' CD ' ' HB2' ' B' ' 159' ' ' LYS . 14.6 Cg_endo -57.21 115.05 2.22 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 N-CA-C 116.037 1.514 . . . . 1.51 116.037 -174.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 161' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -145.57 -168.75 3.05 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 110.911 -2.859 . . . . 1.58 104.374 177.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 50.01 -165.66 0.5 Allowed Glycine 0 CA--C 1.525 0.7 0 CA-C-N 120.62 1.554 . . . . 2.37 113.882 177.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 7.3 p -88.25 39.63 0.91 Allowed 'General case' 0 N--CA 1.482 1.152 0 CA-C-O 122.491 1.138 . . . . 4.07 110.962 -178.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 123.02 12.8 4.7 Favored Glycine 0 CA--C 1.557 2.663 0 CA-C-N 113.351 -1.75 . . . . 2.2 114.857 -178.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -99.92 146.08 17.66 Favored Glycine 0 N--CA 1.471 1.02 0 CA-C-N 120.795 2.297 . . . . 1.62 115.046 -177.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 166' ' ' ARG . . . . . 1.075 ' HB3' ' HB3' ' B' ' 159' ' ' LYS . 0.0 OUTLIER -89.51 152.28 21.52 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 109.302 -0.629 . . . . 3.05 109.302 178.612 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 167' ' ' CYS . . . . . 0.996 ' H ' ' HA ' ' B' ' 159' ' ' LYS . 33.6 t -73.77 107.75 6.2 Favored 'General case' 0 N--CA 1.406 -2.628 0 N-CA-C 108.683 -0.858 . . . . 1.56 108.683 -179.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 168' ' ' ALA . . . . . 1.009 ' HB2' ' HB2' ' B' ' 174' ' ' CYS . . . -73.68 -24.18 59.92 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 119.699 -0.801 . . . . 1.04 109.438 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 169' ' ' ALA . . . . . 0.897 ' CB ' ' HA2' ' B' ' 133' ' ' GLY . . . -171.47 163.48 6.81 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 108.554 -0.906 . . . . 0.98 108.554 -178.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 170' ' ' ALA . . . . . 1.053 ' HA ' ' HB3' ' B' ' 185' ' ' CYS . . . -55.43 125.56 21.42 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 120.89 0.376 . . . . 1.25 111.974 179.263 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 171' ' ' GLY . . . . . 0.541 ' H ' ' CB ' ' B' ' 185' ' ' CYS . . . 79.27 -7.45 52.64 Favored Glycine 0 C--O 1.224 -0.513 0 C-N-CA 120.376 -0.916 . . . . 1.29 114.063 178.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 172' ' ' ILE . . . . . 1.084 HG21 ' HA3' ' A' ' 37' ' ' GLY . 1.6 pp -132.36 100.78 4.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-O 121.89 0.852 . . . . 2.27 110.59 -175.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 173' ' ' CYS . . . . . 0.674 ' HB2' ' HB3' ' B' ' 182' ' ' ASP . 0.1 OUTLIER -91.13 105.88 18.12 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 115.498 -0.774 . . . . 1.94 112.282 -177.811 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 174' ' ' CYS . . . . . 1.009 ' HB2' ' HB2' ' B' ' 168' ' ' ALA . 0.6 OUTLIER -93.94 123.81 37.54 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.535 0.683 . . . . 1.35 111.734 179.651 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 175' ' ' SER . . . . . 0.955 ' HB2' ' HD2' ' B' ' 176' ' ' PRO . 36.1 p -93.31 -178.71 0.89 Allowed Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.114 -0.948 . . . . 2.0 109.071 178.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 176' ' ' PRO . . . . . 0.955 ' HD2' ' HB2' ' B' ' 175' ' ' SER . 73.9 Cg_endo -76.08 29.2 0.39 Allowed 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 121.388 1.392 . . . . 1.9 111.481 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 177' ' ' ASP . . . . . 0.642 ' HB3' ' CE1' ' A' ' 80' ' ' HIS . 1.6 m-20 -145.74 -43.94 0.21 Allowed 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 115.489 -0.778 . . . . 2.72 110.798 179.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 178' ' ' GLY . . . . . 0.517 ' HA3' ' HA ' ' A' ' 80' ' ' HIS . . . -158.27 -141.52 3.17 Favored Glycine 0 CA--C 1.522 0.512 0 C-N-CA 120.776 -0.726 . . . . 0.99 113.137 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 179' ' ' CYS . . . . . 0.759 ' HA ' ' HA ' ' B' ' 174' ' ' CYS . 0.1 OUTLIER -134.5 160.27 38.53 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 110.424 -0.213 . . . . 1.34 110.424 -179.986 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 180' ' ' HIS . . . . . 0.692 ' CE1' ' HB3' ' A' ' 77' ' ' ASP . 2.9 t60 -156.21 134.05 11.12 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 109.886 -0.412 . . . . 2.1 109.886 -176.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 181' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.02 131.88 52.37 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 109.414 -0.588 . . . . 3.06 109.414 -179.08 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 182' ' ' ASP . . . . . 0.674 ' HB3' ' HB2' ' B' ' 173' ' ' CYS . 1.2 p-10 -140.47 133.54 14.83 Favored Pre-proline 0 CA--C 1.541 0.602 0 C-N-CA 120.937 -0.305 . . . . 2.06 111.701 -177.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 183' ' ' PRO . . . . . 0.615 ' HA ' ' HB2' ' B' ' 186' ' ' ASP . 5.9 Cg_exo -79.51 -12.11 14.03 Favored 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 122.684 2.256 . . . . 1.91 113.065 -179.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -63.65 -41.61 98.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.836 0.35 . . . . 1.56 111.026 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 185' ' ' CYS . . . . . 1.053 ' HB3' ' HA ' ' B' ' 170' ' ' ALA . 26.7 m -99.7 22.38 11.04 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.153 -0.476 . . . . 1.94 111.293 179.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 186' ' ' ASP . . . . . 0.615 ' HB2' ' HA ' ' B' ' 183' ' ' PRO . 0.5 OUTLIER . . . . . 0 CA--C 1.504 -0.82 0 N-CA-C 113.927 1.084 . . . . 3.61 113.927 179.136 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 1.051 ' HB3' ' HG2' ' A' ' 20' ' ' ARG . 0.6 OUTLIER . . . . . 0 N--CA 1.44 -0.93 0 CA-C-O 118.743 -0.646 . . . . 2.68 112.154 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.75 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 4.3 mm? -30.68 108.48 0.26 Allowed Pre-proline 0 N--CA 1.474 0.751 0 CA-C-N 119.208 0.913 . . . . 2.48 110.408 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.78 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 49.4 Cg_endo -100.0 114.42 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 123.085 2.523 . . . . 1.49 114.58 -177.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.764 ' HB2' ' HB3' ' A' ' 43' ' ' ARG . 0.1 OUTLIER -132.97 -157.77 0.84 Allowed 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 119.759 -0.162 . . . . 1.0 110.582 -178.465 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.612 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . 80.62 -158.77 41.63 Favored Glycine 0 CA--C 1.507 -0.409 0 CA-C-O 118.564 -1.131 . . . . 1.15 111.202 -177.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.527 ' HD3' ' HG2' ' A' ' 40' ' ' GLU . 84.4 Cg_endo -64.77 84.02 0.17 Allowed 'Trans proline' 0 CA--C 1.515 -0.474 0 CA-C-N 121.122 2.461 . . . . 1.57 115.035 -176.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.07 1.33 84.67 Favored Glycine 0 C--N 1.283 -2.388 0 CA-C-N 111.621 -2.536 . . . . 1.68 114.474 -178.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.64 ' O ' ' HB2' ' A' ' 12' ' ' PRO . . . 85.87 42.73 6.65 Favored Glycine 0 N--CA 1.431 -1.659 0 N-CA-C 117.38 1.712 . . . . 1.36 117.38 174.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -94.63 -14.94 24.43 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-N 114.443 -0.878 . . . . 2.5 111.799 175.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.78 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -107.7 179.39 21.93 Favored Glycine 0 N--CA 1.468 0.807 0 N-CA-C 109.478 -1.449 . . . . 1.02 109.478 -179.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 1.051 ' HG2' ' HB3' ' A' ' 10' ' ' CYS . 0.3 OUTLIER -120.34 174.01 6.78 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 120.833 2.316 . . . . 2.92 110.982 179.021 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 12.7 m -107.3 156.37 18.95 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.028 0.442 . . . . 1.1 112.005 -179.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.507 ' CE1' ' HB2' ' A' ' 28' ' ' CYS . 56.9 m-85 -143.54 16.9 1.84 Allowed 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.601 -0.727 . . . . 1.51 111.231 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.522 ' O ' ' HB3' ' A' ' 44' ' ' CYS . . . 162.45 -143.91 9.17 Favored Glycine 0 C--N 1.331 0.256 0 C-N-CA 120.743 -0.741 . . . . 0.9 112.093 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.44 ' O ' ' HB2' ' A' ' 44' ' ' CYS . 12.1 Cg_endo -90.08 -72.88 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 123.054 2.503 . . . . 1.5 112.579 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.418 ' O ' ' HA ' ' A' ' 36' ' ' VAL . 0.4 OUTLIER -91.79 35.6 0.97 Allowed 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 110.265 -0.272 . . . . 1.26 110.265 179.525 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.999 ' CG1' HG13 ' A' ' 36' ' ' VAL . 13.3 mt -139.81 98.92 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 N-CA-C 113.664 0.987 . . . . 0.83 113.664 -178.228 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.864 ' HB2' ' HA ' ' A' ' 41' ' ' ALA . 3.7 t -119.71 108.71 14.76 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 107.376 -1.342 . . . . 0.92 107.376 176.114 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.803 ' CB ' ' HB1' ' A' ' 68' ' ' ALA . 4.3 m -121.94 161.67 22.45 Favored 'General case' 0 N--CA 1.429 -1.516 0 CA-C-N 114.374 -1.285 . . . . 1.28 112.703 -176.348 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.503 ' O ' ' HB2' ' A' ' 69' ' ' ALA . . . -142.02 -173.42 14.08 Favored Glycine 0 N--CA 1.426 -2.027 0 CA-C-N 113.454 -1.703 . . . . 0.67 110.096 175.193 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.445 ' OD2' ' HG2' ' A' ' 31' ' ' GLU . 17.4 p-10 -67.3 -52.6 38.6 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 112.578 0.585 . . . . 2.27 112.578 -179.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.445 ' HG2' ' OD2' ' A' ' 30' ' ' ASP . 0.4 OUTLIER -119.17 19.12 12.96 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 122.411 1.1 . . . . 1.66 109.468 -178.703 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.712 HD22 ' CE1' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -113.73 -12.32 12.8 Favored 'General case' 0 N--CA 1.415 -2.208 0 CA-C-N 112.902 -1.954 . . . . 1.37 106.665 -178.923 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.701 ' HA2' ' CB ' ' A' ' 69' ' ' ALA . . . 52.81 -134.1 39.88 Favored Glycine 0 N--CA 1.415 -2.727 0 CA-C-N 113.952 -1.476 . . . . 0.73 113.831 177.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.793 ' HB2' HD13 ' A' ' 72' ' ' ILE . 0.9 OUTLIER -127.28 119.99 27.6 Favored 'General case' 0 N--CA 1.429 -1.519 0 N-CA-C 116.024 1.861 . . . . 1.08 116.024 -178.188 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.833 ' HB3' ' CG2' ' A' ' 38' ' ' THR . 8.4 m-85 -95.37 105.06 16.99 Favored 'General case' 0 N--CA 1.417 -2.082 1 N-CA-C 99.622 -4.214 . . . . 1.38 99.622 173.175 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.999 HG13 ' CG1' ' A' ' 26' ' ' ILE . 2.2 t -103.04 88.27 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.642 0 CA-C-O 122.794 1.283 . . . . 0.76 110.273 -176.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.452 ' O ' ' O ' ' A' ' 38' ' ' THR . . . 120.21 -46.48 1.12 Allowed Glycine 0 N--CA 1.461 0.323 0 CA-C-N 113.397 -1.729 . . . . 0.81 115.684 178.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.833 ' CG2' ' HB3' ' A' ' 35' ' ' PHE . 3.2 t -47.36 -174.66 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 117.305 0.553 . . . . 0.77 111.906 -178.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.808 ' HA ' HD12 ' A' ' 42' ' ' LEU . . . -70.17 -23.73 63.02 Favored 'General case' 0 CA--C 1.515 -0.393 0 O-C-N 121.817 -0.552 . . . . 1.02 112.445 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.528 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 1.3 mp0 -60.06 -28.04 67.46 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.586 -0.279 . . . . 2.32 110.769 179.256 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.864 ' HA ' ' HB2' ' A' ' 27' ' ' CYS . . . -93.14 -22.74 18.9 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 122.221 0.208 . . . . 0.87 111.313 -179.086 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.808 HD12 ' HA ' ' A' ' 39' ' ' ALA . 5.0 mt -49.7 -39.76 37.97 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 121.238 0.542 . . . . 1.23 110.716 179.183 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.764 ' HB3' ' HB2' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -56.6 -17.7 9.48 Favored 'General case' 0 CA--C 1.496 -1.123 0 CA-C-N 115.622 -0.717 . . . . 2.92 109.704 178.561 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.522 ' HB3' ' O ' ' A' ' 23' ' ' GLY . 68.0 m -75.31 0.45 16.68 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 120.042 1.292 . . . . 1.57 112.036 -179.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 71.4 tp60 -60.88 -21.32 63.18 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.066 0.46 . . . . 3.31 110.216 178.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -85.8 2.8 44.21 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 119.753 -0.779 . . . . 3.69 111.112 -179.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.447 -0.583 0 CA-C-N 116.147 -0.479 . . . . 3.99 109.739 177.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.63 ' HA ' ' HE3' ' A' ' 59' ' ' LYS . 8.1 t . . . . . 0 N--CA 1.445 -0.717 0 N-CA-C 109.213 -0.662 . . . . 3.12 109.213 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 178.36 -86.64 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 119.998 -1.096 . . . . 2.1 113.15 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.965 ' HB3' ' HB3' ' A' ' 67' ' ' CYS . 15.6 mt-30 -120.6 85.94 2.48 Favored 'General case' 0 N--CA 1.417 -2.081 0 N-CA-C 107.55 -1.278 . . . . 4.36 107.55 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 1.298 ' O ' ' HA ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -136.44 -52.38 0.02 OUTLIER Pre-proline 0 C--N 1.305 -1.333 0 N-CA-C 106.562 -1.644 . . . . 3.55 106.562 179.799 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.83 ' HD2' ' H ' ' A' ' 59' ' ' LYS . 43.8 Cg_endo -84.96 108.5 1.18 Allowed 'Trans proline' 0 C--N 1.298 -2.126 0 CA-C-N 120.404 1.18 . . . . 1.54 114.076 177.009 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.737 ' SG ' ' HB3' ' A' ' 84' ' ' ALA . 3.0 t -142.95 -176.99 5.12 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 113.979 -1.464 . . . . 1.59 108.565 178.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.562 ' O ' ' O ' ' A' ' 61' ' ' CYS . . . 33.46 -166.19 0.01 OUTLIER Glycine 0 CA--C 1.524 0.598 0 C-N-CA 120.729 -0.748 . . . . 2.43 114.468 176.337 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -83.23 50.32 1.73 Allowed 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 122.423 1.106 . . . . 4.11 111.237 179.243 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 121.5 5.18 9.46 Favored Glycine 0 N--CA 1.474 1.172 0 CA-C-N 112.995 -1.911 . . . . 2.21 115.041 171.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.466 ' O ' ' N ' ' A' ' 61' ' ' CYS . . . -103.72 158.31 17.14 Favored Glycine 0 C--N 1.336 0.535 0 C-N-CA 120.957 -0.64 . . . . 1.62 112.767 -178.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 1.298 ' HA ' ' O ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -88.44 152.69 21.73 Favored 'General case' 0 CA--C 1.477 -1.863 0 CA-C-O 121.367 0.603 . . . . 3.02 112.295 -178.865 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.965 ' HB3' ' HB3' ' A' ' 58' ' ' GLN . 0.1 OUTLIER -73.75 108.2 6.44 Favored 'General case' 1 N--CA 1.374 -4.243 0 N-CA-C 107.254 -1.388 . . . . 1.52 107.254 178.145 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.803 ' HB1' ' CB ' ' A' ' 28' ' ' CYS . . . -80.66 -57.24 3.66 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 104.873 -2.269 . . . . 1.07 104.873 178.098 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.856 ' HB3' HD11 ' A' ' 72' ' ' ILE . . . -154.42 161.8 41.51 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 111.785 -2.461 . . . . 1.0 111.636 -173.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.858 ' HA ' ' O ' ' A' ' 85' ' ' CYS . . . -32.8 122.7 0.36 Allowed 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 114.693 1.368 . . . . 1.24 114.693 -179.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.764 ' O ' ' HA ' ' A' ' 81' ' ' GLU . . . 59.45 -5.5 0.09 OUTLIER Glycine 0 CA--C 1.533 1.203 0 N-CA-C 116.801 1.48 . . . . 1.28 116.801 178.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.856 HD11 ' HB3' ' A' ' 69' ' ' ALA . 1.9 pp -121.04 100.07 8.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 122.73 1.252 . . . . 2.27 109.85 177.297 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.539 ' HB3' ' HB3' ' A' ' 61' ' ' CYS . 58.5 m -110.25 111.99 23.67 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 113.481 -1.69 . . . . 1.98 110.189 -177.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.583 ' HA ' ' O ' ' A' ' 78' ' ' GLY . 5.3 m -83.46 133.83 34.89 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 113.531 0.937 . . . . 1.33 113.531 -177.037 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.854 ' HB2' ' HD2' ' A' ' 76' ' ' PRO . 28.9 p -95.62 -179.06 0.86 Allowed Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 113.869 -1.514 . . . . 1.99 107.248 177.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.854 ' HD2' ' HB2' ' A' ' 75' ' ' SER . 57.5 Cg_endo -71.61 31.11 0.24 Allowed 'Trans proline' 0 CA--C 1.532 0.376 0 CA-C-N 120.56 1.236 . . . . 1.86 112.113 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.503 ' H ' ' C ' ' A' ' 75' ' ' SER . 3.0 p30 -145.67 -46.09 0.21 Allowed 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 115.899 -0.591 . . . . 2.65 111.661 179.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 1.142 ' HA3' ' O ' ' B' ' 179' ' ' CYS . . . -160.76 -151.54 6.26 Favored Glycine 0 C--N 1.349 1.28 0 C-N-CA 120.314 -0.946 . . . . 0.99 115.242 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 1.175 ' O ' ' HA3' ' B' ' 178' ' ' GLY . 32.3 m -128.87 133.75 48.05 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-O 123.377 1.561 . . . . 1.34 110.703 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 28.8 p80 -146.04 135.2 22.76 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 112.27 -2.241 . . . . 2.17 112.495 -169.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.764 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 34.4 mt-10 -51.91 123.88 11.38 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 114.132 -1.395 . . . . 3.05 111.067 -179.454 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.401 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 0.0 OUTLIER -146.78 126.04 6.52 Favored Pre-proline 0 C--N 1.317 -0.845 0 CA-C-N 115.044 -0.98 . . . . 2.02 109.293 -179.656 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 82' ' ' ASP . 71.8 Cg_exo -54.77 -13.53 6.19 Favored 'Trans proline' 0 N--CA 1.482 0.838 0 C-N-CA 124.038 3.158 . . . . 1.93 116.21 -177.12 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.737 ' HB3' ' SG ' ' A' ' 61' ' ' CYS . . . -71.42 -32.1 67.99 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 115.094 1.516 . . . . 1.53 115.094 -177.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.858 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 0.1 OUTLIER -91.15 -4.24 56.34 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 115.262 1.579 . . . . 1.88 115.262 -176.158 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.2 t70 . . . . . 0 C--N 1.32 -0.696 0 N-CA-C 113.215 0.82 . . . . 3.6 113.215 -178.737 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 110' ' ' CYS . . . . . 1.095 ' HB3' ' HG2' ' B' ' 120' ' ' ARG . 0.6 OUTLIER . . . . . 0 N--CA 1.438 -1.029 0 CA-C-O 119.026 -0.511 . . . . 2.61 111.854 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 111' ' ' LEU . . . . . 0.76 ' O ' ' HA ' ' B' ' 120' ' ' ARG . 4.2 mm? -30.64 108.54 0.26 Allowed Pre-proline 0 N--CA 1.474 0.743 0 CA-C-N 118.799 0.727 . . . . 2.47 110.271 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 112' ' ' PRO . . . . . 0.734 ' HA ' ' O ' ' B' ' 119' ' ' GLY . 49.9 Cg_endo -100.87 111.93 0.06 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.896 2.397 . . . . 1.47 115.3 -177.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.757 ' HB2' ' HB3' ' B' ' 143' ' ' ARG . 0.1 OUTLIER -129.79 -156.75 0.78 Allowed 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 116.849 -0.159 . . . . 1.0 110.81 -178.476 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 114' ' ' GLY . . . . . 0.613 ' N ' ' SG ' ' B' ' 113' ' ' CYS . . . 80.45 -158.82 42.03 Favored Glycine 0 CA--C 1.506 -0.479 0 CA-C-O 118.714 -1.048 . . . . 1.16 111.276 -177.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 115' ' ' PRO . . . . . 0.529 ' HD3' ' HG2' ' B' ' 140' ' ' GLU . 88.4 Cg_endo -64.97 82.82 0.18 Allowed 'Trans proline' 0 CA--C 1.508 -0.809 0 CA-C-N 120.871 2.336 . . . . 1.57 115.659 -176.259 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 116' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' B' ' 114' ' ' GLY . . . 88.95 0.71 80.79 Favored Glycine 0 N--CA 1.415 -2.754 0 CA-C-N 111.949 -2.387 . . . . 1.7 115.096 -178.172 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 117' ' ' GLY . . . . . 0.645 ' O ' ' HB2' ' B' ' 112' ' ' PRO . . . 93.07 33.27 7.39 Favored Glycine 0 N--CA 1.429 -1.823 0 CA-C-N 120.577 2.189 . . . . 1.38 117.359 174.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -94.02 -14.03 26.29 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 112.828 0.677 . . . . 2.54 112.828 177.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 119' ' ' GLY . . . . . 0.734 ' O ' ' HA ' ' B' ' 112' ' ' PRO . . . -111.98 -174.63 19.68 Favored Glycine 0 C--N 1.345 1.072 0 CA-C-O 117.37 -1.794 . . . . 1.04 108.907 179.042 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 1.095 ' HG2' ' HB3' ' B' ' 110' ' ' CYS . 0.2 OUTLIER -123.59 175.36 6.85 Favored 'General case' 0 C--N 1.349 0.584 0 CA-C-N 122.52 3.16 . . . . 2.89 110.318 -179.032 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 121' ' ' CYS . . . . . . . . . . . . . 10.9 m -106.94 156.56 18.58 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.171 0.51 . . . . 1.07 112.123 -179.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 122' ' ' PHE . . . . . 0.576 ' HE1' ' O ' ' B' ' 128' ' ' CYS . 56.2 m-85 -143.53 17.11 1.84 Allowed 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.497 -0.774 . . . . 1.53 111.163 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 123' ' ' GLY . . . . . 0.532 ' O ' ' HB3' ' B' ' 144' ' ' CYS . . . 162.28 -144.0 9.28 Favored Glycine 0 CA--C 1.519 0.289 0 C-N-CA 120.856 -0.688 . . . . 0.9 112.139 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . 0.493 ' O ' ' HB2' ' B' ' 144' ' ' CYS . 12.1 Cg_endo -89.99 -73.05 0.0 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 123.016 2.477 . . . . 1.51 112.607 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 125' ' ' SER . . . . . 0.438 ' O ' ' HA ' ' B' ' 136' ' ' VAL . 0.4 OUTLIER -91.28 35.31 0.93 Allowed 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 110.108 -0.33 . . . . 1.25 110.108 179.431 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 126' ' ' ILE . . . . . 0.914 ' CG1' HG13 ' B' ' 136' ' ' VAL . 17.9 mt -139.38 98.14 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 114.007 1.114 . . . . 0.85 114.007 -178.02 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 127' ' ' CYS . . . . . 0.834 ' HB2' ' HA ' ' B' ' 141' ' ' ALA . 3.7 t -119.83 109.31 15.43 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 107.553 -1.277 . . . . 0.89 107.553 176.345 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 128' ' ' CYS . . . . . 0.751 ' HB2' ' HB1' ' B' ' 168' ' ' ALA . 3.7 m -132.31 148.13 52.42 Favored 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 115.259 1.577 . . . . 1.23 115.259 -175.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 129' ' ' GLY . . . . . 0.47 ' O ' ' HB2' ' B' ' 169' ' ' ALA . . . -126.9 -168.1 12.48 Favored Glycine 0 N--CA 1.429 -1.812 0 N-CA-C 109.874 -1.291 . . . . 0.66 109.874 179.156 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 130' ' ' ASP . . . . . 0.427 ' OD2' ' HG2' ' B' ' 131' ' ' GLU . 17.9 p-10 -69.1 -54.01 17.28 Favored 'General case' 0 CA--C 1.491 -1.303 0 C-N-CA 123.396 0.678 . . . . 2.35 112.199 -179.091 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 131' ' ' GLU . . . . . 0.427 ' HG2' ' OD2' ' B' ' 130' ' ' ASP . 0.3 OUTLIER -119.56 28.11 8.36 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 117.495 -1.682 . . . . 1.69 109.215 179.609 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 132' ' ' LEU . . . . . 0.737 HD22 ' CE1' ' B' ' 135' ' ' PHE . 0.7 OUTLIER -121.47 -12.2 8.6 Favored 'General case' 0 N--CA 1.424 -1.741 0 N-CA-C 104.289 -2.485 . . . . 1.38 104.289 -175.709 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 133' ' ' GLY . . . . . 0.756 ' HA2' ' CB ' ' B' ' 169' ' ' ALA . . . 48.91 -136.08 20.1 Favored Glycine 0 N--CA 1.407 -3.249 0 CA-C-N 112.831 -1.986 . . . . 0.72 113.359 176.334 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 134' ' ' CYS . . . . . 0.802 ' HB2' HD13 ' B' ' 172' ' ' ILE . 1.1 m -118.88 125.7 50.1 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.273 1.212 . . . . 1.08 114.273 -176.584 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 135' ' ' PHE . . . . . 0.804 ' HB3' ' CG2' ' B' ' 138' ' ' THR . 8.8 m-85 -102.17 104.2 14.77 Favored 'General case' 0 N--CA 1.431 -1.394 1 N-CA-C 99.508 -4.256 . . . . 1.36 99.508 169.628 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 136' ' ' VAL . . . . . 0.914 HG13 ' CG1' ' B' ' 126' ' ' ILE . 2.5 t -103.43 89.3 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.629 0 CA-C-O 122.594 1.188 . . . . 0.75 110.17 -176.257 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 137' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' B' ' 125' ' ' SER . . . 119.24 -47.61 1.01 Allowed Glycine 0 CA--C 1.519 0.3 0 CA-C-N 113.688 -1.596 . . . . 0.83 115.582 179.177 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 138' ' ' THR . . . . . 0.804 ' CG2' ' HB3' ' B' ' 135' ' ' PHE . 3.5 t -50.52 179.53 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 117.418 0.609 . . . . 0.78 112.266 -178.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 139' ' ' ALA . . . . . 0.847 ' HA ' HD12 ' B' ' 142' ' ' LEU . . . -58.08 -36.3 72.65 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.938 -1.028 . . . . 1.04 111.09 -178.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 140' ' ' GLU . . . . . 0.529 ' HG2' ' HD3' ' B' ' 115' ' ' PRO . 1.3 mp0 -53.82 -27.71 31.08 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.761 0.282 . . . . 2.31 111.761 -178.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 141' ' ' ALA . . . . . 0.834 ' HA ' ' HB2' ' B' ' 127' ' ' CYS . . . -88.46 -33.82 17.69 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 116.123 -0.49 . . . . 0.87 109.929 -179.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 142' ' ' LEU . . . . . 0.847 HD12 ' HA ' ' B' ' 139' ' ' ALA . 6.2 mt -42.31 -41.15 2.7 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.013 -0.54 . . . . 1.24 111.748 -178.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 143' ' ' ARG . . . . . 0.757 ' HB3' ' HB2' ' B' ' 113' ' ' CYS . 0.0 OUTLIER -52.55 -26.15 12.44 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 109.354 -0.61 . . . . 2.93 109.354 178.073 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 144' ' ' CYS . . . . . 0.532 ' HB3' ' O ' ' B' ' 123' ' ' GLY . 56.9 m -61.2 -16.56 46.17 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.316 -1.311 . . . . 1.61 110.702 -176.147 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 68.4 tp60 -52.68 -22.38 5.08 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 111.879 0.326 . . . . 3.35 111.879 -179.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -85.79 3.02 43.33 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 119.602 -0.839 . . . . 3.76 110.968 -179.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.448 -0.561 0 CA-C-N 116.056 -0.52 . . . . 4.01 109.686 177.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 156' ' ' SER . . . . . 0.652 ' HA ' ' HE3' ' B' ' 159' ' ' LYS . 7.5 t . . . . . 0 N--CA 1.448 -0.567 0 N-CA-C 108.728 -0.842 . . . . 3.11 108.728 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 176.41 -87.6 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 119.926 -1.13 . . . . 2.07 112.967 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 158' ' ' GLN . . . . . 0.986 ' HB3' ' HB3' ' B' ' 167' ' ' CYS . 16.6 mt-30 -120.92 71.22 0.93 Allowed 'General case' 0 N--CA 1.418 -2.047 0 CA-C-O 122.151 0.976 . . . . 4.34 109.292 179.439 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 159' ' ' LYS . . . . . 1.252 ' O ' ' HA ' ' B' ' 166' ' ' ARG . 0.0 OUTLIER -107.28 -58.57 0.05 OUTLIER Pre-proline 0 C--O 1.205 -1.238 0 CA-C-O 123.72 1.724 . . . . 3.54 110.701 174.48 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 160' ' ' PRO . . . . . 0.697 ' HD2' ' H ' ' B' ' 159' ' ' LYS . 49.5 Cg_endo -85.03 108.0 1.12 Allowed 'Trans proline' 0 N--CA 1.442 -1.553 0 C-N-CA 122.466 2.11 . . . . 1.51 114.76 -176.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 161' ' ' CYS . . . . . 0.708 ' SG ' ' HB3' ' B' ' 184' ' ' ALA . 3.1 t -143.87 -177.8 5.61 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 113.452 -1.704 . . . . 1.58 108.632 178.609 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 162' ' ' GLY . . . . . 0.506 ' O ' ' O ' ' B' ' 161' ' ' CYS . . . 35.49 -166.58 0.01 OUTLIER Glycine 0 CA--C 1.519 0.309 0 C-N-CA 121.077 -0.583 . . . . 2.37 114.414 176.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.89 51.47 1.74 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 121.052 -0.259 . . . . 4.07 111.238 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 119.64 3.83 12.22 Favored Glycine 0 CA--C 1.529 0.93 0 N-CA-C 114.631 0.613 . . . . 2.2 114.631 178.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 165' ' ' GLY . . . . . 0.48 ' O ' ' N ' ' B' ' 161' ' ' CYS . . . -102.73 157.85 17.99 Favored Glycine 0 C--O 1.226 -0.385 0 C-N-CA 120.143 -1.027 . . . . 1.62 112.754 179.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 166' ' ' ARG . . . . . 1.252 ' HA ' ' O ' ' B' ' 159' ' ' LYS . 0.0 OUTLIER -88.57 152.59 21.75 Favored 'General case' 0 CA--C 1.48 -1.73 0 C-N-CA 120.325 -0.55 . . . . 3.05 111.962 -179.625 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 167' ' ' CYS . . . . . 0.986 ' HB3' ' HB3' ' B' ' 158' ' ' GLN . 0.1 OUTLIER -73.68 108.42 6.51 Favored 'General case' 1 N--CA 1.375 -4.212 0 N-CA-C 107.261 -1.385 . . . . 1.56 107.261 178.15 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild core ' B' B ' 168' ' ' ALA . . . . . 0.751 ' HB1' ' HB2' ' B' ' 128' ' ' CYS . . . -83.5 -49.36 9.34 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 117.627 -1.629 . . . . 1.04 107.065 178.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 169' ' ' ALA . . . . . 0.866 ' HB3' HD11 ' B' ' 172' ' ' ILE . . . -161.08 161.54 31.3 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 112.5 -2.136 . . . . 0.98 111.03 -175.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 170' ' ' ALA . . . . . 0.871 ' HA ' ' O ' ' B' ' 185' ' ' CYS . . . -32.69 123.31 0.35 Allowed 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 114.846 1.424 . . . . 1.25 114.846 -179.143 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 171' ' ' GLY . . . . . 0.711 ' O ' ' HA ' ' B' ' 181' ' ' GLU . . . 65.16 -19.18 0.12 Allowed Glycine 0 CA--C 1.529 0.962 0 N-CA-C 116.47 1.348 . . . . 1.29 116.47 177.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 172' ' ' ILE . . . . . 0.866 HD11 ' HB3' ' B' ' 169' ' ' ALA . 2.0 pp -113.16 101.37 12.4 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 CA-C-O 122.684 1.231 . . . . 2.27 110.529 -179.33 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 173' ' ' CYS . . . . . 0.506 ' HB3' ' HB3' ' B' ' 161' ' ' CYS . 59.3 m -110.27 112.21 24.03 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 113.851 -1.522 . . . . 1.94 110.131 -178.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 174' ' ' CYS . . . . . 0.569 ' HA ' ' O ' ' B' ' 178' ' ' GLY . 5.5 m -83.66 133.75 34.81 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 113.56 0.948 . . . . 1.35 113.56 -176.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 175' ' ' SER . . . . . 0.828 ' HB2' ' HD2' ' B' ' 176' ' ' PRO . 28.3 p -95.66 -178.99 0.85 Allowed Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 113.893 -1.503 . . . . 2.0 107.238 177.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 176' ' ' PRO . . . . . 0.828 ' HD2' ' HB2' ' B' ' 175' ' ' SER . 57.4 Cg_endo -71.65 31.08 0.25 Allowed 'Trans proline' 0 CA--C 1.532 0.405 0 CA-C-N 120.584 1.244 . . . . 1.9 112.106 -179.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 177' ' ' ASP . . . . . 0.498 ' H ' ' C ' ' B' ' 175' ' ' SER . 3.0 p30 -145.58 -46.01 0.21 Allowed 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 115.906 -0.588 . . . . 2.72 111.743 179.422 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 178' ' ' GLY . . . . . 1.175 ' HA3' ' O ' ' A' ' 79' ' ' CYS . . . -161.07 -151.19 6.15 Favored Glycine 0 C--N 1.35 1.335 0 C-N-CA 120.295 -0.955 . . . . 0.99 115.033 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 179' ' ' CYS . . . . . 1.142 ' O ' ' HA3' ' A' ' 78' ' ' GLY . 32.7 m -128.66 139.35 52.29 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 122.649 1.214 . . . . 1.34 110.195 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 180' ' ' HIS . . . . . . . . . . . . . 33.3 p80 -156.87 133.11 9.79 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 123.619 1.676 . . . . 2.1 112.367 -168.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 181' ' ' GLU . . . . . 0.711 ' HA ' ' O ' ' B' ' 171' ' ' GLY . 33.8 mt-10 -49.55 123.14 7.19 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 110.967 -2.833 . . . . 3.06 110.733 -177.323 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 182' ' ' ASP . . . . . 0.403 ' HA ' ' HD3' ' B' ' 183' ' ' PRO . 0.1 OUTLIER -146.79 126.06 6.52 Favored Pre-proline 0 C--N 1.315 -0.916 0 CA-C-N 114.677 -1.147 . . . . 2.06 109.103 -179.725 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 183' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' B' ' 182' ' ' ASP . 72.5 Cg_exo -54.82 -13.53 6.26 Favored 'Trans proline' 0 N--CA 1.482 0.85 0 C-N-CA 123.981 3.121 . . . . 1.91 116.241 -177.178 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 184' ' ' ALA . . . . . 0.708 ' HB3' ' SG ' ' B' ' 161' ' ' CYS . . . -71.77 -31.59 66.78 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 114.974 1.472 . . . . 1.56 114.974 -177.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 185' ' ' CYS . . . . . 0.871 ' O ' ' HA ' ' B' ' 170' ' ' ALA . 0.1 OUTLIER -91.1 -4.55 56.16 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 115.298 1.592 . . . . 1.94 115.298 -176.329 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 186' ' ' ASP . . . . . . . . . . . . . 2.2 t70 . . . . . 0 C--N 1.321 -0.664 0 N-CA-C 113.392 0.886 . . . . 3.61 113.392 -178.753 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.608 ' HB2' ' HG2' ' A' ' 20' ' ' ARG . 77.3 m . . . . . 0 N--CA 1.463 0.214 0 CA-C-O 118.766 -0.635 . . . . 2.68 112.525 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.501 ' C ' ' O ' ' A' ' 10' ' ' CYS . 17.4 mt -30.8 136.17 0.21 Allowed Pre-proline 0 N--CA 1.477 0.884 0 CA-C-N 119.033 0.833 . . . . 2.48 111.251 177.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.776 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 41.5 Cg_endo -69.55 147.88 65.18 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.763 2.308 . . . . 1.49 114.881 -178.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.734 ' N ' ' O ' ' A' ' 19' ' ' GLY . 0.0 OUTLIER -149.91 -166.39 2.53 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-O 121.659 0.742 . . . . 1.0 110.951 176.675 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.636 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . 76.16 -159.59 50.54 Favored Glycine 0 C--N 1.337 0.624 0 CA-C-N 114.683 -1.144 . . . . 1.15 114.767 175.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.619 ' HD2' HD21 ' A' ' 32' ' ' LEU . 62.8 Cg_endo -62.1 101.94 0.25 Allowed 'Trans proline' 0 CA--C 1.511 -0.625 0 C-N-CA 124.301 3.334 . . . . 1.57 110.645 177.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.53 -7.74 75.04 Favored Glycine 0 C--N 1.268 -3.198 0 CA-C-N 113.901 -1.499 . . . . 1.68 112.422 179.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.412 ' O ' ' HB2' ' A' ' 12' ' ' PRO . . . 79.33 49.48 6.24 Favored Glycine 0 N--CA 1.397 -3.925 0 C-N-CA 119.714 -1.231 . . . . 1.36 113.515 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.73 -49.91 6.02 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 103.567 -2.753 . . . . 2.5 103.567 173.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.776 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -67.6 165.1 44.69 Favored Glycine 0 C--O 1.219 -0.816 0 C-N-CA 117.985 -2.055 . . . . 1.02 117.404 -165.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.608 ' HG2' ' HB2' ' A' ' 10' ' ' CYS . 0.1 OUTLIER -104.03 147.05 27.83 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 112.691 -1.755 . . . . 2.92 114.667 -172.864 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.448 ' O ' ' HB3' ' A' ' 10' ' ' CYS . 74.1 m -108.9 139.56 43.57 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 114.785 -1.098 . . . . 1.1 111.423 -179.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.631 ' CE1' ' HB2' ' A' ' 28' ' ' CYS . 1.4 m-85 -124.41 -9.78 7.47 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.238 -0.437 . . . . 1.51 112.065 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.491 ' HA3' ' OE2' ' B' ' 181' ' ' GLU . . . -159.05 -161.12 10.86 Favored Glycine 0 C--N 1.334 0.459 0 C-N-CA 120.677 -0.773 . . . . 0.9 112.576 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.559 ' HD2' ' HG2' ' B' ' 181' ' ' GLU . 7.6 Cg_exo -69.76 -53.02 0.29 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.967 2.445 . . . . 1.5 112.24 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.598 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.4 OUTLIER -118.78 44.25 2.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.015 -0.539 . . . . 1.26 110.841 -179.756 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 1.118 HG12 HG13 ' A' ' 36' ' ' VAL . 59.8 mt -142.52 121.21 8.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 N-CA-C 112.609 0.596 . . . . 0.83 112.609 -179.059 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.83 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 6.4 t -135.45 144.2 46.32 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-N 115.417 -0.811 . . . . 0.92 109.075 178.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.933 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 0.5 OUTLIER -136.35 157.66 46.27 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 122.361 1.076 . . . . 1.28 113.884 -177.08 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.609 ' O ' ' HB1' ' A' ' 69' ' ' ALA . . . -151.05 169.33 30.76 Favored Glycine 0 N--CA 1.416 -2.653 0 CA-C-N 113.812 -1.54 . . . . 0.67 110.561 176.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.457 ' OD2' ' HG3' ' A' ' 31' ' ' GLU . 15.3 p-10 -64.37 -48.4 75.64 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 122.79 1.281 . . . . 2.27 108.695 178.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.457 ' HG3' ' OD2' ' A' ' 30' ' ' ASP . 1.3 mt-10 -120.38 17.15 12.21 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 113.149 -1.842 . . . . 1.66 109.157 179.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.756 HD23 ' CZ ' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -120.2 -2.71 10.1 Favored 'General case' 0 N--CA 1.411 -2.422 0 C-N-CA 123.71 0.804 . . . . 1.37 109.334 -177.275 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.933 ' O ' ' HA ' ' A' ' 28' ' ' CYS . . . 47.63 -131.41 16.42 Favored Glycine 0 N--CA 1.433 -1.557 0 CA-C-N 114.887 -1.051 . . . . 0.73 113.616 178.041 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.893 ' HB2' HD13 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -138.68 113.27 8.96 Favored 'General case' 0 CA--C 1.481 -1.699 0 CA-C-N 118.546 1.173 . . . . 1.08 112.119 179.365 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.756 ' CZ ' HD23 ' A' ' 32' ' ' LEU . 26.5 m-85 -86.49 108.12 18.39 Favored 'General case' 0 N--CA 1.425 -1.722 0 N-CA-C 104.993 -2.225 . . . . 1.38 104.993 176.063 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 1.118 HG13 HG12 ' A' ' 26' ' ' ILE . 5.1 t -91.77 85.42 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.756 0 C-N-CA 118.341 -1.344 . . . . 0.76 108.933 -179.098 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.736 ' HA3' HG22 ' B' ' 172' ' ' ILE . . . 89.37 108.12 1.18 Allowed Glycine 0 CA--C 1.524 0.655 0 CA-C-N 112.918 -1.946 . . . . 0.81 115.159 179.179 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.511 HG21 ' HB3' ' A' ' 35' ' ' PHE . 0.1 OUTLIER 179.36 168.31 1.06 Allowed 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 107.904 -1.147 . . . . 0.77 107.904 178.588 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.887 ' HA ' HD12 ' A' ' 42' ' ' LEU . . . -55.52 -32.93 63.34 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 120.547 1.521 . . . . 1.02 114.008 -177.499 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.598 ' HG2' ' HA2' ' A' ' 14' ' ' GLY . 0.2 OUTLIER -65.27 -23.18 66.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.059 0.457 . . . . 2.32 110.561 179.712 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.584 ' O ' ' N ' ' A' ' 44' ' ' CYS . . . -95.9 -14.71 22.91 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 116.069 -0.514 . . . . 0.87 110.906 -179.042 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.887 HD12 ' HA ' ' A' ' 39' ' ' ALA . 4.7 mt -46.25 -44.37 16.32 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-N 119.042 0.837 . . . . 1.23 112.379 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.43 ' HD2' ' O ' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -61.91 -10.88 10.59 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 120.095 -0.642 . . . . 2.92 109.68 178.101 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.584 ' N ' ' O ' ' A' ' 41' ' ' ALA . 38.5 m -76.6 4.81 8.57 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 114.171 -1.377 . . . . 1.57 110.155 174.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.607 ' HB2' ' O ' ' A' ' 42' ' ' LEU . 0.7 OUTLIER -78.79 -18.6 53.88 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.982 -0.554 . . . . 3.31 111.268 179.337 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -86.92 -0.37 56.41 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.051 -0.66 . . . . 3.69 110.539 -179.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.448 -0.559 0 N-CA-C 109.537 -0.542 . . . . 3.99 109.537 177.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.434 ' HB2' ' HA ' ' A' ' 68' ' ' ALA . 17.7 p . . . . . 0 N--CA 1.453 -0.313 0 N-CA-C 108.043 -1.095 . . . . 3.12 108.043 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.633 ' HA3' ' O ' ' A' ' 67' ' ' CYS . . . -82.46 151.72 29.89 Favored Glycine 0 N--CA 1.448 -0.539 0 N-CA-C 109.726 -1.35 . . . . 2.1 109.726 -177.232 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 19.7 mm100 -101.88 77.45 1.71 Allowed 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.976 0.893 . . . . 4.36 109.655 179.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.497 ' HB2' ' HB2' ' A' ' 67' ' ' CYS . 0.0 OUTLIER -141.77 60.47 11.36 Favored Pre-proline 0 C--N 1.31 -1.13 0 N-CA-C 105.746 -1.946 . . . . 3.55 105.746 179.22 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.546 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 30.7 Cg_endo -63.6 78.18 0.14 Allowed 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 122.605 2.203 . . . . 1.54 114.887 -177.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.493 ' O ' ' O ' ' A' ' 65' ' ' GLY . 0.5 OUTLIER -99.26 -176.83 3.42 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 106.468 -1.678 . . . . 1.59 106.468 175.868 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.79 -167.02 51.36 Favored Glycine 0 N--CA 1.442 -0.963 0 C-N-CA 117.945 -2.074 . . . . 2.43 111.809 178.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 20.2 p -86.86 39.41 0.85 Allowed 'General case' 0 N--CA 1.484 1.262 0 CA-C-O 122.223 1.011 . . . . 4.11 111.642 -176.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 120.68 10.38 7.1 Favored Glycine 0 C--N 1.35 1.341 0 CA-C-N 114.013 -1.449 . . . . 2.21 113.886 -178.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.493 ' O ' ' O ' ' A' ' 61' ' ' CYS . . . -103.48 132.99 11.26 Favored Glycine 0 C--N 1.336 0.581 0 C-N-CA 119.657 -1.259 . . . . 1.62 115.401 -178.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.58 ' HB2' ' O ' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -97.29 152.98 18.34 Favored 'General case' 0 C--N 1.333 -0.126 0 C-N-CA 122.84 0.456 . . . . 3.02 110.441 178.555 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.633 ' O ' ' HA3' ' A' ' 57' ' ' GLY . 1.8 m -65.34 108.47 1.95 Allowed 'General case' 0 C--O 1.22 -0.486 0 C-N-CA 120.002 -0.679 . . . . 1.52 110.269 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.483 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . . . -81.61 -15.55 54.31 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 107.802 -1.184 . . . . 1.07 107.802 176.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.859 ' O ' ' O ' ' A' ' 70' ' ' ALA . . . -165.11 162.15 20.02 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 112.801 -2.0 . . . . 1.0 110.405 178.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.859 ' O ' ' O ' ' A' ' 69' ' ' ALA . . . -16.99 -138.11 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.078 0.951 . . . . 1.24 113.287 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.583 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . -64.55 61.11 0.07 OUTLIER Glycine 0 N--CA 1.47 0.936 0 N-CA-C 110.184 -1.166 . . . . 1.28 110.184 -179.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.893 HD13 ' HB2' ' A' ' 34' ' ' CYS . 0.7 OUTLIER -146.04 106.12 0.69 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.817 0 CA-C-N 114.731 -0.734 . . . . 2.27 109.771 174.962 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.521 ' HB2' ' HB3' ' A' ' 82' ' ' ASP . 0.0 OUTLIER -93.25 83.42 4.62 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 116.236 -0.438 . . . . 1.98 110.407 -179.556 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.861 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 0.1 OUTLIER -83.04 136.63 34.42 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.982 -0.554 . . . . 1.33 110.816 -179.914 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.699 ' HB3' ' HD2' ' A' ' 76' ' ' PRO . 5.0 m -104.76 179.4 0.94 Allowed Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.25 -0.887 . . . . 1.99 109.312 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.699 ' HD2' ' HB3' ' A' ' 75' ' ' SER . 96.4 Cg_endo -79.96 25.08 0.61 Allowed 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 121.443 1.429 . . . . 1.86 111.722 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -145.58 -41.42 0.22 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.609 -0.723 . . . . 2.65 110.213 179.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.792 ' HA3' ' O ' ' B' ' 179' ' ' CYS . . . -147.92 -135.29 2.59 Favored Glycine 0 C--N 1.337 0.601 0 C-N-CA 120.574 -0.822 . . . . 0.99 113.07 179.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.861 ' HA ' ' HA ' ' A' ' 74' ' ' CYS . 0.1 OUTLIER -146.85 156.45 43.12 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.625 0.25 . . . . 1.34 110.57 179.954 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.474 ' N ' ' O ' ' A' ' 73' ' ' CYS . 6.6 t-160 -142.42 133.76 26.32 Favored 'General case' 0 CA--C 1.519 -0.249 0 O-C-N 121.989 -0.444 . . . . 2.17 111.638 -178.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.571 ' CG ' ' HD2' ' B' ' 124' ' ' PRO . 2.3 mt-10 -58.56 128.03 35.12 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.901 -0.591 . . . . 3.05 109.717 178.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.521 ' HB3' ' HB2' ' A' ' 73' ' ' CYS . 0.0 OUTLIER -146.28 112.63 4.41 Favored Pre-proline 0 C--N 1.318 -0.799 0 CA-C-N 115.514 -0.766 . . . . 2.02 110.496 -178.928 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.458 ' HA ' ' OD2' ' A' ' 86' ' ' ASP . 1.6 Cg_endo -82.86 -4.4 11.34 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 122.691 2.261 . . . . 1.93 113.231 -179.26 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.99 -35.43 79.94 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.832 0.349 . . . . 1.53 111.048 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.583 ' O ' ' N ' ' A' ' 71' ' ' GLY . 84.4 m -93.64 49.71 1.39 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.107 -0.497 . . . . 1.88 110.869 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.458 ' OD2' ' HA ' ' A' ' 83' ' ' PRO . 16.5 m-20 . . . . . 0 N--CA 1.442 -0.827 0 N-CA-C 112.422 0.527 . . . . 3.6 112.422 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 110' ' ' CYS . . . . . 0.62 ' HB2' ' HG2' ' B' ' 120' ' ' ARG . 79.7 m . . . . . 0 N--CA 1.465 0.318 0 CA-C-O 118.745 -0.645 . . . . 2.61 112.653 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 111' ' ' LEU . . . . . 0.509 ' C ' ' O ' ' B' ' 110' ' ' CYS . 17.8 mt -29.82 136.07 0.18 Allowed Pre-proline 0 N--CA 1.475 0.796 0 CA-C-N 119.034 0.834 . . . . 2.47 111.369 178.412 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 112' ' ' PRO . . . . . 0.819 ' HA ' ' O ' ' B' ' 119' ' ' GLY . 33.6 Cg_endo -65.32 151.99 83.49 Favored 'Trans proline' 0 CA--C 1.536 0.587 0 C-N-CA 123.383 2.722 . . . . 1.47 113.541 -179.34 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.748 ' N ' ' O ' ' B' ' 119' ' ' GLY . 0.0 OUTLIER -156.77 -168.69 2.75 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.232 0.539 . . . . 1.0 111.222 175.471 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 114' ' ' GLY . . . . . 0.66 ' N ' ' SG ' ' B' ' 113' ' ' CYS . . . 76.14 -159.76 50.71 Favored Glycine 0 C--N 1.334 0.437 0 CA-C-N 115.479 -0.782 . . . . 1.16 114.902 176.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 115' ' ' PRO . . . . . 0.618 ' HD2' HD21 ' B' ' 132' ' ' LEU . 68.2 Cg_endo -62.28 98.31 0.18 Allowed 'Trans proline' 0 CA--C 1.511 -0.629 0 C-N-CA 124.215 3.277 . . . . 1.57 112.066 178.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 84.76 3.07 88.38 Favored Glycine 0 C--N 1.284 -2.312 0 CA-C-N 113.63 -1.623 . . . . 1.7 113.132 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 117' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' B' ' 112' ' ' PRO . . . 76.46 41.31 25.55 Favored Glycine 0 N--CA 1.411 -2.976 0 C-N-CA 119.75 -1.214 . . . . 1.38 115.615 176.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.99 -30.1 14.9 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-O 121.809 0.814 . . . . 2.54 110.198 177.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 119' ' ' GLY . . . . . 0.819 ' O ' ' HA ' ' B' ' 112' ' ' PRO . . . -78.65 161.39 48.07 Favored Glycine 0 C--O 1.201 -1.909 0 N-CA-C 118.745 2.258 . . . . 1.04 118.745 -175.212 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.62 ' HG2' ' HB2' ' B' ' 110' ' ' CYS . 0.1 OUTLIER -104.24 142.39 34.61 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 110.214 -2.993 . . . . 2.89 113.747 -172.55 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 121' ' ' CYS . . . . . 0.459 ' O ' ' HB3' ' B' ' 110' ' ' CYS . 73.3 m -108.51 138.98 43.92 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 114.777 -1.101 . . . . 1.07 111.23 -178.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 122' ' ' PHE . . . . . 0.65 ' CE1' ' HB2' ' B' ' 128' ' ' CYS . 1.4 m-85 -124.42 -9.67 7.46 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.185 -0.461 . . . . 1.53 112.052 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 123' ' ' GLY . . . . . 0.517 ' HA3' ' OE2' ' A' ' 81' ' ' GLU . . . -159.22 -161.3 11.06 Favored Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.6 -0.81 . . . . 0.9 112.465 179.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . 0.571 ' HD2' ' CG ' ' A' ' 81' ' ' GLU . 7.9 Cg_exo -69.54 -52.94 0.31 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.93 2.42 . . . . 1.51 112.302 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 125' ' ' SER . . . . . 0.615 ' O ' ' N ' ' B' ' 137' ' ' GLY . 0.4 OUTLIER -118.75 44.03 2.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.054 -0.521 . . . . 1.25 110.787 -179.811 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 126' ' ' ILE . . . . . 0.983 HG12 HG13 ' B' ' 136' ' ' VAL . 57.7 mt -141.8 120.95 10.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 N-CA-C 112.812 0.671 . . . . 0.85 112.812 -179.065 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 127' ' ' CYS . . . . . 0.806 ' O ' ' HA ' ' B' ' 134' ' ' CYS . 7.0 t -135.08 144.79 47.38 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.72 -0.673 . . . . 0.89 109.472 178.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 128' ' ' CYS . . . . . 0.906 ' HA ' ' O ' ' B' ' 133' ' ' GLY . 0.4 OUTLIER -138.99 153.58 48.17 Favored 'General case' 0 CA--C 1.552 1.042 0 N-CA-C 115.541 1.682 . . . . 1.23 115.541 -176.959 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 129' ' ' GLY . . . . . 0.684 ' HA3' ' HB2' ' B' ' 132' ' ' LEU . . . -143.25 165.96 26.89 Favored Glycine 0 N--CA 1.43 -1.72 0 CA-C-N 111.262 -2.699 . . . . 0.66 113.767 179.26 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 130' ' ' ASP . . . . . 0.413 ' OD2' ' HG3' ' B' ' 131' ' ' GLU . 15.4 p-10 -68.97 -41.64 77.69 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 126.028 1.731 . . . . 2.35 110.706 177.146 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 131' ' ' GLU . . . . . 0.413 ' HG3' ' OD2' ' B' ' 130' ' ' ASP . 0.5 OUTLIER -129.69 33.65 4.42 Favored 'General case' 0 CA--C 1.479 -1.78 0 CA-C-N 111.436 -2.62 . . . . 1.69 108.663 170.082 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 132' ' ' LEU . . . . . 0.73 HD23 ' CZ ' ' B' ' 135' ' ' PHE . 0.1 OUTLIER -131.2 -1.44 4.03 Favored 'General case' 0 N--CA 1.401 -2.89 0 N-CA-C 107.645 -1.242 . . . . 1.38 107.645 179.59 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 133' ' ' GLY . . . . . 0.906 ' O ' ' HA ' ' B' ' 128' ' ' CYS . . . 44.32 -133.98 6.64 Favored Glycine 0 N--CA 1.426 -1.992 0 CA-C-N 115.07 -0.968 . . . . 0.72 112.909 179.263 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 134' ' ' CYS . . . . . 0.898 ' HB2' HD13 ' B' ' 172' ' ' ILE . 0.1 OUTLIER -134.9 111.58 9.97 Favored 'General case' 0 CA--C 1.486 -1.512 0 N-CA-C 113.653 0.983 . . . . 1.08 113.653 -178.721 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 135' ' ' PHE . . . . . 0.74 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 27.5 m-85 -84.43 106.82 16.31 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 104.694 -2.336 . . . . 1.36 104.694 176.035 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 136' ' ' VAL . . . . . 0.983 HG13 HG12 ' B' ' 126' ' ' ILE . 12.6 t -92.33 84.79 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.669 0 CA-C-O 122.987 1.375 . . . . 0.75 108.65 -179.178 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 137' ' ' GLY . . . . . 0.749 ' HA3' HG22 ' A' ' 72' ' ' ILE . . . 88.65 107.95 1.07 Allowed Glycine 0 CA--C 1.523 0.579 0 CA-C-N 112.493 -2.139 . . . . 0.83 115.098 179.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 138' ' ' THR . . . . . 0.514 HG21 ' HB3' ' B' ' 135' ' ' PHE . 0.1 OUTLIER -174.01 -179.51 1.71 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 107.704 -1.221 . . . . 0.78 107.704 178.472 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 139' ' ' ALA . . . . . 0.857 ' HA ' HD12 ' B' ' 142' ' ' LEU . . . -65.07 -37.67 88.3 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 119.68 1.127 . . . . 1.04 111.393 179.309 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 140' ' ' GLU . . . . . 0.593 ' HG2' ' HA2' ' B' ' 114' ' ' GLY . 0.2 OUTLIER -62.04 -22.85 66.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.061 0.458 . . . . 2.31 111.386 -179.418 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 141' ' ' ALA . . . . . 0.608 ' O ' ' N ' ' B' ' 144' ' ' CYS . . . -93.39 -19.46 21.28 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.508 -0.769 . . . . 0.87 110.972 -179.411 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 142' ' ' LEU . . . . . 0.857 HD12 ' HA ' ' B' ' 139' ' ' ALA . 4.8 mt -43.95 -45.56 7.78 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.448 0.536 . . . . 1.24 112.448 -178.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 143' ' ' ARG . . . . . 0.503 ' HD2' ' O ' ' B' ' 112' ' ' PRO . 0.0 OUTLIER -55.56 -24.16 30.91 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 107.905 -1.146 . . . . 2.93 107.905 178.331 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 144' ' ' CYS . . . . . 0.608 ' N ' ' O ' ' B' ' 141' ' ' ALA . 35.0 m -69.61 8.49 0.65 Allowed 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 115.838 -0.619 . . . . 1.61 110.559 -179.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 145' ' ' GLN . . . . . 0.582 ' HB2' ' O ' ' B' ' 142' ' ' LEU . 0.7 OUTLIER -78.84 -20.11 50.42 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.015 -0.993 . . . . 3.35 110.838 178.399 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -86.73 -0.45 56.34 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 120.384 -0.526 . . . . 3.76 110.817 -179.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.448 -0.571 0 N-CA-C 109.491 -0.559 . . . . 4.01 109.491 177.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 156' ' ' SER . . . . . 0.439 ' HB2' ' HA ' ' B' ' 168' ' ' ALA . 9.8 p . . . . . 0 N--CA 1.439 -0.989 0 N-CA-C 110.611 -0.144 . . . . 3.11 110.611 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 157' ' ' GLY . . . . . 0.575 ' O ' ' HB2' ' B' ' 166' ' ' ARG . . . -101.39 152.85 18.89 Favored Glycine 0 CA--C 1.49 -1.498 0 N-CA-C 109.14 -1.584 . . . . 2.07 109.14 175.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 18.2 mm100 -103.79 65.81 0.83 Allowed 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 117.352 -1.739 . . . . 4.34 111.157 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 159' ' ' LYS . . . . . 0.689 ' HB2' ' HB2' ' B' ' 167' ' ' CYS . 0.0 OUTLIER -114.37 56.19 0.81 Allowed Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 113.736 -1.574 . . . . 3.54 109.815 172.343 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 160' ' ' PRO . . . . . 0.542 ' HA ' ' HA ' ' B' ' 166' ' ' ARG . 27.2 Cg_endo -62.96 79.16 0.11 Allowed 'Trans proline' 0 CA--C 1.518 -0.299 0 CA-C-N 121.584 1.602 . . . . 1.51 115.818 -173.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 161' ' ' CYS . . . . . 0.468 ' O ' ' O ' ' B' ' 165' ' ' GLY . 0.5 OUTLIER -98.89 -176.47 3.35 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 107.044 -1.465 . . . . 1.58 107.044 176.183 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 69.74 -167.03 48.58 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 118.468 -1.825 . . . . 2.37 111.826 178.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 24.4 p -85.28 41.46 0.89 Allowed 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.058 0.456 . . . . 4.07 111.717 -178.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 120.52 7.07 9.19 Favored Glycine 0 CA--C 1.536 1.346 0 CA-C-O 118.884 -0.953 . . . . 2.2 113.79 -179.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 165' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' B' ' 161' ' ' CYS . . . -102.28 134.29 11.72 Favored Glycine 0 CA--C 1.523 0.57 0 C-N-CA 118.498 -1.811 . . . . 1.62 115.388 -177.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 166' ' ' ARG . . . . . 0.575 ' HB2' ' O ' ' B' ' 157' ' ' GLY . 0.0 OUTLIER -97.3 153.17 18.21 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 114.947 -0.627 . . . . 3.05 110.352 178.603 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 167' ' ' CYS . . . . . 0.689 ' HB2' ' HB2' ' B' ' 159' ' ' LYS . 2.2 m -65.52 108.6 2.06 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 120.008 -0.677 . . . . 1.56 110.131 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 168' ' ' ALA . . . . . 0.488 ' HB3' ' SG ' ' B' ' 128' ' ' CYS . . . -78.96 -19.92 50.49 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 106.637 -1.616 . . . . 1.04 106.637 176.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 169' ' ' ALA . . . . . 0.835 ' O ' ' O ' ' B' ' 170' ' ' ALA . . . -160.89 161.37 31.76 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 111.82 -2.445 . . . . 0.98 111.036 -178.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 170' ' ' ALA . . . . . 0.835 ' O ' ' O ' ' B' ' 169' ' ' ALA . . . -18.06 -135.15 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.771 0.829 . . . . 1.25 113.217 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 171' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' B' ' 185' ' ' CYS . . . -55.85 37.49 0.01 OUTLIER Glycine 0 CA--C 1.537 1.425 0 N-CA-C 114.97 0.748 . . . . 1.29 114.97 -178.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 172' ' ' ILE . . . . . 0.898 HD13 ' HB2' ' B' ' 134' ' ' CYS . 0.7 OUTLIER -134.41 107.01 8.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-O 122.079 0.942 . . . . 2.27 111.865 -176.755 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 173' ' ' CYS . . . . . 0.528 ' HB2' ' HB3' ' B' ' 182' ' ' ASP . 0.0 OUTLIER -93.29 82.91 4.52 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.476 -0.783 . . . . 1.94 110.526 -179.623 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 174' ' ' CYS . . . . . 0.879 ' HA ' ' HA ' ' B' ' 179' ' ' CYS . 0.1 OUTLIER -83.24 136.76 34.28 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.943 -0.571 . . . . 1.35 110.797 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 175' ' ' SER . . . . . 0.685 ' HB3' ' HD2' ' B' ' 176' ' ' PRO . 5.1 m -104.79 179.41 0.94 Allowed Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.312 -0.858 . . . . 2.0 109.236 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 176' ' ' PRO . . . . . 0.685 ' HD2' ' HB3' ' B' ' 175' ' ' SER . 95.6 Cg_endo -80.01 25.13 0.61 Allowed 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 121.406 1.404 . . . . 1.9 111.674 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 177' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -145.53 -41.55 0.22 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.594 -0.73 . . . . 2.72 110.298 179.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 178' ' ' GLY . . . . . 0.799 ' HA3' ' O ' ' A' ' 79' ' ' CYS . . . -147.84 -135.18 2.58 Favored Glycine 0 C--N 1.337 0.617 0 C-N-CA 120.646 -0.788 . . . . 0.99 113.149 179.304 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 179' ' ' CYS . . . . . 0.879 ' HA ' ' HA ' ' B' ' 174' ' ' CYS . 0.1 OUTLIER -146.96 156.3 42.95 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.554 0.216 . . . . 1.34 110.604 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 180' ' ' HIS . . . . . 0.471 ' N ' ' O ' ' B' ' 173' ' ' CYS . 6.6 t-160 -142.19 133.73 26.68 Favored 'General case' 0 CA--C 1.519 -0.23 0 O-C-N 122.034 -0.416 . . . . 2.1 111.648 -178.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 181' ' ' GLU . . . . . 0.559 ' HG2' ' HD2' ' A' ' 24' ' ' PRO . 2.4 mt-10 -58.59 128.08 35.39 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.846 -0.615 . . . . 3.06 109.703 178.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 182' ' ' ASP . . . . . 0.528 ' HB3' ' HB2' ' B' ' 173' ' ' CYS . 0.0 OUTLIER -146.37 112.72 4.38 Favored Pre-proline 0 C--N 1.318 -0.764 0 CA-C-N 115.537 -0.756 . . . . 2.06 110.394 -178.87 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 183' ' ' PRO . . . . . 0.458 ' HA ' ' OD2' ' B' ' 186' ' ' ASP . 1.6 Cg_endo -82.86 -4.41 11.33 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.617 2.212 . . . . 1.91 113.302 -179.344 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -66.94 -35.39 79.88 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.89 0.376 . . . . 1.56 111.032 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 185' ' ' CYS . . . . . 0.572 ' HB2' ' O ' ' B' ' 170' ' ' ALA . 83.4 m -93.86 49.5 1.35 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.07 -0.514 . . . . 1.94 111.007 179.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 186' ' ' ASP . . . . . 0.458 ' OD2' ' HA ' ' B' ' 183' ' ' PRO . 16.8 m-20 . . . . . 0 N--CA 1.443 -0.817 0 N-CA-C 112.364 0.505 . . . . 3.61 112.364 179.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 1.009 ' HB2' ' HG2' ' A' ' 20' ' ' ARG . 53.6 m . . . . . 0 CA--C 1.54 0.568 0 N-CA-C 112.593 0.59 . . . . 2.68 112.593 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.467 ' HG ' ' HD2' ' A' ' 12' ' ' PRO . 6.0 tp -26.76 135.0 0.11 Allowed Pre-proline 0 N--CA 1.486 1.371 0 N-CA-C 113.619 0.97 . . . . 2.48 113.619 179.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.62 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 52.0 Cg_endo -75.04 145.11 30.91 Favored 'Trans proline' 0 CA--C 1.552 1.401 0 C-N-CA 123.384 2.723 . . . . 1.49 117.264 -178.299 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.433 ' O ' ' HA2' ' A' ' 17' ' ' GLY . 0.1 OUTLIER -155.31 173.57 16.46 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-N 112.625 -2.08 . . . . 1.0 115.376 -174.709 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 79.3 -159.97 45.49 Favored Glycine 0 CA--C 1.533 1.185 0 CA-C-N 114.406 -1.27 . . . . 1.15 110.657 -172.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.498 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 60.1 Cg_endo -62.25 109.26 0.8 Allowed 'Trans proline' 0 N--CA 1.488 1.185 0 C-N-CA 123.65 2.9 . . . . 1.57 110.178 178.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 74.96 5.63 76.12 Favored Glycine 0 C--N 1.293 -1.839 0 CA-C-N 114.649 -1.16 . . . . 1.68 112.071 176.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.433 ' HA2' ' O ' ' A' ' 13' ' ' CYS . . . 63.73 62.14 5.55 Favored Glycine 1 N--CA 1.396 -4.024 0 C-N-CA 118.824 -1.655 . . . . 1.36 110.524 -177.756 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.498 ' HG2' ' O ' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -100.29 17.95 20.09 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 105.878 -1.897 . . . . 2.5 105.878 168.892 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.62 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -109.26 -178.61 21.34 Favored Glycine 0 N--CA 1.426 -1.99 0 N-CA-C 117.205 1.642 . . . . 1.02 117.205 -173.087 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 1.009 ' HG2' ' HB2' ' A' ' 10' ' ' CYS . 2.9 mtp-105 -143.12 135.71 27.53 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 110.913 -2.643 . . . . 2.92 112.572 176.009 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.609 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 1.7 m -107.72 159.52 16.42 Favored 'General case' 0 C--N 1.343 0.298 0 CA-C-O 121.554 0.692 . . . . 1.1 112.701 -177.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -132.06 8.51 4.41 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 114.784 -1.098 . . . . 1.51 110.951 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -179.64 -163.9 31.14 Favored Glycine 0 C--N 1.338 0.654 0 C-N-CA 121.046 -0.597 . . . . 0.9 112.478 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.474 ' HG2' ' OE1' ' B' ' 181' ' ' GLU . 12.5 Cg_exo -69.56 -71.01 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.74 2.293 . . . . 1.5 112.305 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.596 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.5 OUTLIER -100.33 33.9 2.54 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 120.933 0.397 . . . . 1.26 110.111 179.508 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.937 HG12 HG13 ' A' ' 36' ' ' VAL . 6.3 mt -139.07 120.54 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 CA-C-N 116.173 -0.467 . . . . 0.83 111.64 -178.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.609 ' HA ' ' HA ' ' A' ' 21' ' ' CYS . 49.6 t -142.22 122.56 13.96 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.765 -0.652 . . . . 0.92 110.179 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 1.104 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -127.59 152.51 47.55 Favored 'General case' 0 CA--C 1.551 0.983 0 N-CA-C 114.521 1.304 . . . . 1.28 114.521 -177.961 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.624 ' O ' ' HB2' ' A' ' 69' ' ' ALA . . . -150.26 -176.29 23.16 Favored Glycine 0 C--N 1.354 1.575 0 N-CA-C 110.927 -0.869 . . . . 0.67 110.927 178.15 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -66.03 -54.01 31.37 Favored 'General case' 0 CA--C 1.56 1.359 0 C-N-CA 124.952 1.301 . . . . 2.27 112.211 179.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.36 -18.79 19.69 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 111.514 -2.585 . . . . 1.66 110.375 172.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.517 ' O ' ' C ' ' A' ' 33' ' ' GLY . 4.1 mt -99.9 7.6 44.76 Favored 'General case' 0 N--CA 1.4 -2.935 0 CA-C-N 115.892 -0.594 . . . . 1.37 110.749 -172.334 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 1.104 ' O ' ' HA ' ' A' ' 28' ' ' CYS . . . 24.87 -136.91 0.01 OUTLIER Glycine 0 C--O 1.21 -1.394 0 CA-C-O 118.635 -1.092 . . . . 0.73 111.959 179.165 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 1.048 ' HB2' HD13 ' A' ' 72' ' ' ILE . 1.0 OUTLIER -129.97 124.05 32.09 Favored 'General case' 0 CA--C 1.498 -1.044 0 CA-C-N 119.051 1.425 . . . . 1.08 112.422 -179.047 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.714 ' CE2' HG21 ' B' ' 138' ' ' THR . 34.7 m-85 -97.91 105.24 17.36 Favored 'General case' 0 N--CA 1.422 -1.842 0 N-CA-C 103.597 -2.742 . . . . 1.38 103.597 174.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.937 HG13 HG12 ' A' ' 26' ' ' ILE . 1.8 t -100.91 85.59 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.884 0 CA-C-O 123.152 1.453 . . . . 0.76 107.112 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.606 ' HA3' HG21 ' B' ' 172' ' ' ILE . . . 125.9 -77.7 0.38 Allowed Glycine 0 CA--C 1.524 0.607 0 CA-C-N 112.925 -1.943 . . . . 0.81 115.06 -179.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.718 HG21 ' CE2' ' B' ' 135' ' ' PHE . 9.9 t -32.2 124.95 0.3 Allowed 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 113.347 0.869 . . . . 0.77 113.347 -177.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.868 ' HA ' ' HG ' ' A' ' 42' ' ' LEU . . . -26.92 -35.02 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 114.12 -1.4 . . . . 1.02 113.409 -179.124 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.524 ' N ' ' O ' ' A' ' 38' ' ' THR . 1.7 mt-10 -48.13 -13.77 0.05 OUTLIER 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.634 0.254 . . . . 2.32 111.05 178.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.662 ' O ' ' N ' ' A' ' 44' ' ' CYS . . . -114.96 -44.42 3.03 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 109.448 -0.575 . . . . 0.87 109.448 178.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.868 ' HG ' ' HA ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -37.88 -19.49 0.01 OUTLIER 'General case' 0 C--N 1.346 0.417 0 N-CA-C 115.481 1.659 . . . . 1.23 115.481 -173.232 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.545 ' N ' HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -68.02 -13.65 62.35 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 106.575 -1.639 . . . . 2.92 106.575 174.708 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.662 ' N ' ' O ' ' A' ' 41' ' ' ALA . 64.0 m -85.42 25.12 1.07 Allowed 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 114.151 -1.386 . . . . 1.57 109.953 177.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -92.31 -18.66 23.05 Favored 'General case' 0 CA--C 1.509 -0.63 0 N-CA-C 107.859 -1.163 . . . . 3.31 107.859 176.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -86.87 5.46 36.73 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-N 115.174 -0.921 . . . . 3.69 109.222 177.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.447 -0.577 0 C-N-CA 119.962 -0.695 . . . . 3.99 109.289 177.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 48.8 m . . . . . 0 N--CA 1.467 0.397 0 N-CA-C 117.595 2.443 . . . . 3.12 117.595 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 134.71 69.94 0.07 OUTLIER Glycine 0 N--CA 1.427 -1.948 0 N-CA-C 109.975 -1.25 . . . . 2.1 109.975 -178.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 -117.95 72.89 0.87 Allowed 'General case' 0 N--CA 1.441 -0.923 0 CA-C-O 122.634 1.207 . . . . 4.36 108.032 179.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.671 ' CB ' ' HB2' ' A' ' 67' ' ' CYS . 10.0 mtmm -144.64 58.34 5.43 Favored Pre-proline 0 C--N 1.302 -1.475 0 CA-C-N 113.132 -1.849 . . . . 3.55 107.197 179.152 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.7 ' HA ' ' O ' ' A' ' 65' ' ' GLY . 37.7 Cg_endo -66.2 86.56 0.25 Allowed 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 122.605 2.204 . . . . 1.54 116.591 -177.231 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.491 ' SG ' ' HB2' ' A' ' 82' ' ' ASP . 0.5 OUTLIER -100.11 -173.44 2.43 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.308 -1.367 . . . . 1.59 107.308 175.471 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 62.83 -166.43 23.13 Favored Glycine 0 CA--C 1.519 0.331 0 C-N-CA 118.264 -1.922 . . . . 2.43 112.296 176.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 64.5 m -77.72 42.9 0.39 Allowed 'General case' 0 C--N 1.327 -0.371 0 O-C-N 122.494 -0.415 . . . . 4.11 111.75 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 110.51 11.31 19.89 Favored Glycine 0 N--CA 1.446 -0.681 0 N-CA-C 116.846 1.498 . . . . 2.21 116.846 176.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.7 ' O ' ' HA ' ' A' ' 60' ' ' PRO . . . -104.73 154.37 17.39 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 120.893 2.347 . . . . 1.62 112.902 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.479 ' HG2' ' H ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -101.12 150.13 23.25 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 121.266 0.555 . . . . 3.02 112.442 -179.763 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.671 ' HB2' ' CB ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -72.36 112.71 8.67 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 113.671 0.989 . . . . 1.52 113.671 -179.951 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.67 ' HB1' ' HB2' ' A' ' 28' ' ' CYS . . . -99.76 -16.32 18.15 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 122.514 1.15 . . . . 1.07 108.053 175.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 1.026 ' HB3' HG12 ' A' ' 72' ' ' ILE . . . -162.96 161.14 25.49 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 112.506 -2.134 . . . . 1.0 116.532 176.466 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.896 ' HA ' ' HB3' ' A' ' 85' ' ' CYS . . . -50.38 121.77 6.1 Favored 'General case' 0 C--N 1.345 0.4 0 CA-C-N 113.719 -1.582 . . . . 1.24 111.725 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.622 ' HA2' ' O ' ' A' ' 82' ' ' ASP . . . 59.83 36.49 90.13 Favored Glycine 0 N--CA 1.443 -0.885 0 N-CA-C 110.018 -1.233 . . . . 1.28 110.018 -178.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 1.048 HD13 ' HB2' ' A' ' 34' ' ' CYS . 0.5 OUTLIER -145.0 108.17 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 O-C-N 121.957 -0.731 . . . . 2.27 109.927 176.984 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -106.04 102.4 11.82 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 108.883 -0.784 . . . . 1.98 108.883 178.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.838 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 3.4 t -92.7 122.42 35.09 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 121.702 0.763 . . . . 1.33 112.283 -178.394 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.615 ' HA ' ' HA2' ' A' ' 65' ' ' GLY . 0.3 OUTLIER -90.59 -179.25 1.12 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 114.375 -1.284 . . . . 1.99 109.733 179.532 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.479 ' HD2' ' CB ' ' A' ' 75' ' ' SER . 86.3 Cg_endo -77.6 25.22 0.49 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 121.828 1.685 . . . . 1.86 113.003 -179.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -145.6 -45.75 0.21 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.921 -0.77 . . . . 2.65 108.921 178.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.561 ' HA3' ' O ' ' B' ' 179' ' ' CYS . . . -149.37 -151.62 5.53 Favored Glycine 0 N--CA 1.446 -0.667 0 CA-C-N 115.39 -0.823 . . . . 0.99 111.659 178.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.838 ' HA ' ' HA ' ' A' ' 74' ' ' CYS . 0.0 OUTLIER -146.9 162.88 37.77 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.846 -0.427 . . . . 1.34 109.846 179.798 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.57 ' HB3' ' HA3' ' B' ' 178' ' ' GLY . 0.1 OUTLIER -150.52 160.82 43.52 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.016 0.436 . . . . 2.17 111.009 -179.036 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.593 ' H ' HD11 ' B' ' 126' ' ' ILE . 0.5 OUTLIER -63.76 146.07 54.58 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.383 -0.599 . . . . 3.05 109.383 179.287 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.622 ' O ' ' HA2' ' A' ' 71' ' ' GLY . 0.8 OUTLIER -145.78 140.77 16.03 Favored Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 120.423 -0.511 . . . . 2.02 111.99 -179.462 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.493 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 5.3 Cg_exo -80.61 -20.9 7.67 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.969 2.446 . . . . 1.93 113.665 -178.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.09 -40.96 87.06 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.162 0.506 . . . . 1.53 110.682 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.896 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 93.2 m -97.21 27.09 4.32 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.779 0.8 . . . . 1.88 110.192 179.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.493 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 1.0 OUTLIER . . . . . 0 C--N 1.317 -0.843 0 CA-C-N 115.198 -0.91 . . . . 3.6 110.559 179.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 110' ' ' CYS . . . . . 0.983 ' HB2' ' HG2' ' B' ' 120' ' ' ARG . 50.9 m . . . . . 0 CA--C 1.541 0.615 0 N-CA-C 112.749 0.648 . . . . 2.61 112.749 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 111' ' ' LEU . . . . . 0.449 ' HG ' ' HD2' ' B' ' 112' ' ' PRO . 6.1 tp -24.32 134.2 0.08 OUTLIER Pre-proline 0 N--CA 1.485 1.281 0 N-CA-C 113.497 0.925 . . . . 2.47 113.497 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 112' ' ' PRO . . . . . 0.598 ' HA ' ' O ' ' B' ' 119' ' ' GLY . 29.2 Cg_endo -68.34 150.77 76.38 Favored 'Trans proline' 0 CA--C 1.547 1.127 0 C-N-CA 123.235 2.624 . . . . 1.47 114.796 -178.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -158.87 177.98 10.58 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 113.395 -1.729 . . . . 1.0 115.449 176.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . 78.06 -160.27 48.06 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 110.22 -1.152 . . . . 1.16 110.22 -175.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 115' ' ' PRO . . . . . 0.402 ' O ' ' HG2' ' B' ' 118' ' ' LYS . 54.6 Cg_endo -63.5 100.03 0.27 Allowed 'Trans proline' 0 N--CA 1.482 0.814 0 C-N-CA 123.985 3.124 . . . . 1.57 114.075 178.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 82.69 5.24 89.62 Favored Glycine 0 C--N 1.29 -2.019 0 CA-C-N 114.61 -1.177 . . . . 1.7 111.876 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . 70.44 47.62 41.73 Favored Glycine 1 N--CA 1.392 -4.288 0 C-N-CA 118.922 -1.608 . . . . 1.38 114.609 179.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 118' ' ' LYS . . . . . 0.402 ' HG2' ' O ' ' B' ' 115' ' ' PRO . 0.0 OUTLIER -91.83 15.84 12.14 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 106.827 -1.546 . . . . 2.54 106.827 175.465 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 119' ' ' GLY . . . . . 0.598 ' O ' ' HA ' ' B' ' 112' ' ' PRO . . . -113.52 -171.17 17.66 Favored Glycine 0 N--CA 1.444 -0.827 0 N-CA-C 115.79 1.076 . . . . 1.04 115.79 -175.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.983 ' HG2' ' HB2' ' B' ' 110' ' ' CYS . 1.7 mtp-105 -146.89 138.94 24.58 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 114.509 -0.845 . . . . 2.89 109.396 -179.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 121' ' ' CYS . . . . . 0.607 ' HA ' ' HA ' ' B' ' 127' ' ' CYS . 1.7 m -107.84 160.86 15.41 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.613 0.721 . . . . 1.07 112.888 -177.129 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -132.18 8.59 4.37 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 114.697 -1.138 . . . . 1.53 110.867 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -179.67 -163.99 31.32 Favored Glycine 0 C--N 1.338 0.684 0 C-N-CA 120.885 -0.674 . . . . 0.9 112.387 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . 0.468 ' HG2' ' OE1' ' A' ' 81' ' ' GLU . 12.4 Cg_exo -69.47 -71.14 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.747 2.298 . . . . 1.51 112.313 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 125' ' ' SER . . . . . 0.595 ' O ' ' N ' ' B' ' 137' ' ' GLY . 0.5 OUTLIER -100.25 34.15 2.45 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 120.973 0.416 . . . . 1.25 110.04 179.436 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 126' ' ' ILE . . . . . 0.889 HG12 HG13 ' B' ' 136' ' ' VAL . 7.8 mt -138.71 120.44 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 CA-C-N 116.083 -0.508 . . . . 0.85 111.943 -178.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 127' ' ' CYS . . . . . 0.607 ' HA ' ' HA ' ' B' ' 121' ' ' CYS . 49.1 t -142.01 122.05 13.72 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 116.156 -0.474 . . . . 0.89 110.133 -179.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 128' ' ' CYS . . . . . 1.076 ' HA ' ' O ' ' B' ' 133' ' ' GLY . 0.0 OUTLIER -124.57 157.34 35.63 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 114.218 1.192 . . . . 1.23 114.218 -178.707 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 129' ' ' GLY . . . . . 0.623 ' N ' ' O ' ' B' ' 133' ' ' GLY . . . -153.78 -177.13 26.93 Favored Glycine 0 N--CA 1.434 -1.472 0 N-CA-C 111.087 -0.805 . . . . 0.66 111.087 177.214 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 130' ' ' ASP . . . . . 0.426 ' OD2' ' HG2' ' B' ' 131' ' ' GLU . 2.4 p-10 -65.08 -53.38 46.49 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 124.337 1.055 . . . . 2.35 111.038 179.518 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 131' ' ' GLU . . . . . 0.426 ' HG2' ' OD2' ' B' ' 130' ' ' ASP . 0.0 OUTLIER -120.96 32.65 5.87 Favored 'General case' 0 CA--C 1.483 -1.613 0 N-CA-C 106.276 -1.75 . . . . 1.69 106.276 174.921 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 132' ' ' LEU . . . . . 0.571 HD22 ' HE1' ' B' ' 135' ' ' PHE . 2.1 mt -135.53 9.7 3.41 Favored 'General case' 0 N--CA 1.393 -3.28 0 N-CA-C 106.413 -1.699 . . . . 1.38 106.413 175.057 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 133' ' ' GLY . . . . . 1.076 ' O ' ' HA ' ' B' ' 128' ' ' CYS . . . 25.66 -128.87 0.03 OUTLIER Glycine 0 N--CA 1.41 -3.089 0 CA-C-N 115.29 -0.868 . . . . 0.72 114.43 178.331 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 134' ' ' CYS . . . . . 1.024 ' HB2' HD13 ' B' ' 172' ' ' ILE . 0.8 OUTLIER -134.96 125.1 25.97 Favored 'General case' 0 CA--C 1.494 -1.192 0 CA-C-N 117.326 0.563 . . . . 1.08 111.614 177.305 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 135' ' ' PHE . . . . . 0.718 ' CE2' HG21 ' A' ' 38' ' ' THR . 34.9 m-85 -99.91 104.99 16.66 Favored 'General case' 0 N--CA 1.422 -1.848 0 N-CA-C 103.29 -2.856 . . . . 1.36 103.29 174.299 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 136' ' ' VAL . . . . . 0.889 HG13 HG12 ' B' ' 126' ' ' ILE . 2.3 t -100.88 85.01 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.792 0 N-CA-C 107.093 -1.447 . . . . 0.75 107.093 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 137' ' ' GLY . . . . . 0.595 ' N ' ' O ' ' B' ' 125' ' ' SER . . . 126.27 -77.5 0.39 Allowed Glycine 0 CA--C 1.526 0.756 0 CA-C-N 113.22 -1.809 . . . . 0.83 114.83 -179.383 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 138' ' ' THR . . . . . 0.714 HG21 ' CE2' ' A' ' 35' ' ' PHE . 9.8 t -33.11 123.2 0.39 Allowed 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 114.346 1.239 . . . . 0.78 114.346 -177.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 139' ' ' ALA . . . . . 0.891 ' HA ' ' HG ' ' B' ' 142' ' ' LEU . . . -24.27 -37.93 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 113.532 -1.667 . . . . 1.04 112.787 -178.038 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 140' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' B' ' 138' ' ' THR . 1.8 mt-10 -48.05 -8.18 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 121.19 0.519 . . . . 2.31 111.92 177.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 141' ' ' ALA . . . . . 0.634 ' O ' ' N ' ' B' ' 144' ' ' CYS . . . -119.23 -45.81 2.53 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 114.941 -1.027 . . . . 0.87 110.605 177.131 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 142' ' ' LEU . . . . . 0.891 ' HG ' ' HA ' ' B' ' 139' ' ' ALA . 0.0 OUTLIER -38.22 -19.82 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 115.59 1.7 . . . . 1.24 115.59 -174.176 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 143' ' ' ARG . . . . . 0.545 ' N ' HD13 ' B' ' 142' ' ' LEU . 0.0 OUTLIER -69.77 -9.69 55.54 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 106.714 -1.587 . . . . 2.93 106.714 174.869 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 144' ' ' CYS . . . . . 0.634 ' N ' ' O ' ' B' ' 141' ' ' ALA . 66.7 m -89.25 26.38 1.65 Allowed 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.447 -0.797 . . . . 1.61 109.641 176.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -91.71 -19.11 22.98 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 3.35 107.708 175.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -86.9 5.46 36.87 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 114.985 -1.007 . . . . 3.76 109.229 178.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.447 -0.595 0 C-N-CA 120.128 -0.629 . . . . 4.01 109.324 177.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 40.2 m . . . . . 0 CA--C 1.542 0.658 0 CA-C-O 122.174 0.988 . . . . 3.11 112.326 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 111.57 77.7 0.89 Allowed Glycine 0 N--CA 1.434 -1.441 0 CA-C-N 112.668 -2.06 . . . . 2.07 112.161 175.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -119.48 60.81 0.83 Allowed 'General case' 0 N--CA 1.433 -1.29 0 CA-C-O 123.189 1.471 . . . . 4.34 108.383 176.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 159' ' ' LYS . . . . . 0.758 ' CB ' ' HB2' ' B' ' 167' ' ' CYS . 10.5 mtmm -116.08 53.68 1.04 Allowed Pre-proline 0 C--N 1.303 -1.427 0 CA-C-N 112.052 -2.34 . . . . 3.54 111.797 173.005 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 160' ' ' PRO . . . . . 0.679 ' HA ' ' O ' ' B' ' 165' ' ' GLY . 36.8 Cg_endo -66.2 87.83 0.25 Allowed 'Trans proline' 0 C--N 1.329 -0.466 0 N-CA-C 117.971 2.258 . . . . 1.51 117.971 -172.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 161' ' ' CYS . . . . . 0.471 ' SG ' ' HB2' ' B' ' 182' ' ' ASP . 0.6 OUTLIER -107.17 178.76 4.46 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 107.092 -1.447 . . . . 1.58 107.092 175.238 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 72.01 -167.34 52.88 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 118.464 -1.827 . . . . 2.37 111.325 -178.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 71.2 m -76.83 40.64 0.25 Allowed 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 120.604 -0.439 . . . . 4.07 111.222 -179.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 109.56 17.76 9.59 Favored Glycine 0 C--N 1.342 0.902 0 C-N-CA 119.019 -1.562 . . . . 2.2 116.199 175.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 165' ' ' GLY . . . . . 0.679 ' O ' ' HA ' ' B' ' 160' ' ' PRO . . . -107.23 154.28 16.65 Favored Glycine 0 C--N 1.346 1.136 0 C-N-CA 119.235 -1.46 . . . . 1.62 112.179 177.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 166' ' ' ARG . . . . . 0.41 ' HG2' ' H ' ' B' ' 166' ' ' ARG . 0.0 OUTLIER -101.89 150.19 23.44 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 112.211 0.449 . . . . 3.05 112.211 179.425 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 167' ' ' CYS . . . . . 0.758 ' HB2' ' CB ' ' B' ' 159' ' ' LYS . 0.0 OUTLIER -72.68 111.88 8.23 Favored 'General case' 0 N--CA 1.438 -1.033 0 C-N-CA 124.054 0.942 . . . . 1.56 113.335 -179.933 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 168' ' ' ALA . . . . . 0.751 ' HB1' ' HB2' ' B' ' 128' ' ' CYS . . . -89.34 -31.98 17.54 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 104.79 -2.3 . . . . 1.04 104.79 174.35 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 169' ' ' ALA . . . . . 1.054 ' HB3' HG12 ' B' ' 172' ' ' ILE . . . -151.02 158.9 44.71 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 111.27 -2.695 . . . . 0.98 116.527 -172.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 170' ' ' ALA . . . . . 0.875 ' HA ' ' HB3' ' B' ' 185' ' ' CYS . . . -51.32 122.74 8.28 Favored 'General case' 0 C--N 1.347 0.496 0 CA-C-N 113.955 -1.475 . . . . 1.25 111.139 -179.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 171' ' ' GLY . . . . . 0.561 ' HA2' ' O ' ' B' ' 182' ' ' ASP . . . 69.84 16.43 72.37 Favored Glycine 0 N--CA 1.428 -1.837 0 C-N-CA 120.642 -0.789 . . . . 1.29 112.611 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 172' ' ' ILE . . . . . 1.054 HG12 ' HB3' ' B' ' 169' ' ' ALA . 0.5 OUTLIER -134.86 110.0 12.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-O 122.05 0.928 . . . . 2.27 111.809 -177.07 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 173' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -106.08 102.04 11.49 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.865 -0.791 . . . . 1.94 108.865 178.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 174' ' ' CYS . . . . . 0.85 ' HA ' ' HA ' ' B' ' 179' ' ' CYS . 3.4 t -92.74 122.34 35.04 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 121.663 0.744 . . . . 1.35 112.33 -178.408 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 175' ' ' SER . . . . . 0.63 ' HA ' ' HA2' ' B' ' 165' ' ' GLY . 0.3 OUTLIER -90.48 -179.2 1.11 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 114.378 -1.283 . . . . 2.0 109.78 179.537 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 176' ' ' PRO . . . . . 0.484 ' HD2' ' CB ' ' B' ' 175' ' ' SER . 86.0 Cg_endo -77.67 25.25 0.5 Allowed 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 121.782 1.655 . . . . 1.9 112.969 -179.267 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 177' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -145.63 -45.61 0.21 Allowed 'General case' 0 C--O 1.237 0.403 0 N-CA-C 109.032 -0.729 . . . . 2.72 109.032 178.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 178' ' ' GLY . . . . . 0.57 ' HA3' ' HB3' ' A' ' 80' ' ' HIS . . . -149.39 -151.67 5.55 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.364 -0.835 . . . . 0.99 111.691 178.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 179' ' ' CYS . . . . . 0.85 ' HA ' ' HA ' ' B' ' 174' ' ' CYS . 0.0 OUTLIER -146.93 162.77 38.03 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.868 -0.419 . . . . 1.34 109.868 179.724 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 180' ' ' HIS . . . . . 0.56 ' HB3' ' HA3' ' A' ' 78' ' ' GLY . 0.1 OUTLIER -150.42 160.74 43.53 Favored 'General case' 0 N--CA 1.464 0.263 0 O-C-N 121.967 -0.458 . . . . 2.1 111.091 -179.117 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 181' ' ' GLU . . . . . 0.618 ' H ' HD11 ' A' ' 26' ' ' ILE . 0.5 OUTLIER -63.57 145.97 54.62 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.435 -0.58 . . . . 3.06 109.435 179.246 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 182' ' ' ASP . . . . . 0.561 ' O ' ' HA2' ' B' ' 171' ' ' GLY . 0.7 OUTLIER -145.85 140.67 15.89 Favored Pre-proline 0 CA--C 1.537 0.475 0 C-N-CA 120.523 -0.471 . . . . 2.06 111.911 -179.366 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 183' ' ' PRO . . . . . 0.504 ' O ' ' HB2' ' B' ' 186' ' ' ASP . 5.2 Cg_exo -80.5 -20.86 7.85 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.977 2.451 . . . . 1.91 113.726 -179.004 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -67.05 -40.99 87.25 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.166 0.507 . . . . 1.56 110.666 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 185' ' ' CYS . . . . . 0.875 ' HB3' ' HA ' ' B' ' 170' ' ' ALA . 85.7 m -97.06 27.06 4.26 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.778 0.799 . . . . 1.94 110.367 179.323 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 186' ' ' ASP . . . . . 0.504 ' HB2' ' O ' ' B' ' 183' ' ' PRO . 1.1 t70 . . . . . 0 C--N 1.316 -0.865 0 CA-C-N 115.048 -0.978 . . . . 3.61 110.242 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.444 -0.759 0 N-CA-C 110.175 -0.305 . . . . 2.68 110.175 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.833 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 1.6 mm? -32.44 109.92 0.31 Allowed Pre-proline 0 N--CA 1.47 0.532 0 N-CA-C 113.672 0.99 . . . . 2.48 113.672 -178.412 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -60.61 157.18 38.25 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.393 2.062 . . . . 1.49 110.267 176.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.516 ' HB3' ' N ' ' A' ' 20' ' ' ARG . 1.0 OUTLIER -159.6 169.94 22.71 Favored 'General case' 0 CA--C 1.552 1.039 0 CA-C-O 121.363 0.601 . . . . 1.0 111.642 173.468 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.778 ' HA2' ' HB3' ' A' ' 40' ' ' GLU . . . 73.49 -160.44 53.72 Favored Glycine 0 CA--C 1.502 -0.769 0 C-N-CA 120.807 -0.711 . . . . 1.15 113.725 177.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.413 ' O ' ' HG2' ' A' ' 15' ' ' PRO . 41.2 Cg_endo -66.68 96.94 0.37 Allowed 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 123.049 2.499 . . . . 1.57 117.145 178.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 86.01 -2.08 87.72 Favored Glycine 1 C--N 1.254 -4.006 0 C-N-CA 119.76 -1.21 . . . . 1.68 114.31 -172.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.46 ' HA2' ' O ' ' A' ' 13' ' ' CYS . . . 79.72 44.95 8.84 Favored Glycine 0 N--CA 1.419 -2.478 0 C-N-CA 118.881 -1.628 . . . . 1.36 114.897 176.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.6 -9.73 34.18 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 113.446 -1.377 . . . . 2.5 111.294 176.041 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.474 ' C ' ' HB3' ' A' ' 13' ' ' CYS . . . -106.32 -174.42 23.34 Favored Glycine 0 CA--C 1.504 -0.643 0 N-CA-C 107.693 -2.163 . . . . 1.02 107.693 178.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.833 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 3.5 ttp180 -129.59 171.59 12.45 Favored 'General case' 0 CA--C 1.552 1.04 0 CA-C-N 121.635 2.717 . . . . 2.92 108.7 -179.475 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.499 ' HB3' ' HG3' ' A' ' 47' ' ' GLU . 1.0 OUTLIER -107.33 143.69 35.26 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 121.28 -0.887 . . . . 1.1 112.739 -178.662 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.424 ' HE2' ' HB3' ' A' ' 20' ' ' ARG . 97.0 m-85 -156.27 57.79 0.58 Allowed 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 114.87 -1.059 . . . . 1.51 109.916 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.505 ' HA3' ' HA ' ' A' ' 76' ' ' PRO . . . 125.97 148.26 7.11 Favored Glycine 0 C--N 1.334 0.432 0 N-CA-C 111.05 -0.82 . . . . 0.9 111.05 -179.095 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.478 ' O ' ' HB1' ' A' ' 41' ' ' ALA . 53.1 Cg_exo -52.3 -75.0 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 121.932 1.755 . . . . 1.5 112.372 -179.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.528 ' HB2' ' CG ' ' B' ' 181' ' ' GLU . 2.0 m -89.37 37.87 0.88 Allowed 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 109.182 -0.673 . . . . 1.26 109.182 178.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 1.082 HG12 HG13 ' A' ' 36' ' ' VAL . 15.9 mt -147.76 102.94 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 CA-C-N 115.269 -0.878 . . . . 0.83 109.586 -179.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.707 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 0.1 OUTLIER -118.68 123.11 44.11 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.648 -0.705 . . . . 0.92 110.53 -177.785 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 1.004 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -142.25 119.4 11.42 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 117.329 2.344 . . . . 1.28 117.329 -178.423 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.465 ' O ' ' CB ' ' A' ' 69' ' ' ALA . . . -108.48 -170.53 21.21 Favored Glycine 0 C--N 1.364 2.121 0 N-CA-C 108.259 -1.936 . . . . 0.67 108.259 175.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.519 ' OD2' ' HG2' ' A' ' 31' ' ' GLU . 20.8 p-10 -64.01 -58.83 5.52 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 114.835 1.42 . . . . 2.27 114.835 -176.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.519 ' HG2' ' OD2' ' A' ' 30' ' ' ASP . 0.0 OUTLIER -108.35 6.52 26.49 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 121.466 0.651 . . . . 1.66 111.477 -177.037 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.949 HD22 ' CZ ' ' A' ' 35' ' ' PHE . 2.2 mt -108.64 -8.44 15.44 Favored 'General case' 0 N--CA 1.398 -3.048 0 N-CA-C 105.332 -2.099 . . . . 1.37 105.332 178.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 1.004 ' O ' ' HA ' ' A' ' 28' ' ' CYS . . . 49.16 -133.15 24.46 Favored Glycine 0 N--CA 1.437 -1.251 0 CA-C-N 114.237 -1.347 . . . . 0.73 112.538 177.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 1.014 ' HB2' HD13 ' A' ' 72' ' ' ILE . 1.2 t -128.42 119.12 24.34 Favored 'General case' 0 CA--C 1.492 -1.286 0 N-CA-C 114.043 1.127 . . . . 1.08 114.043 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 1.076 ' HA ' ' HA ' ' B' ' 135' ' ' PHE . 0.1 OUTLIER -95.51 102.65 14.47 Favored 'General case' 0 N--CA 1.419 -2.02 0 N-CA-C 102.705 -3.072 . . . . 1.38 102.705 173.906 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 1.082 HG13 HG12 ' A' ' 26' ' ' ILE . 3.0 t -87.93 93.65 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.916 0 CA-C-O 123.102 1.43 . . . . 0.76 107.979 -179.13 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.947 ' HA3' HG21 ' B' ' 172' ' ' ILE . . . 94.26 80.0 1.47 Allowed Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 112.089 -2.323 . . . . 0.81 114.178 -178.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.578 HG22 ' O ' ' B' ' 132' ' ' LEU . 71.5 p -159.06 163.37 36.35 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.61 -0.515 . . . . 0.77 109.61 179.034 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.18 -15.67 26.23 Favored 'General case' 0 CA--C 1.527 0.092 0 CA-C-N 118.565 0.62 . . . . 1.02 111.275 178.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.778 ' HB3' ' HA2' ' A' ' 14' ' ' GLY . 40.6 mt-10 -69.23 -13.86 62.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.944 -0.571 . . . . 2.32 109.502 177.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.851 ' O ' ' HB2' ' A' ' 44' ' ' CYS . . . -96.11 -24.11 16.46 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 115.328 -0.851 . . . . 0.87 111.121 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.3 mt -41.06 -32.95 0.28 Allowed 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.136 0.791 . . . . 1.23 113.136 -178.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 5.9 mmm-85 -71.04 -15.18 62.54 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 122.456 1.122 . . . . 2.92 109.561 178.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.851 ' HB2' ' O ' ' A' ' 41' ' ' ALA . 1.3 m -62.46 -27.58 69.22 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 112.663 -2.062 . . . . 1.57 110.699 -178.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -49.86 -41.23 44.87 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.968 0.413 . . . . 3.31 111.764 179.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -85.52 6.27 27.78 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.722 -0.391 . . . . 3.69 110.257 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.499 ' HG3' ' HB3' ' A' ' 21' ' ' CYS . 1.6 tm-20 . . . . . 0 N--CA 1.448 -0.53 0 N-CA-C 109.217 -0.66 . . . . 3.99 109.217 177.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.3 p . . . . . 0 N--CA 1.48 1.033 0 CA-C-O 120.535 0.207 . . . . 3.12 110.852 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.52 115.05 7.16 Favored Glycine 0 CA--C 1.491 -1.428 0 C-N-CA 121.316 -0.468 . . . . 2.1 112.369 -178.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -73.72 79.26 1.55 Allowed 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 108.251 -1.018 . . . . 4.36 108.251 179.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.576 ' O ' ' HA ' ' A' ' 66' ' ' ARG . 8.0 mmmt -135.45 73.87 61.73 Favored Pre-proline 0 C--N 1.31 -1.116 0 N-CA-C 106.079 -1.823 . . . . 3.55 106.079 -179.327 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.623 ' HA ' ' O ' ' A' ' 65' ' ' GLY . 74.2 Cg_endo -75.79 78.8 3.01 Favored 'Trans proline' 0 C--N 1.372 1.777 0 C-N-CA 123.323 2.682 . . . . 1.54 115.515 -177.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 2.3 p -100.72 -176.05 3.07 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 105.118 -2.178 . . . . 1.59 105.118 175.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.02 -168.03 52.31 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 118.203 -1.951 . . . . 2.43 114.444 -178.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.84 40.91 0.88 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 113.891 -1.155 . . . . 4.11 110.353 -177.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 115.48 9.55 12.74 Favored Glycine 0 CA--C 1.544 1.873 0 CA-C-N 113.847 -1.524 . . . . 2.21 115.216 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.844 ' CA ' ' HB3' ' A' ' 75' ' ' SER . . . -103.55 140.41 14.89 Favored Glycine 0 C--N 1.336 0.58 0 CA-C-N 120.529 2.165 . . . . 1.62 116.2 -178.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.576 ' HA ' ' O ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -101.73 156.51 17.45 Favored 'General case' 0 C--N 1.341 0.216 0 C-N-CA 124.496 1.118 . . . . 3.02 109.685 177.837 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.466 ' HB2' ' HB2' ' A' ' 59' ' ' LYS . 1.2 m -52.1 106.28 0.14 Allowed 'General case' 0 CA--C 1.504 -0.82 0 CA-C-N 119.283 0.947 . . . . 1.52 108.793 -179.012 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -78.53 -29.65 46.56 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 106.31 -1.737 . . . . 1.07 106.31 177.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.957 ' O ' HG13 ' A' ' 72' ' ' ILE . . . -162.08 139.04 8.21 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 113.454 -1.703 . . . . 1.0 109.925 -176.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.608 ' O ' ' O ' ' A' ' 69' ' ' ALA . . . 12.7 -143.22 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.374 1.07 . . . . 1.24 113.796 179.127 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.421 ' HA2' ' O ' ' A' ' 82' ' ' ASP . . . -73.44 65.12 1.71 Allowed Glycine 0 CA--C 1.491 -1.443 0 N-CA-C 107.513 -2.235 . . . . 1.28 107.513 179.064 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 1.035 HG21 ' HA3' ' B' ' 137' ' ' GLY . 1.7 pp -150.81 97.17 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.813 0 N-CA-C 106.161 -1.792 . . . . 2.27 106.161 167.191 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.431 ' O ' ' N ' ' A' ' 80' ' ' HIS . 3.9 t -95.62 103.26 15.12 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.317 -0.856 . . . . 1.98 111.48 -175.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.595 ' HB3' ' O ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -129.75 176.15 8.26 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 113.387 0.884 . . . . 1.33 113.387 -179.029 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.902 ' HB2' ' HD2' ' A' ' 76' ' ' PRO . 36.5 p -138.32 -179.27 1.0 Allowed Pre-proline 0 N--CA 1.462 0.15 0 CA-C-N 113.689 -1.596 . . . . 1.99 108.513 178.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.902 ' HD2' ' HB2' ' A' ' 75' ' ' SER . 77.0 Cg_endo -78.02 30.31 0.44 Allowed 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 121.449 1.433 . . . . 1.86 111.511 178.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.425 ' H ' ' C ' ' A' ' 75' ' ' SER . 0.6 OUTLIER -144.96 -34.01 0.36 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.507 -0.769 . . . . 2.65 110.864 179.816 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.595 ' O ' ' HB3' ' A' ' 74' ' ' CYS . . . -158.74 -171.98 25.28 Favored Glycine 0 C--N 1.339 0.738 0 C-N-CA 120.764 -0.732 . . . . 0.99 113.118 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.59 ' HA ' ' HA ' ' A' ' 74' ' ' CYS . 13.6 t -148.27 160.22 43.19 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 122.567 0.347 . . . . 1.34 110.664 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.431 ' N ' ' O ' ' A' ' 73' ' ' CYS . 1.8 t60 -154.71 145.92 22.84 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 120.027 -0.669 . . . . 2.17 111.659 -179.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.585 ' CG ' ' HB2' ' B' ' 125' ' ' SER . 1.8 mt-10 -64.13 132.82 51.59 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.42 -0.585 . . . . 3.05 109.42 178.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.453 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 0.3 OUTLIER -141.62 122.67 8.75 Favored Pre-proline 0 CA--C 1.541 0.621 0 CA-C-N 116.495 -0.32 . . . . 2.02 110.754 -179.08 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 82' ' ' ASP . 1.8 Cg_endo -83.7 -12.79 8.56 Favored 'Trans proline' 0 C--N 1.358 1.076 0 C-N-CA 123.17 2.58 . . . . 1.93 113.97 -177.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.87 -38.65 91.86 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.808 0.337 . . . . 1.53 111.531 -179.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.507 ' HB2' ' O ' ' A' ' 70' ' ' ALA . 78.7 m -95.24 39.7 1.11 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.034 -0.53 . . . . 1.88 111.155 -179.443 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.466 0.368 0 N-CA-C 114.744 1.386 . . . . 3.6 114.744 -178.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 110' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.44 -0.944 0 N-CA-C 109.194 -0.669 . . . . 2.61 109.194 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 111' ' ' LEU . . . . . 0.845 ' O ' ' HA ' ' B' ' 120' ' ' ARG . 1.7 mm? -34.2 109.97 0.37 Allowed Pre-proline 0 N--CA 1.469 0.507 0 N-CA-C 113.436 0.902 . . . . 2.47 113.436 -179.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 112' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -66.19 152.41 81.23 Favored 'Trans proline' 0 N--CA 1.464 -0.242 0 C-N-CA 121.84 1.693 . . . . 1.47 111.607 176.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.584 ' HB3' ' N ' ' B' ' 120' ' ' ARG . 1.0 OUTLIER -154.3 170.69 20.71 Favored 'General case' 0 CA--C 1.557 1.243 0 CA-C-O 121.185 0.517 . . . . 1.0 111.632 177.659 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 114' ' ' GLY . . . . . 0.748 ' HA2' ' HB3' ' B' ' 140' ' ' GLU . . . 74.38 -159.35 52.41 Favored Glycine 0 N--CA 1.467 0.748 0 CA-C-N 116.241 -0.436 . . . . 1.16 114.029 177.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 115' ' ' PRO . . . . . 0.476 ' O ' ' N ' ' B' ' 117' ' ' GLY . 87.6 Cg_endo -57.7 143.53 94.98 Favored 'Trans proline' 0 C--N 1.363 1.315 0 N-CA-C 102.355 -3.748 . . . . 1.57 102.355 175.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 48.06 -3.72 0.01 OUTLIER Glycine 0 C--N 1.274 -2.898 0 O-C-N 118.251 -2.78 . . . . 1.7 116.474 172.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 117' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' B' ' 115' ' ' PRO . . . 78.5 42.93 13.21 Favored Glycine 0 N--CA 1.407 -3.267 0 C-N-CA 116.695 -2.669 . . . . 1.38 114.231 177.143 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.09 -15.97 27.04 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 113.199 -1.5 . . . . 2.54 110.852 177.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . -96.26 -161.29 32.72 Favored Glycine 0 C--N 1.343 0.967 0 N-CA-C 109.074 -1.61 . . . . 1.04 109.074 179.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.845 ' HA ' ' O ' ' B' ' 111' ' ' LEU . 3.5 ttp180 -140.84 170.54 15.56 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 121.706 2.753 . . . . 2.89 106.788 177.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 121' ' ' CYS . . . . . 0.48 ' HB3' ' HG3' ' B' ' 147' ' ' GLU . 1.1 m -107.67 143.83 35.6 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 119.005 0.82 . . . . 1.07 112.83 -178.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 122' ' ' PHE . . . . . 0.434 ' HE2' ' HB3' ' B' ' 120' ' ' ARG . 97.1 m-85 -156.37 57.85 0.57 Allowed 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 114.898 -1.046 . . . . 1.53 109.897 179.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 123' ' ' GLY . . . . . 0.503 ' HA3' ' HA ' ' B' ' 176' ' ' PRO . . . 125.86 148.22 7.12 Favored Glycine 0 C--N 1.334 0.45 0 N-CA-C 110.972 -0.851 . . . . 0.9 110.972 -179.135 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . 0.471 ' O ' ' HB1' ' B' ' 141' ' ' ALA . 53.0 Cg_exo -52.27 -75.15 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 121.91 1.74 . . . . 1.51 112.312 -179.276 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 125' ' ' SER . . . . . 0.585 ' HB2' ' CG ' ' A' ' 81' ' ' GLU . 1.9 m -89.28 37.71 0.87 Allowed 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 109.242 -0.651 . . . . 1.25 109.242 178.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 126' ' ' ILE . . . . . 1.04 HG12 HG13 ' B' ' 136' ' ' VAL . 18.5 mt -147.36 102.93 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 CA-C-N 115.247 -0.888 . . . . 0.85 109.737 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 127' ' ' CYS . . . . . 0.719 ' O ' ' HA ' ' B' ' 134' ' ' CYS . 0.1 OUTLIER -118.65 123.05 44.02 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.65 -0.705 . . . . 0.89 110.511 -177.837 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 128' ' ' CYS . . . . . 0.996 ' HA ' ' O ' ' B' ' 133' ' ' GLY . 0.0 OUTLIER -141.43 120.84 13.17 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 116.642 2.09 . . . . 1.23 116.642 -178.641 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 129' ' ' GLY . . . . . 0.49 ' O ' ' HB1' ' B' ' 169' ' ' ALA . . . -110.49 -169.0 19.46 Favored Glycine 0 C--N 1.366 2.249 0 N-CA-C 107.924 -2.07 . . . . 0.66 107.924 175.304 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 130' ' ' ASP . . . . . 0.514 ' OD2' ' HG2' ' B' ' 131' ' ' GLU . 21.3 p-10 -63.88 -60.88 2.72 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 113.967 1.099 . . . . 2.35 113.967 -177.294 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 131' ' ' GLU . . . . . 0.514 ' HG2' ' OD2' ' B' ' 130' ' ' ASP . 0.1 OUTLIER -115.13 27.52 9.33 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 122.287 1.042 . . . . 1.69 111.132 -178.048 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 132' ' ' LEU . . . . . 0.968 HD22 ' CZ ' ' B' ' 135' ' ' PHE . 1.7 mt -124.02 -8.41 7.73 Favored 'General case' 0 N--CA 1.399 -3.01 0 N-CA-C 102.91 -2.996 . . . . 1.38 102.91 178.253 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 133' ' ' GLY . . . . . 0.996 ' O ' ' HA ' ' B' ' 128' ' ' CYS . . . 46.68 -130.36 11.96 Favored Glycine 0 N--CA 1.417 -2.604 0 CA-C-N 113.312 -1.767 . . . . 0.72 112.694 175.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 134' ' ' CYS . . . . . 1.011 ' HB2' HD13 ' B' ' 172' ' ' ILE . 1.5 t -130.85 118.7 21.13 Favored 'General case' 0 CA--C 1.492 -1.254 0 CA-C-N 120.166 1.983 . . . . 1.08 114.005 -179.356 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 135' ' ' PHE . . . . . 1.076 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -94.49 102.78 14.74 Favored 'General case' 0 N--CA 1.417 -2.085 0 N-CA-C 102.899 -3.0 . . . . 1.36 102.899 174.501 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 136' ' ' VAL . . . . . 1.04 HG13 HG12 ' B' ' 126' ' ' ILE . 3.8 t -87.8 93.15 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.916 0 CA-C-O 123.118 1.437 . . . . 0.75 107.968 -179.213 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 137' ' ' GLY . . . . . 1.035 ' HA3' HG21 ' A' ' 72' ' ' ILE . . . 94.67 79.62 1.46 Allowed Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 112.129 -2.305 . . . . 0.83 114.298 -178.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 138' ' ' THR . . . . . 0.654 HG22 ' O ' ' A' ' 32' ' ' LEU . 72.7 p -158.18 165.08 35.81 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.535 -0.543 . . . . 0.78 109.535 179.187 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -62.56 -14.01 37.53 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 121.107 0.479 . . . . 1.04 110.977 178.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 140' ' ' GLU . . . . . 0.748 ' HB3' ' HA2' ' B' ' 114' ' ' GLY . 40.9 mt-10 -70.15 -15.13 62.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.537 -0.756 . . . . 2.31 109.446 177.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 141' ' ' ALA . . . . . 0.815 ' O ' ' HB2' ' B' ' 144' ' ' CYS . . . -94.51 -25.48 16.84 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.37 -0.832 . . . . 0.87 110.871 -179.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 5.2 mt -40.31 -32.83 0.2 Allowed 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 113.245 0.831 . . . . 1.24 113.245 -177.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 143' ' ' ARG . . . . . . . . . . . . . 6.0 mmm-85 -69.34 -18.5 63.81 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 122.641 1.21 . . . . 2.93 109.141 177.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 144' ' ' CYS . . . . . 0.815 ' HB2' ' O ' ' B' ' 141' ' ' ALA . 1.3 m -60.94 -25.54 66.87 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 112.617 -2.083 . . . . 1.61 111.007 -177.367 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -51.1 -40.89 59.46 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.902 0.382 . . . . 3.35 111.693 178.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -85.55 6.37 27.48 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.68 -0.408 . . . . 3.76 110.211 -179.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 147' ' ' GLU . . . . . 0.48 ' HG3' ' HB3' ' B' ' 121' ' ' CYS . 1.6 tm-20 . . . . . 0 N--CA 1.449 -0.476 0 N-CA-C 109.19 -0.67 . . . . 4.01 109.19 177.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 5.5 p . . . . . 0 N--CA 1.476 0.846 0 CA-C-O 120.971 0.415 . . . . 3.11 111.495 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -56.51 115.12 5.88 Favored Glycine 0 CA--C 1.499 -0.909 0 CA-C-N 116.131 -0.486 . . . . 2.07 112.576 -178.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -76.28 67.45 2.53 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 119.157 -1.017 . . . . 4.34 109.504 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 159' ' ' LYS . . . . . 0.623 ' O ' ' HA ' ' B' ' 166' ' ' ARG . 14.8 mmmt -108.62 70.17 0.38 Allowed Pre-proline 0 C--N 1.318 -0.79 0 CA-C-N 114.043 -1.435 . . . . 3.54 110.852 174.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 160' ' ' PRO . . . . . 0.59 ' HA ' ' O ' ' B' ' 165' ' ' GLY . 68.6 Cg_endo -75.38 82.97 1.96 Allowed 'Trans proline' 0 N--CA 1.463 -0.271 0 C-N-CA 121.747 1.632 . . . . 1.51 115.582 -176.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 161' ' ' CYS . . . . . 0.403 ' N ' ' O ' ' B' ' 165' ' ' GLY . 1.8 p -93.04 -157.98 0.57 Allowed 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 113.107 -1.86 . . . . 1.58 107.279 177.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 52.95 -167.11 1.17 Allowed Glycine 0 N--CA 1.453 -0.203 0 O-C-N 119.287 -2.133 . . . . 2.37 116.938 171.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.64 41.02 0.88 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 112.849 -1.675 . . . . 4.07 110.436 -178.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 115.52 9.72 12.47 Favored Glycine 0 CA--C 1.548 2.136 0 CA-C-N 114.168 -1.378 . . . . 2.2 115.222 -179.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 165' ' ' GLY . . . . . 0.836 ' CA ' ' HB3' ' B' ' 175' ' ' SER . . . -103.93 139.5 14.55 Favored Glycine 0 N--CA 1.464 0.512 0 CA-C-N 120.327 2.064 . . . . 1.62 116.306 -179.051 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 166' ' ' ARG . . . . . 0.623 ' HA ' ' O ' ' B' ' 159' ' ' LYS . 0.0 OUTLIER -101.48 156.39 17.5 Favored 'General case' 0 C--N 1.343 0.323 0 CA-C-N 113.877 -1.162 . . . . 3.05 109.754 178.11 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 167' ' ' CYS . . . . . 0.477 ' HB2' ' HB2' ' B' ' 159' ' ' LYS . 1.2 m -52.05 106.19 0.14 Allowed 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 119.456 1.025 . . . . 1.56 108.813 -179.003 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 168' ' ' ALA . . . . . . . . . . . . . . . -79.58 -27.76 41.15 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 106.602 -1.629 . . . . 1.04 106.602 177.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 169' ' ' ALA . . . . . 0.903 ' O ' HG13 ' B' ' 172' ' ' ILE . . . -163.46 139.67 6.88 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 114.81 -1.086 . . . . 0.98 108.589 -177.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 170' ' ' ALA . . . . . 0.559 ' O ' ' O ' ' B' ' 169' ' ' ALA . . . 11.28 -139.65 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 114.489 1.292 . . . . 1.25 114.489 179.109 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 171' ' ' GLY . . . . . 0.471 ' HA2' ' O ' ' B' ' 182' ' ' ASP . . . -57.2 19.96 0.01 OUTLIER Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 115.72 1.048 . . . . 1.29 115.72 -179.121 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 172' ' ' ILE . . . . . 1.011 HD13 ' HB2' ' B' ' 134' ' ' CYS . 1.7 pp -128.3 99.81 5.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 CA-C-N 118.811 1.305 . . . . 2.27 109.529 -176.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 173' ' ' CYS . . . . . 0.427 ' HB3' ' HB3' ' B' ' 182' ' ' ASP . 4.6 t -94.9 102.95 14.82 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.317 -1.31 . . . . 1.94 111.854 -176.492 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 174' ' ' CYS . . . . . 0.595 ' HB3' ' O ' ' B' ' 178' ' ' GLY . 0.0 OUTLIER -130.0 176.44 8.06 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 113.372 0.878 . . . . 1.35 113.372 -179.118 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 175' ' ' SER . . . . . 0.882 ' HB2' ' HD2' ' B' ' 176' ' ' PRO . 35.9 p -138.42 -179.29 1.01 Allowed Pre-proline 0 N--CA 1.462 0.129 0 CA-C-N 113.666 -1.606 . . . . 2.0 108.493 178.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 176' ' ' PRO . . . . . 0.882 ' HD2' ' HB2' ' B' ' 175' ' ' SER . 77.0 Cg_endo -78.0 30.3 0.44 Allowed 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 121.445 1.43 . . . . 1.9 111.524 178.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 177' ' ' ASP . . . . . 0.426 ' H ' ' C ' ' B' ' 175' ' ' SER . 0.6 OUTLIER -145.06 -33.88 0.36 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 115.534 -0.757 . . . . 2.72 110.84 179.837 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 178' ' ' GLY . . . . . 0.595 ' O ' ' HB3' ' B' ' 174' ' ' CYS . . . -158.82 -172.04 25.42 Favored Glycine 0 C--N 1.339 0.702 0 C-N-CA 120.822 -0.704 . . . . 0.99 113.19 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 179' ' ' CYS . . . . . 0.593 ' HA ' ' HA ' ' B' ' 174' ' ' CYS . 13.6 t -148.23 160.3 43.08 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 122.536 0.335 . . . . 1.34 110.65 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 180' ' ' HIS . . . . . 0.422 ' N ' ' O ' ' B' ' 173' ' ' CYS . 1.8 t60 -154.86 145.89 22.67 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 119.968 -0.693 . . . . 2.1 111.665 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 181' ' ' GLU . . . . . 0.528 ' CG ' ' HB2' ' A' ' 25' ' ' SER . 1.8 mt-10 -64.12 132.91 51.87 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.421 -0.585 . . . . 3.06 109.421 178.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 182' ' ' ASP . . . . . 0.471 ' O ' ' HA2' ' B' ' 171' ' ' GLY . 0.3 OUTLIER -141.71 122.52 8.63 Favored Pre-proline 0 CA--C 1.541 0.613 0 CA-C-N 116.499 -0.319 . . . . 2.06 110.706 -178.984 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 183' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' B' ' 182' ' ' ASP . 1.8 Cg_endo -83.64 -12.73 8.67 Favored 'Trans proline' 0 C--N 1.359 1.097 0 C-N-CA 123.141 2.561 . . . . 1.91 114.009 -178.019 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -63.87 -38.44 91.1 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.845 0.355 . . . . 1.56 111.54 -179.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 185' ' ' CYS . . . . . 0.533 ' HB2' ' O ' ' B' ' 170' ' ' ALA . 86.0 m -95.14 39.02 1.12 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.942 -0.572 . . . . 1.94 111.468 -179.419 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 186' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.535 0.371 0 N-CA-C 115.018 1.488 . . . . 3.61 115.018 -178.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.536 ' HB3' ' HD2' ' A' ' 20' ' ' ARG . 0.5 OUTLIER . . . . . 0 CA--C 1.533 0.319 0 N-CA-C 113.207 0.818 . . . . 2.68 113.207 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.601 HD13 ' HD2' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -31.13 113.94 0.34 Allowed Pre-proline 0 N--CA 1.472 0.648 0 N-CA-C 113.244 0.831 . . . . 2.48 113.244 -179.515 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.791 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 21.9 Cg_endo -93.04 152.74 2.62 Favored 'Trans proline' 0 CA--C 1.535 0.571 0 C-N-CA 124.128 3.219 . . . . 1.49 115.279 -178.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.812 ' N ' ' O ' ' A' ' 19' ' ' GLY . 15.4 p -154.06 -160.36 1.08 Allowed 'General case' 0 C--O 1.243 0.741 0 CA-C-N 115.799 -0.637 . . . . 1.0 109.676 175.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.558 ' HA2' ' HG2' ' A' ' 40' ' ' GLU . . . 74.08 -162.95 54.47 Favored Glycine 0 C--N 1.338 0.65 0 N-CA-C 115.479 0.952 . . . . 1.15 115.479 174.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.655 ' O ' ' HD3' ' A' ' 18' ' ' LYS . 64.5 Cg_endo -61.74 104.31 0.31 Allowed 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 124.411 3.408 . . . . 1.57 110.237 177.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 86.67 -8.83 73.73 Favored Glycine 0 C--N 1.27 -3.125 0 CA-C-N 112.625 -2.08 . . . . 1.68 112.037 -178.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.782 ' O ' ' HB2' ' A' ' 12' ' ' PRO . . . 78.08 44.33 12.01 Favored Glycine 0 N--CA 1.403 -3.555 0 C-N-CA 120.258 -0.973 . . . . 1.36 114.789 179.126 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.657 ' HZ3' ' H ' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -92.8 -49.0 6.28 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 105.494 -2.039 . . . . 2.5 105.494 175.457 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.812 ' O ' ' N ' ' A' ' 13' ' ' CYS . . . -66.46 162.68 43.95 Favored Glycine 0 C--O 1.205 -1.658 0 C-N-CA 118.099 -2.001 . . . . 1.02 116.038 -165.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.536 ' HD2' ' HB3' ' A' ' 10' ' ' CYS . 0.0 OUTLIER -98.53 163.6 12.6 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 115.081 1.512 . . . . 2.92 115.081 -171.052 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.4 m -106.27 134.31 49.61 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 114.266 -1.334 . . . . 1.1 110.772 -177.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -134.26 36.3 3.21 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.208 -0.905 . . . . 1.51 109.857 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 144.93 164.43 10.61 Favored Glycine 0 CA--C 1.521 0.459 0 CA-C-N 115.802 -0.635 . . . . 0.9 112.39 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.436 ' O ' ' HB2' ' A' ' 44' ' ' CYS . 50.6 Cg_exo -52.12 -73.22 0.04 OUTLIER 'Trans proline' 0 CA--C 1.532 0.396 0 C-N-CA 122.715 2.277 . . . . 1.5 112.66 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.654 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.4 OUTLIER -90.96 42.72 1.12 Allowed 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 109.312 -0.625 . . . . 1.26 109.312 178.875 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.678 HG12 HG13 ' A' ' 36' ' ' VAL . 4.4 mt -144.9 121.14 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 N-CA-C 113.561 0.949 . . . . 0.83 113.561 -177.037 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.706 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -138.19 112.42 8.62 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.71 0.767 . . . . 0.92 110.632 178.736 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 1.091 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -131.74 118.53 20.08 Favored 'General case' 0 CA--C 1.557 1.242 0 N-CA-C 114.996 1.48 . . . . 1.28 114.996 -179.319 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.482 ' O ' ' HB2' ' A' ' 69' ' ' ALA . . . -108.22 -165.99 21.24 Favored Glycine 0 N--CA 1.428 -1.849 0 N-CA-C 107.035 -2.426 . . . . 0.67 107.035 175.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -68.51 -60.48 2.4 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 115.322 1.601 . . . . 2.27 115.322 -179.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.28 18.43 21.64 Favored 'General case' 0 CA--C 1.482 -1.639 0 CA-C-O 121.682 0.754 . . . . 1.66 111.464 -176.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.787 HD22 ' CZ ' ' A' ' 35' ' ' PHE . 1.2 mt -115.06 -24.86 8.37 Favored 'General case' 0 N--CA 1.395 -3.195 0 N-CA-C 106.396 -1.705 . . . . 1.37 106.396 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 1.091 ' O ' ' HA ' ' A' ' 28' ' ' CYS . . . 76.18 -132.63 12.97 Favored Glycine 0 N--CA 1.4 -3.713 0 CA-C-N 114.353 -1.294 . . . . 0.73 111.28 177.267 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 1.066 ' HB2' HD13 ' A' ' 72' ' ' ILE . 3.2 t -137.96 118.35 13.75 Favored 'General case' 0 CA--C 1.479 -1.758 0 CA-C-N 118.63 1.215 . . . . 1.08 111.557 178.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.982 ' HA ' ' HA ' ' B' ' 135' ' ' PHE . 0.0 OUTLIER -91.62 107.21 19.05 Favored 'General case' 0 N--CA 1.42 -1.953 0 N-CA-C 102.242 -3.244 . . . . 1.38 102.242 174.106 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.728 HG23 HG23 ' B' ' 136' ' ' VAL . 1.9 t -93.0 89.76 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.587 0 CA-C-O 122.793 1.282 . . . . 0.76 110.21 -177.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.848 ' HA3' HG21 ' B' ' 172' ' ' ILE . . . 102.76 17.44 18.96 Favored Glycine 0 CA--C 1.518 0.241 0 CA-C-N 112.962 -1.926 . . . . 0.81 116.017 178.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.826 HG21 ' CD2' ' B' ' 135' ' ' PHE . 25.9 p -95.39 164.99 12.59 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 118.505 1.152 . . . . 0.77 109.002 178.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.884 ' HA ' HD12 ' A' ' 42' ' ' LEU . . . -49.29 -29.7 6.32 Favored 'General case' 0 CA--C 1.517 -0.291 0 O-C-N 120.963 -1.086 . . . . 1.02 112.906 -177.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.558 ' HG2' ' HA2' ' A' ' 14' ' ' GLY . 1.6 mp0 -62.53 -20.65 64.86 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 120.867 -0.333 . . . . 2.32 110.125 179.217 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.747 ' O ' ' HB2' ' A' ' 44' ' ' CYS . . . -96.14 -24.07 16.45 Favored 'General case' 0 N--CA 1.428 -1.536 0 CA-C-O 119.312 -0.375 . . . . 0.87 110.468 -178.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.884 HD12 ' HA ' ' A' ' 39' ' ' ALA . 1.8 mt -57.4 -27.18 62.11 Favored 'General case' 0 C--N 1.346 0.445 0 CA-C-N 119.791 1.178 . . . . 1.23 110.095 179.223 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.498 ' HD3' ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -77.69 9.27 3.56 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 122.231 1.015 . . . . 2.92 108.901 176.816 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.747 ' HB2' ' O ' ' A' ' 41' ' ' ALA . 5.9 m -83.29 2.95 33.48 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 112.838 -1.983 . . . . 1.57 108.214 172.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 30.9 tp60 -86.84 -8.34 57.39 Favored 'General case' 0 C--N 1.35 0.595 0 O-C-N 121.384 -0.823 . . . . 3.31 110.988 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -85.98 5.29 33.91 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 119.094 -1.042 . . . . 3.69 108.762 179.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 . . . . . 0 N--CA 1.445 -0.716 0 CA-C-N 116.013 -0.539 . . . . 3.99 109.782 177.267 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.2 t . . . . . 0 CA--C 1.529 0.157 0 N-CA-C 109.193 -0.669 . . . . 3.12 109.193 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.405 ' O ' ' HB2' ' A' ' 66' ' ' ARG . . . -76.8 146.88 32.98 Favored Glycine 0 N--CA 1.433 -1.509 0 N-CA-C 110.064 -1.214 . . . . 2.1 110.064 -177.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -113.43 74.17 0.85 Allowed 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 122.153 0.978 . . . . 4.36 108.891 178.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.57 ' HB2' ' HB3' ' A' ' 67' ' ' CYS . 5.9 mmtp -144.1 58.22 5.73 Favored Pre-proline 0 C--N 1.304 -1.393 0 N-CA-C 106.579 -1.638 . . . . 3.55 106.579 178.503 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.538 ' HA ' ' O ' ' A' ' 65' ' ' GLY . 19.6 Cg_endo -59.01 80.45 0.05 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 122.437 2.091 . . . . 1.54 115.048 -177.228 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.499 ' N ' ' O ' ' A' ' 65' ' ' GLY . 0.5 OUTLIER -99.58 -178.64 3.95 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 106.449 -1.686 . . . . 1.59 106.449 175.553 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.533 ' HA3' ' CE1' ' A' ' 80' ' ' HIS . . . 70.49 -166.79 50.8 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 118.103 -1.999 . . . . 2.43 112.31 179.148 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.7 m -86.13 39.68 0.83 Allowed 'General case' 0 N--CA 1.477 0.893 0 CA-C-O 121.843 0.83 . . . . 4.11 111.354 -176.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 120.15 9.99 7.7 Favored Glycine 0 CA--C 1.543 1.789 0 CA-C-N 114.462 -1.244 . . . . 2.21 114.441 -178.111 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.538 ' O ' ' HA ' ' A' ' 60' ' ' PRO . . . -103.45 151.06 17.78 Favored Glycine 0 C--N 1.336 0.559 0 CA-C-N 119.772 1.786 . . . . 1.62 114.913 -179.121 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.405 ' HB2' ' O ' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -99.52 152.51 19.94 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 122.157 0.183 . . . . 3.02 111.048 178.731 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.57 ' HB3' ' HB2' ' A' ' 59' ' ' LYS . 42.9 t -67.6 121.83 16.73 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-O 121.037 0.446 . . . . 1.52 111.606 -179.213 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.15 -16.66 18.51 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.836 0.827 . . . . 1.07 109.021 177.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.698 ' CB ' ' HA2' ' A' ' 33' ' ' GLY . . . -170.09 160.88 8.35 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.326 -1.307 . . . . 1.0 110.756 178.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.417 ' HA ' ' HB3' ' A' ' 85' ' ' CYS . . . -61.5 138.01 58.26 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 122.045 -0.409 . . . . 1.24 111.226 178.31 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.74 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . 64.06 18.97 63.15 Favored Glycine 0 N--CA 1.467 0.756 0 CA-C-N 115.77 -0.65 . . . . 1.28 112.808 -179.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 1.066 HD13 ' HB2' ' A' ' 34' ' ' CYS . 1.3 pp -150.34 105.59 0.37 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.913 0 N-CA-C 112.116 0.413 . . . . 2.27 112.116 173.11 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.567 ' HB2' ' HB3' ' A' ' 82' ' ' ASP . 16.5 t -97.75 110.79 23.29 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 120.869 0.366 . . . . 1.98 110.32 178.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.783 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 72.1 m -92.44 138.84 31.17 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.494 0.664 . . . . 1.33 111.703 -179.336 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.809 ' HB2' ' HD2' ' A' ' 76' ' ' PRO . 54.1 p -113.26 179.55 0.77 Allowed Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 114.82 -1.082 . . . . 1.99 108.948 179.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.809 ' HD2' ' HB2' ' A' ' 75' ' ' SER . 74.0 Cg_endo -76.4 30.87 0.4 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 121.349 1.366 . . . . 1.86 111.997 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.441 ' H ' ' C ' ' A' ' 75' ' ' SER . 18.4 m-20 -144.86 -41.78 0.24 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.544 -0.753 . . . . 2.65 109.983 179.378 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.852 ' HA3' ' O ' ' B' ' 179' ' ' CYS . . . -163.63 -135.07 1.75 Allowed Glycine 0 C--N 1.336 0.551 0 C-N-CA 120.951 -0.642 . . . . 0.99 112.784 179.396 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.841 ' O ' ' HA3' ' B' ' 178' ' ' GLY . 62.7 m -148.1 157.11 43.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.06 0.457 . . . . 1.34 110.314 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.533 ' CE1' ' HA3' ' A' ' 62' ' ' GLY . 1.8 p80 -158.02 153.17 25.61 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.206 -0.598 . . . . 2.17 110.641 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.451 ' OE1' HD11 ' B' ' 126' ' ' ILE . 14.6 mp0 -63.06 140.81 58.91 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.672 -0.411 . . . . 3.05 109.983 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.599 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 2.4 p-10 -140.89 140.88 22.49 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 116.071 -0.513 . . . . 2.02 111.195 -179.328 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 82' ' ' ASP . 10.6 Cg_exo -72.48 -27.35 15.88 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 123.492 2.795 . . . . 1.93 114.571 -177.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.02 -47.44 71.41 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 107.86 -1.163 . . . . 1.53 107.86 179.074 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.74 ' O ' ' N ' ' A' ' 71' ' ' GLY . 2.0 m -99.12 77.97 2.21 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 114.181 -1.372 . . . . 1.88 107.497 176.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.599 ' HB2' ' O ' ' A' ' 82' ' ' ASP . 38.2 t0 . . . . . 0 C--N 1.321 -0.649 0 N-CA-C 114.23 1.196 . . . . 2.29 114.23 -179.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 110' ' ' CYS . . . . . 0.545 ' HB3' ' HD2' ' B' ' 120' ' ' ARG . 0.5 OUTLIER . . . . . 0 CA--C 1.531 0.242 0 N-CA-C 112.654 0.612 . . . . 2.61 112.654 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 111' ' ' LEU . . . . . 0.616 HD13 ' HD2' ' B' ' 112' ' ' PRO . 0.2 OUTLIER -31.07 113.85 0.33 Allowed Pre-proline 0 N--CA 1.469 0.508 0 N-CA-C 113.107 0.78 . . . . 2.47 113.107 -179.629 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 112' ' ' PRO . . . . . 0.853 ' HB2' ' O ' ' B' ' 117' ' ' GLY . 29.0 Cg_endo -90.72 154.31 4.17 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 124.46 3.44 . . . . 1.47 114.417 -179.074 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.829 ' N ' ' O ' ' B' ' 119' ' ' GLY . 15.3 p -156.08 -159.93 0.95 Allowed 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 109.479 -0.563 . . . . 1.0 109.479 174.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 114' ' ' GLY . . . . . 0.543 ' HA2' ' HG2' ' B' ' 140' ' ' GLU . . . 73.45 -163.24 54.78 Favored Glycine 0 C--N 1.337 0.614 0 N-CA-C 115.639 1.016 . . . . 1.16 115.639 175.014 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 115' ' ' PRO . . . . . 0.657 ' O ' ' HD3' ' B' ' 118' ' ' LYS . 67.9 Cg_endo -61.78 100.77 0.2 Allowed 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 124.361 3.374 . . . . 1.57 111.37 178.081 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 86.89 -0.14 86.14 Favored Glycine 0 C--N 1.283 -2.414 0 CA-C-N 112.688 -2.051 . . . . 1.7 112.955 -178.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 117' ' ' GLY . . . . . 0.853 ' O ' ' HB2' ' B' ' 112' ' ' PRO . . . 76.46 37.12 36.67 Favored Glycine 0 N--CA 1.416 -2.659 0 N-CA-C 115.736 1.055 . . . . 1.38 115.736 175.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 118' ' ' LYS . . . . . 0.667 ' HZ1' ' CD1' ' B' ' 132' ' ' LEU . 0.0 OUTLIER -95.69 -30.47 13.73 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 121.753 0.787 . . . . 2.54 111.763 179.448 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 119' ' ' GLY . . . . . 0.829 ' O ' ' N ' ' B' ' 113' ' ' CYS . . . -77.77 158.45 46.77 Favored Glycine 0 C--O 1.193 -2.412 0 N-CA-C 117.499 1.76 . . . . 1.04 117.499 -174.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.545 ' HD2' ' HB3' ' B' ' 110' ' ' CYS . 0.0 OUTLIER -99.84 160.35 14.37 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 111.774 -2.213 . . . . 2.89 113.363 -169.069 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 121' ' ' CYS . . . . . . . . . . . . . 1.4 m -105.43 134.01 49.25 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 114.304 -1.316 . . . . 1.07 110.734 -175.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -134.16 36.3 3.23 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.152 -0.931 . . . . 1.53 109.976 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 145.11 164.51 10.7 Favored Glycine 0 CA--C 1.521 0.445 0 CA-C-N 115.849 -0.614 . . . . 0.9 112.395 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -52.17 -73.13 0.04 OUTLIER 'Trans proline' 0 CA--C 1.532 0.411 0 C-N-CA 122.752 2.302 . . . . 1.51 112.761 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 125' ' ' SER . . . . . 0.637 ' O ' ' N ' ' B' ' 137' ' ' GLY . 0.5 OUTLIER -91.02 42.8 1.12 Allowed 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 109.251 -0.648 . . . . 1.25 109.251 178.778 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 126' ' ' ILE . . . . . 0.698 HG12 HG13 ' B' ' 136' ' ' VAL . 6.3 mt -144.51 121.06 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 N-CA-C 113.667 0.988 . . . . 0.85 113.667 -176.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 127' ' ' CYS . . . . . 0.67 ' O ' ' HA ' ' B' ' 134' ' ' CYS . 0.0 OUTLIER -138.73 111.47 7.7 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-O 121.57 0.7 . . . . 0.89 110.56 178.458 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 128' ' ' CYS . . . . . 1.146 ' HA ' ' O ' ' B' ' 133' ' ' GLY . 0.0 OUTLIER -127.53 129.36 47.23 Favored 'General case' 0 N--CA 1.439 -0.977 0 C-N-CA 124.243 1.017 . . . . 1.23 111.517 179.098 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 129' ' ' GLY . . . . . 0.481 ' O ' ' HB2' ' B' ' 169' ' ' ALA . . . -120.82 -160.35 11.07 Favored Glycine 0 N--CA 1.417 -2.598 0 N-CA-C 104.126 -3.59 . . . . 0.66 104.126 172.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -67.14 -73.23 0.14 Allowed 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 118.283 1.041 . . . . 2.35 111.702 -178.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.97 34.6 2.96 Favored 'General case' 0 CA--C 1.478 -1.792 0 CA-C-O 121.76 0.79 . . . . 1.69 110.505 -173.024 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 132' ' ' LEU . . . . . 0.805 HD22 ' CZ ' ' B' ' 135' ' ' PHE . 1.1 mt -126.49 -23.62 3.75 Favored 'General case' 0 N--CA 1.391 -3.384 0 N-CA-C 104.992 -2.225 . . . . 1.38 104.992 177.181 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 133' ' ' GLY . . . . . 1.146 ' O ' ' HA ' ' B' ' 128' ' ' CYS . . . 73.71 -135.62 20.77 Favored Glycine 1 N--CA 1.39 -4.39 0 N-CA-C 110.275 -1.13 . . . . 0.72 110.275 176.664 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 134' ' ' CYS . . . . . 1.025 ' HB2' HD13 ' B' ' 172' ' ' ILE . 3.1 t -135.97 116.34 13.63 Favored 'General case' 0 CA--C 1.495 -1.168 0 CA-C-N 118.227 1.014 . . . . 1.08 113.519 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 135' ' ' PHE . . . . . 0.982 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -88.57 106.3 18.22 Favored 'General case' 0 N--CA 1.421 -1.879 0 N-CA-C 102.59 -3.115 . . . . 1.36 102.59 175.101 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 136' ' ' VAL . . . . . 0.728 HG23 HG23 ' A' ' 36' ' ' VAL . 2.3 t -92.85 88.02 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-O 123.161 1.458 . . . . 0.75 110.233 -177.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 137' ' ' GLY . . . . . 0.827 ' HA3' HG21 ' A' ' 72' ' ' ILE . . . 102.79 18.43 15.77 Favored Glycine 0 C--N 1.32 -0.328 0 CA-C-N 112.705 -2.043 . . . . 0.83 115.916 178.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 138' ' ' THR . . . . . 0.837 HG21 ' CD2' ' A' ' 35' ' ' PHE . 30.2 p -89.76 177.04 6.61 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 118.071 0.936 . . . . 0.78 108.747 178.614 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 139' ' ' ALA . . . . . 0.875 ' HA ' HD12 ' B' ' 142' ' ' LEU . . . -58.07 -36.36 72.69 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 118.982 0.81 . . . . 1.04 110.516 179.151 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 140' ' ' GLU . . . . . 0.543 ' HG2' ' HA2' ' B' ' 114' ' ' GLY . 1.7 mp0 -59.54 -15.14 16.15 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.439 -0.346 . . . . 2.31 111.683 -179.357 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 141' ' ' ALA . . . . . 0.674 ' O ' ' HB2' ' B' ' 144' ' ' CYS . . . -99.17 -26.74 14.1 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 116.274 -0.421 . . . . 0.87 110.567 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 142' ' ' LEU . . . . . 0.875 HD12 ' HA ' ' B' ' 139' ' ' ALA . 2.2 mt -55.58 -29.22 58.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.311 0.576 . . . . 1.24 109.681 179.179 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 143' ' ' ARG . . . . . 0.534 ' HD3' ' HA ' ' B' ' 140' ' ' GLU . 0.0 OUTLIER -78.51 11.39 2.51 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 109.051 -0.722 . . . . 2.93 109.051 177.132 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 144' ' ' CYS . . . . . 0.674 ' HB2' ' O ' ' B' ' 141' ' ' ALA . 5.8 m -89.32 13.01 14.51 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 107.232 -1.396 . . . . 1.61 107.232 172.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 29.8 tp60 -88.7 -11.86 43.99 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 115.278 -0.874 . . . . 3.35 110.285 177.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -85.95 5.48 32.95 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 119.11 -1.036 . . . . 3.76 109.194 179.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 . . . . . 0 N--CA 1.444 -0.764 0 C-N-CA 120.377 -0.529 . . . . 4.01 109.784 177.322 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 1.9 t . . . . . 0 N--CA 1.45 -0.47 0 N-CA-C 108.744 -0.836 . . . . 3.11 108.744 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 157' ' ' GLY . . . . . 0.407 ' O ' ' HB2' ' B' ' 166' ' ' ARG . . . -88.85 147.16 19.61 Favored Glycine 0 CA--C 1.494 -1.228 0 N-CA-C 109.764 -1.334 . . . . 2.07 109.764 176.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -114.91 62.49 0.68 Allowed 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 117.207 -1.797 . . . . 4.34 110.293 178.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 159' ' ' LYS . . . . . 0.677 ' HB2' ' HB3' ' B' ' 167' ' ' CYS . 7.0 mmtp -117.94 53.9 1.71 Allowed Pre-proline 0 C--N 1.313 -1.02 0 CA-C-N 113.507 -1.679 . . . . 3.54 110.48 172.448 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 160' ' ' PRO . . . . . 0.495 ' HA ' ' O ' ' B' ' 165' ' ' GLY . 15.0 Cg_endo -58.47 81.33 0.05 OUTLIER 'Trans proline' 0 C--N 1.331 -0.363 0 CA-C-N 121.626 1.616 . . . . 1.51 116.072 -173.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 161' ' ' CYS . . . . . 0.489 ' N ' ' O ' ' B' ' 165' ' ' GLY . 0.5 OUTLIER -99.25 -178.29 3.87 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 106.926 -1.509 . . . . 1.58 106.926 175.762 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 162' ' ' GLY . . . . . 0.528 ' HA3' ' CE1' ' B' ' 180' ' ' HIS . . . 69.78 -166.57 49.22 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 118.301 -1.904 . . . . 2.37 112.283 178.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 2.8 m -85.75 39.95 0.82 Allowed 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.634 0.73 . . . . 4.07 111.423 -177.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 121.48 6.74 8.61 Favored Glycine 0 CA--C 1.541 1.656 0 CA-C-N 114.586 -1.188 . . . . 2.2 114.663 -179.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 165' ' ' GLY . . . . . 0.515 ' CA ' ' HA ' ' B' ' 175' ' ' SER . . . -102.14 151.74 18.41 Favored Glycine 0 CA--C 1.523 0.562 0 CA-C-N 119.909 1.855 . . . . 1.62 115.172 -177.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 166' ' ' ARG . . . . . 0.407 ' HB2' ' O ' ' B' ' 157' ' ' GLY . 0.0 OUTLIER -99.2 152.63 19.68 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 122.275 0.23 . . . . 3.05 111.046 179.459 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 167' ' ' CYS . . . . . 0.677 ' HB3' ' HB2' ' B' ' 159' ' ' LYS . 41.9 t -67.73 121.47 16.01 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-O 120.771 0.319 . . . . 1.56 111.611 -179.108 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 168' ' ' ALA . . . . . . . . . . . . . . . -96.4 -19.54 19.11 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.444 -0.947 . . . . 1.04 108.444 177.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 169' ' ' ALA . . . . . 0.69 ' CB ' ' HA2' ' B' ' 133' ' ' GLY . . . -168.68 160.99 11.06 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 113.739 -1.573 . . . . 0.98 111.898 -179.228 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 170' ' ' ALA . . . . . 0.411 ' HA ' ' HB3' ' B' ' 185' ' ' CYS . . . -61.76 138.95 58.37 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.004 0.43 . . . . 1.25 110.596 178.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 171' ' ' GLY . . . . . 0.711 ' N ' ' O ' ' B' ' 185' ' ' CYS . . . 74.43 -1.06 52.74 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 121.191 -0.528 . . . . 1.29 114.113 179.488 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 172' ' ' ILE . . . . . 1.025 HD13 ' HB2' ' B' ' 134' ' ' CYS . 1.3 pp -142.51 107.54 1.51 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.598 0 CA-C-O 121.736 0.779 . . . . 2.27 113.066 -179.29 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 173' ' ' CYS . . . . . 0.562 ' HB2' ' HB3' ' B' ' 182' ' ' ASP . 16.3 t -97.8 110.64 23.17 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.698 -0.683 . . . . 1.94 110.216 178.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 174' ' ' CYS . . . . . 0.756 ' HA ' ' HA ' ' B' ' 179' ' ' CYS . 72.0 m -92.67 138.91 31.09 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.439 0.638 . . . . 1.35 111.755 -179.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 175' ' ' SER . . . . . 0.83 ' HB2' ' HD2' ' B' ' 176' ' ' PRO . 51.7 p -113.35 179.65 0.75 Allowed Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 114.866 -1.061 . . . . 2.0 108.906 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 176' ' ' PRO . . . . . 0.83 ' HD2' ' HB2' ' B' ' 175' ' ' SER . 74.4 Cg_endo -76.39 30.78 0.4 Allowed 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 121.427 1.418 . . . . 1.9 111.918 -179.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 177' ' ' ASP . . . . . 0.439 ' H ' ' C ' ' B' ' 175' ' ' SER . 18.4 m-20 -144.71 -41.67 0.25 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.563 -0.744 . . . . 2.72 110.065 179.342 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 178' ' ' GLY . . . . . 0.841 ' HA3' ' O ' ' A' ' 79' ' ' CYS . . . -163.74 -135.11 1.76 Allowed Glycine 0 C--N 1.337 0.613 0 C-N-CA 121.041 -0.6 . . . . 0.99 112.763 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 179' ' ' CYS . . . . . 0.852 ' O ' ' HA3' ' A' ' 78' ' ' GLY . 62.3 m -148.12 157.05 43.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.949 0.404 . . . . 1.34 110.44 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 180' ' ' HIS . . . . . 0.528 ' CE1' ' HA3' ' B' ' 162' ' ' GLY . 1.8 p80 -157.89 153.2 25.9 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.285 -0.566 . . . . 2.1 110.611 -179.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 181' ' ' GLU . . . . . 0.499 ' OE1' HD11 ' A' ' 26' ' ' ILE . 14.6 mp0 -62.99 140.87 58.91 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.748 -0.381 . . . . 3.06 109.983 179.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 182' ' ' ASP . . . . . 0.588 ' O ' ' HB2' ' B' ' 186' ' ' ASP . 2.4 p-10 -141.02 140.92 22.18 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 116.11 -0.495 . . . . 2.06 111.089 -179.248 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 183' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' B' ' 182' ' ' ASP . 10.4 Cg_exo -72.53 -27.17 15.91 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 123.467 2.778 . . . . 1.91 114.665 -178.057 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -67.13 -47.35 71.37 Favored 'General case' 0 CA--C 1.507 -0.697 0 N-CA-C 107.784 -1.191 . . . . 1.56 107.784 179.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 185' ' ' CYS . . . . . 0.711 ' O ' ' N ' ' B' ' 171' ' ' GLY . 2.2 m -99.16 77.81 2.19 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 114.192 -1.367 . . . . 1.94 107.647 176.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 186' ' ' ASP . . . . . 0.588 ' HB2' ' O ' ' B' ' 182' ' ' ASP . 38.3 t0 . . . . . 0 C--N 1.321 -0.631 0 N-CA-C 114.3 1.222 . . . . 2.28 114.3 -179.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.851 ' O ' ' HG2' ' A' ' 20' ' ' ARG . 71.6 m . . . . . 0 N--CA 1.48 1.074 0 N-CA-C 114.191 1.182 . . . . 2.68 114.191 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.916 HD13 ' HD2' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -29.24 119.99 0.29 Allowed Pre-proline 0 N--CA 1.485 1.303 0 C-N-CA 123.673 0.789 . . . . 2.48 113.025 179.944 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.916 ' HD2' HD13 ' A' ' 11' ' ' LEU . 93.4 Cg_endo -72.21 155.83 55.93 Favored 'Trans proline' 0 C--N 1.358 1.054 0 C-N-CA 124.517 3.478 . . . . 1.49 116.408 -176.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.671 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 15.6 p -159.82 -173.07 3.91 Favored 'General case' 0 C--O 1.268 2.061 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.309 178.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.697 ' HA2' ' HB3' ' A' ' 40' ' ' GLU . . . 76.69 -158.9 49.22 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 121.134 -0.555 . . . . 1.15 114.39 177.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.614 ' HD2' HD11 ' A' ' 32' ' ' LEU . 25.6 Cg_endo -66.51 99.09 0.42 Allowed 'Trans proline' 0 N--CA 1.49 1.305 0 C-N-CA 124.797 3.665 . . . . 1.57 112.725 178.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.43 7.51 84.62 Favored Glycine 0 C--N 1.275 -2.814 0 CA-C-N 113.622 -1.626 . . . . 1.68 111.137 -176.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.893 ' O ' ' HB2' ' A' ' 12' ' ' PRO . . . 55.71 55.78 27.09 Favored Glycine 0 N--CA 1.415 -2.709 0 CA-C-N 113.317 -1.442 . . . . 1.36 110.617 172.486 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.55 ' HE3' ' O ' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -92.53 -51.92 4.89 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 101.908 -3.367 . . . . 2.5 101.908 175.053 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.836 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -56.59 -179.08 0.46 Allowed Glycine 0 CA--C 1.533 1.173 0 CA-C-N 112.446 -2.161 . . . . 1.02 110.999 -168.342 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.851 ' HG2' ' O ' ' A' ' 10' ' ' CYS . 42.9 mtm-85 -132.33 174.22 10.46 Favored 'General case' 0 C--N 1.322 -0.587 0 O-C-N 119.999 -1.883 . . . . 2.92 112.185 -171.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 1.059 ' HB3' ' HG3' ' A' ' 47' ' ' GLU . 1.7 m -104.8 135.2 46.62 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.688 0.756 . . . . 1.1 112.496 -178.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.433 ' CD1' ' HB2' ' A' ' 28' ' ' CYS . 54.4 m-85 -144.97 39.95 1.24 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 114.525 -1.216 . . . . 1.51 109.743 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 141.95 166.35 10.86 Favored Glycine 0 CA--C 1.524 0.624 0 CA-C-N 115.6 -0.727 . . . . 0.9 111.647 -179.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.526 ' HD2' ' OE2' ' B' ' 181' ' ' GLU . 21.2 Cg_exo -65.65 -67.75 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.079 1.852 . . . . 1.5 112.147 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.782 ' C ' HG13 ' A' ' 26' ' ' ILE . 3.1 m -89.08 39.49 0.94 Allowed 'General case' 0 C--O 1.225 -0.196 0 N-CA-C 109.592 -0.522 . . . . 1.26 109.592 179.01 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 1.089 HG12 HG13 ' A' ' 36' ' ' VAL . 0.4 OUTLIER -156.0 120.73 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 N-CA-C 112.15 0.426 . . . . 0.83 112.15 -179.032 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.742 ' HB3' ' CE2' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -125.7 119.09 27.07 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 108.53 -0.915 . . . . 0.92 108.53 178.054 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.785 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 17.9 m -105.9 153.42 21.98 Favored 'General case' 0 CA--C 1.558 1.266 0 N-CA-C 112.646 0.61 . . . . 1.28 112.646 -178.289 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -143.5 167.5 26.55 Favored Glycine 0 C--N 1.373 2.589 0 N-CA-C 109.575 -1.41 . . . . 0.67 109.575 174.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.622 ' OD2' ' HG2' ' A' ' 31' ' ' GLU . 8.4 p-10 -66.37 -39.32 89.04 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 124.906 1.282 . . . . 2.27 109.459 178.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.622 ' HG2' ' OD2' ' A' ' 30' ' ' ASP . 0.9 OUTLIER -124.54 6.46 8.26 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 113.55 -1.659 . . . . 1.66 110.964 179.692 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.982 HD22 ' CE1' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -110.03 -12.7 14.5 Favored 'General case' 0 N--CA 1.423 -1.78 0 CA-C-N 115.235 -0.893 . . . . 1.37 110.626 -177.843 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 1.014 ' HA2' ' HB1' ' A' ' 69' ' ' ALA . . . 60.19 -115.3 7.45 Favored Glycine 0 N--CA 1.428 -1.869 0 CA-C-O 118.139 -1.367 . . . . 0.73 111.842 179.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 1.034 ' HB2' HD13 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -147.45 127.26 13.48 Favored 'General case' 0 CA--C 1.489 -1.375 0 CA-C-N 119.893 1.847 . . . . 1.08 112.367 179.424 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.982 ' CE1' HD22 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -101.16 100.28 10.81 Favored 'General case' 0 N--CA 1.422 -1.838 0 N-CA-C 103.101 -2.925 . . . . 1.38 103.101 174.641 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 1.089 HG13 HG12 ' A' ' 26' ' ' ILE . 2.0 t -91.98 86.12 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.669 0 CA-C-O 123.364 1.554 . . . . 0.76 107.91 -178.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.794 ' HA3' HG21 ' B' ' 172' ' ' ILE . . . 89.79 82.68 1.34 Allowed Glycine 0 CA--C 1.521 0.408 0 CA-C-N 112.338 -2.21 . . . . 0.81 113.487 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.766 HG22 ' O ' ' B' ' 132' ' ' LEU . 49.7 p -156.09 163.17 39.98 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 109.116 -0.698 . . . . 0.77 109.116 179.338 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.869 ' HA ' HD12 ' A' ' 42' ' ' LEU . . . -50.35 -35.89 29.82 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 119.729 1.149 . . . . 1.02 112.766 -178.15 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.697 ' HB3' ' HA2' ' A' ' 14' ' ' GLY . 8.5 mt-10 -58.81 -24.57 62.1 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 109.906 -0.405 . . . . 2.32 109.906 178.033 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.794 ' O ' ' HB2' ' A' ' 44' ' ' CYS . . . -78.63 -23.27 45.93 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 109.514 -0.55 . . . . 0.87 109.514 -179.478 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.869 HD12 ' HA ' ' A' ' 39' ' ' ALA . 0.5 OUTLIER -51.2 -38.72 53.95 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 121.136 -0.977 . . . . 1.23 109.821 178.804 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.795 ' HD2' ' O ' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -66.84 -5.32 11.89 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.21 -0.904 . . . . 2.92 109.986 177.348 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.794 ' HB2' ' O ' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -75.19 -1.01 21.31 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.121 -0.945 . . . . 1.57 111.726 177.122 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.97 -24.84 64.3 Favored 'General case' 0 N--CA 1.453 -0.325 0 O-C-N 121.435 -0.79 . . . . 3.31 110.581 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -84.45 3.05 38.01 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 120.165 -0.614 . . . . 3.69 110.292 179.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 1.059 ' HG3' ' HB3' ' A' ' 21' ' ' CYS . 1.7 tm-20 . . . . . 0 N--CA 1.452 -0.35 0 N-CA-C 109.58 -0.526 . . . . 3.99 109.58 177.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 10.7 m . . . . . 0 CA--C 1.54 0.576 0 N-CA-C 110.772 -0.084 . . . . 3.12 110.772 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -121.41 133.23 9.43 Favored Glycine 0 N--CA 1.435 -1.411 0 N-CA-C 110.748 -0.941 . . . . 2.1 110.748 -179.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.84 76.78 1.03 Allowed 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 107.967 -1.123 . . . . 4.36 107.967 178.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.505 ' O ' ' HA ' ' A' ' 66' ' ' ARG . 0.1 OUTLIER -130.82 71.78 82.2 Favored Pre-proline 0 C--N 1.31 -1.128 0 CA-C-N 114.163 -1.38 . . . . 3.55 107.863 -179.355 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.521 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 36.5 Cg_endo -65.1 78.28 0.21 Allowed 'Trans proline' 0 C--N 1.363 1.296 0 C-N-CA 122.406 2.071 . . . . 1.54 113.642 -178.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -95.69 -173.08 2.77 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 106.008 -1.849 . . . . 1.59 106.008 176.126 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.39 -166.35 34.3 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 118.558 -1.782 . . . . 2.43 113.182 179.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.9 m -87.77 42.48 1.05 Allowed 'General case' 0 N--CA 1.484 1.237 0 CA-C-O 122.642 1.211 . . . . 4.11 110.695 -177.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 115.37 11.09 10.94 Favored Glycine 0 CA--C 1.558 2.728 0 CA-C-N 112.859 -1.973 . . . . 2.21 114.873 -177.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.475 ' CA ' ' HB3' ' A' ' 75' ' ' SER . . . -103.87 129.05 9.72 Favored Glycine 0 N--CA 1.469 0.894 0 CA-C-N 121.477 2.638 . . . . 1.62 116.259 -178.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.749 ' HD3' ' O ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -90.92 155.17 18.94 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 108.993 -0.743 . . . . 3.02 108.993 176.606 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.479 ' SG ' ' HB3' ' A' ' 59' ' ' LYS . 74.0 m -64.8 108.31 1.71 Allowed 'General case' 0 N--CA 1.439 -0.991 0 CA-C-O 121.44 0.638 . . . . 1.52 110.309 -178.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.414 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . . . -94.57 -11.42 29.49 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.089 -0.96 . . . . 1.07 109.756 178.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 1.014 ' HB1' ' HA2' ' A' ' 33' ' ' GLY . . . -165.78 161.39 17.92 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.441 -1.254 . . . . 1.0 110.09 179.164 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.61 ' HA ' ' O ' ' A' ' 85' ' ' CYS . . . -58.02 117.31 4.2 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 113.837 1.051 . . . . 1.24 113.837 -178.315 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.741 ' HA2' ' O ' ' A' ' 82' ' ' ASP . . . 63.49 35.21 91.75 Favored Glycine 0 C--N 1.344 1.012 0 CA-C-N 115.532 -0.758 . . . . 1.28 112.301 179.002 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 1.034 HD13 ' HB2' ' A' ' 34' ' ' CYS . 1.8 pp -150.55 100.85 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.248 1.025 0 CA-C-O 121.924 0.869 . . . . 2.27 110.473 175.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.633 ' HB2' ' HB3' ' A' ' 82' ' ' ASP . 0.0 OUTLIER -85.63 92.07 8.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.696 -1.138 . . . . 1.98 110.661 -178.257 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.624 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 81.6 m -97.15 153.49 17.95 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.722 0.773 . . . . 1.33 112.513 -178.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.892 ' HB2' ' HD2' ' A' ' 76' ' ' PRO . 34.6 p -130.06 -178.97 0.9 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 114.529 -1.214 . . . . 1.99 108.8 179.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.892 ' HD2' ' HB2' ' A' ' 75' ' ' SER . 72.1 Cg_endo -78.07 26.83 0.49 Allowed 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 121.325 1.35 . . . . 1.86 111.761 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.635 ' HB2' ' CE1' ' B' ' 180' ' ' HIS . 3.0 p30 -145.95 -40.07 0.22 Allowed 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 115.786 -0.643 . . . . 2.65 111.417 179.377 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -157.08 -155.12 7.33 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 120.571 -0.823 . . . . 0.99 113.602 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.624 ' HA ' ' HA ' ' A' ' 74' ' ' CYS . 94.9 m -141.07 149.9 42.24 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 122.413 0.285 . . . . 1.34 110.394 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.608 ' CE1' ' HB2' ' B' ' 177' ' ' ASP . 79.6 t60 -140.96 126.4 18.76 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 109.453 -0.573 . . . . 2.17 109.453 -174.017 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.506 ' OE2' ' HD2' ' B' ' 124' ' ' PRO . 17.7 mt-10 -53.21 130.3 34.13 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.273 0.559 . . . . 3.05 111.748 -178.223 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.741 ' O ' ' HA2' ' A' ' 71' ' ' GLY . 0.1 OUTLIER -141.83 118.37 7.25 Favored Pre-proline 0 CA--C 1.547 0.839 0 CA-C-N 115.413 -0.812 . . . . 2.02 110.369 -179.056 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.49 ' HD3' ' HA ' ' A' ' 82' ' ' ASP . 3.7 Cg_exo -81.87 -18.86 7.52 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 122.848 2.365 . . . . 1.93 113.679 -178.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.67 -39.86 95.39 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.823 0.344 . . . . 1.53 111.739 -179.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.61 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 65.1 m -99.98 14.72 29.58 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.395 -0.366 . . . . 1.88 111.768 -179.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.426 ' HA ' ' CA ' ' A' ' 71' ' ' GLY . 0.8 OUTLIER . . . . . 0 C--N 1.322 -0.596 0 C-N-CA 121.063 -0.255 . . . . 3.6 111.413 -178.066 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 110' ' ' CYS . . . . . 0.906 ' O ' ' HG2' ' B' ' 120' ' ' ARG . 73.8 m . . . . . 0 N--CA 1.483 1.193 0 N-CA-C 115.085 1.513 . . . . 2.61 115.085 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 111' ' ' LEU . . . . . 0.93 HD13 ' HD2' ' B' ' 112' ' ' PRO . 0.2 OUTLIER -24.96 119.43 0.21 Allowed Pre-proline 0 N--CA 1.49 1.555 0 C-N-CA 123.684 0.794 . . . . 2.47 113.121 179.897 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 112' ' ' PRO . . . . . 0.972 ' HB2' ' O ' ' B' ' 117' ' ' GLY . 95.8 Cg_endo -71.61 156.13 58.11 Favored 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 124.576 3.517 . . . . 1.47 116.088 -176.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.572 ' C ' ' HA2' ' B' ' 117' ' ' GLY . 16.4 p -159.1 -171.34 3.33 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 115.92 -0.582 . . . . 1.0 111.057 177.436 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 114' ' ' GLY . . . . . 0.749 ' HA2' ' HB3' ' B' ' 140' ' ' GLU . . . 75.68 -159.46 51.08 Favored Glycine 0 CA--C 1.53 1.019 0 N-CA-C 115.069 0.788 . . . . 1.16 115.069 177.463 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 115' ' ' PRO . . . . . 0.596 ' HD2' HD11 ' B' ' 132' ' ' LEU . 22.8 Cg_endo -66.37 102.59 0.59 Allowed 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 124.748 3.632 . . . . 1.57 111.611 178.426 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 87.31 -0.35 85.47 Favored Glycine 0 C--N 1.275 -2.822 0 CA-C-N 114.368 -1.287 . . . . 1.7 111.192 -177.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 117' ' ' GLY . . . . . 0.972 ' O ' ' HB2' ' B' ' 112' ' ' PRO . . . 64.34 44.4 95.47 Favored Glycine 1 N--CA 1.395 -4.061 0 CA-C-N 114.47 -0.865 . . . . 1.38 114.098 177.465 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 118' ' ' LYS . . . . . 0.497 ' HE3' ' O ' ' B' ' 115' ' ' PRO . 0.0 OUTLIER -93.31 -29.97 15.37 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.912 -0.773 . . . . 2.54 108.912 179.742 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 119' ' ' GLY . . . . . 0.807 ' O ' ' HA ' ' B' ' 112' ' ' PRO . . . -60.97 -163.29 0.18 Allowed Glycine 0 CA--C 1.496 -1.152 0 CA-C-O 118.493 -1.171 . . . . 1.04 111.604 -176.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.906 ' HG2' ' O ' ' B' ' 110' ' ' CYS . 48.8 mtm-85 -150.83 171.55 17.03 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 120.273 2.036 . . . . 2.89 108.806 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 121' ' ' CYS . . . . . 1.032 ' HB3' ' HG3' ' B' ' 147' ' ' GLU . 1.8 m -105.3 135.78 46.04 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.693 0.758 . . . . 1.07 112.875 -178.359 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 122' ' ' PHE . . . . . 0.451 ' CD1' ' HB2' ' B' ' 128' ' ' CYS . 54.7 m-85 -145.11 39.88 1.22 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 114.466 -1.243 . . . . 1.53 109.752 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 141.89 166.4 10.86 Favored Glycine 0 CA--C 1.523 0.59 0 CA-C-N 115.624 -0.716 . . . . 0.9 111.681 -179.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . 0.506 ' HD2' ' OE2' ' A' ' 81' ' ' GLU . 21.1 Cg_exo -65.69 -67.82 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.142 1.895 . . . . 1.51 112.065 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 125' ' ' SER . . . . . 0.76 ' C ' HG13 ' B' ' 126' ' ' ILE . 3.2 m -88.97 39.51 0.93 Allowed 'General case' 0 C--O 1.225 -0.205 0 N-CA-C 109.58 -0.526 . . . . 1.25 109.58 178.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 126' ' ' ILE . . . . . 1.044 HG12 HG13 ' B' ' 136' ' ' VAL . 0.5 OUTLIER -155.75 120.32 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 N-CA-C 112.188 0.44 . . . . 0.85 112.188 -178.975 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 127' ' ' CYS . . . . . 0.762 ' HB3' ' CE2' ' B' ' 135' ' ' PHE . 0.1 OUTLIER -125.15 120.76 32.28 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 108.748 -0.834 . . . . 0.89 108.748 178.085 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 128' ' ' CYS . . . . . 0.746 ' HA ' ' O ' ' B' ' 133' ' ' GLY . 8.6 m -111.57 146.37 37.48 Favored 'General case' 0 CA--C 1.571 1.77 0 N-CA-C 114.788 1.403 . . . . 1.23 114.788 -177.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 129' ' ' GLY . . . . . . . . . . . . . . . -133.75 164.45 24.38 Favored Glycine 0 N--CA 1.421 -2.31 0 CA-C-N 114.973 -1.012 . . . . 0.66 112.065 178.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 130' ' ' ASP . . . . . 0.638 ' OD2' ' HG2' ' B' ' 131' ' ' GLU . 9.6 p-10 -72.28 -27.78 62.7 Favored 'General case' 0 C--N 1.292 -1.892 0 C-N-CA 126.275 1.83 . . . . 2.35 111.033 177.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 131' ' ' GLU . . . . . 0.638 ' HG2' ' OD2' ' B' ' 130' ' ' ASP . 1.1 pt-20 -140.49 23.85 2.3 Favored 'General case' 0 CA--C 1.482 -1.672 0 CA-C-N 114.006 -1.452 . . . . 1.69 108.506 172.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 132' ' ' LEU . . . . . 0.973 HD22 ' CE1' ' B' ' 135' ' ' PHE . 0.6 OUTLIER -123.64 -9.54 7.89 Favored 'General case' 0 N--CA 1.408 -2.544 0 N-CA-C 107.327 -1.36 . . . . 1.38 107.327 178.1 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 133' ' ' GLY . . . . . 1.015 ' HA2' ' HB1' ' B' ' 169' ' ' ALA . . . 58.93 -114.47 6.1 Favored Glycine 0 N--CA 1.408 -3.217 0 CA-C-O 117.979 -1.456 . . . . 0.72 112.423 178.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 134' ' ' CYS . . . . . 0.98 ' HB2' HD13 ' B' ' 172' ' ' ILE . 0.1 OUTLIER -148.52 124.07 10.4 Favored 'General case' 0 CA--C 1.478 -1.814 0 CA-C-N 120.326 2.063 . . . . 1.08 113.638 179.98 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 135' ' ' PHE . . . . . 0.973 ' CE1' HD22 ' B' ' 132' ' ' LEU . 0.0 OUTLIER -98.35 99.88 11.11 Favored 'General case' 0 N--CA 1.42 -1.96 0 N-CA-C 102.985 -2.969 . . . . 1.36 102.985 176.054 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 136' ' ' VAL . . . . . 1.044 HG13 HG12 ' B' ' 126' ' ' ILE . 2.3 t -91.91 85.49 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.65 0 CA-C-O 123.507 1.622 . . . . 0.75 107.875 -178.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 137' ' ' GLY . . . . . 0.739 ' HA3' HG21 ' A' ' 72' ' ' ILE . . . 90.21 81.74 1.37 Allowed Glycine 0 C--N 1.317 -0.476 0 CA-C-N 112.081 -2.327 . . . . 0.83 113.416 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 138' ' ' THR . . . . . 0.707 HG22 ' O ' ' A' ' 32' ' ' LEU . 68.7 p -148.41 176.3 10.4 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.624 -0.88 . . . . 0.78 108.624 179.158 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 139' ' ' ALA . . . . . 0.812 ' HA ' HD12 ' B' ' 142' ' ' LEU . . . -61.1 -40.93 95.62 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 119.323 0.965 . . . . 1.04 109.932 178.301 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 140' ' ' GLU . . . . . 0.749 ' HB3' ' HA2' ' B' ' 114' ' ' GLY . 7.7 mt-10 -56.53 -19.1 13.95 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.355 0.598 . . . . 2.31 111.204 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 141' ' ' ALA . . . . . 0.765 ' O ' ' HB2' ' B' ' 144' ' ' CYS . . . -83.26 -20.82 33.78 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 114.906 -1.043 . . . . 0.87 110.054 179.287 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 142' ' ' LEU . . . . . 0.812 HD12 ' HA ' ' B' ' 139' ' ' ALA . 0.5 OUTLIER -53.9 -39.73 66.04 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.939 0.876 . . . . 1.24 109.088 177.704 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 143' ' ' ARG . . . . . 0.793 ' HD2' ' O ' ' B' ' 112' ' ' PRO . 0.2 OUTLIER -67.4 -3.79 9.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.605 -1.179 . . . . 2.93 109.991 177.621 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 144' ' ' CYS . . . . . 0.765 ' HB2' ' O ' ' B' ' 141' ' ' ALA . 0.1 OUTLIER -84.39 18.23 2.31 Favored 'General case' 0 C--N 1.342 0.246 0 O-C-N 120.863 -1.148 . . . . 1.61 110.993 176.148 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.23 -27.12 47.61 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.563 0.696 . . . . 3.35 109.146 175.14 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -84.55 3.17 37.88 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.78 -0.645 . . . . 3.76 110.71 179.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 147' ' ' GLU . . . . . 1.032 ' HG3' ' HB3' ' B' ' 121' ' ' CYS . 1.7 tm-20 . . . . . 0 N--CA 1.453 -0.294 0 N-CA-C 109.607 -0.516 . . . . 4.01 109.607 177.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 156' ' ' SER . . . . . 0.414 ' HB3' ' H ' ' B' ' 157' ' ' GLY . 5.8 m . . . . . 0 N--CA 1.466 0.329 0 N-CA-C 110.874 -0.047 . . . . 3.11 110.874 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 157' ' ' GLY . . . . . 0.414 ' H ' ' HB3' ' B' ' 156' ' ' SER . . . -127.6 134.82 8.43 Favored Glycine 0 N--CA 1.44 -1.043 0 N-CA-C 110.082 -1.207 . . . . 2.07 110.082 178.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.55 67.7 0.66 Allowed 'General case' 0 N--CA 1.444 -0.746 0 CA-C-O 122.144 0.973 . . . . 4.34 109.28 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 159' ' ' LYS . . . . . 0.542 ' O ' ' HA ' ' B' ' 166' ' ' ARG . 0.1 OUTLIER -112.82 69.38 1.11 Allowed Pre-proline 0 C--N 1.315 -0.919 0 CA-C-N 113.929 -1.487 . . . . 3.54 110.634 177.046 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 160' ' ' PRO . . . . . 0.533 ' HA ' ' HA ' ' B' ' 166' ' ' ARG . 33.2 Cg_endo -64.86 79.19 0.19 Allowed 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 121.56 1.507 . . . . 1.51 114.011 -177.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 161' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -93.74 -168.95 1.99 Allowed 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 106.682 -1.599 . . . . 1.58 106.682 176.657 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 60.09 -165.38 12.33 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 118.859 -1.638 . . . . 2.37 113.407 177.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 4.1 m -87.69 42.21 1.03 Allowed 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 122.961 1.363 . . . . 4.07 110.902 -177.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 118.15 6.59 12.12 Favored Glycine 0 CA--C 1.551 2.343 0 CA-C-N 112.552 -2.113 . . . . 2.2 115.095 -179.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 165' ' ' GLY . . . . . 0.48 ' CA ' ' HB3' ' B' ' 175' ' ' SER . . . -102.36 129.59 9.94 Favored Glycine 0 N--CA 1.472 1.07 0 CA-C-N 120.835 2.317 . . . . 1.62 116.708 -177.02 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 166' ' ' ARG . . . . . 0.758 ' H ' ' HD2' ' B' ' 166' ' ' ARG . 0.0 OUTLIER -90.77 155.35 18.86 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 108.858 -0.793 . . . . 3.05 108.858 177.115 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 167' ' ' CYS . . . . . 0.49 ' SG ' ' HB3' ' B' ' 159' ' ' LYS . 69.6 m -64.87 107.86 1.6 Allowed 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 118.392 0.542 . . . . 1.56 110.136 -178.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 168' ' ' ALA . . . . . 0.459 ' HB3' ' SG ' ' B' ' 128' ' ' CYS . . . -89.32 -19.37 25.37 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 122.056 0.931 . . . . 1.04 108.626 178.242 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 169' ' ' ALA . . . . . 1.015 ' HB1' ' HA2' ' B' ' 133' ' ' GLY . . . -159.88 160.94 34.22 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 113.55 -1.659 . . . . 0.98 111.037 -176.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 170' ' ' ALA . . . . . 0.616 ' HA ' ' O ' ' B' ' 185' ' ' CYS . . . -57.91 118.09 4.99 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 113.556 0.947 . . . . 1.25 113.556 -178.326 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 171' ' ' GLY . . . . . 0.657 ' HA2' ' O ' ' B' ' 182' ' ' ASP . . . 71.81 18.79 77.72 Favored Glycine 0 CA--C 1.521 0.441 0 CA-C-N 115.689 -0.687 . . . . 1.29 114.609 177.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 172' ' ' ILE . . . . . 0.98 HD13 ' HB2' ' B' ' 134' ' ' CYS . 1.7 pp -142.32 102.07 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-O 122.458 1.123 . . . . 2.27 111.252 -178.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 173' ' ' CYS . . . . . 0.623 ' HB2' ' HB3' ' B' ' 182' ' ' ASP . 0.0 OUTLIER -85.7 92.12 8.49 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 114.126 -1.397 . . . . 1.94 110.669 -178.38 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 174' ' ' CYS . . . . . 0.646 ' HA ' ' HA ' ' B' ' 179' ' ' CYS . 81.4 m -97.51 153.52 18.1 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.655 0.741 . . . . 1.35 112.478 -178.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 175' ' ' SER . . . . . 0.906 ' HB2' ' HD2' ' B' ' 176' ' ' PRO . 35.1 p -130.02 -178.92 0.89 Allowed Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 114.494 -1.23 . . . . 2.0 108.916 179.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 176' ' ' PRO . . . . . 0.906 ' HD2' ' HB2' ' B' ' 175' ' ' SER . 72.1 Cg_endo -78.15 26.94 0.49 Allowed 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 121.339 1.359 . . . . 1.9 111.727 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 177' ' ' ASP . . . . . 0.608 ' HB2' ' CE1' ' A' ' 80' ' ' HIS . 3.0 p30 -146.07 -39.98 0.22 Allowed 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.772 -0.649 . . . . 2.72 111.357 179.374 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 178' ' ' GLY . . . . . 0.407 ' HA3' ' O ' ' A' ' 79' ' ' CYS . . . -157.12 -155.03 7.29 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 120.588 -0.815 . . . . 0.99 113.51 -179.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 179' ' ' CYS . . . . . 0.646 ' HA ' ' HA ' ' B' ' 174' ' ' CYS . 99.8 m -140.19 156.15 46.63 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 110.054 -0.35 . . . . 1.34 110.054 179.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 180' ' ' HIS . . . . . 0.635 ' CE1' ' HB2' ' A' ' 77' ' ' ASP . 81.3 t60 -150.27 124.13 9.26 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-O 121.387 0.613 . . . . 2.1 110.427 -173.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 181' ' ' GLU . . . . . 0.526 ' OE2' ' HD2' ' A' ' 24' ' ' PRO . 18.5 mt-10 -51.21 129.89 25.37 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 115.105 -0.952 . . . . 3.06 111.98 -175.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 182' ' ' ASP . . . . . 0.657 ' O ' ' HA2' ' B' ' 171' ' ' GLY . 0.1 OUTLIER -141.83 118.28 7.23 Favored Pre-proline 0 CA--C 1.546 0.807 0 CA-C-N 115.333 -0.849 . . . . 2.06 110.371 -179.066 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 183' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' B' ' 182' ' ' ASP . 3.8 Cg_exo -81.84 -18.81 7.59 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 122.813 2.342 . . . . 1.91 113.671 -178.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -63.59 -39.81 95.34 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.781 0.324 . . . . 1.56 111.684 -179.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 185' ' ' CYS . . . . . 0.616 ' O ' ' HA ' ' B' ' 170' ' ' ALA . 68.8 m -99.85 14.76 29.27 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 116.311 -0.404 . . . . 1.94 112.052 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 186' ' ' ASP . . . . . 0.448 ' HA ' ' CA ' ' B' ' 171' ' ' GLY . 0.8 OUTLIER . . . . . 0 C--N 1.322 -0.608 0 C-N-CA 121.015 -0.274 . . . . 3.61 111.71 -178.099 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.7 m . . . . . 0 CA--C 1.536 0.42 0 N-CA-C 111.646 0.239 . . . . 2.68 111.646 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.809 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 4.4 mm? -32.71 114.43 0.4 Allowed Pre-proline 0 N--CA 1.475 0.799 0 N-CA-C 112.067 0.395 . . . . 2.48 112.067 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.729 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 95.7 Cg_endo -88.89 114.45 0.7 Allowed 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.626 2.217 . . . . 1.49 114.408 -178.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.666 ' O ' ' HA2' ' A' ' 17' ' ' GLY . 13.6 p -116.86 -155.31 0.58 Allowed 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 121.586 0.708 . . . . 1.0 110.582 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.417 ' O ' ' N ' ' A' ' 16' ' ' GLY . . . 79.21 -166.46 51.48 Favored Glycine 0 CA--C 1.497 -1.063 0 CA-C-O 119.284 -0.731 . . . . 1.15 111.892 179.182 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.551 ' CG ' HD11 ' A' ' 32' ' ' LEU . 84.8 Cg_endo -64.4 83.81 0.16 Allowed 'Trans proline' 0 N--CA 1.458 -0.561 0 CA-C-N 119.712 1.756 . . . . 1.57 113.374 -178.071 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 14' ' ' GLY . . . 87.99 8.21 72.8 Favored Glycine 0 C--N 1.29 -1.979 0 CA-C-N 111.927 -2.397 . . . . 1.68 115.2 -178.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.666 ' HA2' ' O ' ' A' ' 13' ' ' CYS . . . 91.17 42.77 4.86 Favored Glycine 0 N--CA 1.435 -1.369 0 N-CA-C 118.089 1.995 . . . . 1.36 118.089 172.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.61 -15.85 26.35 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 114.372 -0.914 . . . . 2.5 113.184 177.607 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.729 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -121.31 -179.67 16.12 Favored Glycine 0 N--CA 1.469 0.879 0 CA-C-O 117.707 -1.607 . . . . 1.02 109.084 -179.026 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.809 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 4.2 mpt_? -106.33 173.05 6.48 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 121.804 2.802 . . . . 2.92 110.476 178.218 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.474 ' HB3' ' HG3' ' A' ' 47' ' ' GLU . 0.5 OUTLIER -107.66 135.63 48.78 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 110.372 -0.233 . . . . 1.1 110.372 179.523 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.6 ' HE1' ' HB2' ' A' ' 28' ' ' CYS . 96.0 m-85 -111.51 -68.96 0.9 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.837 0.351 . . . . 1.51 110.574 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -106.63 -153.12 19.72 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 111.133 -0.787 . . . . 0.9 111.133 178.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -88.5 -51.25 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 122.444 2.096 . . . . 1.5 112.1 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.648 ' O ' ' N ' ' A' ' 37' ' ' GLY . 1.2 m -98.84 29.64 3.69 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-N 116.434 -0.348 . . . . 1.26 110.467 179.504 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.987 HG12 HG13 ' A' ' 36' ' ' VAL . 6.9 mt -138.69 116.0 11.57 Favored 'Isoleucine or valine' 0 C--O 1.243 0.717 0 CA-C-O 121.528 0.68 . . . . 0.83 112.771 -178.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.765 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 0.6 OUTLIER -130.76 125.4 33.7 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 114.973 -1.012 . . . . 0.92 110.274 178.626 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.994 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 94.8 m -117.2 161.94 18.66 Favored 'General case' 0 CA--C 1.55 0.972 0 CA-C-N 115.145 -0.934 . . . . 1.28 113.432 -178.293 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.734 ' O ' ' HB1' ' A' ' 69' ' ' ALA . . . -145.48 176.38 24.52 Favored Glycine 0 C--N 1.358 1.801 0 CA-C-N 112.955 -1.929 . . . . 0.67 108.597 176.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -65.78 -53.27 42.62 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 122.367 1.08 . . . . 2.27 110.601 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -120.41 19.1 12.1 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 113.067 -1.878 . . . . 1.66 108.214 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.613 HD22 ' CZ ' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -111.97 -12.6 13.72 Favored 'General case' 0 N--CA 1.405 -2.69 0 CA-C-N 114.229 -1.35 . . . . 1.37 108.033 179.988 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.994 ' O ' ' HA ' ' A' ' 28' ' ' CYS . . . 55.95 -127.67 43.53 Favored Glycine 0 N--CA 1.419 -2.5 0 CA-C-N 114.419 -1.264 . . . . 0.73 112.107 177.399 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.889 ' HB2' HD13 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -143.91 121.36 11.7 Favored 'General case' 0 CA--C 1.493 -1.238 0 N-CA-C 114.527 1.306 . . . . 1.08 114.527 179.68 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.75 ' HA ' ' HA ' ' B' ' 135' ' ' PHE . 0.0 OUTLIER -85.94 105.79 16.66 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 102.605 -3.109 . . . . 1.38 102.605 173.861 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.987 HG13 HG12 ' A' ' 26' ' ' ILE . 2.6 t -92.8 85.53 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.702 0 C-N-CA 118.436 -1.306 . . . . 0.76 108.714 -178.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.655 ' HA3' ' CG2' ' B' ' 172' ' ' ILE . . . 96.55 76.97 1.33 Allowed Glycine 0 CA--C 1.527 0.786 0 CA-C-N 112.464 -2.153 . . . . 0.81 114.071 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.603 HG22 ' O ' ' B' ' 132' ' ' LEU . 47.1 p -155.36 176.67 12.28 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 108.482 -0.933 . . . . 0.77 108.482 178.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 1.1 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -68.9 -13.67 62.57 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-N 119.495 1.043 . . . . 1.02 109.942 178.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.432 ' HG2' ' CE2' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -64.09 -18.55 64.51 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.368 -0.975 . . . . 2.32 108.368 177.903 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.954 ' O ' ' HB2' ' A' ' 44' ' ' CYS . . . -112.14 -12.13 13.69 Favored 'General case' 0 C--O 1.217 -0.631 0 CA-C-N 115.192 -0.913 . . . . 0.87 113.034 -179.276 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 1.1 HD12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -54.32 -19.28 5.14 Favored 'General case' 0 C--N 1.323 -0.545 0 O-C-N 120.966 -1.084 . . . . 1.23 113.29 -177.497 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.769 ' N ' HD13 ' A' ' 42' ' ' LEU . 9.2 ptm85 -79.65 -14.68 58.62 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 106.56 -1.645 . . . . 2.92 106.56 174.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.954 ' HB2' ' O ' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -58.18 -22.65 52.46 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 111.393 -2.639 . . . . 1.57 108.984 -178.383 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.76 -20.25 5.34 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.641 0.608 . . . . 3.31 112.641 179.046 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -85.83 6.75 26.71 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.102 -0.639 . . . . 3.69 110.729 -179.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.474 ' HG3' ' HB3' ' A' ' 21' ' ' CYS . 3.3 mm-40 . . . . . 0 N--CA 1.445 -0.681 0 N-CA-C 109.334 -0.617 . . . . 3.99 109.334 177.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.471 0.605 0 N-CA-C 112.047 0.388 . . . . 3.12 112.047 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.561 ' O ' ' HG3' ' A' ' 66' ' ' ARG . . . 168.32 89.9 0.08 OUTLIER Glycine 0 N--CA 1.434 -1.464 0 N-CA-C 108.053 -2.019 . . . . 2.1 108.053 -179.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -110.61 77.79 1.07 Allowed 'General case' 0 CA--C 1.497 -1.081 0 CA-C-O 122.465 1.126 . . . . 4.36 109.221 -178.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.9 ' HB2' ' HB2' ' A' ' 67' ' ' CYS . 7.7 mptt -140.77 53.06 3.53 Favored Pre-proline 0 C--N 1.293 -1.85 0 CA-C-N 113.279 -1.782 . . . . 3.55 107.391 179.012 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.552 ' CD ' ' N ' ' A' ' 59' ' ' LYS . 11.1 Cg_endo -54.6 97.32 0.05 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.202 0 C-N-CA 122.576 2.184 . . . . 1.54 113.496 -179.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.639 ' N ' ' O ' ' A' ' 65' ' ' GLY . 1.0 OUTLIER -96.91 -166.6 1.42 Allowed 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 111.947 -2.388 . . . . 1.59 107.189 177.56 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' A' ' 61' ' ' CYS . . . 36.91 -164.81 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 119.789 -1.196 . . . . 2.43 115.623 172.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -84.75 47.64 1.41 Allowed 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 113.1 -1.55 . . . . 4.11 111.405 -178.056 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 120.62 9.9 7.42 Favored Glycine 0 C--N 1.349 1.287 0 CA-C-N 114.77 -1.105 . . . . 2.21 115.22 178.04 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.639 ' O ' ' N ' ' A' ' 61' ' ' CYS . . . -105.2 132.62 11.19 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 119.551 -1.309 . . . . 1.62 115.402 -178.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.561 ' HG3' ' O ' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -101.71 154.24 19.06 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 109.38 -0.6 . . . . 3.02 109.38 177.046 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.9 ' HB2' ' HB2' ' A' ' 59' ' ' LYS . 0.5 OUTLIER -59.33 115.24 3.1 Favored 'General case' 0 CA--C 1.496 -1.128 0 N-CA-C 109.183 -0.673 . . . . 1.52 109.183 -179.696 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.404 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . . . -90.72 -19.21 23.82 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 107.785 -1.191 . . . . 1.07 107.785 178.089 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.734 ' HB1' ' O ' ' A' ' 29' ' ' GLY . . . -165.1 162.93 20.51 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 109.471 -0.566 . . . . 1.0 109.471 -177.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.738 ' HA ' ' HB3' ' A' ' 85' ' ' CYS . . . -50.43 132.81 25.03 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 112.927 0.714 . . . . 1.24 112.927 -179.49 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.598 ' H ' ' CB ' ' A' ' 85' ' ' CYS . . . 65.67 -25.6 0.14 Allowed Glycine 0 CA--C 1.526 0.77 0 CA-C-N 115.347 -0.842 . . . . 1.28 115.183 178.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.889 HD13 ' HB2' ' A' ' 34' ' ' CYS . 1.0 OUTLIER -102.37 122.56 54.82 Favored 'Isoleucine or valine' 0 C--O 1.243 0.72 0 CA-C-O 122.148 0.975 . . . . 2.27 111.614 -179.493 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.662 ' HB2' ' HB3' ' A' ' 82' ' ' ASP . 43.8 t -105.27 111.01 23.59 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.372 -0.831 . . . . 1.98 111.178 -179.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.529 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 0.8 OUTLIER -110.99 143.52 41.54 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.731 0.776 . . . . 1.33 112.559 -179.129 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.677 ' HB2' ' HD2' ' A' ' 76' ' ' PRO . 84.0 p -112.16 178.57 0.95 Allowed Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 114.447 -1.251 . . . . 1.99 108.76 179.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.677 ' HD2' ' HB2' ' A' ' 75' ' ' SER . 86.8 Cg_endo -80.54 22.95 0.73 Allowed 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 121.362 1.375 . . . . 1.86 111.649 179.31 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -145.3 -36.93 0.28 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.835 -0.62 . . . . 2.65 110.52 179.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.771 ' HA3' ' O ' ' B' ' 179' ' ' CYS . . . -155.57 -144.0 3.81 Favored Glycine 0 C--N 1.337 0.616 0 C-N-CA 120.47 -0.871 . . . . 0.99 113.385 179.513 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.659 ' O ' ' HA3' ' B' ' 178' ' ' GLY . 0.1 OUTLIER -151.5 157.97 43.0 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.987 0.422 . . . . 1.34 111.22 -179.614 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.459 ' O ' ' HB3' ' A' ' 73' ' ' CYS . 45.3 m80 -147.14 148.32 31.44 Favored 'General case' 0 N--CA 1.461 0.089 0 O-C-N 122.162 -0.336 . . . . 2.17 110.26 179.358 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -64.5 133.99 53.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.547 -0.297 . . . . 3.05 110.496 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.662 ' HB3' ' HB2' ' A' ' 73' ' ' CYS . 0.0 OUTLIER -145.02 117.56 5.36 Favored Pre-proline 0 CA--C 1.538 0.489 0 CA-C-N 116.531 -0.304 . . . . 2.02 110.684 179.864 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -83.96 -9.29 9.79 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 123.024 2.483 . . . . 1.93 113.575 -178.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.76 -22.31 66.04 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.11 0.411 . . . . 1.53 112.11 -179.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.738 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 52.2 m -101.09 20.36 15.75 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 113.515 0.931 . . . . 1.88 113.515 -178.009 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 CA--C 1.518 -0.275 0 C-N-CA 122.911 0.484 . . . . 3.6 111.525 178.578 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 110' ' ' CYS . . . . . . . . . . . . . 1.7 m . . . . . 0 N--CA 1.446 -0.659 0 N-CA-C 110.251 -0.278 . . . . 2.61 110.251 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 111' ' ' LEU . . . . . 0.821 ' O ' ' HA ' ' B' ' 120' ' ' ARG . 4.3 mm? -35.39 114.19 0.52 Allowed Pre-proline 0 N--CA 1.47 0.552 0 C-N-CA 122.655 0.382 . . . . 2.47 111.843 178.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 112' ' ' PRO . . . . . 0.782 ' HA ' ' O ' ' B' ' 119' ' ' GLY . 92.2 Cg_endo -88.13 114.98 0.89 Allowed 'Trans proline' 0 CA--C 1.531 0.368 0 C-N-CA 122.394 2.063 . . . . 1.47 113.931 -179.215 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.618 ' O ' ' HA2' ' B' ' 117' ' ' GLY . 13.8 p -117.2 -153.94 0.54 Allowed 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.642 0.734 . . . . 1.0 110.692 178.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 114' ' ' GLY . . . . . 0.414 ' O ' ' N ' ' B' ' 116' ' ' GLY . . . 78.6 -166.67 52.42 Favored Glycine 0 CA--C 1.5 -0.886 0 CA-C-N 115.601 -0.727 . . . . 1.16 111.864 179.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 115' ' ' PRO . . . . . 0.554 ' CG ' HD11 ' B' ' 132' ' ' LEU . 87.1 Cg_endo -64.66 82.58 0.17 Allowed 'Trans proline' 0 N--CA 1.454 -0.848 0 CA-C-N 119.503 1.652 . . . . 1.57 114.37 -177.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 116' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' B' ' 114' ' ' GLY . . . 89.44 6.86 70.2 Favored Glycine 0 C--N 1.29 -2.01 0 CA-C-N 111.727 -2.488 . . . . 1.7 115.638 -177.028 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 117' ' ' GLY . . . . . 0.618 ' HA2' ' O ' ' B' ' 113' ' ' CYS . . . 93.48 41.87 4.38 Favored Glycine 0 N--CA 1.436 -1.335 0 N-CA-C 117.794 1.877 . . . . 1.38 117.794 173.369 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.92 -15.56 26.18 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 113.18 0.807 . . . . 2.54 113.18 177.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 119' ' ' GLY . . . . . 0.782 ' O ' ' HA ' ' B' ' 112' ' ' PRO . . . -122.19 -170.66 13.77 Favored Glycine 0 C--N 1.347 1.161 0 N-CA-C 108.472 -1.851 . . . . 1.04 108.472 178.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.821 ' HA ' ' O ' ' B' ' 111' ' ' LEU . 4.1 mpt_? -110.94 172.85 6.63 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 121.307 2.554 . . . . 2.89 110.667 178.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 121' ' ' CYS . . . . . 0.484 ' HB3' ' HG3' ' B' ' 147' ' ' GLU . 0.5 OUTLIER -107.8 135.5 49.1 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 110.257 -0.275 . . . . 1.07 110.257 179.662 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 122' ' ' PHE . . . . . 0.611 ' HE1' ' HB2' ' B' ' 128' ' ' CYS . 96.0 m-85 -111.46 -68.94 0.9 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.873 0.368 . . . . 1.53 110.561 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -106.89 -153.22 19.42 Favored Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 111.062 -0.815 . . . . 0.9 111.062 178.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -88.32 -51.24 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 122.38 2.053 . . . . 1.51 112.161 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 125' ' ' SER . . . . . 0.648 ' O ' ' N ' ' B' ' 137' ' ' GLY . 1.4 m -98.64 29.55 3.66 Favored 'General case' 0 C--O 1.223 -0.308 0 CA-C-N 116.478 -0.328 . . . . 1.25 110.376 179.393 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 126' ' ' ILE . . . . . 0.957 HG12 HG13 ' B' ' 136' ' ' VAL . 8.1 mt -138.14 115.63 12.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.645 0 N-CA-C 113.122 0.786 . . . . 0.85 113.122 -178.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 127' ' ' CYS . . . . . 0.787 ' O ' ' HA ' ' B' ' 134' ' ' CYS . 0.5 OUTLIER -130.72 125.33 33.6 Favored 'General case' 0 C--O 1.225 -0.224 0 CA-C-N 115.122 -0.945 . . . . 0.89 110.232 178.689 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 128' ' ' CYS . . . . . 1.016 ' HA ' ' O ' ' B' ' 133' ' ' GLY . 98.6 m -117.09 162.49 17.73 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.19 -0.914 . . . . 1.23 113.387 -178.117 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 129' ' ' GLY . . . . . 0.742 ' O ' ' HB1' ' B' ' 169' ' ' ALA . . . -145.68 176.44 24.67 Favored Glycine 0 C--N 1.358 1.789 0 N-CA-C 108.622 -1.791 . . . . 0.66 108.622 176.364 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -66.56 -53.21 37.13 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 121.966 0.889 . . . . 2.35 110.239 179.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 131' ' ' GLU . . . . . 0.402 ' H ' ' HG2' ' B' ' 131' ' ' GLU . 1.2 pt-20 -122.83 30.53 6.39 Favored 'General case' 0 N--CA 1.424 -1.766 0 CA-C-N 113.676 -1.602 . . . . 1.69 108.06 177.58 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 132' ' ' LEU . . . . . 0.62 HD22 ' CZ ' ' B' ' 135' ' ' PHE . 0.8 OUTLIER -122.24 -11.26 8.42 Favored 'General case' 0 N--CA 1.406 -2.636 0 N-CA-C 106.136 -1.801 . . . . 1.38 106.136 -178.839 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 133' ' ' GLY . . . . . 1.016 ' O ' ' HA ' ' B' ' 128' ' ' CYS . . . 54.51 -126.17 36.5 Favored Glycine 0 N--CA 1.408 -3.169 0 CA-C-N 113.876 -1.511 . . . . 0.72 112.351 175.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 134' ' ' CYS . . . . . 0.897 ' HB2' HD13 ' B' ' 172' ' ' ILE . 0.1 OUTLIER -145.06 120.63 10.41 Favored 'General case' 0 CA--C 1.491 -1.296 0 N-CA-C 115.032 1.493 . . . . 1.08 115.032 -179.841 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 135' ' ' PHE . . . . . 0.75 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -85.3 106.12 16.47 Favored 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 102.72 -3.067 . . . . 1.36 102.72 174.507 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 136' ' ' VAL . . . . . 0.957 HG13 HG12 ' B' ' 126' ' ' ILE . 3.4 t -92.63 85.63 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.601 0 CA-C-O 122.85 1.31 . . . . 0.75 108.513 -178.284 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 137' ' ' GLY . . . . . 0.648 ' N ' ' O ' ' B' ' 125' ' ' SER . . . 96.12 76.5 1.31 Allowed Glycine 0 CA--C 1.526 0.73 0 CA-C-N 112.5 -2.136 . . . . 0.83 114.222 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 138' ' ' THR . . . . . 0.513 HG22 ' O ' ' A' ' 32' ' ' LEU . 49.8 p -155.19 176.31 12.72 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 108.414 -0.958 . . . . 0.78 108.414 178.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 139' ' ' ALA . . . . . 1.103 ' O ' HD12 ' B' ' 142' ' ' LEU . . . -68.64 -12.79 61.81 Favored 'General case' 0 C--O 1.22 -0.487 0 CA-C-N 119.235 0.925 . . . . 1.04 110.133 178.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 140' ' ' GLU . . . . . 0.427 ' HG2' ' HD3' ' B' ' 115' ' ' PRO . 0.9 OUTLIER -65.63 -17.45 64.6 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.483 -0.932 . . . . 2.31 108.483 177.569 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 141' ' ' ALA . . . . . 0.938 ' O ' ' HB2' ' B' ' 144' ' ' CYS . . . -112.62 -12.65 13.39 Favored 'General case' 0 C--O 1.216 -0.688 0 CA-C-N 114.98 -1.009 . . . . 0.87 113.033 -179.46 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 142' ' ' LEU . . . . . 1.103 HD12 ' O ' ' B' ' 139' ' ' ALA . 0.0 OUTLIER -54.24 -19.23 4.9 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 121.097 -1.002 . . . . 1.24 113.222 -177.236 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 143' ' ' ARG . . . . . 0.772 ' N ' HD13 ' B' ' 142' ' ' LEU . 9.3 ptm85 -80.76 -12.58 59.43 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 106.774 -1.565 . . . . 2.93 106.774 174.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 144' ' ' CYS . . . . . 0.938 ' HB2' ' O ' ' B' ' 141' ' ' ALA . 0.1 OUTLIER -58.76 -24.84 62.36 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 111.786 -2.461 . . . . 1.61 108.948 -179.488 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.84 -20.56 2.29 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 112.672 0.619 . . . . 3.35 112.672 179.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -85.85 6.79 26.63 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.128 -0.629 . . . . 3.76 110.754 -179.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 147' ' ' GLU . . . . . 0.484 ' HG3' ' HB3' ' B' ' 121' ' ' CYS . 3.3 mm-40 . . . . . 0 N--CA 1.446 -0.67 0 N-CA-C 109.401 -0.592 . . . . 4.01 109.401 177.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.472 0.651 0 CA-C-O 120.938 0.399 . . . . 3.11 111.5 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 157' ' ' GLY . . . . . 0.539 ' O ' ' HG3' ' B' ' 166' ' ' ARG . . . 165.14 91.05 0.08 OUTLIER Glycine 0 N--CA 1.44 -1.085 0 N-CA-C 108.847 -1.701 . . . . 2.07 108.847 179.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -112.34 65.61 0.64 Allowed 'General case' 0 CA--C 1.501 -0.909 0 CA-C-O 122.762 1.268 . . . . 4.34 110.402 -179.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 159' ' ' LYS . . . . . 0.963 ' HB2' ' HB2' ' B' ' 167' ' ' CYS . 7.3 mptt -113.34 47.66 0.37 Allowed Pre-proline 0 C--N 1.302 -1.499 0 CA-C-N 112.542 -2.117 . . . . 3.54 111.534 173.303 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 160' ' ' PRO . . . . . 0.451 ' HA ' ' HA ' ' B' ' 166' ' ' ARG . 10.0 Cg_endo -53.76 97.52 0.05 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.402 0 CA-C-N 121.3 1.5 . . . . 1.51 114.698 -174.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 161' ' ' CYS . . . . . 0.625 ' N ' ' O ' ' B' ' 165' ' ' GLY . 0.9 OUTLIER -96.9 -166.69 1.44 Allowed 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 112.397 -2.183 . . . . 1.58 107.406 177.626 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 162' ' ' GLY . . . . . 0.41 ' N ' ' SG ' ' B' ' 161' ' ' CYS . . . 37.08 -164.77 0.01 OUTLIER Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 115.746 1.059 . . . . 2.37 115.746 172.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -84.54 47.31 1.34 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 113.177 -1.511 . . . . 4.07 111.465 -178.093 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 120.4 9.82 7.62 Favored Glycine 0 CA--C 1.539 1.549 0 CA-C-N 115.043 -0.981 . . . . 2.2 115.179 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 165' ' ' GLY . . . . . 0.625 ' O ' ' N ' ' B' ' 161' ' ' CYS . . . -104.82 133.38 11.52 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 118.921 -1.609 . . . . 1.62 115.16 -179.55 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 166' ' ' ARG . . . . . 0.539 ' HG3' ' O ' ' B' ' 157' ' ' GLY . 0.0 OUTLIER -102.17 154.19 19.25 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 109.313 -0.625 . . . . 3.05 109.313 176.661 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 167' ' ' CYS . . . . . 0.963 ' HB2' ' HB2' ' B' ' 159' ' ' LYS . 0.5 OUTLIER -59.2 115.54 3.27 Favored 'General case' 0 CA--C 1.499 -0.982 0 N-CA-C 109.214 -0.661 . . . . 1.56 109.214 -179.571 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 168' ' ' ALA . . . . . 0.43 ' HB3' ' SG ' ' B' ' 128' ' ' CYS . . . -89.8 -20.75 23.12 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 107.774 -1.195 . . . . 1.04 107.774 177.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 169' ' ' ALA . . . . . 0.742 ' HB1' ' O ' ' B' ' 129' ' ' GLY . . . -164.38 162.71 22.33 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.375 -0.83 . . . . 0.98 110.682 -177.016 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 170' ' ' ALA . . . . . 0.749 ' HA ' ' HB3' ' B' ' 185' ' ' CYS . . . -49.99 133.0 23.11 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 112.711 0.634 . . . . 1.25 112.711 -179.273 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 171' ' ' GLY . . . . . 0.576 ' H ' ' CB ' ' B' ' 185' ' ' CYS . . . 67.65 -30.74 0.22 Allowed Glycine 0 CA--C 1.527 0.809 0 CA-C-N 115.614 -0.721 . . . . 1.29 114.693 178.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 172' ' ' ILE . . . . . 0.897 HD13 ' HB2' ' B' ' 134' ' ' CYS . 1.0 OUTLIER -99.5 122.78 51.71 Favored 'Isoleucine or valine' 0 C--O 1.242 0.71 0 CA-C-O 122.322 1.058 . . . . 2.27 111.931 -178.138 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 173' ' ' CYS . . . . . 0.656 ' HB2' ' HB3' ' B' ' 182' ' ' ASP . 44.1 t -105.36 110.96 23.51 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.201 -0.909 . . . . 1.94 111.19 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 174' ' ' CYS . . . . . 0.534 ' HA ' ' HA ' ' B' ' 179' ' ' CYS . 0.8 OUTLIER -110.83 143.51 41.29 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.586 0.707 . . . . 1.35 112.603 -179.097 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 175' ' ' SER . . . . . 0.687 ' HB2' ' HD2' ' B' ' 176' ' ' PRO . 83.9 p -112.17 178.53 0.96 Allowed Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 114.542 -1.208 . . . . 2.0 108.778 179.365 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 176' ' ' PRO . . . . . 0.687 ' HD2' ' HB2' ' B' ' 175' ' ' SER . 89.0 Cg_endo -80.53 23.1 0.72 Allowed 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 121.315 1.343 . . . . 1.9 111.663 179.328 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 177' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -145.38 -36.29 0.29 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.812 -0.631 . . . . 2.72 110.711 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 178' ' ' GLY . . . . . 0.659 ' HA3' ' O ' ' A' ' 79' ' ' CYS . . . -156.41 -144.18 3.86 Favored Glycine 0 C--N 1.337 0.587 0 C-N-CA 120.671 -0.776 . . . . 0.99 113.325 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 179' ' ' CYS . . . . . 0.771 ' O ' ' HA3' ' A' ' 78' ' ' GLY . 0.1 OUTLIER -151.51 157.98 43.0 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 120.895 0.378 . . . . 1.34 111.346 -179.489 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 180' ' ' HIS . . . . . 0.459 ' O ' ' HB3' ' B' ' 173' ' ' CYS . 45.4 m80 -147.05 148.36 31.57 Favored 'General case' 0 N--CA 1.46 0.069 0 O-C-N 122.199 -0.313 . . . . 2.1 110.277 179.316 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 181' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -64.5 133.93 53.42 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.645 -0.252 . . . . 3.06 110.486 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 182' ' ' ASP . . . . . 0.656 ' HB3' ' HB2' ' B' ' 173' ' ' CYS . 0.0 OUTLIER -144.99 117.52 5.37 Favored Pre-proline 0 CA--C 1.538 0.496 0 CA-C-N 116.521 -0.309 . . . . 2.06 110.673 179.864 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 183' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' B' ' 182' ' ' ASP . 1.2 Cg_endo -83.97 -9.14 9.85 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 123.039 2.493 . . . . 1.91 113.557 -178.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -66.75 -22.49 66.04 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.05 0.389 . . . . 1.56 112.05 -179.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 185' ' ' CYS . . . . . 0.749 ' HB3' ' HA ' ' B' ' 170' ' ' ALA . 54.1 m -100.94 20.32 15.68 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 113.622 0.971 . . . . 1.94 113.622 -178.024 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 186' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 CA--C 1.518 -0.271 0 C-N-CA 122.858 0.463 . . . . 3.61 111.52 178.577 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.779 ' HB3' ' HB3' ' A' ' 20' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.225 -0.223 0 CA-C-O 120.707 0.289 . . . . 2.68 111.347 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.463 ' C ' ' O ' ' A' ' 10' ' ' CYS . 5.6 tp -29.05 129.9 0.22 Allowed Pre-proline 0 N--CA 1.468 0.45 0 CA-C-O 121.031 0.443 . . . . 2.48 111.948 -179.396 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.871 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 54.5 Cg_endo -70.14 152.28 67.3 Favored 'Trans proline' 0 N--CA 1.475 0.39 0 C-N-CA 123.377 2.718 . . . . 1.49 114.608 -179.128 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.623 ' SG ' ' N ' ' A' ' 14' ' ' GLY . 0.0 OUTLIER -160.97 -170.22 2.64 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 119.422 -0.911 . . . . 1.0 110.946 176.969 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.856 ' HA2' ' HB3' ' A' ' 40' ' ' GLU . . . 77.61 -159.72 48.4 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 115.47 0.948 . . . . 1.15 115.47 178.393 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.597 ' CG ' HD21 ' A' ' 32' ' ' LEU . 74.4 Cg_endo -61.37 104.16 0.29 Allowed 'Trans proline' 0 N--CA 1.487 1.127 0 C-N-CA 124.749 3.633 . . . . 1.57 111.021 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.64 -10.92 60.66 Favored Glycine 0 C--N 1.28 -2.566 0 CA-C-N 113.119 -1.855 . . . . 1.68 111.219 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.518 ' O ' ' HB2' ' A' ' 12' ' ' PRO . . . 76.49 37.36 35.85 Favored Glycine 0 N--CA 1.411 -3.005 0 C-N-CA 119.336 -1.411 . . . . 1.36 111.153 -179.627 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.539 ' HB2' HD12 ' A' ' 32' ' ' LEU . 0.5 OUTLIER -88.09 -37.47 16.21 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 112.973 -1.614 . . . . 2.5 112.29 179.196 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.871 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -89.56 -172.79 45.63 Favored Glycine 0 N--CA 1.423 -2.198 0 CA-C-N 122.055 2.207 . . . . 1.02 110.966 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.779 ' HB3' ' HB3' ' A' ' 10' ' ' CYS . 0.4 OUTLIER -113.14 172.14 7.12 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 124.395 0.703 . . . . 2.92 112.777 -179.407 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.7 m -106.85 145.55 32.01 Favored 'General case' 0 N--CA 1.475 0.809 0 O-C-N 121.826 -0.546 . . . . 1.1 110.455 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.414 ' CZ ' ' O ' ' A' ' 68' ' ' ALA . 76.3 m-85 -142.9 22.39 1.93 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.944 -0.571 . . . . 1.51 111.752 -179.335 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.811 ' O ' ' HB3' ' A' ' 44' ' ' CYS . . . 174.04 -169.45 42.48 Favored Glycine 0 C--O 1.225 -0.444 0 C-N-CA 120.724 -0.751 . . . . 0.9 111.421 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -81.3 -54.18 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.531 2.154 . . . . 1.5 112.333 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.591 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.3 OUTLIER -106.47 12.1 30.0 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.234 -0.439 . . . . 1.26 111.39 -179.963 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.786 HG22 ' SG ' ' A' ' 34' ' ' CYS . 1.2 mt -121.8 122.43 66.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 113.218 0.821 . . . . 0.83 113.218 -177.357 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.682 ' HB3' ' CD2' ' A' ' 35' ' ' PHE . 4.3 t -130.78 116.37 17.88 Favored 'General case' 0 C--O 1.226 -0.155 0 CA-C-O 122.494 1.14 . . . . 0.92 111.48 178.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 1.214 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -121.36 148.48 44.31 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 112.552 -2.113 . . . . 1.28 109.08 -179.546 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.786 ' O ' ' HB1' ' A' ' 69' ' ' ALA . . . -144.01 -167.86 12.09 Favored Glycine 0 CA--C 1.478 -2.223 0 N-CA-C 105.494 -3.042 . . . . 0.67 105.494 174.388 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.462 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 12.3 p-10 -67.18 -69.01 0.34 Allowed 'General case' 0 C--N 1.282 -2.329 0 C-N-CA 118.635 -1.226 . . . . 2.27 112.82 -179.575 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.13 15.1 19.94 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 114.722 -1.127 . . . . 1.66 111.284 -176.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.734 HD22 ' CZ ' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -116.48 -17.69 10.59 Favored 'General case' 0 N--CA 1.4 -2.944 0 CA-C-N 114.568 -1.196 . . . . 1.37 108.208 179.945 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 1.214 ' O ' ' HA ' ' A' ' 28' ' ' CYS . . . 63.19 -128.25 39.12 Favored Glycine 0 N--CA 1.405 -3.428 0 CA-C-N 113.963 -1.471 . . . . 0.73 114.285 178.098 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.87 ' HB2' HG13 ' A' ' 72' ' ' ILE . 4.8 t -141.51 120.09 12.47 Favored 'General case' 0 CA--C 1.5 -0.944 0 N-CA-C 115.572 1.693 . . . . 1.08 115.572 -179.667 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 1.026 ' HA ' ' HA ' ' B' ' 135' ' ' PHE . 0.0 OUTLIER -96.34 107.58 19.97 Favored 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 106.501 -1.666 . . . . 1.38 106.501 176.219 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.833 HG23 HG23 ' B' ' 136' ' ' VAL . 1.8 t -94.72 84.0 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.774 0 N-CA-C 108.008 -1.108 . . . . 0.76 108.008 179.387 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 25' ' ' SER . . . 105.27 102.61 2.8 Favored Glycine 0 CA--C 1.524 0.646 0 CA-C-N 113.451 -1.704 . . . . 0.81 114.007 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.615 ' HB ' ' O ' ' B' ' 132' ' ' LEU . 0.2 OUTLIER 178.66 161.95 0.69 Allowed 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 107.992 -1.114 . . . . 0.77 107.992 179.02 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.818 ' HA ' HD12 ' A' ' 42' ' ' LEU . . . -69.28 -28.24 66.12 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 120.595 1.543 . . . . 1.02 112.175 -179.331 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.856 ' HB3' ' HA2' ' A' ' 14' ' ' GLY . 0.5 OUTLIER -62.23 -12.81 22.34 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.154 0.502 . . . . 2.32 110.524 178.125 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.808 ' O ' ' HB2' ' A' ' 44' ' ' CYS . . . -103.49 -19.32 14.44 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.091 -0.959 . . . . 0.87 110.673 178.108 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.818 HD12 ' HA ' ' A' ' 39' ' ' ALA . 0.7 OUTLIER -46.8 -38.06 9.58 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 112.403 0.52 . . . . 1.23 112.403 -179.298 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.555 ' HD2' ' H ' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -57.82 -22.35 47.14 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-O 122.552 1.167 . . . . 2.92 108.771 177.127 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.811 ' HB3' ' O ' ' A' ' 23' ' ' GLY . 28.6 m -58.8 -10.7 2.55 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-N 112.193 -2.276 . . . . 1.57 109.81 178.401 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.444 ' HB2' ' O ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -77.22 -18.98 57.29 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-O 121.126 0.489 . . . . 3.31 111.73 178.981 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -85.83 10.39 13.91 Favored 'General case' 0 CA--C 1.515 -0.369 0 C-N-CA 119.861 -0.736 . . . . 3.69 110.457 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 . . . . . 0 N--CA 1.442 -0.866 0 N-CA-C 108.865 -0.791 . . . . 3.99 108.865 177.158 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.3 t . . . . . 0 N--CA 1.467 0.412 0 CA-C-O 120.822 0.344 . . . . 3.12 110.406 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 162.01 44.69 0.02 OUTLIER Glycine 0 N--CA 1.442 -0.955 0 N-CA-C 108.66 -1.776 . . . . 2.1 108.66 -179.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.421 ' O ' ' HG3' ' A' ' 58' ' ' GLN . 15.6 pt20 -118.96 86.05 2.48 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-O 122.489 1.137 . . . . 4.36 108.91 -179.255 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.524 ' HB3' ' HB2' ' A' ' 67' ' ' CYS . 0.0 OUTLIER -137.24 69.09 55.75 Favored Pre-proline 0 C--N 1.294 -1.817 0 N-CA-C 104.419 -2.437 . . . . 3.55 104.419 -178.869 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.435 ' HA ' ' O ' ' A' ' 65' ' ' GLY . 55.7 Cg_endo -71.71 91.56 0.7 Allowed 'Trans proline' 0 N--CA 1.446 -1.296 0 C-N-CA 122.858 2.372 . . . . 1.54 115.055 -176.354 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 3.2 p -104.43 -172.32 2.08 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 113.2 -1.818 . . . . 1.59 107.03 176.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 52.21 -166.07 1.14 Allowed Glycine 0 C--N 1.329 0.148 0 C-N-CA 118.52 -1.8 . . . . 2.43 112.258 177.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 8.0 t -73.23 66.51 0.89 Allowed 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 120.33 -0.548 . . . . 4.11 110.967 -179.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 84.18 8.47 83.68 Favored Glycine 0 N--CA 1.436 -1.309 0 CA-C-O 117.752 -1.582 . . . . 2.21 116.592 178.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 1.039 ' HA3' ' HA ' ' A' ' 74' ' ' CYS . . . -100.29 137.33 13.2 Favored Glycine 0 N--CA 1.438 -1.192 0 CA-C-N 122.553 3.177 . . . . 1.62 114.058 -177.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.468 ' O ' ' N ' ' A' ' 74' ' ' CYS . 0.0 OUTLIER -99.66 153.03 19.4 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 114.046 -1.077 . . . . 3.02 112.515 -178.4 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.682 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 44.4 t -51.75 108.62 0.29 Allowed 'General case' 0 N--CA 1.428 -1.56 0 CA-C-N 115.764 -0.653 . . . . 1.52 110.918 -179.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.414 ' O ' ' CZ ' ' A' ' 22' ' ' PHE . . . -99.55 -33.51 10.62 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.929 -0.767 . . . . 1.07 108.929 178.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.786 ' HB1' ' O ' ' A' ' 29' ' ' GLY . . . -159.93 165.32 32.35 Favored 'General case' 0 CA--C 1.495 -1.158 0 C-N-CA 119.428 -0.909 . . . . 1.0 112.432 -178.155 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.798 ' HA ' ' O ' ' A' ' 85' ' ' CYS . . . -37.29 97.4 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.1 -0.955 . . . . 1.24 110.444 -178.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.633 ' HA2' ' O ' ' A' ' 82' ' ' ASP . . . 93.56 -12.58 69.28 Favored Glycine 0 N--CA 1.437 -1.264 0 CA-C-N 114.81 -1.086 . . . . 1.28 114.43 179.293 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.87 HG13 ' HB2' ' A' ' 34' ' ' CYS . 1.7 mm -93.56 124.72 46.1 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.04 0 CA-C-N 119.391 1.596 . . . . 2.27 110.8 -175.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.615 ' HB2' ' HB3' ' A' ' 82' ' ' ASP . 20.6 t -120.79 92.45 3.77 Favored 'General case' 0 N--CA 1.426 -1.658 0 CA-C-N 113.89 -1.504 . . . . 1.98 109.274 -179.313 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 1.044 ' CB ' ' HA ' ' A' ' 79' ' ' CYS . 6.0 p -159.9 -175.89 5.38 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 116.105 1.891 . . . . 1.33 116.105 -177.001 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.852 ' HB2' ' HD2' ' A' ' 76' ' ' PRO . 5.8 p -122.61 -179.9 0.88 Allowed Pre-proline 0 N--CA 1.454 -0.253 0 CA-C-N 113.098 -1.865 . . . . 1.99 108.926 -179.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.852 ' HD2' ' HB2' ' A' ' 75' ' ' SER . 56.2 Cg_endo -72.45 31.38 0.28 Allowed 'Trans proline' 0 CA--C 1.534 0.523 0 C-N-CA 121.671 1.581 . . . . 1.86 113.292 -179.219 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.445 ' OD1' ' N ' ' A' ' 78' ' ' GLY . 1.1 p30 -134.49 -59.97 0.8 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 120.714 0.292 . . . . 2.65 110.397 178.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.932 ' O ' ' HB2' ' A' ' 74' ' ' CYS . . . -124.61 -175.15 14.22 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.507 -0.854 . . . . 0.99 111.74 178.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 1.044 ' HA ' ' CB ' ' A' ' 74' ' ' CYS . 14.1 m -149.44 160.34 43.53 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 117.535 0.668 . . . . 1.34 111.929 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.429 ' HA ' ' HA2' ' B' ' 178' ' ' GLY . 72.5 m80 -149.51 139.8 22.28 Favored 'General case' 0 C--N 1.349 0.585 0 O-C-N 121.714 -0.616 . . . . 2.17 111.879 -178.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -64.72 126.02 26.62 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.921 -0.582 . . . . 3.05 109.725 178.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.633 ' O ' ' HA2' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -139.94 107.51 6.91 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-O 120.864 0.364 . . . . 2.02 111.226 -179.213 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_exo -62.78 -24.09 74.52 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.04 2.493 . . . . 1.93 114.333 -178.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.36 -10.82 27.01 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.979 0.363 . . . . 1.53 111.979 -179.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.798 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 3.8 m -128.18 9.25 6.18 Favored 'General case' 0 C--O 1.215 -0.738 0 CA-C-O 119.053 -0.499 . . . . 1.88 111.321 179.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.597 ' O ' ' HB1' ' A' ' 70' ' ' ALA . 0.5 OUTLIER . . . . . 0 C--N 1.322 -0.595 0 C-N-CA 119.113 -1.035 . . . . 3.6 112.692 -176.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 110' ' ' CYS . . . . . 0.737 ' HB3' ' HB3' ' B' ' 120' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.226 -0.144 0 N-CA-C 111.883 0.327 . . . . 2.61 111.883 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 111' ' ' LEU . . . . . 0.481 ' C ' ' O ' ' B' ' 110' ' ' CYS . 5.4 tp -26.74 129.49 0.18 Allowed Pre-proline 0 CA--C 1.54 0.558 0 N-CA-C 112.209 0.448 . . . . 2.47 112.209 -179.333 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 112' ' ' PRO . . . . . 0.873 ' HA ' ' O ' ' B' ' 119' ' ' GLY . 30.3 Cg_endo -61.43 158.47 35.96 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 124.672 3.581 . . . . 1.47 112.974 179.579 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.623 ' SG ' ' N ' ' B' ' 114' ' ' GLY . 0.0 OUTLIER -168.83 -171.55 1.39 Allowed 'General case' 0 N--CA 1.497 1.907 0 C-N-CA 118.977 -1.089 . . . . 1.0 111.272 170.939 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 114' ' ' GLY . . . . . 0.885 ' HA2' ' HB3' ' B' ' 140' ' ' GLU . . . 77.35 -159.34 48.55 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 120.289 -0.958 . . . . 1.16 115.249 178.201 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 115' ' ' PRO . . . . . 0.627 ' CG ' HD21 ' B' ' 132' ' ' LEU . 96.4 Cg_endo -62.36 96.15 0.15 Allowed 'Trans proline' 0 C--N 1.355 0.885 0 C-N-CA 124.238 3.292 . . . . 1.57 115.398 -178.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 85.76 -0.83 88.1 Favored Glycine 0 C--N 1.285 -2.296 0 CA-C-N 110.573 -3.012 . . . . 1.7 112.197 -177.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 117' ' ' GLY . . . . . 0.519 ' O ' ' HB2' ' B' ' 112' ' ' PRO . . . 73.69 35.9 54.35 Favored Glycine 0 N--CA 1.425 -2.035 0 C-N-CA 120.171 -1.014 . . . . 1.38 112.858 176.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 118' ' ' LYS . . . . . 0.548 ' HB2' HD12 ' B' ' 132' ' ' LEU . 0.6 OUTLIER -87.55 -33.77 18.81 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 114.207 -0.997 . . . . 2.54 112.052 -179.629 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 119' ' ' GLY . . . . . 0.873 ' O ' ' HA ' ' B' ' 112' ' ' PRO . . . -79.67 -164.58 29.21 Favored Glycine 0 CA--C 1.497 -1.063 0 CA-C-O 118.631 -1.094 . . . . 1.04 111.521 -179.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.737 ' HB3' ' HB3' ' B' ' 110' ' ' CYS . 2.3 mtt85 -133.09 172.91 12.01 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 119.736 1.768 . . . . 2.89 106.961 176.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 121' ' ' CYS . . . . . . . . . . . . . 2.6 m -106.16 146.77 29.83 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 118.548 0.613 . . . . 1.07 111.532 -178.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 122' ' ' PHE . . . . . 0.507 ' HE1' ' O ' ' B' ' 128' ' ' CYS . 75.9 m-85 -142.91 22.14 1.94 Allowed 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.687 -0.688 . . . . 1.53 111.778 -179.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 123' ' ' GLY . . . . . 0.851 ' O ' ' HB3' ' B' ' 144' ' ' CYS . . . 174.05 -169.53 42.57 Favored Glycine 0 C--O 1.225 -0.465 0 C-N-CA 120.783 -0.723 . . . . 0.9 111.468 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -81.1 -54.33 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.494 2.129 . . . . 1.51 112.272 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 125' ' ' SER . . . . . 0.605 ' O ' ' N ' ' B' ' 137' ' ' GLY . 0.3 OUTLIER -106.39 12.25 29.97 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.264 -0.425 . . . . 1.25 111.39 -179.878 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 126' ' ' ILE . . . . . 0.814 HG22 ' SG ' ' B' ' 134' ' ' CYS . 1.5 mt -121.73 122.38 66.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 113.088 0.773 . . . . 0.85 113.088 -177.289 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 127' ' ' CYS . . . . . 0.687 ' HB3' ' CD2' ' B' ' 135' ' ' PHE . 4.5 t -131.06 117.66 19.45 Favored 'General case' 0 CA--C 1.522 -0.107 0 CA-C-O 122.542 1.163 . . . . 0.89 111.585 178.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 128' ' ' CYS . . . . . 1.104 ' HA ' ' O ' ' B' ' 133' ' ' GLY . 0.0 OUTLIER -130.62 135.93 48.36 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 112.96 -1.927 . . . . 1.23 112.415 -178.559 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 129' ' ' GLY . . . . . 0.798 ' O ' ' HB1' ' B' ' 169' ' ' ALA . . . -130.41 -161.6 10.44 Favored Glycine 0 N--CA 1.42 -2.413 0 N-CA-C 105.119 -3.193 . . . . 0.66 105.119 177.383 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 130' ' ' ASP . . . . . 0.437 ' O ' ' HB3' ' B' ' 170' ' ' ALA . 14.5 p-10 -68.71 -70.99 0.23 Allowed 'General case' 0 C--N 1.289 -2.06 0 C-N-CA 119.199 -1.001 . . . . 2.35 112.69 -178.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.94 32.53 3.15 Favored 'General case' 0 CA--C 1.49 -1.346 0 CA-C-O 122.085 0.945 . . . . 1.69 110.1 -177.232 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 132' ' ' LEU . . . . . 0.739 HD22 ' CZ ' ' B' ' 135' ' ' PHE . 0.8 OUTLIER -127.45 -16.9 4.77 Favored 'General case' 0 N--CA 1.399 -3.01 0 CA-C-N 113.788 -1.551 . . . . 1.38 106.869 177.075 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 133' ' ' GLY . . . . . 1.104 ' O ' ' HA ' ' B' ' 128' ' ' CYS . . . 58.93 -134.55 52.43 Favored Glycine 0 N--CA 1.402 -3.587 0 CA-C-N 114.372 -1.285 . . . . 0.72 112.529 177.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 134' ' ' CYS . . . . . 0.845 ' HB2' HG13 ' B' ' 172' ' ' ILE . 5.2 t -135.25 119.79 18.11 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 116.15 1.907 . . . . 1.08 116.15 -176.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 135' ' ' PHE . . . . . 1.026 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -94.74 107.58 19.59 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 106.524 -1.658 . . . . 1.36 106.524 176.385 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 136' ' ' VAL . . . . . 0.833 HG23 HG23 ' A' ' 36' ' ' VAL . 2.4 t -94.3 83.56 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.642 0 N-CA-C 107.814 -1.18 . . . . 0.75 107.814 179.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 137' ' ' GLY . . . . . 0.605 ' N ' ' O ' ' B' ' 125' ' ' SER . . . 105.5 102.9 2.83 Favored Glycine 0 CA--C 1.523 0.59 0 CA-C-N 113.637 -1.62 . . . . 0.83 113.944 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 138' ' ' THR . . . . . 0.567 ' HB ' ' O ' ' A' ' 32' ' ' LEU . 0.2 OUTLIER -179.96 165.7 1.24 Allowed 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 107.905 -1.146 . . . . 0.78 107.905 179.131 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 139' ' ' ALA . . . . . 0.856 ' HA ' HD12 ' B' ' 142' ' ' LEU . . . -68.98 -36.97 78.47 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 119.075 0.852 . . . . 1.04 110.225 179.349 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 140' ' ' GLU . . . . . 0.885 ' HB3' ' HA2' ' B' ' 114' ' ' GLY . 0.5 OUTLIER -56.87 -13.7 2.85 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.009 -0.541 . . . . 2.31 111.064 179.83 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 141' ' ' ALA . . . . . 0.723 ' O ' ' HB2' ' B' ' 144' ' ' CYS . . . -101.72 -21.81 14.55 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 116.236 -0.438 . . . . 0.87 109.942 178.351 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 142' ' ' LEU . . . . . 0.856 HD12 ' HA ' ' B' ' 139' ' ' ALA . 0.6 OUTLIER -45.04 -38.06 4.61 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.626 0.602 . . . . 1.24 112.626 -178.483 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 143' ' ' ARG . . . . . 0.578 ' HD2' ' H ' ' B' ' 143' ' ' ARG . 0.0 OUTLIER -54.13 -29.46 45.28 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 107.136 -1.431 . . . . 2.93 107.136 177.148 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 144' ' ' CYS . . . . . 0.851 ' HB3' ' O ' ' B' ' 123' ' ' GLY . 39.8 m -57.15 -4.77 0.21 Allowed 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 113.776 -1.556 . . . . 1.61 110.441 -177.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 145' ' ' GLN . . . . . 0.43 ' HB2' ' O ' ' B' ' 142' ' ' LEU . 0.0 OUTLIER -79.32 -19.31 50.66 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-O 121.255 0.55 . . . . 3.35 111.208 177.584 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -85.81 10.11 14.66 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 119.998 -0.681 . . . . 3.76 110.436 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 . . . . . 0 N--CA 1.441 -0.876 0 N-CA-C 108.852 -0.795 . . . . 4.01 108.852 177.244 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 1.3 t . . . . . 0 N--CA 1.464 0.275 0 CA-C-O 121.026 0.441 . . . . 3.11 111.205 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 165.12 44.52 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 109.085 -1.606 . . . . 2.07 109.085 -179.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -118.74 71.9 0.86 Allowed 'General case' 0 N--CA 1.441 -0.919 0 CA-C-O 122.398 1.094 . . . . 4.34 110.724 -179.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 159' ' ' LYS . . . . . 0.579 ' HB3' ' HB2' ' B' ' 167' ' ' CYS . 0.0 OUTLIER -107.81 66.12 0.26 Allowed Pre-proline 0 C--N 1.31 -1.123 0 CA-C-N 113.202 -1.817 . . . . 3.54 108.486 174.33 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 160' ' ' PRO . . . . . 0.404 ' HA ' ' O ' ' B' ' 165' ' ' GLY . 54.0 Cg_endo -71.4 92.26 0.67 Allowed 'Trans proline' 0 N--CA 1.464 -0.25 0 N-CA-C 116.17 1.565 . . . . 1.51 116.17 -174.077 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 161' ' ' CYS . . . . . . . . . . . . . 1.9 p -99.34 -166.91 1.4 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 113.173 -1.831 . . . . 1.58 108.32 176.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 45.35 -165.03 0.06 OUTLIER Glycine 0 CA--C 1.52 0.356 0 C-N-CA 119.135 -1.507 . . . . 2.37 112.181 173.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 8.1 t -73.11 66.89 0.87 Allowed 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 117.364 0.582 . . . . 4.07 111.496 -179.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 84.46 9.12 82.22 Favored Glycine 0 CA--C 1.541 1.67 0 CA-C-O 117.94 -1.478 . . . . 2.2 116.132 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 165' ' ' GLY . . . . . 0.943 ' HA3' ' HA ' ' B' ' 174' ' ' CYS . . . -96.98 131.25 10.54 Favored Glycine 0 C--N 1.301 -1.383 0 C-N-CA 117.177 -2.439 . . . . 1.62 114.151 -176.238 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 166' ' ' ARG . . . . . 0.428 ' HA ' ' O ' ' B' ' 159' ' ' LYS . 0.0 OUTLIER -100.03 152.41 20.24 Favored 'General case' 0 C--N 1.349 0.551 0 N-CA-C 112.186 0.439 . . . . 3.05 112.186 -179.151 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 167' ' ' CYS . . . . . 0.691 ' HA ' ' O ' ' B' ' 172' ' ' ILE . 46.7 t -51.84 108.77 0.3 Allowed 'General case' 0 N--CA 1.431 -1.425 0 CA-C-N 115.905 -0.589 . . . . 1.56 111.05 -179.282 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 168' ' ' ALA . . . . . 0.401 ' O ' ' CZ ' ' B' ' 122' ' ' PHE . . . -101.33 -30.16 11.64 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.771 -0.649 . . . . 1.04 109.528 178.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 169' ' ' ALA . . . . . 0.812 ' HB2' ' HB2' ' B' ' 128' ' ' CYS . . . -162.31 165.1 27.05 Favored 'General case' 0 CA--C 1.492 -1.258 0 C-N-CA 119.488 -0.885 . . . . 0.98 112.42 -179.271 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 170' ' ' ALA . . . . . 0.788 ' HA ' ' O ' ' B' ' 185' ' ' CYS . . . -36.52 95.98 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.047 -0.979 . . . . 1.25 110.851 -179.106 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 171' ' ' GLY . . . . . 0.692 ' HA2' ' O ' ' B' ' 182' ' ' ASP . . . 88.52 -1.82 84.3 Favored Glycine 0 CA--C 1.525 0.677 0 CA-C-N 114.923 -1.035 . . . . 1.29 115.11 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 172' ' ' ILE . . . . . 0.845 HG13 ' HB2' ' B' ' 134' ' ' CYS . 1.8 mm -96.65 122.24 47.96 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.093 0 CA-C-N 117.865 0.832 . . . . 2.27 110.535 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 173' ' ' CYS . . . . . 0.631 ' HB2' ' HB3' ' B' ' 182' ' ' ASP . 21.6 t -120.89 92.21 3.71 Favored 'General case' 0 N--CA 1.428 -1.561 0 CA-C-N 114.561 -1.2 . . . . 1.94 109.399 -179.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 174' ' ' CYS . . . . . 1.031 ' CB ' ' HA ' ' B' ' 179' ' ' CYS . 5.9 p -160.08 -175.76 5.27 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 116.033 1.864 . . . . 1.35 116.033 -176.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 175' ' ' SER . . . . . 0.851 ' HB2' ' HD2' ' B' ' 176' ' ' PRO . 6.0 p -122.68 -179.89 0.88 Allowed Pre-proline 0 N--CA 1.454 -0.25 0 CA-C-N 113.087 -1.869 . . . . 2.0 108.931 -179.569 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 176' ' ' PRO . . . . . 0.851 ' HD2' ' HB2' ' B' ' 175' ' ' SER . 55.9 Cg_endo -72.38 31.31 0.27 Allowed 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 121.699 1.599 . . . . 1.9 113.292 -179.138 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 177' ' ' ASP . . . . . 0.437 ' OD1' ' N ' ' B' ' 178' ' ' GLY . 1.1 p30 -134.58 -60.02 0.8 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.643 -0.253 . . . . 2.72 110.371 178.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 178' ' ' GLY . . . . . 0.916 ' O ' ' HB2' ' B' ' 174' ' ' CYS . . . -124.51 -175.12 14.22 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.503 -0.856 . . . . 0.99 111.683 178.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 179' ' ' CYS . . . . . 1.031 ' HA ' ' CB ' ' B' ' 174' ' ' CYS . 14.0 m -149.41 160.44 43.43 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 117.526 0.663 . . . . 1.34 111.958 179.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 180' ' ' HIS . . . . . 0.48 ' HA ' ' HA2' ' A' ' 78' ' ' GLY . 72.5 m80 -149.56 139.77 22.2 Favored 'General case' 0 C--N 1.35 0.612 0 C-N-CA 120.232 -0.587 . . . . 2.1 111.819 -178.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 181' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -64.78 125.89 26.22 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.968 -0.56 . . . . 3.06 109.693 178.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 182' ' ' ASP . . . . . 0.692 ' O ' ' HA2' ' B' ' 171' ' ' GLY . 0.0 OUTLIER -139.74 107.59 7.03 Favored Pre-proline 0 CA--C 1.541 0.634 0 CA-C-O 120.85 0.357 . . . . 2.06 111.236 -179.267 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 183' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_exo -62.79 -24.19 74.51 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 123.061 2.507 . . . . 1.91 114.384 -178.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -64.29 -10.52 24.45 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.102 0.408 . . . . 1.56 112.102 -179.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 185' ' ' CYS . . . . . 0.788 ' O ' ' HA ' ' B' ' 170' ' ' ALA . 1.6 m -129.1 10.03 5.8 Favored 'General case' 0 C--O 1.214 -0.784 0 CA-C-O 119.243 -0.408 . . . . 1.94 111.078 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 186' ' ' ASP . . . . . 0.549 ' O ' ' HB1' ' B' ' 170' ' ' ALA . 0.5 OUTLIER . . . . . 0 CA--C 1.511 -0.534 0 C-N-CA 119.186 -1.006 . . . . 3.61 112.511 -176.588 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 62.7 m . . . . . 0 CA--C 1.542 0.664 0 N-CA-C 112.719 0.637 . . . . 2.68 112.719 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.888 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 4.2 mp -31.22 135.31 0.23 Allowed Pre-proline 0 N--CA 1.483 1.192 0 N-CA-C 113.598 0.962 . . . . 2.48 113.598 -178.679 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.402 ' HG2' ' CG ' ' A' ' 43' ' ' ARG . 30.8 Cg_endo -97.47 114.72 0.11 Allowed 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 123.439 2.759 . . . . 1.49 116.251 -178.632 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.528 ' O ' ' HA2' ' A' ' 17' ' ' GLY . 0.5 OUTLIER -127.59 -176.32 3.72 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-O 121.823 0.82 . . . . 1.0 111.46 -178.463 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.404 ' CA ' ' HB2' ' A' ' 40' ' ' GLU . . . 74.17 -178.26 44.32 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 114.524 -1.217 . . . . 1.15 110.438 -178.37 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.473 ' O ' ' HG2' ' A' ' 15' ' ' PRO . 47.3 Cg_endo -63.28 130.92 30.16 Favored 'Trans proline' 0 CA--C 1.507 -0.851 0 N-CA-C 106.317 -2.224 . . . . 1.57 106.317 175.464 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 72.34 -4.16 20.49 Favored Glycine 0 N--CA 1.414 -2.832 0 CA-C-O 119.247 -0.752 . . . . 1.68 113.459 177.07 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.528 ' HA2' ' O ' ' A' ' 13' ' ' CYS . . . 76.53 38.44 32.74 Favored Glycine 1 N--CA 1.391 -4.347 0 C-N-CA 119.121 -1.514 . . . . 1.36 112.189 -178.747 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.42 ' CG ' ' O ' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -97.72 22.0 9.67 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.317 -0.442 . . . . 2.5 110.261 174.439 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -129.58 -175.46 14.05 Favored Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 104.912 -3.275 . . . . 1.02 104.912 177.846 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.724 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 2.7 mtp180 -119.3 159.73 23.58 Favored 'General case' 0 CA--C 1.552 1.045 0 CA-C-N 121.323 2.562 . . . . 2.92 108.444 176.708 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.888 ' HB2' ' HB3' ' A' ' 11' ' ' LEU . 10.7 m -109.09 148.9 30.11 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 119.881 1.219 . . . . 1.1 111.435 -179.742 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -128.38 -52.4 1.28 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.085 -0.507 . . . . 1.51 111.36 179.989 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.431 ' O ' ' HB3' ' A' ' 44' ' ' CYS . . . -119.84 -171.3 14.65 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.935 -0.65 . . . . 0.9 112.26 -179.816 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -68.79 -61.21 0.07 OUTLIER 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.635 2.223 . . . . 1.5 112.755 -179.693 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.609 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.4 OUTLIER -98.15 26.87 4.97 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.822 -0.172 . . . . 1.26 110.749 -179.999 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 1.033 HG12 HG13 ' A' ' 36' ' ' VAL . 3.3 mt -141.37 120.58 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 N-CA-C 113.542 0.941 . . . . 0.83 113.542 -178.307 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.789 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -120.43 140.25 51.65 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 107.653 -1.239 . . . . 0.92 107.653 178.188 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 1.016 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -143.96 100.1 3.51 Favored 'General case' 0 CA--C 1.552 1.05 0 N-CA-C 117.686 2.476 . . . . 1.28 117.686 -174.907 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -101.48 -172.48 28.25 Favored Glycine 0 N--CA 1.431 -1.687 0 N-CA-C 108.423 -1.871 . . . . 0.67 108.423 176.49 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -64.98 -62.75 1.37 Allowed 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 121.338 0.59 . . . . 2.27 112.268 -179.255 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.1 14.69 28.82 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 122.196 0.998 . . . . 1.66 111.365 -177.931 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.735 HD22 ' CE2' ' A' ' 35' ' ' PHE . 4.6 mt -115.88 -5.03 12.04 Favored 'General case' 0 N--CA 1.387 -3.593 0 N-CA-C 104.895 -2.261 . . . . 1.37 104.895 179.063 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 1.016 ' O ' ' HA ' ' A' ' 28' ' ' CYS . . . 43.7 -126.73 5.77 Favored Glycine 0 N--CA 1.432 -1.609 0 CA-C-N 114.243 -1.344 . . . . 0.73 113.918 175.941 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 1.023 ' HB2' HD13 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -132.52 107.95 8.79 Favored 'General case' 0 CA--C 1.49 -1.329 0 CA-C-N 118.008 0.904 . . . . 1.08 113.362 -179.365 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.922 ' HD1' ' HD1' ' B' ' 135' ' ' PHE . 84.7 m-85 -83.06 105.98 14.49 Favored 'General case' 0 N--CA 1.42 -1.93 0 N-CA-C 102.32 -3.215 . . . . 1.38 102.32 174.686 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 1.033 HG13 HG12 ' A' ' 26' ' ' ILE . 3.0 t -97.77 85.27 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.664 0 CA-C-O 123.036 1.398 . . . . 0.76 109.374 -176.992 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.609 ' N ' ' O ' ' A' ' 25' ' ' SER . . . 97.68 89.4 1.9 Allowed Glycine 0 CA--C 1.527 0.842 0 CA-C-N 112.492 -2.14 . . . . 0.81 115.45 178.621 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.684 HG21 ' CE1' ' B' ' 135' ' ' PHE . 0.5 OUTLIER -176.62 168.17 2.64 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 108.603 -0.888 . . . . 0.77 108.603 177.964 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.837 ' HA ' HD12 ' A' ' 42' ' ' LEU . . . -53.54 -26.79 22.65 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 115.781 1.771 . . . . 1.02 115.781 -176.648 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.646 ' OE1' HG23 ' A' ' 38' ' ' THR . 0.0 OUTLIER -66.33 -15.91 63.63 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 119.226 -0.99 . . . . 2.32 109.634 178.545 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.634 ' O ' ' N ' ' A' ' 44' ' ' CYS . . . -88.42 -24.05 23.15 Favored 'General case' 0 N--CA 1.425 -1.693 0 CA-C-O 119.283 -0.389 . . . . 0.87 111.026 -178.979 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.837 HD12 ' HA ' ' A' ' 39' ' ' ALA . 0.4 OUTLIER -44.5 -40.0 5.27 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 119.229 0.922 . . . . 1.23 112.197 179.873 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.412 ' HD3' ' HA ' ' A' ' 43' ' ' ARG . 10.8 tpp85 -64.48 -11.16 30.83 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.708 0.766 . . . . 2.92 109.748 177.713 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.634 ' N ' ' O ' ' A' ' 41' ' ' ALA . 88.8 m -73.61 -8.31 55.46 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 113.763 -1.562 . . . . 1.57 110.728 176.795 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -76.38 -6.73 52.92 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.071 0.397 . . . . 3.31 112.071 179.382 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -86.44 3.87 42.0 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.254 -0.579 . . . . 3.69 111.114 -178.926 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.624 ' HG2' ' O ' ' A' ' 44' ' ' CYS . 12.6 pt-20 . . . . . 0 N--CA 1.448 -0.552 0 N-CA-C 109.592 -0.521 . . . . 3.99 109.592 177.203 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.226 -0.173 0 CA-C-O 120.757 0.313 . . . . 3.12 110.328 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.573 ' O ' ' HB2' ' A' ' 66' ' ' ARG . . . -87.67 144.35 18.89 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 110.049 -1.22 . . . . 2.1 110.049 -176.868 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -101.62 74.83 1.54 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.859 0.838 . . . . 4.36 109.834 179.297 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.748 ' HB3' ' HB2' ' A' ' 67' ' ' CYS . 15.3 tppt? -144.28 57.33 4.8 Favored Pre-proline 0 C--N 1.308 -1.222 0 N-CA-C 106.686 -1.598 . . . . 3.55 106.686 178.072 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.45 ' CD ' ' N ' ' A' ' 59' ' ' LYS . 55.0 Cg_endo -69.1 84.79 0.54 Allowed 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 121.828 1.685 . . . . 1.54 114.343 -177.681 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.444 ' N ' ' O ' ' A' ' 65' ' ' GLY . 0.8 OUTLIER -104.41 -176.49 3.1 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 113.587 -1.642 . . . . 1.59 107.693 177.014 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 62.72 -165.95 23.54 Favored Glycine 0 CA--C 1.505 -0.592 0 C-N-CA 118.712 -1.709 . . . . 2.43 112.852 178.495 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -77.77 52.37 1.02 Allowed 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.635 -0.283 . . . . 4.11 111.49 -179.066 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 102.93 8.71 41.59 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-O 118.988 -0.895 . . . . 2.21 115.001 178.964 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.578 ' HA2' ' HA ' ' A' ' 75' ' ' SER . . . -102.84 138.8 14.14 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 118.575 -1.774 . . . . 1.62 115.38 -178.373 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.573 ' HB2' ' O ' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -102.38 154.34 19.17 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 114.285 -0.958 . . . . 3.02 110.534 179.014 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.748 ' HB2' ' HB3' ' A' ' 59' ' ' LYS . 5.5 t -56.31 109.22 0.57 Allowed 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 109.695 -0.483 . . . . 1.52 109.695 -179.108 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.576 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . . . -91.89 -17.73 24.81 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 107.898 -1.149 . . . . 1.07 107.898 178.773 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 1.06 ' HB3' HD11 ' A' ' 72' ' ' ILE . . . -165.64 156.4 13.53 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 112.946 -1.934 . . . . 1.0 109.262 179.943 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.818 ' O ' ' O ' ' A' ' 69' ' ' ALA . . . -18.11 -139.12 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 114.154 1.168 . . . . 1.24 114.154 -179.705 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.636 ' HA3' ' OD1' ' A' ' 86' ' ' ASP . . . -61.38 53.29 0.03 OUTLIER Glycine 0 N--CA 1.475 1.237 0 N-CA-C 111.387 -0.685 . . . . 1.28 111.387 -177.914 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 1.06 HD11 ' HB3' ' A' ' 69' ' ' ALA . 1.8 pp -151.94 97.96 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.257 1.49 0 CA-C-O 122.204 1.002 . . . . 2.27 109.095 168.804 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.6 ' HB3' ' HB3' ' A' ' 82' ' ' ASP . 0.9 OUTLIER -93.65 95.94 9.51 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.035 -0.984 . . . . 1.98 108.745 -178.872 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.81 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 16.5 m -92.65 162.35 14.2 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 114.512 1.301 . . . . 1.33 114.512 -176.182 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.796 ' HB2' ' HD2' ' A' ' 76' ' ' PRO . 58.6 p -125.16 179.42 1.13 Allowed Pre-proline 0 CA--C 1.531 0.224 0 CA-C-N 113.465 -1.698 . . . . 1.99 108.127 178.748 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.796 ' HD2' ' HB2' ' A' ' 75' ' ' SER . 71.9 Cg_endo -77.22 30.01 0.42 Allowed 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 121.304 1.336 . . . . 1.86 111.909 179.79 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.407 ' H ' ' C ' ' A' ' 75' ' ' SER . 1.6 t70 -145.92 -41.73 0.21 Allowed 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.652 -0.704 . . . . 2.65 110.887 179.971 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 1.247 ' HA3' ' O ' ' B' ' 179' ' ' CYS . . . -151.11 -141.63 3.38 Favored Glycine 0 C--N 1.337 0.591 0 C-N-CA 120.406 -0.902 . . . . 0.99 113.621 -179.815 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 1.214 ' O ' ' HA3' ' B' ' 178' ' ' GLY . 60.2 m -148.22 146.27 28.61 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 123.123 0.569 . . . . 1.34 110.486 -179.658 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.442 ' N ' ' O ' ' A' ' 73' ' ' CYS . 14.5 m80 -133.24 134.06 43.49 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 119.859 -0.737 . . . . 2.17 111.511 179.956 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.404 ' OE1' ' HG2' ' B' ' 124' ' ' PRO . 8.7 mt-10 -59.58 135.95 57.83 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 108.682 -0.858 . . . . 3.05 108.682 178.558 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.6 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 0.7 OUTLIER -142.96 128.97 10.36 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 116.395 -0.366 . . . . 2.02 110.998 -178.706 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 82' ' ' ASP . 15.2 Cg_exo -69.15 -31.29 23.56 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 123.212 2.608 . . . . 1.93 113.07 -179.198 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.62 -3.11 2.83 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.115 -0.493 . . . . 1.53 112.03 -179.705 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.672 ' HB3' ' C ' ' A' ' 70' ' ' ALA . 73.6 m -133.22 20.3 4.04 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 112.074 0.398 . . . . 1.88 112.074 -179.965 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.636 ' OD1' ' HA3' ' A' ' 71' ' ' GLY . 16.8 m-20 . . . . . 0 N--CA 1.449 -0.509 0 N-CA-C 113.805 1.039 . . . . 3.6 113.805 179.854 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 110' ' ' CYS . . . . . . . . . . . . . 64.4 m . . . . . 0 CA--C 1.536 0.419 0 N-CA-C 111.498 0.184 . . . . 2.61 111.498 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' B' B ' 111' ' ' LEU . . . . . 0.865 ' HB3' ' HB2' ' B' ' 121' ' ' CYS . 4.6 mp -33.59 135.22 0.32 Allowed Pre-proline 0 N--CA 1.476 0.827 0 N-CA-C 113.576 0.954 . . . . 2.47 113.576 179.854 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 112' ' ' PRO . . . . . 0.439 ' HG2' ' CG ' ' B' ' 143' ' ' ARG . 41.7 Cg_endo -93.92 122.69 0.42 Allowed 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 123.557 2.838 . . . . 1.47 112.776 179.656 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.473 ' O ' ' HA2' ' B' ' 117' ' ' GLY . 0.4 OUTLIER -135.37 -177.35 4.62 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-O 122.398 1.094 . . . . 1.0 111.248 177.409 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 114' ' ' GLY . . . . . 0.403 ' CA ' ' HB2' ' B' ' 140' ' ' GLU . . . 73.98 -178.41 43.48 Favored Glycine 0 N--CA 1.439 -1.109 0 CA-C-N 113.589 -1.642 . . . . 1.16 110.204 -177.863 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 115' ' ' PRO . . . . . 0.493 ' O ' ' HG2' ' B' ' 115' ' ' PRO . 41.3 Cg_endo -64.97 121.36 8.83 Favored 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 122.041 1.827 . . . . 1.57 109.676 176.13 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 74.52 7.49 79.11 Favored Glycine 0 C--N 1.281 -2.487 0 CA-C-N 115.497 -0.774 . . . . 1.7 113.176 179.61 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 117' ' ' GLY . . . . . 0.473 ' HA2' ' O ' ' B' ' 113' ' ' CYS . . . 74.85 33.45 55.29 Favored Glycine 0 N--CA 1.408 -3.192 0 C-N-CA 119.628 -1.272 . . . . 1.38 114.636 177.311 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 118' ' ' LYS . . . . . 0.411 ' CG ' ' O ' ' B' ' 115' ' ' PRO . 0.0 OUTLIER -91.91 14.34 15.94 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 122.212 0.205 . . . . 2.54 110.722 178.698 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 119' ' ' GLY . . . . . 0.472 ' HA3' ' SG ' ' B' ' 113' ' ' CYS . . . -115.42 -153.8 10.4 Favored Glycine 0 C--N 1.34 0.774 0 N-CA-C 108.198 -1.961 . . . . 1.04 108.198 179.193 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.828 ' HA ' ' O ' ' B' ' 111' ' ' LEU . 2.7 ttp180 -143.08 156.75 44.88 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 123.206 3.503 . . . . 2.89 103.11 172.858 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 121' ' ' CYS . . . . . 0.865 ' HB2' ' HB3' ' B' ' 111' ' ' LEU . 15.8 m -108.74 150.15 28.01 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 120.19 1.359 . . . . 1.07 111.862 -178.036 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -128.57 -52.57 1.26 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.78 -0.645 . . . . 1.53 111.169 179.89 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 123' ' ' GLY . . . . . 0.424 ' O ' ' HB3' ' B' ' 144' ' ' CYS . . . -119.83 -171.23 14.64 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.934 -0.651 . . . . 0.9 112.353 -179.889 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . 0.404 ' HG2' ' OE1' ' A' ' 81' ' ' GLU . 14.2 Cg_exo -68.81 -61.25 0.07 OUTLIER 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.674 2.249 . . . . 1.51 112.809 -179.697 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 125' ' ' SER . . . . . 0.607 ' O ' ' N ' ' B' ' 137' ' ' GLY . 0.4 OUTLIER -98.05 26.81 4.96 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.785 -0.189 . . . . 1.25 110.832 179.87 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 126' ' ' ILE . . . . . 1.081 HG12 HG13 ' B' ' 136' ' ' VAL . 4.1 mt -140.93 120.62 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 113.556 0.947 . . . . 0.85 113.556 -178.209 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 127' ' ' CYS . . . . . 0.778 ' O ' ' HA ' ' B' ' 134' ' ' CYS . 0.0 OUTLIER -121.02 140.17 52.29 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 107.55 -1.278 . . . . 0.89 107.55 177.854 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 128' ' ' CYS . . . . . 1.047 ' HA ' ' O ' ' B' ' 133' ' ' GLY . 0.0 OUTLIER -143.14 106.69 4.61 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 115.671 1.73 . . . . 1.23 115.671 -175.563 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 129' ' ' GLY . . . . . . . . . . . . . . . -109.47 -168.13 20.27 Favored Glycine 0 N--CA 1.422 -2.272 0 CA-C-N 123.698 2.954 . . . . 0.66 106.751 173.983 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -62.61 -70.95 0.17 Allowed 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 117.234 0.517 . . . . 2.35 110.572 -178.952 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.28 32.54 4.73 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 122.688 1.232 . . . . 1.69 110.135 -176.323 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 132' ' ' LEU . . . . . 0.749 HD22 ' CE2' ' B' ' 135' ' ' PHE . 4.0 mt -126.48 -4.74 6.58 Favored 'General case' 0 N--CA 1.385 -3.69 0 N-CA-C 103.845 -2.65 . . . . 1.38 103.845 175.568 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 133' ' ' GLY . . . . . 1.047 ' O ' ' HA ' ' B' ' 128' ' ' CYS . . . 43.95 -123.62 4.79 Favored Glycine 0 N--CA 1.406 -3.366 0 CA-C-N 114.226 -1.352 . . . . 0.72 114.907 174.793 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 134' ' ' CYS . . . . . 1.018 ' HB2' HD13 ' B' ' 172' ' ' ILE . 0.0 OUTLIER -136.66 105.01 5.72 Favored 'General case' 0 CA--C 1.494 -1.189 0 N-CA-C 114.322 1.23 . . . . 1.08 114.322 179.872 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 135' ' ' PHE . . . . . 0.922 ' HD1' ' HD1' ' A' ' 35' ' ' PHE . 82.1 m-85 -80.22 105.39 11.45 Favored 'General case' 0 N--CA 1.42 -1.928 0 N-CA-C 102.399 -3.185 . . . . 1.36 102.399 176.035 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 136' ' ' VAL . . . . . 1.081 HG13 HG12 ' B' ' 126' ' ' ILE . 5.9 t -97.9 84.64 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.671 0 CA-C-O 123.148 1.451 . . . . 0.75 109.24 -177.129 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 137' ' ' GLY . . . . . 0.607 ' N ' ' O ' ' B' ' 125' ' ' SER . . . 97.91 88.65 1.9 Allowed Glycine 0 CA--C 1.527 0.812 0 CA-C-N 112.254 -2.248 . . . . 0.83 115.475 178.442 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 138' ' ' THR . . . . . 0.713 HG21 ' CE1' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -172.14 175.65 3.67 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 108.796 -0.816 . . . . 0.78 108.796 178.045 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 139' ' ' ALA . . . . . 0.836 ' HA ' HD12 ' B' ' 142' ' ' LEU . . . -55.82 -40.41 72.73 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 118.818 0.736 . . . . 1.04 112.562 -178.262 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 140' ' ' GLU . . . . . 0.603 ' OE1' HG23 ' B' ' 138' ' ' THR . 0.0 OUTLIER -57.6 -13.94 4.6 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.089 -0.644 . . . . 2.31 110.862 -178.032 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 141' ' ' ALA . . . . . 0.668 ' O ' ' N ' ' B' ' 144' ' ' CYS . . . -87.12 -30.44 21.09 Favored 'General case' 0 C--O 1.213 -0.866 0 CA-C-N 116.223 -0.444 . . . . 0.87 110.122 179.754 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 142' ' ' LEU . . . . . 0.836 HD12 ' HA ' ' B' ' 139' ' ' ALA . 0.4 OUTLIER -40.86 -41.36 1.57 Allowed 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.462 0.542 . . . . 1.24 112.462 -178.604 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 143' ' ' ARG . . . . . 0.467 ' HA ' ' HD3' ' B' ' 143' ' ' ARG . 8.9 tpp85 -58.17 -23.46 55.44 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 108.37 -0.974 . . . . 2.93 108.37 177.619 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 144' ' ' CYS . . . . . 0.668 ' N ' ' O ' ' B' ' 141' ' ' ALA . 90.9 m -66.61 -5.76 12.76 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 113.889 -1.505 . . . . 1.61 110.596 -177.553 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -78.03 -6.28 54.05 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.847 0.356 . . . . 3.35 111.701 178.906 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -86.33 3.51 43.14 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.355 -0.538 . . . . 3.76 111.01 -178.981 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 147' ' ' GLU . . . . . 0.608 ' HG2' ' O ' ' B' ' 144' ' ' CYS . 12.6 pt-20 . . . . . 0 N--CA 1.449 -0.517 0 N-CA-C 109.656 -0.498 . . . . 4.01 109.656 177.281 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.45 -0.444 0 CA-C-O 119.879 -0.105 . . . . 3.11 111.028 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 157' ' ' GLY . . . . . 0.551 ' O ' ' HB2' ' B' ' 166' ' ' ARG . . . -109.09 146.02 16.64 Favored Glycine 0 CA--C 1.493 -1.342 0 N-CA-C 108.821 -1.712 . . . . 2.07 108.821 175.555 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 11.6 mt-30 -103.3 63.7 0.81 Allowed 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 117.354 -1.739 . . . . 4.34 111.363 -179.165 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 159' ' ' LYS . . . . . 0.876 ' HB3' ' HB2' ' B' ' 167' ' ' CYS . 11.2 tppt? -117.46 52.06 1.21 Allowed Pre-proline 0 C--N 1.314 -0.954 0 CA-C-O 116.694 -1.622 . . . . 3.54 110.294 172.118 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 160' ' ' PRO . . . . . 0.435 ' HA ' ' HA ' ' B' ' 166' ' ' ARG . 43.6 Cg_endo -68.38 86.16 0.43 Allowed 'Trans proline' 0 C--N 1.334 -0.231 0 CA-C-N 122.502 1.929 . . . . 1.51 115.03 -173.305 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 161' ' ' CYS . . . . . 0.448 ' N ' ' O ' ' B' ' 165' ' ' GLY . 0.7 OUTLIER -96.94 -166.57 1.42 Allowed 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 113.117 -1.856 . . . . 1.58 109.302 177.944 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 49.9 -164.67 0.56 Allowed Glycine 0 CA--C 1.524 0.613 0 C-N-CA 118.813 -1.66 . . . . 2.37 113.375 172.127 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -78.13 51.44 0.99 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.233 0.54 . . . . 4.07 111.907 -178.739 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 104.95 7.55 38.24 Favored Glycine 0 CA--C 1.533 1.211 0 N-CA-C 114.965 0.746 . . . . 2.2 114.965 178.281 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 165' ' ' GLY . . . . . 0.598 ' HA2' ' HA ' ' B' ' 175' ' ' SER . . . -101.07 136.25 12.6 Favored Glycine 0 C--O 1.224 -0.494 0 C-N-CA 119.044 -1.55 . . . . 1.62 115.885 -176.854 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 166' ' ' ARG . . . . . 0.551 ' HB2' ' O ' ' B' ' 157' ' ' GLY . 0.0 OUTLIER -102.23 154.17 19.28 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 114.469 -0.865 . . . . 3.05 110.6 178.935 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 167' ' ' CYS . . . . . 0.876 ' HB2' ' HB3' ' B' ' 159' ' ' LYS . 5.4 t -56.52 109.24 0.58 Allowed 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 109.721 -0.474 . . . . 1.56 109.721 -179.017 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 168' ' ' ALA . . . . . 0.579 ' HB3' ' SG ' ' B' ' 128' ' ' CYS . . . -92.31 -17.31 24.89 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 107.879 -1.156 . . . . 1.04 107.879 178.878 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 169' ' ' ALA . . . . . 1.021 ' HB3' HD11 ' B' ' 172' ' ' ILE . . . -165.83 155.89 12.66 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 113.063 -1.881 . . . . 0.98 109.13 179.856 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 170' ' ' ALA . . . . . 0.785 ' O ' ' O ' ' B' ' 169' ' ' ALA . . . -19.17 -134.94 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 114.418 1.266 . . . . 1.25 114.418 -179.623 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 171' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' B' ' 185' ' ' CYS . . . -46.69 19.77 0.0 OUTLIER Glycine 0 CA--C 1.536 1.383 0 N-CA-C 116.359 1.304 . . . . 1.29 116.359 -178.217 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 172' ' ' ILE . . . . . 1.021 HD11 ' HB3' ' B' ' 169' ' ' ALA . 1.8 pp -138.28 99.85 1.56 Allowed 'Isoleucine or valine' 0 C--O 1.251 1.164 0 CA-C-O 123.478 1.609 . . . . 2.27 111.198 -178.818 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 173' ' ' CYS . . . . . 0.593 ' HA ' ' HA ' ' B' ' 167' ' ' CYS . 1.1 t -92.92 95.54 9.56 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 113.523 -1.671 . . . . 1.94 109.022 -179.055 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 174' ' ' CYS . . . . . 0.848 ' HA ' ' HA ' ' B' ' 179' ' ' CYS . 16.3 m -92.82 162.6 14.04 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 114.52 1.304 . . . . 1.35 114.52 -176.25 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 175' ' ' SER . . . . . 0.789 ' HB2' ' HD2' ' B' ' 176' ' ' PRO . 55.6 p -125.27 179.42 1.14 Allowed Pre-proline 0 CA--C 1.532 0.262 0 CA-C-N 113.454 -1.703 . . . . 2.0 108.033 178.842 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 176' ' ' PRO . . . . . 0.789 ' HD2' ' HB2' ' B' ' 175' ' ' SER . 72.0 Cg_endo -77.27 30.14 0.42 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 121.283 1.322 . . . . 1.9 111.9 179.829 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 177' ' ' ASP . . . . . 0.416 ' H ' ' C ' ' B' ' 175' ' ' SER . 1.6 t70 -145.94 -41.79 0.21 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.644 -0.707 . . . . 2.72 110.921 179.939 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 178' ' ' GLY . . . . . 1.214 ' HA3' ' O ' ' A' ' 79' ' ' CYS . . . -150.97 -141.56 3.37 Favored Glycine 0 C--N 1.336 0.533 0 C-N-CA 120.588 -0.815 . . . . 0.99 113.727 -179.89 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 179' ' ' CYS . . . . . 1.247 ' O ' ' HA3' ' A' ' 78' ' ' GLY . 60.3 m -148.38 146.05 28.32 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 123.154 0.582 . . . . 1.34 110.53 -179.653 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 180' ' ' HIS . . . . . 0.455 ' N ' ' O ' ' B' ' 173' ' ' CYS . 14.6 m80 -132.97 134.14 44.1 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 119.797 -0.761 . . . . 2.1 111.508 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 181' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -59.67 135.93 57.83 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.712 -0.847 . . . . 3.06 108.712 178.506 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 182' ' ' ASP . . . . . 0.592 ' HB3' ' HB3' ' B' ' 173' ' ' CYS . 0.7 OUTLIER -143.0 128.94 10.32 Favored Pre-proline 0 C--N 1.319 -0.719 0 CA-C-N 116.443 -0.344 . . . . 2.06 111.069 -178.632 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 183' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -69.19 -31.34 23.29 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 123.188 2.592 . . . . 1.91 113.041 -179.106 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -64.41 -3.28 2.82 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.109 -0.496 . . . . 1.56 111.963 -179.729 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 185' ' ' CYS . . . . . 0.661 ' HB3' ' C ' ' B' ' 170' ' ' ALA . 70.6 m -133.25 20.26 4.02 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 112.227 0.454 . . . . 1.94 112.227 -179.855 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 186' ' ' ASP . . . . . 0.477 ' OD1' ' HA3' ' B' ' 171' ' ' GLY . 17.3 m-20 . . . . . 0 N--CA 1.448 -0.573 0 N-CA-C 113.858 1.058 . . . . 3.61 113.858 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.409 0 CA-C-O 121.097 0.475 . . . . 8.2 111.162 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.776 ' O ' HD22 ' A' ' 3' ' ' LEU . 11.4 p -66.94 119.29 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 CA-C-O 121.996 0.903 . . . . 7.12 111.119 179.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 1.205 HD21 ' CG ' ' A' ' 8' ' ' ARG . 0.3 OUTLIER -155.97 77.66 0.96 Allowed 'General case' 0 C--O 1.257 1.496 0 CA-C-N 113.603 -1.635 . . . . 4.54 107.074 -179.68 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.451 ' O ' HD23 ' A' ' 5' ' ' LEU . 0.8 OUTLIER -61.78 49.61 0.01 OUTLIER 'General case' 0 N--CA 1.439 -1.003 0 C-N-CA 117.858 -1.537 . . . . 6.12 110.248 -179.864 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.792 ' N ' ' O ' ' A' ' 3' ' ' LEU . 96.4 mt -153.51 -79.86 0.1 Allowed 'General case' 1 N--CA 1.377 -4.113 0 CA-C-O 122.611 1.196 . . . . 6.29 109.464 179.362 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -167.38 -63.54 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 113.28 -1.782 . . . . 6.84 113.466 -179.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.5 ' O ' HG13 ' A' ' 7' ' ' VAL . 7.4 p -150.02 121.57 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.8 0 N-CA-C 109.035 -0.728 . . . . 6.15 109.035 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 1.205 ' CG ' HD21 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -77.03 100.77 5.77 Favored 'General case' 0 N--CA 1.424 -1.756 0 CA-C-N 116.015 -0.539 . . . . 7.3 112.441 -179.402 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.473 HG23 ' O ' ' A' ' 9' ' ' THR . 7.1 t -103.57 95.67 6.21 Favored 'General case' 0 N--CA 1.428 -1.534 0 C-N-CA 114.962 -2.695 . . . . 4.01 104.191 172.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.5 m -74.93 79.96 2.16 Favored 'General case' 0 CA--C 1.556 1.2 0 CA-C-N 113.133 -1.849 . . . . 2.64 113.201 -177.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.596 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -34.82 113.29 0.46 Allowed Pre-proline 0 N--CA 1.491 1.609 0 CA-C-N 119.0 0.818 . . . . 2.75 111.661 179.461 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.472 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 71.5 Cg_endo -75.48 117.92 4.97 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 122.82 2.347 . . . . 1.66 113.309 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 5.7 p -130.93 -178.29 4.75 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 121.057 0.456 . . . . 1.3 111.702 178.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.465 ' HA2' ' HB3' ' A' ' 40' ' ' GLU . . . 77.21 -162.54 51.4 Favored Glycine 0 CA--C 1.519 0.303 0 CA-C-N 116.162 -0.472 . . . . 1.23 112.121 -178.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.407 ' O ' ' HG2' ' A' ' 15' ' ' PRO . 44.6 Cg_endo -65.8 100.29 0.42 Allowed 'Trans proline' 0 N--CA 1.48 0.692 0 C-N-CA 124.165 3.244 . . . . 1.78 111.886 177.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.03 5.89 76.29 Favored Glycine 0 C--N 1.299 -1.473 0 CA-C-N 115.316 -0.856 . . . . 1.96 113.465 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.472 ' O ' ' CB ' ' A' ' 12' ' ' PRO . . . 71.95 45.33 42.75 Favored Glycine 0 N--CA 1.426 -2.011 0 N-CA-C 115.71 1.044 . . . . 1.48 115.71 177.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.467 ' HB2' ' CD1' ' A' ' 32' ' ' LEU . 0.5 OUTLIER -94.89 -24.02 17.19 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 112.66 0.615 . . . . 3.06 112.66 -179.828 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -79.5 171.84 54.87 Favored Glycine 0 CA--C 1.495 -1.157 0 CA-C-N 115.235 -0.893 . . . . 1.16 111.64 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.596 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 0.8 OUTLIER -120.86 149.41 42.64 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 109.848 -0.427 . . . . 2.62 109.848 -178.62 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 57.0 m -98.64 127.02 44.42 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.988 0.899 . . . . 1.22 109.741 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.418 ' CE2' ' HB1' ' A' ' 68' ' ' ALA . 3.7 m-85 -109.89 -29.94 8.05 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 113.963 -1.472 . . . . 2.15 111.315 -177.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -157.03 -174.49 26.8 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 121.089 -0.577 . . . . 0.98 112.708 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.41 -54.27 5.22 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 122.747 2.298 . . . . 0.93 113.45 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.588 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.7 OUTLIER -120.65 36.32 4.61 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 122.462 -0.149 . . . . 0.96 111.207 179.695 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.892 HG12 HG13 ' A' ' 36' ' ' VAL . 19.7 mt -140.77 111.42 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 C-N-CA 120.32 -0.552 . . . . 0.99 111.896 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.579 ' SG ' ' O ' ' A' ' 20' ' ' ARG . 0.5 OUTLIER -126.49 120.71 30.39 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 116.528 -0.305 . . . . 1.2 110.19 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.887 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -131.07 127.85 39.03 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 119.526 -0.87 . . . . 1.13 112.65 -179.579 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 33' ' ' GLY . . . -103.92 -169.51 25.24 Favored Glycine 0 N--CA 1.421 -2.325 0 C-N-CA 120.45 -0.881 . . . . 0.79 111.858 178.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -69.87 -51.06 36.54 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 114.694 -0.753 . . . . 2.64 112.969 -178.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -121.08 9.42 10.52 Favored 'General case' 0 CA--C 1.503 -0.836 0 CA-C-N 115.041 -0.981 . . . . 2.1 109.437 -177.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.467 ' CD1' ' HB2' ' A' ' 18' ' ' LYS . 4.7 mt -109.67 -9.83 14.84 Favored 'General case' 0 N--CA 1.408 -2.569 0 N-CA-C 108.871 -0.789 . . . . 1.0 108.871 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.954 ' HA2' ' HB1' ' A' ' 69' ' ' ALA . . . 65.8 -136.0 35.64 Favored Glycine 0 N--CA 1.43 -1.751 0 C-N-CA 120.42 -0.895 . . . . 0.7 112.921 176.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.719 ' HB2' HD13 ' A' ' 72' ' ' ILE . 1.6 t -135.66 125.54 25.73 Favored 'General case' 0 CA--C 1.503 -0.827 0 N-CA-C 114.37 1.248 . . . . 0.94 114.37 -178.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.48 ' HA ' ' HA ' ' B' ' 135' ' ' PHE . 4.2 m-85 -98.88 101.03 12.29 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 104.655 -2.35 . . . . 1.84 104.655 176.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.892 HG13 HG12 ' A' ' 26' ' ' ILE . 3.8 t -87.06 94.48 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 CA-C-O 122.937 1.351 . . . . 0.59 110.603 -178.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.588 ' N ' ' O ' ' A' ' 25' ' ' SER . . . 76.95 83.63 0.5 Allowed Glycine 0 CA--C 1.499 -0.911 0 CA-C-N 112.028 -2.351 . . . . 1.32 112.186 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 19.2 p -149.95 169.08 22.02 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-O 120.972 0.415 . . . . 1.48 111.16 -178.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.683 ' HA ' HD12 ' A' ' 42' ' ' LEU . . . -55.08 -27.73 47.09 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.867 -0.606 . . . . 1.28 110.781 179.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.465 ' HB3' ' HA2' ' A' ' 14' ' ' GLY . 30.1 mp0 -73.56 -29.21 62.29 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 112.665 0.617 . . . . 2.56 112.665 -179.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.422 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . . . -97.55 -1.35 44.13 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 120.701 0.286 . . . . 0.95 110.38 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.683 HD12 ' HA ' ' A' ' 39' ' ' ALA . 1.6 mt -57.61 -32.98 67.75 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 120.939 0.4 . . . . 1.99 110.308 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.7 ptm85 -72.13 -9.07 57.92 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.89 -0.596 . . . . 3.75 110.594 179.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 94.4 m -69.36 -10.18 56.76 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 120.198 -0.601 . . . . 1.32 111.389 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -54.96 -24.76 25.46 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.109 0.48 . . . . 2.8 110.928 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -85.83 5.01 34.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.241 -0.436 . . . . 3.55 110.434 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -80.31 -7.93 59.26 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 108.789 -0.819 . . . . 2.79 108.789 179.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -73.23 -28.79 62.36 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 109.011 -0.737 . . . . 3.48 109.011 177.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -83.91 6.2 22.55 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.948 -0.569 . . . . 6.08 111.451 179.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.6 mp -134.98 97.09 13.95 Favored Pre-proline 0 C--O 1.233 0.231 0 N-CA-C 109.761 -0.459 . . . . 3.65 109.761 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -85.21 29.13 0.54 Allowed 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.026 2.484 . . . . 5.28 113.029 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 30.9 p -134.6 117.96 13.35 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.324 -0.398 . . . . 5.56 110.647 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.37 -166.9 0.22 Allowed 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 121.843 1.695 . . . . 4.53 110.994 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.65 ' SG ' ' HB2' ' A' ' 8' ' ' ARG . 4.0 t -126.4 92.53 3.58 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.77 -0.826 . . . . 2.92 108.77 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.46 ' O ' ' CB ' ' A' ' 56' ' ' SER . 33.4 tt0 53.93 -97.88 0.07 Allowed 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 117.694 -1.603 . . . . 4.75 110.52 -178.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.46 ' CB ' ' O ' ' A' ' 55' ' ' GLN . 1.9 t 92.55 142.3 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.687 0.795 . . . . 3.86 110.835 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.492 ' O ' ' HB2' ' A' ' 66' ' ' ARG . . . -66.12 120.44 15.93 Favored Glycine 0 N--CA 1.429 -1.782 0 C-N-CA 120.213 -0.994 . . . . 2.88 110.827 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.61 77.58 6.21 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 107.886 -1.153 . . . . 5.45 107.886 179.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.482 ' O ' ' HA ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -146.33 58.26 4.45 Favored Pre-proline 0 C--N 1.306 -1.318 0 CA-C-N 114.933 -1.03 . . . . 6.09 108.868 -179.524 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 59' ' ' LYS . 36.8 Cg_endo -64.63 85.5 0.17 Allowed 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.584 2.189 . . . . 2.54 112.235 179.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.506 ' N ' ' O ' ' A' ' 65' ' ' GLY . 0.5 OUTLIER -108.41 -179.4 3.87 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.624 -0.717 . . . . 2.27 109.083 179.44 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.08 -161.01 44.94 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 117.859 -2.115 . . . . 2.47 111.816 178.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 50.9 m -78.79 45.33 0.59 Allowed 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 120.689 0.281 . . . . 3.28 111.637 -179.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 105.28 16.07 17.53 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 120.945 -0.645 . . . . 2.3 114.674 178.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.506 ' O ' ' N ' ' A' ' 61' ' ' CYS . . . -103.7 132.85 11.22 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 119.822 -1.18 . . . . 1.86 114.738 -179.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.492 ' HB2' ' O ' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -93.61 159.16 15.34 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 122.49 0.316 . . . . 3.36 110.95 178.335 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 13.8 t -70.05 106.37 3.21 Favored 'General case' 0 N--CA 1.432 -1.363 0 C-N-CA 119.782 -0.767 . . . . 1.64 109.438 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.418 ' HB1' ' CE2' ' A' ' 22' ' ' PHE . . . -93.15 -17.57 23.59 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.906 0.384 . . . . 1.21 110.613 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.954 ' HB1' ' HA2' ' A' ' 33' ' ' GLY . . . -168.11 164.21 13.45 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 115.969 -0.56 . . . . 1.05 110.377 -178.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.97 ' CB ' ' HB3' ' A' ' 89' ' ' ALA . . . -45.17 121.76 3.04 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 114.218 1.192 . . . . 1.63 114.218 -177.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.649 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . 59.86 31.44 71.96 Favored Glycine 0 CA--C 1.506 -0.526 0 CA-C-N 113.479 -1.691 . . . . 1.58 115.673 176.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.779 HD12 ' SG ' ' A' ' 74' ' ' CYS . 1.3 pt -142.37 112.6 2.73 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-O 122.015 0.912 . . . . 2.04 111.976 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.71 ' HB2' ' HB3' ' A' ' 82' ' ' ASP . 0.0 OUTLIER -93.07 94.2 8.73 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 114.72 -1.127 . . . . 1.72 109.14 179.302 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.779 ' SG ' HD12 ' A' ' 72' ' ' ILE . 43.7 m -102.4 147.94 26.1 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.295 0.569 . . . . 1.37 111.469 -179.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.494 ' CB ' ' HD2' ' A' ' 76' ' ' PRO . 0.3 OUTLIER -122.64 -179.12 0.72 Allowed Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 114.632 -1.167 . . . . 2.25 108.813 179.615 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.494 ' HD2' ' CB ' ' A' ' 75' ' ' SER . 58.0 Cg_endo -74.26 32.6 0.34 Allowed 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 121.883 1.722 . . . . 2.7 112.954 -179.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.475 ' HB3' ' NE2' ' B' ' 180' ' ' HIS . 5.4 m-20 -147.54 -49.68 0.18 Allowed 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.876 -0.602 . . . . 2.63 111.002 178.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.564 ' HA3' ' O ' ' B' ' 179' ' ' CYS . . . -143.69 -152.2 5.61 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 120.412 -0.899 . . . . 0.75 113.727 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.573 ' HA ' ' HA ' ' A' ' 74' ' ' CYS . 5.0 m -138.46 149.82 45.84 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.045 -0.578 . . . . 1.23 110.156 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.636 ' O ' ' N ' ' A' ' 73' ' ' CYS . 0.1 OUTLIER -147.41 145.46 29.24 Favored 'General case' 0 CA--C 1.513 -0.474 0 O-C-N 121.516 -0.74 . . . . 3.01 111.408 -178.404 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -67.95 144.58 55.14 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.344 -0.613 . . . . 2.9 109.344 178.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.71 ' HB3' ' HB2' ' A' ' 73' ' ' CYS . 2.2 p-10 -146.34 121.2 5.41 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 116.066 -0.515 . . . . 2.52 110.055 -177.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 82' ' ' ASP . 38.4 Cg_exo -61.83 -15.08 40.4 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.776 2.317 . . . . 2.98 114.385 -178.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.16 -44.84 78.74 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.908 0.385 . . . . 2.42 111.814 -179.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.962 ' O ' ' HB2' ' A' ' 89' ' ' ALA . 14.0 m -106.04 26.16 10.06 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.681 0.753 . . . . 2.16 109.919 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.653 ' N ' ' HD2' ' A' ' 87' ' ' PRO . 11.6 t0 -85.5 -45.73 0.63 Allowed Pre-proline 0 C--N 1.309 -1.175 0 O-C-N 121.308 -0.87 . . . . 3.14 112.425 -179.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 1.047 ' O ' ' N ' ' A' ' 89' ' ' ALA . 6.1 Cg_exo -59.39 132.5 46.68 Favored 'Trans proline' 0 CA--C 1.483 -2.054 0 N-CA-C 106.688 -2.082 . . . . 2.96 106.688 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.995 ' C ' ' O ' ' A' ' 87' ' ' PRO . 34.3 mm-40 -5.97 75.17 0.0 OUTLIER 'General case' 0 N--CA 1.409 -2.495 0 N-CA-C 101.704 -3.443 . . . . 6.0 101.704 -178.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 1.047 ' N ' ' O ' ' A' ' 87' ' ' PRO . . . -32.91 -30.99 0.01 OUTLIER 'General case' 0 CA--C 1.494 -1.199 0 CA-C-N 113.141 -1.845 . . . . 6.54 111.642 -170.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.58 ' N ' ' O ' ' A' ' 88' ' ' GLU . . . -90.44 166.72 13.1 Favored 'General case' 0 N--CA 1.423 -1.799 0 N-CA-C 103.262 -2.866 . . . . 8.02 103.262 174.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.497 ' O ' ' O ' ' A' ' 92' ' ' SER . 2.7 m-85 -85.86 78.37 9.53 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 121.943 2.156 . . . . 12.31 112.35 -179.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.497 ' O ' ' O ' ' A' ' 91' ' ' PHE . 9.4 t . . . . . 0 C--O 1.246 0.888 0 CA-C-O 118.134 -0.936 . . . . 12.79 111.268 178.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.264 0 CA-C-O 121.548 0.69 . . . . 8.8 111.11 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 6.0 t 60.82 117.42 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.523 0 CA-C-O 123.637 1.684 . . . . 7.16 112.132 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 103' ' ' LEU . . . . . 0.759 HD22 ' N ' ' B' ' 108' ' ' ARG . 2.1 pt? -145.98 139.46 26.17 Favored 'General case' 0 C--N 1.282 -2.336 1 N-CA-C 99.463 -4.273 . . . . 4.51 99.463 175.486 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 104' ' ' ASP . . . . . 0.515 ' O ' HD23 ' B' ' 105' ' ' LEU . 0.4 OUTLIER -64.93 64.23 0.02 OUTLIER 'General case' 0 N--CA 1.429 -1.518 0 C-N-CA 117.647 -1.621 . . . . 6.19 111.073 -173.104 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . 0.694 ' N ' ' O ' ' B' ' 103' ' ' LEU . 70.4 mt -154.3 -83.76 0.07 Allowed 'General case' 1 N--CA 1.372 -4.375 0 CA-C-O 122.825 1.297 . . . . 6.29 111.23 -179.125 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 106' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -169.15 -54.34 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 113.022 -1.899 . . . . 7.05 113.053 -177.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 107' ' ' VAL . . . . . 0.65 ' N ' HD21 ' B' ' 103' ' ' LEU . 8.3 p -147.43 119.08 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.794 0 CA-C-O 121.526 0.679 . . . . 6.18 109.439 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 108' ' ' ARG . . . . . 0.759 ' N ' HD22 ' B' ' 103' ' ' LEU . 0.0 OUTLIER -77.33 104.12 7.66 Favored 'General case' 0 N--CA 1.401 -2.91 0 CA-C-N 114.306 -1.316 . . . . 7.3 109.749 179.457 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 109' ' ' THR . . . . . 0.456 ' O ' HG23 ' B' ' 109' ' ' THR . 4.4 t -107.05 95.25 5.59 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 103.642 -2.725 . . . . 4.05 103.642 171.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 110' ' ' CYS . . . . . . . . . . . . . 1.3 m -75.71 79.27 2.67 Favored 'General case' 0 CA--C 1.552 1.037 0 CA-C-N 112.633 -2.076 . . . . 2.64 113.097 -175.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 111' ' ' LEU . . . . . 0.617 ' O ' ' HA ' ' B' ' 120' ' ' ARG . 0.7 OUTLIER -33.78 112.82 0.41 Allowed Pre-proline 0 N--CA 1.483 1.214 0 CA-C-N 118.554 0.616 . . . . 2.77 112.485 179.533 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 112' ' ' PRO . . . . . 0.46 ' CB ' ' O ' ' B' ' 117' ' ' GLY . 73.3 Cg_endo -75.87 119.44 5.4 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.7 2.267 . . . . 1.7 114.171 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . . . . . . . . . 4.3 p -133.09 -178.16 4.84 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 120.502 -0.479 . . . . 1.26 112.137 178.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 114' ' ' GLY . . . . . 0.467 ' HA2' ' HB3' ' B' ' 140' ' ' GLU . . . 77.17 -162.23 51.25 Favored Glycine 0 CA--C 1.522 0.5 0 CA-C-N 116.037 -0.529 . . . . 1.2 111.999 -177.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 115' ' ' PRO . . . . . 0.406 ' O ' ' HG2' ' B' ' 115' ' ' PRO . 45.1 Cg_endo -66.19 99.32 0.41 Allowed 'Trans proline' 0 N--CA 1.478 0.588 0 C-N-CA 124.089 3.192 . . . . 1.78 112.089 177.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 89.12 5.95 72.33 Favored Glycine 0 C--N 1.298 -1.541 0 CA-C-N 115.404 -0.816 . . . . 1.94 113.436 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 117' ' ' GLY . . . . . 0.46 ' O ' ' CB ' ' B' ' 112' ' ' PRO . . . 72.24 45.03 41.52 Favored Glycine 0 N--CA 1.425 -2.064 0 C-N-CA 120.386 -0.911 . . . . 1.48 115.268 177.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 118' ' ' LYS . . . . . 0.457 ' HB2' ' CD1' ' B' ' 132' ' ' LEU . 0.4 OUTLIER -94.29 -24.67 17.34 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 121.153 0.502 . . . . 3.07 111.94 -179.601 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . -78.84 173.06 55.35 Favored Glycine 0 N--CA 1.438 -1.227 0 C-N-CA 120.589 -0.815 . . . . 1.16 111.893 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.617 ' HA ' ' O ' ' B' ' 111' ' ' LEU . 0.7 OUTLIER -120.85 149.0 43.27 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 110.024 -0.362 . . . . 2.63 110.024 -179.508 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 121' ' ' CYS . . . . . . . . . . . . . 57.3 m -98.16 127.63 44.21 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 119.639 -0.825 . . . . 1.21 110.203 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 122' ' ' PHE . . . . . 0.404 ' CE2' ' HB1' ' B' ' 168' ' ' ALA . 3.5 m-85 -110.9 -28.41 8.38 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 114.413 -1.267 . . . . 2.14 111.657 -177.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -158.12 -175.65 29.29 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 121.149 -0.548 . . . . 0.99 112.445 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -52.42 -54.09 5.78 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 122.85 2.366 . . . . 0.96 113.447 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 125' ' ' SER . . . . . 0.57 ' O ' ' N ' ' B' ' 137' ' ' GLY . 1.0 OUTLIER -121.0 36.77 4.5 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 122.413 -0.18 . . . . 1.0 110.961 179.671 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 126' ' ' ILE . . . . . 0.478 HG12 HG13 ' B' ' 136' ' ' VAL . 16.0 mt -139.72 111.02 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 C-N-CA 120.499 -0.48 . . . . 0.97 112.047 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 127' ' ' CYS . . . . . 0.559 ' SG ' ' O ' ' B' ' 120' ' ' ARG . 0.5 OUTLIER -127.55 119.74 26.66 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 110.099 -0.334 . . . . 1.19 110.099 179.677 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 128' ' ' CYS . . . . . 0.926 ' HA ' ' O ' ' B' ' 133' ' ' GLY . 0.0 OUTLIER -130.09 128.18 41.36 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 119.952 -0.699 . . . . 1.12 112.608 -178.941 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 129' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' B' ' 133' ' ' GLY . . . -105.48 -169.19 23.72 Favored Glycine 0 N--CA 1.418 -2.506 0 C-N-CA 120.065 -1.064 . . . . 0.78 111.989 178.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -70.41 -51.62 28.21 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 115.126 -0.537 . . . . 2.63 112.351 -177.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.8 30.61 5.46 Favored 'General case' 0 CA--C 1.503 -0.861 0 N-CA-C 108.861 -0.792 . . . . 2.1 108.861 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 132' ' ' LEU . . . . . 0.457 ' CD1' ' HB2' ' B' ' 118' ' ' LYS . 3.8 mt -127.06 -7.8 5.98 Favored 'General case' 0 N--CA 1.396 -3.159 0 N-CA-C 106.752 -1.573 . . . . 0.98 106.752 177.374 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 133' ' ' GLY . . . . . 0.996 ' HA2' ' HB1' ' B' ' 169' ' ' ALA . . . 61.87 -136.36 46.4 Favored Glycine 0 N--CA 1.427 -1.942 0 CA-C-N 115.283 -0.871 . . . . 0.68 113.851 176.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 134' ' ' CYS . . . . . 0.749 ' HB2' HD13 ' B' ' 172' ' ' ILE . 1.6 t -134.36 126.24 29.23 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 114.5 1.296 . . . . 0.96 114.5 -178.044 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 135' ' ' PHE . . . . . 0.48 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 4.8 m-85 -99.28 101.09 12.28 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 104.455 -2.424 . . . . 1.84 104.455 176.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 136' ' ' VAL . . . . . 0.478 HG13 HG12 ' B' ' 126' ' ' ILE . 38.3 t -85.58 93.76 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 CA-C-O 122.97 1.367 . . . . 0.6 110.072 -178.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 137' ' ' GLY . . . . . 0.57 ' N ' ' O ' ' B' ' 125' ' ' SER . . . 75.32 84.75 0.35 Allowed Glycine 0 CA--C 1.502 -0.729 0 CA-C-N 112.136 -2.302 . . . . 1.33 112.448 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 138' ' ' THR . . . . . . . . . . . . . 19.1 p -150.22 169.64 20.85 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 120.9 0.381 . . . . 1.48 111.172 -179.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 139' ' ' ALA . . . . . 0.685 ' HA ' HD12 ' B' ' 142' ' ' LEU . . . -55.39 -27.65 49.0 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.038 -0.528 . . . . 1.3 110.805 179.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 140' ' ' GLU . . . . . 0.467 ' HB3' ' HA2' ' B' ' 114' ' ' GLY . 30.2 mp0 -73.52 -29.14 62.28 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 112.542 0.571 . . . . 2.53 112.542 -179.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 141' ' ' ALA . . . . . 0.443 ' HB2' ' HB2' ' B' ' 127' ' ' CYS . . . -97.47 -0.91 45.28 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 120.713 0.292 . . . . 0.98 110.489 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 142' ' ' LEU . . . . . 0.685 HD12 ' HA ' ' B' ' 139' ' ' ALA . 1.6 mt -58.02 -33.05 68.53 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 121.031 0.443 . . . . 2.02 110.318 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 143' ' ' ARG . . . . . . . . . . . . . 2.0 ptm85 -71.96 -9.2 58.03 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.883 -0.599 . . . . 3.76 110.606 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 144' ' ' CYS . . . . . . . . . . . . . 94.2 m -69.48 -9.89 55.71 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 120.169 -0.613 . . . . 1.37 111.414 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -55.04 -24.96 27.41 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.072 0.463 . . . . 2.78 110.802 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -85.81 5.41 32.7 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 116.351 -0.386 . . . . 3.53 110.495 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -80.49 -7.49 59.2 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 108.879 -0.786 . . . . 2.81 108.879 178.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 148' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -74.0 -28.62 61.54 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 108.76 -0.83 . . . . 3.48 108.76 177.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -84.0 6.71 20.96 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.914 -0.585 . . . . 6.08 111.377 179.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 2.9 mp -135.46 96.67 13.59 Favored Pre-proline 0 C--O 1.233 0.223 0 N-CA-C 109.87 -0.418 . . . . 3.66 109.87 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 151' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -85.53 29.62 0.52 Allowed 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.941 2.428 . . . . 5.29 112.97 -179.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 51.6 p -135.28 117.65 12.52 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.359 -0.382 . . . . 5.57 110.496 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 153' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.77 -167.97 0.25 Allowed 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.036 1.824 . . . . 4.53 111.194 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 154' ' ' CYS . . . . . 0.622 ' SG ' ' HB2' ' B' ' 108' ' ' ARG . 4.0 t -125.61 90.4 3.21 Favored 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 109.189 -0.671 . . . . 2.92 109.189 179.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 155' ' ' GLN . . . . . 0.494 ' O ' ' CB ' ' B' ' 156' ' ' SER . 37.1 tt0 55.12 -98.23 0.08 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 118.4 -1.32 . . . . 4.77 109.783 -178.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 156' ' ' SER . . . . . 0.494 ' CB ' ' O ' ' B' ' 155' ' ' GLN . 1.8 t 92.95 137.55 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.235 0.614 . . . . 3.9 111.007 178.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 157' ' ' GLY . . . . . 0.44 ' O ' ' HB2' ' B' ' 166' ' ' ARG . . . -62.04 120.62 22.79 Favored Glycine 0 N--CA 1.441 -0.971 0 C-N-CA 120.159 -1.02 . . . . 2.89 111.025 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.36 60.11 3.67 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.691 0.758 . . . . 5.47 110.27 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 159' ' ' LYS . . . . . 0.576 ' HB2' ' CB ' ' B' ' 167' ' ' CYS . 0.1 OUTLIER -115.42 55.41 1.01 Allowed Pre-proline 0 N--CA 1.443 -0.778 0 CA-C-N 114.766 -1.107 . . . . 6.05 111.541 176.076 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 160' ' ' PRO . . . . . 0.437 ' HA ' ' HA ' ' B' ' 166' ' ' ARG . 30.1 Cg_endo -63.09 85.57 0.12 Allowed 'Trans proline' 0 CA--C 1.531 0.336 0 CA-C-N 121.306 1.502 . . . . 2.53 113.794 -178.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 161' ' ' CYS . . . . . 0.512 ' N ' ' O ' ' B' ' 165' ' ' GLY . 0.5 OUTLIER -109.61 -179.65 3.88 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.05 -0.523 . . . . 2.24 109.705 179.504 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 66.68 -160.75 47.14 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 118.26 -1.924 . . . . 2.45 111.642 178.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 39.0 m -78.57 43.77 0.49 Allowed 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 116.802 0.301 . . . . 3.26 111.53 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 106.86 15.9 15.35 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 120.74 -0.743 . . . . 2.3 114.588 178.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 165' ' ' GLY . . . . . 0.512 ' O ' ' N ' ' B' ' 161' ' ' CYS . . . -103.61 134.08 11.74 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.044 -1.074 . . . . 1.83 114.444 -179.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 166' ' ' ARG . . . . . 0.502 ' HA ' ' O ' ' B' ' 159' ' ' LYS . 0.0 OUTLIER -95.27 158.64 15.37 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 115.415 -0.393 . . . . 3.34 110.875 178.254 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 167' ' ' CYS . . . . . 0.576 ' CB ' ' HB2' ' B' ' 159' ' ' LYS . 14.1 t -70.17 106.1 3.17 Favored 'General case' 0 N--CA 1.435 -1.218 0 C-N-CA 119.731 -0.788 . . . . 1.61 109.342 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 168' ' ' ALA . . . . . 0.404 ' HB1' ' CE2' ' B' ' 122' ' ' PHE . . . -93.12 -18.81 22.15 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.205 0.526 . . . . 1.22 110.782 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 169' ' ' ALA . . . . . 0.996 ' HB1' ' HA2' ' B' ' 133' ' ' GLY . . . -165.63 164.94 19.09 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 115.466 -0.788 . . . . 1.04 110.53 -178.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 170' ' ' ALA . . . . . 0.994 ' CB ' ' HB3' ' B' ' 189' ' ' ALA . . . -46.89 121.71 3.82 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 114.762 1.393 . . . . 1.63 114.762 -177.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 171' ' ' GLY . . . . . 0.759 ' N ' ' O ' ' B' ' 185' ' ' CYS . . . 61.83 29.66 72.94 Favored Glycine 0 C--N 1.315 -0.633 0 CA-C-N 113.974 -1.466 . . . . 1.49 115.896 177.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 172' ' ' ILE . . . . . 0.77 HD12 ' SG ' ' B' ' 174' ' ' CYS . 1.3 pt -142.58 113.71 2.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 118.331 1.066 . . . . 2.05 111.95 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 173' ' ' CYS . . . . . 0.764 ' HB2' ' HB3' ' B' ' 182' ' ' ASP . 0.0 OUTLIER -94.22 93.93 8.05 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 114.56 -1.2 . . . . 1.73 108.81 179.692 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 174' ' ' CYS . . . . . 0.77 ' SG ' HD12 ' B' ' 172' ' ' ILE . 37.2 m -102.22 148.0 25.96 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.458 0.646 . . . . 1.35 111.745 -179.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 175' ' ' SER . . . . . 0.505 ' CB ' ' HD2' ' B' ' 176' ' ' PRO . 0.3 OUTLIER -122.88 -179.26 0.76 Allowed Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 114.627 -1.169 . . . . 2.25 108.914 179.792 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 176' ' ' PRO . . . . . 0.505 ' HD2' ' CB ' ' B' ' 175' ' ' SER . 57.9 Cg_endo -74.02 32.61 0.34 Allowed 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 121.811 1.674 . . . . 2.68 113.044 -179.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 177' ' ' ASP . . . . . 0.457 ' HB3' ' NE2' ' A' ' 80' ' ' HIS . 5.1 m-20 -147.69 -49.53 0.17 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.915 -0.584 . . . . 2.66 110.949 178.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 178' ' ' GLY . . . . . 0.555 ' HA3' ' O ' ' A' ' 79' ' ' CYS . . . -143.49 -151.57 5.49 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 120.492 -0.861 . . . . 0.75 113.944 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 179' ' ' CYS . . . . . 0.602 ' HA ' ' HA ' ' B' ' 174' ' ' CYS . 4.8 m -139.42 149.24 43.83 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 114.879 -0.66 . . . . 1.24 110.095 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 180' ' ' HIS . . . . . 0.613 ' O ' ' N ' ' B' ' 173' ' ' CYS . 0.1 OUTLIER -146.88 145.74 29.94 Favored 'General case' 0 CA--C 1.511 -0.547 0 C-N-CA 119.807 -0.757 . . . . 3.0 111.41 -178.436 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 181' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -67.9 145.26 54.75 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 120.175 -0.61 . . . . 2.9 109.48 178.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 182' ' ' ASP . . . . . 0.764 ' HB3' ' HB2' ' B' ' 173' ' ' CYS . 1.8 p-10 -146.9 121.05 5.11 Favored Pre-proline 0 C--N 1.319 -0.753 0 CA-C-N 116.196 -0.456 . . . . 2.49 110.412 -178.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 183' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -61.51 -14.8 37.35 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 122.653 2.236 . . . . 2.94 114.448 -178.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -67.55 -44.98 76.97 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.846 0.355 . . . . 2.37 111.647 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 185' ' ' CYS . . . . . 0.951 ' O ' ' HB2' ' B' ' 189' ' ' ALA . 11.9 m -106.91 28.87 7.56 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.629 0.728 . . . . 2.13 110.767 -179.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 186' ' ' ASP . . . . . 0.664 ' N ' ' HD2' ' B' ' 187' ' ' PRO . 11.8 t0 -89.05 -46.21 0.43 Allowed Pre-proline 0 C--N 1.319 -0.738 0 CA-C-N 115.835 -0.62 . . . . 3.11 112.52 -179.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 187' ' ' PRO . . . . . 1.093 ' O ' ' N ' ' B' ' 189' ' ' ALA . 3.5 Cg_exo -57.27 136.95 79.37 Favored 'Trans proline' 0 CA--C 1.484 -1.984 0 N-CA-C 105.257 -2.632 . . . . 2.91 105.257 178.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 188' ' ' GLU . . . . . 1.158 ' O ' ' O ' ' B' ' 190' ' ' ALA . 24.5 mm-40 -11.1 79.06 0.0 OUTLIER 'General case' 0 CA--C 1.471 -2.076 0 N-CA-C 101.682 -3.451 . . . . 5.97 101.682 -178.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 189' ' ' ALA . . . . . 1.093 ' N ' ' O ' ' B' ' 187' ' ' PRO . . . -36.96 -27.4 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 114.051 -1.431 . . . . 6.55 111.609 -170.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 190' ' ' ALA . . . . . 1.158 ' O ' ' O ' ' B' ' 188' ' ' GLU . . . -92.37 164.36 13.53 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 103.205 -2.887 . . . . 8.01 103.205 173.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 191' ' ' PHE . . . . . 0.535 ' O ' ' O ' ' B' ' 192' ' ' SER . 2.5 m-85 -84.73 77.95 9.97 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 121.853 2.115 . . . . 12.3 112.537 -179.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 192' ' ' SER . . . . . 0.535 ' O ' ' O ' ' B' ' 191' ' ' PHE . 9.1 t . . . . . 0 C--O 1.244 0.815 0 CA-C-O 118.022 -0.99 . . . . 12.79 111.375 178.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.923 ' O ' HG12 ' A' ' 2' ' ' VAL . . . . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.501 0.191 . . . . 9.95 111.242 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.923 HG12 ' O ' ' A' ' 1' ' ' ALA . 1.0 OUTLIER 88.91 57.44 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 C-N-CA 124.265 1.026 . . . . 8.02 112.915 -179.875 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.899 HD22 ' O ' ' A' ' 2' ' ' VAL . 0.2 OUTLIER -169.72 102.43 0.32 Allowed 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 108.433 -0.951 . . . . 5.86 108.433 177.684 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.482 ' HB2' ' HG2' ' A' ' 55' ' ' GLN . 0.2 OUTLIER -92.6 8.28 39.68 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 116.876 2.176 . . . . 6.22 116.876 -174.13 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.772 HD12 HD12 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -80.78 -70.64 0.51 Allowed 'General case' 0 N--CA 1.424 -1.742 0 CA-C-N 121.17 1.805 . . . . 7.09 110.449 -178.969 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.761 ' H ' HD13 ' A' ' 5' ' ' LEU . 0.2 OUTLIER -156.4 -117.77 0.03 OUTLIER 'General case' 0 C--N 1.267 -3.014 0 N-CA-C 101.597 -3.483 . . . . 8.78 101.597 -178.62 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.428 ' O ' HD11 ' A' ' 5' ' ' LEU . 2.5 m -84.55 176.03 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.482 -1.664 0 N-CA-C 103.936 -2.616 . . . . 7.51 103.936 179.065 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.629 ' CB ' ' HG ' ' A' ' 3' ' ' LEU . 2.8 mtm-85 -73.65 108.5 6.53 Favored 'General case' 0 N--CA 1.426 -1.668 1 CA-C-N 126.481 4.219 . . . . 9.08 107.538 179.132 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.462 ' O ' ' HB2' ' A' ' 54' ' ' CYS . 28.8 m -107.44 97.28 7.05 Favored 'General case' 0 N--CA 1.423 -1.814 0 C-N-CA 114.557 -2.857 . . . . 5.66 103.973 171.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.749 ' HA ' ' HB2' ' A' ' 54' ' ' CYS . 8.4 m -83.09 77.7 9.71 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 115.944 1.831 . . . . 2.68 115.944 179.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.513 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -31.56 110.88 0.3 Allowed Pre-proline 0 N--CA 1.48 1.054 0 CA-C-N 119.055 0.843 . . . . 2.48 110.125 178.739 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.632 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 41.5 Cg_endo -99.98 139.49 0.28 Allowed 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.143 1.896 . . . . 1.49 116.758 -177.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.544 ' HA ' ' HD2' ' A' ' 43' ' ' ARG . 2.4 p -134.59 -165.75 1.71 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 118.674 -1.21 . . . . 1.0 109.866 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.483 ' HA2' ' HG2' ' A' ' 40' ' ' GLU . . . 64.65 -159.45 42.37 Favored Glycine 0 CA--C 1.499 -0.939 0 C-N-CA 121.365 -0.445 . . . . 1.15 113.527 176.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.435 ' C ' ' H ' ' A' ' 17' ' ' GLY . 42.7 Cg_endo -64.75 138.19 57.31 Favored 'Trans proline' 0 N--CA 1.443 -1.448 0 C-N-CA 122.25 1.967 . . . . 1.57 109.029 176.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 55.93 -6.58 0.01 OUTLIER Glycine 0 C--N 1.273 -2.965 0 CA-C-N 114.055 -1.43 . . . . 1.68 114.029 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.435 ' H ' ' C ' ' A' ' 15' ' ' PRO . . . 69.66 40.98 76.53 Favored Glycine 1 N--CA 1.387 -4.567 0 C-N-CA 116.947 -2.549 . . . . 1.36 108.871 -178.455 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.433 ' HB2' HD11 ' A' ' 32' ' ' LEU . 1.6 mttp -93.59 -10.91 33.08 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 111.677 -2.262 . . . . 2.5 113.24 179.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.632 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -122.85 179.0 16.27 Favored Glycine 0 N--CA 1.44 -1.051 0 N-CA-C 106.539 -2.624 . . . . 1.02 106.539 178.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.513 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 0.3 OUTLIER -122.55 170.23 10.21 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 119.95 1.875 . . . . 2.92 112.274 -178.98 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.465 ' O ' HD12 ' A' ' 11' ' ' LEU . 20.2 t -114.66 150.76 34.68 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.735 0.303 . . . . 1.1 111.796 -179.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -131.85 -49.56 0.96 Allowed 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 108.704 -0.85 . . . . 1.51 108.704 177.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.438 ' O ' ' SG ' ' A' ' 21' ' ' CYS . . . -99.29 -154.87 28.54 Favored Glycine 0 N--CA 1.448 -0.553 0 N-CA-C 109.007 -1.637 . . . . 0.9 109.007 176.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -94.18 -60.55 0.01 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.032 0 CA-C-N 119.829 1.814 . . . . 1.5 112.14 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.636 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.6 OUTLIER -90.92 9.82 28.95 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-O 120.615 0.245 . . . . 1.26 110.403 179.05 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.826 HG23 HG13 ' A' ' 36' ' ' VAL . 1.5 mt -120.08 118.08 55.71 Favored 'Isoleucine or valine' 0 C--O 1.245 0.854 0 CA-C-O 122.061 0.934 . . . . 0.83 112.311 -177.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.737 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 0.7 OUTLIER -134.83 130.47 36.09 Favored 'General case' 0 C--O 1.223 -0.31 0 CA-C-N 114.238 -1.346 . . . . 0.92 110.556 -179.492 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 1.086 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -132.4 172.65 12.2 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-O 123.155 1.455 . . . . 1.28 114.167 -178.086 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.481 ' O ' ' HB1' ' A' ' 69' ' ' ALA . . . -156.87 176.0 34.26 Favored Glycine 0 N--CA 1.429 -1.812 0 CA-C-N 111.664 -2.517 . . . . 0.67 108.602 178.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -62.17 -53.0 61.54 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 121.964 0.888 . . . . 2.27 110.453 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.29 11.69 14.11 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 113.79 -1.55 . . . . 1.66 109.402 179.027 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.697 HD22 ' CZ ' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -106.47 -4.2 20.09 Favored 'General case' 0 N--CA 1.412 -2.352 0 N-CA-C 106.897 -1.519 . . . . 1.37 106.897 179.275 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 1.086 ' O ' ' HA ' ' A' ' 28' ' ' CYS . . . 46.76 -140.59 6.77 Favored Glycine 0 N--CA 1.419 -2.441 0 CA-C-N 113.67 -1.604 . . . . 0.73 113.028 178.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.8 ' SG ' HG22 ' A' ' 26' ' ' ILE . 0.5 OUTLIER -138.23 122.16 17.77 Favored 'General case' 0 CA--C 1.493 -1.234 0 N-CA-C 113.168 0.803 . . . . 1.08 113.168 179.709 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.978 ' HA ' ' HA ' ' B' ' 135' ' ' PHE . 0.0 OUTLIER -88.8 106.2 18.21 Favored 'General case' 0 N--CA 1.423 -1.81 0 N-CA-C 104.22 -2.511 . . . . 1.38 104.22 175.437 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.912 HG23 HG23 ' B' ' 136' ' ' VAL . 1.4 t -96.09 83.71 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 N-CA-C 107.734 -1.21 . . . . 0.76 107.734 -179.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.727 ' O ' ' HA3' ' B' ' 133' ' ' GLY . . . 103.01 92.57 2.23 Favored Glycine 0 CA--C 1.531 1.073 0 CA-C-N 112.955 -1.929 . . . . 0.81 114.259 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.475 HG21 ' HB3' ' A' ' 35' ' ' PHE . 0.0 OUTLIER 177.86 167.1 0.72 Allowed 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 108.808 -0.812 . . . . 0.77 108.808 178.455 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.772 ' CB ' HD22 ' A' ' 42' ' ' LEU . . . -61.24 -16.77 48.69 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 119.996 1.271 . . . . 1.02 111.677 179.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.669 ' HB3' ' CD2' ' A' ' 35' ' ' PHE . 5.0 mt-10 -64.19 -14.95 58.68 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.629 -0.508 . . . . 2.32 109.629 178.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.645 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . . . -126.1 -4.81 6.8 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 115.67 -0.696 . . . . 0.87 111.949 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.772 HD22 ' CB ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -73.95 -36.3 64.62 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 108.218 -1.03 . . . . 1.23 108.218 179.231 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.544 ' HD2' ' HA ' ' A' ' 13' ' ' CYS . 1.2 ptp180 -63.52 -5.63 4.08 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 114.31 -1.313 . . . . 2.92 109.529 178.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.599 ' HB3' ' O ' ' A' ' 41' ' ' ALA . 9.3 t -82.2 11.8 4.97 Favored 'General case' 0 N--CA 1.445 -0.701 0 O-C-N 121.572 -0.705 . . . . 1.57 109.166 177.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -73.02 -18.3 61.36 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.945 -0.571 . . . . 3.31 109.477 178.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.42 5.7 33.77 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 119.303 -0.959 . . . . 3.69 109.862 179.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -83.55 0.73 45.34 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.866 -0.607 . . . . 3.99 109.583 177.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -75.32 -28.73 59.78 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 109.38 -0.6 . . . . 3.86 109.38 178.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -113.71 50.24 0.93 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.005 -0.543 . . . . 5.68 110.256 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -141.24 97.0 6.97 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.423 -0.353 . . . . 5.4 111.693 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -87.22 33.92 0.43 Allowed 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.905 2.403 . . . . 4.92 113.162 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 46.8 p -127.93 80.4 72.17 Favored Pre-proline 0 N--CA 1.463 0.21 0 CA-C-O 120.657 0.265 . . . . 5.64 110.869 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.525 ' O ' ' HB3' ' A' ' 5' ' ' LEU . 83.7 Cg_endo -87.06 113.72 1.02 Allowed 'Trans proline' 0 CA--C 1.533 0.463 0 C-N-CA 123.186 2.591 . . . . 5.04 114.291 -178.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.749 ' HB2' ' HA ' ' A' ' 10' ' ' CYS . 0.5 OUTLIER -60.14 96.76 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.375 -0.375 . . . . 2.74 109.99 178.377 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.482 ' HG2' ' HB2' ' A' ' 4' ' ' ASP . 6.7 tp-100 -44.99 125.58 5.25 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 119.557 -0.857 . . . . 5.75 111.009 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -170.29 -154.71 0.11 Allowed 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 116.527 -0.306 . . . . 3.12 111.382 -179.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 56.45 58.57 13.66 Favored Glycine 0 N--CA 1.426 -2.033 0 C-N-CA 121.346 -0.454 . . . . 2.1 112.214 176.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 -119.46 70.46 0.85 Allowed 'General case' 0 N--CA 1.435 -1.206 0 CA-C-O 122.82 1.295 . . . . 4.36 107.684 177.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.642 ' N ' ' CD ' ' A' ' 60' ' ' PRO . 2.2 mmpp? -143.68 44.69 0.51 Allowed Pre-proline 0 C--N 1.303 -1.435 0 CA-C-N 112.428 -2.169 . . . . 3.55 108.089 177.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.642 ' CD ' ' N ' ' A' ' 59' ' ' LYS . 1.3 Cg_endo -42.96 114.75 0.47 Allowed 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 123.629 2.886 . . . . 1.54 115.247 -178.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -146.68 170.53 16.76 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 113.357 -1.747 . . . . 1.59 108.19 177.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 71.07 -168.54 50.28 Favored Glycine 0 CA--C 1.494 -1.264 0 C-N-CA 118.704 -1.713 . . . . 2.43 113.63 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 14.4 p -83.29 44.46 0.95 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.015 -0.593 . . . . 4.11 111.692 -178.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 118.26 9.61 9.43 Favored Glycine 0 C--N 1.334 0.455 0 N-CA-C 115.222 0.849 . . . . 2.21 115.222 177.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.673 ' HA3' ' HA ' ' A' ' 75' ' ' SER . . . -105.16 162.29 14.55 Favored Glycine 0 C--N 1.338 0.642 0 CA-C-N 119.202 1.501 . . . . 1.62 115.178 -178.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.1 153.67 21.19 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 108.524 -0.917 . . . . 3.02 108.524 177.068 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.543 ' HA ' ' HA ' ' A' ' 73' ' ' CYS . 50.5 t -58.7 115.57 3.15 Favored 'General case' 0 N--CA 1.426 -1.669 0 N-CA-C 109.217 -0.66 . . . . 1.52 109.217 -179.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 1.011 ' HB1' ' SG ' ' A' ' 28' ' ' CYS . . . -62.88 -48.37 79.3 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 106.875 -1.528 . . . . 1.07 106.875 178.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.719 ' CB ' ' HA2' ' A' ' 33' ' ' GLY . . . -167.8 163.92 14.15 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 112.9 -1.954 . . . . 1.0 110.736 -174.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 1.073 ' HA ' ' HB3' ' A' ' 85' ' ' CYS . . . -43.96 130.61 5.85 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.428 0.632 . . . . 1.24 112.298 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.727 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . 80.23 -26.09 3.04 Favored Glycine 0 CA--C 1.522 0.481 0 CA-C-N 115.006 -0.997 . . . . 1.28 115.059 177.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.629 ' CD1' ' HB2' ' A' ' 34' ' ' CYS . 1.2 pp -129.25 116.59 40.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 122.319 1.057 . . . . 2.27 111.021 -179.149 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.543 ' HA ' ' HA ' ' A' ' 67' ' ' CYS . 1.6 t -106.13 112.45 25.48 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.175 -1.375 . . . . 1.98 110.578 -177.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.715 ' HB2' ' HB2' ' A' ' 68' ' ' ALA . 3.7 m -84.45 147.85 26.88 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 121.94 0.876 . . . . 1.33 112.752 -177.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.847 ' HB2' ' HD2' ' A' ' 76' ' ' PRO . 12.1 p -122.64 -179.9 0.88 Allowed Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 114.031 -1.44 . . . . 1.99 108.106 178.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.847 ' HD2' ' HB2' ' A' ' 75' ' ' SER . 57.0 Cg_endo -73.73 29.93 0.32 Allowed 'Trans proline' 0 N--CA 1.459 -0.516 0 CA-C-N 119.895 0.998 . . . . 1.86 111.59 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.504 ' H ' ' C ' ' A' ' 75' ' ' SER . 2.5 p30 -145.89 -48.93 0.22 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.607 -0.724 . . . . 2.65 110.63 179.053 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 1.083 ' HA3' ' O ' ' B' ' 179' ' ' CYS . . . -156.3 -140.8 3.05 Favored Glycine 0 C--N 1.336 0.547 0 C-N-CA 120.398 -0.906 . . . . 0.99 113.843 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 1.061 ' O ' ' HA3' ' B' ' 178' ' ' GLY . 0.0 OUTLIER -142.73 153.2 43.11 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.329 -0.436 . . . . 1.34 110.556 -179.826 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 4.2 p-80 -154.36 160.36 41.66 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.096 -0.642 . . . . 2.17 112.008 -178.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.601 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -60.25 140.53 56.98 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.874 -0.603 . . . . 3.05 110.32 179.867 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.492 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 3.7 p-10 -139.75 140.29 24.31 Favored Pre-proline 0 CA--C 1.541 0.598 0 CA-C-N 116.018 -0.537 . . . . 2.02 110.763 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.492 ' HD3' ' HA ' ' A' ' 82' ' ' ASP . 3.2 Cg_exo -77.26 -24.97 8.93 Favored 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 123.159 2.572 . . . . 1.93 114.196 -177.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.37 -43.93 84.57 Favored 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 107.781 -1.192 . . . . 1.53 107.781 178.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 1.073 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 33.2 m -99.95 73.73 1.77 Allowed 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 114.082 -1.417 . . . . 1.88 109.033 177.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 1.051 ' H ' ' HD3' ' A' ' 87' ' ' PRO . 0.2 OUTLIER -171.17 24.19 0.0 OUTLIER Pre-proline 0 C--N 1.312 -1.052 0 CA-C-N 115.558 -0.746 . . . . 3.6 112.01 -179.719 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 1.051 ' HD3' ' H ' ' A' ' 86' ' ' ASP . 15.5 Cg_exo -65.86 -177.33 0.74 Allowed 'Trans proline' 0 CA--C 1.484 -1.987 0 CA-C-N 119.882 0.993 . . . . 2.56 110.406 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.499 ' C ' ' H ' ' A' ' 90' ' ' ALA . 1.7 pt-20 -30.93 -19.88 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 113.66 -1.609 . . . . 4.72 111.075 175.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.803 ' N ' ' O ' ' A' ' 87' ' ' PRO . . . -55.91 7.95 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 113.804 1.039 . . . . 5.29 113.804 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.499 ' H ' ' C ' ' A' ' 88' ' ' GLU . . . -75.26 157.57 34.24 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.145 0.498 . . . . 6.98 111.235 177.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -100.78 99.56 10.1 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.16 -0.927 . . . . 10.21 109.974 177.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 47.1 p . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.205 -0.903 . . . . 11.77 111.021 -179.835 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.496 0 CA-C-O 120.7 0.286 . . . . 10.07 111.114 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 102' ' ' VAL . . . . . 0.51 HG12 ' H ' ' B' ' 103' ' ' LEU . 2.6 t -95.21 -130.61 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.996 0 CA-C-O 121.761 0.791 . . . . 8.41 110.607 179.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 103' ' ' LEU . . . . . 0.739 ' HG ' ' HB3' ' B' ' 108' ' ' ARG . 0.2 OUTLIER -109.28 105.71 15.24 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 106.177 -1.786 . . . . 5.87 106.177 174.992 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 104' ' ' ASP . . . . . 0.721 ' H ' ' HB3' ' B' ' 155' ' ' GLN . 0.6 OUTLIER -82.86 90.64 6.96 Favored 'General case' 0 CA--C 1.513 -0.464 0 C-N-CA 119.655 -0.818 . . . . 6.27 112.213 -175.881 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -148.75 -75.76 0.17 Allowed 'General case' 0 N--CA 1.408 -2.539 0 CA-C-O 123.382 1.563 . . . . 7.2 108.95 179.033 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 106' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 179.48 -34.67 0.01 OUTLIER 'General case' 0 C--N 1.275 -2.663 0 CA-C-N 111.048 -2.796 . . . . 8.55 107.447 -177.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 3.3 m -152.19 170.74 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.473 -2.015 0 N-CA-C 103.85 -2.648 . . . . 7.48 103.85 169.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 108' ' ' ARG . . . . . 0.739 ' HB3' ' HG ' ' B' ' 103' ' ' LEU . 5.6 mtm-85 -75.51 110.88 10.25 Favored 'General case' 0 N--CA 1.428 -1.566 0 CA-C-N 125.956 3.98 . . . . 9.12 106.353 176.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 109' ' ' THR . . . . . 0.455 ' O ' ' HB2' ' B' ' 154' ' ' CYS . 33.5 m -112.0 97.66 6.83 Favored 'General case' 0 CA--C 1.478 -1.797 0 C-N-CA 114.229 -2.989 . . . . 5.69 103.19 171.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 110' ' ' CYS . . . . . 0.76 ' HA ' ' HB2' ' B' ' 154' ' ' CYS . 7.4 m -84.29 78.25 9.83 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-N 112.48 -2.145 . . . . 2.61 115.587 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 111' ' ' LEU . . . . . 0.575 ' O ' ' HA ' ' B' ' 120' ' ' ARG . 0.0 OUTLIER -31.63 110.34 0.3 Allowed Pre-proline 0 N--CA 1.472 0.668 0 CA-C-N 118.614 0.643 . . . . 2.47 109.821 178.761 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 112' ' ' PRO . . . . . 0.646 ' HA ' ' O ' ' B' ' 119' ' ' GLY . 74.1 Cg_endo -82.3 158.97 17.45 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 124.482 3.455 . . . . 1.47 111.307 -179.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.499 ' HA ' ' HD2' ' B' ' 143' ' ' ARG . 3.2 p -155.93 -168.71 2.85 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 120.427 -1.421 . . . . 1.0 109.351 166.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 114' ' ' GLY . . . . . 0.465 ' HA2' ' HG2' ' B' ' 140' ' ' GLU . . . 64.71 -158.85 43.41 Favored Glycine 0 C--N 1.34 0.752 0 C-N-CA 121.007 -0.616 . . . . 1.16 113.482 176.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 115' ' ' PRO . . . . . 0.51 ' O ' ' N ' ' B' ' 117' ' ' GLY . 56.4 Cg_endo -62.01 143.73 95.47 Favored 'Trans proline' 0 CA--C 1.503 -1.031 0 C-N-CA 122.801 2.334 . . . . 1.57 106.962 176.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . 0.425 ' HA3' ' HE3' ' B' ' 118' ' ' LYS . . . 50.0 -4.64 0.01 OUTLIER Glycine 0 N--CA 1.416 -2.662 0 N-CA-C 115.209 0.843 . . . . 1.7 115.209 177.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 117' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' B' ' 115' ' ' PRO . . . 68.18 39.88 88.15 Favored Glycine 1 N--CA 1.394 -4.1 0 C-N-CA 117.102 -2.475 . . . . 1.38 109.623 -178.612 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 118' ' ' LYS . . . . . 0.425 ' HE3' ' HA3' ' B' ' 116' ' ' GLY . 1.6 mmtp -91.99 -13.87 30.35 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 112.318 -1.941 . . . . 2.54 112.949 -178.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 119' ' ' GLY . . . . . 0.646 ' O ' ' HA ' ' B' ' 112' ' ' PRO . . . -113.57 -171.2 17.64 Favored Glycine 0 CA--C 1.5 -0.847 0 N-CA-C 108.324 -1.91 . . . . 1.04 108.324 178.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.575 ' HA ' ' O ' ' B' ' 111' ' ' LEU . 0.4 OUTLIER -136.77 169.74 17.23 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 121.845 2.823 . . . . 2.89 108.625 178.328 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 121' ' ' CYS . . . . . 0.457 ' SG ' ' O ' ' B' ' 123' ' ' GLY . 19.5 t -114.63 151.87 32.81 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.337 0.495 . . . . 1.07 112.337 -178.306 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -131.95 -49.66 0.95 Allowed 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 108.696 -0.853 . . . . 1.53 108.696 176.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 123' ' ' GLY . . . . . 0.457 ' O ' ' SG ' ' B' ' 121' ' ' CYS . . . -99.23 -154.84 28.59 Favored Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 109.115 -1.594 . . . . 0.9 109.115 176.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -94.19 -60.66 0.01 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.958 0 CA-C-N 119.816 1.808 . . . . 1.51 112.151 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 125' ' ' SER . . . . . 0.644 ' O ' ' N ' ' B' ' 137' ' ' GLY . 0.6 OUTLIER -90.65 9.89 27.94 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 110.266 -0.272 . . . . 1.25 110.266 179.031 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 126' ' ' ILE . . . . . 0.804 HG22 ' SG ' ' B' ' 134' ' ' CYS . 1.8 mt -119.98 117.87 55.07 Favored 'Isoleucine or valine' 0 C--O 1.244 0.802 0 CA-C-O 121.962 0.887 . . . . 0.85 112.566 -177.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 127' ' ' CYS . . . . . 0.747 ' O ' ' HA ' ' B' ' 134' ' ' CYS . 0.7 OUTLIER -134.91 130.69 36.29 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-N 114.313 -1.312 . . . . 0.89 110.643 -179.641 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 128' ' ' CYS . . . . . 1.084 ' HA ' ' O ' ' B' ' 133' ' ' GLY . 0.0 OUTLIER -130.96 173.58 10.85 Favored 'General case' 0 CA--C 1.56 1.33 0 CA-C-O 122.814 1.292 . . . . 1.23 114.327 -178.069 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 129' ' ' GLY . . . . . 0.518 ' O ' ' HB1' ' B' ' 169' ' ' ALA . . . -157.32 176.47 34.49 Favored Glycine 0 N--CA 1.427 -1.936 0 CA-C-N 111.643 -2.526 . . . . 0.66 109.045 177.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -62.01 -54.83 36.04 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 109.198 -0.667 . . . . 2.35 109.198 179.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -122.12 29.71 6.91 Favored 'General case' 0 N--CA 1.428 -1.539 0 N-CA-C 108.191 -1.04 . . . . 1.69 108.191 178.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 132' ' ' LEU . . . . . 0.662 HD22 ' CZ ' ' B' ' 135' ' ' PHE . 0.5 OUTLIER -121.09 -3.42 9.57 Favored 'General case' 0 N--CA 1.41 -2.451 0 N-CA-C 104.428 -2.434 . . . . 1.38 104.428 179.103 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 133' ' ' GLY . . . . . 1.084 ' O ' ' HA ' ' B' ' 128' ' ' CYS . . . 42.36 -141.01 1.84 Allowed Glycine 0 N--CA 1.401 -3.664 0 CA-C-N 112.531 -2.122 . . . . 0.72 112.519 176.358 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 134' ' ' CYS . . . . . 0.804 ' SG ' HG22 ' B' ' 126' ' ' ILE . 0.5 OUTLIER -136.75 122.08 19.34 Favored 'General case' 0 CA--C 1.493 -1.23 0 CA-C-N 118.802 1.301 . . . . 1.08 113.629 -178.515 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 135' ' ' PHE . . . . . 0.978 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -88.08 106.35 18.1 Favored 'General case' 0 N--CA 1.422 -1.829 0 N-CA-C 104.326 -2.472 . . . . 1.36 104.326 175.858 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 136' ' ' VAL . . . . . 0.912 HG23 HG23 ' A' ' 36' ' ' VAL . 1.8 t -95.62 83.69 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 N-CA-C 107.725 -1.213 . . . . 0.75 107.725 -179.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 137' ' ' GLY . . . . . 0.756 ' O ' ' HA3' ' A' ' 33' ' ' GLY . . . 102.53 93.03 2.23 Favored Glycine 0 CA--C 1.531 1.055 0 CA-C-N 113.071 -1.877 . . . . 0.83 114.283 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 138' ' ' THR . . . . . 0.466 HG21 ' HB3' ' B' ' 135' ' ' PHE . 0.0 OUTLIER 178.44 169.19 0.82 Allowed 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 108.623 -0.88 . . . . 0.78 108.623 178.576 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 139' ' ' ALA . . . . . 0.775 ' CB ' HD22 ' B' ' 142' ' ' LEU . . . -63.77 -15.33 58.4 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 119.616 1.098 . . . . 1.04 111.373 178.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 140' ' ' GLU . . . . . 0.677 ' HB3' ' CD2' ' B' ' 135' ' ' PHE . 5.0 mt-10 -65.24 -15.87 62.94 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.498 -0.556 . . . . 2.31 109.498 178.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 141' ' ' ALA . . . . . 0.659 ' O ' ' HB3' ' B' ' 144' ' ' CYS . . . -122.78 -11.0 8.23 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.995 -0.548 . . . . 0.87 111.695 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 142' ' ' LEU . . . . . 0.775 HD22 ' CB ' ' B' ' 139' ' ' ALA . 0.0 OUTLIER -69.22 -37.02 77.85 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.382 -0.97 . . . . 1.24 108.382 -178.681 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 143' ' ' ARG . . . . . 0.499 ' HD2' ' HA ' ' B' ' 113' ' ' CYS . 1.1 ptp180 -64.91 -2.29 2.54 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 114.583 -1.189 . . . . 2.93 109.753 178.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 144' ' ' CYS . . . . . 0.659 ' HB3' ' O ' ' B' ' 141' ' ' ALA . 10.3 t -83.4 9.26 11.45 Favored 'General case' 0 N--CA 1.443 -0.786 0 O-C-N 121.556 -0.715 . . . . 1.61 109.125 176.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -71.17 -18.65 62.48 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.598 -0.728 . . . . 3.35 109.711 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.41 5.73 33.61 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 119.234 -0.986 . . . . 3.76 110.035 179.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -83.55 0.73 45.34 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.781 -0.645 . . . . 4.01 109.51 177.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 148' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -75.36 -28.65 59.65 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.35 -0.611 . . . . 3.92 109.35 178.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -113.74 50.17 0.93 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.952 -0.567 . . . . 5.73 110.342 179.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -141.24 97.08 6.95 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.303 -0.408 . . . . 5.46 111.58 -179.358 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 151' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -87.33 33.98 0.43 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.849 2.366 . . . . 5.02 113.068 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 51.1 p -128.0 80.62 71.86 Favored Pre-proline 0 N--CA 1.463 0.207 0 CA-C-O 120.655 0.264 . . . . 5.73 110.868 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 153' ' ' PRO . . . . . 0.504 ' HA ' HD21 ' B' ' 111' ' ' LEU . 90.0 Cg_endo -87.15 114.07 1.03 Allowed 'Trans proline' 0 CA--C 1.533 0.469 0 C-N-CA 123.135 2.556 . . . . 5.1 114.217 -178.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 154' ' ' CYS . . . . . 0.76 ' HB2' ' HA ' ' B' ' 110' ' ' CYS . 0.4 OUTLIER -60.4 98.42 0.06 Allowed 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 109.65 -0.5 . . . . 2.68 109.65 178.207 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 155' ' ' GLN . . . . . 0.721 ' HB3' ' H ' ' B' ' 104' ' ' ASP . 6.7 tp-100 -47.08 126.72 9.48 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 119.551 -0.86 . . . . 5.63 110.721 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -175.63 -162.51 0.1 Allowed 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 110.126 -0.324 . . . . 3.11 110.126 -179.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 64.95 57.13 12.75 Favored Glycine 0 N--CA 1.426 -1.972 0 C-N-CA 120.245 -0.979 . . . . 2.07 112.164 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 158' ' ' GLN . . . . . 0.418 ' C ' ' HD2' ' B' ' 160' ' ' PRO . 12.8 tt0 -120.29 59.83 0.89 Allowed 'General case' 0 N--CA 1.435 -1.19 0 C-N-CA 117.228 -1.789 . . . . 4.34 108.604 176.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 159' ' ' LYS . . . . . 0.615 ' HB2' ' HB3' ' B' ' 167' ' ' CYS . 2.6 mmpp? -118.2 39.23 0.29 Allowed Pre-proline 0 C--N 1.314 -0.943 0 CA-C-N 112.346 -2.206 . . . . 3.54 111.731 171.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 160' ' ' PRO . . . . . 0.454 ' CD ' ' N ' ' B' ' 159' ' ' LYS . 2.3 Cg_endo -41.17 117.21 0.53 Allowed 'Trans proline' 0 C--N 1.34 0.109 0 C-N-CA 122.306 2.004 . . . . 1.51 115.621 -173.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 161' ' ' CYS . . . . . 0.466 ' SG ' ' N ' ' B' ' 162' ' ' GLY . 0.1 OUTLIER -138.73 -170.58 2.88 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 113.198 -1.819 . . . . 1.58 108.715 -179.803 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 162' ' ' GLY . . . . . 0.466 ' N ' ' SG ' ' B' ' 161' ' ' CYS . . . 47.9 -166.03 0.17 Allowed Glycine 0 CA--C 1.528 0.864 0 C-N-CA 119.064 -1.541 . . . . 2.37 114.9 171.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 13.8 p -82.35 44.24 0.86 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 114.981 -0.61 . . . . 4.07 112.216 -178.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 119.33 8.93 8.97 Favored Glycine 0 C--N 1.338 0.64 0 N-CA-C 115.15 0.82 . . . . 2.2 115.15 177.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 165' ' ' GLY . . . . . 0.651 ' HA3' ' HA ' ' B' ' 175' ' ' SER . . . -103.61 160.69 16.28 Favored Glycine 0 CA--C 1.521 0.425 0 C-N-CA 119.551 -1.309 . . . . 1.62 115.684 -178.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 166' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.73 153.23 22.14 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 108.342 -0.985 . . . . 3.05 108.342 176.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 167' ' ' CYS . . . . . 0.615 ' HB3' ' HB2' ' B' ' 159' ' ' LYS . 47.5 t -58.31 115.53 3.02 Favored 'General case' 0 N--CA 1.426 -1.629 0 N-CA-C 109.345 -0.613 . . . . 1.56 109.345 -179.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 168' ' ' ALA . . . . . 0.978 ' HB1' ' SG ' ' B' ' 128' ' ' CYS . . . -63.26 -47.3 82.97 Favored 'General case' 0 N--CA 1.428 -1.546 0 N-CA-C 107.263 -1.384 . . . . 1.04 107.263 178.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 169' ' ' ALA . . . . . 0.811 ' CB ' ' HA2' ' B' ' 133' ' ' GLY . . . -169.01 164.25 11.39 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.189 -1.369 . . . . 0.98 108.967 -175.034 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 170' ' ' ALA . . . . . 1.003 ' HA ' ' HB3' ' B' ' 185' ' ' CYS . . . -44.07 130.71 6.02 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.469 0.652 . . . . 1.25 112.691 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 171' ' ' GLY . . . . . 0.735 ' N ' ' O ' ' B' ' 185' ' ' CYS . . . 78.4 -21.04 3.78 Favored Glycine 0 CA--C 1.521 0.458 0 CA-C-N 114.845 -1.071 . . . . 1.29 115.511 177.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 172' ' ' ILE . . . . . 0.631 ' CD1' ' HB2' ' B' ' 134' ' ' CYS . 1.2 pp -132.43 116.24 27.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 122.408 1.099 . . . . 2.27 110.747 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 173' ' ' CYS . . . . . 0.553 ' HA ' ' H ' ' B' ' 168' ' ' ALA . 1.5 t -106.5 112.5 25.53 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.083 -1.417 . . . . 1.94 110.686 -177.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 174' ' ' CYS . . . . . 0.702 ' HA ' ' HA ' ' B' ' 179' ' ' CYS . 4.4 m -84.29 148.0 26.91 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.903 0.859 . . . . 1.35 112.838 -177.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 175' ' ' SER . . . . . 0.832 ' HB2' ' HD2' ' B' ' 176' ' ' PRO . 11.6 p -122.68 -179.89 0.88 Allowed Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 114.057 -1.429 . . . . 2.0 107.998 178.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 176' ' ' PRO . . . . . 0.832 ' HD2' ' HB2' ' B' ' 175' ' ' SER . 57.3 Cg_endo -73.71 29.92 0.32 Allowed 'Trans proline' 0 N--CA 1.46 -0.482 0 CA-C-N 119.797 0.963 . . . . 1.9 111.681 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 177' ' ' ASP . . . . . 0.505 ' H ' ' C ' ' B' ' 175' ' ' SER . 2.5 p30 -145.78 -49.41 0.22 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.63 -0.713 . . . . 2.72 110.585 179.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 178' ' ' GLY . . . . . 1.061 ' HA3' ' O ' ' A' ' 79' ' ' CYS . . . -155.77 -140.69 3.04 Favored Glycine 0 C--N 1.338 0.652 0 C-N-CA 120.492 -0.861 . . . . 0.99 113.886 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 179' ' ' CYS . . . . . 1.083 ' O ' ' HA3' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -142.94 153.04 42.66 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-N 115.281 -0.46 . . . . 1.34 110.511 -179.892 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 180' ' ' HIS . . . . . . . . . . . . . 4.2 p-80 -154.11 160.39 41.92 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.098 -0.641 . . . . 2.1 111.975 -178.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 181' ' ' GLU . . . . . 0.586 ' HA ' ' O ' ' B' ' 171' ' ' GLY . 0.0 OUTLIER -60.23 140.48 56.99 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.844 -0.616 . . . . 3.06 110.307 179.828 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 182' ' ' ASP . . . . . 0.457 ' HB3' ' HB3' ' B' ' 173' ' ' CYS . 3.7 p-10 -139.69 140.28 24.46 Favored Pre-proline 0 CA--C 1.541 0.627 0 CA-C-N 116.01 -0.541 . . . . 2.06 110.759 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 183' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' B' ' 182' ' ' ASP . 3.4 Cg_exo -77.09 -25.17 8.98 Favored 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 123.236 2.624 . . . . 1.91 114.252 -177.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -66.23 -43.88 85.37 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 107.808 -1.182 . . . . 1.56 107.808 178.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 185' ' ' CYS . . . . . 1.003 ' HB3' ' HA ' ' B' ' 170' ' ' ALA . 33.2 m -100.05 73.44 1.73 Allowed 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 114.037 -1.438 . . . . 1.94 109.067 177.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 186' ' ' ASP . . . . . 1.074 ' H ' ' HD3' ' B' ' 187' ' ' PRO . 0.3 OUTLIER -170.84 24.49 0.0 OUTLIER Pre-proline 0 C--N 1.311 -1.095 0 CA-C-N 115.666 -0.697 . . . . 3.61 111.92 -179.568 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 187' ' ' PRO . . . . . 1.074 ' HD3' ' H ' ' B' ' 186' ' ' ASP . 10.2 Cg_exo -70.61 177.57 6.03 Favored 'Trans proline' 0 N--CA 1.432 -2.103 0 CA-C-N 119.769 0.953 . . . . 2.58 111.011 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 188' ' ' GLU . . . . . 0.507 ' C ' ' O ' ' B' ' 187' ' ' PRO . 1.9 pt-20 -21.71 -24.81 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 113.072 -1.876 . . . . 4.7 109.739 176.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 189' ' ' ALA . . . . . 0.931 ' N ' ' O ' ' B' ' 187' ' ' PRO . . . -47.95 -5.6 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 114.15 1.167 . . . . 5.24 114.15 -179.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 190' ' ' ALA . . . . . 0.446 ' H ' ' C ' ' B' ' 188' ' ' GLU . . . -67.4 157.83 33.17 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.67 0.747 . . . . 6.93 111.952 -179.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 191' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -100.75 99.74 10.31 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 114.688 -1.142 . . . . 10.14 110.209 177.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 44.8 p . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.155 -0.926 . . . . 11.7 111.036 -179.85 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.804 0 CA-C-O 119.974 -0.06 . . . . 9.95 111.128 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.618 ' C ' HD22 ' A' ' 3' ' ' LEU . 12.7 p -177.22 48.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-O 122.804 1.288 . . . . 8.02 111.409 -178.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.979 HD13 ' HB3' ' A' ' 55' ' ' GLN . 3.8 mm? -135.18 99.69 4.33 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 113.33 -1.759 . . . . 5.86 107.096 178.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.694 ' H ' ' HA ' ' A' ' 55' ' ' GLN . 0.6 OUTLIER -77.81 22.8 0.26 Allowed 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.116 -0.698 . . . . 6.22 109.116 178.832 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.588 HD12 ' H ' ' A' ' 6' ' ' ASP . 0.2 OUTLIER -143.96 -133.65 0.09 Allowed 'General case' 0 N--CA 1.433 -1.303 0 N-CA-C 104.233 -2.506 . . . . 7.09 104.233 -175.514 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.588 ' H ' HD12 ' A' ' 5' ' ' LEU . 6.8 t70 -160.24 -42.92 0.05 OUTLIER 'General case' 0 C--N 1.282 -2.356 0 CA-C-O 122.407 1.099 . . . . 8.78 109.879 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.41 ' H ' HD12 ' A' ' 5' ' ' LEU . 7.1 p -127.8 123.31 60.74 Favored 'Isoleucine or valine' 0 CA--C 1.468 -2.176 1 N-CA-C 99.363 -4.31 . . . . 7.51 99.363 170.579 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.428 ' HG2' ' HG2' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -73.44 110.8 8.01 Favored 'General case' 0 N--CA 1.394 -3.27 0 C-N-CA 116.417 -2.113 . . . . 9.08 108.957 -171.955 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.469 ' O ' HD22 ' A' ' 11' ' ' LEU . 0.9 OUTLIER -103.11 96.27 6.67 Favored 'General case' 0 N--CA 1.394 -3.274 0 N-CA-C 100.538 -3.875 . . . . 5.66 100.538 170.54 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.606 ' HB3' ' HD3' ' A' ' 20' ' ' ARG . 1.0 OUTLIER -80.49 74.52 7.37 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 112.971 -1.922 . . . . 2.68 111.689 179.535 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.742 ' H ' HD22 ' A' ' 11' ' ' LEU . 3.4 mm? -30.68 111.08 0.28 Allowed Pre-proline 0 N--CA 1.472 0.673 0 N-CA-C 112.976 0.732 . . . . 2.48 112.976 -178.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.842 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 72.9 Cg_endo -73.96 153.44 47.31 Favored 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 123.087 2.525 . . . . 1.49 111.518 179.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.626 ' O ' ' HA2' ' A' ' 17' ' ' GLY . 16.1 p -160.7 -167.33 1.83 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 119.134 -1.027 . . . . 1.0 111.266 174.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 1.033 ' HA2' ' HB3' ' A' ' 40' ' ' GLU . . . 76.0 -160.38 51.39 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 120.241 -0.981 . . . . 1.15 114.761 177.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.573 ' HD2' ' CZ ' ' A' ' 35' ' ' PHE . 43.5 Cg_endo -64.94 99.07 0.32 Allowed 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 124.198 3.265 . . . . 1.57 113.328 178.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.62 -4.37 84.68 Favored Glycine 0 C--N 1.265 -3.363 0 CA-C-N 112.801 -1.999 . . . . 1.68 111.975 -176.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.626 ' HA2' ' O ' ' A' ' 13' ' ' CYS . . . 71.03 42.52 59.03 Favored Glycine 0 N--CA 1.432 -1.621 0 C-N-CA 118.31 -1.9 . . . . 1.36 113.19 174.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.98 -33.97 18.22 Favored 'General case' 0 C--N 1.359 1.021 0 CA-C-N 112.922 -1.639 . . . . 2.5 111.329 -178.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.842 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -77.55 -167.37 28.89 Favored Glycine 0 N--CA 1.468 0.795 0 C-N-CA 128.194 2.807 . . . . 1.02 111.165 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.729 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -130.74 173.76 10.6 Favored 'General case' 0 CA--C 1.553 1.089 0 N-CA-C 105.268 -2.123 . . . . 2.92 105.268 174.375 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.1 m -105.7 141.62 36.82 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 119.534 1.061 . . . . 1.1 111.395 -178.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -124.48 -48.2 1.82 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.765 -0.652 . . . . 1.51 110.549 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.533 ' HA3' HD12 ' A' ' 26' ' ' ILE . . . -128.94 -177.81 15.06 Favored Glycine 0 C--N 1.33 0.248 0 N-CA-C 111.322 -0.711 . . . . 0.9 111.322 179.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo -64.79 -71.02 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 121.969 1.779 . . . . 1.5 111.219 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.585 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.6 OUTLIER -89.8 41.53 1.05 Allowed 'General case' 0 CA--C 1.521 -0.145 0 N-CA-C 108.788 -0.819 . . . . 1.26 108.788 177.759 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.858 HG23 HG13 ' A' ' 36' ' ' VAL . 2.0 mt -144.92 111.59 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.908 0 CA-C-N 116.079 -0.51 . . . . 0.83 112.184 -177.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.692 ' SG ' ' HA ' ' A' ' 41' ' ' ALA . 0.8 OUTLIER -120.82 130.98 54.19 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 109.574 -0.528 . . . . 0.92 109.574 179.585 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.794 ' SG ' ' HB1' ' A' ' 68' ' ' ALA . 1.6 m -123.84 171.51 9.61 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 117.365 -1.734 . . . . 1.28 114.41 -177.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.571 ' HA3' ' HB2' ' A' ' 32' ' ' LEU . . . -146.85 174.86 26.53 Favored Glycine 0 N--CA 1.415 -2.714 0 N-CA-C 109.405 -1.478 . . . . 0.67 109.405 173.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -65.01 -58.51 5.92 Favored 'General case' 0 N--CA 1.422 -1.829 0 N-CA-C 104.424 -2.436 . . . . 2.27 104.424 177.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -115.07 22.11 13.66 Favored 'General case' 0 CA--C 1.478 -1.809 0 CA-C-N 114.246 -1.343 . . . . 1.66 108.689 -175.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.773 HD22 ' CE1' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -109.92 -17.8 13.54 Favored 'General case' 0 N--CA 1.408 -2.563 0 N-CA-C 105.987 -1.857 . . . . 1.37 105.987 177.793 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.892 ' HA2' ' CB ' ' A' ' 69' ' ' ALA . . . 63.6 -135.83 41.72 Favored Glycine 0 N--CA 1.403 -3.524 0 CA-C-N 113.635 -1.62 . . . . 0.73 110.797 -179.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.832 ' SG ' HG22 ' A' ' 26' ' ' ILE . 0.7 OUTLIER -143.27 122.1 12.68 Favored 'General case' 0 CA--C 1.479 -1.767 0 CA-C-N 119.13 1.465 . . . . 1.08 113.582 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 1.133 ' HA ' ' HA ' ' B' ' 135' ' ' PHE . 0.0 OUTLIER -88.84 105.34 17.67 Favored 'General case' 0 N--CA 1.411 -2.419 0 N-CA-C 103.945 -2.613 . . . . 1.38 103.945 176.13 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.858 HG13 HG23 ' A' ' 26' ' ' ILE . 1.6 t -96.7 85.67 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.863 0 N-CA-C 107.579 -1.267 . . . . 0.76 107.579 -179.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.878 ' HA3' HG12 ' B' ' 172' ' ' ILE . . . 122.03 12.99 5.11 Favored Glycine 0 C--N 1.32 -0.36 0 CA-C-N 113.738 -1.573 . . . . 0.81 115.898 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.697 HG22 ' O ' ' B' ' 132' ' ' LEU . 47.4 p -94.89 164.47 12.9 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 118.496 1.148 . . . . 0.77 110.195 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.641 ' HA ' HD12 ' A' ' 42' ' ' LEU . . . -61.2 -34.82 75.7 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.184 0.516 . . . . 1.02 109.811 179.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 1.033 ' HB3' ' HA2' ' A' ' 14' ' ' GLY . 0.6 OUTLIER -59.83 -14.63 15.9 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.912 -0.586 . . . . 2.32 111.537 -179.397 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.831 ' O ' ' HB2' ' A' ' 44' ' ' CYS . . . -91.95 -26.77 18.26 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 116.285 -0.416 . . . . 0.87 109.982 179.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.641 HD12 ' HA ' ' A' ' 39' ' ' ALA . 9.1 mt -48.21 -36.58 14.03 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 112.505 0.558 . . . . 1.23 112.505 -179.111 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.586 ' C ' ' H ' ' A' ' 45' ' ' GLN . 0.0 OUTLIER -54.91 -28.19 48.8 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 107.502 -1.296 . . . . 2.92 107.502 177.417 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.831 ' HB2' ' O ' ' A' ' 41' ' ' ALA . 1.2 m -54.97 4.01 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 114.435 -1.257 . . . . 1.57 111.18 -176.035 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.586 ' H ' ' C ' ' A' ' 43' ' ' ARG . 17.3 tt0 -72.48 -31.92 65.78 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.212 0.53 . . . . 3.31 110.951 177.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -86.3 6.78 28.19 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.995 0.426 . . . . 3.69 110.685 -179.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 25.0 tp10 -83.17 1.69 39.32 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 109.078 -0.712 . . . . 3.99 109.078 177.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.407 ' C ' ' H ' ' A' ' 50' ' ' LEU . 4.2 t-20 -88.7 -28.49 20.53 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.966 -0.561 . . . . 3.86 109.74 178.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -66.51 8.88 0.2 Allowed 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 112.503 0.557 . . . . 5.68 112.503 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.407 ' H ' ' C ' ' A' ' 48' ' ' ASN . 0.4 OUTLIER -137.35 107.85 8.66 Favored Pre-proline 0 CA--C 1.53 0.198 0 CA-C-O 120.452 0.168 . . . . 5.4 110.953 -179.55 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -78.07 26.21 0.5 Allowed 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.494 2.129 . . . . 4.92 113.463 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 54.0 p -159.87 121.02 1.76 Allowed Pre-proline 0 CA--C 1.532 0.277 0 CA-C-O 120.576 0.227 . . . . 5.64 111.281 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.587 ' O ' HD23 ' A' ' 5' ' ' LEU . 82.9 Cg_endo -77.44 170.95 18.48 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.722 2.282 . . . . 5.04 112.083 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.646 ' C ' ' HG3' ' A' ' 55' ' ' GLN . 30.7 p -78.51 102.68 8.0 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.264 0.554 . . . . 2.74 111.464 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.979 ' HB3' HD13 ' A' ' 3' ' ' LEU . 0.0 OUTLIER 41.14 -142.84 0.06 Allowed 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 115.342 -0.844 . . . . 5.75 112.906 179.152 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.422 ' H ' ' HB2' ' A' ' 55' ' ' GLN . 12.2 t -156.18 -98.32 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 109.071 -0.714 . . . . 3.12 109.071 -179.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 112.97 -107.22 1.95 Allowed Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.555 -0.831 . . . . 2.1 112.652 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.69 87.05 2.67 Favored 'General case' 0 CA--C 1.476 -1.877 0 N-CA-C 102.944 -2.984 . . . . 4.36 102.944 176.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.863 ' CA ' ' H ' ' A' ' 67' ' ' CYS . 15.4 mmtt -137.32 -57.37 0.02 OUTLIER Pre-proline 0 C--N 1.296 -1.76 0 C-N-CA 118.629 -1.228 . . . . 3.55 112.05 -173.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.674 ' HD2' ' H ' ' A' ' 59' ' ' LYS . 9.4 Cg_endo -51.94 98.08 0.04 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.121 0 CA-C-N 120.709 1.289 . . . . 1.54 113.703 -179.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.417 ' SG ' ' N ' ' A' ' 62' ' ' GLY . 0.1 OUTLIER -140.98 -173.77 3.81 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 105.832 -1.914 . . . . 1.59 105.832 178.776 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.434 ' HA3' ' CE1' ' A' ' 80' ' ' HIS . . . 61.91 -165.18 20.73 Favored Glycine 0 C--N 1.316 -0.577 0 C-N-CA 117.454 -2.308 . . . . 2.43 112.548 176.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.4 m -84.39 42.46 0.89 Allowed 'General case' 0 N--CA 1.479 1.0 0 CA-C-O 122.204 1.002 . . . . 4.11 111.575 -176.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 115.78 5.84 17.64 Favored Glycine 0 CA--C 1.535 1.292 0 CA-C-N 113.89 -1.505 . . . . 2.21 114.937 178.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.666 ' CA ' ' HA ' ' A' ' 75' ' ' SER . . . -101.13 153.37 19.05 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 119.132 -1.508 . . . . 1.62 116.481 -174.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.804 ' CB ' ' HB3' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -85.24 152.26 23.45 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 114.354 -0.923 . . . . 3.02 109.553 179.364 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.863 ' H ' ' CA ' ' A' ' 59' ' ' LYS . 0.1 OUTLIER -70.13 107.83 3.84 Favored 'General case' 0 N--CA 1.42 -1.94 0 CA-C-N 119.643 1.11 . . . . 1.52 109.798 -178.767 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.846 ' HB3' HD12 ' A' ' 72' ' ' ILE . . . -67.02 -32.05 73.0 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 115.235 -0.893 . . . . 1.07 109.78 179.176 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.892 ' CB ' ' HA2' ' A' ' 33' ' ' GLY . . . -170.66 164.54 8.2 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.464 -1.244 . . . . 1.0 110.917 -177.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 1.044 ' HA ' ' HB3' ' A' ' 85' ' ' CYS . . . -66.91 70.76 0.08 Allowed 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.264 -0.574 . . . . 1.24 111.985 178.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.608 ' HA2' ' O ' ' A' ' 85' ' ' CYS . . . 164.99 -42.33 0.29 Allowed Glycine 0 CA--C 1.52 0.369 0 CA-C-N 115.818 -0.628 . . . . 1.28 114.227 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.885 HG12 ' HA3' ' B' ' 137' ' ' GLY . 1.3 pp -120.76 121.52 65.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.191 0.52 . . . . 2.27 111.037 -178.006 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.596 ' HB2' ' HB3' ' A' ' 82' ' ' ASP . 0.1 OUTLIER -95.58 111.72 23.58 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.635 -0.711 . . . . 1.98 109.825 -179.888 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.622 ' HB2' ' HB2' ' A' ' 68' ' ' ALA . 1.3 m -84.74 117.3 23.74 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.382 0.61 . . . . 1.33 112.378 -178.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.666 ' HA ' ' CA ' ' A' ' 65' ' ' GLY . 29.6 p -92.66 -179.67 1.12 Allowed Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 114.909 -1.041 . . . . 1.99 109.162 178.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.626 ' CD ' ' HB2' ' A' ' 75' ' ' SER . 4.2 Cg_exo -74.6 29.62 0.35 Allowed 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 121.7 1.6 . . . . 1.86 111.691 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.461 ' H ' ' C ' ' A' ' 75' ' ' SER . 2.4 p30 -145.65 -37.94 0.26 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.704 -0.68 . . . . 2.65 110.825 179.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.791 ' HA3' ' O ' ' B' ' 179' ' ' CYS . . . -170.0 -133.56 1.61 Allowed Glycine 0 C--N 1.339 0.702 0 C-N-CA 120.617 -0.801 . . . . 0.99 113.38 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.825 ' O ' ' HA3' ' B' ' 178' ' ' GLY . 0.0 OUTLIER -146.27 150.93 36.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.126 0.489 . . . . 1.34 110.831 -179.62 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.434 ' CE1' ' HA3' ' A' ' 62' ' ' GLY . 50.2 p-80 -154.25 160.48 41.83 Favored 'General case' 0 C--N 1.331 -0.236 0 O-C-N 122.03 -0.419 . . . . 2.17 111.56 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.556 ' OE2' ' HG2' ' B' ' 124' ' ' PRO . 1.5 mt-10 -59.7 140.75 56.21 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.281 -0.418 . . . . 3.05 110.228 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.596 ' HB3' ' HB2' ' A' ' 73' ' ' CYS . 7.9 p-10 -145.08 140.59 16.28 Favored Pre-proline 0 CA--C 1.535 0.385 0 CA-C-N 116.487 -0.324 . . . . 2.02 111.599 -179.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 82' ' ' ASP . 3.4 Cg_exo -77.58 -14.5 15.95 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 123.243 2.629 . . . . 1.93 113.665 -179.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.3 -46.58 60.4 Favored 'General case' 0 CA--C 1.504 -0.826 0 N-CA-C 107.158 -1.423 . . . . 1.53 107.158 178.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 1.044 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 97.7 m -106.84 84.76 2.04 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 113.559 -1.655 . . . . 1.88 107.493 176.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.937 ' H ' ' CD ' ' A' ' 87' ' ' PRO . 1.2 t70 -165.06 -19.3 0.0 OUTLIER Pre-proline 0 C--N 1.316 -0.856 0 CA-C-N 113.857 -1.52 . . . . 3.6 113.619 -177.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.937 ' CD ' ' H ' ' A' ' 86' ' ' ASP . 5.7 Cg_endo -80.84 66.36 8.84 Favored 'Trans proline' 0 CA--C 1.501 -1.153 0 CA-C-N 120.659 1.271 . . . . 2.56 113.619 -179.197 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.532 ' HG3' ' N ' ' A' ' 89' ' ' ALA . 10.4 pt-20 174.39 -43.39 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 123.172 1.463 . . . . 4.72 109.009 177.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.532 ' N ' ' HG3' ' A' ' 88' ' ' GLU . . . -74.5 -109.78 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 111.745 -2.48 . . . . 5.29 114.812 -176.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -76.04 127.63 33.36 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.051 -1.432 . . . . 6.98 113.486 -175.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -90.99 129.44 36.99 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.28 -0.873 . . . . 10.21 109.762 178.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.9 t . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.218 -0.896 . . . . 11.77 110.986 -179.946 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.19 0 CA-C-O 119.401 -0.333 . . . . 10.07 111.503 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 34.8 t -122.21 141.35 42.96 Favored 'Isoleucine or valine' 0 C--N 1.342 0.278 0 C-N-CA 118.28 -1.368 . . . . 8.41 109.561 176.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 103' ' ' LEU . . . . . 0.736 HD13 ' O ' ' B' ' 106' ' ' ASP . 0.9 OUTLIER -148.43 128.69 13.79 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 120.228 1.377 . . . . 5.87 110.219 177.781 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -97.61 51.61 1.08 Allowed 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 106.529 -1.656 . . . . 6.27 106.529 176.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . 0.715 HD23 ' O ' ' B' ' 153' ' ' PRO . 0.7 OUTLIER -155.0 -123.34 0.03 OUTLIER 'General case' 0 N--CA 1.413 -2.282 0 CA-C-N 113.094 -1.866 . . . . 7.2 106.106 -177.176 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 106' ' ' ASP . . . . . 0.736 ' O ' HD13 ' B' ' 103' ' ' LEU . 6.7 t70 -162.85 -95.35 0.02 OUTLIER 'General case' 0 C--N 1.277 -2.573 0 N-CA-C 106.035 -1.839 . . . . 8.55 106.035 177.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 107' ' ' VAL . . . . . 0.473 ' O ' HD12 ' B' ' 105' ' ' LEU . 2.8 p -89.37 129.65 40.01 Favored 'Isoleucine or valine' 0 CA--C 1.475 -1.909 0 N-CA-C 100.274 -3.972 . . . . 7.48 100.274 175.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 108' ' ' ARG . . . . . 0.44 ' HG2' ' HG2' ' B' ' 155' ' ' GLN . 0.0 OUTLIER -71.37 111.88 7.05 Favored 'General case' 0 N--CA 1.401 -2.904 0 C-N-CA 116.624 -2.031 . . . . 9.12 109.972 -170.207 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 109' ' ' THR . . . . . 0.464 ' O ' HD22 ' B' ' 111' ' ' LEU . 0.9 OUTLIER -104.46 96.77 6.83 Favored 'General case' 0 N--CA 1.397 -3.108 0 N-CA-C 100.46 -3.904 . . . . 5.69 100.46 170.811 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 110' ' ' CYS . . . . . 0.583 ' HB3' ' HD3' ' B' ' 120' ' ' ARG . 0.9 OUTLIER -81.72 74.98 8.68 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 112.577 -2.101 . . . . 2.61 111.441 -179.881 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 111' ' ' LEU . . . . . 0.738 ' H ' HD22 ' B' ' 111' ' ' LEU . 3.4 mm? -30.92 111.48 0.29 Allowed Pre-proline 0 N--CA 1.471 0.614 0 N-CA-C 112.923 0.712 . . . . 2.47 112.923 -178.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 112' ' ' PRO . . . . . 0.89 ' HA ' ' O ' ' B' ' 119' ' ' GLY . 89.6 Cg_endo -81.53 144.66 14.32 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.119 1.879 . . . . 1.47 114.183 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.593 ' O ' ' HA2' ' B' ' 117' ' ' GLY . 18.0 p -150.57 -165.0 2.15 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 118.633 -1.227 . . . . 1.0 111.479 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 114' ' ' GLY . . . . . 1.073 ' HA2' ' HB3' ' B' ' 140' ' ' GLU . . . 76.24 -160.81 51.42 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 120.449 -0.881 . . . . 1.16 115.192 177.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 115' ' ' PRO . . . . . 0.548 ' HD2' ' CZ ' ' B' ' 135' ' ' PHE . 43.4 Cg_endo -63.5 114.76 2.66 Favored 'Trans proline' 0 C--N 1.366 1.478 0 C-N-CA 123.922 3.081 . . . . 1.57 106.945 176.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 77.62 -14.99 8.19 Favored Glycine 0 C--N 1.261 -3.624 0 C-N-CA 123.98 0.8 . . . . 1.7 111.193 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 117' ' ' GLY . . . . . 0.593 ' HA2' ' O ' ' B' ' 113' ' ' CYS . . . 75.12 43.01 27.55 Favored Glycine 0 N--CA 1.413 -2.893 0 C-N-CA 117.767 -2.159 . . . . 1.38 110.909 179.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.38 -27.92 17.22 Favored 'General case' 0 C--N 1.355 0.833 0 CA-C-N 112.269 -1.965 . . . . 2.54 113.345 -179.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 119' ' ' GLY . . . . . 0.89 ' O ' ' HA ' ' B' ' 112' ' ' PRO . . . -102.29 -151.82 24.05 Favored Glycine 0 N--CA 1.431 -1.686 0 N-CA-C 108.507 -1.837 . . . . 1.04 108.507 178.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.669 ' HA ' ' O ' ' B' ' 111' ' ' LEU . 0.0 OUTLIER -127.32 174.51 8.91 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 118.638 1.219 . . . . 2.89 110.714 -177.872 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 121' ' ' CYS . . . . . . . . . . . . . 1.1 m -105.35 140.69 38.09 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.276 0.56 . . . . 1.07 111.092 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -124.52 -48.13 1.82 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.447 -0.797 . . . . 1.53 110.375 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 123' ' ' GLY . . . . . 0.537 ' HA3' HD12 ' B' ' 126' ' ' ILE . . . -128.94 -177.8 15.05 Favored Glycine 0 C--N 1.33 0.247 0 N-CA-C 111.303 -0.719 . . . . 0.9 111.303 179.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . 0.556 ' HG2' ' OE2' ' A' ' 81' ' ' GLU . 20.2 Cg_exo -64.84 -70.97 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 121.942 1.761 . . . . 1.51 111.258 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 125' ' ' SER . . . . . 0.591 ' O ' ' N ' ' B' ' 137' ' ' GLY . 0.6 OUTLIER -89.77 41.47 1.04 Allowed 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 108.7 -0.852 . . . . 1.25 108.7 177.808 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 126' ' ' ILE . . . . . 0.841 HG22 ' SG ' ' B' ' 134' ' ' CYS . 2.2 mt -144.71 111.39 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 CA-C-N 116.025 -0.534 . . . . 0.85 112.374 -177.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 127' ' ' CYS . . . . . 0.686 ' SG ' ' HA ' ' B' ' 141' ' ' ALA . 0.8 OUTLIER -121.1 130.46 53.76 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 109.436 -0.579 . . . . 0.89 109.436 179.352 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 128' ' ' CYS . . . . . 0.793 ' HA ' ' O ' ' B' ' 133' ' ' GLY . 1.0 OUTLIER -125.48 169.03 12.81 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 114.22 1.193 . . . . 1.23 114.22 -177.084 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 129' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' B' ' 133' ' ' GLY . . . -147.88 176.05 26.9 Favored Glycine 0 N--CA 1.419 -2.444 0 N-CA-C 107.515 -2.234 . . . . 0.66 107.515 175.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -66.55 -55.93 13.16 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 106.681 -1.6 . . . . 2.35 106.681 178.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -117.62 31.48 6.69 Favored 'General case' 0 CA--C 1.478 -1.817 0 CA-C-N 113.337 -1.756 . . . . 1.69 109.591 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 132' ' ' LEU . . . . . 0.775 HD22 ' CE1' ' B' ' 135' ' ' PHE . 0.5 OUTLIER -120.99 -14.0 8.51 Favored 'General case' 0 N--CA 1.408 -2.562 0 N-CA-C 104.667 -2.345 . . . . 1.38 104.667 178.239 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 133' ' ' GLY . . . . . 0.876 ' HA2' ' CB ' ' B' ' 169' ' ' ALA . . . 63.08 -132.48 42.85 Favored Glycine 0 N--CA 1.404 -3.476 0 CA-C-N 114.092 -1.413 . . . . 0.72 111.821 177.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 134' ' ' CYS . . . . . 0.841 ' SG ' HG22 ' B' ' 126' ' ' ILE . 1.0 OUTLIER -146.2 121.98 10.57 Favored 'General case' 0 CA--C 1.479 -1.768 0 CA-C-N 119.462 1.631 . . . . 1.08 112.762 178.62 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 135' ' ' PHE . . . . . 1.133 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -88.83 105.78 17.95 Favored 'General case' 0 N--CA 1.409 -2.5 0 N-CA-C 103.959 -2.608 . . . . 1.36 103.959 176.369 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 136' ' ' VAL . . . . . 0.799 HG23 HG23 ' A' ' 36' ' ' VAL . 1.9 t -96.24 85.49 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.781 0 N-CA-C 107.59 -1.263 . . . . 0.75 107.59 -179.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 137' ' ' GLY . . . . . 0.885 ' HA3' HG12 ' A' ' 72' ' ' ILE . . . 122.51 12.7 5.0 Favored Glycine 0 C--O 1.227 -0.296 0 CA-C-N 113.993 -1.458 . . . . 0.83 115.874 179.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 138' ' ' THR . . . . . 0.713 HG22 ' O ' ' A' ' 32' ' ' LEU . 46.6 p -96.74 160.7 14.23 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 118.521 1.16 . . . . 0.78 110.422 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 139' ' ' ALA . . . . . 0.596 ' HA ' HD12 ' B' ' 142' ' ' LEU . . . -62.37 -23.13 66.63 Favored 'General case' 0 N--CA 1.446 -0.641 0 O-C-N 121.965 -0.459 . . . . 1.04 111.85 -179.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 140' ' ' GLU . . . . . 1.073 ' HB3' ' HA2' ' B' ' 114' ' ' GLY . 0.6 OUTLIER -67.45 -14.17 62.69 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.24 0.543 . . . . 2.31 110.781 178.56 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 141' ' ' ALA . . . . . 0.858 ' O ' ' HB2' ' B' ' 144' ' ' CYS . . . -92.74 -26.31 17.81 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 115.562 -0.744 . . . . 0.87 110.304 179.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 142' ' ' LEU . . . . . 0.596 HD12 ' HA ' ' B' ' 139' ' ' ALA . 9.8 mt -47.7 -36.64 11.55 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.146 0.424 . . . . 1.24 112.146 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 143' ' ' ARG . . . . . 0.454 ' HD3' ' O ' ' B' ' 140' ' ' GLU . 0.0 OUTLIER -60.72 -17.47 48.51 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 121.965 0.888 . . . . 2.93 109.567 177.661 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 144' ' ' CYS . . . . . 0.858 ' HB2' ' O ' ' B' ' 141' ' ' ALA . 1.2 m -58.21 -3.83 0.3 Allowed 'General case' 0 CA--C 1.552 1.048 0 CA-C-N 113.178 -1.828 . . . . 1.61 110.868 178.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 145' ' ' GLN . . . . . 0.425 ' H ' ' C ' ' B' ' 143' ' ' ARG . 16.7 tt0 -67.83 -32.85 73.68 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.233 0.54 . . . . 3.35 111.769 179.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -86.35 6.89 27.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.008 0.432 . . . . 3.76 110.701 -179.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 24.9 tp10 -83.0 1.47 39.73 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 109.082 -0.71 . . . . 4.01 109.082 177.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 148' ' ' ASN . . . . . 0.408 ' C ' ' H ' ' B' ' 150' ' ' LEU . 4.2 t-20 -88.61 -28.31 20.76 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.995 -0.548 . . . . 3.92 109.851 178.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -66.66 9.01 0.2 Allowed 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.466 0.543 . . . . 5.73 112.466 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 150' ' ' LEU . . . . . 0.408 ' H ' ' C ' ' B' ' 148' ' ' ASN . 0.4 OUTLIER -137.41 107.84 8.61 Favored Pre-proline 0 N--CA 1.462 0.125 0 CA-C-O 120.479 0.18 . . . . 5.46 110.929 -179.542 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 151' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -78.1 26.18 0.5 Allowed 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.579 2.186 . . . . 5.02 113.482 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 53.1 p -159.87 120.86 1.75 Allowed Pre-proline 0 CA--C 1.533 0.316 0 CA-C-O 120.528 0.204 . . . . 5.73 111.294 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 153' ' ' PRO . . . . . 0.715 ' O ' HD23 ' B' ' 105' ' ' LEU . 85.0 Cg_endo -77.34 170.9 18.63 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.696 2.264 . . . . 5.1 112.174 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 154' ' ' CYS . . . . . 0.65 ' C ' ' HG3' ' B' ' 155' ' ' GLN . 30.6 p -78.53 102.87 8.11 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.108 0.48 . . . . 2.68 111.65 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 155' ' ' GLN . . . . . 0.724 ' HB3' ' CB ' ' B' ' 103' ' ' LEU . 0.0 OUTLIER 41.48 -143.18 0.07 Allowed 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 115.561 -0.745 . . . . 5.63 112.552 179.065 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 156' ' ' SER . . . . . 0.46 ' H ' ' HB2' ' B' ' 155' ' ' GLN . 12.1 t -155.88 -98.49 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.925 -0.768 . . . . 3.11 108.925 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 114.04 -108.81 2.1 Favored Glycine 0 C--N 1.336 0.561 0 C-N-CA 120.02 -1.086 . . . . 2.07 112.404 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 158' ' ' GLN . . . . . 0.435 ' O ' ' HB2' ' B' ' 167' ' ' CYS . 0.0 OUTLIER -124.0 71.41 1.12 Allowed 'General case' 0 CA--C 1.486 -1.502 0 N-CA-C 104.669 -2.345 . . . . 4.34 104.669 176.148 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 159' ' ' LYS . . . . . 0.892 ' HA ' ' H ' ' B' ' 167' ' ' CYS . 18.9 mmtt -107.08 -65.77 0.04 OUTLIER Pre-proline 0 N--CA 1.421 -1.899 0 N-CA-C 116.764 2.135 . . . . 3.54 116.764 -177.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 160' ' ' PRO . . . . . 0.587 ' HD2' ' H ' ' B' ' 159' ' ' LYS . 9.6 Cg_endo -51.96 96.61 0.04 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.267 0 C-N-CA 122.351 2.034 . . . . 1.51 114.722 -174.111 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 161' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -143.62 179.72 6.96 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 112.922 -1.944 . . . . 1.58 105.838 177.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 70.03 -166.21 50.22 Favored Glycine 0 N--CA 1.441 -0.972 0 C-N-CA 117.58 -2.248 . . . . 2.37 111.863 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 2.8 m -83.95 43.55 0.93 Allowed 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 121.869 0.842 . . . . 4.07 111.21 -177.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 112.2 8.54 21.53 Favored Glycine 0 C--N 1.346 1.108 0 CA-C-N 113.961 -1.472 . . . . 2.2 114.775 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 165' ' ' GLY . . . . . 0.667 ' CA ' ' HA ' ' B' ' 175' ' ' SER . . . -103.0 156.12 18.12 Favored Glycine 0 C--N 1.339 0.748 0 CA-C-N 119.916 1.858 . . . . 1.62 116.27 -177.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 166' ' ' ARG . . . . . 0.871 ' CB ' ' HB3' ' B' ' 159' ' ' LYS . 0.0 OUTLIER -85.64 152.19 23.3 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 114.309 -0.945 . . . . 3.05 109.324 178.765 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 167' ' ' CYS . . . . . 0.892 ' H ' ' HA ' ' B' ' 159' ' ' LYS . 0.1 OUTLIER -70.32 107.74 3.9 Favored 'General case' 0 N--CA 1.418 -2.042 0 CA-C-N 119.558 1.072 . . . . 1.56 109.656 -178.853 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 168' ' ' ALA . . . . . 0.884 ' HB3' HD12 ' B' ' 172' ' ' ILE . . . -64.39 -36.1 83.04 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 122.238 1.018 . . . . 1.04 108.718 178.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 169' ' ' ALA . . . . . 0.876 ' CB ' ' HA2' ' B' ' 133' ' ' GLY . . . -168.57 164.59 12.42 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 113.287 -1.779 . . . . 0.98 112.017 -175.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 170' ' ' ALA . . . . . 1.067 ' HA ' ' HB3' ' B' ' 185' ' ' CYS . . . -67.28 71.15 0.11 Allowed 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.127 -0.629 . . . . 1.25 111.93 178.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 171' ' ' GLY . . . . . 0.552 ' HA2' ' O ' ' B' ' 185' ' ' CYS . . . 167.19 -48.83 0.25 Allowed Glycine 0 N--CA 1.455 -0.098 0 CA-C-N 115.525 -0.761 . . . . 1.29 112.74 179.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 172' ' ' ILE . . . . . 0.884 HD12 ' HB3' ' B' ' 168' ' ' ALA . 1.3 pp -115.86 121.77 68.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 C-N-CA 123.139 0.576 . . . . 2.27 111.647 -175.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 173' ' ' CYS . . . . . 0.6 ' HB2' ' HB3' ' B' ' 182' ' ' ASP . 0.1 OUTLIER -95.96 111.65 23.59 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.739 -0.664 . . . . 1.94 109.781 -179.918 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 174' ' ' CYS . . . . . 0.576 ' HB2' ' HB2' ' B' ' 168' ' ' ALA . 1.3 m -84.8 117.48 23.88 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.363 0.601 . . . . 1.35 112.359 -178.26 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 175' ' ' SER . . . . . 0.667 ' HA ' ' CA ' ' B' ' 165' ' ' GLY . 28.6 p -92.75 -179.67 1.11 Allowed Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 114.883 -1.053 . . . . 2.0 109.141 179.019 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 176' ' ' PRO . . . . . 0.612 ' CD ' ' HB2' ' B' ' 175' ' ' SER . 4.2 Cg_exo -74.62 29.67 0.35 Allowed 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 121.718 1.612 . . . . 1.9 111.681 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 177' ' ' ASP . . . . . 0.471 ' H ' ' C ' ' B' ' 175' ' ' SER . 2.4 p30 -145.7 -38.17 0.25 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.672 -0.694 . . . . 2.72 110.753 179.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 178' ' ' GLY . . . . . 0.825 ' HA3' ' O ' ' A' ' 79' ' ' CYS . . . -169.48 -133.87 1.65 Allowed Glycine 0 C--N 1.338 0.642 0 C-N-CA 120.63 -0.795 . . . . 0.99 113.388 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 179' ' ' CYS . . . . . 0.791 ' O ' ' HA3' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -146.08 151.14 37.23 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.073 0.463 . . . . 1.34 110.808 -179.77 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 180' ' ' HIS . . . . . . . . . . . . . 50.1 p-80 -154.56 160.46 41.52 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.625 -0.43 . . . . 2.1 111.542 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 181' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -59.9 140.52 56.61 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.309 -0.405 . . . . 3.06 110.187 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 182' ' ' ASP . . . . . 0.6 ' HB3' ' HB2' ' B' ' 173' ' ' CYS . 7.9 p-10 -144.81 140.61 16.52 Favored Pre-proline 0 CA--C 1.537 0.455 0 CA-C-N 116.493 -0.321 . . . . 2.06 111.629 -179.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 183' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' B' ' 182' ' ' ASP . 3.4 Cg_exo -77.41 -14.71 16.15 Favored 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 123.156 2.57 . . . . 1.91 113.672 -179.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -71.25 -46.62 60.6 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 107.134 -1.432 . . . . 1.56 107.134 178.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 185' ' ' CYS . . . . . 1.067 ' HB3' ' HA ' ' B' ' 170' ' ' ALA . 87.0 m -106.5 84.53 2.03 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 113.566 -1.652 . . . . 1.94 107.515 176.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 186' ' ' ASP . . . . . 0.934 ' H ' ' CD ' ' B' ' 187' ' ' PRO . 1.1 t70 -164.71 -19.78 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.765 0 CA-C-N 113.782 -1.554 . . . . 3.61 113.835 -177.232 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 187' ' ' PRO . . . . . 0.934 ' CD ' ' H ' ' B' ' 186' ' ' ASP . 6.2 Cg_endo -80.96 72.13 6.69 Favored 'Trans proline' 0 C--N 1.361 1.203 0 C-N-CA 121.961 1.774 . . . . 2.58 110.157 179.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 188' ' ' GLU . . . . . 0.548 ' HB3' ' O ' ' B' ' 187' ' ' PRO . 9.8 pt-20 169.57 -40.35 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 110.714 -2.948 . . . . 4.7 111.613 171.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 189' ' ' ALA . . . . . 0.507 ' N ' ' HG3' ' B' ' 188' ' ' GLU . . . -74.31 -96.78 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 119.477 3.14 . . . . 5.24 119.477 -173.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 190' ' ' ALA . . . . . . . . . . . . . . . -89.02 127.74 35.69 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 114.289 -1.323 . . . . 6.93 113.229 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 191' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -90.74 129.2 36.85 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 114.918 -1.037 . . . . 10.14 109.847 178.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 5.8 t . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.24 -0.886 . . . . 11.7 111.085 179.959 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 122.177 0.989 . . . . 9.95 110.702 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -95.48 85.72 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-N 113.379 -1.737 . . . . 8.02 109.3 177.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.999 ' HG ' ' HB3' ' A' ' 8' ' ' ARG . 0.4 OUTLIER -74.05 89.21 1.93 Allowed 'General case' 0 C--N 1.356 0.871 0 C-N-CA 118.839 -1.145 . . . . 5.86 108.943 -177.715 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -91.56 65.85 5.25 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 120.48 1.491 . . . . 6.22 111.63 -178.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.781 HD12 ' O ' ' A' ' 7' ' ' VAL . 1.2 tm? -114.35 -57.79 2.23 Favored 'General case' 0 CA--C 1.454 -2.723 0 CA-C-O 124.804 2.24 . . . . 7.09 109.161 -174.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.653 ' HB2' ' O ' ' A' ' 5' ' ' LEU . 0.2 OUTLIER 156.95 -35.46 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 CA-C-N 108.596 -3.911 . . . . 8.78 111.184 176.454 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.781 ' O ' HD12 ' A' ' 5' ' ' LEU . 10.8 p -158.5 127.87 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-N 112.23 -2.259 . . . . 7.51 105.202 175.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.999 ' HB3' ' HG ' ' A' ' 3' ' ' LEU . 3.7 ptt-85 -78.21 105.86 9.72 Favored 'General case' 0 N--CA 1.406 -2.629 0 C-N-CA 119.466 -0.894 . . . . 9.08 110.648 -178.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.699 ' O ' ' HG2' ' A' ' 53' ' ' PRO . 0.2 OUTLIER -103.86 85.64 2.45 Favored 'General case' 0 N--CA 1.409 -2.521 1 N-CA-C 98.803 -4.517 . . . . 5.66 98.803 169.057 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.673 ' HA ' ' CB ' ' A' ' 54' ' ' CYS . 82.7 m -74.75 66.92 1.54 Allowed 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 112.889 -1.96 . . . . 2.68 112.766 -176.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.941 HD22 ' HG3' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -35.63 108.46 0.37 Allowed Pre-proline 0 N--CA 1.483 1.221 0 C-N-CA 123.555 0.742 . . . . 2.48 112.389 179.28 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.852 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 43.8 Cg_endo -90.08 138.92 2.97 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.988 2.459 . . . . 1.49 114.044 -179.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.502 ' SG ' ' HE2' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -151.43 173.05 15.01 Favored 'General case' 0 C--N 1.351 0.642 0 N-CA-C 106.475 -1.676 . . . . 1.0 106.475 179.014 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.557 ' HA2' ' OE1' ' A' ' 40' ' ' GLU . . . 71.53 -163.26 54.26 Favored Glycine 0 CA--C 1.534 1.243 0 CA-C-N 119.635 1.107 . . . . 1.15 114.445 178.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.808 ' HG2' HD11 ' A' ' 32' ' ' LEU . 10.2 Cg_endo -69.68 130.49 19.52 Favored 'Trans proline' 0 C--N 1.369 1.621 0 C-N-CA 124.414 3.409 . . . . 1.57 113.285 179.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 70.35 -16.51 0.92 Allowed Glycine 0 C--N 1.284 -2.315 0 CA-C-N 112.492 -2.14 . . . . 1.68 109.575 -176.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.643 ' H ' ' C ' ' A' ' 15' ' ' PRO . . . 77.51 16.75 79.95 Favored Glycine 1 N--CA 1.388 -4.532 0 CA-C-N 113.706 -1.247 . . . . 1.36 113.74 178.285 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.447 ' H ' ' HG2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -74.34 6.97 3.15 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 107.846 -1.168 . . . . 2.5 107.846 174.033 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.852 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -71.45 155.68 52.47 Favored Glycine 0 CA--C 1.486 -1.732 0 N-CA-C 106.441 -2.664 . . . . 1.02 106.441 178.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.876 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -148.2 132.71 17.69 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 118.68 1.24 . . . . 2.92 108.955 174.644 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.447 ' O ' HD13 ' A' ' 11' ' ' LEU . 0.5 OUTLIER -103.91 128.12 51.42 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.242 -0.89 . . . . 1.1 112.464 -175.864 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -101.23 -45.25 5.42 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 114.317 -1.311 . . . . 1.51 109.119 178.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -122.05 -132.22 4.06 Favored Glycine 0 CA--C 1.524 0.617 0 CA-C-N 115.415 -0.811 . . . . 0.9 111.892 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -98.1 -72.82 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 123.061 2.507 . . . . 1.5 111.912 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.687 ' O ' HG13 ' A' ' 26' ' ' ILE . 0.9 OUTLIER -89.62 46.97 1.41 Allowed 'General case' 0 C--N 1.333 -0.124 0 N-CA-C 109.301 -0.629 . . . . 1.26 109.301 178.762 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 1.033 HG13 HG13 ' A' ' 36' ' ' VAL . 10.1 mt -151.65 116.97 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.97 0 CA-C-O 121.286 0.565 . . . . 0.83 111.598 -179.059 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.679 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 0.5 OUTLIER -138.77 108.09 6.12 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 107.086 -1.45 . . . . 0.92 107.086 178.865 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.967 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -123.92 130.41 52.55 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 115.276 1.584 . . . . 1.28 115.276 -176.704 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.472 ' O ' ' HB1' ' A' ' 69' ' ' ALA . . . -117.23 179.58 17.43 Favored Glycine 0 C--N 1.354 1.55 0 CA-C-O 122.393 0.996 . . . . 0.67 113.877 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -66.39 -35.98 81.7 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 126.873 2.069 . . . . 2.27 113.471 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.5 0.93 5.02 Favored 'General case' 0 N--CA 1.502 2.163 0 CA-C-O 121.928 0.87 . . . . 1.66 112.969 177.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.84 HD22 ' CE1' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -111.37 -11.71 14.11 Favored 'General case' 0 N--CA 1.416 -2.173 0 CA-C-N 113.836 -1.529 . . . . 1.37 111.559 -175.83 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.967 ' O ' ' HA ' ' A' ' 28' ' ' CYS . . . 57.28 -154.51 19.95 Favored Glycine 0 N--CA 1.437 -1.273 0 CA-C-N 115.634 -0.712 . . . . 0.73 113.494 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.998 ' HB2' HD13 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -107.38 123.37 48.27 Favored 'General case' 0 CA--C 1.502 -0.895 0 N-CA-C 114.137 1.162 . . . . 1.08 114.137 179.19 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.84 ' CE1' HD22 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -95.31 101.96 13.73 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 102.053 -3.314 . . . . 1.38 102.053 173.636 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 1.033 HG13 HG13 ' A' ' 26' ' ' ILE . 2.6 t -90.48 85.0 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 CA-C-O 122.859 1.314 . . . . 0.76 109.834 -177.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.526 ' O ' ' HA3' ' B' ' 133' ' ' GLY . . . 78.94 78.25 0.85 Allowed Glycine 0 N--CA 1.453 -0.181 0 CA-C-N 112.705 -2.043 . . . . 0.81 111.625 -179.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.768 ' CG2' ' HD1' ' B' ' 135' ' ' PHE . 0.8 OUTLIER -151.29 155.06 37.98 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 119.04 -0.505 . . . . 0.77 109.843 -178.704 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.868 ' O ' ' HB2' ' A' ' 42' ' ' LEU . . . -36.28 -43.82 0.38 Allowed 'General case' 0 N--CA 1.484 1.248 0 CA-C-O 120.92 0.39 . . . . 1.02 111.746 -177.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.729 ' O ' ' HG2' ' A' ' 43' ' ' ARG . 59.4 mm-40 -50.37 -49.59 53.78 Favored 'General case' 0 CA--C 1.545 0.774 0 O-C-N 121.996 -0.44 . . . . 2.32 110.276 178.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.85 ' O ' ' HB2' ' A' ' 44' ' ' CYS . . . -72.77 -0.8 14.29 Favored 'General case' 0 C--O 1.216 -0.693 0 CA-C-O 121.584 0.707 . . . . 0.87 111.191 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.868 ' HB2' ' O ' ' A' ' 39' ' ' ALA . 2.4 mt -55.85 -47.32 77.5 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 107.065 -1.457 . . . . 1.23 107.065 176.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.729 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -68.89 1.08 3.65 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 114.654 -1.157 . . . . 2.92 110.658 175.943 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.85 ' HB2' ' O ' ' A' ' 41' ' ' ALA . 1.2 m -63.3 -42.98 99.11 Favored 'General case' 0 C--N 1.345 0.394 0 CA-C-O 118.184 -0.912 . . . . 1.57 109.546 178.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -39.77 -12.76 0.01 OUTLIER 'General case' 0 C--N 1.361 1.107 0 N-CA-C 117.069 2.248 . . . . 3.31 117.069 -177.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.513 ' O ' HD12 ' A' ' 50' ' ' LEU . 1.2 mm-40 -81.34 0.81 35.53 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 118.489 -1.284 . . . . 3.69 108.412 178.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.941 ' HG3' HD22 ' A' ' 11' ' ' LEU . 1.0 OUTLIER -82.19 1.03 38.34 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 114.991 -1.004 . . . . 3.99 109.954 176.666 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 21.3 t30 -66.53 -28.6 68.68 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 108.832 -0.803 . . . . 3.86 108.832 177.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -100.35 33.8 2.57 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 109.341 -0.614 . . . . 5.68 109.341 178.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.824 ' CD1' ' HA ' ' A' ' 47' ' ' GLU . 0.9 OUTLIER -142.23 109.83 5.87 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 115.434 -0.803 . . . . 5.4 111.12 -179.186 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -82.42 50.14 3.33 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 122.156 1.904 . . . . 4.92 112.831 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 62.86 90.43 0.09 OUTLIER Pre-proline 0 N--CA 1.468 0.474 0 CA-C-N 116.129 -0.487 . . . . 5.64 112.055 179.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.752 ' C ' ' HG ' ' A' ' 5' ' ' LEU . 69.9 Cg_endo -97.82 -111.52 0.0 OUTLIER 'Trans proline' 0 CA--C 1.554 1.51 0 C-N-CA 123.186 2.59 . . . . 5.04 113.255 -179.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.768 ' SG ' HD11 ' A' ' 3' ' ' LEU . 27.9 t -32.45 99.58 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.669 1.188 . . . . 2.74 113.392 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -81.64 -118.43 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.123 0 N-CA-C 112.259 0.466 . . . . 5.75 112.259 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.875 ' OG ' HD22 ' A' ' 3' ' ' LEU . 1.4 m 70.01 115.26 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 122.695 0.398 . . . . 3.12 110.879 -179.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.544 ' O ' ' HB2' ' A' ' 66' ' ' ARG . . . 141.71 60.94 0.03 OUTLIER Glycine 0 N--CA 1.434 -1.436 0 N-CA-C 108.527 -1.829 . . . . 2.1 108.527 -178.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -117.22 74.0 0.9 Allowed 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 122.581 1.181 . . . . 4.36 109.672 -179.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 1.0 ' HB3' ' HB3' ' A' ' 67' ' ' CYS . 0.4 OUTLIER -137.62 68.34 52.26 Favored Pre-proline 0 C--N 1.3 -1.562 0 N-CA-C 105.553 -2.018 . . . . 3.55 105.553 178.521 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.443 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 26.4 Cg_endo -62.32 119.21 6.21 Favored 'Trans proline' 0 C--N 1.361 1.188 0 C-N-CA 122.537 2.158 . . . . 1.54 115.514 -176.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -145.56 -171.71 3.74 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 112.514 -2.13 . . . . 1.59 105.647 177.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.449 ' HA2' ' CE1' ' A' ' 80' ' ' HIS . . . 66.62 -166.23 39.43 Favored Glycine 0 N--CA 1.454 -0.121 0 C-N-CA 118.553 -1.784 . . . . 2.43 112.982 178.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 4.6 p -88.05 37.42 0.81 Allowed 'General case' 0 N--CA 1.487 1.381 0 CA-C-O 122.538 1.161 . . . . 4.11 110.677 -176.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 121.5 5.75 9.15 Favored Glycine 0 CA--C 1.557 2.664 0 CA-C-N 112.954 -1.93 . . . . 2.21 114.47 -176.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.893 ' HA2' ' HB3' ' A' ' 75' ' ' SER . . . -100.74 134.89 11.87 Favored Glycine 0 N--CA 1.472 1.099 0 CA-C-N 121.071 2.435 . . . . 1.62 116.275 -176.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.544 ' HB2' ' O ' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -90.43 154.87 19.34 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.023 0.529 . . . . 3.02 110.47 178.405 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 1.0 ' HB3' ' HB3' ' A' ' 59' ' ' LYS . 43.2 t -71.02 103.12 2.6 Favored 'General case' 0 N--CA 1.409 -2.501 0 N-CA-C 108.046 -1.094 . . . . 1.52 108.046 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -76.13 -40.97 51.5 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 105.481 -2.044 . . . . 1.07 105.481 176.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.472 ' HB1' ' O ' ' A' ' 29' ' ' GLY . . . -140.83 160.85 39.17 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 111.59 -2.55 . . . . 1.0 112.12 -173.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.856 ' HA ' ' HB3' ' A' ' 85' ' ' CYS . . . -53.63 120.99 6.89 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 121.602 0.715 . . . . 1.24 112.826 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.584 ' H ' ' CB ' ' A' ' 85' ' ' CYS . . . 77.53 3.71 83.43 Favored Glycine 0 N--CA 1.444 -0.832 0 N-CA-C 116.41 1.324 . . . . 1.28 116.41 176.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.998 HD13 ' HB2' ' A' ' 34' ' ' CYS . 1.1 pp -132.04 106.56 11.43 Favored 'Isoleucine or valine' 0 C--O 1.244 0.79 0 CA-C-N 118.611 1.205 . . . . 2.27 110.702 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.664 ' HB2' ' O ' ' A' ' 80' ' ' HIS . 0.1 OUTLIER -84.63 90.32 7.66 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 115.154 -0.93 . . . . 1.98 109.822 -179.118 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.74 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 0.5 OUTLIER -99.52 132.79 44.62 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 113.326 0.862 . . . . 1.33 113.326 -177.962 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.935 ' HB2' ' HD2' ' A' ' 76' ' ' PRO . 45.8 p -109.3 -177.63 0.49 Allowed Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 114.411 -1.268 . . . . 1.99 108.713 178.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.935 ' HD2' ' HB2' ' A' ' 75' ' ' SER . 64.0 Cg_endo -74.45 30.92 0.34 Allowed 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 121.351 1.367 . . . . 1.86 111.765 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 1.091 ' HB3' ' HD2' ' B' ' 180' ' ' HIS . 4.8 m-20 -143.3 -50.7 0.34 Allowed 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.593 -0.731 . . . . 2.65 110.714 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.774 ' HA2' HD11 ' A' ' 26' ' ' ILE . . . -160.64 -166.22 18.99 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 111.724 -0.55 . . . . 0.99 111.724 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.74 ' HA ' ' HA ' ' A' ' 74' ' ' CYS . 2.9 m -124.8 156.13 38.28 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 117.71 0.755 . . . . 1.34 110.391 179.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.978 ' HD2' ' HB3' ' B' ' 177' ' ' ASP . 5.8 t-80 -140.93 124.72 17.02 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.016 -0.993 . . . . 2.17 108.709 -174.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.85 132.76 14.7 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.366 0.603 . . . . 3.05 111.849 -177.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.542 ' O ' ' HA2' ' A' ' 71' ' ' GLY . 0.8 OUTLIER -141.64 119.79 7.75 Favored Pre-proline 0 CA--C 1.544 0.728 0 CA-C-N 115.138 -0.937 . . . . 2.02 110.443 -178.889 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.698 ' HA ' ' OD2' ' A' ' 86' ' ' ASP . 4.3 Cg_exo -78.28 -13.71 15.15 Favored 'Trans proline' 0 C--N 1.357 0.981 0 C-N-CA 122.822 2.348 . . . . 1.93 113.879 -178.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.38 -38.13 89.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.798 0.332 . . . . 1.53 111.699 -179.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.856 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 21.9 m -91.98 50.42 1.67 Allowed 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 116.193 -0.458 . . . . 1.88 110.569 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.907 ' CB ' ' HB3' ' A' ' 89' ' ' ALA . 78.6 m-20 -133.29 37.11 0.36 Allowed Pre-proline 0 CA--C 1.554 1.105 0 N-CA-C 116.015 1.857 . . . . 3.6 116.015 -177.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.699 ' HD3' ' N ' ' A' ' 86' ' ' ASP . 2.4 Cg_endo -83.64 52.5 3.83 Favored 'Trans proline' 0 N--CA 1.482 0.8 0 C-N-CA 122.685 2.257 . . . . 2.56 111.338 179.204 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.594 ' C ' ' H ' ' A' ' 90' ' ' ALA . 4.8 pt-20 173.72 -32.52 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.615 0 CA-C-N 110.833 -2.894 . . . . 4.72 108.896 -174.159 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.907 ' HB3' ' CB ' ' A' ' 86' ' ' ASP . . . -70.7 18.49 0.06 Allowed 'General case' 0 CA--C 1.565 1.557 0 CA-C-N 110.166 -3.197 . . . . 5.29 109.135 170.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.594 ' H ' ' C ' ' A' ' 88' ' ' GLU . . . -87.05 137.79 32.05 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 126.842 2.057 . . . . 6.98 111.732 176.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -95.57 114.19 25.91 Favored 'General case' 0 C--N 1.344 0.366 0 CA-C-N 112.85 -1.977 . . . . 10.21 111.278 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 2.5 t . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.28 -0.867 . . . . 11.77 111.37 179.257 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.246 0 CA-C-O 121.189 0.519 . . . . 10.07 111.225 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 102' ' ' VAL . . . . . 0.443 HG22 ' N ' ' B' ' 103' ' ' LEU . 7.7 p -88.49 163.69 2.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.478 -0.783 . . . . 8.41 109.727 178.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 103' ' ' LEU . . . . . 1.065 ' HG ' ' HB3' ' B' ' 108' ' ' ARG . 0.2 OUTLIER -161.42 89.03 0.74 Allowed 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 108.754 -0.832 . . . . 5.87 108.754 174.543 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -88.19 59.15 5.12 Favored 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 119.373 -0.931 . . . . 6.27 112.315 -178.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . 0.872 ' HG ' ' O ' ' B' ' 153' ' ' PRO . 0.2 OUTLIER -119.56 -58.08 1.93 Allowed 'General case' 0 CA--C 1.451 -2.842 0 CA-C-O 124.505 2.098 . . . . 7.2 109.684 -175.727 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 106' ' ' ASP . . . . . 0.569 ' HB2' ' O ' ' B' ' 105' ' ' LEU . 0.3 OUTLIER 159.34 -40.14 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 108.925 -3.762 . . . . 8.55 111.02 177.236 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 107' ' ' VAL . . . . . 0.667 ' O ' HD12 ' B' ' 105' ' ' LEU . 12.0 p -155.05 127.1 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-N 112.128 -2.305 . . . . 7.48 105.658 175.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 108' ' ' ARG . . . . . 1.065 ' HB3' ' HG ' ' B' ' 103' ' ' LEU . 2.0 ptt-85 -77.88 106.61 9.84 Favored 'General case' 0 N--CA 1.406 -2.673 0 C-N-CA 119.598 -0.841 . . . . 9.12 110.625 -177.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 109' ' ' THR . . . . . 0.698 ' O ' ' HG2' ' B' ' 153' ' ' PRO . 0.2 OUTLIER -105.21 85.92 2.34 Favored 'General case' 0 N--CA 1.408 -2.564 1 N-CA-C 98.598 -4.594 . . . . 5.69 98.598 168.94 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' B' B ' 110' ' ' CYS . . . . . 0.667 ' HA ' ' CB ' ' B' ' 154' ' ' CYS . 81.5 m -76.06 68.72 2.56 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 112.743 -2.026 . . . . 2.61 112.189 -176.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 111' ' ' LEU . . . . . 0.936 HD22 ' HG3' ' B' ' 147' ' ' GLU . 0.0 OUTLIER -36.29 108.58 0.39 Allowed Pre-proline 0 N--CA 1.481 1.115 0 C-N-CA 123.671 0.789 . . . . 2.47 112.417 178.876 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 112' ' ' PRO . . . . . 0.708 ' HA ' ' O ' ' B' ' 119' ' ' GLY . 39.3 Cg_endo -90.44 138.84 2.75 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 123.08 2.52 . . . . 1.47 114.055 -179.291 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.528 ' N ' ' O ' ' B' ' 119' ' ' GLY . 0.5 OUTLIER -151.79 172.38 16.25 Favored 'General case' 0 C--N 1.347 0.495 0 N-CA-C 106.822 -1.547 . . . . 1.0 106.822 179.435 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 114' ' ' GLY . . . . . 0.568 ' HA2' ' OE1' ' B' ' 140' ' ' GLU . . . 71.89 -163.38 54.41 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 119.931 -1.128 . . . . 1.16 114.379 178.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 115' ' ' PRO . . . . . 0.815 ' HG2' HD11 ' B' ' 132' ' ' LEU . 9.5 Cg_endo -69.65 130.35 19.33 Favored 'Trans proline' 0 C--N 1.367 1.549 0 C-N-CA 124.45 3.433 . . . . 1.57 113.194 178.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 70.73 -16.5 1.02 Allowed Glycine 0 C--N 1.287 -2.186 0 CA-C-N 113.041 -1.89 . . . . 1.7 109.686 -176.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 117' ' ' GLY . . . . . 0.621 ' H ' ' C ' ' B' ' 115' ' ' PRO . . . 76.87 16.44 80.77 Favored Glycine 1 N--CA 1.39 -4.42 0 CA-C-N 113.505 -1.347 . . . . 1.38 113.77 178.369 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 118' ' ' LYS . . . . . 0.474 ' H ' ' HG2' ' B' ' 118' ' ' LYS . 0.0 OUTLIER -73.85 6.95 2.86 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 122.257 1.027 . . . . 2.54 108.253 174.955 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 119' ' ' GLY . . . . . 0.708 ' O ' ' HA ' ' B' ' 112' ' ' PRO . . . -89.59 124.15 7.25 Favored Glycine 0 N--CA 1.419 -2.438 0 CA-C-N 113.933 -1.485 . . . . 1.04 115.332 -178.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.849 ' HA ' ' O ' ' B' ' 111' ' ' LEU . 0.1 OUTLIER -112.96 136.4 52.67 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 120.816 -1.402 . . . . 2.89 112.288 -171.719 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 121' ' ' CYS . . . . . 0.437 ' O ' HD13 ' B' ' 111' ' ' LEU . 0.6 OUTLIER -104.45 127.83 52.23 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.597 0.713 . . . . 1.07 112.131 -177.68 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -101.32 -45.32 5.37 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 114.656 -1.156 . . . . 1.53 109.237 179.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -122.11 -132.33 4.07 Favored Glycine 0 CA--C 1.522 0.524 0 CA-C-N 115.321 -0.854 . . . . 0.9 111.895 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -97.77 -72.84 0.0 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 123.041 2.494 . . . . 1.51 112.02 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 125' ' ' SER . . . . . 0.698 ' O ' HG13 ' B' ' 126' ' ' ILE . 0.9 OUTLIER -89.46 46.73 1.4 Allowed 'General case' 0 C--O 1.225 -0.19 0 N-CA-C 109.288 -0.634 . . . . 1.25 109.288 178.752 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 126' ' ' ILE . . . . . 0.939 ' CG1' HG13 ' B' ' 136' ' ' VAL . 13.4 mt -150.96 116.8 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 CA-C-N 116.041 -0.527 . . . . 0.85 111.735 -178.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 127' ' ' CYS . . . . . 0.675 ' HA ' ' O ' ' B' ' 120' ' ' ARG . 0.5 OUTLIER -139.02 108.3 6.1 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 106.992 -1.484 . . . . 0.89 106.992 178.627 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 128' ' ' CYS . . . . . 0.982 ' HA ' ' O ' ' B' ' 133' ' ' GLY . 0.0 OUTLIER -124.7 129.03 49.73 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 115.357 1.614 . . . . 1.23 115.357 -176.396 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 129' ' ' GLY . . . . . 0.469 ' O ' ' HB1' ' B' ' 169' ' ' ALA . . . -116.21 -178.97 18.18 Favored Glycine 0 C--N 1.356 1.644 0 CA-C-O 122.468 1.038 . . . . 0.66 113.864 -179.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -67.28 -34.88 78.32 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 126.767 2.027 . . . . 2.35 113.42 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.57 17.57 2.91 Favored 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 118.404 -1.319 . . . . 1.69 111.892 176.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 132' ' ' LEU . . . . . 0.862 HD22 ' CE1' ' B' ' 135' ' ' PHE . 0.3 OUTLIER -124.7 -13.5 6.97 Favored 'General case' 0 N--CA 1.42 -1.937 0 CA-C-N 113.17 -1.832 . . . . 1.38 109.306 -176.838 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 133' ' ' GLY . . . . . 0.982 ' O ' ' HA ' ' B' ' 128' ' ' CYS . . . 53.24 -152.48 8.49 Favored Glycine 0 N--CA 1.41 -3.085 0 CA-C-N 114.175 -1.375 . . . . 0.72 114.303 177.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 134' ' ' CYS . . . . . 0.982 ' HB2' HD13 ' B' ' 172' ' ' ILE . 0.1 OUTLIER -104.32 123.58 47.64 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 115.301 1.593 . . . . 1.08 115.301 -178.927 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 135' ' ' PHE . . . . . 0.862 ' CE1' HD22 ' B' ' 132' ' ' LEU . 0.0 OUTLIER -96.59 101.75 13.42 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 102.127 -3.286 . . . . 1.36 102.127 173.238 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 136' ' ' VAL . . . . . 0.939 HG13 ' CG1' ' B' ' 126' ' ' ILE . 3.1 t -90.41 84.71 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 CA-C-O 122.471 1.129 . . . . 0.75 109.689 -176.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 137' ' ' GLY . . . . . 0.703 ' O ' ' HA3' ' A' ' 33' ' ' GLY . . . 78.87 78.05 0.86 Allowed Glycine 0 N--CA 1.453 -0.195 0 CA-C-N 113.059 -1.882 . . . . 0.83 111.631 -179.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 138' ' ' THR . . . . . 0.748 ' CG2' ' HD1' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -150.96 155.74 39.73 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 118.928 -0.558 . . . . 0.78 109.671 -178.794 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 139' ' ' ALA . . . . . 0.865 ' O ' ' HB2' ' B' ' 142' ' ' LEU . . . -36.9 -44.06 0.48 Allowed 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 118.142 0.428 . . . . 1.04 111.949 -177.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 140' ' ' GLU . . . . . 0.724 ' O ' ' HG2' ' B' ' 143' ' ' ARG . 55.4 mm-40 -50.25 -49.42 53.14 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.775 -0.578 . . . . 2.31 110.476 178.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 141' ' ' ALA . . . . . 0.857 ' O ' ' HB2' ' B' ' 144' ' ' CYS . . . -71.02 -3.94 22.25 Favored 'General case' 0 C--O 1.214 -0.787 0 CA-C-O 121.495 0.664 . . . . 0.87 110.968 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 142' ' ' LEU . . . . . 0.865 ' HB2' ' O ' ' B' ' 139' ' ' ALA . 2.4 mt -54.39 -46.94 73.19 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 107.267 -1.382 . . . . 1.24 107.267 177.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 143' ' ' ARG . . . . . 0.724 ' HG2' ' O ' ' B' ' 140' ' ' GLU . 0.0 OUTLIER -68.9 0.81 3.96 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 114.921 -1.036 . . . . 2.93 110.727 175.872 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 144' ' ' CYS . . . . . 0.857 ' HB2' ' O ' ' B' ' 141' ' ' ALA . 1.2 m -63.06 -42.79 99.78 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 118.202 -0.904 . . . . 1.61 109.66 178.204 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -40.18 -12.67 0.01 OUTLIER 'General case' 0 C--N 1.36 1.059 0 N-CA-C 117.016 2.228 . . . . 3.35 117.016 -178.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 146' ' ' GLU . . . . . 0.527 ' O ' HD12 ' B' ' 150' ' ' LEU . 1.2 mm-40 -81.38 0.62 36.53 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 118.515 -1.274 . . . . 3.76 108.342 178.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . 0.936 ' HG3' HD22 ' B' ' 111' ' ' LEU . 1.0 OUTLIER -82.04 0.98 37.87 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 114.984 -1.007 . . . . 4.01 109.931 176.698 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 148' ' ' ASN . . . . . . . . . . . . . 21.3 t30 -66.48 -28.68 68.76 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.785 -0.82 . . . . 3.92 108.785 177.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -100.25 33.67 2.59 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 109.344 -0.613 . . . . 5.73 109.344 178.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 150' ' ' LEU . . . . . 0.825 ' CD1' ' HA ' ' B' ' 147' ' ' GLU . 0.9 OUTLIER -142.2 109.84 5.89 Favored Pre-proline 0 CA--C 1.534 0.33 0 CA-C-N 115.474 -0.785 . . . . 5.46 111.144 -179.169 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 151' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -82.45 50.13 3.32 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.145 1.896 . . . . 5.02 112.868 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 62.88 90.45 0.09 OUTLIER Pre-proline 0 N--CA 1.468 0.452 0 CA-C-N 116.07 -0.514 . . . . 5.73 112.046 179.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 153' ' ' PRO . . . . . 0.872 ' O ' ' HG ' ' B' ' 105' ' ' LEU . 69.7 Cg_endo -97.91 -112.05 0.0 OUTLIER 'Trans proline' 0 CA--C 1.554 1.5 0 C-N-CA 123.281 2.654 . . . . 5.1 113.208 -179.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 154' ' ' CYS . . . . . 0.725 ' SG ' HD21 ' B' ' 103' ' ' LEU . 25.9 t -31.75 100.62 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.704 1.202 . . . . 2.68 113.237 -179.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 155' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -82.92 -117.86 0.02 OUTLIER 'General case' 0 CA--C 1.551 0.989 0 N-CA-C 112.026 0.38 . . . . 5.63 112.026 -179.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 1.4 m 69.78 114.59 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 122.567 0.347 . . . . 3.11 111.321 -179.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 157' ' ' GLY . . . . . 0.536 ' O ' ' HB2' ' B' ' 166' ' ' ARG . . . 142.0 61.71 0.03 OUTLIER Glycine 0 N--CA 1.44 -1.092 0 N-CA-C 109.075 -1.61 . . . . 2.07 109.075 -178.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -117.24 64.15 0.73 Allowed 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 122.508 1.147 . . . . 4.34 110.719 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 159' ' ' LYS . . . . . 1.067 ' HB3' ' HB3' ' B' ' 167' ' ' CYS . 0.5 OUTLIER -118.64 66.79 7.19 Favored Pre-proline 0 C--N 1.31 -1.113 0 CA-C-N 113.126 -1.852 . . . . 3.54 108.083 174.457 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 160' ' ' PRO . . . . . 0.441 ' HA ' ' HA ' ' B' ' 166' ' ' ARG . 23.1 Cg_endo -62.17 119.39 6.47 Favored 'Trans proline' 0 C--O 1.231 0.145 0 N-CA-C 116.259 1.6 . . . . 1.51 116.259 -174.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 161' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -146.49 -174.4 4.45 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 112.84 -1.982 . . . . 1.58 105.84 176.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 162' ' ' GLY . . . . . 0.451 ' HA2' ' CE1' ' B' ' 180' ' ' HIS . . . 69.2 -166.07 48.43 Favored Glycine 0 CA--C 1.508 -0.366 0 C-N-CA 118.5 -1.81 . . . . 2.37 112.51 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 4.6 p -88.0 37.05 0.79 Allowed 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 122.713 1.244 . . . . 4.07 110.644 -175.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 121.57 5.62 9.16 Favored Glycine 0 CA--C 1.556 2.598 0 CA-C-N 112.833 -1.985 . . . . 2.2 114.61 -176.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 165' ' ' GLY . . . . . 0.914 ' HA2' ' HB3' ' B' ' 175' ' ' SER . . . -101.21 135.36 12.12 Favored Glycine 0 C--N 1.346 1.087 0 CA-C-N 121.319 2.56 . . . . 1.62 116.283 -177.007 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 166' ' ' ARG . . . . . 0.536 ' HB2' ' O ' ' B' ' 157' ' ' GLY . 0.0 OUTLIER -90.2 154.93 19.38 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.01 0.524 . . . . 3.05 110.497 178.391 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 167' ' ' CYS . . . . . 1.067 ' HB3' ' HB3' ' B' ' 159' ' ' LYS . 42.9 t -70.96 103.17 2.59 Favored 'General case' 0 N--CA 1.406 -2.633 0 N-CA-C 108.071 -1.085 . . . . 1.56 108.071 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 168' ' ' ALA . . . . . . . . . . . . . . . -75.95 -41.38 51.78 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 105.363 -2.088 . . . . 1.04 105.363 176.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 169' ' ' ALA . . . . . 0.518 ' CB ' ' HA2' ' B' ' 133' ' ' GLY . . . -140.45 160.74 39.32 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 111.547 -2.57 . . . . 0.98 112.047 -173.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 170' ' ' ALA . . . . . 0.866 ' HA ' ' HB3' ' B' ' 185' ' ' CYS . . . -53.76 121.03 7.04 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 121.686 0.755 . . . . 1.25 112.792 -179.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 171' ' ' GLY . . . . . 0.579 ' H ' ' CB ' ' B' ' 185' ' ' CYS . . . 77.52 3.75 83.47 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 116.369 1.308 . . . . 1.29 116.369 176.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 172' ' ' ILE . . . . . 0.982 HD13 ' HB2' ' B' ' 134' ' ' CYS . 1.1 pp -131.97 106.41 11.26 Favored 'Isoleucine or valine' 0 C--O 1.245 0.823 0 CA-C-N 118.482 1.141 . . . . 2.27 110.781 -179.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 173' ' ' CYS . . . . . 0.697 ' HB2' ' O ' ' B' ' 180' ' ' HIS . 0.1 OUTLIER -84.52 90.51 7.65 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 115.153 -0.931 . . . . 1.94 109.755 -179.2 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 174' ' ' CYS . . . . . 0.775 ' HA ' ' HA ' ' B' ' 179' ' ' CYS . 0.5 OUTLIER -99.84 132.86 44.93 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 113.241 0.83 . . . . 1.35 113.241 -177.986 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 175' ' ' SER . . . . . 0.929 ' HB2' ' HD2' ' B' ' 176' ' ' PRO . 43.5 p -109.34 -177.58 0.48 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 114.269 -1.332 . . . . 2.0 108.686 178.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 176' ' ' PRO . . . . . 0.929 ' HD2' ' HB2' ' B' ' 175' ' ' SER . 62.8 Cg_endo -74.48 30.95 0.34 Allowed 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 121.387 1.391 . . . . 1.9 111.768 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 177' ' ' ASP . . . . . 0.978 ' HB3' ' HD2' ' A' ' 80' ' ' HIS . 4.8 m-20 -143.22 -50.79 0.34 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.523 -0.762 . . . . 2.72 110.778 179.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 178' ' ' GLY . . . . . 0.76 ' HA2' HD11 ' B' ' 126' ' ' ILE . . . -160.48 -166.05 18.52 Favored Glycine 0 CA--C 1.522 0.48 0 N-CA-C 111.752 -0.539 . . . . 0.99 111.752 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 179' ' ' CYS . . . . . 0.775 ' HA ' ' HA ' ' B' ' 174' ' ' CYS . 3.1 m -124.26 160.78 27.2 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 117.718 0.759 . . . . 1.34 110.144 179.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 180' ' ' HIS . . . . . 1.091 ' HD2' ' HB3' ' A' ' 77' ' ' ASP . 5.6 t-80 -148.72 123.21 9.72 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-O 121.663 0.744 . . . . 2.1 109.072 -174.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 181' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -46.78 132.41 11.33 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 114.572 -1.194 . . . . 3.06 111.921 -176.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 182' ' ' ASP . . . . . 0.532 ' O ' ' HA2' ' B' ' 171' ' ' GLY . 0.9 OUTLIER -141.54 119.84 7.84 Favored Pre-proline 0 CA--C 1.545 0.751 0 CA-C-N 114.909 -1.041 . . . . 2.06 110.341 -178.735 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 183' ' ' PRO . . . . . 0.704 ' HA ' ' OD2' ' B' ' 186' ' ' ASP . 4.4 Cg_exo -78.31 -13.81 15.06 Favored 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 122.836 2.358 . . . . 1.91 113.854 -178.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -64.26 -38.27 90.44 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.834 0.35 . . . . 1.56 111.661 -179.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 185' ' ' CYS . . . . . 0.866 ' HB3' ' HA ' ' B' ' 170' ' ' ALA . 21.8 m -91.91 50.34 1.67 Allowed 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 116.179 -0.464 . . . . 1.94 110.53 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 186' ' ' ASP . . . . . 0.911 ' CB ' ' HB3' ' B' ' 189' ' ' ALA . 78.5 m-20 -133.09 37.16 0.36 Allowed Pre-proline 0 CA--C 1.551 1.013 0 N-CA-C 116.042 1.867 . . . . 3.61 116.042 -177.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 187' ' ' PRO . . . . . 0.713 ' HD3' ' N ' ' B' ' 186' ' ' ASP . 2.4 Cg_endo -83.46 51.26 3.49 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.539 2.159 . . . . 2.58 111.842 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 188' ' ' GLU . . . . . 0.605 ' C ' ' H ' ' B' ' 190' ' ' ALA . 5.2 pt-20 175.49 -33.67 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.527 0 CA-C-N 110.811 -2.904 . . . . 4.7 108.522 -174.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 189' ' ' ALA . . . . . 0.911 ' HB3' ' CB ' ' B' ' 186' ' ' ASP . . . -69.49 18.95 0.04 OUTLIER 'General case' 0 CA--C 1.567 1.616 0 CA-C-N 110.403 -3.09 . . . . 5.24 109.047 170.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 190' ' ' ALA . . . . . 0.605 ' H ' ' C ' ' B' ' 188' ' ' GLU . . . -87.78 138.51 31.4 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.728 2.011 . . . . 6.93 111.551 176.33 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 191' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -95.62 114.38 26.13 Favored 'General case' 0 C--N 1.343 0.289 0 CA-C-N 112.796 -2.002 . . . . 10.14 111.296 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 2.6 t . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.321 -0.847 . . . . 11.7 111.496 179.339 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.546 ' O ' HD12 ' A' ' 3' ' ' LEU . . . . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 120.818 0.342 . . . . 9.95 110.897 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.548 ' O ' HG13 ' A' ' 2' ' ' VAL . 14.4 p -79.86 75.4 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-O 124.367 2.032 . . . . 8.02 110.708 178.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.753 ' O ' HD22 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -101.83 78.62 1.83 Allowed 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 109.243 -3.617 . . . . 5.86 114.916 -179.909 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.46 60.81 4.2 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 123.109 1.433 . . . . 6.22 108.433 175.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 1.04 HD12 HG12 ' A' ' 7' ' ' VAL . 0.4 OUTLIER -153.53 -135.67 0.06 Allowed 'General case' 0 N--CA 1.386 -3.674 0 CA-C-N 111.208 -2.724 . . . . 7.09 106.147 178.785 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.719 ' H ' HD13 ' A' ' 5' ' ' LEU . 6.0 t0 -158.41 25.02 0.24 Allowed 'General case' 0 C--N 1.291 -1.974 0 CA-C-O 122.388 1.089 . . . . 8.78 109.212 -176.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 1.04 HG12 HD12 ' A' ' 5' ' ' LEU . 4.7 p -151.56 172.94 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.689 0 N-CA-C 104.578 -2.379 . . . . 7.51 104.578 179.067 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.547 ' H ' HG22 ' A' ' 7' ' ' VAL . 2.4 ptp85 -71.05 119.54 15.32 Favored 'General case' 0 CA--C 1.475 -1.909 0 N-CA-C 106.449 -1.686 . . . . 9.08 106.449 -176.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.632 ' HB ' ' HA ' ' A' ' 3' ' ' LEU . 1.4 t -55.17 111.95 0.97 Allowed 'General case' 0 N--CA 1.418 -2.056 0 C-N-CA 117.992 -1.483 . . . . 5.66 109.512 -175.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.439 ' SG ' ' HB3' ' A' ' 20' ' ' ARG . 12.5 p -29.29 111.44 0.06 Allowed 'General case' 0 C--N 1.309 -1.152 0 CA-C-N 111.801 -2.454 . . . . 2.68 113.806 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.415 ' O ' ' O ' ' A' ' 10' ' ' CYS . 26.1 mt -30.96 154.53 0.03 OUTLIER Pre-proline 0 N--CA 1.48 1.039 0 C-N-CA 123.872 0.869 . . . . 2.48 113.305 178.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.719 ' HB2' ' O ' ' A' ' 17' ' ' GLY . 33.4 Cg_endo -91.92 117.39 0.44 Allowed 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 123.312 2.675 . . . . 1.49 116.295 -178.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.647 ' SG ' ' O ' ' A' ' 20' ' ' ARG . 10.6 p -106.64 -156.41 0.58 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.693 1.197 . . . . 1.0 110.515 -176.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 79.96 -168.22 51.98 Favored Glycine 0 CA--C 1.498 -0.987 0 N-CA-C 110.373 -1.091 . . . . 1.15 110.373 -177.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.595 ' HD2' HD11 ' A' ' 32' ' ' LEU . 85.2 Cg_endo -63.8 89.87 0.15 Allowed 'Trans proline' 0 CA--C 1.51 -0.706 0 CA-C-N 119.793 1.796 . . . . 1.57 110.932 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.88 18.3 63.67 Favored Glycine 0 N--CA 1.418 -2.548 0 CA-C-N 114.168 -1.378 . . . . 1.68 114.199 177.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.719 ' O ' ' HB2' ' A' ' 12' ' ' PRO . . . 84.18 36.76 12.19 Favored Glycine 0 N--CA 1.404 -3.485 0 C-N-CA 118.077 -2.011 . . . . 1.36 115.947 176.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.543 ' HG3' ' HG2' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -92.63 -12.54 31.35 Favored 'General case' 0 CA--C 1.559 1.32 0 CA-C-N 115.0 -0.6 . . . . 2.5 110.999 175.896 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.531 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -102.21 -176.79 27.69 Favored Glycine 0 N--CA 1.478 1.467 0 C-N-CA 126.298 1.904 . . . . 1.02 109.379 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.647 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -126.18 168.97 13.32 Favored 'General case' 0 C--N 1.354 0.786 0 CA-C-N 122.707 3.253 . . . . 2.92 105.7 175.368 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.673 ' HB2' ' HG2' ' A' ' 47' ' ' GLU . 33.7 m -108.49 163.08 13.54 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 119.334 0.97 . . . . 1.1 113.331 -178.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -143.47 -57.04 0.4 Allowed 'General case' 0 C--O 1.232 0.146 0 CA-C-N 114.82 -1.082 . . . . 1.51 109.913 178.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.556 ' O ' ' HB3' ' A' ' 44' ' ' CYS . . . -120.54 176.91 16.33 Favored Glycine 0 C--N 1.332 0.319 0 CA-C-N 115.866 -0.606 . . . . 0.9 112.005 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.437 ' HB2' ' OE1' ' B' ' 181' ' ' GLU . 47.7 Cg_exo -53.67 -68.77 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.49 2.127 . . . . 1.5 112.368 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.65 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.5 OUTLIER -95.59 18.19 13.33 Favored 'General case' 0 C--O 1.224 -0.271 0 N-CA-C 109.995 -0.372 . . . . 1.26 109.995 178.878 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.931 HG12 HG13 ' A' ' 36' ' ' VAL . 1.2 mt -122.41 106.26 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 CA-C-O 121.751 0.786 . . . . 0.83 111.797 -177.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.748 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 0.6 OUTLIER -121.94 124.13 43.31 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 114.725 -1.125 . . . . 0.92 109.615 -179.011 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 1.178 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -138.52 112.82 8.72 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 114.978 1.473 . . . . 1.28 114.978 -178.607 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 33' ' ' GLY . . . -106.41 -159.17 22.03 Favored Glycine 0 N--CA 1.429 -1.832 0 N-CA-C 109.559 -1.416 . . . . 0.67 109.559 175.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -65.5 -64.86 0.76 Allowed 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 112.69 0.626 . . . . 2.27 112.69 -178.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.51 17.36 20.85 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 122.61 1.195 . . . . 1.66 109.808 -176.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.595 HD11 ' HD2' ' A' ' 15' ' ' PRO . 0.3 OUTLIER -113.95 -11.72 12.74 Favored 'General case' 0 N--CA 1.404 -2.759 0 N-CA-C 105.486 -2.042 . . . . 1.37 105.486 -179.642 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 1.178 ' O ' ' HA ' ' A' ' 28' ' ' CYS . . . 50.68 -135.48 29.33 Favored Glycine 0 N--CA 1.415 -2.758 0 CA-C-N 114.275 -1.33 . . . . 0.73 111.769 175.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.981 ' HB2' HD13 ' A' ' 72' ' ' ILE . 1.8 t -129.04 111.85 13.41 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-N 118.803 1.301 . . . . 1.08 112.678 179.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.827 ' HA ' ' HA ' ' B' ' 135' ' ' PHE . 6.2 m-30 -85.18 105.41 15.86 Favored 'General case' 0 N--CA 1.408 -2.525 0 N-CA-C 103.543 -2.762 . . . . 1.38 103.543 176.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.931 HG13 HG12 ' A' ' 26' ' ' ILE . 2.2 t -97.27 85.27 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.75 0 CA-C-O 123.129 1.443 . . . . 0.76 107.79 -178.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.779 ' HA3' HG21 ' B' ' 172' ' ' ILE . . . 110.97 92.96 2.17 Favored Glycine 0 CA--C 1.521 0.464 0 CA-C-N 112.427 -2.169 . . . . 0.81 114.263 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.715 ' CG2' ' HB3' ' A' ' 35' ' ' PHE . 0.0 OUTLIER 178.77 169.26 0.89 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 110.096 -0.335 . . . . 0.77 110.096 178.29 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.784 ' HA ' HD12 ' A' ' 42' ' ' LEU . . . -68.42 -35.83 78.21 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.832 -0.347 . . . . 1.02 110.933 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.86 -24.18 14.94 Favored 'General case' 0 C--N 1.332 -0.181 0 O-C-N 122.093 -0.379 . . . . 2.32 111.691 -178.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.675 ' O ' ' N ' ' A' ' 44' ' ' CYS . . . -97.23 -23.33 16.22 Favored 'General case' 0 C--O 1.214 -0.781 0 CA-C-N 116.818 -0.174 . . . . 0.87 111.242 -179.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.784 HD12 ' HA ' ' A' ' 39' ' ' ALA . 1.0 OUTLIER -37.38 -46.73 0.8 Allowed 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.969 0.729 . . . . 1.23 112.969 -175.771 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.531 ' HD2' ' H ' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -53.7 -25.68 19.43 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.813 -0.81 . . . . 2.92 108.813 177.557 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.675 ' N ' ' O ' ' A' ' 41' ' ' ALA . 86.2 m -57.33 -20.57 29.67 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.427 -0.806 . . . . 1.57 110.473 -178.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -39.09 -45.04 1.22 Allowed 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.594 0.59 . . . . 3.31 112.594 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -87.74 -7.57 57.17 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 119.873 -0.731 . . . . 3.69 110.991 -179.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.673 ' HG2' ' HB2' ' A' ' 21' ' ' CYS . 0.8 OUTLIER -85.02 6.46 25.15 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.903 -0.589 . . . . 3.99 109.453 177.139 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.503 ' C ' ' H ' ' A' ' 50' ' ' LEU . 7.5 p-10 -71.9 -26.57 62.37 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.632 -0.713 . . . . 3.86 109.394 177.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 19.7 t80 -51.59 8.31 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 114.565 1.32 . . . . 5.68 114.565 -178.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.575 ' N ' HD13 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -133.16 132.41 22.22 Favored Pre-proline 0 N--CA 1.466 0.336 0 CA-C-N 118.754 0.706 . . . . 5.4 110.738 178.539 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.671 ' HA ' ' HG3' ' A' ' 76' ' ' PRO . 95.6 Cg_endo -86.74 10.64 3.54 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.846 2.364 . . . . 4.92 113.401 -178.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.661 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 0.8 OUTLIER 160.58 -52.08 0.0 OUTLIER Pre-proline 0 N--CA 1.465 0.284 0 CA-C-O 120.686 0.279 . . . . 5.64 111.326 -179.865 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.661 ' HD2' ' N ' ' A' ' 52' ' ' SER . 11.8 Cg_endo -55.71 121.63 10.31 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 123.092 2.528 . . . . 5.04 114.758 -178.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.531 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 0.1 OUTLIER -178.78 107.13 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 115.439 -0.8 . . . . 2.74 109.84 178.139 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.631 ' N ' ' HB2' ' A' ' 5' ' ' LEU . 18.9 pt20 33.06 -156.1 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.4 0.518 . . . . 5.75 112.4 -177.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.2 t -80.13 105.81 11.68 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 112.569 0.581 . . . . 3.12 112.569 -178.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 164.17 35.23 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 110.534 -1.026 . . . . 2.1 110.534 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.535 ' HA ' ' HB2' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -123.26 88.99 3.02 Favored 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 109.043 -0.725 . . . . 4.36 109.043 179.611 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.554 ' HB3' ' HB2' ' A' ' 67' ' ' CYS . 0.5 OUTLIER -135.52 81.39 42.42 Favored Pre-proline 0 C--N 1.296 -1.755 0 N-CA-C 106.065 -1.828 . . . . 3.55 106.065 -178.647 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.501 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 12.0 Cg_endo -55.44 107.18 0.22 Allowed 'Trans proline' 0 C--N 1.358 1.05 0 C-N-CA 123.868 3.046 . . . . 1.54 114.241 -177.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.59 ' SG ' ' HB2' ' A' ' 84' ' ' ALA . 0.5 OUTLIER -144.34 149.63 36.49 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-N 114.333 -1.303 . . . . 1.59 110.144 178.811 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 79.36 -167.26 51.97 Favored Glycine 0 C--N 1.339 0.73 0 C-N-CA 119.039 -1.553 . . . . 2.43 109.683 -173.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.05 66.67 0.15 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 118.668 1.234 . . . . 4.11 112.472 -175.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.22 13.73 80.24 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.984 -0.627 . . . . 2.21 114.347 177.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.482 ' O ' ' O ' ' A' ' 61' ' ' CYS . . . -101.01 122.19 7.51 Favored Glycine 0 CA--C 1.501 -0.836 0 C-N-CA 119.59 -1.29 . . . . 1.62 113.66 -175.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.535 ' HB2' ' HA ' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -86.54 152.24 22.8 Favored 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 110.067 -0.345 . . . . 3.02 110.067 -178.929 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.554 ' HB2' ' HB3' ' A' ' 59' ' ' LYS . 0.1 OUTLIER -67.03 106.54 1.98 Allowed 'General case' 0 N--CA 1.423 -1.802 0 N-CA-C 108.674 -0.862 . . . . 1.52 108.674 -179.196 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -91.88 -23.72 19.55 Favored 'General case' 0 N--CA 1.417 -2.108 0 N-CA-C 107.468 -1.308 . . . . 1.07 107.468 177.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.906 ' HB1' ' HA2' ' A' ' 33' ' ' GLY . . . -169.72 163.26 9.92 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 109.875 -0.417 . . . . 1.0 109.875 -178.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.851 ' HA ' ' HB3' ' A' ' 85' ' ' CYS . . . -37.35 127.06 1.05 Allowed 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 115.611 1.708 . . . . 1.24 115.611 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.627 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . 59.08 -6.39 0.05 OUTLIER Glycine 0 C--N 1.342 0.912 0 N-CA-C 115.97 1.148 . . . . 1.28 115.97 177.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.981 HD13 ' HB2' ' A' ' 34' ' ' CYS . 1.6 pp -117.58 105.82 18.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 117.662 0.731 . . . . 2.27 111.846 -178.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -91.93 106.7 18.66 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.018 -0.992 . . . . 1.98 108.844 179.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.671 ' SG ' HD12 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -129.65 170.49 13.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 122.113 0.958 . . . . 1.33 113.561 -178.436 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.763 ' HB3' ' HD2' ' A' ' 76' ' ' PRO . 10.3 m -130.42 179.62 1.28 Allowed Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 113.297 -1.774 . . . . 1.99 106.947 178.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.763 ' HD2' ' HB3' ' A' ' 75' ' ' SER . 58.1 Cg_endo -75.94 30.81 0.39 Allowed 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 120.994 1.129 . . . . 1.86 112.258 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.433 ' H ' ' C ' ' A' ' 75' ' ' SER . 2.7 m-20 -138.16 -57.15 0.66 Allowed 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.859 -0.61 . . . . 2.65 109.925 179.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.532 ' HA3' ' HD2' ' B' ' 180' ' ' HIS . . . -139.31 -178.15 16.23 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.507 -0.854 . . . . 0.99 112.842 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.515 ' SG ' ' HB ' ' A' ' 72' ' ' ILE . 13.4 t -142.48 160.68 39.8 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 110.139 -0.319 . . . . 1.34 110.139 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.521 ' HD2' ' HA3' ' B' ' 178' ' ' GLY . 0.3 OUTLIER -149.7 134.68 17.93 Favored 'General case' 0 CA--C 1.521 -0.164 0 C-N-CA 119.986 -0.686 . . . . 2.17 112.179 -178.587 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.86 119.46 10.04 Favored 'General case' 0 CA--C 1.51 -0.59 0 N-CA-C 108.363 -0.977 . . . . 3.05 108.363 177.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.423 ' OD1' ' HB2' ' A' ' 84' ' ' ALA . 0.2 OUTLIER -154.48 139.18 11.65 Favored Pre-proline 0 C--N 1.317 -0.846 0 C-N-CA 120.534 -0.466 . . . . 2.02 110.971 -179.013 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 82' ' ' ASP . 12.7 Cg_exo -70.17 41.84 0.36 Allowed 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.987 2.458 . . . . 1.93 113.049 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.59 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . . . -75.11 -58.96 2.96 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-O 122.698 1.237 . . . . 1.53 109.363 178.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.917 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 52.5 m -105.78 80.98 1.6 Allowed 'General case' 0 N--CA 1.435 -1.222 0 CA-C-N 112.507 -2.133 . . . . 1.88 109.102 -179.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.455 ' O ' ' N ' ' A' ' 88' ' ' GLU . 0.0 OUTLIER -97.93 88.87 0.68 Allowed Pre-proline 0 N--CA 1.453 -0.287 0 CA-C-N 116.007 -0.542 . . . . 3.6 111.942 -178.013 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.917 ' HD3' ' O ' ' A' ' 85' ' ' CYS . 19.5 Cg_exo -66.7 76.96 0.38 Allowed 'Trans proline' 0 CA--C 1.506 -0.88 0 C-N-CA 123.017 2.478 . . . . 2.56 108.368 178.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.455 ' N ' ' O ' ' A' ' 86' ' ' ASP . 9.3 pt-20 -170.87 -30.7 0.02 OUTLIER 'General case' 0 N--CA 1.426 -1.647 0 CA-C-N 113.108 -1.86 . . . . 4.72 110.5 177.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.09 71.22 0.16 Allowed 'General case' 0 C--N 1.314 -0.96 0 O-C-N 118.994 -2.317 . . . . 5.29 115.94 -174.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.79 179.78 3.0 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 120.56 -1.337 . . . . 6.98 110.519 -179.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -90.06 63.29 5.84 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 118.591 0.632 . . . . 10.21 110.423 177.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 15.9 p . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.231 -0.89 . . . . 11.77 111.248 -179.892 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 101' ' ' ALA . . . . . 0.532 ' O ' ' CG2' ' B' ' 109' ' ' THR . . . . . . . . 0 N--CA 1.488 1.46 0 CA-C-O 120.559 0.219 . . . . 10.07 111.233 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 102' ' ' VAL . . . . . 0.539 HG22 ' OD1' ' B' ' 104' ' ' ASP . 9.4 p 43.47 48.12 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.138 0 CA-C-O 122.616 1.198 . . . . 8.41 113.68 178.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 103' ' ' LEU . . . . . 0.731 HD13 ' H ' ' B' ' 103' ' ' LEU . 0.0 OUTLIER -69.98 95.03 0.91 Allowed 'General case' 0 N--CA 1.484 1.232 0 CA-C-N 112.717 -2.038 . . . . 5.87 108.825 177.835 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 104' ' ' ASP . . . . . 0.539 ' OD1' HG22 ' B' ' 102' ' ' VAL . 2.4 m-20 -104.99 59.4 0.68 Allowed 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 113.928 -1.487 . . . . 6.27 111.289 178.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . 0.904 HD12 HG12 ' B' ' 107' ' ' VAL . 1.9 tm? -148.71 -87.44 0.09 Allowed 'General case' 0 N--CA 1.381 -3.925 0 N-CA-C 101.787 -3.412 . . . . 7.2 101.787 172.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 106' ' ' ASP . . . . . 0.653 ' N ' HD13 ' B' ' 105' ' ' LEU . 0.5 OUTLIER -168.25 -48.82 0.02 OUTLIER 'General case' 0 C--N 1.277 -2.561 0 CA-C-N 111.99 -2.368 . . . . 8.55 107.744 -179.434 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 107' ' ' VAL . . . . . 0.904 HG12 HD12 ' B' ' 105' ' ' LEU . 4.6 p -84.46 174.46 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.485 -1.531 0 CA-C-N 111.701 -2.499 . . . . 7.48 107.355 -175.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 108' ' ' ARG . . . . . 0.542 ' H ' HG22 ' B' ' 107' ' ' VAL . 2.6 ptp85 -71.41 114.1 9.13 Favored 'General case' 0 N--CA 1.418 -2.052 0 C-N-CA 117.83 -1.548 . . . . 9.12 107.192 -175.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 109' ' ' THR . . . . . 0.537 ' H ' ' HB3' ' B' ' 103' ' ' LEU . 1.6 t -47.37 111.3 0.39 Allowed 'General case' 0 N--CA 1.425 -1.718 0 CA-C-O 122.848 1.309 . . . . 5.69 109.812 -177.021 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 110' ' ' CYS . . . . . 0.45 ' SG ' ' HB3' ' B' ' 120' ' ' ARG . 12.0 p -31.1 110.93 0.07 Allowed 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 112.085 -2.325 . . . . 2.61 114.003 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 111' ' ' LEU . . . . . 0.421 ' O ' ' O ' ' B' ' 110' ' ' CYS . 25.5 mt -30.19 154.3 0.03 OUTLIER Pre-proline 0 N--CA 1.481 1.081 0 N-CA-C 113.314 0.857 . . . . 2.47 113.314 178.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 112' ' ' PRO . . . . . 0.744 ' HB2' ' O ' ' B' ' 117' ' ' GLY . 48.5 Cg_endo -88.14 122.32 1.53 Allowed 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.423 2.749 . . . . 1.47 113.726 -178.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.646 ' SG ' ' O ' ' B' ' 120' ' ' ARG . 8.1 p -109.26 -153.59 0.51 Allowed 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 121.267 0.556 . . . . 1.0 110.625 178.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . 78.9 -168.13 53.26 Favored Glycine 0 CA--C 1.49 -1.498 0 N-CA-C 110.361 -1.096 . . . . 1.16 110.361 -179.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 115' ' ' PRO . . . . . 0.637 ' HD2' HD11 ' B' ' 132' ' ' LEU . 97.2 Cg_endo -64.59 85.93 0.16 Allowed 'Trans proline' 0 N--CA 1.45 -1.044 0 CA-C-N 119.556 1.678 . . . . 1.57 113.608 -178.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 86.13 19.22 57.84 Favored Glycine 0 N--CA 1.423 -2.192 0 CA-C-N 113.154 -1.839 . . . . 1.7 115.083 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 117' ' ' GLY . . . . . 0.744 ' O ' ' HB2' ' B' ' 112' ' ' PRO . . . 87.33 34.7 10.24 Favored Glycine 0 N--CA 1.413 -2.883 0 C-N-CA 119.536 -1.316 . . . . 1.38 116.182 176.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 118' ' ' LYS . . . . . 0.553 ' HG3' ' HG2' ' B' ' 115' ' ' PRO . 0.1 OUTLIER -93.03 -7.37 45.92 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 122.252 0.221 . . . . 2.54 111.267 177.289 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 119' ' ' GLY . . . . . 0.609 ' O ' ' HA ' ' B' ' 112' ' ' PRO . . . -114.89 -169.22 16.0 Favored Glycine 0 C--N 1.344 1.008 0 N-CA-C 108.112 -1.995 . . . . 1.04 108.112 177.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.646 ' O ' ' SG ' ' B' ' 113' ' ' CYS . 0.0 OUTLIER -125.08 168.69 13.03 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 120.934 2.367 . . . . 2.89 108.838 179.589 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 121' ' ' CYS . . . . . 0.681 ' HB2' ' HG2' ' B' ' 147' ' ' GLU . 33.4 m -108.28 162.45 14.08 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.201 0.815 . . . . 1.07 113.201 -178.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -143.52 -56.98 0.4 Allowed 'General case' 0 C--O 1.231 0.107 0 CA-C-N 114.698 -1.137 . . . . 1.53 109.91 179.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 123' ' ' GLY . . . . . 0.58 ' O ' ' HB3' ' B' ' 144' ' ' CYS . . . -120.83 177.07 16.36 Favored Glycine 0 CA--C 1.52 0.36 0 CA-C-N 115.898 -0.592 . . . . 0.9 112.029 179.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . 0.423 ' O ' ' HB2' ' B' ' 144' ' ' CYS . 51.2 Cg_exo -53.58 -68.93 0.06 OUTLIER 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.515 2.143 . . . . 1.51 112.427 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 125' ' ' SER . . . . . 0.654 ' O ' ' N ' ' B' ' 137' ' ' GLY . 0.5 OUTLIER -95.47 18.33 12.88 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-O 120.88 0.372 . . . . 1.25 110.018 178.794 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 126' ' ' ILE . . . . . 0.924 HG12 HG13 ' B' ' 136' ' ' VAL . 1.5 mt -122.21 105.8 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 CA-C-O 121.546 0.688 . . . . 0.85 111.951 -177.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 127' ' ' CYS . . . . . 0.751 ' O ' ' HA ' ' B' ' 134' ' ' CYS . 0.6 OUTLIER -122.02 124.5 44.12 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 114.821 -1.081 . . . . 0.89 109.828 -179.175 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 128' ' ' CYS . . . . . 1.17 ' HA ' ' O ' ' B' ' 133' ' ' GLY . 0.0 OUTLIER -140.16 110.49 6.63 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 115.995 1.85 . . . . 1.23 115.995 -178.097 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 129' ' ' GLY . . . . . 0.433 ' HA2' ' HE ' ' B' ' 120' ' ' ARG . . . -102.77 -161.05 25.78 Favored Glycine 0 N--CA 1.433 -1.53 0 N-CA-C 110.499 -1.04 . . . . 0.66 110.499 176.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -68.32 -56.97 6.73 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 114.766 1.395 . . . . 2.35 114.766 -177.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.34 29.27 7.56 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 122.81 1.29 . . . . 1.69 109.478 178.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 132' ' ' LEU . . . . . 0.637 HD11 ' HD2' ' B' ' 115' ' ' PRO . 0.3 OUTLIER -123.66 -12.21 7.67 Favored 'General case' 0 N--CA 1.4 -2.926 0 N-CA-C 104.16 -2.533 . . . . 1.38 104.16 179.425 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 133' ' ' GLY . . . . . 1.17 ' O ' ' HA ' ' B' ' 128' ' ' CYS . . . 51.09 -132.66 33.16 Favored Glycine 0 N--CA 1.4 -3.755 0 CA-C-N 113.424 -1.716 . . . . 0.72 112.674 176.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 134' ' ' CYS . . . . . 0.997 ' HB2' HD13 ' B' ' 172' ' ' ILE . 1.7 t -129.42 112.43 13.8 Favored 'General case' 0 CA--C 1.495 -1.152 0 CA-C-N 118.413 1.106 . . . . 1.08 112.675 178.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 135' ' ' PHE . . . . . 0.827 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 6.2 m-30 -86.72 105.27 16.83 Favored 'General case' 0 N--CA 1.407 -2.578 0 N-CA-C 103.452 -2.796 . . . . 1.36 103.452 175.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 136' ' ' VAL . . . . . 0.924 HG13 HG12 ' B' ' 126' ' ' ILE . 2.8 t -97.15 85.32 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.728 0 CA-C-O 122.913 1.34 . . . . 0.75 107.64 -178.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 137' ' ' GLY . . . . . 0.801 ' HA3' HG21 ' A' ' 72' ' ' ILE . . . 110.7 92.93 2.18 Favored Glycine 0 CA--C 1.522 0.507 0 CA-C-N 112.64 -2.073 . . . . 0.83 114.193 -179.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 138' ' ' THR . . . . . 0.714 ' CG2' ' HB3' ' B' ' 135' ' ' PHE . 0.0 OUTLIER 178.84 169.97 0.88 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.761 -0.459 . . . . 0.78 109.761 178.298 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 139' ' ' ALA . . . . . 0.711 ' HA ' HD12 ' B' ' 142' ' ' LEU . . . -74.59 -22.89 58.72 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.586 0.588 . . . . 1.04 112.586 -179.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 140' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.7 -25.37 67.37 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.904 -0.318 . . . . 2.31 110.587 178.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 141' ' ' ALA . . . . . 0.682 ' O ' ' N ' ' B' ' 144' ' ' CYS . . . -97.36 -20.79 17.59 Favored 'General case' 0 C--O 1.213 -0.866 0 CA-C-N 116.265 -0.425 . . . . 0.87 111.583 -178.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 142' ' ' LEU . . . . . 0.711 HD12 ' HA ' ' B' ' 139' ' ' ALA . 0.9 OUTLIER -38.16 -47.41 1.15 Allowed 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 112.701 0.63 . . . . 1.24 112.701 -176.73 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 143' ' ' ARG . . . . . 0.508 ' HD2' ' H ' ' B' ' 143' ' ' ARG . 0.0 OUTLIER -54.0 -24.56 17.32 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.07 -0.715 . . . . 2.93 109.07 177.475 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 144' ' ' CYS . . . . . 0.682 ' N ' ' O ' ' B' ' 141' ' ' ALA . 93.6 m -56.09 -24.96 43.55 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 114.292 -1.322 . . . . 1.61 109.496 -179.154 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -36.47 -45.55 0.5 Allowed 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.929 0.714 . . . . 3.35 112.929 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -87.84 -7.39 57.3 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 119.826 -0.75 . . . . 3.76 111.017 -178.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . 0.681 ' HG2' ' HB2' ' B' ' 121' ' ' CYS . 0.8 OUTLIER -85.01 6.04 26.9 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 115.875 -0.602 . . . . 4.01 109.411 177.167 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 148' ' ' ASN . . . . . 0.493 ' C ' ' H ' ' B' ' 150' ' ' LEU . 7.6 p-10 -71.53 -26.64 62.73 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.63 -0.713 . . . . 3.92 109.385 177.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -51.59 8.23 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 114.614 1.338 . . . . 5.73 114.614 -178.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 150' ' ' LEU . . . . . 0.594 ' N ' HD13 ' B' ' 150' ' ' LEU . 0.0 OUTLIER -133.03 132.56 22.43 Favored Pre-proline 0 N--CA 1.466 0.335 0 CA-C-N 118.733 0.697 . . . . 5.46 110.734 178.401 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 151' ' ' PRO . . . . . 0.671 ' HA ' ' HG3' ' B' ' 176' ' ' PRO . 93.7 Cg_endo -86.81 10.59 3.55 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.826 2.35 . . . . 5.02 113.378 -178.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 152' ' ' SER . . . . . 0.661 ' N ' ' HD2' ' B' ' 153' ' ' PRO . 0.7 OUTLIER 160.68 -52.09 0.0 OUTLIER Pre-proline 0 N--CA 1.465 0.321 0 CA-C-O 120.681 0.277 . . . . 5.73 111.255 -179.838 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 153' ' ' PRO . . . . . 0.661 ' HD2' ' N ' ' B' ' 152' ' ' SER . 12.0 Cg_endo -55.84 121.68 10.4 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 123.191 2.594 . . . . 5.1 114.761 -178.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 154' ' ' CYS . . . . . 0.642 ' N ' ' HG ' ' B' ' 105' ' ' LEU . 0.1 OUTLIER -178.37 107.91 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.524 -0.762 . . . . 2.68 109.609 177.911 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 155' ' ' GLN . . . . . 0.624 ' N ' ' HB2' ' B' ' 105' ' ' LEU . 18.8 pt20 32.48 -156.24 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 112.853 0.686 . . . . 5.63 112.853 -177.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 2.3 t -80.31 104.88 11.16 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 112.782 0.66 . . . . 3.11 112.782 -177.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 165.34 34.96 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 CA-C-N 115.015 -0.993 . . . . 2.07 111.22 179.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 158' ' ' GLN . . . . . 0.557 ' HA ' ' HB2' ' B' ' 166' ' ' ARG . 0.0 OUTLIER -122.86 73.42 1.14 Allowed 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 121.437 0.637 . . . . 4.34 111.059 179.395 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 159' ' ' LYS . . . . . 0.476 ' CB ' ' HB2' ' B' ' 167' ' ' CYS . 0.9 OUTLIER -106.18 79.37 0.58 Allowed Pre-proline 0 C--N 1.314 -0.953 0 CA-C-O 117.788 -1.101 . . . . 3.54 110.673 175.544 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 160' ' ' PRO . . . . . 0.497 ' HA ' ' HA ' ' B' ' 166' ' ' ARG . 11.9 Cg_endo -55.2 108.36 0.3 Allowed 'Trans proline' 0 CA--C 1.531 0.343 0 C-N-CA 122.074 1.849 . . . . 1.51 114.868 -177.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 161' ' ' CYS . . . . . 0.596 ' SG ' ' HB2' ' B' ' 184' ' ' ALA . 0.5 OUTLIER -142.08 155.33 45.37 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 114.831 -1.077 . . . . 1.58 108.847 178.652 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 162' ' ' GLY . . . . . 0.44 ' O ' ' N ' ' B' ' 164' ' ' GLY . . . 74.82 -166.24 54.84 Favored Glycine 0 CA--C 1.521 0.427 0 C-N-CA 118.716 -1.707 . . . . 2.37 110.004 -176.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.79 65.11 0.12 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.729 1.264 . . . . 4.07 112.421 -176.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 164' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' B' ' 162' ' ' GLY . . . 78.91 19.6 72.48 Favored Glycine 0 CA--C 1.502 -0.77 0 C-N-CA 120.8 -0.714 . . . . 2.2 113.906 176.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 165' ' ' GLY . . . . . 0.487 ' O ' ' O ' ' B' ' 161' ' ' CYS . . . -103.42 126.44 8.81 Favored Glycine 0 N--CA 1.439 -1.105 0 C-N-CA 119.779 -1.2 . . . . 1.62 112.741 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 166' ' ' ARG . . . . . 0.557 ' HB2' ' HA ' ' B' ' 158' ' ' GLN . 0.0 OUTLIER -87.74 152.89 21.78 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.567 -0.317 . . . . 3.05 110.177 179.453 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 167' ' ' CYS . . . . . 0.476 ' HB2' ' CB ' ' B' ' 159' ' ' LYS . 0.1 OUTLIER -67.29 106.35 2.03 Favored 'General case' 0 N--CA 1.418 -2.058 0 N-CA-C 108.577 -0.898 . . . . 1.56 108.577 -179.299 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 168' ' ' ALA . . . . . 0.404 ' HB1' ' SG ' ' B' ' 128' ' ' CYS . . . -86.43 -33.09 20.54 Favored 'General case' 0 N--CA 1.424 -1.728 0 N-CA-C 105.637 -1.986 . . . . 1.04 105.637 177.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 169' ' ' ALA . . . . . 0.889 ' HB1' ' HA2' ' B' ' 133' ' ' GLY . . . -164.01 163.45 23.38 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 114.502 -1.226 . . . . 0.98 111.403 -174.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 170' ' ' ALA . . . . . 0.861 ' HA ' ' HB3' ' B' ' 185' ' ' CYS . . . -37.03 127.02 0.94 Allowed 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 115.288 1.588 . . . . 1.25 115.288 -179.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 171' ' ' GLY . . . . . 0.633 ' N ' ' O ' ' B' ' 185' ' ' CYS . . . 61.51 -11.94 0.06 OUTLIER Glycine 0 C--N 1.339 0.729 0 N-CA-C 115.806 1.083 . . . . 1.29 115.806 177.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 172' ' ' ILE . . . . . 0.997 HD13 ' HB2' ' B' ' 134' ' ' CYS . 1.6 pp -114.17 106.31 20.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 121.605 0.717 . . . . 2.27 112.191 -176.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 173' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -92.14 106.8 18.73 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.113 -0.949 . . . . 1.94 108.835 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 174' ' ' CYS . . . . . 0.677 ' SG ' HD12 ' B' ' 172' ' ' ILE . 0.0 OUTLIER -129.74 170.44 13.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 122.199 0.999 . . . . 1.35 113.598 -178.441 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 175' ' ' SER . . . . . 0.77 ' HB3' ' HD2' ' B' ' 176' ' ' PRO . 9.9 m -130.29 179.52 1.31 Allowed Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 113.303 -1.771 . . . . 2.0 106.993 178.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 176' ' ' PRO . . . . . 0.77 ' HD2' ' HB3' ' B' ' 175' ' ' SER . 58.1 Cg_endo -75.84 30.83 0.38 Allowed 'Trans proline' 0 N--CA 1.461 -0.422 0 CA-C-N 120.12 1.079 . . . . 1.9 112.28 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 177' ' ' ASP . . . . . 0.428 ' H ' ' C ' ' B' ' 175' ' ' SER . 2.7 m-20 -138.25 -56.96 0.65 Allowed 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.868 -0.606 . . . . 2.72 109.956 179.184 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 178' ' ' GLY . . . . . 0.521 ' HA3' ' HD2' ' A' ' 80' ' ' HIS . . . -139.33 -178.22 16.31 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.598 -0.811 . . . . 0.99 112.948 179.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 179' ' ' CYS . . . . . 0.52 ' SG ' ' HB ' ' B' ' 172' ' ' ILE . 13.4 t -142.55 160.61 39.95 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 110.148 -0.316 . . . . 1.34 110.148 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 180' ' ' HIS . . . . . 0.532 ' HD2' ' HA3' ' A' ' 78' ' ' GLY . 0.3 OUTLIER -149.69 134.74 18.0 Favored 'General case' 0 CA--C 1.521 -0.17 0 C-N-CA 119.925 -0.71 . . . . 2.1 112.187 -178.603 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 181' ' ' GLU . . . . . 0.437 ' OE1' ' HB2' ' A' ' 24' ' ' PRO . 0.2 OUTLIER -63.9 119.5 10.16 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 108.337 -0.986 . . . . 3.06 108.337 177.953 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 182' ' ' ASP . . . . . 0.433 ' HA ' ' HD3' ' B' ' 183' ' ' PRO . 0.2 OUTLIER -154.52 139.14 11.6 Favored Pre-proline 0 C--N 1.316 -0.872 0 C-N-CA 120.452 -0.499 . . . . 2.06 110.939 -178.995 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 183' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' B' ' 182' ' ' ASP . 12.7 Cg_exo -70.09 41.69 0.35 Allowed 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.943 2.429 . . . . 1.91 113.139 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 184' ' ' ALA . . . . . 0.596 ' HB2' ' SG ' ' B' ' 161' ' ' CYS . . . -75.01 -58.94 2.97 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 122.651 1.215 . . . . 1.56 109.343 178.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 185' ' ' CYS . . . . . 0.915 ' O ' ' HD3' ' B' ' 187' ' ' PRO . 49.0 m -105.6 80.33 1.55 Allowed 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 112.508 -2.133 . . . . 1.94 109.297 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 186' ' ' ASP . . . . . 0.411 ' O ' ' N ' ' B' ' 188' ' ' GLU . 0.0 OUTLIER -97.61 88.8 0.64 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.071 -0.513 . . . . 3.61 112.178 -177.984 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 187' ' ' PRO . . . . . 0.915 ' HD3' ' O ' ' B' ' 185' ' ' CYS . 21.3 Cg_exo -66.45 76.4 0.37 Allowed 'Trans proline' 0 CA--C 1.521 -0.128 0 C-N-CA 123.294 2.663 . . . . 2.58 109.22 178.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 188' ' ' GLU . . . . . 0.424 ' HB3' ' O ' ' B' ' 187' ' ' PRO . 6.8 pt-20 174.0 12.72 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 112.896 -1.957 . . . . 4.7 112.218 177.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 189' ' ' ALA . . . . . . . . . . . . . . . -94.5 61.93 2.78 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 113.688 0.996 . . . . 5.24 113.688 175.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 190' ' ' ALA . . . . . . . . . . . . . . . -67.55 177.85 1.83 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 120.064 1.302 . . . . 6.93 111.272 -177.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 191' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -90.21 63.05 5.65 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.722 -0.391 . . . . 10.14 110.107 177.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 15.6 p . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.242 -0.885 . . . . 11.7 111.234 179.984 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.531 ' O ' ' O ' ' A' ' 2' ' ' VAL . . . . . . . . 0 N--CA 1.484 1.275 0 N-CA-C 110.313 -0.254 . . . . 9.95 110.313 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.929 HG13 ' H ' ' A' ' 4' ' ' ASP . 3.7 p 42.47 179.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 112.885 0.698 . . . . 8.02 112.885 178.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.791 ' HG ' ' HD3' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -89.39 12.24 16.86 Favored 'General case' 0 N--CA 1.422 -1.871 0 N-CA-C 113.889 1.07 . . . . 5.86 113.889 178.124 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.929 ' H ' HG13 ' A' ' 2' ' ' VAL . 0.5 OUTLIER -53.39 -103.38 0.0 OUTLIER 'General case' 0 C--N 1.291 -1.955 0 C-N-CA 119.022 -1.071 . . . . 6.22 110.614 -179.332 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.58 ' O ' ' HG ' ' A' ' 5' ' ' LEU . 49.5 tp -152.02 21.04 0.67 Allowed 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 118.01 -1.476 . . . . 7.09 113.619 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.83 -60.55 2.33 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 106.815 -1.55 . . . . 8.78 106.815 179.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.492 ' O ' HG13 ' A' ' 7' ' ' VAL . 3.6 p -160.2 115.97 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.466 -2.28 0 N-CA-C 104.243 -2.503 . . . . 7.51 104.243 163.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.791 ' HD3' ' HG ' ' A' ' 3' ' ' LEU . 0.0 OUTLIER -78.07 116.6 18.66 Favored 'General case' 0 CA--C 1.479 -1.787 0 C-N-CA 115.871 -2.331 . . . . 9.08 105.887 177.525 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.405 ' O ' ' NE ' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -61.97 104.8 0.5 Allowed 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 113.448 -3.301 . . . . 5.66 104.874 179.755 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.844 ' HB3' ' HG2' ' A' ' 20' ' ' ARG . 0.1 OUTLIER -80.64 101.42 9.21 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 113.63 -1.623 . . . . 2.68 114.52 -178.377 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.569 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 1.3 tt -32.21 112.31 0.35 Allowed Pre-proline 0 N--CA 1.484 1.269 0 CA-C-N 119.294 0.952 . . . . 2.48 111.589 177.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.858 ' HB2' ' O ' ' A' ' 17' ' ' GLY . 41.4 Cg_endo -94.82 125.58 0.4 Allowed 'Trans proline' 0 C--N 1.356 0.948 0 C-N-CA 123.567 2.845 . . . . 1.49 114.65 -178.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.629 ' SG ' ' N ' ' A' ' 14' ' ' GLY . 0.0 OUTLIER -140.82 -168.43 2.59 Favored 'General case' 0 C--N 1.353 0.729 0 CA-C-N 118.228 0.467 . . . . 1.0 111.183 -176.472 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 1.022 ' HA2' ' HB3' ' A' ' 40' ' ' GLU . . . 75.23 -163.81 54.14 Favored Glycine 0 CA--C 1.501 -0.787 0 C-N-CA 120.832 -0.699 . . . . 1.15 111.705 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.409 ' HD3' ' OE1' ' A' ' 40' ' ' GLU . 49.5 Cg_endo -63.2 142.04 84.99 Favored 'Trans proline' 0 N--CA 1.446 -1.315 0 N-CA-C 106.867 -2.013 . . . . 1.57 106.867 175.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 62.73 -12.24 0.1 OUTLIER Glycine 0 C--N 1.269 -3.176 0 C-N-CA 124.66 1.124 . . . . 1.68 113.38 -179.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.858 ' O ' ' HB2' ' A' ' 12' ' ' PRO . . . 64.9 20.14 66.28 Favored Glycine 1 N--CA 1.391 -4.333 0 C-N-CA 116.978 -2.534 . . . . 1.36 110.58 179.411 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.464 ' HB2' HD12 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -92.18 -1.61 57.04 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 113.293 -1.454 . . . . 2.5 113.31 179.879 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.811 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -116.67 177.73 16.93 Favored Glycine 0 C--N 1.335 0.476 0 N-CA-C 108.488 -1.845 . . . . 1.02 108.488 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.844 ' HG2' ' HB3' ' A' ' 10' ' ' CYS . 0.5 OUTLIER -119.75 173.06 7.26 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 120.408 2.104 . . . . 2.92 111.193 179.89 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.436 ' CB ' ' HG3' ' A' ' 47' ' ' GLU . 4.6 m -105.86 147.43 28.71 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.027 0.441 . . . . 1.1 110.422 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.412 ' HE1' ' O ' ' A' ' 28' ' ' CYS . 44.0 m-85 -137.6 -52.07 0.64 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.807 -0.633 . . . . 1.51 110.711 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.565 ' O ' ' HB3' ' A' ' 44' ' ' CYS . . . -101.4 -166.2 27.56 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.858 -0.687 . . . . 0.9 111.714 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.454 ' O ' ' HB2' ' A' ' 44' ' ' CYS . 2.4 Cg_endo -77.31 -60.64 0.04 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.404 2.069 . . . . 1.5 111.54 179.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -102.86 26.34 8.21 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.794 -0.639 . . . . 1.26 109.935 179.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.831 HG22 ' SG ' ' A' ' 34' ' ' CYS . 0.6 OUTLIER -131.46 121.33 48.08 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 N-CA-C 113.346 0.869 . . . . 0.83 113.346 -177.402 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.8 t -123.16 118.19 27.1 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 109.022 -0.732 . . . . 0.92 109.022 178.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 1.053 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -132.97 112.26 11.71 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 113.911 1.078 . . . . 1.28 113.911 -177.689 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.835 ' O ' ' HB1' ' A' ' 69' ' ' ALA . . . -105.71 -158.89 22.68 Favored Glycine 0 C--N 1.358 1.784 0 C-N-CA 120.318 -0.944 . . . . 0.67 112.738 178.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.542 ' O ' ' HB2' ' A' ' 70' ' ' ALA . 19.0 p-10 -66.37 -57.09 8.19 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 115.498 1.666 . . . . 2.27 115.498 -176.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -120.29 17.7 12.26 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 121.891 0.853 . . . . 1.66 110.071 -176.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.521 HD22 ' CE1' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -112.93 -24.37 9.56 Favored 'General case' 0 N--CA 1.408 -2.567 0 CA-C-N 113.628 -1.624 . . . . 1.37 107.396 -179.315 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 1.053 ' O ' ' HA ' ' A' ' 28' ' ' CYS . . . 73.22 -128.39 11.61 Favored Glycine 0 N--CA 1.415 -2.727 0 CA-C-N 113.951 -1.477 . . . . 0.73 113.755 177.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.831 ' SG ' HG22 ' A' ' 26' ' ' ILE . 5.1 t -138.72 118.08 12.81 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 114.834 1.42 . . . . 1.08 114.834 -177.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.752 ' HB3' ' CG2' ' A' ' 38' ' ' THR . 0.2 OUTLIER -92.83 106.97 18.85 Favored 'General case' 0 N--CA 1.423 -1.789 0 N-CA-C 105.408 -2.071 . . . . 1.38 105.408 177.031 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.829 ' HA ' HG23 ' A' ' 26' ' ' ILE . 2.2 t -97.9 85.15 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.577 0 C-N-CA 118.718 -1.193 . . . . 0.76 108.856 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.59 ' O ' ' O ' ' A' ' 38' ' ' THR . . . 143.39 -75.78 0.3 Allowed Glycine 0 CA--C 1.524 0.607 0 CA-C-N 114.3 -1.318 . . . . 0.81 115.568 179.203 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.752 ' CG2' ' HB3' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -23.47 154.27 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 113.111 0.782 . . . . 0.77 113.111 -178.298 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.52 ' O ' ' N ' ' A' ' 42' ' ' LEU . . . -60.14 -39.09 85.09 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.971 -0.559 . . . . 1.02 111.366 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 1.022 ' HB3' ' HA2' ' A' ' 14' ' ' GLY . 1.2 mt-10 -40.36 -29.52 0.08 Allowed 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.794 0.665 . . . . 2.32 112.794 -178.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.692 ' O ' ' N ' ' A' ' 44' ' ' CYS . . . -89.16 -20.95 23.6 Favored 'General case' 0 N--CA 1.44 -0.954 0 O-C-N 122.328 -0.232 . . . . 0.87 110.952 -179.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.52 ' N ' ' O ' ' A' ' 39' ' ' ALA . 3.2 mt -39.22 -43.62 1.13 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.819 0.674 . . . . 1.23 112.819 -177.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.406 ' HD3' ' O ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -52.32 -30.44 28.4 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 107.903 -1.147 . . . . 2.92 107.903 177.469 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.692 ' N ' ' O ' ' A' ' 41' ' ' ALA . 70.0 m -53.04 -21.65 4.85 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 114.279 -1.328 . . . . 1.57 110.556 -177.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -49.03 -34.45 13.37 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 113.505 0.928 . . . . 3.31 113.505 -179.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -87.09 -5.0 59.18 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 119.869 -0.733 . . . . 3.69 111.157 -178.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.436 ' HG3' ' CB ' ' A' ' 21' ' ' CYS . 3.9 mm-40 -83.3 6.18 20.62 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 109.512 -0.551 . . . . 3.99 109.512 177.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -74.35 -29.4 61.56 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 116.026 -0.534 . . . . 3.86 109.73 178.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.464 ' C ' HD12 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -95.56 26.13 4.11 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 120.724 -0.39 . . . . 5.68 111.416 -179.753 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.464 HD12 ' C ' ' A' ' 49' ' ' TYR . 4.6 mp -147.32 85.2 6.9 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-O 120.668 0.27 . . . . 5.4 111.558 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -88.47 50.08 1.59 Allowed 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 122.801 2.334 . . . . 4.92 112.673 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.418 ' HB2' ' HD2' ' A' ' 53' ' ' PRO . 24.4 p -73.83 159.22 84.8 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 116.416 -0.356 . . . . 5.64 111.167 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.418 ' HD2' ' HB2' ' A' ' 52' ' ' SER . 72.8 Cg_endo -77.72 -46.04 0.14 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.705 2.27 . . . . 5.04 112.602 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.765 ' HA ' ' HG2' ' A' ' 8' ' ' ARG . 0.0 OUTLIER 72.89 87.75 0.1 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.072 -0.513 . . . . 2.74 112.23 179.584 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.463 ' N ' ' HB3' ' A' ' 8' ' ' ARG . 0.0 OUTLIER 47.5 -87.95 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 112.29 0.478 . . . . 5.75 112.29 178.778 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.442 ' N ' ' O ' ' A' ' 54' ' ' CYS . 47.7 p -145.73 116.84 7.84 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.889 0.376 . . . . 3.12 111.293 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 173.39 38.38 0.04 OUTLIER Glycine 0 N--CA 1.444 -0.815 0 N-CA-C 110.415 -1.074 . . . . 2.1 110.415 -179.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.4 tp60 -120.78 85.58 2.42 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 108.613 -0.884 . . . . 4.36 108.613 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.5 ' O ' ' HA ' ' A' ' 66' ' ' ARG . 0.5 OUTLIER -136.32 82.28 35.22 Favored Pre-proline 0 C--N 1.299 -1.618 0 N-CA-C 106.28 -1.748 . . . . 3.55 106.28 -178.713 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.599 ' HA ' ' O ' ' A' ' 65' ' ' GLY . 60.5 Cg_endo -72.4 73.5 2.75 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 123.197 2.598 . . . . 1.54 113.856 -177.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.406 ' N ' ' O ' ' A' ' 65' ' ' GLY . 4.5 p -99.25 157.87 16.08 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.389 -1.278 . . . . 1.59 109.084 178.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.56 -167.86 54.11 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 119.787 -1.197 . . . . 2.43 112.094 -175.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -76.47 66.09 2.44 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 122.058 0.933 . . . . 4.11 112.623 -175.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.59 19.41 58.35 Favored Glycine 0 C--N 1.339 0.72 0 CA-C-N 114.112 -1.403 . . . . 2.21 114.695 177.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.638 ' HA3' ' HA ' ' A' ' 74' ' ' CYS . . . -105.28 135.01 12.34 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 119.227 -1.463 . . . . 1.62 114.213 -179.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.598 ' HA ' ' HA ' ' A' ' 60' ' ' PRO . 0.0 OUTLIER -107.04 152.99 23.26 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 109.248 -0.649 . . . . 3.02 109.248 177.091 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.7 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 41.7 t -52.77 106.37 0.16 Allowed 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 108.967 -0.753 . . . . 1.52 108.967 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.41 ' N ' ' O ' ' A' ' 72' ' ' ILE . . . -88.96 -36.55 15.81 Favored 'General case' 0 N--CA 1.423 -1.816 0 N-CA-C 106.718 -1.586 . . . . 1.07 106.718 177.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.835 ' HB1' ' O ' ' A' ' 29' ' ' GLY . . . -165.18 165.06 20.03 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 108.985 -0.746 . . . . 1.0 108.985 -177.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.542 ' HB2' ' O ' ' A' ' 30' ' ' ASP . . . -31.24 108.66 0.05 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.25 0.548 . . . . 1.24 111.402 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.84 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . 75.68 -3.4 49.71 Favored Glycine 0 C--O 1.227 -0.336 0 CA-C-N 115.249 -0.887 . . . . 1.28 114.548 179.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.825 HG13 ' HB2' ' A' ' 34' ' ' CYS . 1.6 mm -96.9 119.07 44.48 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.599 0 CA-C-N 117.702 0.751 . . . . 2.27 110.399 -179.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 1.009 ' HB2' ' HB3' ' A' ' 82' ' ' ASP . 1.9 t -118.99 95.61 4.89 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.72 -1.127 . . . . 1.98 108.391 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 1.05 ' HB3' ' HA ' ' A' ' 79' ' ' CYS . 26.7 p -156.13 -174.32 4.9 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 116.912 2.19 . . . . 1.33 116.912 -176.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.528 ' CB ' ' HD2' ' A' ' 76' ' ' PRO . 0.3 OUTLIER -128.56 -178.29 0.77 Allowed Pre-proline 0 N--CA 1.456 -0.169 0 CA-C-N 112.808 -1.996 . . . . 1.99 109.253 -178.831 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.528 ' HD2' ' CB ' ' A' ' 75' ' ' SER . 60.3 Cg_endo -73.28 30.85 0.31 Allowed 'Trans proline' 0 CA--C 1.533 0.464 0 C-N-CA 121.882 1.721 . . . . 1.86 113.413 -179.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -125.88 -60.66 1.28 Allowed 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 109.536 -0.542 . . . . 2.65 109.536 178.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.883 ' O ' ' HB2' ' A' ' 74' ' ' CYS . . . -138.39 -167.29 10.94 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 110.917 -0.873 . . . . 0.99 110.917 178.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 1.05 ' HA ' ' HB3' ' A' ' 74' ' ' CYS . 63.8 m -146.43 161.08 41.16 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 117.534 0.667 . . . . 1.34 111.723 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 34.6 t60 -152.58 150.1 29.17 Favored 'General case' 0 C--N 1.344 0.34 0 C-N-CA 119.896 -0.722 . . . . 2.17 111.388 -178.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.461 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 0.4 OUTLIER -60.71 140.86 57.37 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.764 -0.653 . . . . 3.05 110.422 179.558 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 1.009 ' HB3' ' HB2' ' A' ' 73' ' ' CYS . 0.0 OUTLIER -137.21 138.24 24.76 Favored Pre-proline 0 CA--C 1.544 0.733 0 CA-C-N 115.983 -0.553 . . . . 2.02 111.89 -179.023 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.458 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 2.5 Cg_endo -84.38 -31.68 0.46 Allowed 'Trans proline' 0 C--N 1.359 1.122 0 C-N-CA 123.311 2.674 . . . . 1.93 115.301 -177.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.82 -47.62 84.99 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 108.29 -1.004 . . . . 1.53 108.29 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.84 ' O ' ' N ' ' A' ' 71' ' ' GLY . 81.5 m -96.77 71.68 2.58 Favored 'General case' 0 C--O 1.215 -0.739 0 N-CA-C 105.694 -1.965 . . . . 1.88 105.694 175.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.58 ' CB ' ' HD3' ' A' ' 87' ' ' PRO . 0.9 OUTLIER -94.08 -56.97 0.22 Allowed Pre-proline 0 CA--C 1.497 -1.084 0 C-N-CA 119.089 -1.044 . . . . 3.6 110.582 -177.7 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.58 ' HD3' ' CB ' ' A' ' 86' ' ' ASP . 58.2 Cg_endo -103.79 168.16 0.21 Allowed 'Trans proline' 0 N--CA 1.422 -2.687 0 C-N-CA 122.704 2.27 . . . . 2.56 113.138 -178.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -73.22 61.23 0.62 Allowed 'General case' 0 N--CA 1.428 -1.562 0 C-N-CA 128.354 2.662 . . . . 4.72 108.394 173.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -91.44 29.17 1.52 Allowed 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 108.754 -3.839 . . . . 5.29 107.164 171.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -80.24 163.26 24.14 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 122.445 1.116 . . . . 6.98 113.838 -179.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.423 ' O ' ' CG ' ' A' ' 91' ' ' PHE . 15.3 p90 -81.46 107.92 14.62 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-N 113.039 -1.892 . . . . 10.21 111.36 -179.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.307 -0.854 . . . . 11.77 110.867 179.851 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.242 0 CA-C-O 120.869 0.366 . . . . 10.07 110.969 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 102' ' ' VAL . . . . . 0.461 HG22 ' N ' ' B' ' 103' ' ' LEU . 8.6 p -40.69 154.29 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 115.275 1.583 . . . . 8.41 115.275 -178.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 103' ' ' LEU . . . . . 0.725 ' H ' HD22 ' B' ' 103' ' ' LEU . 0.0 OUTLIER -106.25 144.27 33.19 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 113.425 -1.716 . . . . 5.87 107.888 176.822 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 104' ' ' ASP . . . . . 0.449 ' HB3' ' H ' ' B' ' 105' ' ' LEU . 0.2 OUTLIER -157.7 -130.75 0.03 OUTLIER 'General case' 0 N--CA 1.426 -1.635 0 N-CA-C 105.119 -2.178 . . . . 6.27 105.119 176.227 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . 0.474 HD13 ' O ' ' B' ' 155' ' ' GLN . 6.4 tp -137.02 10.35 3.05 Favored 'General case' 0 CA--C 1.489 -1.395 0 C-N-CA 117.583 -1.647 . . . . 7.2 110.106 175.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 106' ' ' ASP . . . . . 0.404 ' O ' ' HG2' ' B' ' 155' ' ' GLN . 0.8 OUTLIER -79.88 -121.04 0.02 OUTLIER 'General case' 0 CA--C 1.464 -2.335 1 N-CA-C 98.916 -4.476 . . . . 8.55 98.916 176.219 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' B' B ' 107' ' ' VAL . . . . . 0.548 ' O ' HG13 ' B' ' 107' ' ' VAL . 3.1 p -111.42 118.04 56.52 Favored 'Isoleucine or valine' 0 CA--C 1.466 -2.269 0 C-N-CA 112.902 -3.519 . . . . 7.48 105.428 178.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 108' ' ' ARG . . . . . 0.787 ' HG2' ' HA ' ' B' ' 154' ' ' CYS . 0.0 OUTLIER -77.5 115.06 16.96 Favored 'General case' 0 N--CA 1.423 -1.794 0 C-N-CA 116.08 -2.248 . . . . 9.12 106.119 177.935 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 109' ' ' THR . . . . . 0.412 ' O ' ' NE ' ' B' ' 108' ' ' ARG . 0.2 OUTLIER -59.73 105.16 0.35 Allowed 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 113.704 -3.199 . . . . 5.69 105.371 179.718 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 110' ' ' CYS . . . . . 0.829 ' HB3' ' HG2' ' B' ' 120' ' ' ARG . 0.1 OUTLIER -81.81 101.97 10.51 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 113.486 -1.688 . . . . 2.61 114.332 -178.11 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 111' ' ' LEU . . . . . 0.546 ' O ' ' HA ' ' B' ' 120' ' ' ARG . 1.3 tt -32.09 112.06 0.34 Allowed Pre-proline 0 N--CA 1.484 1.253 0 CA-C-N 119.001 0.819 . . . . 2.47 111.626 178.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 112' ' ' PRO . . . . . 0.847 ' HB2' ' O ' ' B' ' 117' ' ' GLY . 43.4 Cg_endo -93.59 127.39 0.61 Allowed 'Trans proline' 0 C--N 1.356 0.921 0 C-N-CA 123.579 2.853 . . . . 1.47 113.937 -178.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.627 ' SG ' ' N ' ' B' ' 114' ' ' GLY . 0.0 OUTLIER -142.54 -168.84 2.84 Favored 'General case' 0 C--N 1.351 0.631 0 O-C-N 121.943 -0.473 . . . . 1.0 111.212 -177.502 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 114' ' ' GLY . . . . . 0.985 ' HA2' ' HB3' ' B' ' 140' ' ' GLU . . . 75.33 -163.74 54.02 Favored Glycine 0 CA--C 1.502 -0.728 0 C-N-CA 120.817 -0.706 . . . . 1.16 111.535 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 115' ' ' PRO . . . . . 0.418 ' C ' ' H ' ' B' ' 117' ' ' GLY . 48.3 Cg_endo -63.23 142.01 84.67 Favored 'Trans proline' 0 N--CA 1.446 -1.281 0 N-CA-C 107.002 -1.961 . . . . 1.57 107.002 175.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 62.86 -12.48 0.1 OUTLIER Glycine 0 C--N 1.27 -3.124 0 C-N-CA 124.792 1.187 . . . . 1.7 113.251 -179.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 117' ' ' GLY . . . . . 0.847 ' O ' ' HB2' ' B' ' 112' ' ' PRO . . . 64.95 20.5 66.78 Favored Glycine 1 N--CA 1.395 -4.086 0 C-N-CA 116.901 -2.571 . . . . 1.38 110.566 179.431 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 118' ' ' LYS . . . . . 0.477 ' HB2' HD12 ' B' ' 132' ' ' LEU . 0.0 OUTLIER -91.92 -2.63 56.7 Favored 'General case' 0 C--N 1.346 0.435 0 CA-C-N 113.003 -1.599 . . . . 2.54 113.241 -179.894 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 119' ' ' GLY . . . . . 0.845 ' O ' ' HA ' ' B' ' 112' ' ' PRO . . . -117.65 -178.29 17.44 Favored Glycine 0 C--N 1.34 0.764 0 N-CA-C 108.607 -1.797 . . . . 1.04 108.607 178.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.829 ' HG2' ' HB3' ' B' ' 110' ' ' CYS . 0.4 OUTLIER -120.73 172.52 7.82 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 119.298 1.549 . . . . 2.89 112.364 -178.886 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 121' ' ' CYS . . . . . 0.431 ' CB ' ' HG3' ' B' ' 147' ' ' GLU . 4.4 m -105.89 147.29 28.91 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.081 0.467 . . . . 1.07 110.347 -179.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 122' ' ' PHE . . . . . 0.411 ' HE1' ' O ' ' B' ' 128' ' ' CYS . 43.9 m-85 -137.53 -52.02 0.64 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.905 -0.589 . . . . 1.53 110.691 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 123' ' ' GLY . . . . . 0.556 ' O ' ' HB3' ' B' ' 144' ' ' CYS . . . -101.45 -166.21 27.52 Favored Glycine 0 C--O 1.229 -0.203 0 C-N-CA 120.836 -0.697 . . . . 0.9 111.677 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . 0.441 ' O ' ' HB2' ' B' ' 144' ' ' CYS . 2.4 Cg_endo -77.31 -60.65 0.04 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 122.469 2.113 . . . . 1.51 111.564 179.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 125' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -102.89 26.44 8.11 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.839 -0.619 . . . . 1.25 109.921 179.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 126' ' ' ILE . . . . . 0.837 HG22 ' SG ' ' B' ' 134' ' ' CYS . 0.8 OUTLIER -131.37 121.37 48.43 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 N-CA-C 113.399 0.889 . . . . 0.85 113.399 -177.41 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 127' ' ' CYS . . . . . . . . . . . . . 1.8 t -123.28 118.05 26.68 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 109.059 -0.719 . . . . 0.89 109.059 178.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 128' ' ' CYS . . . . . 1.059 ' HA ' ' O ' ' B' ' 133' ' ' GLY . 0.0 OUTLIER -132.36 112.0 11.82 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 114.067 1.136 . . . . 1.23 114.067 -177.999 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 129' ' ' GLY . . . . . 0.852 ' O ' ' HB1' ' B' ' 169' ' ' ALA . . . -104.55 -157.96 23.7 Favored Glycine 0 C--N 1.357 1.742 0 C-N-CA 120.298 -0.954 . . . . 0.66 112.992 178.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 130' ' ' ASP . . . . . 0.515 ' O ' ' HB2' ' B' ' 170' ' ' ALA . 18.2 p-10 -68.61 -55.28 12.06 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 115.867 1.802 . . . . 2.35 115.867 -176.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -125.03 30.67 5.81 Favored 'General case' 0 CA--C 1.493 -1.218 0 C-N-CA 118.878 -1.129 . . . . 1.69 109.744 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 132' ' ' LEU . . . . . 0.523 HD22 ' CE1' ' B' ' 135' ' ' PHE . 0.4 OUTLIER -123.82 -23.82 4.59 Favored 'General case' 0 N--CA 1.404 -2.744 0 N-CA-C 105.672 -1.973 . . . . 1.38 105.672 -179.23 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 133' ' ' GLY . . . . . 1.059 ' O ' ' HA ' ' B' ' 128' ' ' CYS . . . 72.15 -126.58 11.85 Favored Glycine 0 N--CA 1.408 -3.195 0 CA-C-N 114.196 -1.366 . . . . 0.72 114.17 175.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 134' ' ' CYS . . . . . 0.837 ' SG ' HG22 ' B' ' 126' ' ' ILE . 5.4 t -140.17 118.13 11.83 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 114.948 1.462 . . . . 1.08 114.948 -177.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 135' ' ' PHE . . . . . 0.766 ' HB3' ' CG2' ' B' ' 138' ' ' THR . 0.1 OUTLIER -93.0 107.14 18.98 Favored 'General case' 0 N--CA 1.424 -1.761 0 N-CA-C 105.4 -2.074 . . . . 1.36 105.4 177.204 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 136' ' ' VAL . . . . . 0.781 ' HA ' HG23 ' B' ' 126' ' ' ILE . 2.5 t -97.56 85.42 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.552 0 C-N-CA 118.861 -1.136 . . . . 0.75 108.712 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 137' ' ' GLY . . . . . 0.596 ' O ' ' O ' ' B' ' 138' ' ' THR . . . 142.65 -76.04 0.31 Allowed Glycine 0 CA--C 1.522 0.524 0 C-N-CA 119.614 -1.279 . . . . 0.83 115.778 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 138' ' ' THR . . . . . 0.766 ' CG2' ' HB3' ' B' ' 135' ' ' PHE . 0.0 OUTLIER -23.27 154.62 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 113.081 0.771 . . . . 0.78 113.081 -178.242 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 139' ' ' ALA . . . . . 0.498 ' O ' ' N ' ' B' ' 142' ' ' LEU . . . -60.45 -39.38 87.35 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 116.147 -0.479 . . . . 1.04 111.144 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 140' ' ' GLU . . . . . 0.985 ' HB3' ' HA2' ' B' ' 114' ' ' GLY . 1.2 mt-10 -40.09 -29.56 0.08 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.84 0.682 . . . . 2.31 112.84 -178.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 141' ' ' ALA . . . . . 0.684 ' O ' ' N ' ' B' ' 144' ' ' CYS . . . -89.16 -20.72 23.88 Favored 'General case' 0 N--CA 1.441 -0.912 0 O-C-N 122.307 -0.246 . . . . 0.87 110.992 -179.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 142' ' ' LEU . . . . . 0.498 ' N ' ' O ' ' B' ' 139' ' ' ALA . 3.1 mt -39.32 -43.81 1.21 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.787 0.662 . . . . 1.24 112.787 -177.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 143' ' ' ARG . . . . . 0.412 ' HD3' ' O ' ' B' ' 140' ' ' GLU . 0.0 OUTLIER -52.18 -30.61 27.73 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 107.947 -1.131 . . . . 2.93 107.947 177.457 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 144' ' ' CYS . . . . . 0.684 ' N ' ' O ' ' B' ' 141' ' ' ALA . 69.4 m -52.96 -21.39 4.32 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 114.083 -1.417 . . . . 1.61 110.538 -177.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -49.39 -34.34 15.95 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 113.538 0.94 . . . . 3.35 113.538 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -87.13 -4.87 59.15 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 119.846 -0.742 . . . . 3.76 111.152 -178.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . 0.431 ' HG3' ' CB ' ' B' ' 121' ' ' CYS . 3.9 mm-40 -83.42 6.18 21.01 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 109.482 -0.562 . . . . 4.01 109.482 177.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 148' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -74.23 -29.54 61.75 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.98 -0.554 . . . . 3.92 109.724 178.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 149' ' ' TYR . . . . . 0.471 ' C ' HD12 ' B' ' 150' ' ' LEU . 0.1 OUTLIER -95.53 26.16 4.08 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 120.782 -0.367 . . . . 5.73 111.445 -179.697 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 150' ' ' LEU . . . . . 0.471 HD12 ' C ' ' B' ' 149' ' ' TYR . 4.6 mp -147.33 85.11 6.93 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-O 120.574 0.226 . . . . 5.46 111.601 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 151' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -88.41 50.11 1.62 Allowed 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 122.819 2.346 . . . . 5.02 112.624 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 152' ' ' SER . . . . . 0.414 ' HB2' ' HD2' ' B' ' 153' ' ' PRO . 29.4 p -73.82 159.23 84.78 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.471 -0.331 . . . . 5.73 111.145 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 153' ' ' PRO . . . . . 0.414 ' HD2' ' HB2' ' B' ' 152' ' ' SER . 72.8 Cg_endo -77.85 -45.81 0.14 Allowed 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.746 2.297 . . . . 5.1 112.544 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 154' ' ' CYS . . . . . 0.787 ' HA ' ' HG2' ' B' ' 108' ' ' ARG . 0.0 OUTLIER 73.26 87.48 0.1 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.905 -0.589 . . . . 2.68 112.2 179.573 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 155' ' ' GLN . . . . . 0.538 ' HG3' ' HA ' ' B' ' 107' ' ' VAL . 0.0 OUTLIER 47.62 -88.84 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.546 0.573 . . . . 5.63 112.546 178.75 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 156' ' ' SER . . . . . 0.435 ' N ' ' O ' ' B' ' 154' ' ' CYS . 50.3 p -145.09 116.81 8.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.218 0.532 . . . . 3.11 111.216 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 173.89 38.18 0.04 OUTLIER Glycine 0 N--CA 1.444 -0.832 0 N-CA-C 110.835 -0.906 . . . . 2.07 110.835 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 5.1 tp60 -120.85 71.54 0.94 Allowed 'General case' 0 N--CA 1.441 -0.883 0 CA-C-O 121.867 0.841 . . . . 4.34 110.275 179.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 159' ' ' LYS . . . . . 0.536 ' O ' ' HA ' ' B' ' 166' ' ' ARG . 0.7 OUTLIER -107.55 79.98 0.87 Allowed Pre-proline 0 C--N 1.316 -0.863 0 CA-C-N 114.068 -1.424 . . . . 3.54 110.643 175.117 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 160' ' ' PRO . . . . . 0.605 ' HA ' ' HA ' ' B' ' 166' ' ' ARG . 59.3 Cg_endo -72.39 74.49 2.59 Favored 'Trans proline' 0 C--N 1.333 -0.249 0 CA-C-N 121.688 1.638 . . . . 1.51 114.521 -177.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 161' ' ' CYS . . . . . . . . . . . . . 4.6 p -98.97 158.92 15.32 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.856 -1.065 . . . . 1.58 109.09 178.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 77.05 -167.85 54.5 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 119.726 -1.226 . . . . 2.37 112.216 -176.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -76.71 65.61 2.51 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 122.173 0.987 . . . . 4.07 112.529 -175.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 84.55 22.24 54.25 Favored Glycine 0 C--N 1.337 0.59 0 CA-C-N 113.858 -1.519 . . . . 2.2 114.626 177.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 165' ' ' GLY . . . . . 0.681 ' HA3' ' HA ' ' B' ' 174' ' ' CYS . . . -108.0 135.77 13.03 Favored Glycine 0 N--CA 1.442 -0.963 0 C-N-CA 119.279 -1.439 . . . . 1.62 113.69 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 166' ' ' ARG . . . . . 0.605 ' HA ' ' HA ' ' B' ' 160' ' ' PRO . 0.0 OUTLIER -106.79 153.27 22.71 Favored 'General case' 0 CA--C 1.521 -0.167 0 N-CA-C 109.273 -0.64 . . . . 3.05 109.273 177.681 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 167' ' ' CYS . . . . . 0.706 ' HA ' ' O ' ' B' ' 172' ' ' ILE . 41.8 t -52.88 106.34 0.16 Allowed 'General case' 0 N--CA 1.424 -1.773 0 N-CA-C 108.932 -0.766 . . . . 1.56 108.932 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 168' ' ' ALA . . . . . 0.432 ' N ' ' O ' ' B' ' 172' ' ' ILE . . . -88.16 -38.05 15.66 Favored 'General case' 0 N--CA 1.423 -1.787 0 N-CA-C 106.402 -1.703 . . . . 1.04 106.402 177.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 169' ' ' ALA . . . . . 0.852 ' HB1' ' O ' ' B' ' 129' ' ' GLY . . . -164.07 165.0 22.77 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 109.196 -0.668 . . . . 0.98 109.196 -176.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 170' ' ' ALA . . . . . 0.515 ' HB2' ' O ' ' B' ' 130' ' ' ASP . . . -31.08 108.69 0.05 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.319 0.58 . . . . 1.25 111.284 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 171' ' ' GLY . . . . . 0.85 ' N ' ' O ' ' B' ' 185' ' ' CYS . . . 75.51 -3.3 49.3 Favored Glycine 0 C--O 1.228 -0.25 0 CA-C-N 115.237 -0.892 . . . . 1.29 114.58 179.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 172' ' ' ILE . . . . . 0.822 HG13 ' HB2' ' B' ' 134' ' ' CYS . 1.6 mm -96.9 119.1 44.51 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.578 0 CA-C-N 117.723 0.762 . . . . 2.27 110.468 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 173' ' ' CYS . . . . . 0.987 ' HB2' ' HB3' ' B' ' 182' ' ' ASP . 1.9 t -118.96 95.83 4.99 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 114.723 -1.126 . . . . 1.94 108.416 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 174' ' ' CYS . . . . . 1.105 ' HB3' ' HA ' ' B' ' 179' ' ' CYS . 26.6 p -156.26 -174.3 4.88 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 116.9 2.185 . . . . 1.35 116.9 -176.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 175' ' ' SER . . . . . 0.517 ' CB ' ' HD2' ' B' ' 176' ' ' PRO . 0.3 OUTLIER -128.53 -178.35 0.78 Allowed Pre-proline 0 N--CA 1.454 -0.239 0 CA-C-N 112.861 -1.972 . . . . 2.0 109.383 -178.877 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 176' ' ' PRO . . . . . 0.517 ' HD2' ' CB ' ' B' ' 175' ' ' SER . 60.3 Cg_endo -73.23 30.95 0.3 Allowed 'Trans proline' 0 CA--C 1.534 0.507 0 C-N-CA 121.865 1.71 . . . . 1.9 113.428 -179.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 177' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -125.94 -60.68 1.28 Allowed 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 109.612 -0.514 . . . . 2.72 109.612 178.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 178' ' ' GLY . . . . . 0.858 ' O ' ' HB2' ' B' ' 174' ' ' CYS . . . -138.44 -167.36 10.96 Favored Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 110.832 -0.907 . . . . 0.99 110.832 178.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 179' ' ' CYS . . . . . 1.105 ' HA ' ' HB3' ' B' ' 174' ' ' CYS . 63.3 m -146.51 161.07 41.24 Favored 'General case' 0 N--CA 1.461 0.101 0 CA-C-N 117.507 0.653 . . . . 1.34 111.632 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 180' ' ' HIS . . . . . . . . . . . . . 34.9 t60 -152.37 150.31 29.56 Favored 'General case' 0 C--N 1.344 0.36 0 C-N-CA 120.014 -0.674 . . . . 2.1 111.401 -178.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 181' ' ' GLU . . . . . 0.458 ' HA ' ' O ' ' B' ' 171' ' ' GLY . 0.4 OUTLIER -60.91 140.82 57.62 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.766 -0.652 . . . . 3.06 110.359 179.557 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 182' ' ' ASP . . . . . 0.987 ' HB3' ' HB2' ' B' ' 173' ' ' CYS . 0.0 OUTLIER -137.19 138.27 24.9 Favored Pre-proline 0 CA--C 1.543 0.701 0 CA-C-N 116.005 -0.543 . . . . 2.06 111.852 -179.024 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 183' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' B' ' 182' ' ' ASP . 2.5 Cg_endo -84.41 -31.66 0.46 Allowed 'Trans proline' 0 C--N 1.358 1.068 0 C-N-CA 123.359 2.706 . . . . 1.91 115.256 -177.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -59.9 -47.6 85.12 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 108.279 -1.008 . . . . 1.56 108.279 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 185' ' ' CYS . . . . . 0.85 ' O ' ' N ' ' B' ' 171' ' ' GLY . 82.2 m -96.68 71.62 2.61 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 105.7 -1.963 . . . . 1.94 105.7 175.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 186' ' ' ASP . . . . . 0.591 ' CB ' ' HD3' ' B' ' 187' ' ' PRO . 0.9 OUTLIER -94.13 -56.97 0.22 Allowed Pre-proline 0 CA--C 1.497 -1.094 0 C-N-CA 119.055 -1.058 . . . . 3.61 110.644 -177.687 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 187' ' ' PRO . . . . . 0.591 ' HD3' ' CB ' ' B' ' 186' ' ' ASP . 59.0 Cg_endo -103.88 168.01 0.21 Allowed 'Trans proline' 0 N--CA 1.424 -2.616 0 C-N-CA 122.796 2.331 . . . . 2.58 113.182 -178.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -73.38 61.12 0.65 Allowed 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 127.951 2.5 . . . . 4.7 108.515 174.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 189' ' ' ALA . . . . . . . . . . . . . . . -91.36 30.01 1.36 Allowed 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 109.001 -3.727 . . . . 5.24 106.868 172.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 190' ' ' ALA . . . . . . . . . . . . . . . -80.84 163.57 23.33 Favored 'General case' 0 C--N 1.345 0.381 0 N-CA-C 113.866 1.062 . . . . 6.93 113.866 -178.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 191' ' ' PHE . . . . . 0.425 ' O ' ' CG ' ' B' ' 191' ' ' PHE . 15.3 p90 -81.5 108.05 14.77 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-N 113.469 -1.696 . . . . 10.14 111.449 -179.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.257 -0.878 . . . . 11.7 110.822 179.916 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.51 ' O ' ' CG2' ' A' ' 2' ' ' VAL . . . . . . . . 0 N--CA 1.489 1.48 0 CA-C-O 120.443 0.163 . . . . 9.95 111.434 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.51 ' CG2' ' O ' ' A' ' 1' ' ' ALA . 9.6 t -168.66 37.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 N-CA-C 108.361 -0.977 . . . . 8.02 108.361 178.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.805 HD23 HG22 ' A' ' 9' ' ' THR . 0.2 OUTLIER -156.63 47.24 0.44 Allowed 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 114.132 1.16 . . . . 5.86 114.132 -178.031 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -92.48 -117.39 0.08 Allowed 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 101.674 -3.454 . . . . 6.22 101.674 170.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.6 19.07 4.84 Favored 'General case' 0 N--CA 1.428 -1.568 0 C-N-CA 120.591 -0.444 . . . . 7.09 110.541 172.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -86.8 -126.95 0.04 OUTLIER 'General case' 0 N--CA 1.434 -1.237 1 N-CA-C 98.164 -4.754 . . . . 8.78 98.164 171.796 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.93 HG22 ' C ' ' A' ' 53' ' ' PRO . 7.5 p -108.38 118.81 56.77 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.049 0 CA-C-N 124.01 3.095 . . . . 7.51 104.696 177.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.784 ' H ' ' H ' ' A' ' 55' ' ' GLN . 8.0 ttm180 -77.34 117.33 18.73 Favored 'General case' 0 CA--C 1.48 -1.72 0 CA-C-O 117.482 -1.246 . . . . 9.08 108.433 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.805 HG22 HD23 ' A' ' 3' ' ' LEU . 4.0 t -52.39 105.89 0.13 Allowed 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 114.534 -2.866 . . . . 5.66 107.693 -178.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 1.013 ' H ' ' HA ' ' A' ' 53' ' ' PRO . 67.9 m -79.49 70.85 6.02 Favored 'General case' 0 C--N 1.34 0.192 0 CA-C-N 112.346 -2.207 . . . . 2.68 112.862 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.922 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 6.9 mp -31.76 108.76 0.28 Allowed Pre-proline 0 N--CA 1.476 0.847 0 CA-C-N 120.036 1.289 . . . . 2.48 110.228 -179.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.86 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 89.8 Cg_endo -82.94 135.69 7.74 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 121.621 1.548 . . . . 1.49 114.593 -178.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.696 ' N ' ' O ' ' A' ' 19' ' ' GLY . 29.3 p -145.15 -175.06 4.55 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 118.267 -1.373 . . . . 1.0 111.322 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.704 ' HA2' ' HB3' ' A' ' 40' ' ' GLU . . . 75.75 -164.35 53.89 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 120.499 -0.857 . . . . 1.15 114.377 178.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.793 ' HD2' HD11 ' A' ' 32' ' ' LEU . 38.3 Cg_endo -63.14 112.75 1.78 Allowed 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 124.861 3.707 . . . . 1.57 109.601 177.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.19 -11.86 53.03 Favored Glycine 0 C--N 1.276 -2.803 0 N-CA-C 110.59 -1.004 . . . . 1.68 110.59 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.692 ' O ' ' HB2' ' A' ' 12' ' ' PRO . . . 68.59 47.3 57.48 Favored Glycine 0 N--CA 1.418 -2.538 0 C-N-CA 117.929 -2.081 . . . . 1.36 111.648 176.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.716 ' HD3' ' O ' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -92.26 -28.91 16.7 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 111.858 -2.171 . . . . 2.5 111.907 179.959 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.86 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -103.8 -178.08 25.73 Favored Glycine 0 C--O 1.213 -1.216 0 O-C-N 121.023 -1.048 . . . . 1.02 115.181 -176.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.922 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -96.16 144.71 26.15 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 115.579 1.696 . . . . 2.92 115.579 -174.588 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.659 ' C ' ' CD1' ' A' ' 22' ' ' PHE . 0.1 OUTLIER -108.25 170.24 8.13 Favored 'General case' 0 C--N 1.344 0.334 0 CA-C-N 113.49 -1.686 . . . . 1.1 109.36 -179.692 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.659 ' CD1' ' C ' ' A' ' 21' ' ' CYS . 33.8 m-85 -156.8 52.54 0.51 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.966 0.412 . . . . 1.51 110.649 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.518 ' O ' ' SG ' ' A' ' 44' ' ' CYS . . . 133.08 -145.68 17.66 Favored Glycine 0 C--O 1.225 -0.433 0 N-CA-C 111.265 -0.734 . . . . 0.9 111.265 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.741 ' HD2' HD12 ' A' ' 26' ' ' ILE . 37.9 Cg_endo -94.86 -70.19 0.0 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 122.779 2.319 . . . . 1.5 112.145 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.635 ' O ' ' N ' ' A' ' 37' ' ' GLY . 2.8 m -92.5 45.52 1.2 Allowed 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 109.746 -0.465 . . . . 1.26 109.746 179.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.811 ' CG2' ' HB3' ' A' ' 74' ' ' CYS . 3.6 mt -145.13 115.04 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 N-CA-C 112.015 0.376 . . . . 0.83 112.015 -177.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.58 ' SG ' ' CE2' ' A' ' 35' ' ' PHE . 1.9 t -149.15 123.75 9.78 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-O 121.346 0.593 . . . . 0.92 110.803 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.94 ' HB3' ' HB1' ' A' ' 68' ' ' ALA . 0.5 OUTLIER -126.37 152.5 46.2 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.201 1.0 . . . . 1.28 110.949 -179.852 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 33' ' ' GLY . . . -143.52 -179.83 20.41 Favored Glycine 0 N--CA 1.424 -2.144 0 C-N-CA 120.386 -0.911 . . . . 0.67 111.273 176.211 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -70.01 -44.93 68.32 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 126.351 1.861 . . . . 2.27 112.442 177.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -121.65 23.42 10.22 Favored 'General case' 0 CA--C 1.471 -2.075 0 CA-C-N 112.956 -1.929 . . . . 1.66 111.31 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.812 HD13 ' HZ ' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -125.62 -36.36 2.44 Favored 'General case' 0 N--CA 1.425 -1.685 0 CA-C-N 113.589 -1.641 . . . . 1.37 109.682 -174.623 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.871 ' O ' ' HA ' ' A' ' 28' ' ' CYS . . . 89.96 -138.85 14.76 Favored Glycine 0 N--CA 1.425 -2.045 0 CA-C-N 114.845 -1.071 . . . . 0.73 114.368 177.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 1.057 ' SG ' HD13 ' A' ' 72' ' ' ILE . 1.3 m -126.75 121.24 31.44 Favored 'General case' 0 CA--C 1.489 -1.384 0 CA-C-N 119.318 1.559 . . . . 1.08 110.37 177.068 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 1.014 ' HA ' ' HA ' ' B' ' 135' ' ' PHE . 0.0 OUTLIER -119.07 107.49 13.56 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 104.578 -2.379 . . . . 1.38 104.578 176.705 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 1.034 HG23 HG23 ' B' ' 136' ' ' VAL . 1.0 OUTLIER -92.07 89.71 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.552 0 CA-C-O 122.077 0.941 . . . . 0.76 109.849 -178.266 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.635 ' N ' ' O ' ' A' ' 25' ' ' SER . . . 88.37 87.3 1.19 Allowed Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 113.907 -1.497 . . . . 0.81 112.101 -179.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.509 HG22 ' O ' ' B' ' 132' ' ' LEU . 40.3 p -150.17 176.03 11.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.807 0.337 . . . . 0.77 110.589 -179.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.665 ' HA ' HD12 ' A' ' 42' ' ' LEU . . . -63.92 -41.68 97.6 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.343 -1.355 . . . . 1.02 107.343 177.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.704 ' HB3' ' HA2' ' A' ' 14' ' ' GLY . 3.0 mm-40 -55.82 -34.37 65.3 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 113.884 -1.507 . . . . 2.32 110.201 179.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.842 ' O ' ' HB2' ' A' ' 44' ' ' CYS . . . -82.75 -37.63 24.37 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 115.349 -0.841 . . . . 0.87 109.953 -179.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.665 HD12 ' HA ' ' A' ' 39' ' ' ALA . 0.2 OUTLIER -38.96 -32.92 0.1 Allowed 'General case' 0 C--O 1.24 0.564 0 CA-C-O 121.105 0.479 . . . . 1.23 110.685 -178.672 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.448 ' O ' ' N ' ' A' ' 45' ' ' GLN . 2.1 mmm180 -51.97 -29.02 18.82 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 108.239 -1.023 . . . . 2.92 108.239 176.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.842 ' HB2' ' O ' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -44.65 -2.66 0.01 OUTLIER 'General case' 0 C--O 1.239 0.552 0 N-CA-C 115.434 1.642 . . . . 1.57 115.434 -176.621 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.448 ' N ' ' O ' ' A' ' 43' ' ' ARG . 0.3 OUTLIER -88.99 3.37 51.86 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 122.624 2.466 . . . . 3.31 107.203 174.976 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.67 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 8.1 tt0 -83.56 11.33 7.28 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 108.505 -0.924 . . . . 3.69 108.505 179.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.794 ' HA ' HD21 ' A' ' 50' ' ' LEU . 0.5 OUTLIER -75.18 3.02 9.46 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 109.263 -0.644 . . . . 3.99 109.263 176.453 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -98.33 -27.05 14.29 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.448 -0.342 . . . . 3.86 111.194 178.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -139.69 55.75 1.66 Allowed 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 112.702 0.63 . . . . 5.68 112.702 -177.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.888 HD22 ' HA ' ' A' ' 11' ' ' LEU . 0.4 OUTLIER -120.12 103.98 44.33 Favored Pre-proline 0 N--CA 1.473 0.689 0 N-CA-C 113.224 0.824 . . . . 5.4 113.224 -177.928 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.448 ' C ' ' HD2' ' A' ' 53' ' ' PRO . 71.0 Cg_endo -101.16 50.8 0.04 OUTLIER 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 124.207 3.271 . . . . 4.92 113.975 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.735 ' O ' ' HB2' ' A' ' 10' ' ' CYS . 6.5 t -120.04 45.96 0.83 Allowed Pre-proline 0 CA--C 1.544 0.732 0 N-CA-C 111.847 0.314 . . . . 5.64 111.847 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 1.013 ' HA ' ' H ' ' A' ' 10' ' ' CYS . 9.5 Cg_endo -52.47 167.05 0.62 Allowed 'Trans proline' 0 N--CA 1.49 1.293 0 C-N-CA 124.12 3.213 . . . . 5.04 116.303 -178.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.737 ' N ' ' O ' ' A' ' 8' ' ' ARG . 4.8 p 154.49 72.5 0.0 OUTLIER 'General case' 0 C--N 1.372 1.557 0 N-CA-C 115.012 1.486 . . . . 2.74 115.012 178.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.784 ' H ' ' H ' ' A' ' 8' ' ' ARG . 0.7 OUTLIER 50.85 -173.89 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 120.568 1.531 . . . . 5.75 112.376 177.96 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.496 ' OG ' ' O ' ' A' ' 55' ' ' GLN . 66.0 m -171.05 -145.4 0.04 OUTLIER 'General case' 0 CA--C 1.558 1.27 0 N-CA-C 112.189 0.44 . . . . 3.12 112.189 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 66' ' ' ARG . . . -133.43 123.11 3.29 Favored Glycine 0 CA--C 1.49 -1.504 0 CA-C-N 114.983 -1.008 . . . . 2.1 111.995 -176.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -111.12 78.78 1.14 Allowed 'General case' 0 N--CA 1.439 -0.988 0 CA-C-O 121.951 0.881 . . . . 4.36 108.901 178.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.753 ' CB ' ' HB2' ' A' ' 67' ' ' CYS . 0.4 OUTLIER -138.15 68.88 48.73 Favored Pre-proline 0 C--N 1.305 -1.326 0 CA-C-O 122.96 1.362 . . . . 3.55 108.247 -179.799 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.442 ' HA ' ' O ' ' A' ' 65' ' ' GLY . 14.6 Cg_endo -55.59 86.78 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.589 2.859 . . . . 1.54 115.191 -178.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.649 ' N ' ' O ' ' A' ' 65' ' ' GLY . 1.8 m -96.64 -173.8 2.84 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 113.786 -1.552 . . . . 1.59 107.062 176.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 45.14 -167.03 0.04 OUTLIER Glycine 0 CA--C 1.53 0.97 0 C-N-CA 119.837 -1.173 . . . . 2.43 114.36 175.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 6.5 t -84.2 61.02 6.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 122.683 1.23 . . . . 4.11 111.256 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 109.93 3.89 29.81 Favored Glycine 0 CA--C 1.532 1.144 0 CA-C-N 112.585 -2.098 . . . . 2.21 116.209 176.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.649 ' O ' ' N ' ' A' ' 61' ' ' CYS . . . -101.4 142.8 15.86 Favored Glycine 0 C--O 1.225 -0.442 0 C-N-CA 117.227 -2.416 . . . . 1.62 115.995 -175.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.468 ' HB2' ' O ' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -98.03 154.0 18.01 Favored 'General case' 0 C--N 1.335 -0.055 0 CA-C-N 114.549 -0.826 . . . . 3.02 110.142 179.274 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.753 ' HB2' ' CB ' ' A' ' 59' ' ' LYS . 3.7 t -44.98 109.48 0.17 Allowed 'General case' 0 CA--C 1.506 -0.74 0 CA-C-O 121.257 0.551 . . . . 1.52 111.763 -178.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.94 ' HB1' ' HB3' ' A' ' 28' ' ' CYS . . . -100.39 -15.42 17.96 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 108.074 -1.084 . . . . 1.07 108.074 177.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -168.19 162.26 12.77 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 114.532 -1.213 . . . . 1.0 110.872 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.562 ' HA ' ' HB3' ' A' ' 85' ' ' CYS . . . -73.3 74.87 1.34 Allowed 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 121.446 0.641 . . . . 1.24 112.673 -179.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.73 ' O ' ' HA ' ' A' ' 81' ' ' GLU . . . 163.53 -51.57 0.3 Allowed Glycine 0 N--CA 1.437 -1.298 0 CA-C-N 114.983 -1.008 . . . . 1.28 112.952 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 1.057 HD13 ' SG ' ' A' ' 34' ' ' CYS . 0.6 OUTLIER -126.63 140.23 49.49 Favored 'Isoleucine or valine' 0 C--O 1.248 0.99 0 CA-C-O 122.83 1.3 . . . . 2.27 110.704 -175.936 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.549 ' HB2' ' HB2' ' A' ' 61' ' ' CYS . 47.9 m -112.15 113.19 25.3 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 114.895 -1.048 . . . . 1.98 110.258 -179.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.811 ' HB3' ' CG2' ' A' ' 26' ' ' ILE . 64.6 m -78.58 144.03 35.92 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.596 -0.729 . . . . 1.33 111.105 -178.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.715 ' HB2' ' HD2' ' A' ' 76' ' ' PRO . 92.0 p -136.76 179.95 1.23 Allowed Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 114.318 -1.31 . . . . 1.99 108.742 -178.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.715 ' HD2' ' HB2' ' A' ' 75' ' ' SER . 66.9 Cg_endo -76.32 29.88 0.4 Allowed 'Trans proline' 0 N--CA 1.452 -0.93 0 N-CA-C 109.822 -0.876 . . . . 1.86 109.822 177.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.545 ' H ' ' C ' ' A' ' 75' ' ' SER . 2.0 m-20 -144.29 -46.73 0.26 Allowed 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.17 -0.923 . . . . 2.65 111.171 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 1.013 ' HA2' HG11 ' A' ' 36' ' ' VAL . . . -170.5 -155.99 10.89 Favored Glycine 0 C--N 1.34 0.785 0 C-N-CA 119.745 -1.217 . . . . 0.99 115.313 179.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 1.011 ' SG ' HG22 ' A' ' 36' ' ' VAL . 10.4 m -140.98 129.29 22.32 Favored 'General case' 0 CA--C 1.555 1.171 0 CA-C-O 122.732 1.253 . . . . 1.34 107.767 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.472 ' CA ' HG22 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -144.42 132.2 21.29 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-N 112.414 -2.175 . . . . 2.17 112.443 -168.392 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.73 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 0.4 OUTLIER -47.36 142.24 4.24 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 114.036 -1.438 . . . . 3.05 109.981 -179.7 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.682 ' OD1' ' HB2' ' A' ' 85' ' ' CYS . 3.1 p-10 -145.26 137.37 13.22 Favored Pre-proline 0 C--N 1.309 -1.174 0 CA-C-N 115.712 -0.676 . . . . 2.02 109.738 -178.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 82' ' ' ASP . 52.7 Cg_exo -57.87 -35.42 98.79 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.667 2.245 . . . . 1.93 114.373 -177.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.8 -51.69 60.82 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 108.616 -0.883 . . . . 1.53 108.616 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.682 ' HB2' ' OD1' ' A' ' 82' ' ' ASP . 3.2 m -98.74 77.09 2.23 Favored 'General case' 0 CA--C 1.499 -1.015 0 N-CA-C 106.703 -1.591 . . . . 1.88 106.703 176.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.58 ' H ' ' CD ' ' A' ' 87' ' ' PRO . 0.6 OUTLIER -131.05 -54.72 0.03 OUTLIER Pre-proline 0 CA--C 1.5 -0.944 0 C-N-CA 119.301 -0.96 . . . . 3.6 110.06 -178.944 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.58 ' CD ' ' H ' ' A' ' 86' ' ' ASP . 9.5 Cg_endo -91.59 165.57 3.44 Favored 'Trans proline' 0 N--CA 1.426 -2.452 0 C-N-CA 122.053 1.836 . . . . 2.56 113.387 -179.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.557 ' O ' ' N ' ' A' ' 90' ' ' ALA . 7.9 pt-20 -66.19 0.32 2.08 Favored 'General case' 0 N--CA 1.432 -1.341 0 C-N-CA 128.16 2.584 . . . . 4.72 109.988 178.262 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -53.4 36.09 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 114.255 1.205 . . . . 5.29 114.255 177.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.557 ' N ' ' O ' ' A' ' 88' ' ' GLU . . . -77.48 163.78 26.03 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 119.33 0.968 . . . . 6.98 111.57 178.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -85.42 63.74 8.25 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.076 -0.511 . . . . 10.21 111.707 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 11.9 p . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.209 -0.9 . . . . 11.77 110.793 179.268 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 101' ' ' ALA . . . . . 0.517 ' O ' HD23 ' B' ' 103' ' ' LEU . . . . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 119.865 -0.112 . . . . 10.07 110.901 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 102' ' ' VAL . . . . . 0.516 HG22 ' O ' ' B' ' 102' ' ' VAL . 8.5 p 30.48 36.66 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.112 0 N-CA-C 113.985 1.106 . . . . 8.41 113.985 177.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 103' ' ' LEU . . . . . 1.08 ' HB2' ' HG3' ' B' ' 108' ' ' ARG . 1.5 pp -160.63 62.13 0.31 Allowed 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 114.143 1.164 . . . . 5.87 114.143 176.212 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 104' ' ' ASP . . . . . 0.435 ' HB3' ' H ' ' B' ' 105' ' ' LEU . 0.1 OUTLIER -101.08 -111.06 0.21 Allowed 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 103.464 -2.791 . . . . 6.27 103.464 170.138 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . 0.435 ' H ' ' HB3' ' B' ' 104' ' ' ASP . 3.1 tp -107.86 15.48 24.44 Favored 'General case' 0 N--CA 1.42 -1.948 0 N-CA-C 108.577 -0.897 . . . . 7.2 108.577 171.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 106' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.59 -121.2 0.02 OUTLIER 'General case' 0 N--CA 1.427 -1.583 1 N-CA-C 98.47 -4.641 . . . . 8.55 98.47 172.364 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 107' ' ' VAL . . . . . 0.933 HG22 ' C ' ' B' ' 153' ' ' PRO . 9.9 p -114.29 118.32 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.753 0 C-N-CA 114.388 -2.925 . . . . 7.48 106.454 179.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 108' ' ' ARG . . . . . 1.08 ' HG3' ' HB2' ' B' ' 103' ' ' LEU . 10.1 ttm180 -78.2 114.87 17.49 Favored 'General case' 0 CA--C 1.482 -1.641 0 CA-C-O 117.649 -1.167 . . . . 9.12 108.32 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 109' ' ' THR . . . . . 0.635 ' HA ' ' HB3' ' B' ' 153' ' ' PRO . 5.6 t -46.94 105.5 0.07 Allowed 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 114.987 -2.685 . . . . 5.69 107.987 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 110' ' ' CYS . . . . . 1.033 ' H ' ' HA ' ' B' ' 153' ' ' PRO . 67.5 m -81.35 70.52 8.22 Favored 'General case' 0 CA--C 1.527 0.095 0 CA-C-N 113.541 -1.663 . . . . 2.61 112.894 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 111' ' ' LEU . . . . . 0.905 ' HA ' HD22 ' B' ' 150' ' ' LEU . 6.9 mp -31.29 108.67 0.27 Allowed Pre-proline 0 N--CA 1.477 0.892 0 CA-C-N 119.962 1.256 . . . . 2.47 110.332 -179.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 112' ' ' PRO . . . . . 0.918 ' HA ' ' O ' ' B' ' 119' ' ' GLY . 84.0 Cg_endo -81.62 138.14 10.56 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 121.926 1.751 . . . . 1.47 113.696 -179.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.564 ' N ' ' O ' ' B' ' 119' ' ' GLY . 31.2 p -149.14 -178.7 6.53 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 120.697 -0.401 . . . . 1.0 111.499 178.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 114' ' ' GLY . . . . . 0.716 ' HA2' ' HB3' ' B' ' 140' ' ' GLU . . . 76.06 -163.1 53.07 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 120.793 -0.718 . . . . 1.16 113.929 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 115' ' ' PRO . . . . . 0.825 ' HD2' HD11 ' B' ' 132' ' ' LEU . 38.8 Cg_endo -64.37 101.5 0.36 Allowed 'Trans proline' 0 N--CA 1.485 1.005 0 C-N-CA 125.234 3.956 . . . . 1.57 114.784 178.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 89.53 -8.05 80.65 Favored Glycine 0 C--N 1.28 -2.566 0 CA-C-N 114.263 -1.335 . . . . 1.7 110.992 -175.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 117' ' ' GLY . . . . . 0.641 ' O ' ' HB2' ' B' ' 112' ' ' PRO . . . 65.28 55.25 22.18 Favored Glycine 0 N--CA 1.421 -2.345 0 CA-C-O 122.451 1.028 . . . . 1.38 111.568 179.081 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 118' ' ' LYS . . . . . 0.654 ' HD3' ' O ' ' B' ' 115' ' ' PRO . 0.0 OUTLIER -94.32 -26.13 16.7 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 112.494 -1.853 . . . . 2.54 111.408 177.94 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 119' ' ' GLY . . . . . 0.918 ' O ' ' HA ' ' B' ' 112' ' ' PRO . . . -95.79 -175.61 36.73 Favored Glycine 0 C--O 1.212 -1.255 0 N-CA-C 116.728 1.451 . . . . 1.04 116.728 -176.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.891 ' HA ' ' O ' ' B' ' 111' ' ' LEU . 0.0 OUTLIER -105.12 142.44 34.89 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 112.729 -1.735 . . . . 2.89 114.71 -178.112 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 121' ' ' CYS . . . . . 0.657 ' C ' ' CD1' ' B' ' 122' ' ' PHE . 0.1 OUTLIER -108.05 169.92 8.32 Favored 'General case' 0 C--N 1.342 0.267 0 CA-C-N 113.573 -1.649 . . . . 1.07 109.3 -178.717 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 122' ' ' PHE . . . . . 0.657 ' CD1' ' C ' ' B' ' 121' ' ' CYS . 33.1 m-85 -156.81 52.55 0.51 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.032 0.444 . . . . 1.53 110.574 -179.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 123' ' ' GLY . . . . . 0.523 ' O ' ' SG ' ' B' ' 144' ' ' CYS . . . 133.09 -145.63 17.63 Favored Glycine 0 C--N 1.334 0.44 0 N-CA-C 111.322 -0.711 . . . . 0.9 111.322 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . 0.769 ' HD2' HD12 ' B' ' 126' ' ' ILE . 37.7 Cg_endo -95.02 -70.22 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 122.729 2.286 . . . . 1.51 112.064 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 125' ' ' SER . . . . . 0.651 ' O ' ' N ' ' B' ' 137' ' ' GLY . 2.8 m -92.27 45.08 1.19 Allowed 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.715 -0.476 . . . . 1.25 109.715 179.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 126' ' ' ILE . . . . . 0.81 ' CG2' ' HB3' ' B' ' 174' ' ' CYS . 3.4 mt -144.01 114.54 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 N-CA-C 112.317 0.488 . . . . 0.85 112.317 -177.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 127' ' ' CYS . . . . . 0.587 ' SG ' ' CE2' ' B' ' 135' ' ' PHE . 1.7 t -148.55 124.4 10.58 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 121.039 0.447 . . . . 0.89 110.887 179.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 128' ' ' CYS . . . . . 0.951 ' HB3' ' HB1' ' B' ' 168' ' ' ALA . 0.8 OUTLIER -129.34 150.44 50.7 Favored 'General case' 0 CA--C 1.509 -0.619 0 CA-C-N 115.896 -0.593 . . . . 1.23 111.484 -178.868 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 129' ' ' GLY . . . . . 0.418 ' O ' ' HB2' ' B' ' 169' ' ' ALA . . . -141.67 -174.46 14.51 Favored Glycine 0 N--CA 1.422 -2.236 0 CA-C-N 120.089 1.313 . . . . 0.66 110.135 177.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -74.33 -44.55 52.01 Favored 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 126.215 1.806 . . . . 2.35 112.375 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -124.32 33.26 5.3 Favored 'General case' 0 CA--C 1.483 -1.606 0 CA-C-N 113.911 -1.495 . . . . 1.69 110.034 177.021 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 132' ' ' LEU . . . . . 0.829 HD13 ' HZ ' ' B' ' 135' ' ' PHE . 0.9 OUTLIER -130.1 -37.7 1.46 Allowed 'General case' 0 N--CA 1.411 -2.38 0 CA-C-N 114.239 -1.346 . . . . 1.38 108.531 -179.418 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 133' ' ' GLY . . . . . 0.915 ' O ' ' HA ' ' B' ' 128' ' ' CYS . . . 79.25 -151.43 34.85 Favored Glycine 0 N--CA 1.435 -1.369 0 CA-C-N 113.585 -1.643 . . . . 0.72 111.195 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 134' ' ' CYS . . . . . 1.056 ' SG ' HD13 ' B' ' 172' ' ' ILE . 3.0 m -107.93 124.2 49.77 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-N 119.691 1.745 . . . . 1.08 112.084 -175.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 135' ' ' PHE . . . . . 1.014 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -121.09 106.97 12.05 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 104.499 -2.408 . . . . 1.36 104.499 174.263 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 136' ' ' VAL . . . . . 1.073 HG22 ' SG ' ' B' ' 179' ' ' CYS . 1.8 t -91.7 89.82 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.396 0 CA-C-O 122.091 0.948 . . . . 0.75 109.635 -178.235 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 137' ' ' GLY . . . . . 0.651 ' N ' ' O ' ' B' ' 125' ' ' SER . . . 87.56 88.59 1.09 Allowed Glycine 0 C--O 1.228 -0.231 0 CA-C-N 114.133 -1.394 . . . . 0.83 112.012 -179.115 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 138' ' ' THR . . . . . 0.505 HG22 ' O ' ' A' ' 32' ' ' LEU . 43.5 p -154.13 171.12 19.64 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 110.313 -0.255 . . . . 0.78 110.313 -179.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 139' ' ' ALA . . . . . 0.722 ' HA ' HD12 ' B' ' 142' ' ' LEU . . . -60.51 -39.48 87.94 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.484 -0.932 . . . . 1.04 108.484 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 140' ' ' GLU . . . . . 0.716 ' HB3' ' HA2' ' B' ' 114' ' ' GLY . 3.0 mm-40 -57.46 -33.61 68.15 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.307 -0.861 . . . . 2.31 110.094 178.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 141' ' ' ALA . . . . . 0.8 ' O ' ' HB2' ' B' ' 144' ' ' CYS . . . -82.11 -39.06 23.89 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 115.062 -0.972 . . . . 0.87 109.508 -179.067 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 142' ' ' LEU . . . . . 0.722 HD12 ' HA ' ' B' ' 139' ' ' ALA . 0.2 OUTLIER -38.94 -31.41 0.06 Allowed 'General case' 0 C--O 1.232 0.156 0 CA-C-N 117.871 0.305 . . . . 1.24 111.578 -178.483 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 143' ' ' ARG . . . . . 0.451 ' O ' ' N ' ' B' ' 145' ' ' GLN . 2.1 mmm180 -52.57 -28.93 23.01 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.401 -0.962 . . . . 2.93 108.401 176.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 144' ' ' CYS . . . . . 0.8 ' HB2' ' O ' ' B' ' 141' ' ' ALA . 0.1 OUTLIER -41.94 -8.11 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 113.648 -1.614 . . . . 1.61 115.002 -176.79 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 145' ' ' GLN . . . . . 0.451 ' N ' ' O ' ' B' ' 143' ' ' ARG . 0.3 OUTLIER -84.51 -0.19 52.13 Favored 'General case' 0 C--O 1.242 0.709 0 CA-C-O 122.525 1.155 . . . . 3.35 108.357 176.098 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 146' ' ' GLU . . . . . 0.67 ' O ' ' HG ' ' B' ' 150' ' ' LEU . 7.7 tt0 -83.91 11.48 7.63 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 115.072 -0.967 . . . . 3.76 109.064 179.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . 0.803 ' HA ' HD21 ' B' ' 150' ' ' LEU . 0.5 OUTLIER -75.3 2.86 10.1 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 109.14 -0.689 . . . . 4.01 109.14 176.44 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 148' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -98.33 -27.02 14.3 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.499 -0.319 . . . . 3.92 111.13 178.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -139.72 55.86 1.65 Allowed 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 112.648 0.61 . . . . 5.73 112.648 -177.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 150' ' ' LEU . . . . . 0.905 HD22 ' HA ' ' B' ' 111' ' ' LEU . 0.4 OUTLIER -120.14 104.12 44.07 Favored Pre-proline 0 N--CA 1.474 0.736 0 N-CA-C 113.212 0.819 . . . . 5.46 113.212 -178.004 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 151' ' ' PRO . . . . . 0.443 ' C ' ' HD2' ' B' ' 153' ' ' PRO . 72.6 Cg_endo -101.34 50.85 0.04 OUTLIER 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 124.17 3.247 . . . . 5.02 113.914 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 152' ' ' SER . . . . . 0.733 ' O ' ' HB2' ' B' ' 110' ' ' CYS . 6.6 t -120.25 46.03 0.87 Allowed Pre-proline 0 CA--C 1.544 0.726 0 N-CA-C 111.821 0.304 . . . . 5.73 111.821 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 153' ' ' PRO . . . . . 1.033 ' HA ' ' H ' ' B' ' 110' ' ' CYS . 10.8 Cg_endo -52.46 167.3 0.59 Allowed 'Trans proline' 0 N--CA 1.49 1.301 0 C-N-CA 124.266 3.31 . . . . 5.1 116.256 -178.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 154' ' ' CYS . . . . . 0.7 ' N ' ' O ' ' B' ' 108' ' ' ARG . 4.7 p 154.55 72.14 0.0 OUTLIER 'General case' 0 C--N 1.374 1.66 0 N-CA-C 115.058 1.503 . . . . 2.68 115.058 178.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 155' ' ' GLN . . . . . 0.751 ' H ' ' H ' ' B' ' 108' ' ' ARG . 0.6 OUTLIER 51.69 -175.65 0.02 OUTLIER 'General case' 0 C--N 1.37 1.491 0 CA-C-N 121.001 1.728 . . . . 5.63 112.394 178.0 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 156' ' ' SER . . . . . 0.402 ' OG ' ' O ' ' B' ' 155' ' ' GLN . 74.4 m -165.95 -135.88 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 113.508 0.929 . . . . 3.11 113.508 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 157' ' ' GLY . . . . . 0.436 ' O ' ' HB2' ' B' ' 166' ' ' ARG . . . -146.92 126.36 2.42 Favored Glycine 0 N--CA 1.439 -1.104 0 N-CA-C 109.794 -1.322 . . . . 2.07 109.794 178.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -112.55 68.02 0.67 Allowed 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 118.784 -1.166 . . . . 4.34 110.023 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 159' ' ' LYS . . . . . 0.848 ' CB ' ' HB2' ' B' ' 167' ' ' CYS . 0.1 OUTLIER -110.9 63.95 0.45 Allowed Pre-proline 0 C--N 1.318 -0.787 0 CA-C-N 113.875 -1.511 . . . . 3.54 112.059 174.514 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 160' ' ' PRO . . . . . 0.441 ' HA ' ' O ' ' B' ' 165' ' ' GLY . 12.8 Cg_endo -55.37 86.78 0.04 OUTLIER 'Trans proline' 0 C--N 1.325 -0.682 0 C-N-CA 121.945 1.764 . . . . 1.51 116.391 -175.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 161' ' ' CYS . . . . . 0.649 ' N ' ' O ' ' B' ' 165' ' ' GLY . 1.4 m -98.81 -177.9 3.8 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.146 -1.427 . . . . 1.58 107.146 175.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 51.58 -167.27 0.71 Allowed Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.365 -0.921 . . . . 2.37 113.956 176.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 7.3 t -84.99 59.39 5.59 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 122.282 1.039 . . . . 4.07 111.664 -178.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 108.84 9.19 26.89 Favored Glycine 0 CA--C 1.544 1.9 0 CA-C-N 113.218 -1.81 . . . . 2.2 115.963 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 165' ' ' GLY . . . . . 0.649 ' O ' ' N ' ' B' ' 161' ' ' CYS . . . -102.59 141.76 15.34 Favored Glycine 0 C--N 1.312 -0.805 0 CA-C-N 121.631 2.716 . . . . 1.62 115.366 -176.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 166' ' ' ARG . . . . . 0.436 ' HB2' ' O ' ' B' ' 157' ' ' GLY . 0.0 OUTLIER -97.94 153.96 18.0 Favored 'General case' 0 N--CA 1.458 -0.056 0 CA-C-N 115.036 -0.582 . . . . 3.05 109.853 178.478 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 167' ' ' CYS . . . . . 0.848 ' HB2' ' CB ' ' B' ' 159' ' ' LYS . 3.6 t -45.42 109.57 0.18 Allowed 'General case' 0 CA--C 1.505 -0.75 0 CA-C-O 121.061 0.458 . . . . 1.56 111.975 -178.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 168' ' ' ALA . . . . . 0.951 ' HB1' ' HB3' ' B' ' 128' ' ' CYS . . . -99.83 -15.58 18.36 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 108.189 -1.041 . . . . 1.04 108.189 177.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 169' ' ' ALA . . . . . 0.418 ' HB2' ' O ' ' B' ' 129' ' ' GLY . . . -168.03 161.98 12.98 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 114.075 -1.42 . . . . 0.98 111.33 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 170' ' ' ALA . . . . . 0.586 ' HA ' ' HB3' ' B' ' 185' ' ' CYS . . . -72.98 74.94 1.19 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.375 0.607 . . . . 1.25 112.622 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 171' ' ' GLY . . . . . 0.763 ' O ' ' HA ' ' B' ' 181' ' ' GLU . . . 163.43 -52.9 0.3 Allowed Glycine 0 C--O 1.22 -0.724 0 CA-C-N 115.231 -0.895 . . . . 1.29 112.504 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 172' ' ' ILE . . . . . 1.056 HD13 ' SG ' ' B' ' 134' ' ' CYS . 0.6 OUTLIER -124.17 139.72 49.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-O 122.93 1.348 . . . . 2.27 111.663 -175.998 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 173' ' ' CYS . . . . . 0.547 ' HB2' ' HB2' ' B' ' 161' ' ' CYS . 48.6 m -112.3 113.5 25.76 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.914 -1.039 . . . . 1.94 110.017 -179.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 174' ' ' CYS . . . . . 0.81 ' HB3' ' CG2' ' B' ' 126' ' ' ILE . 64.1 m -79.41 144.03 34.49 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 115.476 -0.784 . . . . 1.35 110.913 -178.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 175' ' ' SER . . . . . 0.704 ' HB2' ' HD2' ' B' ' 176' ' ' PRO . 59.8 p -136.68 179.86 1.25 Allowed Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 114.328 -1.305 . . . . 2.0 108.799 -178.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 176' ' ' PRO . . . . . 0.704 ' HD2' ' HB2' ' B' ' 175' ' ' SER . 66.9 Cg_endo -76.39 29.76 0.4 Allowed 'Trans proline' 0 N--CA 1.454 -0.835 0 N-CA-C 109.679 -0.931 . . . . 1.9 109.679 177.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 177' ' ' ASP . . . . . 0.541 ' H ' ' C ' ' B' ' 175' ' ' SER . 2.0 m-20 -144.01 -46.44 0.27 Allowed 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.237 -0.892 . . . . 2.72 111.145 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 178' ' ' GLY . . . . . 1.006 ' HA2' HG11 ' B' ' 136' ' ' VAL . . . -171.72 -155.42 10.88 Favored Glycine 0 C--N 1.342 0.874 0 C-N-CA 119.796 -1.192 . . . . 0.99 115.149 179.03 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 179' ' ' CYS . . . . . 1.073 ' SG ' HG22 ' B' ' 136' ' ' VAL . 10.0 m -140.32 136.18 32.95 Favored 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 107.027 -1.471 . . . . 1.34 107.027 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 180' ' ' HIS . . . . . 0.52 ' CA ' HG22 ' B' ' 172' ' ' ILE . 0.2 OUTLIER -156.81 131.48 8.8 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 124.069 1.89 . . . . 2.1 111.824 -167.639 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 181' ' ' GLU . . . . . 0.763 ' HA ' ' O ' ' B' ' 171' ' ' GLY . 0.3 OUTLIER -45.87 141.23 3.16 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 110.326 -3.125 . . . . 3.06 109.851 -177.605 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 182' ' ' ASP . . . . . 0.684 ' OD1' ' HB2' ' B' ' 185' ' ' CYS . 3.1 p-10 -145.15 137.29 13.21 Favored Pre-proline 0 C--N 1.306 -1.291 0 CA-C-N 115.32 -0.854 . . . . 2.06 109.628 -178.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 183' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' B' ' 182' ' ' ASP . 52.1 Cg_exo -57.73 -35.37 98.83 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.618 2.212 . . . . 1.91 114.425 -177.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -64.84 -51.57 61.37 Favored 'General case' 0 CA--C 1.508 -0.656 0 N-CA-C 108.701 -0.851 . . . . 1.56 108.701 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 185' ' ' CYS . . . . . 0.684 ' HB2' ' OD1' ' B' ' 182' ' ' ASP . 3.2 m -98.97 77.08 2.17 Favored 'General case' 0 CA--C 1.499 -0.998 0 N-CA-C 106.772 -1.566 . . . . 1.94 106.772 176.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 186' ' ' ASP . . . . . 0.57 ' H ' ' CD ' ' B' ' 187' ' ' PRO . 0.6 OUTLIER -130.96 -54.81 0.03 OUTLIER Pre-proline 0 CA--C 1.5 -0.943 0 C-N-CA 119.469 -0.892 . . . . 3.61 110.184 -178.907 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 187' ' ' PRO . . . . . 0.57 ' CD ' ' H ' ' B' ' 186' ' ' ASP . 9.4 Cg_endo -90.71 166.17 4.06 Favored 'Trans proline' 0 N--CA 1.426 -2.495 0 C-N-CA 122.092 1.861 . . . . 2.58 112.943 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 188' ' ' GLU . . . . . 0.423 ' C ' ' H ' ' B' ' 190' ' ' ALA . 7.3 pt-20 -74.02 18.24 0.15 Allowed 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 128.018 2.527 . . . . 4.7 109.918 177.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 189' ' ' ALA . . . . . 0.524 ' H ' ' C ' ' B' ' 187' ' ' PRO . . . -64.83 30.8 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 124.777 1.231 . . . . 5.24 113.152 174.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 190' ' ' ALA . . . . . 0.423 ' H ' ' C ' ' B' ' 188' ' ' GLU . . . -73.53 161.42 30.38 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.427 0.632 . . . . 6.93 111.817 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 191' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -85.39 63.65 8.2 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.282 -0.872 . . . . 10.14 111.402 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 11.8 p . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.159 -0.924 . . . . 11.7 110.7 179.285 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.95 ' O ' HG13 ' A' ' 2' ' ' VAL . . . . . . . . 0 N--CA 1.478 0.945 0 CA-C-O 121.363 0.602 . . . . 9.95 111.388 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.95 HG13 ' O ' ' A' ' 1' ' ' ALA . 3.4 m -179.26 108.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 CA-C-N 114.164 -1.38 . . . . 8.02 110.661 -179.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.818 ' HG ' ' HB2' ' A' ' 8' ' ' ARG . 3.4 mm? -71.14 125.58 27.28 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 121.475 0.655 . . . . 5.86 112.456 -178.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.662 ' H ' ' HG2' ' A' ' 55' ' ' GLN . 0.3 OUTLIER -93.88 84.06 4.49 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 106.43 -1.693 . . . . 6.22 106.43 173.836 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.909 HD12 ' H ' ' A' ' 7' ' ' VAL . 1.3 tm? -156.18 -119.76 0.03 OUTLIER 'General case' 0 N--CA 1.397 -3.079 0 CA-C-N 112.586 -2.097 . . . . 7.09 108.236 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.504 ' H ' ' CD1' ' A' ' 5' ' ' LEU . 2.4 t0 -174.26 -14.83 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.771 0 CA-C-N 113.967 -1.469 . . . . 8.78 113.946 -179.162 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.909 ' H ' HD12 ' A' ' 5' ' ' LEU . 13.8 p -163.01 122.73 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.401 -2.888 0 CA-C-N 110.861 -2.881 . . . . 7.51 104.542 168.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.818 ' HB2' ' HG ' ' A' ' 3' ' ' LEU . 0.0 OUTLIER -80.87 108.35 14.46 Favored 'General case' 0 N--CA 1.383 -3.788 0 C-N-CA 116.776 -1.97 . . . . 9.08 107.34 176.107 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.528 HG23 ' HA ' ' A' ' 53' ' ' PRO . 1.2 t -104.52 99.56 9.25 Favored 'General case' 0 N--CA 1.414 -2.226 1 N-CA-C 99.384 -4.302 . . . . 5.66 99.384 167.174 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.2 m -74.84 61.06 0.99 Allowed 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 114.963 -1.017 . . . . 2.68 112.628 -178.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.662 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 0.3 OUTLIER -36.18 112.5 0.52 Allowed Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.804 -0.634 . . . . 2.48 112.628 178.443 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.563 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 56.3 Cg_endo -91.75 145.22 3.11 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 121.696 1.597 . . . . 1.49 113.808 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.682 ' O ' ' HA2' ' A' ' 17' ' ' GLY . 20.8 p -146.12 -174.26 4.39 Favored 'General case' 0 C--N 1.347 0.487 0 C-N-CA 119.043 -1.063 . . . . 1.0 113.543 -179.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.625 ' HA2' ' HG3' ' A' ' 40' ' ' GLU . . . 73.99 -161.38 53.88 Favored Glycine 0 N--CA 1.451 -0.317 0 CA-C-N 115.3 -0.864 . . . . 1.15 113.547 177.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.541 ' O ' ' HG3' ' A' ' 18' ' ' LYS . 39.7 Cg_endo -63.26 101.03 0.28 Allowed 'Trans proline' 0 N--CA 1.481 0.785 0 C-N-CA 123.664 2.909 . . . . 1.57 109.211 176.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 82.85 13.21 78.33 Favored Glycine 0 C--N 1.291 -1.917 0 C-N-CA 120.847 -0.692 . . . . 1.68 111.993 178.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.682 ' HA2' ' O ' ' A' ' 13' ' ' CYS . . . 51.8 49.09 49.1 Favored Glycine 0 N--CA 1.409 -3.136 0 N-CA-C 107.897 -2.081 . . . . 1.36 107.897 174.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.541 ' HG3' ' O ' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -99.94 18.52 18.19 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 112.519 -1.841 . . . . 2.5 111.553 174.299 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.563 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -131.73 -177.7 15.05 Favored Glycine 0 N--CA 1.444 -0.789 0 N-CA-C 104.405 -3.478 . . . . 1.02 104.405 176.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.662 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -124.41 172.58 9.03 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 120.538 2.169 . . . . 2.92 109.453 178.754 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.501 ' HB2' ' HB3' ' A' ' 11' ' ' LEU . 0.8 OUTLIER -105.64 134.97 47.9 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 121.334 -0.854 . . . . 1.1 111.16 -178.367 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.516 ' HE2' ' HA ' ' A' ' 56' ' ' SER . 68.0 m-85 -128.2 13.79 6.68 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.3 -0.864 . . . . 1.51 111.253 -179.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -176.16 -167.82 35.49 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.391 -0.909 . . . . 0.9 112.525 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.523 ' O ' ' HB3' ' A' ' 44' ' ' CYS . 1.9 Cg_endo -81.76 -44.26 0.09 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.814 2.343 . . . . 1.5 112.746 -179.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.438 ' HB2' ' OE2' ' B' ' 181' ' ' GLU . 0.1 OUTLIER -124.62 16.03 8.8 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.938 0.399 . . . . 1.26 110.797 179.823 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.755 HG23 ' HA ' ' A' ' 36' ' ' VAL . 0.8 OUTLIER -126.23 121.76 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.09 0 CA-C-O 121.464 0.649 . . . . 0.83 111.563 -178.041 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.884 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -119.1 132.86 56.04 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-N 115.641 -0.709 . . . . 0.92 109.108 179.051 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 1.133 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -144.82 116.15 8.01 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 112.52 0.563 . . . . 1.28 112.52 -178.718 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.676 ' O ' ' HB1' ' A' ' 69' ' ' ALA . . . -107.43 -163.54 21.74 Favored Glycine 0 N--CA 1.428 -1.866 0 N-CA-C 109.806 -1.318 . . . . 0.67 109.806 177.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.407 ' O ' ' HB2' ' A' ' 70' ' ' ALA . 11.4 t70 -67.54 -60.37 2.61 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 113.885 1.069 . . . . 2.27 113.885 -179.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.51 9.33 23.2 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 115.661 -0.699 . . . . 1.66 111.122 -176.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.825 ' O ' HG22 ' B' ' 138' ' ' THR . 1.0 OUTLIER -109.71 -18.96 13.33 Favored 'General case' 0 N--CA 1.405 -2.687 0 N-CA-C 106.791 -1.559 . . . . 1.37 106.791 179.982 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 1.133 ' O ' ' HA ' ' A' ' 28' ' ' CYS . . . 68.8 -133.86 27.43 Favored Glycine 0 N--CA 1.43 -1.755 0 CA-C-N 114.919 -1.037 . . . . 0.73 115.257 173.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.876 ' HB2' HG13 ' A' ' 72' ' ' ILE . 3.1 t -136.26 117.69 14.74 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-N 118.387 1.094 . . . . 1.08 113.254 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.885 ' HA ' ' HA ' ' B' ' 135' ' ' PHE . 0.0 OUTLIER -100.03 108.67 20.91 Favored 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 106.786 -1.561 . . . . 1.38 106.786 176.984 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.755 ' HA ' HG23 ' A' ' 26' ' ' ILE . 1.7 t -90.92 87.07 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.304 0 CA-C-O 122.473 1.13 . . . . 0.76 110.269 -179.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.441 ' O ' ' HA3' ' B' ' 133' ' ' GLY . . . 102.55 69.29 0.82 Allowed Glycine 0 C--O 1.228 -0.26 0 CA-C-N 112.99 -1.913 . . . . 0.81 113.953 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.881 HG22 ' O ' ' B' ' 132' ' ' LEU . 72.4 p -151.29 164.51 36.46 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 109.251 -0.648 . . . . 0.77 109.251 179.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.756 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -70.62 -16.26 62.82 Favored 'General case' 0 N--CA 1.44 -0.968 0 C-N-CA 119.975 -0.69 . . . . 1.02 110.308 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.625 ' HG3' ' HA2' ' A' ' 14' ' ' GLY . 5.0 mp0 -67.57 -15.83 63.86 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.424 -0.954 . . . . 2.32 108.424 176.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 1.051 ' O ' ' HB2' ' A' ' 44' ' ' CYS . . . -120.91 -10.57 9.08 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-N 116.361 -0.381 . . . . 0.87 111.221 -178.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.756 HD12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -61.71 -20.4 63.46 Favored 'General case' 0 N--CA 1.45 -0.439 0 O-C-N 121.211 -0.93 . . . . 1.23 113.229 -177.867 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.69 ' N ' HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -71.6 -6.78 43.43 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 107.556 -1.276 . . . . 2.92 107.556 174.95 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 1.051 ' HB2' ' O ' ' A' ' 41' ' ' ALA . 0.2 OUTLIER -66.53 -1.54 3.73 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 112.361 -2.2 . . . . 1.57 110.012 176.462 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -82.84 -17.35 44.26 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.02 0.438 . . . . 3.31 111.457 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -85.51 6.42 27.08 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 120.107 -0.637 . . . . 3.69 109.892 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.404 ' HG3' HD13 ' A' ' 11' ' ' LEU . 0.2 OUTLIER -81.99 3.02 28.15 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 109.416 -0.587 . . . . 3.99 109.416 177.427 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -78.12 -29.13 48.7 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.907 -0.405 . . . . 3.86 109.907 178.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -89.47 8.93 28.46 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 116.429 -0.35 . . . . 5.68 110.911 179.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -147.38 101.21 3.79 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-N 116.429 -0.35 . . . . 5.4 110.36 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -82.59 35.47 0.58 Allowed 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.345 2.03 . . . . 4.92 113.181 -179.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.736 ' HB3' HD11 ' A' ' 5' ' ' LEU . 17.5 m -167.11 105.57 0.63 Allowed Pre-proline 0 CA--C 1.538 0.493 0 C-N-CA 121.175 -0.21 . . . . 5.64 111.55 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.692 ' O ' ' HG ' ' A' ' 5' ' ' LEU . 69.5 Cg_endo -86.04 -137.91 0.02 OUTLIER 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 123.349 2.699 . . . . 5.04 112.257 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.439 ' H ' ' HB2' ' A' ' 53' ' ' PRO . 1.8 p -132.28 116.39 16.85 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.045 0.45 . . . . 2.74 111.225 178.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.662 ' HG2' ' H ' ' A' ' 4' ' ' ASP . 0.0 OUTLIER 52.22 -176.39 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.832 -0.622 . . . . 5.75 112.368 -179.965 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.516 ' HA ' ' HE2' ' A' ' 22' ' ' PHE . 0.3 OUTLIER -144.53 -89.4 0.11 Allowed 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.104 -0.953 . . . . 3.12 111.441 179.628 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 160.41 133.73 1.54 Allowed Glycine 0 N--CA 1.444 -0.819 0 N-CA-C 106.509 -2.637 . . . . 2.1 106.509 -179.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -109.0 76.9 1.03 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 118.991 1.396 . . . . 4.36 111.614 -177.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.477 ' N ' ' CD ' ' A' ' 60' ' ' PRO . 0.4 OUTLIER -145.79 57.19 3.88 Favored Pre-proline 0 C--N 1.309 -1.175 0 N-CA-C 106.33 -1.73 . . . . 3.55 106.33 176.799 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.477 ' CD ' ' N ' ' A' ' 59' ' ' LYS . 41.0 Cg_endo -70.3 81.76 0.92 Allowed 'Trans proline' 0 N--CA 1.448 -1.159 0 C-N-CA 122.096 1.864 . . . . 1.54 113.772 -178.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -103.08 179.31 4.31 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 106.988 -1.486 . . . . 1.59 106.988 177.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.16 -169.34 46.49 Favored Glycine 0 N--CA 1.437 -1.246 0 C-N-CA 118.656 -1.735 . . . . 2.43 114.607 178.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 50.2 p -85.46 47.26 1.4 Allowed 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 113.504 -1.348 . . . . 4.11 111.394 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 118.06 5.9 12.93 Favored Glycine 0 C--N 1.336 0.552 0 N-CA-C 115.828 1.091 . . . . 2.21 115.828 175.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.551 ' HA3' ' HA ' ' A' ' 74' ' ' CYS . . . -105.77 137.41 13.76 Favored Glycine 0 CA--C 1.52 0.385 0 N-CA-C 117.044 1.577 . . . . 1.62 117.044 -177.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.436 ' HA ' ' O ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -107.41 153.76 22.32 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 114.176 -1.012 . . . . 3.02 109.111 177.668 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.792 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 2.2 m -59.41 107.64 0.6 Allowed 'General case' 0 N--CA 1.441 -0.891 0 O-C-N 121.968 -0.457 . . . . 1.52 111.442 -177.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -84.21 -20.23 32.68 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.308 -0.627 . . . . 1.07 109.308 177.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.703 ' HB3' ' CG1' ' A' ' 72' ' ' ILE . . . -166.46 164.07 17.23 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.776 -0.647 . . . . 1.0 111.62 179.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.623 ' HA ' ' O ' ' A' ' 85' ' ' CYS . . . -39.76 96.9 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.778 -0.646 . . . . 1.24 110.185 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 1.044 ' C ' HD13 ' A' ' 72' ' ' ILE . . . 73.57 50.23 12.32 Favored Glycine 0 CA--C 1.504 -0.655 0 CA-C-N 114.877 -1.056 . . . . 1.28 111.456 -179.126 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 1.044 HD13 ' C ' ' A' ' 71' ' ' GLY . 0.5 OUTLIER -137.51 98.88 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.817 0 N-CA-C 108.049 -1.093 . . . . 2.27 108.049 170.969 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.461 ' O ' ' HB2' ' A' ' 80' ' ' HIS . 51.2 t -91.91 96.27 10.29 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 108.613 -0.884 . . . . 1.98 108.613 179.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 1.066 ' CB ' ' HA ' ' A' ' 79' ' ' CYS . 24.4 p -167.3 -171.57 1.75 Allowed 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 116.577 2.066 . . . . 1.33 116.577 -176.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.883 ' HB3' ' HD2' ' A' ' 76' ' ' PRO . 72.8 m -124.6 -178.9 0.74 Allowed Pre-proline 0 CA--C 1.531 0.225 0 CA-C-N 112.927 -1.942 . . . . 1.99 108.564 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.883 ' HD2' ' HB3' ' A' ' 75' ' ' SER . 58.0 Cg_endo -73.16 31.17 0.3 Allowed 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 121.717 1.611 . . . . 1.86 113.172 -179.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -134.36 -60.94 0.79 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.85 0.357 . . . . 2.65 110.221 178.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.935 ' O ' ' HB2' ' A' ' 74' ' ' CYS . . . -118.22 -178.51 17.14 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.95 -0.643 . . . . 0.99 111.661 178.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 1.066 ' HA ' ' CB ' ' A' ' 74' ' ' CYS . 22.5 m -152.27 161.37 42.72 Favored 'General case' 0 C--O 1.226 -0.169 0 N-CA-C 112.428 0.529 . . . . 1.34 112.428 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.541 ' HA ' ' HA2' ' B' ' 178' ' ' GLY . 7.1 m80 -143.17 139.04 30.16 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-O 121.173 0.511 . . . . 2.17 111.823 -178.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.477 ' OE2' ' HB2' ' B' ' 125' ' ' SER . 37.0 tt0 -65.51 122.97 18.43 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-N 115.671 -0.695 . . . . 3.05 109.605 178.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.698 ' O ' ' HA2' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -138.9 106.75 7.47 Favored Pre-proline 0 C--N 1.319 -0.749 0 C-N-CA 118.963 -1.095 . . . . 2.02 111.385 179.424 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -63.85 -16.65 56.07 Favored 'Trans proline' 0 C--N 1.356 0.948 0 C-N-CA 123.004 2.47 . . . . 1.93 114.315 -178.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.08 -40.16 96.86 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.108 0.48 . . . . 1.53 110.542 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.632 ' O ' ' N ' ' A' ' 71' ' ' GLY . 68.8 m -94.18 46.74 1.17 Allowed 'General case' 0 C--O 1.219 -0.55 0 CA-C-N 115.484 -0.78 . . . . 1.88 110.351 179.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.563 ' CB ' ' HD3' ' A' ' 87' ' ' PRO . 0.2 OUTLIER -77.78 -58.08 0.93 Allowed Pre-proline 0 N--CA 1.475 0.803 0 O-C-N 121.544 -0.722 . . . . 3.6 112.027 -178.735 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.651 ' O ' ' C ' ' A' ' 88' ' ' GLU . 97.1 Cg_endo -90.99 155.72 3.93 Favored 'Trans proline' 0 CA--C 1.504 -1.016 0 C-N-CA 123.996 3.131 . . . . 2.56 108.721 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.651 ' C ' ' O ' ' A' ' 87' ' ' PRO . 0.2 OUTLIER -30.19 95.26 0.01 OUTLIER 'General case' 0 N--CA 1.417 -2.116 0 C-N-CA 118.309 -1.356 . . . . 4.72 110.45 176.785 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.651 ' N ' ' O ' ' A' ' 87' ' ' PRO . . . -91.99 20.59 5.64 Favored 'General case' 0 C--N 1.285 -2.239 0 N-CA-C 107.019 -1.475 . . . . 5.29 107.019 171.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.2 156.16 39.19 Favored 'General case' 0 C--N 1.356 0.862 0 CA-C-O 122.466 1.127 . . . . 6.98 112.083 177.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -98.35 95.57 7.45 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 112.686 -2.052 . . . . 10.21 109.951 177.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 39.5 m . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.294 -0.86 . . . . 11.77 110.815 179.983 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 101' ' ' ALA . . . . . 0.566 ' N ' HD23 ' B' ' 103' ' ' LEU . . . . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 111.752 0.279 . . . . 10.07 111.752 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 3.7 t 56.25 45.3 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.289 0 C-N-CA 118.547 -1.261 . . . . 8.41 110.022 176.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 103' ' ' LEU . . . . . 0.897 ' HG ' ' HG3' ' B' ' 108' ' ' ARG . 3.3 mm? -104.23 94.23 5.25 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 113.01 -1.905 . . . . 5.87 113.938 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 104' ' ' ASP . . . . . 0.674 ' H ' ' HG2' ' B' ' 155' ' ' GLN . 0.7 OUTLIER -81.86 107.65 14.75 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 114.01 -1.45 . . . . 6.27 111.41 178.931 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . 1.051 HD11 ' HB3' ' B' ' 152' ' ' SER . 2.7 tm? -157.16 -90.8 0.03 OUTLIER 'General case' 0 N--CA 1.4 -2.971 0 N-CA-C 106.348 -1.723 . . . . 7.2 106.348 173.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 106' ' ' ASP . . . . . 0.598 ' HB2' HD13 ' B' ' 105' ' ' LEU . 0.2 OUTLIER -167.71 -48.91 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 111.434 -2.621 . . . . 8.55 107.649 -178.438 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 107' ' ' VAL . . . . . 0.632 ' O ' HD12 ' B' ' 105' ' ' LEU . 11.3 p -141.02 123.07 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.515 0 N-CA-C 102.832 -3.025 . . . . 7.48 102.832 173.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 108' ' ' ARG . . . . . 0.897 ' HG3' ' HG ' ' B' ' 103' ' ' LEU . 0.0 OUTLIER -80.15 110.44 15.56 Favored 'General case' 0 N--CA 1.385 -3.716 0 C-N-CA 117.865 -1.534 . . . . 9.12 107.721 178.355 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 109' ' ' THR . . . . . 0.51 HG23 ' HA ' ' B' ' 153' ' ' PRO . 1.2 t -108.04 99.8 9.2 Favored 'General case' 0 N--CA 1.407 -2.605 1 N-CA-C 98.546 -4.612 . . . . 5.69 98.546 167.784 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 110' ' ' CYS . . . . . . . . . . . . . 1.2 m -77.7 66.46 3.39 Favored 'General case' 0 C--N 1.311 -1.084 0 C-N-CA 118.297 -1.361 . . . . 2.61 111.457 -177.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 111' ' ' LEU . . . . . 0.748 ' O ' ' HA ' ' B' ' 120' ' ' ARG . 0.2 OUTLIER -37.92 112.08 0.61 Allowed Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.007 -0.997 . . . . 2.47 112.367 176.864 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 112' ' ' PRO . . . . . 0.433 ' HA ' ' O ' ' B' ' 119' ' ' GLY . 88.6 Cg_endo -84.49 153.28 12.02 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.339 2.026 . . . . 1.47 111.018 178.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.508 ' O ' ' HA2' ' B' ' 117' ' ' GLY . 20.0 p -154.33 -174.71 5.07 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 113.638 0.977 . . . . 1.0 113.638 174.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 114' ' ' GLY . . . . . 0.606 ' HA2' ' HG3' ' B' ' 140' ' ' GLU . . . 73.54 -161.44 54.15 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.151 -0.931 . . . . 1.16 113.529 177.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 115' ' ' PRO . . . . . 0.547 ' O ' ' HG3' ' B' ' 118' ' ' LYS . 42.8 Cg_endo -64.57 95.74 0.23 Allowed 'Trans proline' 0 C--O 1.224 -0.182 0 C-N-CA 123.11 2.54 . . . . 1.57 112.5 177.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 87.65 11.41 68.5 Favored Glycine 0 C--N 1.283 -2.403 0 CA-C-N 114.767 -1.106 . . . . 1.7 113.228 -178.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 117' ' ' GLY . . . . . 0.508 ' HA2' ' O ' ' B' ' 113' ' ' CYS . . . 62.11 39.41 97.6 Favored Glycine 0 N--CA 1.414 -2.822 0 C-N-CA 118.002 -2.047 . . . . 1.38 111.438 176.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 118' ' ' LYS . . . . . 0.547 ' HG3' ' O ' ' B' ' 115' ' ' PRO . 0.0 OUTLIER -91.85 7.06 43.69 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 113.904 -1.148 . . . . 2.54 112.094 179.644 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 119' ' ' GLY . . . . . 0.433 ' O ' ' HA ' ' B' ' 112' ' ' PRO . . . -115.93 -159.5 11.97 Favored Glycine 0 C--N 1.343 0.961 0 N-CA-C 108.139 -1.984 . . . . 1.04 108.139 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.748 ' HA ' ' O ' ' B' ' 111' ' ' LEU . 0.0 OUTLIER -145.37 170.46 16.29 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 121.098 2.449 . . . . 2.89 105.844 174.685 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 121' ' ' CYS . . . . . 0.493 ' HB2' ' HB3' ' B' ' 111' ' ' LEU . 0.9 OUTLIER -106.26 135.61 47.45 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 119.115 0.87 . . . . 1.07 111.942 -176.769 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 122' ' ' PHE . . . . . 0.549 ' HE2' ' HA ' ' B' ' 156' ' ' SER . 68.7 m-85 -128.12 13.71 6.72 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.038 -0.983 . . . . 1.53 111.287 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -176.16 -167.81 35.49 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.339 -0.934 . . . . 0.9 112.56 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . 0.494 ' O ' ' HB3' ' B' ' 144' ' ' CYS . 2.0 Cg_endo -81.68 -44.37 0.09 OUTLIER 'Trans proline' 0 CA--C 1.532 0.423 0 C-N-CA 122.701 2.267 . . . . 1.51 112.791 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 125' ' ' SER . . . . . 0.477 ' HB2' ' OE2' ' A' ' 81' ' ' GLU . 0.1 OUTLIER -124.73 16.54 8.73 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.983 0.421 . . . . 1.25 110.722 179.823 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 126' ' ' ILE . . . . . 0.739 HG23 ' HA ' ' B' ' 136' ' ' VAL . 1.0 OUTLIER -126.44 121.63 59.3 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 CA-C-O 121.454 0.645 . . . . 0.85 111.57 -178.106 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 127' ' ' CYS . . . . . 0.833 ' HB2' ' HB2' ' B' ' 141' ' ' ALA . 0.1 OUTLIER -119.28 133.59 55.67 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-N 115.578 -0.737 . . . . 0.89 109.078 178.912 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 128' ' ' CYS . . . . . 1.205 ' HA ' ' O ' ' B' ' 133' ' ' GLY . 0.0 OUTLIER -145.53 120.5 10.02 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 118.246 -0.883 . . . . 1.23 111.145 -179.171 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 129' ' ' GLY . . . . . 0.631 ' O ' ' HB1' ' B' ' 169' ' ' ALA . . . -114.69 -156.95 11.56 Favored Glycine 0 N--CA 1.417 -2.613 0 N-CA-C 107.555 -2.218 . . . . 0.66 107.555 176.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -65.85 -71.0 0.21 Allowed 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 122.168 0.187 . . . . 2.35 111.493 -178.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.47 32.25 5.52 Favored 'General case' 0 CA--C 1.498 -1.024 0 C-N-CA 120.095 -0.642 . . . . 1.69 110.027 -175.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 132' ' ' LEU . . . . . 0.881 ' O ' HG22 ' A' ' 38' ' ' THR . 0.8 OUTLIER -124.79 -18.88 5.46 Favored 'General case' 0 N--CA 1.403 -2.802 0 N-CA-C 104.898 -2.26 . . . . 1.38 104.898 176.127 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 133' ' ' GLY . . . . . 1.205 ' O ' ' HA ' ' B' ' 128' ' ' CYS . . . 66.86 -134.96 32.33 Favored Glycine 0 N--CA 1.407 -3.269 0 CA-C-N 115.134 -0.939 . . . . 0.72 114.769 173.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 134' ' ' CYS . . . . . 0.894 ' HB2' HG13 ' B' ' 172' ' ' ILE . 2.7 t -135.14 116.44 14.52 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 114.141 1.163 . . . . 1.08 114.141 -177.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 135' ' ' PHE . . . . . 0.885 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -98.16 107.68 20.21 Favored 'General case' 0 CA--C 1.503 -0.857 0 N-CA-C 107.068 -1.456 . . . . 1.36 107.068 177.158 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 136' ' ' VAL . . . . . 0.739 ' HA ' HG23 ' B' ' 126' ' ' ILE . 2.2 t -90.99 86.57 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.324 0 CA-C-O 122.611 1.196 . . . . 0.75 109.792 -179.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 137' ' ' GLY . . . . . 0.475 ' O ' ' HA3' ' A' ' 33' ' ' GLY . . . 102.47 68.92 0.81 Allowed Glycine 0 C--N 1.321 -0.285 0 CA-C-N 112.85 -1.977 . . . . 0.83 114.135 179.403 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 138' ' ' THR . . . . . 0.825 HG22 ' O ' ' A' ' 32' ' ' LEU . 81.2 p -146.45 173.15 12.55 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.824 -0.806 . . . . 0.78 108.824 178.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 139' ' ' ALA . . . . . 0.79 ' O ' HD12 ' B' ' 142' ' ' LEU . . . -78.35 -17.36 56.61 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 120.197 -0.601 . . . . 1.04 109.669 177.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 140' ' ' GLU . . . . . 0.606 ' HG3' ' HA2' ' B' ' 114' ' ' GLY . 5.3 mp0 -67.48 -14.33 62.83 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.86 -0.793 . . . . 2.31 108.86 176.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 141' ' ' ALA . . . . . 1.034 ' O ' ' HB2' ' B' ' 144' ' ' CYS . . . -120.42 -15.59 8.53 Favored 'General case' 0 C--O 1.218 -0.585 0 CA-C-N 115.198 -0.91 . . . . 0.87 111.802 -179.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 142' ' ' LEU . . . . . 0.79 HD12 ' O ' ' B' ' 139' ' ' ALA . 0.0 OUTLIER -59.91 -21.15 60.71 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 113.529 0.937 . . . . 1.24 113.529 -176.569 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 143' ' ' ARG . . . . . 0.698 ' N ' HD13 ' B' ' 142' ' ' LEU . 0.0 OUTLIER -64.32 -20.63 66.22 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 105.966 -1.865 . . . . 2.93 105.966 175.222 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 144' ' ' CYS . . . . . 1.034 ' HB2' ' O ' ' B' ' 141' ' ' ALA . 0.2 OUTLIER -59.28 2.49 0.06 Allowed 'General case' 0 N--CA 1.486 1.374 0 CA-C-N 113.521 -1.672 . . . . 1.61 110.578 -177.985 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 145' ' ' GLN . . . . . 0.499 ' H ' ' C ' ' B' ' 143' ' ' ARG . 14.4 mm100 -84.03 -17.46 40.32 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.039 0.447 . . . . 3.35 111.004 178.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -85.69 6.49 27.42 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 120.147 -0.621 . . . . 3.76 109.808 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . 0.406 ' HG3' HD13 ' B' ' 111' ' ' LEU . 0.2 OUTLIER -81.87 2.9 28.23 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 120.241 -0.584 . . . . 4.01 109.508 177.331 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 148' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -78.1 -29.09 48.84 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 116.335 -0.393 . . . . 3.92 109.95 178.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -89.44 8.9 28.5 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.459 -0.337 . . . . 5.73 110.966 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -147.33 101.2 3.8 Favored Pre-proline 0 C--N 1.333 -0.151 0 CA-C-N 116.397 -0.365 . . . . 5.46 110.302 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 151' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -82.59 35.34 0.57 Allowed 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.432 2.088 . . . . 5.02 113.223 -179.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 152' ' ' SER . . . . . 1.051 ' HB3' HD11 ' B' ' 105' ' ' LEU . 16.9 m -167.04 105.53 0.63 Allowed Pre-proline 0 CA--C 1.537 0.478 0 N-CA-C 111.678 0.251 . . . . 5.73 111.678 -179.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 153' ' ' PRO . . . . . 0.51 ' HA ' HG23 ' B' ' 109' ' ' THR . 77.4 Cg_endo -86.18 -138.34 0.02 OUTLIER 'Trans proline' 0 CA--C 1.544 1.003 0 C-N-CA 123.239 2.626 . . . . 5.1 112.257 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 154' ' ' CYS . . . . . 0.456 ' HB2' HD12 ' B' ' 103' ' ' LEU . 1.8 p -131.95 116.98 17.83 Favored 'General case' 0 C--N 1.349 0.553 0 CA-C-O 121.281 0.562 . . . . 2.68 111.052 178.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 155' ' ' GLN . . . . . 0.674 ' HG2' ' H ' ' B' ' 104' ' ' ASP . 0.0 OUTLIER 51.1 -174.97 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 115.436 -0.802 . . . . 5.63 112.249 -179.663 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 156' ' ' SER . . . . . 0.549 ' HA ' ' HE2' ' B' ' 122' ' ' PHE . 0.3 OUTLIER -145.46 -94.89 0.1 Allowed 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.425 -0.807 . . . . 3.11 108.997 179.156 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 165.68 136.63 2.05 Favored Glycine 0 CA--C 1.501 -0.798 0 N-CA-C 108.291 -1.924 . . . . 2.07 108.291 -178.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -110.91 64.63 0.61 Allowed 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 117.013 -1.875 . . . . 4.34 112.682 -178.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 159' ' ' LYS . . . . . 0.471 ' HB3' ' SG ' ' B' ' 167' ' ' CYS . 0.2 OUTLIER -118.19 53.63 1.75 Allowed Pre-proline 0 C--N 1.315 -0.893 0 CA-C-N 113.686 -1.597 . . . . 3.54 110.048 170.175 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 160' ' ' PRO . . . . . 0.421 ' HA ' ' HA ' ' B' ' 166' ' ' ARG . 37.7 Cg_endo -69.79 83.9 0.68 Allowed 'Trans proline' 0 CA--C 1.519 -0.244 0 CA-C-N 122.153 1.805 . . . . 1.51 114.46 -173.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 161' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -97.13 -170.91 2.11 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 113.8 -1.545 . . . . 1.58 107.761 178.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 55.87 -167.53 3.27 Favored Glycine 0 N--CA 1.439 -1.159 0 C-N-CA 119.645 -1.264 . . . . 2.37 114.779 173.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 78.8 p -85.65 47.03 1.37 Allowed 'General case' 0 C--N 1.309 -1.168 0 C-N-CA 126.637 1.975 . . . . 4.07 111.66 -179.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 118.35 5.11 13.19 Favored Glycine 0 C--N 1.347 1.189 0 CA-C-N 112.863 -1.971 . . . . 2.2 116.004 173.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 165' ' ' GLY . . . . . 0.546 ' HA3' ' HA ' ' B' ' 174' ' ' CYS . . . -104.0 137.97 13.82 Favored Glycine 0 CA--C 1.522 0.473 0 C-N-CA 118.837 -1.649 . . . . 1.62 117.081 -176.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 166' ' ' ARG . . . . . 0.464 ' HA ' ' O ' ' B' ' 159' ' ' LYS . 0.0 OUTLIER -107.96 153.69 22.7 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 114.006 -1.097 . . . . 3.05 108.99 177.03 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 167' ' ' CYS . . . . . 0.801 ' HA ' ' O ' ' B' ' 172' ' ' ILE . 2.0 m -59.52 107.54 0.6 Allowed 'General case' 0 N--CA 1.438 -1.049 0 O-C-N 121.832 -0.542 . . . . 1.56 111.479 -177.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 168' ' ' ALA . . . . . . . . . . . . . . . -81.62 -24.65 36.26 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 108.808 -0.812 . . . . 1.04 108.808 177.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 169' ' ' ALA . . . . . 0.713 ' HB3' ' CG1' ' B' ' 172' ' ' ILE . . . -163.52 163.94 24.51 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 115.169 -0.923 . . . . 0.98 112.782 -178.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 170' ' ' ALA . . . . . 0.596 ' HA ' ' O ' ' B' ' 185' ' ' CYS . . . -40.97 97.77 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.563 -0.744 . . . . 1.25 110.115 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 171' ' ' GLY . . . . . 0.891 ' C ' HD13 ' B' ' 172' ' ' ILE . . . 88.19 20.73 48.18 Favored Glycine 0 N--CA 1.443 -0.876 0 N-CA-C 115.559 0.983 . . . . 1.29 115.559 179.017 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 172' ' ' ILE . . . . . 0.894 HG13 ' HB2' ' B' ' 134' ' ' CYS . 0.3 OUTLIER -120.19 99.25 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 CA-C-N 117.229 0.515 . . . . 2.27 110.908 -179.801 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 173' ' ' CYS . . . . . 0.455 ' O ' ' HB2' ' B' ' 180' ' ' HIS . 53.2 t -91.51 96.29 10.41 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 108.932 -0.766 . . . . 1.94 108.932 178.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 174' ' ' CYS . . . . . 1.077 ' CB ' ' HA ' ' B' ' 179' ' ' CYS . 21.9 p -167.67 -171.67 1.69 Allowed 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 116.53 2.048 . . . . 1.35 116.53 -176.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 175' ' ' SER . . . . . 0.915 ' HB3' ' HD2' ' B' ' 176' ' ' PRO . 72.3 m -124.48 -178.82 0.73 Allowed Pre-proline 0 CA--C 1.531 0.241 0 CA-C-N 112.981 -1.918 . . . . 2.0 108.537 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 176' ' ' PRO . . . . . 0.915 ' HD2' ' HB3' ' B' ' 175' ' ' SER . 57.9 Cg_endo -73.28 31.13 0.31 Allowed 'Trans proline' 0 CA--C 1.533 0.435 0 C-N-CA 121.725 1.617 . . . . 1.9 113.092 -179.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 177' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -134.32 -60.83 0.79 Allowed 'General case' 0 C--O 1.234 0.277 0 CA-C-O 120.914 0.387 . . . . 2.72 110.267 178.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 178' ' ' GLY . . . . . 0.918 ' O ' ' HB2' ' B' ' 174' ' ' CYS . . . -118.15 -178.52 17.18 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 121.006 -0.616 . . . . 0.99 111.668 178.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 179' ' ' CYS . . . . . 1.077 ' HA ' ' CB ' ' B' ' 174' ' ' CYS . 21.7 m -152.24 161.34 42.76 Favored 'General case' 0 N--CA 1.462 0.127 0 N-CA-C 112.453 0.538 . . . . 1.34 112.453 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 180' ' ' HIS . . . . . 0.529 ' HA ' ' HA2' ' A' ' 78' ' ' GLY . 7.1 m80 -143.15 139.08 30.22 Favored 'General case' 0 CA--C 1.517 -0.295 0 O-C-N 121.897 -0.502 . . . . 2.1 111.763 -178.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 181' ' ' GLU . . . . . 0.438 ' OE2' ' HB2' ' A' ' 25' ' ' SER . 37.4 tt0 -65.57 123.0 18.51 Favored 'General case' 0 CA--C 1.503 -0.858 0 CA-C-N 115.674 -0.694 . . . . 3.06 109.586 178.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 182' ' ' ASP . . . . . 0.766 ' O ' ' HA2' ' B' ' 171' ' ' GLY . 0.0 OUTLIER -138.81 106.6 7.52 Favored Pre-proline 0 C--N 1.319 -0.757 0 C-N-CA 118.957 -1.097 . . . . 2.06 111.346 179.466 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 183' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -63.6 -16.85 57.16 Favored 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 123.034 2.489 . . . . 1.91 114.391 -178.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -63.02 -40.2 97.03 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.177 0.513 . . . . 1.56 110.512 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 185' ' ' CYS . . . . . 0.601 ' O ' ' N ' ' B' ' 171' ' ' GLY . 69.5 m -94.0 46.83 1.18 Allowed 'General case' 0 C--O 1.217 -0.613 0 CA-C-N 115.576 -0.738 . . . . 1.94 110.399 179.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 186' ' ' ASP . . . . . 0.557 ' CB ' ' HD3' ' B' ' 187' ' ' PRO . 0.2 OUTLIER -77.94 -57.84 0.93 Allowed Pre-proline 0 N--CA 1.473 0.719 0 O-C-N 121.518 -0.739 . . . . 3.61 111.861 -178.637 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 187' ' ' PRO . . . . . 0.699 ' O ' ' C ' ' B' ' 188' ' ' GLU . 51.1 Cg_endo -95.89 145.3 1.2 Allowed 'Trans proline' 0 CA--C 1.504 -0.992 0 C-N-CA 123.946 3.097 . . . . 2.58 110.43 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 188' ' ' GLU . . . . . 0.699 ' C ' ' O ' ' B' ' 187' ' ' PRO . 0.1 OUTLIER -20.11 91.6 0.01 OUTLIER 'General case' 0 N--CA 1.413 -2.281 0 C-N-CA 118.822 -1.151 . . . . 4.7 111.695 -176.97 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 189' ' ' ALA . . . . . 0.603 ' N ' ' O ' ' B' ' 187' ' ' PRO . . . -88.31 18.65 4.26 Favored 'General case' 0 N--CA 1.41 -2.432 0 CA-C-N 121.148 1.794 . . . . 5.24 107.142 174.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 190' ' ' ALA . . . . . . . . . . . . . . . -63.44 156.18 26.91 Favored 'General case' 0 C--N 1.355 0.828 0 CA-C-O 122.461 1.125 . . . . 6.93 111.869 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 191' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -98.18 95.85 7.69 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 113.004 -1.907 . . . . 10.14 110.096 177.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 39.4 m . . . . . 0 C--O 1.248 0.994 0 CA-C-O 118.26 -0.876 . . . . 11.7 110.749 -179.969 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.432 ' O ' HD23 ' A' ' 3' ' ' LEU . . . . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 110.181 -0.303 . . . . 9.95 110.181 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.517 ' O ' HG13 ' A' ' 2' ' ' VAL . 6.4 p -59.47 97.49 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.319 0 C-N-CA 119.839 -0.745 . . . . 8.02 111.573 -176.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 1.022 HD13 ' HB3' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -158.01 128.78 6.39 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 119.792 -0.763 . . . . 5.86 112.611 179.78 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -88.24 89.01 7.82 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 105.678 -1.971 . . . . 6.22 105.678 175.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.961 HD12 ' H ' ' A' ' 7' ' ' VAL . 1.3 tm? -159.22 -120.76 0.02 OUTLIER 'General case' 1 N--CA 1.375 -4.198 0 CA-C-N 112.063 -2.335 . . . . 7.09 105.08 178.788 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.475 ' H ' ' CD1' ' A' ' 5' ' ' LEU . 1.4 t70 -171.19 -33.67 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 113.807 -1.542 . . . . 8.78 110.815 -179.066 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.961 ' H ' HD12 ' A' ' 5' ' ' LEU . 15.0 p -147.46 118.11 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.896 0 CA-C-N 110.946 -2.843 . . . . 7.51 105.52 172.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 1.022 ' HB3' HD13 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -79.67 105.38 10.93 Favored 'General case' 0 N--CA 1.388 -3.531 0 CA-C-N 115.272 -0.877 . . . . 9.08 111.401 -177.849 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.685 HG21 ' HD2' ' A' ' 51' ' ' PRO . 1.3 t -102.34 86.01 2.74 Favored 'General case' 0 N--CA 1.412 -2.347 1 N-CA-C 98.772 -4.529 . . . . 5.66 98.772 168.411 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.54 ' HA ' ' HB2' ' A' ' 54' ' ' CYS . 0.8 OUTLIER -74.97 56.23 0.74 Allowed 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 113.155 -1.839 . . . . 2.68 112.329 -176.876 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.898 HD23 ' HB3' ' A' ' 21' ' ' CYS . 15.0 tp -36.93 114.41 0.64 Allowed Pre-proline 0 N--CA 1.476 0.869 0 N-CA-C 114.054 1.131 . . . . 2.48 114.054 179.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.528 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 52.0 Cg_endo -95.73 134.83 0.57 Allowed 'Trans proline' 0 CA--C 1.534 0.513 0 C-N-CA 122.167 1.911 . . . . 1.49 115.216 179.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.661 ' O ' ' HA2' ' A' ' 17' ' ' GLY . 0.5 OUTLIER -140.65 -169.06 2.71 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 113.444 0.905 . . . . 1.0 113.444 -178.389 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.566 ' HA2' ' HB3' ' A' ' 40' ' ' GLU . . . 77.09 -156.18 45.21 Favored Glycine 0 C--N 1.337 0.605 0 CA-C-N 114.932 -1.031 . . . . 1.15 111.899 178.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.612 ' HG2' ' O ' ' A' ' 15' ' ' PRO . 41.4 Cg_endo -62.8 113.44 1.98 Allowed 'Trans proline' 0 N--CA 1.479 0.667 0 C-N-CA 122.783 2.322 . . . . 1.57 106.193 176.161 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 73.3 -7.12 12.25 Favored Glycine 0 C--N 1.276 -2.776 0 CA-C-O 119.067 -0.852 . . . . 1.68 112.73 175.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.661 ' HA2' ' O ' ' A' ' 13' ' ' CYS . . . 77.61 49.69 7.06 Favored Glycine 1 N--CA 1.383 -4.858 0 C-N-CA 118.295 -1.907 . . . . 1.36 111.515 -179.42 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.426 ' CG ' ' O ' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -99.61 9.46 43.11 Favored 'General case' 0 C--N 1.342 0.278 0 CA-C-N 112.864 -1.668 . . . . 2.5 111.946 175.643 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.528 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -124.63 -167.92 12.73 Favored Glycine 0 C--N 1.333 0.404 0 N-CA-C 106.465 -2.654 . . . . 1.02 106.465 178.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.721 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 0.6 OUTLIER -135.98 158.56 44.09 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 121.056 2.428 . . . . 2.92 108.184 -179.925 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.898 ' HB3' HD23 ' A' ' 11' ' ' LEU . 1.7 t -107.65 160.49 15.66 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 112.883 0.697 . . . . 1.1 112.883 -178.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.559 ' HE1' ' O ' ' A' ' 28' ' ' CYS . 60.7 m-85 -126.38 -47.46 1.59 Allowed 'General case' 0 C--N 1.339 0.143 0 CA-C-N 115.538 -0.755 . . . . 1.51 110.184 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -117.46 -159.62 11.46 Favored Glycine 0 CA--C 1.521 0.414 0 CA-C-N 115.723 -0.671 . . . . 0.9 111.559 179.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -84.33 -68.1 0.01 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.32 2.013 . . . . 1.5 111.657 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.409 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.4 OUTLIER -89.41 26.54 1.66 Allowed 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.867 -0.42 . . . . 1.26 109.867 178.753 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.937 HG12 HG13 ' A' ' 36' ' ' VAL . 5.6 mt -144.82 112.81 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 CA-C-O 121.875 0.845 . . . . 0.83 111.771 -178.287 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.587 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 4.7 t -126.57 131.3 51.56 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 114.991 -1.004 . . . . 0.92 109.451 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.792 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -142.44 123.12 14.21 Favored 'General case' 0 CA--C 1.561 1.374 0 N-CA-C 115.38 1.622 . . . . 1.28 115.38 -177.358 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -109.37 -170.34 20.5 Favored Glycine 0 C--N 1.368 2.31 0 N-CA-C 109.117 -1.593 . . . . 0.67 109.117 175.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -66.07 -56.07 13.39 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 114.573 1.323 . . . . 2.27 114.573 -178.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.45 -1.11 16.03 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 122.129 0.966 . . . . 1.66 111.234 -177.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.94 HD22 ' CZ ' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -97.39 -13.0 22.1 Favored 'General case' 0 N--CA 1.407 -2.587 0 N-CA-C 106.531 -1.655 . . . . 1.37 106.531 179.937 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.886 ' HA2' ' CB ' ' A' ' 69' ' ' ALA . . . 58.78 -132.66 52.66 Favored Glycine 0 C--O 1.197 -2.168 0 CA-C-O 118.165 -1.353 . . . . 0.73 112.28 175.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.872 ' HB2' HD13 ' A' ' 72' ' ' ILE . 2.4 t -135.39 122.21 21.08 Favored 'General case' 0 CA--C 1.486 -1.517 0 CA-C-N 118.496 1.148 . . . . 1.08 113.748 -179.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.94 ' CZ ' HD22 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -97.69 100.63 12.02 Favored 'General case' 0 N--CA 1.427 -1.606 0 N-CA-C 103.296 -2.853 . . . . 1.38 103.296 175.426 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.937 HG13 HG12 ' A' ' 26' ' ' ILE . 2.1 t -92.12 83.66 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 CA-C-O 123.319 1.533 . . . . 0.76 107.139 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.798 ' HA3' HG21 ' B' ' 172' ' ' ILE . . . 100.43 85.71 1.87 Allowed Glycine 0 CA--C 1.525 0.689 0 CA-C-N 112.42 -2.173 . . . . 0.81 113.67 -179.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.708 HG22 ' O ' ' B' ' 132' ' ' LEU . 67.0 p -161.56 159.49 27.82 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 109.631 -0.507 . . . . 0.77 109.631 179.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.594 ' HA ' ' CD1' ' A' ' 42' ' ' LEU . . . -62.15 -23.07 66.36 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 118.666 0.666 . . . . 1.02 111.242 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.566 ' HB3' ' HA2' ' A' ' 14' ' ' GLY . 3.2 mm-40 -68.75 -13.05 62.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.795 -0.639 . . . . 2.32 109.704 176.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.536 ' O ' ' HB2' ' A' ' 44' ' ' CYS . . . -100.3 -24.36 14.55 Favored 'General case' 0 C--O 1.205 -1.24 0 N-CA-C 109.154 -0.684 . . . . 0.87 109.154 178.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.66 HD22 ' CE1' ' B' ' 191' ' ' PHE . 26.4 mt -42.5 -38.49 1.95 Allowed 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.31 0.485 . . . . 1.23 112.31 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.648 ' HD3' ' O ' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -69.25 -6.25 28.05 Favored 'General case' 0 CA--C 1.556 1.197 0 CA-C-O 121.822 0.82 . . . . 2.92 110.733 179.348 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.536 ' HB2' ' O ' ' A' ' 41' ' ' ALA . 65.7 m -72.59 -18.21 61.62 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 113.829 -1.532 . . . . 1.57 109.715 177.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -55.48 -17.17 4.7 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.667 -0.697 . . . . 3.31 111.471 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.572 ' O ' HD13 ' A' ' 50' ' ' LEU . 14.2 tt0 -84.43 5.64 26.48 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 120.444 -0.502 . . . . 3.69 110.063 179.177 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.597 ' HA ' ' HB2' ' A' ' 50' ' ' LEU . 17.4 tt0 -82.85 -0.96 50.58 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.89 -0.595 . . . . 3.99 109.833 177.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 15.2 m-20 -73.81 -27.94 61.37 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 109.308 -0.627 . . . . 3.86 109.308 177.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -119.18 41.23 3.13 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 115.76 -0.654 . . . . 5.68 109.75 179.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.597 ' HB2' ' HA ' ' A' ' 47' ' ' GLU . 0.8 OUTLIER -123.58 140.13 33.53 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-N 115.862 -0.608 . . . . 5.4 111.64 -179.001 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.685 ' HD2' HG21 ' A' ' 9' ' ' THR . 2.7 Cg_exo -76.36 50.86 3.04 Favored 'Trans proline' 0 C--N 1.356 0.925 0 C-N-CA 122.891 2.394 . . . . 4.92 113.057 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.754 ' HB2' ' HD2' ' A' ' 53' ' ' PRO . 5.1 p 71.65 171.15 0.11 Allowed Pre-proline 0 N--CA 1.471 0.601 0 N-CA-C 112.401 0.519 . . . . 5.64 112.401 179.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.754 ' HD2' ' HB2' ' A' ' 52' ' ' SER . 13.7 Cg_endo -56.98 -173.0 0.04 OUTLIER 'Trans proline' 0 C--N 1.361 1.205 0 C-N-CA 123.403 2.735 . . . . 5.04 115.147 -178.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.54 ' HB2' ' HA ' ' A' ' 10' ' ' CYS . 1.0 OUTLIER -119.13 116.13 25.7 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 114.313 -1.312 . . . . 2.74 110.157 -179.025 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 66.85 -168.2 0.2 Allowed 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 118.37 0.532 . . . . 5.75 111.426 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.775 ' OG ' ' HG3' ' A' ' 59' ' ' LYS . 0.4 OUTLIER -135.19 -69.59 0.5 Allowed 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 108.72 -0.845 . . . . 3.12 108.72 -179.978 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 103.87 -108.73 3.25 Favored Glycine 0 CA--C 1.479 -2.167 0 N-CA-C 110.806 -0.918 . . . . 2.1 110.806 -178.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.486 ' HB2' ' HB3' ' A' ' 67' ' ' CYS . 3.5 mt-30 -112.56 115.85 29.28 Favored 'General case' 0 N--CA 1.422 -1.85 0 N-CA-C 102.889 -3.004 . . . . 4.36 102.889 175.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.918 ' HB3' ' CD ' ' A' ' 60' ' ' PRO . 0.0 OUTLIER -99.22 -100.11 0.0 OUTLIER Pre-proline 0 C--N 1.305 -1.329 0 CA-C-O 114.575 -2.631 . . . . 3.55 109.558 -173.273 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.918 ' CD ' ' HB3' ' A' ' 59' ' ' LYS . 9.7 Cg_endo -49.84 127.04 17.99 Favored 'Trans proline' 0 N--CA 1.474 0.354 0 CA-C-N 127.036 3.549 . . . . 1.54 118.437 -176.024 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.47 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 5.0 t -145.3 -172.98 3.98 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 110.793 -2.912 . . . . 1.59 106.637 177.08 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 37.89 -162.49 0.01 OUTLIER Glycine 0 N--CA 1.485 1.932 0 N-CA-C 114.857 0.703 . . . . 2.43 114.857 175.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 71.2 m -82.78 51.8 1.98 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 120.438 -0.505 . . . . 4.11 109.887 178.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 112.66 2.26 25.71 Favored Glycine 0 CA--C 1.539 1.548 0 C-N-CA 120.742 -0.742 . . . . 2.21 113.467 -178.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.734 ' HA2' ' HA ' ' A' ' 75' ' ' SER . . . -98.62 129.14 9.8 Favored Glycine 0 N--CA 1.464 0.564 0 C-N-CA 120.646 -0.788 . . . . 1.62 112.461 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.677 ' HA ' ' O ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -78.62 150.36 32.71 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-O 121.039 0.447 . . . . 3.02 111.592 -177.749 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.486 ' HB3' ' HB2' ' A' ' 58' ' ' GLN . 9.1 t -70.77 109.54 5.03 Favored 'General case' 0 N--CA 1.397 -3.086 0 N-CA-C 109.24 -0.652 . . . . 1.52 109.24 -178.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.605 ' HB1' ' SG ' ' A' ' 28' ' ' CYS . . . -85.23 -21.5 29.07 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.775 0.798 . . . . 1.07 108.865 178.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.886 ' CB ' ' HA2' ' A' ' 33' ' ' GLY . . . -168.8 161.18 10.9 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.163 -1.381 . . . . 1.0 109.092 -178.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 1.007 ' HB2' ' HG3' ' A' ' 88' ' ' GLU . . . -55.01 140.18 38.55 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 118.176 0.444 . . . . 1.24 111.138 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.632 ' H ' ' CB ' ' A' ' 85' ' ' CYS . . . 75.14 -44.44 1.6 Allowed Glycine 0 CA--C 1.529 0.943 0 CA-C-N 116.202 -0.453 . . . . 1.28 113.779 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.876 HG21 ' HA3' ' B' ' 137' ' ' GLY . 1.6 pp -97.54 99.14 8.3 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.952 0 CA-C-O 122.142 0.973 . . . . 2.27 111.737 -177.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.487 ' SG ' ' HB3' ' A' ' 82' ' ' ASP . 34.2 m -93.21 104.26 16.46 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 115.531 -0.759 . . . . 1.98 109.302 179.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 1.027 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 33.8 m -84.7 124.63 31.73 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.439 -0.801 . . . . 1.33 112.459 -177.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.968 ' HB3' ' HD2' ' A' ' 76' ' ' PRO . 49.5 m -84.58 -178.52 1.19 Allowed Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 115.067 -0.97 . . . . 1.99 110.431 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.968 ' HD2' ' HB3' ' A' ' 75' ' ' SER . 74.1 Cg_endo -75.7 30.3 0.38 Allowed 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 121.672 1.581 . . . . 1.86 111.942 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.832 ' HB2' ' ND1' ' B' ' 180' ' ' HIS . 2.8 p30 -145.51 -28.41 0.44 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.602 -0.726 . . . . 2.65 110.536 179.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.781 ' HA3' ' O ' ' B' ' 179' ' ' CYS . . . -177.68 -133.17 1.81 Allowed Glycine 0 CA--C 1.521 0.437 0 C-N-CA 121.153 -0.546 . . . . 0.99 112.141 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 1.027 ' HA ' ' HA ' ' A' ' 74' ' ' CYS . 80.4 m -128.43 148.62 50.72 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 109.635 -0.506 . . . . 1.34 109.635 179.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.819 ' ND1' ' HB2' ' B' ' 177' ' ' ASP . 4.5 t60 -138.64 116.33 11.43 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 108.246 -1.02 . . . . 2.17 108.246 -173.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.593 ' HG3' ' O ' ' B' ' 177' ' ' ASP . 0.0 OUTLIER -57.31 117.5 4.16 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.803 0.811 . . . . 3.05 110.268 -178.701 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.63 ' OD1' ' HB3' ' A' ' 84' ' ' ALA . 0.3 OUTLIER -147.37 101.47 3.79 Favored Pre-proline 0 N--CA 1.439 -0.991 0 CA-C-N 114.285 -1.325 . . . . 2.02 108.951 -178.167 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -56.28 -2.19 0.37 Allowed 'Trans proline' 0 C--N 1.361 1.201 0 C-N-CA 123.142 2.561 . . . . 1.93 115.15 -177.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.63 ' HB3' ' OD1' ' A' ' 82' ' ' ASP . . . -65.84 -17.83 64.91 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 111.985 0.365 . . . . 1.53 111.985 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.802 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 13.2 m -99.69 7.01 45.49 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.329 0.862 . . . . 1.88 113.329 -178.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.513 ' N ' ' CD ' ' A' ' 87' ' ' PRO . 0.1 OUTLIER -69.39 -19.91 0.48 Allowed Pre-proline 0 C--N 1.327 -0.384 0 N-CA-C 115.448 1.647 . . . . 3.6 115.448 179.782 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.513 ' CD ' ' N ' ' A' ' 86' ' ' ASP . 5.9 Cg_endo -80.37 57.61 6.6 Favored 'Trans proline' 0 CA--C 1.483 -2.028 0 CA-C-N 121.552 1.59 . . . . 2.56 110.197 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 1.007 ' HG3' ' HB2' ' A' ' 70' ' ' ALA . 6.4 pt-20 174.42 -1.62 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 112.173 -2.285 . . . . 4.72 111.36 176.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.776 ' HB2' ' CB ' ' A' ' 70' ' ' ALA . . . -94.2 57.09 2.3 Favored 'General case' 0 N--CA 1.442 -0.853 0 O-C-N 121.479 -0.763 . . . . 5.29 111.83 179.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.48 179.84 0.07 Allowed 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 118.982 -1.087 . . . . 6.98 112.177 -172.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.637 ' CE1' HD22 ' B' ' 142' ' ' LEU . 0.6 OUTLIER -98.3 95.91 7.69 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 120.636 0.255 . . . . 10.21 110.347 175.988 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.215 -0.898 . . . . 11.77 110.958 -179.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.302 0 CA-C-O 121.39 0.614 . . . . 10.07 111.782 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -84.13 32.83 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.101 -0.954 . . . . 8.41 111.227 179.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 103' ' ' LEU . . . . . 1.017 HD21 ' HB3' ' B' ' 108' ' ' ARG . 6.8 tp -176.4 87.95 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 109.304 -0.628 . . . . 5.87 109.304 175.087 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.18 76.76 2.32 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 105.986 -1.857 . . . . 6.27 105.986 176.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . 0.878 HD11 ' C ' ' B' ' 107' ' ' VAL . 0.2 OUTLIER -159.42 -142.48 0.09 Allowed 'General case' 0 N--CA 1.399 -2.996 0 CA-C-N 111.7 -2.5 . . . . 7.2 106.431 -176.004 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 106' ' ' ASP . . . . . 0.804 ' H ' HD13 ' B' ' 105' ' ' LEU . 5.9 t70 -160.33 -46.55 0.05 OUTLIER 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 116.053 -0.522 . . . . 8.55 111.482 -178.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 107' ' ' VAL . . . . . 0.878 ' C ' HD11 ' B' ' 105' ' ' LEU . 6.2 p -134.67 117.73 24.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 101.393 -3.558 . . . . 7.48 101.393 172.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 108' ' ' ARG . . . . . 1.017 ' HB3' HD21 ' B' ' 103' ' ' LEU . 0.0 OUTLIER -77.84 108.18 10.89 Favored 'General case' 0 N--CA 1.4 -2.961 0 C-N-CA 120.19 -0.604 . . . . 9.12 111.684 -174.493 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 109' ' ' THR . . . . . 0.684 HG21 ' HD2' ' B' ' 151' ' ' PRO . 1.1 t -104.59 85.82 2.39 Favored 'General case' 0 N--CA 1.403 -2.783 1 N-CA-C 98.266 -4.716 . . . . 5.69 98.266 168.799 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 110' ' ' CYS . . . . . 0.569 ' HA ' ' HB2' ' B' ' 154' ' ' CYS . 0.8 OUTLIER -77.31 63.04 2.44 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 113.137 -1.847 . . . . 2.61 111.084 -176.675 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 111' ' ' LEU . . . . . 0.919 HD23 ' HB3' ' B' ' 121' ' ' CYS . 14.8 tp -39.89 113.67 0.92 Allowed Pre-proline 0 N--CA 1.47 0.529 0 CA-C-N 114.913 -1.04 . . . . 2.47 113.771 177.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 112' ' ' PRO . . . . . 0.402 ' HA ' ' O ' ' B' ' 119' ' ' GLY . 73.6 Cg_endo -83.85 152.61 13.0 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 122.515 2.143 . . . . 1.47 110.037 178.055 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.663 ' C ' ' HA2' ' B' ' 117' ' ' GLY . 0.5 OUTLIER -158.7 -170.87 3.21 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 118.88 -1.128 . . . . 1.0 113.182 172.275 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 114' ' ' GLY . . . . . 0.572 ' HA2' ' HB3' ' B' ' 140' ' ' GLU . . . 76.41 -156.15 46.35 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.482 -0.866 . . . . 1.16 111.478 178.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 115' ' ' PRO . . . . . 0.479 ' HG2' ' O ' ' B' ' 115' ' ' PRO . 41.2 Cg_endo -65.31 95.89 0.27 Allowed 'Trans proline' 0 N--CA 1.467 -0.085 0 C-N-CA 122.848 2.366 . . . . 1.57 113.12 178.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 82.9 3.24 90.58 Favored Glycine 0 C--N 1.28 -2.56 0 CA-C-N 114.963 -1.017 . . . . 1.7 112.944 -178.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 117' ' ' GLY . . . . . 0.663 ' HA2' ' C ' ' B' ' 113' ' ' CYS . . . 76.34 45.68 14.12 Favored Glycine 0 N--CA 1.402 -3.604 0 C-N-CA 120.955 -0.64 . . . . 1.38 114.131 178.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.39 -1.91 57.46 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 114.696 -0.752 . . . . 2.54 111.32 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 119' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' B' ' 112' ' ' PRO . . . -107.46 -156.22 19.86 Favored Glycine 0 C--N 1.343 0.92 0 N-CA-C 110.209 -1.156 . . . . 1.04 110.209 -179.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.8 ' HA ' ' O ' ' B' ' 111' ' ' LEU . 1.2 mtm180 -150.64 154.33 37.29 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 120.216 2.008 . . . . 2.89 106.302 176.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 121' ' ' CYS . . . . . 0.919 ' HB3' HD23 ' B' ' 111' ' ' LEU . 1.5 t -107.28 160.95 15.22 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 113.246 0.832 . . . . 1.07 113.246 -177.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 122' ' ' PHE . . . . . 0.533 ' HE1' ' O ' ' B' ' 128' ' ' CYS . 60.8 m-85 -126.43 -47.65 1.58 Allowed 'General case' 0 C--N 1.339 0.113 0 CA-C-N 115.34 -0.846 . . . . 1.53 110.107 179.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -117.29 -159.67 11.52 Favored Glycine 0 CA--C 1.52 0.381 0 CA-C-N 115.797 -0.638 . . . . 0.9 111.634 179.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -84.26 -68.15 0.01 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.344 2.029 . . . . 1.51 111.667 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 125' ' ' SER . . . . . 0.408 ' O ' ' N ' ' B' ' 137' ' ' GLY . 0.4 OUTLIER -89.49 26.65 1.65 Allowed 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 109.943 -0.391 . . . . 1.25 109.943 178.78 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 126' ' ' ILE . . . . . 0.945 HG12 HG13 ' B' ' 136' ' ' VAL . 7.0 mt -144.7 112.59 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 CA-C-O 121.751 0.786 . . . . 0.85 111.827 -178.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 127' ' ' CYS . . . . . 0.576 ' O ' ' HA ' ' B' ' 134' ' ' CYS . 4.6 t -126.45 131.38 51.69 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.112 -0.949 . . . . 0.89 109.234 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 128' ' ' CYS . . . . . 0.817 ' HA ' ' O ' ' B' ' 133' ' ' GLY . 0.0 OUTLIER -142.39 122.16 13.47 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 115.103 1.52 . . . . 1.23 115.103 -176.906 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 129' ' ' GLY . . . . . . . . . . . . . . . -111.46 -166.11 18.28 Favored Glycine 0 C--N 1.373 2.636 0 N-CA-C 108.173 -1.971 . . . . 0.66 108.173 175.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -65.4 -58.74 5.12 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 114.074 1.139 . . . . 2.35 114.074 -177.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.28 21.82 11.57 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.57 0.7 . . . . 1.69 109.921 -177.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 132' ' ' LEU . . . . . 0.929 HD22 ' CZ ' ' B' ' 135' ' ' PHE . 0.4 OUTLIER -114.6 -12.41 12.25 Favored 'General case' 0 N--CA 1.397 -3.085 0 N-CA-C 103.84 -2.652 . . . . 1.38 103.84 175.459 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 133' ' ' GLY . . . . . 0.917 ' HA2' ' CB ' ' B' ' 169' ' ' ALA . . . 57.97 -129.57 49.74 Favored Glycine 1 N--CA 1.394 -4.128 0 CA-C-O 117.249 -1.862 . . . . 0.72 112.989 174.572 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 134' ' ' CYS . . . . . 0.874 ' HB2' HD13 ' B' ' 172' ' ' ILE . 2.5 t -136.96 122.98 20.25 Favored 'General case' 0 CA--C 1.496 -1.116 0 CA-C-N 119.648 1.724 . . . . 1.08 113.696 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 135' ' ' PHE . . . . . 0.929 ' CZ ' HD22 ' B' ' 132' ' ' LEU . 0.0 OUTLIER -98.03 100.21 11.53 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 103.645 -2.724 . . . . 1.36 103.645 175.153 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 136' ' ' VAL . . . . . 0.945 HG13 HG12 ' B' ' 126' ' ' ILE . 2.2 t -92.09 83.14 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.368 0 CA-C-O 123.27 1.509 . . . . 0.75 107.093 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 137' ' ' GLY . . . . . 0.876 ' HA3' HG21 ' A' ' 72' ' ' ILE . . . 100.49 85.36 1.85 Allowed Glycine 0 CA--C 1.525 0.678 0 CA-C-N 112.43 -2.168 . . . . 0.83 113.719 -179.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 138' ' ' THR . . . . . 0.7 HG22 ' O ' ' A' ' 32' ' ' LEU . 67.8 p -157.74 166.53 32.54 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 108.895 -0.78 . . . . 0.78 108.895 179.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 139' ' ' ALA . . . . . 0.576 ' HA ' ' CD1' ' B' ' 142' ' ' LEU . . . -68.58 -24.54 64.61 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 119.294 0.952 . . . . 1.04 110.575 177.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 140' ' ' GLU . . . . . 0.572 ' HB3' ' HA2' ' B' ' 114' ' ' GLY . 3.3 mm-40 -66.81 -11.92 57.09 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.618 -1.173 . . . . 2.31 109.972 177.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 141' ' ' ALA . . . . . 0.491 ' O ' ' HB2' ' B' ' 144' ' ' CYS . . . -102.93 -22.57 13.81 Favored 'General case' 0 C--O 1.211 -0.944 0 C-N-CA 123.736 0.814 . . . . 0.87 109.611 178.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 142' ' ' LEU . . . . . 0.637 HD22 ' CE1' ' A' ' 91' ' ' PHE . 23.8 mt -44.85 -38.42 4.57 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.015 0.436 . . . . 1.24 111.855 -179.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 143' ' ' ARG . . . . . 0.705 ' HD3' ' O ' ' B' ' 143' ' ' ARG . 0.0 OUTLIER -71.43 -1.28 12.58 Favored 'General case' 0 C--O 1.247 0.963 0 CA-C-N 116.05 -0.523 . . . . 2.93 110.063 179.378 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 144' ' ' CYS . . . . . 0.491 ' HB2' ' O ' ' B' ' 141' ' ' ALA . 66.3 m -82.0 -5.5 58.39 Favored 'General case' 0 C--N 1.341 0.226 0 O-C-N 120.825 -1.172 . . . . 1.61 110.108 176.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -60.61 -16.7 41.05 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.619 -0.719 . . . . 3.35 110.113 178.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 146' ' ' GLU . . . . . 0.58 ' O ' HD13 ' B' ' 150' ' ' LEU . 14.0 tt0 -84.32 5.86 25.25 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 120.13 -0.628 . . . . 3.76 110.253 178.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . 0.59 ' HA ' ' HB2' ' B' ' 150' ' ' LEU . 17.4 tt0 -82.81 -1.06 50.72 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 116.038 -0.528 . . . . 4.01 109.892 177.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 148' ' ' ASN . . . . . . . . . . . . . 15.1 m-20 -73.86 -27.78 61.25 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 109.351 -0.611 . . . . 3.92 109.351 177.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -119.22 41.34 3.11 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.748 -0.66 . . . . 5.73 109.738 179.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 150' ' ' LEU . . . . . 0.59 ' HB2' ' HA ' ' B' ' 147' ' ' GLU . 0.8 OUTLIER -123.63 140.04 33.4 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 115.841 -0.618 . . . . 5.46 111.663 -179.001 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 151' ' ' PRO . . . . . 0.684 ' HD2' HG21 ' B' ' 109' ' ' THR . 2.7 Cg_exo -76.35 50.82 3.03 Favored 'Trans proline' 0 C--N 1.356 0.951 0 C-N-CA 122.84 2.36 . . . . 5.02 112.979 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 152' ' ' SER . . . . . 0.775 ' HB2' ' HD2' ' B' ' 153' ' ' PRO . 5.0 p 71.73 171.12 0.11 Allowed Pre-proline 0 N--CA 1.472 0.632 0 N-CA-C 112.414 0.524 . . . . 5.73 112.414 179.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 153' ' ' PRO . . . . . 0.775 ' HD2' ' HB2' ' B' ' 152' ' ' SER . 13.9 Cg_endo -57.02 -172.98 0.04 OUTLIER 'Trans proline' 0 C--N 1.361 1.187 0 C-N-CA 123.365 2.71 . . . . 5.1 115.208 -178.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 154' ' ' CYS . . . . . 0.569 ' HB2' ' HA ' ' B' ' 110' ' ' CYS . 1.0 OUTLIER -119.62 116.39 25.91 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 114.214 -1.357 . . . . 2.68 110.217 -178.997 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 155' ' ' GLN . . . . . 0.523 ' HG3' ' HA ' ' B' ' 103' ' ' LEU . 3.5 tt0 66.54 -165.48 0.22 Allowed 'General case' 0 N--CA 1.478 0.959 0 O-C-N 122.183 -0.323 . . . . 5.63 111.572 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 156' ' ' SER . . . . . 0.714 ' OG ' ' HG3' ' B' ' 159' ' ' LYS . 1.8 t -146.71 -35.09 0.26 Allowed 'General case' 0 C--N 1.351 0.642 0 N-CA-C 116.772 2.138 . . . . 3.11 116.772 -178.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 79.99 -113.76 3.72 Favored Glycine 0 CA--C 1.49 -1.509 0 O-C-N 119.487 -2.008 . . . . 2.07 113.301 173.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 158' ' ' GLN . . . . . 0.699 ' O ' ' HB3' ' B' ' 167' ' ' CYS . 3.3 mt-30 -113.67 96.07 5.67 Favored 'General case' 0 N--CA 1.413 -2.28 0 N-CA-C 106.931 -1.507 . . . . 4.34 106.931 177.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 159' ' ' LYS . . . . . 0.94 ' HB3' ' CD ' ' B' ' 160' ' ' PRO . 0.0 OUTLIER -69.6 -107.2 0.0 OUTLIER Pre-proline 0 CA--C 1.575 1.908 0 N-CA-C 114.196 1.184 . . . . 3.54 114.196 -177.153 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 160' ' ' PRO . . . . . 0.94 ' CD ' ' HB3' ' B' ' 159' ' ' LYS . 10.4 Cg_endo -50.58 126.8 18.94 Favored 'Trans proline' 0 C--N 1.363 1.336 0 N-CA-C 119.271 2.758 . . . . 1.51 119.271 -175.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 161' ' ' CYS . . . . . 0.491 ' HB3' ' HB3' ' B' ' 173' ' ' CYS . 6.5 t -149.05 -179.71 7.23 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 110.94 -2.846 . . . . 1.58 106.667 176.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 47.02 -164.61 0.13 Allowed Glycine 0 C--N 1.345 1.081 0 C-N-CA 119.818 -1.182 . . . . 2.37 114.434 178.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 69.5 m -84.3 48.85 1.55 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.67 0.748 . . . . 4.07 109.913 178.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 117.92 -1.58 17.35 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-N 115.166 -0.925 . . . . 2.2 113.654 178.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 165' ' ' GLY . . . . . 0.712 ' CA ' ' HA ' ' B' ' 175' ' ' SER . . . -97.27 132.4 10.97 Favored Glycine 0 C--N 1.339 0.696 0 C-N-CA 119.318 -1.42 . . . . 1.62 112.257 -176.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 166' ' ' ARG . . . . . 0.644 ' HA ' ' O ' ' B' ' 159' ' ' LYS . 0.0 OUTLIER -78.57 150.48 32.78 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.168 0.509 . . . . 3.05 111.841 -177.591 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 167' ' ' CYS . . . . . 0.699 ' HB3' ' O ' ' B' ' 158' ' ' GLN . 9.1 t -70.77 109.73 5.14 Favored 'General case' 0 N--CA 1.405 -2.702 0 CA-C-N 115.548 -0.751 . . . . 1.56 109.231 -179.206 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 168' ' ' ALA . . . . . 0.59 ' HB1' ' SG ' ' B' ' 128' ' ' CYS . . . -90.09 -14.28 34.08 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 121.583 0.706 . . . . 1.04 110.047 179.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 169' ' ' ALA . . . . . 0.917 ' CB ' ' HA2' ' B' ' 133' ' ' GLY . . . -172.71 161.62 4.82 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.854 -1.067 . . . . 0.98 108.785 177.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 170' ' ' ALA . . . . . 1.011 ' HB2' ' HG3' ' B' ' 188' ' ' GLU . . . -55.55 139.06 45.34 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 118.33 0.514 . . . . 1.25 111.361 179.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 171' ' ' GLY . . . . . 0.687 ' H ' ' CB ' ' B' ' 185' ' ' CYS . . . 67.73 -22.98 0.24 Allowed Glycine 0 CA--C 1.534 1.244 0 N-CA-C 116.35 1.3 . . . . 1.29 116.35 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 172' ' ' ILE . . . . . 0.874 HD13 ' HB2' ' B' ' 134' ' ' CYS . 1.7 pp -111.03 98.17 6.7 Favored 'Isoleucine or valine' 0 C--O 1.244 0.793 0 CA-C-N 118.586 1.193 . . . . 2.27 110.069 177.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 173' ' ' CYS . . . . . 0.491 ' HB3' ' HB3' ' B' ' 161' ' ' CYS . 33.9 m -93.0 104.3 16.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.421 -0.809 . . . . 1.94 109.311 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 174' ' ' CYS . . . . . 1.009 ' HA ' ' HA ' ' B' ' 179' ' ' CYS . 34.0 m -84.84 124.57 31.75 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.33 -0.85 . . . . 1.35 112.265 -177.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 175' ' ' SER . . . . . 0.923 ' HB3' ' HD2' ' B' ' 176' ' ' PRO . 49.5 m -84.47 -178.56 1.2 Allowed Pre-proline 0 CA--C 1.533 0.296 0 CA-C-N 115.075 -0.966 . . . . 2.0 110.515 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 176' ' ' PRO . . . . . 0.923 ' HD2' ' HB3' ' B' ' 175' ' ' SER . 73.9 Cg_endo -75.75 30.31 0.38 Allowed 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 121.675 1.583 . . . . 1.9 111.961 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 177' ' ' ASP . . . . . 0.819 ' HB2' ' ND1' ' A' ' 80' ' ' HIS . 2.8 p30 -145.38 -28.21 0.45 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.598 -0.728 . . . . 2.72 110.545 179.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 178' ' ' GLY . . . . . 0.826 ' HA3' ' O ' ' A' ' 79' ' ' CYS . . . -178.21 -132.65 1.74 Allowed Glycine 0 C--N 1.334 0.447 0 C-N-CA 121.21 -0.519 . . . . 0.99 112.183 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 179' ' ' CYS . . . . . 1.009 ' HA ' ' HA ' ' B' ' 174' ' ' CYS . 81.6 m -128.03 154.18 45.94 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 109.441 -0.577 . . . . 1.34 109.441 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 180' ' ' HIS . . . . . 0.832 ' ND1' ' HB2' ' A' ' 77' ' ' ASP . 4.0 t60 -147.29 115.37 6.54 Favored 'General case' 0 CA--C 1.499 -0.996 0 CA-C-O 121.913 0.863 . . . . 2.1 108.811 -173.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 181' ' ' GLU . . . . . 0.615 ' HG3' ' O ' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -56.73 117.41 3.89 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-N 114.246 -1.343 . . . . 3.06 110.274 -176.746 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 182' ' ' ASP . . . . . 0.615 ' OD1' ' HB3' ' B' ' 184' ' ' ALA . 0.3 OUTLIER -147.38 101.27 3.79 Favored Pre-proline 0 N--CA 1.437 -1.087 0 CA-C-N 114.063 -1.426 . . . . 2.06 108.929 -178.007 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 183' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -56.16 -2.22 0.36 Allowed 'Trans proline' 0 C--N 1.36 1.16 0 C-N-CA 123.229 2.619 . . . . 1.91 115.207 -177.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 184' ' ' ALA . . . . . 0.615 ' HB3' ' OD1' ' B' ' 182' ' ' ASP . . . -65.96 -17.93 65.0 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 111.983 0.364 . . . . 1.56 111.983 -179.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 185' ' ' CYS . . . . . 0.79 ' HB3' ' HA ' ' B' ' 170' ' ' ALA . 12.3 m -100.18 7.82 44.26 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 113.032 0.752 . . . . 1.94 113.032 -178.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 186' ' ' ASP . . . . . 0.525 ' N ' ' CD ' ' B' ' 187' ' ' PRO . 0.1 OUTLIER -69.25 -19.32 0.45 Allowed Pre-proline 0 C--N 1.328 -0.358 0 N-CA-C 115.027 1.491 . . . . 3.61 115.027 179.436 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 187' ' ' PRO . . . . . 0.525 ' CD ' ' N ' ' B' ' 186' ' ' ASP . 3.1 Cg_endo -77.0 45.97 1.82 Allowed 'Trans proline' 0 C--N 1.359 1.085 0 CA-C-N 121.45 1.554 . . . . 2.58 113.985 -179.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 188' ' ' GLU . . . . . 1.011 ' HG3' ' HB2' ' B' ' 170' ' ' ALA . 6.3 pt-20 -173.73 -11.68 0.01 OUTLIER 'General case' 0 C--N 1.285 -2.196 0 CA-C-N 109.913 -3.312 . . . . 4.7 113.742 -178.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 189' ' ' ALA . . . . . 0.782 ' HB2' ' CB ' ' B' ' 170' ' ' ALA . . . -87.44 64.21 8.06 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 123.351 0.661 . . . . 5.24 110.262 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 190' ' ' ALA . . . . . . . . . . . . . . . -66.74 178.68 1.25 Allowed 'General case' 0 C--N 1.353 0.739 0 O-C-N 120.549 -1.344 . . . . 6.93 112.74 -178.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 191' ' ' PHE . . . . . 0.66 ' CE1' HD22 ' A' ' 42' ' ' LEU . 0.6 OUTLIER -96.7 95.47 7.95 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.782 -0.645 . . . . 10.14 110.534 178.468 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.167 -0.92 . . . . 11.7 110.899 -179.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 120.883 0.373 . . . . 9.95 110.987 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.966 HG23 ' H ' ' A' ' 3' ' ' LEU . 4.3 m -81.64 -80.86 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 122.362 1.077 . . . . 8.02 113.158 -178.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.966 ' H ' HG23 ' A' ' 2' ' ' VAL . 0.2 OUTLIER -130.77 120.74 24.23 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 112.653 -2.067 . . . . 5.86 108.192 178.147 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.809 ' O ' ' HG3' ' A' ' 8' ' ' ARG . 10.5 m-20 -161.62 -174.25 4.14 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 111.287 -2.688 . . . . 6.22 107.915 177.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.3 tp -91.57 7.56 40.85 Favored 'General case' 0 CA--C 1.497 -1.068 0 C-N-CA 116.549 -2.06 . . . . 7.09 111.062 -175.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.776 ' O ' ' HG3' ' A' ' 55' ' ' GLN . 0.2 OUTLIER -77.28 -76.62 0.17 Allowed 'General case' 0 CA--C 1.493 -1.221 0 N-CA-C 102.809 -3.034 . . . . 8.78 102.809 -179.784 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.577 ' HA ' ' CB ' ' A' ' 55' ' ' GLN . 7.6 p -151.43 113.78 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.154 0 N-CA-C 104.926 -2.25 . . . . 7.51 104.926 169.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.872 ' HB2' ' H ' ' A' ' 55' ' ' GLN . 18.1 mtp180 -79.58 114.79 18.78 Favored 'General case' 0 CA--C 1.483 -1.608 0 N-CA-C 105.133 -2.173 . . . . 9.08 105.133 176.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.439 HG23 ' O ' ' A' ' 9' ' ' THR . 4.0 t -60.12 105.47 0.41 Allowed 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 115.144 -2.623 . . . . 5.66 107.988 -178.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.609 ' HB3' ' HB3' ' A' ' 20' ' ' ARG . 0.1 OUTLIER -79.29 114.51 18.29 Favored 'General case' 0 CA--C 1.548 0.898 0 CA-C-N 113.649 -1.614 . . . . 2.68 112.856 178.42 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.609 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 4.4 mm? 3.62 111.86 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.461 0 N-CA-C 113.202 0.816 . . . . 2.48 113.202 178.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.615 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 87.6 Cg_endo -79.32 123.98 5.74 Favored 'Trans proline' 0 C--N 1.357 1.019 0 C-N-CA 123.203 2.602 . . . . 1.49 115.866 -178.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.585 ' O ' ' HA2' ' A' ' 17' ' ' GLY . 26.8 p -129.83 -176.23 3.86 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.307 -0.86 . . . . 1.0 111.138 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.463 ' HA2' ' HG2' ' A' ' 40' ' ' GLU . . . 75.54 -161.45 52.7 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 120.312 -0.947 . . . . 1.15 112.43 -178.144 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 1.078 ' HD2' HD11 ' A' ' 32' ' ' LEU . 39.3 Cg_endo -64.95 95.04 0.24 Allowed 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 123.488 2.792 . . . . 1.57 113.108 178.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.51 -2.09 87.76 Favored Glycine 0 C--N 1.288 -2.129 0 CA-C-N 113.868 -1.515 . . . . 1.68 112.724 178.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.585 ' HA2' ' O ' ' A' ' 13' ' ' CYS . . . 84.28 35.69 14.2 Favored Glycine 0 N--CA 1.412 -2.934 0 C-N-CA 118.501 -1.809 . . . . 1.36 116.417 177.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.1 -31.71 61.25 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 112.941 -1.629 . . . . 2.5 107.237 175.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.615 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -79.09 175.04 55.25 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 113.099 -1.864 . . . . 1.02 112.891 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.609 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -139.8 162.99 33.82 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.955 -0.387 . . . . 2.92 109.955 179.749 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 15.6 t -108.66 143.17 38.09 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.438 0.637 . . . . 1.1 112.301 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -127.5 -54.12 1.35 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 114.78 -1.1 . . . . 1.51 108.834 178.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -95.95 149.79 19.43 Favored Glycine 0 C--N 1.331 0.298 0 N-CA-C 110.179 -1.168 . . . . 0.9 110.179 177.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -50.25 -48.21 20.92 Favored 'Trans proline' 0 CA--C 1.531 0.349 0 C-N-CA 121.849 1.699 . . . . 1.5 112.765 -179.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.16 4.06 41.67 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.603 0.24 . . . . 1.26 111.347 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.926 HG12 HG13 ' A' ' 36' ' ' VAL . 0.5 OUTLIER -119.83 122.8 69.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 113.309 0.855 . . . . 0.83 113.309 -178.016 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.463 ' HB3' ' OE1' ' A' ' 40' ' ' GLU . 0.1 OUTLIER -125.84 124.48 41.0 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.01 -0.541 . . . . 0.92 109.704 178.566 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.913 ' HB2' ' HB2' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -131.88 141.12 49.29 Favored 'General case' 0 CA--C 1.562 1.426 0 N-CA-C 114.296 1.221 . . . . 1.28 114.296 -177.594 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.743 ' O ' ' HB1' ' A' ' 69' ' ' ALA . . . -131.71 -174.2 13.57 Favored Glycine 0 C--N 1.369 2.396 0 CA-C-N 113.443 -1.708 . . . . 0.67 110.119 178.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.747 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 18.9 p-10 -63.17 -56.36 17.37 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 113.376 0.88 . . . . 2.27 113.376 -178.017 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.415 ' HG2' ' OD2' ' A' ' 30' ' ' ASP . 0.0 OUTLIER -113.21 5.54 17.03 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-O 121.435 0.636 . . . . 1.66 110.716 -175.798 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 1.078 HD11 ' HD2' ' A' ' 15' ' ' PRO . 0.3 OUTLIER -103.93 -10.24 18.3 Favored 'General case' 0 N--CA 1.419 -2.001 0 N-CA-C 106.272 -1.751 . . . . 1.37 106.272 177.638 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.875 ' O ' ' HB3' ' A' ' 28' ' ' CYS . . . 67.37 -98.09 0.43 Allowed Glycine 0 C--O 1.221 -0.717 0 N-CA-C 118.283 2.073 . . . . 0.73 118.283 172.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.97 ' HB2' HG13 ' A' ' 72' ' ' ILE . 6.0 t -169.25 106.64 0.4 Allowed 'General case' 0 C--N 1.354 0.789 0 CA-C-N 118.644 1.222 . . . . 1.08 109.314 176.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.564 ' HB3' ' CG2' ' A' ' 38' ' ' THR . 3.7 m-30 -89.16 105.24 17.66 Favored 'General case' 0 N--CA 1.427 -1.611 0 N-CA-C 106.036 -1.839 . . . . 1.38 106.036 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.926 HG13 HG12 ' A' ' 26' ' ' ILE . 1.5 t -94.69 88.62 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.195 0 CA-C-O 123.361 1.553 . . . . 0.76 108.72 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.822 ' O ' ' HA3' ' B' ' 133' ' ' GLY . . . 94.63 98.64 1.66 Allowed Glycine 0 C--O 1.228 -0.256 0 CA-C-N 111.633 -2.53 . . . . 0.81 115.979 179.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.565 HG21 ' CE1' ' B' ' 135' ' ' PHE . 0.7 OUTLIER 177.02 170.27 0.53 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.627 0.251 . . . . 0.77 111.057 177.339 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.805 ' HA ' HD12 ' A' ' 42' ' ' LEU . . . -58.97 -14.18 8.54 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.377 0.608 . . . . 1.02 110.547 178.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.587 ' OE2' HD22 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -73.21 -13.16 61.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.741 -1.118 . . . . 2.32 109.327 176.594 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.413 ' O ' ' HB2' ' A' ' 44' ' ' CYS . . . -105.87 -22.53 12.9 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 115.121 -0.945 . . . . 0.87 111.66 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.805 HD12 ' HA ' ' A' ' 39' ' ' ALA . 3.4 mt -44.25 -39.3 4.36 Favored 'General case' 0 C--N 1.344 0.368 0 N-CA-C 113.177 0.806 . . . . 1.23 113.177 -178.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' A' ' 43' ' ' ARG . 3.6 mmp_? -58.36 -19.33 34.58 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.275 0.559 . . . . 2.92 109.768 179.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.642 ' O ' ' N ' ' A' ' 47' ' ' GLU . 97.2 m -65.13 -45.64 84.23 Favored 'General case' 0 C--O 1.223 -0.294 0 N-CA-C 108.533 -0.914 . . . . 1.57 108.533 177.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.449 ' HB2' ' O ' ' A' ' 42' ' ' LEU . 75.3 mm-40 -28.98 -37.75 0.01 OUTLIER 'General case' 0 CA--C 1.551 0.996 0 CA-C-N 113.721 -1.581 . . . . 3.31 113.03 -178.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -87.43 -3.11 59.01 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 119.593 -0.843 . . . . 3.69 111.518 -179.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.642 ' N ' ' O ' ' A' ' 44' ' ' CYS . 1.1 tt0 -81.05 -0.29 39.17 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 115.441 -0.8 . . . . 3.99 109.574 178.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -64.27 -28.18 69.55 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.647 -0.501 . . . . 3.86 109.647 178.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -112.89 47.97 1.06 Allowed 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.254 -0.43 . . . . 5.68 111.091 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.8 mt -143.89 88.23 7.74 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-N 116.335 -0.393 . . . . 5.4 111.094 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -91.19 31.93 0.32 Allowed 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.637 2.225 . . . . 4.92 113.16 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -92.46 118.78 68.19 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.679 -0.237 . . . . 5.64 110.991 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -80.3 116.86 3.38 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.28 1.987 . . . . 5.04 113.062 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.777 ' HA ' ' CD ' ' A' ' 8' ' ' ARG . 28.9 p -86.13 153.46 22.06 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 115.77 -0.65 . . . . 2.74 111.113 179.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.872 ' H ' ' HB2' ' A' ' 8' ' ' ARG . 2.4 tt0 -12.46 -81.35 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 114.761 1.393 . . . . 5.75 114.761 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.601 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 0.6 OUTLIER 86.82 -101.93 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.678 0.791 . . . . 3.12 111.259 -178.478 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 113.84 -63.84 0.29 Allowed Glycine 0 CA--C 1.496 -1.102 0 C-N-CA 120.428 -0.891 . . . . 2.1 112.66 178.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -114.45 127.71 55.97 Favored 'General case' 0 N--CA 1.419 -1.983 0 N-CA-C 104.956 -2.238 . . . . 4.36 104.956 177.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.94 ' O ' ' HA ' ' A' ' 66' ' ' ARG . 2.0 mtmp? -120.22 -100.14 0.0 OUTLIER Pre-proline 0 C--N 1.285 -2.239 0 CA-C-O 114.201 -2.809 . . . . 3.55 105.47 -176.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.797 ' CD ' ' HB3' ' A' ' 59' ' ' LYS . 56.5 Cg_endo -71.34 138.48 33.02 Favored 'Trans proline' 0 C--N 1.318 -1.066 0 CA-C-N 128.211 3.968 . . . . 1.54 115.569 -178.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.51 ' O ' ' SG ' ' A' ' 73' ' ' CYS . 20.6 p -143.18 146.02 33.33 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 114.432 -1.258 . . . . 1.59 110.363 177.085 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.56 -164.05 51.19 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 119.165 -1.493 . . . . 2.43 112.951 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.4 m -76.82 49.62 0.65 Allowed 'General case' 0 CA--C 1.553 1.072 0 N-CA-C 113.119 0.785 . . . . 4.11 113.119 -178.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 110.03 49.81 0.71 Allowed Glycine 0 N--CA 1.475 1.275 0 N-CA-C 115.466 0.947 . . . . 2.21 115.466 174.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.467 ' O ' ' SG ' ' A' ' 61' ' ' CYS . . . -152.3 120.73 1.1 Allowed Glycine 0 N--CA 1.475 1.259 0 C-N-CA 119.415 -1.374 . . . . 1.62 114.041 -179.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.94 ' HA ' ' O ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -83.81 152.76 24.44 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 118.83 1.315 . . . . 3.02 112.697 -177.251 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 20.3 t -65.32 103.1 0.75 Allowed 'General case' 0 N--CA 1.414 -2.234 0 N-CA-C 107.188 -1.412 . . . . 1.52 107.188 -179.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.769 ' HB3' ' HB ' ' A' ' 72' ' ' ILE . . . -80.14 -35.91 35.97 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-N 114.776 -1.102 . . . . 1.07 108.953 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.913 ' HB2' ' HB2' ' A' ' 28' ' ' CYS . . . -169.98 165.27 9.53 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.463 -0.94 . . . . 1.0 108.463 -179.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.747 ' HB3' ' O ' ' A' ' 30' ' ' ASP . . . -40.67 96.0 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.107 0 CA-C-O 122.33 1.062 . . . . 1.24 110.648 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.639 ' C ' HD13 ' A' ' 72' ' ' ILE . . . 93.75 11.51 57.86 Favored Glycine 0 N--CA 1.428 -1.855 0 CA-C-O 117.085 -1.953 . . . . 1.28 117.578 177.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.97 HG13 ' HB2' ' A' ' 34' ' ' CYS . 3.6 mm -109.53 104.15 16.61 Favored 'Isoleucine or valine' 0 C--N 1.361 1.084 0 CA-C-N 123.303 3.551 . . . . 2.27 108.247 178.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.853 ' HB2' ' HB3' ' A' ' 82' ' ' ASP . 6.3 t -89.01 92.53 9.26 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 109.21 -0.663 . . . . 1.98 109.21 -179.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 1.314 ' CB ' ' HA ' ' A' ' 79' ' ' CYS . 31.6 p -163.51 176.3 9.87 Favored 'General case' 0 C--O 1.225 -0.227 0 N-CA-C 115.329 1.603 . . . . 1.33 115.329 -177.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.941 ' HB2' ' HD2' ' A' ' 76' ' ' PRO . 73.2 p -109.33 -178.81 0.59 Allowed Pre-proline 0 N--CA 1.472 0.644 0 CA-C-N 114.051 -1.432 . . . . 1.99 110.414 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.941 ' HD2' ' HB2' ' A' ' 75' ' ' SER . 71.8 Cg_endo -76.23 30.56 0.39 Allowed 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 121.908 1.739 . . . . 1.86 112.606 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.564 ' HA ' ' OE1' ' B' ' 181' ' ' GLU . 4.8 t70 -140.65 -51.13 0.46 Allowed 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.053 -0.521 . . . . 2.65 109.787 179.049 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.894 ' O ' ' HB2' ' A' ' 74' ' ' CYS . . . -119.65 179.92 16.59 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-O 119.44 -0.644 . . . . 0.99 112.382 178.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 1.314 ' HA ' ' CB ' ' A' ' 74' ' ' CYS . 12.8 m -150.52 160.98 43.4 Favored 'General case' 0 C--N 1.348 0.521 0 N-CA-C 113.105 0.78 . . . . 1.34 113.105 179.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.692 ' HB2' ' O ' ' A' ' 73' ' ' CYS . 50.3 m80 -151.9 139.36 19.54 Favored 'General case' 0 C--N 1.353 0.735 0 C-N-CA 119.921 -0.712 . . . . 2.17 112.054 -178.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -65.55 120.11 12.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.043 -0.526 . . . . 3.05 109.965 178.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.853 ' HB3' ' HB2' ' A' ' 73' ' ' CYS . 0.0 OUTLIER -143.91 101.87 4.92 Favored Pre-proline 0 CA--C 1.537 0.459 0 CA-C-N 116.505 -0.316 . . . . 2.02 110.511 -179.219 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -65.79 -8.48 19.72 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 123.115 2.543 . . . . 1.93 113.831 -178.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.616 ' O ' ' HB2' ' A' ' 89' ' ' ALA . . . -67.89 -39.04 83.71 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.784 0.661 . . . . 1.53 112.784 -178.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.699 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 0.5 OUTLIER -94.87 -4.82 46.28 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 112.613 0.597 . . . . 1.88 112.613 -178.694 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.716 ' HB3' ' HD3' ' A' ' 87' ' ' PRO . 1.6 t70 -69.35 -60.69 3.84 Favored Pre-proline 0 N--CA 1.47 0.532 0 N-CA-C 112.636 0.606 . . . . 3.6 112.636 -177.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.716 ' HD3' ' HB3' ' A' ' 86' ' ' ASP . 59.0 Cg_endo -103.44 -158.38 0.03 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 123.575 2.85 . . . . 2.56 112.792 -178.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.452 ' C ' ' H ' ' A' ' 90' ' ' ALA . 10.8 pt-20 -60.85 86.61 0.01 OUTLIER 'General case' 0 N--CA 1.423 -1.81 0 CA-C-O 124.128 1.918 . . . . 4.72 110.648 178.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.616 ' HB2' ' O ' ' A' ' 84' ' ' ALA . . . -81.69 45.04 0.86 Allowed 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 109.407 -3.542 . . . . 5.29 105.308 175.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.452 ' H ' ' C ' ' A' ' 88' ' ' GLU . . . -84.14 125.79 32.49 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 113.68 -1.6 . . . . 6.98 113.163 -172.005 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -81.0 97.32 7.44 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 120.074 1.306 . . . . 10.21 111.894 -177.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 7.2 t . . . . . 0 C--O 1.25 1.108 0 CA-C-O 118.231 -0.89 . . . . 11.77 110.731 179.505 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 101' ' ' ALA . . . . . 0.415 ' C ' HD13 ' B' ' 103' ' ' LEU . . . . . . . . 0 N--CA 1.494 1.755 0 CA-C-O 120.467 0.175 . . . . 10.07 111.411 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 102' ' ' VAL . . . . . 0.479 ' O ' HG12 ' B' ' 102' ' ' VAL . 4.2 t 75.14 43.49 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 CA-C-O 121.863 0.839 . . . . 8.41 112.372 179.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 103' ' ' LEU . . . . . 0.841 ' H ' HD22 ' B' ' 103' ' ' LEU . 0.0 OUTLIER -115.11 111.94 21.81 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 105.029 -2.211 . . . . 5.87 105.029 172.878 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 104' ' ' ASP . . . . . 0.702 ' O ' ' HG3' ' B' ' 108' ' ' ARG . 35.0 m-20 -161.92 -172.99 3.48 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 113.67 -1.605 . . . . 6.27 108.12 179.141 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . 0.469 HD12 ' HA ' ' B' ' 105' ' ' LEU . 6.8 tp -87.81 6.44 35.26 Favored 'General case' 0 CA--C 1.511 -0.551 0 C-N-CA 114.547 -2.861 . . . . 7.2 110.153 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 106' ' ' ASP . . . . . 0.744 ' O ' ' HG3' ' B' ' 155' ' ' GLN . 0.6 OUTLIER -76.93 -76.42 0.17 Allowed 'General case' 0 CA--C 1.48 -1.735 0 N-CA-C 102.728 -3.064 . . . . 8.55 102.728 -179.199 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 107' ' ' VAL . . . . . 0.552 ' HA ' ' CB ' ' B' ' 155' ' ' GLN . 3.8 p -151.24 113.44 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.482 -1.667 0 N-CA-C 104.238 -2.504 . . . . 7.48 104.238 169.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 108' ' ' ARG . . . . . 0.898 ' HB2' ' H ' ' B' ' 155' ' ' GLN . 17.9 mtp180 -79.04 115.32 18.64 Favored 'General case' 0 CA--C 1.48 -1.746 0 N-CA-C 105.433 -2.062 . . . . 9.12 105.433 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 109' ' ' THR . . . . . 0.427 ' O ' HG23 ' B' ' 109' ' ' THR . 4.3 t -59.94 105.84 0.43 Allowed 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 115.097 -2.641 . . . . 5.69 108.006 -178.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 110' ' ' CYS . . . . . 0.588 ' HB3' ' HB3' ' B' ' 120' ' ' ARG . 0.1 OUTLIER -80.38 111.42 16.76 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 113.354 -1.748 . . . . 2.61 113.157 178.914 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 111' ' ' LEU . . . . . 0.604 ' O ' ' HA ' ' B' ' 120' ' ' ARG . 4.4 mm? 6.01 111.74 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.523 0 N-CA-C 113.027 0.751 . . . . 2.47 113.027 178.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 112' ' ' PRO . . . . . 0.599 ' HA ' ' O ' ' B' ' 119' ' ' GLY . 92.8 Cg_endo -80.18 122.63 4.76 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 123.071 2.514 . . . . 1.47 116.219 -178.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.59 ' O ' ' HA2' ' B' ' 117' ' ' GLY . 27.0 p -127.32 -176.16 3.66 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.043 -0.981 . . . . 1.0 111.264 179.122 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 114' ' ' GLY . . . . . 0.462 ' HA2' ' HG2' ' B' ' 140' ' ' GLU . . . 75.59 -161.38 52.6 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 120.484 -0.865 . . . . 1.16 112.43 -178.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 115' ' ' PRO . . . . . 1.045 ' HD2' HD11 ' B' ' 132' ' ' LEU . 38.7 Cg_endo -64.64 95.83 0.24 Allowed 'Trans proline' 0 N--CA 1.479 0.62 0 C-N-CA 123.624 2.882 . . . . 1.57 112.676 178.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 83.17 -2.94 86.15 Favored Glycine 0 C--N 1.29 -2.012 0 CA-C-N 114.13 -1.396 . . . . 1.7 112.781 178.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 117' ' ' GLY . . . . . 0.59 ' HA2' ' O ' ' B' ' 113' ' ' CYS . . . 84.79 35.84 12.59 Favored Glycine 0 N--CA 1.415 -2.754 0 C-N-CA 118.593 -1.765 . . . . 1.38 116.185 176.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 118' ' ' LYS . . . . . 0.423 ' H ' ' HG2' ' B' ' 118' ' ' LYS . 0.1 OUTLIER -74.91 -32.57 61.83 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 112.849 -1.675 . . . . 2.54 106.959 176.216 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 119' ' ' GLY . . . . . 0.599 ' O ' ' HA ' ' B' ' 112' ' ' PRO . . . -79.29 178.44 53.66 Favored Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 113.286 -1.779 . . . . 1.04 112.878 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.604 ' HA ' ' O ' ' B' ' 111' ' ' LEU . 0.0 OUTLIER -141.76 162.7 34.84 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.272 -0.27 . . . . 2.89 110.272 -179.766 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 121' ' ' CYS . . . . . . . . . . . . . 15.3 t -108.66 143.16 38.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.404 0.621 . . . . 1.07 112.305 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -127.47 -54.21 1.35 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.801 -1.09 . . . . 1.53 108.862 178.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -95.96 149.78 19.43 Favored Glycine 0 C--N 1.332 0.325 0 N-CA-C 110.194 -1.162 . . . . 0.9 110.194 177.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -50.29 -48.33 20.47 Favored 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 121.786 1.657 . . . . 1.51 112.804 -179.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 125' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -100.7 3.79 42.62 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.563 0.22 . . . . 1.25 111.339 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 126' ' ' ILE . . . . . 0.903 HG12 HG13 ' B' ' 136' ' ' VAL . 0.6 OUTLIER -119.73 122.8 69.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 113.359 0.874 . . . . 0.85 113.359 -177.968 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 127' ' ' CYS . . . . . 0.437 ' HB3' ' OE1' ' B' ' 140' ' ' GLU . 0.1 OUTLIER -125.14 124.47 41.89 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 109.733 -0.469 . . . . 0.89 109.733 178.689 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 128' ' ' CYS . . . . . 0.937 ' HB2' ' HB2' ' B' ' 169' ' ' ALA . 0.0 OUTLIER -130.45 142.95 50.48 Favored 'General case' 0 CA--C 1.551 1.006 0 N-CA-C 114.277 1.214 . . . . 1.23 114.277 -177.627 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 129' ' ' GLY . . . . . 0.741 ' O ' ' HB1' ' B' ' 169' ' ' ALA . . . -132.05 -173.34 13.3 Favored Glycine 0 C--N 1.359 1.838 0 N-CA-C 110.066 -1.214 . . . . 0.66 110.066 178.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 130' ' ' ASP . . . . . 0.75 ' O ' ' HB3' ' B' ' 170' ' ' ALA . 19.5 p-10 -63.73 -56.21 17.34 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 113.231 0.826 . . . . 2.35 113.231 -178.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 131' ' ' GLU . . . . . 0.42 ' HG2' ' OD2' ' B' ' 130' ' ' ASP . 0.0 OUTLIER -120.51 27.7 8.41 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.507 -0.745 . . . . 1.69 110.41 -179.806 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 132' ' ' LEU . . . . . 1.045 HD11 ' HD2' ' B' ' 115' ' ' PRO . 0.3 OUTLIER -122.46 -8.14 8.61 Favored 'General case' 0 N--CA 1.406 -2.672 0 N-CA-C 102.68 -3.081 . . . . 1.38 102.68 177.246 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 133' ' ' GLY . . . . . 0.888 ' O ' ' HB3' ' B' ' 128' ' ' CYS . . . 62.79 -94.15 0.11 Allowed Glycine 0 N--CA 1.426 -2.028 0 N-CA-C 118.973 2.349 . . . . 0.72 118.973 170.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 134' ' ' CYS . . . . . 0.988 ' HB2' HG13 ' B' ' 172' ' ' ILE . 6.1 t -170.02 106.85 0.34 Allowed 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 119.878 1.839 . . . . 1.08 109.453 176.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 135' ' ' PHE . . . . . 0.572 ' HB3' ' CG2' ' B' ' 138' ' ' THR . 3.6 m-30 -89.72 105.36 17.75 Favored 'General case' 0 N--CA 1.425 -1.683 0 N-CA-C 106.065 -1.828 . . . . 1.36 106.065 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 136' ' ' VAL . . . . . 0.903 HG13 HG12 ' B' ' 126' ' ' ILE . 1.7 t -94.64 89.12 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.197 0 CA-C-O 123.289 1.519 . . . . 0.75 108.561 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 137' ' ' GLY . . . . . 0.651 ' O ' ' HA3' ' A' ' 33' ' ' GLY . . . 93.94 98.83 1.57 Allowed Glycine 0 C--O 1.227 -0.309 0 CA-C-N 111.597 -2.547 . . . . 0.83 115.994 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 138' ' ' THR . . . . . 0.572 ' CG2' ' HB3' ' B' ' 135' ' ' PHE . 0.7 OUTLIER 177.0 170.55 0.52 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.651 0.262 . . . . 0.78 111.102 177.349 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 139' ' ' ALA . . . . . 0.8 ' HA ' HD12 ' B' ' 142' ' ' LEU . . . -58.81 -15.18 11.13 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 121.406 0.622 . . . . 1.04 110.654 178.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 140' ' ' GLU . . . . . 0.594 ' OE2' HD22 ' B' ' 132' ' ' LEU . 0.0 OUTLIER -72.65 -12.9 61.23 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.702 -1.135 . . . . 2.31 109.494 176.767 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 141' ' ' ALA . . . . . 0.406 ' O ' ' HB2' ' B' ' 144' ' ' CYS . . . -105.98 -22.72 12.82 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 115.169 -0.923 . . . . 0.87 111.643 -179.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 142' ' ' LEU . . . . . 0.8 HD12 ' HA ' ' B' ' 139' ' ' ALA . 3.6 mt -44.01 -39.28 4.01 Favored 'General case' 0 C--N 1.345 0.38 0 N-CA-C 113.176 0.806 . . . . 1.24 113.176 -178.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 143' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -58.17 -19.78 35.78 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.361 0.6 . . . . 2.93 109.769 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 144' ' ' CYS . . . . . 0.629 ' O ' ' N ' ' B' ' 147' ' ' GLU . 99.3 m -64.81 -45.77 84.83 Favored 'General case' 0 C--O 1.223 -0.3 0 N-CA-C 108.535 -0.913 . . . . 1.61 108.535 177.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 145' ' ' GLN . . . . . 0.451 ' HB2' ' O ' ' B' ' 142' ' ' LEU . 75.0 mm-40 -28.85 -37.75 0.01 OUTLIER 'General case' 0 CA--C 1.551 0.981 0 CA-C-N 113.668 -1.605 . . . . 3.35 113.05 -178.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -87.45 -3.1 59.01 Favored 'General case' 0 N--CA 1.477 0.905 0 O-C-N 121.253 -0.905 . . . . 3.76 111.5 -179.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . 0.629 ' N ' ' O ' ' B' ' 144' ' ' CYS . 1.1 tt0 -81.11 -0.26 39.28 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.433 -0.803 . . . . 4.01 109.54 178.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 148' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -64.2 -28.24 69.61 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.692 -0.484 . . . . 3.92 109.692 178.141 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -112.77 47.89 1.06 Allowed 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.151 -0.477 . . . . 5.73 111.116 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 6.0 mt -143.86 88.27 7.75 Favored Pre-proline 0 CA--C 1.533 0.311 0 CA-C-N 116.394 -0.366 . . . . 5.46 111.073 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 151' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -91.25 31.91 0.32 Allowed 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.702 2.268 . . . . 5.02 113.167 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -92.48 118.78 68.18 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.657 -0.247 . . . . 5.73 111.009 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 153' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -80.26 116.91 3.39 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.242 1.961 . . . . 5.1 113.126 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 154' ' ' CYS . . . . . 0.78 ' HA ' ' CD ' ' B' ' 108' ' ' ARG . 28.7 p -86.15 153.5 22.02 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 115.735 -0.666 . . . . 2.68 111.127 179.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 155' ' ' GLN . . . . . 0.898 ' H ' ' HB2' ' B' ' 108' ' ' ARG . 2.4 tt0 -12.45 -81.19 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 114.853 1.427 . . . . 5.63 114.853 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 156' ' ' SER . . . . . 0.6 ' HB2' ' O ' ' B' ' 155' ' ' GLN . 0.6 OUTLIER 86.79 -100.12 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.673 0.789 . . . . 3.11 111.417 -178.617 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 111.44 -63.81 0.27 Allowed Glycine 0 C--N 1.338 0.675 0 C-N-CA 120.509 -0.853 . . . . 2.07 113.202 179.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 158' ' ' GLN . . . . . 0.584 ' O ' ' HB3' ' B' ' 167' ' ' CYS . 8.5 mt-30 -115.8 108.09 15.88 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 107.887 -1.153 . . . . 4.34 107.887 178.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 159' ' ' LYS . . . . . 0.889 ' O ' ' HA ' ' B' ' 166' ' ' ARG . 3.6 mtmp? -90.72 -103.75 0.0 OUTLIER Pre-proline 0 C--N 1.3 -1.577 0 CA-C-O 118.753 -0.641 . . . . 3.54 110.341 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 160' ' ' PRO . . . . . 0.854 ' HD3' ' HB3' ' B' ' 159' ' ' LYS . 57.6 Cg_endo -71.64 138.07 31.38 Favored 'Trans proline' 0 C--N 1.353 0.803 0 CA-C-N 122.231 1.833 . . . . 1.51 115.088 -179.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 161' ' ' CYS . . . . . 0.491 ' O ' ' SG ' ' B' ' 173' ' ' CYS . 20.1 p -142.78 146.68 34.48 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 114.155 -1.384 . . . . 1.58 110.013 177.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 69.64 -164.99 50.7 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 119.352 -1.404 . . . . 2.37 112.666 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 1.6 m -76.74 51.31 0.75 Allowed 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 123.872 0.869 . . . . 4.07 112.493 179.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 107.92 49.19 0.85 Allowed Glycine 0 N--CA 1.466 0.648 0 N-CA-C 115.913 1.125 . . . . 2.2 115.913 172.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 165' ' ' GLY . . . . . 0.489 ' O ' ' N ' ' B' ' 161' ' ' CYS . . . -150.95 122.98 1.44 Allowed Glycine 0 N--CA 1.469 0.878 0 C-N-CA 119.525 -1.321 . . . . 1.62 113.607 179.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 166' ' ' ARG . . . . . 0.889 ' HA ' ' O ' ' B' ' 159' ' ' LYS . 0.0 OUTLIER -84.36 152.78 23.86 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 118.841 1.321 . . . . 3.05 112.528 -178.398 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 167' ' ' CYS . . . . . 0.584 ' HB3' ' O ' ' B' ' 158' ' ' GLN . 20.0 t -65.29 103.04 0.73 Allowed 'General case' 0 N--CA 1.416 -2.171 0 N-CA-C 107.175 -1.417 . . . . 1.56 107.175 -179.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 168' ' ' ALA . . . . . 0.762 ' HB3' ' HB ' ' B' ' 172' ' ' ILE . . . -80.42 -35.09 35.61 Favored 'General case' 0 N--CA 1.424 -1.771 0 CA-C-N 114.676 -1.147 . . . . 1.04 108.969 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 169' ' ' ALA . . . . . 0.937 ' HB2' ' HB2' ' B' ' 128' ' ' CYS . . . -170.57 165.26 8.39 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 108.326 -0.99 . . . . 0.98 108.326 -179.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 170' ' ' ALA . . . . . 0.75 ' HB3' ' O ' ' B' ' 130' ' ' ASP . . . -40.76 96.07 0.01 OUTLIER 'General case' 0 C--O 1.232 0.152 0 CA-C-O 122.239 1.018 . . . . 1.25 110.622 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 171' ' ' GLY . . . . . 0.66 ' C ' HD13 ' B' ' 172' ' ' ILE . . . 93.7 11.5 57.92 Favored Glycine 0 N--CA 1.427 -1.932 0 CA-C-O 116.883 -2.065 . . . . 1.29 117.557 177.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 172' ' ' ILE . . . . . 0.988 HG13 ' HB2' ' B' ' 134' ' ' CYS . 3.2 mm -109.59 104.35 16.93 Favored 'Isoleucine or valine' 0 C--N 1.365 1.262 0 CA-C-N 123.685 3.743 . . . . 2.27 108.124 178.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 173' ' ' CYS . . . . . 0.829 ' HB2' ' HB3' ' B' ' 182' ' ' ASP . 6.3 t -88.99 92.43 9.23 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 109.156 -0.683 . . . . 1.94 109.156 -179.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 174' ' ' CYS . . . . . 1.308 ' CB ' ' HA ' ' B' ' 179' ' ' CYS . 31.0 p -163.34 176.17 10.13 Favored 'General case' 0 C--O 1.226 -0.162 0 N-CA-C 115.458 1.651 . . . . 1.35 115.458 -177.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 175' ' ' SER . . . . . 0.944 ' HB2' ' HD2' ' B' ' 176' ' ' PRO . 73.7 p -109.31 -178.86 0.6 Allowed Pre-proline 0 N--CA 1.47 0.557 0 CA-C-N 114.187 -1.369 . . . . 2.0 110.441 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 176' ' ' PRO . . . . . 0.944 ' HD2' ' HB2' ' B' ' 175' ' ' SER . 71.6 Cg_endo -76.11 30.47 0.39 Allowed 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 121.913 1.742 . . . . 1.9 112.675 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 177' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -140.68 -51.16 0.46 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.086 -0.506 . . . . 2.72 109.769 179.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 178' ' ' GLY . . . . . 0.904 ' O ' ' HB2' ' B' ' 174' ' ' CYS . . . -119.65 179.99 16.59 Favored Glycine 0 N--CA 1.445 -0.759 0 CA-C-O 119.412 -0.66 . . . . 0.99 112.18 178.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 179' ' ' CYS . . . . . 1.308 ' HA ' ' CB ' ' B' ' 174' ' ' CYS . 12.5 m -150.47 161.1 43.18 Favored 'General case' 0 C--N 1.346 0.447 0 N-CA-C 113.165 0.802 . . . . 1.34 113.165 179.137 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 180' ' ' HIS . . . . . 0.698 ' HB2' ' O ' ' B' ' 173' ' ' CYS . 49.2 m80 -151.98 139.18 19.28 Favored 'General case' 0 C--N 1.354 0.775 0 C-N-CA 119.786 -0.765 . . . . 2.1 111.998 -178.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 181' ' ' GLU . . . . . 0.564 ' OE1' ' HA ' ' A' ' 77' ' ' ASP . 27.8 mt-10 -65.43 120.05 12.12 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 116.028 -0.533 . . . . 3.06 110.072 178.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 182' ' ' ASP . . . . . 0.829 ' HB3' ' HB2' ' B' ' 173' ' ' CYS . 0.0 OUTLIER -143.81 101.86 4.96 Favored Pre-proline 0 CA--C 1.536 0.413 0 CA-C-N 116.612 -0.267 . . . . 2.06 110.535 -179.187 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 183' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -65.88 -8.37 19.54 Favored 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 123.214 2.609 . . . . 1.91 113.859 -178.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 184' ' ' ALA . . . . . 0.615 ' O ' ' HB2' ' B' ' 189' ' ' ALA . . . -67.97 -39.11 83.4 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.78 0.659 . . . . 1.56 112.78 -179.079 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 185' ' ' CYS . . . . . 0.704 ' O ' ' HA ' ' B' ' 170' ' ' ALA . 0.6 OUTLIER -94.78 -4.73 46.74 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.592 0.59 . . . . 1.94 112.592 -178.744 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 186' ' ' ASP . . . . . 0.715 ' HB3' ' HD3' ' B' ' 187' ' ' PRO . 1.6 t70 -69.32 -60.69 3.86 Favored Pre-proline 0 N--CA 1.47 0.565 0 N-CA-C 112.659 0.614 . . . . 3.61 112.659 -177.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 187' ' ' PRO . . . . . 0.715 ' HD3' ' HB3' ' B' ' 186' ' ' ASP . 58.3 Cg_endo -103.34 -158.62 0.03 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.201 0 C-N-CA 123.518 2.812 . . . . 2.58 112.747 -178.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 188' ' ' GLU . . . . . 0.427 ' C ' ' H ' ' B' ' 190' ' ' ALA . 11.2 pt-20 -60.54 88.23 0.02 OUTLIER 'General case' 0 N--CA 1.422 -1.832 0 CA-C-O 124.493 2.092 . . . . 4.7 109.834 177.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 189' ' ' ALA . . . . . 0.615 ' HB2' ' O ' ' B' ' 184' ' ' ALA . . . -83.01 45.18 0.99 Allowed 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 108.751 -3.84 . . . . 5.24 105.109 174.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 190' ' ' ALA . . . . . 0.427 ' H ' ' C ' ' B' ' 188' ' ' GLU . . . -84.19 127.24 33.81 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 113.781 -1.554 . . . . 6.93 112.983 -171.05 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 191' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -81.45 97.76 7.92 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 121.222 1.828 . . . . 10.14 111.957 -178.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 7.2 t . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.353 -0.832 . . . . 11.7 110.819 179.535 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.284 0 CA-C-O 121.299 0.571 . . . . 9.95 111.616 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.1 t -134.09 55.26 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.135 0 CA-C-N 115.222 -0.899 . . . . 8.02 112.02 178.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.999 HD22 ' H ' ' A' ' 54' ' ' CYS . 0.2 OUTLIER -149.05 18.59 0.98 Allowed 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 116.374 1.99 . . . . 5.86 116.374 175.576 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.66 ' O ' ' HB2' ' A' ' 55' ' ' GLN . 2.4 t70 -39.28 -99.0 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 112.731 0.641 . . . . 6.22 112.731 -177.439 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 1.105 HD13 ' HG3' ' A' ' 55' ' ' GLN . 19.8 tp -148.51 23.06 1.02 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 117.286 -1.765 . . . . 7.09 114.073 -178.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.39 -83.59 0.1 Allowed 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 104.72 -2.326 . . . . 8.78 104.72 176.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.423 ' O ' HG13 ' A' ' 7' ' ' VAL . 9.1 p -128.98 118.56 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.706 0 N-CA-C 102.778 -3.045 . . . . 7.51 102.778 174.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.937 ' HD3' ' H ' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -77.69 109.34 11.6 Favored 'General case' 0 N--CA 1.417 -2.123 0 N-CA-C 108.368 -0.975 . . . . 9.08 108.368 -177.439 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.9 m -75.53 93.33 2.99 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 116.134 -2.226 . . . . 5.66 105.564 177.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.858 ' HB3' ' CG ' ' A' ' 20' ' ' ARG . 61.1 m -81.75 112.84 19.28 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 113.094 -1.866 . . . . 2.68 113.682 -178.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.662 HD23 ' HB2' ' A' ' 21' ' ' CYS . 16.3 tp -35.08 111.8 0.44 Allowed Pre-proline 0 N--CA 1.489 1.516 0 C-N-CA 123.223 0.609 . . . . 2.48 112.625 177.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.908 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 44.9 Cg_endo -86.99 144.21 7.12 Favored 'Trans proline' 0 C--N 1.357 1.012 0 C-N-CA 122.971 2.447 . . . . 1.49 116.992 -177.295 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.555 ' N ' ' O ' ' A' ' 19' ' ' GLY . 27.3 p -149.1 -170.24 3.58 Favored 'General case' 0 C--N 1.355 0.81 0 CA-C-N 115.961 -0.563 . . . . 1.0 109.79 178.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.832 ' CA ' ' HG2' ' A' ' 40' ' ' GLU . . . 75.45 -161.27 52.71 Favored Glycine 0 C--N 1.335 0.51 0 N-CA-C 115.256 0.862 . . . . 1.15 115.256 176.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.46 ' HG2' ' O ' ' A' ' 15' ' ' PRO . 38.0 Cg_endo -64.5 102.54 0.41 Allowed 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 124.027 3.151 . . . . 1.57 111.502 178.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 86.1 -0.98 87.72 Favored Glycine 0 C--N 1.265 -3.385 0 CA-C-N 112.028 -2.351 . . . . 1.68 112.761 -179.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.817 ' O ' ' HB2' ' A' ' 12' ' ' PRO . . . 72.43 43.03 46.9 Favored Glycine 0 N--CA 1.405 -3.385 0 C-N-CA 118.988 -1.577 . . . . 1.36 114.49 173.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.92 -41.13 9.33 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 114.29 -0.955 . . . . 2.5 110.416 177.367 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.908 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -71.38 169.02 50.3 Favored Glycine 0 C--O 1.194 -2.351 0 N-CA-C 116.272 1.269 . . . . 1.02 116.272 -174.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.858 ' CG ' ' HB3' ' A' ' 10' ' ' CYS . 4.2 mpp_? -104.14 160.83 14.53 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 112.747 -1.727 . . . . 2.92 114.926 -172.325 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.662 ' HB2' HD23 ' A' ' 11' ' ' LEU . 5.1 m -106.91 136.94 45.91 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 114.794 -1.093 . . . . 1.1 111.597 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -145.69 24.43 1.37 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.32 -0.855 . . . . 1.51 110.137 179.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 152.28 161.52 10.26 Favored Glycine 0 CA--C 1.521 0.422 0 N-CA-C 111.164 -0.775 . . . . 0.9 111.164 -179.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.661 ' HD2' ' OE2' ' B' ' 181' ' ' GLU . 31.8 Cg_exo -58.7 -64.01 0.12 Allowed 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 121.703 1.602 . . . . 1.5 112.335 -179.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.456 ' O ' ' N ' ' A' ' 37' ' ' GLY . 3.3 m -90.47 39.5 0.98 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.704 0.288 . . . . 1.26 110.289 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.971 HG12 HG13 ' A' ' 36' ' ' VAL . 3.0 mt -155.28 121.19 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 O-C-N 122.114 -0.366 . . . . 0.83 111.612 -179.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -137.86 110.16 7.38 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 120.877 0.37 . . . . 0.92 110.714 179.282 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.811 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -116.5 155.34 28.81 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 113.46 0.911 . . . . 1.28 113.46 179.025 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.516 ' O ' ' HB2' ' A' ' 69' ' ' ALA . . . -149.67 -174.61 21.19 Favored Glycine 0 C--N 1.371 2.494 0 N-CA-C 108.259 -1.936 . . . . 0.67 108.259 177.033 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -67.8 -41.73 82.68 Favored 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 125.892 1.677 . . . . 2.27 115.328 -179.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -122.83 13.23 9.89 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 114.209 -1.359 . . . . 1.66 111.424 178.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.688 HD23 ' CE1' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -120.25 -7.2 9.83 Favored 'General case' 0 N--CA 1.393 -3.323 0 N-CA-C 108.541 -0.911 . . . . 1.37 108.541 -178.383 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.972 ' HA2' ' CB ' ' A' ' 69' ' ' ALA . . . 49.83 -135.71 25.02 Favored Glycine 0 C--O 1.198 -2.103 0 CA-C-O 116.504 -2.276 . . . . 0.73 109.561 179.372 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 1.082 ' HB2' HD13 ' A' ' 72' ' ' ILE . 0.7 OUTLIER -128.71 130.46 47.18 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 121.495 2.648 . . . . 1.08 111.674 -179.842 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.688 ' CE1' HD23 ' A' ' 32' ' ' LEU . 1.3 m-85 -104.12 101.76 11.5 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 102.139 -3.282 . . . . 1.38 102.139 173.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.971 HG13 HG12 ' A' ' 26' ' ' ILE . 2.5 t -92.72 93.97 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.312 0 CA-C-O 123.694 1.711 . . . . 0.76 110.066 -177.113 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.779 ' HA3' ' CG2' ' B' ' 172' ' ' ILE . . . 83.18 80.37 1.0 Allowed Glycine 0 C--N 1.319 -0.379 0 CA-C-N 111.826 -2.443 . . . . 0.81 113.257 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.616 HG21 ' CE1' ' B' ' 135' ' ' PHE . 70.7 p -160.76 -167.31 1.82 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.11 0.481 . . . . 0.77 110.361 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.762 ' HA ' HD12 ' A' ' 42' ' ' LEU . . . -62.14 -40.5 96.15 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 108.817 -0.809 . . . . 1.02 108.817 179.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.832 ' HG2' ' CA ' ' A' ' 14' ' ' GLY . 0.4 OUTLIER -55.9 -26.4 47.21 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 114.986 -1.006 . . . . 2.32 112.38 179.655 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.493 ' O ' ' N ' ' A' ' 44' ' ' CYS . . . -91.63 -35.37 14.26 Favored 'General case' 0 C--O 1.213 -0.845 0 CA-C-N 116.197 -0.456 . . . . 0.87 110.268 -179.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.762 HD12 ' HA ' ' A' ' 39' ' ' ALA . 7.9 mt -39.57 -54.31 2.0 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 114.866 1.432 . . . . 1.23 114.866 -175.483 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.564 ' HD2' ' H ' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -54.75 -23.6 18.61 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 119.982 -0.687 . . . . 2.92 109.763 178.171 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.493 ' N ' ' O ' ' A' ' 41' ' ' ALA . 4.9 t -69.43 17.77 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 112.823 0.675 . . . . 1.57 112.823 -177.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.515 ' H ' ' C ' ' A' ' 43' ' ' ARG . 1.3 tt0 -75.22 -28.84 60.08 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 114.312 -1.313 . . . . 3.31 107.99 176.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -82.33 9.95 7.96 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.224 -0.898 . . . . 3.69 110.837 179.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.464 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . 0.9 OUTLIER -81.43 -0.91 43.68 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 109.745 -0.465 . . . . 3.99 109.745 177.584 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.875 HD22 ' H ' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -76.83 -27.53 55.19 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.401 -0.363 . . . . 3.86 110.118 178.525 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -108.9 15.31 23.57 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.431 -0.349 . . . . 5.68 111.823 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.12 90.22 7.49 Favored Pre-proline 0 CA--C 1.533 0.294 0 N-CA-C 111.584 0.216 . . . . 5.4 111.584 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -91.67 50.47 0.67 Allowed 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 122.804 2.336 . . . . 4.92 112.493 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.83 119.16 73.86 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 116.184 -0.462 . . . . 5.64 111.796 -179.443 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.965 ' HG2' HD13 ' A' ' 3' ' ' LEU . 84.4 Cg_endo -79.48 -48.25 0.08 OUTLIER 'Trans proline' 0 C--N 1.355 0.92 0 C-N-CA 122.248 1.965 . . . . 5.04 113.197 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.999 ' H ' HD22 ' A' ' 3' ' ' LEU . 5.3 p 55.29 125.22 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.781 0.833 . . . . 2.74 112.295 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 1.105 ' HG3' HD13 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -61.62 92.45 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 120.156 -0.617 . . . . 5.75 112.021 -179.533 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.689 ' HB2' ' HG3' ' A' ' 8' ' ' ARG . 0.1 OUTLIER 167.24 131.93 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 122.976 0.511 . . . . 3.12 110.548 179.039 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.632 ' O ' ' HG3' ' A' ' 66' ' ' ARG . . . 99.18 32.14 5.93 Favored Glycine 0 C--N 1.345 1.033 0 C-N-CA 120.566 -0.826 . . . . 2.1 112.348 177.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -122.04 76.09 1.27 Allowed 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 121.908 0.861 . . . . 4.36 111.173 179.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.836 ' HB2' ' HB2' ' A' ' 67' ' ' CYS . 1.6 mmtp -133.41 69.59 77.16 Favored Pre-proline 0 C--N 1.313 -1.01 0 N-CA-C 106.734 -1.58 . . . . 3.55 106.734 178.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.704 ' HA ' ' O ' ' A' ' 65' ' ' GLY . 14.4 Cg_endo -56.9 82.38 0.04 OUTLIER 'Trans proline' 0 C--N 1.368 1.582 0 C-N-CA 123.901 3.068 . . . . 1.54 117.754 -176.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -101.8 -178.35 3.69 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 106.181 -1.785 . . . . 1.59 106.181 173.164 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.09 -167.15 53.14 Favored Glycine 0 C--N 1.339 0.734 0 C-N-CA 119.205 -1.474 . . . . 2.43 112.372 -179.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.6 p -83.04 41.79 0.77 Allowed 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 120.818 -0.353 . . . . 4.11 110.412 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 117.12 9.68 10.41 Favored Glycine 0 CA--C 1.538 1.492 0 CA-C-O 117.124 -1.931 . . . . 2.21 116.204 179.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.704 ' O ' ' HA ' ' A' ' 60' ' ' PRO . . . -102.64 156.3 18.31 Favored Glycine 0 C--N 1.345 1.081 0 CA-C-N 121.767 2.783 . . . . 1.62 113.554 179.147 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.632 ' HG3' ' O ' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -99.21 151.86 20.54 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 111.849 0.314 . . . . 3.02 111.849 179.415 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.836 ' HB2' ' HB2' ' A' ' 59' ' ' LYS . 1.3 m -71.59 106.85 4.18 Favored 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 109.557 -0.534 . . . . 1.52 109.557 178.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.557 ' HB1' ' HB2' ' A' ' 28' ' ' CYS . . . -89.03 -22.04 23.17 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 107.935 -1.135 . . . . 1.07 107.935 177.088 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.972 ' CB ' ' HA2' ' A' ' 33' ' ' GLY . . . -161.7 162.37 29.75 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 112.342 -2.208 . . . . 1.0 113.937 -175.073 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.648 ' HA ' ' O ' ' A' ' 85' ' ' CYS . . . -58.63 122.99 14.81 Favored 'General case' 0 CA--C 1.527 0.092 0 N-CA-C 113.05 0.759 . . . . 1.24 113.05 -178.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.686 ' HA2' ' O ' ' A' ' 82' ' ' ASP . . . 71.33 15.96 75.18 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-N 115.671 -0.695 . . . . 1.28 114.189 178.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 1.082 HD13 ' HB2' ' A' ' 34' ' ' CYS . 1.2 pp -141.73 98.29 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-N 113.932 -1.134 . . . . 2.27 112.733 -178.489 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.562 ' HB2' ' HB3' ' A' ' 82' ' ' ASP . 5.0 t -99.57 85.41 3.13 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 114.021 -1.445 . . . . 1.98 110.224 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 1.049 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 1.8 m -93.88 146.06 24.17 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.258 -0.428 . . . . 1.33 111.169 -179.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.906 ' HB2' ' HD2' ' A' ' 76' ' ' PRO . 53.9 p -109.56 -179.62 0.7 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.84 -0.618 . . . . 1.99 110.029 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.906 ' HD2' ' HB2' ' A' ' 75' ' ' SER . 77.1 Cg_endo -77.67 29.42 0.44 Allowed 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 121.695 1.596 . . . . 1.86 111.436 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.447 ' H ' ' C ' ' A' ' 75' ' ' SER . 0.6 OUTLIER -144.66 -29.44 0.47 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.218 -0.901 . . . . 2.65 110.113 179.41 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.515 ' O ' ' HB3' ' A' ' 74' ' ' CYS . . . -166.91 -145.89 4.65 Favored Glycine 0 CA--C 1.524 0.615 0 CA-C-N 115.977 -0.556 . . . . 0.99 112.603 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 1.049 ' HA ' ' HA ' ' A' ' 74' ' ' CYS . 11.9 t -146.62 159.16 43.8 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 109.808 -0.441 . . . . 1.34 109.808 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 55.3 m-70 -149.67 135.16 18.37 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 120.04 -0.664 . . . . 2.17 110.358 -176.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.701 ' HG3' HD11 ' B' ' 126' ' ' ILE . 2.6 mt-10 -60.79 132.13 52.9 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 109.712 -0.477 . . . . 3.05 109.712 179.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.686 ' O ' ' HA2' ' A' ' 71' ' ' GLY . 0.1 OUTLIER -140.01 112.8 7.52 Favored Pre-proline 0 CA--C 1.545 0.788 0 CA-C-N 116.355 -0.384 . . . . 2.02 110.755 -178.557 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 82' ' ' ASP . 13.9 Cg_exo -70.87 -21.11 28.75 Favored 'Trans proline' 0 C--N 1.359 1.09 0 C-N-CA 122.831 2.354 . . . . 1.93 113.862 -178.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.83 -39.75 94.97 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.718 0.294 . . . . 1.53 111.485 -179.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.648 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 68.4 m -97.95 -0.54 44.64 Favored 'General case' 0 C--O 1.215 -0.739 0 N-CA-C 112.681 0.623 . . . . 1.88 112.681 -179.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.554 ' HA ' ' N ' ' A' ' 71' ' ' GLY . 0.8 OUTLIER -66.48 -56.3 15.95 Favored Pre-proline 0 C--N 1.319 -0.719 0 N-CA-C 112.82 0.674 . . . . 3.6 112.82 -176.58 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.515 ' HD3' ' CB ' ' A' ' 86' ' ' ASP . 10.3 Cg_endo -92.79 -162.69 0.1 Allowed 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 122.874 2.383 . . . . 2.56 113.072 -179.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.505 ' C ' ' H ' ' A' ' 90' ' ' ALA . 0.0 OUTLIER -83.97 50.84 1.91 Allowed 'General case' 0 C--N 1.286 -2.181 0 CA-C-N 110.882 -2.872 . . . . 4.72 107.621 172.967 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -76.19 33.15 0.12 Allowed 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.264 0.554 . . . . 5.29 109.603 176.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.505 ' H ' ' C ' ' A' ' 88' ' ' GLU . . . -53.62 111.5 0.74 Allowed 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.278 -0.874 . . . . 6.98 113.204 -176.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -86.99 128.06 35.08 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 115.383 -0.826 . . . . 10.21 111.406 -179.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 10.8 m . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.184 -0.912 . . . . 11.77 111.316 179.507 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 101' ' ' ALA . . . . . 0.616 ' O ' HG12 ' B' ' 102' ' ' VAL . . . . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.661 0.267 . . . . 10.07 111.183 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 102' ' ' VAL . . . . . 0.924 HG22 ' H ' ' B' ' 103' ' ' LEU . 9.7 p 52.25 -153.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-N 115.441 -0.799 . . . . 8.41 109.911 -178.396 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 103' ' ' LEU . . . . . 0.924 ' H ' HG22 ' B' ' 102' ' ' VAL . 3.1 mm? -59.73 94.74 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 O-C-N 122.111 -0.368 . . . . 5.87 110.971 -179.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 104' ' ' ASP . . . . . 0.592 ' O ' ' HB2' ' B' ' 155' ' ' GLN . 0.6 OUTLIER -73.46 -93.69 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 107.293 -1.373 . . . . 6.27 107.293 176.398 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . 0.954 HD13 HE21 ' B' ' 155' ' ' GLN . 17.2 tp -149.4 28.98 0.79 Allowed 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 116.546 -2.062 . . . . 7.2 114.691 -179.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 106' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -81.25 -108.67 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 104.046 -2.575 . . . . 8.55 104.046 177.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 107' ' ' VAL . . . . . 0.417 ' O ' HG13 ' B' ' 107' ' ' VAL . 8.2 p -106.86 120.34 57.96 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.91 0 N-CA-C 101.991 -3.337 . . . . 7.48 101.991 171.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 108' ' ' ARG . . . . . 0.92 ' HD3' ' H ' ' B' ' 108' ' ' ARG . 0.0 OUTLIER -77.75 108.66 11.14 Favored 'General case' 0 N--CA 1.411 -2.381 0 N-CA-C 108.494 -0.928 . . . . 9.12 108.494 -178.368 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 109' ' ' THR . . . . . 0.644 ' H ' ' CD1' ' B' ' 103' ' ' LEU . 4.8 m -74.77 93.67 2.64 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 116.163 -2.215 . . . . 5.69 105.606 177.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 110' ' ' CYS . . . . . 0.842 ' HB3' ' CG ' ' B' ' 120' ' ' ARG . 59.3 m -82.47 111.57 18.61 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 113.102 -1.863 . . . . 2.61 113.806 -178.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 111' ' ' LEU . . . . . 0.668 ' O ' ' HA ' ' B' ' 120' ' ' ARG . 16.5 tp -34.3 111.58 0.4 Allowed Pre-proline 0 N--CA 1.491 1.579 0 C-N-CA 123.162 0.585 . . . . 2.47 112.553 178.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 112' ' ' PRO . . . . . 0.922 ' HA ' ' O ' ' B' ' 119' ' ' GLY . 68.5 Cg_endo -83.12 147.88 13.13 Favored 'Trans proline' 0 C--N 1.359 1.101 0 C-N-CA 122.811 2.341 . . . . 1.47 115.442 -177.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.513 ' C ' ' HA2' ' B' ' 117' ' ' GLY . 28.0 p -152.06 -170.43 3.64 Favored 'General case' 0 C--O 1.254 1.31 0 CA-C-N 115.378 -0.828 . . . . 1.0 110.081 174.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 114' ' ' GLY . . . . . 0.81 ' CA ' ' HG2' ' B' ' 140' ' ' GLU . . . 75.79 -160.34 51.62 Favored Glycine 0 C--N 1.343 0.969 0 CA-C-N 114.712 -1.131 . . . . 1.16 115.094 176.143 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 115' ' ' PRO . . . . . 0.48 ' HG2' ' O ' ' B' ' 115' ' ' PRO . 35.5 Cg_endo -64.6 106.46 0.74 Allowed 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 124.067 3.178 . . . . 1.57 110.56 178.157 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 87.03 -11.88 63.7 Favored Glycine 0 C--N 1.257 -3.848 0 CA-C-N 112.211 -2.268 . . . . 1.7 111.174 -179.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 117' ' ' GLY . . . . . 0.755 ' O ' ' HB2' ' B' ' 112' ' ' PRO . . . 72.53 52.84 9.37 Favored Glycine 0 N--CA 1.399 -3.791 0 C-N-CA 119.596 -1.288 . . . . 1.38 113.488 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.05 -53.82 3.82 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 104.722 -2.325 . . . . 2.54 104.722 173.084 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 119' ' ' GLY . . . . . 0.922 ' O ' ' HA ' ' B' ' 112' ' ' PRO . . . -58.64 176.3 2.31 Favored Glycine 0 C--O 1.206 -1.643 0 CA-C-N 114.007 -1.451 . . . . 1.04 115.111 -167.279 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.842 ' CG ' ' HB3' ' B' ' 110' ' ' CYS . 4.7 mpp_? -113.83 163.68 14.74 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 114.081 1.141 . . . . 2.89 114.081 -173.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 121' ' ' CYS . . . . . 0.658 ' HB2' HD23 ' B' ' 111' ' ' LEU . 6.8 m -106.86 137.23 45.3 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.521 -1.218 . . . . 1.07 112.034 -179.059 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -145.68 24.35 1.37 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.186 -0.915 . . . . 1.53 110.171 179.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 152.29 161.52 10.26 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 111.196 -0.762 . . . . 0.9 111.196 -179.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . 0.635 ' HD2' ' OE2' ' A' ' 81' ' ' GLU . 32.0 Cg_exo -58.59 -64.11 0.12 Allowed 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 121.749 1.633 . . . . 1.51 112.286 -179.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 125' ' ' SER . . . . . 0.455 ' O ' ' N ' ' B' ' 137' ' ' GLY . 3.2 m -90.58 39.62 0.98 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.665 0.269 . . . . 1.25 110.33 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 126' ' ' ILE . . . . . 1.006 HG12 HG13 ' B' ' 136' ' ' VAL . 3.3 mt -155.07 121.11 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 O-C-N 122.242 -0.286 . . . . 0.85 111.707 -179.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 127' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -138.06 110.02 7.23 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.054 0.454 . . . . 0.89 110.755 179.107 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 128' ' ' CYS . . . . . 0.806 ' HA ' ' O ' ' B' ' 133' ' ' GLY . 0.0 OUTLIER -112.51 157.59 20.95 Favored 'General case' 0 CA--C 1.562 1.417 0 C-N-CA 123.836 0.854 . . . . 1.23 112.647 178.764 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 129' ' ' GLY . . . . . 0.502 ' O ' ' HB2' ' B' ' 169' ' ' ALA . . . -152.56 -175.48 24.15 Favored Glycine 0 C--N 1.38 2.985 0 N-CA-C 109.512 -1.435 . . . . 0.66 109.512 176.047 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -68.28 -45.79 72.12 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.871 1.268 . . . . 2.35 113.068 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.15 25.22 7.9 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-N 114.286 -1.325 . . . . 1.69 110.756 179.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 132' ' ' LEU . . . . . 0.688 HD23 ' CE1' ' B' ' 135' ' ' PHE . 0.2 OUTLIER -126.74 -10.81 6.13 Favored 'General case' 0 N--CA 1.401 -2.919 0 CA-C-N 113.427 -1.715 . . . . 1.38 109.573 179.643 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 133' ' ' GLY . . . . . 0.93 ' HA2' ' CB ' ' B' ' 169' ' ' ALA . . . 53.97 -125.06 32.04 Favored Glycine 0 N--CA 1.414 -2.828 0 CA-C-O 116.212 -2.438 . . . . 0.72 112.29 177.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 134' ' ' CYS . . . . . 1.091 ' HB2' HD13 ' B' ' 172' ' ' ILE . 0.8 OUTLIER -141.09 125.9 18.06 Favored 'General case' 0 CA--C 1.496 -1.099 0 CA-C-N 121.693 2.746 . . . . 1.08 112.261 176.211 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 135' ' ' PHE . . . . . 0.688 ' CE1' HD23 ' B' ' 132' ' ' LEU . 1.2 m-85 -101.13 101.93 12.77 Favored 'General case' 0 N--CA 1.425 -1.724 0 N-CA-C 102.266 -3.235 . . . . 1.36 102.266 175.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 136' ' ' VAL . . . . . 1.006 HG13 HG12 ' B' ' 126' ' ' ILE . 3.1 t -92.53 91.92 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.345 0 CA-C-O 123.317 1.532 . . . . 0.75 110.28 -177.014 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 137' ' ' GLY . . . . . 0.95 ' HA3' HG21 ' A' ' 72' ' ' ILE . . . 85.48 79.88 1.14 Allowed Glycine 0 CA--C 1.507 -0.44 0 CA-C-N 111.941 -2.39 . . . . 0.83 112.998 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 138' ' ' THR . . . . . 0.639 HG22 ' O ' ' A' ' 32' ' ' LEU . 76.4 p -155.96 -159.96 0.96 Allowed 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.427 0.632 . . . . 0.78 111.582 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 139' ' ' ALA . . . . . 0.725 ' HA ' HD12 ' B' ' 142' ' ' LEU . . . -68.67 -41.39 79.35 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.459 -1.246 . . . . 1.04 108.353 176.071 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 140' ' ' GLU . . . . . 0.81 ' HG2' ' CA ' ' B' ' 114' ' ' GLY . 0.3 OUTLIER -54.1 -30.24 47.82 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.093 -1.412 . . . . 2.31 112.248 179.081 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 141' ' ' ALA . . . . . 0.479 ' O ' ' N ' ' B' ' 144' ' ' CYS . . . -88.85 -35.71 16.41 Favored 'General case' 0 C--O 1.207 -1.178 0 N-CA-C 110.3 -0.259 . . . . 0.87 110.3 -178.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 142' ' ' LEU . . . . . 0.725 HD12 ' HA ' ' B' ' 139' ' ' ALA . 6.2 mt -39.04 -54.75 1.67 Allowed 'General case' 0 C--O 1.24 0.566 0 N-CA-C 113.832 1.049 . . . . 1.24 113.832 -173.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 143' ' ' ARG . . . . . 0.562 ' HD2' ' H ' ' B' ' 143' ' ' ARG . 0.0 OUTLIER -55.59 -22.09 20.46 Favored 'General case' 0 CA--C 1.497 -1.094 0 C-N-CA 120.037 -0.665 . . . . 2.93 109.851 177.81 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 144' ' ' CYS . . . . . 0.49 ' SG ' ' HB2' ' B' ' 147' ' ' GLU . 6.7 t -75.46 29.64 0.1 Allowed 'General case' 0 CA--C 1.497 -1.064 0 C-N-CA 119.763 -0.775 . . . . 1.61 111.529 -178.335 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -84.71 -22.37 29.76 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 106.516 -1.661 . . . . 3.35 106.516 175.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -82.07 9.35 8.65 Favored 'General case' 0 C--N 1.343 0.283 0 CA-C-N 115.314 -0.857 . . . . 3.76 110.106 178.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . 0.49 ' HB2' ' SG ' ' B' ' 144' ' ' CYS . 0.9 OUTLIER -81.4 -0.71 42.68 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.771 -0.455 . . . . 4.01 109.771 177.537 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 148' ' ' ASN . . . . . 0.816 HD22 ' H ' ' B' ' 148' ' ' ASN . 0.0 OUTLIER -77.02 -27.53 54.6 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 116.389 -0.369 . . . . 3.92 110.085 178.556 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -108.94 15.25 23.58 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.403 -0.362 . . . . 5.73 111.789 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.1 90.19 7.51 Favored Pre-proline 0 CA--C 1.533 0.307 0 N-CA-C 111.563 0.209 . . . . 5.46 111.563 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 151' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -91.64 50.52 0.68 Allowed 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 122.742 2.295 . . . . 5.02 112.489 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.82 119.16 73.88 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 116.145 -0.48 . . . . 5.73 111.8 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 153' ' ' PRO . . . . . 0.64 ' HG3' HG11 ' B' ' 102' ' ' VAL . 90.3 Cg_endo -79.48 -48.18 0.08 OUTLIER 'Trans proline' 0 C--N 1.356 0.925 0 C-N-CA 122.303 2.002 . . . . 5.1 113.174 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 154' ' ' CYS . . . . . 0.867 ' HA ' ' CB ' ' B' ' 103' ' ' LEU . 5.4 p 55.27 123.6 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.702 0.801 . . . . 2.68 112.596 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 155' ' ' GLN . . . . . 0.954 HE21 HD13 ' B' ' 105' ' ' LEU . 0.0 OUTLIER -59.46 92.04 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 119.623 -0.831 . . . . 5.63 112.376 -179.678 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 156' ' ' SER . . . . . 0.699 ' HB2' ' HG3' ' B' ' 108' ' ' ARG . 0.2 OUTLIER 165.36 125.77 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 112.116 0.414 . . . . 3.11 112.116 178.903 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 157' ' ' GLY . . . . . 0.614 ' O ' ' HG3' ' B' ' 166' ' ' ARG . . . 105.13 33.0 3.84 Favored Glycine 0 CA--C 1.505 -0.593 0 C-N-CA 120.611 -0.804 . . . . 2.07 112.479 179.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -122.15 67.42 0.93 Allowed 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 121.655 0.74 . . . . 4.34 111.858 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 159' ' ' LYS . . . . . 0.965 ' HB2' ' HB2' ' B' ' 167' ' ' CYS . 2.0 mmtp -115.71 67.54 2.83 Favored Pre-proline 0 CA--C 1.539 0.529 0 CA-C-N 114.654 -1.157 . . . . 3.54 109.33 174.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 160' ' ' PRO . . . . . 0.658 ' HA ' ' O ' ' B' ' 165' ' ' GLY . 12.5 Cg_endo -56.33 82.92 0.04 OUTLIER 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 122.942 2.428 . . . . 1.51 118.14 -174.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 161' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -98.1 -171.53 2.17 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 106.347 -1.723 . . . . 1.58 106.347 173.443 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 65.35 -166.02 34.7 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 119.319 -1.42 . . . . 2.37 112.803 177.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 3.9 p -84.46 39.65 0.74 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.758 0.789 . . . . 4.07 110.313 -179.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 121.2 5.03 9.8 Favored Glycine 0 CA--C 1.535 1.284 0 CA-C-O 117.793 -1.559 . . . . 2.2 116.513 178.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 165' ' ' GLY . . . . . 0.658 ' O ' ' HA ' ' B' ' 160' ' ' PRO . . . -101.68 155.86 18.85 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-N 121.241 2.52 . . . . 1.62 114.093 -178.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 166' ' ' ARG . . . . . 0.614 ' HG3' ' O ' ' B' ' 157' ' ' GLY . 0.0 OUTLIER -98.42 151.74 20.25 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.034 0.383 . . . . 3.05 112.034 -179.084 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 167' ' ' CYS . . . . . 0.965 ' HB2' ' HB2' ' B' ' 159' ' ' LYS . 1.3 m -71.58 107.14 4.31 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 109.634 -0.506 . . . . 1.56 109.634 178.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 168' ' ' ALA . . . . . 0.551 ' HB1' ' HB2' ' B' ' 128' ' ' CYS . . . -94.18 -13.84 26.24 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.917 -0.771 . . . . 1.04 108.917 177.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 169' ' ' ALA . . . . . 0.93 ' CB ' ' HA2' ' B' ' 133' ' ' GLY . . . -168.24 163.67 13.1 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.503 -0.771 . . . . 0.98 111.036 -179.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 170' ' ' ALA . . . . . 0.623 ' HA ' ' O ' ' B' ' 185' ' ' CYS . . . -58.78 122.46 13.62 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 113.805 1.039 . . . . 1.25 113.805 -178.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 171' ' ' GLY . . . . . 0.802 ' HA2' ' O ' ' B' ' 182' ' ' ASP . . . 60.94 35.66 90.87 Favored Glycine 0 C--N 1.343 0.963 0 CA-C-N 115.221 -0.9 . . . . 1.29 111.292 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 172' ' ' ILE . . . . . 1.091 HD13 ' HB2' ' B' ' 134' ' ' CYS . 1.2 pp -151.6 97.91 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 113.805 -1.197 . . . . 2.27 111.629 173.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 173' ' ' CYS . . . . . 0.563 ' HB2' ' HB3' ' B' ' 182' ' ' ASP . 5.2 t -99.71 85.85 3.19 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.682 -1.144 . . . . 1.94 110.174 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 174' ' ' CYS . . . . . 1.047 ' HA ' ' HA ' ' B' ' 179' ' ' CYS . 1.8 m -93.85 146.07 24.16 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.023 0.44 . . . . 1.35 111.187 -179.11 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 175' ' ' SER . . . . . 0.92 ' HB2' ' HD2' ' B' ' 176' ' ' PRO . 54.0 p -109.65 -179.65 0.7 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.761 -0.654 . . . . 2.0 110.031 179.505 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 176' ' ' PRO . . . . . 0.92 ' HD2' ' HB2' ' B' ' 175' ' ' SER . 78.6 Cg_endo -77.61 29.38 0.43 Allowed 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 121.675 1.583 . . . . 1.9 111.483 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 177' ' ' ASP . . . . . 0.449 ' H ' ' C ' ' B' ' 175' ' ' SER . 0.6 OUTLIER -144.63 -29.42 0.47 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.178 -0.919 . . . . 2.72 110.142 179.425 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 178' ' ' GLY . . . . . 0.523 ' O ' ' HB3' ' B' ' 174' ' ' CYS . . . -166.94 -145.75 4.6 Favored Glycine 0 CA--C 1.523 0.591 0 CA-C-N 115.944 -0.571 . . . . 0.99 112.571 179.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 179' ' ' CYS . . . . . 1.047 ' HA ' ' HA ' ' B' ' 174' ' ' CYS . 11.7 t -146.4 161.73 39.75 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 109.803 -0.443 . . . . 1.34 109.803 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 180' ' ' HIS . . . . . . . . . . . . . 54.7 m-70 -153.77 134.14 13.46 Favored 'General case' 0 CA--C 1.504 -0.8 0 C-N-CA 119.67 -0.812 . . . . 2.1 111.284 -176.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 181' ' ' GLU . . . . . 0.661 ' OE2' ' HD2' ' A' ' 24' ' ' PRO . 2.5 mt-10 -60.05 132.07 52.8 Favored 'General case' 0 CA--C 1.521 -0.147 0 N-CA-C 109.793 -0.447 . . . . 3.06 109.793 -178.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 182' ' ' ASP . . . . . 0.802 ' O ' ' HA2' ' B' ' 171' ' ' GLY . 0.1 OUTLIER -140.0 112.72 7.51 Favored Pre-proline 0 CA--C 1.545 0.783 0 CA-C-N 116.248 -0.433 . . . . 2.06 110.74 -178.514 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 183' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -70.91 -21.15 28.5 Favored 'Trans proline' 0 C--N 1.359 1.089 0 C-N-CA 122.845 2.363 . . . . 1.91 113.776 -178.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -63.8 -39.83 95.18 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.721 0.296 . . . . 1.56 111.551 -179.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 185' ' ' CYS . . . . . 0.623 ' O ' ' HA ' ' B' ' 170' ' ' ALA . 67.2 m -97.85 -0.84 44.37 Favored 'General case' 0 C--O 1.215 -0.741 0 N-CA-C 112.504 0.557 . . . . 1.94 112.504 -179.376 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 186' ' ' ASP . . . . . 0.543 ' HA ' ' N ' ' B' ' 171' ' ' GLY . 0.8 OUTLIER -66.3 -56.16 17.19 Favored Pre-proline 0 C--N 1.321 -0.643 0 N-CA-C 112.953 0.723 . . . . 3.61 112.953 -176.583 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 187' ' ' PRO . . . . . 0.524 ' HD3' ' CB ' ' B' ' 186' ' ' ASP . 6.0 Cg_endo -87.54 -158.56 0.08 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 123.392 2.728 . . . . 2.58 114.333 -179.064 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 188' ' ' GLU . . . . . 0.54 ' C ' ' H ' ' B' ' 190' ' ' ALA . 0.0 OUTLIER -88.3 50.17 1.93 Allowed 'General case' 0 N--CA 1.407 -2.576 0 CA-C-N 111.241 -2.708 . . . . 4.7 107.877 168.506 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 189' ' ' ALA . . . . . . . . . . . . . . . -72.01 26.58 0.05 OUTLIER 'General case' 0 CA--C 1.549 0.91 0 CA-C-O 121.01 0.433 . . . . 5.24 110.54 176.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 190' ' ' ALA . . . . . 0.54 ' H ' ' C ' ' B' ' 188' ' ' GLU . . . -49.02 111.79 0.53 Allowed 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 113.619 0.97 . . . . 6.93 113.619 -175.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 191' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -87.45 128.17 35.22 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 114.959 -1.018 . . . . 10.14 111.429 179.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 10.9 m . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.253 -0.88 . . . . 11.7 111.326 179.481 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.242 0 N-CA-C 112.046 0.387 . . . . 9.95 112.046 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.54 ' O ' HG13 ' A' ' 2' ' ' VAL . 13.9 p -104.8 97.56 5.74 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.208 0 N-CA-C 113.592 0.96 . . . . 8.02 113.592 177.01 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.877 ' HB2' HG22 ' A' ' 9' ' ' THR . 0.4 OUTLIER -87.05 87.53 7.48 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 120.84 0.352 . . . . 5.86 111.032 178.007 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.18 104.28 7.59 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 107.479 -1.304 . . . . 6.22 107.479 176.125 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 1.044 ' HG ' ' HA ' ' A' ' 54' ' ' CYS . 2.2 tm? -154.25 -100.26 0.04 OUTLIER 'General case' 0 N--CA 1.418 -2.068 0 N-CA-C 106.301 -1.741 . . . . 7.09 106.301 178.267 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.592 ' HB2' ' O ' ' A' ' 5' ' ' LEU . 2.2 t70 166.74 40.27 0.0 OUTLIER 'General case' 0 C--N 1.272 -2.789 0 CA-C-N 113.655 -1.611 . . . . 8.78 107.105 177.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.829 HG22 ' H ' ' A' ' 8' ' ' ARG . 14.8 p -150.31 -174.54 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.902 0 N-CA-C 102.647 -3.094 . . . . 7.51 102.647 -178.404 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.829 ' H ' HG22 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -77.33 135.51 38.39 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 106.122 -1.807 . . . . 9.08 106.122 178.357 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.877 HG22 ' HB2' ' A' ' 3' ' ' LEU . 70.0 p -48.07 105.45 0.07 Allowed 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 123.339 1.543 . . . . 5.66 112.828 -174.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.812 ' N ' ' HG ' ' A' ' 3' ' ' LEU . 0.0 OUTLIER -31.19 112.4 0.09 Allowed 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 111.298 -2.683 . . . . 2.68 115.022 -179.504 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.516 HD23 ' HD2' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -34.36 132.95 0.41 Allowed Pre-proline 0 N--CA 1.481 1.093 0 C-N-CA 124.067 0.947 . . . . 2.48 113.312 177.592 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.86 ' HB2' ' O ' ' A' ' 17' ' ' GLY . 79.0 Cg_endo -87.89 136.46 3.66 Favored 'Trans proline' 0 C--N 1.356 0.933 0 C-N-CA 122.736 2.291 . . . . 1.49 112.784 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 1.054 ' HB2' ' HG3' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -140.97 -162.79 1.42 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 119.975 -0.69 . . . . 1.0 112.163 -179.285 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.476 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . 81.73 -156.27 36.38 Favored Glycine 0 C--N 1.339 0.741 0 CA-C-O 119.323 -0.709 . . . . 1.15 111.836 -178.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.856 ' HG2' ' HD2' ' A' ' 18' ' ' LYS . 42.5 Cg_endo -62.49 108.17 0.68 Allowed 'Trans proline' 0 N--CA 1.483 0.867 0 N-CA-C 105.466 -2.551 . . . . 1.57 105.466 176.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 76.85 -14.37 7.48 Favored Glycine 0 C--N 1.265 -3.372 0 CA-C-O 118.485 -1.175 . . . . 1.68 112.588 176.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.86 ' O ' ' HB2' ' A' ' 12' ' ' PRO . . . 75.37 49.41 9.36 Favored Glycine 0 N--CA 1.401 -3.651 0 C-N-CA 117.075 -2.488 . . . . 1.36 111.825 178.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 1.052 ' HD3' HD11 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -94.99 -12.88 25.89 Favored 'General case' 0 C--N 1.345 0.41 0 CA-C-N 110.358 -2.921 . . . . 2.5 113.142 177.636 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.821 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -115.98 -167.53 14.98 Favored Glycine 0 C--N 1.345 1.082 0 N-CA-C 106.099 -2.801 . . . . 1.02 106.099 178.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.66 ' HB3' ' HB3' ' A' ' 10' ' ' CYS . 1.5 mpt_? -115.08 173.42 6.5 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 122.0 2.9 . . . . 2.92 111.656 -178.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.666 ' HB3' ' HG3' ' A' ' 47' ' ' GLU . 1.2 m -106.25 151.25 25.04 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.882 0.372 . . . . 1.1 110.875 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -124.11 -46.82 1.93 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.117 -0.492 . . . . 1.51 110.776 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.464 ' HA2' ' OE1' ' A' ' 47' ' ' GLU . . . -137.91 -161.18 8.77 Favored Glycine 0 CA--C 1.519 0.321 0 N-CA-C 111.601 -0.6 . . . . 0.9 111.601 179.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -77.87 -63.19 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.071 1.848 . . . . 1.5 111.451 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.442 ' C ' HG13 ' A' ' 26' ' ' ILE . 1.1 m -92.17 33.31 1.08 Allowed 'General case' 0 C--O 1.224 -0.238 0 CA-C-N 116.216 -0.447 . . . . 1.26 109.828 178.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 1.071 HG12 HG13 ' A' ' 36' ' ' VAL . 19.0 mt -149.29 121.34 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-O 121.208 0.528 . . . . 0.83 111.99 -178.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.557 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 6.9 t -140.15 124.7 18.05 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 108.472 -0.936 . . . . 0.92 108.472 179.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.73 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -138.05 121.72 17.46 Favored 'General case' 0 CA--C 1.551 1.016 0 N-CA-C 114.4 1.259 . . . . 1.28 114.4 -177.743 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.516 ' O ' ' HB2' ' A' ' 69' ' ' ALA . . . -102.82 -170.62 26.43 Favored Glycine 0 C--N 1.367 2.291 0 N-CA-C 110.098 -1.201 . . . . 0.67 110.098 176.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -65.85 -53.68 36.65 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 113.773 1.027 . . . . 2.27 113.773 -178.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.54 3.44 12.43 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 122.222 1.01 . . . . 1.66 110.966 -176.245 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 1.052 HD11 ' HD3' ' A' ' 18' ' ' LYS . 0.4 OUTLIER -96.94 -22.24 16.97 Favored 'General case' 0 N--CA 1.415 -2.222 0 CA-C-N 113.887 -1.506 . . . . 1.37 107.382 -178.595 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.857 ' HA2' ' CB ' ' A' ' 69' ' ' ALA . . . 76.49 -135.73 17.82 Favored Glycine 0 N--CA 1.41 -3.094 0 CA-C-O 117.727 -1.596 . . . . 0.73 112.256 176.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 1.03 ' HB2' HD13 ' A' ' 72' ' ' ILE . 3.2 t -140.34 121.76 15.04 Favored 'General case' 0 CA--C 1.498 -1.051 0 CA-C-N 119.582 1.691 . . . . 1.08 114.1 -179.064 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.721 ' CE1' HD22 ' A' ' 32' ' ' LEU . 1.8 m-85 -95.51 102.12 13.89 Favored 'General case' 0 N--CA 1.428 -1.536 0 N-CA-C 103.469 -2.789 . . . . 1.38 103.469 175.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 1.071 HG13 HG12 ' A' ' 26' ' ' ILE . 2.1 t -94.41 84.34 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.137 0 CA-C-O 123.344 1.545 . . . . 0.76 108.622 -178.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 1.084 ' HA3' HG21 ' B' ' 172' ' ' ILE . . . 95.13 79.62 1.47 Allowed Glycine 0 C--N 1.313 -0.699 0 CA-C-N 112.236 -2.256 . . . . 0.81 113.722 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.724 HG21 ' CD2' ' B' ' 135' ' ' PHE . 58.2 p -159.96 177.9 10.28 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.743 -0.836 . . . . 0.77 108.743 179.118 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.73 ' HA ' HD12 ' A' ' 42' ' ' LEU . . . -65.28 -25.01 67.45 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 119.023 0.829 . . . . 1.02 112.27 -178.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.463 ' CG ' ' HA2' ' A' ' 14' ' ' GLY . 0.8 OUTLIER -64.35 -24.76 67.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.854 0.359 . . . . 2.32 110.246 178.664 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.564 ' O ' ' HB2' ' A' ' 44' ' ' CYS . . . -85.46 -10.16 56.5 Favored 'General case' 0 C--O 1.219 -0.5 0 CA-C-N 115.868 -0.605 . . . . 0.87 110.347 178.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.73 HD12 ' HA ' ' A' ' 39' ' ' ALA . 1.1 mt -53.29 -41.83 65.98 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 121.982 -0.449 . . . . 1.23 112.156 -178.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 1.054 ' HG3' ' HB2' ' A' ' 13' ' ' CYS . 5.0 ptm180 -70.78 -16.96 62.79 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 121.788 0.804 . . . . 2.92 109.299 176.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.564 ' HB2' ' O ' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -57.67 -18.83 22.77 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 114.023 -1.444 . . . . 1.57 110.107 -178.27 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -50.62 -25.82 4.66 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.769 -0.65 . . . . 3.31 111.118 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -83.09 8.33 13.28 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.159 0.504 . . . . 3.69 110.375 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.718 ' O ' HD13 ' A' ' 50' ' ' LEU . 6.0 tm-20 -79.64 1.35 26.58 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.751 -0.659 . . . . 3.99 109.349 177.276 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 68.8 m-20 -69.86 -29.39 66.62 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 116.14 -0.482 . . . . 3.86 110.281 178.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -72.85 3.87 4.75 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 112.209 0.448 . . . . 5.68 112.209 -179.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.718 HD13 ' O ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -156.9 110.92 1.95 Allowed Pre-proline 0 CA--C 1.534 0.34 0 O-C-N 122.456 -0.152 . . . . 5.4 110.715 178.625 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -99.19 18.74 0.37 Allowed 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 122.996 2.464 . . . . 4.92 113.827 -178.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.517 ' OG ' ' HD2' ' A' ' 53' ' ' PRO . 3.8 t -126.46 151.14 72.3 Favored Pre-proline 0 C--N 1.33 -0.248 0 C-N-CA 121.177 -0.209 . . . . 5.64 111.413 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.517 ' HD2' ' OG ' ' A' ' 52' ' ' SER . 48.0 Cg_endo -68.18 158.07 59.06 Favored 'Trans proline' 0 C--N 1.356 0.959 0 C-N-CA 122.196 1.93 . . . . 5.04 111.86 179.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 1.044 ' HA ' ' HG ' ' A' ' 5' ' ' LEU . 1.7 m -132.0 -169.2 2.17 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.714 0.293 . . . . 2.74 111.278 -179.259 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.505 ' H ' HD12 ' A' ' 3' ' ' LEU . 0.3 OUTLIER 54.76 170.58 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.36 -0.382 . . . . 5.75 111.924 -179.961 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.427 ' H ' ' HG3' ' A' ' 55' ' ' GLN . 43.0 p -153.58 -164.66 1.95 Allowed 'General case' 0 CA--C 1.544 0.744 0 CA-C-O 121.385 0.612 . . . . 3.12 112.394 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 120.29 -88.26 0.43 Allowed Glycine 0 N--CA 1.464 0.54 0 CA-C-N 114.646 -1.161 . . . . 2.1 114.016 177.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.904 ' O ' ' HB3' ' A' ' 67' ' ' CYS . 41.1 mt-30 -124.16 104.49 8.87 Favored 'General case' 0 CA--C 1.489 -1.404 0 N-CA-C 102.946 -2.983 . . . . 4.36 102.946 177.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 1.088 ' HA ' ' H ' ' A' ' 67' ' ' CYS . 6.6 mmmt -128.68 -68.12 0.02 OUTLIER Pre-proline 0 C--N 1.314 -0.949 0 C-N-CA 118.532 -1.267 . . . . 3.55 112.812 -173.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.672 ' CD ' ' HB2' ' A' ' 59' ' ' LYS . 15.0 Cg_endo -57.08 114.97 2.17 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 CA-C-N 121.534 1.584 . . . . 1.54 115.354 -177.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -144.53 -165.36 2.12 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 111.133 -2.758 . . . . 1.59 104.494 178.159 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 47.24 -165.37 0.13 Allowed Glycine 0 N--CA 1.467 0.741 0 CA-C-N 121.283 1.856 . . . . 2.43 114.611 175.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 4.4 p -87.95 39.43 0.89 Allowed 'General case' 0 N--CA 1.479 1.016 0 CA-C-O 121.997 0.903 . . . . 4.11 110.482 -177.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 121.11 15.46 4.69 Favored Glycine 0 CA--C 1.558 2.732 0 CA-C-N 113.981 -1.463 . . . . 2.21 114.696 -175.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -101.14 146.02 17.21 Favored Glycine 0 N--CA 1.474 1.184 0 CA-C-N 119.913 1.856 . . . . 1.62 114.914 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 1.057 ' HB3' ' HB3' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -89.73 152.53 21.28 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 109.375 -0.602 . . . . 3.02 109.375 177.965 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 1.088 ' H ' ' HA ' ' A' ' 59' ' ' LYS . 36.1 t -73.47 107.53 5.81 Favored 'General case' 0 N--CA 1.407 -2.588 0 N-CA-C 108.736 -0.839 . . . . 1.52 108.736 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 1.011 ' HB2' ' HB2' ' A' ' 74' ' ' CYS . . . -71.58 -28.23 63.68 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.919 -0.771 . . . . 1.07 108.919 179.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.874 ' HB3' ' CG1' ' A' ' 72' ' ' ILE . . . -168.78 163.46 11.84 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.367 -1.288 . . . . 1.0 110.498 -176.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 1.087 ' HA ' ' HB3' ' A' ' 85' ' ' CYS . . . -55.05 122.41 10.89 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 116.111 -0.495 . . . . 1.24 112.119 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.585 ' H ' ' CB ' ' A' ' 85' ' ' CYS . . . 58.38 35.77 80.66 Favored Glycine 0 C--N 1.351 1.416 0 N-CA-C 110.904 -0.878 . . . . 1.28 110.904 -178.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 1.071 HG21 ' HA3' ' B' ' 137' ' ' GLY . 1.5 pp -154.71 97.79 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.644 0 N-CA-C 107.989 -1.115 . . . . 2.27 107.989 169.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.665 ' HB2' ' HB3' ' A' ' 82' ' ' ASP . 0.1 OUTLIER -91.48 106.33 18.42 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 112.21 0.448 . . . . 1.98 112.21 -177.319 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 1.011 ' HB2' ' HB2' ' A' ' 68' ' ' ALA . 0.6 OUTLIER -93.84 123.77 37.41 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.526 0.679 . . . . 1.33 111.663 179.754 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.901 ' HB2' ' HD2' ' A' ' 76' ' ' PRO . 36.2 p -93.26 -178.7 0.89 Allowed Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.102 -0.954 . . . . 1.99 109.035 178.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.901 ' HD2' ' HB2' ' A' ' 75' ' ' SER . 74.0 Cg_endo -76.11 29.28 0.39 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 121.328 1.352 . . . . 1.86 111.517 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.692 ' HB3' ' CE1' ' B' ' 180' ' ' HIS . 1.7 m-20 -145.78 -43.9 0.21 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.418 -0.81 . . . . 2.65 110.809 179.445 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.537 ' HA3' ' HA ' ' B' ' 180' ' ' HIS . . . -158.32 -141.61 3.19 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 120.74 -0.743 . . . . 0.99 113.128 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.766 ' HA ' ' HA ' ' A' ' 74' ' ' CYS . 0.1 OUTLIER -134.82 157.76 45.94 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.55 0.215 . . . . 1.34 110.505 -179.949 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.642 ' CE1' ' HB3' ' B' ' 177' ' ' ASP . 2.8 t60 -152.28 135.11 15.52 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 109.432 -0.581 . . . . 2.17 109.432 -176.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.8 132.19 53.19 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 109.295 -0.631 . . . . 3.05 109.295 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.665 ' HB3' ' HB2' ' A' ' 73' ' ' CYS . 1.2 p-10 -140.64 133.56 14.65 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 120.911 -0.315 . . . . 2.02 111.581 -177.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.736 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 5.7 Cg_exo -79.51 -12.16 14.01 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 122.737 2.292 . . . . 1.93 113.103 -179.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.8 -41.74 97.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.783 0.325 . . . . 1.53 110.944 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 1.087 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 21.5 m -99.88 22.67 10.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.156 0.503 . . . . 1.88 110.919 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.606 ' HB2' ' HA ' ' A' ' 83' ' ' PRO . 0.5 OUTLIER -103.08 -22.21 0.2 Allowed Pre-proline 0 CA--C 1.512 -0.483 0 N-CA-C 113.887 1.069 . . . . 3.6 113.887 179.085 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.736 ' HD3' ' O ' ' A' ' 83' ' ' PRO . 72.2 Cg_exo -46.12 119.97 3.33 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 121.399 1.4 . . . . 2.56 111.199 177.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 2.21 48.19 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 128.299 2.639 . . . . 4.72 113.387 -172.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.637 ' N ' ' O ' ' A' ' 87' ' ' PRO . . . -67.58 0.19 3.34 Favored 'General case' 0 CA--C 1.499 -0.994 0 CA-C-N 111.697 -2.501 . . . . 5.29 113.747 -171.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.88 140.22 58.79 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 118.438 -1.305 . . . . 6.98 110.813 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -102.34 67.57 1.04 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.128 -0.693 . . . . 10.21 109.128 176.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.248 0.99 0 CA-C-O 118.284 -0.865 . . . . 11.77 111.039 -178.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.182 0 CA-C-O 120.781 0.324 . . . . 10.07 111.35 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 11.5 t 60.44 55.1 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 CA-C-O 122.673 1.225 . . . . 8.41 112.671 176.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 103' ' ' LEU . . . . . 1.032 ' HB2' HG22 ' B' ' 109' ' ' THR . 0.4 OUTLIER -79.3 94.1 5.41 Favored 'General case' 0 C--N 1.344 0.333 0 CA-C-N 112.958 -1.928 . . . . 5.87 110.918 179.634 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 104' ' ' ASP . . . . . 0.608 ' HB3' ' OG ' ' B' ' 156' ' ' SER . 0.7 OUTLIER -82.48 101.59 10.79 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 106.714 -1.588 . . . . 6.27 106.714 177.176 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . 1.096 ' HG ' ' HA ' ' B' ' 154' ' ' CYS . 2.4 tm? -158.57 -126.11 0.02 OUTLIER 'General case' 1 N--CA 1.369 -4.485 0 C-N-CA 128.364 2.666 . . . . 7.2 104.621 -179.775 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 106' ' ' ASP . . . . . 0.757 ' H ' ' CD1' ' B' ' 105' ' ' LEU . 3.9 t70 -176.41 50.13 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 104.816 -2.29 . . . . 8.55 104.816 -177.205 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 107' ' ' VAL . . . . . 0.835 HG22 ' H ' ' B' ' 108' ' ' ARG . 9.9 p -154.17 -177.3 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.403 -2.793 0 CA-C-N 112.016 -2.356 . . . . 7.48 106.46 178.261 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 108' ' ' ARG . . . . . 0.835 ' H ' HG22 ' B' ' 107' ' ' VAL . 0.0 OUTLIER -79.67 129.59 34.61 Favored 'General case' 0 N--CA 1.405 -2.7 0 N-CA-C 107.086 -1.45 . . . . 9.12 107.086 176.183 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 109' ' ' THR . . . . . 1.032 HG22 ' HB2' ' B' ' 103' ' ' LEU . 47.0 p -39.46 103.74 0.03 OUTLIER 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 122.971 1.367 . . . . 5.69 113.35 -176.298 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 110' ' ' CYS . . . . . 0.757 ' N ' ' HG ' ' B' ' 103' ' ' LEU . 0.0 OUTLIER -32.13 111.69 0.09 Allowed 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 111.929 -2.396 . . . . 2.61 115.381 -179.797 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 111' ' ' LEU . . . . . 0.509 HD23 ' HD2' ' B' ' 112' ' ' PRO . 0.2 OUTLIER -33.77 133.07 0.37 Allowed Pre-proline 0 N--CA 1.485 1.307 0 C-N-CA 123.979 0.912 . . . . 2.47 113.294 177.603 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 112' ' ' PRO . . . . . 0.845 ' HB2' ' O ' ' B' ' 117' ' ' GLY . 54.0 Cg_endo -92.3 129.09 0.95 Allowed 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.509 2.139 . . . . 1.47 115.253 -179.141 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 1.091 ' HB2' ' HG3' ' B' ' 143' ' ' ARG . 0.0 OUTLIER -133.65 -159.78 0.99 Allowed 'General case' 0 C--N 1.359 1.017 0 C-N-CA 119.473 -0.891 . . . . 1.0 111.299 -175.525 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 114' ' ' GLY . . . . . 0.474 ' N ' ' SG ' ' B' ' 113' ' ' CYS . . . 80.71 -156.91 39.16 Favored Glycine 0 C--N 1.334 0.443 0 CA-C-N 118.613 0.642 . . . . 1.16 111.558 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 115' ' ' PRO . . . . . 0.821 ' HG2' ' HD2' ' B' ' 118' ' ' LYS . 56.6 Cg_endo -65.24 88.59 0.2 Allowed 'Trans proline' 0 N--CA 1.458 -0.58 0 CA-C-N 119.523 1.662 . . . . 1.57 114.177 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 87.51 -3.83 86.21 Favored Glycine 0 C--N 1.265 -3.372 0 CA-C-N 112.056 -2.338 . . . . 1.7 114.202 -176.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 117' ' ' GLY . . . . . 0.845 ' O ' ' HB2' ' B' ' 112' ' ' PRO . . . 75.05 47.58 13.09 Favored Glycine 0 N--CA 1.412 -2.931 0 C-N-CA 118.966 -1.588 . . . . 1.38 113.497 175.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 118' ' ' LYS . . . . . 1.009 ' HD3' HD11 ' B' ' 132' ' ' LEU . 0.0 OUTLIER -90.72 -23.27 20.75 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 112.134 -2.033 . . . . 2.54 111.237 178.96 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 119' ' ' GLY . . . . . 0.728 ' O ' ' HA ' ' B' ' 112' ' ' PRO . . . -101.36 -160.94 27.18 Favored Glycine 0 N--CA 1.478 1.477 0 CA-C-O 117.274 -1.848 . . . . 1.04 109.242 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.64 ' HB3' ' HB3' ' B' ' 110' ' ' CYS . 1.3 mpt_? -124.0 172.83 8.66 Favored 'General case' 0 C--N 1.353 0.728 0 CA-C-N 122.238 3.019 . . . . 2.89 109.329 177.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 121' ' ' CYS . . . . . 0.645 ' HB3' ' HG3' ' B' ' 147' ' ' GLU . 1.2 m -106.11 151.44 24.7 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.927 0.394 . . . . 1.07 111.139 -179.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -124.16 -46.81 1.92 Allowed 'General case' 0 C--N 1.334 -0.101 0 CA-C-N 116.04 -0.527 . . . . 1.53 110.754 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 123' ' ' GLY . . . . . 0.484 ' HA2' ' OE1' ' B' ' 147' ' ' GLU . . . -137.98 -161.19 8.76 Favored Glycine 0 CA--C 1.52 0.374 0 N-CA-C 111.637 -0.585 . . . . 0.9 111.637 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -77.77 -63.21 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.033 1.822 . . . . 1.51 111.538 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 125' ' ' SER . . . . . 0.432 ' C ' HG13 ' B' ' 126' ' ' ILE . 1.1 m -92.05 33.27 1.07 Allowed 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.845 -0.428 . . . . 1.25 109.845 178.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 126' ' ' ILE . . . . . 1.067 HG12 HG13 ' B' ' 136' ' ' VAL . 23.0 mt -149.01 121.23 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 CA-C-O 121.082 0.468 . . . . 0.85 112.111 -178.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 127' ' ' CYS . . . . . 0.549 ' O ' ' HA ' ' B' ' 134' ' ' CYS . 6.6 t -140.34 124.33 17.48 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 108.404 -0.962 . . . . 0.89 108.404 179.217 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 128' ' ' CYS . . . . . 0.729 ' HA ' ' O ' ' B' ' 133' ' ' GLY . 0.0 OUTLIER -137.43 120.95 17.17 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 114.235 1.198 . . . . 1.23 114.235 -177.731 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 129' ' ' GLY . . . . . 0.501 ' O ' ' HB2' ' B' ' 169' ' ' ALA . . . -103.67 -167.65 25.39 Favored Glycine 0 C--N 1.369 2.395 0 CA-C-N 120.148 1.34 . . . . 0.66 109.885 176.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -65.72 -55.07 19.32 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 114.148 1.166 . . . . 2.35 114.148 -177.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -124.06 21.7 8.88 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 121.691 0.758 . . . . 1.69 109.955 -177.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 132' ' ' LEU . . . . . 1.009 HD11 ' HD3' ' B' ' 118' ' ' LYS . 0.4 OUTLIER -112.18 -21.19 11.59 Favored 'General case' 0 N--CA 1.411 -2.417 0 N-CA-C 104.783 -2.303 . . . . 1.38 104.783 179.24 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 133' ' ' GLY . . . . . 0.897 ' HA2' ' CB ' ' B' ' 169' ' ' ALA . . . 75.41 -134.73 17.13 Favored Glycine 1 N--CA 1.393 -4.226 0 CA-C-O 117.07 -1.961 . . . . 0.72 112.499 174.503 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 134' ' ' CYS . . . . . 1.031 ' HB2' HD13 ' B' ' 172' ' ' ILE . 3.1 t -140.75 121.78 14.63 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 120.262 2.031 . . . . 1.08 114.488 -178.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 135' ' ' PHE . . . . . 0.729 ' CE1' HD22 ' B' ' 132' ' ' LEU . 4.1 m-85 -95.16 101.77 13.54 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 103.707 -2.701 . . . . 1.36 103.707 175.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 136' ' ' VAL . . . . . 1.067 HG13 HG12 ' B' ' 126' ' ' ILE . 2.3 t -94.36 83.83 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.076 0 CA-C-O 123.364 1.554 . . . . 0.75 108.597 -178.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 137' ' ' GLY . . . . . 1.071 ' HA3' HG21 ' A' ' 72' ' ' ILE . . . 95.19 79.55 1.46 Allowed Glycine 0 C--N 1.313 -0.697 0 CA-C-N 112.145 -2.298 . . . . 0.83 113.643 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 138' ' ' THR . . . . . 0.604 ' OG1' ' HB3' ' B' ' 135' ' ' PHE . 51.2 p -158.12 -179.05 7.75 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.7 -0.852 . . . . 0.78 108.7 179.074 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 139' ' ' ALA . . . . . 0.733 ' HA ' HD12 ' B' ' 142' ' ' LEU . . . -68.37 -24.78 64.83 Favored 'General case' 0 C--N 1.338 0.109 0 CA-C-N 119.18 0.9 . . . . 1.04 111.934 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 140' ' ' GLU . . . . . 0.457 ' CG ' ' HA2' ' B' ' 114' ' ' GLY . 0.8 OUTLIER -63.98 -25.18 68.01 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.236 -0.438 . . . . 2.31 110.195 178.643 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 141' ' ' ALA . . . . . 0.556 ' O ' ' HB2' ' B' ' 144' ' ' CYS . . . -84.72 -11.22 56.29 Favored 'General case' 0 C--O 1.219 -0.538 0 CA-C-N 115.941 -0.572 . . . . 0.87 110.27 178.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 142' ' ' LEU . . . . . 0.733 HD12 ' HA ' ' B' ' 139' ' ' ALA . 1.1 mt -52.83 -42.09 64.82 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.312 0.486 . . . . 1.24 112.312 -178.018 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 143' ' ' ARG . . . . . 1.091 ' HG3' ' HB2' ' B' ' 113' ' ' CYS . 4.4 ptm180 -68.1 -21.57 64.95 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 108.613 -0.884 . . . . 2.93 108.613 176.299 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 144' ' ' CYS . . . . . 0.556 ' HB2' ' O ' ' B' ' 141' ' ' ALA . 0.1 OUTLIER -56.81 -13.84 2.91 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 113.743 -1.571 . . . . 1.61 110.482 -175.867 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -54.61 -24.93 23.52 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-O 121.242 0.544 . . . . 3.35 111.05 178.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -82.99 8.42 12.77 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 120.473 -0.491 . . . . 3.76 110.213 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . 0.728 ' O ' HD13 ' B' ' 150' ' ' LEU . 6.0 tm-20 -79.58 1.34 26.36 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.821 -0.627 . . . . 4.01 109.375 177.177 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 148' ' ' ASN . . . . . . . . . . . . . 68.9 m-20 -69.85 -29.47 66.73 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 116.183 -0.462 . . . . 3.92 110.259 178.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -72.79 3.92 4.65 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.237 0.458 . . . . 5.73 112.237 -179.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 150' ' ' LEU . . . . . 0.728 HD13 ' O ' ' B' ' 147' ' ' GLU . 0.0 OUTLIER -156.95 110.96 1.94 Allowed Pre-proline 0 CA--C 1.534 0.365 0 CA-C-O 120.423 0.154 . . . . 5.46 110.602 178.652 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 151' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -99.21 18.79 0.36 Allowed 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 123.024 2.482 . . . . 5.02 113.832 -178.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 152' ' ' SER . . . . . 0.519 ' OG ' ' HD2' ' B' ' 153' ' ' PRO . 3.8 t -126.54 151.18 72.57 Favored Pre-proline 0 C--N 1.329 -0.315 0 C-N-CA 121.185 -0.206 . . . . 5.73 111.366 -179.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 153' ' ' PRO . . . . . 0.519 ' HD2' ' OG ' ' B' ' 152' ' ' SER . 47.4 Cg_endo -68.44 158.18 58.72 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 122.117 1.878 . . . . 5.1 111.798 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 154' ' ' CYS . . . . . 1.096 ' HA ' ' HG ' ' B' ' 105' ' ' LEU . 1.7 m -132.66 -170.49 2.45 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.789 0.328 . . . . 2.68 111.128 -179.255 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 155' ' ' GLN . . . . . 0.5 ' H ' HD12 ' B' ' 103' ' ' LEU . 0.3 OUTLIER 56.37 169.17 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.307 -0.406 . . . . 5.63 111.664 179.969 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 156' ' ' SER . . . . . 0.608 ' OG ' ' HB3' ' B' ' 104' ' ' ASP . 34.5 p -151.72 -162.97 1.64 Allowed 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 112.147 0.425 . . . . 3.11 112.147 -179.046 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 120.48 -92.33 0.51 Allowed Glycine 0 C--N 1.339 0.743 0 C-N-CA 120.834 -0.698 . . . . 2.07 113.286 178.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 158' ' ' GLN . . . . . 0.953 ' O ' ' HB3' ' B' ' 167' ' ' CYS . 41.1 mt-30 -124.55 89.67 3.11 Favored 'General case' 0 CA--C 1.493 -1.237 0 N-CA-C 105.246 -2.131 . . . . 4.34 105.246 178.304 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 159' ' ' LYS . . . . . 1.075 ' HB3' ' HB3' ' B' ' 166' ' ' ARG . 6.5 mmmt -105.58 -73.69 0.02 OUTLIER Pre-proline 0 C--N 1.308 -1.232 0 N-CA-C 116.28 1.956 . . . . 3.54 116.28 -175.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 160' ' ' PRO . . . . . 0.64 ' CD ' ' HB2' ' B' ' 159' ' ' LYS . 14.6 Cg_endo -57.21 115.05 2.22 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 N-CA-C 116.037 1.514 . . . . 1.51 116.037 -174.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 161' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -145.57 -168.75 3.05 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 110.911 -2.859 . . . . 1.58 104.374 177.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 50.01 -165.66 0.5 Allowed Glycine 0 CA--C 1.525 0.7 0 CA-C-N 120.62 1.554 . . . . 2.37 113.882 177.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 7.3 p -88.25 39.63 0.91 Allowed 'General case' 0 N--CA 1.482 1.152 0 CA-C-O 122.491 1.138 . . . . 4.07 110.962 -178.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 123.02 12.8 4.7 Favored Glycine 0 CA--C 1.557 2.663 0 CA-C-N 113.351 -1.75 . . . . 2.2 114.857 -178.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -99.92 146.08 17.66 Favored Glycine 0 N--CA 1.471 1.02 0 CA-C-N 120.795 2.297 . . . . 1.62 115.046 -177.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 166' ' ' ARG . . . . . 1.075 ' HB3' ' HB3' ' B' ' 159' ' ' LYS . 0.0 OUTLIER -89.51 152.28 21.52 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 109.302 -0.629 . . . . 3.05 109.302 178.612 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 167' ' ' CYS . . . . . 0.996 ' H ' ' HA ' ' B' ' 159' ' ' LYS . 33.6 t -73.77 107.75 6.2 Favored 'General case' 0 N--CA 1.406 -2.628 0 N-CA-C 108.683 -0.858 . . . . 1.56 108.683 -179.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 168' ' ' ALA . . . . . 1.009 ' HB2' ' HB2' ' B' ' 174' ' ' CYS . . . -73.68 -24.18 59.92 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 119.699 -0.801 . . . . 1.04 109.438 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 169' ' ' ALA . . . . . 0.897 ' CB ' ' HA2' ' B' ' 133' ' ' GLY . . . -171.47 163.48 6.81 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 108.554 -0.906 . . . . 0.98 108.554 -178.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 170' ' ' ALA . . . . . 1.053 ' HA ' ' HB3' ' B' ' 185' ' ' CYS . . . -55.43 125.56 21.42 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 120.89 0.376 . . . . 1.25 111.974 179.263 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 171' ' ' GLY . . . . . 0.541 ' H ' ' CB ' ' B' ' 185' ' ' CYS . . . 79.27 -7.45 52.64 Favored Glycine 0 C--O 1.224 -0.513 0 C-N-CA 120.376 -0.916 . . . . 1.29 114.063 178.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 172' ' ' ILE . . . . . 1.084 HG21 ' HA3' ' A' ' 37' ' ' GLY . 1.6 pp -132.36 100.78 4.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-O 121.89 0.852 . . . . 2.27 110.59 -175.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 173' ' ' CYS . . . . . 0.674 ' HB2' ' HB3' ' B' ' 182' ' ' ASP . 0.1 OUTLIER -91.13 105.88 18.12 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 115.498 -0.774 . . . . 1.94 112.282 -177.811 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 174' ' ' CYS . . . . . 1.009 ' HB2' ' HB2' ' B' ' 168' ' ' ALA . 0.6 OUTLIER -93.94 123.81 37.54 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.535 0.683 . . . . 1.35 111.734 179.651 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 175' ' ' SER . . . . . 0.955 ' HB2' ' HD2' ' B' ' 176' ' ' PRO . 36.1 p -93.31 -178.71 0.89 Allowed Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.114 -0.948 . . . . 2.0 109.071 178.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 176' ' ' PRO . . . . . 0.955 ' HD2' ' HB2' ' B' ' 175' ' ' SER . 73.9 Cg_endo -76.08 29.2 0.39 Allowed 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 121.388 1.392 . . . . 1.9 111.481 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 177' ' ' ASP . . . . . 0.642 ' HB3' ' CE1' ' A' ' 80' ' ' HIS . 1.6 m-20 -145.74 -43.94 0.21 Allowed 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 115.489 -0.778 . . . . 2.72 110.798 179.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 178' ' ' GLY . . . . . 0.517 ' HA3' ' HA ' ' A' ' 80' ' ' HIS . . . -158.27 -141.52 3.17 Favored Glycine 0 CA--C 1.522 0.512 0 C-N-CA 120.776 -0.726 . . . . 0.99 113.137 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 179' ' ' CYS . . . . . 0.759 ' HA ' ' HA ' ' B' ' 174' ' ' CYS . 0.1 OUTLIER -134.5 160.27 38.53 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 110.424 -0.213 . . . . 1.34 110.424 -179.986 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 180' ' ' HIS . . . . . 0.692 ' CE1' ' HB3' ' A' ' 77' ' ' ASP . 2.9 t60 -156.21 134.05 11.12 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 109.886 -0.412 . . . . 2.1 109.886 -176.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 181' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.02 131.88 52.37 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 109.414 -0.588 . . . . 3.06 109.414 -179.08 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 182' ' ' ASP . . . . . 0.674 ' HB3' ' HB2' ' B' ' 173' ' ' CYS . 1.2 p-10 -140.47 133.54 14.83 Favored Pre-proline 0 CA--C 1.541 0.602 0 C-N-CA 120.937 -0.305 . . . . 2.06 111.701 -177.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 183' ' ' PRO . . . . . 0.758 ' O ' ' HD3' ' B' ' 187' ' ' PRO . 5.9 Cg_exo -79.51 -12.11 14.03 Favored 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 122.684 2.256 . . . . 1.91 113.065 -179.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -63.65 -41.61 98.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.836 0.35 . . . . 1.56 111.026 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 185' ' ' CYS . . . . . 1.053 ' HB3' ' HA ' ' B' ' 170' ' ' ALA . 26.7 m -99.7 22.38 11.04 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.153 -0.476 . . . . 1.94 111.293 179.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 186' ' ' ASP . . . . . 0.615 ' HB2' ' HA ' ' B' ' 183' ' ' PRO . 0.5 OUTLIER -103.28 -22.32 0.2 Allowed Pre-proline 0 CA--C 1.504 -0.82 0 N-CA-C 113.927 1.084 . . . . 3.61 113.927 179.136 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 187' ' ' PRO . . . . . 0.758 ' HD3' ' O ' ' B' ' 183' ' ' PRO . 81.5 Cg_exo -46.44 117.08 1.82 Allowed 'Trans proline' 0 N--CA 1.454 -0.802 0 CA-C-N 120.531 1.225 . . . . 2.58 111.457 177.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 2.15 57.26 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.349 0 C-N-CA 128.769 2.827 . . . . 4.7 110.032 -176.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 189' ' ' ALA . . . . . 0.558 ' N ' ' O ' ' B' ' 187' ' ' PRO . . . -74.85 -1.55 22.76 Favored 'General case' 0 CA--C 1.488 -1.409 0 CA-C-N 109.338 -3.574 . . . . 5.24 112.836 -175.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 190' ' ' ALA . . . . . . . . . . . . . . . -61.37 143.83 55.09 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 116.748 -1.981 . . . . 6.93 110.032 -176.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 191' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -103.15 68.19 0.97 Allowed 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.077 -0.712 . . . . 10.14 109.077 174.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.17 -0.919 . . . . 11.7 111.189 -178.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.92 ' O ' HG22 ' A' ' 2' ' ' VAL . . . . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 118.435 -0.793 . . . . 9.95 112.76 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.92 HG22 ' O ' ' A' ' 1' ' ' ALA . 16.2 m 125.88 88.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 CA-C-O 121.9 0.857 . . . . 8.02 109.802 -179.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 1.044 HD13 ' HB3' ' A' ' 55' ' ' GLN . 0.1 OUTLIER -154.06 71.59 0.86 Allowed 'General case' 0 CA--C 1.51 -0.595 0 CA-C-N 114.507 -1.224 . . . . 5.86 110.01 179.668 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.634 ' N ' ' HA ' ' A' ' 55' ' ' GLN . 1.7 t70 -62.98 -2.75 1.32 Allowed 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 112.629 0.603 . . . . 6.22 112.629 -177.102 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.708 ' O ' ' HB2' ' A' ' 6' ' ' ASP . 2.9 tm? -96.39 -73.13 0.61 Allowed 'General case' 0 N--CA 1.418 -2.056 0 N-CA-C 107.125 -1.435 . . . . 7.09 107.125 176.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.768 ' H ' HD12 ' A' ' 3' ' ' LEU . 0.8 OUTLIER 155.87 -21.0 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 111.108 -2.769 . . . . 8.78 110.317 179.762 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.442 ' C ' HD11 ' A' ' 3' ' ' LEU . 14.6 p -157.04 126.94 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 N-CA-C 101.923 -3.362 . . . . 7.51 101.923 177.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 1.086 ' HB2' ' HG2' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -74.17 110.14 8.22 Favored 'General case' 0 N--CA 1.404 -2.775 0 N-CA-C 107.503 -1.295 . . . . 9.08 107.503 -175.948 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.6 m -104.4 94.85 5.56 Favored 'General case' 0 N--CA 1.396 -3.138 0 N-CA-C 101.898 -3.371 . . . . 5.66 101.898 171.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 1.051 ' HB3' ' HG2' ' A' ' 20' ' ' ARG . 0.6 OUTLIER -83.16 103.76 12.82 Favored 'General case' 0 C--N 1.288 -2.103 0 CA-C-N 112.754 -2.021 . . . . 2.68 112.154 178.275 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.75 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 4.3 mm? -30.68 108.48 0.26 Allowed Pre-proline 0 N--CA 1.474 0.751 0 CA-C-N 119.208 0.913 . . . . 2.48 110.408 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.78 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 49.4 Cg_endo -100.0 114.42 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 123.085 2.523 . . . . 1.49 114.58 -177.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.764 ' HB2' ' HB3' ' A' ' 43' ' ' ARG . 0.1 OUTLIER -132.97 -157.77 0.84 Allowed 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 119.759 -0.162 . . . . 1.0 110.582 -178.465 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.612 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . 80.62 -158.77 41.63 Favored Glycine 0 CA--C 1.507 -0.409 0 CA-C-O 118.564 -1.131 . . . . 1.15 111.202 -177.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.527 ' HD3' ' HG2' ' A' ' 40' ' ' GLU . 84.4 Cg_endo -64.77 84.02 0.17 Allowed 'Trans proline' 0 CA--C 1.515 -0.474 0 CA-C-N 121.122 2.461 . . . . 1.57 115.035 -176.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.07 1.33 84.67 Favored Glycine 0 C--N 1.283 -2.388 0 CA-C-N 111.621 -2.536 . . . . 1.68 114.474 -178.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.64 ' O ' ' HB2' ' A' ' 12' ' ' PRO . . . 85.87 42.73 6.65 Favored Glycine 0 N--CA 1.431 -1.659 0 N-CA-C 117.38 1.712 . . . . 1.36 117.38 174.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -94.63 -14.94 24.43 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-N 114.443 -0.878 . . . . 2.5 111.799 175.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.78 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -107.7 179.39 21.93 Favored Glycine 0 N--CA 1.468 0.807 0 N-CA-C 109.478 -1.449 . . . . 1.02 109.478 -179.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 1.051 ' HG2' ' HB3' ' A' ' 10' ' ' CYS . 0.3 OUTLIER -120.34 174.01 6.78 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 120.833 2.316 . . . . 2.92 110.982 179.021 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 12.7 m -107.3 156.37 18.95 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.028 0.442 . . . . 1.1 112.005 -179.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.507 ' CE1' ' HB2' ' A' ' 28' ' ' CYS . 56.9 m-85 -143.54 16.9 1.84 Allowed 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.601 -0.727 . . . . 1.51 111.231 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.522 ' O ' ' HB3' ' A' ' 44' ' ' CYS . . . 162.45 -143.91 9.17 Favored Glycine 0 C--N 1.331 0.256 0 C-N-CA 120.743 -0.741 . . . . 0.9 112.093 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.44 ' O ' ' HB2' ' A' ' 44' ' ' CYS . 12.1 Cg_endo -90.08 -72.88 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 123.054 2.503 . . . . 1.5 112.579 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.418 ' O ' ' HA ' ' A' ' 36' ' ' VAL . 0.4 OUTLIER -91.79 35.6 0.97 Allowed 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 110.265 -0.272 . . . . 1.26 110.265 179.525 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.999 ' CG1' HG13 ' A' ' 36' ' ' VAL . 13.3 mt -139.81 98.92 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 N-CA-C 113.664 0.987 . . . . 0.83 113.664 -178.228 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.864 ' HB2' ' HA ' ' A' ' 41' ' ' ALA . 3.7 t -119.71 108.71 14.76 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 107.376 -1.342 . . . . 0.92 107.376 176.114 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.803 ' CB ' ' HB1' ' A' ' 68' ' ' ALA . 4.3 m -121.94 161.67 22.45 Favored 'General case' 0 N--CA 1.429 -1.516 0 CA-C-N 114.374 -1.285 . . . . 1.28 112.703 -176.348 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.503 ' O ' ' HB2' ' A' ' 69' ' ' ALA . . . -142.02 -173.42 14.08 Favored Glycine 0 N--CA 1.426 -2.027 0 CA-C-N 113.454 -1.703 . . . . 0.67 110.096 175.193 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.445 ' OD2' ' HG2' ' A' ' 31' ' ' GLU . 17.4 p-10 -67.3 -52.6 38.6 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 112.578 0.585 . . . . 2.27 112.578 -179.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.445 ' HG2' ' OD2' ' A' ' 30' ' ' ASP . 0.4 OUTLIER -119.17 19.12 12.96 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 122.411 1.1 . . . . 1.66 109.468 -178.703 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.712 HD22 ' CE1' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -113.73 -12.32 12.8 Favored 'General case' 0 N--CA 1.415 -2.208 0 CA-C-N 112.902 -1.954 . . . . 1.37 106.665 -178.923 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.701 ' HA2' ' CB ' ' A' ' 69' ' ' ALA . . . 52.81 -134.1 39.88 Favored Glycine 0 N--CA 1.415 -2.727 0 CA-C-N 113.952 -1.476 . . . . 0.73 113.831 177.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.793 ' HB2' HD13 ' A' ' 72' ' ' ILE . 0.9 OUTLIER -127.28 119.99 27.6 Favored 'General case' 0 N--CA 1.429 -1.519 0 N-CA-C 116.024 1.861 . . . . 1.08 116.024 -178.188 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.833 ' HB3' ' CG2' ' A' ' 38' ' ' THR . 8.4 m-85 -95.37 105.06 16.99 Favored 'General case' 0 N--CA 1.417 -2.082 1 N-CA-C 99.622 -4.214 . . . . 1.38 99.622 173.175 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.999 HG13 ' CG1' ' A' ' 26' ' ' ILE . 2.2 t -103.04 88.27 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.642 0 CA-C-O 122.794 1.283 . . . . 0.76 110.273 -176.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.452 ' O ' ' O ' ' A' ' 38' ' ' THR . . . 120.21 -46.48 1.12 Allowed Glycine 0 N--CA 1.461 0.323 0 CA-C-N 113.397 -1.729 . . . . 0.81 115.684 178.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.833 ' CG2' ' HB3' ' A' ' 35' ' ' PHE . 3.2 t -47.36 -174.66 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 117.305 0.553 . . . . 0.77 111.906 -178.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.808 ' HA ' HD12 ' A' ' 42' ' ' LEU . . . -70.17 -23.73 63.02 Favored 'General case' 0 CA--C 1.515 -0.393 0 O-C-N 121.817 -0.552 . . . . 1.02 112.445 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.528 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 1.3 mp0 -60.06 -28.04 67.46 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.586 -0.279 . . . . 2.32 110.769 179.256 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.864 ' HA ' ' HB2' ' A' ' 27' ' ' CYS . . . -93.14 -22.74 18.9 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 122.221 0.208 . . . . 0.87 111.313 -179.086 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.808 HD12 ' HA ' ' A' ' 39' ' ' ALA . 5.0 mt -49.7 -39.76 37.97 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 121.238 0.542 . . . . 1.23 110.716 179.183 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.764 ' HB3' ' HB2' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -56.6 -17.7 9.48 Favored 'General case' 0 CA--C 1.496 -1.123 0 CA-C-N 115.622 -0.717 . . . . 2.92 109.704 178.561 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.522 ' HB3' ' O ' ' A' ' 23' ' ' GLY . 68.0 m -75.31 0.45 16.68 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 120.042 1.292 . . . . 1.57 112.036 -179.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 71.4 tp60 -60.88 -21.32 63.18 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.066 0.46 . . . . 3.31 110.216 178.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -85.8 2.8 44.21 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 119.753 -0.779 . . . . 3.69 111.112 -179.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -82.61 3.11 30.09 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 116.147 -0.479 . . . . 3.99 109.739 177.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -84.92 -27.55 26.51 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 116.134 -0.485 . . . . 3.86 110.73 179.167 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.426 ' H ' ' HD1' ' A' ' 49' ' ' TYR . 0.4 OUTLIER -123.98 42.17 3.31 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.039 0.447 . . . . 5.68 111.677 -179.509 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.671 ' CD2' HD11 ' A' ' 11' ' ' LEU . 0.5 OUTLIER -147.05 98.4 4.06 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.76 -0.655 . . . . 5.4 110.61 178.956 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -79.6 46.77 2.31 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.59 2.193 . . . . 4.92 112.96 -179.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 49.3 m -95.56 107.57 34.16 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.488 -0.324 . . . . 5.64 111.006 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -80.19 -24.39 5.65 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.842 2.361 . . . . 5.04 112.656 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.58 ' SG ' ' HG3' ' A' ' 8' ' ' ARG . 52.8 t 65.84 99.12 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.432 -0.349 . . . . 2.74 111.075 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 1.086 ' HG2' ' HB2' ' A' ' 8' ' ' ARG . 0.4 OUTLIER 20.53 -103.88 0.01 OUTLIER 'General case' 0 C--N 1.343 0.324 0 N-CA-C 114.335 1.235 . . . . 5.75 114.335 179.036 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.631 ' HB3' ' HB ' ' A' ' 2' ' ' VAL . 8.1 t -169.5 144.78 3.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.412 -0.813 . . . . 3.12 109.213 -178.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 178.36 -86.64 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 119.998 -1.096 . . . . 2.1 113.15 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.965 ' HB3' ' HB3' ' A' ' 67' ' ' CYS . 15.6 mt-30 -120.6 85.94 2.48 Favored 'General case' 0 N--CA 1.417 -2.081 0 N-CA-C 107.55 -1.278 . . . . 4.36 107.55 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 1.298 ' O ' ' HA ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -136.44 -52.38 0.02 OUTLIER Pre-proline 0 C--N 1.305 -1.333 0 N-CA-C 106.562 -1.644 . . . . 3.55 106.562 179.799 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.83 ' HD2' ' H ' ' A' ' 59' ' ' LYS . 43.8 Cg_endo -84.96 108.5 1.18 Allowed 'Trans proline' 0 C--N 1.298 -2.126 0 CA-C-N 120.404 1.18 . . . . 1.54 114.076 177.009 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.737 ' SG ' ' HB3' ' A' ' 84' ' ' ALA . 3.0 t -142.95 -176.99 5.12 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 113.979 -1.464 . . . . 1.59 108.565 178.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.562 ' O ' ' O ' ' A' ' 61' ' ' CYS . . . 33.46 -166.19 0.01 OUTLIER Glycine 0 CA--C 1.524 0.598 0 C-N-CA 120.729 -0.748 . . . . 2.43 114.468 176.337 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -83.23 50.32 1.73 Allowed 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 122.423 1.106 . . . . 4.11 111.237 179.243 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 121.5 5.18 9.46 Favored Glycine 0 N--CA 1.474 1.172 0 CA-C-N 112.995 -1.911 . . . . 2.21 115.041 171.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.466 ' O ' ' N ' ' A' ' 61' ' ' CYS . . . -103.72 158.31 17.14 Favored Glycine 0 C--N 1.336 0.535 0 C-N-CA 120.957 -0.64 . . . . 1.62 112.767 -178.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 1.298 ' HA ' ' O ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -88.44 152.69 21.73 Favored 'General case' 0 CA--C 1.477 -1.863 0 CA-C-O 121.367 0.603 . . . . 3.02 112.295 -178.865 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.965 ' HB3' ' HB3' ' A' ' 58' ' ' GLN . 0.1 OUTLIER -73.75 108.2 6.44 Favored 'General case' 1 N--CA 1.374 -4.243 0 N-CA-C 107.254 -1.388 . . . . 1.52 107.254 178.145 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.803 ' HB1' ' CB ' ' A' ' 28' ' ' CYS . . . -80.66 -57.24 3.66 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 104.873 -2.269 . . . . 1.07 104.873 178.098 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.856 ' HB3' HD11 ' A' ' 72' ' ' ILE . . . -154.42 161.8 41.51 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 111.785 -2.461 . . . . 1.0 111.636 -173.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.858 ' HA ' ' O ' ' A' ' 85' ' ' CYS . . . -32.8 122.7 0.36 Allowed 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 114.693 1.368 . . . . 1.24 114.693 -179.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.764 ' O ' ' HA ' ' A' ' 81' ' ' GLU . . . 59.45 -5.5 0.09 OUTLIER Glycine 0 CA--C 1.533 1.203 0 N-CA-C 116.801 1.48 . . . . 1.28 116.801 178.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.856 HD11 ' HB3' ' A' ' 69' ' ' ALA . 1.9 pp -121.04 100.07 8.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 122.73 1.252 . . . . 2.27 109.85 177.297 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.539 ' HB3' ' HB3' ' A' ' 61' ' ' CYS . 58.5 m -110.25 111.99 23.67 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 113.481 -1.69 . . . . 1.98 110.189 -177.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.583 ' HA ' ' O ' ' A' ' 78' ' ' GLY . 5.3 m -83.46 133.83 34.89 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 113.531 0.937 . . . . 1.33 113.531 -177.037 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.854 ' HB2' ' HD2' ' A' ' 76' ' ' PRO . 28.9 p -95.62 -179.06 0.86 Allowed Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 113.869 -1.514 . . . . 1.99 107.248 177.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.854 ' HD2' ' HB2' ' A' ' 75' ' ' SER . 57.5 Cg_endo -71.61 31.11 0.24 Allowed 'Trans proline' 0 CA--C 1.532 0.376 0 CA-C-N 120.56 1.236 . . . . 1.86 112.113 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.503 ' H ' ' C ' ' A' ' 75' ' ' SER . 3.0 p30 -145.67 -46.09 0.21 Allowed 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 115.899 -0.591 . . . . 2.65 111.661 179.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 1.142 ' HA3' ' O ' ' B' ' 179' ' ' CYS . . . -160.76 -151.54 6.26 Favored Glycine 0 C--N 1.349 1.28 0 C-N-CA 120.314 -0.946 . . . . 0.99 115.242 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 1.175 ' O ' ' HA3' ' B' ' 178' ' ' GLY . 32.3 m -128.87 133.75 48.05 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-O 123.377 1.561 . . . . 1.34 110.703 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 28.8 p80 -146.04 135.2 22.76 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 112.27 -2.241 . . . . 2.17 112.495 -169.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.764 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 34.4 mt-10 -51.91 123.88 11.38 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 114.132 -1.395 . . . . 3.05 111.067 -179.454 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.401 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 0.0 OUTLIER -146.78 126.04 6.52 Favored Pre-proline 0 C--N 1.317 -0.845 0 CA-C-N 115.044 -0.98 . . . . 2.02 109.293 -179.656 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.745 ' HB3' ' HB1' ' A' ' 89' ' ' ALA . 71.8 Cg_exo -54.77 -13.53 6.19 Favored 'Trans proline' 0 N--CA 1.482 0.838 0 C-N-CA 124.038 3.158 . . . . 1.93 116.21 -177.12 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.737 ' HB3' ' SG ' ' A' ' 61' ' ' CYS . . . -71.42 -32.1 67.99 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 115.094 1.516 . . . . 1.53 115.094 -177.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.858 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 0.1 OUTLIER -91.15 -4.24 56.34 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 115.262 1.579 . . . . 1.88 115.262 -176.158 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.736 ' O ' ' N ' ' A' ' 88' ' ' GLU . 2.2 t70 -117.69 84.9 20.64 Favored Pre-proline 0 C--N 1.32 -0.696 0 N-CA-C 113.215 0.82 . . . . 3.6 113.215 -178.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -49.49 65.47 0.02 OUTLIER 'Trans proline' 0 CA--C 1.546 1.076 0 C-N-CA 123.754 2.969 . . . . 2.56 113.192 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.736 ' N ' ' O ' ' A' ' 86' ' ' ASP . 12.7 pt-20 179.48 21.99 0.0 OUTLIER 'General case' 0 CA--C 1.591 2.521 0 C-N-CA 130.935 3.694 . . . . 4.72 110.186 169.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.745 ' HB1' ' HB3' ' A' ' 83' ' ' PRO . . . -51.81 -3.43 0.02 OUTLIER 'General case' 0 C--N 1.313 -0.982 0 O-C-N 119.027 -2.296 . . . . 5.29 115.411 -167.239 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.446 ' H ' ' C ' ' A' ' 88' ' ' GLU . . . -24.75 135.9 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 114.248 1.203 . . . . 6.98 114.248 -176.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -88.24 136.07 33.15 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 113.545 -1.661 . . . . 10.21 111.82 -178.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 2.9 t . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.327 -0.844 . . . . 11.77 111.399 179.163 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.415 0 N-CA-C 109.739 -0.467 . . . . 10.07 109.739 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 102' ' ' VAL . . . . . 0.616 ' C ' HD22 ' B' ' 103' ' ' LEU . 4.2 m -85.78 168.58 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 116.613 -2.035 . . . . 8.41 110.62 -175.132 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 103' ' ' LEU . . . . . 0.709 ' H ' ' HD2' ' B' ' 153' ' ' PRO . 4.3 mm? -123.33 105.58 9.97 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 120.93 1.696 . . . . 5.87 109.518 175.441 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 104' ' ' ASP . . . . . 1.088 ' O ' ' HA ' ' B' ' 155' ' ' GLN . 0.5 OUTLIER -73.84 -87.97 0.03 OUTLIER 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 116.293 -2.163 . . . . 6.27 108.866 179.44 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . 0.509 ' O ' ' HG ' ' B' ' 105' ' ' LEU . 23.2 tp -156.5 41.57 0.36 Allowed 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 112.334 -2.212 . . . . 7.2 111.306 -177.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 106' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -95.55 -48.45 5.82 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 122.367 1.08 . . . . 8.55 108.705 176.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 107' ' ' VAL . . . . . 0.413 ' O ' HD12 ' B' ' 103' ' ' LEU . 8.7 p -155.61 125.67 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.948 0 CA-C-N 113.047 -1.888 . . . . 7.48 106.059 177.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 108' ' ' ARG . . . . . 1.097 ' HB2' ' HG2' ' B' ' 155' ' ' GLN . 0.0 OUTLIER -74.27 111.12 9.13 Favored 'General case' 0 N--CA 1.398 -3.039 0 N-CA-C 107.416 -1.327 . . . . 9.12 107.416 -177.374 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 3.7 m -106.94 95.42 5.71 Favored 'General case' 0 N--CA 1.399 -2.988 0 N-CA-C 101.544 -3.502 . . . . 5.69 101.544 172.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 110' ' ' CYS . . . . . 1.095 ' HB3' ' HG2' ' B' ' 120' ' ' ARG . 0.6 OUTLIER -84.32 103.86 13.85 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 111.916 -2.402 . . . . 2.61 111.854 178.875 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 111' ' ' LEU . . . . . 0.76 ' O ' ' HA ' ' B' ' 120' ' ' ARG . 4.2 mm? -30.64 108.54 0.26 Allowed Pre-proline 0 N--CA 1.474 0.743 0 CA-C-N 118.799 0.727 . . . . 2.47 110.271 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 112' ' ' PRO . . . . . 0.734 ' HA ' ' O ' ' B' ' 119' ' ' GLY . 49.9 Cg_endo -100.87 111.93 0.06 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.896 2.397 . . . . 1.47 115.3 -177.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.757 ' HB2' ' HB3' ' B' ' 143' ' ' ARG . 0.1 OUTLIER -129.79 -156.75 0.78 Allowed 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 116.849 -0.159 . . . . 1.0 110.81 -178.476 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 114' ' ' GLY . . . . . 0.613 ' N ' ' SG ' ' B' ' 113' ' ' CYS . . . 80.45 -158.82 42.03 Favored Glycine 0 CA--C 1.506 -0.479 0 CA-C-O 118.714 -1.048 . . . . 1.16 111.276 -177.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 115' ' ' PRO . . . . . 0.529 ' HD3' ' HG2' ' B' ' 140' ' ' GLU . 88.4 Cg_endo -64.97 82.82 0.18 Allowed 'Trans proline' 0 CA--C 1.508 -0.809 0 CA-C-N 120.871 2.336 . . . . 1.57 115.659 -176.259 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' B' ' 114' ' ' GLY . . . 88.95 0.71 80.79 Favored Glycine 0 N--CA 1.415 -2.754 0 CA-C-N 111.949 -2.387 . . . . 1.7 115.096 -178.172 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 117' ' ' GLY . . . . . 0.645 ' O ' ' HB2' ' B' ' 112' ' ' PRO . . . 93.07 33.27 7.39 Favored Glycine 0 N--CA 1.429 -1.823 0 CA-C-N 120.577 2.189 . . . . 1.38 117.359 174.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -94.02 -14.03 26.29 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 112.828 0.677 . . . . 2.54 112.828 177.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 119' ' ' GLY . . . . . 0.734 ' O ' ' HA ' ' B' ' 112' ' ' PRO . . . -111.98 -174.63 19.68 Favored Glycine 0 C--N 1.345 1.072 0 CA-C-O 117.37 -1.794 . . . . 1.04 108.907 179.042 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 1.095 ' HG2' ' HB3' ' B' ' 110' ' ' CYS . 0.2 OUTLIER -123.59 175.36 6.85 Favored 'General case' 0 C--N 1.349 0.584 0 CA-C-N 122.52 3.16 . . . . 2.89 110.318 -179.032 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 121' ' ' CYS . . . . . . . . . . . . . 10.9 m -106.94 156.56 18.58 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.171 0.51 . . . . 1.07 112.123 -179.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 122' ' ' PHE . . . . . 0.576 ' HE1' ' O ' ' B' ' 128' ' ' CYS . 56.2 m-85 -143.53 17.11 1.84 Allowed 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.497 -0.774 . . . . 1.53 111.163 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 123' ' ' GLY . . . . . 0.532 ' O ' ' HB3' ' B' ' 144' ' ' CYS . . . 162.28 -144.0 9.28 Favored Glycine 0 CA--C 1.519 0.289 0 C-N-CA 120.856 -0.688 . . . . 0.9 112.139 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . 0.493 ' O ' ' HB2' ' B' ' 144' ' ' CYS . 12.1 Cg_endo -89.99 -73.05 0.0 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 123.016 2.477 . . . . 1.51 112.607 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 125' ' ' SER . . . . . 0.438 ' O ' ' HA ' ' B' ' 136' ' ' VAL . 0.4 OUTLIER -91.28 35.31 0.93 Allowed 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 110.108 -0.33 . . . . 1.25 110.108 179.431 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 126' ' ' ILE . . . . . 0.914 ' CG1' HG13 ' B' ' 136' ' ' VAL . 17.9 mt -139.38 98.14 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 114.007 1.114 . . . . 0.85 114.007 -178.02 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 127' ' ' CYS . . . . . 0.834 ' HB2' ' HA ' ' B' ' 141' ' ' ALA . 3.7 t -119.83 109.31 15.43 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 107.553 -1.277 . . . . 0.89 107.553 176.345 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 128' ' ' CYS . . . . . 0.751 ' HB3' ' O ' ' B' ' 133' ' ' GLY . 3.7 m -132.31 148.13 52.42 Favored 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 115.259 1.577 . . . . 1.23 115.259 -175.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 129' ' ' GLY . . . . . 0.47 ' O ' ' HB2' ' B' ' 169' ' ' ALA . . . -126.9 -168.1 12.48 Favored Glycine 0 N--CA 1.429 -1.812 0 N-CA-C 109.874 -1.291 . . . . 0.66 109.874 179.156 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 130' ' ' ASP . . . . . 0.427 ' OD2' ' HG2' ' B' ' 131' ' ' GLU . 17.9 p-10 -69.1 -54.01 17.28 Favored 'General case' 0 CA--C 1.491 -1.303 0 C-N-CA 123.396 0.678 . . . . 2.35 112.199 -179.091 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 131' ' ' GLU . . . . . 0.427 ' HG2' ' OD2' ' B' ' 130' ' ' ASP . 0.3 OUTLIER -119.56 28.11 8.36 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 117.495 -1.682 . . . . 1.69 109.215 179.609 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 132' ' ' LEU . . . . . 0.737 HD22 ' CE1' ' B' ' 135' ' ' PHE . 0.7 OUTLIER -121.47 -12.2 8.6 Favored 'General case' 0 N--CA 1.424 -1.741 0 N-CA-C 104.289 -2.485 . . . . 1.38 104.289 -175.709 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 133' ' ' GLY . . . . . 0.756 ' HA2' ' CB ' ' B' ' 169' ' ' ALA . . . 48.91 -136.08 20.1 Favored Glycine 0 N--CA 1.407 -3.249 0 CA-C-N 112.831 -1.986 . . . . 0.72 113.359 176.334 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 134' ' ' CYS . . . . . 0.802 ' HB2' HD13 ' B' ' 172' ' ' ILE . 1.1 m -118.88 125.7 50.1 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.273 1.212 . . . . 1.08 114.273 -176.584 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 135' ' ' PHE . . . . . 0.804 ' HB3' ' CG2' ' B' ' 138' ' ' THR . 8.8 m-85 -102.17 104.2 14.77 Favored 'General case' 0 N--CA 1.431 -1.394 1 N-CA-C 99.508 -4.256 . . . . 1.36 99.508 169.628 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 136' ' ' VAL . . . . . 0.914 HG13 ' CG1' ' B' ' 126' ' ' ILE . 2.5 t -103.43 89.3 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.629 0 CA-C-O 122.594 1.188 . . . . 0.75 110.17 -176.257 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 137' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' B' ' 125' ' ' SER . . . 119.24 -47.61 1.01 Allowed Glycine 0 CA--C 1.519 0.3 0 CA-C-N 113.688 -1.596 . . . . 0.83 115.582 179.177 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 138' ' ' THR . . . . . 0.804 ' CG2' ' HB3' ' B' ' 135' ' ' PHE . 3.5 t -50.52 179.53 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 117.418 0.609 . . . . 0.78 112.266 -178.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 139' ' ' ALA . . . . . 0.847 ' HA ' HD12 ' B' ' 142' ' ' LEU . . . -58.08 -36.3 72.65 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.938 -1.028 . . . . 1.04 111.09 -178.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 140' ' ' GLU . . . . . 0.529 ' HG2' ' HD3' ' B' ' 115' ' ' PRO . 1.3 mp0 -53.82 -27.71 31.08 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.761 0.282 . . . . 2.31 111.761 -178.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 141' ' ' ALA . . . . . 0.834 ' HA ' ' HB2' ' B' ' 127' ' ' CYS . . . -88.46 -33.82 17.69 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 116.123 -0.49 . . . . 0.87 109.929 -179.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 142' ' ' LEU . . . . . 0.847 HD12 ' HA ' ' B' ' 139' ' ' ALA . 6.2 mt -42.31 -41.15 2.7 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.013 -0.54 . . . . 1.24 111.748 -178.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 143' ' ' ARG . . . . . 0.757 ' HB3' ' HB2' ' B' ' 113' ' ' CYS . 0.0 OUTLIER -52.55 -26.15 12.44 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 109.354 -0.61 . . . . 2.93 109.354 178.073 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 144' ' ' CYS . . . . . 0.532 ' HB3' ' O ' ' B' ' 123' ' ' GLY . 56.9 m -61.2 -16.56 46.17 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.316 -1.311 . . . . 1.61 110.702 -176.147 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 68.4 tp60 -52.68 -22.38 5.08 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 111.879 0.326 . . . . 3.35 111.879 -179.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -85.79 3.02 43.33 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 119.602 -0.839 . . . . 3.76 110.968 -179.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -82.76 3.3 29.88 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 116.056 -0.52 . . . . 4.01 109.686 177.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 148' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -84.95 -27.49 26.49 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 116.092 -0.504 . . . . 3.92 110.703 179.133 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 149' ' ' TYR . . . . . 0.421 ' HD1' ' H ' ' B' ' 149' ' ' TYR . 0.4 OUTLIER -124.06 42.23 3.29 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.936 0.398 . . . . 5.73 111.555 -179.455 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 150' ' ' LEU . . . . . 0.69 ' CD2' HD11 ' B' ' 111' ' ' LEU . 0.5 OUTLIER -147.09 98.36 4.05 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.815 -0.629 . . . . 5.46 110.525 178.939 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 151' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -79.5 46.46 2.22 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.581 2.187 . . . . 5.02 112.983 -179.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 152' ' ' SER . . . . . 0.467 ' HB3' HD23 ' B' ' 103' ' ' LEU . 50.3 m -95.48 107.11 30.93 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 116.468 -0.333 . . . . 5.73 111.214 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 153' ' ' PRO . . . . . 0.709 ' HD2' ' H ' ' B' ' 103' ' ' LEU . 92.6 Cg_endo -79.46 -24.43 6.41 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 123.046 2.498 . . . . 5.1 112.691 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 154' ' ' CYS . . . . . 0.577 ' SG ' ' HG3' ' B' ' 108' ' ' ARG . 53.5 t 66.0 98.12 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.284 -0.416 . . . . 2.68 111.421 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 155' ' ' GLN . . . . . 1.097 ' HG2' ' HB2' ' B' ' 108' ' ' ARG . 0.5 OUTLIER 21.75 -104.61 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 114.366 1.247 . . . . 5.63 114.366 178.914 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 156' ' ' SER . . . . . 0.652 ' HA ' ' HE3' ' B' ' 159' ' ' LYS . 7.5 t -168.15 146.22 4.34 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 108.728 -0.842 . . . . 3.11 108.728 -178.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 176.41 -87.6 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 119.926 -1.13 . . . . 2.07 112.967 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 158' ' ' GLN . . . . . 0.986 ' HB3' ' HB3' ' B' ' 167' ' ' CYS . 16.6 mt-30 -120.92 71.22 0.93 Allowed 'General case' 0 N--CA 1.418 -2.047 0 CA-C-O 122.151 0.976 . . . . 4.34 109.292 179.439 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 159' ' ' LYS . . . . . 1.252 ' O ' ' HA ' ' B' ' 166' ' ' ARG . 0.0 OUTLIER -107.28 -58.57 0.05 OUTLIER Pre-proline 0 C--O 1.205 -1.238 0 CA-C-O 123.72 1.724 . . . . 3.54 110.701 174.48 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 160' ' ' PRO . . . . . 0.697 ' HD2' ' H ' ' B' ' 159' ' ' LYS . 49.5 Cg_endo -85.03 108.0 1.12 Allowed 'Trans proline' 0 N--CA 1.442 -1.553 0 C-N-CA 122.466 2.11 . . . . 1.51 114.76 -176.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 161' ' ' CYS . . . . . 0.708 ' SG ' ' HB3' ' B' ' 184' ' ' ALA . 3.1 t -143.87 -177.8 5.61 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 113.452 -1.704 . . . . 1.58 108.632 178.609 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 162' ' ' GLY . . . . . 0.506 ' O ' ' O ' ' B' ' 161' ' ' CYS . . . 35.49 -166.58 0.01 OUTLIER Glycine 0 CA--C 1.519 0.309 0 C-N-CA 121.077 -0.583 . . . . 2.37 114.414 176.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.89 51.47 1.74 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 121.052 -0.259 . . . . 4.07 111.238 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 119.64 3.83 12.22 Favored Glycine 0 CA--C 1.529 0.93 0 N-CA-C 114.631 0.613 . . . . 2.2 114.631 178.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 165' ' ' GLY . . . . . 0.48 ' O ' ' N ' ' B' ' 161' ' ' CYS . . . -102.73 157.85 17.99 Favored Glycine 0 C--O 1.226 -0.385 0 C-N-CA 120.143 -1.027 . . . . 1.62 112.754 179.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 166' ' ' ARG . . . . . 1.252 ' HA ' ' O ' ' B' ' 159' ' ' LYS . 0.0 OUTLIER -88.57 152.59 21.75 Favored 'General case' 0 CA--C 1.48 -1.73 0 C-N-CA 120.325 -0.55 . . . . 3.05 111.962 -179.625 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 167' ' ' CYS . . . . . 0.986 ' HB3' ' HB3' ' B' ' 158' ' ' GLN . 0.1 OUTLIER -73.68 108.42 6.51 Favored 'General case' 1 N--CA 1.375 -4.212 0 N-CA-C 107.261 -1.385 . . . . 1.56 107.261 178.15 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' B' B ' 168' ' ' ALA . . . . . 0.751 ' HB1' ' HB2' ' B' ' 128' ' ' CYS . . . -83.5 -49.36 9.34 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 117.627 -1.629 . . . . 1.04 107.065 178.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 169' ' ' ALA . . . . . 0.866 ' HB3' HD11 ' B' ' 172' ' ' ILE . . . -161.08 161.54 31.3 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 112.5 -2.136 . . . . 0.98 111.03 -175.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 170' ' ' ALA . . . . . 0.871 ' HA ' ' O ' ' B' ' 185' ' ' CYS . . . -32.69 123.31 0.35 Allowed 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 114.846 1.424 . . . . 1.25 114.846 -179.143 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 171' ' ' GLY . . . . . 0.711 ' O ' ' HA ' ' B' ' 181' ' ' GLU . . . 65.16 -19.18 0.12 Allowed Glycine 0 CA--C 1.529 0.962 0 N-CA-C 116.47 1.348 . . . . 1.29 116.47 177.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 172' ' ' ILE . . . . . 0.866 HD11 ' HB3' ' B' ' 169' ' ' ALA . 2.0 pp -113.16 101.37 12.4 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 CA-C-O 122.684 1.231 . . . . 2.27 110.529 -179.33 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 173' ' ' CYS . . . . . 0.506 ' HB3' ' HB3' ' B' ' 161' ' ' CYS . 59.3 m -110.27 112.21 24.03 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 113.851 -1.522 . . . . 1.94 110.131 -178.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 174' ' ' CYS . . . . . 0.569 ' HA ' ' O ' ' B' ' 178' ' ' GLY . 5.5 m -83.66 133.75 34.81 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 113.56 0.948 . . . . 1.35 113.56 -176.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 175' ' ' SER . . . . . 0.828 ' HB2' ' HD2' ' B' ' 176' ' ' PRO . 28.3 p -95.66 -178.99 0.85 Allowed Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 113.893 -1.503 . . . . 2.0 107.238 177.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 176' ' ' PRO . . . . . 0.828 ' HD2' ' HB2' ' B' ' 175' ' ' SER . 57.4 Cg_endo -71.65 31.08 0.25 Allowed 'Trans proline' 0 CA--C 1.532 0.405 0 CA-C-N 120.584 1.244 . . . . 1.9 112.106 -179.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 177' ' ' ASP . . . . . 0.498 ' H ' ' C ' ' B' ' 175' ' ' SER . 3.0 p30 -145.58 -46.01 0.21 Allowed 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 115.906 -0.588 . . . . 2.72 111.743 179.422 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 178' ' ' GLY . . . . . 1.175 ' HA3' ' O ' ' A' ' 79' ' ' CYS . . . -161.07 -151.19 6.15 Favored Glycine 0 C--N 1.35 1.335 0 C-N-CA 120.295 -0.955 . . . . 0.99 115.033 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 179' ' ' CYS . . . . . 1.142 ' O ' ' HA3' ' A' ' 78' ' ' GLY . 32.7 m -128.66 139.35 52.29 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 122.649 1.214 . . . . 1.34 110.195 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 180' ' ' HIS . . . . . . . . . . . . . 33.3 p80 -156.87 133.11 9.79 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 123.619 1.676 . . . . 2.1 112.367 -168.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 181' ' ' GLU . . . . . 0.711 ' HA ' ' O ' ' B' ' 171' ' ' GLY . 33.8 mt-10 -49.55 123.14 7.19 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 110.967 -2.833 . . . . 3.06 110.733 -177.323 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 182' ' ' ASP . . . . . 0.403 ' HA ' ' HD3' ' B' ' 183' ' ' PRO . 0.1 OUTLIER -146.79 126.06 6.52 Favored Pre-proline 0 C--N 1.315 -0.916 0 CA-C-N 114.677 -1.147 . . . . 2.06 109.103 -179.725 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 183' ' ' PRO . . . . . 0.669 ' HB3' ' CB ' ' B' ' 189' ' ' ALA . 72.5 Cg_exo -54.82 -13.53 6.26 Favored 'Trans proline' 0 N--CA 1.482 0.85 0 C-N-CA 123.981 3.121 . . . . 1.91 116.241 -177.178 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 184' ' ' ALA . . . . . 0.708 ' HB3' ' SG ' ' B' ' 161' ' ' CYS . . . -71.77 -31.59 66.78 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 114.974 1.472 . . . . 1.56 114.974 -177.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 185' ' ' CYS . . . . . 0.871 ' O ' ' HA ' ' B' ' 170' ' ' ALA . 0.1 OUTLIER -91.1 -4.55 56.16 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 115.298 1.592 . . . . 1.94 115.298 -176.329 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 186' ' ' ASP . . . . . 0.669 ' O ' ' N ' ' B' ' 188' ' ' GLU . 2.2 t70 -117.88 85.23 22.34 Favored Pre-proline 0 C--N 1.321 -0.664 0 N-CA-C 113.392 0.886 . . . . 3.61 113.392 -178.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -49.3 63.47 0.02 OUTLIER 'Trans proline' 0 CA--C 1.555 1.565 0 C-N-CA 123.955 3.103 . . . . 2.58 114.945 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 188' ' ' GLU . . . . . 0.669 ' N ' ' O ' ' B' ' 186' ' ' ASP . 13.5 pt-20 174.67 49.44 0.0 OUTLIER 'General case' 1 N--CA 1.379 -4.002 1 C-N-CA 133.246 4.618 . . . . 4.7 104.799 171.088 . . . . . . . . 4 3 . 1 . 013 nuclear nobuild full ' B' B ' 189' ' ' ALA . . . . . 0.669 ' CB ' ' HB3' ' B' ' 183' ' ' PRO . . . -77.22 11.75 1.76 Allowed 'General case' 0 C--N 1.303 -1.419 1 CA-C-N 129.21 5.459 . . . . 5.24 114.012 -178.245 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 190' ' ' ALA . . . . . 0.457 ' C ' ' O ' ' B' ' 189' ' ' ALA . . . -28.76 137.77 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.947 0.721 . . . . 6.93 112.947 -178.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 191' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -89.28 136.16 33.18 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.966 -1.015 . . . . 10.14 111.564 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 3.1 t . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.337 -0.84 . . . . 11.7 111.454 179.054 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 121.192 0.52 . . . . 9.95 111.312 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.817 HG23 ' HB3' ' A' ' 6' ' ' ASP . 1.5 m -135.43 126.82 45.47 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.122 0 CA-C-N 115.308 -0.86 . . . . 8.02 112.416 178.315 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.678 ' HA ' ' HA ' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -80.49 111.98 17.4 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 106.265 -1.754 . . . . 5.86 106.265 175.327 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -169.73 -101.36 0.01 OUTLIER 'General case' 0 N--CA 1.421 -1.922 0 CA-C-N 111.681 -2.509 . . . . 6.22 106.198 171.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 16.8 tp -142.08 12.24 2.01 Favored 'General case' 0 CA--C 1.503 -0.861 0 CA-C-N 112.249 -2.251 . . . . 7.09 109.321 178.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.817 ' HB3' HG23 ' A' ' 2' ' ' VAL . 0.9 OUTLIER -80.56 -83.54 0.11 Allowed 'General case' 0 CA--C 1.483 -1.603 0 N-CA-C 101.375 -3.565 . . . . 8.78 101.375 175.426 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.618 ' HA ' ' CG ' ' A' ' 55' ' ' GLN . 1.8 p -139.18 117.7 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.157 1 N-CA-C 99.993 -4.077 . . . . 7.51 99.993 165.332 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.978 ' HB2' ' H ' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -79.26 119.16 21.93 Favored 'General case' 0 CA--C 1.485 -1.543 0 CA-C-N 122.736 2.516 . . . . 9.08 107.742 177.831 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.1 t -65.22 104.9 0.99 Allowed 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 114.211 -2.995 . . . . 5.66 107.593 -179.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.608 ' HB2' ' HG2' ' A' ' 20' ' ' ARG . 77.3 m -80.23 112.88 17.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 113.831 -1.532 . . . . 2.68 112.525 178.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.501 ' C ' ' O ' ' A' ' 10' ' ' CYS . 17.4 mt -30.8 136.17 0.21 Allowed Pre-proline 0 N--CA 1.477 0.884 0 CA-C-N 119.033 0.833 . . . . 2.48 111.251 177.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.776 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 41.5 Cg_endo -69.55 147.88 65.18 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.763 2.308 . . . . 1.49 114.881 -178.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.734 ' N ' ' O ' ' A' ' 19' ' ' GLY . 0.0 OUTLIER -149.91 -166.39 2.53 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-O 121.659 0.742 . . . . 1.0 110.951 176.675 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.636 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . 76.16 -159.59 50.54 Favored Glycine 0 C--N 1.337 0.624 0 CA-C-N 114.683 -1.144 . . . . 1.15 114.767 175.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.619 ' HD2' HD21 ' A' ' 32' ' ' LEU . 62.8 Cg_endo -62.1 101.94 0.25 Allowed 'Trans proline' 0 CA--C 1.511 -0.625 0 C-N-CA 124.301 3.334 . . . . 1.57 110.645 177.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.53 -7.74 75.04 Favored Glycine 0 C--N 1.268 -3.198 0 CA-C-N 113.901 -1.499 . . . . 1.68 112.422 179.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.412 ' O ' ' HB2' ' A' ' 12' ' ' PRO . . . 79.33 49.48 6.24 Favored Glycine 0 N--CA 1.397 -3.925 0 C-N-CA 119.714 -1.231 . . . . 1.36 113.515 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.73 -49.91 6.02 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 103.567 -2.753 . . . . 2.5 103.567 173.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.776 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -67.6 165.1 44.69 Favored Glycine 0 C--O 1.219 -0.816 0 C-N-CA 117.985 -2.055 . . . . 1.02 117.404 -165.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.608 ' HG2' ' HB2' ' A' ' 10' ' ' CYS . 0.1 OUTLIER -104.03 147.05 27.83 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 112.691 -1.755 . . . . 2.92 114.667 -172.864 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.448 ' O ' ' HB3' ' A' ' 10' ' ' CYS . 74.1 m -108.9 139.56 43.57 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 114.785 -1.098 . . . . 1.1 111.423 -179.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.631 ' CE1' ' HB2' ' A' ' 28' ' ' CYS . 1.4 m-85 -124.41 -9.78 7.47 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.238 -0.437 . . . . 1.51 112.065 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.491 ' HA3' ' OE2' ' B' ' 181' ' ' GLU . . . -159.05 -161.12 10.86 Favored Glycine 0 C--N 1.334 0.459 0 C-N-CA 120.677 -0.773 . . . . 0.9 112.576 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.559 ' HD2' ' HG2' ' B' ' 181' ' ' GLU . 7.6 Cg_exo -69.76 -53.02 0.29 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.967 2.445 . . . . 1.5 112.24 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.598 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.4 OUTLIER -118.78 44.25 2.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.015 -0.539 . . . . 1.26 110.841 -179.756 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 1.118 HG12 HG13 ' A' ' 36' ' ' VAL . 59.8 mt -142.52 121.21 8.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 N-CA-C 112.609 0.596 . . . . 0.83 112.609 -179.059 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.83 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 6.4 t -135.45 144.2 46.32 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-N 115.417 -0.811 . . . . 0.92 109.075 178.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.933 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 0.5 OUTLIER -136.35 157.66 46.27 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 122.361 1.076 . . . . 1.28 113.884 -177.08 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.609 ' O ' ' HB1' ' A' ' 69' ' ' ALA . . . -151.05 169.33 30.76 Favored Glycine 0 N--CA 1.416 -2.653 0 CA-C-N 113.812 -1.54 . . . . 0.67 110.561 176.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.457 ' OD2' ' HG3' ' A' ' 31' ' ' GLU . 15.3 p-10 -64.37 -48.4 75.64 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 122.79 1.281 . . . . 2.27 108.695 178.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.457 ' HG3' ' OD2' ' A' ' 30' ' ' ASP . 1.3 mt-10 -120.38 17.15 12.21 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 113.149 -1.842 . . . . 1.66 109.157 179.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.756 HD23 ' CZ ' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -120.2 -2.71 10.1 Favored 'General case' 0 N--CA 1.411 -2.422 0 C-N-CA 123.71 0.804 . . . . 1.37 109.334 -177.275 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.933 ' O ' ' HA ' ' A' ' 28' ' ' CYS . . . 47.63 -131.41 16.42 Favored Glycine 0 N--CA 1.433 -1.557 0 CA-C-N 114.887 -1.051 . . . . 0.73 113.616 178.041 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.893 ' HB2' HD13 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -138.68 113.27 8.96 Favored 'General case' 0 CA--C 1.481 -1.699 0 CA-C-N 118.546 1.173 . . . . 1.08 112.119 179.365 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.756 ' CZ ' HD23 ' A' ' 32' ' ' LEU . 26.5 m-85 -86.49 108.12 18.39 Favored 'General case' 0 N--CA 1.425 -1.722 0 N-CA-C 104.993 -2.225 . . . . 1.38 104.993 176.063 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 1.118 HG13 HG12 ' A' ' 26' ' ' ILE . 5.1 t -91.77 85.42 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.756 0 C-N-CA 118.341 -1.344 . . . . 0.76 108.933 -179.098 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.736 ' HA3' HG22 ' B' ' 172' ' ' ILE . . . 89.37 108.12 1.18 Allowed Glycine 0 CA--C 1.524 0.655 0 CA-C-N 112.918 -1.946 . . . . 0.81 115.159 179.179 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.511 HG21 ' HB3' ' A' ' 35' ' ' PHE . 0.1 OUTLIER 179.36 168.31 1.06 Allowed 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 107.904 -1.147 . . . . 0.77 107.904 178.588 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.887 ' HA ' HD12 ' A' ' 42' ' ' LEU . . . -55.52 -32.93 63.34 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 120.547 1.521 . . . . 1.02 114.008 -177.499 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.598 ' HG2' ' HA2' ' A' ' 14' ' ' GLY . 0.2 OUTLIER -65.27 -23.18 66.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.059 0.457 . . . . 2.32 110.561 179.712 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.584 ' O ' ' N ' ' A' ' 44' ' ' CYS . . . -95.9 -14.71 22.91 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 116.069 -0.514 . . . . 0.87 110.906 -179.042 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.887 HD12 ' HA ' ' A' ' 39' ' ' ALA . 4.7 mt -46.25 -44.37 16.32 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-N 119.042 0.837 . . . . 1.23 112.379 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.43 ' HD2' ' O ' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -61.91 -10.88 10.59 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 120.095 -0.642 . . . . 2.92 109.68 178.101 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.584 ' N ' ' O ' ' A' ' 41' ' ' ALA . 38.5 m -76.6 4.81 8.57 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 114.171 -1.377 . . . . 1.57 110.155 174.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.607 ' HB2' ' O ' ' A' ' 42' ' ' LEU . 0.7 OUTLIER -78.79 -18.6 53.88 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.982 -0.554 . . . . 3.31 111.268 179.337 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.567 ' HA ' ' CD2' ' A' ' 49' ' ' TYR . 16.8 tt0 -86.92 -0.37 56.41 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.051 -0.66 . . . . 3.69 110.539 -179.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.03 3.67 29.34 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 109.537 -0.542 . . . . 3.99 109.537 177.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.44 ' ND2' ' HG3' ' A' ' 24' ' ' PRO . 0.4 OUTLIER -97.36 -28.22 14.13 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 116.131 -0.486 . . . . 3.86 109.997 178.704 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.567 ' CD2' ' HA ' ' A' ' 46' ' ' GLU . 43.2 m-85 -69.88 8.92 0.61 Allowed 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.238 0.459 . . . . 5.68 112.238 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.7 mt -131.18 121.17 18.51 Favored Pre-proline 0 CA--C 1.529 0.146 0 O-C-N 122.348 -0.22 . . . . 5.4 111.23 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -80.73 48.93 3.06 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.353 2.035 . . . . 4.92 112.203 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 61.9 p -139.66 159.59 64.64 Favored Pre-proline 0 CA--C 1.531 0.231 0 CA-C-N 116.3 -0.409 . . . . 5.64 110.812 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.41 ' O ' ' CD ' ' A' ' 8' ' ' ARG . 2.2 Cg_endo -82.89 -163.63 0.22 Allowed 'Trans proline' 0 CA--C 1.535 0.541 0 C-N-CA 123.279 2.653 . . . . 5.04 113.524 -179.021 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.836 ' HA ' ' CB ' ' A' ' 8' ' ' ARG . 0.5 OUTLIER -160.5 126.07 3.94 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.64 -0.709 . . . . 2.74 109.398 -179.887 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.978 ' H ' ' HB2' ' A' ' 8' ' ' ARG . 0.7 OUTLIER -48.86 -169.76 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.303 0 CA-C-O 121.963 0.887 . . . . 5.75 112.901 -178.784 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.434 ' HB2' ' HA ' ' A' ' 68' ' ' ALA . 17.7 p 172.88 -162.1 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 114.345 -1.298 . . . . 3.12 108.043 178.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.633 ' HA3' ' O ' ' A' ' 67' ' ' CYS . . . -82.46 151.72 29.89 Favored Glycine 0 N--CA 1.448 -0.539 0 N-CA-C 109.726 -1.35 . . . . 2.1 109.726 -177.232 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 19.7 mm100 -101.88 77.45 1.71 Allowed 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.976 0.893 . . . . 4.36 109.655 179.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.497 ' HB2' ' HB2' ' A' ' 67' ' ' CYS . 0.0 OUTLIER -141.77 60.47 11.36 Favored Pre-proline 0 C--N 1.31 -1.13 0 N-CA-C 105.746 -1.946 . . . . 3.55 105.746 179.22 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.546 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 30.7 Cg_endo -63.6 78.18 0.14 Allowed 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 122.605 2.203 . . . . 1.54 114.887 -177.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.493 ' O ' ' O ' ' A' ' 65' ' ' GLY . 0.5 OUTLIER -99.26 -176.83 3.42 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 106.468 -1.678 . . . . 1.59 106.468 175.868 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.79 -167.02 51.36 Favored Glycine 0 N--CA 1.442 -0.963 0 C-N-CA 117.945 -2.074 . . . . 2.43 111.809 178.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 20.2 p -86.86 39.41 0.85 Allowed 'General case' 0 N--CA 1.484 1.262 0 CA-C-O 122.223 1.011 . . . . 4.11 111.642 -176.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 120.68 10.38 7.1 Favored Glycine 0 C--N 1.35 1.341 0 CA-C-N 114.013 -1.449 . . . . 2.21 113.886 -178.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.493 ' O ' ' O ' ' A' ' 61' ' ' CYS . . . -103.48 132.99 11.26 Favored Glycine 0 C--N 1.336 0.581 0 C-N-CA 119.657 -1.259 . . . . 1.62 115.401 -178.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.58 ' HB2' ' O ' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -97.29 152.98 18.34 Favored 'General case' 0 C--N 1.333 -0.126 0 C-N-CA 122.84 0.456 . . . . 3.02 110.441 178.555 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.633 ' O ' ' HA3' ' A' ' 57' ' ' GLY . 1.8 m -65.34 108.47 1.95 Allowed 'General case' 0 C--O 1.22 -0.486 0 C-N-CA 120.002 -0.679 . . . . 1.52 110.269 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.483 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . . . -81.61 -15.55 54.31 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 107.802 -1.184 . . . . 1.07 107.802 176.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.859 ' O ' ' O ' ' A' ' 70' ' ' ALA . . . -165.11 162.15 20.02 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 112.801 -2.0 . . . . 1.0 110.405 178.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.859 ' O ' ' O ' ' A' ' 69' ' ' ALA . . . -16.99 -138.11 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.078 0.951 . . . . 1.24 113.287 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.583 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . -64.55 61.11 0.07 OUTLIER Glycine 0 N--CA 1.47 0.936 0 N-CA-C 110.184 -1.166 . . . . 1.28 110.184 -179.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.893 HD13 ' HB2' ' A' ' 34' ' ' CYS . 0.7 OUTLIER -146.04 106.12 0.69 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.817 0 CA-C-N 114.731 -0.734 . . . . 2.27 109.771 174.962 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.521 ' HB2' ' HB3' ' A' ' 82' ' ' ASP . 0.0 OUTLIER -93.25 83.42 4.62 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 116.236 -0.438 . . . . 1.98 110.407 -179.556 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.861 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 0.1 OUTLIER -83.04 136.63 34.42 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.982 -0.554 . . . . 1.33 110.816 -179.914 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.699 ' HB3' ' HD2' ' A' ' 76' ' ' PRO . 5.0 m -104.76 179.4 0.94 Allowed Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.25 -0.887 . . . . 1.99 109.312 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.699 ' HD2' ' HB3' ' A' ' 75' ' ' SER . 96.4 Cg_endo -79.96 25.08 0.61 Allowed 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 121.443 1.429 . . . . 1.86 111.722 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -145.58 -41.42 0.22 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.609 -0.723 . . . . 2.65 110.213 179.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.792 ' HA3' ' O ' ' B' ' 179' ' ' CYS . . . -147.92 -135.29 2.59 Favored Glycine 0 C--N 1.337 0.601 0 C-N-CA 120.574 -0.822 . . . . 0.99 113.07 179.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.861 ' HA ' ' HA ' ' A' ' 74' ' ' CYS . 0.1 OUTLIER -146.85 156.45 43.12 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.625 0.25 . . . . 1.34 110.57 179.954 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.474 ' N ' ' O ' ' A' ' 73' ' ' CYS . 6.6 t-160 -142.42 133.76 26.32 Favored 'General case' 0 CA--C 1.519 -0.249 0 O-C-N 121.989 -0.444 . . . . 2.17 111.638 -178.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.571 ' CG ' ' HD2' ' B' ' 124' ' ' PRO . 2.3 mt-10 -58.56 128.03 35.12 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.901 -0.591 . . . . 3.05 109.717 178.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.521 ' HB3' ' HB2' ' A' ' 73' ' ' CYS . 0.0 OUTLIER -146.28 112.63 4.41 Favored Pre-proline 0 C--N 1.318 -0.799 0 CA-C-N 115.514 -0.766 . . . . 2.02 110.496 -178.928 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.458 ' HA ' ' OD2' ' A' ' 86' ' ' ASP . 1.6 Cg_endo -82.86 -4.4 11.34 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 122.691 2.261 . . . . 1.93 113.231 -179.26 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.99 -35.43 79.94 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.832 0.349 . . . . 1.53 111.048 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.635 ' C ' ' HD3' ' A' ' 87' ' ' PRO . 84.4 m -93.64 49.71 1.39 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.107 -0.497 . . . . 1.88 110.869 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.755 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 16.5 m-20 -116.68 35.19 0.2 Allowed Pre-proline 0 N--CA 1.442 -0.827 0 N-CA-C 112.422 0.527 . . . . 3.6 112.422 179.44 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.71 ' HD3' ' N ' ' A' ' 86' ' ' ASP . 1.6 Cg_endo -78.68 63.2 8.51 Favored 'Trans proline' 0 C--N 1.362 1.259 0 N-CA-C 106.697 -2.078 . . . . 2.56 106.697 176.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.471 ' HG3' ' N ' ' A' ' 89' ' ' ALA . 4.6 pt-20 178.11 -30.7 0.01 OUTLIER 'General case' 0 CA--C 1.477 -1.831 0 CA-C-N 112.239 -2.255 . . . . 4.72 110.396 179.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.755 ' HB3' ' HB3' ' A' ' 86' ' ' ASP . . . -72.51 49.93 0.22 Allowed 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 110.906 -2.861 . . . . 5.29 111.798 178.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.28 119.6 15.65 Favored 'General case' 0 C--N 1.312 -1.024 0 C-N-CA 127.335 2.254 . . . . 6.98 111.641 178.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -71.17 130.44 41.47 Favored 'General case' 0 C--N 1.354 0.765 0 CA-C-N 111.252 -2.704 . . . . 10.21 113.626 -174.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 12.5 t . . . . . 0 C--O 1.248 1.022 0 CA-C-N 114.356 -1.293 . . . . 11.77 110.654 179.378 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 101' ' ' ALA . . . . . 0.603 ' HB3' ' OD2' ' B' ' 104' ' ' ASP . . . . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 121.19 0.519 . . . . 10.07 111.172 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 102' ' ' VAL . . . . . 0.474 ' O ' HG12 ' B' ' 102' ' ' VAL . 23.6 t -86.79 -13.74 10.53 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.329 0 CA-C-O 122.291 1.043 . . . . 8.41 111.361 -175.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 103' ' ' LEU . . . . . 1.093 ' HA ' ' HA ' ' B' ' 108' ' ' ARG . 0.3 OUTLIER -153.28 111.18 3.58 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 102.349 -3.204 . . . . 5.87 102.349 176.506 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 104' ' ' ASP . . . . . 0.603 ' OD2' ' HB3' ' B' ' 101' ' ' ALA . 0.4 OUTLIER -165.84 -105.91 0.01 OUTLIER 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 105.902 -1.888 . . . . 6.27 105.902 176.176 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . 0.409 ' H ' ' HB3' ' B' ' 104' ' ' ASP . 10.2 tp -133.94 6.54 3.68 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 113.39 -1.732 . . . . 7.2 109.812 176.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 106' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.33 -63.83 1.27 Allowed 'General case' 0 CA--C 1.496 -1.12 0 N-CA-C 102.837 -3.023 . . . . 8.55 102.837 176.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 107' ' ' VAL . . . . . 0.631 ' HA ' ' CG ' ' B' ' 155' ' ' GLN . 2.7 p -154.48 114.92 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.541 0 N-CA-C 102.93 -2.989 . . . . 7.48 102.93 163.267 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 108' ' ' ARG . . . . . 1.093 ' HA ' ' HA ' ' B' ' 103' ' ' LEU . 0.0 OUTLIER -80.11 117.42 20.91 Favored 'General case' 0 CA--C 1.475 -1.913 0 CA-C-N 122.17 2.259 . . . . 9.12 107.638 178.436 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 109' ' ' THR . . . . . 0.412 ' CG2' HD23 ' B' ' 103' ' ' LEU . 2.5 t -63.9 105.27 0.81 Allowed 'General case' 0 C--N 1.317 -0.809 0 C-N-CA 114.256 -2.978 . . . . 5.69 107.437 -179.226 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 110' ' ' CYS . . . . . 0.62 ' HB2' ' HG2' ' B' ' 120' ' ' ARG . 79.7 m -81.63 111.21 17.7 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 113.76 -1.564 . . . . 2.61 112.653 178.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 111' ' ' LEU . . . . . 0.509 ' C ' ' O ' ' B' ' 110' ' ' CYS . 17.8 mt -29.82 136.07 0.18 Allowed Pre-proline 0 N--CA 1.475 0.796 0 CA-C-N 119.034 0.834 . . . . 2.47 111.369 178.412 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 112' ' ' PRO . . . . . 0.819 ' HA ' ' O ' ' B' ' 119' ' ' GLY . 33.6 Cg_endo -65.32 151.99 83.49 Favored 'Trans proline' 0 CA--C 1.536 0.587 0 C-N-CA 123.383 2.722 . . . . 1.47 113.541 -179.34 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.748 ' N ' ' O ' ' B' ' 119' ' ' GLY . 0.0 OUTLIER -156.77 -168.69 2.75 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.232 0.539 . . . . 1.0 111.222 175.471 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 114' ' ' GLY . . . . . 0.66 ' N ' ' SG ' ' B' ' 113' ' ' CYS . . . 76.14 -159.76 50.71 Favored Glycine 0 C--N 1.334 0.437 0 CA-C-N 115.479 -0.782 . . . . 1.16 114.902 176.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 115' ' ' PRO . . . . . 0.618 ' HD2' HD21 ' B' ' 132' ' ' LEU . 68.2 Cg_endo -62.28 98.31 0.18 Allowed 'Trans proline' 0 CA--C 1.511 -0.629 0 C-N-CA 124.215 3.277 . . . . 1.57 112.066 178.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 84.76 3.07 88.38 Favored Glycine 0 C--N 1.284 -2.312 0 CA-C-N 113.63 -1.623 . . . . 1.7 113.132 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 117' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' B' ' 112' ' ' PRO . . . 76.46 41.31 25.55 Favored Glycine 0 N--CA 1.411 -2.976 0 C-N-CA 119.75 -1.214 . . . . 1.38 115.615 176.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.99 -30.1 14.9 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-O 121.809 0.814 . . . . 2.54 110.198 177.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 119' ' ' GLY . . . . . 0.819 ' O ' ' HA ' ' B' ' 112' ' ' PRO . . . -78.65 161.39 48.07 Favored Glycine 0 C--O 1.201 -1.909 0 N-CA-C 118.745 2.258 . . . . 1.04 118.745 -175.212 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.62 ' HG2' ' HB2' ' B' ' 110' ' ' CYS . 0.1 OUTLIER -104.24 142.39 34.61 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 110.214 -2.993 . . . . 2.89 113.747 -172.55 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 121' ' ' CYS . . . . . 0.459 ' O ' ' HB3' ' B' ' 110' ' ' CYS . 73.3 m -108.51 138.98 43.92 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 114.777 -1.101 . . . . 1.07 111.23 -178.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 122' ' ' PHE . . . . . 0.65 ' CE1' ' HB2' ' B' ' 128' ' ' CYS . 1.4 m-85 -124.42 -9.67 7.46 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.185 -0.461 . . . . 1.53 112.052 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 123' ' ' GLY . . . . . 0.517 ' HA3' ' OE2' ' A' ' 81' ' ' GLU . . . -159.22 -161.3 11.06 Favored Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.6 -0.81 . . . . 0.9 112.465 179.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . 0.571 ' HD2' ' CG ' ' A' ' 81' ' ' GLU . 7.9 Cg_exo -69.54 -52.94 0.31 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.93 2.42 . . . . 1.51 112.302 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 125' ' ' SER . . . . . 0.615 ' O ' ' N ' ' B' ' 137' ' ' GLY . 0.4 OUTLIER -118.75 44.03 2.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.054 -0.521 . . . . 1.25 110.787 -179.811 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 126' ' ' ILE . . . . . 0.983 HG12 HG13 ' B' ' 136' ' ' VAL . 57.7 mt -141.8 120.95 10.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 N-CA-C 112.812 0.671 . . . . 0.85 112.812 -179.065 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 127' ' ' CYS . . . . . 0.806 ' O ' ' HA ' ' B' ' 134' ' ' CYS . 7.0 t -135.08 144.79 47.38 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.72 -0.673 . . . . 0.89 109.472 178.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 128' ' ' CYS . . . . . 0.906 ' HA ' ' O ' ' B' ' 133' ' ' GLY . 0.4 OUTLIER -138.99 153.58 48.17 Favored 'General case' 0 CA--C 1.552 1.042 0 N-CA-C 115.541 1.682 . . . . 1.23 115.541 -176.959 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 129' ' ' GLY . . . . . 0.684 ' HA3' ' HB2' ' B' ' 132' ' ' LEU . . . -143.25 165.96 26.89 Favored Glycine 0 N--CA 1.43 -1.72 0 CA-C-N 111.262 -2.699 . . . . 0.66 113.767 179.26 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 130' ' ' ASP . . . . . 0.413 ' OD2' ' HG3' ' B' ' 131' ' ' GLU . 15.4 p-10 -68.97 -41.64 77.69 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 126.028 1.731 . . . . 2.35 110.706 177.146 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 131' ' ' GLU . . . . . 0.413 ' HG3' ' OD2' ' B' ' 130' ' ' ASP . 0.5 OUTLIER -129.69 33.65 4.42 Favored 'General case' 0 CA--C 1.479 -1.78 0 CA-C-N 111.436 -2.62 . . . . 1.69 108.663 170.082 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 132' ' ' LEU . . . . . 0.73 HD23 ' CZ ' ' B' ' 135' ' ' PHE . 0.1 OUTLIER -131.2 -1.44 4.03 Favored 'General case' 0 N--CA 1.401 -2.89 0 N-CA-C 107.645 -1.242 . . . . 1.38 107.645 179.59 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 133' ' ' GLY . . . . . 0.906 ' O ' ' HA ' ' B' ' 128' ' ' CYS . . . 44.32 -133.98 6.64 Favored Glycine 0 N--CA 1.426 -1.992 0 CA-C-N 115.07 -0.968 . . . . 0.72 112.909 179.263 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 134' ' ' CYS . . . . . 0.898 ' HB2' HD13 ' B' ' 172' ' ' ILE . 0.1 OUTLIER -134.9 111.58 9.97 Favored 'General case' 0 CA--C 1.486 -1.512 0 N-CA-C 113.653 0.983 . . . . 1.08 113.653 -178.721 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 135' ' ' PHE . . . . . 0.74 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 27.5 m-85 -84.43 106.82 16.31 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 104.694 -2.336 . . . . 1.36 104.694 176.035 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 136' ' ' VAL . . . . . 0.983 HG13 HG12 ' B' ' 126' ' ' ILE . 12.6 t -92.33 84.79 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.669 0 CA-C-O 122.987 1.375 . . . . 0.75 108.65 -179.178 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 137' ' ' GLY . . . . . 0.749 ' HA3' HG22 ' A' ' 72' ' ' ILE . . . 88.65 107.95 1.07 Allowed Glycine 0 CA--C 1.523 0.579 0 CA-C-N 112.493 -2.139 . . . . 0.83 115.098 179.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 138' ' ' THR . . . . . 0.514 HG21 ' HB3' ' B' ' 135' ' ' PHE . 0.1 OUTLIER -174.01 -179.51 1.71 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 107.704 -1.221 . . . . 0.78 107.704 178.472 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 139' ' ' ALA . . . . . 0.857 ' HA ' HD12 ' B' ' 142' ' ' LEU . . . -65.07 -37.67 88.3 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 119.68 1.127 . . . . 1.04 111.393 179.309 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 140' ' ' GLU . . . . . 0.593 ' HG2' ' HA2' ' B' ' 114' ' ' GLY . 0.2 OUTLIER -62.04 -22.85 66.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.061 0.458 . . . . 2.31 111.386 -179.418 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 141' ' ' ALA . . . . . 0.608 ' O ' ' N ' ' B' ' 144' ' ' CYS . . . -93.39 -19.46 21.28 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.508 -0.769 . . . . 0.87 110.972 -179.411 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 142' ' ' LEU . . . . . 0.857 HD12 ' HA ' ' B' ' 139' ' ' ALA . 4.8 mt -43.95 -45.56 7.78 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.448 0.536 . . . . 1.24 112.448 -178.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 143' ' ' ARG . . . . . 0.503 ' HD2' ' O ' ' B' ' 112' ' ' PRO . 0.0 OUTLIER -55.56 -24.16 30.91 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 107.905 -1.146 . . . . 2.93 107.905 178.331 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 144' ' ' CYS . . . . . 0.608 ' N ' ' O ' ' B' ' 141' ' ' ALA . 35.0 m -69.61 8.49 0.65 Allowed 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 115.838 -0.619 . . . . 1.61 110.559 -179.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 145' ' ' GLN . . . . . 0.582 ' HB2' ' O ' ' B' ' 142' ' ' LEU . 0.7 OUTLIER -78.84 -20.11 50.42 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.015 -0.993 . . . . 3.35 110.838 178.399 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 146' ' ' GLU . . . . . 0.573 ' HA ' ' CD2' ' B' ' 149' ' ' TYR . 16.5 tt0 -86.73 -0.45 56.34 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 120.384 -0.526 . . . . 3.76 110.817 -179.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.94 3.52 29.64 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 109.491 -0.559 . . . . 4.01 109.491 177.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 148' ' ' ASN . . . . . 0.442 ' ND2' ' HG3' ' B' ' 124' ' ' PRO . 0.4 OUTLIER -97.21 -28.28 14.16 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 116.195 -0.457 . . . . 3.92 110.076 178.676 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 149' ' ' TYR . . . . . 0.573 ' CD2' ' HA ' ' B' ' 146' ' ' GLU . 43.1 m-85 -69.84 9.03 0.58 Allowed 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 112.305 0.483 . . . . 5.73 112.305 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 1.7 mt -131.28 121.11 18.38 Favored Pre-proline 0 CA--C 1.529 0.159 0 O-C-N 122.442 -0.161 . . . . 5.46 111.2 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 151' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -80.7 49.01 3.08 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.404 2.069 . . . . 5.02 112.255 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 61.4 p -139.76 159.57 64.49 Favored Pre-proline 0 CA--C 1.53 0.199 0 CA-C-N 116.273 -0.421 . . . . 5.73 110.767 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 153' ' ' PRO . . . . . 0.414 ' O ' ' CD ' ' B' ' 108' ' ' ARG . 2.2 Cg_endo -82.85 -163.72 0.23 Allowed 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 123.343 2.695 . . . . 5.1 113.427 -178.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 154' ' ' CYS . . . . . 0.835 ' HA ' ' CB ' ' B' ' 108' ' ' ARG . 0.5 OUTLIER -159.88 127.21 4.59 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.709 -0.678 . . . . 2.68 109.196 -179.937 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 155' ' ' GLN . . . . . 0.964 ' H ' ' HB2' ' B' ' 108' ' ' ARG . 0.7 OUTLIER -50.03 -170.44 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.235 0 CA-C-N 119.29 0.95 . . . . 5.63 112.819 -178.491 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 156' ' ' SER . . . . . 0.439 ' HB2' ' HA ' ' B' ' 168' ' ' ALA . 9.8 p -176.31 -143.91 0.02 OUTLIER 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 114.662 -1.154 . . . . 3.11 110.611 177.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 157' ' ' GLY . . . . . 0.575 ' O ' ' HB2' ' B' ' 166' ' ' ARG . . . -101.39 152.85 18.89 Favored Glycine 0 CA--C 1.49 -1.498 0 N-CA-C 109.14 -1.584 . . . . 2.07 109.14 175.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 18.2 mm100 -103.79 65.81 0.83 Allowed 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 117.352 -1.739 . . . . 4.34 111.157 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 159' ' ' LYS . . . . . 0.689 ' HB2' ' HB2' ' B' ' 167' ' ' CYS . 0.0 OUTLIER -114.37 56.19 0.81 Allowed Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 113.736 -1.574 . . . . 3.54 109.815 172.343 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 160' ' ' PRO . . . . . 0.542 ' HA ' ' HA ' ' B' ' 166' ' ' ARG . 27.2 Cg_endo -62.96 79.16 0.11 Allowed 'Trans proline' 0 CA--C 1.518 -0.299 0 CA-C-N 121.584 1.602 . . . . 1.51 115.818 -173.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 161' ' ' CYS . . . . . 0.468 ' O ' ' O ' ' B' ' 165' ' ' GLY . 0.5 OUTLIER -98.89 -176.47 3.35 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 107.044 -1.465 . . . . 1.58 107.044 176.183 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 69.74 -167.03 48.58 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 118.468 -1.825 . . . . 2.37 111.826 178.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 24.4 p -85.28 41.46 0.89 Allowed 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.058 0.456 . . . . 4.07 111.717 -178.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 120.52 7.07 9.19 Favored Glycine 0 CA--C 1.536 1.346 0 CA-C-O 118.884 -0.953 . . . . 2.2 113.79 -179.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 165' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' B' ' 161' ' ' CYS . . . -102.28 134.29 11.72 Favored Glycine 0 CA--C 1.523 0.57 0 C-N-CA 118.498 -1.811 . . . . 1.62 115.388 -177.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 166' ' ' ARG . . . . . 0.575 ' HB2' ' O ' ' B' ' 157' ' ' GLY . 0.0 OUTLIER -97.3 153.17 18.21 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 114.947 -0.627 . . . . 3.05 110.352 178.603 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 167' ' ' CYS . . . . . 0.689 ' HB2' ' HB2' ' B' ' 159' ' ' LYS . 2.2 m -65.52 108.6 2.06 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 120.008 -0.677 . . . . 1.56 110.131 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 168' ' ' ALA . . . . . 0.488 ' HB3' ' SG ' ' B' ' 128' ' ' CYS . . . -78.96 -19.92 50.49 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 106.637 -1.616 . . . . 1.04 106.637 176.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 169' ' ' ALA . . . . . 0.835 ' O ' ' O ' ' B' ' 170' ' ' ALA . . . -160.89 161.37 31.76 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 111.82 -2.445 . . . . 0.98 111.036 -178.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 170' ' ' ALA . . . . . 0.835 ' O ' ' O ' ' B' ' 169' ' ' ALA . . . -18.06 -135.15 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.771 0.829 . . . . 1.25 113.217 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 171' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' B' ' 185' ' ' CYS . . . -55.85 37.49 0.01 OUTLIER Glycine 0 CA--C 1.537 1.425 0 N-CA-C 114.97 0.748 . . . . 1.29 114.97 -178.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 172' ' ' ILE . . . . . 0.898 HD13 ' HB2' ' B' ' 134' ' ' CYS . 0.7 OUTLIER -134.41 107.01 8.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-O 122.079 0.942 . . . . 2.27 111.865 -176.755 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 173' ' ' CYS . . . . . 0.528 ' HB2' ' HB3' ' B' ' 182' ' ' ASP . 0.0 OUTLIER -93.29 82.91 4.52 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.476 -0.783 . . . . 1.94 110.526 -179.623 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 174' ' ' CYS . . . . . 0.879 ' HA ' ' HA ' ' B' ' 179' ' ' CYS . 0.1 OUTLIER -83.24 136.76 34.28 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.943 -0.571 . . . . 1.35 110.797 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 175' ' ' SER . . . . . 0.685 ' HB3' ' HD2' ' B' ' 176' ' ' PRO . 5.1 m -104.79 179.41 0.94 Allowed Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.312 -0.858 . . . . 2.0 109.236 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 176' ' ' PRO . . . . . 0.685 ' HD2' ' HB3' ' B' ' 175' ' ' SER . 95.6 Cg_endo -80.01 25.13 0.61 Allowed 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 121.406 1.404 . . . . 1.9 111.674 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 177' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -145.53 -41.55 0.22 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.594 -0.73 . . . . 2.72 110.298 179.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 178' ' ' GLY . . . . . 0.799 ' HA3' ' O ' ' A' ' 79' ' ' CYS . . . -147.84 -135.18 2.58 Favored Glycine 0 C--N 1.337 0.617 0 C-N-CA 120.646 -0.788 . . . . 0.99 113.149 179.304 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 179' ' ' CYS . . . . . 0.879 ' HA ' ' HA ' ' B' ' 174' ' ' CYS . 0.1 OUTLIER -146.96 156.3 42.95 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.554 0.216 . . . . 1.34 110.604 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 180' ' ' HIS . . . . . 0.471 ' N ' ' O ' ' B' ' 173' ' ' CYS . 6.6 t-160 -142.19 133.73 26.68 Favored 'General case' 0 CA--C 1.519 -0.23 0 O-C-N 122.034 -0.416 . . . . 2.1 111.648 -178.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 181' ' ' GLU . . . . . 0.559 ' HG2' ' HD2' ' A' ' 24' ' ' PRO . 2.4 mt-10 -58.59 128.08 35.39 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.846 -0.615 . . . . 3.06 109.703 178.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 182' ' ' ASP . . . . . 0.528 ' HB3' ' HB2' ' B' ' 173' ' ' CYS . 0.0 OUTLIER -146.37 112.72 4.38 Favored Pre-proline 0 C--N 1.318 -0.764 0 CA-C-N 115.537 -0.756 . . . . 2.06 110.394 -178.87 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 183' ' ' PRO . . . . . 0.458 ' HA ' ' OD2' ' B' ' 186' ' ' ASP . 1.6 Cg_endo -82.86 -4.41 11.33 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.617 2.212 . . . . 1.91 113.302 -179.344 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -66.94 -35.39 79.88 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.89 0.376 . . . . 1.56 111.032 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 185' ' ' CYS . . . . . 0.639 ' C ' ' HD3' ' B' ' 187' ' ' PRO . 83.4 m -93.86 49.5 1.35 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.07 -0.514 . . . . 1.94 111.007 179.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 186' ' ' ASP . . . . . 0.729 ' HB3' ' HB3' ' B' ' 189' ' ' ALA . 16.8 m-20 -116.38 35.27 0.2 Allowed Pre-proline 0 N--CA 1.443 -0.817 0 N-CA-C 112.364 0.505 . . . . 3.61 112.364 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 187' ' ' PRO . . . . . 0.721 ' HD3' ' N ' ' B' ' 186' ' ' ASP . 1.3 Cg_endo -78.19 59.3 6.97 Favored 'Trans proline' 0 CA--C 1.489 -1.753 0 N-CA-C 108.432 -1.411 . . . . 2.58 108.432 177.29 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 188' ' ' GLU . . . . . 0.502 ' HG3' ' N ' ' B' ' 189' ' ' ALA . 4.8 pt-20 -177.51 -34.02 0.01 OUTLIER 'General case' 0 CA--C 1.481 -1.711 0 CA-C-N 113.011 -1.904 . . . . 4.7 109.149 -177.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 189' ' ' ALA . . . . . 0.729 ' HB3' ' HB3' ' B' ' 186' ' ' ASP . . . -68.95 47.29 0.06 Allowed 'General case' 0 C--N 1.355 0.843 0 CA-C-N 111.221 -2.718 . . . . 5.24 112.66 179.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 190' ' ' ALA . . . . . . . . . . . . . . . -69.11 123.46 21.15 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 125.674 1.59 . . . . 6.93 111.928 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 191' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -71.69 130.92 42.34 Favored 'General case' 0 C--N 1.34 0.154 0 CA-C-N 112.061 -2.336 . . . . 10.14 113.83 -175.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 13.9 t . . . . . 0 C--O 1.249 1.029 0 CA-C-N 114.375 -1.284 . . . . 11.7 110.525 179.202 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.615 ' O ' HG22 ' A' ' 2' ' ' VAL . . . . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 120.891 0.377 . . . . 9.95 111.469 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.615 HG22 ' O ' ' A' ' 1' ' ' ALA . 0.2 OUTLIER -167.76 49.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 108.526 -0.916 . . . . 8.02 108.526 177.605 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.622 HD12 ' HE ' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -98.13 -12.95 21.23 Favored 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 118.187 2.662 . . . . 5.86 118.187 -175.989 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -59.0 -80.95 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 122.891 2.587 . . . . 6.22 114.625 -176.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.501 HD12 ' HB2' ' A' ' 55' ' ' GLN . 11.9 tp -151.54 24.5 0.69 Allowed 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 114.592 1.331 . . . . 7.09 114.592 -177.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -88.73 -67.62 0.82 Allowed 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 104.499 -2.408 . . . . 8.78 104.499 174.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 1.066 ' HA ' ' HG2' ' A' ' 55' ' ' GLN . 7.1 p -156.52 114.23 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.414 -2.263 0 CA-C-N 112.422 -2.172 . . . . 7.51 105.669 166.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.756 ' HB2' ' H ' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -82.05 115.44 21.19 Favored 'General case' 0 N--CA 1.41 -2.461 0 N-CA-C 107.135 -1.432 . . . . 9.08 107.135 176.824 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 31.6 p -65.77 107.12 1.69 Allowed 'General case' 0 C--N 1.289 -2.049 0 C-N-CA 113.78 -3.168 . . . . 5.66 106.003 177.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 1.009 ' HB2' ' HG2' ' A' ' 20' ' ' ARG . 53.6 m -78.48 113.77 16.79 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 114.652 -1.158 . . . . 2.68 112.593 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.467 ' HG ' ' HD2' ' A' ' 12' ' ' PRO . 6.0 tp -26.76 135.0 0.11 Allowed Pre-proline 0 N--CA 1.486 1.371 0 N-CA-C 113.619 0.97 . . . . 2.48 113.619 179.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.62 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 52.0 Cg_endo -75.04 145.11 30.91 Favored 'Trans proline' 0 CA--C 1.552 1.401 0 C-N-CA 123.384 2.723 . . . . 1.49 117.264 -178.299 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.433 ' O ' ' HA2' ' A' ' 17' ' ' GLY . 0.1 OUTLIER -155.31 173.57 16.46 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-N 112.625 -2.08 . . . . 1.0 115.376 -174.709 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 79.3 -159.97 45.49 Favored Glycine 0 CA--C 1.533 1.185 0 CA-C-N 114.406 -1.27 . . . . 1.15 110.657 -172.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.498 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 60.1 Cg_endo -62.25 109.26 0.8 Allowed 'Trans proline' 0 N--CA 1.488 1.185 0 C-N-CA 123.65 2.9 . . . . 1.57 110.178 178.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 74.96 5.63 76.12 Favored Glycine 0 C--N 1.293 -1.839 0 CA-C-N 114.649 -1.16 . . . . 1.68 112.071 176.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.433 ' HA2' ' O ' ' A' ' 13' ' ' CYS . . . 63.73 62.14 5.55 Favored Glycine 1 N--CA 1.396 -4.024 0 C-N-CA 118.824 -1.655 . . . . 1.36 110.524 -177.756 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.498 ' HG2' ' O ' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -100.29 17.95 20.09 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 105.878 -1.897 . . . . 2.5 105.878 168.892 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.62 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -109.26 -178.61 21.34 Favored Glycine 0 N--CA 1.426 -1.99 0 N-CA-C 117.205 1.642 . . . . 1.02 117.205 -173.087 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 1.009 ' HG2' ' HB2' ' A' ' 10' ' ' CYS . 2.9 mtp-105 -143.12 135.71 27.53 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 110.913 -2.643 . . . . 2.92 112.572 176.009 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.609 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 1.7 m -107.72 159.52 16.42 Favored 'General case' 0 C--N 1.343 0.298 0 CA-C-O 121.554 0.692 . . . . 1.1 112.701 -177.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -132.06 8.51 4.41 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 114.784 -1.098 . . . . 1.51 110.951 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -179.64 -163.9 31.14 Favored Glycine 0 C--N 1.338 0.654 0 C-N-CA 121.046 -0.597 . . . . 0.9 112.478 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.474 ' HG2' ' OE1' ' B' ' 181' ' ' GLU . 12.5 Cg_exo -69.56 -71.01 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.74 2.293 . . . . 1.5 112.305 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.596 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.5 OUTLIER -100.33 33.9 2.54 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 120.933 0.397 . . . . 1.26 110.111 179.508 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.937 HG12 HG13 ' A' ' 36' ' ' VAL . 6.3 mt -139.07 120.54 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 CA-C-N 116.173 -0.467 . . . . 0.83 111.64 -178.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.609 ' HA ' ' HA ' ' A' ' 21' ' ' CYS . 49.6 t -142.22 122.56 13.96 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.765 -0.652 . . . . 0.92 110.179 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 1.104 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -127.59 152.51 47.55 Favored 'General case' 0 CA--C 1.551 0.983 0 N-CA-C 114.521 1.304 . . . . 1.28 114.521 -177.961 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.624 ' O ' ' HB2' ' A' ' 69' ' ' ALA . . . -150.26 -176.29 23.16 Favored Glycine 0 C--N 1.354 1.575 0 N-CA-C 110.927 -0.869 . . . . 0.67 110.927 178.15 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.579 ' CB ' ' HB3' ' A' ' 91' ' ' PHE . 2.5 p-10 -66.03 -54.01 31.37 Favored 'General case' 0 CA--C 1.56 1.359 0 C-N-CA 124.952 1.301 . . . . 2.27 112.211 179.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.36 -18.79 19.69 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 111.514 -2.585 . . . . 1.66 110.375 172.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.517 ' O ' ' C ' ' A' ' 33' ' ' GLY . 4.1 mt -99.9 7.6 44.76 Favored 'General case' 0 N--CA 1.4 -2.935 0 CA-C-N 115.892 -0.594 . . . . 1.37 110.749 -172.334 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 1.104 ' O ' ' HA ' ' A' ' 28' ' ' CYS . . . 24.87 -136.91 0.01 OUTLIER Glycine 0 C--O 1.21 -1.394 0 CA-C-O 118.635 -1.092 . . . . 0.73 111.959 179.165 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 1.048 ' HB2' HD13 ' A' ' 72' ' ' ILE . 1.0 OUTLIER -129.97 124.05 32.09 Favored 'General case' 0 CA--C 1.498 -1.044 0 CA-C-N 119.051 1.425 . . . . 1.08 112.422 -179.047 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.714 ' CE2' HG21 ' B' ' 138' ' ' THR . 34.7 m-85 -97.91 105.24 17.36 Favored 'General case' 0 N--CA 1.422 -1.842 0 N-CA-C 103.597 -2.742 . . . . 1.38 103.597 174.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.937 HG13 HG12 ' A' ' 26' ' ' ILE . 1.8 t -100.91 85.59 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.884 0 CA-C-O 123.152 1.453 . . . . 0.76 107.112 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.606 ' HA3' HG21 ' B' ' 172' ' ' ILE . . . 125.9 -77.7 0.38 Allowed Glycine 0 CA--C 1.524 0.607 0 CA-C-N 112.925 -1.943 . . . . 0.81 115.06 -179.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.718 HG21 ' CE2' ' B' ' 135' ' ' PHE . 9.9 t -32.2 124.95 0.3 Allowed 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 113.347 0.869 . . . . 0.77 113.347 -177.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.868 ' HA ' ' HG ' ' A' ' 42' ' ' LEU . . . -26.92 -35.02 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 114.12 -1.4 . . . . 1.02 113.409 -179.124 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.524 ' N ' ' O ' ' A' ' 38' ' ' THR . 1.7 mt-10 -48.13 -13.77 0.05 OUTLIER 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.634 0.254 . . . . 2.32 111.05 178.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.662 ' O ' ' N ' ' A' ' 44' ' ' CYS . . . -114.96 -44.42 3.03 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 109.448 -0.575 . . . . 0.87 109.448 178.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.868 ' HG ' ' HA ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -37.88 -19.49 0.01 OUTLIER 'General case' 0 C--N 1.346 0.417 0 N-CA-C 115.481 1.659 . . . . 1.23 115.481 -173.232 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.545 ' N ' HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -68.02 -13.65 62.35 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 106.575 -1.639 . . . . 2.92 106.575 174.708 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.662 ' N ' ' O ' ' A' ' 41' ' ' ALA . 64.0 m -85.42 25.12 1.07 Allowed 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 114.151 -1.386 . . . . 1.57 109.953 177.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -92.31 -18.66 23.05 Favored 'General case' 0 CA--C 1.509 -0.63 0 N-CA-C 107.859 -1.163 . . . . 3.31 107.859 176.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -86.87 5.46 36.73 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-N 115.174 -0.921 . . . . 3.69 109.222 177.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.34 3.34 31.99 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 119.962 -0.695 . . . . 3.99 109.289 177.419 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.448 ' C ' ' H ' ' A' ' 50' ' ' LEU . 2.8 t-20 -87.86 -28.0 21.87 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 116.055 -0.52 . . . . 3.86 109.966 178.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -59.72 8.22 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.324 0.861 . . . . 5.68 113.324 -179.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.647 ' O ' HD12 ' A' ' 50' ' ' LEU . 0.5 OUTLIER -148.71 107.77 3.51 Favored Pre-proline 0 N--CA 1.463 0.18 0 O-C-N 122.099 -0.376 . . . . 5.4 111.245 179.82 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -78.24 50.14 3.25 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.504 2.136 . . . . 4.92 112.693 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.426 ' HB2' ' HD2' ' A' ' 53' ' ' PRO . 10.7 p -114.08 160.15 33.55 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.445 -0.343 . . . . 5.64 110.392 179.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.481 ' O ' ' HG3' ' A' ' 8' ' ' ARG . 57.3 Cg_endo -72.04 -174.25 1.31 Allowed 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.452 2.102 . . . . 5.04 113.237 -179.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.609 ' HA ' ' CB ' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -157.1 95.57 1.51 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.763 -0.653 . . . . 2.74 109.697 179.879 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 1.066 ' HG2' ' HA ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -56.65 178.29 0.06 Allowed 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 119.848 -0.741 . . . . 5.75 111.866 -179.121 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.506 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 48.8 m 86.68 100.46 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 117.595 2.443 . . . . 3.12 117.595 175.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 134.71 69.94 0.07 OUTLIER Glycine 0 N--CA 1.427 -1.948 0 N-CA-C 109.975 -1.25 . . . . 2.1 109.975 -178.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 -117.95 72.89 0.87 Allowed 'General case' 0 N--CA 1.441 -0.923 0 CA-C-O 122.634 1.207 . . . . 4.36 108.032 179.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.671 ' CB ' ' HB2' ' A' ' 67' ' ' CYS . 10.0 mtmm -144.64 58.34 5.43 Favored Pre-proline 0 C--N 1.302 -1.475 0 CA-C-N 113.132 -1.849 . . . . 3.55 107.197 179.152 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.7 ' HA ' ' O ' ' A' ' 65' ' ' GLY . 37.7 Cg_endo -66.2 86.56 0.25 Allowed 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 122.605 2.204 . . . . 1.54 116.591 -177.231 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.491 ' SG ' ' HB2' ' A' ' 82' ' ' ASP . 0.5 OUTLIER -100.11 -173.44 2.43 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.308 -1.367 . . . . 1.59 107.308 175.471 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 62.83 -166.43 23.13 Favored Glycine 0 CA--C 1.519 0.331 0 C-N-CA 118.264 -1.922 . . . . 2.43 112.296 176.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 64.5 m -77.72 42.9 0.39 Allowed 'General case' 0 C--N 1.327 -0.371 0 O-C-N 122.494 -0.415 . . . . 4.11 111.75 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 110.51 11.31 19.89 Favored Glycine 0 N--CA 1.446 -0.681 0 N-CA-C 116.846 1.498 . . . . 2.21 116.846 176.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.7 ' O ' ' HA ' ' A' ' 60' ' ' PRO . . . -104.73 154.37 17.39 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 120.893 2.347 . . . . 1.62 112.902 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.479 ' H ' ' HG2' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -101.12 150.13 23.25 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 121.266 0.555 . . . . 3.02 112.442 -179.763 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.671 ' HB2' ' CB ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -72.36 112.71 8.67 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 113.671 0.989 . . . . 1.52 113.671 -179.951 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.67 ' HB1' ' HB2' ' A' ' 28' ' ' CYS . . . -99.76 -16.32 18.15 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 122.514 1.15 . . . . 1.07 108.053 175.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 1.026 ' HB3' HG12 ' A' ' 72' ' ' ILE . . . -162.96 161.14 25.49 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 112.506 -2.134 . . . . 1.0 116.532 176.466 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.96 ' HB2' ' HB3' ' A' ' 89' ' ' ALA . . . -50.38 121.77 6.1 Favored 'General case' 0 C--N 1.345 0.4 0 CA-C-N 113.719 -1.582 . . . . 1.24 111.725 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.622 ' HA2' ' O ' ' A' ' 82' ' ' ASP . . . 59.83 36.49 90.13 Favored Glycine 0 N--CA 1.443 -0.885 0 N-CA-C 110.018 -1.233 . . . . 1.28 110.018 -178.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 1.048 HD13 ' HB2' ' A' ' 34' ' ' CYS . 0.5 OUTLIER -145.0 108.17 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 O-C-N 121.957 -0.731 . . . . 2.27 109.927 176.984 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -106.04 102.4 11.82 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 108.883 -0.784 . . . . 1.98 108.883 178.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.838 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 3.4 t -92.7 122.42 35.09 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 121.702 0.763 . . . . 1.33 112.283 -178.394 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.615 ' HA ' ' HA2' ' A' ' 65' ' ' GLY . 0.3 OUTLIER -90.59 -179.25 1.12 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 114.375 -1.284 . . . . 1.99 109.733 179.532 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.479 ' HD2' ' CB ' ' A' ' 75' ' ' SER . 86.3 Cg_endo -77.6 25.22 0.49 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 121.828 1.685 . . . . 1.86 113.003 -179.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -145.6 -45.75 0.21 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.921 -0.77 . . . . 2.65 108.921 178.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.561 ' HA3' ' O ' ' B' ' 179' ' ' CYS . . . -149.37 -151.62 5.53 Favored Glycine 0 N--CA 1.446 -0.667 0 CA-C-N 115.39 -0.823 . . . . 0.99 111.659 178.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.838 ' HA ' ' HA ' ' A' ' 74' ' ' CYS . 0.0 OUTLIER -146.9 162.88 37.77 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.846 -0.427 . . . . 1.34 109.846 179.798 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.57 ' HB3' ' HA3' ' B' ' 178' ' ' GLY . 0.1 OUTLIER -150.52 160.82 43.52 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.016 0.436 . . . . 2.17 111.009 -179.036 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.593 ' H ' HD11 ' B' ' 126' ' ' ILE . 0.5 OUTLIER -63.76 146.07 54.58 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.383 -0.599 . . . . 3.05 109.383 179.287 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.622 ' O ' ' HA2' ' A' ' 71' ' ' GLY . 0.8 OUTLIER -145.78 140.77 16.03 Favored Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 120.423 -0.511 . . . . 2.02 111.99 -179.462 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.493 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 5.3 Cg_exo -80.61 -20.9 7.67 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.969 2.446 . . . . 1.93 113.665 -178.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.09 -40.96 87.06 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.162 0.506 . . . . 1.53 110.682 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.896 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 93.2 m -97.21 27.09 4.32 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.779 0.8 . . . . 1.88 110.192 179.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.7 ' N ' ' HD2' ' A' ' 87' ' ' PRO . 1.0 OUTLIER -77.29 -46.38 2.65 Favored Pre-proline 0 C--N 1.317 -0.843 0 CA-C-N 115.198 -0.91 . . . . 3.6 110.559 179.64 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.7 ' HD2' ' N ' ' A' ' 86' ' ' ASP . 17.9 Cg_endo -61.93 111.13 1.13 Allowed 'Trans proline' 0 N--CA 1.445 -1.324 0 C-N-CA 121.429 1.419 . . . . 2.56 111.396 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.592 ' C ' ' O ' ' A' ' 87' ' ' PRO . 0.2 OUTLIER -14.81 86.75 0.0 OUTLIER 'General case' 0 CA--C 1.469 -2.137 0 N-CA-C 104.299 -2.482 . . . . 4.72 104.299 -179.04 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.96 ' HB3' ' HB2' ' A' ' 70' ' ' ALA . . . -92.33 7.47 42.71 Favored 'General case' 0 CA--C 1.499 -0.985 0 CA-C-N 108.666 -3.879 . . . . 5.29 110.276 -178.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -55.39 112.78 1.19 Allowed 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 118.944 -1.102 . . . . 6.98 110.199 -177.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.579 ' HB3' ' CB ' ' A' ' 30' ' ' ASP . 8.1 t80 -87.12 133.42 33.62 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 120.312 -0.555 . . . . 10.21 109.621 178.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 12.5 m . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.174 -0.917 . . . . 11.77 110.621 -179.235 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 101' ' ' ALA . . . . . 0.613 ' O ' HG13 ' B' ' 102' ' ' VAL . . . . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 121.091 0.472 . . . . 10.07 111.285 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 102' ' ' VAL . . . . . 0.927 HG23 ' HB2' ' B' ' 106' ' ' ASP . 0.0 OUTLIER 177.2 155.78 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 108.106 -1.072 . . . . 8.41 108.106 -176.981 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 103' ' ' LEU . . . . . 0.772 ' HA ' ' HA ' ' B' ' 108' ' ' ARG . 0.1 OUTLIER -99.45 42.52 1.1 Allowed 'General case' 0 CA--C 1.503 -0.862 0 CA-C-O 122.394 1.092 . . . . 5.87 112.349 -175.891 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -105.84 -100.72 0.34 Allowed 'General case' 0 N--CA 1.398 -3.047 0 N-CA-C 101.566 -3.494 . . . . 6.27 101.566 168.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 6.1 tp -125.69 16.73 8.11 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 118.501 -1.28 . . . . 7.2 113.431 -177.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 106' ' ' ASP . . . . . 0.927 ' HB2' HG23 ' B' ' 102' ' ' VAL . 0.1 OUTLIER -84.23 -92.73 0.08 Allowed 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 103.148 -2.908 . . . . 8.55 103.148 173.921 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 107' ' ' VAL . . . . . 1.032 ' HA ' ' HG2' ' B' ' 155' ' ' GLN . 5.4 p -132.2 115.43 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.177 0 N-CA-C 103.836 -2.653 . . . . 7.48 103.836 171.381 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 108' ' ' ARG . . . . . 0.772 ' HA ' ' HA ' ' B' ' 103' ' ' LEU . 0.0 OUTLIER -81.36 115.86 20.92 Favored 'General case' 0 CA--C 1.465 -2.295 0 N-CA-C 107.301 -1.37 . . . . 9.12 107.301 177.609 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 30.7 p -65.61 107.52 1.76 Allowed 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 113.975 -3.09 . . . . 5.69 105.976 177.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 110' ' ' CYS . . . . . 0.983 ' HB2' ' HG2' ' B' ' 120' ' ' ARG . 50.9 m -79.22 111.23 15.25 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 114.686 -1.143 . . . . 2.61 112.749 -179.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 111' ' ' LEU . . . . . 0.449 ' HG ' ' HD2' ' B' ' 112' ' ' PRO . 6.1 tp -24.32 134.2 0.08 OUTLIER Pre-proline 0 N--CA 1.485 1.281 0 N-CA-C 113.497 0.925 . . . . 2.47 113.497 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 112' ' ' PRO . . . . . 0.598 ' HA ' ' O ' ' B' ' 119' ' ' GLY . 29.2 Cg_endo -68.34 150.77 76.38 Favored 'Trans proline' 0 CA--C 1.547 1.127 0 C-N-CA 123.235 2.624 . . . . 1.47 114.796 -178.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -158.87 177.98 10.58 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 113.395 -1.729 . . . . 1.0 115.449 176.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . 78.06 -160.27 48.06 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 110.22 -1.152 . . . . 1.16 110.22 -175.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 115' ' ' PRO . . . . . 0.402 ' O ' ' HG2' ' B' ' 118' ' ' LYS . 54.6 Cg_endo -63.5 100.03 0.27 Allowed 'Trans proline' 0 N--CA 1.482 0.814 0 C-N-CA 123.985 3.124 . . . . 1.57 114.075 178.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 82.69 5.24 89.62 Favored Glycine 0 C--N 1.29 -2.019 0 CA-C-N 114.61 -1.177 . . . . 1.7 111.876 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . 70.44 47.62 41.73 Favored Glycine 1 N--CA 1.392 -4.288 0 C-N-CA 118.922 -1.608 . . . . 1.38 114.609 179.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 118' ' ' LYS . . . . . 0.402 ' HG2' ' O ' ' B' ' 115' ' ' PRO . 0.0 OUTLIER -91.83 15.84 12.14 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 106.827 -1.546 . . . . 2.54 106.827 175.465 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 119' ' ' GLY . . . . . 0.598 ' O ' ' HA ' ' B' ' 112' ' ' PRO . . . -113.52 -171.17 17.66 Favored Glycine 0 N--CA 1.444 -0.827 0 N-CA-C 115.79 1.076 . . . . 1.04 115.79 -175.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.983 ' HG2' ' HB2' ' B' ' 110' ' ' CYS . 1.7 mtp-105 -146.89 138.94 24.58 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 114.509 -0.845 . . . . 2.89 109.396 -179.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 121' ' ' CYS . . . . . 0.607 ' HA ' ' HA ' ' B' ' 127' ' ' CYS . 1.7 m -107.84 160.86 15.41 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.613 0.721 . . . . 1.07 112.888 -177.129 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -132.18 8.59 4.37 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 114.697 -1.138 . . . . 1.53 110.867 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -179.67 -163.99 31.32 Favored Glycine 0 C--N 1.338 0.684 0 C-N-CA 120.885 -0.674 . . . . 0.9 112.387 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . 0.468 ' HG2' ' OE1' ' A' ' 81' ' ' GLU . 12.4 Cg_exo -69.47 -71.14 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.747 2.298 . . . . 1.51 112.313 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 125' ' ' SER . . . . . 0.595 ' O ' ' N ' ' B' ' 137' ' ' GLY . 0.5 OUTLIER -100.25 34.15 2.45 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 120.973 0.416 . . . . 1.25 110.04 179.436 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 126' ' ' ILE . . . . . 0.889 HG12 HG13 ' B' ' 136' ' ' VAL . 7.8 mt -138.71 120.44 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 CA-C-N 116.083 -0.508 . . . . 0.85 111.943 -178.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 127' ' ' CYS . . . . . 0.607 ' HA ' ' HA ' ' B' ' 121' ' ' CYS . 49.1 t -142.01 122.05 13.72 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 116.156 -0.474 . . . . 0.89 110.133 -179.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 128' ' ' CYS . . . . . 1.076 ' HA ' ' O ' ' B' ' 133' ' ' GLY . 0.0 OUTLIER -124.57 157.34 35.63 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 114.218 1.192 . . . . 1.23 114.218 -178.707 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 129' ' ' GLY . . . . . 0.623 ' N ' ' O ' ' B' ' 133' ' ' GLY . . . -153.78 -177.13 26.93 Favored Glycine 0 N--CA 1.434 -1.472 0 N-CA-C 111.087 -0.805 . . . . 0.66 111.087 177.214 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 130' ' ' ASP . . . . . 0.56 ' CB ' ' HB3' ' B' ' 191' ' ' PHE . 2.4 p-10 -65.08 -53.38 46.49 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 124.337 1.055 . . . . 2.35 111.038 179.518 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 131' ' ' GLU . . . . . 0.426 ' HG2' ' OD2' ' B' ' 130' ' ' ASP . 0.0 OUTLIER -120.96 32.65 5.87 Favored 'General case' 0 CA--C 1.483 -1.613 0 N-CA-C 106.276 -1.75 . . . . 1.69 106.276 174.921 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 132' ' ' LEU . . . . . 0.571 HD22 ' HE1' ' B' ' 135' ' ' PHE . 2.1 mt -135.53 9.7 3.41 Favored 'General case' 0 N--CA 1.393 -3.28 0 N-CA-C 106.413 -1.699 . . . . 1.38 106.413 175.057 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 133' ' ' GLY . . . . . 1.076 ' O ' ' HA ' ' B' ' 128' ' ' CYS . . . 25.66 -128.87 0.03 OUTLIER Glycine 0 N--CA 1.41 -3.089 0 CA-C-N 115.29 -0.868 . . . . 0.72 114.43 178.331 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 134' ' ' CYS . . . . . 1.024 ' HB2' HD13 ' B' ' 172' ' ' ILE . 0.8 OUTLIER -134.96 125.1 25.97 Favored 'General case' 0 CA--C 1.494 -1.192 0 CA-C-N 117.326 0.563 . . . . 1.08 111.614 177.305 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 135' ' ' PHE . . . . . 0.718 ' CE2' HG21 ' A' ' 38' ' ' THR . 34.9 m-85 -99.91 104.99 16.66 Favored 'General case' 0 N--CA 1.422 -1.848 0 N-CA-C 103.29 -2.856 . . . . 1.36 103.29 174.299 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 136' ' ' VAL . . . . . 0.889 HG13 HG12 ' B' ' 126' ' ' ILE . 2.3 t -100.88 85.01 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.792 0 N-CA-C 107.093 -1.447 . . . . 0.75 107.093 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 137' ' ' GLY . . . . . 0.595 ' N ' ' O ' ' B' ' 125' ' ' SER . . . 126.27 -77.5 0.39 Allowed Glycine 0 CA--C 1.526 0.756 0 CA-C-N 113.22 -1.809 . . . . 0.83 114.83 -179.383 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 138' ' ' THR . . . . . 0.714 HG21 ' CE2' ' A' ' 35' ' ' PHE . 9.8 t -33.11 123.2 0.39 Allowed 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 114.346 1.239 . . . . 0.78 114.346 -177.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 139' ' ' ALA . . . . . 0.891 ' HA ' ' HG ' ' B' ' 142' ' ' LEU . . . -24.27 -37.93 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 113.532 -1.667 . . . . 1.04 112.787 -178.038 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 140' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' B' ' 138' ' ' THR . 1.8 mt-10 -48.05 -8.18 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 121.19 0.519 . . . . 2.31 111.92 177.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 141' ' ' ALA . . . . . 0.634 ' O ' ' N ' ' B' ' 144' ' ' CYS . . . -119.23 -45.81 2.53 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 114.941 -1.027 . . . . 0.87 110.605 177.131 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 142' ' ' LEU . . . . . 0.891 ' HG ' ' HA ' ' B' ' 139' ' ' ALA . 0.0 OUTLIER -38.22 -19.82 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 115.59 1.7 . . . . 1.24 115.59 -174.176 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 143' ' ' ARG . . . . . 0.545 ' N ' HD13 ' B' ' 142' ' ' LEU . 0.0 OUTLIER -69.77 -9.69 55.54 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 106.714 -1.587 . . . . 2.93 106.714 174.869 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 144' ' ' CYS . . . . . 0.634 ' N ' ' O ' ' B' ' 141' ' ' ALA . 66.7 m -89.25 26.38 1.65 Allowed 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.447 -0.797 . . . . 1.61 109.641 176.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -91.71 -19.11 22.98 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 3.35 107.708 175.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -86.9 5.46 36.87 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 114.985 -1.007 . . . . 3.76 109.229 178.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.27 3.38 31.55 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 120.128 -0.629 . . . . 4.01 109.324 177.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 148' ' ' ASN . . . . . 0.463 ' C ' ' H ' ' B' ' 150' ' ' LEU . 2.8 t-20 -87.97 -27.98 21.74 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 116.064 -0.517 . . . . 3.92 109.929 178.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -59.69 8.2 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 113.174 0.805 . . . . 5.73 113.174 -179.413 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 150' ' ' LEU . . . . . 0.636 ' O ' HD12 ' B' ' 150' ' ' LEU . 0.4 OUTLIER -148.6 107.82 3.54 Favored Pre-proline 0 N--CA 1.462 0.173 0 CA-C-N 117.948 0.34 . . . . 5.46 111.321 179.79 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 151' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -78.34 50.14 3.26 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.386 2.057 . . . . 5.02 112.722 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 152' ' ' SER . . . . . 0.425 ' HB2' ' HD2' ' B' ' 153' ' ' PRO . 10.8 p -114.06 160.12 33.6 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.356 -0.384 . . . . 5.73 110.39 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 153' ' ' PRO . . . . . 0.517 ' O ' ' HG3' ' B' ' 108' ' ' ARG . 57.3 Cg_endo -72.07 -174.02 1.25 Allowed 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.356 2.037 . . . . 5.1 113.19 -179.257 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 154' ' ' CYS . . . . . 0.61 ' HA ' ' CB ' ' B' ' 108' ' ' ARG . 0.1 OUTLIER -157.08 95.73 1.52 Allowed 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.761 -0.654 . . . . 2.68 109.739 179.858 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 155' ' ' GLN . . . . . 1.032 ' HG2' ' HA ' ' B' ' 107' ' ' VAL . 0.0 OUTLIER -56.7 179.3 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 119.6 -0.84 . . . . 5.63 111.861 -179.252 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 156' ' ' SER . . . . . 0.496 ' HB2' ' O ' ' B' ' 155' ' ' GLN . 40.2 m 87.87 117.37 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 122.174 0.988 . . . . 3.11 112.326 177.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 111.57 77.7 0.89 Allowed Glycine 0 N--CA 1.434 -1.441 0 CA-C-N 112.668 -2.06 . . . . 2.07 112.161 175.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -119.48 60.81 0.83 Allowed 'General case' 0 N--CA 1.433 -1.29 0 CA-C-O 123.189 1.471 . . . . 4.34 108.383 176.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 159' ' ' LYS . . . . . 0.758 ' CB ' ' HB2' ' B' ' 167' ' ' CYS . 10.5 mtmm -116.08 53.68 1.04 Allowed Pre-proline 0 C--N 1.303 -1.427 0 CA-C-N 112.052 -2.34 . . . . 3.54 111.797 173.005 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 160' ' ' PRO . . . . . 0.679 ' HA ' ' O ' ' B' ' 165' ' ' GLY . 36.8 Cg_endo -66.2 87.83 0.25 Allowed 'Trans proline' 0 C--N 1.329 -0.466 0 N-CA-C 117.971 2.258 . . . . 1.51 117.971 -172.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 161' ' ' CYS . . . . . 0.471 ' SG ' ' HB2' ' B' ' 182' ' ' ASP . 0.6 OUTLIER -107.17 178.76 4.46 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 107.092 -1.447 . . . . 1.58 107.092 175.238 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 72.01 -167.34 52.88 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 118.464 -1.827 . . . . 2.37 111.325 -178.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 71.2 m -76.83 40.64 0.25 Allowed 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 120.604 -0.439 . . . . 4.07 111.222 -179.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 109.56 17.76 9.59 Favored Glycine 0 C--N 1.342 0.902 0 C-N-CA 119.019 -1.562 . . . . 2.2 116.199 175.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 165' ' ' GLY . . . . . 0.679 ' O ' ' HA ' ' B' ' 160' ' ' PRO . . . -107.23 154.28 16.65 Favored Glycine 0 C--N 1.346 1.136 0 C-N-CA 119.235 -1.46 . . . . 1.62 112.179 177.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 166' ' ' ARG . . . . . 0.41 ' HG2' ' H ' ' B' ' 166' ' ' ARG . 0.0 OUTLIER -101.89 150.19 23.44 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 112.211 0.449 . . . . 3.05 112.211 179.425 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 167' ' ' CYS . . . . . 0.758 ' HB2' ' CB ' ' B' ' 159' ' ' LYS . 0.0 OUTLIER -72.68 111.88 8.23 Favored 'General case' 0 N--CA 1.438 -1.033 0 C-N-CA 124.054 0.942 . . . . 1.56 113.335 -179.933 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 168' ' ' ALA . . . . . 0.751 ' HB1' ' HB2' ' B' ' 128' ' ' CYS . . . -89.34 -31.98 17.54 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 104.79 -2.3 . . . . 1.04 104.79 174.35 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 169' ' ' ALA . . . . . 1.054 ' HB3' HG12 ' B' ' 172' ' ' ILE . . . -151.02 158.9 44.71 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 111.27 -2.695 . . . . 0.98 116.527 -172.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 170' ' ' ALA . . . . . 0.941 ' HB2' ' HB3' ' B' ' 189' ' ' ALA . . . -51.32 122.74 8.28 Favored 'General case' 0 C--N 1.347 0.496 0 CA-C-N 113.955 -1.475 . . . . 1.25 111.139 -179.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 171' ' ' GLY . . . . . 0.561 ' HA2' ' O ' ' B' ' 182' ' ' ASP . . . 69.84 16.43 72.37 Favored Glycine 0 N--CA 1.428 -1.837 0 C-N-CA 120.642 -0.789 . . . . 1.29 112.611 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 172' ' ' ILE . . . . . 1.054 HG12 ' HB3' ' B' ' 169' ' ' ALA . 0.5 OUTLIER -134.86 110.0 12.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-O 122.05 0.928 . . . . 2.27 111.809 -177.07 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 173' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -106.08 102.04 11.49 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.865 -0.791 . . . . 1.94 108.865 178.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 174' ' ' CYS . . . . . 0.85 ' HA ' ' HA ' ' B' ' 179' ' ' CYS . 3.4 t -92.74 122.34 35.04 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 121.663 0.744 . . . . 1.35 112.33 -178.408 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 175' ' ' SER . . . . . 0.63 ' HA ' ' HA2' ' B' ' 165' ' ' GLY . 0.3 OUTLIER -90.48 -179.2 1.11 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 114.378 -1.283 . . . . 2.0 109.78 179.537 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 176' ' ' PRO . . . . . 0.484 ' HD2' ' CB ' ' B' ' 175' ' ' SER . 86.0 Cg_endo -77.67 25.25 0.5 Allowed 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 121.782 1.655 . . . . 1.9 112.969 -179.267 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 177' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -145.63 -45.61 0.21 Allowed 'General case' 0 C--O 1.237 0.403 0 N-CA-C 109.032 -0.729 . . . . 2.72 109.032 178.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 178' ' ' GLY . . . . . 0.57 ' HA3' ' HB3' ' A' ' 80' ' ' HIS . . . -149.39 -151.67 5.55 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.364 -0.835 . . . . 0.99 111.691 178.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 179' ' ' CYS . . . . . 0.85 ' HA ' ' HA ' ' B' ' 174' ' ' CYS . 0.0 OUTLIER -146.93 162.77 38.03 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.868 -0.419 . . . . 1.34 109.868 179.724 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 180' ' ' HIS . . . . . 0.56 ' HB3' ' HA3' ' A' ' 78' ' ' GLY . 0.1 OUTLIER -150.42 160.74 43.53 Favored 'General case' 0 N--CA 1.464 0.263 0 O-C-N 121.967 -0.458 . . . . 2.1 111.091 -179.117 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 181' ' ' GLU . . . . . 0.618 ' H ' HD11 ' A' ' 26' ' ' ILE . 0.5 OUTLIER -63.57 145.97 54.62 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.435 -0.58 . . . . 3.06 109.435 179.246 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 182' ' ' ASP . . . . . 0.561 ' O ' ' HA2' ' B' ' 171' ' ' GLY . 0.7 OUTLIER -145.85 140.67 15.89 Favored Pre-proline 0 CA--C 1.537 0.475 0 C-N-CA 120.523 -0.471 . . . . 2.06 111.911 -179.366 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 183' ' ' PRO . . . . . 0.504 ' O ' ' HB2' ' B' ' 186' ' ' ASP . 5.2 Cg_exo -80.5 -20.86 7.85 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.977 2.451 . . . . 1.91 113.726 -179.004 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -67.05 -40.99 87.25 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.166 0.507 . . . . 1.56 110.666 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 185' ' ' CYS . . . . . 0.875 ' HB3' ' HA ' ' B' ' 170' ' ' ALA . 85.7 m -97.06 27.06 4.26 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.778 0.799 . . . . 1.94 110.367 179.323 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 186' ' ' ASP . . . . . 0.7 ' N ' ' HD2' ' B' ' 187' ' ' PRO . 1.1 t70 -77.25 -46.35 2.67 Favored Pre-proline 0 C--N 1.316 -0.865 0 CA-C-N 115.048 -0.978 . . . . 3.61 110.242 179.618 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 187' ' ' PRO . . . . . 0.7 ' HD2' ' N ' ' B' ' 186' ' ' ASP . 22.5 Cg_endo -62.71 107.79 0.65 Allowed 'Trans proline' 0 N--CA 1.439 -1.682 0 C-N-CA 121.28 1.32 . . . . 2.58 112.292 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 188' ' ' GLU . . . . . 0.532 ' C ' ' O ' ' B' ' 187' ' ' PRO . 0.3 OUTLIER -12.59 81.15 0.0 OUTLIER 'General case' 0 CA--C 1.468 -2.197 0 CA-C-O 125.274 2.464 . . . . 4.7 106.261 -179.539 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 189' ' ' ALA . . . . . 0.941 ' HB3' ' HB2' ' B' ' 170' ' ' ALA . . . -86.76 4.61 40.18 Favored 'General case' 0 N--CA 1.439 -0.998 1 CA-C-N 108.289 -4.05 . . . . 5.24 109.789 -176.901 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 190' ' ' ALA . . . . . . . . . . . . . . . -51.18 116.98 2.28 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 116.894 -1.923 . . . . 6.93 109.502 -174.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 191' ' ' PHE . . . . . 0.56 ' HB3' ' CB ' ' B' ' 130' ' ' ASP . 8.2 t80 -88.54 134.13 33.96 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 119.591 1.087 . . . . 10.14 109.826 176.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 13.1 m . . . . . 0 C--O 1.247 0.969 0 CA-C-O 118.142 -0.932 . . . . 11.7 110.727 -179.396 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.694 0 CA-C-O 120.673 0.273 . . . . 9.95 111.697 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 8.0 m -143.72 40.49 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-O 121.094 0.473 . . . . 8.02 112.256 -179.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.811 ' HG ' ' CD2' ' A' ' 5' ' ' LEU . 3.7 tp -162.0 114.96 1.79 Allowed 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.116 -1.068 . . . . 5.86 108.116 178.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.421 ' O ' ' O ' ' A' ' 5' ' ' LEU . 0.3 OUTLIER -76.59 -58.48 3.26 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 113.227 -1.806 . . . . 6.22 112.291 -177.584 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.871 HD11 ' HA ' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -22.36 -116.09 0.0 OUTLIER 'General case' 0 CA--C 1.478 -1.818 0 CA-C-N 111.06 -2.791 . . . . 7.09 113.411 -173.4 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.833 ' H ' ' HG ' ' A' ' 5' ' ' LEU 0.287 5.8 t70 -174.61 -40.34 0.01 OUTLIER 'General case' 0 C--N 1.278 -2.512 0 CA-C-O 123.509 1.623 . . . . 8.78 109.499 -175.291 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.4 p -137.28 122.47 25.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 N-CA-C 102.633 -3.099 . . . . 7.51 102.633 171.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.871 ' HA ' HD11 ' A' ' 5' ' ' LEU . 12.0 ttp180 -76.72 105.64 7.91 Favored 'General case' 0 N--CA 1.385 -3.697 0 C-N-CA 118.076 -1.45 . . . . 9.08 108.347 -178.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.771 ' O ' HD22 ' A' ' 11' ' ' LEU . 22.4 m -105.77 94.19 5.05 Favored 'General case' 0 N--CA 1.384 -3.755 1 N-CA-C 98.364 -4.68 . . . . 5.66 98.364 168.507 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.45 62.42 1.86 Allowed 'General case' 0 C--N 1.288 -2.07 0 CA-C-N 114.032 -1.44 . . . . 2.68 110.175 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.833 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 1.6 mm? -32.44 109.92 0.31 Allowed Pre-proline 0 N--CA 1.47 0.532 0 N-CA-C 113.672 0.99 . . . . 2.48 113.672 -178.412 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -60.61 157.18 38.25 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.393 2.062 . . . . 1.49 110.267 176.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.516 ' HB3' ' N ' ' A' ' 20' ' ' ARG . 1.0 OUTLIER -159.6 169.94 22.71 Favored 'General case' 0 CA--C 1.552 1.039 0 CA-C-O 121.363 0.601 . . . . 1.0 111.642 173.468 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.778 ' HA2' ' HB3' ' A' ' 40' ' ' GLU . . . 73.49 -160.44 53.72 Favored Glycine 0 CA--C 1.502 -0.769 0 C-N-CA 120.807 -0.711 . . . . 1.15 113.725 177.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.413 ' HG2' ' O ' ' A' ' 15' ' ' PRO . 41.2 Cg_endo -66.68 96.94 0.37 Allowed 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 123.049 2.499 . . . . 1.57 117.145 178.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 86.01 -2.08 87.72 Favored Glycine 1 C--N 1.254 -4.006 0 C-N-CA 119.76 -1.21 . . . . 1.68 114.31 -172.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.46 ' HA2' ' O ' ' A' ' 13' ' ' CYS . . . 79.72 44.95 8.84 Favored Glycine 0 N--CA 1.419 -2.478 0 C-N-CA 118.881 -1.628 . . . . 1.36 114.897 176.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.6 -9.73 34.18 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 113.446 -1.377 . . . . 2.5 111.294 176.041 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.474 ' C ' ' HB3' ' A' ' 13' ' ' CYS . . . -106.32 -174.42 23.34 Favored Glycine 0 CA--C 1.504 -0.643 0 N-CA-C 107.693 -2.163 . . . . 1.02 107.693 178.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.833 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 3.5 ttp180 -129.59 171.59 12.45 Favored 'General case' 0 CA--C 1.552 1.04 0 CA-C-N 121.635 2.717 . . . . 2.92 108.7 -179.475 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.499 ' HB3' ' HG3' ' A' ' 47' ' ' GLU . 1.0 OUTLIER -107.33 143.69 35.26 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 121.28 -0.887 . . . . 1.1 112.739 -178.662 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.424 ' HE2' ' HB3' ' A' ' 20' ' ' ARG . 97.0 m-85 -156.27 57.79 0.58 Allowed 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 114.87 -1.059 . . . . 1.51 109.916 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.505 ' HA3' ' HA ' ' A' ' 76' ' ' PRO . . . 125.97 148.26 7.11 Favored Glycine 0 C--N 1.334 0.432 0 N-CA-C 111.05 -0.82 . . . . 0.9 111.05 -179.095 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.478 ' O ' ' HB1' ' A' ' 41' ' ' ALA . 53.1 Cg_exo -52.3 -75.0 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 121.932 1.755 . . . . 1.5 112.372 -179.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.528 ' HB2' ' CG ' ' B' ' 181' ' ' GLU . 2.0 m -89.37 37.87 0.88 Allowed 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 109.182 -0.673 . . . . 1.26 109.182 178.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 1.082 HG12 HG13 ' A' ' 36' ' ' VAL . 15.9 mt -147.76 102.94 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 CA-C-N 115.269 -0.878 . . . . 0.83 109.586 -179.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.707 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 0.1 OUTLIER -118.68 123.11 44.11 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.648 -0.705 . . . . 0.92 110.53 -177.785 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 1.004 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -142.25 119.4 11.42 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 117.329 2.344 . . . . 1.28 117.329 -178.423 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.465 ' O ' ' CB ' ' A' ' 69' ' ' ALA . . . -108.48 -170.53 21.21 Favored Glycine 0 C--N 1.364 2.121 0 N-CA-C 108.259 -1.936 . . . . 0.67 108.259 175.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.519 ' OD2' ' HG2' ' A' ' 31' ' ' GLU . 20.8 p-10 -64.01 -58.83 5.52 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 114.835 1.42 . . . . 2.27 114.835 -176.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.519 ' HG2' ' OD2' ' A' ' 30' ' ' ASP . 0.0 OUTLIER -108.35 6.52 26.49 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 121.466 0.651 . . . . 1.66 111.477 -177.037 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.949 HD22 ' CZ ' ' A' ' 35' ' ' PHE . 2.2 mt -108.64 -8.44 15.44 Favored 'General case' 0 N--CA 1.398 -3.048 0 N-CA-C 105.332 -2.099 . . . . 1.37 105.332 178.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 1.004 ' O ' ' HA ' ' A' ' 28' ' ' CYS . . . 49.16 -133.15 24.46 Favored Glycine 0 N--CA 1.437 -1.251 0 CA-C-N 114.237 -1.347 . . . . 0.73 112.538 177.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 1.014 ' HB2' HD13 ' A' ' 72' ' ' ILE . 1.2 t -128.42 119.12 24.34 Favored 'General case' 0 CA--C 1.492 -1.286 0 N-CA-C 114.043 1.127 . . . . 1.08 114.043 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 1.076 ' HA ' ' HA ' ' B' ' 135' ' ' PHE . 0.1 OUTLIER -95.51 102.65 14.47 Favored 'General case' 0 N--CA 1.419 -2.02 0 N-CA-C 102.705 -3.072 . . . . 1.38 102.705 173.906 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 1.082 HG13 HG12 ' A' ' 26' ' ' ILE . 3.0 t -87.93 93.65 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.916 0 CA-C-O 123.102 1.43 . . . . 0.76 107.979 -179.13 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.947 ' HA3' HG21 ' B' ' 172' ' ' ILE . . . 94.26 80.0 1.47 Allowed Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 112.089 -2.323 . . . . 0.81 114.178 -178.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.578 HG22 ' O ' ' B' ' 132' ' ' LEU . 71.5 p -159.06 163.37 36.35 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.61 -0.515 . . . . 0.77 109.61 179.034 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.18 -15.67 26.23 Favored 'General case' 0 CA--C 1.527 0.092 0 CA-C-N 118.565 0.62 . . . . 1.02 111.275 178.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.778 ' HB3' ' HA2' ' A' ' 14' ' ' GLY . 40.6 mt-10 -69.23 -13.86 62.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.944 -0.571 . . . . 2.32 109.502 177.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.851 ' O ' ' HB2' ' A' ' 44' ' ' CYS . . . -96.11 -24.11 16.46 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 115.328 -0.851 . . . . 0.87 111.121 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.544 HD21 ' HB3' ' B' ' 191' ' ' PHE . 5.3 mt -41.06 -32.95 0.28 Allowed 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.136 0.791 . . . . 1.23 113.136 -178.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 5.9 mmm-85 -71.04 -15.18 62.54 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 122.456 1.122 . . . . 2.92 109.561 178.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.851 ' HB2' ' O ' ' A' ' 41' ' ' ALA . 1.3 m -62.46 -27.58 69.22 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 112.663 -2.062 . . . . 1.57 110.699 -178.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -49.86 -41.23 44.87 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.968 0.413 . . . . 3.31 111.764 179.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -85.52 6.27 27.78 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.722 -0.391 . . . . 3.69 110.257 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.499 ' HG3' ' HB3' ' A' ' 21' ' ' CYS . 1.6 tm-20 -82.04 1.36 36.14 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.217 -0.66 . . . . 3.99 109.217 177.478 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -91.92 -28.27 17.37 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.984 -0.553 . . . . 3.86 109.795 178.417 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -91.9 11.64 24.29 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 115.971 -0.559 . . . . 5.68 111.387 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.697 HD23 HG21 ' A' ' 9' ' ' THR . 4.4 mp -141.02 93.19 8.28 Favored Pre-proline 0 CA--C 1.53 0.187 0 CA-C-N 116.792 -0.186 . . . . 5.4 110.884 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -85.19 45.74 1.67 Allowed 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 122.452 2.101 . . . . 4.92 113.041 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.562 ' O ' ' HB ' ' A' ' 9' ' ' THR . 1.4 p -133.43 91.74 25.98 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 116.454 -0.339 . . . . 5.64 110.806 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -90.11 138.07 2.77 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.537 2.158 . . . . 5.04 112.99 -179.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.864 ' HA ' HD13 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -63.53 92.26 0.06 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.985 -0.552 . . . . 2.74 111.344 179.711 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.778 ' HB2' HD12 ' A' ' 3' ' ' LEU . 8.8 tt0 44.1 -106.43 0.1 Allowed 'General case' 0 CA--C 1.552 1.044 0 N-CA-C 112.688 0.625 . . . . 5.75 112.688 179.446 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.3 p 89.95 143.25 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.791 0.837 . . . . 3.12 110.852 -178.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.52 115.05 7.16 Favored Glycine 0 CA--C 1.491 -1.428 0 C-N-CA 121.316 -0.468 . . . . 2.1 112.369 -178.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -73.72 79.26 1.55 Allowed 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 108.251 -1.018 . . . . 4.36 108.251 179.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.576 ' O ' ' HA ' ' A' ' 66' ' ' ARG . 8.0 mmmt -135.45 73.87 61.73 Favored Pre-proline 0 C--N 1.31 -1.116 0 N-CA-C 106.079 -1.823 . . . . 3.55 106.079 -179.327 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.623 ' HA ' ' O ' ' A' ' 65' ' ' GLY . 74.2 Cg_endo -75.79 78.8 3.01 Favored 'Trans proline' 0 C--N 1.372 1.777 0 C-N-CA 123.323 2.682 . . . . 1.54 115.515 -177.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 2.3 p -100.72 -176.05 3.07 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 105.118 -2.178 . . . . 1.59 105.118 175.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.02 -168.03 52.31 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 118.203 -1.951 . . . . 2.43 114.444 -178.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.84 40.91 0.88 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 113.891 -1.155 . . . . 4.11 110.353 -177.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 115.48 9.55 12.74 Favored Glycine 0 CA--C 1.544 1.873 0 CA-C-N 113.847 -1.524 . . . . 2.21 115.216 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.844 ' CA ' ' HB3' ' A' ' 75' ' ' SER . . . -103.55 140.41 14.89 Favored Glycine 0 C--N 1.336 0.58 0 CA-C-N 120.529 2.165 . . . . 1.62 116.2 -178.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.576 ' HA ' ' O ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -101.73 156.51 17.45 Favored 'General case' 0 C--N 1.341 0.216 0 C-N-CA 124.496 1.118 . . . . 3.02 109.685 177.837 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.466 ' HB2' ' HB2' ' A' ' 59' ' ' LYS . 1.2 m -52.1 106.28 0.14 Allowed 'General case' 0 CA--C 1.504 -0.82 0 CA-C-N 119.283 0.947 . . . . 1.52 108.793 -179.012 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -78.53 -29.65 46.56 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 106.31 -1.737 . . . . 1.07 106.31 177.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.957 ' O ' HG13 ' A' ' 72' ' ' ILE . . . -162.08 139.04 8.21 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 113.454 -1.703 . . . . 1.0 109.925 -176.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.775 ' HB1' ' HB2' ' A' ' 89' ' ' ALA . . . 12.7 -143.22 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.374 1.07 . . . . 1.24 113.796 179.127 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.421 ' HA2' ' O ' ' A' ' 82' ' ' ASP . . . -73.44 65.12 1.71 Allowed Glycine 0 CA--C 1.491 -1.443 0 N-CA-C 107.513 -2.235 . . . . 1.28 107.513 179.064 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 1.035 HG21 ' HA3' ' B' ' 137' ' ' GLY . 1.7 pp -150.81 97.17 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.813 0 N-CA-C 106.161 -1.792 . . . . 2.27 106.161 167.191 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.431 ' O ' ' N ' ' A' ' 80' ' ' HIS . 3.9 t -95.62 103.26 15.12 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.317 -0.856 . . . . 1.98 111.48 -175.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.595 ' HB3' ' O ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -129.75 176.15 8.26 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 113.387 0.884 . . . . 1.33 113.387 -179.029 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.902 ' HB2' ' HD2' ' A' ' 76' ' ' PRO . 36.5 p -138.32 -179.27 1.0 Allowed Pre-proline 0 N--CA 1.462 0.15 0 CA-C-N 113.689 -1.596 . . . . 1.99 108.513 178.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.902 ' HD2' ' HB2' ' A' ' 75' ' ' SER . 77.0 Cg_endo -78.02 30.31 0.44 Allowed 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 121.449 1.433 . . . . 1.86 111.511 178.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.425 ' H ' ' C ' ' A' ' 75' ' ' SER . 0.6 OUTLIER -144.96 -34.01 0.36 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.507 -0.769 . . . . 2.65 110.864 179.816 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.595 ' O ' ' HB3' ' A' ' 74' ' ' CYS . . . -158.74 -171.98 25.28 Favored Glycine 0 C--N 1.339 0.738 0 C-N-CA 120.764 -0.732 . . . . 0.99 113.118 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.59 ' HA ' ' HA ' ' A' ' 74' ' ' CYS . 13.6 t -148.27 160.22 43.19 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 122.567 0.347 . . . . 1.34 110.664 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.431 ' N ' ' O ' ' A' ' 73' ' ' CYS . 1.8 t60 -154.71 145.92 22.84 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 120.027 -0.669 . . . . 2.17 111.659 -179.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.585 ' CG ' ' HB2' ' B' ' 125' ' ' SER . 1.8 mt-10 -64.13 132.82 51.59 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.42 -0.585 . . . . 3.05 109.42 178.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.453 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 0.3 OUTLIER -141.62 122.67 8.75 Favored Pre-proline 0 CA--C 1.541 0.621 0 CA-C-N 116.495 -0.32 . . . . 2.02 110.754 -179.08 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 82' ' ' ASP . 1.8 Cg_endo -83.7 -12.79 8.56 Favored 'Trans proline' 0 C--N 1.358 1.076 0 C-N-CA 123.17 2.58 . . . . 1.93 113.97 -177.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.87 -38.65 91.86 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.808 0.337 . . . . 1.53 111.531 -179.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.507 ' HB2' ' O ' ' A' ' 70' ' ' ALA . 78.7 m -95.24 39.7 1.11 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.034 -0.53 . . . . 1.88 111.155 -179.443 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.821 ' N ' ' HD2' ' A' ' 87' ' ' PRO . 0.1 OUTLIER -70.62 -31.27 2.08 Favored Pre-proline 0 N--CA 1.466 0.368 0 N-CA-C 114.744 1.386 . . . . 3.6 114.744 -178.769 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.821 ' HD2' ' N ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER -10.68 -115.35 0.0 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.252 0 C-N-CA 123.543 2.829 . . . . 2.56 115.696 177.708 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.97 35.62 0.13 Allowed 'General case' 0 C--N 1.272 -2.773 0 CA-C-N 110.087 -3.233 . . . . 4.72 109.749 179.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.775 ' HB2' ' HB1' ' A' ' 70' ' ' ALA . . . -97.11 39.23 1.19 Allowed 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 113.006 -1.906 . . . . 5.29 106.003 172.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.83 161.49 29.52 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 114.078 1.14 . . . . 6.98 114.078 -177.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.714 ' HB3' HD21 ' B' ' 142' ' ' LEU . 15.7 p90 -85.25 100.32 11.7 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 114.531 -1.213 . . . . 10.21 110.507 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 19.0 t . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.206 -0.902 . . . . 11.77 110.746 -179.795 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.336 0 N-CA-C 110.369 -0.234 . . . . 10.07 110.369 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 28.0 t -144.2 125.73 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 CA-C-O 121.769 0.795 . . . . 8.41 110.18 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -85.38 114.15 22.22 Favored 'General case' 0 C--O 1.225 -0.207 0 CA-C-N 114.338 -1.301 . . . . 5.87 111.16 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 104' ' ' ASP . . . . . 0.567 ' H ' ' HG3' ' B' ' 155' ' ' GLN . 3.6 t70 -77.58 76.43 4.11 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 105.541 -2.022 . . . . 6.27 105.541 175.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . 0.895 HD22 ' O ' ' B' ' 153' ' ' PRO . 0.3 OUTLIER -151.3 -128.85 0.04 OUTLIER 'General case' 0 N--CA 1.412 -2.364 0 CA-C-N 112.905 -1.952 . . . . 7.2 106.708 -174.117 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 106' ' ' ASP . . . . . 0.739 ' H ' ' HG ' ' B' ' 105' ' ' LEU . 4.2 t70 -168.65 -41.83 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 107.813 -1.18 . . . . 8.55 107.813 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 107' ' ' VAL . . . . . 0.542 ' O ' HD21 ' B' ' 105' ' ' LEU . 7.2 p -139.89 123.84 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 N-CA-C 103.422 -2.807 . . . . 7.48 103.422 174.44 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 108' ' ' ARG . . . . . 0.821 ' HG3' ' SG ' ' B' ' 154' ' ' CYS . 11.4 ttp180 -76.03 106.96 7.91 Favored 'General case' 0 N--CA 1.388 -3.556 0 C-N-CA 118.655 -1.218 . . . . 9.12 108.101 -178.475 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 109' ' ' THR . . . . . 0.768 ' O ' HD22 ' B' ' 111' ' ' LEU . 24.4 m -108.45 94.3 4.99 Favored 'General case' 0 N--CA 1.385 -3.696 1 N-CA-C 97.718 -4.919 . . . . 5.69 97.718 168.929 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 110' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -78.49 66.88 4.14 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 113.239 -1.8 . . . . 2.61 109.194 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 111' ' ' LEU . . . . . 0.845 ' O ' ' HA ' ' B' ' 120' ' ' ARG . 1.7 mm? -34.2 109.97 0.37 Allowed Pre-proline 0 N--CA 1.469 0.507 0 N-CA-C 113.436 0.902 . . . . 2.47 113.436 -179.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 112' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -66.19 152.41 81.23 Favored 'Trans proline' 0 N--CA 1.464 -0.242 0 C-N-CA 121.84 1.693 . . . . 1.47 111.607 176.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.584 ' HB3' ' N ' ' B' ' 120' ' ' ARG . 1.0 OUTLIER -154.3 170.69 20.71 Favored 'General case' 0 CA--C 1.557 1.243 0 CA-C-O 121.185 0.517 . . . . 1.0 111.632 177.659 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 114' ' ' GLY . . . . . 0.748 ' HA2' ' HB3' ' B' ' 140' ' ' GLU . . . 74.38 -159.35 52.41 Favored Glycine 0 N--CA 1.467 0.748 0 CA-C-N 116.241 -0.436 . . . . 1.16 114.029 177.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 115' ' ' PRO . . . . . 0.476 ' O ' ' N ' ' B' ' 117' ' ' GLY . 87.6 Cg_endo -57.7 143.53 94.98 Favored 'Trans proline' 0 C--N 1.363 1.315 0 N-CA-C 102.355 -3.748 . . . . 1.57 102.355 175.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 48.06 -3.72 0.01 OUTLIER Glycine 0 C--N 1.274 -2.898 0 O-C-N 118.251 -2.78 . . . . 1.7 116.474 172.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 117' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' B' ' 115' ' ' PRO . . . 78.5 42.93 13.21 Favored Glycine 0 N--CA 1.407 -3.267 0 C-N-CA 116.695 -2.669 . . . . 1.38 114.231 177.143 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.09 -15.97 27.04 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 113.199 -1.5 . . . . 2.54 110.852 177.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . -96.26 -161.29 32.72 Favored Glycine 0 C--N 1.343 0.967 0 N-CA-C 109.074 -1.61 . . . . 1.04 109.074 179.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.845 ' HA ' ' O ' ' B' ' 111' ' ' LEU . 3.5 ttp180 -140.84 170.54 15.56 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 121.706 2.753 . . . . 2.89 106.788 177.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 121' ' ' CYS . . . . . 0.48 ' HB3' ' HG3' ' B' ' 147' ' ' GLU . 1.1 m -107.67 143.83 35.6 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 119.005 0.82 . . . . 1.07 112.83 -178.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 122' ' ' PHE . . . . . 0.434 ' HE2' ' HB3' ' B' ' 120' ' ' ARG . 97.1 m-85 -156.37 57.85 0.57 Allowed 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 114.898 -1.046 . . . . 1.53 109.897 179.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 123' ' ' GLY . . . . . 0.503 ' HA3' ' HA ' ' B' ' 176' ' ' PRO . . . 125.86 148.22 7.12 Favored Glycine 0 C--N 1.334 0.45 0 N-CA-C 110.972 -0.851 . . . . 0.9 110.972 -179.135 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . 0.471 ' O ' ' HB1' ' B' ' 141' ' ' ALA . 53.0 Cg_exo -52.27 -75.15 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 121.91 1.74 . . . . 1.51 112.312 -179.276 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 125' ' ' SER . . . . . 0.585 ' HB2' ' CG ' ' A' ' 81' ' ' GLU . 1.9 m -89.28 37.71 0.87 Allowed 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 109.242 -0.651 . . . . 1.25 109.242 178.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 126' ' ' ILE . . . . . 1.04 HG12 HG13 ' B' ' 136' ' ' VAL . 18.5 mt -147.36 102.93 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 CA-C-N 115.247 -0.888 . . . . 0.85 109.737 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 127' ' ' CYS . . . . . 0.719 ' O ' ' HA ' ' B' ' 134' ' ' CYS . 0.1 OUTLIER -118.65 123.05 44.02 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.65 -0.705 . . . . 0.89 110.511 -177.837 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 128' ' ' CYS . . . . . 0.996 ' HA ' ' O ' ' B' ' 133' ' ' GLY . 0.0 OUTLIER -141.43 120.84 13.17 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 116.642 2.09 . . . . 1.23 116.642 -178.641 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 129' ' ' GLY . . . . . 0.49 ' O ' ' HB1' ' B' ' 169' ' ' ALA . . . -110.49 -169.0 19.46 Favored Glycine 0 C--N 1.366 2.249 0 N-CA-C 107.924 -2.07 . . . . 0.66 107.924 175.304 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 130' ' ' ASP . . . . . 0.514 ' OD2' ' HG2' ' B' ' 131' ' ' GLU . 21.3 p-10 -63.88 -60.88 2.72 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 113.967 1.099 . . . . 2.35 113.967 -177.294 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 131' ' ' GLU . . . . . 0.514 ' HG2' ' OD2' ' B' ' 130' ' ' ASP . 0.1 OUTLIER -115.13 27.52 9.33 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 122.287 1.042 . . . . 1.69 111.132 -178.048 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 132' ' ' LEU . . . . . 0.968 HD22 ' CZ ' ' B' ' 135' ' ' PHE . 1.7 mt -124.02 -8.41 7.73 Favored 'General case' 0 N--CA 1.399 -3.01 0 N-CA-C 102.91 -2.996 . . . . 1.38 102.91 178.253 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 133' ' ' GLY . . . . . 0.996 ' O ' ' HA ' ' B' ' 128' ' ' CYS . . . 46.68 -130.36 11.96 Favored Glycine 0 N--CA 1.417 -2.604 0 CA-C-N 113.312 -1.767 . . . . 0.72 112.694 175.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 134' ' ' CYS . . . . . 1.011 ' HB2' HD13 ' B' ' 172' ' ' ILE . 1.5 t -130.85 118.7 21.13 Favored 'General case' 0 CA--C 1.492 -1.254 0 CA-C-N 120.166 1.983 . . . . 1.08 114.005 -179.356 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 135' ' ' PHE . . . . . 1.076 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -94.49 102.78 14.74 Favored 'General case' 0 N--CA 1.417 -2.085 0 N-CA-C 102.899 -3.0 . . . . 1.36 102.899 174.501 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 136' ' ' VAL . . . . . 1.04 HG13 HG12 ' B' ' 126' ' ' ILE . 3.8 t -87.8 93.15 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.916 0 CA-C-O 123.118 1.437 . . . . 0.75 107.968 -179.213 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 137' ' ' GLY . . . . . 1.035 ' HA3' HG21 ' A' ' 72' ' ' ILE . . . 94.67 79.62 1.46 Allowed Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 112.129 -2.305 . . . . 0.83 114.298 -178.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 138' ' ' THR . . . . . 0.654 HG22 ' O ' ' A' ' 32' ' ' LEU . 72.7 p -158.18 165.08 35.81 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.535 -0.543 . . . . 0.78 109.535 179.187 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 139' ' ' ALA . . . . . . . . . . . . . . . -62.56 -14.01 37.53 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 121.107 0.479 . . . . 1.04 110.977 178.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 140' ' ' GLU . . . . . 0.748 ' HB3' ' HA2' ' B' ' 114' ' ' GLY . 40.9 mt-10 -70.15 -15.13 62.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.537 -0.756 . . . . 2.31 109.446 177.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 141' ' ' ALA . . . . . 0.815 ' O ' ' HB2' ' B' ' 144' ' ' CYS . . . -94.51 -25.48 16.84 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.37 -0.832 . . . . 0.87 110.871 -179.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 142' ' ' LEU . . . . . 0.714 HD21 ' HB3' ' A' ' 91' ' ' PHE . 5.2 mt -40.31 -32.83 0.2 Allowed 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 113.245 0.831 . . . . 1.24 113.245 -177.327 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 143' ' ' ARG . . . . . . . . . . . . . 6.0 mmm-85 -69.34 -18.5 63.81 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 122.641 1.21 . . . . 2.93 109.141 177.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 144' ' ' CYS . . . . . 0.815 ' HB2' ' O ' ' B' ' 141' ' ' ALA . 1.3 m -60.94 -25.54 66.87 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 112.617 -2.083 . . . . 1.61 111.007 -177.367 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -51.1 -40.89 59.46 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.902 0.382 . . . . 3.35 111.693 178.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -85.55 6.37 27.48 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.68 -0.408 . . . . 3.76 110.211 -179.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . 0.48 ' HG3' ' HB3' ' B' ' 121' ' ' CYS . 1.6 tm-20 -82.1 1.36 36.34 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.19 -0.67 . . . . 4.01 109.19 177.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 148' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -91.98 -28.19 17.37 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.931 -0.577 . . . . 3.92 109.724 178.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -91.95 11.66 24.35 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.0 -0.545 . . . . 5.73 111.335 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 150' ' ' LEU . . . . . 0.671 HD23 HG21 ' B' ' 109' ' ' THR . 4.4 mp -141.03 93.21 8.27 Favored Pre-proline 0 CA--C 1.53 0.187 0 CA-C-N 116.817 -0.174 . . . . 5.46 110.837 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 151' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -85.15 45.66 1.66 Allowed 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.415 2.077 . . . . 5.02 113.027 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 152' ' ' SER . . . . . 0.554 ' O ' ' HB ' ' B' ' 109' ' ' THR . 1.4 p -133.43 91.84 25.72 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.506 -0.315 . . . . 5.73 110.891 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 153' ' ' PRO . . . . . 0.895 ' O ' HD22 ' B' ' 105' ' ' LEU . 97.4 Cg_endo -90.2 138.07 2.73 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.427 2.085 . . . . 5.1 112.976 -179.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 154' ' ' CYS . . . . . 0.821 ' SG ' ' HG3' ' B' ' 108' ' ' ARG . 0.0 OUTLIER -63.78 93.96 0.09 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.934 -0.575 . . . . 2.68 111.011 179.714 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 155' ' ' GLN . . . . . 0.567 ' HG3' ' H ' ' B' ' 104' ' ' ASP . 8.9 tt0 42.57 -106.52 0.08 Allowed 'General case' 0 CA--C 1.553 1.082 0 N-CA-C 112.837 0.68 . . . . 5.63 112.837 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 156' ' ' SER . . . . . 0.408 ' CB ' ' O ' ' B' ' 155' ' ' GLN . 5.5 p 89.29 139.7 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.894 0.878 . . . . 3.11 111.495 -179.165 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -56.51 115.12 5.88 Favored Glycine 0 CA--C 1.499 -0.909 0 CA-C-N 116.131 -0.486 . . . . 2.07 112.576 -178.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -76.28 67.45 2.53 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 119.157 -1.017 . . . . 4.34 109.504 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 159' ' ' LYS . . . . . 0.623 ' O ' ' HA ' ' B' ' 166' ' ' ARG . 14.8 mmmt -108.62 70.17 0.38 Allowed Pre-proline 0 C--N 1.318 -0.79 0 CA-C-N 114.043 -1.435 . . . . 3.54 110.852 174.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 160' ' ' PRO . . . . . 0.59 ' HA ' ' O ' ' B' ' 165' ' ' GLY . 68.6 Cg_endo -75.38 82.97 1.96 Allowed 'Trans proline' 0 N--CA 1.463 -0.271 0 C-N-CA 121.747 1.632 . . . . 1.51 115.582 -176.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 161' ' ' CYS . . . . . 0.403 ' N ' ' O ' ' B' ' 165' ' ' GLY . 1.8 p -93.04 -157.98 0.57 Allowed 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 113.107 -1.86 . . . . 1.58 107.279 177.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 52.95 -167.11 1.17 Allowed Glycine 0 N--CA 1.453 -0.203 0 O-C-N 119.287 -2.133 . . . . 2.37 116.938 171.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.64 41.02 0.88 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 112.849 -1.675 . . . . 4.07 110.436 -178.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 115.52 9.72 12.47 Favored Glycine 0 CA--C 1.548 2.136 0 CA-C-N 114.168 -1.378 . . . . 2.2 115.222 -179.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 165' ' ' GLY . . . . . 0.836 ' CA ' ' HB3' ' B' ' 175' ' ' SER . . . -103.93 139.5 14.55 Favored Glycine 0 N--CA 1.464 0.512 0 CA-C-N 120.327 2.064 . . . . 1.62 116.306 -179.051 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 166' ' ' ARG . . . . . 0.623 ' HA ' ' O ' ' B' ' 159' ' ' LYS . 0.0 OUTLIER -101.48 156.39 17.5 Favored 'General case' 0 C--N 1.343 0.323 0 CA-C-N 113.877 -1.162 . . . . 3.05 109.754 178.11 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 167' ' ' CYS . . . . . 0.477 ' HB2' ' HB2' ' B' ' 159' ' ' LYS . 1.2 m -52.05 106.19 0.14 Allowed 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 119.456 1.025 . . . . 1.56 108.813 -179.003 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 168' ' ' ALA . . . . . . . . . . . . . . . -79.58 -27.76 41.15 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 106.602 -1.629 . . . . 1.04 106.602 177.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 169' ' ' ALA . . . . . 0.903 ' O ' HG13 ' B' ' 172' ' ' ILE . . . -163.46 139.67 6.88 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 114.81 -1.086 . . . . 0.98 108.589 -177.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 170' ' ' ALA . . . . . 0.675 ' HB1' ' HB2' ' B' ' 189' ' ' ALA . . . 11.28 -139.65 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 114.489 1.292 . . . . 1.25 114.489 179.109 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 171' ' ' GLY . . . . . 0.471 ' HA2' ' O ' ' B' ' 182' ' ' ASP . . . -57.2 19.96 0.01 OUTLIER Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 115.72 1.048 . . . . 1.29 115.72 -179.121 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 172' ' ' ILE . . . . . 1.011 HD13 ' HB2' ' B' ' 134' ' ' CYS . 1.7 pp -128.3 99.81 5.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 CA-C-N 118.811 1.305 . . . . 2.27 109.529 -176.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 173' ' ' CYS . . . . . 0.427 ' HB3' ' HB3' ' B' ' 182' ' ' ASP . 4.6 t -94.9 102.95 14.82 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.317 -1.31 . . . . 1.94 111.854 -176.492 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 174' ' ' CYS . . . . . 0.595 ' HB3' ' O ' ' B' ' 178' ' ' GLY . 0.0 OUTLIER -130.0 176.44 8.06 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 113.372 0.878 . . . . 1.35 113.372 -179.118 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 175' ' ' SER . . . . . 0.882 ' HB2' ' HD2' ' B' ' 176' ' ' PRO . 35.9 p -138.42 -179.29 1.01 Allowed Pre-proline 0 N--CA 1.462 0.129 0 CA-C-N 113.666 -1.606 . . . . 2.0 108.493 178.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 176' ' ' PRO . . . . . 0.882 ' HD2' ' HB2' ' B' ' 175' ' ' SER . 77.0 Cg_endo -78.0 30.3 0.44 Allowed 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 121.445 1.43 . . . . 1.9 111.524 178.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 177' ' ' ASP . . . . . 0.426 ' H ' ' C ' ' B' ' 175' ' ' SER . 0.6 OUTLIER -145.06 -33.88 0.36 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 115.534 -0.757 . . . . 2.72 110.84 179.837 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 178' ' ' GLY . . . . . 0.595 ' O ' ' HB3' ' B' ' 174' ' ' CYS . . . -158.82 -172.04 25.42 Favored Glycine 0 C--N 1.339 0.702 0 C-N-CA 120.822 -0.704 . . . . 0.99 113.19 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 179' ' ' CYS . . . . . 0.593 ' HA ' ' HA ' ' B' ' 174' ' ' CYS . 13.6 t -148.23 160.3 43.08 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 122.536 0.335 . . . . 1.34 110.65 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 180' ' ' HIS . . . . . 0.422 ' N ' ' O ' ' B' ' 173' ' ' CYS . 1.8 t60 -154.86 145.89 22.67 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 119.968 -0.693 . . . . 2.1 111.665 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 181' ' ' GLU . . . . . 0.528 ' CG ' ' HB2' ' A' ' 25' ' ' SER . 1.8 mt-10 -64.12 132.91 51.87 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.421 -0.585 . . . . 3.06 109.421 178.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 182' ' ' ASP . . . . . 0.471 ' O ' ' HA2' ' B' ' 171' ' ' GLY . 0.3 OUTLIER -141.71 122.52 8.63 Favored Pre-proline 0 CA--C 1.541 0.613 0 CA-C-N 116.499 -0.319 . . . . 2.06 110.706 -178.984 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 183' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' B' ' 182' ' ' ASP . 1.8 Cg_endo -83.64 -12.73 8.67 Favored 'Trans proline' 0 C--N 1.359 1.097 0 C-N-CA 123.141 2.561 . . . . 1.91 114.009 -178.019 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -63.87 -38.44 91.1 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.845 0.355 . . . . 1.56 111.54 -179.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 185' ' ' CYS . . . . . 0.533 ' HB2' ' O ' ' B' ' 170' ' ' ALA . 86.0 m -95.14 39.02 1.12 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.942 -0.572 . . . . 1.94 111.468 -179.419 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 186' ' ' ASP . . . . . 0.826 ' N ' ' HD2' ' B' ' 187' ' ' PRO . 0.1 OUTLIER -70.36 -31.36 2.22 Favored Pre-proline 0 CA--C 1.535 0.371 0 N-CA-C 115.018 1.488 . . . . 3.61 115.018 -178.848 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 187' ' ' PRO . . . . . 0.826 ' HD2' ' N ' ' B' ' 186' ' ' ASP . 0.1 OUTLIER -10.08 -116.13 0.0 OUTLIER 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 123.665 2.91 . . . . 2.58 115.547 177.497 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.95 60.41 5.41 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 101.47 -3.53 . . . . 4.7 101.47 175.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 189' ' ' ALA . . . . . 0.715 ' HB3' ' O ' ' B' ' 186' ' ' ASP . . . -112.27 31.33 6.36 Favored 'General case' 0 CA--C 1.509 -0.6 1 CA-C-N 106.737 -4.756 . . . . 5.24 108.234 163.147 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 190' ' ' ALA . . . . . . . . . . . . . . . -72.6 161.77 30.35 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 114.755 1.391 . . . . 6.93 114.755 -173.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 191' ' ' PHE . . . . . 0.544 ' HB3' HD21 ' A' ' 42' ' ' LEU . 15.6 p90 -85.26 100.42 11.77 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 114.076 -1.42 . . . . 10.14 110.271 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 18.5 t . . . . . 0 C--O 1.248 0.981 0 CA-C-O 118.251 -0.88 . . . . 11.7 110.735 -179.858 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.56 ' O ' HG22 ' A' ' 2' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.637 0.256 . . . . 9.95 111.581 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.654 ' O ' ' HG3' ' A' ' 55' ' ' GLN . 24.0 m 50.27 47.45 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-O 122.149 0.976 . . . . 8.02 109.76 -176.343 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.836 HD13 ' HB2' ' A' ' 55' ' ' GLN . 0.5 OUTLIER -109.89 77.44 1.05 Allowed 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 112.914 -1.948 . . . . 5.86 109.775 179.725 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -68.48 64.17 0.11 Allowed 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 118.538 -1.265 . . . . 6.22 109.479 -177.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.737 ' HG ' ' HD2' ' A' ' 53' ' ' PRO . 0.2 OUTLIER -148.74 -102.21 0.08 Allowed 'General case' 0 N--CA 1.41 -2.454 0 N-CA-C 105.757 -1.942 . . . . 7.09 105.757 -179.141 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.537 ' H ' HD13 ' A' ' 5' ' ' LEU . 9.7 t70 -171.49 -106.16 0.01 OUTLIER 'General case' 0 C--N 1.274 -2.688 0 CA-C-N 113.631 -1.622 . . . . 8.78 107.242 178.135 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.461 ' O ' ' CD1' ' A' ' 5' ' ' LEU . 5.1 p -89.76 132.09 35.35 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.997 0 N-CA-C 103.152 -2.907 . . . . 7.51 103.152 175.35 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.01 109.29 7.39 Favored 'General case' 0 N--CA 1.4 -2.936 0 C-N-CA 116.946 -1.902 . . . . 9.08 112.373 -174.51 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.472 ' O ' ' HB2' ' A' ' 54' ' ' CYS . 0.1 OUTLIER -105.63 100.23 9.8 Favored 'General case' 0 N--CA 1.407 -2.622 0 N-CA-C 100.217 -3.994 . . . . 5.66 100.217 167.265 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.553 ' HA ' ' CB ' ' A' ' 54' ' ' CYS . 0.5 OUTLIER -77.21 75.58 3.77 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 115.295 -0.866 . . . . 2.68 113.207 -178.717 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.601 HD13 ' HD2' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -31.13 113.94 0.34 Allowed Pre-proline 0 N--CA 1.472 0.648 0 N-CA-C 113.244 0.831 . . . . 2.48 113.244 -179.515 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.791 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 21.9 Cg_endo -93.04 152.74 2.62 Favored 'Trans proline' 0 CA--C 1.535 0.571 0 C-N-CA 124.128 3.219 . . . . 1.49 115.279 -178.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.812 ' N ' ' O ' ' A' ' 19' ' ' GLY . 15.4 p -154.06 -160.36 1.08 Allowed 'General case' 0 C--O 1.243 0.741 0 CA-C-N 115.799 -0.637 . . . . 1.0 109.676 175.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.558 ' HA2' ' HG2' ' A' ' 40' ' ' GLU . . . 74.08 -162.95 54.47 Favored Glycine 0 C--N 1.338 0.65 0 N-CA-C 115.479 0.952 . . . . 1.15 115.479 174.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.655 ' O ' ' HD3' ' A' ' 18' ' ' LYS . 64.5 Cg_endo -61.74 104.31 0.31 Allowed 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 124.411 3.408 . . . . 1.57 110.237 177.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 86.67 -8.83 73.73 Favored Glycine 0 C--N 1.27 -3.125 0 CA-C-N 112.625 -2.08 . . . . 1.68 112.037 -178.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.782 ' O ' ' HB2' ' A' ' 12' ' ' PRO . . . 78.08 44.33 12.01 Favored Glycine 0 N--CA 1.403 -3.555 0 C-N-CA 120.258 -0.973 . . . . 1.36 114.789 179.126 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.657 ' HZ3' ' H ' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -92.8 -49.0 6.28 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 105.494 -2.039 . . . . 2.5 105.494 175.457 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.812 ' O ' ' N ' ' A' ' 13' ' ' CYS . . . -66.46 162.68 43.95 Favored Glycine 0 C--O 1.205 -1.658 0 C-N-CA 118.099 -2.001 . . . . 1.02 116.038 -165.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.536 ' HD2' ' HB3' ' A' ' 10' ' ' CYS . 0.0 OUTLIER -98.53 163.6 12.6 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 115.081 1.512 . . . . 2.92 115.081 -171.052 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.4 m -106.27 134.31 49.61 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 114.266 -1.334 . . . . 1.1 110.772 -177.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -134.26 36.3 3.21 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.208 -0.905 . . . . 1.51 109.857 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 144.93 164.43 10.61 Favored Glycine 0 CA--C 1.521 0.459 0 CA-C-N 115.802 -0.635 . . . . 0.9 112.39 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.436 ' O ' ' HB2' ' A' ' 44' ' ' CYS . 50.6 Cg_exo -52.12 -73.22 0.04 OUTLIER 'Trans proline' 0 CA--C 1.532 0.396 0 C-N-CA 122.715 2.277 . . . . 1.5 112.66 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.654 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.4 OUTLIER -90.96 42.72 1.12 Allowed 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 109.312 -0.625 . . . . 1.26 109.312 178.875 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.678 HG12 HG13 ' A' ' 36' ' ' VAL . 4.4 mt -144.9 121.14 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 N-CA-C 113.561 0.949 . . . . 0.83 113.561 -177.037 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.706 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -138.19 112.42 8.62 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.71 0.767 . . . . 0.92 110.632 178.736 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 1.091 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -131.74 118.53 20.08 Favored 'General case' 0 CA--C 1.557 1.242 0 N-CA-C 114.996 1.48 . . . . 1.28 114.996 -179.319 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.482 ' O ' ' HB2' ' A' ' 69' ' ' ALA . . . -108.22 -165.99 21.24 Favored Glycine 0 N--CA 1.428 -1.849 0 N-CA-C 107.035 -2.426 . . . . 0.67 107.035 175.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -68.51 -60.48 2.4 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 115.322 1.601 . . . . 2.27 115.322 -179.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.28 18.43 21.64 Favored 'General case' 0 CA--C 1.482 -1.639 0 CA-C-O 121.682 0.754 . . . . 1.66 111.464 -176.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.787 HD22 ' CZ ' ' A' ' 35' ' ' PHE . 1.2 mt -115.06 -24.86 8.37 Favored 'General case' 0 N--CA 1.395 -3.195 0 N-CA-C 106.396 -1.705 . . . . 1.37 106.396 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 1.091 ' O ' ' HA ' ' A' ' 28' ' ' CYS . . . 76.18 -132.63 12.97 Favored Glycine 0 N--CA 1.4 -3.713 0 CA-C-N 114.353 -1.294 . . . . 0.73 111.28 177.267 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 1.066 ' HB2' HD13 ' A' ' 72' ' ' ILE . 3.2 t -137.96 118.35 13.75 Favored 'General case' 0 CA--C 1.479 -1.758 0 CA-C-N 118.63 1.215 . . . . 1.08 111.557 178.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.982 ' HA ' ' HA ' ' B' ' 135' ' ' PHE . 0.0 OUTLIER -91.62 107.21 19.05 Favored 'General case' 0 N--CA 1.42 -1.953 0 N-CA-C 102.242 -3.244 . . . . 1.38 102.242 174.106 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.728 HG23 HG23 ' B' ' 136' ' ' VAL . 1.9 t -93.0 89.76 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.587 0 CA-C-O 122.793 1.282 . . . . 0.76 110.21 -177.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.848 ' HA3' HG21 ' B' ' 172' ' ' ILE . . . 102.76 17.44 18.96 Favored Glycine 0 CA--C 1.518 0.241 0 CA-C-N 112.962 -1.926 . . . . 0.81 116.017 178.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.826 HG21 ' CD2' ' B' ' 135' ' ' PHE . 25.9 p -95.39 164.99 12.59 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 118.505 1.152 . . . . 0.77 109.002 178.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.884 ' HA ' HD12 ' A' ' 42' ' ' LEU . . . -49.29 -29.7 6.32 Favored 'General case' 0 CA--C 1.517 -0.291 0 O-C-N 120.963 -1.086 . . . . 1.02 112.906 -177.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.558 ' HG2' ' HA2' ' A' ' 14' ' ' GLY . 1.6 mp0 -62.53 -20.65 64.86 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 120.867 -0.333 . . . . 2.32 110.125 179.217 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.747 ' O ' ' HB2' ' A' ' 44' ' ' CYS . . . -96.14 -24.07 16.45 Favored 'General case' 0 N--CA 1.428 -1.536 0 CA-C-O 119.312 -0.375 . . . . 0.87 110.468 -178.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.884 HD12 ' HA ' ' A' ' 39' ' ' ALA . 1.8 mt -57.4 -27.18 62.11 Favored 'General case' 0 C--N 1.346 0.445 0 CA-C-N 119.791 1.178 . . . . 1.23 110.095 179.223 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.498 ' HD3' ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -77.69 9.27 3.56 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 122.231 1.015 . . . . 2.92 108.901 176.816 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.747 ' HB2' ' O ' ' A' ' 41' ' ' ALA . 5.9 m -83.29 2.95 33.48 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 112.838 -1.983 . . . . 1.57 108.214 172.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 30.9 tp60 -86.84 -8.34 57.39 Favored 'General case' 0 C--N 1.35 0.595 0 O-C-N 121.384 -0.823 . . . . 3.31 110.988 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.49 ' HA ' ' CD2' ' A' ' 49' ' ' TYR . 7.2 mt-10 -85.98 5.29 33.91 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 119.094 -1.042 . . . . 3.69 108.762 179.1 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -79.3 2.87 19.87 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 116.013 -0.539 . . . . 3.99 109.782 177.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 40.9 p30 -99.19 -28.86 13.15 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 120.911 -0.316 . . . . 3.86 110.488 178.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.49 ' CD2' ' HA ' ' A' ' 46' ' ' GLU . 4.7 m-85 -87.09 9.32 20.17 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 120.951 -0.3 . . . . 5.68 111.305 179.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.415 ' CD1' HD21 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -143.21 117.67 6.25 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.838 -0.164 . . . . 5.4 111.092 -179.539 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -79.74 45.45 1.95 Allowed 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 122.315 2.01 . . . . 4.92 112.321 179.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.669 ' HA ' HD21 ' A' ' 5' ' ' LEU . 3.4 p -156.36 104.23 2.03 Favored Pre-proline 0 C--O 1.232 0.168 0 CA-C-O 120.604 0.24 . . . . 5.64 111.642 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.737 ' HD2' ' HG ' ' A' ' 5' ' ' LEU . 94.3 Cg_endo -95.52 -4.97 1.92 Allowed 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 123.342 2.695 . . . . 5.04 114.724 -178.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.553 ' CB ' ' HA ' ' A' ' 10' ' ' CYS . 10.2 t 69.18 80.67 0.19 Allowed 'General case' 0 N--CA 1.473 0.692 0 O-C-N 122.279 -0.263 . . . . 2.74 111.343 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.836 ' HB2' HD13 ' A' ' 3' ' ' LEU . 0.0 OUTLIER 27.43 -144.29 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 112.865 0.691 . . . . 5.75 112.865 179.793 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.548 ' H ' ' CD ' ' A' ' 55' ' ' GLN . 3.2 t -167.8 172.88 8.76 Favored 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 109.193 -0.669 . . . . 3.12 109.193 -179.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.405 ' O ' ' HB2' ' A' ' 66' ' ' ARG . . . -76.8 146.88 32.98 Favored Glycine 0 N--CA 1.433 -1.509 0 N-CA-C 110.064 -1.214 . . . . 2.1 110.064 -177.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -113.43 74.17 0.85 Allowed 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 122.153 0.978 . . . . 4.36 108.891 178.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.57 ' HB2' ' HB3' ' A' ' 67' ' ' CYS . 5.9 mmtp -144.1 58.22 5.73 Favored Pre-proline 0 C--N 1.304 -1.393 0 N-CA-C 106.579 -1.638 . . . . 3.55 106.579 178.503 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.538 ' HA ' ' O ' ' A' ' 65' ' ' GLY . 19.6 Cg_endo -59.01 80.45 0.05 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 122.437 2.091 . . . . 1.54 115.048 -177.228 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.499 ' N ' ' O ' ' A' ' 65' ' ' GLY . 0.5 OUTLIER -99.58 -178.64 3.95 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 106.449 -1.686 . . . . 1.59 106.449 175.553 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.533 ' HA3' ' CE1' ' A' ' 80' ' ' HIS . . . 70.49 -166.79 50.8 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 118.103 -1.999 . . . . 2.43 112.31 179.148 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.7 m -86.13 39.68 0.83 Allowed 'General case' 0 N--CA 1.477 0.893 0 CA-C-O 121.843 0.83 . . . . 4.11 111.354 -176.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 120.15 9.99 7.7 Favored Glycine 0 CA--C 1.543 1.789 0 CA-C-N 114.462 -1.244 . . . . 2.21 114.441 -178.111 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.538 ' O ' ' HA ' ' A' ' 60' ' ' PRO . . . -103.45 151.06 17.78 Favored Glycine 0 C--N 1.336 0.559 0 CA-C-N 119.772 1.786 . . . . 1.62 114.913 -179.121 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.405 ' HB2' ' O ' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -99.52 152.51 19.94 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 122.157 0.183 . . . . 3.02 111.048 178.731 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.57 ' HB3' ' HB2' ' A' ' 59' ' ' LYS . 42.9 t -67.6 121.83 16.73 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-O 121.037 0.446 . . . . 1.52 111.606 -179.213 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.15 -16.66 18.51 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.836 0.827 . . . . 1.07 109.021 177.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.698 ' CB ' ' HA2' ' A' ' 33' ' ' GLY . . . -170.09 160.88 8.35 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.326 -1.307 . . . . 1.0 110.756 178.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.417 ' HA ' ' HB3' ' A' ' 85' ' ' CYS . . . -61.5 138.01 58.26 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 122.045 -0.409 . . . . 1.24 111.226 178.31 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.74 ' N ' ' O ' ' A' ' 85' ' ' CYS . . . 64.06 18.97 63.15 Favored Glycine 0 N--CA 1.467 0.756 0 CA-C-N 115.77 -0.65 . . . . 1.28 112.808 -179.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 1.066 HD13 ' HB2' ' A' ' 34' ' ' CYS . 1.3 pp -150.34 105.59 0.37 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.913 0 N-CA-C 112.116 0.413 . . . . 2.27 112.116 173.11 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.567 ' HB2' ' HB3' ' A' ' 82' ' ' ASP . 16.5 t -97.75 110.79 23.29 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 120.869 0.366 . . . . 1.98 110.32 178.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.783 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 72.1 m -92.44 138.84 31.17 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.494 0.664 . . . . 1.33 111.703 -179.336 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.809 ' HB2' ' HD2' ' A' ' 76' ' ' PRO . 54.1 p -113.26 179.55 0.77 Allowed Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 114.82 -1.082 . . . . 1.99 108.948 179.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.809 ' HD2' ' HB2' ' A' ' 75' ' ' SER . 74.0 Cg_endo -76.4 30.87 0.4 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 121.349 1.366 . . . . 1.86 111.997 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.441 ' H ' ' C ' ' A' ' 75' ' ' SER . 18.4 m-20 -144.86 -41.78 0.24 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.544 -0.753 . . . . 2.65 109.983 179.378 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.852 ' HA3' ' O ' ' B' ' 179' ' ' CYS . . . -163.63 -135.07 1.75 Allowed Glycine 0 C--N 1.336 0.551 0 C-N-CA 120.951 -0.642 . . . . 0.99 112.784 179.396 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.841 ' O ' ' HA3' ' B' ' 178' ' ' GLY . 62.7 m -148.1 157.11 43.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.06 0.457 . . . . 1.34 110.314 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.533 ' CE1' ' HA3' ' A' ' 62' ' ' GLY . 1.8 p80 -158.02 153.17 25.61 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.206 -0.598 . . . . 2.17 110.641 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.451 ' OE1' HD11 ' B' ' 126' ' ' ILE . 14.6 mp0 -63.06 140.81 58.91 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.672 -0.411 . . . . 3.05 109.983 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.599 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 2.4 p-10 -140.89 140.88 22.49 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 116.071 -0.513 . . . . 2.02 111.195 -179.328 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 82' ' ' ASP . 10.6 Cg_exo -72.48 -27.35 15.88 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 123.492 2.795 . . . . 1.93 114.571 -177.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.02 -47.44 71.41 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 107.86 -1.163 . . . . 1.53 107.86 179.074 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.74 ' O ' ' N ' ' A' ' 71' ' ' GLY . 2.0 m -99.12 77.97 2.21 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 114.181 -1.372 . . . . 1.88 107.497 176.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.985 ' H ' ' CD ' ' A' ' 87' ' ' PRO . 38.2 t0 -164.89 3.09 0.0 OUTLIER Pre-proline 0 C--N 1.321 -0.649 0 N-CA-C 114.23 1.196 . . . . 2.29 114.23 -179.136 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.985 ' CD ' ' H ' ' A' ' 86' ' ' ASP . 59.5 Cg_endo -83.46 132.31 5.85 Favored 'Trans proline' 0 C--N 1.357 1.01 0 C-N-CA 121.475 1.45 . . . . 0.0 111.541 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.408 ' H ' ' HG2' ' A' ' 88' ' ' GLU . 0.5 OUTLIER -8.09 36.81 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 117.036 2.236 . . . . 4.72 117.036 -173.668 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.961 ' N ' ' O ' ' A' ' 87' ' ' PRO . . . -61.16 -38.08 85.18 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 113.635 -1.62 . . . . 5.29 108.888 -176.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -88.85 111.04 21.58 Favored 'General case' 0 C--N 1.299 -1.611 0 C-N-CA 128.396 2.678 . . . . 6.98 112.76 178.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -88.56 88.46 7.62 Favored 'General case' 0 C--N 1.359 1.001 0 CA-C-N 110.156 -3.202 . . . . 10.21 110.957 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 2.4 m . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.219 -0.896 . . . . 11.77 110.801 -179.964 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.779 0 N-CA-C 110.578 -0.156 . . . . 10.07 110.578 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 102' ' ' VAL . . . . . 0.416 ' O ' ' CD2' ' B' ' 103' ' ' LEU . 5.9 m -92.97 -173.44 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 120.787 -0.365 . . . . 8.41 111.625 -177.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 103' ' ' LEU . . . . . 0.706 ' HA ' ' HG3' ' B' ' 155' ' ' GLN . 0.3 OUTLIER -161.14 93.04 0.94 Allowed 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 108.873 -0.788 . . . . 5.87 108.873 177.127 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -81.7 70.77 8.66 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 107.155 -1.424 . . . . 6.27 107.155 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . 1.066 HD21 ' HA ' ' B' ' 108' ' ' ARG . 2.2 tp -153.62 -119.32 0.03 OUTLIER 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 108.882 -0.785 . . . . 7.2 108.882 -172.214 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 106' ' ' ASP . . . . . 1.065 ' H ' ' HG ' ' B' ' 105' ' ' LEU . 5.0 t70 -170.42 -44.43 0.02 OUTLIER 'General case' 0 C--N 1.289 -2.06 0 CA-C-O 121.396 0.617 . . . . 8.55 109.589 179.084 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 107' ' ' VAL . . . . . 0.516 ' O ' HD21 ' B' ' 105' ' ' LEU . 7.5 p -149.71 127.84 2.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 101.948 -3.353 . . . . 7.48 101.948 173.334 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 108' ' ' ARG . . . . . 1.066 ' HA ' HD21 ' B' ' 105' ' ' LEU . 0.0 OUTLIER -73.45 111.69 8.82 Favored 'General case' 0 N--CA 1.401 -2.919 0 C-N-CA 117.903 -1.519 . . . . 9.12 112.201 -175.26 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 109' ' ' THR . . . . . 0.465 ' O ' ' HB2' ' B' ' 154' ' ' CYS . 0.1 OUTLIER -111.06 100.28 8.99 Favored 'General case' 0 N--CA 1.402 -2.833 1 N-CA-C 99.134 -4.395 . . . . 5.69 99.134 167.733 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' B' B ' 110' ' ' CYS . . . . . 0.559 ' HA ' ' CB ' ' B' ' 154' ' ' CYS . 0.5 OUTLIER -78.56 75.96 5.06 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 113.978 -1.465 . . . . 2.61 112.654 -177.928 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 111' ' ' LEU . . . . . 0.616 HD13 ' HD2' ' B' ' 112' ' ' PRO . 0.2 OUTLIER -31.07 113.85 0.33 Allowed Pre-proline 0 N--CA 1.469 0.508 0 N-CA-C 113.107 0.78 . . . . 2.47 113.107 -179.629 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 112' ' ' PRO . . . . . 0.853 ' HB2' ' O ' ' B' ' 117' ' ' GLY . 29.0 Cg_endo -90.72 154.31 4.17 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 124.46 3.44 . . . . 1.47 114.417 -179.074 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.829 ' N ' ' O ' ' B' ' 119' ' ' GLY . 15.3 p -156.08 -159.93 0.95 Allowed 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 109.479 -0.563 . . . . 1.0 109.479 174.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 114' ' ' GLY . . . . . 0.543 ' HA2' ' HG2' ' B' ' 140' ' ' GLU . . . 73.45 -163.24 54.78 Favored Glycine 0 C--N 1.337 0.614 0 N-CA-C 115.639 1.016 . . . . 1.16 115.639 175.014 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 115' ' ' PRO . . . . . 0.657 ' O ' ' HD3' ' B' ' 118' ' ' LYS . 67.9 Cg_endo -61.78 100.77 0.2 Allowed 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 124.361 3.374 . . . . 1.57 111.37 178.081 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 86.89 -0.14 86.14 Favored Glycine 0 C--N 1.283 -2.414 0 CA-C-N 112.688 -2.051 . . . . 1.7 112.955 -178.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 117' ' ' GLY . . . . . 0.853 ' O ' ' HB2' ' B' ' 112' ' ' PRO . . . 76.46 37.12 36.67 Favored Glycine 0 N--CA 1.416 -2.659 0 N-CA-C 115.736 1.055 . . . . 1.38 115.736 175.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 118' ' ' LYS . . . . . 0.667 ' HZ1' ' CD1' ' B' ' 132' ' ' LEU . 0.0 OUTLIER -95.69 -30.47 13.73 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 121.753 0.787 . . . . 2.54 111.763 179.448 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 119' ' ' GLY . . . . . 0.829 ' O ' ' N ' ' B' ' 113' ' ' CYS . . . -77.77 158.45 46.77 Favored Glycine 0 C--O 1.193 -2.412 0 N-CA-C 117.499 1.76 . . . . 1.04 117.499 -174.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.545 ' HD2' ' HB3' ' B' ' 110' ' ' CYS . 0.0 OUTLIER -99.84 160.35 14.37 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 111.774 -2.213 . . . . 2.89 113.363 -169.069 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 121' ' ' CYS . . . . . . . . . . . . . 1.4 m -105.43 134.01 49.25 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 114.304 -1.316 . . . . 1.07 110.734 -175.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -134.16 36.3 3.23 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.152 -0.931 . . . . 1.53 109.976 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 145.11 164.51 10.7 Favored Glycine 0 CA--C 1.521 0.445 0 CA-C-N 115.849 -0.614 . . . . 0.9 112.395 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -52.17 -73.13 0.04 OUTLIER 'Trans proline' 0 CA--C 1.532 0.411 0 C-N-CA 122.752 2.302 . . . . 1.51 112.761 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 125' ' ' SER . . . . . 0.637 ' O ' ' N ' ' B' ' 137' ' ' GLY . 0.5 OUTLIER -91.02 42.8 1.12 Allowed 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 109.251 -0.648 . . . . 1.25 109.251 178.778 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 126' ' ' ILE . . . . . 0.698 HG12 HG13 ' B' ' 136' ' ' VAL . 6.3 mt -144.51 121.06 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 N-CA-C 113.667 0.988 . . . . 0.85 113.667 -176.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 127' ' ' CYS . . . . . 0.67 ' O ' ' HA ' ' B' ' 134' ' ' CYS . 0.0 OUTLIER -138.73 111.47 7.7 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-O 121.57 0.7 . . . . 0.89 110.56 178.458 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 128' ' ' CYS . . . . . 1.146 ' HA ' ' O ' ' B' ' 133' ' ' GLY . 0.0 OUTLIER -127.53 129.36 47.23 Favored 'General case' 0 N--CA 1.439 -0.977 0 C-N-CA 124.243 1.017 . . . . 1.23 111.517 179.098 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 129' ' ' GLY . . . . . 0.481 ' O ' ' HB2' ' B' ' 169' ' ' ALA . . . -120.82 -160.35 11.07 Favored Glycine 0 N--CA 1.417 -2.598 0 N-CA-C 104.126 -3.59 . . . . 0.66 104.126 172.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -67.14 -73.23 0.14 Allowed 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 118.283 1.041 . . . . 2.35 111.702 -178.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.97 34.6 2.96 Favored 'General case' 0 CA--C 1.478 -1.792 0 CA-C-O 121.76 0.79 . . . . 1.69 110.505 -173.024 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 132' ' ' LEU . . . . . 0.805 HD22 ' CZ ' ' B' ' 135' ' ' PHE . 1.1 mt -126.49 -23.62 3.75 Favored 'General case' 0 N--CA 1.391 -3.384 0 N-CA-C 104.992 -2.225 . . . . 1.38 104.992 177.181 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 133' ' ' GLY . . . . . 1.146 ' O ' ' HA ' ' B' ' 128' ' ' CYS . . . 73.71 -135.62 20.77 Favored Glycine 1 N--CA 1.39 -4.39 0 N-CA-C 110.275 -1.13 . . . . 0.72 110.275 176.664 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 134' ' ' CYS . . . . . 1.025 ' HB2' HD13 ' B' ' 172' ' ' ILE . 3.1 t -135.97 116.34 13.63 Favored 'General case' 0 CA--C 1.495 -1.168 0 CA-C-N 118.227 1.014 . . . . 1.08 113.519 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 135' ' ' PHE . . . . . 0.982 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -88.57 106.3 18.22 Favored 'General case' 0 N--CA 1.421 -1.879 0 N-CA-C 102.59 -3.115 . . . . 1.36 102.59 175.101 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 136' ' ' VAL . . . . . 0.728 HG23 HG23 ' A' ' 36' ' ' VAL . 2.3 t -92.85 88.02 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-O 123.161 1.458 . . . . 0.75 110.233 -177.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 137' ' ' GLY . . . . . 0.827 ' HA3' HG21 ' A' ' 72' ' ' ILE . . . 102.79 18.43 15.77 Favored Glycine 0 C--N 1.32 -0.328 0 CA-C-N 112.705 -2.043 . . . . 0.83 115.916 178.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 138' ' ' THR . . . . . 0.837 HG21 ' CD2' ' A' ' 35' ' ' PHE . 30.2 p -89.76 177.04 6.61 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 118.071 0.936 . . . . 0.78 108.747 178.614 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 139' ' ' ALA . . . . . 0.875 ' HA ' HD12 ' B' ' 142' ' ' LEU . . . -58.07 -36.36 72.69 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 118.982 0.81 . . . . 1.04 110.516 179.151 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 140' ' ' GLU . . . . . 0.543 ' HG2' ' HA2' ' B' ' 114' ' ' GLY . 1.7 mp0 -59.54 -15.14 16.15 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.439 -0.346 . . . . 2.31 111.683 -179.357 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 141' ' ' ALA . . . . . 0.674 ' O ' ' HB2' ' B' ' 144' ' ' CYS . . . -99.17 -26.74 14.1 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 116.274 -0.421 . . . . 0.87 110.567 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 142' ' ' LEU . . . . . 0.875 HD12 ' HA ' ' B' ' 139' ' ' ALA . 2.2 mt -55.58 -29.22 58.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.311 0.576 . . . . 1.24 109.681 179.179 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 143' ' ' ARG . . . . . 0.534 ' HD3' ' HA ' ' B' ' 140' ' ' GLU . 0.0 OUTLIER -78.51 11.39 2.51 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 109.051 -0.722 . . . . 2.93 109.051 177.132 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 144' ' ' CYS . . . . . 0.674 ' HB2' ' O ' ' B' ' 141' ' ' ALA . 5.8 m -89.32 13.01 14.51 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 107.232 -1.396 . . . . 1.61 107.232 172.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 29.8 tp60 -88.7 -11.86 43.99 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 115.278 -0.874 . . . . 3.35 110.285 177.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 146' ' ' GLU . . . . . 0.491 ' HA ' ' CD2' ' B' ' 149' ' ' TYR . 7.2 mt-10 -85.95 5.48 32.95 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 119.11 -1.036 . . . . 3.76 109.194 179.205 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -79.47 3.15 19.46 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 120.377 -0.529 . . . . 4.01 109.784 177.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 148' ' ' ASN . . . . . . . . . . . . . 40.5 p30 -99.3 -28.85 13.12 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 120.778 -0.369 . . . . 3.92 110.463 178.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 149' ' ' TYR . . . . . 0.491 ' CD2' ' HA ' ' B' ' 146' ' ' GLU . 4.7 m-85 -87.08 9.47 19.67 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 121.005 -0.278 . . . . 5.73 111.339 179.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 150' ' ' LEU . . . . . 0.411 ' CD1' HD21 ' B' ' 111' ' ' LEU . 0.1 OUTLIER -143.39 117.72 6.17 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-O 120.504 0.193 . . . . 5.46 111.018 -179.539 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 151' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -80.0 45.63 2.01 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.353 2.036 . . . . 5.02 112.354 179.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 3.7 p -156.49 104.32 2.01 Favored Pre-proline 0 CA--C 1.531 0.235 0 CA-C-O 120.645 0.26 . . . . 5.73 111.37 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 153' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -95.64 -5.2 1.84 Allowed 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 123.4 2.733 . . . . 5.1 114.649 -178.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 154' ' ' CYS . . . . . 0.978 ' HA ' HD22 ' B' ' 105' ' ' LEU . 9.1 t 69.64 81.37 0.17 Allowed 'General case' 0 N--CA 1.473 0.707 0 O-C-N 122.225 -0.297 . . . . 2.68 111.204 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 155' ' ' GLN . . . . . 0.706 ' HG3' ' HA ' ' B' ' 103' ' ' LEU . 0.0 OUTLIER 26.41 -145.08 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 112.785 0.661 . . . . 5.63 112.785 -179.916 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 156' ' ' SER . . . . . 0.563 ' H ' ' CD ' ' B' ' 155' ' ' GLN . 1.9 t -159.14 -175.27 5.16 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 108.744 -0.836 . . . . 3.11 108.744 179.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 157' ' ' GLY . . . . . 0.407 ' O ' ' HB2' ' B' ' 166' ' ' ARG . . . -88.85 147.16 19.61 Favored Glycine 0 CA--C 1.494 -1.228 0 N-CA-C 109.764 -1.334 . . . . 2.07 109.764 176.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -114.91 62.49 0.68 Allowed 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 117.207 -1.797 . . . . 4.34 110.293 178.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 159' ' ' LYS . . . . . 0.677 ' HB2' ' HB3' ' B' ' 167' ' ' CYS . 7.0 mmtp -117.94 53.9 1.71 Allowed Pre-proline 0 C--N 1.313 -1.02 0 CA-C-N 113.507 -1.679 . . . . 3.54 110.48 172.448 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 160' ' ' PRO . . . . . 0.495 ' HA ' ' O ' ' B' ' 165' ' ' GLY . 15.0 Cg_endo -58.47 81.33 0.05 OUTLIER 'Trans proline' 0 C--N 1.331 -0.363 0 CA-C-N 121.626 1.616 . . . . 1.51 116.072 -173.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 161' ' ' CYS . . . . . 0.489 ' N ' ' O ' ' B' ' 165' ' ' GLY . 0.5 OUTLIER -99.25 -178.29 3.87 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 106.926 -1.509 . . . . 1.58 106.926 175.762 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 162' ' ' GLY . . . . . 0.528 ' HA3' ' CE1' ' B' ' 180' ' ' HIS . . . 69.78 -166.57 49.22 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 118.301 -1.904 . . . . 2.37 112.283 178.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 2.8 m -85.75 39.95 0.82 Allowed 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.634 0.73 . . . . 4.07 111.423 -177.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 121.48 6.74 8.61 Favored Glycine 0 CA--C 1.541 1.656 0 CA-C-N 114.586 -1.188 . . . . 2.2 114.663 -179.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 165' ' ' GLY . . . . . 0.515 ' CA ' ' HA ' ' B' ' 175' ' ' SER . . . -102.14 151.74 18.41 Favored Glycine 0 CA--C 1.523 0.562 0 CA-C-N 119.909 1.855 . . . . 1.62 115.172 -177.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 166' ' ' ARG . . . . . 0.407 ' HB2' ' O ' ' B' ' 157' ' ' GLY . 0.0 OUTLIER -99.2 152.63 19.68 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 122.275 0.23 . . . . 3.05 111.046 179.459 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 167' ' ' CYS . . . . . 0.677 ' HB3' ' HB2' ' B' ' 159' ' ' LYS . 41.9 t -67.73 121.47 16.01 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-O 120.771 0.319 . . . . 1.56 111.611 -179.108 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 168' ' ' ALA . . . . . . . . . . . . . . . -96.4 -19.54 19.11 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.444 -0.947 . . . . 1.04 108.444 177.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 169' ' ' ALA . . . . . 0.69 ' CB ' ' HA2' ' B' ' 133' ' ' GLY . . . -168.68 160.99 11.06 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 113.739 -1.573 . . . . 0.98 111.898 -179.228 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 170' ' ' ALA . . . . . 0.411 ' HA ' ' HB3' ' B' ' 185' ' ' CYS . . . -61.76 138.95 58.37 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.004 0.43 . . . . 1.25 110.596 178.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 171' ' ' GLY . . . . . 0.711 ' N ' ' O ' ' B' ' 185' ' ' CYS . . . 74.43 -1.06 52.74 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 121.191 -0.528 . . . . 1.29 114.113 179.488 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 172' ' ' ILE . . . . . 1.025 HD13 ' HB2' ' B' ' 134' ' ' CYS . 1.3 pp -142.51 107.54 1.51 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.598 0 CA-C-O 121.736 0.779 . . . . 2.27 113.066 -179.29 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 173' ' ' CYS . . . . . 0.562 ' HB2' ' HB3' ' B' ' 182' ' ' ASP . 16.3 t -97.8 110.64 23.17 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.698 -0.683 . . . . 1.94 110.216 178.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 174' ' ' CYS . . . . . 0.756 ' HA ' ' HA ' ' B' ' 179' ' ' CYS . 72.0 m -92.67 138.91 31.09 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.439 0.638 . . . . 1.35 111.755 -179.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 175' ' ' SER . . . . . 0.83 ' HB2' ' HD2' ' B' ' 176' ' ' PRO . 51.7 p -113.35 179.65 0.75 Allowed Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 114.866 -1.061 . . . . 2.0 108.906 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 176' ' ' PRO . . . . . 0.83 ' HD2' ' HB2' ' B' ' 175' ' ' SER . 74.4 Cg_endo -76.39 30.78 0.4 Allowed 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 121.427 1.418 . . . . 1.9 111.918 -179.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 177' ' ' ASP . . . . . 0.439 ' H ' ' C ' ' B' ' 175' ' ' SER . 18.4 m-20 -144.71 -41.67 0.25 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.563 -0.744 . . . . 2.72 110.065 179.342 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 178' ' ' GLY . . . . . 0.841 ' HA3' ' O ' ' A' ' 79' ' ' CYS . . . -163.74 -135.11 1.76 Allowed Glycine 0 C--N 1.337 0.613 0 C-N-CA 121.041 -0.6 . . . . 0.99 112.763 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 179' ' ' CYS . . . . . 0.852 ' O ' ' HA3' ' A' ' 78' ' ' GLY . 62.3 m -148.12 157.05 43.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.949 0.404 . . . . 1.34 110.44 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 180' ' ' HIS . . . . . 0.528 ' CE1' ' HA3' ' B' ' 162' ' ' GLY . 1.8 p80 -157.89 153.2 25.9 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.285 -0.566 . . . . 2.1 110.611 -179.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 181' ' ' GLU . . . . . 0.499 ' OE1' HD11 ' A' ' 26' ' ' ILE . 14.6 mp0 -62.99 140.87 58.91 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.748 -0.381 . . . . 3.06 109.983 179.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 182' ' ' ASP . . . . . 0.588 ' O ' ' HB2' ' B' ' 186' ' ' ASP . 2.4 p-10 -141.02 140.92 22.18 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 116.11 -0.495 . . . . 2.06 111.089 -179.248 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 183' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' B' ' 182' ' ' ASP . 10.4 Cg_exo -72.53 -27.17 15.91 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 123.467 2.778 . . . . 1.91 114.665 -178.057 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -67.13 -47.35 71.37 Favored 'General case' 0 CA--C 1.507 -0.697 0 N-CA-C 107.784 -1.191 . . . . 1.56 107.784 179.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 185' ' ' CYS . . . . . 0.711 ' O ' ' N ' ' B' ' 171' ' ' GLY . 2.2 m -99.16 77.81 2.19 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 114.192 -1.367 . . . . 1.94 107.647 176.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 186' ' ' ASP . . . . . 0.955 ' H ' ' CD ' ' B' ' 187' ' ' PRO . 38.3 t0 -164.65 3.32 0.0 OUTLIER Pre-proline 0 C--N 1.321 -0.631 0 N-CA-C 114.3 1.222 . . . . 2.28 114.3 -179.298 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 187' ' ' PRO . . . . . 0.955 ' CD ' ' H ' ' B' ' 186' ' ' ASP . 74.4 Cg_endo -86.19 124.17 2.42 Favored 'Trans proline' 0 N--CA 1.45 -1.07 0 CA-C-N 120.916 1.363 . . . . 2.31 114.254 -179.182 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 188' ' ' GLU . . . . . 0.505 ' C ' ' O ' ' B' ' 187' ' ' PRO . 0.7 OUTLIER -8.91 64.95 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.137 0 CA-C-O 123.808 1.766 . . . . 4.7 109.011 -173.486 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 189' ' ' ALA . . . . . 0.811 ' N ' ' O ' ' B' ' 187' ' ' PRO . . . -83.18 -36.85 24.37 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 110.727 -2.942 . . . . 5.24 109.226 173.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 190' ' ' ALA . . . . . . . . . . . . . . . -90.11 109.82 20.86 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 110.002 -3.272 . . . . 6.93 112.463 178.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 191' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -88.28 88.72 7.72 Favored 'General case' 0 C--N 1.353 0.748 0 CA-C-N 110.766 -2.924 . . . . 10.14 110.561 -179.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 2.4 m . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.24 -0.886 . . . . 11.7 110.708 -179.757 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.816 ' O ' HG22 ' A' ' 2' ' ' VAL . . . . . . . . 0 N--CA 1.488 1.451 0 N-CA-C 111.62 0.23 . . . . 9.95 111.62 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.816 HG22 ' O ' ' A' ' 1' ' ' ALA . 1.4 m 80.25 43.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 O-C-N 124.678 1.236 . . . . 8.02 111.545 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 1.125 HD11 ' HB3' ' A' ' 5' ' ' LEU . 2.0 tm? -82.99 101.88 11.37 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 114.395 -1.275 . . . . 5.86 112.23 178.151 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.756 ' O ' ' HB3' ' A' ' 55' ' ' GLN . 1.6 m-20 -81.94 82.0 7.72 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 106.126 -1.805 . . . . 6.22 106.126 177.47 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 1.125 ' HB3' HD11 ' A' ' 3' ' ' LEU . 1.4 tm? -153.71 -68.91 0.14 Allowed 'General case' 0 CA--C 1.48 -1.741 0 CA-C-O 123.437 1.589 . . . . 7.09 109.398 -177.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.772 ' H ' HD11 ' A' ' 3' ' ' LEU . 0.6 OUTLIER 155.36 -23.67 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 CA-C-N 110.452 -3.067 . . . . 8.78 111.71 174.926 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.744 HG22 ' H ' ' A' ' 8' ' ' ARG . 3.6 p -89.61 178.5 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.409 -2.522 0 CA-C-N 112.835 -1.984 . . . . 7.51 109.675 -178.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.744 ' H ' HG22 ' A' ' 7' ' ' VAL . 4.3 ttp85 -80.21 114.32 19.03 Favored 'General case' 0 N--CA 1.406 -2.67 0 N-CA-C 104.391 -2.448 . . . . 9.08 104.391 177.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 1.013 ' CB ' ' HB2' ' A' ' 3' ' ' LEU . 14.7 t -40.04 111.92 0.23 Allowed 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 123.113 1.435 . . . . 5.66 112.213 -174.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.851 ' O ' ' HG2' ' A' ' 20' ' ' ARG . 71.6 m -19.02 123.67 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 111.021 -2.809 . . . . 2.68 114.191 -175.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 1.085 HD23 HD22 ' A' ' 50' ' ' LEU . 0.2 OUTLIER -29.24 119.99 0.29 Allowed Pre-proline 0 N--CA 1.485 1.303 0 C-N-CA 123.673 0.789 . . . . 2.48 113.025 179.944 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.916 ' HD2' HD13 ' A' ' 11' ' ' LEU . 93.4 Cg_endo -72.21 155.83 55.93 Favored 'Trans proline' 0 C--N 1.358 1.054 0 C-N-CA 124.517 3.478 . . . . 1.49 116.408 -176.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.671 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 15.6 p -159.82 -173.07 3.91 Favored 'General case' 0 C--O 1.268 2.061 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.309 178.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.697 ' HA2' ' HB3' ' A' ' 40' ' ' GLU . . . 76.69 -158.9 49.22 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 121.134 -0.555 . . . . 1.15 114.39 177.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.614 ' HD2' HD11 ' A' ' 32' ' ' LEU . 25.6 Cg_endo -66.51 99.09 0.42 Allowed 'Trans proline' 0 N--CA 1.49 1.305 0 C-N-CA 124.797 3.665 . . . . 1.57 112.725 178.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.43 7.51 84.62 Favored Glycine 0 C--N 1.275 -2.814 0 CA-C-N 113.622 -1.626 . . . . 1.68 111.137 -176.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.893 ' O ' ' HB2' ' A' ' 12' ' ' PRO . . . 55.71 55.78 27.09 Favored Glycine 0 N--CA 1.415 -2.709 0 CA-C-N 113.317 -1.442 . . . . 1.36 110.617 172.486 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.55 ' HE3' ' O ' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -92.53 -51.92 4.89 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 101.908 -3.367 . . . . 2.5 101.908 175.053 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.836 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -56.59 -179.08 0.46 Allowed Glycine 0 CA--C 1.533 1.173 0 CA-C-N 112.446 -2.161 . . . . 1.02 110.999 -168.342 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.851 ' HG2' ' O ' ' A' ' 10' ' ' CYS . 42.9 mtm-85 -132.33 174.22 10.46 Favored 'General case' 0 C--N 1.322 -0.587 0 O-C-N 119.999 -1.883 . . . . 2.92 112.185 -171.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 1.059 ' HB3' ' HG3' ' A' ' 47' ' ' GLU . 1.7 m -104.8 135.2 46.62 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.688 0.756 . . . . 1.1 112.496 -178.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.433 ' CD1' ' HB2' ' A' ' 28' ' ' CYS . 54.4 m-85 -144.97 39.95 1.24 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 114.525 -1.216 . . . . 1.51 109.743 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 141.95 166.35 10.86 Favored Glycine 0 CA--C 1.524 0.624 0 CA-C-N 115.6 -0.727 . . . . 0.9 111.647 -179.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.526 ' HD2' ' OE2' ' B' ' 181' ' ' GLU . 21.2 Cg_exo -65.65 -67.75 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.079 1.852 . . . . 1.5 112.147 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.782 ' C ' HG13 ' A' ' 26' ' ' ILE . 3.1 m -89.08 39.49 0.94 Allowed 'General case' 0 C--O 1.225 -0.196 0 N-CA-C 109.592 -0.522 . . . . 1.26 109.592 179.01 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 1.089 HG12 HG13 ' A' ' 36' ' ' VAL . 0.4 OUTLIER -156.0 120.73 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 N-CA-C 112.15 0.426 . . . . 0.83 112.15 -179.032 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.742 ' HB3' ' CE2' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -125.7 119.09 27.07 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 108.53 -0.915 . . . . 0.92 108.53 178.054 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.785 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 17.9 m -105.9 153.42 21.98 Favored 'General case' 0 CA--C 1.558 1.266 0 N-CA-C 112.646 0.61 . . . . 1.28 112.646 -178.289 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -143.5 167.5 26.55 Favored Glycine 0 C--N 1.373 2.589 0 N-CA-C 109.575 -1.41 . . . . 0.67 109.575 174.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.622 ' OD2' ' HG2' ' A' ' 31' ' ' GLU . 8.4 p-10 -66.37 -39.32 89.04 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 124.906 1.282 . . . . 2.27 109.459 178.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.622 ' HG2' ' OD2' ' A' ' 30' ' ' ASP . 0.9 OUTLIER -124.54 6.46 8.26 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 113.55 -1.659 . . . . 1.66 110.964 179.692 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.982 HD22 ' CE1' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -110.03 -12.7 14.5 Favored 'General case' 0 N--CA 1.423 -1.78 0 CA-C-N 115.235 -0.893 . . . . 1.37 110.626 -177.843 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 1.014 ' HA2' ' HB1' ' A' ' 69' ' ' ALA . . . 60.19 -115.3 7.45 Favored Glycine 0 N--CA 1.428 -1.869 0 CA-C-O 118.139 -1.367 . . . . 0.73 111.842 179.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 1.034 ' HB2' HD13 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -147.45 127.26 13.48 Favored 'General case' 0 CA--C 1.489 -1.375 0 CA-C-N 119.893 1.847 . . . . 1.08 112.367 179.424 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.982 ' CE1' HD22 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -101.16 100.28 10.81 Favored 'General case' 0 N--CA 1.422 -1.838 0 N-CA-C 103.101 -2.925 . . . . 1.38 103.101 174.641 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 1.089 HG13 HG12 ' A' ' 26' ' ' ILE . 2.0 t -91.98 86.12 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.669 0 CA-C-O 123.364 1.554 . . . . 0.76 107.91 -178.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.794 ' HA3' HG21 ' B' ' 172' ' ' ILE . . . 89.79 82.68 1.34 Allowed Glycine 0 CA--C 1.521 0.408 0 CA-C-N 112.338 -2.21 . . . . 0.81 113.487 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.766 HG22 ' O ' ' B' ' 132' ' ' LEU . 49.7 p -156.09 163.17 39.98 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 109.116 -0.698 . . . . 0.77 109.116 179.338 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.869 ' HA ' HD12 ' A' ' 42' ' ' LEU . . . -50.35 -35.89 29.82 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 119.729 1.149 . . . . 1.02 112.766 -178.15 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.697 ' HB3' ' HA2' ' A' ' 14' ' ' GLY . 8.5 mt-10 -58.81 -24.57 62.1 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 109.906 -0.405 . . . . 2.32 109.906 178.033 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.794 ' O ' ' HB2' ' A' ' 44' ' ' CYS . . . -78.63 -23.27 45.93 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 109.514 -0.55 . . . . 0.87 109.514 -179.478 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.869 HD12 ' HA ' ' A' ' 39' ' ' ALA . 0.5 OUTLIER -51.2 -38.72 53.95 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 121.136 -0.977 . . . . 1.23 109.821 178.804 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.795 ' HD2' ' O ' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -66.84 -5.32 11.89 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.21 -0.904 . . . . 2.92 109.986 177.348 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.794 ' HB2' ' O ' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -75.19 -1.01 21.31 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.121 -0.945 . . . . 1.57 111.726 177.122 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.97 -24.84 64.3 Favored 'General case' 0 N--CA 1.453 -0.325 0 O-C-N 121.435 -0.79 . . . . 3.31 110.581 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -84.45 3.05 38.01 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 120.165 -0.614 . . . . 3.69 110.292 179.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 1.059 ' HG3' ' HB3' ' A' ' 21' ' ' CYS . 1.7 tm-20 -81.88 2.96 28.01 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.58 -0.526 . . . . 3.99 109.58 177.26 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 24.5 t30 -94.99 -26.99 15.86 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.045 -0.525 . . . . 3.86 109.948 178.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -110.38 9.99 23.44 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.388 -0.369 . . . . 5.68 111.951 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 1.085 HD22 HD23 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -145.16 80.25 11.22 Favored Pre-proline 0 CA--C 1.536 0.411 0 CA-C-O 120.359 0.123 . . . . 5.4 111.279 179.995 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -95.37 50.82 0.19 Allowed 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 123.056 2.504 . . . . 4.92 112.829 -179.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.562 ' HB3' HG21 ' A' ' 7' ' ' VAL . 59.7 m -83.99 118.25 70.82 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-N 116.399 -0.364 . . . . 5.64 111.913 -179.335 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.546 ' O ' HG11 ' A' ' 7' ' ' VAL . 90.9 Cg_endo -81.8 121.41 3.67 Favored 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 122.51 2.14 . . . . 5.04 111.661 179.056 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 1.121 ' HA ' ' HG ' ' A' ' 5' ' ' LEU . 10.2 p -120.69 -160.18 0.83 Allowed 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.864 0.364 . . . . 2.74 111.882 -178.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.84 ' H ' HD21 ' A' ' 3' ' ' LEU . 0.4 OUTLIER -61.38 126.06 26.01 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.08 -0.509 . . . . 5.75 110.867 178.575 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 10.7 m -155.06 -160.32 1.04 Allowed 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 116.9 -0.137 . . . . 3.12 110.772 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -121.41 133.23 9.43 Favored Glycine 0 N--CA 1.435 -1.411 0 N-CA-C 110.748 -0.941 . . . . 2.1 110.748 -179.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.84 76.78 1.03 Allowed 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 107.967 -1.123 . . . . 4.36 107.967 178.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.505 ' O ' ' HA ' ' A' ' 66' ' ' ARG . 0.1 OUTLIER -130.82 71.78 82.2 Favored Pre-proline 0 C--N 1.31 -1.128 0 CA-C-N 114.163 -1.38 . . . . 3.55 107.863 -179.355 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.521 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 36.5 Cg_endo -65.1 78.28 0.21 Allowed 'Trans proline' 0 C--N 1.363 1.296 0 C-N-CA 122.406 2.071 . . . . 1.54 113.642 -178.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -95.69 -173.08 2.77 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 106.008 -1.849 . . . . 1.59 106.008 176.126 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.39 -166.35 34.3 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 118.558 -1.782 . . . . 2.43 113.182 179.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.9 m -87.77 42.48 1.05 Allowed 'General case' 0 N--CA 1.484 1.237 0 CA-C-O 122.642 1.211 . . . . 4.11 110.695 -177.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 115.37 11.09 10.94 Favored Glycine 0 CA--C 1.558 2.728 0 CA-C-N 112.859 -1.973 . . . . 2.21 114.873 -177.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.475 ' CA ' ' HB3' ' A' ' 75' ' ' SER . . . -103.87 129.05 9.72 Favored Glycine 0 N--CA 1.469 0.894 0 CA-C-N 121.477 2.638 . . . . 1.62 116.259 -178.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.749 ' HD3' ' O ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -90.92 155.17 18.94 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 108.993 -0.743 . . . . 3.02 108.993 176.606 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.479 ' SG ' ' HB3' ' A' ' 59' ' ' LYS . 74.0 m -64.8 108.31 1.71 Allowed 'General case' 0 N--CA 1.439 -0.991 0 CA-C-O 121.44 0.638 . . . . 1.52 110.309 -178.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.414 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . . . -94.57 -11.42 29.49 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.089 -0.96 . . . . 1.07 109.756 178.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 1.014 ' HB1' ' HA2' ' A' ' 33' ' ' GLY . . . -165.78 161.39 17.92 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.441 -1.254 . . . . 1.0 110.09 179.164 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.61 ' HA ' ' O ' ' A' ' 85' ' ' CYS . . . -58.02 117.31 4.2 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 113.837 1.051 . . . . 1.24 113.837 -178.315 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.741 ' HA2' ' O ' ' A' ' 82' ' ' ASP . . . 63.49 35.21 91.75 Favored Glycine 0 C--N 1.344 1.012 0 CA-C-N 115.532 -0.758 . . . . 1.28 112.301 179.002 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 1.034 HD13 ' HB2' ' A' ' 34' ' ' CYS . 1.8 pp -150.55 100.85 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.248 1.025 0 CA-C-O 121.924 0.869 . . . . 2.27 110.473 175.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.633 ' HB2' ' HB3' ' A' ' 82' ' ' ASP . 0.0 OUTLIER -85.63 92.07 8.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.696 -1.138 . . . . 1.98 110.661 -178.257 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.624 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 81.6 m -97.15 153.49 17.95 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.722 0.773 . . . . 1.33 112.513 -178.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.892 ' HB2' ' HD2' ' A' ' 76' ' ' PRO . 34.6 p -130.06 -178.97 0.9 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 114.529 -1.214 . . . . 1.99 108.8 179.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.892 ' HD2' ' HB2' ' A' ' 75' ' ' SER . 72.1 Cg_endo -78.07 26.83 0.49 Allowed 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 121.325 1.35 . . . . 1.86 111.761 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.635 ' HB2' ' CE1' ' B' ' 180' ' ' HIS . 3.0 p30 -145.95 -40.07 0.22 Allowed 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 115.786 -0.643 . . . . 2.65 111.417 179.377 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -157.08 -155.12 7.33 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 120.571 -0.823 . . . . 0.99 113.602 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.624 ' HA ' ' HA ' ' A' ' 74' ' ' CYS . 94.9 m -141.07 149.9 42.24 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 122.413 0.285 . . . . 1.34 110.394 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.608 ' CE1' ' HB2' ' B' ' 177' ' ' ASP . 79.6 t60 -140.96 126.4 18.76 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 109.453 -0.573 . . . . 2.17 109.453 -174.017 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.506 ' OE2' ' HD2' ' B' ' 124' ' ' PRO . 17.7 mt-10 -53.21 130.3 34.13 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.273 0.559 . . . . 3.05 111.748 -178.223 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.741 ' O ' ' HA2' ' A' ' 71' ' ' GLY . 0.1 OUTLIER -141.83 118.37 7.25 Favored Pre-proline 0 CA--C 1.547 0.839 0 CA-C-N 115.413 -0.812 . . . . 2.02 110.369 -179.056 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.49 ' HD3' ' HA ' ' A' ' 82' ' ' ASP . 3.7 Cg_exo -81.87 -18.86 7.52 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 122.848 2.365 . . . . 1.93 113.679 -178.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.67 -39.86 95.39 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.823 0.344 . . . . 1.53 111.739 -179.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.61 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 65.1 m -99.98 14.72 29.58 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.395 -0.366 . . . . 1.88 111.768 -179.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.51 ' CB ' ' HD3' ' A' ' 87' ' ' PRO . 0.8 OUTLIER -66.15 -55.5 20.65 Favored Pre-proline 0 C--N 1.322 -0.596 0 C-N-CA 121.063 -0.255 . . . . 3.6 111.413 -178.066 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.605 ' C ' ' H ' ' A' ' 89' ' ' ALA . 73.4 Cg_endo -104.19 -170.97 0.06 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.687 0 C-N-CA 122.639 2.226 . . . . 2.56 113.901 -178.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.421 ' C ' ' H ' ' A' ' 90' ' ' ALA . 5.5 pt-20 -56.6 26.93 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.045 0 CA-C-N 110.809 -2.905 . . . . 4.72 112.019 179.272 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.605 ' H ' ' C ' ' A' ' 87' ' ' PRO . . . -79.62 13.56 2.01 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 108.136 -1.061 . . . . 5.29 108.136 171.251 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.421 ' H ' ' C ' ' A' ' 88' ' ' GLU . . . -76.41 141.25 41.5 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-O 122.083 0.944 . . . . 6.98 111.511 177.302 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -100.47 101.53 12.5 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 113.447 -1.706 . . . . 10.21 110.241 176.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 16.6 m . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.354 -0.832 . . . . 11.77 110.941 179.927 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 101' ' ' ALA . . . . . 0.648 ' O ' HG13 ' B' ' 102' ' ' VAL . . . . . . . . 0 N--CA 1.485 1.283 0 CA-C-O 120.5 0.191 . . . . 10.07 110.608 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 102' ' ' VAL . . . . . 0.648 HG13 ' O ' ' B' ' 101' ' ' ALA . 0.0 OUTLIER 173.05 -176.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 N-CA-C 113.042 0.756 . . . . 8.41 113.042 -179.788 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 103' ' ' LEU . . . . . 1.02 HD21 ' HB2' ' B' ' 154' ' ' CYS . 23.1 tp -107.07 115.26 29.86 Favored 'General case' 0 CA--C 1.5 -0.975 0 N-CA-C 106.138 -1.801 . . . . 5.87 106.138 174.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.32 69.06 8.11 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 106.543 -1.651 . . . . 6.27 106.543 177.169 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . 1.0 HD12 HG12 ' B' ' 107' ' ' VAL . 1.2 tm? -139.2 -80.86 0.31 Allowed 'General case' 0 CA--C 1.47 -2.118 0 C-N-CA 117.62 -1.632 . . . . 7.2 109.608 -176.459 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 106' ' ' ASP . . . . . 0.803 ' N ' HD13 ' B' ' 105' ' ' LEU . 0.5 OUTLIER 150.57 40.17 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 111.94 -2.391 . . . . 8.55 108.722 175.395 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 107' ' ' VAL . . . . . 1.0 HG12 HD12 ' B' ' 105' ' ' LEU . 3.6 p -155.95 177.46 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.562 0 C-N-CA 125.542 1.537 . . . . 7.48 108.752 -176.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 108' ' ' ARG . . . . . 0.761 ' H ' HG22 ' B' ' 107' ' ' VAL . 4.4 ttp85 -80.91 116.78 21.06 Favored 'General case' 0 N--CA 1.413 -2.298 0 N-CA-C 104.32 -2.474 . . . . 9.12 104.32 179.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 109' ' ' THR . . . . . 0.917 ' HB ' ' HB2' ' B' ' 103' ' ' LEU . 5.6 t -38.28 111.17 0.16 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.927 0.87 . . . . 5.69 112.73 -176.147 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 110' ' ' CYS . . . . . 0.906 ' O ' ' HG2' ' B' ' 120' ' ' ARG . 73.8 m -18.7 118.05 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.193 0 CA-C-N 112.454 -2.157 . . . . 2.61 115.085 -177.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 111' ' ' LEU . . . . . 1.064 HD23 HD22 ' B' ' 150' ' ' LEU . 0.2 OUTLIER -24.96 119.43 0.21 Allowed Pre-proline 0 N--CA 1.49 1.555 0 C-N-CA 123.684 0.794 . . . . 2.47 113.121 179.897 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 112' ' ' PRO . . . . . 0.972 ' HB2' ' O ' ' B' ' 117' ' ' GLY . 95.8 Cg_endo -71.61 156.13 58.11 Favored 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 124.576 3.517 . . . . 1.47 116.088 -176.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.572 ' C ' ' HA2' ' B' ' 117' ' ' GLY . 16.4 p -159.1 -171.34 3.33 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 115.92 -0.582 . . . . 1.0 111.057 177.436 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 114' ' ' GLY . . . . . 0.749 ' HA2' ' HB3' ' B' ' 140' ' ' GLU . . . 75.68 -159.46 51.08 Favored Glycine 0 CA--C 1.53 1.019 0 N-CA-C 115.069 0.788 . . . . 1.16 115.069 177.463 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 115' ' ' PRO . . . . . 0.596 ' HD2' HD11 ' B' ' 132' ' ' LEU . 22.8 Cg_endo -66.37 102.59 0.59 Allowed 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 124.748 3.632 . . . . 1.57 111.611 178.426 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 87.31 -0.35 85.47 Favored Glycine 0 C--N 1.275 -2.822 0 CA-C-N 114.368 -1.287 . . . . 1.7 111.192 -177.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 117' ' ' GLY . . . . . 0.972 ' O ' ' HB2' ' B' ' 112' ' ' PRO . . . 64.34 44.4 95.47 Favored Glycine 1 N--CA 1.395 -4.061 0 CA-C-N 114.47 -0.865 . . . . 1.38 114.098 177.465 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 118' ' ' LYS . . . . . 0.497 ' HE3' ' O ' ' B' ' 115' ' ' PRO . 0.0 OUTLIER -93.31 -29.97 15.37 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.912 -0.773 . . . . 2.54 108.912 179.742 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 119' ' ' GLY . . . . . 0.807 ' O ' ' HA ' ' B' ' 112' ' ' PRO . . . -60.97 -163.29 0.18 Allowed Glycine 0 CA--C 1.496 -1.152 0 CA-C-O 118.493 -1.171 . . . . 1.04 111.604 -176.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.906 ' HG2' ' O ' ' B' ' 110' ' ' CYS . 48.8 mtm-85 -150.83 171.55 17.03 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 120.273 2.036 . . . . 2.89 108.806 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 121' ' ' CYS . . . . . 1.032 ' HB3' ' HG3' ' B' ' 147' ' ' GLU . 1.8 m -105.3 135.78 46.04 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.693 0.758 . . . . 1.07 112.875 -178.359 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 122' ' ' PHE . . . . . 0.451 ' CD1' ' HB2' ' B' ' 128' ' ' CYS . 54.7 m-85 -145.11 39.88 1.22 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 114.466 -1.243 . . . . 1.53 109.752 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 141.89 166.4 10.86 Favored Glycine 0 CA--C 1.523 0.59 0 CA-C-N 115.624 -0.716 . . . . 0.9 111.681 -179.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . 0.506 ' HD2' ' OE2' ' A' ' 81' ' ' GLU . 21.1 Cg_exo -65.69 -67.82 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.142 1.895 . . . . 1.51 112.065 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 125' ' ' SER . . . . . 0.76 ' C ' HG13 ' B' ' 126' ' ' ILE . 3.2 m -88.97 39.51 0.93 Allowed 'General case' 0 C--O 1.225 -0.205 0 N-CA-C 109.58 -0.526 . . . . 1.25 109.58 178.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 126' ' ' ILE . . . . . 1.044 HG12 HG13 ' B' ' 136' ' ' VAL . 0.5 OUTLIER -155.75 120.32 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 N-CA-C 112.188 0.44 . . . . 0.85 112.188 -178.975 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 127' ' ' CYS . . . . . 0.762 ' HB3' ' CE2' ' B' ' 135' ' ' PHE . 0.1 OUTLIER -125.15 120.76 32.28 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 108.748 -0.834 . . . . 0.89 108.748 178.085 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 128' ' ' CYS . . . . . 0.746 ' HA ' ' O ' ' B' ' 133' ' ' GLY . 8.6 m -111.57 146.37 37.48 Favored 'General case' 0 CA--C 1.571 1.77 0 N-CA-C 114.788 1.403 . . . . 1.23 114.788 -177.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 129' ' ' GLY . . . . . . . . . . . . . . . -133.75 164.45 24.38 Favored Glycine 0 N--CA 1.421 -2.31 0 CA-C-N 114.973 -1.012 . . . . 0.66 112.065 178.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 130' ' ' ASP . . . . . 0.638 ' OD2' ' HG2' ' B' ' 131' ' ' GLU . 9.6 p-10 -72.28 -27.78 62.7 Favored 'General case' 0 C--N 1.292 -1.892 0 C-N-CA 126.275 1.83 . . . . 2.35 111.033 177.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 131' ' ' GLU . . . . . 0.638 ' HG2' ' OD2' ' B' ' 130' ' ' ASP . 1.1 pt-20 -140.49 23.85 2.3 Favored 'General case' 0 CA--C 1.482 -1.672 0 CA-C-N 114.006 -1.452 . . . . 1.69 108.506 172.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 132' ' ' LEU . . . . . 0.973 HD22 ' CE1' ' B' ' 135' ' ' PHE . 0.6 OUTLIER -123.64 -9.54 7.89 Favored 'General case' 0 N--CA 1.408 -2.544 0 N-CA-C 107.327 -1.36 . . . . 1.38 107.327 178.1 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 133' ' ' GLY . . . . . 1.015 ' HA2' ' HB1' ' B' ' 169' ' ' ALA . . . 58.93 -114.47 6.1 Favored Glycine 0 N--CA 1.408 -3.217 0 CA-C-O 117.979 -1.456 . . . . 0.72 112.423 178.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 134' ' ' CYS . . . . . 0.98 ' HB2' HD13 ' B' ' 172' ' ' ILE . 0.1 OUTLIER -148.52 124.07 10.4 Favored 'General case' 0 CA--C 1.478 -1.814 0 CA-C-N 120.326 2.063 . . . . 1.08 113.638 179.98 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 135' ' ' PHE . . . . . 0.973 ' CE1' HD22 ' B' ' 132' ' ' LEU . 0.0 OUTLIER -98.35 99.88 11.11 Favored 'General case' 0 N--CA 1.42 -1.96 0 N-CA-C 102.985 -2.969 . . . . 1.36 102.985 176.054 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 136' ' ' VAL . . . . . 1.044 HG13 HG12 ' B' ' 126' ' ' ILE . 2.3 t -91.91 85.49 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.65 0 CA-C-O 123.507 1.622 . . . . 0.75 107.875 -178.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 137' ' ' GLY . . . . . 0.739 ' HA3' HG21 ' A' ' 72' ' ' ILE . . . 90.21 81.74 1.37 Allowed Glycine 0 C--N 1.317 -0.476 0 CA-C-N 112.081 -2.327 . . . . 0.83 113.416 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 138' ' ' THR . . . . . 0.707 HG22 ' O ' ' A' ' 32' ' ' LEU . 68.7 p -148.41 176.3 10.4 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.624 -0.88 . . . . 0.78 108.624 179.158 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 139' ' ' ALA . . . . . 0.812 ' HA ' HD12 ' B' ' 142' ' ' LEU . . . -61.1 -40.93 95.62 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 119.323 0.965 . . . . 1.04 109.932 178.301 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 140' ' ' GLU . . . . . 0.749 ' HB3' ' HA2' ' B' ' 114' ' ' GLY . 7.7 mt-10 -56.53 -19.1 13.95 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.355 0.598 . . . . 2.31 111.204 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 141' ' ' ALA . . . . . 0.765 ' O ' ' HB2' ' B' ' 144' ' ' CYS . . . -83.26 -20.82 33.78 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 114.906 -1.043 . . . . 0.87 110.054 179.287 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 142' ' ' LEU . . . . . 0.812 HD12 ' HA ' ' B' ' 139' ' ' ALA . 0.5 OUTLIER -53.9 -39.73 66.04 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.939 0.876 . . . . 1.24 109.088 177.704 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 143' ' ' ARG . . . . . 0.793 ' HD2' ' O ' ' B' ' 112' ' ' PRO . 0.2 OUTLIER -67.4 -3.79 9.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.605 -1.179 . . . . 2.93 109.991 177.621 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 144' ' ' CYS . . . . . 0.765 ' HB2' ' O ' ' B' ' 141' ' ' ALA . 0.1 OUTLIER -84.39 18.23 2.31 Favored 'General case' 0 C--N 1.342 0.246 0 O-C-N 120.863 -1.148 . . . . 1.61 110.993 176.148 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.23 -27.12 47.61 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.563 0.696 . . . . 3.35 109.146 175.14 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -84.55 3.17 37.88 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.78 -0.645 . . . . 3.76 110.71 179.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . 1.032 ' HG3' ' HB3' ' B' ' 121' ' ' CYS . 1.7 tm-20 -81.7 2.76 28.23 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.607 -0.516 . . . . 4.01 109.607 177.32 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 148' ' ' ASN . . . . . . . . . . . . . 24.7 t30 -94.94 -26.87 15.95 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.019 -0.537 . . . . 3.92 109.943 178.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -110.38 9.97 23.44 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.418 -0.355 . . . . 5.73 111.891 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 150' ' ' LEU . . . . . 1.064 HD22 HD23 ' B' ' 111' ' ' LEU . 0.1 OUTLIER -145.15 80.33 11.19 Favored Pre-proline 0 CA--C 1.535 0.39 0 C-N-CA 121.31 -0.156 . . . . 5.46 111.243 -179.998 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 151' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -95.43 50.83 0.19 Allowed 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 123.065 2.51 . . . . 5.02 112.814 -179.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 152' ' ' SER . . . . . 0.533 ' HB3' HG21 ' B' ' 107' ' ' VAL . 59.8 m -83.94 118.23 70.77 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 116.342 -0.39 . . . . 5.73 111.965 -179.459 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 153' ' ' PRO . . . . . 0.568 ' O ' HG11 ' B' ' 107' ' ' VAL . 91.9 Cg_endo -81.6 121.69 3.82 Favored 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 122.434 2.089 . . . . 5.1 111.563 179.077 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 154' ' ' CYS . . . . . 1.02 ' HB2' HD21 ' B' ' 103' ' ' LEU . 8.9 p -120.96 -160.87 0.87 Allowed 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 112.076 0.399 . . . . 2.68 112.076 -178.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 155' ' ' GLN . . . . . 0.761 ' N ' ' HB2' ' B' ' 105' ' ' LEU . 0.4 OUTLIER -60.92 125.58 24.24 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 120.636 -0.426 . . . . 5.63 110.707 178.561 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 156' ' ' SER . . . . . 0.414 ' HB3' ' H ' ' B' ' 157' ' ' GLY . 5.8 m -152.0 -155.85 0.65 Allowed 'General case' 0 N--CA 1.466 0.329 0 O-C-N 122.517 -0.114 . . . . 3.11 110.874 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 157' ' ' GLY . . . . . 0.414 ' H ' ' HB3' ' B' ' 156' ' ' SER . . . -127.6 134.82 8.43 Favored Glycine 0 N--CA 1.44 -1.043 0 N-CA-C 110.082 -1.207 . . . . 2.07 110.082 178.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.55 67.7 0.66 Allowed 'General case' 0 N--CA 1.444 -0.746 0 CA-C-O 122.144 0.973 . . . . 4.34 109.28 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 159' ' ' LYS . . . . . 0.542 ' O ' ' HA ' ' B' ' 166' ' ' ARG . 0.1 OUTLIER -112.82 69.38 1.11 Allowed Pre-proline 0 C--N 1.315 -0.919 0 CA-C-N 113.929 -1.487 . . . . 3.54 110.634 177.046 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 160' ' ' PRO . . . . . 0.533 ' HA ' ' HA ' ' B' ' 166' ' ' ARG . 33.2 Cg_endo -64.86 79.19 0.19 Allowed 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 121.56 1.507 . . . . 1.51 114.011 -177.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 161' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -93.74 -168.95 1.99 Allowed 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 106.682 -1.599 . . . . 1.58 106.682 176.657 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 60.09 -165.38 12.33 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 118.859 -1.638 . . . . 2.37 113.407 177.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 4.1 m -87.69 42.21 1.03 Allowed 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 122.961 1.363 . . . . 4.07 110.902 -177.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 118.15 6.59 12.12 Favored Glycine 0 CA--C 1.551 2.343 0 CA-C-N 112.552 -2.113 . . . . 2.2 115.095 -179.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 165' ' ' GLY . . . . . 0.48 ' CA ' ' HB3' ' B' ' 175' ' ' SER . . . -102.36 129.59 9.94 Favored Glycine 0 N--CA 1.472 1.07 0 CA-C-N 120.835 2.317 . . . . 1.62 116.708 -177.02 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 166' ' ' ARG . . . . . 0.758 ' H ' ' HD2' ' B' ' 166' ' ' ARG . 0.0 OUTLIER -90.77 155.35 18.86 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 108.858 -0.793 . . . . 3.05 108.858 177.115 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 167' ' ' CYS . . . . . 0.49 ' SG ' ' HB3' ' B' ' 159' ' ' LYS . 69.6 m -64.87 107.86 1.6 Allowed 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 118.392 0.542 . . . . 1.56 110.136 -178.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 168' ' ' ALA . . . . . 0.459 ' HB3' ' SG ' ' B' ' 128' ' ' CYS . . . -89.32 -19.37 25.37 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 122.056 0.931 . . . . 1.04 108.626 178.242 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 169' ' ' ALA . . . . . 1.015 ' HB1' ' HA2' ' B' ' 133' ' ' GLY . . . -159.88 160.94 34.22 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 113.55 -1.659 . . . . 0.98 111.037 -176.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 170' ' ' ALA . . . . . 0.616 ' HA ' ' O ' ' B' ' 185' ' ' CYS . . . -57.91 118.09 4.99 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 113.556 0.947 . . . . 1.25 113.556 -178.326 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 171' ' ' GLY . . . . . 0.657 ' HA2' ' O ' ' B' ' 182' ' ' ASP . . . 71.81 18.79 77.72 Favored Glycine 0 CA--C 1.521 0.441 0 CA-C-N 115.689 -0.687 . . . . 1.29 114.609 177.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 172' ' ' ILE . . . . . 0.98 HD13 ' HB2' ' B' ' 134' ' ' CYS . 1.7 pp -142.32 102.07 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-O 122.458 1.123 . . . . 2.27 111.252 -178.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 173' ' ' CYS . . . . . 0.623 ' HB2' ' HB3' ' B' ' 182' ' ' ASP . 0.0 OUTLIER -85.7 92.12 8.49 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 114.126 -1.397 . . . . 1.94 110.669 -178.38 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 174' ' ' CYS . . . . . 0.646 ' HA ' ' HA ' ' B' ' 179' ' ' CYS . 81.4 m -97.51 153.52 18.1 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.655 0.741 . . . . 1.35 112.478 -178.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 175' ' ' SER . . . . . 0.906 ' HB2' ' HD2' ' B' ' 176' ' ' PRO . 35.1 p -130.02 -178.92 0.89 Allowed Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 114.494 -1.23 . . . . 2.0 108.916 179.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 176' ' ' PRO . . . . . 0.906 ' HD2' ' HB2' ' B' ' 175' ' ' SER . 72.1 Cg_endo -78.15 26.94 0.49 Allowed 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 121.339 1.359 . . . . 1.9 111.727 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 177' ' ' ASP . . . . . 0.608 ' HB2' ' CE1' ' A' ' 80' ' ' HIS . 3.0 p30 -146.07 -39.98 0.22 Allowed 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.772 -0.649 . . . . 2.72 111.357 179.374 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 178' ' ' GLY . . . . . 0.407 ' HA3' ' O ' ' A' ' 79' ' ' CYS . . . -157.12 -155.03 7.29 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 120.588 -0.815 . . . . 0.99 113.51 -179.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 179' ' ' CYS . . . . . 0.646 ' HA ' ' HA ' ' B' ' 174' ' ' CYS . 99.8 m -140.19 156.15 46.63 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 110.054 -0.35 . . . . 1.34 110.054 179.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 180' ' ' HIS . . . . . 0.635 ' CE1' ' HB2' ' A' ' 77' ' ' ASP . 81.3 t60 -150.27 124.13 9.26 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-O 121.387 0.613 . . . . 2.1 110.427 -173.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 181' ' ' GLU . . . . . 0.526 ' OE2' ' HD2' ' A' ' 24' ' ' PRO . 18.5 mt-10 -51.21 129.89 25.37 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 115.105 -0.952 . . . . 3.06 111.98 -175.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 182' ' ' ASP . . . . . 0.657 ' O ' ' HA2' ' B' ' 171' ' ' GLY . 0.1 OUTLIER -141.83 118.28 7.23 Favored Pre-proline 0 CA--C 1.546 0.807 0 CA-C-N 115.333 -0.849 . . . . 2.06 110.371 -179.066 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 183' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' B' ' 182' ' ' ASP . 3.8 Cg_exo -81.84 -18.81 7.59 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 122.813 2.342 . . . . 1.91 113.671 -178.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -63.59 -39.81 95.34 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.781 0.324 . . . . 1.56 111.684 -179.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 185' ' ' CYS . . . . . 0.616 ' O ' ' HA ' ' B' ' 170' ' ' ALA . 68.8 m -99.85 14.76 29.27 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 116.311 -0.404 . . . . 1.94 112.052 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 186' ' ' ASP . . . . . 0.517 ' CB ' ' HD3' ' B' ' 187' ' ' PRO . 0.8 OUTLIER -66.78 -55.6 16.95 Favored Pre-proline 0 C--N 1.322 -0.608 0 C-N-CA 121.015 -0.274 . . . . 3.61 111.71 -178.099 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 187' ' ' PRO . . . . . 0.546 ' C ' ' H ' ' B' ' 189' ' ' ALA . 57.1 Cg_endo -99.66 -169.36 0.1 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.17 0 C-N-CA 123.284 2.656 . . . . 2.58 113.883 -179.049 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 188' ' ' GLU . . . . . 0.406 ' C ' ' H ' ' B' ' 190' ' ' ALA . 5.9 pt-20 -61.64 30.47 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 111.586 -2.552 . . . . 4.7 112.189 175.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 189' ' ' ALA . . . . . 0.546 ' H ' ' C ' ' B' ' 187' ' ' PRO . . . -82.24 16.02 2.18 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 107.895 -1.15 . . . . 5.24 107.895 169.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 190' ' ' ALA . . . . . 0.406 ' H ' ' C ' ' B' ' 188' ' ' GLU . . . -78.4 140.89 38.67 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-O 122.3 1.048 . . . . 6.93 111.547 176.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 191' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -100.18 101.56 12.62 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 113.145 -1.843 . . . . 10.14 110.194 177.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 16.6 m . . . . . 0 C--O 1.248 0.975 0 CA-C-O 118.279 -0.867 . . . . 11.7 110.898 -179.989 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.441 0 CA-C-O 121.515 0.674 . . . . 9.95 112.009 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.1 p -138.01 135.76 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.262 0 CA-C-O 123.046 1.403 . . . . 8.02 113.025 179.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.907 ' HG ' ' HG3' ' A' ' 8' ' ' ARG . 1.1 mm? -69.95 118.39 12.74 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 111.976 -2.375 . . . . 5.86 110.611 178.152 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.479 ' H ' ' HG3' ' A' ' 55' ' ' GLN . 1.1 m-20 -98.85 53.56 1.0 Allowed 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 113.005 -1.907 . . . . 6.22 109.994 178.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 1.1 HD13 ' H ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -141.67 -66.92 0.4 Allowed 'General case' 0 N--CA 1.383 -3.806 0 CA-C-N 111.71 -2.496 . . . . 7.09 107.974 175.905 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 1.1 ' H ' HD13 ' A' ' 5' ' ' LEU . 0.2 OUTLIER 165.7 -42.18 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.965 0 CA-C-O 125.132 2.396 . . . . 8.78 111.554 -178.597 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.887 ' C ' HD11 ' A' ' 5' ' ' LEU . 8.2 p -156.72 129.27 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.05 1 CA-C-N 107.232 -4.531 . . . . 7.51 108.486 172.902 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.907 ' HG3' ' HG ' ' A' ' 3' ' ' LEU . 0.0 OUTLIER -74.94 103.55 5.19 Favored 'General case' 0 N--CA 1.385 -3.71 0 C-N-CA 116.362 -2.135 . . . . 9.08 108.811 -179.841 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -112.06 98.36 7.29 Favored 'General case' 0 N--CA 1.395 -3.205 1 N-CA-C 99.941 -4.096 . . . . 5.66 99.941 166.426 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.7 m -77.01 59.68 1.7 Allowed 'General case' 0 C--N 1.282 -2.363 0 C-N-CA 118.437 -1.305 . . . . 2.68 111.646 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.809 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 4.4 mm? -32.71 114.43 0.4 Allowed Pre-proline 0 N--CA 1.475 0.799 0 N-CA-C 112.067 0.395 . . . . 2.48 112.067 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.729 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 95.7 Cg_endo -88.89 114.45 0.7 Allowed 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.626 2.217 . . . . 1.49 114.408 -178.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.666 ' O ' ' HA2' ' A' ' 17' ' ' GLY . 13.6 p -116.86 -155.31 0.58 Allowed 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 121.586 0.708 . . . . 1.0 110.582 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.417 ' O ' ' N ' ' A' ' 16' ' ' GLY . . . 79.21 -166.46 51.48 Favored Glycine 0 CA--C 1.497 -1.063 0 CA-C-O 119.284 -0.731 . . . . 1.15 111.892 179.182 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.551 ' CG ' HD11 ' A' ' 32' ' ' LEU . 84.8 Cg_endo -64.4 83.81 0.16 Allowed 'Trans proline' 0 N--CA 1.458 -0.561 0 CA-C-N 119.712 1.756 . . . . 1.57 113.374 -178.071 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 14' ' ' GLY . . . 87.99 8.21 72.8 Favored Glycine 0 C--N 1.29 -1.979 0 CA-C-N 111.927 -2.397 . . . . 1.68 115.2 -178.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.666 ' HA2' ' O ' ' A' ' 13' ' ' CYS . . . 91.17 42.77 4.86 Favored Glycine 0 N--CA 1.435 -1.369 0 N-CA-C 118.089 1.995 . . . . 1.36 118.089 172.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.61 -15.85 26.35 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 114.372 -0.914 . . . . 2.5 113.184 177.607 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.729 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -121.31 -179.67 16.12 Favored Glycine 0 N--CA 1.469 0.879 0 CA-C-O 117.707 -1.607 . . . . 1.02 109.084 -179.026 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.809 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 4.2 mpt_? -106.33 173.05 6.48 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 121.804 2.802 . . . . 2.92 110.476 178.218 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.474 ' HB3' ' HG3' ' A' ' 47' ' ' GLU . 0.5 OUTLIER -107.66 135.63 48.78 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 110.372 -0.233 . . . . 1.1 110.372 179.523 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.6 ' HE1' ' HB2' ' A' ' 28' ' ' CYS . 96.0 m-85 -111.51 -68.96 0.9 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.837 0.351 . . . . 1.51 110.574 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -106.63 -153.12 19.72 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 111.133 -0.787 . . . . 0.9 111.133 178.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -88.5 -51.25 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 122.444 2.096 . . . . 1.5 112.1 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.648 ' O ' ' N ' ' A' ' 37' ' ' GLY . 1.2 m -98.84 29.64 3.69 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-N 116.434 -0.348 . . . . 1.26 110.467 179.504 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.987 HG12 HG13 ' A' ' 36' ' ' VAL . 6.9 mt -138.69 116.0 11.57 Favored 'Isoleucine or valine' 0 C--O 1.243 0.717 0 CA-C-O 121.528 0.68 . . . . 0.83 112.771 -178.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.765 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 0.6 OUTLIER -130.76 125.4 33.7 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 114.973 -1.012 . . . . 0.92 110.274 178.626 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.994 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 94.8 m -117.2 161.94 18.66 Favored 'General case' 0 CA--C 1.55 0.972 0 CA-C-N 115.145 -0.934 . . . . 1.28 113.432 -178.293 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.734 ' O ' ' HB1' ' A' ' 69' ' ' ALA . . . -145.48 176.38 24.52 Favored Glycine 0 C--N 1.358 1.801 0 CA-C-N 112.955 -1.929 . . . . 0.67 108.597 176.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -65.78 -53.27 42.62 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 122.367 1.08 . . . . 2.27 110.601 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.577 ' OE2' ' HA ' ' A' ' 91' ' ' PHE . 1.1 pt-20 -120.41 19.1 12.1 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 113.067 -1.878 . . . . 1.66 108.214 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.613 HD22 ' CZ ' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -111.97 -12.6 13.72 Favored 'General case' 0 N--CA 1.405 -2.69 0 CA-C-N 114.229 -1.35 . . . . 1.37 108.033 179.988 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.994 ' O ' ' HA ' ' A' ' 28' ' ' CYS . . . 55.95 -127.67 43.53 Favored Glycine 0 N--CA 1.419 -2.5 0 CA-C-N 114.419 -1.264 . . . . 0.73 112.107 177.399 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.889 ' HB2' HD13 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -143.91 121.36 11.7 Favored 'General case' 0 CA--C 1.493 -1.238 0 N-CA-C 114.527 1.306 . . . . 1.08 114.527 179.68 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.75 ' HA ' ' HA ' ' B' ' 135' ' ' PHE . 0.0 OUTLIER -85.94 105.79 16.66 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 102.605 -3.109 . . . . 1.38 102.605 173.861 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.987 HG13 HG12 ' A' ' 26' ' ' ILE . 2.6 t -92.8 85.53 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.702 0 C-N-CA 118.436 -1.306 . . . . 0.76 108.714 -178.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.655 ' HA3' ' CG2' ' B' ' 172' ' ' ILE . . . 96.55 76.97 1.33 Allowed Glycine 0 CA--C 1.527 0.786 0 CA-C-N 112.464 -2.153 . . . . 0.81 114.071 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.603 HG22 ' O ' ' B' ' 132' ' ' LEU . 47.1 p -155.36 176.67 12.28 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 108.482 -0.933 . . . . 0.77 108.482 178.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 1.1 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -68.9 -13.67 62.57 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-N 119.495 1.043 . . . . 1.02 109.942 178.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.432 ' HG2' ' CE2' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -64.09 -18.55 64.51 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.368 -0.975 . . . . 2.32 108.368 177.903 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.954 ' O ' ' HB2' ' A' ' 44' ' ' CYS . . . -112.14 -12.13 13.69 Favored 'General case' 0 C--O 1.217 -0.631 0 CA-C-N 115.192 -0.913 . . . . 0.87 113.034 -179.276 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 1.1 HD12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -54.32 -19.28 5.14 Favored 'General case' 0 C--N 1.323 -0.545 0 O-C-N 120.966 -1.084 . . . . 1.23 113.29 -177.497 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.769 ' N ' HD13 ' A' ' 42' ' ' LEU . 9.2 ptm85 -79.65 -14.68 58.62 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 106.56 -1.645 . . . . 2.92 106.56 174.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.954 ' HB2' ' O ' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -58.18 -22.65 52.46 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 111.393 -2.639 . . . . 1.57 108.984 -178.383 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.76 -20.25 5.34 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.641 0.608 . . . . 3.31 112.641 179.046 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -85.83 6.75 26.71 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.102 -0.639 . . . . 3.69 110.729 -179.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.474 ' HG3' ' HB3' ' A' ' 21' ' ' CYS . 3.3 mm-40 -82.49 0.88 40.35 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 109.334 -0.617 . . . . 3.99 109.334 177.473 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 23.3 p-10 -75.26 -29.36 60.14 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.713 -0.477 . . . . 3.86 109.713 178.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -80.78 9.08 6.78 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.473 -0.331 . . . . 5.68 111.605 179.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.5 mt -134.51 130.48 19.97 Favored Pre-proline 0 C--N 1.333 -0.139 0 CA-C-O 120.507 0.194 . . . . 5.4 111.028 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -80.86 9.8 3.63 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.493 2.129 . . . . 4.92 112.532 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 178.42 150.26 0.42 Allowed Pre-proline 0 CA--C 1.529 0.15 0 CA-C-O 120.657 0.265 . . . . 5.64 110.799 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -79.27 -104.21 0.01 OUTLIER 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 122.661 2.24 . . . . 5.04 112.283 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 9.0 p -158.5 117.02 3.01 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 109.892 -0.41 . . . . 2.74 109.892 179.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.592 ' CD ' ' HA ' ' A' ' 3' ' ' LEU . 1.2 pm0 -56.47 134.78 54.26 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 119.916 -0.714 . . . . 5.75 112.18 -178.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.544 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 0.3 OUTLIER 168.76 67.71 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 112.047 0.388 . . . . 3.12 112.047 178.734 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.561 ' O ' ' HG3' ' A' ' 66' ' ' ARG . . . 168.32 89.9 0.08 OUTLIER Glycine 0 N--CA 1.434 -1.464 0 N-CA-C 108.053 -2.019 . . . . 2.1 108.053 -179.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -110.61 77.79 1.07 Allowed 'General case' 0 CA--C 1.497 -1.081 0 CA-C-O 122.465 1.126 . . . . 4.36 109.221 -178.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.9 ' HB2' ' HB2' ' A' ' 67' ' ' CYS . 7.7 mptt -140.77 53.06 3.53 Favored Pre-proline 0 C--N 1.293 -1.85 0 CA-C-N 113.279 -1.782 . . . . 3.55 107.391 179.012 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.552 ' CD ' ' N ' ' A' ' 59' ' ' LYS . 11.1 Cg_endo -54.6 97.32 0.05 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.202 0 C-N-CA 122.576 2.184 . . . . 1.54 113.496 -179.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.639 ' N ' ' O ' ' A' ' 65' ' ' GLY . 1.0 OUTLIER -96.91 -166.6 1.42 Allowed 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 111.947 -2.388 . . . . 1.59 107.189 177.56 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' A' ' 61' ' ' CYS . . . 36.91 -164.81 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 119.789 -1.196 . . . . 2.43 115.623 172.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -84.75 47.64 1.41 Allowed 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 113.1 -1.55 . . . . 4.11 111.405 -178.056 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 120.62 9.9 7.42 Favored Glycine 0 C--N 1.349 1.287 0 CA-C-N 114.77 -1.105 . . . . 2.21 115.22 178.04 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.639 ' O ' ' N ' ' A' ' 61' ' ' CYS . . . -105.2 132.62 11.19 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 119.551 -1.309 . . . . 1.62 115.402 -178.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.561 ' HG3' ' O ' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -101.71 154.24 19.06 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 109.38 -0.6 . . . . 3.02 109.38 177.046 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.9 ' HB2' ' HB2' ' A' ' 59' ' ' LYS . 0.5 OUTLIER -59.33 115.24 3.1 Favored 'General case' 0 CA--C 1.496 -1.128 0 N-CA-C 109.183 -0.673 . . . . 1.52 109.183 -179.696 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.404 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . . . -90.72 -19.21 23.82 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 107.785 -1.191 . . . . 1.07 107.785 178.089 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.734 ' HB1' ' O ' ' A' ' 29' ' ' GLY . . . -165.1 162.93 20.51 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 109.471 -0.566 . . . . 1.0 109.471 -177.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.916 ' HB2' ' HG3' ' A' ' 88' ' ' GLU . . . -50.43 132.81 25.03 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 112.927 0.714 . . . . 1.24 112.927 -179.49 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.598 ' H ' ' CB ' ' A' ' 85' ' ' CYS . . . 65.67 -25.6 0.14 Allowed Glycine 0 CA--C 1.526 0.77 0 CA-C-N 115.347 -0.842 . . . . 1.28 115.183 178.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.889 HD13 ' HB2' ' A' ' 34' ' ' CYS . 1.0 OUTLIER -102.37 122.56 54.82 Favored 'Isoleucine or valine' 0 C--O 1.243 0.72 0 CA-C-O 122.148 0.975 . . . . 2.27 111.614 -179.493 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.662 ' HB2' ' HB3' ' A' ' 82' ' ' ASP . 43.8 t -105.27 111.01 23.59 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.372 -0.831 . . . . 1.98 111.178 -179.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.529 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 0.8 OUTLIER -110.99 143.52 41.54 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.731 0.776 . . . . 1.33 112.559 -179.129 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.677 ' HB2' ' HD2' ' A' ' 76' ' ' PRO . 84.0 p -112.16 178.57 0.95 Allowed Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 114.447 -1.251 . . . . 1.99 108.76 179.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.677 ' HD2' ' HB2' ' A' ' 75' ' ' SER . 86.8 Cg_endo -80.54 22.95 0.73 Allowed 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 121.362 1.375 . . . . 1.86 111.649 179.31 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -145.3 -36.93 0.28 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.835 -0.62 . . . . 2.65 110.52 179.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.771 ' HA3' ' O ' ' B' ' 179' ' ' CYS . . . -155.57 -144.0 3.81 Favored Glycine 0 C--N 1.337 0.616 0 C-N-CA 120.47 -0.871 . . . . 0.99 113.385 179.513 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.659 ' O ' ' HA3' ' B' ' 178' ' ' GLY . 0.1 OUTLIER -151.5 157.97 43.0 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.987 0.422 . . . . 1.34 111.22 -179.614 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.459 ' O ' ' HB3' ' A' ' 73' ' ' CYS . 45.3 m80 -147.14 148.32 31.44 Favored 'General case' 0 N--CA 1.461 0.089 0 O-C-N 122.162 -0.336 . . . . 2.17 110.26 179.358 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -64.5 133.99 53.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.547 -0.297 . . . . 3.05 110.496 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.662 ' HB3' ' HB2' ' A' ' 73' ' ' CYS . 0.0 OUTLIER -145.02 117.56 5.36 Favored Pre-proline 0 CA--C 1.538 0.489 0 CA-C-N 116.531 -0.304 . . . . 2.02 110.684 179.864 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -83.96 -9.29 9.79 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 123.024 2.483 . . . . 1.93 113.575 -178.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.76 -22.31 66.04 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.11 0.411 . . . . 1.53 112.11 -179.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.738 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 52.2 m -101.09 20.36 15.75 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 113.515 0.931 . . . . 1.88 113.515 -178.009 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.617 ' N ' ' CD ' ' A' ' 87' ' ' PRO . 1.2 m-20 -69.43 -36.54 7.19 Favored Pre-proline 0 CA--C 1.518 -0.275 0 C-N-CA 122.911 0.484 . . . . 3.6 111.525 178.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.617 ' CD ' ' N ' ' A' ' 86' ' ' ASP . 1.3 Cg_endo -76.46 71.72 5.79 Favored 'Trans proline' 0 CA--C 1.497 -1.362 0 N-CA-C 107.595 -1.733 . . . . 2.56 107.595 177.321 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.916 ' HG3' ' HB2' ' A' ' 70' ' ' ALA . 8.1 pt-20 169.45 -15.33 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 113.032 -1.895 . . . . 4.72 108.805 176.103 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.55 -11.6 61.04 Favored 'General case' 0 C--N 1.366 1.315 0 C-N-CA 124.538 1.135 . . . . 5.29 113.892 -177.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.49 128.38 35.43 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-O 124.22 1.962 . . . . 6.98 111.019 173.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.577 ' HA ' ' OE2' ' A' ' 31' ' ' GLU . 35.4 p90 -96.8 91.62 5.76 Favored 'General case' 0 C--N 1.356 0.878 0 CA-C-N 109.562 -3.472 . . . . 10.21 109.643 178.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 52.2 p . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.198 -0.906 . . . . 11.77 111.235 -179.333 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 101' ' ' ALA . . . . . 0.44 ' O ' HG12 ' B' ' 102' ' ' VAL . . . . . . . . 0 N--CA 1.488 1.452 0 CA-C-O 120.795 0.331 . . . . 10.07 111.481 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 102' ' ' VAL . . . . . 0.604 ' O ' HG13 ' B' ' 102' ' ' VAL . 12.0 p 46.85 89.5 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 C-N-CA 124.056 0.942 . . . . 8.41 113.447 -178.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 103' ' ' LEU . . . . . 0.492 ' N ' HD22 ' B' ' 103' ' ' LEU . 2.6 mm? -112.2 105.07 13.31 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.387 0.613 . . . . 5.87 110.654 179.254 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 104' ' ' ASP . . . . . 0.424 ' H ' ' CG ' ' B' ' 155' ' ' GLN . 0.6 OUTLIER -105.91 62.54 0.66 Allowed 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 122.61 1.195 . . . . 6.27 110.488 179.287 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . 1.016 HD13 ' H ' ' B' ' 106' ' ' ASP . 0.0 OUTLIER -153.04 -74.39 0.13 Allowed 'General case' 0 N--CA 1.384 -3.759 0 C-N-CA 128.308 2.643 . . . . 7.2 107.346 177.658 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 106' ' ' ASP . . . . . 1.016 ' H ' HD13 ' B' ' 105' ' ' LEU . 0.2 OUTLIER -173.32 -71.66 0.01 OUTLIER 'General case' 0 C--N 1.267 -2.999 0 N-CA-C 109.716 -0.476 . . . . 8.55 109.716 -177.931 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 107' ' ' VAL . . . . . 0.954 ' O ' HD21 ' B' ' 105' ' ' LEU . 2.7 p -138.89 141.86 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.684 1 N-CA-C 96.057 -5.534 . . . . 7.48 96.057 173.878 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 108' ' ' ARG . . . . . 0.789 ' O ' ' HD2' ' B' ' 108' ' ' ARG . 0.0 OUTLIER -73.96 108.55 6.85 Favored 'General case' 0 N--CA 1.4 -2.93 0 C-N-CA 116.621 -2.031 . . . . 9.12 110.076 -177.678 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.49 98.13 5.99 Favored 'General case' 0 N--CA 1.4 -2.95 1 N-CA-C 99.136 -4.394 . . . . 5.69 99.136 167.496 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 110' ' ' CYS . . . . . . . . . . . . . 1.7 m -79.39 66.0 4.72 Favored 'General case' 0 C--N 1.294 -1.817 0 C-N-CA 117.657 -1.617 . . . . 2.61 110.251 -178.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 111' ' ' LEU . . . . . 0.821 ' O ' ' HA ' ' B' ' 120' ' ' ARG . 4.3 mm? -35.39 114.19 0.52 Allowed Pre-proline 0 N--CA 1.47 0.552 0 C-N-CA 122.655 0.382 . . . . 2.47 111.843 178.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 112' ' ' PRO . . . . . 0.782 ' HA ' ' O ' ' B' ' 119' ' ' GLY . 92.2 Cg_endo -88.13 114.98 0.89 Allowed 'Trans proline' 0 CA--C 1.531 0.368 0 C-N-CA 122.394 2.063 . . . . 1.47 113.931 -179.215 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.618 ' O ' ' HA2' ' B' ' 117' ' ' GLY . 13.8 p -117.2 -153.94 0.54 Allowed 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.642 0.734 . . . . 1.0 110.692 178.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 114' ' ' GLY . . . . . 0.414 ' O ' ' N ' ' B' ' 116' ' ' GLY . . . 78.6 -166.67 52.42 Favored Glycine 0 CA--C 1.5 -0.886 0 CA-C-N 115.601 -0.727 . . . . 1.16 111.864 179.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 115' ' ' PRO . . . . . 0.554 ' CG ' HD11 ' B' ' 132' ' ' LEU . 87.1 Cg_endo -64.66 82.58 0.17 Allowed 'Trans proline' 0 N--CA 1.454 -0.848 0 CA-C-N 119.503 1.652 . . . . 1.57 114.37 -177.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' B' ' 114' ' ' GLY . . . 89.44 6.86 70.2 Favored Glycine 0 C--N 1.29 -2.01 0 CA-C-N 111.727 -2.488 . . . . 1.7 115.638 -177.028 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 117' ' ' GLY . . . . . 0.618 ' HA2' ' O ' ' B' ' 113' ' ' CYS . . . 93.48 41.87 4.38 Favored Glycine 0 N--CA 1.436 -1.335 0 N-CA-C 117.794 1.877 . . . . 1.38 117.794 173.369 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.92 -15.56 26.18 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 113.18 0.807 . . . . 2.54 113.18 177.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 119' ' ' GLY . . . . . 0.782 ' O ' ' HA ' ' B' ' 112' ' ' PRO . . . -122.19 -170.66 13.77 Favored Glycine 0 C--N 1.347 1.161 0 N-CA-C 108.472 -1.851 . . . . 1.04 108.472 178.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.821 ' HA ' ' O ' ' B' ' 111' ' ' LEU . 4.1 mpt_? -110.94 172.85 6.63 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 121.307 2.554 . . . . 2.89 110.667 178.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 121' ' ' CYS . . . . . 0.484 ' HB3' ' HG3' ' B' ' 147' ' ' GLU . 0.5 OUTLIER -107.8 135.5 49.1 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 110.257 -0.275 . . . . 1.07 110.257 179.662 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 122' ' ' PHE . . . . . 0.611 ' HE1' ' HB2' ' B' ' 128' ' ' CYS . 96.0 m-85 -111.46 -68.94 0.9 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.873 0.368 . . . . 1.53 110.561 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -106.89 -153.22 19.42 Favored Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 111.062 -0.815 . . . . 0.9 111.062 178.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -88.32 -51.24 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 122.38 2.053 . . . . 1.51 112.161 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 125' ' ' SER . . . . . 0.648 ' O ' ' N ' ' B' ' 137' ' ' GLY . 1.4 m -98.64 29.55 3.66 Favored 'General case' 0 C--O 1.223 -0.308 0 CA-C-N 116.478 -0.328 . . . . 1.25 110.376 179.393 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 126' ' ' ILE . . . . . 0.957 HG12 HG13 ' B' ' 136' ' ' VAL . 8.1 mt -138.14 115.63 12.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.645 0 N-CA-C 113.122 0.786 . . . . 0.85 113.122 -178.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 127' ' ' CYS . . . . . 0.787 ' O ' ' HA ' ' B' ' 134' ' ' CYS . 0.5 OUTLIER -130.72 125.33 33.6 Favored 'General case' 0 C--O 1.225 -0.224 0 CA-C-N 115.122 -0.945 . . . . 0.89 110.232 178.689 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 128' ' ' CYS . . . . . 1.016 ' HA ' ' O ' ' B' ' 133' ' ' GLY . 98.6 m -117.09 162.49 17.73 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.19 -0.914 . . . . 1.23 113.387 -178.117 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 129' ' ' GLY . . . . . 0.742 ' O ' ' HB1' ' B' ' 169' ' ' ALA . . . -145.68 176.44 24.67 Favored Glycine 0 C--N 1.358 1.789 0 N-CA-C 108.622 -1.791 . . . . 0.66 108.622 176.364 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -66.56 -53.21 37.13 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 121.966 0.889 . . . . 2.35 110.239 179.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 131' ' ' GLU . . . . . 0.567 ' OE2' ' HA ' ' B' ' 191' ' ' PHE . 1.2 pt-20 -122.83 30.53 6.39 Favored 'General case' 0 N--CA 1.424 -1.766 0 CA-C-N 113.676 -1.602 . . . . 1.69 108.06 177.58 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 132' ' ' LEU . . . . . 0.62 HD22 ' CZ ' ' B' ' 135' ' ' PHE . 0.8 OUTLIER -122.24 -11.26 8.42 Favored 'General case' 0 N--CA 1.406 -2.636 0 N-CA-C 106.136 -1.801 . . . . 1.38 106.136 -178.839 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 133' ' ' GLY . . . . . 1.016 ' O ' ' HA ' ' B' ' 128' ' ' CYS . . . 54.51 -126.17 36.5 Favored Glycine 0 N--CA 1.408 -3.169 0 CA-C-N 113.876 -1.511 . . . . 0.72 112.351 175.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 134' ' ' CYS . . . . . 0.897 ' HB2' HD13 ' B' ' 172' ' ' ILE . 0.1 OUTLIER -145.06 120.63 10.41 Favored 'General case' 0 CA--C 1.491 -1.296 0 N-CA-C 115.032 1.493 . . . . 1.08 115.032 -179.841 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 135' ' ' PHE . . . . . 0.75 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -85.3 106.12 16.47 Favored 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 102.72 -3.067 . . . . 1.36 102.72 174.507 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 136' ' ' VAL . . . . . 0.957 HG13 HG12 ' B' ' 126' ' ' ILE . 3.4 t -92.63 85.63 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.601 0 CA-C-O 122.85 1.31 . . . . 0.75 108.513 -178.284 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 137' ' ' GLY . . . . . 0.648 ' N ' ' O ' ' B' ' 125' ' ' SER . . . 96.12 76.5 1.31 Allowed Glycine 0 CA--C 1.526 0.73 0 CA-C-N 112.5 -2.136 . . . . 0.83 114.222 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 138' ' ' THR . . . . . 0.513 HG22 ' O ' ' A' ' 32' ' ' LEU . 49.8 p -155.19 176.31 12.72 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 108.414 -0.958 . . . . 0.78 108.414 178.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 139' ' ' ALA . . . . . 1.103 ' O ' HD12 ' B' ' 142' ' ' LEU . . . -68.64 -12.79 61.81 Favored 'General case' 0 C--O 1.22 -0.487 0 CA-C-N 119.235 0.925 . . . . 1.04 110.133 178.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 140' ' ' GLU . . . . . 0.427 ' HG2' ' HD3' ' B' ' 115' ' ' PRO . 0.9 OUTLIER -65.63 -17.45 64.6 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.483 -0.932 . . . . 2.31 108.483 177.569 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 141' ' ' ALA . . . . . 0.938 ' O ' ' HB2' ' B' ' 144' ' ' CYS . . . -112.62 -12.65 13.39 Favored 'General case' 0 C--O 1.216 -0.688 0 CA-C-N 114.98 -1.009 . . . . 0.87 113.033 -179.46 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 142' ' ' LEU . . . . . 1.103 HD12 ' O ' ' B' ' 139' ' ' ALA . 0.0 OUTLIER -54.24 -19.23 4.9 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 121.097 -1.002 . . . . 1.24 113.222 -177.236 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 143' ' ' ARG . . . . . 0.772 ' N ' HD13 ' B' ' 142' ' ' LEU . 9.3 ptm85 -80.76 -12.58 59.43 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 106.774 -1.565 . . . . 2.93 106.774 174.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 144' ' ' CYS . . . . . 0.938 ' HB2' ' O ' ' B' ' 141' ' ' ALA . 0.1 OUTLIER -58.76 -24.84 62.36 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 111.786 -2.461 . . . . 1.61 108.948 -179.488 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.84 -20.56 2.29 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 112.672 0.619 . . . . 3.35 112.672 179.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -85.85 6.79 26.63 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.128 -0.629 . . . . 3.76 110.754 -179.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . 0.484 ' HG3' ' HB3' ' B' ' 121' ' ' CYS . 3.3 mm-40 -82.62 1.16 39.6 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 109.401 -0.592 . . . . 4.01 109.401 177.406 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 148' ' ' ASN . . . . . . . . . . . . . 23.3 p-10 -75.36 -29.35 59.87 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.719 -0.474 . . . . 3.92 109.719 178.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -80.72 9.03 6.78 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.432 -0.349 . . . . 5.73 111.585 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 10.5 mt -134.57 130.48 19.91 Favored Pre-proline 0 C--N 1.332 -0.161 0 CA-C-O 120.495 0.188 . . . . 5.46 111.054 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 151' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -80.89 9.83 3.63 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.466 2.111 . . . . 5.02 112.578 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 178.42 150.22 0.42 Allowed Pre-proline 0 CA--C 1.529 0.169 0 CA-C-N 116.611 -0.268 . . . . 5.73 110.795 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 153' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -79.38 -104.24 0.01 OUTLIER 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 122.662 2.241 . . . . 5.1 112.32 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 154' ' ' CYS . . . . . 0.87 ' HA ' ' HG ' ' B' ' 105' ' ' LEU . 8.1 p -158.48 118.09 3.18 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 109.883 -0.414 . . . . 2.68 109.883 179.124 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 155' ' ' GLN . . . . . 0.549 ' O ' ' HB2' ' B' ' 156' ' ' SER . 1.3 pm0 -57.97 134.42 56.36 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 120.322 -0.551 . . . . 5.63 111.839 -178.401 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 156' ' ' SER . . . . . 0.549 ' HB2' ' O ' ' B' ' 155' ' ' GLN . 0.3 OUTLIER 168.47 70.75 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 120.938 0.399 . . . . 3.11 111.5 179.043 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 157' ' ' GLY . . . . . 0.539 ' O ' ' HG3' ' B' ' 166' ' ' ARG . . . 165.14 91.05 0.08 OUTLIER Glycine 0 N--CA 1.44 -1.085 0 N-CA-C 108.847 -1.701 . . . . 2.07 108.847 179.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -112.34 65.61 0.64 Allowed 'General case' 0 CA--C 1.501 -0.909 0 CA-C-O 122.762 1.268 . . . . 4.34 110.402 -179.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 159' ' ' LYS . . . . . 0.963 ' HB2' ' HB2' ' B' ' 167' ' ' CYS . 7.3 mptt -113.34 47.66 0.37 Allowed Pre-proline 0 C--N 1.302 -1.499 0 CA-C-N 112.542 -2.117 . . . . 3.54 111.534 173.303 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 160' ' ' PRO . . . . . 0.451 ' HA ' ' HA ' ' B' ' 166' ' ' ARG . 10.0 Cg_endo -53.76 97.52 0.05 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.402 0 CA-C-N 121.3 1.5 . . . . 1.51 114.698 -174.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 161' ' ' CYS . . . . . 0.625 ' N ' ' O ' ' B' ' 165' ' ' GLY . 0.9 OUTLIER -96.9 -166.69 1.44 Allowed 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 112.397 -2.183 . . . . 1.58 107.406 177.626 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 162' ' ' GLY . . . . . 0.41 ' N ' ' SG ' ' B' ' 161' ' ' CYS . . . 37.08 -164.77 0.01 OUTLIER Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 115.746 1.059 . . . . 2.37 115.746 172.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -84.54 47.31 1.34 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 113.177 -1.511 . . . . 4.07 111.465 -178.093 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 120.4 9.82 7.62 Favored Glycine 0 CA--C 1.539 1.549 0 CA-C-N 115.043 -0.981 . . . . 2.2 115.179 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 165' ' ' GLY . . . . . 0.625 ' O ' ' N ' ' B' ' 161' ' ' CYS . . . -104.82 133.38 11.52 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 118.921 -1.609 . . . . 1.62 115.16 -179.55 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 166' ' ' ARG . . . . . 0.539 ' HG3' ' O ' ' B' ' 157' ' ' GLY . 0.0 OUTLIER -102.17 154.19 19.25 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 109.313 -0.625 . . . . 3.05 109.313 176.661 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 167' ' ' CYS . . . . . 0.963 ' HB2' ' HB2' ' B' ' 159' ' ' LYS . 0.5 OUTLIER -59.2 115.54 3.27 Favored 'General case' 0 CA--C 1.499 -0.982 0 N-CA-C 109.214 -0.661 . . . . 1.56 109.214 -179.571 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 168' ' ' ALA . . . . . 0.43 ' HB3' ' SG ' ' B' ' 128' ' ' CYS . . . -89.8 -20.75 23.12 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 107.774 -1.195 . . . . 1.04 107.774 177.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 169' ' ' ALA . . . . . 0.742 ' HB1' ' O ' ' B' ' 129' ' ' GLY . . . -164.38 162.71 22.33 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.375 -0.83 . . . . 0.98 110.682 -177.016 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 170' ' ' ALA . . . . . 0.892 ' HB2' ' HG3' ' B' ' 188' ' ' GLU . . . -49.99 133.0 23.11 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 112.711 0.634 . . . . 1.25 112.711 -179.273 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 171' ' ' GLY . . . . . 0.576 ' H ' ' CB ' ' B' ' 185' ' ' CYS . . . 67.65 -30.74 0.22 Allowed Glycine 0 CA--C 1.527 0.809 0 CA-C-N 115.614 -0.721 . . . . 1.29 114.693 178.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 172' ' ' ILE . . . . . 0.897 HD13 ' HB2' ' B' ' 134' ' ' CYS . 1.0 OUTLIER -99.5 122.78 51.71 Favored 'Isoleucine or valine' 0 C--O 1.242 0.71 0 CA-C-O 122.322 1.058 . . . . 2.27 111.931 -178.138 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 173' ' ' CYS . . . . . 0.656 ' HB2' ' HB3' ' B' ' 182' ' ' ASP . 44.1 t -105.36 110.96 23.51 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.201 -0.909 . . . . 1.94 111.19 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 174' ' ' CYS . . . . . 0.534 ' HA ' ' HA ' ' B' ' 179' ' ' CYS . 0.8 OUTLIER -110.83 143.51 41.29 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.586 0.707 . . . . 1.35 112.603 -179.097 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 175' ' ' SER . . . . . 0.687 ' HB2' ' HD2' ' B' ' 176' ' ' PRO . 83.9 p -112.17 178.53 0.96 Allowed Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 114.542 -1.208 . . . . 2.0 108.778 179.365 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 176' ' ' PRO . . . . . 0.687 ' HD2' ' HB2' ' B' ' 175' ' ' SER . 89.0 Cg_endo -80.53 23.1 0.72 Allowed 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 121.315 1.343 . . . . 1.9 111.663 179.328 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 177' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -145.38 -36.29 0.29 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.812 -0.631 . . . . 2.72 110.711 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 178' ' ' GLY . . . . . 0.659 ' HA3' ' O ' ' A' ' 79' ' ' CYS . . . -156.41 -144.18 3.86 Favored Glycine 0 C--N 1.337 0.587 0 C-N-CA 120.671 -0.776 . . . . 0.99 113.325 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 179' ' ' CYS . . . . . 0.771 ' O ' ' HA3' ' A' ' 78' ' ' GLY . 0.1 OUTLIER -151.51 157.98 43.0 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 120.895 0.378 . . . . 1.34 111.346 -179.489 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 180' ' ' HIS . . . . . 0.459 ' O ' ' HB3' ' B' ' 173' ' ' CYS . 45.4 m80 -147.05 148.36 31.57 Favored 'General case' 0 N--CA 1.46 0.069 0 O-C-N 122.199 -0.313 . . . . 2.1 110.277 179.316 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 181' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -64.5 133.93 53.42 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.645 -0.252 . . . . 3.06 110.486 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 182' ' ' ASP . . . . . 0.656 ' HB3' ' HB2' ' B' ' 173' ' ' CYS . 0.0 OUTLIER -144.99 117.52 5.37 Favored Pre-proline 0 CA--C 1.538 0.496 0 CA-C-N 116.521 -0.309 . . . . 2.06 110.673 179.864 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 183' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' B' ' 182' ' ' ASP . 1.2 Cg_endo -83.97 -9.14 9.85 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 123.039 2.493 . . . . 1.91 113.557 -178.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -66.75 -22.49 66.04 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.05 0.389 . . . . 1.56 112.05 -179.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 185' ' ' CYS . . . . . 0.749 ' HB3' ' HA ' ' B' ' 170' ' ' ALA . 54.1 m -100.94 20.32 15.68 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 113.622 0.971 . . . . 1.94 113.622 -178.024 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 186' ' ' ASP . . . . . 0.622 ' N ' ' CD ' ' B' ' 187' ' ' PRO . 1.2 m-20 -69.45 -36.46 7.05 Favored Pre-proline 0 CA--C 1.518 -0.271 0 C-N-CA 122.858 0.463 . . . . 3.61 111.52 178.577 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 187' ' ' PRO . . . . . 0.622 ' CD ' ' N ' ' B' ' 186' ' ' ASP . 1.2 Cg_endo -76.32 70.19 6.26 Favored 'Trans proline' 0 CA--C 1.497 -1.345 0 C-N-CA 121.554 1.503 . . . . 2.58 108.28 177.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 188' ' ' GLU . . . . . 0.892 ' HG3' ' HB2' ' B' ' 170' ' ' ALA . 8.2 pt-20 170.1 -14.21 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 112.821 -1.991 . . . . 4.7 109.064 176.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 189' ' ' ALA . . . . . . . . . . . . . . . -71.79 -11.13 60.66 Favored 'General case' 0 C--N 1.363 1.184 0 C-N-CA 124.401 1.08 . . . . 5.24 113.831 -177.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 190' ' ' ALA . . . . . . . . . . . . . . . -72.68 131.87 42.95 Favored 'General case' 0 N--CA 1.418 -2.043 0 CA-C-O 124.173 1.939 . . . . 6.93 111.026 172.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 191' ' ' PHE . . . . . 0.567 ' HA ' ' OE2' ' B' ' 131' ' ' GLU . 35.8 p90 -97.55 91.77 5.6 Favored 'General case' 0 C--N 1.35 0.599 0 CA-C-N 109.24 -3.618 . . . . 10.14 109.923 177.26 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 53.0 p . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.179 -0.915 . . . . 11.7 111.125 -179.343 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.452 ' O ' HG22 ' A' ' 9' ' ' THR . . . . . . . . 0 N--CA 1.485 1.308 0 CA-C-O 121.053 0.454 . . . . 9.95 111.879 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.487 ' O ' HG12 ' A' ' 2' ' ' VAL . 18.6 t 53.46 51.12 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 N-CA-C 112.874 0.694 . . . . 8.02 112.874 176.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.846 ' CB ' ' HD3' ' A' ' 8' ' ' ARG . 0.6 OUTLIER -129.17 112.98 14.51 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 115.822 -0.626 . . . . 5.86 109.331 -179.554 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.71 ' O ' ' HB2' ' A' ' 55' ' ' GLN . 0.1 OUTLIER -154.29 -153.3 0.45 Allowed 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 103.208 -2.886 . . . . 6.22 103.208 178.174 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 1.068 HD13 ' HB3' ' A' ' 55' ' ' GLN . 0.1 OUTLIER -86.23 9.78 16.64 Favored 'General case' 0 C--N 1.347 0.486 0 C-N-CA 114.967 -2.693 . . . . 7.09 109.852 175.539 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.54 -85.67 0.06 Allowed 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 104.919 -2.252 . . . . 8.78 104.919 -179.577 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.892 ' HA ' ' HB2' ' A' ' 56' ' ' SER . 2.4 p -149.76 115.33 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.455 -2.705 0 C-N-CA 115.72 -2.392 . . . . 7.51 105.014 172.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.869 ' HG2' ' HA ' ' A' ' 54' ' ' CYS . 9.2 tpt180 -77.59 116.55 18.23 Favored 'General case' 0 CA--C 1.462 -2.431 0 C-N-CA 118.818 -1.153 . . . . 9.08 108.688 -177.348 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.548 ' O ' ' HD2' ' A' ' 8' ' ' ARG . 2.5 t -64.54 108.21 1.6 Allowed 'General case' 0 N--CA 1.426 -1.628 0 C-N-CA 114.023 -3.071 . . . . 5.66 103.079 176.096 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.779 ' HB3' ' HB3' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -69.71 114.93 8.38 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.845 -1.071 . . . . 2.68 111.347 -176.96 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.463 ' C ' ' O ' ' A' ' 10' ' ' CYS . 5.6 tp -29.05 129.9 0.22 Allowed Pre-proline 0 N--CA 1.468 0.45 0 CA-C-O 121.031 0.443 . . . . 2.48 111.948 -179.396 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.871 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 54.5 Cg_endo -70.14 152.28 67.3 Favored 'Trans proline' 0 N--CA 1.475 0.39 0 C-N-CA 123.377 2.718 . . . . 1.49 114.608 -179.128 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.623 ' SG ' ' N ' ' A' ' 14' ' ' GLY . 0.0 OUTLIER -160.97 -170.22 2.64 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 119.422 -0.911 . . . . 1.0 110.946 176.969 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.856 ' HA2' ' HB3' ' A' ' 40' ' ' GLU . . . 77.61 -159.72 48.4 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 115.47 0.948 . . . . 1.15 115.47 178.393 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.597 ' CG ' HD21 ' A' ' 32' ' ' LEU . 74.4 Cg_endo -61.37 104.16 0.29 Allowed 'Trans proline' 0 N--CA 1.487 1.127 0 C-N-CA 124.749 3.633 . . . . 1.57 111.021 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.64 -10.92 60.66 Favored Glycine 0 C--N 1.28 -2.566 0 CA-C-N 113.119 -1.855 . . . . 1.68 111.219 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.518 ' O ' ' HB2' ' A' ' 12' ' ' PRO . . . 76.49 37.36 35.85 Favored Glycine 0 N--CA 1.411 -3.005 0 C-N-CA 119.336 -1.411 . . . . 1.36 111.153 -179.627 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.539 ' HB2' HD12 ' A' ' 32' ' ' LEU . 0.5 OUTLIER -88.09 -37.47 16.21 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 112.973 -1.614 . . . . 2.5 112.29 179.196 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.871 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -89.56 -172.79 45.63 Favored Glycine 0 N--CA 1.423 -2.198 0 CA-C-N 122.055 2.207 . . . . 1.02 110.966 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.779 ' HB3' ' HB3' ' A' ' 10' ' ' CYS . 0.4 OUTLIER -113.14 172.14 7.12 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 124.395 0.703 . . . . 2.92 112.777 -179.407 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.7 m -106.85 145.55 32.01 Favored 'General case' 0 N--CA 1.475 0.809 0 O-C-N 121.826 -0.546 . . . . 1.1 110.455 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.414 ' CZ ' ' O ' ' A' ' 68' ' ' ALA . 76.3 m-85 -142.9 22.39 1.93 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.944 -0.571 . . . . 1.51 111.752 -179.335 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.811 ' O ' ' HB3' ' A' ' 44' ' ' CYS . . . 174.04 -169.45 42.48 Favored Glycine 0 C--O 1.225 -0.444 0 C-N-CA 120.724 -0.751 . . . . 0.9 111.421 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -81.3 -54.18 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.531 2.154 . . . . 1.5 112.333 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.591 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.3 OUTLIER -106.47 12.1 30.0 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.234 -0.439 . . . . 1.26 111.39 -179.963 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.786 HG22 ' SG ' ' A' ' 34' ' ' CYS . 1.2 mt -121.8 122.43 66.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 113.218 0.821 . . . . 0.83 113.218 -177.357 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.682 ' HB3' ' CD2' ' A' ' 35' ' ' PHE . 4.3 t -130.78 116.37 17.88 Favored 'General case' 0 C--O 1.226 -0.155 0 CA-C-O 122.494 1.14 . . . . 0.92 111.48 178.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 1.214 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -121.36 148.48 44.31 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 112.552 -2.113 . . . . 1.28 109.08 -179.546 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.786 ' O ' ' HB1' ' A' ' 69' ' ' ALA . . . -144.01 -167.86 12.09 Favored Glycine 0 CA--C 1.478 -2.223 0 N-CA-C 105.494 -3.042 . . . . 0.67 105.494 174.388 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.462 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 12.3 p-10 -67.18 -69.01 0.34 Allowed 'General case' 0 C--N 1.282 -2.329 0 C-N-CA 118.635 -1.226 . . . . 2.27 112.82 -179.575 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.13 15.1 19.94 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 114.722 -1.127 . . . . 1.66 111.284 -176.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.734 HD22 ' CZ ' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -116.48 -17.69 10.59 Favored 'General case' 0 N--CA 1.4 -2.944 0 CA-C-N 114.568 -1.196 . . . . 1.37 108.208 179.945 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 1.214 ' O ' ' HA ' ' A' ' 28' ' ' CYS . . . 63.19 -128.25 39.12 Favored Glycine 0 N--CA 1.405 -3.428 0 CA-C-N 113.963 -1.471 . . . . 0.73 114.285 178.098 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.87 ' HB2' HG13 ' A' ' 72' ' ' ILE . 4.8 t -141.51 120.09 12.47 Favored 'General case' 0 CA--C 1.5 -0.944 0 N-CA-C 115.572 1.693 . . . . 1.08 115.572 -179.667 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 1.026 ' HA ' ' HA ' ' B' ' 135' ' ' PHE . 0.0 OUTLIER -96.34 107.58 19.97 Favored 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 106.501 -1.666 . . . . 1.38 106.501 176.219 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.833 HG23 HG23 ' B' ' 136' ' ' VAL . 1.8 t -94.72 84.0 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.774 0 N-CA-C 108.008 -1.108 . . . . 0.76 108.008 179.387 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 25' ' ' SER . . . 105.27 102.61 2.8 Favored Glycine 0 CA--C 1.524 0.646 0 CA-C-N 113.451 -1.704 . . . . 0.81 114.007 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.615 ' HB ' ' O ' ' B' ' 132' ' ' LEU . 0.2 OUTLIER 178.66 161.95 0.69 Allowed 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 107.992 -1.114 . . . . 0.77 107.992 179.02 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.818 ' HA ' HD12 ' A' ' 42' ' ' LEU . . . -69.28 -28.24 66.12 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 120.595 1.543 . . . . 1.02 112.175 -179.331 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.856 ' HB3' ' HA2' ' A' ' 14' ' ' GLY . 0.5 OUTLIER -62.23 -12.81 22.34 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.154 0.502 . . . . 2.32 110.524 178.125 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.808 ' O ' ' HB2' ' A' ' 44' ' ' CYS . . . -103.49 -19.32 14.44 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.091 -0.959 . . . . 0.87 110.673 178.108 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.818 HD12 ' HA ' ' A' ' 39' ' ' ALA . 0.7 OUTLIER -46.8 -38.06 9.58 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 112.403 0.52 . . . . 1.23 112.403 -179.298 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.555 ' HD2' ' H ' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -57.82 -22.35 47.14 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-O 122.552 1.167 . . . . 2.92 108.771 177.127 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.811 ' HB3' ' O ' ' A' ' 23' ' ' GLY . 28.6 m -58.8 -10.7 2.55 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-N 112.193 -2.276 . . . . 1.57 109.81 178.401 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.444 ' HB2' ' O ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -77.22 -18.98 57.29 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-O 121.126 0.489 . . . . 3.31 111.73 178.981 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -85.83 10.39 13.91 Favored 'General case' 0 CA--C 1.515 -0.369 0 C-N-CA 119.861 -0.736 . . . . 3.69 110.457 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -81.03 2.5 26.81 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 108.865 -0.791 . . . . 3.99 108.865 177.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -94.64 -28.94 15.1 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 116.303 -0.408 . . . . 3.86 110.134 178.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -105.08 30.26 5.71 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.308 -0.405 . . . . 5.68 110.981 179.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -124.37 131.87 24.23 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 120.633 0.254 . . . . 5.4 111.454 -179.485 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -77.05 12.92 1.62 Allowed 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.739 2.293 . . . . 4.92 113.045 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 35.0 p -103.69 105.94 50.0 Favored Pre-proline 0 CA--C 1.531 0.22 0 CA-C-O 120.438 0.161 . . . . 5.64 110.653 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -88.16 -4.66 6.82 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.924 2.416 . . . . 5.04 112.937 -179.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.869 ' HA ' ' HG2' ' A' ' 8' ' ' ARG . 1.8 t 63.68 97.2 0.04 OUTLIER 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 116.602 -0.272 . . . . 2.74 111.352 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 1.068 ' HB3' HD13 ' A' ' 5' ' ' LEU . 19.1 mm100 -103.36 72.34 1.15 Allowed 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 118.706 -1.198 . . . . 5.75 111.776 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.892 ' HB2' ' HA ' ' A' ' 7' ' ' VAL . 1.3 t 173.2 79.66 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.679 -0.691 . . . . 3.12 110.406 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 162.01 44.69 0.02 OUTLIER Glycine 0 N--CA 1.442 -0.955 0 N-CA-C 108.66 -1.776 . . . . 2.1 108.66 -179.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.421 ' O ' ' HG3' ' A' ' 58' ' ' GLN . 15.6 pt20 -118.96 86.05 2.48 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-O 122.489 1.137 . . . . 4.36 108.91 -179.255 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.524 ' HB3' ' HB2' ' A' ' 67' ' ' CYS . 0.0 OUTLIER -137.24 69.09 55.75 Favored Pre-proline 0 C--N 1.294 -1.817 0 N-CA-C 104.419 -2.437 . . . . 3.55 104.419 -178.869 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.435 ' HA ' ' O ' ' A' ' 65' ' ' GLY . 55.7 Cg_endo -71.71 91.56 0.7 Allowed 'Trans proline' 0 N--CA 1.446 -1.296 0 C-N-CA 122.858 2.372 . . . . 1.54 115.055 -176.354 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 3.2 p -104.43 -172.32 2.08 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 113.2 -1.818 . . . . 1.59 107.03 176.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 52.21 -166.07 1.14 Allowed Glycine 0 C--N 1.329 0.148 0 C-N-CA 118.52 -1.8 . . . . 2.43 112.258 177.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 8.0 t -73.23 66.51 0.89 Allowed 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 120.33 -0.548 . . . . 4.11 110.967 -179.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 84.18 8.47 83.68 Favored Glycine 0 N--CA 1.436 -1.309 0 CA-C-O 117.752 -1.582 . . . . 2.21 116.592 178.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 1.039 ' HA3' ' HA ' ' A' ' 74' ' ' CYS . . . -100.29 137.33 13.2 Favored Glycine 0 N--CA 1.438 -1.192 0 CA-C-N 122.553 3.177 . . . . 1.62 114.058 -177.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.468 ' O ' ' N ' ' A' ' 74' ' ' CYS . 0.0 OUTLIER -99.66 153.03 19.4 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 114.046 -1.077 . . . . 3.02 112.515 -178.4 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.682 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 44.4 t -51.75 108.62 0.29 Allowed 'General case' 0 N--CA 1.428 -1.56 0 CA-C-N 115.764 -0.653 . . . . 1.52 110.918 -179.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.414 ' O ' ' CZ ' ' A' ' 22' ' ' PHE . . . -99.55 -33.51 10.62 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.929 -0.767 . . . . 1.07 108.929 178.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.786 ' HB1' ' O ' ' A' ' 29' ' ' GLY . . . -159.93 165.32 32.35 Favored 'General case' 0 CA--C 1.495 -1.158 0 C-N-CA 119.428 -0.909 . . . . 1.0 112.432 -178.155 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.798 ' HA ' ' O ' ' A' ' 85' ' ' CYS . . . -37.29 97.4 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.1 -0.955 . . . . 1.24 110.444 -178.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.633 ' HA2' ' O ' ' A' ' 82' ' ' ASP . . . 93.56 -12.58 69.28 Favored Glycine 0 N--CA 1.437 -1.264 0 CA-C-N 114.81 -1.086 . . . . 1.28 114.43 179.293 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.87 HG13 ' HB2' ' A' ' 34' ' ' CYS . 1.7 mm -93.56 124.72 46.1 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.04 0 CA-C-N 119.391 1.596 . . . . 2.27 110.8 -175.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.615 ' HB2' ' HB3' ' A' ' 82' ' ' ASP . 20.6 t -120.79 92.45 3.77 Favored 'General case' 0 N--CA 1.426 -1.658 0 CA-C-N 113.89 -1.504 . . . . 1.98 109.274 -179.313 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 1.044 ' CB ' ' HA ' ' A' ' 79' ' ' CYS . 6.0 p -159.9 -175.89 5.38 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 116.105 1.891 . . . . 1.33 116.105 -177.001 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.852 ' HB2' ' HD2' ' A' ' 76' ' ' PRO . 5.8 p -122.61 -179.9 0.88 Allowed Pre-proline 0 N--CA 1.454 -0.253 0 CA-C-N 113.098 -1.865 . . . . 1.99 108.926 -179.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.852 ' HD2' ' HB2' ' A' ' 75' ' ' SER . 56.2 Cg_endo -72.45 31.38 0.28 Allowed 'Trans proline' 0 CA--C 1.534 0.523 0 C-N-CA 121.671 1.581 . . . . 1.86 113.292 -179.219 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.445 ' OD1' ' N ' ' A' ' 78' ' ' GLY . 1.1 p30 -134.49 -59.97 0.8 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 120.714 0.292 . . . . 2.65 110.397 178.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.932 ' O ' ' HB2' ' A' ' 74' ' ' CYS . . . -124.61 -175.15 14.22 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.507 -0.854 . . . . 0.99 111.74 178.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 1.044 ' HA ' ' CB ' ' A' ' 74' ' ' CYS . 14.1 m -149.44 160.34 43.53 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 117.535 0.668 . . . . 1.34 111.929 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.429 ' HA ' ' HA2' ' B' ' 178' ' ' GLY . 72.5 m80 -149.51 139.8 22.28 Favored 'General case' 0 C--N 1.349 0.585 0 O-C-N 121.714 -0.616 . . . . 2.17 111.879 -178.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -64.72 126.02 26.62 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.921 -0.582 . . . . 3.05 109.725 178.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.633 ' O ' ' HA2' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -139.94 107.51 6.91 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-O 120.864 0.364 . . . . 2.02 111.226 -179.213 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_exo -62.78 -24.09 74.52 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.04 2.493 . . . . 1.93 114.333 -178.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.36 -10.82 27.01 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.979 0.363 . . . . 1.53 111.979 -179.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.798 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 3.8 m -128.18 9.25 6.18 Favored 'General case' 0 C--O 1.215 -0.738 0 CA-C-O 119.053 -0.499 . . . . 1.88 111.321 179.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.597 ' O ' ' HB1' ' A' ' 70' ' ' ALA . 0.5 OUTLIER -72.35 -58.05 3.27 Favored Pre-proline 0 C--N 1.322 -0.595 0 C-N-CA 119.113 -1.035 . . . . 3.6 112.692 -176.512 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.506 ' HD3' ' CB ' ' A' ' 86' ' ' ASP . 44.6 Cg_endo -114.69 -171.53 0.02 OUTLIER 'Trans proline' 0 N--CA 1.436 -1.876 0 C-N-CA 123.196 2.597 . . . . 2.56 113.487 -176.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.474 ' C ' ' H ' ' A' ' 90' ' ' ALA . 5.9 pt-20 -69.79 75.15 0.44 Allowed 'General case' 0 N--CA 1.426 -1.63 0 CA-C-N 112.783 -2.008 . . . . 4.72 108.824 177.246 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -76.03 48.57 0.5 Allowed 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 104.546 -2.391 . . . . 5.29 104.546 174.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.474 ' H ' ' C ' ' A' ' 88' ' ' GLU . . . -64.84 134.33 53.83 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 115.138 1.533 . . . . 6.98 115.138 -172.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -89.73 96.25 10.61 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.532 -0.467 . . . . 10.21 110.962 178.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.2 t . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.241 -0.885 . . . . 11.77 110.918 179.782 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 120.783 0.325 . . . . 10.07 111.137 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 102' ' ' VAL . . . . . 0.507 ' O ' HG13 ' B' ' 102' ' ' VAL . 13.8 p -102.24 88.04 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.311 0 CA-C-O 123.204 1.478 . . . . 8.41 114.531 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 103' ' ' LEU . . . . . 0.846 ' H ' HD22 ' B' ' 103' ' ' LEU . 0.0 OUTLIER -100.55 83.41 2.6 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 111.21 -2.723 . . . . 5.87 112.418 175.371 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 104' ' ' ASP . . . . . 0.602 ' O ' ' HB2' ' B' ' 155' ' ' GLN . 2.9 m-20 -139.61 -178.3 5.34 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 105.911 -1.885 . . . . 6.27 105.911 173.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . 1.082 HD13 ' HB3' ' B' ' 155' ' ' GLN . 0.1 OUTLIER -80.37 12.21 3.12 Favored 'General case' 0 CA--C 1.504 -0.805 0 CA-C-O 121.754 0.788 . . . . 7.2 111.42 -179.694 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 106' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.0 -91.42 0.04 OUTLIER 'General case' 0 CA--C 1.492 -1.279 0 N-CA-C 101.029 -3.693 . . . . 8.55 101.029 175.485 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 107' ' ' VAL . . . . . 0.93 ' HA ' ' HB2' ' B' ' 156' ' ' SER . 2.3 p -147.11 116.19 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.468 -2.176 0 N-CA-C 104.736 -2.32 . . . . 7.48 104.736 173.415 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 108' ' ' ARG . . . . . 0.858 ' HG2' ' HA ' ' B' ' 154' ' ' CYS . 9.9 tpt180 -77.05 116.5 17.76 Favored 'General case' 0 CA--C 1.464 -2.33 0 C-N-CA 119.232 -0.987 . . . . 9.12 108.852 -177.363 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 109' ' ' THR . . . . . 0.531 ' O ' ' HD2' ' B' ' 108' ' ' ARG . 2.8 t -64.4 108.52 1.65 Allowed 'General case' 0 N--CA 1.423 -1.782 0 C-N-CA 114.097 -3.041 . . . . 5.69 103.145 175.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 110' ' ' CYS . . . . . 0.737 ' HB3' ' HB3' ' B' ' 120' ' ' ARG . 0.0 OUTLIER -69.28 111.71 5.38 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 114.479 -1.237 . . . . 2.61 111.883 -177.243 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 111' ' ' LEU . . . . . 0.481 ' C ' ' O ' ' B' ' 110' ' ' CYS . 5.4 tp -26.74 129.49 0.18 Allowed Pre-proline 0 CA--C 1.54 0.558 0 N-CA-C 112.209 0.448 . . . . 2.47 112.209 -179.333 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 112' ' ' PRO . . . . . 0.873 ' HA ' ' O ' ' B' ' 119' ' ' GLY . 30.3 Cg_endo -61.43 158.47 35.96 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 124.672 3.581 . . . . 1.47 112.974 179.579 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.623 ' SG ' ' N ' ' B' ' 114' ' ' GLY . 0.0 OUTLIER -168.83 -171.55 1.39 Allowed 'General case' 0 N--CA 1.497 1.907 0 C-N-CA 118.977 -1.089 . . . . 1.0 111.272 170.939 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 114' ' ' GLY . . . . . 0.885 ' HA2' ' HB3' ' B' ' 140' ' ' GLU . . . 77.35 -159.34 48.55 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 120.289 -0.958 . . . . 1.16 115.249 178.201 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 115' ' ' PRO . . . . . 0.627 ' CG ' HD21 ' B' ' 132' ' ' LEU . 96.4 Cg_endo -62.36 96.15 0.15 Allowed 'Trans proline' 0 C--N 1.355 0.885 0 C-N-CA 124.238 3.292 . . . . 1.57 115.398 -178.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 85.76 -0.83 88.1 Favored Glycine 0 C--N 1.285 -2.296 0 CA-C-N 110.573 -3.012 . . . . 1.7 112.197 -177.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 117' ' ' GLY . . . . . 0.519 ' O ' ' HB2' ' B' ' 112' ' ' PRO . . . 73.69 35.9 54.35 Favored Glycine 0 N--CA 1.425 -2.035 0 C-N-CA 120.171 -1.014 . . . . 1.38 112.858 176.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 118' ' ' LYS . . . . . 0.548 ' HB2' HD12 ' B' ' 132' ' ' LEU . 0.6 OUTLIER -87.55 -33.77 18.81 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 114.207 -0.997 . . . . 2.54 112.052 -179.629 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 119' ' ' GLY . . . . . 0.873 ' O ' ' HA ' ' B' ' 112' ' ' PRO . . . -79.67 -164.58 29.21 Favored Glycine 0 CA--C 1.497 -1.063 0 CA-C-O 118.631 -1.094 . . . . 1.04 111.521 -179.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.737 ' HB3' ' HB3' ' B' ' 110' ' ' CYS . 2.3 mtt85 -133.09 172.91 12.01 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 119.736 1.768 . . . . 2.89 106.961 176.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 121' ' ' CYS . . . . . . . . . . . . . 2.6 m -106.16 146.77 29.83 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 118.548 0.613 . . . . 1.07 111.532 -178.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 122' ' ' PHE . . . . . 0.507 ' HE1' ' O ' ' B' ' 128' ' ' CYS . 75.9 m-85 -142.91 22.14 1.94 Allowed 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.687 -0.688 . . . . 1.53 111.778 -179.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 123' ' ' GLY . . . . . 0.851 ' O ' ' HB3' ' B' ' 144' ' ' CYS . . . 174.05 -169.53 42.57 Favored Glycine 0 C--O 1.225 -0.465 0 C-N-CA 120.783 -0.723 . . . . 0.9 111.468 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -81.1 -54.33 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.494 2.129 . . . . 1.51 112.272 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 125' ' ' SER . . . . . 0.605 ' O ' ' N ' ' B' ' 137' ' ' GLY . 0.3 OUTLIER -106.39 12.25 29.97 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.264 -0.425 . . . . 1.25 111.39 -179.878 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 126' ' ' ILE . . . . . 0.814 HG22 ' SG ' ' B' ' 134' ' ' CYS . 1.5 mt -121.73 122.38 66.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 113.088 0.773 . . . . 0.85 113.088 -177.289 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 127' ' ' CYS . . . . . 0.687 ' HB3' ' CD2' ' B' ' 135' ' ' PHE . 4.5 t -131.06 117.66 19.45 Favored 'General case' 0 CA--C 1.522 -0.107 0 CA-C-O 122.542 1.163 . . . . 0.89 111.585 178.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 128' ' ' CYS . . . . . 1.104 ' HA ' ' O ' ' B' ' 133' ' ' GLY . 0.0 OUTLIER -130.62 135.93 48.36 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 112.96 -1.927 . . . . 1.23 112.415 -178.559 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 129' ' ' GLY . . . . . 0.798 ' O ' ' HB1' ' B' ' 169' ' ' ALA . . . -130.41 -161.6 10.44 Favored Glycine 0 N--CA 1.42 -2.413 0 N-CA-C 105.119 -3.193 . . . . 0.66 105.119 177.383 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 130' ' ' ASP . . . . . 0.437 ' O ' ' HB3' ' B' ' 170' ' ' ALA . 14.5 p-10 -68.71 -70.99 0.23 Allowed 'General case' 0 C--N 1.289 -2.06 0 C-N-CA 119.199 -1.001 . . . . 2.35 112.69 -178.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.94 32.53 3.15 Favored 'General case' 0 CA--C 1.49 -1.346 0 CA-C-O 122.085 0.945 . . . . 1.69 110.1 -177.232 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 132' ' ' LEU . . . . . 0.739 HD22 ' CZ ' ' B' ' 135' ' ' PHE . 0.8 OUTLIER -127.45 -16.9 4.77 Favored 'General case' 0 N--CA 1.399 -3.01 0 CA-C-N 113.788 -1.551 . . . . 1.38 106.869 177.075 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 133' ' ' GLY . . . . . 1.104 ' O ' ' HA ' ' B' ' 128' ' ' CYS . . . 58.93 -134.55 52.43 Favored Glycine 0 N--CA 1.402 -3.587 0 CA-C-N 114.372 -1.285 . . . . 0.72 112.529 177.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 134' ' ' CYS . . . . . 0.845 ' HB2' HG13 ' B' ' 172' ' ' ILE . 5.2 t -135.25 119.79 18.11 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 116.15 1.907 . . . . 1.08 116.15 -176.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 135' ' ' PHE . . . . . 1.026 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -94.74 107.58 19.59 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 106.524 -1.658 . . . . 1.36 106.524 176.385 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 136' ' ' VAL . . . . . 0.833 HG23 HG23 ' A' ' 36' ' ' VAL . 2.4 t -94.3 83.56 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.642 0 N-CA-C 107.814 -1.18 . . . . 0.75 107.814 179.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 137' ' ' GLY . . . . . 0.605 ' N ' ' O ' ' B' ' 125' ' ' SER . . . 105.5 102.9 2.83 Favored Glycine 0 CA--C 1.523 0.59 0 CA-C-N 113.637 -1.62 . . . . 0.83 113.944 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 138' ' ' THR . . . . . 0.567 ' HB ' ' O ' ' A' ' 32' ' ' LEU . 0.2 OUTLIER -179.96 165.7 1.24 Allowed 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 107.905 -1.146 . . . . 0.78 107.905 179.131 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 139' ' ' ALA . . . . . 0.856 ' HA ' HD12 ' B' ' 142' ' ' LEU . . . -68.98 -36.97 78.47 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 119.075 0.852 . . . . 1.04 110.225 179.349 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 140' ' ' GLU . . . . . 0.885 ' HB3' ' HA2' ' B' ' 114' ' ' GLY . 0.5 OUTLIER -56.87 -13.7 2.85 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.009 -0.541 . . . . 2.31 111.064 179.83 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 141' ' ' ALA . . . . . 0.723 ' O ' ' HB2' ' B' ' 144' ' ' CYS . . . -101.72 -21.81 14.55 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 116.236 -0.438 . . . . 0.87 109.942 178.351 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 142' ' ' LEU . . . . . 0.856 HD12 ' HA ' ' B' ' 139' ' ' ALA . 0.6 OUTLIER -45.04 -38.06 4.61 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.626 0.602 . . . . 1.24 112.626 -178.483 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 143' ' ' ARG . . . . . 0.578 ' HD2' ' H ' ' B' ' 143' ' ' ARG . 0.0 OUTLIER -54.13 -29.46 45.28 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 107.136 -1.431 . . . . 2.93 107.136 177.148 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 144' ' ' CYS . . . . . 0.851 ' HB3' ' O ' ' B' ' 123' ' ' GLY . 39.8 m -57.15 -4.77 0.21 Allowed 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 113.776 -1.556 . . . . 1.61 110.441 -177.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 145' ' ' GLN . . . . . 0.43 ' HB2' ' O ' ' B' ' 142' ' ' LEU . 0.0 OUTLIER -79.32 -19.31 50.66 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-O 121.255 0.55 . . . . 3.35 111.208 177.584 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -85.81 10.11 14.66 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 119.998 -0.681 . . . . 3.76 110.436 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -81.01 2.75 25.65 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 108.852 -0.795 . . . . 4.01 108.852 177.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 148' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -94.83 -28.83 15.04 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 116.354 -0.384 . . . . 3.92 110.098 178.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -105.09 30.21 5.76 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.379 -0.373 . . . . 5.73 111.052 179.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -124.3 131.78 24.23 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.623 -0.262 . . . . 5.46 111.47 -179.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 151' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.01 13.04 1.58 Allowed 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.72 2.28 . . . . 5.02 113.094 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 35.6 p -103.77 105.87 49.9 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-O 120.531 0.205 . . . . 5.73 110.655 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 153' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -88.18 -4.51 6.82 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.924 2.416 . . . . 5.1 112.963 -179.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 154' ' ' CYS . . . . . 0.858 ' HA ' ' HG2' ' B' ' 108' ' ' ARG . 1.8 t 63.33 96.32 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.758 -0.201 . . . . 2.68 111.454 179.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 155' ' ' GLN . . . . . 1.082 ' HB3' HD13 ' B' ' 105' ' ' LEU . 19.0 mm100 -102.23 71.37 1.24 Allowed 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 119.286 -0.966 . . . . 5.63 111.952 -179.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 156' ' ' SER . . . . . 0.93 ' HB2' ' HA ' ' B' ' 107' ' ' VAL . 1.3 t 174.05 76.57 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.773 -0.649 . . . . 3.11 111.205 179.61 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 165.12 44.52 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 109.085 -1.606 . . . . 2.07 109.085 -179.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -118.74 71.9 0.86 Allowed 'General case' 0 N--CA 1.441 -0.919 0 CA-C-O 122.398 1.094 . . . . 4.34 110.724 -179.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 159' ' ' LYS . . . . . 0.579 ' HB3' ' HB2' ' B' ' 167' ' ' CYS . 0.0 OUTLIER -107.81 66.12 0.26 Allowed Pre-proline 0 C--N 1.31 -1.123 0 CA-C-N 113.202 -1.817 . . . . 3.54 108.486 174.33 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 160' ' ' PRO . . . . . 0.404 ' HA ' ' O ' ' B' ' 165' ' ' GLY . 54.0 Cg_endo -71.4 92.26 0.67 Allowed 'Trans proline' 0 N--CA 1.464 -0.25 0 N-CA-C 116.17 1.565 . . . . 1.51 116.17 -174.077 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 161' ' ' CYS . . . . . . . . . . . . . 1.9 p -99.34 -166.91 1.4 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 113.173 -1.831 . . . . 1.58 108.32 176.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 45.35 -165.03 0.06 OUTLIER Glycine 0 CA--C 1.52 0.356 0 C-N-CA 119.135 -1.507 . . . . 2.37 112.181 173.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 8.1 t -73.11 66.89 0.87 Allowed 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 117.364 0.582 . . . . 4.07 111.496 -179.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 84.46 9.12 82.22 Favored Glycine 0 CA--C 1.541 1.67 0 CA-C-O 117.94 -1.478 . . . . 2.2 116.132 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 165' ' ' GLY . . . . . 0.943 ' HA3' ' HA ' ' B' ' 174' ' ' CYS . . . -96.98 131.25 10.54 Favored Glycine 0 C--N 1.301 -1.383 0 C-N-CA 117.177 -2.439 . . . . 1.62 114.151 -176.238 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 166' ' ' ARG . . . . . 0.428 ' HA ' ' O ' ' B' ' 159' ' ' LYS . 0.0 OUTLIER -100.03 152.41 20.24 Favored 'General case' 0 C--N 1.349 0.551 0 N-CA-C 112.186 0.439 . . . . 3.05 112.186 -179.151 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 167' ' ' CYS . . . . . 0.691 ' HA ' ' O ' ' B' ' 172' ' ' ILE . 46.7 t -51.84 108.77 0.3 Allowed 'General case' 0 N--CA 1.431 -1.425 0 CA-C-N 115.905 -0.589 . . . . 1.56 111.05 -179.282 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 168' ' ' ALA . . . . . 0.401 ' O ' ' CZ ' ' B' ' 122' ' ' PHE . . . -101.33 -30.16 11.64 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.771 -0.649 . . . . 1.04 109.528 178.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 169' ' ' ALA . . . . . 0.812 ' HB2' ' HB2' ' B' ' 128' ' ' CYS . . . -162.31 165.1 27.05 Favored 'General case' 0 CA--C 1.492 -1.258 0 C-N-CA 119.488 -0.885 . . . . 0.98 112.42 -179.271 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 170' ' ' ALA . . . . . 0.788 ' HA ' ' O ' ' B' ' 185' ' ' CYS . . . -36.52 95.98 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.047 -0.979 . . . . 1.25 110.851 -179.106 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 171' ' ' GLY . . . . . 0.692 ' HA2' ' O ' ' B' ' 182' ' ' ASP . . . 88.52 -1.82 84.3 Favored Glycine 0 CA--C 1.525 0.677 0 CA-C-N 114.923 -1.035 . . . . 1.29 115.11 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 172' ' ' ILE . . . . . 0.845 HG13 ' HB2' ' B' ' 134' ' ' CYS . 1.8 mm -96.65 122.24 47.96 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.093 0 CA-C-N 117.865 0.832 . . . . 2.27 110.535 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 173' ' ' CYS . . . . . 0.631 ' HB2' ' HB3' ' B' ' 182' ' ' ASP . 21.6 t -120.89 92.21 3.71 Favored 'General case' 0 N--CA 1.428 -1.561 0 CA-C-N 114.561 -1.2 . . . . 1.94 109.399 -179.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 174' ' ' CYS . . . . . 1.031 ' CB ' ' HA ' ' B' ' 179' ' ' CYS . 5.9 p -160.08 -175.76 5.27 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 116.033 1.864 . . . . 1.35 116.033 -176.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 175' ' ' SER . . . . . 0.851 ' HB2' ' HD2' ' B' ' 176' ' ' PRO . 6.0 p -122.68 -179.89 0.88 Allowed Pre-proline 0 N--CA 1.454 -0.25 0 CA-C-N 113.087 -1.869 . . . . 2.0 108.931 -179.569 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 176' ' ' PRO . . . . . 0.851 ' HD2' ' HB2' ' B' ' 175' ' ' SER . 55.9 Cg_endo -72.38 31.31 0.27 Allowed 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 121.699 1.599 . . . . 1.9 113.292 -179.138 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 177' ' ' ASP . . . . . 0.437 ' OD1' ' N ' ' B' ' 178' ' ' GLY . 1.1 p30 -134.58 -60.02 0.8 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.643 -0.253 . . . . 2.72 110.371 178.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 178' ' ' GLY . . . . . 0.916 ' O ' ' HB2' ' B' ' 174' ' ' CYS . . . -124.51 -175.12 14.22 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.503 -0.856 . . . . 0.99 111.683 178.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 179' ' ' CYS . . . . . 1.031 ' HA ' ' CB ' ' B' ' 174' ' ' CYS . 14.0 m -149.41 160.44 43.43 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 117.526 0.663 . . . . 1.34 111.958 179.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 180' ' ' HIS . . . . . 0.48 ' HA ' ' HA2' ' A' ' 78' ' ' GLY . 72.5 m80 -149.56 139.77 22.2 Favored 'General case' 0 C--N 1.35 0.612 0 C-N-CA 120.232 -0.587 . . . . 2.1 111.819 -178.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 181' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -64.78 125.89 26.22 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.968 -0.56 . . . . 3.06 109.693 178.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 182' ' ' ASP . . . . . 0.692 ' O ' ' HA2' ' B' ' 171' ' ' GLY . 0.0 OUTLIER -139.74 107.59 7.03 Favored Pre-proline 0 CA--C 1.541 0.634 0 CA-C-O 120.85 0.357 . . . . 2.06 111.236 -179.267 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 183' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_exo -62.79 -24.19 74.51 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 123.061 2.507 . . . . 1.91 114.384 -178.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -64.29 -10.52 24.45 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.102 0.408 . . . . 1.56 112.102 -179.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 185' ' ' CYS . . . . . 0.788 ' O ' ' HA ' ' B' ' 170' ' ' ALA . 1.6 m -129.1 10.03 5.8 Favored 'General case' 0 C--O 1.214 -0.784 0 CA-C-O 119.243 -0.408 . . . . 1.94 111.078 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 186' ' ' ASP . . . . . 0.549 ' O ' ' HB1' ' B' ' 170' ' ' ALA . 0.5 OUTLIER -73.48 -57.74 2.57 Favored Pre-proline 0 CA--C 1.511 -0.534 0 C-N-CA 119.186 -1.006 . . . . 3.61 112.511 -176.588 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 187' ' ' PRO . . . . . 0.498 ' HD3' ' CB ' ' B' ' 186' ' ' ASP . 95.9 Cg_endo -108.38 -166.63 0.03 OUTLIER 'Trans proline' 0 N--CA 1.428 -2.341 0 C-N-CA 122.967 2.445 . . . . 2.58 113.824 -177.033 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 188' ' ' GLU . . . . . 0.496 ' C ' ' H ' ' B' ' 190' ' ' ALA . 6.1 pt-20 -74.77 72.38 2.02 Favored 'General case' 0 N--CA 1.414 -2.266 0 CA-C-N 111.359 -2.655 . . . . 4.7 109.255 173.187 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 189' ' ' ALA . . . . . . . . . . . . . . . -75.31 47.71 0.39 Allowed 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 107.279 -1.378 . . . . 5.24 107.279 175.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 190' ' ' ALA . . . . . 0.496 ' H ' ' C ' ' B' ' 188' ' ' GLU . . . -58.47 134.78 56.97 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 113.096 -1.866 . . . . 6.93 113.94 -172.051 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 191' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -89.93 96.45 10.68 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 120.707 -0.397 . . . . 10.14 110.707 178.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 1.2 t . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.252 -0.88 . . . . 11.7 111.01 179.798 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.709 ' O ' HG13 ' A' ' 2' ' ' VAL . . . . . . . . 0 N--CA 1.496 1.855 0 N-CA-C 112.236 0.458 . . . . 9.95 112.236 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.709 HG13 ' O ' ' A' ' 1' ' ' ALA . 0.0 OUTLIER -172.97 171.75 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-O 121.606 0.717 . . . . 8.02 110.521 179.358 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 1.043 ' HG ' ' HG3' ' A' ' 8' ' ' ARG . 3.6 mm? -79.65 144.85 33.38 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 114.962 -1.017 . . . . 5.86 110.225 179.127 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.6 69.42 1.22 Allowed 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 105.269 -2.123 . . . . 6.22 105.269 175.906 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.922 HD12 ' HA ' ' A' ' 54' ' ' CYS . 0.8 OUTLIER -155.93 -146.98 0.19 Allowed 'General case' 0 N--CA 1.389 -3.5 0 CA-C-N 109.941 -3.3 . . . . 7.09 104.873 177.478 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.495 ' H ' ' CD2' ' A' ' 5' ' ' LEU . 6.3 t70 -153.23 -8.76 0.17 Allowed 'General case' 0 CA--C 1.587 2.388 0 CA-C-O 123.179 1.466 . . . . 8.78 112.61 178.954 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.746 ' O ' HD13 ' A' ' 5' ' ' LEU . 8.1 m -154.66 126.3 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.402 -2.866 0 C-N-CA 130.603 3.561 . . . . 7.51 103.833 173.634 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 1.043 ' HG3' ' HG ' ' A' ' 3' ' ' LEU . 0.7 OUTLIER -76.1 109.21 9.57 Favored 'General case' 0 N--CA 1.391 -3.417 0 N-CA-C 105.928 -1.878 . . . . 9.08 105.928 179.121 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.877 ' OG1' HD21 ' A' ' 50' ' ' LEU . 0.7 OUTLIER -106.9 98.06 7.77 Favored 'General case' 0 N--CA 1.392 -3.362 0 N-CA-C 101.882 -3.377 . . . . 5.66 101.882 171.491 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 62.7 m -79.79 60.97 3.59 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 114.278 -1.328 . . . . 2.68 112.719 -179.721 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.888 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 4.2 mp -31.22 135.31 0.23 Allowed Pre-proline 0 N--CA 1.483 1.192 0 N-CA-C 113.598 0.962 . . . . 2.48 113.598 -178.679 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.402 ' HG2' ' CG ' ' A' ' 43' ' ' ARG . 30.8 Cg_endo -97.47 114.72 0.11 Allowed 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 123.439 2.759 . . . . 1.49 116.251 -178.632 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.528 ' O ' ' HA2' ' A' ' 17' ' ' GLY . 0.5 OUTLIER -127.59 -176.32 3.72 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-O 121.823 0.82 . . . . 1.0 111.46 -178.463 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.404 ' CA ' ' HB2' ' A' ' 40' ' ' GLU . . . 74.17 -178.26 44.32 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 114.524 -1.217 . . . . 1.15 110.438 -178.37 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.473 ' HG2' ' O ' ' A' ' 15' ' ' PRO . 47.3 Cg_endo -63.28 130.92 30.16 Favored 'Trans proline' 0 CA--C 1.507 -0.851 0 N-CA-C 106.317 -2.224 . . . . 1.57 106.317 175.464 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 72.34 -4.16 20.49 Favored Glycine 0 N--CA 1.414 -2.832 0 CA-C-O 119.247 -0.752 . . . . 1.68 113.459 177.07 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.528 ' HA2' ' O ' ' A' ' 13' ' ' CYS . . . 76.53 38.44 32.74 Favored Glycine 1 N--CA 1.391 -4.347 0 C-N-CA 119.121 -1.514 . . . . 1.36 112.189 -178.747 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.42 ' CG ' ' O ' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -97.72 22.0 9.67 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.317 -0.442 . . . . 2.5 110.261 174.439 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -129.58 -175.46 14.05 Favored Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 104.912 -3.275 . . . . 1.02 104.912 177.846 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.724 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 2.7 mtp180 -119.3 159.73 23.58 Favored 'General case' 0 CA--C 1.552 1.045 0 CA-C-N 121.323 2.562 . . . . 2.92 108.444 176.708 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.888 ' HB2' ' HB3' ' A' ' 11' ' ' LEU . 10.7 m -109.09 148.9 30.11 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 119.881 1.219 . . . . 1.1 111.435 -179.742 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -128.38 -52.4 1.28 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.085 -0.507 . . . . 1.51 111.36 179.989 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.431 ' O ' ' HB3' ' A' ' 44' ' ' CYS . . . -119.84 -171.3 14.65 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.935 -0.65 . . . . 0.9 112.26 -179.816 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -68.79 -61.21 0.07 OUTLIER 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.635 2.223 . . . . 1.5 112.755 -179.693 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.609 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.4 OUTLIER -98.15 26.87 4.97 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.822 -0.172 . . . . 1.26 110.749 -179.999 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 1.033 HG12 HG13 ' A' ' 36' ' ' VAL . 3.3 mt -141.37 120.58 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 N-CA-C 113.542 0.941 . . . . 0.83 113.542 -178.307 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.789 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -120.43 140.25 51.65 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 107.653 -1.239 . . . . 0.92 107.653 178.188 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 1.016 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -143.96 100.1 3.51 Favored 'General case' 0 CA--C 1.552 1.05 0 N-CA-C 117.686 2.476 . . . . 1.28 117.686 -174.907 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -101.48 -172.48 28.25 Favored Glycine 0 N--CA 1.431 -1.687 0 N-CA-C 108.423 -1.871 . . . . 0.67 108.423 176.49 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -64.98 -62.75 1.37 Allowed 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 121.338 0.59 . . . . 2.27 112.268 -179.255 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.1 14.69 28.82 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 122.196 0.998 . . . . 1.66 111.365 -177.931 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.735 HD22 ' CE2' ' A' ' 35' ' ' PHE . 4.6 mt -115.88 -5.03 12.04 Favored 'General case' 0 N--CA 1.387 -3.593 0 N-CA-C 104.895 -2.261 . . . . 1.37 104.895 179.063 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 1.016 ' O ' ' HA ' ' A' ' 28' ' ' CYS . . . 43.7 -126.73 5.77 Favored Glycine 0 N--CA 1.432 -1.609 0 CA-C-N 114.243 -1.344 . . . . 0.73 113.918 175.941 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 1.023 ' HB2' HD13 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -132.52 107.95 8.79 Favored 'General case' 0 CA--C 1.49 -1.329 0 CA-C-N 118.008 0.904 . . . . 1.08 113.362 -179.365 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.922 ' HD1' ' HD1' ' B' ' 135' ' ' PHE . 84.7 m-85 -83.06 105.98 14.49 Favored 'General case' 0 N--CA 1.42 -1.93 0 N-CA-C 102.32 -3.215 . . . . 1.38 102.32 174.686 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 1.033 HG13 HG12 ' A' ' 26' ' ' ILE . 3.0 t -97.77 85.27 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.664 0 CA-C-O 123.036 1.398 . . . . 0.76 109.374 -176.992 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.609 ' N ' ' O ' ' A' ' 25' ' ' SER . . . 97.68 89.4 1.9 Allowed Glycine 0 CA--C 1.527 0.842 0 CA-C-N 112.492 -2.14 . . . . 0.81 115.45 178.621 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.684 HG21 ' CE1' ' B' ' 135' ' ' PHE . 0.5 OUTLIER -176.62 168.17 2.64 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 108.603 -0.888 . . . . 0.77 108.603 177.964 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.837 ' HA ' HD12 ' A' ' 42' ' ' LEU . . . -53.54 -26.79 22.65 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 115.781 1.771 . . . . 1.02 115.781 -176.648 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.646 ' OE1' HG23 ' A' ' 38' ' ' THR . 0.0 OUTLIER -66.33 -15.91 63.63 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 119.226 -0.99 . . . . 2.32 109.634 178.545 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.634 ' O ' ' N ' ' A' ' 44' ' ' CYS . . . -88.42 -24.05 23.15 Favored 'General case' 0 N--CA 1.425 -1.693 0 CA-C-O 119.283 -0.389 . . . . 0.87 111.026 -178.979 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.837 HD12 ' HA ' ' A' ' 39' ' ' ALA . 0.4 OUTLIER -44.5 -40.0 5.27 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 119.229 0.922 . . . . 1.23 112.197 179.873 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.412 ' HD3' ' HA ' ' A' ' 43' ' ' ARG . 10.8 tpp85 -64.48 -11.16 30.83 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.708 0.766 . . . . 2.92 109.748 177.713 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.634 ' N ' ' O ' ' A' ' 41' ' ' ALA . 88.8 m -73.61 -8.31 55.46 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 113.763 -1.562 . . . . 1.57 110.728 176.795 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -76.38 -6.73 52.92 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.071 0.397 . . . . 3.31 112.071 179.382 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.579 ' HG3' ' HE1' ' A' ' 49' ' ' TYR . 0.4 OUTLIER -86.44 3.87 42.0 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.254 -0.579 . . . . 3.69 111.114 -178.926 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.624 ' HG2' ' O ' ' A' ' 44' ' ' CYS . 12.6 pt-20 -83.79 1.81 41.14 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 109.592 -0.521 . . . . 3.99 109.592 177.203 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -71.79 -28.94 63.95 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 109.393 -0.595 . . . . 3.86 109.393 178.135 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.579 ' HE1' ' HG3' ' A' ' 46' ' ' GLU . 6.0 p90 -117.21 25.01 10.77 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.975 0.417 . . . . 5.68 110.997 179.603 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.877 HD21 ' OG1' ' A' ' 9' ' ' THR . 3.9 tt -127.05 142.59 44.16 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.906 -0.588 . . . . 5.4 111.512 -179.19 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.633 ' HD2' ' HG ' ' A' ' 50' ' ' LEU . 85.4 Cg_endo -84.8 50.82 3.02 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.71 2.273 . . . . 4.92 113.054 -179.98 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.573 ' HB2' ' O ' ' A' ' 51' ' ' PRO . 4.0 m 75.47 151.35 0.14 Allowed Pre-proline 0 N--CA 1.468 0.447 0 CA-C-N 116.231 -0.44 . . . . 5.64 111.716 179.737 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.614 ' HA ' ' O ' ' A' ' 9' ' ' THR . 43.9 Cg_endo -66.67 165.05 26.77 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.214 2.609 . . . . 5.04 113.306 -179.312 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.922 ' HA ' HD12 ' A' ' 5' ' ' LEU . 25.2 p -60.79 116.29 4.31 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.632 -0.713 . . . . 2.74 111.666 -179.631 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.479 ' CG ' HD13 ' A' ' 3' ' ' LEU . 12.8 pt20 42.43 -169.47 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 115.025 -0.989 . . . . 5.75 112.816 -179.67 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -169.77 178.88 3.9 Favored 'General case' 0 C--N 1.345 0.395 0 CA-C-O 120.757 0.313 . . . . 3.12 110.328 -179.458 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.573 ' O ' ' HB2' ' A' ' 66' ' ' ARG . . . -87.67 144.35 18.89 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 110.049 -1.22 . . . . 2.1 110.049 -176.868 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -101.62 74.83 1.54 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.859 0.838 . . . . 4.36 109.834 179.297 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.748 ' HB3' ' HB2' ' A' ' 67' ' ' CYS . 15.3 tppt? -144.28 57.33 4.8 Favored Pre-proline 0 C--N 1.308 -1.222 0 N-CA-C 106.686 -1.598 . . . . 3.55 106.686 178.072 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.45 ' CD ' ' N ' ' A' ' 59' ' ' LYS . 55.0 Cg_endo -69.1 84.79 0.54 Allowed 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 121.828 1.685 . . . . 1.54 114.343 -177.681 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.444 ' N ' ' O ' ' A' ' 65' ' ' GLY . 0.8 OUTLIER -104.41 -176.49 3.1 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 113.587 -1.642 . . . . 1.59 107.693 177.014 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 62.72 -165.95 23.54 Favored Glycine 0 CA--C 1.505 -0.592 0 C-N-CA 118.712 -1.709 . . . . 2.43 112.852 178.495 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -77.77 52.37 1.02 Allowed 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.635 -0.283 . . . . 4.11 111.49 -179.066 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 102.93 8.71 41.59 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-O 118.988 -0.895 . . . . 2.21 115.001 178.964 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.578 ' HA2' ' HA ' ' A' ' 75' ' ' SER . . . -102.84 138.8 14.14 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 118.575 -1.774 . . . . 1.62 115.38 -178.373 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.573 ' HB2' ' O ' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -102.38 154.34 19.17 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 114.285 -0.958 . . . . 3.02 110.534 179.014 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.748 ' HB2' ' HB3' ' A' ' 59' ' ' LYS . 5.5 t -56.31 109.22 0.57 Allowed 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 109.695 -0.483 . . . . 1.52 109.695 -179.108 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.576 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . . . -91.89 -17.73 24.81 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 107.898 -1.149 . . . . 1.07 107.898 178.773 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 1.06 ' HB3' HD11 ' A' ' 72' ' ' ILE . . . -165.64 156.4 13.53 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 112.946 -1.934 . . . . 1.0 109.262 179.943 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.818 ' O ' ' O ' ' A' ' 69' ' ' ALA . . . -18.11 -139.12 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 114.154 1.168 . . . . 1.24 114.154 -179.705 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.636 ' HA3' ' OD1' ' A' ' 86' ' ' ASP . . . -61.38 53.29 0.03 OUTLIER Glycine 0 N--CA 1.475 1.237 0 N-CA-C 111.387 -0.685 . . . . 1.28 111.387 -177.914 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 1.06 HD11 ' HB3' ' A' ' 69' ' ' ALA . 1.8 pp -151.94 97.96 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.257 1.49 0 CA-C-O 122.204 1.002 . . . . 2.27 109.095 168.804 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.6 ' HB3' ' HB3' ' A' ' 82' ' ' ASP . 0.9 OUTLIER -93.65 95.94 9.51 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.035 -0.984 . . . . 1.98 108.745 -178.872 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.81 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 16.5 m -92.65 162.35 14.2 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 114.512 1.301 . . . . 1.33 114.512 -176.182 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.796 ' HB2' ' HD2' ' A' ' 76' ' ' PRO . 58.6 p -125.16 179.42 1.13 Allowed Pre-proline 0 CA--C 1.531 0.224 0 CA-C-N 113.465 -1.698 . . . . 1.99 108.127 178.748 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.796 ' HD2' ' HB2' ' A' ' 75' ' ' SER . 71.9 Cg_endo -77.22 30.01 0.42 Allowed 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 121.304 1.336 . . . . 1.86 111.909 179.79 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.407 ' H ' ' C ' ' A' ' 75' ' ' SER . 1.6 t70 -145.92 -41.73 0.21 Allowed 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.652 -0.704 . . . . 2.65 110.887 179.971 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 1.247 ' HA3' ' O ' ' B' ' 179' ' ' CYS . . . -151.11 -141.63 3.38 Favored Glycine 0 C--N 1.337 0.591 0 C-N-CA 120.406 -0.902 . . . . 0.99 113.621 -179.815 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 1.214 ' O ' ' HA3' ' B' ' 178' ' ' GLY . 60.2 m -148.22 146.27 28.61 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 123.123 0.569 . . . . 1.34 110.486 -179.658 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.442 ' N ' ' O ' ' A' ' 73' ' ' CYS . 14.5 m80 -133.24 134.06 43.49 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 119.859 -0.737 . . . . 2.17 111.511 179.956 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.404 ' OE1' ' HG2' ' B' ' 124' ' ' PRO . 8.7 mt-10 -59.58 135.95 57.83 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 108.682 -0.858 . . . . 3.05 108.682 178.558 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.6 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 0.7 OUTLIER -142.96 128.97 10.36 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 116.395 -0.366 . . . . 2.02 110.998 -178.706 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 82' ' ' ASP . 15.2 Cg_exo -69.15 -31.29 23.56 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 123.212 2.608 . . . . 1.93 113.07 -179.198 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.62 -3.11 2.83 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.115 -0.493 . . . . 1.53 112.03 -179.705 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.672 ' HB3' ' C ' ' A' ' 70' ' ' ALA . 73.6 m -133.22 20.3 4.04 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 112.074 0.398 . . . . 1.88 112.074 -179.965 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.788 ' N ' ' HD3' ' A' ' 87' ' ' PRO . 16.8 m-20 -107.37 20.66 0.06 OUTLIER Pre-proline 0 N--CA 1.449 -0.509 0 N-CA-C 113.805 1.039 . . . . 3.6 113.805 179.854 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.788 ' HD3' ' N ' ' A' ' 86' ' ' ASP . 1.9 Cg_endo -77.78 65.7 8.18 Favored 'Trans proline' 0 CA--C 1.5 -1.218 0 N-CA-C 106.64 -2.1 . . . . 2.56 106.64 176.138 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.52 ' OE2' ' HB2' ' A' ' 70' ' ' ALA . 4.7 pt-20 177.25 -35.37 0.01 OUTLIER 'General case' 0 CA--C 1.473 -1.997 0 CA-C-N 113.283 -1.78 . . . . 4.72 108.842 -179.709 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.487 ' N ' ' HG3' ' A' ' 88' ' ' GLU . . . -77.36 38.43 0.23 Allowed 'General case' 0 C--N 1.354 0.769 0 CA-C-N 110.542 -3.026 . . . . 5.29 109.01 176.541 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.465 ' H ' ' C ' ' A' ' 88' ' ' GLU . . . -79.2 147.08 32.75 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 113.846 -1.525 . . . . 6.98 111.367 -179.092 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -63.05 127.66 32.27 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.422 0.63 . . . . 10.21 112.288 -175.418 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 6.2 t . . . . . 0 C--O 1.248 0.98 0 CA-C-N 114.898 -1.046 . . . . 11.77 110.554 179.863 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.465 0 N-CA-C 111.786 0.291 . . . . 10.07 111.786 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 1.2 t -163.47 153.85 2.7 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.283 0 CA-C-O 122.311 1.053 . . . . 8.41 111.265 -179.913 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 103' ' ' LEU . . . . . 0.681 ' HA ' ' HB3' ' B' ' 155' ' ' GLN . 0.7 OUTLIER -76.48 110.89 11.39 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 113.066 -1.879 . . . . 5.87 114.275 -178.241 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.59 76.02 5.1 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 122.813 1.292 . . . . 6.27 108.428 175.991 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . 0.924 HD12 ' O ' ' B' ' 107' ' ' VAL . 0.3 OUTLIER -156.18 -130.28 0.03 OUTLIER 'General case' 0 N--CA 1.391 -3.379 0 C-N-CA 128.181 2.592 . . . . 7.2 105.455 177.193 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 106' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -163.11 -44.35 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.052 -1.092 . . . . 8.55 108.052 -178.718 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 107' ' ' VAL . . . . . 0.924 ' O ' HD12 ' B' ' 105' ' ' LEU . 5.9 m -121.85 127.32 75.4 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.374 0 N-CA-C 102.731 -3.062 . . . . 7.48 102.731 171.439 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 108' ' ' ARG . . . . . 0.616 ' HG3' HD13 ' B' ' 103' ' ' LEU . 0.7 OUTLIER -75.07 111.64 10.5 Favored 'General case' 0 N--CA 1.391 -3.385 0 N-CA-C 106.029 -1.841 . . . . 9.12 106.029 179.148 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 109' ' ' THR . . . . . 0.792 ' HB ' HD11 ' B' ' 150' ' ' LEU . 0.7 OUTLIER -111.05 98.06 7.27 Favored 'General case' 0 N--CA 1.39 -3.449 0 N-CA-C 101.134 -3.654 . . . . 5.69 101.134 171.77 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 110' ' ' CYS . . . . . . . . . . . . . 64.4 m -81.9 66.86 7.66 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 113.599 -1.637 . . . . 2.61 111.498 -179.079 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 111' ' ' LEU . . . . . 0.865 ' HB3' ' HB2' ' B' ' 121' ' ' CYS . 4.6 mp -33.59 135.22 0.32 Allowed Pre-proline 0 N--CA 1.476 0.827 0 N-CA-C 113.576 0.954 . . . . 2.47 113.576 179.854 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 112' ' ' PRO . . . . . 0.439 ' HG2' ' CG ' ' B' ' 143' ' ' ARG . 41.7 Cg_endo -93.92 122.69 0.42 Allowed 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 123.557 2.838 . . . . 1.47 112.776 179.656 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.473 ' O ' ' HA2' ' B' ' 117' ' ' GLY . 0.4 OUTLIER -135.37 -177.35 4.62 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-O 122.398 1.094 . . . . 1.0 111.248 177.409 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 114' ' ' GLY . . . . . 0.403 ' CA ' ' HB2' ' B' ' 140' ' ' GLU . . . 73.98 -178.41 43.48 Favored Glycine 0 N--CA 1.439 -1.109 0 CA-C-N 113.589 -1.642 . . . . 1.16 110.204 -177.863 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 115' ' ' PRO . . . . . 0.493 ' HG2' ' O ' ' B' ' 115' ' ' PRO . 41.3 Cg_endo -64.97 121.36 8.83 Favored 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 122.041 1.827 . . . . 1.57 109.676 176.13 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 74.52 7.49 79.11 Favored Glycine 0 C--N 1.281 -2.487 0 CA-C-N 115.497 -0.774 . . . . 1.7 113.176 179.61 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 117' ' ' GLY . . . . . 0.473 ' HA2' ' O ' ' B' ' 113' ' ' CYS . . . 74.85 33.45 55.29 Favored Glycine 0 N--CA 1.408 -3.192 0 C-N-CA 119.628 -1.272 . . . . 1.38 114.636 177.311 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 118' ' ' LYS . . . . . 0.411 ' CG ' ' O ' ' B' ' 115' ' ' PRO . 0.0 OUTLIER -91.91 14.34 15.94 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 122.212 0.205 . . . . 2.54 110.722 178.698 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 119' ' ' GLY . . . . . 0.472 ' HA3' ' SG ' ' B' ' 113' ' ' CYS . . . -115.42 -153.8 10.4 Favored Glycine 0 C--N 1.34 0.774 0 N-CA-C 108.198 -1.961 . . . . 1.04 108.198 179.193 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.828 ' HA ' ' O ' ' B' ' 111' ' ' LEU . 2.7 ttp180 -143.08 156.75 44.88 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 123.206 3.503 . . . . 2.89 103.11 172.858 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 121' ' ' CYS . . . . . 0.865 ' HB2' ' HB3' ' B' ' 111' ' ' LEU . 15.8 m -108.74 150.15 28.01 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 120.19 1.359 . . . . 1.07 111.862 -178.036 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -128.57 -52.57 1.26 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.78 -0.645 . . . . 1.53 111.169 179.89 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 123' ' ' GLY . . . . . 0.424 ' O ' ' HB3' ' B' ' 144' ' ' CYS . . . -119.83 -171.23 14.64 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.934 -0.651 . . . . 0.9 112.353 -179.889 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . 0.404 ' HG2' ' OE1' ' A' ' 81' ' ' GLU . 14.2 Cg_exo -68.81 -61.25 0.07 OUTLIER 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.674 2.249 . . . . 1.51 112.809 -179.697 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 125' ' ' SER . . . . . 0.607 ' O ' ' N ' ' B' ' 137' ' ' GLY . 0.4 OUTLIER -98.05 26.81 4.96 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.785 -0.189 . . . . 1.25 110.832 179.87 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 126' ' ' ILE . . . . . 1.081 HG12 HG13 ' B' ' 136' ' ' VAL . 4.1 mt -140.93 120.62 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 113.556 0.947 . . . . 0.85 113.556 -178.209 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 127' ' ' CYS . . . . . 0.778 ' O ' ' HA ' ' B' ' 134' ' ' CYS . 0.0 OUTLIER -121.02 140.17 52.29 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 107.55 -1.278 . . . . 0.89 107.55 177.854 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 128' ' ' CYS . . . . . 1.047 ' HA ' ' O ' ' B' ' 133' ' ' GLY . 0.0 OUTLIER -143.14 106.69 4.61 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 115.671 1.73 . . . . 1.23 115.671 -175.563 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 129' ' ' GLY . . . . . . . . . . . . . . . -109.47 -168.13 20.27 Favored Glycine 0 N--CA 1.422 -2.272 0 CA-C-N 123.698 2.954 . . . . 0.66 106.751 173.983 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -62.61 -70.95 0.17 Allowed 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 117.234 0.517 . . . . 2.35 110.572 -178.952 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.28 32.54 4.73 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 122.688 1.232 . . . . 1.69 110.135 -176.323 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 132' ' ' LEU . . . . . 0.749 HD22 ' CE2' ' B' ' 135' ' ' PHE . 4.0 mt -126.48 -4.74 6.58 Favored 'General case' 0 N--CA 1.385 -3.69 0 N-CA-C 103.845 -2.65 . . . . 1.38 103.845 175.568 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 133' ' ' GLY . . . . . 1.047 ' O ' ' HA ' ' B' ' 128' ' ' CYS . . . 43.95 -123.62 4.79 Favored Glycine 0 N--CA 1.406 -3.366 0 CA-C-N 114.226 -1.352 . . . . 0.72 114.907 174.793 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 134' ' ' CYS . . . . . 1.018 ' HB2' HD13 ' B' ' 172' ' ' ILE . 0.0 OUTLIER -136.66 105.01 5.72 Favored 'General case' 0 CA--C 1.494 -1.189 0 N-CA-C 114.322 1.23 . . . . 1.08 114.322 179.872 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 135' ' ' PHE . . . . . 0.922 ' HD1' ' HD1' ' A' ' 35' ' ' PHE . 82.1 m-85 -80.22 105.39 11.45 Favored 'General case' 0 N--CA 1.42 -1.928 0 N-CA-C 102.399 -3.185 . . . . 1.36 102.399 176.035 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 136' ' ' VAL . . . . . 1.081 HG13 HG12 ' B' ' 126' ' ' ILE . 5.9 t -97.9 84.64 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.671 0 CA-C-O 123.148 1.451 . . . . 0.75 109.24 -177.129 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 137' ' ' GLY . . . . . 0.607 ' N ' ' O ' ' B' ' 125' ' ' SER . . . 97.91 88.65 1.9 Allowed Glycine 0 CA--C 1.527 0.812 0 CA-C-N 112.254 -2.248 . . . . 0.83 115.475 178.442 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 138' ' ' THR . . . . . 0.713 HG21 ' CE1' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -172.14 175.65 3.67 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 108.796 -0.816 . . . . 0.78 108.796 178.045 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 139' ' ' ALA . . . . . 0.836 ' HA ' HD12 ' B' ' 142' ' ' LEU . . . -55.82 -40.41 72.73 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 118.818 0.736 . . . . 1.04 112.562 -178.262 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 140' ' ' GLU . . . . . 0.603 ' OE1' HG23 ' B' ' 138' ' ' THR . 0.0 OUTLIER -57.6 -13.94 4.6 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.089 -0.644 . . . . 2.31 110.862 -178.032 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 141' ' ' ALA . . . . . 0.668 ' O ' ' N ' ' B' ' 144' ' ' CYS . . . -87.12 -30.44 21.09 Favored 'General case' 0 C--O 1.213 -0.866 0 CA-C-N 116.223 -0.444 . . . . 0.87 110.122 179.754 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 142' ' ' LEU . . . . . 0.836 HD12 ' HA ' ' B' ' 139' ' ' ALA . 0.4 OUTLIER -40.86 -41.36 1.57 Allowed 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.462 0.542 . . . . 1.24 112.462 -178.604 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 143' ' ' ARG . . . . . 0.467 ' HA ' ' HD3' ' B' ' 143' ' ' ARG . 8.9 tpp85 -58.17 -23.46 55.44 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 108.37 -0.974 . . . . 2.93 108.37 177.619 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 144' ' ' CYS . . . . . 0.668 ' N ' ' O ' ' B' ' 141' ' ' ALA . 90.9 m -66.61 -5.76 12.76 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 113.889 -1.505 . . . . 1.61 110.596 -177.553 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -78.03 -6.28 54.05 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.847 0.356 . . . . 3.35 111.701 178.906 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 146' ' ' GLU . . . . . 0.596 ' HG3' ' HE1' ' B' ' 149' ' ' TYR . 0.4 OUTLIER -86.33 3.51 43.14 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.355 -0.538 . . . . 3.76 111.01 -178.981 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . 0.608 ' HG2' ' O ' ' B' ' 144' ' ' CYS . 12.6 pt-20 -83.51 1.59 41.1 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.656 -0.498 . . . . 4.01 109.656 177.281 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 148' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -71.53 -28.95 64.23 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 109.47 -0.567 . . . . 3.92 109.47 178.11 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 149' ' ' TYR . . . . . 0.596 ' HE1' ' HG3' ' B' ' 146' ' ' GLU . 6.0 p90 -117.32 25.21 10.61 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.35 -0.386 . . . . 5.73 110.887 179.682 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 150' ' ' LEU . . . . . 0.85 HD22 HD11 ' B' ' 111' ' ' LEU . 5.0 tt -127.49 142.5 44.25 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.91 -0.587 . . . . 5.46 111.502 -179.125 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 151' ' ' PRO . . . . . 0.637 ' HD2' ' HG ' ' B' ' 150' ' ' LEU . 85.1 Cg_endo -84.72 50.73 3.01 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.76 2.307 . . . . 5.02 113.053 -179.634 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 152' ' ' SER . . . . . 0.561 ' HB2' ' O ' ' B' ' 151' ' ' PRO . 3.9 m 75.53 151.38 0.14 Allowed Pre-proline 0 N--CA 1.467 0.387 0 CA-C-O 121.017 0.437 . . . . 5.73 111.639 179.739 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 153' ' ' PRO . . . . . 0.623 ' HA ' ' O ' ' B' ' 109' ' ' THR . 43.8 Cg_endo -66.5 165.75 24.08 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.138 2.559 . . . . 5.1 113.29 -179.306 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 154' ' ' CYS . . . . . . . . . . . . . 21.5 p -61.88 115.98 4.48 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.57 -0.741 . . . . 2.68 111.747 -179.679 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 155' ' ' GLN . . . . . 0.681 ' HB3' ' HA ' ' B' ' 103' ' ' LEU . 12.5 pt20 43.74 -171.29 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 114.736 -1.12 . . . . 5.63 112.672 179.891 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -157.19 -162.44 1.21 Allowed 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 120.901 -0.319 . . . . 3.11 111.028 -179.876 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 157' ' ' GLY . . . . . 0.551 ' O ' ' HB2' ' B' ' 166' ' ' ARG . . . -109.09 146.02 16.64 Favored Glycine 0 CA--C 1.493 -1.342 0 N-CA-C 108.821 -1.712 . . . . 2.07 108.821 175.555 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 11.6 mt-30 -103.3 63.7 0.81 Allowed 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 117.354 -1.739 . . . . 4.34 111.363 -179.165 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 159' ' ' LYS . . . . . 0.876 ' HB3' ' HB2' ' B' ' 167' ' ' CYS . 11.2 tppt? -117.46 52.06 1.21 Allowed Pre-proline 0 C--N 1.314 -0.954 0 CA-C-O 116.694 -1.622 . . . . 3.54 110.294 172.118 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 160' ' ' PRO . . . . . 0.435 ' HA ' ' HA ' ' B' ' 166' ' ' ARG . 43.6 Cg_endo -68.38 86.16 0.43 Allowed 'Trans proline' 0 C--N 1.334 -0.231 0 CA-C-N 122.502 1.929 . . . . 1.51 115.03 -173.305 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 161' ' ' CYS . . . . . 0.448 ' N ' ' O ' ' B' ' 165' ' ' GLY . 0.7 OUTLIER -96.94 -166.57 1.42 Allowed 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 113.117 -1.856 . . . . 1.58 109.302 177.944 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 49.9 -164.67 0.56 Allowed Glycine 0 CA--C 1.524 0.613 0 C-N-CA 118.813 -1.66 . . . . 2.37 113.375 172.127 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -78.13 51.44 0.99 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.233 0.54 . . . . 4.07 111.907 -178.739 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 104.95 7.55 38.24 Favored Glycine 0 CA--C 1.533 1.211 0 N-CA-C 114.965 0.746 . . . . 2.2 114.965 178.281 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 165' ' ' GLY . . . . . 0.598 ' HA2' ' HA ' ' B' ' 175' ' ' SER . . . -101.07 136.25 12.6 Favored Glycine 0 C--O 1.224 -0.494 0 C-N-CA 119.044 -1.55 . . . . 1.62 115.885 -176.854 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 166' ' ' ARG . . . . . 0.551 ' HB2' ' O ' ' B' ' 157' ' ' GLY . 0.0 OUTLIER -102.23 154.17 19.28 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 114.469 -0.865 . . . . 3.05 110.6 178.935 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 167' ' ' CYS . . . . . 0.876 ' HB2' ' HB3' ' B' ' 159' ' ' LYS . 5.4 t -56.52 109.24 0.58 Allowed 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 109.721 -0.474 . . . . 1.56 109.721 -179.017 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 168' ' ' ALA . . . . . 0.579 ' HB3' ' SG ' ' B' ' 128' ' ' CYS . . . -92.31 -17.31 24.89 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 107.879 -1.156 . . . . 1.04 107.879 178.878 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 169' ' ' ALA . . . . . 1.021 ' HB3' HD11 ' B' ' 172' ' ' ILE . . . -165.83 155.89 12.66 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 113.063 -1.881 . . . . 0.98 109.13 179.856 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 170' ' ' ALA . . . . . 0.785 ' O ' ' O ' ' B' ' 169' ' ' ALA . . . -19.17 -134.94 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 114.418 1.266 . . . . 1.25 114.418 -179.623 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 171' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' B' ' 185' ' ' CYS . . . -46.69 19.77 0.0 OUTLIER Glycine 0 CA--C 1.536 1.383 0 N-CA-C 116.359 1.304 . . . . 1.29 116.359 -178.217 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 172' ' ' ILE . . . . . 1.021 HD11 ' HB3' ' B' ' 169' ' ' ALA . 1.8 pp -138.28 99.85 1.56 Allowed 'Isoleucine or valine' 0 C--O 1.251 1.164 0 CA-C-O 123.478 1.609 . . . . 2.27 111.198 -178.818 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 173' ' ' CYS . . . . . 0.593 ' HA ' ' HA ' ' B' ' 167' ' ' CYS . 1.1 t -92.92 95.54 9.56 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 113.523 -1.671 . . . . 1.94 109.022 -179.055 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 174' ' ' CYS . . . . . 0.848 ' HA ' ' HA ' ' B' ' 179' ' ' CYS . 16.3 m -92.82 162.6 14.04 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 114.52 1.304 . . . . 1.35 114.52 -176.25 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 175' ' ' SER . . . . . 0.789 ' HB2' ' HD2' ' B' ' 176' ' ' PRO . 55.6 p -125.27 179.42 1.14 Allowed Pre-proline 0 CA--C 1.532 0.262 0 CA-C-N 113.454 -1.703 . . . . 2.0 108.033 178.842 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 176' ' ' PRO . . . . . 0.789 ' HD2' ' HB2' ' B' ' 175' ' ' SER . 72.0 Cg_endo -77.27 30.14 0.42 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 121.283 1.322 . . . . 1.9 111.9 179.829 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 177' ' ' ASP . . . . . 0.416 ' H ' ' C ' ' B' ' 175' ' ' SER . 1.6 t70 -145.94 -41.79 0.21 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.644 -0.707 . . . . 2.72 110.921 179.939 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 178' ' ' GLY . . . . . 1.214 ' HA3' ' O ' ' A' ' 79' ' ' CYS . . . -150.97 -141.56 3.37 Favored Glycine 0 C--N 1.336 0.533 0 C-N-CA 120.588 -0.815 . . . . 0.99 113.727 -179.89 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 179' ' ' CYS . . . . . 1.247 ' O ' ' HA3' ' A' ' 78' ' ' GLY . 60.3 m -148.38 146.05 28.32 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 123.154 0.582 . . . . 1.34 110.53 -179.653 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 180' ' ' HIS . . . . . 0.455 ' N ' ' O ' ' B' ' 173' ' ' CYS . 14.6 m80 -132.97 134.14 44.1 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 119.797 -0.761 . . . . 2.1 111.508 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 181' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -59.67 135.93 57.83 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.712 -0.847 . . . . 3.06 108.712 178.506 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 182' ' ' ASP . . . . . 0.592 ' HB3' ' HB3' ' B' ' 173' ' ' CYS . 0.7 OUTLIER -143.0 128.94 10.32 Favored Pre-proline 0 C--N 1.319 -0.719 0 CA-C-N 116.443 -0.344 . . . . 2.06 111.069 -178.632 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 183' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -69.19 -31.34 23.29 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 123.188 2.592 . . . . 1.91 113.041 -179.106 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -64.41 -3.28 2.82 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.109 -0.496 . . . . 1.56 111.963 -179.729 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 185' ' ' CYS . . . . . 0.661 ' HB3' ' C ' ' B' ' 170' ' ' ALA . 70.6 m -133.25 20.26 4.02 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 112.227 0.454 . . . . 1.94 112.227 -179.855 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 186' ' ' ASP . . . . . 0.79 ' N ' ' HD3' ' B' ' 187' ' ' PRO . 17.3 m-20 -107.65 20.65 0.06 OUTLIER Pre-proline 0 N--CA 1.448 -0.573 0 N-CA-C 113.858 1.058 . . . . 3.61 113.858 179.761 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 187' ' ' PRO . . . . . 0.79 ' HD3' ' N ' ' B' ' 186' ' ' ASP . 1.9 Cg_endo -77.79 66.15 8.14 Favored 'Trans proline' 0 CA--C 1.485 -1.974 0 N-CA-C 106.424 -2.183 . . . . 2.58 106.424 176.371 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 188' ' ' GLU . . . . . 0.531 ' HB3' ' O ' ' B' ' 187' ' ' PRO . 4.5 pt-20 176.55 -34.01 0.01 OUTLIER 'General case' 0 CA--C 1.475 -1.911 0 CA-C-O 123.838 1.78 . . . . 4.7 108.213 -179.261 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 189' ' ' ALA . . . . . 0.481 ' N ' ' HG3' ' B' ' 188' ' ' GLU . . . -77.13 34.09 0.15 Allowed 'General case' 0 C--N 1.366 1.284 0 CA-C-N 110.504 -3.044 . . . . 5.24 110.407 176.111 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 190' ' ' ALA . . . . . 0.464 ' H ' ' C ' ' B' ' 188' ' ' GLU . . . -76.5 145.31 39.23 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 112.999 -1.909 . . . . 6.93 111.37 -176.256 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 191' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -62.62 128.18 34.75 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.45 0.643 . . . . 10.14 112.356 -174.189 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 6.0 t . . . . . 0 C--O 1.25 1.096 0 CA-C-N 114.989 -1.005 . . . . 11.7 110.573 179.833 . . . . . . . . 0 0 . 1 stop_ save_